Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 32.5;liver: 99.7"	"Group enriched"	"Detected in some"	23	"CACO-2: 13.5;Hep G2: 35.0"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.1	0.1	0.1	1.7	0.1	0.0	0.1	0.1	0.1	0.1	14.4	0.0	0.0	8.7	0.1	0.6	0.1	0.1	3.0	0.1	0.1	0.1	9.5	99.7	0.1	0.0	0.1	0.0	0.1	5.6	0.0	0.1	0.0	0.1	0.1	3.8	0.0	0.1	0.0	0.1	0.1	32.5	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	1.6	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
AAGAB	"FLJ11506, p34"	ENSG00000103591	"Alpha and gamma adaptin binding protein"	Q6PD74	15	67201033-67255195	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039371, HPA040174"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA039371: AB_10805476, HPA040174: AB_10805605"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (1.36e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavourable (9.48e-4)"	"unprognostic (1.53e-1)"	19.3	23.6	17.0	15.6	22.5	15.6	20.3	13.3	29.8	16.7	23.6	14.7	24.1	13.3	18.1	24.7	22.3	14.6	16.1	14.8	15.9	22.5	29.5	22.2	15.2	15.4	17.7	20.2	14.4	18.0	29.9	39.1	16.0	31.5	16.9	29.7	14.9	19.3	19.0	33.4	14.3	21.9	18.4	13.8	18.2	20.1	23.8	13.4	25.9	28.8	18.1	21.4	19.8	14.1	16.1	23.9	28.4	24.7	27.7	26.8	20.1	18.0	32.7	23.6	24.2	23.5	19.1	11.8	19.0	28.1	23.0	26.6	24.2	19.6	17.4	19.5	19.9	36.5	49.1	22.2	24.2	24.2	23.2	16.5	24.6	9.9	25.4	28.0	19.4	18.6	30.6	17.1	36.8	18.2	34.1	24.7	22.4	22.0	17.0	12.0	20.2	11.9	19.1	30.3	21.0	21.2	42.6	33.8	21.6	22.8	16.5	26.9	26.9	21.5	18.9	21.1	25.4	18.7	26.4	12.8	43.1	26.1	19.9	26.2	20.9	28.4	18.9	18.5	23.5	24.6	26.8	16.1	20.8	22.1	23.9	12.5	17.7	19.4	10.1	27.7	24.7	17.7	25.1	20.1	17.0	22.5	13.3	29.8	15.9	22.5	17.7	20.2	31.5	13.4
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 109.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	5.1	5.9	11.0	5.7	11.9	7.8	6.9	25.2	26.5	4.8	4.2	3.9	6.3	3.8	4.7	7.1	3.8	4.9	4.3	7.9	14.4	12.8	7.2	3.1	7.5	6.8	9.4	11.6	3.3	6.7	109.7	10.3	6.9	10.2	5.0	4.6	4.7	3.6	12.3	6.8	3.7	3.7	5.4	9.3	5.5	5.4	4.1	6.9	4.7	16.0	2.1	5.3	4.9	5.8	1.0	0.8	4.1	3.9	2.8	5.6	1.3	16.5	9.9	9.1	8.8	8.7	9.7	29.3	13.5	10.7	8.2	7.2	10.0	6.6	0.5	3.3	17.5	7.7	7.0	7.0	16.7	12.3	2.9	9.0	6.0	6.8	7.9	6.3	21.4	8.3	6.2	15.4	19.9	17.3	1.9	9.3	14.2	2.8	5.8	3.3	4.4	5.5	3.9	9.9	1.4	6.4	34.7	3.0	4.8	7.8	6.0	7.0	3.5	8.9	17.2	18.3	12.3	13.1	13.2	9.2	2.4	1.0	15.3	10.7	12.5	2.5	1.4	0.6	4.5	0.6	4.2	0.4	4.0	3.0	0.8	1.0	5.6	4.5	4.1	2.8	3.9	0.7	3.1	1.3	11.0	11.9	25.2	26.5	14.4	12.8	9.4	11.6	10.2	6.9
AAMP		ENSG00000127837	"Angio associated migratory cell protein"	Q13685	2	218264123-218270257	"Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017717, HPA031868"	Approved		Supported	Microtubules,Cytosol				Microtubules	Cytosol	"CAB017717: , HPA031868: "	"unprognostic (1.57e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.39e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (4.94e-7)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.09e-2)"	36.3	40.4	41.2	35.5	49.1	15.9	36.7	40.8	48.5	36.5	48.5	30.8	48.3	38.7	38.2	34.1	50.0	40.1	50.2	39.7	37.3	35.7	38.2	49.8	28.8	29.0	39.0	51.4	53.1	59.2	44.0	37.9	40.4	40.8	39.3	37.2	28.7	43.9	41.4	47.8	42.6	39.0	42.8	32.8	32.2	51.4	50.9	36.5	27.8	46.6	33.6	32.1	39.9	34.6	30.2	50.9	15.7	53.2	27.2	31.6	41.8	32.1	27.1	19.2	26.4	29.9	20.8	36.9	22.4	35.7	43.4	32.3	57.9	25.3	16.0	33.1	28.6	24.4	39.0	34.1	34.4	26.3	49.4	36.7	27.8	65.6	41.5	34.3	24.3	26.2	39.9	45.4	39.8	25.2	49.5	21.2	28.5	47.4	30.0	58.2	32.0	19.0	22.4	25.5	28.7	26.7	41.3	25.1	23.8	15.0	33.7	32.8	26.7	26.8	21.7	32.1	21.2	20.8	26.9	27.5	49.3	27.3	30.3	22.4	20.8	15.7	44.2	14.9	28.8	53.2	29.3	27.3	25.4	26.1	50.9	30.2	31.6	28.8	7.0	27.2	50.2	29.7	27.2	41.8	41.2	49.1	40.8	48.5	37.3	35.7	39.0	51.4	40.8	36.5
AANAT	SNAT	ENSG00000129673	"Aralkylamine N-acetyltransferase"	Q16613	17	76453351-76470117	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Melatonin biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 27.7;testis: 8.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.5;SCLC-21H: 5.6;U-266/70: 4.5;U-266/84: 4.7;U-698: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA054321			Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA054321: "	"unprognostic (7.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.81e-7)"	"unprognostic (1.04e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.34e-2)"	0.3	0.2	1.2	3.8	0.8	2.7	0.3	1.3	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.4	1.8	0.3	1.2	1.5	0.3	0.3	0.3	3.3	1.7	0.7	0.4	0.3	0.0	0.9	0.3	1.9	0.3	0.0	27.7	0.3	0.3	1.8	3.3	0.7	0.3	1.2	2.2	0.2	8.2	0.3	0.3	0.8	0.3	0.3	0.9	0.3	1.3	1.3	2.2	0.1	1.8	0.2	0.0	0.9	4.5	0.7	0.5	0.0	0.1	0.5	0.0	0.4	0.3	0.1	0.1	3.2	3.7	0.5	0.0	1.1	0.0	0.0	0.3	0.0	1.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.9	0.4	0.5	0.1	0.1	1.2	0.4	0.2	0.2	1.9	0.0	0.1	5.6	0.4	0.1	0.2	1.5	2.8	0.7	0.0	0.0	1.8	0.2	0.1	4.5	4.7	6.6	1.2	0.4	0.8	2.0	0.1	2.2	0.2	0.0	0.0	0.6	0.1	0.0	0.0	1.3	0.0	0.2	0.6	1.8	0.0	1.3	0.1	0.0	1.2	0.8	1.3	0.9	1.2	1.5	1.7	0.7	1.9	0.3
AARS	"AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase"	P49588	16	70252295-70289543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034261, HPA040870, HPA044223"	Supported		Enhanced	Cytosol			700000	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	22.8	25.3	28.0	19.6	34.8	5.9	22.6	36.4	54.0	22.3	18.4	30.6	21.4	16.8	22.0	33.9	14.5	20.4	14.1	20.9	29.5	31.7	25.5	36.4	19.5	17.9	40.3	40.5	18.7	45.4	61.2	23.1	21.0	37.5	23.2	17.5	17.3	30.1	30.0	25.2	14.1	14.4	28.4	33.2	16.7	21.1	12.2	32.7	10.3	42.1	10.6	20.9	17.7	26.9	13.4	11.6	3.9	13.3	21.3	13.4	11.6	22.9	38.7	10.7	39.6	25.0	22.7	25.8	18.2	25.3	23.0	29.1	31.7	31.0	26.1	24.5	18.3	26.9	30.9	24.8	32.4	11.8	11.1	25.7	16.4	28.1	66.2	15.4	15.4	26.8	37.5	44.2	99.0	22.8	32.7	34.5	17.2	52.0	16.5	18.1	20.0	22.3	31.6	6.7	57.0	15.7	11.8	13.3	11.4	50.6	11.9	44.8	37.3	33.9	15.0	17.0	16.5	16.8	15.1	48.7	31.9	48.1	29.1	24.1	33.2	3.9	8.6	3.9	12.6	12.7	12.8	13.4	10.9	12.1	11.6	11.4	13.1	13.4	1.3	21.3	13.3	7.9	8.4	11.6	28.0	34.8	36.4	54.0	29.5	31.7	40.3	40.5	37.5	32.7
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44299654-44313326	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA035636: AB_10670837, HPA061396: "	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	8.6	10.7	15.9	16.2	11.8	11.4	9.9	23.5	19.8	11.4	14.5	11.4	13.0	15.3	14.1	10.4	17.2	13.4	15.9	10.4	13.2	8.9	10.3	12.6	10.9	13.4	12.4	14.3	17.1	13.8	16.2	14.2	10.1	11.1	13.2	9.8	11.2	14.4	14.6	10.2	16.8	18.3	12.1	8.8	14.1	12.3	12.9	14.1	14.7	12.3	10.4	13.4	10.2	13.9	7.1	3.2	3.7	3.4	3.7	5.5	2.8	10.4	7.9	10.3	19.0	6.1	5.7	13.7	8.7	4.5	9.2	8.9	8.5	5.7	11.5	13.9	3.7	7.9	11.4	12.4	3.6	8.1	18.3	13.4	7.7	10.0	4.0	12.4	11.9	4.8	7.9	7.4	7.9	7.8	15.8	11.3	4.9	11.7	10.4	10.7	7.7	7.7	12.4	6.3	7.9	4.8	9.5	24.6	8.9	7.5	8.4	11.6	7.8	16.2	6.6	10.0	10.0	6.1	10.8	6.7	6.2	11.9	5.6	11.0	17.1	3.7	2.4	0.0	3.4	3.3	5.5	3.6	4.8	4.4	2.6	7.1	4.7	4.3	0.7	3.7	3.4	3.2	3.0	2.8	15.9	11.8	23.5	19.8	13.2	8.9	12.4	14.3	11.1	14.1
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122075647-122144280	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.1;NTERA-2: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Enhanced	Vesicles,Mitochondria			17000	Mitochondria	Vesicles	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favourable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	13.9	9.5	7.4	4.8	11.8	1.6	11.2	2.7	9.8	16.0	8.1	12.5	8.2	2.2	16.8	11.6	6.4	14.9	6.7	12.6	8.8	3.7	14.4	35.8	9.1	3.3	15.2	5.0	36.7	10.7	14.9	10.4	7.1	9.9	9.2	3.8	9.2	5.4	10.4	11.3	4.4	5.5	9.3	12.1	5.2	9.0	5.1	13.2	0.8	7.8	8.3	3.1	11.0	9.0	1.0	0.4	3.5	0.1	0.3	1.2	0.1	0.1	0.0	16.2	26.1	13.5	8.7	6.3	4.4	4.7	4.6	6.7	7.4	0.2	0.0	0.3	3.1	2.8	18.6	8.4	6.3	0.0	6.8	5.6	3.6	4.8	11.1	0.0	1.8	7.6	0.2	5.5	5.8	11.0	1.5	10.3	3.1	0.0	0.5	0.0	25.5	1.0	8.4	8.6	0.3	2.1	1.8	1.6	0.5	1.4	0.0	2.7	0.4	0.0	5.0	9.0	2.7	4.1	4.2	2.2	1.6	0.0	3.3	0.5	3.4	3.5	0.1	0.0	0.7	0.0	0.1	0.5	0.8	0.0	0.4	1.0	1.2	0.5	0.0	0.3	0.0	0.0	0.7	0.1	7.4	11.8	2.7	7.3	8.8	3.7	15.2	5.0	9.9	13.2
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948875-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	8.2	6.8	5.7	11.4	9.8	14.4	7.1	7.5	6.9	7.5	8.8	9.2	7.5	6.2	9.7	6.3	7.6	8.2	7.5	9.8	5.9		7.6	8.7	6.8	11.0	10.1	4.5	11.1	8.8	8.5	5.2	11.1	8.3	7.1	8.6	4.6	6.7	9.2	13.0	8.3	8.5	8.5	7.9	11.2	7.0	8.7	10.2	18.5	9.5	7.2	13.1	10.4	13.5	19.4	18.8	32.1	27.3	20.5	27.2	19.0	20.4	33.1	7.2	14.4	9.7	11.3	13.3	13.2	9.7	15.0	13.3	22.7	14.3	37.0	16.8	11.4	18.1	27.2	15.2	20.3	18.8	20.3	17.2	13.1	15.9	11.9	27.7	14.6	9.9	27.3	19.4	17.3	10.8	23.8	11.2	12.9	15.0	30.3	20.9	9.1	12.7	19.7	21.7	19.9	12.5	18.1	15.7	6.8	19.4	8.0	17.7	13.9	14.3	12.1	11.6	19.7	24.5	41.3	12.6	17.9	27.9	14.5	20.7	20.5	14.2	20.2	32.1	23.9	27.3	23.5	18.0	21.5	25.0	18.8	19.4	19.6	19.6	26.1	20.5	25.9	17.4	27.2	19.0										
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 44.3;MCF7: 28.5;RH-30: 25.1;T-47d: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria			1500000	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.36e-5)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	11.8	6.7	1.9	0.6	0.5	1.4	0.8	0.7	0.2	4.4	0.3	1.4	0.5	0.8	3.0	0.7	2.8	0.9	0.8	0.6	1.9	0.0	44.3	3.1	0.4	3.0	2.5	1.2	1.2	0.5	0.2	0.3	1.0	0.2	28.5	0.7	0.2	1.0	0.1	3.4	25.1	0.6	0.4	7.0	1.9	5.7	0.6	0.4	0.0	15.6	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.0	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141888	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 20.2;ASC TERT1: 29.3;HSkMC: 12.8;HUVEC TERT2: 27.3"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA064878: , HPA067180: "	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favourable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	31.4	4.3	1.4	2.0	6.6	0.4	12.1	0.7	1.9	12.3	9.9	4.7	2.9	1.8	7.9	6.9	10.5	4.9	7.2	13.2	1.5	0.9	3.0	53.9	9.3	3.6	10.9	0.2	22.0	1.9	1.1	6.0	1.8	11.2	8.0	3.4	4.2	7.1	1.9	6.6	5.0	3.9	9.8	21.0	1.8	4.4	5.0	9.3	0.0	6.7	6.6	2.5	16.6	11.7	0.0	1.2	0.0	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	20.2	29.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	12.8	0.0	1.6	0.4	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.0	0.3	1.4	6.6	0.7	1.9	1.5	0.9	10.9	0.2	11.2	9.3
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1040101-1065572	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"		"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 26.2;HMC-1: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"				"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: "	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (7.26e-4)"	"prognostic favourable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	6.0	3.5	6.2	20.2	4.8	35.2	7.6	13.6	11.1	5.0	5.8	1.9	4.7	4.9	2.1	3.9	7.5	2.8	5.5	2.3	5.3	6.5	5.3	3.6	9.5	17.7	5.2	5.1	1.0	7.0	5.6	34.5	3.1	7.7	4.9	4.2	34.7	9.9	6.5	5.5	11.1	11.1	1.8	6.7	26.6	7.9	1.6	4.3	19.8	7.0	3.9	14.5	5.1	4.9	1.5	9.9	10.8	2.5	1.9	2.6	1.2	5.6	5.3	1.1	3.3	6.5	2.9	5.4	0.8	0.8	0.3	0.6	4.0	2.1	11.0	3.8	0.7	5.6	2.3	5.0	0.3	7.3	2.1	8.5	26.2	4.0	2.5	3.1	31.6	2.7	1.8	1.5	2.8	1.8	8.5	6.8	1.0	1.3	3.1	2.3	0.6	2.5	2.8	0.6	7.9	2.7	10.6	0.7	2.1	6.2	1.9	0.6	3.6	5.1	2.7	0.6	1.3	2.8	0.8	8.0	7.7	6.0	1.4	7.6	1.3	4.3	2.5	7.0	2.6	1.7	1.6	1.0	1.5	1.8	2.8	1.5	1.4	2.1	10.8	1.9	1.6	9.9	0.6	1.2	6.2	4.8	13.6	11.1	5.3	6.5	5.2	5.1	7.7	4.3
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209766-219219017	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"			22000	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: "	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavourable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavourable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.1	8.4	8.2	3.9	13.5	10.2	9.2	7.6	9.1	6.9	7.6	5.4	8.3	8.1	7.1	10.1	9.0	8.4	8.5	9.5	5.6	8.2	6.9	16.2	7.2	4.9	9.8	7.6	13.1	7.1	8.0	6.0	3.7	9.2	9.2	4.2	6.0	5.6	11.3	24.0	5.5	8.0	9.5	9.2	3.2	6.8	19.5	7.7	0.8	9.9	11.3	4.7	14.8	6.0	2.8	5.6	1.3	1.1	1.2	3.2	2.4	0.1	10.0	2.0	12.6	14.1	5.0	12.4	3.7	3.5	4.1	4.1	15.3	2.2	0.1	19.3	3.6	21.6	0.2	1.5	1.3	6.4	2.2	15.6	11.0	28.2	17.0	0.0	5.2	7.4	1.8	2.7	0.0	7.2	13.3	1.9	2.8	5.1	1.0	0.1	3.2	4.1	5.2	6.4	0.6	2.2	0.2	7.4	7.9	7.8	18.5	8.2	5.5	0.3	3.2	5.5	0.2	7.4	4.3	5.1	4.0	0.0	6.3	0.1	7.4	1.3	1.1	0.0	1.7	0.9	0.5	2.8	1.3	0.7	0.9	2.3	3.2	2.1	0.0	1.2	0.8	5.6	1.1	2.4	8.2	13.5	7.6	9.1	5.6	8.2	9.8	7.6	9.2	7.7
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051554-75156732	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Supported	Mitochondria				Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favourable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	15.1	18.0	12.3	14.7	14.3	13.0	14.6	26.0	16.2	11.6	15.2	12.0	13.7	19.0	14.7	13.6	14.7	11.7	10.0	21.4	11.7	7.1	15.6	22.4	12.2	15.9	13.0	8.5	16.4	12.4	14.7	22.6	11.5	14.0	10.6	15.4	9.5	12.9	15.5	34.6	15.3	15.9	14.9	12.2	13.9	14.8	5.4	16.2	19.7	12.4	19.3	16.0	13.9	13.3	19.4	19.3	7.0	18.7	12.2	21.5	12.4	11.4	11.2	11.5	14.5	7.6	18.9	5.5	8.1	9.1	7.4	12.7	13.9	17.0	18.0	15.6	6.6	12.0	22.2	10.3	12.6	19.3	18.4	12.1	22.5	10.3	6.3	19.6	10.5	13.4	9.8	10.0	13.1	16.0	13.1	23.3	8.0	6.9	14.8	14.4	19.5	15.7	15.0	22.1	21.0	9.6	11.4	13.8	9.1	19.1	17.5	10.9	7.8	13.8	8.3	7.6	14.8	15.8	7.8	7.6	19.3	16.3	7.4	23.6	8.0	5.9	18.7	7.0	11.5	17.7	12.3	18.1	12.8	12.4	19.3	19.4	21.5	16.0	2.2	12.2	13.4	11.9	17.4	12.4	12.3	14.3	26.0	16.2	11.7	7.1	13.0	8.5	14.0	16.2
ABCB8	"EST328128, M-ABC1, MABC1"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favourable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favourable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favourable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	12.6	22.8	14.4	13.8	22.0	12.2	8.5	24.9	24.8	16.3	12.3	22.2	10.4	19.3	16.5	14.9	17.6	12.9	11.5	13.0	14.5	12.8	14.5	33.5	11.7	13.3	19.1	17.9	13.3	12.6	15.4	20.1	23.6	15.9	12.3	9.5	12.5	11.1	12.8	11.2	13.7	14.7	12.7	13.3	11.5	13.1	13.6	19.5	14.0	18.4	11.7	10.6	9.6	10.4	4.4	10.4	10.3	6.7	4.0	7.5	3.6	12.4	19.6	5.0	15.9	8.0	4.7	10.1	6.6	6.8	10.5	11.1	7.8	20.8	6.5	8.8	6.9	13.2	7.3	13.6	4.7	8.1	8.0	5.2	7.8	9.3	5.2	4.0	12.9	8.0	10.3	12.4	5.2	10.4	27.1	9.0	7.8	27.8	15.1	7.5	3.4	22.3	7.2	3.2	23.2	7.0	5.3	4.9	9.8	7.0	20.0	6.3	7.9	5.2	6.4	9.8	2.6	7.0	9.8	9.1	4.5	4.7	13.8	9.6	9.9	10.3	4.5	3.4	7.5	6.7	5.2	4.4	5.3	6.1	6.3	3.5	4.9	6.9	1.1	4.0	4.7	10.4	5.6	3.6	14.4	22.0	24.9	24.8	14.5	12.8	19.1	17.9	15.9	19.5
ABCB9	EST122234	ENSG00000150967	"ATP binding cassette subfamily B member 9"	Q9NP78	12	122920951-122981649	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.2"	"Group enriched"	"Detected in many"	5	"B-cells: 6.2;granulocytes: 4.1;T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033052, HPA035113, HPA035114"	Approved		Supported	Vesicles				Vesicles		"CAB033052: AB_2273463, HPA035113: , HPA035114: AB_10601329"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (5.65e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.71e-2)"	3.6	4.2	9.5	3.0	13.1	5.3	3.8	19.7	17.0	2.9	4.0	5.8	2.3	5.0	4.2	9.7	4.7	4.7	4.6	4.6	9.0	11.5	3.3	2.7	3.4	3.1	10.8	10.9	4.7	4.3	6.6	9.9	3.5	9.8	3.5	4.1	3.0	7.7	5.6	3.4	6.0	6.1	3.9	7.5	4.0	4.0	21.3	6.4	2.5	3.6	2.0	3.7	2.9	2.7	6.2	0.4	4.1	0.7	0.5	1.9	1.8	3.7	6.9	3.8	3.7	1.6	3.2	1.8	2.4	3.5	4.2	2.7	2.9	4.2	4.2	2.8	2.4	3.5	2.8	5.8	1.6	0.8	5.6	18.0	5.6	4.6	1.9	0.8	7.3	4.5	2.3	6.1	1.9	4.6	3.6	3.1	2.3	8.2	1.3	1.7	1.2	6.8	5.0	1.1	3.9	2.0	2.4	4.1	1.3	1.2	8.8	8.5	10.1	1.2	2.0	3.0	10.3	9.3	6.8	10.0	5.6	1.1	5.3	2.0	16.3	4.1	0.7	0.7	0.8	0.4	1.9	6.2	0.8	0.7	0.4	1.2	1.5	1.4	1.7	0.5	0.3	0.3	0.5	1.8	9.5	13.1	19.7	17.0	9.0	11.5	10.8	10.9	9.8	6.4
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949577-16143074	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.5;eosinophil: 3.1;T-reg: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.5;T-cells: 2.1"	"Low region specificity"	"Detected in all"							HPA002380	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA002380: AB_1844432"	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavourable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	8.9	8.2	2.4	8.3	3.1	8.4	9.6	4.4	5.0	8.3	10.7	2.6	15.5	3.5	10.5	12.7	14.7	5.6	9.6	8.0	2.1	2.4	4.5	1.6	10.9	12.2	3.0	2.1	6.8	5.8	18.4	4.2	5.2	4.1	9.6	4.1	12.0	16.9	10.9	20.8	6.6	8.2	16.4	4.0	9.2	10.9	15.1	2.3	26.8	15.7	12.6	15.6	15.3	11.8	0.7	0.5	7.5	0.5	0.4	2.1	0.2	2.2	24.2	0.1	6.3	5.6	3.5	1.3	7.1	8.7	6.2	6.4	3.8	17.5	6.6	38.2	13.7	6.5	2.0	7.0	4.7	11.5	2.2	8.1	14.2	14.0	16.7	2.9	21.1	7.3	4.7	1.8	1.0	6.8	8.2	3.4	1.9	4.5	5.2	2.7	3.8	3.6	18.5	3.6	3.2	2.3	8.2	3.5	5.8	9.0	9.8	2.4	3.4	1.5	0.6	0.4	1.4	5.1	5.7	6.3	3.2	2.2	3.2	3.0	0.7	7.5	0.1	3.1	0.6	0.4	0.6	0.7	0.5	0.6	0.5	0.3	0.6	0.6	0.0	0.4	0.5	0.3	2.1	0.2	2.4	3.1	4.4	5.0	2.1	2.4	3.0	2.1	4.1	2.3
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692252	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 53.5;liver: 66.2"	"Cell line enhanced"	"Detected in many"		"A549: 33.9;CAPAN-2: 25.9;HeLa: 14.3;RPTEC TERT1: 14.8;RT4: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.2;non-classical monocyte: 7.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB037136: AB_477165, HPA048483: "	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavourable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.5	36.0	0.4	17.0	0.4	0.5	7.7	0.3	0.4	1.9	23.9	0.8	14.1	10.3	1.6	4.6	5.3	1.0	53.5	0.8	0.4	0.4	13.5	66.2	9.0	10.3	0.6	0.0	1.0	22.2	1.7	0.8	3.5	1.5	5.4	7.7	0.8	4.7	23.6	0.4	4.8	37.0	2.5	4.6	4.9	12.8	1.0	0.0	0.8	4.5	7.0	7.9	7.1	3.5	0.0	1.6	1.3	7.6	0.3	0.5	7.4	2.4	33.9	0.0	0.1	1.9	3.0	0.0	4.5	5.7	0.3	0.3	1.8	25.9	0.0	3.5	8.8	6.2	0.0	0.4	0.4	0.0	0.0	0.7	14.3	10.3	7.7	0.0	0.0	3.4	2.5	1.3	2.8	0.6	0.0	0.0	3.5	7.9	0.0	0.0	0.0	4.5	0.0	0.0	0.1	14.8	14.7	0.0	0.3	8.2	1.4	0.0	1.1	0.0	7.5	0.2	1.5	0.1	3.6	0.0	0.0	0.0	3.7	0.0	0.3	0.3	2.8	0.0	0.0	6.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	1.3	0.3	7.6	0.2	0.5	7.4	0.4	0.4	0.3	0.4	0.4	0.4	0.6	0.0	1.5	0.0
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16148928-16223522	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 37.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 16.7"					"Cell type enriched"	"Detected in some"	5	"classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038105			Supported	"Plasma membrane"				"Plasma membrane"		"HPA038105: "	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	2.3	1.4	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.1	1.5			7.0	0.0	0.0	0.0	0.3	1.2	0.8	0.1	0.1	9.0	27.4	2.8	0.0	0.2		0.1	6.7	0.5	0.1	0.0		0.7	1.2		6.7	0.2	1.7	0.0	3.7	0.0	0.2	0.1	2.2	0.0			2.2		0.0	0.0	0.0	0.2	0.9	1.3	7.3	0.6	0.1	1.2	0.0	0.9	0.4	0.0	0.0	0.5	1.1	0.0	0.2	0.5	0.9	3.7	1.4	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	0.1	37.7	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.6	0.0	0.4	0.1	4.8	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	7.3	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.9	0.2	0.1	0.1	1.3	0.6	0.1	0.1	0.0	1.2										
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418455-94518666	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes				Peroxisomes		"CAB032516: AB_2257637, CAB075749: , HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favourable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	8.9	14.2	13.1	9.5	13.3	10.3	16.8	11.2	12.8	11.8	21.2	14.9	24.9	21.4	9.8	14.6	15.4	10.0	17.3	16.0	12.7	10.3	29.3	60.6	11.2	9.9	13.2	10.4	8.1	16.7	18.3	14.6	11.2	14.3	11.0	20.1	21.4	13.2	24.0	12.9	17.1	21.7	10.8	16.5	7.6	20.8	10.2	12.7	46.5	13.7	10.8	9.9	11.8	11.1	3.1	8.4	3.9	6.2	8.0	7.4	4.2	27.7	13.0	13.5	12.8	10.4	11.5	20.0	14.5	11.3	16.7	18.6	40.6	8.8	17.2	18.8	18.3	20.4	15.5	18.8	23.5	13.8	13.4	19.5	19.3	35.2	10.1	17.3	6.0	9.6	10.6	19.4	7.5	10.2	8.7	10.4	17.2	3.9	29.0	9.1	15.5	18.6	16.4	28.1	6.6	16.5	42.5	10.2	16.8	25.1	26.7	18.9	9.8	14.4	10.1	12.5	18.0	21.8	19.2	5.9	5.4	16.8	9.7	8.9	5.8	0.3	5.3	3.9	6.5	6.2	6.1	2.8	5.9	7.4	8.4	3.1	7.1	6.9	1.3	8.0	5.2	2.2	6.5	4.2	13.1	13.3	11.2	12.8	12.7	10.3	13.2	10.4	14.3	12.7
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145097932-145129179	"Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol				Cytosol		"CAB012476: , HPA036846: "	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favourable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	27.5	19.4	17.5	23.3	23.7	17.5	25.3	21.0	23.2	20.8	16.5	17.7	14.7	14.4	19.5	15.8	28.5	19.4	16.4	19.5	19.5	18.0	23.1	40.1	17.3	27.3	22.1	15.5	28.2	34.2	23.0	31.7	21.2	26.0	18.4	21.1	11.0	19.0	15.1	33.1	19.9	14.1	20.7	22.1	29.0	16.7	21.2	20.7	36.5	20.1	29.7	29.5	26.0	19.0	9.9	13.2	1.0	8.8	10.4	18.2	9.9	26.4	13.9	21.5	14.8	18.7	27.1	21.1	29.0	21.0	35.4	25.0	20.9	25.2	43.5	9.4	25.8	17.8	32.0	37.8	48.0	24.2	18.8	24.5	10.4	18.5	24.7	56.4	19.8	20.0	26.5	37.4	52.9	37.9	49.2	32.6	37.7	15.9	54.0	18.9	17.7	32.2	28.8	25.9	31.1	26.6	17.7	26.9	13.2	17.7	30.1	20.8	17.9	22.1	25.0	35.1	21.6	24.4	35.0	29.2	46.6	46.5	21.5	49.3	38.8	1.0	6.7	0.7	9.2	8.8	18.2	9.9	11.1	11.1	13.2	9.2	15.6	12.9	0.6	10.4	8.1	7.4	12.4	9.9	17.5	23.7	21.0	23.2	19.5	18.0	22.1	15.5	26.0	20.7
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571376-30597179	"Plasma proteins, Predicted intracellular proteins"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol				Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	16.1	12.5	12.1	11.8	13.9	31.9	12.4	12.1	15.7	11.4	13.7	9.8	9.5	7.1	17.0	9.6	14.6	10.9	10.6	13.1	12.0	7.3	15.5	18.3	13.5	9.4	10.6	10.5	12.5	14.0	23.1	16.6	21.6	13.7	12.4	13.6	9.2	14.1	15.3	70.6	21.3	17.6	15.2	12.7	13.9	19.6	22.0	13.2	14.7	13.8	14.9	13.0	14.2	13.5	10.1	9.3	4.1	7.9	11.9	14.3	6.5	12.0	5.4	7.1	9.6	7.9	5.2	3.2	10.2	5.3	7.1	9.8	17.9	3.0	10.1	11.2	6.4	8.7	10.4	5.9	13.7	7.2	9.0	12.3	7.5	5.6	2.5	12.5	4.0	4.6	6.2	11.0	2.8	2.2	22.5	3.7	7.8	2.6	6.5	2.8	4.9	3.3	20.6	7.0	10.6	5.4	11.0	6.5	13.3	5.6	15.5	3.0	3.9	3.4	7.1	13.8	4.2	3.2	5.5	13.5	21.8	17.6	1.5	14.6	10.0	4.1	7.9	3.4	14.3	6.7	12.2	10.1	10.4	12.8	7.1	9.1	9.5	9.7	3.7	11.9	7.3	9.3	5.9	6.5	12.1	13.9	12.1	15.7	12.0	7.3	10.6	10.5	13.7	13.2
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000033050	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151212490-151227230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA020091, CAB020682, HPA021815, HPA030388"	Approved		Enhanced	Cytosol				Cytosol		"CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"	"unprognostic (6.80e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (9.52e-6)"	"unprognostic (1.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.84e-3)"	18.3	15.4	14.9	15.9	18.8	9.7	12.6	19.0	29.6	10.9	14.2	16.3	12.9	9.5	14.9	17.7	16.1	13.7	13.6	22.2	14.5	17.4	14.2	10.6	12.4	16.1	16.4	23.3	13.6	17.7	25.1	14.9	15.2	17.1	13.9	17.7	13.7	12.5	16.8	46.6	17.4	10.7	21.7	12.7	15.5	13.9	20.7	16.7	15.8	14.8	16.5	22.4	14.5	11.2	13.0	14.2	6.8	15.0	15.7	22.4	14.5	17.8	29.0	10.1	36.1	20.7	17.4	13.8	21.6	18.6	28.2	24.0	24.6	12.5	29.3	18.8	24.2	14.1	31.8	26.5	27.5	14.6	26.5	12.2	14.4	14.9	24.4	28.8	19.5	22.9	22.5	31.4	18.5	23.7	34.9	12.3	25.1	45.2	32.0	34.3	24.5	31.5	20.6	16.3	27.0	19.4	13.0	17.7	17.1	20.6	21.7	14.5	9.3	14.9	21.2	18.0	7.3	21.5	32.7	23.9	25.5	21.6	24.9	28.9	34.1	6.8	12.1	4.0	15.9	14.3	22.4	12.7	16.2	15.9	14.2	13.0	15.3	15.8	1.7	15.7	15.0	10.2	16.9	14.5	14.9	18.8	19.0	29.6	14.5	17.4	16.4	23.3	17.1	16.7
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.0;MCF7: 18.7;MOLT-4: 17.3;RPMI-8226: 14.2;SCLC-21H: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 19.2;neutrophil: 20.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favourable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	19.9	36.4	14.2	10.0	17.6	6.2	13.3	15.9	15.3	7.7	12.1	17.8	3.8	15.3	5.6	3.8	4.1	6.5	11.9	9.7	12.4	8.0	8.2	5.6	25.2	23.1	20.8	12.2	6.0	4.7	15.4	11.1	12.0	9.6	6.3	13.5	12.1	13.7	6.7	26.8	15.1	18.6	5.8	7.0	29.4	13.7	1.9	19.5	15.4	8.5	5.2	10.4	12.5	12.6	4.8	1.4	20.5	0.9	3.7	4.0	1.0	0.0	3.4	2.7	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.4	0.0	0.5	0.0	5.0	0.0	4.7	0.3	5.7	11.4	0.0	10.5	0.0	0.2	1.2	15.0	0.0	2.3	10.6	0.0	0.0	0.0	18.7	17.3	0.1	0.8	5.9	0.2	0.0	14.2	0.0	1.6	13.1	3.4	2.1	7.9	0.0	3.3	0.5	6.7	0.0	2.8	0.0	0.0	7.7	2.2	0.0	0.0	1.9	0.3	0.9	0.9	19.2	1.8	0.3	3.4	3.1	3.7	3.6	0.6	4.8	3.5	2.9	20.5	3.7	0.1	1.4	4.0	1.0	14.2	17.6	15.9	15.3	12.4	8.0	20.8	12.2	9.6	19.5
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell line enhanced"	"Detected in many"		"A549: 19.9;BEWO: 34.7;MCF7: 11.5;RPMI-8226: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"											"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.7	19.9	5.9	0.0	0.2	0.0	34.7	0.7	0.6	1.0	1.7	4.4	0.2	0.0	0.2	0.1	5.8	0.2	0.6	1.5	5.6	0.9	0.2	0.1	5.9	0.0	0.3	0.0	0.1	2.4	2.3	0.1	1.8	0.4	0.0	0.6	11.5	2.7	0.1	2.0	0.0	1.3	0.0	17.4	0.0	4.2	0.1	0.2	4.1	0.4	0.5	0.1	0.0	0.0	0.8	0.7	0.2	0.0	5.5	2.1	0.0	1.5	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5
ABHD11	"PP1226, WBSCR21"	ENSG00000106077	"Abhydrolase domain containing 11"	Q8NFV4	7	73736094-73738867	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.1;SK-BR-3: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024042, HPA049641"	Approved		Supported	Mitochondria			450000	Mitochondria		"HPA024042: AB_1844445, HPA049641: "	"unprognostic (4.74e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.66e-7)"	"unprognostic (3.61e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.29e-2)"	5.6	8.9	7.7	11.5	8.7	4.2	12.2	8.8	9.2	8.1	28.5	8.3	14.8	15.7	6.0	12.7	8.3	14.0	17.0	20.1	7.1	8.1	21.6	6.6	8.4	6.9	8.6	5.6	5.0	18.9	7.3	10.8	40.2	10.0	14.7	17.5	7.8	23.9	22.2	9.8	7.9	28.1	5.6	5.9	5.2	8.3	6.1	5.6	6.9	20.1	8.4	12.6	5.8	5.4	8.3	12.9	12.2	21.0	9.7	6.7	8.0	17.2	4.0	2.7	6.3	1.4	2.0	15.3	8.0	3.3	4.9	5.8	4.9	19.5	8.2	2.4	3.3	7.6	1.2	4.6	3.4	3.0	5.9	4.0	2.7	3.0	2.6	4.3	4.4	1.8	1.9	6.2	3.0	3.5	5.4	4.7	4.6	34.1	3.3	5.5	3.2	14.9	1.8	4.4	15.1	11.3	8.2	7.0	3.0	6.4	43.4	2.6	14.1	2.9	3.4	4.2	4.0	17.8	8.2	2.9	1.5	5.5	6.7	4.2	7.7	6.1	13.1	12.2	6.0	21.0	4.8	6.3	6.7	6.2	12.9	8.3	6.3	4.4	10.5	9.7	20.7	6.3	4.4	8.0	7.7	8.7	8.8	9.2	7.1	8.1	8.6	5.6	10.0	5.6
ABHD14A	"DKFZP564O243, DORZ1"	ENSG00000248487	"Abhydrolase domain containing 14A"	Q9BUJ0	3	51971426-51981199	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038153, HPA056913"	Approved		Enhanced	Vesicles			260000	Vesicles		"HPA038153: , HPA056913: "	"unprognostic (4.15e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.92e-2)"	"prognostic favourable (4.72e-4)"	"unprognostic (3.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.30e-2)"	11.8	28.0	23.3	6.0	25.8	9.0	9.2	39.6	45.0	18.3	7.3	12.2	8.5	8.0	6.9	23.2	5.4	19.6	9.3	16.4	22.3	27.8	26.2	13.0	9.7	8.9	16.6	23.4	14.8	20.6	15.6	21.3	7.0	18.7	11.6	5.6	26.1	17.7	12.5	23.8	3.9	6.6	8.8	14.5	7.7	11.0	6.2	7.0	6.6	24.1	8.4	8.8	9.2	7.4	15.4	13.9	4.5	6.0	12.0	30.9	15.3	2.8	5.4	3.4	10.4	34.7	17.5	1.9	3.7	6.2	4.5	6.1	6.1	11.3	3.1	2.6	9.2	2.4	3.8	4.1	1.4	10.2	4.2	9.2	15.9	20.2	9.7	12.6	12.4	16.5	2.9	3.8	1.9	5.8	3.7	10.7	7.0	3.2	5.8	12.9	1.9	12.8	4.2	1.8	29.8	8.6	4.4	7.1	11.1	9.4	2.0	5.5	2.9	13.9	3.4	4.1	4.5	9.9	4.3	15.7	14.6	2.6	7.7	20.2	5.9	2.1	6.0	4.5	30.2	3.5	30.9	15.4	26.7	26.8	10.4	12.4	24.6	26.2	0.6	12.0	2.2	13.9	25.7	15.3	23.3	25.8	39.6	45.0	22.3	27.8	16.6	23.4	18.7	7.0
ABI1	"ABI-1, E3B1, SSH3BP1"	ENSG00000136754	"Abl interactor 1"	Q8IZP0	10	26746593-26861087	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008375, HPA029973, HPA068407"	Approved		Enhanced	"Plasma membrane,Cell Junctions,Cytosol"			400000	"Plasma membrane, Cell Junctions"	Cytosol	"CAB008375: AB_592744, HPA029973: , HPA068407: "	"unprognostic (2.83e-3)"	"unprognostic (8.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	24.0	14.0	32.0	28.1	32.6	54.1	21.4	28.2	35.5	22.5	22.7	19.8	14.8	24.8	23.9	15.4	45.1	20.3	21.6	14.1	47.3	23.1	21.9	17.8	22.5	32.1	25.0	26.4	25.3	17.0	19.1	14.4	22.7	20.9	19.1	24.8	26.7	30.9	17.0	16.6	33.0	26.0	21.6	27.5	25.5	23.9	12.4	20.5	43.5	18.8	27.3	40.9	25.2	30.3	36.1	26.8	51.5	28.0	20.5	44.5	31.5	23.2	13.1	10.7	10.5	16.2	20.0	16.0	23.6	16.1	17.5	20.4	15.3	27.6	42.8	12.1	25.0	26.1	12.9	15.3	19.5	28.5	11.5	18.8	8.9	10.8	11.1	9.1	19.0	13.6	19.5	17.1	10.2	21.1	13.8	27.4	17.8	10.0	21.3	8.7	8.8	6.3	23.1	19.9	27.5	18.6	10.8	8.9	9.5	19.6	19.2	19.7	12.4	14.5	26.2	13.4	16.5	16.9	12.0	6.1	9.8	50.9	19.3	23.3	9.6	35.5	23.8	51.5	27.0	28.0	25.8	36.1	25.9	30.0	26.8	28.6	24.4	26.5	37.9	20.5	26.7	22.3	44.5	31.5	32.0	32.6	28.2	31.9	47.3	23.1	25.0	26.4	20.9	20.5
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713946-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	20.1	11.6	12.4	15.0	18.1	10.7	22.0	6.7	16.0	28.9	34.3	29.1	12.1	11.9	26.6	16.9	21.4	20.8	30.9	14.2	10.3	8.4	9.9	6.7	13.8	8.7	24.1	9.4	24.2	12.2	27.7	14.5	13.6	17.1	27.3	15.8	19.4	14.6	18.0	10.8	14.2	17.0	66.6	14.3	10.8	21.9	9.8	21.2	5.8	19.5	11.4	9.1	35.8	31.9	3.1	3.1	1.1	5.0	2.4	2.6	1.6	7.0	15.7	16.9	20.4	24.8	30.3	6.2	12.4	19.5	14.6	12.4	12.3	9.2	11.6	7.2	16.5	13.7	8.5	11.5	10.8	7.3	5.3	7.6	26.9	10.5	16.9	11.7	10.7	22.1	12.7	26.1	16.2	20.2	42.6	9.3	17.8	13.4	14.8	9.6	18.7	11.6	17.2	21.9	12.6	14.7	8.3	15.8	19.7	20.8	8.1	10.0	15.9	10.8	23.1	56.0	14.5	21.4	19.5	2.8	6.6	15.6	23.1	9.7	17.7	0.2	2.1	1.1	2.0	1.2	2.6	3.1	2.0	1.9	2.0	1.4	1.9	1.7	0.2	2.4	5.0	3.1	0.9	1.6	12.4	18.1	6.7	16.0	10.3	8.4	24.1	9.4	17.1	21.2
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099327-179229684	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 31.7;TIME: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB017106: , HPA001866: AB_1078082, HPA072754: "	"unprognostic (3.05e-1)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavourable (8.40e-4)"	14.3	5.2	8.6	7.4	13.7	3.7	8.3	14.9	10.6	9.2	6.6	5.8	4.5	4.0	5.4	4.7	3.9	4.3	18.8	6.8	9.7	3.9	4.9	4.3	11.5	3.7	6.5	6.1	5.6	8.4	9.2	8.4	6.1	8.1	5.1	5.2	5.8	4.5	4.4	5.2	6.6	3.7	6.9	6.2	3.9	4.7	9.2	8.6	3.6	5.8	3.1	3.6	6.7	11.2	2.8	2.0	3.8	1.2	1.8	2.2	0.6	10.0	5.5	3.7	2.5	3.2	7.3	2.3	11.1	9.1	13.7	9.9	4.0	3.1	5.8	8.2	7.9	5.0	5.2	3.7	19.4	3.6	4.8	2.8	5.0	2.0	5.8	3.1	0.9	6.7	4.9	19.4	31.7	15.1	6.6	1.7	17.7	2.6	2.4	1.6	3.6	1.8	3.7	6.2	2.8	4.6	1.6	2.3	5.1	9.2	2.9	22.8	2.6	2.6	29.5	14.2	10.6	6.8	17.8	3.1	3.8	6.0	6.7	1.7	13.7	3.8	1.2	0.4	2.2	0.4	1.0	1.8	1.4	1.4	0.9	2.8	1.9	2.0	2.6	1.8	0.5	2.0	0.8	0.6	8.6	13.7	14.9	10.6	9.7	3.9	6.5	6.1	8.1	8.6
ABLIM1	"abLIM, LIMAB1, limatin"	ENSG00000099204	"Actin binding LIM protein 1"	O14639	10	114431113-114685003	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 43.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 84.9"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 43.9"	"Group enriched"	"Detected in many"	11	"B-cells: 14.8;NK-cells: 17.1;T-cells: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038951, HPA038952"	Approved		Supported	Cytosol				Cytosol		"HPA038951: AB_10673017, HPA038952: AB_10670915"	"unprognostic (2.25e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.23e-1)"	"prognostic favourable (2.72e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.87e-2)"	66.7	23.6	11.2	16.8	14.1	3.0	21.2	84.9	14.1	18.7	14.7	6.8	10.7	9.6	16.9	9.8	73.5	13.7	14.1	55.9	10.0	9.2	14.1	7.3	15.7	13.8	10.1	5.6	64.4	7.4	12.8	22.7	8.3	12.8	14.0	15.3	26.6	53.8	18.6	18.6	25.3	16.0	15.4	9.9	8.4	31.3	17.2	3.1	38.3	75.8	44.3	70.4	20.3	28.0	14.8	0.1	2.3	0.0	17.1	43.9	12.7	11.7	8.6	31.3	7.1	0.3	0.1	0.3	2.4	0.8	0.6	1.4	11.8	19.0	15.6	33.7	2.8	25.8	10.3	16.7	0.7	5.3	9.1	0.1	25.1	32.4	0.1	6.1	0.1	0.4	43.2	4.1	13.7	12.4	0.0	24.2	0.1	4.4	1.2	2.7	12.0	10.0	0.5	6.6	20.2	10.0	26.7	10.9	13.5	10.1	15.5	5.6	7.9	0.0	8.4	0.0	11.3	0.2	4.6	0.1	0.0	36.2	0.5	13.6	0.2	2.3	0.0	0.2	8.8	0.0	17.0	12.4	16.5	9.9	0.1	14.8	43.9	27.8	0.7	17.1	0.0	0.1	8.9	12.7	11.2	14.1	84.9	11.1	10.0	9.2	10.1	5.6	12.8	3.1
ABRAXAS1	"ABRA1, ABRAXAS, CCDC98, FAM175A, FLJ13614"	ENSG00000163322	"Abraxas 1, BRCA1 A complex subunit"	Q6UWZ7	4	83459517-83523348	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 24.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037654	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA037654: "	"unprognostic (1.44e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.99e-2)"	"unprognostic (4.98e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.98e-2)"	"prognostic favourable (1.53e-4)"	"unprognostic (2.24e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.57e-2)"	13.2	5.7	2.4	6.4	3.7	8.6	7.4	2.0	2.7	15.4	9.7	3.8	3.7	4.4	16.9	7.1	9.3	7.3	7.0	6.4	2.4	2.6	7.8	3.4	7.4	10.0	4.0	2.0	23.2	7.2	3.3	4.6	4.4	5.4	13.2	3.3	4.2	5.3	7.9	25.0	7.1	6.3	13.6	6.4	9.6	5.3	13.3	3.7	25.7	13.1	7.2	5.1	13.3	8.4	7.0	3.5	6.5	5.0	8.5	10.6	3.8	3.7	2.5	4.9	6.1	4.3	18.2	2.6	3.1	3.6	1.5	2.0	5.1	6.4	14.8	2.5	3.1	2.0	2.4	2.0	2.5	6.1	1.7	8.7	2.9	6.1	3.5	10.1	8.2	7.9	1.7	1.9	1.7	6.0	24.0	9.4	3.3	2.4	11.1	3.9	7.9	3.6	6.1	5.4	3.8	2.9	3.2	4.7	3.9	3.9	1.7	6.6	4.7	4.2	8.3	5.3	5.6	5.3	4.0	8.3	5.5	11.1	4.7	8.9	3.7	6.5	5.0	4.2	4.5	4.2	5.5	4.0	7.0	5.0	3.5	7.0	10.6	8.4	6.4	8.5	4.1	2.8	5.7	3.8	2.4	3.7	2.0	2.1	2.4	2.6	4.0	2.0	5.4	3.7
ABRAXAS2	"ABRO1, Em:AC068896.4, FAM175B, KIAA0157"	ENSG00000165660	"Abraxas 2, BRISC complex subunit"	Q15018	10	124801785-124836670	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037591, HPA037592, HPA074089"	Approved		Supported	Cytosol				Cytosol		"HPA037591: AB_10671877, HPA037592: , HPA074089: "	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	18.4	17.3	16.1	13.1	16.5	14.3	17.0	16.3	20.5	15.6	14.8	10.6	8.1	13.7	16.0	13.3	17.9	13.9	11.2	13.2	15.1	14.5	18.6	19.9	12.5	15.4	13.1	14.4	15.1	11.8	17.5	13.9	17.7	15.9	13.5	14.5	8.5	14.9	13.5	32.2	19.1	20.8	14.4	16.1	20.3	13.2	11.1	12.1	23.9	20.5	16.0	17.4	16.2	16.2	12.2	13.9	18.5	15.2	7.8	12.2	7.7	14.0	9.6	10.4	14.2	13.5	13.4	9.0	14.6	23.0	17.4	16.2	7.7	13.6	15.8	12.4	15.7	15.9	16.3	13.7	18.5	13.7	11.3	12.0	8.0	9.6	17.3	20.5	12.6	14.7	16.7	17.1	31.1	13.1	12.5	10.9	14.1	9.2	15.7	18.4	8.9	9.0	12.7	11.0	9.6	12.8	7.2	7.2	13.2	11.6	11.2	15.7	9.2	14.2	11.3	9.4	7.5	10.9	17.3	11.4	10.6	15.3	12.3	10.2	6.6	18.5	11.4	10.4	8.9	15.2	12.2	12.1	10.3	12.1	13.9	12.2	11.2	12.1	4.6	7.8	12.0	9.4	11.9	7.7	16.1	16.5	16.3	20.5	15.1	14.5	13.1	14.4	15.9	12.1
ABTB1	"BPOZ, Btb3, BTBD21, EF1ABP"	ENSG00000114626	"Ankyrin repeat and BTB domain containing 1"	Q969K4	3	127672935-127680920	"Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 107.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035022, HPA035023"	Uncertain		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035022: AB_10669998, HPA035023: AB_10602104"	"unprognostic (6.76e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.55e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.92e-3)"	20.4	13.7	11.7	17.7	20.1	42.3	14.2	43.4	27.2	15.4	14.3	13.8	12.9	12.3	15.6	10.9	9.6	13.1	17.6	20.4	10.9	8.2	11.4	8.3	15.5	22.1	9.7	15.8	15.8	11.2	7.8	15.3	12.0	11.4	13.5	4.9	12.4	15.2	14.5	25.1	11.6	13.0	13.3	7.5	41.4	11.7	5.9	12.5	17.8	10.2	9.1	10.4	14.6	17.4	2.9	3.8	107.3	8.6	3.2	5.8	5.1	3.1	7.5	0.7	1.5	7.2	6.8	5.7	5.0	8.6	3.4	4.8	0.2	6.6	1.4	8.9	3.8	1.4	0.0	3.7	0.8	14.5	2.1	2.3	13.4	1.8	5.7	0.3	7.0	8.5	4.0	3.5	0.9	3.6	0.1	10.2	3.7	5.0	3.4	9.8	0.6	8.3	2.1	4.2	9.7	5.1	1.9	7.0	4.6	3.6	4.3	18.1	1.1	2.5	6.5	3.6	3.0	6.4	1.6	8.3	2.7	0.4	8.4	2.9	5.6	4.5	8.6	20.5	2.4	6.2	2.3	2.5	2.6	2.3	3.8	2.9	2.2	1.9	107.3	3.2	5.4	2.4	5.8	5.1	11.7	20.1	43.4	27.2	10.9	8.2	9.7	15.8	11.4	12.5
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150988-34358008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 31.6"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"eosinophil: 8.1;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA020065: AB_1844459, HPA030699: "	"unprognostic (3.00e-1)"	"prognostic unfavourable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favourable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	3.1	13.7	4.8	2.7	6.7	3.2	2.2	5.0	5.8	8.0	8.5	10.6	18.2	11.7	7.4	6.3	4.4	4.1	3.2	13.0	4.7	3.9	8.4	8.0	2.9	2.7	9.0	1.5	2.8	2.2	0.3	2.8	8.1	15.8	4.5	3.6	7.5	8.7	31.6	19.4	5.6	20.2	3.6	20.2	1.2	3.0	3.1	7.7	6.4	2.1	3.5	2.8	3.4	5.0	0.0	2.8	8.1	0.4	0.0	0.1	0.1	4.0	12.1	4.9	1.3	1.3	0.1	4.9	2.4	1.9	2.1	4.1	2.9	3.0	0.1	4.1	3.0	7.9	2.7	2.8	1.8	0.1	6.7	0.0	7.1	12.8	0.7	6.5	0.9	0.7	1.5	4.3	1.9	0.0	1.3	0.3	1.3	10.1	0.2	7.8	6.1	6.6	1.2	2.9	4.6	7.7	9.7	6.2	5.1	6.0	18.8	4.8	4.0	2.8	0.6	2.4	0.4	7.5	4.3	0.7	0.3	0.1	5.5	1.8	7.3	0.0	0.1	8.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.1	0.1	4.8	6.7	5.0	5.6	4.7	3.9	9.0	1.5	15.8	7.7
AC004556.1		ENSG00000276345			Unmapped	2585-11802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 13.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 25.2;K-562: 21.1;MOLT-4: 23.7;NB-4: 45.7;PC-3: 42.6;WM-115: 30.7"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA050406	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"				Mitochondria	"Nucleoli fibrillar center"	"HPA050406: "																		0.9	0.0		0.9		0.0	8.3		3.7	0.0	3.8			0.0	1.3	5.9	0.0	1.5	1.7	9.3			1.6	3.0	0.0	0.0			2.4	2.0	0.0		0.0		1.5	0.0		2.2	0.0	6.1	1.4	3.6	0.0		0.9	1.2	0.0			0.3		0.0	1.4		2.8	4.7	13.0	9.6	3.2	6.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	8.3	11.8	12.8	9.2	25.2	0.2	0.0	0.0	0.0	0.1	0.1	0.1	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	8.5	21.1	11.6	0.1	0.1	23.7	45.7	0.0	42.6	0.1	7.5	0.0	11.9	7.2	0.0	0.1	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	30.7	13.0	5.6	3.1	2.8	9.6	2.4	2.5	4.5	6.0	4.1	2.8	4.5	5.2	1.0	3.2	4.0	4.7	5.9	4.0										
AC008560.1		ENSG00000253251	"Uncharacterized protein FLJ26957 "	Q6ZNX1	5	65624765-65630891	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA066071: , HPA068764: "	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (1.17e-4)"	5.8	7.1	7.3	6.5	13.1	31.5	10.0	8.7	13.3	5.4	6.6	7.1	5.5	7.0	5.9	7.4	6.3	5.3	6.1	4.9	8.2	7.9	11.6	9.7	6.2	9.9	9.9	8.0	5.9	8.7	3.8	13.1	6.5	11.3	10.7	7.6	5.7	6.4	6.6	6.6	7.0	7.6	7.8	9.1	8.9	6.0	7.5	8.6	10.4	6.9	6.4	8.3	5.3	5.0	5.0	4.4	13.4	4.1	6.3	8.8	2.9	2.8	3.7	5.7	12.0	3.3	3.8	6.8	4.3	3.8	6.1	7.8	6.4	8.7	5.1	4.9	5.0	3.6	5.5	5.2	9.2	6.7	6.9	4.6	9.7	8.5	2.6	5.0	8.0	2.3	7.3	6.4	6.8	4.1	6.5	12.0	5.0	7.1	7.2	7.3	4.5	2.2	5.0	5.4	7.9	5.1	6.1	7.8	5.9	3.8	3.5	10.8	4.2	4.5	3.2	5.7	7.5	4.4	6.8	7.6	13.9	11.3	4.2	6.2	5.3	13.4	4.1	7.5	5.4	3.7	5.7	5.0	6.5	5.6	3.7	4.9	8.8	8.1	4.3	6.3	4.1	4.4	7.9	2.9	7.3	13.1	8.7	13.3	8.2	7.9	9.9	8.0	11.3	8.6
AC058822.1		ENSG00000282278			4	53377839-54295272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"brain: 19.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.3;fHDF/TERT166: 12.4;HDLM-2: 3.3;NTERA-2: 2.8;U-2197: 2.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058202			Supported	Nucleoplasm				Nucleoplasm		"HPA058202: "																		4.3	2.6	3.6	9.5	5.0	2.7	3.4	4.3	19.1	4.7	4.6	3.4	2.6	2.6	5.5	2.6	3.2	2.6	2.6	4.5	2.6		3.0	3.3	5.4	3.9	3.6	5.1	7.8	6.6	2.6	5.3	5.3	3.8	4.0	2.8	2.6	3.0	3.1	3.2	2.6	7.1	6.5	3.3	4.7	4.1	4.7	4.2	9.3	4.3	3.0	4.2	4.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	2.0	0.0	0.2	5.3	0.0	0.1	0.9	0.0	0.0	0.0	12.4	0.0	1.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	2.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1										
AC092143.1		ENSG00000198211			16	89919165-89936092	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"testis: 10.9"	"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 18.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB011512, HPA043640, HPA046280"	Uncertain		Supported	Microtubules				Microtubules		"CAB011512: AB_444319, HPA043640: , HPA046280: "					"unprognostic (2.90e-4)"				"unprognostic (6.87e-2)"									0.4	0.2	0.2	0.1	0.8	0.3	0.1	0.4	0.7	1.0	0.5	0.6	0.0	0.1	1.2	0.9	1.0	0.7	1.5	1.8	0.2	0.4	0.1	1.3	0.4	0.1	0.9	0.4	4.0	0.2	0.1	0.7	1.4	2.0	2.6	0.1	0.3	0.1	0.1	0.6	5.1	0.4	0.5	2.8	0.6	0.1	10.9	0.2	0.0	0.3	0.0	0.1	1.0	5.1	0.1	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.1	0.4	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.3	0.2	0.8	0.4	0.7	0.2	0.4	0.9	0.4	2.0	0.2
AC118549.1		ENSG00000036549	"ZZ-type zinc finger-containing protein 3 "	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA053663: , HPA054913: , HPA066197: "	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	17.8	17.4	20.8	14.1	23.6	11.6	21.6	20.4	20.3	18.1	16.2	16.1	18.3	12.1	18.3	14.3	14.5	15.3	12.1	13.7	16.9	11.7	18.8	20.0	12.3	15.8	24.1	17.8	24.1	14.5	19.0	28.2	13.9	14.4	16.0	13.0	10.5	15.2	16.8	19.0	16.9	12.4	17.0	16.2	11.5	13.5	9.9	23.6	17.9	26.5	8.6	16.0	20.1	14.9	7.9	7.4	5.6	5.1	7.4	10.4	5.0	13.2	6.8	12.5	9.6	11.0	17.5	13.3	17.0	15.7	15.7	17.3	7.6	7.1	17.4	15.3	14.2	12.2	16.5	11.0	23.8	13.6	13.1	21.6	13.7	9.4	17.0	22.2	6.1	13.3	17.0	17.4	34.1	16.0	20.9	13.6	15.2	6.3	11.1	6.9	18.6	15.5	13.1	21.5	8.9	11.0	14.1	15.8	13.3	10.2	11.7	30.0	7.0	12.2	13.1	13.7	16.8	22.1	21.9	10.2	14.3	18.5	13.4	19.5	10.4	0.1	4.6	5.6	6.9	5.1	10.4	7.9	8.2	8.1	7.4	7.9	10.2	9.2	0.9	7.4	4.7	5.0	10.4	5.0	20.8	23.6	20.4	20.3	16.9	11.7	24.1	17.8	14.4	23.6
AC139530.2		ENSG00000262660			17	81703371-81720539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.4;MOLT-4: 18.0;SK-BR-3: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA022853, HPA023043, HPA023048"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950"		"unprognostic (2.36e-3)"					"unprognostic (1.17e-1)"		"unprognostic (2.87e-1)"								"unprognostic (3.83e-1)"	2.4	3.6	2.3	2.3	3.0	1.5	6.3	2.7	5.7	2.3	4.6	0.8	2.7	13.8	3.4	1.5	4.6	2.3	2.7	16.3	2.4	2.3	4.9	16.6	3.0	4.2	2.5	1.5	2.3	9.9	3.6	2.3	3.4	2.2	2.4	1.5	1.1	3.1	2.4	15.5	2.4	5.9	1.6	2.3	3.3	2.6	2.6	0.6	3.0	2.4	12.6	3.0	2.3	2.3	0.0	0.4	0.0	0.1	0.8	0.6	0.1	1.2	0.6	1.8	4.6	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.3	0.3	0.9	0.3	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.0	0.6	0.3	0.0	6.4	0.0	0.8	18.0	0.7	1.0	0.0	3.2	0.3	1.1	0.0	0.0	3.2	1.5	0.0	6.8	1.8	2.9	1.5	0.0	0.5	1.1	1.0	1.7	0.6	0.0	0.7	1.1	0.5	2.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	2.3	3.0	2.7	3.7	2.4	2.3	2.5	1.5	2.2	0.6
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Enhanced	Peroxisomes			4300000	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favourable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favourable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favourable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	9.5	12.7	11.0	5.6	11.9	9.6	10.2	8.1	14.3	6.7	16.1	12.5	10.6	23.4	4.9	13.3	12.1	4.6	16.0	17.7	10.2	8.9	48.7	152.1	8.2	5.9	14.0	9.4	5.0	19.2	7.4	5.9	6.8	11.0	13.4	12.4	7.3	11.5	9.4	9.8	6.2	23.8	4.8	12.7	10.0	8.5	4.4	10.9	5.7	9.3	10.1	10.2	9.4	7.0	9.2	47.0	32.8	45.2	17.8	19.3	18.8	8.4	9.2	3.1	9.9	13.6	7.9	10.9	7.8	11.3	8.9	8.5	12.3	9.5	5.0	5.6	12.4	5.6	8.5	13.1	4.9	7.3	8.8	6.5	8.1	34.8	8.8	14.8	14.5	14.7	9.4	7.6	5.5	12.0	6.0	5.9	9.9	11.0	14.3	10.6	3.3	11.2	3.3	6.0	8.4	25.1	25.1	2.7	4.2	7.6	85.3	5.4	8.8	11.9	8.7	5.4	5.2	10.7	10.6	7.8	5.0	3.9	8.8	12.9	8.5	15.3	29.9	32.8	13.6	40.7	11.4	9.2	13.1	13.3	47.0	8.7	13.0	12.1	20.4	17.8	45.2	27.7	19.3	18.8	11.0	11.9	8.1	14.3	10.2	8.9	14.0	9.4	11.0	10.9
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782167-49813960	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 245.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria			3200000	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavourable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favourable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	22.7	12.9	9.4	6.9	10.7	4.4	13.0	3.6	7.0	4.1	27.2	8.0	7.8	25.9	5.1	5.1	7.1	4.1	9.2	38.9	6.8	7.0	60.3	245.7	7.9	7.5	10.7	6.1	6.4	13.6	6.3	7.1	7.5	6.7	7.9	18.4	9.5	3.3	6.2	22.9	4.2	37.0	11.3	9.7	6.9	6.0	6.5	7.5	8.4	15.7	8.8	5.0	8.1	4.9	13.0	31.8	27.5	33.0	35.5	40.9	28.6	0.7	13.9	23.2	21.2	30.7	16.2	11.8	7.1	11.6	12.0	9.3	29.5	12.0	12.4	15.2	26.1	0.9	38.6	4.5	11.9	37.9	9.1	8.8	18.1	34.9	14.5	0.1	16.6	21.4	1.5	19.4	6.1	19.6	7.6	11.7	33.2	16.0	0.5	19.1	21.0	5.6	30.4	49.6	45.4	40.5	0.6	33.3	26.4	0.5	16.3	1.1	9.2	12.8	9.3	10.2	12.9	15.4	7.7	23.8	27.4	31.6	7.3	17.9	9.3	13.1	25.9	27.5	32.1	33.0	40.9	13.0	19.2	28.6	31.8	9.7	16.4	24.3	2.5	35.5	31.1	14.9	22.6	28.6	9.4	10.7	3.6	7.0	6.8	7.0	10.7	6.1	6.7	7.5
ACACA	"ACAC, ACC, ACC1"	ENSG00000278540	"Acetyl-CoA carboxylase alpha"	Q13085	17	37084988-37406818	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013715, HPA036650, HPA063018"	Approved		Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"				Cytosol	"Nucleoli fibrillar center, Actin filaments"	"CAB013715: , HPA036650: , HPA063018: "	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (8.81e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.89e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-2)"	10.7	4.8	5.6	2.5	7.7	3.0	18.5	6.0	11.5	5.3	4.2	6.9	12.7	3.8	4.5	11.7	9.2	3.8	3.6	2.3	4.9		3.0	5.8	7.3	3.5	6.3	4.6	4.3	2.3	13.6	7.9	2.6	6.1	12.2	5.1	4.8	4.6	14.4	11.3	5.4	2.5	7.8	4.2	2.3	3.9	5.5	5.7	2.0	4.2	4.5	5.0	4.3	4.6	4.4	3.2	1.3	4.1	2.0	3.9	2.0	14.6	3.0	17.9	18.8	25.0	24.7	6.2	6.6	9.3	6.8	12.4	11.9	2.5	2.0	5.4	10.5	15.2	3.3	22.3	10.7	5.8	9.8	11.7	7.7	12.1	4.0	6.3	2.4	19.9	13.0	18.1	13.5	12.0	27.9	1.4	1.0	12.4	6.7	9.7	13.6	9.7	10.3	11.3	2.7	16.2	16.7	20.3	8.0	11.8	5.5	5.2	11.1	7.2	10.6	5.8	9.3	8.1	1.6	3.9	4.7	18.3	5.3	5.3	8.0	1.1	2.8	0.3	2.3	4.1	2.1	2.7	2.5	2.7	3.2	4.4	3.9	2.7	1.3	2.0	2.7	2.4	3.2	2.0										
ACAD9	"MGC14452, NPD002"	ENSG00000177646	"Acyl-CoA dehydrogenase family member 9"	Q9H845	3	128879596-128916067	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037716, HPA046720"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA037716: AB_10673638, HPA046720: AB_2679773"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (3.67e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-3)"	"prognostic favourable (4.32e-8)"	"unprognostic (1.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.96e-2)"	18.1	20.6	14.0	13.1	15.4	8.0	15.4	14.7	17.9	13.6	13.4	15.9	21.1	11.3	16.9	13.1	21.6	15.6	16.4	21.6	10.7	13.2	15.8	24.0	11.6	10.4	13.6	17.8	13.1	21.1	30.6	14.2	13.8	13.6	13.0	12.4	16.0	19.0	16.0	30.8	45.0	10.1	13.8	10.2	12.1	14.6	19.5	10.8	13.9	14.8	18.2	14.9	12.6	14.0	7.2	14.0	4.1	18.1	5.0	7.5	8.9	25.0	13.1	10.6	7.8	16.4	11.5	11.3	12.5	13.8	24.0	20.6	18.5	15.3	18.6	11.7	15.7	21.0	18.4	24.4	15.9	12.3	12.6	16.9	26.6	13.0	12.0	13.3	7.9	12.5	9.6	13.9	15.8	19.3	8.0	9.0	15.9	25.3	19.5	11.0	6.4	18.8	15.2	9.9	18.9	16.8	16.0	12.3	7.9	19.4	18.3	12.1	24.1	28.7	11.5	10.1	8.7	10.1	11.8	9.0	4.3	16.2	16.0	12.4	12.6	3.1	12.0	4.1	7.5	14.7	7.2	7.2	6.8	6.4	14.0	4.9	5.7	7.3	1.0	5.0	18.1	7.9	6.5	8.9	14.0	15.4	14.7	17.9	10.7	13.2	13.6	17.8	13.6	10.8
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Cell line enhanced"	"Detected in all"		"Daudi: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria			1200000	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favourable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	6.9	5.5	17.4	7.6	15.0	12.3	4.9	13.0	10.6	12.8	10.8	10.3	11.1	75.9	11.5	9.3	6.4	14.7	11.0	15.9	29.3	7.2	24.9	16.9	15.8	10.5	21.2	6.9	14.2	6.4	11.1	6.7	10.0	25.3	17.2	13.7	2.6	24.9	10.0	14.0	13.3	32.5	22.9	7.9	21.2	18.3	9.4	11.9	10.5	31.4	27.1	9.3	26.9	5.4	8.7	8.6	7.4	21.3	11.2	16.0	33.7	7.4	17.3	9.9	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Mitochondria			15000	Mitochondria	Nucleoplasm	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favourable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favourable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.3	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	3.3	4.3	1.3	0.5	10.5	5.3	5.2	2.2	12.0	6.2	0.4	23.7	10.3	2.0	1.7	0.1	4.0	4.2	0.0	1.7	4.2	7.2	12.0	1.3	3.0	5.4	2.7	1.4	7.3	11.6	0.7	4.0	6.2	0.0	9.9	5.0	8.2	4.4	0.1	3.1	3.0	0.6	10.1	5.7	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058311	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 28.9;liver: 114.2"	"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041458	Enhanced		Supported	Mitochondria			63000	Mitochondria		"HPA041458: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favourable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	4.6	9.4	6.7	2.4	9.0	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5.0	5.3	8.0	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6.0	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5.0	4.1	6.3	6.8	13.5	5.0	9.0	11.7	6.0	9.5	6.8	5.1	9.3	7.0	8.7	4.5	5.9	12.0	5.9	6.0	6.0	3.1	10.0	4.1	5.0	4.0	7.9	4.1	9.9	6.5	8.2	5.2	2.1	34.6	4.9	7.3	5.0	6.4	4.2	3.7	3.4	5.7	5.0	7.4	7.4	4.4	7.0	6.1	3.1	4.3	8.3	10.7	3.1	8.5	10.6	1.0	5.9	9.1	2.7	9.3	8.3	3.6	6.0	3.2	2.9	7.4	7.1	8.3	9.4	5.3	5.0	7.0	2.4	13.5	5.0	12.3	10.0	5.0	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9.0	3.0	4.1	7.6	6.0	6.7	9.0	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol			19000000	"Nucleoli, Mitochondria"	"Nucleoplasm, Cytosol"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	32.7	69.2	22.8	18.2	21.1	15.1	24.1	19.8	18.4	21.1	44.0	16.5	26.7	51.7	17.4	19.7	31.5	14.2	24.4	118.2	20.2	12.2	35.2	90.0	17.3	9.8	18.5	16.8	15.5	67.8	31.5	32.3	40.2	20.9	22.1	24.2	20.0	27.4	29.0	132.3	20.3	51.2	25.0	15.7	21.9	28.7	11.5	18.6	14.6	29.6	36.9	21.2	22.4	31.8	8.3	32.0	37.9	29.0	11.6	14.9	20.0	33.2	31.9	13.1	18.0	56.6	20.8	24.8	24.5	34.1	28.0	17.4	12.9	30.2	17.8	20.5	51.4	25.7	8.8	26.8	24.8	56.5	9.0	9.5	22.7	19.6	27.2	9.0	24.8	23.2	24.6	23.4	36.9	25.1	12.2	21.8	44.9	12.6	9.4	10.9	6.2	12.6	13.1	14.5	42.4	62.2	30.4	3.5	8.6	34.6	44.0	20.1	20.2	13.9	25.0	24.8	18.6	12.5	23.9	20.4	9.5	0.9	45.6	16.0	18.0	6.8	29.0	37.9	13.5	18.0	12.4	8.3	10.9	14.9	32.0	7.6	8.3	10.2	6.3	11.6	12.0	26.0	9.7	20.0	22.8	21.1	19.8	18.4	20.2	12.2	18.5	16.8	20.9	18.6
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108121516-108147776	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 267.1"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria			870000	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	18.8	28.5	8.9	6.9	9.5	5.4	16.9	5.6	11.6	8.5	16.8	8.5	9.4	15.5	8.8	8.9	8.8	7.6	5.1	53.8	7.4	7.4	88.8	267.1	7.3	6.0	9.9	9.9	10.3	27.3	14.3	6.3	3.8	22.4	7.6	13.1	10.6	27.1	15.9	65.0	8.2	10.9	16.4	8.1	7.7	13.9	14.2	7.2	1.7	10.1	32.1	5.2	12.3	6.9	18.8	20.2	2.3	14.7	7.7	20.7	11.6	15.8	13.0	10.3	29.6	33.3	29.5	5.7	15.2	16.3	16.5	19.3	35.8	16.4	8.8	26.2	17.0	16.8	29.8	14.4	18.0	17.5	24.4	25.3	14.8	32.5	23.0	23.9	15.0	26.7	16.0	14.4	27.0	17.5	35.1	13.1	26.3	9.1	14.1	22.3	10.1	29.1	19.7	20.3	85.2	22.6	10.4	16.5	19.6	24.8	32.2	16.6	27.5	19.6	19.5	17.8	10.4	16.2	18.3	4.4	12.9	16.5	7.9	47.9	12.6	0.8	9.8	2.3	15.6	14.7	17.7	18.8	17.6	17.5	20.2	10.2	15.5	14.3	1.0	7.7	14.4	7.0	20.7	11.6	8.9	9.5	5.6	11.6	7.4	7.4	9.9	9.9	22.4	7.2
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159760328-159779055	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 20.4;liver: 31.0"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 48.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Supported	Nucleoplasm,Cytosol			16000000	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favourable (1.12e-4)"	"prognostic unfavourable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	1.6	2.6	2.7	1.5	1.7	1.6	2.2	2.2	6.3	2.1	4.3			3.2	1.4	4.8	5.7	1.0	0.7	0.7	2.9	3.6	3.0	31.0	1.8	2.5	2.9		2.1	0.7	1.3	1.2	0.9		4.2	3.9		2.3	0.5	0.1	2.4	1.6	1.4	5.1	1.1	1.7	6.6			0.9		4.2	1.1	2.6	13.3	9.5	12.3	8.4	10.0	20.4	12.2	6.9	6.5	44.3	16.9	6.3	11.8	1.5	6.2	7.3	14.7	25.4	25.4	8.9	5.9	3.1	4.8	6.7	18.3	48.0	17.4	3.5	18.8	13.6	10.6	42.2	6.4	7.8	3.7	6.4	3.5	24.2	10.4	7.1	14.6	9.9	8.9	12.4	13.5	12.5	14.9	4.8	8.4	9.9	18.0	34.2	9.1	11.9	6.7	7.1	4.6	2.4	8.9	15.7	4.4	5.4	4.7	7.6	15.8	4.7	8.7	14.4	1.6	15.5	8.1	6.1	7.1	12.3	13.9	8.4	13.7	13.3	15.9	13.8	9.5	13.3	16.0	12.3	3.2	10.0	5.6	8.7	20.4	12.2										
ACBD3	"GCP60, GOCAP1, GOLPH1, PAP7"	ENSG00000182827	"Acyl-CoA binding domain containing 3"	Q9H3P7	1	226144679-226186730	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015594	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA015594: AB_1844491"	"unprognostic (1.82e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.54e-3)"	38.0	19.7	17.6	21.4	21.3	22.3	27.9	23.0	20.5	30.1	22.7	19.1	25.4	17.2	25.8	28.5	39.8	23.0	23.9	23.8	19.2	18.8	26.3	30.6	25.3	19.1	20.6	18.4	31.6	27.5	31.1	35.4	45.0	25.9	25.9	25.9	14.2	31.2	30.8	29.0	28.9	21.0	23.4	20.0	22.4	30.8	19.2	23.4	21.8	29.3	26.2	28.5	34.7	31.8	8.4	2.5	3.2	3.0	1.7	2.9	1.1	18.8	12.9	11.0	6.8	34.0	30.5	21.3	23.8	24.9	14.3	18.4	16.6	23.6	20.2	21.9	30.6	14.9	15.4	15.5	20.1	8.4	18.0	9.8	13.5	15.1	21.9	15.6	12.1	22.5	20.9	17.7	23.4	16.3	18.1	14.3	22.9	9.5	11.5	12.3	16.2	17.0	10.8	24.1	20.3	13.4	17.2	12.5	18.1	21.1	23.7	22.5	24.3	18.1	20.4	14.3	10.1	34.6	22.4	27.4	28.4	25.3	17.0	10.6	23.5	3.2	2.4	2.3	1.8	3.0	2.9	8.4	2.4	1.7	1.8	7.9	2.8	2.5	2.6	1.7	2.6	2.5	2.9	1.1	17.6	21.3	23.0	20.5	19.2	18.8	20.6	18.4	25.9	23.4
ACBD5	"DKFZp434A2417, KIAA1996"	ENSG00000107897	"Acyl-CoA binding domain containing 5"	Q5T8D3	10	27195214-27242130	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011861, HPA012145"	Enhanced		Enhanced	Peroxisomes				Peroxisomes		"HPA011861: AB_1844493, HPA012145: AB_1844494"	"prognostic unfavourable (3.33e-4)"	"unprognostic (4.93e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-2)"	"prognostic favourable (4.68e-5)"	"unprognostic (7.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.37e-3)"	9.2	15.7	25.7	7.1	21.5	7.7	7.4	13.7	21.3	8.4	15.5	17.7	9.1	23.0	5.6	6.1	7.2	7.4	9.0	23.0	23.0	21.1	22.8	44.7	8.5	7.6	27.4	14.0	6.3	6.5	18.9	6.0	7.8	21.3	9.2	12.6	12.9	7.2	10.2	15.8	9.3	24.6	5.3	31.0	8.4	12.2	10.8	20.9	5.7	16.6	7.6	7.6	9.7	5.8	7.0	12.9	11.5	14.0	9.0	16.6	7.4	12.2	37.5	8.1	9.0	9.8	9.0	10.2	15.4	6.2	14.1	17.1	9.3	19.4	5.5	13.6	10.9	10.0	12.0	8.1	12.1	12.5	11.8	7.6	11.2	7.1	11.4	4.9	10.3	8.7	9.0	11.8	6.8	10.3	6.3	8.4	18.3	9.3	10.1	4.1	6.4	4.8	8.7	21.3	9.5	22.7	11.0	11.5	22.8	17.4	19.1	9.0	9.3	5.6	14.5	13.8	7.6	21.5	12.4	9.8	13.4	9.9	13.9	12.1	5.9	9.4	13.1	10.5	16.6	12.9	16.4	7.0	8.3	13.0	12.9	7.0	5.7	12.0	11.5	9.0	14.0	9.3	7.3	7.4	25.7	21.5	13.7	19.2	23.0	21.1	27.4	14.0	21.3	20.9
ACD	"Pip1, Ptop, Tint1, Tpp1"	ENSG00000102977	"ACD, shelterin complex subunit and telomerase recruitment factor"	Q96AP0	16	67657512-67660815	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA049411, HPA057660"	Approved		Enhanced	"Nuclear bodies"				"Nuclear bodies"		"HPA049411: , HPA057660: "	"unprognostic (1.47e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavourable (2.42e-6)"	"unprognostic (1.50e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.30e-1)"	9.8	9.7	10.8	12.0	13.4	15.9	9.6	20.5	21.7	12.5	10.4	10.3	9.5	7.6	13.3	8.4	7.9	16.0	9.7	8.6	9.6	9.5	9.1	5.3	9.4	16.7	10.1	9.5	23.2	9.2	10.8	11.9	8.8	11.3	11.2	4.8	11.2	9.5	12.6	11.9	9.6	8.3	12.2	8.3	12.2	8.9	21.1	7.4	16.8	11.8	4.8	13.3	12.4	9.0	27.7	14.2	17.1	14.4	25.3	26.1	14.9	19.0	15.2	8.8	8.6	4.4	3.0	18.6	7.8	5.6	12.6	15.2	19.8	9.4	5.2	9.3	4.5	15.5	5.5	15.2	4.2	5.4	17.8	11.2	6.6	19.9	2.8	14.6	18.2	4.2	5.1	16.6	8.5	8.0	6.8	3.6	6.1	20.8	14.3	14.4	11.0	10.3	20.0	9.6	22.2	5.1	7.9	12.9	10.9	29.8	3.2	6.8	7.1	8.4	6.3	13.2	10.9	15.5	11.8	10.0	12.7	16.7	12.1	9.5	11.0	17.1	11.5	13.5	26.1	13.3	22.5	27.7	24.6	22.7	13.0	23.1	19.1	20.6	16.2	25.3	14.4	14.2	23.4	14.9	10.8	13.4	20.5	21.7	9.6	9.5	10.1	9.5	11.3	7.4
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavourable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	32.4	44.4	34.6	46.6	36.2	57.6	32.5	45.7	41.8	36.6	30.1	39.1	35.2	28.5	52.9	32.2	39.3	34.6	33.3	29.7	33.1	28.3	34.9	35.5	28.8	41.1	34.4	27.7	43.9	34.5	51.1	48.3	37.0	33.7	35.4	34.6	31.5	33.0	38.3	43.8	38.1	35.1	40.1	35.0	52.9	34.0	34.5	40.6	44.2	38.5	27.1	45.9	30.5	47.8	6.9	6.8	13.4	4.9	9.7	5.5	2.7	23.2	24.0	37.9	30.7	23.7	19.1	38.1	26.0	18.4	31.4	25.7	31.8	27.4	43.2	15.4	21.5	25.7	52.4	29.7	32.3	30.3	23.2	38.0	25.4	43.7	13.6	41.2	33.8	22.3	18.4	32.2	27.1	27.4	35.0	17.3	23.7	29.1	46.7	40.7	42.6	23.0	42.4	29.5	23.0	26.1	41.1	25.3	18.6	34.5	22.6	20.5	18.6	33.4	28.0	21.5	21.6	20.4	24.0	18.4	20.7	44.8	19.2	31.3	23.3	4.1	4.9	5.6	5.5	4.5	4.4	4.4	3.7	4.2	4.1	6.9	5.1	4.6	13.4	9.7	3.7	6.8	3.8	2.7	34.6	36.2	45.7	41.8	33.1	28.3	34.4	27.7	33.7	40.6
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 96.2;salivary gland: 74.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 31.4;HEL: 10.0;SK-BR-3: 16.8;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 7.3;NK-cell: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.3;NK-cells: 2.2"	"Group enriched"	"Detected in many"	9	"amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6"	"Low region specificity"	"Detected in all"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA013819: AB_1846126, HPA073493: "	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	10.4	0.9	0.4	0.7	0.5	0.4	5.3	0.2	0.4	2.9	1.8	0.1	0.6	0.7	2.0	5.2	2.5	2.4	1.2	1.0	0.5	0.4	1.1	14.5	1.5	1.0	0.5	0.2	0.9	0.7	0.3	0.6	96.2	0.2	1.1	2.0	0.3	74.8	0.4	2.1	2.5	1.0	3.2	0.7	1.1	0.9	1.5	0.1	0.4	3.8	2.3	2.0	3.2	4.1	0.8	0.4	7.3	0.6	2.2	0.4	0.3	0.1	0.0	0.1	0.2	1.4	0.1	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	10.0	0.2	1.7	0.0	0.1	1.1	0.3	0.3	0.0	0.0	0.0	1.3	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	4.4	0.1	0.1	0.7	16.8	0.0	1.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	6.4	0.1	0.7	0.2	7.3	0.4	0.5	0.1	0.2	0.1	0.2	0.4	0.8	0.3	0.3	1.0	2.2	0.6	0.3	0.1	0.3	0.4	0.5	0.2	0.4	0.5	0.4	0.5	0.2	0.2	0.1
ACKR3	"CMKOR1, CXCR7, GPR159, RDC1"	ENSG00000144476	"Atypical chemokine receptor 3"	P25106	2	236567787-236582358	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HeLa: 22.8;MCF7: 16.8;RT4: 66.7;SiHa: 20.4;U-2197: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 6.1;T-cells: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032003, HPA049718"	Approved		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA032003: , HPA049718: "	"unprognostic (1.65e-2)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-3)"	"unprognostic (6.69e-2)"	"prognostic unfavourable (1.76e-6)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (9.71e-2)"	"unprognostic (8.57e-3)"	"prognostic unfavourable (2.93e-4)"	56.1	2.9	5.4	6.9	5.6	1.7	28.5	2.2	6.4	10.7	15.2	8.9	9.1	5.7	9.9	20.4	23.6	14.6	15.3	30.2	8.4	3.0	3.8	29.6	10.9	7.2	3.8	6.5	19.3	25.7	2.2	10.7	59.6	8.4	14.2	12.8	25.2	8.9	8.9	36.4	16.0	15.7	32.6	7.2	70.9	12.6	9.4	5.5	0.2	34.3	22.3	8.6	59.2	17.8	1.0	0.2	0.1	0.5	6.1	6.1	0.6	0.0	0.0	1.3	0.0	2.3	0.0	9.8	0.5	0.3	0.4	1.0	0.1	0.0	0.0	1.1	0.0	14.3	0.0	5.1	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.6	13.1	0.0	0.0	2.3	0.2	0.0	0.0	16.8	0.0	0.0	2.3	0.1	0.0	1.6	0.1	0.0	66.7	0.0	0.0	20.4	0.1	0.0	0.0	0.0	0.0	0.1	5.3	70.1	0.0	0.2	0.0	0.0	0.2	1.4	0.1	0.0	0.1	0.0	4.1	0.3	6.1	0.6	2.1	5.0	0.2	1.0	1.8	2.3	0.1	6.1	0.5	0.0	3.1	0.6	5.4	5.6	2.2	6.4	8.4	3.0	3.8	6.5	8.4	5.5
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866908-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			2100000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	38.3	24.0	16.7	26.2	22.9	19.1	35.7	21.5	29.1	22.9	22.2	25.1	18.0	30.7	27.0	24.9	23.2	23.7	28.2	18.4	18.3	33.7	37.8	22.2	23.3	27.4	23.1	17.9	19.0	30.6	27.1	19.5	26.7	49.0	41.3	23.2	15.6	25.4	19.6	10.9	19.6	29.6	27.2	26.2	24.5	24.6	20.7	21.4	32.0	21.3	18.2	24.6	20.3	21.3	16.1	23.9	25.2	26.3	16.0	23.9	21.4	23.2	79.1	37.4	32.2	57.8	54.3	34.4	32.7	35.8	41.2	51.8	40.1	26.8	37.8	21.0	45.8	37.0	48.2	56.0	34.5	34.0	46.1	21.6	45.6	41.7	26.9	34.9	28.3	43.1	16.9	72.4	14.6	43.4	26.6	30.2	34.1	23.7	57.4	19.6	24.3	14.4	37.7	45.2	48.4	42.2	41.4	70.4	38.7	23.3	73.0	25.0	43.5	33.4	46.6	32.2	26.5	32.3	53.6	17.7	22.5	35.9	54.4	27.1	26.1	18.9	20.7	25.2	23.8	22.1	22.5	16.1	19.0	21.3	23.9	13.8	14.6	16.1	10.7	16.0	26.3	13.9	23.9	21.4	16.7	22.9	21.5	27.7	18.3	33.7	23.1	17.9	49.0	21.4
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol			8000000	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favourable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	41.4	27.2	9.6	7.1	9.4	1.5	30.1	8.9	8.1	9.3	19.7	6.2	6.4	21.9	12.8	14.6	12.8	7.2	8.9	15.1	6.5	7.6	40.5	80.9	9.2	9.4	6.1	6.2	14.1	27.9	8.9	8.7	11.3	7.7	10.7	9.8	11.7	11.7	9.5	11.2	5.5	28.4	14.5	6.0	6.4	13.5	11.4	5.9	6.0	18.4	7.2	5.1	13.9	11.7	4.7	7.1	21.4	8.8	4.7	7.4	6.2	9.4	8.7	6.7	10.6	52.5	28.5	3.0	17.9	44.1	8.2	6.5	9.1	2.9	1.9	5.7	18.7	1.3	13.3	17.1	16.6	6.0	3.6	13.8	9.4	9.9	26.4	1.3	5.6	24.8	5.3	21.2	15.0	21.3	4.9	4.1	23.4	2.4	7.3	6.6	7.0	9.2	5.7	10.0	1.9	31.4	8.7	0.8	2.8	18.6	0.7	1.9	4.3	3.4	23.0	30.1	10.2	10.0	4.6	2.0	3.8	3.7	21.0	4.6	2.6	21.4	8.7	2.4	7.4	8.8	6.4	4.7	5.2	5.7	7.1	4.2	6.8	7.0	1.0	4.7	7.2	3.4	2.8	6.2	9.6	9.4	8.9	8.1	6.5	7.6	6.1	6.2	7.7	5.9
ACOT11	"BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1"	ENSG00000162390	"Acyl-CoA thioesterase 11"	Q8WXI4	1	54542257-54639192	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.5;HaCaT: 12.9;RT4: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041047	Enhanced		Supported	Cytosol				Cytosol		"HPA041047: "	"unprognostic (9.73e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (9.37e-4)"	"unprognostic (3.61e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.02e-1)"	"prognostic favourable (3.07e-8)"	"unprognostic (5.89e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.49e-3)"	1.3	4.1	5.7	1.9	7.3	3.0	1.2	3.7	8.6	3.7	10.9	9.6	10.0	28.2	3.6	5.2	14.8	2.7	4.0	22.2	5.9	2.6	15.1	1.2	1.7	1.5	3.1	9.5	4.6	3.0	9.4	18.8	1.4	11.1	3.9	9.5	22.0	9.4	4.5	6.8	2.6	22.5	14.6	6.2	1.3	9.0	6.6	3.9	0.0	10.1	5.7	2.7	9.1	5.5	1.3	1.3	8.3	1.3	0.9	0.9	0.6	4.4	2.9	1.5	0.9	0.6	1.4	2.3	2.6	0.3	0.9	0.7	4.3	11.5	1.0	4.4	2.2	12.9	0.6	2.3	0.5	2.6	1.1	10.7	4.1	1.8	0.2	1.2	1.8	1.4	2.6	0.4	1.1	2.3	0.6	1.6	3.0	1.4	0.6	1.8	2.4	0.6	0.9	7.7	1.0	1.0	27.0	3.0	3.0	1.2	1.0	0.5	1.2	3.4	2.4	2.1	1.8	1.3	1.0	1.8	0.9	1.1	0.9	8.0	0.9	2.0	1.3	8.3	0.8	0.7	0.7	0.7	0.7	0.5	1.3	1.3	0.9	0.9	2.8	0.9	0.9	0.9	0.6	0.6	5.7	7.3	3.7	8.6	5.9	2.6	3.1	9.5	11.1	3.9
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6394391	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 20.5;plasmacytoid DC: 19.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol			29000	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (2.31e-5)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	4.7	13.3	25.8	10.8	29.8	7.7	3.9	23.9	50.0	4.4	18.3	11.3	0.5	33.2	5.1	3.8	14.3	4.4	5.3	6.3	27.8	43.9	29.4	9.1	8.6	12.3	36.0	20.7	5.3	4.0	1.9	18.5	7.4	49.9	5.6	13.5	6.6	4.1	4.9	1.5	9.4	33.2	14.3	14.2	8.9	6.2	13.1	6.9	9.0	2.3	6.5	11.6	9.1	6.6	1.0	19.4	0.4	0.6	20.5	4.4	2.8	23.4	20.4	20.2	21.7	4.6	7.7	7.6	20.2	10.5	30.0	18.0	70.5	7.6	28.7	14.9	16.4	23.2	32.5	54.0	11.3	25.2	28.4	15.1	16.2	24.9	19.0	17.6	12.6	6.8	10.3	24.8	29.4	16.8	12.3	6.2	15.8	27.3	36.8	18.7	10.1	47.4	44.1	23.2	19.4	16.8	9.0	11.0	31.3	18.2	28.0	64.4	9.9	8.3	27.2	27.3	16.0	27.1	31.9	5.2	21.4	40.4	17.3	30.9	16.6	0.0	0.1	0.1	4.1	0.6	1.0	1.0	3.4	3.6	2.9	0.4	1.2	2.3	0.4	20.5	0.5	19.4	4.4	2.8	25.8	29.8	23.9	50.0	27.8	43.9	36.0	20.7	49.9	6.9
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857406	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria				Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favourable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	7.0	22.6	23.5	10.9	24.3	16.5	8.7	14.4	32.6	6.8	17.1	13.5	9.9	23.3	6.5	13.1	15.8	12.2	10.1	27.0	22.8	19.3	15.3	19.0	9.7	12.1	22.1	19.0	8.3	17.4	5.9	11.4	8.1	19.5	9.6	14.3	10.4	14.4	7.3	21.7	16.7	22.2	7.3	14.6	9.1	16.7	12.8	11.1	17.1	12.4	8.6	12.2	10.9	7.2	20.5	27.0	31.0	26.2	11.2	22.5	18.8	7.6	9.2	3.1	6.3	8.9	5.4	5.5	5.2	4.2	7.3	6.8	13.4	10.7	9.6	23.6	7.1	15.0	6.0	13.0	2.5	7.1	10.6	9.6	12.4	12.8	8.0	9.1	9.0	6.3	9.9	7.0	5.0	4.5	8.5	11.9	5.1	21.5	13.0	11.9	5.6	24.5	6.3	5.8	17.1	7.7	8.7	10.9	5.1	11.5	29.4	17.8	16.1	22.5	5.1	18.1	4.0	9.3	8.6	10.1	15.0	6.0	22.4	9.6	9.6	20.0	26.2	31.0	18.8	25.0	17.1	20.5	18.1	17.0	27.0	19.3	16.1	17.3	18.7	11.2	23.4	17.0	22.5	18.8	23.5	24.3	14.4	32.6	22.8	19.3	22.1	19.0	19.5	11.1
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732573-111118222	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 29.7;lung: 20.8;placenta: 23.8"	"Group enriched"	"Detected in some"	4	"A-431: 8.9;RPMI-8226: 16.2;RT4: 20.8;U-266/70: 14.1"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035392: , HPA035393: "	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (6.48e-4)"	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0.0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1.0	0.6	4.1	1.1	0.7	0.6	0.3	8.9	0.0	0.2	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.2	0.1	0.1	1.0	0.0	0.0	0.0	0.2	3.1	0.2	0.4	0.2	0.0	0.1	0.2	0.1	0.9	0.0	0.1	0.0	1.4	1.4	0.1	3.2	0.7	0.4	3.1	0.4	0.1	0.1	16.2	0.0	20.8	2.0	0.4	0.1	0.4	0.1	0.2	0.9	0.3	0.2	0.4	0.2	0.1	14.1	3.6	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1.0	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 147.8;ASC TERT1: 35.9;HSkMC: 78.5;RPTEC TERT1: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	5.9	1.8	1.1	3.1	147.8	35.9	1.0	3.3	1.6	2.0	1.4	0.4	1.7	2.5	0.3	3.9	3.7	5.3	2.1	1.6	12.1	1.9	1.8	1.6	4.9	23.8	4.8	4.5	78.5	18.2	1.6	8.5	2.6	0.8	7.6	9.6	3.1	0.3	6.7	0.2	2.6	0.9	1.0	3.1	46.8	17.1	4.5	4.2	3.0	9.1	10.2	3.4	4.9	2.8	1.7	2.0	4.2	1.0	2.9	1.5	1.1	5.7	6.7	2.7	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;RT4: 43.4;U-937: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria			22000	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: , HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favourable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.4	0.2	0.2	0.0	0.8	0.1	1.0	0.3	2.2	0.0	0.1	10.4	42.4	14.0	2.6	0.5	0.1	0.0	0.0	0.2	11.6	0.0	10.9	0.4	18.1	2.8	16.9	18.5	1.9	0.0	0.2	0.0	0.8	0.0	6.3	0.0	0.0	0.0	7.8	0.0	0.4	3.8	0.0	8.5	1.1	43.4	0.0	0.2	16.9	6.5	0.0	0.0	9.5	12.3	0.1	0.1	0.7	0.7	4.6	0.0	6.8	0.3	21.2	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5
ACTA2	ACTSA	ENSG00000107796	"Actin, alpha 2, smooth muscle, aorta"	P62736	10	88935074-88991339	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 59.5;fHDF/TERT166: 92.0;HHSteC: 94.7;HSkMC: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 143.1"	"CAB000002, CAB003761, CAB013531, HPA041264, HPA041271"	Enhanced		Supported	"Actin filaments"				"Actin filaments"		"CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: , HPA041271: "	"unprognostic (7.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (1.37e-8)"	"unprognostic (1.87e-3)"	"unprognostic (2.30e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.09e-3)"	48.1	9.5	1.6	76.4	5.2	0.0	40.0	1.2	7.5	264.5	121.9	5.4	120.3	9.4	332.1	158.2	209.0	151.1	204.3	51.7	1.7	1.8	38.1	12.8	36.5	19.1	3.6	6.4	136.5	3.9	1.9	2.8	52.8	11.8	188.5	35.9	55.2	31.8	251.1	19.9	16.3	32.1	378.4	3.3	44.0	82.3	84.9	1.5	2.2	17.8	24.9	12.8	354.7	71.3	3.3	5.5	10.5	6.7	1.8	29.5	5.0	0.5	2.7	7.2	15.0	29.9	59.5	1.4	15.8	19.9	1.7	6.7	0.0	1.2	1.0	1.7	92.0	0.2	0.2	3.6	1.6	8.5	1.6	0.0	0.8	16.8	94.7	0.1	0.4	52.1	6.6	10.9	4.2	1.6	0.0	1.0	18.7	1.5	0.1	4.0	0.3	0.1	0.2	0.0	0.6	3.9	0.7	0.1	1.1	1.4	1.1	0.1	4.7	0.1	4.0	3.5	0.5	4.4	1.3	3.1	0.2	0.0	4.4	1.4	3.7	10.5	6.5	8.7	9.6	4.4	7.6	3.3	7.9	10.8	5.5	1.0	0.9	6.1	5.7	1.8	6.7	0.2	29.5	5.0	1.6	5.2	1.2	7.5	1.7	1.8	3.6	6.4	11.8	1.5
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562880-179588408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavourable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	18.8	17.9	9.9	23.4	16.8	8.7	21.3	8.7	9.6	16.8	21.3	15.3	15.6	14.5	24.8	16.4	23.2	16.3	14.9	24.2	8.7	7.4	19.6	18.6	14.6	17.4	16.7	5.4	24.8	20.9	13.7	23.4	20.1	13.7	17.7	23.5	10.4	19.0	17.4	12.8	19.4	19.8	16.1	14.8	19.3	16.7	47.5	17.0	46.1	21.9	20.4	23.8	18.7	22.7	17.5	19.8	8.0	16.1	14.5	22.4	13.8	46.1	14.0	34.9	18.4	13.3	14.6	27.4	18.6	14.5	34.8	29.5	31.5	22.7	36.1	33.5	17.5	21.3	30.4	22.9	43.4	35.8	25.4	29.6	15.5	23.8	15.3	36.7	18.5	10.2	23.5	22.5	19.0	19.8	23.0	20.7	25.0	31.6	32.1	22.7	30.9	31.4	30.2	29.2	66.8	27.5	18.7	28.7	20.5	28.7	28.8	28.8	56.1	30.2	14.9	24.9	21.5	25.5	56.2	13.5	20.1	55.5	13.8	39.0	27.3	3.3	11.3	8.0	15.1	14.3	20.0	17.5	17.5	17.4	19.8	13.7	19.2	19.4	1.5	14.5	16.1	11.2	22.4	13.8	9.9	16.8	8.7	9.6	8.7	7.4	16.7	5.4	13.7	17.0
ACTR8	INO80N	ENSG00000113812	"ARP8 actin related protein 8 homolog"	Q9H981	3	53867066-53882202	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 28.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA065236: "	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favourable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	13.2	11.2	19.8	12.6	20.0	11.3	12.9	25.6	24.5	13.7	12.4	13.9	10.5	9.9	14.1	14.3	14.1	12.8	11.3	24.3	18.2	13.7	17.9	11.8	12.4	17.0	17.7	15.5	15.0	15.8	21.9	22.0	14.8	16.0	13.0	16.8	12.5	14.2	12.6	20.1	14.5	11.9	15.3	16.1	14.4	12.6	27.5	19.9	19.9	16.8	10.5	19.2	16.1	11.8	6.1	6.3	28.8	7.1	8.6	8.5	4.4	6.4	7.9	15.6	12.9	12.8	16.2	11.7	15.3	19.5	20.7	16.5	12.4	7.9	19.7	4.5	20.9	5.5	11.7	10.5	19.6	7.9	4.9	19.6	12.4	13.2	15.2	20.8	17.5	12.7	10.8	21.4	13.4	15.9	8.8	6.9	20.8	7.5	6.9	12.4	14.5	12.7	9.1	9.8	11.7	15.6	18.0	4.6	13.4	9.9	8.7	8.7	5.6	11.6	10.8	15.8	10.3	14.5	13.7	19.3	24.5	20.1	11.7	15.2	9.8	28.8	4.7	5.8	5.8	7.1	5.8	6.1	5.4	5.5	6.3	3.8	5.7	6.1	2.4	8.6	4.2	4.6	8.5	4.4	19.8	20.0	25.6	24.5	18.2	13.7	17.7	15.5	16.0	19.9
ADA		ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0"	"Cell line enriched"	"Detected in many"	8	"MOLT-4: 197.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 64.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"			650000	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (6.77e-5)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	8.1	3.2	2.5	5.4	6.5	5.3	5.1	0.9	5.0	2.8	7.4	5.0	1.8	142.2	1.7	3.4	4.6	2.4	3.0	9.2	2.7	0.8	1.3	2.1	2.8	8.9	3.6	2.3	1.2	2.4	0.8	0.3	1.8	3.9	1.8	1.5	0.7	2.6	1.3	2.0	2.8	5.0	2.1	1.3	9.5	19.7	1.6	6.1	99.0	2.8	2.1	7.6	3.6	2.6	1.3	41.6	0.5	64.0	16.9	10.3	9.6	1.4	3.9	2.0	1.3	3.9	5.4	3.3	1.4	0.8	1.4	1.0	1.8	1.5	4.0	1.7	1.8	0.2	1.4	5.8	0.8	0.3	1.8	0.8	0.7	1.4	1.6	0.6	2.1	26.1	2.5	0.5	0.9	5.4	2.0	3.3	0.6	3.4	197.1	2.9	0.5	1.4	10.6	2.8	9.8	0.2	0.0	0.0	0.9	2.1	0.4	2.5	0.4	1.9	1.7	1.0	2.0	2.2	0.2	4.3	2.7	8.3	0.3	3.3	0.9	0.0	1.8	0.2	8.7	30.7	5.7	1.3	7.3	10.3	6.8	1.0	5.7	8.1	0.5	16.9	64.0	41.6	5.3	9.6	2.5	6.5	0.9	5.0	2.7	0.8	3.6	2.3	3.9	6.1
ADAM10	"CD156c, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588807-58749978	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"		8200000	"Plasma membrane"	"Nucleoplasm, Vesicles"	"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavourable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	25.9	11.1	15.5	17.1	17.7	15.6	20.0	25.2	17.6	18.6	20.1	15.7	12.7	13.9	19.9	11.8	17.1	13.8	18.0	18.8	17.6	13.7	20.8	14.8	25.0	26.1	23.1	12.4	13.9	13.1	10.9	11.6	36.1	14.5	23.6	16.7	14.6	12.4	19.1	8.9	15.4	15.6	12.8	30.4	40.4	18.4	8.5	18.9	38.5	27.3	9.2	14.9	30.0	19.1	6.2	12.7	26.9	23.7	9.8	12.2	12.8	11.8	26.9	7.3	8.0	9.4	13.6	18.5	10.2	30.4	7.5	10.5	12.4	15.7	5.5	31.6	9.1	24.3	4.4	10.8	10.0	8.2	5.6	9.4	9.8	11.5	10.5	6.6	27.2	11.9	8.0	5.2	7.7	14.6	5.9	15.0	13.2	4.4	21.9	7.6	10.0	3.8	9.1	24.0	14.1	17.5	32.1	8.0	5.2	11.1	12.9	17.6	7.7	13.3	10.3	9.9	11.0	76.0	9.8	8.4	18.1	6.0	13.8	12.9	17.3	12.9	18.8	10.4	8.1	21.5	12.2	5.3	8.0	7.1	12.7	6.2	8.4	7.0	26.9	9.8	23.7	5.8	10.3	12.8	15.5	17.7	25.2	16.9	17.6	13.7	23.1	12.4	14.5	18.9
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	50	"placenta: 487.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 46.4;hTEC/SVTERT24-B: 29.2;U-2197: 28.8;U-251 MG: 25.7;U-87 MG: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"			"Plasma membrane"		"HPA030866: , HPA030867: AB_10602428, HPA030868: "	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	6.0	0.0	0.6	2.1	2.8	0.0	5.9	0.6	0.6	8.0	0.5	0.5	0.4	0.0	2.6	0.5	0.5	0.1	4.6	0.7	0.6	0.7	1.0	0.4	1.1	1.0	0.8	0.5	8.2	0.6	0.0	1.1	487.4	0.8	0.7	0.1	0.9	1.1	0.4	0.5	0.3	0.4	1.5	0.7	0.5	0.1	0.7	0.6	0.5	0.4	0.5	1.2	4.5	0.8	0.0	0.0	0.0	0.0	0.0	9.8	0.1	4.9	0.7	2.0	0.0	5.9	12.2	0.0	12.9	1.0	4.4	11.1	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.4	4.8	0.5	0.1	0.0	7.9	0.0	0.9	0.0	10.3	14.9	0.0	29.2	0.9	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.8	0.0	1.5	1.3	0.1	13.3	0.1	8.8	1.5	0.0	0.2	0.0	0.0	0.0	15.9	5.3	28.8	25.7	0.0	0.1	0.0	22.1	0.0	9.8	0.0	0.0	0.0	0.5	0.0	9.8	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	2.8	0.6	0.6	0.6	0.7	0.8	0.5	0.8	0.6
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9555792	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, CAB025906, HPA051575"	Approved		Supported	Cytosol	"Intracellular and membrane"		27000	Cytosol		"CAB025906: , HPA010738: AB_1078100, HPA051575: "	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (4.23e-5)"	18.6	11.0	13.6	15.4	13.8	21.9	14.7	20.4	15.5	14.0	11.7	13.8	8.3	8.7	14.2	15.8	18.7	10.7	17.4	13.4	11.2	12.4	12.4	7.8	24.7	15.0	11.6	11.7	18.1	9.6	10.9	11.9	29.0	11.2	8.2	9.4	10.6	12.5	9.8	12.3	16.7	11.1	13.9	14.3	21.4	8.9	17.4	12.3	14.7	12.5	13.9	20.3	12.3	14.4	7.0	7.7	16.0	10.2	6.0	7.9	6.0	7.7	12.7	13.4	13.9	26.5	19.8	24.2	8.1	13.8	9.4	13.9	11.2	18.7	22.1	11.8	10.2	14.2	9.9	17.2	12.9	8.8	9.9	11.3	9.6	9.9	37.5	11.0	12.7	22.1	17.4	15.0	29.1	23.5	15.3	8.5	10.0	7.3	8.3	11.1	11.1	5.2	9.6	13.2	10.5	12.5	12.9	7.9	19.8	9.1	11.1	19.3	5.7	14.2	18.8	16.7	8.7	11.7	15.4	11.1	10.0	19.2	13.8	7.1	19.8	16.0	9.8	7.6	6.1	10.2	7.9	7.0	5.0	5.1	7.7	5.1	4.5	4.6	11.8	6.0	9.5	4.3	5.7	6.0	13.6	13.8	20.4	13.1	11.2	12.4	11.6	11.7	11.2	12.3
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184308-161199056	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.7;HUVEC TERT2: 12.9;SH-SY5Y: 7.2;TIME: 10.8;U-251 MG: 9.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7"	"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"			"Nuclear speckles"		"CAB025876: , HPA051296: , HPA068374: "	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	58.0	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0.0	1.9	5.8	2.0	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11.0	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0.0	1.7	1.7	7.7	1.7	3.0	12.0	15.5	1.9	8.1	1.7	15.7	0.0	7.5	1.2	1.4	8.7	4.0	0.5	8.0	1.0	0.2	0.4	0.6	0.2	0.0	0.0	0.2	0.1	6.0	3.8	0.5	4.8	0.2	0.4	2.8	0.1	0.1	0.2	4.1	1.5	0.1	0.0	0.0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0.0	0.1	4.2	0.0	10.7	0.1	12.9	0.1	0.3	0.3	0.1	0.0	0.2	4.8	0.0	0.1	4.7	0.1	0.0	0.1	0.1	7.2	0.0	0.1	0.1	0.2	0.5	10.8	6.8	0.1	0.3	9.6	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1.0	0.4	0.1	8.0	0.3	0.2	2.6	20.7	1.5	10.0	3.4	2.3	28.6	3.5	20.5	15.7
ADAMTS5	"ADAMTS11, ADMP-2"	ENSG00000154736	"ADAM metallopeptidase with thrombospondin type 1 motif 5"	Q9UNA0	21	26917912-26966513	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 21.2;placenta: 20.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.3;ASC TERT1: 9.9;fHDF/TERT166: 9.3;RH-30: 24.7;U-87 MG: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA005661, CAB025996, HPA030906, HPA030908"	Approved		Supported	Nucleoplasm	"Secreted to extracellular matrix"		18000	Nucleoplasm		"CAB025996: , HPA005661: AB_1078101, HPA030906: , HPA030908: "	"unprognostic (1.97e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.38e-8)"	"unprognostic (1.11e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.15e-1)"	14.1	0.4	1.0	1.6	0.6	0.0	21.2	2.5	0.9	5.5	2.3	0.4	7.2	0.3	10.7	8.2	1.2	3.3	1.0	6.9	1.0	0.0	1.6	0.8	1.2	0.4	1.1	0.4	14.9	0.4	0.1	0.4	20.9	1.5	2.2	0.8	2.3	1.8	9.7	11.0	3.3	2.4	6.2	1.1	6.4	1.8	2.3	0.4	0.6	5.3	1.5	0.6	2.8	3.1	0.0	0.2	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.3	9.9	0.0	1.2	0.2	1.4	0.5	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	2.0	0.0	0.9	0.0	0.3	0.0	2.4	0.0	0.0	5.4	0.0	0.9	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.0	0.0	24.7	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.3	1.3	0.5	0.0	0.0	0.0	8.9	0.1	1.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.6	2.5	0.9	1.0	0.0	1.1	0.4	1.5	0.4
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759203-78811431	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 31.9"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA045284: , HPA048453: "	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.0	4.1	0.7	4.1	2.5	0.3	2.8	1.5	1.8	4.3	2.9	1.7	1.4	2.2	8.6	1.9	2.2	1.6	9.9	31.9	1.7	0.6	1.5	0.8	5.3	3.2	1.2	0.7	8.7	1.0	0.4	0.7	4.0	2.3	1.5	0.6	4.4	0.9	1.1	1.8	1.4	2.8	4.5	1.3	4.1	1.7	3.5	2.6	0.3	1.6	1.1	1.4	3.1	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.8	2.1	2.0	2.4	6.1	1.0	0.3	0.3	0.1	0.0	0.0	0.0	1.4	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.5	0.1	0.0	2.0	0.0	76.1	0.9	0.6	0.5	0.3	6.9	0.0	0.2	1.6	0.0	0.0	1.3	1.3	0.4	4.8	2.2	0.0	0.1	0.2	0.0	7.0	1.3	0.0	0.1	0.9	0.1	8.5	2.8	0.3	0.9	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.5	1.5	1.8	1.7	0.6	1.2	0.7	2.3	2.6
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897901-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;intestine: 30.8"	"Cell line enhanced"	"Detected in many"		"A-431: 35.6;CAPAN-2: 25.7;HaCaT: 16.3;HMC-1: 24.6;THP-1: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	3.0	2.1	32.9	8.9	25.9	8.1	1.2	13.8	41.8	3.6	30.8	30.3	1.7	16.7	2.6	1.3	4.5	4.2	6.2	3.9	36.1	17.7	6.5	1.6	5.8	3.3	28.0	20.1	0.7	5.4	3.7	1.3	3.0	19.3	1.9	20.6	0.9	3.0	3.1	0.8	2.0	22.8	7.7	36.1	7.4	16.3	1.1	19.3	0.0	4.8	0.4	2.3	5.1	1.0	1.3	5.5	3.4	11.7	1.6	6.8	3.7	35.6	1.3	0.0	1.2	0.5	0.0	0.4	1.1	0.0	0.3	0.1	14.2	25.7	0.0	3.5	0.2	16.3	1.9	2.7	0.1	0.2	1.5	0.0	2.2	8.0	0.6	0.2	24.6	0.6	7.6	0.0	0.0	0.0	0.1	0.0	0.0	11.4	0.0	9.6	1.1	0.0	4.8	0.0	0.1	1.9	8.6	1.1	0.3	1.1	0.4	0.1	9.2	41.9	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	1.3	1.1	7.6	3.4	6.8	8.1	3.3	1.3	2.0	6.1	5.5	1.1	0.6	3.1	3.4	1.6	11.7	0.4	0.9	3.7	32.9	25.9	13.8	33.4	36.1	17.7	28.0	20.1	19.3	19.3
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB056157: , HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.1	30.3	26.0	32.0	26.3	27.3	31.0	18.0	36.3	60.5	52.6	26.1	25.8	47.2	29.2	28.8	25.5	33.2	34.3	30.8	45.8	16.7	24.6	21.5	14.8	28.7	34.7	27.3	26.5	25.1	31.0	31.8	31.0	23.2	36.3	21.1	32.0	41.9	17.9	43.0	22.9	40.1	21.4	37.9	20.8	29.2	25.9	30.9	31.2	50.4	37.0	33.9	42.7	28.2	21.8	21.4	17.9	20.9	43.1	47.1	50.7	21.1	22.9	24.5	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase, RNA specific B1"	P78563	21	45073853-45226560	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 59.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.3;HHSteC: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavourable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	12.2	5.3	7.1	10.4	8.4	4.5	8.9	33.1	11.6	11.7	17.2	2.5	5.6	2.9	13.4	6.6	14.0	8.8	11.1	6.7	7.3	8.1	4.6	4.0	19.9	11.8	7.4	8.1	5.3	4.7	19.0	3.7	12.0	13.6	14.7	5.0	11.0	4.6	8.7	11.8	10.8	5.9	59.9	3.5	10.5	11.7	3.8	4.0	3.9	3.8	4.5	8.4	34.6	20.3	6.1	2.1	4.8	0.6	0.5	2.6	0.5	3.1	0.4	2.4	2.9	3.0	2.1	3.3	2.1	3.5	6.7	4.3	4.9	0.5	1.0	5.7	10.3	0.3	3.6	8.7	7.5	0.7	3.2	6.8	27.3	3.2	31.7	4.6	3.3	11.3	3.8	2.4	7.1	7.1	1.5	0.4	19.6	2.3	3.0	4.4	4.0	4.7	0.9	2.3	3.1	1.5	1.0	14.4	3.8	16.7	0.7	5.3	1.6	3.7	7.4	2.2	2.7	9.0	7.8	3.1	1.4	0.8	2.0	10.9	11.9	1.3	0.2	4.8	1.1	0.6	1.8	2.4	2.6	1.6	0.0	6.1	1.8	1.4	0.2	0.5	0.3	2.1	1.6	0.5	7.1	8.4	33.1	11.6	7.3	8.1	7.4	8.1	13.6	4.0
ADAT1		ENSG00000065457	"Adenosine deaminase, tRNA specific 1"	Q9BUB4	16	75596981-75623300	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040713, HPA040903"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA040713: AB_10795371, HPA040903: AB_10794071"	"unprognostic (7.71e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.27e-2)"	14.8	17.1	12.5	12.6	18.2	13.0	15.1	11.0	23.3	13.5	12.4	21.4	11.8	10.1	15.1	24.4	12.0	12.6	15.8	10.4	17.2	15.1	17.2	17.8	12.8	21.2	16.7	20.5	11.1	15.3	33.5	16.7	14.0	22.3	15.3	15.1	11.8	12.2	14.2	9.0	21.2	13.6	12.6	16.0	21.3	11.7	51.8	16.8	19.4	20.6	9.2	16.7	17.1	11.3	12.5	8.6	15.0	13.0	12.1	20.5	8.3	13.9	23.0	13.8	14.3	20.8	17.1	12.9	15.5	17.8	21.2	16.9	18.9	21.4	16.6	16.5	14.0	16.0	12.7	19.9	21.0	10.9	7.5	7.3	15.9	13.3	15.4	14.2	16.5	18.9	15.7	31.4	25.7	17.7	12.3	7.5	18.6	52.4	16.4	13.4	11.3	9.8	19.5	11.9	20.6	20.6	21.5	19.6	20.2	35.1	11.0	9.6	22.8	9.4	12.9	34.0	14.0	13.6	14.9	15.9	22.3	46.3	14.7	15.1	28.1	9.6	7.2	15.0	14.7	8.4	20.5	12.5	13.8	20.0	8.0	11.8	8.5	12.0	9.5	12.1	13.0	8.6	14.0	8.3	12.5	18.2	11.0	23.3	17.2	15.1	16.7	20.5	22.3	16.8
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449758	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 17.6;RPMI-8226: 3.1;RPTEC TERT1: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 347.3"	"Region enriched"	"Detected in all"	6	"basal ganglia: 205.1"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: "	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favourable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	13.3	3.0	12.5	3.7	32.0	0.6	9.3	2.6	14.4	4.5	11.7	10.4	3.1	4.2	6.2	4.4	13.8	5.3	7.3	69.9	10.4	8.3	5.3	2.4	2.6	2.0	15.0	8.6	10.1	5.7	1.1	7.7	4.8	9.7	13.8	4.6	4.6	3.1	16.3	2.2	1.1	4.8	13.5	8.8	4.7	9.6	5.9	16.0	0.0	1.0	0.2	2.6	9.5	8.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	1.5	0.1	0.1	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.3	0.2	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	17.6	0.0	0.0	1.0	0.1	0.0	0.4	3.1	6.3	0.6	2.2	2.0	0.0	0.6	0.1	0.0	0.1	0.0	0.1	1.5	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	12.5	32.0	2.6	14.4	10.4	8.3	15.0	8.6	9.7	16.0
ADCYAP1R1	"PAC1, PAC1R, PACAPR"	ENSG00000078549	"ADCYAP receptor type I"	P41586	7	31052461-31111479	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.2;fallopian tube: 25.1"	"Group enriched"	"Detected in some"	6	"AF22: 5.4;NTERA-2: 7.2;SCLC-21H: 6.1;SH-SY5Y: 10.9"	"Cancer enriched"	"Detected in some"	11	"glioma: 45.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030739, HPA049877"	Enhanced		Enhanced	Vesicles				Vesicles		"HPA030739: , HPA049877: "	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-2)"	"prognostic favourable (5.78e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.67e-3)"	"unprognostic (6.43e-4)"	"unprognostic (1.09e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-4)"	5.4	10.6	23.6	2.7	24.2	0.9	2.9	13.7	71.2	12.8	2.7	13.4	0.0	1.6	5.4	2.3	3.3	25.1	2.0	2.8	22.1	21.6	1.0	1.1	1.6	1.0	19.0	20.2	1.9	2.2	2.9	4.4	1.0	18.7	2.1	2.0	0.0	2.6	3.7	1.9	1.8	2.0	3.9	6.5	1.3	1.6	2.2	13.3	0.0	2.3	0.9	1.6	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	10.9	0.0	0.0	0.0	0.0	0.0	0.3	0.9	1.3	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.6	24.2	13.7	17.3	22.1	21.6	19.0	20.2	18.7	13.3
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"			1400000	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favourable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favourable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	44.0	31.7	43.1	27.9	52.1	26.7	35.6	46.3	66.6	37.5	43.3	47.2	27.3	30.8	47.9	29.2	35.1	43.0	33.1	41.1	39.5	34.1	36.8	23.4	38.0	27.9	40.5	46.7	65.3	25.0	31.3	28.4	31.2	44.7	43.1	30.7	36.3	26.2	54.9	69.5	25.5	33.6	58.1	33.8	34.9	32.6	25.2	37.0	25.5	27.9	19.6	28.5	45.3	34.9	21.3	16.2	21.5	6.5	16.4	12.9	9.1	18.3	15.4	36.7	18.9	54.4	40.7	13.8	31.2	37.5	32.6	27.6	22.6	23.4	9.6	16.4	53.4	11.8	27.4	26.2	27.3	12.3	12.6	27.2	13.4	21.8	26.6	16.1	19.4	40.1	24.6	28.6	11.5	40.5	28.2	23.4	37.0	10.8	49.6	22.6	20.6	21.9	22.0	20.3	11.3	23.8	40.8	22.0	28.6	22.5	9.2	19.3	21.6	15.4	48.8	26.7	13.8	21.8	25.7	18.8	15.2	12.3	25.7	20.1	25.7	11.0	4.8	21.5	12.9	4.5	11.8	16.1	7.2	10.8	7.5	21.3	6.8	8.1	6.7	16.4	6.5	16.2	9.2	9.1	43.1	52.1	46.3	66.6	39.5	34.1	40.5	46.7	44.7	37.0
ADD3	ADDL	ENSG00000148700	"Adducin 3"	Q9UEY8	10	109996368-110135565	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.4;ASC TERT1: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009797, HPA035696"	Supported		Supported	"Plasma membrane"			29000	"Plasma membrane"		"CAB009797: AB_2223583, HPA035696: "	"unprognostic (2.66e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.42e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.37e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.92e-2)"	22.9	9.4	65.7	15.9	46.8	15.8	40.4	29.6	44.4	27.2	26.0	44.1	20.1	32.4	11.8	28.7	17.1	22.4	31.9	26.1	63.3	29.9	45.7	11.4	16.2	29.5	37.5	42.8	20.3	31.3	10.4	15.0	14.9	41.1	15.4	30.5	22.3	25.7	16.6	5.1	17.6	37.7	13.4	54.5	17.1	28.6	21.7	52.7	24.0	41.9	9.3	29.1	21.3	22.0	20.7	9.0	46.8	11.5	25.6	35.2	31.2	7.0	1.4	10.5	4.5	71.4	67.2	4.6	9.0	24.4	6.0	11.3	15.3	23.0	22.5	10.8	13.8	2.4	9.5	6.4	9.1	2.2	10.7	2.0	7.4	10.5	8.1	7.5	17.1	32.6	3.1	14.4	0.6	8.4	5.6	12.4	10.3	0.2	8.0	6.8	6.5	3.6	6.8	13.6	1.1	15.1	3.6	1.6	16.8	6.6	2.2	15.4	2.7	2.6	2.0	3.6	10.3	7.5	2.0	17.6	7.7	21.0	10.8	3.8	6.1	46.8	10.4	37.2	28.2	9.7	22.7	20.7	30.3	24.4	9.0	16.3	35.2	28.1	18.2	25.6	11.5	6.0	27.4	31.2	65.7	46.8	29.6	44.4	63.3	29.9	37.5	42.8	41.1	52.7
ADGRB2	BAI2	ENSG00000121753	"Adhesion G protein-coupled receptor B2"	O60241	1	31727117-31764893	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 52.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 20.5;SH-SY5Y: 15.0;T-47d: 17.3;U-2 OS: 16.9"	"Cancer enhanced"	"Detected in many"		"glioma: 20.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052612, HPA054617"			Enhanced	Centrosome			49000	Centrosome		"HPA052612: , HPA054617: "	"prognostic favourable (6.46e-4)"	"unprognostic (1.74e-1)"	"unprognostic (7.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-4)"	"prognostic unfavourable (4.02e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.75e-3)"	"unprognostic (7.98e-2)"	2.2	5.4	15.9	1.3	26.8	1.1	1.4	7.9	52.0	2.4	1.4	7.3	0.0	5.2	2.4	1.2	1.6	2.2	2.1	2.8	18.9	8.0	1.4	0.9	1.3	1.3	7.4	16.5	1.8	1.4	1.3	2.7	3.8	8.4	2.4	1.1	1.3	1.4	3.1	1.1	1.5	5.0	2.4	2.9	1.8	1.8	3.2	6.3	1.5	3.2	0.0	1.1	2.0	0.5	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.5	4.4	4.1	11.9	1.2	0.7	2.0	2.8	4.5	2.7	4.9	0.2	1.3	0.0	2.8	1.2	0.4	1.8	0.2	0.4	3.1	1.8	0.0	20.5	0.0	0.1	0.0	1.5	0.7	0.3	3.8	0.0	0.4	0.4	0.1	3.0	0.4	7.8	0.1	5.1	1.3	11.9	0.4	0.4	0.0	5.6	3.1	15.0	6.4	0.4	0.5	17.3	0.0	0.1	2.1	16.9	0.3	0.7	0.0	0.0	0.4	6.6	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	15.9	26.8	7.9	37.6	18.9	8.0	7.4	16.5	8.4	6.3
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.1;HSkMC: 15.1"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"			9700000	"Plasma membrane, Cytosol"		"HPA047814: , HPA060902: "	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (4.55e-4)"	"prognostic favourable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.2	0.0	0.1	1.7	5.1	1.1	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.5	1.4	0.3	15.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.9	0.4	0.1	0.1	0.9	2.1	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1										
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	7	"ASC TERT1: 3.9;HaCaT: 4.4"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497361-3519736	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 127.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: "	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	13.5	19.1	10.8	9.0	11.5	6.4	15.1	5.2	9.2	12.5	60.6	9.3	29.9	27.3	11.7	17.8	16.3	11.4	35.5	49.5	9.0	7.9	42.6	127.7	10.8	12.4	11.3	9.4	12.8	14.7	9.2	8.4	18.7	9.6	24.5	11.8	10.7	22.7	27.0	43.1	7.9	38.9	17.3	11.7	16.6	18.3	8.0	7.9	4.9	12.9	18.9	10.4	14.7	17.9	14.2	37.8	64.7	26.5	10.1	17.7	32.2	12.0	14.7	13.3	10.6	46.7	22.8	24.9	25.2	32.6	27.4	19.9	20.9	13.8	5.7	39.9	26.7	11.0	15.7	11.8	14.1	10.2	35.1	17.6	9.5	33.8	39.1	18.2	39.5	25.2	15.7	12.8	16.0	17.2	13.1	10.0	21.5	27.1	6.1	32.1	11.6	23.0	6.5	8.5	32.4	19.0	18.0	14.9	15.0	13.9	14.7	9.6	15.6	19.3	14.3	18.9	7.7	9.2	14.1	9.9	23.9	23.4	13.9	28.3	9.9	14.2	26.5	64.7	6.3	25.2	6.8	14.2	14.9	5.9	25.6	11.2	17.7	5.9	12.3	10.1	22.0	37.8	13.8	32.2	10.8	11.5	5.2	9.2	9.0	7.9	11.3	9.4	9.6	7.9
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968192-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 25.2;HaCaT: 65.1;PC-3: 35.5;RT4: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.9;naive CD8 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	11	"T-cells: 3.9"					"Low region specificity"	"Detected in many"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol			580000	"Nucleoplasm, Cytosol"		"HPA026810: "																		123.4	9.5	15.7	21.4	6.1	1.5	109.7	1.6	8.4	44.3	65.3	6.8	21.6	66.2	25.3	34.6	24.3	34.7	29.9	24.8	17.3	6.1	20.3	10.3	32.5	5.4	10.5	9.3	54.7	12.6	7.2	11.7	8.7	7.2	38.6	7.0	23.6	41.5	38.8	30.5	23.7	69.5	19.8	9.6	10.0	12.2	12.5	9.9	1.2	29.7	38.6	8.3	39.5	41.6	0.0	0.3	0.0	0.3	0.0	3.9	0.6	25.2	0.3	0.0	0.0	2.1	12.4	1.7	8.8	9.5	0.0	0.0	0.9	3.2	0.0	0.3	10.8	65.1	0.0	2.1	0.1	0.9	0.0	0.0	2.7	0.2	1.2	0.0	0.4	0.3	4.1	0.0	5.8	3.6	0.1	3.5	0.3	3.1	0.1	0.6	0.1	35.5	0.1	0.0	0.3	0.4	45.2	1.6	0.1	3.0	13.5	0.1	16.7	0.3	9.6	0.3	2.0	1.7	0.0	0.5	0.4	0.0	0.7	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.3	0.0	3.9	2.8	0.0	0.0	0.0	0.0	0.2	0.6	15.7	6.1	1.6	7.9	17.3	6.1	10.5	9.3	7.2	9.9
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151185-74709303	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Purine salvage"	"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 71.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409"	Approved		Supported	Nucleoplasm,Cytosol			320000	"Nucleoplasm, Cytosol"		"CAB032876: AB_2242229, HPA038391: , HPA038409: AB_10675798"	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (1.93e-4)"	"prognostic favourable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	13.8	10.7	11.8	13.6	25.4	12.1	14.5	11.2	11.8	9.5	9.3	9.0	9.6	8.8	6.6	10.6	29.4	8.9	6.3	15.7	9.8	11.1	19.0	71.9	15.1	17.9	12.3	9.3	5.2	12.6	15.1	23.5	43.2	11.6	8.7	10.8	8.5	13.1	11.4	18.1	20.8	6.4	8.3	13.2	11.3	7.4	11.9	10.3	13.4	20.8	24.1	21.9	12.6	14.7	49.3	23.0	5.4	21.6	6.5	15.7	9.8	37.5	8.5	9.0	12.0	9.0	13.9	20.7	32.6	25.9	25.3	28.4	23.7	39.2	19.7	8.2	13.1	34.4	10.5	34.7	40.6	13.2	12.1	12.5	13.9	25.5	10.3	20.0	5.1	12.8	23.0	18.4	45.9	22.0	9.9	6.4	19.0	21.0	23.5	27.1	2.5	60.0	22.7	15.6	16.9	27.7	20.7	7.1	8.4	14.3	55.8	10.8	37.1	15.1	18.8	8.4	15.5	22.4	26.9	9.2	10.4	22.2	15.9	28.8	5.1	1.3	10.1	1.4	4.5	18.0	10.0	29.7	9.5	8.2	23.0	49.3	7.9	6.5	5.4	6.5	21.6	16.7	15.7	9.8	11.8	25.4	11.2	11.8	9.8	11.1	12.3	9.3	11.6	10.3
ADORA1	RDC7	ENSG00000163485	"Adenosine A1 receptor"	P30542	1	203090654-203167405	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 38.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 19.3;MCF7: 11.6;RH-30: 31.9;RPTEC TERT1: 15.5;SK-BR-3: 17.3;U-138 MG: 10.4"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044383			Supported	"Plasma membrane"				"Plasma membrane"		"HPA044383: "	"unprognostic (3.93e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.76e-4)"	4.5	1.0	19.7	2.6	21.7	0.8	6.1	9.7	38.7	1.1	1.6	27.4	0.0	2.0	2.0	1.6	1.6	2.0	1.8	13.8	19.8	12.1	4.2	1.0	2.8	1.4	22.8	13.4	0.8	15.5	15.5	0.9	8.9	25.0	1.2	1.6	1.8	8.9	1.3	2.0	1.9	1.8	1.3	20.7	7.4	1.6	16.3	15.9	0.0	3.2	0.0	1.4	3.4	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.3	0.1	0.1	0.8	0.1	0.9	1.4	0.3	0.2	19.3	0.3	0.0	4.4	3.5	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	3.0	11.6	0.0	0.0	5.0	0.0	0.0	31.9	1.0	15.5	0.0	0.3	0.3	2.1	17.3	0.2	1.0	0.4	0.0	10.4	5.3	0.0	5.6	0.0	0.0	0.0	5.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	19.7	21.7	9.7	25.7	19.8	12.1	22.8	13.4	25.0	15.9
ADPRHL2	"ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylhydrolase like 2"	Q9NX46	1	36088875-36093932	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA026739, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA026641: , HPA026739: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	15.5	27.6	17.4	15.2	17.4	16.9	20.0	16.5	22.7	15.9	17.3	30.3	17.7	15.6	14.3	17.8	26.3	28.4	13.5	15.1	19.1	18.9	19.8	16.5	20.7	19.1	25.8	18.5	19.7	27.6	15.1	14.0	20.9	19.7	16.6	12.9	12.2	21.9	20.2	26.4	24.4	17.7	22.2	23.5	18.0	14.1	25.1	20.0	21.2	21.2	22.3	19.7	16.1	15.9	27.7	38.9	34.1	38.8	23.5	29.3	29.2	25.2	10.7	12.8	18.0	11.8	8.6	18.3	18.8	15.9	30.5	30.1	12.7	23.0	18.1	18.5	18.8	15.8	16.1	28.9	18.3	12.9	20.2	16.4	13.0	16.9	22.3	18.6	9.8	10.1	22.1	27.6	12.1	19.3	14.1	15.0	14.2	12.2	18.8	28.3	27.5	22.2	15.4	13.5	18.2	27.3	20.8	15.7	24.9	13.8	14.5	30.7	14.9	16.2	13.2	17.7	18.2	24.4	24.9	19.5	18.7	16.0	25.5	18.6	10.8	18.2	32.4	34.1	25.5	38.7	24.0	23.6	27.9	29.3	38.9	27.7	28.3	24.0	31.4	23.5	38.8	24.6	22.8	29.2	17.4	17.4	16.5	22.7	19.1	18.9	25.8	18.5	19.7	20.0
ADRA1B		ENSG00000170214	"Adrenoceptor alpha 1B"	P35368	5	159865080-159972544	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.6;liver: 20.3;lymphoid tissue: 17.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.0;HaCaT: 6.6;TIME: 11.0;U-2 OS: 9.2;U-251 MG: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074416			Supported	"Plasma membrane"				"Plasma membrane"		"HPA074416: "	"unprognostic (4.93e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (6.00e-5)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.12e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (1.40e-6)"	"unprognostic (5.24e-4)"	"unprognostic (2.54e-1)"	"prognostic favourable (3.19e-5)"	"unprognostic (1.59e-2)"	5.3	2.9	5.3	0.9	9.0	0.4	2.3	1.3	21.6	0.9	1.2	0.7	0.8	1.2	1.5	3.6	1.1	3.6	1.3	3.3	6.2	5.8	7.4	20.3	4.7	2.3	1.2	13.9	6.2	0.8	1.0	0.8	1.1	5.2	1.6	1.1	0.9	1.0	1.9	1.6	1.3	1.7	1.2	0.9	17.4	0.9	0.8	0.5	0.0	2.0	0.0	1.1	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.7	0.3	0.0	2.4	0.9	0.1	0.5	0.2	0.6	0.3	0.0	4.2	0.0	13.0	3.8	6.6	0.0	0.5	0.3	0.0	0.3	0.0	1.6	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.6	0.0	0.7	0.0	4.5	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.0	11.0	0.1	9.2	0.0	7.0	0.0	0.0	0.0	3.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	9.0	1.3	21.6	6.2	5.8	1.2	13.9	5.2	0.5
ADRM1	"ARM1, GP110, Rpn13"	ENSG00000130706	"Adhesion regulating molecule 1"	Q16186	20	62302093-62308862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042266	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042266: AB_10794044"	"unprognostic (5.49e-2)"	"unprognostic (5.14e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (9.02e-6)"	"unprognostic (4.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.47e-2)"	22.9	22.9	14.8	23.4	16.8	30.5	17.0	24.1	29.3	14.7	16.9	18.8	12.4	24.0	19.9	15.3	23.9	14.0	20.4	24.6	14.6	15.1	21.7	54.5	15.7	22.1	15.5	13.4	17.2	34.9	9.5	13.4	27.6	21.4	14.8	7.9	14.8	21.0	18.3	86.6	26.4	19.5	17.3	15.4	23.5	20.1	30.0	10.1	23.8	16.4	29.1	29.4	17.3	14.6	79.2	67.2	69.4	78.0	51.7	77.6	70.9	33.7	37.8	10.6	22.6	10.2	7.5	28.9	22.3	15.2	41.9	16.8	112.7	35.8	18.2	40.8	12.7	38.2	13.4	32.8	12.9	21.2	27.3	44.1	27.4	59.4	17.2	22.7	42.1	9.4	20.2	27.3	10.9	16.2	32.2	19.9	9.6	45.4	28.5	44.6	36.0	56.5	23.0	18.7	28.8	11.2	25.4	19.0	23.7	24.1	38.3	26.8	26.6	25.1	23.7	41.9	44.4	40.8	44.7	42.5	33.4	24.3	44.1	22.9	30.3	48.3	66.3	69.4	66.0	78.0	58.9	79.2	59.8	62.7	67.2	75.5	45.1	51.4	62.2	51.7	65.0	62.7	77.6	70.9	14.8	16.8	24.1	29.3	14.6	15.1	15.5	13.4	21.4	10.1
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346500-40390463	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol			180000	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavourable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	9.3	11.6	5.0	13.7	8.5	11.2	9.0	6.8	10.1	7.9	9.5	7.3	4.4	6.0	10.8	9.4	9.7	9.0	6.9	14.6	4.5	4.7	12.0	17.3	6.8	17.6	4.9	4.9	10.5	21.8	5.4	9.1	9.5	5.1	7.1	9.7	9.2	14.7	6.4	79.0	6.2	9.4	10.7	4.9	14.5	9.6	10.9	4.4	18.8	8.4	23.6	15.5	9.5	7.4	15.3	28.8	11.0	22.7	19.8	34.0	24.6	21.0	24.9	21.4	30.5	14.5	20.4	24.8	19.3	19.1	41.8	32.0	41.1	12.4	61.3	16.4	22.3	15.9	47.7	31.0	43.0	16.3	44.9	27.8	28.1	37.8	30.3	90.4	23.4	21.9	17.6	36.7	39.0	30.9	32.8	26.9	31.2	23.5	27.9	32.3	34.9	26.6	42.6	45.0	43.5	26.9	16.7	13.8	13.6	23.0	12.7	36.5	17.6	28.6	20.4	22.4	41.5	19.7	36.9	25.6	44.6	47.0	18.6	33.6	21.8	11.0	19.3	7.8	16.2	22.7	22.8	15.3	34.0	21.7	28.8	14.9	27.0	20.8	1.9	19.8	20.2	14.9	34.0	24.6	5.0	8.5	6.8	10.1	4.5	4.7	4.9	4.9	5.1	4.4
ADSS		ENSG00000035687	"Adenylosuccinate synthase"	P30520	1	244408494-244452134	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Supported	"Plasma membrane,Cytosol"			620000	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.4	17.8	23.2	23.8	31.2	29.2	26.3	18.3	26.3	20.9	20.9	35.9	27.1	21.1	18.9	23.3	27.7	18.3	15.8	9.8	24.9	23.4	25.1	19.3	19.2	21.2	42.5	16.6	20.9	21.2	26.6	17.7	21.0	34.9	19.8	22.7	13.1	25.0	21.7	11.0	26.5	23.2	22.9	29.3	24.9	24.7	48.9	36.7	26.7	26.3	17.9	24.8	26.5	21.8	10.9	13.6	24.6	21.3	15.5	16.0	11.9	25.4	14.1	12.3	10.8	14.4	20.7	22.7	25.8	21.7	18.5	14.1	18.5	24.7	22.8	17.1	19.8	19.3	13.4	16.8	20.8	16.9	23.7	15.2	14.1	14.0	17.4	35.8	19.6	14.1	20.4	17.2	17.5	66.0	26.3	17.0	18.4	6.1	23.0	24.1	32.7	15.6	21.3	11.7	24.6	30.7	15.9	16.7	14.7	21.9	20.4	25.7	14.1	19.1	28.8	17.2	9.4	19.8	26.7	20.6	27.0	17.2	14.2	42.1	25.3	24.6	15.8	13.0	15.0	20.5	16.0	10.9	13.7	12.8	13.6	8.6	11.8	13.3	11.9	15.5	21.3	5.5	14.7	11.9	23.2	31.2	18.3	26.3	24.9	23.4	42.5	16.6	34.9	36.7
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;BJ: 46.1;BJ hTERT+: 30.4;fHDF/TERT166: 49.4;WM-115: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"		2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: , HPA063595: , HPA064970: "	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	35.0	12.4	0.2	46.1	30.4	5.2	1.1	0.0	0.0	1.2	5.1	49.4	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	2.3	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	16.6	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.2	0.1	3.3	8.1	0.0	21.4	0.1	0.0	0.2	0.2	24.3	0.1	0.0	28.3	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6
AEBP2	MGC17922	ENSG00000139154	"AE binding protein 2"	Q6ZN18	12	19404045-19720801	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020893, HPA022282"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA020893: AB_2670528, HPA022282: "	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (3.24e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	20.9	27.6	26.8	23.6	24.0	13.8	19.1	31.9	32.4	28.2	19.6	13.3	14.6	11.8	25.7	16.2	27.0	20.4	20.2	16.9	21.4	13.5	21.1	14.8	16.3	19.0	14.1	25.0	26.5	14.2	30.5	19.0	40.2	15.6	25.1	15.9	18.2	21.8	24.5	15.8	28.7	15.8	25.2	16.6	16.4	15.3	15.8	19.2	19.6	23.7	11.5	22.5	28.9	28.7	5.2	4.0	6.0	4.4	9.6	9.9	1.9	9.3	12.3	12.7	6.6	9.7	12.3	33.7	8.8	10.8	13.6	14.5	14.1	17.0	15.4	7.3	11.9	11.7	27.7	10.6	21.5	43.5	10.5	13.9	18.1	9.4	11.9	17.3	9.6	10.8	11.6	11.2	16.7	10.9	7.7	0.7	12.8	10.9	19.0	25.2	26.6	5.8	15.2	27.1	10.5	10.0	19.8	3.3	7.6	18.5	7.3	9.2	10.2	11.1	12.0	12.8	9.8	3.9	13.2	4.2	7.7	33.0	9.6	7.9	9.4	6.0	4.4	4.0	7.3	4.3	7.3	3.7	7.3	6.3	3.1	5.2	6.4	9.9	5.0	9.6	3.3	4.0	7.0	1.9	26.8	24.0	31.9	32.4	21.4	13.5	14.1	25.0	15.6	19.2
AEN	"FLJ12484, FLJ12562, ISG20L1"	ENSG00000181026	"Apoptosis enhancing nuclease"	Q8WTP8	15	88621296-88632282	"Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048599			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA048599: AB_2756313"	"unprognostic (8.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-2)"	"prognostic favourable (1.72e-4)"	"unprognostic (1.52e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.00e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.10e-2)"	9.4	10.4	6.5	10.2	7.2	14.8	11.2	2.8	5.0	8.0	7.8	4.9	13.4	5.0	9.3	10.2	8.9	7.0	23.0	8.2	4.7	8.5	7.9	17.4	9.1	15.4	13.1	3.1	11.2	18.8	6.7	21.3	11.0	7.8	11.6	9.1	4.3	14.5	9.1	18.8	5.9	8.0	10.6	9.3	14.2	11.1	14.3	4.6	14.0	16.6	10.9	13.7	12.5	5.4	9.3	4.1	0.6	3.6	3.0	15.0	7.6	4.9	22.2	13.9	11.9	6.2	7.5	29.5	17.8	16.3	13.7	16.9	18.2	9.7	21.5	5.7	9.7	7.2	51.2	14.4	11.6	5.2	20.2	11.5	9.0	30.1	15.2	9.5	11.6	9.2	12.7	17.1	14.1	11.4	18.1	12.2	16.7	11.6	11.7	8.0	33.5	12.9	15.4	9.9	15.9	5.7	10.8	11.0	10.1	7.2	8.2	13.7	6.8	10.9	10.4	14.0	19.6	5.7	23.9	23.7	15.9	18.4	12.9	10.7	27.4	0.0	1.8	0.6	5.3	3.1	10.0	9.3	9.1	6.9	4.1	9.3	10.0	8.8	0.4	3.0	3.6	2.4	15.0	7.6	6.5	7.2	2.8	5.0	4.7	8.5	13.1	3.1	7.8	4.6
AES	"GRG5, TLE5"	ENSG00000104964	"Amino-terminal enhancer of split"	Q08117	19	3052910-3063107	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 15.8;T-cells: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049499			Supported	Nucleoplasm				Nucleoplasm		"HPA049499: "	"unprognostic (1.08e-1)"	"unprognostic (3.32e-3)"	"unprognostic (7.15e-2)"	"prognostic favourable (3.89e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.15e-1)"	"prognostic favourable (7.74e-4)"	"unprognostic (7.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.78e-3)"	43.9	64.7	83.7	31.4	62.1	30.7	71.9	115.4	95.8	49.7	61.4	23.4	46.9	30.3	51.6	30.9	58.3	52.5	52.1	131.7	70.9	56.0	38.9	35.4	53.9	66.7	56.7	47.7	63.1	66.5	44.1	42.2	64.1	55.1	52.9	32.3	47.7	102.4	73.2	162.7	43.8	34.4	69.9	39.7	56.4	46.9	25.6	26.2	59.2	61.4	49.8	40.3	64.2	55.7	15.8	6.0	6.7	2.3	8.1	49.4	17.6	27.7	32.7	22.6	43.6	27.9	30.8	18.0	34.6	47.6	44.9	39.2	13.7	28.1	40.8	39.8	44.4	23.8	26.7	51.4	22.3	68.8	12.3	15.1	32.8	24.9	50.0	21.9	20.7	34.3	41.0	21.5	20.1	41.7	53.1	20.8	37.3	28.0	54.4	23.9	20.5	32.4	57.9	26.0	29.6	53.1	57.5	59.4	62.4	33.2	43.8	34.7	32.8	28.9	58.8	38.9	26.0	33.6	32.5	1.1	0.2	57.2	35.6	36.1	35.6	6.7	1.4	3.6	28.5	2.3	21.9	13.0	37.5	29.7	2.6	15.8	49.4	32.3	1.0	8.1	1.8	6.0	48.5	17.6	83.7	62.1	115.4	95.8	70.9	56.0	56.7	47.7	55.1	26.2
AFAP1	"AFAP, AFAP-110"	ENSG00000196526	"Actin filament associated protein 1"	Q8N556	4	7758714-7939926	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.0;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015642, CAB024712"	Enhanced		Supported	"Actin filaments,Focal adhesion sites,Cytosol"				"Actin filaments, Cytosol"	"Focal adhesion sites"	"CAB024712: , HPA015642: AB_1844632"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (8.18e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.44e-2)"	14.0	3.9	9.5	11.6	10.2	1.0	15.8	10.3	12.2	11.0	17.8	4.4	6.5	6.7	18.7	6.6	13.1	9.0	14.7	11.0	7.1	5.8	5.2	1.8	8.7	5.3	4.7	6.9	12.1	6.6	31.9	13.0	14.4	5.6	10.3	11.7	12.4	9.6	12.7	5.7	5.8	8.8	32.1	8.3	4.6	8.4	21.7	3.2	3.3	8.6	5.6	6.1	16.2	13.1	0.0	0.0	6.0	0.9	0.0	2.9	1.5	10.3	7.7	5.5	4.3	5.3	9.7	7.2	15.4	22.9	14.9	13.7	2.4	2.4	0.0	5.2	24.9	5.0	2.9	6.2	9.8	0.2	1.9	0.0	11.1	1.4	15.0	0.0	0.1	6.0	4.7	18.5	12.2	17.8	0.2	2.3	7.7	3.3	0.1	0.0	2.3	14.9	0.0	4.1	0.5	1.6	1.3	10.8	18.1	5.3	3.7	4.1	1.3	0.1	42.0	18.2	4.1	23.6	7.5	0.0	0.0	0.0	6.5	0.0	20.7	0.0	0.9	6.0	1.1	0.2	1.4	0.0	1.6	1.5	0.0	0.0	2.9	1.3	2.3	0.0	0.1	0.0	1.3	1.5	9.5	10.2	10.3	10.8	7.1	5.8	4.7	6.9	5.6	3.2
AFAP1L2	"Em:AC005383.4, FLJ14564, KIAA1914, XB130"	ENSG00000169129	"Actin filament associated protein 1 like 2"	Q8N4X5	10	114294824-114404756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 47.9"	"Cell line enhanced"	"Detected in some"		"A-431: 25.8;CAPAN-2: 27.9;EFO-21: 20.8;HaCaT: 35.5;RPMI-8226: 18.2;RPTEC TERT1: 21.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebellum: 169.5;olfactory region: 48.1"	HPA037843	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA037843: AB_10669990"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (3.76e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.55e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-1)"	4.5	1.7	9.0	5.9	6.3	0.3	7.1	24.7	8.8	12.9	7.1	5.3	30.5	2.4	22.3	9.7	5.9	13.8	3.6	2.9	7.8	7.1	9.1	1.2	3.2	2.4	8.0	6.7	9.3	8.2	35.1	1.8	10.6	5.5	7.9	3.2	8.1	4.2	28.4	1.8	5.7	4.0	11.1	5.7	39.9	4.1	1.5	6.5	3.4	47.9	7.5	4.3	3.7	14.0	4.0	0.3	0.4	0.0	0.8	4.0	1.4	25.8	3.8	3.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	27.9	0.0	20.8	0.2	35.5	0.0	9.7	0.0	0.5	0.0	0.0	0.2	0.0	1.1	0.0	1.0	0.0	10.5	2.9	2.6	0.1	0.0	0.0	0.0	1.0	0.6	0.0	0.2	0.2	0.3	0.3	18.2	21.9	0.2	0.1	0.1	0.8	0.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.6	3.8	2.7	2.8	0.0	4.0	0.9	2.2	0.4	0.8	0.0	0.3	4.0	1.4	9.0	6.3	24.7	8.5	7.8	7.1	8.0	6.7	5.5	6.5
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: "	"prognostic unfavourable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	17.0	7.4	14.9	13.0	17.2	1.8	23.5	17.8	19.3	19.6	26.3	16.1	25.5	22.2	15.8	17.7	59.5	27.9	18.2	13.9	15.6	7.2	20.6	29.3	26.3	5.1	17.1	12.5	16.2	29.7	16.4	27.4	18.7	16.1	20.9	27.2	15.3	38.6	18.6	12.7	24.8	42.3	17.4	13.0	13.5	21.1	16.3	15.2	2.1	25.7	13.7	24.5	16.3	27.9	3.5	0.6	2.9	0.5	0.0	1.2	0.0	19.4	6.1	42.4	15.1	4.1	3.5	31.6	7.9	4.0	6.8	8.5	25.9	12.1	3.4	14.7	4.7	9.4	17.6	16.2	12.3	21.9	18.2	0.1	2.6	19.6	6.2	2.1	9.3	2.4	10.9	11.5	27.1	12.6	38.9	13.6	4.4	8.3	0.2	0.1	10.4	2.8	12.5	11.1	14.7	12.5	9.5	19.7	12.0	8.0	30.5	12.0	3.6	0.8	18.5	3.2	15.4	13.7	13.0	0.2	16.5	7.1	9.5	4.5	27.8	0.0	0.5	0.0	1.0	0.5	0.6	3.5	1.2	0.4	0.6	2.7	0.0	0.5	2.9	0.0	0.3	0.0	0.6	0.0	14.9	17.2	17.8	19.3	15.6	7.2	17.1	12.5	16.1	15.2
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100142739	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.3;T-47d: 11.7;U-698: 34.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 16.2;naive B-cell: 27.5;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	16	"B-cells: 27.5;dendritic cells: 12.8"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: "	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.2	2.4	6.0	40.2	6.1	10.3	16.6	20.5	9.9	4.2	4.2	1.8	0.8	1.2	8.9	1.7	4.1	4.1	2.3	4.9	6.3	6.2	1.8	2.4	7.6	23.3	5.4	6.8	7.5	1.1	0.3	5.2	6.9	4.4	18.9	2.3	5.5	6.6	3.3	1.0	1.0	5.9	8.6	6.6	43.6	4.8	6.0	2.5	34.7	1.7	0.7	42.0	7.4	2.7	27.5	12.8	0.2	0.2	0.9	1.2	0.4	0.1	0.0	9.8	3.4	0.0	0.4	0.0	1.3	0.3	2.9	1.0	0.0	0.0	23.3	0.1	1.5	0.1	0.2	0.0	1.7	5.9	2.8	0.0	0.1	0.0	0.2	0.1	6.7	0.6	0.0	6.1	0.1	0.0	0.1	0.0	0.0	0.1	1.9	0.3	1.3	1.6	3.2	0.0	0.1	0.0	0.0	9.7	3.4	0.1	0.1	6.3	11.7	10.7	3.9	9.3	2.5	0.3	1.5	0.2	0.0	34.5	8.7	0.8	0.7	0.2	0.2	0.0	0.0	0.2	0.2	16.2	0.1	0.0	2.9	27.5	1.2	0.0	0.1	0.9	0.2	12.8	0.0	0.4	6.0	6.1	20.5	9.9	6.3	6.2	5.4	6.8	4.4	2.5
AFF4	"AF5Q31, MCEF"	ENSG00000072364	"AF4/FMR2 family member 4"	Q9UHB7	5	132875379-132963634	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023690, HPA029634"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA023690: AB_1844633, HPA029634: "	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (1.69e-1)"	22.9	29.6	22.8	19.1	38.7	38.3	23.6	37.8	25.6	26.2	21.8	25.2	22.1	14.6	27.6	19.5	29.8	20.8	26.8	21.3	18.7	18.7	25.7	24.2	24.8	19.6	19.0	19.7	34.0	24.9	48.8	40.1	20.4	18.3	26.7	18.5	27.5	25.2	25.1	32.1	22.2	17.8	24.4	18.8	17.3	24.8	17.6	24.4	26.6	33.9	15.7	19.2	26.3	24.7	8.7	5.2	12.2	4.9	3.8	5.5	1.5	16.8	13.6	18.8	20.8	14.5	17.5	14.7	18.3	19.7	16.9	21.6	20.1	11.1	8.6	21.8	23.9	8.5	15.1	22.6	28.3	6.1	9.7	10.6	18.6	7.1	18.6	3.7	11.1	20.5	15.1	29.2	29.8	16.1	7.6	7.3	21.0	6.4	10.2	4.0	7.2	5.6	6.9	18.3	3.2	14.7	23.8	14.7	15.5	20.8	5.1	20.7	10.8	6.0	22.7	20.3	17.3	17.8	19.4	10.1	17.2	7.8	19.1	6.9	13.8	12.2	2.4	3.8	5.5	2.0	4.1	7.7	5.1	3.7	2.9	8.7	5.3	4.6	5.2	3.8	4.9	5.2	2.5	1.5	22.8	38.7	37.8	25.6	18.7	18.7	19.0	19.7	18.3	24.4
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favourable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	11.5	15.8	11.8	14.3	14.0	11.7	19.9	17.2	30.3	11.2	25.7	9.5	12.7	33.1	11.4	10.1	18.3	10.4	11.2	77.4	13.2	13.1	27.2	22.9	16.3	23.7	12.0	13.2	12.0	23.1	34.3	12.6	9.9	16.9	10.8	23.5	12.2	14.9	14.8	61.0	17.5	35.0	15.1	14.0	9.9	16.0	8.9	7.1	10.7	16.9	22.4	13.2	14.0	11.6	10.1	15.8	8.5	12.3	19.9	15.2	8.4	16.9	17.4	12.4	14.0	14.4	15.7	16.6	19.0	19.0	27.3	20.0	26.9	10.5	48.9	21.0	17.3	17.1	31.4	21.9	22.3	11.4	13.4	14.6	19.0	25.1	19.7	55.1	22.0	17.4	24.0	25.8	34.2	19.8	32.9	29.0	13.3	26.9	19.7	16.9	17.3	12.8	22.2	39.3	40.8	23.4	37.8	23.2	16.2	29.9	32.4	26.7	14.9	25.0	15.0	32.5	28.0	30.9	24.8	20.4	23.5	31.4	17.8	21.7	14.9	2.6	11.5	8.5	8.7	12.3	10.7	10.1	10.4	13.7	15.8	7.7	13.3	15.2	0.8	19.9	10.8	8.1	6.4	8.4	11.8	14.0	17.2	30.3	13.2	13.1	12.0	13.2	16.9	7.1
AFTPH	"FLJ20080, FLJ23793, MGC33965, Nbla10388"	ENSG00000119844	Aftiphilin	Q6ULP2	2	64524305-64593005	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034990, HPA034991"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"				Cytosol	"Golgi apparatus, Vesicles"	"HPA034990: AB_2674398, HPA034991: AB_10603577"	"unprognostic (7.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-2)"	"prognostic favourable (2.37e-5)"	"prognostic favourable (8.44e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.83e-4)"	12.4	14.8	18.0	25.8	20.0	11.4	20.8	29.8	22.9	14.9	20.1	9.5	16.7	14.1	12.9	28.6	20.7	14.7	16.9	13.5	15.6	14.5	34.8	20.3	18.7	20.7	12.8	21.4	13.1	19.4	26.8	22.6	9.8	16.3	22.3	21.5	9.8	18.5	17.4	12.2	21.8	19.0	14.7	12.2	17.1	20.0	15.1	16.7	20.0	16.0	9.9	24.7	16.5	20.9	16.4	11.8	21.4	10.2	4.9	9.0	4.2	14.0	9.3	7.0	8.4	9.0	7.7	11.6	8.1	12.2	13.4	10.1	10.7	10.7	20.9	8.0	10.0	11.5	12.0	11.3	17.5	20.3	6.6	10.0	5.9	12.5	9.6	19.0	17.2	3.8	24.1	8.6	19.8	10.4	7.4	19.1	8.2	8.0	10.2	23.3	6.4	7.0	8.4	11.2	13.6	24.1	15.2	12.9	6.5	8.6	19.6	16.6	11.8	14.6	8.9	10.0	11.6	8.4	9.0	21.6	12.8	32.3	7.6	21.7	11.0	21.4	6.9	11.6	5.8	6.7	6.9	16.4	7.3	7.0	9.0	14.8	7.0	5.6	12.1	4.9	10.2	11.8	9.0	4.2	18.0	20.0	29.8	22.9	15.6	14.5	12.8	21.4	16.3	16.7
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.9;lymphoid tissue: 18.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 17.6;Karpas-707: 17.2;RH-30: 43.0"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Group enriched"	"Detected in many"	4	"amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"				"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	3.8	1.8	34.3	11.8	40.2	8.1	0.7	48.2	55.9	0.6	2.1	1.2	0.0	2.0	1.5	0.9	1.6	0.8	2.8	4.3	37.6	8.9	1.2	0.8	2.2	13.5	6.3	3.1	1.2	2.4	1.7	1.2	1.7	2.5	1.0	1.2	0.7	4.5	0.9	8.3	2.1	2.2	0.8	2.1	10.0	2.1	0.9	0.7	18.8	0.9	1.5	16.6	2.9	0.6	1.9	1.4	6.3	1.2	2.3	6.3	1.7	3.0	4.4	8.6	2.5	0.0	0.0	4.9	2.0	0.4	0.0	0.2	0.5	2.8	7.7	0.6	0.0	1.9	0.0	0.0	0.0	8.4	1.3	8.5	0.7	1.4	0.0	8.7	17.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	5.2	15.4	5.6	1.4	4.6	6.4	43.0	5.5	0.0	2.5	2.4	8.9	1.1	1.5	1.8	1.1	6.2	4.7	2.4	4.0	4.5	1.5	7.3	4.3	3.9	4.3	5.8	4.0	6.0	0.8	1.0	4.8	1.2	5.1	1.9	4.8	5.1	1.4	1.6	2.0	3.0	6.3	2.3	0.7	1.2	6.3	1.7	34.3	40.2	48.2	35.4	37.6	8.9	6.3	3.1	2.5	0.7
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 91.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"				"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	3.8	8.1	3.9	3.5	4.8	3.8	4.2	3.1	6.6	5.0	6.8	6.6	11.7	2.8	5.4	9.3	6.3	7.2	6.6	4.1	3.4	3.9	8.2	3.0	3.6	3.2	3.5	3.4	5.9	5.9	11.2	6.2	6.3	5.4	6.8	3.8	7.7	8.2	5.9	2.6	6.8	3.9	8.6	3.4	4.6	5.4	91.6	3.5	8.4	9.9	4.9	4.4	7.8	3.5	5.7	5.4	7.1	2.3	11.2	6.3	4.6	22.8	14.8	24.3	16.2	5.2	10.5	27.2	4.7	10.2	13.6	14.1	12.8	17.5	12.7	14.8	8.1	10.5	19.4	21.2	15.1	10.6	28.8	18.6	18.5	27.6	10.6	8.9	6.3	10.9	16.1	11.9	9.8	14.2	15.9	10.4	13.1	9.0	26.0	13.5	17.2	10.2	26.9	27.5	19.9	13.9	5.8	16.3	23.3	9.2	7.3	15.1	10.9	6.9	6.7	12.7	17.5	6.1	10.0	20.7	10.8	26.0	14.1	10.3	11.3	7.1	2.3	5.7	4.5	1.3	3.4	5.7	5.7	6.3	5.4	3.0	5.1	2.8	1.4	11.2	0.9	3.0	3.6	4.6	3.9	4.8	3.1	6.6	3.4	3.9	3.5	3.4	5.4	3.5
AGFG1	"HRB, RAB, RIP"	ENSG00000173744	"ArfGAP with FG repeats 1"	P52594	2	227472152-227561214	"Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Transport"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008741	Approved		Supported	Vesicles			28000	Vesicles		"HPA008741: AB_1850752"	"unprognostic (5.76e-2)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (8.73e-3)"	"unprognostic (6.31e-3)"	"prognostic favourable (6.10e-4)"	"unprognostic (9.30e-3)"	"prognostic unfavourable (7.31e-6)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (3.43e-5)"	"unprognostic (2.03e-2)"	"unprognostic (5.78e-2)"	"prognostic unfavourable (6.92e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.24e-3)"	43.2	26.4	19.9	27.7	26.5	80.1	34.4	18.1	31.3	16.7	26.2	31.5	15.7	25.6	18.1	16.8	29.3	18.2	23.6	28.2	22.6	19.7	22.7	24.7	35.0	33.0	25.4	20.4	20.9	20.9	25.3	13.8	44.0	24.6	14.0	20.5	18.2	19.7	15.3	21.2	22.8	29.1	23.4	39.2	32.2	19.7	51.5	20.8	26.4	21.0	17.3	30.4	23.5	19.8	5.3	5.2	9.0	8.4	1.6	5.5	2.5	18.3	30.5	16.1	15.7	27.6	20.4	61.2	24.5	23.5	29.4	26.2	23.9	21.2	13.1	18.7	26.9	19.5	27.7	31.7	38.3	22.0	15.4	28.8	26.5	44.1	29.7	19.5	18.3	12.5	34.0	37.2	35.3	29.5	30.1	35.5	35.3	26.2	23.3	17.6	25.1	15.9	21.6	26.6	9.3	29.3	25.3	15.1	11.7	20.0	26.1	23.3	11.1	22.3	28.8	25.4	20.3	36.5	21.4	20.6	13.8	18.5	27.6	16.7	29.1	5.4	8.4	2.7	2.6	6.8	5.5	3.0	3.1	2.6	5.2	5.3	2.6	4.7	9.0	1.6	6.4	3.6	3.6	2.5	19.9	26.5	18.1	31.3	22.6	19.7	25.4	20.4	24.6	20.8
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551189-141655244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 37.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"			Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: "	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	8.7	12.0	11.9	8.0	19.0	5.9	10.6	21.3	23.7	8.8	8.9	10.2	8.8	6.4	16.8	17.1	9.5	11.9	6.8	24.5	16.1	12.3	16.0	10.5	8.4	10.0	11.8	18.8	10.8	8.0	15.7	13.3	9.9	14.2	10.1	13.4	10.6	13.5	10.7	8.4	6.8	8.8	15.0	13.9	12.2	9.0	12.9	9.0	7.8	9.8	8.4	15.6	8.4	8.5	4.6	6.4	0.4	5.5	37.9	10.3	5.7	12.2	13.3	13.2	10.9	10.5	13.0	9.0	13.0	12.7	20.9	20.9	10.3	9.5	13.8	11.7	12.4	9.1	18.4	15.1	22.5	16.2	16.4	12.8	6.3	10.2	15.6	8.8	6.9	14.4	13.3	18.3	18.0	16.0	19.0	19.7	10.1	12.3	23.9	4.1	14.0	15.0	15.5	2.3	41.2	13.3	10.4	11.6	15.9	13.5	16.3	13.4	8.7	9.7	8.9	9.7	7.6	12.9	18.7	15.0	14.8	6.6	15.9	4.1	26.6	0.0	2.6	0.4	9.1	5.5	6.5	4.6	7.4	10.3	6.4	2.5	5.5	9.6	0.2	37.9	3.2	2.5	7.2	5.7	11.9	19.0	21.3	23.7	16.1	12.3	11.8	18.8	14.2	9.0
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			16000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: "	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	11.8	3.5	4.2	6.9	7.0	6.6	14.2	3.8	5.6	3.3	5.9	13.3	4.0	15.6	7.3	6.4	6.7	24.6	7.4	6.3	8.3	7.8	9.1	12.2	7.4	4.6	8.0	5.5	8.1	4.8	4.6	3.9	5.2	14.9	1.1	3.4	3.7	9.4	2.5	6.7	4.6	0.0	1.4	0.8	10.1	16.1	10.5	7.3	10.9	10.5	5.8	7.5	5.4	5.3	4.0	5.8	5.4	3.7	4.5	3.5	18.1	7.1	2.1	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute 2, RISC catalytic component"	Q9UKV8	8	140520156-140635619	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA058075"	Approved		Supported	"Nucleoplasm,Cell Junctions"			35000000	"Nucleoplasm, Cell Junctions"		"CAB019309: , HPA058075: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	11.2	6.6	7.7	9.9	13.1	16.2	25.0	9.9	11.4	7.5	9.2	12.1	12.8	5.3	10.2	10.4	10.6	8.6	8.8	12.4	8.8	5.3	6.9	7.4	13.2	12.5	13.4	5.0	11.8	8.4	13.2	8.8	9.9	10.7	7.5	6.9	5.6	8.1	12.6	37.1	14.1	7.5	15.0	11.7	6.9	10.0	5.9	12.7	11.1	8.6	8.2	8.9	10.4	18.4	2.5	2.1	6.4	2.6	2.4	3.0	1.5	12.6	10.5	10.8	12.3	7.1	8.4	9.1	8.0	5.8	3.6	4.5	11.6	3.8	14.6	10.1	7.7	8.6	18.2	8.6	8.0	8.2	9.5	17.1	18.0	7.4	6.4	7.0	5.8	5.7	7.8	10.0	10.4	8.3	17.8	9.2	11.7	19.2	12.1	5.6	8.0	18.3	12.5	9.1	6.6	4.6	13.2	12.7	9.2	12.5	4.3	8.9	11.0	10.3	11.6	6.3	17.5	9.8	12.8	8.2	2.6	10.3	4.6	12.8	9.2	1.8	2.6	0.7	2.7	2.3	3.0	1.3	2.6	2.3	2.1	2.5	2.7	2.7	6.4	2.4	2.3	1.5	2.1	1.5	7.7	13.1	9.9	11.4	8.8	5.3	13.4	5.0	10.7	12.7
AGO3	"EIF2C3, FLJ12765, hAGO3"	ENSG00000126070	"Argonaute 3, RISC catalytic component"	Q9H9G7	1	35930718-36072500	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048342, HPA075436"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Cytoplasmic bodies"	Nucleoplasm	"HPA048342: , HPA075436: "	"unprognostic (4.10e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (5.70e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.39e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.81e-1)"	9.8	8.1	8.8	16.2	11.7	20.6	9.6	12.8	9.6	9.4	7.4	13.8	10.4	4.6	9.5	10.9	7.8	7.4	8.8	9.5	8.0	7.4	8.2	11.3	9.6	9.3	11.5	6.1	10.8	9.7	13.3	28.0	11.0	9.1	9.8	7.1	8.7	7.7	14.1	8.3	12.5	7.3	12.0	10.9	8.3	8.0	21.4	13.5	14.4	9.7	4.7	10.1	8.4	13.9	6.5	5.1	14.0	6.0	6.0	5.5	2.3	6.6	4.6	5.9	4.6	8.2	5.0	7.0	5.5	5.7	8.5	9.1	5.0	7.5	7.3	6.8	5.6	5.6	6.2	4.0	11.3	10.2	3.9	9.0	8.0	3.8	4.4	8.7	7.6	2.4	3.6	12.2	7.7	7.2	9.7	10.8	7.4	2.5	6.3	4.7	10.1	8.1	7.7	7.9	7.3	2.7	6.5	7.2	4.5	9.7	2.4	3.4	3.7	3.6	5.6	5.9	15.1	5.2	5.9	5.9	10.2	10.3	3.0	5.6	5.6	8.5	4.7	13.2	5.5	4.2	3.5	6.2	3.6	3.9	5.1	6.5	5.0	5.0	14.0	6.0	6.0	4.5	3.4	2.3	8.8	11.7	12.8	9.6	8.0	7.4	11.5	6.1	9.1	13.5
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.4;fHDF/TERT166: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"				"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: , HPA073355: "	"prognostic unfavourable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavourable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	11.7	32.3	21.5	8.3	33.1	7.4	12.1	18.7	32.4	26.9	22.1	19.6	19.6	32.0	25.1	53.3	13.8	26.9	22.3	19.4	22.8	21.1	26.4	20.3	24.3	10.7	20.3	23.6	33.1	18.5	1.3	16.6	18.5	22.4	18.5	24.8	17.5	17.4	19.5	25.5	9.1	46.9	17.9	18.6	11.7	27.8	27.7	17.4	12.1	33.4	9.0	14.6	19.3	12.7	6.7	13.8	13.2	9.6	8.9	10.1	5.7	0.0	0.1	13.5	0.0	35.4	23.9	12.6	0.0	0.0	0.0	0.0	27.6	0.0	0.0	11.6	33.8	3.3	29.1	9.6	0.0	0.0	22.6	0.0	0.0	29.0	0.0	0.0	27.4	13.3	12.5	0.0	12.6	8.2	17.4	17.8	29.3	7.3	0.0	6.3	0.0	4.2	0.1	0.0	0.1	8.8	0.0	0.0	0.0	13.4	4.3	15.1	16.9	0.0	5.8	0.0	5.0	0.0	0.0	10.7	10.1	4.4	17.4	0.0	0.0	2.7	5.7	13.2	9.2	9.6	8.7	6.7	5.8	10.1	10.3	5.9	5.0	7.3	11.0	8.9	6.6	13.8	7.8	5.7	21.5	33.1	18.7	32.4	22.8	21.1	20.3	23.6	22.4	17.4
AGPAT5	"FLJ11210, LPAAT-e, LPAAT-epsilon"	ENSG00000155189	"1-acylglycerol-3-phosphate O-acyltransferase 5"	Q9NUQ2	8	6708357-6759666	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010644, HPA010950, HPA011646"	Approved		Supported	Mitochondria				Mitochondria		"HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: "	"unprognostic (1.05e-3)"	"unprognostic (4.69e-1)"	"prognostic favourable (8.82e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (4.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.09e-3)"	5.9	12.5	20.0	8.5	20.7	5.1	9.8	10.0	21.2	6.0	12.2	16.5	6.8	9.3	9.3	19.1	8.4	9.7	5.9	4.0	19.3	16.9	14.2	14.3	5.1	16.8	18.7	9.5	6.4	16.2	11.4	18.5	16.3	14.2	11.0	12.3	3.3	5.4	16.0	10.2	5.1	8.4	8.6	30.6	8.6	11.0	30.8	12.7	14.3	7.3	6.8	10.4	7.3	5.7	11.0	8.4	3.0	4.8	5.3	3.9	2.9	9.2	7.4	11.7	6.9	3.1	5.0	10.4	4.9	5.1	7.4	7.1	4.6	7.3	20.2	3.3	3.2	11.0	8.9	9.9	12.9	4.4	6.1	24.9	5.8	10.4	7.8	10.4	10.9	6.6	8.4	7.2	9.6	12.8	18.4	10.9	12.1	6.0	18.8	12.8	20.4	5.8	13.6	14.1	7.9	6.7	13.1	23.9	12.5	4.7	8.7	9.3	3.9	13.7	5.3	12.0	5.7	4.6	13.6	4.1	12.6	11.0	7.1	12.6	14.3	3.0	4.1	2.6	1.9	4.8	3.9	8.7	3.0	3.3	2.7	11.0	2.3	2.7	0.4	5.3	4.2	8.4	2.7	2.9	20.0	20.7	10.0	14.6	19.3	16.9	18.7	9.5	14.2	12.7
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392644-177559299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Enhanced	Peroxisomes	"Intracellular and membrane"		9300	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favourable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	22.9	17.7	13.5	21.2	14.9	28.3	17.1	14.9	13.4	16.0	23.5	17.2	14.1	14.1	22.4	10.5	18.4	12.5	16.0	23.9	14.2	13.5	20.8	21.2	15.2	14.7	17.4	11.8	16.4	21.2	37.0	11.7	14.7	15.0	14.7	24.0	8.0	18.2	10.8	23.2	9.6	17.6	21.3	31.8	17.1	14.5	19.1	13.7	29.5	14.2	14.4	14.5	16.9	20.7	3.4	7.6	11.2	6.8	5.6	6.4	3.0	17.7	11.4	8.1	8.3	10.4	11.4	19.3	13.9	6.9	11.9	11.8	21.2	12.4	20.0	30.4	14.4	19.4	21.8	14.2	15.6	26.4	7.4	27.8	19.8	24.9	10.6	30.1	29.6	9.9	9.0	19.1	15.2	23.8	19.0	12.5	14.3	0.0	24.3	10.2	13.8	18.9	19.5	24.2	12.1	20.3	21.3	10.0	12.1	26.4	2.3	16.4	0.1	12.5	24.4	10.7	36.7	10.9	24.3	16.2	28.0	10.0	9.8	13.5	4.1	3.8	6.1	11.2	4.3	6.7	6.4	3.4	5.5	5.3	7.6	2.1	5.3	3.1	1.3	5.6	6.8	0.7	6.2	3.0	13.5	14.9	14.9	13.4	14.2	13.5	17.4	11.8	15.0	13.7
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 160.2;gallbladder: 147.0;seminal vesicle: 159.4"	"Cell line enhanced"	"Detected in some"		"A549: 31.4;RPTEC TERT1: 75.0;RT4: 44.3;T-47d: 160.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		22000	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	0.9	0.9	0.9	23.0	0.9	0.0	5.3	0.9	0.9	52.8	58.8	1.3	160.2	36.5	4.8	51.9	4.0	23.7	147.0	0.9	0.9	0.9	3.3	0.9	19.0	0.0	0.8	0.0	4.0	59.2	0.0	11.3	1.6	0.1	18.8	97.7	0.0	70.0	159.4	0.9	1.1	62.2	3.3	0.8	0.9	107.6	0.9	0.0	0.1	1.1	20.0	97.7	13.2	3.7	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.1	4.7	0.0	0.0	0.0	3.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	10.4	0.0	1.3	0.0	0.0	0.0	0.0	5.2	0.1	0.2	0.0	18.7	0.1	0.0	0.6	75.0	44.3	0.2	0.2	0.0	12.0	0.0	160.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.8	0.0	0.1	0.0
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859405-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 40.5;intestine: 99.1"	"Cell line enriched"	"Detected in some"	41	"T-47d: 86.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"		31000	"Endoplasmic reticulum"	Vesicles	"HPA053942: "	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.0	0.6	7.5	0.7	0.0	13.1	0.7	0.6	4.4	45.8	0.6	0.6	29.2	1.2	5.4	0.9	40.5	11.8	0.6	0.6	0.3	1.5	0.6	26.3	0.6	0.6	0.6	5.1	1.9	0.0	12.9	2.8	1.9	1.1	38.9	0.6	9.4	0.6	0.6	0.3	99.1	1.2	0.8	0.6	17.1	1.0	0.6	0.6	1.4	1.9	3.9	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.3	0.1	0.0	0.1	0.0	86.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.6	0.6	0.3	0.6	0.6	1.9	0.6
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020123-1056118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 45.6;EFO-21: 53.1;HaCaT: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		15000000	"Plasma membrane, Cytosol"		"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	10.2	2.8	13.0	5.3	12.4	2.9	8.3	2.3	24.0	11.3	8.5	20.5	8.9	9.8	8.2	14.5	8.8	11.4	37.2	8.1	10.9	8.3	36.0	9.3	18.1	2.3	9.3	7.0	7.6	25.2	5.7	5.0	11.0	12.7	8.7	2.5	13.6	26.5	10.8	4.7	18.6	11.2	3.9	7.7	7.2	14.1	7.5	8.1	6.4	27.0	9.5	7.6	13.7	6.2	0.0	0.1	0.0	0.5	0.0	1.1	0.1	26.5	16.5	3.2	10.7	0.5	0.7	28.8	13.4	4.3	9.0	5.5	13.9	45.6	0.5	53.1	2.0	46.2	1.1	16.5	1.0	1.0	6.3	0.0	21.6	14.5	3.9	0.3	5.4	2.4	7.2	2.8	6.2	1.5	5.5	0.1	0.7	21.8	0.2	3.8	6.9	12.0	4.2	6.3	4.0	15.8	11.8	0.8	6.4	27.3	29.6	26.0	26.0	2.0	23.5	11.1	39.3	1.5	10.8	0.3	0.2	0.9	7.0	2.4	2.9	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	13.0	12.4	2.3	22.0	10.9	8.3	9.3	7.0	12.7	8.1
AGTRAP	ATRAP	ENSG00000177674	"Angiotensin II receptor associated protein"	Q6RW13	1	11736084-11754802	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 96.5"	"Cell line enhanced"	"Detected in many"		"U-937: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044120	Approved		Supported	Vesicles				Vesicles		"HPA044120: AB_10960748"	"unprognostic (1.08e-3)"	"unprognostic (2.98e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavourable (6.57e-7)"	"unprognostic (4.44e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.89e-2)"	16.5	19.2	8.7	16.6	10.8	65.5	31.0	3.1	10.0	13.0	9.7	16.7	15.6	6.5	10.3	37.0	19.6	28.4	14.5	22.0	8.9	6.9	29.7	11.0	26.4	35.6	14.2	6.6	15.0	27.2	7.9	12.2	15.2	16.5	33.2	5.6	17.1	22.2	13.5	25.3	13.2	8.4	13.4	12.9	31.0	12.3	15.3	10.7	11.4	25.5	12.6	14.6	15.2	26.0	5.2	35.2	85.3	96.5	7.7	21.7	53.1	14.8	18.4	4.6	10.2	7.8	10.0	8.6	7.8	13.5	9.6	8.4	11.7	36.2	1.6	35.7	9.5	12.6	7.7	37.2	3.0	0.8	16.9	0.4	11.1	13.9	24.3	7.3	18.1	9.9	29.5	31.6	16.8	12.9	19.5	14.7	5.4	12.2	3.6	21.6	8.2	18.8	1.2	4.2	7.4	15.8	1.4	4.1	6.1	14.4	7.3	13.3	16.6	15.6	7.3	12.5	8.7	19.5	8.2	5.5	6.4	8.7	31.7	53.0	5.7	45.4	96.5	74.3	21.7	47.6	10.8	5.2	8.2	12.9	35.2	4.0	8.8	11.7	85.3	7.7	39.8	2.9	9.6	53.1	8.7	10.8	3.1	10.0	8.9	6.9	14.2	6.6	16.5	10.7
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine-glyoxylate aminotransferase"	P21549	2	240868479-240880502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	172	"liver: 247.3"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 13.1"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles			5200000	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favourable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	247.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.2	0.0	0.0	0.0	0.1	0.0	0.8	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931978	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.4"	"Group enriched"	"Detected in many"	5	"B-cells: 5.0;granulocytes: 8.4;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	20.2	13.7	10.4	11.0	17.4	17.3	14.3	23.3	12.9	12.2	12.6	7.5	10.3	8.3	13.8	8.2	10.7	14.7	8.9	14.9	10.1	6.8	13.4	13.1	9.7	9.5	11.6	8.3	23.3	12.3	19.2	17.6	10.7	10.9	10.1	8.1	7.4	10.7	11.5	15.6	11.3	10.3	10.1	11.4	12.5	12.7	33.9	11.3	17.9	15.3	8.8	9.7	14.5	20.9	5.0	1.1	8.4	0.9	0.7	2.9	0.7	23.7	12.1	10.7	9.4	10.7	10.7	22.7	17.3	8.5	12.6	10.4	11.8	9.1	23.6	18.9	9.0	20.5	17.1	8.9	21.4	16.7	7.2	14.9	13.2	10.3	8.0	21.5	11.7	10.1	7.9	16.3	16.7	9.2	41.3	11.5	12.0	5.5	16.0	9.8	24.9	13.2	19.7	17.4	18.3	7.8	12.0	13.5	19.7	22.7	8.6	9.2	11.1	13.4	11.9	13.0	15.0	18.3	32.5	21.0	29.4	26.4	10.5	13.7	12.6	0.7	0.6	1.7	1.7	0.3	1.3	5.0	1.9	1.6	0.8	1.3	2.9	1.5	8.4	0.7	0.9	1.1	2.9	0.7	10.4	17.4	23.3	12.9	10.1	6.8	11.6	8.3	10.9	11.3
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA041225, HPA044675"	Approved		Supported	Cytosol			3900000	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	15.3	18.6	11.7	15.4	15.0	17.0	24.3	6.3	16.4	25.1	30.0	14.7	18.4	24.6	20.2	23.9	43.4	26.6	22.4	26.0	12.0	12.8	52.2	99.8	19.1	18.1	16.0	10.6	39.1	72.0	15.7	15.0	44.5	13.2	26.9	20.2	14.4	32.4	18.3	48.2	14.8	20.4	18.8	15.7	17.9	22.2	33.3	13.4	25.0	52.8	31.0	29.2	18.2	20.5	9.1	24.1	2.3	26.0	4.6	7.4	11.4	36.8	48.4	20.5	36.2	24.0	25.8	23.6	15.2	21.8	33.9	27.0	130.7	31.9	57.5	27.1	19.4	42.4	48.3	85.2	21.8	7.6	29.3	69.4	24.1	84.1	25.8	32.3	22.8	53.4	38.8	21.0	33.9	23.1	33.7	14.6	17.9	39.1	42.2	30.6	26.3	47.2	31.7	52.2	40.4	30.3	26.3	35.6	23.7	30.3	36.0	50.4	54.1	30.1	14.6	29.5	31.4	14.8	28.6	21.8	31.9	34.6	21.7	20.0	15.7	2.3	13.7	0.4	4.1	26.0	6.7	9.1	6.0	5.3	21.1	7.8	6.6	7.4	1.1	4.6	16.5	24.1	6.7	11.4	11.7	15.0	6.3	16.4	12.0	12.8	16.0	10.6	13.2	13.4
AHCYL1	"IRBIT, PPP1R78, XPVKONA"	ENSG00000168710	"Adenosylhomocysteinase like 1"	O43865	1	109984686-110023741	"Predicted intracellular proteins"	"One-carbon metabolism"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042589	Approved		Supported	Cytosol				Cytosol		"HPA042589: AB_10793885"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (7.00e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-3)"	24.0	25.7	61.7	11.7	71.2	4.8	19.7	33.2	61.4	26.7	26.3	47.7	17.7	46.5	21.0	36.0	18.3	28.0	24.7	13.9	51.6	57.2	38.6	25.4	16.5	10.5	72.3	49.9	17.6	27.1	53.0	16.3	20.6	55.7	17.3	19.7	9.7	17.9	25.8	27.1	14.2	22.9	21.8	48.8	12.1	19.6	10.2	47.5	6.8	28.6	8.6	13.4	16.7	15.3	8.0	6.2	8.7	9.3	3.9	8.2	3.7	22.6	19.4	18.2	18.8	44.1	26.0	30.1	18.0	20.4	17.1	16.9	14.9	13.2	9.6	15.4	26.5	14.6	16.1	20.6	22.7	80.8	13.9	16.0	25.1	15.7	45.8	13.6	11.3	26.5	13.0	21.3	31.3	21.5	11.5	19.7	17.6	18.0	11.3	6.8	21.5	15.0	12.4	37.9	10.7	37.4	23.0	17.8	11.6	28.0	33.5	37.6	17.9	13.7	18.5	16.5	16.2	19.4	16.0	16.2	6.7	8.3	34.0	15.0	33.7	5.0	8.8	7.7	4.3	9.3	4.4	6.8	4.4	5.7	6.2	8.0	4.6	4.4	8.7	3.9	6.3	5.7	8.2	3.7	61.7	71.2	33.2	51.5	51.6	57.2	72.3	49.9	55.7	47.5
AHDC1	"DJ159A19.3, RP1-159A19.1"	ENSG00000126705	"AT-hook DNA binding motif containing 1"	Q5TGY3	1	27534035-27604431	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028648, HPA028685, HPA028691"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781"	"unprognostic (1.96e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (4.43e-1)"	"prognostic favourable (2.68e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (5.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	10.2	17.6	16.9	6.7	12.9	4.6	7.7	40.3	21.7	15.3	8.7	5.8	6.7	5.2	16.8	6.6	20.4	13.5	7.5	9.9	15.2	7.4	7.2	5.6	6.6	5.7	8.2	12.7	19.0	7.5	4.3	16.0	8.4	13.7	8.0	3.0	8.8	15.4	13.1	41.5	21.3	5.6	11.0	14.6	18.2	9.3	8.9	12.9	9.1	12.8	10.9	10.6	9.8	14.0	0.6	1.6	0.9	0.7	2.0	1.4	0.7	7.5	6.9	9.7	5.2	3.1	5.2	9.9	7.0	5.1	4.9	4.1	2.6	7.1	1.1	5.2	4.8	7.5	1.0	9.2	1.4	2.8	3.7	5.9	6.2	3.5	3.0	1.6	3.1	4.9	3.8	3.5	2.2	2.5	7.1	0.8	8.2	3.6	5.1	8.5	7.2	8.6	22.4	11.7	0.6	3.3	1.0	16.8	6.4	4.9	8.1	2.0	4.0	1.3	4.8	8.5	7.0	6.3	2.2	2.4	1.7	1.2	7.3	4.7	4.8	0.9	0.4	0.5	1.2	0.6	0.7	0.5	1.0	1.2	0.4	0.6	1.4	1.0	0.7	2.0	0.7	1.6	1.1	0.7	16.9	12.9	40.3	21.7	15.2	7.4	8.2	12.7	13.7	12.9
AHNAK	MGC5395	ENSG00000124942	"AHNAK nucleoprotein"	Q09666	11	62433542-62556235	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 84.9;fHDF/TERT166: 79.0;TIME: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019010, HPA019070, HPA026643"	Uncertain		Enhanced	"Plasma membrane,Cytosol"			950000	"Plasma membrane, Cytosol"		"HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.98e-3)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (3.47e-6)"	85.2	8.2	15.3	35.3	9.3	10.0	91.1	9.3	10.8	69.7	66.3	16.8	36.4	13.0	52.2	47.4	96.9	39.4	59.2	55.8	20.9	6.0	18.4	16.0	54.9	16.6	16.2	13.4	40.2	8.9	8.0	5.3	39.8	15.9	42.6	26.8	29.6	35.5	36.8	64.8	88.4	38.2	101.5	16.1	16.9	38.3	16.9	16.2	5.8	18.4	72.9	44.0	54.3	86.1	8.2	28.9	15.3	30.1	11.1	16.7	12.2	26.0	15.4	1.4	6.4	63.3	84.9	10.2	23.7	29.1	15.1	8.5	13.2	9.3	0.0	9.0	79.0	34.8	5.9	29.2	19.4	21.1	0.9	3.1	22.9	3.9	12.1	4.3	20.8	30.6	34.3	29.7	27.2	31.1	2.9	20.2	30.6	10.1	0.0	8.4	0.4	23.4	0.0	6.5	15.6	33.6	17.1	0.0	1.3	23.9	10.1	10.1	19.4	4.0	82.6	27.0	17.6	33.5	10.4	3.6	0.7	0.0	20.5	1.4	8.8	15.3	30.1	0.1	16.7	17.5	11.0	8.2	10.7	13.1	28.9	5.2	1.4	7.6	0.4	11.1	14.0	7.9	7.9	12.2	15.3	9.3	9.3	10.8	20.9	6.0	16.2	13.4	15.9	16.2
AHNAK2	C14orf78	ENSG00000185567	"AHNAK nucleoprotein 2"	Q8IVF2	14	104937244-104978357	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 131.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.1;ASC TERT1: 32.0;HBEC3-KT: 28.1;hTCEpi: 70.8;hTERT-HME1: 30.2;TIME: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"									"HPA000878, HPA002940, HPA004145, HPA020111"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA000878: , HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: "	"unprognostic (3.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.31e-3)"	"unprognostic (9.55e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (2.79e-5)"	"unprognostic (3.43e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavourable (4.05e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.23e-5)"	6.9	1.8	2.9	2.0	5.6	1.0	8.5	3.0	13.7	17.2	23.0	2.9	5.7	1.7	16.3	2.9	25.8	7.1	3.2	1.5	2.4	3.1	1.1	10.8	2.3	1.0	2.7	11.6	1.8	1.2	1.2	0.7	1.8	23.3	5.7	5.1	10.1	6.0	14.6	1.6	131.1	4.8	19.9	4.8	1.1	7.1	3.2	0.8	0.0	1.2	14.4	3.0	10.0	19.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	19.7	0.0	1.3	28.1	32.0	0.0	2.4	5.0	0.8	0.4	0.0	8.8	0.0	3.3	18.5	14.2	0.0	28.1	0.4	0.0	0.1	0.0	13.0	0.1	2.6	0.0	0.9	4.1	70.8	2.8	30.2	12.3	0.0	0.0	14.2	1.6	0.0	0.0	0.0	9.7	0.0	1.3	0.0	19.2	0.0	0.1	0.1	10.4	0.0	0.4	1.3	0.0	31.7	6.8	4.2	7.7	2.1	0.0	0.0	0.0	20.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.9	5.6	3.0	13.7	2.4	3.1	2.7	11.6	23.3	0.8
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.3;hTERT-HME1: 29.5;RT4: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.45e-2)"	23.1	12.2	2.5	13.2	3.5	19.8	19.1	1.6	3.5	14.6	14.0	5.7	8.7	8.5	11.9	10.1	14.2	11.2	22.2	14.8	3.2	2.2	7.3	23.9	26.4	20.0	6.5	2.5	21.3	6.8	4.5	3.8	69.6	3.7	21.4	8.9	10.9	11.1	8.5	5.2	16.6	13.7	12.1	4.8	15.6	13.3	6.8	4.0	7.1	12.4	7.9	12.3	26.7	26.6	1.1	9.3	5.6	7.6	3.1	2.9	2.0	3.0	2.5	1.0	0.0	7.7	5.3	0.4	6.3	9.2	2.9	4.3	3.1	6.8	0.0	1.9	9.3	8.5	0.6	5.8	7.8	0.1	1.4	1.8	3.2	2.7	14.5	3.0	4.5	7.2	28.3	11.2	29.5	9.8	0.2	0.0	13.3	1.6	0.0	4.8	0.8	4.0	0.0	0.0	0.1	9.4	24.3	0.9	0.0	4.7	5.2	4.6	3.6	1.0	1.6	1.2	0.0	16.1	0.0	1.3	0.0	0.0	20.6	11.9	20.2	0.7	7.6	5.6	0.7	3.6	1.1	0.8	2.6	1.4	9.3	1.1	1.5	1.1	0.8	3.1	1.3	2.2	2.9	2.0	2.5	3.5	1.6	3.5	3.2	2.2	6.5	2.5	3.7	4.0
AHRR	"AHH, AHHR, bHLHe77, KIAA1234"	ENSG00000063438	"Aryl-hydrocarbon receptor repressor"	A9YTQ3	5	304176-438291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 44.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 23.4;HMC-1: 35.1;NB-4: 42.2;WM-115: 24.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA021483			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021483: AB_1855110"	"unprognostic (2.06e-4)"	"unprognostic (3.48e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.33e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-6)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.55e-2)"	0.8	0.4	1.0	4.6	0.8	0.2	2.4	0.4	1.4	2.4	1.2	0.7	1.4	0.7	1.6	0.9	1.4	0.5	4.4	0.3	1.2	1.0	0.6	0.4	6.2	0.4	0.3	0.0	2.1	1.0	0.1	1.3	2.1	0.9	0.6	1.2	2.7	0.9	0.3	0.6	5.8	1.7	0.9	0.3	4.7	0.7	44.3	0.3	0.1	0.9	1.8	4.2	2.0	3.6	0.9	2.3	1.0	0.5	0.0	1.0	0.3	0.1	3.9	0.6	0.5	2.1	4.5	4.6	8.3	11.2	4.7	9.3	0.1	3.1	0.3	4.4	15.1	0.2	0.7	0.2	2.1	0.6	1.7	3.9	23.4	0.1	1.6	1.1	35.1	0.9	0.3	3.2	0.4	1.7	0.6	0.3	5.0	0.3	0.3	42.2	0.1	3.9	0.6	0.2	0.4	0.1	0.0	5.5	0.2	11.1	2.1	5.7	0.2	14.4	2.0	8.7	1.1	9.8	0.3	1.3	2.1	0.3	3.7	0.3	24.7	0.0	0.5	1.0	0.3	0.0	0.1	0.2	0.6	0.3	0.0	0.9	0.1	0.1	0.5	0.0	0.1	2.3	1.0	0.3	1.0	0.8	0.4	1.4	1.2	1.0	0.3	0.0	0.9	0.3
AHSA1	"Aha1, C14orf3, hAha1, p38"	ENSG00000100591	"Activator of HSP90 ATPase activity 1"	O95433	14	77457870-77469474	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000903, CAB006244"	Supported		Supported	Cytosol			28000	Cytosol		"CAB006244: AB_425858, HPA000903: AB_1078112"	"unprognostic (3.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavourable (5.04e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-1)"	23.7	39.3	37.8	26.9	44.4	20.7	58.9	33.1	52.1	25.7	27.9	22.6	28.9	21.0	31.7	34.9	27.2	56.4	18.6	47.8	38.2	38.2	31.5	28.4	21.9	29.4	61.8	29.7	30.3	25.4	32.0	37.0	34.9	50.1	32.0	34.9	11.5	24.7	35.3	48.5	20.8	20.7	40.0	42.5	21.5	22.8	40.5	54.3	26.0	37.6	24.5	40.3	24.8	177.1	44.3	36.6	34.5	45.1	42.3	42.3	26.9	33.4	66.2	18.1	23.7	28.1	20.3	31.9	25.0	19.8	39.3	29.5	49.6	29.0	62.4	19.6	24.4	38.4	65.4	32.0	43.8	24.8	38.9	29.4	33.0	59.8	20.8	18.6	42.5	17.9	42.8	26.4	12.9	37.0	36.3	20.1	24.5	92.1	45.6	35.3	31.5	69.8	36.8	21.5	31.1	30.9	34.9	28.0	30.8	23.1	51.8	21.4	31.6	25.6	19.2	21.3	30.3	23.8	35.5	20.3	40.8	47.9	30.9	37.2	23.4	32.6	28.2	34.5	37.8	39.0	42.3	44.3	34.8	38.7	36.6	34.3	40.0	40.1	20.2	42.3	45.1	34.1	40.0	26.9	37.8	44.4	33.1	52.1	38.2	38.2	61.8	29.7	50.1	54.3
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186612923-186621318	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	269	"liver: 402.0"	"Cell line enriched"	"Detected in some"	77	"Hep G2: 210.3"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	225100000000	140000000000	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	402.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	210.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor, mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"	Apoptosis	"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 41.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA028961: , HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.92e-4)"	32.9	7.8	3.1	6.6	5.9	1.3	41.9	5.0	3.7	3.5	9.0	2.1	22.1	7.6	4.5	9.6	9.1	4.0	7.6	19.7	2.8	4.1	10.2	18.2	8.1	4.0	2.9	2.4	7.5	3.6	3.9	3.1	5.2	3.5	6.4	5.9	9.2	5.8	15.2	9.1	2.8	9.9	7.8	3.7	5.9	6.5	3.1	2.1	1.0	10.8	6.4	7.3	11.8	15.7	3.4	0.7	1.5	1.0	7.8	3.5	1.2	8.6	15.1	0.4	3.9	9.1	3.4	0.1	3.5	8.6	7.2	8.1	11.6	16.8	1.2	8.9	4.8	9.4	4.3	1.2	2.0	16.9	0.7	0.0	8.9	56.6	19.6	0.0	2.2	4.6	2.8	11.5	2.4	3.2	6.6	7.5	3.7	11.0	0.3	0.4	1.5	4.9	0.2	1.4	4.1	3.8	6.4	1.3	0.3	6.4	5.6	9.8	0.2	2.4	3.9	0.1	8.9	5.3	10.1	5.6	10.4	2.4	4.8	0.3	4.7	1.5	0.9	1.0	3.5	0.8	3.1	3.4	1.2	3.0	0.7	2.9	1.7	2.7	1.0	7.8	1.0	0.5	2.4	1.2	3.1	5.9	5.0	3.7	2.8	4.1	2.9	2.4	3.5	2.1
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 44.7;lymphoid tissue: 43.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.1;HDLM-2: 43.3;Karpas-707: 17.2;U-266/70: 14.5;U-266/84: 10.9;U-87 MG: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"memory B-cell: 44.7;naive B-cell: 14.3"	"Lineage enriched"	"Detected in many"	9	"B-cells: 44.7"	"Low region specificity"	"Detected in all"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: "	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	0.7	0.3	1.3	28.2	0.9	0.4	0.6	0.5	0.6	0.4	1.9	0.1	0.0	0.7	0.2	0.2	4.1	0.5	1.1	0.5	1.2	0.6	0.9	0.8	2.0	24.1	0.5	0.2	0.6	0.3	0.0	8.8	0.4	0.5	0.7	1.0	0.5	1.9	0.0	0.2	0.3	12.8	0.2	2.6	43.8	1.3	1.4	1.4	1.4	0.7	0.6	25.9	4.0	0.5	44.7	1.2	4.7	2.4	0.0	3.3	1.4	5.2	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.5	0.4	0.3	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.3	43.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	2.8	0.0	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	14.5	10.9	0.2	13.4	1.1	2.2	4.2	2.4	0.0	0.6	2.1	1.7	44.7	1.6	1.1	1.2	14.3	0.1	0.4	4.7	0.0	2.2	0.0	3.3	1.4	1.3	0.9	0.5	0.6	1.2	0.6	0.5	0.2	0.5	1.4
AIMP1	"EMAP-2, EMAPII, p43, SCYE1"	ENSG00000164022	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 1"	Q12904	4	106315544-106349226	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis"	"Cytokine, RNA-binding, tRNA-binding"	Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017618, HPA018476"	Supported		Enhanced	Cytosol	"Secreted to blood"	6500000		Cytosol		"CAB017618: AB_2285445, HPA018476: AB_1848137"	"unprognostic (1.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	30.7	26.6	20.2	25.7	24.5	42.2	30.3	22.5	22.9	29.9	33.7	17.0	33.6	27.7	29.3	28.4	35.0	25.6	23.7	23.6	21.2	18.4	40.4	35.3	23.4	24.6	29.8	21.8	35.9	27.2	24.1	44.0	27.3	26.5	29.8	28.4	14.1	25.6	32.1	67.8	22.6	39.1	32.8	30.1	26.9	25.2	15.9	29.4	31.3	35.9	40.6	25.8	41.2	25.9	28.2	35.9	24.6	32.7	23.7	33.4	16.6	22.7	14.6	15.4	21.6	18.4	27.6	25.7	30.4	23.3	23.7	28.5	25.0	33.5	40.3	22.9	25.2	22.7	23.3	28.8	34.0	22.4	14.6	23.7	18.8	39.8	35.2	46.9	27.5	21.3	33.2	25.2	41.0	20.5	40.6	21.7	26.2	16.4	31.7	22.4	17.4	14.5	26.0	31.0	36.2	29.4	19.8	24.6	18.2	19.4	53.6	27.3	25.6	33.1	17.5	31.4	28.6	23.2	35.3	24.7	34.6	41.1	26.1	36.8	33.6	22.4	26.9	24.6	21.8	29.0	26.0	27.7	27.3	21.8	27.6	28.2	28.5	25.9	3.7	23.7	32.7	35.9	33.4	16.6	20.2	24.5	22.5	22.9	21.2	18.4	29.8	21.8	26.5	29.4
AIP	"ARA9, FKBP16, XAP2"	ENSG00000110711	"Aryl hydrocarbon receptor interacting protein"	O00170	11	67483041-67491103	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033674, HPA050217, CAB069477"	Approved		Supported	Cytosol				Cytosol		"CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: "	"unprognostic (2.59e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.45e-2)"	23.1	30.5	30.7	31.1	32.6	25.1	29.0	30.3	34.2	27.8	38.5	26.6	24.2	23.7	30.6	24.2	30.8	25.0	28.6	34.7	28.0	25.4	28.0	20.7	24.7	55.2	34.2	24.6	45.5	23.0	18.2	22.0	23.6	27.1	36.2	14.6	21.4	25.0	28.1	26.5	15.9	25.0	29.8	30.2	37.9	22.9	18.2	30.4	34.6	38.0	16.6	33.5	33.1	60.6	56.5	49.8	36.9	38.0	37.6	80.0	41.7	20.5	23.9	13.8	13.2	17.7	17.8	10.5	13.0	16.3	22.5	16.5	37.4	20.5	36.7	31.8	14.3	16.7	15.5	13.6	8.6	53.6	16.8	22.2	26.1	22.2	18.4	22.2	39.0	21.2	12.9	19.9	13.0	11.4	12.6	22.1	14.6	39.4	47.2	54.8	13.0	30.7	21.0	20.9	32.4	15.6	12.3	21.8	21.8	16.8	12.0	51.2	16.2	22.6	18.8	19.8	19.3	29.0	11.9	18.1	24.8	28.7	27.1	17.4	15.2	36.9	28.9	31.0	49.5	33.4	53.5	56.5	58.5	57.9	43.1	48.7	53.2	50.8	19.0	37.6	38.0	49.8	80.0	41.7	30.7	32.6	30.3	34.2	28.0	25.4	34.2	24.6	27.1	30.4
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866480-127877743	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 84.5;skeletal muscle: 279.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol			32000000	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	7.7	9.2	19.6	3.7	18.8	6.5	3.9	9.8	17.3	10.5	8.6	18.1	12.2	5.2	3.4	17.3	9.0	84.5	12.0	60.4	17.6	18.5	6.3	10.7	18.7	2.2	16.4	15.3	12.3	4.6	5.6	7.1	2.9	17.5	5.2	10.8	7.0	13.4	15.7	279.0	3.4	2.6	6.3	11.5	5.6	5.8	9.8	11.1	0.0	10.5	61.5	4.0	4.4	4.4	1.2	3.4	2.8	0.4	1.4	1.5	1.2	15.2	6.6	8.4	11.5	20.5	41.8	7.7	10.6	10.7	18.9	11.5	4.8	9.7	0.4	11.6	21.8	22.0	0.0	11.8	7.6	2.4	7.3	2.2	18.9	8.4	11.5	0.0	0.3	31.7	23.0	14.0	10.2	25.2	8.9	0.6	21.4	14.5	0.0	0.3	3.0	20.4	0.4	8.5	3.3	12.6	1.1	13.7	8.5	28.0	16.1	8.1	12.9	9.1	20.8	13.2	5.4	46.5	10.1	1.0	0.1	0.0	16.6	0.0	9.2	0.9	0.4	0.4	1.5	0.3	1.1	0.3	0.6	1.1	0.1	1.2	0.3	1.1	2.8	1.4	0.4	3.4	0.3	1.2	19.6	18.8	9.8	17.3	17.6	18.5	16.4	15.3	17.5	11.1
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709559-4742043	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 85.0;HEL: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063324	Enhanced		Supported	Mitochondria			68000	Mitochondria		"HPA063324: "	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favourable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	24.6	25.1	20.9	9.8	22.4	6.8	24.0	14.6	17.5	17.7	23.7	15.3	16.0	24.4	18.9	17.5	28.3	14.0	16.1	90.0	22.4	16.4	37.7	75.1	16.4	13.1	25.2	15.2	22.4	15.7	16.9	14.1	13.0	22.9	19.0	23.0	17.4	14.5	19.1	72.0	18.1	22.0	21.2	24.1	12.1	22.5	9.3	24.9	15.2	20.8	32.8	14.9	20.1	17.1	7.0	14.4	17.0	5.6	14.7	17.1	10.2	8.7	7.3	12.5	5.1	17.5	12.9	0.9	11.0	26.0	6.9	10.4	1.2	9.7	8.1	3.8	14.0	5.6	9.1	10.6	11.8	85.0	6.9	54.4	13.0	22.0	13.8	5.7	2.8	20.4	9.5	5.9	8.2	20.3	4.1	11.1	20.7	5.2	5.5	16.5	11.2	2.7	7.4	4.5	4.0	20.2	12.2	20.7	13.0	12.9	4.2	7.4	5.8	11.4	12.6	5.8	5.9	15.2	8.6	2.8	1.8	10.0	10.6	4.3	4.1	6.8	5.6	17.0	16.2	4.4	14.7	7.0	12.5	14.8	10.5	6.9	16.6	17.1	1.9	14.7	3.4	14.4	16.7	10.2	20.9	22.4	14.6	17.5	22.4	16.4	25.2	15.2	22.9	24.9
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 89.7;liver: 50.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;myeloid DC: 5.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1"	"Low region specificity"	"Detected in all"							"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"		18000	Mitochondria		"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (4.36e-4)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	12.4	1.6	11.7	3.7	11.2	2.7	13.4	12.0	9.9	4.0	9.5	4.0	4.7	2.7	3.9	4.4	12.3	4.2	8.6	26.0	9.3	7.1	89.7	50.7	1.6	1.4	6.3	9.1	5.8	1.8	8.2	2.6	4.5	7.2	8.9	7.7	4.4	9.4	7.3	2.2	14.0	3.5	13.6	8.1	1.2	7.8	6.0	5.0	0.4	1.9	5.7	3.2	12.4	7.4	0.5	5.3	1.6	6.1	0.6	0.5	1.4	20.2	1.4	1.6	6.9	15.3	14.6	3.5	3.4	4.3	7.4	20.8	30.4	2.4	10.9	9.0	5.3	13.1	5.4	25.6	30.0	9.1	6.2	10.6	6.8	58.2	0.7	8.2	1.3	8.1	14.4	7.3	21.4	0.2	13.1	0.1	11.3	8.7	0.3	0.3	7.1	12.2	0.0	11.9	1.9	11.0	0.9	5.9	4.5	6.1	0.4	4.8	8.5	3.6	1.2	12.4	10.7	0.9	5.8	11.5	5.1	0.6	20.1	3.0	0.7	1.6	6.1	0.0	0.2	1.4	0.4	0.5	0.2	0.5	5.3	0.4	0.2	0.2	1.0	0.6	0.2	0.8	0.1	1.4	11.7	11.2	12.0	9.9	9.3	7.1	6.3	9.1	7.2	5.0
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282051-77559969	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.7;BJ: 20.3;fHDF/TERT166: 23.1;LHCN-M2: 58.2;U-2 OS: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 10.9;naive CD4 T-cell: 14.2"	"Group enriched"	"Detected in many"	15	"dendritic cells: 10.9;T-cells: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: "	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favourable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.8	2.1	43.8	1.9	35.7	3.7	14.1	1.3	95.5	2.0	1.8	20.4	0.0	1.8	1.6	1.5	1.8	1.8	1.7	1.5	35.8	11.8	2.0	1.2	1.4	2.5	13.0	41.1	1.5	2.1	2.4	1.4	1.8	11.4	2.7	1.8	0.0	3.1	2.7	1.3	2.4	1.7	1.7	14.2	2.4	2.9	7.3	13.9	0.0	1.7	0.0	2.1	1.5	0.4	0.8	10.9	0.7	0.7	0.1	14.2	1.9	0.0	1.1	0.8	0.0	10.9	29.7	0.4	20.3	4.3	3.3	1.4	0.1	0.5	0.1	0.1	23.1	0.1	0.0	0.0	1.7	0.7	0.2	0.1	0.1	0.0	0.5	0.1	0.0	3.6	0.1	0.6	1.3	9.5	0.2	0.2	58.2	0.2	0.0	0.1	1.1	7.4	0.5	2.1	0.3	9.0	0.3	4.5	1.1	0.0	0.0	1.2	0.1	0.1	2.3	8.0	18.2	0.4	0.6	4.7	4.2	0.0	1.6	1.0	2.9	0.7	0.7	0.0	3.4	0.1	0.5	0.8	3.2	1.6	10.9	0.8	14.2	7.8	0.5	0.1	0.2	1.2	1.4	1.9	43.8	35.7	1.3	47.1	35.8	11.8	13.0	41.1	11.4	13.9
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"				"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	27.6	27.7	25.1	16.9	25.4	14.8	23.3	21.5	23.6	17.6	22.7	11.3	16.4	18.3	18.3	30.4	26.7	15.4	15.1	17.9	23.2	22.2	30.2	42.3	17.0	18.7	20.9	16.2	18.8	17.2	15.8	26.3	21.5	23.3	18.2	20.6	12.3	14.5	14.6	41.4	11.9	24.0	16.7	19.6	21.8	17.0	46.1	17.5	25.2	24.3	24.2	18.8	19.7	13.7	22.2	22.0	14.3	15.9	16.6	21.2	10.0	17.2	9.6	12.6	16.8	20.7	13.8	23.7	26.0	9.8	12.8	15.9	26.8	14.9	37.0	24.6	11.8	5.8	19.7	12.4	19.6	15.1	9.5	18.2	20.5	20.4	16.9	21.6	7.9	8.0	16.4	12.7	18.3	8.3	17.0	12.2	16.4	20.0	19.9	14.6	10.5	6.4	23.4	15.7	20.5	20.1	14.1	6.5	6.4	13.4	10.8	18.6	11.5	24.4	10.9	9.6	15.4	17.9	21.5	14.7	30.6	32.8	12.4	31.8	12.4	13.7	13.0	14.3	15.5	15.9	16.1	22.2	18.4	19.3	18.0	18.1	20.1	21.2	2.1	16.6	14.2	22.0	18.1	10.0	25.1	25.4	21.5	23.6	23.2	22.2	20.9	16.2	23.3	17.5
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA030804: , HPA030805: , HPA031779: AB_10603674, HPA031781: , HPA036324: , HPA036711: "	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	4.6	4.7	7.7	5.6	8.4	4.7	8.3	13.5	8.7	5.0	6.5	8.5	4.1	5.0	6.3	11.1	6.2	11.3	5.2	6.9	9.1	10.3	7.6	4.5	6.7	5.5	9.4	4.9	6.7	4.6	15.4	33.3	4.4	11.5	5.9	6.7	3.7	7.0	6.3	6.1	5.5	6.2	5.7	11.7	6.5	6.1	22.0	7.7	20.5	11.4	4.1	5.0	5.9	4.4	11.2	2.9	15.1	4.1	4.9	6.4	1.6	2.6	1.8	7.7	13.7	7.2	4.5	5.7	4.0	5.0	4.2	5.8	2.9	5.3	5.6	2.1	3.8	4.6	2.2	4.4	9.0	11.9	4.8	4.2	4.5	2.9	5.9	5.3	2.6	3.6	8.5	7.8	10.2	5.5	4.0	4.7	3.1	5.3	4.6	3.6	1.7	2.9	6.1	4.3	5.2	6.2	5.1	9.4	8.0	4.9	4.7	6.7	6.0	6.5	5.9	4.1	2.7	5.9	2.6	2.5	2.1	3.3	8.2	6.7	2.2	15.1	2.8	6.5	5.1	1.5	4.4	10.5	5.1	6.1	2.0	11.2	6.4	5.5	5.4	4.9	4.1	2.9	3.6	1.6	7.7	8.4	13.5	8.7	9.1	10.3	9.4	4.9	11.5	7.7
AKAP1	"AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17"	ENSG00000121057	"A-kinase anchoring protein 1"	Q92667	17	57085092-57121349	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 80.1;testis: 75.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008620, HPA008691, CAB019286"	Supported		Supported	Mitochondria				Mitochondria		"CAB019286: , HPA008620: , HPA008691: AB_1078119"	"unprognostic (5.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.00e-1)"	"prognostic favourable (7.86e-9)"	"unprognostic (6.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.38e-1)"	16.4	6.1	13.5	9.2	16.3	2.8	14.7	13.4	12.5	10.3	28.1	8.7	9.3	22.6	10.2	14.3	18.1	12.5	19.2	35.0	10.0	6.6	11.9	26.4	8.3	4.4	13.6	9.9	9.0	16.4	18.8	7.1	3.3	7.9	15.5	20.6	9.3	13.6	13.9	80.1	10.2	25.2	23.5	8.4	4.9	22.2	75.4	10.1	4.7	14.9	19.7	7.4	20.5	9.8	3.3	6.5	2.8	3.3	6.0	7.4	2.1	16.5	20.7	28.8	9.4	7.5	4.9	17.3	6.9	6.7	9.1	6.5	22.1	14.9	26.6	19.7	5.3	26.3	16.1	15.2	9.2	14.5	23.4	22.6	18.3	42.0	7.0	21.2	8.7	4.3	15.1	10.1	14.2	9.2	15.0	10.3	5.2	14.1	26.7	8.1	10.5	22.3	20.6	12.2	21.7	6.1	19.6	22.1	14.5	5.5	16.1	9.0	11.0	21.9	6.8	8.0	9.0	10.3	15.6	10.2	12.7	20.0	5.1	16.6	7.1	2.8	1.7	0.6	4.7	3.3	4.1	3.3	3.8	3.8	4.0	2.4	7.4	4.0	0.2	6.0	0.9	6.5	2.8	2.1	13.5	16.3	13.4	12.5	10.0	6.6	13.6	9.9	7.9	10.1
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	20.5	24.2	22.5	19.4	25.5	16.1	21.2	22.8	27.9	21.2	19.4	17.4	13.4	16.1	22.3	15.9	18.5	19.2	18.4	14.4	20.1	17.9	22.7	14.9	18.5	24.3	22.4	23.2	24.3	16.2	28.0	20.3	20.3	19.2	19.5	20.3	16.1	17.8	21.3	13.7	17.5	18.5	22.9	19.0	28.6	20.2	22.9	24.2	25.9	26.0	9.1	20.5	22.2	22.7	7.3	6.1	24.4	10.3	5.1	7.9	3.0	11.0	13.3	8.9	6.2	11.8	14.9	16.4	12.9	13.9	14.4	17.4	14.4	6.7	9.5	8.8	10.2	11.8	11.4	10.8	19.7	7.8	9.8	8.1	13.0	6.9	11.2	5.9	13.4	12.5	13.6	13.1	16.3	11.6	5.2	4.8	15.0	8.0	10.9	8.8	5.8	4.6	7.3	29.2	4.9	12.0	7.0	3.0	9.1	14.9	7.0	12.3	17.0	6.6	10.1	11.2	9.3	9.5	11.9	6.0	6.4	11.6	14.8	7.1	10.7	3.6	7.3	8.8	6.7	10.3	6.1	6.0	6.5	7.2	6.1	7.3	7.9	7.0	24.4	5.1	9.3	4.6	4.9	3.0	22.5	25.5	22.8	27.9	20.1	17.9	22.4	23.2	19.2	24.2
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239999-151358557	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 43.1;TIME: 42.9;U-251 MG: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	184	"basophil: 20.4"	"Lineage enriched"	"Detected in single"	184	"granulocytes: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			6400000	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavourable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	52.5	11.2	11.5	11.0	18.1	2.0	38.5	31.3	21.2	11.5	23.4	1.9	5.9	6.1	20.5	13.6	12.8	15.6	32.3	22.8	9.8	17.4	14.9	20.6	18.2	6.9	11.4	9.9	49.0	7.6	2.0	11.1	24.1	28.7	13.5	9.4	26.6	3.3	14.7	11.3	4.1	10.6	27.9	14.1	8.1	12.4	62.0	6.6	0.3	11.4	6.6	2.8	34.5	24.7	0.0	0.0	20.4	0.0	0.0	0.1	0.0	1.7	8.6	12.4	0.0	23.4	35.1	4.3	10.0	5.4	4.5	4.5	0.2	32.5	0.0	4.0	7.5	0.2	23.5	7.4	4.0	11.1	8.6	0.1	9.6	7.9	2.6	0.0	2.2	24.8	0.0	19.1	1.0	29.4	2.1	0.2	16.3	0.1	0.0	0.0	7.7	10.1	43.1	0.5	0.0	26.1	1.4	8.8	5.1	3.2	0.1	5.7	0.6	0.1	42.9	0.6	8.0	25.6	45.9	0.0	0.0	0.0	14.9	0.0	8.6	20.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.1	31.3	19.1	9.8	17.4	11.4	9.9	28.7	6.6
AKAP13	"AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB"	ENSG00000170776	"A-kinase anchoring protein 13"	Q12802	15	85380571-85749358	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019773	Approved		Supported	Cytosol				Cytosol		"HPA019773: AB_1844686"	"unprognostic (4.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.69e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.81e-3)"	35.9	11.1	7.2	32.5	9.3	23.7	17.1	1.9	7.8	24.6	13.6	8.4	23.0	7.8	57.8	24.5	16.1	16.3	22.1	40.5	8.8	6.1	10.9	14.0	54.9	40.1	9.0	5.5	20.0	26.4	8.0	40.5	22.5	12.4	16.7	10.4	17.2	17.8	26.5	35.8	17.0	21.0	37.4	13.7	42.9	17.8	15.0	7.1	36.0	26.0	18.7	38.6	24.6	18.2	19.3	27.1	61.4	19.4	27.7	35.4	11.0	4.6	10.2	7.4	2.7	11.2	12.5	4.1	3.8	8.1	3.3	3.2	3.9	3.8	21.4	5.4	6.5	9.5	8.1	3.4	3.2	15.7	4.1	28.1	6.9	2.9	6.2	5.6	56.6	9.1	9.1	4.1	14.0	8.8	1.8	10.2	5.0	2.2	8.1	4.3	4.7	4.2	5.8	7.4	7.8	5.3	9.4	4.7	8.5	10.1	2.9	5.2	2.1	4.8	10.0	4.0	2.8	2.4	3.7	16.1	10.1	17.1	2.4	18.7	3.1	61.4	17.8	46.3	35.4	14.9	19.7	19.3	23.7	26.2	10.3	19.2	20.1	22.1	29.0	27.7	19.4	27.1	18.8	11.0	7.2	9.3	1.9	7.8	8.8	6.1	9.0	5.5	12.4	7.1
AKAP17A	"721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y"	ENSG00000197976	"A-kinase anchoring protein 17A"	Q02040	X	1591593-1602514	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043247, HPA051020"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA043247: AB_10964776, HPA051020: "	"unprognostic (4.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.25e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.91e-3)"	"prognostic favourable (2.42e-4)"	"unprognostic (1.55e-3)"	"prognostic unfavourable (3.52e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.03e-2)"	"prognostic favourable (1.11e-5)"	7.4	10.3	28.1	14.5	42.3	18.0	24.5	27.5	25.2	32.8	7.2	2.5	2.5	14.2	40.9	9.7	9.2	9.1	7.4	12.5	27.1	3.4	20.3	16.4	12.2	15.4	37.6	27.1	38.0	15.6	5.2	31.0	42.7	33.7	12.6	4.3	2.5	17.0	7.8	6.9	12.3	11.6	3.2	27.8	21.4	14.2	7.0	37.2	2.5	16.1	2.5	8.9	6.8	47.6	1.8	1.8	7.0	1.0	1.3	1.6	0.4	9.5	12.3	9.8	11.1	4.8	6.2	24.1	10.4	4.2	8.4	7.1	13.6	8.8	14.4	6.7	5.1	8.4	6.0	5.2	5.0	11.8	20.5	17.9	11.8	12.6	10.4	6.9	30.1	5.5	9.6	6.2	6.9	5.7	11.2	9.1	4.9	6.3	15.3	30.0	14.7	10.7	11.6	11.7	12.0	5.6	6.6	11.0	16.1	8.1	13.2	12.5	8.6	12.7	11.0	13.1	6.0	11.3	8.9	39.6	6.6	20.0	5.3	11.3	3.4	7.0	1.0	1.9	0.8	0.5	0.9	1.8	1.0	1.6	0.6	1.2	0.8	0.8	4.1	1.3	0.8	1.8	0.5	0.4	28.1	42.3	27.5	25.2	27.1	3.4	37.6	27.1	33.7	37.2
AKAP8	"AKAP95, DKFZp586B1222"	ENSG00000105127	"A-kinase anchoring protein 8"	O43823	19	15353385-15379798	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004776	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA004776: AB_1078122"	"unprognostic (9.04e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.17e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.78e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.57e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.83e-2)"	17.7	12.1	7.0	14.0	11.9	32.8	13.9	15.7	10.9	14.8	11.5	11.6	7.9	18.0	14.9	14.9	13.4	12.9	10.9	10.8	7.6	5.8	12.9	14.2	11.7	12.9	10.9	5.9	13.5	13.7	11.4	9.4	17.8	9.3	11.8	7.7	13.7	13.5	15.8	25.7	16.1	14.5	14.9	9.3	16.0	13.3	12.4	11.1	15.2	12.3	12.1	16.0	13.6	11.4	7.2	9.7	2.3	9.3	5.6	7.9	4.9	14.5	10.5	10.5	9.6	3.6	5.3	12.8	8.8	7.6	9.0	8.1	15.8	18.1	14.4	9.3	8.7	11.0	7.8	11.0	5.8	13.8	11.5	16.4	12.0	14.5	4.2	22.1	13.5	7.5	5.9	7.7	2.5	7.6	11.8	9.8	6.0	18.5	13.4	10.0	15.7	13.9	14.2	9.5	15.4	4.6	18.8	9.7	10.2	9.4	13.6	10.4	7.7	9.4	14.7	13.4	8.2	12.9	17.1	13.0	10.5	16.7	9.9	15.4	10.8	0.0	6.7	2.3	7.6	7.3	7.9	7.2	6.5	7.8	9.7	6.4	5.9	6.2	0.9	5.6	9.3	7.8	7.9	4.9	7.0	11.9	15.7	10.9	7.6	5.8	10.9	5.9	9.3	11.1
AKAP8L	"HAP95, NAKAP95"	ENSG00000011243	"A-kinase anchoring protein 8 like"	Q9ULX6	19	15380048-15419141	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042485, HPA042546"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA042485: AB_2678019, HPA042546: AB_2678046"	"unprognostic (9.52e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-2)"	"prognostic favourable (8.04e-4)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (1.08e-7)"	"unprognostic (2.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.34e-3)"	13.9	20.6	25.6	12.1	35.8	55.1	14.3	51.0	30.3	17.9	15.9	20.6	20.0	10.7	15.3	26.8	13.6	18.7	13.4	23.4	24.6	17.9	14.8	16.3	17.0	17.3	25.4	22.3	23.9	10.7	23.6	25.6	18.8	23.9	17.6	13.0	19.7	13.7	17.8	31.9	17.8	12.0	14.6	19.5	16.4	13.7	28.5	30.0	15.5	18.0	13.8	18.7	15.1	16.6	4.2	3.0	5.9	2.7	0.7	3.6	1.3	12.6	13.3	20.1	9.3	17.5	20.4	10.5	11.6	13.0	19.4	17.2	22.6	18.7	11.5	19.7	13.7	14.5	27.8	15.9	15.9	19.6	22.8	22.3	14.1	16.9	31.2	19.8	14.6	18.0	27.0	15.9	20.0	13.9	25.3	23.1	11.7	18.4	20.4	18.8	15.7	23.5	24.2	11.3	13.8	14.6	9.2	18.3	12.1	13.8	15.5	18.0	11.3	19.2	17.2	12.0	8.4	18.5	18.7	35.4	20.8	24.0	10.0	20.9	11.6	0.1	2.7	2.2	1.2	1.4	3.4	1.4	1.5	1.9	3.0	4.2	1.7	2.6	5.9	0.7	1.8	1.9	3.6	1.3	25.6	35.8	51.0	30.3	24.6	17.9	25.4	22.3	23.9	30.0
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940867-92110673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"				"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favourable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	13.7	15.9	18.0	22.6	17.1	14.9	15.6	35.8	17.5	14.4	24.5	4.7	17.2	25.5	13.0	17.1	15.3	12.4	15.0	14.8	13.3	7.0	19.5	25.1	19.9	13.2	12.4	12.3	22.3	21.3	22.1	40.5	12.9	14.0	11.9	25.3	11.1	20.1	25.9	29.6	16.1	29.1	12.0	11.1	10.4	15.0	6.9	14.4	10.3	14.9	15.7	8.6	14.0	14.2	34.4	39.5	31.9	16.6	10.6	20.3	3.4	11.2	7.0	10.4	6.6	14.9	11.0	7.4	8.4	5.7	4.3	5.5	11.9	9.8	10.2	12.2	7.4	10.4	10.0	5.5	8.1	9.2	8.5	11.2	12.2	7.8	6.1	18.5	11.9	6.9	8.8	8.9	10.2	9.3	16.6	16.7	7.3	16.3	12.6	7.3	8.0	8.7	7.7	17.4	8.2	5.9	12.4	17.0	11.9	17.8	20.0	8.6	5.2	9.0	17.1	8.7	11.2	15.2	11.4	12.0	13.2	13.7	7.7	9.4	9.8	31.9	16.6	21.4	18.4	9.3	15.4	31.4	18.7	16.7	7.2	34.4	20.3	19.3	23.2	10.6	16.3	39.5	14.9	3.4	18.0	17.1	35.8	17.5	13.3	7.0	12.4	12.3	14.0	14.4
AKIP1	"BCA3, C11orf17"	ENSG00000166452	"A-kinase interacting protein 1"	Q9NQ31	11	8911139-8920084	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061391			Supported	Nucleoplasm				Nucleoplasm		"HPA061391: "	"unprognostic (7.79e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (5.15e-4)"	"unprognostic (6.58e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (6.24e-9)"	"unprognostic (1.03e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.77e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.19e-1)"	13.2	26.4	18.8	12.0	19.6	10.2	11.7	16.3	19.7	13.2	14.8	16.6	13.5	14.4	19.8	19.4	23.9	14.0	17.4	26.9	16.7	17.7	15.7	13.6	16.2	10.5	17.6	22.6	17.6	14.0	14.5	14.8	17.0	15.4	17.5	12.3	15.8	16.8	16.9	35.2	9.6	16.0	22.3	16.5	20.2	12.7	22.1	11.2	12.5	20.9	13.5	10.7	15.5	14.6	4.5	20.8	1.2	15.6	5.8	25.9	8.6	31.8	29.5	13.0	12.5	12.7	15.7	10.4	23.5	19.0	14.6	14.2	15.8	19.7	5.8	18.9	17.0	21.4	6.3	11.3	10.1	28.3	16.6	10.1	16.5	13.9	14.8	13.3	12.1	13.6	15.8	7.1	26.3	13.0	20.4	6.2	26.7	10.5	10.6	12.3	10.7	22.7	11.2	9.4	7.3	14.9	13.6	9.1	8.9	27.1	12.1	12.7	13.8	11.1	21.4	20.5	18.4	34.6	22.9	9.6	23.6	1.4	21.1	16.2	21.5	1.2	15.6	0.6	7.8	13.4	8.1	4.5	9.1	8.6	19.7	4.5	6.2	10.8	0.9	5.8	6.5	20.8	25.9	8.6	18.8	19.6	16.3	19.7	16.7	17.7	17.6	22.6	15.4	11.2
AKIRIN2	"C6orf166, dJ486L4.2, FLJ10342"	ENSG00000135334	"Akirin 2"	Q53H80	6	87675072-87702209	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064239			Supported	Nucleoplasm				Nucleoplasm		"HPA064239: "	"unprognostic (9.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.62e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	27.9	24.1	23.7	19.9	27.0	53.4	22.0	19.3	27.8	13.7	14.1	17.5	10.3	11.4	16.3	22.5	20.5	16.2	14.4	20.1	22.1	21.1	14.8	27.8	21.9	34.5	19.3	18.6	20.7	8.5	12.0	15.5	16.7	17.3	13.4	11.9	21.3	15.5	11.6	54.2	12.9	13.6	15.9	20.2	35.7	12.1	20.7	14.7	45.0	14.1	14.8	26.1	21.4	14.9	15.4	27.0	51.9	25.6	12.5	13.6	11.1	10.4	11.3	32.5	18.3	20.6	14.3	19.1	18.5	11.9	15.6	15.3	17.9	8.1	27.6	20.2	19.1	16.1	18.0	13.5	18.0	35.0	22.4	15.9	10.2	39.9	22.5	13.6	13.7	16.4	13.9	19.0	19.0	16.9	30.9	19.3	20.0	13.7	4.3	28.1	23.0	17.6	17.0	23.1	11.2	19.3	9.3	24.4	23.2	11.3	6.7	18.0	8.1	32.5	21.5	12.8	8.6	10.7	24.0	18.7	20.7	17.5	14.0	17.9	20.3	23.1	20.6	21.7	10.7	25.6	11.0	15.4	10.5	10.3	19.5	12.6	8.3	8.7	51.9	12.5	24.6	27.0	13.6	11.1	23.7	27.0	19.3	24.5	22.1	21.1	19.3	18.6	17.3	14.7
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 71.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.6;MOLT-4: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA052367: , HPA063993: "	"unprognostic (5.19e-3)"	"prognostic favourable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favourable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favourable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favourable (2.29e-4)"	7.2	2.8	4.6	41.8	4.9	17.5	6.1	2.0	4.5	13.9	7.3	5.9	2.4	5.7	13.4	4.5	3.3	11.4	12.9	2.8	4.9	3.8	3.9	5.6	11.2	30.4	4.9	3.3	9.9	3.4	0.8	3.6	2.8	4.9	5.3	4.7	7.1	10.2	4.2	1.6	2.5	18.4	8.8	3.6	43.1	7.3	3.9	4.8	71.2	4.0	4.5	42.9	6.1	6.4	7.2	8.8	16.6	6.1	11.9	16.6	6.4	1.4	1.5	1.8	1.3	12.7	1.4	7.9	1.5	1.9	1.5	1.2	2.7	1.6	17.2	1.6	1.4	3.3	1.2	0.4	0.5	31.6	0.7	1.8	0.7	1.7	15.1	16.7	18.9	2.5	2.8	1.3	1.4	2.7	1.6	20.8	0.6	2.4	30.0	21.7	6.8	1.7	18.6	0.3	3.9	14.4	0.8	0.9	1.7	0.4	1.4	4.6	3.9	9.2	4.3	0.8	1.7	0.3	1.4	4.4	4.8	14.6	1.0	8.5	0.7	8.0	6.1	9.6	16.6	4.6	13.1	6.5	8.9	14.1	4.1	7.2	7.9	10.6	16.6	11.9	4.1	8.8	7.0	6.4	4.6	4.9	2.0	4.5	4.9	3.8	4.9	3.3	4.9	4.8
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol			8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favourable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favourable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.5	15.4	19.6	45.7	17.1	34.5	9.9	12.7	40.7	15.7	22.3	21.1	22.9	28.5	16.1	16.4	20.6	23.5	20.2	43.4	39.6	30.3	26.4	38.0	25.8	21.6	40.2	39.5	12.0	32.6	20.0	11.9	32.4	13.2	23.7	16.4	37.4	26.2	47.1	48.6	22.5	26.0	15.0	16.9	67.6	24.7	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.5	29.9	19.1	15.5	39.6	6.8	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell line enhanced"	"Detected in many"		"A549: 121.0;BJ hTERT+: 222.0;RPTEC TERT1: 105.0;U-87 MG: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol			1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: "	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.3	121.0	13.6	19.3	58.9	16.0	36.3	13.0	222.0	19.1	24.8	5.6	12.3	0.0	6.0	21.7	5.7	14.8	12.9	15.2	4.8	13.6	6.8	18.2	16.4	84.4	0.0	0.0	14.9	9.7	27.3	7.3	26.9	0.0	4.5	21.1	0.2	20.0	9.2	22.7	0.1	20.9	8.7	10.1	105.0	65.4	10.2	22.7	90.9	0.1	9.5	0.0	10.2	21.2	18.9	8.8	1.7	14.1	12.5	13.7	33.8	99.9	0.0	11.3	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in some"	82	"A549: 252.0;Hep G2: 69.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"											"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: "	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	252.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	69.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.1;HDLM-2: 12.0;Hep G2: 10.5;SK-BR-3: 5.1;U-87 MG: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: "	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (8.36e-4)"	"prognostic unfavourable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.1	0.1	0.0	0.6	0.5	0.9	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	12.0	0.0	0.1	0.1	10.5	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.2	0.2	3.1	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.5	5.1	0.0	0.0	0.3	0.0	0.1	0.7	0.3	0.0	0.2	0.2	0.2	6.5	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Group enriched"	"Detected in many"	10	"ASC diff: 186.6;Hep G2: 316.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"											"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: "	"unprognostic (1.54e-2)"	"prognostic favourable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.6	0.1	25.8	186.6	22.5	0.0	0.8	5.7	0.3	0.2	0.5	0.0	0.0	0.3	5.8	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.2	316.4	1.8	0.1	0.0	11.4	1.6	2.7	1.6	0.6	5.5	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2
AKR1E2	"AKR1CL2, AKRDC1, MGC10612"	ENSG00000165568	"Aldo-keto reductase family 1 member E2"	Q96JD6	10	4786629-4848062	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"testis: 35.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;RT4: 9.6;U-2197: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;myeloid DC: 1.6;naive CD4 T-cell: 1.4;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;granulocytes: 3.2;T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037821, HPA037822"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA037821: , HPA037822: AB_10671722"	"unprognostic (2.33e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.62e-4)"	"unprognostic (5.62e-2)"	3.3	1.6	1.8	3.2	2.6	2.4	4.2	1.4	2.5	2.6	2.3	0.7	3.4	1.8	5.0	1.7	1.9	1.4	5.0	2.7	1.5	1.5	1.8	1.1	4.4	2.8	1.4	2.1	1.5	2.7	3.7	1.2	2.6	1.9	1.7	1.7	5.0	1.9	2.6	2.3	2.0	1.7	2.9	2.1	1.5	2.1	35.0	0.9	0.8	4.5	2.0	0.6	1.7	2.9	0.1	1.8	3.2	0.4	0.0	1.4	0.3	0.4	5.3	2.0	0.9	0.0	0.0	0.1	2.1	0.1	0.1	0.0	8.2	0.8	0.0	0.0	5.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	1.0	5.6	1.0	0.0	6.0	4.6	0.0	0.0	4.9	0.6	0.0	2.2	3.9	0.0	0.0	0.0	1.5	9.6	0.0	4.5	7.7	2.1	4.1	4.1	2.2	3.6	0.0	1.8	18.3	0.0	2.5	0.0	0.0	0.1	0.0	1.5	3.2	0.4	0.3	0.1	0.2	0.0	0.1	0.4	0.2	1.6	0.0	1.4	0.4	0.1	0.0	0.0	1.8	0.0	0.3	1.8	2.6	1.4	2.5	1.5	1.5	1.4	2.1	1.9	0.9
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312146	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	Cytosol			2700000	Cytosol		"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: "	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (8.59e-4)"	21.2	39.0	25.2	14.0	26.9	15.2	22.0	19.8	26.2	32.9	38.5	28.1	28.7	56.0	20.2	23.0	25.7	35.1	31.9	31.2	22.0	19.4	49.3	32.4	14.4	21.9	24.9	26.2	31.6	60.8	14.8	19.0	17.2	23.6	19.9	19.5	25.8	21.4	24.9	33.8	18.8	43.1	20.8	20.0	16.3	22.3	21.6	21.4	24.7	22.9	20.2	18.3	16.7	21.6	23.0	40.1	13.7	29.0	22.2	27.1	23.5	24.2	15.3	16.8	15.5	26.7	26.0	11.2	18.1	22.2	25.5	22.9	19.4	20.5	17.6	19.4	24.3	19.4	18.8	27.3	12.1	14.0	29.8	11.0	14.8	31.0	20.8	12.1	8.9	25.8	21.6	19.5	12.0	21.5	16.0	16.5	26.0	24.2	23.6	11.8	4.8	19.3	24.9	21.0	31.0	24.8	10.7	31.7	11.8	19.8	17.9	30.5	35.6	42.4	16.8	16.0	16.9	17.1	13.5	20.1	12.6	21.4	34.5	27.9	22.5	0.1	29.0	13.7	23.0	23.7	26.8	23.0	20.7	20.3	40.1	21.4	23.9	20.6	3.4	22.2	17.8	35.0	27.1	23.5	25.2	26.9	19.8	26.2	22.0	19.4	24.9	26.2	23.6	21.4
AKT1	"AKT, PKB, PRKBA, RAC"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 30.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 30.7"	"Low region specificity"	"Detected in all"							"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules				Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	31.7	45.4	22.9	24.2	23.6	20.3	40.0	20.9	29.5	24.7	32.6	20.0	30.8	22.5	27.0	21.5	33.0	25.5	30.3	47.7	22.9	19.1	26.3	49.2	31.3	21.0	22.1	14.7	25.9	43.0	20.3	16.7	28.4	21.5	31.1	18.2	25.3	30.4	36.1	23.8	20.4	24.0	40.5	17.5	35.4	32.6	16.2	18.8	26.3	32.7	22.4	29.3	36.7	35.9	3.2	5.2	30.7	5.8	5.7	6.2	3.0	15.1	30.3	25.0	37.2	19.4	20.1	28.0	27.9	34.0	41.3	33.1	19.8	18.3	18.3	21.5	38.2	19.7	17.7	26.0	18.0	41.8	7.2	13.9	18.1	21.3	21.5	22.6	36.3	28.8	21.9	20.7	13.8	30.8	12.1	20.4	26.4	113.2	28.4	28.9	6.5	21.7	26.8	23.2	12.5	19.1	37.7	28.7	23.9	23.3	30.5	17.5	39.9	33.7	24.6	27.7	13.3	39.4	28.0	22.2	10.7	15.8	23.3	19.1	33.3	3.3	5.3	30.7	5.4	5.2	4.0	2.9	4.8	6.2	3.6	3.2	2.5	5.7	11.8	5.7	5.8	5.2	4.7	3.0	22.9	23.6	20.9	29.5	22.9	19.1	22.1	14.7	21.5	18.8
AKT1S1	"Lobe, MGC2865, PRAS40"	ENSG00000204673	"AKT1 substrate 1"	Q96B36	19	49869033-49878459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021903, HPA043590, HPA064427"	Uncertain		Supported	Cytosol				Cytosol		"CAB021903: , HPA043590: , HPA064427: "	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-1)"	"prognostic favourable (6.60e-4)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (7.34e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.65e-1)"	22.2	22.9	16.2	11.9	18.1	10.7	13.8	12.9	19.9	16.9	15.3	21.3	20.1	18.8	17.1	13.5	21.1	14.7	14.6	20.1	15.1	12.6	15.0	43.0	11.7	7.2	17.4	11.3	15.5	17.3	19.1	14.7	25.7	18.3	15.1	13.0	14.8	17.2	19.2	72.7	21.2	16.3	15.8	13.7	10.5	16.2	13.5	21.4	7.4	17.8	20.5	10.5	15.4	29.5	1.9	3.5	5.0	4.3	2.0	3.0	1.3	23.3	28.3	8.3	19.1	17.7	19.0	14.7	21.0	23.8	19.9	17.3	15.2	15.7	4.7	10.8	23.7	16.1	14.3	23.9	11.7	10.5	39.8	5.6	16.3	14.4	15.8	4.8	9.2	23.3	22.1	21.6	24.5	18.4	18.5	6.2	17.9	16.4	4.6	12.1	21.7	41.3	5.6	11.6	14.2	19.8	16.6	19.4	22.6	18.0	32.1	12.8	16.8	9.6	17.6	41.3	21.5	11.8	20.6	9.1	22.2	4.9	23.8	9.0	19.6	0.4	3.1	2.4	2.1	4.0	1.4	1.2	1.6	2.3	2.3	1.9	1.4	2.3	5.0	2.0	4.3	3.5	3.0	1.3	16.2	18.1	12.9	19.9	15.1	12.6	17.4	11.3	18.3	21.4
AKT2		ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: "	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	31.1	20.3	15.4	17.6	15.2	21.3	18.2	46.3	18.2	23.3	18.2	23.4	21.2	12.3	22.8	28.0	22.1	22.7	14.0	23.1	15.4	10.0	23.0	62.5	14.6	17.8	17.9	13.3	27.8	24.5	21.1	24.0	17.5	14.7	19.7	12.3	26.8	18.5	24.3	48.5	18.3	17.1	20.0	16.8	18.7	15.5	21.3	15.7	26.6	52.6	29.5	23.6	19.6	19.9	6.3	8.8	7.7	4.4	3.2	4.9	2.4	22.4	55.4	21.1	21.7	26.3	32.2	11.7	15.0	22.2	31.1	27.8	24.3	20.9	22.9	13.4	33.1	9.8	23.4	31.3	20.1	21.9	26.7	15.0	35.1	15.3	16.5	17.2	18.1	29.7	18.8	21.1	20.1	6.7	19.3	24.0	17.3	18.7	27.3	8.4	11.4	14.9	18.2	11.5	16.5	24.2	36.8	29.1	17.8	15.4	26.4	12.5	20.8	22.2	6.7	19.0	18.8	17.0	23.5	22.4	19.2	18.8	18.6	20.4	15.5	7.6	4.4	3.6	4.5	2.0	4.5	3.9	3.6	3.0	3.0	6.3	3.5	4.9	7.7	3.2	2.6	8.8	2.7	2.4	15.4	15.2	46.3	18.2	15.4	10.0	17.9	13.3	14.7	15.7
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol				Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (9.27e-4)"	15.4	17.0	16.0	7.8	15.2	2.2	11.0	39.9	33.4	16.9	16.1	12.4	17.4	4.1	19.7	12.3	10.0	11.8	12.1	9.8	15.5	13.6	12.8	4.0	11.3	7.9	14.2	15.8	29.8	4.4	15.1	14.6	17.0	18.4	19.4	6.6	8.9	4.1	23.9	4.8	4.7	8.1	20.4	12.1	9.9	8.7	10.4	14.8	2.9	17.7	5.0	6.2	17.2	18.6	1.9	0.8	1.2	0.9	3.8	3.6	0.6	23.5	2.4	14.9	0.0	11.0	12.6	7.9	13.3	12.2	8.6	7.6	0.1	9.7	0.0	0.0	16.8	0.3	8.2	5.3	11.4	5.9	6.4	0.3	0.0	0.0	5.7	0.1	2.6	6.5	0.0	10.7	9.7	17.6	0.0	0.1	3.9	0.0	5.0	1.1	6.3	3.7	2.7	9.1	0.1	2.9	0.8	19.1	25.3	0.1	0.0	23.8	0.0	8.0	13.8	15.3	11.8	0.1	11.0	1.3	0.4	2.8	11.2	1.2	12.8	1.2	0.9	0.5	2.3	0.3	3.6	1.0	2.2	2.5	0.8	1.9	1.9	1.7	0.2	3.8	0.7	0.6	0.7	0.6	16.0	15.2	39.9	22.9	15.5	13.6	14.2	15.8	18.4	14.8
AL035078.4		ENSG00000285283	"Reticulocalbin-1 "	Q15293	11	31812391-32104665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.2"	"Cell line enhanced"	"Detected in many"		"BJ: 62.6;RT4: 42.4"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA038474	Uncertain		Supported	"Endoplasmic reticulum"			2300000	"Endoplasmic reticulum"		"HPA038474: AB_10672595"																		4.7	0.9	1.6	7.5	2.4	0.0	0.3	16.2	3.2	0.3	5.9	1.7	0.3	0.9	3.8	0.3	1.7	4.3	0.3	0.3	3.1		0.4	2.8	1.4	0.3	2.2	1.9	6.1	0.3	0.0	1.8	1.6	3.0	0.3	0.8	6.9	0.3	0.3	3.3	0.0	2.4	4.6	3.6	0.5	2.2	0.3	1.0	0.3	0.5	0.3	0.7	1.9	0.3	0.6	5.3	0.4	3.5	3.2	2.1	1.7	7.3	12.2	11.8	11.3	3.4	2.0	6.6	62.6	20.8	11.0	10.2	5.9	9.4	0.0	20.6	23.6	6.4	8.8	7.1	12.1	5.0	1.4	3.6	8.9	0.7	0.0	3.1	1.5	10.4	1.3	12.1	7.9	15.5	1.2	3.8	0.1	2.5	4.8	0.0	5.0	0.1	2.7	38.9	1.5	0.0	42.4	4.9	1.8	12.2	0.8	7.5	8.9	0.1	37.1	28.2	11.9	17.0	23.9	0.0	0.0	0.1	29.9	1.2	12.8	0.0	3.5	0.0	2.1	3.4	1.9	0.6	0.2	1.8	5.3	0.1	0.3	0.9	0.4	3.2	2.0	0.6	0.0	1.7										
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 167.6;liver: 136.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 55.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Enhanced	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favourable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favourable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	9.2	167.6	7.8	6.7	10.6	39.1	8.9	17.0	15.4	6.0	11.0	12.0	15.3	11.4	6.3	11.8	10.5	4.7	8.7	24.8	8.8	7.0	14.1	136.4	13.5	10.0	7.6	9.9	5.8	6.1	8.5	5.8	13.4	12.2	7.3	11.1	8.3	15.7	16.9	24.6	6.8	17.4	6.5	7.3	6.3	12.2	9.7	5.0	7.5	7.4	11.4	9.6	12.1	7.6	6.8	8.4	55.0	12.2	8.8	11.3	6.3	10.4	16.2	11.5	10.6	18.0	13.4	31.4	15.4	14.3	20.6	20.0	21.6	19.8	9.8	3.9	10.7	6.2	16.5	12.6	16.9	19.0	6.4	12.6	12.8	16.4	25.5	20.4	25.3	16.7	11.9	32.7	10.9	18.8	7.4	8.1	18.7	8.5	9.6	31.0	9.9	28.2	5.8	7.2	15.5	18.1	63.4	6.1	4.0	24.9	12.3	13.9	7.0	29.0	13.5	11.5	11.4	23.7	22.2	12.0	20.8	14.8	12.9	22.1	18.3	55.0	9.2	27.8	6.9	12.2	11.3	6.8	7.2	7.7	8.4	6.0	6.5	7.0	14.2	8.8	10.2	4.8	9.7	6.3	7.8	10.6	17.0	15.4	8.8	7.0	7.6	9.9	12.2	5.0
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 3075.8"	"Cell line enriched"	"Detected in some"	39	"Hep G2: 308.4"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	40000000000000		"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	308.4	0.0	7.9	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	6.8	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	0.0	2.5	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.1
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Supported	Mitochondria			23000	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favourable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.2	17.3	16.6	43.6	22.4	21.7	17.9	21.3	32.1	21.7	27.3	34.6	14.6	62.1	20.0	33.5	24.2	33.3	21.9	24.7	17.6	26.2	19.7	12.3	49.1	14.7	34.3	22.0	22.7	13.5	17.7	34.7	22.7	18.3	13.1	16.2	26.2	31.0	22.1	19.6	17.3	29.2	19.1	21.3	25.3	13.9	16.6	16.5	16.9	13.5	15.7	20.1	16.0	18.8	9.0	14.4	23.2	24.4	15.1	11.2	38.0	17.6	39.8	11.5	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900662-73080442	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 207.2"	"Cell line enhanced"	"Detected in some"		"A549: 287.9;Hep G2: 88.6;RPTEC TERT1: 51.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"classical monocyte: 34.2"	"Lineage enriched"	"Detected in many"	30	"monocytes: 34.2"					"Region enriched"	"Detected in many"	6	"midbrain: 171.1"	"HPA002123, CAB020690"	Approved	Approved	Enhanced	Cytosol			62000000	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favourable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	20.0	26.9	8.8	12.3	21.4	3.9	10.8	44.8	11.7	33.6	53.6	14.5	65.3	77.1	25.5	87.1	14.5	27.8	38.3	8.9	12.5	5.9	86.7	207.2	31.4	9.4	56.4	3.6	35.8	69.7	0.7	57.5	7.9	14.0	20.0	13.1	30.2	31.8	40.3	12.1	2.7	76.5	17.1	29.1	16.3	75.5	43.0	14.9	2.0	45.8	21.0	16.8	14.1	16.0	0.3	0.5	1.1	34.2	0.0	0.1	10.5	0.0	287.9	0.0	0.0	1.6	0.0	0.1	10.0	0.0	0.0	0.0	9.6	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	0.0	88.6	1.0	0.0	0.0	0.5	0.0	0.0	0.0	10.3	1.1	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	3.2	0.1	51.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.2	0.5	0.0	5.8	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	1.1	0.0	0.4	0.3	0.0	10.5	8.8	21.4	44.8	11.7	12.5	5.9	56.4	3.6	14.0	14.9
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 42.0;HaCaT: 52.3;HBEC3-KT: 129.5;U-2197: 74.4;U-87 MG: 59.2;WM-115: 61.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: "	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.0	5.6	0.0	0.0	9.3	4.1	0.1	0.3	0.3	0.2	0.1	0.1	33.7	0.3	0.5	11.3	52.3	1.0	129.5	0.8	0.0	0.2	0.2	2.3	0.0	3.1	0.1	0.2	2.9	3.6	2.9	0.5	0.4	0.0	0.2	0.2	0.4	0.0	0.2	1.1	34.2	0.0	0.5	0.2	0.0	35.3	0.0	3.0	13.1	11.5	3.9	1.1	0.3	6.6	0.0	0.1	74.4	1.6	0.0	0.3	0.2	59.2	0.0	61.1	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021037	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria			210000	Mitochondria	"Nucleoplasm, Vesicles"	"HPA021037: AB_1844724"	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	23.9	22.3	6.9	11.0	9.8	11.7	5.5	11.5	5.8	9.7	10.0	14.9	4.7	15.1	6.9	16.1	3.4	22.7	24.3	9.7	16.9	9.8	7.5	16.4	44.2	7.1	11.9	8.5	13.9	5.3	7.9	6.9	9.2	21.6	14.8	14.7	9.1	0.0	4.8	20.5	10.0	4.9	41.8	11.5	8.7	10.8	15.1	7.0	8.7	5.8	6.7	5.5	9.3	6.2	11.2	18.6	9.3	14.3	2.2	4.3	6.0	5.8	12.2	7.6	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7
ALDH1L1	"10-fTHF, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 48.1;liver: 148.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 23.4;Karpas-707: 24.1;RPMI-8226: 12.6;RT4: 64.5;U-266/70: 13.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol			640000	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favourable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	28.9	12.1	13.7	1.8	17.1	1.2	6.0	8.6	10.9	7.8	4.9	5.7	2.3	1.1	1.9	2.2	3.6	3.4	1.9	8.1	8.9	5.3	48.1	148.7	1.3	1.2	9.2	10.1	11.3	10.2	1.4	0.9	1.1	10.8	3.3	3.3	5.1	34.1	4.1	30.7	1.5	1.3	2.4	7.7	1.1	1.9	4.9	6.2	0.0	1.7	6.2	2.8	11.0	3.1	0.1	0.8	0.8	0.2	0.2	0.4	0.0	0.4	0.0	0.0	0.0	10.6	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.9	0.7	3.1	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	23.4	3.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	24.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.3	64.5	0.1	0.1	0.3	3.1	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	13.3	4.1	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	13.7	17.1	8.6	10.9	8.9	5.3	9.2	10.1	10.8	6.2
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105084577	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"pancreas: 48.9;salivary gland: 31.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.6;ASC TERT1: 30.9;fHDF/TERT166: 35.1;HHSteC: 19.9;HSkMC: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA039481: AB_10795465, HPA059282: "	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	4.2	1.2	3.2	2.7	1.9	0.7	2.7	5.3	2.7	5.5	2.2	0.9	3.3	2.4	2.9	3.2	1.5	2.6	2.7	2.9	1.6	2.0	0.7	0.4	2.7	2.0	2.0	2.1	1.0	48.9	0.7	2.8	1.1	2.5	3.6	2.3	4.8	31.6	4.5	1.0	1.5	1.3	5.4	5.3	1.2	3.7	0.8	1.3	0.0	2.2	1.4	3.0	3.9	2.2	0.2	1.3	0.0	0.1	0.0	0.1	0.1	4.3	0.4	0.2	9.4	22.6	30.9	0.5	14.0	9.0	1.8	4.8	0.5	0.0	0.0	0.5	35.1	0.0	0.0	0.3	2.3	0.0	0.1	0.2	0.0	1.1	19.9	1.7	0.0	25.0	1.1	4.7	8.9	1.0	0.7	12.6	3.6	0.0	0.0	0.1	0.5	0.1	0.0	0.0	1.3	0.0	0.0	3.3	1.6	0.0	2.9	7.1	2.0	14.9	0.1	1.4	1.3	0.0	0.7	15.7	4.1	0.0	5.7	6.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.1	3.2	1.9	5.3	2.4	1.6	2.0	2.0	2.1	2.5	1.3
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell line enriched"	"Detected in some"	20	"A549: 321.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: , HPA063783: "	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favourable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	321.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	16.1	0.0	0.1	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494852-24537207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 40.3;U-698: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria			44000	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favourable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favourable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	5.8	4.8	23.7	8.3	27.4	3.1	4.1	13.5	21.5	4.1	6.0	9.5	1.2	7.7	3.9	3.1	5.6	13.5	4.4	9.8	17.3	21.0	18.4	62.6	5.0	8.9	16.0	14.7	5.8	6.6	11.4	4.5	2.2	13.0	6.2	5.7	4.1	3.9	4.3	31.1	6.9	5.4	2.8	10.9	4.8	5.2	3.7	8.8	21.4	12.1	4.9	8.8	6.3	5.5	3.9	3.8	0.4	0.2	1.6	6.8	1.2	3.2	2.9	2.1	3.1	0.0	0.0	3.5	0.3	0.6	0.8	0.5	11.5	0.8	40.3	6.1	0.3	0.0	3.4	0.4	0.5	4.1	5.6	6.3	1.9	13.1	0.5	9.7	0.8	0.3	1.6	0.1	0.0	0.0	3.1	0.0	0.6	7.5	11.8	5.8	0.8	1.5	13.6	0.6	0.3	2.4	6.4	3.6	3.2	3.8	0.4	3.9	5.7	5.3	0.0	0.4	2.0	0.1	2.0	5.7	8.5	50.3	0.0	3.1	0.4	0.4	0.1	0.2	1.7	0.0	3.3	3.7	2.4	2.8	0.2	3.9	6.8	5.7	0.4	1.6	0.2	3.8	1.6	1.2	23.7	27.4	13.5	21.5	17.3	21.0	16.0	14.7	13.0	8.8
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell line enhanced"	"Detected in all"		"T-47d: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria			9100	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favourable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.8	10.2	9.2	3.2	6.1	3.5	6.0	9.0	5.2	5.4	7.2	6.9	2.7	12.9	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.7	1.3	1.2	15.0	6.5	4.5	11.4	6.1	4.0	7.5	2.4	17.7	3.7	2.0	4.5	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	29.6	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.1	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023296	Enhanced		Supported	Mitochondria,Cytosol			140000	Mitochondria	Cytosol	"HPA023296: AB_1844738"	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	14.8	9.8	27.8	46.0	23.2	13.8	35.5	17.8	22.0	20.7	26.8	27.6	14.3	0.0	18.2	13.9	11.1	8.6	60.2	19.1	0.0	10.4	2.8	14.7	23.4	11.3	0.0	0.0	16.9	14.2	16.1	11.6	16.5	0.0	0.0	18.2	9.7	0.6	0.0	18.8	8.3	8.9	31.6	0.0	19.7	11.3	9.5	11.3	0.0	9.8	10.3	17.7	0.6	20.0	6.0	18.6	6.9	12.2	0.0	0.0	0.0	3.2	0.0	9.6	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917390-134950122	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 26.2;liver: 90.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5;RPTEC TERT1: 6.3"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026292, HPA055414"	Enhanced		Supported	Centrosome			24000	Centrosome		"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favourable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	0.3	0.3	0.8	0.3	1.0	0.6	0.3	1.9	0.9	0.3	0.6	0.3	0.3	0.2	0.3	0.6	0.3	0.1	0.3	0.3	1.4	0.6	26.2	90.1	0.3	0.3	1.1	0.4	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.8	0.3	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.3	1.5	1.1	5.9	0.9	2.3	1.3	0.6	0.2	1.0	1.5	0.8	0.5	0.2	1.4	0.4	0.5	0.1	0.9	0.5	0.7	0.4	0.5	0.0	1.1	1.1	0.0	0.8	1.2	5.5	3.6	3.8	5.2	0.6	1.4	2.0	1.5	1.8	0.4	0.9	0.4	5.3	2.2	0.2	0.0	1.7	2.3	0.3	1.1	0.1	0.5	0.5	6.3	0.8	1.6	0.5	0.3	0.1	1.3	0.9	0.3	0.4	0.8	3.1	1.2	1.5	5.5	1.7	0.9	0.7	1.4	0.5	5.9	0.9	0.9	1.3	0.3	0.5	1.0	1.2	0.7	0.1	1.5	1.1	0.9	2.4	2.3	0.4	1.1	1.2	0.6	0.8	1.0	1.9	0.9	1.4	0.6	1.1	0.4	0.3	0.3
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Supported	Cytosol			1200000000	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavourable (5.79e-5)"	"prognostic unfavourable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.7	104.6	31.5	101.2	48.3	55.1	100.7	84.0	87.6	85.7	107.2	73.9	107.0	94.6	137.8	84.8	106.0	63.1	183.2	62.9	41.6	83.0	77.4	83.9	163.2	75.4	112.5	83.1	75.5	64.7	96.2	64.7	63.1	66.6	62.5	90.8	197.9	68.4	93.0	78.3	88.2	102.1	50.6	211.5	106.7	79.0	63.1	44.4	52.4	221.1	78.4	94.0	76.3	75.0	126.6	50.5	69.0	90.8	123.5	84.3	86.6	235.6	109.3	99.9	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9
ALDOA		ENSG00000285043	"Aldolase, fructose-bisphosphate A"	P04075	16	30053090-30070420	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA004177	Uncertain		Supported	Cytosol			1200000000	Cytosol		"HPA004177: AB_1078128"																		1.8	0.9	2.7	1.1	5.0	2.1	7.2	0.7	7.7	4.9	1.5	2.0	2.4	0.0	2.5	3.9	0.9	3.6	1.6	5.3	2.3		1.3	0.0	2.3	2.0	0.8	4.4	2.2	0.8	0.8	3.0	1.4	4.0	2.4	0.5	2.8	1.6	7.5	10.6	0.6	0.1	1.9	0.4	1.7	1.3	11.6	0.8	1.2	4.7	0.2	2.7	1.2	1.0	7.0	6.6	0.9	6.2	4.2	8.5	12.5	3.7	8.8	1.9	6.2	1.5	5.2	1.5	4.0	6.9	5.4	21.6	3.6	5.0	24.5	5.9	6.8	6.3	14.0	10.9	3.8	4.3	7.9	6.0	8.2	5.9	11.5	10.5	2.3	5.1	0.5	10.7	12.2	7.7	1.2	7.1	13.4	3.9	4.9	8.0	2.1	5.5	7.6	4.0	22.4	15.1	0.7	6.1	5.0	1.0	1.6	1.5	5.1	4.0	1.7	8.0	2.4	3.7	5.3	7.3	5.5	8.0	7.6	11.4	3.5	0.1	6.2	0.1	5.3	2.6	7.4	7.0	7.0	5.7	6.6	6.2	8.5	6.6	0.9	4.2	2.3	5.6	5.4	12.5										
ALG2	"CDG1I, CDGIi, FLJ14511, hALPG2, NET38"	ENSG00000119523	"ALG2, alpha-1,3/1,6-mannosyltransferase"	Q9H553	9	99216426-99221956	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041512, HPA041601"	Approved		Enhanced	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA041512: AB_10794380, HPA041601: AB_10794302"	"unprognostic (8.86e-3)"	"unprognostic (4.39e-1)"	"unprognostic (2.37e-1)"	"prognostic favourable (8.44e-5)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.06e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.28e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.81e-1)"	12.5	28.0	9.2	9.4	9.7	10.5	16.4	13.1	12.5	18.8	12.9	11.6	31.1	11.0	15.2	39.2	12.3	15.8	13.9	12.1	8.3	9.5	24.8	45.5	16.0	12.8	10.8	6.5	18.4	43.4	14.7	22.4	22.5	12.0	16.7	14.9	14.7	24.1	32.6	13.3	8.7	15.5	12.6	11.3	15.9	15.0	12.6	9.7	14.8	26.0	9.9	15.8	12.9	11.8	16.8	41.0	18.2	18.5	17.5	26.4	17.8	8.1	11.0	8.1	11.6	30.1	19.6	16.7	16.7	26.6	17.1	14.9	13.1	11.8	8.8	7.8	19.2	32.3	13.7	17.9	17.2	13.3	6.3	5.2	8.7	19.4	36.2	9.2	9.9	21.4	23.4	14.5	26.4	19.1	9.1	19.9	15.8	17.1	4.6	10.9	10.5	15.5	5.4	16.5	13.7	22.9	10.4	8.7	7.1	12.3	22.7	21.5	9.2	7.8	13.6	11.7	11.6	14.9	10.4	18.7	10.1	3.8	22.0	7.3	5.7	18.2	18.5	11.2	18.6	14.6	26.4	16.8	17.7	18.4	23.0	13.3	15.4	15.0	5.0	17.5	12.9	41.0	18.8	17.8	9.2	9.7	13.1	12.5	8.3	9.5	10.8	6.5	12.0	9.7
ALG6		ENSG00000088035	"ALG6, alpha-1,3-glucosyltransferase"	Q9Y672	1	63367590-63438562	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062536			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA062536: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favourable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavourable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	9.7	13.7	9.3	13.5	13.5	8.8	11.6	12.2	12.6	9.9	11.8	10.1	9.0	12.1	11.0	14.3	16.7	9.6	9.1	9.9	11.2	7.1	10.3	14.6	10.0	13.4	8.2	11.1	10.8	11.5	10.6	10.0	14.1	11.6	8.9	14.0	10.2	12.9	11.9	8.0	13.7	13.5	7.5	10.5	14.5	10.0	6.9	8.7	25.9	9.7	8.5	21.7	10.0	11.6	7.5	7.9	24.2	7.4	7.4	10.6	5.6	5.3	4.8	8.5	7.8	10.2	8.8	11.2	6.3	2.2	3.3	3.8	5.6	5.4	13.9	15.2	5.2	10.3	12.4	10.1	6.0	15.6	9.8	10.7	5.5	4.6	5.0	12.7	9.3	7.3	6.1	8.1	3.0	12.5	11.3	11.2	7.7	7.0	12.2	10.7	26.0	7.2	12.5	12.0	16.4	9.5	7.4	7.9	4.3	16.8	17.5	16.5	9.7	7.2	6.8	5.5	5.5	11.6	8.1	9.5	13.3	11.5	5.3	12.7	18.4	24.2	7.4	13.6	8.8	6.6	10.6	7.5	7.2	8.5	7.9	5.6	8.7	9.1	4.3	7.4	6.4	6.5	9.4	5.6	9.3	13.5	12.2	12.6	11.2	7.1	8.2	11.1	11.6	8.7
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921566	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.1;pituitary gland: 17.9"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 26.4"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	1.8	3.1	3.6	1.2	4.4	0.3	1.1	0.5	8.1	0.7	2.1	2.0	0.0	0.7	0.5	0.5	0.6	0.5	1.2	0.4	3.4	4.9	0.4	0.5	1.1	0.5	2.7	4.2	0.6	0.4	0.4	17.9	0.5	5.5	0.5	1.2	2.4	0.9	0.8	0.3	0.9	1.5	0.9	2.1	0.5	0.8	4.9	0.9	0.0	1.6	0.0	0.3	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	3.5	0.0	0.0	0.1	0.3	26.4	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	4.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	4.4	0.5	5.9	3.4	4.9	2.7	4.2	5.5	0.9
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708020	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"			Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: , HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favourable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	8.2	8.5	6.2	6.7	8.6	2.7	9.7	9.6	8.8	9.7	9.1	8.2	4.5	6.5	7.0	5.9	7.1	8.0	5.8	11.1	5.4	5.7	7.9	9.4	5.9	8.3	6.5	3.7	8.3	7.9	8.4	11.2	10.2	6.4	9.3	9.1	9.9	7.2	8.7	16.5	8.2	6.7	7.8	5.5	8.3	7.8	9.9	6.6	12.7	8.8	6.5	10.3	8.5	9.4	5.4	4.9	11.4	5.7	5.2	5.3	3.2	5.2	7.8	6.4	4.3	6.9	7.5	8.0	5.5	7.2	12.2	13.7	7.9	3.2	8.1	3.1	5.0	4.8	13.9	5.9	14.4	5.5	5.4	4.3	4.6	6.6	9.7	4.5	2.8	6.4	9.9	7.1	11.3	9.9	6.6	4.7	6.5	8.3	6.0	5.9	7.0	10.1	6.1	6.5	5.4	7.0	4.7	8.2	6.1	4.5	4.7	5.9	11.6	4.7	4.5	5.1	5.2	5.6	4.4	5.9	9.3	7.9	3.4	6.5	5.0	11.4	5.0	2.2	5.0	5.7	4.3	5.4	4.7	5.0	4.9	4.9	5.0	3.9	1.4	5.2	3.8	2.6	5.3	3.2	6.2	8.6	9.6	8.8	5.4	5.7	6.5	3.7	6.4	6.6
ALKBH2	"ABH2, MGC90512"	ENSG00000189046	"AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase"	Q6NS38	12	109088188-109093631	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011198, HPA045392, HPA051976"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB011198: AB_261971, HPA045392: , HPA051976: "	"prognostic favourable (6.67e-5)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.43e-3)"	"prognostic unfavourable (1.41e-5)"	"unprognostic (1.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.24e-2)"	"prognostic favourable (8.67e-4)"	16.1	12.3	13.6	16.9	13.4	8.2	22.3	12.7	20.5	12.9	11.7	15.2	14.6	9.0	18.0	14.2	14.1	18.3	12.2	12.3	13.5	12.3	12.0	25.6	9.8	17.0	14.3	8.9	23.1	18.5	7.1	7.8	8.1	15.7	15.0	10.7	10.8	18.9	18.5	20.0	25.0	10.7	15.9	15.4	12.3	12.6	14.3	13.5	11.3	13.9	19.7	16.5	15.5	13.8	16.9	13.1	1.1	6.7	9.0	18.2	6.9	12.9	22.2	12.7	28.4	9.0	12.2	20.2	8.6	5.8	9.1	10.3	23.4	9.3	20.0	8.6	5.0	9.5	21.3	8.7	5.4	17.7	19.0	10.0	12.6	21.3	11.9	13.7	9.3	12.5	18.9	8.6	22.2	3.5	14.7	12.0	6.1	22.8	12.6	27.6	17.6	22.6	11.2	12.4	21.5	12.1	18.1	13.1	22.6	9.2	29.7	18.0	18.3	8.5	3.6	10.2	11.1	9.6	12.7	16.8	19.4	43.5	8.7	11.9	16.3	1.1	5.1	0.7	8.0	6.7	14.1	16.2	12.1	11.2	5.1	16.9	18.2	10.7	0.9	9.0	4.3	13.1	9.0	6.9	13.6	13.4	12.7	20.5	13.5	12.3	14.3	8.9	15.7	13.5
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase"	Q96Q83	11	43880811-43920266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: "	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	17.6	14.2	14.3	13.2	16.7	8.6	26.5	21.2	22.7	19.1	15.7	19.5	12.8	13.2	22.6	31.2	16.2	20.0	16.4	12.5	14.3	13.4	15.6	25.8	15.1	17.3	15.0	14.4	21.8	23.5	22.1	16.6	9.1	15.6	19.1	16.6	19.5	25.5	19.1	29.1	20.2	15.0	18.3	14.8	17.8	17.0	17.3	12.1	14.5	16.4	21.4	22.2	15.2	17.4	14.9	18.5	21.2	21.0	17.1	21.3	13.8	7.4	12.9	5.1	0.0	10.0	12.9	0.0	9.0	20.0	18.1	17.8	6.0	5.7	1.1	5.7	13.6	10.1	7.0	15.6	16.9	0.0	24.7	10.8	8.7	12.6	24.9	19.8	14.5	13.6	27.1	8.0	39.1	13.0	15.3	11.8	9.0	8.8	17.8	10.2	9.4	19.0	5.2	11.1	13.9	10.9	11.6	9.7	7.8	7.0	11.0	16.5	15.9	12.2	9.1	10.3	5.7	16.8	12.9	10.7	11.2	12.0	15.3	8.4	8.4	21.2	12.9	7.1	17.0	14.1	16.2	14.4	17.4	15.1	18.5	14.9	21.3	18.9	2.3	17.1	21.0	16.3	16.2	13.8	14.3	16.7	21.2	22.7	14.3	13.4	15.0	14.4	15.6	12.1
ALKBH6	MGC15677	ENSG00000239382	"AlkB homolog 6"	Q3KRA9	19	36009120-36014239	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073835, HPA074340"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"				Nucleoplasm	"Focal adhesion sites"	"HPA073835: , HPA074340: "	"unprognostic (1.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.86e-5)"	"unprognostic (6.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (8.78e-4)"	"unprognostic (1.77e-2)"	"unprognostic (2.31e-5)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.05e-3)"	8.4	7.0	14.1	6.4	15.2	6.8	6.3	7.8	18.9	5.8	8.2	7.8	2.5	6.6	6.5	6.6	6.5	8.2	7.7	9.2	13.0	14.9	5.7	12.6	6.8	8.7	14.8	12.5	5.4	3.4	8.2	8.5	6.2	19.5	9.7	4.6	6.5	8.7	9.9	6.3	5.8	6.4	8.5	10.5	8.9	9.6	4.2	4.9	5.7	6.2	3.7	8.4	7.2	4.7	18.1	13.5	29.5	15.0	15.7	19.5	9.4	10.3	11.1	4.2	6.2	6.6	4.0	7.1	10.3	6.9	12.1	12.3	4.6	5.5	9.1	16.5	5.7	4.1	4.4	11.9	6.4	14.3	8.0	5.2	4.2	4.9	7.5	4.5	16.0	6.0	8.6	10.0	3.4	8.2	8.1	6.9	6.5	10.8	10.8	5.9	3.3	7.2	6.9	5.8	6.5	8.7	4.6	5.1	5.3	7.0	8.4	8.6	6.7	10.2	3.5	6.3	9.3	14.3	10.0	13.0	7.7	6.4	13.7	5.1	6.7	29.5	11.4	27.3	17.1	15.0	13.0	18.1	15.5	16.1	9.6	14.6	13.2	12.8	9.6	15.7	11.7	13.5	19.5	9.4	14.1	15.2	7.8	18.9	13.0	14.9	14.8	12.5	19.5	4.9
ALKBH7	"MGC10974, SPATA11"	ENSG00000125652	"AlkB homolog 7"	Q9BT30	19	6372433-6375251	"Predicted intracellular proteins"	Necrosis	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008539, HPA039571, HPA039872"	Approved		Supported	Mitochondria				Mitochondria		"HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710"	"unprognostic (5.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.54e-1)"	"prognostic favourable (7.83e-6)"	"unprognostic (7.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	10.8	14.7	13.7	14.1	15.2	12.7	13.6	16.3	15.8	12.3	25.0	11.1	28.4	30.9	12.4	18.8	17.2	15.4	18.7	49.3	12.6	11.9	17.1	32.7	20.2	26.3	14.2	11.9	19.0	65.0	10.2	14.0	7.9	15.8	15.5	9.8	16.0	29.7	21.5	62.9	11.9	29.6	15.8	15.9	9.9	14.2	96.5	7.3	29.9	19.4	29.5	16.2	12.6	13.6	34.3	43.8	19.7	32.8	18.4	45.9	28.4	9.7	8.4	7.5	13.0	4.2	11.9	9.2	5.8	6.3	6.4	6.8	14.8	6.3	12.5	22.0	9.0	7.5	3.3	5.9	1.2	12.7	11.8	6.7	6.2	13.8	12.4	4.1	10.2	13.6	11.9	5.5	4.4	7.9	7.6	28.2	4.8	19.7	19.8	13.9	10.3	35.4	14.0	3.8	26.4	7.1	7.6	10.0	14.8	3.9	12.7	24.5	14.4	15.3	5.2	6.4	8.3	23.5	6.7	40.6	29.4	8.3	12.1	13.2	5.5	9.9	32.8	4.9	17.1	26.5	23.5	34.3	29.8	23.3	38.8	31.6	45.9	36.0	19.7	18.4	20.4	43.8	25.3	28.4	13.7	15.2	16.3	15.8	12.6	11.9	14.2	11.9	15.8	7.3
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502726-107565746	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Oxidoreductase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA038724: , HPA038725: AB_10674838, HPA061514: "	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	9.7	6.7	7.2	14.1	12.6	6.1	11.3	9.9	11.7	8.6	7.4	7.6	9.4	6.7	9.5	7.1	9.8	7.4	6.0	12.4	7.4	7.6	9.2	9.5	7.5	11.5	7.2	5.5	9.9	7.0	13.4	10.0	6.9	7.9	8.9	7.9	8.1	7.7	7.5	12.6	9.7	7.8	9.0	7.0	10.8	6.8	5.8	5.8	9.2	11.1	5.7	12.0	8.9	8.1	3.7	3.3	0.5	4.1	4.8	6.2	2.2	4.9	6.0	6.3	6.8	3.5	7.7	5.1	9.5	7.0	7.0	7.6	11.1	9.0	11.5	5.5	9.1	8.9	9.3	7.6	9.2	10.3	6.1	9.6	2.3	5.1	5.2	12.2	11.9	4.7	8.7	9.0	11.5	8.7	13.6	3.9	5.5	4.4	11.0	6.2	8.2	9.9	10.1	9.7	8.0	5.6	5.4	5.7	6.3	5.4	4.1	4.0	6.8	3.7	8.1	15.3	9.2	5.0	11.8	3.6	3.8	9.0	4.3	8.3	15.0	0.0	2.0	0.5	4.5	4.1	4.3	1.9	3.3	3.9	3.3	3.7	6.2	5.2	0.0	4.8	2.7	2.0	3.5	2.2	7.2	12.6	9.9	11.7	7.4	7.6	7.2	5.5	7.9	5.8
ALMS1	KIAA0328	ENSG00000116127	"ALMS1, centrosome and basal body associated protein"		2	73385758-73610793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 23.2"	"Cell line enhanced"	"Detected in all"		"RH-30: 23.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035276, HPA035277, HPA043200"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Centrosome, Cytosol"	Nucleoplasm	"HPA035276: , HPA035277: , HPA043200: AB_10796689"	"unprognostic (2.86e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.91e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.58e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	3.4	1.7	3.0	6.5	5.5	6.3	3.9	5.5	4.5	6.0	4.0	5.4	4.3	2.0	7.4	3.9	2.2	7.9	4.3	1.6	3.4		3.5	2.1	2.7	2.5	2.0	5.0	11.0	4.0	6.1	6.6	3.2	3.6	3.6	3.3	4.7	2.3	5.8	2.3	1.8	2.4	4.2	3.2	2.1	2.8	23.2	3.4	6.7	5.1	1.9	3.2	2.9	4.1	0.8	1.3	1.3	0.4	0.5	1.2	0.0	8.4	3.3	6.2	4.5	2.4	4.0	3.9	2.9	3.2	4.8	3.6	3.7	1.1	7.9	1.8	4.8	3.7	10.4	3.2	7.2	4.7	2.9	5.3	3.7	2.9	2.1	7.3	2.6	3.1	1.9	6.6	3.3	4.2	5.9	4.2	4.0	2.5	6.9	3.3	8.0	3.1	7.7	23.8	3.3	1.2	3.0	5.1	6.0	6.6	1.1	2.7	1.4	1.8	2.6	6.7	7.0	5.3	6.9	4.9	2.5	8.5	2.5	4.2	3.0	0.0	0.1	1.3	1.2	0.2	0.3	0.2	0.6	0.1	0.1	0.8	0.4	0.6	0.0	0.5	0.4	1.3	0.1	0.0										
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	5	"A-431: 17.1;HEL: 27.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Cytosol"			5800000	Cytosol	"Nuclear speckles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.1	2.9	1.3	1.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	2.5	0.6	0.8	0.6	0.0	2.2	0.0	0.1	0.0	1.8	2.2	27.4	3.8	1.8	0.1	0.2	4.5	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.2	0.3	0.6	0.9	0.6	0.9	0.5	0.4	0.0	2.2	0.1	0.6	0.5	0.5	0.2	1.0	0.7	3.2	1.5	0.8	1.4	0.7	0.5	0.2	0.5	0.8	2.0	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase, type B"	O15296	17	8039017-8049134	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.0;HSkMC: 12.7;hTCEpi: 26.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 6.1;myeloid DC: 6.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.8;monocytes: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA010562: "	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	8.9	0.6	0.4	0.7	0.6	0.3	57.4	0.1	0.4	7.6	4.6	0.1	0.0	0.2	0.3	0.7	30.6	0.8	0.5	0.2	1.3	0.0	2.9	0.7	44.0	7.1	1.8	0.3	0.8	0.8	0.2	0.9	0.7	1.3	35.9	0.3	0.1	3.6	0.2	0.3	15.4	1.9	0.2	4.1	3.1	1.6	1.0	2.0	0.5	0.8	6.6	4.1	1.1	12.9	0.0	6.8	0.2	6.1	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	12.7	26.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	1.7	0.4	0.6	0.1	0.4	1.3	0.0	1.8	0.3	1.3	2.0
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;Daudi: 21.8;HMC-1: 15.6;Karpas-707: 6.9;RT4: 10.2;U-266/70: 10.3;U-698: 7.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA071285: "	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavourable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (7.18e-4)"	7.4	3.9	2.9	18.3	7.4	39.9	5.8	13.2	3.2	3.4	6.5	6.4	1.0	4.5	3.2	4.7	4.9	5.4	8.0	6.1	3.9	2.6	4.8	2.6	34.7	36.9	9.0	1.7	2.6	10.0	1.3	1.7	11.2	6.1	7.8	3.4	3.2	6.6	3.4	1.1	2.9	14.4	7.8	8.4	41.8	4.5	2.0	6.2	2.4	3.0	1.4	16.7	27.2	10.5	14.8	11.1	45.2	21.3	0.0	0.5	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	6.0	21.8	0.7	0.0	0.3	0.2	0.0	0.0	0.4	0.2	4.2	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.8	0.2	10.2	0.5	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.0	10.3	1.9	7.2	0.0	0.1	0.0	36.7	21.3	27.0	0.0	20.0	0.1	14.8	0.5	0.2	11.1	10.4	0.0	0.0	45.2	0.0	19.6	0.3	0.1	9.5	2.9	7.4	13.2	3.2	3.9	2.6	9.0	1.7	6.1	6.2
ALX1	CART1	ENSG00000180318	"ALX homeobox 1"	Q15699	12	85280107-85301784	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 13.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 15.2;HUVEC TERT2: 11.1;SK-MEL-30: 18.3;THP-1: 12.0;WM-115: 9.7"	"Cancer enriched"	"Detected in some"	10	"melanoma: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001598, HPA018905"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"				"Nuclear bodies"	"Nucleoplasm, Golgi apparatus"	"HPA001598: AB_1078400, HPA018905: AB_1844783"	"unprognostic (4.92e-3)"	"unprognostic (8.09e-2)"		"unprognostic (1.09e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.24e-2)"		"unprognostic (2.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-5)"		"unprognostic (8.97e-2)"		"unprognostic (1.43e-1)"	1.9	0.0	0.1	0.0	0.2	0.0	4.8	0.0	0.2	5.4	0.1	0.0	0.8	0.0	5.4	8.5	0.1	4.7	0.0	0.1	0.2	0.2	8.3	0.0	0.1	0.0	0.2	0.0	3.6	0.1	0.0	1.6	0.1	0.0	1.6	0.0	13.9	3.8	2.0	0.4	3.3	0.1	1.1	0.0	0.0	0.1	1.5	0.0	0.0	0.2	4.0	0.0	2.4	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.3	0.0	0.0	15.2	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	5.6	0.0	0.0	0.0	1.8	3.9	0.0	0.0	18.3	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0
ALX4	"FPP, KIAA1788, PFM, PFM2"	ENSG00000052850	"ALX homeobox 4"	Q9H161	11	44260444-44310166	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 10.5;retina: 14.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.3;BJ: 4.4;HAP1: 6.2;HEK 293: 6.3;HEL: 8.7;K-562: 4.0;SiHa: 9.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"olfactory region: 11.1"	"Region enriched"	"Detected in single"	35	"olfactory region: 27.7"	HPA001903			Supported	Nucleoplasm				Nucleoplasm		"HPA001903: "	"unprognostic (7.56e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.63e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.34e-6)"	"unprognostic (3.62e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.03e-1)"	1.6	0.1	0.6	0.0	1.6	0.0	10.5	0.7	1.6	2.0	0.1	1.4	0.0	0.0	2.4	2.4	0.5	0.8	0.3	0.9	1.3	0.7	0.3	0.0	0.5	0.0	0.4	2.2	0.2	0.1	0.2	0.3	0.0	0.3	2.0	0.0	14.4	5.6	0.1	3.1	2.8	0.0	1.1	0.2	0.1	0.1	2.5	0.5	0.0	0.4	4.2	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.3	0.0	0.0	0.0	4.4	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.2	0.0	0.0	1.3	6.3	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.7	1.6	1.3	0.7	0.4	2.2	0.3	0.5
ALYREF	"ALY, ALY/REF, BEF, REF, THOC4"	ENSG00000183684	"Aly/REF export factor"		17	81887844-81891586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"CAB016281, HPA019799, HPA061282"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: "	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-2)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.74e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.09e-2)"	17.5	15.7	15.7	29.4	15.4	76.6	17.4	13.4	23.8	17.8	20.1	17.7	14.3	20.2	16.3	15.8	30.4	18.2	17.8	27.2	13.4	13.0	16.7	21.9	19.0	34.7	14.8	13.9	19.7	22.9	10.7	17.0	23.0	12.7	16.1	15.1	15.9	18.2	13.2	27.2	22.2	19.3	16.0	15.8	25.3	16.9	50.5	10.2	61.8	19.8	33.7	36.4	15.5	18.3	3.6	5.5	0.5	2.8	2.1	3.9	1.1	37.4	35.4	24.7	24.2	5.1	6.9	31.6	18.9	10.2	39.5	24.8	39.8	24.9	41.5	15.2	15.1	21.8	35.7	20.1	17.0	15.8	63.1	30.1	22.4	42.5	10.3	48.1	27.4	6.8	9.2	23.1	9.2	23.4	38.1	25.4	14.5	40.7	101.4	81.8	33.8	37.9	68.0	30.6	21.4	8.2	22.5	33.9	44.2	18.1	43.2	15.3	33.1	48.9	15.3	40.5	40.7	18.9	63.4	30.5	14.9	53.2	21.4	30.7	34.4	0.3	2.8	0.2	3.9	2.8	2.5	2.7	2.7	2.6	3.0	3.6	0.7	2.0	0.5	2.1	2.5	5.5	1.4	1.1	15.7	15.4	13.4	23.8	13.4	13.0	14.8	13.9	12.7	10.2
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 58.5;U-266/84: 30.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"			65000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favourable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.0	6.5	3.7	4.7	2.6	4.0	6.3	5.4	4.0	2.5	1.9	21.1	4.9	1.3	2.9	7.6	1.9	0.9	3.9	2.6	4.0	3.4	3.1	4.7	6.1	1.8	1.9	1.0	6.1	1.9	3.2	1.2	2.8	1.1	4.8	7.3	2.9	1.5	2.4	3.3	10.6	1.9	6.1	2.0	11.1	20.3	2.0	2.8	8.9	6.4	5.4	4.9	1.9	5.0	8.3	1.8	2.0	4.3	58.5	30.5	2.3	2.3	3.9	6.1	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1
AMER1	"FAM123B, FLJ39827, RP11-403E24.2, WTX"	ENSG00000184675	"APC membrane recruitment protein 1"	Q5JTC6	X	64185117-64205744	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065214, HPA065265"	Approved		Supported	"Nuclear bodies,Vesicles,Plasma membrane"				"Nuclear bodies"	"Vesicles, Plasma membrane"	"HPA065214: , HPA065265: "	"unprognostic (1.56e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.89e-1)"	3.0	3.4	3.0	2.8	5.6	2.3	3.0	8.8	4.9	6.8	4.7	3.1	7.8	3.3	9.8	11.3	6.9	5.2	2.4	3.5	3.0	3.4	4.2	7.1	2.8	2.6	4.5	1.6	15.5	8.1	5.1	3.9	2.0	6.3	4.5	3.2	6.8	7.0	5.3	9.0	4.8	3.7	6.6	2.9	3.7	5.1	1.4	4.3	2.4	3.4	6.5	3.4	4.3	5.7	0.4	0.2	0.0	0.3	2.0	1.0	0.1	2.9	2.2	5.6	4.5	2.2	2.1	4.5	1.4	1.2	2.0	1.3	7.1	1.0	5.6	1.8	2.9	4.1	12.0	3.9	2.0	2.6	2.4	3.4	4.4	4.5	1.6	7.2	0.9	3.0	5.2	1.5	3.1	1.2	5.2	5.7	1.1	3.4	4.7	3.9	15.1	4.3	11.3	9.2	4.1	0.9	0.9	2.5	3.8	3.5	4.8	1.9	1.5	2.1	0.7	2.5	5.8	6.5	1.8	2.9	2.0	4.3	1.1	8.2	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.4	0.0	0.4	0.0	0.3	1.0	0.0	0.0	2.0	0.0	0.2	0.9	0.1	3.0	5.6	8.8	4.9	3.0	3.4	4.5	1.6	6.3	4.3
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425538	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"				"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: , HPA077835: "	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	13.9	25.9	21.3	10.6	23.8	14.1	28.7	12.6	25.0	17.2	21.0	24.5	18.5	21.6	16.6	25.2	20.8	15.3	13.7	17.6	20.6	20.2	35.2	50.0	13.3	19.3	22.3	14.3	20.5	14.0	33.3	13.0	41.6	18.9	14.9	11.8	23.8	12.6	18.6	71.6	11.9	18.8	16.0	25.0	14.3	12.2	36.8	17.5	14.6	18.6	10.1	19.3	15.5	16.9	18.3	10.6	21.4	13.1	11.7	9.7	4.0	17.4	24.4	10.7	19.6	33.4	18.8	9.4	18.9	23.4	25.7	20.2	21.6	16.6	45.6	21.9	25.5	16.4	16.3	14.7	24.6	10.2	16.8	13.8	10.1	23.2	29.3	10.7	16.0	21.8	21.3	20.5	24.6	14.9	14.3	6.3	18.6	11.1	16.0	11.4	5.0	16.8	18.1	21.5	17.1	15.9	18.3	10.7	8.2	44.4	15.6	14.3	46.9	11.2	19.3	24.3	13.3	12.3	12.7	13.6	11.9	24.2	17.6	7.8	11.1	21.4	8.5	10.9	6.9	9.9	9.7	18.3	8.7	7.1	7.8	15.6	9.1	9.5	10.5	11.7	13.1	10.6	9.0	4.0	21.3	23.8	12.6	25.0	20.6	20.2	22.3	14.3	18.9	17.5
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840815	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.0;epididymis: 102.0"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA067290: , HPA067853: "	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favourable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favourable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	3.7	2.3	18.4	2.0	17.9	1.3	5.5	3.0	14.0	8.1	3.5	13.9	40.0	3.1	4.7	102.0	3.8	9.7	3.1	3.7	15.4	10.9	8.2	2.5	3.0	1.6	14.4	10.3	5.4	2.7	8.4	7.0	14.9	18.0	5.6	4.3	1.2	6.9	27.6	25.2	2.7	3.6	3.5	15.7	2.1	3.3	2.7	13.5	0.1	3.8	9.3	1.8	3.2	4.3	0.5	0.2	0.0	0.6	1.9	1.5	0.2	3.0	0.0	17.6	0.7	0.3	0.3	6.5	0.6	0.0	0.0	0.0	7.4	0.6	0.4	3.6	2.7	6.4	19.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.0	3.9	0.5	0.1	0.0	0.0	0.4	0.3	4.8	0.2	7.8	0.1	6.1	5.4	0.1	8.2	8.1	0.0	6.0	0.1	0.0	6.8	0.6	0.1	0.1	2.2	5.2	0.0	7.0	0.5	0.0	0.0	0.8	0.1	4.5	0.0	0.0	0.0	1.1	0.4	1.5	0.5	0.7	1.0	0.2	0.2	0.7	0.6	0.0	1.9	0.6	0.2	1.0	0.2	18.4	17.9	3.0	14.0	15.4	10.9	14.4	10.3	18.0	13.5
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760, HPA050590"	Approved		Enhanced	Cytosol			380000	Cytosol		"HPA027137: , HPA045760: , HPA050590: "	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	8.1	22.7	20.2	21.7	41.3	64.4	4.9	16.3	26.8	9.5	10.1	9.5	6.3	17.1	9.0	6.0	5.9	11.8	13.2	5.2	21.7	19.4	7.8	13.0	8.2	10.7	14.2	14.2	16.3	9.4	13.0	37.1	10.8	18.3	9.7	5.7	15.7	9.1	12.2	2.1	10.0	11.6	9.1	8.5	15.9	8.3	5.3	12.2	10.3	6.4	3.0	7.5	8.2	8.1	2.8	8.8	29.7	24.5	3.0	4.3	5.4	10.9	12.8	18.8	15.8	16.4	16.4	7.1	15.6	32.0	16.0	15.8	9.7	4.7	5.4	12.0	29.3	8.6	9.8	14.5	9.9	8.8	13.3	28.6	16.8	10.8	15.4	12.1	30.8	18.3	7.7	21.2	16.5	13.8	8.8	14.8	11.4	17.0	17.9	29.0	12.1	13.6	12.8	7.2	8.4	14.7	6.7	14.6	15.3	10.7	13.0	12.7	7.3	11.3	13.2	19.8	23.0	24.2	16.1	29.6	14.3	7.8	29.5	18.9	20.6	0.5	9.2	11.2	3.4	19.6	4.3	2.8	3.3	3.4	8.8	1.7	3.8	2.8	29.7	3.0	24.5	1.4	2.6	5.4	20.2	41.3	16.3	26.8	21.7	19.4	14.2	14.2	18.3	12.2
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.2;skeletal muscle: 61.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;CAPAN-2: 19.0;HMC-1: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA038662: , HPA047408: "	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	2.9	13.7	5.3	13.8	14.0	39.2	2.3	2.3	7.8	3.3	3.4	19.6	0.7	4.7	3.1	4.2	5.2	8.0	4.6	2.1	7.4	7.1	4.2	1.5	4.5	12.7	15.2	5.7	2.3	2.5	24.9	14.5	3.7	11.2	5.5	4.9	4.3	4.7	2.8	61.0	10.8	5.0	3.1	12.8	8.3	4.6	1.4	12.6	14.8	2.7	7.6	14.2	6.1	5.1	7.6	3.9	17.0	6.0	3.3	5.3	2.3	7.4	1.1	0.3	0.1	4.0	2.9	0.4	6.8	24.3	1.7	1.7	3.7	19.0	2.7	0.6	3.1	4.7	0.1	6.4	5.0	6.7	0.2	6.7	0.9	0.5	1.3	9.1	20.2	10.6	10.0	3.3	4.3	0.7	10.1	2.9	5.5	0.2	5.3	11.9	0.9	6.7	2.0	8.8	9.8	0.3	6.3	2.8	1.5	1.5	0.2	0.4	0.2	3.1	1.8	7.7	0.1	5.3	0.2	2.7	1.5	2.9	8.9	9.1	0.2	6.6	6.0	17.0	2.3	3.8	5.3	7.6	3.3	2.5	3.9	5.8	3.7	2.5	8.3	3.3	1.6	2.5	1.9	2.3	5.3	14.0	2.3	7.8	7.4	7.1	15.2	5.7	11.2	12.6
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631567	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 57.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 31.8;ASC TERT1: 18.8;BJ hTERT+ SV40 Large T+: 12.3;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 11.3;HSkMC: 11.0;U-138 MG: 12.1;WM-115: 10.8"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.8	2.4	17.4	2.5	17.7	1.0	2.8	29.7	57.2	7.7	2.2	1.8	0.0	1.4	5.1	4.7	4.5	5.7	4.2	6.5	13.5	16.0	3.7	1.4	1.6	1.3	10.4	20.4	1.7	2.9	1.2	12.6	1.0	26.5	2.4	2.5	4.8	1.5	4.2	2.9	1.3	1.9	5.0	4.9	1.9	2.0	3.5	1.5	0.0	1.2	0.2	1.1	2.9	1.7	0.2	1.6	0.0	0.8	0.7	2.9	0.2	0.0	0.0	8.0	0.0	31.8	18.8	0.0	1.1	0.0	12.3	14.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	11.3	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	11.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	0.1	4.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.1	8.5	4.2	4.5	0.0	0.1	0.0	8.2	0.1	10.8	0.0	0.8	0.0	2.9	0.2	1.7	0.0	1.0	1.5	0.2	0.2	0.4	2.0	0.0	0.7	0.2	1.6	0.2	0.2	17.4	17.7	29.7	32.9	13.5	16.0	10.4	20.4	26.5	1.5
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416775-49422753	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.2;Hep G2: 29.5;NTERA-2: 5.3;SH-SY5Y: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005566	Supported		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favourable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	10.9	6.6	8.0	8.8	6.0	6.6	16.7	10.4	8.4	10.0	7.4	21.3	10.9	9.2	11.1	3.4	9.7	13.0	16.6	7.4	2.0	21.4	41.2	5.6	2.3	7.6	8.3	14.5	18.5	16.3	10.4	2.5	10.7	9.1	10.1	12.2	9.8	20.0	3.8	5.4	11.0	7.1	5.8	7.9	8.1	2.6	7.4	1.7	8.7	0.4	1.8	6.2	8.1	0.7	5.4	4.7	3.2	8.9	1.6	2.3	0.1	0.5	0.7	0.1	0.4	0.0	10.2	0.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.2	0.2	0.1	0.4	0.1	0.2	0.1	0.0	0.3	29.5	1.1	0.0	0.1	0.3	0.7	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.2	0.2	5.3	0.1	0.0	0.1	0.2	0.7	0.2	0.0	7.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	3.2	4.7	0.0	1.9	0.1	0.6	0.0	0.0	5.4	0.7	1.6	1.5	0.3	8.9	0.7	0.5	0.0	2.3	6.6	8.8	16.7	10.4	7.4	2.0	7.6	8.3	10.7	7.4
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68247574-68257164	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: "	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	22.3	21.3	29.3	13.7	43.3	14.2	20.8	29.2	35.8	19.8	19.8	20.3	19.6	11.9	19.0	25.3	22.3	24.6	17.7	33.6	26.8	23.7	26.8	16.6	14.1	22.4	26.0	27.0	23.4	20.4	29.4	25.4	18.9	28.3	21.1	15.0	19.0	17.9	25.1	39.9	15.5	13.5	19.3	27.8	16.6	15.7	77.2	20.5	15.5	28.4	20.6	22.4	20.2	14.9	20.9	17.2	31.4	21.1	34.8	31.2	19.7	23.3	25.9	22.0	18.6	16.9	29.5	34.6	16.9	22.9	29.5	24.8	10.6	15.0	35.0	19.1	26.2	11.5	17.9	49.9	38.7	12.3	16.9	12.8	11.5	20.7	32.0	11.7	22.2	25.1	56.0	27.4	51.0	29.8	13.1	22.4	37.2	17.4	26.3	10.9	10.3	24.3	10.0	59.9	26.2	17.7	12.4	22.2	17.4	15.7	32.5	31.6	25.6	8.0	15.5	39.7	18.9	14.2	18.3	31.4	28.8	60.3	28.0	16.6	20.0	31.4	14.4	19.6	22.1	16.6	28.6	17.4	27.3	29.0	17.2	20.9	24.4	26.3	25.2	34.8	21.1	15.7	31.2	19.7	29.3	43.3	29.2	35.8	26.8	23.7	26.0	27.0	28.3	20.5
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	29.3	26.1	44.9	21.9	34.1	39.6	27.2	19.5	31.8	19.4	26.3	14.8	30.3	26.1	19.2	27.5	31.7	24.6	26.0	63.6	32.9	26.7	25.9	38.4	18.5	26.7	35.2	31.8	17.2	40.3	12.6	20.6	25.7	29.8	25.4	12.2	18.1	48.8	24.0	94.2	21.6	24.8	25.4	27.6	18.9	25.9	42.2	27.3	18.5	32.5	45.7	17.0	23.5	25.5	54.9	107.5	74.0	80.1	43.1	52.8	80.4	40.9	96.2	22.9	33.9	18.3	20.9	26.3	19.9	15.6	18.0	20.6	39.5	36.1	12.9	22.2	17.5	23.9	9.1	25.4	6.5	19.0	69.7	19.3	42.7	59.5	20.5	14.4	17.1	23.1	23.1	18.4	15.1	28.9	26.4	37.7	18.7	73.7	35.0	23.8	21.6	71.8	14.6	21.8	25.9	16.4	36.8	28.8	46.8	21.4	33.8	38.8	41.3	35.2	17.2	35.1	28.1	37.6	37.2	18.5	7.7	16.3	36.9	22.0	28.0	70.1	80.1	74.0	45.3	63.7	42.8	54.9	46.4	49.5	64.6	51.6	45.2	43.5	40.5	43.1	59.3	107.5	52.8	80.4	44.9	34.1	19.5	31.8	32.9	26.7	35.2	31.8	29.8	27.3
ANAPC16	"APC16, bA570G20.3, C10orf104, CENP-27, FLJ33728"	ENSG00000166295	"Anaphase promoting complex subunit 16"	Q96DE5	10	72216000-72235860	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037815	Approved		Supported	Cytosol				Cytosol		"HPA037815: AB_10672288"	"unprognostic (2.87e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.75e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-3)"	16.9	26.7	13.9	15.6	15.9	10.8	18.7	21.6	15.8	18.3	21.2	9.4	25.8	13.1	19.1	19.9	22.7	19.9	17.0	35.6	14.8	9.5	24.9	22.7	15.8	21.6	18.7	9.8	23.4	49.0	17.9	27.3	12.4	13.6	23.9	15.3	17.5	41.4	26.2	46.3	14.2	19.6	26.4	14.4	23.2	23.6	11.9	18.0	25.5	32.3	20.5	20.9	22.4	32.2	32.1	23.5	18.4	11.9	16.5	26.2	15.5	11.1	5.6	5.7	6.8	15.5	7.4	4.4	4.0	7.7	5.4	5.1	6.8	14.8	11.3	6.6	5.4	9.0	4.9	9.6	5.4	13.1	8.4	5.7	5.2	6.7	18.7	9.7	7.1	9.6	43.4	4.8	16.3	6.5	8.3	13.7	6.2	7.0	8.0	9.6	4.4	3.2	4.7	5.2	11.0	13.8	4.9	8.4	7.7	6.8	18.3	13.5	5.8	10.0	8.7	2.9	6.8	4.6	6.0	13.8	11.6	11.7	8.0	18.5	3.3	16.2	11.3	18.4	16.7	11.4	18.2	27.7	18.7	16.4	9.0	32.1	26.2	20.9	10.5	16.5	11.9	23.5	16.3	15.5	13.9	15.9	21.6	15.8	14.8	9.5	18.7	9.8	13.6	18.0
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188549	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB018692: AB_2258285, HPA066539: "	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favourable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favourable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favourable (3.67e-4)"	"prognostic favourable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.6	15.5	13.3	15.3	17.9	19.0	14.1	21.8	26.9	12.2	11.8	28.5	17.7	17.1	15.1	12.3	13.6	13.8	16.4	14.1	12.5	10.2	12.3	19.1	13.1	19.1	22.4	14.5	15.4	23.7	10.6	12.6	11.0	16.2	15.2	5.0	15.5	25.7	14.5	20.0	25.0	16.2	9.4	13.3	19.3	16.2	31.6	13.4	14.0	14.4	11.7	15.2	13.2	11.7	1.4	2.3	0.6	3.2	1.1	2.4	3.3	10.1	22.6	5.5	9.0	6.6	4.0	17.2	9.1	5.9	8.7	6.7	13.6	10.6	11.0	10.9	6.1	21.1	6.6	7.0	1.3	14.0	11.2	6.6	26.4	12.3	7.9	10.0	11.5	8.0	5.6	5.8	3.1	10.6	9.7	13.6	4.1	28.7	12.0	14.1	11.1	17.3	14.4	13.5	20.4	6.8	9.0	7.2	11.0	13.9	18.9	5.8	20.1	13.8	11.1	13.0	10.4	15.4	8.2	6.6	9.7	11.9	10.4	6.9	9.3	0.3	2.3	0.4	2.4	2.4	1.4	1.4	1.2	1.9	1.9	1.4	1.4	1.5	0.6	1.1	3.2	2.3	1.2	3.3	13.3	17.9	21.8	26.9	12.5	10.2	22.4	14.5	16.2	13.4
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015826	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria"				Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavourable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.20e-4)"	11.4	11.7	18.0	10.8	32.6	9.5	17.8	21.6	22.7	14.5	9.3	16.9	8.6	8.6	14.8	14.2	10.2	12.2	10.4	9.2	17.4	13.8	13.3	13.0	11.0	15.8	17.0	13.9	19.1	10.5	15.5	14.8	10.8	13.8	14.5	11.0	12.3	9.8	11.2	11.0	15.1	10.7	12.2	14.9	15.5	10.5	9.0	15.9	19.5	14.0	7.9	14.9	10.8	9.7	7.8	7.2	7.6	5.9	14.1	11.3	6.7	8.6	6.9	11.3	9.6	8.6	12.7	10.1	7.1	11.9	11.4	11.4	4.6	6.4	8.4	6.5	7.0	6.8	12.9	6.8	11.5	15.7	7.8	8.4	5.5	4.5	9.5	8.3	10.1	7.8	8.8	8.9	9.1	9.6	9.7	8.7	13.0	2.8	9.5	5.6	26.5	5.0	4.8	20.2	8.7	8.9	5.8	5.5	16.1	8.5	11.6	13.1	8.9	6.1	7.1	9.4	5.0	11.5	10.7	6.4	6.1	5.6	10.5	6.2	8.6	7.4	5.9	7.6	7.4	5.5	9.1	7.8	9.2	7.6	7.2	5.3	9.8	8.1	4.0	14.1	4.4	4.4	11.3	6.7	18.0	32.6	21.6	22.7	17.4	13.8	17.0	13.9	13.8	15.9
ANK2	LQT4	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818109-113383740	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.1;ASC TERT1: 22.5;RH-30: 30.8;SH-SY5Y: 15.5"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"				"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: , HPA035970: "	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	17.3	8.7	34.0	6.3	42.1	0.8	10.7	43.7	58.5	20.9	9.5	24.5	0.6	4.3	10.5	4.3	8.3	5.8	13.0	56.7	29.4	30.3	59.8	2.0	4.6	5.1	28.7	38.7	19.0	2.4	1.6	8.6	2.0	42.1	5.4	7.2	7.8	2.6	8.7	66.9	3.5	4.7	15.2	19.0	15.1	3.8	5.8	24.2	0.0	5.6	4.4	4.5	4.5	4.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	10.2	4.2	16.1	22.5	0.0	1.0	1.8	0.7	2.0	4.0	0.0	4.2	1.4	3.6	0.0	7.5	0.4	0.6	1.9	6.2	2.4	0.0	1.7	1.0	1.0	0.7	9.6	1.6	0.9	3.9	0.0	0.0	6.9	3.4	0.1	0.2	0.0	5.3	1.7	0.5	30.8	0.0	0.1	0.0	8.3	15.5	0.1	0.3	5.3	0.1	0.6	0.0	3.2	1.7	0.2	1.9	4.1	1.1	0.6	12.7	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	42.1	43.7	54.3	29.4	30.3	28.7	38.7	42.1	24.2
ANK3		ENSG00000151150	"Ankyrin 3"	Q12955	10	60026298-60733490	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 95.4;parathyroid gland: 74.4"	"Cell line enhanced"	"Detected in many"		"RT4: 24.3;SK-BR-3: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"CAB013249, CAB015179, HPA038455"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: "	"unprognostic (1.91e-1)"	"unprognostic (5.33e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (8.88e-16)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	2.7	3.1	21.1	3.1	24.8	1.1	9.1	95.4	29.1	5.5	10.5	21.5	19.4	15.7	9.7	52.9	7.1	8.2	8.9	31.2	24.4	16.4	38.9	6.6	10.1	2.5	26.8	19.8	5.2	5.0	74.4	10.5	31.9	31.9	8.6	8.8	6.5	16.1	19.4	29.2	16.0	10.6	5.9	16.5	5.9	6.3	3.4	30.0	0.6	17.2	4.6	3.4	5.6	6.6	6.2	3.5	1.7	0.4	2.1	7.7	1.3	4.1	2.4	15.0	0.2	0.0	0.9	11.6	0.3	0.2	0.0	0.3	10.7	8.1	0.2	4.9	0.3	5.9	8.0	7.2	0.2	0.2	5.4	0.1	4.6	0.0	3.1	0.0	0.2	7.4	4.6	3.8	0.2	1.7	2.0	10.1	3.4	13.8	0.0	0.4	6.8	13.0	0.0	10.8	2.0	2.7	24.3	7.8	1.4	0.3	24.4	0.0	14.2	0.0	4.9	0.4	1.5	6.6	0.7	0.4	0.0	0.0	2.7	0.1	9.3	1.7	0.4	0.6	4.1	0.3	3.7	6.2	7.0	2.2	0.2	1.9	7.7	1.9	1.1	2.1	0.4	3.5	1.0	1.3	21.1	24.8	95.4	29.1	24.4	16.4	26.8	19.8	31.9	30.0
ANKFY1	"ANKHZN, BTBD23, KIAA1255, RANK-5, ZFYVE14"	ENSG00000185722	"Ankyrin repeat and FYVE domain containing 1"	Q9P2R3	17	4163907-4263977	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024513, HPA024522, HPA065849"	Approved		Enhanced	Endosomes			5600	Endosomes		"HPA024513: AB_1844830, HPA024522: AB_10601453, HPA065849: "	"unprognostic (4.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.05e-1)"	14.7	19.3	16.5	15.6	21.9	15.8	14.1	20.1	25.6	15.9	25.2	33.7	9.4	12.4	27.0	12.3	15.3	17.5	13.3	11.3	19.6	14.2	13.0	15.3	16.7	13.9	21.3	17.2	23.3	13.7	27.1	16.4	15.4	23.2	14.1	15.8	16.0	16.2	14.5	15.3	21.6	15.0	16.6	20.7	16.1	14.7	12.2	26.6	15.4	16.1	8.4	16.5	17.6	15.4	1.6	3.8	2.3	9.7	1.3	4.0	2.6	11.1	25.7	17.8	11.9	24.1	18.4	11.5	12.4	13.1	20.3	20.1	11.4	7.6	9.7	10.2	18.7	17.6	16.2	13.2	17.8	5.1	16.6	9.5	18.4	10.6	13.4	5.6	11.5	19.2	14.0	14.4	10.7	11.8	9.1	9.4	13.7	8.6	8.4	6.1	7.5	9.1	12.8	11.8	5.3	10.5	15.1	6.0	9.3	17.9	8.4	11.0	9.7	7.4	15.0	12.7	6.7	17.4	16.4	3.1	2.4	3.3	15.6	11.6	15.2	1.6	5.0	2.2	4.0	9.7	3.8	1.3	2.6	2.9	3.8	1.6	2.7	2.6	2.3	1.3	9.3	1.5	2.6	2.6	16.5	21.9	20.1	24.7	19.6	14.2	21.3	17.2	23.2	26.6
ANKIB1	"DKFZP434A0225, KIAA1386"	ENSG00000001629	"Ankyrin repeat and IBR domain containing 1"	Q9P2G1	7	92246234-92401384	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019358, HPA021780"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA019358: AB_1844831, HPA021780: "	"unprognostic (1.77e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.20e-1)"	11.9	11.8	21.4	9.2	29.2	5.8	12.3	15.0	25.5	13.6	12.1	34.9	16.0	10.7	12.6	16.4	11.8	10.0	14.7	9.7	22.7	20.0	25.3	10.1	10.6	11.5	31.1	18.4	13.1	12.7	28.5	10.9	12.2	23.4	10.2	12.6	8.4	12.7	18.4	8.6	14.0	11.3	13.4	23.8	11.4	10.9	19.4	35.0	11.5	17.1	4.5	11.1	13.1	13.3	4.8	4.5	3.1	2.0	3.2	4.9	1.1	17.3	10.6	9.4	14.2	17.4	18.6	10.0	13.6	15.6	13.2	17.4	7.7	26.8	10.0	12.0	20.1	8.4	8.6	14.3	20.2	16.9	7.1	6.3	12.2	6.2	11.9	9.0	14.0	12.6	12.1	15.6	20.6	14.9	8.0	21.6	15.6	14.0	19.1	8.4	10.2	12.0	7.2	11.5	10.7	14.0	15.0	13.0	15.4	19.4	21.9	11.5	9.1	5.1	13.3	25.6	20.7	28.8	13.8	13.6	24.2	12.6	14.8	10.9	29.2	2.8	1.3	3.1	2.7	2.0	2.2	3.9	2.6	3.8	1.1	4.8	2.2	2.8	0.8	3.2	1.6	4.5	4.9	1.1	21.4	29.2	15.0	25.5	22.7	20.0	31.1	18.4	23.4	35.0
ANKLE2	"KIAA0692, Lem4, LEMD7"	ENSG00000176915	"Ankyrin repeat and LEM domain containing 2"	Q86XL3	12	132725503-132761888	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003602, HPA074838"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane"				"Endoplasmic reticulum, Plasma membrane"		"HPA003602: AB_1858349, HPA074838: "	"unprognostic (4.43e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (3.97e-6)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.10e-2)"	"prognostic unfavourable (1.90e-8)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.92e-3)"	"unprognostic (2.09e-1)"	20.1	26.4	14.9	21.3	17.6	27.2	21.8	23.3	20.4	15.6	15.4	19.6	15.1	14.6	18.9	16.8	23.7	18.6	17.0	16.5	12.4	10.7	16.3	16.3	21.6	24.1	16.0	11.3	20.7	18.1	17.2	22.3	18.3	15.2	17.2	13.9	16.7	19.1	15.7	19.9	27.3	22.8	18.5	13.4	27.4	16.8	43.7	14.1	31.4	17.4	15.8	27.9	16.4	28.6	4.8	3.3	7.7	2.2	4.7	5.5	1.4	20.8	19.5	20.5	12.6	11.9	18.8	25.7	25.5	19.1	25.6	19.7	22.2	14.3	16.4	13.4	22.4	25.2	17.8	23.2	24.6	7.0	22.1	20.8	32.7	10.4	13.3	22.4	14.7	17.4	23.8	24.3	18.1	18.2	18.7	6.5	26.1	15.0	20.8	37.0	17.3	18.8	24.0	13.4	6.9	18.4	27.3	25.1	15.5	32.9	13.9	11.2	24.4	16.3	26.0	30.9	22.3	16.4	28.4	12.1	11.9	20.1	23.9	14.9	17.3	1.4	2.2	7.7	3.6	2.1	4.8	4.8	5.3	5.5	3.3	4.3	5.0	4.1	1.3	4.7	2.2	3.2	4.7	1.4	14.9	17.6	23.3	20.4	12.4	10.7	16.0	11.3	15.2	14.1
ANKRA2		ENSG00000164331	"Ankyrin repeat family A member 2"	Q9H9E1	5	73552335-73565686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003968, HPA065263"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003968: , HPA065263: "	"unprognostic (1.75e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.13e-3)"	13.0	19.4	11.9	9.2	17.1	18.7	20.9	22.8	18.3	15.7	13.5	16.6	13.1	15.0	20.0	21.0	13.3	18.5	15.0	12.2	18.1	15.8	9.6	15.9	20.7	13.9	20.6	12.3	23.3	19.7	11.4	30.2	15.4	23.1	19.8	16.4	17.5	19.0	14.3	14.5	13.4	15.3	17.8	30.7	13.0	16.2	10.3	15.8	18.1	22.2	4.5	14.7	14.9	13.3	10.7	5.9	16.9	7.4	7.0	15.5	7.3	5.1	3.9	5.7	6.0	10.5	16.0	17.5	7.0	10.5	6.1	9.2	1.1	7.9	4.8	5.7	6.9	3.7	2.7	12.5	8.8	10.0	4.7	4.2	3.0	5.4	8.2	2.5	8.3	16.5	16.9	7.4	7.6	6.8	4.1	8.1	7.0	3.1	4.3	6.4	3.1	2.9	2.6	6.2	6.6	4.8	6.4	7.7	6.0	5.3	4.3	8.3	6.4	4.1	8.5	2.5	3.0	3.9	5.0	15.8	11.4	4.1	6.2	4.1	7.1	16.9	5.7	11.3	8.7	4.6	10.5	10.7	10.2	12.1	4.9	8.4	15.5	14.2	9.0	7.0	7.4	5.9	11.7	7.3	11.9	17.1	22.8	18.3	18.1	15.8	20.6	12.3	23.1	15.8
ANKRD11	"LZ16, T13"	ENSG00000167522	"Ankyrin repeat domain 11"	Q6UB99	16	89267619-89490561	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019288, HPA049470"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019288: , HPA049470: "	"unprognostic (7.31e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (6.39e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (7.67e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.16e-1)"	24.2	23.3	22.8	25.6	23.1	48.7	41.4	32.3	31.7	22.0	24.1	22.9	22.0	22.4	26.9	18.9	25.0	23.4	23.4	22.2	24.6	20.0	17.8	15.1	32.3	33.8	20.8	21.0	32.6	27.9	33.7	31.5	18.8	19.3	20.5	14.9	23.3	21.4	25.8	27.0	35.8	24.1	26.7	20.3	26.1	22.6	21.3	22.1	26.1	21.6	19.3	19.6	23.4	34.4	4.2	7.2	11.7	5.9	9.8	4.5	1.8	22.0	27.6	27.8	21.3	17.2	17.8	26.9	25.2	16.9	15.3	10.8	32.2	23.7	20.5	17.5	18.3	22.4	19.0	23.2	17.3	10.1	22.7	16.1	19.1	25.7	26.0	11.8	18.4	19.7	23.6	20.0	25.9	18.3	34.6	16.4	19.1	20.9	19.6	29.9	24.4	25.5	40.6	32.1	17.1	15.8	18.5	16.4	20.1	36.4	7.6	26.1	17.9	18.7	33.8	32.2	30.1	17.8	27.7	29.9	10.5	25.5	25.9	19.7	17.3	7.5	3.9	3.7	3.8	4.0	4.3	3.1	4.3	4.5	2.1	4.2	3.8	3.5	11.7	9.8	5.9	7.2	4.2	1.8	22.8	23.1	32.3	31.7	24.6	20.0	20.8	21.0	19.3	22.1
ANKRD12	"FLJ20053, GAC-1, KIAA0874"	ENSG00000101745	"Ankyrin repeat domain 12"	Q6UB98	18	9136228-9285985	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040705	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040705: AB_10673301"	"unprognostic (2.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.03e-2)"	17.0	10.9	22.2	23.1	26.1	19.6	15.4	48.1	25.4	17.8	18.8	10.1	18.2	13.7	14.6	15.4	16.1	12.1	16.1	12.3	19.9	13.5	14.7	16.5	14.6	22.1	20.2	18.3	16.3	16.7	15.5	16.4	19.2	17.4	15.9	13.6	9.5	15.7	20.6	25.8	21.8	18.1	17.2	21.3	20.3	15.3	29.3	23.8	11.4	18.2	13.0	19.5	24.2	22.6	18.7	19.2	51.2	10.7	8.8	19.0	5.2	4.1	2.8	3.9	2.6	6.3	6.5	3.2	6.5	6.1	2.3	3.2	2.5	3.2	5.8	3.8	4.5	3.9	2.9	2.5	6.3	6.1	3.5	2.6	2.0	3.7	4.6	6.1	8.5	3.4	5.7	3.3	5.4	3.9	6.0	45.8	5.7	2.3	4.1	4.2	1.4	2.9	3.7	5.5	21.1	3.0	6.6	9.1	3.3	6.4	3.2	4.6	3.9	5.2	8.4	17.3	8.0	13.8	6.0	13.4	20.6	10.8	8.5	3.3	6.5	27.4	8.7	25.5	14.5	7.7	16.1	18.7	18.7	13.9	5.9	17.3	19.0	14.8	51.2	8.8	10.7	19.2	13.0	5.2	22.2	26.1	48.1	25.4	19.9	13.5	20.2	18.3	17.4	23.8
ANKRD13A	"ANKRD13, NY-REN-25"	ENSG00000076513	"Ankyrin repeat domain 13A"	Q8IZ07	12	109999186-110039763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 48.8;HBF TERT88: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039488, HPA043218"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA039488: AB_10673612, HPA043218: AB_2678367"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-3)"	"unprognostic (5.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (7.70e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (6.77e-4)"	"unprognostic (9.71e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.29e-2)"	11.1	12.3	7.0	19.8	12.6	18.3	10.2	6.8	12.8	10.6	13.8	23.3	8.6	7.9	12.0	6.9	19.9	9.8	13.1	9.1	9.2	6.4	12.8	14.0	15.1	28.7	13.1	8.3	11.1	10.6	6.5	5.3	39.4	9.5	12.6	13.0	17.1	21.7	15.1	6.2	21.1	16.8	31.0	12.3	24.2	12.7	45.8	13.8	13.3	19.1	8.0	36.5	21.5	13.0	3.9	2.5	8.9	4.2	1.4	2.9	1.3	37.4	1.7	4.1	3.8	6.4	6.3	5.1	37.7	36.2	36.5	19.5	5.0	2.5	25.0	2.9	48.8	4.5	5.2	5.7	49.4	27.9	4.3	9.2	3.9	4.1	5.6	10.7	11.1	5.5	6.1	15.6	9.0	5.5	7.1	4.1	16.2	1.3	9.4	4.7	2.2	7.8	8.2	11.5	9.9	5.3	4.9	8.5	4.0	7.0	13.9	4.8	6.3	9.1	6.9	27.4	4.8	15.1	20.3	8.8	5.2	33.4	13.4	7.5	3.9	2.6	1.9	8.9	0.9	4.2	2.9	3.9	2.4	1.1	2.5	1.9	1.4	1.8	6.0	1.4	2.0	1.9	1.0	1.3	7.0	12.6	6.8	12.8	9.2	6.4	13.1	8.3	9.5	13.8
ANKRD13B	FLJ25555	ENSG00000198720	"Ankyrin repeat domain 13B"	Q86YJ7	17	29589769-29614761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.1;SH-SY5Y: 31.6;SK-BR-3: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051886, HPA063748"	Uncertain		Supported	Vesicles				Vesicles		"HPA051886: AB_2681652, HPA063748: "	"unprognostic (1.61e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-2)"	"prognostic favourable (7.58e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (5.92e-6)"	"unprognostic (9.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.36e-3)"	8.0	6.6	10.2	4.2	14.3	2.6	12.0	34.9	28.6	7.2	4.2	16.4	2.6	2.7	12.3	3.5	5.4	9.9	7.5	6.4	12.4	9.3	1.7	1.1	3.9	3.6	14.7	10.0	10.5	3.6	5.5	6.9	2.7	7.7	5.2	2.7	3.4	4.8	4.8	8.5	10.0	3.3	8.2	13.7	3.1	3.5	16.1	12.7	2.0	2.8	2.2	2.2	7.2	8.5	0.7	0.3	0.0	0.0	0.1	1.6	0.1	3.6	7.7	8.2	17.4	4.6	4.3	2.7	0.9	0.6	1.4	1.6	3.5	0.6	4.1	3.4	1.6	13.6	4.8	4.0	0.2	6.9	16.4	2.2	15.1	2.9	1.7	1.9	2.4	4.0	5.2	1.4	2.7	6.0	3.4	3.4	1.4	3.5	10.3	4.9	6.6	6.0	16.6	5.0	11.5	1.7	1.6	28.1	31.6	3.0	24.3	2.8	3.9	2.4	4.3	3.7	4.0	3.9	3.6	5.7	7.4	5.0	2.5	6.7	2.6	0.0	0.0	0.0	0.2	0.0	0.8	0.7	0.0	1.6	0.3	0.1	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.1	10.2	14.3	34.9	17.5	12.4	9.3	14.7	10.0	7.7	12.7
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: "	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	19.6	20.2	28.9	23.2	32.4	10.3	24.8	41.2	29.9	22.8	19.4	21.2	19.5	18.2	19.3	24.2	22.2	23.5	18.8	20.4	23.4	21.6	25.3	25.3	18.0	17.4	22.3	19.4	23.4	22.8	40.2	34.6	23.2	31.8	19.7	24.2	21.5	23.1	23.1	32.7	22.2	18.5	20.7	18.0	17.7	19.2	13.5	25.1	22.3	22.7	15.9	21.1	21.1	18.9	4.5	7.6	3.2	2.8	9.3	5.3	1.7	12.1	13.4	21.5	16.9	24.1	21.3	11.7	18.0	21.2	16.2	15.7	16.3	16.1	33.2	15.0	18.4	10.3	26.7	15.9	22.5	12.9	11.4	22.5	14.6	23.6	13.0	29.4	14.0	17.9	17.4	23.2	18.6	21.5	31.5	12.3	19.4	11.3	24.1	10.5	13.9	13.6	19.3	23.6	13.7	17.3	18.5	20.8	14.1	17.4	19.7	9.4	10.5	11.7	25.9	17.1	16.4	15.3	14.1	10.2	5.2	25.4	13.9	13.0	17.5	2.3	2.8	3.0	5.3	1.8	2.7	3.0	3.3	3.6	2.3	4.5	3.2	3.6	3.2	9.3	2.1	7.6	2.0	1.7	28.9	32.4	41.2	29.9	23.4	21.6	22.3	19.4	31.8	25.1
ANKRD18A	"FLJ35740, KIAA2015"	ENSG00000180071	"Ankyrin repeat domain 18A"	Q8IVF6	9	38571358-38620660	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"bone marrow: 24.4;brain: 11.1;testis: 19.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 16.9;THP-1: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA046346: , HPA046695: , HPA049923: , HPA051288: "	"unprognostic (4.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.94e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.14e-1)"	0.5	0.7	1.4	0.8	9.1	24.4	1.1	0.4	4.1	1.0	2.1	8.5	2.4	0.9	0.7	1.1	1.4	1.2	2.7	1.1	3.0	2.2	1.5	1.2	1.5	0.8	4.8	2.3	0.4	4.1	2.5	3.2	0.7	8.7	1.6	1.5	0.4	0.9	3.9	0.4	2.4	1.5	0.7	11.1	0.5	2.0	19.1	6.9	0.0	3.8	0.0	0.5	0.7	0.8	0.4	0.0	1.1	0.0	0.1	1.7	0.1	4.6	3.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.0	0.0	0.9	3.5	3.3	0.0	0.0	4.8	0.0	4.8	2.8	0.0	16.9	0.4	0.0	2.3	0.0	3.1	0.0	1.6	0.4	0.3	4.3	0.1	0.8	3.7	2.1	0.0	6.4	6.4	2.1	1.9	1.5	3.0	2.3	0.5	0.1	2.5	8.0	4.4	0.0	1.3	0.1	0.0	0.3	0.5	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.5	0.0	0.7	0.0	1.3	0.8	0.0	0.4	0.7	1.7	0.5	0.1	0.0	0.0	1.0	0.1	1.4	9.1	0.4	4.1	3.0	2.2	4.8	2.3	8.7	6.9
ANKRD2	ARPP	ENSG00000165887	"Ankyrin repeat domain 2"	Q9GZV1	10	97572499-97583884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 472.2"	"Cell line enhanced"	"Detected in some"		"A-431: 14.5;BJ hTERT+ SV40 Large T+: 5.4;HaCaT: 11.5;RPTEC TERT1: 12.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040842, HPA040884"	Enhanced		Enhanced	Vesicles				Vesicles		"HPA040842: AB_10963794, HPA040884: AB_10969453"	"unprognostic (1.27e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	2.3	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.2	2.7	0.0	0.1	47.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.3	472.2	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.0	1.2	1.1	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	14.5	5.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	5.4	3.5	0.2	4.5	0.0	0.6	0.1	11.5	0.0	3.9	3.6	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.6	1.7	3.2	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.8	0.7	0.0	0.0	0.0	3.7	0.0	1.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0
ANKRD23	"DARP, FLJ32449, MARP3"	ENSG00000163126	"Ankyrin repeat domain 23"	Q86SG2	2	96824526-96857934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 184.5"	"Cell line enriched"	"Detected in some"	8	"Karpas-707: 29.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA036201	Approved		Supported	"Nucleoplasm,Actin filaments"				Nucleoplasm	"Actin filaments"	"HPA036201: AB_10673347"	"unprognostic (2.48e-1)"	"unprognostic (7.83e-4)"	"unprognostic (4.93e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.81e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-6)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.70e-4)"	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	2.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.7	0.0	0.1	2.2	0.1	184.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	12.2	0.9	0.1	0.1	0.4	0.2	0.5	0.0	0.9	1.2	0.4	0.3	0.5	0.3	0.6	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.2	0.1	0.8	0.7	0.3	0.4	0.1	0.1	0.5	1.3	0.2	0.2	0.4	0.0	0.1	0.6	29.0	0.2	0.7	0.3	0.6	0.3	0.2	1.0	0.0	3.6	0.1	0.6	1.0	0.1	0.2	0.5	0.0	0.8	0.0	0.2	0.3	0.4	0.5	0.0	1.3	0.4	0.2	0.3	0.8	0.3	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.9	0.0	0.2	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ANKRD34A	ANKRD34	ENSG00000272031	"Ankyrin repeat domain 34A"	Q69YU3	1	145959442-145964582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 18.1"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.4"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.5;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029642, HPA029643"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA029642: AB_10599277, HPA029643: AB_10601878"	"unprognostic (1.98e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.66e-8)"	"unprognostic (6.36e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.23e-2)"	0.8	1.3	6.4	2.0	10.5	0.3	0.6	7.8	18.1	0.9	0.7	1.2	0.0	1.6	1.5	1.2	0.9	0.7	1.1	1.7	4.2		0.5	0.2	0.7	1.4	0.4	6.7	1.6	0.5	2.0	1.2	0.5	5.7	1.7	0.4	1.3	0.8	2.2	2.3	0.8	1.6	1.6	0.0	1.4	1.1	0.5	1.0	0.0	0.6	0.0	1.5	0.9	0.0	1.5	0.4	0.6	0.3	0.3	3.5	1.0	1.4	0.7	0.7	2.4	3.5	2.7	0.3	2.7	5.1	0.6	1.7	0.2	0.8	2.7	0.3	3.4	0.6	1.1	0.8	0.4	5.8	1.7	0.2	2.1	0.0	0.5	0.3	2.3	2.4	0.3	2.2	2.5	0.9	1.3	6.3	4.0	2.5	1.1	0.8	0.3	3.0	0.3	0.6	12.4	1.1	0.1	3.4	2.5	0.5	0.1	1.6	3.6	0.4	0.8	6.2	4.2	5.3	1.3	4.4	8.4	0.4	6.1	2.2	0.4	0.0	0.1	0.6	3.5	0.3	2.6	1.5	1.7	1.9	0.4	1.4	2.3	3.4	0.3	0.3	0.0	0.1	1.7	1.0										
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: "	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	7.7	8.9	11.0	3.9	15.2	3.3	10.9	9.9	20.9	17.2	7.5	6.0	5.4	4.8	4.9	4.1	35.8	8.0	4.8	13.6	12.0	9.6	6.4	14.2	12.4	3.0	12.3	5.8	14.8	13.5	1.7	11.7	10.7	16.8	24.1	7.0	8.4	35.4	21.9	22.1	7.3	4.9	5.0	16.1	4.6	5.2	8.7	14.2	1.5	14.2	18.6	12.2	14.3	22.8	7.7	4.2	10.2	3.9	3.2	8.1	3.0	6.6	1.0	0.7	3.8	5.2	3.3	3.6	3.1	2.3	2.3	5.0	1.6	1.9	3.2	1.3	5.6	2.5	3.6	4.0	2.9	9.0	1.0	2.2	3.4	4.8	2.2	2.0	4.9	0.6	4.3	2.1	3.0	2.8	3.3	5.4	6.2	1.7	1.7	8.0	1.1	5.3	0.5	1.0	8.7	2.8	0.5	5.3	9.5	2.1	2.1	9.2	1.9	1.3	3.7	4.9	3.9	2.8	3.5	10.2	2.9	1.4	14.0	1.5	5.7	0.4	3.8	10.2	5.5	3.5	4.7	7.6	4.3	8.1	2.6	7.7	3.3	4.7	2.0	3.2	3.9	4.2	5.1	3.0	11.0	15.2	9.9	20.9	12.0	9.6	12.3	5.8	16.8	14.2
ANKRD6	KIAA0957	ENSG00000135299	"Ankyrin repeat domain 6"	Q9Y2G4	6	89433170-89633834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.8"	"Cell line enhanced"	"Detected in many"		"AF22: 10.0;BEWO: 30.6;HAP1: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;intermediate monocyte: 2.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020693, HPA035694, HPA064642"	Approved		Enhanced	Vesicles				Vesicles		"CAB020693: , HPA035694: , HPA064642: "	"unprognostic (3.80e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.10e-1)"	3.9	2.2	11.7	3.0	7.8	1.6	3.9	47.8	17.8	5.7	2.9	2.8	1.1	1.0	6.1	4.4	4.9	11.7	5.7	8.9	7.8	9.1	5.4	4.5	5.7	2.5	4.2	12.0	15.6	4.3	9.3	4.2	4.3	7.3	3.6	1.1	6.6	7.7	2.3	4.0	1.9	1.8	5.4	5.0	2.0	2.6	6.1	3.7	2.0	5.6	3.3	2.5	4.4	4.0	0.3	0.1	3.0	2.9	0.6	1.0	0.3	0.0	1.2	10.0	4.2	0.1	0.4	30.6	0.1	0.1	0.0	0.6	0.3	0.8	0.0	1.0	0.0	0.0	9.1	5.1	0.4	0.0	6.8	3.6	0.0	0.3	0.1	0.0	1.4	0.6	1.4	0.0	0.0	1.0	0.3	2.3	0.0	1.1	0.1	0.3	2.8	1.0	3.6	0.0	0.0	1.5	5.1	6.6	2.3	0.8	6.7	3.3	1.9	2.2	0.0	1.6	0.6	0.1	0.8	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.4	3.0	1.0	2.9	0.0	0.0	0.7	0.0	0.1	0.3	0.3	0.4	0.7	0.6	0.0	0.0	0.2	0.3	11.7	7.8	47.8	11.6	7.8	9.1	4.2	12.0	7.3	3.7
ANKRD61		ENSG00000157999	"Ankyrin repeat domain 61"	A6NGH8	7	6031376-6036386	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"bone marrow: 8.7;testis: 9.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029511, HPA050732"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA029511: AB_10602430, HPA050732: "	"unprognostic (1.40e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-1)"	0.5	0.5	0.0	0.7	0.2	8.7	0.7	0.5	0.9	0.4	0.3			0.6	0.6	0.0	0.4	0.5	0.2	0.6	0.1	0.1	0.3	0.5	0.5	1.1	0.0		0.8	1.0	0.1	0.5	0.4		0.4	0.0		0.9	0.0	0.6	2.1	0.8	0.0	0.2	0.9	0.9	9.1			0.9		0.0	0.5	0.5	0.6	1.5	0.9	1.1	0.0	0.8	0.3	2.1	5.9	1.8	2.7	0.3	0.3	2.5	1.4	0.4	0.6	0.6	2.9	5.5	1.1	0.6	0.2	2.2	1.0	0.0	0.7	0.3	0.7	1.5	12.5	0.3	0.2	1.6	2.5	0.4	1.2	0.5	1.1	0.5	1.9	1.7	0.7	3.7	0.3	1.8	0.9	0.7	1.5	0.5	0.3	0.5	2.8	1.3	2.5	1.4	1.6	0.2	2.9	1.0	1.2	2.3	4.8	2.8	1.7	1.6	1.8	0.9	0.7	1.4	1.4	0.9	1.1	0.0	0.1	1.1	0.0	0.0	0.0	0.8	1.5	0.6	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.3										
ANKRD7	TSA806	ENSG00000106013	"Ankyrin repeat domain 7"	Q92527	7	118214669-118496171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"testis: 184.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;SCLC-21H: 9.9;U-266/70: 12.7;WM-115: 4.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043489, HPA052941"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA043489: AB_10959304, HPA052941: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-4)"		"unprognostic (3.13e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.49e-2)"		"unprognostic (1.69e-1)"	"unprognostic (5.51e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.57e-4)"	"unprognostic (3.32e-2)"	0.1	0.1	0.5	0.0	0.8	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.1	1.3	0.1	0.1	0.0	0.1	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.9	0.0	1.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	184.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	3.1	0.4	1.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.2	1.6	0.0	0.0	0.1	0.3	0.1	1.4	1.0	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.4	0.7	0.0	0.0	0.0	2.2	1.4	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	2.4	0.0	0.0	1.9	0.0	1.2	0.4	0.0	1.1	0.3	0.0	12.7	0.6	0.5	1.8	0.0	4.0	0.0	0.0	1.0	0.4	0.0	0.3	3.1	0.2	0.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.4	0.0	0.1	0.5	0.8	0.1	1.0	0.4	0.1	0.1	0.3	1.0	0.0
ANKS1B	"AIDA-1, ANKS2, cajalin-2, EB-1"	ENSG00000185046	"Ankyrin repeat and sterile alpha motif domain containing 1B"	Q7Z6G8	12	98726457-99984654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 66.2;skeletal muscle: 28.2"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;ASC TERT1: 7.0;SCLC-21H: 12.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA044628, HPA078230"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"HPA044628: , HPA078230: "	"unprognostic (5.50e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.97e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.75e-3)"	2.3	4.5	21.4	1.7	41.2	1.2	3.7	21.0	66.2	3.3	2.3	27.5	0.0	1.5	3.3	2.4	3.9	4.4	2.2	2.2	28.3	17.3	5.4	1.8	2.0	1.6	20.3	24.8	9.7	2.1	1.9	4.4	2.7	16.0	4.1	2.1	0.1	3.8	3.7	28.2	1.9	1.6	3.3	25.8	2.0	1.8	7.6	23.0	0.0	6.3	0.0	1.3	2.1	0.8	2.1	2.4	5.3	3.1	3.1	8.3	1.3	0.3	2.5	11.8	2.8	4.8	7.0	0.7	0.0	1.2	0.9	0.9	0.2	0.9	1.0	0.5	1.7	0.5	0.1	0.1	0.2	1.4	0.8	0.1	0.8	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.3	0.3	0.9	0.2	0.7	0.5	0.5	3.4	2.2	0.8	0.0	0.3	0.1	0.0	12.9	1.4	1.1	3.8	1.5	4.4	0.1	0.1	1.0	1.1	0.7	0.7	0.1	0.7	0.6	1.1	0.3	1.1	5.3	1.4	2.1	1.7	2.1	2.5	1.9	2.9	1.6	1.3	2.1	2.4	2.3	3.9	3.1	3.1	2.4	8.3	1.3	21.4	41.2	21.0	27.9	28.3	17.3	20.3	24.8	16.0	23.0
ANKS3	"FLJ32345, FLJ32767, KIAA1977"	ENSG00000168096	"Ankyrin repeat and sterile alpha motif domain containing 3"	Q6ZW76	16	4696510-4734378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041409, HPA041482"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041409: AB_10794375, HPA041482: AB_10795594"	"unprognostic (3.02e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-3)"	6.9	10.1	7.4	6.4	12.0	4.2	8.9	14.5	11.1	8.1	9.3	8.2	5.0	6.2	8.7	6.7	8.2	9.3	6.8	5.6	8.3	8.5	10.5	5.0	5.8	8.6	10.0	10.9	15.7	16.5	6.8	14.2	5.6	9.7	9.1	3.2	10.9	14.4	10.2	7.7	8.3	4.8	11.7	7.0	5.2	6.1	8.0	7.5	3.2	9.4	3.4	4.7	7.6	7.5	3.3	5.3	0.0	1.6	1.3	3.8	1.1	1.9	23.1	3.0	6.6	5.8	4.8	6.9	8.6	7.0	8.0	7.2	11.9	4.8	4.4	10.9	5.7	3.9	6.5	4.7	3.6	5.6	12.4	3.9	10.7	2.9	6.4	2.1	3.6	3.0	5.1	7.7	7.4	1.5	9.4	1.4	4.8	7.1	4.2	7.8	8.1	4.4	6.7	7.4	7.8	6.1	2.4	9.7	9.4	4.5	6.6	3.7	6.5	2.8	2.6	5.9	8.1	11.0	4.4	6.9	12.2	6.5	3.1	2.2	6.8	0.0	1.1	0.0	2.4	1.6	2.9	3.3	2.7	1.7	1.9	3.3	3.8	2.5	0.0	1.3	1.4	5.3	1.7	1.1	7.4	12.0	14.5	11.1	8.3	8.5	10.0	10.9	9.7	7.5
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389806-36453791	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.4;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 98.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: , CAB068175: , HPA005680: , HPA050556: "	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (5.97e-7)"	"prognostic unfavourable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavourable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.7	0.6	13.9	7.2	10.5	20.9	1.3	1.8	36.7	1.9	3.9	1.6	0.0	2.9	1.3	2.4	12.8	0.6	1.4	0.6	24.0	12.1	0.7	0.8	3.3	4.2	30.5	2.5	0.9	0.4	0.3	0.3	12.9	9.7	0.7	5.5	0.0	0.9	0.3	0.4	8.9	3.4	9.4	63.4	1.6	3.3	9.2	12.5	32.7	0.6	17.7	6.7	2.6	1.3	0.0	0.3	0.6	0.9	0.0	1.7	2.0	67.1	14.1	11.7	8.9	1.6	4.1	12.7	42.4	24.8	51.2	38.4	9.6	20.8	3.4	12.3	21.4	34.6	9.2	24.8	98.4	2.2	6.7	4.6	15.9	8.0	0.2	6.6	5.4	0.9	1.1	33.3	22.0	15.9	9.7	7.1	41.7	10.1	5.6	7.7	13.0	15.0	4.1	35.3	2.2	11.3	11.0	5.0	5.9	22.3	25.9	3.9	17.5	7.6	15.1	32.1	36.1	18.9	49.5	3.0	4.7	6.2	10.9	10.7	67.3	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.9	0.5	0.3	0.0	0.6	0.0	0.6	0.0	0.3	0.2	1.7	2.0	13.9	10.5	1.8	7.7	24.0	12.1	30.5	2.5	9.7	12.5
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Group enriched"	"Detected in some"	5	"A-431: 33.8;CAPAN-2: 52.0;HaCaT: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA032148: , HPA057356: "	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favourable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	33.8	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.6	0.0	63.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	4.9	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.8	0.2	4.1	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: "	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favourable (6.70e-4)"	"prognostic favourable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	21.6	12.7	11.8	12.6	13.2	20.6	22.0	18.2	14.1	17.5	27.4	14.3	13.2	42.0	17.9	12.4	19.8	10.4	16.7	10.5	12.3	15.2	22.2	10.5	13.6	10.7	17.3	12.3	12.7	14.4	18.6	14.4	17.5	19.4	10.7	24.4	18.6	23.1	19.5	11.3	24.6	52.9	19.9	23.6	9.4	11.1	9.1	8.8	5.5	17.7	15.8	13.9	13.7	17.0	2.0	8.5	22.4	12.5	6.3	4.6	4.3	8.8	7.1	7.9	8.3	32.2	17.3	9.7	26.2	43.6	13.4	17.1	4.8	8.3	1.0	8.4	34.5	4.9	6.2	14.3	16.3	9.9	4.4	11.6	9.6	5.2	14.1	2.0	9.5	16.1	11.4	16.5	22.5	31.3	8.7	7.6	29.6	6.3	2.2	1.5	9.4	8.3	1.8	5.7	3.0	26.4	9.4	1.9	5.8	10.3	8.5	6.0	18.1	4.3	25.4	20.4	7.6	21.4	11.9	4.9	6.4	0.3	18.6	4.4	13.4	4.4	12.5	0.9	4.6	7.1	2.7	1.9	3.2	3.1	8.5	2.0	2.8	4.3	22.4	6.3	7.7	1.5	3.5	4.3	11.8	13.2	18.2	14.1	12.3	15.2	17.3	12.3	19.4	8.8
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 46.9;retina: 30.6;testis: 13.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.4;HUVEC TERT2: 8.3;U-2 OS: 22.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.1"	"Region enriched"	"Detected in some"	4	"basal ganglia: 20.0"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: "	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	5.8	0.1	1.0	1.3	2.3	0.0	4.3	1.2	1.3	3.3	1.0	1.6	0.9	0.8	1.8	2.1	0.9	1.9	1.5	3.9	1.9	0.9	1.2	0.9	4.7	0.9	1.6	2.0	0.9	0.9	1.4	0.9	46.9	1.2	1.4	0.7	30.6	0.9	1.6	2.3	0.6	0.9	2.1	1.1	1.9	1.0	13.4	0.9	0.9	1.6	1.3	0.9	1.3	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.2	2.1	0.0	3.9	0.0	0.0	0.2	1.8	0.0	8.4	0.4	0.9	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.6	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	1.6	0.0	0.8	0.0	0.0	4.0	0.0	1.6	0.0	0.9	0.1	0.1	0.0	0.0	2.0	1.4	0.0	1.1	0.0	0.2	0.0	22.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	1.0	2.3	1.2	1.3	1.9	0.9	1.6	2.0	1.2	0.9
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			740000	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: , HPA067561: "	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	25.8	20.4	32.7	32.0	40.1	46.0	28.2	50.7	33.7	24.5	30.7	40.5	16.0	27.0	26.8	21.7	28.8	30.0	23.4	47.8	32.3	23.6	30.0	29.6	27.2	55.0	33.9	30.0	26.7	25.6	24.2	18.3	38.6	26.6	30.4	35.4	27.2	23.6	27.8	41.7	18.9	28.9	30.5	42.7	40.1	29.8	9.4	36.7	75.0	29.0	18.5	52.4	35.7	27.6	12.7	19.8	27.7	19.9	18.1	12.3	9.6	26.0	32.0	42.1	36.3	14.8	13.0	28.0	13.7	18.5	27.0	22.8	26.4	49.1	84.6	25.8	15.5	38.3	97.4	28.1	32.5	38.1	33.1	64.0	27.1	33.0	9.2	50.3	34.6	10.4	19.9	14.8	29.6	39.2	46.5	33.1	23.1	18.2	50.5	41.3	37.4	16.2	70.9	39.1	50.2	23.8	41.2	55.9	34.7	20.9	23.6	38.7	31.4	66.0	17.5	28.0	44.6	19.3	36.7	20.1	55.7	98.0	18.6	84.7	25.6	8.1	17.6	27.7	11.9	19.9	10.0	12.7	9.8	12.3	19.8	12.7	12.1	10.6	18.1	18.1	16.8	17.6	11.2	9.6	32.7	40.1	50.7	33.7	32.3	23.6	33.9	30.0	26.6	36.7
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983361-98015943	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			290000	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: , HPA067561: , HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	43.0	24.6	37.9	46.5	55.5	105.7	37.7	15.6	30.1	43.2	38.9	81.0	24.6	32.7	46.3	38.4	40.4	28.4	39.2	27.0	41.8	32.0	26.0	35.9	35.0	70.4	55.7	21.7	51.1	46.0	29.3	20.7	37.5	41.8	38.9	42.3	26.2	32.5	29.7	29.4	38.6	34.9	45.3	88.3	38.6	36.7	19.0	47.6	85.9	37.0	31.9	81.8	64.5	58.6	34.8	32.6	36.8	44.6	22.7	51.3	25.1	70.9	38.4	42.8	35.7	24.1	42.7	39.0	36.9	32.7	39.7	33.5	48.1	34.9	87.1	22.1	24.7	47.0	57.7	41.6	45.6	56.5	32.5	75.3	33.0	51.9	31.0	129.1	43.9	32.3	30.5	31.8	65.8	34.4	144.9	61.7	30.5	94.8	97.4	114.8	16.7	38.2	58.2	66.8	41.4	25.9	29.8	34.6	30.2	43.3	42.3	37.8	23.9	48.3	41.7	25.9	42.0	32.5	38.7	56.0	63.2	52.6	24.0	51.8	48.2	23.1	27.2	36.8	22.7	30.9	31.3	34.8	42.7	31.9	32.6	29.6	51.3	38.7	11.3	22.7	44.6	31.8	50.8	25.1	37.9	55.5	15.6	30.1	41.8	32.0	55.7	21.7	41.8	47.6
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472665-48473624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.3;REH: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: , HPA067561: "		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.1	0.9	0.3	0.0	0.2	0.1	0.2	0.2	0.6	0.0	0.5			0.0	0.6	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.7	0.0	0.2		1.1	0.1	0.0	0.2	0.5		0.3	0.2		0.4	0.3	0.2	0.0	0.1	0.2	0.2	0.5	0.2	0.9			0.8		0.0	0.4	0.1	0.1	0.1	0.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.4	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0										
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			18000	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: , HPA067561: "	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	11.5	18.3	31.2	21.0	30.9	38.4	10.6	50.3	20.6	14.3	11.3	18.3	13.5	12.9	16.5	21.0	12.8	12.8	11.9	19.8	22.9	25.9	18.6	16.8	13.3	38.4	26.5	19.5	19.1	6.9	20.1	14.7	12.3	21.2	14.2	10.9	20.1	9.2	20.9	25.5	12.5	14.5	25.2	32.7	20.3	9.9	6.0	17.8	52.2	18.1	13.6	34.7	20.6	12.1	24.5	8.2	20.7	10.5	14.6	27.0	15.7	33.7	21.9	45.7	22.7	3.6	5.3	17.4	18.2	10.3	17.6	16.9	16.1	24.0	61.6	16.2	10.4	11.8	25.7	11.3	25.3	70.5	15.6	42.7	27.2	23.2	3.4	85.6	21.7	4.3	1.8	16.4	15.2	13.0	40.8	36.5	16.1	35.1	34.9	22.3	46.1	10.0	37.2	25.4	32.4	12.5	13.6	15.0	25.8	38.0	6.1	10.7	16.5	43.8	13.4	9.0	25.5	9.3	36.4	47.2	47.3	60.4	10.3	61.9	16.4	20.7	10.5	16.3	18.0	7.3	27.0	24.5	24.2	19.7	8.2	17.0	17.4	21.6	7.2	14.6	8.8	5.7	25.7	15.7	31.2	30.9	50.3	20.6	22.9	25.9	26.5	19.5	21.2	17.8
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784889-89815401	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 195.3;kidney: 78.7;pancreas: 93.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.0;BJ: 76.7;BJ hTERT+: 109.7;HMC-1: 69.8;HSkMC: 67.4;HUVEC TERT2: 85.8;TIME: 85.8;U-2197: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 59.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"			1500000000	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: "	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	21.3	1.1	0.6	2.9	0.8	9.5	17.0	1.0	1.3	8.2	21.2	0.8	0.5	195.3	1.4	8.4	3.6	1.4	27.7	3.7	0.4	0.3	78.7	37.7	9.7	9.3	0.9	0.9	1.8	93.9	0.0	0.7	14.7	1.3	8.6	4.7	4.0	6.6	1.8	1.6	4.9	155.8	4.3	1.2	7.2	0.8	4.7	0.2	5.6	1.5	4.2	3.8	4.7	3.0	0.0	6.9	59.4	12.8	0.0	0.0	5.5	0.0	4.9	0.0	0.0	60.1	77.0	0.5	76.7	109.7	9.4	8.3	0.5	0.0	0.0	0.9	65.8	0.0	0.5	0.0	3.7	0.0	0.0	14.5	0.4	11.4	35.4	1.0	69.8	67.4	0.1	29.7	0.0	85.8	0.4	0.1	3.6	0.0	0.0	34.1	0.2	5.2	0.0	0.0	0.8	42.9	0.0	0.1	0.7	0.0	0.1	0.0	0.0	6.7	85.8	41.4	0.0	93.5	0.0	0.0	0.0	0.0	0.1	0.0	2.2	5.7	12.8	10.4	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	59.4	0.0	12.0	0.1	0.0	5.5	0.6	0.8	1.0	1.3	0.4	0.3	0.9	0.9	1.3	0.2
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151757-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 432.6;tongue: 235.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		77000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: , HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favourable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favourable (4.57e-5)"	"prognostic unfavourable (6.19e-6)"	52.7	3.5	2.7	11.5	3.3	81.4	45.9	0.9	2.5	61.5	8.5	3.6	5.5	2.4	6.9	11.2	432.6	11.9	14.9	8.9	3.2	2.5	9.1	2.1	37.3	7.6	4.3	1.9	11.7	2.4	0.5	6.3	149.5	13.5	12.9	4.4	6.4	93.0	7.2	7.9	11.6	6.4	12.3	6.5	5.9	5.9	5.6	3.1	3.9	21.7	235.4	153.3	18.0	83.1	0.7	98.9	146.2	79.1	27.3	52.5	102.8	65.9	104.2	4.7	4.9	66.5	63.3	0.3	114.3	71.4	47.3	32.1	3.0	59.7	0.1	37.8	99.7	81.2	10.1	69.2	37.5	37.3	0.7	5.0	31.0	0.1	53.1	11.0	2.5	36.4	57.4	47.8	94.0	67.0	20.9	2.8	58.3	0.2	19.4	6.0	5.9	42.4	0.0	26.6	0.2	106.4	14.0	0.0	0.0	39.3	1.0	26.4	0.2	1.7	82.7	55.5	34.9	76.2	58.6	0.4	0.1	0.2	128.1	10.2	83.4	146.2	79.1	141.1	52.2	21.5	52.5	0.7	47.0	45.9	98.9	0.2	13.7	25.4	8.6	27.3	19.3	3.5	8.3	102.8	2.7	3.3	0.9	2.5	3.2	2.5	4.3	1.9	13.5	3.1
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol			530000	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favourable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	44.1	7.3	19.4	27.8	23.8	37.0	61.1	22.8	24.4	26.4	34.4	8.6	18.4	28.6	20.2	36.4	49.5	23.9	47.5	57.1	17.2	8.3	39.1	21.9	35.1	38.1	10.8	14.2	27.3	24.0	26.2	9.7	35.0	7.5	28.9	27.6	16.7	20.2	27.8	39.5	18.6	44.1	28.1	11.2	22.9	29.3	15.1	6.6	45.7	18.9	39.2	31.8	34.9	39.6	12.7	14.4	77.9	12.1	11.6	21.9	13.0	34.7	30.5	1.8	9.0	39.1	38.6	19.5	26.0	67.0	16.2	16.8	27.6	54.4	2.3	18.8	38.9	45.5	7.8	21.7	9.8	59.1	13.9	14.2	18.1	21.4	22.9	15.6	35.3	40.7	13.2	9.0	6.9	23.0	13.9	26.4	12.8	20.7	19.0	34.5	3.3	64.7	14.5	2.7	52.6	27.4	32.3	0.8	6.3	11.2	45.0	25.4	13.3	19.2	27.7	11.4	17.1	26.0	13.6	16.1	21.9	15.1	11.9	26.1	7.5	22.6	12.1	77.9	14.5	9.6	15.3	12.7	18.3	20.3	9.1	10.9	17.3	14.9	43.8	11.6	10.7	14.4	21.9	13.0	19.4	23.8	22.8	24.4	17.2	8.3	10.8	14.2	7.5	6.6
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6"	"Group enriched"	"Detected in some"	13	"A549: 23.3;HDLM-2: 12.0"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Region enhanced"	"Detected in single"		"midbrain: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.1	0.3	0.7	0.5	0.0	0.4	0.1	0.4	0.2	30.3	0.4	41.9	66.5	1.1	2.6	0.2	13.3	38.7	0.1	0.5	0.6	2.1	4.3	0.1	0.1	3.0	0.1	0.9	0.3	0.0	0.1	0.1	0.7	1.1	8.1	0.2	0.2	20.7	0.1	0.1	108.6	0.4	8.0	0.1	0.7	2.3	0.3	0.1	0.1	0.1	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.5	0.6	3.0	0.1	0.7	0.3
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551519-78610451	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 83.0"	"Cell line enhanced"	"Detected in many"		"A-431: 52.0;CACO-2: 53.3;CAPAN-2: 72.2;EFO-21: 44.2;hTERT-HME1: 73.6;RPTEC TERT1: 62.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	319	"neutrophil: 51.3"	"Lineage enriched"	"Detected in single"	319	"granulocytes: 51.3"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Enhanced	Cytosol			7400000	Cytosol		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favourable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	20.3	1.1	4.0	7.1	7.4	83.0	16.2	2.4	6.8	7.0	8.5	2.3	0.9	4.2	3.4	4.2	25.0	4.6	11.7	20.5	5.2	5.2	19.8	1.6	46.0	5.7	6.6	5.6	2.8	14.7	6.5	5.8	33.7	10.4	18.8	7.4	2.6	50.8	3.6	14.2	4.1	9.3	5.3	4.0	11.0	23.4	1.8	5.0	2.0	45.3	13.6	7.4	2.8	5.9	0.1	0.0	51.3	0.1	0.0	0.0	0.5	52.0	9.9	0.1	0.1	0.1	0.2	0.0	0.6	0.0	1.5	1.4	53.3	72.2	0.0	44.2	1.8	20.6	0.0	38.1	2.3	0.2	0.4	4.6	21.3	3.2	6.1	0.6	0.0	0.3	33.8	0.5	73.6	15.1	0.1	0.0	0.2	2.0	0.2	0.0	1.6	7.3	0.0	0.1	0.0	62.0	6.0	0.0	0.0	30.7	7.6	2.2	1.3	0.6	19.1	0.1	6.9	0.0	11.7	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	51.3	0.0	0.1	0.0	0.0	0.5	4.0	7.4	2.4	6.8	5.2	5.2	6.6	5.6	10.4	5.0
AP002495.1		ENSG00000254469	"Putative short transient receptor potential channel 2-like protein "	Q6ZNB5	11	71865509-71928654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051121, HPA051124"	Uncertain		Enhanced	Nucleoli				Nucleoli		"HPA051121: , HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	5.8	6.9	8.2	7.7	7.3	9.1	7.3	7.4	8.7	7.5	6.3	11.6	21.7	6.1	9.2	13.2	6.2	7.2	5.0	4.8	6.4	4.9	7.6	5.1	5.4	8.9	6.8	5.4	12.1	7.2	7.4	12.7	4.8	6.6	7.2	8.5	10.4	7.9	15.7	5.9	8.8	7.5	6.4	6.5	7.9	6.9	9.7	11.9	11.6	8.7	3.6	12.2	7.1	6.8	6.0	7.5	3.4	4.5	1.8	8.5	3.2	2.8	6.4	5.1	4.8	1.9	2.0	3.2	3.3	2.5	3.5	3.3	7.5	7.2	6.2	3.0	2.1	9.2	5.4	3.4	3.9	9.0	4.7	9.9	7.1	4.4	1.4	4.8	3.4	2.6	1.6	5.7	4.6	5.2	6.7	9.2	3.5	5.8	4.8	3.5	5.5	4.7	4.0	18.6	4.3	3.7	3.6	7.6	7.8	4.8	4.5	10.1	6.5	2.3	4.8	2.7	4.8	5.2	2.0	5.7	9.0	7.7	4.6	5.1	4.4	3.4	3.0	2.5	4.6	4.5	2.9	4.2	8.5	6.3	3.5	6.0	8.2	6.8	2.6	1.8	2.7	7.5	7.1	3.2	8.2	7.3	7.4	8.7	6.4	4.9	6.8	5.4	6.6	11.9
AP1AR	"2C18, C4orf16, gamma-BAR, PRO0971"	ENSG00000138660	"Adaptor related protein complex 1 associated regulatory protein"	Q63HQ0	4	112231737-112270047	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035863, HPA058115"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA035863: AB_10672098, HPA058115: "	"unprognostic (1.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.15e-2)"	"prognostic favourable (4.05e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-3)"	"prognostic favourable (7.79e-4)"	11.6	17.8	16.3	12.7	24.0	3.7	18.6	22.1	23.6	10.1	18.9	8.3	16.8	23.4	13.4	9.3	16.5	8.7	13.9	9.2	22.1	16.3	24.4	21.8	11.5	12.2	16.5	16.1	15.3	11.7	37.6	9.6	12.8	18.1	10.3	18.0	6.8	16.5	14.8	9.4	15.7	25.9	14.1	11.9	13.8	13.6	15.4	15.2	10.2	12.5	11.5	12.9	13.3	14.9	9.0	11.2	5.9	12.0	10.5	11.8	6.2	10.1	5.5	11.7	11.9	10.7	7.8	12.0	9.2	22.3	6.7	8.0	5.3	19.7	23.3	8.0	5.9	4.7	11.8	7.2	11.6	26.7	7.3	7.6	6.2	16.5	16.4	18.7	12.3	8.6	16.5	6.0	17.0	10.5	8.5	19.4	7.0	9.7	16.9	12.4	9.3	5.9	14.9	13.5	12.0	12.9	7.2	12.9	16.8	6.4	23.0	16.7	7.6	6.5	9.7	9.5	11.8	14.2	7.6	17.9	31.6	26.9	9.9	7.2	8.1	5.9	8.9	3.0	5.4	12.0	7.2	9.0	8.4	8.2	11.2	8.0	11.8	11.6	1.4	10.5	9.5	5.5	8.7	6.2	16.3	24.0	22.1	23.6	22.1	16.3	16.5	16.1	18.1	15.2
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 beta 1 subunit"	Q10567	22	29327680-29423179	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Enhanced	"Golgi apparatus,Vesicles,Cytosol"			1000000	"Golgi apparatus, Vesicles"	Cytosol	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favourable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	22.2	25.8	28.0	32.3	35.2	29.9	17.2	37.3	43.1	17.2	23.9	26.5	23.9	32.1	14.8	18.4	46.4	17.7	22.0	16.6	24.4	30.4	24.2	25.8	21.2	37.2	29.4	24.1	12.7	28.4	48.2	31.1	32.3	31.9	27.3	21.8	24.1	29.5	31.2	31.3	34.0	28.7	19.3	22.4	33.0	24.9	23.4	16.7	25.2	21.6	25.5	37.4	25.6	21.0	12.2	16.9	3.1	17.3	4.0	5.8	11.6	26.9	15.4	16.0	17.0	12.3	9.0	20.0	19.0	21.2	23.4	22.4	23.5	11.1	14.9	12.6	21.6	24.3	22.9	32.0	14.9	19.1	33.4	24.7	20.0	13.3	13.7	35.2	34.2	12.9	11.9	22.3	18.0	32.4	16.9	18.2	15.4	29.5	14.8	11.7	12.4	17.5	28.4	17.6	39.6	16.5	61.4	25.4	18.0	23.5	27.6	11.8	22.4	16.1	27.9	27.0	16.7	15.4	19.8	19.8	10.3	27.3	19.2	15.3	15.7	0.0	15.5	3.1	5.8	17.3	5.8	10.1	3.9	4.9	16.9	12.2	3.2	3.2	1.7	4.0	17.3	5.2	5.2	11.6	28.0	35.2	37.3	43.1	24.4	30.4	29.4	24.1	31.9	16.7
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 gamma 1 subunit"	O43747	16	71729000-71809201	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol			150000	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: "	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favourable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	23.2	29.8	20.4	19.2	26.3	59.1	22.4	31.8	29.2	19.7	20.4	29.2	19.8	19.2	19.6	23.9	30.1	17.9	18.7	14.5	18.5	17.4	32.8	29.5	23.8	20.0	24.2	20.1	18.3	25.6	53.5	27.4	25.1	27.9	20.8	23.4	20.8	28.2	20.2	30.0	27.7	24.4	16.0	20.3	24.3	24.8	26.5	26.7	30.0	23.1	21.8	28.3	18.1	20.1	7.5	8.5	17.6	8.8	7.6	9.0	4.2	16.2	23.8	18.3	18.6	19.7	18.7	15.9	16.9	16.2	22.7	21.9	22.9	18.1	20.2	16.3	23.0	20.8	24.8	18.6	30.6	8.1	12.7	13.2	12.5	17.4	11.6	15.8	43.9	15.6	13.2	30.2	18.7	19.2	17.5	8.6	22.2	29.0	14.6	13.3	16.7	10.4	23.6	14.7	21.6	21.2	18.7	16.9	10.1	20.9	13.2	9.4	23.1	12.5	22.6	19.5	15.2	10.4	12.3	13.6	17.5	41.8	15.7	12.8	16.6	5.8	7.9	10.9	8.3	8.8	8.3	6.3	7.3	9.0	8.5	7.5	5.9	7.2	17.6	7.6	6.8	6.0	7.3	4.2	20.4	26.3	31.8	29.2	18.5	17.4	24.2	20.1	27.9	26.7
AP1M2	"AP1-mu2, HSMU1B, mu2"	ENSG00000129354	"Adaptor related protein complex 1 mu 2 subunit"	Q9Y6Q5	19	10572671-10587315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 34.7;Hep G2: 61.9;MCF7: 53.3;RT4: 33.2;U-2 OS: 34.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"basophil: 5.6;neutrophil: 9.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054999			Supported	Vesicles				Vesicles		"HPA054999: "	"unprognostic (8.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-1)"	"prognostic favourable (2.07e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.23e-2)"	"prognostic favourable (3.73e-6)"	"unprognostic (1.80e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.06e-1)"	1.6	0.2	1.0	6.1	0.7	0.0	9.1	0.6	0.8	7.5	24.5	0.8	44.4	17.3	1.8	20.4	22.2	12.9	34.4	0.6	0.6	0.3	37.3	1.2	10.5	0.6	0.6	0.6	4.7	33.5	16.0	16.1	31.5	0.8	12.5	17.7	0.6	28.4	36.4	1.2	15.3	38.2	1.1	0.6	0.6	20.4	10.3	0.6	3.0	36.6	17.5	14.2	9.6	7.7	0.0	0.3	9.4	1.7	0.0	0.2	3.7	28.3	14.4	0.0	2.1	0.0	0.0	13.4	0.0	0.0	0.4	0.3	34.7	16.7	0.0	13.5	0.2	19.8	0.0	22.1	0.6	0.1	0.2	1.3	10.1	61.9	0.2	0.0	0.1	0.0	16.8	0.8	0.0	0.0	0.0	0.1	0.2	53.3	0.1	0.3	6.4	0.0	0.5	1.9	0.1	0.5	33.2	14.0	0.0	0.0	24.6	0.1	25.2	0.0	0.0	0.1	34.9	0.2	0.4	0.0	0.1	0.2	0.0	0.0	0.0	5.6	0.5	3.5	0.0	0.8	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	9.4	0.0	1.7	0.2	0.0	3.7	1.0	0.7	0.6	0.8	0.6	0.3	0.6	0.6	0.8	0.6
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 sigma 1 subunit"	P61966	7	101154400-101161596	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA060945: "	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	7.6	9.7	30.6	7.9	41.1	3.0	10.8	7.9	45.8	6.8	16.5	6.4	4.6	23.3	6.6	10.6	10.9	8.9	9.3	4.2	22.9	14.6	16.6	15.5	6.7	6.9	12.3	25.3	7.9	8.0	6.3	10.5	10.2	10.1	10.9	14.2	4.6	10.4	6.1	3.5	12.3	18.0	7.9	8.7	7.7	13.2	6.9	9.3	4.7	9.3	7.4	8.5	8.7	6.1	4.4	8.2	2.1	5.5	1.9	5.9	4.2	26.2	21.3	14.3	27.1	10.6	17.5	31.1	17.6	11.9	12.0	12.8	11.4	33.5	5.9	30.8	19.2	13.0	8.2	27.1	10.7	13.3	13.3	4.0	13.4	14.2	13.1	10.7	19.9	19.5	20.7	11.8	5.1	17.7	12.8	23.7	29.6	65.4	8.9	23.1	22.9	43.0	5.6	6.5	12.3	28.8	22.4	11.3	37.0	10.0	26.6	32.1	11.7	10.0	18.3	17.3	30.2	6.5	12.1	5.3	11.2	11.3	44.0	11.9	34.8	0.8	5.5	0.5	4.2	4.9	3.7	4.4	5.9	4.7	7.4	3.8	3.5	3.2	2.1	1.9	2.8	8.2	5.5	4.2	30.6	41.1	7.9	35.1	22.9	14.6	12.3	25.3	10.1	9.3
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 sigma 2 subunit"	P56377	X	15825806-15854931	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 66.0;SK-MEL-30: 87.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 55.2;monocytes: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA049894: , HPA060945: "	"prognostic favourable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favourable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	10.1	8.2	21.2	11.7	17.9	12.6	9.7	13.0	17.6	12.0	17.3	9.8	12.6	4.8	25.7	218.0	9.8	5.6	7.0	34.2	12.7	19.9	5.2	5.8	8.9	11.6	16.1	11.8	4.5	4.1	8.2	11.7	13.1	39.7	5.5	8.0	13.3	5.1	13.2	41.4	5.0	8.7	24.9	18.5	14.1	9.9	8.6	11.4	9.8	10.7	8.6	9.6	8.5	5.9	8.2	55.2	12.5	74.9	5.5	8.4	44.8	3.3	2.8	31.9	15.7	6.0	4.1	1.1	10.0	4.7	7.8	10.0	2.0	3.5	5.7	44.7	14.6	3.9	8.8	2.7	13.0	8.1	14.1	3.4	5.0	3.1	5.3	12.7	3.8	2.4	2.8	7.4	7.6	15.6	3.1	66.0	14.0	1.8	3.3	6.7	42.5	10.5	7.2	23.3	11.5	8.7	0.8	3.9	15.5	4.5	1.3	87.3	14.9	13.0	8.2	13.3	5.1	18.5	9.3	7.6	17.3	12.1	7.1	5.7	32.3	8.2	74.9	8.0	5.6	67.8	5.4	8.2	5.7	4.5	55.2	7.5	4.1	4.0	12.5	5.5	34.7	17.9	8.4	44.8	21.2	17.9	13.0	17.6	12.7	19.9	16.1	11.8	39.7	11.4
AP1S3		ENSG00000152056	"Adaptor related protein complex 1 sigma 3 subunit"	Q96PC3	2	223751686-223838027	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 50.0;epididymis: 64.5;seminal vesicle: 39.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 55.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA066782	Approved		Supported	Vesicles				Vesicles		"HPA066782: "	"unprognostic (9.45e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.65e-3)"	"prognostic unfavourable (3.36e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.08e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.61e-2)"	1.9	1.4	1.6	5.4	3.0	1.8	1.6	2.2	1.9	1.6	1.8	0.2	50.0	3.1	0.8	64.5	5.8	1.7	7.6	1.0	2.3	1.7	7.0	1.9	5.2	3.8	1.1	1.0	0.8	5.1	3.3	6.8	4.6	0.9	2.5	2.0	1.9	4.1	39.6	0.5	1.6	4.1	0.9	1.0	3.1	6.2	1.1	0.4	0.8	10.5	3.1	5.7	8.1	2.9	8.8	5.3	4.9	0.5	0.7	1.6	0.7	8.9	8.5	1.0	3.2	0.5	0.2	4.6	3.7	0.9	1.9	1.7	55.0	7.0	3.5	3.1	0.5	14.8	2.7	10.2	2.8	5.1	4.3	0.3	13.5	5.6	0.2	1.1	0.4	0.1	11.1	3.4	11.7	1.3	0.5	0.8	1.1	3.8	0.1	0.2	1.2	6.0	1.3	0.0	1.5	17.4	17.6	2.5	0.7	2.0	3.6	1.2	1.7	1.6	0.6	0.3	1.9	1.0	2.9	3.5	3.0	9.6	1.3	0.4	2.0	4.9	0.5	0.4	1.1	0.3	0.8	8.8	0.5	0.4	2.2	3.5	0.4	0.7	1.9	0.7	0.2	5.3	1.6	0.7	1.6	3.0	2.2	1.9	2.3	1.7	1.1	1.0	0.9	0.4
AP2A1	"ADTAA, CLAPA1"	ENSG00000196961	"Adaptor related protein complex 2 alpha 1 subunit"	O95782	19	49766968-49807113	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 15.8"	"Lineage enriched"	"Detected in all"	4	"monocytes: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004306	Approved		Supported	Vesicles			300000	Vesicles		"CAB004306: AB_2274034"	"unprognostic (4.33e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.85e-3)"	"unprognostic (4.84e-1)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (2.82e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (2.83e-9)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.72e-3)"	26.5	37.8	23.7	21.7	34.3	40.9	19.8	32.2	58.6	18.4	15.9	22.2	11.5	22.3	25.2	13.1	23.0	23.0	17.9	23.7	21.5	22.0	15.2	31.7	15.3	23.7	20.1	28.2	26.1	22.5	10.3	15.1	29.4	37.6	15.3	9.7	16.5	16.5	18.8	39.6	26.2	22.8	19.8	18.1	22.8	15.8	48.5	14.6	15.5	13.2	14.3	13.5	20.1	18.0	1.1	3.9	3.4	15.8	2.0	1.8	3.0	23.1	33.5	11.6	26.7	20.9	25.5	23.7	27.5	18.8	17.1	17.9	17.2	14.7	10.4	10.5	28.4	21.1	8.7	19.8	7.3	16.3	19.8	15.4	22.5	18.5	23.0	12.3	25.8	40.1	14.5	19.0	9.9	20.2	38.3	14.5	16.1	18.3	13.4	16.4	11.8	34.5	15.3	27.3	13.2	10.1	29.5	8.9	11.9	30.3	21.1	11.4	17.7	17.5	27.8	44.6	24.7	18.6	19.5	21.7	26.7	10.9	31.4	18.1	18.6	0.2	3.9	2.6	1.8	10.9	1.3	1.1	1.1	1.1	3.9	0.9	0.9	1.1	3.4	2.0	15.8	1.2	1.5	3.0	23.7	34.3	32.2	58.6	21.5	22.0	20.1	28.2	37.6	14.6
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 alpha 2 subunit"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles			93000	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: "	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	21.9	11.1	20.2	8.7	20.7	18.4	23.2	50.9	32.4	17.5	13.9	9.5	10.4	16.8	16.3	8.5	12.2	21.5	10.1	14.7	22.6	20.0	19.4	16.3	13.3	18.1	16.1	21.1	11.2	14.7	7.8	15.5	16.3	16.9	15.5	16.3	11.5	21.7	14.7	13.3	16.5	12.0	18.5	18.1	34.5	17.0	16.4	6.7	12.4	12.1	5.0	9.1	10.5	10.5	3.4	3.7	6.8	4.6	3.4	5.4	1.7	5.5	2.5	3.0	8.7	11.3	11.6	7.3	7.9	2.7	4.9	4.0	0.9	6.0	5.8	6.9	9.4	7.3	7.0	4.4	3.1	4.2	18.1	1.7	7.7	3.0	4.4	2.2	4.1	13.7	4.8	2.4	4.9	6.7	5.8	4.5	4.9	0.5	2.0	2.5	1.7	14.1	3.5	2.0	6.3	7.4	5.0	9.4	8.0	8.9	7.3	1.1	4.2	0.8	10.5	1.6	1.9	2.2	4.0	3.6	2.9	4.3	3.0	2.8	2.4	3.3	4.6	3.8	3.1	4.6	1.8	1.7	3.2	1.8	3.7	3.4	3.4	3.5	6.8	3.4	3.8	3.7	5.4	1.7	20.2	20.7	50.9	32.4	22.6	20.0	16.1	21.1	16.9	6.7
AP2B1	"ADTB2, CLAPB1"	ENSG00000006125	"Adaptor related protein complex 2 beta 1 subunit"	P63010	17	35578046-35726409	"Cancer-related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017631, HPA056733, HPA067983"	Approved		Supported	Vesicles			680000	Vesicles		"CAB017631: AB_2058201, HPA056733: , HPA067983: "	"unprognostic (1.49e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.50e-1)"	"prognostic favourable (2.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-2)"	20.1	19.9	36.6	16.3	51.3	18.6	27.6	32.8	59.0	27.8	29.8	35.2	17.0	15.1	20.0	33.1	13.1	22.9	20.2	30.3	36.8	36.1	32.9	16.0	23.6	16.0	35.5	39.9	28.7	15.4	75.6	30.0	30.6	40.7	20.0	39.0	21.8	18.7	25.3	23.3	13.1	16.7	26.1	37.0	18.4	21.6	45.3	27.4	18.5	31.5	10.6	20.1	19.6	21.5	12.6	10.7	15.8	15.4	9.5	19.4	10.3	42.4	54.5	28.1	32.9	46.4	51.0	12.0	21.9	33.5	32.3	34.9	30.5	37.2	20.7	19.5	40.8	40.6	38.4	62.8	46.2	24.7	35.5	28.0	39.9	16.6	26.6	26.9	19.8	32.5	24.9	32.7	49.7	50.8	42.4	30.0	50.5	8.6	26.1	13.1	22.6	39.3	22.0	40.1	15.1	40.7	24.6	23.1	28.4	27.2	9.6	29.9	39.2	18.2	50.4	24.6	22.7	26.5	32.7	12.7	23.0	19.5	31.5	20.1	26.0	15.0	11.3	15.8	16.6	15.4	17.8	12.6	14.9	14.9	10.6	11.5	6.9	8.7	13.3	9.5	15.1	10.7	19.4	10.3	36.6	51.3	32.8	59.0	36.8	36.1	35.5	39.9	40.7	27.4
AP2M1	"AP50, CLAPM1, mu2"	ENSG00000161203	"Adaptor related protein complex 2 mu 1 subunit"	Q96CW1	3	184174689-184184091	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036849, HPA069870"	Uncertain		Supported	"Plasma membrane"			340000	"Plasma membrane"		"HPA036849: AB_10672101, HPA069870: "	"unprognostic (1.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (9.12e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (2.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.28e-1)"	37.6	78.2	58.6	38.3	78.2	47.7	32.5	64.2	111.9	52.4	42.7	33.5	35.4	40.7	46.7	27.0	54.9	39.1	41.2	86.8	62.5	64.6	39.7	36.8	35.8	35.2	57.5	83.0	49.8	26.0	53.6	48.2	59.0	79.8	40.0	35.6	44.4	40.2	61.3	33.9	38.1	36.1	60.3	41.5	34.1	32.9	27.8	32.1	30.5	35.3	34.5	37.1	49.5	38.8	26.4	59.3	51.4	62.6	34.9	39.5	77.6	47.9	36.9	31.8	35.7	51.1	53.8	32.9	80.9	47.1	91.5	64.4	39.7	35.2	22.0	99.0	121.0	54.6	42.9	54.7	75.8	45.2	53.6	56.9	42.4	35.1	60.4	27.9	36.2	68.2	31.1	57.9	37.2	67.9	27.2	43.3	85.6	109.9	35.9	16.6	77.4	55.4	33.5	40.6	43.6	56.7	43.8	33.9	24.7	63.5	80.0	37.5	107.1	34.1	72.8	58.1	47.2	56.7	106.6	39.1	34.2	49.2	109.5	41.3	37.8	37.5	62.6	51.4	32.5	52.7	32.0	26.4	30.3	31.1	59.3	25.5	26.1	26.7	28.5	34.9	42.2	29.7	39.5	77.6	58.6	78.2	64.2	111.9	62.5	64.6	57.5	83.0	79.8	32.1
AP4S1	"AP47B, CLA20, SPG52"	ENSG00000100478	"Adaptor related protein complex 4 sigma 1 subunit"	Q9Y587	14	31025106-31096450	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039963	Approved		Supported	Vesicles				Vesicles		"HPA039963: AB_10795240"	"unprognostic (4.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (7.44e-4)"	"unprognostic (3.79e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.02e-1)"	"prognostic favourable (2.87e-6)"	"unprognostic (2.20e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.59e-2)"	4.2	6.1	16.6	5.8	18.4	4.8	8.2	15.9	22.2	6.0	6.6	5.9	4.0	3.3	7.3	6.6	4.6	7.0	6.4	8.2	12.2	10.8	7.2	5.6	4.9	10.7	8.5	11.3	10.8	8.0	6.5	7.7	6.3	9.0	5.8	3.9	4.7	5.0	6.5	11.0	4.1	3.8	7.6	7.3	6.9	4.0	16.5	7.3	4.5	8.3	2.4	6.9	5.5	4.4	5.5	4.6	7.0	4.8	11.5	8.8	2.4	7.7	10.9	9.5	2.7	4.1	7.3	7.5	5.0	9.2	8.2	8.6	10.5	12.7	8.9	5.1	6.3	8.6	6.3	8.7	14.1	7.5	3.7	13.1	4.3	16.4	8.4	11.7	8.0	5.7	5.4	8.0	11.3	9.8	6.7	6.2	9.8	10.9	7.6	6.6	11.3	9.4	8.0	8.7	1.3	9.3	11.1	5.2	5.6	9.1	4.7	13.6	10.1	5.7	7.6	6.6	5.6	4.6	4.5	7.6	13.9	13.0	3.8	3.7	4.8	7.0	1.8	3.0	3.7	4.8	5.8	5.1	5.7	4.5	1.8	5.5	5.3	6.7	3.7	11.5	3.7	4.6	8.8	2.4	16.6	18.4	15.9	22.2	12.2	10.8	8.5	11.3	9.0	7.3
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 sigma 1 subunit"	Q9NUS5	20	3820524-3828837	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: , HPA048244: "	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favourable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	9.4	14.9	10.1	8.6	13.4	10.7	6.8	7.9	15.3	6.7	10.6	12.0	13.9	10.4	7.1	11.8	8.5	8.2	10.6	13.2	10.2	9.3	12.4	18.9	7.9	19.3	8.9	10.7	8.1	16.9	12.1	9.4	13.0	7.1	8.2	7.5	13.4	13.8	7.0	27.2	7.3	9.9	6.7	8.2	10.2	9.9	19.9	6.3	11.2	13.2	11.2	8.3	7.0	5.8	7.8	10.8	4.7	12.9	6.5	11.9	6.6	10.9	20.9	2.9	2.0	4.1	5.2	3.6	6.7	5.4	6.6	5.3	17.7	11.8	6.3	7.2	7.0	9.8	2.5	10.8	2.3	3.4	7.0	10.5	6.1	15.2	6.9	7.2	6.4	8.9	6.1	8.2	6.5	7.7	7.4	12.5	8.7	18.0	16.7	6.4	2.6	17.1	7.1	4.9	6.5	7.4	8.9	9.1	3.6	6.6	20.3	11.0	10.0	3.7	10.5	13.9	6.7	7.1	12.5	6.7	7.4	3.5	4.8	6.5	11.9	1.7	8.3	4.7	11.9	12.9	9.2	6.1	10.1	9.9	10.8	7.8	9.4	8.7	2.1	6.5	7.0	8.7	10.3	6.6	10.1	13.4	7.9	15.3	10.2	9.3	8.9	10.7	7.1	6.3
AP5Z1	"KIAA0415, SPG48, zeta"	ENSG00000242802	"Adaptor related protein complex 5 zeta 1 subunit"	O43299	7	4775622-4794312	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035693	Supported		Supported	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"HPA035693: AB_10960687"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.01e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.19e-1)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.22e-1)"	15.2	18.6	9.5	19.2	11.1	20.8	11.3	14.3	14.9	10.7	12.6	13.5	6.3	22.2	14.0	11.0	10.8	10.6	9.9	8.0	8.6	6.8	9.9	9.2	12.6	18.6	10.9	9.7	12.6	16.9	5.6	11.5	9.6	10.3	11.6	4.6	13.1	15.0	12.8	8.4	21.8	19.1	13.0	8.5	23.4	17.1	10.1	12.6	18.2	11.3	6.6	16.9	13.2	10.6	11.7	11.3	15.7	17.0	12.3	13.4	9.8	11.2	5.0	1.3	8.9	5.7	4.0	12.4	8.9	5.1	7.0	5.7	9.7	10.4	7.7	5.4	5.8	13.5	1.2	5.5	0.7	5.8	5.4	5.7	11.9	7.0	18.7	9.9	16.3	8.2	4.3	5.8	2.3	4.6	9.8	8.5	2.9	12.0	2.9	22.6	8.4	12.3	7.3	4.4	7.1	2.2	10.7	5.1	9.5	7.5	11.9	8.5	10.5	16.1	11.5	7.3	8.6	14.7	6.6	17.8	11.4	4.6	10.9	12.4	14.7	1.7	12.9	15.7	13.4	17.0	10.7	10.5	9.2	11.8	11.3	11.7	10.1	8.4	13.5	12.3	14.2	10.2	8.6	9.8	9.5	11.1	14.3	14.9	8.6	6.8	10.9	9.7	10.3	12.6
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645141-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favourable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	10.5	4.7	10.3	11.0	11.0	36.1	8.8	13.4	11.5	10.8	11.6	8.2	5.5	7.0	10.6	7.5	6.2	6.3	11.6	5.8	10.2	8.6	5.8	6.8	11.8	11.2	8.8	6.7	10.8	7.4	5.7	6.2	10.1	8.2	9.1	12.9	8.5	8.2	6.4	6.0	7.5	14.9	7.2	10.9	15.9	8.6	6.1	9.3	15.7	7.0	3.9	14.2	9.5	9.0	2.8	6.3	33.0	8.7	1.1	1.9	1.5	4.3	6.6	20.2	7.7	6.9	12.2	5.6	11.0	8.3	8.4	8.5	4.2	3.2	6.6	3.1	9.2	7.3	14.1	8.0	10.6	4.6	5.7	12.0	6.3	5.2	2.4	11.7	15.5	5.0	2.5	8.5	4.4	14.4	5.6	3.4	12.3	1.2	6.2	12.3	5.5	3.8	7.8	16.1	2.1	4.9	7.8	2.9	5.0	8.6	3.6	3.2	6.3	17.6	11.1	5.7	4.5	6.5	3.5	2.3	4.3	7.3	2.2	16.5	7.5	6.2	8.7	7.2	1.9	3.6	1.5	2.4	1.4	1.1	6.3	2.8	1.4	0.9	33.0	1.1	3.6	4.6	0.9	1.5	10.3	11.0	13.4	11.5	10.2	8.6	8.8	6.7	8.2	9.3
APBA1	"D9S411E, MINT1, X11"	ENSG00000107282	"Amyloid beta precursor protein binding family A member 1"	Q02410	9	69427530-69672306	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7"	"Cell line enhanced"	"Detected in some"		"BJ: 7.0;BJ hTERT+: 5.9;HAP1: 16.8;SCLC-21H: 6.5;TIME: 7.6;U-138 MG: 7.0;U-266/70: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061287			Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA061287: "	"unprognostic (4.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.21e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.66e-3)"	2.9	2.9	20.2	1.8	18.6	0.6	4.0	15.5	21.7	4.2	4.1	6.2	0.6	1.7	4.0	1.2	3.4	2.6	3.0	2.9	16.0	19.3	2.3	8.7	1.9	1.6	19.1	13.7	7.5	2.9	14.5	3.5	3.1	15.7	2.2	4.2	2.7	5.5	2.8	4.0	3.8	2.1	2.2	5.5	6.0	1.7	3.5	6.7	0.0	1.5	0.6	1.2	2.4	2.0	0.0	0.1	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.6	0.0	3.1	2.3	0.1	7.0	5.9	0.1	0.1	0.0	0.0	0.0	3.2	2.9	0.1	16.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	0.0	2.8	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	2.4	6.5	4.3	0.3	0.9	0.1	0.0	0.0	7.6	7.0	0.8	0.0	0.5	6.9	3.0	0.0	0.2	0.1	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.0	20.2	18.6	15.5	19.7	16.0	19.3	19.1	13.7	15.7	6.7
APBA2	"D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L"	ENSG00000034053	"Amyloid beta precursor protein binding family A member 2"	Q99767	15	28884483-29118315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 33.4"	"Cell line enhanced"	"Detected in some"		"HEL: 7.4;SH-SY5Y: 18.3;U-937: 13.1"	"Cancer enhanced"	"Detected in many"		"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.8;naive CD8 T-cell: 7.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037065, HPA058796, HPA070376"	Uncertain		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"CAB037065: AB_477178, HPA058796: , HPA070376: "	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.21e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.28e-1)"	1.8	3.3	17.6	3.0	12.1	3.0	1.7	33.4	28.9	1.2	2.0	3.6	0.0	2.5	2.1	2.5	6.7	1.4	2.1	1.6	24.2	14.9	1.4	1.8	2.1	3.6	15.1	14.9	1.8	2.6	1.2	2.3	1.6	7.5	3.0	2.1	1.6	1.8	1.7	1.6	1.8	2.7	1.4	16.2	7.9	1.8	5.6	2.7	1.9	1.9	0.0	3.4	2.9	0.4	0.0	0.0	0.1	0.0	1.8	7.8	2.5	0.0	1.4	0.6	3.4	0.0	0.0	0.0	0.8	1.2	0.1	0.5	0.0	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	2.8	7.4	0.0	0.1	2.9	0.0	0.2	0.4	2.3	0.4	0.0	3.9	4.3	0.1	0.0	0.4	0.2	2.1	1.0	3.0	0.0	0.3	0.1	0.0	0.0	4.9	18.3	0.0	0.0	0.1	0.0	0.9	3.9	0.0	4.0	0.0	0.8	0.0	0.1	0.0	0.1	13.1	1.6	0.0	0.0	0.0	1.4	0.0	0.2	0.0	2.1	4.7	0.0	0.0	7.8	7.5	0.1	1.8	0.0	0.0	0.0	2.5	17.6	12.1	33.4	28.9	24.2	14.9	15.1	14.9	7.5	2.7
APBB1	"Fe65, RIR"	ENSG00000166313	"Amyloid beta precursor protein binding family B member 1"	O00213	11	6395124-6419414	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 34.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038521, HPA038522"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA038521: , HPA038522: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (1.86e-5)"	"unprognostic (2.21e-1)"	"prognostic favourable (7.44e-13)"	"unprognostic (1.32e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	7.9	14.0	26.0	6.9	26.0	1.9	5.5	54.3	84.6	11.5	9.6	31.1	3.7	4.5	15.7	3.2	9.2	19.7	7.0	21.8	29.5	23.9	9.2	2.3	9.4	7.5	27.0	30.7	21.3	9.5	14.8	15.7	5.4	25.8	10.9	3.3	5.5	8.0	16.5	21.5	4.6	5.2	19.5	36.4	5.9	5.7	7.2	24.7	6.0	7.7	2.5	6.6	7.7	5.8	6.3	0.6	3.0	0.6	5.5	34.4	11.3	0.0	5.9	20.6	9.2	11.2	11.5	0.0	9.6	16.8	16.8	21.2	10.7	4.1	0.0	1.5	17.6	0.2	17.9	3.0	8.0	10.7	13.5	0.1	3.8	0.3	8.0	0.0	4.0	10.3	0.7	7.8	1.2	20.8	0.4	0.3	6.1	0.2	0.2	0.0	7.4	6.3	0.1	0.8	0.0	0.7	0.0	28.3	16.0	1.4	1.2	6.4	0.8	1.3	9.1	1.7	10.4	11.1	1.9	5.6	2.6	0.7	8.7	0.0	5.7	3.0	0.6	0.1	9.1	0.5	9.8	2.6	12.7	11.7	0.6	6.3	34.4	20.0	0.5	5.5	0.2	0.1	17.0	11.3	26.0	26.0	54.3	49.3	29.5	23.9	27.0	30.7	25.8	24.7
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438203-26567803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.2;lymphoid tissue: 100.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.2;MOLT-4: 21.6;REH: 48.6;U-698: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA017009: , HPA063903: "	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favourable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	18.3	3.9	7.9	27.7	14.2	25.8	10.1	1.2	7.3	2.6	3.9	16.6	0.0	4.5	2.0	1.5	2.9	4.9	7.5	4.8	7.3	4.9	4.8	25.4	11.1	28.2	14.5	3.2	1.5	3.0	1.3	2.7	5.5	11.1	2.5	4.5	1.6	4.0	1.6	1.5	2.8	12.0	4.7	21.9	41.5	5.4	1.3	12.1	100.5	3.0	0.7	26.2	8.0	3.9	11.0	14.8	54.2	10.3	5.3	9.5	3.5	0.0	0.4	0.0	0.0	3.4	5.6	2.9	9.4	1.8	5.4	5.2	0.0	0.0	25.2	0.1	6.2	0.0	0.0	0.0	7.5	0.0	0.0	18.2	0.0	0.0	0.0	3.4	0.0	8.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	21.6	4.8	0.0	0.0	48.6	0.0	17.8	1.5	0.0	0.0	0.0	0.8	0.1	0.0	0.0	11.9	0.0	0.0	0.1	1.7	0.0	4.4	0.0	51.7	4.4	17.8	0.0	19.0	7.1	16.1	9.5	6.9	7.7	9.5	8.1	7.9	4.4	11.0	9.3	9.0	54.2	5.3	10.3	14.8	7.6	3.5	7.9	14.2	1.2	7.3	7.3	4.9	14.5	3.2	11.1	12.1
APBB3	FE65L2	ENSG00000113108	"Amyloid beta precursor protein binding family B member 3"	O95704	5	140558268-140564781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005571, HPA076196"	Approved		Supported	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA005571: AB_1844912, HPA076196: "	"unprognostic (7.63e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.98e-1)"	"prognostic favourable (6.79e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.06e-6)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.67e-2)"	4.2	5.6	7.5	4.3	9.2	3.3	3.4	26.6	23.8	4.5	4.3	8.2	5.7	2.0	4.7	6.3	4.2	6.0	7.8	8.2	9.7	13.1	3.3	3.4	3.2	2.6	7.9	7.3	4.3	3.5	8.2	11.0	5.7	10.9	5.9	3.6	8.7	8.8	7.4	2.5	3.4	2.8	4.1	4.2	4.7	4.4	11.8	5.5	2.0	6.7	3.3	3.4	3.8	2.3	1.4	1.8	7.7	3.6	0.7	1.4	1.1	0.6	0.7	0.5	2.9	0.0	1.2	5.7	1.4	1.7	2.1	3.9	1.9	1.7	2.4	3.3	2.5	1.1	0.0	2.2	0.6	2.3	1.2	0.8	5.2	0.1	3.5	0.8	1.0	7.6	0.9	1.8	1.4	1.5	0.4	6.5	2.2	1.4	0.3	1.8	1.2	3.6	0.4	0.7	1.4	1.8	1.5	9.0	4.4	3.8	1.3	5.1	4.0	3.9	1.1	0.4	1.0	0.0	0.2	2.5	1.9	0.3	0.9	0.6	0.8	7.7	1.4	0.0	1.4	3.6	0.9	0.5	1.0	1.3	1.0	1.4	0.6	1.3	3.3	0.7	0.6	1.8	1.0	1.1	7.5	9.2	26.6	17.4	9.7	13.1	7.9	7.3	10.9	5.5
APC2	APCL	ENSG00000115266	"APC2, WNT signaling pathway regulator"	O95996	19	1446302-1473244	"Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 59.4"	"Cell line enhanced"	"Detected in some"		"AF22: 6.3;SCLC-21H: 7.6;SH-SY5Y: 25.9"	"Cancer enriched"	"Detected in some"	27	"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078002			Supported	"Cytokinetic bridge,Midbody,Cytosol"				"Cytokinetic bridge, Midbody"	Cytosol	"HPA078002: "	"unprognostic (1.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.88e-5)"	"unprognostic (3.64e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.49e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.98e-3)"	1.5	4.7	17.3	1.4	16.4	1.5	1.3	21.7	59.4	1.4	1.6	20.7	0.0	2.1	1.4	1.4	1.4	1.5	1.6	1.4	16.8	13.9	1.3	1.3	1.4	1.4	15.0	14.0	1.3	2.0	1.3	3.0	1.4	17.1	1.4	1.4	0.8	1.7	1.4	1.6	1.4	1.8	1.5	13.9	1.4	1.4	1.8	14.5	0.0	1.5	0.0	1.3	1.6	0.0	1.1	0.2	0.4	0.0	0.0	0.1	0.1	0.2	0.5	6.3	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0.0	0.7	0.0	0.0	7.6	25.9	0.9	0.0	0.4	0.1	0.0	0.0	0.5	0.5	0.2	0.2	1.9	0.4	0.3	0.7	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	17.3	16.4	21.7	21.3	16.8	13.9	15.0	14.0	17.1	14.5
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674002-49683963	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol			1600000	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favourable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	12.3	31.4	14.3	16.9	18.4	17.3	13.5	14.2	28.2	13.4	23.5	14.4	25.3	24.2	14.1	19.0	23.8	17.2	19.1	23.1	14.2	14.2	33.6	36.9	15.0	23.9	13.9	20.0	13.9	22.7	33.5	26.6	18.6	16.3	16.1	26.6	19.5	19.8	19.8	55.1	16.9	21.7	14.1	9.8	19.2	21.9	22.3	11.7	22.6	26.6	26.6	20.7	19.9	13.7	20.5	26.2	30.4	27.9	21.8	29.5	28.1	25.4	20.8	22.8	29.6	19.9	13.4	30.2	16.6	21.4	23.4	25.1	33.4	27.6	32.6	18.7	18.9	23.6	25.4	38.5	17.8	15.5	10.5	35.1	34.7	27.3	19.8	37.6	54.7	15.2	29.2	13.4	27.8	21.1	21.7	16.2	23.2	23.5	26.5	19.1	13.5	19.0	10.1	19.6	42.3	46.3	60.4	10.9	18.9	18.8	45.7	20.7	30.1	20.1	9.6	14.5	25.4	22.6	22.4	18.6	13.2	19.4	25.0	26.6	20.8	30.2	25.5	30.4	28.5	27.9	22.5	20.5	23.5	26.7	26.2	17.4	24.9	24.2	8.0	21.8	26.7	21.0	29.5	28.1	14.3	18.4	14.2	28.2	14.2	14.2	13.9	20.0	16.3	11.7
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Lyase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm			98000	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: , HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavourable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	43.9	52.8	30.6	33.2	32.5	55.6	43.6	24.1	44.9	38.5	41.9	37.3	28.4	44.1	53.2	30.1	40.7	42.9	46.4	34.4	28.0	27.4	44.4	61.3	31.8	44.5	30.2	31.1	64.7	48.4	31.8	21.7	29.4	34.4	36.1	39.8	36.0	35.5	38.9	53.2	41.2	37.6	40.9	30.1	51.0	41.7	20.9	28.3	73.2	51.2	38.5	48.4	41.8	32.7	35.0	53.0	1.5	23.7	20.6	32.5	38.4	43.9	54.1	48.5	44.7	34.1	49.3	41.8	41.3	44.5	61.6	53.5	39.4	43.7	84.9	36.9	31.5	47.2	57.7	43.7	57.2	37.9	24.6	34.4	32.0	65.6	35.9	109.2	35.8	50.9	48.3	40.1	39.8	51.4	39.9	28.0	49.3	42.8	69.9	46.0	47.8	48.9	77.8	54.5	35.6	51.7	59.3	58.5	37.3	44.8	55.9	44.4	34.0	49.4	33.1	32.5	54.5	32.7	38.5	37.6	65.1	57.3	14.5	69.4	41.0	0.1	23.7	1.5	19.0	20.5	25.9	35.0	23.8	22.6	46.8	31.4	32.5	28.3	1.5	20.6	12.4	53.0	14.1	38.4	30.6	32.5	24.1	44.9	28.0	27.4	30.2	31.1	34.4	28.3
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000357-55009057	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: "	"unprognostic (2.90e-2)"	"prognostic favourable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favourable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (6.63e-4)"	11.1	12.8	8.6	12.0	12.3	11.9	10.2	8.7	11.8	10.0	12.3	13.7	8.2	12.3	11.5	12.6	20.8	10.7	13.9	10.6	8.7	7.2	15.4	18.5	10.3	14.2	9.7	6.0	14.4	10.7	10.7	12.7	17.8	8.8	11.0	15.1	9.1	10.4	10.0	10.3	16.7	18.7	10.0	9.9	18.0	10.8	7.7	8.9	21.9	10.6	10.2	27.4	11.6	12.7	6.7	9.4	9.2	9.9	26.6	7.5	6.3	22.0	19.8	7.9	11.4	11.5	7.7	13.4	9.1	12.3	17.6	17.3	10.8	18.6	14.6	14.3	8.5	16.6	18.0	17.3	13.4	11.8	13.7	17.7	19.8	10.9	7.4	10.9	16.8	7.6	14.2	24.9	9.0	14.0	9.1	9.9	13.1	21.5	14.7	14.3	15.6	24.0	13.1	13.1	15.9	9.5	11.1	7.3	8.0	17.2	20.9	8.8	16.4	8.5	8.1	10.5	15.2	21.1	11.8	10.3	13.3	12.1	11.2	18.7	12.4	9.2	7.8	8.5	7.5	9.9	6.2	6.1	7.1	7.4	9.4	6.7	6.4	6.2	2.9	26.6	8.3	5.1	7.5	6.3	8.6	12.3	8.7	11.8	8.7	7.2	9.7	6.0	8.8	8.9
API5	"AAC-11, AAC11, API5L1"	ENSG00000166181	"Apoptosis inhibitor 5"	Q9BZZ5	11	43311963-43344529	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026598	Approved		Enhanced	"Nuclear speckles"			7900	"Nuclear speckles"		"HPA026598: AB_1844927"	"unprognostic (4.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-1)"	"prognostic favourable (1.06e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.05e-2)"	33.4	31.3	31.8	31.1	39.8	21.9	35.4	54.5	45.0	33.3	33.0	32.3	26.7	32.1	39.0	26.1	36.9	30.2	25.4	21.5	33.0	30.1	38.4	51.4	26.4	37.3	31.5	37.4	31.7	35.4	41.9	31.6	32.0	40.3	32.1	36.8	19.9	32.8	33.2	38.3	31.9	39.0	37.3	40.0	38.0	31.1	24.5	31.5	52.3	40.9	26.8	42.1	32.4	29.5	24.8	24.2	19.4	25.2	45.4	31.7	30.8	26.3	28.8	38.0	22.7	26.5	26.3	25.3	26.3	28.8	37.6	36.1	20.3	11.6	32.0	20.6	28.1	32.7	45.5	30.6	51.7	36.6	41.8	29.0	16.9	17.5	23.2	48.0	27.2	21.2	31.6	18.7	33.3	31.2	47.1	28.0	25.1	16.2	39.9	19.4	65.6	27.1	42.5	38.7	24.4	27.2	31.0	29.4	19.3	31.6	27.3	24.3	33.4	22.0	27.1	32.0	23.9	42.9	42.7	23.1	33.3	50.2	27.2	28.2	19.1	19.4	18.4	19.4	27.7	25.2	31.7	24.8	27.7	28.7	24.2	23.0	28.5	29.6	4.0	45.4	24.3	15.5	23.5	30.8	31.8	39.8	54.5	45.0	33.0	30.1	31.5	37.4	40.3	31.5
APLF	"C2orf13, MGC47799, Xip1, ZCCHH1"	ENSG00000169621	"Aprataxin and PNKP like factor"	Q8IW19	2	68467561-68655862	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029396, HPA034642, HPA034643"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA029396: AB_10610285, HPA034642: , HPA034643: AB_10602431"	"unprognostic (9.37e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.29e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.39e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.44e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.85e-3)"	5.2	4.4	3.8	7.3	6.5	2.8	8.2	1.1	5.0	8.0	5.7	3.1	3.8	2.6	8.8	4.0	10.6	3.3	4.1	3.8	4.7	2.0	3.7	5.1	3.4	5.8	3.6	2.1	4.3	3.8	4.1	5.1	6.2	3.2	8.5	2.7	2.3	6.4	4.8	5.4	9.2	3.3	9.2	5.6	5.7	3.6	4.1	6.1	5.1	4.4	7.5	5.8	6.9	6.9	1.1	1.4	9.3	1.2	1.5	2.2	0.9	3.6	0.9	4.1	4.1	5.5	7.4	2.1	3.2	5.8	1.9	2.4	2.3	3.0	6.7	2.6	2.6	1.2	0.5	4.4	4.5	6.2	0.8	5.5	0.8	1.4	2.6	1.9	4.9	4.1	3.7	2.7	4.1	1.4	1.1	4.8	1.9	0.6	2.6	5.0	2.2	1.6	3.6	1.4	3.0	3.8	2.0	1.2	2.7	3.2	0.4	3.8	0.3	1.1	3.6	6.7	1.5	3.4	2.5	4.4	2.4	5.1	2.9	2.7	4.3	9.3	0.9	3.1	0.9	1.2	1.0	1.1	1.4	1.3	1.3	1.0	1.5	0.8	0.0	1.5	0.9	1.4	2.2	0.9	3.8	6.5	1.1	5.0	4.7	2.0	3.6	2.1	3.2	6.1
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	145	"intestine: 224.8;liver: 442.2"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 151.8"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	1290000000000	89000000000	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: "	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	0.3	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.1	0.1	68.9	0.0	0.0	24.9	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.1	442.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	224.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.9	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
APOBEC3H	ARP10	ENSG00000100298	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3H"	Q6NTF7	22	39097224-39104067	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 15.7;ductus deferens: 14.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;HDLM-2: 4.2;Karpas-707: 11.0;U-266/70: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdT-cell: 15.7;MAIT T-cell: 6.6;memory CD4 T-cell: 8.6;memory CD8 T-cell: 13.2;naive CD8 T-cell: 6.4;NK-cell: 11.8;T-reg: 7.5"	"Group enriched"	"Detected in many"	14	"NK-cells: 11.8;T-cells: 15.7"									"HPA021492, HPA058565"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA021492: AB_10964888, HPA058565: "	"unprognostic (7.09e-3)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.81e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (8.73e-12)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.55e-3)"	"prognostic favourable (8.43e-7)"	1.7	2.2	0.7	6.2	1.2	4.9	1.0	0.8	0.9	1.5	2.3	0.9	14.1	0.4	1.7	6.4	1.5	1.9	2.7	5.9	0.7	0.7	2.3	1.3	4.2	5.3	2.0	1.0	0.9	3.8	0.8	2.0	1.3	1.2	1.6	5.6	1.1	3.3	3.6	2.7	0.5	2.7	1.6	2.1	7.5	2.0	4.0	0.3	3.7	1.8	1.2	5.5	3.1	1.5	1.0	0.1	0.0	1.0	11.8	15.7	2.9	0.0	0.7	0.1	0.0	0.0	0.4	3.2	0.0	0.2	0.3	0.1	0.0	0.3	4.3	1.6	0.4	0.2	0.0	0.9	0.0	4.2	0.5	1.0	0.2	0.1	0.4	0.0	3.2	2.8	2.5	0.3	0.4	0.0	0.0	11.0	1.3	1.3	2.0	0.4	0.0	0.0	2.3	0.0	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	7.4	1.0	0.2	0.3	1.8	0.1	0.0	0.2	0.0	15.7	0.3	6.6	1.0	8.6	13.2	0.1	0.3	0.5	6.4	0.0	11.8	1.0	0.0	7.5	2.9	0.7	1.2	0.8	0.9	0.7	0.7	2.0	1.0	1.2	0.3
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	550	"liver: 823.7"	"Cell line enriched"	"Detected in some"	20	"Hep G2: 162.9"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	171400000000	44000000000	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favourable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavourable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	823.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.7	0.9	1.3	1.0	1.3	0.2	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	162.9	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.3	0.0	0.0	1.3	0.4	1.3	0.5	1.3	0.8	0.8	0.6	0.7	1.4	0.9	0.8	0.9	1.0	0.4	0.5	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.1;HDLM-2: 45.5;HSkMC: 7.4;K-562: 9.7;SCLC-21H: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 4.3"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"			Vesicles		"HPA049797: , HPA055435: "	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favourable (2.40e-6)"	2.3	0.8	1.1	2.7	1.3	0.0	2.3	0.9	1.0	2.4	1.2	0.7	0.7	2.2	2.0	0.7	2.4	3.1	3.2	2.8	0.8	1.0	10.3	1.1	7.3	1.7	1.0	0.7	4.2	0.9	0.0	1.9	3.0	1.2	9.0	1.5	1.8	2.9	1.6	1.0	1.6	5.4	2.1	2.3	1.1	2.3	0.7	1.2	7.1	1.1	0.7	2.3	7.4	1.4	0.4	3.8	0.6	4.3	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.9	8.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	45.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.3	9.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	20.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	4.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	3.8	0.3	0.0	0.0	0.2	0.8	0.2	0.0	0.0	1.2	1.1	1.3	0.9	1.0	0.8	1.0	1.0	0.7	1.2	1.2
APOL6	"APOL-VI, APOLVI"	ENSG00000221963	"Apolipoprotein L6"	Q9BWW8	22	35648395-35668409	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB028574, HPA029165, HPA029167"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832"	"unprognostic (7.25e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.76e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"prognostic favourable (6.61e-4)"	40.6	9.2	4.8	18.8	5.5	10.1	32.3	1.9	4.2	7.4	17.9	4.1	5.0	14.0	8.8	9.5	9.8	5.9	12.5	9.3	4.0	4.3	15.4	36.9	15.8	17.0	4.6	2.2	17.0	4.7	3.7	5.1	8.9	5.9	11.7	8.9	6.4	10.1	5.6	7.4	3.6	36.6	6.4	7.6	19.5	10.1	2.5	4.5	12.7	24.8	7.7	13.4	8.5	14.1	1.2	2.8	9.2	9.0	5.9	9.1	4.2	7.0	2.3	0.2	0.8	17.9	9.0	10.0	3.0	8.1	10.1	12.7	1.1	8.1	9.9	1.5	7.9	9.3	0.0	4.9	2.6	18.6	0.1	4.2	1.5	2.2	14.1	5.7	7.3	11.4	3.3	3.4	1.9	2.0	0.4	18.0	1.8	0.7	8.0	1.8	0.3	3.0	3.4	3.9	4.8	4.4	16.3	0.2	0.1	4.8	4.2	5.6	0.7	6.7	2.2	2.5	1.5	1.7	1.6	9.6	7.6	0.9	4.8	9.1	3.5	6.4	5.6	2.9	9.1	8.9	7.7	1.2	6.1	7.2	2.8	1.0	6.0	6.7	9.2	5.9	9.0	0.3	6.3	4.2	4.8	5.5	1.9	4.2	4.0	4.3	4.6	2.2	5.9	4.5
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 109.5"	"Cell line enhanced"	"Detected in many"		"AF22: 26.1;HDLM-2: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 5.8;olfactory region: 24.7"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA052462: , HPA058882: "	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	109.5	8.8	11.2	9.2	17.7	0.6	34.4	9.8	17.5	25.5	9.0	7.7	2.9	2.5	7.1	7.0	18.8	14.0	18.7	22.3	13.0	11.8	7.4	9.3	7.1	3.4	16.6	3.3	10.0	12.8	17.2	4.7	44.8	16.7	7.2	7.1	8.1	4.4	3.7	16.6	7.4	6.0	28.0	13.9	4.7	5.3	5.4	12.4	5.7	34.4	9.9	3.3	10.9	7.1	2.3	1.7	4.8	0.9	0.8	2.7	0.3	4.3	0.1	26.1	0.8	0.8	1.5	0.2	4.2	6.9	4.3	6.3	1.7	4.6	1.3	0.4	1.6	1.4	1.0	0.2	7.3	13.2	1.0	0.4	1.3	0.0	1.6	0.6	0.4	1.0	1.2	1.5	3.3	3.2	0.4	1.8	2.2	0.8	0.7	0.7	0.1	0.8	2.0	0.5	0.6	0.5	0.4	2.3	2.4	4.0	0.4	9.5	0.1	2.1	3.9	1.0	1.4	5.8	3.8	1.3	0.6	1.0	1.4	2.8	4.8	4.8	0.9	0.7	0.9	0.4	1.1	2.2	2.0	1.3	0.6	2.3	1.6	1.0	4.4	0.8	0.6	1.7	2.7	0.3	11.2	17.7	9.8	17.5	13.0	11.8	16.6	3.3	16.7	12.4
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811944	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Supported	Nucleoplasm,Cytosol			1200000	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	22.9	37.1	10.9	33.6	13.2	32.9	31.6	10.1	15.3	22.7	31.1	10.7	33.6	27.1	19.9	28.3	50.7	21.0	30.4	22.5	9.1	8.2	27.7	60.4	30.6	94.2	14.8	10.7	17.9	58.2	19.4	15.6	19.3	11.0	25.1	15.1	13.9	48.2	37.4	26.2	49.8	24.3	18.4	12.1	30.4	27.5	16.0	12.2	37.9	29.5	49.7	35.8	18.5	32.8	65.4	92.1	24.2	70.2	58.2	83.7	104.7	25.4	37.4	7.3	33.0	9.0	17.9	39.1	19.3	17.2	22.8	8.9	38.5	30.9	23.7	37.8	10.9	27.3	12.0	31.7	4.6	16.7	71.6	20.2	17.7	40.2	28.6	13.8	16.5	19.1	34.3	18.1	23.0	28.4	42.4	17.8	11.5	93.8	39.0	40.8	28.2	49.0	42.0	11.4	56.1	25.1	17.3	36.5	22.4	36.8	21.5	20.8	71.0	27.5	18.3	20.6	18.0	16.6	18.9	35.0	29.3	65.2	30.3	36.8	18.1	8.5	70.2	24.2	63.0	57.7	83.7	63.2	81.9	67.5	71.6	65.4	75.9	64.3	4.3	58.2	37.1	92.1	66.1	104.7	10.9	13.2	10.1	15.3	9.1	8.2	14.8	10.7	11.0	12.2
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32972606-33025168	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA064930: "	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favourable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	12.9	20.3	17.5	11.2	18.4	19.9	16.5	15.1	21.7	12.0	15.2	19.3	9.3	11.7	14.7	12.9	19.1	14.7	8.0	11.9	13.3	13.9	17.9	23.4	12.6	11.8	16.4	16.5	11.8	14.3	15.8	14.3	12.1	20.2	12.1	18.1	14.6	12.5	11.9	14.1	20.6	13.8	14.6	15.7	11.7	12.5	18.2	14.5	8.8	10.5	12.6	16.1	13.4	12.1	17.1	18.4	16.1	20.8	26.4	19.4	15.0	21.2	16.1	12.3	10.6	12.5	11.0	16.2	14.2	14.8	17.4	19.2	21.4	7.5	16.6	8.6	11.9	11.3	20.0	19.1	21.6	22.4	8.2	9.8	23.1	21.8	14.6	15.8	9.4	14.7	23.4	19.9	25.9	16.6	14.8	16.5	16.2	9.1	14.2	23.2	18.7	17.3	12.8	8.5	11.8	14.3	12.9	8.5	7.2	13.0	11.7	9.5	13.3	6.5	10.2	9.7	12.9	16.7	14.6	7.2	11.8	16.6	14.4	12.9	7.7	9.1	17.7	14.9	13.4	16.3	17.6	17.0	15.2	15.5	18.4	17.1	18.0	14.6	16.1	26.4	20.8	17.9	19.4	15.0	17.5	18.4	15.1	21.7	13.3	13.9	16.4	16.5	20.2	14.5
AQP1	"CHIP28, CO"	ENSG00000240583	"Aquaporin 1 (Colton blood group)"	P29972	7	30911694-30925516	"Blood group antigen proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 156.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.5;HeLa: 6.9;SH-SY5Y: 7.7;U-2 OS: 9.5;WM-115: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001707, HPA019206"	Enhanced		Supported	"Plasma membrane"			250000	"Plasma membrane"		"CAB001707: , HPA019206: AB_1844965"	"unprognostic (4.18e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (6.52e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.05e-2)"	"prognostic favourable (1.32e-8)"	"unprognostic (3.43e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.21e-2)"	68.2	8.0	9.9	8.7	17.1	9.4	51.9	10.7	13.0	46.5	18.1	62.1	7.7	10.8	28.0	20.8	58.8	29.0	36.3	46.7	18.1	15.4	156.5	4.2	103.2	9.1	36.9	17.8	16.4	49.9	12.9	4.0	9.1	63.2	32.4	10.6	8.3	19.8	22.7	35.2	24.8	18.2	41.2	56.4	2.9	18.2	15.0	17.8	1.9	21.3	33.5	12.5	36.0	76.7	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.6	0.4	1.8	0.4	1.2	0.4	0.0	0.0	0.2	0.3	0.0	20.5	1.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	6.9	0.0	0.4	0.1	0.0	3.2	0.0	0.1	0.0	2.8	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	5.0	0.1	0.7	0.0	0.1	7.7	1.2	0.6	0.0	0.1	0.1	0.0	0.0	9.5	0.7	0.3	0.5	0.3	0.0	0.1	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.9	17.1	10.7	13.0	18.1	15.4	36.9	17.8	63.2	17.8
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.0;HeLa: 50.9;RT4: 47.4;SK-BR-3: 32.8;U-266/70: 34.0;U-266/84: 44.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA014924: "	"unprognostic (4.29e-2)"	"prognostic favourable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.5	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	28.0	1.3	0.1	0.0	13.3	1.3	0.9	50.9	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.1	14.3	13.0	1.5	6.2	12.7	4.9	1.1	0.1	0.2	21.2	2.3	0.2	47.4	0.4	1.0	7.1	32.8	0.0	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.0	44.0	3.1	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969839	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA040624: , HPA055647: "	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	15.5	15.8	8.0	14.0	12.4	9.7	16.1	11.2	14.3	16.6	11.2	11.8	8.7	9.2	18.5	11.8	18.3	12.3	8.7	9.9	8.4	7.5	14.4	11.2	10.7	12.6	8.7	6.9	15.5	13.6	16.8	13.2	15.3	13.2	12.0	11.8	12.4	15.1	11.3	8.7	14.2	13.0	14.3	8.3	16.8	12.9	15.8	9.2	27.9	14.8	8.5	16.5	15.7	14.9	5.9	5.5	7.1	5.1	4.5	6.5	2.9	5.0	13.0	8.7	9.1	11.8	11.0	4.5	6.2	7.9	8.2	7.4	5.9	3.1	4.1	4.0	10.4	8.0	14.5	8.8	9.2	5.8	5.9	13.2	11.5	5.4	6.7	10.7	6.2	8.5	5.9	6.5	6.9	7.0	9.3	4.1	8.1	3.4	6.1	7.1	8.6	5.4	8.4	14.9	4.1	8.3	8.9	9.5	7.4	10.1	9.6	2.2	6.8	8.3	9.1	6.2	3.4	4.2	5.4	5.0	6.1	8.3	7.7	9.3	6.2	7.1	4.7	2.7	6.5	5.1	5.7	4.0	5.7	6.2	3.8	5.9	5.8	6.4	2.3	4.5	3.0	5.5	4.6	2.9	8.0	12.4	11.2	13.4	8.4	7.5	8.7	6.9	13.2	9.2
ARCN1	COPD	ENSG00000095139	"Archain 1"	P48444	11	118572390-118603033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037573, HPA044874"	Approved		Enhanced	"Golgi apparatus,Vesicles"			340000	Vesicles	"Golgi apparatus"	"HPA037573: AB_10696938, HPA044874: "	"unprognostic (1.46e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (2.97e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.56e-3)"	46.9	37.4	26.7	30.3	32.9	15.0	35.7	34.4	38.8	48.8	36.7	37.3	39.9	36.0	39.8	61.6	38.6	32.6	38.0	39.5	28.7	30.6	39.1	61.4	34.0	27.3	30.4	24.7	45.1	65.2	49.7	64.7	46.0	38.3	42.4	39.6	29.3	62.0	46.9	25.8	31.9	47.1	41.9	34.3	34.9	38.1	37.9	29.7	39.0	44.1	29.3	39.2	46.9	42.1	22.7	29.1	46.2	33.0	34.1	39.5	26.7	24.3	20.4	35.8	26.1	44.1	47.1	19.3	61.5	54.7	27.9	33.3	64.4	32.3	25.7	52.8	68.6	33.0	40.0	36.2	38.9	35.3	18.7	55.1	14.8	35.0	50.1	33.8	32.3	41.1	30.1	46.0	42.9	42.2	28.4	36.1	52.4	39.1	30.4	30.1	22.5	27.3	26.5	34.8	39.1	33.7	26.5	24.6	24.7	34.2	33.4	17.3	42.5	30.3	38.5	35.2	17.3	33.2	28.4	21.2	18.8	37.4	20.7	31.7	41.8	46.2	26.4	26.3	30.5	33.0	39.5	22.7	30.2	29.3	29.1	20.7	29.1	26.6	23.1	34.1	32.1	24.4	28.3	26.7	26.7	32.9	34.4	38.8	28.7	30.6	30.4	24.7	38.3	29.7
ARFGAP1	"ARF1GAP, bA261N11.3, FLJ10767"	ENSG00000101199	"ADP ribosylation factor GTPase activating protein 1"	Q8N6T3	20	63272785-63289793	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051019, HPA056273"	Approved		Supported	"Nuclear membrane,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Nuclear membrane"	"HPA051019: AB_2681313, HPA056273: AB_2683084"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.86e-3)"	"unprognostic (8.62e-2)"	"prognostic favourable (4.57e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (3.48e-7)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.86e-1)"	12.3	13.8	17.8	16.7	21.8	12.4	10.4	29.2	28.9	16.0	16.6	27.1	15.3	14.8	17.3	17.9	13.4	16.0	20.0	14.3	17.5	17.2	13.7	14.8	13.1	16.6	26.0	19.9	16.7	32.8	13.7	40.9	17.9	19.2	16.2	11.7	20.1	21.3	18.1	10.4	21.9	15.7	14.8	15.9	17.2	21.1	19.9	22.7	11.2	15.0	10.3	15.5	16.0	11.9	7.4	8.2	8.3	12.6	6.6	9.9	7.0	11.0	21.0	9.2	10.9	11.0	12.5	18.0	16.2	13.4	33.0	16.6	50.0	12.4	8.4	14.9	19.4	15.3	8.3	26.2	10.3	5.5	9.3	6.5	20.3	42.1	16.9	9.8	13.6	10.7	16.9	15.9	9.0	11.6	11.7	9.8	8.8	18.2	17.6	9.2	12.2	18.1	9.9	13.2	8.1	8.1	13.5	9.8	10.8	19.4	20.7	20.2	15.2	12.6	15.0	20.2	27.4	12.2	12.8	10.1	6.5	9.2	20.5	6.9	12.5	6.9	7.6	8.3	8.8	10.5	9.9	4.8	4.8	8.0	8.2	7.4	4.9	4.6	3.6	6.6	12.6	6.2	5.9	7.0	17.8	21.8	29.2	28.9	17.5	17.2	26.0	19.9	19.2	22.7
ARFGAP2	"FLJ14576, IRZ, Zfp289, ZNF289"	ENSG00000149182	"ADP ribosylation factor GTPase activating protein 2"	Q8N6H7	11	47164299-47177125	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016649, HPA018152"	Enhanced		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA016649: AB_1844980, HPA018152: AB_1844979"	"unprognostic (1.69e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.00e-2)"	"prognostic favourable (7.65e-7)"	"unprognostic (2.05e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.20e-2)"	17.4	22.6	23.1	16.5	31.3	35.8	21.6	33.1	50.8	23.6	20.7	33.9	14.0	19.6	20.9	19.8	27.5	25.7	16.5	22.4	22.3	20.4	22.4	32.9	20.5	23.1	20.7	22.5	23.6	33.0	30.2	18.8	29.1	27.8	23.5	20.2	29.1	27.4	22.5	49.8	39.0	25.0	19.6	19.3	24.3	24.5	22.8	20.3	29.9	25.2	16.3	28.2	21.3	19.5	30.9	30.5	40.8	41.9	30.6	36.7	43.7	19.8	12.5	19.9	15.1	16.6	13.9	18.1	18.5	16.8	22.6	17.1	13.9	16.3	31.9	11.9	20.8	30.9	16.5	26.2	14.5	14.7	16.9	27.5	28.4	17.3	19.6	33.9	30.5	20.7	29.1	11.8	25.6	21.3	36.9	24.5	20.4	35.3	17.5	30.4	15.2	16.8	26.2	33.3	40.9	21.5	28.7	19.3	16.9	21.4	29.2	13.1	47.0	26.2	16.7	20.4	15.8	18.3	23.4	21.0	19.9	27.1	14.2	28.2	20.1	38.8	31.5	40.8	36.7	35.4	33.1	28.2	28.4	32.5	30.5	30.9	32.0	31.8	19.6	30.6	41.9	16.4	32.3	43.7	23.1	31.3	33.1	50.8	22.3	20.4	20.7	22.5	27.8	20.3
ARFGAP3	ARFGAP1	ENSG00000242247	"ADP ribosylation factor GTPase activating protein 3"	Q9NP61	22	42796502-42858106	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000638	Approved		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA000638: AB_1078188"	"unprognostic (3.29e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (8.97e-6)"	"unprognostic (5.83e-2)"	"unprognostic (8.85e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (2.65e-4)"	"unprognostic (1.73e-1)"	19.0	48.7	12.5	14.5	13.4	18.4	18.8	15.9	12.8	26.6	15.0	14.2	26.5	16.1	18.4	24.8	13.0	13.4	16.6	14.6	12.3	11.0	28.9	42.1	18.6	12.3	17.5	9.9	17.9	53.9	16.3	41.7	21.8	13.4	30.2	13.9	13.6	49.1	31.2	17.6	12.1	36.4	15.2	13.9	16.5	21.4	23.4	15.2	15.4	37.9	9.0	16.2	21.5	23.7	12.8	27.7	32.4	23.9	23.4	31.5	13.9	18.1	5.9	13.1	7.7	18.1	30.5	5.4	35.1	23.6	15.9	19.3	7.1	10.2	9.2	7.8	31.3	4.5	5.7	10.0	17.3	5.6	7.8	10.8	8.2	11.1	25.2	9.7	16.9	13.4	17.9	13.3	23.9	16.2	4.8	41.5	27.5	4.7	14.8	5.2	2.1	7.1	9.5	29.5	11.4	25.1	8.4	4.6	2.9	17.0	6.8	13.7	7.1	7.2	20.9	18.8	13.7	16.4	9.4	30.1	14.4	10.2	13.5	10.4	14.5	32.4	17.0	18.0	24.3	21.9	31.5	12.6	16.1	21.2	16.6	12.8	10.6	14.7	26.5	23.4	23.9	27.7	13.8	13.9	12.5	13.4	15.9	12.8	12.3	11.0	17.5	9.9	13.4	15.2
ARFGEF1	"ARFGEP1, BIG1, DKFZP434L057, p200"	ENSG00000066777	"ADP ribosylation factor guanine nucleotide exchange factor 1"	Q9Y6D6	8	67173511-67343677	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023399, HPA023822"	Supported	Supported	Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA023399: AB_1844981, HPA023822: AB_1844982"	"prognostic unfavourable (8.76e-4)"	"unprognostic (1.62e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.31e-1)"	"prognostic favourable (2.48e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.61e-2)"	17.0	17.1	14.5	24.3	15.6	24.9	14.0	20.4	16.3	17.7	24.7	9.5	24.7	16.8	15.4	20.3	23.8	13.1	16.0	12.0	11.3	11.7	23.9	15.3	18.6	22.7	11.4	9.5	15.1	21.4	38.6	21.8	17.4	16.7	15.8	17.7	13.2	20.7	29.4	20.9	18.4	26.9	13.8	12.0	20.1	19.5	27.1	12.6	36.7	22.9	15.7	16.8	22.9	17.7	2.1	3.7	8.4	3.7	3.7	6.1	1.3	15.5	10.1	9.9	3.7	11.4	15.8	11.7	10.9	12.3	11.2	11.4	6.2	15.2	11.8	4.8	13.8	11.2	11.8	15.4	13.8	15.1	8.3	19.8	6.2	6.6	9.9	10.1	19.8	9.6	11.1	10.1	17.2	15.9	12.1	12.8	12.9	3.5	23.8	4.8	21.7	9.3	11.6	7.1	2.4	18.6	29.0	3.9	7.7	7.1	17.2	9.7	29.7	9.1	19.3	7.7	10.3	10.1	8.2	11.3	12.3	8.9	12.2	10.4	7.2	8.0	2.6	6.6	4.8	3.7	6.1	2.1	3.2	3.9	2.6	2.1	5.3	4.5	8.4	3.7	1.5	3.7	5.9	1.3	14.5	15.6	20.4	16.3	11.3	11.7	11.4	9.5	16.7	12.6
ARFGEF2	BIG2	ENSG00000124198	"ADP ribosylation factor guanine nucleotide exchange factor 2"	Q9Y6D5	20	48921890-49036693	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 95.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026078, CAB026382"	Supported		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB026382: , HPA026078: AB_1844983"	"unprognostic (1.50e-2)"	"unprognostic (9.56e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.94e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (6.15e-7)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.90e-2)"	12.9	29.8	9.4	16.6	15.9	15.6	18.7	14.2	21.8	12.7	15.6	12.5	19.2	15.8	13.8	12.4	15.2	10.4	12.8	19.2	11.1	11.0	17.1	20.1	11.5	14.3	11.5	12.6	12.2	21.6	95.3	17.1	15.4	16.1	12.6	17.6	13.4	15.1	24.7	16.2	15.5	16.5	11.6	11.9	14.0	17.4	23.2	8.5	15.5	23.6	11.6	16.0	16.1	11.6	2.5	2.4	7.3	1.7	1.8	2.8	1.0	9.4	10.9	5.1	3.3	9.6	8.7	12.8	7.9	10.7	21.1	10.5	19.8	11.1	13.5	12.1	11.4	11.4	10.0	12.6	18.4	5.0	3.7	10.0	11.1	18.3	12.3	12.2	11.6	9.0	13.9	14.0	14.8	14.8	7.6	13.5	11.3	4.2	7.6	6.7	5.0	10.0	8.0	13.2	16.5	11.0	13.7	4.6	5.5	23.1	38.1	15.2	15.2	12.6	18.5	20.4	9.3	10.3	7.3	20.7	18.7	10.0	13.3	6.6	6.8	7.3	1.7	0.7	1.6	1.1	2.8	1.6	1.9	1.8	2.4	2.5	2.7	2.4	0.5	1.8	1.1	2.4	0.5	1.0	9.4	15.9	14.2	21.8	11.1	11.0	11.5	12.6	16.1	8.5
ARFIP1	HSU52521	ENSG00000164144	"ADP ribosylation factor interacting protein 1"	P53367	4	152779937-152918463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005080, HPA037375, HPA063759"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB005080: AB_2058797, HPA037375: , HPA063759: "	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"prognostic favourable (5.75e-5)"	"unprognostic (1.49e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-2)"	"prognostic favourable (2.83e-10)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.22e-3)"	17.8	15.6	12.2	22.6	13.2	2.8	22.3	15.7	12.3	22.8	25.3	17.5	25.6	20.9	21.1	23.8	23.4	17.6	20.8	11.9	12.6	13.2	23.6	15.3	20.3	14.9	16.1	9.5	22.9	18.8	20.4	22.5	29.0	13.5	23.8	26.4	19.1	19.6	23.9	12.7	19.1	29.9	18.5	18.3	18.5	20.2	12.7	13.9	14.7	23.9	10.2	17.9	24.3	20.4	8.4	10.9	35.7	13.8	12.3	7.6	7.7	13.0	9.8	13.7	13.4	21.6	22.1	16.9	15.8	22.3	15.9	15.2	11.4	27.5	10.5	5.3	21.9	9.4	14.1	15.9	19.9	8.8	8.8	10.4	10.0	11.2	15.3	19.5	22.0	15.5	17.8	13.5	13.4	14.6	12.1	22.8	22.3	15.2	10.9	10.9	11.5	10.0	6.3	7.7	9.7	28.8	17.6	17.3	14.3	11.9	22.4	15.7	20.1	10.5	9.1	15.5	11.0	14.9	11.1	25.1	20.6	14.4	19.6	19.5	21.3	12.1	12.0	17.9	6.7	13.8	6.7	8.4	5.3	5.5	10.9	7.7	4.1	5.5	35.7	12.3	12.6	1.3	7.6	7.7	12.2	13.2	15.7	12.3	12.6	13.2	16.1	9.5	13.5	13.9
ARFRP1	"ARL18, ARP, Arp1"	ENSG00000101246	"ADP ribosylation factor related protein 1"	Q13795	20	63698642-63708025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047028, HPA050634"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA047028: AB_2679908, HPA050634: "	"unprognostic (6.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.39e-1)"	22.6	20.2	19.0	19.4	22.6	12.4	15.6	23.5	21.4	18.5	18.9	19.9	29.3	26.3	22.6	12.4	21.2	19.4	17.7	25.0	18.6	17.6	19.0	20.9	17.2	21.7	23.9	22.0	21.1	26.5	16.2	16.3	18.6	22.4	19.3	12.1	22.5	23.6	24.8	29.8	15.8	21.5	28.9	17.5	26.7	16.9	15.3	18.7	16.9	16.4	16.3	18.1	14.8	21.4	20.8	30.1	20.2	19.5	21.0	31.3	21.2	11.8	14.6	4.7	4.9	4.7	5.2	6.8	14.6	9.8	31.9	11.6	27.3	10.3	14.6	10.1	8.5	16.3	5.1	16.3	5.6	5.0	7.3	10.7	14.8	23.3	16.7	12.1	10.1	7.2	21.2	8.3	10.2	11.6	15.8	11.2	7.8	6.6	23.8	16.8	7.3	21.3	19.0	6.5	14.9	6.7	9.9	7.9	8.1	14.8	21.6	5.0	9.5	15.7	9.1	18.7	7.4	7.0	14.7	11.7	4.9	11.2	12.5	8.1	10.5	20.2	19.3	13.4	26.8	19.1	22.7	20.5	24.5	25.6	17.3	20.8	31.3	27.5	9.7	21.0	19.5	30.1	19.0	21.2	19.0	22.6	23.5	21.4	18.6	17.6	23.9	22.0	22.4	18.7
ARG2		ENSG00000081181	"Arginase 2"	P78540	14	67619798-67651720	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 53.7;thyroid gland: 75.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 25.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000663, CAB009435"	Enhanced		Supported	Mitochondria				Mitochondria		"CAB009435: AB_2059089, HPA000663: AB_1078192"	"unprognostic (8.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-3)"	"unprognostic (4.62e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.26e-1)"	1.5	3.9	2.4	1.7	6.4	0.6	2.7	8.3	5.3	9.3	5.4	0.5	2.0	2.1	3.7	2.3	7.3	0.8	4.9	2.1	3.3	5.5	41.4	2.0	1.7	0.6	3.2	1.7	8.8	2.6	32.1	22.5	4.4	4.6	53.7	1.1	3.4	26.6	3.8	17.2	0.8	10.4	2.2	3.9	0.7	1.4	1.9	2.1	0.1	75.4	13.6	2.2	5.3	4.1	2.5	1.7	2.0	1.4	0.3	2.9	3.4	3.5	0.5	6.2	4.0	0.9	0.0	8.4	2.8	7.5	9.1	15.4	15.3	1.8	6.0	0.7	1.8	0.8	25.0	11.3	11.0	0.2	6.2	2.7	1.1	17.5	2.7	0.6	16.4	0.4	14.8	4.4	21.6	15.3	7.9	0.0	0.6	1.7	0.9	0.6	11.8	0.2	0.2	0.8	6.9	7.4	6.0	13.8	5.2	1.7	1.7	2.6	6.4	0.2	3.1	2.7	6.9	0.2	2.0	0.5	0.9	2.0	5.5	3.1	4.6	0.3	1.4	2.0	1.1	0.5	0.5	0.7	0.3	0.9	1.7	2.5	0.6	0.6	1.7	0.3	1.2	0.1	2.9	3.4	2.4	6.4	8.3	5.3	3.3	5.5	3.2	1.7	4.6	2.1
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568164	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: "	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favourable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favourable (7.34e-5)"	43.5	31.8	59.1	46.5	63.6	67.5	46.1	82.1	72.8	37.9	41.7	44.9	33.5	35.2	62.2	50.9	38.1	50.2	55.0	40.4	55.7	20.6	30.5	24.4	65.3	75.7	62.5	44.5	65.2	34.1	24.0	61.1	48.3	44.0	38.9	48.6	35.5	46.8	48.2	34.1	53.0	54.3	43.3	51.8	50.4	42.8	25.9	67.2	40.2	45.5	22.0	61.0	44.0	44.9	23.7	23.2	34.7	18.0	16.5	18.6	10.9	26.1	14.4	66.0	14.8	10.5	18.2	14.7	29.0	8.8	9.8	14.9	29.6	38.0	31.7	10.0	11.3	29.5	13.9	12.0	18.4	41.2	14.8	36.5	89.5	15.2	9.3	58.7	24.2	16.2	15.8	8.9	12.0	12.4	13.1	24.7	12.6	9.2	23.2	31.2	17.4	5.5	40.0	16.5	15.1	11.0	30.4	17.3	24.7	13.7	22.0	6.5	17.3	30.4	22.5	13.1	13.1	14.5	16.3	27.7	22.8	38.0	27.1	37.6	15.0	34.7	18.0	16.7	18.6	14.6	17.2	20.7	13.8	11.6	14.4	23.7	15.8	13.8	30.3	16.5	13.4	23.2	15.5	10.9	59.1	63.6	82.1	72.8	55.7	20.6	62.5	44.5	44.0	67.2
ARHGAP1	"CDC42GAP, p50rhoGAP, RhoGAP"	ENSG00000175220	"Rho GTPase activating protein 1"	Q07960	11	46677080-46700615	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004689, HPA008285"	Approved	Approved	Supported	Vesicles			16000000	Vesicles		"HPA004689: AB_1078194, HPA008285: AB_1078195"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.07e-2)"	"prognostic unfavourable (2.14e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.24e-2)"	39.9	23.0	17.5	21.3	24.0	17.5	25.8	9.5	30.1	35.6	23.9	42.9	13.1	15.2	43.0	23.9	36.8	31.0	40.2	63.3	23.0	14.8	19.8	19.4	17.9	22.0	17.5	17.7	32.6	17.0	18.6	16.7	32.0	17.1	36.3	20.0	33.8	21.6	39.3	15.1	26.9	19.5	58.5	18.1	29.0	21.4	21.4	24.1	21.0	20.0	16.2	27.2	59.5	27.1	7.9	17.1	18.8	33.4	11.6	14.3	10.3	7.0	17.7	8.9	12.6	44.6	32.9	10.6	15.6	16.0	14.5	13.3	10.6	9.4	10.3	8.6	32.0	17.7	7.0	23.9	10.9	7.1	7.7	11.3	9.1	12.5	14.7	9.6	17.0	43.4	15.0	11.1	13.9	12.4	7.3	9.7	17.6	25.6	6.4	9.5	23.0	9.3	7.7	12.8	15.2	13.7	26.7	3.2	10.2	14.4	22.4	6.0	28.2	11.0	15.4	26.8	8.4	31.6	15.7	10.3	11.3	7.7	25.1	16.2	12.5	12.0	16.3	15.6	14.3	28.2	10.2	7.7	11.3	12.1	16.1	7.9	9.9	11.2	18.8	11.6	33.4	17.1	13.4	10.3	17.5	24.0	9.5	30.1	23.0	14.8	17.5	17.7	17.1	24.1
ARHGAP19	"FLJ00194, MGC14258"	ENSG00000213390	"Rho GTPase activating protein 19"	Q14CB8	10	97222173-97292673	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 30.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA035777, HPA043231"	Uncertain		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA035777: , HPA043231: AB_10796791"	"unprognostic (5.88e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (7.47e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.29e-2)"	5.6	3.7	5.6	8.8	7.6	18.3	8.6	7.2	5.3	7.4	5.1	11.7	3.2	4.1	6.9	3.4	6.1	6.0	4.0	4.9	5.7	4.6	4.6	3.2	5.5	14.1	10.9	3.6	11.4	3.4	8.0	7.3	6.0	7.4	5.8	5.3	7.3	6.4	3.7	4.0	6.0	6.6	5.3	14.2	12.0	4.3	20.1	7.0	30.4	4.4	5.5	14.3	6.7	5.9	5.5	5.3	15.5	7.3	4.1	6.0	5.1	8.2	2.7	14.9	26.0	1.0	3.9	4.6	4.1	4.2	6.6	4.6	5.3	7.5	18.5	3.5	2.8	5.6	12.5	5.1	8.4	9.2	6.8	12.1	3.4	3.5	0.9	18.7	13.0	2.0	1.8	4.6	10.6	8.9	12.0	9.8	5.7	4.1	16.9	4.0	8.0	2.5	20.4	12.7	5.2	2.0	3.7	1.1	6.9	3.0	1.5	6.8	9.2	9.8	4.1	2.7	3.2	4.1	10.6	8.8	9.0	25.0	3.4	22.1	2.9	15.3	7.3	10.2	5.2	6.6	4.9	5.5	5.1	4.8	5.3	5.5	6.0	5.3	15.5	4.1	5.7	3.0	5.9	5.1	5.6	7.6	7.2	5.3	5.7	4.6	10.9	3.6	7.4	7.0
ARHGAP21	"ARHGAP10, KIAA1424"	ENSG00000107863	"Rho GTPase activating protein 21"	Q5T5U3	10	24583609-24723668	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036610, HPA057861"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"				"Cell Junctions, Actin filaments"	"Plasma membrane"	"HPA036610: AB_10669910, HPA057861: "	"unprognostic (7.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	19.6	13.6	34.5	7.1	38.5	4.7	15.6	37.9	39.3	16.2	12.0	39.1	4.4	9.4	14.8	6.0	8.4	14.0	13.5	15.0	43.1	25.2	8.5	9.8	15.7	3.5	42.3	24.0	25.5	11.0	12.4	9.7	12.1	27.3	8.2	14.1	6.7	16.0	9.1	10.9	4.7	11.5	13.7	54.8	6.0	19.5	10.4	43.7	2.7	9.8	3.7	4.2	9.2	9.3	0.2	1.6	3.6	1.9	1.0	2.0	1.0	22.6	10.0	24.7	20.9	17.4	25.1	8.5	16.3	10.8	10.0	14.2	7.3	14.4	4.2	5.6	25.8	15.0	13.0	16.3	14.8	13.9	8.3	24.9	21.6	5.2	10.4	0.0	3.9	10.2	17.9	13.1	14.2	17.1	10.5	38.1	19.6	4.4	11.7	0.8	3.8	5.4	2.6	8.7	2.3	6.7	4.0	4.2	4.3	11.1	6.2	13.2	6.5	3.5	19.0	14.4	9.2	15.8	11.7	4.2	7.5	3.0	14.9	4.3	9.7	3.6	0.8	1.6	0.5	1.9	0.4	0.2	0.6	1.6	1.3	0.0	2.0	1.2	0.1	1.0	0.9	1.6	1.0	1.0	34.5	38.5	37.9	36.1	43.1	25.2	42.3	24.0	27.3	43.7
ARHGAP22	RhoGAP2	ENSG00000128805	"Rho GTPase activating protein 22"	Q7Z5H3	10	48446034-48656265	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 32.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 15.4;LHCN-M2: 26.1;TIME: 27.7;U-87 MG: 34.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6"	"Group enriched"	"Detected in many"	29	"B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020696, HPA040391, HPA064439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB020696: , HPA040391: , HPA064439: "	"unprognostic (1.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (2.16e-8)"	"unprognostic (7.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.66e-2)"	2.6	3.1	10.2	6.7	12.5	3.0	2.0	7.3	12.2	1.8	2.7	32.3	1.0	1.7	2.1	1.9	1.6	2.2	4.4	3.3	12.5	9.6	1.2	0.8	2.9	6.0	18.3	6.6	7.7	1.5	2.7	1.8	2.2	24.6	3.2	2.8	1.6	3.4	3.2	3.9	3.4	2.5	3.4	27.3	6.2	2.3	4.6	18.4	2.0	6.0	0.4	5.4	3.1	1.9	2.6	2.9	0.0	3.2	0.0	0.0	0.9	2.5	0.5	0.1	0.0	2.2	8.8	1.7	13.5	6.2	1.2	1.7	2.7	0.3	0.0	0.5	5.2	4.9	0.1	4.5	2.2	0.2	4.6	7.1	0.0	0.0	1.1	0.8	0.8	2.1	4.6	15.4	1.2	8.4	6.7	1.3	26.1	0.1	0.1	0.0	2.9	0.2	0.0	0.0	3.2	2.6	0.2	0.4	2.7	0.6	0.0	0.2	0.1	0.1	27.7	12.7	0.2	1.6	9.4	0.0	0.0	0.0	34.4	0.1	2.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	10.2	12.5	7.3	9.2	12.5	9.6	18.3	6.6	24.6	18.4
ARHGAP28	"FLJ10312, KIAA1314"	ENSG00000088756	"Rho GTPase activating protein 28"	Q9P2N2	18	6729718-6915716	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.4"	"Cell line enhanced"	"Detected in many"		"AF22: 22.3;CACO-2: 23.2;U-2 OS: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 7.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030413, HPA030414, HPA030415"	Enhanced		Supported	"Cell Junctions"				"Cell Junctions"		"HPA030413: AB_10601455, HPA030414: AB_10670042, HPA030415: AB_10669598"	"unprognostic (8.33e-2)"	"unprognostic (8.79e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.94e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.56e-3)"	"unprognostic (9.52e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.59e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.76e-2)"	8.6	1.9	0.9	4.4	0.9	0.3	12.7	0.8	1.0	13.5	5.1	0.1	2.8	1.0	5.7	8.5	1.3	2.1	7.3	4.2	0.9	1.0	6.9	0.7	9.3	2.8	0.8	0.5	9.9	7.4	4.9	1.3	16.1	0.6	9.1	1.3	3.9	1.7	4.2	16.0	2.2	3.4	4.3	1.5	21.5	1.5	39.4	0.0	3.5	5.0	4.2	0.4	4.8	3.9	0.6	0.6	7.1	0.5	0.4	0.3	0.1	0.1	0.1	22.3	2.1	4.4	7.6	3.8	1.8	3.9	1.6	3.6	23.2	0.1	0.1	0.7	0.2	1.0	0.0	0.5	2.7	0.6	1.3	0.0	1.9	0.1	0.7	0.1	0.1	9.5	0.4	1.9	0.1	5.2	0.6	1.8	2.6	0.3	0.3	0.2	7.0	1.1	0.1	1.6	0.1	0.0	1.8	2.3	9.3	0.1	1.8	0.3	0.1	0.0	0.8	0.3	10.4	7.4	0.2	0.1	0.0	0.1	3.5	0.2	0.7	1.5	0.5	0.7	0.3	0.2	0.2	0.2	0.2	0.3	0.1	0.6	0.2	0.3	7.1	0.4	0.1	0.6	0.1	0.1	0.9	0.9	0.8	1.0	0.9	1.0	0.8	0.5	0.6	0.0
ARHGAP30	FLJ00267	ENSG00000186517	"Rho GTPase activating protein 30"	Q7Z6I6	1	161046946-161069970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;lymphoid tissue: 45.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.0;HL-60: 23.9;HMC-1: 33.7;Karpas-707: 25.0;THP-1: 23.8;U-266/70: 37.7;U-266/84: 24.9;U-698: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036300	Enhanced		Supported	Vesicles				Vesicles		"HPA036300: AB_10601117"	"unprognostic (7.31e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (9.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.65e-2)"	6.1	3.0	2.6	23.3	3.9	20.4	3.1	0.6	2.4	2.2	3.9	3.5	1.4	3.5	2.0	3.7	8.0	3.3	5.9	4.1	1.9	1.7	3.0	3.3	11.3	27.9	4.3	0.7	1.8	1.8	0.3	1.5	2.5	3.4	2.3	3.2	2.6	6.1	1.8	0.9	11.2	13.7	2.9	4.3	45.9	4.1	1.4	4.5	38.1	2.0	2.4	33.2	5.6	3.8	8.3	12.3	27.1	24.0	10.2	19.7	14.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	31.0	0.1	0.0	0.6	0.0	0.0	0.0	14.4	0.0	10.3	0.0	0.0	0.0	23.9	33.7	0.0	0.3	0.0	0.0	0.0	0.0	25.0	0.0	0.2	19.3	5.5	0.0	0.0	12.2	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	23.8	0.2	0.0	0.1	0.0	0.1	37.7	24.9	26.5	0.1	19.1	0.0	3.3	15.5	17.6	19.7	18.3	15.1	7.1	13.2	16.1	12.3	8.3	11.0	14.7	27.1	10.2	24.0	8.4	13.2	14.7	2.6	3.9	0.6	2.4	1.9	1.7	4.3	0.7	3.4	4.5
ARHGAP35	"GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP"	ENSG00000160007	"Rho GTPase activating protein 35"	Q9NRY4	19	46918676-47005077	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, GTPase activation, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037311, HPA055184, HPA056470"	Approved		Supported	"Nuclear bodies,Aggresome"				"Nuclear bodies"	Aggresome	"CAB037311: AB_477435, HPA055184: , HPA056470: "	"unprognostic (5.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.78e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.92e-1)"	"prognostic favourable (5.55e-8)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	4.0	3.1	11.9	1.9	9.0	0.8	5.4	6.1	11.7	4.5	4.4			3.9	3.9	3.3	5.3	4.3	2.6	8.7	10.7	9.9	6.7	7.7	4.8	2.1	8.4		6.2	4.2	17.3	4.4	2.0		4.4	3.9		4.8	5.6	9.0	3.4	5.1	4.2	4.6	2.2	3.1	13.8			7.0		2.4	4.5	2.2	1.1	1.4	0.9	1.2	1.0	3.1	1.1	20.0	22.8	15.4	13.6	14.1	11.8	2.6	10.9	15.7	11.1	12.8	12.2	7.2	10.8	7.8	44.7	12.3	14.2	14.2	15.4	7.4	5.9	14.6	16.0	9.4	13.2	8.6	12.4	11.9	14.3	12.6	13.5	10.0	9.7	3.9	12.7	11.8	8.3	13.5	8.0	8.4	9.3	10.5	3.3	9.3	40.2	15.5	14.7	20.2	19.0	8.1	17.9	10.5	12.5	9.8	7.8	10.6	12.9	4.1	7.4	8.8	22.0	9.0	23.9	0.9	1.0	0.9	2.8	0.8	2.9	0.8	2.6	3.1	1.3	1.1	1.0	1.2	0.4	1.0	1.2	1.4	0.8	1.1										
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 18.6;epididymis: 38.0;skin 1: 26.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HBEC3-KT: 12.0;RPTEC TERT1: 10.5;SK-BR-3: 11.3;T-47d: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.3	0.3	0.3	0.0	18.6	0.3	0.5	1.6	0.3	0.4	5.2	0.8	0.6	38.0	15.8	0.0	0.9	0.3	0.3	0.1	4.1	0.3	1.8	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	3.0	0.0	0.3	1.9	5.1	0.3	26.7	0.3	0.7	0.3	0.3	2.6	1.2	0.6	0.3	0.3	5.2	6.6	3.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.8	0.0	3.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	11.3	0.0	13.7	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.3	0.3	0.6
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA046993: , HPA056507: "	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favourable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	11.3	13.1	29.8	8.4	26.1	4.0	13.0	39.1	29.2	14.2	14.6	11.5	7.9	16.0	13.2	11.9	31.5	11.1	15.3	28.0	29.5	19.6	20.8	14.5	12.8	5.9	26.8	23.4	23.3	13.5	21.8	27.6	16.9	24.2	14.7	12.3	9.2	26.0	14.5	11.5	14.0	17.3	13.4	26.6	18.7	13.3	20.4	30.6	8.8	32.5	7.7	8.0	15.6	25.8	7.3	9.0	1.5	1.8	6.8	7.4	2.3	18.6	15.2	15.2	22.2	20.0	14.1	8.7	11.6	14.4	7.1	10.7	19.3	18.3	5.5	10.4	14.7	19.9	14.5	12.5	13.9	5.5	8.4	8.3	9.4	28.2	13.6	5.0	5.0	15.6	25.5	6.6	25.0	8.7	7.3	16.5	11.5	9.8	10.9	0.2	7.5	18.3	11.9	18.7	1.0	15.6	49.9	23.6	9.2	31.3	16.8	23.7	17.4	0.3	13.9	13.2	19.9	10.9	8.5	6.3	12.3	0.8	6.6	5.4	35.9	1.5	1.8	0.0	4.0	0.8	4.8	7.3	7.0	3.7	6.1	7.1	7.4	4.3	0.6	6.8	1.3	9.0	5.7	2.3	29.8	26.1	39.1	29.2	29.5	19.6	26.8	23.4	24.2	30.6
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11137543-11665701	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 57.3;seminal vesicle: 58.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.8;ASC TERT1: 19.2;HEL: 18.9;HMC-1: 13.3;HSkMC: 18.9;K-562: 13.7;RT4: 10.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		920000	Cytosol		"HPA001798: , HPA036779: AB_10672229, HPA064390: "	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	9.4	1.2	16.7	2.6	10.0	0.7	6.3	0.6	2.9	9.5	11.7	4.1	57.3	2.0	10.2	9.0	4.1	7.6	5.4	3.6	5.6	4.3	6.0	1.1	8.7	1.2	2.3	3.6	15.1	1.9	1.1	6.6	6.2	2.7	24.8	3.7	3.2	2.5	58.8	8.0	2.3	4.2	12.1	3.1	5.0	4.1	2.2	3.3	0.0	25.9	3.1	1.4	14.3	8.0	1.3	0.2	1.0	0.9	0.0	0.1	2.7	0.0	0.0	1.3	0.0	14.8	19.2	0.3	0.1	0.3	0.7	0.5	0.1	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.7	0.0	0.2	18.9	0.0	0.0	5.4	0.0	13.3	18.9	0.0	1.3	0.0	0.3	13.7	6.4	0.8	0.0	0.0	0.0	0.3	0.2	0.0	6.3	8.0	4.5	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	3.8	0.1	0.3	0.0	0.0	0.1	0.0	2.0	1.0	0.3	0.5	0.0	0.9	0.0	1.3	0.0	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.7	0.2	0.0	2.7	16.7	10.0	0.6	2.9	5.6	4.3	2.3	3.6	2.7	3.3
ARHGDIA	"GDIA1, RHOGDI"	ENSG00000141522	"Rho GDP dissociation inhibitor alpha"	P52565	17	81867721-81871406	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010005, HPA021407"	Approved		Supported	Cytosol			49000000	Cytosol		"CAB010005: AB_2227516, HPA021407: AB_1856267"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (5.32e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.88e-3)"	67.9	52.5	43.8	71.8	59.5	91.1	57.2	20.4	65.7	41.2	55.4	44.6	29.7	85.9	50.0	34.1	55.0	40.9	46.2	36.7	41.5	44.6	50.9	64.9	56.0	68.2	39.9	43.4	49.7	65.9	30.6	42.9	52.8	39.0	44.1	27.2	39.9	52.7	43.2	36.7	41.0	88.8	35.7	41.7	57.1	68.4	26.3	35.4	67.1	41.2	41.4	49.9	42.2	44.8	17.0	24.0	35.0	41.0	18.4	29.9	22.8	64.7	64.0	20.8	33.3	19.3	24.2	23.8	55.7	35.9	41.9	31.2	31.4	24.7	34.3	23.8	42.1	35.7	23.0	42.0	17.7	26.6	58.9	36.2	38.2	40.7	39.3	57.0	53.2	30.6	19.5	30.3	26.4	63.7	29.8	48.3	33.6	39.0	82.7	58.1	24.7	56.6	37.9	26.7	27.4	27.5	40.1	27.7	81.5	29.3	75.4	52.2	35.4	46.9	70.1	83.7	71.5	77.1	94.5	42.6	22.2	35.4	72.6	34.4	56.7	15.7	20.5	35.0	29.9	31.3	28.5	17.0	25.0	28.5	21.2	13.2	16.8	19.7	13.3	18.4	41.0	24.0	23.9	22.8	43.8	59.5	20.4	65.7	41.5	44.6	39.9	43.4	39.0	35.4
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942017-14961728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"blood: 333.1;bone marrow: 150.7;lymphoid tissue: 221.4"	"Cell line enhanced"	"Detected in many"		"HEL: 101.6;HL-60: 118.9;HMC-1: 134.6;MOLT-4: 140.7;REH: 118.4;U-698: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol			120000000	Cytosol		"CAB018584: AB_647972, HPA051235: "	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favourable (3.42e-4)"	40.3	13.4	9.0	66.1	18.4	150.7	27.9	1.8	8.9	14.6	14.5	13.9	3.6	8.5	14.7	13.2	16.9	18.2	18.3	20.5	8.3	7.8	24.5	20.0	41.3	93.9	17.0	3.9	11.7	7.1	3.9	8.1	35.6	11.4	18.0	16.1	20.4	22.4	7.6	13.3	14.7	38.3	15.7	17.9	157.8	11.1	11.2	15.8	221.4	22.7	12.4	108.1	31.2	13.5	114.0	95.5	267.1	151.9	96.3	231.1	333.1	9.3	0.3	0.3	20.8	1.4	1.1	0.1	0.3	0.1	0.1	0.1	1.2	10.3	75.4	4.8	1.7	10.3	0.0	16.7	1.1	0.1	0.0	101.6	0.2	0.0	0.3	118.9	134.6	0.1	2.1	0.0	1.5	58.5	0.5	28.9	1.8	0.0	140.7	85.6	0.4	0.1	118.4	1.3	33.7	3.3	52.2	0.1	0.0	0.1	13.5	0.1	0.7	86.6	74.1	0.3	0.7	0.1	2.2	4.8	0.7	108.9	0.3	83.4	0.1	206.0	109.9	267.1	125.6	130.8	123.3	114.0	144.4	140.7	95.5	103.2	141.1	146.5	237.7	96.3	151.9	41.4	231.1	333.1	9.0	18.4	1.8	8.9	8.3	7.8	17.0	3.9	11.4	15.8
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883161-41930150	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 61.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favourable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavourable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	15.5	8.4	10.7	40.1	16.5	50.0	13.8	8.7	13.8	11.7	14.1	23.3	9.7	13.7	12.7	9.6	12.2	13.0	14.1	9.3	10.6	6.2	12.4	10.4	23.7	57.8	18.1	8.5	12.5	10.8	7.0	11.8	9.6	11.8	11.4	5.8	12.1	13.1	9.2	5.2	12.9	29.3	9.0	12.2	61.0	17.0	3.7	15.6	43.6	13.4	8.6	40.8	12.4	11.7	11.1	10.8	13.7	26.9	15.4	26.3	14.3	19.9	24.3	5.6	7.0	8.0	8.4	6.6	10.6	16.2	13.4	11.8	7.4	17.3	26.8	19.5	9.6	11.8	7.2	16.4	4.2	25.1	8.3	21.6	10.5	9.7	11.7	23.1	35.7	10.1	10.9	13.0	8.5	12.8	8.5	16.5	7.7	13.8	16.1	17.9	6.4	18.9	24.4	10.5	15.8	8.2	11.0	3.7	15.7	14.8	6.6	12.1	7.7	39.5	17.2	17.9	12.0	9.5	16.3	22.5	14.3	23.2	14.6	36.7	28.2	5.1	9.4	13.7	25.1	19.8	20.3	10.8	19.1	26.3	10.8	11.1	20.0	20.4	13.7	15.4	26.9	5.8	19.4	14.3	10.7	16.5	8.7	13.8	10.6	6.2	18.1	8.5	11.8	15.6
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045370	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	11.9	13.0	17.5	11.6	13.4	4.3	12.3	28.8	22.4	12.3	13.2	9.2	22.0	14.4	14.7	11.9	13.1	12.2	14.3	13.2	13.6	16.0	10.9	7.6	12.7	8.0	13.9	13.7	15.6	11.0	31.7	15.4	12.3	13.1	11.4	12.9	14.5	9.3	25.1	14.7	11.2	23.3	15.2	9.1	9.8	11.9	20.9	9.9	1.0	14.9	5.3	6.3	13.2	12.6	0.4	0.9	3.3	2.8	0.0	1.0	0.7	6.9	13.7	11.8	8.9	15.7	8.1	13.4	6.9	10.3	10.8	7.9	9.2	7.4	0.9	12.1	12.0	7.5	8.0	7.2	6.0	9.9	4.9	3.4	8.2	6.0	9.1	6.9	12.3	12.5	7.9	9.9	7.7	7.7	5.6	0.6	7.2	9.0	1.7	3.8	14.6	8.4	0.2	5.8	3.8	5.3	11.4	2.2	13.5	14.8	12.0	12.5	10.7	15.9	11.6	11.1	7.1	9.7	7.1	10.0	6.1	0.6	7.0	0.9	36.7	0.0	1.4	0.0	0.0	2.8	0.0	0.4	0.6	0.0	0.9	0.0	0.6	1.0	3.3	0.0	1.5	0.0	0.3	0.7	17.5	13.4	28.8	22.4	13.6	16.0	13.9	13.7	13.1	9.9
ARHGEF15	"ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF"	ENSG00000198844	"Rho guanine nucleotide exchange factor 15"	O94989	17	8310241-8322516	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.3"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 22.9;TIME: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044443, HPA063495"			Supported	"Plasma membrane"				"Plasma membrane"		"HPA044443: AB_10960424, HPA063495: "	"unprognostic (3.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.82e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-3)"	47.3	3.6	1.5	4.6	2.6	0.3	24.7	0.9	2.8	9.6	5.7	2.0	3.3	3.1	19.9	4.9	5.0	5.9	7.5	18.5	3.8	1.4	9.7	4.2	19.4	3.0	2.2	1.5	6.8	2.8	4.2	3.0	14.1	3.1	8.7	2.1	10.7	3.4	5.1	15.0	4.9	4.1	7.0	1.7	6.9	4.4	2.7	1.1	0.6	8.7	8.4	2.9	9.4	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.6	0.9	2.8	3.8	1.4	2.2	1.5	3.1	1.1
ARHGEF18	"KIAA0521, MGC15913, P114-RhoGEF"	ENSG00000104880	"Rho/Rac guanine nucleotide exchange factor 18"	Q6ZSZ5	19	7395113-7472477	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042689, HPA071867"	Approved		Enhanced	Cytosol				Cytosol		"HPA042689: AB_10794385, HPA071867: "	"unprognostic (2.55e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.65e-2)"	"prognostic favourable (4.21e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.26e-2)"	"prognostic favourable (3.11e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.79e-3)"	8.7	13.3	12.3	16.7	15.0	18.3	7.1	13.2	22.2	9.9	19.3	19.9	10.4	19.0	16.1	7.4	15.6	10.6	12.7	5.4	10.9	8.8	15.8	10.9	12.2	20.6	14.6	12.9	9.3	23.0	16.2	13.3	11.5	11.8	11.3	8.1	12.5	13.1	12.2	7.7	11.8	27.8	8.7	10.4	31.2	17.4	10.6	14.0	4.6	10.7	8.5	13.0	12.6	12.9	8.9	3.3	8.6	4.2	1.7	5.9	3.5	21.8	12.5	6.4	9.3	5.3	5.6	20.9	10.0	7.6	13.4	13.9	17.0	10.7	21.8	20.8	6.4	16.2	6.3	19.2	3.5	28.5	11.2	10.6	9.1	10.2	14.5	11.8	13.0	6.6	13.9	13.2	8.6	6.3	9.5	9.6	10.9	7.7	12.7	13.7	10.4	20.6	17.1	11.0	7.6	5.5	22.5	6.2	9.6	11.0	10.3	12.5	11.5	11.5	15.0	11.5	12.8	17.3	12.2	23.6	17.4	13.4	10.6	10.0	9.8	8.6	1.9	8.3	4.1	3.4	5.9	4.2	5.5	5.9	2.1	8.9	5.0	5.1	4.2	1.7	4.2	3.3	4.0	3.5	12.3	15.0	13.2	22.2	10.9	8.8	14.6	12.9	11.8	14.0
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 9.8;U-251 MG: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: "	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favourable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	11.2	4.0	9.1	5.8	8.7	1.0	9.8	5.6	17.8	9.2	20.0	6.5	3.3	10.3	5.9	3.1	12.0	8.3	17.6	4.1	8.7	4.6	3.1	22.0	18.6	1.0	5.4	6.3	5.3	27.1	13.9	2.9	4.7	12.2	5.3	3.7	4.4	4.1	5.5	1.5	7.0	11.5	12.7	9.7	1.6	12.3	7.4	5.5	0.0	4.1	2.5	2.0	7.4	11.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	5.2	3.0	6.0	4.1	2.7	0.4	0.1	0.3	0.0	1.5	1.7	2.4	0.4	2.4	0.4	0.1	6.2	3.0	1.5	2.8	0.0	7.9	0.0	2.2	0.8	2.5	0.8	0.1	0.9	0.1	1.9	0.3	0.1	0.0	0.0	1.0	6.0	1.0	0.1	3.8	2.6	0.0	9.8	0.0	0.5	3.5	2.2	0.7	0.7	8.6	1.3	5.2	0.4	0.0	0.9	3.9	0.0	17.7	2.5	0.4	0.0	1.6	0.0	6.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.1	8.7	5.6	10.1	8.7	4.6	5.4	6.3	12.2	5.5
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889841-38975449	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 42.5"	"Group enriched"	"Detected in some"	4	"BEWO: 8.8;HeLa: 3.9;SiHa: 11.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 42.5"	"Cell type enriched"	"Detected in single"	8	"eosinophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Region enriched"	"Detected in single"	32	"cerebellum: 314.4"	"Region enriched"	"Detected in many"	11	"cerebellum: 47.0"	"HPA034661, HPA041051"	Enhanced		Supported	Vesicles				Vesicles		"HPA034661: AB_10669679, HPA041051: "	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.3	4.0	3.7	1.0	8.6	0.0	1.7	42.5	3.4	2.3	0.7	0.6	0.7	0.1	2.8	5.1	0.7	2.2	1.4	0.8	3.3	3.6	1.4	0.2	1.2	0.5	2.0	2.9	6.8	0.2	2.2	3.5	0.8	3.2	1.7	0.6	0.8	0.4	1.2	0.4	1.3	0.6	1.0	1.5	0.5	0.9	10.1	2.4	0.2	1.4	0.2	0.4	1.2	0.6	0.2	0.1	6.7	0.8	0.0	0.2	0.1	0.3	0.0	0.4	0.2	0.2	0.2	8.8	0.8	0.0	0.0	0.0	0.1	0.2	0.4	0.1	0.8	0.0	0.0	0.0	0.0	1.8	0.9	0.2	3.9	0.3	0.7	0.3	0.3	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.9	0.4	0.4	0.3	11.0	0.4	0.0	0.0	0.3	0.6	0.2	1.4	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.1	0.0	0.6	6.7	0.0	0.8	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	3.7	8.6	42.5	3.4	3.3	3.6	2.0	2.9	3.2	2.4
ARHGEF40	"FLJ10357, solo"	ENSG00000165801	"Rho guanine nucleotide exchange factor 40"	Q8TER5	14	21070270-21090240	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.4;ASC TERT1: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 2.8;neutrophil: 9.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030745, HPA030746, HPA030757"	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.95e-2)"	15.7	32.9	9.3	7.4	9.2	1.7	12.4	16.5	8.2	16.2	8.2	11.4	30.9	3.5	13.6	12.6	5.9	9.3	20.2	7.8	10.2	4.6	7.2	16.9	9.3	4.2	12.6	4.5	15.7	16.6	17.7	6.6	6.3	9.1	9.8	6.3	10.3	20.1	30.0	6.5	4.9	5.2	11.2	10.5	19.5	6.4	4.7	10.8	1.3	11.0	4.9	2.5	8.6	9.6	0.0	1.0	9.2	1.3	0.1	0.0	0.5	1.6	1.5	17.4	3.1	14.7	22.2	0.6	5.8	15.7	6.8	5.3	0.7	4.1	0.0	0.9	11.4	2.5	1.5	2.0	2.6	3.2	0.6	2.3	1.7	4.7	2.0	1.5	8.6	9.0	1.4	5.9	1.8	0.0	0.7	0.7	5.5	0.2	0.0	4.8	3.9	0.3	0.5	11.5	0.7	4.4	2.1	0.4	6.0	3.2	0.3	4.7	1.5	5.1	2.8	14.1	9.2	6.2	2.7	1.4	0.0	0.0	4.8	2.1	3.8	0.0	1.3	2.8	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.2	0.1	0.0	0.0	0.0	0.5	9.3	9.2	16.5	8.2	10.2	4.6	12.6	4.5	9.1	10.8
ARHGEF5	"GEF5, P60, TIM, TIM1"	ENSG00000050327	"Rho guanine nucleotide exchange factor 5"	Q12774	7	144355288-144380632	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 20.4;CAPAN-2: 13.9;hTCEpi: 15.3;WM-115: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"B-cells: 3.1;granulocytes: 1.1;T-cells: 4.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020980, HPA029504, HPA044188, HPA045619, HPA045699"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: , HPA045619: , HPA045699: "	"unprognostic (1.45e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.95e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (3.28e-7)"	"unprognostic (4.67e-2)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.76e-2)"	2.3	1.0	1.2	5.2	1.8	0.9	7.6	1.2	1.2	4.6	7.7	1.2	7.4	8.5	3.4	7.8	16.6	2.5	8.4	1.3	1.2	0.4	9.0	6.7	4.8	3.2	1.2	1.2	3.0	8.8	7.7	4.3	14.3	2.6	6.6	4.6	4.0	17.7	9.4	1.2	21.1	16.7	2.2	1.7	2.4	6.5	1.4	1.2	1.5	11.6	10.0	4.5	3.4	6.9	3.1	0.2	1.1	0.1	0.0	4.2	0.4	20.4	1.9	0.0	0.0	0.0	0.0	7.0	2.2	1.4	1.0	1.2	6.9	13.9	0.0	6.7	0.9	9.5	0.8	9.5	1.0	0.0	2.9	0.0	3.1	1.0	2.3	0.0	0.0	3.6	15.3	0.7	7.1	0.2	0.0	0.0	0.8	8.4	0.0	0.0	4.5	3.8	0.8	0.0	0.2	11.3	7.0	0.0	0.0	8.6	8.5	3.7	5.2	1.3	0.2	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	15.0	0.0	0.0	0.0	0.8	0.1	1.3	1.8	2.7	2.1	0.1	3.1	2.7	0.7	1.1	0.0	0.0	0.2	4.2	0.4	1.2	1.8	1.2	1.2	1.2	0.4	1.2	1.2	2.6	1.2
ARHGEF9	"KIAA0424, PEM-2"	ENSG00000131089	"Cdc42 guanine nucleotide exchange factor 9"	O43307	X	63634967-63809274	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035419, HPA055291"	Approved		Supported	Cytosol				Cytosol		"HPA035419: AB_10669859, HPA055291: "	"unprognostic (3.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.02e-5)"	"unprognostic (4.56e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.98e-2)"	5.7	9.6	22.6	4.5	42.6	3.2	6.9	19.5	38.2	6.0	8.2	7.1	1.2	10.9	6.2	4.2	7.7	5.4	6.0	22.0	24.6	22.4	6.8	4.1	4.3	4.6	12.5	28.3	10.4	4.8	11.8	8.3	4.4	17.4	8.2	8.7	9.9	4.5	7.0	3.9	7.0	8.1	8.4	8.5	4.9	6.9	2.2	9.9	2.1	6.1	0.8	5.4	7.3	3.2	5.4	3.7	1.8	3.6	11.5	8.5	2.8	4.5	7.0	11.0	7.0	5.0	6.8	0.9	8.3	6.9	7.7	6.7	0.5	4.9	9.6	6.1	5.1	0.1	4.9	10.1	7.5	13.1	5.0	8.1	3.1	0.4	2.5	4.1	3.5	8.3	4.5	3.8	12.6	5.1	1.1	15.8	7.5	6.5	8.3	2.3	7.6	8.1	12.6	22.6	9.5	4.8	4.1	0.2	3.1	3.9	7.5	4.2	5.3	4.8	2.6	5.1	5.2	24.1	3.5	5.4	4.1	7.5	6.1	7.4	3.6	1.0	2.8	1.8	8.5	3.6	5.6	3.5	4.6	4.9	3.7	5.4	5.6	5.2	1.6	11.5	2.4	2.9	4.1	2.8	22.6	42.6	19.5	37.2	24.6	22.4	12.5	28.3	17.4	9.9
ARID1A	"B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1"	ENSG00000117713	"AT-rich interaction domain 1A"	O14497	1	26693236-26782110	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005456, CAB016334"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016334: AB_673396, HPA005456: AB_1078205"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.54e-2)"	18.6	18.4	17.4	24.9	17.0	33.8	27.8	23.6	19.1	20.3	23.7	21.7	23.9	15.8	24.1	17.3	23.2	20.6	21.9	15.5	14.8	12.8	13.7	15.9	18.8	35.6	20.3	19.2	24.1	23.9	27.5	15.8	19.3	17.2	16.5	16.4	18.9	21.4	23.1	22.6	20.6	20.7	18.4	15.4	25.9	19.5	16.5	19.8	57.3	24.8	14.2	24.5	24.4	20.4	4.3	5.3	7.4	3.3	4.7	5.1	3.5	18.9	18.0	25.6	26.6	7.4	7.1	12.0	8.9	7.7	12.2	8.7	13.2	12.8	26.8	7.8	11.5	11.5	22.2	9.8	14.3	33.2	8.7	22.8	11.7	8.8	6.1	33.7	7.3	8.2	7.0	14.4	10.3	10.5	27.2	30.0	7.9	9.0	28.4	13.1	27.0	8.4	29.7	16.9	15.2	7.6	12.8	23.9	19.7	15.6	13.2	10.7	3.9	19.2	18.4	13.1	12.7	12.2	14.4	14.3	18.8	12.3	8.0	21.6	11.6	0.4	3.3	2.9	4.0	2.9	5.1	4.3	3.2	4.9	3.1	4.3	4.0	4.4	7.4	4.7	2.8	5.3	1.5	3.5	17.4	17.0	23.6	19.1	14.8	12.8	20.3	19.2	17.2	19.8
ARID1B	"6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R"	ENSG00000049618	"AT-rich interaction domain 1B"	Q8NFD5	6	156777374-157210779	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016511, HPA075291"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA016511: AB_1845008, HPA075291: "	"prognostic unfavourable (1.04e-4)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (4.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-1)"	18.3	15.0	20.2	18.8	20.9	25.8	19.3	42.1	32.8	20.0	17.4	26.3	21.7	15.3	23.0	14.2	18.6	20.7	15.9	16.8	20.4	11.3	14.2	10.6	17.0	18.3	19.4	16.7	30.2	18.5	47.4	29.2	12.2	17.7	17.7	13.3	24.0	20.0	20.2	30.6	27.3	17.8	21.7	14.9	21.1	15.0	10.7	24.6	24.0	23.8	13.3	26.3	23.5	21.0	9.5	11.9	5.6	3.0	2.7	5.6	1.6	7.0	10.9	16.1	21.9	13.2	12.2	11.0	7.5	9.9	9.8	9.8	9.6	10.3	22.4	4.7	12.8	9.0	13.7	12.3	9.7	22.5	9.7	16.2	11.0	11.4	9.3	13.5	11.9	13.8	9.9	14.9	13.3	13.6	19.0	17.5	7.0	8.3	15.6	15.2	8.1	5.8	35.6	6.9	12.1	6.7	13.2	14.8	18.9	15.1	15.9	8.8	10.7	21.2	13.9	12.4	13.2	11.4	14.7	12.1	10.8	28.7	10.8	16.2	16.6	5.6	3.0	2.5	5.4	2.4	5.0	6.8	4.7	3.8	2.3	9.5	4.0	5.6	5.5	2.7	2.6	11.9	4.6	1.6	20.2	20.9	42.1	32.8	20.4	11.3	19.4	16.7	17.7	24.6
ARID2	"BAF200, DKFZp686G052, FLJ30619, KIAA1557"	ENSG00000189079	"AT-rich interaction domain 2"	Q68CP9	12	45729665-45908040	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063044			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA063044: "	"unprognostic (8.41e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.15e-2)"	"prognostic favourable (5.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (9.71e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.53e-2)"	9.0	7.9	7.1	14.6	7.2	14.0	11.8	15.7	8.8	10.2	11.4	8.2	17.9	6.4	12.2	10.7	11.5	8.8	10.6	8.2	7.4	5.8	8.7	6.9	10.2	13.0	9.6	3.8	12.2	10.7	18.4	15.1	10.3	7.5	9.9	8.1	10.1	9.7	20.6	8.6	13.5	12.6	12.5	7.3	10.2	9.0	30.9	11.0	33.3	11.5	8.2	11.2	10.0	10.0	2.1	5.3	10.5	4.9	3.1	4.4	1.3	5.4	7.8	14.0	6.1	6.0	4.2	7.6	3.8	5.4	5.3	5.0	11.1	5.6	10.5	7.0	5.2	6.6	11.3	6.4	7.7	4.6	5.4	13.9	8.6	5.4	4.1	10.9	6.4	3.4	4.9	6.7	10.7	5.4	11.7	10.9	4.7	7.1	15.6	7.8	8.3	4.2	12.1	10.0	10.1	5.1	9.0	7.6	9.7	6.2	7.2	6.0	10.9	21.9	6.4	5.7	6.9	3.8	4.9	7.3	6.0	29.3	4.4	28.7	4.0	10.5	1.7	4.2	4.1	2.2	4.3	1.7	3.7	4.4	2.4	2.1	3.6	3.3	2.4	3.1	4.9	5.3	3.1	1.3	7.1	7.2	15.7	8.8	7.4	5.8	9.6	3.8	7.5	11.0
ARID3A	"BRIGHT, DRIL1"	ENSG00000116017	"AT-rich interaction domain 3A"	Q99856	19	925781-975934	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 38.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 62.8;CACO-2: 21.2;K-562: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004793, HPA076330"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA004793: AB_1847870, HPA076330: AB_2732309"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (1.95e-5)"	"unprognostic (4.00e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-2)"	4.0	2.3	1.7	6.2	2.3	11.5	4.4	4.8	3.8	3.6	5.0	1.6	3.3	4.2	2.9	2.9	4.1	2.7	3.2	2.1	2.2	1.5	4.4	2.6	6.1	7.8	2.8	2.0	1.6	5.5	3.4	4.1	38.3	2.1	2.3	1.8	2.6	2.8	5.6	2.0	3.3	5.0	2.6	2.4	8.3	3.4	17.8	2.5	6.6	2.1	2.1	4.6	4.0	6.9	1.5	9.2	6.4	2.9	1.9	0.5	0.8	1.1	1.4	5.2	1.3	2.2	1.6	62.8	4.9	3.2	2.6	1.8	21.2	0.1	0.4	1.1	1.6	0.4	2.1	1.1	1.1	6.5	1.5	2.1	1.8	19.0	0.9	7.2	5.4	2.4	1.6	1.6	0.4	0.9	27.3	6.1	0.7	1.6	2.8	8.3	5.0	0.3	6.3	1.6	4.0	0.3	1.0	2.5	4.8	1.5	1.3	0.9	2.2	19.5	1.4	1.7	2.4	2.5	0.5	14.3	12.7	3.7	1.1	4.3	1.2	0.8	2.4	1.6	0.5	2.1	0.5	1.5	0.3	0.4	1.5	0.9	0.5	0.2	6.4	1.9	2.9	9.2	0.3	0.8	1.7	2.3	4.8	3.8	2.2	1.5	2.8	2.0	2.1	2.5
ARID3B	"BDP, DRIL2"	ENSG00000179361	"AT-rich interaction domain 3B"	Q8IVW6	15	74541177-74598131	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.7;HAP1: 20.0;NTERA-2: 35.5;U-266/70: 21.6"	"Cancer enhanced"	"Detected in all"		"testis cancer: 10.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	7	"cerebellum: 67.3"	HPA050320	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA050320: "	"unprognostic (2.97e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.20e-1)"	2.5	2.0	2.5	5.8	2.4	21.1	2.4	8.0	4.0	3.2	5.2	2.6	5.2	4.4	2.7	2.1	5.5	2.4	8.4	3.9	2.0	2.8	3.1	3.6	6.7	11.0	2.0	0.2	1.5	5.7	1.8	8.3	17.5	3.6	4.3	4.1	9.1	5.6	6.9	6.1	2.7	6.4	1.8	2.5	9.2	7.0	19.5	2.1	7.2	3.7	1.8	10.4	3.2	8.2	3.7	2.1	14.4	2.2	4.3	6.0	3.2	2.9	1.2	16.6	3.6	0.6	0.3	17.8	0.7	0.8	1.0	1.1	19.7	1.4	0.3	0.8	0.7	3.6	20.0	2.7	0.9	18.5	4.6	11.5	2.0	5.3	0.4	1.8	7.5	0.4	1.2	1.7	1.7	1.7	10.0	6.8	0.2	0.7	4.9	6.1	35.5	1.0	2.2	0.6	4.7	0.9	3.1	4.2	7.5	0.9	1.8	3.5	2.3	3.3	1.1	1.4	1.7	1.1	2.2	21.6	13.6	2.1	0.7	2.8	0.5	2.8	2.0	7.5	6.0	1.7	3.5	3.7	3.5	4.4	1.5	1.8	2.7	3.4	14.4	4.3	2.2	2.1	4.8	3.2	2.5	2.4	8.0	4.0	2.0	2.8	2.0	0.2	3.6	2.1
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298385-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favourable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favourable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	15.1	8.5	17.3	15.1	22.2	34.5	13.4	45.9	27.0	12.8	12.0	7.9	12.7	10.2	11.6	9.7	10.1	10.7	10.7	10.0	13.3	11.5	11.3	21.7	12.0	15.8	9.6	18.7	15.3	11.4	17.2	22.9	11.3	17.3	10.8	10.6	6.4	10.8	13.5	10.6	13.2	12.3	12.5	11.0	15.3	10.2	7.9	15.0	15.0	12.6	4.5	12.8	13.8	11.9	15.1	7.5	42.7	14.1	10.7	11.1	3.6	6.6	5.6	15.7	7.7	7.8	9.5	7.9	7.9	6.8	5.4	8.6	6.5	10.5	16.0	8.5	6.6	7.7	6.9	3.8	8.0	11.2	4.4	7.2	6.3	6.3	4.7	15.2	10.5	7.1	4.2	5.2	5.4	8.5	8.2	13.2	5.7	8.9	11.0	13.7	3.1	6.8	11.3	13.5	4.7	5.8	11.8	13.5	11.7	13.4	6.8	9.4	11.6	14.0	12.1	9.2	7.2	7.4	3.6	4.3	3.2	14.7	5.5	9.7	4.6	19.3	7.6	21.7	8.5	7.8	9.5	11.6	10.3	8.8	5.6	15.1	11.1	10.8	42.7	10.7	14.1	7.5	7.2	3.6	17.3	22.2	45.9	27.0	13.3	11.5	9.6	18.7	17.3	15.0
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552638	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 71.4;RPMI-8226: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favourable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	20.1	4.1	6.8	24.5	8.7	14.6	26.2	3.1	8.8	10.5	14.6	4.9	4.1	7.2	17.5	16.1	9.1	11.5	16.8	17.8	7.0	5.5	5.4	7.2	26.0	29.0	10.7	3.1	11.4	9.8	3.8	6.6	13.0	17.4	14.7	3.7	11.4	8.2	5.1	26.1	7.3	12.3	33.1	13.6	14.9	10.1	5.4	6.2	12.4	8.2	7.7	15.7	19.5	12.0	5.2	12.8	21.4	5.3	17.7	11.5	8.8	0.8	0.3	0.4	1.4	0.8	0.9	2.1	1.4	4.8	1.7	1.5	0.8	0.2	0.2	0.9	0.8	1.2	0.3	0.0	0.5	71.4	1.1	1.7	0.3	1.6	0.9	1.2	1.3	0.6	1.6	1.3	0.2	1.5	1.4	10.8	0.6	0.7	2.3	4.2	0.9	0.0	3.2	3.0	31.5	0.2	0.6	0.6	0.2	0.1	0.1	1.1	0.0	2.6	1.3	1.5	1.8	1.6	1.2	6.7	5.2	0.8	0.8	2.9	1.3	7.2	5.3	21.4	11.5	4.8	11.1	4.4	9.7	10.7	7.1	5.2	10.8	10.5	15.3	17.7	3.3	12.8	11.0	8.8	6.8	8.7	3.1	8.8	7.0	5.5	10.7	3.1	17.4	6.2
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA067381: , HPA069715: , HPA070963: "	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favourable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	15.0	16.2	14.1	12.8	20.6	16.0	19.2	22.7	22.5	14.1	18.6	25.4	13.9	10.0	18.7	29.2	14.9	16.2	12.8	38.5	15.8	14.9	14.3	17.2	14.5	17.8	24.7	18.3	18.3	20.5	23.1	19.8	15.3	19.7	16.5	15.5	19.2	13.2	19.5	71.3	11.4	14.4	23.0	18.8	17.5	15.7	27.5	21.4	17.7	18.7	15.2	17.2	16.4	14.1	20.6	21.7	27.6	24.5	15.8	32.6	25.3	14.2	14.4	13.9	19.6	20.6	11.3	18.8	16.8	19.6	21.0	23.3	15.0	12.7	29.1	7.9	17.9	8.6	28.5	17.1	25.8	19.5	17.3	29.9	19.0	12.3	18.6	22.1	14.4	12.1	25.9	26.2	35.6	15.7	23.6	20.0	18.6	9.8	22.3	9.1	23.6	21.8	8.3	15.9	24.2	12.3	19.2	6.1	16.4	16.5	20.7	16.1	10.5	15.7	15.0	12.8	18.5	19.1	26.3	26.1	50.3	36.8	14.0	18.5	16.0	27.6	24.5	26.2	32.6	21.6	22.1	19.5	20.9	26.7	21.7	20.6	21.6	27.8	17.2	15.8	13.5	18.7	22.9	25.3	14.1	20.6	22.7	22.5	15.8	14.9	24.7	18.3	19.7	21.4
ARL1	ARFL1	ENSG00000120805	"ADP ribosylation factor like GTPase 1"	P40616	12	101393120-101407820	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062656, HPA073012"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA062656: , HPA073012: "	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (6.41e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.46e-2)"	23.4	46.2	24.7	19.6	33.7	7.4	33.1	20.1	34.2	48.9	28.8	18.3	44.4	24.5	28.7	39.1	36.2	27.0	24.0	37.0	23.4	29.4	40.7	44.5	22.5	16.4	25.4	28.3	35.9	34.0	41.7	57.8	35.4	39.7	39.9	32.4	22.6	43.3	47.3	35.0	18.0	25.7	31.4	24.3	18.3	29.2	18.1	16.7	15.0	45.0	24.3	24.2	35.2	27.6	19.1	24.9	23.7	19.9	13.6	21.0	14.5	17.6	17.0	16.7	14.5	47.2	47.5	22.2	36.1	43.7	24.5	23.7	19.7	13.1	16.0	22.2	41.8	12.3	18.9	24.7	28.3	12.8	14.5	15.1	9.5	30.2	35.2	17.2	11.5	28.5	22.0	24.4	39.2	26.2	19.9	9.3	31.9	20.7	14.2	17.2	16.0	23.3	11.1	16.8	18.2	37.0	35.6	11.1	7.3	17.4	22.8	27.6	38.5	12.0	19.6	18.7	10.7	25.2	15.4	15.8	15.7	16.1	26.9	13.1	20.1	23.7	16.1	11.0	14.1	18.3	21.0	19.1	16.6	18.4	20.5	18.1	17.1	13.3	1.5	13.6	19.9	24.9	20.7	14.5	24.7	33.7	20.1	34.2	23.4	29.4	25.4	28.3	39.7	16.7
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323051-30338227	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"				"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: , HPA048127: AB_2680277"	"prognostic favourable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favourable (7.49e-4)"	13.9	21.5	24.5	12.9	29.1	6.3	18.7	22.7	23.4	17.0	14.5	8.0	22.4	8.7	18.1	22.7	11.1	15.8	12.4	20.5	17.7	15.5	16.5	17.6	10.3	23.5	15.5	20.5	20.1	15.0	33.4	28.6	10.6	15.1	19.0	10.3	9.0	17.0	19.9	28.0	11.6	12.5	18.3	16.0	18.2	14.4	14.5	15.0	11.6	23.3	13.9	19.1	16.1	15.1	17.6	12.7	5.5	9.6	24.4	28.7	11.2	5.7	8.3	9.3	8.2	15.3	16.6	4.7	11.2	14.2	10.2	11.3	4.6	2.2	23.4	7.7	8.1	9.7	13.5	9.5	14.5	18.5	16.8	7.0	6.6	8.0	24.1	12.6	8.1	17.2	19.2	4.8	18.3	11.2	11.1	12.8	17.8	5.4	11.3	10.4	10.8	11.6	10.0	22.8	9.5	13.7	8.0	10.6	11.3	8.8	11.7	13.8	12.5	7.1	9.8	11.7	6.2	23.0	10.6	20.0	11.3	15.2	11.2	7.9	11.1	5.5	9.6	3.0	12.1	9.4	28.7	17.6	14.8	13.4	12.7	14.0	13.7	13.1	1.7	24.4	7.0	9.1	9.5	11.2	24.5	29.1	22.7	23.4	17.7	15.5	15.5	20.5	15.1	15.0
ARL3	ARFL3	ENSG00000138175	"ADP ribosylation factor like GTPase 3"	P36405	10	102673731-102714407	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036292, HPA063596"	Approved		Supported	Nucleoplasm,Centrosome			17000	Centrosome	Nucleoplasm	"HPA036292: AB_10673618, HPA063596: "	"unprognostic (1.36e-1)"	"unprognostic (2.89e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.99e-3)"	"unprognostic (5.58e-2)"	"prognostic favourable (1.71e-6)"	"unprognostic (5.62e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-1)"	8.8	13.8	24.8	6.6	29.4	2.9	11.4	24.1	32.9	14.1	8.9	9.6	8.2	6.8	17.1	16.7	10.2	23.0	8.3	29.9	19.9	21.4	22.7	8.1	9.6	5.5	20.2	16.0	25.2	9.9	18.9	21.0	7.7	17.6	12.1	7.7	21.5	8.8	14.5	7.9	7.9	6.4	13.4	14.2	5.3	9.0	13.6	9.3	4.1	17.3	5.5	7.2	16.0	13.8	5.0	7.8	14.9	8.1	4.5	11.1	5.8	8.5	14.8	20.4	14.9	9.5	14.2	3.6	6.8	10.4	8.3	9.1	5.1	4.4	3.6	6.6	11.0	6.4	7.7	9.1	10.4	9.3	8.0	5.8	10.6	4.8	10.3	2.7	5.8	7.2	7.7	11.5	6.8	9.5	2.6	3.6	13.8	8.8	5.4	4.3	7.8	5.9	4.6	15.1	3.1	11.0	4.6	7.2	15.7	5.2	1.1	8.0	27.2	2.7	5.4	5.7	8.0	11.5	9.3	2.6	5.1	6.6	15.0	8.0	4.9	2.3	8.1	2.7	4.5	6.5	11.1	5.0	7.8	6.5	7.8	3.5	4.8	5.7	14.9	4.5	5.5	5.7	5.2	5.8	24.8	29.4	24.1	25.6	19.9	21.4	20.2	16.0	17.6	9.3
ARL4A	ARL4	ENSG00000122644	"ADP ribosylation factor like GTPase 4A"	P40617	7	12686856-12690934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.3;K-562: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA064513			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA064513: "	"unprognostic (8.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.94e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.42e-3)"	"unprognostic (9.49e-3)"	22.6	3.6	12.3	6.7	6.7	30.8	21.5	3.0	15.8	16.9	19.4	3.2	7.4	11.3	13.6	9.9	23.5	11.0	7.5	7.0	6.0	4.6	5.2	6.6	8.6	9.5	10.3	11.0	5.2	3.5	1.8	5.6	19.2	8.5	12.0	13.7	4.0	39.0	6.8	4.2	34.9	44.6	12.8	6.5	9.5	10.3	71.2	6.7	3.7	8.8	9.2	6.5	10.5	25.0	22.8	7.4	3.3	15.4	6.5	17.6	7.3	10.0	10.7	28.7	61.3	4.6	7.7	0.0	4.1	3.8	6.8	4.1	9.5	7.6	0.0	1.8	5.8	2.9	6.3	5.2	6.9	2.2	4.7	2.1	14.1	8.8	9.6	8.8	3.7	3.4	20.9	3.9	17.7	16.1	72.8	9.9	6.9	4.3	0.4	12.5	10.4	12.4	0.0	10.0	4.7	8.9	4.9	5.2	4.9	6.8	7.2	1.4	3.5	7.3	5.6	2.7	9.6	10.2	16.6	4.5	5.9	2.3	7.1	3.7	10.8	3.3	7.8	0.3	6.3	13.0	17.6	21.4	15.0	9.7	7.4	22.8	7.4	6.1	1.1	6.5	15.4	6.6	8.9	7.3	12.3	6.7	3.0	15.8	6.0	4.6	10.3	11.0	8.5	6.7
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497053	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 74.3;U-2197: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavourable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (6.99e-5)"	9.3	6.8	11.1	17.7	9.6	30.3	12.8	19.2	21.2	6.4	6.2	4.9	3.1	3.9	3.6	9.4	13.9	7.6	19.2	3.6	9.1	16.5	8.5	7.9	9.9	28.9	9.4	11.8	2.6	3.6	0.8	5.4	16.8	23.9	6.7	7.4	5.9	14.2	3.6	1.7	15.1	8.1	3.6	5.3	28.0	7.9	1.9	1.8	44.7	2.5	4.4	20.1	14.0	10.8	5.9	17.8	18.7	0.5	18.2	29.7	8.7	7.4	23.0	3.0	0.3	2.7	0.8	7.6	0.7	3.4	0.9	1.7	10.6	14.6	0.0	1.9	1.9	5.6	3.0	15.9	1.1	6.9	1.0	0.0	0.1	0.1	2.8	0.0	0.6	1.7	10.6	9.0	5.5	1.5	0.1	24.7	4.2	1.0	21.4	0.0	3.0	5.2	0.0	13.2	4.2	74.3	8.3	10.8	1.9	0.2	1.7	1.1	0.2	0.4	3.4	14.9	5.7	40.7	14.3	12.3	4.4	0.3	25.5	0.0	7.7	18.7	0.4	8.4	29.7	0.5	29.2	5.9	20.7	23.5	3.2	5.7	18.7	20.9	0.7	18.2	0.2	17.8	25.8	8.7	11.1	9.6	19.2	21.2	9.1	16.5	9.4	11.8	23.9	1.8
ARMC1	"Arcp, FLJ10511"	ENSG00000104442	"Armadillo repeat containing 1"	Q9NVT9	8	65602456-65634217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026085	Approved		Supported	Mitochondria				Mitochondria		"HPA026085: AB_1845031"	"prognostic unfavourable (4.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (8.18e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavourable (9.15e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.66e-1)"	16.2	16.5	25.5	13.1	25.6	11.5	19.2	30.4	32.3	17.1	19.0	22.6	10.2	15.8	19.7	17.8	17.7	14.1	12.3	21.6	26.9	24.0	22.9	23.5	12.6	18.1	24.5	18.7	20.4	15.2	18.4	18.9	16.7	27.1	19.2	17.6	13.1	15.1	18.8	22.2	11.6	15.3	22.5	27.5	15.0	14.5	10.0	18.9	20.7	15.4	10.4	20.0	20.4	14.0	8.8	6.1	20.7	7.9	9.6	10.5	5.8	22.6	16.2	15.8	14.7	15.7	14.4	11.5	20.4	15.2	21.7	16.1	11.9	18.4	35.3	5.2	18.4	15.2	28.3	16.4	29.5	20.0	14.7	27.3	10.3	17.3	21.0	10.3	14.9	13.1	19.0	17.8	24.6	22.2	28.2	25.2	23.2	14.5	37.9	13.6	16.4	18.0	22.1	19.7	12.4	17.2	10.7	11.8	12.8	12.9	16.3	19.2	26.2	12.1	13.1	20.6	15.1	15.6	19.0	18.7	19.7	23.9	19.4	19.2	19.9	20.7	4.8	6.1	7.6	7.9	10.5	8.8	9.1	9.1	6.1	6.8	9.4	9.3	0.6	9.6	7.2	5.3	9.5	5.8	25.5	25.6	30.4	32.3	26.9	24.0	24.5	18.7	27.1	18.9
ARMC10	"MGC3195, SVH"	ENSG00000170632	"Armadillo repeat containing 10"	Q8N2F6	7	103074881-103099764	"Predicted intracellular proteins, Predicted membrane proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011036, HPA011057"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA011036: AB_1080139, HPA011057: AB_1080137"	"unprognostic (7.03e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (8.90e-6)"	"unprognostic (3.85e-3)"	"prognostic unfavourable (3.58e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.90e-2)"	"prognostic unfavourable (2.49e-6)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.67e-2)"	21.6	21.7	28.0	12.6	25.0	9.1	24.5	11.4	28.0	24.4	18.6	24.7	20.8	14.0	20.4	24.2	22.2	23.2	20.0	16.7	26.2	26.2	27.4	30.2	15.0	15.7	26.3	24.2	26.5	28.7	26.0	12.0	15.4	19.7	22.2	18.8	17.6	15.7	23.4	15.8	21.6	12.8	20.3	25.5	14.4	19.8	14.1	19.6	21.5	30.7	15.6	15.7	22.3	20.5	5.1	6.8	6.6	5.4	3.9	4.7	2.2	12.5	10.7	6.4	12.3	13.3	12.7	6.4	8.8	9.6	6.4	7.8	5.8	14.9	22.6	19.1	7.7	11.3	8.9	9.8	9.1	8.4	10.2	8.0	4.6	2.7	13.4	21.8	9.6	8.2	17.4	8.0	13.2	14.5	19.4	14.0	11.3	23.2	16.0	16.9	14.2	11.6	9.7	6.6	29.3	16.1	8.8	7.2	9.8	12.0	18.2	13.3	7.3	10.9	9.6	9.9	9.5	23.2	13.2	21.5	33.7	18.2	11.2	20.4	12.4	0.0	4.4	6.6	2.6	5.4	4.5	4.0	4.1	4.4	6.8	5.1	4.6	4.7	0.9	3.9	2.8	5.3	4.2	2.2	28.0	25.0	11.4	28.0	26.2	26.2	26.3	24.2	19.7	19.6
ARMC6	MGC19595	ENSG00000105676	"Armadillo repeat containing 6"	Q6NXE6	19	19033575-19060311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041420, HPA041681"	Supported		Enhanced	Cytosol				Cytosol		"HPA041420: , HPA041681: AB_10793928"	"unprognostic (2.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.40e-1)"	9.8	10.1	10.3	9.6	11.3	12.9	10.6	13.0	20.1	8.5	10.2	10.2	5.7	8.9	9.5	10.0	10.9	9.2	9.5	11.4	10.7	12.0	10.4	54.4	8.0	12.6	10.1	11.4	10.1	6.7	9.2	11.2	10.3	12.6	10.9	8.2	11.0	12.2	8.1	14.8	9.4	7.9	8.4	8.7	11.1	8.3	17.1	7.2	21.4	16.1	12.3	10.7	8.4	7.5	10.3	19.8	6.3	13.9	20.7	16.4	11.8	21.5	14.7	10.8	13.3	5.2	9.0	14.0	14.0	8.2	23.0	17.1	20.6	19.5	32.8	22.8	11.7	11.0	25.8	16.5	12.7	6.9	36.2	16.5	13.9	16.5	11.6	29.5	19.3	11.3	15.9	15.6	11.0	14.5	28.7	12.7	12.5	26.4	31.0	23.8	25.1	30.4	25.8	9.8	23.4	11.2	14.6	25.0	10.8	11.2	14.4	11.4	12.3	18.5	9.4	11.8	10.3	16.7	28.5	9.8	17.3	31.5	9.8	40.0	15.3	6.3	13.3	3.5	16.4	13.9	12.3	10.2	9.2	14.2	19.8	10.3	12.0	13.5	2.8	20.7	10.8	12.7	15.9	11.8	10.3	11.3	13.0	20.1	10.7	12.0	10.1	11.4	12.6	7.2
ARMC7	FLJ22160	ENSG00000125449	"Armadillo repeat containing 7"	Q9H6L4	17	75109952-75130265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024229, HPA053076"	Uncertain		Supported	Cytosol				Cytosol		"HPA024229: AB_2059152, HPA053076: "	"unprognostic (1.35e-1)"	"prognostic favourable (2.98e-4)"	"unprognostic (7.73e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.86e-2)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.98e-2)"	7.5	7.5	11.1	14.1	9.8	6.1	12.0	26.6	13.8	7.8	13.5	7.6	8.8	15.3	7.9	8.1	11.2	8.4	10.1	9.8	10.5	7.9	31.6	13.3	15.8	19.5	7.8	7.4	6.3	8.9	11.2	7.9	9.2	9.5	11.9	11.3	8.9	11.4	12.3	7.2	12.6	13.7	8.5	6.9	15.0	15.5	9.8	8.4	14.8	14.9	5.9	13.4	9.6	11.1	11.9	10.5	22.1	11.3	11.6	16.6	9.1	10.0	20.1	6.1	5.6	5.1	2.9	6.6	5.7	6.1	10.8	9.8	16.4	9.7	5.9	7.4	5.1	8.2	9.8	4.0	5.2	5.8	15.9	11.3	8.9	10.1	10.8	8.5	10.9	3.9	7.6	6.8	4.1	9.8	10.3	11.8	3.6	14.0	16.3	9.5	3.0	15.3	9.5	12.3	10.9	24.0	17.8	5.6	8.4	10.4	10.6	11.9	12.3	8.4	7.7	11.0	10.4	4.6	8.6	10.1	3.6	8.5	4.9	6.3	7.9	20.5	11.3	22.1	15.8	8.0	13.7	11.9	11.4	13.2	10.5	9.5	8.8	13.2	15.4	11.6	6.1	9.0	16.6	9.1	11.1	9.8	26.6	13.8	10.5	7.9	7.8	7.4	9.5	8.4
ARMCX6	"FLJ20811, GASP10"	ENSG00000198960	"Armadillo repeat containing, X-linked 6"	Q7L4S7	X	101615118-101618001	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043030, HPA048125"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane"	"HPA043030: , HPA048125: "	"unprognostic (1.20e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.38e-2)"	15.1	17.2	11.7	12.1	12.1	7.6	12.7	10.9	12.1	18.7	12.0	15.4	22.6	6.7	17.3	25.9	17.3	14.1	12.4	15.6	11.3	12.6	14.1	12.2	11.2	12.1	13.1	10.3	21.3	27.2	23.4	21.0	16.3	13.1	17.7	9.0	11.8	39.2	23.5	6.5	11.3	10.4	17.1	16.7	22.6	10.6	9.0	11.4	17.9	17.3	9.7	19.3	18.8	13.7	12.8	14.1	10.0	7.0	8.1	8.7	6.4	6.6	7.8	12.3	7.0	25.2	15.0	2.4	13.9	13.6	12.5	24.5	4.7	6.4	7.1	14.3	13.0	6.9	11.9	5.6	9.8	6.1	7.3	6.6	10.9	6.2	11.6	6.4	8.4	9.3	5.8	7.7	4.0	12.7	5.4	9.1	18.7	16.3	9.4	0.0	8.8	1.6	9.7	16.5	2.6	9.0	0.9	6.8	6.4	8.2	0.0	10.4	5.7	3.1	9.8	15.3	6.9	21.2	3.2	11.3	6.0	0.0	4.5	1.7	5.0	10.0	3.8	6.3	6.5	7.0	8.7	12.8	7.0	7.3	8.1	9.1	8.4	7.8	0.5	8.1	5.0	14.1	3.9	6.4	11.7	12.1	10.9	12.1	11.3	12.6	13.1	10.3	13.1	11.4
ARNT	"bHLHe2, HIF-1beta"	ENSG00000143437	"Aryl hydrocarbon receptor nuclear translocator"	P27540	1	150809705-150876768	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"U-698: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001759, CAB004318"	Supported		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB004318: AB_626698, HPA001759: AB_1078213"	"unprognostic (1.81e-1)"	"unprognostic (8.14e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.27e-3)"	"unprognostic (5.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.67e-1)"	"unprognostic (6.45e-2)"	"unprognostic (6.92e-2)"	23.5	20.8	12.1	14.5	12.6	11.3	25.1	25.4	14.4	28.0	17.2	18.7	12.8	10.9	26.1	14.4	16.6	20.4	17.9	20.0	10.2	8.2	14.4	32.2	21.6	12.0	11.6	9.5	31.8	22.4	16.5	22.9	31.7	12.3	18.2	16.4	28.3	15.2	16.3	25.5	21.9	15.2	22.6	14.0	19.2	16.5	14.9	12.3	18.8	16.1	13.9	18.0	23.0	24.4	6.6	12.7	23.9	15.6	8.0	8.8	9.7	4.0	4.1	6.2	4.7	13.4	12.9	8.4	4.5	9.0	6.2	5.7	3.5	4.1	4.2	4.1	8.1	4.6	5.6	5.1	5.4	6.7	3.4	5.0	7.0	4.1	7.7	6.0	5.9	10.0	4.8	7.5	6.7	7.6	6.5	8.5	6.4	7.8	4.8	3.3	5.1	3.2	6.0	7.5	6.0	4.9	4.1	4.1	6.1	8.8	6.0	3.5	7.7	13.1	5.4	5.2	4.6	4.1	3.9	9.7	7.0	94.7	6.3	0.2	3.5	23.9	15.6	13.9	8.8	14.7	7.9	6.2	7.2	8.4	12.7	6.6	7.0	7.1	8.1	8.0	14.7	5.2	7.2	9.7	12.1	12.6	25.4	14.4	10.2	8.2	11.6	9.5	12.3	12.3
ARNT2	"bHLHe1, KIAA0307"	ENSG00000172379	"Aryl hydrocarbon receptor nuclear translocator 2"	Q9HBZ2	15	80404350-80597937	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 73.2"	"Cell line enhanced"	"Detected in many"		"AF22: 16.0;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;LHCN-M2: 14.5;SK-MEL-30: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001056, CAB005081"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB005081: AB_2243005, HPA001056: AB_1845042"	"unprognostic (2.04e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.00e-1)"	"prognostic favourable (1.46e-6)"	"unprognostic (2.20e-1)"	"prognostic favourable (7.51e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.62e-2)"	1.4	2.3	30.6	2.3	35.5	1.0	1.8	9.1	73.2	4.2	2.4	14.3	0.0	2.0	5.3	7.2	2.3	4.9	2.7	3.7	32.8	17.4	11.5	1.0	4.4	2.3	19.2	23.4	9.3	3.2	4.2	3.6	1.7	11.9	5.1	2.4	2.0	1.5	4.8	7.0	2.3	2.5	3.7	13.2	3.2	3.9	8.0	12.7	0.0	6.0	0.0	2.9	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	16.0	0.0	0.1	2.1	0.0	6.8	9.6	7.9	16.2	0.0	0.0	0.0	1.7	8.0	0.2	5.8	0.3	10.1	0.0	1.6	0.3	0.0	0.5	0.5	0.0	4.1	7.6	0.3	3.5	0.1	0.0	0.0	0.1	14.5	7.5	0.0	0.0	3.2	0.1	0.0	0.2	0.0	3.4	11.3	8.5	11.7	0.8	0.1	17.3	0.3	0.0	0.0	12.6	2.5	0.3	8.0	0.0	0.0	0.0	4.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	35.5	9.1	36.0	32.8	17.4	19.2	23.4	11.9	12.7
ARNTL	"bHLHe5, BMAL1, JAP3, MOP3, PASD3"	ENSG00000133794	"Aryl hydrocarbon receptor nuclear translocator like"	O00327	11	13276652-13387266	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045962, HPA050938"	Supported		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"			Nucleoplasm	Vesicles	"CAB045962: AB_11124144, HPA050938: "	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.08e-2)"	12.3	28.5	13.4	10.3	13.3	13.4	18.2	24.4	25.2	16.4	10.3	5.7	10.6	11.8	10.4	6.5	9.3	9.7	9.4	8.1	11.5	7.5	11.1	17.3	12.1	15.0	6.7	13.1	21.1	9.8	6.1	17.8	9.2	9.3	7.5	8.9	8.6	11.2	8.2	19.2	27.2	10.9	11.7	9.6	10.4	9.6	16.2	9.3	29.2	17.6	0.7	12.2	8.1	17.0	2.8	6.1	20.0	7.8	9.8	19.7	7.3	6.8	6.6	6.1	4.1	11.8	7.6	4.8	6.9	7.4	6.8	8.0	3.3	10.0	0.1	2.2	5.2	2.6	4.8	8.2	5.9	11.7	5.0	3.1	5.4	1.7	21.1	1.4	13.0	9.4	21.7	2.5	18.2	4.8	1.8	12.2	6.8	3.7	3.2	0.7	1.7	3.6	4.2	7.7	3.3	6.6	1.6	1.3	11.9	5.7	2.0	6.6	4.4	5.8	9.3	7.1	5.5	16.7	3.9	3.5	9.4	0.0	7.0	3.6	6.1	4.4	6.7	13.7	14.3	6.9	19.7	2.4	13.4	12.9	6.1	2.8	7.8	9.1	20.0	9.8	7.8	1.1	8.5	7.3	13.4	13.3	24.4	25.2	11.5	7.5	6.7	13.1	9.3	9.3
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;U-2197: 47.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059074: "	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.5	1.3	5.7	9.8	5.9	2.2	3.3	3.6	10.6	6.8	3.1	1.1	0.0	2.9	1.5	0.5	30.0	1.5	3.9	1.9	9.1	2.8	1.6	10.3	2.7	5.0	2.1	6.8	0.9	2.3	2.4	1.5	14.7	2.6	1.9	3.5	0.0	9.2	0.9	1.0	7.7	2.8	4.7	2.0	1.2	10.9	2.8	1.3	3.8	1.2	15.4	21.1	5.9	12.5	0.6	1.4	4.5	0.5	0.5	1.5	0.2	21.5	5.5	1.2	0.4	1.1	3.3	17.4	7.6	10.1	5.0	7.9	5.2	16.8	0.1	4.3	3.6	8.9	3.6	26.8	12.8	34.6	4.6	4.1	3.6	4.3	1.4	8.3	1.8	1.2	2.4	17.5	13.7	23.5	2.1	8.8	5.7	2.6	4.5	4.6	9.5	19.4	8.5	20.3	1.3	4.2	12.4	4.0	0.6	3.9	0.6	0.1	0.8	2.7	15.9	16.3	9.4	47.3	31.6	1.3	2.3	0.0	14.0	6.8	3.2	4.5	0.5	0.5	0.2	0.3	0.2	0.5	0.2	0.2	1.4	0.6	0.2	0.3	2.4	0.5	0.2	0.3	1.5	0.2	5.7	5.9	3.6	10.6	9.1	2.8	2.1	6.8	2.6	1.3
ARPC1B	"ARC41, p40-ARC, p41-ARC"	ENSG00000130429	"Actin related protein 2/3 complex subunit 1B"	O15143	7	99374249-99394814	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 213.6"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004832	Approved		Supported	Vesicles,Cytosol			53000000	"Vesicles, Cytosol"		"HPA004832: AB_1845044"	"unprognostic (5.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (2.57e-4)"	"unprognostic (4.37e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.27e-2)"	31.8	17.8	8.7	50.7	14.4	56.4	35.4	1.9	7.7	17.9	30.7	8.4	18.1	32.6	17.4	21.8	16.0	18.3	23.4	24.4	5.7	7.0	27.9	34.8	40.0	92.8	10.7	3.7	11.6	13.0	3.8	13.1	36.2	9.4	15.6	10.5	20.6	18.3	15.1	10.6	10.0	42.3	12.1	10.2	81.8	16.3	10.8	9.3	31.0	23.0	13.7	37.2	19.0	21.1	53.5	133.7	127.2	154.4	38.9	83.4	213.6	15.7	28.6	2.2	6.2	8.3	30.2	21.9	21.9	22.1	8.8	7.8	18.6	61.4	27.3	41.0	23.8	11.9	2.8	19.3	3.6	22.2	10.3	19.9	8.3	12.8	24.0	19.9	67.8	16.8	10.0	12.4	12.4	23.2	22.1	66.0	12.8	72.7	22.0	43.6	7.8	62.4	17.8	1.9	67.0	18.2	7.8	1.8	5.8	14.9	65.8	110.1	15.5	40.6	34.0	25.2	20.9	44.4	27.5	12.3	24.4	33.5	25.1	52.0	45.1	53.7	153.2	121.6	53.8	154.4	50.2	53.5	62.8	59.6	133.7	42.8	37.0	49.3	127.2	38.9	142.0	77.9	83.4	213.6	8.7	14.4	1.9	7.7	5.7	7.0	10.7	3.7	9.4	9.3
ARPC2	"ARC34, p34-Arc"	ENSG00000163466	"Actin related protein 2/3 complex subunit 2"	O15144	2	218217094-218254356	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001994, HPA008352"	Approved		Supported	"Golgi apparatus,Cytosol"			24000000	Cytosol	"Golgi apparatus"	"CAB001994: , HPA008352: AB_1854887"	"unprognostic (7.42e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavourable (1.07e-7)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.41e-2)"	46.9	28.8	32.6	78.6	37.9	79.5	67.1	19.3	31.4	34.1	42.5	19.9	26.3	34.0	37.2	35.8	103.4	30.2	51.2	52.3	40.7	25.0	38.2	35.1	71.8	118.3	26.4	27.8	30.7	31.2	18.9	23.0	67.1	26.8	35.6	48.6	23.7	39.0	32.7	60.1	56.2	59.2	69.1	23.9	73.7	43.8	36.5	22.3	59.0	27.2	72.7	102.5	58.5	49.7	60.6	101.2	167.7	145.0	50.0	76.2	149.4	46.7	20.5	29.5	21.9	39.6	53.3	54.9	73.1	70.6	61.8	62.2	63.5	49.8	38.2	39.9	83.1	54.5	39.9	108.1	72.9	31.8	28.4	38.8	31.0	34.8	44.4	80.9	109.7	35.4	87.5	61.8	51.3	80.6	18.3	75.6	94.7	32.4	43.9	94.9	35.1	20.0	33.5	26.1	52.0	62.2	85.3	17.4	31.7	26.6	29.6	62.8	21.4	74.5	70.1	80.5	30.8	36.1	54.7	41.2	43.6	66.7	58.3	50.9	60.5	106.1	97.2	143.7	75.0	131.3	50.2	60.6	58.9	72.7	101.2	47.6	42.1	62.0	167.7	50.0	145.0	56.1	76.2	149.4	32.6	37.9	19.3	31.4	40.7	25.0	26.4	27.8	26.8	22.3
ARRB1	ARR1	ENSG00000137486	"Arrestin beta 1"	P49407	11	75264182-75351705	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 49.5;RH-30: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 37.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.7;granulocytes: 14.7;monocytes: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003763, HPA049318, HPA070249"	Approved		Supported	Nucleoplasm			2100000	Nucleoplasm		"CAB003763: AB_562248, HPA049318: , HPA070249: "	"unprognostic (3.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	20.9	5.4	27.7	14.7	31.7	9.6	15.9	24.4	36.7	6.9	17.8	11.2	2.0	15.4	7.6	4.5	13.8	12.1	9.2	12.2	25.0	16.0	9.1	7.4	37.3	9.7	19.1	25.7	12.5	28.8	1.8	3.3	17.7	21.8	12.0	16.9	10.1	8.5	7.5	7.2	11.6	18.5	15.9	6.4	26.5	23.1	3.1	19.0	3.8	6.4	3.9	7.2	13.2	7.9	0.1	12.7	14.7	37.5	3.9	3.6	10.9	1.5	7.0	7.3	3.5	6.4	5.5	15.0	1.5	5.1	1.9	1.3	10.2	7.1	0.6	17.9	1.4	0.3	2.9	0.0	0.7	0.0	1.6	49.5	0.9	6.1	1.6	1.4	19.1	2.7	0.3	3.2	0.0	21.4	24.0	0.0	3.6	4.0	0.9	16.7	5.3	2.1	5.4	34.5	1.9	7.6	6.1	3.8	4.0	2.6	18.4	4.4	13.5	8.0	17.8	1.4	1.9	5.7	0.1	0.0	0.0	0.0	1.0	23.1	1.7	8.3	19.8	13.0	3.6	31.3	1.3	0.1	1.7	2.0	12.7	0.0	1.5	2.1	14.7	3.9	37.5	0.2	1.5	10.9	27.7	31.7	24.4	36.7	25.0	16.0	19.1	25.7	21.8	19.0
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710489-4721499	"Predicted intracellular proteins"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.8;lymphoid tissue: 66.6"	"Cell line enhanced"	"Detected in all"		"HMC-1: 70.2;NB-4: 42.1;U-937: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065681			Supported	Vesicles				Vesicles		"HPA065681: "	"unprognostic (1.12e-1)"	"prognostic favourable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavourable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	21.6	15.6	23.7	47.8	18.3	102.8	10.0	28.1	26.3	8.7	16.1	20.4	1.9	23.0	7.4	7.8	7.1	10.8	14.8	10.2	27.3	20.9	10.5	15.6	35.0	31.3	20.1	19.6	8.7	8.3	6.6	10.2	16.0	19.7	7.4	13.2	10.7	8.7	6.2	5.5	5.8	21.0	13.7	21.7	66.6	12.5	5.0	18.3	23.5	6.4	3.2	17.0	15.7	7.1	2.2	18.0	52.9	32.8	5.9	11.4	16.0	3.6	19.5	7.7	7.3	1.5	2.1	4.0	2.9	3.9	8.6	10.7	6.7	3.1	10.2	2.6	2.2	6.2	12.7	4.0	8.9	24.3	18.4	41.5	9.9	11.8	2.3	18.5	70.2	2.0	5.2	10.5	4.2	6.5	2.7	10.3	1.9	6.5	18.5	42.1	4.1	4.1	21.7	6.8	11.3	2.9	2.0	8.0	11.0	6.5	11.2	5.0	5.4	8.7	5.6	3.2	6.4	5.5	10.9	4.3	5.8	5.8	8.5	60.1	4.7	22.6	30.4	52.5	11.0	31.5	7.8	2.2	7.1	11.4	18.0	1.9	6.8	9.0	52.9	5.9	32.8	4.4	6.0	16.0	23.7	18.3	28.1	26.3	27.3	20.9	20.1	19.6	19.7	18.3
ARRDC4	FLJ36045	ENSG00000140450	"Arrestin domain containing 4"	Q8NCT1	15	97960698-97973838	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.7;BJ: 38.5;HSkMC: 21.7;hTCEpi: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 2.3;classical monocyte: 5.1;eosinophil: 3.1;intermediate monocyte: 3.6;myeloid DC: 2.4;neutrophil: 3.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.4;granulocytes: 3.1;monocytes: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039934, HPA042109"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA039934: , HPA042109: AB_10795606"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-3)"	"unprognostic (4.49e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.77e-2)"	9.2	9.3	11.4	11.5	18.4	6.7	14.8	3.3	16.3	9.4	27.4	67.3	11.6	11.2	10.7	11.9	11.8	10.8	14.7	9.7	18.7	9.2	14.1	21.8	14.1	6.4	18.1	15.2	7.4	25.0	3.7	6.5	13.0	29.4	8.3	17.0	4.6	6.5	13.5	10.1	25.3	15.3	14.0	48.7	5.9	18.1	10.2	41.9	1.9	14.9	4.5	3.5	11.7	12.4	0.5	2.4	3.1	5.1	0.1	0.1	0.8	2.1	0.0	0.3	5.6	2.5	18.7	0.0	38.5	17.2	5.1	2.3	2.3	1.3	0.0	5.4	1.7	2.2	1.4	13.4	8.3	0.0	3.6	3.7	0.7	1.5	1.0	2.5	5.8	21.7	33.3	5.8	6.9	0.2	5.1	0.0	1.8	6.9	0.4	2.1	1.1	0.8	0.0	0.3	0.0	10.0	4.7	1.9	3.3	5.8	2.1	10.4	0.8	3.9	0.0	1.5	1.1	8.0	1.8	0.0	0.0	0.0	3.3	0.4	4.0	2.3	5.1	3.1	0.1	3.6	0.0	0.5	0.0	0.0	2.4	0.4	0.1	0.0	3.0	0.1	0.6	0.6	0.0	0.8	11.4	18.4	3.3	16.3	18.7	9.2	18.1	15.2	29.4	41.9
ARSE	"CDPX, CDPX1"	ENSG00000157399	"Arylsulfatase E (chondrodysplasia punctata 1)"	P51690	X	2934632-2968310	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 43.0;pancreas: 99.4"	"Cell line enhanced"	"Detected in many"		"A549: 32.0;CACO-2: 19.8;Hep G2: 29.7;NTERA-2: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"					"Low region specificity"	"Detected in all"			"HPA060518, HPA070651"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA060518: , HPA070651: "	"unprognostic (2.07e-1)"	"unprognostic (6.60e-3)"	"prognostic favourable (8.95e-4)"	"unprognostic (8.74e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.76e-2)"	0.2	0.1	0.9	2.4	1.1	0.0	0.4	0.3	0.7	0.8	7.9	0.7	1.3	6.5	1.1	2.3	0.3	1.3	8.4	0.4	0.9	0.8	16.6	43.0	0.8	0.2	0.6	1.0	2.5	99.4	0.0	0.4	0.7	0.7	0.4	6.4	0.6	0.2	0.9	0.2	0.1	7.8	0.5	0.6	0.2	1.2	0.7	0.6	0.2	0.2	0.3	0.2	0.2	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	32.0	3.0	0.0	0.9	1.7	0.5	1.3	2.8	1.4	1.7	19.8	0.0	0.0	6.0	0.0	0.0	0.0	0.2	0.8	0.0	2.1	0.0	0.0	29.7	0.8	0.0	0.0	3.2	0.0	1.1	0.0	1.3	0.0	0.0	4.0	0.0	0.0	0.0	14.9	0.0	0.9	0.4	0.1	3.5	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	0.7	0.9	0.8	0.6	1.0	0.7	0.6
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 20.0;HUVEC TERT2: 18.0;LHCN-M2: 18.3;TIME: 23.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 15.4"	"HPA036481, HPA036482"	Uncertain		Supported	"Actin filaments"	"Secreted in other tissues"			"Actin filaments"		"HPA036481: , HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavourable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	3.5	2.2	2.6	2.0	2.7	0.0	2.6	10.3	3.4	7.9	4.7	0.9	4.1	1.0	4.8	2.2	9.1	4.6	6.0	5.2	1.5	1.2	9.4	3.4	6.9	3.5	1.8	3.6	4.7	2.6	13.3	1.8	6.7	4.2	7.2	5.4	1.8	9.1	3.9	0.8	1.7	1.7	10.5	2.9	0.5	5.8	0.9	2.0	0.6	1.9	3.6	1.7	7.5	18.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	2.4	0.2	0.0	4.4	9.1	0.0	20.0	15.2	12.6	4.9	0.5	1.4	0.0	2.5	9.5	2.1	0.1	4.9	15.8	0.0	0.9	0.0	1.9	0.0	13.6	0.0	0.0	5.6	5.0	8.5	17.5	18.0	0.0	0.0	18.3	0.1	0.0	0.0	0.6	3.6	0.0	2.2	0.0	16.5	0.0	0.0	0.7	1.3	0.2	0.9	0.1	0.0	23.0	14.5	4.0	2.1	9.4	0.0	0.0	0.0	7.1	0.0	4.4	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	10.3	3.4	1.5	1.2	1.8	3.6	4.2	2.0
ARVCF		ENSG00000099889	"ARVCF, delta catenin family member"	O00192	22	19969896-20016808	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 30.8"	"Cell line enhanced"	"Detected in many"		"K-562: 15.4;SCLC-21H: 14.7;SH-SY5Y: 11.3;U-2 OS: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016162, HPA055264, HPA063675"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"CAB016162: AB_2058690, HPA055264: , HPA063675: "	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (5.76e-6)"	3.4	6.6	9.0	1.8	6.1	6.0	3.2	30.8	11.1	3.4	3.2	7.7	3.5	2.7	4.2	14.6	3.1	2.6	8.0	6.2	8.1	8.1	5.0	4.9	3.9	1.4	3.8	6.8	2.9	8.7	4.9	7.3	2.7	5.9	6.1	1.1	6.4	8.7	4.6	13.4	5.3	3.7	3.6	4.0	13.4	5.2	5.2	2.8	0.5	12.1	1.6	1.5	2.8	1.8	0.0	0.6	0.0	0.2	0.7	1.2	0.8	3.2	0.3	4.4	5.7	0.0	0.0	4.6	0.8	0.3	0.2	0.5	0.9	0.7	1.3	3.6	0.4	3.0	0.7	1.4	0.0	0.4	5.5	0.4	0.3	3.4	1.3	0.4	1.0	0.1	0.5	0.2	0.2	3.6	15.4	0.4	0.0	2.9	0.2	2.0	4.5	1.8	8.2	0.2	0.4	0.8	0.7	14.7	11.3	0.9	1.4	2.2	1.2	0.3	1.3	0.1	12.9	0.5	0.3	1.8	0.5	0.4	0.2	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	1.2	0.0	0.7	0.0	0.6	0.0	0.8	9.0	6.1	30.8	8.9	8.1	8.1	3.8	6.8	5.9	2.8
ASAP2	"CENTB3, DDEF2, KIAA0400, PAP, SHAG1"	ENSG00000151693	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 2"	O43150	2	9206765-9405683	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018615	Approved		Supported	Cytosol			66000	Cytosol		"CAB018615: AB_2242947"	"unprognostic (1.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (4.68e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.58e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.24e-2)"	13.7	3.4	7.3	8.2	14.5	0.9	11.7	16.3	13.9	13.8	15.3	8.1	6.8	12.1	19.3	10.5	8.1	10.1	16.5	10.5	8.1	5.6	21.7	3.7	9.0	2.6	10.7	7.3	7.9	7.0	12.4	44.1	9.2	10.8	6.6	14.4	10.7	7.1	8.9	3.3	12.3	13.5	12.6	8.7	1.6	21.6	38.5	7.8	0.1	17.5	6.1	3.3	8.5	11.4	0.0	0.9	6.2	0.0	0.0	0.0	0.3	11.8	6.9	12.6	7.5	9.3	13.1	2.1	11.9	9.6	8.8	8.9	4.7	17.8	0.0	10.6	13.4	11.4	6.9	21.0	10.9	8.5	2.9	2.7	5.3	9.0	22.8	0.0	0.8	4.9	8.6	10.6	34.6	18.1	1.2	1.2	34.2	7.4	3.4	0.7	6.0	8.1	6.6	19.0	2.2	17.3	9.2	5.6	21.6	10.0	6.6	11.1	4.6	1.9	28.2	14.9	0.7	11.5	10.9	0.0	0.0	0.0	10.8	0.0	18.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	7.3	14.5	16.3	11.6	8.1	5.6	10.7	7.3	10.8	7.8
ASAP3	"CENTB6, DDEFL1, FLJ20199, UPLC1"	ENSG00000088280	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 3"	Q8TDY4	1	23428563-23484568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.3;ASC TERT1: 18.3;HSkMC: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020537, HPA020546"	Approved		Supported	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA020537: , HPA020546: "	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-3)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (3.87e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"prognostic favourable (2.80e-4)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (8.30e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.18e-1)"	"prognostic favourable (5.12e-5)"	"unprognostic (3.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.27e-2)"	10.6	15.5	8.7	5.9	9.9	0.7	15.2	2.6	8.3	11.0	8.9	6.6	13.5	2.4	7.9	7.7	12.9	8.7	7.8	20.7	6.9	5.1	10.7	7.4	7.9	2.3	9.2	6.1	29.6	13.7	13.7	7.4	12.4	16.3	12.0	6.8	8.2	14.6	25.5	24.2	32.5	3.7	9.9	15.4	1.9	8.9	9.4	6.7	0.2	12.0	12.0	6.2	7.0	17.7	0.1	0.0	0.0	1.6	0.0	0.4	0.4	1.0	1.0	10.4	6.8	19.3	18.3	12.9	1.9	2.2	2.9	3.8	0.7	0.0	5.3	2.2	3.6	4.9	7.2	1.7	1.7	0.2	0.9	0.3	2.8	6.6	10.4	0.0	0.5	23.3	2.6	4.7	4.2	2.2	3.6	0.0	1.8	2.2	0.7	0.0	1.8	2.4	2.7	1.1	0.0	2.0	2.1	0.3	3.5	8.2	2.0	2.0	7.8	0.0	0.8	1.2	3.1	3.5	0.1	2.3	2.3	0.6	0.5	0.0	0.7	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.4	8.7	9.9	2.6	8.3	6.9	5.1	9.2	6.1	16.3	6.7
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	15.9	15.4	10.9	15.5	14.5	13.6	13.4	16.1	11.7	16.7	13.2	7.7	10.1	11.4	16.4	12.9	18.4	11.3	11.1	14.9	9.7	8.4	10.4	28.3	12.6	13.1	13.1	7.6	13.8	15.1	25.0	38.6	26.1	10.4	16.4	17.1	6.4	15.4	14.0	13.6	15.3	16.1	12.2	15.5	17.7	11.5	11.7	12.4	25.0	10.6	11.6	15.2	16.0	17.9	8.5	9.4	5.9	6.4	6.0	7.8	1.8	7.0	8.8	13.3	8.2	14.9	19.0	20.7	31.0	20.0	10.7	12.4	18.0	5.7	21.7	6.1	20.8	15.9	11.4	27.5	17.4	13.7	9.8	16.4	16.5	11.7	13.7	17.4	12.7	17.2	14.1	15.6	19.9	19.6	19.4	9.9	29.5	6.8	8.6	5.3	7.0	6.7	10.5	10.1	8.0	10.6	20.0	8.7	6.6	12.9	11.7	5.3	6.5	9.9	26.9	12.0	9.1	10.3	13.0	4.3	3.9	19.4	8.6	13.2	12.5	5.9	3.9	2.4	6.7	6.4	7.8	5.8	5.6	6.0	4.1	8.5	6.5	6.2	0.3	6.0	5.2	9.4	4.3	1.8	10.9	14.5	16.1	11.7	9.7	8.4	13.1	7.6	10.4	12.4
ASF1A	"CIA, DKFZP547E2110"	ENSG00000111875	"Anti-silencing function 1A histone chaperone"	Q9Y294	6	118894220-118909167	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030502, HPA071495"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA030502: , HPA071495: "	"unprognostic (7.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (5.02e-7)"	"unprognostic (8.28e-2)"	"unprognostic (8.42e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.95e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.09e-3)"	7.8	14.1	21.5	9.1	23.8	7.9	14.4	20.3	17.5	12.9	10.4	12.6	16.1	8.5	12.3	15.6	13.7	12.3	9.0	14.6	18.1	19.2	14.4	13.3	15.0	16.3	21.6	14.9	20.9	10.8	25.7	12.9	9.5	15.2	12.0	12.5	9.1	11.6	15.4	16.6	12.9	11.7	11.6	21.4	15.2	11.8	10.5	14.8	36.9	20.2	14.9	16.4	13.3	12.2	13.4	12.8	12.2	7.9	12.1	30.8	17.6	6.2	4.0	14.2	9.4	12.2	7.2	11.4	8.5	8.5	11.1	12.6	5.0	5.4	10.5	14.0	6.0	6.9	12.2	10.9	14.3	7.5	11.3	15.4	9.7	31.7	8.5	25.9	8.0	6.3	11.1	9.6	14.7	14.7	23.8	28.1	13.1	6.5	30.3	20.5	5.9	13.8	16.6	5.8	13.0	14.9	8.1	9.1	7.0	8.6	8.8	9.9	5.0	24.3	12.7	5.2	7.7	7.1	13.0	8.7	14.5	15.3	13.6	20.7	11.2	6.6	6.0	12.2	16.3	6.3	22.7	13.4	26.6	20.9	12.8	8.1	29.1	23.8	1.0	12.1	7.9	9.7	30.8	17.6	21.5	23.8	20.3	17.5	18.1	19.2	21.6	14.9	15.2	14.8
ASF1B	FLJ10604	ENSG00000105011	"Anti-silencing function 1B histone chaperone"	Q9NVP2	19	14119509-14136956	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 39.2;lymphoid tissue: 45.1;testis: 45.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 39.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054036, HPA069385"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA054036: , HPA069385: "	"unprognostic (3.14e-1)"	"prognostic favourable (4.45e-5)"	"unprognostic (2.41e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (8.48e-3)"	"prognostic unfavourable (2.22e-16)"	"prognostic favourable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.31e-2)"	1.3	1.6	0.7	15.1	1.3	10.0	0.9	0.3	0.8	2.0	7.2	0.8	1.1	4.9	0.9	1.9	9.3	0.7	3.0	1.2	0.6	0.4	1.5	1.4	3.1	11.5	0.9	0.3	1.0	0.8	0.0	0.9	3.8	0.9	0.9	7.6	0.7	2.0	0.3	0.7	2.9	5.2	1.5	1.0	6.4	3.1	45.2	0.6	45.1	0.7	6.4	14.0	1.9	2.9	0.8	0.8	39.2	5.2	1.0	3.3	2.0	28.5	11.1	17.4	13.3	1.7	1.6	7.6	15.2	12.5	28.5	36.1	11.5	14.0	27.3	14.0	7.6	17.6	18.6	10.5	22.4	24.2	13.4	25.9	23.4	8.0	0.1	17.3	16.1	0.3	0.7	16.0	5.5	11.0	22.2	38.3	14.0	32.4	35.2	14.7	7.9	27.0	33.9	25.8	22.5	8.8	12.3	21.4	7.8	18.0	13.2	7.6	9.9	17.9	5.3	16.6	10.3	41.8	25.1	20.6	20.7	34.8	13.1	31.8	16.1	0.4	4.0	1.0	1.4	5.2	0.8	0.8	1.2	1.5	0.8	0.8	0.7	1.3	39.2	1.0	5.1	0.3	3.3	2.0	0.7	1.3	0.3	0.8	0.6	0.4	0.9	0.3	0.9	0.6
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 171.0"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 102.0"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 13.7;monocytes: 39.1"	"Region enriched"	"Detected in many"	9	"cerebellum: 49.4"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Intracellular and membrane"			Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	0.2	0.1	0.8	0.9	0.6	0.6	0.2	2.8	1.8	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.7	0.1	0.8	0.8	0.1	171.0	0.7	0.3	0.4	1.2	0.1	0.3	0.9	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.3	0.3	0.5	0.2	2.9	0.2	0.1	1.4	0.1	0.1	0.3	0.1	0.2	13.7	2.1	39.1	0.1	0.3	10.1	0.0	0.1	2.0	0.9	0.0	0.0	0.1	0.1	0.1	0.2	0.3	3.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.3	102.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	1.8	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.1	39.1	0.1	0.1	17.9	0.3	0.1	0.0	0.0	13.7	0.2	0.1	0.1	1.1	0.1	4.5	0.6	0.1	10.1	0.8	0.6	2.8	1.8	0.8	0.8	0.4	1.2	0.7	0.2
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 154.1"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 105.4"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 36.9;myeloid DC: 21.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 21.7;monocytes: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"			4700000	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	0.2	0.0	0.3	1.4	0.1	1.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	3.4	0.2	0.2	0.0	0.2	154.1	0.5	4.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	21.7	0.5	36.9	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	36.9	0.2	0.0	3.8	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	9.5	0.3	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155562807	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favourable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	20.1	10.1	12.1	17.7	14.5	12.3	14.5	23.6	15.5	15.4	17.7	15.5	20.4	8.2	18.7	12.5	12.5	12.2	10.0	11.0	11.8	10.6	13.0	8.9	10.6	9.4	16.6	11.5	23.5	10.0	24.4	22.6	12.9	13.2	18.9	10.7	10.7	11.8	22.2	21.8	12.8	12.8	17.4	14.5	8.6	10.4	7.8	14.3	15.6	16.8	7.1	10.6	17.8	19.9	11.0	5.7	16.5	5.3	8.6	10.7	1.7	13.6	11.8	7.7	6.7	17.4	18.8	8.7	11.1	11.7	7.6	6.4	8.7	9.2	6.1	11.3	14.5	14.2	12.1	9.8	12.1	6.0	7.8	7.5	11.6	4.7	8.5	8.4	5.9	11.5	10.9	12.7	12.5	9.0	10.7	9.2	12.7	10.7	5.7	4.5	7.3	11.4	5.2	16.0	7.0	8.4	15.1	7.9	11.8	17.5	15.9	8.6	12.7	18.2	13.9	11.8	12.6	11.1	13.7	8.6	4.9	9.8	9.2	6.3	10.1	16.5	5.3	11.0	8.3	3.2	7.9	10.0	7.8	6.3	2.5	11.0	10.7	5.5	12.8	8.6	3.5	5.7	8.6	1.7	12.1	14.5	23.6	15.2	11.8	10.6	16.6	11.5	13.2	14.3
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105242-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favourable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	22.3	17.0	24.2	16.7	26.7	24.0	19.7	26.1	28.2	20.9	20.0	21.9	14.7	14.5	20.8	16.1	21.6	18.2	19.6	20.6	21.0	23.4	21.0	20.6	16.0	21.4	20.3	26.8	24.1	30.1	28.3	13.9	24.3	23.1	19.4	20.9	16.0	18.1	20.0	31.8	18.8	23.0	21.8	20.1	20.3	18.8	41.7	16.0	36.2	19.5	15.3	24.1	20.1	17.4	12.6	17.0	33.9	16.6	16.6	13.2	11.4	13.8	7.3	12.4	12.3	8.9	11.2	15.9	14.1	14.8	17.8	15.7	7.9	6.3	15.6	12.0	11.8	8.3	15.9	7.9	16.9	6.0	7.2	63.6	7.9	16.5	12.9	10.2	12.9	9.6	7.5	8.2	9.2	13.9	42.6	12.1	17.3	8.0	27.1	12.8	16.0	4.7	11.3	13.7	6.7	9.2	10.5	5.7	10.1	10.4	6.9	11.4	8.3	12.0	10.8	11.0	11.2	15.6	11.2	11.6	14.5	13.9	11.2	13.4	15.1	18.2	13.9	33.9	11.1	16.6	11.8	12.5	12.5	13.1	17.0	12.6	13.2	12.1	11.8	16.6	15.0	9.7	13.0	11.4	24.2	26.7	26.1	28.2	21.0	23.4	20.3	26.8	23.1	16.0
ASIC1	"ACCN2, BNaC2, hBNaC2"	ENSG00000110881	"Acid sensing ion channel subunit 1"	P78348	12	50057548-50083611	"FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 43.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 16.8;SH-SY5Y: 19.4"	"Cancer enhanced"	"Detected in many"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058870			Supported	"Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"		"HPA058870: "	"unprognostic (5.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.97e-7)"	"unprognostic (7.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-5)"	2.5	1.7	13.9	1.8	20.3	0.8	2.9	20.1	43.7	5.3	3.1	12.8	0.3	2.3	2.5	1.2	3.4	3.6	4.0	2.2	12.3	14.3	1.6	0.9	1.3	1.3	12.9	8.5	1.4	1.4	5.2	0.5	1.5	10.2	4.5	2.5	1.8	5.6	3.4	1.3	1.5	2.5	3.6	5.4	1.1	4.3	1.4	11.0	0.4	1.1	0.0	1.0	2.6	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	2.1	4.7	6.2	14.0	1.9	2.9	3.5	1.5	4.1	2.7	2.7	3.3	1.7	1.3	3.2	0.9	2.2	6.1	5.2	1.6	1.3	16.8	4.2	6.6	2.0	2.7	6.3	15.8	7.4	2.5	0.4	0.6	0.5	2.8	0.1	2.2	2.6	6.0	12.3	2.6	8.3	6.1	5.9	2.8	1.3	0.2	9.2	19.4	3.5	1.2	2.1	7.7	4.1	0.4	2.7	9.1	1.8	0.8	0.0	0.0	0.0	3.5	5.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	13.9	20.3	20.1	18.3	12.3	14.3	12.9	8.5	10.2	11.0
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.7;epididymis: 18.4;ovary: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.5;HSkMC: 5.3;U-698: 3.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 5.4"	"Cell type enriched"	"Detected in single"	321	"plasmacytoid DC: 43.7"	"Lineage enriched"	"Detected in single"	321	"dendritic cells: 43.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"			Vesicles		"HPA048636: "	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	0.5	0.1	0.3	0.3	0.3	0.2	1.9	0.3	0.8	2.0	1.0	0.3	0.3	0.0	2.0	18.4	0.3	2.1	0.3	10.3	5.4	0.0	0.3	0.5	0.3	0.4	0.3	0.3	24.8	0.3	0.0	0.3	0.3	0.7	2.5	0.0	0.3	0.3	0.3	0.3	5.4	0.3	0.3	1.3	0.3	0.1	7.1	0.3	0.3	0.3	0.3	0.8	0.5	0.4	0.1	43.7	0.0	0.0	0.0	0.0	0.2	0.1	2.3	0.8	0.8	0.5	1.6	0.2	0.2	0.0	0.0	0.0	6.5	0.1	2.4	0.5	0.6	0.3	0.0	0.0	0.0	0.1	1.6	3.4	0.7	1.1	0.0	0.0	0.9	5.3	0.0	0.0	0.0	0.0	1.2	2.0	0.0	0.7	0.5	3.4	0.0	1.3	0.7	0.6	2.9	0.0	0.2	0.6	0.6	0.0	0.4	3.8	0.6	0.4	0.7	1.2	1.2	0.2	0.6	0.8	0.7	3.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.2	0.3	0.3	0.3	0.8	5.4	0.0	0.3	0.3	0.7	0.3
ASMTL		ENSG00000169093	"Acetylserotonin O-methyltransferase like"	O95671	X	1403139-1453762	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA003630, HPA021865"	Supported		Enhanced	Cytosol				Cytosol		"HPA003630: AB_1078230, HPA021865: AB_1845099"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.17e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.70e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-1)"	10.4	11.7	28.5	8.9	42.3	9.1	33.6	24.5	38.9	46.4	10.6	3.3	3.3	6.9	52.0	9.2	8.6	11.4	8.2	50.0	29.4	11.4	35.2	15.3	7.0	11.8	25.5	55.3	47.6	13.2	9.9	31.4	27.5	36.7	12.5	4.6	3.3	16.2	16.0	10.0	11.0	8.9	7.5	31.9	11.5	9.0	4.6	25.0	3.3	12.8	3.3	7.2	9.1	31.5	19.8	23.3	34.5	16.4	27.8	16.9	12.3	5.2	9.1	10.9	8.3	6.6	10.3	15.3	6.2	8.2	7.1	9.2	8.4	6.3	9.2	3.5	8.2	1.9	2.8	3.0	4.5	13.7	9.2	8.0	6.1	9.9	15.0	3.7	51.6	13.6	5.2	5.4	5.3	8.4	4.0	7.5	5.6	19.6	16.0	14.7	13.2	5.7	13.1	10.4	22.5	5.0	2.9	0.4	5.1	8.4	10.8	7.7	2.5	5.0	10.9	6.0	6.6	11.3	2.3	9.7	2.9	23.5	7.6	5.4	1.7	20.1	14.2	34.5	16.9	16.4	14.8	13.8	15.3	15.6	12.1	19.8	13.5	10.6	20.4	27.8	11.5	23.3	16.5	12.3	28.5	42.3	24.5	38.9	29.4	11.4	25.5	55.3	36.7	25.0
ASNA1	"ARSA-I, GET3, TRC40"	ENSG00000198356	"ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli			52000	Nucleoli	Nucleoplasm	"HPA045951: , HPA048087: "	"unprognostic (2.87e-1)"	"prognostic favourable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favourable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavourable (8.47e-4)"	22.3	33.9	32.3	23.1	32.8	35.1	22.2	28.2	51.9	23.5	27.2	26.1	23.6	24.7	24.8	30.3	33.3	30.7	28.9	48.0	30.5	27.9	46.9	28.5	21.2	26.6	29.2	26.5	24.2	30.3	23.8	25.2	32.0	27.3	21.8	18.3	30.9	26.7	21.5	35.7	28.9	24.7	21.3	24.5	26.5	24.2	30.9	18.5	25.8	40.7	28.0	23.5	28.7	20.6	12.5	27.1	16.0	26.9	9.3	20.2	19.4	33.2	27.5	14.8	31.8	29.4	18.1	18.2	17.3	23.9	33.6	26.5	21.5	16.6	15.4	27.1	22.4	17.9	20.4	23.1	16.1	23.6	31.9	13.2	20.8	24.4	31.4	19.5	25.8	20.9	20.4	27.1	16.1	23.7	16.4	20.9	26.2	74.5	25.8	15.7	37.3	51.8	19.2	22.9	30.0	31.3	28.5	27.4	23.3	23.4	31.6	27.7	26.0	18.9	20.2	47.5	16.1	52.6	40.2	37.6	63.2	14.1	33.4	32.1	26.2	16.0	26.9	15.0	16.1	20.4	13.7	12.5	14.4	14.2	27.1	10.6	10.4	12.8	9.6	9.3	23.7	17.8	20.2	19.4	32.3	32.8	28.2	51.9	30.5	27.9	29.2	26.5	27.3	18.5
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97852118-97872542	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;T-cells: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol				Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (8.79e-5)"	"prognostic unfavourable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavourable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	6.5	7.5	15.9	10.9	21.4	7.6	9.9	31.7	32.3	5.7	10.1	9.4	5.6	6.5	10.0	19.9	10.2	6.9	6.8	9.2	24.5	20.4	6.5	5.9	9.6	16.0	16.3	13.4	19.2	68.0	16.7	16.7	3.2	35.9	9.2	12.7	4.4	49.9	9.3	3.5	13.6	7.8	11.3	20.6	11.0	20.8	16.9	9.2	3.6	16.7	8.2	15.0	9.6	6.6	8.6	1.4	1.5	1.2	2.2	13.2	3.2	18.8	7.2	7.3	59.3	5.8	8.2	17.9	13.9	8.9	6.7	19.9	9.3	7.6	14.8	7.0	28.3	8.6	18.9	22.0	15.9	18.5	14.0	4.7	3.6	6.9	53.7	30.2	13.3	16.1	74.0	8.7	53.8	5.4	26.5	52.6	10.4	39.9	0.8	8.0	10.0	19.7	2.3	1.3	38.8	4.3	3.7	31.9	24.0	3.6	19.3	75.0	8.2	21.2	1.4	3.3	21.8	8.7	6.5	62.4	31.1	56.4	41.2	13.8	31.7	1.5	0.3	0.5	3.8	1.2	4.9	8.6	7.4	3.4	1.4	6.2	10.2	5.5	1.5	2.2	0.8	0.1	13.2	3.2	15.9	21.4	31.7	32.3	24.5	20.4	16.3	13.4	35.9	9.2
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"			900000	"Endoplasmic reticulum"		"HPA055161: , HPA059303: "	"unprognostic (8.07e-2)"	"prognostic unfavourable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	50.0	72.7	10.2	6.2	45.8	43.5	3.5	89.8	83.5	38.5	40.4	12.4	66.7	3.8	6.2	52.6	18.7	6.3	31.3	65.8	1.4	6.4	8.9	44.2	34.0	29.4	1.3	1.4	35.7	7.1	21.4	27.3	16.2	2.4	3.6	33.8	10.6	0.3	1.8	5.8	42.9	2.4	11.0	0.8	23.5	41.5	10.6	3.7	27.9	13.2	11.1	5.4	2.4	50.8	39.0	20.0	35.6	31.6	2.3	2.9	0.1	102.6	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6
ASPSCR1	"ASPL, ASPS, TUG, UBXD9, UBXN9"	ENSG00000169696	"ASPSCR1, UBX domain containing tether for SLC2A4"	Q9BZE9	17	81976807-82017406	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"Hep G2: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026749	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"HPA026749: AB_1845114"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (8.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-3)"	"prognostic favourable (2.67e-4)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.01e-2)"	10.3	12.6	14.3	12.6	14.5	16.8	10.6	16.5	20.8	9.9	12.9	16.7	11.8	17.5	10.1	15.8	11.9	9.3	15.1	11.5	13.1	12.6	15.8	31.9	14.1	14.8	18.9	12.9	8.8	17.8	17.0	19.7	21.8	14.8	13.2	7.1	14.4	22.6	9.9	25.1	15.5	14.4	9.1	12.6	13.2	13.0	16.9	14.6	9.8	16.4	12.9	13.0	9.7	8.3	8.1	14.6	15.7	11.3	7.2	10.5	5.2	4.9	8.8	3.4	5.0	2.2	2.7	14.9	4.7	3.6	5.7	5.6	5.1	5.8	5.1	4.9	3.4	2.4	3.7	3.6	1.8	3.5	11.2	5.7	7.2	80.8	7.1	5.0	8.3	3.1	3.9	2.9	2.0	5.5	5.7	7.3	3.2	17.0	4.6	10.9	4.3	6.4	5.1	5.0	10.4	5.6	4.6	9.2	9.4	3.9	12.3	8.8	7.4	12.0	4.5	9.9	6.8	7.2	5.9	5.3	3.2	5.7	5.3	5.1	5.9	15.7	11.3	8.0	6.7	7.6	4.0	7.9	10.5	9.0	14.6	8.1	8.0	6.0	2.9	7.2	9.3	9.1	4.9	5.2	14.3	14.5	16.5	20.8	13.1	12.6	18.9	12.9	14.8	14.6
ASXL2	"ASXH2, FLJ10898, KIAA1685"	ENSG00000143970	"Additional sex combs like 2, transcriptional regulator"	Q76L83	2	25733753-25878516	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034646, HPA058040"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA034646: , HPA058040: "	"unprognostic (4.78e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.68e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.75e-2)"	15.0	14.9	14.5	14.1	16.5	10.4	13.1	23.0	16.1	14.4	13.9	15.7	13.0	9.8	14.7	9.9	17.5	12.1	10.0	14.2	15.2	8.9	14.7	10.2	13.1	15.3	14.3	8.5	11.4	12.1	28.0	17.4	17.4	13.9	10.5	14.2	12.6	15.3	14.1	20.5	14.2	12.9	13.3	12.3	15.4	12.1	20.7	18.0	26.2	16.5	10.7	17.0	16.7	13.5	3.0	3.7	4.7	2.7	1.8	4.5	1.3	15.4	9.3	7.2	5.1	7.2	10.1	9.3	8.6	13.4	8.4	7.6	10.3	8.4	9.7	5.0	9.7	9.7	14.2	10.5	12.2	9.6	6.5	17.1	8.4	11.4	6.1	18.9	17.1	5.0	10.9	12.8	10.2	10.7	14.9	7.8	8.9	6.3	8.9	6.3	10.2	6.7	10.0	24.7	7.8	7.7	10.6	7.9	8.9	10.4	9.8	8.7	5.5	8.1	14.2	11.9	13.6	10.3	12.3	15.9	15.6	20.2	11.1	16.0	8.5	2.1	2.4	3.7	4.5	2.7	3.6	2.7	3.5	3.9	2.3	3.0	3.0	3.6	4.7	1.8	2.4	3.7	2.5	1.3	14.5	16.5	23.0	16.1	15.2	8.9	14.3	8.5	13.9	18.0
ATAD2	"ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000"	ENSG00000156802	"ATPase family, AAA domain containing 2"	Q6PL18	8	123319850-123416350	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.8"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029424, CAB056158"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB056158: , HPA029424: AB_10611680"	"unprognostic (1.56e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.02e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (8.33e-15)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.17e-2)"	4.1	4.9	4.6	12.6	9.2	22.8	7.2	5.6	6.9	14.0	8.6	1.5	13.4	5.3	4.7	5.0	10.7	4.7	3.5	13.7	4.2	6.3	2.2	10.1	9.8	13.7	4.0	4.3	9.9	3.9	3.5	18.7	5.2	4.0	11.4	7.5	2.4	6.8	15.4	13.8	7.2	6.6	5.5	4.1	8.8	6.9	20.2	3.4	53.8	4.8	6.3	12.7	9.9	5.9	4.3	2.3	7.2	2.8	4.0	7.4	1.8	25.0	9.8	13.9	4.7	2.5	3.2	6.1	19.7	6.8	17.0	19.0	7.4	10.9	16.4	6.0	6.2	12.0	18.6	6.3	27.3	22.8	9.9	29.5	10.5	15.0	1.0	10.8	14.6	1.0	0.9	16.1	5.4	5.2	13.8	16.8	12.6	26.0	30.9	8.1	2.5	9.8	16.2	16.6	8.9	6.0	11.5	17.9	7.8	28.5	74.4	5.0	15.1	10.2	3.2	12.9	17.8	10.2	23.6	5.4	9.6	15.2	8.4	18.1	10.1	7.2	1.5	5.4	2.9	1.3	4.0	4.3	4.2	4.8	2.3	2.8	2.8	3.0	0.4	4.0	2.8	0.3	7.4	1.8	4.6	9.2	5.6	6.9	4.2	6.3	4.0	4.3	4.0	3.4
ATAD2B	KIAA1240	ENSG00000119778	"ATPase family, AAA domain containing 2B"	Q9ULI0	2	23748664-23927114	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034555	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA034555: AB_10601665"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.93e-3)"	"unprognostic (5.57e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.56e-3)"	"prognostic unfavourable (2.35e-5)"	"unprognostic (2.46e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.98e-1)"	9.5	6.0	10.8	13.9	11.7	16.7	12.2	17.1	8.1	8.9	6.8	7.0	7.5	9.8	10.1	5.6	11.3	8.1	7.8	7.2	9.2	4.9	6.2	8.0	13.9	13.0	8.7	5.2	11.9	8.8	10.6	14.0	7.9	7.9	8.5	8.7	8.8	9.5	5.1	17.1	15.9	9.6	13.4	8.0	9.4	7.6	8.1	10.5	25.3	10.5	6.1	12.5	7.5	13.3	7.6	11.5	13.2	8.8	6.0	5.9	1.8	3.7	3.2	10.3	4.7	3.0	3.3	8.0	2.5	2.0	3.3	2.3	5.0	1.8	12.2	2.3	2.3	4.9	7.9	2.7	2.7	7.9	3.8	10.2	3.9	5.9	3.3	9.1	7.6	2.6	4.9	2.0	3.3	4.5	10.8	5.4	2.5	6.3	8.4	10.7	6.1	1.8	9.7	11.1	2.7	3.6	8.3	4.8	7.9	6.8	8.4	3.6	4.1	9.1	4.2	3.3	3.8	2.8	2.9	5.7	2.5	9.2	1.8	10.4	3.0	12.4	8.8	5.1	4.5	5.1	4.9	7.6	4.1	3.9	7.9	7.6	5.9	4.8	13.2	6.0	6.1	11.5	3.5	1.8	10.8	11.7	17.1	8.1	9.2	4.9	8.7	5.2	7.9	10.5
ATAD3A	FLJ10709	ENSG00000197785	"ATPase family, AAA domain containing 3A"	Q9NVI7	1	1512151-1534687	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA058968, HPA064867, HPA065305"	Approved		Supported	Mitochondria				Mitochondria		"HPA058968: , HPA064867: , HPA065305: "	"unprognostic (8.42e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavourable (5.90e-5)"	"unprognostic (6.62e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.87e-3)"	10.8	13.9	11.2	16.3	11.3	25.0	9.3	9.3	14.8	9.2	11.0	11.1	12.5	16.4	10.4	7.6	16.8	9.3	11.9	15.9	9.2	8.2	12.9	26.7	9.7	13.9	10.5	13.3	8.5	20.4	8.1	16.6	11.3	8.3	10.7	6.2	9.6	19.5	9.5	31.1	13.3	12.2	8.9	8.5	12.4	13.0	12.7	9.1	14.0	12.4	21.1	14.3	9.3	9.4	3.3	4.7	1.3	6.2	5.1	4.0	2.1	21.0	11.9	5.2	13.4	2.6	3.2	12.5	17.4	5.2	15.4	9.3	30.4	14.5	11.6	12.0	6.8	18.0	7.4	10.3	2.6	11.2	31.8	20.3	29.2	20.3	5.0	29.1	13.0	3.6	3.3	12.4	5.2	6.6	31.7	9.0	5.5	14.8	21.9	26.7	10.7	25.5	23.8	9.9	24.1	4.2	8.8	26.6	10.5	10.8	16.4	13.7	7.2	14.4	9.0	15.7	12.3	24.0	21.2	13.4	13.2	46.8	15.4	43.8	7.0	0.2	4.0	1.3	3.3	2.9	2.5	3.3	3.8	4.0	4.7	3.0	3.4	1.5	0.1	5.1	6.2	4.4	2.8	2.1	11.2	11.3	9.3	14.8	9.2	8.2	10.5	13.3	8.3	9.1
ATAD3B	"KIAA1273, TOB3"	ENSG00000160072	"ATPase family, AAA domain containing 3B"	Q5T9A4	1	1471769-1497848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 3.7"	"Low lineage specificity"	"Detected in many"											"HPA058968, HPA064867, HPA065305"	Approved		Supported	Mitochondria				Mitochondria		"HPA058968: , HPA064867: , HPA065305: "	"unprognostic (6.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.68e-1)"	"prognostic unfavourable (1.81e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (5.48e-9)"	"unprognostic (2.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.68e-1)"	13.7	7.6	7.5	18.9	9.5	24.3	10.4	11.6	10.8	7.4	9.6	8.7	8.2	12.1	10.0	7.0	11.3	8.1	8.4	6.4	7.5	6.5	9.9	14.5	9.8	17.3	9.5	8.1	10.1	16.5	3.2	13.6	10.3	7.6	11.0	3.8	8.8	16.3	16.5	9.9	15.8	12.3	8.8	6.8	14.5	15.4	9.3	8.2	7.9	9.3	6.6	13.1	5.9	10.0	0.3	0.8	1.4	3.7	0.2	2.0	0.5	6.8	0.0	2.1	11.5	0.6	0.9	15.7	11.1	2.6	10.9	8.3	25.5	20.3	9.7	3.5	4.3	12.7	14.0	7.0	2.3	8.3	13.2	6.7	16.7	15.5	2.6	11.2	8.0	2.5	0.4	17.9	1.1	3.7	20.0	2.1	3.9	3.5	13.3	13.1	22.4	25.5	10.7	3.3	7.1	3.1	4.5	8.9	7.1	8.2	10.6	9.4	1.6	4.0	4.7	2.9	6.4	17.2	11.7	6.4	8.8	23.6	9.4	18.7	3.3	0.0	0.7	1.4	1.6	3.7	2.0	0.3	1.0	1.4	0.8	0.0	0.3	0.1	0.0	0.2	1.9	0.5	0.0	0.5	7.5	9.5	11.6	10.8	7.5	6.5	9.5	8.1	7.6	8.2
ATE1		ENSG00000107669	"Arginyltransferase 1"	O95260	10	121740421-121928801	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038444, HPA057549"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA038444: AB_10672745, HPA057549: "	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-1)"	15.4	16.9	14.6	16.8	18.8	14.7	16.9	23.1	20.8	17.4	18.8	17.6	12.6	13.5	14.4	14.3	15.7	13.6	14.4	27.5	15.0	18.4	23.1	23.0	14.0	11.7	17.6	14.0	14.4	13.4	23.6	22.5	15.0	15.4	16.5	20.0	19.0	14.1	16.6	33.6	12.0	16.2	25.8	15.6	12.9	12.0	18.1	14.6	21.4	22.0	11.2	14.3	22.8	15.2	14.0	14.4	17.1	11.5	9.9	16.0	8.5	9.8	16.8	13.0	11.0	9.0	10.8	8.9	8.7	15.6	10.4	11.0	21.7	12.2	12.1	7.2	9.9	10.1	12.1	8.6	10.1	20.0	10.7	4.3	7.3	17.6	9.2	18.6	10.2	7.9	8.0	10.8	22.9	11.2	6.7	25.2	8.3	6.2	10.1	7.6	6.7	8.1	9.8	13.7	7.1	13.2	8.5	3.7	12.2	11.7	8.3	17.9	6.1	4.7	13.8	6.0	5.9	8.9	15.4	21.9	30.2	14.8	9.3	12.9	5.0	17.1	11.1	14.7	16.0	11.1	15.5	13.0	13.9	13.7	9.4	14.0	15.7	14.3	8.1	9.9	11.5	14.4	13.6	8.5	14.6	18.8	23.1	20.8	15.0	18.4	17.6	14.0	15.4	14.6
ATF1	TREB36	ENSG00000123268	"Activating transcription factor 1"	P18846	12	50763710-50821122	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016222, HPA055069, HPA055406"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016222: AB_2290030, HPA055069: , HPA055406: "	"unprognostic (1.71e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (3.65e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.94e-2)"	"unprognostic (4.31e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.27e-1)"	"unprognostic (8.75e-2)"	24.4	20.7	9.8	13.7	9.5	10.2	16.2	28.1	10.6	22.4	19.7	8.1	14.6	12.3	19.2	14.2	16.2	15.5	13.4	20.0	10.8	8.0	17.7	19.8	15.1	15.8	12.2	6.0	24.7	11.8	18.1	15.2	36.1	11.9	20.7	15.1	12.5	16.3	14.2	37.9	12.9	18.8	13.4	12.3	22.9	12.7	9.3	13.9	34.4	30.8	16.3	16.2	21.6	20.0	13.3	13.6	26.3	12.3	12.2	18.8	11.6	13.4	9.7	10.3	10.5	14.9	15.8	25.6	14.3	24.6	22.6	17.8	19.9	21.3	18.5	23.6	16.5	11.2	12.1	14.7	24.2	18.2	12.6	20.4	22.0	10.6	28.5	29.3	19.6	16.9	23.3	16.1	26.6	10.9	24.8	17.9	16.7	19.9	18.4	18.6	15.0	15.6	17.7	16.0	21.9	17.2	9.3	13.9	7.5	30.2	13.2	21.5	18.3	17.9	7.5	15.9	19.3	13.4	11.3	9.9	11.7	29.7	15.4	16.5	7.5	4.2	11.5	26.3	13.9	12.3	15.8	13.0	15.1	16.4	13.6	13.3	18.8	14.3	7.3	12.2	7.7	6.2	17.9	11.6	9.8	9.5	28.1	10.6	10.8	8.0	12.2	6.0	11.9	13.9
ATF2	"CRE-BP1, CREB2, HB16, TREB7"	ENSG00000115966	"Activating transcription factor 2"	P15336	2	175072250-175168382	"Enzymes, Predicted intracellular proteins, Transcription factors"	"DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003769, HPA022134"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB003769: AB_562241, HPA022134: AB_1845138"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (7.08e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.21e-3)"	"unprognostic (6.70e-2)"	25.3	21.0	25.3	14.3	29.3	14.3	19.7	39.6	33.4	27.5	15.9	18.0	15.7	12.8	22.4	22.6	16.0	19.5	17.9	14.1	25.1	28.0	23.0	26.8	15.2	17.6	23.2	18.4	27.3	19.0	24.0	33.0	19.9	29.6	19.0	16.0	14.9	16.8	19.1	13.9	10.1	13.2	18.3	22.9	17.5	13.8	19.9	18.9	34.6	32.6	10.2	20.1	21.7	16.7	15.0	18.7	24.2	14.8	15.3	22.0	14.3	7.2	6.4	19.0	12.3	17.0	18.2	8.8	11.9	20.4	14.5	21.0	13.8	13.6	10.9	13.1	14.0	7.1	14.4	7.2	22.7	13.5	8.3	15.4	11.7	30.0	19.1	14.2	16.2	13.6	16.3	18.6	22.2	19.9	12.5	17.1	16.2	5.5	23.0	17.8	17.7	14.6	20.1	8.8	16.9	21.2	6.4	15.8	13.1	14.9	4.6	17.5	10.4	15.9	12.5	16.9	8.8	9.0	7.1	16.3	24.6	14.0	13.2	13.6	11.4	24.2	14.4	16.8	18.2	12.8	22.0	15.0	15.7	18.8	18.7	12.7	18.3	19.9	9.3	15.3	14.8	10.5	19.8	14.3	25.3	29.3	39.6	33.4	25.1	28.0	23.2	18.4	29.6	18.9
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 43.4;HDLM-2: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA001562	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	41.5	21.5	9.5	41.0	7.1	9.4	30.2	3.0	8.0	30.0	16.2	15.3	36.4	5.0	34.9	28.6	31.4	38.1	33.4	31.8	6.5	6.9	19.4	36.1	42.8	4.6	13.5	6.5	23.1	16.0	15.1	12.4	65.1	9.4	30.4	15.0	8.1	12.1	138.4	13.2	39.5	11.4	76.1	13.0	5.4	31.6	10.7	12.4	1.5	45.5	37.3	7.4	38.3	33.8	0.3	2.2	6.1	8.1	0.0	0.4	0.8	6.6	0.4	13.4	2.8	1.3	3.4	43.4	4.8	3.9	4.1	9.9	8.9	5.0	0.1	2.2	0.3	3.7	8.0	1.3	6.8	31.7	7.7	0.5	3.9	3.1	24.6	2.8	7.5	6.0	21.6	11.5	26.9	0.8	3.1	25.3	0.6	0.8	8.5	1.8	9.6	2.8	2.5	8.9	5.7	0.5	0.9	6.0	6.1	6.2	11.2	18.8	6.5	2.0	0.8	1.2	6.4	4.0	2.1	20.0	8.4	2.2	4.0	1.5	3.5	6.1	0.9	0.0	0.4	5.5	0.4	0.1	0.1	0.0	2.2	0.3	0.0	0.0	0.3	0.0	8.1	1.1	0.0	0.8	9.5	7.1	3.0	8.0	6.5	6.9	13.5	6.5	9.4	12.4
ATF4	"CREB-2, TAXREB67, TXREB"	ENSG00000128272	"Activating transcription factor 4"	P18848	22	39519695-39522685	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011596	Approved		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"CAB011596: AB_725569"	"unprognostic (2.51e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavourable (9.77e-5)"	"unprognostic (7.06e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.95e-1)"	66.7	46.6	35.0	35.8	42.1	137.9	134.9	38.1	44.1	46.9	99.1	27.3	66.6	40.2	52.1	45.1	69.9	39.8	47.0	44.1	35.7	30.6	41.5	90.1	53.0	37.1	69.3	21.8	53.6	125.3	24.7	40.2	56.8	49.7	70.0	41.2	39.6	241.8	72.7	127.2	42.6	44.3	119.7	64.3	43.2	70.1	23.8	50.4	21.6	62.5	66.7	49.3	118.9	104.7	29.2	32.6	24.1	26.4	19.3	23.0	19.9	38.4	23.5	41.1	52.8	46.0	45.7	68.1	46.5	73.6	37.6	48.1	51.7	29.5	74.2	10.2	34.7	30.4	66.5	55.1	45.9	45.6	48.1	50.8	24.1	52.4	101.9	95.2	48.1	77.1	120.2	67.1	98.8	36.2	53.7	79.9	28.5	24.3	56.8	69.4	35.9	30.6	59.1	27.2	76.4	49.1	32.9	62.0	25.8	20.9	56.1	135.9	34.5	118.2	28.4	22.7	65.7	24.7	31.6	87.1	103.4	86.2	25.0	48.7	50.6	24.1	26.4	17.5	16.2	22.5	20.8	29.2	21.7	20.7	32.6	21.1	23.0	20.8	13.2	19.3	23.6	20.2	22.8	19.9	35.0	42.1	38.1	44.1	35.7	30.6	69.3	21.8	49.7	50.4
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	24	"liver: 470.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 78.3;THP-1: 65.2;U-266/84: 99.3;U-698: 46.7"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.9;intermediate monocyte: 11.7;myeloid DC: 7.5;plasmacytoid DC: 18.7"	"Group enriched"	"Detected in all"	7	"dendritic cells: 18.7;monocytes: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavourable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	4.6	6.6	2.1	5.0	2.7	2.9	7.0	1.3	2.2	2.4	2.9	2.4	3.9	4.6	2.3	4.0	3.4	2.6	3.1	4.2	2.1	2.1	3.0	470.7	2.8	5.0	2.2	1.4	2.6	3.8	1.4	1.9	4.4	2.1	2.8	1.6	2.6	3.1	2.5	4.3	2.1	4.2	2.5	2.6	3.3	2.8	5.3	1.9	3.8	20.0	3.3	5.5	5.6	7.1	1.1	18.7	2.2	11.9	1.5	1.3	2.5	9.8	6.9	2.6	1.8	2.8	2.4	2.7	7.2	6.0	7.4	4.6	5.2	5.4	8.8	3.7	4.1	3.6	3.3	2.9	3.5	45.0	3.3	6.0	2.1	3.9	1.9	23.3	17.2	16.6	4.7	5.4	1.3	3.2	5.4	78.3	3.6	9.2	3.3	5.1	1.3	9.3	27.9	2.9	3.6	8.4	13.4	4.3	3.0	16.7	7.2	5.0	5.8	65.2	5.4	14.5	9.2	1.7	7.3	2.1	99.3	46.7	11.3	9.3	5.4	0.3	11.9	0.7	0.7	11.7	1.3	1.1	0.9	0.9	7.5	0.7	0.7	0.9	2.2	1.5	3.0	18.7	0.9	2.5	2.1	2.7	1.3	2.2	2.1	2.1	2.2	1.4	2.1	1.9
ATF7IP	"FLJ10688, p621"	ENSG00000171681	"Activating transcription factor 7 interacting protein"	Q6VMQ6	12	14365632-14502935	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016578, HPA023505"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA016578: AB_1845147, HPA023505: AB_1845148"	"unprognostic (2.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.88e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.78e-2)"	17.5	15.0	11.1	36.4	15.3	25.2	16.6	29.4	12.7	18.0	12.9	14.1	16.0	7.3	16.1	14.5	20.2	13.0	15.2	18.3	11.7	8.3	11.3	14.0	16.2	25.2	13.8	10.7	19.5	13.0	23.3	23.3	22.4	11.9	15.7	12.3	14.4	21.7	18.0	25.4	15.6	16.6	15.4	12.3	23.9	12.5	30.1	13.6	38.8	20.2	12.6	24.5	17.2	27.3	25.0	9.9	15.9	9.7	8.6	13.4	6.6	10.9	6.5	27.2	15.7	14.4	18.4	5.9	11.5	6.7	9.3	14.4	15.0	11.8	18.4	8.1	8.1	11.1	16.8	10.9	21.3	13.1	9.9	12.3	11.2	3.3	8.4	8.3	7.3	9.8	9.1	11.5	12.0	20.3	7.2	10.0	14.7	10.4	12.0	7.3	17.3	6.3	25.0	30.0	9.9	8.1	21.6	8.7	7.2	13.5	7.9	7.6	8.0	9.8	9.3	13.2	8.5	7.6	9.8	6.5	6.3	26.0	8.4	7.9	14.2	15.9	8.1	13.6	12.9	6.3	13.4	16.9	11.0	12.5	7.2	25.0	8.9	12.2	13.5	8.6	9.7	9.9	13.4	6.6	11.1	15.3	29.4	12.7	11.7	8.3	13.8	10.7	11.9	13.6
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814308-72843674	"Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.9;lymphoid tissue: 52.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 28.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA045444: , HPA050312: "	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favourable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	7.8	6.6	7.1	20.7	8.0	60.9	7.2	7.4	6.2	9.5	9.7	10.5	7.6	5.5	11.9	7.5	10.2	8.3	11.6	5.8	7.4	4.8	7.2	6.5	16.3	16.4	10.7	7.0	10.1	8.0	5.7	11.5	5.2	8.6	7.3	8.9	11.3	10.1	5.5	3.6	35.7	13.1	10.4	7.9	52.0	6.6	2.6	8.3	3.2	6.5	8.0	19.6	8.5	8.5	2.0	4.7	28.5	7.1	2.4	2.6	1.4	1.5	1.4	4.3	3.3	5.0	4.2	2.6	3.3	3.3	1.6	2.5	1.7	3.6	9.9	2.2	4.2	3.0	0.5	11.1	2.8	7.8	1.7	7.7	7.0	2.7	3.7	10.1	32.2	4.0	1.5	3.7	4.6	5.0	1.0	13.6	1.9	4.9	11.6	17.4	0.6	1.6	5.7	3.0	4.3	5.4	5.0	3.1	2.5	1.4	7.4	3.0	3.7	13.9	7.0	4.5	1.7	8.2	2.5	6.1	1.5	4.3	2.0	9.0	2.5	2.4	7.1	18.1	1.3	3.9	1.3	1.2	1.9	2.6	4.7	2.0	1.0	1.2	28.5	2.4	4.7	0.8	1.7	1.4	7.1	8.0	7.4	6.2	7.4	4.8	10.7	7.0	8.6	8.3
ATG2B	"C14orf103, FLJ10242"	ENSG00000066739	"Autophagy related 2B"	Q96BY7	14	96279202-96363870	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000880, HPA001427, HPA019665"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000880: AB_1078888, HPA001427: AB_1845551, HPA019665: AB_2274278"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.45e-2)"	"unprognostic (7.60e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.49e-2)"	3.6	3.4	2.6	2.5	4.1	4.4	5.2	9.2	4.5	3.9	3.2			3.1	4.9	4.4	2.9	4.0	3.0	2.7	3.2	3.3	4.5	6.0	3.4	3.1	3.0		5.1	8.1	9.7	4.1	2.7		4.0	3.2		3.1	3.1	5.2	9.3	4.3	3.8	2.7	3.9	3.6	6.5			4.9		3.5	3.3	3.6	1.5	1.6	2.1	1.0	2.5	3.0	0.7	4.0	5.1	6.4	5.0	11.1	10.3	5.1	6.0	8.5	6.5	7.5	2.7	2.8	9.0	5.7	9.7	5.6	8.6	5.9	10.6	8.3	4.4	3.9	5.6	2.4	7.3	7.2	4.4	8.6	6.0	8.8	7.0	8.3	4.5	8.2	5.2	6.5	6.5	6.2	3.1	5.3	6.0	14.3	6.1	7.3	5.0	6.2	7.1	9.0	3.7	4.3	5.8	4.1	11.0	3.6	1.7	8.9	3.8	8.2	6.7	8.4	7.5	5.0	3.5	0.6	1.0	1.7	1.6	0.6	3.0	1.5	1.8	1.7	1.3	1.5	1.9	2.0	2.1	2.5	1.0	1.6	2.7	0.7										
ATG3	"APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96"	ENSG00000144848	"Autophagy related 3"	Q9NT62	3	112532509-112562046	"Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037260, HPA040471"	Enhanced		Supported	"Plasma membrane,Cytosol"			26000	"Plasma membrane, Cytosol"		"CAB037260: AB_1078236, HPA040471: "	"unprognostic (2.77e-2)"	"prognostic favourable (6.82e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (9.35e-6)"	"unprognostic (6.79e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (7.52e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	24.2	27.7	30.8	30.3	34.2	51.6	23.1	19.5	26.8	20.0	24.3	29.9	16.6	24.5	18.0	17.0	23.6	15.7	17.4	20.9	31.4	27.1	32.2	36.2	23.2	31.0	38.9	17.9	21.1	29.0	24.5	27.7	24.5	33.3	18.5	26.9	13.1	20.3	22.3	18.7	19.6	27.9	19.6	53.3	40.1	23.5	51.7	34.8	33.8	28.2	23.4	28.6	21.6	19.7	12.3	34.5	35.6	61.9	9.7	15.0	24.0	31.2	17.1	16.1	16.3	21.2	17.6	18.1	27.6	20.2	27.3	25.0	23.9	18.7	39.4	21.0	23.8	22.7	26.2	23.9	38.5	6.7	12.7	24.7	17.0	15.3	33.1	43.2	21.1	16.2	18.3	26.8	41.3	25.4	21.1	33.9	28.8	27.4	25.5	20.4	17.6	34.0	22.3	14.4	33.2	22.7	17.1	27.7	10.9	22.9	22.0	32.2	24.7	32.5	20.4	29.3	23.9	12.3	24.1	22.1	21.1	60.9	26.7	40.3	21.4	10.8	34.3	23.9	8.6	51.6	10.7	12.3	10.6	10.6	34.5	11.5	10.4	10.2	35.6	9.7	61.9	7.4	15.0	24.0	30.8	34.2	19.5	26.8	31.4	27.1	38.9	17.9	33.3	34.8
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA067683: "	"unprognostic (2.85e-1)"	"prognostic favourable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favourable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favourable (2.39e-7)"	"prognostic favourable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	6.4	10.8	5.1	9.2	7.8	35.0	6.3	15.6	14.9	6.2	18.4	9.8	8.1	26.0	6.1	7.2	18.4	5.5	7.6	15.4	4.6	4.9	14.5	8.8	7.3	9.8	9.6	6.4	7.0	16.1	8.2	12.1	6.9	7.3	9.7	7.3	7.8	11.5	8.5	31.5	17.7	27.3	4.0	4.5	12.0	10.5	29.0	8.8	19.9	9.8	16.4	10.5	7.5	9.6	2.0	7.6	5.7	1.6	2.2	3.6	1.4	6.9	4.7	6.5	8.8	1.2	1.0	5.1	4.3	4.3	6.1	6.8	7.8	2.3	4.5	8.2	0.5	11.0	4.0	3.7	0.8	4.4	10.6	11.9	11.4	4.3	4.1	4.7	12.2	1.0	7.7	5.3	1.9	1.8	8.8	10.9	1.9	11.2	14.0	29.1	9.9	12.8	10.3	4.0	8.0	3.5	9.4	24.6	9.5	6.3	12.4	4.9	7.6	11.7	3.4	9.4	5.9	18.9	9.5	9.7	6.6	5.3	8.0	9.3	10.6	3.0	1.6	5.7	2.1	1.5	3.1	2.0	2.5	2.3	1.1	1.0	2.5	3.4	0.5	2.2	0.7	7.6	3.6	1.4	5.1	7.8	15.6	14.9	4.6	4.9	9.6	6.4	7.3	8.8
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			13000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favourable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favourable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	27.0	18.6	14.8	21.1	21.9	37.5	16.6	14.1	29.2	16.4	15.2	26.2	13.4	11.6	28.9	15.9	18.9	17.4	15.1	12.3	14.0	13.1	13.1	11.8	18.4	18.8	14.8	17.1	15.5	13.1	18.7	23.0	18.7	21.6	12.9	17.8	19.3	16.6	11.6	15.8	22.2	16.9	18.3	16.6	19.7	13.1	19.7	13.9	17.7	12.7	12.2	21.6	16.5	15.2	4.0	23.8	31.3	39.7	5.9	4.8	14.2	18.2	14.4	6.5	3.4	11.3	15.0	32.0	17.2	22.4	17.2	20.1	6.1	16.6	8.4	10.4	15.2	5.6	7.2	24.1	29.6	7.4	9.0	6.0	13.9	7.3	15.0	17.4	20.1	15.4	11.2	33.3	21.0	23.7	8.9	6.9	23.8	11.9	4.9	8.2	5.0	18.7	6.2	7.7	7.4	13.0	13.2	5.7	5.7	12.2	10.4	6.6	11.3	17.0	16.1	14.2	10.3	9.2	24.0	4.4	11.5	14.1	22.9	16.4	19.0	13.1	39.7	24.5	4.8	22.9	3.7	4.0	4.0	4.5	23.8	3.7	3.5	4.2	31.3	5.9	16.3	4.2	3.4	14.2	14.8	21.9	14.1	29.2	14.0	13.1	14.8	17.1	21.6	13.9
ATG9A	"APG9L1, FLJ22169"	ENSG00000198925	"Autophagy related 9A"	Q7Z3C6	2	219219380-219229717	"Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA059551	Uncertain		Supported	Vesicles				Vesicles		"HPA059551: "	"unprognostic (1.53e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (2.18e-5)"	"unprognostic (8.99e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.95e-2)"	13.9	14.3	15.2	9.0	26.1	23.3	13.2	26.7	37.9	12.2	15.0	23.8	10.0	17.1	14.9	9.4	17.6	10.4	13.3	23.4	14.2	13.2	12.6	21.0	13.6	10.2	18.5	14.0	12.9	16.7	27.0	10.8	20.3	20.6	12.8	14.3	12.5	14.0	14.9	61.3	17.5	19.8	18.0	14.3	13.0	13.0	47.0	16.3	7.8	13.1	16.6	12.6	14.7	12.3	5.0	6.6	8.8	16.8	8.4	7.6	8.5	9.5	12.6	9.9	22.7	20.4	21.4	12.7	17.9	21.1	25.1	22.9	19.1	13.4	2.4	14.4	29.3	21.3	16.0	20.6	19.2	7.7	24.4	19.2	32.5	21.8	20.2	5.1	14.7	21.4	34.2	26.1	24.5	25.7	26.1	9.8	17.3	12.5	4.1	10.7	6.9	10.1	5.6	13.1	9.7	14.7	14.1	15.2	8.8	18.1	16.8	15.8	6.2	12.4	17.4	25.0	11.6	10.1	16.1	5.3	5.0	3.9	20.3	12.0	13.5	4.8	9.4	4.3	6.2	14.4	6.6	5.0	4.9	7.6	6.6	3.4	4.7	5.5	8.8	8.4	16.8	2.9	5.6	8.5	15.2	26.1	26.7	37.9	14.2	13.2	18.5	14.0	20.6	16.3
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311817-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Enhanced	"Plasma membrane,Cytosol"			3400000	"Plasma membrane, Cytosol"		"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavourable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	19.4	27.4	21.1	23.0	28.4	16.9	24.8	12.1	32.3	20.6	26.7	29.1	18.1	23.4	27.9	15.6	19.1	21.9	19.1	18.2	20.3	21.1	23.1	35.6	17.3	36.1	29.7	19.9	23.4	32.9	25.1	21.1	31.1	24.4	21.9	35.9	19.5	14.4	29.4	35.5	17.0	20.6	26.7	21.7	29.0	20.4	15.0	28.0	46.3	16.1	13.5	35.3	27.6	18.0	21.7	13.4	2.9	8.9	19.6	22.8	10.0	20.2	30.7	17.1	29.1	23.0	23.3	8.6	20.7	18.0	23.7	27.2	59.1	31.8	29.5	25.7	21.6	21.3	37.6	31.2	34.0	21.9	36.4	35.9	26.3	53.0	29.8	44.9	18.4	19.7	24.0	31.6	38.2	15.8	46.3	24.6	32.5	29.9	39.1	21.8	65.9	17.2	36.4	24.7	26.4	25.1	32.7	26.9	18.6	16.6	20.5	23.4	33.6	16.0	13.9	20.1	20.8	25.9	13.0	31.1	40.6	61.2	17.5	25.1	29.0	2.9	6.0	0.1	13.2	8.9	22.8	21.7	18.6	20.0	13.4	13.2	18.9	17.5	0.7	19.6	7.4	11.7	17.7	10.0	21.1	28.4	12.1	32.3	20.3	21.1	29.7	19.9	24.4	28.0
ATL2	ARL6IP2	ENSG00000119787	"Atlastin GTPase 2"	Q8NHH9	2	38294880-38377285	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029108, HPA075302"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA029108: AB_10670557, HPA075302: "	"unprognostic (5.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (4.51e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.86e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.84e-1)"	11.9	19.1	14.2	15.2	28.0	15.7	23.4	29.4	17.1	18.2	31.0	7.2	12.3	19.0	21.8	12.3	25.8	18.3	15.5	11.5	12.9	7.9	16.6	25.0	15.0	9.9	10.2	15.9	24.2	14.3	8.8	15.6	10.1	9.8	19.6	15.5	14.0	29.2	19.5	32.8	29.7	23.7	35.3	8.3	13.8	22.9	9.9	12.1	17.9	32.2	24.8	19.0	28.5	20.7	5.4	3.8	13.0	3.8	3.5	6.0	3.5	34.4	17.6	20.9	15.3	19.3	12.3	26.7	12.7	11.3	15.6	15.5	20.0	26.9	29.3	14.4	8.1	41.5	25.8	12.8	24.1	29.6	22.5	17.1	12.5	27.5	10.8	21.1	15.7	8.7	30.6	13.8	19.7	14.3	28.7	15.3	12.1	12.7	22.2	19.6	29.6	12.1	19.8	24.2	17.8	12.0	19.0	10.8	19.0	15.6	16.8	15.5	8.9	12.3	8.9	15.4	21.6	14.6	24.2	21.0	18.5	32.8	9.8	20.9	18.6	1.3	3.3	13.0	3.3	2.9	4.7	4.1	4.3	3.5	3.8	5.4	6.0	4.9	4.4	3.5	3.8	2.8	4.6	3.5	14.2	28.0	29.4	17.1	12.9	7.9	10.2	15.9	9.8	12.1
ATL3	DKFZP564J0863	ENSG00000184743	"Atlastin GTPase 3"	Q6DD88	11	63624087-63671921	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065702, HPA076616"			Enhanced	"Endoplasmic reticulum"			1600000	"Endoplasmic reticulum"		"HPA065702: , HPA076616: "	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (4.52e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-3)"	40.3	17.7	7.9	11.8	10.4	8.2	28.3	5.6	7.4	20.9	15.0	12.4	14.0	6.7	22.5	15.7	23.4	14.5	15.1	9.7	7.0	5.0	15.0	23.6	15.9	24.7	10.9	5.4	22.3	18.4	12.9	8.8	11.8	9.8	17.9	11.7	14.0	17.5	15.4	7.6	20.3	11.0	35.6	12.8	12.0	14.1	43.3	10.7	11.0	18.9	14.2	13.0	32.2	22.3	6.2	9.6	6.6	13.7	7.4	11.8	8.1	13.1	12.8	3.6	8.8	19.0	26.0	0.0	15.7	18.7	15.8	10.8	10.2	20.7	7.7	16.2	27.0	8.4	6.7	10.6	22.8	11.4	1.7	7.8	14.3	0.0	12.5	15.4	11.8	16.5	17.7	20.2	13.2	17.0	8.7	21.6	18.3	14.3	5.6	9.7	4.6	10.1	12.1	9.0	11.5	13.2	9.5	2.0	5.4	47.0	11.3	15.1	20.8	5.9	23.4	33.2	15.9	32.5	10.9	6.1	8.4	15.6	17.9	10.4	20.1	6.6	9.1	4.0	10.8	12.4	11.8	6.2	9.0	8.7	9.6	5.2	7.5	10.1	3.9	7.4	13.7	4.8	9.9	8.1	7.9	10.4	5.6	7.4	7.0	5.0	10.9	5.4	9.8	10.7
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222484-108369102	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB000102: , HPA067142: "	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	8.3	10.9	12.7	26.5	19.3	16.8	9.4	17.7	14.4	10.9	8.5	10.9	8.8	6.0	11.2	11.4	6.9	9.5	9.2	9.6	12.4	8.5	7.7	9.5	10.1	33.4	19.6	6.7	20.5	20.7	15.7	29.2	8.8	14.5	9.1	7.9	7.2	15.1	9.8	6.2	8.4	16.5	10.6	23.4	22.6	8.9	6.1	17.9	19.5	10.7	5.1	26.9	10.7	10.7	13.7	6.1	13.5	12.5	7.6	18.5	4.4	2.6	3.8	7.5	4.0	9.8	14.3	1.9	6.0	6.7	3.5	5.8	4.7	6.3	9.4	8.9	4.8	4.0	5.7	5.0	5.4	7.5	3.3	8.5	4.7	4.7	5.1	10.2	9.2	9.2	3.1	5.2	10.2	7.2	8.2	6.4	6.8	1.9	7.0	9.4	6.1	3.8	5.5	5.2	14.8	3.9	5.4	5.1	6.3	6.9	3.2	10.3	4.9	5.8	11.3	8.6	4.8	4.9	5.6	4.3	4.5	47.4	5.7	11.3	9.6	13.5	5.7	3.8	14.9	5.3	10.4	11.1	10.5	11.3	2.7	13.7	18.5	17.9	10.8	7.6	12.5	6.1	5.3	4.4	12.7	19.3	17.7	14.4	12.4	8.5	19.6	6.7	14.5	17.9
ATMIN	"ASCIZ, KIAA0431, ZNF822"	ENSG00000166454	"ATM interactor"	O43313	16	81035847-81047358	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054967, HPA066900"	Approved		Supported	"Nuclear bodies"	"Intracellular and membrane"			"Nuclear bodies"		"HPA054967: , HPA066900: "	"unprognostic (9.92e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.26e-2)"	"prognostic favourable (6.80e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-1)"	14.0	13.2	23.1	9.9	22.8	6.3	13.7	23.4	27.3	13.7	11.7	17.6	9.4	11.7	13.2	17.6	17.9	11.2	10.9	13.7	21.5	23.8	18.5	16.4	9.8	11.6	21.3	16.7	14.1	14.8	37.2	16.7	18.6	24.5	17.1	13.1	18.5	12.5	14.8	15.0	16.1	11.6	14.8	17.4	11.2	11.6	19.7	13.5	12.6	19.4	8.5	13.4	14.8	11.9	3.4	2.3	1.2	1.9	4.0	4.9	1.3	14.4	12.2	16.2	18.9	17.7	12.5	24.3	9.5	13.8	9.0	5.1	8.1	8.3	11.3	12.4	14.1	14.1	15.7	8.1	11.6	7.5	8.7	7.8	7.6	9.5	16.5	13.4	12.3	13.1	14.0	8.7	14.2	9.3	12.2	6.9	12.8	23.2	10.6	9.7	18.9	9.1	18.7	7.8	6.6	14.2	15.2	13.0	16.8	30.1	9.5	7.7	16.0	12.0	12.1	11.6	11.9	11.2	8.8	11.2	16.8	28.2	10.7	8.8	10.7	0.8	1.9	1.2	4.4	1.5	3.4	3.4	4.9	4.1	1.8	3.4	4.2	4.5	0.5	4.0	1.2	2.3	4.7	1.3	23.1	22.8	23.4	27.3	21.5	23.8	21.3	16.7	24.5	13.5
ATN1	"B37, D12S755E, DRPLA"	ENSG00000111676	"Atrophin 1"	P54259	12	6924463-6942321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA031619	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031619: AB_10601667"	"unprognostic (3.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (7.20e-4)"	"unprognostic (1.44e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.35e-2)"	37.6	38.6	34.6	20.1	28.1	4.3	25.9	57.5	45.5	33.7	30.5	27.0	38.3	22.8	35.7	17.2	21.2	34.7	28.0	25.6	32.8	22.4	21.6	8.8	26.3	11.9	24.4	33.8	72.0	28.7	37.4	43.8	27.6	29.2	28.9	14.2	29.2	44.0	40.9	26.5	28.3	20.5	33.4	29.5	19.3	22.3	8.8	29.4	2.3	42.0	7.3	9.1	30.0	57.6	2.6	2.1	2.5	0.5	0.5	2.5	0.7	15.4	20.2	21.8	44.0	20.7	18.7	36.5	18.5	16.0	19.0	13.6	20.4	18.5	4.2	5.9	22.8	10.4	13.3	18.1	10.1	49.1	13.3	19.7	18.7	9.6	32.1	3.9	30.0	30.2	13.4	23.8	18.7	18.6	16.6	8.5	16.8	22.2	8.6	3.6	44.7	8.6	18.1	11.8	3.1	13.9	21.9	6.8	21.8	18.9	22.0	13.2	8.4	11.1	24.0	22.4	28.9	17.6	28.3	6.5	2.2	2.9	17.4	5.2	23.4	1.9	0.5	2.5	2.5	0.3	2.2	2.6	1.1	1.4	0.6	2.3	1.4	1.9	0.0	0.5	0.1	2.1	1.2	0.7	34.6	28.1	57.5	45.5	32.8	22.4	24.4	33.8	29.2	29.4
ATOH8	"bHLHa21, FLJ14708, HATH6"	ENSG00000168874	"Atonal bHLH transcription factor 8"	Q96SQ7	2	85751344-85788066	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"thyroid gland: 41.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.2;RH-30: 18.8;RT4: 12.1;TIME: 17.7;U-2197: 12.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;MAIT T-cell: 1.7"	"Group enriched"	"Detected in many"	12	"monocytes: 2.9;T-cells: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA028406			Supported	Nucleoplasm				Nucleoplasm		"HPA028406: "	"unprognostic (7.70e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.56e-1)"	"prognostic favourable (8.98e-6)"	"unprognostic (3.32e-2)"	"prognostic favourable (3.80e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-2)"	36.4	2.4	3.7	2.4	4.3	0.8	19.9	2.9	4.9	10.5	4.0	4.3	4.5	2.7	11.5	2.2	5.0	7.6	5.7	12.9	5.0	2.0	3.6	30.8	21.1	4.5	6.3	2.1	9.7	4.3	1.0	2.3	3.2	5.4	9.0	1.3	6.4	3.5	12.1	25.2	8.4	3.2	5.8	4.1	8.1	4.4	2.0	4.6	0.3	41.8	4.2	1.1	10.4	24.5	0.0	0.2	0.0	2.9	0.0	1.7	0.4	0.0	3.6	5.0	11.2	4.9	0.3	0.1	9.4	1.0	2.8	1.2	0.0	0.0	0.0	3.5	6.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	8.4	0.5	3.2	0.0	0.0	3.7	0.0	0.0	0.0	1.9	0.0	0.0	7.7	0.1	0.0	0.0	0.1	0.1	0.0	18.8	0.1	0.0	12.1	8.3	1.8	1.8	0.0	0.6	0.0	0.0	17.7	4.4	0.1	12.3	0.0	0.0	0.0	0.0	1.5	0.0	8.7	0.0	2.9	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	3.7	4.3	2.9	4.9	5.0	2.0	6.3	2.1	5.4	4.6
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485288-47593486	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 55.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 31.5"									HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA050808: "	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favourable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	8.1	9.7	7.6	6.8	8.0	1.4	6.9	3.9	7.5	10.2	7.4	5.2	10.4	4.5	12.9	10.1	15.2	6.7	8.6	7.4	7.3	4.0	14.5	5.8	9.4	6.7	7.0	4.8	10.0	6.2	16.9	18.6	55.7	8.1	8.1	4.5	7.7	7.5	11.5	2.8	14.8	6.0	11.4	8.9	12.7	7.6	3.9	7.3	3.6	10.7	5.4	9.2	9.9	13.1	3.6	1.8	31.5	2.9	1.0	0.9	0.6	1.5	1.0	2.4	1.6	6.8	7.4	0.4	10.5	12.7	5.0	9.1	5.4	9.0	4.7	3.9	16.9	2.7	24.5	8.8	7.8	1.8	1.9	3.7	1.7	0.3	6.0	1.1	2.3	6.3	6.7	9.8	6.6	8.5	0.0	2.5	13.7	0.5	2.5	0.7	0.8	1.3	2.8	5.3	0.0	9.1	1.8	1.6	2.9	4.9	1.2	3.1	2.2	1.2	12.8	12.5	2.5	1.1	4.5	1.1	0.8	0.0	6.1	6.9	4.0	31.5	1.4	0.1	0.6	2.3	0.9	1.3	0.2	0.3	1.8	3.6	0.0	0.4	0.7	1.0	2.9	1.1	0.3	0.6	7.6	8.0	3.9	7.5	7.3	4.0	7.0	4.8	8.1	7.3
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Enhanced	Vesicles				Vesicles		"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favourable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	11.1	11.5	7.2	8.3	16.4	15.7	7.9	5.0	12.5	13.6	5.8	24.4	8.7	9.5	13.7	9.2	8.5	10.8	14.6	19.6	7.2	5.4	12.9	12.3	36.9	7.5	17.7	6.9	8.6	13.2	36.1	17.8	11.2	12.8	5.0	3.6	10.0	12.0	9.0	11.2	11.4	8.7	9.1	12.5	10.2	6.1	9.7	16.2	2.1	16.4	6.4	6.0	5.7	11.3	4.2	1.1	6.4	3.1	0.0	1.0	0.6	13.8	7.1	9.0	10.6	4.6	6.2	16.1	6.6	3.9	5.7	4.6	22.3	16.1	7.0	8.1	5.6	11.8	8.1	5.5	5.5	7.0	7.6	8.1	5.9	11.6	7.3	15.2	13.3	4.2	4.2	6.8	4.2	14.8	5.6	1.2	3.9	5.2	6.9	9.6	3.9	5.1	6.0	3.6	4.0	30.9	3.2	14.5	4.0	6.4	8.4	5.5	3.2	20.3	9.7	0.0	12.3	7.3	5.0	3.8	7.5	2.9	2.5	14.3	6.2	0.0	2.3	3.1	1.0	3.1	0.6	1.3	0.6	0.5	1.1	4.2	0.7	0.4	6.4	0.0	2.7	1.1	0.1	0.6	7.2	16.4	5.0	12.5	7.2	5.4	17.7	6.9	12.8	16.2
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926514	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"			100000	"Plasma membrane"		"CAB020697: , HPA048963: "	"unprognostic (2.31e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.75e-1)"	"prognostic favourable (5.19e-5)"	"unprognostic (2.60e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavourable (6.32e-6)"	"unprognostic (8.11e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.29e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.15e-2)"	50.5	79.9	12.7	26.3	23.3	17.5	105.9	25.7	35.1	17.7	48.2	9.1	16.8	37.3	17.9	14.6	36.9	20.0	47.8	44.0	16.0	18.9	24.9	7.7	44.9	43.4	21.3	12.8	34.7	11.5	6.3	33.8	32.6	43.3	20.5	58.1	23.9	18.4	24.8	7.4	85.4	57.3	24.3	28.4	16.5	13.5	21.1	13.6	14.5	15.6	41.4	18.4	21.9	31.5	10.4	26.8	13.6	60.9	7.8	20.0	22.5	46.3	28.8	27.1	25.4	72.9	21.2	62.2	54.4	49.5	39.6	44.9	44.8	23.3	37.9	49.2	41.3	101.8	26.9	26.0	45.1	20.6	34.1	33.0	32.5	29.0	28.8	27.2	26.0	22.5	62.1	31.0	30.0	42.2	22.7	33.6	40.5	21.1	27.6	45.5	37.7	13.8	37.9	20.3	38.5	33.2	35.8	22.4	15.2	71.0	33.1	73.0	25.2	33.1	29.3	34.8	13.4	52.0	31.6	25.1	32.2	61.0	45.4	29.6	28.6	13.6	27.1	8.9	19.2	44.5	14.1	10.4	15.6	20.0	26.8	7.5	9.2	16.7	1.9	7.8	60.9	16.4	16.9	22.5	12.7	23.3	25.7	35.1	16.0	18.9	21.3	12.8	43.3	13.6
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57941541-57957269	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.8;RH-30: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: "	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	6.7	4.9	4.3	5.2	5.3	11.3	4.8	6.1	4.8	5.6	8.2	1.3	2.5	3.9	3.2	4.2	7.3	3.1	2.4	6.4	4.2	3.6	5.4	6.2	2.7	6.8	2.7	3.8	4.2	5.8	3.2	3.0	3.5	2.9	5.1	8.2	2.3	3.4	3.3	11.7	5.6	4.3	6.5	3.4	3.7	3.8	39.5	2.0	20.8	4.7	5.9	4.7	6.3	6.2	3.0	4.5	12.0	4.5	2.6	5.6	3.0	1.9	1.5	1.9	2.2	2.8	2.7	1.0	1.9	1.9	2.2	2.1	1.2	2.4	6.8	2.4	1.4	1.8	1.8	1.9	3.8	3.4	1.8	4.4	1.2	1.9	1.2	8.9	3.0	1.4	1.5	1.3	0.5	1.5	4.6	4.9	1.8	3.0	4.8	14.8	1.6	3.7	3.1	48.8	2.8	1.8	2.5	1.2	1.8	3.0	2.8	1.5	4.9	8.4	0.8	1.6	2.8	2.1	1.8	4.0	2.1	3.5	1.8	9.6	2.7	7.6	4.5	12.0	3.5	2.4	2.6	3.0	4.0	3.3	4.5	3.0	4.3	4.0	1.9	2.6	4.2	2.1	5.6	3.0	4.3	5.3	6.1	4.8	4.2	3.6	2.7	3.8	2.9	2.0
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 58.4;LHCN-M2: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavourable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	8.7	5.1	23.4	12.5	53.8	40.5	8.8	30.9	44.1	9.0	14.0	4.1	4.0	17.8	8.2	5.8	6.5	8.4	11.3	5.2	29.0	11.8	7.4	10.0	9.2	11.8	7.8	31.5	7.6	7.4	13.7	8.7	11.7	9.2	6.4	14.8	2.9	5.6	6.9	10.9	11.3	12.8	8.7	6.1	12.7	12.4	9.8	16.4	5.7	6.3	6.0	12.3	9.9	7.4	27.1	16.2	41.5	25.6	8.4	16.3	6.2	4.1	21.1	8.3	4.0	12.1	19.3	3.8	12.8	41.9	12.4	19.8	8.4	3.9	8.2	0.9	17.7	3.7	7.3	3.5	34.7	2.8	8.5	2.9	7.4	7.4	39.5	12.2	4.9	15.9	6.7	38.6	58.4	3.1	4.8	3.0	90.7	6.6	3.8	5.2	6.5	10.1	5.4	26.8	3.4	11.8	19.3	7.9	4.3	14.8	4.2	3.5	6.1	1.4	2.2	33.7	5.5	12.3	13.9	2.3	3.5	8.8	15.3	3.5	7.4	2.7	13.0	6.7	7.1	13.6	9.0	27.1	12.4	9.0	16.2	27.0	4.6	5.7	41.5	8.4	25.6	2.9	16.3	6.2	23.4	53.8	30.9	44.1	29.0	11.8	7.8	31.5	9.2	16.4
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626561-203744081	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 42.6;BJ hTERT+: 60.6;fHDF/TERT166: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"			21000	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: "	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	23.0	14.0	24.8	10.8	14.2	5.9	11.6	9.4	23.6	32.6	44.2	7.5	12.9	5.3	69.6	13.1	20.4	27.0	13.9	24.0	13.1	8.7	5.0	14.2	16.1	5.3	6.4	19.2	21.9	6.4	8.0	4.8	16.2	9.3	17.0	13.4	11.6	7.5	31.5	5.4	22.0	13.2	74.2	5.7	4.8	16.4	13.1	7.5	9.0	8.3	8.4	7.7	32.8	14.2	1.0	4.2	4.5	2.2	4.2	10.4	2.6	9.3	1.7	3.4	3.2	26.5	39.5	18.3	42.6	60.6	7.3	6.2	0.8	4.8	2.1	6.2	45.9	9.2	5.0	5.9	7.6	27.0	1.8	6.3	8.5	0.5	9.5	9.0	11.2	28.7	5.8	23.2	3.6	13.8	2.7	4.3	5.3	0.5	9.1	3.0	2.1	5.3	4.7	2.6	3.4	2.4	0.8	1.0	1.5	15.0	2.2	6.8	2.0	4.4	12.1	17.6	2.6	29.5	10.2	2.9	4.2	1.2	17.6	6.5	5.2	3.0	2.2	0.0	10.4	1.5	7.9	1.0	6.6	8.3	2.4	0.3	1.6	4.2	4.5	4.2	2.2	4.2	6.3	2.6	24.8	14.2	9.4	23.6	13.1	8.7	6.4	19.2	9.3	7.5
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"			28000	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: "	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favourable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	18.6	22.9	29.6	14.5	29.4	20.4	36.8	24.5	34.6	22.2	21.6	23.0	14.3	14.4	19.3	18.0	16.9	23.4	16.8	19.2	31.6	32.3	28.0	17.1	30.7	16.0	31.8	25.4	18.5	14.6	47.6	31.0	19.6	26.7	54.0	22.4	18.1	20.3	16.6	16.1	21.3	16.0	19.2	44.6	11.1	18.7	16.0	25.6	20.5	21.7	15.5	15.4	19.3	29.6	4.7	7.6	21.6	7.0	8.7	7.2	4.9	36.2	14.2	14.3	13.8	40.0	32.5	15.4	39.6	52.8	19.9	25.2	23.1	29.9	13.1	27.5	37.4	43.2	26.8	21.8	29.2	28.4	9.6	35.0	15.1	10.7	25.6	13.9	42.7	25.4	22.0	20.9	23.8	21.1	10.0	23.9	24.5	16.1	13.6	11.1	16.2	15.5	9.9	14.3	20.7	36.7	24.4	22.1	13.2	34.0	10.6	19.9	15.8	11.5	28.7	21.2	11.9	27.3	18.2	15.5	18.8	19.5	21.9	10.5	17.7	21.6	7.0	12.1	6.3	6.0	5.9	4.7	6.2	5.6	7.6	2.9	4.3	4.3	3.5	8.7	7.0	6.6	7.2	4.9	29.6	29.4	24.5	34.6	31.6	32.3	31.8	25.4	26.7	25.6
ATP5F1A	"ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM"	ENSG00000152234	"ATP synthase F1 subunit alpha"	P25705	18	46080248-46104334	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013067, HPA040622, HPA044202"	Enhanced		Supported	Mitochondria			51000000	Mitochondria		"CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855"	"unprognostic (3.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.50e-2)"	"prognostic favourable (1.22e-15)"	"unprognostic (4.60e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.87e-3)"	30.1	60.0	34.7	30.3	45.8	22.4	33.9	52.6	65.0	27.0	52.1	20.5	39.3	55.6	25.2	30.5	44.4	30.0	27.9	196.2	31.4	36.1	94.0	64.8	25.2	40.2	42.3	31.8	28.6	49.0	73.2	35.9	25.7	41.5	28.3	54.9	37.6	42.6	42.8	182.2	34.0	50.4	36.6	22.6	32.1	46.7	24.0	19.9	45.6	35.1	99.7	41.1	31.5	26.4	58.7	110.9	17.9	64.5	44.2	63.6	124.8	42.5	43.4	57.8	54.2	70.4	78.2	64.1	49.3	69.9	76.0	66.7	64.9	33.7	100.9	30.3	59.7	79.4	99.5	75.7	71.0	44.9	55.9	66.7	56.0	80.4	46.1	141.1	63.4	72.1	53.2	54.8	57.1	78.3	53.8	59.7	64.9	44.3	72.5	69.4	54.1	45.8	71.8	67.2	136.5	103.0	104.2	58.8	54.9	36.1	45.2	60.5	58.2	82.4	45.5	41.9	36.2	21.9	42.9	68.6	58.7	65.0	41.7	84.9	44.5	11.8	64.5	17.9	43.5	58.2	55.8	58.7	52.4	47.5	110.9	44.0	63.6	52.8	6.7	44.2	52.2	54.0	58.9	124.8	34.7	45.8	52.6	65.0	31.4	36.1	42.3	31.8	41.5	19.9
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56646068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria			100000000	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavourable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favourable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	41.3	66.2	32.4	34.1	53.4	39.3	33.1	55.4	92.6	26.1	73.0	34.4	36.1	68.1	27.9	28.5	58.6	28.5	36.9	225.0	33.2	34.9	95.2	85.7	28.3	39.2	40.5	35.5	25.1	42.7	85.2	30.1	31.3	69.6	29.0	78.5	42.8	64.7	38.1	236.2	42.3	74.6	35.5	24.9	33.5	51.0	31.4	18.3	47.5	38.4	123.6	45.8	36.6	32.8	41.2	91.7	40.2	90.1	36.3	46.6	105.6	65.7	80.0	63.6	98.1	57.4	61.4	112.4	66.9	62.5	115.7	65.9	129.9	73.4	117.0	72.5	82.4	88.2	134.0	81.1	104.8	54.8	92.8	128.3	74.7	79.6	71.1	143.5	90.9	75.2	81.9	90.4	116.8	95.0	115.5	134.9	97.0	61.0	106.3	84.4	107.0	154.1	102.4	71.2	149.1	126.0	117.2	72.8	64.7	102.2	146.4	113.7	137.4	108.5	64.4	45.6	50.8	66.5	72.2	65.1	80.9	121.0	68.6	96.0	69.8	40.2	64.6	34.6	40.2	80.6	44.9	41.2	38.0	42.7	91.7	31.7	31.1	36.7	17.8	36.3	90.1	46.3	46.6	105.6	32.4	53.4	55.4	92.6	33.2	34.9	40.5	35.5	69.6	18.3
ATP5IF1	"ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898"	ENSG00000130770	"ATP synthase inhibitory factor subunit 1"	Q9UII2	1	28236109-28246906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027999	Supported		Enhanced	Mitochondria			1800000	Mitochondria		"HPA027999: AB_10600984"	"unprognostic (2.80e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.95e-1)"	"prognostic favourable (6.38e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.40e-2)"	"prognostic favourable (8.20e-4)"	"unprognostic (5.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.15e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-3)"	17.1	35.1	65.9	32.1	64.0	58.5	20.9	41.8	71.7	24.6	54.5	15.7	33.8	78.2	18.6	24.1	26.4	31.9	38.4	135.2	51.8	60.7	60.2	55.4	20.1	28.7	46.8	58.7	20.5	33.8	20.7	37.6	19.4	53.0	30.4	30.5	24.8	34.5	34.4	135.2	26.3	58.7	15.4	31.0	25.9	45.0	72.4	26.2	24.3	25.0	44.6	23.5	17.9	18.6	56.5	64.2	35.7	35.2	39.1	64.8	55.2	45.1	23.4	13.8	13.0	10.4	11.4	16.4	20.3	10.0	17.4	17.1	22.5	33.1	31.9	30.5	12.3	27.5	15.7	20.2	13.8	23.8	53.0	27.3	101.5	30.3	11.3	20.8	27.7	13.1	33.5	15.5	12.5	16.6	48.2	29.2	12.4	30.0	30.9	38.5	45.8	29.0	29.6	15.3	45.1	33.8	30.0	27.9	20.0	25.1	26.2	25.8	38.9	23.1	17.1	5.6	15.5	22.0	23.9	75.6	45.5	44.1	26.7	57.1	6.5	30.3	35.2	35.7	46.5	31.7	46.2	56.5	49.6	49.1	42.3	43.7	46.7	45.0	30.9	39.1	28.3	64.2	64.8	55.2	65.9	64.0	41.8	71.7	51.8	60.7	46.8	58.7	53.0	26.2
ATP5MD	"bA792D24.4, DAPIT, MGC14697, USMG5"	ENSG00000173915	"ATP synthase membrane subunit DAPIT"	Q96IX5	10	103389041-103396466	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044798			Supported	Mitochondria				Mitochondria		"HPA044798: "	"unprognostic (4.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.03e-2)"	48.0	46.2	91.7	26.2	67.0	26.6	56.1	33.5	71.7	38.4	77.9	21.2	29.2	43.8	22.1	72.3	56.3	28.8	31.0	131.5	67.8	57.4	79.3	92.5	24.6	27.7	65.2	44.4	19.7	58.1	21.1	38.2	25.9	46.0	30.0	75.8	23.4	52.7	43.3	146.9	22.4	57.3	39.1	41.4	26.1	40.9	20.2	30.7	22.9	31.3	125.5	39.8	41.2	28.9	71.3	109.1	101.2	85.2	50.7	76.6	66.4	60.2	64.1	60.6	72.3	67.8	85.2	39.7	58.0	73.2	59.3	66.4	103.1	67.3	34.7	33.7	65.6	61.8	56.7	59.1	81.9	45.5	101.9	36.0	82.5	115.2	65.9	73.4	55.9	68.7	92.8	53.3	84.3	76.4	47.1	57.9	99.1	93.5	59.5	126.4	45.0	108.5	38.7	37.0	54.0	141.0	98.3	23.0	53.2	30.6	47.0	83.4	41.8	68.2	43.2	29.4	45.1	44.5	75.9	61.1	99.8	57.8	62.1	75.3	22.2	101.2	65.9	88.7	55.9	85.2	63.3	71.3	76.6	65.7	73.3	51.5	65.9	65.6	55.8	50.7	80.6	109.1	71.7	66.4	91.7	67.0	33.5	71.7	67.8	57.4	65.2	44.4	46.0	30.7
ATP5ME	ATP5I	ENSG00000169020	"ATP synthase membrane subunit e"	P56385	4	672436-674338	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 221.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035010	Enhanced		Supported	Mitochondria			220000	Mitochondria		"HPA035010: AB_10669853"	"unprognostic (1.42e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-3)"	41.2	48.1	69.3	30.8	69.0	34.4	34.2	27.7	67.6	29.3	66.6	28.2	44.4	60.0	20.5	34.1	40.1	23.1	31.6	95.8	62.0	49.2	47.5	68.9	25.8	25.2	68.6	48.7	26.2	57.9	24.5	26.6	19.6	62.2	23.9	43.9	17.8	40.7	37.2	221.8	22.3	55.6	45.8	67.2	23.3	40.7	14.1	47.7	10.9	22.1	98.7	28.1	18.9	31.1	166.1	148.1	142.2	135.7	107.4	127.6	158.4	49.1	46.5	67.0	54.6	56.5	52.5	37.4	47.9	38.4	36.4	32.3	44.7	48.7	25.5	46.1	50.6	31.5	54.0	75.5	20.0	22.5	99.7	75.0	86.2	111.5	58.7	95.4	33.0	65.1	44.4	41.7	42.2	44.5	62.0	27.9	41.3	70.8	82.2	125.0	78.8	121.8	50.1	49.0	55.5	69.5	85.8	65.1	51.1	34.8	46.9	53.2	53.6	65.8	51.5	32.7	31.1	28.8	66.8	65.3	107.7	80.6	48.1	65.8	35.8	103.7	135.7	142.2	98.5	112.1	101.0	166.1	121.1	109.2	135.4	123.2	110.3	110.3	122.3	107.4	97.7	148.1	127.6	158.4	69.3	69.0	27.7	67.6	62.0	49.2	68.6	48.7	62.2	47.7
ATP5MF	"ATP5J2, ATP5JL"	ENSG00000241468	"ATP synthase membrane subunit f"	P56134	7	99448475-99466331	"Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067267, HPA070412"	Approved		Supported	Mitochondria			1400000	Mitochondria		"HPA067267: , HPA070412: "	"unprognostic (2.43e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.55e-3)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.31e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.78e-2)"	42.4	49.0	68.0	36.6	52.0	46.4	42.8	37.3	58.8	30.7	62.7	19.0	39.9	62.9	21.2	41.2	57.4	24.8	36.6	94.5	53.9	49.8	59.6	93.5	30.0	35.5	54.6	43.6	20.7	63.6	16.3	36.7	33.4	36.3	35.0	47.3	30.9	57.1	45.2	178.8	27.8	61.5	24.6	33.0	35.6	43.4	58.3	25.5	52.9	37.9	98.0	37.6	27.8	30.2	68.3	129.7	117.2	104.1	58.3	84.0	140.0	87.2	77.0	65.0	104.9	51.2	52.0	41.1	58.0	45.1	62.3	67.5	81.8	80.6	81.8	61.1	35.9	53.8	71.8	66.3	66.6	58.9	92.2	55.4	123.2	105.4	38.7	94.4	63.5	59.3	64.1	54.1	57.4	59.2	112.3	90.3	65.2	205.0	141.2	163.9	92.4	90.8	63.3	54.2	139.9	131.2	97.0	62.5	68.9	75.9	187.7	54.8	47.3	122.6	50.2	54.9	87.7	90.6	84.5	51.7	118.8	170.7	63.4	92.4	84.1	90.0	104.0	117.2	54.2	104.1	51.7	68.3	63.5	61.0	129.7	56.9	55.8	59.5	49.7	58.3	79.2	102.7	84.0	140.0	68.0	52.0	37.3	58.8	53.9	49.8	54.6	43.6	36.3	25.5
ATP5MG	"ATP5JG, ATP5L"	ENSG00000167283	"ATP synthase membrane subunit g"	O75964	11	118401154-118431496	"Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044629	Approved		Supported	Mitochondria			590000	Mitochondria		"HPA044629: "	"unprognostic (1.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.41e-2)"	"prognostic favourable (4.09e-5)"	"unprognostic (6.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.05e-2)"	32.3	42.4	45.3	31.8	46.7	36.0	39.6	38.1	40.4	25.6	39.0	21.1	30.3	33.8	33.9	40.4	27.9	26.5	30.1	85.8	37.5	38.4	55.6	42.6	29.1	41.9	39.2	23.6	31.3	70.1	25.8	31.1	23.6	28.3	26.3	41.5	39.0	71.9	29.5	68.4	20.9	39.5	47.3	27.8	30.7	29.5	17.9	15.7	53.2	33.7	60.2	43.7	30.0	23.6	42.7	54.6	30.8	48.0	32.5	53.5	98.1	21.5	11.2	29.5	28.5	25.5	28.6	23.6	22.1	25.2	20.3	21.6	28.2	35.0	42.8	46.2	24.0	27.6	29.6	30.9	22.6	34.1	19.5	67.6	10.5	17.0	26.2	38.4	32.4	30.4	29.3	25.0	23.9	27.3	30.9	35.9	28.3	38.7	53.6	48.0	18.7	31.2	36.9	24.7	47.0	52.8	18.6	23.4	17.7	33.3	54.1	16.3	39.3	35.9	26.8	16.8	18.8	14.3	25.2	16.4	22.4	43.5	12.5	44.8	20.9	28.8	48.0	30.8	27.1	33.3	39.3	42.7	42.9	35.5	49.9	34.6	53.5	40.2	24.0	32.5	31.5	54.6	45.8	98.1	45.3	46.7	38.1	40.4	37.5	38.4	39.2	23.6	28.3	15.7
ATP5MGL	"ATP5K2, ATP5L2, dJ222E13.5"	ENSG00000249222	"ATP synthase membrane subunit g like"	Q7Z4Y8	22	42639803-42640601	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 3.9;bone marrow: 4.5"	"Cell line enhanced"	"Detected in some"		"RT4: 2.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA044629	Uncertain		Supported	Mitochondria				Mitochondria		"HPA044629: "	"unprognostic (4.53e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-3)"	0.4	0.7	0.4	0.0	0.4	4.5	0.3	0.6	0.5	0.0	0.2			0.4	0.4	2.4	0.3	0.4	0.4	1.2	0.3	0.4	0.4	0.7	0.2	1.0	0.3		0.5	0.4	0.0	0.4	0.0		0.3	0.0		0.9	0.1	0.7	3.1	0.5	0.0	0.3	0.4	1.0	0.3			0.5		0.1	0.5	0.2	1.2	1.0	3.9	1.2	0.6	1.0	1.1	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.3	1.6	0.3	1.0	0.2	0.6	0.2	0.0	0.0	0.8	0.6	1.2	0.0	2.0	0.7	0.0	0.0	1.2	0.0	0.0	0.9	0.5	0.8	0.0	1.3	0.0	0.5	0.8	1.7	1.5	0.0	0.2	0.0	0.6	0.0	2.4	0.2	0.1	0.0	0.7	0.2	0.2	0.0	0.0	1.2	0.8	0.8	0.6	0.6	1.1	0.1	0.3	0.7	0.9	2.3	1.2	0.7	0.6	0.6	0.5	1.2	0.9	0.6	0.5	1.2	1.0	0.7	3.9	0.6	0.7	1.0	0.7	1.1										
ATP5MPL	"6.8PL, C14orf2, MLQ, MP68"	ENSG00000156411	"ATP synthase membrane subunit 6.8PL"	P56378	14	103912288-103928269	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA058978, HPA060520"	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"				Mitochondria	"Nucleoli fibrillar center"	"HPA058978: , HPA060520: "	"unprognostic (1.37e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (6.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.14e-2)"	23.1	34.5	69.4	19.3	64.3	40.2	34.9	31.0	91.7	21.0	43.0	16.0	26.8	44.1	16.5	39.1	27.3	21.3	20.5	87.5	57.5	44.7	43.0	45.2	15.7	28.6	54.0	41.4	22.1	38.2	17.2	29.2	20.5	30.4	22.1	45.6	20.1	28.9	30.3	117.3	17.3	33.6	24.6	28.5	19.5	25.8	17.5	24.4	18.9	23.6	58.9	30.9	18.4	17.2	51.8	63.1	91.6	91.0	32.8	54.6	98.1	38.3	44.4	38.5	36.6	46.1	47.9	38.0	30.1	34.2	37.8	33.1	38.3	27.3	40.3	31.8	30.8	32.8	49.5	36.3	51.2	33.3	50.0	44.9	37.6	58.9	30.4	54.3	31.3	50.2	49.4	25.6	27.4	42.4	27.3	43.3	41.5	114.1	52.4	77.5	30.0	84.9	33.7	33.6	36.6	57.6	54.7	33.3	39.8	25.2	47.3	56.7	58.6	64.6	22.8	14.9	23.3	40.1	24.6	33.2	56.4	56.4	34.9	31.0	25.0	54.8	91.0	55.0	37.5	68.0	41.7	51.8	47.8	42.3	63.1	43.6	54.6	48.4	91.6	32.8	65.0	61.2	46.5	98.1	69.4	64.3	31.0	91.7	57.5	44.7	54.0	41.4	30.4	24.4
ATP5PB	ATP5F1	ENSG00000116459	"ATP synthase peripheral stalk-membrane subunit b"	P24539	1	111448864-111462773	"Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046067, HPA057347"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"		640000	Mitochondria		"HPA046067: AB_10960850, HPA057347: AB_2683416"	"unprognostic (4.18e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.18e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.92e-1)"	"prognostic favourable (3.26e-9)"	"prognostic favourable (8.07e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	11.6	16.0	16.8	11.4	22.6	8.0	10.4	30.7	28.8	10.7	30.0	10.4	11.3	16.1	14.4	10.7	21.1	13.7	9.7	57.1	16.4	15.4	30.5	26.2	10.2	14.2	16.1	15.5	12.6	15.3	18.0	13.3	16.3	22.8	13.4	17.8	9.8	20.4	12.4	83.6	9.7	25.4	13.7	13.9	13.7	13.1	11.4	10.1	18.7	18.6	34.0	15.4	15.5	11.5	8.3	10.8	4.3	10.0	5.9	11.9	22.9	15.3	3.5	13.1	10.1	8.4	7.6	8.4	17.0	18.8	17.7	14.8	6.2	7.8	21.0	15.9	11.2	16.0	19.0	21.0	15.9	16.6	7.4	21.0	4.9	4.2	6.2	26.4	21.2	6.6	9.0	19.5	18.3	14.1	18.4	9.3	10.1	7.1	45.0	6.2	9.9	24.1	11.6	40.7	8.2	14.0	5.2	9.6	3.0	13.3	19.0	14.0	15.2	9.5	13.6	8.3	14.8	16.2	16.8	12.8	12.1	49.9	20.2	20.1	15.5	1.9	10.0	4.3	9.7	6.4	8.6	7.5	10.8	9.2	10.8	8.3	11.9	7.3	2.9	5.9	5.0	5.9	9.0	22.9	16.8	22.6	30.7	28.8	16.4	15.4	16.1	15.5	22.8	10.1
ATP5PD	"ATP5H, ATP5JD, ATPQ"	ENSG00000167863	"ATP synthase peripheral stalk subunit d"	O75947	17	75038863-75046985	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042777, HPA048459"	Enhanced		Supported	Mitochondria			1600000	Mitochondria		"HPA042777: AB_2678160, HPA048459: AB_2680402"	"unprognostic (1.37e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.29e-2)"	38.8	38.5	54.3	28.6	48.6	25.6	37.8	34.5	50.4	30.0	52.9	19.6	33.2	46.6	25.8	47.4	58.9	25.7	31.0	143.6	47.7	44.8	78.8	86.2	24.8	29.2	45.7	39.2	28.5	43.3	38.5	29.8	35.4	40.3	33.1	53.1	35.4	56.8	36.3	184.2	35.5	59.9	39.1	32.8	32.7	40.4	15.7	21.3	30.3	48.7	88.5	33.7	45.8	29.0	72.5	100.7	90.9	103.8	54.9	100.0	86.2	66.4	58.4	44.7	58.3	72.9	89.3	60.2	57.2	75.5	64.2	61.3	45.6	52.3	45.1	38.1	71.5	60.6	53.8	74.9	86.1	21.9	45.7	46.0	48.6	89.8	71.8	58.6	30.3	75.8	59.7	52.2	74.7	85.4	47.9	61.5	78.9	64.5	58.0	65.9	34.1	83.0	41.1	129.6	83.5	132.7	65.1	45.1	49.5	67.5	107.7	91.1	106.7	59.8	44.0	80.0	55.9	69.4	66.7	49.4	39.0	46.1	71.6	58.9	51.5	67.2	90.5	90.9	58.3	103.8	67.4	72.5	100.0	71.6	100.7	57.6	90.9	83.5	50.7	54.9	83.1	89.8	94.6	86.2	54.3	48.6	34.5	50.4	47.7	44.8	45.7	39.2	40.3	21.3
ATP5PF	"ATP5, ATP5A, ATP5J, ATPM, CF6"	ENSG00000154723	"ATP synthase peripheral stalk subunit F6"	P18859	21	25716503-25735673	"Plasma proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031069	Supported		Supported	Mitochondria			720000	Mitochondria		"HPA031069: AB_10603676"	"unprognostic (3.52e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.83e-2)"	"prognostic favourable (2.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-2)"	39.8	46.8	49.0	20.3	43.6	23.0	32.6	30.8	46.6	25.9	48.6	26.1	22.4	43.0	24.0	57.4	45.2	21.6	19.2	148.9	41.1	37.1	72.8	111.0	18.7	22.2	47.0	27.0	23.9	37.4	31.2	37.5	33.9	45.7	32.6	47.9	33.9	47.1	37.5	164.7	18.7	57.9	46.9	32.8	25.0	37.6	21.0	25.8	31.4	32.1	69.9	29.9	42.0	23.1	87.8	102.4	80.9	91.5	69.1	95.2	112.2	41.6	30.0	38.3	43.0	41.2	38.0	47.5	36.9	42.9	36.1	35.3	68.9	32.9	51.4	24.5	36.4	22.9	51.2	44.2	39.8	44.9	54.4	107.1	61.0	68.4	46.6	78.2	35.1	37.1	54.6	34.5	31.0	41.9	66.8	63.2	52.6	46.6	54.1	79.2	68.8	54.5	42.3	74.4	97.0	77.0	57.0	43.7	48.6	62.0	62.7	56.8	45.3	70.4	31.6	27.6	33.1	25.7	31.7	63.1	103.1	65.0	42.4	81.8	34.5	69.2	88.8	80.9	60.3	91.5	64.0	87.8	80.2	74.6	102.4	71.6	79.6	78.0	56.9	69.1	89.7	96.4	95.2	112.2	49.0	43.6	30.8	46.6	41.1	37.1	47.0	27.0	45.7	25.8
ATP5PO	"ATP5O, ATPO, OSCP"	ENSG00000241837	"ATP synthase peripheral stalk subunit OSCP"	P48047	21	33903453-33915980	"Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB016209, HPA041394"	Enhanced		Enhanced	Mitochondria			4000000	Mitochondria		"CAB016209: AB_631361, HPA041394: "	"unprognostic (2.08e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.81e-1)"	"prognostic favourable (9.34e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.89e-3)"	32.6	26.8	49.3	27.7	43.5	34.9	37.8	35.0	44.8	28.7	45.0	21.6	24.2	48.2	25.1	34.3	44.2	28.9	30.3	139.4	40.8	36.7	61.3	57.5	20.6	31.5	45.6	38.4	38.0	40.1	29.5	19.2	25.1	46.4	32.5	52.4	27.2	38.8	28.6	130.6	28.7	57.5	34.8	29.3	27.3	43.2	25.4	20.1	42.7	37.4	98.0	36.2	39.4	26.5	71.9	94.0	48.5	71.5	46.8	73.3	112.2	41.9	19.7	54.9	53.8	37.7	48.4	61.1	24.0	42.2	40.4	39.7	57.7	40.7	56.2	20.7	36.4	23.8	59.1	82.0	47.9	41.9	58.9	84.3	31.5	57.3	43.5	63.8	29.2	49.2	50.2	39.1	64.3	55.6	67.6	73.0	51.9	43.2	48.7	62.7	62.6	58.3	50.3	54.2	106.1	110.7	37.3	44.4	25.7	41.2	61.7	54.6	62.2	70.5	31.3	26.6	31.7	47.4	27.2	48.2	52.6	58.9	49.1	109.6	38.3	33.4	69.9	48.5	44.5	71.5	53.0	71.9	58.8	52.9	94.0	59.0	73.3	61.5	17.2	46.8	62.6	55.9	70.1	112.2	49.3	43.5	35.0	44.8	40.8	36.7	45.6	38.4	46.4	20.1
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747019-113812056	"Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.6"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035083, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol			2700000	"Nucleoplasm, Vesicles"	Cytosol	"CAB006910: , HPA035083: AB_2674453, HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favourable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	12.8	19.8	24.1	10.4	33.2	7.4	12.7	34.8	52.8	14.0	11.1	10.3	5.6	9.3	7.5	8.2	13.2	10.0	10.8	4.7	26.2	38.2	47.9	18.2	12.3	11.4	25.4	25.0	6.2	10.5	39.3	13.5	12.3	52.0	11.2	11.8	14.7	18.0	8.4	4.5	12.6	7.9	8.2	13.6	13.7	10.9	8.9	8.3	9.6	21.0	5.7	13.6	10.2	8.2	3.8	16.4	33.6	15.4	3.8	3.4	6.0	25.0	11.4	14.4	12.5	30.3	13.6	15.3	13.6	20.8	14.3	19.8	21.5	20.2	20.5	32.3	19.8	16.3	32.4	17.9	18.8	9.3	8.9	18.2	17.7	16.5	25.1	13.3	21.3	18.3	12.4	18.5	12.9	23.2	20.8	15.6	21.2	16.4	9.7	6.0	18.0	14.3	8.4	10.4	23.3	39.1	23.9	27.9	10.3	23.8	16.2	17.8	24.6	10.8	21.3	13.3	10.0	9.1	8.1	16.3	17.5	19.0	26.2	16.9	14.8	9.2	15.4	5.2	2.8	11.7	2.6	3.8	2.6	2.7	16.4	2.9	2.5	2.9	33.6	3.8	9.5	4.6	3.4	6.0	24.1	33.2	34.8	52.8	26.2	38.2	25.4	25.0	52.0	8.3
ATP6V1B2	"ATP6B2, HO57, VATB, Vma2, VPP3"	ENSG00000147416	"ATPase H+ transporting V1 subunit B2"	P21281	8	20197367-20226819	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 116.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 69.7;eosinophil: 47.6;intermediate monocyte: 62.5;myeloid DC: 34.5;neutrophil: 116.0;non-classical monocyte: 54.1"	"Group enriched"	"Detected in all"	10	"dendritic cells: 34.5;granulocytes: 116.0;monocytes: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008147	Enhanced		Supported	Vesicles			240000	Vesicles		"HPA008147: AB_1845195"	"unprognostic (1.90e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"prognostic favourable (8.41e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.25e-2)"	17.1	29.9	31.7	25.8	45.0	14.4	13.2	39.2	72.9	12.2	13.9	15.9	5.5	16.2	10.6	12.2	15.3	10.3	14.8	13.9	33.8	47.8	53.9	18.0	22.8	17.5	46.9	47.1	10.9	12.2	18.8	23.6	18.5	64.2	11.0	16.5	17.3	12.8	10.9	18.2	18.2	21.1	15.0	19.2	20.9	10.7	24.0	12.7	10.3	12.7	9.3	17.5	14.3	12.4	4.9	34.5	116.0	69.7	4.8	7.1	51.1	10.7	18.0	22.4	7.3	30.7	19.0	20.2	24.2	15.6	31.3	32.4	20.3	6.3	19.1	9.8	23.1	9.2	17.7	16.1	33.3	8.0	11.9	13.2	8.2	15.5	36.0	9.4	27.7	16.9	14.8	19.4	17.9	19.5	19.7	18.5	33.4	6.1	27.5	11.2	16.6	7.9	11.4	28.9	9.9	28.9	17.0	17.4	25.1	11.7	15.9	77.1	20.6	17.4	20.6	15.7	12.0	25.9	19.3	7.5	10.1	22.5	21.8	22.5	39.8	15.9	69.7	47.6	5.7	62.5	6.2	4.9	5.9	6.1	34.5	4.3	6.1	6.0	116.0	4.8	54.1	8.4	7.1	51.1	31.7	45.0	39.2	69.0	33.8	47.8	46.9	47.1	64.2	12.7
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: "	"unprognostic (5.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (3.29e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.83e-1)"	17.1	23.1	25.1	16.8	36.7	6.5	15.7	26.2	58.8	13.6	11.1	11.4	7.6	12.1	14.1	10.9	10.6	12.2	13.7	19.0	28.5	28.0	35.0	18.1	12.9	15.9	23.2	33.3	14.4	12.9	21.3	29.2	20.2	45.1	13.2	13.7	11.5	10.4	12.2	11.7	8.5	12.8	14.5	15.0	14.3	12.1	13.0	12.5	10.7	26.9	8.4	15.6	15.5	10.7	10.6	16.3	27.9	24.3	10.0	12.5	10.8	29.5	17.8	9.4	7.0	24.7	16.0	11.6	22.2	22.2	24.9	29.5	13.1	30.0	19.0	25.5	17.6	11.9	18.6	17.3	35.7	12.5	14.3	18.6	13.5	15.6	26.4	9.9	22.4	15.3	22.5	33.5	16.1	18.7	23.6	15.7	27.7	13.4	18.6	7.3	8.3	17.2	10.8	16.7	14.4	27.9	21.3	12.1	10.4	12.5	11.9	38.9	24.8	11.8	22.3	14.5	14.7	32.2	15.5	20.5	7.4	18.1	28.1	20.6	14.0	8.4	17.4	20.6	9.1	24.3	10.2	10.6	7.7	8.9	16.3	10.2	9.0	9.7	27.9	10.0	22.1	8.8	12.5	10.8	25.1	36.7	26.2	58.8	28.5	28.0	23.2	33.3	45.1	12.5
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA012887: AB_1845205, HPA048107: "	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	9.8	7.4	2.6	8.6	4.6	6.4	8.5	2.3	2.9	8.2	7.7	5.9	9.6	4.8	9.5	7.6	10.0	5.7	4.5	5.1	2.9	2.8	9.0	3.3	9.3	9.3	4.1	1.7	7.3	6.3	13.2	15.9	5.0	4.3	8.2	4.4	5.2	12.3	10.3	6.1	15.9	8.5	7.8	6.3	10.8	7.0	2.7	6.0	15.6	6.0	7.1	11.7	11.8	7.0	2.3	1.4	10.7	2.4	1.7	3.0	1.2	2.5	6.7	4.5	4.6	4.3	4.5	0.8	3.9	5.4	2.3	4.8	0.9	3.0	3.7	5.8	3.8	3.1	5.8	3.1	4.4	5.5	4.0	1.9	6.5	0.7	5.4	3.3	3.5	4.8	1.3	5.0	1.5	6.1	15.3	14.4	4.3	2.2	3.5	1.1	1.3	1.4	2.9	7.5	12.6	3.9	7.2	1.4	17.1	9.6	2.4	4.9	1.8	1.1	7.7	3.1	3.1	4.3	1.5	4.7	8.3	4.3	5.1	2.0	4.7	8.3	2.0	5.5	2.4	1.9	1.2	2.0	1.7	1.7	1.3	2.3	2.1	3.0	10.7	1.7	2.4	1.4	0.6	1.2	2.6	4.6	2.3	2.9	2.9	2.8	4.1	1.7	4.3	6.0
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 18.5;liver: 13.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.8;CACO-2: 10.8;HEL: 28.6;Hep G2: 9.9;RPTEC TERT1: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA009137: , HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.4	0.7	1.8	2.4	2.9	1.8	1.6	7.0	2.8	1.4	6.8	1.1	1.1	10.5	1.6	1.9	1.1	1.9	18.5	1.8	2.1	2.1	2.1	13.5	1.2	1.1	1.6	1.1	2.0	1.7	7.7	1.2	7.1	3.5	1.9	2.6	1.4	3.0	1.1	1.1	0.7	9.6	1.5	1.1	1.6	4.5	7.1	1.6	1.1	1.1	1.1	1.1	2.1	1.1	0.0	0.0	1.0	0.3	0.0	0.5	0.1	0.4	1.6	2.9	2.6	0.6	0.5	18.8	0.8	0.2	0.9	0.6	10.8	0.1	0.0	0.3	1.4	0.2	2.0	2.4	0.6	0.2	4.0	28.6	0.3	9.9	0.9	0.3	6.7	1.2	2.8	0.1	1.1	2.0	7.6	0.0	0.8	0.5	0.1	0.7	0.9	0.9	1.0	0.8	0.0	16.7	1.8	2.2	1.2	1.0	1.6	1.1	4.5	0.2	1.1	0.1	1.0	1.6	0.3	0.3	0.4	0.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.8	2.9	7.0	2.8	2.1	2.1	1.6	1.1	3.5	1.6
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.8;Daudi: 27.6;HEL: 9.7;REH: 9.5;SH-SY5Y: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles			20000	Vesicles		"HPA052935: "	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favourable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	5.3	8.6	14.2	8.0	29.6	18.5	4.8	7.2	32.0	3.1	11.3	27.3	8.4	4.2	3.4	11.6	2.9	3.5	2.8	8.0	13.7	8.8	4.0	2.1	10.6	12.5	18.0	17.4	15.1	10.0	38.9	6.9	2.6	15.3	7.9	10.7	3.9	4.4	15.2	16.9	3.2	8.1	3.1	23.1	7.8	10.5	2.8	24.9	8.9	34.9	1.9	10.3	4.5	4.0	4.4	3.8	0.9	3.3	3.2	7.3	0.9	0.0	0.1	0.2	16.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	27.6	7.8	0.1	1.4	4.0	0.0	0.0	4.4	2.7	9.7	0.9	0.4	0.0	2.3	0.2	0.3	0.0	0.0	0.0	0.1	0.0	3.1	0.0	1.2	3.5	0.8	1.2	0.3	9.5	0.0	3.1	6.0	0.3	3.0	9.2	0.2	5.8	0.0	1.9	0.0	0.2	0.0	1.3	0.3	0.0	1.1	0.0	5.6	0.4	3.3	0.1	0.0	1.0	0.9	6.0	0.4	3.2	2.6	1.9	6.5	0.9	4.4	2.9	7.3	0.9	3.2	3.3	3.8	1.4	0.9	14.2	29.6	7.2	22.1	13.7	8.8	18.0	17.4	15.3	24.9
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25372071-26025851	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 34.9;pituitary gland: 37.0;testis: 10.4"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 21.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: "	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	1.1	4.9	11.2	1.4	11.4	0.8	2.2	34.9	30.2	1.1	1.3	1.3	0.0	1.4	2.1	4.8	0.9	0.9	1.0	1.0	9.4	11.8	1.3	0.8	2.3	1.9	6.7	10.4	1.2	1.9	0.9	37.0	1.2	19.8	1.1	1.3	3.1	1.0	1.0	1.3	0.9	1.5	1.0	3.5	1.3	1.8	10.4	1.4	0.0	1.0	0.0	1.2	1.2	0.3	0.0	0.0	0.2	0.0	0.2	3.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.0	0.6	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	21.9	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.7	0.3	3.7	0.0	2.0	0.7	0.0	2.7	1.0	0.2	0.1	3.3	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.1	1.1	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.8	0.6	0.0	0.0	2.3	3.3	0.2	0.2	0.0	0.0	0.7	0.6	11.2	11.4	34.9	18.4	9.4	11.8	6.7	10.4	19.8	1.4
ATPAF2	"ATP12, Atp12p, LP3663, MGC29736"	ENSG00000171953	"ATP synthase mitochondrial F1 complex assembly factor 2"	Q8N5M1	17	17977409-18039209	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023329, HPA059422"	Supported		Enhanced	Cytosol				Cytosol		"HPA023329: AB_1845209, HPA059422: "	"unprognostic (3.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (4.40e-2)"	"prognostic favourable (4.95e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.70e-3)"	"unprognostic (1.67e-2)"	"prognostic favourable (6.00e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.15e-1)"	"unprognostic (2.62e-2)"	9.8	23.1	14.2	11.0	12.5	18.0	11.4	18.1	20.9	10.3	14.3	17.1	12.7	11.5	9.9	12.1	16.1	11.1	8.9	25.3	12.4	12.6	19.1	21.6	9.8	12.5	12.7	11.6	9.8	14.5	20.0	14.2	11.5	13.0	11.3	14.1	15.4	19.5	10.7	28.3	16.4	13.8	11.2	10.9	13.6	12.9	17.3	12.5	12.9	14.2	13.5	19.1	13.0	10.4	13.0	24.2	6.9	20.6	3.9	6.0	9.7	8.1	15.2	10.1	9.6	10.1	11.0	10.2	7.2	10.6	15.6	13.3	20.2	12.5	16.5	16.3	12.5	12.8	9.6	15.5	13.7	13.1	7.5	3.6	9.9	11.6	17.1	5.2	11.4	13.1	11.1	14.0	7.9	17.8	5.7	5.8	8.5	16.7	12.0	7.9	6.8	8.7	12.5	17.7	18.8	12.5	7.3	6.5	8.9	9.6	5.0	8.9	16.0	10.4	7.4	3.9	8.3	14.5	6.9	4.0	5.0	6.0	7.2	7.6	20.3	3.5	20.6	6.9	4.8	14.0	5.3	13.0	3.7	4.6	24.2	9.4	5.7	4.4	1.4	3.9	10.1	20.5	6.0	9.7	14.2	12.5	18.1	20.9	12.4	12.6	12.7	11.6	13.0	12.5
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449235-142578826	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA054320: "	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavourable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	10.5	24.3	7.7	11.4	15.9	10.1	14.8	11.3	14.6	10.1	8.5	10.0	10.4	6.0	14.7	16.8	9.4	12.1	9.3	8.8	9.8	7.1	9.6	12.0	10.3	16.0	10.0	8.1	12.3	13.6	18.0	22.5	8.8	12.5	11.0	11.2	9.5	12.5	10.8	7.7	11.2	10.9	9.8	8.8	14.2	9.0	15.3	9.7	19.0	13.8	7.7	15.1	10.9	10.6	5.8	2.8	2.2	4.0	6.7	6.0	0.8	22.5	11.1	7.4	8.4	10.6	11.6	8.8	12.4	7.0	9.3	9.6	5.2	7.2	18.4	12.9	8.8	14.6	10.9	11.5	14.1	5.9	7.2	10.1	8.4	5.0	4.7	16.9	5.7	9.1	6.4	8.8	10.5	9.6	7.0	8.3	9.5	9.9	12.7	7.0	7.1	7.9	10.6	10.8	13.3	9.4	10.5	5.3	5.3	22.9	8.3	8.1	12.1	6.9	12.4	9.5	4.8	12.3	13.3	10.8	6.4	17.1	12.3	6.6	7.5	0.7	2.7	2.2	4.4	4.0	6.0	3.1	3.2	4.2	2.8	5.8	4.1	4.0	1.7	6.7	2.5	2.5	2.4	0.8	7.7	15.9	11.3	14.6	9.8	7.1	10.0	8.1	12.5	9.7
ATRIP	"FLJ12343, MGC20625, MGC21482, MGC26740"	ENSG00000164053	"ATR interacting protein"	Q8WXE1	3	48446710-48467645	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.3"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033109, HPA047590"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB033109: AB_634993, HPA047590: "	"unprognostic (5.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"unprognostic (4.72e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.52e-2)"	6.1	5.3	4.9	6.2	5.5	7.1	6.5	9.4	6.4	7.0	5.2	7.2	5.1	3.8	8.2	5.1	7.0	5.7	5.0	5.4	3.5	2.8	5.4	5.4	6.0	5.5	4.8	3.6	6.8	5.3	5.3	5.5	9.2	3.8	6.2	6.0	6.5	5.1	7.2	7.3	8.0	4.6	5.4	3.4	6.3	5.2	38.3	4.6	13.4	9.3	6.6	9.0	5.5	6.2	0.9	2.9	1.0	1.4	1.4	3.4	1.5	6.9	2.9	8.1	6.1	5.0	8.4	8.6	10.6	5.0	13.2	11.0	4.2	4.9	15.5	5.0	4.5	7.3	9.1	8.4	12.9	9.2	4.6	12.1	12.9	2.9	2.7	11.7	7.8	3.5	2.6	7.1	3.4	5.8	9.6	8.1	12.3	3.9	9.8	4.1	6.3	8.7	6.6	7.4	11.4	4.4	3.5	4.0	5.8	8.5	8.7	3.4	7.3	4.5	6.4	8.8	5.8	10.5	12.3	9.5	15.1	10.7	4.6	8.8	4.9	0.7	1.4	0.0	3.3	0.8	0.5	0.9	3.0	1.7	0.9	0.5	2.1	3.3	1.0	1.4	1.0	2.9	3.4	1.5	4.9	5.5	9.4	6.4	3.5	2.8	4.8	3.6	3.8	4.6
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX, chromatin remodeler"	P46100	X	77504878-77786269	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: , HPA001906: AB_1078249, HPA064684: "	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	16.4	16.6	24.5	18.9	29.3	24.3	16.3	48.2	26.4	20.6	15.4	7.1	18.9	10.2	20.2	17.1	13.5	13.8	13.4	15.1	22.9	15.8	16.6	12.2	15.9	18.6	21.1	21.3	25.4	18.3	35.7	28.1	15.9	20.2	18.4	12.6	7.1	15.8	16.5	20.1	14.1	13.5	22.3	15.3	20.1	15.6	6.5	22.4	23.7	19.8	12.7	16.5	19.9	21.1	21.9	12.8	21.5	11.5	14.6	17.7	5.7	15.1	24.4	25.1	16.8	12.5	16.8	8.9	13.1	12.1	9.7	11.5	8.3	13.3	21.0	13.5	13.9	13.5	20.0	7.8	16.6	11.8	13.1	12.7	29.0	6.1	6.8	16.5	4.4	11.1	7.7	14.3	13.7	17.1	14.9	24.2	12.1	11.9	12.7	8.6	18.1	18.9	20.6	34.6	10.8	9.5	20.3	14.3	24.7	26.4	10.4	8.7	8.3	8.4	23.6	13.7	21.3	15.4	9.2	7.2	22.3	18.9	10.1	13.1	12.1	21.3	6.9	13.8	17.7	8.7	17.1	19.2	16.3	13.7	5.1	21.9	16.8	13.5	21.5	14.6	11.5	12.8	12.8	5.7	24.5	29.3	48.2	26.4	22.9	15.8	21.1	21.3	20.2	22.4
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: "	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	8.1	9.1	17.7	11.9	25.1	5.5	9.1	33.7	29.5	14.8	13.5	12.9	10.3	8.2	20.5	9.8	11.1	11.0	12.1	11.8	18.0	11.0	9.1	10.1	14.8	11.6	21.1	17.7	10.7	10.3	18.4	11.6	10.3	16.4	14.2	8.5	9.8	8.4	14.0	26.3	12.0	8.3	19.1	16.1	11.4	10.3	8.1	25.6	4.6	11.8	12.5	7.4	11.7	11.3	0.4	0.8	4.4	1.7	0.1	2.5	0.8	3.3	2.0	0.7	0.0	3.5	4.8	4.6	3.7	8.6	2.2	2.6	2.1	2.1	0.1	5.0	7.1	3.2	0.2	2.3	3.3	1.9	3.6	0.5	3.2	6.7	5.6	3.1	5.5	3.7	4.4	4.7	4.0	4.6	0.0	4.1	1.9	1.7	0.2	3.6	0.7	3.3	0.2	4.5	3.0	3.1	5.8	0.2	1.9	3.4	4.3	7.0	2.8	5.4	7.0	3.2	4.9	3.7	3.3	24.1	13.8	0.1	2.0	3.2	7.7	0.7	1.7	0.4	2.5	1.3	1.9	0.4	1.7	2.4	0.8	0.1	0.2	1.5	4.4	0.1	0.7	0.4	1.3	0.8	17.7	25.1	33.7	29.5	18.0	11.0	21.1	17.7	16.4	25.6
ATXN10	"E46L, FLJ37990, SCA10"	ENSG00000130638	"Ataxin 10"	Q9UBB4	22	45671798-45845307	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049531	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA049531: "	"unprognostic (5.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.48e-2)"	"unprognostic (6.98e-2)"	18.1	33.3	40.2	20.6	40.5	20.9	38.5	31.7	75.3	28.5	20.6	20.9	22.0	13.8	28.8	23.9	27.5	33.6	23.3	42.3	44.5	42.4	32.0	37.0	30.5	38.8	35.6	41.2	35.4	33.5	39.7	32.6	28.1	38.1	28.3	21.8	18.0	22.6	30.1	47.5	18.3	13.6	29.7	38.3	18.3	18.5	31.5	22.3	34.0	37.2	21.8	28.7	26.8	21.8	23.3	52.2	28.1	40.4	25.2	31.0	33.3	40.8	21.2	41.2	24.9	18.9	28.5	22.2	46.8	50.0	33.5	36.8	10.6	27.5	42.2	19.3	46.8	24.5	29.7	31.2	36.2	7.7	30.6	19.8	40.8	20.3	27.3	52.8	14.8	29.3	21.7	17.4	27.4	24.4	14.4	23.5	50.7	17.4	28.7	23.8	27.2	16.4	41.5	15.8	34.2	42.6	39.1	22.8	35.8	29.1	17.5	31.6	26.4	28.3	22.2	33.9	12.6	12.1	15.3	23.1	13.9	34.0	21.1	22.2	35.9	19.0	31.7	28.1	23.4	37.6	31.0	23.3	23.3	28.3	52.2	22.6	25.7	24.8	1.5	25.2	40.4	18.5	21.9	33.3	40.2	40.5	31.7	75.3	44.5	42.4	35.6	41.2	38.1	22.3
ATXN1L	BOAT1	ENSG00000224470	"Ataxin 1 like"	P0C7T5	16	71845991-71885268	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062596, HPA062789"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA062596: , HPA062789: "	"unprognostic (1.51e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (5.33e-8)"	"unprognostic (1.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (8.42e-4)"	19.2	12.0	17.1	14.2	15.9	41.3	16.2	11.9	20.9	15.0	15.4	22.7	9.1	10.2	19.4	9.8	14.7	14.2	14.5	11.9	13.5	10.9	23.4	10.0	14.9	11.4	14.7	13.1	16.7	16.3	29.3	10.3	14.6	14.7	14.4	11.9	14.2	14.4	14.0	15.9	18.6	14.9	16.3	14.5	13.8	16.0	25.3	16.9	10.9	15.1	8.2	12.9	16.2	18.5	1.8	1.3	3.2	2.1	2.0	3.0	1.4	8.4	11.5	11.7	8.6	13.8	6.9	13.8	7.2	8.0	13.1	10.0	16.4	9.5	9.5	11.3	11.2	14.9	9.9	10.9	14.3	2.6	8.8	7.0	12.0	11.4	10.4	8.4	14.3	9.8	14.0	14.8	10.7	11.8	7.8	7.6	7.7	24.1	14.2	8.4	10.7	5.5	15.3	11.9	11.3	9.1	11.9	6.3	10.7	14.3	7.6	8.8	11.8	9.0	14.2	14.4	15.2	9.0	9.6	17.3	14.5	22.7	9.0	5.7	12.1	3.2	1.5	1.7	2.3	2.1	1.6	1.8	1.7	2.0	1.3	1.5	3.0	2.7	2.2	2.0	0.9	0.8	3.0	1.4	17.1	15.9	11.9	20.9	13.5	10.9	14.7	13.1	14.7	16.9
ATXN2	"ATX2, SCA2, TNRC13"	ENSG00000204842	"Ataxin 2"	Q99700	12	111443485-111599676	"Disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018295, HPA020339, HPA021146"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132"	"unprognostic (3.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (2.34e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.40e-2)"	21.3	23.4	25.1	24.3	26.5	15.5	34.5	32.4	32.8	21.2	20.7	32.6	20.5	17.6	24.0	20.3	17.6	26.5	20.8	25.9	24.6	26.7	19.0	20.8	30.2	15.2	29.5	25.9	30.2	16.8	33.4	23.3	25.2	26.4	22.0	17.6	21.0	16.2	24.0	28.0	15.1	15.4	26.7	28.8	16.5	16.8	30.8	30.2	18.4	23.8	14.2	13.1	22.7	24.5	9.9	8.0	11.1	10.8	10.7	10.6	4.8	19.0	22.8	20.5	22.0	21.1	18.1	17.4	25.1	14.8	18.0	15.3	13.6	14.3	15.2	8.9	26.0	15.5	28.0	10.9	22.3	13.8	24.2	23.3	12.6	22.9	28.5	15.5	12.8	17.9	12.1	22.3	24.6	16.3	29.0	9.2	21.3	14.8	12.7	13.8	20.3	15.0	12.2	12.5	12.1	17.0	24.0	18.9	16.6	25.9	29.0	13.2	17.6	9.2	25.6	21.8	13.7	19.8	14.1	15.7	21.4	15.9	12.3	12.9	14.7	10.3	6.8	11.1	8.2	6.8	10.6	9.9	9.2	9.3	8.0	6.1	8.5	7.1	7.8	10.7	10.8	4.8	4.1	4.8	25.1	26.5	32.4	32.8	24.6	26.7	29.5	25.9	26.4	30.2
ATXN2L	"A2D, A2lp"	ENSG00000168488	"Ataxin 2 like"	Q8WWM7	16	28823035-28837237	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041506, HPA043391, HPA071955"	Approved		Enhanced	Cytosol				Cytosol		"HPA041506: , HPA043391: , HPA071955: "	"unprognostic (1.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.63e-2)"	"prognostic unfavourable (9.85e-4)"	"unprognostic (5.59e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (7.99e-7)"	"unprognostic (1.79e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.98e-1)"	24.7	31.1	32.5	38.7	30.4	56.8	44.9	57.9	42.5	27.4	24.6	28.0	22.8	35.1	28.4	22.9	29.5	26.2	25.8	24.8	31.1	22.2	30.9	32.9	37.1	46.2	33.8	36.1	31.7	34.8	39.9	44.8	31.2	28.9	29.2	22.8	22.5	30.9	34.2	27.9	31.7	31.9	27.8	33.6	44.0	30.2	77.2	33.1	45.2	31.4	19.5	36.8	25.5	38.8	6.8	9.5	4.2	3.7	3.0	4.0	1.4	17.8	22.9	23.8	26.8	14.7	15.2	28.0	18.0	17.5	19.8	22.2	28.9	21.3	41.5	23.1	12.7	26.0	22.3	18.1	22.0	32.4	19.8	27.6	27.2	29.3	26.5	31.0	39.0	19.4	21.8	28.0	40.4	17.4	36.0	52.6	16.2	25.4	37.7	52.7	24.1	16.0	49.9	16.5	28.8	11.8	18.5	24.8	19.8	10.5	20.0	21.7	21.8	32.8	20.7	24.7	20.5	15.8	24.6	75.4	52.3	37.2	18.6	29.8	28.4	0.7	3.7	2.2	2.9	3.3	3.0	6.8	3.5	3.5	2.7	5.7	3.3	4.0	4.2	3.0	2.6	9.5	2.8	1.4	32.5	30.4	57.9	42.5	31.1	22.2	33.8	36.1	28.9	33.1
AUNIP	"AIBp, C1orf135, MGC2603"	ENSG00000127423	"Aurora kinase A and ninein interacting protein"	Q9H7T9	1	25831913-25859458	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 35.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028730	Uncertain		Supported	Centrosome				Centrosome		"HPA028730: AB_10670830"	"unprognostic (8.05e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.96e-3)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.70e-6)"	"unprognostic (5.00e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.59e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-6)"	"unprognostic (3.61e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.62e-1)"	0.4	1.6	2.5	3.4	1.4	7.2	0.6	2.1	4.0	0.5	1.1	0.2	0.1	1.3	0.5	0.8	2.1	0.5	0.4	0.8	2.8	0.9	0.6	0.8	0.6	1.6	0.9	1.4	0.5	0.5	0.2	0.7	7.0	2.6	0.6	1.3	0.0	0.6	1.7	0.9	0.8	1.1	0.5	0.5	1.2	0.8	35.3	0.0	5.3	0.5	3.2	2.3	0.9	0.9	1.4	2.0	4.4	3.5	1.5	2.3	1.1	11.5	3.3	5.3	6.7	0.2	0.4	5.2	6.7	3.1	13.4	11.0	2.8	8.9	11.5	5.1	2.3	9.4	14.3	6.5	10.8	6.4	11.5	25.2	5.4	4.3	0.1	12.2	11.1	0.3	3.3	8.2	5.7	3.0	15.5	5.7	3.7	6.3	8.9	10.4	9.4	4.2	7.3	10.4	7.1	4.1	3.8	7.7	3.6	9.3	10.5	7.3	3.8	6.3	1.2	3.9	6.1	8.1	5.9	2.2	4.5	8.6	2.7	20.6	6.3	4.4	2.5	1.7	0.6	3.5	0.4	0.9	1.0	0.8	2.0	1.4	0.9	1.3	2.2	1.5	2.1	1.6	2.3	1.1	2.5	1.4	2.1	4.0	2.8	0.9	0.9	1.4	2.6	0.0
AURKAIP1	"AIP, AKIP, FLJ20608"	ENSG00000175756	"Aurora kinase A interacting protein 1"	Q9NWT8	1	1373730-1375495	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031821	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA031821: AB_10601458"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.31e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.34e-1)"	"prognostic favourable (8.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.84e-1)"	26.6	29.3	30.3	19.6	30.5	20.9	16.3	17.8	40.5	14.1	27.9	18.7	18.3	33.5	14.3	18.3	25.0	14.5	22.9	55.2	25.3	23.4	35.0	59.1	14.4	17.6	29.0	23.0	14.8	41.2	16.8	18.7	23.6	21.9	17.2	13.6	20.0	35.8	20.4	115.9	20.2	29.5	15.9	18.5	16.9	24.7	73.8	12.6	16.0	27.1	41.4	20.7	18.2	15.2	53.4	81.9	82.5	67.5	36.1	61.6	59.2	38.7	23.6	12.9	23.2	11.5	14.5	23.9	23.6	15.7	37.4	26.6	41.3	36.0	20.5	35.2	15.9	28.7	17.7	31.2	10.8	24.5	50.1	16.5	30.9	38.1	22.6	21.3	22.5	19.0	14.1	26.2	10.6	20.2	32.5	28.4	21.7	29.6	26.1	76.1	24.4	67.2	30.5	15.9	44.0	29.5	10.3	41.5	31.1	16.9	59.1	56.0	25.6	49.9	15.2	23.2	29.8	27.6	34.7	37.1	33.8	43.0	32.3	31.5	15.6	60.8	67.5	70.6	51.1	53.6	48.4	53.1	53.9	53.7	58.0	53.4	50.7	49.3	82.5	36.1	46.0	81.9	61.6	59.2	30.3	30.5	17.8	40.5	25.3	23.4	29.0	23.0	21.9	12.6
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"CAB005862: AB_449204, HPA037708: "	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.0	28.2	42.0	20.2	0.9	1.4	16.1	19.7	10.6	40.8	37.7	36.5	12.4	41.0	10.2	7.8	30.2	30.5	13.5	33.8	18.0	50.1	24.4	16.1	30.8	0.1	12.9	24.0	0.7	0.6	23.9	15.0	18.8	15.2	15.9	17.9	19.5	46.8	18.3	26.1	12.6	31.7	38.7	17.0	8.9	8.1	9.1	13.0	17.5	7.9	13.4	13.8	8.7	7.3	16.4	16.9	14.7	51.2	11.6	7.7	30.8	7.9	19.6	33.1	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	10.8	8.3	13.7	18.9	17.1	28.1	21.0	26.4	13.6	10.4	15.8	12.7	9.4	17.3	12.6	8.5	14.1	10.7	12.7	11.0	11.5	7.7	9.8	9.6	13.6	13.4	15.6	10.6	13.3	17.7	11.1	11.9	8.4	13.9	11.4	10.2	9.6	13.9	9.5	17.7	16.9	17.6	18.9	9.6	15.1	15.2	9.6	14.6	17.5	12.7	7.5	14.5	11.9	22.9	1.8	1.4	5.5	1.1	3.6	10.4	2.4	9.4	13.8	7.3	12.9	5.5	5.1	15.5	6.4	5.9	8.9	7.7	20.2	11.1	14.7	9.9	6.6	13.7	11.5	10.0	4.0	14.4	18.8	9.5	11.5	14.7	9.4	10.9	10.6	5.0	17.5	9.2	11.3	5.8	23.7	8.1	4.0	25.4	11.7	7.6	16.8	8.4	22.2	6.7	20.4	6.7	5.6	16.8	10.3	12.2	13.7	20.1	9.0	13.9	6.6	8.9	9.5	10.2	9.2	9.4	9.2	18.0	4.2	7.3	8.7	1.4	1.1	5.5	10.4	0.9	9.5	1.8	3.0	7.0	0.8	1.6	3.2	4.3	3.2	3.6	0.7	1.4	3.0	2.4	13.7	17.1	26.4	13.6	11.5	7.7	15.6	10.6	13.9	14.6
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219203-41261766	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 66.1;U-251 MG: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 8.8;plasmacytoid DC: 18.3"	"Group enriched"	"Detected in many"	14	"dendritic cells: 18.3;NK-cells: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"			61000000	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: , HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	38.0	15.4	10.6	11.7	12.7	1.3	27.1	6.3	12.1	26.2	26.8	13.4	8.1	9.1	28.0	19.4	21.8	17.4	17.8	18.5	11.5	6.1	7.8	13.0	20.0	7.6	10.6	9.3	20.9	5.1	9.6	5.6	26.6	10.1	19.5	10.2	16.8	7.8	20.4	14.1	13.8	12.8	29.4	10.7	27.3	16.2	22.4	10.4	3.4	12.0	8.4	5.8	35.6	18.3	0.1	18.3	0.9	0.2	8.8	0.3	0.2	52.5	21.2	1.3	0.1	4.8	4.8	0.0	41.8	37.6	61.4	38.1	1.1	24.7	0.0	17.0	66.1	4.4	0.0	28.1	52.9	0.0	0.0	0.0	14.0	0.8	17.4	0.0	0.0	3.6	0.5	36.2	56.2	22.7	2.0	0.0	38.0	0.0	0.0	0.0	0.5	10.2	0.0	22.4	0.0	27.4	0.0	0.0	0.0	10.8	0.0	0.2	0.1	0.9	46.6	43.5	29.7	41.5	70.8	0.0	0.1	0.1	29.0	0.0	32.3	0.9	0.2	0.1	0.1	0.2	0.2	0.1	0.3	0.1	4.2	0.1	0.2	0.2	0.3	8.8	0.1	18.3	0.2	0.2	10.6	12.7	6.3	12.1	11.5	6.1	10.6	9.3	10.1	10.4
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 238.2"	"Cell line enriched"	"Detected in some"	7	"THP-1: 150.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.3;neutrophil: 7.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.6;monocytes: 3.3"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"		290000	Vesicles		"HPA055851: , HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.3	0.2	0.4	0.2	0.5	238.2	0.6	0.0	0.6	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.2	0.8	0.2	34.6	0.4	0.5	0.2	1.5	15.3	0.2	0.2	0.0	0.5	0.1	0.1	0.9	3.8	0.2	0.2	0.2	0.2	0.6	0.2	1.0	0.4	0.2	0.2	0.1	18.6	0.2	1.2	0.0	20.6	1.3	0.0	0.2	0.1	0.4	0.0	0.8	7.6	3.3	0.0	0.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	150.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	3.3	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	7.6	0.0	0.5	0.0	0.0	4.1	0.4	0.5	0.0	0.6	0.4	0.5	0.2	0.0	0.2	0.0
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711477-44718877	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Immunity		"Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"		3200000000	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	127.2	50.9	24.2	109.2	29.8	131.1	85.2	11.8	23.1	70.5	111.4	29.1	43.3	79.1	72.7	74.7	80.5	36.8	112.8	73.6	26.0	23.1	109.7	140.3	191.2	172.1	42.2	18.8	54.8	42.7	7.8	40.5	91.9	33.1	78.7	128.9	53.5	121.5	40.9	45.7	94.1	178.5	55.1	56.7	272.8	52.5	30.0	29.5	108.0	97.7	71.5	131.6	135.9	73.5	138.9	74.9	341.3	132.8	128.8	215.8	323.7	33.1	14.7	1.4	8.3	54.6	73.6	52.1	22.0	44.9	35.8	60.9	19.1	77.4	15.8	31.1	21.4	29.3	5.5	9.8	17.2	110.7	13.0	60.2	89.2	22.1	41.6	33.7	36.1	37.2	9.1	11.0	11.8	24.4	15.3	2.2	39.6	17.7	13.8	89.0	2.4	31.4	16.8	36.0	100.3	31.2	137.5	5.8	2.1	23.0	18.7	25.9	6.2	175.3	48.5	70.3	7.8	92.6	42.9	41.0	93.8	29.5	68.5	111.3	33.6	221.2	90.4	210.9	126.8	132.8	125.9	138.9	171.7	141.1	58.9	109.4	137.0	167.5	341.3	128.8	106.5	74.9	215.8	323.7	24.2	29.8	11.8	23.1	26.0	23.1	42.2	18.8	33.1	29.5
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134411918	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 76.0"	"Cell line enhanced"	"Detected in some"		"AF22: 17.0;HMC-1: 18.8;NTERA-2: 16.3;SH-SY5Y: 6.2"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.8;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	39	"T-cells: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468"	Enhanced		Supported	Vesicles	"Secreted in brain"			Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	1.5	5.8	38.9	1.7	23.7	2.1	5.6	9.2	76.0	1.7	1.5	25.8	0.0	1.8	1.6	1.7	1.4	1.6	1.7	1.5	43.4	14.9	2.1	6.0	1.8	3.3	30.3	19.5	1.5	1.7	1.4	0.9	1.4	19.7	4.2	1.5	2.1	2.2	1.8	1.4	1.8	1.6	1.5	45.1	2.1	6.0	1.8	25.2	0.0	7.7	0.0	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	17.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.9	0.0	0.8	1.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	16.3	0.0	0.3	0.0	1.2	0.0	0.1	2.3	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.8	1.9	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.4	38.9	23.7	9.2	33.7	43.4	14.9	30.3	19.5	19.7	25.2
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	460364-563509	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 43.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 25.8;HDLM-2: 9.1;HEK 293: 9.1;NTERA-2: 11.4;U-937: 11.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"			"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favourable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.3	5.7	1.4	2.1	3.8	1.5	1.1	0.3	8.2	6.1	12.8	0.6	0.4	0.8	8.5	2.9	6.0	3.4	9.6	16.8	5.6	0.9	4.1	0.3	6.2	0.2	0.9	1.7	2.1	7.9	2.5	14.7	0.1	2.0	1.6	9.8	1.5	3.8	1.1	2.7	11.0	1.7	1.9	0.5	0.4	43.1	8.0	0.1	1.0	2.1	9.1	4.1	1.8	4.0	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	25.8	0.0	0.0	0.0	0.0	6.4	5.0	0.0	0.6	0.0	2.8	6.4	0.7	0.0	9.1	9.1	0.0	0.0	1.3	0.0	0.0	3.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.4	0.5	0.4	3.5	0.0	6.2	5.5	3.1	2.0	0.6	0.2	0.7	0.6	2.0	0.0	0.0	2.0	0.2	0.6	0.0	0.1	0.1	0.0	11.1	4.3	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	3.8	0.3	8.2	5.6	0.9	0.9	1.7	2.0	0.1
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 55.7;SiHa: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"		98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favourable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	15.9	11.8	2.2	3.0	11.2	19.8	39.9	16.6	20.9	10.0	10.0	7.2	18.6	6.1	10.6	24.2	8.6	2.2	20.6	10.1	55.7	2.2	3.5	49.2	5.5	22.1	2.8	5.9	22.1	36.9	11.4	14.0	10.6	3.9	7.6	9.5	13.9	2.5	5.7	1.3	3.6	3.4	2.0	4.0	30.1	13.9	1.6	2.1	105.0	20.5	4.1	25.9	5.2	9.8	7.2	8.5	23.1	6.4	1.2	2.8	3.8	22.3	3.9	2.6	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"			12000	"Golgi apparatus, Vesicles"		"HPA007620: , HPA047739: "	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavourable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	18.6	8.6	34.5	10.1	22.4	4.6	15.6	8.1	35.7	18.4	16.1	16.1	10.7	9.4	13.3	8.5	20.2	11.4	11.9	23.3	25.3	18.9	8.4	24.2	7.7	4.4	18.9	15.6	15.3	39.5	9.9	10.6	9.9	12.7	13.5	10.4	8.7	21.4	21.5	41.0	19.5	9.4	21.3	16.1	5.2	11.2	11.4	11.3	1.9	9.0	12.1	10.1	16.5	11.7	1.7	0.4	0.1	0.6	0.2	2.6	0.7	19.8	14.5	15.2	25.8	20.6	18.5	15.2	22.6	18.6	18.0	16.5	9.5	17.6	13.1	11.5	36.0	13.8	13.5	23.1	8.4	13.2	25.7	8.7	10.1	21.8	16.7	8.3	0.3	16.1	27.0	12.9	26.4	20.8	16.4	8.5	14.0	14.3	4.3	8.3	21.1	18.2	15.6	20.4	20.5	12.7	9.3	27.6	22.9	9.9	31.2	15.1	13.6	9.9	16.3	31.3	40.2	21.6	25.1	3.0	5.9	5.6	14.0	6.3	20.9	0.0	0.2	0.0	2.6	0.6	2.4	1.7	1.2	2.2	0.4	0.5	0.0	2.0	0.1	0.2	0.1	0.2	1.1	0.7	34.5	22.4	8.1	35.7	25.3	18.9	18.9	15.6	12.7	11.3
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"			74000	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	20.7	18.7	16.5	17.2	22.1	17.3	33.4	20.1	23.2	15.0	19.0	12.4	22.2	18.4	13.6	21.0	20.4	17.2	17.5	17.2	13.4	14.7	22.5	21.7	20.8	21.6	16.4	13.4	25.4	37.5	15.8	29.1	41.0	16.6	18.5	19.3	14.8	33.0	27.8	19.5	20.2	15.1	11.7	14.1	26.6	21.5	28.4	16.4	14.8	28.2	10.7	21.4	20.6	22.9	16.7	22.6	7.1	12.6	15.1	25.5	11.9	9.7	6.5	9.6	12.7	14.3	7.3	15.3	5.6	10.0	11.6	10.7	12.7	19.9	9.0	16.0	6.2	9.9	10.1	6.2	6.9	9.4	12.3	5.1	4.3	10.2	10.3	10.1	14.4	10.2	9.2	10.7	11.6	13.1	16.6	20.3	9.4	10.1	6.6	9.7	12.0	13.8	8.0	5.4	22.2	9.8	6.0	13.7	16.2	5.6	14.8	11.7	14.8	18.5	5.5	5.8	10.5	6.5	16.2	73.3	39.5	12.0	8.6	8.7	9.2	5.1	8.9	7.1	17.6	10.1	15.7	16.7	16.7	16.8	10.8	13.5	16.4	15.4	5.9	15.1	12.6	22.6	25.5	11.9	16.5	22.1	20.1	23.2	13.4	14.7	16.4	13.4	16.6	16.4
B4GALT4	beta4Gal-T4	ENSG00000121578	"Beta-1,4-galactosyltransferase 4"	O60513	3	119211732-119241103	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046819, HPA063546"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"HPA046819: AB_2679824, HPA063546: "	"unprognostic (4.07e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	9.6	7.7	7.0	8.6	8.5	11.6	8.8	5.3	6.6	10.1	20.8	8.2	12.6	14.6	15.1	43.4	13.2	12.6	21.3	11.1	6.0	6.2	15.0	11.8	8.9	8.0	7.7	7.3	13.5	20.8	8.5	16.2	23.7	9.1	9.4	17.9	10.2	10.1	16.1	4.8	10.9	40.4	11.3	9.3	8.2	16.8	5.8	6.5	8.5	10.8	6.5	11.4	13.0	8.7	3.7	4.7	11.2	4.6	11.7	12.2	4.8	17.3	33.6	3.9	2.8	12.2	10.2	20.0	38.0	16.8	17.7	17.8	19.8	5.6	3.8	8.0	19.9	23.8	6.6	5.1	17.9	7.3	2.3	5.1	5.6	10.5	8.4	3.0	4.6	7.3	7.1	7.6	6.0	1.7	3.5	3.9	7.3	6.5	1.4	2.6	5.1	9.1	1.4	3.6	1.4	9.7	19.0	3.4	8.0	9.1	4.0	8.2	8.7	1.4	1.2	8.4	7.7	4.2	4.2	8.8	6.9	4.9	7.0	2.8	7.0	11.2	3.7	6.8	12.2	4.6	6.9	3.7	6.0	6.4	4.7	2.9	11.3	6.8	2.2	11.7	4.0	3.1	2.3	4.8	7.0	8.5	5.3	6.6	6.0	6.2	7.7	7.3	9.1	6.5
BAALC		ENSG00000164929	"BAALC, MAP3K1 and KLF4 binding"	Q8WXS3	8	103140710-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 121.3"	"Cell line enhanced"	"Detected in some"		"AF22: 24.4;BJ hTERT+: 8.5;SCLC-21H: 13.3;SH-SY5Y: 9.8;U-87 MG: 36.2"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"NK-cell: 6.9"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: "	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	7.8	11.1	42.3	3.2	51.9	3.9	3.0	12.5	121.3	2.8	2.9	18.9	0.0	2.3	3.0	2.0	2.2	4.6	2.9	3.2	38.1	34.5	2.8	3.4	4.9	2.6	48.3	25.1	2.7	2.6	1.9	5.2	5.7	41.4	2.0	2.9	0.0	2.1	2.4	3.0	2.7	2.8	3.1	51.2	8.8	2.4	2.6	24.6	0.0	2.8	0.0	2.2	2.8	0.3	0.2	0.1	0.0	0.0	6.9	0.1	0.4	0.2	1.4	24.4	0.2	0.2	7.3	0.0	1.2	8.5	0.0	0.1	0.2	0.0	0.1	0.2	4.6	0.4	0.4	0.0	0.0	0.0	1.4	0.2	0.3	0.0	0.5	0.0	0.5	1.4	1.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.6	0.4	0.1	0.1	0.5	0.0	0.0	13.3	9.8	0.2	0.0	0.0	0.1	0.1	1.4	7.7	0.5	0.2	0.5	0.0	0.1	0.1	36.2	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.4	42.3	51.9	12.5	43.6	38.1	34.5	48.3	25.1	41.4	24.6
BABAM1	"C19orf62, FLJ20571, HSPC142, MERIT40, NBA1"	ENSG00000105393	"BRISC and BRCA1 A complex member 1"	Q9NWV8	19	17267350-17281249	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA054386, HPA068786, HPA077609"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA054386: , HPA068786: , HPA077609: "	"unprognostic (5.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.74e-2)"	23.2	26.7	39.8	24.2	33.6	37.3	23.7	32.5	50.0	25.6	25.6	24.5	18.7	25.5	24.9	20.5	26.3	22.0	26.8	36.8	35.2	33.3	24.0	31.2	21.6	30.7	34.4	33.8	23.6	29.2	22.2	15.7	31.9	25.8	22.7	23.8	20.8	30.5	25.5	72.7	25.0	23.4	23.9	23.3	29.1	24.5	24.6	22.2	34.5	19.2	33.5	31.3	21.4	19.8	44.7	51.6	51.6	50.1	33.2	55.2	59.7	34.9	19.6	19.9	18.8	22.2	15.8	45.3	21.0	28.0	42.5	42.4	22.5	41.9	24.8	50.2	29.1	17.4	23.2	29.1	27.3	35.6	37.1	21.8	26.1	27.2	18.0	39.1	27.9	23.9	20.3	28.1	16.8	35.7	36.3	29.2	30.7	28.6	39.4	37.2	51.8	42.3	26.5	26.3	32.7	31.2	17.3	19.3	34.9	25.5	26.7	22.9	23.4	31.7	25.7	25.9	16.4	31.5	34.9	39.2	46.8	32.7	36.6	51.9	24.3	50.0	50.1	51.6	45.4	46.0	43.4	44.7	42.0	43.8	51.6	43.3	39.2	38.6	12.6	33.2	43.4	42.8	55.2	59.7	39.8	33.6	32.5	50.0	35.2	33.3	34.4	33.8	25.8	22.2
BABAM2	"BRCC4, BRCC45, BRE"	ENSG00000158019	"BRISC and BRCA1 A complex member 2"	Q9NXR7	2	27889941-28338901	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"adrenal gland: 172.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017926	Approved		Supported	Cytosol				Cytosol		"HPA017926: AB_1845443"	"unprognostic (1.28e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavourable (6.33e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.22e-2)"	14.5	172.1	11.7	11.4	19.3	16.9	12.3	9.6	21.3	14.3	11.2	11.3	14.2	8.8	23.2	17.1	12.0	15.5	15.6	25.2	12.5	12.7	25.0	17.1	11.5	18.9	9.9	13.8	16.7	14.5	21.8	23.5	11.6	13.4	11.8	13.1	16.3	10.3	15.6	28.7	11.5	11.1	18.2	9.1	16.7	11.6	26.3	6.7	13.9	11.9	13.6	15.7	14.2	11.8	23.5	39.7	38.6	30.2	24.8	31.7	23.6	14.3	15.8	12.8	13.5	16.5	22.3	12.6	7.3	18.4	13.8	14.3	13.4	14.8	16.3	24.5	17.5	9.6	10.4	19.0	20.3	13.7	13.7	19.4	6.9	14.9	23.9	10.1	15.9	54.2	16.7	19.1	20.0	14.6	9.9	17.9	19.1	12.1	11.7	12.4	9.7	10.4	10.9	20.3	15.6	39.7	7.5	8.4	13.4	8.5	15.1	14.5	10.8	13.4	11.7	13.1	17.6	12.0	9.9	20.4	19.8	21.3	24.4	27.8	13.7	38.6	30.2	12.3	28.5	24.0	31.7	23.5	24.2	26.8	39.7	17.9	23.1	22.0	16.0	24.8	23.3	15.8	27.8	23.6	11.7	19.3	9.6	21.3	12.5	12.7	9.9	13.8	13.4	6.7
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 53.0;pancreas: 161.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (6.76e-4)"	6.5	7.1	12.1	3.8	18.8	2.2	5.5	9.6	22.4	9.8	4.6	42.5	2.7	3.4	9.3	5.6	7.6	8.6	9.1	5.9	16.9	12.4	6.8	12.1	7.3	2.8	28.8	15.0	11.4	161.1	12.8	4.2	6.3	26.4	6.5	4.7	6.9	5.3	9.9	6.2	7.2	3.6	11.7	53.0	5.7	4.9	4.1	21.4	0.0	6.3	2.3	2.8	6.7	5.5	4.0	2.2	0.7	3.2	2.2	6.7	1.1	3.9	4.6	9.6	14.7	32.0	34.5	0.4	21.2	18.5	10.3	8.4	3.6	6.2	0.7	5.2	38.3	6.9	10.3	6.1	8.5	2.3	5.5	2.3	7.9	4.3	15.8	0.8	0.5	29.9	9.5	13.2	12.8	8.9	0.8	0.4	18.9	14.2	0.6	1.9	6.2	10.4	1.8	4.3	0.8	4.4	2.2	12.5	14.0	7.9	1.0	2.3	10.2	2.7	12.1	18.6	2.0	19.4	6.8	0.3	0.3	0.4	8.7	1.2	13.0	0.6	2.0	0.7	2.0	3.2	5.2	4.0	6.7	5.3	2.2	1.8	3.1	2.7	0.0	2.2	1.3	1.3	6.3	1.1	12.1	18.8	9.6	21.7	16.9	12.4	28.8	15.0	26.4	21.4
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926529-90296908	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Group enriched"	"Detected in some"	6	"Daudi: 51.5;U-698: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 15.4"	"Lineage enriched"	"Detected in many"	4	"B-cells: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051384: , HPA058384: "	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	2.9	2.1	5.3	29.8	5.6	18.5	4.1	11.4	6.9	5.4	2.2	6.3	1.0	1.3	6.8	2.1	1.9	3.0	2.3	2.6	5.2	2.9	1.7	5.8	5.8	26.7	5.2	4.0	6.3	4.0	5.8	1.9	2.4	4.9	3.7	1.7	0.9	5.2	2.2	7.9	5.4	6.5	2.8	5.2	7.6	1.8	3.4	6.9	26.9	2.0	2.4	20.6	4.8	3.3	15.4	0.2	1.8	0.0	1.5	3.7	0.4	0.3	0.0	1.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	51.5	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	1.1	0.0	2.0	4.5	0.0	0.1	1.0	0.0	0.5	0.4	7.0	1.3	0.9	0.0	0.1	1.7	4.8	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.7	0.0	0.0	3.4	0.1	30.2	0.2	0.5	0.3	1.8	0.0	0.7	0.4	0.0	0.8	2.1	0.8	0.7	0.2	15.4	3.7	2.4	0.0	1.5	0.0	0.2	0.1	0.4	5.3	5.6	11.4	6.9	5.2	2.9	5.2	4.0	4.9	6.9
BAD	"BBC2, BCL2L8"	ENSG00000002330	"BCL2 associated agonist of cell death"	Q92934	11	64269830-64284704	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004205, HPA028185, HPA062105"	Approved		Enhanced	Mitochondria				Mitochondria		"CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: "	"unprognostic (1.47e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-2)"	23.1	23.2	35.3	12.6	30.7	17.7	20.6	15.9	43.9	21.2	25.7	22.7	20.1	24.0	18.3	19.7	18.8	23.2	22.5	30.3	32.7	23.8	21.4	22.3	17.7	14.3	29.6	20.2	18.8	26.9	19.4	15.2	24.9	18.4	22.9	13.6	23.1	39.9	27.0	23.9	20.4	21.1	17.2	22.9	14.9	37.8	18.6	14.8	19.3	29.2	15.8	14.1	18.2	14.4	26.5	42.0	43.5	32.3	24.0	30.7	23.1	31.9	30.1	8.8	13.2	10.7	13.1	12.9	13.6	15.9	21.0	16.7	18.3	18.4	6.9	24.5	12.7	17.0	5.7	21.4	4.2	26.7	21.0	8.5	27.2	8.7	16.5	7.4	16.0	12.6	18.5	16.1	9.9	13.2	3.2	14.9	9.1	31.8	16.5	16.7	3.4	38.5	15.7	5.2	19.3	12.7	15.1	18.2	24.4	13.7	16.3	16.6	24.5	11.1	10.9	25.7	17.4	39.8	14.9	28.3	21.0	7.0	21.0	5.3	14.0	32.5	32.3	43.5	25.3	24.0	25.8	26.0	26.9	24.6	22.5	26.5	19.4	20.0	41.7	24.0	22.6	42.0	30.7	23.1	35.3	30.7	15.9	43.9	32.7	23.8	29.6	20.2	18.4	14.8
BAG1		ENSG00000107262	"BCL2 associated athanogene 1"	Q99933	9	33247820-33264720	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 81.3;NB-4: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002486, HPA018121"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB002486: AB_563422, HPA018121: AB_1845255"	"unprognostic (4.49e-3)"	"unprognostic (4.52e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.23e-1)"	"prognostic favourable (2.22e-16)"	"unprognostic (4.45e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-2)"	21.5	22.1	30.0	14.6	34.3	25.2	28.6	21.2	25.0	21.4	32.0	18.3	19.5	20.8	15.5	20.4	26.9	17.4	34.8	48.6	25.0	24.3	41.9	34.5	21.2	14.1	33.8	20.1	14.4	43.2	40.9	24.9	16.6	20.0	24.7	27.7	18.2	38.5	26.4	93.2	26.7	27.2	22.2	27.7	21.4	32.5	46.0	20.5	14.9	29.7	41.9	21.2	30.8	27.3	10.2	18.8	29.4	11.6	8.2	9.0	5.1	10.4	10.4	8.9	19.5	13.6	8.0	12.4	8.5	12.2	13.1	13.5	7.3	10.1	34.7	6.4	8.6	13.2	10.3	7.0	8.7	17.5	9.7	17.3	81.3	11.4	11.5	39.5	21.1	8.1	39.3	6.1	14.8	15.5	19.9	17.4	10.8	16.4	27.0	77.7	17.2	15.3	14.2	12.7	22.3	16.6	30.6	28.5	17.1	38.0	33.5	8.5	15.2	48.2	8.2	5.9	7.5	17.2	14.8	13.9	21.5	18.8	4.9	21.4	3.3	12.2	11.5	29.4	5.8	11.6	5.2	6.8	6.6	6.9	14.0	10.2	9.0	5.4	7.0	8.2	11.2	18.8	7.8	5.1	30.0	34.3	21.2	25.0	25.0	24.3	33.8	20.1	20.0	20.5
BAG2		ENSG00000112208	"BCL2 associated athanogene 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 67.0;urinary bladder: 51.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavourable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (6.24e-3)"	3.4	3.5	3.7	8.7	2.8	1.2	4.6	4.1	3.4	18.4	24.5	0.8	14.8	1.9	29.4	9.5	13.4	5.9	6.9	17.2	3.3	3.5	3.7	3.8	4.1	2.3	3.3	2.3	15.4	1.5	0.6	4.5	6.7	3.4	23.7	4.3	2.6	1.5	15.1	9.9	1.7	5.7	67.0	3.4	1.3	7.4	6.7	2.6	1.6	7.6	6.0	1.9	51.0	17.1	5.9	1.4	0.9	0.4	3.3	6.1	1.9	9.3	5.2	2.2	7.8	5.5	15.9	6.2	15.2	14.5	11.0	10.5	6.7	4.8	3.1	14.6	24.0	1.7	12.6	1.3	10.6	9.9	9.3	9.1	7.8	15.1	8.5	8.0	2.1	7.7	0.7	9.0	8.5	8.5	18.4	4.5	10.8	0.7	5.6	6.7	8.4	5.4	5.2	6.2	6.3	13.1	1.5	2.8	2.5	6.8	0.5	5.5	1.2	7.0	11.6	6.3	10.3	13.2	15.0	3.0	2.9	6.9	5.6	3.2	0.6	0.1	0.3	0.9	3.3	0.4	3.9	5.9	3.1	3.3	1.4	4.3	6.1	5.1	0.3	3.3	0.1	0.5	3.2	1.9	3.7	2.8	4.1	3.4	3.3	3.5	3.3	2.3	3.4	2.6
BAG3		ENSG00000151929	"BCL2 associated athanogene 3"	O95817	10	119651370-119677819	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 115.2;vagina: 160.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.6"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			890000	"Plasma membrane, Cytosol"		"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	17.8	14.1	18.8	7.7	25.7	2.7	38.3	18.4	20.7	11.7	14.1	7.3	6.5	6.3	10.1	10.6	23.3	8.7	17.0	38.2	20.6	14.3	16.8	10.1	14.3	5.9	20.9	4.5	7.3	9.3	27.6	8.8	16.5	27.4	14.4	6.7	5.5	14.6	12.9	115.2	18.5	5.6	20.4	35.8	4.4	15.1	8.1	20.6	1.3	11.1	32.7	12.8	14.0	160.1	0.3	0.8	0.4	1.1	0.2	7.6	1.0	26.1	29.8	8.3	10.8	21.6	15.2	15.6	23.9	20.3	18.3	15.8	12.6	12.8	1.0	11.4	20.5	39.1	8.5	42.2	12.7	12.8	14.0	1.4	8.0	15.7	18.3	0.0	6.1	15.3	24.4	13.3	21.1	20.4	11.2	6.5	18.2	37.4	1.4	5.8	3.2	34.1	0.0	11.8	4.5	13.8	5.9	1.5	1.4	9.5	16.9	12.4	10.5	3.5	25.4	9.7	8.4	13.1	34.1	6.0	3.5	0.6	18.1	0.4	7.3	0.0	1.0	0.0	1.2	1.1	2.0	0.3	4.4	1.5	0.8	0.0	7.6	2.7	0.4	0.2	0.5	0.2	3.0	1.0	18.8	25.7	18.4	20.7	20.6	14.3	20.9	4.5	27.4	20.6
BAG5		ENSG00000166170	"BCL2 associated athanogene 5"	Q9UL15	14	103556544-103562831	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016429	Enhanced		Supported	Vesicles				Vesicles		"HPA016429: AB_1845261"	"unprognostic (3.02e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.80e-2)"	"prognostic favourable (1.58e-8)"	"unprognostic (2.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.53e-1)"	16.0	6.7	8.4	8.1	9.4	13.2	10.6	14.8	10.6	11.5	10.1	10.6	9.5	7.0	11.7	9.5	13.6	9.3	7.4	7.3	8.9	8.4	13.5	8.5	8.8	9.3	8.7	7.6	11.4	7.0	9.0	13.2	16.1	10.3	10.3	8.4	8.2	10.4	11.2	9.3	13.1	11.5	10.7	9.7	11.9	8.4	69.8	8.6	11.1	17.0	10.7	11.8	11.7	9.4	10.1	15.3	22.8	21.2	14.7	14.2	12.7	14.6	13.4	16.0	14.3	14.8	15.1	18.0	16.9	11.8	12.1	11.4	11.1	17.4	26.0	15.0	16.5	21.3	12.7	17.9	19.3	11.9	9.6	17.1	15.7	8.2	9.5	22.5	17.6	10.7	23.2	12.7	15.9	12.5	13.7	19.1	16.3	17.7	20.8	10.0	9.6	16.4	21.4	20.2	11.0	19.7	37.6	18.6	12.4	19.7	16.0	12.8	20.8	12.1	16.8	13.3	11.5	20.6	17.2	13.2	20.7	30.6	15.0	11.8	16.5	22.8	14.1	12.8	11.6	15.7	13.9	8.3	12.8	10.8	15.3	10.1	14.2	12.9	10.7	14.7	21.2	7.2	11.3	12.7	8.4	9.4	14.8	10.6	8.9	8.4	8.7	7.6	10.3	8.6
BAG6	"BAT3, D6S52E, G3"	ENSG00000204463	"BCL2 associated athanogene 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"		2000000	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: , HPA053291: "	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	20.8	30.1	16.1	18.4	21.7	16.9	18.1	22.1	31.2	23.9	23.8	22.3	17.9	38.2	25.1	38.6	19.9	23.8	21.4	25.5	15.1	14.1	20.6	41.8	25.7	18.1	15.9	15.6	22.0	22.2	6.6	20.7	27.0	17.5	20.5	30.7	24.4	20.9	19.6	50.5	22.3	31.0	17.3	13.2	23.7	26.1	101.8	16.2	39.9	22.9	30.4	27.1	18.3	19.3	4.8	8.4	8.2	7.5	3.2	6.3	3.1	1.9	14.2	16.6	3.3	8.3	12.8	3.7	3.4	2.7	3.3	3.5	35.3	1.6	2.5	25.7	27.5	2.4	2.0	29.1	5.3	4.1	39.0	11.0	1.8	22.5	12.5	3.2	32.6	10.3	11.8	2.9	3.8	9.5	20.7	11.4	23.8	5.5	2.0	19.4	2.1	2.6	4.8	2.2	4.5	14.2	5.1	2.4	4.5	1.2	4.1	3.3	29.8	27.4	1.8	11.3	8.6	1.9	3.3	15.0	19.8	21.8	15.3	2.7	3.5	8.2	5.7	6.6	6.3	7.5	5.0	4.4	4.4	4.1	4.5	4.8	3.5	4.2	5.8	3.2	6.8	8.4	3.0	3.1	16.1	21.7	22.1	31.2	15.1	14.1	15.9	15.6	17.5	16.2
BAHD1	KIAA0945	ENSG00000140320	"Bromo adjacent homology domain containing 1"	Q8TBE0	15	40439721-40468242	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041196			Supported	Nucleoplasm				Nucleoplasm		"HPA041196: AB_10803999"	"prognostic unfavourable (1.55e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.81e-2)"	"prognostic favourable (1.29e-10)"	"unprognostic (4.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	12.7	24.3	11.8	15.7	13.8	10.1	19.5	11.3	16.1	12.1	12.5	10.6	19.1	13.0	15.0	15.6	13.1	15.8	13.2	12.8	12.7	8.7	13.8	13.8	14.8	13.5	12.9	13.2	26.1	16.6	19.6	15.6	14.4	10.9	13.6	8.7	10.2	14.1	16.1	13.5	13.4	13.0	11.3	9.1	14.5	13.8	21.7	12.2	18.4	23.9	8.0	12.9	15.7	22.5	2.4	1.8	3.8	3.2	3.9	4.1	1.2	9.8	5.0	9.0	14.8	7.3	5.7	19.7	8.1	5.8	8.9	8.8	13.8	4.7	7.4	10.9	7.2	19.8	14.6	6.1	5.0	14.2	9.3	19.5	7.8	6.7	6.9	8.4	14.8	7.5	6.2	5.4	5.4	7.6	19.1	6.3	5.2	9.3	9.3	12.7	8.9	9.5	16.1	10.2	6.1	9.8	11.8	14.2	8.6	4.9	26.1	5.7	20.9	13.6	8.9	9.7	10.9	13.7	8.3	9.6	10.5	8.5	10.1	13.1	6.5	1.9	0.9	3.8	4.1	1.8	2.2	1.7	2.9	2.3	1.0	2.4	3.8	3.3	1.0	3.9	3.2	1.8	0.9	1.2	11.8	13.8	11.3	16.1	12.7	8.7	12.9	13.2	10.9	12.2
BAIAP2	"BAP2, IRSp53"	ENSG00000175866	"BAI1 associated protein 2"	Q9UQB8	17	81035122-81117432	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023310, HPA027421"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023310: AB_1845264, HPA027421: AB_10602392"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (7.58e-6)"	10.1	10.9	29.0	4.1	37.4	1.7	11.5	19.6	45.3	14.6	11.8	11.4	18.0	4.3	10.1	26.0	45.9	20.6	17.6	8.7	22.1	10.6	20.6	26.3	20.0	3.6	7.3	24.3	5.1	7.6	8.4	19.2	17.0	9.8	25.7	7.1	11.8	17.0	17.1	3.9	52.6	4.9	10.8	5.4	6.2	20.1	9.2	12.3	2.1	10.2	20.1	20.2	11.1	20.5	0.1	15.4	4.8	7.8	1.3	2.7	2.3	29.9	13.8	8.9	11.5	7.1	9.5	10.3	12.4	8.1	11.2	5.0	18.7	15.2	0.1	9.0	10.9	29.2	8.1	14.2	4.3	0.1	10.2	6.1	12.2	13.9	6.6	0.0	8.9	4.0	16.8	9.2	4.9	6.0	7.8	0.2	6.4	15.9	1.2	6.7	3.7	12.2	1.8	2.2	24.6	34.3	10.5	11.7	12.8	19.8	28.7	33.3	25.2	6.9	7.3	26.2	24.9	4.3	13.1	0.4	0.1	0.4	22.8	1.0	5.6	0.0	5.9	0.4	2.7	7.8	0.9	0.1	1.0	0.9	8.3	0.1	1.2	1.5	4.8	1.3	7.2	15.4	0.4	2.3	29.0	37.4	19.6	45.3	22.1	10.6	7.3	24.3	9.8	12.3
BAIAP2L1	IRTKS	ENSG00000006453	"BAI1 associated protein 2 like 1"	Q9UHR4	7	98291651-98401068	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA019484, HPA021257, HPA023874, HPA029503"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330"	"unprognostic (1.75e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.31e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	4.7	11.2	1.3	16.9	1.1	0.0	10.3	0.3	0.9	6.1	27.3	1.1	10.8	16.2	3.6	4.7	17.9	6.8	29.6	2.1	0.7	0.6	8.9	31.0	15.4	0.9	0.8	0.2	2.6	47.4	4.7	16.9	17.0	1.2	15.2	12.5	6.5	14.7	12.3	3.3	11.3	34.0	3.4	0.7	1.4	33.0	11.6	0.4	2.1	18.0	11.2	14.1	18.9	12.9	1.3	2.7	0.1	0.2	0.0	0.9	0.1	16.0	12.8	0.3	0.3	0.0	0.6	21.5	4.1	2.7	2.2	1.6	17.7	24.2	0.7	6.2	1.5	14.3	6.0	17.6	2.0	0.0	7.7	0.0	5.5	10.1	2.7	0.0	5.8	0.6	23.9	1.2	17.6	0.0	9.5	0.0	1.8	13.5	0.0	0.0	10.1	6.9	0.0	0.2	2.6	13.7	14.2	9.2	1.8	9.6	28.0	4.9	7.8	0.4	0.5	3.2	15.6	0.6	1.9	0.3	4.8	8.1	0.3	2.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	1.3	0.9	0.2	0.1	0.0	0.2	2.7	0.1	0.1	1.3	1.1	0.3	0.9	0.7	0.6	0.8	0.2	1.2	0.4
BANF1	BAF	ENSG00000175334	"Barrier to autointegration factor 1"	O75531	11	66002079-66004149	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB032896, HPA039242"	Enhanced		Supported	Nucleoplasm,Cytosol			77000	Nucleoplasm	Cytosol	"CAB032896: AB_2061090, HPA039242: "	"unprognostic (1.69e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.16e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.57e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	31.2	39.7	38.2	31.6	33.9	24.0	33.5	30.8	38.1	40.7	32.4	33.2	26.5	25.0	38.8	44.4	43.8	58.4	33.4	51.0	35.4	32.5	38.6	61.0	24.6	35.7	33.8	24.7	60.0	40.8	33.5	27.3	40.1	27.5	52.6	33.1	31.1	38.0	38.8	112.7	25.5	29.9	38.9	35.8	39.7	26.8	44.2	27.8	57.6	71.5	54.5	43.8	36.4	45.8	40.0	44.6	14.7	42.8	32.5	30.4	43.8	62.7	63.5	42.8	41.5	21.9	29.1	21.6	34.9	32.6	65.2	41.3	36.8	50.6	54.4	64.5	46.1	44.2	56.2	58.2	47.9	42.7	33.6	63.2	40.2	45.7	26.8	45.7	48.8	27.0	37.5	41.6	36.7	47.5	50.3	43.7	62.9	101.7	51.2	89.9	48.4	44.5	48.1	42.4	123.3	58.6	31.9	34.6	44.6	37.8	62.6	43.3	69.7	35.3	32.9	50.0	55.5	56.5	48.7	32.1	57.9	68.1	43.9	39.1	45.4	14.7	41.6	13.9	29.2	41.7	27.6	40.0	24.5	28.3	44.6	37.8	28.3	30.4	4.4	32.5	42.8	40.0	20.6	43.8	38.2	33.9	30.8	38.1	35.4	32.5	33.8	24.7	27.5	27.8
BANP	"BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1"	ENSG00000172530	"BTG3 associated nuclear protein"	Q8N9N5	16	87949244-88077318	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047164	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA047164: "	"unprognostic (1.82e-1)"	"unprognostic (7.84e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.89e-2)"	11.9	14.2	17.0	19.4	20.7	21.1	15.4	35.8	21.5	13.6	11.3	11.8	22.0	10.1	14.3	7.2	10.7	13.5	10.0	10.9	13.2	9.0	10.9	17.6	13.4	17.1	24.4	8.9	18.2	12.7	16.5	15.2	14.9	18.3	12.9	7.5	11.7	12.4	17.7	13.6	12.2	12.4	9.0	16.3	17.7	10.3	19.0	23.3	23.2	13.8	8.0	13.0	12.1	27.5	14.4	16.4	36.0	11.4	12.8	15.2	10.2	8.8	14.2	7.0	10.5	6.3	7.7	23.9	10.7	5.5	10.6	7.2	15.4	12.4	11.9	14.6	2.5	10.2	10.6	4.9	3.8	9.2	11.3	7.5	8.8	12.7	5.4	7.9	6.1	2.3	7.9	6.5	4.7	6.5	12.4	6.9	6.4	10.3	10.8	10.3	12.3	17.2	11.7	8.2	8.6	6.3	4.2	10.5	8.7	13.6	8.1	9.9	9.9	10.2	7.9	11.5	8.0	6.7	10.5	5.6	9.6	18.5	6.9	12.2	11.0	12.1	11.2	21.7	13.3	9.9	11.0	14.4	14.0	11.6	13.7	13.2	15.2	13.4	36.0	12.8	11.4	16.4	12.3	10.2	17.0	20.7	35.8	21.5	13.2	9.0	24.4	8.9	18.3	23.3
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401013-52410350	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: , HPA055560: "	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favourable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	13.8	17.6	35.6	14.7	33.3	37.3	13.5	21.8	50.4	12.5	17.0	16.3	11.5	12.4	14.7	14.6	21.2	12.1	15.7	16.4	41.5	15.5	16.6	19.0	14.9	15.2	19.4	27.6	16.9	16.3	30.0	11.1	14.8	19.6	14.4	14.9	15.6	17.9	14.6	24.8	40.5	13.9	14.5	10.0	16.1	13.3	37.3	14.7	18.6	15.3	12.9	16.0	14.1	11.7	5.5	8.4	11.3	5.0	3.0	8.5	3.9	15.3	17.5	21.2	18.0	20.5	13.2	23.9	15.2	19.7	24.7	19.2	21.1	14.4	22.0	7.6	21.2	12.5	22.3	24.5	15.8	21.8	21.1	27.3	37.0	21.8	19.1	25.6	24.3	19.7	32.9	27.3	14.7	19.7	23.3	19.5	18.6	13.3	30.3	35.1	23.9	21.3	13.1	17.2	21.7	15.2	24.9	8.1	26.1	18.7	5.4	22.2	15.3	35.4	21.1	22.4	20.6	26.8	28.2	29.6	38.9	31.5	24.4	27.0	26.4	3.4	5.0	7.4	8.5	3.9	4.0	5.0	6.8	6.9	3.3	5.5	4.9	6.4	11.3	3.0	3.1	8.4	6.0	3.9	35.6	33.3	21.8	50.4	41.5	15.5	19.4	27.6	19.6	14.7
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: , HPA044864: "	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	4.4	1.9	3.2	11.8	4.8	16.1	4.9	1.2	5.8	7.3	5.4	5.4	3.6	3.7	6.8	5.0	10.0	4.1	3.9	3.6	3.4	2.8	2.2	2.1	5.3	8.2	5.1	1.9	5.8	3.7	3.6	6.3	3.8	4.5	5.7	6.1	1.9	4.7	6.5	12.4	16.3	4.5	7.5	5.3	4.7	3.8	9.5	3.9	25.8	4.0	8.0	9.9	8.3	7.8	9.7	6.6	6.0	3.4	6.1	16.0	2.0	7.7	4.3	11.7	6.0	1.6	2.0	8.0	9.4	5.5	9.3	10.7	5.4	7.7	8.3	4.5	3.9	8.5	8.4	5.5	13.3	6.6	4.4	8.3	7.9	5.7	0.6	9.2	8.4	2.7	0.8	8.2	4.5	3.1	4.6	23.5	8.9	6.4	16.5	9.6	9.2	2.2	14.3	11.8	7.5	2.7	6.5	3.7	5.9	8.6	9.9	3.4	10.2	9.2	2.7	12.0	8.4	7.0	8.5	7.1	7.9	16.9	4.8	7.0	8.0	2.9	1.7	6.0	4.8	3.4	3.1	8.9	5.3	5.2	3.0	9.7	2.5	3.6	0.5	6.1	2.9	6.6	16.0	2.0	3.2	4.8	1.2	5.8	3.4	2.8	5.1	1.9	4.5	3.9
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 59.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033311, HPA068414"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB033311: AB_781574, HPA068414: "	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	7.7	0.0	1.9	0.0	59.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	7.3	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.3;epididymis: 126.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 113.7;SiHa: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 42.4"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 42.4"	"Low region specificity"	"Detected in many"							"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"			85000000	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: "	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	9.2	6.7	64.3	28.4	37.4	31.1	4.8	37.2	107.3	16.2	5.2	4.0	15.1	3.8	15.5	126.9	4.0	3.6	12.7	4.4	65.0	55.8	4.2	7.7	9.1	30.2	30.1	56.6	11.7	2.5	3.6	6.4	36.4	21.9	32.2	5.5	7.9	3.8	11.5	1.6	6.0	5.7	14.2	11.0	21.9	9.2	2.2	4.3	3.7	3.6	1.3	35.4	17.6	13.0	2.5	1.6	42.4	1.1	0.6	0.1	0.2	0.0	17.0	21.2	0.0	10.2	10.9	30.4	21.2	7.0	17.9	19.0	0.8	0.0	6.6	3.0	15.2	1.4	13.5	14.8	23.3	2.7	7.6	0.0	113.7	0.0	22.7	13.1	0.1	18.7	18.5	20.2	17.0	19.3	0.0	0.0	19.0	24.4	0.0	12.0	15.6	5.2	0.0	0.0	3.6	6.4	4.2	13.6	2.8	109.2	10.0	0.0	0.0	13.6	24.6	23.7	0.0	1.9	3.4	0.2	0.0	3.5	23.9	16.3	3.1	6.2	1.1	7.8	0.0	0.4	0.0	1.8	0.0	0.0	1.6	2.5	0.0	0.0	42.4	0.6	0.6	0.1	0.1	0.2	64.3	37.4	37.2	107.3	65.0	55.8	30.1	56.6	21.9	4.3
BATF	"B-ATF, BATF1, SFA-2"	ENSG00000156127	"Basic leucine zipper ATF-like transcription factor"	Q16520	14	75522425-75547015	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.1;lymphoid tissue: 26.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 81.1;MCF7: 30.5;RT4: 19.1;SK-BR-3: 15.6;U-937: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"T-cells: 41.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA059588, HPA064962"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA059588: , HPA064962: "	"unprognostic (3.33e-3)"	"unprognostic (4.87e-3)"	"prognostic unfavourable (8.30e-4)"	"prognostic favourable (5.35e-6)"	"unprognostic (3.02e-2)"	"prognostic favourable (7.91e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavourable (3.74e-9)"	"unprognostic (4.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (4.30e-4)"	4.9	1.3	0.9	15.8	4.7	13.8	7.6	0.2	1.9	2.8	2.8	0.2	1.0	2.0	1.3	1.4	2.6	1.9	7.0	3.1	1.0	0.7	1.9	3.0	7.9	20.2	2.1	0.2	1.6	1.6	0.5	1.2	3.7	1.9	5.2	1.1	1.0	6.0	8.3	0.9	2.8	8.0	2.6	2.7	26.6	5.7	0.7	1.9	6.2	2.7	3.4	23.1	10.4	7.3	7.1	9.0	5.0	8.9	6.4	41.1	8.4	1.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.1	0.0	1.8	0.0	0.3	2.7	2.2	8.4	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.0	30.5	1.0	6.6	0.0	0.0	0.2	0.0	1.4	0.0	19.1	0.0	0.0	0.0	15.6	0.6	1.4	4.2	0.0	0.0	0.0	1.0	0.0	7.6	8.0	0.0	0.0	22.5	0.0	1.2	8.9	2.7	19.6	4.9	15.4	7.1	21.4	25.1	9.0	5.2	8.6	18.1	5.0	6.4	4.2	1.0	41.1	8.4	0.9	4.7	0.2	1.9	1.0	0.7	2.1	0.2	1.9	1.9
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440398-73522278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA067010"	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB037081: AB_477637, CAB037158: AB_477636, HPA067010: "	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	23.3	22.3	21.4	26.4	23.9	20.7	24.6	32.4	23.4	24.6	24.2	21.1	34.1	15.3	26.3	19.8	18.1	20.6	16.5	19.8	22.4	21.4	17.1	23.4	19.4	24.7	29.3	19.4	31.8	20.2	34.9	27.0	23.1	22.3	23.1	20.5	16.4	18.0	30.8	28.9	14.6	19.2	28.7	22.9	22.2	18.8	16.2	27.3	46.5	23.5	17.9	27.7	24.7	24.4	5.3	6.2	6.1	3.1	5.6	6.3	1.7	20.6	21.3	29.4	32.8	15.2	16.3	9.8	20.1	15.5	19.4	20.5	17.3	15.7	39.1	4.7	17.9	14.6	35.7	13.4	29.3	22.0	18.1	23.3	25.3	14.9	17.0	35.1	19.7	11.6	13.1	23.9	29.5	15.4	40.5	24.6	21.7	19.6	35.9	16.2	19.0	16.0	36.6	25.8	26.0	11.0	16.3	29.5	25.2	28.7	32.1	16.8	19.7	17.6	18.0	33.7	19.4	20.2	34.2	14.3	22.7	67.1	19.1	33.3	30.5	6.1	3.1	1.9	6.3	2.2	5.5	2.5	4.8	4.6	2.1	5.3	3.8	4.1	2.2	5.6	1.7	6.2	4.7	1.7	21.4	23.9	32.4	23.4	22.4	21.4	29.3	19.4	22.3	27.3
BAZ2A	"KIAA0314, TIP5, WALp3"	ENSG00000076108	"Bromodomain adjacent to zinc finger domain 2A"	Q9UIF9	12	56595596-56636816	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005782, HPA063806"			Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA005782: AB_10601089, HPA063806: "	"unprognostic (1.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.43e-1)"	25.5	22.8	18.2	25.5	22.4	45.5	25.5	39.0	26.0	25.6	23.2	24.6	23.2	20.1	25.2	21.8	28.0	21.5	24.1	19.1	18.7	11.6	19.9	19.7	31.5	25.0	23.1	13.5	32.6	26.2	33.8	36.1	29.0	19.4	21.9	22.1	27.6	24.0	34.5	24.7	26.0	27.6	19.4	19.2	32.9	20.9	34.1	24.4	46.1	26.4	19.6	30.3	27.3	30.5	5.1	8.6	20.1	9.0	12.6	3.6	1.7	20.4	20.8	27.0	22.5	15.7	16.0	27.2	14.2	19.6	20.2	14.9	24.5	24.8	30.3	21.1	16.6	17.7	31.9	18.8	18.7	19.4	17.1	34.3	12.8	12.4	17.4	19.7	25.9	14.1	19.5	17.5	25.5	20.2	36.4	36.7	11.6	13.1	16.3	13.2	24.6	15.9	13.9	20.0	20.6	14.6	20.2	18.3	15.1	23.8	25.0	13.1	27.6	18.1	27.8	10.2	20.4	13.3	10.0	20.5	19.2	28.1	9.8	14.3	15.3	6.5	5.1	3.7	3.6	4.5	3.0	4.3	2.8	2.7	1.8	5.1	2.4	2.1	20.1	12.6	9.0	8.6	2.5	1.7	18.2	22.4	39.0	26.0	18.7	11.6	23.1	13.5	19.4	24.4
BBS4		ENSG00000140463	"Bardet-Biedl syndrome 4"	Q96RK4	15	72686179-72738476	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039418	Approved		Supported	Cytosol				Cytosol		"HPA039418: AB_10672962"	"unprognostic (3.47e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	"prognostic favourable (2.57e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.76e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.05e-1)"	8.9	15.5	11.1	8.5	16.6	7.3	12.4	10.7	17.9	14.9	10.6	17.2	9.8	5.6	14.1	18.0	8.1	19.9	10.4	11.9	11.2	13.6	17.5	13.6	11.4	8.0	12.1	14.5	14.8	11.1	16.9	31.3	8.6	23.8	23.8	8.8	29.8	7.8	11.0	17.2	10.1	8.0	12.9	13.2	7.6	10.5	25.7	10.2	13.1	18.0	6.0	8.3	12.4	9.6	6.0	3.8	4.8	4.0	13.0	7.9	3.5	3.1	8.3	18.5	7.8	9.1	11.3	4.9	6.3	13.2	6.3	8.1	4.3	10.8	5.1	13.5	5.3	4.7	4.8	5.2	5.7	5.3	5.9	6.0	7.4	4.8	7.6	5.3	4.7	10.5	7.2	8.9	7.0	4.8	13.0	4.5	9.8	5.6	4.8	5.0	25.8	3.7	3.3	9.2	6.4	10.6	8.0	9.0	10.5	11.1	8.2	16.3	11.0	5.9	6.7	7.2	5.6	34.1	3.5	9.4	9.1	10.8	8.2	8.0	9.7	4.8	2.4	3.8	6.9	4.0	6.7	5.5	5.8	7.2	2.0	6.0	6.1	7.9	2.0	13.0	2.9	3.8	6.8	3.5	11.1	16.6	10.7	17.9	11.2	13.6	12.1	14.5	23.8	10.2
BBX	"HBP2, HSPC339, MDS001"	ENSG00000114439	"BBX, HMG-box containing"	Q8WY36	3	107522936-107811324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006049, HPA050646"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006049: , HPA050646: "	"unprognostic (7.57e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	10.6	22.6	13.1	11.0	20.6	11.2	10.8	12.8	15.1	14.3	13.2	15.4	27.8	6.7	15.1	28.3	10.2	13.2	12.7	11.5	14.8	11.6	14.9	7.3	10.8	10.4	24.5	9.0	21.0	9.0	35.7	39.6	17.8	17.5	17.4	7.3	9.1	11.8	25.1	8.5	7.5	9.4	14.0	26.7	14.1	9.6	43.9	25.5	13.5	19.3	8.0	10.1	15.9	15.6	33.7	16.3	25.2	17.5	25.2	26.1	11.4	18.7	17.4	15.0	22.5	13.4	19.5	12.2	17.8	18.4	16.2	18.0	1.9	15.3	9.7	22.3	11.3	13.0	16.8	21.7	24.5	12.6	7.8	14.6	14.1	4.1	15.9	20.0	9.0	16.3	15.9	16.3	32.8	13.6	6.7	14.7	13.7	6.2	11.3	2.0	7.3	14.8	16.0	14.2	11.0	10.3	14.2	10.8	11.0	31.5	3.1	15.5	12.5	4.5	17.8	19.9	14.8	7.3	12.7	6.3	4.2	11.0	18.0	10.4	11.5	25.2	9.1	21.6	22.6	9.2	26.1	32.8	20.3	22.8	12.7	33.7	25.7	21.1	14.9	25.2	17.5	16.3	13.4	11.4	13.1	20.6	12.8	15.1	14.8	11.6	24.5	9.0	17.5	25.5
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724746	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"			6800000	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	60.7	43.4	38.3	20.3	38.8	27.4	71.3	22.2	48.1	28.7	31.8	27.1	27.5	28.8	30.2	48.6	42.4	31.0	26.8	26.7	34.1	36.5	41.6	52.4	42.2	50.0	38.1	26.0	29.1	67.6	36.0	27.4	43.6	44.5	34.3	36.6	30.7	44.5	37.7	15.6	37.3	37.8	32.4	33.6	36.7	24.8	31.6	21.1	25.4	53.1	27.2	37.1	38.1	30.8	72.7	109.7	104.4	97.5	68.2	89.8	150.4	54.7	51.7	14.4	71.8	63.8	19.4	33.3	26.6	30.6	31.8	40.8	41.6	40.3	32.1	121.7	43.1	55.6	35.8	55.9	26.6	15.8	53.4	20.2	40.9	35.7	31.3	32.9	43.9	25.8	48.6	30.9	36.4	38.8	27.4	58.6	35.5	57.3	21.1	44.8	16.4	53.5	23.0	16.0	71.9	49.7	60.2	18.8	26.6	11.9	59.3	40.0	21.7	37.2	40.4	27.9	27.5	37.7	53.3	60.1	115.8	42.6	54.5	44.6	24.4	80.3	80.6	77.5	89.0	86.1	79.5	71.2	89.8	88.1	69.9	72.7	79.4	86.4	104.4	68.2	97.5	109.7	72.4	150.4	38.3	38.8	22.2	48.1	34.1	36.5	38.1	26.0	44.5	21.1
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2, pre-mRNA processing factor"	O75934	1	114567557-114581639	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"				"Nuclear speckles, Centrosome"		"HPA067881: "	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favourable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (4.27e-4)"	"prognostic favourable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (5.24e-4)"	"unprognostic (1.87e-1)"	23.2	28.0	36.7	17.6	34.1	43.0	25.0	30.4	40.6	21.3	19.7	16.5	17.3	16.7	22.9	33.2	26.0	16.6	20.7	24.5	31.6	41.8	28.7	32.9	17.5	22.4	37.0	28.8	26.8	18.2	22.9	32.5	17.4	39.0	24.1	21.0	13.9	19.5	26.7	38.4	19.0	19.0	20.1	26.9	20.8	18.3	21.2	24.6	20.0	27.8	24.5	22.1	31.1	19.5	30.4	24.8	30.9	22.6	35.4	40.1	32.9	18.9	6.9	14.4	13.6	7.7	9.0	21.6	14.3	11.0	19.0	19.6	9.7	7.8	16.9	19.8	9.2	9.3	16.7	14.1	26.5	15.2	15.0	8.8	13.8	14.0	13.9	22.2	9.6	8.1	15.5	19.6	24.3	12.4	16.9	12.7	15.6	116.3	19.8	16.6	24.9	15.8	14.2	25.4	11.8	13.3	16.6	18.8	12.5	17.8	13.8	21.9	12.2	17.6	10.8	11.6	15.5	23.3	26.8	13.8	14.2	27.3	22.7	18.6	43.9	21.6	18.5	30.9	29.3	21.9	40.1	30.4	36.7	35.7	19.4	26.7	38.2	37.2	17.6	35.4	22.6	24.8	35.8	32.9	36.7	34.1	30.4	40.6	31.6	41.8	37.0	28.8	39.0	24.6
BCAT2	"BCAM, BCT2"	ENSG00000105552	"Branched chain amino acid transaminase 2"	O15382	19	48795062-48811029	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054091	Enhanced		Supported	Mitochondria			3400000	Mitochondria		"HPA054091: "	"unprognostic (2.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.06e-1)"	"prognostic favourable (3.68e-5)"	"unprognostic (1.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.50e-3)"	11.8	34.1	6.7	10.9	7.7	3.8	15.0	15.0	10.7	11.9	16.7	11.3	15.8	10.2	12.9	9.8	24.6	11.9	15.2	25.1	6.8	6.9	22.6	8.0	19.9	16.3	9.8	7.8	22.3	42.6	9.0	12.3	27.5	22.0	16.8	12.1	6.3	24.7	17.2	23.3	9.8	10.3	17.5	7.6	10.9	22.8	15.9	10.7	12.5	19.1	23.3	16.7	29.2	12.2	15.0	18.2	1.8	9.8	8.8	15.4	7.1	17.4	21.0	5.6	11.8	23.3	7.9	9.9	7.7	3.9	9.5	9.3	21.0	10.7	20.5	8.9	6.9	8.3	8.6	13.5	4.8	12.8	21.7	7.5	9.4	1.3	22.6	10.1	7.1	11.4	8.6	7.1	10.3	13.2	9.6	12.7	3.4	20.8	13.8	10.8	4.9	10.2	21.1	9.6	22.6	9.0	72.2	30.1	8.6	11.8	19.4	5.7	12.3	5.0	7.3	9.3	9.0	10.9	9.6	11.9	15.8	9.8	5.0	15.8	6.0	0.0	8.7	1.8	9.7	9.8	13.6	15.0	11.7	12.4	16.1	12.8	10.8	9.6	0.4	8.8	3.7	18.2	15.4	7.1	6.7	7.7	15.0	10.7	6.8	6.9	9.8	7.8	22.0	10.7
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038011: "	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	24.0	25.0	27.9	28.8	28.0	32.3	33.4	28.0	30.2	20.8	23.0	15.0	27.8	19.7	21.1	35.9	27.6	21.3	17.9	28.7	28.7	21.3	35.0	45.9	19.0	27.6	23.6	22.0	28.0	29.2	19.8	27.6	19.8	33.5	27.3	26.3	14.4	34.7	26.7	132.7	19.3	23.5	29.7	35.6	27.2	28.2	28.6	24.1	24.6	26.0	32.0	28.7	24.0	47.9	30.9	30.7	16.1	35.4	26.0	33.8	19.0	53.9	28.1	31.9	35.3	18.2	20.1	26.7	29.1	27.8	36.0	33.4	45.9	36.3	38.0	18.3	26.5	30.0	54.4	41.2	50.4	34.9	37.0	38.2	24.3	50.6	23.1	52.4	24.3	20.6	24.9	42.9	45.4	34.1	42.2	19.5	30.4	32.3	33.8	53.0	24.6	42.4	32.4	33.6	22.8	31.8	26.0	17.0	17.3	21.7	35.6	35.6	19.2	23.3	22.8	16.8	29.7	24.7	52.3	20.0	22.3	56.5	33.0	27.3	12.9	12.4	28.7	16.1	24.6	34.7	33.8	30.9	28.2	26.8	30.7	28.9	31.9	28.6	4.7	26.0	35.4	26.5	29.7	19.0	27.9	28.0	28.0	30.2	28.7	21.3	23.6	22.0	33.5	24.1
BCDIN3D		ENSG00000186666	"BCDIN3 domain containing RNA methyltransferase"	Q7Z5W3	12	49836039-49843129	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039911	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA039911: AB_10673021"	"unprognostic (2.21e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.96e-3)"	"prognostic favourable (3.24e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (1.03e-5)"	"unprognostic (2.31e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (1.06e-4)"	5.6	9.3	6.9	6.0	8.4	2.6	7.8	8.9	9.0	6.1	6.0	7.2	6.9	4.9	8.3	7.5	9.1	7.7	4.9	5.3	5.9	4.5	7.3	10.5	4.5	8.3	9.8	4.8	8.5	11.9	8.4	12.7	6.5	6.6	8.7	5.7	5.2	15.4	6.9	32.8	7.6	8.4	5.3	7.6	9.3	8.4	5.3	7.7	15.2	9.9	4.2	10.8	7.4	6.0	9.9	5.0	5.9	6.6	6.2	10.3	4.6	3.3	4.8	4.6	7.2	9.7	5.7	4.8	4.7	6.1	4.9	5.2	2.5	8.9	3.0	5.3	2.0	4.5	4.6	2.7	2.7	10.2	6.2	4.1	3.7	1.6	7.7	4.7	4.1	3.1	11.0	3.4	4.9	2.2	7.4	8.2	3.0	8.5	5.2	7.6	4.6	8.6	5.5	4.4	5.9	4.8	3.1	6.4	8.9	5.5	9.0	6.6	11.2	5.2	2.6	4.1	3.2	6.2	2.5	7.8	6.7	5.6	4.5	3.5	2.8	5.9	5.4	2.8	7.6	6.5	10.1	9.9	9.4	7.2	5.0	9.1	10.3	9.7	4.6	6.2	6.6	3.0	7.8	4.6	6.9	8.4	8.9	9.0	5.9	4.5	9.8	4.8	6.6	7.7
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"			Mitochondria	Nucleoli	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favourable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	6.9	2.6	9.9	13.2	10.0	8.8	7.9	4.9	10.3	8.1	11.2	4.2	9.6	19.7	5.3	11.8	7.0	5.5	6.5	11.5	24.5	8.1	9.7	6.8	5.7	11.2	13.9	4.4	8.4	6.8	5.6	7.0	9.7	8.2	17.7	18.2	3.8	5.0	8.1	7.3	3.4	12.8	30.7	16.8	22.6	10.6	6.6	9.3	8.4	7.0	4.9	9.0	10.7	4.1	4.9	3.4	4.5	6.6	12.6	12.3	6.5	6.0	10.4	7.3	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4
BCKDK		ENSG00000103507	"Branched chain ketoacid dehydrogenase kinase"	O14874	16	31106107-31112791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017995, HPA056067"	Supported		Supported	Mitochondria				Mitochondria		"HPA017995: AB_1845309, HPA056067: "	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.97e-2)"	15.4	29.7	11.9	13.1	15.0	9.4	18.3	18.8	21.3	11.7	14.1	9.6	19.9	11.2	14.8	14.9	14.9	13.8	15.1	39.2	14.2	10.3	21.3	46.5	18.2	32.5	10.7	17.3	15.1	52.4	17.4	8.9	11.4	13.2	14.9	9.9	10.4	33.9	25.7	67.7	21.5	12.2	19.9	15.6	16.0	19.9	11.2	9.3	8.0	11.7	25.9	10.6	15.3	12.0	6.9	26.8	26.6	33.0	6.3	6.8	13.6	18.1	20.4	11.5	17.3	14.2	14.3	12.5	15.8	19.5	24.6	24.1	13.3	12.1	17.0	23.0	19.7	12.6	8.1	27.5	15.9	13.7	25.3	18.4	13.9	24.2	25.1	9.5	16.9	21.0	11.1	21.1	17.6	26.2	9.3	16.1	36.8	30.9	8.8	12.6	9.8	16.5	17.8	16.8	31.3	18.8	12.5	17.8	16.3	12.3	30.3	9.8	18.2	9.2	16.8	18.8	10.9	19.2	13.1	16.8	6.0	6.0	21.3	13.8	17.6	12.2	33.0	23.1	5.7	27.4	5.6	6.9	5.2	4.2	26.8	5.4	4.4	5.0	26.6	6.3	19.3	5.8	6.8	13.6	11.9	15.0	18.8	21.3	14.2	10.3	10.7	17.3	13.2	9.3
BCL11A	"BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856"	ENSG00000119866	"B cell CLL/lymphoma 11A"	Q9H165	2	60450520-60555154	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 107.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.3;MOLT-4: 18.7;REH: 19.1;U-698: 41.8;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 39.6;naive B-cell: 53.7;plasmacytoid DC: 107.1"	"Group enriched"	"Detected in many"	16	"B-cells: 53.7;dendritic cells: 107.1"	"Group enriched"	"Detected in all"	5	"amygdala: 42.3;basal ganglia: 57.1;cerebral cortex: 62.7;hippocampal formation: 65.3;olfactory region: 101.8"	"Group enriched"	"Detected in all"	4	"basal ganglia: 58.3;cerebral cortex: 93.2;hippocampal formation: 97.2;olfactory region: 128.9"	"CAB014891, HPA029003"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB014891: , HPA029003: "	"unprognostic (4.10e-3)"	"unprognostic (6.72e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.37e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.27e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.99e-2)"	1.5	2.4	6.6	13.9	14.6	17.0	5.5	1.8	34.5	3.9	8.6	0.2	0.1	7.6	1.8	1.4	13.6	4.8	2.2	4.7	14.5	3.4	1.7	1.5	3.0	21.2	3.5	14.4	1.6	11.3	1.2	3.9	0.9	9.6	4.8	5.1	0.0	11.4	2.0	1.4	24.9	11.4	2.9	2.0	13.5	3.3	2.0	2.6	20.9	2.4	4.0	30.4	3.6	7.8	53.7	107.1	1.3	5.1	1.0	0.1	1.2	0.2	0.0	1.7	0.0	0.3	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	20.3	0.1	0.0	4.1	6.3	3.0	0.0	0.3	6.0	0.0	0.2	0.1	0.0	7.3	0.0	0.7	1.6	0.0	1.0	1.0	0.3	0.1	0.0	0.0	18.7	7.4	11.5	0.1	19.1	0.5	7.7	0.0	0.3	8.2	2.0	0.1	0.1	0.1	0.1	3.5	0.5	0.1	4.8	0.1	0.0	0.3	0.0	41.8	0.0	13.4	0.6	0.4	2.9	0.5	0.0	5.1	0.1	39.6	0.0	0.0	10.7	53.7	0.1	0.1	1.3	1.0	3.7	107.1	0.1	1.2	6.6	14.6	1.8	34.5	14.5	3.4	3.5	14.4	9.6	2.6
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2, apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 22.3;U-266/70: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.3;MAIT T-cell: 7.6;memory B-cell: 5.2;memory CD4 T-cell: 6.3;memory CD8 T-cell: 3.8;naive B-cell: 4.1;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.5;T-reg: 6.7"	"Group enriched"	"Detected in many"	8	"B-cells: 5.2;T-cells: 7.6"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: "	"unprognostic (1.11e-3)"	"prognostic favourable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favourable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.47e-4)"	"unprognostic (2.63e-1)"	12.9	3.0	10.1	15.7	9.4	5.3	24.6	4.7	8.4	14.8	7.8	7.4	9.1	5.0	17.1	9.3	4.7	12.2	9.2	6.5	10.0	8.1	8.5	2.3	5.0	14.6	10.8	5.6	18.2	2.9	19.6	7.0	22.4	9.2	8.4	5.9	10.8	5.4	15.7	20.0	6.3	10.5	8.6	9.3	17.8	5.4	3.5	10.5	21.0	35.6	2.9	13.4	7.9	16.4	5.2	0.3	0.7	0.2	0.7	7.6	1.9	0.4	0.1	2.3	1.8	2.7	0.4	0.8	0.2	0.2	0.7	0.5	1.1	0.1	0.0	0.4	0.2	0.1	2.0	0.3	0.4	13.3	0.4	0.0	0.6	0.2	0.5	12.1	1.8	0.5	0.2	0.9	1.9	0.2	0.2	22.3	0.4	0.4	2.5	5.2	0.5	0.4	11.4	0.5	8.6	3.8	1.8	1.9	1.8	0.0	0.0	2.7	0.1	10.2	0.1	3.0	1.0	0.3	1.5	77.6	10.2	0.8	0.5	8.6	1.7	0.7	0.0	0.0	2.3	0.0	7.6	5.2	6.3	3.8	0.1	4.1	5.1	4.5	0.1	0.7	0.2	0.3	6.7	1.9	10.1	9.4	4.7	8.4	10.0	8.1	10.8	5.6	9.2	10.5
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria				Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: "	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favourable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	15.3	17.4	13.3	7.6	14.2	10.9	17.3	13.0	17.4	9.2	11.9	14.8	8.8	8.3	10.5	10.7	14.5	11.7	10.0	18.9	12.7	12.2	18.9	20.9	10.6	9.3	14.4	13.4	10.4	22.0	25.8	12.3	14.1	12.2	11.1	14.1	15.2	12.4	9.5	61.2	15.5	12.4	11.7	13.0	8.3	11.2	22.9	11.5	12.1	13.5	14.5	12.3	14.6	10.2	6.5	11.3	4.7	17.3	10.4	8.3	9.5	14.0	6.3	10.1	9.6	16.8	16.2	13.4	10.1	17.7	15.0	17.1	7.1	9.4	12.2	7.3	14.4	19.3	11.6	15.5	15.7	11.7	8.8	11.5	5.7	3.7	21.0	16.0	10.0	13.1	18.2	12.8	34.7	13.1	28.5	11.5	16.3	9.5	8.1	5.1	8.0	7.9	8.6	15.6	4.5	15.6	9.7	14.3	9.0	13.3	13.5	24.1	9.2	15.8	13.0	8.9	4.6	12.7	9.6	9.9	8.9	10.5	13.3	12.3	15.2	3.8	17.3	4.7	4.6	15.6	5.7	6.5	6.2	5.7	11.3	5.4	5.5	4.5	4.4	10.4	11.0	5.7	8.3	9.5	13.3	14.2	13.0	17.4	12.7	12.2	14.4	13.4	12.2	11.5
BCL3	"BCL4, D19S37"	ENSG00000069399	"B cell CLL/lymphoma 3"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.5;Karpas-707: 22.0;SiHa: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody				Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: "	"prognostic favourable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	17.7	13.0	4.0	21.1	5.6	35.2	18.7	1.4	4.7	11.7	14.9	2.4	5.9	24.5	10.4	9.7	27.1	12.5	22.7	20.1	3.9	2.0	17.8	52.1	36.4	20.5	4.3	0.5	26.5	13.2	2.4	9.2	9.5	5.6	16.0	8.0	8.8	13.7	13.7	20.2	9.0	35.5	11.5	6.5	41.6	15.0	8.3	4.0	6.5	13.9	22.9	37.0	18.7	11.9	1.3	2.6	16.5	2.4	1.8	1.5	0.7	3.8	13.4	0.3	7.1	2.6	5.4	0.6	2.4	2.6	1.5	2.2	2.8	7.1	3.8	5.5	4.7	4.3	0.9	4.0	0.9	26.5	0.2	0.4	7.0	3.6	6.2	0.3	11.4	9.4	3.2	3.3	4.2	4.0	0.5	22.0	0.9	3.2	0.0	2.9	0.3	5.6	1.7	2.7	1.4	6.8	8.1	0.0	0.4	28.2	14.4	0.7	5.0	2.9	6.7	4.8	5.0	7.5	0.9	20.9	8.2	3.9	8.9	0.5	3.6	0.2	2.4	4.2	0.7	1.6	1.0	1.3	0.9	1.1	2.1	1.1	0.5	0.6	16.5	1.8	0.9	2.6	1.5	0.7	4.0	5.6	1.4	4.7	3.9	2.0	4.3	0.5	5.6	4.0
BCL6	"BCL5, BCL6A, LAZ3, ZBTB27, ZNF51"	ENSG00000113916	"B cell CLL/lymphoma 6"	P41182	3	187721377-187745727	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Immunity, Inflammatory response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 114.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;Daudi: 42.1;HSkMC: 30.6;U-698: 58.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 63.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 63.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000307, HPA004899, HPA050645"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: "	"unprognostic (5.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.62e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.27e-9)"	"unprognostic (5.22e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.58e-2)"	47.1	14.3	21.8	23.2	25.9	50.6	48.0	58.7	23.7	21.2	21.2	19.2	11.5	4.1	17.7	8.8	20.9	28.3	22.3	18.6	21.5	8.0	10.1	20.1	26.3	24.5	31.6	9.3	20.2	15.6	9.1	23.3	7.5	28.5	17.3	5.8	15.9	19.1	11.8	114.3	36.4	8.1	24.4	50.1	27.2	16.1	10.2	26.6	18.9	14.8	10.4	22.4	24.9	20.0	3.9	5.6	63.4	15.4	0.9	1.3	5.2	1.2	3.6	3.5	0.8	26.8	21.4	3.9	4.2	10.4	4.9	5.2	2.5	2.0	42.1	3.1	5.3	2.0	1.1	2.8	4.2	8.9	1.4	0.0	1.7	6.0	13.9	0.5	0.2	30.6	17.9	6.0	9.2	2.7	0.4	7.3	4.7	1.4	1.4	0.3	0.3	2.7	11.7	1.8	0.2	3.4	6.2	0.8	0.0	4.9	2.1	2.7	9.2	1.5	5.5	11.9	1.9	4.3	1.9	5.4	1.7	58.5	6.5	1.5	8.4	1.6	6.9	4.1	1.3	8.7	1.3	1.4	0.8	1.2	5.6	3.9	0.5	0.6	63.4	0.9	15.4	0.9	0.6	5.2	21.8	25.9	58.7	23.7	21.5	8.0	31.6	9.3	28.5	26.6
BCL9L	DLNB11	ENSG00000186174	"B cell CLL/lymphoma 9 like"	Q86UU0	11	118893875-118925608	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049370, HPA053421"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA049370: , HPA053421: "	"unprognostic (1.67e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.90e-3)"	18.4	18.9	10.2	17.2	10.0	13.3	23.8	31.7	9.9	27.4	16.4	6.7	15.8	13.2	22.3	12.8	18.9	22.2	21.2	15.6	9.0	4.1	10.9	9.0	17.1	13.8	9.5	7.7	22.2	16.4	9.0	6.5	31.9	9.1	16.1	4.1	14.5	21.5	14.7	19.1	19.9	14.6	22.8	7.9	13.9	14.0	9.0	8.6	13.0	12.2	11.9	16.7	21.9	25.6	0.6	0.6	1.1	0.5	0.7	2.2	0.8	12.2	22.2	3.2	5.8	10.4	10.1	20.4	16.9	13.1	5.4	3.1	23.6	24.4	3.3	22.6	17.7	23.7	1.5	31.0	1.4	4.0	0.8	3.3	12.4	8.1	11.7	1.1	3.2	12.7	19.4	6.4	13.0	4.7	4.2	3.9	3.7	20.5	2.4	0.9	3.8	12.8	5.2	1.3	2.2	5.6	8.5	1.7	2.5	23.8	36.2	3.4	28.4	1.4	15.8	17.2	13.2	5.2	14.3	0.8	0.0	0.9	9.3	3.8	9.8	0.0	0.5	0.0	2.2	0.0	1.5	0.3	1.2	1.3	0.1	0.6	1.9	1.5	1.1	0.7	0.0	0.6	0.2	0.8	10.2	10.0	31.7	9.9	9.0	4.1	9.5	7.7	9.1	8.6
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"			190000	"Nuclear speckles"		"HPA006484: , HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavourable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favourable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	22.6	20.9	19.3	20.6	33.6	93.9	26.8	56.9	31.0	27.6	23.2	13.3	18.1	15.2	25.8	21.3	22.7	22.9	12.4	17.0	20.4	19.0	19.3	22.0	19.9	22.7	24.4	19.5	33.5	20.5	34.8	50.2	25.5	27.8	21.4	23.7	14.2	23.5	18.2	26.8	22.2	20.8	23.1	22.4	22.7	22.2	16.7	27.2	38.6	24.7	21.5	25.4	24.0	23.2	22.2	25.2	35.7	20.4	29.1	24.9	13.4	18.2	15.9	37.7	31.4	12.0	10.2	19.2	34.9	21.7	23.5	25.1	22.6	12.4	38.5	21.8	26.7	17.8	42.2	23.0	29.6	21.2	26.2	47.9	22.9	24.5	13.9	80.1	30.5	13.9	11.5	33.2	20.8	20.8	42.5	19.1	24.6	21.8	31.9	9.1	27.7	16.6	29.0	47.4	17.1	17.6	35.1	32.1	22.2	34.2	16.5	13.3	15.4	16.2	28.6	18.7	27.4	22.3	34.0	16.2	29.2	53.1	11.1	25.8	21.6	15.4	16.4	24.2	21.1	20.4	21.0	22.2	19.4	17.6	25.2	19.8	24.9	22.3	35.7	29.1	19.7	14.9	14.7	13.4	19.3	33.6	56.9	31.0	20.4	19.0	24.4	19.5	27.8	27.2
BCOR	"FLJ20285, KIAA1575"	ENSG00000183337	"BCL6 corepressor"	Q6W2J9	X	40049815-40177329	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA056308, HPA073591"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA056308: , HPA073591: "	"unprognostic (2.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavourable (1.30e-5)"	"unprognostic (3.82e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.83e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.55e-1)"	9.1	12.8	8.7	8.7	10.5	20.6	13.3	11.5	12.0	10.0	12.6	22.7	11.9	7.8	11.1	13.9	13.6	10.4	8.6	13.0	7.1	5.4	11.2	13.3	11.4	15.2	12.9	8.4	19.8	13.6	19.7	11.9	12.5	10.7	13.2	8.2	13.7	11.1	16.5	28.8	13.6	10.3	12.9	8.6	11.4	11.5	9.8	15.8	18.4	16.0	11.4	13.5	13.8	25.5	6.5	7.3	7.6	7.1	8.2	6.8	11.8	12.9	8.6	17.5	21.4	2.0	1.5	3.0	4.4	7.0	5.6	4.6	3.6	5.2	11.8	5.2	8.2	12.1	28.5	3.7	5.0	20.6	25.9	13.1	13.2	14.1	3.4	10.6	7.6	2.6	5.5	6.2	3.6	7.6	33.7	28.5	6.9	8.3	24.0	22.2	17.2	13.4	11.7	18.1	13.3	10.3	8.2	12.5	22.7	9.2	8.2	6.9	8.8	23.4	6.2	6.1	7.7	8.9	4.9	16.9	13.1	12.3	5.3	9.7	9.3	7.6	5.0	4.5	6.8	6.1	4.3	6.5	4.7	3.9	7.3	5.5	4.7	4.8	1.1	8.2	7.1	3.1	5.5	11.8	8.7	10.5	11.5	12.0	7.1	5.4	12.9	8.4	10.7	15.8
BDH1	"BDH, SDR9C1"	ENSG00000161267	"3-hydroxybutyrate dehydrogenase 1"	Q02338	3	197509783-197573323	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 156.0"	"Cell line enhanced"	"Detected in many"		"U-937: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030947, HPA058709"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA030947: AB_10669548, HPA058709: "	"unprognostic (2.72e-2)"	"prognostic favourable (1.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (9.86e-7)"	"unprognostic (2.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.85e-3)"	"prognostic favourable (7.12e-8)"	"unprognostic (5.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.02e-1)"	3.5	2.8	6.6	5.2	11.2	4.7	4.6	18.1	13.8	4.0	13.9	4.6	6.3	9.6	2.1	3.6	12.9	5.5	6.1	19.6	6.3	5.8	6.0	156.0	2.0	4.2	5.9	9.1	3.0	2.8	5.8	3.6	1.4	7.7	4.5	11.1	6.2	8.6	4.4	7.3	8.0	13.7	2.4	3.5	2.3	4.7	1.8	3.6	5.4	5.2	11.3	7.4	3.6	3.6	6.1	4.6	2.9	1.6	4.7	9.9	4.0	10.5	1.4	0.6	5.4	0.9	0.0	0.0	1.2	1.0	5.5	3.1	9.5	3.5	0.0	15.7	0.3	4.9	4.8	2.5	2.1	0.1	0.0	5.6	3.6	3.2	4.0	12.4	5.9	1.6	3.0	2.1	4.6	1.3	0.0	4.2	0.1	18.8	9.5	8.4	4.1	1.9	9.1	2.0	14.4	5.8	4.8	10.0	4.3	3.8	0.5	2.0	12.7	10.4	0.1	0.3	1.8	0.0	9.9	4.9	9.2	0.1	0.3	35.3	0.7	2.9	1.6	0.6	5.9	0.2	8.2	6.1	6.5	5.3	4.2	5.5	9.9	5.9	0.0	4.7	0.3	4.6	4.2	4.0	6.6	11.2	18.1	13.8	6.3	5.8	5.9	9.1	7.7	3.6
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103079435-103099883	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 139.1"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol				Cytosol		"HPA036028: AB_10670674, HPA036029: "	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.75e-4)"	"unprognostic (9.69e-3)"	12.4	33.1	22.6	7.7	26.0	2.8	17.6	9.6	18.5	15.7	18.9	14.8	12.3	36.7	11.6	18.8	10.4	16.6	13.5	14.9	26.6	15.4	139.1	39.3	13.8	6.0	38.2	15.6	26.2	8.3	23.5	14.8	8.1	29.0	13.0	11.2	27.0	10.2	15.2	6.9	7.9	34.8	10.2	29.7	6.7	11.8	7.2	32.4	10.4	25.1	12.0	7.6	11.0	11.8	9.5	7.5	1.4	4.1	11.6	18.5	7.5	2.6	4.5	25.9	7.8	27.1	30.1	3.7	6.2	16.0	5.9	10.0	3.6	10.4	10.8	10.9	9.6	1.3	13.4	10.0	6.9	6.3	8.1	2.1	6.6	11.9	17.4	6.2	3.1	24.1	9.4	10.1	2.3	20.0	6.5	3.4	22.7	1.4	27.8	6.1	7.9	2.1	20.1	25.1	6.3	41.4	5.0	3.5	12.6	11.0	5.9	7.0	5.2	5.1	12.2	7.0	3.7	4.5	2.4	6.5	6.5	11.1	9.3	7.5	5.8	1.4	4.1	0.2	11.9	1.8	12.8	9.5	12.1	11.3	5.8	9.0	14.2	15.3	0.3	11.6	0.3	7.5	18.5	7.5	22.6	26.0	9.6	18.5	26.6	15.4	38.2	15.6	29.0	32.4
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.3;BJ hTERT+: 41.1;U-87 MG: 17.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 13.5;pons and medulla: 5.7"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003551, HPA050841"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA003551: , HPA050841: "	"unprognostic (1.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.11e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.49e-2)"	9.0	1.2	1.5	3.7	1.0	0.0	4.7	13.5	1.1	12.2	9.0	1.3	4.4	5.6	8.5	12.7	14.9	5.1	21.1	4.3	0.8	0.7	12.1	0.7	2.2	0.4	0.9	0.3	4.7	6.8	0.9	1.1	2.9	5.7	6.9	9.2	0.9	3.1	11.3	2.7	4.0	10.3	11.3	1.3	0.4	4.2	3.2	0.0	0.6	3.6	13.9	4.4	16.7	13.5	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.7	2.6	0.0	4.8	7.3	22.3	0.0	2.4	41.1	1.4	1.6	0.1	4.5	0.0	0.1	3.7	6.4	0.0	1.0	1.2	0.5	0.0	0.0	0.5	0.0	3.5	0.0	0.0	6.8	3.3	4.1	2.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.0	1.5	0.5	0.7	6.8	0.0	0.4	0.0	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.0	17.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.5	1.0	13.5	1.1	0.8	0.7	0.9	0.3	5.7	0.0
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5;smooth muscle: 10.5"	"Cell line enhanced"	"Detected in many"		"BJ: 22.4;BJ hTERT+ SV40 Large T+: 17.2;BJ hTERT+ SV40 Large T+ RasG12V: 13.1;HBF TERT88: 16.5;U-138 MG: 24.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"	19244000		"Nuclear speckles, Mitochondria"		"CAB009564: AB_2064213, HPA031440: , HPA056104: "	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.9	1.3	5.0	0.6	4.5	0.5	0.6	9.4	14.5	1.6	0.8	0.6	0.7	0.8	0.7	8.2	1.4	0.5	2.1	5.8	8.5	5.7	0.9	0.5	4.1	0.4	2.5	4.7	1.2	1.0	0.2	2.3	3.7	12.7	4.9	0.4	3.0	0.9	4.2	1.3	2.1	0.5	10.5	1.0	0.6	0.9	1.3	0.0	0.0	2.3	0.0	0.4	3.2	1.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	1.6	6.6	0.2	0.0	2.3	1.9	0.0	22.4	4.3	17.2	13.1	0.0	2.6	0.0	2.1	8.1	1.0	0.1	0.2	16.5	0.1	0.1	0.0	2.2	0.0	10.0	0.1	0.1	5.8	2.2	3.8	2.2	0.7	0.0	0.0	2.7	0.0	0.0	0.0	2.1	1.8	0.0	1.3	0.0	2.5	0.0	0.1	0.6	4.3	0.0	0.0	0.1	0.0	7.4	24.1	4.0	9.3	5.0	0.3	0.0	0.0	9.3	0.6	1.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.1	0.7	0.4	0.0	0.1	0.0	0.4	1.0	0.1	5.0	4.5	9.4	9.4	8.5	5.7	2.5	4.7	12.7	0.0
BDP1	"HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR"	ENSG00000145734	"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB"	A6H8Y1	5	71455615-71567820	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 7.2;TIME: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064166, HPA077984"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA064166: , HPA077984: "	"unprognostic (4.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.86e-2)"	7.8	8.7	6.1	4.4	9.0	3.3	7.9	13.1	9.8	5.9	4.4	2.5	3.3	1.5	6.1	3.3	5.0	7.8	5.2	4.0	6.6	3.4	6.5	4.2	3.7	3.5	6.3	5.6	5.0	10.7	1.5	10.0	3.7	5.7	4.9	4.1	1.9	4.9	6.1	10.0	6.5	4.1	6.1	4.1	4.7	3.6	4.9	7.5	6.7	7.9	2.5	3.0	5.7	3.7	2.5	1.4	1.8	0.4	1.9	1.3	0.1	0.1	2.3	4.4	1.0	0.1	0.5	4.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.3	1.5	0.0	0.1	0.0	3.5	0.0	0.0	0.1	5.6	1.0	2.7	0.6	0.0	0.0	0.0	0.0	0.7	4.0	7.2	0.0	1.8	2.3	0.0	0.4	0.0	4.8	4.6	0.0	4.0	1.9	1.7	0.0	6.0	0.0	0.9	3.5	0.0	0.0	9.6	4.7	0.1	1.5	0.0	1.4	3.8	0.0	0.0	0.4	5.1	0.0	0.1	1.8	1.3	0.4	0.6	0.9	0.6	0.5	0.6	2.5	1.3	0.9	0.5	1.9	0.0	1.4	0.4	0.1	6.1	9.0	13.1	9.8	6.6	3.4	6.3	5.6	5.7	7.5
BET1L	"GOLIM3, GS15"	ENSG00000177951	"Bet1 golgi vesicular membrane trafficking protein like"	Q9NYM9	11	167784-207428	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039819	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA039819: AB_10673020"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (9.80e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.49e-2)"	18.6	20.3	11.4	23.4	15.2	9.2	19.2	14.4	19.8	22.3	18.0	21.0	34.1	17.0	23.4	28.6	16.2	21.7	25.3	18.7	11.6	12.6	21.4	30.3	20.4	20.4	14.9	13.7	33.8	62.2	29.3	31.4	17.3	15.8	27.3	18.0	24.4	35.1	28.0	11.6	18.6	22.4	26.1	13.4	22.3	21.8	27.4	10.5	18.4	27.0	15.6	22.4	25.8	21.0	18.1	12.3	34.3	15.1	15.1	22.5	15.9	18.4	15.4	9.2	11.3	28.5	25.2	13.3	19.7	26.0	21.2	21.8	19.1	17.9	16.3	9.6	35.7	17.2	10.6	18.0	16.3	12.6	11.4	15.1	8.1	19.3	26.4	17.1	29.5	28.3	24.3	12.5	33.7	14.3	21.9	17.1	13.5	10.0	12.5	10.9	14.0	17.5	13.0	13.6	11.0	17.4	8.3	10.0	12.2	17.6	28.5	19.2	14.6	13.5	15.8	16.5	7.7	6.7	9.7	30.3	13.8	14.4	22.3	14.4	15.0	27.0	10.4	34.3	16.7	15.1	20.0	18.1	19.3	17.0	10.5	15.1	22.5	17.3	24.5	15.1	13.2	12.3	14.6	15.9	11.4	15.2	14.4	19.8	11.6	12.6	14.9	13.7	15.8	10.5
BEX3	"Bex, DXS6984E, HGR74, NADE, NGFRAP1"	ENSG00000166681	"Brain expressed X-linked 3"	Q00994	X	103376340-103378077	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 18.8;naive CD4 T-cell: 40.8;naive CD8 T-cell: 18.8;T-reg: 32.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018886	Approved		Supported	Cytosol				Cytosol		"HPA018886: AB_1854453"	"unprognostic (7.74e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.15e-3)"	"prognostic unfavourable (7.23e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.28e-4)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.68e-2)"	21.1	66.1	73.2	9.4	84.2	6.7	22.2	47.1	92.1	28.9	15.2	22.7	30.8	7.7	35.4	134.6	16.0	36.8	18.8	42.9	71.3	87.4	49.8	23.0	22.0	6.7	63.7	75.8	92.7	28.4	39.7	51.5	49.3	82.6	40.8	14.4	18.5	23.4	59.1	4.7	9.0	9.8	29.8	65.2	20.0	13.3	28.1	33.5	10.6	57.0	8.9	7.3	22.7	20.0	1.2	3.5	3.7	0.9	6.4	40.8	17.1	23.5	35.4	68.6	25.8	62.0	69.9	29.1	26.8	47.1	34.7	55.7	37.0	27.6	0.0	49.5	33.2	9.8	47.3	33.3	37.8	0.1	32.0	10.7	56.2	10.3	46.2	0.1	4.4	71.9	29.8	46.2	43.3	53.7	0.0	0.1	65.7	56.2	25.0	0.3	85.3	26.1	0.0	39.7	0.0	38.3	44.4	44.8	44.8	29.5	0.3	39.8	16.5	3.7	31.8	22.2	14.5	42.9	12.1	0.2	0.1	0.1	45.4	0.0	21.5	0.0	0.9	0.2	1.0	0.2	0.6	1.2	18.8	5.0	1.5	0.3	40.8	18.8	3.7	6.4	0.1	3.5	32.3	17.1	73.2	84.2	47.1	79.7	71.3	87.4	63.7	75.8	82.6	33.5
BEX4	"BEXL1, FLJ10097"	ENSG00000102409	"Brain expressed X-linked 4"	Q9NWD9	X	103215092-103217246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 37.4;HMC-1: 45.3;K-562: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA045105, HPA051935"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045105: AB_10966792, HPA051935: "	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.03e-1)"	"unprognostic (6.33e-2)"	"prognostic favourable (9.41e-4)"	"unprognostic (1.62e-2)"	"prognostic favourable (2.54e-14)"	"unprognostic (1.62e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.33e-2)"	9.8	36.8	63.8	8.6	71.4	21.5	20.8	53.6	68.8	20.7	14.3	29.5	11.5	6.4	25.5	99.8	17.7	24.5	14.8	35.1	61.6	77.6	34.9	5.1	15.8	10.7	54.3	54.7	38.8	12.6	40.7	34.1	29.4	50.5	30.1	10.1	18.0	27.1	32.1	2.5	7.5	8.7	20.9	51.2	23.1	9.6	16.2	24.4	8.6	47.8	3.5	12.3	14.1	11.5	12.9	28.3	36.7	10.4	34.0	25.7	15.0	0.0	0.0	23.2	0.0	5.9	4.1	20.7	5.4	4.7	10.2	18.9	0.0	0.3	0.0	9.1	3.8	0.1	9.3	1.2	11.4	0.0	8.7	37.4	0.0	0.0	18.1	28.0	45.3	15.3	3.1	5.3	0.0	11.9	52.4	0.1	3.1	0.1	19.5	0.2	28.0	1.6	0.0	6.7	0.1	9.4	0.5	17.3	26.4	1.9	0.3	1.1	0.9	0.3	0.3	1.3	8.3	0.1	0.0	3.0	1.3	0.0	3.9	0.0	1.1	36.7	8.6	14.8	12.1	10.4	10.1	12.9	14.7	12.2	18.2	12.6	25.7	20.2	1.9	34.0	8.5	28.3	13.5	15.0	63.8	71.4	53.6	68.8	61.6	77.6	54.3	54.7	50.5	24.4
BFSP1	"CP115, CP94, filensin, LIFL-H"	ENSG00000125864	"Beaded filament structural protein 1"	Q12934	20	17493905-17569220	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 18.3;SK-BR-3: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 6.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.5;T-cells: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040748, HPA042038"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA040748: AB_10963786, HPA042038: AB_10964054"	"unprognostic (2.24e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-1)"	"prognostic favourable (1.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-6)"	"unprognostic (5.11e-2)"	"unprognostic (5.53e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.35e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.50e-2)"	2.5	1.8	3.5	2.5	5.6	0.8	2.6	2.8	4.4	3.5	1.8	0.9	5.5	0.8	10.7	5.4	5.1	2.2	4.8	2.4	3.2	3.7	6.1	1.1	4.1	0.6	3.3	1.7	5.3	2.7	4.8	1.3	4.5	3.0	3.3	1.2	2.3	2.0	4.0	3.0	1.8	0.9	2.7	6.9	0.8	1.1	8.0	0.7	0.6	5.3	2.3	1.5	5.1	1.1	0.0	0.0	0.7	0.0	1.5	6.1	0.5	0.7	7.5	2.4	0.3	0.6	2.5	0.4	1.9	8.7	1.2	1.2	3.3	6.4	0.0	1.5	1.0	1.1	2.6	1.5	1.0	1.6	2.0	0.5	1.1	1.0	1.4	0.4	0.8	3.0	4.6	0.7	2.1	5.2	0.2	0.4	3.9	1.4	0.0	1.0	5.7	2.1	0.0	1.7	0.4	18.3	1.3	2.5	0.3	2.2	9.9	3.8	4.8	1.6	5.9	0.3	0.6	0.6	1.8	0.0	0.1	0.0	1.3	0.0	1.5	0.1	0.0	0.0	6.1	0.0	0.2	0.0	1.7	1.0	0.0	0.0	0.1	0.5	0.7	1.5	0.0	0.0	0.0	0.5	3.5	5.6	2.8	4.4	3.2	3.7	3.3	1.7	3.0	0.7
BHLHB9	"GASP3, KIAA1701, p60TRP"	ENSG00000198908	"Basic helix-loop-helix family member b9"	Q6PI77	X	102720688-102753540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 21.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000887			Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA000887: "	"unprognostic (4.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.42e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.40e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.74e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (8.88e-2)"	2.8	6.4	8.6	1.6	13.0	2.7	3.7	15.3	20.6	5.5	3.4	8.7	2.3	2.1	7.5	5.8	2.9	4.5	3.0	4.9	8.9	12.5	6.3	3.8	2.6	1.5	7.2	12.7	9.9	3.6	9.1	7.1	4.8	21.1	7.2	2.9	3.9	3.6	8.2	4.8	3.4	2.5	7.2	6.3	2.7	2.5	4.4	7.3	1.7	6.6	1.2	2.0	4.1	3.4	0.7	0.3	0.9	0.2	5.3	2.0	0.5	0.5	4.0	13.0	3.9	4.1	2.4	5.2	3.4	4.7	5.7	10.9	3.3	2.3	0.0	3.6	3.9	2.8	7.1	3.8	6.4	0.0	4.2	1.0	3.3	0.7	6.6	0.7	1.3	4.3	3.4	2.5	0.3	5.7	3.0	3.5	5.0	2.2	2.6	0.4	7.6	3.0	1.4	3.8	0.0	3.7	5.8	5.8	5.4	3.8	1.1	0.4	3.2	1.8	5.8	1.5	4.0	2.2	3.3	1.9	4.7	0.0	3.5	0.9	2.4	0.9	0.2	0.2	1.0	0.1	0.9	0.4	1.1	2.0	0.1	0.7	1.3	1.7	0.7	5.3	0.1	0.3	1.6	0.5	8.6	13.0	15.3	20.6	8.9	12.5	7.2	12.7	21.1	7.3
BHLHE40	"BHLHB2, bHLHe40, Clast5, DEC1, SHARP2, STRA13"	ENSG00000134107	"Basic helix-loop-helix family member e40"	O14503	3	4979116-4985323	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 86.1;Karpas-707: 41.5;U-87 MG: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 32.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028922	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA028922: AB_2672828"	"unprognostic (8.64e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (5.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.03e-3)"	41.2	32.0	15.7	19.1	17.0	55.5	52.7	6.5	28.7	33.3	22.4	13.7	10.5	10.8	23.7	34.3	84.2	14.8	35.3	40.4	11.9	9.0	34.6	63.1	30.2	17.1	11.2	16.1	45.1	27.5	26.9	25.6	24.2	17.4	33.7	17.4	50.9	28.8	26.7	79.5	49.6	12.6	22.8	21.8	12.4	13.9	13.5	12.9	5.1	21.2	47.3	39.5	57.1	62.4	3.0	7.2	32.1	3.4	18.9	9.7	3.6	7.1	9.6	0.0	2.7	5.8	4.5	14.4	1.3	3.6	1.4	5.6	0.6	7.2	0.0	3.6	2.5	5.6	1.2	19.5	2.4	86.1	0.8	1.7	7.0	2.1	5.6	4.5	35.7	10.4	11.6	16.4	4.7	5.4	9.3	41.5	3.7	5.0	0.6	1.9	0.5	15.8	0.1	3.2	4.0	13.7	1.4	0.1	0.3	23.9	6.3	6.9	14.4	6.9	7.1	5.7	5.5	5.2	8.9	32.3	14.1	0.2	40.7	3.5	2.7	32.1	3.4	18.7	9.4	1.7	9.7	3.0	5.2	6.3	5.5	1.5	1.2	4.0	5.1	18.9	0.2	7.2	0.3	3.6	15.7	17.0	6.5	28.7	11.9	9.0	11.2	16.1	17.4	12.9
BHLHE41	"BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120026-26125127	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 15.1;RT4: 47.2;U-266/70: 20.2;U-87 MG: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	35	"memory B-cell: 5.3;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	54	"B-cells: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA056035: , HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favourable (1.09e-4)"	7.0	11.7	23.8	5.8	32.3	1.2	10.7	22.9	26.9	30.6	7.6	33.3	3.0	2.8	6.9	15.6	3.2	34.5	14.1	14.7	25.9	19.6	3.8	1.4	9.1	6.0	38.9	14.0	10.9	6.4	6.2	11.2	8.3	28.3	8.2	9.1	19.0	13.4	11.7	58.9	3.8	4.3	4.3	49.6	6.2	4.4	4.0	44.0	0.9	43.6	6.4	13.3	16.5	6.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	8.0	3.7	1.8	0.8	1.4	0.1	0.5	0.0	5.0	0.0	0.7	1.6	4.2	0.1	0.7	0.4	0.0	0.6	0.3	0.0	0.0	0.3	2.1	0.1	0.6	0.4	2.9	5.8	0.0	0.0	15.1	0.9	0.4	0.0	1.4	3.9	2.9	0.0	0.7	11.5	1.9	47.2	0.0	0.1	0.5	0.2	10.6	0.0	0.0	2.5	2.7	3.2	0.3	2.2	20.2	11.6	0.0	17.4	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	32.3	22.9	26.9	25.9	19.6	38.9	14.0	28.3	44.0
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111779-79132290	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 105.9;liver: 216.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.2;NTERA-2: 3.5;SCLC-21H: 2.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 90.6;renal cancer: 50.4"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol			9200000	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favourable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.1	1.5	0.0	105.9	216.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	4.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.2	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.6	0.1	0.0
BICD2	KIAA0699	ENSG00000185963	"BICD cargo adaptor 2"	Q8TD16	9	92711363-92764812	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023013, HPA024452"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA023013: AB_1845352, HPA024452: AB_1845353"	"unprognostic (9.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (1.39e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.39e-2)"	10.4	7.8	13.9	8.9	12.5	7.2	7.1	13.2	13.1	13.1	9.9	7.7	7.9	3.2	9.7	4.5	27.2	7.2	6.7	15.6	11.8	5.8	7.5	5.2	9.1	9.3	13.4	9.8	8.4	7.2	21.7	3.8	9.8	11.9	7.4	3.7	6.6	9.1	10.0	13.9	40.3	5.9	9.7	9.2	11.3	5.9	5.9	11.0	8.5	6.2	16.3	18.2	10.6	17.2	3.3	5.2	10.5	7.5	1.5	2.4	2.0	14.1	11.7	8.7	8.9	17.0	11.7	12.3	13.7	9.9	7.8	6.2	6.8	6.4	15.9	9.0	15.2	44.3	9.7	21.8	8.9	7.6	10.6	8.4	11.4	9.4	10.1	11.5	13.6	12.0	30.5	13.0	10.0	11.6	8.2	12.4	17.0	9.2	10.9	7.2	6.0	14.4	12.1	18.9	8.4	12.5	11.9	6.1	9.4	9.6	9.0	6.2	3.7	5.4	15.5	14.6	9.7	24.4	14.8	10.2	7.4	14.1	12.3	7.1	12.7	2.2	4.4	5.6	1.8	5.2	1.8	2.7	2.0	2.4	5.2	3.3	1.9	1.7	10.5	1.5	7.5	4.5	1.2	2.0	13.9	12.5	13.2	13.1	11.8	5.8	13.4	9.8	11.9	11.0
BICRAL	"GLTSCR1L, KIAA0240"	ENSG00000112624	"BRD4 interacting chromatin remodeling complex associated protein like"	Q6AI39	6	42746958-42868560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029390, HPA029391"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA029390: AB_10599730, HPA029391: AB_10599949"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (9.25e-2)"	"prognostic favourable (5.47e-4)"	"unprognostic (2.74e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.54e-2)"	12.7	7.1	9.8	11.0	10.9	8.3	12.1	39.6	14.4	12.6	10.6	16.3	10.0	7.2	14.6	9.8	8.0	13.0	8.8	8.4	8.5	9.2	7.7	6.8	9.3	17.5	9.1	12.0	20.9	9.8	17.5	16.2	6.2	10.7	11.8	11.9	17.1	10.6	10.7	9.8	12.8	10.1	12.1	9.6	12.2	9.0	10.5	10.3	17.1	14.0	6.3	14.6	13.4	11.4	2.8	1.4	7.5	1.6	2.9	4.5	1.1	5.2	4.2	3.8	6.2	7.9	9.3	3.3	4.8	4.9	4.2	3.2	1.9	3.8	12.4	4.3	7.9	4.2	3.7	4.9	7.0	9.2	2.3	8.7	4.2	5.4	4.2	7.3	7.9	5.6	9.5	4.1	7.6	4.3	8.3	11.1	5.0	6.4	1.2	4.2	4.3	2.7	7.6	2.2	12.2	4.3	3.5	13.1	7.0	5.3	7.7	5.4	6.7	8.7	5.0	5.9	5.9	3.8	4.7	10.2	5.9	19.1	3.5	9.4	4.2	3.9	1.1	5.1	4.5	0.8	4.0	2.5	2.8	4.4	0.9	2.8	2.7	3.3	7.5	2.9	1.6	1.4	3.1	1.1	9.8	10.9	39.6	14.4	8.5	9.2	9.1	12.0	10.7	10.3
BID		ENSG00000015475	"BH3 interacting domain death agonist"	P55957	22	17734138-17774770	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 96.5;bone marrow: 55.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 44.3;eosinophil: 68.5;intermediate monocyte: 75.7;myeloid DC: 36.3;neutrophil: 96.5;non-classical monocyte: 92.8;plasmacytoid DC: 25.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 36.3;granulocytes: 96.5;monocytes: 92.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000722, CAB003771"	Enhanced		Supported	Cytosol			2400000	Cytosol		"CAB003771: AB_365478, HPA000722: AB_1078283"	"unprognostic (1.59e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.50e-13)"	"unprognostic (4.66e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.18e-2)"	13.0	5.2	16.8	21.7	18.7	55.0	8.5	17.1	23.0	3.9	12.2	9.3	1.0	11.2	4.3	7.1	6.7	4.9	11.3	9.6	17.8	12.8	6.1	31.9	13.7	22.5	16.5	6.3	3.7	8.9	4.3	3.5	6.9	8.1	7.1	8.3	4.5	8.0	3.8	11.3	4.7	13.0	5.3	10.9	29.1	9.5	2.4	9.2	21.0	5.5	5.9	12.8	16.2	9.4	5.5	36.3	96.5	92.8	11.6	10.1	37.0	28.5	22.7	3.9	11.6	3.9	7.7	5.1	14.1	11.5	11.4	9.8	13.2	17.1	4.8	11.1	6.1	24.4	3.4	3.4	6.3	9.2	16.9	22.9	9.0	23.9	4.7	23.5	26.7	7.1	8.3	11.2	2.7	11.4	17.2	6.8	5.7	56.4	40.1	33.4	11.9	12.6	18.5	8.4	7.3	3.1	37.1	23.2	17.1	2.8	10.1	9.7	20.1	32.9	19.6	6.5	9.4	10.9	11.0	10.1	15.7	17.9	20.0	26.8	8.7	13.8	44.3	68.5	8.8	75.7	8.2	5.5	8.1	9.6	36.3	3.2	6.4	7.5	96.5	11.6	92.8	25.3	10.1	37.0	16.8	18.7	17.1	23.0	17.8	12.8	16.5	6.3	8.1	9.2
BIN1	"AMPH2, AMPHL, SH3P9"	ENSG00000136717	"Bridging integrator 1"	O00499	2	127048027-127107355	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"skeletal muscle: 399.9"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 37.0;MAIT T-cell: 32.5;memory B-cell: 32.2;memory CD4 T-cell: 38.4;memory CD8 T-cell: 36.9;naive B-cell: 34.1;naive CD4 T-cell: 36.2;naive CD8 T-cell: 34.4;NK-cell: 31.2;T-reg: 45.0"	"Group enriched"	"Detected in many"	9	"B-cells: 34.1;NK-cells: 31.2;T-cells: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001945, HPA003894, HPA005437"	Enhanced		Supported	Cytosol			1200000	Cytosol		"CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284"	"unprognostic (2.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.22e-3)"	9.5	12.1	21.0	6.7	26.8	3.7	4.2	10.3	24.9	6.2	5.4	36.2	3.6	5.3	5.6	7.3	8.8	7.8	6.4	3.1	24.8	15.2	10.3	4.9	4.6	9.3	26.8	15.8	6.8	5.3	7.3	4.9	6.5	17.3	9.2	4.4	7.9	4.9	7.2	399.9	2.7	5.0	11.6	22.1	10.4	6.1	3.1	26.8	0.0	4.7	30.8	7.3	9.0	7.9	34.1	4.0	1.1	0.6	31.2	45.0	22.4	15.3	8.4	10.1	12.0	30.4	24.4	3.5	4.6	10.1	11.1	7.3	32.2	9.5	0.0	14.3	8.7	2.0	4.5	7.6	3.0	1.7	1.2	4.5	13.8	2.1	27.4	0.0	0.9	22.2	1.9	24.0	4.4	15.0	0.9	0.5	13.7	0.3	1.4	12.8	7.6	9.6	3.5	11.2	1.4	39.3	0.0	6.6	18.8	16.8	6.5	5.1	0.4	2.9	17.9	12.8	12.6	16.3	15.5	0.4	0.4	0.0	18.9	0.8	5.8	0.1	0.6	0.1	37.0	0.3	32.5	32.2	38.4	36.9	2.8	34.1	36.2	34.4	1.1	31.2	0.5	4.0	45.0	22.4	21.0	26.8	10.3	24.9	24.8	15.2	26.8	15.8	17.3	26.8
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	20.9	25.8	19.1	23.3	24.1	25.9	57.0	20.5	28.5	25.1	22.2	18.4	18.7	19.3	24.6	31.1	18.6	17.0	21.1	39.2	19.1	18.3	24.3	36.8	34.0	47.2	23.3	15.8	21.5	40.8	22.0	27.3	24.3	22.3	19.6	22.2	14.3	21.9	22.1	38.8	17.3	24.4	23.8	26.3	27.6	19.0	19.7	15.5	51.2	18.9	17.3	21.9	22.2	20.2	5.8	12.6	37.5	16.6	12.2	12.0	9.8	9.6	7.2	11.1	8.7	14.1	19.5	7.1	37.5	14.4	21.5	13.1	8.9	24.1	10.6	37.2	17.2	10.7	7.2	9.9	25.9	14.2	3.7	10.7	5.3	10.8	14.4	6.4	6.9	12.4	19.3	12.3	15.8	14.7	9.6	0.0	38.7	3.1	6.8	5.7	5.3	7.0	3.4	14.4	7.1	16.6	11.2	4.6	6.1	13.1	8.0	11.2	12.6	7.8	24.1	45.6	10.3	13.7	24.2	4.4	6.0	7.3	9.8	8.2	33.2	31.7	16.6	37.5	9.1	15.2	7.5	5.8	8.7	8.4	12.6	5.6	11.3	11.3	25.5	12.2	16.3	7.6	12.0	9.8	19.1	24.1	20.5	28.5	19.1	18.3	23.3	15.8	22.3	15.5
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.0;lymphoid tissue: 46.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;Daudi: 33.0;HDLM-2: 31.2;hTERT-HME1: 32.8;U-266/70: 22.0;U-266/84: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.9;naive B-cell: 32.9"	"Group enriched"	"Detected in many"	10	"B-cells: 32.9;T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favourable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	6.9	3.3	1.4	43.9	2.3	5.1	5.4	0.5	2.0	5.3	13.1	0.5	2.8	6.8	2.9	3.7	8.4	3.9	13.9	6.0	2.2	1.3	10.8	12.5	21.8	46.3	2.8	1.2	3.4	7.0	1.1	14.5	0.9	2.2	8.7	6.2	1.1	9.2	4.7	2.2	5.5	46.0	7.3	3.0	34.9	15.9	3.2	2.7	34.2	3.0	4.1	34.0	12.6	6.2	32.9	0.8	2.0	2.6	2.5	17.1	2.8	6.3	5.1	0.0	0.1	0.1	0.7	0.6	0.5	4.3	0.6	0.7	0.9	37.5	33.0	17.0	0.3	3.6	0.0	0.9	2.1	31.2	0.1	0.1	1.5	0.2	6.5	0.5	0.7	0.7	4.6	2.1	32.8	0.1	0.1	0.0	0.8	0.0	2.2	0.3	0.1	0.2	0.0	0.3	1.6	8.5	3.3	0.0	0.1	0.5	0.5	0.3	1.6	0.3	1.7	7.2	0.7	0.4	6.5	22.0	18.8	11.6	1.3	1.8	0.8	2.0	0.9	0.4	1.4	2.2	2.5	32.9	10.7	3.5	0.8	32.9	7.5	2.2	0.5	2.5	2.6	0.3	17.1	2.8	1.4	2.3	0.5	2.0	2.2	1.3	2.8	1.2	2.2	2.7
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Protease inhibitor, Repressor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.6;testis: 51.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 14.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"				"Cytokinetic bridge"		"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (5.28e-6)"	"prognostic unfavourable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	2.3	1.5	0.4	14.1	0.7	20.8	5.3	0.7	0.6	1.9	4.8	0.3	0.2	4.6	0.9	1.4	13.4	0.4	2.2	2.4	0.5	0.4	1.3	2.2	2.4	9.7	0.6	0.2	0.9	0.8	0.0	0.4	6.1	0.5	0.9	5.2	0.2	2.1	0.2	0.6	3.5	4.7	2.4	0.7	6.3	3.2	51.4	0.3	61.6	0.5	14.4	11.7	2.0	3.2	2.5	0.8	0.5	0.0	2.2	14.0	3.0	31.6	29.6	26.7	28.9	1.7	2.8	9.8	24.4	13.7	34.8	22.9	24.2	12.5	32.6	9.9	14.1	16.9	27.0	15.6	30.5	11.0	37.5	21.5	17.5	28.4	0.2	20.7	16.2	0.9	1.1	19.3	14.3	24.6	26.9	27.6	26.7	18.3	44.0	19.8	19.9	52.1	23.0	43.4	25.2	8.2	11.7	33.0	22.8	18.7	21.2	16.6	28.0	19.6	9.2	42.2	37.4	18.2	34.6	20.0	16.1	37.7	15.4	8.7	36.6	0.0	0.0	0.0	0.7	0.0	0.2	2.5	4.3	2.8	0.8	0.3	0.0	0.4	0.5	2.2	0.0	0.3	14.0	3.0	0.4	0.7	0.7	0.6	0.5	0.4	0.6	0.2	0.5	0.3
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"			Supported	"Golgi apparatus,Vesicles,Mitotic spindle"				"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: "	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	15.0	16.7	10.3	20.7	14.4	18.4	16.1	21.9	13.7	16.2	13.0	15.3	15.6	8.7	17.2	13.9	13.2	13.1	11.7	11.4	9.8	7.3	14.1	14.8	12.5	16.1	13.9	11.8	23.6	24.8	32.5	17.4	14.1	14.8	11.3	13.6	11.5	14.7	17.1	20.9	14.9	16.0	12.5	13.3	16.1	13.9	13.0	14.4	23.1	21.5	9.2	17.2	16.2	12.0	3.8	2.8	10.6	2.4	2.3	3.4	0.7	15.1	12.7	11.8	5.1	9.3	13.2	7.1	6.7	9.5	8.3	7.9	8.7	3.6	16.3	5.4	12.6	7.0	16.5	10.0	10.3	13.0	7.5	22.0	8.0	7.2	5.1	20.4	7.8	8.8	4.9	13.0	11.6	12.3	17.8	7.0	7.7	5.8	10.2	4.7	7.9	7.5	10.4	19.0	5.5	6.0	15.6	8.8	13.5	13.3	6.9	6.1	4.6	7.3	19.2	8.7	9.8	5.9	10.2	9.4	13.1	21.8	6.3	10.1	5.7	10.6	1.6	0.9	2.7	1.2	3.4	1.7	2.1	2.3	1.3	3.8	2.3	2.6	2.7	2.3	2.4	2.8	1.6	0.7	10.3	14.4	21.9	13.7	9.8	7.3	13.9	11.8	14.8	14.4
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 62.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: , HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.1	0.4	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3
BIVM-ERCC5		ENSG00000270181	"BIVM-ERCC5 readthrough"		13	102799110-102875994	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"brain: 10.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.9;HEK 293: 11.9;HeLa: 5.1;PC-3: 6.6;SCLC-21H: 3.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 2.9"	"Low lineage specificity"	"Detected in many"											"HPA045845, HPA050126, HPA050374"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA045845: , HPA050126: , HPA050374: "													"unprognostic (6.01e-2)"					1.0	1.0	2.7	3.7	4.5	1.1	1.4	10.6	5.7	1.0	2.9	1.3	2.6	1.0	2.1	1.1	1.0	2.6	1.0	1.9	2.7		3.2	2.4	2.3	1.5	2.2	2.7	1.0	1.9	1.0	2.7	1.3	2.6	2.0	1.0	1.1	1.0	2.7	1.0	1.0	1.0	2.6	0.6	1.8	2.6	1.2	2.3	0.3	1.7	1.5	1.0	1.0	1.0	0.0	2.8	0.0	1.4	1.3	2.9	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.7	0.0	0.1	0.6	2.9	0.3	0.0	0.0	0.0	11.9	0.0	5.1	0.0	0.5	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.1	3.3	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.6	2.9	0.0	0.7	1.0	2.8	0.0	0.2	0.1	0.0	1.3	0.0	0.0	0.3	1.0										
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"Bloom syndrome RecQ like helicase"	P54132	15	90717327-90816165	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	1.8	0.4	3.1	11.4	1.5	5.5	0.6	4.7	2.6	0.7	1.9	0.9	0.5	1.4	1.2	1.1	2.9	0.4	1.3	1.0	2.3	2.4	0.9	0.5	2.0	7.7	2.8	0.2	0.9	0.4	0.0	1.2	3.6	0.5	0.7	2.5	0.7	7.8	0.0	1.7	0.6	2.8	0.5	1.9	6.7	1.4	4.9	0.5	36.7	0.6	3.1	9.3	1.4	0.7	7.4	1.2	4.3	1.6	4.6	5.0	1.6	5.4	7.8	8.7	5.1	0.0	0.4	5.5	4.1	1.2	4.7	5.1	6.8	3.8	14.1	2.6	1.1	9.1	13.4	3.7	6.1	8.5	9.9	14.7	8.4	2.2	0.0	14.1	7.3	0.0	0.0	4.7	2.4	3.3	12.7	4.4	4.9	3.4	10.6	7.8	9.3	1.7	10.8	16.4	5.4	1.1	9.8	6.5	6.1	3.3	4.4	2.6	3.1	11.6	1.8	3.4	6.3	3.5	8.7	3.2	13.1	14.7	1.9	10.0	5.8	2.5	1.0	4.3	3.1	1.2	4.8	7.4	2.8	3.8	1.2	4.3	2.0	2.2	0.8	4.6	1.6	1.2	5.0	1.6	3.1	1.5	4.7	1.7	2.3	2.4	2.8	0.2	0.5	0.5
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248195-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 67.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			59000000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	11.2	8.3	9.0	17.1	10.2	8.5	14.2	12.1	14.5	10.5	9.8	8.5	9.6	6.7	13.1	12.2	15.7	8.4	10.1	9.7	7.5	7.2	13.6	7.5	13.6	20.3	9.5	8.5	8.8	15.3	15.0	8.3	14.6	9.2	8.4	8.5	7.3	12.8	9.5	15.0	67.5	10.0	15.7	11.1	13.2	9.2	12.4	8.6	24.7	9.3	15.5	13.6	10.8	11.7	4.6	6.6	0.9	5.7	9.8	17.3	6.3	10.1	16.1	15.6	10.8	10.7	11.5	7.5	9.5	5.9	15.0	13.0	23.6	3.0	30.3	17.0	7.6	7.1	33.7	13.0	12.7	8.0	26.5	18.6	14.5	20.0	15.6	33.8	11.5	13.5	0.9	11.7	6.8	22.0	39.6	12.4	6.2	7.7	41.8	24.7	14.9	7.5	36.3	40.5	20.0	12.0	9.1	36.0	12.9	8.4	16.4	10.3	11.2	17.5	14.0	9.3	18.7	4.1	16.8	15.0	30.8	40.9	7.1	0.0	12.4	0.0	5.7	0.9	10.5	3.9	17.3	4.6	12.6	13.7	6.5	4.2	11.6	12.3	0.7	9.8	1.9	6.6	12.4	6.3	9.0	10.2	12.1	14.5	7.5	7.2	9.5	8.5	9.2	8.6
BLNK	"BASH, bca, BLNK-s, Ly57, SLP-65, SLP65"	ENSG00000095585	"B cell linker"	Q8WV28	10	96191702-96271587	"Disease related genes, Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.7;lymphoid tissue: 47.1"	"Group enriched"	"Detected in some"	6	"Daudi: 17.9;REH: 43.3;RPMI-8226: 23.9;U-698: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 35.9;naive B-cell: 31.0;plasmacytoid DC: 50.7"	"Group enriched"	"Detected in many"	117	"B-cells: 35.9;dendritic cells: 50.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009333, CAB016291, HPA038309, HPA038310"	Enhanced		Supported	"Plasma membrane,Cytoplasmic bodies"				"Plasma membrane, Cytoplasmic bodies"		"CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: "	"unprognostic (4.86e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.46e-3)"	"prognostic favourable (2.67e-6)"	2.3	2.0	6.9	22.1	8.9	4.2	3.0	1.3	4.8	6.2	15.0	13.7	9.8	17.7	1.9	15.3	31.1	2.7	9.9	1.5	6.4	3.6	18.9	29.5	3.2	24.4	8.9	4.4	1.4	10.4	9.3	2.4	5.0	9.2	5.4	8.5	2.4	9.5	11.5	1.2	6.3	20.6	1.2	16.7	41.7	13.3	1.4	8.7	3.6	6.4	12.8	47.1	6.8	11.8	35.9	50.7	0.2	0.3	0.3	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.1	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	43.3	0.0	23.9	0.2	3.3	0.0	0.0	0.0	4.1	0.0	6.1	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	65.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	35.9	0.0	0.0	4.4	31.0	0.0	0.0	0.2	0.3	0.0	50.7	0.0	1.8	6.9	8.9	1.3	4.8	6.4	3.6	8.9	4.4	9.2	8.7
BLOC1S5	"dJ303A1.3, MU, MUTED"	ENSG00000188428	"Biogenesis of lysosomal organelles complex 1 subunit 5"	Q8TDH9	6	8013567-8064414	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB025613, HPA077525"	Uncertain		Supported	Vesicles				Vesicles		"CAB025613: , HPA077525: "	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (8.12e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.60e-3)"	12.2	13.9	10.1	11.0	11.1	4.8	14.1	8.8	8.9	12.0	9.7	9.0	6.4	5.9	14.3	10.5	10.7	9.2	8.2	9.7	7.6	7.0	23.2	14.7	8.0	11.8	10.3	6.0	14.2	8.8	17.2	8.6	9.2	7.4	12.0	7.8	10.6	9.6	13.6	11.3	10.3	10.0	13.4	12.4	12.0	9.2	8.2	9.2	24.1	14.6	7.2	13.8	12.1	10.4	15.7	14.8	16.9	11.2	15.1	15.2	11.4	3.6	3.9	8.6	11.1	9.5	11.9	5.8	3.9	5.5	5.7	5.6	8.0	3.5	12.5	27.1	5.0	3.3	6.3	3.0	8.1	12.5	6.8	7.5	3.0	14.5	8.5	12.8	8.7	5.2	8.0	5.7	8.6	10.1	15.3	2.3	8.0	4.0	14.9	8.5	4.7	5.5	12.3	9.9	19.8	10.7	3.1	8.1	4.3	4.0	6.1	12.1	7.7	6.8	4.4	9.0	6.5	5.3	3.4	10.2	20.3	11.4	3.6	10.6	9.2	13.6	9.0	16.9	11.5	11.2	14.8	15.7	14.8	14.6	14.8	14.8	15.2	15.1	2.1	15.1	6.1	6.0	13.0	11.4	10.1	11.1	8.8	8.9	7.6	7.0	10.3	6.0	7.4	9.2
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol			1600000	Cytosol		"HPA019709: , HPA042865: AB_10797024, HPA054322: "	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favourable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	31.7	13.1	14.5	16.2	14.7	23.8	22.5	13.3	21.9	22.7	25.9	9.1	12.6	5.2	19.3	58.7	35.8	18.7	17.5	21.7	11.9	16.2	26.8	6.0	27.7	25.1	15.8	15.4	26.4	14.8	19.3	13.1	12.2	20.5	21.8	8.8	17.2	17.9	21.1	23.0	15.1	12.2	26.4	10.6	40.9	17.7	9.3	6.7	12.1	19.0	21.3	21.5	28.5	18.9	4.9	23.2	27.5	61.6	3.4	14.0	30.7	11.4	22.3	6.5	27.1	13.9	18.6	0.3	7.8	24.3	13.4	16.4	5.3	6.9	0.0	15.1	12.4	15.1	19.9	19.8	11.5	53.8	13.9	24.7	20.5	32.6	35.5	2.7	9.3	12.6	33.6	14.1	9.4	22.7	16.4	13.7	10.1	12.4	8.6	1.5	8.8	25.7	19.0	11.3	62.2	29.7	6.4	8.4	25.9	16.0	16.0	13.0	36.0	18.5	13.8	12.3	13.7	5.4	13.3	18.5	14.6	0.0	20.1	11.2	19.1	7.8	50.5	27.5	7.0	61.6	6.6	4.9	14.0	11.7	23.2	2.4	7.5	5.8	4.5	3.4	57.7	3.4	13.6	30.7	14.5	14.7	13.3	21.9	11.9	16.2	15.8	15.4	20.5	6.7
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465840	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.6"	"Cell line enhanced"	"Detected in many"		"A549: 82.6;K-562: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 73.4"	"Group enriched"	"Detected in all"	7	"dendritic cells: 54.8;monocytes: 73.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			440000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	36.9	17.9	10.9	12.8	12.2	137.6	28.9	3.5	10.9	17.0	26.7	7.7	18.5	20.9	14.1	19.6	45.3	14.6	19.0	31.0	8.2	8.6	31.8	72.4	37.3	30.0	11.7	9.6	21.3	19.4	5.7	5.6	32.2	13.8	22.9	7.7	17.5	27.1	22.1	43.4	16.7	26.4	22.1	9.7	47.1	31.1	7.6	7.9	6.6	24.3	42.9	24.4	29.9	22.1	8.6	54.8	9.1	73.4	4.0	5.3	34.4	34.8	82.6	1.1	12.3	11.5	11.1	9.8	4.4	12.9	6.0	11.7	16.2	31.7	11.7	34.0	7.9	11.1	4.2	9.6	1.2	19.8	3.6	17.8	12.5	9.8	26.5	0.2	5.2	10.8	18.2	8.0	4.4	6.3	75.0	21.3	7.0	54.2	0.9	1.0	0.3	23.1	8.2	3.9	18.9	7.5	23.5	0.0	1.8	13.4	35.2	13.5	34.3	2.7	6.8	16.0	17.2	24.6	2.3	11.6	13.6	4.4	41.8	7.0	6.2	5.0	73.4	2.6	4.6	33.7	4.4	8.6	4.0	4.0	54.8	5.4	4.2	3.3	9.1	4.0	16.9	11.5	5.3	34.4	10.9	12.2	3.5	10.9	8.2	8.6	11.7	9.6	13.8	7.9
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: "	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	17.5	13.5	15.7	12.2	18.6	19.7	17.3	21.0	24.1	19.6	14.3	7.8	12.7	10.5	14.4	13.2	29.3	11.8	14.5	14.7	13.8	11.6	19.6	13.1	11.3	9.4	14.0	18.0	17.4	12.0	15.5	30.3	16.9	20.5	19.9	14.1	7.5	16.0	15.2	13.5	15.7	17.3	18.8	16.7	10.9	12.4	35.6	15.8	19.1	19.1	17.5	13.6	22.1	20.8	5.2	5.1	31.4	7.5	8.9	10.9	5.1	24.5	7.9	7.9	6.7	12.0	18.5	12.7	21.9	15.4	23.3	25.8	9.2	16.1	3.7	12.4	14.5	18.0	7.7	13.6	18.4	7.6	7.5	6.6	9.7	6.4	12.6	12.6	9.4	13.6	17.6	17.5	15.8	12.2	11.4	9.9	21.4	5.2	5.5	5.8	9.5	11.8	3.2	12.4	7.6	22.4	8.3	4.9	14.8	14.3	19.5	16.4	21.7	9.0	14.6	13.9	10.9	12.9	17.7	10.0	11.9	9.2	10.8	5.8	21.4	31.4	5.9	23.2	6.2	7.5	7.9	5.2	7.7	7.0	5.1	4.8	6.9	7.4	12.0	8.9	7.0	3.9	10.9	5.1	15.7	18.6	21.0	24.1	13.8	11.6	14.0	18.0	20.5	15.8
BMP2	BMP2A	ENSG00000125845	"Bone morphogenetic protein 2"	P12643	20	6767664-6780280	"Cancer-related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.7;HeLa: 13.5;hTERT-HME1: 12.2;RT4: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"NK-cell: 2.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA058610, CAB078457"			Enhanced	Vesicles	"Secreted to blood"	24353		Vesicles		"CAB078457: AB_2532532, HPA058610: "	"unprognostic (2.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.12e-3)"	"unprognostic (8.51e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.39e-3)"	"unprognostic (7.81e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.49e-2)"	11.1	1.1	1.6	10.5	3.1	0.6	5.3	1.8	7.5	3.7	13.1	2.6	1.9	4.2	3.4	6.7	3.7	3.7	15.6	3.9	2.4	1.6	3.6	3.8	12.8	1.3	2.9	1.3	3.1	9.2	4.7	2.3	7.6	2.7	8.8	9.5	18.3	2.0	1.2	2.6	9.1	13.4	3.4	1.4	8.0	13.8	1.1	2.7	0.3	13.2	6.2	3.1	14.1	9.1	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.5	2.3	0.0	0.0	20.7	0.0	0.0	0.3	0.7	6.9	4.1	1.8	0.0	0.0	3.7	0.0	13.5	0.0	1.0	0.0	0.5	0.1	6.3	0.0	12.2	4.2	0.0	0.0	0.1	0.0	0.0	3.9	0.5	0.5	4.0	0.0	0.3	1.5	16.5	0.7	1.0	4.9	0.0	0.0	0.0	4.3	1.0	1.2	1.8	0.0	0.5	0.2	0.5	0.0	2.1	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	1.6	3.1	1.8	3.3	2.4	1.6	2.9	1.3	2.7	2.7
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916372	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 37.9;HMC-1: 41.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favourable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	11.4	11.1	15.6	18.6	15.0	15.3	12.0	8.2	12.7	11.1	13.9	20.3	2.1	8.0	11.3	9.6	15.7	10.0	12.3	17.0	18.0	9.5	8.3	10.2	14.1	22.9	20.9	12.0	6.5	6.4	7.7	7.8	14.4	14.5	8.4	18.9	11.4	10.2	6.0	7.5	14.5	15.9	10.4	28.3	19.2	7.4	19.6	16.5	19.9	12.5	5.9	24.4	9.7	12.8	2.7	1.7	3.8	2.6	0.4	0.4	0.5	5.4	2.0	3.0	3.9	5.9	5.6	2.3	5.2	8.1	5.9	7.7	3.7	2.9	6.6	2.7	25.2	1.3	3.5	4.2	10.8	1.8	1.2	37.9	2.4	1.7	6.5	7.9	41.1	8.2	5.5	9.2	8.5	7.9	10.2	19.0	6.9	1.1	4.7	3.3	1.4	1.3	6.8	5.4	1.6	7.2	2.9	4.7	2.5	7.6	3.9	4.6	1.4	4.1	7.7	5.8	2.3	9.6	5.6	3.5	1.4	2.5	5.1	9.9	4.0	0.4	2.2	1.2	0.1	0.9	0.1	2.7	0.1	0.0	1.7	2.7	0.4	0.2	3.8	0.4	2.6	1.3	0.0	0.5	15.6	15.0	8.2	12.7	18.0	9.5	20.9	12.0	14.5	16.5
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376936-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA017385: AB_1845397, HPA049014: "	"unprognostic (2.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	18.1	15.0	12.1	9.8	14.2	1.1	10.2	9.5	17.1	15.7	11.7	8.2	6.5	5.5	12.9	10.2	10.6	10.3	13.2	14.6	10.8	13.5	10.7	11.5	24.9	4.4	10.4	14.5	12.0	7.0	15.5	6.1	21.7	10.8	11.0	7.7	11.4	7.1	9.1	10.6	7.2	8.1	15.3	7.5	8.9	7.2	12.9	3.8	3.9	11.6	5.2	5.4	11.1	8.9	1.6	2.6	0.9	2.7	1.1	3.6	0.9	5.7	5.4	5.5	8.7	13.9	13.4	10.7	11.9	12.0	10.4	10.4	4.7	8.7	2.0	13.9	24.0	10.8	7.2	9.2	16.3	5.9	4.9	6.0	5.7	7.3	9.6	1.7	4.7	9.8	8.7	7.6	10.2	30.0	3.9	9.9	12.8	10.7	1.4	1.5	3.0	4.9	3.9	10.9	3.0	8.9	12.2	5.6	5.6	12.6	7.6	14.0	5.8	4.0	33.0	21.2	11.3	7.2	7.2	1.4	1.7	0.6	5.1	3.8	6.1	0.5	2.0	0.9	3.4	1.8	2.5	1.5	1.3	2.2	2.3	1.6	2.7	1.4	0.6	1.1	2.7	2.6	3.6	0.9	12.1	14.2	9.5	17.1	10.8	13.5	10.4	14.5	10.8	3.8
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1, ribosome biogenesis factor"	Q14692	10	42782801-42834937	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA036589: AB_10601460, HPA043081: "	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavourable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	17.8	15.3	10.4	15.8	19.7	17.4	16.2	22.5	20.6	15.5	12.9	13.7	11.2	11.8	23.1	13.4	17.8	14.0	10.0	14.4	10.8	13.3	17.8	16.8	14.1	17.2	12.6	15.4	17.5	16.2	24.7	28.0	15.3	22.8	14.1	15.4	12.3	18.8	14.0	29.9	18.1	13.8	14.7	15.0	18.3	13.5	14.8	13.4	20.7	14.0	17.2	19.2	14.4	15.9	9.8	8.4	3.4	9.1	6.2	11.6	5.6	16.6	14.2	13.8	15.7	10.5	8.7	13.4	14.0	14.8	16.5	14.3	19.5	13.1	8.8	10.0	12.0	14.6	22.5	18.0	21.8	12.9	15.7	11.8	11.0	16.6	9.0	31.9	11.2	7.7	9.2	17.8	17.4	12.5	20.7	9.6	11.7	14.0	17.7	10.6	17.5	15.1	16.3	14.5	9.5	9.2	14.7	10.6	11.3	12.2	13.6	11.5	16.5	9.2	15.1	7.8	27.9	15.5	22.7	7.7	9.5	26.0	11.3	23.7	5.9	3.4	5.1	2.9	8.6	9.1	10.2	9.8	10.6	9.3	8.4	7.4	11.6	10.0	0.7	6.2	7.4	4.4	7.5	5.6	10.4	19.7	22.5	20.6	10.8	13.3	12.6	15.4	22.8	13.4
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 57.1"	"Cell line enriched"	"Detected in single"	121	"HUVEC TERT2: 88.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	8.2	0.3	0.1	1.0	0.7	3.6	5.4	0.1	0.3	2.2	5.5	0.1	4.6	2.4	2.6	57.1	1.5	2.5	2.6	10.5	0.5	0.0	0.2	0.9	3.7	6.5	0.4	0.0	1.4	0.9	0.2	0.6	2.6	0.7	2.2	1.4	0.5	1.5	0.6	4.2	1.6	5.5	2.2	0.4	2.4	1.5	1.9	0.1	0.2	2.2	1.1	0.8	2.8	2.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.7	0.1
BNC1	"BNC, HsT19447"	ENSG00000169594	"Basonuclin 1"	Q01954	15	83255903-83284714	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.4;testis: 27.5;tongue: 20.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 15.9;HBEC3-KT: 36.3;hTCEpi: 40.8;hTERT-HME1: 39.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063183, HPA066947, HPA077428"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA063183: , HPA066947: , HPA077428: "	"unprognostic (1.86e-3)"	"unprognostic (1.08e-1)"		"unprognostic (7.89e-3)"	"unprognostic (5.55e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.89e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (8.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.01e-2)"	12.7	0.1	0.0	1.6	0.1	0.0	0.9	0.0	0.4	2.7	1.5	0.1	0.0	0.0	0.4	10.8	13.4	0.8	0.1	1.4	0.1	0.0	0.1	0.1	0.7	1.3	0.2	0.2	0.6	0.0	0.0	0.0	1.9	0.5	0.4	0.0	0.7	1.7	0.2	0.1	7.9	0.2	0.3	0.3	0.1	0.0	27.5	0.0	6.0	0.2	20.2	3.7	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	1.3	2.1	0.0	0.6	0.1	6.9	9.7	0.0	0.1	0.0	0.3	4.2	15.9	0.8	36.3	12.6	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	1.8	40.8	6.2	39.8	6.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.5	0.0
BNC2	"BSN2, FLJ20043"	ENSG00000173068	"Basonuclin 2"	Q6ZN30	9	16409503-16870843	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 35.8;ovary: 37.0"	"Cell line enhanced"	"Detected in many"		"HSkMC: 18.1;Karpas-707: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"gdT-cell: 5.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA018525, HPA059419"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA018525: AB_1845402, HPA059419: "	"unprognostic (2.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.14e-3)"	4.3	1.0	0.5	5.1	0.7	0.3	4.3	0.5	0.7	19.8	7.6	1.8	2.9	0.8	35.8	5.5	3.8	14.3	9.3	3.8	1.2	0.5	7.6	0.4	2.6	0.9	0.9	0.5	37.0	0.5	2.7	1.5	2.2	2.3	6.4	2.1	11.0	1.3	4.8	7.6	2.9	2.8	23.1	2.0	0.5	3.0	4.7	1.0	0.9	1.7	3.6	1.3	8.5	9.0	0.1	0.0	0.0	0.0	1.0	5.8	3.2	0.1	0.9	0.7	0.0	9.9	12.2	1.5	6.1	10.8	4.4	3.6	0.0	0.0	0.0	2.0	4.2	0.0	2.9	0.0	4.5	0.1	1.1	0.1	2.9	0.0	7.6	0.0	0.2	18.1	0.0	9.3	0.0	9.8	0.0	22.1	6.2	0.0	0.0	1.5	3.6	5.6	0.0	6.9	14.8	3.3	0.2	0.1	0.5	0.0	0.0	10.5	0.0	0.0	9.6	10.4	7.6	8.3	11.2	0.1	0.0	0.0	4.2	1.3	1.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	1.0	0.0	0.0	0.0	3.2	0.5	0.7	0.5	0.7	1.2	0.5	0.9	0.5	2.3	1.0
BNIP1	"Nip1, SEC20"	ENSG00000113734	"BCL2 interacting protein 1"	Q12981	5	173144442-173164387	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008009, HPA008149"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA008009: AB_1078291, HPA008149: "	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.07e-2)"	12.0	14.5	13.3	9.5	14.5	34.0	13.7	10.1	16.9	10.5	11.1	13.4	9.0	10.2	10.2	15.0	11.4	10.8	9.4	13.0	12.2	14.9	14.5	14.1	10.1	10.9	13.7	12.0	11.3	22.5	13.6	14.7	13.1	17.5	10.6	13.4	10.8	12.4	9.6	20.9	9.0	9.8	10.8	11.8	11.8	11.5	28.1	9.3	14.4	13.1	9.3	12.4	9.9	10.1	9.9	12.7	3.4	9.3	9.6	14.6	8.5	10.7	9.6	11.6	14.3	7.1	16.7	12.9	9.1	14.4	19.6	19.7	16.6	14.9	11.6	10.9	13.6	8.6	14.9	25.9	20.0	18.9	12.0	10.4	6.4	8.7	18.9	16.6	13.1	9.4	13.2	18.0	22.8	14.8	10.0	14.1	15.9	25.1	18.3	14.7	5.1	11.5	12.1	9.3	14.2	11.2	6.6	14.7	9.1	8.1	10.3	19.6	17.4	13.3	11.8	16.9	12.6	14.5	18.4	10.8	12.6	17.8	15.6	17.1	10.9	0.0	8.5	3.4	14.6	9.3	12.4	9.0	12.8	10.5	10.3	9.9	11.0	10.8	0.3	9.6	7.2	12.7	11.1	8.5	13.3	14.5	10.1	16.9	12.2	14.9	13.7	12.0	17.5	9.3
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26382898-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"				Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (3.95e-4)"	"unprognostic (7.59e-3)"	61.7	27.8	32.7	18.2	39.1	79.4	40.1	26.1	39.0	35.0	19.9	32.3	30.7	11.5	27.3	34.0	26.7	26.4	28.0	36.0	36.0	27.4	39.9	22.9	31.3	20.7	43.1	31.9	63.4	10.4	26.8	16.0	51.2	41.0	23.7	14.9	20.9	22.1	39.2	21.0	38.1	14.5	26.5	47.9	19.5	16.7	33.0	43.9	17.8	21.5	12.4	25.2	48.3	30.8	14.2	30.4	68.7	53.9	7.8	17.6	36.3	18.1	6.9	16.6	11.2	46.3	29.2	14.0	18.4	54.1	17.3	38.3	3.1	8.8	5.6	17.4	34.6	9.3	8.2	23.6	57.6	3.6	4.5	23.2	7.2	5.4	25.8	2.0	40.3	35.0	18.6	19.6	11.8	22.1	10.4	13.6	36.2	7.9	14.3	7.6	5.3	7.6	7.7	21.1	11.0	17.9	11.8	17.7	15.8	8.9	1.8	13.9	9.1	4.4	28.9	32.5	14.1	20.3	4.1	20.0	9.0	7.5	49.4	4.2	7.3	49.9	53.9	32.1	7.6	27.8	6.7	12.4	11.4	8.3	30.4	14.2	17.6	12.8	68.7	7.8	17.4	6.9	15.0	36.3	32.7	39.1	26.1	39.0	36.0	27.4	43.1	31.9	41.0	43.9
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 30.7;ASC diff: 45.3;BJ hTERT+: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025806, HPA060778, HPA061787"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"		4500000	"Nucleoplasm, Plasma membrane"		"CAB025806: , HPA060778: , HPA061787: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favourable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (1.18e-5)"	19.4	4.8	5.3	10.4	8.1	0.4	21.6	4.2	6.0	26.6	23.8	5.4	10.6	3.9	25.8	25.3	19.6	33.2	14.5	20.3	13.3	2.9	4.7	1.0	3.6	3.6	5.5	2.2	26.1	12.0	1.9	12.5	1.9	26.2	21.2	3.9	45.6	17.9	17.4	4.6	25.7	9.6	35.2	36.7	3.5	11.8	9.2	7.6	1.2	13.4	12.9	4.9	28.4	25.0	1.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	2.9	10.7	30.7	45.3	2.4	0.3	4.9	16.2	1.2	1.0	0.0	0.0	0.0	3.0	8.3	0.0	2.1	1.0	0.4	0.0	1.3	0.0	1.0	0.0	0.2	0.1	0.1	7.8	0.7	0.6	0.1	0.0	0.0	0.0	0.2	0.8	0.1	0.5	2.7	2.6	0.0	4.8	0.0	0.2	0.0	3.2	4.6	0.0	0.2	0.1	1.3	0.1	0.0	1.7	2.9	0.0	1.6	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	5.3	8.1	4.2	6.0	13.3	2.9	5.5	2.2	26.2	7.6
BOD1L1	"BOD1L, FAM44A, FLJ33215, KIAA1327"	ENSG00000038219	"Biorientation of chromosomes in cell division 1 like 1"	Q8NFC6	4	13568738-13627723	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036943, HPA037362, HPA041290"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA036943: , HPA037362: AB_10670380, HPA041290: "	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.15e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"prognostic favourable (3.48e-6)"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.60e-2)"	17.5	12.6	18.9	23.8	24.3	40.2	18.3	30.4	34.9	21.5	16.8	10.4	18.2	12.1	20.5	19.8	15.2	16.9	14.1	13.6	18.4	12.4	14.2	12.6	22.8	22.0	20.1	21.7	26.8	16.0	28.6	16.0	18.3	21.1	15.4	14.5	7.1	17.1	27.3	13.2	19.5	20.9	18.2	21.1	26.9	16.1	18.0	21.6	23.4	16.4	11.7	22.3	16.5	16.2	2.2	2.5	12.2	1.4	0.7	1.6	0.5	10.1	13.7	13.7	9.8	16.6	17.7	10.5	11.8	12.4	9.8	11.1	10.2	11.1	13.7	5.4	12.9	6.9	11.1	11.7	19.1	9.4	6.4	19.2	17.3	12.5	10.3	28.9	16.0	14.1	13.4	20.4	15.8	10.1	13.5	16.4	12.3	6.0	14.9	19.3	17.5	11.9	11.4	20.3	5.5	18.3	10.3	8.2	14.9	13.0	4.6	10.5	5.4	11.2	22.9	15.3	8.0	9.4	15.5	19.5	11.4	17.3	15.0	13.7	12.1	2.5	1.4	2.8	1.6	1.4	1.3	1.7	1.0	1.1	0.9	2.2	1.5	1.1	12.2	0.7	0.9	2.5	0.9	0.5	18.9	24.3	30.4	34.9	18.4	12.4	20.1	21.7	21.1	21.6
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135398-74147994	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"				"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: "	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	18.5	16.1	23.2	11.7	26.0	18.0	20.4	15.6	29.8	11.0	24.0	7.5	12.1	18.4	10.0	13.8	12.6	11.2	12.5	56.8	18.9	21.0	22.0	15.7	14.1	14.7	24.1	18.1	6.9	27.8	12.8	12.3	7.7	17.6	11.5	19.7	11.9	21.5	14.2	57.2	5.9	15.3	14.4	15.8	8.8	16.8	8.2	10.6	7.7	12.1	27.9	11.1	8.9	9.1	14.3	20.7	3.4	9.7	15.2	32.0	13.9	23.5	30.7	11.2	11.0	20.7	19.6	27.6	22.0	13.0	24.5	16.8	39.9	11.0	15.6	20.2	19.0	12.5	25.6	31.4	22.0	30.5	42.2	19.8	21.3	60.8	18.5	38.8	9.7	15.6	24.1	23.8	29.6	18.2	41.4	18.5	26.5	36.3	32.4	29.0	16.4	47.1	21.3	29.1	32.0	32.4	23.9	16.9	10.1	15.6	25.7	27.1	14.7	24.7	10.0	20.3	34.7	22.7	43.6	17.0	29.9	21.4	21.4	31.2	18.2	3.4	4.8	1.1	23.2	9.1	25.3	14.3	32.0	24.5	12.1	12.4	28.0	24.1	0.9	15.2	9.7	20.7	27.8	13.9	23.2	26.0	15.6	29.8	18.9	21.0	24.1	18.1	17.6	10.6
BOP1	KIAA0124	ENSG00000261236	"Block of proliferation 1"	Q14137	8	144262102-144291370	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 66.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047869, HPA066764"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA047869: , HPA066764: "	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavourable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	4.8	4.3	5.7	7.7	5.9	7.8	6.4	6.3	6.9	2.0	3.9	1.6	2.0	5.1	2.7	1.5	6.8	2.6	4.8	5.1	5.5		2.8	6.2	2.3	6.6	4.1	6.7	2.7	17.5	5.1	2.2	3.2	4.3	2.9	1.5	1.5	5.8	3.0	19.0	7.4	4.5	4.9	2.0	4.8	4.4	8.3	3.3	6.3	3.9	6.7	4.5	3.5	6.9	5.2	6.4	2.5	4.7	3.5	5.7	2.5	12.4	24.3	3.3	14.3	1.9	2.2	12.4	8.6	1.8	8.7	5.5	18.4	7.2	15.1	14.7	3.3	10.0	6.1	10.2	2.0	13.3	24.5	19.0	14.7	13.9	4.6	8.4	10.5	4.5	5.1	7.3	6.6	5.4	19.1	5.1	3.3	31.5	22.5	10.7	8.2	66.9	17.3	5.0	23.0	3.6	8.3	18.8	7.5	9.2	11.9	5.8	8.8	8.0	10.2	8.0	24.7	10.7	24.6	4.8	3.0	12.6	5.9	13.6	10.5	0.0	4.7	2.5	4.4	4.7	4.8	5.2	4.9	5.7	6.4	4.5	4.4	4.1	0.2	3.5	4.0	4.1	4.2	2.5										
BORCS5	"LOH12CR1, LOH1CR12"	ENSG00000165714	"BLOC-1 related complex subunit 5"	Q969J3	12	12357079-12469694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039509, HPA043627"	Approved		Supported	Cytosol				Cytosol		"HPA039509: , HPA043627: "	"unprognostic (1.82e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (6.78e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.51e-2)"	8.9	11.9	13.6	8.3	19.4	17.7	13.7	10.8	20.8	9.5	8.6	20.4	4.8	5.9	8.4	19.7	11.1	7.5	8.4	10.9	12.9	14.9	8.6	11.5	9.1	9.4	16.1	18.2	8.1	13.5	14.5	9.9	8.8	16.6	9.1	7.9	10.0	7.7	7.3	10.7	10.7	6.7	10.1	16.0	8.7	8.9	11.3	15.0	9.0	8.5	4.4	12.2	8.8	8.9	8.3	7.8	9.7	10.5	12.9	14.4	6.7	4.3	4.5	3.3	3.3	7.7	10.3	4.0	4.0	4.6	4.8	5.9	11.1	4.4	5.4	2.3	6.1	3.2	5.6	5.5	5.2	15.3	5.0	3.0	4.4	6.3	7.4	3.0	4.4	5.9	4.0	6.4	7.5	5.5	4.1	7.5	6.1	9.1	4.5	3.2	10.2	2.8	3.8	4.8	5.7	5.9	2.8	4.1	4.8	4.2	3.5	8.4	2.6	3.6	4.7	3.1	7.3	4.1	3.6	3.9	3.4	12.2	6.8	5.0	5.3	2.5	6.5	9.7	11.3	10.5	13.3	8.3	12.8	12.3	7.8	6.5	8.7	8.8	7.1	12.9	6.7	5.3	14.4	6.7	13.6	19.4	10.8	20.8	12.9	14.9	16.1	18.2	16.6	15.0
BORCS6	"C17orf59, FLJ20014"	ENSG00000196544	"BLOC-1 related complex subunit 6"	Q96GS4	17	8188333-8190907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045415, HPA060791"	Uncertain		Supported	Centrosome,Cytosol				Cytosol	Centrosome	"HPA045415: AB_10964575, HPA060791: "	"unprognostic (2.11e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.25e-2)"	"prognostic favourable (2.78e-4)"	"unprognostic (3.84e-2)"	"unprognostic (9.91e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (2.60e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.10e-2)"	3.1	4.5	3.5	3.8	3.4	2.8	2.6	3.2	3.9	2.3	4.4			6.3	3.7	2.9	5.5	2.3	1.6	4.4	3.4	2.6	3.9	3.7	3.7	4.8	3.7		2.3	8.4	4.7	2.1	3.0		2.9	1.9		4.3	4.3	11.5	6.2	5.5	2.1	2.8	6.8	3.9	2.1			2.7		3.7	3.3	2.9	13.4	11.3	27.0	12.0	14.5	17.4	10.5	4.7	5.4	1.9	3.9	4.0	3.0	7.6	3.5	3.8	3.3	3.6	3.0	3.3	4.2	7.7	2.7	6.8	2.9	3.9	1.1	12.7	11.9	3.3	5.3	4.7	4.6	1.9	7.2	3.1	4.2	3.0	3.4	5.2	3.5	9.0	2.0	5.2	6.4	5.5	1.3	6.3	7.8	2.4	6.4	4.5	2.7	2.3	5.2	3.6	2.7	2.9	4.0	3.0	4.3	2.1	1.8	3.4	3.6	13.8	6.1	2.0	3.0	6.9	2.5	21.4	10.1	27.0	16.2	10.3	13.1	12.8	13.7	17.4	11.3	13.4	13.2	14.6	9.5	14.5	12.0	9.9	12.4	10.5										
BPTF	"FAC1, FALZ, NURF301"	ENSG00000171634	"Bromodomain PHD finger transcription factor"	Q12830	17	67825524-67984378	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029069, HPA048289"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA029069: AB_10602597, HPA048289: "	"unprognostic (1.22e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.24e-2)"	"prognostic favourable (8.46e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	16.1	16.2	28.0	28.6	28.7	22.3	19.5	61.9	35.3	20.7	18.5	18.9	17.0	12.1	20.1	24.0	17.9	17.8	17.4	13.9	26.6	17.7	17.1	14.7	24.1	31.7	31.6	22.2	27.1	16.3	31.3	29.7	17.2	26.0	17.3	18.0	14.5	16.9	18.4	17.9	29.5	18.2	16.5	18.4	21.1	17.4	23.6	33.5	41.4	19.0	12.3	30.1	16.7	32.5	12.6	10.4	15.1	4.8	9.7	7.3	1.4	13.2	17.4	25.6	12.9	14.3	13.6	14.0	10.4	9.8	12.6	10.9	16.0	9.6	54.6	7.7	11.7	10.4	25.0	11.2	20.5	7.6	24.1	20.9	16.8	21.9	6.8	30.5	16.9	9.9	12.7	12.5	9.6	23.5	23.7	15.7	10.9	20.4	31.1	15.2	19.5	15.9	22.5	30.9	10.7	11.0	16.7	19.2	22.1	14.3	38.7	14.7	16.3	17.7	16.4	19.2	15.0	7.0	12.8	12.9	13.0	32.5	9.0	14.9	7.4	15.1	3.9	7.5	7.3	2.2	5.9	5.7	5.9	5.7	2.8	12.6	6.2	6.4	8.9	9.7	4.8	10.4	4.2	1.4	28.0	28.7	61.9	35.3	26.6	17.7	31.6	22.2	26.0	33.5
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685986	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"				Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: "	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.8	9.9	9.8	7.2	11.6	26.5	9.6	10.0	12.8	8.3	9.3	10.0	8.0	8.6	10.1	7.0	9.4	8.4	7.3	8.8	8.6	8.7	8.4	9.3	7.9	9.7	9.2	8.5	9.7	7.8	9.4	10.4	9.8	12.0	8.3	9.0	6.7	8.9	9.7	19.1	12.7	9.3	9.1	11.1	9.6	7.9	55.9	10.1	12.4	9.5	5.6	10.4	10.2	11.8	12.7	11.7	25.7	13.5	16.6	18.5	11.6	9.7	14.4	11.8	13.5	12.6	10.7	19.7	13.7	11.6	16.0	12.3	19.3	6.8	18.8	8.2	13.0	12.0	16.4	11.2	17.1	12.0	10.6	23.3	9.0	13.0	15.9	20.4	15.8	12.0	16.0	13.8	22.4	13.8	24.1	6.2	13.1	12.3	16.9	19.7	15.9	15.2	15.8	12.9	16.8	10.5	20.6	14.7	10.9	16.1	13.7	13.4	15.0	13.0	12.7	10.3	9.6	9.2	9.7	15.9	20.0	20.8	9.7	11.3	11.2	16.1	13.0	24.0	14.7	13.5	14.3	12.7	15.4	14.7	11.7	12.5	14.6	14.8	25.7	16.6	10.6	8.4	18.5	11.6	9.8	11.6	10.0	12.8	8.6	8.7	9.2	8.5	12.0	10.1
BRAT1	"BAAT1, C7orf27, MGC22916"	ENSG00000106009	"BRCA1 associated ATM activator 1"	Q6PJG6	7	2537877-2555727	"Disease related genes, Predicted intracellular proteins"	"DNA damage"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029455, HPA076508"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA029455: AB_10600761, HPA076508: "	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.04e-3)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (5.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (8.88e-2)"	"unprognostic (3.71e-2)"	16.1	19.2	12.2	13.0	14.3	12.1	10.1	20.4	12.9	11.4	9.6	14.3	9.4	16.5	12.2	11.7	10.3	11.4	15.8	8.1	13.4	9.1	9.1	13.7	15.9	11.6	14.7	9.8	13.8	17.0	9.9	12.5	11.0	8.9	14.0	3.1	12.9	20.0	13.7	12.0	19.0	13.8	8.8	11.3	14.6	14.5	17.0	10.6	19.2	14.5	5.8	12.3	10.2	10.8	14.2	23.1	18.7	22.2	10.2	17.1	14.6	14.8	13.6	3.2	11.8	3.0	2.8	10.9	5.1	2.9	4.5	3.9	9.7	9.2	11.3	8.2	3.4	15.1	3.8	5.8	0.7	4.4	19.9	5.2	10.0	6.1	3.9	7.0	8.1	4.8	4.2	4.5	1.3	5.1	16.5	4.0	3.1	21.3	4.9	32.8	15.6	21.0	12.1	9.8	10.8	2.8	4.7	8.7	13.4	7.7	12.9	5.3	11.6	14.3	5.0	6.0	19.5	12.5	9.8	9.1	7.0	8.0	6.8	14.0	14.3	3.6	22.2	12.3	16.8	20.2	14.7	14.2	15.2	17.1	23.1	12.6	12.8	13.7	18.7	10.2	17.4	16.4	13.0	14.6	12.2	14.3	20.4	12.9	13.4	9.1	14.7	9.8	8.9	10.6
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1, DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: "	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	4.8	4.3	6.0	9.6	11.3	15.3	5.1	12.9	10.6	5.4	9.2	3.4	6.8	4.3	5.4	5.5	9.1	5.5	3.3	6.5	6.6	5.3	4.2	7.7	4.9	13.0	7.5	5.9	5.1	4.7	4.2	11.0	5.3	10.5	4.1	10.4	3.7	5.4	7.4	7.3	8.3	6.7	5.5	9.2	5.9	5.1	17.6	7.0	10.9	15.6	7.3	14.6	5.5	5.6	2.0	9.1	9.7	12.7	1.4	1.3	10.7	15.5	25.2	13.9	11.1	2.3	5.2	13.6	18.3	7.9	15.4	14.7	15.3	12.1	35.9	3.4	7.0	18.0	18.9	10.2	25.9	16.4	13.8	16.9	19.8	13.2	0.5	30.1	14.7	1.4	1.7	23.2	7.4	7.9	25.4	15.4	14.5	10.3	25.2	9.9	7.6	6.7	17.4	29.3	14.7	5.7	15.1	9.6	10.3	14.1	4.7	6.9	12.4	13.9	5.2	13.8	11.2	17.8	19.1	7.2	17.6	27.6	11.1	17.9	14.4	4.6	12.7	1.8	1.3	4.0	1.3	1.1	1.3	1.0	9.1	2.0	1.2	1.3	9.7	1.4	1.5	1.4	0.4	10.7	6.0	11.3	12.9	10.6	6.6	5.3	7.5	5.9	10.5	7.0
BRCC3	"BRCC36, C6.1A, CXorf53"	ENSG00000185515	"BRCA1/BRCA2-containing complex subunit 3"	P46736	X	155071420-155123074	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Metalloprotease, Protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA048737			Supported	Nucleoplasm				Nucleoplasm		"HPA048737: "	"unprognostic (1.16e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.90e-1)"	12.9	14.8	11.3	11.2	16.5	14.0	12.9	20.0	18.6	11.8	19.5	9.1	15.2	16.7	9.4	11.8	20.4	12.1	8.3	10.3	10.3	12.1	18.3	12.3	9.4	12.5	10.4	10.5	10.7	12.2	14.3	11.8	14.2	15.3	12.2	19.5	8.7	15.5	12.6	21.3	10.0	19.2	13.1	8.9	11.1	13.7	3.9	12.9	10.2	13.9	13.7	12.7	11.4	11.6	13.4	16.2	25.0	17.8	21.0	19.0	12.3	31.4	19.5	8.2	6.4	6.2	5.1	13.6	12.9	8.2	7.9	17.5	17.6	13.8	30.3	23.6	8.2	12.2	21.1	11.5	11.5	17.6	16.9	6.1	30.7	14.6	5.5	21.4	9.5	6.3	5.2	12.9	11.0	10.8	9.9	9.0	6.4	13.3	8.2	7.6	7.3	13.9	12.9	14.1	12.6	9.5	14.9	13.5	5.8	8.5	13.6	7.7	9.4	7.3	12.1	7.1	10.9	10.4	19.4	11.5	18.7	39.4	10.3	20.1	8.2	22.6	14.7	25.0	16.2	17.8	19.0	13.4	16.0	14.8	16.2	11.8	12.5	14.0	8.0	21.0	16.9	10.4	18.6	12.3	11.3	16.5	20.0	18.6	10.3	12.1	10.4	10.5	15.3	12.9
BRD1	"BRL, BRPF2"	ENSG00000100425	"Bromodomain containing 1"	O95696	22	49773283-49827512	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000807, HPA001063"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA000807: AB_1078298, HPA001063: AB_1078297"	"unprognostic (1.96e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.95e-3)"	12.1	9.3	11.3	11.5	12.8	17.0	17.3	32.4	13.0	15.8	14.5	10.8	11.8	15.3	18.9	9.3	14.6	15.5	14.6	8.9	8.6	7.5	7.4	8.0	11.3	11.2	9.6	11.1	19.3	20.3	10.8	13.5	14.8	11.3	11.9	8.2	13.9	14.0	11.7	16.8	23.7	14.7	14.3	7.6	14.8	14.9	38.9	11.7	23.8	13.4	12.1	16.0	15.3	14.2	2.2	2.3	1.7	6.3	1.9	2.9	1.1	8.4	8.6	15.9	8.9	6.6	5.9	13.5	9.4	6.5	9.9	7.8	13.0	5.7	9.0	5.6	7.7	12.2	10.1	6.7	4.3	8.9	18.4	8.9	13.1	7.9	12.8	20.2	12.7	8.7	10.5	5.8	7.4	7.2	10.1	9.9	5.0	13.9	15.1	10.6	10.9	7.0	22.5	13.9	9.2	3.9	12.4	10.2	18.1	12.0	15.8	12.3	7.3	16.8	8.8	9.2	10.0	6.9	8.5	11.8	2.8	12.8	6.5	7.2	8.1	0.8	1.6	1.7	1.5	0.7	2.9	1.2	2.4	2.7	1.1	2.2	2.4	2.7	1.7	1.9	6.3	2.3	0.8	1.1	11.3	12.8	32.4	13.0	8.6	7.5	9.6	11.1	11.3	11.7
BRD2	"BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3"	ENSG00000204256	"Bromodomain containing 2"	P25440	6	32968660-32981505	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042816	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA042816: AB_10794766"	"unprognostic (2.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-2)"	26.1	35.1	26.8	30.1	28.9	96.2	26.8	42.2	28.8	34.9	27.4	30.6	46.4	21.2	35.0	28.7	33.2	33.0	27.6	21.7	26.5	20.1	28.9	27.5	28.1	28.2	34.9	19.5	40.6	65.5	28.8	33.7	27.2	29.0	28.5	21.8	29.3	32.6	41.7	28.6	28.7	25.6	27.1	26.4	33.4	32.2	66.9	33.1	38.7	58.5	27.1	33.2	26.8	35.8	12.3	13.0	14.0	11.2	12.9	19.5	12.0	18.8	7.3	18.3	13.4	10.0	9.1	25.7	14.8	18.3	18.7	16.2	7.8	13.0	14.2	16.4	21.0	9.9	11.6	12.0	16.6	13.8	53.0	13.6	9.3	6.5	14.2	22.4	23.9	9.4	10.4	16.8	15.3	6.7	17.2	28.4	7.2	3.7	25.2	3.9	10.3	6.9	29.8	5.4	20.1	5.0	8.8	28.2	11.2	16.6	20.9	20.8	14.3	12.7	8.4	25.9	12.3	7.3	18.4	42.3	35.2	35.5	7.3	13.1	15.5	10.2	9.1	14.0	19.5	11.2	17.6	12.3	13.0	13.1	13.0	11.8	9.1	13.5	12.9	12.9	10.9	10.8	16.3	12.0	26.8	28.9	42.2	28.8	26.5	20.1	34.9	19.5	29.0	33.1
BRD4	"CAP, HUNK1, HUNKI, MCAP"	ENSG00000141867	"Bromodomain containing 4"	O60885	19	15235519-15332545	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015055, HPA061646, CAB068177, CAB068178"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB068177: , CAB068178: , HPA015055: AB_1845435, HPA061646: "	"unprognostic (2.83e-3)"	"unprognostic (2.39e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.53e-3)"	"unprognostic (3.03e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.98e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	23.0	20.7	27.8	25.6	30.1	25.2	20.4	32.1	29.9	20.8	19.6	17.2	18.9	17.6	23.4	12.5	22.9	18.6	15.8	21.3	20.3	12.4	18.1	25.3	22.5	22.7	14.8	17.6	27.3	31.3	19.1	18.8	34.0	17.6	20.8	10.7	18.9	22.0	19.3	47.7	27.3	21.0	20.3	13.9	26.8	20.2	20.1	16.8	34.2	21.5	11.6	23.7	20.9	24.8	6.9	4.3	11.6	4.4	4.9	3.5	2.0	20.5	20.7	12.9	24.4	12.4	8.8	15.6	15.1	12.4	12.0	12.6	21.9	31.0	25.8	25.1	16.5	20.6	15.0	14.3	10.4	25.8	9.9	24.4	18.2	19.0	18.9	24.0	27.2	12.9	14.8	14.8	29.3	11.6	41.3	26.2	7.6	26.6	22.6	17.4	26.4	24.4	28.4	13.6	16.1	9.5	22.2	15.6	14.2	20.0	14.7	17.1	14.7	16.5	18.4	31.3	15.0	27.8	23.8	21.4	18.8	13.1	17.3	19.6	24.2	5.2	3.6	3.9	3.5	4.4	2.7	5.4	3.1	2.9	2.1	6.9	3.1	2.9	11.6	4.9	3.9	4.3	2.2	2.0	27.8	30.1	32.1	29.9	20.3	12.4	14.8	17.6	17.6	16.8
BRD7	"BP75, CELTIX1"	ENSG00000166164	"Bromodomain containing 7"	Q9NPI1	16	50313487-50368934	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042389, CAB046458, HPA060171"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB046458: AB_2066024, HPA042389: , HPA060171: "	"unprognostic (2.10e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.38e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.46e-2)"	"prognostic favourable (1.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.34e-2)"	23.5	26.9	38.8	33.7	39.0	42.2	39.1	34.5	35.9	24.5	30.7	32.4	26.4	23.4	29.0	38.1	37.3	27.1	24.4	41.2	35.3	31.9	29.9	22.9	27.9	32.1	38.4	26.9	26.8	36.5	53.3	35.1	37.9	42.6	29.5	30.3	22.2	26.9	30.7	37.9	31.2	31.1	27.2	48.1	32.1	29.0	41.5	36.4	46.1	31.2	26.5	36.4	24.5	40.0	8.8	11.2	9.6	6.8	12.3	12.1	3.7	21.9	19.4	34.2	20.3	14.5	14.3	22.5	18.1	17.9	28.6	13.0	32.6	22.4	32.9	19.0	16.0	20.4	31.2	18.2	33.1	14.9	25.9	22.3	15.6	45.0	17.1	30.7	24.6	10.5	27.5	14.7	25.4	19.0	32.1	10.6	17.4	14.3	34.7	41.4	26.8	18.5	42.8	32.1	23.9	25.1	15.6	26.6	21.6	22.0	21.4	14.8	12.8	27.9	19.1	18.2	22.2	14.9	17.5	5.0	1.9	56.3	14.3	22.4	18.0	8.2	6.8	9.6	8.8	5.7	6.8	8.0	8.9	8.1	5.4	8.8	10.1	12.1	4.0	12.3	5.1	11.2	8.5	3.7	38.8	39.0	34.5	35.9	35.3	31.9	38.4	26.9	42.6	36.4
BRD8	"p120, SMAP"	ENSG00000112983	"Bromodomain containing 8"	Q9H0E9	5	138139766-138178986	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001841	Supported		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA001841: AB_1845438"	"unprognostic (1.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (1.09e-6)"	"unprognostic (1.73e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavourable (7.80e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-2)"	11.9	14.1	21.0	10.4	22.1	14.0	18.2	28.9	24.8	17.1	15.7	21.1	14.4	11.1	20.0	31.2	13.8	18.9	12.0	11.6	16.5	16.6	15.5	14.2	14.0	13.5	18.5	16.8	24.9	17.8	19.8	37.0	17.7	22.1	17.2	18.4	15.4	14.7	18.5	15.3	16.8	12.8	18.7	16.6	16.4	14.3	54.6	20.7	25.5	20.5	7.7	15.3	14.3	14.0	9.7	10.6	17.8	9.6	20.7	15.3	8.3	11.7	15.4	27.1	43.4	19.8	18.6	24.5	18.2	20.3	26.5	28.0	23.0	26.4	11.7	18.3	16.8	13.9	28.5	17.6	28.7	20.6	21.2	15.9	36.5	15.6	11.0	9.6	16.9	13.8	11.7	20.9	19.1	16.8	14.2	15.3	17.6	13.1	19.5	15.4	12.2	8.0	19.1	22.4	14.3	17.8	17.3	24.0	12.1	21.8	9.5	16.6	16.4	17.9	10.5	13.1	15.2	9.0	15.8	13.6	15.0	16.3	10.0	14.3	12.0	12.7	9.6	11.9	14.1	6.9	14.8	9.7	12.0	12.4	10.6	9.6	15.3	15.1	17.8	20.7	7.1	7.4	11.0	8.3	21.0	22.1	28.9	24.8	16.5	16.6	18.5	16.8	22.1	20.7
BRF2	"BRFU, FLJ11052, TFIIIB50"	ENSG00000104221	"BRF2, RNA polymerase III transcription initiation factor subunit"	Q9HAW0	8	37843268-37849904	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019269, HPA023378"	Supported		Supported	Nucleoli				Nucleoli		"CAB019269: , HPA023378: AB_1845446"	"unprognostic (9.85e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.41e-2)"	12.6	10.3	8.4	8.3	9.9	19.0	12.1	9.8	17.9	12.8	11.0	8.7	9.7	7.5	14.7	10.4	9.2	12.9	8.6	17.0	9.9	8.6	8.7	8.8	9.0	11.6	10.2	10.7	20.2	16.2	8.4	11.1	12.9	9.5	14.8	8.5	11.4	10.6	13.3	32.4	11.9	8.1	12.4	7.4	11.0	9.5	13.1	9.9	21.7	10.7	10.7	9.0	11.5	19.0	12.8	8.3	10.2	8.8	16.6	19.1	10.2	9.6	7.5	7.4	9.8	10.3	7.6	8.7	11.6	9.1	15.5	10.7	9.7	7.0	11.8	17.0	7.1	10.1	9.5	7.2	7.7	7.5	9.6	14.7	6.3	7.8	10.7	5.8	8.8	10.1	9.5	15.5	6.6	5.0	17.9	10.7	5.0	5.7	18.3	8.4	12.7	9.6	11.4	8.6	6.1	5.6	6.5	6.3	8.3	5.5	8.0	13.0	17.0	12.8	6.7	8.3	11.1	17.9	11.9	13.3	17.8	14.0	11.4	8.9	14.6	10.2	8.8	9.5	12.7	7.8	12.7	12.7	13.3	12.9	6.9	12.8	19.1	15.3	3.6	16.6	7.2	8.3	11.5	10.2	8.4	9.9	9.8	17.9	9.9	8.6	10.2	10.7	9.5	9.9
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61681266-61863521	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 41.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favourable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favourable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	1.0	0.9	0.7	6.3	3.5	9.1	1.1	0.6	1.4	1.4	2.6	0.2	0.6	2.8	1.5	1.2	3.7	0.8	1.8	0.4	0.5	0.5	0.6	2.3	1.3	4.0	0.5	0.9	2.1	1.3	0.1	0.4	1.7	0.7	1.0	2.8	0.4	1.4	0.0	0.4	2.7	5.5	1.0	0.5	2.3	1.3	10.8	0.4	30.1	0.4	2.0	6.6	1.3	1.7	2.2	0.5	2.1	0.3	0.6	3.7	0.5	12.3	4.2	12.2	6.9	0.4	1.1	2.7	11.4	6.7	12.2	15.8	4.3	3.9	7.3	2.6	2.4	4.5	6.3	2.3	16.4	1.8	7.7	7.5	6.7	5.3	0.1	9.6	4.4	0.2	0.1	9.7	2.6	2.6	5.2	5.0	7.6	41.4	15.2	3.3	2.6	3.6	9.5	23.4	3.5	1.6	5.6	4.9	12.7	4.4	1.5	1.8	4.1	3.7	2.2	18.0	13.1	6.6	13.1	3.1	6.0	7.9	3.7	4.6	4.5	2.1	0.3	1.5	0.5	0.2	0.6	2.2	1.2	0.6	0.4	1.8	1.8	0.9	1.0	0.6	0.2	0.5	3.7	0.5	0.7	3.5	0.6	1.4	0.5	0.5	0.5	0.9	0.7	0.4
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"BRX1, biogenesis of ribosomes"	Q8TDN6	5	34915376-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039614			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039614: AB_10963698"	"prognostic unfavourable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavourable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favourable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.9	18.4	20.4	15.6	24.0	30.6	23.7	24.9	24.1	16.4	14.4	10.7	18.9	11.9	18.1	18.2	23.4	17.6	11.9	16.4	15.8	15.2	17.0	18.6	14.0	22.2	21.1	15.6	19.4	13.4	15.6	19.1	24.5	20.9	15.9	16.5	7.7	15.7	14.5	19.7	15.9	13.3	22.9	18.6	17.0	14.7	13.4	21.9	17.0	16.6	14.2	23.1	21.6	21.7	22.9	14.0	4.1	10.4	15.0	22.1	16.2	14.7	14.5	14.9	20.5	6.5	9.2	29.4	18.2	12.9	24.6	15.7	19.8	19.5	32.5	9.4	10.8	12.3	26.0	18.8	28.0	17.4	25.7	21.7	34.9	17.7	17.8	34.5	15.0	11.1	12.2	22.7	20.5	11.3	37.9	10.0	16.0	16.0	23.9	37.8	24.0	21.4	21.5	27.0	13.9	14.1	17.2	18.0	16.1	37.7	26.4	16.9	16.5	21.3	6.7	18.9	20.7	13.6	34.8	9.0	19.2	41.3	16.4	39.7	23.5	4.1	8.5	4.0	14.4	7.9	20.4	22.9	17.7	18.1	10.7	18.0	22.1	19.6	0.5	15.0	10.4	14.0	16.4	16.2	20.4	24.0	24.9	24.1	15.8	15.2	21.1	15.6	20.9	21.9
BRMS1L	"BRMS1, FLJ39177, MGC11296"	ENSG00000100916	"Breast cancer metastasis-suppressor 1 like"	Q5PSV4	14	35826318-35932325	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046623	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA046623: "	"prognostic unfavourable (5.78e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (2.56e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.04e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.66e-1)"	"prognostic favourable (6.55e-5)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (6.87e-6)"	8.4	14.3	15.5	5.0	18.6	3.0	8.7	18.6	21.4	8.7	6.0	7.2	5.9	4.5	9.0	8.1	9.0	6.7	5.9	15.4	13.2	13.3	12.3	8.3	6.7	3.9	11.5	16.7	10.4	4.3	14.9	7.8	9.9	15.9	9.4	5.3	3.9	5.6	9.2	16.3	8.0	3.9	9.8	11.0	4.7	5.6	7.1	11.0	2.2	10.1	5.8	5.2	7.3	9.6	2.1	2.3	0.8	3.4	1.0	4.0	2.2	6.9	7.1	12.4	7.1	11.3	14.4	18.5	7.3	7.1	11.4	11.2	4.5	5.9	5.6	7.5	10.1	9.0	9.8	13.3	16.4	6.2	12.0	5.1	7.2	19.8	8.0	2.5	4.3	10.0	9.1	8.8	7.5	8.1	2.4	4.5	12.7	9.3	2.9	4.2	4.9	10.6	3.0	13.8	4.3	9.2	8.0	3.7	9.5	8.4	9.9	8.3	11.2	3.6	4.9	10.9	6.6	6.1	7.1	4.2	5.5	3.4	2.7	5.6	6.6	0.1	1.4	0.8	2.8	3.2	2.4	2.1	3.0	3.7	0.9	1.5	4.0	3.6	0.1	1.0	3.4	2.3	3.4	2.2	15.5	18.6	18.6	17.5	13.2	13.3	11.5	16.7	15.9	11.0
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 25.9;SH-SY5Y: 23.2;WM-115: 21.1"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA021212: AB_1845455, HPA061719: "	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.4	9.8	28.6	3.2	23.6	1.0	1.6	26.7	65.0	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3.0	2.3	3.9	6.5	33.4	20.0	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11.0	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1.0	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0.0	3.0	0.0	1.6	3.2	0.7	0.0	0.3	0.0	0.9	0.1	0.8	0.2	0.3	1.2	15.3	8.0	0.0	0.6	0.1	2.4	3.4	3.3	4.8	5.9	2.7	3.1	1.7	2.7	0.1	3.2	0.1	3.1	14.4	12.6	2.0	1.6	0.6	3.3	0.6	5.9	2.1	0.3	3.3	0.0	0.1	2.8	18.8	2.9	0.8	3.6	0.7	11.1	1.0	8.3	3.8	0.5	0.2	0.0	25.9	23.2	0.0	0.4	5.6	1.3	1.7	0.0	6.3	6.7	3.5	4.6	15.6	11.4	7.0	6.5	1.4	21.1	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	28.6	23.6	26.7	40.2	33.4	20.0	20.4	14.8	13.3	7.2
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"CAB034184: AB_2243666, HPA030943: , HPA030944: , HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	10.9	16.7	33.0	15.4	36.8	13.4	16.3	15.5	40.2	12.3	12.0	14.3	10.5	8.8	13.0	21.1	10.2	11.8	9.9	12.9	29.1	32.9	13.9	21.8	10.0	12.9	24.3	17.7	16.2	17.2	12.8	12.0	15.2	13.4	13.2	11.5	13.0	9.3	11.8	14.6	11.9	9.6	13.1	16.1	9.6	9.9	17.2	10.5	22.4	17.7	9.3	13.2	12.1	11.6	8.5	7.2	11.6	6.1	10.2	11.1	3.8	10.2	4.1	10.1	5.6	6.5	9.8	10.4	5.9	7.0	4.6	5.4	3.9	7.0	33.0	6.2	8.0	5.1	9.4	6.8	7.3	7.6	7.8	22.4	7.2	7.1	8.2	12.3	6.3	6.7	11.3	6.3	16.0	6.8	16.5	16.6	6.4	7.9	8.4	14.6	10.6	5.8	14.9	7.9	10.4	5.6	6.6	8.0	10.3	12.6	15.3	8.8	12.9	17.3	7.5	6.1	2.9	3.5	4.4	18.5	12.7	16.1	7.3	13.2	4.8	4.4	5.2	11.6	10.7	6.1	8.3	8.5	9.2	11.0	7.2	6.3	11.1	9.0	5.7	10.2	3.8	6.8	10.3	3.8	33.0	36.8	15.5	40.0	29.1	32.9	24.3	17.7	13.4	10.5
BSDC1	"FLJ10276, RP4-811H24.7"	ENSG00000160058	"BSD domain containing 1"	Q9NW68	1	32365103-32394731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 36.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031358, HPA031360"	Approved		Supported	"Golgi apparatus,Plasma membrane"				"Golgi apparatus"	"Plasma membrane"	"HPA031358: AB_2673841, HPA031360: AB_10601120"	"unprognostic (1.42e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.48e-1)"	"prognostic favourable (8.82e-5)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.07e-1)"	21.9	34.7	30.5	16.8	33.9	45.6	22.8	44.0	41.2	20.7	20.5	34.4	30.8	20.7	25.9	36.8	19.9	22.5	23.4	19.6	27.7	27.1	20.1	41.4	19.6	16.6	27.8	27.2	32.0	37.1	44.5	26.4	28.1	32.5	24.8	24.3	22.2	30.4	21.2	19.0	25.1	23.9	22.8	28.9	20.1	21.4	40.4	27.3	16.2	23.9	16.1	20.3	19.5	19.8	8.4	6.8	36.4	5.8	5.2	6.8	5.4	17.8	9.6	19.9	18.5	28.4	23.8	16.1	20.4	27.8	26.0	26.2	14.1	16.4	12.9	23.4	29.5	16.4	15.7	15.3	20.8	24.5	19.8	10.4	18.1	16.1	26.5	13.0	17.9	24.0	34.3	23.6	16.4	22.4	27.8	22.2	18.7	9.3	15.1	11.7	17.4	15.6	12.5	15.1	17.3	18.9	13.8	29.1	16.1	19.1	19.9	19.5	16.0	11.5	22.2	16.3	13.8	22.7	17.1	25.2	29.9	9.4	21.0	14.2	12.2	36.4	4.9	17.2	6.5	5.8	6.8	5.9	5.8	5.4	4.6	8.4	6.8	5.9	8.1	5.2	5.1	6.8	6.1	5.4	30.5	33.9	44.0	41.2	27.7	27.1	27.8	27.2	32.5	27.3
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405648	"CD markers, Plasma proteins, Predicted membrane proteins"	"Antiviral defense, B-cell activation, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 101.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA017060	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017060: AB_1845467"	"prognostic favourable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	29.6	72.2	8.4	31.1	9.8	13.6	27.9	2.5	7.6	14.4	12.0	5.6	24.8	6.9	13.4	36.7	8.6	26.8	30.1	13.9	7.9	4.9	24.7	30.8	44.9	16.6	10.0	5.2	101.0	6.9	0.3	8.6	31.5	8.8	15.6	4.8	8.4	11.4	17.5	6.0	3.2	14.0	11.3	9.0	32.9	12.3	8.5	9.4	10.3	10.3	5.9	12.3	14.0	42.4	26.2	74.1	35.8	66.4	57.9	32.6	54.5	39.2	0.0	0.1	18.1	0.0	0.1	6.2	0.1	3.0	58.0	78.1	18.4	35.4	30.4	42.9	24.2	0.1	26.4	2.9	1.8	33.5	0.2	0.4	63.6	17.9	33.2	14.3	38.6	0.1	0.0	19.1	0.0	14.7	17.3	75.8	0.0	10.7	6.8	25.1	19.9	50.8	12.8	0.1	63.5	13.8	0.1	0.0	0.1	40.1	1.5	48.2	30.4	20.3	0.1	0.2	1.4	0.0	0.4	39.1	51.0	20.1	0.1	56.7	0.2	35.8	61.6	21.0	32.6	66.4	30.8	21.0	27.5	30.2	50.7	26.2	22.5	25.6	20.3	57.9	59.3	74.1	24.8	54.5	8.4	9.8	2.5	7.6	7.9	4.9	10.0	5.2	8.8	9.4
BTBD10	"GMRP-1, GMRP1, MGC13007"	ENSG00000148925	"BTB domain containing 10"	Q9BSF8	11	13388001-13463297	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046777	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA046777: "	"unprognostic (2.38e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.27e-1)"	11.0	10.3	18.7	10.5	36.3	9.3	11.0	17.7	33.2	13.0	14.2	9.4	12.7	10.5	13.5	9.8	23.3	9.8	12.1	13.6	17.0	18.8	9.2	7.7	10.2	11.0	14.6	17.4	11.8	7.1	16.4	13.3	19.1	23.7	12.5	16.8	7.1	9.2	14.9	10.5	10.4	9.1	17.2	13.3	9.4	13.8	28.8	12.4	8.9	10.8	10.2	13.4	18.6	16.3	9.4	14.5	33.1	23.3	12.1	11.5	8.4	21.7	15.5	14.0	9.4	12.7	12.5	17.8	23.0	13.4	17.9	16.3	14.9	25.7	15.1	11.0	17.1	17.8	10.6	24.6	21.1	15.0	11.2	8.0	5.9	8.8	19.8	10.8	18.7	10.8	27.5	10.3	23.8	36.0	4.5	15.5	18.3	13.2	10.9	5.9	6.0	14.1	9.8	12.0	9.2	28.2	17.7	6.0	8.5	13.7	11.2	7.7	7.9	5.8	32.5	18.3	15.1	17.7	13.2	5.8	20.2	10.1	12.7	9.3	15.6	18.1	12.6	18.4	9.7	19.3	11.5	9.4	9.2	10.6	14.5	9.0	10.5	10.4	33.1	12.1	23.3	6.3	11.3	8.4	18.7	36.3	17.7	33.2	17.0	18.8	14.6	17.4	23.7	12.4
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318413-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 61.8"	"Cell line enhanced"	"Detected in many"		"A549: 19.0;Hep G2: 10.0;MOLT-4: 12.7;PC-3: 9.0;RT4: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA055898: , HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.9	1.1	3.7	2.4	6.6	3.3	2.7	4.6	10.2	6.8	1.0	2.2	3.2	1.1	1.3	1.5	24.1	0.8	1.2	1.0	2.9	9.4	3.7	1.4	1.0	4.0	8.3	3.0	0.6	1.2	61.8	3.2	2.0	19.0	3.1	1.0	1.7	6.2	1.6	0.9	8.4	1.6	1.0	4.9	1.5	1.0	1.1	1.2	24.8	14.4	9.5	9.0	2.3	7.9	0.3	1.3	2.8	0.8	0.3	7.2	1.2	0.1	19.0	3.9	0.0	1.4	0.4	0.0	0.4	0.0	0.2	0.0	0.2	3.1	0.0	4.7	0.1	6.9	3.9	7.2	0.2	0.0	1.2	0.0	0.1	10.0	0.0	0.1	0.0	1.5	3.0	0.0	2.3	0.5	0.0	0.0	0.1	0.6	12.7	1.5	4.0	9.0	0.0	6.1	0.0	0.0	8.6	5.0	1.9	0.0	0.2	0.0	0.4	0.5	0.8	0.0	0.2	0.0	1.5	0.0	0.0	0.0	5.0	1.9	0.0	1.3	0.8	1.1	2.1	0.3	7.2	0.1	2.4	1.4	1.3	0.3	3.0	2.7	2.8	0.3	0.6	0.2	1.1	1.2	3.7	6.6	4.6	10.2	2.9	9.4	8.3	3.0	19.0	1.2
BTBD3	"dJ742J24.1, KIAA0952"	ENSG00000132640	"BTB domain containing 3"	Q9Y2F9	20	11890723-11926609	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 65.0;HeLa: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041424, HPA042048"	Uncertain		Supported	Vesicles				Vesicles		"HPA041424: AB_10794667, HPA042048: AB_10796469"	"unprognostic (3.93e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavourable (2.51e-5)"	"prognostic unfavourable (6.94e-4)"	"unprognostic (4.87e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.37e-2)"	8.9	18.5	32.9	5.5	25.2	8.7	10.4	53.8	40.7	12.2	17.1	32.4	3.8	8.7	15.8	10.1	8.3	12.9	11.1	11.1	56.8	19.8	9.8	6.2	10.0	3.0	25.6	21.2	9.0	10.6	10.5	6.7	33.6	20.9	13.0	14.7	8.4	10.9	9.3	11.5	16.7	8.7	13.8	24.3	6.0	21.2	11.7	22.5	4.1	9.6	5.0	2.5	13.8	7.3	0.3	2.9	0.6	6.3	1.4	0.7	1.1	1.8	5.2	14.1	65.0	2.9	3.1	3.8	5.8	3.7	6.6	4.2	2.9	2.8	0.5	4.9	8.4	4.8	7.3	4.1	10.7	0.0	6.5	1.8	51.3	6.2	3.1	3.0	1.1	5.6	5.1	5.9	4.8	3.7	3.2	5.0	6.5	1.3	3.5	2.7	6.7	1.4	4.7	2.8	1.8	6.0	9.0	6.2	10.9	16.2	6.6	14.0	3.9	3.0	2.8	3.6	9.2	3.3	6.4	1.8	2.4	0.0	2.3	0.8	23.5	0.0	2.2	0.2	0.0	3.4	0.0	0.1	0.0	0.0	2.9	0.3	0.7	0.0	0.6	1.4	6.3	2.0	0.0	1.1	32.9	25.2	53.8	40.7	56.8	19.8	25.6	21.2	20.9	22.5
BTBD8		ENSG00000189195	"BTB domain containing 8"	Q5XKL5	1	92080305-92184725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 42.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA024216, HPA035311"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA024216: AB_1852385, HPA035311: AB_10671933"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.04e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.15e-1)"	3.4	4.6	11.7	1.2	27.3	0.7	3.3	20.3	42.3	2.3	2.4	4.0	0.6	1.7	3.4	4.7	2.0	3.3	2.3	2.8	7.8	2.1	2.4	1.9	2.5	1.4	4.5	23.3	5.0	2.7	5.1	6.0	2.5	16.4	3.3	2.5	1.2	2.8	2.7	2.3	1.8	2.1	2.0	6.6	1.8	2.4	8.3	9.9	0.2	3.7	0.0	1.1	4.7	2.7	0.5	0.8	0.6	0.7	0.9	2.3	0.4	2.8	2.3	1.7	0.0	5.2	10.5	5.7	1.8	2.5	1.5	1.9	0.5	3.3	1.2	6.7	1.6	0.8	1.3	3.3	2.4	2.9	1.9	2.1	0.6	0.9	1.1	1.1	1.3	6.1	2.8	0.9	1.8	1.6	2.5	0.8	2.8	1.7	0.8	2.2	1.7	1.8	1.8	1.7	0.2	3.3	2.1	0.9	1.5	3.0	1.5	1.5	2.3	1.6	1.1	2.0	1.2	1.1	0.7	2.2	0.9	0.0	1.6	0.2	0.4	0.0	0.6	0.0	2.3	0.1	0.5	0.5	1.0	0.9	0.0	0.5	1.8	1.4	0.6	0.9	0.7	0.8	0.9	0.4	11.7	27.3	20.3	42.3	7.8	2.1	4.5	23.3	16.4	9.9
BTF3	"BTF3a, BTF3b, NACB"	ENSG00000145741	"Basic transcription factor 3"	P20290	5	73498408-73505635	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013007, HPA056420"	Approved		Supported	Cytosol			100000	Cytosol		"CAB013007: , HPA056420: "	"unprognostic (3.48e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.16e-1)"	98.4	64.4	44.7	67.6	40.8	98.2	105.6	38.2	49.0	111.8	87.3	45.8	69.7	62.2	107.5	67.3	141.3	75.1	68.7	69.1	40.7	41.3	74.4	107.7	66.6	100.6	46.7	41.6	172.4	111.0	44.3	44.5	90.8	44.8	110.9	75.1	53.0	102.7	76.0	157.9	107.7	87.7	95.7	53.2	84.4	76.9	56.5	41.0	132.6	123.5	131.7	113.4	135.1	88.0	89.0	104.4	19.3	77.0	75.6	102.1	159.0	96.7	65.0	70.6	100.8	70.9	119.5	110.8	67.7	95.4	118.5	114.2	83.6	110.9	146.8	107.1	70.5	68.5	102.7	175.1	136.2	60.7	131.7	83.0	62.4	109.0	103.4	78.5	67.1	103.5	139.9	76.2	141.5	107.6	77.2	95.6	99.6	88.0	117.7	147.4	89.7	65.4	90.0	83.9	182.1	124.5	97.8	82.9	110.7	66.5	76.0	136.1	97.7	162.0	77.2	51.4	69.9	61.2	182.7	90.0	91.6	136.7	68.0	120.4	75.5	19.3	77.0	19.3	52.5	60.9	88.6	89.0	89.8	73.3	104.4	71.3	99.5	87.1	10.8	75.6	47.8	58.7	102.1	159.0	44.7	40.8	38.2	49.0	40.7	41.3	46.7	41.6	44.8	41.0
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 77.5;lymphoid tissue: 37.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;HEL: 40.0;HMC-1: 144.1;U-937: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 77.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"			610000	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	7.3	2.4	3.3	23.5	5.6	14.0	2.6	0.8	3.6	2.3	3.0	4.7	0.3	2.2	1.9	2.6	2.4	2.0	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1.0	1.0	2.5	12.9	3.3	10.8	37.0	3.1	1.3	6.3	4.0	1.7	1.8	36.7	5.8	2.0	13.7	13.2	77.5	20.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	16.0	144.1	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	11.2	0.2	0.0	12.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	13.7	0.0	20.9	0.0	77.5	11.3	19.3	0.0	18.1	0.0	13.7	0.0	0.0	13.2	13.7	0.0	0.0	4.5	0.0	20.7	6.0	0.0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637698-110678114	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 56.5;testis: 30.9"	"Cell line enhanced"	"Detected in many"		"HEL: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA006123			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavourable (1.03e-5)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	1.1	0.9	0.5	15.8	1.0	8.9	0.6	0.3	1.0	1.2	2.8	0.4	0.0	2.4	0.7	2.3	5.8	0.5	1.0	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1.0	0.7	0.0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0.0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2.0	1.8	2.4	3.0	0.2	1.4	6.1	1.1	29.9	8.8	23.1	14.5	1.0	1.7	12.3	15.6	10.3	27.2	20.5	18.4	17.2	20.3	9.7	9.0	13.1	29.5	11.3	33.8	16.1	14.4	67.2	9.4	14.7	0.2	19.3	19.0	0.4	0.7	20.9	10.4	15.8	29.4	42.4	22.2	9.8	32.3	16.2	22.3	16.6	21.5	19.8	31.0	5.5	9.5	15.5	6.7	11.1	9.4	8.4	7.4	16.4	6.5	12.4	20.2	9.3	21.6	22.2	20.8	25.0	8.3	15.0	21.7	3.0	0.0	0.7	0.6	0.2	0.9	1.8	2.5	1.0	0.8	1.4	1.6	1.5	0.0	1.4	0.1	2.4	6.1	1.1	0.5	1.0	0.3	1.0	0.5	0.5	0.6	0.2	0.5	0.1
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221136	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.5;testis: 25.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.8;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008419			Supported	Cytosol				Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (7.43e-6)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	1.0	0.9	0.3	18.4	0.6	11.4	1.5	0.4	0.5	1.3	4.0	0.4	0.1	3.3	1.1	0.8	6.5	0.5	1.1	0.6	0.4	0.4	0.8	0.7	1.8	8.7	0.4	0.3	0.6	0.5	0.0	0.4	3.4	0.5	0.6	4.4	0.3	1.6	0.1	0.7	2.3	2.9	1.2	0.6	5.4	1.7	25.6	0.1	49.5	0.5	3.1	10.6	1.1	2.0	2.8	2.8	0.0	0.2	0.7	0.7	0.5	21.6	11.0	35.1	13.9	0.8	2.5	11.3	20.5	11.5	22.0	19.1	16.0	8.3	19.6	11.5	7.4	24.4	33.1	11.1	24.0	16.8	17.8	28.6	28.4	14.9	0.0	25.7	15.7	0.5	0.6	13.4	12.7	15.9	24.6	20.9	21.9	7.3	20.2	15.7	23.7	12.5	21.7	28.8	14.8	6.7	11.0	22.9	14.1	12.7	12.1	4.5	14.1	13.4	9.2	16.9	17.9	16.8	18.2	10.9	18.5	32.0	9.0	29.0	21.9	0.0	0.0	0.0	0.2	0.2	0.3	2.4	0.7	0.6	0.7	2.8	0.1	0.4	0.0	0.7	0.1	2.8	0.0	0.5	0.3	0.6	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.1
BUB3	BUB3L	ENSG00000154473	"BUB3, mitotic checkpoint protein"	O43684	10	123154277-123170467	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003601, CAB037075"	Supported		Supported	Nucleoplasm			100000000	Nucleoplasm		"CAB037075: AB_1078310, HPA003601: AB_1078309"	"unprognostic (7.82e-2)"	"prognostic favourable (2.04e-4)"	"unprognostic (9.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.93e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (4.45e-5)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (6.30e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (3.81e-7)"	"unprognostic (8.80e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.71e-2)"	23.8	35.1	21.1	35.3	26.6	51.0	27.9	30.4	28.3	20.2	27.7	31.3	22.3	24.5	24.5	22.7	38.2	22.1	20.7	19.6	19.8	28.3	24.1	25.1	22.4	51.8	33.3	23.6	27.4	20.5	20.7	37.3	22.6	31.3	21.8	29.6	16.8	26.5	21.4	23.4	28.9	30.3	22.2	29.1	38.8	24.4	35.4	28.2	67.8	28.1	22.8	49.0	30.3	26.5	43.0	25.8	32.7	24.3	45.6	71.6	52.4	51.2	51.7	33.4	36.9	19.0	18.0	28.8	53.6	57.4	59.8	47.6	44.8	35.4	46.1	20.1	24.5	33.2	49.3	58.1	62.9	37.4	49.2	29.0	62.7	49.1	19.8	56.5	36.1	14.9	22.9	53.1	68.4	40.1	35.1	46.4	53.6	44.2	46.5	35.0	20.5	48.8	63.7	16.7	29.6	27.2	57.0	25.0	25.2	30.3	20.5	25.7	23.3	29.3	31.4	47.1	28.8	29.5	79.0	24.9	35.1	71.8	25.6	56.2	19.8	32.7	23.6	32.4	53.5	24.3	48.1	43.0	49.1	54.2	24.2	37.5	52.9	55.7	11.7	45.6	21.2	25.8	71.6	52.4	21.1	26.6	30.4	28.3	19.8	28.3	33.3	23.6	31.3	28.2
BUD13	"Cwc26, fSAP71, MGC13125"	ENSG00000137656	"BUD13 homolog"	Q9BRD0	11	116748170-116772988	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038340, HPA038341"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA038340: AB_2675967, HPA038341: AB_10671528"	"unprognostic (1.89e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (5.07e-5)"	"unprognostic (1.77e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-1)"	15.1	10.0	9.7	20.4	12.4	12.9	16.1	19.0	15.5	21.2	20.6	16.1	11.6	12.8	19.4	13.8	16.3	16.8	13.7	13.2	9.5	9.4	12.4	11.3	14.4	17.5	10.8	7.8	20.4	13.8	15.7	13.3	18.0	11.0	17.1	16.3	13.5	14.7	13.4	18.5	15.1	20.8	15.5	12.4	18.1	14.7	29.8	11.9	37.9	18.1	14.0	21.2	16.6	22.6	10.8	8.5	20.1	8.7	7.1	11.9	5.7	10.9	6.0	17.1	10.2	5.5	6.6	8.5	10.9	12.1	12.6	12.3	14.2	16.7	23.4	13.9	9.0	15.5	13.8	8.5	13.9	13.6	5.6	27.2	4.4	10.7	6.7	22.9	16.3	5.9	9.9	10.6	10.8	12.2	17.4	11.6	10.3	8.7	27.9	20.3	10.2	9.7	21.2	14.7	18.0	8.9	12.7	10.2	13.5	12.7	9.4	5.0	12.8	15.2	6.9	14.4	9.2	7.3	14.5	4.8	5.9	19.3	4.7	21.2	12.8	14.3	7.8	20.1	10.9	7.8	11.9	10.8	9.4	8.6	8.5	8.8	10.8	8.8	9.5	7.1	8.7	7.5	8.0	5.7	9.7	12.4	19.0	15.5	9.5	9.4	10.8	7.8	11.0	11.9
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23, rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA052185: "	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavourable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	16.6	23.4	16.3	15.0	18.8	19.6	18.3	12.3	20.6	17.5	19.3	17.9	19.5	18.3	19.1	30.6	17.5	24.1	23.1	34.2	16.0	17.5	28.1	36.3	16.1	18.3	25.3	17.5	19.3	27.9	14.3	21.8	22.1	16.4	16.5	19.8	20.3	25.1	25.6	52.2	19.3	21.6	21.2	18.7	18.7	18.9	97.0	16.5	22.1	25.8	22.6	22.7	18.7	14.8	43.9	49.0	14.4	18.3	30.1	37.6	31.4	22.1	24.4	8.9	71.0	12.4	11.0	14.9	15.3	13.8	19.8	16.2	33.9	29.9	25.9	8.1	16.5	15.9	20.6	14.9	18.3	18.1	23.9	11.3	28.6	13.6	15.6	31.5	16.5	9.9	17.1	17.4	15.8	12.7	44.4	47.9	17.1	34.9	19.8	43.3	21.4	28.1	17.7	17.5	112.7	21.9	16.0	27.1	20.4	20.5	54.6	22.6	34.4	25.3	13.7	17.1	21.8	21.5	32.7	16.6	29.0	43.4	39.2	24.1	35.7	11.5	17.1	14.4	30.7	18.3	34.3	43.9	35.5	33.6	31.5	38.0	37.6	34.4	3.2	30.1	16.2	49.0	37.3	31.4	16.3	18.8	12.3	20.6	16.0	17.5	25.3	17.5	16.4	16.5
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137174	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.3;skeletal muscle: 37.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 18.4;WM-115: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;granulocytes: 2.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	1.0	2.3	2.4	7.6	0.6	8.9	0.7	4.1	2.6	11.5	6.7	6.7	1.7	5.3	2.8	5.3	2.5	2.1	29.3	2.8	2.5	1.5	0.7	2.3	0.9	10.4	1.3	1.2	1.0	0.8	3.5	3.5	6.1	5.4	3.5	3.6	1.6	10.0	37.1	0.8	2.7	19.4	10.7	0.7	5.9	10.0	6.3	0.0	1.6	8.6	0.8	10.3	8.6	0.5	1.2	2.9	0.3	0.4	0.4	0.1	0.8	1.2	4.7	0.8	6.9	9.5	2.1	3.5	2.5	5.5	7.3	0.3	0.0	0.0	0.0	6.6	0.0	2.0	1.2	5.1	0.0	1.7	0.0	0.6	0.2	1.5	0.0	0.3	5.5	4.3	8.5	0.7	2.4	0.0	11.9	12.1	0.1	0.1	0.6	1.0	0.0	3.4	18.4	0.0	0.0	0.0	6.2	10.7	2.2	0.0	4.7	0.0	12.0	5.4	8.8	0.0	0.0	9.2	1.1	0.4	0.0	5.2	0.0	18.5	2.9	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.4	0.0	0.5	0.3	0.3	1.7	0.4	0.1	1.2	0.1	0.1	2.3	7.6	0.7	4.1	2.8	2.5	10.4	1.3	6.1	6.3
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921188-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavourable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	11.5	13.4	6.0	11.5	7.2	6.0	17.5	5.0	8.9	7.8	7.9	4.6	5.3	4.0	11.0	5.4	11.7	9.3	10.0	17.6	5.9	6.8	8.0	18.6	7.1	7.4	5.8	6.5	11.8	15.9	10.6	5.4	11.3	7.4	8.0	6.8	4.8	9.6	7.9	31.7	9.2	5.0	12.6	6.3	9.9	7.3	8.9	4.6	20.1	7.1	11.9	12.9	7.3	10.1	4.0	9.3	0.9	3.4	4.5	5.5	2.2	12.2	15.2	8.4	11.9	6.3	7.1	17.2	12.5	6.6	19.8	14.5	21.0	3.2	22.6	11.4	9.4	8.2	25.6	18.3	15.6	8.1	27.9	21.1	10.7	23.6	10.9	15.0	9.3	9.1	11.9	18.5	16.9	13.6	26.8	5.0	13.1	20.9	15.8	15.2	6.5	16.0	18.8	11.5	14.4	11.0	10.4	16.9	10.3	8.4	7.6	14.6	8.8	13.2	10.5	11.6	13.6	7.9	18.2	5.9	7.6	49.0	3.9	15.3	12.0	0.0	3.4	0.9	3.9	3.4	5.5	3.8	2.5	3.1	5.4	4.0	1.3	3.0	0.3	4.5	3.1	9.3	3.1	2.2	6.0	7.2	5.0	8.9	5.9	6.8	5.8	6.5	7.4	4.6
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126670446	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 48.4;U-2197: 14.8;U-266/84: 10.4;U-87 MG: 15.4;WM-115: 12.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	1.9	0.8	7.5	1.0	21.5	0.8	9.2	1.4	18.7	0.9	0.9	30.9	0.0	0.7	0.8	0.8	0.9	0.7	1.1	0.8	10.8	5.9	0.9	0.8	0.8	0.7	26.0	5.9	0.9	1.1	0.7	0.5	1.3	14.4	0.9	1.0	1.7	18.6	0.7	0.9	1.9	0.8	0.8	17.2	0.8	0.7	12.3	28.0	0.0	1.3	0.0	2.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	48.4	0.0	0.1	0.0	1.9	0.0	14.8	0.2	0.0	10.4	0.0	15.4	0.0	12.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	21.5	1.4	11.3	10.8	5.9	26.0	5.9	14.4	28.0
C11orf1	FLJ23499	ENSG00000137720	"Chromosome 11 open reading frame 1"	Q9H5F2	11	111878935-111885975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038410, HPA057519"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA038410: AB_10672591, HPA057519: "	"unprognostic (1.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.96e-1)"	"prognostic favourable (9.32e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.86e-2)"	"prognostic favourable (1.39e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.08e-1)"	11.5	21.2	20.3	12.5	34.8	8.9	29.2	8.3	13.9	12.6	15.8	11.2	21.0	11.8	10.4	39.3	17.7	17.0	19.8	20.8	16.6	18.2	40.1	31.2	15.8	12.4	20.2	12.0	17.1	47.6	19.9	18.9	8.3	14.3	16.6	15.8	12.7	22.6	29.5	8.3	16.9	15.5	10.2	17.4	10.0	15.6	31.4	12.2	10.6	24.2	15.0	10.2	14.2	9.5	14.8	19.0	5.0	8.2	9.5	22.0	6.3	8.1	10.5	13.7	15.1	15.8	12.2	14.2	4.5	11.6	3.7	4.7	17.4	15.2	29.8	21.7	7.7	9.6	5.5	16.6	5.9	13.2	7.8	10.1	2.2	13.4	10.0	14.7	7.1	22.2	26.2	13.2	25.5	4.5	14.4	22.6	12.5	7.9	19.9	23.1	15.7	16.0	10.2	14.2	41.5	23.0	15.0	12.3	11.8	2.8	10.7	9.7	21.3	10.4	3.9	13.8	9.9	6.0	6.2	13.2	19.3	44.5	7.0	17.5	8.3	3.3	4.4	5.0	8.2	8.2	15.4	14.8	13.7	10.4	6.4	10.2	22.0	16.4	1.1	9.5	5.5	19.0	9.7	6.3	20.3	34.8	8.3	13.9	16.6	18.2	20.2	12.0	14.3	12.2
C11orf52	"FLJ25219, MGC14839"	ENSG00000149300	"Chromosome 11 open reading frame 52"	Q96A22	11	111918032-111926872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.9;Hep G2: 9.2;RPTEC TERT1: 13.4;SK-BR-3: 11.5;T-47d: 37.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038387, HPA038388"	Uncertain		Enhanced	"Cell Junctions"				"Cell Junctions"		"HPA038387: AB_10670167, HPA038388: AB_2675987"	"unprognostic (1.30e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.84e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.57e-1)"	"unprognostic (8.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.44e-1)"		"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	1.8	0.5	0.7	1.0	1.9	0.0	13.8	3.2	0.8	1.7	7.6	0.9	25.9	4.9	2.1	12.8	3.9	8.9	11.3	2.0	1.0	0.6	38.7	12.9	12.7	0.3	2.9	0.3	2.2	38.0	12.6	12.8	25.8	2.2	9.1	2.9	1.6	23.8	33.9	5.3	5.5	12.4	1.0	2.5	0.6	10.9	0.8	1.0	0.8	22.9	2.1	3.0	4.6	3.6	0.0	0.0	0.0	0.1	0.0	0.7	0.0	2.0	0.0	0.0	0.0	1.4	0.1	8.4	0.4	0.4	0.0	0.0	3.2	10.9	0.0	5.1	1.2	2.6	0.0	0.6	0.0	0.0	0.3	0.0	0.2	9.2	0.0	0.0	0.0	0.2	2.5	0.0	0.1	0.5	0.0	0.0	0.7	8.2	0.0	0.0	0.0	0.8	0.0	0.7	0.0	13.4	7.3	0.5	0.0	0.0	11.5	0.0	37.6	0.7	0.9	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.9	3.2	0.8	1.0	0.6	2.9	0.3	2.2	1.0
C11orf71	FLJ20010	ENSG00000180425	"Chromosome 11 open reading frame 71"	Q6IPW1	11	114391443-114400511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"testis: 83.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA063943, HPA074787"			Supported	Nucleoplasm				Nucleoplasm		"HPA063943: , HPA074787: "	"unprognostic (1.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-2)"	"prognostic favourable (6.94e-4)"	"unprognostic (7.35e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (7.01e-9)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.17e-2)"	3.9	7.3	5.7	3.4	12.1	2.2	5.7	4.1	8.1	4.2	4.9	10.2	5.6	5.5	3.7	18.0	3.2	5.4	3.9	5.4	6.9	6.1	10.6	15.0	3.9	4.3	10.3	4.7	5.0	6.9	8.7	6.9	2.5	6.7	5.6	4.6	5.7	7.2	5.0	9.9	5.6	5.1	2.1	5.7	5.4	5.2	83.2	12.2	6.4	9.5	4.7	3.2	3.1	3.1	10.5	13.6	14.5	17.7	13.2	11.9	11.3	1.1	3.2	3.4	11.0	5.2	3.0	2.4	0.5	1.4	1.3	1.2	2.7	19.6	5.2	7.0	0.8	5.1	2.2	2.3	1.7	6.0	1.3	3.9	2.3	5.3	5.0	2.3	4.5	4.9	2.6	1.8	5.6	1.7	4.1	4.9	2.6	4.5	4.1	3.5	1.8	2.1	3.1	2.8	13.4	3.0	2.4	9.5	3.7	12.3	1.4	1.9	9.3	1.2	1.7	0.3	5.2	3.9	0.9	4.8	7.9	4.1	0.7	5.4	1.4	11.7	17.7	11.1	10.3	11.1	6.3	7.0	7.0	7.1	10.6	10.5	11.4	11.9	14.5	13.2	12.2	13.6	7.7	11.3	5.7	12.1	4.1	8.1	6.9	6.1	10.3	4.7	6.7	12.2
C11orf91		ENSG00000205177	"Chromosome 11 open reading frame 91"	Q3C1V1	11	33698261-33700801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 7.2;gallbladder: 7.2;testis: 16.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 14.9;hTERT-HME1: 9.6;HUVEC TERT2: 7.6;TIME: 11.6;U-2197: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047064, HPA050487"	Uncertain		Supported	Vesicles				Vesicles		"HPA047064: , HPA050487: "	"unprognostic (9.22e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.68e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	7.2	0.2	1.2	2.1	3.0	0.9	2.1	0.3	1.3	0.3	0.3	0.3	0.3	0.0	0.4	0.9	4.3	0.3	7.2	0.7	0.4	0.6	0.9	0.9	1.4	0.3	0.7	0.3	0.6	1.9	0.0	0.3	1.0	1.3	0.3	0.0	0.3	0.9	0.3	0.4	1.3	0.3	0.8	0.8	0.3	2.7	16.6	0.3	0.6	0.3	0.3	0.3	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	1.4	0.0	0.0	0.0	1.7	0.0	0.8	0.4	0.2	0.6	0.0	0.1	1.7	0.6	0.4	14.9	1.2	0.4	0.0	0.0	2.8	0.7	0.3	0.0	0.0	0.0	0.1	1.2	9.6	7.6	0.0	2.3	3.6	0.0	0.0	0.3	0.0	4.7	0.0	0.0	0.0	1.0	1.9	0.0	0.3	0.0	1.5	0.1	0.0	0.0	11.6	1.1	0.3	9.6	0.3	0.7	0.5	0.0	2.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	0.3	1.3	0.4	0.6	0.7	0.3	1.3	0.3
C12orf10	"Gamm1, MYG, MYG1"	ENSG00000139637	"Chromosome 12 open reading frame 10"	Q9HB07	12	53299686-53307177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 85.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038626, HPA038627"	Approved	Supported	Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA038626: AB_10674692, HPA038627: "	"unprognostic (5.33e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.61e-1)"	16.1	18.7	21.5	13.0	18.4	13.7	17.8	18.4	32.2	17.9	15.1	14.0	18.7	14.3	17.7	18.3	15.9	28.4	16.6	20.2	19.7	21.3	18.8	15.7	13.0	23.6	25.0	23.9	33.3	27.6	20.6	15.7	11.7	27.7	14.6	11.9	14.3	19.4	19.7	22.4	15.7	13.1	17.7	14.3	12.1	16.2	85.6	12.9	19.4	24.1	18.3	15.0	17.3	15.0	26.1	31.1	12.2	27.4	19.2	33.3	23.2	13.0	30.1	10.6	16.9	11.6	17.4	1.2	8.7	14.0	19.9	14.4	27.2	14.2	12.6	20.6	12.0	14.8	14.9	18.9	10.8	10.4	29.2	13.0	24.9	31.6	27.0	13.4	8.8	17.3	14.4	18.3	18.6	17.7	0.7	26.1	13.3	61.4	18.0	22.1	17.8	29.1	17.0	10.1	29.3	17.1	14.6	21.5	20.7	9.7	19.2	21.1	30.2	12.9	11.5	19.4	18.3	13.9	13.6	23.6	24.5	13.9	24.6	11.5	14.9	7.8	27.4	12.2	18.3	20.6	27.5	26.1	24.6	18.4	31.1	22.0	25.9	23.4	6.9	19.2	15.4	19.4	33.3	23.2	21.5	18.4	18.4	32.2	19.7	21.3	25.0	23.9	27.7	12.9
C12orf43	FLJ12448	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"				Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: "	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavourable (1.29e-6)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	10.0	8.6	12.1	7.5	12.9	7.5	8.7	15.2	19.6	7.4	10.2	8.5	3.1	5.7	11.4	5.3	7.2	11.2	5.8	8.7	8.4	8.5	7.2	12.0	7.8	9.2	8.3	11.1	14.3	8.8	9.3	6.8	8.3	13.1	7.3	6.4	8.0	10.0	8.0	7.2	6.4	5.8	10.0	7.1	7.3	7.2	7.1	6.7	7.5	7.6	4.0	8.4	9.6	6.9	16.2	10.7	5.8	13.7	11.0	19.9	13.4	9.8	22.2	11.6	9.1	10.4	8.2	12.9	12.2	12.6	20.5	13.0	15.9	9.3	18.3	12.6	11.8	11.2	13.7	18.6	12.3	21.9	15.3	14.6	9.4	11.8	12.3	19.3	11.8	9.6	9.9	18.8	11.9	11.7	17.3	4.9	10.8	16.1	21.0	15.2	20.8	16.6	19.0	13.8	13.7	12.6	14.7	15.9	10.2	16.3	7.1	13.1	19.4	9.1	11.2	11.4	13.7	9.1	12.8	8.9	12.8	14.3	14.9	11.6	16.8	3.7	10.3	5.8	16.9	13.7	15.4	16.2	16.7	16.4	10.7	13.0	19.9	16.9	1.6	11.0	11.4	8.6	15.1	13.4	12.1	12.9	15.2	19.6	8.4	8.5	8.3	11.1	13.1	6.7
C12orf57	"C10, GRCC10"	ENSG00000111678	"Chromosome 12 open reading frame 57"	Q99622	12	6942978-6946003	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046182, HPA059163, HPA066043"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA046182: , HPA059163: , HPA066043: "	"unprognostic (5.89e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.20e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-2)"	"prognostic favourable (8.74e-4)"	"unprognostic (4.25e-2)"	"prognostic unfavourable (2.32e-7)"	"unprognostic (1.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.81e-2)"	"unprognostic (8.39e-3)"	34.1	46.2	40.0	22.3	36.3	32.5	57.5	32.9	47.1	55.1	40.6	17.3	66.1	22.7	63.7	48.5	38.2	55.3	54.2	61.1	30.9	35.3	38.0	43.3	34.2	47.5	35.3	23.2	132.1	116.3	14.1	49.9	26.5	23.1	58.6	20.7	42.5	52.9	73.4	45.5	42.6	22.3	45.3	21.7	22.8	30.9	25.9	16.3	91.6	50.8	29.3	34.1	50.6	78.1	33.4	43.5	11.8	15.8	17.6	52.6	30.8	13.9	41.1	48.1	47.3	33.3	39.9	15.9	18.4	45.7	16.0	25.6	16.3	23.9	4.3	14.7	28.6	13.5	18.3	22.8	3.8	25.0	38.1	37.3	33.9	23.0	63.3	15.2	36.7	47.8	27.3	12.3	17.0	26.9	12.8	37.9	14.7	41.9	31.8	19.7	85.9	15.1	35.5	42.9	63.8	21.4	35.3	21.4	62.8	29.6	30.3	36.9	7.6	80.5	28.2	32.3	30.6	12.8	27.3	28.2	22.7	23.1	33.2	0.3	21.5	11.8	3.9	3.6	38.8	6.4	25.6	25.2	43.8	41.0	5.8	33.4	52.6	42.9	1.6	17.6	15.8	43.5	38.1	30.8	40.0	36.3	32.9	47.1	30.9	35.3	35.3	23.2	23.1	16.3
C12orf66	FLJ32549	ENSG00000174206	"Chromosome 12 open reading frame 66"	Q96MD2	12	64186316-64222296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046743, HPA052855"	Uncertain		Supported	"Lysosomes,Cytokinetic bridge"				Lysosomes	"Cytokinetic bridge"	"HPA046743: , HPA052855: "	"unprognostic (7.44e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.07e-2)"	6.0	9.7	6.9	6.0	14.5	2.9	10.2	4.4	11.5	5.7	5.1	15.7	4.5	5.8	4.9	9.4	7.9	7.5	4.7	4.2	7.5	6.8	10.2	15.3	5.2	9.4	21.7	6.8	7.6	13.9	14.8	5.6	3.9	9.4	4.6	6.0	4.3	6.4	6.0	9.1	10.3	5.2	4.5	12.3	8.6	5.5	6.0	11.7	5.7	10.5	6.0	8.6	6.3	6.0	8.4	4.4	0.4	2.7	3.7	10.3	4.4	4.9	7.9	1.5	4.3	4.1	6.9	4.2	2.7	3.4	4.1	2.6	2.4	3.9	15.6	3.8	2.1	5.7	6.3	4.9	4.4	11.8	4.2	5.6	1.9	2.2	5.4	6.1	3.3	5.3	8.3	5.3	9.7	2.9	7.8	10.4	4.1	9.4	6.9	5.3	7.1	6.2	3.5	4.6	11.8	6.1	5.8	3.6	3.5	4.4	6.2	4.4	10.0	3.9	2.2	4.1	2.7	4.0	2.6	13.9	11.4	8.8	6.3	5.4	4.6	0.4	2.7	0.2	3.7	2.5	6.2	8.4	6.9	5.4	4.4	7.5	9.8	9.1	0.3	3.7	1.7	3.1	10.3	4.4	6.9	14.5	4.4	11.5	7.5	6.8	21.7	6.8	9.4	11.7
C14orf119	FLJ20671	ENSG00000179933	"Chromosome 14 open reading frame 119"	Q9NWQ9	14	23094765-23100462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003638	Uncertain		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA003638: AB_2243669"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.26e-3)"	"prognostic unfavourable (5.42e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.61e-2)"	"prognostic favourable (3.30e-5)"	"unprognostic (1.63e-1)"	28.2	35.0	16.3	22.0	18.5	9.2	38.9	11.6	17.3	30.4	28.4	17.0	23.9	22.6	29.9	30.3	32.0	23.5	22.4	29.6	16.3	19.9	36.3	24.6	30.4	37.3	22.4	15.1	25.2	39.4	16.7	28.1	32.2	23.1	27.9	35.8	27.1	28.0	28.1	21.2	20.7	27.4	33.5	20.1	33.8	28.2	33.0	16.7	27.2	40.0	26.3	33.1	25.8	24.0	34.6	37.4	72.7	40.2	30.2	45.0	43.7	13.6	13.6	20.5	12.4	45.3	39.5	16.5	23.0	34.1	30.4	36.2	10.7	21.3	10.4	12.0	37.3	23.5	19.5	30.6	42.3	16.6	9.5	15.7	11.3	45.8	35.7	23.5	24.6	48.0	27.6	25.6	18.9	33.2	10.4	11.7	33.3	19.7	11.0	18.2	12.8	20.8	9.8	15.3	12.0	34.5	22.1	9.9	9.0	19.2	18.1	19.9	12.2	13.7	26.7	14.5	12.7	21.7	10.3	11.0	12.9	12.8	13.3	14.9	12.9	63.7	40.2	72.7	32.6	25.7	37.1	34.6	37.2	36.2	37.4	28.5	39.1	38.3	23.8	30.2	17.3	25.2	45.0	43.7	16.3	18.5	11.6	17.3	16.3	19.9	22.4	15.1	23.1	16.7
C15orf39	"DKFZP434H132, FLJ46337"	ENSG00000167173	"Chromosome 15 open reading frame 39"	Q6ZRI6	15	75195643-75212169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;granulocytes: 16.9;monocytes: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039961, HPA041907"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA039961: AB_10673024, HPA041907: "	"unprognostic (3.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.46e-2)"	"prognostic favourable (7.94e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.47e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.14e-1)"	14.7	10.2	3.5	9.6	5.3	36.1	9.0	2.5	4.1	11.8	8.5	3.1	3.8	7.9	16.5	5.8	13.1	11.5	13.9	7.7	3.5	3.3	5.6	5.3	11.7	11.6	3.3	2.2	23.3	11.4	5.2	7.5	24.4	3.9	10.0	3.9	7.7	12.5	5.3	4.4	9.9	7.6	10.0	3.3	21.1	6.6	71.7	3.2	11.1	7.8	9.0	17.0	10.5	13.7	0.8	5.7	16.9	10.4	2.2	1.3	2.2	7.6	15.6	3.4	4.0	4.6	3.0	10.3	2.2	4.5	2.6	2.8	19.3	10.6	17.2	7.5	3.2	10.3	14.5	6.6	0.7	16.8	16.4	34.1	7.6	13.2	5.3	9.8	35.3	4.0	5.3	5.5	2.6	6.6	14.6	25.8	0.8	4.5	9.4	11.9	10.6	6.3	8.6	2.6	18.3	1.6	6.0	9.9	3.2	5.1	11.9	8.0	4.0	12.5	5.6	4.5	6.8	8.1	6.4	18.7	11.7	10.0	4.5	19.0	4.4	4.8	4.2	12.2	1.3	8.2	1.0	0.8	0.7	0.9	2.7	0.5	0.6	0.8	16.9	2.2	10.4	5.7	0.9	2.2	3.5	5.3	2.5	4.1	3.5	3.3	3.3	2.2	3.9	3.2
C17orf50		ENSG00000270806	"Chromosome 17 open reading frame 50"	Q8WW18	17	35760897-35765079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 63.6"	"Cell line enriched"	"Detected in some"	5	"HaCaT: 10.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.3;dendritic cells: 3.5;T-cells: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA043184, HPA063464"			Supported	Nucleoplasm				Nucleoplasm		"HPA043184: , HPA063464: "	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.12e-3)"		"unprognostic (2.04e-2)"		"unprognostic (1.97e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	63.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.5	0.0	0.6	0.2	3.7	0.6	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	10.6	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.1	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.6	1.9	2.3	2.0	1.2	0.0	1.9	3.5	3.7	0.0	0.2	0.0	3.5	0.0	0.6										
C19orf12	"DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43"	ENSG00000131943	"Chromosome 19 open reading frame 12"	Q9NSK7	19	29698886-29715789	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 57.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046930	Approved		Supported	Cytosol				Cytosol		"HPA046930: AB_10962836"	"unprognostic (1.76e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.94e-3)"	"unprognostic (7.93e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.22e-3)"	57.4	14.7	11.9	7.6	11.3	2.3	33.9	10.5	14.3	7.2	7.7	5.8	5.4	10.8	7.1	7.6	7.5	6.2	8.7	14.0	9.5	11.6	11.5	36.9	5.6	11.4	10.3	10.7	7.8	9.6	7.7	6.9	7.4	11.1	6.7	5.5	10.5	9.5	7.6	27.5	8.2	9.6	7.6	6.5	7.5	6.0	4.2	5.2	8.9	5.4	9.2	7.4	7.2	11.0	3.7	4.3	2.3	2.1	5.6	14.3	6.0	10.3	20.5	10.1	12.6	25.1	15.6	15.6	12.3	12.3	12.3	16.1	9.8	4.3	8.5	13.1	15.5	4.6	8.4	5.2	8.4	22.2	14.8	9.5	6.8	16.9	14.2	7.3	12.6	17.8	11.0	7.4	6.0	11.1	7.2	11.0	12.8	7.2	5.1	5.3	6.0	5.1	10.1	10.4	6.4	9.4	10.4	6.2	13.1	7.3	9.7	19.2	4.1	8.2	11.1	26.2	20.4	10.6	11.1	15.5	13.7	6.3	15.6	4.4	10.9	0.9	2.0	1.0	14.3	2.1	8.2	3.7	8.1	10.2	1.8	3.2	8.5	10.5	2.3	5.6	2.1	4.3	9.7	6.0	11.9	11.3	10.5	14.3	9.5	11.6	10.3	10.7	11.1	5.2
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304161-38305009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 105.8;tongue: 78.5"	"Cell line enhanced"	"Detected in some"		"A-431: 69.7;A549: 107.5;CAPAN-2: 66.4;HBEC3-KT: 64.5;hTCEpi: 67.5;PC-3: 61.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 15.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.1"									"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA054406: , HPA059696: "	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	6.9	0.6	0.5	16.4	0.7	0.3	5.0	0.5	0.8	14.5	58.8	0.6	3.5	34.6	3.9	4.3	88.4	18.2	45.2	9.9	0.8	0.3	5.8	1.0	34.8	0.6	0.7	1.4	4.9	0.8	0.0	2.0	10.0	1.7	10.3	18.2	1.2	21.5	6.8	2.8	53.3	105.8	2.9	3.1	1.9	28.7	1.5	0.5	1.5	4.4	78.5	39.2	16.2	35.1	0.1	15.1	1.4	0.6	0.3	0.4	14.6	69.7	107.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	66.4	0.0	39.9	0.0	26.2	0.0	64.5	0.0	0.0	0.0	0.0	22.6	1.8	0.5	0.0	0.0	0.0	67.5	0.0	43.3	1.1	0.0	0.0	0.0	18.0	0.0	0.1	0.1	61.5	0.0	0.0	0.0	40.8	20.7	0.1	0.0	40.7	29.5	0.0	9.2	0.2	14.6	0.0	20.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.6	1.4	0.3	0.0	0.3	0.1	0.2	0.1	15.1	0.1	0.4	0.3	0.9	0.3	0.0	0.9	0.0	14.6	0.5	0.7	0.5	0.8	0.8	0.3	0.7	1.4	1.7	0.5
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 35.4;skeletal muscle: 118.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favourable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	3.2	2.9	4.5	4.2	5.7	4.7	4.4	5.8	9.1	3.5	3.3	9.2	3.6	3.8	3.8	3.1	7.4	2.8	3.5	35.4	4.2	3.8	2.9	4.4	3.4	4.5	6.2	5.0	3.6	3.8	3.7	3.7	4.8	5.6	4.5	2.5	3.6	4.9	4.6	118.0	5.2	3.6	3.7	4.8	3.7	3.0	10.0	5.3	5.0	3.8	6.4	4.7	4.1	5.0	2.1	1.6	20.2	1.6	1.7	2.3	1.3	12.9	19.9	8.4	9.1	5.0	4.5	11.6	13.4	6.2	12.7	15.4	16.5	5.4	15.1	7.5	6.3	6.5	10.2	12.3	5.3	18.5	12.5	12.3	12.4	12.5	3.7	12.4	8.0	4.5	7.3	17.1	6.1	7.7	15.0	8.9	10.7	12.6	18.5	7.0	5.4	7.6	18.4	13.8	7.6	4.1	11.4	10.8	8.8	14.4	13.6	5.2	8.1	10.3	10.1	16.0	11.2	10.8	18.3	10.7	14.7	15.0	6.8	11.9	11.0	20.2	1.6	4.7	1.3	1.4	1.6	1.6	2.3	2.1	1.6	2.1	1.6	1.2	5.7	1.7	1.6	1.6	1.6	1.3	4.5	5.7	5.8	9.1	4.2	3.8	6.2	5.0	5.6	5.3
C19orf66	"FLJ11286, IRAV, RyDEN"	ENSG00000130813	"Chromosome 19 open reading frame 66"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Antiviral defense"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 24.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042001: AB_10794167"	"prognostic favourable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favourable (1.35e-4)"	9.8	13.8	13.7	17.6	12.1	9.0	9.9	10.6	16.9	14.5	11.2	8.4	10.3	9.6	12.6	14.1	8.9	16.4	15.5	6.9	11.0	13.9	11.5	55.8	11.6	14.4	9.0	13.5	14.5	10.0	14.1	12.8	9.8	10.0	12.4	6.1	11.6	13.0	15.8	3.7	7.6	14.2	9.7	8.6	14.0	8.3	3.7	8.6	9.8	11.9	5.4	13.0	12.9	10.1	8.8	6.7	11.6	12.0	17.5	21.2	10.0	2.7	1.6	1.7	1.2	6.5	8.8	0.7	3.3	18.0	24.5	26.0	0.2	2.4	1.7	1.0	8.5	1.2	0.8	6.0	0.4	11.8	0.0	5.1	1.1	4.1	12.7	1.7	2.9	15.8	4.5	3.8	0.6	7.0	0.7	6.8	4.9	2.2	5.8	3.4	0.4	2.5	5.3	0.0	3.2	3.6	4.3	0.2	1.5	4.7	0.4	13.8	0.2	4.6	5.1	2.1	1.0	2.8	0.4	8.3	2.6	0.4	5.6	1.6	4.1	11.1	8.3	11.6	15.9	7.4	21.2	8.8	13.5	17.1	6.7	6.9	11.5	12.1	10.8	17.5	12.0	1.3	13.9	10.0	13.7	12.1	10.6	16.9	11.0	13.9	9.0	13.5	10.0	8.6
C19orf70	"MIC13, P117, QIL1"	ENSG00000174917	"Chromosome 19 open reading frame 70"	Q5XKP0	19	5678421-5680896	"Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042672	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"			Mitochondria	Nucleoplasm	"HPA042672: AB_10794531"	"unprognostic (9.54e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.04e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (7.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.47e-2)"	20.2	23.6	32.9	14.5	28.4	13.2	16.0	11.0	29.8	13.0	22.2	13.5	17.8	25.4	12.2	26.8	22.7	16.7	24.0	70.2	27.2	26.5	30.5	38.4	12.7	21.1	32.1	21.1	13.5	24.2	13.2	15.6	12.4	16.9	16.6	11.7	13.6	28.7	22.7	79.1	17.6	20.7	14.7	20.9	14.1	18.2	33.4	12.3	11.6	20.3	45.0	12.6	15.4	11.8	43.6	48.2	11.6	42.2	27.4	39.5	40.7	23.9	19.9	6.9	13.2	16.3	16.9	9.0	15.9	15.1	18.4	15.2	15.8	12.5	10.4	25.9	13.9	17.9	3.6	22.5	5.3	17.2	37.9	10.2	13.8	17.5	23.0	13.9	12.8	19.8	20.4	9.9	13.8	13.1	15.7	32.7	13.8	21.7	21.0	16.6	7.3	63.6	11.5	8.3	38.2	20.0	15.1	16.2	20.7	4.9	31.4	22.2	19.2	17.1	13.4	18.1	7.7	33.0	22.5	49.4	32.6	8.3	26.9	22.3	18.3	8.9	35.5	11.6	33.6	42.2	39.5	43.6	38.6	37.2	41.2	35.6	38.1	35.9	5.6	27.4	35.6	48.2	30.9	40.7	32.9	28.4	11.0	29.8	27.2	26.5	32.1	21.1	16.9	12.3
C1D	"LRP1, Rrp47, SUN-CoR, SUNCOR"	ENSG00000197223	"C1D nuclear receptor corepressor"	Q13901	2	68041130-68110948	"Predicted intracellular proteins"	"Apoptosis, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037413, HPA037588"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA037413: , HPA037588: AB_10672907"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.01e-1)"	17.1	20.1	15.9	13.3	17.9	31.5	17.2	13.9	26.5	15.4	16.3	12.4	15.4	14.7	14.9	14.6	13.8	13.9	12.4	15.8	14.9	15.6	28.4	29.8	14.4	21.0	14.8	16.8	14.9	27.3	12.5	25.3	18.6	17.0	14.8	13.9	8.6	13.5	14.0	29.4	11.7	19.2	12.2	17.2	16.4	15.1	13.8	18.6	17.4	18.0	16.4	14.7	13.2	20.0	20.0	16.1	32.1	19.6	22.6	19.7	9.4	21.4	12.1	15.1	12.6	15.3	19.4	20.1	27.9	19.3	19.6	16.2	21.0	24.2	27.2	17.0	18.7	10.6	17.8	13.0	30.6	28.9	21.4	31.9	10.2	24.1	15.5	39.5	33.9	16.0	21.9	14.7	14.1	15.0	25.3	23.7	18.0	10.9	26.2	34.2	16.2	15.0	16.6	18.0	21.4	17.7	15.6	13.2	15.1	10.2	17.8	27.6	13.0	26.8	16.6	16.9	19.5	20.6	24.5	22.8	25.3	34.3	21.6	24.6	19.2	28.1	14.3	32.1	15.9	18.5	18.7	20.0	18.0	13.2	16.1	17.2	19.6	19.7	29.0	22.6	19.6	15.0	19.0	9.4	15.9	17.9	13.9	26.5	14.9	15.6	14.8	16.8	17.0	18.6
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavourable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	13.8	15.1	12.0	9.3	15.0	9.3	14.5	17.9	20.5	12.9	11.1	11.4	16.2	11.0	15.9	14.3	13.7	13.9	10.5	11.1	13.1	12.9	12.8	12.0	8.8	14.1	13.6	15.0	19.7	19.6	20.5	10.9	14.6	15.9	15.0	7.8	12.9	20.3	14.8	15.2	14.9	8.5	11.6	9.9	10.1	11.1	11.2	12.2	13.1	15.7	9.1	12.6	13.7	12.8	11.4	27.5	3.3	5.0	12.2	16.2	7.5	8.2	9.5	8.2	13.4	7.2	5.2	18.7	9.9	7.1	15.0	11.1	14.4	10.0	11.7	12.0	4.3	12.0	15.1	10.1	15.4	18.7	17.0	13.4	9.6	9.0	13.9	14.5	8.8	7.0	12.5	14.8	19.3	7.5	26.2	14.3	8.5	5.7	14.1	6.4	25.6	18.3	14.0	17.2	32.2	7.9	7.1	24.8	11.9	8.7	13.5	20.1	7.6	6.6	5.0	15.1	9.5	12.1	20.1	11.7	13.0	24.0	7.5	14.3	15.8	1.7	5.0	3.3	10.3	3.9	16.1	11.4	12.4	9.9	5.9	10.3	16.2	13.8	0.9	12.2	4.2	27.5	6.2	7.5	12.0	15.0	17.9	20.5	13.1	12.9	13.6	15.0	15.9	12.2
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018521-207032756	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1"	"Cell line enhanced"	"Detected in some"		"A-431: 17.8;CAPAN-2: 31.8;HaCaT: 39.2;HBEC3-KT: 37.7;hTCEpi: 20.0;RPTEC TERT1: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			7900	"Plasma membrane, Cytosol"		"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favourable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.3	0.2	1.6	0.2	0.0	4.1	0.2	0.4	7.1	8.3	0.3	0.2	8.4	1.0	1.1	49.4	0.6	14.0	0.2	0.3	0.1	4.3	1.1	42.8	0.2	0.2	0.2	0.5	7.0	0.0	0.9	1.4	0.4	18.8	2.7	0.3	12.5	1.9	0.3	14.4	16.5	0.6	0.2	0.4	20.3	0.4	0.2	0.4	6.8	16.0	37.1	6.1	12.3	0.0	0.0	0.7	0.0	0.1	0.0	1.8	17.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	31.8	0.0	2.1	0.0	39.2	0.0	37.7	0.0	0.0	0.0	3.3	0.3	0.5	0.0	0.0	0.2	0.0	20.0	0.0	11.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	18.4	4.7	0.0	0.1	0.3	3.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.8	0.2	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.4	0.2
C1orf174	RP13-531C17.2	ENSG00000198912	"Chromosome 1 open reading frame 174"	Q8IYL3	1	3889125-3900293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008270, HPA065778"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA008270: AB_1845633, HPA065778: "	"unprognostic (4.91e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (5.84e-4)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (7.62e-4)"	"unprognostic (7.24e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (2.73e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-2)"	17.6	17.4	15.0	18.8	16.5	24.0	17.8	16.3	19.2	15.4	16.9	21.3	11.6	15.6	19.4	20.1	19.3	19.7	21.1	13.4	15.3	15.4	18.1	24.8	14.5	20.2	15.8	17.1	19.6	20.0	5.4	13.3	24.4	16.7	18.9	15.6	16.5	15.9	17.2	22.9	15.6	16.5	20.1	13.7	22.4	16.5	18.9	15.3	26.9	21.9	19.7	22.4	19.5	15.0	16.5	18.7	30.4	28.8	16.1	27.6	13.6	14.0	8.2	13.1	11.0	11.0	6.9	9.2	13.0	7.3	11.6	11.9	12.0	22.4	11.2	14.6	9.6	13.7	13.8	8.9	13.0	19.0	13.3	28.9	8.4	17.6	6.8	20.6	15.1	7.3	5.8	12.2	9.8	9.3	22.6	11.5	8.1	10.6	21.2	15.9	14.8	17.5	16.2	21.8	10.5	7.9	8.6	12.6	10.4	11.8	17.7	17.8	7.3	12.6	10.0	16.8	12.6	27.9	12.3	4.4	4.2	21.5	8.2	22.9	5.5	27.7	16.1	30.4	27.6	28.8	24.0	16.5	18.7	20.9	18.7	15.2	17.9	22.7	13.3	16.1	18.8	10.3	19.3	13.6	15.0	16.5	16.3	19.2	15.3	15.4	15.8	17.1	16.7	15.3
C1orf198	"DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710"	ENSG00000119280	"Chromosome 1 open reading frame 198"	Q9H425	1	230837119-230869589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004798	Approved		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA004798: AB_1848722"	"unprognostic (7.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (4.50e-5)"	"unprognostic (3.53e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.77e-2)"	22.6	8.8	25.7	6.6	30.4	2.9	18.6	5.2	31.9	23.4	12.9	66.2	3.5	7.4	17.4	10.2	10.2	13.8	20.4	26.9	27.5	19.4	8.2	6.7	41.9	8.3	44.9	16.2	18.2	17.2	17.1	3.4	19.3	37.4	11.8	7.7	9.1	12.0	21.5	39.0	17.3	7.8	29.2	57.4	10.6	13.0	4.4	36.7	1.5	14.8	6.8	5.7	12.9	10.9	2.8	2.3	10.6	3.6	4.2	3.9	6.6	6.8	5.3	14.6	9.8	27.8	20.4	24.9	12.8	20.6	6.7	6.7	16.9	3.9	8.3	8.1	44.2	4.5	7.6	2.8	5.0	27.2	7.2	1.3	5.0	5.6	11.9	4.2	1.3	24.5	4.4	2.6	2.9	4.2	2.6	2.8	4.6	4.7	3.3	2.0	16.9	4.4	7.9	10.3	1.8	5.3	8.3	8.4	13.4	6.5	8.7	4.5	11.0	3.7	3.2	10.9	11.0	2.4	7.5	5.2	2.3	2.5	2.8	2.7	30.4	10.6	1.7	0.5	2.8	3.6	3.5	2.8	1.9	1.1	2.3	1.9	3.9	3.2	1.4	4.2	1.7	0.3	0.8	6.6	25.7	30.4	5.2	26.8	27.5	19.4	44.9	16.2	37.4	36.7
C1orf52	"FLJ44982, gm117"	ENSG00000162642	"Chromosome 1 open reading frame 52"	Q8N6N3	1	85249953-85259672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036072, HPA061790"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA036072: AB_10602696, HPA061790: "	"unprognostic (1.59e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (5.37e-5)"	"unprognostic (6.67e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (4.93e-4)"	"prognostic unfavourable (1.17e-7)"	"unprognostic (8.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.14e-1)"	"unprognostic (2.05e-2)"	14.4	13.5	22.4	13.4	30.1	42.9	17.4	13.8	25.8	11.8	12.3	19.1	9.4	11.3	14.2	16.9	12.0	11.3	12.2	13.0	25.4	19.3	9.9	13.3	14.6	20.3	20.6	19.9	13.9	14.2	11.0	15.6	21.0	17.9	13.1	11.9	8.8	11.5	11.8	18.0	19.8	10.7	12.0	18.7	14.1	12.0	17.0	20.3	12.4	11.4	8.8	14.3	11.2	12.3	27.3	20.8	25.6	21.4	15.5	23.6	16.7	13.2	6.0	11.7	9.8	12.8	9.8	20.4	13.5	8.2	14.9	14.6	8.6	7.1	12.2	12.8	11.9	8.8	23.7	7.7	15.0	12.6	14.8	16.5	10.6	10.7	11.3	16.9	7.7	7.8	11.0	13.0	9.9	9.3	19.5	13.5	8.7	3.6	12.9	13.8	36.3	8.7	14.3	13.6	5.3	14.8	8.3	7.2	11.2	3.8	10.5	19.9	6.0	27.6	9.0	8.2	12.2	15.0	16.6	12.8	21.4	18.6	4.8	13.0	9.2	25.6	15.1	22.8	16.4	21.4	17.6	27.3	15.6	14.2	19.4	16.7	23.6	22.9	23.6	15.5	17.6	20.8	12.9	16.7	22.4	30.1	13.8	25.8	25.4	19.3	20.6	19.9	17.9	20.3
C21orf2	"A2, LRRC76, YF5"	ENSG00000160226	"Chromosome 21 open reading frame 2"	O43822	21	44328944-44339402	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, DNA damage"		"Ciliopathy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030283, HPA030284, CAB034126, CAB034128"	Supported		Supported	Vesicles,Mitochondria,Cytosol				Mitochondria	"Vesicles, Cytosol"	"CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700"	"unprognostic (1.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (1.49e-1)"	"prognostic favourable (4.08e-4)"	"unprognostic (2.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.06e-1)"	18.8	13.4	19.8	11.3	21.6	19.7	9.2	10.3	23.4	13.8	14.7	18.2	14.3	13.4	12.6	19.1	6.9	14.7	13.2	11.3	19.5	16.6	18.0	11.6	12.8	12.4	16.4	19.1	15.2	14.5	7.4	17.6	12.4	13.2	12.3	3.9	14.3	16.1	17.2	21.0	22.3	15.4	5.8	12.6	16.1	21.1	16.7	11.2	10.9	16.4	8.1	13.0	8.1	7.0	10.8	21.7	1.2	8.5	12.1	9.7	4.9	7.8	3.3	3.2	4.1	2.1	1.4	12.6	4.1	2.4	1.6	0.9	6.0	2.4	5.7	8.2	1.4	3.8	0.6	0.7	0.4	8.6	8.2	5.9	2.6	7.0	2.8	6.3	6.4	1.9	1.4	0.7	1.4	1.0	7.2	9.8	1.0	9.8	6.9	15.6	8.0	5.1	17.8	4.1	12.7	1.9	11.6	8.4	7.8	5.7	1.3	6.8	6.1	14.0	4.6	3.6	4.6	3.8	3.0	16.1	8.4	3.9	8.8	12.8	6.4	1.2	7.1	1.0	7.1	8.5	8.5	10.8	7.3	9.7	7.3	8.6	8.5	8.2	0.9	12.1	6.2	21.7	4.0	4.9	19.8	21.6	10.3	22.4	19.5	16.6	16.4	19.1	13.2	11.2
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1"	"Cell line enhanced"	"Detected in many"		"REH: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.2"	"Low lineage specificity"	"Detected in many"											"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: "	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favourable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.3	1.8	2.2	4.3	5.0	11.1	5.2	3.6	3.1	3.2	3.5	4.6	3.3	4.7	2.2	9.7	3.1	27.2	3.2	2.6	2.9	2.9	1.3	1.3	9.1	5.9	2.9	1.8	8.0	3.2	1.4	25.1	2.1	5.8	2.3	2.7	1.9	2.5	1.7	1.6	5.3	4.3	1.5	1.8	2.8	3.7	5.7	2.2	22.7	1.8	2.1	4.6	1.7	2.1	2.1	1.8	8.2	0.5	0.7	1.8	0.9	12.2	5.6	14.9	9.3	1.5	2.0	8.3	7.6	2.8	5.3	5.2	2.6	9.0	8.9	1.9	2.1	9.9	4.0	3.2	1.6	9.2	8.7	14.3	14.7	1.4	0.3	4.0	8.2	0.9	0.7	3.8	0.9	3.3	8.1	23.7	4.3	5.0	19.9	5.5	6.4	2.8	29.6	6.7	7.9	1.6	2.3	12.3	7.7	5.7	4.1	1.8	10.0	8.1	2.3	3.3	9.4	3.2	4.5	9.6	4.2	4.2	5.8	17.7	8.5	8.2	0.5	1.1	0.9	0.3	0.5	0.2	1.1	1.2	0.1	2.1	1.8	1.4	0.7	0.7	0.2	1.8	1.3	0.9	2.2	5.0	3.6	3.1	2.9	2.9	2.9	1.8	5.8	2.2
C2orf42	FLJ20558	ENSG00000115998	"Chromosome 2 open reading frame 42"	Q9NWW7	2	70149880-70248615	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031840, HPA031841, HPA031842"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031840: , HPA031841: AB_10601124, HPA031842: "	"unprognostic (8.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.73e-1)"	"prognostic favourable (5.94e-5)"	"unprognostic (4.66e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.49e-3)"	6.2	5.9	6.2	4.3	8.7	3.1	6.8	10.7	11.8	6.4	4.5	11.5	6.6	3.2	6.6	8.5	5.0	8.7	5.7	4.2	7.2	6.4	6.3	11.2	4.5	8.2	7.3	6.2	8.3	5.0	8.6	8.2	5.9	6.7	5.0	4.0	7.4	4.6	5.8	4.8	4.9	4.6	5.8	6.1	6.7	4.4	41.2	8.2	9.7	6.2	2.1	8.3	6.2	7.5	12.8	6.6	8.0	6.6	17.9	14.2	9.0	4.9	8.3	8.0	7.2	15.9	9.8	9.0	12.0	8.0	10.1	8.4	6.4	4.6	6.2	7.0	7.5	7.0	8.1	6.8	10.7	10.9	7.2	7.5	5.9	6.4	14.2	6.2	7.6	11.6	13.0	9.2	11.9	9.3	6.3	24.8	12.7	4.7	7.9	8.8	5.6	9.0	7.7	10.7	11.5	8.2	6.0	6.6	6.6	6.4	11.0	12.1	4.7	7.5	7.2	8.8	6.1	8.1	9.6	13.3	13.2	6.4	7.2	10.0	7.7	1.9	6.6	8.0	11.2	6.1	14.2	12.8	11.4	13.4	6.6	11.5	13.2	13.7	7.0	17.9	6.1	6.0	12.6	9.0	6.2	8.7	10.7	11.8	7.2	6.4	7.3	6.2	6.7	8.2
C2orf49	"asw, MGC5509"	ENSG00000135974	"Chromosome 2 open reading frame 49"	Q9BVC5	2	105337359-105349211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043846, HPA060814"	Approved		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA043846: , HPA060814: "	"unprognostic (4.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (6.51e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.94e-2)"	"prognostic unfavourable (5.06e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.04e-2)"	15.9	14.8	17.2	15.8	20.4	24.3	17.3	25.6	22.4	19.7	15.0	21.9	19.9	13.4	22.0	13.5	18.6	19.0	14.2	21.3	20.0	16.0	13.4	15.0	14.0	16.9	25.3	19.9	30.7	19.3	13.0	12.0	19.2	18.1	17.2	15.1	12.4	15.9	17.2	28.2	14.3	14.8	18.3	22.9	15.3	19.7	19.2	22.1	26.5	18.8	13.1	18.8	18.1	21.2	16.7	18.4	17.9	13.5	8.2	11.7	6.4	14.9	10.7	13.5	13.6	15.2	18.7	24.1	15.1	15.7	13.3	18.4	23.3	15.0	17.6	18.9	12.8	14.4	18.4	12.8	17.4	22.9	14.1	19.1	9.2	17.9	18.8	15.8	15.8	13.5	22.3	18.8	17.1	11.9	26.5	14.6	18.7	11.6	19.2	18.3	17.6	12.9	12.8	19.9	20.1	14.9	14.4	16.0	12.8	13.3	12.1	17.5	11.8	17.9	19.5	14.2	19.9	10.1	12.2	18.6	15.0	18.6	14.2	16.1	13.7	10.2	13.5	11.1	9.4	7.9	9.2	14.3	10.5	9.1	8.8	16.7	11.7	9.8	17.9	8.2	10.6	18.4	11.6	6.4	17.2	20.4	25.6	22.4	20.0	16.0	25.3	19.9	18.1	22.1
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453941-37623495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 37.7;placenta: 38.3"	"Group enriched"	"Detected in some"	5	"RT4: 32.8;SK-BR-3: 13.1;T-47d: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 11.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"				"Cell Junctions"		"HPA043458: AB_10960696, HPA052894: "	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favourable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	2.0	0.5	2.6	1.5	2.7	1.6	2.2	2.8	5.4	6.5	14.6	2.5	2.3	10.3	4.2	1.9	2.1	1.7	7.4	0.7	4.4	1.7	11.9	26.2	2.8	0.0	3.1	2.5	0.6	37.7	5.8	6.1	38.3	6.2	1.9	14.0	1.9	22.2	9.8	0.6	1.7	11.0	2.3	3.8	0.6	12.4	1.5	2.2	0.0	1.3	1.0	3.3	5.9	2.9	0.9	2.2	11.4	2.1	1.2	1.2	0.3	0.0	0.0	1.3	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	5.3	2.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.2	0.7	0.0	3.2	0.0	5.2	32.8	0.4	0.1	0.2	13.1	0.4	47.0	0.2	0.2	0.1	1.9	0.0	0.6	0.1	0.0	0.2	0.0	2.7	2.3	0.9	2.1	2.5	0.8	0.3	0.5	0.3	0.5	0.5	0.3	0.9	0.8	1.2	11.4	1.2	0.2	2.2	0.9	0.3	2.6	2.7	2.8	5.4	4.4	1.7	3.1	2.5	6.2	2.2
C4orf48		ENSG00000243449	"Chromosome 4 open reading frame 48"	Q5BLP8	4	2041993-2043970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.4;brain: 37.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 37.8;NB-4: 27.1;PC-3: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052447	Uncertain		Supported	Cytosol	"Secreted to blood"		32000	Cytosol		"HPA052447: "	"unprognostic (7.96e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.17e-3)"	11.4	7.8	25.5	9.7	22.2	5.6	4.8	7.7	37.2	3.4	19.7	18.2	3.2	6.5	4.1	3.0	1.2	3.2	3.1	3.8	26.4	26.2	5.2	2.5	4.7	8.7	24.8	15.6	2.9	16.8	5.6	19.8	5.3	14.9	3.9	3.1	4.3	5.1	4.3	3.3	3.7	16.6	2.4	30.7	9.6	9.8	13.9	15.7	1.2	2.2	0.7	2.4	2.6	2.6	29.8	49.4	67.5	78.4	4.5	31.0	28.4	7.6	6.4	1.2	5.9	0.5	0.9	8.5	7.4	1.4	1.3	1.3	4.4	4.6	1.0	7.1	0.2	2.1	0.1	0.8	0.4	4.6	37.8	2.4	3.5	2.4	1.3	4.9	16.9	0.7	1.4	0.3	0.0	1.4	8.0	0.0	0.9	4.7	5.6	27.1	3.8	82.0	13.0	2.0	2.5	1.1	2.9	10.3	14.5	3.6	0.1	9.9	2.0	2.4	6.2	3.6	7.7	2.6	8.2	5.7	4.9	0.0	3.5	3.1	4.9	11.5	78.4	67.5	21.5	50.6	22.0	29.8	27.8	23.9	44.2	22.6	16.0	16.7	59.0	4.5	44.0	49.4	31.0	28.4	25.5	22.2	7.7	37.2	26.4	26.2	24.8	15.6	14.9	15.7
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 5.8;HMC-1: 7.4;U-87 MG: 8.8;U-937: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 75.8"	"Group enriched"	"Detected in many"	42	"granulocytes: 75.8;monocytes: 20.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Supported	Vesicles				Vesicles		"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favourable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavourable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavourable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	33.7	8.0	1.9	34.9	7.0	46.2	8.7	0.7	3.0	5.6	6.0	3.7	1.6	1.0	4.1	4.9	3.5	14.3	16.5	11.7	7.6	3.2	5.3	9.1	38.1	26.9	3.8	1.2	7.6	3.6	1.3	27.9	12.8	10.9	4.2	1.9	7.8	2.9	1.1	7.0	1.1	3.0	11.4	11.2	48.8	4.2	6.3	1.3	2.3	2.5	1.7	3.4	12.2	2.7	0.1	1.1	75.8	20.5	0.1	0.1	2.6	1.4	5.3	0.3	0.5	1.0	0.4	1.1	1.0	0.6	0.3	0.1	0.2	5.8	0.4	1.1	1.2	2.0	0.7	0.8	0.2	1.0	0.7	0.2	4.9	0.8	0.6	2.6	7.4	0.8	3.0	0.6	0.9	0.0	0.3	2.6	0.2	1.5	0.3	3.4	1.8	0.8	0.3	0.1	0.4	1.8	1.2	0.0	0.1	0.5	0.5	0.8	0.4	3.0	0.0	0.1	3.1	0.4	0.3	0.4	0.4	0.3	8.8	8.9	0.3	7.0	8.9	6.9	0.1	15.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	75.8	0.1	20.5	0.2	0.0	2.6	1.9	7.0	0.7	3.0	7.6	3.2	3.8	1.2	10.9	1.3
C5orf24	FLJ37562	ENSG00000181904	"Chromosome 5 open reading frame 24"	Q7Z6I8	5	134845680-134859737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057749, HPA062502"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA057749: , HPA062502: "	"unprognostic (8.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.33e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.45e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (4.75e-2)"	22.8	26.7	24.1	16.7	32.6	20.8	37.7	44.8	38.2	22.0	21.5	19.8	17.0	21.7	29.7	16.7	22.8	18.3	21.5	23.2	24.9	23.8	40.7	41.8	22.6	21.3	22.2	23.0	21.0	14.9	30.2	18.5	27.9	22.7	22.6	19.0	21.4	18.0	20.4	21.0	18.9	20.2	29.8	32.5	20.3	17.6	14.6	22.4	15.4	30.0	12.1	14.2	24.6	18.5	8.4	12.9	11.1	11.3	6.4	9.3	4.4	10.3	8.7	18.1	26.4	22.6	26.7	6.5	22.3	15.8	12.4	14.9	11.6	11.8	9.7	19.5	15.8	7.1	10.2	15.4	21.6	7.1	14.6	10.9	20.7	13.5	17.2	4.6	12.9	21.9	18.9	17.8	20.5	22.7	7.5	12.0	26.7	5.9	10.2	8.1	4.0	9.0	11.7	17.3	10.9	31.5	9.7	11.3	21.6	23.2	6.2	32.6	12.7	15.3	24.9	25.1	10.9	18.2	15.9	12.7	9.0	12.0	18.3	13.4	18.5	5.0	11.3	11.1	7.3	8.5	5.9	8.4	4.9	5.8	9.4	8.2	9.3	5.6	2.2	6.4	7.0	12.9	5.7	4.4	24.1	32.6	44.8	38.2	24.9	23.8	22.2	23.0	22.7	22.4
C5orf51	LOC285636	ENSG00000205765	"Chromosome 5 open reading frame 51"	A6NDU8	5	41904188-41921636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043779, HPA063816"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043779: , HPA063816: "	"unprognostic (6.64e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.93e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.67e-2)"	16.6	12.4	15.9	12.7	21.5	3.4	15.9	20.5	21.3	14.7	12.5	23.5	12.6	10.5	14.9	21.9	16.2	11.4	12.2	12.8	16.0	17.5	15.3	14.0	10.7	13.1	20.6	12.3	22.1	11.9	24.1	18.6	17.2	25.1	16.5	12.6	13.2	12.9	15.4	7.2	14.1	11.9	16.8	22.1	12.8	11.5	9.4	18.5	16.2	19.0	6.9	14.0	18.9	13.5	5.6	6.8	21.0	7.4	5.6	7.4	7.9	7.4	5.7	11.7	24.3	23.9	18.9	12.7	8.8	15.3	12.5	13.3	5.7	7.6	8.0	10.9	9.8	4.8	15.4	8.3	18.1	10.7	4.7	7.7	17.2	8.5	29.0	9.8	5.9	18.3	12.1	14.6	16.9	10.7	13.7	13.8	13.1	7.7	9.2	10.1	11.6	3.1	8.1	16.2	12.4	8.3	7.2	7.1	11.1	28.1	13.5	14.5	15.0	10.1	7.7	14.8	8.9	11.2	8.5	7.0	11.3	8.2	16.5	17.2	10.5	21.0	6.9	6.6	4.7	5.6	6.0	5.1	5.5	5.0	6.8	5.6	7.4	4.9	4.7	5.6	7.4	4.1	3.9	7.9	15.9	21.5	20.5	21.3	16.0	17.5	20.6	12.3	25.1	18.5
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 20.9;eosinophil: 12.3;neutrophil: 6.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: "	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	4.8	6.5	7.6	3.8	7.6	2.4	6.1	7.1	11.0	5.0	5.2	6.3	2.6	2.1	5.3	11.0	5.2	6.5	5.9	5.8	9.2	8.6	7.7	5.9	4.8	5.2	10.0	9.1	7.2	5.1	12.6	6.5	5.8	12.2	8.2	3.4	4.0	5.0	9.2	5.7	3.9	5.3	5.8	9.6	5.2	5.3	11.0	5.3	5.8	7.7	4.5	3.8	5.3	4.4	2.1	1.4	20.9	1.9	1.6	2.2	1.1	3.4	9.0	3.2	4.8	4.6	2.5	3.6	6.9	2.6	4.5	4.1	5.9	4.5	9.1	5.3	6.6	5.9	3.4	6.1	5.2	4.3	8.6	4.8	9.2	3.5	8.3	3.6	3.1	5.0	4.1	4.5	4.6	3.5	6.0	2.1	3.8	6.5	1.9	3.5	3.9	11.6	2.2	3.5	3.8	2.6	8.6	4.0	4.6	10.1	3.0	3.6	4.0	3.5	9.2	4.6	5.2	4.9	4.3	4.8	10.7	2.8	4.2	4.6	9.8	20.9	1.9	12.3	1.5	1.8	2.2	2.1	1.1	1.4	1.4	1.7	1.6	1.6	6.4	1.6	1.7	0.6	0.8	1.1	7.6	7.6	7.1	11.0	9.2	8.6	10.0	9.1	12.2	5.3
C7orf43	FLJ10925	ENSG00000146826	"Chromosome 7 open reading frame 43"	Q8WVR3	7	100154420-100158715	"Predicted intracellular proteins"			"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019359, HPA029463, HPA029464"	Approved		Enhanced	"Vesicles,Plasma membrane,Centriolar satellite"				Vesicles	"Plasma membrane, Centriolar satellite"	"HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205"	"unprognostic (1.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.36e-3)"	"unprognostic (5.68e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-1)"	"prognostic favourable (6.19e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.54e-3)"	7.0	10.4	10.6	23.0	11.3	12.2	12.2	24.8	23.2	6.7	14.0	9.4	13.6	16.2	9.6	10.8	12.1	8.4	10.5	6.4	12.8	13.9	12.3	12.9	19.0	21.4	10.8	10.6	5.7	11.6	18.7	14.5	21.6	14.6	10.2	13.5	8.8	13.5	10.8	10.1	28.1	16.4	6.9	6.0	25.8	14.9	26.8	6.9	17.6	12.2	7.4	14.0	8.5	7.8	2.1	0.7	5.2	1.7	0.5	2.6	1.0	4.8	6.2	7.3	12.3	4.6	2.5	8.2	9.0	7.1	6.2	4.6	4.8	5.7	6.1	8.3	6.8	9.3	3.5	7.1	2.4	11.4	6.7	4.5	7.8	4.2	5.5	5.7	21.4	5.1	4.9	6.1	4.7	5.4	9.9	11.1	8.1	14.9	12.8	12.2	8.2	9.0	7.7	3.3	6.8	5.4	5.5	9.3	9.9	8.0	23.5	4.8	4.8	6.9	7.5	12.4	10.6	16.5	6.9	16.6	15.6	6.1	7.0	7.8	13.2	1.7	1.0	3.5	2.0	1.6	1.4	0.9	2.6	1.8	0.7	2.1	1.5	2.2	5.2	0.5	1.7	0.6	0.2	1.0	10.6	11.3	24.8	23.2	12.8	13.9	10.8	10.6	14.6	6.9
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330722-68819022	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;parathyroid gland: 19.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.4;HEK 293: 5.7;LHCN-M2: 4.9;RH-30: 5.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: "	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	4.2	0.9	7.4	0.8	10.6	1.1	1.5	9.6	8.4	4.0	0.7	9.6	0.2	0.7	1.5	2.5	2.1	15.3	3.2	1.6	8.9	7.0	1.0	0.7	8.3	0.8	3.7	5.0	1.4	2.1	19.9	2.7	0.9	10.4	3.9	0.9	3.5	1.4	2.2	0.9	1.8	0.8	1.7	3.2	0.8	1.7	1.4	6.7	0.0	1.0	1.1	0.7	1.2	1.1	1.8	2.0	2.9	0.7	1.3	1.8	0.5	0.3	0.0	0.8	0.4	1.2	2.2	0.2	1.4	4.4	0.7	0.6	0.3	0.4	0.2	0.9	1.2	0.3	0.3	0.8	0.2	0.1	5.7	0.7	1.0	0.4	0.2	0.1	0.5	0.1	0.6	0.8	1.5	0.1	0.3	1.0	4.9	0.6	0.1	0.5	2.5	0.1	0.2	5.3	0.1	0.6	0.4	1.1	0.1	0.3	0.3	0.0	2.5	0.2	0.1	1.0	0.6	3.3	0.2	0.8	0.0	0.1	0.4	0.3	0.8	2.1	0.7	1.2	1.4	0.3	1.1	1.0	1.2	1.1	0.3	1.8	1.5	1.8	2.9	1.3	0.5	2.0	0.8	0.5	7.4	10.6	9.6	8.4	8.9	7.0	3.7	5.0	10.4	6.7
C8orf44	FLJ11267	ENSG00000213865	"Chromosome 8 open reading frame 44"	Q96CB5	8	66667615-66685564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA043660, HPA054753"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA043660: AB_10794889, HPA054753: "	"unprognostic (6.19e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.73e-2)"	"prognostic favourable (4.21e-4)"	"unprognostic (7.35e-2)"	"prognostic unfavourable (1.08e-7)"	"unprognostic (4.01e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (2.68e-6)"	5.8	4.5	15.8	6.1	18.1	8.6	9.6	16.6	14.9	6.6	5.3	10.4	7.2	4.3	8.4	27.7	4.2	7.7	5.6	5.8	10.6	7.7	5.9	4.0	4.7	10.1	11.4	9.0	10.2	4.6	6.8	14.6	5.8	8.6	6.8	8.3	8.9	7.7	7.0	11.6	12.4	5.3	5.9	9.2	7.5	6.4	15.3	11.5	9.4	10.8	3.0	8.0	6.8	6.0	5.8	4.4	5.7	3.1	0.6	3.8	1.5	8.8	3.5	5.9	4.1	3.6	7.0	3.2	2.5	2.4	3.3	3.9	3.5	10.0	9.9	1.6	4.2	6.1	5.6	2.1	4.7	7.4	5.4	8.3	10.6	7.3	2.9	3.7	5.9	5.9	4.9	4.5	4.8	4.2	9.5	6.6	3.3	3.2	4.2	5.2	5.1	4.4	4.1	1.9	2.0	4.9	1.9	4.8	3.8	2.6	1.7	3.2	5.9	2.4	6.0	3.6	4.7	3.4	1.5	7.8	2.6	4.1	5.8	4.0	1.8	5.7	3.1	4.0	1.9	2.5	1.4	5.8	2.4	2.2	2.6	4.8	3.8	2.8	3.6	0.6	1.3	4.4	3.4	1.5	15.8	18.1	16.6	14.9	10.6	7.7	11.4	9.0	8.6	11.5
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7"	"Group enriched"	"Detected in some"	6	"SK-BR-3: 9.7;T-47d: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050769	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA050769: "	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.4	0.0	0.4	1.7	0.4	0.0	6.1	0.4	0.4	5.3	16.1	0.5	10.5	9.1	1.0	0.4	2.4	1.5	7.1	0.4	0.4	0.0	0.4	0.5	3.6	0.4	0.4	0.4	0.4	3.9	0.0	0.8	0.4	0.4	11.6	20.9	0.4	34.3	17.0	0.4	3.8	7.0	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	1.6	5.2	1.3	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	1.4	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.0	9.7	0.0	18.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
C9orf78	"HCA59, HSPC220"	ENSG00000136819	"Chromosome 9 open reading frame 78"	Q9NZ63	9	129827290-129835863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021216, HPA021232, HPA021242"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838"	"unprognostic (1.00e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.43e-2)"	"prognostic favourable (3.49e-7)"	"unprognostic (5.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	23.9	29.0	42.7	24.5	44.0	73.8	28.0	37.0	34.5	24.0	24.7	27.6	25.5	21.8	24.1	28.9	26.2	21.5	24.8	28.7	40.3	39.6	44.8	41.7	21.8	35.7	39.5	30.8	31.1	26.3	20.9	26.6	24.5	29.3	27.5	27.6	18.0	26.7	26.4	45.8	27.8	25.9	28.9	38.7	28.1	22.5	32.3	32.8	42.0	33.6	23.5	34.0	32.4	31.3	28.5	22.9	57.6	43.6	37.8	52.8	34.4	10.1	10.1	10.8	16.8	19.3	13.0	13.4	14.7	11.9	13.1	9.6	10.5	10.7	15.8	11.9	16.7	21.7	14.7	12.5	11.0	15.5	10.6	25.1	17.9	11.0	12.9	36.5	26.0	11.9	22.2	16.0	13.7	12.0	63.0	19.3	16.0	24.2	46.7	46.9	16.0	24.0	13.5	16.6	33.3	13.1	6.9	9.0	17.1	22.2	20.6	17.5	18.0	25.8	13.5	19.7	14.9	19.3	18.5	8.6	25.1	25.7	16.4	29.7	16.0	36.4	23.3	57.6	44.4	35.3	43.9	28.5	46.4	48.0	19.2	28.1	52.8	48.2	18.0	37.8	43.6	22.9	48.9	34.4	42.7	44.0	37.0	34.5	40.3	39.6	39.5	30.8	29.3	32.8
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149936-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;HUVEC TERT2: 1.7;NTERA-2: 3.9;RPMI-8226: 1.5;RPTEC TERT1: 2.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 50.1"	"Cell type enriched"	"Detected in some"	7	"neutrophil: 37.0"	"Lineage enriched"	"Detected in single"	370	"granulocytes: 37.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 336.9"	"Low region specificity"	"Detected in many"			"HPA011089, HPA017258"	Enhanced		Supported	Vesicles			190000	Vesicles		"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (2.07e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.76e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-2)"	32.2	0.9	3.4	9.8	4.4	5.7	46.4	50.1	11.8	2.3	81.7	2.0	31.5	1.4	2.3	17.4	0.9	1.7	12.2	8.8	4.7	2.6	12.0	0.3	33.3	2.4	3.5	5.2	1.9	9.5	3.3	5.1	3.2	3.0	2.4	54.9	20.3	4.8	24.0	10.0	1.0	3.2	1.1	2.1	4.9	2.5	1.2	0.3	0.2	23.1	5.0	0.2	1.7	7.9	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.5	0.9	0.0	0.3	0.0	0.0	0.4	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.0	0.0	0.2	1.5	2.2	0.0	0.8	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.9	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	50.1	11.8	4.7	2.6	3.5	5.2	3.0	0.3
CA5B		ENSG00000169239	"Carbonic anhydrase 5B"	Q9Y2D0	X	15688830-15788409	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.4;fHDF/TERT166: 17.5;hTERT-HME1: 23.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012618	Uncertain		Supported	Mitochondria				Mitochondria		"HPA012618: AB_1846000"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.59e-5)"	"unprognostic (2.50e-1)"	"unprognostic (6.89e-4)"	"unprognostic (4.11e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (6.66e-6)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.08e-1)"	9.3	4.6	10.6	4.9	11.1	4.1	10.2	3.1	7.8	28.7	3.6	11.5	1.4	2.2	9.8	3.7	8.1	9.5	9.1	6.5	9.9	8.2	10.3	7.8	7.3	8.8	12.2	6.7	15.2	4.4	16.8	4.4	3.9	13.1	6.2	4.7	29.5	8.3	6.2	2.0	7.5	4.1	9.4	7.1	5.3	5.4	23.0	8.1	2.3	8.9	10.9	11.6	6.3	9.4	4.3	3.5	2.7	3.6	7.9	13.3	7.0	2.7	1.6	1.9	3.1	5.8	15.4	1.1	2.9	3.7	2.1	3.1	0.8	1.8	0.8	3.0	17.5	3.0	6.8	3.3	3.8	0.7	3.2	1.5	2.1	0.7	5.7	1.9	3.3	3.6	3.5	2.8	23.0	3.1	0.7	2.0	10.1	1.5	1.5	1.5	0.7	12.2	0.9	1.4	1.4	3.3	2.0	1.7	3.6	4.0	1.4	2.6	2.0	1.9	4.2	2.5	1.7	13.6	1.6	1.5	1.5	0.8	2.8	3.8	4.7	2.7	3.0	0.3	13.1	3.6	11.4	3.6	13.3	12.3	3.5	4.3	9.8	8.3	1.7	7.9	2.3	0.5	10.0	7.0	10.6	11.1	3.1	7.8	9.9	8.2	12.2	6.7	13.1	8.1
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell line enhanced"	"Detected in some"		"A-431: 39.6;HDLM-2: 20.7;U-87 MG: 83.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in all"			"CAB005100, CAB017107, HPA055207"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	Cytosol	"CAB005100: AB_2066539, CAB017107: , HPA055207: "	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favourable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.3	20.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favourable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	14.4	14.6	15.9	18.5	22.9	34.2	13.4	47.2	29.2	17.5	17.3	23.3	22.6	17.6	24.9	17.2	12.4	23.7	16.9	15.4	14.7	13.2	18.2	13.7	19.7	22.4	12.7	17.4	16.6	18.2	24.4	24.9	12.0	17.8	17.6	11.4	19.0	18.6	24.2	10.2	20.7	16.7	18.0	10.9	21.2	18.6	24.4	10.8	22.5	27.0	10.6	19.3	14.1	14.2	4.1	2.7	15.9	3.7	4.8	7.0	2.0	12.3	9.0	12.3	10.8	11.2	13.0	17.3	10.4	9.1	8.4	9.6	11.1	6.1	14.4	5.8	10.4	11.8	14.6	9.5	7.5	24.0	14.3	12.4	10.2	23.2	5.3	28.4	13.4	11.0	6.2	10.3	7.8	14.0	25.6	7.9	4.8	15.9	13.4	30.9	7.6	6.5	13.1	9.1	18.0	7.6	12.6	15.9	13.6	12.9	9.1	13.2	8.1	12.9	11.4	19.6	15.3	7.5	7.5	13.9	8.3	8.7	9.1	13.7	8.1	5.9	3.7	12.9	5.5	2.5	6.2	2.5	4.2	7.0	2.3	4.1	5.0	4.6	15.9	4.8	1.7	2.7	3.2	2.0	15.9	22.9	47.2	29.2	14.7	13.2	12.7	17.4	17.8	10.8
CABLES1	"FLJ35924, HsT2563"	ENSG00000134508	"Cdk5 and Abl enzyme substrate 1"	Q8TDN4	18	23134564-23260467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 40.6"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 42.2;U-266/70: 61.0"	"Cancer enriched"	"Detected in all"	5	"melanoma: 38.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073649			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"		"HPA073649: "	"unprognostic (1.27e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"prognostic favourable (4.71e-6)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.81e-2)"	12.0	2.9	22.3	1.6	31.5	1.8	40.6	8.6	23.4	4.7	4.1	3.0	0.0	6.0	7.7	2.7	5.6	9.2	4.2	3.2	13.9	11.9	10.8	8.0	17.0	2.0	17.2	12.9	3.3	2.0	31.3	2.6	8.4	13.6	2.8	4.2	17.1	17.0	3.9	1.1	13.5	5.1	5.7	3.8	2.6	11.6	2.8	9.2	0.3	12.2	0.2	1.8	5.4	7.1	0.3	0.5	0.0	0.2	4.2	0.4	0.0	3.5	3.9	3.3	0.2	2.0	0.1	5.7	0.8	4.8	1.1	0.7	2.6	6.3	0.1	3.7	4.0	3.1	2.5	0.6	0.9	0.1	5.4	0.2	10.8	10.0	1.7	0.6	0.2	1.2	0.5	1.4	1.7	13.1	0.1	4.5	3.2	8.1	0.0	2.3	2.1	13.0	0.8	11.8	13.4	5.9	8.6	3.1	2.3	7.2	9.1	42.2	14.6	1.9	21.8	13.6	0.1	0.4	1.0	61.0	23.2	7.4	0.0	5.2	4.6	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.1	0.3	0.3	0.0	0.4	0.0	4.2	0.2	0.5	0.1	0.0	22.3	31.5	8.6	23.4	13.9	11.9	17.2	12.9	13.6	9.2
CABYR	"CBP86, CT88, FSP-2"	ENSG00000154040	"Calcium binding tyrosine phosphorylation regulated"	O75952	18	24138956-24161603	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 91.1"	"Cell line enhanced"	"Detected in many"		"SiHa: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 6.3;memory B-cell: 6.6;naive B-cell: 7.1;neutrophil: 2.9"	"Group enriched"	"Detected in many"	5	"B-cells: 7.1;granulocytes: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040703, HPA047801"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA040703: , HPA047801: "	"unprognostic (1.18e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	0.8	1.2	3.9	0.7	3.2	0.7	2.3	0.7	4.8	3.0	0.7	3.5	0.0	0.7	1.5	1.2	1.0	1.8	1.0	0.5	3.6	2.1	0.6	0.5	0.6	0.8	3.1	3.0	0.9	0.7	0.4	9.5	0.7	5.4	1.0	0.8	0.6	0.9	1.0	0.6	1.1	0.7	1.7	2.3	0.7	0.8	91.1	2.9	0.0	0.7	0.0	0.7	1.5	0.6	7.1	0.7	6.3	0.5	1.3	1.0	0.4	3.3	9.0	2.5	1.3	2.8	7.0	10.7	6.0	3.9	7.4	8.1	1.7	6.7	0.1	4.9	8.9	3.3	2.5	5.2	7.9	0.4	4.0	0.2	4.9	2.0	4.0	0.2	0.4	8.4	8.4	9.6	2.5	2.2	0.0	0.2	2.0	1.0	0.1	0.3	8.0	5.2	0.5	0.3	0.1	3.2	4.2	5.3	6.5	18.4	3.8	0.3	8.4	0.9	1.2	0.6	1.8	2.5	0.1	0.2	0.2	0.0	3.6	0.6	0.3	6.3	0.5	1.0	0.4	0.3	0.2	6.6	0.5	0.5	0.2	7.1	0.4	1.0	2.9	1.3	0.5	0.7	0.2	0.4	3.9	3.2	0.7	4.8	3.6	2.1	3.1	3.0	5.4	2.9
CACTIN	"C19orf29, cactin, fSAPc, NY-REN-24"	ENSG00000105298	"Cactin, spliceosome C complex subunit"	Q8WUQ7	19	3610641-3626815	"Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042504, HPA042548"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA042504: AB_10797501, HPA042548: AB_10794760"	"unprognostic (1.18e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.09e-1)"	"prognostic favourable (3.69e-5)"	"unprognostic (5.93e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.55e-3)"	16.1	14.4	18.3	19.4	17.8	19.8	16.2	19.2	19.9	11.8	12.4	13.1	12.3	14.5	14.2	9.6	11.9	13.0	13.0	10.3	14.2	10.9	11.9	14.8	11.7	16.5	14.3	9.9	21.4	14.9	8.9	11.1	11.3	13.4	13.4	8.5	10.3	15.5	12.8	28.6	22.0	16.2	12.2	9.8	23.0	15.7	14.4	15.0	13.9	12.6	11.9	12.7	11.3	18.5	2.1	4.3	0.8	2.9	0.9	3.7	1.3	14.4	8.4	7.1	12.1	5.2	5.1	10.8	10.4	4.2	6.3	7.0	8.3	6.5	12.2	8.9	6.5	13.5	7.4	8.7	3.8	12.2	9.7	7.5	11.4	9.9	7.2	10.2	11.0	5.0	8.5	5.8	4.0	9.0	16.7	13.6	3.3	8.7	18.2	8.9	15.1	9.8	19.3	9.2	11.4	5.8	7.4	9.8	13.7	11.7	8.3	8.4	6.6	11.8	11.6	8.4	10.7	18.4	18.1	20.9	13.9	13.4	10.4	16.4	11.3	0.0	1.2	0.0	3.7	2.9	1.3	2.0	1.8	1.7	1.0	2.1	2.0	2.5	0.8	0.9	0.4	4.3	1.4	1.3	18.3	17.8	19.2	19.1	14.2	10.9	14.3	9.9	13.4	15.0
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175011715	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 117.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Approved		Enhanced	Nucleoplasm,Cytosol			360000	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: "	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favourable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	15.1	15.9	38.3	20.3	39.7	24.6	36.2	36.1	46.5	16.0	16.7	10.7	12.5	13.3	14.0	22.5	13.9	15.6	12.7	13.0	36.9	39.1	23.4	18.5	13.3	25.2	33.8	22.8	26.5	10.1	21.4	17.2	19.1	33.1	17.0	18.6	7.9	11.8	17.2	29.8	12.6	14.0	14.4	29.0	13.3	11.7	23.3	27.5	16.2	19.1	12.6	23.9	16.6	117.2	26.7	20.1	17.3	30.2	25.3	29.0	25.8	30.4	21.1	31.1	13.3	10.4	11.7	20.0	23.4	13.9	30.4	22.2	21.7	19.1	32.2	24.5	16.6	16.7	38.7	17.1	31.5	17.0	23.6	24.1	20.8	23.3	7.9	32.4	15.1	7.8	10.6	24.9	15.1	21.3	48.3	18.1	21.8	11.3	49.8	29.6	29.5	9.8	22.5	22.1	37.1	21.6	24.4	21.4	20.6	15.9	27.9	24.1	21.6	28.4	11.0	17.3	18.5	24.1	37.5	17.5	50.2	71.4	14.5	28.5	20.1	17.3	16.1	15.9	19.0	24.4	22.1	26.7	27.5	23.0	20.1	20.4	29.0	25.7	8.7	25.3	30.2	16.6	28.5	25.8	38.3	39.7	36.1	46.5	36.9	39.1	33.8	22.8	33.1	27.5
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217390-27243943	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA057266, HPA069341"	Supported		Supported	Nucleoplasm			26000	Nucleoplasm		"CAB007781: AB_562057, HPA057266: AB_2683387, HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	12.0	11.9	10.1	23.1	12.4	11.1	18.9	13.3	13.1	14.6	12.4	10.9	9.7	12.1	21.0	18.0	16.3	16.6	15.8	9.8	8.6	8.8	13.1	22.9	13.0	27.9	11.8	9.5	24.4	18.1	10.7	16.4	10.6	10.1	12.5	11.6	12.9	11.7	18.3	12.3	26.0	13.2	17.3	12.5	18.7	11.4	21.3	10.8	35.2	13.8	14.1	18.5	12.7	13.1	5.1	4.9	0.8	2.3	3.7	7.9	2.6	25.2	22.9	10.2	20.4	16.6	13.7	8.1	10.7	7.5	13.6	9.7	25.9	10.1	22.6	9.7	9.8	14.3	30.0	14.2	10.2	14.8	24.2	32.3	17.4	13.5	8.3	25.4	16.3	10.4	11.7	19.7	22.5	14.5	22.7	12.6	11.9	25.4	16.2	37.8	24.5	17.4	28.4	30.6	23.5	10.0	12.9	20.5	10.3	15.0	10.7	12.5	8.3	10.7	13.0	20.6	17.0	16.0	21.5	26.2	16.9	46.2	8.3	24.5	17.7	0.0	1.2	0.5	4.7	2.3	4.0	5.1	6.5	7.7	2.7	5.0	4.3	4.3	0.8	3.7	1.2	4.9	7.9	2.6	10.1	12.4	13.3	13.1	8.6	8.8	11.8	9.5	10.1	10.8
CADM1	"BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1"	ENSG00000182985	"Cell adhesion molecule 1"	Q9BY67	11	115169218-115504957	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 69.0;WM-115: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.6;myeloid DC: 10.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 10.2;T-cells: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037266	Enhanced		Supported	"Cell Junctions"			200000000	"Cell Junctions"		"CAB037266: AB_532287"	"unprognostic (1.50e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (4.11e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.40e-2)"	3.5	15.2	31.3	3.0	33.7	0.5	8.3	53.7	24.8	11.5	7.1	16.9	22.9	4.0	9.1	53.1	6.5	11.4	6.2	12.2	21.5	26.5	15.2	31.3	34.3	6.3	14.2	19.0	6.6	8.0	47.6	24.0	18.1	27.8	7.9	4.4	32.9	17.8	15.1	3.9	5.5	4.4	4.5	11.5	3.9	6.6	23.3	17.1	1.0	34.5	1.3	6.9	6.6	3.6	1.8	10.2	0.1	0.0	0.5	10.6	1.8	0.0	5.4	6.1	0.0	0.0	0.0	0.0	5.7	9.7	0.7	0.0	69.0	6.2	0.0	18.4	8.6	1.1	1.1	6.4	0.4	0.2	9.5	0.0	2.0	26.3	0.0	0.0	13.6	0.0	9.3	0.0	15.4	0.2	0.0	0.6	1.0	4.6	4.5	0.1	5.7	0.0	0.0	0.1	14.0	10.8	0.2	12.1	26.0	0.0	6.1	4.9	22.0	0.3	0.0	0.5	11.2	5.6	3.0	15.6	22.4	4.4	8.8	0.0	44.5	0.1	0.0	0.0	10.6	0.0	4.7	1.8	3.9	2.8	10.2	0.3	0.1	2.7	0.0	0.5	0.0	0.0	6.3	1.8	31.3	33.7	53.7	24.8	21.5	26.5	14.2	19.0	27.8	17.1
CALB1	CALB	ENSG00000104327	"Calbindin 1"	P05937	8	90058608-90095475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	15	"brain: 73.8;kidney: 121.9"	"Cell line enhanced"	"Detected in many"		"A-431: 39.2;EFO-21: 59.4;NTERA-2: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.4;monocytes: 2.5"	"Region enhanced"	"Detected in many"		"cerebellum: 483.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 88.7;cerebellum: 312.3"	"CAB002138, HPA023099, HPA056734"	Enhanced		Supported	Vesicles				Vesicles		"CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220"	"unprognostic (2.19e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.61e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.37e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-1)"	1.6	1.2	19.6	1.4	73.8	1.0	1.4	66.0	10.9	3.1	1.3	0.5	0.0	1.0	1.0	2.0	1.7	2.0	0.9	1.0	13.8	15.2	121.9	1.5	2.1	1.0	2.8	6.4	0.9	2.0	1.3	3.2	2.2	12.8	0.9	1.4	0.8	1.3	0.8	1.4	1.7	1.1	1.2	14.7	1.1	1.3	2.1	10.6	0.0	1.4	0.0	1.0	1.0	0.1	0.5	0.6	6.4	2.5	0.0	0.2	1.0	39.2	2.1	8.8	0.6	0.2	1.4	1.2	0.6	4.0	0.3	0.5	0.3	4.7	0.2	59.4	0.0	13.7	12.7	15.7	2.7	0.1	0.7	1.4	16.5	0.3	1.7	0.2	0.7	0.6	5.1	0.8	7.8	10.5	2.7	1.1	10.5	0.2	0.6	0.1	19.3	7.9	0.3	0.2	0.7	4.7	0.3	1.4	0.9	10.6	0.7	0.1	0.5	0.4	0.0	1.5	8.4	1.9	3.4	1.0	1.3	0.3	0.2	0.1	0.1	2.6	0.5	1.5	0.2	0.7	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.2	6.4	0.0	2.5	0.6	0.0	1.0	19.6	73.8	66.0	10.9	13.8	15.2	2.8	6.4	12.8	10.6
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390438	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 50.6;brain: 118.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.1;HEL: 23.4;HMC-1: 51.0;U-2 OS: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol			6400	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	50.6	11.6	10.1	5.1	7.5	0.9	18.2	31.2	9.9	1.7	8.9	1.7	0.0	1.7	1.4	3.0	3.0	2.4	2.0	2.2	5.9	74.2	0.9	0.9	2.1	0.9	17.7	7.5	5.6	1.4	0.9	3.0	0.9	118.9	1.1	6.0	4.9	2.1	1.3	1.0	1.0	2.7	2.7	7.5	0.9	1.2	14.6	1.5	0.0	0.8	0.2	1.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.7	6.5	0.0	0.2	0.0	1.2	0.2	0.1	0.2	0.0	0.0	8.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.2	0.0	0.0	51.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	14.6	0.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	7.5	31.2	9.9	5.9	74.2	17.7	7.5	118.9	1.5
CALCOCO1	"calphoglin, Cocoa, KIAA1536"	ENSG00000012822	"Calcium binding and coiled-coil domain 1"	Q9P1Z2	12	53708517-53727745	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.2;HSkMC: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038313, HPA038314"	Approved		Enhanced	Vesicles,Cytosol			11000	Cytosol	Vesicles	"HPA038313: AB_10675794, HPA038314: AB_10672587"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.63e-3)"	"unprognostic (9.88e-3)"	31.6	18.9	30.9	13.6	45.6	14.2	27.7	88.2	46.5	22.5	34.9	27.7	23.5	13.7	27.3	29.7	24.0	25.5	28.0	44.8	32.1	15.4	19.7	14.6	35.0	13.6	28.8	25.3	29.1	26.0	36.9	28.1	23.2	30.3	26.1	15.6	27.1	33.0	33.8	59.2	54.4	20.3	35.8	20.5	22.1	30.7	14.4	38.7	11.1	22.5	20.4	16.3	34.6	23.0	8.1	5.4	34.7	10.3	8.3	14.7	10.1	5.0	5.1	7.3	9.1	45.2	30.1	5.0	9.5	22.5	8.2	10.5	2.2	17.9	2.0	10.2	25.3	5.4	3.4	9.6	7.2	8.3	6.2	3.6	10.3	1.7	23.3	1.4	8.3	43.2	22.1	8.2	7.1	14.9	3.0	16.7	14.3	2.1	4.1	5.1	1.6	5.5	5.0	4.3	6.6	12.3	3.1	4.5	8.0	7.1	2.7	9.7	8.0	4.6	16.4	3.3	4.9	3.8	1.5	16.6	5.3	0.7	16.1	1.7	4.6	34.7	9.2	33.4	12.7	10.2	9.3	6.7	9.0	10.1	5.4	8.1	8.0	8.6	32.6	8.3	10.3	4.0	14.7	10.1	30.9	45.6	88.2	46.5	32.1	15.4	28.8	25.3	30.3	38.7
CALCOCO2	"MGC17318, NDP52"	ENSG00000136436	"Calcium binding and coiled-coil domain 2"	Q13137	17	48830988-48866522	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA022989, HPA023019, HPA023195"	Enhanced		Supported	Vesicles,Cytosol				Cytosol	Vesicles	"HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916"	"unprognostic (3.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.65e-2)"	70.5	30.8	20.6	21.0	29.5	22.2	50.8	22.1	28.1	38.5	40.2	26.8	32.7	27.0	39.4	35.6	41.3	36.1	28.4	55.5	24.8	16.6	36.6	48.7	42.6	28.2	36.8	24.8	37.7	22.7	24.6	46.3	26.5	32.3	37.3	42.1	46.9	30.0	31.8	70.1	31.3	35.2	47.8	42.8	29.5	35.5	51.8	37.3	25.0	48.4	32.3	26.0	46.4	74.2	18.0	22.0	44.4	40.7	33.2	34.2	24.7	26.3	17.1	7.2	13.9	53.9	39.1	20.9	25.6	34.5	29.7	33.4	31.9	17.3	8.9	25.8	31.1	14.7	17.5	21.7	35.8	40.8	14.5	8.4	10.7	12.4	62.0	28.5	43.2	57.5	32.4	31.4	22.9	21.7	15.4	27.1	25.7	7.7	24.5	15.2	2.2	21.1	16.3	35.4	16.8	11.4	8.4	2.9	6.2	8.0	5.2	22.8	33.5	16.0	21.0	32.5	9.9	19.8	18.1	24.1	33.4	6.3	19.7	14.5	13.3	30.2	36.2	36.3	19.8	39.5	18.9	18.0	17.7	20.3	22.0	16.6	18.1	19.6	44.4	33.2	40.7	11.1	34.2	24.7	20.6	29.5	22.1	28.1	24.8	16.6	36.8	24.8	32.3	37.3
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187343129-187448460	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.0"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.2;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: "	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	42.4	5.2	4.9	6.4	3.8	0.2	19.6	7.3	9.4	21.2	12.6	2.6	4.0	3.1	17.9	6.8	16.3	6.5	13.4	15.1	4.5	3.8	16.5	12.5	91.0	16.9	4.7	3.5	15.2	3.7	8.2	5.3	6.4	7.5	10.7	5.3	7.5	8.4	4.4	5.0	4.2	5.6	14.5	18.1	9.1	5.0	7.9	2.8	2.3	16.9	11.8	4.7	10.6	14.0	0.2	11.2	0.1	3.3	1.2	1.1	1.1	0.0	0.0	3.1	0.0	2.3	0.5	0.0	0.2	0.4	0.0	0.3	0.0	0.3	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.5	0.0	0.0	1.7	0.0	0.0	1.6	0.1	0.1	0.7	61.0	0.0	0.8	0.4	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.1	14.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.2	0.0	0.0	0.1	2.2	0.0	0.2	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	11.2	0.0	1.1	0.2	0.1	1.2	1.2	3.3	0.0	1.1	4.9	3.8	7.3	3.7	4.5	3.8	4.7	3.5	7.5	2.8
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970728	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 224.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 78.6;fHDF/TERT166: 127.8;U-138 MG: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"			110000000	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	38.6	17.4	6.7	33.4	11.1	0.0	26.6	11.9	9.1	83.1	141.0	6.0	111.4	12.6	82.3	59.8	122.8	45.8	46.3	20.1	7.7	5.0	33.5	39.6	26.1	12.9	8.7	8.5	76.3	6.9	4.1	17.8	57.4	8.9	87.8	25.1	10.9	12.4	133.3	15.3	12.9	39.2	224.5	8.5	35.9	64.5	29.7	9.7	2.1	20.3	14.1	5.3	205.3	70.4	0.1	0.2	4.3	0.2	0.4	0.2	5.9	12.0	7.9	17.9	15.7	62.2	50.4	17.7	70.9	78.6	24.4	27.1	14.4	0.3	0.0	16.9	127.8	2.8	11.4	21.1	33.2	0.1	3.8	0.4	9.4	9.7	40.9	0.0	0.0	38.7	15.7	27.3	15.4	20.5	0.0	0.1	36.4	0.0	0.0	0.2	21.4	2.7	0.1	15.9	0.0	5.0	3.2	3.1	7.8	24.9	3.3	9.5	0.7	0.1	54.7	82.0	14.3	15.5	24.1	0.0	0.0	0.0	28.5	0.0	61.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	4.3	0.4	0.0	0.0	0.0	5.9	6.7	11.1	11.9	9.1	7.7	5.0	8.7	8.5	8.9	9.7
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		450000000	"Endoplasmic reticulum"		"CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.61e-1)"	"prognostic favourable (1.10e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (2.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.27e-2)"	67.5	55.5	31.9	58.9	36.1	86.4	64.6	20.9	38.9	50.2	52.3	42.5	65.7	44.1	61.6	108.4	65.2	49.1	67.5	62.5	31.6	35.2	81.9	302.6	61.8	83.6	33.5	33.4	59.6	124.3	56.4	60.3	98.0	35.7	53.1	60.0	43.2	121.0	68.6	25.1	34.2	53.8	56.9	42.1	66.6	49.7	65.0	32.7	61.6	250.6	55.0	65.2	39.4	68.0	25.1	57.2	16.1	38.6	26.3	48.4	16.2	116.3	46.0	63.2	137.7	79.9	72.1	57.9	155.6	127.8	93.8	136.6	70.3	93.7	74.7	143.7	180.5	46.4	69.1	99.2	95.0	55.5	39.4	62.2	56.0	106.9	188.8	249.7	84.4	66.8	46.0	86.9	73.6	112.8	53.2	37.9	76.1	80.4	69.3	163.3	56.2	65.3	53.6	53.6	90.4	82.4	66.7	24.0	51.4	96.5	53.1	31.8	71.0	103.6	97.6	78.4	49.4	111.4	69.5	47.3	42.2	75.1	110.4	109.0	86.1	16.1	19.5	10.1	48.4	38.6	34.3	25.1	29.2	36.7	20.4	22.4	21.6	39.2	6.6	26.3	30.8	57.2	21.5	16.2	31.9	36.1	20.9	38.9	31.6	35.2	33.5	33.4	35.7	32.7
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128771807	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		15000000	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (4.60e-5)"	33.6	20.7	10.2	30.8	13.6	6.2	27.6	7.8	13.0	33.6	35.0	13.9	34.0	8.4	57.0	29.4	29.7	27.3	24.0	60.0	10.5	9.0	23.6	38.3	31.4	17.0	14.0	9.8	28.5	21.5	18.6	19.7	104.6	14.4	29.9	21.1	18.7	26.9	40.2	26.5	12.5	16.6	78.1	17.4	26.6	25.6	14.3	10.8	8.1	25.5	16.7	13.4	57.0	27.6	14.0	19.5	13.4	22.9	13.7	18.5	16.4	16.2	13.7	32.0	10.2	89.4	86.8	17.6	112.0	97.7	41.2	54.4	17.7	25.1	8.0	20.3	154.3	9.5	16.5	21.9	62.2	4.9	11.5	8.9	20.4	19.6	40.9	12.6	16.5	58.5	16.3	56.7	22.2	37.3	15.1	11.7	79.8	9.2	9.2	7.4	21.5	13.8	7.6	23.1	12.6	17.1	9.0	3.3	19.2	36.1	33.3	45.1	7.1	10.0	50.0	114.2	14.7	95.2	49.5	18.9	23.3	15.0	118.9	16.0	116.4	11.2	21.7	13.4	18.5	22.9	17.0	14.0	12.7	13.8	18.6	10.0	11.3	13.4	2.8	13.7	18.2	19.5	13.6	16.4	10.2	13.6	7.8	13.0	10.5	9.0	14.0	9.8	14.4	10.8
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 41.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"			680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: , HPA051785: , HPA053973: "	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.7	0.0	1.0	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	5.2	0.0	0.2	0.1	2.3	0.1	0.9	0.1	0.0	0.0	41.0	2.2	0.2	0.0	0.0	1.9	0.1	0.2	0.2	0.3	0.2	0.0	0.5	0.4	0.1	0.1	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell line enhanced"	"Detected in many"		"REH: 18.7;SCLC-21H: 19.6;U-138 MG: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA050835: , HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favourable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.1	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.1	2.6	2.7	0.4	0.5	0.4	2.7	0.2	1.4	0.7	0.4	1.5	9.1	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.6	0.4	1.9	0.0	0.0	3.3	0.4	5.9	0.1	0.1	7.9	3.6	18.7	5.4	1.5	0.6	2.1	19.6	4.2	1.8	0.5	0.1	6.0	0.1	0.0	20.4	8.9	1.9	3.3	2.2	3.3	2.7	4.7	1.1	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5
CAMK4	CaMK-GR	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.9;lymphoid tissue: 71.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.2;MOLT-4: 12.6;SH-SY5Y: 16.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3"	"Lineage enriched"	"Detected in single"	26	"T-cells: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	1.1	6.5	9.5	6.4	34.2	4.6	1.0	48.9	16.5	1.8	2.3	1.0	0.0	2.4	1.3	0.8	1.4	0.9	2.7	0.9	5.9	3.2	1.4	2.5	1.9	12.0	2.3	6.8	1.4	0.9	0.3	1.3	0.6	3.4	5.8	2.5	0.1	1.7	2.6	0.8	0.9	3.8	1.5	2.0	4.2	2.6	13.8	6.6	71.7	1.0	0.0	8.1	2.8	1.1	0.7	0.0	0.4	0.0	0.6	19.8	3.4	0.0	0.0	1.4	1.0	0.3	1.1	0.0	0.3	3.2	3.8	3.7	0.0	0.0	0.0	2.0	0.1	0.1	3.1	0.3	2.8	41.2	2.6	0.6	1.3	0.0	0.1	0.2	0.1	0.1	0.0	8.0	0.8	0.6	0.0	1.5	0.2	0.0	12.6	0.0	1.9	0.1	1.9	2.4	0.1	1.4	0.0	9.1	16.1	0.5	0.0	2.7	0.0	0.2	0.0	7.8	4.6	0.0	6.9	1.3	0.1	0.0	3.8	0.0	3.0	0.0	0.0	0.0	2.8	0.0	14.1	0.7	10.3	7.8	0.0	0.2	19.8	10.9	0.4	0.6	0.0	0.0	11.3	3.4	9.5	34.2	48.9	15.1	5.9	3.2	2.3	6.8	3.4	6.6
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	"Calcium/calmodulin dependent protein kinase kinase 1"	Q8N5S9	17	3860315-3894891	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.9;salivary gland: 27.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 17.8;U-87 MG: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009111, HPA028062"	Approved		Supported	Cytosol				Cytosol		"CAB009111: AB_2068406, HPA028062: AB_1845954"	"unprognostic (1.39e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.40e-3)"	"unprognostic (2.94e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.70e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.10e-1)"	4.3	10.2	15.3	5.1	21.4	3.7	4.7	23.2	38.9	4.1	3.2	2.2	4.0	3.1	7.5	5.2	4.2	3.7	3.8	5.7	13.8	6.8	1.5	1.0	4.0	2.5	5.5	16.0	6.0	7.5	5.0	10.1	2.3	11.2	3.3	3.1	2.5	27.1	11.2	2.2	7.8	3.7	6.2	2.2	4.3	2.9	6.1	5.0	1.7	7.2	2.3	2.5	5.6	4.9	0.1	1.6	5.6	4.1	0.0	1.0	1.1	4.8	8.4	0.9	4.2	3.0	5.4	0.3	3.4	3.7	3.2	1.5	3.0	1.5	2.9	3.6	6.4	14.5	2.3	4.1	2.0	0.1	7.7	3.3	17.8	1.1	3.1	0.5	2.6	4.1	3.5	6.1	2.1	1.4	2.6	0.1	1.6	1.3	4.0	1.9	0.9	7.9	2.1	3.7	3.4	3.5	3.1	4.9	2.7	1.3	10.0	2.2	3.8	1.1	2.0	5.6	7.6	7.1	2.7	0.4	0.2	0.1	20.5	2.8	0.7	0.0	1.8	3.6	0.6	3.9	1.0	0.0	0.6	0.5	1.6	0.1	0.6	0.3	5.6	0.0	4.1	0.8	0.0	1.1	15.3	21.4	23.2	38.9	13.8	6.8	5.5	16.0	11.2	5.0
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	"Calcium/calmodulin dependent protein kinase kinase 2"	Q96RR4	12	121237691-121298308	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 125.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 125.5"	"Group enriched"	"Detected in many"	5	"classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol				Cytosol		"HPA017389: AB_1845956, HPA063713: "	"unprognostic (5.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	11.7	6.5	19.7	7.8	30.2	13.8	8.8	125.5	45.5	9.0	9.5	7.1	2.6	12.8	8.6	5.3	8.3	11.8	6.3	6.9	11.2	5.1	7.1	8.9	9.6	6.9	6.2	17.3	10.5	5.8	6.4	4.1	7.5	9.1	12.2	9.7	6.2	7.5	13.2	5.1	9.1	13.2	10.3	6.2	14.1	7.6	3.6	5.8	5.2	6.1	4.5	7.2	7.2	7.4	2.2	7.2	26.1	19.4	3.6	2.2	6.3	12.3	9.3	6.9	13.4	20.8	19.4	10.6	10.2	10.9	8.4	7.7	9.7	5.3	19.1	8.6	20.7	10.2	8.5	11.0	6.6	13.1	16.7	9.5	6.2	9.5	14.1	21.6	9.1	12.5	16.4	7.9	18.0	19.6	11.0	10.4	8.1	12.0	23.9	17.8	5.0	10.5	15.6	8.0	16.9	8.1	13.8	26.6	10.6	13.4	7.2	8.5	17.9	26.4	14.3	6.9	5.6	5.8	5.6	39.7	23.6	14.5	12.9	15.1	6.8	0.7	14.2	26.1	2.1	19.4	2.2	2.2	1.7	1.9	7.2	1.2	1.5	1.7	17.2	3.6	16.5	1.6	1.3	6.3	19.7	30.2	125.5	45.5	11.2	5.1	6.2	17.3	9.1	5.8
CAMKMT	"C2orf34, CLNMT"	ENSG00000143919	"Calmodulin-lysine N-methyltransferase"	Q7Z624	2	44361950-44772592	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067912			Supported	Nucleoplasm				Nucleoplasm		"HPA067912: "	"unprognostic (2.28e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"prognostic favourable (9.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.57e-2)"	7.1	8.0	13.9	10.8	21.7	13.9	8.2	15.4	13.1	9.8	10.8	8.2	8.7	8.7	11.0	10.5	8.8	8.1	14.8	7.3	11.8	14.8	11.4	7.0	8.2	8.1	14.1	4.3	6.7	17.6	15.7	17.6	5.2	13.7	5.8	10.9	8.4	12.0	6.4	10.9	9.7	10.8	8.2	10.5	8.4	7.8	19.0	12.6	13.7	12.1	8.1	10.7	7.9	10.0	17.7	9.9	9.3	8.5	7.7	17.2	6.9	7.0	4.4	5.4	4.9	5.7	5.8	11.5	5.9	4.1	3.0	3.9	8.1	6.4	6.8	6.6	3.8	5.9	7.3	9.1	5.3	25.4	10.5	10.0	9.3	15.2	2.2	6.5	7.1	2.4	5.6	4.1	7.8	4.4	7.9	12.1	4.9	7.3	11.8	13.2	9.9	4.7	7.0	6.4	13.6	14.6	7.9	10.6	9.6	5.6	16.8	6.2	6.1	5.5	6.0	4.1	4.8	4.9	4.3	9.7	8.0	12.3	4.5	11.5	3.1	9.3	8.5	5.9	11.7	6.7	11.7	17.7	11.2	9.7	9.5	13.4	17.2	13.5	5.1	7.7	7.1	9.9	16.0	6.9	13.9	21.7	15.4	13.1	11.8	14.8	14.1	4.3	13.7	12.6
CAMSAP1	"DKFZp434F195, FLJ31228"	ENSG00000130559	"Calmodulin regulated spectrin associated protein 1"	Q5T5Y3	9	135808487-135907228	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020527, HPA024161"	Approved		Supported	"Mitotic spindle,Cytosol"				"Mitotic spindle, Cytosol"		"HPA020527: , HPA024161: AB_1845967"	"unprognostic (3.18e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	"prognostic favourable (3.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-3)"	8.0	8.6	12.4	6.5	15.7	10.5	8.3	23.9	21.7	7.6	6.3	14.3	7.2	4.1	9.5	6.9	22.0	9.8	6.5	9.2	11.2	10.8	5.2	4.8	8.2	6.6	10.4	9.9	13.5	9.5	8.9	9.4	6.5	12.2	8.0	4.7	24.2	7.3	8.6	32.7	10.4	4.3	8.6	10.3	6.2	6.2	20.8	9.2	10.0	5.7	14.4	11.4	7.6	10.0	2.4	1.1	3.8	1.6	1.0	2.1	1.2	9.1	13.5	22.2	15.6	5.2	4.6	10.9	7.4	6.2	8.1	6.1	11.8	8.0	4.2	10.7	9.3	18.8	11.7	8.0	6.2	14.3	6.5	6.1	15.1	5.9	7.9	10.6	9.2	6.0	10.2	10.3	14.2	9.0	12.6	9.2	10.5	16.3	9.8	6.6	12.7	9.8	19.3	18.5	10.3	8.1	11.2	24.3	23.9	9.5	6.9	10.3	9.7	8.8	11.1	15.4	12.1	11.3	12.5	4.6	8.6	11.6	10.0	7.2	8.8	3.8	1.5	0.3	1.1	1.6	2.1	2.4	1.8	1.7	0.9	0.5	1.3	1.9	0.5	1.0	1.3	1.1	1.4	1.2	12.4	15.7	23.9	21.5	11.2	10.8	10.4	9.9	12.2	9.2
CAMSAP2	"CAMSAP1L1, KIAA1078"	ENSG00000118200	"Calmodulin regulated spectrin associated protein family member 2"	Q08AD1	1	200739558-200860704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026304, HPA026511, HPA027302"	Enhanced		Supported	"Microtubule ends,Cytosol"				"Microtubule ends"	Cytosol	"HPA026304: AB_1852376, HPA026511: AB_1852378, HPA027302: AB_1852380"	"unprognostic (1.19e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.82e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (8.23e-3)"	"unprognostic (9.56e-2)"	11.6	11.9	12.8	4.5	15.2	0.1	7.4	16.8	29.7	11.3	5.8	16.6	5.9	2.7	14.4	7.7	8.1	6.6	8.9	7.7	13.0	11.9	8.9	5.0	10.5	2.3	10.3	11.1	14.5	3.9	20.7	6.1	13.0	17.4	8.2	4.7	8.6	5.0	10.0	5.4	9.0	2.7	11.6	10.2	5.6	5.0	10.1	7.0	1.8	13.8	5.3	4.1	13.1	7.4	0.1	0.5	0.7	0.6	0.0	1.4	0.1	11.2	7.6	10.5	9.5	8.5	11.3	12.1	11.4	9.9	9.2	7.7	5.5	6.8	0.0	6.5	12.6	10.2	10.8	16.8	11.1	6.7	5.5	0.5	11.5	2.5	9.5	0.7	2.9	8.2	25.9	14.7	57.9	14.0	1.4	3.6	14.9	5.9	0.1	0.2	9.8	10.8	4.5	11.6	5.1	7.9	8.3	5.5	9.8	16.8	10.4	9.4	9.9	0.6	16.7	15.1	9.0	9.4	14.1	7.2	11.9	6.0	11.0	1.7	11.4	0.7	0.6	0.0	0.3	0.1	0.4	0.1	1.4	0.0	0.5	0.0	1.4	0.4	0.0	0.0	0.1	0.2	0.8	0.1	12.8	15.2	16.8	16.3	13.0	11.9	10.3	11.1	17.4	7.0
CAMTA1	KIAA0833	ENSG00000171735	"Calmodulin binding transcription activator 1"	Q9Y6Y1	1	6785324-7769706	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036342, HPA036343"	Approved		Supported	Cytosol				Cytosol		"HPA036342: , HPA036343: AB_10671839"	"unprognostic (1.11e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"prognostic favourable (4.10e-4)"	"unprognostic (3.90e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.17e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.03e-3)"	18.4	24.3	31.6	12.2	30.7	12.1	21.7	24.4	37.1	16.5	30.2	19.9	13.2	28.3	20.0	46.7	22.7	16.8	17.7	58.1	26.4	27.6	36.7	37.2	16.5	13.3	31.2	26.5	17.1	18.6	22.0	17.6	14.3	47.5	22.2	27.1	25.0	27.1	29.6	48.0	12.9	30.4	38.4	23.9	15.7	21.5	23.0	19.4	14.7	30.8	20.5	17.5	31.3	18.7	19.8	32.3	28.3	32.4	10.3	18.1	18.9	21.5	12.2	33.9	17.2	17.5	26.8	9.5	23.5	18.1	25.3	21.4	14.7	27.5	18.0	18.5	24.5	13.4	17.7	24.2	36.2	13.4	19.2	20.2	28.8	28.7	28.5	15.3	14.7	18.0	16.9	18.2	28.1	28.1	14.2	24.4	29.1	20.9	20.3	42.0	23.4	14.3	13.6	30.2	39.7	34.1	12.6	35.1	28.3	16.6	24.7	36.0	13.4	19.2	16.4	18.0	15.2	18.5	14.6	18.7	23.0	48.2	26.9	34.5	10.1	27.5	32.4	28.3	11.5	19.4	12.5	19.8	18.0	14.2	30.6	16.2	14.7	12.8	6.6	10.3	14.7	32.3	18.1	18.9	31.6	30.7	24.4	37.1	26.4	27.6	31.2	26.5	47.5	19.4
CAND1	"DKFZp434M1414, KIAA0829, TIP120, TIP120A"	ENSG00000111530	"Cullin associated and neddylation dissociated 1"	Q86VP6	12	67269281-67319951	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055748, HPA062833, HPA069053"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"			4200000	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074"	"unprognostic (1.50e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	21.3	26.7	28.7	19.1	38.3	19.6	27.0	34.6	32.6	23.9	20.0	17.5	17.0	19.7	22.8	29.9	26.6	20.6	19.0	15.2	24.8	27.0	25.4	27.7	18.7	25.4	23.3	29.0	29.0	22.1	33.2	27.1	23.3	33.2	24.1	21.7	15.8	19.6	22.0	11.1	29.5	19.5	22.4	21.5	20.2	19.3	26.9	23.8	39.4	27.0	17.0	30.2	21.1	22.1	11.9	7.8	6.1	10.1	14.7	15.2	4.3	22.2	23.0	35.1	24.9	26.9	21.1	23.5	22.2	19.2	23.4	20.7	21.3	12.8	48.2	19.4	22.2	21.4	37.6	25.2	26.9	18.3	22.5	27.2	18.5	20.1	17.7	31.9	15.5	19.8	19.2	21.4	19.8	21.8	21.4	27.1	25.2	21.9	28.9	21.7	37.1	16.1	28.3	30.0	20.4	21.6	38.1	36.0	17.9	27.6	25.5	17.9	27.3	14.7	18.5	18.7	12.1	12.8	16.7	8.9	10.9	41.1	22.2	19.0	19.1	6.1	5.0	5.5	11.6	5.9	14.1	8.6	14.2	12.7	7.8	11.9	15.2	12.7	2.2	14.7	10.1	6.6	14.7	4.3	28.7	38.3	34.6	31.8	24.8	27.0	23.3	29.0	33.2	23.8
CANX	"CNX, IP90, P90"	ENSG00000127022	Calnexin	P27824	5	179678628-179730925	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004738, HPA009433, HPA009696"	Enhanced		Enhanced	"Endoplasmic reticulum"			82000000	"Endoplasmic reticulum"		"CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379"	"unprognostic (6.56e-2)"	"unprognostic (9.34e-3)"	"prognostic favourable (1.38e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (2.15e-1)"	49.3	35.4	40.0	35.8	40.9	57.6	37.8	27.3	49.1	93.0	33.6	37.1	48.3	44.0	42.7	115.4	31.6	31.7	30.0	51.3	36.9	50.9	61.6	120.8	34.7	30.1	47.5	27.9	41.0	78.2	13.7	33.0	70.5	44.9	33.5	55.1	32.2	121.5	48.5	28.5	23.4	68.5	60.5	48.8	38.2	31.7	34.3	30.0	31.0	113.4	25.9	29.9	41.4	47.6	10.1	26.3	25.9	28.9	18.7	22.6	30.0	8.2	23.4	19.9	12.1	42.8	31.8	10.1	42.8	47.0	49.4	42.0	20.3	19.2	62.9	60.1	34.3	5.7	31.2	23.3	56.5	16.1	9.5	10.1	58.4	13.2	58.3	19.3	9.6	6.2	42.9	26.5	77.2	20.4	7.9	24.5	5.4	7.7	9.7	0.3	4.0	1.4	10.1	14.4	6.8	36.4	24.5	10.0	2.4	12.0	5.2	107.2	40.5	8.5	38.0	11.3	18.9	12.8	33.2	7.4	25.8	15.9	17.1	12.6	11.0	25.9	28.9	8.8	17.7	21.2	22.6	10.1	13.9	16.3	26.3	7.7	9.5	10.6	6.1	18.7	18.0	25.3	10.1	30.0	40.0	40.9	27.3	33.3	36.9	50.9	47.5	27.9	44.9	30.0
CAP1	CAP	ENSG00000131236	"Cyclase associated actin cytoskeleton regulatory protein 1"	Q01518	1	40040233-40072649	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 201.2"	"Cell line enhanced"	"Detected in all"		"THP-1: 199.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030124	Approved		Supported	Cytosol			270000000	Cytosol		"HPA030124: AB_10600799"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (1.44e-6)"	"unprognostic (5.37e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	70.0	31.8	33.3	68.7	41.0	74.6	42.4	16.6	37.4	40.1	58.2	42.7	25.2	37.9	69.4	28.9	60.9	44.6	36.9	27.2	28.6	26.6	56.6	52.0	58.2	63.7	37.2	26.9	44.5	22.6	29.7	22.5	74.4	39.5	42.0	57.7	31.3	39.8	39.7	20.6	37.1	58.9	62.9	42.7	79.9	44.6	39.0	30.0	62.4	40.2	32.6	83.1	53.3	40.8	27.4	70.6	201.2	106.1	37.2	57.6	115.5	44.0	19.1	24.2	14.3	34.4	32.3	36.1	78.1	47.2	44.1	44.5	27.5	46.8	34.2	31.9	64.3	27.7	28.9	57.2	60.8	45.7	17.1	53.7	21.1	21.6	31.7	33.1	153.1	32.9	29.5	67.3	38.1	37.2	20.0	23.0	65.9	13.0	26.3	18.2	39.2	21.5	19.9	32.1	21.0	46.7	46.6	11.5	24.1	33.2	38.5	53.0	17.8	199.4	66.1	37.7	34.3	19.7	66.1	18.8	36.9	31.4	49.6	37.0	49.4	95.4	60.2	201.2	57.6	88.9	45.3	27.4	41.7	55.1	70.6	26.3	35.4	47.9	128.3	37.2	106.1	27.7	55.1	115.5	33.3	41.0	16.6	37.4	28.6	26.6	37.2	26.9	39.5	30.0
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394748-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 121.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 79.6;HMC-1: 114.2;SK-MEL-30: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 79.0;classical monocyte: 97.4;eosinophil: 58.2;intermediate monocyte: 36.4;memory B-cell: 50.1;myeloid DC: 121.1;naive B-cell: 37.1;NK-cell: 48.3;plasmacytoid DC: 84.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"		6700000	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favourable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	44.3	4.9	10.1	18.3	10.8	32.4	17.6	3.3	7.6	19.9	13.8	17.6	17.7	6.8	14.0	16.0	52.3	12.9	25.2	4.1	8.5	6.5	35.4	2.9	44.3	26.9	14.7	4.8	10.6	8.9	40.3	5.2	15.6	11.9	15.0	11.0	7.6	22.5	19.3	2.6	39.2	11.5	9.9	17.6	10.9	25.9	8.4	10.0	21.2	31.5	28.1	40.2	27.0	31.1	50.1	121.1	79.0	97.4	48.3	9.7	67.5	22.3	10.8	0.0	1.0	7.6	16.6	11.6	8.6	0.9	8.4	8.3	1.3	79.6	2.8	12.1	16.0	26.1	0.0	16.8	3.6	17.2	0.6	8.0	19.8	4.7	6.0	4.5	114.2	14.4	13.0	7.6	9.5	5.5	0.9	6.6	5.8	18.9	12.0	53.2	3.3	14.3	12.0	1.3	1.3	32.0	11.2	0.1	0.1	10.7	14.4	83.0	5.9	56.7	21.2	18.0	3.9	0.6	0.3	0.1	0.6	1.2	40.8	60.6	0.2	79.0	97.4	58.2	1.1	36.4	3.4	50.1	9.7	3.7	121.1	37.1	2.8	1.3	14.1	48.3	10.3	84.1	9.6	67.5	10.1	10.8	3.3	7.6	8.5	6.5	14.7	4.8	11.9	10.0
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 88.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol			28000000	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favourable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	22.0	15.6	9.6	23.8	11.6	18.2	18.8	17.7	20.1	25.8	33.3	8.4	23.0	25.4	19.3	30.2	86.9	28.1	39.1	21.4	8.8	11.2	27.8	21.3	19.4	19.5	10.8	9.7	21.4	24.9	13.3	14.1	38.1	16.8	27.3	17.0	15.8	39.7	24.3	24.2	38.9	49.9	16.5	7.7	21.3	20.7	8.3	6.7	32.1	37.5	50.2	53.7	33.7	35.2	16.7	22.8	34.5	24.8	15.7	19.6	28.5	47.4	25.3	7.2	16.1	13.2	16.7	22.0	14.1	22.5	16.6	12.7	16.1	42.7	11.9	23.6	26.8	70.2	9.4	59.6	5.3	12.6	7.5	28.3	14.6	15.7	13.1	6.6	39.8	18.4	32.1	14.1	6.9	28.5	16.8	9.6	13.6	30.5	13.1	21.0	20.9	22.9	13.0	7.4	7.2	22.6	88.3	13.0	9.6	14.9	57.7	13.6	24.8	13.1	24.7	13.0	8.9	27.6	6.3	5.9	4.3	14.1	22.6	8.1	14.0	34.3	24.8	34.5	19.6	23.7	15.7	15.6	15.5	17.7	22.8	16.7	9.1	12.5	15.8	15.7	14.0	17.9	16.6	28.5	9.6	11.6	17.7	20.1	8.8	11.2	10.8	9.7	16.8	6.7
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol			1500000	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (6.21e-4)"	56.2	41.0	23.8	20.7	22.2	11.1	61.1	26.1	20.9	40.3	44.8	18.3	23.3	14.5	29.1	44.5	56.3	40.1	58.9	33.0	26.5	13.1	41.6	13.3	58.6	18.2	27.4	18.2	32.4	26.8	53.7	12.7	26.4	23.8	27.2	44.4	16.5	62.5	31.9	48.1	16.5	22.7	35.7	32.3	15.9	48.2	17.2	24.7	5.0	29.9	39.7	35.9	28.3	38.8	9.0	41.6	1.7	29.1	6.0	28.7	28.2	45.7	29.3	9.4	6.3	31.4	43.6	9.0	43.3	62.9	31.5	17.9	23.2	36.8	0.0	14.3	48.0	28.6	10.1	68.4	29.3	11.7	10.5	0.8	15.0	2.9	28.2	2.4	1.5	23.3	22.2	49.0	26.2	62.4	13.1	12.2	92.6	0.9	0.1	2.1	5.2	38.3	3.8	30.7	0.7	54.3	2.7	2.0	10.9	22.3	60.9	13.5	9.2	11.0	95.9	29.5	24.5	25.4	55.5	3.6	6.9	0.1	73.9	5.1	32.4	1.7	29.1	1.7	28.7	19.5	24.5	9.0	20.0	27.7	41.6	3.6	6.4	17.4	1.5	6.0	17.5	1.9	19.9	28.2	23.8	22.2	26.1	20.9	26.5	13.1	27.4	18.2	23.8	24.7
CAPRIN1	"caprin-1, GPIAP1, M11S1, RNG105"	ENSG00000135387	"Cell cycle associated protein 1"	Q14444	11	34051683-34101156	"Predicted intracellular proteins"	Differentiation	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018126, HPA063617"	Approved		Enhanced	Cytosol				Cytosol		"HPA018126: AB_1849929, HPA063617: "	"unprognostic (3.79e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (8.67e-8)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	36.7	34.5	32.7	32.0	37.5	38.4	41.5	45.8	48.7	40.4	32.0	34.0	31.2	30.2	42.6	31.6	36.1	40.8	28.7	34.4	32.1	30.5	35.8	27.8	30.8	36.0	27.5	35.7	41.0	30.6	61.2	33.4	36.8	29.7	32.4	40.4	26.2	35.3	37.7	43.8	29.8	31.3	42.6	38.3	35.5	28.3	80.0	30.3	64.3	35.1	32.9	38.8	41.5	32.9	14.3	26.0	15.8	28.2	21.6	20.7	17.7	32.6	39.3	58.9	34.0	45.4	46.5	30.5	42.1	42.4	49.3	46.2	35.9	20.0	52.5	25.3	51.3	44.0	74.9	49.1	60.0	31.5	40.3	41.0	39.6	31.3	27.8	65.1	31.3	40.9	27.4	31.2	58.2	49.1	52.4	24.9	52.3	26.2	56.4	12.7	30.1	37.2	44.1	80.3	23.3	31.4	62.1	39.1	38.2	47.4	26.0	23.3	45.8	28.0	46.9	41.6	29.7	42.3	47.5	27.2	39.3	56.8	29.8	28.8	47.3	15.8	21.2	8.8	14.1	27.4	20.7	14.3	16.6	17.3	26.0	12.8	17.5	16.5	9.4	21.6	28.2	14.2	19.4	17.7	32.7	37.5	45.8	48.7	32.1	30.5	27.5	35.7	29.7	30.3
CAPRIN2	"C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140"	ENSG00000110888	"Caprin family member 2"	Q6IMN6	12	30709552-30754951	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039746	Supported		Supported	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA039746: AB_10672902"	"unprognostic (7.45e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.50e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"prognostic favourable (8.36e-4)"	5.5	7.8	12.5	5.3	20.6	9.3	5.0	19.9	15.7	7.3	5.3	4.4	9.5	4.0	8.6	10.5	3.6	4.9	6.1	17.4	11.8	19.0	6.5	5.3	6.5	5.4	11.2	11.6	8.3	5.5	22.4	11.0	4.2	18.2	7.4	5.7	6.1	3.1	10.0	5.6	10.6	4.6	8.4	11.5	6.7	6.5	22.3	9.4	4.3	5.7	3.9	5.0	6.1	8.1	4.1	4.2	7.5	1.5	2.6	5.4	0.9	4.6	3.2	6.1	5.2	6.1	6.5	3.7	8.6	7.3	3.7	5.1	1.7	3.0	2.7	7.6	9.0	3.7	3.2	14.0	6.8	4.0	3.6	11.3	5.3	6.5	3.4	1.7	1.1	7.4	5.6	12.0	9.7	8.4	0.7	2.7	8.8	0.9	2.2	2.9	7.2	9.9	1.0	9.2	1.3	1.6	16.7	7.7	4.7	3.2	2.3	3.7	2.1	0.5	11.4	7.2	4.0	22.0	15.8	5.3	3.7	2.4	8.8	0.5	4.7	7.5	1.5	1.2	4.4	0.6	5.4	3.7	2.8	4.6	0.6	4.1	3.1	2.8	0.3	2.6	0.7	4.2	1.8	0.9	12.5	20.6	19.9	13.7	11.8	19.0	11.2	11.6	18.2	9.4
CARD19	"bA370F5.1, BinCARD, C9orf89, MGC11115"	ENSG00000165233	"Caspase recruitment domain family member 19"	Q96LW7	9	93096218-93113283	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010921, HPA010990, HPA038297"	Approved		Supported	Mitochondria				Mitochondria		"HPA010921: AB_10670295, HPA010990: , HPA038297: "	"unprognostic (7.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (7.47e-5)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	15.1	17.8	9.9	8.1	10.6	6.8	19.6	19.8	15.0	13.5	18.1	13.9	6.4	13.7	13.8	14.2	12.9	12.3	13.0	14.5	9.7	7.5	18.1	12.2	12.0	7.8	14.8	10.7	9.6	9.1	6.1	8.1	7.6	13.7	10.2	7.6	9.9	12.1	10.7	15.5	14.6	12.2	12.5	12.5	12.5	15.7	19.9	10.3	5.3	10.0	13.4	7.1	15.5	12.6	5.6	17.3	23.0	21.7	9.2	11.5	12.3	11.9	11.7	1.4	3.5	1.9	3.7	4.9	9.9	4.9	7.0	3.1	2.8	4.0	2.6	7.0	3.5	20.8	1.2	8.0	0.6	49.1	4.6	4.5	2.5	6.5	7.9	4.0	4.3	9.2	2.5	5.0	2.0	8.1	2.0	4.8	4.7	23.6	4.3	10.9	1.4	26.6	2.9	7.8	10.4	8.5	4.5	3.6	6.6	5.3	2.6	10.8	5.9	4.3	8.0	3.5	7.1	6.6	3.0	3.9	3.5	0.5	14.6	4.1	12.2	14.1	21.7	12.8	6.1	16.0	6.2	5.6	6.0	6.5	17.3	3.3	5.5	5.5	23.0	9.2	9.1	6.2	11.5	12.3	9.9	10.6	19.8	15.0	9.7	7.5	14.8	10.7	13.7	10.3
CARD8	"CARDINAL, Dakar, KIAA0955, NDPP, TUCAN"	ENSG00000105483	"Caspase recruitment domain family member 8"	Q9Y2G2	19	48180770-48255946	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 33.4;HUVEC TERT2: 43.3;NB-4: 37.5;TIME: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042071, HPA043513"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA042071: , HPA043513: "	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (1.63e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.19e-2)"	"prognostic favourable (1.72e-5)"	33.9	10.0	7.9	19.3	11.4	14.9	17.2	7.2	9.5	11.9	8.7	10.1	6.9	8.1	14.0	8.1	7.5	9.4	9.7	10.5	8.6	5.2	8.7	10.1	16.8	25.6	13.3	3.3	8.1	10.5	6.9	11.3	15.0	10.2	9.6	8.0	10.2	8.9	6.2	12.0	6.8	15.1	11.1	16.2	42.1	9.9	9.8	11.7	24.1	11.4	9.2	23.9	12.8	10.1	10.2	12.8	53.6	20.0	8.3	14.1	9.5	3.9	9.1	8.8	2.9	2.9	4.5	3.4	3.6	4.7	5.8	9.1	3.1	5.8	7.6	4.6	3.7	2.4	5.2	2.7	5.5	12.6	4.4	33.4	4.5	6.4	3.8	15.9	25.6	3.7	2.0	2.9	3.5	43.3	4.5	10.0	4.5	2.7	6.5	37.5	2.2	2.2	11.2	3.9	2.0	3.3	4.9	3.0	4.5	6.0	4.2	5.1	2.6	14.1	41.0	3.4	4.3	1.4	5.9	9.2	22.3	5.1	1.6	11.4	6.0	25.0	15.2	23.0	10.4	19.9	11.5	10.2	10.2	11.8	12.8	9.6	9.8	10.4	53.6	8.3	20.0	9.0	14.1	9.5	7.9	11.4	7.2	9.5	8.6	5.2	13.3	3.3	10.2	11.7
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871513-10923070	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 64.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"CAB032961: AB_2068446, HPA043561: , HPA048073: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavourable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (8.37e-4)"	12.2	8.8	12.3	12.6	16.1	13.2	9.6	12.5	17.7	15.8	14.0	9.3	9.0	11.5	19.6	9.1	20.5	14.8	12.4	14.7	11.2	7.2	9.3	14.5	8.9	12.4	7.8	10.2	13.0	16.9	8.2	6.9	15.3	9.5	12.6	10.2	12.0	11.4	13.2	64.3	12.5	12.0	15.6	6.6	9.8	11.1	17.5	8.6	9.4	10.0	12.7	15.6	15.8	15.9	1.3	1.6	0.3	1.4	0.1	2.6	0.4	22.4	16.7	24.1	32.6	20.1	27.5	23.1	16.2	28.1	24.1	23.2	25.8	8.3	31.0	19.4	28.2	21.5	24.5	24.3	15.2	34.7	20.0	9.5	10.9	31.3	17.2	14.3	12.4	18.8	15.9	16.4	19.8	30.4	22.8	27.9	14.1	40.7	24.9	12.3	29.7	27.9	34.9	12.3	36.0	14.5	11.7	17.5	16.8	11.6	14.0	15.6	14.0	12.3	18.2	29.0	16.4	27.5	18.9	27.2	21.4	27.1	19.1	23.0	12.6	0.0	1.4	0.2	1.2	1.4	0.5	1.3	0.9	2.6	1.3	1.3	1.0	0.9	0.3	0.1	0.7	1.6	0.8	0.4	12.3	16.1	12.5	17.7	11.2	7.2	7.8	10.2	9.5	8.6
CARMIL1	"CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A"	ENSG00000079691	"Capping protein regulator and myosin 1 linker 1"	Q5VZK9	6	25279078-25620530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 20.8;RPTEC TERT1: 21.5;SK-BR-3: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029038, HPA029039"	Enhanced		Supported	Cytosol				Cytosol		"HPA029038: AB_10601668, HPA029039: AB_10611382"	"unprognostic (2.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.15e-3)"	"unprognostic (8.25e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-1)"	8.1	7.2	10.1	7.1	12.3	1.2	9.3	20.0	10.3	8.2	15.3	4.5	8.0	20.8	5.2	10.7	7.7	8.2	11.7	7.5	9.0	5.5	12.8	3.3	11.3	13.7	5.8	8.3	8.3	6.4	9.8	7.0	6.6	6.5	5.2	14.2	7.1	10.0	10.7	1.4	8.3	30.5	7.9	6.2	4.3	10.3	20.8	3.5	6.7	7.7	4.8	7.6	8.7	9.6	4.1	2.6	0.0	3.1	1.5	3.0	0.5	7.5	7.6	2.1	2.7	2.0	1.0	7.4	2.6	5.8	2.7	4.9	8.1	5.7	2.6	8.5	4.1	8.2	8.2	7.3	2.0	6.5	4.3	6.3	8.9	1.0	5.5	0.2	1.0	1.1	5.0	5.3	8.2	0.1	0.2	2.1	1.7	5.9	0.4	0.0	2.9	3.1	0.9	1.2	20.8	21.5	6.9	5.5	1.2	11.4	19.7	7.4	4.8	0.2	0.1	2.0	3.6	9.6	2.6	0.3	0.1	4.2	3.2	2.3	7.6	0.0	1.1	0.0	0.0	1.3	0.2	0.7	0.4	0.2	1.1	4.1	3.0	0.5	0.0	1.5	3.1	2.6	0.0	0.5	10.1	12.3	20.0	10.3	9.0	5.5	5.8	8.3	6.5	3.5
CARS	CARS1	ENSG00000110619	"Cysteinyl-tRNA synthetase"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol			110000	Cytosol		"CAB075734: , CAB075735: , CAB075736: , CAB075737: , HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	24.9	15.9	15.8	15.8	17.7	9.0	15.9	9.5	29.1	13.4	16.3	19.1	11.1	15.9	14.0	10.7	16.0	10.8	14.2	12.5	15.3	18.7	10.7	22.1	15.1	17.2	23.3	15.9	14.5	42.5	14.9	15.9	14.0	23.0	10.8	17.6	7.4	20.3	14.8	24.6	18.8	17.8	21.0	16.1	14.8	22.8	13.4	17.3	9.8	23.0	14.5	22.7	14.4	19.4	8.3	13.3	18.0	23.9	16.4	18.1	11.6	7.5	3.8	5.0	15.0	19.5	18.0	4.5	19.3	22.0	13.3	24.1	9.4	18.0	11.7	5.7	24.3	19.4	16.3	21.9	18.4	34.1	3.7	6.6	6.6	7.2	46.8	13.7	14.5	29.6	17.3	11.5	12.9	17.5	11.0	41.5	13.1	11.5	9.6	0.0	18.7	6.9	4.6	8.3	14.6	0.0	12.6	10.7	14.2	4.7	13.6	21.1	0.0	0.0	6.0	5.5	5.1	13.6	0.2	30.9	28.1	7.4	0.0	7.2	10.8	7.7	12.0	8.8	15.2	10.5	13.0	8.3	13.6	13.6	13.3	6.0	7.5	12.1	18.0	16.4	23.9	5.2	18.1	11.6	15.8	17.7	9.5	29.1	15.3	18.7	23.3	15.9	23.0	17.3
CASC4	"DKFZp459F1927, H63"	ENSG00000166734	"Cancer susceptibility 4"	Q6P4E1	15	44288729-44415758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043015, HPA049488"	Enhanced		Enhanced	"Golgi apparatus"			400000	"Golgi apparatus"		"HPA043015: AB_2678271, HPA049488: AB_2680790"	"unprognostic (2.64e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.60e-2)"	"prognostic favourable (1.45e-5)"	"unprognostic (2.15e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.12e-1)"	21.0	48.4	40.2	17.4	40.2	7.8	24.1	29.9	35.6	34.5	24.8	29.6	37.5	15.6	28.8	30.3	13.4	30.7	27.8	23.6	39.5	34.2	30.5	32.6	22.3	15.2	32.4	22.8	32.3	21.2	40.9	42.8	18.7	33.8	38.8	24.4	25.6	24.8	34.0	14.1	9.1	16.2	24.8	40.6	18.5	27.3	18.7	33.2	17.0	46.7	12.1	15.5	21.8	20.8	9.8	9.1	28.2	12.6	8.0	13.5	8.9	13.3	11.5	15.7	27.2	42.4	37.1	9.7	24.5	36.8	13.3	17.1	5.5	23.3	3.9	33.7	34.4	16.0	10.0	7.3	14.2	20.4	5.6	6.2	13.5	10.0	19.7	12.2	21.3	21.9	8.3	14.8	11.4	15.4	9.4	30.2	16.4	6.5	10.3	9.4	4.3	7.9	8.8	9.0	12.3	17.0	15.5	6.9	16.3	18.6	17.1	7.7	18.8	14.4	23.0	23.7	12.7	34.9	20.7	24.6	41.9	8.2	27.7	17.1	15.2	10.7	10.6	15.0	12.1	7.7	13.5	9.8	10.1	12.0	9.1	9.5	7.9	8.0	28.2	8.0	12.6	8.2	9.9	8.9	40.2	40.2	29.9	34.0	39.5	34.2	32.4	22.8	33.8	33.2
CASKIN2	"ANKS5B, FLJ21609, KIAA1139"	ENSG00000177303	"CASK interacting protein 2"	Q8WXE0	17	75500261-75515583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071906, HPA075184"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA071906: , HPA075184: "	"unprognostic (1.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.12e-3)"	"unprognostic (5.27e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.47e-5)"	"unprognostic (1.82e-2)"	"prognostic favourable (4.83e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.95e-2)"	25.4	13.4	10.7	6.2	13.7	0.8	16.4	8.6	15.1	11.6	8.7	18.4	9.3	10.8	15.5	7.3	11.1	13.3	13.7	16.8	10.9	7.6	14.9	10.1	24.6	5.7	11.2	7.9	13.5	10.9	10.6	8.5	14.4	11.5	9.2	3.9	18.1	12.5	11.6	13.3	8.6	8.3	13.0	9.5	27.1	9.2	5.9	12.6	0.6	13.8	7.5	3.0	9.1	11.9	0.1	0.9	0.1	0.3	0.2	0.6	0.0	8.7	11.6	6.9	9.8	4.6	2.9	7.7	4.4	5.9	10.8	7.0	12.5	3.7	0.2	5.1	5.1	8.1	5.6	5.1	2.7	3.0	7.3	6.2	10.7	5.0	5.4	0.2	8.7	2.4	7.1	5.6	4.0	10.9	4.4	1.1	3.3	20.3	15.7	0.5	5.1	11.9	8.4	14.9	1.4	7.0	8.9	7.1	7.1	9.3	12.7	7.6	9.4	2.6	9.2	11.1	10.2	5.4	5.7	1.0	3.7	0.9	3.9	0.2	7.7	0.0	0.3	0.0	0.6	0.1	0.1	0.1	0.3	0.6	0.2	0.1	0.3	0.4	0.1	0.2	0.2	0.9	0.4	0.0	10.7	13.7	8.6	15.1	10.9	7.6	11.2	7.9	11.5	12.6
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 64.2;lymphoid tissue: 40.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 37.8;HBEC3-KT: 17.9;HHSteC: 20.3;U-937: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"olfactory region: 22.8"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	7.4	3.9	6.6	15.1	17.0	8.2	6.9	3.5	7.0	4.1	12.8	2.2	2.9	34.0	3.0	4.2	10.6	4.3	7.3	4.9	9.3	3.0	6.4	5.8	20.5	16.2	16.7	2.6	4.4	3.4	0.2	3.7	8.7	13.3	6.1	13.9	3.7	7.0	3.2	1.6	9.9	37.2	5.2	17.4	40.7	5.6	1.5	11.0	4.1	3.7	5.6	9.0	9.7	13.2	7.3	39.6	40.5	64.2	11.1	34.3	31.2	0.4	0.1	0.0	1.8	2.0	4.2	0.3	1.9	37.8	4.8	13.2	0.0	0.2	6.1	0.7	2.1	2.7	0.0	17.9	1.1	4.0	0.0	0.3	0.2	0.4	20.3	7.1	0.0	7.2	12.7	3.9	10.4	2.0	0.0	0.0	1.1	0.0	0.2	9.9	0.0	0.1	5.9	0.1	4.8	0.1	2.9	0.1	0.1	5.6	0.3	8.3	0.4	16.4	2.4	4.4	0.2	0.4	0.5	0.0	1.7	0.0	2.7	44.7	0.9	12.3	42.8	23.2	25.4	64.2	34.3	7.3	18.1	22.0	39.6	6.0	9.9	16.4	40.5	11.1	64.0	1.4	22.2	31.2	6.6	17.0	3.5	7.0	9.3	3.0	16.7	2.6	13.3	11.0
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 76.7;eosinophil: 62.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Supported	Nucleoplasm,Mitochondria			310000	"Nucleoplasm, Mitochondria"		"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favourable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	20.7	11.6	10.8	16.9	10.5	16.7	10.0	22.3	9.2	10.4	25.4	12.8	12.5	32.3	13.9	11.5	22.8	8.9	12.0	8.8	10.0	8.8	10.6	18.7	12.4	23.6	10.2	8.5	8.3	10.0	4.6	13.6	29.4	9.7	8.8	20.9	8.2	13.0	10.0	12.6	9.5	49.7	9.3	12.6	26.5	18.7	6.4	10.9	44.7	7.8	13.5	24.3	16.2	11.0	4.2	5.2	76.7	10.6	9.2	9.9	7.0	8.2	4.6	18.3	8.7	11.4	15.2	10.6	24.8	18.8	17.4	10.1	8.3	6.9	11.5	3.9	12.1	7.0	14.5	8.8	19.9	29.4	7.9	18.3	3.6	19.3	13.6	14.9	17.5	20.7	10.8	11.0	9.0	21.5	15.1	72.7	17.9	3.5	23.5	13.9	18.1	5.8	17.0	8.6	11.0	15.0	13.5	10.5	11.4	10.7	9.8	13.9	5.3	9.7	14.6	8.0	7.3	5.9	11.4	33.8	31.7	7.9	9.7	10.4	11.3	76.7	4.2	62.8	5.5	6.8	5.7	4.2	5.1	7.8	5.2	3.1	3.9	5.8	5.8	9.2	10.6	4.1	9.9	7.0	10.8	10.5	22.3	9.2	10.0	8.8	10.2	8.5	9.7	10.9
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.8"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favourable (9.93e-4)"	8.1	6.1	3.6	6.7	4.3	5.3	14.3	2.8	3.8	6.9	25.5	2.8	4.5	23.4	5.9	4.3	8.7	5.3	11.7	4.9	4.0	2.0	11.0	14.3	5.6	8.5	5.0	1.6	7.0	13.0	2.3	6.4	4.3	4.5	8.1	19.5	3.4	8.0	10.3	3.4	6.5	42.8	14.0	6.6	9.1	9.2	2.7	4.3	14.5	11.2	3.3	8.4	8.2	12.7	4.4	8.0	8.5	7.0	5.6	21.3	8.0	12.4	4.0	8.3	7.5	6.1	6.0	12.3	7.0	4.8	6.2	6.8	6.7	25.6	1.3	8.1	7.1	5.8	9.9	11.0	5.0	19.7	6.5	10.9	3.6	5.9	4.9	10.9	7.7	6.6	8.2	6.0	1.5	11.8	14.1	38.8	10.1	7.0	28.1	6.9	6.3	7.3	9.8	5.3	6.8	20.6	11.8	8.8	6.6	7.4	13.3	4.1	5.7	4.0	10.0	6.9	7.4	3.3	7.9	5.7	10.3	1.4	9.0	13.1	3.5	8.5	5.3	6.3	4.9	4.8	5.3	4.1	17.8	9.3	6.0	4.4	21.3	11.8	1.1	5.6	7.0	8.0	16.4	8.0	3.6	4.3	2.8	3.8	4.0	2.0	5.0	1.6	4.5	4.3
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: "	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	14.1	10.6	2.0	31.6	2.6	27.1	10.2	1.4	1.8	7.9	18.5	3.9	7.0	9.6	9.6	12.0	11.7	9.1	12.1	4.4	2.1	2.3	16.4	14.8	17.1	28.3	3.9	1.1	8.2	7.6	1.8	5.9	12.3	3.2	9.8	8.7	4.4	9.6	8.4	2.7	7.4	34.7	5.1	5.0	37.7	7.4	3.8	2.7	43.7	6.7	10.7	43.4	9.6	7.3	13.8	13.7	52.5	17.0	22.2	26.4	12.0	14.3	12.2	3.6	9.9	10.0	14.6	5.5	6.3	6.2	7.5	12.4	16.4	25.0	1.6	13.9	4.9	7.3	7.8	7.5	14.8	9.3	7.1	14.0	9.9	15.6	8.1	10.8	15.2	12.7	18.5	14.2	11.1	7.1	12.5	31.2	6.8	5.9	14.1	11.5	5.8	10.9	10.6	7.4	25.5	14.1	16.0	1.0	0.5	8.2	13.6	8.1	3.6	8.5	8.8	8.1	8.4	4.2	4.9	28.3	12.6	9.7	12.2	14.6	7.6	20.7	13.0	24.9	25.0	17.0	23.1	13.8	20.5	26.4	13.7	7.8	13.3	16.9	52.5	22.2	15.6	6.1	24.0	12.0	2.0	2.6	1.4	1.8	2.1	2.3	3.9	1.1	3.2	2.7
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 201.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			18000000	"Endoplasmic reticulum, Cytosol"		"CAB009491: AB_2259755, HPA036881: , HPA036882: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (4.98e-4)"	38.3	20.7	10.4	25.0	16.3	22.1	32.0	8.7	21.7	38.0	44.6	10.5	18.6	25.6	24.8	25.9	87.4	19.5	25.5	98.5	11.9	10.6	27.2	38.2	29.5	21.1	14.3	12.5	26.9	14.8	22.3	25.3	52.6	24.8	30.0	34.5	12.7	38.7	23.2	201.9	40.7	56.3	36.2	18.7	21.7	22.2	21.2	15.6	10.1	25.6	51.2	34.1	42.2	57.0	24.5	32.7	12.4	48.0	18.3	26.6	27.2	47.9	39.6	6.7	17.5	40.6	75.7	23.7	34.2	48.4	27.4	35.7	9.7	29.3	6.9	32.4	46.3	81.7	12.7	46.5	33.2	44.6	12.0	8.9	41.9	11.6	31.2	5.8	15.5	34.2	43.1	39.3	64.1	30.6	7.5	22.4	33.3	15.1	2.8	0.2	5.2	14.7	2.7	22.7	11.8	54.4	20.3	28.4	6.8	34.9	19.2	22.3	11.7	6.3	40.6	37.4	15.9	24.9	34.5	7.5	20.0	3.2	42.4	3.1	10.3	2.5	48.0	7.0	26.6	29.0	25.2	24.5	23.9	26.5	32.7	22.7	12.2	16.3	12.4	18.3	32.2	9.0	24.2	27.2	10.4	16.3	8.7	21.7	11.9	10.6	14.3	12.5	24.8	15.6
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 9.5;HDLM-2: 10.3;SCLC-21H: 16.0;SK-BR-3: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	3.4	0.9	0.3	2.5	1.5	2.8	6.0	0.3	0.7	6.1	20.7	0.5	14.7	8.8	11.0	2.4	9.9	3.4	13.8	9.9	0.2	0.2	4.5	1.4	7.4	0.8	0.8	0.3	1.7	4.4	0.0	4.0	1.2	0.9	12.1	2.4	19.8	17.0	17.4	29.9	25.3	27.1	8.0	0.2	1.2	9.2	1.0	0.8	0.2	1.9	14.4	6.2	7.2	7.2	0.5	3.5	1.9	2.2	1.6	1.6	0.4	9.5	0.8	1.8	1.7	0.0	0.0	0.4	0.3	0.1	0.3	0.3	2.0	2.2	0.4	2.0	0.4	8.3	1.8	1.9	0.1	10.3	3.3	0.6	1.6	2.2	0.3	1.1	3.1	0.1	7.1	0.1	0.6	0.3	0.0	0.0	0.0	5.1	0.5	6.8	0.2	0.5	0.8	1.2	0.1	1.6	3.9	16.0	1.4	2.5	15.2	0.2	8.1	1.0	0.1	0.0	1.3	0.8	0.2	0.0	0.0	1.0	0.0	2.9	0.1	1.9	0.2	1.2	1.6	0.4	0.7	0.4	0.6	1.1	0.6	0.5	0.0	0.5	0.4	1.6	2.2	3.5	0.3	0.4	0.3	1.5	0.3	0.7	0.2	0.2	0.8	0.3	0.9	0.8
CAT		ENSG00000121691	Catalase	P04040	11	34438925-34472062	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.3;liver: 184.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 75.2;THP-1: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	13	"eosinophil: 258.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 258.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles			960000000	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favourable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favourable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	70.0	33.0	9.4	10.1	9.6	54.2	36.1	3.1	7.7	15.3	26.6	18.6	15.7	22.2	13.5	9.5	14.8	14.2	19.0	22.4	10.7	5.2	50.4	184.8	26.1	21.3	14.5	6.0	11.0	24.7	7.1	5.0	16.4	10.2	23.2	11.3	11.4	14.5	13.2	27.8	19.7	29.2	11.6	11.3	17.9	15.9	6.2	11.6	23.4	41.7	14.9	11.5	20.4	24.9	7.6	19.9	258.3	17.5	5.5	5.0	17.8	6.1	6.8	5.0	7.8	48.4	21.1	10.6	7.8	9.9	8.8	9.7	3.8	6.2	15.2	7.6	15.5	14.7	8.4	8.5	9.8	13.2	7.7	12.8	7.3	21.9	5.7	75.2	6.4	11.3	5.9	2.6	1.0	10.6	26.5	6.3	11.1	5.8	15.4	13.4	0.0	16.6	10.9	23.8	12.4	24.1	23.3	2.6	4.0	8.8	14.2	11.6	20.3	62.8	7.5	5.3	5.2	13.2	4.6	5.1	2.9	3.2	10.4	51.8	3.8	12.5	17.5	258.3	3.2	14.7	3.8	7.6	3.8	3.6	19.9	6.8	3.8	4.0	17.1	5.5	15.5	13.4	5.0	17.8	9.4	9.6	3.1	7.7	10.7	5.2	14.5	6.0	10.2	11.6
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524785-116561184	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 142.2;BJ hTERT+: 149.8;HBEC3-KT: 145.9;LHCN-M2: 152.1;U-138 MG: 121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 10.6;memory B-cell: 6.0"	"Group enriched"	"Detected in many"	37	"B-cells: 6.0;granulocytes: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: "	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	143.9	2.3	2.4	27.5	5.9	0.0	70.5	1.0	3.8	73.8	57.4	2.6	32.3	4.3	84.6	40.9	51.1	31.4	42.0	60.2	2.7	2.3	5.7	4.2	132.7	8.6	7.9	4.5	26.6	3.8	2.0	1.9	92.0	4.2	42.3	13.7	13.6	12.8	26.5	33.3	21.7	18.6	104.0	5.5	28.6	30.1	21.5	5.2	2.8	92.1	34.7	6.6	85.9	33.7	6.0	0.1	10.6	0.0	0.0	0.2	1.1	27.4	22.4	0.6	0.2	92.9	142.2	1.3	65.5	149.8	36.2	38.2	0.1	40.9	0.0	23.2	77.0	51.8	0.1	145.9	55.1	1.8	1.2	0.0	8.9	0.0	12.8	0.0	0.1	48.5	31.0	52.8	35.0	109.0	0.0	1.5	152.1	2.8	0.0	0.0	2.1	10.8	0.3	1.5	15.6	20.5	0.1	0.0	0.0	20.1	1.3	3.2	0.1	0.2	83.7	121.4	13.9	46.3	18.0	6.1	0.9	0.1	48.9	0.0	43.8	10.6	0.0	0.0	0.0	0.0	0.0	6.0	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	2.4	5.9	1.0	3.8	2.7	2.3	7.9	4.5	4.2	5.2
CAVIN1	"cavin-1, CGL4, PTRF"	ENSG00000177469	"Caveolae associated protein 1"	Q6NZI2	17	42402452-42423517	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"RNA-binding, rRNA-binding"	"Congenital generalized lipodystrophy, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 110.3;TIME: 91.5;U-138 MG: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049838, HPA074213"	Supported		Supported	"Vesicles,Plasma membrane"			29000	"Plasma membrane"	Vesicles	"HPA049838: AB_2680907, HPA074213: "	"unprognostic (1.59e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (6.36e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (5.92e-4)"	"unprognostic (7.18e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.44e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavourable (5.87e-4)"	105.6	12.7	4.7	26.4	5.4	0.7	111.2	4.5	7.6	68.6	52.0	15.3	31.9	7.1	65.6	45.6	60.3	37.1	74.0	37.3	6.4	4.6	12.1	6.6	47.0	15.6	7.7	6.1	57.8	6.8	7.5	6.9	47.7	13.6	51.8	12.4	34.0	17.4	53.8	45.4	28.6	18.6	115.4	14.7	23.9	27.0	24.3	5.2	3.3	30.4	47.9	12.6	80.6	57.9	0.9	0.6	2.7	0.5	0.7	1.2	0.2	30.6	26.3	0.5	7.0	35.6	42.9	0.7	110.3	48.1	44.1	35.0	13.2	2.0	0.0	22.1	78.8	50.7	4.7	33.0	36.1	0.1	0.9	13.4	16.1	6.4	22.5	0.0	0.1	29.4	12.2	34.6	11.9	59.4	9.1	0.1	18.8	0.4	0.7	0.1	2.6	0.1	0.0	17.6	0.0	18.8	0.1	0.0	0.2	37.0	0.6	8.8	3.0	0.2	91.5	93.8	44.1	33.5	40.0	0.0	0.0	0.1	27.8	0.0	10.5	2.7	0.5	0.3	0.5	0.4	0.3	0.3	1.2	0.3	0.2	0.9	0.6	0.3	2.3	0.7	0.4	0.6	0.3	0.2	4.7	5.4	4.5	7.6	6.4	4.6	7.7	6.1	13.6	5.2
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834302-191847255	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 27.6;HEL: 20.1;HUVEC TERT2: 62.5;LHCN-M2: 96.9;TIME: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 9.9;neutrophil: 8.9"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			160000000	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: "	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (8.45e-5)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	60.3	8.9	4.9	10.1	8.3	1.8	37.8	2.8	6.1	26.1	32.6	2.8	14.5	3.9	23.9	17.4	18.2	19.5	45.3	46.5	7.1	5.3	15.9	10.4	57.9	20.1	8.9	5.6	20.4	7.6	3.2	4.3	11.6	5.8	19.3	8.9	9.8	6.9	11.2	35.7	3.8	10.6	39.3	7.1	52.9	8.8	7.2	4.4	0.3	34.5	20.1	2.8	33.2	34.5	0.1	1.0	9.9	0.8	0.4	0.1	39.0	0.0	3.4	1.2	0.0	0.1	0.6	0.0	0.7	0.6	0.1	0.2	0.0	0.0	0.0	4.4	27.6	0.6	0.0	5.4	0.4	0.0	0.0	20.1	0.2	7.6	7.8	0.0	0.0	1.5	3.6	0.5	1.7	62.5	7.2	0.0	96.9	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	2.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.8	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	8.9	0.4	0.4	1.0	0.1	39.0	4.9	8.3	2.8	6.1	7.1	5.3	8.9	5.6	5.8	4.4
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100587906	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 83.8;tongue: 52.4"	"Cell line enhanced"	"Detected in many"		"AF22: 7.2;NTERA-2: 10.1;SCLC-21H: 15.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	3.5	0.0	0.3	0.1	0.6	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.2	2.7	1.9	0.0	0.1	16.4	0.5	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.8	0.0	83.8	0.1	0.0	0.1	0.7	0.0	0.1	1.4	0.0	0.1	0.2	52.4	1.6	0.0	0.0	0.4	0.3	1.4	0.4	0.7	0.7	0.0	0.5	0.4	7.2	2.7	1.6	2.4	5.2	1.3	1.0	1.0	1.2	0.0	0.5	0.3	0.3	0.6	0.3	3.4	0.1	2.1	1.7	2.4	0.0	1.1	0.0	0.5	0.3	0.4	5.8	0.3	1.0	0.6	1.2	0.2	0.3	4.5	0.1	2.0	0.3	10.1	0.8	2.9	6.8	0.0	0.8	0.4	15.5	4.1	0.2	0.3	1.4	0.2	0.2	1.3	1.8	1.4	1.3	1.1	0.4	1.3	0.7	1.9	0.1	1.3	0.6	0.3	0.2	0.5	0.4	0.2	0.2	0.7	0.5	0.1	0.4	0.5	0.5	1.4	0.7	0.3	0.3	0.2	0.0	0.3	0.6	0.5	0.3	0.5	0.3	0.5	0.1	0.0	0.0
CBFA2T3	"ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4"	ENSG00000129993	"CBFA2/RUNX1 translocation partner 3"	O75081	16	88874858-88977204	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.9"	"Cell line enhanced"	"Detected in some"		"HEL: 21.0;K-562: 36.7;MCF7: 17.0;MOLT-4: 18.6;NB-4: 22.7;REH: 36.9;T-47d: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 26.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059931, HPA062423, HPA065890"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA059931: , HPA062423: , HPA065890: "	"unprognostic (2.47e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.98e-1)"	"prognostic favourable (3.95e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.04e-5)"	"unprognostic (2.18e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.35e-3)"	10.0	1.7	3.6	11.3	7.4	8.2	6.1	26.0	5.4	2.3	3.9	1.3	1.4	3.9	3.2	2.1	2.1	1.9	2.5	6.2	3.0	3.0	0.7	2.0	6.4	9.5	2.0	3.8	0.9	24.9	0.7	2.7	3.8	2.3	3.7	1.5	3.1	4.5	2.9	14.2	2.6	5.5	1.5	1.2	14.7	3.5	3.2	2.2	75.9	2.4	2.0	10.3	3.6	4.8	3.7	11.6	3.6	4.9	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.0	0.0	0.0	0.0	5.5	10.4	0.0	0.0	0.0	0.0	0.0	36.7	0.1	0.0	17.0	18.6	22.7	0.4	0.0	36.9	0.2	3.7	0.0	0.0	7.2	1.6	0.8	0.1	0.1	16.8	5.8	0.1	0.0	0.1	0.1	0.0	0.1	0.1	12.2	0.0	6.4	0.0	1.1	2.7	2.7	0.0	3.2	0.0	3.7	0.0	0.0	7.1	2.1	0.0	0.0	3.6	0.1	4.9	11.6	0.0	1.7	3.6	7.4	26.0	5.4	3.0	3.0	2.0	3.8	2.3	2.2
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206276-119313926	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Supported	Cytosol				Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	9.9	5.5	9.1	17.0	11.1	11.1	8.8	10.7	12.0	6.2	7.5	8.7	3.0	5.7	9.9	5.3	7.5	7.4	6.3	5.9	8.0	9.6	5.5	4.0	10.3	16.3	8.1	6.9	6.3	5.6	16.6	4.1	9.1	9.3	5.3	7.5	6.4	5.4	7.1	3.9	7.4	8.6	10.6	8.9	13.3	7.3	32.3	5.1	40.9	6.0	5.5	15.6	7.6	7.7	1.8	3.3	11.8	3.7	0.6	1.9	1.0	6.3	4.8	16.8	10.5	5.0	6.0	9.9	6.8	7.1	6.6	6.6	10.2	7.8	15.0	6.2	8.6	9.3	11.5	5.8	14.5	8.5	2.7	15.4	3.6	3.1	6.2	17.9	17.6	5.2	6.5	16.9	18.2	16.3	12.4	6.3	11.9	6.8	9.5	10.0	8.7	5.3	10.3	8.4	2.8	5.9	5.1	2.3	7.0	12.7	5.5	4.5	5.8	15.1	13.6	10.3	7.3	7.2	8.9	2.1	3.1	12.2	4.2	15.5	7.3	0.8	3.2	2.4	1.3	3.7	1.1	1.8	1.6	1.3	3.3	1.8	1.8	1.9	11.8	0.6	3.1	1.8	1.4	1.0	9.1	11.1	10.7	12.0	8.0	9.6	8.1	6.9	9.3	5.1
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	38.4	9.0	3.7	19.5	4.9	15.5	16.3	24.4	3.8	13.7	18.7	5.9	7.7	9.3	13.8	12.2	8.3	12.5	13.4	27.5	3.8	4.8	7.4	6.7	16.3	19.1	4.4	1.9	17.7	6.8	3.4	13.5	25.4	7.9	12.9	8.0	11.6	9.1	6.3	10.3	8.5	13.8	25.6	5.7	16.4	12.4	9.2	5.2	11.6	13.5	7.0	18.0	24.9	24.1	5.1	3.1	2.8	2.1	10.3	9.9	1.6	1.6	2.2	7.6	3.7	8.7	8.8	4.9	5.6	2.8	1.6	2.7	2.9	1.9	3.6	4.0	3.0	2.8	1.0	1.0	2.0	2.7	2.9	1.9	11.7	1.8	12.8	1.3	1.4	8.4	3.0	4.4	12.0	5.5	2.0	11.5	3.5	2.0	1.9	0.9	2.7	3.2	4.1	2.3	0.6	4.0	7.2	5.8	6.4	6.7	0.8	8.8	1.6	2.9	3.1	23.4	2.0	3.2	1.3	6.5	0.5	5.6	6.2	1.2	1.5	0.7	1.5	2.8	9.9	0.9	8.8	2.2	5.1	5.6	1.3	5.1	4.4	8.0	1.0	10.3	2.1	3.1	5.6	1.6	3.7	4.9	24.4	3.8	3.8	4.8	4.4	1.9	7.9	5.2
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743697-107761667	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	15.8	12.0	11.7	13.6	20.0	38.8	16.8	18.7	19.4	15.3	17.2	19.2	11.6	10.8	22.9	9.7	14.4	14.2	10.2	11.5	11.9	10.7	11.6	12.5	12.9	16.5	12.6	14.3	18.2	15.5	14.5	17.2	13.5	16.5	18.7	13.0	14.7	12.8	19.6	32.6	16.6	14.4	16.2	15.1	15.8	14.7	21.1	13.3	29.0	15.8	11.8	19.3	17.6	12.7	17.9	16.7	32.2	15.7	23.4	40.3	20.1	13.5	15.5	12.0	15.3	11.0	9.6	8.2	10.2	10.6	11.5	11.4	10.4	13.8	19.6	14.8	11.5	9.6	16.6	12.4	15.8	13.9	10.5	16.0	11.4	8.7	12.8	23.5	15.7	10.0	11.5	15.5	17.0	11.8	25.1	16.7	11.0	23.1	32.1	16.0	17.2	10.6	14.9	13.0	20.3	8.7	12.5	12.8	20.0	15.2	22.4	11.1	7.5	12.0	11.5	17.9	12.9	16.9	15.6	27.2	29.5	31.8	11.0	14.7	15.1	32.2	14.2	23.3	19.0	14.7	28.0	17.9	30.1	21.8	16.7	17.4	20.9	19.6	21.9	23.4	15.7	9.0	40.3	20.1	11.7	20.0	18.7	19.4	11.9	10.7	12.6	14.3	16.5	13.3
CBX1	"CBX, HP1-BETA, HP1Hs-beta, M31, MOD1"	ENSG00000108468	"Chromobox 1"	P83916	17	48070052-48101521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB012265	Supported		Supported	"Nucleoplasm,Nuclear bodies"			35000	"Nucleoplasm, Nuclear bodies"		"CAB012265: AB_297216"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.48e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.73e-2)"	17.4	19.1	39.4	19.5	40.5	8.6	25.5	40.0	39.7	31.3	18.8	22.0	15.4	11.1	39.6	29.3	18.7	22.5	16.4	18.3	35.0	33.4	22.9	12.5	15.6	18.6	32.2	38.0	47.6	12.4	27.8	20.7	19.9	30.8	23.1	19.9	13.5	15.5	29.3	35.4	16.7	11.8	32.8	41.8	18.5	14.2	39.6	31.8	30.9	23.5	12.9	26.1	20.2	19.6	12.7	7.6	25.0	9.1	6.3	9.5	4.1	38.1	21.9	72.1	33.9	14.6	13.1	39.9	35.5	17.2	34.7	37.3	57.1	15.3	26.3	38.1	27.9	15.4	26.5	22.4	61.3	48.8	21.3	21.3	21.9	21.0	8.9	20.3	13.3	9.3	12.5	25.8	33.1	28.3	26.5	12.3	27.8	23.9	56.7	13.9	27.4	28.3	42.7	59.7	16.8	20.1	22.0	25.6	63.8	24.5	8.1	12.8	38.4	14.5	19.7	48.5	44.8	20.6	35.7	17.3	39.2	25.3	13.3	9.0	21.5	2.8	9.1	11.2	9.5	9.1	7.9	11.4	8.6	7.8	7.1	12.7	9.1	7.5	25.0	6.3	6.4	7.6	8.4	4.1	39.4	40.5	40.0	35.1	35.0	33.4	32.2	38.0	30.8	31.8
CBX2	"CDCA6, MGC10561"	ENSG00000173894	"Chromobox 2"	Q14781	17	79778132-79787983	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.9;testis: 16.5"	"Cell line enhanced"	"Detected in many"		"REH: 31.5;SK-BR-3: 45.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023083	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA023083: "	"unprognostic (1.37e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.25e-11)"	"unprognostic (1.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-8)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.07e-1)"	2.1	0.6	1.6	1.3	2.5	3.4	8.1	0.5	1.5	1.7	0.8	0.6	2.9	0.6	4.0	3.4	6.0	1.7	1.1	3.3	0.8	0.7	1.3	0.9	2.2	2.2	1.8	1.1	4.1	2.2	0.4	0.5	3.9	1.3	1.3	0.4	1.0	2.1	1.5	1.3	3.4	1.0	1.2	0.8	2.5	0.9	16.5	1.8	17.9	1.7	6.8	2.4	1.5	3.5	0.8	0.4	0.0	0.6	0.0	0.4	0.2	2.4	6.8	12.6	22.8	0.1	0.2	4.5	0.9	0.4	0.4	0.8	7.0	0.5	9.8	2.0	0.1	1.2	14.5	0.4	0.3	1.4	7.8	0.5	7.3	4.6	0.5	2.9	2.1	0.2	0.9	0.2	0.6	2.5	6.7	0.7	0.4	10.2	15.2	7.2	12.5	7.9	31.5	9.4	5.9	0.5	3.5	15.4	23.9	3.9	45.7	2.6	8.3	4.4	1.8	4.5	13.5	1.3	1.7	3.0	1.5	6.0	0.1	7.9	5.3	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.6	0.4	0.0	0.2	1.6	2.5	0.5	1.5	0.8	0.7	1.8	1.1	1.3	1.8
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213356	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"			40000	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavourable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavourable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavourable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	40.7	49.4	41.2	54.3	38.8	65.8	69.4	37.4	45.9	33.9	38.4	20.3	39.0	49.8	39.5	42.1	36.4	33.9	28.6	43.3	39.0	40.8	51.1	45.8	37.0	68.6	44.9	37.2	45.3	31.8	22.4	27.5	45.4	51.1	30.7	43.7	23.7	35.0	45.6	60.4	27.1	56.4	46.7	66.9	54.0	29.3	45.1	33.7	92.3	32.1	38.2	65.0	39.8	38.1	38.8	37.4	55.2	48.4	39.5	60.7	35.1	49.3	21.8	46.7	46.2	16.8	30.6	36.8	38.8	29.6	29.6	30.1	25.8	41.7	75.1	31.3	25.6	39.5	39.0	32.4	48.5	20.7	29.1	42.8	28.8	28.7	18.5	67.6	41.6	22.4	28.4	23.4	33.5	39.9	68.5	37.2	50.0	28.2	65.1	81.6	59.5	31.6	42.7	43.5	61.9	43.1	27.7	57.2	63.5	32.1	68.4	35.6	58.1	61.4	29.6	26.9	48.9	31.4	51.4	55.2	79.5	127.7	23.5	58.3	121.5	47.8	38.4	55.2	34.6	47.6	42.8	38.8	51.7	42.7	37.4	35.8	55.0	54.0	39.3	39.5	48.4	30.5	60.7	35.1	41.2	38.8	37.4	45.9	39.0	40.8	44.9	37.2	51.1	33.7
CBX4	"hPC2, NBP16, PC2"	ENSG00000141582	"Chromobox 4"	O00257	17	79833156-79839429	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 38.4;SK-MEL-30: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008228, HPA012021"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA008228: AB_1078413, HPA012021: "	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (8.72e-8)"	"unprognostic (7.49e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-1)"	7.1	9.9	11.6	11.3	14.8	109.1	7.0	9.0	22.5	5.9	6.2	20.4	6.3	8.3	5.9	6.3	14.8	6.7	10.3	12.0	12.9	12.9	6.5	15.3	9.0	13.9	15.4	10.8	9.3	16.8	16.2	14.8	17.0	13.9	8.9	4.8	14.5	12.9	6.9	3.8	20.6	8.5	5.2	12.6	16.3	10.8	5.5	13.1	29.2	8.3	6.7	19.2	8.6	7.1	3.6	4.2	5.2	1.7	1.0	3.8	1.3	10.6	9.6	2.9	12.5	1.8	1.7	8.2	4.8	2.9	1.8	1.9	6.9	6.0	4.1	6.9	1.9	5.5	3.2	3.2	1.3	4.4	6.1	2.3	9.1	12.8	9.0	12.2	18.3	2.3	19.0	1.6	2.9	1.5	7.1	23.3	1.9	7.6	16.7	12.5	1.6	9.7	17.4	2.9	18.5	2.5	5.1	3.0	5.8	7.3	38.4	42.7	9.1	19.6	3.8	10.4	9.2	6.4	6.2	20.2	10.3	11.6	6.5	10.6	13.8	3.9	1.4	4.1	2.4	1.5	1.8	3.3	3.1	3.3	0.9	3.6	3.8	3.5	5.2	1.0	1.7	4.2	0.5	1.3	11.6	14.8	9.0	22.5	12.9	12.9	15.4	10.8	13.9	13.1
CBX5	"HP1, HP1-ALPHA, HP1Hs-alpha"	ENSG00000094916	"Chromobox 5"	P45973	12	54230940-54280133	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016699, CAB017548"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB017548: AB_2071368, HPA016699: AB_1850627"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.05e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.97e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.64e-2)"	9.7	18.2	26.3	16.3	28.4	17.3	16.0	22.3	32.3	13.8	12.0	25.3	10.4	8.7	11.7	18.0	11.2	18.9	10.6	22.0	22.1	28.4	20.8	10.1	11.6	19.8	22.4	18.8	22.2	12.2	42.5	26.8	13.9	20.4	13.9	13.0	19.5	10.5	16.0	14.1	19.5	10.4	12.6	25.3	11.7	11.8	26.8	20.3	37.0	27.4	9.0	23.4	10.0	11.6	11.3	18.4	3.7	6.1	6.2	8.2	3.6	8.7	25.9	40.8	18.8	5.4	11.8	9.4	13.5	9.7	11.5	11.9	10.1	28.0	24.1	18.2	13.3	7.3	28.9	8.4	19.6	38.2	6.3	21.2	29.5	3.5	4.2	11.2	9.1	5.8	5.7	19.6	17.3	12.6	24.1	24.0	18.8	15.1	35.6	11.8	32.6	3.1	35.4	22.8	13.4	11.9	8.0	20.5	31.6	25.3	5.8	2.9	22.1	19.0	16.5	19.4	16.8	7.3	15.9	6.1	6.6	46.3	12.3	11.5	20.2	0.8	4.7	3.7	6.2	4.9	5.0	9.4	6.7	5.7	7.8	11.3	6.6	6.1	0.7	6.2	6.1	18.4	8.2	3.6	26.3	28.4	22.3	27.2	22.1	28.4	22.4	18.8	20.4	20.3
CBX7		ENSG00000100307	"Chromobox 7"	O95931	22	39120167-39152674	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.5;U-266/70: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011574, HPA048677, HPA056480"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB011574: AB_726005, HPA048677: , HPA056480: "	"prognostic favourable (6.18e-4)"	"prognostic favourable (3.63e-4)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.11e-3)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.03e-3)"	"prognostic favourable (2.45e-5)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.63e-2)"	17.6	23.1	26.1	14.2	34.3	4.0	14.0	45.0	44.7	20.1	29.3	17.2	24.1	12.3	27.8	21.9	18.0	24.7	19.1	36.5	23.9	19.5	17.6	6.4	19.1	17.2	18.7	29.5	36.9	15.0	33.4	17.1	6.2	19.7	27.1	10.6	21.1	24.0	44.0	38.6	15.4	15.8	35.9	12.9	22.0	18.8	6.5	19.9	4.5	16.9	10.8	15.1	26.2	21.1	3.7	0.7	5.5	0.9	1.7	5.1	1.6	4.4	1.9	0.9	7.2	8.9	3.4	2.4	4.2	5.2	2.3	2.8	0.9	3.0	0.7	5.0	3.1	1.6	0.6	1.9	1.7	23.5	2.3	0.1	3.0	0.4	3.1	1.0	9.3	1.7	2.9	1.1	0.4	0.6	1.1	11.9	1.8	4.2	1.5	0.5	0.5	3.2	1.7	1.5	6.3	1.1	1.8	2.4	0.5	2.1	3.1	4.8	3.8	1.7	1.7	3.9	7.4	3.9	1.8	20.4	11.4	2.7	7.9	1.7	1.6	0.6	0.5	4.8	3.7	0.1	3.8	2.9	4.0	4.0	0.1	3.7	5.1	4.8	5.5	1.7	0.9	0.7	3.8	1.6	26.1	34.3	45.0	44.7	23.9	19.5	18.7	29.5	19.7	19.9
CBX8	"HPC3, PC3, RC1"	ENSG00000141570	"Chromobox 8"	Q9HC52	17	79792132-79801683	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031462	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031462: AB_10601252"	"unprognostic (4.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (3.94e-6)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"prognostic favourable (3.84e-5)"	"unprognostic (4.74e-1)"	"prognostic unfavourable (5.39e-7)"	"unprognostic (6.99e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.51e-1)"	"unprognostic (5.99e-2)"	5.0	4.6	6.3	7.5	4.3	3.6	4.6	4.4	7.2	3.8	4.3	5.1	3.9	5.4	3.6	20.5	3.9	13.9	7.3	4.8	5.6	2.7	6.9	7.8	6.2	5.0	4.5	5.0	3.2	7.9	10.0	11.0	4.7	4.7	3.6	1.6	5.9	4.8	6.9	3.9	4.2	4.1	2.2	3.3	4.3	5.5	13.6	5.5	12.8	4.4	1.7	4.0	2.6	2.5	4.9	5.7	14.6	6.8	3.0	3.4	2.1	7.7	15.9	4.2	15.3	2.3	1.4	5.2	3.9	2.8	3.4	2.3	8.6	4.0	5.7	11.2	2.2	7.3	5.4	1.2	1.5	4.3	7.6	2.0	8.4	9.1	2.7	8.5	17.9	1.3	2.4	2.1	0.7	0.7	5.0	2.5	1.0	9.5	9.6	12.6	1.7	8.6	9.0	3.8	10.4	2.6	5.3	6.2	12.5	5.7	18.2	9.1	9.5	11.1	1.8	7.1	9.9	2.9	6.2	7.3	2.8	3.7	4.5	8.5	4.0	1.0	5.2	14.6	3.4	6.5	1.2	4.9	1.9	2.0	5.7	2.1	1.9	1.8	6.5	3.0	6.8	4.6	1.9	2.1	6.3	4.3	4.4	7.2	5.6	2.7	4.5	5.0	4.7	5.5
CC2D1A	"FLJ20241, MRT3"	ENSG00000132024	"Coiled-coil and C2 domain containing 1A"	Q6P1N0	19	13906201-13930879	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005436, CAB015220"	Supported		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB015220: , HPA005436: AB_1078884"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (7.02e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.67e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.71e-2)"	11.2	9.5	19.1	14.5	18.7	9.1	12.0	30.5	22.2	11.4	28.7	13.6	15.3	43.2	10.1	10.0	18.2	16.9	16.6	10.4	17.8	21.3	12.6	16.2	11.9	9.5	15.8	20.1	11.5	30.0	17.3	18.7	12.2	16.1	14.2	14.7	13.3	32.7	16.9	18.7	28.6	35.3	11.1	12.6	11.3	21.0	10.1	13.7	10.6	12.0	13.6	13.7	13.1	14.1	2.4	3.0	4.1	5.2	1.6	4.8	2.0	22.0	9.3	3.1	12.8	6.3	5.2	9.9	7.7	9.5	12.5	12.0	12.8	6.7	11.6	12.6	7.7	16.2	5.8	11.7	4.3	16.9	32.0	5.7	11.4	8.0	10.5	4.7	16.9	6.3	14.3	7.7	5.1	8.4	5.9	9.5	4.0	23.4	11.1	12.9	7.0	16.7	11.5	6.9	9.2	8.5	16.8	11.5	6.7	10.2	15.5	11.6	11.4	9.0	7.9	9.6	4.8	21.2	9.3	16.2	7.2	6.0	12.2	15.9	8.7	3.9	3.2	4.1	4.8	5.2	1.9	2.4	2.3	2.1	3.0	1.3	1.2	2.7	2.8	1.6	4.8	2.5	1.9	2.0	19.1	18.7	30.5	22.2	17.8	21.3	15.8	20.1	16.1	13.7
CC2D1B	KIAA1836	ENSG00000154222	"Coiled-coil and C2 domain containing 1B"	Q5T0F9	1	52345723-52366193	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027500, HPA031426"	Uncertain		Supported	Nucleoplasm,Vesicles			140000	Nucleoplasm	Vesicles	"HPA027500: AB_10600693, HPA031426: "	"unprognostic (1.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (1.45e-5)"	"unprognostic (3.39e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.87e-1)"	14.6	16.0	12.6	14.5	20.0	7.4	11.5	12.9	18.8	9.6	13.0	22.5	10.8	14.3	11.1	15.2	16.5	9.6	13.6	14.9	14.3	14.9	17.7	15.5	17.9	18.7	21.0	17.2	14.1	17.2	15.3	20.0	16.2	20.6	12.7	11.0	17.3	16.1	14.0	25.6	15.6	14.9	11.3	29.2	16.9	14.4	24.3	19.2	17.9	17.1	17.1	15.7	12.8	10.8	2.9	1.7	11.2	1.8	2.7	4.0	1.9	10.0	14.2	6.4	9.3	22.0	8.2	15.5	13.3	20.1	16.1	12.7	9.9	7.9	7.2	11.3	13.9	7.2	7.8	15.7	6.7	11.8	9.2	7.9	12.0	7.6	16.3	9.0	17.6	12.8	14.6	18.4	13.0	10.1	12.1	7.2	16.0	7.6	9.9	7.3	11.7	14.0	6.6	12.9	8.4	14.9	14.7	7.6	6.5	12.4	18.4	16.7	6.6	11.9	13.6	20.6	11.5	10.9	14.7	10.5	9.9	7.8	22.9	10.4	20.7	11.2	1.8	4.0	4.0	1.0	3.0	2.9	3.2	2.9	1.7	2.2	2.5	3.4	2.6	2.7	0.8	1.7	2.3	1.9	12.6	20.0	12.9	18.8	14.3	14.9	21.0	17.2	20.6	19.2
CCAR1	"CARP-1, CARP1, FLJ10590"	ENSG00000060339	"Cell division cycle and apoptosis regulator 1"	Q8IX12	10	68721012-68792377	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007856, HPA048513"	Supported		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA007856: AB_1078415, HPA048513: "	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.71e-2)"	"prognostic unfavourable (1.41e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"prognostic favourable (4.05e-5)"	"unprognostic (2.89e-2)"	"unprognostic (3.21e-3)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.41e-2)"	24.2	28.0	22.6	38.7	27.9	27.8	24.6	36.9	31.7	26.0	28.7	21.5	24.7	22.7	23.9	23.7	26.5	19.7	23.2	21.6	21.3	20.5	27.4	22.3	23.4	37.5	31.7	17.9	32.1	22.9	28.6	44.3	29.2	23.6	25.0	31.1	26.0	26.7	37.9	47.0	32.3	25.4	24.5	30.4	28.6	23.5	18.9	29.9	42.1	28.5	20.6	37.4	28.8	25.0	12.4	18.6	12.3	12.8	8.8	16.0	9.1	26.4	27.7	32.0	21.4	13.9	13.4	24.9	23.7	20.4	25.9	17.8	36.5	21.6	31.2	13.1	16.3	20.9	33.4	18.8	28.4	21.3	21.0	25.0	19.1	22.6	15.8	39.4	29.4	13.4	23.4	21.8	26.9	20.7	34.0	20.2	24.9	19.1	26.2	25.0	31.9	25.9	30.7	19.1	18.6	22.6	20.2	18.5	16.1	23.3	38.4	23.3	26.0	24.2	20.2	16.1	20.3	17.3	25.5	14.0	18.4	33.5	13.5	26.6	15.2	4.9	12.8	12.3	15.5	11.5	13.8	12.3	11.0	14.9	18.6	12.4	13.3	14.0	3.1	8.8	12.8	11.8	16.0	9.1	22.6	27.9	36.9	31.7	21.3	20.5	31.7	17.9	23.6	29.9
CCAR2	"DBC-1, DBC1, KIAA1967, NET35"	ENSG00000158941	"Cell cycle and apoptosis regulator 2"	Q8N163	8	22604632-22621514	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Metalloenzyme inhibitor, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019907, HPA019943, CAB072827, CAB072828"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"			5300	"Nucleoplasm, Nuclear bodies"		"CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454"	"unprognostic (3.42e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.54e-2)"	"prognostic favourable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.77e-1)"	28.6	32.7	27.8	35.4	38.3	63.1	29.9	45.0	59.1	26.7	33.0	38.4	28.0	25.7	37.3	24.6	31.7	32.8	30.0	21.9	24.6	25.0	25.2	28.1	29.7	39.7	24.8	36.3	37.8	28.0	34.5	31.5	32.3	33.2	28.8	23.4	27.2	29.1	25.4	44.4	39.8	30.9	25.2	22.4	41.2	29.7	62.4	25.0	63.5	29.4	23.3	37.0	30.6	26.2	13.3	10.7	14.4	21.0	12.2	24.3	14.3	26.2	49.2	47.6	24.8	18.9	15.9	31.7	25.8	25.5	38.2	34.2	44.1	21.8	43.5	32.6	28.2	33.0	43.7	30.7	27.7	17.6	26.1	51.4	38.0	34.2	17.5	28.1	44.0	16.4	27.6	30.4	18.8	27.4	53.6	27.7	28.1	31.4	84.5	29.7	69.3	18.0	56.7	39.3	23.3	19.8	62.6	23.8	55.6	29.1	33.5	22.3	30.5	26.6	44.2	28.4	37.6	34.1	34.0	20.4	25.3	51.2	31.9	24.7	44.0	12.9	10.1	14.4	24.3	17.4	20.7	13.3	18.2	18.3	10.7	13.2	18.3	19.0	3.7	12.2	21.0	10.1	20.9	14.3	27.8	38.3	45.0	59.1	24.6	25.0	24.8	36.3	33.2	25.0
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430940-59697380	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 28.0"	"Cell line enhanced"	"Detected in some"		"BJ: 26.2;BJ hTERT+: 26.9;BJ hTERT+ SV40 Large T+ RasG12V: 25.2;HBF TERT88: 30.2;hTERT-HME1: 40.9;LHCN-M2: 45.9;TIME: 24.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 10.0"	"Group enriched"	"Detected in some"	7	"basophil: 9.6;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	10.0	12.6	2.4	3.8	1.1	0.4	3.5	0.4	2.0	16.8	15.8	0.6	8.2	0.8	12.1	2.8	2.3	6.9	6.9	2.1	10.0	0.5	3.1	4.3	16.5	3.6	0.4	2.1	28.0	0.8	0.4	2.6	0.3	1.7	3.0	2.3	9.1	1.0	3.5	10.6	3.3	3.0	4.9	0.3	0.3	1.7	2.1	1.3	0.2	1.0	0.0	0.7	2.9	5.1	0.8	0.4	9.6	0.3	0.8	0.3	0.2	5.1	0.4	0.0	0.0	4.1	12.9	8.0	26.2	26.9	19.1	25.2	0.0	0.1	0.1	0.0	10.4	0.5	0.0	16.9	30.2	0.1	0.1	0.0	0.1	0.1	9.5	0.1	0.0	8.6	0.7	14.9	40.9	0.9	0.0	0.1	45.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.5	0.1	0.2	0.0	0.0	0.2	0.0	0.1	24.7	0.0	2.6	3.9	0.0	0.1	0.0	0.0	1.3	0.1	0.6	9.6	0.3	0.8	0.3	0.2	0.2	0.4	0.2	0.2	0.1	0.8	0.3	0.3	2.7	0.8	0.2	0.4	0.2	0.2	2.4	1.1	0.4	2.0	10.0	0.5	0.4	2.1	1.7	1.3
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 11.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041925: , HPA043219: "	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favourable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favourable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"	15.9	18.7	31.6	8.7	43.9	4.4	14.5	27.2	29.8	13.9	10.4	14.3	10.5	7.2	13.2	11.2	13.0	12.5	14.2	18.0	32.3	21.2	23.5	19.2	10.4	14.8	20.3	14.4	20.9	13.8	19.2	17.5	8.8	15.2	14.7	5.2	12.4	18.0	19.6	34.1	9.3	8.3	20.0	15.1	15.6	13.0	15.9	10.8	13.7	18.0	6.5	14.1	16.9	10.0	11.1	9.0	0.0	2.4	0.6	3.4	1.5	3.8	15.3	6.7	11.7	4.8	4.6	0.9	3.3	6.0	11.7	9.9	3.3	6.1	11.3	2.6	6.3	3.4	11.3	7.2	3.3	0.6	38.9	12.0	10.3	5.8	14.5	0.8	6.9	7.4	0.9	2.7	0.6	3.7	8.7	7.3	5.7	1.0	7.2	4.8	3.2	8.5	11.4	3.4	7.8	12.1	0.3	7.4	13.8	2.7	19.1	6.6	8.3	7.8	4.1	3.6	3.7	0.3	2.4	4.3	1.5	14.7	9.7	3.9	0.2	0.0	2.4	0.0	0.5	1.6	1.5	7.8	0.5	0.7	3.0	11.1	3.4	2.0	0.0	0.6	0.1	9.0	0.3	1.5	31.6	43.9	27.2	29.4	32.3	21.2	20.3	14.4	15.2	10.8
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267188-115296831	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.4"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045120, HPA050621"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in male reproductive system"			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: , HPA050621: "	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	5.5	4.3	9.7	5.7	13.2	7.0	7.7	12.6	12.8	6.5	9.8	7.0	4.3	8.1	6.6	7.3	6.3	4.9	3.9	6.4	11.0	9.0	3.5	1.7	6.1	4.8	9.7	7.6	2.9	13.2	6.5	12.1	3.0	12.6	7.7	10.6	1.9	6.8	8.6	4.5	5.5	6.8	7.7	14.0	5.3	7.0	40.4	11.8	3.7	4.7	3.2	4.7	7.1	4.8	5.3	11.0	11.6	5.5	3.1	3.8	2.1	5.3	2.6	5.4	8.5	3.5	6.7	1.3	4.8	2.5	3.6	4.2	1.1	3.1	6.6	4.0	3.3	3.4	5.6	2.7	7.6	5.2	4.3	4.3	4.0	1.7	4.6	5.6	2.2	3.0	3.3	4.7	6.2	5.5	1.8	5.4	4.8	4.1	8.5	4.9	5.8	4.7	9.1	6.7	49.2	3.5	1.9	8.1	10.6	5.2	3.3	14.3	5.6	8.3	5.5	4.8	3.2	9.1	6.6	5.9	5.7	1.3	3.2	4.5	2.8	0.2	5.5	11.6	3.4	4.4	3.8	3.2	2.6	2.9	5.9	5.3	3.4	2.3	3.6	3.1	5.0	11.0	0.1	2.1	9.7	13.2	12.6	12.8	11.0	9.0	9.7	7.6	12.6	11.8
CCDC115	"ccp1, FLJ30131, MGC12981"	ENSG00000136710	"Coiled-coil domain containing 115"	Q96NT0	2	130338241-130342349	"Disease related genes, Predicted intracellular proteins"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034598	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA034598: AB_10601697"	"prognostic favourable (7.59e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.16e-2)"	18.7	18.4	25.1	14.7	25.9	17.2	21.5	23.4	39.8	27.1	22.3	24.6	17.9	18.1	22.3	28.9	24.2	25.6	19.9	15.0	25.2	24.1	24.9	14.9	21.8	22.6	26.1	22.5	36.1	24.0	25.3	17.1	23.2	28.1	21.3	17.2	19.1	23.8	25.4	9.4	26.5	19.1	17.7	24.1	19.5	16.9	13.0	16.8	17.1	25.3	14.2	28.4	20.3	20.1	34.0	32.8	51.5	56.2	26.7	34.4	38.7	12.6	6.7	8.2	5.2	16.8	17.8	10.4	6.6	16.0	13.2	15.3	14.9	28.2	16.7	22.6	10.1	13.3	6.9	10.9	10.4	19.9	12.6	12.1	3.8	18.5	14.2	13.8	24.1	15.2	25.9	8.3	4.8	13.6	11.9	14.0	15.8	12.1	21.1	22.8	11.3	17.2	16.9	9.4	14.0	11.5	12.2	9.4	14.4	8.6	15.1	14.6	15.0	14.8	10.9	7.4	8.0	11.9	5.0	7.7	8.0	15.7	13.8	13.4	8.8	36.8	33.1	51.5	29.7	45.3	26.6	33.8	32.1	31.7	32.8	34.0	30.9	28.8	11.4	26.7	56.2	25.8	34.4	38.7	25.1	25.9	23.4	39.8	25.2	24.1	26.1	22.5	28.1	16.8
CCDC12	MGC23918	ENSG00000160799	"Coiled-coil domain containing 12"	Q8WUD4	3	46921726-46982010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA056814, HPA060530"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA056814: , HPA060530: "	"unprognostic (1.47e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.15e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.08e-2)"	"prognostic favourable (1.15e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.65e-2)"	11.1	14.0	7.8	10.5	9.2	15.1	8.9	13.0	10.3	17.4	13.0	6.1	35.7	11.8	12.5	14.9	50.9	8.4	23.7	11.3	8.3	7.8	10.0	9.5	15.6	13.8	8.2	6.2	9.9	11.2	5.5	8.2	9.0	7.6	14.4	6.1	7.3	52.0	56.7	48.9	16.5	10.4	10.1	7.9	11.5	13.5	6.6	5.2	6.7	9.8	19.6	27.6	11.6	13.5	54.3	55.7	31.9	39.5	31.3	40.9	29.6	17.1	14.5	17.0	8.8	9.6	7.9	13.1	17.4	9.0	13.2	9.7	18.7	14.9	33.7	15.9	10.5	9.7	14.4	16.2	5.6	33.0	10.9	36.9	21.3	28.1	13.2	39.5	26.4	10.7	15.4	16.7	14.9	12.8	39.4	16.7	6.4	20.8	30.6	37.5	22.2	12.0	13.0	13.2	21.5	13.6	18.1	9.1	17.6	21.4	17.7	16.5	13.4	39.4	26.1	8.9	17.5	18.0	27.7	22.0	47.9	41.8	12.4	28.1	12.7	11.1	37.4	31.9	40.9	38.3	32.1	54.3	31.6	35.7	35.0	53.5	27.3	32.2	11.3	31.3	39.5	55.7	38.5	29.6	7.8	9.2	13.0	9.4	8.3	7.8	8.2	6.2	7.6	5.2
CCDC124		ENSG00000007080	"Coiled-coil domain containing 124"	Q96CT7	19	17933016-17943991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041708, HPA046765"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041708: AB_2677628, HPA046765: "	"unprognostic (9.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.22e-1)"	32.2	21.8	28.8	23.1	25.7	28.1	16.3	16.8	34.4	15.0	22.3	16.8	16.5	20.0	29.0	17.8	22.0	13.6	20.0	34.8	26.5	22.3	18.1	24.4	15.5	16.2	26.4	23.8	15.5	29.4	14.0	12.3	16.3	18.5	17.6	7.6	16.1	34.7	19.9	96.8	20.6	21.2	20.5	20.2	20.7	26.7	14.0	13.3	13.6	19.1	29.0	14.1	17.0	33.2	30.2	39.1	31.9	42.4	32.4	42.2	28.7	48.3	34.5	11.8	23.3	7.9	6.1	38.8	24.3	8.0	13.0	11.0	25.9	20.3	37.1	35.3	10.1	18.6	13.0	23.2	3.8	38.8	71.2	30.7	27.0	29.9	15.3	34.4	21.2	9.7	15.5	13.1	12.6	13.6	39.2	15.7	6.6	47.7	33.6	43.7	26.7	59.1	33.2	21.5	40.4	10.6	17.5	23.5	33.9	16.9	19.7	24.2	18.0	12.9	28.7	22.0	27.4	42.2	37.5	22.1	23.4	35.6	27.4	41.7	27.7	27.4	39.0	31.9	42.2	42.4	33.5	28.2	32.8	38.8	39.1	30.2	26.1	31.6	9.5	32.4	30.2	34.5	36.9	28.7	28.8	25.7	16.8	30.4	26.5	22.3	26.4	23.8	18.5	13.3
CCDC13	FLJ25467	ENSG00000244607	"Coiled-coil domain containing 13"	Q8IYE1	3	42692663-42773253	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.2;fallopian tube: 13.6;testis: 15.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;Daudi: 1.2;HDLM-2: 2.9;NTERA-2: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA047429	Approved		Supported	Centrosome				Centrosome		"HPA047429: "	"unprognostic (3.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.83e-7)"	"unprognostic (6.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (2.04e-2)"	0.7	1.0	3.0	0.7	12.2	0.6	0.7	0.8	4.0	1.3	0.9	6.3	2.3	1.1	2.1	7.0	0.7	13.6	1.5	1.7	3.7	2.7	1.1	1.7	2.5	0.7	1.9	4.6	1.5	2.0	1.0	3.7	0.7	8.1	0.7	1.4	1.5	1.6	1.1	2.0	0.6	1.1	0.9	3.4	0.8	0.8	15.0	2.5	0.0	1.9	0.3	0.6	0.7	0.5	0.0	0.0	0.1	0.2	0.5	1.2	0.2	0.0	0.0	0.0	1.1	2.3	0.9	0.7	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.1	2.9	0.8	0.0	0.3	0.0	0.0	0.0	0.4	0.6	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	3.0	12.2	0.8	4.0	3.7	2.7	1.9	4.6	8.1	2.5
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666364-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Supported	Nucleoli				Nucleoli		"HPA052637: , HPA053914: "	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (1.35e-7)"	"prognostic unfavourable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	11.3	10.9	10.9	16.0	14.1	20.2	10.2	11.3	17.0	10.3	11.5	8.0	8.9	16.2	9.1	6.4	25.2	9.2	9.1	9.1	12.1	9.0	10.6	12.1	8.7	18.8	12.4	11.9	8.4	12.0	9.4	8.4	11.2	11.8	13.1	6.4	5.7	13.0	9.9	12.7	29.8	11.8	10.3	9.1	17.7	11.4	13.4	12.4	9.8	9.2	13.1	16.6	10.6	14.7	12.8	12.6	10.2	9.2	11.9	11.2	5.9	12.4	24.6	6.7	11.9	4.8	4.9	13.4	14.2	6.8	20.5	11.3	21.6	7.5	12.8	7.6	8.5	16.3	13.8	16.0	7.6	6.5	21.2	19.9	10.9	17.1	7.4	15.2	13.0	7.1	8.6	18.8	8.5	14.3	18.8	6.8	9.6	13.5	15.1	16.4	16.0	24.8	18.1	12.7	8.2	6.4	11.3	16.4	21.2	13.0	26.8	11.6	19.3	12.6	9.8	29.6	17.3	11.9	19.6	18.1	10.4	13.0	10.7	14.9	16.7	1.9	7.8	10.2	11.2	8.4	7.0	10.3	9.7	9.6	7.4	12.8	10.7	9.6	3.5	11.9	9.2	12.6	9.5	5.9	10.9	14.1	11.3	17.0	12.1	9.0	12.4	11.9	11.8	12.4
CCDC14	"DKFZp434L1050, FLJ12892"	ENSG00000175455	"Coiled-coil domain containing 14"	Q49A88	3	123897305-123961408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035278, HPA035279"	Uncertain		Enhanced	Centrosome				Centrosome		"HPA035278: , HPA035279: AB_10601253"	"unprognostic (7.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.45e-2)"	"prognostic favourable (5.27e-4)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (6.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavourable (4.76e-4)"	"prognostic unfavourable (3.50e-8)"	"unprognostic (2.14e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.37e-2)"	"prognostic favourable (2.72e-5)"	11.3	9.7	13.6	22.4	15.2	30.0	19.1	8.0	16.2	14.5	18.8	10.8	7.7	12.0	20.4	31.9	10.2	15.8	14.9	9.1	13.6	8.7	13.3	13.7	14.1	14.3	14.3	13.0	20.6	15.4	7.8	24.4	9.7	14.5	17.2	31.8	9.6	14.3	9.8	5.9	20.2	15.9	13.6	17.4	13.7	12.8	22.5	16.0	36.5	14.0	11.2	13.3	12.7	13.0	2.1	4.5	3.0	2.2	6.0	5.6	1.9	16.5	9.7	30.1	11.9	4.2	6.2	14.1	33.4	11.0	16.2	18.7	7.6	11.9	4.9	8.6	6.9	18.9	10.9	5.5	22.0	4.1	7.7	19.7	17.9	7.1	3.9	12.9	12.7	6.2	3.5	8.4	9.0	7.7	10.2	9.1	11.1	8.2	11.2	6.1	9.0	11.4	19.3	12.5	5.6	9.3	13.6	10.5	12.5	19.6	4.9	12.7	11.7	9.5	10.0	39.2	20.4	12.0	10.8	8.6	6.0	14.8	13.2	9.9	13.6	2.8	1.6	3.0	3.9	2.2	2.6	2.1	3.4	3.3	1.0	2.0	3.8	3.2	0.3	6.0	0.6	4.5	5.6	1.9	13.6	15.2	8.0	16.2	13.6	8.7	14.3	13.0	14.5	16.0
CCDC174	"C3orf19, FLJ33839"	ENSG00000154781	"Coiled-coil domain containing 174"	Q6PII3	3	14651746-14672659	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043468, HPA060129"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA043468: , HPA060129: "	"unprognostic (6.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favourable (3.81e-5)"	16.8	12.9	15.7	13.4	17.5	27.1	17.1	22.3	18.2	19.2	18.5	17.8	15.2	16.8	24.0	14.5	16.1	15.5	12.9	14.4	13.1	10.9	17.9	15.3	13.0	15.7	17.9	14.8	28.0	18.6	15.7	29.9	15.6	16.9	17.7	13.7	12.6	16.1	15.7	26.9	17.4	20.6	14.9	18.7	20.2	18.2	15.3	19.2	23.1	17.5	9.8	18.4	19.0	17.6	14.7	9.5	21.0	9.9	15.4	16.7	8.4	5.1	5.7	8.6	9.1	12.0	9.9	21.9	6.9	9.9	8.7	6.8	6.3	6.0	10.7	5.0	6.0	4.6	6.2	5.7	6.8	8.0	7.6	10.8	6.7	6.7	17.5	10.6	12.6	11.4	14.8	11.7	14.4	7.4	10.8	9.8	6.4	9.0	11.1	9.3	11.6	9.3	8.3	8.1	8.7	8.9	9.1	4.2	11.4	8.0	6.3	11.1	9.6	15.1	6.8	7.0	6.8	6.4	7.9	13.0	11.5	12.4	7.0	8.2	9.5	21.0	9.5	18.4	12.1	9.7	14.1	14.7	15.1	13.9	8.4	13.3	16.7	13.3	18.4	15.4	9.9	9.5	10.3	8.4	15.7	17.5	22.3	18.2	13.1	10.9	17.9	14.8	16.9	19.2
CCDC43	FLJ31795	ENSG00000180329	"Coiled-coil domain containing 43"	Q96MW1	17	44673069-44689779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 50.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA023391	Approved		Enhanced	Cytosol				Cytosol		"HPA023391: AB_1846146"	"unprognostic (6.05e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (3.42e-5)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.11e-1)"	10.4	10.4	14.3	8.5	15.6	13.8	10.0	14.9	14.7	7.9	9.3	9.8	7.2	9.1	8.2	9.0	10.7	7.6	6.1	16.3	13.8	10.4	11.2	7.5	7.5	9.6	11.9	9.2	7.3	9.4	12.3	5.8	14.2	14.4	9.8	12.0	6.9	8.9	7.6	50.6	8.8	8.8	8.6	14.4	9.8	8.5	7.3	9.6	10.9	10.8	17.1	10.9	9.1	7.8	11.5	17.5	10.7	17.9	15.8	14.7	10.0	12.2	14.7	14.0	12.3	9.6	14.2	25.7	18.7	11.1	18.4	18.2	19.8	13.2	21.4	14.6	15.1	9.7	22.9	21.6	26.9	26.1	26.7	19.2	24.2	29.1	17.1	26.7	14.4	12.7	22.0	19.1	26.1	17.8	20.2	14.9	18.6	15.2	26.0	19.1	14.4	18.9	17.0	35.1	18.5	18.8	8.0	14.1	13.9	13.7	11.0	18.9	28.2	18.2	15.3	22.9	16.9	13.6	24.8	15.2	19.2	24.8	16.7	15.6	16.3	10.5	16.0	10.7	12.9	17.9	11.9	9.3	12.2	14.3	17.5	11.5	12.0	13.0	3.3	15.8	11.7	12.4	14.7	10.0	14.3	15.6	14.9	14.7	13.8	10.4	11.9	9.2	14.4	9.6
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745250-63776351	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	26.2	42.1	26.7	18.7	43.3	11.4	26.7	32.4	31.3	24.4	38.2	23.0	29.2	39.9	20.6	26.3	28.9	21.2	22.8	42.4	26.5	24.0	40.0	71.8	27.4	13.9	29.4	24.8	27.0	30.5	49.3	28.5	49.9	26.4	29.3	38.4	17.7	30.0	29.7	71.9	23.5	44.0	20.7	31.5	26.8	35.9	15.1	34.7	13.3	29.4	24.3	18.1	29.8	24.5	19.9	41.9	37.4	30.8	20.8	25.7	24.2	38.7	36.9	22.9	20.1	32.4	21.6	44.8	39.8	25.8	27.2	32.2	32.5	35.4	30.6	21.3	27.7	31.9	27.7	24.3	48.2	10.7	28.2	44.0	30.4	31.7	31.1	35.1	23.2	22.6	34.3	37.4	32.3	22.6	49.0	26.8	22.1	31.3	26.9	12.9	20.0	37.6	25.0	44.7	42.1	32.6	44.3	21.1	28.7	26.6	68.2	31.8	45.0	19.1	28.8	50.9	32.6	36.9	45.5	26.9	31.9	31.6	29.7	22.4	41.0	22.2	30.7	37.4	22.1	30.8	25.7	19.9	21.9	20.3	41.9	16.0	22.9	20.2	24.5	20.8	30.4	27.9	23.4	24.2	26.7	43.3	32.4	31.3	26.5	24.0	29.4	24.8	26.4	34.7
CCDC50	"C3orf6, DFNA44, Ymer"	ENSG00000152492	"Coiled-coil domain containing 50"	Q8IVM0	3	191329077-191398670	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 95.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 95.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001336	Approved		Supported	Cytosol				Cytosol		"HPA001336: AB_1078421"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.73e-2)"	"unprognostic (8.29e-2)"	"prognostic unfavourable (2.48e-5)"	"unprognostic (3.03e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.19e-1)"	35.2	17.5	15.8	23.7	15.5	5.1	41.4	11.7	14.2	19.3	21.7	17.2	21.7	14.0	23.4	21.6	20.4	21.7	29.6	22.7	14.9	11.0	25.1	38.5	22.3	22.7	15.9	9.3	28.9	31.1	17.1	14.7	20.3	14.6	20.5	15.4	16.2	21.4	20.8	19.2	14.3	22.3	37.5	14.5	32.5	21.2	18.7	14.4	11.7	25.5	14.4	23.4	30.4	23.8	20.1	95.0	0.3	3.4	3.5	3.2	2.4	18.0	6.0	23.6	6.2	21.2	18.8	8.2	33.5	33.6	24.2	24.3	12.8	7.2	3.5	41.4	18.8	20.7	18.8	14.9	36.3	26.3	9.2	2.4	8.1	14.6	31.3	8.8	9.6	15.0	20.1	19.1	43.4	37.0	8.0	19.4	21.3	6.2	0.0	5.6	8.3	25.7	13.6	13.1	17.6	26.2	7.8	5.5	8.4	11.9	12.9	23.2	8.9	8.0	37.7	23.9	19.9	17.2	42.9	30.1	13.0	0.2	12.8	0.0	19.2	0.0	3.4	0.3	0.9	3.1	0.4	20.1	1.0	0.6	6.6	10.0	0.2	0.2	0.3	3.5	1.6	95.0	3.2	2.4	15.8	15.5	11.7	14.2	14.9	11.0	15.9	9.3	14.6	14.4
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria				"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.24e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	9.9	14.9	10.1	7.1	12.7	4.5	9.6	10.4	15.9	8.9	12.8	7.5	12.4	11.6	8.2	11.4	15.9	9.7	8.4	12.3	9.2	8.2	15.2	17.8	7.1	9.0	9.9	15.4	8.7	8.5	9.4	7.4	8.5	10.6	7.7	15.1	9.9	11.0	11.2	16.3	10.9	8.8	11.6	8.8	14.7	7.9	10.7	8.9	10.4	11.3	16.1	12.0	8.8	9.7	19.2	18.2	4.8	10.4	10.6	14.8	9.7	9.6	11.8	7.1	8.3	10.5	11.1	19.5	6.4	5.9	12.9	10.6	18.6	16.2	21.0	9.2	5.1	14.1	17.4	21.0	7.9	9.8	11.4	17.9	18.7	13.9	16.2	8.7	8.2	8.4	47.7	16.0	17.5	7.3	9.9	6.1	12.2	9.2	10.1	11.3	15.5	19.1	7.0	8.3	16.2	17.5	12.1	5.9	12.3	10.6	11.6	17.2	12.5	13.5	5.5	7.5	10.2	18.6	12.3	9.9	14.5	10.9	10.0	18.9	7.0	2.0	10.4	4.8	12.0	10.2	12.1	19.2	11.2	14.8	18.2	15.4	11.7	13.4	4.5	10.6	6.1	15.2	13.4	9.7	10.1	12.7	10.4	15.9	9.2	8.2	9.9	15.4	10.6	8.9
CCDC6	"D10S170, H4, PTC, TPC, TST1"	ENSG00000108091	"Coiled-coil domain containing 6"	Q16204	10	59788763-59906656	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019049, HPA019051"	Enhanced		Supported	Cytosol				Cytosol		"HPA019049: AB_1846163, HPA019051: AB_1846164"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.98e-3)"	"prognostic favourable (5.48e-4)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.95e-4)"	"unprognostic (4.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.19e-2)"	13.7	13.3	22.8	11.7	41.8	12.8	20.7	13.8	27.1	23.0	23.9	11.3	10.7	20.4	28.4	16.6	33.2	23.6	16.2	11.2	17.0	18.1	19.4	10.9	15.5	18.7	13.8	17.6	19.8	22.5	16.8	13.7	13.3	14.5	18.7	18.4	9.6	25.5	14.0	18.2	26.0	20.4	28.1	11.8	14.5	16.6	12.6	12.3	10.6	19.1	14.8	20.7	21.7	23.8	7.1	7.3	0.2	3.4	1.2	2.3	1.4	15.8	14.3	7.2	16.1	11.0	16.6	14.7	7.8	10.4	7.8	9.2	27.8	31.1	13.6	11.8	13.0	23.5	14.4	14.2	11.7	20.3	7.2	11.1	11.6	16.9	13.3	12.6	10.4	12.0	18.9	13.0	32.0	11.5	8.3	8.7	10.1	21.3	5.2	7.3	11.5	9.8	7.1	11.8	8.5	13.1	13.6	7.4	6.4	9.8	41.5	8.7	26.3	6.8	11.7	7.3	13.4	11.3	13.0	4.6	5.3	6.2	11.6	24.2	4.5	0.0	2.9	0.0	1.5	3.4	1.8	6.7	2.3	2.1	7.3	7.1	2.2	1.6	0.2	1.2	1.9	1.9	2.1	1.4	22.8	41.8	13.8	27.1	17.0	18.1	13.8	17.6	14.5	12.3
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621818	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"				"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	8.4	7.5	9.3	7.6	11.7	6.5	12.0	31.0	15.1	11.7	11.0	9.6	7.6	5.9	12.7	12.7	6.7	12.9	7.6	8.4	9.8	6.4	9.2	4.6	7.7	10.1	10.8	10.6	14.7	7.1	10.1	32.9	7.6	11.0	9.7	9.4	7.8	9.1	10.9	11.9	5.7	7.7	11.1	11.2	8.7	8.0	8.6	12.9	11.9	12.1	5.7	10.2	11.0	9.7	2.6	1.1	7.0	2.2	5.0	14.1	2.7	5.4	1.9	6.1	3.6	9.2	5.4	4.8	7.0	6.4	9.2	8.1	4.2	4.3	15.2	1.6	3.7	3.0	3.4	6.4	10.3	5.4	4.1	9.5	8.4	4.8	6.5	12.1	3.6	5.3	9.3	7.6	5.4	5.8	8.8	2.4	7.1	4.4	9.7	7.7	9.9	7.5	3.3	5.2	8.2	5.5	1.9	2.3	4.2	8.4	5.4	5.1	1.9	5.3	3.1	6.9	5.4	6.4	9.5	4.9	5.2	8.1	5.1	13.9	5.4	7.0	1.5	3.3	4.3	1.9	5.6	2.6	7.4	5.3	1.1	1.7	8.6	6.2	0.3	5.0	2.2	1.0	14.1	2.7	9.3	11.7	31.0	15.1	9.8	6.4	10.8	10.6	11.0	12.9
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842071-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 200.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (7.36e-5)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	13.5	12.4	7.3	8.6	11.0	6.1	11.2	3.3	11.2	5.8	6.7	7.9	3.4	7.4	8.4	5.0	9.3	7.4	8.3	9.3	6.7	6.4	8.1	11.4	5.4	8.2	10.0	6.0	11.3	13.6	200.8	12.7	7.3	8.5	11.9	4.7	6.7	6.4	6.2	20.2	10.4	6.2	7.3	6.7	9.3	7.7	47.8	8.7	10.2	7.9	12.6	6.5	8.6	6.5	6.9	20.0	5.0	19.5	4.2	8.5	6.7	20.9	28.6	7.1	20.4	5.7	9.5	9.7	14.1	11.0	26.0	14.0	24.3	14.1	25.7	27.0	7.6	19.7	23.9	17.0	12.0	9.0	26.4	13.1	12.7	33.9	19.1	20.4	22.4	10.9	13.0	24.0	15.2	19.2	41.7	13.2	12.7	24.8	30.6	31.1	28.6	41.1	21.0	10.6	64.6	9.0	8.9	16.0	10.3	9.1	21.0	16.5	21.2	8.2	12.5	25.9	15.9	35.1	30.5	11.2	16.5	27.8	21.2	22.1	31.3	2.6	9.1	5.0	6.5	19.5	6.9	6.9	6.9	6.0	20.0	6.5	8.5	7.4	0.7	4.2	6.3	11.2	6.2	6.7	7.3	11.0	3.3	11.2	6.7	6.4	10.0	6.0	8.5	8.7
CCDC90B	"MDS011, MDS025"	ENSG00000137500	"Coiled-coil domain containing 90B"	Q9GZT6	11	83259097-83286407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011130, HPA011931"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA011130: AB_1846170, HPA011931: AB_2072332"	"unprognostic (5.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.57e-3)"	"unprognostic (5.76e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.41e-1)"	15.8	32.0	25.0	11.1	23.3	11.6	18.0	14.3	17.9	15.4	14.5	14.6	17.2	12.1	12.6	29.3	14.3	13.5	15.2	18.2	22.3	25.6	16.4	31.3	11.0	15.0	29.9	14.9	19.4	16.6	15.2	29.5	18.3	24.5	16.3	14.9	8.4	14.5	14.8	12.2	11.6	18.2	14.9	43.9	17.1	13.6	42.2	28.3	15.5	21.6	12.3	13.5	14.8	13.0	18.5	12.7	32.6	19.0	22.5	21.1	12.4	7.3	10.9	18.6	6.0	25.3	19.1	11.4	15.0	12.9	9.5	10.2	12.7	25.5	17.9	19.7	22.2	9.4	8.2	19.2	12.7	12.5	6.5	11.0	7.4	10.6	21.3	11.1	9.6	21.3	26.0	12.2	35.1	21.5	16.3	15.3	34.4	13.0	11.2	14.3	15.4	13.6	13.0	16.7	15.4	19.6	10.9	9.1	21.0	10.5	8.5	9.8	22.0	10.4	20.6	18.6	11.7	34.8	10.1	14.9	19.5	18.2	7.5	9.0	18.3	30.8	8.9	32.6	12.3	19.0	15.6	18.5	17.9	17.0	12.7	16.9	15.5	15.5	4.5	22.5	19.0	9.3	21.1	12.4	25.0	23.3	14.3	17.9	22.3	25.6	29.9	14.9	24.5	28.3
CCDC91	"DKFZp779L1558, FLJ11088, p56"	ENSG00000123106	"Coiled-coil domain containing 91"	Q7Z6B0	12	28133249-28581511	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038169	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA038169: AB_10672506"	"unprognostic (6.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.98e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (7.69e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-1)"	14.3	16.8	16.3	14.5	20.6	9.4	14.6	14.8	22.5	11.3	12.9	10.8	14.4	10.5	16.3	16.6	14.5	11.3	13.4	26.5	16.1	19.8	18.2	13.4	11.3	13.1	18.2	17.1	16.8	22.9	23.3	26.2	10.6	32.3	14.0	11.5	11.5	14.2	15.6	32.7	9.1	11.9	21.2	21.6	13.9	14.8	36.3	15.3	23.3	22.3	9.7	11.6	21.0	16.1	6.5	4.2	16.0	5.4	7.1	8.5	3.6	10.2	7.4	6.8	0.3	7.1	6.6	12.8	8.8	9.3	7.7	9.9	5.1	13.9	5.4	7.6	10.4	11.9	6.3	14.1	11.7	15.7	5.1	17.8	14.2	4.1	11.0	16.9	8.9	6.5	14.2	7.7	22.6	6.1	16.1	18.1	7.3	3.7	16.7	14.5	14.0	7.0	10.3	19.8	9.2	12.5	7.1	5.8	10.5	16.6	5.6	26.4	10.8	13.5	4.6	16.5	11.4	16.2	5.0	22.8	24.7	14.8	14.2	13.9	9.3	16.0	2.4	3.4	5.5	4.6	7.3	6.5	7.1	7.9	3.4	5.5	8.5	7.7	0.8	7.1	5.4	4.2	8.1	3.6	16.3	20.6	14.8	22.5	16.1	19.8	18.2	17.1	32.3	15.3
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: "	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favourable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	19.3	11.1	35.2	9.4	24.6	3.8	16.3	17.0	34.5	11.4	11.7	16.4	6.0	14.4	11.8	18.6	8.9	12.6	10.6	23.6	33.6	26.5	11.5	11.0	20.1	8.2	27.2	23.0	13.0	11.8	18.3	14.9	17.3	34.2	11.2	7.8	13.6	9.0	12.9	22.3	7.7	14.2	14.2	22.4	9.4	11.1	24.0	13.0	8.0	15.3	4.9	6.6	10.7	12.7	1.7	1.3	4.6	1.3	1.3	3.7	1.8	4.0	4.5	2.3	4.0	15.2	8.4	4.1	6.8	12.9	3.8	4.1	2.4	1.2	1.9	2.4	8.5	2.8	2.5	1.7	2.6	12.6	5.9	2.5	1.6	1.5	8.1	0.4	9.7	4.7	7.8	4.8	3.0	10.6	2.5	0.9	3.4	2.7	2.4	4.4	1.0	10.1	3.1	1.3	0.5	5.2	4.2	4.4	6.3	3.3	1.7	4.6	4.8	2.2	10.5	7.7	1.7	4.9	2.3	3.2	1.7	0.6	6.1	3.4	3.2	4.6	1.3	1.9	2.3	0.7	3.7	1.6	3.0	3.5	1.0	1.7	2.3	2.8	1.2	1.3	0.1	1.3	0.5	1.8	35.2	24.6	17.0	34.5	33.6	26.5	27.2	23.0	34.2	13.0
CCDC93	FLJ10996	ENSG00000125633	"Coiled-coil domain containing 93"	Q567U6	2	117915478-118014133	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054183	Approved		Enhanced	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA054183: "	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavourable (2.97e-6)"	"unprognostic (2.51e-1)"	"unprognostic (8.12e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.52e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (9.66e-4)"	"unprognostic (2.40e-2)"	23.0	20.6	12.9	21.9	14.3	27.2	14.5	23.9	15.6	12.3	18.1	12.8	16.0	17.3	16.8	16.9	10.9	12.3	14.9	23.4	13.1	13.0	14.6	11.0	15.9	16.0	11.8	11.5	20.3	18.0	24.0	26.8	18.6	13.3	11.4	16.0	14.6	13.6	24.9	20.6	16.0	18.1	17.2	15.1	17.1	12.1	15.9	12.0	17.4	17.1	10.2	20.4	11.9	19.2	4.2	3.0	6.3	5.5	3.9	5.7	2.3	13.5	6.0	16.6	14.6	24.1	16.6	14.1	16.1	10.6	10.6	10.9	13.0	8.7	11.6	11.1	12.6	11.8	9.6	8.3	13.9	15.0	9.8	14.6	10.5	17.4	10.7	15.8	16.7	11.3	8.7	16.6	19.8	11.2	8.0	8.2	11.8	5.8	10.0	17.2	7.5	9.8	12.8	13.0	7.8	8.8	14.5	13.3	7.9	10.5	8.0	11.3	6.7	9.8	15.7	18.3	15.4	15.4	11.1	10.9	11.3	18.4	10.6	11.8	10.6	6.3	4.2	4.5	5.7	5.5	5.6	4.2	4.1	4.7	3.0	4.1	5.6	4.8	4.4	3.9	3.4	1.5	1.8	2.3	12.9	14.3	23.9	15.6	13.1	13.0	11.8	11.5	13.3	12.0
CCDC94	FLJ10374	ENSG00000105248	"Coiled-coil domain containing 94"	Q9BW85	19	4247079-4269090	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043606, HPA055675"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA043606: AB_10963431, HPA055675: AB_2682880"	"unprognostic (1.75e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.72e-1)"	"prognostic favourable (6.32e-4)"	"prognostic favourable (8.04e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.46e-3)"	18.1	14.8	16.1	14.5	17.3	50.5	14.3	22.0	20.3	15.5	16.2	18.4	15.6	17.9	17.2	14.6	16.9	16.8	12.5	12.2	16.2	13.6	18.1	16.7	14.7	20.8	20.4	17.1	23.3	24.7	12.2	10.4	23.2	15.6	15.4	10.9	16.0	19.7	14.5	21.5	19.7	15.2	13.6	17.3	18.7	16.1	16.6	20.0	18.8	20.0	26.3	18.8	14.0	12.5	24.8	19.3	22.6	19.3	16.8	25.0	13.9	17.1	16.7	9.4	7.5	5.6	7.4	9.6	7.0	8.9	13.1	14.5	14.9	10.6	20.1	8.0	10.5	13.1	15.2	16.6	9.2	11.5	15.0	12.9	10.9	17.3	8.3	16.8	18.1	7.9	10.0	11.5	17.1	10.5	18.2	23.4	5.4	23.7	17.7	10.4	22.4	12.8	10.4	7.9	17.8	12.2	17.0	13.6	14.1	6.2	13.6	12.5	9.8	15.8	11.8	9.3	9.8	18.6	17.3	25.5	18.1	19.9	13.0	17.9	9.9	15.2	15.2	22.6	21.2	19.3	18.9	23.3	20.5	19.5	18.5	24.8	24.5	20.2	9.4	16.8	13.8	19.3	25.0	13.9	16.1	17.3	22.0	20.3	16.2	13.6	20.4	17.1	15.6	20.0
CCDC97	"FLJ40267, MGC20255"	ENSG00000142039	"Coiled-coil domain containing 97"	Q96F63	19	41310189-41324883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043320, HPA043572"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043320: AB_10964344, HPA043572: AB_10962488"	"unprognostic (9.25e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"	20.4	15.3	15.5	20.7	18.8	21.5	16.8	16.1	24.7	21.3	16.7	26.7	17.8	15.1	21.3	26.6	22.9	24.5	15.8	16.4	14.6	14.1	16.5	13.3	15.4	23.2	16.0	16.2	27.4	20.6	20.8	21.9	22.9	18.6	19.0	12.6	20.9	21.1	17.2	28.8	21.5	18.4	15.6	21.0	24.2	17.3	39.9	16.8	27.7	17.9	20.4	27.2	17.7	19.7	13.6	7.6	14.6	13.3	11.5	16.8	8.3	12.9	28.4	15.1	17.5	19.9	15.9	10.9	8.7	7.1	13.9	11.9	16.8	12.5	12.3	9.4	7.2	8.8	20.6	17.4	10.6	22.6	20.0	11.3	12.8	11.0	15.2	18.7	24.5	15.4	22.4	16.1	13.5	9.5	14.4	23.7	13.2	9.4	17.0	4.5	7.0	10.3	19.3	12.0	9.0	12.7	24.7	13.5	12.0	19.5	21.5	8.5	14.7	14.3	11.3	12.0	12.1	6.2	14.4	24.4	20.8	11.9	11.4	13.8	15.9	9.0	8.3	9.7	15.3	9.2	16.8	11.3	10.3	10.9	6.8	13.6	11.4	10.0	14.6	11.5	13.3	7.6	8.5	8.3	15.5	18.8	16.1	24.7	14.6	14.1	16.0	16.2	18.6	16.8
CCHCR1	"C6orf18, HCR"	ENSG00000204536	"Coiled-coil alpha-helical rod protein 1"	Q8TD31	6	31142439-31158238	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 50.1"	"Cell line enhanced"	"Detected in many"		"A-431: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054167			Supported	Cytosol				Cytosol		"HPA054167: "	"unprognostic (6.68e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-2)"	2.4	2.7	5.6	2.8	6.2	1.2	3.1	5.2	6.4	3.7	4.5	2.9	9.1	9.4	6.3	5.6	3.9	8.0	2.9	2.5	4.0	2.7	4.3	2.9	3.0	5.5	4.1	5.6	5.5	7.6	1.7	2.5	1.5	4.5	5.3	3.2	3.4	3.5	6.8	10.1	7.0	5.9	3.9	2.6	3.4	6.6	50.1	3.8	4.3	6.2	3.1	4.2	3.4	4.0	2.0	3.4	1.4	2.1	2.5	4.3	2.3	22.3	1.7	6.3	1.0	3.9	4.6	5.9	1.9	0.6	0.3	0.7	9.0	0.4	2.9	10.7	5.0	0.9	0.3	9.0	0.9	3.3	14.3	10.6	7.4	6.8	2.2	0.2	7.0	5.9	1.0	4.1	0.9	4.8	4.1	6.2	2.6	1.6	3.9	11.8	0.4	0.1	7.1	8.4	5.4	5.8	2.2	17.7	2.9	7.3	0.0	1.8	2.5	5.6	0.6	9.3	3.0	0.2	5.6	14.5	8.4	12.1	1.9	2.6	0.9	0.3	2.1	1.4	2.9	0.9	2.5	1.3	2.6	4.3	1.5	2.0	4.0	4.0	0.6	2.5	1.2	3.4	4.0	2.3	5.6	6.2	5.2	6.4	4.0	2.7	4.1	5.6	4.5	3.8
CCM2	"C7orf22, MGC4607, OSM"	ENSG00000136280	"CCM2 scaffolding protein"	Q9BSQ5	7	44999475-45076469	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020273, HPA021669, HPA065815"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: "	"unprognostic (4.30e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.92e-1)"	"unprognostic (2.65e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (5.06e-7)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.48e-1)"	16.7	18.3	31.6	20.7	52.0	11.2	8.6	21.3	36.1	9.7	12.5	13.9	8.6	10.5	7.2	7.0	10.6	8.4	9.1	13.7	29.8	23.1	7.9	31.6	12.4	30.7	29.0	14.2	8.2	17.9	16.5	11.2	11.5	17.8	7.7	8.8	6.9	13.6	12.6	27.0	13.4	10.6	13.3	14.7	20.8	11.2	10.5	11.5	37.5	7.4	8.2	23.4	15.4	12.6	14.8	7.3	32.4	13.8	17.6	50.6	11.1	14.0	15.5	9.3	18.5	17.6	15.5	6.9	17.0	14.0	12.2	16.5	11.2	14.6	19.8	13.2	21.5	18.3	5.7	22.0	8.1	22.0	11.1	8.8	12.4	7.9	15.6	3.6	23.7	17.5	14.5	21.4	9.2	22.2	10.0	16.1	24.4	21.1	17.3	48.0	10.7	17.3	9.3	5.3	16.1	12.5	13.6	18.0	14.0	13.9	11.0	7.5	12.6	16.5	16.8	16.7	14.1	16.6	16.3	28.9	22.6	40.0	16.3	13.1	20.0	27.1	10.5	31.2	17.3	12.1	11.6	13.6	20.5	18.7	7.2	14.8	19.9	14.7	32.4	17.6	13.8	7.3	50.6	11.1	31.6	52.0	21.3	36.1	29.8	23.1	29.0	14.2	17.8	11.5
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823933	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 122.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 6.8"	"Low region specificity"	"Detected in single"							"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavourable (9.17e-5)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	3.2	1.5	1.3	18.6	1.7	21.6	1.8	5.1	1.2	2.5	6.3	1.0	0.8	6.6	2.2	2.1	11.7	1.7	2.4	3.2	1.8	1.8	1.7	1.6	3.4	15.6	1.6	0.8	4.5	0.9	0.5	3.2	12.0	1.3	2.2	7.8	1.0	2.1	0.8	1.1	4.2	7.4	2.4	1.8	8.9	2.9	8.4	0.8	122.3	1.4	18.8	18.4	2.5	5.1	0.3	0.9	0.6	0.3	1.7	6.8	1.9	38.1	9.9	27.3	11.6	1.4	3.8	22.3	26.6	11.7	35.5	26.4	21.6	23.7	35.1	7.2	14.0	12.9	34.3	15.7	29.2	16.8	15.8	28.2	13.2	21.0	0.3	42.4	20.0	0.9	1.2	14.6	8.8	21.2	40.0	35.3	28.1	13.7	54.0	24.6	21.5	11.1	24.8	52.8	17.1	10.0	7.6	11.6	12.3	14.0	17.1	7.4	14.3	18.0	12.4	16.6	25.2	17.5	25.4	22.4	23.7	40.2	9.5	43.2	18.4	0.0	0.3	0.6	0.2	0.1	0.1	0.3	2.0	1.4	0.9	0.1	0.0	0.5	0.3	1.7	0.3	0.1	6.8	1.9	1.3	1.7	5.1	1.2	1.8	1.8	1.6	0.8	1.3	0.8
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167010-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 71.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: , HPA061448: "	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.54e-7)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	3.2	4.6	2.7	23.9	4.8	20.5	4.6	6.5	5.6	4.4	9.9	1.6	1.6	9.3	3.5	2.8	28.8	3.3	3.5	1.9	3.5	4.2	4.6	2.9	3.4	23.6	4.0	4.2	3.7	4.0	1.6	2.6	12.1	11.5	2.6	14.2	1.7	5.3	1.7	2.0	6.4	8.7	6.4	2.5	9.1	7.1	21.7	1.3	71.4	6.3	23.3	30.1	5.3	7.5	13.2	5.1	2.4	4.1	6.5	14.7	5.5	58.7	40.7	55.8	49.6	2.9	5.0	131.9	26.0	19.5	68.7	58.1	60.1	55.4	36.1	31.7	24.0	37.1	56.1	56.9	77.1	35.4	27.8	22.9	33.9	41.4	0.9	19.9	26.2	2.2	3.6	39.4	27.5	36.6	27.7	28.7	55.9	55.9	27.3	23.8	31.1	25.8	28.7	40.3	37.0	25.1	21.7	28.4	17.9	44.8	21.1	19.3	40.3	20.9	15.4	15.3	49.8	27.6	65.0	14.4	26.6	50.4	21.2	35.0	47.0	2.4	1.8	1.2	2.8	4.1	4.0	13.2	7.6	6.7	5.1	8.6	2.5	2.4	1.0	6.5	1.9	4.2	14.7	5.5	2.7	4.8	6.5	5.6	3.5	4.2	4.0	4.2	11.5	1.3
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105078-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.2;testis: 73.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"T-reg: 17.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (2.83e-4)"	"prognostic unfavourable (4.63e-4)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	2.0	1.1	0.4	21.0	0.4	24.7	2.5	0.3	0.6	1.8	5.5	0.5	0.2	5.2	1.0	1.5	11.3	0.5	1.6	1.2	0.4	0.4	1.0	1.0	1.9	12.0	0.4	0.3	0.8	0.7	0.0	0.4	6.7	0.4	1.1	6.3	0.4	2.1	0.6	0.4	3.6	5.1	2.0	1.3	5.2	3.0	73.9	0.2	70.2	0.8	10.3	16.0	1.8	3.4	1.8	2.3	0.7	0.1	3.0	17.8	1.8	28.4	25.1	41.3	10.2	1.8	3.8	21.9	23.6	15.2	36.6	30.1	40.6	17.6	26.5	17.1	15.2	35.2	39.0	20.1	34.6	27.5	20.9	34.3	29.4	23.0	0.5	25.5	22.1	1.4	2.7	15.7	20.1	24.8	34.6	42.6	27.6	20.7	29.1	37.2	30.5	14.9	34.0	58.4	26.9	11.5	20.2	25.7	17.4	32.4	17.6	21.3	30.5	25.5	12.9	18.2	31.0	20.1	44.9	19.0	28.4	47.1	11.9	58.4	25.7	0.0	0.1	0.6	0.1	0.0	0.2	1.8	3.9	4.1	2.3	0.9	0.0	0.1	0.7	3.0	0.0	0.1	17.8	1.8	0.4	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.2
CCNB3		ENSG00000147082	"Cyclin B3"	Q8WWL7	X	50202713-50351910	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.1;epididymis: 11.6;pituitary gland: 3.7;testis: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;Karpas-707: 3.9;U-2 OS: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA000496			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA000496: AB_1078605"	"unprognostic (1.57e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.48e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.63e-2)"	0.7	0.7	0.9	0.3	3.5	0.2	0.8	0.4	1.7	0.4	0.4	5.8	0.0	0.4	0.3	11.6	0.4	0.7	0.6	0.6	1.3	1.5	0.7	1.1	0.7	0.4	2.4	2.0	0.4	0.9	0.7	3.7	0.9	4.3	0.5	0.4	0.0	0.5	0.8	1.4	1.0	0.3	0.3	6.1	0.6	1.0	14.8	1.3	0.1	0.9	1.1	0.5	0.4	0.2	0.3	0.3	0.0	0.5	0.0	2.2	0.1	0.4	1.5	0.8	0.5	0.2	0.2	0.0	0.1	0.3	0.3	0.4	1.2	4.8	1.4	1.0	0.3	0.2	0.7	0.5	0.3	1.2	1.6	1.0	0.0	0.0	1.3	1.1	1.0	0.8	0.2	0.3	0.9	0.5	0.2	3.9	1.2	0.0	0.6	0.2	0.7	0.1	0.0	1.7	0.1	0.2	0.5	0.1	0.9	0.4	0.2	1.0	3.4	0.3	0.4	2.0	3.5	0.9	0.6	1.0	0.7	2.1	0.6	0.4	0.3	0.0	0.0	0.0	2.2	0.5	0.3	0.3	0.5	0.0	0.3	0.3	0.4	1.0	0.0	0.0	0.3	0.0	0.1	0.1	0.9	3.5	0.4	1.7	1.3	1.5	2.4	2.0	4.3	1.3
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542380-99568973	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: "	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favourable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	18.0	21.1	14.5	16.8	20.4	13.7	23.8	23.2	24.3	15.6	17.3	8.7	21.8	19.8	13.5	28.1	26.5	11.7	24.7	12.0	14.9	16.9	31.5	47.4	16.2	23.4	13.6	12.6	13.5	35.6	20.8	31.8	24.4	17.6	18.2	15.9	12.4	37.0	20.9	13.1	15.4	22.6	17.3	12.1	21.1	20.2	8.6	10.0	27.3	30.7	16.8	21.9	17.5	15.5	20.1	15.0	21.5	13.9	17.7	26.6	18.8	26.8	8.0	15.4	30.0	11.5	15.8	38.7	19.5	23.5	23.7	30.3	30.7	15.8	52.6	21.0	16.1	17.5	23.5	26.4	37.5	13.2	25.3	32.6	13.4	26.8	20.9	36.4	10.7	15.6	16.1	16.7	21.0	23.5	44.2	19.7	20.7	13.6	13.3	26.9	20.6	13.3	22.8	25.9	20.9	30.6	30.4	23.1	14.1	9.8	22.2	22.7	13.0	34.9	18.7	13.0	17.4	13.6	28.6	14.0	21.4	45.2	22.0	26.0	16.0	21.5	12.9	10.7	14.2	13.9	26.6	20.1	17.9	14.5	15.0	16.0	20.1	15.7	2.5	17.7	10.4	15.0	18.0	18.8	14.5	20.4	23.2	24.3	14.9	16.9	13.6	12.6	17.6	10.0
CCND1	"BCL1, D11S287E, PRAD1, U21B31"	ENSG00000110092	"Cyclin D1"	P24385	11	69641087-69654474	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation"	"Cyclin, Repressor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 94.3;WM-115: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.0;myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000024, HPA027802"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB000024: AB_563678, HPA027802: "	"unprognostic (4.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (5.51e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.57e-1)"	52.0	11.6	9.7	6.0	9.7	0.7	22.8	3.4	7.7	15.4	8.9	15.4	19.9	8.4	18.8	23.1	37.7	11.8	31.0	23.9	10.8	8.8	14.5	68.1	22.2	3.7	12.4	5.6	6.5	31.5	83.2	16.6	38.1	10.0	30.7	6.8	24.8	25.6	21.7	2.0	43.6	10.4	16.5	12.6	12.9	19.2	4.0	7.5	9.0	17.1	23.1	23.6	21.4	22.1	3.0	3.4	0.8	0.0	0.0	0.9	0.3	47.6	19.1	6.3	0.1	19.6	20.7	13.7	75.6	28.1	8.8	5.2	21.4	37.0	0.0	34.3	39.3	34.9	0.6	20.5	15.9	0.1	3.8	0.0	4.7	21.7	4.7	0.3	0.7	11.7	4.0	12.4	4.8	15.1	0.0	0.1	69.5	20.2	0.0	2.7	11.6	21.1	0.1	20.2	1.1	41.0	29.5	1.0	25.0	0.9	17.9	47.0	10.9	0.9	63.0	43.4	12.1	18.8	51.3	94.3	56.3	0.1	37.1	0.6	131.3	0.8	0.0	0.0	0.9	0.0	0.1	3.0	0.4	0.2	3.4	2.5	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.3	9.7	9.7	3.4	7.7	10.8	8.8	12.4	5.6	10.0	7.5
CCND2		ENSG00000118971	"Cyclin D2"	P30279	12	4273772-4305350	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 32.3;HBEC3-KT: 29.5;HDLM-2: 49.7;Karpas-707: 71.7;RH-30: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049138, HPA054196"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA049138: , HPA054196: "	"unprognostic (2.98e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-2)"	"prognostic favourable (2.52e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.52e-1)"	"prognostic favourable (9.76e-5)"	"unprognostic (7.06e-2)"	13.7	39.3	20.8	12.0	15.9	23.6	10.4	6.1	22.3	14.4	28.3	8.1	24.3	18.5	21.9	41.9	12.2	16.5	9.1	36.9	17.5	7.3	6.0	5.7	12.8	24.5	7.9	17.0	11.6	18.4	8.3	19.2	23.5	9.3	16.4	24.2	14.1	8.3	22.4	2.0	9.2	19.6	45.5	14.0	16.5	11.1	5.2	8.6	6.2	18.5	6.9	13.6	22.3	16.3	3.9	2.1	4.6	1.0	9.1	14.8	5.4	0.0	0.0	32.3	0.0	5.6	0.8	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.2	0.0	4.1	0.9	29.5	0.0	49.7	0.8	0.3	0.0	0.2	0.1	12.6	2.7	10.8	4.9	0.0	22.3	0.0	3.4	71.7	6.2	0.0	0.0	16.6	13.3	0.0	0.0	46.9	23.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	9.4	0.0	0.0	1.2	12.1	0.0	0.1	9.1	0.0	4.1	1.0	4.6	9.1	0.2	13.7	3.9	13.0	11.0	2.1	1.5	8.2	9.8	1.5	9.1	0.1	1.0	14.8	5.4	20.8	15.9	6.1	22.3	17.5	7.3	7.9	17.0	9.3	8.6
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934933-42050357	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 129.2;lymphoid tissue: 142.5"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 92.5;REH: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA071369"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB000116: , HPA071369: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (8.08e-6)"	"unprognostic (2.11e-1)"	20.2	39.8	16.1	28.9	17.5	74.7	36.0	13.3	19.8	13.3	17.3	11.3	14.1	16.0	10.8	10.4	13.5	13.4	19.0	16.3	15.4	14.5	13.7	8.0	32.1	83.8	14.1	15.5	11.1	10.9	5.0	10.1	21.9	9.3	14.2	11.4	10.2	18.1	14.4	6.5	14.6	22.0	11.7	11.5	51.2	18.0	7.4	10.0	142.5	26.8	9.3	32.8	13.0	16.6	24.1	42.4	129.2	45.8	39.0	52.8	66.2	9.0	33.1	3.5	7.7	6.3	12.9	40.2	10.6	6.1	11.0	8.1	6.2	4.1	39.0	18.0	7.1	5.6	9.2	13.0	5.7	6.6	6.0	61.8	14.8	5.0	13.9	10.1	54.6	12.3	8.5	10.6	4.0	13.5	31.1	3.8	15.7	12.2	92.5	48.5	1.5	7.1	87.9	13.5	4.3	25.4	6.1	11.8	3.1	9.0	11.6	5.2	7.1	39.5	22.5	12.2	6.7	10.6	11.9	2.5	1.9	60.9	7.1	21.3	7.4	129.2	30.5	87.7	52.8	35.1	37.0	16.4	36.4	42.5	42.4	24.1	42.8	45.0	42.8	39.0	45.8	27.8	23.2	66.2	16.1	17.5	13.3	19.8	15.4	14.5	14.1	15.5	9.3	10.0
CCNDBP1	"DIP1, GCIP, HHM"	ENSG00000166946	"Cyclin D1 binding protein 1"	O95273	15	43185118-43197176	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.4"	"Cell line enriched"	"Detected in many"	8	"HEL: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020664, HPA041065"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB020664: , HPA041065: "	"unprognostic (4.48e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.68e-2)"	15.6	10.9	3.4	12.6	5.3	55.4	17.5	10.8	9.5	8.8	9.4	5.6	11.5	7.6	11.3	10.7	18.3	10.4	9.6	14.1	3.9	6.9	8.2	8.4	11.6	23.6	6.1	5.6	5.6	13.4	5.2	9.6	24.1	9.3	8.8	9.0	7.7	11.3	12.8	21.1	12.0	12.9	8.2	6.0	12.8	11.8	5.9	5.4	8.3	15.6	5.9	11.0	15.9	11.7	5.4	2.9	16.9	8.0	4.6	7.6	1.6	0.3	0.3	0.6	0.3	1.6	1.1	0.6	0.4	2.0	0.4	0.4	0.5	0.4	0.6	0.5	1.3	0.6	1.4	0.6	0.2	0.9	1.4	16.6	0.8	0.6	1.2	0.8	1.0	1.9	1.6	0.2	0.6	1.2	1.0	0.6	0.5	0.0	0.5	1.9	1.2	0.4	0.5	0.6	1.4	2.1	0.7	0.8	1.3	0.6	0.5	0.4	0.1	1.6	1.6	0.5	0.2	1.2	0.3	1.9	0.7	0.3	1.7	1.8	0.5	16.9	1.9	4.9	5.2	3.3	5.4	4.4	5.6	5.1	1.6	5.4	5.9	6.1	6.1	4.6	8.0	2.9	7.6	1.6	3.4	5.3	10.8	9.5	3.9	6.9	6.1	5.6	9.3	5.4
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811898-29824308	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;placenta: 46.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavourable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.6	6.8	2.4	4.5	2.9	23.3	0.6	6.3	3.3	0.8	3.0	1.7	1.1	2.3	1.2	0.6	4.7	0.7	2.2	4.4	2.3	2.8	1.2	0.7	1.1	4.6	1.9	1.9	0.9	1.4	1.7	1.0	46.7	2.8	1.1	3.8	1.5	3.2	1.2	2.2	4.4	2.5	3.0	1.7	4.6	2.0	12.3	1.6	4.1	1.6	2.1	5.9	2.7	2.5	2.7	1.6	1.6	1.9	0.0	1.4	0.5	4.0	8.4	6.5	9.2	1.4	1.6	79.9	6.5	1.4	2.9	3.5	8.5	8.2	3.4	15.3	2.8	1.2	7.6	3.3	4.1	10.8	4.7	2.9	8.2	8.9	1.1	11.3	7.7	1.6	1.8	3.9	0.5	3.5	11.6	1.5	4.3	6.0	6.2	3.2	10.8	2.0	9.3	7.6	2.6	2.2	6.5	5.5	4.6	9.3	11.5	1.0	2.5	8.4	2.0	6.7	25.4	4.0	4.3	6.5	4.5	23.4	3.8	1.4	3.6	0.0	0.1	0.0	0.6	1.9	1.1	2.7	0.5	0.4	1.6	0.2	0.1	0.9	1.6	0.0	1.9	0.0	1.4	0.5	2.4	2.9	6.3	3.3	2.3	2.8	1.9	1.9	2.8	1.6
CCNF	"FBX1, FBXO1"	ENSG00000162063	"Cyclin F"	P41002	16	2429394-2458854	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060596, HPA070495, HPA071600"	Enhanced		Supported	Centrosome				Centrosome		"HPA060596: , HPA070495: AB_2686273, HPA071600: AB_2686424"	"unprognostic (3.87e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (7.46e-7)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.58e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-1)"	2.1	1.8	4.1	6.0	3.2	9.2	5.1	11.6	4.9	2.1	3.0	1.9	3.6	4.4	1.5	3.4	8.1	1.5	1.5	1.8	4.3	3.9	1.7	1.6	2.2	10.5	1.9	3.1	1.8	1.7	0.8	1.8	3.8	2.4	3.0	3.2	0.7	3.2	3.4	2.5	7.2	3.2	1.8	1.7	4.7	2.6	5.1	2.3	35.7	1.6	3.4	14.2	5.0	2.9	2.7	1.4	0.1	1.1	4.1	3.1	1.7	8.3	13.2	12.7	11.6	0.8	1.2	10.0	10.1	5.0	14.1	10.9	26.3	10.3	17.7	3.4	5.7	14.3	21.1	7.8	6.8	12.5	10.0	19.4	13.7	8.0	1.0	12.7	12.7	0.8	1.0	10.0	4.8	10.5	20.6	11.6	7.1	18.2	18.5	8.4	12.6	6.1	31.0	15.0	15.8	3.9	3.7	12.4	7.0	15.1	13.2	2.7	14.0	6.5	7.2	7.8	20.3	5.5	10.5	7.1	8.5	30.6	2.2	12.7	10.6	0.0	1.1	0.0	2.8	0.6	1.7	2.7	1.5	3.1	0.5	2.6	1.2	1.7	0.1	4.1	0.9	1.4	2.2	1.7	4.1	3.2	11.6	4.9	4.3	3.9	1.9	3.1	2.4	2.3
CCNG1	CCNG	ENSG00000113328	"Cyclin G1"	P51959	5	163437569-163446151	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB000350	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB000350: "	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (7.00e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.89e-2)"	32.3	24.8	11.1	16.0	14.6	9.6	20.5	9.0	9.7	27.9	43.5	11.0	14.1	41.4	22.3	23.6	24.7	19.4	25.8	29.8	11.5	10.3	40.4	46.6	20.7	26.0	22.5	9.1	44.1	42.5	13.5	12.6	17.9	17.0	39.3	26.9	12.6	25.6	18.1	51.7	10.2	68.7	35.8	27.1	22.7	24.6	17.0	15.8	26.5	38.3	29.7	15.6	48.1	21.4	23.2	23.3	15.9	14.0	15.4	36.5	22.8	9.5	10.7	44.6	25.0	38.6	74.4	47.0	13.2	32.4	13.5	30.5	23.1	19.5	23.4	13.5	17.6	3.9	24.6	33.0	19.9	11.2	31.1	18.5	14.2	40.1	42.2	8.5	12.5	80.7	19.1	13.3	13.7	43.2	15.8	16.7	45.6	5.9	14.9	11.5	20.4	9.7	13.0	21.9	12.9	32.7	37.0	10.6	12.0	0.0	5.5	26.9	20.9	27.4	25.1	8.7	18.8	7.3	11.5	14.9	5.8	15.8	15.5	14.4	14.5	15.9	10.3	11.8	15.1	14.0	22.3	23.2	26.6	20.6	23.3	14.5	36.5	29.8	4.2	15.4	13.0	8.9	31.3	22.8	11.1	14.6	9.0	9.7	11.5	10.3	22.5	9.1	17.0	15.8
CCNH	"CycH, p34, p37"	ENSG00000134480	"Cyclin H"	P51946	5	87318416-87413019	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019416, HPA044138"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB019416: AB_2259936, HPA044138: "	"unprognostic (5.65e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.01e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.93e-2)"	"unprognostic (6.43e-2)"	"unprognostic (8.79e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavourable (3.92e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.62e-2)"	32.4	25.8	18.7	16.1	25.2	28.9	25.5	40.9	29.9	16.3	14.7	19.2	16.9	16.0	15.5	23.7	17.4	14.9	23.2	20.3	23.4	19.4	22.6	33.8	21.7	19.6	20.8	21.4	24.3	21.0	24.3	32.5	14.8	27.3	25.3	19.0	16.6	17.9	20.5	24.4	13.7	18.8	15.7	22.1	17.2	16.3	46.9	22.3	28.4	25.7	13.9	23.6	19.7	16.4	19.9	23.1	33.5	25.7	16.7	22.8	19.0	19.4	9.3	9.2	6.1	13.4	9.5	9.4	14.1	18.4	25.0	34.8	15.7	11.0	13.2	4.9	21.9	9.9	11.5	22.9	23.6	14.5	14.6	23.5	16.7	15.2	24.2	18.8	19.1	13.2	8.6	13.1	31.8	21.9	15.5	22.5	20.7	11.6	13.2	15.6	3.7	36.3	11.0	21.4	19.4	21.0	10.5	9.2	5.8	7.8	7.0	17.0	17.1	14.8	15.0	24.4	9.4	14.1	12.4	7.2	6.8	19.7	15.7	17.8	10.8	20.1	21.8	33.5	15.3	24.9	22.7	19.9	20.3	20.6	23.1	16.6	21.0	20.1	18.2	16.7	25.7	13.7	22.8	19.0	18.7	25.2	40.9	29.9	23.4	19.4	20.8	21.4	27.3	22.3
CCNK	CPR4	ENSG00000090061	"Cyclin K"	O75909	14	99481169-99535044	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Cyclin	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000645, HPA077073"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA000645: AB_1078606, HPA077073: "	"unprognostic (8.07e-2)"	"unprognostic (9.32e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"unprognostic (9.22e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.78e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.21e-2)"	21.9	18.4	16.1	20.3	20.6	70.4	16.9	25.0	17.6	20.4	21.0	26.2	15.3	20.4	20.2	16.6	25.2	18.6	15.8	18.4	17.0	13.2	18.7	16.5	21.5	21.4	18.9	11.0	26.0	16.9	12.6	28.7	21.0	16.7	16.2	23.2	20.6	21.6	16.2	36.3	20.6	22.5	16.9	19.0	23.1	20.1	50.5	22.4	35.9	19.1	21.0	29.7	21.0	18.5	6.8	6.0	15.6	7.0	6.0	9.3	3.9	16.1	18.1	18.7	15.6	15.2	16.0	34.4	21.5	19.3	22.4	26.1	26.2	21.5	25.4	15.0	23.1	18.4	19.9	27.6	31.6	24.8	10.4	23.5	12.3	22.5	20.1	33.1	26.9	17.2	21.5	22.3	25.8	16.8	21.3	22.7	19.4	34.6	25.4	13.3	18.4	16.2	22.9	25.1	13.4	12.5	30.9	15.4	11.5	19.2	9.9	8.9	27.2	15.0	20.4	8.1	13.0	70.7	19.2	19.4	25.2	31.1	20.8	15.4	16.5	5.8	6.5	13.9	9.3	7.0	8.1	6.8	7.2	8.0	5.6	6.6	8.4	7.6	15.6	6.0	6.8	6.0	7.3	3.9	16.1	20.6	25.0	17.6	17.0	13.2	18.9	11.0	16.7	22.4
CCNL1	ania-6a	ENSG00000163660	"Cyclin L1"	Q9UK58	3	157146508-157160760	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057911			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"		"HPA057911: "	"unprognostic (1.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-3)"	"unprognostic (7.50e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (1.01e-6)"	"unprognostic (3.71e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.62e-2)"	"prognostic favourable (6.96e-7)"	32.0	23.2	12.4	36.1	18.7	60.9	26.5	17.1	15.0	16.8	24.3	13.6	17.0	19.8	15.2	20.0	16.7	21.5	25.8	15.6	11.7	8.7	20.4	29.5	23.2	20.6	20.9	9.8	23.3	24.2	13.5	25.3	17.5	18.7	18.0	10.4	15.9	14.9	26.5	16.1	18.5	28.0	19.2	24.6	27.7	19.8	8.6	18.0	25.9	18.5	17.7	20.8	20.2	22.4	12.3	11.3	24.0	8.5	13.1	15.0	6.7	13.1	8.6	11.6	8.5	11.9	7.9	12.1	8.4	9.8	10.0	9.2	14.9	10.3	14.9	7.6	6.2	11.2	8.8	10.0	9.1	13.1	10.8	9.9	9.2	12.4	9.8	6.5	5.6	9.4	18.4	9.5	12.6	7.8	6.3	8.8	7.2	10.9	11.9	11.9	10.4	10.4	11.3	10.3	21.4	6.3	8.0	6.8	12.8	7.0	6.0	16.7	6.1	17.8	6.5	9.2	5.4	10.1	10.8	18.3	15.0	18.9	9.4	9.1	8.7	4.3	8.5	12.5	11.6	7.1	12.2	11.2	10.8	11.9	10.6	12.3	15.0	12.1	24.0	13.1	8.2	11.3	11.9	6.7	12.4	18.7	17.1	15.0	11.7	8.7	20.9	9.8	18.7	18.0
CCNL2	"ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138"	ENSG00000221978	"Cyclin L2"	Q96S94	1	1385711-1399328	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053137	Supported		Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA053137: "	"unprognostic (3.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (4.61e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.71e-1)"	"prognostic favourable (1.46e-7)"	22.2	28.4	26.7	22.2	34.5	22.9	26.7	56.3	32.5	29.1	23.8	28.2	27.9	26.7	33.9	24.0	24.1	30.1	26.4	18.7	30.3	10.7	24.5	35.5	22.6	22.8	38.6	27.1	40.7	36.6	30.9	32.1	26.3	26.9	27.9	16.6	24.1	27.5	29.4	23.4	33.4	27.4	28.2	27.7	27.9	26.8	11.1	32.9	19.5	33.5	16.1	23.3	30.2	28.8	14.9	13.7	14.3	12.4	13.7	14.6	4.9	10.7	11.0	29.0	12.9	16.3	25.4	14.7	25.4	12.9	12.5	12.5	13.9	22.7	13.1	14.8	16.0	26.0	11.7	15.9	9.3	8.0	28.2	14.5	46.6	18.2	19.2	9.6	17.2	31.7	11.5	12.6	18.7	13.7	17.0	12.6	14.4	12.4	10.3	29.0	10.6	19.9	20.5	7.6	15.0	21.4	13.7	18.7	24.4	16.1	24.9	14.5	19.1	14.5	23.7	28.3	13.7	12.5	9.9	24.2	5.1	21.9	15.3	20.4	7.7	10.4	12.4	14.3	13.1	10.0	10.3	12.7	12.1	14.6	13.7	14.9	13.3	11.9	10.8	13.7	11.8	13.3	6.8	4.9	26.7	34.5	56.3	32.5	30.3	10.7	38.6	27.1	26.9	32.9
CCNT1	"CCNT, CYCT1, HIVE1"	ENSG00000129315	"Cyclin T1"	O60563	12	48688458-48716998	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004892, CAB009016"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009016: AB_2073888, HPA004892: AB_1078607"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.78e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.92e-1)"	16.6	14.9	13.1	12.9	17.4	38.1	15.7	20.9	17.7	13.4	12.6	16.5	10.9	9.9	19.9	13.0	13.8	15.8	10.5	11.8	13.5	8.5	13.0	14.1	15.6	14.9	14.3	13.2	21.5	15.9	18.4	19.6	18.5	14.5	12.8	12.4	12.8	12.6	11.2	18.8	16.4	14.6	13.3	12.1	16.8	13.8	22.6	15.7	22.4	16.5	10.9	15.9	15.3	13.2	5.5	4.4	14.8	2.8	3.7	4.9	0.9	7.5	10.5	10.3	10.3	8.3	9.7	12.6	10.2	8.0	7.7	6.3	13.0	9.3	20.6	13.4	6.5	9.5	16.6	7.2	11.5	11.4	10.6	21.4	16.9	5.9	9.8	23.5	10.9	7.7	10.8	9.7	13.3	6.4	20.5	8.9	9.3	4.8	10.9	11.0	11.3	8.6	10.7	16.6	8.8	7.7	13.9	11.0	12.6	15.6	8.5	12.4	11.3	13.6	6.5	8.9	9.1	6.3	8.9	13.8	18.5	18.4	10.1	33.6	5.1	6.8	2.8	7.9	3.6	1.8	4.9	4.3	3.1	3.5	1.7	5.5	4.5	4.0	14.8	3.7	2.0	4.4	1.8	0.9	13.1	17.4	20.9	17.7	13.5	8.5	14.3	13.2	14.5	15.7
CCP110	"CP110, KIAA0419"	ENSG00000103540	"Centriolar coiled-coil protein 110"	O43303	16	19523811-19553408	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039402	Approved		Supported	Centrosome				Centrosome		"HPA039402: AB_10671041"	"unprognostic (2.83e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.37e-1)"	5.2	5.9	19.0	6.0	39.1	12.6	9.0	19.1	28.4	7.6	4.5	13.2	4.6	3.7	8.9	7.3	6.4	13.0	5.7	4.4	23.6	15.0	4.5	3.4	8.1	7.1	40.0	13.3	10.6	3.7	9.6	17.2	4.6	20.6	7.3	5.5	2.1	4.8	7.1	4.3	5.5	4.5	7.6	16.0	5.8	6.1	31.6	36.6	10.9	6.9	1.9	7.1	5.7	6.6	4.5	4.0	13.0	5.3	2.3	5.6	2.5	11.2	5.2	12.9	12.5	6.5	5.8	6.7	12.0	7.0	10.7	12.1	4.2	6.0	16.5	7.6	5.9	7.9	13.2	3.8	18.1	7.5	6.0	8.2	7.2	7.2	3.2	21.1	10.6	2.8	5.3	12.0	7.4	8.2	8.6	8.3	12.5	8.7	21.6	8.2	9.9	3.9	27.6	24.1	5.8	4.9	4.7	25.5	12.9	13.0	6.2	3.9	11.3	12.9	4.8	12.5	8.3	8.4	9.8	9.3	8.6	12.0	8.0	9.1	7.3	13.0	3.8	6.7	5.5	3.6	3.5	3.3	4.9	5.2	4.0	4.5	5.6	3.2	7.7	2.3	5.3	2.6	3.9	2.5	19.0	39.1	19.1	28.4	23.6	15.0	40.0	13.3	20.6	36.6
CCR10	GPR2	ENSG00000184451	"C-C motif chemokine receptor 10"	P46092	17	42678889-42683917	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.6;RPMI-8226: 6.2;U-266/70: 17.7;U-266/84: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 31.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.9;T-cells: 31.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011684, HPA048007, HPA069188"	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB011684: AB_731502, HPA048007: , HPA069188: "	"unprognostic (3.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.18e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-11)"	"unprognostic (2.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-1)"	10.0	5.4	5.7	4.8	5.3	0.7	3.0	7.3	7.3	3.9	9.7	0.9	1.5	5.1	5.8	1.4	1.5	4.5	1.5	2.5	3.5	5.0	1.6	0.5	2.2	12.5	1.9	5.0	5.2	2.6	0.4	14.0	2.3	4.1	2.1	1.0	1.1	4.0	2.0	9.1	1.1	8.7	1.8	4.4	4.3	5.0	2.2	1.2	0.5	1.5	0.3	3.6	1.0	2.0	2.3	10.9	0.1	0.3	0.0	31.1	0.7	0.5	0.8	1.1	4.9	0.3	0.8	1.1	2.4	0.5	0.2	0.4	0.7	0.3	0.1	0.3	0.3	0.9	0.0	0.1	0.1	2.3	1.2	0.0	3.1	0.4	0.7	0.0	0.3	0.8	0.0	0.4	0.0	0.1	2.6	8.6	0.0	0.3	0.1	2.3	0.6	1.2	0.6	0.2	6.2	1.1	0.0	0.8	1.1	0.7	0.0	0.2	0.8	0.9	2.4	2.9	0.6	0.9	0.3	17.7	8.0	2.5	1.4	0.7	0.9	0.0	0.3	0.1	0.2	0.0	0.1	2.3	5.2	2.6	0.2	2.1	0.6	0.8	0.0	0.0	0.1	10.9	31.1	0.7	5.7	5.3	7.3	7.3	3.5	5.0	1.9	5.0	4.1	1.2
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951574-32956349	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 28.9;lymphoid tissue: 57.1"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 65.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 28.9"	"Lineage enriched"	"Detected in single"	48	"T-cells: 28.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031613	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.63e-3)"	"unprognostic (8.70e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.59e-7)"	"unprognostic (3.02e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.40e-1)"	1.5	0.6	0.3	12.6	0.4	1.5	1.1	0.3	0.3	1.1	1.1	0.1	0.7	0.4	1.0	0.6	1.6	0.8	3.8	0.8	0.3	0.3	1.8	0.9	6.0	24.1	0.3	0.0	0.5	0.5	0.5	0.5	0.1	0.1	1.5	1.2	0.8	4.3	0.2	1.8	2.2	5.0	0.4	0.4	10.2	1.3	2.7	0.0	57.1	1.3	2.8	29.7	8.6	1.1	0.2	0.2	0.5	0.1	0.1	28.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	65.5	0.0	3.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.2	0.1	0.2	0.1	6.0	1.8	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.2	28.9	0.8	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	0.1	0.0
CCT2	Cctb	ENSG00000166226	"Chaperonin containing TCP1 subunit 2"	P78371	12	69585334-69601570	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003197, HPA003198"	Enhanced		Supported	Cytosol			9100000	Cytosol		"HPA003197: AB_1078425, HPA003198: AB_1078424"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-2)"	"prognostic unfavourable (8.38e-4)"	"prognostic unfavourable (3.61e-9)"	"unprognostic (5.28e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (6.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.21e-2)"	29.4	32.1	25.7	28.3	31.4	45.8	33.8	39.2	37.0	25.0	27.0	23.1	21.0	20.7	27.8	18.0	32.1	28.0	21.9	30.8	25.0	29.9	46.0	39.7	22.5	33.6	24.7	22.2	30.7	28.6	29.1	28.2	29.5	45.3	27.5	34.8	19.6	21.6	22.1	46.6	22.6	22.2	32.8	23.1	33.3	25.1	81.7	20.3	55.7	34.8	41.2	40.5	31.4	32.0	29.7	28.2	10.3	25.3	23.2	29.5	24.5	37.9	59.1	52.7	50.3	24.4	27.7	60.2	41.4	30.5	68.2	42.2	79.4	18.5	83.6	40.2	33.5	37.5	82.0	47.3	83.5	45.9	60.2	60.8	46.3	48.8	27.3	74.6	39.4	24.2	30.3	65.8	38.7	45.0	73.7	25.0	62.7	56.0	69.6	65.1	73.5	61.3	56.2	57.4	55.4	56.9	71.2	50.9	43.3	43.1	48.1	42.5	62.1	55.7	28.9	35.9	43.8	42.0	62.1	30.4	57.3	88.2	31.2	52.5	43.6	10.3	15.4	4.4	19.1	25.3	29.5	29.7	22.4	24.9	28.2	24.2	26.6	27.9	1.5	23.2	22.0	25.8	23.8	24.5	25.7	31.4	39.2	37.0	25.0	29.9	24.7	22.2	45.3	20.3
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Supported	"Plasma membrane,Cytosol"			4000000	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	38.8	68.8	37.6	41.8	43.2	26.9	51.2	54.5	51.4	35.1	42.1	46.2	33.8	37.9	50.4	34.8	56.1	52.2	29.2	41.5	36.7	41.6	60.8	61.9	30.9	48.1	43.5	32.8	53.0	59.0	56.7	55.9	39.2	43.0	38.1	50.0	35.3	34.4	41.4	66.4	38.2	39.5	59.7	41.2	41.6	41.9	49.8	47.6	62.1	60.0	49.9	60.7	44.8	82.4	34.8	39.3	14.2	30.5	30.8	45.1	43.9	50.2	57.4	39.2	37.5	43.5	32.4	51.1	47.1	37.4	74.5	45.8	56.8	46.7	83.1	54.8	39.4	47.4	124.0	61.2	63.7	44.5	78.0	52.7	46.7	44.8	32.1	65.1	44.4	41.1	36.7	66.8	62.3	63.0	90.4	30.0	44.2	46.8	85.7	40.0	79.3	83.2	69.0	39.7	89.9	54.6	31.8	53.1	54.8	43.3	76.4	41.9	67.6	79.8	43.5	30.3	45.2	31.7	83.8	55.9	99.2	123.6	35.3	41.6	49.1	14.2	25.3	11.2	31.2	30.5	41.6	34.1	34.7	34.2	39.3	34.8	45.1	37.8	3.6	30.8	30.2	25.5	35.5	43.9	37.6	43.2	54.5	51.4	36.7	41.6	43.5	32.8	43.0	47.6
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868089-61888804	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol			3400000	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavourable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	35.1	42.3	34.8	33.3	38.7	32.4	63.3	41.2	40.6	37.7	36.2	26.0	34.4	26.7	43.1	32.6	47.9	44.6	25.3	49.0	31.4	33.7	43.1	37.6	28.7	54.1	42.1	33.9	66.4	65.9	39.7	32.8	37.7	40.0	37.6	35.4	21.5	32.1	35.9	52.5	37.5	28.1	42.5	39.7	36.2	38.1	49.4	37.7	55.6	50.0	40.8	50.9	39.3	93.4	30.3	31.4	13.7	29.8	31.6	39.1	34.6	41.7	48.7	32.6	30.1	27.1	41.3	54.7	38.2	27.4	55.3	37.1	84.8	30.4	67.3	38.9	27.3	30.2	63.8	49.0	58.4	33.0	62.7	43.0	25.2	53.2	24.4	52.8	28.8	35.0	34.2	44.5	46.3	46.1	61.0	21.8	47.0	37.5	45.5	72.6	58.5	43.5	51.7	50.9	45.5	38.4	28.8	28.4	23.9	27.7	35.4	49.3	25.6	39.1	28.9	30.7	44.7	22.8	61.9	33.3	44.5	114.2	30.4	61.1	40.2	13.7	19.0	7.5	27.8	27.2	35.7	30.3	29.6	33.3	31.4	27.5	39.1	38.0	2.7	31.6	29.8	20.3	30.7	34.6	34.8	38.7	41.2	40.6	31.4	33.7	42.1	33.9	40.0	37.7
CCZ1	"C7orf28A, CCZ1A, CGI-43"	ENSG00000122674	"CCZ1 homolog, vacuolar protein trafficking and biogenesis associated"	P86791	7	5898725-5926550	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles				Vesicles		"HPA045114: , HPA050006: "	"unprognostic (1.91e-1)"	"unprognostic (2.97e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.10e-1)"	"unprognostic (9.25e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-1)"	17.2	33.0	19.0	16.5	22.6	25.7	27.9	19.5	28.2	15.5	15.7	15.4	10.5	16.5	18.9	15.8	23.2	15.2	16.7	23.3	19.1	17.0	15.9	21.2	17.1	32.3	17.8	23.5	13.5	39.1	25.7	17.2	15.7	19.4	15.6	19.9	13.7	28.9	13.9	33.3	19.3	18.5	16.7	18.6	18.4	16.0	36.1	12.6	19.4	17.7	23.9	20.3	19.7	15.8	3.7	7.1	10.2	10.4	9.2	16.6	2.8	47.0	18.4	25.3	32.5	26.3	24.3	17.7	18.8	22.5	18.7	20.0	8.9	24.2	28.9	10.8	28.0	25.5	17.5	20.0	20.5	12.9	26.8	14.5	22.7	16.2	26.6	29.3	17.0	24.7	24.7	13.9	13.5	33.9	33.7	22.3	27.0	28.2	19.3	38.5	47.5	25.0	27.7	25.2	23.5	15.1	28.4	24.2	43.3	18.2	36.4	19.0	26.8	37.3	25.4	19.0	49.4	22.3	29.6	17.0	28.8	34.6	12.9	39.3	41.3	10.2	4.9	8.6	5.5	7.6	5.5	3.7	7.2	7.1	7.1	2.7	4.6	5.4	4.7	9.2	10.4	4.3	16.6	2.8	19.0	22.6	19.5	28.2	19.1	17.0	17.8	23.5	19.4	12.6
CCZ1B	"C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819"	ENSG00000146574	"CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated"	P86790	7	6794134-6826770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles				Vesicles		"HPA045114: , HPA050006: "	"unprognostic (8.06e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.24e-1)"	2.5	4.5	3.6	2.1	4.4	3.2	4.2	3.8	8.4	2.7	3.5	10.7	2.1	2.6	3.5	7.0	5.7	5.3	3.5	2.6	4.0	3.6	3.0	2.4	3.4	3.7	2.9	2.1	3.0	3.3	11.8	2.6	2.7	9.1	3.0	2.5	5.2	6.6	7.0	10.6	3.4	2.7	2.1	2.7	3.0	3.2	5.4	2.1	3.0	2.5	2.1	3.5	4.3	2.6	4.3	5.6	10.5	9.5	6.1	6.6	1.8	12.8	4.7	9.3	23.1	8.3	8.2	10.3	8.0	12.1	9.8	10.8	5.3	8.5	5.4	9.6	11.5	8.8	17.5	10.1	11.1	3.2	6.2	3.8	5.7	13.2	8.6	27.2	19.3	5.4	5.4	9.3	4.9	8.4	7.2	6.3	9.7	22.1	13.0	12.2	25.9	8.7	8.1	20.0	6.7	7.2	9.6	14.5	23.2	9.0	17.6	12.0	14.4	31.2	9.2	2.7	8.7	11.3	17.2	6.4	13.1	3.9	9.0	28.5	16.6	10.5	3.8	6.5	3.8	4.6	4.5	4.3	4.5	5.6	4.8	3.9	3.2	4.2	4.8	6.1	9.5	5.6	6.6	1.8	3.6	4.4	3.8	8.4	4.0	3.6	2.9	2.1	9.1	2.1
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"parathyroid gland: 203.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 61.6;BJ hTERT+: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane"			120000000	"Plasma membrane"		"HPA008992: , HPA015723: "	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavourable (2.65e-4)"	"prognostic unfavourable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (4.68e-4)"	27.4	1.5	1.6	1.9	2.2	1.9	6.5	0.4	1.9	15.0	7.1	3.4	2.0	1.5	22.5	8.5	22.4	3.4	2.4	8.2	1.8	1.4	3.5	1.4	14.5	1.4	1.7	1.4	2.8	1.2	203.4	0.6	5.0	3.0	7.1	2.1	0.6	4.2	2.2	4.1	12.4	2.4	12.6	4.5	1.7	1.5	3.3	2.8	6.3	1.7	16.8	4.7	8.7	8.0	0.3	2.6	1.4	0.4	0.6	0.4	0.3	9.2	8.3	0.5	0.0	12.7	61.6	0.0	8.4	37.8	2.8	6.1	0.0	5.4	0.0	5.2	17.3	26.1	0.9	16.9	3.7	2.5	1.4	3.3	6.8	1.4	2.7	0.0	0.0	16.9	13.4	5.2	21.1	20.0	0.0	0.0	12.6	0.2	0.2	0.0	0.6	5.4	0.7	2.4	11.4	1.2	1.0	0.0	0.0	19.1	0.1	8.3	0.2	1.5	18.5	26.4	3.7	4.7	7.2	0.1	5.2	0.0	10.6	0.0	23.4	0.6	0.4	0.3	0.2	0.2	0.1	0.2	0.3	0.2	2.6	0.3	0.4	0.2	1.4	0.6	0.2	1.4	0.1	0.3	1.6	2.2	0.4	1.9	1.8	1.4	1.7	1.4	3.0	2.8
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 189.4;liver: 165.8"	"Cell line enhanced"	"Detected in many"		"A549: 8.9;CACO-2: 13.6;SiHa: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 189.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 52.3;monocytes: 189.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Supported	Vesicles	"Secreted to blood"	2752500000	15000000000	Vesicles		"CAB033631: AB_781932, CAB072865: , CAB072866: , HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	27.9	44.1	9.0	42.7	25.2	9.8	11.7	3.5	8.9	5.6	10.0	6.0	1.8	5.4	5.6	24.0	4.5	12.0	14.6	18.9	11.7	7.4	12.7	165.8	23.8	34.7	21.6	2.9	14.2	5.3	4.3	10.1	37.3	18.9	8.5	9.2	14.6	28.5	5.8	10.2	3.5	12.1	21.4	18.2	35.5	6.6	6.5	17.3	2.2	7.9	5.8	6.6	15.9	3.8	0.5	23.6	52.3	189.4	0.2	0.4	124.2	0.1	8.9	0.1	0.5	1.2	0.3	0.4	0.8	4.1	1.3	1.6	13.6	2.1	0.4	0.6	4.9	3.8	0.0	1.6	0.2	0.1	0.9	0.3	0.5	1.8	4.8	1.0	0.4	3.9	0.2	0.2	1.3	0.0	0.2	0.2	1.2	0.3	0.0	0.5	0.2	0.3	0.3	0.4	1.1	0.2	0.0	2.4	1.0	16.3	0.4	0.5	0.3	1.7	0.6	0.2	0.3	1.5	1.2	0.7	0.9	0.5	0.4	0.4	0.1	0.4	189.4	1.0	0.3	36.6	0.4	0.5	0.2	0.2	23.6	0.1	0.3	0.2	52.3	0.2	4.8	1.3	0.1	124.2	9.0	25.2	3.5	8.9	11.7	7.4	21.6	2.9	18.9	17.3
CD1D		ENSG00000158473	"CD1d molecule"	P15813	1	158179947-158184896	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.5;lymphoid tissue: 17.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 9.1;HHSteC: 14.1;MOLT-4: 18.6;THP-1: 11.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 49.5;intermediate monocyte: 22.4;myeloid DC: 49.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 49.5;monocytes: 49.5"					"Low region specificity"	"Detected in all"			"CAB016107, HPA072662"	Enhanced		Supported	"Endoplasmic reticulum"			720000	"Endoplasmic reticulum"		"CAB016107: AB_626960, HPA072662: "	"unprognostic (8.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (9.31e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.38e-1)"	1.5	1.2	0.0	8.6	0.0	2.6	1.2	0.0	0.0	0.8	2.5			9.5	1.5	0.0	0.4	1.4	2.0	1.4	0.0	0.1	1.6	10.5	2.3	5.5	0.2		0.3	0.7	0.0	0.6	0.0		1.4	3.7		0.7	0.3	0.6	0.0	12.2	2.2	0.4	17.8	1.4	1.4			1.8		3.4	1.6	0.5	6.3	49.5	2.5	49.5	0.1	0.1	23.5	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.2	0.0	4.8	0.0	9.1	0.0	0.0	0.1	0.2	0.0	0.0	14.1	0.1	0.0	5.3	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	18.6	1.8	0.8	0.0	0.0	0.0	0.0	0.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	2.9	0.0	0.0	0.5	0.0	0.5	0.0	5.2	0.7	0.0	49.5	0.1	0.0	22.4	0.1	6.3	0.0	0.0	49.5	4.7	0.0	0.0	2.5	0.1	3.6	0.5	0.0	23.5										
CD200R1	"CD200R, HCRTR2, MOX2R, OX2R"	ENSG00000163606	"CD200 receptor 1"	Q8TD46	3	112921209-112975122	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 46.7;lymphoid tissue: 21.2"	"Cell line enriched"	"Detected in some"	8	"HEL: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 46.7;eosinophil: 12.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 46.7"									HPA068512			Supported	"Plasma membrane"	"Intracellular and membrane"		1500000	"Plasma membrane"		"HPA068512: "	"unprognostic (1.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-3)"	3.6	1.6	1.0	9.5	1.4	1.8	3.8	0.8	1.4	5.0	3.5	0.3	1.5	2.0	3.9	5.4	7.5	1.3	2.7	5.8	1.0	1.2	1.4	3.4	4.3	9.0	1.0	0.0	1.0	1.1	0.5	1.0	7.8	0.4	4.2	3.5	2.4	2.5	1.6	0.9	3.4	3.3	1.7	0.9	21.2	1.7	2.5	0.5	15.8	2.0	3.9	17.0	3.8	2.0	2.3	5.8	46.7	0.8	0.6	3.7	1.3	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.2	25.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.0	46.7	0.8	12.7	1.0	0.4	1.8	2.3	3.7	2.1	5.8	1.2	3.6	1.7	0.2	0.6	0.1	0.1	1.0	1.3	1.0	1.4	0.8	1.4	1.0	1.2	1.0	0.0	0.4	0.5
CD24	CD24A	ENSG00000272398	"CD24 molecule"		6	106969831-106975627	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	6	"kidney: 383.7"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 65.1;RPTEC TERT1: 307.7;SK-BR-3: 89.5"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	26	"eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0"	"Group enriched"	"Detected in many"	202	"B-cells: 23.4;granulocytes: 30.4"									"HPA045879, CAB078471"			Enhanced	Vesicles	"Intracellular and membrane"			Vesicles		"CAB078471: AB_10983158, HPA045879: "	"prognostic unfavourable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favourable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	0.5	0.5	12.8	2.4	9.9	17.9	25.5	0.5	2.9	69.5	30.6	0.7	1.6	1.2	34.5	5.9	38.1	6.0	25.1	4.2	22.7		383.7	0.8	0.7	0.9	4.8	7.2	15.6	40.0	0.0	5.7	48.2	13.0	3.2	21.2	0.7	15.9	16.6	0.4	0.5	0.8	2.2	4.9	0.7	16.4	0.5	6.5	0.4	48.8	1.2	11.3	4.0	8.1	23.4	0.0	30.4	0.1	0.0	0.0	0.6	22.9	14.2	0.2	1.8	0.0	0.0	27.0	0.0	0.1	0.1	0.0	0.2	0.1	2.2	7.1	0.0	47.5	8.1	17.9	0.1	0.0	0.1	0.0	17.6	1.0	0.0	0.3	0.1	0.1	20.7	0.2	1.2	0.1	0.5	0.0	0.4	28.8	0.1	0.1	65.1	5.5	53.8	0.0	0.2	307.7	59.3	40.3	29.7	16.3	89.5	0.0	41.3	0.1	0.0	0.0	0.2	0.2	0.7	0.0	0.1	30.4	0.3	0.1	0.1	0.1	0.0	30.4	0.0	0.0	0.0	23.4	0.0	0.0	0.0	15.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.6										
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"			160000	"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (7.57e-5)"	15.2	9.9	5.3	18.0	7.6	6.6	11.9	13.6	6.1	13.2	23.5	6.2	19.0	31.0	13.2	12.9	20.1	8.0	14.7	7.3	4.9	5.3	31.3	19.2	17.3	8.0	5.8	4.0	9.9	19.3	24.0	14.4	17.2	7.3	15.0	20.9	6.6	17.5	19.4	8.7	13.0	31.9	9.5	7.7	17.0	22.3	8.7	6.4	55.1	13.3	13.3	13.8	16.9	15.5	1.3	12.2	3.7	0.7	3.8	2.4	0.7	20.4	8.1	2.5	5.2	3.5	5.2	20.3	5.0	6.2	6.8	8.7	13.3	14.5	26.5	21.2	6.5	7.7	8.4	12.6	11.2	10.5	13.6	14.7	6.8	11.9	4.7	8.2	5.7	3.6	11.9	6.5	9.5	11.0	25.7	8.5	6.2	6.4	15.5	3.0	7.5	2.9	8.3	6.5	12.1	43.1	36.6	7.7	3.0	10.1	13.6	9.8	12.8	5.2	13.1	13.8	11.6	4.4	14.2	6.5	10.8	19.0	14.7	4.4	7.0	1.9	0.7	3.7	1.5	0.5	2.4	1.2	1.4	1.5	1.5	1.3	1.3	2.0	0.1	3.8	0.4	12.2	1.1	0.7	5.3	7.6	13.6	6.1	4.9	5.3	5.8	4.0	7.3	6.4
CD2BP2	"LIN1, PPP1R59, Snu40, U5-52K"	ENSG00000169217	"CD2 cytoplasmic tail binding protein 2"	O95400	16	30350766-30355361	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041508, HPA061309"	Enhanced		Enhanced	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA041508: , HPA061309: "	"unprognostic (5.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	24.6	33.0	23.6	27.8	24.4	17.8	22.5	27.6	43.4	24.2	25.4	27.4	31.8	25.8	32.3	29.0	23.1	30.0	35.6	27.4	23.1	23.7	24.8	18.2	22.3	30.2	23.2	27.3	29.7	30.9	46.3	30.3	22.3	20.3	25.8	21.3	20.8	27.4	40.7	31.7	22.0	22.6	28.1	20.6	32.0	24.5	23.4	19.8	26.8	29.8	25.9	36.5	22.9	19.9	38.2	28.1	51.3	39.0	29.2	37.6	29.9	21.3	26.1	22.0	19.9	18.4	17.6	18.7	23.9	28.8	27.2	29.3	19.9	26.0	33.1	29.6	25.9	23.6	22.5	28.0	21.9	19.6	26.5	14.0	24.7	23.4	26.5	19.8	25.9	18.8	23.7	30.2	19.4	28.2	15.8	25.5	27.1	51.5	27.3	16.8	29.6	15.4	40.5	18.3	24.9	22.1	21.6	18.1	34.7	16.0	28.3	16.0	26.8	16.1	20.1	31.4	21.9	15.7	20.8	42.8	31.1	30.5	21.5	18.4	25.6	36.3	26.3	46.2	31.7	30.8	25.1	36.2	25.8	29.4	23.3	38.2	21.8	26.9	51.3	29.2	39.0	28.1	37.6	29.9	23.6	24.4	27.6	43.4	23.1	23.7	23.2	27.3	20.3	19.8
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.3;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in some"		"HEL: 27.9;HL-60: 37.1;HMC-1: 27.8;NB-4: 17.7;RPMI-8226: 20.0;THP-1: 21.8;U-937: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 49.3;monocytes: 37.6"									"CAB011442, HPA035832, HPA064807"	Approved		Supported	"Nucleoplasm,Plasma membrane"			1400000	"Nucleoplasm, Plasma membrane"		"CAB011442: , HPA035832: , HPA064807: "	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	10.2	4.3	3.6	8.4	6.0	23.0	6.5	0.8	3.5	2.6	2.7	4.4	0.3	2.5	2.3	5.2	1.7	3.9	5.3	7.5	3.1	2.5	4.1	6.4	11.6	45.4	6.4	1.8	1.9	1.9	0.5	1.7	5.4	5.2	2.6	3.4	2.6	2.9	2.1	1.2	2.5	4.0	5.6	9.9	31.6	2.8	1.5	5.8	2.5	1.7	0.2	2.7	4.7	2.3	0.1	49.3	4.6	37.6	3.3	0.2	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	37.1	27.8	0.0	0.0	0.0	0.0	0.0	5.1	7.0	0.0	0.0	0.0	17.7	0.0	8.5	0.0	1.4	20.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.8	0.2	4.8	0.4	0.6	0.0	0.1	2.4	0.0	3.2	27.4	0.1	3.3	37.6	2.3	0.0	27.3	0.1	0.0	0.0	0.1	49.3	0.1	0.0	0.0	4.6	3.3	12.6	1.4	0.2	14.7	3.6	6.0	0.8	3.5	3.1	2.5	6.4	1.8	5.2	5.8
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 80.8;HEL: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"			92000000	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: "	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	80.8	0.8	0.1	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	0.0	0.1	0.1	38.4	0.1	6.1	0.0	0.0	0.0	7.8	3.1	0.0	0.0	0.2	1.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	2.7	4.4	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.2	10.2	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853230	"Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 94.9;seminal vesicle: 104.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 49.8;Karpas-707: 13.9;MOLT-4: 12.6;REH: 10.0;U-266/70: 10.8;U-698: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.3"	"Group enriched"	"Detected in all"	4	"B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3"	"Low region specificity"	"Detected in all"							"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favourable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	4.1	3.3	3.8	17.6	8.5	9.3	2.6	0.7	12.0	1.0	3.2	10.4	14.6	4.3	0.7	0.9	2.3	2.4	1.5	5.0	4.0	4.2	1.2	5.4	4.7	16.1	4.9	3.1	0.6	0.7	0.0	2.5	0.6	3.1	10.8	2.7	4.4	2.8	104.1	14.2	0.5	6.2	0.9	1.8	20.6	2.0	0.7	2.5	94.9	2.8	2.0	13.2	7.6	0.9	9.0	5.1	1.3	2.2	15.3	2.3	3.7	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.9	0.0	0.0	12.6	3.0	0.0	0.0	10.0	0.0	7.8	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	2.2	0.2	0.0	0.0	0.0	0.0	10.8	0.1	9.4	0.1	2.4	0.1	0.0	1.7	0.0	1.1	2.2	0.3	9.0	1.4	1.2	4.1	6.6	2.3	1.8	1.3	15.3	1.4	5.1	2.1	3.7	3.8	8.5	0.7	6.2	4.0	4.2	4.9	3.1	3.1	2.5
CD3EAP	"ASE-1, CAST, PAF49"	ENSG00000117877	"CD3e molecule associated protein"	O15446	19	45406209-45410766	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-251 MG: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"				"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavourable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	7.3	5.9	7.7	8.4	9.7	4.0	7.1	14.9	9.0	5.6	5.5	6.5	2.9	4.9	6.4	3.0	9.9	7.1	6.4	6.7	7.1	6.4	5.2	6.8	4.5	7.2	8.1	6.0	8.7	18.3	6.6	7.3	5.1	8.0	5.2	4.9	3.1	7.2	4.6	14.2	8.4	4.3	6.6	5.6	5.8	4.3	5.2	9.3	3.6	6.1	7.8	8.5	5.5	5.8	3.5	15.9	1.3	3.7	3.2	4.1	2.1	10.2	10.6	1.7	7.8	2.5	2.1	6.9	4.9	1.7	8.7	5.1	10.4	7.4	16.0	5.2	3.7	9.9	15.3	14.0	6.2	7.8	9.9	8.9	4.0	7.6	4.3	8.9	3.1	3.2	9.1	12.7	6.9	6.3	20.2	3.2	8.4	12.1	6.8	2.6	12.4	8.9	9.2	6.8	10.5	3.5	7.6	10.6	3.9	10.5	14.0	2.2	7.0	5.4	6.1	12.5	13.0	7.1	64.5	5.8	23.0	17.0	6.2	12.8	9.0	0.9	2.8	0.3	1.7	3.7	3.4	2.8	2.2	2.4	5.0	3.5	3.1	4.1	1.3	3.2	3.3	15.9	1.2	2.1	7.7	9.7	14.9	9.0	7.1	6.4	8.1	6.0	8.0	9.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 187.6"	"Cell line enriched"	"Detected in single"	78	"MOLT-4: 64.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	30	"gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2"	"Lineage enriched"	"Detected in many"	37	"T-cells: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: "	"prognostic favourable (6.33e-4)"	"prognostic favourable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	1.1	0.6	0.4	7.1	0.4	0.5	0.8	0.3	0.3	0.7	2.3	0.4	0.4	2.0	0.9	0.6	1.5	1.1	1.9	0.6	0.4	0.4	1.2	0.9	2.4	17.2	0.5	0.2	0.7	0.7	0.0	0.5	0.4	0.3	1.0	1.6	0.9	2.9	0.3	5.9	0.6	8.1	0.2	0.8	11.5	2.4	0.5	0.2	187.6	1.4	1.7	19.2	2.5	1.1	0.1	0.2	1.2	0.2	0.2	46.7	14.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	64.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.2	0.2	43.5	0.1	25.6	0.1	36.1	37.1	0.1	0.1	37.6	46.7	1.2	0.2	0.1	0.2	34.2	14.1	0.4	0.4	0.3	0.3	0.4	0.4	0.5	0.2	0.3	0.2
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820808	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 111.5;parathyroid gland: 78.4"	"Group enriched"	"Detected in some"	6	"HEL: 33.5;HL-60: 13.5;NB-4: 19.3;THP-1: 38.1;U-937: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4"	"Group enriched"	"Detected in many"	20	"dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1"	"Region enriched"	"Detected in single"	15	"basal ganglia: 41.4"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB000011: AB_442062, CAB068180: , HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	13.8	5.4	6.1	16.0	5.8	4.4	5.6	1.2	4.3	4.5	5.1	8.6	1.8	3.6	3.5	8.3	3.0	5.5	7.3	5.4	4.9	4.4	6.1	32.2	24.0	30.8	6.3	3.1	3.0	3.1	78.4	3.4	10.9	6.2	4.1	6.5	5.7	5.4	3.9	1.9	3.5	9.5	5.2	10.2	49.1	3.9	2.8	5.7	111.5	3.9	4.1	18.6	8.6	3.2	0.1	46.7	1.9	42.5	0.3	29.1	33.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	33.5	0.0	0.2	3.7	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	19.3	0.3	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.1	42.2	0.3	0.3	42.5	1.1	0.0	29.1	0.1	29.3	0.1	24.8	0.1	1.9	0.3	33.3	46.7	26.4	33.6	6.1	5.8	1.2	4.3	4.9	4.4	6.3	3.1	6.2	5.7
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138870-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000112, CAB000316, HPA005785"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"		2400000000	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavourable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	45.5	9.0	10.5	42.5	21.7	53.0	35.6	4.7	13.4	43.2	19.5	26.3	8.3	10.6	80.5	20.3	66.5	18.6	48.0	11.7	14.9	9.3	12.4	9.1	43.4	48.4	31.5	6.1	12.8	83.9	0.8	3.8	19.4	40.7	30.1	24.5	30.2	148.2	22.4	15.9	107.7	18.9	44.5	100.5	30.9	19.9	7.2	20.3	17.9	20.6	53.9	53.7	55.0	54.2	22.7	41.0	19.1	65.2	54.6	53.1	59.9	41.5	37.6	0.3	0.1	22.7	62.8	0.1	81.5	63.8	45.4	25.3	2.5	13.1	0.0	10.9	115.5	71.7	0.8	88.6	62.4	8.9	0.4	1.5	18.5	0.0	22.4	21.1	97.8	28.3	70.0	61.1	49.6	15.9	0.3	13.6	43.5	0.2	1.9	13.9	0.8	11.1	0.1	7.7	0.6	66.5	12.0	0.1	0.1	15.4	0.4	36.9	2.2	1.2	45.6	56.6	10.2	69.4	83.7	23.6	25.4	0.2	85.9	11.9	82.2	19.1	65.2	6.0	26.2	45.7	37.0	22.7	39.8	34.9	41.0	16.2	34.5	28.7	16.4	54.6	59.3	14.2	53.1	59.9	10.5	21.7	4.7	13.4	14.9	9.3	31.5	6.1	40.7	20.3
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043094-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"			2000000	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (3.54e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.05e-3)"	"unprognostic (8.77e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (1.69e-4)"	"unprognostic (7.37e-2)"	"unprognostic (3.78e-1)"	"prognostic favourable (7.29e-5)"	"unprognostic (1.83e-1)"	16.2	24.3	23.0	28.8	46.5	58.0	29.0	44.0	55.5	20.5	25.7	42.5	13.4	19.8	16.2	30.4	46.7	31.7	26.0	26.7	24.1	24.4	19.1	22.1	49.6	35.1	27.4	28.8	16.2	25.7	11.5	34.8	23.3	43.6	40.2	29.0	15.7	43.8	18.9	18.1	19.3	21.2	21.0	37.7	29.0	33.4	20.6	25.0	34.4	30.1	22.0	42.5	25.1	29.1	40.1	35.6	44.1	64.4	45.1	65.3	51.7	45.4	8.2	16.4	9.3	23.6	25.4	21.7	17.2	26.9	13.4	22.9	0.4	25.7	20.9	27.9	16.5	31.2	9.1	17.3	17.5	12.3	6.3	53.1	7.6	0.7	13.7	37.8	71.8	16.3	10.6	12.8	10.3	13.2	12.5	49.6	19.9	23.3	45.9	14.2	6.8	20.9	24.5	12.1	29.5	34.0	18.1	12.5	7.8	10.2	20.4	17.4	36.9	12.4	12.7	34.7	6.4	19.4	11.6	19.2	13.0	29.3	25.3	19.0	9.5	31.7	24.7	44.1	40.2	48.1	35.0	40.1	47.0	42.0	35.6	39.2	35.4	38.3	30.1	45.1	64.4	27.7	65.3	51.7	23.0	46.5	44.0	55.5	24.1	24.4	27.4	28.8	43.6	25.0
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711851	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.3;lymphoid tissue: 86.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.0;HMC-1: 42.5;U-266/70: 90.0;U-266/84: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB002497, HPA055146"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"		2600000	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: "	"prognostic favourable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favourable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	5.5	1.4	1.0	44.6	0.9	23.1	2.8	0.6	0.7	3.2	5.0	0.5	1.1	3.2	1.9	2.5	7.3	2.1	4.8	1.8	1.0	1.0	3.6	3.1	15.4	86.3	1.6	0.3	2.3	1.5	0.0	1.3	2.2	0.8	2.8	5.7	2.4	13.9	1.5	1.3	1.2	21.2	1.7	3.8	66.6	5.0	1.3	0.2	50.8	2.9	3.6	58.0	8.6	2.6	34.6	53.6	35.8	74.1	24.9	57.9	81.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	4.5	42.5	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	13.2	6.5	0.0	0.0	0.8	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.0	60.1	15.4	0.0	11.4	0.0	28.2	52.2	35.8	42.4	74.1	57.9	34.6	48.3	48.8	53.6	27.9	49.7	52.5	13.4	24.9	73.5	9.4	36.4	81.3	1.0	0.9	0.6	0.7	1.0	1.0	1.6	0.3	0.8	0.2
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 272.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356"	Supported		Supported	Vesicles	"Intracellular and membrane"			Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323"	"unprognostic (8.76e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.66e-3)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.02e-2)"	115.3	88.2	42.5	44.9	37.2	67.4	106.3	13.7	33.1	80.6	84.7	34.4	71.5	39.9	99.7	177.9	70.9	60.4	102.7	154.4	36.9	39.0	106.6	92.5	109.6	113.8	49.8	27.2	93.8	187.1	33.3	49.3	176.9	50.8	82.9	81.8	102.1	105.0	83.7	92.7	38.5	72.4	88.2	43.6	107.7	74.8	52.1	30.5	17.6	108.1	50.7	47.4	96.3	82.2	9.6	40.3	147.4	50.8	58.4	29.8	56.6	21.9	38.3	21.0	20.4	272.1	170.6	27.7	89.3	163.9	52.9	57.7	42.7	44.3	6.3	28.5	133.0	20.4	15.2	37.0	68.1	17.8	14.3	34.5	29.9	23.5	108.3	15.3	82.2	125.6	36.8	58.8	53.9	58.3	19.4	44.2	168.3	35.1	3.1	20.8	19.1	44.5	6.9	46.1	15.8	89.5	74.8	8.2	21.0	24.5	18.5	160.6	26.1	51.2	43.3	34.2	25.0	47.2	29.9	18.1	11.2	4.4	98.1	9.9	62.5	89.6	50.8	147.4	29.8	38.5	21.8	9.6	11.9	23.7	40.3	6.5	5.3	18.1	55.7	58.4	26.1	27.0	10.0	56.6	42.5	37.2	13.7	33.1	36.9	39.0	49.8	27.2	50.8	30.5
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579467-7582113	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 179.1;lymphoid tissue: 139.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 73.3;U-87 MG: 115.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 68.4;monocytes: 179.1"	"Low region specificity"	"Detected in all"							"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: , CAB072862: , HPA048982: "	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	118.4	28.5	12.5	46.8	21.6	46.8	40.9	2.9	11.2	27.1	38.1	15.5	2.1	57.0	9.6	24.1	26.9	17.3	33.7	39.0	10.1	6.9	20.9	43.1	84.4	102.5	21.1	4.4	15.8	7.5	2.1	8.5	34.7	15.7	12.1	18.5	12.8	22.2	4.4	16.1	9.4	58.3	15.6	26.0	139.1	17.6	9.4	16.3	13.3	8.8	12.3	21.1	31.4	19.1	3.7	68.4	11.0	179.1	0.9	0.5	125.6	35.1	7.1	0.4	0.5	73.3	28.0	0.3	11.2	30.7	14.9	17.4	1.5	10.6	0.4	12.8	32.6	1.5	0.1	7.1	10.1	0.3	1.3	5.6	1.7	8.5	6.2	2.7	31.7	8.8	1.4	31.2	23.0	3.9	2.2	3.6	14.4	0.2	0.2	2.4	0.4	5.2	0.4	0.6	20.7	3.0	1.5	0.2	0.4	9.3	4.7	10.9	0.2	21.6	12.2	19.0	1.1	19.0	14.6	0.2	0.2	0.2	115.5	6.9	9.6	10.1	155.1	0.9	0.4	179.1	0.5	3.7	0.2	0.3	40.9	2.0	0.3	0.2	11.0	0.9	170.1	68.4	0.3	125.6	12.5	21.6	2.9	11.2	10.1	6.9	21.1	4.4	15.7	16.3
CD74	DHLAG	ENSG00000019582	"CD74 molecule"	P04233	5	150401637-150412929	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 504.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 115.7;Daudi: 178.0;HDLM-2: 255.6;REH: 154.1;RPMI-8226: 104.9;U-266/70: 85.9;U-698: 98.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 191.6;intermediate monocyte: 303.5;memory B-cell: 467.7;myeloid DC: 437.9;naive B-cell: 504.7;non-classical monocyte: 140.0;plasmacytoid DC: 303.2"	"Group enriched"	"Detected in all"	5	"B-cells: 504.7;dendritic cells: 437.9;monocytes: 303.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002506, HPA010592"	Enhanced		Supported	"Golgi apparatus"			90000	"Golgi apparatus"		"CAB002506: AB_563630, HPA010592: AB_1078482"	"prognostic favourable (1.06e-4)"	"unprognostic (1.48e-2)"	"unprognostic (4.80e-3)"	"prognostic favourable (6.53e-6)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.24e-2)"	137.8	95.7	53.2	177.0	81.4	40.7	104.2	8.4	43.5	89.6	68.2	79.0	30.0	98.3	60.0	73.9	43.6	68.1	81.3	104.1	46.9	43.5	168.3	60.1	222.5	310.1	78.3	23.1	53.4	34.1	15.1	51.0	27.9	79.8	72.6	63.6	72.9	123.0	55.4	40.5	56.6	182.8	55.1	123.1	372.1	77.3	23.7	68.1	201.1	83.4	45.6	288.2	91.7	47.0	504.7	437.9	76.1	303.5	42.2	41.2	238.1	1.9	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	23.1	115.7	178.0	7.2	0.0	0.5	0.0	0.0	0.0	255.6	0.0	5.8	0.1	14.1	0.3	0.4	0.3	1.4	0.0	0.0	0.0	0.0	0.4	70.9	0.0	0.0	0.2	0.8	0.3	0.0	154.1	0.2	104.9	0.5	7.5	0.2	0.5	0.3	0.2	5.1	4.7	21.3	0.2	0.6	0.5	0.5	0.2	85.9	9.2	98.6	41.3	8.0	37.7	6.3	191.6	76.1	16.8	303.5	18.7	467.7	14.8	24.8	437.9	504.7	7.8	13.5	16.8	42.2	140.0	303.2	41.2	238.1	53.2	81.4	8.4	43.5	46.9	43.5	78.3	23.1	79.8	68.1
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397419	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 231.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 41.4;naive B-cell: 37.6"	"Lineage enriched"	"Detected in all"	4	"B-cells: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane"			1900000	"Plasma membrane"		"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavourable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	102.5	43.7	52.8	40.1	57.0	9.6	79.3	31.7	63.2	124.7	88.9	75.8	261.4	21.1	143.5	141.5	56.8	123.1	86.8	101.2	46.6	52.8	65.5	123.9	107.4	82.4	70.4	51.3	77.9	62.4	41.4	42.9	61.2	63.0	89.3	34.0	46.6	59.7	263.3	22.6	59.6	39.7	138.9	59.3	64.5	52.1	57.6	53.3	25.3	66.3	38.5	37.9	93.5	80.2	41.4	2.1	5.7	1.8	3.5	9.9	2.7	24.5	25.5	20.5	31.3	231.4	131.6	17.2	46.5	103.0	37.6	38.0	23.9	0.1	21.0	16.8	130.3	32.3	12.6	33.1	15.5	9.9	38.9	3.2	9.7	0.0	76.6	13.6	27.6	95.6	47.3	15.3	23.3	35.9	14.3	36.9	52.5	18.8	11.5	17.4	24.6	20.7	23.7	10.3	13.4	40.4	16.6	22.1	24.5	14.8	39.0	28.0	12.9	24.9	47.8	19.2	14.2	35.9	15.9	27.3	6.2	38.3	27.9	8.1	32.8	0.2	0.9	5.7	6.0	1.4	9.9	41.4	4.3	9.4	0.6	37.6	2.6	5.0	0.3	3.5	1.8	2.1	3.0	2.7	52.8	57.0	31.7	63.2	46.6	52.8	70.4	51.3	63.0	53.3
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;HEL: 23.7;HL-60: 6.7;HMC-1: 27.1;MOLT-4: 6.6;U-698: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"			36000000	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: "	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	15.9	4.8	3.8	18.5	4.5	6.7	3.7	1.3	3.4	3.3	3.2	7.9	7.7	2.5	2.5	4.3	2.7	3.1	6.4	5.0	3.8	3.0	3.1	5.1	9.2	26.0	6.0	2.2	1.8	4.3	0.9	1.9	7.1	5.3	3.7	4.7	2.4	4.3	9.8	1.6	2.7	9.6	4.1	11.1	25.6	3.5	2.8	5.9	13.8	2.9	2.3	16.3	5.8	2.7	5.1	5.4	21.0	7.3	1.0	8.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	6.7	27.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	6.6	5.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	1.5	0.0	21.0	7.3	11.0	6.9	6.3	5.2	5.1	5.9	8.2	5.4	4.7	3.5	6.3	1.0	1.0	2.4	3.2	7.9	6.1	3.8	4.5	1.3	3.4	3.8	3.0	6.0	2.2	5.3	5.9
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"blood: 82.2;lymphoid tissue: 262.3"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"MAIT T-cell: 36.7;memory CD8 T-cell: 82.2;naive CD8 T-cell: 77.8"	"Lineage enriched"	"Detected in many"	20	"T-cells: 82.2"					"Low region specificity"	"Detected in all"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"		500000	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: , HPA037756: "	"unprognostic (1.29e-3)"	"prognostic favourable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favourable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"	2.4	1.4	1.4	7.4	2.8	6.8	1.5	1.4	1.2	2.1	5.3	0.8	0.8	4.2	1.5	2.1	2.0	2.1	4.5	1.6	1.2	1.6	1.3	2.1	6.0	23.8	1.0	0.5	1.7	1.2	0.0	0.9	0.6	0.7	2.3	1.9	1.8	3.0	1.1	0.8	0.7	12.2	0.7	1.7	46.4	5.4	1.0	0.5	262.3	2.2	1.6	8.1	3.8	1.9	0.0	0.1	0.6	0.1	4.0	82.2	17.4	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.8	17.4	1.1	0.6	0.3	0.1	0.9	3.9	0.0	0.4	0.9	2.4	0.2	0.1	0.0	0.4	0.5	0.0	0.0	0.6	0.1	0.0	0.1	0.3	0.9	0.0	0.0	0.1	0.1	0.1	0.0	4.8	0.0	36.7	0.0	0.3	82.2	0.0	0.0	0.3	77.8	0.6	4.0	0.1	0.1	0.1	17.4	1.4	2.8	1.4	1.2	1.2	1.6	1.0	0.5	0.7	0.5
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 132.1;lymphoid tissue: 61.5"	"Cell line enriched"	"Detected in some"	55	"RPMI-8226: 154.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory CD8 T-cell: 73.5;naive CD8 T-cell: 132.1"	"Lineage enriched"	"Detected in many"	40	"T-cells: 132.1"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB004353: AB_627211, HPA029164: "	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favourable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavourable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"	1.2	0.7	1.0	5.3	1.0	3.9	1.0	1.3	1.3	21.2	1.1	1.0	1.0	2.5	1.2	1.0	1.0	1.1	1.8	1.0	1.0	1.8	1.0	1.0	2.7	14.4	1.7	1.0	1.3	1.0	6.4	7.4	1.0	2.2	1.3	1.3	1.0	1.0	1.0	1.0	0.9	11.4	1.0	1.5	12.7	2.3	1.0	1.0	61.5	1.5	1.0	8.1	1.8	1.3	0.1	0.1	3.2	0.1	0.1	132.1	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	154.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.2	0.1	0.0	2.0	0.1	10.0	0.0	0.2	73.5	0.0	0.1	0.5	132.1	0.7	0.1	0.1	0.1	0.2	36.3	1.0	1.0	1.3	1.3	1.0	1.8	1.7	1.0	2.2	1.0
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 127.8;HUVEC TERT2: 82.6;RT4: 94.7;TIME: 188.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"basophil: 137.8;eosinophil: 98.3"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 137.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"			68000000	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favourable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (8.93e-5)"	"unprognostic (9.26e-2)"	38.1	44.5	20.0	24.1	36.2	3.1	48.2	6.8	29.6	55.0	68.3	63.1	151.6	19.5	36.2	43.4	139.8	38.4	23.2	39.2	30.3	15.6	39.9	12.2	61.1	8.2	43.3	23.3	14.1	23.3	89.5	15.2	13.0	28.7	77.9	73.5	25.5	91.6	180.4	11.3	60.1	29.6	62.2	48.9	12.2	27.7	10.4	47.7	6.0	63.6	112.3	85.8	54.5	76.0	1.9	0.9	137.8	5.6	0.2	1.1	5.6	33.9	14.9	0.3	9.2	14.7	15.1	12.9	20.1	40.2	6.9	10.6	10.9	127.8	0.1	5.0	4.3	74.5	7.8	40.2	5.3	1.7	5.5	0.1	11.3	2.3	6.3	0.1	42.8	0.0	29.9	12.6	10.9	82.6	1.5	0.1	4.3	48.6	0.1	3.7	11.6	15.0	0.3	24.6	43.2	67.6	94.7	0.0	2.9	20.0	16.6	17.2	7.7	3.5	188.9	0.7	18.9	0.7	2.4	0.1	0.1	5.1	11.8	0.0	18.6	137.8	5.6	98.3	0.1	1.8	0.2	0.5	0.1	0.1	0.9	1.9	0.4	1.1	2.6	0.2	0.0	0.3	0.0	5.6	20.0	36.2	6.8	29.6	30.3	15.6	43.3	23.3	28.7	47.7
CD99L2	"CD99B, MIC2L1"	ENSG00000102181	"CD99 molecule like 2"	Q8TCZ2	X	150766337-150898816	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038782, HPA038783, HPA061400"	Enhanced		Supported	"Plasma membrane"			790000	"Plasma membrane"		"HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: "	"unprognostic (2.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.12e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.56e-2)"	"prognostic favourable (4.96e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (2.74e-5)"	"unprognostic (5.50e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (9.23e-2)"	"prognostic unfavourable (8.74e-4)"	27.1	16.5	23.3	9.2	30.1	4.5	17.8	27.5	56.7	19.2	12.6	21.0	5.5	6.7	17.6	16.5	9.7	17.6	12.4	32.1	26.3	32.0	14.0	17.0	14.9	9.6	30.5	26.6	26.0	8.4	9.7	8.7	21.5	43.1	13.9	7.4	11.9	8.3	22.0	72.2	6.7	8.0	20.8	31.9	12.5	8.0	7.6	13.3	3.0	7.3	6.9	7.0	10.7	7.7	7.2	10.7	9.4	15.1	8.8	8.9	8.4	2.2	22.6	8.6	10.7	45.6	28.5	2.5	18.6	21.9	9.4	13.6	1.6	2.9	8.2	45.3	32.4	3.7	11.7	12.6	7.8	19.1	9.1	3.5	5.4	2.2	12.3	5.9	6.8	26.9	4.2	6.9	13.3	11.1	2.4	21.6	11.8	4.8	5.2	8.6	3.6	12.3	5.2	7.0	11.2	9.2	1.5	11.4	5.8	7.3	6.3	8.3	1.8	10.2	13.0	14.0	4.3	18.1	13.4	18.4	30.4	8.0	17.6	11.9	10.5	9.4	11.2	7.6	8.8	9.9	7.8	6.4	8.2	8.9	10.7	7.2	8.3	8.5	2.8	8.8	15.1	7.8	5.9	8.4	23.3	30.1	27.5	55.2	26.3	32.0	30.5	26.6	43.1	13.3
CDAN1	"CDA-I, CDAI"	ENSG00000140326	"Codanin 1"	Q8IWY9	15	42723544-42737128	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039404, HPA040787"	Supported		Enhanced	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039404: AB_10673530, HPA040787: AB_2677137"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavourable (1.07e-4)"	"unprognostic (7.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.04e-1)"	6.5	9.0	8.4	9.8	8.1	14.4	9.8	16.2	9.7	11.8	6.8	8.7	9.4	6.0	11.0	9.6	7.1	9.1	7.2	5.2	6.4	4.4	6.3	6.7	6.6	8.0	8.3	7.4	21.7	9.6	9.1	9.5	6.7	5.8	11.4	5.5	9.3	10.6	10.1	6.6	10.1	6.9	9.3	5.1	8.1	8.0	14.7	8.6	14.7	9.0	3.3	8.2	10.2	12.2	0.3	0.8	3.7	0.3	0.0	0.6	0.1	6.8	4.7	6.4	9.2	5.7	4.9	7.7	9.1	3.8	8.9	6.5	11.7	3.6	3.3	10.1	5.0	13.6	6.8	4.1	2.6	8.4	6.3	12.4	8.4	4.5	4.2	9.1	11.7	6.7	4.6	5.6	4.1	6.7	15.8	5.0	7.2	3.8	7.0	12.1	3.2	7.5	10.1	8.0	2.9	2.8	6.8	5.2	6.1	7.1	10.0	1.5	7.6	13.7	4.8	9.3	8.4	7.6	10.3	10.0	10.4	7.5	4.9	13.6	7.6	3.7	0.3	1.7	0.5	0.1	0.6	0.1	0.4	0.5	0.0	0.3	0.4	0.3	0.4	0.0	0.0	0.8	0.1	0.1	8.4	8.1	16.2	9.7	6.4	4.4	8.3	7.4	5.8	8.6
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell line enhanced"	"Detected in many"		"K-562: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	6.2	2.4	5.8	6.5	5.5	13.7	12.2	1.8	6.2	7.7	11.8	4.8	2.2	7.2	15.1	4.8	3.4	13.7	3.6	4.1	8.8	3.5	6.6	2.4	12.3	15.4	3.8	5.4	5.8	6.7	9.8	8.1	7.6	4.6	10.0	6.3	8.3	7.7	3.9	4.3	5.6	22.6	5.0	3.2	9.6	6.0	38.2	4.7	12.0	6.1	3.4	11.3	5.8	8.4	4.8	6.1	11.6	3.7	3.9	13.0	4.1	2.2	1.8	5.8	6.5	2.1	1.6	4.0	2.8	1.9	2.8	2.3	6.1	1.9	1.1	2.1	1.7	1.7	3.9	1.6	2.9	2.2	9.7	3.9	1.7	1.9	0.8	5.2	7.0	1.3	0.4	3.0	1.0	4.9	30.0	3.4	4.1	0.9	4.2	5.9	3.5	2.3	4.6	7.5	1.1	1.9	5.0	1.0	1.8	3.0	2.9	3.9	1.3	6.8	2.1	1.6	3.5	2.6	1.6	1.7	0.6	1.7	1.9	4.9	0.9	11.6	3.7	8.4	7.3	3.3	13.0	4.8	11.3	8.4	3.5	3.1	11.0	5.8	5.5	3.9	2.3	6.1	5.6	4.1	5.8	5.5	1.8	6.2	8.8	3.5	3.8	5.4	4.6	4.7
CDC14B	"Cdc14B1, Cdc14B2, CDC14B3, hCDC14B"	ENSG00000081377	"Cell division cycle 14B"	O60729	9	96490241-96619830	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.1;ASC TERT1: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.9"	"Lineage enhanced"	"Detected in many"		"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013312, HPA064747"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA013312: AB_1846354, HPA064747: "	"unprognostic (5.69e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-1)"	"prognostic favourable (2.97e-10)"	"unprognostic (2.01e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (2.82e-4)"	"unprognostic (7.40e-2)"	7.3	6.2	6.8	3.0	7.5	4.4	15.7	2.4	6.6	5.3	5.0	14.8	7.1	4.5	4.0	3.7	3.5	7.1	5.9	8.2	6.0	4.6	9.1	16.0	4.9	1.8	9.5	4.0	5.8	7.3	17.1	5.2	3.4	7.1	5.7	5.4	8.3	3.8	7.2	2.2	3.3	7.7	4.2	9.3	2.2	9.3	16.9	8.2	0.2	13.6	2.2	2.1	10.4	10.3	1.6	0.0	9.9	0.0	0.1	2.9	0.8	5.1	2.9	3.1	3.2	15.1	22.7	8.5	3.8	5.0	2.5	4.1	9.9	8.3	0.0	3.7	8.0	5.8	4.4	3.0	3.0	1.3	4.1	0.8	1.0	7.7	2.4	0.0	0.1	9.3	1.5	2.7	2.5	0.5	3.0	0.6	3.5	2.5	0.0	0.8	5.8	2.5	0.0	1.9	0.1	4.0	8.0	0.9	4.9	2.6	0.8	1.5	0.7	1.7	1.5	2.5	3.0	6.5	2.7	0.1	0.0	0.0	2.7	0.0	6.0	9.9	0.0	3.1	2.9	0.0	1.6	1.6	1.3	2.3	0.0	0.8	2.3	1.4	0.0	0.1	0.0	0.0	1.6	0.8	6.8	7.5	2.4	6.6	6.0	4.6	9.5	4.0	7.1	8.2
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358955-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.0;testis: 73.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: , HPA055288: "	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.3	1.2	0.6	16.6	1.1	20.2	1.8	0.8	1.3	2.1	6.2	2.8	0.4	5.8	1.1	1.6	17.8	0.4	1.9	1.2	0.9	0.5	2.2	1.2	1.8	13.4	1.1	0.7	0.9	0.5	0.0	0.4	3.9	1.2	0.8	7.0	0.4	2.9	0.4	0.6	4.6	6.4	2.8	1.2	7.8	4.4	73.2	0.7	42.0	1.2	11.7	21.7	1.9	4.2	4.5	0.9	0.8	0.1	9.8	11.2	2.7	51.7	25.3	35.3	23.0	1.2	3.1	33.9	24.0	21.6	70.1	37.4	39.6	43.2	30.0	14.1	22.0	36.5	38.6	45.8	58.5	23.5	28.5	43.9	25.0	24.5	0.3	30.6	16.0	1.0	2.1	48.6	44.1	29.7	19.8	20.6	31.7	20.0	29.4	18.8	44.7	34.1	42.8	48.5	19.0	17.1	13.8	20.9	10.3	42.5	28.7	13.3	20.1	38.8	15.4	21.0	49.2	23.3	74.5	15.9	14.0	31.1	15.0	38.2	31.2	0.0	0.1	0.0	0.4	0.0	0.0	4.5	3.3	3.6	0.9	0.9	0.1	0.3	0.8	9.8	0.0	0.2	11.2	2.7	0.6	1.1	0.8	1.3	0.9	0.5	1.1	0.7	1.2	0.7
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Supported	"Vesicles,Mitotic spindle"				Vesicles	"Mitotic spindle"	"HPA038892: , HPA038893: , HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavourable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavourable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	12.1	8.7	15.1	27.7	23.3	26.0	28.8	49.6	21.1	13.0	14.7	12.8	4.6	14.9	17.0	10.3	11.7	13.0	18.6	7.5	15.7	12.5	13.3	11.0	33.0	42.8	21.9	12.5	17.3	5.7	7.5	21.0	30.3	13.8	11.0	12.0	7.7	7.4	10.2	6.2	19.8	16.8	14.8	14.7	24.5	14.1	6.3	22.3	33.3	18.7	20.8	31.6	15.3	16.3	4.5	1.3	1.5	1.8	9.3	15.5	5.9	29.8	64.5	8.6	14.3	10.6	10.4	4.3	14.8	22.2	24.8	18.5	11.2	43.3	20.8	6.4	15.1	43.7	11.7	24.6	11.7	8.0	12.6	11.2	20.7	13.5	42.3	8.7	5.8	10.2	19.8	23.0	27.2	13.7	7.2	55.1	14.6	24.0	27.1	12.7	6.4	27.6	14.2	24.4	14.9	16.9	2.8	6.2	13.5	35.1	33.5	17.2	11.3	4.5	11.3	13.3	16.1	24.1	19.6	13.4	21.2	8.4	6.8	8.6	12.8	1.5	1.4	0.0	13.6	1.8	12.7	3.5	13.6	13.7	1.3	4.5	11.4	13.2	0.1	9.3	0.9	0.7	15.5	5.9	15.1	23.3	49.6	21.1	15.7	12.5	21.9	12.5	13.8	22.3
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285265-138338355	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 23.3;testis: 22.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB003800, HPA066991"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: "	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favourable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.03e-6)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	1.1	0.6	0.3	6.7	0.4	5.2	1.1	0.4	0.6	0.6	3.3	0.1	0.7	3.0	0.3	0.6	2.5	0.2	0.4	0.7	0.4	0.4	0.4	0.6	0.7	2.6	0.4	0.3	0.3	0.3	0.0	0.4	1.9	0.3	0.4	4.0	0.0	1.2	0.7	0.2	1.1	3.7	0.5	0.3	1.7	1.2	22.3	0.2	23.3	0.3	1.8	5.0	0.6	0.9	1.0	0.1	0.7	0.0	2.1	2.7	0.5	13.5	5.6	19.0	14.6	0.4	1.9	4.8	8.1	8.8	18.6	25.7	13.6	26.3	6.3	6.9	4.9	7.3	15.6	12.5	18.0	5.2	10.7	4.8	7.7	10.1	0.1	3.2	4.9	0.4	0.5	11.0	9.0	11.9	7.0	12.4	11.3	7.4	8.8	8.1	4.9	6.2	5.8	17.3	7.3	3.2	4.1	9.6	5.9	18.3	5.6	8.7	9.3	6.7	3.6	10.3	8.7	7.1	13.0	7.6	6.2	6.2	4.1	6.9	7.8	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.5	0.3	0.0	0.2	0.0	0.0	0.7	2.1	0.0	0.1	2.7	0.5	0.3	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.2
CDC27	"ANAPC3, APC3, D0S1430E, D17S978E, NUC2"	ENSG00000004897	"Cell division cycle 27"	P30260	17	47117703-47189422	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016315, HPA028129, HPA052399, HPA065835"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: , HPA065835: "	"unprognostic (2.34e-2)"	"unprognostic (8.83e-3)"	"prognostic favourable (1.77e-4)"	"unprognostic (4.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavourable (4.38e-4)"	"prognostic unfavourable (8.15e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (6.39e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.66e-2)"	29.2	18.9	19.4	18.7	25.2	23.0	23.3	26.0	33.0	23.7	17.2	14.8	13.8	14.4	23.2	19.6	17.6	17.6	18.6	22.8	18.3	22.6	16.8	23.8	20.4	21.3	19.4	23.9	19.5	14.3	27.8	26.8	25.0	31.5	17.6	18.2	14.6	15.7	16.5	31.6	15.5	15.3	24.4	17.7	24.2	16.1	23.5	17.4	25.2	42.8	15.5	22.9	23.6	17.3	9.0	7.7	9.6	10.3	12.8	11.6	5.4	23.2	24.9	20.9	16.9	14.1	22.5	12.4	32.9	29.7	31.5	32.3	15.9	12.3	31.3	22.2	27.6	11.2	22.5	18.6	43.4	45.0	23.1	36.4	26.4	14.1	15.3	21.4	16.6	16.3	9.2	28.3	22.4	32.5	29.0	17.5	25.6	19.8	26.2	9.7	9.9	20.4	14.1	53.8	13.9	18.9	14.7	13.9	17.0	16.5	5.8	18.3	17.6	15.1	34.5	32.9	28.6	20.8	24.3	17.9	31.0	28.5	18.2	12.8	22.7	9.6	4.4	6.2	8.1	10.3	7.8	6.0	6.8	8.5	6.0	9.0	6.7	7.6	5.7	12.8	7.4	7.7	11.6	5.4	19.4	25.2	26.0	33.0	18.3	22.6	19.4	23.9	31.5	17.4
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34"	P49427	19	531712-542092	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370"	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	16.5	15.9	21.3	11.3	19.1	24.7	20.4	25.7	30.9	16.0	20.5	19.5	10.5	15.4	13.3	13.4	15.6	14.5	13.6	35.6	21.1	18.2	12.1	36.0	13.0	9.9	18.5	19.8	17.0	37.4	11.3	17.0	24.9	16.2	17.2	10.6	15.3	26.4	18.5	63.9	19.0	13.2	18.6	14.3	12.7	15.7	43.6	15.0	12.2	13.1	17.0	8.7	19.2	16.4	2.9	2.8	11.5	4.5	1.5	4.1	1.3	18.4	18.4	23.7	19.5	10.8	10.3	23.7	16.6	12.7	17.9	18.7	28.6	11.3	10.2	17.4	11.8	12.8	18.6	14.0	9.2	16.6	50.0	9.4	12.2	30.9	26.9	13.2	11.4	13.3	21.0	15.1	15.8	21.3	40.2	20.4	11.8	26.4	18.0	17.6	29.9	17.9	16.7	12.2	17.1	13.5	11.0	30.9	22.9	14.4	15.0	27.6	12.0	19.4	17.4	13.1	15.6	30.4	22.1	20.4	15.6	13.6	17.9	18.7	13.5	4.5	3.5	6.2	2.3	3.4	1.7	2.9	3.2	4.1	2.8	1.7	2.5	2.4	11.5	1.5	4.5	2.3	3.1	1.3	21.3	19.1	25.7	30.9	21.1	18.2	18.5	19.8	16.2	15.0
CDC37	P50CDC37	ENSG00000105401	"Cell division cycle 37"	Q16543	19	10391134-10420121	"Cancer-related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003928, CAB004214"	Supported		Supported	Cytosol			260000	Cytosol		"CAB004214: AB_627232, HPA003928: AB_1846373"	"unprognostic (2.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"prognostic favourable (2.33e-4)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.02e-2)"	47.3	29.7	33.0	41.6	33.0	41.8	42.0	35.8	46.8	31.9	35.5	17.8	32.7	31.8	36.3	34.8	37.9	30.1	42.8	49.5	28.1	31.3	33.6	35.6	38.2	33.4	26.6	36.4	34.4	34.2	26.8	24.2	34.3	32.9	31.5	27.7	21.6	37.0	34.4	148.6	29.3	31.3	28.7	23.0	43.5	34.0	23.4	29.8	32.6	33.5	50.7	34.6	33.0	48.0	33.2	45.2	40.0	46.0	40.2	52.3	53.0	52.9	35.2	19.0	27.1	26.2	22.9	24.5	62.9	28.6	39.7	34.1	40.2	20.9	31.6	51.1	38.4	33.1	25.7	40.8	27.5	25.4	75.8	60.0	28.5	56.9	41.4	34.7	27.5	27.9	22.4	46.3	20.9	50.8	46.5	38.3	30.6	50.4	34.6	85.5	46.5	62.5	34.5	25.5	36.2	36.3	34.6	22.2	32.4	29.5	31.2	26.9	21.4	37.5	56.4	46.5	26.7	63.7	50.2	52.2	51.3	39.1	36.5	56.5	37.5	29.2	46.0	40.0	52.3	45.8	47.3	33.2	42.3	46.9	45.2	29.1	33.0	38.1	26.6	40.2	44.1	38.4	44.0	53.0	33.0	33.0	35.8	46.8	28.1	31.3	26.6	36.4	32.9	29.8
CDC37L1	"CDC37B, FLJ20639, HARC"	ENSG00000106993	"Cell division cycle 37 like 1"	Q7L3B6	9	4679559-4708398	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.8"	"Cell line enriched"	"Detected in all"	4	"HDLM-2: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021175	Approved		Supported	Cytosol				Cytosol		"HPA021175: AB_10959752"	"unprognostic (1.18e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.71e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.78e-2)"	"unprognostic (7.97e-2)"	"prognostic favourable (2.66e-7)"	"unprognostic (8.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.28e-2)"	14.9	12.6	10.4	7.1	15.4	5.6	10.5	12.4	14.9	12.2	10.0	7.1	11.2	7.8	10.9	12.0	15.8	10.1	11.6	28.6	11.2	12.6	13.4	42.0	8.4	9.0	10.0	9.9	12.4	15.1	9.3	13.7	7.5	17.3	13.0	6.5	6.2	9.4	11.1	58.8	8.1	8.0	17.9	8.8	6.3	9.5	10.8	8.9	7.0	12.2	14.0	7.2	18.0	16.1	10.7	6.2	14.8	6.8	8.1	20.7	7.9	7.1	6.4	3.4	5.5	12.4	9.2	5.2	8.4	5.8	5.1	5.8	2.0	4.4	4.5	2.3	6.1	3.1	3.8	5.0	5.0	52.8	3.2	12.0	7.0	5.5	7.5	4.8	4.9	5.9	6.7	3.8	6.0	3.6	1.4	7.0	5.6	3.4	3.7	10.0	8.7	2.3	3.0	4.2	2.6	7.3	2.9	9.8	4.9	6.2	5.0	4.1	4.2	4.6	3.9	7.7	3.6	4.3	5.5	5.4	8.6	3.3	6.9	3.4	2.4	14.8	5.7	11.0	13.3	5.3	13.1	10.7	13.4	14.0	5.4	10.5	20.7	18.5	6.8	8.1	6.8	6.2	12.1	7.9	10.4	15.4	12.4	14.9	11.2	12.6	10.0	9.9	17.3	8.9
CDC40	"EHB3, FLJ10564, PRP17, PRPF17"	ENSG00000168438	"Cell division cycle 40"	O60508	6	110180141-110254275	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046620			Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA046620: "	"unprognostic (4.19e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.09e-1)"	13.1	20.7	13.4	13.9	32.8	36.3	15.3	15.4	34.1	15.0	12.7	12.4	11.7	12.0	13.8	12.1	13.3	12.7	11.7	11.3	18.0	11.0	19.9	19.9	12.0	19.5	12.7	12.5	18.7	14.3	17.1	34.0	11.9	14.7	14.5	13.8	11.4	13.3	11.6	16.4	11.8	14.9	13.1	11.6	21.3	12.4	13.1	13.3	29.1	18.1	12.7	19.8	14.2	12.6	23.6	19.8	18.3	17.3	12.4	14.0	7.7	6.5	6.1	11.0	19.1	11.4	11.8	9.0	12.8	15.8	12.9	16.5	13.4	6.8	22.0	14.4	11.4	9.4	16.9	10.4	18.5	17.6	12.8	18.0	8.7	7.2	14.9	23.1	24.3	10.7	10.0	13.7	11.1	12.9	18.0	13.3	12.9	6.4	17.1	8.7	11.0	6.7	15.1	13.0	7.6	9.6	14.0	11.8	11.7	9.4	8.3	9.1	7.8	22.4	14.4	7.1	7.0	16.5	14.1	6.7	9.0	19.9	11.5	19.5	10.2	18.3	15.0	15.3	11.7	15.8	11.3	23.0	11.6	11.9	12.4	23.6	14.0	12.0	16.9	12.4	17.3	19.8	12.7	7.7	13.4	32.8	15.4	34.1	18.0	11.0	12.7	12.5	14.7	13.3
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22052627-22092946	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"			42000000	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: "	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavourable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	76.4	42.0	42.2	45.8	45.9	103.1	44.1	48.8	51.3	46.4	56.1	63.0	27.7	42.1	93.6	33.5	62.0	40.5	42.9	36.3	43.7	56.8	66.3	67.2	55.0	60.3	48.5	33.9	59.0	35.2	30.7	33.0	83.6	55.7	44.1	56.6	40.5	72.9	35.3	38.8	50.1	61.7	52.0	61.7	66.9	45.4	34.6	24.8	60.3	44.4	48.8	60.1	50.8	45.8	25.3	36.0	67.9	71.4	29.4	36.3	48.6	54.8	26.2	45.9	39.7	54.8	57.9	49.2	59.3	56.8	66.1	61.5	31.4	66.9	44.5	46.7	73.2	35.8	42.9	65.6	79.5	58.9	33.1	77.2	35.9	37.0	48.2	66.2	64.1	53.3	71.7	61.5	36.1	95.7	43.1	49.2	77.5	23.1	41.5	53.2	30.3	32.2	34.9	53.7	41.5	57.4	51.1	33.4	30.4	53.0	41.3	43.9	43.7	38.2	83.4	48.8	46.2	62.8	35.2	27.3	54.8	50.9	42.9	72.3	49.8	46.3	45.6	52.3	33.9	60.0	33.0	25.3	36.3	34.5	36.0	24.1	26.6	35.0	67.9	29.4	71.4	23.5	33.7	48.6	42.2	45.9	48.8	51.3	43.7	56.8	48.5	33.9	55.7	24.8
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	"CDC42 binding protein kinase gamma"	Q6DT37	11	64823387-64844569	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.1;HaCaT: 14.3;MCF7: 19.3;RT4: 11.7;SK-BR-3: 11.9;T-47d: 11.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"cerebellum: 19.4"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"cerebellum: 5.9"	"Low region specificity"	"Detected in single"			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol				Cytosol		"HPA027382: AB_1846378, HPA061836: "	"unprognostic (3.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"prognostic favourable (5.99e-13)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.99e-3)"	0.5	2.7	0.8	2.1	0.5	1.1	3.5	19.4	0.8	2.9	9.1	0.8	6.3	8.2	1.0	8.0	14.3	2.9	10.5	0.5	0.7	0.0	3.5	0.5	4.2	0.7	0.5	0.5	1.5	7.9	7.0	6.5	13.0	2.0	4.4	3.4	1.0	14.3	7.6	0.5	22.4	19.7	1.6	0.8	0.8	8.5	2.5	0.7	1.8	3.9	8.1	7.7	5.4	6.3	0.4	0.0	0.0	0.0	0.2	1.0	0.1	5.5	0.8	0.5	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	7.4	4.7	0.1	2.8	0.0	14.3	0.8	5.6	0.0	0.2	2.2	0.4	3.1	2.3	0.0	0.1	1.4	0.0	7.0	0.0	0.1	0.0	3.7	0.0	0.0	19.3	0.1	1.0	1.7	0.8	0.8	0.3	2.6	3.4	11.7	10.2	0.5	1.8	11.9	0.3	11.6	0.2	0.0	0.0	2.0	0.0	0.0	1.3	1.3	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.8	0.5	19.4	0.8	0.7	0.0	0.5	0.5	2.0	0.7
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560447-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 9.4;intermediate monocyte: 2.9;myeloid DC: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;monocytes: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006379	Approved		Supported	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA006379: AB_1078486"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	19.1	26.2	12.1	10.6	29.4	1.9	21.9	2.9	27.3	17.2	13.0	68.7	7.2	19.7	21.0	6.2	25.0	20.4	31.9	12.2	18.3	10.1	14.6	57.4	18.6	6.9	41.4	13.1	31.7	80.8	7.4	5.7	24.9	28.7	11.5	9.9	12.0	36.5	16.9	7.2	22.4	13.8	13.2	34.5	9.7	69.5	8.8	34.2	0.4	9.7	14.2	14.2	10.3	19.2	0.6	3.5	0.4	9.4	0.6	0.3	3.5	30.2	8.8	3.8	17.1	6.1	10.5	18.6	17.4	10.3	20.1	13.9	21.5	3.9	0.0	6.1	20.1	23.6	4.5	8.7	6.7	3.7	15.2	0.1	8.5	12.9	43.8	0.0	0.1	19.5	13.2	16.5	15.8	14.9	18.9	0.1	8.2	10.3	0.0	0.1	3.4	19.9	0.1	6.9	0.6	7.0	0.4	0.1	0.7	12.7	28.4	27.2	12.6	2.7	22.7	42.2	25.2	20.2	24.0	0.0	0.1	0.0	16.7	0.1	33.9	0.4	9.4	0.0	0.2	2.9	0.2	0.0	0.1	0.1	3.5	0.6	0.1	0.3	0.3	0.6	0.2	0.4	0.0	3.5	12.1	29.4	2.9	27.3	18.3	10.1	41.4	13.1	28.7	34.2
CDC42EP2	"BORG1, CEP2"	ENSG00000149798	"CDC42 effector protein 2"	O14613	11	65314818-65322429	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 28.3;U-2197: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 13.3;intermediate monocyte: 29.8;neutrophil: 46.1;non-classical monocyte: 21.7"	"Group enriched"	"Detected in many"	13	"granulocytes: 46.1;monocytes: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038562	Approved		Supported	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA038562: AB_10671745"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.73e-3)"	"prognostic unfavourable (2.89e-5)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-2)"	47.2	5.1	7.7	11.8	37.7	2.1	32.1	3.2	15.4	15.9	11.2	39.1	4.7	12.6	13.9	6.3	11.5	12.7	20.5	11.4	10.7	6.6	9.9	6.5	15.0	8.8	31.4	8.9	10.5	7.9	2.2	4.3	16.9	19.7	8.5	4.5	2.5	4.1	8.3	7.0	4.6	10.6	11.6	24.4	15.3	12.0	2.4	24.7	0.0	17.3	7.0	3.2	18.6	16.2	0.2	2.8	46.1	29.8	0.0	0.1	3.9	5.0	6.1	2.2	3.5	8.3	13.3	0.7	5.2	19.0	5.8	7.1	10.2	9.8	0.9	13.0	11.6	6.0	2.4	13.9	1.8	1.9	3.2	1.2	8.3	7.0	22.4	0.3	0.6	6.0	1.8	16.0	14.7	14.4	2.3	3.1	5.3	8.1	0.8	0.8	3.5	28.3	1.3	1.2	1.7	11.1	2.8	0.7	2.3	11.0	9.3	1.0	1.8	0.4	15.9	4.2	4.2	30.8	2.1	1.1	1.7	1.7	6.7	0.4	3.3	0.0	13.3	0.5	0.1	29.8	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	46.1	0.0	21.7	0.2	0.0	3.9	7.7	37.7	3.2	15.4	10.7	6.6	31.4	8.9	19.7	24.7
CDC42EP3	"BORG2, CEP3, UB1"	ENSG00000163171	"CDC42 effector protein 3"	Q9UKI2	2	37641882-37738468	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034986, HPA061792"	Approved		Supported	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA034986: AB_10602207, HPA061792: "	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.14e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.53e-2)"	19.7	2.1	5.1	5.7	5.8	18.9	14.0	2.4	6.6	13.6	14.4	2.9	1.8	0.9	33.3	6.6	5.0	8.6	4.9	14.3	2.6	1.8	8.4	3.0	10.6	5.7	3.2	2.3	7.7	7.4	1.1	5.5	6.0	3.8	24.9	4.9	7.9	5.8	28.5	27.8	5.3	6.3	25.4	3.2	6.9	5.4	60.2	2.7	14.8	6.4	3.5	5.2	14.9	8.2	7.2	8.4	51.9	30.3	10.1	21.8	13.8	16.7	6.5	3.8	0.2	14.6	7.7	5.8	14.5	38.6	22.6	16.5	11.9	6.8	3.1	11.5	34.2	8.1	4.6	17.3	23.2	11.2	1.3	5.3	6.6	0.0	28.3	1.2	0.3	23.2	16.2	19.5	43.5	13.1	0.8	2.4	106.2	0.1	0.7	9.4	7.5	3.9	0.4	28.0	1.5	16.3	8.1	4.1	11.3	7.1	5.1	8.7	1.7	10.0	9.7	27.1	7.0	7.1	14.7	4.4	5.9	1.0	11.2	8.1	37.5	11.0	21.8	1.7	20.2	15.3	21.8	7.2	13.1	17.3	8.4	2.9	4.4	11.1	51.9	10.1	30.3	0.2	9.4	13.8	5.1	5.8	2.4	6.6	2.6	1.8	3.2	2.3	3.8	2.7
CDC42EP4	"BORG4, CEP4, KAIA1777, MGC17125, MGC3740"	ENSG00000179604	"CDC42 effector protein 4"	Q9H3Q1	17	73283624-73312175	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 15.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023335, HPA024797"	Approved	Supported	Supported	"Plasma membrane,Actin filaments,Microtubules"				"Actin filaments, Microtubules"	"Plasma membrane"	"HPA023335: AB_10603783, HPA024797: AB_10600696"	"unprognostic (8.76e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (6.29e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	36.0	27.7	24.4	15.2	31.2	8.8	65.2	35.5	45.4	23.5	21.6	28.7	33.4	24.3	23.9	44.5	19.7	41.8	25.2	27.6	28.9	18.4	12.0	15.4	15.9	12.2	20.8	21.1	50.3	50.8	19.9	20.8	15.8	30.7	18.0	13.0	21.8	22.0	38.5	16.7	16.4	22.0	18.9	30.6	11.9	21.6	13.7	24.2	5.9	26.5	14.2	18.9	14.1	46.1	0.1	3.6	4.7	15.6	0.2	0.1	1.4	11.3	26.5	9.9	8.1	20.2	16.9	25.0	10.1	12.7	9.7	7.1	5.6	16.2	0.0	9.0	12.4	8.1	6.9	6.8	6.0	0.5	6.4	2.5	13.7	13.3	10.0	0.4	2.8	21.0	5.9	8.2	4.3	10.9	6.9	0.5	6.0	8.5	0.4	3.3	5.4	18.4	0.3	4.4	1.2	11.6	13.0	6.5	9.8	7.3	21.4	7.1	24.9	3.7	11.0	9.2	18.9	7.1	7.3	0.5	0.4	0.0	14.7	1.8	23.5	2.8	2.6	4.7	0.1	7.0	0.1	0.1	0.0	0.0	3.6	0.0	0.1	0.0	4.6	0.2	15.6	0.1	0.0	1.4	24.4	31.2	35.5	25.1	28.9	18.4	20.8	21.1	30.7	24.2
CDC42SE1	"SCIP1, SPEC1"	ENSG00000197622	"CDC42 small effector 1"	Q9NRR8	1	151050971-151070325	"Predicted intracellular proteins"	"Cell shape, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027634	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA027634: AB_10600861"	"unprognostic (1.59e-2)"	"unprognostic (5.76e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavourable (2.19e-6)"	"unprognostic (9.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.86e-3)"	"unprognostic (4.12e-2)"	26.8	21.7	15.7	33.8	21.6	39.2	22.1	13.8	19.7	18.7	17.5	23.9	25.0	11.4	18.5	20.1	45.2	20.2	25.0	21.5	15.8	13.9	21.2	15.9	34.0	42.6	30.0	14.8	22.2	18.1	45.5	19.1	46.6	21.5	27.1	20.0	14.7	33.5	32.1	12.0	27.4	27.5	21.4	21.6	60.3	21.3	6.0	23.3	29.3	23.3	27.7	47.7	24.5	29.2	10.0	11.7	74.8	16.1	17.7	24.2	6.2	13.0	6.2	10.7	6.7	8.4	8.1	16.5	9.9	10.3	11.4	9.8	5.9	14.0	9.5	8.1	11.1	16.3	11.3	17.4	10.0	14.9	6.0	15.3	6.5	2.9	11.2	13.5	24.6	9.1	28.1	14.3	11.2	14.2	24.0	22.3	12.8	19.5	9.8	9.8	12.0	6.8	8.7	9.1	10.6	14.4	21.0	4.6	10.9	8.5	18.5	17.4	20.6	24.3	13.4	11.2	8.2	8.5	18.0	14.7	11.7	100.0	8.0	10.3	24.6	20.7	9.0	44.1	19.1	16.1	15.2	9.4	16.4	17.2	11.7	10.0	13.8	16.9	74.8	17.7	15.6	4.4	24.2	6.2	15.7	21.6	13.8	19.7	15.8	13.9	30.0	14.8	21.5	23.3
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell line enhanced"	"Detected in many"		"K-562: 86.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.1	11.0	13.7	10.7	0.6	1.3	5.8	16.2	7.6	18.7	18.6	8.4	7.3	14.6	5.7	4.8	12.6	14.6	10.7	16.8	17.8	24.7	19.5	12.4	9.2	0.7	28.3	10.7	0.4	0.5	14.3	6.4	9.4	86.6	18.4	10.9	17.5	22.9	13.4	4.1	8.3	19.1	22.8	6.4	4.3	12.6	17.7	9.3	8.8	9.7	2.8	6.3	12.6	3.6	14.6	23.4	11.0	14.7	6.3	11.6	17.0	7.7	14.2	19.5	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2
CDC5L	"CDC5, CEF1, hCDC5, PCDC5RP"	ENSG00000096401	"Cell division cycle 5 like"	Q99459	6	44387525-44450426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006302, HPA011361, CAB012275"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379"	"unprognostic (2.67e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (7.02e-5)"	"unprognostic (1.01e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	21.3	18.6	17.1	17.4	17.6	24.5	18.3	30.3	22.1	19.4	16.1	12.2	13.9	12.6	18.2	20.5	20.4	15.1	12.0	18.0	17.4	15.3	16.4	24.7	12.8	16.3	16.6	15.0	21.8	15.0	32.4	26.1	20.8	19.2	19.6	15.6	8.6	16.8	13.6	30.8	14.8	15.9	23.2	18.1	17.6	14.3	16.9	19.1	28.4	16.0	17.4	18.1	26.0	16.6	11.5	13.6	21.1	17.6	14.8	14.8	8.2	20.4	8.0	19.7	16.0	8.1	10.6	11.2	14.9	11.7	18.9	20.9	10.4	7.0	19.5	12.5	11.9	13.0	20.5	11.8	28.4	16.4	18.5	26.0	8.0	13.4	7.4	19.5	14.1	8.1	10.4	18.4	16.0	12.2	19.9	11.5	17.0	13.7	18.0	13.4	13.9	7.4	14.1	22.7	12.6	10.7	12.2	21.9	19.1	12.0	8.1	15.9	11.5	19.0	11.2	16.3	16.6	12.6	21.0	9.9	12.0	35.8	10.5	17.0	16.3	16.7	13.9	17.4	11.7	16.6	13.3	10.7	11.4	12.9	13.6	11.5	12.2	11.8	21.1	14.8	17.6	11.8	14.8	8.2	17.1	17.6	30.3	22.1	17.4	15.3	16.6	15.0	19.2	19.1
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287633-40304657	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA050114, HPA065070"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"				"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: , HPA065070: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	1.8	2.9	3.1	10.8	2.6	16.8	1.5	2.3	6.0	2.7	5.8	0.8	2.7	5.3	1.9	1.6	9.0	1.3	5.4	1.6	1.9	1.4	1.8	5.1	2.8	10.6	1.0	1.5	1.5	3.6	1.1	1.2	9.4	0.8	1.4	5.6	0.2	3.2	4.1	0.9	2.3	7.9	2.4	1.6	7.7	2.7	14.8	1.2	30.0	1.3	5.0	10.1	4.1	3.0	0.7	6.2	0.2	0.3	2.2	3.4	1.2	25.0	17.3	21.0	14.9	1.1	2.3	19.1	27.3	8.2	23.9	29.0	19.6	11.2	20.2	17.1	5.8	36.4	18.1	12.4	23.8	10.7	14.2	16.4	20.7	17.6	0.7	22.4	10.1	0.5	0.9	27.7	16.7	7.2	29.9	19.0	11.6	13.1	32.5	5.4	17.2	6.4	24.0	51.0	19.1	4.0	28.2	14.4	12.9	24.8	85.2	8.4	17.3	19.4	6.0	17.3	24.7	28.3	32.3	7.9	17.2	39.0	15.0	14.8	18.9	0.1	0.3	0.0	1.3	0.0	0.9	0.7	1.2	2.1	1.4	0.7	0.9	2.1	0.2	2.2	0.0	6.2	3.4	1.2	3.1	2.6	2.3	6.0	1.9	1.4	1.0	1.5	0.8	1.2
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500893-91525764	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"				Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: "	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	2.5	3.7	5.7	7.6	8.9	15.4	4.3	19.4	10.3	2.5	4.2	1.4	0.9	4.2	2.8	2.6	4.7	1.7	2.6	1.9	6.8	5.2	3.6	2.3	5.1	11.7	4.0	4.7	3.7	2.4	2.2	12.3	7.9	5.2	2.7	6.8	2.3	2.5	2.3	1.0	6.8	4.9	3.3	5.9	15.1	2.6	21.2	4.7	18.7	2.5	4.5	12.0	4.2	3.0	1.6	3.5	0.1	1.6	2.4	6.5	2.1	14.0	4.2	27.1	7.7	0.6	3.6	8.6	5.3	4.2	10.5	11.5	8.7	5.0	9.7	7.5	3.3	6.1	17.8	6.0	14.6	16.1	15.3	14.8	12.0	4.1	1.0	16.1	5.4	1.9	1.8	9.6	5.5	4.0	19.5	14.2	7.2	5.1	13.7	14.4	22.5	9.9	17.1	22.5	6.2	4.6	10.6	21.6	8.5	16.9	4.7	9.4	4.4	7.9	3.3	12.0	10.6	9.2	8.0	5.2	6.6	26.1	4.3	15.6	4.4	0.0	1.6	0.0	5.9	1.2	5.2	1.5	4.5	5.6	3.5	1.6	2.5	5.1	0.1	2.4	0.3	2.1	6.5	2.1	5.7	8.9	19.4	10.3	6.8	5.2	4.0	4.7	5.2	4.7
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121997-193253901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016359, HPA030772"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA030772: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	23.4	20.0	18.1	16.8	22.9	21.0	20.1	25.6	22.6	20.4	20.1	14.5	16.3	12.0	26.8	15.2	20.6	14.9	16.4	21.4	18.4	15.0	18.8	17.1	17.2	16.6	19.7	15.9	23.3	14.5	27.1	24.8	17.3	19.4	26.9	16.2	13.6	17.3	19.0	44.5	15.0	14.5	25.6	23.9	16.0	15.7	16.3	22.1	20.6	27.1	14.1	15.8	26.8	35.0	6.6	6.7	10.2	7.0	9.0	12.5	5.2	13.3	12.0	15.9	10.2	14.9	14.5	12.2	14.4	14.0	17.4	15.3	8.2	15.9	17.4	10.2	17.7	13.1	14.4	13.6	21.3	11.0	6.8	12.6	10.9	8.0	14.0	17.1	12.6	11.8	13.2	16.3	15.6	14.8	19.1	14.1	23.3	12.3	13.9	8.5	15.3	4.5	12.5	9.6	16.6	20.4	9.3	4.8	13.1	18.0	22.2	20.5	19.1	12.4	16.5	17.0	3.9	14.4	14.7	13.2	9.8	14.3	10.2	10.5	29.6	6.6	7.0	10.2	9.3	6.8	12.5	6.6	9.2	9.2	6.7	5.4	8.4	8.7	7.4	9.0	5.7	4.9	9.3	5.2	18.1	22.9	25.6	22.6	18.4	15.0	19.7	15.9	19.4	22.1
CDCA2	"PPP1R81, Repo-Man"	ENSG00000184661	"Cell division cycle associated 2"	Q69YH5	8	25458997-25507920	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 38.8;testis: 17.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.6;T-reg: 1.9"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA026293, HPA030049"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA026293: AB_1846384, HPA030049: AB_10600862"	"unprognostic (2.12e-1)"	"unprognostic (4.75e-3)"	"prognostic favourable (9.62e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.47e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (2.30e-14)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.30e-2)"	0.8	0.5	0.3	11.3	0.5	5.5	0.6	0.3	0.3	0.7	3.3	0.2	0.0	1.3	0.5	0.2	2.8	0.3	0.1	0.6	0.3	0.3	0.5	0.5	0.6	4.4	0.4	0.2	0.4	0.3	0.0	0.4	3.3	0.3	0.5	2.0	0.1	0.7	0.0	0.4	1.0	3.3	0.6	1.0	3.9	0.8	17.7	0.4	38.8	0.4	3.5	5.9	0.6	1.0	0.7	0.0	0.0	0.0	2.6	1.9	0.8	14.7	13.9	13.0	10.8	1.1	2.0	8.6	16.5	9.8	14.5	14.5	11.9	6.8	17.5	7.1	6.8	13.5	18.0	8.4	21.4	6.5	5.2	17.9	10.1	6.4	0.2	7.9	8.7	1.1	0.5	10.1	6.9	10.4	14.0	20.2	13.2	5.8	22.2	3.7	13.3	6.2	11.4	14.4	6.4	4.1	8.0	5.5	5.9	14.0	6.8	6.5	7.5	3.9	7.2	10.8	17.3	20.3	15.2	3.4	6.9	18.5	7.7	10.4	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.6	0.0	0.0	1.9	0.8	0.3	0.5	0.3	0.3	0.3	0.3	0.4	0.2	0.3	0.4
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059416, HPA064971"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA059416: , HPA064971: "	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavourable (4.19e-4)"	"prognostic unfavourable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavourable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	4.5	2.6	1.7	11.5	2.6	38.3	4.1	8.3	3.2	8.7	3.7	2.6	4.5	4.1	5.6	4.0	16.6	4.1	4.2	2.4	1.5	1.3	2.8	3.0	5.1	9.1	2.7	1.4	5.0	6.2	1.6	1.9	12.4	3.3	4.6	2.7	3.3	5.3	2.2	1.3	21.8	4.4	3.1	2.3	6.7	3.6	12.8	2.3	24.9	5.1	11.2	15.0	3.7	8.8	7.4	4.2	8.3	4.3	10.6	14.7	5.5	15.0	15.7	18.2	13.7	3.1	5.2	23.8	22.5	6.9	17.7	15.5	19.2	19.3	19.8	12.3	7.9	24.2	12.7	25.9	10.4	21.6	10.0	12.5	13.4	16.0	3.8	22.1	10.5	3.7	8.1	13.6	12.8	11.9	13.7	20.5	12.2	36.9	20.6	14.9	13.5	36.0	20.0	26.5	7.3	6.0	17.5	10.6	13.1	21.5	8.6	17.3	17.0	14.9	18.5	15.7	19.9	21.5	29.9	7.6	9.4	20.2	13.1	11.2	25.9	0.9	3.6	8.3	10.9	3.9	13.3	7.4	11.4	14.7	3.9	5.2	6.8	8.0	1.3	10.6	4.3	4.2	8.9	5.5	1.7	2.6	8.3	3.2	1.5	1.3	2.7	1.4	3.3	2.3
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"NK-cell: 5.8;T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.8;T-cells: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023691	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA023691: AB_1846392"	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.3	1.3	1.1	12.3	1.1	27.4	4.3	1.0	2.8	1.6	3.8	0.6	0.0	3.3	0.9	1.4	7.9	0.7	1.4	1.3	1.1	0.9	1.3	1.3	1.9	9.5	1.1	0.5	0.8	0.7	0.2	0.7	5.5	1.3	0.9	4.7	0.1	1.5	0.1	0.7	2.4	3.6	1.7	0.7	5.7	2.1	27.9	0.2	39.9	0.7	6.6	9.9	1.5	2.3	1.2	0.8	0.3	0.5	5.8	4.2	1.4	30.7	17.6	16.9	14.3	1.1	1.8	14.1	22.0	9.2	25.8	20.6	18.0	18.7	28.0	12.7	7.1	21.3	27.3	12.1	25.2	28.0	11.9	25.2	12.8	15.1	0.1	26.8	20.4	0.6	1.1	24.1	11.2	7.8	28.5	51.8	15.7	25.5	37.8	27.7	26.6	21.4	33.2	18.6	26.7	5.3	11.8	22.0	16.5	14.1	20.2	14.9	26.0	13.2	4.9	23.4	24.2	24.6	24.4	26.2	41.5	45.6	9.4	16.5	24.1	0.0	0.2	0.3	0.8	0.0	0.1	0.7	1.1	0.6	0.8	1.2	0.1	0.8	0.1	5.8	0.5	0.7	4.2	1.4	1.1	1.1	1.0	2.8	1.1	0.9	1.1	0.5	1.3	0.2
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 8.3;olfactory region: 21.4"	"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA005565: AB_2078680"	"unprognostic (1.67e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (4.96e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.97e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.53e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.47e-2)"	1.1	0.6	1.2	28.0	1.5	9.7	1.8	0.5	1.4	8.3	12.3	2.8	2.6	14.9	7.9	1.7	12.9	2.3	6.6	0.9	2.0	1.4	0.8	0.4	1.3	17.2	1.3	2.2	1.1	2.9	0.0	0.4	7.3	3.4	3.2	14.8	1.1	3.3	0.6	4.3	8.3	16.4	1.5	2.0	2.9	7.6	8.1	2.0	71.4	0.9	10.5	24.0	2.3	8.0	2.6	4.2	0.3	0.7	3.6	9.4	2.7	9.8	7.6	17.9	19.4	0.8	3.3	18.7	5.9	2.1	14.2	16.0	11.7	12.5	27.6	7.6	3.6	10.3	28.3	10.7	20.7	13.2	15.6	6.2	5.5	14.8	0.9	40.3	5.9	2.7	0.9	7.7	6.4	6.4	14.9	6.3	4.1	7.9	61.8	40.7	21.1	5.3	43.7	13.6	17.5	6.8	8.7	5.2	9.2	9.3	3.1	5.0	0.0	15.9	2.9	9.3	4.0	3.0	10.9	1.7	3.7	38.7	5.8	22.5	7.8	0.0	0.7	0.0	1.4	0.0	0.5	2.6	3.9	7.6	4.2	0.3	0.3	1.4	0.3	3.6	0.0	0.6	9.4	2.7	1.2	1.5	0.5	1.4	2.0	1.4	1.3	2.2	3.4	2.0
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900900-21946084	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"olfactory region: 22.0"	HPA027169	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058"	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	6.2	1.2	3.7	19.9	9.6	24.2	8.0	6.5	4.2	8.4	9.0	7.8	3.9	5.2	11.1	3.6	6.0	7.0	5.4	12.5	3.9	2.5	2.7	4.5	7.3	18.7	6.2	4.0	13.9	17.4	1.0	1.6	2.2	3.7	7.6	10.2	5.8	10.5	8.0	2.7	13.6	8.7	6.6	3.0	9.3	12.7	12.6	5.3	47.9	20.0	5.1	16.5	6.0	9.4	38.5	21.8	11.8	1.3	0.8	9.7	3.3	19.6	6.7	6.3	0.1	3.5	4.4	0.0	16.1	13.9	12.5	17.8	2.5	17.9	41.0	5.3	13.8	12.1	10.0	16.5	25.4	0.0	6.6	9.8	20.0	1.6	4.5	25.8	0.1	8.3	3.0	9.7	28.4	24.7	13.5	0.0	9.7	7.3	32.5	9.3	36.3	8.4	32.7	22.8	27.4	3.5	3.7	23.3	19.0	7.3	4.5	7.3	10.9	11.7	10.4	13.7	16.9	23.8	19.4	21.1	14.5	53.0	13.1	34.8	13.4	0.3	0.6	11.8	0.6	0.9	0.1	28.6	1.9	0.9	4.3	38.5	9.7	3.9	1.1	0.8	1.3	21.8	2.7	3.3	3.7	9.6	6.5	4.2	3.9	2.5	6.2	4.0	3.7	5.3
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692418-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Cytokinetic bridge"				Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.2	1.4	0.9	12.9	1.7	19.0	1.7	0.8	1.6	1.8	6.0	1.1	0.7	5.3	1.4	1.3	9.6	0.7	2.4	0.8	0.9	0.9	1.3	1.5	2.0	12.2	1.8	1.3	0.9	1.0	0.1	0.8	3.7	1.3	1.0	7.7	0.7	2.1	1.0	0.9	4.0	5.4	1.6	1.2	5.4	3.5	44.7	1.7	51.6	0.9	6.5	14.6	1.6	2.9	2.8	1.8	4.5	5.0	6.3	8.9	2.5	28.0	12.3	23.2	16.7	1.0	2.0	15.6	21.2	10.7	37.5	26.6	19.1	21.1	34.1	8.6	13.5	16.0	26.6	14.1	39.9	22.7	11.9	30.7	13.1	15.1	0.2	29.5	15.9	0.7	1.0	21.1	18.7	16.5	25.9	36.7	27.0	12.5	27.2	18.1	26.8	17.0	26.5	31.7	19.5	8.5	11.8	20.7	9.1	23.3	11.0	14.3	16.1	11.2	9.9	18.5	19.6	10.5	33.1	25.0	32.4	46.5	8.7	27.5	21.1	0.0	1.1	1.8	2.5	2.2	4.5	2.8	5.7	3.3	1.0	2.5	1.9	3.8	4.5	6.3	5.0	1.8	8.9	2.5	0.9	1.7	0.8	1.6	0.9	0.9	1.8	1.3	1.3	1.7
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737225-68835548	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 125.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 105.6;CACO-2: 35.5;CAPAN-2: 49.6;HaCaT: 47.9;hTCEpi: 33.8;MCF7: 29.3;RT4: 36.5;T-47d: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"myeloid DC: 2.8;plasmacytoid DC: 8.5"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"			22000000	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: , CAB072856: , CAB072857: , HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.1	0.7	1.3	14.8	1.5	0.5	15.3	0.8	1.1	14.4	63.8	1.8	42.4	25.5	4.7	18.6	48.5	9.7	48.9	0.8	1.5	1.0	24.2	64.9	24.4	0.5	1.8	0.9	5.6	71.5	62.2	13.2	55.2	2.8	28.9	25.9	11.8	66.6	43.7	0.8	30.5	125.5	1.5	1.1	3.5	21.6	2.1	1.8	11.7	83.0	26.2	32.6	16.8	21.7	0.0	8.5	0.0	0.0	0.3	0.4	0.1	21.3	2.2	0.0	0.0	0.0	0.0	105.6	0.0	0.0	0.0	0.0	35.5	49.6	0.0	0.4	0.0	47.9	0.0	23.8	0.0	4.1	0.6	0.0	0.1	7.6	0.0	0.0	0.2	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.1	0.8	0.1	0.0	0.0	0.3	8.7	36.5	1.3	0.1	0.2	0.0	9.0	31.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.8	0.0	0.0	0.0	0.0	0.3	0.0	8.5	0.1	0.1	1.3	1.5	0.8	1.1	1.5	1.0	1.8	0.9	2.8	1.8
CDH13	CDHH	ENSG00000140945	"Cadherin 13"	P55290	16	82626803-83800640	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 47.5;U-138 MG: 61.3;U-87 MG: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.9;monocytes: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001380, CAB025863"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"		230000000	"Plasma membrane"		"CAB025863: , HPA001380: AB_1078371"	"unprognostic (2.50e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.06e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (1.73e-6)"	"unprognostic (5.16e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	14.0	2.3	13.9	2.7	14.8	0.7	7.6	0.6	32.5	32.7	3.6	2.0	2.8	1.3	36.1	8.9	6.4	6.1	3.6	34.6	5.2	9.9	3.7	1.4	10.8	1.2	4.2	13.3	3.2	0.8	1.1	0.7	4.0	3.8	2.8	4.2	0.9	4.0	5.0	37.2	14.3	1.8	19.5	3.4	1.6	1.7	3.6	1.6	0.0	4.1	21.3	2.7	4.6	14.6	1.0	0.9	2.9	7.2	0.1	0.1	0.3	2.2	0.0	0.8	0.1	14.0	13.5	0.0	10.0	11.0	11.6	5.0	0.0	0.0	0.0	1.9	29.1	18.9	0.2	14.9	17.5	0.0	0.1	0.0	7.4	0.0	8.1	0.1	0.1	1.7	13.0	23.3	28.5	5.7	0.0	0.1	47.5	0.1	0.0	0.1	2.3	4.1	0.0	12.5	0.0	10.0	0.1	0.0	0.0	17.9	0.1	0.0	0.2	0.0	9.1	61.3	5.0	0.4	9.0	0.0	0.0	0.0	53.4	0.1	15.0	2.9	1.0	2.4	0.1	3.8	0.1	0.9	0.1	0.0	0.9	1.0	0.1	0.1	2.0	0.1	7.2	0.6	0.1	0.3	13.9	14.8	0.6	32.5	5.2	9.9	4.2	13.3	3.8	1.6
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171767-89195492	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 44.2;skeletal muscle: 60.3"	"Cell line enriched"	"Detected in some"	5	"RH-30: 56.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	24	"cerebellum: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"cerebellum: 17.6"	"Region enriched"	"Detected in many"	6	"cerebellum: 17.9"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"			390000	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: "	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.8	0.2	0.0	0.1	0.0	0.1	0.1	44.2	0.2	0.7	0.1	0.0	0.0	0.2	0.1	2.8	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.2	0.1	0.0	0.0	0.1	0.9	0.1	0.0	0.8	1.8	0.5	0.1	0.0	0.3	0.2	60.3	0.1	0.1	0.1	0.3	0.6	0.1	0.3	0.0	0.0	0.1	6.5	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.0	0.0	0.0	0.0	0.1	0.0	56.6	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	44.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127171-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 184.4"	"Group enriched"	"Detected in some"	7	"CACO-2: 33.3;U-266/70: 55.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"			3400000	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.3	0.2	0.2	17.6	0.3	0.3	0.3	0.2	0.2	0.3	88.9	0.2	0.2	54.5	0.4	0.3	0.4	0.4	7.0	0.6	0.2	0.3	0.3	0.3	0.3	0.5	0.2	0.2	0.3	0.4	0.0	0.3	0.2	0.2	0.4	44.0	0.2	0.3	0.2	0.3	0.2	184.4	1.4	0.2	0.6	0.3	0.3	0.2	0.3	0.2	0.2	0.5	0.4	0.3	1.5	0.8	12.1	1.0	1.4	0.6	0.1	0.1	6.1	0.3	0.4	0.0	0.1	0.5	0.1	0.1	0.0	0.1	33.3	1.5	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.5	0.1	0.6	0.2	0.1	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.4	0.2	0.5	0.2	0.2	0.4	0.1	1.0	0.1	0.1	0.6	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.3	0.5	0.2	55.3	0.1	0.1	0.1	0.2	0.3	2.5	1.0	1.2	0.5	0.8	0.3	0.6	0.5	0.4	0.8	1.5	0.5	0.6	12.1	1.4	0.5	0.7	0.5	0.1	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27950966-28177446	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.6;parathyroid gland: 35.4"	"Cell line enhanced"	"Detected in many"		"AF22: 56.4;BJ: 40.7;fHDF/TERT166: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.4;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			160000000	"Plasma membrane, Cell Junctions"		"CAB000141: , CAB018580: AB_626778, CAB078686: , HPA058574: "	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	29.6	9.8	1.5	9.4	0.5	0.5	5.7	16.1	3.2	2.0	8.0	0.2	0.8	3.1	1.9	0.6	4.7	1.7	77.6	9.9	9.6	9.2	23.3	0.7	1.1	6.0	9.1	3.4	0.7	35.4	5.4	0.5	5.9	1.4	0.8	6.8	0.5	4.6	0.4	0.5	0.9	3.2	6.7	5.9	2.5	19.6	7.4	0.9	2.8	0.0	1.0	1.0	1.3	0.0	0.0	4.4	0.0	0.7	0.9	0.0	0.0	4.5	56.4	0.0	8.9	1.8	0.0	40.7	12.4	16.6	15.2	0.0	0.0	0.0	21.9	84.2	6.0	9.2	0.0	23.6	0.1	5.9	0.0	15.2	14.0	8.5	0.0	0.0	0.8	0.1	38.1	6.7	14.5	0.0	0.0	12.9	0.0	10.2	0.0	7.5	4.9	0.0	6.7	7.7	0.0	1.8	14.7	25.5	0.0	0.0	4.5	0.0	0.0	2.2	36.0	11.5	0.5	29.4	0.0	0.0	0.0	6.9	0.0	27.7	4.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	0.0	0.0	9.8	9.4	5.7	10.1	9.9	9.6	6.0	9.1	5.9	7.4
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958427-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.1;prostate: 15.3"	"Cell line enriched"	"Detected in some"	6	"RT4: 33.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;eosinophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"				"Plasma membrane"	Microtubules	"HPA015722: AB_2077659, HPA047578: "	"unprognostic (2.42e-1)"	"prognostic favourable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.8	0.5	0.8	0.7	1.2	1.3	0.8	2.0	1.1	3.8	0.7	0.7	0.7	0.5	1.3	0.7	3.8	2.5	0.7	0.7	1.2	1.0	0.7	0.7	2.9	0.7	1.3	0.7	2.0	0.7	0.7	1.9	0.7	1.4	15.3	0.4	1.4	2.8	0.7	1.0	0.4	0.7	0.7	1.6	0.7	1.9	0.7	0.7	4.2	0.7	0.7	16.1	6.2	1.3	0.0	0.9	1.6	1.4	0.0	0.2	0.4	0.0	0.5	0.1	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.6	0.6	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.2	0.2	0.1	1.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.4	0.1	0.0	0.0	0.6	0.0	33.9	0.7	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.0	1.4	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	1.2	2.0	1.1	1.2	1.0	1.3	0.7	1.4	0.7
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68722616	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;retina: 40.5"	"Cell line enhanced"	"Detected in some"		"A-431: 24.4;HaCaT: 67.7;HBEC3-KT: 32.6;hTCEpi: 26.1;hTERT-HME1: 19.9;RPTEC TERT1: 29.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"pons and medulla: 16.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavourable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	2.2	0.1	1.0	2.5	1.2	0.0	8.7	1.5	1.1	10.5	1.0	2.2	3.0	0.3	9.4	10.3	23.5	8.9	1.4	0.4	1.1	0.8	8.3	0.2	3.6	2.1	0.6	0.4	32.6	0.4	0.5	3.6	6.4	16.0	11.7	0.5	40.5	9.3	4.4	0.1	21.2	0.4	4.1	1.5	10.0	0.7	2.2	0.1	44.0	2.0	26.1	20.1	2.5	6.7	0.9	0.6	1.4	0.5	0.6	0.8	0.2	24.4	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	14.6	9.1	0.0	0.1	0.0	67.7	0.6	32.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.1	0.0	19.9	0.0	0.0	0.0	0.0	12.7	0.0	0.0	1.2	2.0	0.0	0.0	0.0	29.3	11.0	0.1	0.0	0.2	0.0	11.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.2	0.4	0.2	0.3	0.6	0.5	0.4	0.1	0.9	0.6	0.8	1.4	0.6	0.2	0.6	0.2	0.2	1.0	1.2	1.5	1.1	1.1	0.8	0.6	0.4	16.0	0.1
CDH4		ENSG00000179242	"Cadherin 4"	P55283	20	61252426-61940617	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.9;hTERT-HME1: 10.4;U-2 OS: 14.2;U-251 MG: 24.7"	"Group enriched"	"Detected in many"	6	"glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015613			Supported	"Plasma membrane"				"Plasma membrane"		"HPA015613: AB_1845905"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	1.0	1.2	17.4	0.7	15.8	0.9	0.9	1.3	13.6	0.9	0.7	4.0	0.0	0.8	0.9	0.7	1.4	2.6	0.9	1.0	10.2	6.9	0.8	0.9	1.0	0.9	2.8	11.8	6.2	2.0	0.7	0.5	0.9	3.3	0.8	0.7	0.6	1.5	3.6	9.8	2.7	0.8	0.7	1.6	10.2	0.8	1.9	3.1	0.0	1.7	0.0	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.9	7.9	0.0	0.1	0.5	0.1	2.2	0.0	4.0	0.4	0.2	0.0	0.0	0.2	2.6	2.9	0.0	4.3	1.6	0.2	0.0	0.0	0.1	0.1	5.5	0.0	0.1	0.8	1.0	0.8	10.4	0.8	0.0	0.0	1.6	0.3	0.1	0.0	0.9	0.0	0.0	0.0	1.1	2.5	0.0	0.7	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	14.2	0.1	24.7	4.6	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.0	17.4	15.8	1.3	13.6	10.2	6.9	2.8	11.8	3.3	3.1
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404786	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 96.6"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 111.2;TIME: 95.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"			1000000000	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	48.7	5.6	4.0	6.2	5.8	0.6	28.1	2.6	4.8	11.1	6.6	3.4	5.5	3.7	18.7	11.2	8.4	7.2	12.6	21.7	4.5	4.3	7.8	12.7	43.7	9.7	6.5	2.8	7.7	3.6	5.0	3.5	96.6	7.6	9.0	4.8	8.5	5.2	4.4	19.0	7.0	6.8	12.1	5.4	10.8	5.7	6.7	3.3	1.2	16.6	15.7	4.5	11.7	11.3	0.0	0.6	0.4	0.8	0.1	0.1	1.1	0.0	0.0	0.6	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	111.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	95.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	1.1	4.0	5.8	2.6	4.8	4.5	4.3	6.5	2.8	7.6	3.3
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193750-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 73.8"	"Cell line enriched"	"Detected in some"	8	"EFO-21: 104.0"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Cell Junctions"			1200000	"Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	6.7	1.9	3.4	2.2	7.5	0.6	3.9	1.1	8.4	7.0	2.1	2.4	1.0	2.1	4.5	8.4	3.8	10.0	13.4	3.0	3.3	4.3	73.8	1.4	6.5	1.1	5.0	4.8	3.5	1.3	2.5	2.1	5.3	5.6	2.4	1.7	20.4	1.4	2.9	1.9	1.8	2.0	4.0	6.3	1.4	1.8	0.9	5.5	0.0	3.5	3.3	1.3	4.4	3.4	0.6	0.5	1.7	0.5	0.7	0.4	0.3	0.0	0.4	13.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	104.0	0.0	0.0	10.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.3	0.0	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.3	1.5	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.3	0.2	0.6	0.3	0.4	1.7	0.7	0.5	0.5	0.3	0.3	3.4	7.5	1.1	6.7	3.3	4.3	5.0	4.8	5.6	5.5
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510675-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA049352: "	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favourable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	17.7	14.2	36.8	6.9	41.6	5.1	8.2	36.4	54.6	13.6	9.5	16.3	2.7	30.0	13.4	4.4	8.0	10.9	9.5	25.0	33.8	37.1	23.7	13.2	9.6	8.2	34.2	38.9	18.7	22.9	10.4	19.3	8.5	26.3	13.2	4.1	7.8	10.8	14.7	34.0	9.1	24.2	8.7	20.7	12.0	9.2	10.1	15.7	13.0	10.6	6.7	6.9	7.8	6.3	8.7	9.2	19.3	19.2	14.3	15.9	7.2	3.8	1.6	5.4	1.6	0.4	0.0	0.1	5.9	0.9	5.8	5.0	9.3	1.5	0.2	6.0	4.8	0.1	4.9	20.8	1.0	13.1	9.3	17.6	6.2	24.1	3.9	8.5	11.0	5.7	10.8	5.2	0.8	4.6	0.3	4.8	6.5	0.4	6.6	11.1	12.0	4.6	25.0	4.8	48.1	1.2	0.1	16.3	7.0	11.8	0.5	7.3	2.1	4.7	0.2	3.0	8.9	2.0	0.2	12.9	11.9	17.8	0.1	8.6	2.0	3.2	7.9	19.3	15.9	12.5	8.6	8.7	5.7	8.9	7.6	8.3	11.4	9.7	6.2	14.3	19.2	9.2	9.1	7.2	36.8	41.6	36.4	50.3	33.8	37.1	34.2	38.9	26.3	15.7
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavourable (1.10e-6)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.2	18.4	48.9	19.3	3.2	4.9	20.1	36.5	26.6	44.5	42.9	43.0	42.7	44.2	14.2	10.0	30.0	33.2	21.2	46.4	31.4	24.2	23.2	18.1	24.9	0.5	35.5	24.0	0.9	2.1	28.8	28.1	26.7	35.3	54.5	49.5	12.8	44.6	25.5	21.5	38.7	38.8	45.5	21.7	17.0	16.0	22.9	20.1	24.5	37.3	18.9	40.2	21.8	11.0	19.0	40.6	20.0	49.8	21.4	34.3	39.9	16.4	39.8	23.6	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"				Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: , HPA059634: , HPA067060: "	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favourable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favourable (3.63e-4)"	12.3	19.9	16.8	16.4	23.8	17.3	10.1	14.8	21.9	11.1	18.3	8.1	16.4	23.4	12.1	21.7	14.4	14.4	19.4	8.7	15.3	12.6	22.2	33.9	11.8	14.0	13.3	19.4	11.3	22.2	21.6	27.7	13.6	15.8	13.6	12.6	8.1	17.2	8.9	17.5	14.1	20.7	9.0	10.7	15.9	19.0	8.7	13.6	8.0	27.1	10.1	12.1	10.8	14.5	7.8	14.5	3.4	15.3	15.2	13.3	8.8	14.5	9.5	7.7	3.1	3.2	6.1	8.0	12.0	6.8	8.6	2.9	7.3	11.1	12.9	6.2	10.4	10.2	3.3	16.8	5.4	2.8	8.0	5.1	10.6	0.8	13.2	8.2	9.3	7.4	5.6	5.4	8.2	15.0	13.3	1.7	9.8	19.0	9.9	23.5	15.6	7.2	14.4	10.4	18.1	15.4	11.6	7.5	16.3	15.1	7.0	3.5	16.5	13.0	13.2	5.9	15.1	6.1	8.2	6.6	3.6	4.0	8.9	14.2	8.3	3.2	11.7	3.4	12.9	15.3	10.9	6.8	11.4	8.9	14.5	7.8	13.3	10.9	1.5	15.2	11.2	10.0	8.8	8.8	16.8	23.8	14.8	21.9	15.3	12.6	13.3	19.4	15.8	13.6
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	"Cyclin dependent kinase 11A"	Q9UQ88	1	1702730-1724324	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.5"	"Low lineage specificity"	"Detected in all"											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: "	"unprognostic (6.25e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.32e-3)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.97e-2)"	"prognostic unfavourable (5.06e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (1.15e-6)"	"unprognostic (1.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	14.3	14.9	17.2	23.7	26.9	39.7	13.0	35.2	32.7	12.5	16.4	14.3	6.1	29.2	16.5	8.5	12.1	12.6	10.2	10.2	19.4	8.4	11.7	12.5	19.0	20.3	22.6	9.0	16.2	12.9	12.2	27.5	12.9	17.1	14.4	14.6	11.6	12.7	10.3	21.5	15.1	34.9	13.1	26.0	24.2	15.7	16.4	25.1	14.9	14.6	7.6	22.4	13.5	15.2	7.4	11.8	33.5	6.3	4.4	5.5	1.4	16.1	9.7	7.0	6.4	9.2	7.4	6.9	15.9	7.1	7.9	9.2	12.2	14.8	17.2	9.7	4.6	12.0	6.5	8.2	6.3	13.1	10.4	15.3	18.3	10.9	6.1	17.1	22.1	8.5	5.6	6.9	4.5	13.6	17.9	14.4	6.6	9.1	7.9	13.4	9.7	8.3	14.5	10.7	8.3	6.4	7.3	7.8	11.3	13.9	16.4	19.1	11.0	7.1	13.8	12.5	12.1	5.6	8.8	20.1	14.6	21.6	4.2	13.9	3.9	16.7	6.3	7.7	5.5	3.4	4.2	6.2	4.7	4.2	2.0	7.4	4.7	4.0	33.5	4.4	3.7	11.8	4.5	1.4	17.2	26.9	35.2	32.7	19.4	8.4	22.6	9.0	17.1	25.1
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461511-39564907	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	16.0	13.1	12.4	17.4	9.2	32.4	14.0	23.4	17.8	18.2	17.6	9.6	15.7	11.1	15.7	12.0	16.9	12.2	12.5	11.0	10.1	6.7	10.2	18.5	13.5	15.2	10.9	14.3	17.4	11.3	19.0	12.2	18.4	9.5	12.7	11.7	10.4	15.6	11.1	11.1	17.0	16.5	11.0	10.6	16.3	11.8	18.9	8.3	29.0	15.0	5.4	17.3	16.3	20.5	5.1	4.0	10.4	2.9	6.6	4.0	0.9	8.7	10.8	6.5	6.1	4.8	5.4	6.1	7.9	6.7	10.9	8.1	13.3	5.4	12.4	7.0	8.3	14.2	13.0	10.0	10.5	8.1	11.2	13.4	7.4	10.3	4.7	18.3	9.4	5.8	6.9	13.2	10.5	6.6	22.7	8.2	6.2	4.1	14.9	4.7	6.8	4.9	9.9	14.1	7.0	4.1	10.5	7.0	4.5	10.1	85.6	6.9	11.0	7.9	7.1	9.9	7.9	6.9	10.2	6.7	4.8	17.5	7.0	7.8	6.4	10.4	2.9	4.1	4.0	2.2	3.0	2.9	2.5	2.7	1.8	5.1	2.9	2.7	9.7	6.6	1.8	4.0	2.0	0.9	12.4	9.2	23.4	17.8	10.1	6.7	10.9	14.3	9.5	8.3
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39949646-40099580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA059241: "	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	16.9	15.3	16.0	29.0	14.5	26.7	20.4	23.3	18.2	16.6	18.3	16.4	14.2	11.3	20.3	17.7	20.9	18.1	20.2	13.6	14.3	11.3	14.7	17.5	19.6	21.9	16.5	15.1	24.2	15.3	26.3	15.3	14.8	12.0	15.5	15.5	14.9	17.6	14.5	19.4	16.7	16.3	16.4	11.5	17.4	14.5	20.2	15.7	31.2	23.1	14.6	21.5	18.5	23.6	14.0	3.9	7.9	3.4	5.0	5.0	1.4	15.6	9.3	16.3	15.5	14.7	14.4	11.2	12.5	13.6	11.5	14.4	9.7	10.8	28.4	7.3	13.1	19.1	13.3	11.0	17.0	13.9	9.8	12.6	11.4	8.8	14.1	19.2	13.8	8.5	14.8	13.1	17.6	13.5	21.3	19.7	11.9	8.0	15.2	13.6	23.5	10.9	16.9	10.8	11.4	10.8	15.8	11.6	16.8	15.9	34.4	11.3	14.1	23.9	16.0	15.9	15.2	10.2	17.0	16.2	13.7	23.4	11.6	17.4	20.2	7.9	2.7	4.4	5.0	2.2	3.4	7.6	4.8	3.7	1.5	14.0	4.9	4.9	7.6	5.0	3.4	3.9	4.3	1.4	16.0	14.5	23.3	18.2	14.3	11.3	16.5	15.1	12.0	15.7
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	"Cyclin dependent kinase 14"	O94921	7	90466424-91210590	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 9.8;granulocytes: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015267	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA015267: AB_1855249"	"prognostic favourable (5.86e-4)"	"unprognostic (3.96e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (7.79e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.39e-3)"	8.2	4.7	19.8	7.1	19.4	6.1	8.3	28.6	34.9	10.6	5.2	3.7	0.6	2.7	8.6	3.2	3.1	12.0	11.9	11.5	25.8	15.5	19.8	12.7	9.2	10.9	17.3	17.4	14.9	14.2	3.8	14.2	5.9	22.8	11.3	3.4	4.3	7.7	7.0	5.4	2.7	3.8	7.4	7.0	7.5	7.4	7.2	4.5	0.9	13.1	1.6	11.9	6.9	6.7	9.8	0.9	7.5	0.7	0.1	0.2	0.6	7.0	0.0	14.1	1.8	13.2	13.4	3.2	5.9	5.6	3.6	3.9	0.1	3.4	25.0	0.7	5.8	2.1	0.7	8.3	7.0	0.0	3.3	0.0	4.7	0.1	6.1	7.1	0.1	9.5	2.1	10.8	3.9	4.6	0.1	30.8	7.3	0.0	0.0	2.7	8.9	3.8	19.2	19.4	19.0	1.9	1.9	3.1	9.1	15.0	0.0	0.3	1.9	3.6	11.3	15.7	20.1	13.1	9.0	17.4	13.3	17.9	5.9	9.4	15.3	7.5	0.3	0.5	0.0	0.7	0.0	9.8	0.0	0.0	0.9	5.3	0.0	0.0	5.6	0.1	0.5	0.1	0.2	0.6	19.8	19.4	28.6	34.9	25.8	15.5	17.3	17.4	22.8	4.5
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966769-55972784	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 105.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: "	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.94e-4)"	"prognostic unfavourable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavourable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	10.7	7.6	4.5	20.8	6.5	18.7	11.5	4.2	4.3	12.6	11.6	3.5	6.0	6.1	10.7	6.4	13.6	10.8	12.6	10.1	5.4	2.2	8.3	16.7	19.5	12.2	6.0	2.0	14.2	8.3	5.2	4.2	49.0	7.3	10.8	9.1	51.2	9.3	9.9	10.8	14.6	9.3	11.8	5.0	12.5	10.1	7.8	5.1	39.3	9.5	10.7	14.7	16.7	10.1	9.3	10.8	5.2	3.9	4.5	7.6	4.3	16.5	8.9	19.6	10.9	4.0	5.2	36.2	20.6	10.8	25.6	24.0	18.7	15.9	15.7	15.5	7.6	10.6	14.9	9.0	26.1	18.5	14.6	18.1	14.8	7.1	1.3	14.3	13.1	2.7	2.3	17.3	6.0	12.9	17.2	14.3	17.8	12.7	29.6	12.1	7.8	13.3	29.0	18.9	11.8	7.4	16.2	8.1	10.5	23.5	8.6	105.5	18.6	10.5	7.2	17.7	17.2	13.6	15.0	8.2	9.4	19.6	10.0	10.5	15.2	5.2	3.6	3.1	7.0	3.9	7.0	9.3	3.2	5.0	2.7	6.1	3.0	5.3	1.7	4.5	1.6	10.8	7.6	4.3	4.5	6.5	4.2	4.3	5.4	2.2	6.0	2.0	7.3	5.1
CDK20	"CCRK, p42"	ENSG00000156345	"Cyclin dependent kinase 20"	Q8IZL9	9	87966441-87974753	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.4;THP-1: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.2"	"Group enriched"	"Detected in many"	7	"NK-cells: 7.2;T-cells: 5.0"	"Low region specificity"	"Detected in all"							"HPA007666, HPA027379, HPA027401"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553"	"unprognostic (4.60e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.69e-2)"	"prognostic favourable (2.59e-4)"	"unprognostic (2.32e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.04e-2)"	"prognostic favourable (2.12e-5)"	"unprognostic (8.24e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.42e-2)"	2.6	16.2	10.8	2.4	13.0	1.6	4.1	8.7	17.1	8.7	5.0	6.1	5.1	5.3	7.2	6.0	2.8	19.5	5.6	3.0	8.6	10.7	8.2	3.2	4.0	2.0	5.8	14.3	9.5	4.8	7.6	10.8	3.1	9.3	6.1	3.4	7.7	3.6	8.6	2.1	3.6	7.6	5.5	3.1	1.6	3.7	17.7	5.2	0.8	6.8	1.2	1.1	6.3	3.0	0.1	0.8	0.4	0.8	7.2	5.0	1.3	2.3	3.0	2.4	7.6	1.7	2.4	1.0	2.1	4.2	5.8	5.4	0.7	3.5	0.0	3.3	3.5	3.1	0.0	2.1	2.4	5.9	2.4	0.0	1.9	0.0	7.4	2.8	3.3	1.9	4.4	9.2	3.8	0.0	0.3	0.0	1.7	7.0	1.9	0.8	1.9	1.1	0.0	0.0	0.1	7.4	2.0	14.4	4.0	2.5	3.0	3.6	3.3	21.6	0.0	2.6	1.0	0.5	2.4	3.8	3.6	0.0	9.3	1.9	2.7	0.0	0.7	0.4	1.3	0.8	0.5	0.0	3.0	1.9	0.7	0.1	5.0	3.2	0.1	7.2	0.7	0.8	2.7	1.3	10.8	13.0	8.7	17.1	8.6	10.7	5.8	14.3	9.3	5.2
CDK2AP1	"doc-1, DOC1, DORC1, p12DOC-1, ST19"	ENSG00000111328	"Cyclin dependent kinase 2 associated protein 1"	O14519	12	123260971-123272334	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.0;intermediate monocyte: 40.5;myeloid DC: 14.9;non-classical monocyte: 44.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 14.9;monocytes: 44.8"									"CAB019377, HPA057648, HPA068833"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB019377: , HPA057648: , HPA068833: "	"unprognostic (1.56e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.77e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (5.27e-7)"	"unprognostic (9.32e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.18e-1)"	29.9	28.3	60.4	20.1	55.4	21.0	61.5	27.4	61.6	42.6	22.8	62.8	15.0	13.1	34.5	45.2	30.9	25.5	29.9	30.1	61.0	52.4	20.8	18.2	21.1	22.2	76.4	30.3	16.9	16.4	24.2	22.4	21.4	53.6	33.0	21.9	16.4	51.0	35.4	26.6	21.6	12.6	41.0	96.8	17.7	19.4	22.7	59.9	17.9	16.6	22.1	18.0	36.9	23.4	0.2	14.9	5.1	44.8	0.3	0.5	7.6	15.9	22.5	60.1	64.1	48.7	60.8	10.9	52.0	48.9	41.7	32.1	16.9	15.4	0.0	23.3	80.0	14.8	63.7	34.0	34.7	9.9	16.0	8.6	13.7	26.7	26.0	13.2	9.3	38.6	35.6	24.2	15.7	59.2	11.4	0.1	78.5	30.9	17.5	21.4	39.4	16.9	67.1	26.0	6.9	33.9	38.8	57.0	66.7	38.2	18.7	51.1	36.3	13.3	36.1	39.0	20.4	22.8	34.2	2.8	5.2	14.7	21.0	6.4	84.7	3.8	13.0	5.1	0.2	40.5	0.5	0.2	0.2	0.3	14.9	0.0	0.1	0.2	0.7	0.3	44.8	1.4	0.1	7.6	60.4	55.4	27.4	52.2	61.0	52.4	76.4	30.3	53.6	59.9
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 125.1;LHCN-M2: 138.1;RH-30: 434.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: "	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	32.2	43.1	13.8	22.2	15.7	24.0	45.0	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31.0	32.3	27.4	14.5	12.1	24.0	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25.0	16.0	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.3	10.8	14.3	12.7	13.1	11.5	9.5	5.4	17.6	23.8	19.8	15.4	8.9	13.6	9.7	8.4	7.2	19.7	125.1	18.1	6.7	9.1	12.7	7.3	10.8	15.4	14.4	8.8	11.3	9.2	14.6	16.8	15.3	13.5	11.7	138.1	13.5	13.7	11.7	16.8	11.0	12.4	434.6	12.6	7.4	14.7	12.9	12.1	9.5	7.2	14.4	9.6	17.5	6.9	11.2	10.5	12.6	10.9	5.8	9.5	20.9	10.3	13.3	13.4	1.7	14.3	2.6	26.2	19.9	27.0	29.6	23.1	23.7	21.0	28.1	32.1	28.5	1.2	15.8	12.0	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16.0	17.5
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB008909: , HPA064535: "	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5.0	6.2	5.8	25.0	19.7	9.0	7.7	5.3	6.0	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6.0	6.3	5.7	6.5	6.2	6.0	8.6	5.2	5.7	3.1	7.7	6.8	6.0	3.6	6.9	6.7	3.1	6.6	21.5	9.0	21.7	9.5	14.9	10.6	11.6	14.0	13.1	21.3	14.5	10.7	6.5	7.7	12.8	15.2	12.6	9.9	10.9	11.5	27.7	9.5	8.3	21.0	11.8	7.0	9.1	12.5	12.6	12.3	9.8	9.6	10.2	23.7	11.5	8.8	12.5	3.9	10.2	12.8	8.4	15.2	22.6	27.4	20.8	14.4	22.1	13.4	5.4	12.8	13.2	8.8	8.3	35.7	11.1	13.7	14.6	6.4	9.0	8.6	15.0	3.9	11.2	14.4	19.6	21.4	4.5	23.6	14.7	26.8	7.8	19.0	9.0	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25.0	19.7	15.4	15.4	20.8	7.7
CDK5R1	"Nck5a, p35, p35nck5a"	ENSG00000176749	"Cyclin dependent kinase 5 regulatory subunit 1"	Q15078	17	32486619-32491256	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 58.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 31.5;SK-MEL-30: 22.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000252			Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA000252: "	"unprognostic (1.08e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.74e-5)"	"unprognostic (1.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.03e-1)"	1.6	3.3	21.9	6.4	21.1	4.9	1.8	26.0	58.8	1.2	1.6	3.6	0.0	2.0	1.6	1.0	5.5	1.5	1.6	1.6	21.4	17.3	1.5	1.3	1.4	11.5	7.6	24.5	3.2	2.0	1.3	3.0	1.4	7.8	1.4	1.5	0.9	1.2	1.3	1.8	2.2	2.0	1.3	4.1	7.7	2.2	5.2	3.2	1.2	1.1	0.3	12.3	1.7	1.1	0.6	1.8	2.9	0.9	0.7	4.2	1.5	2.0	1.1	5.2	1.6	0.6	1.0	0.6	1.2	0.7	1.5	2.0	3.0	0.5	1.0	1.2	1.0	0.9	2.0	1.2	2.1	0.3	3.9	0.3	0.5	1.1	0.2	0.6	1.1	0.6	3.1	1.6	1.3	1.1	2.0	1.2	3.2	0.8	1.7	0.8	3.3	1.1	1.5	3.1	3.6	0.7	0.9	31.5	8.5	1.2	0.7	22.6	1.3	2.4	1.1	2.1	3.2	0.8	3.2	0.6	0.8	1.0	1.8	2.9	5.1	0.0	0.9	1.2	2.3	0.8	1.8	0.6	3.1	1.3	0.2	0.5	4.2	2.6	2.9	0.7	0.4	1.8	0.4	1.5	21.9	21.1	26.0	37.3	21.4	17.3	7.6	24.5	7.8	3.2
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"				Centrosome	"Cell Junctions"	"CAB079753: , HPA035820: AB_10671939, HPA046529: "	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.8	23.3	14.0	10.1	14.9	12.5	12.3	9.5	14.0	13.1	13.2	12.6	17.8	5.7	12.0	21.0	18.4	14.1	13.5	14.2	7.4	15.2	30.8	23.3	9.5	18.7	10.2	26.8	9.4	12.4	16.4	12.1	14.0	15.5	18.3	21.5	20.0	12.0	21.6	12.7	19.7	27.9	8.4	10.0	7.6	15.3	17.6	21.4	11.8	14.2	27.6	12.9	8.1	12.2	13.3	14.2	13.9	11.3	15.7	20.0	12.7	12.0	25.5	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981774	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favourable (7.31e-5)"	15.5	19.7	20.8	30.0	38.3	21.2	22.5	35.7	31.9	21.1	21.2	27.1	39.4	24.1	26.2	45.4	20.8	26.1	22.0	14.4	23.2	16.7	23.2	31.0	18.8	22.0	31.3	25.8	28.9	51.9	29.4	41.3	15.4	27.3	24.2	25.5	25.1	44.0	26.4	10.7	16.8	25.8	18.4	18.2	32.3	28.6	40.1	29.5	32.3	29.7	16.5	24.6	20.0	18.5	22.8	26.9	27.2	33.5	22.4	22.3	21.0	22.3	36.0	19.9	35.6	16.7	16.8	35.7	16.3	19.8	16.5	15.2	28.2	21.7	26.9	33.8	17.0	21.9	12.9	18.3	18.5	39.7	17.0	12.8	42.9	38.2	18.7	15.1	14.3	19.1	15.5	14.8	29.1	15.9	15.1	25.0	16.7	42.8	41.1	24.5	12.0	15.6	22.0	33.5	30.5	16.4	28.1	13.6	32.6	12.6	11.3	16.4	25.7	19.8	12.7	13.7	12.2	16.5	20.8	32.9	31.0	16.6	17.1	21.0	16.6	9.1	33.5	27.2	20.9	32.7	22.3	22.1	20.0	18.5	26.9	22.8	18.1	19.9	15.7	22.4	32.5	24.4	19.0	21.0	20.8	38.3	35.7	31.9	23.2	16.7	31.3	25.8	27.3	29.5
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 91.7;REH: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavourable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (2.33e-5)"	6.6	11.3	6.0	9.1	7.5	22.5	5.9	2.4	6.0	7.8	10.0	9.6	5.7	7.5	6.0	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7.0	5.2	5.0	10.0	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2.0	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8.0	74.6	4.3	9.2	10.3	6.7	9.0	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6.0	2.8	7.8	5.0	2.3	2.6	1.6	6.3	3.9	3.1	3.0	7.7	4.7	4.7	3.6	4.2	3.8	4.3	9.0	7.4	10.3	3.0	11.8	5.4	7.4	1.4	7.3	0.5	2.5	4.9	4.2	20.0	1.2	11.2	13.0	5.6	1.2	91.7	0.7	2.4	2.6	44.8	27.6	7.9	4.3	0.1	4.1	26.8	0.7	2.1	3.7	0.1	12.0	4.6	10.3	16.1	4.0	12.6	7.0	0.1	6.3	1.5	25.0	13.6	4.9	1.9	6.5	5.2	3.9	5.9	2.0	5.5	5.6	4.0	3.6	7.1	4.0	1.1	3.9	4.8	5.6	2.8	2.3	6.0	7.5	2.4	6.0	6.9	4.2	7.0	5.2	7.5	8.0
CDKL1	KKIALRE	ENSG00000100490	"Cyclin dependent kinase like 1"	Q00532	14	50329404-50416461	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 16.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059605, HPA065919"	Uncertain		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA059605: , HPA065919: "	"unprognostic (4.12e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (5.53e-8)"	"unprognostic (1.21e-1)"	"unprognostic (7.96e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.31e-3)"	7.1	2.1	7.5	1.8	5.1	0.9	3.0	2.7	20.2	14.1	5.9	1.6	2.5	8.4	12.1	2.3	2.6	16.4	2.6	2.9	7.1	2.4	18.8	1.1	4.3	3.0	2.0	12.3	10.5	2.0	1.4	1.4	4.9	2.9	4.0	5.7	1.6	2.5	8.4	1.7	3.0	3.0	7.7	3.1	3.7	2.0	1.9	1.4	1.3	5.0	6.1	2.1	7.0	5.6	5.7	1.3	6.0	2.5	3.8	6.7	2.6	6.0	4.8	0.6	2.4	6.5	7.8	0.3	2.1	3.8	2.2	2.5	1.9	5.7	0.4	2.6	4.6	4.2	0.9	0.6	2.5	6.6	2.3	6.4	2.1	1.7	7.3	5.8	3.5	1.7	3.5	4.5	10.0	8.4	2.6	2.6	1.0	0.3	1.9	3.1	0.7	2.3	0.7	2.8	1.8	6.9	2.3	1.1	1.3	2.4	16.5	0.6	0.2	4.9	2.6	5.7	2.9	5.6	4.7	0.8	0.4	0.4	0.9	6.1	6.9	6.0	2.5	4.4	6.3	2.3	6.2	4.6	4.4	6.7	1.3	5.7	3.4	3.7	1.4	3.8	0.3	1.2	4.1	2.6	7.5	5.1	2.7	20.2	7.1	2.4	2.0	12.3	2.9	1.4
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0"	"Cell line enhanced"	"Detected in many"		"A549: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	3.3	3.2	8.0	1.8	24.7	3.2	4.3	3.9	28.0	5.4	2.7	7.7	1.8	1.5	4.5	2.8	5.2	2.8	3.1	5.0	8.0	3.7	6.3	2.2	6.9	1.4	3.5	13.2	6.7	4.5	6.2	5.0	5.4	5.9	6.7	2.2	2.0	3.9	4.4	3.0	3.5	1.9	4.0	5.7	2.3	4.9	14.0	5.7	1.6	5.1	0.8	2.1	5.6	4.6	0.7	1.0	7.7	1.0	0.5	0.6	0.2	1.7	12.3	3.5	3.1	3.3	4.5	2.5	2.0	3.8	2.8	3.2	4.0	2.3	1.9	0.4	1.3	0.5	4.0	3.0	5.9	0.5	2.6	0.0	7.1	3.1	1.6	0.1	0.8	2.6	3.1	6.8	7.1	1.3	0.1	1.9	4.2	1.7	0.8	0.8	7.1	3.0	0.7	3.8	0.1	2.4	8.9	0.7	4.4	4.5	1.1	2.2	1.6	0.7	7.3	4.3	1.9	7.9	1.5	0.3	0.1	0.3	2.4	0.5	4.2	7.7	1.0	2.1	0.6	0.6	0.3	0.2	0.4	0.3	0.3	0.7	0.6	0.6	4.7	0.5	0.6	1.0	0.2	0.2	8.0	24.7	3.9	28.0	8.0	3.7	3.5	13.2	5.9	5.7
CDKN1A	"CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1"	ENSG00000124762	"Cyclin dependent kinase inhibitor 1A"	P38936	6	36676460-36687339	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 97.4;HSkMC: 71.6;hTCEpi: 92.6;LHCN-M2: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 21.0;non-classical monocyte: 27.7"	"Group enriched"	"Detected in many"	8	"B-cells: 8.8;dendritic cells: 8.5;monocytes: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000064, HPA005946, CAB069401"	Supported		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB000064: , CAB069401: AB_1620493, HPA005946: "	"unprognostic (7.99e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.58e-1)"	"prognostic favourable (3.14e-5)"	"unprognostic (1.57e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-2)"	"unprognostic (7.55e-3)"	"prognostic favourable (4.95e-5)"	"unprognostic (8.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-2)"	81.2	27.0	8.2	21.9	29.8	22.0	38.0	4.8	13.7	25.2	60.8	13.9	10.2	39.8	17.5	17.7	63.5	49.4	47.3	35.9	22.2	8.4	29.1	102.2	55.8	6.3	16.6	4.9	59.1	45.5	12.8	22.8	38.6	44.1	42.0	40.7	8.8	18.0	11.4	98.6	43.5	144.9	40.2	29.6	13.6	25.2	25.3	10.3	6.6	22.7	42.2	27.4	50.5	44.4	8.8	8.5	1.8	27.7	0.2	1.1	13.3	3.0	12.4	9.6	0.2	33.8	60.5	17.6	50.3	40.8	6.2	24.5	1.1	2.9	2.0	1.8	31.5	6.9	0.4	55.5	10.1	4.0	2.5	0.3	10.3	15.4	97.4	0.0	15.1	71.6	92.6	57.1	18.0	32.4	0.5	14.2	72.2	6.4	0.4	1.2	1.2	1.8	6.1	7.9	3.5	11.0	23.1	4.3	4.2	11.6	1.0	2.3	3.8	12.6	17.9	10.9	10.3	0.7	4.1	23.9	4.6	6.1	14.1	1.1	30.3	0.0	9.3	0.2	0.2	21.0	0.3	8.8	0.4	0.3	8.0	5.7	0.1	0.1	1.8	0.2	27.7	8.5	1.1	13.3	8.2	29.8	4.8	13.7	22.2	8.4	16.6	4.9	44.1	10.3
CDKN1B	"KIP1, P27KIP1"	ENSG00000111276	"Cyclin dependent kinase inhibitor 1B"	P46527	12	12715058-12722371	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003691, CAB021888, HPA059086"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB003691: AB_425362, CAB021888: , HPA059086: "	"unprognostic (5.67e-2)"	"unprognostic (9.76e-2)"	"prognostic favourable (5.15e-4)"	"unprognostic (6.90e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (8.39e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	29.8	30.9	30.2	25.0	30.0	40.2	45.3	64.5	50.6	31.6	34.4	35.6	19.9	29.2	33.1	19.8	26.0	24.3	24.3	21.2	33.0	29.5	20.8	23.3	29.2	38.5	42.9	25.1	46.2	15.1	22.2	15.9	26.8	26.3	25.1	22.2	31.4	23.5	24.2	48.8	26.1	26.4	19.4	46.0	34.3	19.4	19.2	39.0	43.0	29.4	21.4	25.5	34.1	29.1	6.2	3.3	19.2	4.5	6.2	10.6	2.9	12.8	6.4	34.3	5.9	11.8	6.7	16.8	12.1	19.2	16.7	20.6	18.3	14.6	0.1	4.6	6.9	12.3	16.0	5.9	15.0	21.8	11.3	10.0	17.6	18.4	15.8	8.5	7.1	7.4	12.8	5.5	16.1	9.9	10.7	36.7	5.9	16.5	11.9	12.2	13.7	6.0	8.8	11.2	21.5	8.0	13.9	13.0	21.4	17.3	12.5	22.6	6.6	19.1	6.7	8.3	13.2	7.5	11.7	31.8	21.0	11.6	10.3	12.8	8.0	4.5	3.1	6.8	5.4	3.1	5.6	6.2	6.9	6.5	3.2	4.8	7.4	5.2	19.2	6.2	4.5	3.3	10.6	2.9	30.2	30.0	64.5	50.6	33.0	29.5	42.9	25.1	26.3	39.0
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967753-21995301	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.6;pituitary gland: 39.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.0;HEK 293: 56.7;HeLa: 53.1;SK-MEL-30: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 22.6"	"Group enriched"	"Detected in many"	8	"B-cells: 7.2;T-cells: 22.6"					"Low region specificity"	"Detected in many"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli				Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: "	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavourable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favourable (5.19e-4)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	5.4	8.6	2.9	4.5	3.9	1.8	5.3	1.7	3.1	1.2	2.5	4.4	0.1	1.2	1.2	1.9	6.3	3.0	2.6	0.7	1.7	1.0	0.9	1.2	3.0	3.0	3.6	1.6	1.5	1.5	8.5	39.3	6.7	5.0	1.9	1.1	1.2	2.4	2.9	0.9	1.3	3.7	1.0	3.0	8.9	6.0	13.0	1.9	3.9	1.4	3.0	14.0	2.7	1.5	7.2	0.2	0.8	1.8	0.4	22.6	2.2	2.1	0.0	0.3	14.1	0.1	0.1	6.1	2.3	0.0	19.6	34.9	3.5	50.0	7.2	32.2	1.6	6.0	5.9	36.4	15.8	30.9	56.7	0.0	53.1	2.3	1.5	3.5	3.0	3.8	0.0	19.8	11.0	2.0	0.0	32.9	17.9	0.1	0.3	0.0	0.4	29.2	0.0	13.3	26.4	4.0	0.0	33.0	2.3	38.0	6.3	53.0	7.5	0.1	6.5	0.1	0.4	0.0	0.1	14.7	8.3	29.4	0.0	9.4	0.1	0.8	1.3	0.2	6.2	0.6	9.7	7.2	8.0	11.0	0.2	7.0	0.5	4.7	0.4	0.4	1.8	0.0	22.6	2.2	2.9	3.9	1.7	3.1	1.7	1.0	3.6	1.6	5.0	1.9
CDKN2AIP	"CARF, FLJ20036"	ENSG00000168564	"CDKN2A interacting protein"	Q9NXV6	4	183444591-183448198	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041397, HPA062142"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA041397: AB_10794297, HPA062142: "	"unprognostic (9.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.65e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (3.00e-5)"	"unprognostic (2.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.23e-2)"	14.2	14.3	13.9	13.6	15.6	32.3	15.9	20.8	13.8	18.1	18.1	15.0	10.1	18.7	17.1	13.2	27.7	13.0	13.3	15.0	13.0	12.9	18.1	17.2	17.8	17.8	15.4	10.7	24.0	18.4	15.9	21.9	16.4	14.0	21.5	14.2	13.0	15.9	15.2	11.1	14.2	18.0	14.8	13.7	16.0	17.2	20.1	12.2	24.7	23.4	20.6	27.3	16.6	24.1	8.3	4.6	28.5	5.9	8.1	14.7	8.4	5.0	2.9	8.5	6.1	7.2	5.2	6.4	8.6	7.2	8.9	5.9	4.2	4.9	17.0	1.8	5.8	4.0	7.7	6.3	9.3	6.9	4.6	17.6	13.7	5.4	5.7	12.9	7.1	6.1	5.9	5.2	6.9	7.0	8.8	18.3	6.1	2.7	14.5	10.5	6.2	5.9	12.5	4.1	6.8	59.2	4.8	8.7	7.5	6.1	26.1	10.2	3.8	11.2	4.0	3.1	4.4	2.8	6.9	8.9	3.6	8.7	4.9	11.1	5.0	28.5	4.8	10.4	9.0	5.6	9.4	7.4	11.1	9.7	4.6	8.3	14.7	13.3	5.7	8.1	5.9	3.1	10.9	8.4	13.9	15.6	20.8	13.8	13.0	12.9	15.4	10.7	14.0	12.2
CDKN2D	"INK4D, p19"	ENSG00000129355	"Cyclin dependent kinase inhibitor 2D"	P55273	19	10566462-10569059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.1;bone marrow: 119.4"	"Cell line enhanced"	"Detected in many"		"HEL: 32.4;MOLT-4: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011201, HPA043546"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB011201: AB_261049, HPA043546: "	"unprognostic (3.08e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.55e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.90e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	5.5	4.7	27.9	6.8	24.2	119.4	4.1	14.3	28.7	2.6	3.9	4.2	0.5	3.9	2.4	2.5	3.8	3.0	4.0	8.4	22.9	17.9	2.7	2.1	6.6	11.1	14.3	14.3	2.8	2.8	2.6	3.4	4.8	11.8	2.5	3.6	2.4	3.2	3.0	6.3	6.0	3.5	4.6	5.7	9.7	2.8	10.9	3.6	18.6	1.8	2.8	8.4	4.2	2.4	17.3	16.0	44.1	10.7	11.9	11.3	9.5	10.9	1.7	5.6	3.7	3.0	4.7	1.4	7.2	8.5	8.0	7.0	2.2	2.6	3.0	2.4	7.6	2.3	1.9	1.8	2.9	12.2	4.6	32.4	2.0	3.6	3.5	3.2	26.3	1.9	6.0	4.1	3.0	2.2	1.3	26.7	7.9	1.5	39.9	17.1	1.1	8.4	6.5	5.5	1.8	3.6	0.9	7.9	4.2	5.1	3.8	5.5	3.4	8.6	1.7	9.5	4.9	15.6	10.7	16.8	5.7	5.6	10.0	5.5	6.7	35.9	5.6	23.5	10.0	6.8	8.0	17.3	8.3	11.3	5.4	15.9	7.9	9.4	44.1	11.9	10.7	16.0	6.7	9.5	27.9	24.2	14.3	28.7	22.9	17.9	14.3	14.3	11.8	3.6
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 80.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.1"	"Group enriched"	"Detected in all"	5	"NK-cells: 5.8;T-cells: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol				Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: "	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavourable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	2.4	1.0	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1.0	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3.0	1.4	1.9	1.0	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0.0	1.0	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4.0	2.2	1.0	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2.0	1.6	1.1	1.4	5.8	16.1	2.9	55.8	21.5	16.5	16.4	2.7	3.3	9.5	13.4	19.7	28.5	31.6	16.1	27.9	27.5	9.8	20.8	41.2	25.0	16.2	53.3	32.9	12.1	14.0	15.4	26.7	2.0	17.5	10.0	1.2	1.0	17.8	31.0	18.1	7.0	35.3	34.2	39.8	24.0	14.2	5.8	46.6	14.9	14.5	5.9	15.1	12.3	6.7	8.6	24.4	14.5	10.7	30.0	14.9	6.6	12.7	43.4	19.9	31.6	8.5	9.8	18.9	21.2	25.2	23.1	0.0	1.3	1.1	1.2	1.4	0.6	2.0	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803213-88809258	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Disease mutation, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.2;esophagus: 7.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA017224: AB_1846468"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavourable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.4	0.4	0.7	2.7	0.9	25.2	0.4	0.0	1.2	1.2	2.5			2.9	0.3	0.0	7.1	0.3	0.0	0.1	0.6	2.2	0.5	0.6	0.9	3.2	1.7		0.0	0.4	0.9	2.1	2.0		0.3	1.0		0.8	0.1	0.0	3.3	3.2	0.3	0.8	3.1	1.7	3.3			0.1		2.1	0.2	1.9	3.7	2.1	3.5	0.9	1.7	4.0	0.7	9.6	10.1	4.4	7.4	0.2	0.9	17.8	6.6	1.8	5.2	3.3	20.6	10.0	14.3	7.3	1.4	12.5	5.5	4.4	1.7	5.1	23.8	13.4	8.9	17.2	0.0	7.6	5.9	0.4	0.3	5.3	1.1	1.6	21.8	4.8	1.9	23.9	31.0	39.3	11.4	8.1	33.3	6.0	12.6	1.1	7.3	10.6	7.9	11.4	3.6	5.0	11.3	15.6	1.7	7.3	11.6	10.9	9.7	17.8	15.4	19.6	5.3	19.4	8.7	0.5	0.9	3.5	2.7	0.5	1.1	1.2	2.7	2.7	1.0	3.7	4.0	2.4	2.1	1.7	0.7	2.1	3.0	0.7										
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573730-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Enhanced	"Nucleoli,Plasma membrane,Cytosol"			220000	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	46.4	26.5	20.7	45.7	22.4	44.9	38.1	13.2	22.3	25.6	29.5	20.2	16.2	18.5	27.0	26.1	34.1	22.0	25.4	50.5	19.0	18.3	26.2	40.2	34.3	47.6	22.5	20.6	32.8	34.4	25.6	22.5	34.8	24.4	24.6	23.9	18.7	24.6	16.7	106.6	23.1	27.7	33.1	25.4	56.6	31.4	38.2	21.5	61.1	33.9	32.5	52.1	43.8	37.2	10.6	14.2	14.7	11.1	5.3	20.8	4.5	49.7	11.6	20.5	13.5	23.7	29.3	24.3	27.5	35.9	27.6	27.4	28.7	20.1	63.7	41.9	30.8	21.5	29.3	27.5	51.8	40.7	11.0	37.6	12.8	17.6	36.9	41.8	24.2	27.8	28.9	24.6	66.5	34.8	27.0	42.8	39.9	14.3	34.2	24.2	20.7	14.9	20.9	27.3	51.0	29.0	20.3	16.3	12.3	26.1	19.5	32.7	63.0	25.7	43.1	29.5	27.9	23.4	27.2	62.5	46.8	150.0	16.5	25.4	17.1	11.5	9.6	14.7	12.2	10.7	12.8	10.6	11.7	12.4	8.5	6.5	9.4	14.4	8.7	5.3	11.1	14.2	20.8	4.5	20.7	22.4	13.2	22.3	19.0	18.3	22.5	20.6	24.4	21.5
CDX2	CDX3	ENSG00000165556	"Caudal type homeobox 2"	Q99626	13	27962137-27971139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 21.2"	"Group enriched"	"Detected in some"	6	"CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 8.0"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 63.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002221, HPA045669, HPA049580"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002221: AB_563649, HPA045669: , HPA049580: "		"unprognostic (1.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.92e-1)"		"unprognostic (8.11e-3)"	"unprognostic (4.19e-6)"	"unprognostic (1.73e-4)"		"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.51e-2)"		"unprognostic (6.07e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	21.2			13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	1.6	0.0	0.0	0.0		0.1	14.3		0.0	0.0	0.0	0.0	16.3	0.3	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	4.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	8.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CDYL	"CDYL1, DKFZP586C1622"	ENSG00000153046	"Chromodomain Y like"	Q9Y232	6	4706159-4955551	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Lyase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035578	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA035578: "	"unprognostic (1.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.38e-3)"	"prognostic favourable (1.53e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.94e-1)"	18.4	9.2	13.3	14.2	14.4	19.3	16.5	8.1	15.8	19.8	16.2	13.3	20.6	8.2	22.2	15.5	19.6	14.7	11.7	14.5	11.0	8.6	9.9	6.9	11.8	12.7	12.5	10.7	13.3	8.5	12.7	8.3	35.4	12.8	12.5	15.8	11.0	12.8	15.3	24.7	23.2	12.2	17.7	8.5	12.6	13.3	10.1	12.9	11.3	11.7	12.5	15.2	17.7	24.8	1.8	11.2	5.1	2.1	2.3	2.4	1.9	13.6	12.0	17.2	14.5	13.6	9.3	20.0	13.1	10.6	12.5	13.1	9.6	9.5	2.9	13.7	10.1	12.1	14.0	15.9	15.1	9.5	12.6	11.6	11.7	8.7	17.3	15.1	13.4	7.4	28.5	14.2	21.8	12.1	21.1	8.8	6.2	12.2	8.6	14.1	17.9	13.2	10.8	15.4	23.7	8.3	11.2	14.9	9.0	16.0	13.9	20.7	8.4	14.9	16.1	14.8	13.0	10.7	15.2	20.3	32.6	10.7	5.0	9.9	16.0	5.1	2.1	0.8	2.4	1.1	1.7	1.4	1.7	1.8	2.5	1.8	1.0	1.7	0.6	2.3	1.2	11.2	0.2	1.9	13.3	14.4	8.1	15.8	11.0	8.6	12.5	10.7	12.8	12.9
CEACAM5	"CD66e, CEA"	ENSG00000105388	"Carcinoembryonic antigen related cell adhesion molecule 5"	P06731	19	41708585-41729798	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 17.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"		19000000	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	0.1	0.1	0.1	78.8	0.1	0.0	0.1	0.1	0.2	12.5	117.1	0.2	0.1	2.5	0.9	0.1	103.5	0.3	1.2	0.1	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.5	0.1	0.3	118.2	0.2	6.8	0.1	0.1	0.6	12.8	3.3	0.1	0.1	20.1	0.2	0.1	0.6	0.2	29.4	100.6	2.0	14.1	0.6	0.6	1.8	0.7	0.6	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.1	0.0	17.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.0	0.4	1.4	0.3	0.0	0.1	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.1	0.1	0.2	1.2	0.3	0.8	0.3	0.2	0.1	0.5	0.2	0.3	0.6	0.6	0.4	0.5	1.8	0.6	0.7	0.5	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT/enhancer binding protein beta"	P17676	20	50190734-50192689	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 121.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 13.6;monocytes: 6.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004213: AB_626772, HPA061355: , HPA062267: "	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavourable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	56.9	54.7	7.0	35.9	9.9	21.1	34.4	1.8	6.2	22.8	25.2	6.4	8.0	8.0	19.4	11.2	19.2	21.7	20.2	33.6	8.4	4.4	15.3	92.5	51.3	20.4	9.5	3.0	33.6	18.6	4.1	7.4	75.1	7.7	21.1	5.0	14.0	14.6	11.7	121.9	23.9	19.4	12.6	9.5	40.3	15.3	14.3	8.1	1.5	46.1	25.3	10.7	30.8	30.6	0.4	1.2	13.6	6.1	0.4	0.5	0.5	7.5	3.4	0.3	4.1	19.5	7.7	34.0	10.3	16.2	7.1	6.3	3.4	7.0	4.9	19.7	4.2	10.4	1.1	10.0	4.8	3.6	2.5	1.5	4.5	5.0	24.1	2.4	9.9	8.2	26.6	9.0	16.0	0.9	7.2	9.3	4.4	2.8	1.1	5.4	2.2	10.0	3.5	1.0	5.6	2.3	1.8	2.0	1.3	8.5	21.1	45.6	5.6	14.0	1.3	14.8	11.2	12.6	9.9	19.7	8.1	4.4	27.0	5.7	6.4	5.9	3.0	9.1	0.4	5.3	0.1	0.4	0.4	0.5	1.2	0.3	0.3	0.2	13.6	0.4	6.1	0.0	0.2	0.5	7.0	9.9	1.8	6.2	8.4	4.4	9.5	3.0	7.7	8.1
CEBPD	"C/EBP-delta, CELF, CRP3, NF-IL6-beta"	ENSG00000221869	"CCAAT/enhancer binding protein delta"	P49716	8	47736909-47739086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 17.1;HSkMC: 16.9;NB-4: 35.9;SiHa: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 20.9;monocytes: 7.8"					"Low region specificity"	"Detected in some"			HPA067581			Supported	Nucleoplasm				Nucleoplasm		"HPA067581: "	"prognostic favourable (2.28e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.87e-7)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.40e-2)"	27.3	14.9	4.7	14.3	4.7	6.5	12.3	4.7	7.7	7.3	9.5	4.7	4.7	6.1	5.8	4.7	5.4	12.6	4.7	9.5	4.7	1.3	8.2	25.7	10.5	4.7	4.7	4.7	21.5	7.3	0.6	8.4	11.3	4.7	11.0	2.6	7.5	6.4	4.7	9.1	6.8	9.6	4.7	4.7	13.5	8.8	9.4	4.7	4.7	7.1	14.1	4.7	11.7	9.4	0.1	2.7	20.9	7.8	1.3	2.4	0.9	2.3	1.8	0.1	0.0	10.5	10.9	13.2	6.0	4.6	1.7	3.6	3.5	3.7	0.0	4.4	1.5	2.4	0.4	3.1	0.5	0.0	0.9	0.1	1.4	1.5	17.1	1.0	0.0	16.9	8.3	0.4	4.0	0.3	1.0	1.9	0.6	0.7	0.0	35.9	0.7	0.6	0.0	1.3	0.1	4.9	1.8	0.7	0.2	14.8	2.0	1.4	1.6	8.2	1.5	0.3	1.1	4.0	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.9	7.8	3.6	0.8	3.0	2.4	0.0	0.1	0.4	2.7	0.1	0.0	0.0	20.9	1.3	1.1	0.0	0.1	0.9	4.7	4.7	4.7	7.7	4.7	1.3	4.7	4.7	4.7	4.7
CEBPE	CRP1	ENSG00000092067	"CCAAT/enhancer binding protein epsilon"	Q15744	14	23117304-23119616	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 87.1;bone marrow: 29.4"	"Group enriched"	"Detected in some"	4	"HL-60: 58.0;NB-4: 30.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	201	"eosinophil: 87.1"	"Lineage enriched"	"Detected in single"	237	"granulocytes: 87.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.3	0.0	0.1	0.8	0.2	29.4	0.1	0.1	1.3	0.1	0.1	0.1	0.1	1.4	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.1	0.2	2.7	0.2	0.3	0.1	0.1	0.1	0.0	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.9	0.1	0.3	7.7	0.4	0.1	0.1	2.6	0.1	0.1	0.8	0.2	0.1	0.0	0.1	87.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	30.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.3	87.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	1.3	0.1	0.1	0.3	0.1	0.1	0.1
CEBPG	"GPE1BP, IG/EBP-1"	ENSG00000153879	"CCAAT/enhancer binding protein gamma"	P53567	19	33373330-33382686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012024	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA012024: AB_1846503"	"unprognostic (5.56e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.29e-3)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (8.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.01e-2)"	16.8	7.2	13.0	10.3	14.3	12.4	21.3	17.9	14.2	9.6	22.6	7.3	6.5	25.2	10.6	7.5	16.4	9.4	8.9	11.3	12.5	14.5	10.0	35.8	13.3	8.8	13.2	9.7	12.2	21.7	10.7	15.7	14.5	13.0	9.6	22.5	6.7	15.2	7.8	34.5	21.0	42.8	13.7	20.9	9.6	14.8	10.7	11.4	9.7	20.0	19.1	11.0	12.3	34.6	8.5	17.1	9.6	20.8	5.4	10.4	9.3	12.0	12.9	11.0	11.0	5.3	7.9	15.3	9.2	7.8	7.7	9.4	12.6	6.1	18.5	8.0	4.6	6.1	19.1	9.1	13.5	34.7	8.9	9.8	5.5	13.6	17.8	16.3	11.2	10.3	43.3	9.7	33.5	9.5	13.6	21.4	6.3	7.6	11.7	10.3	6.2	7.5	13.3	7.5	7.3	4.8	7.6	21.7	13.1	9.3	9.4	21.7	8.0	33.2	9.1	8.0	11.2	8.8	13.7	13.0	9.6	12.1	8.4	18.3	10.9	9.6	16.8	7.3	8.0	19.0	7.8	8.5	8.6	9.0	17.1	6.4	8.4	8.3	2.0	5.4	20.8	5.9	10.4	9.3	13.0	14.3	17.9	14.2	12.5	14.5	13.2	9.7	13.0	11.4
CELF1	"BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR"	ENSG00000149187	"CUGBP Elav-like family member 1"	Q92879	11	47465933-47565569	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016114, HPA044597, CAB069989"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: "	"unprognostic (1.05e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.08e-2)"	"prognostic unfavourable (7.55e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.34e-2)"	18.4	22.8	28.3	19.9	30.8	25.8	22.7	49.5	29.8	17.8	20.7	16.6	22.9	14.7	22.9	20.1	21.5	19.0	16.5	19.3	18.7	14.1	18.5	36.5	21.0	24.0	12.8	20.2	18.9	19.2	54.3	19.6	18.2	14.6	16.3	17.7	18.4	18.0	19.7	45.4	20.1	20.1	31.4	11.9	22.3	17.9	20.4	17.7	15.8	19.5	17.0	24.6	20.6	23.8	15.4	12.4	20.6	15.5	7.0	16.1	8.0	17.6	31.4	26.2	26.8	20.6	22.0	22.3	19.0	19.7	24.0	25.2	26.7	21.0	46.7	13.3	20.4	26.5	40.4	27.0	40.5	19.5	17.7	14.3	41.3	19.0	20.0	22.4	15.9	16.9	16.6	26.1	31.8	21.9	26.9	19.1	15.3	23.6	23.1	18.0	36.6	18.6	23.9	20.9	18.3	20.7	31.7	24.6	20.8	25.3	23.5	15.4	33.2	14.9	25.1	27.5	27.1	26.2	25.7	16.4	14.9	37.2	22.2	10.8	22.3	10.9	10.8	20.6	12.8	9.6	16.1	14.6	13.5	14.5	12.4	15.4	14.7	12.1	14.6	7.0	15.5	7.7	9.2	8.0	28.3	30.8	49.5	29.8	18.7	14.1	12.8	20.2	14.6	17.7
CELF4	BRUNOL4	ENSG00000101489	"CUGBP Elav-like family member 4"	Q9BZC1	18	37243047-37566037	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 69.1"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 31.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013322, HPA037986"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA013322: , HPA037986: AB_10673035"	"unprognostic (7.87e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.42e-7)"	"unprognostic (2.95e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-3)"	"unprognostic (6.13e-2)"	1.4	10.7	40.2	1.7	25.2	1.1	1.3	45.3	69.1	1.1	1.6	0.9	0.0	1.6	1.3	1.5	1.4	1.3	2.0	1.7	27.0	26.3	1.4	1.3	1.4	1.6	13.5	26.3	2.0	4.2	1.2	8.1	1.7	13.1	1.5	1.3	0.5	2.5	1.1	8.3	2.0	1.9	1.3	3.7	1.7	1.6	3.9	5.6	0.0	2.3	0.0	1.0	1.2	0.0	0.7	0.5	2.4	0.9	0.9	0.9	0.4	0.1	0.1	0.5	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.7	0.0	0.4	0.0	0.1	0.0	0.5	0.3	0.0	1.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.2	0.1	0.4	1.1	0.2	0.1	0.0	1.4	0.0	0.1	31.0	7.6	0.8	0.2	0.0	0.1	0.1	0.0	1.0	0.4	0.2	0.1	2.0	0.3	0.1	0.1	0.1	0.1	2.4	0.5	0.5	0.7	0.6	0.7	0.7	0.4	0.4	0.3	0.7	0.8	0.9	1.3	0.9	0.9	0.5	0.6	0.4	40.2	25.2	45.3	31.1	27.0	26.3	13.5	26.3	13.1	5.6
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537170	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 23.8;HaCaT: 15.0;T-47d: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 3.0;naive B-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Supported	"Plasma membrane"				"Plasma membrane"		"HPA052976: , HPA060521: "	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	3.4	0.5	0.6	5.0	1.4	0.3	4.1	0.4	0.3	8.7	1.3	0.9	3.6	0.3	5.7	7.5	14.2	11.1	5.3	4.6	0.7	0.7	16.2	0.8	19.3	4.2	0.4	0.0	6.0	2.6	7.5	3.8	3.4	2.2	7.2	0.4	3.8	22.6	3.0	0.3	13.9	2.3	3.1	0.4	1.8	3.6	2.8	0.0	1.8	5.7	12.7	12.8	3.1	5.0	3.0	0.2	0.0	0.0	0.7	0.1	0.0	8.5	23.8	4.5	3.9	0.0	0.0	2.1	0.7	1.5	1.4	0.3	5.7	6.7	0.0	11.8	0.1	15.0	3.7	11.4	0.5	0.0	4.6	0.0	9.5	0.2	0.2	1.5	0.6	0.0	10.6	0.0	9.5	0.0	0.0	0.0	0.0	10.8	0.0	1.7	1.7	3.8	0.0	0.0	2.8	6.3	5.3	0.2	0.3	7.4	6.0	1.2	17.0	5.0	0.3	0.0	0.1	0.0	0.1	4.5	0.2	2.4	5.9	0.0	5.1	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.6	1.4	0.4	0.3	0.7	0.7	0.4	0.0	2.2	0.0
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 53.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.6"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB008371: AB_591074, HPA073086: "	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (2.88e-8)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	1.2	0.9	0.2	12.1	0.2	3.5	3.0	0.2	0.2	1.3	3.5	0.4	0.3	5.3	0.9	1.5	8.5	0.1	1.2	1.5	0.2	0.3	0.8	0.7	1.4	8.2	0.3	0.0	0.5	0.7	0.0	0.3	3.1	0.3	0.5	3.2	0.1	1.7	0.0	0.3	4.5	3.6	0.8	0.3	4.9	1.8	7.8	0.0	53.7	0.4	9.2	10.0	1.3	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	30.8	7.1	11.1	6.1	0.8	1.8	9.2	9.6	7.3	13.0	11.1	5.1	10.1	9.3	6.2	3.4	9.1	9.9	5.1	12.8	27.5	9.6	15.7	3.2	8.6	0.2	9.1	17.5	0.1	0.6	5.1	7.1	6.7	12.7	19.2	10.2	10.4	13.1	14.0	9.9	13.1	15.6	19.8	10.2	5.7	1.4	9.5	9.5	9.2	10.2	7.5	6.1	9.7	4.7	8.0	20.3	9.5	15.8	19.2	19.0	37.9	3.9	18.8	15.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.0	0.3	0.0
CENPB		ENSG00000125817	"Centromere protein B"	P07199	20	3783851-3786690	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011626, HPA053507, HPA054405"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"CAB011626: AB_726801, HPA053507: , HPA054405: "	"unprognostic (2.01e-1)"	"unprognostic (8.47e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (2.40e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.46e-1)"	30.4	18.9	41.2	18.0	41.6	11.9	22.9	13.0	28.9	22.4	23.0	41.1	18.7	19.6	18.4	19.8	22.3	18.1	27.3	26.9	41.9	29.1	19.8	20.3	20.0	16.0	48.0	14.7	25.0	23.9	22.7	12.1	15.2	22.0	18.6	12.3	13.0	27.6	24.3	58.3	32.6	19.9	20.1	55.8	19.8	21.9	9.0	21.9	19.6	21.7	26.4	14.9	20.7	28.0	3.7	4.2	1.4	4.5	3.9	5.0	2.5	31.6	40.8	8.0	17.1	17.1	13.6	5.1	22.8	16.6	14.7	11.9	16.6	22.9	11.1	7.2	21.1	25.6	6.4	25.9	7.4	15.7	10.9	23.5	14.7	14.6	19.9	7.6	7.9	15.4	14.0	21.0	13.5	12.5	15.1	7.0	12.4	52.2	22.7	17.5	10.1	48.8	19.0	1.0	8.0	15.3	19.6	19.8	14.7	18.9	26.6	17.7	16.7	17.0	21.3	25.6	13.8	22.0	34.7	8.5	12.2	6.5	8.9	27.4	16.7	0.1	4.5	1.4	5.0	4.0	3.5	2.5	3.6	3.1	3.2	3.7	3.3	3.8	0.6	3.9	2.6	4.2	1.0	2.5	41.2	41.6	13.0	28.9	41.9	29.1	48.0	14.7	22.0	21.9
CENPC	"CENP-C, CENPC1, hcp-4, MIF2"	ENSG00000145241	"Centromere protein C"	Q03188	4	67468748-67545606	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049740, HPA058252"			Enhanced	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA049740: , HPA058252: "	"unprognostic (4.35e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.31e-3)"	"unprognostic (7.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (6.40e-2)"	"prognostic favourable (9.67e-4)"	"unprognostic (3.22e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.32e-2)"	"prognostic favourable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-3)"	9.4	8.6	9.3	11.9	14.6	12.9	13.5	26.9	12.2	12.6	7.3	4.6	6.2	5.6	12.6	10.1	9.1	10.1	6.6	6.9	8.0	5.8	9.0	6.6	8.7	7.7	11.8	7.7	20.9	16.4	8.0	21.2	6.3	9.1	12.3	6.0	5.0	10.2	13.4	5.3	9.8	9.1	10.3	13.4	10.5	9.5	7.5	12.6	17.7	13.0	9.1	6.8	10.2	10.4	5.1	2.4	2.8	1.5	1.6	5.0	1.2	0.8	1.0	2.8	1.6	3.3	2.0	1.5	1.0	0.9	1.3	1.1	1.2	2.2	4.4	1.5	1.3	1.5	3.7	1.7	2.0	1.7	0.7	3.5	1.8	1.6	1.2	6.2	1.5	2.5	0.6	1.0	2.2	0.7	4.9	3.0	1.9	1.5	8.4	5.7	3.0	0.6	4.1	6.9	1.5	1.7	1.5	4.7	2.3	2.1	4.2	1.2	1.3	2.3	1.0	1.8	1.2	1.3	0.9	2.3	1.0	4.7	2.0	3.6	1.1	2.7	1.3	2.8	3.2	1.5	1.9	3.3	3.6	3.4	1.1	5.1	5.0	3.7	1.0	1.6	1.1	2.4	2.0	1.2	9.3	14.6	26.9	12.2	8.0	5.8	11.8	7.7	9.1	12.6
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664588	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 19.5;lymphoid tissue: 67.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB070134: AB_2229328, HPA052382: , HPA064308: "	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	1.6	1.5	1.0	10.7	1.3	19.5	1.1	0.4	0.9	2.1	5.6	0.3	0.0	4.6	1.2	1.7	9.4	0.8	0.4	1.7	0.6	0.6	1.0	0.8	3.2	6.2	0.6	0.5	1.4	0.6	0.0	0.4	6.4	0.8	0.7	4.5	0.4	1.9	0.0	0.5	4.7	6.4	1.6	1.5	3.8	2.3	9.4	0.6	67.5	0.6	7.6	7.6	1.4	2.9	0.3	0.3	0.0	0.0	0.7	1.9	0.2	32.2	18.3	39.5	20.6	1.5	2.0	15.4	20.0	8.2	12.0	11.9	14.5	20.0	30.8	11.9	11.1	20.1	24.3	13.1	20.5	26.8	15.3	25.3	28.1	20.7	0.2	35.7	13.8	0.7	1.0	17.3	20.0	12.6	22.7	18.4	21.5	12.3	21.1	14.3	35.0	8.1	22.5	55.8	10.1	11.8	8.0	18.5	25.2	27.0	18.0	10.4	21.5	13.7	16.5	21.9	25.8	18.1	41.3	14.2	15.3	29.6	9.5	25.8	19.3	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1.4	0.4	0.3	0.3	1.9	0.8	0.0	0.7	0.0	0.3	1.7	0.2	1.0	1.3	0.4	0.9	0.6	0.6	0.6	0.5	0.8	0.6
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189548-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.8;testis: 37.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favourable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavourable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.0	1.9	2.9	15.2	3.1	19.1	5.5	2.1	3.0	3.9	4.7	1.2	0.7	4.2	2.9	3.1	7.7	2.5	2.8	4.4	2.7	2.1	1.9	2.2	3.6	11.1	2.6	3.7	3.6	1.6	1.6	2.7	6.8	1.8	2.4	5.5	1.6	3.0	1.5	3.6	6.0	4.0	2.4	2.6	6.2	2.5	37.3	1.8	31.8	1.8	10.2	12.2	3.1	4.3	12.1	6.1	2.5	3.6	7.5	9.8	4.2	18.1	5.6	26.4	20.6	1.7	5.5	14.0	8.9	9.6	20.0	21.7	7.7	23.2	39.1	10.8	5.3	13.6	17.2	20.7	25.7	11.8	11.9	9.1	9.6	7.6	0.6	13.1	9.4	2.1	4.3	13.0	14.4	6.7	16.1	15.6	15.4	10.1	42.2	18.8	22.9	4.9	26.3	34.8	30.1	6.3	6.7	18.2	24.3	9.8	6.7	7.9	9.3	8.9	3.2	10.0	16.8	13.2	22.2	19.3	29.1	31.3	15.3	26.6	18.8	0.6	1.8	2.5	4.5	3.0	7.3	11.8	7.6	5.7	2.8	12.1	9.8	8.3	0.4	7.5	3.6	6.1	8.7	4.2	2.9	3.1	2.1	3.0	2.7	2.1	2.6	3.7	1.8	1.8
CENPI	"CENP-I, FSHPRH1, LRPR1, Mis6"	ENSG00000102384	"Centromere protein I"	Q92674	X	101098218-101163681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061297			Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"HPA061297: "	"unprognostic (3.10e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.78e-6)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.62e-3)"	"unprognostic (1.20e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-13)"	"unprognostic (1.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-1)"	2.6	1.8	1.5	10.8	4.7	9.1	4.0	1.7	2.9	3.7	3.9	3.6	0.0	4.0	4.1	2.2	7.1	2.7	2.8	1.7	1.8	1.4	1.5	1.6	2.9	7.7	3.3	1.8	4.5	1.2	0.3	1.3	3.6	2.6	1.8	5.3	1.2	2.0	0.8	1.5	4.5	3.8	4.3	4.3	4.0	3.3	4.6	2.7	18.3	1.3	4.1	11.0	3.1	3.7	2.6	2.9	4.8	2.8	3.2	3.3	1.2	16.9	11.7	14.5	11.1	1.8	3.3	6.4	18.3	9.8	18.6	37.8	15.6	10.8	12.4	6.6	7.2	9.9	21.1	9.7	26.1	7.7	5.4	7.6	16.7	5.9	0.2	10.0	8.4	1.3	0.8	24.7	3.1	15.8	5.4	22.9	18.0	11.9	9.9	3.6	11.1	14.4	9.3	20.9	8.0	4.6	10.1	9.2	4.9	22.5	6.4	3.8	6.3	3.3	6.4	17.5	14.7	16.3	14.6	3.7	8.5	14.0	6.9	13.4	13.5	2.2	2.1	2.3	2.0	2.8	1.3	2.6	2.0	2.6	1.0	2.1	1.6	1.7	4.8	3.2	2.6	2.9	3.3	1.2	1.5	4.7	1.7	2.9	1.8	1.4	3.3	1.8	2.6	2.7
CENPM	"C22orf18, CENP-M, MGC861, Pane1"	ENSG00000100162	"Centromere protein M"	Q9NSP4	22	41938721-41947164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.3;lymphoid tissue: 41.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 19.5;T-reg: 23.3"	"Group enriched"	"Detected in many"	7	"B-cells: 19.5;T-cells: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042404, HPA056500"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA042404: , HPA056500: "	"unprognostic (3.78e-2)"	"prognostic favourable (3.40e-5)"	"unprognostic (7.15e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (5.50e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (5.99e-7)"	"unprognostic (9.54e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.73e-2)"	"unprognostic (5.61e-2)"	1.6	1.4	1.1	31.9	0.9	18.2	3.8	1.9	1.2	1.7	6.9	1.1	0.4	6.0	1.4	2.2	8.9	9.6	4.3	3.2	1.0	0.8	2.1	1.4	4.2	17.0	1.0	0.4	1.4	0.6	0.0	0.4	3.4	0.8	1.2	3.7	1.1	3.3	0.9	0.5	6.3	7.2	1.1	0.9	9.7	4.5	13.5	0.4	41.5	0.9	5.5	18.8	3.2	3.3	19.5	0.3	0.8	0.1	2.9	23.3	4.0	22.1	22.8	12.7	8.4	1.0	0.9	5.4	10.9	5.7	19.3	19.7	26.4	11.9	28.8	8.2	5.7	8.5	9.6	11.2	4.8	8.2	40.0	13.5	24.4	18.3	1.0	25.5	15.3	0.8	0.8	12.3	5.8	7.2	10.2	27.9	11.2	34.2	25.4	26.7	6.9	16.9	24.5	12.7	30.0	7.8	13.3	14.6	2.8	16.9	10.1	5.7	9.6	16.6	3.6	18.7	28.0	12.3	18.1	14.9	10.3	26.6	6.5	21.3	20.4	0.8	0.1	0.0	3.2	0.0	4.3	13.1	9.4	4.1	0.3	19.5	1.8	2.4	0.5	2.9	0.0	0.2	23.3	4.0	1.1	0.9	1.9	1.2	1.0	0.8	1.0	0.4	0.8	0.4
CENPN	"BM039, C16orf60, FLJ13607, FLJ22660"	ENSG00000166451	"Centromere protein N"	Q96H22	16	81006498-81033114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA052870			Supported	Nucleoplasm				Nucleoplasm		"HPA052870: "	"unprognostic (1.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.69e-3)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavourable (1.46e-5)"	"unprognostic (3.02e-2)"	"prognostic unfavourable (4.86e-4)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.99e-2)"	4.2	4.9	4.8	8.2	5.0	26.9	3.2	2.4	5.4	2.7	6.6	5.9	4.8	6.4	2.6	6.8	9.9	2.1	3.7	7.3	5.0	4.6	6.5	21.0	5.2	8.9	6.0	4.5	2.4	3.9	12.0	2.5	8.8	5.1	25.3	7.0	1.5	3.7	4.7	5.6	3.5	7.7	5.6	6.1	5.9	5.1	11.8	5.6	24.6	4.2	12.6	10.2	4.2	3.8	6.6	8.5	2.9	3.7	4.0	10.1	2.7	22.9	22.1	19.1	17.0	5.3	4.2	23.0	23.6	16.6	38.4	17.1	40.2	18.6	13.0	13.6	13.9	19.7	15.4	17.1	49.9	7.8	13.2	11.5	18.0	26.8	2.5	16.6	22.6	3.7	1.8	35.0	12.3	17.5	21.0	18.8	19.6	42.1	21.3	21.4	20.3	12.2	25.1	18.1	14.0	6.9	15.6	12.2	11.1	35.7	9.0	10.7	21.2	9.6	9.2	28.3	28.8	18.7	26.4	13.2	28.8	49.5	13.4	11.9	24.5	0.0	1.7	2.9	2.5	3.3	2.3	1.9	3.9	2.1	8.5	6.6	1.9	2.0	1.4	4.0	3.7	2.7	10.1	2.7	4.8	5.0	2.4	5.4	5.0	4.6	6.0	4.5	5.1	5.6
CENPO	"CENP-O, MGC11266"	ENSG00000138092	"Centromere protein O"	Q9BU64	2	24793136-24822376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.7;testis: 28.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046189			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA046189: "	"unprognostic (1.67e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavourable (1.73e-6)"	"unprognostic (5.56e-2)"	"unprognostic (4.02e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (5.71e-13)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	6.9	6.0	6.6	7.6	7.8	15.4	6.3	6.2	11.9	4.4	6.6	8.3	2.6	6.5	4.6	3.9	6.3	3.6	3.4	3.3	8.4	6.4	5.3	3.5	4.9	9.2	6.2	6.5	6.6	4.9	4.2	5.2	6.7	7.9	4.4	7.9	3.6	4.1	2.8	5.6	7.9	6.0	4.6	6.3	6.6	4.8	28.9	5.7	28.7	5.0	6.5	11.4	4.7	4.9	1.6	4.1	0.3	1.2	2.1	3.5	1.3	13.7	16.3	19.0	10.0	2.3	3.5	10.6	16.7	10.0	23.7	18.2	20.7	7.0	9.6	1.9	10.3	7.4	18.6	6.3	15.9	12.4	9.7	15.0	10.3	13.8	1.1	12.5	11.4	1.7	1.1	23.6	5.2	10.9	17.5	10.9	14.6	9.6	17.1	9.2	13.6	10.4	13.9	24.6	5.1	6.0	8.4	12.5	13.6	9.9	7.8	3.6	7.5	5.3	7.0	21.9	20.0	7.2	18.5	6.7	8.8	19.4	6.8	12.2	16.7	0.0	1.2	0.0	3.5	0.9	1.5	1.6	1.6	2.0	1.9	1.3	1.2	2.7	0.3	2.1	1.1	4.1	2.7	1.3	6.6	7.8	6.2	11.9	8.4	6.4	6.2	6.5	7.9	5.7
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325484-92620533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: "	"unprognostic (5.48e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favourable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	5.0	5.1	6.8	8.9	8.8	15.5	4.9	14.9	7.4	6.0	3.8	3.5	1.4	4.5	6.4	4.1	8.4	3.6	4.6	4.3	5.4	4.6	3.5	3.2	3.5	7.8	6.1	4.5	4.6	7.5	7.8	9.4	5.3	6.8	4.8	4.5	5.5	5.0	2.8	11.8	30.0	3.2	4.8	4.4	5.4	3.0	8.7	6.5	14.8	3.0	7.4	9.1	4.4	8.0	6.7	4.8	4.1	10.3	5.1	8.2	4.0	7.9	5.0	7.0	5.1	2.9	3.2	6.7	8.4	4.7	10.4	8.4	2.3	4.5	10.0	3.9	2.6	9.5	6.8	4.6	9.8	14.3	8.0	10.3	4.5	3.2	1.5	20.9	9.9	3.4	2.6	10.1	6.5	5.2	11.0	14.6	7.9	5.0	29.4	6.3	5.7	9.4	10.0	11.5	11.2	1.6	8.0	15.7	5.5	9.5	6.1	3.0	3.2	6.5	2.5	10.2	5.0	15.4	11.9	9.7	11.4	13.2	11.4	10.5	9.2	3.0	3.2	4.1	4.9	10.3	8.2	6.7	5.3	4.1	3.6	5.7	5.0	4.8	0.8	5.1	5.1	4.8	5.7	4.0	6.8	8.8	14.9	7.4	5.4	4.6	6.1	4.5	6.8	6.5
CENPQ	"C6orf139, CENP-Q, FLJ10545"	ENSG00000031691	"Centromere protein Q"	Q7L2Z9	6	49463378-49493107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029043, HPA046634, HPA054965"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA029043: , HPA046634: , HPA054965: "	"unprognostic (7.39e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (2.49e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (2.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.76e-2)"	"prognostic favourable (6.26e-4)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.48e-3)"	"unprognostic (8.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.56e-1)"	7.2	7.6	10.4	11.2	15.4	6.4	8.7	10.9	11.4	6.6	5.8	6.4	5.8	4.2	7.5	7.1	12.1	6.4	5.4	10.0	11.5	9.3	7.6	6.8	5.8	10.0	19.8	7.7	10.4	4.8	4.6	8.9	9.1	15.3	7.4	7.5	2.7	5.5	5.4	6.9	6.1	5.1	7.0	18.7	8.8	5.6	8.8	18.3	15.1	6.0	9.1	12.7	9.5	6.4	7.8	5.0	7.2	3.1	4.4	5.6	2.3	16.2	4.5	14.5	9.0	3.9	6.2	12.8	21.1	12.1	20.3	28.6	5.5	6.6	11.0	10.6	6.0	5.9	7.5	7.6	30.1	11.9	10.5	8.1	7.3	8.9	1.6	17.1	10.2	2.8	4.2	24.8	8.7	7.4	12.4	11.0	15.0	4.7	12.0	8.1	9.0	4.2	8.7	17.2	11.9	5.9	6.7	7.8	7.8	9.9	5.9	11.1	7.6	15.8	4.3	15.8	12.3	12.4	18.8	5.0	13.0	9.9	10.7	13.0	15.2	4.1	2.2	7.2	4.0	2.7	4.2	7.6	4.3	4.6	2.5	7.8	4.7	4.5	1.6	4.4	3.1	5.0	5.6	2.3	10.4	15.4	10.9	11.4	11.5	9.3	19.8	7.7	15.3	18.3
CENPT	"C16orf56, CENP-T, FLJ13111"	ENSG00000102901	"Centromere protein T"	Q96BT3	16	67828157-67847811	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041220, HPA058036"	Approved		Enhanced	"Nuclear bodies"				"Nuclear bodies"		"HPA041220: , HPA058036: "	"unprognostic (9.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.04e-2)"	"unprognostic (3.15e-2)"	"prognostic favourable (2.96e-4)"	"unprognostic (6.64e-3)"	"prognostic unfavourable (1.57e-7)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.74e-3)"	10.1	7.3	14.1	11.8	11.8	11.5	9.6	28.2	17.4	13.3	11.5	7.6	7.7	6.8	10.9	12.0	9.9	10.5	6.3	11.9	11.5	12.2	7.6	8.5	6.7	8.5	10.2	10.8	13.5	18.6	9.9	8.5	17.2	10.5	8.8	5.8	8.4	11.4	13.3	11.5	31.9	8.9	12.0	7.9	7.8	9.3	22.5	10.9	8.1	8.6	7.1	8.0	9.9	8.7	7.1	8.2	8.3	10.0	6.6	11.9	7.6	4.8	4.8	6.7	6.8	5.6	5.4	10.0	19.4	9.0	20.3	16.4	5.1	3.7	2.1	4.8	12.9	8.0	5.0	8.7	6.9	3.4	6.3	0.8	2.1	7.2	3.6	0.4	4.6	5.9	5.2	13.9	3.0	8.2	12.2	2.4	9.6	7.6	6.2	6.8	9.0	4.7	8.6	3.0	11.2	7.5	2.0	2.6	4.6	14.6	3.0	3.8	4.0	6.5	6.3	2.9	5.0	4.4	4.5	4.7	3.6	12.0	2.2	3.9	4.9	2.0	10.0	8.3	9.4	9.0	10.1	7.0	8.8	11.9	8.2	7.1	8.0	10.4	4.4	6.6	5.6	8.1	11.1	7.6	14.1	11.8	28.2	17.4	11.5	12.2	10.2	10.8	10.5	10.9
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694618-184734133	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 30.0;testis: 50.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 14.1;eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"				"Nucleoplasm, Centriolar satellite"		"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavourable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	2.7	1.7	1.4	7.8	1.0	30.7	3.1	1.2	1.3	2.8	4.4	1.2	2.9	2.8	1.4	3.2	11.2	0.9	1.7	1.0	1.2	0.6	1.4	2.3	2.0	9.5	1.3	0.2	1.1	1.3	0.7	0.6	7.0	1.0	2.0	5.1	0.9	3.5	0.5	1.2	7.1	5.2	1.5	1.0	5.8	2.3	50.2	0.6	30.0	0.9	7.3	9.1	1.6	4.5	0.8	1.7	14.3	2.8	3.0	2.5	0.7	23.0	6.5	28.0	14.1	1.5	2.4	14.8	13.9	6.2	11.4	7.9	7.7	13.3	19.2	1.3	6.5	9.2	23.0	14.2	11.7	9.3	9.2	16.5	5.9	3.9	0.2	29.1	11.5	1.2	0.7	14.0	2.6	11.9	18.1	57.7	21.3	15.3	37.4	18.6	14.8	8.7	29.7	9.1	5.6	6.3	8.9	19.8	21.1	10.1	12.9	10.5	17.7	16.0	7.1	10.2	13.3	10.5	16.0	8.5	8.6	15.7	14.3	22.6	33.4	14.1	0.7	14.3	0.6	1.9	0.4	0.8	1.0	1.0	0.5	0.8	0.6	0.8	0.1	3.0	2.8	1.7	2.5	0.7	1.4	1.0	1.2	1.3	1.2	0.6	1.3	0.2	1.0	0.6
CENPW	"C6orf173, CUG2"	ENSG00000203760	"Centromere protein W"	Q5EE01	6	126340174-126348875	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067285			Supported	Nucleoplasm				Nucleoplasm		"HPA067285: "	"unprognostic (3.51e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.26e-3)"	"unprognostic (9.61e-3)"	"unprognostic (3.78e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavourable (1.21e-5)"	"unprognostic (1.11e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-1)"	5.5	3.3	3.3	14.8	2.6	27.1	5.2	1.4	4.9	9.9	9.6	1.3	7.7	5.3	17.4	12.4	16.8	5.9	3.5	2.2	5.3	1.5	2.9	2.7	4.0	9.1	1.3	4.5	4.8	1.7	0.0	2.0	4.8	1.6	4.7	11.7	1.8	6.5	2.9	2.1	5.8	7.0	10.5	1.8	5.5	5.0	43.2	0.8	28.6	2.0	21.4	17.0	4.6	7.9	5.2	14.6	2.6	15.2	5.6	8.9	5.0	20.5	14.0	26.4	23.4	2.9	3.1	23.0	16.3	11.8	22.9	27.8	42.2	13.7	24.3	14.9	10.3	25.3	21.7	26.1	32.0	27.9	40.1	23.5	36.0	44.4	0.9	34.0	17.4	1.7	2.9	18.9	14.1	24.2	38.9	15.4	18.8	33.3	27.6	55.9	16.1	21.2	29.5	18.0	16.9	10.1	9.1	28.6	12.8	13.9	12.5	18.5	12.4	33.1	13.5	21.1	23.1	29.2	44.9	10.9	20.9	43.3	12.6	43.3	25.0	2.6	13.2	1.8	1.7	15.2	0.6	5.2	3.7	3.4	12.3	2.3	2.9	2.4	2.5	5.6	10.1	14.6	8.9	5.0	3.3	2.6	1.4	4.9	5.3	1.5	1.3	4.5	1.6	0.8
CEP128	"C14orf145, C14orf61"	ENSG00000100629	"Centrosomal protein 128"	Q6ZU80	14	80476983-80959517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 61.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 25.2;MOLT-4: 21.6;U-266/70: 45.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.6;T-cells: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000602, HPA001116, HPA018498"	Uncertain		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite"	Cytosol	"HPA000602: , HPA001116: AB_1078323, HPA018498: AB_1845560"	"unprognostic (6.13e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.48e-1)"	3.8	2.0	5.2	6.5	7.6	10.5	7.5	13.6	5.4	3.4	3.6	4.2	2.7	3.2	4.0	2.2	4.4	4.8	2.0	3.1	3.8	2.5	2.4	2.0	3.8	8.1	6.9	3.1	4.4	2.1	4.2	8.6	2.3	4.5	2.9	3.3	2.3	4.5	3.2	3.1	5.1	3.0	4.0	5.5	6.3	3.1	9.0	6.8	61.2	5.7	3.1	9.1	6.0	4.4	2.2	8.6	1.7	0.8	1.1	9.6	0.8	5.9	3.1	2.8	2.3	0.6	1.1	1.5	6.7	2.0	3.9	3.9	2.1	3.4	13.7	1.2	1.9	3.2	3.0	1.9	7.5	7.7	1.9	2.6	3.9	1.1	0.3	2.7	3.5	0.2	0.5	5.6	3.0	2.9	3.3	25.2	3.7	3.7	21.6	1.4	2.1	3.9	3.9	6.9	10.7	0.8	3.1	3.6	1.7	5.4	2.2	1.1	2.5	2.0	2.7	8.6	4.7	2.3	6.5	45.6	1.8	6.1	2.4	3.6	2.9	0.0	0.8	1.7	2.9	0.3	2.3	2.2	3.2	2.2	2.5	0.9	2.8	1.3	0.1	1.1	0.5	8.6	9.6	0.8	5.2	7.6	13.6	5.4	3.8	2.5	6.9	3.1	4.5	6.8
CEP131	"AZ1, AZI1, KIAA1118"	ENSG00000141577	"Centrosomal protein 131"	Q9UPN4	17	81189593-81222999	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024019	Approved		Supported	"Microtubules,Cytokinetic bridge,Centriolar satellite"				"Microtubules, Cytokinetic bridge, Centriolar satellite"		"HPA024019: AB_1845227"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavourable (9.68e-5)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.32e-3)"	8.4	8.3	8.9	15.7	9.2	18.8	7.7	23.5	11.7	7.0	6.1	10.7	5.6	10.4	10.6	9.0	7.2	7.9	11.1	8.5	9.0	7.8	8.0	4.4	8.9	15.2	6.9	8.4	10.0	9.1	4.6	11.6	9.4	8.3	8.1	2.7	9.7	12.5	5.7	18.0	15.4	9.1	9.5	7.8	18.2	10.7	23.7	9.3	15.6	9.0	4.5	10.4	7.0	7.8	5.1	3.8	4.0	7.4	1.9	2.6	1.3	11.0	10.8	5.8	10.5	1.0	1.5	18.4	7.7	1.3	5.7	4.4	12.7	5.6	7.9	4.4	1.9	8.0	1.7	3.8	1.3	3.2	14.8	7.6	16.6	21.6	1.6	6.5	16.9	1.3	2.6	4.1	1.1	4.0	5.4	4.7	1.4	12.5	15.0	12.7	5.1	9.6	15.3	6.7	3.3	2.1	9.8	13.3	15.0	9.9	6.2	9.4	9.4	6.5	5.3	10.3	17.9	9.1	10.1	12.1	2.0	5.9	5.3	5.7	7.3	4.0	1.6	1.0	2.6	4.3	0.8	5.1	1.5	2.1	3.5	3.7	2.2	1.6	2.5	1.9	7.4	3.8	0.2	1.3	8.9	9.2	23.5	11.7	9.0	7.8	6.9	8.4	8.3	9.3
CEP152	"KIAA0912, MCPH9, SCKL5"	ENSG00000103995	"Centrosomal protein 152"	O94986	15	48712928-48811146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease mutation, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039408	Approved		Supported	Centrosome				Centrosome		"HPA039408: AB_10795288"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.87e-4)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.25e-1)"	4.0	3.0	3.5	10.1	5.5	21.4	4.8	9.9	10.3	3.7	6.9	0.9	5.4	4.7	3.3	3.4	5.5	3.3	3.0	4.4	4.5	1.5	7.1	2.4	4.4	6.3	3.3	1.6	5.5	6.0	2.4	5.8	9.0	4.7	3.5	5.1	1.8	5.1	6.9	1.7	4.7	7.9	3.3	9.0	6.1	4.1	15.8	4.8	18.4	6.2	2.4	7.1	3.7	7.6	5.3	4.4	6.0	4.1	3.6	3.3	1.4	4.7	3.6	7.5	9.1	1.3	2.5	4.8	8.3	3.5	6.2	7.6	7.8	4.0	10.9	3.6	2.4	11.2	8.4	3.0	9.1	9.6	5.1	17.6	18.5	4.2	0.9	14.7	8.3	0.9	2.4	6.8	4.0	4.5	10.6	13.3	5.2	2.6	10.8	13.8	4.7	3.7	13.3	10.1	13.5	2.2	4.6	9.0	6.0	6.5	5.4	2.5	4.1	7.2	3.6	15.2	8.0	11.7	9.2	5.6	6.2	12.8	4.9	21.5	10.6	4.5	3.2	5.3	2.7	4.1	2.3	2.9	3.0	2.8	2.4	5.3	3.3	3.3	6.0	3.6	4.1	4.4	3.1	1.4	3.5	5.5	9.9	10.3	4.5	1.5	3.3	1.6	4.7	4.8
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227635	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	5.9	4.3	4.2	5.3	6.0	3.8	5.4	9.4	7.8	6.4	6.3	4.8	6.6	2.1	9.1	4.4	4.1	7.2	5.2	4.0	4.5	2.6	7.7	2.6	5.3	4.6	4.8	3.2	7.9	4.1	9.6	19.1	4.5	5.8	4.7	4.9	2.7	5.5	4.6	4.1	4.1	4.2	6.4	7.6	5.8	4.9	14.4	6.4	11.6	7.7	2.1	4.2	7.3	5.4	2.5	1.8	2.2	1.3	0.1	2.6	0.8	2.9	1.3	8.7	9.5	5.2	7.8	5.5	3.3	3.2	4.7	5.8	3.8	4.0	3.2	3.2	2.6	4.6	5.1	3.1	7.5	8.0	3.5	5.8	5.9	2.8	2.9	6.2	5.6	3.6	2.3	4.8	1.8	5.2	11.7	3.7	3.4	1.5	1.6	4.0	5.7	2.0	8.9	11.2	1.7	3.5	2.7	6.0	7.5	2.3	1.4	2.5	3.1	4.6	4.2	4.7	4.2	4.1	3.7	2.9	3.9	1.9	2.9	3.4	5.8	0.0	1.3	1.5	1.9	1.2	2.6	2.5	1.5	1.7	0.7	1.6	1.2	2.0	2.2	0.1	1.0	1.8	0.3	0.8	4.2	6.0	9.4	7.8	4.5	2.6	4.8	3.2	5.8	6.4
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413268	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606, HPA061504"	Uncertain		Enhanced	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA037605: AB_10672908, HPA037606: AB_10672498, HPA061504: "	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.1	6.8	7.8	11.2	10.4	7.0	7.2	17.4	7.8	10.5	6.8	9.1	11.2	4.7	17.4	9.4	9.7	12.9	12.1	4.6	6.9	6.8	7.1	7.2	7.3	7.7	7.4	8.3	13.9	28.1	10.8	19.1	5.1	8.2	7.4	5.8	16.4	6.9	7.6	3.1	8.3	6.2	11.5	10.4	9.7	6.3	29.7	8.3	10.8	9.6	5.0	14.4	8.0	8.0	18.0	21.1	36.5	16.6	11.8	21.4	4.3	8.8	12.4	9.1	18.2	9.2	15.8	2.9	17.7	9.9	12.7	12.5	15.3	14.5	17.6	12.8	10.9	11.8	10.1	10.4	10.9	17.4	8.4	5.3	12.2	4.8	13.6	7.6	11.9	10.9	8.9	19.3	18.8	16.4	14.4	11.6	9.9	7.7	7.0	6.9	6.5	13.5	9.4	10.9	6.9	5.6	7.7	10.7	15.5	14.0	8.6	10.1	11.8	8.9	17.7	15.2	9.5	14.6	16.1	4.1	5.0	10.5	7.4	8.7	10.0	30.7	15.7	9.4	15.9	12.9	10.1	15.2	20.0	17.9	5.8	18.0	18.9	15.1	36.5	11.8	16.6	21.1	21.4	4.3	7.8	10.4	17.4	7.8	6.9	6.8	7.4	8.3	8.2	8.3
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.7"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Enhanced	"Mitotic spindle,Centrosome,Cytosol"				Centrosome	"Mitotic spindle, Cytosol"	"HPA042151: , HPA045597: , HPA045787: "	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavourable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	9.5	6.1	13.7	10.8	13.2	36.5	6.8	27.7	23.2	7.4	5.4	11.4	3.1	3.1	9.1	5.2	5.5	6.4	11.1	8.6	12.8	11.2	3.8	6.7	8.4	7.3	19.3	13.7	13.3	2.8	2.8	10.8	9.8	20.2	5.0	4.2	3.3	4.2	5.5	9.3	4.2	4.7	7.4	25.8	7.8	4.2	53.7	18.0	11.6	14.4	3.3	8.9	8.6	6.6	9.4	8.4	12.3	10.1	2.8	4.7	2.1	6.0	5.1	13.1	11.1	8.2	15.9	2.8	16.1	9.5	12.1	11.4	3.1	5.9	4.5	9.8	13.6	3.0	11.3	6.9	17.2	10.0	6.5	4.6	4.8	2.2	7.1	8.2	8.8	10.0	1.9	38.5	16.9	28.1	11.3	4.7	15.3	1.3	5.0	4.3	16.5	14.5	9.0	9.4	1.5	2.5	1.0	19.0	25.7	8.2	0.7	7.7	2.8	11.1	31.1	22.6	6.7	12.1	18.4	4.6	5.9	9.0	12.0	7.5	51.8	3.5	8.3	7.6	1.9	10.0	2.7	3.6	3.8	1.6	8.4	9.4	4.7	2.7	12.3	2.8	10.1	5.5	2.9	2.1	13.7	13.2	27.7	15.8	12.8	11.2	19.3	13.7	20.2	18.0
CEP19	"C3orf34, MGC14126"	ENSG00000174007	"Centrosomal protein 19"	Q96LK0	3	196706277-196712293	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 12.9;eosinophil: 17.5;neutrophil: 45.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047614, HPA071138"	Enhanced		Supported	Centrosome				Centrosome		"HPA047614: , HPA071138: "	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (5.51e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.33e-2)"	3.2	5.2	10.2	5.7	11.7	2.4	2.4	7.3	10.8	3.6	2.3	3.0	2.6	2.0	3.3	6.2	3.2	8.0	3.8	2.4	8.4	9.0	5.2	2.3	3.2	5.0	6.5	6.0	3.8	1.4	6.1	9.2	3.9	8.3	3.5	2.2	2.5	2.3	4.4	1.3	3.3	2.0	3.0	4.4	6.1	1.7	17.5	4.4	8.3	5.1	0.4	6.3	4.0	2.6	1.4	3.4	45.3	1.3	2.3	3.5	1.2	5.1	3.6	5.0	3.1	11.6	9.0	1.5	4.2	8.0	4.6	6.0	1.8	3.5	3.9	12.2	2.1	2.3	3.3	1.1	5.5	5.3	3.4	5.9	1.8	0.5	4.7	2.7	7.6	4.1	5.0	6.0	1.6	1.9	3.2	4.8	4.7	2.7	6.6	4.8	2.6	6.1	7.9	3.1	2.7	4.9	0.5	5.0	3.6	5.8	0.8	6.5	4.5	5.2	1.5	5.4	1.2	8.2	2.8	14.8	14.1	8.0	7.6	6.9	5.2	12.9	1.3	17.5	1.8	0.9	2.0	1.1	2.6	2.3	0.8	1.4	3.5	2.2	45.3	2.3	1.0	3.4	1.4	1.2	10.2	11.7	7.3	10.8	8.4	9.0	6.5	6.0	8.3	4.4
CEP250	"C-NAP1, CEP2"	ENSG00000126001	"Centrosomal protein 250"	Q9BV73	20	35455164-35519280	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"		"Cone-rod dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064875			Supported	Centrosome				Centrosome		"HPA064875: "	"unprognostic (6.35e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (1.77e-7)"	"unprognostic (1.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.47e-2)"	"prognostic favourable (9.27e-6)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.97e-6)"	"unprognostic (1.30e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.57e-2)"	7.2	8.3	15.2	12.9	23.6	20.0	6.3	35.1	19.7	9.9	8.3	12.0	13.1	7.2	11.4	9.8	9.8	12.8	7.7	6.5	10.8	12.7	6.0	5.3	7.3	21.7	10.6	11.3	15.6	7.7	19.0	17.8	6.7	11.5	11.9	8.9	11.2	10.3	9.8	8.8	13.4	9.6	10.3	11.8	17.4	7.9	18.5	14.7	12.2	8.3	6.2	14.1	10.2	9.4	6.0	12.7	14.8	2.2	6.4	10.0	4.0	13.2	15.4	7.5	14.0	11.4	10.4	11.5	6.6	7.3	10.5	8.3	20.6	10.9	14.2	8.9	9.4	14.7	8.1	20.0	11.8	2.6	3.2	26.7	11.5	18.9	6.9	13.0	14.8	7.4	12.2	17.8	25.3	10.7	9.2	13.6	17.8	6.8	15.9	13.2	5.2	17.5	9.3	21.8	3.9	10.0	15.1	10.4	11.3	18.0	12.5	8.6	8.6	11.4	17.2	47.5	12.4	17.6	9.6	4.8	5.2	13.2	25.8	8.8	8.0	14.8	1.7	4.5	10.0	2.2	6.3	5.4	4.3	8.0	3.7	6.0	5.2	5.7	0.7	6.4	1.4	12.7	4.5	4.0	15.2	23.6	35.1	19.7	10.8	12.7	10.6	11.3	11.5	14.7
CEP290	"3H11Ag, BBS14, CT87, FLJ13615, JBTS5, KIAA0373, LCA10, MKS4, NPHP6, POC3, rd16, SLSN6"	ENSG00000198707	"Centrosomal protein 290"	O15078	12	88049014-88142216	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	Activator	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Joubert syndrome, Leber congenital amaurosis, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB029995, HPA043918, HPA064397"	Approved		Supported	Centrosome				Centrosome		"CAB029995: , HPA043918: , HPA064397: "	"unprognostic (7.42e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavourable (3.21e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.84e-3)"	7.0	7.7	14.4	15.5	17.2	9.3	9.8	15.2	19.5	10.0	8.1	5.4	7.6	5.2	13.3	11.8	4.9	10.6	7.3	6.4	11.3	10.9	7.9	4.7	7.0	8.2	13.2	13.4	17.7	6.7	21.7	22.4	8.3	12.7	10.4	7.5	4.9	4.8	7.7	4.0	7.0	6.1	8.7	14.0	7.5	7.6	15.7	15.5	8.9	12.1	4.1	6.4	8.5	7.5	9.3	5.7	1.9	1.9	3.2	6.5	0.7	8.8	8.2	10.4	4.8	8.9	18.4	5.2	10.9	6.8	5.6	5.2	11.7	5.3	8.9	4.3	5.5	9.5	3.9	4.9	9.4	5.9	6.9	7.7	5.6	5.9	8.2	9.9	4.3	8.6	5.9	11.7	11.1	10.6	14.8	3.3	11.0	4.2	6.9	12.9	4.1	9.7	5.0	12.2	6.8	7.7	9.0	8.0	9.7	6.4	4.8	8.3	11.3	5.1	11.3	14.1	6.6	9.1	10.4	9.2	10.8	9.3	4.5	5.0	5.8	0.0	1.6	1.9	5.4	1.1	5.6	6.5	5.5	5.2	0.7	9.3	5.6	6.5	0.3	3.2	1.9	5.7	4.2	0.7	14.4	17.2	15.2	19.5	11.3	10.9	13.2	13.4	12.7	15.5
CEP295	KIAA1731	ENSG00000166004	"Centrosomal protein 295"	Q9C0D2	11	93661639-93730358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038595, HPA038596, HPA038597"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038595: , HPA038596: AB_10672720, HPA038597: "	"unprognostic (1.35e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.18e-2)"	8.4	7.4	15.8	12.1	15.4	19.6	11.7	30.6	20.5	10.0	10.0	6.1	9.4	8.6	10.5	11.2	8.4	7.7	7.6	6.5	12.1	8.1	7.6	6.3	8.6	14.1	10.7	14.7	12.2	8.1	8.5	24.5	8.5	12.1	10.6	9.8	5.1	7.9	9.4	13.4	12.5	9.2	7.8	13.8	11.7	8.0	15.5	15.0	11.6	12.3	5.2	9.9	10.7	8.9	6.3	3.0	9.1	3.1	2.7	3.0	0.6	7.1	6.6	17.0	14.6	7.9	7.8	8.3	9.2	6.8	8.8	10.3	12.1	13.8	2.2	13.8	5.8	13.4	8.5	6.8	9.0	10.2	6.6	13.0	19.0	6.0	4.8	11.7	12.8	5.6	4.0	8.3	7.4	7.3	14.7	13.8	11.1	6.1	6.0	19.3	5.7	6.8	12.1	16.1	8.7	7.2	12.6	10.2	9.6	14.6	9.8	2.6	16.1	6.4	7.4	8.3	10.8	14.8	7.1	5.1	11.1	14.4	4.9	13.8	11.3	4.1	3.1	5.7	2.8	1.5	2.2	5.0	2.5	1.9	1.3	6.3	3.0	2.5	9.1	2.7	2.0	3.0	1.7	0.6	15.8	15.4	30.6	20.5	12.1	8.1	10.7	14.7	12.1	15.0
CEP350	"CAP350, KIAA0480"	ENSG00000135837	"Centrosomal protein 350"	Q5VT06	1	179954738-180114880	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028355, HPA028357, HPA030845, CAB079754"	Enhanced		Enhanced	Centrosome				Centrosome		"CAB079754: , HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: "	"unprognostic (9.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.84e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (4.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.13e-1)"	17.2	11.3	13.8	18.9	18.0	26.5	14.0	23.1	14.8	15.3	16.9	13.1	10.5	11.1	13.9	11.9	13.4	11.9	10.8	12.8	13.1	9.4	11.4	12.6	12.4	16.9	17.7	12.3	18.0	13.7	27.2	25.5	14.4	16.2	11.6	13.9	9.0	13.5	12.1	44.2	15.1	22.1	11.5	14.6	17.8	13.4	28.8	18.5	29.8	13.9	11.6	16.5	17.0	20.1	7.2	5.9	8.1	3.7	3.2	6.1	1.3	12.7	9.3	12.0	4.2	10.2	9.5	11.2	8.7	11.7	7.5	8.3	10.3	7.7	14.2	9.5	7.8	15.8	9.0	5.0	9.9	13.7	6.2	10.1	11.7	6.4	11.2	19.9	9.5	9.4	7.9	9.8	12.9	9.2	19.5	10.8	8.1	9.4	11.6	5.6	11.2	2.3	10.1	13.2	10.9	5.3	26.7	8.4	9.0	14.5	9.8	16.6	10.6	17.9	9.3	10.7	7.5	9.4	9.2	18.9	23.8	27.8	5.0	8.6	15.9	2.3	3.7	8.1	5.4	3.4	6.1	4.1	3.9	3.4	3.0	7.2	4.2	3.5	7.3	3.2	3.0	5.9	5.7	1.3	13.8	18.0	23.1	14.8	13.1	9.4	17.7	12.3	16.2	18.5
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496632-93529092	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.9;testis: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023430	Approved		Supported	"Plasma membrane,Midbody,Centriolar satellite"				"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavourable (3.20e-9)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (0.00e+0)"	"prognostic favourable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	3.2	1.4	0.5	12.1	0.4	3.1	3.6	0.3	0.6	2.0	5.2	0.3	0.2	4.6	0.8	1.5	11.6	0.6	2.5	0.7	0.4	0.5	1.5	0.7	4.4	10.1	0.6	0.2	0.8	0.6	0.0	0.7	3.8	0.5	0.8	6.5	0.4	2.3	0.2	0.7	3.0	5.2	3.5	1.1	4.8	3.2	19.3	0.3	52.9	0.7	10.8	11.0	2.7	3.3	0.1	0.1	0.0	0.0	0.0	4.4	0.0	51.0	20.4	13.6	17.2	1.5	3.1	7.6	28.1	19.9	26.7	27.7	21.6	27.5	13.6	12.4	18.2	29.2	16.4	13.8	32.1	41.0	8.5	5.1	12.6	7.3	0.1	8.8	11.9	0.7	1.0	28.4	34.7	24.6	4.6	25.9	30.1	11.8	23.2	13.4	5.3	14.9	10.1	22.2	7.5	12.0	6.3	5.6	7.9	21.6	6.7	17.0	17.5	9.0	15.3	16.9	23.7	23.2	46.1	11.6	15.7	16.7	13.2	33.4	15.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.5	0.4	0.3	0.6	0.4	0.5	0.6	0.2	0.5	0.3
CEP57	"KIAA0092, Translokin, TSP57"	ENSG00000166037	"Centrosomal protein 57"	Q86XR8	11	95789965-95832693	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018315	Approved		Supported	Microtubules,Cytosol	"Intracellular and membrane"			Microtubules	Cytosol	"HPA018315: AB_1846537"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (7.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.25e-1)"	16.8	13.7	12.9	25.9	20.6	21.6	17.4	27.9	16.2	25.6	33.8	6.9	19.2	27.0	18.5	18.8	18.2	16.5	22.9	14.0	13.3	14.1	14.9	34.4	19.0	28.9	12.6	15.2	27.2	24.5	13.6	26.1	13.3	15.0	21.5	15.6	10.5	14.1	22.3	12.6	15.8	28.8	22.2	14.6	19.8	15.3	24.3	12.7	46.5	23.4	15.7	23.9	27.5	18.3	17.2	15.5	17.6	11.0	18.6	25.3	13.0	11.2	5.6	19.4	14.4	8.3	17.1	15.4	12.8	20.6	17.7	20.1	20.1	24.2	20.3	17.9	9.5	19.0	14.6	12.7	18.8	15.9	9.7	27.9	16.3	16.7	15.3	28.3	16.9	11.5	18.1	18.1	34.9	14.7	18.0	11.2	14.1	5.5	30.6	37.4	9.9	12.8	19.1	23.2	17.0	14.9	12.5	9.3	13.5	15.2	15.1	16.1	15.4	18.4	8.2	15.5	12.5	22.7	12.2	8.2	16.0	22.7	6.4	31.6	13.4	11.3	9.1	17.6	16.5	11.0	21.2	17.2	21.0	18.8	11.9	16.2	20.2	19.2	8.5	18.6	9.1	15.5	25.3	13.0	12.9	20.6	27.9	16.2	13.3	14.1	12.6	15.2	15.0	12.7
CEP68	KIAA0582	ENSG00000011523	"Centrosomal protein 68"	Q76N32	2	65056366-65087004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040493, HPA040620"	Enhanced		Supported	"Nucleoplasm,Centriolar satellite"				"Nucleoplasm, Centriolar satellite"		"HPA040493: AB_10673411, HPA040620: AB_10794144"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.84e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (3.93e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.71e-1)"	18.4	7.3	12.7	9.2	17.0	5.0	16.2	24.8	22.2	19.2	13.2	11.9	8.5	6.6	20.0	10.4	11.7	16.9	12.7	15.7	12.5	11.9	8.4	3.3	9.2	10.6	11.3	17.6	26.4	10.6	13.2	7.5	11.8	15.0	14.2	8.6	11.6	12.0	15.4	28.2	13.6	8.7	17.3	10.3	10.2	9.7	7.6	7.8	10.3	11.6	12.9	9.9	13.4	13.0	5.1	8.7	1.5	5.5	5.2	11.1	3.0	2.7	5.0	9.7	7.1	8.8	9.9	17.9	2.6	4.8	4.1	3.6	3.8	2.5	4.7	3.4	4.8	3.9	6.3	4.1	4.4	5.7	5.4	6.4	1.8	4.6	2.4	3.6	4.6	9.3	5.8	3.8	5.3	11.7	5.8	15.2	5.2	3.2	6.0	6.6	9.8	4.0	6.3	11.8	5.5	3.7	3.7	17.2	11.7	5.3	3.9	5.6	2.3	2.3	4.6	3.9	5.4	6.1	2.6	16.6	4.6	11.1	2.1	2.8	4.7	1.0	1.7	0.4	3.0	3.1	3.4	3.4	7.0	5.6	4.3	5.1	11.1	6.6	1.5	5.2	5.5	8.7	5.1	3.0	12.7	17.0	24.8	22.2	12.5	11.9	11.3	17.6	15.0	7.8
CEP72	"FLJ10565, KIAA1519"	ENSG00000112877	"Centrosomal protein 72"	Q9P209	5	612272-667168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.7;HeLa: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.2;NK-cells: 7.7;T-cells: 3.2"	"Region enriched"	"Detected in single"	8	"cerebellum: 15.8"	"Not detected"	"Not detected"			"HPA058235, HPA074879"	Approved		Supported	Centrosome				Centrosome		"HPA058235: , HPA074879: "	"unprognostic (2.06e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.94e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.24e-2)"	2.5	2.3	4.7	6.5	6.5	7.1	4.0	7.3	5.9	5.4	3.0	6.6	2.0	3.8	4.8	3.1	4.6	4.5	9.1	2.2	4.5	2.7	2.8	4.2	4.8	6.4	3.8	3.5	7.6	6.2	3.7	4.5	4.0	3.3	3.5	2.5	4.8	4.6	3.2	2.6	6.0	3.4	4.9	3.3	4.0	4.9	18.8	4.3	9.4	4.9	2.6	7.9	2.9	3.6	3.2	0.7	0.6	1.0	7.7	3.2	1.4	4.3	7.1	6.4	9.0	0.6	0.6	11.6	1.9	0.8	4.3	3.8	6.4	6.7	5.1	5.0	0.8	4.2	4.5	3.2	1.7	26.7	7.1	5.7	21.5	2.5	0.8	6.5	3.8	0.7	1.4	3.7	2.5	1.6	5.7	6.1	2.1	3.3	9.7	5.7	4.2	6.7	7.4	3.7	7.1	1.4	3.4	4.9	3.8	13.8	4.6	1.2	4.5	5.1	0.5	4.1	6.1	3.9	2.6	3.9	3.7	5.1	2.6	9.2	4.3	0.0	0.6	0.6	2.4	0.2	3.2	2.6	2.1	2.2	0.2	3.2	3.0	3.0	0.0	7.7	1.0	0.7	2.6	1.4	4.7	6.5	7.3	5.9	4.5	2.7	3.8	3.5	3.3	4.3
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Supported	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"				Nucleoli	"Golgi apparatus, Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.4	6.7	10.8	11.4	3.0	2.8	21.1	6.8	3.2	9.5	10.1	8.6	12.6	12.8	9.3	2.8	11.9	12.0	5.7	9.5	9.4	10.4	18.1	13.1	9.0	3.1	16.5	20.0	1.4	5.6	7.9	5.8	4.2	24.3	17.9	6.9	4.8	15.8	20.0	10.4	11.1	16.1	12.5	11.9	4.7	2.0	18.3	8.4	9.6	8.0	8.0	7.3	11.8	4.9	7.7	12.9	9.0	10.5	14.1	20.6	16.0	4.8	29.1	14.6	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5
CEP89	"CCDC123, FLJ14640"	ENSG00000121289	"Centrosomal protein 89"	Q96ST8	19	32875925-32971991	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039382, HPA040056"			Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane"	"HPA039382: , HPA040056: AB_10671048"	"unprognostic (4.23e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (8.78e-5)"	"unprognostic (1.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.47e-2)"	10.1	9.5	8.5	8.3	12.1	6.8	11.6	16.4	14.4	12.9	10.5	12.5	9.7	6.4	17.0	11.3	10.1	14.8	8.3	8.8	8.1	6.4	9.8	5.6	9.4	8.9	7.9	8.4	17.1	9.0	11.3	20.2	8.8	9.1	15.0	7.4	10.2	10.3	10.2	10.5	10.7	7.4	11.4	6.6	7.7	8.1	8.4	8.4	10.1	11.8	5.0	7.6	10.2	11.4	7.7	5.1	12.7	6.1	2.8	6.9	2.1	13.1	18.1	12.6	10.8	6.8	8.0	7.3	10.7	7.1	18.9	14.5	6.5	8.2	5.4	5.8	10.8	7.6	12.3	8.6	13.1	14.2	7.5	4.2	12.6	6.2	5.4	5.8	4.2	9.6	12.0	17.8	11.7	14.1	6.4	8.1	8.7	10.0	6.6	4.5	5.4	5.8	7.3	6.8	4.7	8.6	7.4	17.8	13.1	10.9	7.6	6.1	5.7	4.8	9.0	13.7	12.2	11.7	10.8	4.0	6.2	4.9	11.8	5.5	10.2	12.7	4.4	2.1	4.0	6.1	6.9	4.7	4.2	3.4	2.4	7.7	4.1	4.7	5.3	2.8	3.0	5.1	4.4	2.1	8.5	12.1	16.4	14.4	8.1	6.4	7.9	8.4	9.1	8.4
CEP97	"FLJ23047, LRRIQ2"	ENSG00000182504	"Centrosomal protein 97"	Q8IW35	3	101723925-101770562	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002980	Uncertain		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA002980: AB_1848820"	"unprognostic (7.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.05e-1)"	3.8	4.3	7.5	5.2	11.8	6.6	4.1	15.2	11.8	4.5	3.9	12.1	3.6	2.5	5.7	4.1	3.8	8.7	3.5	3.5	7.9	4.9	3.5	2.9	3.7	6.5	15.3	7.0	5.4	3.1	10.2	9.9	4.1	12.8	3.9	3.7	3.0	4.1	3.6	4.8	4.1	3.9	6.6	8.1	4.3	3.5	20.0	14.8	10.8	5.3	1.7	6.8	4.7	4.1	2.7	1.3	5.1	1.1	0.9	2.5	0.8	9.3	5.6	9.5	6.9	5.3	4.2	2.9	10.1	7.1	7.8	9.7	2.4	4.4	8.1	4.6	5.6	6.3	7.1	5.5	13.2	8.9	3.4	4.7	6.1	1.7	2.6	5.8	7.2	2.5	4.4	6.7	5.7	4.3	3.7	14.6	9.5	2.8	9.5	3.0	3.3	7.3	7.0	13.2	5.5	2.5	3.6	18.2	7.4	5.4	3.5	4.8	6.0	5.0	4.3	10.6	7.9	3.1	7.3	9.2	8.4	14.6	4.3	5.3	10.4	5.1	0.4	1.9	2.2	0.1	1.8	2.7	1.9	1.3	0.5	1.7	1.3	1.1	3.1	0.9	1.1	1.3	2.5	0.8	7.5	11.8	15.2	11.8	7.9	4.9	15.3	7.0	12.8	14.8
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536676-181680665	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5"	"Cell line enhanced"	"Detected in some"		"HEL: 26.2;HL-60: 14.5;MOLT-4: 35.2;NB-4: 30.9;SCLC-21H: 23.7;THP-1: 14.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"cerebellum: 49.5;pons and medulla: 13.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 31.8"	"HPA035443, HPA035444, HPA043203"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035443: , HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.6	1.2	9.2	2.0	14.4	1.1	49.5	2.5	3.7	1.7	4.2	0.4	3.1	1.0	5.3	0.6	5.8	4.1	0.5	2.9	1.3	8.1	1.3	5.0	13.8	0.6	1.4	2.9	0.8	0.1	2.1	2.0	13.7	1.0	0.0	6.8	1.0	0.4	0.5	0.5	6.4	0.4	1.0	17.9	2.8	1.1	1.1	0.4	0.9	0.4	1.1	4.3	1.3	4.0	5.2	12.6	12.7	4.7	6.9	4.2	0.0	0.5	0.6	0.0	0.0	0.1	0.0	4.1	0.1	0.1	0.1	0.0	0.1	4.4	0.0	0.1	2.6	0.1	0.1	0.1	0.0	0.4	26.2	0.3	0.0	0.1	14.5	0.7	0.1	0.3	0.1	0.2	0.0	0.0	4.6	0.0	0.0	35.2	30.9	0.6	0.2	7.5	2.2	0.6	0.3	0.0	23.7	0.7	0.0	0.0	0.1	0.0	14.6	2.4	1.2	0.6	0.1	1.0	11.3	6.3	2.0	0.9	9.8	10.7	2.0	4.7	12.6	4.5	12.7	3.7	4.0	6.4	6.9	5.2	3.4	3.5	4.5	0.7	4.7	10.9	2.9	1.4	4.2	1.2	2.0	49.5	2.5	2.9	1.3	0.6	1.4	13.7	1.1
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975004	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 142.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027262	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"			24000	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717"	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	19.4	65.5	17.0	10.5	36.1	13.9	22.6	9.6	21.3	19.8	21.1	59.3	22.1	19.6	16.9	19.0	12.5	21.1	21.6	14.4	23.0	16.1	60.9	142.3	28.6	14.0	50.1	14.5	21.8	29.7	28.7	17.6	24.0	25.5	18.5	18.8	16.5	12.3	19.2	7.1	9.1	33.3	21.2	63.7	13.2	23.4	10.2	38.7	10.2	35.5	8.8	14.0	17.5	25.6	12.3	23.5	56.6	27.0	19.3	33.6	26.2	25.7	28.2	23.8	51.0	71.1	43.7	17.8	26.4	38.8	50.3	34.6	29.5	45.7	22.7	44.1	41.4	29.4	33.0	28.1	41.4	30.8	26.9	31.3	19.8	35.8	51.5	35.5	38.8	39.7	36.3	44.4	55.4	31.3	33.5	52.0	62.8	38.8	23.2	20.5	36.5	50.5	26.5	16.2	36.2	54.5	21.9	22.0	34.3	29.1	51.7	30.1	61.6	53.9	24.3	36.5	16.4	32.9	46.4	33.7	37.8	142.5	41.0	15.2	36.9	56.6	27.0	44.0	28.0	14.6	33.6	12.3	25.7	28.4	23.4	11.4	22.9	22.2	29.2	19.3	10.2	23.5	28.8	26.2	17.0	36.1	9.6	21.3	23.0	16.1	50.1	14.5	25.5	38.7
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.6;skin 1: 29.0;testis: 37.9"	"Cell line enriched"	"Detected in some"	6	"hTCEpi: 37.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.4	0.0	0.4	0.4	0.4	0.0	1.9	0.4	0.4	6.0	0.4	0.4	0.4	0.0	0.4	0.4	25.6	0.3	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	3.6	0.4	0.4	29.0	0.4	0.4	0.4	0.4	0.0	37.9	0.4	0.4	0.4	0.4	8.5	0.4	11.2	0.0	0.0	1.5	0.6	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	0.2	0.2	0.0	0.7	0.3	0.0	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 21.2;NB-4: 38.2;U-937: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favourable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favourable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favourable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	6.2	6.7	17.5	10.5	22.9	2.5	21.6	14.5	19.3	13.2	6.8	24.3	7.8	4.6	9.9	41.8	26.4	11.9	7.7	9.7	16.1	10.8	16.5	32.4	12.9	12.2	26.9	13.3	13.8	56.7	11.6	10.1	2.2	16.8	22.4	3.2	26.2	34.8	12.8	2.1	20.9	6.1	8.5	20.3	8.6	9.9	8.4	29.0	6.4	38.1	9.5	15.9	9.3	13.2	13.3	2.7	16.9	4.4	13.5	5.2	3.5	0.1	0.9	0.9	10.0	0.3	0.0	0.7	1.3	3.3	1.5	0.7	7.5	0.8	15.6	11.1	0.0	5.3	6.5	0.1	0.7	13.7	5.1	3.0	0.1	21.2	12.9	0.0	8.5	5.0	8.4	3.5	7.6	0.1	2.2	0.5	0.0	0.3	1.2	38.2	10.2	3.7	18.8	0.2	1.2	2.5	0.0	3.8	5.1	1.6	0.3	5.4	7.4	3.5	0.0	1.1	3.2	7.5	0.0	9.8	7.8	11.9	0.0	23.9	1.1	5.9	4.4	16.9	5.2	2.3	3.9	13.3	3.0	3.1	2.7	12.1	2.8	2.6	14.0	13.5	1.5	2.6	3.5	3.5	17.5	22.9	14.5	19.3	16.1	10.8	26.9	13.3	16.8	29.0
CERS6	LASS6	ENSG00000172292	"Ceramide synthase 6"	Q6ZMG9	2	168455862-168775137	"Predicted membrane proteins"	"Inflammatory response, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 9.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044683, HPA063527"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA044683: AB_10965059, HPA063527: "	"unprognostic (2.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.92e-3)"	"prognostic unfavourable (7.31e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.80e-2)"	12.3	13.5	17.7	12.2	17.5	9.6	14.2	28.0	23.2	12.3	24.4	6.5	19.8	22.4	17.4	17.0	12.7	9.8	9.7	26.9	14.5	15.9	12.1	11.7	9.4	12.5	11.0	15.9	15.6	7.3	15.8	14.6	8.3	9.2	12.2	27.1	13.4	6.9	17.1	9.4	20.0	28.3	11.0	8.5	6.9	21.0	11.0	8.1	25.1	24.1	7.4	7.5	11.8	30.5	0.8	9.0	0.7	1.7	1.1	1.7	0.5	5.8	5.2	9.3	10.7	23.1	17.2	0.0	5.9	6.0	6.3	8.5	8.2	12.9	0.0	8.5	5.3	11.1	12.0	13.7	10.6	0.0	8.2	10.7	5.6	5.9	20.3	22.5	5.2	19.2	39.3	13.2	10.4	3.2	5.7	0.0	13.1	6.3	19.7	6.3	8.7	7.6	15.3	17.6	10.1	6.0	17.6	12.9	15.6	5.7	14.7	3.0	13.1	12.8	1.8	16.1	6.7	4.4	10.1	0.1	0.0	0.0	10.6	12.0	10.8	0.7	1.7	0.0	0.3	1.2	0.6	0.2	0.6	0.3	1.3	0.8	1.7	1.3	0.2	1.1	1.0	9.0	0.0	0.5	17.7	17.5	28.0	23.2	14.5	15.9	11.0	15.9	9.2	8.1
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 355.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 93.9;THP-1: 101.2"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	18	"classical monocyte: 32.6;myeloid DC: 32.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 32.9;monocytes: 32.6"	"Not detected"	"Not detected"							"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		40000000	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (9.92e-4)"	27.1	1.7	0.3	0.5	0.4	2.1	24.7	0.4	0.6	3.1	8.9	0.5	1.5	2.4	7.3	2.1	4.5	6.7	57.7	8.1	0.3	0.0	0.7	355.0	19.8	2.3	0.3	0.6	3.9	1.3	0.0	0.8	1.1	0.6	11.2	1.0	3.8	3.9	4.0	1.6	1.4	3.5	10.2	0.7	4.4	7.0	1.0	0.3	0.4	1.7	2.3	1.5	8.2	16.1	0.2	32.9	0.2	32.6	0.1	1.6	12.1	0.0	0.6	0.0	0.0	14.1	0.0	0.4	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	101.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	20.3	0.0	0.0	32.6	0.1	1.3	1.8	0.5	0.2	0.2	1.6	32.9	0.2	0.2	0.4	0.2	0.1	0.4	1.7	0.1	12.1	0.3	0.4	0.4	0.6	0.3	0.0	0.3	0.6	0.6	0.3
CETN3	CEN3	ENSG00000153140	"Centrin 3"	O15182	5	90392261-90409786	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035608, HPA063704"	Enhanced		Supported	Centrosome				Centrosome		"HPA035608: AB_10601098, HPA063704: "	"unprognostic (2.08e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (2.22e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	8.6	11.6	13.7	8.0	16.3	3.6	12.4	11.5	17.9	11.5	8.9	8.7	8.9	5.2	11.0	11.5	11.4	12.0	5.6	14.4	15.6	11.4	10.6	6.9	12.1	9.3	18.2	13.2	17.1	5.8	11.8	34.3	10.0	20.6	10.3	10.7	5.9	7.8	9.7	11.7	8.2	5.6	7.7	37.2	7.6	6.7	63.1	16.5	7.3	7.9	6.1	10.5	7.5	9.6	17.2	19.9	9.4	10.5	11.4	14.9	4.7	16.7	7.4	30.0	6.1	16.9	23.0	18.0	18.3	11.3	17.6	21.9	11.2	20.6	31.7	18.3	8.6	12.0	25.6	24.7	29.2	25.4	11.8	16.1	11.1	14.0	12.1	11.9	10.1	14.4	16.3	12.8	21.4	11.0	20.3	14.2	19.7	11.1	19.6	18.7	10.6	19.1	17.9	21.0	16.1	15.6	6.2	16.4	16.8	17.8	9.2	12.9	17.3	16.1	12.3	10.6	15.2	14.7	24.5	13.2	23.6	28.1	12.4	26.9	10.7	7.8	6.7	9.4	9.3	8.1	9.7	17.2	10.3	9.9	7.4	14.6	14.9	11.9	0.8	11.4	10.5	19.9	8.0	4.7	13.7	16.3	11.5	17.9	15.6	11.4	18.2	13.2	20.6	16.5
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706989-127716002	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5"	"Cell line enhanced"	"Detected in many"		"A549: 9.1;HeLa: 7.4;MCF7: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 19.8;pons and medulla: 30.2"	"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favourable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7.0	1.6	0.2	1.0	24.0	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0.0	0.0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0.0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0.0	0.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	9.1	0.9	1.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.9	1.3	1.4	1.4	0.0	4.5	0.0	0.0	0.0	3.4	1.0	0.9	7.4	2.2	0.0	0.7	2.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	6.5	1.3	0.5	0.8	4.9	2.0	0.9	1.5	0.0	0.4	6.3	1.1	1.9	3.6	0.7	3.2	0.3	1.7	1.9	1.5	4.9	0.8	1.0	2.5	1.1	0.7	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	19.8	0.1	0.3	4.6	5.8	0.0	0.0	30.2	3.5
CFAP20	"C16orf80, fSAP23, GTL3"	ENSG00000070761	"Cilia and flagella associated protein 20"	Q9Y6A4	16	58113588-58129450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018195	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA018195: AB_1850408"	"unprognostic (9.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.47e-1)"	13.5	18.4	20.7	10.8	37.3	15.8	16.1	19.4	30.2	16.8	12.5	26.0	12.1	12.8	15.4	18.2	14.6	28.0	13.4	31.4	22.7	27.2	15.5	25.0	15.1	17.0	21.6	18.1	24.9	13.2	22.1	24.4	22.8	20.2	14.5	12.3	16.8	12.8	14.4	8.1	14.9	12.0	13.3	21.7	13.3	11.9	21.6	19.8	30.6	20.2	9.7	15.6	12.5	13.4	23.0	24.6	28.1	13.5	26.9	39.8	21.8	17.8	14.9	24.3	13.0	9.1	7.3	19.0	16.9	11.9	27.0	17.5	23.1	19.4	18.6	24.6	11.4	18.5	22.5	16.8	26.7	10.6	24.2	10.4	8.7	30.0	10.6	15.7	21.0	8.2	11.7	17.1	15.6	16.4	17.3	8.9	21.1	13.9	44.7	31.8	22.3	30.1	43.5	30.4	17.6	14.9	11.2	22.2	19.6	30.3	11.9	16.5	10.2	19.8	11.3	16.6	21.8	18.1	19.2	10.9	10.3	35.8	10.9	16.6	22.5	28.1	13.5	22.9	21.9	12.9	21.0	23.0	22.9	23.3	15.0	21.2	31.0	26.2	11.3	26.9	12.7	24.6	39.8	21.8	20.7	37.3	19.4	30.2	22.7	27.2	21.6	18.1	20.2	19.8
CFAP36	"BARTL1, CCDC104, MGC15407"	ENSG00000163001	"Cilia and flagella associated protein 36"	Q96G28	2	55519604-55545879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008994, HPA017061"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA008994: AB_2275429, HPA017061: AB_1846129"	"unprognostic (8.11e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.66e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.96e-1)"	13.0	22.7	34.6	9.9	46.6	7.3	25.3	16.7	39.4	23.3	16.7	10.2	18.1	7.8	24.4	39.1	12.3	32.7	21.1	15.4	28.6	34.9	32.4	9.1	15.1	11.0	27.7	29.5	29.3	15.8	32.8	47.1	10.6	36.7	22.1	12.1	13.5	10.6	24.6	6.5	8.1	8.4	19.7	19.3	8.8	16.6	66.4	14.4	8.9	39.9	7.7	9.8	21.7	13.3	8.0	6.2	6.3	2.9	5.5	25.2	8.3	18.9	15.0	16.3	21.3	21.5	41.7	9.9	11.9	24.5	18.4	15.4	11.3	7.0	6.8	28.0	15.6	12.6	12.6	16.6	23.8	16.5	24.9	10.0	14.7	11.7	23.7	18.4	12.4	20.5	27.1	24.9	29.5	20.4	12.5	5.6	23.2	14.2	11.1	20.5	8.3	15.0	8.7	19.3	7.1	37.4	10.7	24.5	12.3	16.2	8.3	22.0	13.6	6.4	10.5	18.8	11.5	19.4	16.1	10.1	4.6	2.3	31.9	8.4	8.6	6.3	2.1	6.2	9.1	2.3	17.5	8.0	25.2	14.5	2.7	5.2	21.0	12.8	2.4	5.5	2.9	6.2	13.7	8.3	34.6	46.6	16.7	39.4	28.6	34.9	27.7	29.5	36.7	14.4
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900163	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 35.5;testis: 29.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.0;HEL: 14.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 6.0;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.3	0.3	2.0	0.4	7.5	0.6	0.5	0.0	0.2	2.5	0.2	11.9	0.0	0.4	1.3	10.5	0.4	35.5	0.2	0.5	3.1	2.8	0.3	0.2	6.1	0.3	0.1	0.1	7.3	0.1	0.1	0.2	3.3	12.5	0.2	0.2	0.0	0.2	0.5	0.2	0.3	0.2	0.4	0.5	0.5	0.6	29.7	3.4	0.0	0.7	0.0	0.3	0.4	0.1	0.7	0.3	6.0	0.3	0.2	0.5	0.2	2.5	0.6	0.0	0.0	0.1	0.2	11.0	1.3	1.6	2.4	1.0	1.8	3.2	1.0	0.5	0.6	1.5	0.3	0.3	1.4	0.6	0.3	14.2	0.6	0.1	0.7	1.2	0.5	1.0	0.7	2.6	0.9	1.6	1.5	0.5	0.4	3.4	0.2	1.1	0.6	1.2	0.0	1.1	0.4	0.3	0.6	1.0	0.2	1.3	3.8	0.4	3.8	0.2	2.1	1.0	2.9	1.9	2.3	1.1	0.0	0.4	5.3	0.5	0.8	0.0	0.3	6.0	0.0	0.3	0.0	0.5	0.3	0.5	0.3	0.7	0.0	0.5	4.9	0.2	0.0	0.3	0.0	0.2	2.0	7.5	0.0	0.1	3.1	2.8	0.1	0.1	12.5	3.4
CFAP97	"DKFZp434F1728, hmw, KIAA1430"	ENSG00000164323	"Cilia and flagella associated protein 97"	Q9P2B7	4	185159665-185209504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049446, HPA053335"	Approved		Supported	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA049446: , HPA053335: "	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.29e-1)"	23.2	12.5	11.2	17.2	13.7	4.4	19.5	11.6	15.1	18.7	15.9	8.8	17.1	7.0	19.2	13.3	18.2	15.2	14.2	13.2	11.3	10.3	18.4	24.8	15.0	19.4	12.7	12.5	25.4	13.7	23.2	20.7	12.7	13.5	19.2	10.8	10.7	15.0	23.6	11.6	13.0	9.9	21.8	17.4	19.2	12.5	32.2	14.5	14.7	25.8	11.9	14.5	27.9	14.7	17.0	16.0	3.5	9.4	10.2	19.3	5.3	12.1	7.6	10.2	17.5	12.1	21.0	6.2	15.8	14.4	12.2	9.5	4.7	15.4	30.7	5.5	18.7	6.8	11.3	14.2	16.4	27.1	7.5	12.3	4.6	10.9	15.0	16.0	9.8	13.8	20.0	13.3	29.4	10.6	21.7	28.9	17.1	5.8	8.4	8.3	5.8	6.2	13.3	5.0	19.0	15.0	6.6	6.9	18.5	12.0	11.8	22.7	7.9	10.3	15.1	11.4	7.2	4.5	12.7	11.5	5.1	9.5	14.5	14.6	23.1	3.5	3.7	1.4	16.0	6.3	19.3	17.0	16.0	15.5	4.5	16.3	16.1	11.2	0.7	10.2	9.4	16.0	10.7	5.3	11.2	13.7	11.6	15.1	11.3	10.3	12.7	12.5	13.5	14.5
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116104-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 79.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favourable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	35.4	17.6	13.7	29.8	17.4	66.8	31.6	26.9	12.6	20.5	25.7	13.5	31.3	17.5	24.7	27.6	21.0	19.2	22.1	58.1	14.7	7.7	24.9	18.9	58.5	34.3	16.8	8.9	14.6	14.3	9.1	18.7	28.3	12.6	23.2	17.7	20.9	21.8	27.4	113.7	16.7	26.8	30.5	13.8	35.7	19.4	10.9	14.8	17.2	31.2	26.2	31.4	24.1	33.7	5.3	6.6	79.2	12.6	8.7	11.8	7.8	5.1	10.6	7.6	4.5	23.6	18.1	9.4	13.1	22.9	8.7	10.6	12.2	19.4	1.4	12.5	15.2	3.8	2.4	9.9	13.9	38.8	7.4	7.8	9.1	19.8	16.5	5.8	25.9	19.7	9.8	14.6	12.9	44.0	26.3	32.7	15.7	4.3	2.7	23.2	2.6	8.0	2.8	1.8	11.1	10.8	10.7	1.7	3.0	8.8	7.8	10.3	5.5	10.9	47.7	18.2	7.6	6.7	6.4	54.5	17.9	8.7	12.9	4.7	9.0	16.3	12.1	13.5	11.7	12.3	10.3	5.3	10.1	11.0	6.6	4.0	6.4	8.3	79.2	8.7	12.6	4.6	11.8	7.8	13.7	17.4	26.9	12.6	14.7	7.7	16.8	8.9	12.6	14.8
CGGBP1	"CGGBP, p20-CGGBP"	ENSG00000163320	"CGG triplet repeat binding protein 1"	Q9UFW8	3	88051944-88149885	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 108.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035568, HPA037017"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035568: AB_10670022, HPA037017: AB_2675433"	"unprognostic (2.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.00e-1)"	"prognostic favourable (7.79e-4)"	29.6	23.9	26.1	27.5	28.6	38.5	80.0	33.3	36.9	28.7	28.3	19.4	23.7	23.1	30.7	23.6	23.5	24.2	23.6	33.8	23.1	21.6	28.4	30.8	29.1	39.4	24.4	26.4	37.1	25.9	40.6	33.2	26.4	21.2	27.3	26.0	23.7	25.2	24.9	30.8	19.2	30.0	29.7	28.9	33.9	25.1	22.4	22.0	76.0	32.7	16.7	37.4	27.7	30.9	24.8	19.9	41.6	23.0	20.8	25.1	19.8	7.8	13.5	22.5	16.0	19.8	17.7	7.2	15.8	14.3	16.6	19.7	9.8	11.6	17.2	10.7	14.1	6.3	17.7	11.9	20.5	26.0	9.8	26.3	11.9	8.8	17.6	17.4	18.7	15.9	12.4	18.3	23.6	16.9	12.4	18.0	18.7	12.5	26.1	12.4	12.3	11.4	16.9	21.1	12.3	12.4	12.0	4.4	14.8	13.3	7.6	37.2	11.5	21.1	16.4	20.1	14.8	108.8	16.4	13.2	15.9	18.8	15.3	17.0	17.2	41.6	21.2	39.4	23.3	21.7	22.7	22.5	20.7	23.9	19.9	24.8	25.1	20.5	39.8	20.8	23.0	17.9	23.0	19.8	26.1	28.6	33.3	36.9	23.1	21.6	24.4	26.4	21.2	22.0
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.0;CACO-2: 37.3;CAPAN-2: 24.6;RT4: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			24000000	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favourable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	3.9	0.3	2.1	8.5	5.1	0.0	4.1	11.9	3.5	2.2	18.0	3.7	15.5	23.9	1.0	3.5	5.9	6.1	11.9	0.5	1.4	1.4	10.7	15.0	12.4	0.2	5.0	1.0	1.4	25.3	22.1	4.7	1.9	4.8	4.6	11.6	1.8	19.8	14.4	0.2	11.6	44.1	1.8	1.9	0.2	13.6	6.4	4.3	0.9	3.6	2.3	4.3	6.9	3.8	1.2	0.9	2.6	1.0	1.6	2.4	0.1	11.7	1.3	1.1	1.9	0.0	0.0	15.0	0.0	0.0	0.3	0.4	37.3	24.6	0.5	4.0	0.0	11.2	3.6	2.1	0.2	7.0	2.5	1.0	0.5	0.8	0.0	0.2	1.6	0.0	0.4	0.5	0.3	0.1	0.5	3.6	0.0	10.8	2.0	0.2	9.6	1.0	2.2	1.2	1.7	7.9	18.1	3.8	1.9	0.7	11.4	0.4	14.1	0.1	0.2	0.1	3.6	0.2	0.5	3.3	3.3	2.1	0.1	1.3	0.9	1.1	1.0	0.4	2.4	0.4	0.7	0.7	0.7	0.5	0.1	1.2	0.8	1.4	2.6	1.6	0.5	0.9	0.7	0.1	2.1	5.1	11.9	3.5	1.4	1.4	5.0	1.0	4.8	4.3
CGNL1	"FLJ14957, JACOP, KIAA1749, PCING"	ENSG00000128849	"Cingulin like 1"	Q0VF96	15	57375967-57550727	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.8;HUVEC TERT2: 31.0;TIME: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013500, HPA056911, HPA069214"	Enhanced		Supported	"Nuclear bodies,Cell Junctions"				"Cell Junctions"	"Nuclear bodies"	"CAB013500: , HPA056911: , HPA069214: "	"unprognostic (1.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.52e-2)"	"prognostic favourable (3.55e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.51e-3)"	"prognostic favourable (5.58e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (1.37e-6)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.18e-2)"	3.1	8.7	10.8	1.7	9.8	0.6	14.6	3.2	12.2	25.7	2.0	7.3	8.9	1.4	14.9	4.9	7.7	7.0	2.7	13.6	11.2	7.8	54.8	26.2	15.3	1.3	8.3	5.9	8.1	13.6	12.5	2.9	20.8	10.9	27.6	2.3	11.1	32.0	12.7	1.0	7.4	1.7	10.6	5.3	0.8	9.0	5.2	9.7	1.3	15.0	4.2	8.0	10.0	14.6	0.5	0.2	1.1	0.1	0.3	0.2	0.0	0.0	0.7	7.8	0.0	0.0	0.0	0.1	0.1	1.7	0.6	1.4	4.8	0.0	0.0	6.9	1.0	0.0	3.7	0.0	1.0	0.0	0.6	0.0	0.1	3.3	0.1	0.0	0.0	0.3	0.2	0.8	0.0	31.0	0.0	0.0	1.2	1.3	0.0	0.1	3.8	0.3	0.0	3.9	0.1	2.6	0.0	0.2	0.4	0.0	3.0	0.0	0.3	0.3	18.9	0.0	2.0	0.0	1.0	0.0	0.0	0.0	0.1	3.5	0.0	0.9	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.2	1.1	0.3	0.0	0.2	0.1	0.0	10.8	9.8	3.2	12.2	11.2	7.8	8.3	5.9	10.9	9.7
CGRRF1	"CGR19, RNF197"	ENSG00000100532	"Cell growth regulator with ring finger domain 1"	Q99675	14	54509812-54539309	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002930	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA002930: AB_1078507"	"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (6.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.64e-3)"	"prognostic favourable (2.57e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.74e-1)"	13.3	12.8	18.3	5.7	19.2	10.2	17.3	21.9	18.9	12.7	11.4	16.2	12.7	8.0	14.3	20.1	8.4	12.6	8.3	12.7	15.2	15.4	20.8	10.3	9.9	10.9	16.6	14.6	11.4	19.5	11.2	16.5	10.0	20.1	14.7	9.9	9.8	9.7	16.3	20.7	5.0	9.6	12.4	18.2	8.8	10.2	24.9	16.7	3.0	18.0	6.3	7.2	12.6	9.2	11.9	6.4	31.3	10.7	12.4	13.7	11.7	8.3	7.5	7.8	7.1	13.6	8.5	6.0	8.2	7.4	11.9	11.7	6.9	9.4	4.6	10.3	6.7	7.4	8.3	6.9	14.1	9.6	7.1	6.4	1.9	8.7	16.9	3.7	3.7	8.4	13.4	8.9	14.6	8.3	2.6	5.7	10.8	14.8	3.8	5.7	5.2	11.9	8.5	9.5	2.7	9.2	11.0	5.7	4.7	6.5	3.5	12.3	9.2	3.3	7.1	14.7	12.5	6.2	6.8	4.2	4.9	6.6	9.1	4.5	9.7	31.3	7.9	13.4	12.3	9.0	12.3	11.1	13.4	13.5	6.4	11.9	13.7	12.6	8.0	12.4	10.7	5.6	13.5	11.7	18.3	19.2	21.9	18.9	15.2	15.4	16.6	14.6	20.1	16.7
CHAF1A	"CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150"	ENSG00000167670	"Chromatin assembly factor 1 subunit A"	Q13111	19	4402662-4445018	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.2;granulocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015186	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB015186: AB_628065"	"unprognostic (1.91e-1)"	"prognostic favourable (8.22e-5)"	"unprognostic (2.49e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.89e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.54e-2)"	"prognostic favourable (4.15e-6)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.03e-2)"	5.3	5.3	6.3	14.6	7.3	28.2	5.3	12.6	8.8	4.7	7.2	4.9	8.6	6.9	4.7	5.1	11.5	4.7	5.2	4.0	6.1	3.9	3.0	4.5	4.6	13.3	5.5	5.6	4.6	4.4	3.3	4.3	7.5	5.4	6.5	7.2	4.1	7.8	8.1	12.2	11.3	7.0	6.8	4.8	8.2	5.6	20.4	4.9	27.8	3.3	9.8	11.5	6.7	5.9	1.7	15.2	4.3	2.4	1.0	0.8	0.9	21.2	14.5	24.2	15.2	2.4	3.0	12.5	20.2	8.3	17.1	19.4	17.6	7.6	32.7	8.4	6.4	16.7	20.6	13.8	20.3	18.8	22.7	20.3	21.7	13.8	1.2	23.5	16.6	1.6	2.9	14.0	6.0	8.0	24.5	29.7	10.4	12.2	38.0	13.2	27.0	12.1	28.3	19.1	18.7	4.4	25.3	17.2	13.3	13.8	9.8	8.0	8.6	17.6	5.8	14.1	12.4	24.0	24.4	14.9	22.0	31.4	11.9	30.4	16.7	2.9	2.3	4.3	0.5	2.4	0.4	1.7	0.6	0.1	2.0	0.8	0.6	0.4	1.2	1.0	0.4	15.2	0.8	0.9	6.3	7.3	12.6	8.8	6.1	3.9	5.5	5.6	5.4	4.9
CHAF1B	"CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7"	ENSG00000159259	"Chromatin assembly factor 1 subunit B"	Q13112	21	36385378-36419015	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 20.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021679, CAB033604"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB033604: AB_2229411, HPA021679: AB_1846621"	"unprognostic (2.28e-2)"	"prognostic favourable (5.44e-5)"	"prognostic favourable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (6.14e-6)"	"unprognostic (2.14e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.66e-6)"	"unprognostic (5.89e-2)"	"unprognostic (5.00e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.36e-1)"	2.4	1.4	2.8	3.7	5.9	9.3	4.1	7.2	9.4	2.4	3.0	2.0	1.2	2.8	3.9	2.8	4.4	2.3	1.6	2.9	2.0	2.7	1.7	1.4	2.1	4.5	1.8	4.1	2.7	6.9	3.1	2.1	2.1	3.8	2.9	3.6	4.6	5.2	1.6	20.7	4.4	3.1	2.4	1.5	2.5	2.1	6.2	0.2	12.3	1.7	3.6	7.3	1.8	2.6	2.8	1.3	3.7	0.8	4.4	5.1	1.7	14.7	8.9	15.3	8.7	1.1	3.1	8.4	10.5	6.0	13.0	13.7	10.1	7.9	11.6	4.7	5.4	4.9	15.7	6.9	10.6	11.7	12.3	18.0	9.6	7.1	0.8	11.4	8.8	1.9	1.7	12.1	5.3	6.1	15.6	10.9	6.6	10.3	17.7	6.7	10.7	6.5	26.1	8.3	6.6	4.5	7.3	9.3	7.7	16.0	12.3	5.7	9.6	7.8	3.7	10.6	5.3	9.4	12.1	8.0	14.8	13.6	6.7	12.6	13.4	3.1	0.8	1.0	3.7	0.4	3.3	2.6	2.9	2.8	0.7	2.8	1.9	3.0	3.7	4.4	0.7	1.3	5.1	1.7	2.8	5.9	7.2	9.4	2.0	2.7	1.8	4.1	3.8	0.2
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314335-114337626	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"				Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	13.7	16.8	11.8	12.7	18.5	16.5	13.3	25.2	19.8	12.4	13.3	15.9	10.9	13.7	16.7	11.7	12.6	16.7	10.7	10.3	11.6	12.2	12.7	20.6	12.3	19.9	12.5	12.4	17.8	20.8	12.8	9.5	13.5	16.6	14.5	14.3	12.4	13.2	14.7	16.1	12.6	16.4	14.2	11.4	16.8	16.3	11.6	11.9	35.0	15.2	9.8	23.1	14.3	11.2	7.9	14.5	7.0	6.8	3.7	5.7	2.5	15.2	6.7	24.7	10.4	8.9	13.7	10.5	16.2	13.7	15.4	17.3	9.8	9.3	31.6	6.6	12.7	9.8	18.0	13.0	23.1	12.2	22.0	20.7	9.6	8.6	10.0	30.1	12.4	13.5	8.1	12.2	12.0	7.4	13.1	8.7	19.7	6.1	20.0	8.8	18.5	8.7	20.1	11.6	10.9	11.7	9.5	12.0	14.2	9.3	21.2	15.4	12.1	25.5	8.1	8.5	13.6	9.0	9.9	11.2	11.4	34.3	16.9	17.8	16.3	7.0	4.0	5.2	4.7	4.6	5.7	6.8	4.3	4.5	4.5	7.9	3.5	3.9	1.0	3.7	6.8	14.5	2.8	2.5	11.8	18.5	25.2	19.8	11.6	12.2	12.5	12.4	16.6	11.9
CHCHD1	"C10orf34, FLJ25854"	ENSG00000172586	"Coiled-coil-helix-coiled-coil-helix domain containing 1"	Q96BP2	10	73782047-73783652	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039046	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"				"Nucleoplasm, Mitochondria"	"Nucleoli fibrillar center"	"HPA039046: AB_10673234"	"unprognostic (4.97e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.58e-2)"	"prognostic favourable (5.42e-4)"	16.4	33.6	22.6	21.7	21.5	16.5	32.0	21.3	29.4	16.4	24.7	9.2	25.9	28.0	16.8	38.6	29.5	17.8	25.3	36.1	19.3	18.4	32.9	37.8	28.9	23.8	19.4	20.9	15.6	47.2	16.3	19.7	25.3	21.2	21.5	20.8	12.7	31.9	28.7	45.1	16.6	24.3	22.0	15.3	24.8	23.4	24.8	15.6	21.0	29.5	31.6	20.6	17.0	18.1	30.7	38.2	22.2	27.3	17.9	32.1	18.2	22.0	16.8	14.1	20.0	11.7	11.5	14.3	11.5	13.5	11.6	15.7	15.1	20.1	11.0	12.8	10.2	15.6	13.8	14.9	9.7	16.7	26.3	8.4	14.1	23.1	13.8	12.8	13.5	10.6	18.7	9.9	6.7	16.1	12.8	12.5	15.3	22.3	15.7	28.3	13.5	111.5	15.1	11.0	14.2	19.0	12.4	7.0	13.8	7.2	50.3	23.6	28.2	17.9	9.5	7.4	16.2	12.2	19.8	12.5	13.0	17.3	17.3	26.0	5.7	22.2	27.0	15.9	19.7	27.3	23.7	30.7	24.2	23.5	26.6	26.1	20.3	20.5	11.1	17.9	21.5	38.2	32.1	18.2	22.6	21.5	21.3	29.4	19.3	18.4	19.4	20.9	21.2	15.6
CHCHD10	"C22orf16, N27C7-4"	ENSG00000250479	"Coiled-coil-helix-coiled-coil-helix domain containing 10"	Q8WYQ3	22	23765834-23768443	"Disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 127.0;skeletal muscle: 226.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003440	Enhanced		Supported	Mitochondria				Mitochondria		"HPA003440: AB_1078348"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.90e-2)"	"unprognostic (9.80e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	"prognostic favourable (2.15e-7)"	"unprognostic (5.19e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.62e-3)"	23.1	14.9	25.8	16.4	33.9	5.7	20.0	11.8	31.0	17.3	39.4	9.6	18.3	30.6	6.1	15.5	20.2	7.6	11.3	127.0	23.7	23.5	40.4	86.1	8.3	16.9	25.8	18.4	4.8	24.3	36.4	12.7	11.7	14.5	11.7	31.6	24.3	33.7	22.2	226.6	7.2	30.2	12.8	12.2	13.0	17.3	4.1	9.6	3.0	27.8	73.1	15.8	13.8	9.3	9.4	7.3	7.6	7.8	0.8	5.0	1.0	6.0	16.4	5.1	21.2	11.2	7.1	8.2	2.1	5.8	6.0	7.0	30.6	8.2	18.5	5.7	10.4	19.5	27.8	8.7	5.5	6.0	30.3	4.7	13.0	28.9	19.1	13.6	22.0	13.8	23.1	9.1	2.4	7.3	8.4	11.9	5.4	30.5	4.3	8.6	3.7	41.6	16.0	0.8	42.6	28.4	13.7	9.0	4.8	2.9	36.5	28.0	13.0	10.7	3.2	0.2	0.2	3.7	0.0	4.7	2.0	12.8	5.0	11.4	2.7	0.2	3.9	7.6	2.8	7.8	1.9	9.4	3.2	4.0	1.7	7.8	5.0	3.6	0.1	0.8	6.9	7.3	3.7	1.0	25.8	33.9	11.8	31.0	23.7	23.5	25.8	18.4	14.5	9.6
CHCHD2	C7orf17	ENSG00000106153	"Coiled-coil-helix-coiled-coil-helix domain containing 2"	Q9Y6H1	7	56101569-56106576	"Disease related genes, Predicted intracellular proteins"	Transcription	Activator	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 220.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027407, HPA052510"	Uncertain		Enhanced	Mitochondria				Mitochondria		"HPA027407: AB_10959659, HPA052510: AB_2681856"	"unprognostic (8.68e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.90e-2)"	"prognostic unfavourable (1.90e-5)"	"prognostic unfavourable (9.41e-5)"	"unprognostic (4.38e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-2)"	41.5	112.8	57.2	33.0	59.5	73.0	46.0	39.3	56.9	38.0	46.6	33.2	45.5	51.9	34.2	53.8	50.1	39.2	44.3	75.3	46.8	50.2	56.2	66.9	34.2	62.6	58.3	49.0	43.8	77.8	28.4	42.8	38.4	42.3	41.3	40.1	45.3	56.5	70.0	147.2	33.0	49.3	45.7	42.6	34.1	44.2	27.1	28.1	48.9	62.1	65.9	38.8	38.5	30.9	63.2	107.7	52.6	69.1	51.5	72.8	121.3	220.2	38.6	25.4	52.5	20.1	27.8	18.8	32.4	30.8	41.8	40.5	35.3	36.9	64.6	42.9	19.8	37.5	32.2	35.5	33.7	41.9	58.5	38.1	32.5	50.2	37.5	51.3	61.6	24.7	40.6	31.3	38.5	31.2	79.9	39.3	34.0	30.5	69.0	158.9	55.0	61.5	46.6	24.8	106.0	37.4	28.8	48.5	60.4	25.5	63.0	40.7	72.0	73.4	24.9	25.8	60.5	106.8	47.6	36.3	51.7	115.2	40.6	55.4	32.0	40.5	69.1	52.6	53.1	61.0	54.8	63.2	57.2	56.3	79.5	57.8	51.6	52.8	37.0	51.5	59.5	107.7	72.8	121.3	57.2	59.5	39.3	56.9	46.8	50.2	58.3	49.0	42.3	28.1
CHCHD3	"FLJ20420, Mic19, MINOS3, PPP1R22"	ENSG00000106554	"Coiled-coil-helix-coiled-coil-helix domain containing 3"	Q9NX63	7	132784868-133082088	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 109.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042935	Enhanced		Supported	Mitochondria			110000	Mitochondria		"HPA042935: AB_10794538"	"unprognostic (1.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"prognostic favourable (1.15e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.03e-2)"	15.2	15.8	9.9	13.4	11.6	15.4	13.7	10.1	14.2	10.5	17.3	9.8	7.9	19.9	13.2	9.7	10.5	9.7	10.4	42.6	9.5	8.9	23.2	17.9	11.7	10.6	10.4	8.0	11.6	9.8	13.9	17.0	10.7	10.9	10.5	18.3	11.5	10.6	11.1	109.1	9.0	20.5	13.9	9.7	12.2	13.9	6.4	10.8	19.7	14.6	30.1	13.2	12.9	13.6	19.0	28.2	15.4	29.9	21.2	19.9	15.3	23.8	24.5	25.0	34.4	18.1	16.6	14.8	23.5	22.3	26.7	29.7	28.8	26.6	19.9	9.3	14.8	16.8	28.9	20.2	37.8	25.9	27.3	20.5	25.3	16.7	35.8	45.9	15.3	15.0	13.9	36.6	38.4	18.7	43.6	18.3	24.8	31.5	66.8	40.4	40.9	28.4	33.3	36.5	28.4	26.1	19.9	31.8	39.8	19.5	15.3	44.3	12.9	27.5	15.4	25.7	11.0	40.2	42.0	17.6	22.5	50.1	40.4	39.4	35.9	14.9	21.8	15.4	16.1	29.9	15.3	19.0	14.7	15.5	28.2	11.7	13.0	14.5	3.1	21.2	24.1	24.6	19.9	15.3	9.9	11.6	10.1	14.2	9.5	8.9	10.4	8.0	10.9	10.8
CHCHD4	"FLJ31709, MIA40, TIMM40"	ENSG00000163528	"Coiled-coil-helix-coiled-coil-helix domain containing 4"	Q8N4Q1	3	14112077-14124870	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA034688, HPA063727"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA034688: AB_10696361, HPA063727: "	"unprognostic (3.89e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (8.63e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.65e-2)"	"unprognostic (7.85e-3)"	11.4	13.3	15.0	8.8	16.4	3.3	12.8	11.6	17.7	9.2	15.8	12.6	9.5	15.7	8.7	11.7	12.1	10.9	9.8	27.3	13.7	13.5	22.3	20.1	7.8	8.9	17.0	10.7	11.5	18.8	21.7	9.3	9.2	13.5	12.7	17.2	9.6	10.7	13.8	32.2	8.9	12.7	15.3	11.1	9.6	11.9	9.4	14.3	7.2	13.4	12.4	13.2	14.0	16.4	14.1	19.8	7.9	18.1	16.6	14.3	8.6	8.0	16.7	8.7	8.6	7.6	8.6	25.4	8.7	8.1	10.8	9.5	9.8	6.6	17.4	8.6	6.6	6.6	18.0	18.0	13.3	10.8	18.0	20.3	12.4	13.0	12.7	13.6	8.8	7.5	19.2	17.6	28.3	12.0	21.0	15.6	11.4	17.0	17.0	8.2	13.4	22.6	12.3	8.8	37.0	12.1	8.8	7.2	8.9	9.8	31.6	12.6	15.1	13.9	4.3	9.9	7.2	12.2	15.8	8.7	23.0	17.3	9.8	21.1	7.2	5.7	12.5	7.9	6.6	18.1	11.4	11.2	11.0	9.9	19.8	14.1	14.3	9.7	5.4	16.6	17.5	8.1	12.2	8.6	15.0	16.4	11.6	17.7	13.7	13.5	17.0	10.7	13.5	14.3
CHCHD5	"C2orf9, MGC11104, MIC14, MIX14"	ENSG00000125611	"Coiled-coil-helix-coiled-coil-helix domain containing 5"	Q9BSY4	2	112584240-112589275	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038263	Approved		Supported	Mitochondria				Mitochondria		"HPA038263: AB_10671525"	"unprognostic (3.56e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.36e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.18e-3)"	"unprognostic (8.04e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	12.7	17.8	15.1	11.4	15.0	15.7	15.6	9.0	13.4	10.5	12.4	11.7	19.8	17.5	11.4	17.5	16.2	20.0	16.7	20.3	12.0	12.1	20.3	36.6	12.9	17.6	16.7	11.4	10.7	36.8	10.2	20.0	11.9	10.1	13.4	6.5	11.0	12.6	37.7	33.3	12.9	16.1	11.8	12.1	11.7	15.2	50.0	12.9	20.7	20.2	23.4	8.6	13.0	12.1	27.9	40.2	32.1	35.4	28.6	37.1	28.6	13.4	22.5	10.1	0.0	4.1	8.8	9.6	5.9	7.8	12.3	8.8	24.4	16.6	10.3	23.7	8.2	9.9	3.8	13.2	1.6	11.1	18.4	13.9	7.3	19.2	18.2	11.8	9.8	11.7	11.3	16.2	10.0	6.7	14.4	15.7	7.7	33.4	10.5	18.6	11.2	11.1	0.3	8.4	20.2	16.1	12.3	12.9	14.5	7.5	11.4	13.2	14.6	10.5	9.3	12.3	17.5	7.4	8.5	28.3	26.6	11.9	17.1	3.2	14.5	11.1	35.4	32.1	26.3	31.6	22.3	24.0	25.1	24.9	31.8	27.9	26.1	26.9	19.2	28.6	28.7	40.2	37.1	28.6	15.1	15.0	9.0	13.2	12.0	12.1	16.7	11.4	10.1	12.9
CHCHD6	"CHCM1, MGC13016, Mic25, PPP1R23"	ENSG00000159685	"Coiled-coil-helix-coiled-coil-helix domain containing 6"	Q9BRQ6	3	126704220-126960406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047673, HPA051975"	Approved		Supported	Mitochondria				Mitochondria		"HPA047673: AB_10961761, HPA051975: "	"unprognostic (3.94e-2)"	"prognostic favourable (7.46e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (6.76e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.11e-3)"	5.5	13.8	23.2	5.8	20.8	3.8	8.7	8.9	27.0	7.4	5.3	8.7	4.9	4.1	6.7	5.6	7.2	14.6	5.6	11.6	31.1	17.0	7.5	6.1	8.3	3.7	15.3	18.8	14.5	15.1	6.7	7.7	4.4	11.4	7.0	3.4	7.6	14.2	8.9	4.0	8.1	4.6	5.8	9.9	4.8	7.4	34.0	7.6	3.3	12.3	5.9	4.3	5.0	7.4	10.5	6.3	1.8	3.5	6.3	11.1	4.3	18.6	10.9	9.7	23.4	3.4	5.3	5.6	7.2	4.9	8.5	8.2	15.0	8.2	8.2	16.8	4.3	11.0	7.2	19.8	4.2	2.2	19.7	6.7	8.0	14.6	10.3	14.7	4.5	5.3	12.1	4.1	8.7	5.5	6.1	4.9	7.4	14.0	21.4	14.6	11.6	12.4	11.5	14.8	19.7	7.4	8.1	17.8	11.1	7.4	12.7	23.0	7.4	5.5	4.9	9.5	11.9	12.8	7.4	6.3	2.9	10.1	10.7	4.8	8.8	0.0	2.3	1.8	6.9	3.5	8.7	7.8	9.8	8.1	6.3	10.5	9.5	11.1	0.0	6.3	3.3	4.4	8.9	4.3	23.2	20.8	8.9	25.6	31.1	17.0	15.3	18.8	11.4	7.6
CHD1L	ALC1	ENSG00000131778	"Chromodomain helicase DNA binding protein 1 like"	Q86WJ1	1	147242641-147295766	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027789, HPA028670"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA027789: AB_10601099, HPA028670: AB_10601257"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.97e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (1.31e-9)"	"unprognostic (5.51e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.16e-1)"	11.2	12.2	16.1	14.1	16.5	26.9	18.2	23.0	20.0	9.8	16.1	29.5	6.4	18.4	16.0	12.2	10.4	13.4	12.5	9.2	17.3	13.6	11.8	26.1	13.7	16.1	27.3	12.6	9.5	18.5	12.6	17.9	11.8	18.2	13.2	20.0	11.6	9.5	11.9	12.0	15.9	20.9	18.4	24.7	21.3	12.9	27.8	22.2	18.5	8.9	9.4	16.9	8.5	11.9	15.3	19.0	7.6	8.3	8.2	9.1	9.0	19.2	16.7	19.2	12.2	13.5	13.2	15.9	17.3	14.7	16.3	15.4	16.1	13.4	25.1	8.1	17.3	18.4	16.2	18.9	14.4	24.9	22.7	24.1	13.4	41.1	14.3	31.0	15.5	12.2	9.3	16.0	18.4	17.8	27.5	11.7	19.7	21.4	23.5	16.7	25.2	22.1	26.4	17.8	19.8	15.3	13.8	11.6	19.6	15.7	19.7	15.1	10.7	45.2	16.1	11.0	16.7	9.9	27.0	10.1	14.0	20.8	22.4	13.7	16.6	7.6	8.1	3.7	9.0	6.8	9.1	12.5	7.9	7.8	19.0	15.3	8.0	8.9	0.8	8.2	8.3	15.8	5.5	9.0	16.1	16.5	23.0	20.0	17.3	13.6	27.3	12.6	18.2	22.2
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93028005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA060744: , HPA060960: "	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	23.7	16.6	18.7	23.6	21.1	66.7	21.8	35.1	22.8	24.1	19.9	19.7	17.6	15.7	26.1	31.9	20.3	18.4	16.8	15.3	18.5	15.7	17.7	17.6	30.4	25.2	22.1	13.9	26.3	20.9	27.5	41.9	33.1	19.1	22.4	16.1	22.1	21.2	19.9	24.3	25.2	24.3	20.3	30.8	26.9	20.8	20.4	22.4	39.5	28.8	11.3	37.4	34.7	19.0	25.5	17.2	34.5	6.3	8.0	17.5	4.6	10.7	5.8	15.9	7.0	9.9	24.5	12.2	10.1	10.3	6.8	8.5	7.4	14.1	2.6	8.5	8.7	16.0	9.2	9.9	9.6	0.0	5.4	12.7	11.7	6.4	13.4	13.4	10.0	15.4	12.2	8.1	16.5	11.5	13.2	30.3	10.3	6.6	6.9	7.0	10.1	6.6	10.0	14.5	14.5	7.1	14.5	8.8	9.5	17.5	6.4	13.1	7.2	11.4	18.4	5.6	7.4	4.8	6.4	28.9	11.6	11.0	8.6	8.1	4.8	14.9	6.3	15.0	12.9	3.3	11.8	25.5	12.6	10.1	3.3	23.4	17.5	12.5	34.5	8.0	5.8	17.2	12.3	4.6	18.7	21.1	35.1	22.8	18.5	15.7	22.1	13.9	19.1	22.4
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012008	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavourable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	23.5	34.9	21.9	50.0	33.5	27.2	25.9	29.4	25.1	28.1	29.5	29.3	38.5	18.6	37.2	35.4	29.1	28.0	40.3	52.8	23.5	19.2	29.5	25.0	25.5	30.9	33.6	19.4	34.6	27.4	58.4	25.3	29.5	27.2	21.5	26.0	26.5	24.8	46.2	33.7	31.1	24.4	36.6	30.3	29.4	27.2	29.7	28.9	75.7	38.4	33.7	38.4	34.7	24.3	12.6	16.8	12.8	9.1	13.5	16.7	5.8	20.5	18.7	46.5	17.4	19.1	21.5	27.3	22.8	22.2	25.2	23.2	31.2	16.0	44.2	9.1	25.7	18.4	43.6	25.1	34.0	33.0	22.4	61.7	29.1	19.5	16.6	48.4	29.6	20.7	12.5	24.3	17.1	29.3	48.5	22.1	23.9	25.7	45.9	15.8	44.5	17.7	39.4	28.6	24.1	15.9	24.3	22.0	28.3	29.3	32.6	22.6	14.9	27.6	27.2	25.7	54.8	18.8	26.6	35.8	21.3	56.4	17.0	29.6	18.8	9.0	7.7	9.2	12.2	9.1	12.0	10.5	10.3	11.1	7.9	12.6	13.0	12.3	12.8	13.5	8.1	16.8	16.7	5.8	21.9	33.5	29.4	25.1	23.5	19.2	33.6	19.4	27.2	28.9
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Group enriched"	"Detected in some"	4	"SCLC-21H: 16.6;U-2 OS: 7.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	16.6	0.2	0.1	0.0	0.0	2.8	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678778-60868028	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.1"	"Cell line enhanced"	"Detected in many"		"AF22: 25.8;SCLC-21H: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.3"	HPA053075			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA053075: "	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.9	2.2	7.0	7.9	11.2	25.1	4.1	47.1	9.0	2.3	5.7	13.4	3.1	5.9	2.6	3.2	5.1	3.2	3.1	4.1	8.1	4.3	3.6	3.6	4.7	7.0	8.1	3.3	1.4	6.4	12.4	9.9	5.6	9.9	2.9	5.5	6.4	5.7	2.8	10.3	5.7	6.6	2.4	7.5	6.1	4.5	4.3	12.2	1.6	5.4	2.2	7.3	2.9	5.9	12.2	0.6	12.6	0.6	0.0	5.5	0.4	3.8	1.9	25.8	4.5	0.0	0.0	8.1	0.2	0.0	0.9	0.8	4.8	3.6	7.5	0.4	0.0	2.3	13.2	3.8	0.8	2.8	7.1	17.6	3.2	6.3	1.1	5.3	3.3	0.5	2.9	0.0	4.3	3.8	1.3	6.7	0.6	3.9	8.3	6.0	17.7	0.9	17.3	6.1	2.4	2.0	4.4	23.6	11.7	0.7	2.9	7.2	5.2	5.0	4.4	0.2	4.2	0.2	2.1	7.1	4.1	11.7	1.5	0.6	6.6	10.4	0.3	12.6	2.6	0.1	3.3	8.0	2.9	0.9	0.1	12.2	5.5	2.0	7.1	0.0	0.6	0.6	0.2	0.4	7.0	11.2	47.1	6.5	8.1	4.3	8.1	3.3	9.9	12.2
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA052186: , HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favourable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	13.9	14.5	13.0	14.8	21.5	34.8	17.0	28.9	25.7	15.8	14.4	26.6	14.1	11.1	18.3	13.4	17.4	15.9	11.7	12.3	13.5	13.3	14.0	11.2	15.5	18.5	15.4	15.2	20.7	19.0	34.7	25.3	15.2	20.3	16.3	14.6	19.3	15.7	14.9	16.9	24.5	16.4	17.2	13.1	19.2	16.1	15.2	18.1	29.9	17.4	10.4	24.8	16.6	14.5	12.3	7.8	12.8	7.4	8.7	8.6	3.0	16.2	21.3	23.6	11.0	15.1	13.1	13.4	12.9	14.9	19.7	19.7	18.5	14.1	26.9	8.2	17.3	20.0	28.9	18.2	25.0	20.6	13.2	23.6	14.3	22.4	14.0	32.6	22.5	17.6	14.8	22.1	15.9	17.5	16.4	14.4	14.9	17.5	23.4	13.3	18.0	18.1	22.0	17.9	9.1	14.6	30.1	17.3	16.6	20.3	15.8	11.2	11.1	15.8	20.5	16.4	12.6	9.6	15.3	16.4	19.5	26.9	6.6	12.1	16.3	12.8	4.8	12.1	7.7	5.0	8.6	5.8	6.8	7.5	3.3	12.3	7.4	6.4	11.0	8.7	7.4	7.8	5.7	3.0	13.0	21.5	28.9	25.7	13.5	13.3	15.4	15.2	20.3	18.1
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 80.0;seminal vesicle: 66.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 11.7"	"Low region specificity"	"Detected in single"							HPA044364			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA044364: "	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favourable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	3.0	2.5	2.5	9.0	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80.0	5.0	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2.0	1.8	9.6	3.0	1.2	3.8	4.0	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3.0	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1.0	12.7	10.4	23.4	14.2	4.8	10.3	10.2	17.9	8.6	11.5	12.4	25.4	28.3	33.4	18.5	7.0	15.4	14.3	9.4	14.2	20.9	6.6	61.9	8.7	13.0	1.5	31.6	11.8	5.3	2.0	14.5	10.3	13.6	31.3	29.4	15.1	6.6	46.9	15.5	23.7	9.4	28.6	21.9	17.5	10.6	17.0	14.8	15.7	14.7	10.2	4.3	27.5	10.3	9.1	16.6	14.1	8.0	16.4	6.6	11.8	47.6	6.1	23.8	19.4	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2.0	0.4	1.2	0.4	1.8	11.7	1.0	2.5	2.8	1.1	2.2	2.4	2.4	3.0	1.2	1.5	1.5
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	5.6	8.3	2.5	13.0	7.0	13.7	5.6	0.7	5.6	6.6	9.8	2.5	4.8	6.8	4.8	10.9	10.0	4.3	6.0	6.0	4.1	2.3	5.3	6.5	7.9	10.1	6.7	1.6	12.9	6.7	1.2	4.2	10.1	5.1	8.3	10.6	8.7	7.0	5.8	2.2	6.3	8.5	5.4	5.0	9.8	5.8	9.7	3.6	13.1	7.5	4.8	13.7	6.2	6.7	11.8	8.7	6.5	8.4	2.9	4.4	3.7	14.7	4.7	13.5	16.7	3.8	19.2	8.7	7.3	8.6	9.7	14.2	12.0	10.1	17.4	6.2	5.1	14.2	20.5	13.4	11.3	12.4	15.7	22.9	9.0	19.8	3.8	14.5	16.8	8.1	6.2	12.4	11.0	10.7	13.8	15.2	9.0	20.7	11.6	23.3	19.0	12.0	25.3	9.2	20.3	6.0	6.1	7.9	4.5	8.1	14.5	8.0	9.9	13.4	3.7	7.8	9.3	6.8	3.8	9.2	16.2	34.0	7.4	15.2	9.9	6.5	3.7	1.2	1.1	8.4	2.3	11.8	2.2	2.1	8.7	8.4	4.4	2.8	0.3	2.9	4.1	7.0	2.8	3.7	2.5	7.0	0.7	5.6	4.1	2.3	6.7	1.6	5.1	3.6
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923080-92935293	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 577.6"	"Group enriched"	"Detected in some"	134	"SCLC-21H: 43.3;SH-SY5Y: 117.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 97.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		78000000	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: , HPA017369: AB_1846698"	"prognostic favourable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favourable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavourable (3.99e-4)"	2.0	81.9	6.6	3.1	18.7	1.3	1.3	0.5	97.9	1.9	36.1	4.0	0.0	15.8	1.3	1.3	1.2	1.3	1.3	1.2	11.2	14.0	1.3	1.2	1.4	1.2	8.0	36.1	1.2	15.9	577.6	81.1	1.2	17.1	2.0	7.9	0.4	1.3	1.3	1.2	1.3	38.8	1.3	2.5	1.3	51.9	32.5	0.7	0.0	5.9	0.0	1.2	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	43.3	117.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.6	18.7	0.5	97.9	11.2	14.0	8.0	36.1	17.1	0.7
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911430-5925361	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 424.9;pituitary gland: 177.5"	"Group enriched"	"Detected in some"	23	"SCLC-21H: 65.1;SH-SY5Y: 99.7"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.6;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"		24000000	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favourable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	3.4	424.9	8.2	1.4	10.2	0.8	1.0	82.5	16.4	0.8	3.0	2.1	1.2	7.7	0.9	1.3	0.8	2.5	0.8	7.6	20.7	15.4	1.7	0.7	1.0	1.1	7.2	9.1	3.0	17.0	0.8	177.5	0.8	51.8	5.6	2.5	0.7	0.9	1.2	2.1	0.9	4.4	0.9	2.3	0.8	19.7	2.4	0.8	0.0	1.9	0.4	0.9	0.8	0.1	0.0	0.6	0.0	0.0	0.0	2.6	0.2	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	65.1	99.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.2	8.2	10.2	82.5	16.4	20.7	15.4	7.2	9.1	51.8	0.8
CHIC2	BTL	ENSG00000109220	"Cysteine rich hydrophobic domain 2"	Q9UKJ5	4	54009789-54064690	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA026784, HPA076603"	Uncertain		Enhanced	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA026782: AB_1846654, HPA026784: , HPA076603: "	"unprognostic (4.56e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.47e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (2.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.40e-2)"	17.0	17.5	9.5	14.6	9.7	23.7	17.1	17.9	12.0	12.8	14.2	7.1	11.9	13.0	16.8	14.9	25.3	11.0	22.1	14.3	7.3	7.9	12.3	20.2	17.7	13.5	6.6	10.0	13.2	9.9	5.5	16.7	18.5	9.9	12.3	9.6	15.9	15.3	9.9	10.9	24.7	20.6	10.8	8.1	18.5	12.9	50.1	8.3	32.3	11.8	11.6	20.5	12.9	16.3	8.4	10.9	63.8	15.9	13.6	15.6	13.6	11.5	2.1	6.4	5.6	10.7	8.2	6.3	16.0	17.0	9.6	9.7	8.3	10.4	9.8	14.4	10.3	3.5	8.6	11.7	10.4	5.4	4.4	5.3	2.0	6.2	32.1	8.7	11.1	11.1	9.6	14.5	22.2	14.0	5.7	7.4	19.1	3.1	10.2	14.0	4.2	7.9	6.6	3.5	3.8	11.0	3.9	9.3	8.8	3.8	5.6	11.7	3.0	13.0	23.9	12.3	9.6	17.6	10.3	8.8	4.2	8.0	9.1	8.7	8.9	56.0	15.9	32.2	12.6	12.4	12.1	8.4	12.8	14.2	10.9	8.2	11.8	12.7	63.8	13.6	12.5	9.1	15.6	13.6	9.5	9.7	17.9	12.0	7.3	7.9	6.6	10.0	9.9	8.3
CHML	REP-2	ENSG00000203668	"CHM like, Rab escort protein 2"	P26374	1	241628853-241640254	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA029627, HPA029628, HPA062967"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: "	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.57e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (9.23e-5)"	"unprognostic (1.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.09e-1)"	6.5	3.8	6.0	5.7	10.5	10.8	7.7	3.6	18.0	6.0	6.4	3.1	1.4	3.8	7.6	5.0	6.1	7.2	5.6	5.1	5.3	5.1	6.5	21.1	12.5	10.0	4.9	13.1	13.3	5.6	8.5	8.2	30.7	4.2	3.7	6.1	2.0	5.8	3.0	7.1	6.5	6.5	5.6	3.7	9.3	5.6	9.9	2.2	14.8	11.0	2.2	5.1	5.2	6.6	1.6	2.9	3.0	1.3	0.5	1.4	0.2	17.4	5.4	8.5	6.7	2.6	7.7	16.6	6.9	3.5	6.0	4.2	9.9	3.2	4.8	10.6	4.6	3.6	11.9	7.5	11.3	9.2	10.9	6.3	22.1	6.9	5.2	15.0	8.2	6.4	3.4	8.0	8.3	4.7	17.0	6.0	7.1	6.8	9.9	10.1	11.3	17.6	15.1	10.5	16.1	6.1	10.9	10.9	18.0	8.7	6.7	7.5	7.8	9.8	9.5	12.4	24.0	6.2	13.1	6.9	16.9	5.2	12.0	9.1	19.1	3.0	0.9	0.6	0.5	1.3	0.8	1.3	0.3	0.4	0.8	1.6	1.4	1.1	0.1	0.5	0.8	2.9	0.1	0.2	6.0	10.5	3.6	18.0	5.3	5.1	4.9	13.1	4.2	2.2
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851396-11854449	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 250.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA061997: , HPA062896: "	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favourable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	16.0	13.6	14.9	12.5	11.6	19.5	13.3	8.8	16.0	10.1	14.1	10.0	13.8	14.0	10.4	14.7	14.5	9.1	14.6	17.0	11.2	12.3	12.2	11.2	11.3	14.0	11.6	11.9	11.3	11.2	9.7	12.4	11.8	12.1	10.3	14.1	9.4	12.6	29.5	250.9	15.2	20.4	11.6	13.8	11.3	12.8	6.8	10.0	14.2	19.9	19.4	9.9	14.3	10.1	6.7	13.1	34.4	16.5	7.4	9.1	10.6	12.8	12.6	16.4	13.8	21.5	15.1	23.8	13.8	23.3	9.4	12.6	16.3	13.0	8.0	20.7	14.9	11.0	7.4	19.2	8.4	7.4	9.2	5.8	19.2	13.4	15.9	22.1	10.0	21.9	41.6	10.5	24.5	13.6	9.8	10.4	14.8	15.9	15.3	17.0	6.8	6.3	7.9	8.4	13.7	25.2	17.7	16.0	16.0	23.4	11.0	21.1	9.0	20.4	19.8	21.2	11.2	16.7	14.7	12.5	14.3	10.2	19.6	10.3	10.0	10.9	16.5	27.7	7.2	15.3	6.6	6.5	6.7	8.5	13.1	6.7	8.4	7.7	34.4	7.4	15.0	11.7	9.1	10.6	14.9	11.6	8.8	16.0	11.2	12.3	11.6	11.9	12.1	10.0
CHMP2B	"CHMP2.5, DKFZP564O123, VPS2B"	ENSG00000083937	"Charged multivesicular body protein 2B"	Q9UQN3	3	87227271-87255548	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035069, HPA052754"	Uncertain		Supported	Cytosol				Cytosol		"HPA035069: AB_10602798, HPA052754: "	"unprognostic (7.83e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavourable (2.11e-5)"	"unprognostic (5.76e-2)"	"prognostic favourable (1.74e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.21e-1)"	21.8	21.5	20.1	17.6	23.5	36.5	22.1	12.5	35.9	23.6	32.4	21.4	19.2	30.1	28.2	20.5	30.9	20.1	23.4	26.2	20.8	22.0	30.9	36.1	21.5	17.7	29.5	21.0	22.9	23.5	14.7	41.7	45.1	30.7	29.2	30.5	14.7	22.7	25.4	30.1	22.9	45.8	24.8	52.6	22.3	24.3	13.3	25.6	14.5	35.5	26.3	16.4	30.7	25.3	21.2	22.4	53.4	24.8	11.4	20.0	14.3	16.4	18.0	6.1	3.9	11.1	9.0	7.8	13.0	16.5	10.8	13.9	14.0	27.0	5.9	9.2	14.0	8.4	7.9	9.0	13.1	10.4	8.3	7.2	6.5	5.7	9.8	9.7	10.1	6.9	15.2	10.6	14.4	8.2	4.4	8.9	11.5	11.8	9.4	4.0	7.9	16.1	5.0	7.6	5.6	8.1	16.9	2.3	2.4	12.7	10.4	19.8	9.3	3.0	7.4	10.0	9.2	106.3	8.8	9.0	13.3	10.1	10.9	5.5	7.2	42.8	20.8	53.4	11.9	24.8	16.0	20.0	14.9	14.6	22.4	21.2	14.1	13.7	40.3	11.4	24.7	12.8	20.0	14.3	20.1	23.5	12.5	35.9	20.8	22.0	29.5	21.0	30.7	25.6
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282069	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol				"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	29.7	37.5	48.0	24.3	48.6	18.8	36.2	39.9	49.4	28.3	39.0	28.1	28.4	38.1	28.2	36.3	39.2	31.4	30.6	35.1	45.1	45.2	55.6	39.2	35.6	26.1	44.1	47.5	26.5	19.9	36.4	34.8	55.7	47.4	40.8	40.9	19.8	26.0	30.2	27.1	25.6	51.9	27.5	49.2	33.0	37.3	21.2	37.0	24.9	42.0	26.1	26.0	33.7	33.5	12.4	27.8	51.2	24.6	18.1	16.6	18.1	30.8	23.0	23.4	15.1	35.9	32.7	21.9	30.9	35.0	49.3	54.8	17.5	19.6	16.7	34.2	29.0	13.4	24.5	25.2	40.1	34.5	17.3	14.0	46.5	19.0	31.2	17.7	27.6	34.7	46.7	33.1	30.9	25.6	15.0	22.1	38.8	14.1	18.4	54.9	21.5	28.4	11.3	20.8	11.0	40.5	16.9	11.5	29.6	31.4	18.5	28.3	18.9	28.0	25.5	24.7	25.8	21.1	27.3	14.7	29.1	19.2	35.6	12.3	15.8	31.5	20.1	40.2	10.7	21.6	11.5	12.4	14.3	14.0	18.3	10.6	13.2	12.5	51.2	18.1	24.6	27.8	16.6	18.1	48.0	48.6	39.9	49.4	45.1	45.2	44.1	47.5	47.4	37.0
CHMP7	MGC29816	ENSG00000147457	"Charged multivesicular body protein 7"	Q8WUX9	8	23243637-23262000	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.1"	"Cell line enhanced"	"Detected in all"		"Daudi: 24.5;U-698: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 31.7"	"Group enriched"	"Detected in all"	12	"B-cells: 15.2;T-cells: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036119	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036119: AB_10673000"	"unprognostic (2.94e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.59e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.83e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.06e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.30e-1)"	6.4	12.7	7.3	29.2	7.4	15.4	11.0	10.5	9.2	7.5	9.2	5.6	6.4	8.1	10.0	4.5	7.5	7.3	7.6	9.8	6.3	8.0	6.9	7.4	7.2	48.8	7.8	5.8	8.1	12.4	4.4	7.0	5.3	7.3	7.4	7.3	4.1	12.5	7.9	13.8	7.5	13.7	9.8	6.5	26.2	10.5	7.0	6.8	76.1	7.7	5.9	43.3	9.3	13.7	15.2	1.3	1.8	1.9	1.8	31.7	11.8	3.8	5.3	2.8	4.8	2.6	2.7	3.3	3.2	2.3	4.7	3.9	6.0	3.0	24.5	3.8	2.3	3.7	2.7	3.9	1.8	6.6	4.9	5.1	6.8	3.1	2.4	1.3	7.4	2.2	2.7	4.5	1.3	3.8	5.7	3.3	2.6	3.8	4.3	5.7	4.7	4.1	1.8	2.3	3.4	2.4	5.0	3.7	3.5	2.4	3.6	1.4	4.0	2.7	4.2	5.7	3.8	4.1	2.5	9.7	5.1	29.4	4.4	4.1	4.3	0.4	1.9	1.8	2.5	1.7	5.2	14.6	16.6	7.7	1.3	15.2	31.7	17.9	1.7	1.8	1.2	1.1	17.3	11.8	7.3	7.4	10.5	9.2	6.3	8.0	7.8	5.8	7.3	6.8
CHORDC1	"CHP-1, CHP1"	ENSG00000110172	"Cysteine and histidine rich domain containing 1"	Q9UHD1	11	90201160-90223364	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 100.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041040	Approved		Supported	Cytosol			51000	Cytosol		"HPA041040: AB_10794185"	"unprognostic (2.29e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (4.93e-7)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.27e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-1)"	13.9	17.8	24.9	18.1	31.9	17.8	22.2	29.9	30.7	12.5	10.9	9.0	10.6	10.6	13.8	17.3	13.1	13.2	12.4	17.1	23.6	24.6	11.0	16.2	12.4	21.3	37.8	12.9	19.8	9.5	14.1	47.6	21.3	33.7	14.8	13.2	6.1	9.6	13.0	12.9	12.4	9.0	12.8	39.8	15.3	12.1	13.1	40.2	14.2	16.8	8.7	23.3	14.9	100.9	12.6	11.9	7.9	12.5	14.5	15.5	9.3	9.6	27.8	9.3	6.1	8.9	5.0	14.0	12.0	4.0	11.5	10.2	39.7	7.6	17.0	20.2	5.1	13.2	27.1	6.3	14.3	15.1	13.8	16.8	16.2	18.8	7.1	11.9	11.2	1.8	7.4	10.9	12.8	9.1	24.5	7.5	13.6	4.9	11.1	16.3	10.9	23.1	16.7	5.8	9.4	9.6	4.4	8.9	3.8	13.3	10.8	4.8	17.7	5.6	8.7	8.6	19.0	12.9	14.2	3.5	27.2	13.6	2.7	17.7	7.7	6.8	7.7	7.9	12.0	12.5	12.9	12.6	13.1	12.5	11.9	10.8	14.0	13.3	2.3	14.5	8.0	9.2	15.5	9.3	24.9	31.9	29.9	30.7	23.6	24.6	37.8	12.9	33.7	40.2
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538947-219543787	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"			Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.96e-4)"	8.6	14.1	9.7	8.4	11.8	1.4	6.8	8.5	19.4	22.1	8.6	11.3	23.0	18.4	17.0	24.6	7.9	9.2	17.1	36.3	12.2	10.7	11.3	52.1	11.6	5.4	9.0	10.5	38.1	60.7	16.3	36.9	62.7	10.4	19.3	3.8	27.4	31.6	19.9	4.3	9.0	13.3	9.1	8.3	4.5	15.6	34.2	7.0	3.8	17.9	7.4	10.6	11.9	8.5	1.3	11.1	6.9	0.1	2.1	3.0	0.8	18.5	3.7	2.7	23.2	10.6	16.6	31.8	18.9	16.0	5.4	4.9	10.3	16.4	5.8	40.7	18.2	23.8	1.8	11.4	0.8	8.9	6.4	2.0	5.2	44.5	14.8	1.8	12.2	22.3	20.1	5.4	5.2	0.0	12.9	14.2	5.1	29.2	0.2	4.8	11.5	14.3	0.0	8.8	11.3	6.4	8.4	6.8	10.4	9.1	8.8	25.8	3.0	6.3	0.4	19.9	10.9	23.7	9.8	17.1	5.3	2.6	18.2	1.8	20.0	2.1	0.0	6.9	2.4	0.1	3.0	1.3	1.9	1.6	0.0	0.1	2.2	0.8	0.0	2.1	0.0	11.1	1.2	0.8	9.7	11.8	8.5	19.4	12.2	10.7	9.0	10.5	10.4	7.0
CHPT1	CPT1	ENSG00000111666	"Choline phosphotransferase 1"	Q8WUD6	12	101696947-101744140	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 19.4;eosinophil: 9.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067643	Approved		Supported	Vesicles				Vesicles		"HPA067643: "	"unprognostic (1.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.70e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (7.41e-4)"	"unprognostic (1.79e-1)"	18.0	21.6	19.3	14.3	20.4	21.4	76.7	12.8	16.7	22.2	40.0	11.0	15.8	36.5	9.3	25.0	10.9	14.7	17.1	71.4	18.5	14.5	30.6	64.6	20.2	30.5	17.8	14.5	11.3	14.2	12.6	7.6	9.6	12.8	16.3	21.0	14.0	53.1	22.8	18.5	13.5	42.9	16.7	17.4	13.0	23.1	28.3	12.6	3.3	26.0	7.4	8.7	17.7	38.7	3.0	2.5	19.4	1.5	3.3	0.8	0.4	3.4	16.3	4.4	9.4	35.2	11.8	12.6	12.7	14.6	12.8	8.3	6.0	2.4	5.3	7.2	17.2	5.3	26.6	4.4	12.2	8.0	22.5	21.6	8.7	35.0	19.7	10.6	4.4	11.1	1.3	5.7	10.6	6.3	31.3	13.8	12.5	8.5	6.3	36.8	11.7	21.6	4.9	8.6	3.8	5.8	13.7	4.3	3.3	11.7	16.9	31.5	17.2	7.3	4.6	11.7	6.1	9.1	12.3	7.9	2.4	6.5	9.2	12.4	17.0	19.4	1.5	9.7	0.4	1.2	0.4	3.0	0.8	0.7	2.0	2.0	0.3	0.4	2.2	3.3	1.4	2.5	0.4	0.4	19.3	20.4	12.8	16.7	18.5	14.5	17.8	14.5	12.8	12.6
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.8"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.9;SH-SY5Y: 31.8;U-266/70: 13.2;U-266/84: 9.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 8.7"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Group enriched"	"Detected in many"	18	"monocytes: 1.2;T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: "	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.8	0.0	2.1	1.4	1.8	0.0	0.8	0.8	8.7	0.8	5.9	0.8	0.8	0.8	1.4	0.8	6.6	0.3	0.8	0.8	2.5	1.8	0.8	0.8	1.5	0.8	0.8	1.1	4.3	8.7	0.2	0.8	0.8	0.8	3.8	2.2	39.8	13.7	2.5	0.8	0.7	1.2	3.3	0.8	1.0	4.8	1.7	0.8	1.3	1.3	0.8	1.6	7.1	0.8	0.0	0.0	0.0	1.2	0.0	2.3	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	3.4	0.3	2.3	1.6	0.0	2.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	5.5	0.5	0.8	0.0	0.0	2.8	5.0	0.0	0.7	9.9	0.4	0.5	0.0	31.8	0.0	0.1	0.1	1.1	0.0	0.0	1.3	0.5	0.1	0.3	13.2	9.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	1.2	0.7	0.0	0.5	0.4	0.0	0.0	2.3	0.7	0.0	0.0	0.7	0.0	0.5	0.2	2.1	1.8	0.8	8.7	2.5	1.8	0.8	1.1	0.8	0.8
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 96.7"	"Group enriched"	"Detected in some"	18	"LHCN-M2: 87.3;RH-30: 71.4"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Cell type enriched"	"Detected in single"	27	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA071554	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA071554: "	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	4.5	0.0	0.5	0.5	0.1	0.0	0.6	0.0	0.4	0.7	1.7	0.0	0.1	0.2	0.0	4.6	1.2	0.0	0.0	0.3	2.0	0.1	0.0	0.2	0.7	0.9	0.1	0.0	0.0	0.0	0.0	12.1	0.2	0.0	2.4	1.0	0.0	1.5	0.0	96.7	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.5	0.0	4.5	1.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	87.3	0.0	0.0	0.0	0.0	0.0	0.0	71.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.1	0.0	0.4	2.0	0.1	0.1	0.0	0.0	0.0
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 49.1"	"Cell line enriched"	"Detected in single"	72	"RH-30: 42.8"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.4"	"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: , HPA065404: "				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	49.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119331-143124014	"Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 20.0;ASC TERT1: 20.6;HEL: 15.9;HHSteC: 41.3;HMC-1: 19.0;HSkMC: 21.7;U-266/70: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	4	"monocytes: 11.4;NK-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: "	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	6.5	2.6	8.2	11.6	16.6	20.0	4.1	9.8	15.1	4.6	3.1	6.5	2.6	3.6	6.4	2.7	2.0	1.6	3.1	2.6	7.3	10.4	4.8	1.6	5.1	10.2	10.6	5.8	3.6	2.0	1.5	5.5	15.3	14.0	7.6	2.3	5.9	4.0	15.9	2.7	3.0	4.9	6.0	32.9	17.0	5.4	2.3	4.8	24.7	5.4	0.1	8.1	7.4	5.4	1.4	1.8	0.8	11.4	4.8	0.8	0.9	0.0	0.1	1.0	0.9	20.0	20.6	0.0	1.1	3.2	0.8	0.7	0.0	0.0	0.2	0.7	0.7	0.0	0.7	2.7	0.4	0.2	0.5	15.9	0.0	0.0	41.3	0.4	19.0	21.7	3.3	1.0	3.4	1.2	1.8	1.0	5.2	0.0	2.9	4.0	5.6	2.7	0.1	0.3	0.0	0.5	0.7	1.3	0.0	0.2	0.0	1.8	0.0	0.6	4.1	2.4	1.4	3.2	4.6	18.2	0.2	1.1	4.7	3.0	12.6	0.7	0.6	0.8	0.4	4.5	0.0	1.4	0.1	0.2	1.8	1.0	0.8	0.6	0.3	4.8	11.4	0.1	0.5	0.9	8.2	16.6	9.8	15.1	7.3	10.4	10.6	5.8	14.0	4.8
CHTF18	"C16orf41, C321D2.4, CHL12, Ctf18"	ENSG00000127586	"Chromosome transmission fidelity factor 18"	Q8WVB6	16	788046-800737	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040976, HPA056209"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA040976: , HPA056209: "	"unprognostic (3.83e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.80e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavourable (1.43e-8)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.89e-2)"	"prognostic favourable (2.78e-4)"	2.4	3.1	8.3	6.7	5.6	16.8	3.1	11.1	4.7	5.0	5.3	4.1	4.1	6.1	4.1	2.8	5.1	3.2	2.4	1.7	2.7	2.3	2.6	2.0	2.9	4.4	4.4	4.6	5.2	3.1	0.7	2.4	4.1	3.5	3.2	1.7	4.0	4.0	2.6	2.4	8.3	7.2	1.8	2.3	5.9	6.7	11.3	4.3	15.5	3.1	3.8	7.3	2.9	3.6	1.0	1.4	4.6	3.0	2.1	2.4	0.7	7.9	3.9	3.2	2.6	0.3	0.2	28.1	5.0	1.4	2.6	1.8	6.9	6.1	9.0	5.2	0.8	8.9	0.7	3.9	0.0	5.1	11.5	3.9	4.6	3.5	0.0	2.4	7.8	0.1	0.5	2.4	1.3	2.1	6.0	3.0	0.6	15.4	9.6	9.2	4.1	4.7	17.3	8.1	11.7	0.8	2.3	4.2	5.3	3.6	8.2	2.7	5.9	6.0	1.4	3.8	13.8	6.8	6.8	7.2	2.3	5.0	1.2	3.6	6.5	4.6	0.6	0.0	2.4	3.0	1.5	0.4	1.1	1.9	1.4	1.0	1.3	0.3	0.3	2.1	1.6	0.8	1.4	0.7	8.3	5.6	11.1	4.7	2.7	2.3	4.4	4.6	3.5	4.3
CHTF8	"CTF8, DERPC, FLJ20400"	ENSG00000168802	"Chromosome transmission fidelity factor 8"	"P0CG12, P0CG13"	16	69118010-69132584	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051872, HPA065522"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA051872: , HPA065522: "	"unprognostic (7.86e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.46e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.86e-3)"	"unprognostic (9.88e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (3.59e-9)"	"unprognostic (3.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.45e-1)"	27.8	29.9	20.5	25.1	26.8	12.7	34.3	18.5	24.4	29.3	27.8	18.8	36.3	18.4	33.5	40.5	33.1	38.5	26.0	25.7	18.5	15.5	42.0	46.8	27.2	32.2	24.8	23.0	30.9	60.8	37.0	27.6	38.0	17.6	31.4	26.7	31.4	38.7	30.2	22.9	30.4	30.3	30.0	18.7	37.9	30.9	32.1	20.6	51.5	56.9	23.2	37.1	27.8	32.4	35.7	32.5	46.9	35.7	26.3	32.9	32.2	33.8	31.3	42.1	26.9	34.5	33.5	32.9	30.3	29.1	48.5	40.4	34.4	48.2	35.2	39.5	27.9	41.1	44.7	52.0	41.0	24.0	24.0	36.1	22.8	20.1	28.9	35.4	36.9	29.1	35.7	38.0	27.8	49.3	39.8	14.8	40.7	29.6	40.8	34.9	40.5	24.4	58.3	22.2	46.2	39.5	26.1	35.7	29.0	43.2	19.1	35.4	34.1	44.4	31.2	30.1	28.4	17.7	27.0	28.8	37.3	52.9	27.2	24.8	33.7	46.9	32.5	28.6	27.1	35.7	30.8	30.5	27.8	31.5	32.5	35.7	28.6	27.2	18.1	26.3	34.9	29.3	32.9	32.2	20.5	26.8	18.5	24.4	18.5	15.5	24.8	23.0	17.6	20.6
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: "	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favourable (2.69e-4)"	22.1	26.5	34.6	33.0	41.1	42.5	32.8	40.6	51.0	25.1	22.7	29.1	29.7	23.4	29.9	30.0	28.5	30.0	22.1	35.3	32.3	24.9	26.0	29.9	32.3	33.6	42.6	32.8	34.6	37.9	31.9	29.2	31.0	32.3	27.0	26.5	20.8	25.0	30.5	83.6	31.5	25.4	29.1	47.1	37.7	25.9	35.0	39.8	34.5	32.8	30.6	33.3	21.6	33.1	29.2	34.8	43.0	28.2	20.5	31.9	27.4	26.3	23.3	39.6	24.0	17.2	12.7	31.5	18.6	17.3	26.7	23.1	25.9	26.8	29.8	28.4	17.4	24.4	38.0	27.3	17.7	34.8	35.1	23.4	35.5	21.4	21.4	35.9	29.6	14.7	31.7	25.7	36.7	21.3	28.8	23.1	19.9	33.4	38.5	36.4	45.9	29.2	24.0	24.2	33.0	25.8	36.5	24.1	27.9	19.9	28.9	31.1	31.0	49.8	18.2	18.0	26.7	22.6	30.0	32.3	27.0	34.6	18.9	29.5	20.9	43.0	28.0	25.2	31.7	28.2	31.5	29.2	31.2	30.7	34.8	27.4	31.9	28.4	19.8	20.5	25.5	26.8	31.8	27.4	34.6	41.1	40.6	51.0	32.3	24.9	42.6	32.8	32.3	39.8
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Conserved helix-loop-helix ubiquitous kinase"	O15111	10	100188298-100229619	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	16.6	16.6	14.0	14.3	18.9	21.3	14.2	16.0	15.8	11.8	15.0	13.0	13.9	16.1	14.7	12.4	13.5	12.0	11.7	14.5	13.3	17.6	27.2	35.8	14.0	20.8	17.9	6.9	11.4	14.5	19.6	18.2	14.2	16.4	12.9	17.6	9.5	13.9	12.5	23.6	11.0	20.6	16.1	18.6	18.7	15.1	12.5	15.6	22.5	14.5	11.7	15.5	13.8	13.6	3.7	3.4	7.2	4.8	4.0	4.3	1.4	15.6	13.2	13.6	20.2	13.1	11.8	10.5	19.9	19.6	18.6	22.8	14.8	9.3	21.2	11.8	13.5	15.5	22.6	10.6	21.0	22.5	19.5	14.1	10.5	16.3	11.2	26.0	20.7	9.4	11.3	21.5	21.0	13.2	15.9	17.6	20.3	9.5	20.5	16.1	8.8	9.7	13.4	15.1	9.7	11.8	10.1	8.1	12.1	10.8	8.4	17.3	16.7	15.9	13.9	11.7	13.2	12.7	22.6	20.8	18.7	20.7	12.8	21.2	9.2	2.6	3.0	5.1	2.4	4.8	4.0	3.7	3.0	4.3	3.4	2.1	3.3	4.2	7.2	4.0	3.2	2.1	2.8	1.4	14.0	18.9	16.0	15.8	13.3	17.6	17.9	6.9	16.4	15.6
CIAPIN1	Anamorsin	ENSG00000005194	"Cytokine induced apoptosis inhibitor 1"	Q6FI81	16	57428169-57447528	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041350, HPA042182"	Enhanced		Supported	Mitochondria			6400	Mitochondria		"HPA041350: AB_10796665, HPA042182: AB_10794646"	"unprognostic (1.78e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (1.41e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.62e-1)"	"prognostic favourable (4.42e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.86e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.16e-1)"	13.5	21.0	12.8	12.6	19.1	11.5	12.2	18.3	29.3	10.6	19.3	14.8	8.7	14.5	11.9	10.7	18.9	10.8	15.9	23.9	12.8	16.5	20.7	19.7	13.1	14.1	15.6	17.6	10.5	17.2	18.9	11.9	21.8	21.0	11.7	17.3	14.2	15.0	11.3	35.3	17.5	15.0	14.2	10.6	14.4	13.7	44.0	10.7	19.2	15.8	18.0	20.9	13.1	12.1	22.7	32.4	17.3	27.5	27.5	48.8	45.5	15.9	23.8	25.6	19.8	14.7	10.1	22.2	18.8	15.9	32.6	15.3	26.7	13.0	17.1	27.1	14.1	30.8	34.2	25.0	28.2	10.0	20.9	22.0	20.9	28.0	24.1	26.7	22.9	16.0	27.6	23.4	29.9	31.7	30.8	10.6	18.6	15.8	26.4	21.4	34.8	35.0	49.4	30.8	35.8	21.7	18.1	22.6	28.3	40.1	28.7	18.1	21.0	23.4	20.3	14.3	18.7	14.4	20.8	28.2	35.9	57.3	17.4	25.7	22.5	13.9	27.5	17.3	26.9	25.7	24.8	22.7	22.7	28.3	32.4	22.3	48.8	43.0	6.7	27.5	20.8	27.7	24.3	45.5	12.8	19.1	18.3	29.3	12.8	16.5	15.6	17.6	21.0	10.7
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: , HPA048825: "	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favourable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	16.5	40.1	15.0	31.1	14.7	42.5	21.8	4.1	13.8	24.1	51.6	15.4	31.0	31.6	12.2	37.2	39.9	37.2	43.3	47.7	14.8	14.0	49.8	74.5	27.9	27.6	17.5	13.8	17.8	67.8	20.2	24.0	20.6	18.3	30.3	34.0	16.7	40.4	44.5	21.2	10.0	67.5	13.9	13.6	29.3	23.8	25.7	11.0	21.5	37.8	27.8	44.3	38.0	16.3	87.9	43.0	49.4	45.4	35.9	55.2	64.9	24.5	55.6	4.9	17.7	21.8	22.8	8.1	26.0	22.8	21.5	19.3	21.7	43.9	7.1	28.2	30.6	25.5	10.5	30.0	11.7	16.8	23.9	15.9	38.3	36.0	21.5	31.9	15.5	16.2	18.1	20.1	13.9	27.5	21.4	11.3	16.3	48.2	24.0	37.1	7.9	28.6	13.6	13.5	28.9	54.9	42.0	4.1	4.9	35.6	28.9	27.8	22.4	19.3	17.3	23.8	17.0	28.7	31.8	15.4	24.1	8.3	38.5	36.5	10.2	25.3	39.3	49.4	46.0	45.4	37.7	87.9	55.2	50.2	43.0	70.7	46.0	45.5	22.8	35.9	41.0	28.5	44.3	64.9	15.0	14.7	4.1	13.8	14.8	14.0	17.5	13.8	18.3	11.0
CIC	KIAA0306	ENSG00000079432	"Capicua transcriptional repressor"	Q96RK0	19	42268537-42295797	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026388, HPA044341, HPA064725"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB026388: , HPA044341: , HPA064725: "	"unprognostic (2.02e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.54e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.72e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.56e-1)"	18.6	15.7	30.5	22.8	29.9	28.1	20.3	46.8	31.6	17.5	14.7	24.7	13.0	16.5	28.6	12.3	12.3	22.1	17.4	12.1	25.5	15.2	14.9	15.1	15.8	21.5	25.2	20.1	31.5	22.6	16.6	22.6	13.2	20.4	14.4	6.2	19.0	23.8	20.8	21.0	34.1	16.1	16.3	16.5	24.7	14.5	31.5	25.6	13.6	16.8	10.6	13.4	13.6	17.4	2.3	2.0	5.0	2.6	0.6	2.5	1.6	17.6	32.0	12.3	16.9	8.0	15.1	6.0	13.5	11.3	11.4	10.6	9.0	10.9	12.3	12.9	10.6	8.6	6.8	20.4	3.7	29.8	9.2	10.3	20.2	10.7	10.1	5.8	29.4	18.0	12.0	12.9	7.6	10.4	10.1	25.9	6.4	16.8	11.4	11.1	7.7	18.2	9.8	10.5	7.3	9.5	16.6	15.9	13.1	12.8	8.0	10.1	9.5	12.5	19.9	27.3	22.2	9.3	16.4	21.5	14.8	8.4	21.2	9.2	16.1	3.4	1.8	1.0	2.5	2.6	1.9	1.7	1.3	1.6	1.7	2.3	0.9	1.5	5.0	0.6	1.9	2.0	0.5	1.6	30.5	29.9	46.8	31.6	25.5	15.2	25.2	20.1	20.4	25.6
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 22.8;REH: 40.0;U-698: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	8.0	5.9	4.6	47.7	7.1	4.3	6.8	1.5	5.5	6.3	3.7	10.6	4.2	10.4	8.1	10.4	4.8	5.2	8.1	4.9	4.7	3.5	8.8	2.9	15.0	27.0	9.4	1.1	2.5	3.5	1.9	4.0	1.2	6.6	5.5	4.3	5.5	13.3	4.3	2.9	4.4	17.4	3.7	15.6	25.9	6.2	1.5	7.4	12.6	6.1	5.2	67.2	6.3	6.8	27.3	19.0	6.5	11.9	0.7	0.5	1.7	0.1	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	5.5	5.0	0.8	0.0	0.9	0.0	0.0	0.1	22.8	0.2	2.9	1.0	0.6	0.0	0.4	0.4	1.0	0.0	0.1	0.0	0.0	0.3	2.0	0.1	0.3	0.2	0.4	0.1	0.1	40.0	0.3	3.5	0.0	1.6	0.9	0.1	0.9	0.3	0.9	0.5	1.6	0.3	2.1	0.3	0.6	0.2	8.4	0.6	11.8	7.5	0.5	6.8	0.2	11.9	6.5	0.3	9.5	0.1	17.9	0.1	0.5	17.7	27.3	0.1	0.2	2.8	0.7	10.0	19.0	0.4	1.7	4.6	7.1	1.5	5.5	4.7	3.5	9.4	1.1	6.6	7.4
CIP2A	KIAA1524	ENSG00000163507	"Cell proliferation regulating inhibitor of protein phosphatase 2A"	Q8TCG1	3	108549869-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavourable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	2.1	2.3	2.5	8.5	6.3	10.4	3.6	6.3	6.2	3.2	3.1	2.6	0.8	2.0	3.2	1.8	4.0	1.8	2.0	2.7	2.9	2.1	2.2	1.6	2.2	10.2	2.0	3.2	3.8	1.8	1.8	3.0	3.3	2.4	3.0	4.4	2.2	2.3	1.4	2.0	1.9	2.7	2.5	2.4	5.5	2.0	8.5	1.5	21.5	1.9	1.5	8.0	4.0	2.7	1.9	0.3	0.7	1.1	0.0	1.6	0.6	18.6	5.6	15.7	10.0	0.7	1.5	6.4	14.2	6.7	16.8	19.8	6.7	8.4	12.6	4.9	5.1	9.5	5.3	5.0	30.7	4.0	5.2	15.1	7.6	5.0	0.2	9.7	10.8	0.6	1.0	13.1	5.4	7.5	9.3	20.4	16.5	3.8	11.6	8.6	16.1	9.6	13.3	14.6	6.9	5.1	5.2	7.6	10.0	10.4	4.1	5.8	7.0	6.9	5.5	17.3	19.6	5.2	17.0	4.7	5.2	20.9	7.6	10.5	17.6	0.6	0.3	0.7	0.0	0.5	1.3	1.2	0.7	0.3	0.0	1.9	0.7	1.6	0.0	0.0	1.1	0.3	0.8	0.6	2.5	6.3	6.3	6.2	2.9	2.1	2.0	3.2	2.4	1.5
CIR1	CIR	ENSG00000138433	"Corepressor interacting with RBPJ, 1"	Q86X95	2	174348022-174395715	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 56.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015784, HPA061442"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA015784: AB_1846782, HPA061442: "	"unprognostic (3.17e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.56e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favourable (9.80e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavourable (1.04e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-3)"	"prognostic favourable (2.04e-5)"	24.1	20.8	27.0	21.9	38.1	48.4	31.0	41.0	34.8	33.6	22.8	19.8	27.2	21.4	23.9	38.6	23.8	24.7	19.8	23.1	25.1	24.7	28.4	22.3	22.2	23.4	26.2	28.3	30.0	24.4	22.5	54.0	36.9	32.3	31.6	22.8	14.0	21.2	23.5	30.8	27.5	34.3	20.3	27.6	32.4	21.0	26.9	30.7	35.8	35.8	21.4	23.7	37.8	22.2	12.0	11.9	56.9	10.1	13.3	10.9	7.6	10.3	5.9	14.1	11.2	19.7	27.7	20.9	17.2	24.4	17.2	21.3	11.0	16.1	7.2	16.2	16.8	12.6	11.6	12.2	20.8	13.3	15.3	15.0	9.4	17.8	19.2	17.8	13.9	22.7	22.3	18.9	14.2	17.0	15.4	16.2	16.3	9.9	22.1	28.2	12.9	16.7	12.6	20.3	21.3	20.3	16.6	16.4	19.3	11.8	15.2	26.0	11.4	26.5	17.4	14.1	10.2	13.2	8.8	18.5	15.7	2.7	20.1	9.3	12.2	17.8	10.1	15.8	9.1	9.2	9.0	12.0	10.3	9.6	6.4	11.8	10.9	10.0	56.9	13.3	9.4	11.9	10.5	7.6	27.0	38.1	41.0	34.8	25.1	24.7	26.2	28.3	32.3	30.7
CIRBP	CIRP	ENSG00000099622	"Cold inducible RNA binding protein"	Q14011	19	1259384-1274880	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060537			Supported	Nucleoplasm			33000	Nucleoplasm		"HPA060537: "	"unprognostic (2.77e-3)"	"prognostic favourable (3.63e-4)"	"unprognostic (9.80e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.38e-3)"	"prognostic favourable (2.50e-4)"	"unprognostic (6.43e-2)"	"unprognostic (2.29e-2)"	"prognostic favourable (2.69e-4)"	"unprognostic (1.82e-1)"	"prognostic favourable (3.65e-7)"	"unprognostic (1.04e-1)"	"unprognostic (5.76e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.49e-2)"	57.0	64.6	54.3	54.4	63.7	55.9	72.7	92.0	88.7	78.6	55.7	98.9	75.2	33.2	82.9	86.4	38.5	89.5	75.1	62.4	47.8	57.1	51.7	34.7	51.4	66.6	45.3	95.9	154.5	115.1	101.0	92.2	48.9	61.6	67.8	40.1	115.4	91.5	100.1	119.1	68.5	48.9	93.0	50.0	56.7	60.7	67.4	37.5	33.7	73.7	65.1	63.7	58.5	49.1	70.6	67.4	48.3	54.6	52.3	58.6	40.5	37.0	8.0	58.5	29.6	26.1	29.4	15.2	40.8	57.6	32.1	28.8	14.6	14.4	74.6	22.1	42.1	17.6	24.5	36.9	24.9	33.4	7.1	44.4	8.4	18.8	95.5	68.7	32.4	72.1	33.3	20.7	90.8	28.9	29.1	60.3	33.2	26.3	35.2	18.6	23.1	13.6	44.0	47.1	36.7	36.3	31.2	27.8	50.5	43.1	19.7	32.4	41.0	19.4	35.0	23.6	14.5	56.2	35.5	80.1	86.3	62.6	20.3	28.5	30.8	43.5	21.4	48.3	56.1	36.7	57.3	62.5	50.2	50.3	23.9	70.6	57.6	54.1	36.8	52.3	54.6	67.4	58.6	40.5	54.3	63.7	92.0	88.7	47.8	57.1	45.3	95.9	61.6	37.5
CISD1	"C10orf70, MDS029, mitoNEET, ZCD1"	ENSG00000122873	"CDGSH iron sulfur domain 1"	Q9NZ45	10	58269058-58289586	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 63.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA074383			Supported	Mitochondria				Mitochondria		"HPA074383: "	"prognostic unfavourable (1.11e-4)"	"unprognostic (8.60e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (6.69e-4)"	4.7	8.9	14.0	5.4	21.6	1.4	5.4	14.8	24.9	6.2	10.3	3.7	3.6	17.8	5.2	3.9	9.5	5.7	6.4	32.1	16.2	17.6	20.8	13.2	4.1	4.9	14.7	19.5	6.4	4.8	63.1	10.5	5.0	16.6	6.9	7.7	5.8	8.0	6.7	43.9	7.2	16.7	8.9	9.0	4.2	6.4	3.0	6.0	3.5	8.7	20.4	5.1	8.3	4.4	7.6	9.5	3.0	5.8	6.1	8.3	5.1	11.9	6.1	4.9	8.9	6.6	7.4	2.9	10.2	11.7	10.2	14.1	14.4	11.3	21.4	8.6	10.5	7.9	13.2	9.1	9.2	9.6	17.9	5.6	10.2	11.5	7.5	9.9	4.4	9.2	7.5	9.7	14.9	11.9	12.4	10.0	7.1	4.0	8.4	10.7	5.2	19.2	6.5	18.1	11.2	13.7	4.2	15.5	5.5	7.8	20.9	7.2	13.9	5.3	11.7	4.4	7.9	12.6	12.0	10.2	16.7	16.1	11.8	9.9	4.2	0.0	5.8	0.3	5.7	4.2	6.7	7.6	6.6	6.6	9.5	6.0	7.7	7.5	3.0	6.1	2.6	6.2	8.3	5.1	14.0	21.6	14.8	24.9	16.2	17.6	14.7	19.5	16.6	6.0
CISD2	"ERIS, Miner1, NAF-1, WFS2, ZCD2"	ENSG00000145354	"CDGSH iron sulfur domain 2"	Q8N5K1	4	102868974-102892807	"Disease related genes, Predicted membrane proteins"	Autophagy		"Deafness, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015914	Approved		Supported	"Endoplasmic reticulum"			80000	"Endoplasmic reticulum"		"HPA015914: AB_1846794"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.48e-3)"	"unprognostic (9.12e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	8.1	13.8	14.8	13.5	11.3	13.7	11.2	14.5	16.1	13.5	8.3	9.3	9.3	5.0	9.4	14.4	8.5	8.2	11.5	10.6	14.5	17.7	19.8	40.5	8.0	12.8	17.9	8.2	8.2	29.7	13.3	10.7	9.5	15.6	7.8	10.7	9.4	16.3	10.5	4.9	7.7	12.5	8.0	16.7	13.0	7.0	7.6	8.4	11.2	21.2	5.6	8.9	6.8	9.3	5.1	6.9	11.0	5.7	7.9	6.6	4.2	10.5	3.5	3.8	4.7	9.5	10.4	2.4	8.3	3.0	3.5	5.4	4.1	17.8	7.7	7.3	7.7	5.2	18.1	6.5	16.3	6.8	2.8	6.6	2.4	4.2	6.9	11.8	10.6	3.9	10.0	14.9	11.7	6.3	14.3	13.8	9.5	2.8	10.2	3.4	7.4	2.7	4.2	3.9	13.9	8.6	3.3	8.8	5.3	4.9	8.4	7.7	5.5	2.5	2.8	10.5	11.7	14.1	4.9	10.7	14.4	15.6	7.5	3.6	8.0	7.2	5.6	11.0	5.4	5.1	5.8	5.1	5.5	5.6	5.3	4.0	3.8	4.9	4.1	7.9	5.7	6.9	6.6	4.2	14.8	11.3	14.5	16.1	14.5	17.7	17.9	8.2	15.6	8.4
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 247.1;pituitary gland: 62.8;testis: 89.9"	"Group enriched"	"Detected in some"	5	"AN3-CA: 17.5;SK-MEL-30: 69.6"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 18.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA049051: "	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favourable (6.10e-4)"	"prognostic favourable (3.95e-4)"	"unprognostic (2.99e-2)"	0.5	0.6	3.5	0.5	2.2	0.4	6.0	0.9	2.8	1.3	0.5	0.3	5.3	0.5	1.0	247.1	0.4	0.5	0.4	0.4	2.4	18.9	0.6	0.4	0.5	0.4	1.1	0.9	0.5	0.6	0.4	62.8	0.4	2.7	2.1	0.4	27.8	0.4	1.2	0.4	0.4	0.5	1.7	0.5	0.4	0.4	89.9	0.0	0.0	1.7	0.0	0.4	0.4	0.0	0.0	0.8	2.2	0.5	0.0	1.1	1.1	0.1	0.1	0.7	17.5	0.8	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	6.3	0.4	0.0	1.8	2.5	0.3	0.1	0.0	0.0	0.1	3.4	0.3	0.2	0.2	0.3	0.0	0.7	0.1	0.1	0.2	0.0	1.3	1.0	1.2	0.0	1.2	0.9	0.0	0.2	7.9	4.1	0.1	1.5	69.6	0.5	0.4	0.0	0.1	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	1.6	0.0	0.5	2.2	0.4	0.0	1.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	3.5	2.2	0.9	2.8	2.4	18.9	1.1	0.9	2.7	0.0
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374620	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 76.8;fHDF/TERT166: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favourable (3.40e-4)"	"prognostic unfavourable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	42.8	34.5	6.8	27.1	11.2	71.7	35.4	24.2	27.9	22.2	23.6	6.0	19.0	9.3	53.3	26.5	24.1	58.1	27.0	37.7	4.7	6.6	24.9	55.2	40.6	14.3	3.7	7.2	84.0	35.3	58.5	6.0	75.7	17.4	23.3	11.4	26.1	31.4	44.6	44.5	34.8	19.6	23.3	3.7	40.6	21.4	17.7	3.0	11.2	99.7	18.7	16.6	17.6	24.4	1.9	2.9	20.0	6.6	2.3	4.7	2.2	2.8	1.7	5.9	17.4	25.2	27.0	22.3	76.8	57.2	35.1	33.1	15.2	4.3	2.0	11.3	133.5	3.4	1.8	1.7	25.0	56.7	5.7	42.1	9.6	1.2	20.6	12.4	4.6	21.5	8.3	15.3	11.8	6.4	15.7	10.1	45.5	6.3	2.1	15.5	5.5	2.6	3.0	4.3	18.2	16.8	6.5	6.5	0.1	5.5	21.1	2.4	9.1	42.7	35.0	28.2	9.0	8.3	4.3	3.0	2.6	3.1	8.7	10.7	1.9	2.1	6.6	20.0	3.0	3.7	4.3	1.0	4.7	4.3	2.9	1.9	4.1	2.1	3.3	2.3	4.9	1.3	2.7	2.2	6.8	11.2	24.2	27.9	4.7	6.6	3.7	7.2	17.4	3.0
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128166064-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA020380: , HPA020387: "	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	31.9	24.3	33.6	23.8	36.0	36.7	36.7	39.4	40.4	31.5	35.7	28.0	21.3	26.8	33.6	20.9	30.3	33.5	26.7	25.5	30.5	19.9	19.7	12.1	22.2	24.8	29.4	27.5	56.3	41.7	23.1	21.1	21.9	23.4	30.1	21.8	23.3	31.3	28.8	51.4	49.6	26.1	40.0	27.3	22.5	28.9	35.4	37.0	30.3	22.8	24.2	27.0	35.2	39.3	6.7	4.6	4.9	5.8	8.1	8.3	3.2	22.9	27.8	23.8	22.4	24.6	29.8	23.3	18.1	27.3	33.4	19.0	25.4	20.2	27.1	15.5	30.5	33.5	18.3	19.5	18.3	24.5	20.9	25.8	34.9	16.3	28.4	23.9	30.8	28.8	35.0	36.5	31.1	22.5	62.4	23.4	20.0	53.7	31.3	24.3	20.6	28.6	26.6	25.1	27.8	15.1	15.8	29.7	23.0	40.3	28.6	24.0	29.7	31.2	23.9	35.7	25.4	40.4	34.0	27.2	30.7	26.1	25.3	16.1	38.2	4.6	4.3	4.9	5.0	5.8	4.5	5.7	6.1	6.4	4.6	6.7	6.1	5.5	0.7	8.1	4.3	4.6	8.3	3.2	33.6	36.0	39.4	40.4	30.5	19.9	29.4	27.5	23.4	37.0
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736607-112764677	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;lymphoid tissue: 38.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Mitotic spindle,Cytosol"				"Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: "	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	1.5	0.7	0.6	9.2	0.6	13.4	1.3	0.7	0.6	0.6	1.8	0.0	0.3	1.5	0.5	1.4	3.8	0.7	0.1	2.3	0.6	0.5	0.7	0.7	1.2	5.3	0.6	0.2	0.6	0.6	0.0	0.5	3.2	0.2	0.6	2.4	0.0	1.0	0.0	0.6	1.5	2.4	0.9	0.6	2.2	0.9	9.0	0.1	38.3	0.6	5.9	6.0	0.9	0.7	1.0	0.8	1.8	0.7	1.6	1.8	0.4	19.9	4.0	15.8	7.1	0.9	1.5	3.2	16.5	13.7	17.2	16.4	3.7	5.8	13.7	6.9	6.5	7.7	9.1	8.7	29.0	19.0	4.0	22.8	5.6	3.2	0.0	10.7	13.7	0.4	0.8	21.6	12.3	7.8	6.0	20.0	14.0	2.9	12.9	4.1	6.7	13.0	9.4	16.6	3.6	2.9	7.8	8.7	5.5	6.7	5.6	5.7	5.4	5.0	5.5	19.1	14.9	15.2	12.1	4.3	8.3	11.7	8.2	7.7	29.9	0.8	0.5	0.7	0.5	0.7	0.4	0.9	1.2	1.1	0.5	1.0	0.5	0.7	1.8	1.6	0.7	0.8	1.8	0.4	0.6	0.6	0.7	0.6	0.6	0.5	0.6	0.2	0.2	0.1
CKB	CKBB	ENSG00000166165	"Creatine kinase B"	P12277	14	103519659-103523111	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 158.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 53.1;HEK 293: 135.1;SCLC-21H: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"non-classical monocyte: 50.0"	"Lineage enriched"	"Detected in many"	17	"monocytes: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001254, CAB047313"	Enhanced		Supported	Cytosol			50000000	Cytosol		"CAB047313: , HPA001254: AB_1078528"	"unprognostic (9.97e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.89e-3)"	"prognostic favourable (4.02e-8)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.13e-1)"	32.4	27.3	75.4	10.4	114.6	3.1	5.3	94.3	158.5	29.1	121.5	51.4	23.8	17.6	37.3	8.9	28.6	35.7	17.8	36.4	60.7	43.2	26.7	3.4	12.8	3.6	63.4	93.3	15.8	10.2	20.3	9.7	3.7	63.3	107.5	55.0	43.9	18.3	92.1	19.1	14.4	17.5	53.2	31.9	3.6	66.7	22.1	50.9	0.0	19.8	7.8	3.9	43.0	13.0	0.0	2.9	1.4	50.0	0.0	0.1	0.9	0.3	6.7	26.9	1.4	0.2	0.2	0.5	2.9	0.0	0.3	0.1	53.1	0.8	0.0	3.2	2.0	5.9	7.8	0.1	0.0	1.2	135.1	10.0	29.7	18.2	1.1	0.0	8.2	1.0	0.0	0.2	0.1	0.0	17.4	0.4	0.4	2.2	0.2	0.3	10.5	21.0	1.7	0.5	27.6	4.9	0.2	76.9	31.6	5.7	0.9	2.1	2.5	4.1	0.1	0.1	5.2	0.5	12.6	1.3	0.3	0.9	0.7	0.2	0.9	0.3	0.1	1.4	0.0	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	50.0	0.0	0.1	0.9	75.4	114.6	94.3	152.7	60.7	43.2	63.4	93.3	63.3	50.9
CLASP2	KIAA0627	ENSG00000163539	"Cytoplasmic linker associated protein 2"	O75122	3	33496245-33718356	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067071			Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA067071: "	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.48e-6)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.72e-2)"	7.9	14.5	20.6	6.5	31.6	6.0	9.0	45.4	67.1	13.0	8.9	50.7	3.4	5.6	11.7	6.7	10.2	9.4	10.0	22.0	19.1	16.8	10.4	6.1	8.6	7.9	33.4	22.1	16.1	6.5	11.6	16.1	8.7	44.7	9.8	7.7	13.4	6.5	12.4	31.7	7.3	6.7	11.2	29.7	7.7	6.8	6.5	37.3	4.1	8.1	4.9	8.6	8.0	7.5	8.4	8.7	4.7	8.4	12.3	7.2	5.6	7.2	16.0	18.4	15.4	12.0	11.8	13.2	13.6	12.8	16.0	17.3	9.3	7.6	23.9	7.9	10.6	6.3	23.7	10.8	19.5	19.2	16.9	23.5	14.1	8.2	5.7	23.1	20.1	7.2	10.8	17.3	16.5	15.4	22.8	13.7	17.2	4.0	17.1	9.9	13.6	10.2	18.5	17.3	12.9	10.2	8.3	15.4	26.1	15.7	12.3	13.5	11.6	20.6	14.7	12.6	11.0	9.4	14.9	9.7	18.1	19.8	11.4	16.0	15.9	4.7	5.9	3.3	4.8	6.3	7.2	8.4	4.2	4.5	8.7	5.6	5.7	5.2	1.2	12.3	8.4	8.3	4.5	5.6	20.6	31.6	45.4	38.7	19.1	16.8	33.4	22.1	44.7	37.3
CLASRP	"CLASP, SFRS16, SWAP2"	ENSG00000104859	"CLK4 associating serine/arginine rich protein"	Q8N2M8	19	45039040-45070956	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA060469, HPA062455"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA060469: , HPA062455: "	"unprognostic (2.99e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (9.77e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (1.69e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-1)"	"prognostic favourable (1.02e-5)"	14.5	12.2	14.1	16.5	24.6	40.4	13.6	19.0	25.7	12.0	14.5	27.4	13.0	17.6	14.4	14.5	14.7	13.8	13.4	9.6	16.2	12.2	11.6	11.6	13.9	17.7	26.8	16.2	18.3	28.6	13.7	19.8	12.0	18.4	14.7	9.4	10.7	16.8	17.2	21.5	17.0	20.6	14.6	22.1	18.5	18.3	14.3	22.4	7.8	14.7	9.9	14.1	11.7	15.3	7.1	5.1	9.2	3.6	2.7	4.1	2.0	11.0	15.9	6.5	4.8	2.1	3.3	14.4	9.6	3.6	7.4	7.4	7.3	10.6	17.4	7.3	3.7	12.2	9.9	7.2	3.3	8.6	14.6	10.2	8.5	9.1	4.9	6.8	14.1	4.2	4.0	5.0	8.9	5.0	16.3	9.9	2.5	11.1	18.4	22.9	9.0	9.3	14.6	7.3	13.2	4.9	11.1	7.5	11.7	7.7	7.4	7.0	9.5	15.1	7.5	7.2	9.1	6.1	14.5	14.3	11.6	15.6	5.1	11.2	5.9	0.7	3.6	5.5	3.8	2.6	3.5	7.1	2.3	4.1	3.2	6.4	3.3	2.9	9.2	2.7	3.0	5.1	1.9	2.0	14.1	24.6	19.0	25.7	16.2	12.2	26.8	16.2	18.4	22.4
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424086-86456558	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1"	"Cell line enriched"	"Detected in some"	5	"hTCEpi: 67.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"		66000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: "	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.1	0.1	27.7	0.2	0.1	0.4	0.1	1.1	0.7	105.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	1.4	0.3	0.1	5.1	0.1	0.1	36.4	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.1	42.1	33.9	6.1	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	12.3	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	10.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	67.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108929508-108963457	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	17.4	19.5	17.5	13.2	24.8	7.1	19.1	22.8	26.1	19.0	16.4	28.4	22.9	15.6	22.1	31.2	12.2	16.9	15.8	20.2	19.5	15.2	12.2	23.5	15.1	10.9	24.4	16.3	23.3	28.5	26.6	24.4	20.0	20.5	23.1	15.3	17.7	21.8	24.1	29.3	16.1	14.8	19.3	21.5	13.7	17.9	8.3	24.3	5.1	21.7	10.4	12.9	17.1	16.0	7.7	9.5	9.0	15.4	7.1	9.4	5.5	23.6	10.3	13.4	23.1	18.7	16.9	17.3	19.7	16.2	14.0	15.1	11.1	9.9	5.6	21.2	15.6	9.1	12.0	7.5	17.9	17.9	10.8	14.0	12.9	10.2	15.0	13.8	15.5	12.4	11.2	16.1	13.3	12.8	16.9	23.1	10.2	9.4	1.2	5.4	10.1	9.3	12.8	6.8	13.4	11.7	14.1	8.0	12.3	23.1	24.9	17.8	7.8	9.4	13.8	18.7	15.0	17.8	19.3	16.8	13.7	8.7	22.8	11.2	40.2	4.1	9.2	9.0	9.1	11.1	9.4	7.7	7.7	7.2	8.0	5.9	8.7	7.9	1.6	7.1	15.4	9.5	9.2	5.5	17.5	24.8	22.8	26.1	19.5	15.2	24.4	16.3	20.5	24.3
CLCN3	"ClC-3, CLC3"	ENSG00000109572	"Chloride voltage-gated channel 3"	P51790	4	169612633-169723673	"Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044723	Approved		Supported	Vesicles				Vesicles		"HPA044723: AB_10959733"	"unprognostic (1.92e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.10e-4)"	"unprognostic (2.49e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.38e-3)"	11.6	21.1	27.6	10.9	29.9	5.9	18.4	24.9	37.7	15.0	26.7	32.4	15.5	17.1	11.1	17.7	26.6	15.6	22.0	19.6	29.3	29.7	22.2	14.7	11.9	9.0	32.7	22.7	14.0	23.4	29.4	38.7	14.5	36.1	19.5	30.8	20.6	48.5	13.5	14.6	18.0	16.5	10.4	46.1	9.0	23.2	18.4	25.4	10.8	21.7	18.4	13.5	20.5	16.7	8.6	11.9	6.2	8.1	6.9	11.5	7.9	11.8	12.2	18.3	23.3	37.4	31.5	9.0	15.9	19.9	10.7	13.1	8.6	26.8	14.6	9.9	13.2	10.1	22.8	9.8	18.0	12.9	8.9	12.2	19.9	9.9	25.5	14.6	20.5	21.9	22.6	19.0	18.9	19.3	30.2	33.5	18.9	4.2	20.0	3.4	7.5	8.3	9.0	8.1	11.4	22.4	24.4	19.9	19.6	14.1	15.5	24.8	10.5	6.9	16.3	8.6	9.7	13.8	12.3	14.9	22.4	13.0	25.9	5.6	22.7	6.2	6.5	4.7	9.0	8.1	11.5	8.6	6.7	8.2	9.5	7.4	10.4	9.2	5.3	6.9	6.5	11.9	8.1	7.9	27.6	29.9	24.9	36.8	29.3	29.7	32.7	22.7	36.1	25.4
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922615-50099235	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 24.9;RH-30: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 6.6;monocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: "	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favourable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	4.4	4.1	2.5	2.4	2.9	2.1	3.4	9.4	3.4	2.3	3.1	2.6	4.7	5.0	9.8	26.7	3.7	4.6	7.6	2.2	3.1	2.8	46.1	15.8	4.7	3.0	2.6	2.5	10.8	6.7	2.6	8.3	7.3	5.9	2.7	3.7	7.6	4.0	3.5	5.6	6.2	6.4	3.8	4.3	3.0	4.0	5.9	2.3	1.2	3.6	4.0	2.3	2.4	3.1	0.2	6.6	0.5	1.8	0.3	0.4	0.5	1.7	2.8	2.1	3.3	8.3	5.2	4.6	1.5	0.7	0.9	1.2	24.9	1.7	1.8	0.8	1.7	1.4	6.7	0.8	1.5	0.7	4.6	1.7	1.4	6.5	3.9	2.3	3.3	3.1	1.1	2.5	3.7	3.6	2.7	2.7	2.9	1.8	0.8	0.6	3.1	1.3	1.0	38.6	2.7	3.7	2.8	3.7	2.7	2.1	2.1	3.1	1.9	1.1	1.8	1.0	2.1	7.6	0.9	2.2	6.7	4.1	1.6	3.7	5.0	0.1	1.8	0.0	0.2	1.5	0.3	0.2	0.4	0.4	3.8	0.2	0.1	0.1	0.5	0.3	0.3	6.6	0.0	0.5	2.5	2.9	9.4	3.4	3.1	2.8	2.6	2.5	5.9	2.3
CLCN7	"CLC-7, CLC7, OPTA2, PPP1R63"	ENSG00000103249	"Chloride voltage-gated channel 7"	P51798	16	1444934-1475580	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043019, HPA043586"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA043019: AB_10964727, HPA043586: AB_10965322"	"unprognostic (2.69e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.90e-2)"	"prognostic favourable (5.23e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.49e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.54e-1)"	19.5	34.7	23.2	18.7	23.0	35.0	19.4	22.9	26.8	16.7	15.5	29.3	15.4	18.3	18.8	16.8	12.5	15.8	17.0	15.0	21.9	17.5	19.5	22.7	17.7	19.6	30.3	18.5	14.2	24.1	30.9	19.5	15.5	22.2	14.6	9.4	34.4	17.5	17.5	22.5	21.7	18.9	17.3	18.0	24.8	18.1	17.6	29.5	16.4	21.8	10.9	14.9	17.2	10.2	2.5	2.3	2.0	6.4	0.5	1.6	1.5	5.1	14.3	8.0	12.7	18.3	9.3	12.7	6.9	16.0	15.2	19.0	11.1	19.1	5.8	14.3	9.4	10.8	7.3	8.9	4.6	9.3	11.4	4.2	13.3	11.0	32.0	10.7	17.1	18.5	12.4	13.7	11.8	9.7	16.8	11.4	7.7	10.2	7.5	18.3	8.0	8.1	35.1	5.4	16.2	7.5	7.3	9.1	9.3	11.1	14.1	44.7	12.4	28.6	9.5	13.4	6.1	14.7	6.5	17.3	11.2	6.1	11.2	20.3	8.3	0.0	3.0	2.0	1.6	5.4	0.7	2.2	0.9	0.7	2.3	2.5	0.4	0.6	0.6	0.5	6.4	2.3	0.3	1.5	23.2	23.0	22.9	26.8	21.9	17.5	30.3	18.5	22.2	29.5
CLDN11	"OSP, OTM"	ENSG00000013297	"Claudin 11"	O75508	3	170418865-170454733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;ovary: 47.7;testis: 86.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 56.4;ASC TERT1: 71.2;EFO-21: 42.2;HUVEC TERT2: 60.9;TIME: 96.3"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009789, HPA013166, HPA013657"	Enhanced		Supported	"Lipid droplets,Cell Junctions"				"Cell Junctions"	"Lipid droplets"	"CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: "	"prognostic favourable (6.31e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (5.28e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.70e-11)"	"unprognostic (2.50e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.29e-1)"	8.2	1.9	14.1	2.0	40.6	1.7	6.3	3.5	50.3	1.9	3.4	85.9	0.5	2.2	2.7	4.6	4.6	4.2	18.9	4.0	28.7	13.0	3.2	2.8	2.8	2.1	59.5	17.1	47.7	2.1	1.8	5.5	4.2	37.3	5.1	2.5	0.6	4.7	4.2	1.7	3.6	2.6	2.8	80.6	2.6	2.5	86.1	47.9	0.0	2.0	0.9	2.0	6.3	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	56.4	71.2	0.0	0.7	3.6	4.6	7.7	0.0	9.4	0.0	42.2	5.7	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	3.2	17.4	0.0	0.0	26.0	0.0	25.3	0.0	60.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	96.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.1	40.6	3.5	25.0	28.7	13.0	59.5	17.1	37.3	47.9
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Group enriched"	"Detected in some"	20	"A549: 16.6;CACO-2: 13.4;RPTEC TERT1: 29.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: "	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.4;thyroid gland: 91.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 65.0;PC-3: 13.9;RPMI-8226: 11.1;SCLC-21H: 17.2;T-47d: 30.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.1;pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA014361	Enhanced		Supported	"Cell Junctions"			15000	"Cell Junctions"		"HPA014361: "	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favourable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.3	0.1	0.1	11.5	0.1	0.2	7.1	3.1	0.2	3.8	77.9	1.6	21.8	24.3	2.8	8.8	0.3	9.4	11.3	0.1	0.2	0.4	20.7	16.0	6.0	0.2	0.0	0.0	4.3	38.0	0.2	7.4	3.1	3.0	14.6	8.0	1.9	31.1	32.1	0.1	2.1	100.4	0.5	0.0	0.1	0.7	1.2	0.0	2.2	91.6	0.9	3.6	0.8	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.5	0.7	1.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.2	10.3	0.0	2.9	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.0	0.1	0.3	0.6	13.9	0.0	0.0	11.1	0.6	0.0	17.2	0.2	0.0	9.9	0.0	30.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	3.1	0.2	0.2	0.4	0.0	0.0	3.0	0.0
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832693	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 141.0"	"Cell line enhanced"	"Detected in some"		"A-431: 43.1;BEWO: 50.7;CAPAN-2: 94.7;MCF7: 48.3;PC-3: 61.7;RT4: 41.7;SK-BR-3: 80.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002610	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavourable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favourable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	0.7	0.2	0.4	17.1	0.4	0.0	17.1	0.4	0.5	17.5	53.7	0.7	23.2	25.0	5.1	15.9	62.3	15.4	15.4	0.5	0.4	0.3	30.2	2.0	28.8	0.4	0.4	0.4	5.5	32.4	2.7	3.5	78.1	1.3	31.8	24.7	0.7	52.0	25.7	0.6	35.3	93.3	2.7	0.4	0.4	2.7	2.5	0.4	3.8	141.0	60.9	55.7	38.5	21.0	0.1	0.1	0.2	0.1	0.1	0.6	0.0	43.1	0.5	0.0	0.2	0.0	0.0	50.7	0.4	0.0	0.0	0.0	22.5	94.7	0.0	3.5	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	48.3	0.0	0.2	0.0	61.7	0.0	0.8	1.0	11.6	41.7	10.1	0.2	0.0	80.3	0.1	31.4	0.1	0.0	0.1	1.8	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.3	0.4	0.4	1.3	0.4
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012456-3014505	"Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.5;MCF7: 19.1;SCLC-21H: 15.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076613			Supported	"Vesicles,Cell Junctions"				"Cell Junctions"	Vesicles	"HPA076613: "	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.4	0.4	0.5	2.1	5.2	0.3	16.5	1.4	0.6	1.0	0.3	0.3	1.8	0.3	0.9	0.3	2.3	1.1	0.4	0.8	0.8	0.6	2.6	1.5	0.3	1.4	0.3	0.3	9.6	4.8	15.9	10.2	0.5	0.3	0.1	0.3	1.7	0.3	1.5	0.4	1.2	0.3	2.2	1.0	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	5.5	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	19.1	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.2	0.1	15.0	0.1	0.7	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.1	16.5	1.4	0.8	0.8	1.4	0.3	0.5	0.3
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254103-38256369	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 63.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 17.0;HUVEC TERT2: 92.2;TIME: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"myeloid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"			3600000	"Endoplasmic reticulum, Golgi apparatus"		"HPA039468: AB_2676524, HPA048119: "	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favourable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	32.2	3.9	3.2	6.8	4.3	0.0	47.8	2.3	3.9	14.5	9.3	3.4	5.9	5.9	18.4	13.3	9.3	9.9	13.6	23.7	3.8	3.4	6.8	11.4	63.2	7.9	4.9	2.2	7.6	3.3	5.0	2.8	15.0	4.4	11.8	4.4	10.8	5.5	6.5	36.5	6.5	7.4	12.1	3.9	9.0	5.9	6.8	2.2	1.4	14.0	21.1	3.8	9.4	14.8	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	92.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	4.3	2.3	3.9	3.8	3.4	4.9	2.2	4.4	2.2
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8"	"Group enriched"	"Detected in some"	23	"HL-60: 14.8;U-937: 57.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"classical monocyte: 11.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA054137: "	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.4	3.2	1.8	7.3	2.4	35.8	0.8	0.8	2.5	1.7	0.4	1.9	0.6	0.4	0.8	0.5	1.4	1.2	2.0	3.8	7.6	3.1	2.9	2.1	13.9	0.3	2.4	0.5	2.7	2.6	1.4	1.1	2.7	8.2	0.9	0.5	0.8	2.7	0.8	0.3	2.7	0.3	1.5	4.8	2.1	0.4	0.9	4.8	1.1	1.4	4.9	1.4	1.9	1.1	0.0	0.5	1.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	1.9	1.8	2.4	0.8	2.5	7.6	3.1	2.4	0.5	8.2	4.8
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	9	"blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	5	"HEL: 15.7;Karpas-707: 21.7;U-698: 55.5;U-937: 30.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 42.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 42.4"									HPA063928			Supported	"Plasma membrane,Centriolar satellite"				"Plasma membrane, Centriolar satellite"		"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"	2.7	1.0	0.8	9.8	1.1	0.9	1.1	0.3	0.9	0.6	1.7	1.3	0.1	1.6	0.7	1.3	2.6	0.9	1.5	2.7	1.0	0.9	1.6	1.4	1.9	15.5	1.3	0.7	0.5	1.7	0.0	0.9	0.5	0.9	0.8	2.8	0.8	1.5	0.1	0.5	0.5	11.5	0.9	2.5	20.5	2.6	0.6	0.3	2.2	0.9	0.5	20.6	2.8	2.4	42.4	8.6	0.7	4.6	0.0	3.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	55.5	0.0	30.5	0.0	0.7	2.6	0.1	1.7	4.6	0.0	42.4	1.4	3.5	6.1	14.5	0.0	0.5	0.1	0.0	4.6	8.6	0.1	2.1	0.8	1.1	0.3	0.9	1.0	0.9	1.3	0.7	0.9	0.3
CLGN		ENSG00000153132	Calmegin	O14967	4	140388455-140427968	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 18.4;U-251 MG: 29.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB020709: , HPA048761: , HPA058627: "	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	3.6	2.1	0.7	3.7	1.2	1.6	5.9	3.5	0.8	1.4	0.5	0.0	0.4	1.0	1.6	0.9	7.0	0.4	40.3	0.9	3.4	0.4	3.7	0.5	0.5	1.4	1.6	1.8	1.6	0.2	23.6	0.3	8.6	11.9	0.8	2.4	0.6	0.6	0.4	0.3	0.8	0.9	0.8	0.3	1.6	52.6	0.3	3.1	1.5	0.0	0.8	0.6	0.4	0.5	1.0	3.4	1.1	0.0	0.0	0.1	0.0	4.0	4.3	2.7	1.7	8.9	1.0	0.0	3.8	4.1	7.6	0.1	0.3	0.0	11.6	0.4	0.1	2.9	0.0	6.7	0.2	3.5	1.1	4.1	3.0	17.6	14.8	0.2	1.0	16.3	0.4	0.4	0.1	0.7	0.0	0.0	0.2	18.4	0.2	4.8	11.5	12.3	0.0	0.1	0.0	0.1	6.9	12.4	2.6	1.6	0.7	0.8	2.2	0.0	11.1	2.0	4.0	29.2	5.9	12.7	8.0	17.9	0.6	1.2	3.4	1.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	5.9	3.5	0.9	3.4	1.4	1.6	8.6	0.3
CLIC1	"G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020825, CAB040557"	Enhanced		Supported	Cytosol			78000000	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	64.5	22.9	7.4	33.7	11.3	35.3	41.1	2.5	8.3	38.7	50.3	9.0	27.1	24.5	30.0	29.2	59.0	26.3	60.8	35.5	7.9	7.7	70.8	28.3	58.6	59.6	13.9	3.7	34.8	30.3	11.1	17.0	72.3	12.1	42.2	43.5	20.0	37.7	33.6	18.3	45.0	54.9	31.5	13.6	79.9	34.8	16.7	9.2	52.9	46.1	37.4	58.5	49.2	40.0	39.0	30.5	70.9	39.4	33.5	37.2	67.9	26.7	12.4	20.4	10.6	13.6	28.8	10.2	11.9	24.5	21.9	18.4	28.5	20.1	11.0	17.4	42.5	16.2	15.2	35.7	29.6	8.7	8.0	21.0	10.7	24.6	17.6	36.6	29.7	17.8	18.9	36.9	35.3	36.6	24.2	34.9	42.0	17.8	17.0	47.7	1.8	18.2	3.0	11.2	25.9	49.2	16.7	3.9	4.6	9.9	11.4	16.6	7.8	51.9	24.2	30.5	21.5	9.5	37.6	11.4	21.3	14.8	14.7	27.6	31.3	45.8	36.5	48.1	37.2	39.4	30.3	39.0	22.5	34.5	30.5	30.4	7.0	21.9	70.9	33.5	33.8	17.2	31.0	67.9	7.4	11.3	2.5	8.3	7.9	7.7	13.9	3.7	12.1	9.2
CLIC2	XAP121	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 62.3;vagina: 66.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 36.5;K-562: 19.7;Karpas-707: 18.2;RPMI-8226: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 24.5;monocytes: 9.5"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"			290000	"Plasma membrane"	Nucleoplasm	"HPA047381: , HPA060101: "	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	26.5	3.7	3.8	7.5	6.1	3.4	24.1	2.6	4.8	15.5	6.8	0.6	3.3	4.0	11.3	10.5	10.4	6.5	9.8	9.4	3.7	3.4	5.4	6.3	31.0	15.6	7.5	1.4	12.5	2.6	2.0	7.8	4.5	6.8	9.1	6.9	3.0	5.4	3.2	10.3	5.2	7.3	10.2	5.2	32.1	4.7	5.6	4.3	6.9	62.3	8.7	12.4	14.0	66.1	0.0	24.5	0.6	9.5	1.1	0.1	1.0	0.2	0.0	0.4	0.3	0.3	2.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	36.5	0.2	5.1	0.1	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	19.7	18.2	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	31.1	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.4	0.0	1.7	0.5	0.7	0.3	1.1	1.6	0.0	0.9	1.1	0.6	0.0	1.8	0.1	0.0	9.5	0.1	0.0	0.0	0.1	24.5	0.0	0.0	0.0	0.6	1.1	6.5	2.5	0.0	1.0	3.8	6.1	2.6	4.8	3.7	3.4	7.5	1.4	6.8	4.3
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994635-136996803	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 163.5;esophagus: 74.1;placenta: 103.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 66.8;MCF7: 30.4;SK-BR-3: 12.7;T-47d: 29.0;TIME: 23.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	10	"plasmacytoid DC: 163.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 163.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA005963	Enhanced		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (7.74e-4)"	1.9	0.2	0.1	1.6	0.2	1.2	1.1	0.0	0.5	17.6	0.5	0.1	0.0	0.2	1.3	6.8	74.1	0.6	0.8	1.8	0.2	0.1	0.4	0.2	27.3	1.4	0.2	0.2	0.4	0.2	0.1	0.5	103.5	0.8	1.0	0.1	1.3	8.2	0.6	0.2	25.0	0.8	0.3	0.6	2.2	2.9	0.6	0.0	15.7	55.5	53.4	43.1	0.8	28.1	0.2	163.5	0.6	0.1	17.1	15.8	10.2	5.4	0.0	0.0	0.0	0.1	0.3	66.8	0.5	0.2	0.1	0.0	0.3	2.7	0.0	4.4	4.7	2.4	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.1	12.7	0.0	29.0	0.0	23.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	15.8	0.1	6.9	0.1	2.2	9.6	0.6	0.2	0.5	8.6	0.6	17.1	0.1	163.5	0.7	10.2	0.1	0.2	0.0	0.5	0.2	0.1	0.2	0.2	0.8	0.0
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745357-24844324	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 13.0;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	Cytosol			20000000	Cytosol		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavourable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favourable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	45.3	16.9	20.6	26.3	26.7	7.6	35.4	4.5	20.0	52.1	46.4	41.6	23.2	8.9	68.0	27.4	42.0	34.7	29.7	77.4	23.5	16.5	71.2	19.9	40.8	12.9	28.2	13.0	37.6	13.5	10.8	6.1	53.7	22.3	51.9	19.1	29.1	18.2	45.2	20.9	12.6	19.3	87.2	33.6	15.1	33.4	20.9	26.4	7.1	17.7	11.2	15.0	106.7	42.3	13.0	5.3	2.2	5.1	0.0	0.3	3.3	26.0	2.9	26.4	20.9	36.0	78.3	15.2	70.9	66.4	30.0	36.4	5.8	13.7	17.1	41.3	91.5	9.4	18.0	17.5	75.7	4.3	8.5	6.5	8.1	10.0	50.3	2.2	0.7	36.2	30.3	42.9	43.4	49.6	5.0	16.6	85.9	4.3	4.1	3.2	25.8	13.5	10.3	31.1	6.3	30.7	6.7	4.9	12.7	18.7	8.0	51.7	7.1	13.2	77.4	55.2	21.2	24.4	27.1	10.0	13.8	13.9	40.7	18.4	16.7	0.7	5.1	2.2	0.3	4.1	0.0	13.0	0.3	0.2	5.3	11.9	0.2	0.2	1.1	0.0	3.3	1.6	0.0	3.3	20.6	26.7	4.5	15.8	23.5	16.5	28.2	13.0	22.3	26.4
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9"	"Group enriched"	"Detected in some"	8	"CAPAN-2: 13.3;EFO-21: 9.4;HDLM-2: 4.9;REH: 11.4;U-266/70: 12.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.8"	"Lineage enriched"	"Detected in single"	23	"T-cells: 8.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"			1000000	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	7.4	0.6	0.8	3.2	1.5	0.0	2.3	0.6	1.1	6.0	10.2	0.3	0.4	5.6	0.8	2.5	2.2	1.2	2.1	65.6	0.9	1.2	17.5	0.5	32.8	0.4	1.1	1.4	0.7	0.7	0.4	1.3	22.0	0.8	0.9	7.5	7.8	2.0	0.4	99.9	0.7	46.2	1.4	0.9	16.1	0.9	1.0	0.0	0.2	4.8	18.8	1.5	1.0	4.3	0.3	0.0	0.0	0.0	0.3	8.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.3	0.0	9.4	0.0	0.3	0.0	0.1	0.0	4.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	11.4	0.3	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	8.8	0.3	3.6	2.2	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	1.6	0.8	0.8	1.5	0.6	1.1	0.9	1.2	1.1	1.4	0.8	0.0
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859175	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 95.0;eosinophil: 27.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 95.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles			340000	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (6.77e-4)"	"unprognostic (3.56e-1)"	22.0	23.3	12.6	27.1	18.8	38.1	18.8	13.6	14.7	22.0	27.9	10.0	43.8	28.8	19.1	30.3	56.4	17.1	40.3	23.4	14.0	12.7	40.8	48.6	22.3	19.2	11.7	11.7	20.1	25.3	47.9	25.9	30.1	14.3	21.5	23.7	11.3	39.9	47.1	38.7	26.0	34.6	30.9	13.0	19.0	29.4	12.1	13.0	23.6	30.3	23.3	32.8	37.1	33.8	7.8	9.9	95.0	7.8	8.8	12.7	7.5	22.7	32.9	23.5	21.8	32.7	27.6	33.7	32.1	33.3	31.8	44.9	45.8	36.0	42.9	36.9	30.5	34.4	31.8	37.1	45.4	20.2	25.7	28.6	29.6	22.9	33.4	39.0	38.8	20.5	27.9	35.6	40.2	29.7	24.4	23.9	25.5	20.0	30.6	21.7	24.6	34.1	27.6	35.2	36.2	31.8	41.0	20.7	22.5	23.2	40.2	31.6	27.7	27.6	29.8	27.8	20.6	25.3	31.4	27.9	26.5	55.0	22.5	44.7	24.3	95.0	7.4	27.6	7.4	7.8	12.7	7.8	7.1	7.3	9.9	7.0	6.2	6.6	2.8	8.8	7.8	7.8	10.1	7.5	12.6	18.8	13.6	14.7	14.0	12.7	11.7	11.7	14.3	13.0
CLIP1	"CLIP, CLIP-170, CLIP170, CYLN1, RSN"	ENSG00000130779	"CAP-Gly domain containing linker protein 1"	P30622	12	122271432-122422632	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004399, HPA026678"	Approved		Supported	"Microtubule ends,Cytosol"			7700	"Microtubule ends, Cytosol"		"CAB004399: AB_671001, HPA026678: AB_1846954"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.52e-3)"	14.4	12.6	9.8	9.1	10.9	6.4	11.7	44.5	11.5	11.6	19.5	4.3	13.9	5.7	14.3	10.1	24.8	7.5	7.7	11.8	9.3	7.5	10.0	15.2	10.0	5.8	6.5	9.5	6.3	9.1	37.8	10.9	36.5	8.7	13.2	7.1	6.7	11.8	15.1	96.5	16.8	9.1	31.1	7.2	5.9	9.6	6.1	6.9	3.7	24.1	25.9	10.1	22.2	16.6	5.3	5.4	18.2	10.6	3.9	7.2	3.7	15.3	19.4	12.0	12.1	10.3	15.9	20.9	21.9	20.9	14.9	9.3	9.0	7.6	6.9	14.8	28.4	19.7	7.6	9.0	16.9	28.9	5.5	2.3	12.9	9.5	20.5	7.9	12.7	10.5	31.0	17.1	25.9	14.9	8.6	4.7	14.9	8.9	4.9	2.8	4.5	17.2	4.6	9.3	3.4	13.4	17.6	4.6	2.9	47.0	11.5	19.2	9.9	4.7	28.8	11.3	12.2	26.5	14.3	5.3	4.1	4.1	19.4	4.0	7.8	3.6	6.5	5.2	7.2	10.6	5.4	5.3	6.7	6.5	5.4	3.6	5.0	3.7	18.2	3.9	8.6	3.5	5.8	3.7	9.8	10.9	44.5	11.5	9.3	7.5	6.5	9.5	8.7	6.9
CLIP4	"FLJ21069, RSNL2"	ENSG00000115295	"CAP-Gly domain containing linker protein family member 4"	Q8N3C7	2	29097705-29189643	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 29.9;hTERT-HME1: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043366, HPA056246"	Uncertain		Enhanced	Vesicles				Vesicles		"HPA043366: AB_10963051, HPA056246: "	"unprognostic (1.97e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.62e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (3.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-2)"	16.8	9.7	12.1	8.6	19.5	2.0	18.8	12.7	19.7	8.3	13.4	17.3	7.2	4.8	13.1	8.8	22.1	12.5	12.7	26.6	13.7	12.1	7.7	4.6	17.2	8.7	19.8	12.8	22.3	6.2	12.1	22.9	39.2	15.8	16.5	7.1	15.7	10.4	15.2	46.0	28.0	7.3	23.5	18.4	9.1	8.1	15.2	14.4	7.1	31.1	16.8	9.8	19.6	13.0	1.1	1.8	1.3	17.5	3.9	9.8	3.7	28.7	8.0	1.2	4.4	11.8	17.8	0.0	11.4	19.6	6.4	7.4	0.2	19.0	3.6	5.8	19.6	11.9	1.3	8.8	9.2	6.6	1.9	0.0	10.1	0.4	29.9	0.0	5.9	12.4	22.6	8.5	31.0	4.4	0.1	11.4	9.7	0.2	2.7	1.2	0.3	1.8	0.0	7.3	0.5	11.8	5.1	1.9	5.0	9.9	4.0	10.3	0.0	1.7	14.0	1.5	11.7	5.0	4.9	5.9	0.0	0.0	7.0	0.0	4.6	1.3	4.6	0.1	6.3	10.7	9.8	1.1	4.8	6.5	1.8	0.4	5.5	5.4	0.9	3.9	17.5	0.0	1.7	3.7	12.1	19.5	12.7	19.7	13.7	12.1	19.8	12.8	15.8	14.4
CLK1		ENSG00000013441	"CDC like kinase 1"	P49759	2	200853009-200864744	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: "	"unprognostic (9.79e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.19e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.18e-1)"	"prognostic favourable (2.28e-4)"	26.3	55.1	27.8	30.5	43.4	97.6	40.2	40.1	40.7	42.2	23.0	19.9	39.1	12.9	29.1	34.5	26.3	19.1	35.8	26.7	31.0	21.9	21.8	35.3	28.2	30.1	56.0	23.1	48.1	20.9	36.6	41.5	40.0	34.4	34.3	16.5	13.7	25.6	37.1	27.3	32.1	14.9	36.8	55.2	32.4	15.1	12.4	52.6	25.0	30.4	20.2	25.6	51.2	71.8	13.2	9.8	26.2	6.2	6.5	14.4	7.4	8.1	6.1	10.3	3.1	11.7	12.9	8.1	8.8	12.6	9.0	12.0	11.4	5.3	2.8	6.0	5.5	8.8	13.0	4.1	18.5	12.4	11.4	8.3	15.5	14.1	7.0	8.7	14.2	5.9	18.6	11.3	19.9	5.2	10.0	36.8	12.8	5.5	10.2	26.4	6.5	14.0	10.4	12.2	14.6	6.2	5.3	10.4	8.2	7.7	2.9	12.8	2.4	6.0	8.0	10.1	6.9	9.7	9.7	21.7	9.0	6.5	6.5	7.1	6.8	26.2	6.2	13.3	13.6	4.4	13.1	13.2	12.8	12.1	4.1	10.1	14.4	11.4	12.7	6.5	4.2	9.8	13.0	7.4	27.8	43.4	40.1	40.7	31.0	21.9	56.0	23.1	34.4	52.6
CLK2	clk2	ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA055366: , HPA059507: "	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (5.43e-4)"	15.3	16.6	14.6	15.0	19.0	12.9	17.1	33.1	20.2	22.3	18.0	18.7	18.1	14.5	22.6	19.9	15.5	18.2	13.9	11.8	17.1	7.3	17.3	18.2	14.7	22.2	16.9	16.9	24.7	15.9	29.2	21.6	19.2	13.5	22.1	13.5	16.1	16.4	18.2	10.4	21.4	15.6	17.0	13.5	27.0	13.7	13.7	20.3	18.1	22.9	8.0	22.2	16.7	20.1	2.8	1.9	4.8	1.7	0.7	4.1	1.1	6.0	5.2	18.9	5.8	9.5	5.1	16.1	5.4	6.6	4.2	4.2	5.5	4.3	13.1	7.5	3.7	8.7	9.4	7.0	4.0	9.5	7.4	10.4	5.4	7.0	8.2	12.9	10.5	4.1	6.4	6.1	12.3	7.3	14.6	9.1	6.3	10.4	8.8	7.7	12.3	7.4	9.8	11.4	14.1	10.6	13.5	9.0	12.8	2.0	6.5	5.0	9.9	15.9	4.8	2.6	6.9	4.7	4.5	17.4	14.8	11.9	5.1	9.3	2.9	4.8	1.7	3.4	2.0	0.8	2.9	2.8	3.4	1.8	1.8	2.4	3.4	4.1	2.1	0.7	0.8	1.9	1.7	1.1	14.6	19.0	33.1	20.2	17.1	7.3	16.9	16.9	13.5	20.3
CLK3	clk3	ENSG00000179335	"CDC like kinase 3"	P49761	15	74598500-74645414	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"				"Nucleoplasm, Intermediate filaments"		"HPA046817: AB_10964124"	"unprognostic (4.10e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavourable (2.05e-6)"	"unprognostic (1.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.14e-3)"	"prognostic unfavourable (5.92e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-2)"	20.9	17.2	15.7	24.7	22.5	62.7	31.1	23.4	18.8	24.9	24.6	23.1	16.4	18.6	24.1	17.7	25.3	17.3	21.2	16.4	17.8	13.5	17.2	16.0	19.6	21.9	29.3	14.5	23.7	21.8	19.0	19.9	27.9	16.7	20.6	14.4	19.9	24.8	20.9	28.4	24.1	20.7	19.8	19.2	23.8	19.6	31.5	23.3	28.8	21.0	12.0	23.7	23.2	19.8	38.9	36.0	60.7	46.0	43.6	43.4	39.7	22.3	14.2	18.8	10.5	24.2	18.5	14.8	15.3	24.2	21.9	26.9	19.2	14.8	20.4	11.3	13.6	15.8	35.0	14.7	14.3	28.9	19.1	25.0	21.1	13.3	38.5	6.7	19.4	23.2	29.3	28.7	24.0	23.9	12.1	14.9	12.7	15.8	19.8	22.7	12.0	10.0	16.1	9.0	13.3	17.0	16.2	10.6	12.4	12.2	13.6	13.5	12.9	13.5	11.0	13.0	10.0	8.1	20.0	24.4	19.6	16.7	11.4	33.0	16.3	32.9	34.4	45.0	38.5	37.4	37.4	37.7	41.1	39.7	31.9	38.9	42.1	40.1	60.7	43.6	46.0	36.0	43.4	39.7	15.7	22.5	23.4	18.8	17.8	13.5	29.3	14.5	16.7	23.3
CLNS1A	"CLCI, ICln"	ENSG00000074201	"Chloride nucleotide-sensitive channel 1A"	P54105	11	77514936-77637805	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017840, HPA031707, HPA031708, HPA032045"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Cytosol"	Microtubules	"CAB017840: , HPA031707: , HPA031708: , HPA032045: "	"unprognostic (1.30e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.12e-3)"	"unprognostic (5.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	22.6	44.7	43.0	31.3	37.3	27.8	36.4	24.5	45.6	30.0	31.9	41.8	26.2	22.1	29.3	47.4	41.5	34.5	29.9	33.2	37.2	39.5	26.8	90.9	20.8	41.2	45.3	31.2	49.2	44.9	26.5	28.9	29.0	38.5	28.7	35.7	29.6	28.2	27.4	43.1	24.4	26.3	26.1	48.5	32.5	28.5	21.7	31.7	47.0	40.5	36.8	45.1	31.9	28.8	33.4	45.9	12.8	34.1	31.8	32.7	30.6	24.4	24.1	40.3	29.9	30.2	43.4	16.3	21.6	33.4	35.3	31.9	58.9	35.1	55.3	36.0	26.3	29.8	48.7	44.9	43.3	30.9	29.7	54.3	30.4	33.9	25.4	80.2	25.2	34.8	52.5	31.1	59.1	40.0	71.2	17.1	34.6	36.4	52.7	65.4	38.0	45.3	28.5	78.4	59.3	25.5	34.4	41.1	46.8	29.1	33.1	20.0	44.9	35.1	26.3	26.4	32.3	51.4	20.8	34.4	47.9	59.3	10.4	30.2	21.1	12.8	33.1	12.2	21.0	34.1	24.0	32.1	26.8	23.1	45.9	33.4	32.7	27.5	2.3	31.8	28.7	28.2	23.0	30.6	43.0	37.3	24.5	45.6	37.2	39.5	45.3	31.2	38.5	31.7
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55547138	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	9.3	9.2	7.8	5.8	11.7	1.7	8.4	16.2	14.3	12.5	9.5	5.2	9.2	7.1	10.5	8.4	13.9	8.1	6.7	10.5	7.9	7.9	12.4	9.1	8.2	9.4	7.0	9.8	11.7	8.6	18.7	21.9	8.5	8.4	9.7	8.4	5.6	8.2	9.2	16.1	9.4	12.6	13.8	8.3	9.1	9.6	18.5	5.0	4.0	14.7	5.9	5.2	8.4	17.1	2.5	3.6	0.6	3.0	2.9	4.7	1.4	13.4	5.9	5.3	8.3	8.0	8.1	2.6	13.9	11.4	9.7	9.0	3.7	10.7	3.6	7.2	16.1	11.3	6.8	10.8	16.5	4.4	2.4	2.9	6.2	4.6	7.1	4.7	3.4	4.7	10.7	13.4	13.2	9.1	6.6	7.4	14.6	7.4	2.6	2.6	3.8	6.8	1.7	6.1	2.4	7.5	7.3	5.2	4.7	10.0	12.4	6.3	4.2	2.6	12.5	13.2	14.1	4.3	18.7	6.7	4.8	2.3	11.7	4.2	10.4	0.0	3.0	0.6	2.8	3.0	4.7	1.4	3.2	2.5	3.6	2.5	1.9	2.4	0.6	2.9	2.7	2.1	3.1	1.4	7.8	11.7	16.2	14.3	7.9	7.9	7.0	9.8	8.4	5.0
CLP1	"hClp1, HEAB"	ENSG00000172409	"Cleavage and polyadenylation factor I subunit 1"	Q92989	11	57648992-57661868	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057770	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA057770: "	"unprognostic (1.33e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.07e-1)"	10.8	11.7	7.0	11.2	8.8	23.5	9.6	7.2	10.9	8.5	9.3	5.6	7.6	9.0	12.0	10.0	13.6	10.1	6.2	8.1	6.0	4.5	9.9	12.8	8.7	9.9	6.5	5.1	7.3	11.8	7.2	6.8	17.3	6.1	10.5	9.2	5.6	10.3	8.1	16.7	11.8	11.7	11.2	5.0	15.4	11.5	11.3	6.5	15.4	11.8	10.8	13.2	8.8	6.9	16.2	19.0	23.7	19.1	12.8	20.9	11.6	14.0	14.1	14.1	14.9	15.6	10.4	13.5	13.8	15.3	20.9	17.6	13.0	12.7	23.3	16.9	11.5	17.3	19.5	22.3	23.3	15.8	11.4	12.6	10.1	14.7	11.9	19.3	15.3	11.5	15.9	17.7	12.7	18.9	20.4	8.1	16.8	10.0	13.9	22.0	21.6	14.8	15.0	22.8	24.7	11.2	10.0	7.7	15.1	11.7	12.1	18.9	22.5	14.8	13.1	11.3	15.2	19.2	11.1	13.0	16.5	25.4	12.3	10.4	11.9	23.7	19.1	19.9	17.6	16.0	20.9	16.2	15.8	17.8	19.0	14.1	18.2	16.6	22.3	12.8	15.7	11.0	16.0	11.6	7.0	8.8	7.2	10.9	6.0	4.5	6.5	5.1	6.1	6.5
CLPP		ENSG00000125656	"Caseinolytic mitochondrial matrix peptidase proteolytic subunit"	Q16740	19	6361452-6368910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010649	Supported		Supported	Mitochondria				Mitochondria		"HPA010649: AB_1078538"	"unprognostic (2.28e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.17e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (6.50e-4)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.86e-3)"	22.1	27.3	18.4	22.5	18.8	20.1	19.9	16.6	20.9	16.1	23.2	17.9	22.2	25.4	16.9	15.1	26.6	15.3	19.2	28.9	17.4	16.7	28.5	64.7	15.5	35.5	19.0	15.2	23.7	32.7	11.6	18.5	18.4	13.6	19.1	14.1	18.6	26.3	23.4	73.1	17.8	26.0	14.8	16.7	21.2	21.3	21.1	11.4	54.8	27.0	25.1	25.3	20.7	23.2	29.7	37.5	14.9	20.0	27.6	46.3	32.9	31.6	21.1	15.4	28.1	9.7	13.5	16.0	18.8	13.8	26.8	24.0	16.9	11.6	31.9	29.3	15.0	19.8	15.2	23.7	10.1	33.1	47.9	23.5	18.6	25.0	26.3	21.2	31.1	17.1	17.4	18.6	20.8	26.0	23.2	43.2	17.5	37.0	36.3	22.2	22.2	49.4	25.6	18.6	48.3	19.9	17.7	25.5	24.4	11.9	29.1	27.6	15.0	30.4	18.1	17.7	16.4	41.6	35.4	55.6	46.4	30.7	24.3	29.9	28.1	5.5	20.0	10.5	28.0	17.7	33.2	28.3	39.9	34.5	24.1	29.7	35.2	34.1	14.9	27.6	12.1	37.5	46.3	32.9	18.4	18.8	16.6	20.9	17.4	16.7	19.0	15.2	13.6	11.4
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit"	O76031	15	65148219-65185342	"Predicted intracellular proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"			Mitochondria	"Nucleoplasm, Cytosol"	"HPA040262: AB_10793961, HPA048199: "	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favourable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	10.4	12.8	11.3	8.9	12.7	7.7	10.2	10.9	10.7	11.7	13.4	11.2	4.7	9.3	9.8	10.3	15.5	8.9	9.6	15.9	10.7	9.2	16.8	50.9	9.4	8.8	12.8	8.1	10.8	10.6	11.0	6.3	10.6	9.8	9.7	8.9	7.4	8.9	7.1	25.8	15.6	12.6	10.8	9.7	9.7	9.9	9.3	12.6	17.8	12.9	14.7	10.2	12.5	9.5	7.7	9.8	11.4	7.1	8.2	9.2	4.4	5.2	9.0	7.8	9.9	8.4	10.8	8.5	6.0	6.8	6.6	7.0	8.9	7.4	16.3	5.1	8.1	11.3	28.7	8.0	7.1	6.4	5.2	12.2	8.7	11.3	12.0	15.6	7.1	12.8	11.0	6.1	11.7	8.4	11.2	5.8	7.7	6.6	7.3	13.8	8.8	4.0	14.5	9.4	16.8	12.5	12.2	6.8	5.5	8.1	13.1	8.8	5.9	13.2	7.4	6.7	5.9	5.4	5.6	6.2	9.4	8.6	6.6	19.8	5.2	3.5	7.1	10.3	7.6	5.7	7.0	7.7	6.7	5.6	6.4	7.2	9.2	7.3	11.4	8.2	5.1	9.8	5.7	4.4	11.3	12.7	10.9	10.7	10.7	9.2	12.8	8.1	9.8	12.6
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769967	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	12	"basal ganglia: 7.0"	"Low region specificity"	"Detected in all"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA026305: , HPA026312: "	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favourable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	1.5	0.8	0.9	11.5	1.0	12.6	1.7	0.3	3.6	0.9	2.1	0.1	0.0	1.0	0.5	0.9	2.9	0.5	2.8	0.6	1.1	0.6	1.0	0.7	1.9	6.0	0.6	0.1	0.5	0.5	0.3	0.4	4.3	0.7	0.5	2.7	1.9	1.0	0.0	0.4	1.2	3.4	1.0	0.8	4.4	1.1	10.0	0.5	30.4	0.5	4.2	6.6	0.9	1.2	0.9	0.9	3.4	1.1	1.3	1.6	1.1	8.5	7.1	15.7	8.2	1.1	2.0	5.9	17.7	5.0	13.0	17.4	11.4	8.0	18.4	5.8	4.7	8.7	15.2	6.1	20.4	12.6	6.9	25.9	15.7	5.0	0.0	21.2	15.3	0.4	0.2	22.4	1.6	7.0	17.4	12.8	12.4	5.6	22.2	4.8	14.8	5.1	14.2	23.7	5.5	2.7	14.3	5.8	6.8	15.4	4.7	3.1	4.1	8.3	5.0	18.7	14.2	11.5	19.7	4.6	11.3	19.4	5.9	15.2	15.1	1.6	1.1	1.1	1.6	0.5	0.5	0.4	1.0	0.8	0.9	0.9	0.4	0.8	3.4	1.3	0.7	0.8	1.3	1.1	0.9	1.0	0.3	3.6	1.1	0.6	0.6	0.1	0.7	0.5
CLTA	Lca	ENSG00000122705	"Clathrin light chain A"	P09496	9	36190856-36304781	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002665, HPA050918, HPA054667"	Enhanced		Enhanced	Vesicles,Endosomes,Lysosomes			2100000	"Vesicles, Endosomes, Lysosomes"		"CAB002665: , HPA050918: , HPA054667: "	"prognostic favourable (5.64e-4)"	"unprognostic (7.62e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (9.46e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (1.01e-4)"	"unprognostic (4.98e-2)"	60.0	64.8	65.0	46.9	60.8	35.4	55.5	68.6	86.3	58.1	71.4	55.5	35.8	65.6	58.1	64.5	63.8	65.2	56.4	31.4	62.6	62.0	72.2	60.0	48.7	53.1	67.1	67.0	78.1	52.8	42.8	47.0	78.2	67.9	53.3	67.6	48.1	58.8	47.6	33.2	47.5	58.3	52.4	71.5	59.6	56.3	48.3	41.9	58.2	77.1	49.4	54.5	46.2	60.5	31.3	57.3	29.1	59.5	22.6	40.5	45.9	60.3	48.5	36.6	27.8	53.5	53.9	59.0	62.7	47.8	50.5	59.5	36.3	27.2	45.7	34.8	41.7	25.8	45.8	43.6	46.5	30.9	37.0	35.0	49.4	37.1	71.9	37.1	32.5	59.2	48.4	57.9	46.0	62.3	30.4	24.1	76.0	21.0	33.3	47.3	58.4	69.5	32.2	24.3	25.9	68.2	43.3	28.4	47.8	26.2	30.8	51.5	27.8	45.9	79.6	40.8	45.9	46.6	65.2	16.2	38.0	48.5	50.3	52.2	35.9	29.1	56.6	28.0	26.5	59.5	27.8	31.3	28.9	27.2	57.3	30.6	26.4	22.8	22.2	22.6	45.6	49.5	40.5	45.9	65.0	60.8	68.6	86.3	62.6	62.0	67.1	67.0	67.9	41.9
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392455-176416569	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 103.7;MCF7: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"			350000	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	20.4	24.1	29.7	18.7	26.7	13.5	16.0	27.5	47.9	27.7	34.7	14.2	11.4	35.4	15.0	15.7	94.2	12.7	28.4	65.7	26.4	26.9	20.3	15.0	15.6	12.2	25.9	22.7	24.3	19.7	17.9	19.8	61.2	28.7	16.8	18.1	19.4	22.2	19.3	93.7	81.8	41.1	27.1	15.4	14.2	39.6	9.9	10.1	14.3	17.2	55.4	31.2	26.1	45.3	4.3	9.9	28.0	9.9	7.4	11.6	3.6	32.8	15.8	4.5	19.1	10.1	7.6	36.8	42.4	16.5	26.9	19.3	20.3	15.4	7.2	25.0	19.0	31.4	7.6	103.7	10.5	49.2	14.1	4.8	23.4	12.5	15.9	7.6	12.9	8.0	36.1	14.7	17.4	12.6	9.2	18.5	14.8	92.2	12.0	11.6	3.6	23.5	13.1	7.9	23.6	14.2	13.4	19.3	6.6	20.1	22.2	14.4	9.0	14.8	27.2	9.7	14.5	17.6	23.9	14.7	10.1	9.7	7.8	16.3	11.0	2.8	9.9	28.0	7.2	7.5	3.7	3.1	6.4	7.0	9.9	4.3	5.2	5.5	18.7	7.4	9.7	8.0	11.6	3.6	29.7	26.7	27.5	47.9	26.4	26.9	25.9	22.7	28.7	10.1
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"			51000000	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: "	"unprognostic (1.56e-1)"	"prognostic unfavourable (7.35e-4)"	"prognostic favourable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavourable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.02e-4)"	39.5	45.7	47.4	35.1	57.6	30.7	57.9	59.1	83.6	38.1	45.0	25.1	47.7	27.9	38.7	52.3	32.1	30.9	34.1	39.9	47.1	53.7	48.6	46.0	46.5	60.7	53.9	59.3	29.8	23.3	96.1	30.0	51.5	57.0	38.9	48.9	22.7	28.6	54.4	44.2	30.5	27.7	45.8	47.8	28.0	34.2	29.4	28.8	28.0	43.7	26.6	31.2	37.1	40.6	10.0	24.6	13.9	24.6	12.3	15.6	13.1	46.9	71.1	35.1	34.7	59.3	48.3	40.1	50.5	53.3	45.3	47.3	43.5	28.9	32.7	58.0	71.7	31.0	52.2	42.0	60.5	35.1	28.1	53.6	45.0	67.5	45.2	36.6	31.0	45.7	25.7	68.8	44.4	50.0	53.3	46.3	70.5	83.7	21.7	10.9	30.2	41.5	19.3	58.8	39.6	50.7	66.7	31.5	37.5	31.3	20.5	29.9	48.7	23.1	63.9	83.1	49.6	39.6	51.7	36.5	51.2	30.2	60.9	24.8	50.7	10.5	20.9	13.9	12.7	24.6	15.6	10.0	11.7	13.7	24.6	9.1	10.0	11.0	13.4	12.3	20.7	16.1	14.5	13.1	47.4	57.6	59.1	83.6	47.1	53.7	53.9	59.3	57.0	28.8
CLUAP1	"CFAP22, FAP22, FLJ13297, IFT38, KIAA0643"	ENSG00000103351	"Clusterin associated protein 1"	Q96AJ1	16	3500924-3539048	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036976, HPA044191"	Uncertain		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA036976: AB_10602209, HPA044191: "	"unprognostic (1.78e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.21e-1)"	"prognostic favourable (3.01e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.12e-2)"	8.3	10.4	12.3	6.8	22.3	3.3	12.7	13.6	18.8	19.2	11.7	12.1	15.7	4.0	23.0	14.7	10.2	27.6	9.5	9.4	11.4	12.5	16.5	6.8	10.5	6.7	11.9	17.8	22.7	10.7	30.5	22.1	9.3	15.8	15.4	8.9	12.0	10.0	18.3	8.8	6.0	6.0	17.6	11.7	5.7	8.8	34.6	10.3	8.2	19.5	6.2	5.2	12.7	9.1	4.7	4.5	2.7	2.7	5.5	19.8	4.1	8.2	10.0	11.5	15.4	17.5	18.2	6.0	10.5	14.1	17.1	12.8	2.7	16.9	4.0	9.2	17.0	8.7	7.5	12.3	14.7	3.3	7.1	3.7	5.7	5.4	20.5	6.6	4.1	11.7	13.7	16.0	15.9	9.3	10.8	0.6	12.6	9.9	6.1	7.3	11.9	5.8	13.7	8.0	8.1	25.7	2.5	12.8	11.0	6.2	4.9	7.6	10.2	15.3	6.1	11.7	7.9	9.0	8.1	6.9	5.6	1.1	4.5	3.9	8.1	2.7	2.5	0.7	4.5	2.7	8.5	4.7	13.0	7.7	4.5	4.0	19.8	13.4	1.0	5.5	1.6	4.5	6.7	4.1	12.3	22.3	13.6	18.8	11.4	12.5	11.9	17.8	15.8	10.3
CLUH	"CLU1, KIAA0664"	ENSG00000132361	"Clustered mitochondria homolog"	O75153	17	2689386-2712663	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.2"	"Cell line enhanced"	"Detected in all"		"CACO-2: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031505, HPA044346"	Uncertain		Supported	"Nuclear bodies,Vesicles"				Vesicles	"Nuclear bodies"	"HPA031505: , HPA044346: AB_10962153"	"unprognostic (3.48e-2)"	"unprognostic (3.97e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.64e-2)"	"unprognostic (5.11e-2)"	"prognostic favourable (1.92e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.26e-2)"	14.1	21.0	9.6	10.4	12.4	7.8	10.2	16.0	20.9	7.6	17.5	10.6	7.4	29.4	8.4	6.9	28.7	7.6	11.2	31.8	8.5	6.9	28.6	75.2	7.4	8.2	7.0	9.7	8.3	20.3	7.0	8.2	6.2	12.5	9.4	8.1	9.9	18.9	8.4	65.6	20.0	20.9	9.9	6.5	9.9	13.6	11.4	7.5	6.8	10.1	22.1	15.9	12.4	10.0	4.5	5.0	0.4	5.9	1.1	4.7	1.5	18.6	33.3	2.4	8.4	5.0	3.6	27.8	10.0	3.5	10.8	7.8	67.1	7.6	34.1	12.0	4.7	34.2	11.1	13.0	3.6	12.2	24.6	18.7	25.8	23.2	4.6	14.8	12.2	6.0	7.8	12.2	6.3	5.5	22.8	10.3	3.2	20.1	16.6	14.5	7.6	19.2	27.2	10.4	18.0	6.8	28.9	11.2	8.9	11.4	31.5	11.7	18.9	7.7	10.5	9.0	12.4	24.6	21.9	5.2	5.9	12.9	9.3	19.8	10.6	0.0	4.3	0.0	3.4	5.9	2.6	4.1	2.0	1.8	4.4	4.5	4.7	4.1	0.4	1.1	3.6	5.0	2.6	1.5	9.6	12.4	16.0	20.9	8.5	6.9	7.0	9.7	12.5	7.5
CMC2	"C16orf61, DC13, MGC45036"	ENSG00000103121	"C-X9-C motif containing 2"	Q9NRP2	16	80966448-81020270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006871, CAB026396"	Approved		Supported	Mitochondria				Mitochondria		"CAB026396: , HPA006871: AB_1845581"	"unprognostic (2.43e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.57e-3)"	"prognostic favourable (2.64e-5)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-1)"	8.2	17.0	31.5	8.9	30.9	25.5	15.0	18.7	28.7	7.2	11.8	22.2	8.7	12.8	6.4	11.9	12.5	5.5	11.5	42.3	28.3	27.9	24.7	29.1	9.5	13.3	30.7	16.0	5.7	19.7	19.2	11.1	11.0	23.9	15.2	11.8	7.0	10.3	9.3	32.0	6.2	13.5	10.6	27.8	9.5	13.5	28.1	20.3	9.8	10.3	13.0	11.0	11.8	7.0	21.9	25.3	20.1	17.9	24.7	34.6	10.3	21.8	31.2	23.4	14.0	7.8	7.9	13.8	22.2	10.1	19.8	10.2	21.3	15.0	10.1	16.6	10.6	15.8	15.9	12.9	26.3	14.8	19.1	15.4	22.3	22.7	12.8	12.6	26.4	6.8	7.3	23.9	13.5	17.5	36.4	13.6	19.2	41.7	19.7	41.0	13.8	18.8	24.8	12.7	12.9	15.3	11.0	19.7	11.4	33.8	12.0	25.4	23.9	11.7	10.1	18.0	25.3	17.3	22.3	14.0	30.4	56.2	13.7	16.4	20.9	14.9	16.6	20.1	17.4	16.0	16.3	21.9	22.1	17.9	17.8	18.9	15.7	17.8	7.1	24.7	17.9	25.3	34.6	10.3	31.5	30.9	18.7	28.7	28.3	27.9	30.7	16.0	23.9	20.3
CMC4	"MTCP1, MTCP1NB, p8, P8MTCP1"	ENSG00000182712	"C-X9-C motif containing 4"	P56277	X	155061622-155071362	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA045866	Approved		Supported	Mitochondria				Mitochondria		"HPA045866: AB_10964642"										"unprognostic (4.54e-3)"				"unprognostic (7.31e-2)"				11.5	9.2	13.4	9.2	12.6	6.2	26.7	7.1	8.9	11.0	11.3	6.7	13.2	9.7	9.9	13.6	12.5	8.9	8.3	49.6	10.9	10.0	12.0	21.8	15.0	26.2	13.7	5.7	11.9	34.6	7.1	11.4	6.8	11.6	10.5	6.0	7.6	14.5	12.6	21.2	8.2	11.4	15.2	15.8	8.3	8.5	7.3	7.4	5.4	14.5	10.0	7.7	12.4	8.7	11.3	10.8	11.8	7.5	12.0	9.0	4.6	19.6	5.0	3.0	6.6	8.4	8.1	4.7	3.9	5.6	5.6	9.5	3.7	3.8	13.5	10.3	4.3	6.5	4.0	5.2	4.0	14.3	10.1	2.2	3.4	4.5	8.6	4.2	3.1	7.7	8.5	5.8	7.6	4.7	2.2	5.0	5.8	7.4	5.6	7.9	1.8	14.3	4.3	7.0	8.8	6.3	1.2	6.2	5.1	5.2	5.8	6.8	4.3	2.4	5.5	8.6	5.3	5.5	5.2	20.3	20.4	36.0	8.1	9.7	5.6	1.1	7.5	11.8	9.0	4.2	8.7	11.0	7.1	8.3	10.8	11.3	2.2	5.9	0.8	12.0	1.5	2.1	8.2	4.6	13.4	12.6	7.1	8.9	10.9	10.0	13.7	5.7	11.6	7.4
CMIP		ENSG00000153815	"C-Maf inducing protein"	Q8IY22	16	81445170-81711762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054424, HPA066710"	Approved		Supported	Nucleoplasm,Cytosol			360000	"Nucleoplasm, Cytosol"		"HPA054424: AB_2682484, HPA066710: AB_2685708"	"unprognostic (6.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.02e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavourable (9.47e-7)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (1.59e-1)"	19.1	19.7	34.3	25.6	27.9	19.6	15.4	13.1	46.5	28.5	26.5	13.0	7.1	33.5	15.5	14.1	26.5	20.3	27.8	9.3	28.1	35.7	15.8	11.4	18.8	17.2	19.4	30.6	17.7	16.5	8.9	26.4	23.8	19.4	13.4	20.0	7.8	15.5	14.0	6.3	24.5	40.5	19.1	15.7	18.0	28.2	11.0	13.2	20.8	11.3	10.2	16.1	22.2	37.2	0.8	0.5	5.7	1.7	0.5	1.0	0.9	11.2	37.8	7.5	3.8	3.9	3.2	15.3	8.2	5.6	5.2	2.3	12.7	23.2	5.0	7.0	6.8	11.6	4.8	27.3	5.0	3.2	3.5	24.3	7.1	22.1	3.9	7.4	52.7	3.1	11.6	9.6	12.4	14.3	21.2	4.4	3.1	11.3	13.0	9.3	5.9	8.0	23.6	2.4	4.9	6.5	11.2	39.3	7.9	19.1	7.1	2.4	5.5	10.0	9.8	8.3	8.9	8.0	7.4	5.6	4.3	22.0	9.8	8.8	3.3	4.8	1.7	2.1	1.0	1.2	0.5	0.1	0.2	0.3	0.5	0.8	0.1	0.5	5.7	0.5	0.3	0.5	0.2	0.9	34.3	27.9	13.1	33.7	28.1	35.7	19.4	30.6	19.4	13.2
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"		2100000	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	35.0	17.0	28.5	30.4	24.4	14.8	72.2	18.0	35.8	26.8	44.8	17.8	20.9	53.7	16.5	19.3	42.2	13.5	39.2	28.6	28.0	31.4	26.2	88.2	36.8	46.2	35.1	16.8	16.2	42.3	19.3	16.6	16.0	25.4	32.8	48.1	16.2	50.8	18.3	30.4	22.2	64.9	46.9	33.1	21.6	35.9	8.6	18.2	25.6	31.7	26.7	28.0	34.0	39.0	11.2	10.6	23.1	12.4	15.0	17.5	12.1	30.3	17.0	22.0	19.7	40.3	47.2	31.3	54.1	32.6	32.9	33.5	15.1	21.1	45.0	27.9	36.7	20.7	16.3	28.0	45.1	68.1	13.3	35.0	23.5	26.1	26.3	49.8	25.6	26.4	33.9	27.4	30.8	34.0	32.9	36.4	42.8	11.1	40.4	23.5	14.0	23.6	25.2	38.2	33.8	32.0	33.5	20.0	10.6	38.7	45.0	31.0	11.2	29.8	31.8	41.2	23.8	39.3	44.4	26.5	36.6	30.7	32.5	30.9	28.1	23.1	10.2	18.2	13.6	10.7	17.5	11.2	15.5	16.7	10.6	10.2	14.7	14.0	4.2	15.0	12.4	8.9	16.0	12.1	28.5	24.4	18.0	35.8	28.0	31.4	35.1	16.8	25.4	18.2
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavourable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	14.4	17.4	23.1	17.3	17.7	22.4	14.6	25.0	25.0	14.5	18.0	15.5	21.3	15.0	19.5	19.4	12.6	16.9	15.0	18.8	17.6	16.1	13.9	16.6	15.2	19.2	16.0	22.7	22.6	18.4	24.4	20.2	20.6	16.9	16.3	13.1	17.1	17.6	17.9	28.9	16.6	16.5	17.6	12.5	21.7	15.9	63.9	17.8	18.4	15.7	14.1	20.7	16.2	14.8	11.1	9.8	8.1	13.2	9.7	11.5	7.8	6.9	6.6	9.5	15.5	10.8	9.9	11.5	8.3	11.5	21.1	23.7	9.9	4.6	14.4	9.4	12.2	7.8	12.1	8.6	16.2	9.9	10.7	7.9	7.7	11.0	8.3	11.4	5.4	8.5	6.4	11.6	8.3	9.8	17.6	10.6	11.0	11.3	14.4	10.2	4.8	6.3	11.5	11.3	8.2	6.8	8.4	10.5	7.9	9.3	7.2	11.9	12.2	8.8	9.0	12.7	9.5	5.0	9.3	12.1	6.3	76.3	5.0	12.0	13.9	8.1	10.2	6.4	10.1	13.2	8.5	11.1	8.9	10.7	9.8	8.1	9.9	8.0	6.6	9.7	9.9	8.2	11.5	7.8	23.1	17.7	25.0	25.0	17.6	16.1	16.0	22.7	16.9	17.8
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129169484-129183922	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Supported	Nucleoplasm,Cytosol			43000	"Nucleoplasm, Cytosol"		"HPA063097: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	54.2	52.8	36.4	33.6	33.7	35.9	46.6	43.5	35.6	58.1	47.1	34.5	40.5	32.4	54.5	49.4	55.6	40.9	48.5	78.2	33.0	32.0	38.0	71.6	47.5	40.6	39.7	30.3	67.4	65.4	39.3	33.5	41.5	33.3	62.3	37.1	41.3	48.9	50.9	182.1	46.7	40.6	71.9	38.0	43.2	43.1	32.1	33.1	39.0	67.3	81.1	41.2	76.1	63.5	74.3	60.3	120.1	84.1	61.7	83.4	172.9	61.2	36.3	53.0	42.0	53.0	45.5	41.8	48.2	76.5	52.6	60.5	53.2	43.2	81.5	41.4	44.8	46.1	69.2	55.9	71.3	54.7	50.4	78.7	37.5	57.2	52.8	84.4	45.3	43.9	65.6	36.8	133.0	46.4	58.9	56.1	55.0	73.3	78.2	62.1	64.6	61.4	68.8	49.2	97.1	54.4	59.1	72.2	57.8	38.0	37.6	102.2	43.3	58.1	48.8	39.0	38.4	53.5	48.7	52.8	48.0	128.2	40.1	57.9	51.4	93.4	84.1	96.8	64.1	63.8	80.6	74.3	77.4	68.9	60.3	62.7	83.4	72.0	120.1	61.7	48.9	35.1	73.9	172.9	36.4	33.7	43.5	35.6	33.0	32.0	39.7	30.3	33.3	33.1
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 75.1;RPMI-8226: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol			2400000	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	19.0	11.5	31.0	19.1	36.0	6.1	16.9	10.4	33.0	39.4	37.6	45.2	27.0	51.3	12.5	35.3	20.4	38.9	25.9	11.6	31.1	26.4	89.0	66.4	22.1	23.0	36.1	24.1	11.4	27.6	15.7	13.7	28.8	27.2	34.7	22.2	14.1	16.9	32.7	7.5	11.8	71.1	10.4	39.4	39.2	27.2	6.5	32.5	10.9	43.9	11.6	21.4	28.4	12.0	29.6	49.0	12.5	44.4	31.4	23.9	30.3	10.0	13.6	9.9	9.3	12.1	7.2	41.6	10.6	10.0	14.5	14.5	7.9	10.8	12.7	13.5	11.5	15.3	15.0	20.1	10.4	19.0	5.9	12.6	6.9	12.5	17.6	24.7	19.7	10.8	15.5	12.5	22.7	12.7	13.3	75.1	9.6	11.3	13.1	11.8	14.9	8.1	14.3	11.4	96.6	57.1	42.2	10.7	5.6	8.3	59.0	14.1	24.7	10.2	13.2	15.6	13.3	3.4	7.1	14.1	57.6	17.0	10.5	18.1	13.0	7.8	30.0	12.5	21.8	44.4	23.8	28.9	17.6	20.3	49.0	29.6	19.1	20.7	4.4	31.4	43.1	43.0	23.9	30.3	31.0	36.0	10.4	33.0	31.1	26.4	36.1	24.1	27.2	32.5
CNEP1R1	"C16orf69, FLJ38101, NEP1-R1, TMEM188"	ENSG00000205423	"CTD nuclear envelope phosphatase 1 regulatory subunit 1"	Q8N9A8	16	50024410-50037088	"Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042815, HPA077906"	Uncertain		Supported	Cytosol				Cytosol		"HPA042815: AB_10794765, HPA077906: "	"unprognostic (4.11e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.37e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	15.4	12.7	14.5	16.3	15.0	25.1	17.0	19.1	17.2	10.6	11.3	12.2	4.0	10.9	13.0	17.1	17.2	10.9	13.5	14.3	12.8	12.6	12.5	12.9	14.1	19.7	17.7	11.9	12.9	13.6	11.7	17.3	18.5	14.0	10.6	16.7	14.9	12.2	10.7	10.5	13.9	12.9	13.9	12.9	21.4	11.9	22.4	14.1	12.4	8.4	10.3	18.6	12.8	12.6	5.5	9.6	28.7	18.7	6.3	9.6	7.2	7.5	7.3	8.6	9.1	17.3	16.6	12.8	15.4	11.8	14.9	9.0	7.6	10.9	8.7	11.6	12.6	12.1	7.0	7.6	19.0	6.2	8.3	4.0	4.4	11.9	11.7	5.4	12.7	12.4	12.8	9.7	7.7	10.2	5.0	5.0	18.9	2.2	10.4	13.8	6.4	9.8	13.2	11.4	8.7	10.0	5.1	6.8	8.0	14.4	5.9	5.5	5.2	6.7	13.2	14.5	11.6	13.6	5.4	8.2	7.4	10.2	8.1	5.6	11.8	7.4	12.2	8.6	9.6	15.7	8.9	5.5	7.6	7.0	9.6	4.9	7.6	8.9	28.7	6.3	18.7	3.8	7.4	7.2	14.5	15.0	19.1	17.2	12.8	12.6	17.7	11.9	14.0	14.1
CNN3		ENSG00000117519	"Calponin 3"	Q15417	1	94896949-94927278	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.7;naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	14	"B-cells: 9.7;T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009849, HPA051237"	Enhanced		Enhanced	"Actin filaments,Cytosol"			320000	"Actin filaments"	Cytosol	"CAB009849: AB_2276410, HPA051237: "	"unprognostic (8.47e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.22e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-2)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.33e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.99e-4)"	49.3	78.5	53.4	27.9	53.9	1.2	82.7	25.3	44.7	55.1	36.3	30.8	20.8	45.4	74.0	31.4	53.6	39.4	55.3	33.0	46.8	40.3	74.2	50.6	59.0	28.6	45.3	27.0	61.5	28.0	21.6	33.5	88.5	67.8	38.8	30.2	47.5	32.9	48.9	16.1	16.6	33.4	68.6	78.2	30.8	30.6	21.1	41.9	9.3	44.3	18.4	17.2	48.7	74.5	9.7	0.1	0.4	0.1	0.7	11.1	2.6	44.8	8.7	49.6	43.7	35.5	31.9	22.0	21.7	43.0	36.6	58.1	40.2	4.0	0.0	50.1	28.0	12.9	36.2	19.3	53.0	0.1	12.8	2.0	6.1	30.4	66.0	0.0	0.0	29.8	3.0	45.2	10.5	32.8	0.4	4.1	95.4	0.0	2.1	0.1	38.1	4.7	0.0	59.2	0.2	47.7	18.7	3.0	30.4	18.1	7.7	30.6	13.9	4.5	20.1	24.5	42.0	9.0	70.6	5.0	2.9	0.1	5.3	0.0	36.7	0.1	0.0	0.0	1.9	0.1	3.1	3.9	2.0	1.1	0.1	9.7	11.1	7.6	0.4	0.7	0.1	0.0	0.0	2.6	53.4	53.9	25.3	43.6	46.8	40.3	45.3	27.0	67.8	41.9
CNNM2	ACDP2	ENSG00000148842	"Cyclin and CBS domain divalent metal cation transport mediator 2"	Q9H8M5	10	102918293-103090221	"Disease related genes, Predicted membrane proteins"	"Ion transport, Transport"		"Disease mutation, Epilepsy, Mental retardation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 35.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059954, HPA071631"			Enhanced	Vesicles				Vesicles		"HPA059954: , HPA071631: "	"unprognostic (2.18e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.51e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-1)"	"prognostic favourable (2.39e-8)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.56e-1)"	5.7	19.8	9.5	6.6	13.8	13.3	5.0	16.8	15.1	6.0	11.8	12.5	8.0	6.9	6.6	5.8	3.3	8.9	9.4	4.1	7.8	10.9	15.6	7.9	6.4	4.1	10.4	8.6	8.8	6.8	35.6	10.6	14.3	9.6	5.0	11.2	7.7	5.2	7.1	3.0	7.2	7.7	6.9	9.3	4.1	5.4	8.0	12.7	3.3	10.0	1.9	3.0	6.2	5.4	1.3	1.3	2.8	0.8	4.5	1.1	0.4	4.6	7.7	3.1	8.1	7.8	3.1	8.3	2.2	9.3	3.0	3.8	5.4	4.2	1.8	3.4	3.2	6.2	6.5	4.3	2.3	3.0	11.5	2.6	4.2	11.0	4.5	1.8	3.5	4.2	6.3	3.0	10.4	1.8	4.4	10.5	1.7	7.9	2.1	2.1	4.9	4.8	5.1	3.9	2.2	2.3	2.8	4.4	5.6	5.5	1.3	5.8	10.0	3.5	1.5	4.2	6.2	2.9	3.9	11.4	12.7	3.3	7.3	6.2	1.7	1.9	0.8	0.7	1.0	0.8	0.8	1.3	0.7	0.5	0.6	0.7	0.8	0.7	2.8	4.5	0.4	1.3	1.1	0.4	9.5	13.8	16.8	15.1	7.8	10.9	10.4	8.6	9.6	12.7
CNOT1	"AD-005, CDC39, KIAA1007, NOT1, NOT1H"	ENSG00000125107	"CCR4-NOT transcription complex subunit 1"	A5YKK6	16	58519951-58629886	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046577, HPA049664"	Approved		Supported	Cytosol			210000	Cytosol		"HPA046577: , HPA049664: "	"unprognostic (1.30e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	20.4	26.5	14.9	31.5	16.5	18.2	18.8	24.2	16.8	21.3	26.6	16.7	26.6	24.3	22.2	19.1	45.6	19.0	15.4	15.5	14.2	9.0	18.8	20.9	19.6	24.1	19.0	12.3	22.6	21.8	39.6	25.4	23.2	16.1	15.9	26.6	17.3	28.3	27.2	32.6	27.4	31.4	20.0	13.6	25.8	22.7	53.9	18.1	45.1	20.2	22.6	32.6	26.9	26.0	15.4	14.6	18.8	20.9	14.6	19.2	10.6	25.9	30.6	23.3	18.7	11.3	14.5	26.8	20.6	18.0	23.7	17.6	34.6	15.7	39.6	9.9	15.7	25.6	37.4	21.0	32.1	14.7	20.4	30.8	25.2	39.5	15.4	47.4	34.5	13.9	14.4	27.5	32.4	18.4	36.0	11.6	16.0	10.6	36.6	12.4	24.1	26.6	46.7	40.3	25.1	13.4	36.6	19.3	12.5	69.9	23.7	11.7	14.2	24.8	20.6	17.4	17.3	13.1	18.0	26.5	26.7	80.4	18.4	20.2	16.1	18.3	11.6	13.0	14.6	15.9	19.2	15.4	14.1	14.6	14.6	14.2	12.6	13.5	18.8	14.6	20.9	7.4	14.8	10.6	14.9	16.5	24.2	16.8	14.2	9.0	19.0	12.3	16.1	18.1
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 51.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol				Cytosol		"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	13.6	7.8	8.6	21.5	8.2	15.3	11.0	11.1	9.2	7.8	7.3	7.0	4.6	7.5	11.4	6.3	10.2	7.1	8.3	7.5	6.0	5.7	7.7	10.8	12.7	19.2	7.6	7.3	8.8	10.8	14.6	10.0	12.3	6.7	8.4	8.9	10.3	9.9	7.4	9.1	12.2	11.5	8.4	6.9	23.4	7.9	7.3	5.6	51.3	9.1	6.2	21.1	10.7	10.3	7.5	6.1	20.2	9.3	7.4	10.0	4.4	8.6	5.6	7.1	4.7	8.4	7.3	7.0	6.9	9.1	6.2	8.4	2.2	9.7	15.0	8.8	9.6	5.6	9.1	9.6	8.3	15.0	5.1	14.0	7.8	6.3	5.3	13.9	12.3	4.7	12.4	6.9	12.8	19.6	11.7	20.1	7.1	5.9	25.7	7.0	3.2	1.8	6.3	20.0	10.7	7.1	9.8	8.7	4.2	11.9	10.9	4.8	3.5	7.2	21.3	6.0	6.6	11.3	3.8	25.8	11.0	18.7	6.5	6.1	4.4	20.2	4.7	10.2	10.0	7.0	10.0	5.3	7.5	7.8	4.5	7.5	7.3	8.5	6.7	7.4	9.3	6.1	6.0	4.4	8.6	8.2	11.1	9.2	6.0	5.7	7.6	7.3	6.7	5.6
CNOT7	CAF1	ENSG00000198791	"CCR4-NOT transcription complex subunit 7"	Q9UIV1	8	17224964-17246878	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069543			Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA069543: "	"unprognostic (1.55e-1)"	"unprognostic (4.49e-2)"	"prognostic favourable (4.99e-4)"	"unprognostic (4.61e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.52e-1)"	18.3	25.8	28.7	23.8	37.0	24.2	23.3	34.6	31.8	17.5	22.8	15.9	19.8	20.8	22.2	26.1	24.5	20.6	19.8	21.4	22.3	29.3	28.2	36.8	17.9	32.0	22.3	22.5	25.9	28.0	40.4	29.7	25.0	23.1	19.3	24.6	18.2	32.3	22.4	43.2	18.5	22.7	20.6	19.8	27.6	19.0	26.9	22.4	60.6	33.6	19.6	34.3	25.5	19.4	57.8	49.9	46.6	50.7	45.2	67.0	52.2	20.6	25.6	38.6	28.6	16.3	17.2	26.7	26.7	22.8	31.0	27.6	29.9	16.6	28.6	29.4	23.3	16.6	40.6	33.6	45.3	11.8	19.5	37.6	19.8	32.2	21.0	25.2	23.3	16.4	28.0	26.4	28.3	36.9	31.4	31.9	31.2	16.2	61.9	23.6	42.5	19.6	33.8	28.7	21.5	27.0	45.6	48.7	32.6	18.8	16.8	30.4	20.1	21.5	24.6	23.2	32.9	25.8	29.9	16.6	52.8	50.1	21.7	24.1	22.8	46.3	43.3	46.6	38.1	50.7	45.3	57.8	52.9	45.2	49.9	57.1	67.0	52.7	37.9	45.2	43.5	44.9	57.5	52.2	28.7	37.0	34.6	31.8	22.3	29.3	22.3	22.5	23.1	22.4
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966741-41977731	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 211.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 49.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol			730000	Nucleoplasm	Cytosol	"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	9.1	8.9	51.4	9.5	72.8	6.7	8.1	13.4	125.3	10.3	7.5	211.7	2.3	7.1	8.0	12.7	15.0	9.3	10.8	7.6	78.4	40.7	14.7	9.6	6.7	10.5	86.7	49.0	11.2	9.2	5.8	4.4	7.8	66.7	11.7	6.4	3.6	15.1	13.2	7.6	11.1	6.4	10.1	160.2	7.1	7.4	4.6	63.5	2.1	7.2	2.2	11.2	9.8	5.7	9.9	49.1	7.3	13.1	7.3	7.5	9.1	13.7	23.5	22.3	27.5	19.1	18.0	9.6	17.2	26.5	44.8	50.6	18.4	12.6	14.6	13.9	22.4	23.7	15.0	11.4	15.6	14.5	19.0	14.2	16.2	31.9	20.6	13.8	12.9	29.7	8.2	24.5	6.0	20.4	10.0	12.0	15.6	8.7	35.4	12.5	5.2	16.8	22.1	32.8	14.2	11.9	14.1	13.1	17.7	21.8	32.9	38.3	14.7	20.7	20.4	17.5	19.2	23.7	20.3	13.5	15.3	11.7	17.3	10.7	68.2	4.9	12.1	7.3	7.5	13.1	5.9	9.9	6.5	6.0	11.1	7.0	5.9	6.9	2.6	7.3	10.3	49.1	7.2	9.1	51.4	72.8	13.4	93.8	78.4	40.7	86.7	49.0	66.7	63.5
CNPY2	"Cnpy2, HP10390, TMEM4, ZSIG9"	ENSG00000257727	"Canopy FGF signaling regulator 2"	Q9Y2B0	12	56309842-56316336	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038465, HPA038466"	Supported		Supported	Cytosol	"Intracellular and membrane"		62000	Cytosol		"HPA038465: AB_10967609, HPA038466: AB_10672646"	"unprognostic (3.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (8.37e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (2.32e-8)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.06e-2)"	17.8	31.4	19.0	16.1	23.8	14.0	27.3	17.3	24.1	29.9	23.7	23.3	40.1	23.0	21.1	46.4	19.1	26.1	19.9	16.9	19.0	20.4	26.7	53.2	17.3	14.9	21.2	21.8	25.7	59.9	19.9	39.3	39.7	21.6	23.4	24.2	18.9	46.2	33.4	10.9	12.3	26.4	16.8	22.5	20.2	23.6	13.7	20.4	13.0	38.0	15.5	16.2	19.7	17.4	33.1	35.3	22.2	36.4	30.1	38.7	33.7	16.3	29.4	21.1	19.3	57.5	22.5	42.7	18.6	37.0	34.7	24.7	39.2	29.2	15.2	32.1	40.0	23.8	26.3	20.8	20.2	18.3	24.6	14.6	31.0	34.5	28.6	27.4	22.3	26.1	31.6	28.5	32.2	28.0	23.3	39.2	23.8	26.8	16.8	32.5	21.5	41.9	19.8	17.3	32.1	26.9	12.6	22.7	13.4	27.3	27.3	27.3	25.8	60.3	15.1	15.2	11.5	16.4	22.2	19.3	25.6	11.4	28.1	26.8	24.2	22.2	36.4	18.3	33.4	26.1	38.7	33.1	37.2	35.2	35.3	27.6	37.9	34.3	5.2	30.1	15.9	34.3	31.2	33.7	19.0	23.8	17.3	24.1	19.0	20.4	21.2	21.8	21.6	20.4
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Group enriched"	"Detected in some"	7	"ASC diff: 39.4;HSkMC: 26.0"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced		Supported	"Plasma membrane,Actin filaments"				"Plasma membrane"	"Actin filaments"	"HPA042256: , HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	19.4	6.4	18.0	5.2	15.8	1.5	14.9	13.8	30.5	3.9	5.5	0.8	0.8	2.3	3.1	4.7	3.7	5.5	3.6	1.4	17.6	7.7	0.9	0.7	6.4	6.5	2.3	14.7	4.1	1.8	1.3	18.3	5.2	4.2	1.5	5.1	0.0	4.3	4.0	1.7	2.4	4.2	5.8	3.2	2.3	2.3	2.7	2.8	0.0	2.6	0.0	9.9	2.7	3.1	2.9	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	39.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.8	1.3	0.0	2.6	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.0	3.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.7	3.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	18.0	15.8	13.8	21.4	17.6	7.7	2.3	14.7	4.2	2.8
CNST	"C1orf71, FLJ32001, PPP1R64"	ENSG00000162852	"Consortin, connexin sorting protein"	Q6PJW8	1	246566444-246668584	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007225, HPA007226"	Approved		Supported	Vesicles			4600000	Vesicles		"HPA007225: AB_1848869, HPA007226: "	"unprognostic (1.55e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.76e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.77e-3)"	"unprognostic (2.26e-1)"	15.5	21.7	10.2	13.7	22.3	21.8	12.8	25.1	22.4	10.6	14.6	8.1	10.2	11.0	14.7	9.4	18.6	10.0	9.7	11.1	9.5	17.6	9.9	25.1	12.4	16.4	11.2	14.1	12.1	11.0	15.2	17.4	11.9	13.7	9.7	13.4	11.6	9.4	9.6	35.5	11.6	15.5	18.4	7.6	12.3	9.6	17.2	9.3	24.6	15.4	10.2	18.6	14.9	11.0	21.1	6.6	21.6	11.1	7.8	19.3	9.0	4.2	5.6	4.1	3.6	6.8	8.0	8.4	13.8	13.7	14.0	10.7	5.4	5.6	12.4	6.2	13.7	4.4	6.4	4.7	19.2	6.9	2.2	14.6	5.1	4.0	9.9	7.2	28.2	7.5	4.5	13.6	14.5	4.3	18.5	5.5	7.9	3.1	7.9	3.3	13.5	4.9	7.8	7.4	10.1	5.3	12.4	9.5	11.4	5.9	3.5	17.1	6.4	6.4	6.1	17.5	4.2	7.2	9.4	16.8	21.3	12.6	4.3	10.8	16.9	21.6	4.7	12.9	8.8	5.0	9.6	19.4	15.0	8.1	4.6	21.1	19.3	10.3	6.2	7.8	11.1	6.6	18.1	9.0	10.2	22.3	25.1	22.4	9.5	17.6	11.2	14.1	13.7	9.3
CNTNAP5	"caspr5, FLJ31966"	ENSG00000155052	"Contactin associated protein like 5"	Q8WYK1	2	124025287-124915287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 22.4"	"Cell line enhanced"	"Detected in some"		"AF22: 3.2;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA069095, HPA069356"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA069095: , HPA069356: "				"unprognostic (6.32e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.23e-1)"		"unprognostic (2.25e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-6)"	"unprognostic (3.65e-3)"	"unprognostic (5.32e-2)"		"unprognostic (9.58e-2)"	0.7	2.8	12.9	0.7	7.9	1.0	0.7	3.3	22.4	0.6	0.8	1.5	0.0	1.0	0.7	0.7	0.7	0.6	4.2	0.7	14.0	4.0	1.2	0.7	0.7	0.7	2.2	8.4	0.6	1.1	0.7	0.8	0.7	15.2	0.8	0.8	0.4	0.6	1.0	0.7	0.8	0.9	0.8	1.9	0.7	0.7	0.9	2.8	0.0	0.7	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.1	0.0	1.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.9	7.9	3.3	22.4	14.0	4.0	2.2	8.4	15.2	2.8
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074863-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020468, HPA020480, HPA051583"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA020468: , HPA020480: , HPA051583: "	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	7.7	4.7	5.5	22.2	11.7	24.0	6.8	10.9	8.7	8.4	5.5	4.9	5.9	3.8	7.3	6.4	5.6	8.4	5.1	4.4	6.6	4.3	4.0	3.8	9.3	20.3	8.1	4.1	10.6	5.2	4.0	17.3	5.8	7.0	7.2	5.5	4.4	6.3	8.6	2.8	5.2	8.8	5.7	9.7	14.8	7.1	30.2	9.8	26.7	6.2	4.2	19.2	8.6	7.1	12.7	10.5	15.0	6.9	4.8	10.4	2.5	5.3	3.6	10.0	7.2	1.5	2.3	1.7	3.7	2.8	2.9	2.5	2.1	5.9	24.6	1.4	2.7	11.3	3.3	2.2	4.8	14.9	2.6	12.8	6.5	2.5	2.1	34.8	15.6	1.4	1.7	3.1	7.5	6.4	8.3	14.1	2.8	3.4	13.6	11.9	3.4	2.9	12.9	15.1	7.0	1.4	2.5	3.8	5.7	12.7	2.3	2.9	4.9	16.7	4.7	3.1	5.4	4.8	6.8	9.8	10.7	16.7	2.6	14.4	7.1	12.2	6.9	15.0	7.5	4.5	5.7	10.8	7.7	5.5	3.4	12.7	9.3	6.6	2.7	4.8	5.8	10.5	10.4	2.5	5.5	11.7	10.9	8.7	6.6	4.3	8.1	4.1	7.0	9.8
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949918	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	9.0	7.4	7.5	9.2	10.1	18.4	9.3	11.2	12.7	13.0	10.9	9.8	9.9	6.8	21.3	12.6	11.0	10.4	9.0	7.1	9.5	8.0	9.2	8.7	15.0	8.4	9.3	9.9	11.4	11.0	16.5	9.6	9.9	9.9	9.9	12.5	10.3	9.6	8.6	6.8	16.9	9.1	16.3	7.0	9.9	8.4	51.2	6.4	16.0	10.4	6.2	11.2	9.3	10.0	2.1	7.6	9.4	3.4	3.4	3.5	2.6	22.1	14.5	21.8	12.0	9.2	12.7	7.1	19.3	18.1	27.1	20.8	12.3	8.3	22.8	10.3	16.9	17.9	16.8	13.5	30.3	22.4	13.2	15.1	23.8	9.7	13.6	14.0	23.4	11.6	10.0	19.0	19.2	16.7	10.9	11.2	18.7	7.2	21.2	13.5	4.8	11.4	22.6	14.9	8.5	12.5	6.8	7.1	12.8	15.6	8.0	6.2	10.9	8.9	13.6	15.1	12.8	20.5	26.6	17.2	11.5	15.8	13.0	17.9	21.5	9.4	2.5	1.0	2.9	3.4	2.6	2.1	2.2	3.5	1.7	1.5	1.4	2.4	0.4	3.4	1.4	7.6	2.9	2.6	7.5	10.1	11.2	12.7	9.5	8.0	9.3	9.9	9.9	6.4
COA1	"C7orf44, FLJ10803, MITRAC15"	ENSG00000106603	"Cytochrome c oxidase assembly factor 1 homolog"	Q9GZY4	7	43608456-43729717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA011944	Approved		Supported	Mitochondria				Mitochondria		"HPA011944: AB_1848671"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.85e-3)"	"prognostic unfavourable (7.84e-5)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.39e-2)"	13.8	16.2	22.4	14.4	21.7	17.6	14.5	13.8	24.0	11.8	10.9	14.4	17.4	11.4	14.8	14.3	15.1	9.6	10.9	47.8	19.7	18.5	23.4	14.4	11.9	24.2	23.0	13.2	11.1	23.9	9.4	22.1	11.3	17.4	10.9	14.7	17.9	17.5	17.7	55.5	7.0	12.6	9.7	19.9	16.2	14.5	11.8	14.3	16.2	15.8	22.4	28.3	14.8	8.8	21.0	17.9	24.2	17.2	18.6	21.0	14.4	10.6	28.7	23.8	23.5	7.0	7.9	15.9	15.0	25.7	20.3	21.2	21.9	24.5	20.3	25.3	9.1	15.6	27.5	23.0	25.8	18.2	25.2	25.2	17.0	20.1	11.6	19.6	11.2	6.5	14.8	14.8	22.0	18.5	42.7	17.7	16.6	14.6	28.8	49.3	14.9	20.8	17.5	21.8	37.5	24.9	12.0	14.7	26.3	15.0	27.9	9.6	20.9	13.2	13.7	10.1	22.1	9.9	21.1	42.6	34.4	36.4	28.8	25.3	26.9	1.3	15.3	16.0	12.9	17.2	9.5	19.7	12.0	13.2	17.9	21.0	16.9	21.0	24.2	18.6	14.6	16.0	11.5	14.4	22.4	21.7	13.8	24.0	19.7	18.5	23.0	13.2	17.4	14.3
COA3	"CCDC56, COX25, HSPC009, MITRAC12"	ENSG00000183978	"Cytochrome c oxidase assembly factor 3"	Q9Y2R0	17	42795147-42798704	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031966	Approved		Supported	Mitochondria				Mitochondria		"HPA031966: AB_10602115"	"unprognostic (1.20e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (5.65e-2)"	"prognostic favourable (8.93e-4)"	"unprognostic (7.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.52e-1)"	"prognostic favourable (6.62e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.01e-2)"	13.4	17.8	34.5	11.1	26.7	4.6	20.6	19.5	31.8	18.7	33.7	18.0	18.2	35.9	14.0	62.6	30.2	26.2	20.0	26.3	29.3	26.0	57.2	44.1	13.7	14.1	31.2	22.2	17.0	97.0	16.2	15.0	17.8	26.1	22.0	31.6	14.9	30.3	25.1	28.7	12.6	33.5	14.5	21.6	12.2	27.1	9.5	17.1	13.1	22.8	28.6	19.8	14.1	18.1	56.1	49.2	46.0	59.1	46.2	50.5	59.7	16.0	54.5	25.1	13.7	23.2	19.8	15.5	12.6	19.3	30.3	27.5	21.5	20.4	0.9	35.9	15.4	15.7	19.3	30.9	28.7	15.7	50.7	10.8	25.7	67.9	16.5	14.6	13.2	20.0	23.3	28.5	16.4	24.0	17.3	14.0	26.8	26.4	4.8	32.1	11.4	19.7	19.2	36.7	27.6	30.7	22.2	18.7	15.7	12.9	13.7	21.9	42.7	19.2	14.6	33.2	17.3	14.0	16.7	16.5	17.8	8.6	24.9	14.6	22.4	46.0	59.1	36.8	39.8	54.9	41.6	56.1	41.4	40.2	49.2	51.2	38.4	38.2	6.3	46.2	45.5	32.9	50.5	59.7	34.5	26.7	19.5	31.8	29.3	26.0	31.2	22.2	26.1	17.1
COA5	"C2orf64, FLJ27524, MGC52110, Pet191"	ENSG00000183513	"Cytochrome c oxidase assembly factor 5"	Q86WW8	2	98599310-98608515	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA057768	Uncertain		Supported	Mitochondria				Mitochondria		"HPA057768: "	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.69e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (1.32e-3)"	"unprognostic (3.71e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.50e-1)"	"prognostic favourable (1.00e-5)"	13.7	21.4	30.9	12.2	29.3	9.1	20.6	31.3	28.2	18.6	15.0	20.3	18.5	15.4	20.2	33.5	11.1	20.5	13.4	19.3	28.3	26.5	28.1	23.4	13.9	15.8	30.7	29.0	23.6	16.8	21.0	19.1	14.2	23.4	19.8	15.9	13.7	16.2	20.3	30.7	18.0	13.5	14.7	32.7	15.6	16.0	15.6	21.5	15.3	24.5	10.1	16.1	13.9	15.0	24.7	30.3	28.1	25.5	18.1	30.0	22.0	12.7	5.4	16.9	12.3	19.9	16.5	14.1	7.4	5.9	8.0	8.4	11.0	11.0	6.5	13.5	5.9	9.0	14.7	7.8	9.7	16.8	13.7	9.0	11.1	18.0	14.5	8.5	8.4	15.9	17.0	5.6	7.4	8.6	12.6	7.6	8.8	10.7	11.4	15.2	11.7	12.0	7.0	12.6	14.2	17.5	6.9	12.9	16.3	6.3	7.8	18.5	9.7	18.0	7.5	12.3	11.0	7.3	6.1	12.4	17.4	8.2	14.8	19.0	10.0	18.2	25.5	28.0	25.2	22.7	21.9	23.5	23.0	24.1	24.1	24.7	28.1	27.9	28.1	18.1	23.7	30.3	30.0	22.0	30.9	29.3	31.3	25.9	28.3	26.5	30.7	29.0	23.4	21.5
COA6	C1orf31	ENSG00000168275	"Cytochrome c oxidase assembly factor 6"	Q5JTJ3	1	234373456-234384049	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA028588	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA028588: AB_10601123"	"unprognostic (6.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.25e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.19e-1)"	"prognostic favourable (7.12e-4)"	11.0	17.8	26.4	14.4	33.9	9.4	16.6	14.3	27.5	9.7	17.7	5.7	12.9	26.4	8.4	20.3	15.5	9.4	14.2	19.1	19.3	15.7	21.4	21.4	13.6	16.2	16.3	16.1	9.1	16.7	7.6	9.5	8.7	13.4	13.3	15.6	6.0	13.6	11.6	52.7	8.7	19.7	10.6	11.4	12.5	14.4	5.8	13.3	13.1	13.6	20.2	12.0	11.6	14.6	27.5	33.3	19.7	31.3	18.3	36.6	20.2	17.8	22.9	8.3	9.4	8.8	17.3	26.5	13.1	8.0	13.8	13.0	17.6	23.9	17.9	24.4	7.5	22.8	12.9	16.2	11.0	22.1	55.2	8.0	26.1	46.6	33.7	19.7	15.6	11.4	21.8	18.1	14.0	17.0	38.9	16.1	15.0	9.5	18.6	38.1	20.4	10.9	11.1	10.0	35.1	17.2	17.0	14.8	10.8	12.8	22.6	40.4	20.1	34.0	12.8	16.4	13.6	22.0	39.2	19.2	37.2	21.8	12.5	31.2	29.2	19.7	31.3	9.7	18.5	28.5	18.2	27.5	29.9	23.0	33.3	18.0	31.3	23.1	8.1	18.3	23.8	22.5	36.6	20.2	26.4	33.9	14.3	27.5	19.3	15.7	16.3	16.1	13.4	13.3
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.0;pancreas: 136.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.1;Hep G2: 19.7;K-562: 38.7;NB-4: 32.1;SCLC-21H: 35.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 63.0"	"Group enriched"	"Detected in some"	13	"memory B-cell: 24.0;naive B-cell: 7.7"	"Lineage enriched"	"Detected in many"	20	"B-cells: 24.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6"	HPA065086			Supported	Vesicles	"Secreted to extracellular matrix"		88000	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	1.1	1.4	2.1	1.1	63.0	1.3	0.9	1.1	2.3	4.0	0.8	1.4	1.6	0.6	0.6	1.0	0.6	2.2	1.2	0.9	1.2	2.9	1.8	0.5	0.5	3.1	0.8	1.9	0.6	136.8	0.4	3.3	0.9	2.1	14.7	1.0	0.8	1.8	21.8	0.6	4.6	0.7	0.7	1.4	0.8	0.8	1.8	7.9	0.0	0.6	0.7	2.4	1.1	7.8	24.0	0.0	0.1	0.3	0.0	1.1	0.6	0.0	11.0	1.0	0.0	0.2	0.0	6.9	0.0	0.0	2.0	5.5	6.5	0.3	0.1	0.5	0.0	0.0	6.9	0.0	3.4	0.0	30.1	5.5	2.5	19.7	0.0	0.5	2.3	0.4	0.0	0.2	0.0	0.1	38.7	1.6	0.5	0.2	2.7	32.1	3.7	1.1	8.1	0.0	0.2	0.3	1.0	35.7	9.6	0.8	0.1	0.0	0.0	15.0	0.2	0.0	0.0	0.1	0.0	1.8	4.7	3.4	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	24.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.6	2.1	63.0	1.1	2.3	1.2	2.9	0.8	1.9	2.1	7.9
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536630	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: "	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	12.5	17.4	8.7	17.1	14.0	10.9	17.0	19.7	14.5	16.9	17.1	13.0	22.4	13.2	16.9	20.6	14.4	14.0	12.8	12.5	8.9	9.4	16.5	46.2	12.1	11.7	9.3	10.0	17.9	29.4	10.9	22.6	32.9	11.5	20.9	20.7	12.9	28.3	25.2	12.5	14.7	18.8	13.3	10.1	14.8	15.6	9.9	11.2	17.4	18.5	8.7	18.5	14.8	14.8	5.1	7.2	7.4	4.6	4.9	8.0	3.8	5.8	5.3	10.2	9.1	13.4	15.4	9.7	9.7	13.8	11.4	9.5	7.7	10.8	8.0	4.3	11.5	12.8	8.4	9.8	17.3	6.2	6.8	9.0	6.4	13.5	16.6	13.1	8.6	11.5	14.9	7.5	26.8	11.0	5.8	4.9	13.5	9.0	7.2	12.4	8.3	6.4	8.5	5.9	7.4	10.6	9.5	5.1	9.2	6.3	12.4	12.9	8.5	13.6	10.3	5.5	4.3	10.2	6.1	6.9	3.7	8.3	10.5	6.7	9.7	7.4	4.1	7.3	7.5	4.6	8.0	5.1	5.8	6.4	3.1	4.9	6.6	6.1	3.7	4.9	2.9	7.2	6.2	3.8	8.7	14.0	19.7	14.5	8.9	9.4	9.3	10.0	11.5	11.2
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201555-107564514	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: "	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (1.15e-1)"	17.2	15.8	15.2	13.7	14.9	16.5	13.9	16.1	17.7	24.8	12.1	15.0	18.3	8.8	28.4	14.0	16.4	10.9	20.3	25.7	13.3	10.3	12.7	8.9	12.9	9.5	14.7	12.5	16.7	18.9	40.3	28.4	14.4	13.4	25.6	14.1	10.5	34.0	20.6	16.5	15.8	12.5	23.8	17.5	10.8	13.1	12.6	15.3	14.0	26.3	11.5	17.3	13.9	21.4	9.8	8.6	10.1	12.9	7.0	12.3	8.9	16.2	7.5	6.8	2.6	2.0	1.8	6.7	12.0	14.3	6.4	10.2	4.8	7.5	2.3	4.6	11.8	8.4	2.8	2.1	9.3	11.3	2.1	1.8	3.1	8.0	1.5	4.6	10.7	6.1	1.1	12.5	14.0	18.4	5.2	8.9	12.3	8.0	4.8	0.0	0.9	8.1	2.1	3.0	4.2	5.5	7.8	1.5	10.1	4.1	12.4	13.1	1.2	3.0	20.9	3.9	6.6	19.8	7.0	2.9	6.7	5.0	10.5	6.4	18.9	9.9	10.8	10.1	9.6	12.5	12.3	9.8	12.0	10.3	8.6	8.2	10.2	10.1	5.1	7.0	12.9	5.5	9.5	8.9	15.2	14.9	16.1	17.7	13.3	10.3	14.7	12.5	13.4	15.3
COG7		ENSG00000168434	"Component of oligomeric golgi complex 7"	P83436	16	23388493-23453180	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040758, HPA041824, HPA064645"	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA040758: AB_2677120, HPA041824: , HPA064645: "	"unprognostic (1.72e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.21e-2)"	"prognostic favourable (6.95e-4)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.58e-1)"	"prognostic favourable (3.14e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.14e-1)"	11.0	15.8	12.3	12.9	16.5	12.1	14.1	12.6	16.9	16.5	14.8	19.6	15.1	11.5	16.5	16.5	13.8	21.6	14.9	11.5	12.4	12.4	15.2	12.1	11.8	8.8	14.2	12.4	16.2	16.3	27.9	28.0	14.7	12.3	18.1	16.9	17.4	17.5	20.8	11.2	16.7	11.8	12.9	14.1	11.4	17.6	18.6	14.1	13.0	17.2	10.6	12.9	13.6	13.5	5.8	10.7	10.8	12.2	6.9	12.1	6.1	8.0	15.6	9.7	11.0	8.7	14.4	8.8	9.0	11.4	10.6	10.7	6.6	14.2	3.7	9.5	14.2	12.3	8.7	11.0	8.2	12.2	13.2	3.9	12.0	17.4	9.2	10.8	11.7	9.2	9.0	8.1	8.6	12.3	9.4	11.1	8.5	23.4	7.2	8.0	8.7	7.6	14.7	8.5	13.5	11.6	7.9	5.9	7.5	10.1	11.6	7.7	17.0	14.1	8.6	11.9	6.3	10.9	6.4	10.2	10.8	5.1	15.8	6.4	11.3	10.8	8.9	9.3	8.5	10.3	10.5	5.6	8.0	8.1	10.7	5.8	8.3	12.1	2.2	6.9	12.2	7.6	9.2	6.1	12.3	16.5	12.6	16.9	12.4	12.4	14.2	12.4	12.3	14.1
COG8		ENSG00000272617	"Component of oligomeric golgi complex 8"	Q96MW5	16	69326913-69339667	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041406, HPA049429"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA041406: , HPA049429: "																		9.3	13.7	11.4	10.5	12.7	5.8	10.8	13.1	16.1	11.6	10.7	17.9	10.3	10.9	8.8	13.1	10.2	9.8	10.4	8.5	12.4	11.5	23.8	25.2	9.7	9.3	14.4	8.0	11.4	11.7	21.1	10.5	8.0	10.7	9.7	12.7	12.4	9.9	9.5	15.2	12.3	11.0	11.1	8.0	10.5	8.5	40.2	13.5	17.4	11.6	7.4	13.0	7.3	9.4	9.6	10.0	7.7	8.0	13.9	12.8	6.6	7.6	16.4	15.5	17.6	19.2	12.6	7.4	9.6	13.4	17.5	17.5	10.5	15.7	11.3	3.7	14.2	13.4	22.6	16.5	18.1	3.6	6.7	7.7	13.7	21.6	13.9	16.1	8.2	11.6	17.0	18.5	15.2	10.9	11.2	7.7	13.8	22.2	14.8	17.6	17.4	2.3	22.1	7.0	22.2	25.8	9.3	15.2	13.3	17.8	9.8	10.4	29.1	17.4	6.3	12.4	8.2	10.0	10.0	7.2	9.8	24.6	11.8	10.3	14.0	4.1	8.0	7.7	8.0	7.1	8.1	7.1	10.5	12.8	10.0	9.6	9.9	10.9	5.0	13.9	7.9	4.9	7.9	6.6	11.4	12.7	13.1	16.1	12.4	11.5	14.4	8.0	10.7	13.5
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938187-56961054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA068537, CAB069400"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies"				Nucleoplasm	"Nucleoli, Nuclear bodies"	"CAB017524: AB_1121780, CAB069400: , HPA027885: , HPA068537: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favourable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	8.7	5.6	7.3	5.5	8.1	10.9	8.2	12.6	8.9	8.9	6.4	7.6	4.9	6.7	8.1	8.1	8.5	6.8	4.9	5.3	5.8	5.7	7.0	8.5	5.3	7.7	7.1	6.5	8.6	9.1	8.5	9.7	9.5	8.2	7.8	7.3	5.8	7.5	9.1	7.9	7.8	7.0	5.9	7.2	8.1	6.4	58.8	6.0	12.3	8.7	5.3	8.5	7.7	7.3	22.5	13.7	14.0	13.4	12.7	17.8	8.6	13.0	9.9	20.5	7.9	7.0	8.4	14.2	9.4	8.9	14.4	15.4	13.6	11.3	15.8	19.1	7.5	7.6	13.8	10.9	20.6	18.9	17.5	25.7	9.5	15.3	7.6	21.6	15.7	7.8	13.6	10.8	11.7	12.2	22.2	13.2	13.4	16.5	17.0	13.8	12.0	10.0	8.1	25.2	12.6	9.8	13.2	17.4	17.2	6.3	6.3	15.7	22.7	21.2	8.6	16.8	12.7	8.1	12.1	19.6	24.4	18.5	8.7	12.0	10.2	14.0	11.5	13.9	13.9	10.4	15.6	22.5	15.4	14.6	11.3	21.6	17.8	17.2	6.8	12.7	13.4	13.7	15.2	8.6	7.3	8.1	12.6	8.9	5.8	5.7	7.1	6.5	8.2	6.0
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 55.3;HBEC3-KT: 88.6;hTCEpi: 115.1;hTERT-HME1: 98.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: "	"prognostic favourable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.7	0.0	55.3	0.0	88.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.1	0.0	98.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	5.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394561-94431232	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 244.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 150.8;ASC TERT1: 181.0;BJ: 148.1;BJ hTERT+: 108.7;fHDF/TERT166: 501.0;HSkMC: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		21000000	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: "	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	44.7	9.8	1.2	34.9	4.3	0.0	33.4	1.7	2.4	244.6	26.5	2.1	54.1	3.8	166.9	139.1	28.2	36.6	101.4	45.1	1.3	0.8	10.2	4.1	37.1	20.4	1.8	2.8	68.3	10.9	1.8	6.0	70.6	3.8	40.3	10.1	23.0	17.5	28.0	12.1	35.6	15.2	100.7	3.2	16.4	16.1	49.7	1.1	5.6	14.7	42.7	12.6	62.4	55.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	55.8	150.8	181.0	0.0	148.1	108.7	24.4	32.5	0.0	0.1	0.0	0.1	501.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	157.1	0.0	19.2	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	62.2	0.0	38.5	4.2	0.0	0.0	0.0	15.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	1.7	2.4	1.3	0.8	1.8	2.8	3.8	1.1
COL21A1		ENSG00000124749	"Collagen type XXI alpha 1 chain"	Q96P44	6	56056590-56394094	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031212			Supported	Cytosol	"Secreted to extracellular matrix"		180000	Cytosol		"HPA031212: AB_10599941"	"unprognostic (1.69e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.32e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-3)"	3.9	1.6	6.6	2.1	2.3	0.3	3.0	5.1	3.6	25.8	11.3	5.2	7.9	0.8	20.0	7.0	3.3	7.6	3.9	4.5	8.5	2.5	1.4	1.5	7.4	0.7	3.6	4.6	3.9	2.1	0.8	3.6	26.4	6.9	5.4	2.2	5.9	4.4	10.9	2.3	6.3	2.6	24.2	5.3	0.7	5.7	3.8	5.8	0.0	2.1	4.1	0.8	10.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.1	0.0	1.0	18.9	6.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.1	0.0	19.2	0.7	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.6	2.3	5.1	3.6	8.5	2.5	3.6	4.6	6.9	5.8
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914006	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 46.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.4;RT4: 9.9;SCLC-21H: 6.7;U-2 OS: 5.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"			Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavourable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	12.0	0.2	1.3	1.1	0.0	0.1	6.8	1.1	1.3	0.7	1.4	10.8	0.3	2.4	1.9	0.2	0.5	0.4	0.2	0.3	0.8	2.8	0.1	0.1	0.5	0.3	0.0	0.3	0.2	1.7	46.5	0.0	1.9	4.7	0.1	1.6	0.8	5.1	0.5	0.1	0.4	2.2	1.8	0.3	3.7	0.8	0.1	1.4	0.3	0.7	1.7	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.9	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.8	0.3	0.3	0.8	0.3	0.0	1.9	0.1
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513027	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 125.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 142.4;WM-115: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010751, HPA029118"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"		1900000	Vesicles		"CAB010751: AB_476828, HPA029118: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (9.25e-4)"	87.2	9.5	4.6	26.1	3.3	0.1	50.1	2.0	3.0	37.2	53.1	1.9	30.3	7.6	48.4	25.5	23.0	26.3	52.4	26.6	3.6	1.4	18.4	5.7	35.9	17.5	3.8	1.7	25.7	8.3	7.3	3.8	125.7	5.0	26.9	5.5	12.2	7.6	29.3	26.3	9.2	16.9	84.1	2.8	58.5	23.4	11.0	1.9	4.2	16.0	8.0	5.7	65.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.4	6.5	29.5	0.0	38.5	16.0	46.5	40.1	14.5	23.9	11.2	0.7	0.0	0.0	142.4	9.3	11.2	0.0	12.0	4.6	1.5	6.1	0.0	11.0	0.3	28.4	0.0	0.1	7.2	0.7	16.7	11.5	24.9	0.0	0.0	3.9	0.2	0.0	1.0	4.6	2.3	0.0	12.2	0.0	26.3	0.2	0.9	4.8	0.0	0.1	12.5	0.0	0.5	42.8	13.1	33.4	0.3	21.7	0.0	0.2	0.5	0.3	0.0	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.6	3.3	2.0	3.0	3.6	1.4	3.8	1.7	5.0	1.9
COL4A3BP	"CERT, GPBP, STARD11"	ENSG00000113163	"Collagen type IV alpha 3 binding protein"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 51.1;WM-115: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: "	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favourable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	30.0	25.5	16.5	17.1	21.9	17.9	21.4	34.4	21.2	26.9	19.9	14.9	21.5	13.5	20.5	11.6	21.9	17.1	17.4	14.9	15.2	16.3	21.1	22.7	19.6	13.4	22.5	12.4	17.9	12.4	24.6	25.9	17.8	18.2	19.0	14.6	14.8	17.5	16.1	33.4	14.2	19.3	18.9	16.6	17.2	17.0	21.3	20.7	17.8	37.4	14.3	15.9	21.8	19.1	6.4	9.8	20.9	16.6	5.1	8.8	5.7	16.3	8.5	8.2	7.1	51.1	14.3	10.9	9.2	11.4	7.1	9.5	12.7	9.4	7.9	20.0	9.8	10.0	12.4	12.7	10.9	9.7	5.8	6.6	9.3	6.7	13.0	6.5	7.6	10.7	9.0	8.3	9.5	8.2	11.9	12.0	9.3	8.6	7.7	4.9	10.5	6.3	6.6	10.8	7.3	11.6	19.9	6.3	6.3	11.6	8.2	11.4	7.9	11.2	11.1	4.8	5.8	8.6	7.5	11.2	14.6	9.3	8.4	11.2	44.2	5.0	13.9	10.6	6.0	15.6	5.6	6.0	6.2	5.6	9.8	6.4	5.9	5.8	20.9	5.1	16.6	5.7	8.8	5.7	16.5	21.9	34.4	21.2	15.2	16.3	22.5	12.4	18.2	20.7
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 56.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.4;fHDF/TERT166: 149.5;LHCN-M2: 43.9;TIME: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA053107: "	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavourable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	20.5	4.7	1.0	6.1	3.0	0.1	7.5	2.4	0.9	5.8	16.9	1.8	11.8	0.6	5.9	16.8	15.3	6.4	6.8	26.7	1.2	1.4	9.4	1.9	36.5	0.5	1.8	2.1	7.7	0.9	32.3	9.4	5.5	2.9	13.1	4.8	38.7	5.2	8.8	5.0	2.3	2.7	18.8	3.0	0.9	4.2	6.4	0.6	0.0	56.0	6.4	0.8	21.3	12.1	0.4	0.1	0.9	0.2	0.3	0.4	0.1	0.0	0.0	0.4	0.0	22.0	36.4	0.0	8.9	5.8	9.0	18.1	0.0	0.0	0.0	0.8	149.5	0.0	0.0	11.6	23.5	0.0	0.0	0.0	1.2	0.0	4.0	0.0	0.0	20.7	0.4	7.0	11.8	17.5	0.0	0.0	43.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.1	4.2	3.3	0.2	4.7	0.0	0.0	0.0	8.3	0.0	32.1	0.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.4	0.4	0.7	0.3	0.1	0.1	0.1	0.1	1.0	3.0	2.4	0.9	1.2	1.4	1.8	2.1	2.9	0.6
COMMD1	"C2orf5, MGC27155, MURR1"	ENSG00000173163	"Copper metabolism domain containing 1"	Q8N668	2	61888724-62147247	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034633, HPA049223"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034633: AB_10601800, HPA049223: "	"unprognostic (6.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.77e-1)"	19.6	26.2	18.6	23.2	22.3	14.2	22.8	26.7	21.4	20.1	16.6	16.7	21.2	18.2	21.0	26.2	25.3	18.0	16.8	41.7	16.1	15.2	25.4	28.8	15.6	17.3	17.8	22.4	19.9	32.8	15.0	30.0	21.2	16.8	19.0	19.0	17.9	26.6	24.3	32.1	21.0	14.4	24.7	19.9	16.1	19.5	26.8	19.0	16.3	23.6	20.3	19.7	17.6	19.5	33.0	42.7	17.1	36.5	31.2	31.8	35.7	10.0	13.0	14.9	11.5	19.2	22.3	12.7	12.1	20.5	24.6	18.0	22.1	9.2	17.8	10.4	22.6	7.9	8.1	14.8	26.6	19.1	9.9	13.8	7.6	24.4	16.5	21.4	10.9	16.2	17.2	11.9	14.2	24.7	8.4	29.1	26.0	18.9	16.5	38.1	12.6	17.8	11.8	19.4	20.3	22.3	11.1	8.9	10.1	13.7	23.1	12.3	14.6	9.4	11.6	22.2	19.1	13.8	18.5	12.8	10.0	22.1	13.0	19.1	19.2	16.5	36.5	17.1	25.1	30.8	24.6	33.0	28.4	27.7	42.7	30.7	27.2	29.0	3.0	31.2	26.2	39.6	31.8	35.7	18.6	22.3	26.7	21.4	16.1	15.2	17.8	22.4	16.8	19.0
COMMD10	PTD002	ENSG00000145781	"COMM domain containing 10"	Q9Y6G5	5	116084991-116412762	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045441, HPA054156"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA045441: AB_10961905, HPA054156: "	"unprognostic (1.14e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (2.99e-4)"	"unprognostic (9.47e-2)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (1.59e-1)"	20.5	26.6	18.6	22.8	20.3	13.3	21.9	17.9	20.5	20.0	16.9	15.7	26.7	12.7	18.6	31.5	18.6	13.4	16.6	28.4	16.3	16.8	33.2	22.4	15.4	19.0	23.4	15.0	18.2	23.0	15.2	29.1	22.3	18.9	20.6	19.6	15.1	27.2	24.1	15.1	11.5	20.4	18.7	19.1	25.1	19.3	12.9	17.9	19.1	27.0	14.3	20.6	18.2	17.3	12.0	23.6	12.7	21.4	15.9	10.8	13.5	16.6	17.1	18.4	9.8	13.3	18.8	20.5	13.0	14.2	18.3	15.3	13.7	20.9	8.5	15.6	18.0	9.6	10.3	20.3	27.3	24.5	7.6	10.1	5.8	10.6	15.1	7.9	19.2	11.9	13.6	11.7	14.3	18.1	6.5	5.8	23.7	11.1	14.9	19.0	15.8	7.9	15.1	19.5	24.6	25.6	10.6	9.8	13.1	15.8	14.3	18.2	17.5	30.1	10.8	15.9	19.6	7.3	22.4	6.2	8.3	21.7	15.4	30.1	18.4	7.6	18.2	12.7	7.8	21.4	10.6	12.0	10.1	9.7	23.6	8.3	9.9	10.1	3.3	15.9	19.6	17.4	10.8	13.5	18.6	20.3	17.9	20.5	16.3	16.8	23.4	15.0	18.9	17.9
COMMD4	FLJ20452	ENSG00000140365	"COMM domain containing 4"	Q9H0A8	15	75335891-75343224	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066957	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA066957: "	"unprognostic (7.77e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.07e-2)"	15.9	35.2	16.1	20.7	17.5	20.4	16.2	12.6	23.1	14.4	19.5	21.7	22.2	21.9	20.7	26.2	17.7	15.7	30.1	16.6	13.9	12.9	25.1	28.1	24.3	17.4	15.6	15.4	13.7	15.2	14.9	16.2	23.7	14.1	15.2	15.9	20.9	30.8	16.6	13.2	15.2	20.1	16.7	16.6	19.3	18.3	32.7	14.7	30.4	20.3	27.4	17.3	16.4	14.5	17.3	26.0	14.6	22.3	26.9	33.4	13.8	33.1	51.5	23.7	30.7	10.4	15.0	23.3	25.7	24.0	44.3	44.9	29.7	44.4	21.2	24.3	19.4	34.9	45.1	26.9	22.3	15.5	57.7	25.2	41.4	32.7	18.4	19.6	24.7	16.7	14.3	28.7	5.5	22.0	25.9	30.9	34.1	39.4	16.9	21.8	33.3	30.3	29.9	38.4	27.9	22.6	29.4	19.1	28.0	33.4	25.2	39.3	38.9	35.0	20.3	31.4	29.9	31.6	45.1	22.1	50.5	24.3	34.6	40.6	30.2	10.8	17.3	14.6	33.4	22.3	20.8	17.3	20.9	24.6	19.0	15.8	12.6	19.7	3.6	26.9	18.7	26.0	30.9	13.8	16.1	17.5	12.6	23.1	13.9	12.9	15.6	15.4	14.1	14.7
COMMD5	"FLJ13008, HCaRG, HT002"	ENSG00000170619	"COMM domain containing 5"	Q9GZQ3	8	144841042-144853736	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046905			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA046905: "	"unprognostic (2.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (5.05e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.24e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-3)"	24.7	22.3	18.2	16.7	18.1	27.6	14.6	26.0	22.9	15.2	19.1	18.1	17.7	17.8	16.6	15.3	18.9	15.9	17.0	20.9	18.4	17.1	18.0	21.8	20.0	21.0	23.8	12.2	13.4	20.3	11.0	18.3	16.3	15.9	15.8	10.5	16.4	22.4	17.4	16.0	17.5	15.5	17.9	18.5	22.2	16.9	11.7	16.8	17.7	23.6	14.3	19.0	20.2	15.1	29.3	36.6	36.3	42.6	32.0	33.8	31.8	16.0	18.9	9.2	12.3	11.4	9.1	8.2	9.4	10.0	16.0	12.6	11.5	12.7	11.1	20.8	11.3	10.9	11.4	15.4	6.9	14.5	16.1	23.3	18.1	19.2	15.3	7.9	20.3	12.0	14.1	10.9	8.2	12.2	16.6	20.6	12.8	29.3	7.0	8.2	14.0	38.4	9.2	10.6	17.0	15.4	14.4	21.6	18.8	15.6	9.5	13.4	18.4	14.8	11.2	12.1	23.8	16.9	18.2	8.6	9.1	10.2	16.7	14.7	15.5	28.5	42.6	36.3	29.3	34.6	26.1	29.3	22.8	28.7	36.6	26.1	22.8	25.3	25.7	32.0	21.8	13.4	33.8	31.8	18.2	18.1	26.0	22.9	18.4	17.1	23.8	12.2	15.9	16.8
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450796-47463719	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favourable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	11.4	14.0	14.7	13.9	21.3	13.1	10.9	9.5	18.8	9.7	12.5	5.7	7.7	13.1	9.7	17.3	21.1	8.3	10.0	19.1	14.1	14.0	32.5	16.1	15.1	21.4	13.9	15.0	8.4	10.4	15.5	20.5	20.0	11.3	9.2	13.4	6.5	9.8	9.2	7.7	12.5	17.1	12.8	11.6	14.5	10.0	16.9	10.9	15.2	15.7	19.7	17.5	15.5	12.7	21.1	32.7	39.8	36.4	23.9	22.9	27.9	12.4	6.9	6.1	3.1	13.0	18.6	8.5	18.8	12.5	12.4	16.9	11.6	14.8	20.0	15.8	17.7	6.7	19.5	15.3	22.4	11.8	8.8	11.5	7.7	8.9	17.7	28.0	14.8	15.9	20.7	11.7	13.1	15.6	8.5	8.2	30.1	6.9	16.6	22.7	4.2	9.0	8.4	13.9	4.3	35.5	10.2	12.0	6.1	7.8	6.4	14.9	11.7	18.6	12.8	17.7	17.0	15.7	22.3	8.7	10.4	16.1	19.2	36.8	12.7	39.8	26.2	29.5	21.3	34.9	22.9	21.1	19.6	21.1	32.7	18.8	18.5	21.0	12.9	23.9	36.4	15.3	22.0	27.9	14.7	21.3	9.5	18.8	14.1	14.0	13.9	15.0	11.3	10.9
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941607-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 139.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"			560000	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favourable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favourable (5.67e-4)"	"prognostic unfavourable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	18.6	49.0	29.4	14.3	28.8	24.3	27.8	19.6	32.9	22.4	23.4	42.4	36.1	21.0	19.8	33.8	58.1	19.4	36.8	28.1	28.9	22.3	31.1	139.3	30.9	17.0	29.0	18.4	36.3	27.2	14.1	12.7	59.0	23.3	25.7	8.9	24.9	67.3	30.9	21.5	27.7	28.6	15.5	41.0	17.8	24.8	18.2	23.7	11.5	19.2	44.0	32.0	36.3	28.0	11.2	55.1	10.9	60.0	12.9	15.6	28.0	19.0	19.6	2.2	19.4	22.1	19.7	0.8	21.6	27.3	18.5	21.3	16.6	22.2	7.7	9.6	30.9	26.1	3.7	23.2	4.9	16.6	24.7	13.7	10.5	38.7	41.3	22.8	5.5	25.0	28.7	16.1	16.0	17.4	55.4	16.4	15.0	118.0	8.9	41.0	4.8	6.6	13.5	19.4	10.6	19.6	60.5	9.5	8.3	7.2	61.3	17.8	13.2	64.3	20.8	33.2	12.7	10.9	16.2	6.0	2.5	6.3	35.8	30.9	22.8	10.2	60.0	10.9	15.6	39.9	12.8	11.2	10.8	12.6	47.7	10.7	9.6	10.6	2.4	12.9	26.6	55.1	13.3	28.0	29.4	28.8	19.6	32.9	28.9	22.3	29.0	18.4	23.3	23.7
COPB1	COPB	ENSG00000129083	"Coatomer protein complex subunit beta 1"	P53618	11	14443440-14500027	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"			400000	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: , HPA064403: "	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (6.91e-4)"	"prognostic unfavourable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	30.9	33.0	18.4	23.5	20.8	31.2	55.4	23.7	23.6	32.5	26.6	15.5	42.0	25.9	32.2	33.0	32.2	28.3	25.1	34.8	18.9	16.8	37.6	56.6	38.4	53.9	22.6	15.5	31.3	52.2	40.1	43.5	52.3	22.2	31.9	31.3	17.2	43.4	41.7	21.9	24.7	33.1	39.7	26.1	29.8	30.2	21.7	20.6	46.0	37.7	26.7	28.0	28.2	27.3	26.7	33.9	27.9	30.4	28.0	39.6	24.8	31.2	26.8	28.7	21.5	48.0	55.7	23.2	47.4	49.8	42.3	49.7	20.7	48.7	30.4	21.3	59.8	34.5	32.3	31.8	52.3	28.4	26.8	32.3	19.2	31.5	42.6	29.6	32.8	38.8	42.0	28.2	53.6	44.2	23.9	25.0	53.2	23.5	26.9	18.2	14.9	29.2	22.1	39.6	20.7	38.1	28.9	18.4	19.8	36.7	29.7	24.3	27.0	25.9	44.8	40.7	21.1	43.8	25.7	13.4	22.6	33.5	30.7	18.5	37.9	27.3	24.9	27.9	32.2	30.4	39.6	26.7	27.5	32.9	33.9	22.6	27.6	28.6	20.5	28.0	30.3	20.4	29.3	24.8	18.4	20.8	23.7	23.6	18.9	16.8	22.6	15.5	22.2	20.6
COPE	epsilon-COP	ENSG00000105669	"Coatomer protein complex subunit epsilon"	O14579	19	18899514-18919397	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034345, HPA041605, HPA043576"	Supported		Enhanced	"Golgi apparatus"			210000	"Golgi apparatus"		"CAB034345: AB_2081323, HPA041605: , HPA043576: "	"unprognostic (1.48e-1)"	"prognostic favourable (2.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.75e-2)"	29.8	44.6	44.7	43.1	48.1	72.4	25.8	25.8	56.3	36.2	37.8	47.7	32.5	48.1	29.5	32.6	40.9	30.7	32.4	40.0	40.5	39.5	48.4	113.3	30.2	42.7	46.1	36.3	30.6	62.4	23.5	44.8	45.9	39.5	34.3	20.7	33.8	75.5	38.8	35.3	30.8	46.3	23.0	44.5	41.8	41.0	41.8	33.3	65.5	52.3	30.8	45.3	31.7	27.4	57.6	98.3	90.3	89.8	48.0	64.5	112.2	30.7	30.0	17.2	30.5	15.7	18.6	49.7	27.0	25.9	30.4	34.7	36.0	25.2	25.1	36.7	22.7	20.9	14.1	27.2	6.0	15.5	63.0	14.9	27.0	54.4	41.9	29.6	38.4	22.7	25.8	18.4	20.2	23.8	22.8	64.6	15.3	73.2	32.1	56.2	32.4	71.8	36.9	15.5	73.7	19.6	31.1	24.1	38.6	16.9	27.4	29.3	23.1	48.7	23.8	19.3	14.3	48.9	28.4	62.1	54.1	30.6	33.1	51.5	32.0	84.3	89.8	90.3	53.8	77.3	47.3	57.6	51.7	47.1	78.9	51.2	38.7	44.1	89.5	48.0	64.4	98.3	64.5	112.2	44.7	48.1	25.8	56.3	40.5	39.5	46.1	36.3	39.5	33.3
COPG1	COPG	ENSG00000181789	"Coatomer protein complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"			110000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: "	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavourable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	25.2	39.4	21.1	22.2	28.0	20.1	37.3	23.6	50.3	43.3	42.1	24.3	50.6	34.2	27.6	66.5	29.5	24.4	34.5	33.4	24.2	26.7	32.4	72.1	36.5	39.4	23.0	21.6	28.6	75.6	47.6	49.7	49.3	34.9	45.1	45.1	22.4	59.9	45.5	24.1	24.3	32.4	29.1	20.7	29.0	36.3	23.6	16.2	26.9	33.0	22.0	27.7	19.9	24.1	15.7	31.9	34.9	33.0	31.1	31.8	26.0	32.4	16.5	24.1	20.9	56.6	45.9	25.8	52.9	50.6	36.5	46.2	30.3	20.2	17.8	30.8	75.2	19.6	19.9	31.2	39.8	21.7	8.2	29.6	21.8	48.9	51.6	22.4	31.8	47.9	27.5	29.2	48.2	32.8	10.3	43.1	43.9	49.3	13.1	22.8	14.4	20.2	14.2	22.7	34.5	45.5	27.0	15.1	17.6	40.6	30.4	48.5	33.6	32.8	44.4	19.9	18.9	42.0	20.4	33.7	16.1	31.2	48.6	17.1	38.1	34.9	26.8	20.2	26.2	33.0	31.8	15.0	23.7	25.7	31.9	15.7	18.5	21.6	21.3	31.1	29.7	29.4	23.6	26.0	21.1	28.0	23.6	50.3	24.2	26.7	23.0	21.6	34.9	16.2
COPRS	"C17orf79, COPR5, HSA272196, TTP1"	ENSG00000172301	"Coordinator of PRMT5 and differentiation stimulator"	Q9NQ92	17	31851864-31859337	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA052552	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA052552: "	"unprognostic (1.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.11e-2)"	20.9	19.0	32.6	9.7	31.0	6.3	30.3	23.0	37.6	15.3	24.2	11.8	15.6	8.0	15.2	57.3	10.5	24.9	14.9	24.7	28.2	35.5	22.7	31.0	12.3	9.2	29.7	31.3	24.3	20.7	12.2	18.9	9.4	23.9	27.5	13.6	16.0	14.6	23.5	19.9	7.8	7.9	21.2	16.0	8.1	14.1	75.0	14.4	2.6	28.1	11.2	12.7	16.1	18.5	5.8	4.5	3.5	3.5	0.0	3.0	0.4	21.5	28.4	14.3	14.6	23.4	22.5	10.0	24.2	30.3	27.7	28.4	17.7	5.8	12.2	13.5	28.8	12.9	25.1	14.5	31.5	4.1	37.6	3.3	16.3	20.8	23.8	11.4	9.8	14.4	19.1	37.3	20.5	14.8	16.6	10.2	30.1	18.6	16.9	36.3	10.8	14.3	13.5	26.5	22.1	16.2	13.3	12.9	10.0	14.3	6.9	22.1	22.8	12.3	8.3	73.0	19.8	26.0	33.5	17.5	16.2	12.4	38.2	10.6	9.8	3.5	3.5	0.0	1.1	3.3	3.0	3.8	1.1	0.2	4.5	5.8	0.6	0.7	1.2	0.0	1.6	1.8	1.5	0.4	32.6	31.0	23.0	37.6	28.2	35.5	29.7	31.3	23.9	14.4
COPS2	"ALIEN, CSN2, TRIP15"	ENSG00000166200	"COP9 signalosome subunit 2"	P61201	15	49106068-49155661	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016867, HPA018271, HPA061071"	Approved		Supported	"Vesicles,Cytokinetic bridge"			190000	Vesicles	"Cytokinetic bridge"	"HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: "	"unprognostic (3.47e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.10e-3)"	36.6	26.7	23.3	15.6	34.3	48.9	30.1	29.7	35.7	35.1	27.9	10.6	26.4	19.2	26.8	21.5	34.1	20.3	24.3	27.0	21.4	21.6	27.8	33.0	25.7	18.3	28.7	20.4	36.4	25.4	26.6	30.4	25.6	41.4	30.1	19.2	8.1	19.1	22.6	59.8	20.6	27.9	34.8	37.5	22.5	21.7	26.6	27.3	22.1	33.4	27.8	20.9	56.8	33.6	11.7	15.7	8.9	17.8	11.6	20.8	11.5	22.1	13.1	28.1	23.6	34.6	49.4	19.4	38.9	37.3	34.2	31.5	27.6	12.2	36.7	26.7	37.3	32.7	39.8	32.3	37.8	24.9	16.0	34.1	28.3	22.2	26.5	32.2	17.9	41.5	26.4	27.8	49.3	35.8	43.8	19.7	37.2	11.9	17.1	16.1	18.2	17.2	18.8	26.5	54.9	36.3	33.5	27.4	19.9	22.4	24.1	31.0	23.9	32.5	23.0	33.7	18.0	62.9	40.8	17.9	45.8	46.3	31.4	52.4	27.2	8.0	13.8	8.9	10.6	17.8	19.5	11.7	16.1	15.3	15.7	10.1	20.8	13.1	5.6	11.6	15.7	10.2	20.8	11.5	23.3	34.3	29.7	35.7	21.4	21.6	28.7	20.4	41.4	27.3
COPS3	"CSN3, SGN3"	ENSG00000141030	"COP9 signalosome subunit 3"	Q9UNS2	17	17246820-17281293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021997, HPA050557"	Approved		Supported	Nucleoplasm,Cytosol			29000	Nucleoplasm	Cytosol	"HPA021997: AB_1847152, HPA050557: "	"unprognostic (3.35e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavourable (1.56e-4)"	"prognostic unfavourable (8.65e-5)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-3)"	15.2	15.2	16.3	15.7	21.9	51.9	16.3	20.8	24.7	15.4	15.4	15.7	14.9	13.9	14.3	14.1	21.0	12.1	10.0	22.7	17.5	18.8	16.1	21.0	11.7	18.7	17.4	15.2	16.0	26.2	17.6	21.8	21.7	26.7	16.5	17.1	11.9	17.1	15.7	69.4	15.7	13.3	16.9	15.9	14.3	15.8	39.5	11.8	31.4	15.2	24.4	21.9	16.1	14.0	28.1	45.2	37.7	35.8	32.3	33.0	38.2	37.8	35.6	27.9	24.2	13.4	18.4	17.1	29.6	18.1	42.8	34.5	58.3	14.2	52.5	24.0	23.5	27.8	37.9	29.3	48.6	20.9	53.9	36.6	27.6	25.0	22.9	31.3	41.7	16.6	22.3	29.6	29.7	24.7	29.8	19.5	27.0	38.0	57.7	39.8	25.0	22.9	43.5	49.9	27.3	17.1	16.7	21.9	19.1	25.9	12.1	23.4	18.1	21.1	17.7	26.1	29.2	47.0	50.4	15.6	20.2	28.1	22.6	31.2	26.2	20.8	30.5	29.4	27.6	35.8	31.9	27.2	32.2	31.6	45.2	28.1	32.2	30.5	37.7	32.3	34.6	21.8	33.0	38.2	16.3	21.9	20.8	24.7	17.5	18.8	17.4	15.2	26.7	11.8
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036894, HPA042828"	Uncertain		Supported	"Nuclear speckles"			84000	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: "	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favourable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favourable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	16.3	24.1	22.5	12.5	35.8	21.1	19.4	20.8	33.0	20.5	15.6	13.4	11.5	13.8	19.2	18.0	20.6	16.1	13.5	34.9	22.0	28.9	23.3	18.3	13.1	16.0	24.2	25.4	20.2	14.5	22.3	32.0	21.7	35.7	18.8	15.4	11.6	14.1	19.4	55.1	16.3	12.9	20.1	15.6	17.0	14.3	27.6	14.6	24.8	23.2	23.9	18.6	20.8	14.9	20.3	22.4	34.2	27.7	25.4	28.5	24.1	16.9	10.1	22.1	20.1	19.8	25.5	12.0	22.5	29.3	25.8	23.0	14.5	17.7	29.0	19.9	47.4	12.9	27.3	23.2	35.0	18.2	19.3	16.8	16.6	13.9	16.4	28.3	47.8	19.2	16.2	19.3	16.5	34.2	21.0	16.4	31.2	14.1	33.7	20.9	12.1	13.8	24.2	16.7	15.9	20.7	15.7	23.3	13.6	15.0	23.8	14.3	17.9	15.6	22.3	18.1	19.3	13.6	16.0	17.2	10.4	31.9	17.4	18.4	17.8	34.2	18.4	26.0	22.9	24.9	28.5	20.3	25.4	26.2	22.4	18.6	24.3	26.0	4.2	25.4	27.7	14.6	23.1	24.1	22.5	35.8	20.8	33.0	22.0	28.9	24.2	25.4	35.7	14.6
COPS5	"CSN5, JAB1, MOV-34, SGN5"	ENSG00000121022	"COP9 signalosome subunit 5"	Q92905	8	67043079-67083783	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004242, HPA004845, HPA051531"	Supported		Enhanced	Nucleoplasm			27000	Nucleoplasm		"CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: "	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-2)"	20.2	26.3	29.4	19.6	28.6	16.2	28.1	28.5	40.3	18.0	21.7	15.6	20.2	22.0	17.6	21.7	24.0	17.7	15.5	46.8	27.6	27.5	27.4	33.7	16.8	17.5	31.8	29.9	17.0	20.7	23.3	21.7	24.3	33.7	18.3	25.5	9.9	19.6	18.9	64.0	16.8	22.5	23.3	39.2	16.1	20.7	27.4	31.3	19.6	18.5	29.2	22.4	18.3	16.5	20.7	35.1	33.7	30.0	26.5	28.1	22.3	30.2	28.7	24.4	22.3	25.7	27.4	19.4	26.7	21.9	37.1	33.4	18.6	37.3	28.1	12.3	27.5	25.3	32.7	29.4	40.9	26.9	28.2	39.9	28.9	24.9	24.9	25.2	24.3	24.9	37.7	30.2	39.0	36.1	47.2	19.5	33.2	28.1	44.3	44.2	32.4	33.1	28.5	17.5	22.1	39.2	27.0	14.8	20.4	15.3	29.7	25.8	48.8	26.0	26.7	18.8	23.3	22.7	20.8	24.6	31.3	37.4	27.5	28.7	25.6	26.0	28.6	33.7	20.8	30.0	21.7	20.7	20.1	23.1	35.1	17.5	21.6	19.1	21.2	26.5	28.3	18.4	28.1	22.3	29.4	28.6	28.5	40.3	27.6	27.5	31.8	29.9	33.7	31.3
COPS6	"CSN6, MOV34-34KD"	ENSG00000168090	"COP9 signalosome subunit 6"	Q7L5N1	7	100088954-100092200	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044315	Approved		Supported	Nucleoplasm	"Intracellular and membrane"		58000	Nucleoplasm		"HPA044315: AB_10959750"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (6.72e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-2)"	25.4	30.0	37.7	20.2	50.6	19.7	25.6	31.5	43.3	32.5	30.4	26.5	15.1	19.3	31.0	39.8	33.4	33.7	32.4	47.2	31.5	32.1	31.7	41.2	20.1	30.4	33.3	32.6	30.8	42.8	38.1	28.2	29.1	34.1	27.4	26.6	25.0	28.3	35.7	53.1	23.4	19.2	45.2	30.1	22.7	26.9	25.5	30.8	29.4	27.6	21.6	25.8	26.7	24.8	53.4	67.6	58.9	64.0	48.2	69.4	45.3	31.8	45.4	27.3	32.3	24.0	28.7	17.3	29.0	44.6	48.6	35.7	37.1	30.2	22.1	37.5	47.4	24.4	30.8	49.0	49.2	21.9	48.3	18.8	45.1	28.6	50.3	21.3	19.5	28.3	32.5	52.2	55.9	66.3	26.9	31.9	57.1	79.3	47.1	31.7	24.6	54.6	22.5	45.4	52.6	38.5	30.0	42.8	31.8	29.9	59.2	21.9	24.4	21.1	34.8	46.8	42.7	56.0	50.9	23.6	26.1	45.2	35.4	29.0	69.0	58.9	61.9	51.7	61.1	64.0	61.2	53.4	61.3	57.8	67.6	49.8	48.3	53.9	24.1	48.2	57.4	50.2	69.4	45.3	37.7	50.6	31.5	43.3	31.5	32.1	33.3	32.6	34.1	30.8
COPS7A	CSN7A	ENSG00000111652	"COP9 signalosome subunit 7A"	Q9UBW8	12	6723741-6731875	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026915	Supported		Supported	Nucleoplasm,Cytosol			66000	Nucleoplasm	Cytosol	"HPA026915: AB_1847156"	"unprognostic (3.50e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	24.1	26.0	31.6	16.6	38.1	8.8	20.5	29.6	59.5	18.2	18.5	25.0	14.1	15.8	20.1	27.9	29.1	25.8	20.1	42.2	29.6	27.9	26.2	29.6	18.8	14.6	31.6	36.9	20.1	23.1	33.9	24.3	25.4	45.3	24.7	17.5	23.8	22.1	24.5	44.6	20.9	14.1	24.2	22.5	16.2	18.1	14.9	13.9	9.2	26.1	29.6	17.6	22.7	17.6	13.7	27.1	35.9	28.4	11.5	16.5	17.8	18.8	20.0	9.6	9.4	28.6	34.2	23.5	23.3	30.5	23.6	24.0	13.9	26.4	13.1	10.1	31.1	15.3	13.0	23.8	22.6	17.9	14.5	12.2	13.7	17.6	24.7	12.8	7.6	31.7	23.1	27.8	55.4	18.3	8.7	5.3	33.1	15.3	7.4	8.1	25.9	18.4	5.1	19.7	12.9	20.0	19.0	5.5	13.0	15.3	19.5	25.6	8.3	18.6	18.8	25.2	13.2	22.1	22.4	6.1	6.5	10.5	42.9	16.6	27.5	29.4	23.1	35.9	15.9	28.4	16.5	11.3	13.7	14.2	27.1	13.7	14.2	14.0	18.7	11.5	22.5	16.8	12.1	17.8	31.6	38.1	29.6	59.5	29.6	27.9	31.6	36.9	45.3	13.9
COPS7B	CSN7B	ENSG00000144524	"COP9 signalosome subunit 7B"	Q9H9Q2	2	231781671-231809254	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034675, HPA034676"	Uncertain		Supported	Nucleoplasm			33000	Nucleoplasm		"HPA034675: AB_10696360, HPA034676: "	"unprognostic (3.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (4.77e-2)"	"prognostic unfavourable (8.37e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (1.50e-6)"	"unprognostic (2.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.55e-3)"	11.9	19.4	17.4	13.0	25.2	12.4	14.3	20.8	35.0	16.7	17.0	31.0	19.6	8.7	18.4	13.9	15.9	19.6	11.1	13.2	17.3	14.2	14.6	16.9	14.4	20.1	29.7	18.2	18.0	14.1	29.3	40.9	18.5	23.4	18.3	19.3	17.5	17.7	19.9	15.3	20.8	15.8	21.2	21.7	21.8	18.5	24.5	24.5	19.0	17.8	11.8	26.3	15.9	16.9	13.8	12.5	10.3	12.3	15.4	14.2	10.8	12.0	10.7	15.6	17.4	11.8	14.8	17.6	10.1	9.4	16.4	19.7	18.1	13.7	11.7	11.0	12.3	9.6	23.4	18.2	24.7	19.8	21.9	22.4	9.7	25.2	12.6	24.0	13.1	10.2	18.7	18.4	13.5	18.7	24.7	9.7	15.0	15.8	22.6	19.8	24.8	11.4	26.6	19.3	12.8	12.5	10.7	17.1	14.8	9.6	8.0	17.7	10.3	19.8	12.0	12.0	11.5	13.2	13.4	15.7	12.7	32.8	11.6	17.2	12.0	10.3	8.2	4.4	13.1	9.4	12.7	13.8	10.3	11.9	12.5	13.0	14.2	10.0	2.0	15.4	12.3	9.7	10.0	10.8	17.4	25.2	20.8	35.0	17.3	14.2	29.7	18.2	23.4	24.5
COPS8	"COP9, CSN8, MGC1297, SGN8"	ENSG00000198612	"COP9 signalosome subunit 8"	Q99627	2	237085312-237100466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 77.7;U-138 MG: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036485	Uncertain		Supported	Nucleoplasm,Cytosol			110000	Nucleoplasm	Cytosol	"HPA036485: AB_10670720"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavourable (4.70e-5)"	"unprognostic (1.34e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	20.1	23.1	25.2	15.6	37.0	15.7	17.9	15.2	33.8	20.6	14.0	16.7	8.6	7.7	20.9	18.3	12.5	18.0	19.9	37.8	31.7	27.9	24.2	15.6	12.3	13.5	23.6	25.8	23.7	10.8	18.2	15.0	19.8	28.1	16.6	11.7	18.6	12.7	18.1	64.5	12.3	9.7	25.4	21.3	10.4	13.5	20.8	15.4	14.8	17.5	20.3	14.5	18.0	13.2	32.4	26.9	26.1	25.9	32.2	36.2	31.7	9.4	8.0	17.6	8.7	50.5	40.0	11.7	16.7	16.6	17.2	19.1	5.2	9.6	6.5	6.4	18.1	7.2	17.2	22.7	24.0	15.3	11.1	9.5	10.3	18.5	34.9	12.3	5.6	65.8	26.3	17.2	77.7	20.0	13.1	6.3	54.2	9.0	15.1	12.6	15.5	11.8	11.6	20.9	13.0	21.2	7.7	8.6	14.9	10.0	8.6	24.8	9.9	10.1	21.0	92.0	15.5	18.0	18.0	12.1	10.0	20.9	28.7	7.5	23.2	21.9	22.8	26.1	29.7	25.0	36.2	32.4	31.7	33.8	26.9	26.9	30.8	32.1	7.0	32.2	25.9	19.4	33.1	31.7	25.2	37.0	15.2	32.3	31.7	27.9	23.6	25.8	28.1	15.4
COQ4	CGI-92	ENSG00000167113	"Coenzyme Q4"	Q9Y3A0	9	128322536-128334072	"Disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021406, HPA042945"	Supported		Supported	Mitochondria				Mitochondria		"HPA021406: , HPA042945: AB_10961047"	"unprognostic (9.15e-2)"	"prognostic favourable (2.97e-5)"	"unprognostic (2.29e-1)"	"prognostic favourable (4.93e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.89e-2)"	"prognostic favourable (5.76e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.14e-3)"	15.5	29.4	22.6	21.4	29.9	12.2	25.4	20.7	33.8	19.8	23.0	15.7	34.8	53.8	14.8	30.5	32.8	37.7	24.0	23.9	22.6	21.7	31.8	33.4	28.9	28.6	18.9	31.4	18.1	43.8	24.7	30.7	13.1	27.7	22.2	18.0	15.2	32.9	50.7	29.6	31.6	37.3	20.1	25.7	15.9	23.1	17.5	14.3	13.6	34.5	25.0	16.7	18.5	17.9	18.3	28.2	8.0	15.5	14.1	21.1	13.2	11.0	16.7	10.1	11.1	7.4	10.5	18.3	9.8	6.4	12.8	9.1	14.3	13.9	14.9	8.7	7.5	31.7	8.6	11.6	4.8	7.2	17.2	5.4	36.0	15.9	12.2	15.5	8.3	12.2	13.6	10.6	11.6	10.1	36.2	10.2	8.1	30.7	18.9	11.9	11.2	19.6	18.5	14.0	28.3	15.7	10.9	18.9	13.5	19.1	22.8	11.9	29.3	5.3	13.8	12.2	11.4	17.6	13.1	17.4	14.3	12.2	15.5	7.5	8.4	7.8	14.2	8.0	21.1	15.5	19.1	18.3	19.2	20.9	17.7	16.0	15.5	18.9	1.8	14.1	15.2	28.2	15.2	13.2	22.6	29.9	20.7	33.8	22.6	21.7	18.9	31.4	27.7	14.3
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226897536-226987545	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 216.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 33.0;RPMI-8226: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria				Mitochondria		"HPA061662: "	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	13.3	25.4	2.8	2.7	4.5	5.3	8.5	14.5	3.9	3.2	7.3	4.1	4.2	6.9	3.6	5.5	7.3	5.0	6.1	41.0	2.7	1.8	3.8	17.7	2.7	4.1	5.0	2.4	7.2	20.3	1.6	1.6	2.0	3.8	6.5	2.0	1.9	7.2	5.0	216.5	4.4	4.4	7.8	2.9	3.5	8.8	3.0	4.7	2.7	4.6	50.2	5.8	10.2	3.5	15.2	9.3	32.3	11.5	9.9	11.8	11.6	3.2	5.8	1.5	4.5	4.7	3.1	23.6	1.5	1.3	2.2	2.9	9.2	5.2	9.5	7.3	1.0	3.7	2.9	3.3	0.5	9.9	33.0	6.6	4.8	15.1	1.0	10.0	4.1	5.9	5.1	1.7	2.3	1.0	11.4	7.8	0.3	4.3	5.8	14.7	6.4	12.0	5.7	7.1	30.2	0.7	2.4	24.3	9.9	3.0	11.8	8.5	6.2	13.6	1.2	2.5	2.3	3.5	5.5	17.6	15.4	5.0	2.3	11.4	2.4	19.7	11.5	32.3	8.7	8.6	8.3	12.1	8.5	7.7	9.3	15.2	11.8	9.0	21.9	9.9	6.5	4.1	10.6	11.6	2.8	4.5	14.5	3.9	2.7	1.8	5.0	2.4	3.8	4.7
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	"Coenzyme Q8B"	Q96D53	19	40691529-40718207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	"unprognostic (7.57e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.65e-2)"	13.6	17.8	21.1	13.1	16.4	11.5	10.0	24.1	19.2	13.6	13.6	18.6	14.8	17.9	15.0	13.2	16.6	26.5	16.7	14.7	15.7	10.7	11.8	15.6	12.1	12.2	15.5	12.1	16.3	19.4	12.6	32.7	7.9	13.2	15.1	5.7	12.3	16.8	17.6	10.3	12.9	18.6	16.2	15.6	12.1	17.5	12.5	16.7	16.8	15.5	6.9	13.2	14.8	11.8	12.9	15.0	17.7	15.6	9.7	13.1	10.5	8.2	33.7	6.9	13.3	6.2	6.0	6.4	7.7	8.3	5.8	6.2	10.5	15.0	11.0	14.9	4.4	7.1	4.8	8.6	2.1	13.2	10.0	10.6	20.5	5.8	10.7	3.6	16.5	7.9	9.2	4.2	5.1	6.5	5.6	6.0	4.0	5.0	4.7	4.4	5.3	3.5	7.9	9.7	8.3	10.1	13.9	12.4	10.1	10.3	15.8	16.7	14.2	13.8	6.1	5.0	17.0	3.6	4.5	6.7	5.4	5.6	18.9	4.2	6.9	15.8	15.6	14.6	11.6	15.4	13.1	12.9	9.0	12.4	15.0	11.7	8.9	9.1	17.7	9.7	13.7	8.7	8.8	10.5	21.1	16.4	24.1	19.2	15.7	10.7	15.5	12.1	13.2	16.7
CORO1B	coronin-2	ENSG00000172725	"Coronin 1B"	Q9BR76	11	67435510-67443821	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017616, HPA040113, HPA070456"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			200000000	"Plasma membrane, Cytosol"		"CAB017616: AB_2087018, HPA040113: , HPA070456: "	"unprognostic (1.94e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.02e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.64e-3)"	26.0	24.0	12.6	20.6	16.1	9.7	21.6	9.7	19.0	25.8	37.0	20.3	23.1	35.0	28.7	34.0	31.2	25.6	35.3	15.2	12.6	11.0	27.5	36.4	21.6	23.3	15.9	10.7	21.2	24.2	15.4	16.1	29.2	14.3	31.4	19.1	20.5	42.5	27.4	9.2	16.7	44.7	20.5	14.8	34.7	29.8	13.9	16.5	16.1	31.6	23.3	20.0	25.8	20.8	4.2	17.5	10.9	47.1	2.4	12.3	11.7	18.9	18.6	9.0	18.4	23.4	20.4	13.5	13.4	28.5	23.1	17.5	31.1	28.1	0.6	28.1	19.0	16.4	10.1	17.9	4.1	4.3	8.8	13.3	12.2	13.3	37.3	0.2	28.7	27.6	16.0	19.5	9.0	29.1	9.8	2.0	13.1	54.0	2.9	1.5	11.6	17.6	2.6	9.4	3.3	15.5	23.7	10.2	12.7	12.7	34.6	41.7	43.3	15.2	23.0	15.8	11.4	21.3	8.3	0.3	0.6	3.0	25.4	1.8	15.9	10.9	22.9	1.7	1.9	47.1	1.4	4.2	9.3	3.0	17.5	1.4	5.3	2.3	10.9	2.4	45.8	13.5	12.3	11.7	12.6	16.1	9.7	19.0	12.6	11.0	15.9	10.7	14.3	16.5
CORO6	FLJ14871	ENSG00000167549	"Coronin 6"	Q6QEF8	17	29614756-29622907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 130.9"	"Cell line enhanced"	"Detected in many"		"REH: 12.2;RH-30: 13.9;SH-SY5Y: 17.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"basophil: 3.9;eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021556			Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA021556: "	"unprognostic (7.12e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-4)"	"unprognostic (9.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.00e-4)"	"unprognostic (6.70e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (9.61e-7)"	"unprognostic (8.48e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.13e-2)"	2.7	1.6	5.7	1.2	17.7	0.9	2.2	4.5	12.4	1.4	4.4	0.7	1.6	1.3	3.3	3.4	6.9	3.5	2.4	28.4	5.2	3.3	0.9	0.8	2.1	1.0	1.8	8.7	1.2	1.0	11.7	1.0	25.7	8.1	4.0	1.7	1.2	3.8	2.7	130.9	2.0	2.4	5.6	1.3	1.1	2.1	1.0	3.6	0.0	21.3	18.3	1.1	4.9	1.9	0.0	0.0	3.9	0.0	0.0	0.1	0.1	7.5	3.3	2.9	0.0	4.6	2.5	4.7	2.5	0.9	1.6	0.7	0.2	0.0	0.1	0.6	4.0	8.0	2.2	0.4	0.8	0.1	3.8	0.0	6.3	0.9	7.5	0.0	0.4	9.1	0.7	0.8	0.0	1.7	0.5	0.1	5.4	0.0	5.0	0.2	1.0	0.1	12.2	13.9	0.3	0.4	0.0	0.0	17.1	0.7	2.3	0.0	0.0	1.1	0.5	1.1	0.0	1.3	1.1	6.4	3.4	0.9	2.4	0.0	0.0	3.9	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	17.7	4.5	12.4	5.2	3.3	1.8	8.7	8.1	3.6
COTL1	CLP	ENSG00000103187	"Coactosin like F-actin binding protein 1"	Q14019	16	84565594-84618077	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Chaperone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 206.6;lymphoid tissue: 103.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 110.8;eosinophil: 160.2;intermediate monocyte: 190.1;myeloid DC: 117.3;neutrophil: 86.8;non-classical monocyte: 206.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 117.3;granulocytes: 160.2;monocytes: 206.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008918, CAB062328"	Enhanced		Supported	Cytosol			28000000	Cytosol		"CAB062328: AB_2084785, HPA008918: "	"unprognostic (2.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.70e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.35e-3)"	28.6	9.9	20.4	68.1	19.5	57.7	13.7	12.4	18.1	7.6	16.5	25.3	2.4	22.0	13.2	8.4	8.2	13.2	18.7	7.2	19.6	24.9	34.3	12.4	26.6	103.0	28.9	8.1	10.8	7.5	5.1	13.1	29.4	23.2	11.8	16.7	30.8	7.7	7.6	5.1	5.1	26.1	16.2	27.8	92.3	29.6	8.0	13.4	33.0	10.1	5.2	62.0	29.3	7.6	28.5	117.3	160.2	206.6	30.8	32.5	108.3	52.7	44.1	101.0	106.6	11.6	32.0	30.5	46.0	29.7	36.3	14.0	59.8	82.0	14.6	14.1	34.5	26.6	6.1	36.2	36.6	0.1	7.8	27.5	9.3	15.8	32.7	30.8	109.2	25.5	5.8	35.0	31.3	17.3	2.5	6.1	21.6	8.5	9.4	18.6	12.4	45.2	1.0	3.4	0.9	53.3	22.5	16.0	0.8	42.9	10.3	22.9	7.7	25.1	44.3	52.3	29.8	16.8	33.4	1.1	5.5	12.0	40.9	15.0	127.4	29.6	110.8	160.2	3.6	190.1	4.8	28.5	23.0	21.7	117.3	13.2	10.3	12.1	86.8	30.8	206.6	6.0	32.5	108.3	20.4	19.5	12.4	18.1	19.6	24.9	28.9	8.1	23.2	13.4
COX10		ENSG00000006695	"COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor"	Q12887	17	14069496-14208677	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Heme biosynthesis"	Transferase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 34.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol				Mitochondria	"Nucleoli, Cytosol"	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favourable (4.32e-6)"	"prognostic favourable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	5.5	6.9	5.3	5.7	6.5	7.0	5.4	6.5	7.2	4.4	11.8	4.1	2.9	9.7	5.1	3.6	9.4	4.8	3.5	18.9	5.8	3.8	10.0	9.3	5.2	8.4	4.5	2.8	4.9	9.6	7.2	6.4	6.6	5.7	5.2	10.1	5.5	6.7	4.8	34.9	6.0	10.9	7.2	4.0	4.6	7.7	15.5	4.9	5.9	5.2	9.6	7.4	7.2	5.8	11.9	13.6	4.0	14.1	8.8	17.5	9.8	8.6	16.6	6.9	9.9	6.9	6.3	15.7	10.5	7.4	19.2	13.3	14.5	6.4	20.4	8.3	10.5	16.7	14.1	13.5	15.5	11.0	14.1	12.1	13.4	16.0	12.2	12.5	11.4	9.1	17.0	12.0	15.3	10.1	16.4	7.0	8.4	10.7	10.6	8.2	10.5	8.6	8.9	23.4	14.4	12.1	16.2	5.2	8.8	10.8	14.4	13.0	8.1	7.1	8.3	8.4	7.0	8.5	13.2	8.5	11.9	9.2	12.6	13.0	10.3	3.0	10.6	4.0	9.9	14.1	10.4	11.9	11.6	10.3	13.6	8.2	12.6	11.9	1.2	8.8	11.9	4.6	17.5	9.8	5.3	6.5	6.5	7.2	5.8	3.8	4.5	2.8	5.7	4.9
COX14	"C12orf62, MGC14288"	ENSG00000178449	"COX14, cytochrome c oxidase assembly factor"	Q96I36	12	50111979-50120457	"Disease related genes, Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044618, HPA062014"	Approved		Supported	Mitochondria				Mitochondria		"HPA044618: AB_10960419, HPA062014: "	"unprognostic (5.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.20e-3)"	"prognostic unfavourable (7.90e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-3)"	33.1	30.2	25.9	16.7	33.7	17.5	27.8	46.4	28.9	18.5	24.0	16.7	29.7	28.1	13.9	34.0	17.6	17.1	22.1	60.1	23.4	24.9	39.5	40.4	18.2	18.6	29.6	28.7	16.6	19.6	19.5	26.1	15.0	27.8	18.5	22.0	25.1	26.4	30.5	75.4	13.1	27.1	20.5	24.8	19.0	20.9	8.4	26.6	8.7	25.4	38.5	16.7	19.3	21.8	56.8	65.7	56.4	52.2	38.7	58.6	52.5	16.4	31.6	7.0	15.9	31.1	19.1	14.0	12.7	16.4	18.7	16.2	30.1	21.3	15.5	36.6	15.4	16.0	11.8	17.9	16.2	17.0	44.5	30.4	28.0	24.3	13.0	23.7	27.1	24.0	24.8	14.0	16.3	17.1	14.7	30.2	19.0	36.0	19.2	33.7	11.5	42.5	15.8	12.3	35.5	27.1	27.3	18.7	11.1	19.4	35.1	36.9	23.4	20.1	14.9	11.6	12.7	18.9	11.1	22.1	31.6	18.8	17.0	20.6	6.3	56.4	52.2	46.0	43.2	48.9	45.4	56.8	54.5	47.6	49.5	47.1	52.0	50.9	18.8	38.7	44.3	65.7	58.6	52.5	25.9	33.7	46.4	28.9	23.4	24.9	29.6	28.7	27.8	26.6
COX15	CEMCOX2	ENSG00000014919	"COX15, cytochrome c oxidase assembly homolog"	Q7KZN9	10	99711844-99732100	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037727, HPA037728, HPA066096"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: "	"unprognostic (9.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.34e-2)"	"prognostic favourable (9.21e-6)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.40e-2)"	14.0	31.6	15.5	13.5	23.8	7.8	15.3	15.2	25.6	13.8	17.9	23.0	14.2	15.5	18.2	15.5	17.3	16.4	16.8	19.3	14.4	15.5	25.3	27.1	11.0	15.4	15.2	16.2	20.7	15.3	17.0	26.7	17.1	22.7	15.9	20.1	21.9	13.5	14.0	28.8	14.4	14.1	16.0	14.6	17.0	15.1	14.2	14.0	21.0	18.9	12.0	23.0	19.4	13.6	17.4	18.0	21.7	23.1	11.7	13.0	12.9	14.5	31.5	13.4	29.2	19.3	15.1	10.9	11.2	14.3	16.9	16.0	23.5	20.9	27.2	18.4	9.7	21.5	28.6	15.7	18.4	12.5	14.0	15.6	16.0	24.3	20.3	21.0	14.9	16.4	14.6	17.8	28.9	17.6	17.7	21.1	15.4	15.4	15.1	15.5	14.8	14.9	18.7	19.5	17.5	15.6	10.5	11.0	18.2	20.1	11.0	19.0	42.1	8.7	13.9	8.8	12.6	13.1	16.6	17.2	22.3	18.3	15.6	34.1	7.4	21.7	17.4	16.4	10.7	20.1	12.4	17.4	12.2	12.3	18.0	16.5	12.6	12.9	13.3	11.7	23.1	8.3	13.0	12.9	15.5	23.8	15.2	25.6	14.4	15.5	15.2	16.2	22.7	14.0
COX16	"C14orf112, HSPC203"	ENSG00000133983	"COX16, cytochrome c oxidase assembly homolog"	Q9P0S2	14	70325081-70359731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062659	Uncertain		Supported	Mitochondria				Mitochondria		"HPA062659: "	"unprognostic (5.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"prognostic favourable (1.03e-12)"	"unprognostic (4.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.72e-1)"	19.3	25.2	23.6	15.4	20.4	10.9	23.5	14.8	23.3	16.2	19.6	16.8	16.8	21.8	12.4	29.6	19.9	18.3	18.5	24.0	19.4	20.1	30.6	40.6	15.3	16.0	20.9	16.2	16.9	32.3	12.3	18.3	19.1	20.3	19.7	21.2	13.4	28.9	16.7	39.7	17.0	24.6	11.3	20.6	23.5	24.4	11.7	15.3	19.9	25.9	29.2	18.4	14.2	14.2	22.3	22.9	11.1	17.2	20.4	19.4	18.0	31.4	14.8	18.8	18.1	11.9	18.4	14.5	16.3	14.4	15.2	15.9	10.7	29.4	10.5	12.2	15.1	13.0	13.8	17.1	19.9	9.2	14.8	11.8	11.9	10.7	6.9	13.7	14.7	16.3	12.8	9.5	9.3	16.4	8.4	16.6	18.7	25.2	20.5	14.2	18.9	22.5	15.0	18.8	17.2	20.2	14.7	20.7	18.1	15.5	30.7	11.0	23.0	20.2	15.5	14.1	25.7	14.7	15.5	14.8	12.6	9.6	24.9	5.1	16.6	11.1	16.7	3.9	13.3	17.1	15.5	22.3	17.2	15.2	17.6	17.9	17.3	17.6	1.3	20.4	17.2	22.9	19.4	18.0	23.6	20.4	14.8	23.3	19.4	20.1	20.9	16.2	20.3	15.3
COX17		ENSG00000138495	"COX17, cytochrome c oxidase copper chaperone"	Q14061	3	119654513-119677454	"Cancer-related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042226, HPA048158"	Supported		Supported	Mitochondria			1000000	Mitochondria		"HPA042226: , HPA048158: "	"unprognostic (1.98e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.11e-3)"	"unprognostic (2.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.64e-2)"	16.6	42.9	20.0	18.2	19.4	21.2	30.4	21.1	20.4	10.2	16.8	9.2	43.5	22.0	11.9	22.9	11.7	11.0	13.6	53.5	17.2	23.0	27.6	37.0	17.8	20.3	23.2	15.2	7.9	39.9	21.1	45.7	18.2	33.7	17.2	16.2	19.4	25.6	33.3	80.4	8.7	21.0	15.4	20.8	15.3	22.3	13.4	16.7	11.1	16.6	37.1	17.2	13.7	20.1	35.6	53.5	52.8	46.9	19.8	33.9	22.0	27.2	28.5	15.6	3.8	6.0	5.6	5.6	15.2	9.2	14.1	14.7	25.1	19.8	19.7	18.5	7.2	10.3	15.4	15.5	8.5	24.8	18.5	17.1	22.6	19.8	6.9	24.9	32.0	6.4	15.0	8.8	12.1	9.1	13.9	47.5	16.3	44.4	25.0	35.9	17.5	47.6	11.1	10.5	32.6	21.9	16.1	26.0	11.4	18.8	18.1	22.8	22.7	39.7	7.2	12.1	19.0	7.6	20.9	33.8	33.7	41.8	17.2	19.1	20.8	50.1	22.4	52.8	21.8	33.2	23.0	35.6	27.2	24.7	22.9	27.2	21.7	22.6	17.7	19.8	46.9	53.5	33.9	22.0	20.0	19.4	21.1	20.4	17.2	23.0	23.2	15.2	33.7	16.7
COX19	MGC104475	ENSG00000240230	"COX19, cytochrome c oxidase assembly factor"	Q49B96	7	898778-975599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021226	Approved		Supported	Cytosol				Cytosol		"HPA021226: AB_1847176"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-3)"	8.1	22.1	11.9	9.4	15.8	16.6	9.6	25.4	13.3	8.6	10.2	14.5	10.8	15.7	9.2	8.5	10.2	15.0	8.3	9.5	11.3	9.7	10.6	9.9	8.8	11.4	18.5	10.4	12.7	16.4	13.9	13.7	8.4	14.1	10.8	10.5	8.0	13.3	9.0	18.9	16.5	13.3	8.7	12.6	13.6	13.4	11.2	15.3	8.5	10.5	12.4	11.6	9.2	9.9	12.5	15.0	15.1	9.9	10.1	15.2	7.6	14.5	3.6	4.3	5.5	3.2	4.6	8.4	6.4	4.7	5.8	4.9	9.8	8.2	7.1	2.2	3.9	9.8	4.5	4.7	4.7	2.2	7.4	3.2	4.5	7.5	10.0	7.4	6.9	5.5	10.0	4.5	10.5	3.7	9.0	6.0	3.7	8.8	3.4	7.9	11.2	9.7	7.7	0.8	3.5	4.8	6.2	5.7	5.7	3.8	15.0	11.7	7.9	17.7	4.4	5.7	8.0	6.4	9.9	7.4	5.3	7.3	5.1	10.4	9.6	15.1	9.9	13.9	11.2	9.7	11.8	12.5	12.1	10.1	8.4	12.2	15.2	14.3	9.5	10.1	9.9	15.0	11.1	7.6	11.9	15.8	25.4	13.3	11.3	9.7	18.5	10.4	14.1	15.3
COX20	"FAM36A, FLJ43269"	ENSG00000203667	"COX20, cytochrome c oxidase assembly factor"	Q5RI15	1	244835322-244845057	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043617, HPA045490"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA043617: AB_10965694, HPA045490: AB_10962869"	"unprognostic (5.84e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"prognostic favourable (3.13e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.02e-3)"	13.1	37.9	30.2	17.5	28.9	12.5	14.9	22.0	25.8	11.8	20.5	11.8	9.3	18.2	17.5	16.9	20.6	11.4	16.2	35.4	22.8	27.7	36.7	23.6	11.1	13.4	32.1	18.3	26.7	15.1	14.3	15.1	15.0	19.2	20.2	11.8	27.9	11.3	15.5	33.3	8.1	19.4	42.5	22.0	10.1	17.9	21.1	17.0	10.4	17.5	20.2	10.7	23.0	16.5	18.2	16.3	11.6	18.4	12.2	22.5	10.5	36.2	9.1	9.2	28.7	6.3	4.8	21.6	15.3	10.2	8.7	7.9	25.9	25.4	5.5	19.4	10.3	9.5	4.8	12.3	11.9	15.4	3.3	10.6	13.4	23.8	8.4	26.1	16.4	4.3	5.9	12.9	9.0	10.0	21.9	23.0	18.0	9.0	14.0	11.6	24.3	18.9	10.3	11.4	33.6	16.3	8.6	5.4	14.7	19.1	10.1	19.8	18.7	7.5	19.4	19.5	25.7	17.0	32.8	36.5	50.1	11.7	24.9	29.1	18.6	5.7	8.8	11.6	15.4	18.4	15.1	18.2	18.3	16.8	15.0	16.0	11.0	16.9	1.7	12.2	17.8	16.3	22.5	10.5	30.2	28.9	22.0	25.8	22.8	27.7	32.1	18.3	19.2	17.0
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807044	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria			970000	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favourable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	41.6	38.6	101.1	54.0	100.2	66.5	60.6	51.6	86.9	38.1	87.1	38.9	43.9	77.6	33.9	69.3	54.7	50.4	59.8	218.6	82.3	73.0	59.7	69.5	29.6	49.1	100.1	65.9	45.4	71.2	55.7	36.3	36.8	57.0	37.6	98.4	40.6	65.9	53.1	172.3	48.0	76.5	51.2	58.4	40.1	56.5	21.8	38.7	46.6	49.1	112.6	70.2	47.1	52.4	123.0	144.1	74.8	130.8	74.7	121.9	222.6	44.1	72.0	48.9	65.3	90.7	85.1	84.5	40.3	82.5	76.4	38.2	121.7	66.9	72.4	49.6	64.2	88.9	69.6	81.0	68.0	24.6	71.9	40.4	60.9	118.2	81.8	36.6	30.1	98.6	125.8	62.5	85.4	79.7	67.9	29.7	64.7	159.1	73.4	113.6	65.7	84.8	83.3	30.8	63.3	113.3	87.6	58.2	47.3	85.4	54.3	65.3	79.6	102.4	56.0	38.3	44.4	35.2	43.1	60.0	57.0	166.4	58.5	72.7	43.0	50.9	130.8	74.8	72.5	112.8	88.4	123.0	96.3	85.0	144.1	116.1	121.9	100.0	50.7	74.7	98.6	107.7	102.7	222.6	101.1	100.2	51.6	86.9	82.3	73.0	100.1	65.9	57.0	38.7
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646040-97648383	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 336.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria			2200000	Mitochondria		"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (2.73e-4)"	39.8	25.3	54.5	20.8	46.1	27.6	23.9	22.6	46.4	19.5	58.6	16.0	27.6	44.5	13.1	22.3	31.9	19.4	24.0	160.6	39.9	36.0	44.8	52.5	13.8	16.1	48.1	32.5	17.7	24.6	19.9	17.5	18.1	39.0	21.5	31.5	14.3	36.5	29.2	336.2	18.9	38.6	19.9	30.8	17.9	40.4	13.4	23.0	14.2	25.8	65.4	15.3	19.4	16.7	85.1	111.2	115.8	122.5	48.1	83.6	145.2	19.5	22.9	14.1	23.4	16.7	15.2	61.0	25.2	14.1	16.7	18.7	63.1	20.5	33.0	54.2	16.1	29.9	16.3	25.3	7.6	25.7	69.2	44.4	25.3	75.3	32.1	42.2	32.6	28.1	22.4	16.1	12.6	14.3	32.6	14.6	12.9	48.4	26.6	61.1	27.8	120.1	26.1	24.3	49.4	22.5	30.1	28.1	30.0	24.5	29.6	47.3	15.7	44.1	26.0	15.3	26.1	24.5	16.2	38.1	36.0	25.2	27.8	36.2	15.8	96.9	122.5	99.8	54.7	114.1	52.6	85.1	66.3	57.1	111.2	68.8	64.5	57.5	115.8	48.1	95.9	75.8	83.6	145.2	54.5	46.1	22.6	46.4	39.9	36.0	48.1	32.5	39.0	23.0
COX6A1	COX6A	ENSG00000111775	"Cytochrome c oxidase subunit 6A1"	P12074	12	120438090-120440742	"Disease related genes, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062394	Approved		Supported	Mitochondria				Mitochondria		"HPA062394: "	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.82e-1)"	"prognostic favourable (6.50e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.63e-2)"	49.2	48.0	171.0	32.1	103.0	52.6	43.8	44.4	107.5	37.3	96.8	38.5	32.4	102.8	28.0	47.0	59.3	41.8	37.6	41.5	121.5	92.0	85.8	102.6	32.4	39.6	140.0	57.9	27.7	62.7	43.8	38.3	44.4	86.9	43.1	74.3	31.3	63.8	44.2	10.6	37.7	85.7	38.1	67.2	32.1	60.8	28.1	61.2	33.7	48.2	36.0	40.1	42.1	35.0	74.5	102.2	60.5	69.8	47.8	87.4	83.0	46.7	100.0	57.0	59.5	43.9	37.4	69.8	29.8	39.8	52.9	45.2	120.9	47.7	98.5	89.1	42.0	78.2	55.5	65.3	34.4	59.0	119.6	52.8	57.2	88.6	40.6	57.9	38.0	45.0	80.7	48.3	57.3	44.5	51.8	30.8	43.9	130.8	83.4	146.6	51.9	146.8	57.1	38.2	92.2	83.5	112.7	75.2	65.4	54.6	53.6	70.0	96.1	66.1	33.5	33.0	40.8	34.0	41.4	47.9	65.8	76.2	51.8	56.8	43.9	38.5	65.5	58.3	54.4	69.5	58.5	74.5	64.3	59.5	95.1	59.2	59.1	59.3	60.5	47.8	69.8	102.2	87.4	83.0	171.0	103.0	44.4	107.5	121.5	92.0	140.0	57.9	86.9	61.2
COX6B1	"COX6B, COXG"	ENSG00000126267	"Cytochrome c oxidase subunit 6B1"	P14854	19	35648223-35658861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004192	Supported		Supported	Mitochondria			1200000	Mitochondria		"HPA004192: AB_1847180"	"unprognostic (5.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.88e-1)"	"prognostic favourable (5.42e-4)"	"unprognostic (2.10e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.48e-3)"	37.2	32.2	62.1	32.1	58.7	46.2	42.8	31.1	57.6	34.1	65.0	25.2	41.2	52.7	27.1	70.2	52.4	36.3	39.8	132.5	51.5	52.2	61.1	68.9	24.7	40.4	57.4	60.2	29.2	41.1	41.4	28.8	30.2	39.2	30.2	77.1	31.8	54.9	44.2	168.4	35.1	63.2	37.6	38.7	30.7	42.0	21.0	29.0	42.7	37.6	110.6	52.7	33.8	31.6	110.6	115.5	111.1	116.1	61.2	107.9	167.5	42.8	102.5	44.5	59.3	58.5	59.9	41.3	34.9	53.0	57.7	58.4	83.6	43.2	48.4	61.9	55.0	31.5	71.3	59.3	56.8	56.2	48.9	82.8	54.8	81.9	46.2	74.4	43.2	70.3	74.4	53.9	31.3	56.0	51.6	72.5	58.0	83.0	52.2	54.9	33.0	69.1	45.3	48.9	80.0	131.6	85.7	39.1	44.7	56.2	96.9	34.5	38.4	80.8	33.4	33.4	38.3	35.4	54.3	43.5	52.2	65.7	44.1	57.7	42.9	87.7	108.6	94.7	65.5	116.1	62.4	110.6	90.5	76.1	111.8	92.7	89.6	79.4	111.1	61.2	107.8	115.5	107.9	167.5	62.1	58.7	31.1	57.6	51.5	52.2	57.4	60.2	39.2	29.0
COX6C		ENSG00000164919	"Cytochrome c oxidase subunit 6C"	P09669	8	99873200-99894062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014295, CAB016244"	Enhanced		Enhanced	Mitochondria			53000	Mitochondria		"CAB016244: AB_2085703, HPA014295: "	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	20.5	43.1	66.1	21.6	56.2	44.4	23.3	28.5	63.8	18.7	46.0	14.3	29.4	113.7	38.8	64.1	31.6	27.4	23.5	113.0	54.8	46.9	38.7	66.8	18.2	23.2	58.8	36.7	32.7	26.5	12.1	24.0	30.7	38.8	23.3	38.1	20.6	32.4	30.1	232.1	31.2	55.8	38.7	40.4	23.7	35.1	29.6	23.5	17.9	19.5	80.6	17.8	31.0	21.3	45.9	62.3	55.7	50.6	37.2	73.5	48.0	16.7	6.7	7.9	32.2	18.0	13.1	13.2	5.5	5.2	3.8	4.3	6.8	35.9	40.7	41.6	8.5	22.3	4.5	45.6	6.3	7.3	11.4	84.4	8.1	19.8	11.7	38.9	26.1	12.1	60.7	3.1	7.0	5.6	5.9	73.1	6.3	16.0	40.4	35.8	15.1	15.6	46.9	2.6	39.8	57.2	89.2	24.5	14.9	3.8	83.6	40.8	58.9	24.9	4.8	28.6	37.2	30.2	7.8	18.2	14.6	24.1	40.2	15.8	25.3	55.7	29.3	22.1	40.1	42.3	41.8	45.9	61.0	42.5	43.8	41.7	73.5	65.7	3.5	37.2	50.6	62.3	56.9	48.0	66.1	56.2	28.5	63.8	54.8	46.9	58.8	36.7	38.8	23.5
COX7A2L	"COX7AR, COX7RP, EB1, SIG81"	ENSG00000115944	"Cytochrome c oxidase subunit 7A2 like"	O14548	2	42333546-42425088	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059124, CAB073545"			Enhanced	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"CAB073545: , HPA059124: "	"unprognostic (3.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (4.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.02e-1)"	25.1	73.3	47.3	24.4	63.3	47.7	45.4	35.2	58.2	33.4	33.8	21.0	28.8	31.7	30.2	37.9	20.9	31.2	27.1	49.8	40.4	45.3	50.9	48.9	24.0	28.1	42.6	35.6	49.8	49.3	24.9	42.7	24.0	34.9	29.5	36.2	32.3	37.0	30.3	24.4	21.5	32.1	28.4	33.1	23.1	29.4	24.8	20.5	28.0	35.8	35.8	30.9	24.5	31.1	45.1	59.7	57.2	48.7	40.5	53.7	100.9	37.5	24.1	26.8	29.0	46.0	65.6	32.0	31.2	45.6	28.5	36.4	26.4	27.2	33.3	31.3	35.7	16.9	31.9	33.0	41.8	51.2	24.5	22.5	17.3	46.8	54.2	33.8	25.1	64.3	66.6	27.9	67.4	40.1	32.8	57.2	44.1	30.6	40.3	56.3	26.2	25.1	22.0	46.5	28.3	40.8	30.5	31.8	36.4	13.1	32.9	89.4	23.6	39.5	30.2	25.9	33.9	31.3	30.4	47.0	52.5	25.0	36.6	36.8	21.9	57.2	48.7	27.2	39.0	42.0	50.0	45.1	47.9	45.3	53.1	37.6	53.7	46.1	21.6	40.5	46.3	59.7	52.8	100.9	47.3	63.3	35.2	58.2	40.4	45.3	42.6	35.6	34.9	20.5
CPEB1	"CPEB, FLJ13203"	ENSG00000214575	"Cytoplasmic polyadenylation element binding protein 1"	Q9BZB8	15	82543201-82648861	"Predicted intracellular proteins"	"mRNA processing, Translation regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.0"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 15.8;U-2197: 45.7;U-87 MG: 16.6"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.5"	"Group enriched"	"Detected in many"	27	"B-cells: 1.8;T-cells: 3.5"									HPA040396			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA040396: "	"unprognostic (3.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.50e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	2.1	5.6	7.5	1.6	10.8	0.5	2.1	11.9	15.7	5.2	5.3	9.4	0.2	1.6	4.2	8.7	4.0	9.2	4.3	2.9	6.2	6.2	1.6	0.8	1.9	0.8	12.4	9.0	15.4	1.6	1.4	8.3	0.6	13.0	2.7	2.9	3.9	1.4	4.4	2.2	1.5	2.2	3.9	7.7	0.9	2.6	32.0	8.1	0.0	2.7	0.0	0.8	5.5	3.8	1.8	0.0	0.0	0.0	0.0	3.5	0.6	0.0	1.5	0.1	0.1	1.1	0.0	0.0	1.2	0.1	0.7	0.6	0.0	0.0	0.0	2.7	0.4	0.0	2.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.8	0.0	1.0	0.6	0.0	1.5	0.0	0.0	3.6	0.0	0.5	0.0	0.2	0.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	4.5	1.0	3.9	0.2	15.8	0.0	0.5	0.0	8.3	3.3	45.7	2.5	2.3	5.8	0.6	16.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.7	1.8	0.3	1.8	0.0	0.5	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.6	7.5	10.8	11.9	15.7	6.2	6.2	12.4	9.0	13.0	8.1
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047259, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"			160000	"Nucleoplasm, Nuclear membrane"		"HPA047259: , HPA072634: "	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	32.0	25.3	23.1	32.9	25.6	36.5	31.8	34.0	24.7	35.5	31.5	23.9	26.3	18.4	38.8	35.1	30.8	34.3	27.8	22.1	22.1	16.0	25.4	23.2	33.3	28.7	22.0	24.8	41.6	27.5	21.5	33.3	39.3	19.4	30.0	27.6	27.4	27.9	25.9	23.9	32.9	31.9	40.5	19.2	42.4	26.3	25.6	23.1	64.8	36.3	27.1	44.4	34.9	33.7	39.4	43.9	52.1	31.0	60.1	53.8	44.7	41.0	32.5	18.5	7.7	2.3	3.1	14.1	19.9	35.6	48.4	32.0	97.7	18.1	28.9	19.2	29.5	15.9	14.3	37.6	30.0	5.4	10.9	72.9	25.6	70.7	22.3	23.6	10.2	20.7	38.8	19.5	23.2	30.5	9.5	14.8	23.5	22.6	35.0	31.7	4.5	31.5	25.0	55.4	19.7	19.7	29.7	13.0	14.6	44.9	21.4	30.4	22.2	23.6	19.9	51.4	9.4	16.7	20.9	10.0	10.1	20.0	37.0	13.0	11.3	13.6	31.0	52.1	39.6	30.4	53.8	39.4	38.0	36.6	43.9	37.0	37.7	37.4	42.9	60.1	28.9	24.0	46.0	44.7	23.1	25.6	34.0	24.7	22.1	16.0	22.0	24.8	19.4	23.1
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514427-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol			52000	"Nucleoplasm, Cytosol"	"Nucleoli, Mitochondria"	"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favourable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	26.5	16.6	21.3	9.8	18.0	35.1	20.6	18.8	13.5	26.0	16.4	20.9	13.2	15.1	28.6	12.6	40.5	15.9	14.6	24.4	17.6	19.7	29.8	25.5	16.9	22.6	19.7	10.5	26.7	24.1	25.4	28.9	16.1	17.0	22.4	16.5	21.0	20.6	15.3	10.4	18.7	19.5	20.9	18.7	18.3	16.9	9.7	14.1	30.5	33.6	21.8	29.7	25.4	20.0	14.6	31.4	28.2	24.3	15.0	18.3	14.4	34.3	12.1	8.4	10.9	32.4	25.3	6.9	16.5	24.6	13.8	15.7	7.8	11.8	9.4	11.0	20.1	26.6	18.0	17.6	24.9	10.0	14.1	1.5	8.9	9.3	11.2	0.8	0.8	17.1	19.0	15.3	20.4	16.9	8.4	18.2	17.1	13.3	16.5	0.5	3.2	17.6	7.9	7.7	44.0	17.9	24.7	17.8	14.0	14.4	66.0	10.4	25.1	2.6	18.0	12.4	12.1	16.4	12.8	13.0	15.6	2.6	17.8	3.5	11.4	10.8	16.7	26.4	18.3	19.1	14.2	14.6	14.8	12.8	30.8	14.1	13.3	14.3	28.2	15.0	24.3	31.4	10.5	14.4	21.3	18.0	18.8	13.5	17.6	19.7	19.7	10.5	17.0	14.1
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98521132-98593723	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Cell line enhanced"	"Detected in all"		"HEL: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Enhanced	Mitochondria			140000	Mitochondria		"HPA015736: AB_1847194, HPA054448: "	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	6.6	8.9	12.6	9.0	29.9	30.2	6.6	10.1	21.1	7.5	8.2	29.6	5.7	17.7	8.8	6.4	14.1	6.4	7.2	6.9	17.5	11.7	5.6	29.3	6.3	9.1	42.9	16.2	9.5	6.9	9.9	5.5	14.8	23.7	7.4	10.3	3.4	7.2	7.2	8.5	10.8	12.3	7.7	32.8	9.1	7.7	3.9	36.0	7.7	6.2	7.0	9.8	8.5	10.4	1.7	1.7	0.0	2.1	2.1	3.0	0.7	16.3	7.9	7.0	12.4	13.2	9.8	20.3	10.5	7.6	10.9	12.4	13.1	5.1	1.7	11.9	5.5	11.9	8.7	11.4	18.6	5.2	7.6	56.9	4.5	16.9	6.7	12.0	13.5	7.7	9.6	10.3	4.3	10.3	10.9	7.4	10.2	5.0	12.1	10.3	8.3	14.5	8.6	16.0	7.5	9.2	6.8	4.6	4.6	11.1	3.8	31.6	5.9	7.7	8.6	16.2	15.9	9.2	7.7	11.3	8.9	9.1	16.1	13.2	11.8	0.0	2.1	0.0	1.4	1.0	2.5	1.7	2.4	2.9	1.7	1.5	0.8	3.0	0.0	2.1	0.7	1.1	1.1	0.7	12.6	29.9	10.1	21.1	17.5	11.7	42.9	16.2	23.7	36.0
CPPED1	"CSTP1, FLJ11151"	ENSG00000103381	"Calcineurin like phosphoesterase domain containing 1"	Q9BRF8	16	12659799-12804017	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 44.4;HMC-1: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 93.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040938, HPA041970"	Uncertain		Supported	"Plasma membrane,Cytosol"			380000	Cytosol	"Plasma membrane"	"HPA040938: AB_10673443, HPA041970: "	"prognostic unfavourable (9.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.64e-1)"	"prognostic favourable (1.62e-9)"	"unprognostic (5.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.40e-2)"	10.9	11.5	8.3	14.3	14.3	9.5	8.5	2.7	11.8	9.2	13.8	20.8	7.4	16.3	8.2	6.2	23.1	7.2	8.9	10.7	11.2	9.5	26.2	31.4	10.4	21.2	20.7	7.7	6.4	4.1	4.3	6.5	36.6	17.6	9.1	11.9	10.2	15.1	7.3	6.4	6.8	20.5	10.0	22.1	27.4	8.1	18.2	13.1	5.8	11.1	8.4	16.9	9.8	9.6	1.5	23.1	93.6	43.7	1.9	1.8	14.6	1.5	9.3	1.0	2.4	3.9	8.4	0.1	17.0	4.6	9.2	7.5	4.5	4.8	2.2	17.7	12.4	0.1	0.0	4.2	9.5	5.2	2.6	19.3	1.4	44.4	2.4	0.0	42.0	8.4	0.9	0.8	6.6	13.7	6.7	1.4	22.4	1.9	1.7	8.9	2.8	1.3	3.6	6.0	4.8	13.8	2.9	4.9	3.2	0.0	15.5	6.1	3.3	4.2	20.4	13.2	2.7	0.0	0.0	0.0	0.3	3.5	2.9	9.8	2.8	6.1	30.6	19.3	1.3	43.7	1.1	1.5	1.1	1.4	23.1	1.0	0.3	0.8	93.6	1.9	40.6	5.6	1.8	14.6	8.3	14.3	2.7	11.8	11.2	9.5	20.7	7.7	17.6	13.1
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645227-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 94.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 37.7;ASC TERT1: 43.3;Karpas-707: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"		51000000	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favourable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	17.4	12.6	12.5	10.1	18.3	9.5	15.4	8.3	11.3	26.3	16.5	19.4	21.1	9.4	24.5	19.5	9.1	16.8	20.0	24.1	14.0	9.2	26.4	22.1	13.9	12.3	27.6	8.8	35.3	18.8	20.7	14.2	12.4	16.6	18.1	10.9	19.8	10.9	18.6	5.0	9.1	14.1	30.8	15.3	12.9	14.5	7.3	24.5	1.3	94.4	8.1	7.2	16.9	19.3	1.8	12.8	62.6	17.5	6.3	7.3	8.4	0.6	1.9	1.6	0.4	37.7	43.3	0.5	11.5	17.5	4.1	8.5	1.3	0.8	1.1	9.4	18.2	0.6	0.7	0.8	3.9	10.4	1.5	9.8	1.8	5.7	8.3	2.3	12.7	22.6	2.1	4.7	1.2	1.8	9.5	31.5	9.2	0.6	0.3	4.8	1.2	1.9	2.2	0.3	0.5	8.5	4.4	1.2	0.8	4.1	0.4	8.9	4.4	9.5	8.2	18.0	2.1	0.8	4.2	3.1	0.7	0.4	11.4	7.8	11.9	5.4	17.5	10.8	7.3	12.0	7.3	1.5	5.5	6.3	12.8	1.8	5.0	6.7	62.6	6.3	11.0	3.7	5.7	8.4	12.5	18.3	8.3	11.3	14.0	9.2	27.6	8.8	16.6	24.5
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 298.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 88.4;SK-BR-3: 26.7"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	Nucleoli			2100000	Nucleoli		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	0.4	0.1	0.5	0.3	1.6	0.0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0.0	0.4	1.1	1.4	0.3	0.0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0.0	0.4	0.4	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.3	6.2	4.2	4.1	7.2	6.6	2.2	2.7	2.6	4.1	0.6	0.0	1.0	0.1	2.4	1.1	0.2	3.7	6.6	0.0	1.9	3.9	88.4	5.5	1.3	2.0	0.0	3.7	2.8	5.2	5.3	0.2	3.9	0.3	4.3	1.1	0.1	0.2	2.4	0.6	0.2	5.7	0.5	5.6	0.0	0.1	0.4	15.5	26.7	3.0	0.0	0.6	2.9	6.8	2.1	2.0	4.8	0.0	0.3	0.0	4.5	4.3	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5
CPSF1	CPSF160	ENSG00000071894	"Cleavage and polyadenylation specific factor 1"	Q10570	8	144393229-144409349	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065167, HPA068906"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA065167: , HPA068906: "	"unprognostic (6.37e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (6.54e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.90e-2)"	"unprognostic (9.66e-3)"	11.9	13.5	13.4	18.6	17.2	27.0	14.3	28.5	18.0	11.7	15.1	16.3	14.9	40.7	17.8	8.9	13.0	16.2	14.3	10.3	13.0	8.2	13.0	15.0	13.7	17.4	16.6	11.5	19.8	22.4	7.3	21.6	11.1	15.4	18.4	7.6	14.9	26.9	13.8	14.7	25.2	29.8	11.7	11.0	21.2	16.3	27.9	16.1	27.1	17.7	10.6	16.0	13.1	13.4	7.5	8.8	4.9	9.3	5.7	10.0	5.8	9.3	13.2	12.1	12.6	6.4	5.2	11.8	8.8	5.6	7.3	7.6	13.3	12.2	10.9	8.6	6.6	8.6	6.7	7.5	2.0	9.7	19.6	21.3	14.8	21.3	5.5	8.1	13.2	5.7	3.2	6.6	3.9	9.6	17.8	9.3	3.6	40.1	21.1	17.0	7.3	18.7	15.2	4.8	8.7	7.7	13.9	9.8	9.7	11.4	7.1	6.4	12.6	9.0	8.2	5.0	19.3	10.9	9.8	5.5	4.3	10.2	6.7	13.7	5.9	4.9	7.8	4.9	8.0	9.3	8.4	6.9	8.5	8.4	8.8	7.5	7.5	7.1	1.5	5.7	8.6	4.1	10.0	5.8	13.4	17.2	28.5	18.0	13.0	8.2	16.6	11.5	15.4	16.1
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457371	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA049094: , HPA066470: "	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	15.2	11.6	19.3	11.8	19.0	15.7	11.8	20.9	25.6	9.3	9.8	19.8	13.1	12.4	11.1	11.4	13.6	11.2	10.3	10.0	21.5	16.0	10.0	11.7	9.3	20.3	16.8	17.4	13.4	25.4	7.3	12.7	15.1	21.9	11.6	10.2	9.9	17.3	12.2	21.2	18.4	9.6	10.5	20.3	13.9	11.5	38.4	14.6	8.7	11.0	10.7	17.8	10.5	10.4	10.2	6.4	3.1	4.1	5.0	9.7	3.9	14.6	12.8	22.0	17.4	9.0	10.3	26.0	9.7	12.2	15.1	20.0	21.1	19.7	21.1	13.2	9.5	12.8	15.1	15.2	14.6	15.4	16.1	10.0	14.7	20.3	47.1	18.0	12.9	18.7	13.2	16.0	24.4	13.8	25.9	25.1	14.3	36.1	37.1	33.2	20.0	18.2	15.1	14.7	24.9	9.5	13.8	17.4	20.1	11.2	23.3	22.9	9.7	19.4	7.5	14.2	19.8	24.3	18.4	23.4	24.6	30.7	10.9	18.0	16.8	1.4	4.1	3.1	4.4	3.3	5.8	10.2	6.7	7.9	5.2	8.5	8.5	7.6	1.6	5.0	2.6	6.4	9.7	3.9	19.3	19.0	20.9	25.6	21.5	16.0	16.8	17.4	21.9	14.6
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239537-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"			500000	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	22.3	26.4	29.4	28.1	32.6	52.0	23.1	49.1	32.2	24.8	20.7	24.3	21.3	21.8	27.4	34.5	27.1	23.2	17.0	21.8	24.3	16.4	20.0	19.7	21.6	36.1	23.6	26.8	42.2	23.5	28.6	36.4	21.0	24.9	21.5	21.5	22.2	25.6	21.4	25.4	23.3	23.1	22.3	20.7	24.7	21.9	22.1	25.8	42.8	25.5	10.5	32.9	21.3	24.2	22.0	25.5	21.0	21.5	19.3	30.2	12.4	28.4	24.0	35.5	24.8	13.8	15.7	26.7	18.8	22.4	26.8	25.4	24.9	19.6	45.4	19.3	19.0	26.9	34.7	22.2	28.7	29.6	23.7	36.6	24.8	28.5	20.6	49.4	26.8	18.8	17.6	21.6	8.9	20.6	37.6	48.8	22.2	33.1	46.2	32.3	34.2	20.5	46.9	28.0	31.8	21.1	33.9	29.9	26.3	25.2	23.7	25.6	28.4	35.0	23.6	20.3	24.9	19.1	30.7	31.4	25.3	56.8	16.4	28.9	26.0	21.0	17.1	18.7	19.7	21.5	20.9	22.0	22.0	20.2	25.5	19.0	17.0	20.1	5.2	19.3	17.8	18.3	30.2	12.4	29.4	32.6	49.1	32.2	24.3	16.4	23.6	26.8	24.9	25.8
CPSF7	"CFIM59, FLJ12529"	ENSG00000149532	"Cleavage and polyadenylation specific factor 7"	Q8N684	11	61402641-61430031	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041094	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041094: AB_10794187"	"unprognostic (6.87e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavourable (9.83e-4)"	"unprognostic (5.35e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.18e-2)"	23.3	25.6	23.2	24.3	39.0	34.5	25.6	31.6	49.5	26.9	25.4	35.4	34.9	22.6	41.6	33.5	27.0	31.6	19.9	20.9	25.0	19.9	25.2	33.6	24.0	28.5	24.3	24.9	40.5	29.0	36.1	47.8	26.9	29.2	27.6	25.5	33.2	28.4	28.4	36.7	33.9	27.6	32.5	27.2	33.9	26.9	31.3	28.5	45.6	36.0	19.8	32.3	27.1	26.3	10.4	10.5	14.2	8.3	8.5	12.9	7.4	26.3	26.5	37.1	29.4	20.1	17.9	26.2	21.9	21.1	29.2	22.4	30.9	22.7	39.6	23.6	23.4	32.7	35.6	25.1	35.7	26.2	18.2	33.4	34.2	24.8	20.4	40.4	29.7	18.9	20.6	31.0	45.3	19.7	40.0	25.5	21.0	31.9	39.9	32.9	36.5	20.9	37.6	29.3	32.6	21.8	32.7	25.3	25.8	29.2	25.8	27.0	35.7	17.3	19.8	32.4	27.7	30.3	22.6	35.2	41.4	45.6	18.9	19.5	23.7	14.2	7.4	9.2	12.2	8.3	12.9	10.4	9.7	12.3	10.5	10.0	10.7	10.8	14.0	8.5	6.1	8.9	6.6	7.4	23.2	39.0	31.6	49.5	25.0	19.9	24.3	24.9	29.2	28.5
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria			790000	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	18.0	18.3	9.9	9.9	12.1	15.8	24.4	7.0	10.3	12.8	31.9	8.2	14.1	33.7	17.0	7.2	11.2	12.8	14.7	14.6	12.0	6.6	30.6	62.0	13.1	10.1	10.5	8.6	17.0	24.4	16.9	13.8	8.7	10.8	15.6	22.0	19.7	12.9	11.4	6.9	10.3	33.4	16.9	8.7	18.9	16.8	10.4	9.0	17.9	13.2	7.5	7.6	11.3	30.2	2.5	11.9	10.6	8.6	5.7	8.8	2.5	8.3	14.8	2.1	14.5	9.5	8.6	0.6	6.7	5.5	5.3	1.1	0.5	28.3	0.0	24.8	17.6	27.5	18.8	4.0	1.6	13.4	1.8	20.5	16.2	6.8	14.2	11.9	24.9	8.9	1.9	10.6	6.4	18.8	2.1	16.9	4.8	24.0	9.7	21.1	0.2	15.8	27.1	0.3	36.5	12.5	20.9	0.3	9.5	18.5	35.7	5.9	31.9	11.6	18.8	11.6	0.2	23.2	9.6	13.2	16.8	8.5	12.2	8.8	12.6	9.2	7.8	10.6	8.8	8.6	5.1	2.3	5.5	5.3	5.0	2.5	3.4	7.0	3.8	5.7	7.2	11.9	2.9	2.5	9.9	12.1	7.0	10.3	12.0	6.6	10.5	8.6	10.8	9.0
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196429-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli, Mitochondria"		"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favourable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	7.5	15.5	5.3	6.8	6.1	2.3	6.5	4.0	7.2	5.1	15.4	9.4	10.7	16.6	5.1	7.6	10.5	5.4	11.3	21.4	4.3	4.5	19.8	69.0	6.9	8.3	5.7	3.7	5.3	15.9	10.7	11.5	18.1	6.4	6.0	15.6	13.8	11.8	12.2	13.6	6.0	18.9	5.5	5.2	10.3	10.1	11.2	4.7	9.7	8.3	7.2	10.3	8.0	4.9	5.9	12.4	10.0	13.1	4.8	8.0	6.5	7.8	3.3	7.7	7.5	6.6	3.9	8.8	4.9	5.0	7.1	6.6	1.6	6.7	13.5	7.5	2.3	7.9	14.3	11.3	6.0	7.4	8.4	7.7	4.5	1.3	9.8	7.3	7.4	8.4	9.7	5.1	4.4	4.8	9.8	4.8	4.4	4.6	5.7	6.0	14.4	8.8	6.6	7.3	14.3	8.8	7.4	11.5	7.7	9.8	12.5	18.5	14.5	15.6	4.7	4.0	3.2	7.0	4.0	14.9	9.1	8.3	5.1	8.4	5.8	4.1	8.4	10.0	5.1	12.6	6.2	4.5	4.9	5.9	12.4	5.9	8.0	5.5	5.1	4.8	13.1	6.4	7.0	6.5	5.3	6.1	4.0	7.2	4.3	4.5	5.7	3.7	6.4	4.7
CPVL		ENSG00000106066	"Carboxypeptidase, vitellogenic like"	Q9H3G5	7	28995231-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.9;lymphoid tissue: 84.0"	"Cell line enriched"	"Detected in many"	4	"RPTEC TERT1: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 95.8;intermediate monocyte: 81.6;myeloid DC: 111.9"	"Group enriched"	"Detected in many"	52	"dendritic cells: 111.9;monocytes: 95.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		510000	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: , HPA056466: "	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavourable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavourable (4.99e-4)"	19.0	6.2	4.0	15.0	9.1	11.9	7.7	11.6	3.4	9.1	10.0	7.7	4.2	7.6	6.9	20.4	6.4	7.2	10.2	30.2	6.1	4.4	39.1	12.3	13.5	30.5	6.6	2.3	10.1	8.5	0.2	6.1	31.3	20.1	8.4	6.0	15.8	3.5	5.2	7.9	5.1	13.3	8.1	9.7	84.0	4.7	10.6	4.2	29.7	51.9	5.0	8.1	11.0	15.7	0.1	111.9	1.9	95.8	0.5	0.3	74.4	0.2	0.0	3.2	0.0	0.0	0.0	30.9	0.0	0.0	0.3	0.0	9.3	0.0	0.0	14.7	0.1	0.5	8.2	0.6	0.1	0.0	7.6	10.4	0.1	22.3	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.1	6.9	0.0	0.2	0.0	9.6	0.0	5.0	2.5	0.0	0.0	0.0	129.2	3.5	1.9	1.5	8.5	20.2	15.6	2.4	7.7	0.0	0.0	0.1	0.0	1.8	2.8	31.1	0.1	0.0	3.9	3.3	1.0	95.8	0.4	0.2	81.6	0.3	0.1	0.1	0.1	111.9	0.1	0.1	0.1	1.9	0.5	26.0	2.9	0.1	74.4	4.0	9.1	11.6	3.4	6.1	4.4	6.6	2.3	20.1	4.2
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 154.2;tongue: 80.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 160.3;MCF7: 61.1;T-47d: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA004135	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	4.9	1.1	1.0	1.7	3.2	0.7	16.8	1.3	2.1	66.8	1.3	1.2	38.5	0.0	13.9	2.8	154.2	13.1	2.8	1.2	0.9	2.1	1.4	0.2	0.7	0.4	0.8	2.9	5.9	0.8	2.7	5.0	7.0	3.7	6.7	0.7	7.9	10.6	28.0	0.5	25.7	0.9	8.8	1.1	0.8	0.5	1.1	0.9	2.1	2.2	80.5	33.5	10.0	66.6	0.1	0.0	0.4	0.0	0.0	1.3	0.5	10.2	0.5	11.7	0.1	15.3	22.9	0.0	21.8	160.3	1.7	2.2	18.2	37.8	0.1	10.8	23.1	13.3	2.8	0.0	0.5	0.2	0.8	0.0	1.4	0.1	3.0	0.0	0.2	7.2	1.0	2.5	0.0	0.0	0.0	0.2	0.1	61.1	0.1	0.1	14.1	5.7	0.1	0.0	0.3	0.2	0.4	29.2	2.1	0.3	37.8	0.1	124.2	0.0	0.0	0.4	6.7	3.6	1.3	0.9	2.2	0.1	3.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	0.0	0.1	1.3	1.2	0.4	0.0	0.0	0.0	0.0	0.5	1.0	3.2	1.3	2.1	0.9	2.1	0.8	2.9	3.7	0.9
CRB3	MGC17303	ENSG00000130545	"Crumbs 3, cell polarity complex component"	Q9BUF7	19	6463777-6467221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 26.2;BEWO: 16.8;CACO-2: 17.6;HaCaT: 17.2;hTCEpi: 13.3;SK-BR-3: 14.0;T-47d: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.3"	"Group enriched"	"Detected in many"	17	"B-cells: 3.8;T-cells: 11.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA013835	Enhanced		Supported	"Cell Junctions"				"Cell Junctions"		"HPA013835: AB_1847214"	"unprognostic (3.25e-1)"	"unprognostic (4.41e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (4.54e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (8.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-2)"	"prognostic favourable (8.06e-5)"	0.4	0.1	0.4	5.9	0.5	0.0	2.6	0.4	0.4	4.1	24.4	0.6	20.7	19.8	2.2	12.6	24.2	4.3	14.8	0.4	0.5	0.1	24.8	28.5	11.7	1.4	0.4	0.5	1.4	37.2	7.0	7.7	6.5	1.8	5.0	5.5	4.1	19.3	16.9	0.4	18.3	33.6	0.9	0.4	0.6	16.1	1.6	0.4	0.8	19.4	7.7	10.6	5.2	7.0	3.8	0.0	0.4	0.0	0.0	11.3	2.7	26.2	3.2	0.0	0.1	0.0	0.0	16.8	0.0	0.0	0.0	0.0	17.6	11.1	0.1	10.6	0.0	17.2	0.2	5.8	0.0	0.0	0.2	0.0	0.1	9.7	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.2	0.0	6.9	0.0	0.2	0.6	0.0	0.0	0.0	0.3	7.8	11.1	0.0	0.0	0.1	14.0	0.0	12.2	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	1.7	3.8	5.6	2.6	0.0	1.3	11.3	4.5	0.4	0.0	0.0	0.0	3.6	2.7	0.4	0.5	0.4	0.4	0.5	0.1	0.4	0.5	1.8	0.4
CREB1		ENSG00000118260	"CAMP responsive element binding protein 1"	P16220	2	207529737-207603431	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003803, HPA019150"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB003803: AB_562092, HPA019150: AB_1847220"	"unprognostic (1.20e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.45e-2)"	21.2	12.9	19.4	24.8	17.0	22.9	16.7	25.5	18.7	17.6	15.7	14.3	14.7	12.6	19.3	14.9	17.9	15.4	15.5	14.4	15.4	14.5	14.6	13.1	17.7	21.7	15.8	17.7	20.5	12.9	19.8	20.0	19.8	16.1	16.3	16.2	11.2	16.2	14.9	11.6	14.3	15.2	19.5	19.8	19.0	13.3	39.2	18.5	38.4	19.7	13.3	27.7	16.1	23.6	22.1	20.7	34.8	19.1	28.4	22.5	14.5	15.4	13.8	25.7	9.8	15.1	15.5	14.6	9.9	14.9	17.3	18.2	14.0	15.7	10.0	13.4	14.6	13.5	23.2	13.6	25.5	16.0	8.4	18.4	12.4	14.3	12.6	17.3	13.5	11.1	10.1	14.3	21.3	24.3	12.9	14.7	21.3	10.6	26.4	10.3	18.3	8.4	20.6	14.0	13.2	15.4	16.0	17.7	15.4	13.8	10.1	11.9	11.3	19.0	11.6	14.1	15.1	14.8	12.7	13.3	16.8	23.1	17.4	16.0	14.8	16.9	17.0	16.8	17.3	18.0	15.4	22.1	16.6	16.7	20.7	20.2	19.9	13.5	34.8	28.4	19.1	11.3	22.5	14.5	19.4	17.0	25.5	18.7	15.4	14.5	15.8	17.7	16.1	18.5
CREB3	"Luman, LZIP, sLZIP"	ENSG00000107175	"CAMP responsive element binding protein 3"	O43889	9	35732335-35737004	"Predicted membrane proteins, Transcription factors"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030978			Supported	Cytosol				Cytosol		"HPA030978: "	"unprognostic (1.73e-3)"	"unprognostic (9.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.62e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (4.63e-2)"	"prognostic favourable (5.40e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (3.77e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	15.7	25.1	23.7	12.0	27.6	5.6	19.4	18.5	30.2	25.4	20.3	17.6	28.2	12.8	20.9	22.5	15.0	23.9	25.2	16.3	19.4	21.3	21.3	42.3	15.9	15.3	23.1	17.1	20.2	26.3	22.1	23.1	19.5	17.3	32.9	16.7	17.4	31.7	37.6	12.6	9.9	14.6	26.0	19.6	13.0	20.5	23.0	14.0	9.1	24.4	9.4	14.9	22.0	17.6	17.7	19.4	14.8	16.9	15.9	21.8	15.7	12.2	11.4	12.1	9.0	25.4	16.6	7.9	22.4	35.8	23.9	24.8	12.7	6.0	4.4	9.9	32.7	4.7	7.7	18.5	15.8	16.4	6.4	3.4	10.1	5.8	32.4	5.6	6.8	14.5	15.2	23.2	22.7	14.6	4.9	7.4	24.5	6.0	5.8	2.0	7.5	15.0	6.4	5.3	5.6	19.3	5.9	5.6	7.8	8.9	7.9	5.3	12.1	2.4	15.6	15.8	8.9	11.5	13.7	4.3	5.2	5.3	16.6	2.0	17.2	14.8	16.9	6.3	19.2	16.0	20.7	17.7	16.8	21.8	17.9	12.3	13.7	13.4	7.7	15.9	12.8	19.4	18.5	15.7	23.7	27.6	18.5	30.2	19.4	21.3	23.1	17.1	17.3	14.0
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002067	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"				"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: "	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	14.9	19.8	4.7	17.1	9.8	10.8	15.7	1.9	6.0	25.4	16.7	11.4	18.7	11.6	28.2	25.5	12.8	16.2	16.2	20.4	5.6	4.3	17.0	11.7	14.6	15.2	11.8	3.7	25.9	16.0	38.4	28.8	81.6	9.8	15.9	9.5	24.9	26.5	23.3	5.0	6.9	17.5	17.7	6.2	12.1	14.1	9.8	9.1	7.0	35.8	10.9	18.1	21.3	15.7	4.6	12.4	7.4	5.6	6.5	11.8	3.2	4.0	6.2	11.8	0.2	20.2	20.1	8.9	20.0	32.5	14.1	14.2	8.5	3.6	0.8	5.4	21.7	2.1	6.9	14.7	27.6	5.8	3.4	25.3	8.5	20.2	13.4	7.6	36.3	8.3	9.4	17.7	20.8	18.5	13.0	11.8	16.4	7.2	2.4	9.4	4.2	4.4	5.3	6.4	6.7	11.0	4.1	3.0	7.1	6.5	16.9	8.9	2.4	5.7	19.7	18.9	2.9	22.7	7.3	14.0	4.8	5.3	22.7	21.5	41.9	7.4	5.6	5.9	8.2	2.9	10.6	4.0	6.0	8.6	5.8	4.6	2.2	3.8	2.1	6.5	1.5	12.4	11.8	3.2	4.7	9.8	1.9	6.0	5.6	4.3	11.8	3.7	9.8	9.1
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880726	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: "	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favourable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	18.5	10.9	17.2	22.8	17.5	37.0	17.4	42.6	18.8	20.1	17.2	16.8	17.1	9.9	25.1	15.2	14.1	18.9	21.3	14.5	17.1	8.7	11.1	12.3	16.9	14.4	20.5	12.0	31.6	23.4	24.3	13.0	13.3	15.8	18.4	11.6	14.6	14.9	16.7	28.2	20.4	16.4	17.0	13.6	17.4	14.7	29.1	20.2	29.6	19.5	13.8	16.1	19.0	29.9	4.7	2.3	10.6	3.8	2.0	2.7	1.1	5.5	14.3	18.6	8.2	11.4	11.3	9.6	8.0	13.5	13.9	13.5	12.9	10.5	15.4	9.6	15.3	10.8	21.4	6.6	15.8	26.0	8.6	12.1	13.2	8.2	12.6	12.1	17.4	10.0	6.7	15.4	18.6	10.4	13.7	21.1	7.5	19.1	8.0	5.8	15.2	5.9	37.8	14.7	11.8	5.4	7.5	15.5	10.2	13.7	13.5	8.1	12.0	11.9	16.1	17.0	16.9	8.7	7.3	9.9	10.6	29.9	3.4	7.3	11.9	2.9	1.7	1.3	2.7	2.2	1.4	4.7	1.3	2.0	1.0	3.3	1.4	1.7	10.6	2.0	3.8	2.3	1.3	1.1	17.2	17.5	42.6	18.8	17.1	8.7	20.5	12.0	15.8	20.2
CREBRF	"C5orf41, LRF"	ENSG00000164463	"CREB3 regulatory factor"	Q8IUR6	5	173056352-173139284	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015329			Supported	Nucleoplasm				Nucleoplasm		"HPA015329: "	"unprognostic (8.00e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.69e-2)"	"prognostic favourable (3.20e-7)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (9.30e-4)"	18.0	10.6	15.9	9.2	17.3	53.5	16.5	29.7	23.1	13.8	12.4	5.6	11.7	7.9	15.2	11.2	8.5	10.9	9.4	10.0	16.6	6.7	13.9	10.7	16.3	16.0	19.0	11.0	18.4	9.3	16.6	18.0	13.0	14.9	11.8	8.4	6.7	13.2	13.0	12.2	15.6	12.9	16.1	15.1	14.7	10.3	12.0	18.4	9.2	21.7	3.8	9.6	15.3	19.1	4.9	2.6	19.0	2.6	1.3	4.1	1.4	0.9	2.2	2.2	3.4	10.0	13.4	5.1	3.0	14.9	2.9	5.5	3.0	5.1	1.8	7.3	3.0	1.3	1.0	2.3	4.0	6.7	2.0	1.4	1.4	1.0	7.8	1.1	8.4	8.1	6.1	3.1	7.8	3.4	1.3	9.7	3.3	1.8	1.7	1.6	0.6	1.1	1.6	1.5	2.8	4.0	2.0	1.7	2.5	3.1	1.3	11.3	1.4	2.1	5.6	4.3	1.4	2.9	0.8	10.9	9.1	3.3	3.2	2.0	1.5	3.5	2.4	4.9	3.3	2.1	3.0	2.6	3.3	2.7	1.2	4.9	4.1	3.2	19.0	1.3	2.6	2.6	2.9	1.4	15.9	17.3	29.7	23.1	16.6	6.7	19.0	11.0	14.9	18.4
CREM	hCREM-2	ENSG00000095794	"CAMP responsive element modulator"	Q03060	10	35126791-35212958	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001818, CAB018352"	Enhanced		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB018352: AB_673599, HPA001818: AB_1078566"	"unprognostic (1.78e-1)"	"unprognostic (6.26e-3)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (9.27e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavourable (1.23e-5)"	"unprognostic (4.44e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.52e-1)"	21.9	61.4	14.3	21.3	15.1	8.1	15.4	6.2	13.8	10.6	8.0	8.4	10.2	4.1	13.3	10.8	8.2	9.9	19.7	19.5	14.5	15.2	15.4	26.1	19.6	7.1	12.7	8.3	21.4	8.2	8.3	24.2	42.0	20.1	12.2	6.4	9.6	5.7	19.2	10.0	3.2	7.0	11.0	15.5	21.8	7.5	74.9	7.7	8.1	10.8	6.8	7.3	18.1	11.7	6.4	11.2	10.1	4.9	8.6	14.6	8.2	9.0	14.5	12.3	12.6	8.6	9.0	12.3	11.9	9.3	7.5	10.4	1.7	3.8	15.4	11.6	6.9	2.1	10.5	7.8	11.0	37.8	7.7	5.4	10.0	6.8	10.3	1.3	5.8	7.9	9.8	14.6	4.5	20.8	15.9	6.4	11.4	7.3	9.4	3.9	3.6	33.4	5.8	6.4	2.8	13.2	3.6	2.9	7.8	5.6	4.9	31.5	2.7	4.0	27.6	5.7	7.4	15.7	7.8	2.8	3.8	5.3	13.7	12.2	4.9	4.7	3.3	10.1	11.5	4.9	14.2	6.4	12.7	10.1	3.8	5.5	9.0	10.4	9.0	8.6	3.6	11.2	14.6	8.2	14.3	15.1	6.2	13.8	14.5	15.2	12.7	8.3	20.1	7.7
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917426-20953749	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol			1500000	Nucleoplasm	Cytosol	"HPA000532: , HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.4	15.2	25.0	18.1	24.1	41.9	18.4	34.0	31.7	17.8	19.9	26.4	12.3	20.2	18.9	12.8	25.2	19.9	13.6	22.6	22.6	23.8	16.4	24.9	19.0	21.3	24.6	26.1	26.9	21.7	22.2	17.9	25.1	20.7	18.8	18.7	16.7	14.5	19.1	48.1	22.7	19.1	18.6	23.6	19.6	14.3	12.6	19.8	35.7	16.6	17.8	24.7	17.7	24.6	11.7	14.8	19.2	21.5	11.0	19.7	16.8	11.2	6.7	15.2	11.9	10.3	6.6	16.4	7.6	9.4	11.8	13.4	11.1	5.1	14.5	6.2	8.0	14.5	17.8	12.2	14.1	12.3	17.4	20.1	7.4	12.2	10.3	21.3	10.3	6.7	16.3	10.2	17.6	10.4	87.6	12.0	9.5	10.6	12.4	10.0	12.0	7.4	16.2	24.2	3.5	7.9	9.9	9.9	12.7	12.8	11.3	9.3	9.7	11.9	8.4	18.8	21.4	7.0	9.6	11.5	11.1	16.9	13.9	9.1	11.5	13.4	13.0	19.2	17.5	12.5	18.9	11.6	15.8	17.5	14.8	11.7	19.7	18.4	14.1	11.0	21.5	7.4	12.8	16.8	25.0	24.1	34.0	31.7	22.6	23.8	24.6	26.1	20.7	19.8
CRLF3	"CREME9, CYTOR4"	ENSG00000176390	"Cytokine receptor like factor 3"	Q8IUI8	17	30769388-30824776	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 43.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007596	Enhanced		Supported	"Plasma membrane,Cytosol"			830000	"Plasma membrane, Cytosol"		"HPA007596: AB_1847241"	"unprognostic (1.02e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.52e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.31e-7)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.51e-2)"	8.7	4.8	8.8	22.7	8.3	16.7	7.3	12.4	9.4	6.9	7.0	5.9	3.9	5.5	6.3	3.6	15.4	6.1	7.0	5.8	7.5	6.6	5.3	5.4	9.7	28.6	6.6	9.3	5.8	5.5	5.1	6.9	12.3	7.3	6.6	7.4	4.4	7.5	3.9	3.8	10.7	11.3	6.1	8.7	22.0	5.9	9.6	6.7	26.7	5.7	4.5	27.8	10.3	9.3	15.9	13.9	43.6	21.8	12.9	35.7	25.2	6.2	6.9	4.3	9.0	7.9	6.2	6.5	5.9	5.8	11.5	12.1	9.1	4.3	20.9	8.9	7.3	11.0	7.3	4.9	13.9	9.7	13.4	8.7	6.1	6.0	4.4	11.5	6.5	3.6	6.9	9.3	7.9	11.2	22.1	22.2	7.2	3.8	25.4	12.7	8.6	4.6	11.3	14.0	12.2	7.6	5.3	3.1	7.3	6.3	9.4	6.5	7.2	5.8	5.9	6.7	8.3	10.7	14.4	9.3	7.7	14.0	6.4	9.4	7.4	15.5	18.8	43.6	13.0	19.2	13.7	15.9	18.3	14.6	13.9	14.9	35.7	26.4	38.3	12.9	21.8	7.2	20.1	25.2	8.8	8.3	12.4	9.4	7.5	6.6	6.6	9.3	7.3	6.7
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.1;pituitary gland: 23.0"	"Cell line enhanced"	"Detected in some"		"AF22: 20.4;HAP1: 29.2;NTERA-2: 21.2;REH: 55.5;RH-30: 32.7;SCLC-21H: 42.4;SH-SY5Y: 26.8"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favourable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	8.2	24.2	2.5	21.7	0.7	1.0	32.0	63.1	3.3	2.0	5.9	0.1	1.5	11.7	0.7	2.7	4.3	4.3	2.6	22.2	23.9	2.4	0.9	4.2	1.8	9.9	18.1	6.9	4.8	0.9	23.0	4.6	12.3	3.0	1.9	4.6	2.6	3.1	1.0	3.3	2.5	11.6	4.7	1.4	3.5	2.8	4.5	0.0	2.4	0.9	1.3	2.9	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	20.4	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	29.2	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	21.2	0.6	55.5	32.7	4.9	0.0	0.0	42.4	26.8	0.0	0.1	0.3	0.2	0.0	1.7	1.0	7.1	0.6	0.6	3.7	0.5	0.0	2.5	0.2	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	21.7	32.0	34.2	22.2	23.9	9.9	18.1	12.3	4.5
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972979	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 135.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"				"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favourable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favourable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	5.0	3.8	3.2	3.2	7.0	2.1	2.5	12.9	3.0	3.9	2.8	5.4	2.2	2.4	5.1	2.4	3.2	9.9	2.3	2.1	4.6	3.5	2.4	1.8	3.9	3.2	2.1	2.5	5.0	4.2	3.0	3.6	2.2	11.3	3.3	0.6	30.6	135.2	2.9	8.2	14.4	3.1	1.8	2.3	6.4	3.5	1.9	4.3	2.1	2.5	2.3	1.8	2.9	3.8	1.1	0.6	1.7	0.8	1.3	2.8	0.6	4.1	1.7	3.2	3.2	2.3	2.1	1.3	3.0	1.0	1.0	1.1	0.2	1.9	10.9	2.8	1.2	4.9	0.8	2.2	0.1	0.9	5.8	5.0	5.3	0.8	3.9	0.3	5.1	1.8	5.2	0.9	0.9	1.6	0.7	2.8	0.3	3.5	3.3	1.2	11.6	2.7	3.1	4.2	3.7	0.7	1.1	9.8	10.6	3.2	2.1	9.7	4.2	1.4	4.3	2.8	3.7	7.0	2.3	5.0	3.6	2.2	2.7	0.7	3.3	0.0	0.4	1.7	1.6	0.8	2.8	0.7	1.3	1.3	0.2	1.1	1.1	0.9	0.1	1.3	0.3	0.6	1.3	0.6	3.2	7.0	12.9	3.0	4.6	3.5	2.1	2.5	11.3	4.3
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683677-18782333	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022035	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255"	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favourable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favourable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.6	7.7	26.0	7.4	38.8	3.2	3.8	40.7	30.1	5.0	4.4	6.5	4.3	6.5	6.8	5.6	3.1	10.5	5.5	5.6	17.7	7.8	6.6	4.5	5.7	6.3	6.4	18.1	6.7	10.0	8.4	11.3	6.4	6.0	7.0	2.6	5.1	8.8	9.4	12.4	5.5	6.2	4.3	4.8	8.1	8.0	7.5	10.2	1.9	7.4	1.1	3.7	4.6	3.5	4.1	3.8	1.8	3.4	1.1	3.0	1.3	4.3	8.0	5.8	9.3	5.4	4.6	16.5	4.8	3.2	4.6	4.5	5.4	5.7	6.1	10.2	4.6	4.7	1.7	3.0	1.1	2.7	13.9	5.1	7.1	8.8	5.2	7.0	14.5	7.4	2.9	4.0	1.2	2.6	4.0	5.6	2.6	16.0	4.5	8.1	7.5	11.8	7.2	2.5	6.7	2.9	7.8	10.7	9.6	5.4	5.2	5.8	5.8	4.3	4.6	5.3	8.1	9.6	5.5	3.8	3.0	4.0	6.1	7.6	4.0	1.5	3.4	1.8	1.7	1.3	1.8	2.3	2.7	3.0	3.0	4.1	2.3	1.8	1.7	1.1	1.9	3.8	1.8	1.3	26.0	38.8	40.7	30.1	17.7	7.8	6.4	18.1	6.0	10.2
CRTC2	TORC2	ENSG00000160741	"CREB regulated transcription coactivator 2"	Q53ET0	1	153947669-153958625	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028454, HPA028465"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028454: AB_10599617, HPA028465: AB_10601991"	"unprognostic (4.91e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.75e-4)"	"unprognostic (4.32e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (1.35e-7)"	"unprognostic (7.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.35e-1)"	"prognostic favourable (6.12e-5)"	22.4	19.7	21.0	23.1	26.6	28.7	21.1	31.8	22.8	21.5	18.9	29.5	15.6	13.3	24.3	20.2	17.7	22.7	18.4	17.4	20.4	11.3	21.4	22.9	26.0	31.1	25.7	16.3	32.3	20.6	22.7	19.7	24.2	18.6	20.1	15.9	21.9	20.1	22.1	24.6	24.0	23.5	21.5	19.2	39.4	18.9	18.1	28.1	22.1	23.6	10.9	29.7	23.4	21.0	6.1	4.6	10.1	5.9	4.6	5.0	1.8	14.7	11.1	10.8	12.2	17.7	13.0	16.5	8.4	17.2	15.9	13.1	11.3	14.8	14.2	13.2	14.4	16.8	12.9	16.7	8.9	18.5	16.8	7.2	11.3	8.7	18.0	11.7	12.0	17.0	16.3	17.5	14.4	14.7	11.5	17.1	11.4	23.4	12.6	19.5	8.4	13.7	9.4	7.4	11.9	16.8	12.0	9.1	14.9	13.3	27.3	20.7	13.1	22.9	10.9	12.9	11.6	13.7	14.0	28.0	18.1	9.7	11.9	10.0	9.4	5.2	3.9	8.4	4.6	5.9	3.8	4.5	4.7	5.0	3.4	6.1	3.2	3.8	10.1	4.6	4.7	4.6	3.1	1.8	21.0	26.6	31.8	22.8	20.4	11.3	25.7	16.3	18.6	28.1
CRTC3	FLJ21868	ENSG00000140577	"CREB regulated transcription coactivator 3"	Q6UUV7	15	90529925-90645345	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043735, HPA063691"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043735: AB_10794286, HPA063691: "	"unprognostic (7.60e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.30e-1)"	22.3	14.0	13.7	17.0	20.9	11.4	26.6	15.0	16.2	21.2	22.2	27.5	15.3	8.9	23.9	14.5	15.1	19.4	21.5	17.2	14.0	9.7	10.7	11.7	19.2	21.7	24.1	10.9	45.9	13.9	17.1	9.6	20.2	15.7	18.2	11.7	17.4	19.9	22.0	16.1	15.8	13.7	31.8	20.3	13.1	14.2	15.3	23.6	12.8	22.7	9.2	18.1	24.0	29.6	5.3	2.1	16.0	2.5	3.3	6.6	3.0	4.7	7.9	5.4	8.8	11.7	8.7	24.7	6.1	8.9	9.6	9.1	6.5	4.8	0.1	4.4	12.6	8.0	8.6	5.3	7.6	8.2	10.0	12.1	39.3	3.0	13.3	3.1	20.7	9.7	8.5	7.9	10.7	6.9	6.4	2.8	7.1	5.5	1.3	4.5	1.9	3.7	4.1	8.6	0.2	3.4	10.1	9.9	8.8	17.8	5.9	9.9	5.9	5.9	8.5	10.7	7.9	9.9	7.0	3.7	5.0	3.6	4.4	6.3	5.1	16.0	2.5	1.4	3.7	0.8	4.2	3.1	4.5	4.0	1.6	5.3	6.6	4.1	0.5	3.3	0.3	2.1	4.2	3.0	13.7	20.9	15.0	16.2	14.0	9.7	24.1	10.9	15.7	23.6
CRY1	PHLL1	ENSG00000008405	"Cryptochrome circadian regulator 1"	Q16526	12	106991364-107093829	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018762	Approved		Supported	"Nucleoplasm,Nuclear membrane,Microtubules"				"Nucleoplasm, Nuclear membrane, Microtubules"		"CAB018762: AB_2083970"	"unprognostic (1.21e-3)"	"unprognostic (4.74e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	12.2	12.2	8.7	8.5	12.6	9.5	18.3	29.2	10.3	12.4	14.3	12.4	5.0	10.7	14.3	12.9	10.7	15.8	16.3	12.2	10.5	8.7	16.0	13.7	18.0	5.0	17.4	7.3	10.7	12.9	8.6	10.0	13.4	13.1	11.2	8.3	8.7	9.4	11.8	10.8	8.7	17.6	15.9	15.4	10.1	14.6	37.6	15.1	26.5	20.1	6.2	7.5	9.5	18.4	1.7	3.5	6.8	6.4	4.7	13.9	4.7	8.5	8.7	10.7	11.8	7.7	4.9	19.2	9.2	9.8	18.7	12.7	10.0	5.2	0.0	5.8	8.5	5.9	13.7	4.7	20.5	8.6	8.5	8.4	7.8	6.9	9.9	8.6	7.4	4.6	4.9	13.7	13.0	15.5	9.4	7.5	11.5	6.0	19.2	9.7	13.1	12.7	17.2	27.1	3.0	13.1	10.1	19.4	10.0	17.3	11.3	5.5	8.0	4.8	6.8	11.0	11.8	7.5	8.1	13.9	13.0	4.0	5.3	8.2	8.9	6.8	2.5	4.4	11.2	3.8	13.9	1.6	8.5	7.0	3.5	1.7	8.0	7.8	1.1	4.7	6.4	2.3	11.0	4.7	8.7	12.6	29.2	10.3	10.5	8.7	17.4	7.3	13.1	15.1
CRY2		ENSG00000121671	"Cryptochrome circadian regulator 2"	Q49AN0	11	45847118-45883248	"Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037577	Supported		Supported	"Nuclear speckles,Cytosol"	"Intracellular and membrane"			"Nuclear speckles"	Cytosol	"HPA037577: AB_10672497"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"prognostic unfavourable (1.67e-4)"	"unprognostic (1.31e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.09e-2)"	"prognostic favourable (6.82e-5)"	"unprognostic (1.48e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.07e-2)"	"prognostic favourable (4.39e-4)"	"unprognostic (1.01e-1)"	"prognostic favourable (6.44e-15)"	"unprognostic (8.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.24e-1)"	17.4	13.3	18.2	8.8	27.4	17.2	16.7	29.8	36.5	17.7	12.1	15.4	10.5	7.6	16.2	12.4	11.2	20.8	18.7	39.5	15.6	13.1	15.7	27.8	15.7	6.7	12.7	15.0	26.3	23.4	20.6	16.4	9.3	11.5	15.0	7.3	35.5	14.4	17.1	58.2	24.3	8.5	18.7	10.4	9.2	12.2	17.4	9.6	5.9	23.6	22.4	10.3	17.4	10.6	7.8	5.2	7.6	10.6	10.4	10.4	7.1	1.2	3.6	5.6	6.6	15.3	7.7	12.3	4.3	7.8	5.5	4.1	5.9	2.9	8.4	3.4	9.1	7.4	5.3	4.5	3.8	8.9	4.8	5.5	6.3	8.0	5.8	6.7	7.6	9.0	6.7	4.3	6.8	3.8	10.7	14.4	5.0	4.5	5.7	8.0	15.2	4.4	9.8	8.1	3.9	4.0	6.8	9.0	3.4	7.3	6.6	3.7	8.8	4.8	4.8	7.9	4.8	12.0	3.0	13.4	9.2	6.9	4.8	3.0	4.7	5.7	5.0	7.6	8.7	7.1	7.2	7.8	8.4	9.3	5.2	7.7	10.3	10.4	2.6	10.4	10.6	3.8	6.9	7.1	18.2	27.4	29.8	36.5	15.6	13.1	12.7	15.0	11.5	9.6
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908565-111923722	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Eye lens protein"	"Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 743.1;skeletal muscle: 581.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 230.1;fHDF/TERT166: 75.0"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			12000	"Plasma membrane, Cytosol"		"CAB002053: AB_442024, CAB040560: , HPA057100: "	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.70e-5)"	107.4	11.5	47.8	16.7	82.3	2.1	69.5	24.8	153.7	22.4	23.6	132.9	7.2	5.5	14.8	25.9	41.9	13.5	14.0	743.1	65.9	44.0	151.8	3.8	8.4	3.9	139.2	29.7	8.8	6.6	3.3	8.6	16.1	80.7	30.3	12.9	23.3	30.6	75.1	581.1	18.1	6.2	45.2	168.0	5.5	11.6	3.9	101.8	0.0	40.7	94.1	9.2	16.2	53.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.3	230.1	10.1	1.6	6.4	0.2	0.1	0.2	0.1	0.0	0.0	3.8	75.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	1.2	0.6	1.9	0.0	0.0	8.1	1.0	0.0	0.5	0.0	0.5	0.2	18.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.8	3.4	0.5	0.0	0.1	29.8	10.7	0.8	0.3	0.1	0.0	0.0	0.6	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	82.3	24.8	48.5	65.9	44.0	139.2	29.7	80.7	101.8
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.7;brain: 61.3;heart muscle: 45.9"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 30.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Cell type enriched"	"Detected in single"	26	"plasmacytoid DC: 23.7"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.7"	"Group enriched"	"Detected in many"	12	"amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol			110000	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.4	0.5	7.6	0.5	61.3	0.5	1.0	15.6	21.2	1.8	2.2	0.0	0.0	0.7	0.8	0.3	2.3	0.5	2.3	45.9	6.5	2.1	17.8	4.2	2.7	0.5	1.0	15.5	0.5	0.8	0.6	3.3	0.3	0.1	10.5	2.6	1.0	4.8	0.3	4.0	1.4	1.0	2.0	0.9	0.5	0.6	1.6	1.2	0.0	0.5	0.0	1.5	8.3	0.8	0.9	23.7	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	1.6	0.0	0.0	0.0	0.4	7.0	0.0	0.7	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.3	3.2	0.0	0.0	0.0	0.2	30.5	0.0	1.2	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.3	7.6	61.3	15.6	20.7	6.5	2.1	1.0	15.5	0.1	1.2
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.0;liver: 79.8"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021921, HPA023290"	Approved		Supported	Cytosol			7200000	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	6.0	13.4	7.5	4.6	5.4	0.2	8.8	4.2	5.9	19.8	12.6	3.9	27.1	11.3	11.9	29.1	9.7	11.5	15.7	10.4	6.0	9.0	100.0	79.8	7.1	4.8	6.5	3.5	9.4	26.1	13.2	17.2	3.7	11.1	13.8	4.9	9.4	5.9	21.9	5.6	5.6	19.8	14.1	6.8	5.4	9.5	4.9	5.9	7.1	17.1	7.9	5.8	14.8	15.8	18.2	8.9	4.7	8.6	14.4	21.7	9.0	2.5	24.3	12.6	3.6	14.5	15.9	8.5	7.8	12.4	11.4	12.8	19.0	10.0	13.6	13.8	15.2	6.7	10.2	9.9	18.6	15.7	4.1	5.6	7.6	38.0	7.6	4.8	11.7	7.3	8.8	18.2	3.3	9.5	17.8	4.9	23.7	5.6	8.7	8.1	9.4	15.8	5.6	11.8	5.0	96.4	7.8	3.5	6.2	1.8	13.2	8.6	11.8	1.6	4.6	2.7	6.8	8.6	11.8	3.5	6.8	6.7	22.3	1.9	7.8	4.7	5.2	0.9	18.2	7.7	14.7	18.2	17.9	16.7	8.9	13.7	15.7	16.7	0.8	14.4	8.6	7.5	21.7	9.0	7.5	5.4	4.2	5.9	6.0	9.0	6.5	3.5	11.1	5.9
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300392	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 125.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria			4400000	Mitochondria		"CAB075750: , CAB075751: , CAB075752: , CAB075753: , CAB075754: , HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favourable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	37.1	35.5	11.9	16.3	20.4	19.3	55.6	28.5	43.8	17.2	27.4	14.1	11.3	25.3	19.9	10.8	31.7	16.5	14.0	79.2	11.2	14.5	26.7	12.3	17.3	30.8	12.3	14.2	16.9	20.7	28.1	14.3	11.9	24.8	16.2	32.7	19.8	23.1	17.5	125.9	22.8	27.0	21.2	15.0	18.4	21.4	7.9	11.1	20.7	17.9	48.2	26.1	22.9	19.1	19.5	37.1	59.6	27.8	15.9	19.7	18.2	35.4	38.4	31.3	40.7	41.7	38.8	20.4	29.6	29.1	52.1	36.5	54.1	34.9	69.4	29.1	37.3	38.5	86.6	44.5	49.9	24.1	44.0	47.7	27.9	39.0	23.4	58.3	34.3	42.7	42.6	40.9	49.6	58.6	49.3	41.7	45.5	28.5	48.2	18.0	24.9	55.5	47.0	36.8	52.4	32.3	36.1	41.2	27.0	38.3	45.6	30.0	63.5	34.0	38.8	26.3	36.9	37.1	31.2	27.5	41.9	45.2	24.3	42.9	24.7	14.5	22.0	59.6	15.2	27.8	19.7	19.5	18.3	14.3	37.1	16.7	19.4	15.4	9.8	15.9	27.0	20.5	19.3	18.2	11.9	20.4	28.5	43.8	11.2	14.5	12.3	14.2	24.8	11.1
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 266.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 222.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"			13000	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: "	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	71.2	31.4	33.5	25.8	33.2	37.9	42.1	29.6	35.4	39.0	64.7	29.6	35.9	29.5	46.4	38.9	58.8	30.3	29.4	64.2	33.2	31.7	37.4	39.5	34.2	31.4	41.6	31.4	43.9	37.2	50.3	38.4	38.8	44.4	52.6	32.9	32.0	43.2	42.0	266.5	33.8	46.5	88.3	42.4	32.2	39.9	41.5	35.1	39.6	55.7	73.9	31.9	75.4	45.5	43.9	59.0	57.9	65.2	48.1	62.3	80.5	60.6	21.4	38.1	38.0	43.5	56.6	53.3	53.6	40.1	36.1	29.4	31.3	18.4	47.8	45.3	51.1	25.8	42.2	41.6	52.7	58.4	28.8	46.9	39.0	27.7	38.5	34.8	28.0	41.0	45.3	43.2	57.1	41.3	47.5	31.4	44.1	222.4	46.7	22.2	72.6	28.9	35.0	118.0	22.5	28.7	47.8	47.1	31.3	52.5	43.8	40.6	22.5	55.7	49.7	42.7	58.9	56.0	58.8	48.0	52.2	53.6	55.2	39.6	130.2	46.4	57.7	57.9	40.9	60.8	55.5	43.9	52.2	49.7	59.0	34.7	62.3	52.3	40.9	48.1	65.2	23.0	56.7	80.5	33.5	33.2	29.6	35.4	33.2	31.7	41.6	31.4	44.4	35.1
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol			64000	"Nucleoplasm, Cytosol"		"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavourable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavourable (6.91e-4)"	15.7	18.9	19.5	18.7	23.7	13.7	21.2	24.9	31.3	17.5	14.2	13.4	14.0	12.0	19.5	15.5	25.5	17.3	11.8	17.8	20.0	17.7	18.8	18.7	12.8	24.0	27.3	19.4	18.7	17.3	23.2	16.8	23.1	24.2	16.7	18.4	8.4	15.5	17.0	34.3	20.9	12.4	21.7	31.3	12.6	17.1	50.9	21.0	27.0	14.7	28.1	25.3	18.3	17.5	12.8	14.8	9.4	15.9	16.8	18.0	12.8	35.5	24.8	30.3	23.3	11.8	15.2	32.9	28.1	14.9	88.5	37.5	81.0	28.8	36.5	37.7	17.8	41.3	44.5	52.8	84.5	5.9	21.6	25.3	29.1	39.2	7.2	27.8	13.9	8.5	19.8	43.2	25.1	29.2	35.7	14.4	33.1	12.2	33.5	14.4	25.5	37.0	21.4	49.9	28.4	19.4	24.9	26.7	15.5	44.9	48.7	16.0	40.6	18.2	18.8	47.1	39.6	27.7	39.8	8.4	20.4	34.2	28.1	22.5	25.0	9.4	11.8	2.7	11.0	15.2	16.5	12.8	16.8	13.4	14.8	10.4	18.0	15.3	3.3	16.8	15.9	6.6	14.4	12.8	19.5	23.7	24.9	31.3	20.0	17.7	27.3	19.4	24.2	21.0
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.6;ASC TERT1: 29.3;BJ hTERT+: 30.7;HHSteC: 70.9;HSkMC: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 7.0;eosinophil: 16.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	423300	17000000	"Plasma membrane"	"Nuclear bodies"	"HPA076624: "	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavourable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	38.1	21.4	11.5	14.6	16.7	10.1	36.5	4.3	14.6	13.8	12.8	28.2	3.6	8.5	12.0	10.1	11.3	15.7	20.6	16.0	11.4	5.8	10.7	10.3	23.5	16.9	24.3	5.4	16.9	11.3	6.7	5.2	26.0	19.2	16.3	11.0	12.2	12.4	11.6	12.7	10.4	12.7	16.0	21.9	25.8	11.9	7.5	20.3	2.9	12.4	7.8	11.0	20.6	29.2	0.0	0.0	16.5	0.0	0.0	1.0	0.1	1.5	5.7	2.9	1.1	46.6	29.3	1.0	6.7	30.7	5.3	4.9	0.2	0.8	0.0	8.4	16.4	1.2	1.2	2.2	2.0	18.6	0.9	2.0	3.3	1.9	70.9	0.0	2.6	45.3	0.6	11.7	7.1	1.0	0.4	1.1	6.3	0.1	0.0	0.3	1.0	0.5	0.2	1.5	0.1	2.2	1.5	0.1	0.3	1.9	0.5	2.3	0.4	0.2	3.5	5.6	1.9	24.5	3.7	0.5	0.2	0.0	14.1	0.0	20.7	7.0	0.0	16.5	0.2	0.0	0.5	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	11.5	16.7	4.3	14.6	11.4	5.8	24.3	5.4	19.2	20.3
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.5;lymphoid tissue: 82.6"	"Group enriched"	"Detected in some"	5	"BEWO: 50.6;SK-BR-3: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 60.7;non-classical monocyte: 82.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"		1500000000	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	20.9	12.4	18.2	28.1	18.9	1.8	7.7	2.8	13.5	9.3	8.3	25.4	1.1	9.2	5.9	13.1	8.4	7.9	16.1	8.7	16.4	13.7	7.8	15.1	13.7	25.4	21.3	6.0	5.3	5.2	5.9	6.4	52.1	17.1	8.5	8.4	16.8	8.0	8.7	3.0	5.8	14.5	16.2	25.8	82.6	9.0	4.9	23.0	3.1	4.2	2.9	8.2	16.4	4.7	0.0	19.1	2.9	82.5	0.0	0.1	13.9	1.7	0.0	0.0	0.0	0.8	0.2	50.6	0.1	0.0	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	19.3	0.0	0.0	7.2	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.0	2.6	0.9	0.0	0.4	18.1	0.5	0.1	60.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	2.9	0.0	82.5	1.4	0.0	13.9	18.2	18.9	2.8	13.4	16.4	13.7	21.3	6.0	17.1	23.0
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073790-132076170	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;lung: 6.8;pancreas: 4.5"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 44.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"	36150		Vesicles		"HPA057404: , HPA062006: "	"unprognostic (7.29e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.09e-2)"		"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.68e-3)"		"unprognostic (1.87e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-2)"	0.2	0.1	0.1	3.9	0.1	1.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.7	0.0	1.5	0.1	1.1	0.2	0.1	0.1	0.3	0.9	6.8	0.3	0.1	0.0	0.1	4.5	0.0	0.1	0.5	0.0	0.2	0.7	0.0	1.9	0.0	0.1	0.4	1.0	0.6	0.1	1.0	0.2	0.2	0.0	0.4	0.2	0.0	1.8	2.3	0.1	0.0	0.0	0.0	0.0	9.5	0.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	2.5	0.0	3.5	0.0	0.7	0.0	0.1	0.0	3.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.2	6.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492197-149551552	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Supported	Cytosol				Cytosol		"CAB016680: AB_1614518, HPA051334: "	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favourable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	33.5	35.8	26.0	26.9	35.2	71.0	40.2	32.0	39.3	33.8	38.2	28.2	40.5	23.2	41.0	29.4	66.1	31.8	36.0	45.7	24.4	26.1	24.0	30.1	37.5	27.3	28.0	29.8	31.7	23.9	46.9	30.9	28.7	38.0	38.1	31.4	25.5	38.5	39.3	51.4	48.4	31.8	45.8	33.9	23.6	34.2	28.6	24.1	38.6	32.0	53.1	41.1	45.0	40.0	28.6	40.6	47.4	39.6	34.2	41.9	40.8	36.1	24.1	40.7	38.5	42.0	51.5	43.5	51.6	49.1	40.2	42.4	47.0	49.0	19.3	57.1	54.8	37.0	28.7	69.5	61.6	27.9	17.3	26.1	28.0	21.6	37.8	40.8	42.0	42.1	72.1	45.2	72.8	46.3	22.0	29.1	45.3	22.6	37.5	16.5	21.4	58.8	28.0	32.2	21.9	28.0	63.0	31.4	28.2	38.3	51.4	62.8	48.2	35.6	45.9	47.4	24.9	31.4	49.1	27.0	34.5	29.7	44.2	29.7	57.2	47.4	36.6	35.4	29.0	38.7	33.1	28.6	36.7	32.9	40.6	23.4	39.9	34.0	31.1	34.2	39.6	24.2	41.9	40.8	26.0	35.2	32.0	39.3	24.4	26.1	28.0	29.8	38.0	24.1
CSNK1G1	CK1gamma1	ENSG00000169118	"Casein kinase 1 gamma 1"	Q9HCP0	15	64165517-64356259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018209			Supported	Cytosol				Cytosol		"HPA018209: AB_1847278"	"unprognostic (9.10e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	7.2	7.8	10.2	11.9	15.1	11.6	8.7	12.2	10.6	8.7	7.4	7.6	11.6	7.0	11.1	9.9	15.7	10.8	7.8	5.6	8.9	7.6	8.6	6.0	8.4	9.6	6.6	4.7	8.5	8.8	10.4	16.1	7.2	7.2	6.8	7.9	10.1	8.2	14.5	6.5	10.4	6.8	11.1	5.3	8.2	6.8	41.3	7.3	11.8	11.5	5.6	11.2	8.3	10.6	4.1	4.1	8.8	5.1	5.3	8.0	2.4	5.1	10.7	7.8	10.1	6.7	9.1	7.1	6.3	6.5	10.7	9.7	8.5	10.0	8.0	3.4	9.9	11.7	20.3	12.7	12.6	15.2	5.2	7.4	8.6	5.7	7.7	13.8	8.9	8.1	16.9	10.9	15.7	11.7	9.0	8.4	9.6	7.0	7.0	4.3	7.2	5.6	11.8	9.7	6.4	8.6	20.4	12.5	7.6	8.3	5.0	7.3	8.7	5.4	12.6	9.8	11.7	7.7	7.7	9.7	18.6	6.8	9.1	10.2	6.0	0.9	3.6	5.6	5.7	5.1	8.0	3.6	5.1	4.1	2.7	4.1	5.1	4.7	8.8	5.3	4.3	4.1	3.9	2.4	10.2	15.1	12.2	10.6	8.9	7.6	6.6	4.7	7.2	7.3
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: , HPA061698: "	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	21.5	26.7	23.2	20.6	31.3	16.7	24.1	26.3	32.8	22.2	26.1	28.2	19.5	21.9	24.3	15.7	31.9	23.3	17.7	29.2	21.8	21.9	24.5	23.1	18.6	21.9	21.3	22.6	24.9	27.5	27.7	24.6	23.1	29.4	20.7	24.2	19.6	23.8	22.4	58.8	27.0	22.5	23.3	21.3	21.8	26.5	51.6	23.2	30.3	22.4	22.4	25.7	26.2	22.8	19.8	25.4	23.3	27.3	18.7	19.4	15.7	43.6	39.0	35.9	22.1	13.8	24.0	23.3	25.6	25.9	29.7	33.1	39.2	28.6	39.0	16.4	21.0	33.9	39.5	38.3	42.4	13.6	14.3	52.7	10.4	37.9	23.6	45.8	11.7	22.0	40.6	27.3	76.2	32.0	51.7	25.6	27.1	14.4	55.0	16.3	51.5	26.8	32.7	31.5	31.7	25.6	27.6	37.7	30.0	21.9	42.2	38.9	28.1	18.0	30.1	31.6	27.1	20.4	37.9	26.6	62.8	38.4	15.8	27.5	31.8	23.3	19.7	22.2	16.1	27.3	19.4	19.8	15.7	15.5	25.4	18.9	16.0	15.0	12.1	18.7	25.2	21.1	16.4	15.7	23.2	31.3	26.3	32.8	21.8	21.9	21.3	22.6	29.4	23.2
CSPG4	"HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2"	ENSG00000173546	"Chondroitin sulfate proteoglycan 4"	Q6UVK1	15	75674322-75712848	"Predicted membrane proteins"	"Angiogenesis, Differentiation, Tissue remodeling"	"Developmental protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 19.7;SK-MEL-30: 44.8;U-138 MG: 28.9;WM-115: 42.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 1.9"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"			28000000	"Plasma membrane"	Nucleoplasm	"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: "	"unprognostic (5.21e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavourable (7.60e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavourable (4.93e-5)"	36.1	3.1	8.3	10.0	7.9	1.0	19.5	1.6	7.8	15.3	29.2	7.2	6.9	4.6	21.3	14.9	19.9	9.4	18.2	9.2	6.5	5.2	3.5	1.5	10.9	1.4	6.6	5.2	7.0	3.8	3.0	1.6	20.9	6.6	11.4	3.9	10.0	3.4	16.7	25.7	8.0	9.1	37.9	5.4	3.8	14.0	2.5	6.3	0.0	4.7	6.0	1.3	30.3	10.9	0.0	0.1	0.0	0.0	1.9	0.0	0.0	3.5	0.0	0.3	2.2	0.5	3.1	0.0	19.7	8.8	13.8	9.0	0.0	13.7	0.0	0.4	13.7	0.1	0.0	0.1	4.3	0.1	0.0	0.0	5.7	0.0	3.2	0.0	0.0	1.5	0.0	4.2	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	44.8	0.3	0.3	0.0	28.9	5.7	1.1	0.2	0.0	0.0	0.0	6.3	0.1	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	8.3	7.9	1.6	5.9	6.5	5.2	6.6	5.2	6.6	6.3
CSPP1	"CSPP, FLJ22490, JBTS21"	ENSG00000104218	"Centrosome and spindle pole associated protein 1"	Q1MSJ5	8	67062426-67196263	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056174			Supported	"Centriolar satellite"				"Centriolar satellite"		"HPA056174: "	"unprognostic (1.44e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavourable (2.98e-4)"	"unprognostic (2.93e-1)"	8.3	5.9	10.6	10.4	15.5	9.2	11.1	19.1	14.3	9.4	7.3	10.6	6.9	8.5	10.5	8.7	7.5	20.6	11.7	7.0	9.9	9.8	17.1	9.4	11.0	7.3	11.3	8.6	11.5	11.0	10.2	13.0	18.2	14.1	7.9	8.2	8.1	7.3	11.3	24.5	8.2	7.6	8.0	18.0	6.8	8.0	25.7	15.0	10.3	9.9	5.0	6.3	7.6	7.5	6.2	6.7	10.3	5.1	3.9	5.4	1.8	9.0	6.2	7.9	10.4	9.3	7.4	9.4	7.9	6.6	8.3	8.0	6.9	11.8	10.3	2.1	4.5	7.8	13.9	4.3	10.8	5.3	9.8	11.2	6.5	5.9	5.2	10.0	7.8	5.4	4.5	6.0	11.3	4.8	21.2	6.9	6.2	4.4	23.1	10.2	8.5	9.4	14.3	7.9	6.6	8.6	6.4	4.7	4.7	4.5	8.1	6.4	13.2	5.7	5.9	9.8	7.5	4.3	6.6	8.2	5.2	11.7	6.4	9.0	6.9	10.3	5.1	1.8	5.1	4.9	4.8	5.3	5.4	4.0	3.4	6.2	5.2	4.8	1.6	3.9	3.6	6.7	5.2	1.8	10.6	15.5	19.1	14.3	9.9	9.8	11.3	8.6	14.1	15.0
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: "	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (1.07e-4)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	33.5	24.9	5.9	16.4	11.5	70.1	20.4	4.9	8.6	16.2	14.4	11.4	13.9	5.1	12.9	9.6	25.9	35.8	28.7	19.7	5.4	5.3	9.6	33.3	35.7	7.9	8.8	3.3	24.9	16.3	11.7	17.6	30.9	15.3	15.8	6.8	9.7	10.9	50.1	22.4	19.9	21.0	26.9	11.9	9.2	20.3	11.4	7.5	8.9	14.5	14.6	7.8	21.4	16.9	3.6	3.9	15.9	9.2	2.2	2.5	1.9	2.3	5.2	1.3	2.6	2.6	2.8	4.3	8.6	12.0	7.2	5.9	7.3	2.1	7.7	1.8	6.5	2.6	1.6	11.3	3.5	11.4	2.1	8.7	4.2	5.5	3.3	2.1	8.7	1.3	6.2	11.2	1.8	9.7	6.6	13.6	5.8	7.4	0.4	3.5	6.2	4.4	3.6	5.7	12.5	5.7	8.5	3.8	0.6	4.7	35.4	2.9	3.9	4.0	4.8	3.7	15.7	3.1	6.3	3.5	2.9	3.5	8.0	2.7	4.6	0.1	2.7	3.2	1.7	5.6	2.1	3.6	1.6	1.9	3.0	3.6	2.0	1.3	15.9	2.2	9.2	3.9	2.5	1.9	5.9	11.5	4.9	8.6	5.4	5.3	8.8	3.3	15.3	7.5
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 160.1;ASC TERT1: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 163.9;intermediate monocyte: 211.0;myeloid DC: 269.6;non-classical monocyte: 135.1;plasmacytoid DC: 153.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 269.6;monocytes: 211.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"		4100000000	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favourable (8.77e-4)"	95.8	72.6	229.0	37.9	254.7	22.2	68.6	61.4	196.7	76.6	78.2	75.4	39.5	59.4	47.6	143.6	73.8	64.9	89.4	79.7	157.4	96.2	35.9	67.3	58.0	91.2	148.3	90.6	51.4	142.1	34.5	45.6	25.8	69.9	55.2	66.1	195.0	338.2	74.2	44.2	44.9	77.9	57.3	73.3	85.5	105.5	57.4	68.4	40.7	43.2	40.1	31.9	49.4	50.2	0.6	269.6	27.4	211.0	6.4	2.4	106.7	12.6	28.8	6.7	15.5	160.1	109.6	12.6	22.1	30.8	15.2	12.3	54.7	19.6	0.0	20.8	30.1	43.0	6.2	44.1	4.7	0.0	21.3	13.0	5.7	93.0	57.3	0.6	21.9	84.8	37.2	20.4	21.9	23.7	11.8	0.3	21.1	20.2	0.1	13.8	9.0	63.2	0.4	8.2	17.5	62.4	28.7	7.4	8.5	16.1	4.8	27.4	13.6	47.7	59.8	14.4	10.4	20.1	8.2	13.6	0.4	0.1	12.3	28.6	16.2	1.4	163.9	1.0	2.4	211.0	0.9	0.6	0.6	1.6	269.6	0.5	0.6	1.2	27.4	6.4	135.1	153.5	0.4	106.7	229.0	254.7	61.4	196.7	157.4	96.2	148.3	90.6	69.9	68.4
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell line enhanced"	"Detected in all"		"RT4: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol			6100000	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: "	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	57.8	17.5	5.8	7.3	30.9	25.4	14.4	12.5	14.5	7.9	7.9	13.5	32.5	4.7	9.7	19.5	10.4	13.3	14.0	5.0	19.4	15.8	13.1	13.5	15.6	27.6	3.2	10.9	26.9	14.6	21.8	10.8	11.0	9.7	25.8	11.6	14.6	4.1	10.1	14.0	30.2	6.8	3.3	53.1	22.7	90.4	5.5	4.9	16.5	8.8	35.2	8.2	8.1	16.9	13.2	6.9	12.3	7.9	6.4	11.2	8.7	57.4	15.2	9.2	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1
CSTF1		ENSG00000101138	"Cleavage stimulation factor subunit 1"	Q05048	20	56392371-56406369	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019270, HPA047275, HPA065000"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB019270: , HPA047275: , HPA065000: "	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	14.3	16.6	9.7	15.0	15.9	6.8	17.1	14.8	14.9	13.2	11.9	14.5	9.1	8.1	17.5	12.6	16.4	15.2	12.0	11.9	10.2	9.6	18.1	27.5	12.8	17.2	12.9	9.4	20.1	18.4	20.1	19.0	14.1	12.2	14.1	12.7	14.6	22.8	11.7	18.7	16.9	13.6	13.6	10.5	17.1	14.1	28.2	11.4	32.5	15.8	15.8	21.9	14.9	12.1	15.1	15.7	9.4	11.6	21.0	22.6	12.9	8.4	8.0	10.2	7.1	10.6	9.7	11.1	11.6	12.8	23.1	17.3	17.4	12.3	17.5	12.5	8.5	14.3	16.4	19.7	27.3	5.5	5.7	17.0	14.4	10.5	6.4	14.3	11.0	9.2	11.5	12.9	11.1	13.8	14.4	8.5	13.9	19.8	15.7	7.3	9.4	10.6	11.8	22.0	15.4	11.1	8.8	11.4	7.8	15.5	42.9	11.5	17.2	9.9	7.5	18.8	12.0	7.7	11.1	6.0	9.3	19.0	14.8	9.4	8.9	7.5	11.6	9.0	14.9	10.1	19.0	14.8	19.1	16.8	14.9	15.1	21.1	18.4	9.4	21.0	8.2	15.7	22.6	12.9	9.7	15.9	14.8	14.9	10.2	9.6	12.9	9.4	12.2	11.4
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100840932	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	8.6	11.1	10.1	14.1	14.6	12.2	10.5	18.8	14.5	10.0	14.9	9.1	15.8	11.4	11.9	11.8	30.1	11.3	8.8	7.8	12.7	10.5	10.3	7.9	9.1	14.7	11.2	11.6	9.8	8.1	11.9	12.7	9.5	10.8	10.3	16.5	9.7	13.0	16.8	7.2	11.8	12.7	10.7	12.5	11.8	9.1	18.9	11.2	20.6	9.0	9.4	24.2	11.3	12.8	15.8	19.6	14.6	20.9	19.1	21.2	12.7	17.1	20.2	12.8	12.6	7.4	6.3	18.8	13.7	12.2	22.8	34.2	22.2	15.2	16.8	16.9	8.8	17.6	31.6	17.3	26.0	15.8	20.4	15.3	19.2	15.2	10.5	20.2	17.1	6.0	8.5	24.6	15.4	13.7	24.4	16.9	13.4	20.7	16.8	15.4	37.2	19.9	17.5	22.2	20.2	8.9	15.7	11.7	15.0	21.9	10.2	9.6	10.3	11.3	11.3	13.5	22.0	17.4	17.6	10.9	22.2	20.8	11.5	24.4	16.3	14.6	14.6	10.1	21.2	16.5	16.6	15.8	18.7	20.0	19.6	13.4	16.4	16.2	2.4	19.1	20.9	13.5	20.3	12.7	10.1	14.6	18.8	14.5	12.7	10.5	11.2	11.6	10.8	11.2
CSTF2T	"CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64"	ENSG00000177613	"Cleavage stimulation factor subunit 2 tau variant"	Q9H0L4	10	51695487-51699591	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039216, HPA062021"	Approved		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA039216: AB_10795462, HPA062021: "	"unprognostic (2.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.96e-1)"	20.2	23.5	16.5	20.0	21.6	14.0	15.2	16.2	24.0	14.8	13.5	29.6	9.9	14.3	16.8	13.4	13.1	19.0	12.7	17.4	18.4	16.6	15.5	15.4	11.9	21.7	21.3	16.5	23.3	16.3	30.2	14.1	14.6	23.5	15.8	13.5	12.6	13.4	12.5	25.0	13.3	16.8	16.8	28.0	24.6	17.7	11.6	20.1	31.9	17.0	12.6	22.9	17.0	13.2	4.6	5.5	5.5	5.1	13.9	6.8	3.2	8.3	10.0	15.1	15.8	21.3	14.6	1.0	11.9	11.1	13.8	13.5	13.2	12.3	24.2	6.9	10.4	13.2	11.3	12.5	12.6	14.0	12.8	13.9	10.6	2.4	10.3	5.3	12.8	21.0	9.7	12.1	14.1	10.3	14.9	13.8	11.9	7.1	21.8	8.6	5.5	21.6	17.4	30.4	5.1	10.6	7.0	12.7	16.3	9.9	10.4	10.6	19.4	10.0	10.9	8.8	12.1	8.1	14.8	17.6	6.5	17.4	18.4	12.6	7.6	3.7	5.0	5.5	4.9	5.1	6.8	2.3	3.6	3.8	5.5	4.6	6.2	5.3	1.5	13.9	3.4	3.5	5.7	3.2	16.5	21.6	16.2	24.0	18.4	16.6	21.3	16.5	23.5	20.1
CSTF3	CstF-77	ENSG00000176102	"Cleavage stimulation factor subunit 3"	Q12996	11	33077188-33162371	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039743, HPA040168"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA039743: AB_10795682, HPA040168: AB_10794025"	"unprognostic (2.38e-1)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (3.77e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (8.20e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (1.61e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-3)"	9.6	16.0	27.4	16.4	38.2	11.2	16.0	30.7	35.5	12.1	13.2	11.2	14.4	16.0	16.2	50.9	16.2	13.0	13.2	11.9	24.9	23.4	15.0	19.5	12.7	20.0	17.7	22.2	17.0	12.8	21.3	45.2	15.6	17.4	18.7	16.9	12.7	13.5	13.3	12.3	21.7	14.6	12.8	20.4	15.9	15.7	21.8	19.1	20.9	19.4	15.1	16.8	13.3	15.2	9.2	11.3	9.4	11.8	9.3	13.3	5.3	18.1	18.0	33.5	22.3	8.8	15.5	25.1	18.4	11.4	19.9	26.8	13.8	14.8	19.6	12.6	11.2	23.7	29.4	16.9	31.6	20.0	49.7	20.2	39.1	22.6	10.2	26.2	12.6	11.6	12.0	15.0	15.0	25.5	26.6	14.3	26.0	13.6	24.6	13.7	16.3	22.1	20.0	33.2	15.1	21.2	25.7	25.6	14.6	20.9	12.2	14.0	21.9	16.9	15.8	16.2	20.8	27.0	23.5	13.4	18.8	17.1	20.2	26.0	15.9	5.4	7.9	9.4	9.6	9.9	11.0	9.2	11.4	9.2	11.3	8.3	12.3	12.2	4.3	9.3	11.8	8.6	13.3	5.3	27.4	38.2	30.7	35.5	24.9	23.4	17.7	22.2	17.4	19.1
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9"	"Group enriched"	"Detected in some"	37	"K-562: 28.2;RPMI-8226: 62.9;SK-BR-3: 41.1;U-266/84: 71.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA071467: , HPA076586: "							"prognostic unfavourable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.2	1.0	0.4	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.2			0.0	0.0	0.0	1.0	2.9	0.0	8.5	0.0	0.0	0.1	0.8	0.2	0.0	0.2		0.8	3.6	0.0	0.4	4.4		0.2	0.0		0.1	0.0	5.7	0.2	0.0	0.0	0.0	0.3	0.6	11.9			0.0		0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.5	71.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CTAGE5	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, MEA6, MGEA, MGEA11, MGEA6"	ENSG00000150527	"CTAGE family member 5, ER export factor"	"O15320, Q96PC5"	14	39230231-39388513	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 43.9;Hep G2: 36.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: , HPA055459: "	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	9.3	16.9	7.3	11.4	7.3	7.3	7.9	5.1	7.9	12.1	22.8	5.8	13.5	28.5	8.5	17.9	18.5	8.4	15.1	7.5	6.4	5.9	34.7	52.2	10.6	9.0	7.8	6.5	8.6	20.6	22.9	20.6	6.0	21.1	8.9	12.6	6.0	22.3	17.0	17.4	6.4	52.4	6.9	9.7	9.7	16.0	8.7	8.6	10.1	17.0	15.9	7.0	8.3	10.9	8.7	12.5	24.5	13.5	9.8	11.6	8.4	7.8	8.7	3.7	6.5	7.5	8.5	5.1	4.6	4.8	3.3	3.4	6.7	43.9	9.4	14.4	5.2	12.0	4.4	5.2	3.9	7.3	3.7	5.9	4.2	36.3	17.6	7.9	11.0	5.2	29.8	3.3	24.9	5.4	5.5	24.2	4.9	7.5	5.0	6.4	4.2	7.3	5.2	6.5	11.7	15.3	8.5	3.1	1.8	10.8	11.5	7.0	11.0	8.5	8.4	5.1	3.3	3.7	3.0	13.8	11.9	9.3	2.9	5.0	4.2	22.5	11.8	17.6	11.6	12.3	10.5	8.5	8.9	10.8	12.5	8.7	11.0	10.2	24.5	9.8	13.5	8.7	8.1	8.4	7.3	7.3	5.1	7.9	6.4	5.9	7.8	6.5	21.1	8.6
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211448-1249953	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: "	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favourable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favourable (8.94e-4)"	32.3	35.8	42.4	39.8	44.4	31.3	54.6	70.7	56.1	27.6	29.4	29.2	29.0	44.9	35.8	30.8	31.9	38.2	37.6	41.2	41.5	45.7	29.3	36.0	28.5	48.4	38.0	41.2	35.4	62.2	28.4	48.1	27.2	30.2	32.6	21.6	28.2	44.9	27.9	74.2	33.9	43.6	29.7	29.3	47.0	33.5	16.7	27.2	44.9	29.4	30.5	30.2	32.2	38.6	15.6	25.0	11.6	16.2	16.1	24.5	10.3	22.5	33.3	25.8	31.6	18.1	13.1	22.2	17.8	16.6	22.2	22.6	28.5	54.7	27.6	20.7	20.7	18.1	15.6	23.4	6.7	20.9	18.8	25.0	37.7	36.4	30.2	22.4	35.7	22.5	18.0	18.8	10.9	16.5	28.3	47.5	12.2	37.2	72.1	70.7	30.5	32.2	51.1	15.5	36.0	14.2	28.7	48.5	30.4	17.0	18.4	23.5	40.3	34.6	21.1	37.1	20.9	21.2	38.0	34.6	33.0	31.9	29.3	35.0	29.1	8.6	11.9	11.6	24.5	16.2	18.4	15.3	17.2	20.8	14.7	15.6	13.5	19.5	9.3	16.1	15.8	25.0	14.6	10.3	42.4	44.4	70.7	56.1	41.5	45.7	38.0	41.2	30.2	27.2
CTCF		ENSG00000102974	"CCCTC-binding factor"	P49711	16	67562407-67639185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Chromosome partition, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004122, CAB062550, CAB068181, CAB068182"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB062550: , CAB068181: , CAB068182: , HPA004122: "	"unprognostic (2.70e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (4.21e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (3.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-2)"	19.1	17.5	22.3	35.0	24.3	32.2	20.2	31.6	26.6	23.0	19.4	20.5	21.0	16.5	24.2	15.4	23.1	21.7	20.3	17.6	21.8	16.7	19.5	19.5	17.2	27.9	22.3	21.0	24.6	21.2	42.4	21.8	23.5	17.9	19.4	23.2	14.3	19.9	24.9	29.4	25.2	21.4	22.0	20.2	26.1	18.5	14.8	22.9	68.8	20.7	16.2	35.5	22.6	26.7	10.1	7.9	9.6	6.2	4.9	7.2	1.9	10.9	16.9	22.5	8.9	10.3	8.8	18.3	10.5	11.1	15.5	14.9	13.8	11.4	34.4	8.5	9.1	14.2	21.7	11.8	17.6	12.2	14.3	20.8	9.6	15.8	7.0	23.6	20.0	7.1	14.3	11.6	13.0	11.8	18.2	14.4	12.8	21.5	49.5	9.0	19.5	11.3	36.2	18.5	18.9	9.5	15.9	19.3	13.4	19.0	11.1	9.3	13.7	14.7	11.2	13.4	13.9	10.2	11.5	12.6	15.8	50.1	7.7	14.2	14.3	9.4	3.4	4.9	6.7	3.4	6.3	7.9	7.2	5.4	3.1	10.1	5.9	6.7	9.6	4.9	6.2	7.9	5.4	1.9	22.3	24.3	31.6	26.6	21.8	16.7	22.3	21.0	17.9	22.9
CTDSP1	"NLIIF, SCP1"	ENSG00000144579	"CTD small phosphatase 1"	Q9GZU7	2	218398256-218405941	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062654			Supported	Nucleoplasm				Nucleoplasm		"HPA062654: "	"unprognostic (1.97e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.57e-1)"	32.9	22.5	15.9	21.9	13.9	19.9	41.1	12.2	16.4	34.8	30.7	27.6	31.8	24.2	34.5	30.7	31.3	30.9	43.4	25.9	15.5	8.6	34.1	47.5	30.2	33.2	15.0	13.1	44.9	50.8	28.8	12.6	71.3	15.9	41.5	19.8	35.4	34.3	31.5	23.2	30.5	41.3	33.7	12.4	39.1	34.2	15.1	16.1	33.2	41.0	27.2	29.9	32.5	28.4	3.4	6.6	29.3	12.4	6.7	11.0	7.5	10.1	13.1	7.8	25.5	21.1	19.7	29.3	13.7	19.8	13.3	11.5	17.1	25.5	6.2	11.9	24.2	20.9	11.5	16.5	6.8	22.0	9.0	23.5	16.1	22.9	25.4	14.4	32.9	22.4	20.2	10.1	11.4	19.5	19.0	22.1	14.0	28.5	12.6	42.1	5.4	13.5	17.5	10.9	13.3	16.9	12.6	5.2	12.9	12.0	26.1	12.9	14.4	34.7	17.0	21.2	12.9	16.1	6.0	14.2	9.2	14.5	18.8	13.7	11.7	20.3	12.4	29.3	11.0	10.2	7.1	3.4	6.7	7.0	6.6	3.2	4.3	5.7	24.5	6.7	10.4	2.3	5.6	7.5	15.9	13.9	12.2	16.4	15.5	8.6	15.0	13.1	15.9	16.1
CTDSPL2	"FLJ10523, HSPC129"	ENSG00000137770	"CTD small phosphatase like 2"	Q05D32	15	44427234-44529038	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040763, HPA062198"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA040763: AB_10960989, HPA062198: "	"unprognostic (6.64e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (8.36e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.16e-1)"	17.4	11.1	13.0	15.9	16.3	19.8	17.0	33.2	18.4	17.7	14.2	11.6	15.7	11.2	21.3	13.3	14.6	15.4	13.3	11.8	11.5	9.3	12.8	11.5	14.3	20.1	13.4	10.7	22.7	13.0	13.4	21.1	17.6	11.6	14.7	12.8	12.2	15.6	12.7	17.9	16.0	14.9	16.0	11.6	16.5	11.8	21.7	13.8	35.5	17.4	9.7	20.9	18.4	15.8	12.3	16.0	10.3	13.1	17.0	16.5	11.2	10.8	5.4	23.0	11.5	3.5	8.2	12.7	11.2	9.7	14.6	18.7	11.0	10.2	11.5	10.9	7.9	15.4	13.1	7.7	17.3	11.4	6.2	14.3	14.3	6.8	5.2	24.7	12.8	6.5	5.8	10.3	13.6	11.3	16.6	12.9	10.6	4.7	29.3	8.6	12.1	7.8	32.8	31.6	10.7	7.8	14.6	10.5	15.4	13.9	11.4	6.4	15.3	22.5	9.7	18.2	19.8	17.5	19.0	7.7	29.0	35.4	8.6	19.6	14.0	6.0	12.8	10.3	12.7	13.1	11.9	12.3	12.4	11.5	16.0	12.1	13.4	15.0	9.0	17.0	9.9	10.2	16.5	11.2	13.0	16.3	33.2	18.4	11.5	9.3	13.4	10.7	11.6	13.8
CTIF	KIAA0427	ENSG00000134030	"Cap binding complex dependent translation initiation factor"	O43310	18	48539046-48863217	"Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016865, HPA024801"	Uncertain		Supported	Cytosol				Cytosol		"HPA016865: AB_1852311, HPA024801: AB_1852312"	"unprognostic (5.84e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.35e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.33e-3)"	40.7	15.7	17.3	8.0	21.9	5.2	18.2	28.8	34.5	10.3	12.8	12.4	6.2	6.6	12.3	7.2	19.2	8.5	16.7	18.1	17.2	23.4	9.1	12.7	12.8	4.1	19.7	24.5	29.8	9.2	9.6	12.1	10.1	22.7	9.5	5.0	10.0	11.9	13.4	16.0	7.2	7.5	15.6	23.1	7.1	11.0	8.0	16.3	0.9	9.9	4.7	3.7	12.7	13.0	0.1	0.8	0.8	0.7	0.0	1.4	0.1	2.2	2.5	3.3	4.3	8.6	4.6	1.9	11.6	9.8	9.3	8.5	2.5	1.3	0.0	2.6	16.0	4.9	2.4	6.6	4.0	0.0	2.0	1.0	5.5	6.0	16.5	1.8	3.3	6.4	10.8	5.8	10.4	6.6	2.8	7.2	5.8	1.2	0.6	1.4	1.7	2.0	1.2	3.8	3.0	2.7	3.1	7.2	7.2	4.1	4.5	3.4	2.8	2.2	13.2	8.6	8.0	2.5	2.1	2.5	2.9	0.0	7.6	1.2	3.8	0.8	0.7	0.7	1.4	0.4	0.3	0.1	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	17.3	21.9	28.8	34.5	17.2	23.4	19.7	24.5	22.7	16.3
CTNNA1	CAP102	ENSG00000044115	"Catenin alpha 1"	P35221	5	138610967-138935034	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021089, HPA046119, HPA063535"	Approved		Enhanced	"Plasma membrane,Cell Junctions"			5400	"Plasma membrane, Cell Junctions"		"CAB021089: AB_10123543, HPA046119: , HPA063535: "	"unprognostic (2.25e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (6.18e-2)"	"prognostic favourable (7.34e-7)"	"unprognostic (1.54e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-1)"	55.9	54.0	39.6	24.4	50.2	10.9	55.1	16.5	39.5	43.4	58.9	68.5	33.9	44.2	53.0	47.5	76.9	45.8	41.1	68.6	38.8	32.3	62.2	37.7	49.8	27.0	57.3	29.3	42.7	38.1	55.5	25.6	54.0	45.5	39.4	49.0	35.6	48.8	43.5	30.5	49.8	53.9	59.6	49.7	30.9	48.2	18.7	56.6	8.1	51.2	46.4	44.1	48.4	45.1	3.8	15.2	9.8	21.8	0.3	5.0	7.1	32.5	23.8	36.0	53.3	31.4	34.5	54.9	33.0	41.6	31.6	40.1	49.5	44.3	0.1	28.0	49.2	25.0	24.7	54.3	36.8	18.7	21.5	13.7	39.1	30.0	37.9	0.2	13.4	21.7	43.5	37.7	41.5	59.5	7.5	14.2	34.0	28.8	0.3	4.2	14.5	0.5	12.9	21.0	19.6	66.7	43.6	14.4	19.0	60.9	85.7	49.8	30.3	9.4	50.4	33.3	18.0	20.6	22.8	5.1	9.6	1.9	31.7	5.9	42.9	2.2	17.1	1.5	2.9	21.8	1.9	3.8	2.1	2.1	15.2	3.2	0.1	1.1	9.8	0.3	20.2	3.7	5.0	7.1	39.6	50.2	16.5	39.5	38.8	32.3	57.3	29.3	45.5	56.6
CTNNB1	"armadillo, beta-catenin, CTNNB"	ENSG00000168036	"Catenin beta 1"	P35222	3	41194741-41260096	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway"	Activator	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000108, CAB001950, HPA029159, HPA029160"	Supported		Enhanced	"Plasma membrane"			1000000	"Plasma membrane"		"CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996"	"unprognostic (2.47e-1)"	"unprognostic (3.48e-2)"	"prognostic favourable (7.54e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.79e-2)"	52.9	54.5	38.8	33.5	45.9	46.3	70.5	78.8	59.3	71.7	49.6	57.3	34.2	48.7	79.2	42.5	46.3	49.8	45.0	42.1	38.6	41.5	46.9	53.2	53.6	31.6	37.0	47.0	84.2	38.6	59.2	44.0	82.6	41.5	50.8	50.1	75.9	53.9	49.7	31.2	44.7	70.4	66.5	39.4	41.0	37.3	29.0	39.3	40.1	62.3	44.5	36.6	46.9	54.2	10.1	13.5	7.5	14.5	11.1	13.5	4.8	22.6	30.2	63.7	35.6	34.4	28.2	48.9	25.6	36.4	42.8	42.5	20.8	32.4	18.6	23.4	45.2	17.0	46.1	73.9	45.9	17.2	31.4	30.0	40.1	74.3	25.7	17.0	14.4	41.0	33.5	51.1	31.1	37.6	21.2	11.6	47.4	23.0	11.9	9.2	58.0	23.5	9.0	41.5	12.4	26.5	70.9	15.2	25.8	42.4	21.6	113.7	35.4	35.4	48.4	32.2	24.7	20.6	37.5	7.2	11.2	19.8	33.0	21.5	53.7	4.3	8.1	6.9	11.2	14.5	13.5	9.6	10.5	12.1	13.5	10.1	10.7	10.8	7.5	11.1	13.7	11.7	12.6	4.8	38.8	45.9	78.8	59.3	38.6	41.5	37.0	47.0	41.5	39.3
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	21.0	14.7	19.6	25.8	21.4	27.3	18.9	20.9	21.3	20.3	23.5	18.4	31.7	16.1	25.4	25.2	18.9	21.0	17.7	25.6	17.5	15.8	19.3	35.3	19.3	26.9	17.9	14.7	21.7	14.6	14.5	22.6	22.4	17.5	19.4	18.1	16.1	15.5	34.3	27.3	20.1	19.7	23.8	16.6	49.5	25.9	35.5	20.6	31.0	15.9	15.5	29.7	22.2	29.3	24.9	31.4	60.3	29.1	21.7	18.2	18.4	15.3	14.2	13.6	10.6	9.8	8.1	21.5	9.8	10.3	23.6	20.9	52.9	12.4	17.1	14.4	9.9	16.5	18.2	23.2	25.5	8.2	9.1	56.1	7.8	25.8	10.2	17.7	74.6	8.6	13.8	13.3	13.3	14.1	15.1	7.0	12.6	12.7	28.7	23.6	12.2	20.6	20.2	26.3	12.9	10.3	12.9	10.9	13.0	17.0	24.5	17.2	12.0	14.3	10.4	23.7	14.1	15.5	15.9	8.2	10.4	19.9	16.6	11.1	12.5	60.3	22.3	27.9	15.8	29.1	15.0	24.9	15.4	16.2	31.4	23.4	15.5	16.6	4.9	21.7	28.7	24.7	18.2	18.4	19.6	21.4	20.9	21.3	17.5	15.8	17.9	14.7	17.5	20.6
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 12.5;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 10.2;monocytes: 12.5"					"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"			15000	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favourable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	39.7	19.9	15.1	20.4	17.0	3.2	31.4	15.0	20.5	28.8	41.9	25.7	49.2	37.5	32.7	32.7	76.3	22.9	28.8	18.2	15.6	10.3	30.6	31.2	34.0	11.6	14.4	12.8	23.3	50.4	41.9	34.5	49.8	16.4	29.7	39.8	34.4	46.4	39.1	11.8	48.7	82.0	22.8	17.2	25.9	39.4	27.8	14.7	7.1	38.4	34.9	45.6	32.3	38.9	1.4	10.2	0.4	12.5	0.4	0.5	2.3	37.4	28.1	25.1	16.8	13.6	18.6	35.6	17.2	19.4	15.6	14.9	21.8	41.6	0.7	30.4	21.3	49.2	20.2	26.1	20.0	0.4	6.6	9.3	11.0	24.6	14.1	2.0	14.7	20.5	31.6	19.7	20.2	47.4	14.0	0.4	17.2	12.1	0.7	3.5	17.9	15.1	0.7	21.2	0.8	23.3	40.0	2.3	11.2	24.3	33.3	25.4	35.0	2.5	40.1	15.0	12.9	14.7	9.7	1.3	0.8	1.1	14.0	1.2	26.4	0.0	6.9	0.2	0.2	12.5	0.5	1.0	0.1	0.4	10.2	1.4	0.2	0.3	0.4	0.4	11.9	3.1	0.2	2.3	15.1	17.0	15.0	20.5	15.6	10.3	14.4	12.8	16.4	14.7
CTNS	"CTNS-LSB, PQLC4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636468-3661542	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"				"Vesicles, Intermediate filaments"		"HPA046947: "	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favourable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favourable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	9.6	19.0	8.5	8.2	11.9	8.3	12.1	5.0	9.9	18.8	8.2	16.1	34.8	10.8	10.3	7.2	7.3	8.3	10.6	9.3	7.7	5.9	23.9	16.4	11.4	9.1	12.1	5.6	12.6	32.7	11.3	14.5	13.2	8.5	10.2	6.4	11.4	10.5	46.2	22.6	18.0	9.2	7.9	10.2	12.2	12.9	27.0	13.0	11.7	9.0	6.5	9.0	10.1	9.1	3.5	19.6	13.7	5.6	2.5	3.3	3.7	6.1	13.8	8.1	6.9	13.2	6.7	5.1	6.0	10.1	6.9	8.7	7.7	6.1	3.7	6.4	4.0	15.8	7.1	4.1	5.3	46.0	12.5	4.2	10.4	6.2	17.8	2.8	28.8	8.3	5.2	7.3	5.9	7.6	4.3	5.8	6.5	5.6	2.8	2.7	3.6	6.1	6.2	3.3	8.7	6.2	6.3	1.6	5.9	7.0	9.4	7.0	6.6	2.8	8.9	6.8	4.3	15.4	4.9	4.7	6.0	1.7	10.5	3.0	4.6	13.7	5.6	12.1	1.9	3.7	2.7	3.5	2.3	3.3	5.4	3.1	2.9	3.1	2.0	2.5	3.8	19.6	2.6	3.7	8.5	11.9	5.0	9.9	7.7	5.9	12.1	5.6	8.5	13.0
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979335-41012565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Supported	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"CAB017111: , HPA051322: "	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	7.1	10.0	4.5	10.8	7.8	9.7	5.1	5.9	9.8	14.4	23.6	5.8	16.3	4.3	25.9	8.4	11.3	21.9	13.4	6.7	4.7	5.1	8.6	26.4	7.0	9.4	7.9	4.7	10.1	6.3	16.8	5.4	7.7	6.2	14.4	9.8	9.1	56.5	19.6	13.2	5.8	13.5	35.8	5.1	7.5	9.0	11.8	6.7	14.6	4.5	11.3	13.2	21.3	9.5	6.0	12.8	0.0	7.3	6.6	7.0	3.8	21.1	19.4	27.5	22.1	7.6	9.5	43.2	37.2	16.0	40.9	27.6	38.1	18.8	39.7	16.9	17.0	15.0	29.4	27.8	40.9	16.6	22.3	24.3	25.9	12.0	24.9	32.4	19.1	10.4	15.1	42.3	30.4	18.6	24.4	17.5	28.6	11.9	35.0	12.1	37.5	23.1	27.0	33.4	25.7	20.7	19.3	36.9	18.0	23.2	25.0	9.2	8.7	44.8	15.2	27.1	35.4	18.2	46.2	11.3	13.2	35.3	17.7	25.8	28.1	0.0	4.0	0.0	4.6	7.3	6.6	6.0	5.3	4.8	12.0	3.9	4.4	7.0	0.0	6.6	6.1	12.8	6.6	3.8	4.5	7.8	5.9	9.8	4.7	5.1	7.9	4.7	6.2	6.7
CTR9	"KIAA0155, p150TSP, SH2BP1, TSBP"	ENSG00000198730	"CTR9 homolog, Paf1/RNA polymerase II complex component"	Q6PD62	11	10750987-10801625	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061027, HPA068122"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA061027: , HPA068122: "	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.27e-2)"	"prognostic favourable (3.65e-6)"	"unprognostic (6.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	16.7	26.7	15.9	19.9	17.4	18.4	26.1	17.5	17.1	21.5	15.8	13.0	20.3	14.2	21.4	44.1	23.7	17.7	13.7	24.2	18.8	14.8	20.5	35.0	15.6	23.8	14.3	14.0	25.4	18.8	36.5	31.4	26.7	16.0	17.5	16.4	14.0	19.1	20.2	24.0	18.3	19.2	16.6	15.7	26.6	17.6	24.4	15.8	39.1	20.9	13.1	21.9	19.6	21.1	11.9	11.9	27.2	12.1	17.5	18.5	9.5	12.7	9.9	14.4	13.6	31.5	12.6	7.0	14.2	9.5	11.5	12.2	16.4	27.5	11.6	7.9	11.7	13.3	17.6	11.7	18.9	17.8	21.2	59.4	10.5	9.3	10.0	23.2	33.1	11.7	9.6	7.4	10.0	13.2	24.0	14.3	13.9	5.8	14.8	9.1	11.9	12.5	13.8	17.5	8.0	9.9	17.6	6.6	15.8	12.9	12.8	9.9	11.3	10.3	12.9	9.8	10.0	17.1	7.6	7.8	18.4	12.8	10.4	15.7	9.9	27.2	10.0	19.8	14.1	12.1	18.5	11.6	14.9	13.6	11.9	11.9	14.7	13.8	7.5	17.5	11.2	6.0	12.4	9.5	15.9	17.4	17.5	17.1	18.8	14.8	14.3	14.0	16.0	15.8
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898820	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 125.7"	"Cell line enhanced"	"Detected in all"		"ASC diff: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"		18000000	Vesicles		"CAB024930: , HPA031068: AB_10601205"	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	29.0	125.7	12.0	22.8	19.5	22.1	35.3	11.4	30.0	14.1	50.6	17.4	16.2	29.4	18.2	19.3	20.7	12.7	28.0	32.6	11.5	11.6	88.2	43.8	28.4	38.9	12.3	16.1	23.9	19.2	28.3	16.5	47.7	15.7	18.2	50.5	30.1	20.5	15.1	19.3	28.2	40.6	19.6	11.9	38.8	19.7	14.3	11.2	8.0	18.1	24.9	22.4	23.3	18.7	7.0	16.6	81.1	46.1	12.0	31.2	50.0	14.4	14.9	2.8	12.7	116.2	60.2	6.4	20.8	55.4	22.8	29.7	27.9	38.9	3.1	24.1	38.9	23.1	7.5	14.0	14.3	6.0	7.0	8.2	10.4	48.6	25.9	13.0	33.9	47.8	16.9	14.7	3.3	24.8	8.1	47.8	24.7	29.7	3.3	12.0	2.8	35.4	5.2	14.5	17.2	18.2	12.7	5.6	5.3	34.6	60.6	58.0	14.8	18.7	22.8	45.8	10.7	25.9	16.3	23.6	29.7	2.2	82.5	17.3	18.8	60.6	46.1	81.1	7.5	26.6	31.2	7.0	12.9	13.2	16.6	3.6	4.7	6.9	24.7	12.0	17.7	6.6	23.9	50.0	12.0	19.5	11.4	30.0	11.5	11.6	12.3	16.1	15.7	11.2
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 237.0;fHDF/TERT166: 137.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"		130000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favourable (5.76e-4)"	"prognostic unfavourable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.1	3.7	16.0	65.8	74.1	11.6	121.4	237.0	42.5	50.4	13.9	37.9	0.1	17.6	137.7	35.4	5.1	33.5	26.9	3.1	5.0	9.4	3.4	34.1	67.0	2.1	7.0	81.1	45.7	38.4	34.4	83.1	7.8	21.5	35.3	5.1	0.8	3.4	3.1	9.8	3.3	3.8	16.4	12.9	10.1	1.6	9.5	14.0	7.6	63.3	12.3	6.3	115.1	72.3	24.5	23.1	22.6	21.4	15.5	0.5	82.9	8.1	33.8	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88293592-88337787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 218.6"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		19000000	Vesicles		"CAB025364: , HPA066610: , HPA068434: "	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favourable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	40.7	20.5	6.7	44.5	10.6	12.0	35.3	1.5	5.6	14.0	25.3	7.1	6.2	20.4	16.1	24.0	21.8	16.7	36.6	53.3	6.8	6.5	62.7	18.1	110.1	218.6	12.5	3.6	11.0	24.8	3.8	17.3	43.4	9.4	13.8	33.1	27.0	35.1	5.8	10.0	11.7	28.5	14.2	14.6	86.6	13.5	10.8	9.2	19.5	17.7	25.3	30.0	30.2	16.9	8.5	75.9	52.5	92.6	34.7	42.4	31.2	11.2	11.5	4.5	9.4	12.2	33.0	30.2	77.1	112.0	44.0	31.8	31.2	51.8	17.5	41.0	41.8	18.2	7.0	32.6	35.2	30.8	12.7	22.8	31.9	35.1	16.2	28.9	15.4	45.9	23.1	33.9	69.6	43.2	20.7	21.1	5.3	2.1	13.0	40.0	23.6	35.7	17.0	4.7	31.0	56.6	18.9	1.2	9.5	13.0	17.2	10.1	3.8	19.8	21.0	3.0	27.3	20.9	48.9	9.0	12.8	17.7	8.0	61.1	16.7	12.5	32.5	52.5	42.4	69.3	36.5	8.5	19.5	37.8	35.1	4.6	9.9	23.8	37.2	34.7	92.6	75.9	28.4	31.2	6.7	10.6	1.5	5.6	6.8	6.5	12.5	3.6	9.4	9.2
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 82.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5;HaCaT: 31.0;RT4: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 42.8"	"Group enriched"	"Detected in all"	5	"B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"		10000000	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	16.7	10.6	9.5	24.2	7.0	5.4	23.9	4.5	9.8	25.1	11.4	17.7	14.7	10.6	10.3	17.1	7.8	13.1	29.2	16.5	14.8	6.7	66.7	18.7	82.6	65.4	12.1	11.6	14.6	25.8	12.3	6.5	7.7	9.4	18.6	6.6	6.7	15.4	15.9	7.0	13.5	16.6	9.8	10.8	20.3	15.6	6.7	15.7	6.6	8.5	4.8	34.8	39.6	13.5	20.6	41.2	1.4	42.8	1.3	7.6	27.3	16.0	1.1	0.4	4.7	1.1	0.0	5.2	1.6	0.6	2.8	1.5	7.0	42.5	5.6	1.7	0.1	31.0	2.0	7.7	2.3	23.6	0.1	0.1	0.2	16.2	1.6	0.0	1.0	0.8	2.2	0.0	0.0	0.2	11.4	0.0	3.8	1.7	3.6	9.8	1.2	0.3	0.0	0.3	0.9	9.8	118.0	0.5	1.1	6.9	3.9	9.6	1.5	5.3	2.2	0.0	1.0	0.0	0.7	0.1	12.2	3.1	0.0	10.3	1.7	0.0	42.8	0.4	1.4	28.3	7.6	20.6	4.1	2.1	41.2	12.0	0.4	0.7	1.4	1.3	17.0	4.2	3.1	27.3	9.5	7.0	4.5	9.8	14.8	6.7	12.1	11.6	9.4	15.7
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150796208-150808323	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.1"	"Group enriched"	"Detected in some"	8	"ASC diff: 200.2;ASC TERT1: 73.3;BJ hTERT+: 161.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 6.7"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"			Vesicles		"HPA050346: "	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavourable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	104.1	2.4	1.2	6.5	1.6	1.3	79.3	2.4	2.3	70.6	23.6	2.2	10.1	2.7	72.5	25.9	26.5	12.5	53.4	14.7	1.1	1.1	3.4	1.8	8.7	10.4	1.1	1.7	25.4	2.9	0.3	3.0	30.6	2.6	24.2	11.5	56.0	10.9	6.8	19.9	44.0	11.0	26.9	2.0	5.6	8.6	24.1	0.9	1.1	7.1	13.2	10.7	38.0	48.2	0.1	1.0	1.0	6.7	0.5	1.2	1.8	0.1	0.1	0.3	0.3	200.2	73.3	0.2	5.7	161.8	0.4	0.8	0.0	0.1	0.1	0.2	11.1	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	1.0	0.1	0.4	14.6	0.5	4.5	0.1	0.6	0.0	0.5	0.4	0.3	0.0	0.7	1.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.6	0.3	0.0	3.0	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.6	0.5	1.1	17.0	0.0	0.9	0.0	6.7	1.0	0.7	3.4	0.2	0.0	0.6	0.2	0.4	0.1	0.3	0.5	0.6	0.5	2.0	1.0	1.2	1.8	1.2	1.6	2.4	2.3	1.1	1.1	1.1	1.7	2.6	0.9
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58995185-59007247	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.2;intermediate monocyte: 2.7;memory B-cell: 1.0;myeloid DC: 3.9;naive B-cell: 1.9;neutrophil: 3.5;non-classical monocyte: 2.9;plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"		85000000	Vesicles		"CAB025114: , HPA049876: , HPA053504: "	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	70.7	27.9	12.4	40.8	20.4	20.7	51.2	14.6	13.5	25.4	52.8	16.0	19.9	40.8	20.6	25.5	20.1	20.7	22.3	50.1	9.8	13.3	34.9	83.7	54.3	61.2	18.8	10.5	29.7	29.0	30.6	27.6	38.6	19.2	28.8	37.8	31.5	40.3	17.7	20.7	12.9	63.6	26.4	22.1	56.5	19.2	13.8	14.9	18.4	42.4	17.5	35.8	29.8	21.5	1.9	3.9	3.5	3.2	0.3	0.6	0.8	27.2	21.2	0.0	0.0	25.0	28.8	15.0	44.9	49.7	34.4	30.8	41.0	45.9	15.0	29.7	118.0	21.8	13.5	42.5	23.6	47.9	1.8	13.7	34.4	0.0	26.2	1.6	47.7	24.5	25.7	15.0	18.0	54.4	9.9	7.6	23.0	0.0	0.1	14.8	1.7	21.2	0.3	0.1	18.0	25.1	6.4	0.4	0.3	34.9	40.4	0.1	18.7	23.2	59.8	0.0	23.2	30.2	0.2	36.2	22.0	2.8	0.4	33.1	0.0	0.0	3.2	0.3	0.6	2.7	0.0	1.0	0.4	0.1	3.9	1.9	0.4	0.1	3.5	0.3	2.9	2.2	0.2	0.8	12.4	20.4	14.6	13.5	9.8	13.3	18.8	10.5	19.2	14.9
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 128.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"			34000000	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: "	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (2.19e-6)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	37.5	53.6	33.0	19.7	36.7	5.7	32.0	33.3	41.1	41.3	35.3	42.3	33.7	37.1	48.8	40.2	49.4	35.5	56.2	37.3	28.5	23.5	47.2	24.9	30.5	13.7	45.0	32.0	46.3	40.0	28.9	38.3	32.3	37.2	38.9	32.4	24.4	38.0	38.5	31.5	52.9	39.2	43.1	36.0	21.4	51.3	30.2	38.6	7.7	36.0	44.5	26.7	33.2	38.2	0.1	0.8	4.6	0.2	0.0	0.4	13.9	128.4	28.3	9.6	11.0	16.2	25.3	15.8	27.5	27.5	24.3	19.2	37.4	32.4	5.0	27.3	35.2	28.6	11.4	28.9	17.8	10.1	11.5	0.5	21.1	17.5	35.0	0.1	6.8	35.7	20.4	26.8	15.2	20.3	14.4	0.9	23.9	35.1	0.2	1.8	10.4	17.3	0.0	11.8	4.0	27.1	41.9	7.9	13.5	20.1	27.6	45.7	22.5	0.5	25.3	21.4	13.7	33.2	18.3	2.2	1.4	0.3	42.7	0.1	29.2	1.4	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	4.6	0.0	0.2	0.8	0.0	13.9	33.0	36.7	33.3	41.1	28.5	23.5	45.0	32.0	37.2	38.6
CTU2	"C16orf84, NCS2"	ENSG00000174177	"Cytosolic thiouridylase subunit 2"	Q2VPK5	16	88706463-88715386	"Predicted intracellular proteins"	"tRNA processing"		"Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041135, HPA041894"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA041135: AB_10794543, HPA041894: AB_10796463"	"unprognostic (4.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavourable (5.68e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	10.9	10.5	13.0	10.9	12.8	12.0	7.8	11.6	17.4	9.0	8.8	11.7	4.6	9.5	11.4	6.7	8.1	8.8	8.5	11.0	12.8	10.2	6.5	11.4	7.7	12.2	12.9	15.3	12.5	15.7	7.0	10.9	7.5	9.9	8.3	4.4	5.8	15.6	9.6	25.4	11.5	7.8	14.7	8.7	9.1	9.5	22.8	11.2	9.3	9.7	11.1	7.9	8.3	7.2	7.5	7.7	1.4	8.0	8.1	9.3	4.6	6.9	10.9	4.3	9.2	3.7	3.8	10.6	7.3	5.6	8.1	4.0	12.8	6.6	10.2	9.8	4.6	6.9	7.1	7.1	2.2	3.1	21.4	7.1	4.5	12.8	6.2	6.9	5.4	4.2	5.2	6.4	6.9	6.8	26.1	2.9	3.0	18.6	18.9	15.7	6.4	17.7	15.3	3.3	10.7	2.8	2.7	14.2	6.9	11.9	2.2	4.5	6.5	7.6	7.6	8.5	10.9	9.6	7.9	9.6	4.8	29.0	7.1	15.0	9.2	1.4	6.4	0.0	9.3	8.0	7.8	6.9	8.4	9.0	7.7	7.5	8.9	7.1	0.5	8.1	6.5	7.6	4.7	4.6	13.0	12.8	11.6	17.4	12.8	10.2	12.9	15.3	9.9	11.2
CUEDC2	"C10orf66, MGC2491"	ENSG00000107874	"CUE domain containing 2"	Q9H467	10	102423245-102432661	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036544, HPA041829"	Uncertain		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA036544: AB_10670111, HPA041829: "	"unprognostic (2.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.78e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.58e-2)"	18.8	26.2	29.9	14.9	28.5	13.0	16.2	22.0	49.7	19.8	20.3	19.0	18.5	10.8	19.6	20.8	17.1	25.1	22.7	38.7	25.5	22.3	20.1	18.2	14.9	15.3	27.5	29.5	27.9	23.3	24.4	16.7	14.6	25.4	20.7	12.6	17.5	21.5	22.4	61.6	13.2	11.2	23.6	23.6	15.1	16.3	13.5	18.2	16.5	20.0	25.5	15.8	17.1	14.9	37.4	50.1	35.5	50.5	38.2	36.1	36.0	15.7	18.0	28.2	33.2	23.5	30.3	10.6	13.3	42.9	28.5	21.8	5.6	15.9	26.2	28.3	22.2	15.5	18.3	28.7	14.1	23.4	18.6	16.1	15.3	5.6	39.9	12.4	11.0	35.6	26.7	27.8	27.7	29.4	12.5	26.2	31.9	16.9	28.8	27.6	9.7	11.3	33.4	34.6	13.5	29.0	7.3	14.0	33.5	8.9	8.8	27.1	26.9	19.7	16.8	14.2	13.5	18.1	17.7	32.5	26.3	17.4	25.7	43.3	11.3	34.1	50.5	35.5	32.3	39.7	36.1	34.8	32.1	33.7	50.1	37.4	32.0	30.7	19.2	38.2	24.6	43.3	35.7	36.0	29.9	28.5	22.0	49.7	25.5	22.3	27.5	29.5	25.4	18.2
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli			190000	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: "	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	26.0	20.9	21.2	20.4	22.4	22.3	27.5	27.5	26.2	23.9	25.8	19.5	22.5	16.7	30.2	23.7	22.7	21.2	18.7	25.7	21.1	21.8	16.9	35.2	20.5	26.5	21.7	16.7	25.0	17.9	24.9	30.7	32.0	21.0	23.9	18.8	22.7	19.6	25.0	58.9	20.5	21.2	37.7	26.3	21.9	22.4	65.6	23.7	16.9	24.5	24.6	24.5	26.1	28.8	16.8	24.1	13.4	17.1	22.1	20.8	16.1	30.7	23.9	23.5	36.3	18.5	20.8	29.8	25.4	30.0	25.7	24.5	25.4	21.5	42.2	20.4	25.1	20.8	33.5	23.7	30.3	27.5	28.5	24.9	16.9	24.6	21.7	28.2	23.7	17.0	23.3	18.8	19.1	28.0	38.4	32.6	28.0	29.4	24.5	32.3	44.0	22.9	29.8	20.7	40.6	21.1	22.5	33.8	24.8	29.6	35.3	20.0	11.6	22.4	21.5	18.4	6.4	37.2	29.2	30.6	21.2	41.8	37.4	31.5	27.1	13.4	15.2	12.0	16.1	17.1	18.6	16.8	16.7	18.6	24.1	14.4	20.8	16.7	2.1	22.1	14.5	5.5	15.9	16.1	21.2	22.4	27.5	26.2	21.1	21.8	21.7	16.7	21.0	23.7
CUL2		ENSG00000108094	"Cullin 2"	Q13617	10	35008551-35090642	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002677, HPA024578"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002677: , HPA024578: AB_1847338"	"unprognostic (8.11e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (8.24e-6)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavourable (9.32e-5)"	"unprognostic (2.26e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.29e-1)"	16.2	14.9	17.2	12.6	22.6	14.3	13.6	16.8	20.9	11.6	14.3	9.0	18.1	11.9	13.6	9.5	14.3	12.1	10.1	15.7	15.4	15.1	12.2	17.2	11.9	15.4	14.3	20.8	12.9	17.7	21.4	19.3	21.9	17.3	13.3	13.0	7.0	12.8	14.1	33.7	14.2	12.4	16.1	14.0	15.1	14.5	27.9	15.4	20.3	13.7	14.4	16.6	15.6	12.3	11.4	11.9	10.0	13.7	11.3	17.4	7.7	19.6	11.6	15.4	13.2	17.6	19.4	16.3	23.2	13.0	23.0	23.3	15.5	18.9	15.7	12.9	24.5	18.2	22.3	21.4	26.5	18.4	14.5	20.4	12.6	13.7	19.3	11.1	13.4	18.7	17.9	25.2	8.8	25.6	23.3	14.3	25.2	13.4	18.3	6.2	5.6	47.7	15.5	24.9	9.8	21.2	15.5	7.5	10.0	13.0	16.4	18.3	12.5	12.7	23.4	14.3	15.9	24.3	15.1	6.0	8.1	18.9	27.4	25.1	10.0	9.6	9.3	10.0	12.3	13.7	17.4	10.8	14.0	14.7	11.9	11.4	16.7	15.5	4.4	11.3	13.3	5.4	16.6	7.7	17.2	22.6	16.8	20.9	15.4	15.1	14.3	20.8	17.3	15.4
CUL4B		ENSG00000158290	"Cullin 4B"	Q13620	X	120524609-120575794	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003046, HPA011880, CAB017786, HPA058979"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: "	"unprognostic (2.34e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.12e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	20.9	24.0	19.0	19.2	28.1	12.2	25.3	28.9	25.7	32.6	20.5	12.1	25.7	14.0	24.2	47.2	29.3	19.6	18.5	19.4	18.5	20.2	19.1	20.4	23.8	23.5	17.3	20.4	30.1	18.8	34.4	48.3	17.0	18.4	30.8	17.2	15.7	17.3	27.3	10.8	17.7	16.3	36.0	20.5	19.9	17.0	34.0	17.3	29.8	18.8	13.9	24.1	40.4	22.5	7.6	12.5	15.4	4.3	5.5	8.3	4.9	12.0	10.2	8.5	9.0	37.5	19.0	6.9	27.3	32.8	22.6	23.7	9.2	34.2	12.1	9.4	62.8	9.0	17.4	8.0	25.8	7.0	9.0	5.9	14.8	6.5	16.2	6.3	8.4	21.3	6.1	13.0	11.3	40.4	9.1	9.4	21.8	6.4	8.3	6.6	12.9	10.3	7.0	8.4	12.3	7.5	6.0	9.7	8.1	20.2	9.9	10.0	8.4	5.8	53.2	16.3	9.0	21.7	24.4	6.0	10.4	15.1	17.6	8.6	14.6	5.8	4.3	9.0	7.2	3.8	7.7	7.6	7.0	6.6	5.1	5.7	7.9	8.3	15.4	5.5	2.7	12.5	8.2	4.9	19.0	28.1	28.9	25.7	18.5	20.2	17.3	20.4	18.4	17.3
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038619	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649"	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	11.6	4.9	5.7	9.8	8.7	7.9	9.8	3.5	6.5	5.3	5.9	7.2	3.5	4.4	4.9	8.0	6.2	5.1	5.8	13.2	5.9	4.7	5.3	11.0	5.1	7.9	8.6	6.6	4.6	4.5	3.5	3.6	4.5	5.5	6.0	6.4	6.9	5.7	5.4	122.1	5.8	6.2	11.6	7.4	9.2	6.0	14.1	8.3	9.2	4.3	25.1	7.3	13.5	11.4	32.8	24.2	47.1	19.4	25.5	36.3	19.3	9.3	20.2	7.1	21.6	26.4	12.1	3.9	7.7	9.9	7.8	8.8	9.3	7.2	34.2	6.9	13.1	8.1	14.5	12.8	8.7	10.1	13.8	11.3	9.1	14.6	12.2	21.0	5.6	12.5	8.0	12.4	25.8	13.3	10.0	7.6	5.8	6.5	18.8	21.7	7.1	7.6	12.8	8.3	13.1	8.1	3.9	2.3	5.3	3.5	5.6	9.7	9.0	12.0	7.4	3.2	4.4	3.5	10.1	12.5	16.2	24.0	10.6	45.1	2.9	26.5	19.4	47.1	27.2	15.2	28.3	32.8	25.9	25.9	21.0	29.0	36.3	27.8	30.8	25.5	18.5	24.2	24.7	19.3	5.7	8.7	3.5	6.5	5.9	4.7	8.6	6.6	5.5	8.3
CUX1	"CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6"	ENSG00000257923	"Cut like homeobox 1"	"Q13948, P39880"	7	101815904-102283958	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Transport"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003277, HPA003317"	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA003277: AB_10601804, HPA003317: "	"unprognostic (5.86e-2)"	"unprognostic (5.39e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"prognostic favourable (5.72e-7)"	"unprognostic (1.12e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-1)"	19.3	12.7	22.9	19.2	24.4	19.5	12.3	48.6	29.9	31.6	26.4	23.1	17.3	22.2	52.1	17.4	23.9	24.5	23.2	53.8	18.8	18.3	27.4	16.0	22.0	11.8	20.4	11.7	33.0	41.4	34.4	30.2	24.4	16.9	22.8	17.2	26.8	26.3	16.9	31.0	15.9	25.3	27.5	31.6	15.0	23.4	8.3	17.1	44.0	33.5	23.2	24.1	31.8	21.9	2.0	12.1	4.7	21.0	3.0	2.2	4.5	14.3	15.4	10.9	13.4	8.8	18.3	6.8	14.4	15.3	6.1	4.0	9.1	9.2	18.5	23.2	14.2	11.8	6.9	11.6	3.7	8.9	7.7	6.5	11.4	7.6	23.5	8.4	3.6	12.7	23.7	4.7	10.7	7.9	15.1	15.8	5.7	29.5	27.3	10.3	4.4	16.1	18.1	9.0	22.0	10.1	16.4	10.0	29.8	12.6	31.6	12.3	6.2	10.1	11.7	25.9	17.5	19.5	8.2	10.3	4.9	40.1	23.9	7.8	18.0	2.1	8.6	1.5	2.1	8.8	2.2	2.0	1.6	2.2	7.0	1.7	1.6	2.2	4.7	3.0	21.0	12.1	1.5	4.5	22.9	24.4	48.6	29.9	18.8	18.3	20.4	11.7	16.9	17.1
CWC22	"EIF4GL, fSAPb, KIAA1604, NCM"	ENSG00000163510	"CWC22 spliceosome associated protein homolog"	Q9HCG8	2	179944876-180007113	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036748	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA036748: AB_10669913"	"unprognostic (1.90e-1)"	"unprognostic (7.10e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (7.42e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.80e-2)"	"prognostic unfavourable (7.76e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-3)"	20.4	14.2	15.8	17.3	16.8	18.1	19.2	33.5	24.6	21.1	17.0	10.5	13.5	12.4	21.5	14.3	18.4	17.6	15.5	14.8	17.5	11.9	17.2	20.7	14.7	21.3	14.4	19.6	25.4	14.7	21.8	25.0	17.8	17.0	20.4	15.2	9.1	15.4	14.7	20.2	15.9	17.4	23.6	19.0	20.5	15.4	10.9	16.3	26.5	20.7	17.6	21.7	21.8	23.8	12.4	9.9	26.4	11.9	10.9	16.4	8.2	9.4	5.9	16.5	11.0	11.9	14.3	12.6	12.6	14.8	15.5	15.1	13.3	12.0	18.7	11.3	9.1	10.4	15.6	11.7	23.5	16.4	13.8	25.0	7.7	18.0	11.8	34.7	13.9	9.3	14.2	19.5	26.4	11.5	27.1	11.5	10.1	9.5	18.1	18.1	25.3	9.5	16.7	20.4	14.0	10.7	12.0	11.3	15.3	10.3	8.3	14.3	6.2	22.0	9.8	13.2	11.3	8.7	13.0	10.1	10.6	22.8	11.9	14.1	13.3	26.4	9.5	21.5	12.3	11.9	12.4	12.4	13.3	14.5	9.9	11.3	16.4	12.8	15.9	10.9	8.9	6.3	11.3	8.2	15.8	16.8	33.5	24.6	17.5	11.9	14.4	19.6	17.0	16.3
CWC25	"CCDC49, FLJ20291"	ENSG00000273559	"CWC25 spliceosome associated protein homolog"	Q9NXE8	17	38800434-38825481	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 29.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014874, HPA062997"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"CAB014874: , HPA062997: "	"unprognostic (2.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.79e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.68e-3)"	6.0	4.4	5.1	5.5	5.8	29.7	4.6	6.6	6.2	5.5	4.8	4.4	5.4	5.4	6.0	3.6	3.9	3.1	4.5	3.0	4.3		4.6	4.8	4.6	6.5	5.0	3.7	5.0	4.3	4.0	7.8	7.5	4.4	5.1	4.1	4.4	4.5	6.3	7.6	8.6	5.6	4.3	6.5	5.2	4.0	10.4	5.8	7.8	4.6	4.4	6.4	5.4	5.6	4.5	4.8	18.0	5.2	3.4	4.4	2.5	5.8	7.3	5.2	7.3	6.3	5.2	4.6	6.1	4.8	8.7	6.5	6.1	6.1	7.8	4.5	5.8	13.4	5.8	4.6	9.4	6.8	8.1	5.5	7.4	6.4	6.3	13.5	9.0	5.4	7.4	7.0	6.1	5.3	8.5	7.9	5.6	3.8	14.1	14.2	4.6	4.4	10.3	7.1	6.2	7.6	5.9	5.0	4.6	6.0	4.0	7.2	6.2	10.8	5.7	6.0	5.2	7.8	9.9	7.1	5.7	10.1	6.5	7.3	5.9	7.6	5.2	5.8	3.9	3.0	3.3	4.2	3.6	3.7	3.6	4.5	4.4	3.3	18.0	3.4	4.1	4.8	3.1	2.5										
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated protein homolog"	Q6UX04	5	64768930-65018763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: "	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavourable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	15.6	16.4	22.0	14.9	30.4	21.7	16.4	30.1	25.6	16.5	17.5	13.8	14.0	11.8	19.4	15.7	17.3	14.9	13.8	22.1	20.6	19.9	17.5	12.1	12.8	17.0	22.3	20.7	23.3	10.9	21.4	28.8	17.5	26.2	18.6	18.7	11.4	13.3	16.0	24.0	13.8	15.9	24.7	23.3	15.0	13.9	19.6	23.6	22.5	17.2	18.2	18.6	18.6	20.0	15.1	14.6	8.6	11.5	17.0	15.9	9.0	15.2	10.2	18.3	33.9	15.7	19.2	20.5	16.0	13.4	18.0	18.9	17.0	19.4	22.6	28.1	16.6	9.7	19.2	29.0	32.8	18.8	15.7	17.0	17.2	14.1	24.1	17.7	11.5	12.8	22.3	22.6	28.8	19.0	16.5	14.9	17.8	15.1	24.6	16.1	14.8	12.3	22.9	24.7	23.5	17.1	13.3	21.8	9.6	19.5	8.0	18.1	17.4	26.1	15.7	10.6	18.7	16.9	25.5	11.7	15.1	22.2	19.8	31.2	18.7	8.6	11.5	7.9	12.8	11.3	15.5	15.1	14.2	15.9	14.6	11.9	15.4	15.9	2.5	17.0	8.5	12.0	15.1	9.0	22.0	30.4	30.1	25.6	20.6	19.9	22.3	20.7	26.2	23.6
CX3CL1	"ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1"	ENSG00000006210	"C-X3-C motif chemokine ligand 1"	P78423	16	57372458-57385048	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 13.4;HDLM-2: 36.5;Hep G2: 27.2;RPTEC TERT1: 16.2;SK-BR-3: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026192, HPA040361"	Approved		Supported	"Plasma membrane"	"Secreted to blood"	1867500		"Plasma membrane"		"CAB026192: , HPA040361: AB_10796453"	"unprognostic (6.89e-3)"	"prognostic favourable (9.46e-4)"	"unprognostic (1.52e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-2)"	"prognostic favourable (8.52e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	24.3	3.6	13.4	4.7	26.6	0.7	42.5	3.8	45.1	12.4	5.9	6.9	8.7	4.2	12.1	7.0	10.7	11.7	14.9	12.0	16.4	13.8	14.5	11.2	35.3	6.0	9.2	18.0	5.2	9.6	3.8	4.5	3.4	11.7	22.3	4.5	12.2	39.9	34.4	9.2	9.9	5.0	21.7	6.6	1.5	5.0	3.8	3.9	0.8	12.0	5.7	4.9	19.7	6.7	1.0	0.8	2.1	0.7	0.8	0.6	0.2	0.0	0.3	3.5	3.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	13.4	0.0	0.1	0.0	0.0	0.0	36.5	0.2	0.0	0.0	27.2	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	0.0	16.2	0.0	0.1	3.1	0.0	9.5	0.8	0.0	0.1	0.0	0.1	2.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.7	0.5	0.6	0.4	0.3	0.6	0.4	0.3	0.2	1.0	0.4	0.6	2.1	0.8	0.4	0.8	0.2	0.2	13.4	26.6	3.8	37.3	16.4	13.8	9.2	18.0	11.7	3.9
CXADR	CAR	ENSG00000154639	"CXADR, Ig-like cell adhesion molecule"	P78310	21	17512382-17593579	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 31.7;Hep G2: 20.5;NTERA-2: 36.7;RT4: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"		11000	"Plasma membrane, Cell Junctions"		"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	4.0	3.1	6.4	3.2	9.4	1.3	5.8	2.0	15.4	6.3	27.1	12.5	9.0	24.9	3.3	9.3	15.0	6.5	17.2	10.8	7.9	5.5	5.1	28.6	9.9	4.2	9.2	5.6	1.1	12.0	5.2	11.1	0.3	11.6	9.2	15.4	3.7	16.3	15.8	0.6	30.0	41.4	2.1	13.0	1.4	17.6	8.5	6.9	0.9	13.1	4.9	3.8	14.7	10.0	0.8	0.4	2.6	0.5	0.9	2.7	0.9	5.5	3.1	15.2	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.9	31.7	4.9	2.0	6.8	0.0	9.6	7.6	2.0	0.3	3.1	6.5	0.0	9.1	20.5	0.9	0.6	0.0	0.0	8.3	0.4	0.1	3.0	0.1	0.1	0.0	0.3	1.2	0.0	36.7	0.0	0.0	5.1	3.9	12.7	35.4	6.1	4.1	3.6	4.1	2.1	8.4	0.1	0.1	0.0	9.1	0.1	2.2	1.5	2.5	0.1	1.2	0.0	0.2	2.6	0.5	0.4	0.5	0.2	1.0	0.3	2.6	0.6	0.1	0.8	2.7	0.8	1.4	0.9	0.2	0.4	0.5	0.9	6.4	9.4	2.0	15.4	7.9	5.5	9.2	5.6	11.6	6.9
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137253	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 216.1"	"Group enriched"	"Detected in some"	11	"BEWO: 12.1;HL-60: 6.7;HMC-1: 14.1;THP-1: 12.8;U-937: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	59	"neutrophil: 216.1"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 216.1"	"Low region specificity"	"Detected in single"							"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"				"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	9.3	0.9	1.3	25.6	1.5	4.0	0.6	1.2	1.3	5.2	0.6	0.5	2.5	0.0	0.8	1.1	18.1	3.3	5.2	4.3	1.5	0.6	0.7	4.6	16.7	40.5	6.6	0.0	1.2	1.7	0.0	0.7	4.5	1.7	1.9	0.3	1.8	3.3	2.6	0.6	3.0	0.7	1.4	4.1	30.6	1.0	1.1	0.7	0.6	0.6	4.8	10.1	5.4	6.4	0.0	1.6	216.1	1.9	0.4	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	14.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.0	0.2	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	12.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	3.6	1.9	3.2	1.9	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.7	216.1	0.4	0.2	1.6	0.0	1.0	1.3	1.5	1.2	1.3	1.5	0.6	6.6	0.0	1.7	0.7
CXorf67		ENSG00000187690	"Chromosome X open reading frame 67"	Q86X51	X	51406915-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 14.3;testis: 21.4"	"Cell line enriched"	"Detected in single"	46	"U-2 OS: 27.0"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;naive CD4 T-cell: 1.2"	"Group enriched"	"Detected in many"	11	"B-cells: 1.1;T-cells: 1.2"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.1	0.2	0.3	0.2	0.6	0.1	0.1	2.8	0.4	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.2	0.2	0.2	0.1	0.7	0.1	0.0	1.5	14.3	0.1	0.4	0.1	0.1	0.9	0.2	0.1	0.2	0.2	0.1	0.4	0.7	0.1	21.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.7	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	2.8	0.4	0.3	0.5	0.2	0.1	0.1	0.1
CXXC1	"CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1"	ENSG00000154832	"CXXC finger protein 1"	Q9P0U4	18	50282343-50288304	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044511	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA044511: AB_10963081"	"unprognostic (4.47e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (4.18e-6)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.08e-2)"	"prognostic favourable (2.60e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-2)"	12.1	16.9	17.5	20.0	20.3	40.3	12.4	42.4	23.1	15.7	15.2	15.7	18.7	18.3	16.8	10.2	15.5	19.8	17.5	13.6	18.2	12.2	16.5	14.9	13.9	23.6	22.6	13.1	23.6	32.8	13.7	14.3	22.4	18.7	15.6	9.1	14.1	24.7	19.4	12.1	17.2	15.1	17.7	11.7	19.3	17.3	15.5	20.3	25.8	15.5	14.0	18.6	17.5	20.1	22.0	16.6	24.5	16.9	16.0	21.1	15.0	8.3	11.3	8.5	16.1	6.9	4.9	17.7	10.9	7.5	10.9	9.6	8.2	6.2	23.6	5.7	4.9	13.6	14.3	10.4	3.1	19.3	12.6	19.0	12.3	13.0	5.0	44.5	20.7	4.8	8.1	12.0	6.2	7.3	11.7	20.2	5.5	11.7	26.3	21.9	18.8	7.6	26.5	8.9	19.0	5.8	5.0	18.0	17.3	8.5	5.5	6.9	7.0	18.8	11.2	15.3	9.7	6.8	9.2	34.8	24.4	19.4	9.7	16.5	13.0	17.7	14.1	24.5	19.2	16.9	21.1	22.0	17.7	19.3	16.6	21.7	19.6	16.2	6.2	16.0	13.1	12.1	19.6	15.0	17.5	20.3	42.4	23.1	18.2	12.2	22.6	13.1	18.7	20.3
CXXC5	"HSPC195, RINF, WID"	ENSG00000171604	"CXXC finger protein 5"	Q7LFL8	5	139647299-139683882	"Predicted intracellular proteins"	Transcription	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 68.2"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036508, HPA058148"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036508: AB_10673620, HPA058148: "	"unprognostic (3.08e-2)"	"unprognostic (9.03e-2)"	"prognostic favourable (2.40e-4)"	"prognostic unfavourable (4.10e-7)"	"unprognostic (2.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.57e-1)"	12.3	9.5	22.4	9.3	19.9	22.2	9.2	68.2	38.8	17.5	10.2	39.3	5.1	6.0	9.9	18.0	10.1	18.1	11.4	15.8	23.9	16.7	25.6	33.8	9.0	15.5	30.9	21.7	5.4	24.9	18.2	18.6	10.4	25.4	8.1	7.9	14.2	30.0	11.7	39.7	9.8	9.1	8.4	36.7	18.1	11.4	19.0	27.5	20.5	12.5	7.7	13.5	9.6	9.9	29.3	19.1	0.7	2.1	21.8	10.2	3.4	9.3	7.9	8.8	3.3	12.3	16.9	3.4	6.1	9.4	2.6	5.3	17.4	9.6	12.4	27.4	16.4	10.8	1.8	4.7	1.3	1.3	3.0	18.5	7.0	12.2	5.3	4.0	0.6	6.0	1.0	4.5	1.3	0.7	17.2	2.0	19.3	24.5	4.4	13.1	10.6	2.2	8.0	17.9	18.9	20.2	6.8	28.0	28.8	2.2	56.6	4.6	30.9	19.3	3.8	22.0	4.3	10.4	5.5	7.4	15.5	23.4	33.1	1.4	12.1	0.3	2.1	0.1	3.2	0.4	10.2	27.7	0.3	2.3	1.8	29.3	0.2	0.9	0.7	21.8	0.1	19.1	0.4	3.4	22.4	19.9	68.2	38.8	23.9	16.7	30.9	21.7	25.4	27.5
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250847-74292016	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 266.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.3;RT4: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol			780000	"Vesicles, Cytosol"		"CAB006333: , HPA047548: , HPA058547: "	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favourable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	25.0	13.2	4.3	11.0	5.8	1.5	39.4	6.9	5.9	7.5	68.2	4.3	38.5	37.7	4.9	16.0	8.3	7.0	34.8	14.5	4.1	3.7	76.2	266.8	67.0	9.2	6.5	3.4	25.1	75.3	10.1	6.5	7.2	5.2	13.5	9.0	6.2	7.6	54.9	4.3	11.4	70.7	21.2	11.5	10.3	18.0	12.2	5.5	4.6	4.6	7.9	4.3	21.6	18.8	34.9	16.9	2.1	12.9	10.2	38.0	13.5	9.8	16.8	8.8	0.0	151.3	26.9	11.7	6.8	14.7	14.5	21.8	19.8	10.7	12.0	4.8	12.4	22.0	0.0	9.3	11.6	22.4	11.7	4.4	9.2	52.5	23.5	8.4	5.8	45.0	7.4	8.2	4.2	7.9	7.1	4.5	12.1	17.7	4.7	10.0	3.9	10.9	11.7	2.8	0.2	14.4	66.0	25.1	10.4	6.6	18.0	8.0	35.6	8.0	7.4	0.0	11.4	3.5	8.6	3.2	13.0	3.7	8.9	2.3	8.4	1.1	9.6	2.1	16.7	10.8	38.0	28.5	18.7	19.6	16.9	34.9	18.4	23.1	1.1	10.2	12.9	14.8	14.4	13.5	4.3	5.8	6.9	5.9	4.1	3.7	6.5	3.4	5.2	5.5
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649568	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 115.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"			67000000	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	79.7	57.1	33.2	22.8	32.6	19.3	86.8	19.5	33.1	52.4	31.9	37.6	51.8	25.9	51.9	35.0	39.1	39.3	38.6	86.4	31.3	24.1	43.3	78.2	43.5	30.3	31.8	25.4	58.8	21.9	15.1	27.2	32.1	33.9	40.6	21.3	37.9	29.3	96.4	34.4	43.1	32.5	55.5	36.3	20.2	33.7	44.0	25.9	14.1	30.1	28.4	23.2	43.4	53.5	28.6	37.6	70.3	39.7	14.2	22.3	19.7	16.2	10.4	17.2	10.5	115.5	91.8	10.1	47.8	44.4	35.7	31.9	13.6	12.8	7.7	21.4	88.4	15.0	11.4	23.7	18.4	8.3	25.6	10.9	18.0	26.2	29.4	15.2	20.4	55.3	18.8	25.7	17.1	29.5	9.4	40.0	48.5	17.9	14.9	14.0	6.8	19.2	11.0	20.9	17.0	27.5	11.9	7.6	9.9	15.8	15.3	17.4	12.2	14.7	45.2	38.8	24.2	26.1	18.0	10.6	11.5	9.4	45.2	8.9	31.9	26.3	25.7	70.3	19.7	32.4	19.9	28.6	19.1	21.6	37.6	26.4	13.6	14.3	13.4	14.2	39.7	34.3	22.3	19.7	33.2	32.6	19.5	33.1	31.3	24.1	31.8	25.4	33.9	25.9
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA042671: , HPA060463: "	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	1.7	4.9	1.9	0.8	1.9	1.6	2.4	1.3	1.7	2.5	2.2			2.6	2.5	2.3	2.1	2.9	2.0	3.5	2.1	1.7	2.7	2.6	1.5	2.1	2.3		5.0	4.1	1.8	4.2	1.1		2.1	2.7		3.2	1.4	3.7	3.9	1.5	2.4	1.8	2.5	2.8	1.2			3.1		2.2	2.8	1.8	1.4	1.8	2.6	3.5	3.1	1.5	1.2	4.0	5.4	7.4	7.7	6.1	5.8	2.5	3.2	4.6	6.3	6.8	5.1	4.4	6.7	3.8	2.2	3.7	11.5	3.3	7.1	7.6	4.7	7.6	8.7	5.2	4.6	6.5	3.9	3.1	4.5	7.4	3.4	5.4	8.2	3.2	4.5	5.0	6.5	3.6	7.4	4.3	10.5	9.1	6.2	2.8	4.6	11.0	5.4	2.1	7.3	6.5	5.1	5.0	2.4	4.8	3.9	7.0	5.7	4.8	7.7	9.9	5.4	13.9	7.2	2.2	1.8	1.6	1.0	3.5	0.8	1.1	1.5	0.6	1.6	1.4	1.2	1.2	2.6	3.1	0.8	1.8	0.5	1.2										
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095027-144097525	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.2"	"Cell line enhanced"	"Detected in all"		"PC-3: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"			110000	Mitochondria	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	16.0	31.3	16.2	13.2	20.1	19.5	12.1	19.1	32.1	13.0	33.3	13.4	14.4	38.1	13.9	10.1	36.2	15.5	13.1	92.1	16.6	14.1	44.8	55.9	11.2	16.5	18.0	18.6	15.0	21.4	17.9	10.6	16.0	17.7	16.5	25.3	13.3	23.3	17.2	145.2	17.7	42.6	16.3	11.8	18.3	22.4	13.9	11.5	21.5	21.7	43.8	18.5	19.9	14.4	34.9	76.7	22.1	60.0	30.2	26.1	58.5	22.2	50.4	13.4	28.0	11.1	12.3	25.8	12.8	15.6	32.7	21.5	35.2	27.8	31.5	28.9	17.1	33.0	29.2	25.4	12.3	19.3	38.7	33.8	42.5	32.2	19.9	19.9	22.1	17.9	31.8	20.8	41.3	18.9	30.7	28.2	17.0	79.8	37.3	18.5	15.5	151.2	33.0	17.9	55.2	26.8	35.8	36.0	15.9	35.7	49.4	26.2	40.6	30.6	14.4	20.8	44.4	23.0	38.9	31.3	22.7	23.4	26.5	34.1	26.6	22.1	59.7	15.9	24.1	60.0	25.4	34.9	20.1	25.8	76.7	29.4	19.7	25.4	5.8	30.2	44.8	42.9	26.1	58.5	16.2	20.1	19.1	32.1	16.6	14.1	18.0	18.6	17.7	11.5
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25120091-25125361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 109.6;skeletal muscle: 103.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria			190000000	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	20.3	29.3	29.8	20.0	44.8	17.1	14.7	25.1	41.1	12.1	62.1	13.3	9.6	35.4	11.4	10.7	26.6	11.0	13.1	109.6	30.2	26.4	39.8	37.0	13.4	13.8	30.7	34.7	12.2	9.3	24.8	18.6	10.3	29.9	13.7	58.5	13.5	14.9	15.7	103.7	11.3	30.2	21.8	28.0	15.6	24.3	23.5	18.1	17.3	18.3	41.2	20.0	15.9	14.3	35.5	38.0	17.1	38.3	25.2	31.0	25.2	43.0	24.1	26.1	36.3	15.0	11.6	26.9	41.5	17.1	31.1	36.2	39.9	29.5	49.6	20.4	18.1	51.2	53.0	39.1	55.0	14.7	23.8	41.3	28.6	28.3	23.6	94.3	36.8	15.4	35.0	31.1	67.5	27.8	75.6	52.6	33.0	19.9	51.5	36.7	48.9	45.7	36.3	31.4	47.4	48.4	42.3	53.0	25.2	21.6	92.4	33.4	47.9	56.5	20.1	28.6	52.1	44.1	76.6	54.4	63.0	110.8	38.1	68.7	79.2	17.1	20.0	14.0	25.3	38.3	31.0	35.5	23.4	26.8	38.0	26.0	22.4	26.8	3.0	25.2	33.6	27.8	29.5	25.2	29.8	44.8	25.1	41.1	30.2	26.4	30.7	34.7	29.9	18.1
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 24.4;Hep G2: 18.6;HHSteC: 37.2;HSkMC: 30.3;SH-SY5Y: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: "	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favourable (2.55e-5)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	48.1	16.1	6.2	9.5	8.3	1.1	34.4	10.9	11.6	13.3	19.0	1.5	8.4	15.2	8.8	8.4	12.5	8.8	24.1	43.4	4.2	11.2	6.9	13.6	17.8	9.5	6.3	5.5	11.2	7.6	8.5	5.0	10.0	17.7	22.8	7.0	23.7	10.4	9.4	17.1	8.2	17.8	17.6	3.5	8.0	13.1	9.3	2.2	1.1	22.0	11.4	3.4	35.1	41.5	4.4	0.4	2.4	0.3	2.5	1.3	0.5	0.0	0.3	0.6	0.1	24.4	7.2	8.2	0.2	0.6	0.1	0.2	0.0	0.1	0.0	7.9	0.7	0.2	0.0	10.5	0.0	0.0	0.0	0.1	0.1	18.6	37.2	0.0	0.0	30.3	2.3	0.8	0.8	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.0	0.2	40.6	0.0	0.0	0.8	0.0	0.2	0.0	1.0	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.1	3.1	0.0	0.3	0.4	0.5	0.2	0.3	3.4	0.4	0.2	0.4	4.4	0.7	1.3	2.4	2.5	0.2	0.0	0.5	0.5	6.2	8.3	10.9	11.6	4.2	11.2	6.3	5.5	17.7	2.2
CYHR1	"CHRP, KIAA0496, MGC13010"	ENSG00000187954	"Cysteine and histidine rich 1"	Q6ZMK1	8	144449582-144465677	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053653, HPA059543"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA053653: , HPA059543: "	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (1.58e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.54e-2)"	18.7	26.9	30.3	10.9	30.2	10.3	15.8	49.5	29.5	19.4	16.6	21.4	40.6	14.7	17.1	25.3	15.3	24.3	17.2	33.4	26.4	20.3	16.4	17.2	14.1	13.9	22.0	21.5	19.3	40.2	29.1	28.2	11.2	22.3	28.3	9.5	16.9	40.4	41.6	35.3	22.9	14.5	17.2	16.1	14.7	16.3	26.9	25.6	10.1	19.5	13.8	11.7	19.6	15.8	10.1	19.1	4.8	8.7	3.3	17.4	7.0	11.3	14.7	9.4	12.0	16.8	11.7	12.1	8.3	8.4	7.8	10.5	6.4	16.1	5.3	16.9	12.3	17.4	7.7	12.6	3.1	12.5	12.9	11.7	17.1	11.2	24.4	3.1	6.4	20.6	16.1	10.1	12.6	9.2	17.7	14.4	7.7	27.0	14.7	8.5	6.3	29.8	14.3	3.9	13.7	11.9	10.5	14.1	8.5	17.5	14.0	18.4	19.3	12.6	10.6	10.2	11.3	11.1	8.4	7.3	4.9	4.1	14.6	10.6	7.7	2.1	8.7	4.8	7.2	5.6	11.6	9.7	8.9	5.9	9.0	10.1	17.4	9.6	4.4	3.3	6.2	19.1	3.5	7.0	30.3	30.2	49.5	29.5	26.4	20.3	22.0	21.5	22.3	25.6
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"				"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: "	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	9.3	16.2	13.9	22.9	26.4	51.1	9.1	14.2	20.9	9.2	10.3	18.8	12.8	10.2	16.1	8.1	15.3	8.5	13.3	12.7	15.7	17.0	9.4	13.2	15.6	30.7	16.3	14.3	11.5	12.2	20.3	27.8	9.8	20.0	11.0	12.7	13.3	12.6	10.9	31.7	12.4	14.2	12.5	16.3	23.4	12.4	22.6	13.7	16.9	16.2	8.0	29.3	14.1	12.6	9.2	10.2	31.4	9.8	13.6	19.1	10.2	9.1	2.9	3.3	3.7	5.3	7.7	3.0	13.6	19.9	14.2	8.4	2.4	4.3	10.6	4.9	13.2	3.6	3.9	8.2	21.1	46.4	6.0	5.3	5.1	1.9	10.6	5.2	24.9	8.4	6.7	17.1	17.9	5.7	2.2	9.2	19.8	1.3	5.1	7.6	3.5	4.8	4.6	6.8	10.1	4.6	3.2	4.3	3.3	11.5	3.9	3.3	3.9	6.6	6.4	24.3	5.5	8.5	5.5	24.3	23.1	11.8	17.8	5.9	5.1	31.4	8.6	20.8	10.7	9.8	12.9	9.2	15.8	14.4	10.2	6.2	14.7	11.4	19.4	13.6	9.5	6.2	19.1	10.2	13.9	26.4	14.2	20.9	15.7	17.0	16.3	14.3	20.0	13.7
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153449-54173973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2"	"Group enriched"	"Detected in some"	16	"A549: 92.9;Hep G2: 27.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022261, HPA063771"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"				"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: "	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.1	0.1	0.4	0.2	0.7	0.0	2.5	0.1	0.4	2.5	0.1	0.0	0.3	0.0	11.2	0.4	4.4	0.3	0.0	0.1	0.4	0.8	38.8	0.3	1.6	0.1	0.2	0.0	0.1	0.1	0.0	0.7	7.0	0.3	7.0	0.0	0.1	0.3	1.5	0.1	1.0	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.4	1.4	5.9	25.8	31.2	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	92.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.4	0.4	0.8	0.2	0.0	0.3	0.0
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 149.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 72.6;HSkMC: 13.9;RPTEC TERT1: 18.5;SK-MEL-30: 29.8;WM-115: 11.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 176.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 38.2;neutrophil: 30.6"	"Group enriched"	"Detected in many"	20	"granulocytes: 30.6;monocytes: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Supported	Mitochondria				Mitochondria		"HPA059155: "	"prognostic favourable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favourable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	14.4	12.3	6.3	4.7	13.4	0.7	5.5	2.4	7.5	6.5	21.9	16.9	24.9	21.0	5.0	5.4	3.5	9.2	5.1	6.9	8.3	6.2	12.6	149.0	22.4	5.6	19.9	5.7	9.5	2.4	6.3	7.1	2.0	12.1	11.6	6.0	15.1	10.0	21.5	10.0	3.9	36.8	5.0	18.8	3.1	3.5	3.7	15.7	3.7	3.1	4.0	7.6	5.5	5.7	0.1	1.7	30.6	38.2	0.0	0.1	10.0	0.0	0.0	0.7	0.0	1.3	0.8	0.1	0.8	3.0	1.0	2.1	3.6	0.1	0.0	1.5	2.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.1	72.6	4.2	0.1	0.0	13.9	0.1	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	0.1	0.8	0.1	0.0	0.7	0.1	18.5	0.0	0.0	0.0	0.0	0.0	29.8	0.5	0.7	1.6	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	38.2	0.1	0.0	4.3	0.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	30.6	0.0	0.3	0.2	0.0	10.0	6.3	13.4	2.4	7.5	8.3	6.2	19.9	5.7	12.1	15.7
CYP27C1	FLJ16008	ENSG00000186684	"Cytochrome P450 family 27 subfamily C member 1"	Q4G0S4	2	127184120-127220078	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 10.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.6;HDLM-2: 12.4;TIME: 12.5;U-138 MG: 12.7;U-251 MG: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in some"			"HPA062460, HPA068731"			Enhanced	Vesicles				Vesicles		"HPA062460: , HPA068731: "	"unprognostic (1.90e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.31e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.29e-4)"	"unprognostic (3.49e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.64e-2)"	2.7	1.0	0.6	2.4	2.4	0.8	0.6	0.4	1.8	5.2	1.9	1.5	0.4	0.5	1.3	0.8	4.4	1.0	1.5	2.0	0.4	0.9	0.4	0.4	0.4	0.6	2.9	0.4	0.4	0.4	0.0	0.4	0.4	0.7	2.2	0.7	4.2	0.4	1.5	0.8	10.6	1.0	0.4	0.4	0.4	0.5	0.7	3.6	0.4	0.4	2.2	1.6	2.7	4.5	1.5	1.3	3.6	1.0	1.8	1.4	0.2	1.3	3.9	2.0	0.2	0.1	0.0	0.2	0.5	3.6	2.0	0.9	0.1	3.0	0.2	0.1	2.3	8.6	3.2	1.8	0.6	12.4	1.5	0.0	2.2	0.1	0.0	0.1	0.1	0.1	0.1	0.5	1.2	0.5	0.1	0.5	2.3	0.1	0.3	0.1	4.4	1.1	0.1	0.2	0.0	6.5	1.1	0.1	0.7	5.5	0.0	0.0	0.2	0.1	12.5	12.7	2.2	6.2	8.3	0.2	0.1	0.1	0.1	0.1	0.9	2.4	1.0	0.7	1.2	0.7	1.0	0.9	1.0	0.8	0.3	1.5	1.1	1.4	3.6	1.8	0.7	1.3	0.8	0.2	0.6	2.4	0.4	1.3	0.4	0.9	2.9	0.4	0.7	3.6
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193049-41207539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9"	"Cell line enhanced"	"Detected in many"		"A549: 37.2;CACO-2: 19.2;HaCaT: 19.9;NTERA-2: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.5;myeloid DC: 33.1"	"Group enriched"	"Detected in many"	121	"dendritic cells: 33.1;monocytes: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA049227: , HPA069248: "	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.2	0.8	0.8	2.3	1.0	0.5	0.6	0.1	1.0	1.7	18.3	1.2	0.5	37.6	0.3	0.9	10.1	2.4	29.1	1.0	1.4	1.6	0.9	2.1	3.8	3.3	5.6	0.4	0.8	0.6	0.0	0.9	1.6	4.5	0.9	7.2	1.1	3.8	0.3	0.1	2.0	62.7	0.6	1.1	4.0	45.9	0.5	1.2	2.6	0.4	15.8	21.0	3.2	2.7	0.0	33.1	0.0	9.5	0.0	0.1	3.9	1.4	37.2	0.0	0.0	0.0	0.0	1.8	0.2	0.3	0.4	0.1	19.2	5.4	0.1	4.4	0.2	19.9	6.5	10.1	0.1	0.0	0.1	5.0	2.0	6.9	7.9	0.0	0.1	0.3	0.5	0.5	0.3	0.3	2.2	0.1	0.0	0.7	0.1	0.1	28.2	4.8	0.1	0.0	0.3	0.6	7.9	0.0	0.2	3.7	0.0	0.0	4.9	1.9	4.2	0.0	1.6	0.7	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.0	9.5	0.0	0.0	2.3	0.1	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	3.9	0.8	1.0	0.1	1.0	1.4	1.6	5.6	0.4	4.5	1.2
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 92.0"	"Cell line enriched"	"Detected in some"	8	"RT4: 79.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles				Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favourable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	41.6	2.2	0.0	0.6	0.1	0.3	45.5	0.1	0.3	9.5	6.7	0.1	7.2	0.7	2.1	2.8	17.9	18.5	0.8	13.5	0.0	0.0	1.4	0.2	92.0	1.5	1.7	0.1	3.3	0.9	0.5	4.8	0.9	0.8	15.4	0.5	2.8	5.0	6.9	14.4	10.4	3.4	6.8	3.5	0.5	3.0	1.7	0.1	0.7	12.7	4.5	5.7	36.5	18.9	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	1.7	0.1	0.8	0.1
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112151-92142952	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavourable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	10.3	27.0	16.7	8.1	22.1	10.5	15.5	13.3	32.0	11.8	21.1	32.9	6.3	33.1	9.1	15.3	23.4	7.1	10.3	9.9	18.6	20.8	18.6	80.9	22.2	5.0	17.2	13.7	21.0	20.2	32.4	11.9	8.8	47.1	18.2	16.9	17.1	11.0	7.7	4.3	12.8	28.8	8.3	43.7	7.3	18.1	35.7	19.5	2.3	14.1	18.7	10.0	9.0	13.2	14.2	14.1	3.5	13.9	6.7	10.7	7.1	24.6	12.1	30.5	19.5	21.5	35.2	4.3	8.4	25.4	10.9	29.8	29.0	45.1	21.5	13.3	14.4	21.6	26.6	53.0	12.7	9.0	18.8	6.2	12.9	21.8	29.3	12.6	9.3	25.5	24.1	42.5	44.8	11.1	23.2	49.6	12.8	25.2	2.7	11.7	22.8	12.1	8.7	6.3	48.5	49.4	41.8	21.5	14.4	17.8	35.4	26.0	12.8	15.2	13.2	15.0	16.7	21.6	10.9	16.9	15.0	19.6	11.5	16.8	19.1	1.8	9.7	3.5	10.7	13.9	7.1	14.2	7.6	8.4	14.1	10.7	7.2	9.2	1.5	6.7	8.3	12.4	5.8	7.1	16.7	22.1	13.3	32.0	18.6	20.8	17.2	13.7	47.1	19.5
CYTH2	"ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like"	ENSG00000105443	"Cytohesin 2"	Q99418	19	48469032-48482314	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB014872, HPA060662"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"			11000	Cytosol	"Golgi apparatus, Plasma membrane"	"CAB014872: , HPA060662: "	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.33e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (3.21e-4)"	13.5	14.2	12.7	14.1	13.6	8.0	19.5	11.4	24.4	21.9	11.7	12.9	14.8	23.2	15.4	15.9	18.8	15.0	25.5	8.3	12.4	7.4	19.2	8.9	15.2	10.0	13.2	18.9	14.4	17.3	35.1	21.0	21.1	12.4	18.0	9.7	13.5	24.2	14.4	7.4	19.9	23.0	12.2	8.7	13.0	19.2	42.0	13.5	18.4	46.2	15.1	10.6	15.6	15.9	4.1	5.6	11.1	4.0	1.8	6.1	3.2	9.2	14.1	42.8	9.6	6.5	5.6	7.8	7.3	6.7	7.8	7.4	7.7	12.7	6.1	7.7	6.3	11.7	8.2	8.9	5.0	9.3	11.2	8.6	17.6	8.3	5.8	5.2	11.8	7.2	15.3	9.7	6.2	10.1	8.6	21.5	10.3	7.5	8.7	38.3	4.6	5.8	11.2	6.4	4.2	13.3	20.3	12.6	12.4	8.0	22.5	6.2	10.6	7.0	10.9	17.0	8.6	4.0	10.4	21.4	11.3	4.0	6.2	10.4	11.8	4.1	4.0	3.3	4.1	3.0	2.7	4.1	5.3	6.1	3.3	2.7	4.9	3.4	11.1	1.8	3.9	5.6	5.3	3.2	12.7	13.6	11.4	24.4	12.4	7.4	13.2	18.9	12.4	13.5
CYTH3	"ARNO3, cytohesin-3, GRP1, PSCD3"	ENSG00000008256	"Cytohesin 3"	O43739	7	6161776-6272644	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.6"	"Cell line enhanced"	"Detected in many"		"WM-115: 35.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 47.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013979	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA013979: AB_1855799"	"unprognostic (6.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (2.63e-5)"	24.0	9.1	10.9	6.6	14.4	6.1	22.0	14.2	17.6	10.4	16.4	7.0	5.7	15.1	13.0	8.1	13.4	12.6	13.9	21.1	11.4	7.2	8.8	3.0	14.0	5.4	9.4	10.7	11.0	6.6	9.4	7.1	66.6	9.4	6.8	6.7	17.8	8.6	8.7	12.3	15.6	18.5	15.2	8.5	7.5	9.2	26.0	6.5	2.9	20.4	10.8	5.0	7.7	16.5	0.6	1.8	0.7	0.4	3.3	5.9	0.4	21.2	5.4	5.1	3.5	24.1	28.5	7.3	12.6	11.0	12.5	11.9	8.3	10.6	2.9	7.7	25.4	20.1	3.5	9.1	8.3	0.2	5.1	0.8	6.4	1.0	11.5	0.8	1.3	20.1	4.2	6.6	9.6	2.1	3.3	0.4	9.1	3.5	0.7	3.8	3.6	7.3	3.8	13.8	1.6	9.6	2.6	3.3	6.4	7.8	27.4	22.1	1.6	6.0	7.8	8.6	22.8	9.2	7.7	1.0	0.3	3.0	2.7	2.3	35.0	0.7	0.4	0.0	2.2	0.2	5.9	0.3	1.0	2.4	0.4	0.6	0.1	1.5	0.3	3.3	0.4	1.8	0.8	0.4	10.9	14.4	14.2	17.6	11.4	7.2	9.4	10.7	9.4	6.5
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.2"	"Cell line enhanced"	"Detected in some"		"HEL: 41.7;HUVEC TERT2: 33.5;NB-4: 81.5;WM-115: 19.7"	"Cancer enhanced"	"Detected in many"		"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 18.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"			"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: "	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (7.43e-4)"	"prognostic unfavourable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (1.25e-4)"	5.2	2.3	6.5	2.0	6.0	10.8	6.4	0.7	4.2	11.0	4.9	9.2	4.9	1.0	10.1	2.8	5.3	7.3	4.6	4.4	5.4	4.4	1.2	0.8	17.1	9.4	6.2	2.1	2.5	1.1	1.7	1.6	42.2	4.7	10.5	1.8	4.5	4.0	14.2	0.8	3.3	2.1	4.2	11.0	1.1	4.9	2.2	8.4	0.5	5.7	3.6	4.8	13.2	7.4	0.0	0.3	1.9	1.0	18.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	33.5	0.0	1.7	0.0	0.0	0.0	81.5	0.1	0.0	1.2	1.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.1	0.0	0.0	11.4	0.0	7.9	0.0	0.0	0.2	0.0	0.0	0.0	1.0	19.7	1.9	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.1	18.8	0.0	0.3	0.0	0.6	6.5	6.0	0.7	4.2	5.4	4.4	6.2	2.1	4.7	8.4
D2HGDH	"D2HGD, FLJ42195, MGC25181"	ENSG00000180902	"D-2-hydroxyglutarate dehydrogenase"	Q8N465	2	241734579-241768816	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056216, HPA060548"	Uncertain		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA056216: , HPA060548: "	"unprognostic (2.85e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (9.11e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.05e-2)"	7.3	17.0	10.9	13.3	10.7	11.5	7.7	9.8	9.5	12.2	15.9	11.7	32.4	7.8	14.6	30.6	12.0	11.7	22.6	8.7	11.3	7.9	13.8	18.7	8.7	7.7	12.2	8.5	10.6	17.1	18.7	26.4	7.4	13.0	12.3	10.1	13.1	13.8	22.2	24.3	27.1	10.5	11.8	7.0	10.0	9.9	4.3	11.3	6.1	15.2	14.0	12.5	11.3	9.5	5.0	1.1	0.0	0.6	0.0	2.8	0.3	6.5	7.0	4.1	6.6	10.0	5.4	14.4	6.0	8.0	6.4	5.1	7.6	14.4	5.4	2.9	6.2	15.1	3.9	5.0	2.8	5.9	3.8	10.0	6.3	13.1	5.6	11.9	8.0	9.6	9.1	5.0	5.0	6.2	12.9	3.4	5.6	11.0	9.9	12.2	1.9	13.5	12.4	4.6	10.2	11.7	23.7	13.5	4.5	6.1	15.8	4.1	9.6	4.2	2.5	9.9	3.8	5.1	3.7	6.4	1.2	8.3	6.9	13.2	6.5	0.0	0.5	0.0	0.8	0.6	1.2	5.0	0.3	2.8	1.1	0.6	1.6	0.6	0.0	0.0	0.6	0.3	1.9	0.3	10.9	10.7	9.8	9.5	11.3	7.9	12.2	8.5	13.0	11.3
DAAM2	KIAA0381	ENSG00000146122	"Dishevelled associated activator of morphogenesis 2"	Q86T65	6	39792298-39904877	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 83.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 25.6;LHCN-M2: 25.1;SK-MEL-30: 31.0;U-138 MG: 9.6;WM-115: 12.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	29	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051300, HPA054630"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA051300: , HPA054630: "	"unprognostic (7.53e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.93e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.24e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.54e-2)"	"unprognostic (7.94e-2)"	"unprognostic (8.54e-4)"	21.5	17.8	34.8	6.7	43.0	1.7	7.8	4.4	52.2	9.3	6.4	83.3	8.0	7.6	7.5	8.5	28.3	8.9	5.9	6.1	40.4	25.2	5.9	4.0	8.4	2.8	42.8	24.8	7.3	5.2	3.5	2.1	9.4	41.3	8.7	7.1	5.1	4.3	17.6	23.8	4.4	8.9	13.7	48.8	15.5	7.0	8.7	51.9	0.0	5.0	2.1	2.2	4.6	4.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.7	0.1	0.1	4.4	5.9	1.0	0.5	0.4	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	4.1	0.0	0.0	25.6	0.0	0.1	0.0	0.0	0.0	0.0	25.1	0.0	0.6	0.0	0.7	0.0	0.0	4.5	3.5	0.0	0.0	0.9	1.0	0.0	0.3	31.0	0.0	0.0	0.2	9.6	2.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	34.8	43.0	4.4	28.9	40.4	25.2	42.8	24.8	41.3	51.9
DAB1		ENSG00000173406	"DAB1, reelin adaptor protein"	O75553	1	56994778-58546734	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4;intestine: 20.8"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 29.3;HeLa: 10.5;NTERA-2: 13.0;RT4: 17.3;WM-115: 14.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 31.4"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.5"	"Group enriched"	"Detected in many"	16	"granulocytes: 1.4;T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032329, HPA052033, HPA067495"	Enhanced		Enhanced	Vesicles				Vesicles		"CAB032329: AB_638973, HPA052033: , HPA067495: "	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.30e-4)"	"unprognostic (3.90e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.67e-2)"	1.8	1.7	5.8	0.3	3.8	0.0	0.7	31.4	6.2	1.7	1.0	1.8	0.5	15.0	1.0	1.0	0.6	1.6	0.8	1.8	5.3	1.4	0.7	7.5	0.8	0.2	1.1	4.2	1.2	0.7	0.0	0.7	0.0	2.0	4.0	0.3	2.9	5.2	10.2	0.6	0.6	20.8	0.3	1.1	0.6	1.0	0.9	0.7	0.0	0.8	0.0	0.1	1.9	1.0	0.0	0.0	1.4	0.0	0.2	5.5	0.1	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	13.0	0.0	3.2	0.0	0.1	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	1.4	0.5	0.0	5.5	0.0	2.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	5.8	3.8	31.4	6.2	5.3	1.4	1.1	4.2	2.0	0.7
DAB2	DOC-2	ENSG00000153071	"DAB2, clathrin adaptor protein"	P98082	5	39371675-39462300	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 194.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.2;ASC TERT1: 45.4;fHDF/TERT166: 65.6;TIME: 39.5;U-138 MG: 46.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 52.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"plasmacytoid DC: 26.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009314, HPA028888"	Enhanced		Enhanced	"Nucleoli fibrillar center,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Nucleoli fibrillar center"	"CAB009314: AB_638976, HPA028888: "	"unprognostic (1.24e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.37e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (7.38e-6)"	"unprognostic (3.11e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (9.67e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	51.6	44.2	2.6	12.2	3.5	0.6	21.8	6.1	2.6	16.6	14.0	4.1	4.5	3.3	16.6	34.8	10.8	9.6	13.3	25.1	2.9	3.0	75.2	6.9	22.4	31.8	4.0	2.1	12.7	11.3	3.2	3.9	194.4	4.7	11.6	14.6	14.6	12.9	5.3	12.7	9.3	10.4	16.0	5.2	21.1	7.2	8.7	2.5	7.3	10.9	8.4	7.4	17.8	14.7	0.1	26.6	2.2	2.5	0.9	1.3	7.0	0.0	1.5	2.4	5.3	42.2	45.4	3.0	27.2	27.9	10.7	17.7	19.9	0.0	0.0	1.7	65.6	0.0	0.3	0.9	15.1	0.0	0.8	3.6	36.2	6.5	10.2	0.0	4.7	28.2	0.0	17.5	3.1	32.2	0.0	0.9	17.7	0.1	0.3	0.0	1.6	3.0	0.9	6.2	0.0	7.1	0.5	0.0	0.0	3.2	1.7	15.2	0.1	0.9	39.5	46.0	5.1	5.3	2.2	0.0	0.0	0.0	16.0	3.4	5.9	2.2	1.2	0.2	1.3	2.5	0.0	0.1	0.2	0.7	3.4	0.1	0.1	1.0	1.8	0.9	0.6	26.6	0.2	7.0	2.6	3.5	6.1	2.6	2.9	3.0	4.0	2.1	4.7	2.5
DACH1	DACH	ENSG00000276644	"Dachshund family transcription factor 1"	Q9UI36	13	71437966-71867192	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.0;HAP1: 12.5;HEK 293: 9.3;HL-60: 20.3;NB-4: 9.0;SCLC-21H: 20.9;SH-SY5Y: 16.7;THP-1: 14.7"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	15	"basophil: 4.7;eosinophil: 9.2;NK-cell: 4.9;plasmacytoid DC: 7.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 9.2;NK-cells: 4.9"	"Region enriched"	"Detected in many"	5	"basal ganglia: 34.7"	"Region enriched"	"Detected in all"	5	"basal ganglia: 34.0"	HPA012672	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA012672: AB_1847466"	"unprognostic (3.16e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.17e-2)"	4.9	12.2	0.6	3.8	15.5	5.7	9.2	1.8	2.9	11.4	5.4	0.0	3.5	5.4	6.3	4.1	0.9	2.9	15.8	3.0	0.2		10.2	1.9	10.2	0.3	0.0	1.5	0.9	1.8	7.3	24.4	7.3	4.9	7.9	3.5	19.6	1.9	6.9	3.6	0.6	9.6	2.1	2.9	7.8	1.8	6.1	6.6	6.1	0.0	1.2	0.2	2.1	10.2	0.0	7.5	9.2	0.2	4.9	0.0	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.5	0.0	0.0	0.0	9.3	0.1	0.0	0.0	0.2	20.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	9.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	20.9	16.7	0.0	0.0	0.0	0.5	14.7	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	4.7	0.2	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	4.9	0.0	7.5	0.0	0.1										
DACT1	"DAPPER, DAPPER1, FRODO, HDPR1, THYEX3"	ENSG00000165617	"Dishevelled binding antagonist of beta catenin 1"	Q9NYF0	14	58633967-58648321	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 9.7;U-138 MG: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 1.9;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003016, HPA074619"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA003016: AB_1078623, HPA074619: "	"unprognostic (2.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	7.1	7.0	5.0	3.2	4.5	1.0	8.7	24.5	6.5	8.2	5.0	2.6	7.0	4.8	7.5	5.1	2.5	4.7	21.4	7.2	3.2	3.0	4.8	3.1	7.4	2.9	4.0	4.6	21.8	2.2	3.5	3.6	9.9	7.8	10.6	5.8	11.5	2.9	11.8	3.5	2.4	4.3	10.0	7.5	5.6	5.7	8.0	3.5	1.6	14.7	1.7	1.8	9.5	12.8	0.4	1.6	0.0	0.0	0.0	1.9	0.1	0.0	0.0	3.0	0.1	3.5	3.9	0.0	1.7	2.1	1.8	1.6	0.2	0.1	0.0	0.1	5.1	2.6	8.5	0.0	1.0	1.9	1.8	0.0	0.1	0.0	6.3	0.0	1.0	4.5	0.2	6.7	0.0	0.1	0.0	0.0	1.2	0.0	0.6	0.0	2.8	0.7	3.5	4.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	9.7	0.0	0.3	0.0	24.2	8.4	0.3	6.1	3.3	1.2	0.0	2.6	1.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	1.6	0.0	0.1	5.0	4.5	24.5	6.5	3.2	3.0	4.0	4.6	7.8	3.5
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		70000000	Vesicles		"CAB001960: , CAB016353: AB_627292"	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	19.2	17.4	16.5	10.1	21.1	2.8	16.2	17.3	27.1	17.3	23.9	24.1	13.1	14.1	23.4	14.3	19.1	19.6	19.7	40.9	19.9	10.3	22.7	31.7	18.9	6.3	16.7	15.7	22.6	35.0	32.7	15.8	45.6	18.1	18.6	18.9	22.2	19.9	24.3	57.3	18.7	17.5	27.9	14.0	7.3	22.2	29.4	16.3	6.0	15.3	24.0	14.3	20.4	15.0	3.2	3.6	1.8	6.1	1.9	3.7	3.3	19.5	19.5	13.6	33.6	18.2	8.9	62.0	13.8	20.5	23.7	15.3	16.0	20.8	2.7	14.0	22.5	36.7	11.8	17.9	14.7	2.6	3.9	1.8	19.6	18.2	8.1	2.4	3.9	7.8	16.2	22.5	7.5	21.2	2.8	2.1	6.4	15.7	2.0	1.6	14.5	6.5	1.2	13.2	4.6	18.6	27.5	4.8	9.9	16.6	45.8	22.4	38.6	4.8	11.0	9.0	14.3	16.7	19.7	2.4	4.9	1.7	10.9	2.6	54.2	1.8	2.8	1.1	3.3	3.5	3.7	3.2	2.8	2.5	1.8	2.6	3.0	2.4	0.6	1.9	6.1	3.6	1.9	3.3	16.5	21.1	17.3	27.1	19.9	10.3	16.7	15.7	18.1	16.3
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA069377: "	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	20.1	28.2	12.6	12.7	20.3	25.8	29.8	18.4	26.1	19.1	18.0	11.4	19.4	15.1	14.3	17.5	16.2	12.5	26.6	18.9	12.4	13.8	24.0	88.0	18.4	25.2	11.6	5.8	22.5	47.0	14.2	19.0	45.7	7.5	14.6	10.6	14.6	34.1	22.3	22.0	22.1	31.3	16.0	13.2	15.1	14.0	27.1	7.9	7.2	23.1	15.1	16.8	15.6	20.8	5.6	18.9	13.6	14.7	2.4	8.4	7.5	11.5	13.3	5.7	7.5	8.7	6.8	4.6	16.3	11.1	14.1	15.3	7.0	12.7	6.2	7.1	7.9	17.1	9.3	8.6	8.1	2.8	6.5	3.3	15.2	4.8	9.4	9.4	5.3	6.0	14.3	9.4	9.3	6.0	9.4	3.1	8.3	8.1	3.3	13.4	20.8	10.1	29.0	6.6	13.5	8.8	4.3	7.4	4.4	9.2	14.1	2.7	9.9	17.7	7.4	12.2	23.2	15.2	7.6	3.3	5.9	5.3	6.0	14.8	14.7	6.2	14.7	13.6	4.4	13.9	3.9	5.6	3.5	2.9	18.9	3.6	8.4	4.8	7.3	2.4	12.2	3.2	2.9	7.5	12.6	20.3	18.4	23.4	12.4	13.8	11.6	5.8	7.5	7.9
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	27.8	36.5	22.9	26.3	25.9	28.9	34.2	19.5	23.6	23.5	33.4	19.5	22.8	29.4	28.7	28.1	31.3	21.8	23.2	56.3	27.0	26.4	32.8	52.2	23.9	49.0	24.9	23.0	23.3	38.5	20.7	27.1	20.5	23.0	27.9	32.1	24.5	28.0	27.1	64.0	30.9	26.5	36.0	23.2	30.8	30.3	31.6	21.1	44.4	27.6	28.4	38.0	38.0	24.1	39.0	41.1	15.9	35.2	34.0	56.5	39.6	32.3	21.0	17.2	27.2	25.4	32.1	42.3	27.3	28.9	28.1	24.6	38.7	39.8	46.2	55.7	22.2	33.1	25.5	23.8	30.7	28.9	18.6	28.1	18.8	35.1	34.8	38.4	25.1	26.9	34.2	35.8	47.4	27.6	60.7	32.9	29.2	43.0	33.7	45.0	30.4	34.4	27.9	21.6	49.0	33.4	31.0	20.0	35.5	26.2	77.4	47.1	48.0	63.3	23.6	23.9	25.2	29.5	45.8	36.0	53.7	53.2	23.8	34.5	30.7	13.9	30.1	15.9	31.3	35.2	51.4	39.0	45.1	38.0	41.1	32.2	56.5	48.4	13.0	34.0	31.9	26.8	45.0	39.6	22.9	25.9	19.5	23.6	27.0	26.4	24.9	23.0	23.0	21.1
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;skeletal muscle: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.0;HaCaT: 8.3;HMC-1: 17.0;MCF7: 8.6"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4"	"Lineage enriched"	"Detected in many"	23	"granulocytes: 51.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA071581: "	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	8.2	1.6	2.6	6.8	5.0	10.3	5.2	1.4	3.9	3.6	16.6	12.0	8.3	14.2	1.7	1.5	2.1	1.2	1.7	17.6	3.6	2.0	2.2	1.4	14.0	2.5	6.8	3.0	0.7	1.7	1.1	1.1	0.3	4.7	3.1	4.7	1.9	4.8	4.8	46.1	4.6	25.8	1.2	3.4	4.7	6.9	2.0	6.5	1.1	22.3	8.7	3.3	2.1	9.6	0.3	2.2	51.8	0.0	0.7	0.6	0.3	2.8	2.0	5.6	1.4	10.0	0.4	0.1	1.9	6.0	1.0	1.1	0.8	1.4	0.2	0.6	6.0	8.3	3.5	0.1	0.6	0.2	0.1	1.1	3.9	0.1	0.1	0.1	17.0	1.0	7.2	0.3	0.2	0.6	0.4	0.1	0.7	8.6	0.0	0.3	0.6	2.0	2.6	0.0	0.3	0.0	2.8	0.4	0.3	0.4	1.1	0.0	4.8	0.4	0.4	0.8	1.0	1.3	1.6	0.6	0.2	0.0	0.0	2.7	0.2	19.1	0.0	51.8	0.6	0.0	0.2	0.3	0.1	0.5	0.0	0.1	0.0	0.4	16.4	0.7	0.0	2.2	0.0	0.3	2.6	5.0	1.4	3.9	3.6	2.0	6.8	3.0	4.7	6.5
DARS		ENSG00000115866	"Aspartyl-tRNA synthetase"	P14868	2	135906677-135986100	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol			160000	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavourable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	30.3	29.7	35.0	27.6	35.5	19.7	34.9	18.0	28.3	27.6	25.4	25.6	26.9	14.8	30.1	26.7	44.4	26.9	19.6	29.8	29.0	28.8	34.6	35.5	19.7	32.3	32.1	25.6	34.0	27.0	26.4	24.5	31.7	23.8	31.0	20.3	20.6	26.6	28.3	45.1	30.6	21.4	42.4	33.8	29.8	23.6	12.8	25.0	42.0	33.0	33.1	36.7	45.3	30.2	48.6	30.5	11.2	18.8	36.6	42.7	30.6	47.1	19.4	16.6	17.5	18.5	23.2	38.0	23.6	26.5	25.9	25.4	41.8	20.6	55.1	37.0	19.4	27.2	25.4	30.6	47.1	25.2	22.7	33.5	19.2	43.4	23.9	44.8	22.3	22.3	24.7	28.9	26.1	14.2	35.9	17.6	21.4	22.2	34.3	38.6	19.5	18.5	42.0	36.1	38.5	31.1	18.4	11.8	22.5	18.1	16.4	18.4	18.0	32.0	10.7	22.7	22.7	16.7	23.4	48.5	26.4	59.3	35.7	34.2	14.0	6.0	18.8	11.2	27.5	18.3	41.2	48.6	41.3	36.0	30.5	43.8	42.7	37.0	7.3	36.6	14.0	29.2	36.9	30.6	35.0	35.5	18.0	23.8	29.0	28.8	32.1	25.6	23.8	25.0
DARS2	FLJ10514	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824503-173858546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favourable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	17.0	22.2	6.3	10.1	8.1	5.4	9.0	7.5	8.6	7.8	15.1	6.7	8.3	11.7	10.4	6.1	13.4	6.4	5.9	11.2	5.5	6.0	21.9	14.8	8.2	11.0	6.4	4.2	9.5	14.9	18.1	15.3	10.9	10.0	8.5	16.6	10.2	10.2	6.2	10.6	6.0	16.1	6.2	9.0	11.4	11.3	8.4	6.9	26.1	12.2	6.3	12.5	9.7	8.1	9.3	9.0	4.8	10.7	5.0	9.3	5.2	29.2	19.6	12.2	7.6	9.3	13.3	15.6	12.9	10.7	18.7	14.3	18.3	26.4	15.9	17.7	10.3	30.1	33.7	21.8	25.6	18.1	16.5	13.7	9.8	12.8	9.1	11.6	12.5	9.6	10.0	18.9	19.3	18.6	27.7	12.5	15.5	8.1	14.7	6.5	23.6	17.6	17.4	15.6	29.2	17.0	9.8	16.0	14.7	14.2	31.6	20.3	33.1	15.3	8.2	9.6	15.2	13.2	20.6	9.8	24.8	18.4	5.6	12.9	20.7	4.4	7.0	4.8	6.6	10.7	9.3	9.3	7.2	5.8	9.0	7.3	7.7	4.8	0.7	5.0	7.4	3.7	5.1	5.2	6.3	8.1	7.5	8.6	5.5	6.0	6.4	4.2	10.0	6.9
DAXX	DAP6	ENSG00000204209	"Death domain associated protein"	Q9UER7	6	33318558-33323016	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002224, HPA008736, HPA008797, CAB025546, HPA065779"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: , HPA065779: "	"prognostic favourable (6.05e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavourable (6.32e-7)"	"unprognostic (2.43e-1)"	"unprognostic (5.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	10.4	14.3	10.7	13.5	11.9	8.8	10.8	11.3	14.8	11.8	12.2	9.4	7.3	11.2	13.2	43.7	13.5	12.6	12.1	9.1	9.7	7.3	9.2	12.0	10.3	18.3	10.2	8.5	13.8	18.6	24.4	10.4	11.6	11.6	13.0	14.1	7.3	10.7	15.2	14.8	11.6	12.7	15.5	8.1	20.4	10.5	20.2	11.5	25.0	16.1	6.8	30.9	11.5	10.9	17.0	5.9	12.6	11.2	15.3	18.2	21.8	2.2	0.0	7.1	2.9	1.2	2.3	4.7	7.0	23.1	18.0	13.3	0.8	2.4	7.0	2.5	5.4	1.3	0.1	5.7	16.7	8.3	15.7	9.1	12.5	11.2	3.9	9.6	2.6	6.1	8.5	2.0	5.4	0.5	5.0	4.5	5.6	5.3	3.8	21.5	0.4	3.3	5.9	0.1	7.8	1.4	0.7	8.6	2.2	0.0	0.4	3.7	2.2	0.2	5.9	4.5	5.6	0.2	0.1	7.8	16.3	15.1	3.3	4.4	4.7	7.8	7.5	12.6	16.3	8.0	18.2	16.6	15.4	15.8	5.9	17.0	13.9	14.1	7.4	15.3	11.2	5.9	17.1	21.8	10.7	11.9	11.3	14.8	9.7	7.3	10.2	8.5	11.6	11.5
DAZAP1	MGC19907	ENSG00000071626	"DAZ associated protein 1"	Q96EP5	19	1407569-1435687	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004201, HPA004631"	Enhanced		Enhanced	Nucleoplasm,Cytosol			1700000	Nucleoplasm	Cytosol	"HPA004201: AB_1078627, HPA004631: AB_1078626"	"unprognostic (1.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-3)"	22.1	15.0	11.4	33.1	14.2	37.1	32.9	16.1	19.4	15.2	21.4	22.2	17.2	28.3	17.8	11.0	30.9	16.0	13.5	26.7	11.5	9.2	17.1	38.1	18.7	29.2	16.8	12.4	20.7	28.3	11.9	11.4	22.2	13.3	15.9	15.6	16.8	17.0	12.0	31.4	20.2	28.7	17.7	10.9	28.5	22.0	46.8	15.0	43.8	15.9	22.6	21.0	21.4	27.7	7.1	6.1	4.3	7.5	6.5	7.1	3.1	52.7	19.2	12.9	23.5	5.7	7.0	37.0	23.8	11.9	19.5	16.1	19.1	26.2	62.2	14.6	11.5	29.8	17.0	22.7	16.5	43.5	27.0	32.0	18.4	19.4	13.3	38.7	27.5	7.0	15.0	13.2	24.3	17.0	47.6	32.8	12.1	21.6	67.8	34.5	39.8	19.4	49.0	20.6	38.3	14.6	17.9	25.7	23.0	15.7	24.8	28.7	22.5	51.7	18.4	16.1	21.8	28.0	51.9	38.9	39.9	49.4	19.4	37.8	24.5	3.2	5.5	4.3	6.5	7.5	7.1	7.1	6.0	6.9	4.9	5.5	6.0	6.4	2.4	6.5	5.2	6.1	6.1	3.1	11.4	14.2	16.1	19.4	11.5	9.2	16.8	12.4	13.3	15.0
DAZAP2	KIAA0058	ENSG00000183283	"DAZ associated protein 2"	Q15038	12	51238292-51271362	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045940			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA045940: "	"unprognostic (1.00e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.75e-3)"	"unprognostic (8.43e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (3.94e-9)"	"unprognostic (1.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.84e-3)"	53.5	54.3	45.1	46.0	52.2	152.2	47.8	35.9	67.9	43.5	53.9	88.3	30.4	52.3	56.8	37.5	48.6	59.8	51.1	57.2	43.5	39.2	72.8	64.1	53.3	63.6	68.6	46.0	40.5	38.5	46.0	20.5	30.3	57.0	38.7	60.2	51.3	50.8	53.3	50.7	42.6	63.7	48.0	72.0	63.8	47.7	23.8	57.8	63.6	62.4	30.2	64.1	63.4	37.1	55.4	71.7	186.5	108.9	50.4	70.2	204.7	29.5	43.0	17.7	16.4	38.8	33.7	9.7	19.7	43.9	40.1	32.2	28.3	41.7	25.9	55.2	44.0	25.7	28.6	37.1	34.4	35.2	35.2	44.5	25.5	13.3	45.1	43.7	61.3	46.9	43.4	39.4	31.9	50.9	24.5	59.1	27.4	45.7	44.5	18.3	3.1	13.3	23.4	25.7	28.4	37.0	41.1	20.2	18.4	33.1	22.5	20.9	33.6	58.2	37.9	19.4	19.5	24.1	25.5	45.1	47.7	32.4	31.0	29.3	13.1	84.8	108.9	170.2	60.0	88.0	54.2	55.4	53.3	56.3	71.7	51.9	60.8	51.1	186.5	50.4	80.9	46.6	70.2	204.7	45.1	52.2	35.9	67.9	43.5	39.2	68.6	46.0	57.0	57.8
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909541	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 11.8;testis: 34.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA042923			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA042923: "	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavourable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	1.1	1.2	1.4	5.9	2.0	1.8	3.0	1.9	1.9	1.4	2.1	0.0	0.6	1.2	1.2	1.4	1.7	1.1	1.5	1.0	1.5	1.4	1.2	1.1	2.4	5.0	1.3	1.0	3.4	1.3	1.2	1.8	1.4	0.8	1.2	1.2	0.0	1.2	1.1	1.9	1.3	1.5	0.9	1.2	4.6	1.1	34.2	0.7	11.8	1.4	1.9	2.7	1.6	1.1	1.3	0.9	4.0	0.4	0.9	1.6	0.5	1.3	1.4	2.9	3.8	0.7	0.6	0.9	1.4	0.3	1.5	2.9	2.2	0.9	3.1	1.1	0.8	1.3	3.0	0.8	1.6	2.2	2.0	1.9	1.7	0.5	0.2	2.4	1.6	0.7	0.8	1.7	1.6	1.3	1.7	6.4	2.0	2.3	4.1	2.9	3.0	2.8	1.1	4.6	3.6	1.2	0.2	4.3	2.8	1.9	3.2	1.5	1.3	2.5	0.5	1.8	2.1	4.6	3.0	3.7	7.6	3.0	1.2	4.3	3.8	4.0	0.4	0.4	1.2	0.3	0.3	0.8	1.1	0.6	0.2	1.3	1.1	1.3	1.1	0.9	0.4	0.9	1.6	0.5	1.4	2.0	1.9	1.9	1.5	1.4	1.3	1.0	0.8	0.7
DBF4B	"ASKL1, chifb, DRF1, FLJ13087, ZDBF1B"	ENSG00000161692	"DBF4 zinc finger B"	Q8NFT6	17	44708608-44752264	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA048465	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA048465: "	"unprognostic (2.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.53e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.39e-1)"	2.6	2.0	8.0	5.8	6.1	5.6	3.4	7.1	9.4	3.6	4.1	5.3	3.3	2.4	6.4	11.4	3.5	5.9	4.3	2.0	6.7	3.7	3.1	1.6	3.0	4.7	6.7	4.7	5.9	2.3	2.6	4.5	3.3	6.2	5.4	4.1	6.4	3.3	4.8	5.4	6.5	3.7	5.3	4.7	4.4	3.2	10.9	6.4	6.9	6.8	2.5	5.2	4.2	3.2	1.5	0.9	1.8	1.6	0.0	2.2	0.5	3.9	8.4	6.3	4.6	0.6	1.2	5.5	4.3	1.9	9.0	8.9	3.6	3.4	5.9	2.4	1.5	3.8	5.5	1.8	10.4	9.7	8.8	7.5	6.4	4.6	0.3	5.0	6.5	0.5	0.6	5.0	1.6	4.4	9.4	6.2	4.8	4.2	7.4	3.1	2.7	4.5	6.6	7.3	2.5	2.1	2.5	3.5	3.8	4.1	1.3	3.4	4.2	3.4	2.0	3.1	6.0	4.0	7.7	2.9	3.6	7.7	2.4	4.4	4.8	0.0	0.9	1.8	0.3	1.6	0.2	1.5	0.2	0.3	0.9	0.4	0.0	2.2	0.0	0.0	1.3	0.7	0.6	0.5	8.0	6.1	7.1	9.4	6.7	3.7	6.7	4.7	6.2	6.4
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 201.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	37	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.2	201.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0
DBN1	D0S117E	ENSG00000113758	"Drebrin 1"	Q16643	5	177456608-177474401	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.0;T-cells: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051452, HPA056940"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"			17000000	"Plasma membrane, Actin filaments"		"HPA051452: AB_2681489, HPA056940: AB_2683279"	"unprognostic (3.81e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.57e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.64e-1)"	"prognostic favourable (8.28e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-3)"	21.4	9.0	21.7	15.0	42.4	5.4	13.5	12.0	46.0	25.7	21.7	8.8	8.7	8.6	37.4	15.0	19.2	16.2	21.5	13.9	24.2	20.9	15.1	2.7	12.1	7.3	11.9	22.1	20.2	13.2	9.1	17.1	6.7	20.3	14.9	5.8	9.3	24.8	23.0	21.3	12.7	10.0	29.5	8.6	7.8	17.0	14.4	9.4	19.8	20.0	11.0	4.4	20.6	12.0	0.2	5.1	6.0	0.9	0.1	12.7	1.5	2.9	10.1	33.8	58.9	8.0	12.7	10.5	36.1	9.3	21.2	17.8	34.9	10.6	0.0	25.8	28.0	4.7	14.9	26.2	10.0	0.8	12.9	19.6	13.2	14.5	28.5	7.3	3.6	16.6	6.9	23.7	7.1	34.9	9.0	4.7	15.4	4.2	20.1	11.2	48.9	22.7	60.2	36.6	5.9	15.8	4.2	39.8	54.1	11.8	5.2	20.0	14.4	7.6	53.9	23.7	32.2	5.2	16.7	1.1	0.5	31.6	9.9	6.9	14.5	6.0	0.9	0.7	9.2	0.5	12.7	0.1	0.2	6.6	1.4	0.2	0.3	4.5	2.5	0.1	0.4	5.1	0.0	1.5	21.7	42.4	12.0	40.8	24.2	20.9	11.9	22.1	20.3	9.4
DBNL	"ABP1, HIP-55, SH3P7"	ENSG00000136279	"Drebrin like"	Q9UJU6	7	44044640-44069456	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Endocytosis, Immunity, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020265, HPA027735"	Enhanced		Supported	Nucleoplasm,Cytosol			15000000	Cytosol	Nucleoplasm	"HPA020265: AB_1850723, HPA027735: AB_10603790"	"unprognostic (9.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (2.25e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.51e-2)"	23.9	19.6	21.2	45.4	17.4	34.1	20.5	11.4	24.0	23.9	21.0	19.6	23.5	17.9	22.0	21.8	65.6	19.1	32.7	18.0	18.3	18.8	18.9	18.4	23.6	49.8	19.1	23.8	15.2	19.2	16.7	18.5	25.8	16.1	21.0	15.2	17.2	23.4	22.3	15.9	26.2	23.2	25.2	19.8	46.8	24.7	13.0	15.8	31.0	18.2	32.0	52.3	23.6	31.6	46.7	66.0	64.1	73.7	31.6	35.4	80.5	19.4	28.4	17.8	19.3	22.2	14.3	16.5	32.1	26.8	32.0	26.9	28.4	27.2	43.7	23.3	34.9	34.6	10.3	37.5	12.0	23.3	12.0	14.8	21.3	16.2	22.5	22.1	27.6	13.5	15.0	30.4	10.6	21.9	18.6	15.2	30.3	28.3	39.6	24.9	14.5	24.0	22.0	14.5	21.7	20.7	27.2	21.6	28.7	21.9	43.0	6.8	31.7	30.9	35.1	26.3	23.8	15.2	37.1	35.6	15.3	24.5	24.7	25.1	62.2	39.2	66.3	50.2	35.4	73.7	28.0	46.7	26.7	28.8	63.9	45.8	27.0	28.2	64.1	31.6	71.0	66.0	31.3	80.5	21.2	17.4	11.4	24.0	18.3	18.8	19.1	23.8	16.1	15.8
DBR1		ENSG00000138231	"Debranching RNA lariats 1"	Q9UK59	3	138161012-138174949	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035365	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035365: AB_10611956"	"unprognostic (1.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.33e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.79e-2)"	11.8	13.5	9.3	10.0	10.5	20.7	12.2	12.5	10.5	13.3	10.1	14.4	12.8	8.3	15.8	13.6	12.3	11.8	12.4	9.3	9.3	8.9	13.4	12.2	15.3	12.6	11.0	10.5	13.7	15.5	13.1	16.1	9.1	10.0	12.3	10.1	12.7	12.8	10.7	10.8	11.9	12.4	11.6	10.9	17.0	18.3	5.8	12.0	22.3	13.2	7.7	13.6	11.0	12.7	8.3	9.8	14.3	11.2	9.2	13.3	7.0	14.6	6.1	11.1	12.3	6.2	5.8	11.6	8.7	6.4	9.5	11.6	10.3	6.6	13.5	16.7	7.8	11.0	12.8	4.3	12.5	11.5	10.5	14.6	8.0	8.4	7.6	18.8	12.9	7.9	7.3	8.8	8.3	7.8	9.4	2.9	9.5	11.3	18.4	11.1	12.8	7.2	11.6	12.6	12.3	8.2	14.4	10.8	13.9	23.3	8.2	12.5	15.3	15.4	7.3	8.0	5.6	14.8	10.1	4.5	6.1	28.2	5.2	13.6	10.4	4.8	8.1	14.3	10.4	11.2	13.3	8.3	11.8	9.9	9.8	8.0	12.1	13.1	3.5	9.2	9.0	6.0	9.5	7.0	9.3	10.5	12.5	10.5	9.3	8.9	11.0	10.5	10.0	12.0
DBT		ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	8.6	14.1	8.3	5.0	13.6	3.9	8.7	8.0	11.8	8.5	7.8	7.9	13.6	6.6	9.8	6.6	13.6	8.6	5.2	18.1	8.6	7.3	22.2	29.1	8.0	5.3	10.2	8.2	9.1	13.7	10.2	12.3	7.3	9.4	12.0	7.6	5.2	11.3	8.3	15.7	8.1	5.8	11.2	8.6	6.0	12.6	5.7	8.2	9.6	13.0	8.7	6.3	12.8	7.7	4.4	2.6	3.3	3.1	4.0	5.0	2.1	11.5	5.7	5.2	10.6	11.6	10.1	12.2	7.9	6.4	7.1	8.6	11.8	4.4	10.5	11.6	4.7	10.4	11.6	8.4	8.9	11.1	6.7	7.6	10.9	5.8	9.9	10.0	3.6	9.8	9.3	5.8	9.1	6.6	12.2	11.5	5.6	2.6	8.3	3.2	11.0	11.4	8.1	19.2	7.9	7.8	10.5	9.2	5.7	17.5	15.6	13.2	12.3	6.2	7.6	7.0	4.7	8.9	7.1	8.1	8.2	5.4	8.3	6.2	3.1	3.3	2.2	1.8	4.9	3.1	5.0	4.4	4.4	4.2	2.2	4.1	4.5	4.2	2.1	4.0	2.7	2.6	3.4	2.1	8.3	13.6	8.0	11.8	8.6	7.3	10.2	8.2	9.4	8.2
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA036142: AB_10669666, HPA052445: , HPA053203: "	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favourable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	13.3	12.5	11.5	16.3	12.3	12.9	12.2	17.9	12.5	9.6	10.3	11.0	12.5	7.6	13.1	10.1	11.3	9.2	8.4	8.8	9.6	6.8	11.0	11.1	10.9	13.0	11.1	9.1	11.9	11.1	24.8	12.9	15.4	10.3	10.1	10.9	8.6	12.5	11.8	28.1	14.1	11.8	10.4	9.1	11.9	10.7	50.7	10.9	18.5	14.2	7.6	16.7	12.5	16.5	7.3	6.4	3.3	6.0	7.3	10.7	6.2	10.7	13.2	12.9	11.6	11.6	9.3	12.2	12.1	9.1	13.1	12.9	14.4	10.5	26.2	6.7	9.5	9.5	24.2	10.8	17.0	18.2	12.0	22.4	18.1	12.4	8.5	29.2	16.3	6.1	12.6	16.9	12.4	10.1	13.1	17.1	10.2	10.9	22.3	11.9	13.5	14.6	9.5	13.8	17.3	10.2	16.8	6.7	11.9	13.3	12.4	7.3	8.4	12.4	12.6	10.8	14.5	17.7	18.5	11.6	15.7	27.0	12.5	20.1	8.8	3.2	4.0	3.3	9.4	4.5	10.7	7.1	8.1	8.0	6.4	7.3	8.9	7.3	1.0	7.3	6.0	5.2	8.7	6.2	11.5	12.3	17.9	12.5	9.6	6.8	11.1	9.1	10.3	10.9
DCAF11	"GL014, PRO2389, WDR23"	ENSG00000100897	"DDB1 and CUL4 associated factor 11"	Q8TEB1	14	24114195-24125242	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003583, HPA031157"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA003583: , HPA031157: AB_10603002"	"unprognostic (1.50e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.23e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-1)"	"prognostic favourable (3.50e-13)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.68e-1)"	7.6	20.8	14.4	12.1	15.4	21.7	10.3	14.2	23.0	8.1	14.0	11.5	18.7	23.7	8.8	14.1	13.5	10.5	13.6	13.9	14.1	10.9	15.3	56.2	9.8	13.1	12.3	15.5	11.8	42.5	21.1	12.6	8.6	10.4	11.6	11.3	12.3	18.3	19.4	26.8	8.9	25.2	9.5	9.7	14.2	14.4	13.4	9.4	13.1	17.1	13.2	10.5	10.6	7.3	12.8	18.0	20.9	16.5	23.9	17.2	14.8	6.2	10.5	5.1	4.8	5.9	4.7	9.3	5.1	7.8	9.4	8.9	6.5	10.4	11.0	4.9	6.5	9.1	8.7	7.3	6.3	11.1	5.2	10.5	11.1	33.4	8.0	13.0	14.5	5.1	8.6	4.9	9.6	6.9	6.8	11.2	5.4	19.6	12.8	11.2	3.1	9.4	12.1	9.5	13.0	6.8	15.9	10.9	7.3	4.3	15.2	7.7	8.8	11.0	3.9	7.0	5.9	5.7	6.0	17.2	16.2	13.3	5.3	10.4	7.8	15.1	15.3	20.9	15.8	16.5	13.7	12.8	14.2	14.4	18.0	12.5	14.7	13.7	13.2	23.9	13.1	9.3	17.2	14.8	14.4	15.4	14.2	23.0	14.1	10.9	12.3	15.5	10.4	9.4
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: "	"prognostic unfavourable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavourable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	27.5	24.8	23.2	23.6	16.9	19.6	17.4	20.6	15.8	19.6	20.1	24.4	27.0	38.4	35.3	21.5	20.8	31.4	26.3	38.0	36.6	22.3	53.1	14.9	27.7	19.3	21.7	22.9	15.9	18.2	28.8	48.0	27.2	35.6	16.9	29.8	22.5	41.1	22.8	35.5	38.8	26.8	28.2	39.6	28.5	23.1	29.6	28.1	12.9	20.2	23.3	31.1	14.9	17.8	20.0	32.1	25.7	27.5	18.7	32.5	54.3	26.9	47.5	25.5	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0
DCAF17	"C2orf37, FLJ13096"	ENSG00000115827	"DDB1 and CUL4 associated factor 17"	Q5H9S7	2	171434217-171485052	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053339, HPA055040"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA053339: , HPA055040: "	"unprognostic (1.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.27e-1)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (2.79e-2)"	7.9	9.8	12.3	9.7	19.0	5.7	12.2	14.5	12.1	11.2	10.4	14.5	8.7	8.4	16.2	12.5	9.2	9.2	9.0	7.1	13.6	9.4	11.2	8.3	7.3	12.6	19.2	8.0	14.1	13.1	13.8	10.9	10.0	10.9	10.2	9.2	9.4	9.0	10.2	7.4	13.5	9.5	14.6	17.2	11.5	8.1	10.5	17.3	15.4	19.6	5.0	11.0	10.7	11.1	3.9	2.0	2.3	2.9	2.0	7.1	3.0	6.7	5.6	7.3	8.6	9.3	10.0	11.3	6.0	6.1	6.0	5.7	6.6	4.5	19.6	4.4	7.3	6.7	7.4	7.3	8.4	9.0	5.0	9.0	4.5	11.9	9.5	12.7	6.5	7.8	9.7	7.7	17.2	6.5	14.0	6.8	8.3	4.1	13.9	11.8	10.9	3.5	10.6	9.7	10.6	5.2	6.1	6.5	9.4	5.6	4.8	5.9	3.7	6.7	7.8	7.0	6.3	3.9	5.1	10.3	14.0	16.5	7.4	6.6	7.2	2.3	2.6	1.0	5.0	2.9	7.1	2.8	4.0	3.5	2.0	3.9	4.4	5.4	0.1	2.0	2.5	1.5	3.5	3.0	12.3	19.0	14.5	12.1	13.6	9.4	19.2	8.0	10.9	17.3
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"				"Nucleoplasm, Focal adhesion sites"		"HPA054305: "	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	10.6	17.0	10.9	7.8	12.2	6.2	8.8	10.5	17.8	10.2	11.5	3.9	8.4	6.2	9.5	11.4	9.3	7.7	8.2	43.8	7.6	5.5	9.5	26.2	7.3	4.8	5.2	11.5	8.3	6.1	10.8	11.3	7.8	6.5	10.5	8.7	5.7	10.3	11.9	155.9	6.4	7.8	10.2	4.8	5.9	9.8	21.5	4.8	7.8	8.2	27.3	7.3	9.1	7.3	6.2	7.7	12.5	13.9	4.4	7.2	5.0	22.9	11.0	6.1	9.9	20.2	28.8	21.5	23.5	35.3	16.7	24.9	18.2	19.4	19.0	13.7	30.3	17.3	9.5	17.6	23.7	10.7	10.2	20.2	16.7	13.1	16.3	9.0	9.7	20.4	17.8	15.8	13.2	18.2	22.8	15.7	24.5	5.3	10.0	8.3	3.9	12.2	7.8	12.6	14.7	41.7	11.2	9.0	7.1	18.8	17.3	12.9	29.6	11.1	25.6	16.7	10.4	16.1	9.7	16.9	13.7	14.8	22.3	7.8	6.8	6.0	7.0	12.5	6.7	9.6	7.2	6.2	5.4	5.8	7.7	4.5	5.0	6.4	7.2	4.4	13.9	4.6	6.1	5.0	10.9	12.2	10.5	17.8	7.6	5.5	5.2	11.5	6.5	4.8
DCAF7	"HAN11, SWAN-1, WDR68"	ENSG00000136485	"DDB1 and CUL4 associated factor 7"	P61962	17	63550461-63594266	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022948, HPA022962"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA022948: AB_1858820, HPA022962: AB_1858821"	"unprognostic (7.75e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic favourable (3.49e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.18e-2)"	17.0	18.4	27.6	25.8	24.8	7.9	15.6	20.8	27.3	21.1	22.9	27.1	22.5	24.9	19.4	19.4	20.5	19.6	20.1	17.1	24.9	22.3	26.7	20.9	23.5	25.5	22.2	16.5	17.1	20.0	39.2	19.0	25.7	19.4	22.4	25.7	21.1	18.0	24.5	11.5	15.8	26.7	18.8	24.4	28.8	19.8	32.5	22.2	47.1	21.9	13.0	30.3	20.7	16.2	10.2	12.1	13.6	17.3	10.0	13.6	8.4	11.1	15.9	27.9	17.8	9.7	8.0	7.4	11.2	9.9	12.4	10.6	11.6	12.1	20.7	9.1	11.1	12.0	23.2	15.7	16.0	7.9	14.8	26.9	10.2	13.6	10.0	29.9	15.7	6.7	10.4	7.2	16.6	19.3	28.3	9.7	15.7	13.7	32.3	14.4	9.0	21.5	25.9	33.2	11.7	18.2	17.0	26.9	49.8	10.1	19.6	13.2	14.5	24.4	20.3	20.6	9.5	10.3	18.4	10.1	13.0	11.1	11.7	19.5	12.2	11.5	12.6	13.6	13.6	15.0	11.0	9.4	9.5	10.5	12.1	10.2	8.7	9.2	5.5	10.0	17.3	9.0	6.6	8.4	27.6	24.8	20.8	27.3	24.9	22.3	22.2	16.5	19.4	22.2
DCC	"IGDCC1, NTN1R1"	ENSG00000187323	"DCC netrin 1 receptor"	P43146	18	52340172-53535903	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.0;testis: 16.5"	"Group enriched"	"Detected in some"	4	"AF22: 15.1;U-266/70: 46.8;U-266/84: 22.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055376, HPA069552"	Enhanced		Supported	"Golgi apparatus"			25000	"Golgi apparatus"		"HPA055376: , HPA069552: "	"unprognostic (1.96e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.22e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-3)"	0.5	1.9	6.3	0.8	22.0	0.4	0.6	0.7	10.1	0.8	0.9	1.3	0.0	0.5	0.4	1.0	0.7	0.7	0.5	0.5	18.4	2.0	0.9	0.5	3.8	0.4	1.5	9.9	0.7	1.2	0.6	1.1	0.4	5.3	1.3	0.8	0.0	0.8	3.5	0.4	0.8	0.7	0.5	2.4	0.8	0.8	16.5	6.5	0.7	0.5	0.0	1.1	0.8	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	46.8	22.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	22.0	0.7	10.1	18.4	2.0	1.5	9.9	5.3	6.5
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171756-24358052	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 37.0;kidney: 46.4;pancreas: 22.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 19.7;EFO-21: 13.8;Hep G2: 22.3;RPTEC TERT1: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Cytosol"	"Microtubules, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: , HPA031584: "	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.1	0.9	1.1	0.2	1.5	0.0	3.5	0.3	0.9	1.6	0.3	0.2	1.0	0.3	3.4	37.0	0.2	5.8	7.7	0.2	1.3	1.7	46.4	1.8	3.9	0.0	0.6	0.5	2.1	22.7	7.6	4.3	1.7	1.8	1.5	0.3	2.8	0.9	3.7	0.5	0.2	0.2	0.4	0.5	0.1	1.1	3.7	0.2	0.2	8.4	0.0	0.2	1.0	0.1	1.2	0.5	1.3	0.4	1.0	0.5	0.2	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	1.5	0.1	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.3	0.5	0.2	0.2	0.5	0.5	0.3	0.3	1.2	0.4	0.4	1.3	1.0	0.2	0.5	0.2	0.2	1.1	1.5	0.3	0.9	1.3	1.7	0.6	0.5	1.8	0.2
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Cell line enhanced"	"Detected in all"		"Daudi: 59.7;U-698: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA059609: , HPA062773: "	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	8.0	8.3	11.9	30.9	16.8	17.2	6.9	11.4	14.8	5.6	8.6	10.4	2.6	7.6	7.5	4.4	8.8	5.5	6.1	5.5	12.3	13.1	5.8	4.8	9.7	42.8	11.7	10.3	6.0	5.0	3.6	4.2	7.9	11.1	5.9	10.4	6.4	6.3	4.0	6.8	7.9	12.4	7.5	17.6	17.5	8.2	5.6	8.6	80.9	8.3	3.8	39.9	9.5	6.5	27.9	34.2	17.5	12.7	18.5	24.9	25.1	6.6	4.4	9.7	5.7	3.0	5.3	5.6	17.2	6.4	13.6	11.4	2.9	14.5	59.7	7.4	7.1	3.9	8.6	5.4	18.4	12.6	5.3	12.3	5.1	4.5	3.1	24.6	15.9	2.7	6.6	8.3	5.0	7.7	4.9	22.7	15.5	3.8	30.4	9.7	4.7	5.4	25.8	19.7	4.7	6.8	4.6	8.6	9.2	6.4	12.7	7.5	5.7	12.9	6.2	15.4	11.6	12.9	9.2	8.6	5.6	48.4	10.7	15.4	11.4	13.1	10.7	17.5	16.2	12.7	20.3	27.9	21.8	20.0	14.3	26.4	23.4	23.5	5.4	18.5	12.1	34.2	24.9	25.1	11.9	16.8	11.4	14.8	12.3	13.1	11.7	10.3	11.1	8.6
DCLRE1A	"hSNM1, KIAA0086, PSO2, SNM1"	ENSG00000198924	"DNA cross-link repair 1A"	Q6PJP8	10	113834725-113854383	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036907	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA036907: AB_10673626"	"unprognostic (1.22e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (5.74e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.34e-2)"	3.4	7.1	7.0	4.1	8.1	4.5	6.1	10.2	9.9	5.0	5.3	3.7	4.5	4.7	5.9	6.9	6.5	5.0	4.0	4.8	6.0	6.4	7.3	15.6	7.0	7.5	6.0	2.6	6.5	9.4	10.7	16.9	4.8	8.4	7.4	6.3	5.6	5.4	5.0	6.8	4.2	5.2	4.8	5.5	6.8	5.9	5.2	5.2	8.2	6.1	2.8	6.0	5.1	3.4	1.4	2.1	1.8	0.8	1.9	6.0	2.5	10.5	8.9	13.6	13.7	1.8	3.0	7.8	6.4	6.6	8.8	10.2	6.9	14.6	8.2	7.3	3.2	8.9	12.9	5.6	11.5	16.2	11.1	14.0	5.9	8.8	5.9	14.6	13.3	2.0	6.9	7.4	13.1	5.3	16.0	9.0	4.9	6.3	7.0	5.9	6.6	4.8	4.1	16.1	5.4	5.8	5.0	5.9	9.8	3.7	6.4	9.6	7.7	7.1	4.6	5.1	10.1	6.9	10.6	10.5	11.9	12.8	7.6	21.4	7.3	1.8	0.6	1.4	5.8	0.4	3.8	1.4	2.6	3.9	2.1	0.7	1.9	3.2	0.3	1.9	0.8	0.9	6.0	2.5	7.0	8.1	10.2	9.9	6.0	6.4	6.0	2.6	8.4	5.2
DCLRE1B	"FLJ12810, FLJ13998, SNM1B"	ENSG00000118655	"DNA cross-link repair 1B"	Q9H816	1	113905141-113914086	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MCF7: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064934			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA064934: "	"unprognostic (1.21e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.92e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (4.50e-5)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (6.70e-4)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (5.03e-7)"	"unprognostic (1.24e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.08e-2)"	8.7	4.9	6.7	8.3	6.8	13.1	7.3	15.4	7.8	6.7	6.8	8.3	0.4	4.3	6.9	4.3	8.4	7.0	5.8	5.4	7.0	5.6	5.3	4.2	8.0	15.1	6.7	4.5	7.7	3.8	3.4	3.1	8.7	6.5	4.4	7.8	6.1	4.6	5.0	3.4	7.0	5.5	8.7	8.5	12.8	4.7	7.2	6.4	20.9	5.1	8.2	9.6	5.9	5.9	2.3	4.2	2.4	7.0	8.7	4.4	3.5	8.1	3.0	5.8	6.5	4.3	3.1	3.6	6.5	4.8	8.9	9.8	3.6	2.7	7.8	4.4	5.0	4.3	8.0	7.1	11.7	6.7	5.6	6.4	4.8	3.2	1.1	7.3	6.5	3.8	2.4	12.9	7.0	4.7	9.6	6.6	9.6	33.4	11.2	5.5	4.5	7.2	9.1	17.5	3.7	3.1	3.0	5.1	4.5	6.3	5.3	4.3	3.4	7.4	2.8	10.9	11.6	17.7	9.1	3.1	3.3	8.7	9.1	7.6	18.0	2.4	7.0	1.9	3.4	6.4	4.3	1.4	4.4	3.1	4.2	2.3	2.6	3.6	0.3	8.7	3.7	1.5	2.4	3.5	6.7	6.8	15.4	7.8	7.0	5.6	6.7	4.5	6.5	6.4
DCLRE1C	"A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C"	ENSG00000152457	"DNA cross-link repair 1C"	Q96SD1	10	14897359-14954432	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069295			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA069295: "	"unprognostic (8.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.36e-2)"	"prognostic favourable (1.30e-4)"	"unprognostic (8.02e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (7.98e-4)"	"unprognostic (1.91e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavourable (9.03e-8)"	"unprognostic (2.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.45e-3)"	7.0	5.1	4.8	13.8	9.9	15.2	6.9	6.8	5.9	6.2	6.0	6.0	6.2	6.0	5.7	4.8	9.5	5.8	4.6	4.8	5.4	3.5	5.9	3.3	5.9	14.8	6.9	3.4	6.1	4.4	5.3	7.2	5.0	6.3	7.0	6.2	5.0	6.8	9.2	3.7	7.8	7.8	8.2	8.2	13.3	6.9	2.8	8.3	23.3	7.1	5.6	16.5	9.7	8.0	23.5	17.2	19.3	14.5	8.0	12.2	6.7	11.8	5.8	4.8	10.4	5.0	6.5	5.1	7.4	3.9	10.1	10.2	6.4	10.0	16.0	3.0	5.7	9.9	5.5	3.9	8.4	9.3	5.8	11.9	5.3	4.2	4.0	7.4	14.0	5.2	3.6	9.8	4.0	5.6	7.6	13.5	6.1	5.4	10.8	7.2	3.4	2.7	12.3	6.8	8.9	5.2	4.6	2.7	5.1	7.9	8.3	20.6	9.7	13.6	4.6	6.2	9.1	12.8	7.8	7.7	13.5	16.3	6.3	7.9	8.7	19.3	11.1	14.9	10.1	14.5	12.1	19.3	11.7	12.2	16.2	23.5	10.2	11.3	10.7	8.0	12.7	17.2	9.0	6.7	4.8	9.9	6.8	5.9	5.4	3.5	6.9	3.4	6.3	8.3
DCP1A	"HSA275986, SMAD4IP1, SMIF"	ENSG00000272886	"Decapping mRNA 1A"	Q9NPI6	3	53283428-53347610	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 30.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013202	Approved		Supported	"Cytoplasmic bodies"				"Cytoplasmic bodies"		"HPA013202: AB_1857287"	"unprognostic (2.10e-1)"	"unprognostic (7.61e-2)"	"prognostic favourable (9.01e-4)"	"unprognostic (9.79e-3)"	"unprognostic (7.68e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (3.25e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.33e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	8.0	5.7	4.8	5.4	6.9	18.5	6.1	11.1	8.8	7.2	4.7	6.8	2.1	3.9	8.4	5.8	5.5	6.5	5.5	5.4	4.3		4.6	4.9	5.1	6.3	5.1	3.7	11.2	6.9	8.5	10.0	9.9	5.8	5.8	5.8	7.0	3.8	5.0	5.0	4.9	6.4	7.6	5.8	6.5	4.1	4.9	6.0	11.4	6.1	4.0	10.0	8.2	5.8	26.7	17.4	23.6	25.8	29.4	30.3	19.0	5.7	6.0	14.2	11.4	9.8	10.2	19.0	6.8	9.0	15.1	14.2	17.5	10.5	13.4	2.8	8.6	4.9	18.3	7.0	13.2	11.9	8.2	13.0	8.2	9.1	8.5	15.4	17.8	8.0	6.8	13.6	11.1	10.9	10.9	14.5	7.3	3.5	21.2	7.8	9.0	8.8	9.8	9.5	9.2	6.3	13.0	7.4	12.1	11.7	7.7	10.1	5.0	12.0	11.6	7.3	10.4	7.4	10.1	9.1	7.9	15.5	8.8	9.0	12.8	23.6	13.6	22.4	24.3	14.4	30.1	21.7	24.8	28.1	15.0	26.7	30.3	28.1	13.9	29.4	25.8	17.4	16.9	19.0										
DCP1B	FLJ31638	ENSG00000151065	"Decapping mRNA 1B"	Q8IZD4	12	1946054-2004535	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 19.1"	"Low region specificity"	"Detected in all"							HPA039709	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA039709: AB_10672901"	"unprognostic (9.60e-2)"	"unprognostic (7.19e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.84e-2)"	"unprognostic (7.42e-2)"	7.3	14.3	8.6	7.1	9.9	2.4	7.4	10.7	8.4	11.0	17.9	6.7	5.6	4.8	18.1	9.8	6.1	11.5	9.2	3.2	10.3	4.9	6.5	7.2	6.4	7.0	7.6	8.2	12.9	8.5	8.5	19.8	6.0	6.1	11.7	8.4	7.5	7.2	11.6	8.7	6.2	7.7	29.1	8.5	7.5	9.9	15.8	7.5	10.0	8.0	1.7	7.1	14.4	8.2	3.8	3.9	2.6	3.4	4.0	19.1	3.8	0.1	3.4	6.2	4.8	7.9	10.0	10.4	4.2	8.3	5.3	6.6	0.2	5.3	8.2	1.5	6.1	0.0	4.2	4.4	4.6	13.9	4.6	3.5	2.6	4.9	10.6	4.8	4.0	7.6	7.3	4.8	4.1	8.6	2.1	3.4	6.4	4.2	6.7	4.1	13.6	1.5	3.9	2.9	1.5	6.2	0.0	0.9	4.5	3.6	3.0	3.0	3.0	4.5	5.0	2.5	9.3	5.8	4.2	2.9	2.1	5.6	6.1	3.2	6.4	2.6	2.1	0.2	7.9	3.1	9.7	3.8	8.0	7.6	3.9	3.8	6.3	8.0	0.4	4.0	3.4	2.0	19.1	3.8	8.6	9.9	10.7	8.4	10.3	4.9	7.6	8.2	6.1	7.5
DCPS	"HINT-5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126303752-126345749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol			1400000	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: "	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	11.1	13.1	6.8	14.4	8.2	13.5	9.2	8.5	14.5	12.1	10.6	6.8	8.0	7.8	12.4	9.6	14.4	9.9	13.9	10.9	5.5	6.1	13.3	39.6	9.9	18.5	6.3	5.8	11.8	17.2	7.0	9.5	14.1	6.8	12.7	11.7	13.3	17.4	9.4	21.8	11.3	9.7	11.3	7.1	21.9	9.6	13.4	6.5	22.0	12.7	18.5	22.1	15.1	9.8	13.2	39.5	3.2	14.3	7.8	14.6	7.1	10.5	6.6	8.3	13.7	6.4	8.6	6.9	5.6	8.3	8.6	8.7	12.5	21.7	14.4	21.2	8.9	12.4	11.7	17.6	5.7	27.2	6.3	21.1	7.6	10.8	14.0	22.6	19.1	8.7	11.1	10.9	14.9	11.5	8.5	24.7	9.4	15.2	14.4	25.9	5.8	22.7	10.0	12.1	27.4	8.3	11.8	10.7	8.2	17.0	13.9	10.3	23.6	14.2	7.3	13.5	6.3	6.4	10.5	9.9	9.2	14.9	3.9	39.2	33.8	1.7	9.2	3.2	8.8	14.3	8.2	13.2	8.5	9.0	15.4	9.0	6.0	6.8	0.5	7.8	12.6	39.5	14.6	7.1	6.8	8.2	8.5	14.5	5.5	6.1	6.3	5.8	6.8	6.5
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436808-94479682	"Enzymes, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	58	"retina: 151.5;skin 1: 54.2"	"Cell line enriched"	"Detected in single"	259	"SK-MEL-30: 75.0"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.2	0.2	0.5	0.1	1.5	0.1	1.7	0.2	0.6	0.2	0.1	0.3	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.1	0.3	0.2	0.0	151.5	1.4	0.2	0.2	54.2	0.2	0.1	0.8	0.1	0.0	0.3	0.4	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	0.2	0.6	0.4	0.5	0.3	0.1	0.3	0.4
DCTN1		ENSG00000204843	"Dynactin subunit 1"	Q14203	2	74361154-74392087	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"		"Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009108, HPA034635, HPA071875"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"			220000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB009108: AB_2090601, HPA034635: , HPA071875: "	"unprognostic (1.14e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"prognostic favourable (2.34e-7)"	"unprognostic (5.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.12e-3)"	20.7	21.1	36.0	13.7	54.6	11.1	14.0	45.9	70.9	23.5	17.1	37.8	8.9	11.8	18.5	9.8	22.9	19.7	15.1	37.7	39.5	35.8	13.5	10.0	18.9	10.9	37.7	40.3	21.9	15.2	70.2	21.6	17.2	54.6	16.5	14.0	13.2	23.5	21.7	39.5	19.9	13.7	26.5	32.2	12.4	16.0	25.5	26.7	9.4	17.0	9.5	12.8	17.2	18.0	11.6	12.1	12.9	15.8	9.8	16.7	15.5	18.7	22.0	20.7	21.6	38.0	28.3	16.7	30.3	31.6	38.6	27.6	29.2	14.5	25.9	12.4	62.8	18.8	25.2	38.4	29.5	32.1	25.4	26.8	17.7	24.5	29.3	14.6	33.2	34.0	18.8	41.9	25.1	33.0	11.5	18.5	29.1	16.1	26.5	15.1	22.3	23.4	23.8	36.4	18.5	21.4	11.6	25.5	22.6	16.9	20.4	18.2	13.1	10.6	24.9	35.2	25.6	15.1	22.4	11.5	9.1	23.5	32.9	23.8	24.6	7.3	11.4	12.9	16.7	14.2	13.5	11.6	9.5	12.4	12.1	8.6	6.8	7.5	9.8	9.8	15.8	9.6	8.1	15.5	36.0	54.6	45.9	70.9	39.5	35.8	37.7	40.3	54.6	26.7
DCTN2	"DCTN-50, RBP50"	ENSG00000175203	"Dynactin subunit 2"	Q13561	12	57530102-57547331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039715, HPA040040"	Enhanced		Supported	Centrosome			3200000	Centrosome		"HPA039715: AB_10795154, HPA040040: AB_10794870"	"unprognostic (1.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (1.38e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.41e-3)"	24.3	32.6	40.9	18.5	44.3	19.6	25.8	93.4	72.9	28.7	31.5	26.8	23.1	21.4	29.7	34.0	38.5	28.7	21.9	37.4	38.3	48.6	24.8	19.6	21.1	20.7	49.7	44.8	31.0	34.7	31.4	24.6	23.1	41.8	24.7	33.9	15.2	32.7	31.5	40.0	29.7	22.9	42.2	40.2	17.3	28.7	28.7	25.9	18.1	24.8	28.7	29.4	22.5	27.1	24.3	34.7	31.0	36.2	24.9	32.9	38.2	24.3	29.2	32.5	23.9	51.8	54.4	18.8	27.7	48.1	52.4	39.9	21.1	21.4	25.5	32.6	43.7	18.7	26.8	33.2	41.4	29.3	30.2	22.8	18.4	23.7	36.1	15.5	16.9	48.3	55.8	32.6	56.3	52.7	34.7	36.8	49.3	28.4	26.1	19.7	15.8	32.6	19.1	26.9	22.5	40.5	28.6	49.7	33.6	26.7	22.1	24.1	37.1	14.2	42.5	31.8	24.8	19.3	17.9	24.3	23.9	25.5	29.6	18.9	31.1	25.1	31.7	31.0	28.2	36.2	29.9	24.3	28.9	30.5	34.7	22.1	21.6	26.5	18.9	24.9	35.8	26.2	32.9	38.2	40.9	44.3	93.4	72.9	38.3	48.6	49.7	44.8	41.8	25.9
DCTN3	DCTN-22	ENSG00000137100	"Dynactin subunit 3"	O75935	9	34613545-34620523	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044905	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA044905: AB_10960996"	"unprognostic (3.38e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.47e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.88e-2)"	"unprognostic (4.41e-2)"	"prognostic favourable (2.10e-5)"	"unprognostic (1.26e-3)"	"unprognostic (4.24e-3)"	"prognostic favourable (5.76e-11)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.43e-2)"	26.4	32.5	42.4	16.2	49.1	46.5	30.4	33.7	58.3	25.7	23.3	20.7	22.2	21.4	24.6	25.5	33.7	31.7	23.1	42.8	36.3	37.4	32.8	32.4	21.1	21.9	35.8	48.4	32.6	33.7	29.8	36.3	23.0	37.4	27.4	20.6	27.5	32.4	28.6	69.1	37.9	18.3	28.0	26.2	19.4	23.7	16.2	22.0	42.6	32.4	37.1	29.2	22.5	24.9	28.5	44.6	62.3	45.9	29.9	56.0	46.8	34.0	28.6	26.6	27.8	23.7	33.1	11.0	29.1	27.2	40.6	32.0	18.3	12.8	15.7	18.3	38.3	13.6	24.1	30.5	26.0	49.2	30.3	10.4	50.6	15.7	25.6	27.4	31.9	29.1	26.4	28.0	18.4	26.7	12.4	32.6	35.3	28.0	34.5	74.0	8.0	46.2	17.4	14.4	21.5	19.5	12.1	8.8	22.7	21.6	19.9	11.1	26.6	31.5	24.2	25.6	20.7	29.0	28.2	22.0	28.5	10.4	40.3	16.0	52.0	62.3	44.0	59.3	35.2	44.2	32.0	28.5	37.8	37.2	44.0	28.3	29.9	35.7	38.4	29.9	45.9	44.6	56.0	46.8	42.4	49.1	33.7	58.3	36.3	37.4	35.8	48.4	37.4	22.0
DCTN6	WS-3	ENSG00000104671	"Dynactin subunit 6"	O00399	8	30156297-30183640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024049, HPA024558"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Nucleoli, Cytosol"	"Plasma membrane"	"HPA024049: AB_1847524, HPA024558: AB_1847525"	"unprognostic (1.28e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-2)"	"unprognostic (9.26e-2)"	"prognostic favourable (5.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.43e-1)"	29.5	34.6	41.4	15.6	39.4	23.3	32.6	23.6	43.6	21.0	20.6	27.4	15.4	14.2	24.1	27.2	24.1	18.0	20.0	44.5	37.7	35.2	32.8	27.5	20.3	15.3	42.3	36.3	26.3	19.5	31.0	27.7	32.7	41.4	21.9	22.5	16.5	20.3	23.7	20.4	17.5	15.6	26.0	46.2	16.8	19.3	13.9	30.3	15.4	33.7	18.2	17.9	25.7	18.8	7.4	19.8	9.5	15.9	10.2	11.2	6.9	18.9	18.2	23.0	12.1	21.0	28.9	14.8	25.8	29.9	25.2	26.4	11.8	12.6	14.1	27.7	27.0	14.1	15.9	21.8	29.7	11.3	12.4	20.2	15.6	18.5	16.2	11.4	17.2	24.4	31.2	18.0	19.3	22.5	22.6	15.6	26.7	14.4	21.1	16.4	18.8	11.6	11.3	17.3	12.3	35.8	18.6	37.8	21.4	15.0	18.5	25.6	17.8	16.2	21.6	13.7	47.8	11.2	18.3	6.6	7.4	18.2	25.2	13.1	23.8	9.5	14.1	4.9	8.6	15.9	9.8	7.4	7.8	10.1	16.8	5.5	9.0	11.2	4.5	10.2	15.1	19.8	8.7	6.9	41.4	39.4	23.6	43.6	37.7	35.2	42.3	36.3	41.4	30.3
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	16.9	22.9	15.9	9.9	26.1	3.5	13.5	15.4	24.8	15.9	14.3	12.8	15.5	7.6	17.8	17.3	13.4	13.6	14.2	14.9	29.8	22.3	19.4	36.5	10.4	10.7	17.7	22.0	20.8	9.8	9.9	19.8	9.3	24.6	16.6	12.0	9.4	15.9	22.9	14.3	10.2	9.8	31.4	24.0	11.4	14.6	20.4	13.4	3.9	16.8	8.6	8.2	20.3	13.7	4.6	2.9	10.2	4.2	4.4	10.7	5.3	5.6	10.2	13.8	19.9	14.1	14.2	5.3	17.6	13.1	10.1	9.1	6.5	6.1	4.2	11.4	19.9	5.7	17.5	11.0	13.9	2.7	5.1	7.5	7.9	15.7	29.8	10.4	10.1	14.6	13.1	11.5	10.1	10.1	8.3	3.1	17.4	8.3	12.7	7.3	8.1	8.3	6.1	7.1	2.4	13.1	6.7	8.1	8.8	7.6	9.4	14.6	9.7	6.6	16.4	13.4	11.0	10.7	14.0	5.8	8.2	3.9	9.4	9.9	7.6	5.5	4.2	10.2	7.2	3.7	10.7	4.6	8.1	8.0	2.9	3.3	7.8	8.5	1.7	4.4	2.6	1.9	3.7	5.3	15.9	26.1	15.4	24.8	29.8	22.3	17.7	22.0	24.6	13.4
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.6;ASC TERT1: 13.2;EFO-21: 16.9;fHDF/TERT166: 10.5;SK-MEL-30: 10.6;U-2 OS: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012509	Uncertain		Supported	"Centriolar satellite,Cytosol"			1800000	Cytosol	"Centriolar satellite"	"HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	24.3	7.8	12.5	11.1	10.3	5.5	22.7	3.1	7.8	32.1	17.0	7.9	12.9	2.6	34.6	22.0	18.4	18.1	26.7	20.7	11.8	10.8	16.9	12.9	37.4	16.5	10.6	6.6	22.5	4.3	3.0	6.2	13.7	13.1	19.8	5.4	13.0	18.1	13.2	6.8	15.1	22.3	27.1	18.9	21.4	11.4	7.3	9.9	14.1	35.4	17.1	8.9	16.3	23.4	2.9	5.5	8.0	2.7	2.3	0.5	0.3	0.4	6.6	0.2	1.4	10.6	13.2	0.7	0.6	0.3	0.4	0.1	4.3	0.7	0.2	16.9	10.5	0.8	0.0	6.2	0.0	0.1	8.9	0.5	0.5	0.1	0.3	0.9	0.0	8.5	0.1	0.8	0.1	0.1	0.2	2.2	0.0	3.6	0.5	2.5	0.1	0.2	0.3	0.5	0.0	7.5	0.7	0.4	0.9	0.3	0.0	10.6	0.7	0.9	1.1	0.8	12.6	0.2	0.1	2.7	9.2	2.5	7.3	1.5	0.2	8.0	0.8	7.7	0.5	2.6	0.3	2.9	0.2	0.3	1.5	2.5	0.1	0.1	1.3	2.3	2.7	5.5	0.4	0.3	12.5	10.3	3.1	7.8	11.8	10.8	10.6	6.6	13.1	9.9
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm			170000	Nucleoplasm		"CAB032821: AB_639050, HPA045174: , HPA068456: "	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favourable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	19.3	83.3	19.9	14.1	24.9	16.1	19.7	22.9	33.8	21.3	16.2	24.9	33.3	18.4	23.9	30.6	19.8	26.2	17.4	21.1	18.1	20.8	21.7	26.8	16.0	21.7	18.3	23.4	31.1	23.5	107.3	22.0	80.3	27.3	19.4	17.8	33.0	23.9	27.2	57.1	24.1	19.7	20.7	16.7	17.5	19.7	36.1	14.4	33.3	22.1	20.4	21.0	22.6	17.9	19.6	30.5	17.8	23.5	22.0	32.5	23.8	39.4	42.6	41.4	36.2	39.4	37.2	62.2	37.1	48.1	45.1	34.2	46.1	33.4	59.7	33.0	50.8	36.9	60.7	44.2	48.7	30.1	32.8	34.3	40.9	47.6	27.6	48.9	29.8	43.8	30.4	44.6	38.5	48.4	68.9	32.7	39.6	47.9	60.4	23.0	54.9	36.8	49.8	52.5	62.4	31.5	43.8	36.9	37.6	40.1	46.9	36.9	58.1	20.8	39.9	32.1	30.3	36.6	26.2	37.7	39.8	53.0	35.4	26.2	31.0	17.8	20.9	17.7	24.8	23.5	32.5	19.6	22.4	24.8	30.5	17.9	20.7	23.1	2.5	22.0	21.0	16.8	24.4	23.8	19.9	24.9	22.9	33.8	18.1	20.8	18.3	23.4	27.3	14.4
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: "	"prognostic favourable (7.29e-4)"	"prognostic favourable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	12.2	22.2	5.3	13.3	8.6	8.1	11.3	11.0	8.2	16.8	13.5	7.3	13.4	6.0	18.2	14.1	25.4	14.3	13.0	6.1	4.7	2.9	6.6	20.8	11.3	16.1	15.0	5.0	9.8	15.6	6.1	8.6	5.5	6.3	20.9	12.3	8.1	17.6	14.8	6.3	36.9	11.0	19.0	17.6	15.1	9.1	7.6	7.6	23.3	6.6	16.7	26.0	17.3	15.2	11.4	6.1	11.5	11.0	7.4	27.0	9.0	8.2	22.3	9.3	7.0	6.0	12.2	11.0	9.1	21.3	11.6	13.7	3.6	4.8	19.9	1.9	8.3	14.6	5.3	18.5	5.8	4.9	10.0	4.7	21.3	16.5	5.9	5.4	12.4	16.3	21.0	5.8	13.0	34.0	1.2	9.7	19.0	15.6	20.7	2.6	3.0	8.1	10.4	2.3	10.7	4.9	8.2	4.9	6.1	11.1	3.2	2.9	20.4	1.8	14.6	35.7	16.3	7.8	4.2	10.2	7.7	4.4	13.4	6.9	12.8	5.9	8.1	11.5	12.1	11.0	11.7	11.4	12.7	11.7	6.1	7.4	9.4	10.1	2.2	7.4	9.2	0.1	27.0	9.0	5.3	8.6	11.0	8.2	4.7	2.9	15.0	5.0	6.3	7.6
DDHD2	"KIAA0725, SAMWD1, SPG54"	ENSG00000085788	"DDHD domain containing 2"	O94830	8	38225218-38275558	"Disease related genes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015202, HPA023143, HPA023147"	Supported		Supported	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535"	"unprognostic (1.49e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.49e-1)"	20.1	14.3	24.5	13.5	27.1	9.4	14.9	34.4	48.1	18.9	13.5	23.2	10.6	15.3	16.6	18.7	16.9	15.5	13.9	21.3	26.6	25.1	17.4	9.1	13.0	13.8	28.6	24.9	24.3	16.4	17.3	15.4	11.8	27.5	18.6	13.4	20.0	13.6	23.8	21.4	12.5	17.1	16.7	37.3	12.5	11.0	16.8	17.9	8.8	15.0	9.3	16.4	14.9	13.3	13.3	5.5	3.7	4.0	13.2	12.3	5.9	25.0	11.4	25.9	12.7	10.4	14.0	8.4	7.9	14.2	18.9	17.0	13.7	9.9	10.0	11.1	13.7	9.7	14.6	14.6	28.9	8.5	10.0	35.6	15.7	13.0	9.0	4.2	5.6	7.2	11.7	11.7	12.2	22.3	25.2	10.9	11.9	5.3	28.1	6.3	5.8	6.8	15.0	22.4	6.8	10.3	15.0	9.4	14.6	19.2	10.2	9.7	11.7	11.2	20.3	10.8	14.4	10.7	12.5	11.6	10.4	22.7	17.7	8.1	15.3	2.1	3.1	3.7	9.6	4.0	10.7	8.3	8.6	10.6	5.5	13.3	9.5	6.7	0.3	13.2	2.8	3.0	12.3	5.9	24.5	27.1	34.4	48.1	26.6	25.1	28.6	24.9	27.5	17.9
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617500-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol			170000	"Nucleoplasm, Cytosol"		"HPA043119: , HPA043225: "	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	14.8	8.1	5.1	10.5	7.1	10.5	15.0	8.7	8.4	8.7	10.8	8.2	9.8	9.0	12.3	9.6	19.4	7.7	8.3	12.5	5.8	4.7	10.4	24.9	10.2	9.1	6.7	5.2	8.3	9.4	14.8	8.0	11.5	7.5	12.1	7.9	11.5	13.5	13.8	54.8	13.3	9.2	8.0	6.5	9.9	6.9	4.3	6.0	11.1	7.6	11.7	16.4	12.1	12.3	3.8	5.4	0.8	2.3	2.0	3.5	1.4	7.4	4.3	7.9	8.2	10.9	8.6	7.7	4.7	3.6	4.1	3.6	10.6	6.8	18.8	5.5	5.1	8.0	17.2	7.6	7.0	8.6	11.5	14.7	7.3	10.4	4.7	19.4	7.4	8.5	9.0	7.7	8.3	8.4	23.5	7.0	5.0	5.0	11.2	6.4	7.6	3.6	10.6	11.2	11.1	5.8	6.2	9.7	5.4	8.8	14.2	13.0	7.4	5.1	7.3	6.0	5.1	6.7	5.7	6.6	7.9	15.2	4.7	14.2	4.6	0.7	2.3	0.4	3.3	2.1	2.9	2.6	2.5	2.6	2.3	3.8	2.8	3.5	0.8	2.0	1.6	5.4	2.3	1.4	5.1	7.1	8.7	8.4	5.8	4.7	6.7	5.2	7.5	6.0
DDIT3	"CHOP, CHOP10, GADD153"	ENSG00000175197	"DNA damage inducible transcript 3"	P35638	12	57516588-57521737	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 122.9;hTERT-HME1: 61.8;SK-MEL-30: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 50.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058416, HPA068416"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA058416: , HPA068416: "	"unprognostic (1.12e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (6.55e-4)"	"unprognostic (8.55e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	19.1	25.5	15.9	8.3	29.9	82.2	21.4	16.7	25.2	14.8	13.5	20.1	15.7	10.6	19.5	55.8	13.0	13.1	16.0	25.8	18.6	19.8	28.8	26.1	17.1	8.8	34.4	15.5	27.3	13.0	13.5	26.8	18.0	32.1	22.8	13.9	27.3	20.7	13.9	18.0	16.3	10.9	15.4	21.8	11.2	14.7	14.3	35.3	2.9	88.9	12.6	9.4	30.2	17.0	13.8	4.6	50.8	5.4	9.2	10.9	5.1	2.5	2.4	1.5	5.2	14.1	9.6	8.2	7.2	15.9	10.7	10.1	8.4	6.8	3.7	7.2	2.1	3.2	5.8	1.1	11.1	3.0	2.3	2.9	2.6	6.1	122.9	4.6	4.5	27.4	23.3	18.1	61.8	2.5	12.4	14.2	4.7	1.5	3.0	6.0	3.0	5.6	1.7	33.7	3.2	3.8	3.3	3.2	2.3	2.1	2.4	57.3	5.2	12.2	1.4	7.3	3.1	6.9	6.2	25.2	8.4	3.9	8.8	4.3	12.9	27.5	5.4	13.5	8.0	4.6	7.0	13.8	5.7	7.3	3.7	13.1	10.9	9.9	50.8	9.2	5.1	4.6	6.5	5.1	15.9	29.9	16.7	25.2	18.6	19.8	34.4	15.5	32.1	35.3
DDIT4	"Dig2, FLJ20500, REDD-1, REDD1, RTP801"	ENSG00000168209	"DNA damage inducible transcript 4"	Q9NX09	10	72273920-72276036	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 159.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 65.0;hTCEpi: 220.7;hTERT-HME1: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034507, HPA034508"	Approved		Supported	Cytosol				Cytosol		"HPA034507: AB_2674199, HPA034508: AB_10601206"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (7.65e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.96e-3)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (9.72e-2)"	"prognostic unfavourable (2.54e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.66e-1)"	29.0	43.9	27.3	28.0	28.0	35.5	88.2	23.1	27.1	38.7	18.7	6.4	14.4	7.5	16.3	13.5	37.0	14.5	21.7	23.0	28.2	8.4	13.6	27.5	33.7	26.5	45.5	11.6	73.4	159.3	5.4	16.4	16.2	34.4	15.8	5.1	10.2	41.2	29.2	29.5	21.0	13.0	11.7	22.8	17.5	19.6	8.1	34.9	30.8	13.4	11.1	34.5	37.8	47.7	25.9	40.5	9.7	2.5	70.6	57.1	40.9	12.5	9.1	1.8	16.9	12.2	7.0	5.5	3.8	4.2	1.4	5.7	1.0	27.2	1.4	11.6	0.6	14.7	2.6	65.0	3.1	20.4	3.4	1.5	20.6	6.7	48.5	4.2	6.1	29.7	220.7	5.8	81.1	5.4	12.1	33.9	4.9	5.2	2.5	5.8	0.4	2.1	1.4	2.1	24.0	11.6	3.0	3.3	4.7	9.0	14.2	51.0	2.0	9.5	11.2	0.4	3.6	0.8	2.0	24.1	13.3	3.7	24.2	9.6	2.8	9.2	1.6	9.7	50.4	2.5	48.6	17.9	32.8	27.8	7.2	25.9	57.1	42.9	5.3	70.6	2.0	40.5	24.0	40.9	27.3	28.0	23.1	27.1	28.2	8.4	45.5	11.6	34.4	34.9
DDN	KIAA0749	ENSG00000181418	Dendrin	O94850	12	48995149-48999309	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 40.8;skeletal muscle: 73.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.3;RPMI-8226: 19.7;SCLC-21H: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"amygdala: 228.1;basal ganglia: 257.7;cerebral cortex: 232.0;hippocampal formation: 236.4;olfactory region: 128.1"	HPA060952	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA060952: "	"unprognostic (2.80e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.56e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.20e-5)"	"unprognostic (8.61e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-6)"	"unprognostic (1.72e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.53e-2)"	0.7	0.7	40.5	0.8	40.8	1.3	0.7	0.0	38.5	0.7	0.7	0.2	0.0	0.7	0.7	3.8	1.0	0.7	0.7	0.9	30.5	2.0	4.8	0.7	0.7	0.9	2.9	9.3	0.7	0.8	0.8	0.0	0.7	0.0	1.6	0.7	0.0	0.7	0.7	73.8	0.8	0.8	0.7	0.0	0.8	0.8	0.8	1.2	0.0	0.7	0.0	0.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.3	0.3	0.2	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	4.4	0.4	0.0	0.2	0.0	1.5	10.3	0.0	0.1	0.5	4.7	2.3	0.5	1.0	0.0	5.3	0.2	0.0	0.1	0.1	0.0	0.1	0.0	3.5	0.2	0.1	5.2	5.8	0.1	1.4	4.8	0.3	19.7	0.0	0.1	10.3	1.0	0.2	0.5	0.2	0.2	0.7	0.1	0.2	0.5	0.2	0.0	1.2	2.3	4.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	40.5	40.8	0.0	31.9	30.5	2.0	2.9	9.3	0.0	1.2
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415562	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 14.5;U-937: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.9;myeloid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	3.7	11.0	5.2	1.1	12.1	1.6	3.3	1.9	5.5	2.7	3.6	10.8	4.9	8.6	2.7	5.4	1.2	6.1	3.9	21.0	6.9	3.4	12.3	12.8	3.9	1.3	8.0	6.1	1.2	5.5	18.6	1.9	2.1	8.0	2.9	3.9	2.3	4.9	3.2	11.3	0.8	7.9	5.6	7.7	2.6	1.9	0.4	8.2	0.0	3.3	5.7	0.5	3.6	1.6	0.0	7.3	0.1	4.9	1.7	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.2	1.0	0.2	5.1	1.2	0.9	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	2.3	4.6	0.0	4.7	0.0	4.0	1.6	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.0	1.8	4.2	0.0	0.0	0.2	0.0	0.1	0.1	2.9	14.5	0.0	4.6	0.1	0.1	0.0	0.4	0.6	0.7	1.0	0.9	1.0	0.1	0.0	2.4	0.1	0.3	0.0	1.9	16.1	0.0	0.1	4.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	1.7	1.6	0.0	0.0	1.5	5.2	12.1	1.9	5.5	6.9	3.4	8.0	6.1	8.0	8.2
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"			3300000	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: , HPA052867: "	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favourable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (4.88e-4)"	"prognostic unfavourable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavourable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	25.7	42.7	17.0	28.7	21.6	37.1	42.5	13.9	26.7	32.8	35.3	16.4	52.0	27.3	37.1	54.7	33.2	32.7	40.0	53.2	13.9	15.7	36.0	59.8	37.2	84.7	16.5	18.3	42.4	146.9	25.4	37.2	71.6	16.1	24.9	39.1	29.5	51.3	58.3	25.5	25.1	35.6	32.2	12.8	49.8	36.5	35.1	15.0	32.5	51.5	28.7	34.5	26.7	30.0	45.6	80.1	50.1	57.1	49.7	58.9	80.7	46.3	29.8	26.0	77.0	51.7	54.1	54.3	39.1	78.7	63.7	65.8	39.6	97.2	38.5	65.2	63.3	40.2	35.8	47.9	47.2	30.5	36.8	33.3	19.4	52.0	77.1	51.7	86.2	55.4	53.4	53.3	64.4	72.7	16.1	64.3	38.2	35.4	24.5	42.8	26.7	31.6	21.6	34.9	68.4	52.0	20.5	18.9	32.9	42.2	43.0	58.1	34.4	80.2	37.3	36.7	38.7	63.4	36.0	76.3	82.0	25.9	60.5	69.2	49.3	44.7	55.7	50.1	55.7	57.1	58.9	45.6	48.2	51.3	80.1	39.6	44.1	46.6	14.2	49.7	48.5	65.4	49.2	80.7	17.0	21.6	13.9	26.7	13.9	15.7	16.5	18.3	16.1	15.0
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787400	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.6;ASC TERT1: 59.9;BJ hTERT+: 44.3;fHDF/TERT166: 31.7;HSkMC: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Supported	"Plasma membrane,Actin filaments"			850000	"Plasma membrane, Actin filaments"		"HPA070112: "	"unprognostic (4.12e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.73e-7)"	"unprognostic (1.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.10e-3)"	42.1	43.5	4.7	10.9	6.9	0.2	15.6	7.9	7.1	30.3	30.4	9.0	18.6	3.3	24.2	17.7	25.0	13.4	16.6	15.4	7.9	4.7	4.0	3.3	8.9	5.1	12.9	3.4	26.4	2.2	2.1	4.0	6.6	12.7	21.8	9.1	30.7	6.4	19.3	5.2	6.1	10.1	34.3	19.7	3.4	14.1	8.3	7.5	0.0	8.6	12.8	4.1	29.0	18.3	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	16.0	60.6	59.9	0.2	23.6	44.3	10.3	14.9	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.1	14.1	12.7	0.1	0.0	0.0	0.0	26.3	0.0	0.0	42.5	0.1	18.2	0.4	11.8	0.1	5.0	9.4	0.0	0.0	0.0	0.1	0.1	0.0	6.7	0.1	0.0	0.0	0.0	9.7	0.0	0.0	0.8	0.0	0.0	0.6	16.5	3.6	8.3	3.2	0.7	1.3	0.0	14.9	0.0	16.7	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	4.7	6.9	7.9	7.1	7.9	4.7	12.9	3.4	12.7	7.5
DDRGK1	"C20orf116, dJ1187M17.3, UFBP1"	ENSG00000198171	"DDRGK domain containing 1"	Q96HY6	20	3190350-3204685	"Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013373, HPA013705"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"HPA013373: AB_2091955, HPA013705: "	"unprognostic (2.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.10e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.29e-2)"	"prognostic favourable (2.01e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.90e-2)"	29.5	47.3	28.5	18.6	45.7	17.8	20.5	33.4	38.2	22.1	23.9	29.8	23.7	35.3	21.5	17.8	21.1	21.0	24.3	17.7	27.0	21.8	28.5	54.0	27.0	17.5	47.9	22.9	23.9	43.6	37.5	17.7	31.3	30.9	27.3	16.6	20.6	48.5	29.3	29.5	22.2	31.9	17.1	36.8	20.2	31.5	14.7	39.3	12.6	34.0	14.2	16.2	20.8	29.4	15.1	32.0	24.4	20.2	12.3	21.0	12.9	29.5	37.3	9.2	17.2	21.0	8.0	13.3	18.9	9.1	11.7	12.8	29.3	21.6	17.7	15.4	10.4	33.2	9.5	28.2	4.3	12.0	17.7	15.0	12.4	50.8	28.8	16.9	16.3	12.5	27.7	22.3	16.0	10.6	20.7	21.3	7.4	16.2	11.5	31.5	11.4	17.2	15.3	8.2	26.9	18.9	27.8	20.5	12.6	19.4	54.9	17.5	23.3	10.4	16.0	18.8	8.4	13.2	28.7	16.0	18.0	7.5	5.2	14.3	10.9	11.7	20.2	24.4	19.6	13.3	19.5	15.1	20.9	21.0	20.5	15.1	18.7	18.2	5.4	12.3	12.1	32.0	18.6	12.9	28.5	45.7	33.4	38.2	27.0	21.8	47.9	22.9	30.9	39.3
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15631111	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Enhanced	Nucleoplasm,Cytosol			46000	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favourable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	23.8	28.2	29.3	17.6	35.0	17.1	30.1	35.3	37.2	25.1	24.5	15.0	20.5	21.0	24.3	25.6	27.7	21.0	15.8	47.6	34.7	25.3	35.8	35.2	17.8	16.0	24.5	36.9	23.6	27.6	42.1	41.2	28.1	35.1	22.2	28.1	14.8	23.9	24.5	67.5	24.5	25.9	31.0	21.0	17.1	24.1	19.2	23.0	23.0	29.6	24.8	21.5	26.1	19.8	18.7	22.8	19.2	25.1	23.0	26.6	19.9	19.1	29.4	41.8	31.2	36.3	31.9	48.2	40.3	33.8	39.7	33.4	46.9	19.8	49.7	19.6	46.4	29.2	57.1	38.6	42.0	21.1	37.1	54.5	39.3	59.1	27.3	44.5	25.7	24.7	26.7	33.0	31.8	35.7	55.5	16.4	39.1	26.8	24.3	33.6	53.8	24.8	29.4	63.3	36.0	45.4	38.6	33.7	42.2	27.5	29.0	36.6	20.2	18.9	28.8	33.3	34.5	20.9	45.4	21.5	37.3	67.1	30.0	35.7	31.0	19.2	20.0	11.5	20.2	25.1	21.3	18.7	23.4	23.4	22.8	18.0	26.6	23.6	3.1	23.0	23.2	19.5	21.6	19.9	29.3	35.0	35.3	37.2	34.7	25.3	24.5	36.9	35.1	23.0
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073845-31104791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"				Nucleoplasm	"Nucleoli fibrillar center, Centrosome"	"HPA065197: "	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	6.3	5.3	6.4	8.0	8.7	21.0	5.9	18.1	10.5	7.6	6.1	6.0	8.8	7.1	11.0	3.7	7.6	7.5	5.1	4.0	7.0	2.7	6.5	7.0	4.9	14.9	8.4	4.6	9.6	19.0	7.7	9.3	5.6	7.1	8.0	8.6	5.0	11.3	7.1	8.8	14.2	12.1	8.0	6.7	10.9	8.0	8.2	9.4	33.2	7.2	6.4	11.1	5.8	7.8	5.8	4.9	1.3	7.3	4.3	5.5	1.9	12.4	12.2	14.1	12.6	2.2	4.7	20.8	7.7	3.9	9.1	9.7	14.4	21.2	16.3	10.8	4.1	12.3	11.1	10.6	7.3	14.9	22.8	19.4	20.2	8.9	0.8	13.6	12.6	4.5	4.7	11.5	9.0	4.4	9.5	36.5	6.5	10.3	23.3	20.4	29.7	6.5	18.8	22.1	22.7	4.8	14.2	10.2	7.5	7.9	12.2	3.9	10.3	8.7	3.6	7.9	15.6	15.3	14.0	14.8	11.4	39.0	9.4	10.9	7.2	0.0	2.3	1.3	4.2	2.5	3.3	5.2	4.0	3.1	3.1	5.8	4.1	5.5	1.1	4.3	7.3	4.9	3.4	1.9	6.4	8.7	18.1	10.5	7.0	2.7	8.4	4.6	7.1	9.4
DDX17	P72	ENSG00000100201	"DEAD-box helicase 17"	Q92841	22	38483440-38507660	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024908, HPA063142"	Supported		Supported	"Nuclear speckles"	"Intracellular and membrane"		90000	"Nuclear speckles"		"CAB024908: , HPA063142: "	"unprognostic (1.46e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.36e-2)"	"prognostic favourable (6.06e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.19e-3)"	49.7	43.1	46.3	49.2	54.5	19.8	50.8	69.7	52.0	47.7	53.3	56.5	54.4	33.1	58.5	82.9	37.5	52.2	46.1	39.9	47.0	31.2	34.3	41.9	41.5	52.6	64.0	37.7	67.8	41.5	68.5	83.7	49.4	46.0	46.2	36.8	51.4	43.9	51.8	89.2	60.3	38.7	52.7	47.1	54.1	39.7	24.6	63.1	69.3	59.8	29.2	47.7	54.5	52.9	10.3	12.4	23.7	9.5	4.0	9.9	6.1	29.6	28.8	58.8	35.3	39.0	44.9	30.7	25.3	25.3	37.0	36.0	27.5	24.8	57.6	17.5	33.1	32.8	64.3	35.9	41.4	56.7	36.7	35.8	48.2	32.9	41.8	45.7	42.6	31.3	47.1	24.1	41.7	42.2	36.9	65.2	29.3	19.3	32.1	38.9	37.8	14.0	58.3	32.8	35.3	35.1	39.7	34.0	20.0	39.7	31.4	41.9	27.1	35.3	34.2	31.6	19.7	20.1	19.0	50.4	34.8	49.6	40.8	29.6	38.8	8.5	9.5	11.0	9.9	7.3	9.4	9.0	8.0	7.1	6.8	10.3	5.8	7.5	23.7	4.0	6.8	12.4	7.9	6.1	46.3	54.5	69.7	52.0	47.0	31.2	64.0	37.7	46.0	63.1
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814650-117832379	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Supported	Nucleoli				Nucleoli		"HPA035400: AB_10672091, HPA041056: "	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	35.3	21.3	20.5	28.7	26.0	17.4	31.2	27.1	25.6	31.2	27.9	16.7	21.6	20.9	32.0	22.9	27.8	28.5	21.3	22.9	19.6	19.1	32.0	40.3	24.1	35.0	25.5	22.9	36.3	29.5	21.0	25.9	25.0	25.0	25.0	30.3	11.5	24.2	26.6	37.0	24.9	26.3	28.3	30.8	46.5	26.2	22.9	31.1	40.7	31.3	23.9	37.6	37.6	23.7	22.2	20.5	9.4	18.5	17.2	23.6	16.3	21.5	9.8	14.7	13.2	8.7	7.9	24.2	12.8	10.1	17.7	15.7	24.1	14.3	31.8	21.0	10.6	16.8	28.5	16.6	26.2	16.2	19.9	30.4	9.2	24.2	12.2	40.5	15.9	8.2	15.3	22.5	22.8	10.6	33.1	13.8	13.5	13.4	22.1	21.2	36.8	14.8	19.3	22.9	27.9	11.7	12.8	14.1	24.0	14.9	16.4	16.6	10.4	22.4	8.1	15.9	23.4	11.1	23.0	15.9	19.8	88.2	11.7	19.2	7.1	6.2	13.8	9.4	16.2	17.3	20.6	22.2	19.3	18.5	12.5	19.1	23.6	20.7	3.6	17.2	18.5	20.5	15.0	16.3	20.5	26.0	27.1	25.6	19.6	19.1	25.5	22.9	25.0	31.1
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111755245-111768016	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 81.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favourable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavourable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	3.1	2.8	2.9	2.7	4.3	5.9	9.8	5.8	5.1	2.7	2.6	1.8	2.6	2.0	4.0	2.9	2.6	3.7	1.7	2.0	4.3	1.6	2.7	2.4	4.1	3.8	2.4	1.9	3.9	2.9	4.0	3.9	2.7	3.4	2.9	2.6	1.2	2.6	2.7	5.1	2.5	3.5	2.9	5.6	4.5	2.8	81.7	3.3	5.1	3.2	1.7	4.1	2.9	5.0	11.9	7.4	12.7	7.4	10.5	14.1	7.8	11.4	4.7	12.2	11.0	8.8	7.0	11.4	11.2	8.7	16.1	15.7	7.0	4.0	26.8	8.8	7.6	9.2	14.4	11.3	18.0	12.2	13.0	13.0	9.2	7.2	8.8	12.8	9.6	7.0	9.9	13.7	13.9	11.1	12.4	9.8	12.2	10.8	15.7	13.0	15.3	9.6	15.4	20.1	6.7	10.5	9.0	12.7	11.5	10.8	13.5	18.0	8.4	13.6	9.8	9.8	14.5	17.5	13.0	4.9	6.9	20.5	10.2	13.2	22.1	12.7	7.0	6.9	10.0	7.3	13.3	11.9	11.7	11.8	7.4	10.1	14.1	12.3	5.0	10.5	7.4	5.2	11.7	7.8	2.9	4.3	5.8	5.1	4.3	1.6	2.4	1.9	3.4	3.3
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956128-68985073	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	Nucleoplasm,Nucleoli			14000	Nucleoli	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	37.5	16.0	10.0	26.6	13.3	46.8	24.4	8.0	11.8	18.5	20.1	7.2	16.2	13.3	18.7	13.7	28.3	20.1	17.6	19.1	11.4	8.0	25.1	48.0	25.9	24.4	14.9	7.2	30.2	27.9	15.6	20.7	22.8	18.3	14.0	17.6	5.9	18.0	17.8	61.2	22.5	18.5	19.0	20.4	43.5	19.0	12.9	13.3	27.1	18.1	24.1	25.8	33.2	22.4	12.6	11.5	17.1	17.3	7.7	15.0	6.2	32.8	19.5	11.4	35.2	10.3	13.6	24.1	22.6	18.3	29.2	24.9	63.1	22.5	49.6	13.9	18.7	29.3	43.9	28.2	39.2	15.4	30.9	34.7	13.9	26.2	22.1	82.5	33.0	14.0	36.7	34.9	58.4	21.2	66.0	24.8	20.5	15.0	32.3	18.0	31.2	41.7	28.9	18.7	24.3	19.4	17.7	23.6	25.3	20.3	45.1	26.3	25.5	17.3	21.8	17.2	24.3	23.0	39.6	28.6	37.8	73.2	14.3	62.6	11.6	5.0	9.7	17.1	8.4	15.0	15.0	12.6	10.9	11.0	11.5	10.4	10.3	11.3	4.5	7.7	17.3	10.8	7.9	6.2	10.0	13.3	8.0	11.8	11.4	8.0	14.9	7.2	18.3	13.3
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829764-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: "	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	26.1	26.5	29.5	35.6	34.2	19.4	27.2	32.8	35.6	26.7	32.8	23.3	27.5	27.9	31.0	22.3	31.0	31.1	25.2	25.1	29.8	20.3	25.2	37.7	27.7	35.2	26.5	25.3	36.2	30.4	32.2	28.1	34.4	25.0	29.9	32.6	24.7	31.1	27.0	44.4	30.6	32.3	29.4	24.1	40.0	30.6	24.9	32.0	46.8	28.2	29.8	38.9	28.9	47.9	12.0	11.5	19.6	13.3	11.2	19.8	10.6	21.6	49.4	23.5	24.9	23.5	16.3	25.0	26.8	20.6	30.5	19.4	48.1	28.9	27.3	29.5	22.2	19.6	50.9	24.4	26.1	42.8	27.0	36.2	42.1	21.7	12.7	36.5	33.0	15.7	22.0	32.3	19.4	24.9	47.9	24.5	22.1	30.0	34.6	34.7	34.9	23.5	37.0	27.8	21.7	18.0	30.5	29.0	16.9	26.9	30.8	11.2	30.1	33.6	22.3	23.1	16.9	11.3	21.2	18.5	25.8	33.0	19.6	25.8	12.6	17.1	11.1	19.6	19.5	13.3	19.8	12.0	14.5	17.6	10.8	11.4	14.0	16.9	11.9	11.2	8.9	11.5	13.1	10.6	29.5	34.2	32.8	35.6	29.8	20.3	26.5	25.3	25.0	32.0
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68021274-68023442	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: "	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favourable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	9.8	12.7	6.2	6.7	8.3	19.7	7.1	6.0	12.9	8.3	7.2	6.4	6.8	5.2	7.5	7.3	9.7	7.1	7.0	9.2	5.2	5.9	8.9	12.4	5.8	18.4	6.4	5.1	8.6	13.3	6.8	4.6	17.1	6.6	6.1	6.0	7.8	6.3	5.2	16.2	9.9	7.9	5.3	3.0	11.1	7.0	11.5	2.7	14.6	10.2	7.3	10.6	8.0	4.8	17.8	18.0	22.9	19.1	17.0	22.9	16.6	6.1	9.1	4.5	5.4	6.3	3.5	10.5	4.2	6.2	10.6	7.6	8.8	9.8	23.0	6.5	5.2	11.1	6.4	10.2	6.3	3.1	10.5	8.3	4.8	9.1	8.5	13.0	9.0	6.8	11.1	8.7	8.0	5.9	14.8	3.6	4.7	13.7	13.6	18.3	11.0	6.8	13.4	4.2	24.6	7.4	7.1	9.4	6.3	17.1	4.9	9.3	9.4	14.3	4.2	4.7	4.0	6.7	6.9	8.1	9.8	22.1	5.8	10.1	6.3	17.7	19.1	22.9	15.7	18.8	17.3	12.6	14.6	16.9	18.0	17.8	22.9	16.9	6.3	17.0	18.5	9.0	13.8	16.6	6.2	8.3	6.0	12.9	5.2	5.9	6.4	5.1	6.6	2.7
DDX31	"FLJ13633, FLJ14578, FLJ23349, PPP1R25"	ENSG00000125485	"DEAD-box helicase 31"	Q9H8H2	9	132592997-132670401	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020891			Supported	"Nucleoli,Golgi apparatus,Vesicles"				Nucleoli	"Golgi apparatus, Vesicles"	"HPA020891: "	"unprognostic (5.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.94e-2)"	"prognostic unfavourable (1.68e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	6.8	6.9	8.2	15.3	11.2	6.0	12.3	18.4	8.5	7.5	6.6	9.4	12.6	5.0	8.9	8.8	9.8	8.8	7.5	5.4	6.3	6.3	8.4	9.2	12.0	15.1	9.1	5.7	16.9	17.3	10.0	8.8	5.8	9.8	9.2	8.0	7.4	12.7	12.6	12.9	14.0	7.2	12.7	12.9	8.7	6.8	15.2	8.3	6.8	22.7	10.8	13.8	7.2	12.6	5.0	4.5	1.9	2.7	3.1	6.9	3.0	7.1	13.2	6.5	8.9	7.9	7.2	12.7	7.6	7.5	12.1	9.2	14.7	14.7	17.8	7.0	7.1	20.0	20.3	8.9	9.7	10.9	7.5	9.6	11.8	7.7	9.6	17.1	7.9	6.3	12.2	12.3	17.4	7.9	17.7	7.0	10.0	15.3	11.9	9.3	16.0	13.6	12.6	11.5	20.5	11.0	6.8	11.7	8.3	14.0	12.4	10.6	26.0	5.0	6.6	20.5	9.3	11.6	11.8	3.4	10.7	13.9	7.4	10.9	15.4	0.0	1.9	1.9	5.7	2.7	4.7	4.2	5.5	4.4	4.5	5.0	6.9	5.1	0.3	3.1	1.9	2.8	3.6	3.0	8.2	11.2	18.4	8.5	6.3	6.3	9.1	5.7	9.8	8.3
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"			120000	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: , HPA058450: "	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavourable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favourable (1.43e-5)"	27.1	31.0	16.1	33.3	20.6	11.3	29.1	37.3	22.7	34.9	35.4	31.8	25.6	8.2	53.4	75.4	40.2	43.5	23.8	28.3	16.3	12.8	25.3	28.6	29.1	26.5	19.2	15.6	49.8	36.8	17.6	50.6	25.9	19.7	35.3	19.3	35.3	26.4	34.4	39.0	24.7	33.2	25.8	30.8	39.9	27.7	21.3	17.8	45.5	31.2	30.5	37.1	32.9	27.7	5.1	8.5	3.8	6.2	3.4	7.4	5.5	3.0	16.1	13.3	6.5	13.5	11.6	7.7	3.4	3.9	10.0	9.0	4.0	4.0	3.1	11.7	16.7	5.6	15.1	25.6	9.4	2.7	40.3	5.5	4.7	9.6	4.5	7.4	6.0	17.9	15.4	10.1	31.7	6.3	23.8	2.5	8.3	2.1	6.5	27.0	5.6	2.8	5.5	5.9	3.6	20.2	3.9	6.1	17.0	6.8	3.1	3.9	2.3	6.4	3.5	1.3	4.8	1.2	8.9	10.2	12.6	25.0	0.8	10.4	5.3	3.5	6.1	3.8	5.4	6.2	6.7	4.5	6.8	6.5	8.5	5.1	7.4	6.8	3.4	3.4	5.6	6.5	7.3	5.5	16.1	20.6	37.3	22.7	16.3	12.8	19.2	15.6	19.7	17.8
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3, Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 40.6;HEL: 41.4;U-266/84: 34.4;U-698: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favourable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	12.0	10.5	4.9	29.5	14.1	46.1	8.7	17.0	16.3	0.4	24.4	12.6	31.5	7.6	0.4	29.7	12.2	0.4	14.2	10.8	5.6	7.1	8.9	26.5	20.0	17.7	5.7	0.0	0.4	14.5	0.4	12.2	14.0	20.2	26.7	15.8	15.1	20.4	32.6	17.7	8.4	16.0	40.7	6.2	34.3	8.9	41.9	0.0	26.9	10.8	21.4	19.3	14.4	0.0	6.1	8.8	6.5	7.1	6.5	8.4	3.8	0.1	7.5	0.0	0.0	0.0	0.0	5.5	18.6	13.3	9.8	12.1	0.0	0.0	40.6	0.0	18.3	0.0	0.0	0.0	17.3	10.2	0.0	41.4	0.0	12.2	9.7	0.0	0.0	10.3	11.6	0.0	0.0	0.0	0.0	0.0	11.6	0.0	16.0	0.0	7.4	0.0	0.0	4.9	7.4	10.5	11.2	12.2	0.0	0.0	0.0	13.6	0.0	9.7	13.3	15.3	0.0	0.0	12.2	21.9	34.4	30.2	1.8	0.0	0.0	1.6	6.2	5.7	8.4	7.1	7.7	6.1	6.4	7.1	8.8	5.9	7.8	6.5	6.5	6.5	4.6	2.5	5.7	3.8	4.9	14.1	17.0	16.3	5.6	7.1	5.7	0.0	20.2	0.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177517469	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: "	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavourable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	17.9	22.7	27.0	25.1	30.7	17.2	16.5	22.8	39.2	19.1	21.2	16.9	18.5	25.5	19.5	16.5	23.0	22.1	17.1	15.3	29.3	20.1	23.7	29.3	16.8	19.9	22.1	24.8	21.2	18.0	22.2	15.1	22.1	27.4	16.3	15.4	19.0	19.0	17.5	36.6	21.7	26.8	16.7	14.8	21.9	19.7	16.8	15.4	24.9	22.9	18.2	23.5	19.6	18.4	15.9	22.5	16.4	22.8	18.6	20.6	18.0	21.0	24.1	13.2	15.5	13.6	16.1	44.5	18.9	11.5	13.9	10.3	39.2	19.7	23.6	28.8	17.8	17.3	17.2	43.3	9.5	56.4	21.6	30.0	24.5	23.2	18.0	31.0	31.9	15.8	15.3	13.2	17.8	17.7	26.0	16.9	16.4	45.4	25.8	15.2	23.2	19.5	28.1	16.0	27.8	15.5	24.5	15.7	17.2	20.1	26.8	22.6	18.7	45.3	18.9	25.5	15.1	16.2	29.4	20.3	23.8	40.3	27.9	34.2	16.7	10.6	22.8	16.4	16.1	21.5	20.6	15.9	16.0	15.3	22.5	14.1	14.8	15.5	7.7	18.6	21.4	10.2	15.6	18.0	27.0	30.7	22.8	39.2	29.3	20.1	22.1	24.8	27.4	15.4
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	32.4	28.2	27.1	26.3	39.4	24.2	32.5	34.1	40.7	39.1	31.2	33.7	20.9	23.0	39.2	30.7	26.1	34.4	35.1	25.6	25.6	26.7	23.0	25.7	26.4	27.5	29.6	35.8	43.5	41.8	36.8	26.2	30.7	34.1	39.0	28.0	28.8	34.0	35.6	44.7	29.2	26.7	37.7	27.3	26.9	30.5	28.6	21.5	33.2	26.1	21.8	33.7	42.6	25.4	7.6	5.0	8.4	4.4	6.7	6.6	2.8	30.8	32.5	29.3	30.0	29.7	24.1	31.6	30.5	27.4	27.9	27.4	30.5	20.5	43.2	11.9	34.0	24.8	33.0	27.0	37.0	12.7	21.7	32.5	31.5	37.0	29.3	37.6	22.3	30.6	25.8	25.2	30.7	27.6	36.1	18.3	28.3	25.2	35.9	21.0	27.9	17.4	31.4	50.3	22.1	25.5	36.5	18.5	35.0	23.0	41.5	25.9	28.4	31.1	29.3	41.3	25.2	16.7	35.7	20.6	16.4	39.8	21.2	20.9	21.6	2.6	3.9	8.4	6.2	3.2	6.6	4.1	5.2	6.1	5.0	7.6	6.6	6.4	2.9	6.7	4.4	3.0	3.1	2.8	27.1	39.4	34.1	40.7	25.6	26.7	29.6	35.8	34.1	21.5
DDX46	"FLJ25329, KIAA0801, Prp5, PRPF5"	ENSG00000145833	"DEAD-box helicase 46"	Q7L014	5	134758771-134855133	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036554, HPA057501"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA036554: AB_10673621, HPA057501: AB_2683449"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (9.01e-6)"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.50e-2)"	22.2	21.8	18.8	29.4	23.8	22.7	22.7	39.0	24.8	25.1	21.4	17.5	18.6	19.0	26.8	19.8	23.7	21.0	15.8	18.3	17.7	13.0	22.9	22.7	21.6	26.6	22.9	15.1	25.8	24.2	27.2	37.5	22.1	21.7	19.0	24.2	12.8	23.9	23.3	46.6	26.3	23.0	24.6	27.8	30.0	22.2	17.8	25.9	40.4	22.1	21.0	29.1	23.1	28.9	27.0	23.5	34.6	19.9	19.4	20.4	9.7	25.7	23.6	16.8	21.9	6.6	7.4	23.3	17.2	13.4	18.3	20.6	35.7	18.8	32.5	14.9	11.5	16.0	24.7	16.4	21.6	21.8	22.5	39.1	25.8	14.4	5.7	35.4	21.1	6.6	9.0	19.2	10.9	14.4	33.2	14.0	13.5	12.3	30.4	13.8	23.2	10.7	26.6	44.0	16.4	10.0	22.3	20.0	19.1	24.1	11.5	12.5	17.9	20.3	17.9	19.4	13.5	14.8	34.1	11.0	29.9	43.1	13.4	33.8	12.2	25.7	19.9	27.6	20.0	17.5	18.0	22.0	19.6	19.8	15.2	27.0	20.4	20.3	34.6	19.4	15.7	23.5	17.1	9.7	18.8	23.8	39.0	24.8	17.7	13.0	22.9	15.1	21.7	25.9
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli				Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	29.3	24.1	19.9	21.6	25.6	31.0	29.1	27.4	26.9	26.7	26.2	28.2	21.4	16.0	33.7	21.0	28.9	27.5	17.9	22.6	20.0	19.4	29.6	38.1	23.2	26.1	28.2	19.9	33.7	31.0	25.8	23.8	27.6	25.1	29.2	24.2	25.5	27.1	27.7	40.6	28.1	20.4	34.1	21.4	25.6	28.0	26.8	29.8	29.7	39.4	27.9	33.7	35.7	26.7	22.0	25.0	3.5	19.1	16.6	26.0	14.0	39.6	17.2	16.9	13.7	16.6	16.4	28.8	17.1	19.6	36.5	34.2	25.9	25.6	20.4	6.7	23.1	25.9	24.2	19.7	41.1	28.8	17.3	18.7	12.8	14.7	14.1	21.2	12.0	15.8	18.7	21.6	17.9	28.0	18.0	4.6	19.9	14.2	17.2	14.7	74.0	10.5	19.1	32.8	12.3	22.2	28.6	7.4	18.8	20.7	13.3	17.0	5.4	16.1	12.5	14.7	35.8	9.4	25.6	6.5	11.8	37.0	15.7	11.1	16.9	3.3	14.4	3.5	21.8	19.1	26.0	22.0	19.4	20.1	25.0	21.2	25.8	24.2	1.7	16.6	18.2	14.7	18.7	14.0	19.9	25.6	27.4	26.9	20.0	19.4	28.2	19.9	25.1	29.8
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64499616-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043"	Supported		Enhanced	Nucleoplasm			150000	Nucleoplasm		"CAB005868: AB_446484, HPA020043: AB_1847572"	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	91.6	61.4	46.9	80.0	68.0	108.3	94.7	61.6	58.9	81.6	81.1	53.3	104.2	27.4	106.7	94.5	64.5	96.9	101.4	53.9	48.5	30.6	53.1	68.0	84.8	70.9	62.8	44.1	74.0	49.3	88.9	110.5	56.6	73.1	59.5	55.4	50.9	62.2	103.6	77.6	59.7	54.7	113.1	71.0	67.6	69.0	39.7	57.8	82.1	81.1	77.7	69.3	91.0	63.9	46.9	59.6	66.4	66.2	40.3	60.8	109.8	54.0	20.4	61.8	39.1	57.2	53.9	39.3	53.6	69.2	65.7	65.9	22.1	33.1	79.3	30.7	70.4	32.2	66.5	61.7	74.4	28.1	47.7	51.6	15.5	16.9	41.9	65.6	55.0	60.7	53.3	60.1	46.9	70.2	40.8	67.8	50.6	32.2	137.1	19.1	36.0	63.0	85.9	65.2	55.8	40.3	25.9	43.4	72.9	52.0	50.5	65.3	47.3	36.9	49.3	40.0	44.7	43.1	55.5	37.9	74.6	140.0	42.4	32.3	47.1	66.4	62.5	66.4	53.7	56.9	60.8	46.9	42.9	51.7	59.6	46.8	44.5	43.1	37.8	40.3	66.2	37.0	50.2	109.8	46.9	68.0	61.6	58.9	48.5	30.6	62.8	44.1	73.1	57.8
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901278-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA037388: AB_10671752, HPA037389: , HPA058196: "	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	25.0	17.8	16.7	25.5	19.2	14.7	24.8	20.8	17.0	26.5	25.3	13.1	24.0	12.9	30.0	22.6	24.0	23.0	17.5	20.3	15.7	15.0	18.6	16.1	16.4	24.5	17.6	15.0	35.3	24.1	24.9	35.2	23.0	16.1	30.0	18.1	12.6	19.5	25.0	26.6	18.3	17.4	31.9	18.3	22.0	19.9	25.6	17.3	33.0	26.1	21.5	25.7	35.4	27.2	14.2	10.3	10.7	12.2	13.8	20.2	10.9	19.3	12.5	22.2	27.5	18.9	24.7	14.2	20.7	22.8	18.7	17.7	28.0	16.9	25.2	12.5	18.2	17.4	21.5	15.2	23.4	22.1	16.3	13.5	12.4	12.2	19.1	28.1	16.9	19.0	15.9	17.8	49.8	15.0	24.1	15.4	23.0	15.5	26.8	27.0	12.9	28.1	23.3	25.3	4.5	14.7	11.6	15.5	21.4	15.2	17.8	22.8	20.7	18.3	13.0	14.6	17.1	16.5	28.1	20.9	18.8	21.4	15.7	29.4	8.5	5.5	7.8	10.7	15.0	12.2	18.3	13.6	18.5	15.4	10.3	14.2	20.2	17.7	2.7	13.8	9.6	10.2	16.1	10.9	16.7	19.2	20.8	17.0	15.7	15.0	17.6	15.0	16.1	17.3
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643464	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA056173: "	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	6.4	4.5	4.3	5.3	5.5	9.1	4.6	8.1	6.5	6.9	6.1	4.8	5.0	5.9	7.8	10.7	6.7	3.5	5.0	3.0	4.5		9.4	7.1	4.2	5.1	5.4	3.1	6.3	4.4	6.2	8.8	5.8	6.5	6.1	6.0	4.0	4.1	4.8	6.7	6.0	10.6	4.8	6.2	5.7	4.8	4.8	4.9	8.7	5.7	5.8	6.1	6.0	6.9	4.0	5.7	3.5	4.2	3.5	4.7	1.5	4.7	9.8	1.0	9.7	5.5	4.9	4.2	6.5	5.8	8.5	8.3	5.0	1.8	2.7	4.5	4.3	4.4	10.8	7.1	11.4	6.5	12.2	6.0	6.2	4.0	5.4	7.7	3.2	5.1	7.2	5.5	6.9	9.8	0.8	1.8	5.0	1.5	11.7	4.0	5.5	0.4	7.5	8.5	5.0	9.7	5.4	7.2	5.8	7.7	1.8	4.7	3.4	6.0	6.5	7.0	4.3	3.5	7.3	2.3	3.8	5.4	5.7	4.9	5.5	3.4	3.2	3.5	4.2	4.2	3.3	3.6	4.0	3.5	2.3	4.0	3.4	4.7	2.8	3.5	2.4	5.7	3.1	1.5										
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999961-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 11.5"	"Cell line enhanced"	"Detected in some"		"K-562: 6.2;RPMI-8226: 3.2;U-2197: 2.1;U-266/84: 14.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620941	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039962: , HPA044101: "	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavourable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	15.0	13.5	12.3	16.4	14.0	27.7	16.3	21.4	13.9	13.0	13.2	15.7	16.2	12.0	14.7	13.2	14.2	15.0	11.8	8.8	11.4	10.9	10.2	17.8	11.2	19.9	15.6	10.3	17.5	25.9	13.8	20.3	12.3	14.4	14.4	14.5	11.9	15.2	12.6	12.6	21.4	12.9	11.9	10.5	18.8	11.6	11.2	14.8	16.9	12.2	12.5	16.5	11.9	23.1	13.4	12.8	7.3	10.0	12.2	15.7	8.5	10.0	14.2	10.9	11.0	9.4	7.5	16.5	12.4	4.6	11.1	7.7	16.1	7.3	14.8	10.0	5.4	12.3	16.6	9.2	13.0	11.1	15.1	20.0	15.7	11.9	7.1	24.6	15.8	6.2	9.8	13.1	15.3	7.9	20.4	7.9	7.8	10.3	24.1	33.5	16.9	14.2	18.2	11.7	9.7	7.8	17.4	13.0	10.8	10.1	13.1	16.9	23.4	16.0	8.1	9.6	12.6	15.6	15.3	14.6	18.0	26.9	9.1	17.7	16.3	2.8	9.2	7.3	12.0	10.0	12.7	13.4	11.6	12.5	7.5	11.3	15.7	14.7	5.6	12.2	5.9	12.8	9.1	8.5	12.3	14.0	21.4	13.9	11.4	10.9	15.6	10.3	14.4	14.8
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565417-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	Nucleoli				Nucleoli		"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavourable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.8	12.0	10.3	12.4	11.9	12.4	9.2	13.6	18.9	11.9	10.0	12.2	8.6	11.9	12.8	10.3	13.1	12.6	12.5	9.3	10.6	9.9	17.7	29.2	8.9	13.2	10.4	9.3	15.0	22.5	13.1	11.9	12.3	12.2	14.1	9.0	11.0	16.9	11.5	16.9	16.3	11.4	8.4	8.8	12.1	10.6	14.6	10.9	14.5	13.8	16.7	15.1	9.2	10.3	12.8	16.0	6.9	16.5	15.7	12.3	12.7	7.6	20.4	1.5	4.4	2.0	2.0	6.8	7.2	3.7	8.2	7.3	13.2	7.5	13.5	9.4	2.7	13.1	3.3	7.2	1.5	5.0	20.7	8.8	12.9	10.0	3.5	9.3	4.9	2.9	5.2	7.3	4.6	4.2	18.2	3.8	5.3	10.0	4.6	8.6	11.1	19.2	3.8	7.2	5.3	4.7	8.1	5.2	8.4	9.6	14.9	5.5	10.8	9.6	8.8	6.8	9.8	4.6	18.2	12.4	18.9	19.3	7.5	11.4	9.5	6.9	11.8	4.3	9.9	15.3	12.3	11.5	10.7	11.1	16.0	12.8	12.3	10.3	0.4	15.7	16.5	7.7	10.1	12.7	10.3	11.9	13.6	18.9	10.6	9.9	10.4	9.3	12.2	10.9
DDX6	"HLR2, RCK"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747766-118791149	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"				"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	29.8	23.0	25.0	24.1	41.0	43.3	25.1	41.9	39.2	26.9	23.2	29.4	14.5	17.1	30.1	22.9	31.8	23.4	17.5	26.8	25.5	25.1	22.8	24.6	23.4	32.2	21.9	27.1	38.2	27.9	30.9	43.2	26.1	29.6	24.9	20.8	25.4	26.8	22.9	43.8	23.9	24.1	27.8	30.4	30.6	21.2	19.9	24.0	46.0	27.9	19.4	42.8	33.0	25.7	12.2	6.5	17.8	10.3	7.2	12.6	5.7	11.7	16.0	25.8	25.4	22.6	23.3	16.9	15.9	20.9	14.8	14.1	23.3	18.1	26.9	16.7	26.0	18.8	30.1	23.2	23.9	20.2	6.0	51.8	10.3	18.9	15.0	37.1	20.0	24.6	17.1	21.9	35.7	23.6	23.8	39.1	20.9	32.0	27.0	17.2	18.3	11.8	29.8	20.8	21.5	17.3	30.4	17.1	23.6	30.0	24.1	9.5	28.2	14.6	26.9	24.6	13.5	14.0	16.0	12.2	15.8	32.1	9.8	17.9	21.0	10.5	4.1	11.6	10.1	5.7	12.6	11.4	9.9	10.4	4.7	12.2	12.4	10.8	17.8	7.2	10.3	6.5	8.9	5.7	25.0	41.0	41.9	39.2	25.5	25.1	21.9	27.1	29.6	24.0
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216293-168318807	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 22.5;BJ hTERT+ SV40 Large T+ RasG12V: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"				Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavourable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	18.0	8.3	4.1	18.5	5.0	4.4	9.0	1.3	3.8	11.4	14.8	4.3	5.1	8.8	10.8	15.2	10.7	8.1	11.5	8.5	3.7	3.5	10.0	8.8	21.6	18.7	4.2	3.2	20.3	5.5	8.8	6.7	25.5	5.6	11.6	14.3	9.0	15.6	6.2	5.6	7.9	16.7	11.2	6.1	18.9	29.2	5.7	3.9	23.2	14.5	6.0	9.3	8.2	7.2	4.1	2.5	3.2	6.3	7.6	10.0	3.5	5.5	1.2	2.8	1.1	2.1	7.7	3.1	1.8	13.5	22.5	21.8	0.0	12.2	0.0	1.1	3.0	4.6	0.3	4.5	6.5	4.3	0.5	8.7	4.8	0.0	10.1	3.2	2.2	6.9	1.9	5.7	1.3	8.4	0.0	1.6	2.8	0.3	4.9	2.4	0.5	1.6	3.3	1.4	0.1	6.6	3.4	0.6	0.6	3.5	0.9	13.6	0.9	4.1	5.6	1.4	1.4	0.5	1.4	1.0	0.2	0.0	4.3	3.8	3.9	3.2	2.8	2.6	8.5	5.1	10.0	4.1	6.7	8.0	2.5	3.3	6.8	8.5	2.8	7.6	6.3	0.2	5.5	3.5	4.1	5.0	1.3	3.8	3.7	3.5	4.2	3.2	5.6	3.9
DEAF1	"NUDR, SPN, ZMYND5"	ENSG00000177030	"DEAF1, transcription factor"	O75398	11	644233-706715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030302	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"	"Intracellular and membrane"			Nucleoplasm	"Nucleoli fibrillar center"	"HPA030302: "	"unprognostic (1.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.90e-2)"	"prognostic unfavourable (9.70e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.15e-2)"	4.8	5.9	36.1	6.5	19.9	4.5	16.9	19.4	26.2	5.4	4.3	5.3	5.2	4.8	7.5	6.3	6.8	9.8	6.0	8.3	30.2	15.7	4.5	2.8	5.3	4.4	18.3	3.4	6.0	13.2	5.9	14.5	5.2	9.7	6.7	2.2	3.6	11.8	4.7	7.8	6.6	4.0	7.2	8.1	4.0	7.2	5.7	9.8	15.2	12.0	2.7	5.3	7.0	20.3	1.2	4.4	3.3	3.0	3.5	5.9	1.6	7.3	4.5	7.3	3.9	7.1	9.4	5.7	5.4	7.1	11.7	8.5	4.8	6.3	2.1	6.0	5.4	4.9	7.0	5.0	1.7	9.0	41.4	4.9	2.5	3.7	12.9	10.8	8.0	7.9	6.9	2.1	5.9	9.2	10.9	8.7	4.4	3.7	4.0	9.9	17.0	9.5	9.9	2.5	8.1	8.2	0.9	10.4	10.9	4.0	5.9	3.9	3.6	3.1	10.6	3.8	2.1	1.6	4.7	9.6	3.5	3.8	4.4	7.2	7.5	0.0	3.0	3.3	2.4	1.7	2.6	1.2	4.7	2.7	4.4	0.8	5.9	3.2	1.8	3.5	1.9	0.5	1.7	1.6	36.1	19.9	19.4	26.2	30.2	15.7	18.3	3.4	9.7	9.8
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 129.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol			740000	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavourable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.3	5.9	17.4	19.7	12.2	19.9	3.7	9.1	15.7	5.9	9.3	2.3	10.3	7.9	7.2	10.9	7.8	6.4	9.2	9.9	11.9	0.7	19.0	5.3	9.4	15.3	4.1	3.9	15.7	7.1	4.7	8.0	17.7	19.7	15.7	28.5	11.9	11.8	6.1	1.1	17.8	10.0	4.6	14.1	29.2	26.0	0.7	6.6	13.8	129.9	10.9	16.6	10.7	15.9	10.1	4.8	13.3	5.4	7.9	6.0	9.3	9.6	9.4	12.8	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6, guanine nucleotide exchange factor"	Q9H4E7	6	35297852-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 51.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.8;MOLT-4: 23.8;NB-4: 31.8;REH: 22.0;THP-1: 25.5;U-937: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favourable (3.02e-6)"	"prognostic favourable (1.08e-4)"	"prognostic unfavourable (1.71e-4)"	"prognostic favourable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavourable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	2.9	2.0	4.5	34.8	4.6	30.3	3.4	0.9	3.1	4.3	4.7	6.9	4.7	5.3	3.1	11.1	15.3	2.7	6.8	2.6	3.8	2.7	3.1	2.5	7.5	42.7	5.3	1.0	2.0	16.5	0.7	5.1	4.2	4.8	10.6	4.0	2.9	14.1	6.7	0.9	14.4	15.2	2.4	7.1	32.6	8.3	6.7	5.0	42.6	4.7	9.3	51.7	6.7	8.6	13.9	21.0	43.5	13.8	25.9	31.5	20.7	7.6	0.0	0.2	0.2	0.0	0.1	9.7	0.8	1.2	0.2	0.2	0.4	3.3	9.1	2.8	0.4	5.0	0.0	6.4	0.1	0.3	0.3	10.2	0.1	4.0	0.2	18.3	13.4	1.5	8.2	0.1	7.4	0.0	4.5	21.8	0.0	3.9	23.8	31.8	0.4	0.9	22.0	0.2	12.2	0.8	5.8	0.1	0.0	0.6	1.9	1.7	5.3	25.5	1.2	0.1	0.2	0.0	0.1	12.5	11.5	7.5	0.0	38.2	0.0	16.3	13.8	43.5	31.5	11.0	25.8	13.9	25.7	31.0	21.0	12.5	27.1	26.1	26.7	25.9	9.9	13.9	26.9	20.7	4.5	4.6	0.9	3.1	3.8	2.7	5.3	1.0	4.8	5.0
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 164.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria				Mitochondria		"HPA076422: "	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavourable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavourable (2.53e-4)"	19.2	10.7	14.7	14.1	15.7	20.0	28.6	11.9	17.8	17.8	17.0	19.9	15.8	15.0	17.2	13.4	16.1	13.1	13.5	16.6	15.1	16.4	12.8	17.3	16.1	24.5	22.0	17.4	14.4	9.3	11.8	15.1	40.1	17.9	27.6	9.4	15.9	14.8	20.1	7.6	164.4	12.1	23.3	22.1	13.0	14.6	9.2	19.3	7.7	19.7	12.3	15.7	15.5	24.9	31.7	39.5	43.6	25.7	16.1	24.4	16.8	14.8	10.5	13.9	10.2	60.2	38.9	10.7	41.5	46.7	29.2	35.0	9.6	11.4	11.8	54.0	37.5	15.7	16.1	14.1	32.4	17.2	28.7	8.5	11.5	5.8	36.6	17.0	18.4	38.7	31.6	26.8	15.1	28.7	12.5	13.0	37.3	5.4	8.6	9.2	17.2	15.5	7.9	19.6	7.6	37.0	4.0	9.0	14.5	22.1	34.8	21.9	11.8	24.8	26.1	28.0	8.9	32.2	40.4	9.3	11.0	10.8	30.2	8.5	31.4	32.3	22.3	43.6	12.7	25.7	24.4	23.9	21.5	17.5	39.5	31.7	17.1	15.0	26.1	16.1	17.4	13.2	22.0	16.8	14.7	15.7	11.9	17.8	15.1	16.4	22.0	17.4	17.9	19.3
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223868-18264823	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015226, HPA054505, HPA057799"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB015226: , HPA054505: , HPA057799: "	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	30.9	20.0	22.9	41.8	29.5	50.8	28.9	41.5	30.2	31.0	35.8	11.4	24.0	28.2	32.9	19.7	31.0	23.8	19.2	33.5	26.8	14.1	19.3	23.8	29.2	42.7	30.7	17.6	28.3	19.3	20.5	27.8	24.3	27.7	33.9	29.9	11.0	26.8	21.4	40.2	23.2	35.9	51.3	28.1	29.8	24.2	12.6	32.9	58.8	44.9	33.9	38.4	45.1	43.3	40.0	40.2	57.7	49.3	34.0	46.3	35.0	59.7	17.6	46.7	38.9	9.4	16.4	27.1	55.1	30.5	49.8	67.5	28.8	22.5	68.1	58.5	24.8	35.9	34.5	27.3	83.8	45.8	33.0	42.1	31.7	33.6	9.2	64.1	34.3	8.1	13.6	34.3	27.1	23.8	51.1	0.0	31.7	21.5	46.2	28.8	28.6	19.7	61.6	62.0	39.9	24.0	34.6	28.6	26.3	49.7	43.2	30.1	38.9	26.4	24.1	58.4	32.4	32.5	68.6	4.2	10.0	71.8	13.9	32.7	54.0	51.1	49.3	21.9	41.4	39.3	46.3	40.0	42.1	42.5	40.2	33.2	33.5	32.0	57.7	34.0	43.9	31.0	40.6	35.0	22.9	29.5	41.5	30.2	26.8	14.1	30.7	17.6	27.7	32.9
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favourable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	11.4	12.2	17.4	13.9	19.8	32.5	10.0	18.6	21.2	10.9	14.8	12.8	10.3	15.8	13.3	9.0	11.3	13.0	10.5	10.3	15.9	12.8	16.4	14.5	9.4	11.6	11.8	14.9	12.0	8.9	20.1	19.0	23.9	13.9	11.0	14.1	14.5	8.5	11.8	11.0	9.3	17.2	14.4	10.1	20.2	9.9	12.1	13.2	10.6	15.5	5.6	9.5	10.6	17.4	1.5	8.4	11.2	15.2	0.5	1.3	3.2	14.7	8.7	7.9	14.9	5.4	8.5	36.6	14.4	21.7	12.3	10.6	11.9	6.6	11.9	3.0	11.6	8.4	6.7	10.4	12.0	5.0	5.1	5.6	21.2	8.7	7.2	6.7	3.8	7.8	9.4	10.1	17.4	10.9	15.3	9.1	9.9	8.4	8.0	9.7	15.7	13.3	12.4	7.7	10.1	6.1	5.2	16.8	13.6	11.6	7.7	8.9	10.5	17.0	5.0	13.3	5.1	15.4	7.5	14.0	10.8	8.2	11.1	13.4	8.7	11.2	15.2	2.8	1.3	10.1	0.7	1.1	0.9	0.6	8.4	1.5	0.6	0.7	9.3	0.5	8.2	1.3	0.4	3.2	17.4	19.8	18.6	21.2	15.9	12.8	11.8	14.9	13.9	13.2
DENND1B	"C1orf218, FAM31B, FLJ20054, MGC27044"	ENSG00000213047	"DENN domain containing 1B"	Q6P3S1	1	197504748-197775696	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042586	Uncertain		Supported	"Nuclear speckles,Cytosol"				Cytosol	"Nuclear speckles"	"HPA042586: "	"unprognostic (8.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.54e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-2)"	5.9	3.9	6.2	12.7	8.3	6.4	8.7	3.9	5.6	5.7	13.0	1.4	8.8	7.5	3.6	6.4	9.0	3.1	5.4	7.3	4.9	4.9	7.9	6.6	7.3	7.8	4.0	2.7	5.6	8.7	9.9	15.9	3.6	3.7	7.5	7.8	6.4	9.9	15.8	6.5	3.8	21.6	4.1	3.5	7.7	6.1	4.4	2.6	17.9	8.2	6.5	11.7	6.9	6.8	2.3	2.0	5.0	0.6	5.8	3.6	0.7	5.9	1.5	1.7	2.9	0.8	4.4	2.7	4.6	3.2	2.8	1.7	1.6	3.8	10.9	2.4	7.0	3.1	2.7	3.3	2.5	8.2	2.9	3.9	3.0	0.7	2.4	12.8	4.9	1.5	4.5	1.1	3.2	1.2	3.0	16.9	2.8	1.1	6.8	6.6	0.6	1.5	4.2	1.5	8.5	7.0	5.6	2.9	4.6	7.1	4.8	1.2	2.0	11.2	3.4	0.3	2.8	0.1	2.7	8.6	0.0	5.5	3.0	5.2	5.3	5.0	0.3	2.3	2.1	0.6	1.1	2.3	1.4	3.3	1.5	0.7	0.8	1.5	1.0	5.8	0.6	2.0	3.6	0.7	6.2	8.3	3.9	5.6	4.9	4.9	4.0	2.7	3.7	2.6
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946696	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: "	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavourable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favourable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	14.5	9.6	14.4	21.5	13.6	30.7	9.9	23.5	19.7	8.6	8.3	11.9	3.1	9.2	10.3	7.9	7.7	8.8	9.9	12.4	10.5	9.8	8.6	7.9	14.2	25.8	12.5	8.5	12.4	11.0	8.5	8.3	10.1	12.6	7.9	6.3	8.0	10.2	7.6	40.6	8.6	12.7	8.8	9.3	25.9	9.2	5.5	12.9	15.7	9.4	5.9	21.1	10.7	7.7	3.0	4.8	3.9	6.2	2.0	3.9	3.0	5.8	11.3	8.8	8.8	5.3	5.1	9.1	5.8	6.3	9.2	8.6	6.8	6.8	14.8	9.9	3.9	10.5	7.9	5.3	4.1	13.4	7.1	13.0	11.8	6.5	7.3	13.6	26.5	4.6	9.4	8.5	9.2	6.5	13.8	8.3	5.2	12.1	16.5	12.6	12.2	11.1	17.7	5.9	8.4	4.4	8.8	10.4	12.8	6.1	14.5	8.2	10.4	33.7	6.7	9.9	9.7	8.2	9.2	25.3	17.8	19.5	6.8	10.8	11.8	2.5	3.8	1.1	3.3	6.2	3.9	2.9	2.6	1.9	3.7	3.0	1.3	2.8	3.9	2.0	4.9	4.8	1.7	3.0	14.4	13.6	23.5	19.7	10.5	9.8	12.5	8.5	12.6	12.9
DENND4C	"bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF"	ENSG00000137145	"DENN domain containing 4C"	Q5VZ89	9	19230435-19373545	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014917, HPA015096"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles, Cytosol"		"HPA014917: AB_2261659, HPA015096: AB_1845831"	"unprognostic (4.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"prognostic favourable (3.51e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	31.5	14.0	7.4	11.2	9.4	5.8	17.8	17.7	10.4	18.8	17.9	7.3	17.5	17.4	15.0	12.7	15.8	12.5	9.9	13.7	8.0	5.7	10.2	10.1	16.3	7.2	9.1	6.7	16.3	16.0	16.9	18.2	14.6	8.4	14.9	14.5	10.4	16.9	12.2	11.5	20.5	18.4	19.1	8.9	9.8	13.8	9.0	9.6	14.3	12.9	8.3	11.0	22.3	17.7	3.0	4.0	8.5	2.1	8.1	10.2	3.4	11.6	10.9	7.9	10.2	17.3	21.0	14.4	6.7	10.1	7.1	9.5	5.4	7.7	4.9	5.6	8.8	6.3	9.2	5.6	8.7	32.5	5.2	22.6	12.6	6.3	8.6	5.2	12.9	8.2	12.8	6.2	10.6	13.2	6.1	5.7	9.0	4.4	9.2	11.6	5.9	5.5	8.3	4.6	7.1	18.7	22.4	8.0	5.9	6.0	13.5	4.7	8.3	7.1	12.3	6.3	3.5	6.9	6.9	3.9	9.4	2.6	5.2	5.1	3.5	8.5	2.1	2.5	7.8	1.1	10.2	2.5	6.7	7.8	4.0	3.0	6.1	7.3	1.1	8.1	1.1	4.0	4.8	3.4	7.4	9.4	17.7	10.4	8.0	5.7	9.1	6.7	8.4	9.6
DENND6A	"AFI1A, FAM116A, FLJ34969"	ENSG00000174839	"DENN domain containing 6A"	Q8IWF6	3	57625457-57693089	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062618, HPA069725, HPA071711"	Approved		Supported	Vesicles				Vesicles		"HPA062618: , HPA069725: , HPA071711: "	"unprognostic (6.20e-2)"	"unprognostic (3.86e-2)"	"prognostic favourable (9.21e-4)"	"unprognostic (1.76e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (6.36e-4)"	"unprognostic (7.16e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.12e-1)"	"prognostic favourable (7.77e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.94e-1)"	18.6	12.0	8.6	16.7	12.4	15.0	18.1	18.6	12.8	19.8	16.9	15.3	15.3	9.7	23.7	16.8	16.1	16.3	13.7	11.4	9.3	9.7	14.6	10.5	15.1	20.9	10.7	10.6	29.8	10.5	16.1	17.2	16.0	12.1	15.3	13.0	21.4	14.8	17.2	22.0	14.2	16.9	22.3	12.2	21.8	13.8	11.3	9.6	23.0	19.6	11.3	19.8	18.2	17.4	1.7	1.5	13.5	1.6	2.4	4.4	1.0	12.0	9.9	13.3	8.2	7.1	8.1	7.6	6.3	8.0	7.8	6.2	6.3	13.5	14.2	2.7	6.5	6.4	10.6	13.3	6.6	3.6	9.5	11.2	10.7	4.8	6.9	8.5	6.6	8.6	9.7	5.3	14.1	11.1	7.6	15.7	5.6	5.2	18.4	10.6	7.6	6.8	7.8	7.9	10.5	9.6	20.4	4.6	16.5	12.4	10.4	9.0	6.7	10.5	12.2	9.6	5.1	10.1	16.3	11.7	15.0	14.9	11.2	14.4	13.9	13.5	1.2	1.6	3.2	1.3	3.6	1.1	2.9	3.0	1.5	1.7	4.4	3.2	2.0	2.4	1.6	1.2	1.5	1.0	8.6	12.4	18.6	12.8	9.3	9.7	10.7	10.6	12.1	9.6
DEPDC1	"DEP.8, DEPDC1A, FLJ20354, SDP35"	ENSG00000024526	"DEP domain containing 1"	Q5TB30	1	68474152-68497221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"GTPase activation, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.6;testis: 19.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017845	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"CAB017845: "	"unprognostic (2.73e-1)"	"unprognostic (7.40e-2)"	"prognostic favourable (8.70e-5)"	"unprognostic (1.23e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.73e-3)"	"unprognostic (4.37e-6)"	"unprognostic (3.39e-3)"	"unprognostic (1.57e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.04e-6)"	"unprognostic (2.18e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-1)"	1.3	0.8	0.7	12.1	0.5	5.1	1.9	0.3	0.7	1.2	3.3	0.1	0.5	2.9	0.5	0.7	6.5	0.6	0.3	1.3	2.1	0.6	0.7	0.8	2.0	5.5	0.5	0.2	0.6	0.5	0.3	0.4	7.4	0.3	2.5	4.3	0.5	1.3	0.0	0.4	1.7	3.7	1.5	0.4	3.1	1.4	19.5	0.0	28.6	0.5	5.4	5.7	1.5	2.0	0.3	0.0	0.0	0.0	0.8	2.6	0.3	15.5	7.2	13.8	6.3	0.9	2.0	10.8	20.0	9.2	17.0	14.8	5.9	6.5	0.0	14.9	8.2	10.5	20.0	10.4	28.9	13.6	13.1	12.7	12.8	3.4	0.2	10.9	0.0	0.7	0.5	19.5	10.9	12.3	8.6	12.4	30.3	3.5	0.0	4.1	11.8	9.8	0.0	41.1	5.1	6.9	4.2	15.5	7.2	20.0	8.5	10.4	7.7	5.5	7.2	11.0	12.6	19.4	23.1	7.8	16.7	0.1	10.4	3.8	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.6	0.3	0.7	0.5	0.3	0.7	2.1	0.6	0.5	0.2	0.3	0.0
DEPP1	"C10orf10, DEPP, FIG, Fseg"	ENSG00000165507	"DEPP1, autophagy regulator"	Q9NTK1	10	44970981-44978810	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 204.9;breast: 227.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.4;HDLM-2: 23.9;HHSteC: 62.2;HSkMC: 48.4;HUVEC TERT2: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013687, HPA037818, HPA037819"	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"			Mitochondria	Vesicles	"CAB013687: , HPA037818: , HPA037819: "	"unprognostic (3.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.89e-2)"	"prognostic unfavourable (2.29e-6)"	"unprognostic (2.30e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.74e-1)"	204.9	14.6	8.7	14.1	16.8	2.4	227.9	10.8	19.7	14.1	36.5	2.9	10.0	7.4	25.0	14.9	23.5	25.5	28.0	37.0	8.5	6.0	13.0	48.2	70.7	20.6	9.4	3.3	51.2	107.1	4.7	12.2	33.4	21.6	25.8	5.7	12.1	16.2	13.0	81.0	19.6	9.9	30.2	39.0	9.5	12.7	31.9	11.0	0.8	33.3	13.4	19.1	52.1	27.6	0.0	3.7	1.2	0.3	0.0	0.7	1.4	6.7	0.0	0.1	0.0	34.4	16.8	1.7	0.0	2.3	0.1	0.4	0.2	2.5	0.0	0.3	3.0	0.2	0.2	2.0	0.1	23.9	0.9	0.0	0.0	2.4	62.2	0.0	0.0	48.4	0.1	0.0	0.3	38.3	0.0	14.7	0.1	0.0	0.0	0.3	0.0	0.2	1.1	0.4	5.6	0.1	2.4	1.3	0.0	0.0	0.3	1.3	0.0	1.6	0.3	1.8	1.3	0.1	1.6	0.4	0.6	0.0	10.4	0.6	0.9	0.0	0.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.5	0.0	0.1	3.7	0.0	1.4	8.7	16.8	10.8	19.7	8.5	6.0	9.4	3.3	21.6	11.0
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 67.6;skeletal muscle: 65.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 29.8;RPMI-8226: 53.0;RPTEC TERT1: 43.9;U-698: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 17.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 17.1"	"Low region specificity"	"Detected in all"							"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	8.1	30.2	6.4	5.2	11.0	1.1	9.7	5.1	9.2	18.9	12.7	17.8	5.7	7.8	16.0	5.7	7.2	12.7	6.1	4.3	7.3	6.3	22.7	7.5	2.7	8.5	9.5	6.1	12.5	5.6	13.3	13.6	4.4	7.5	6.4	4.8	0.7	67.6	7.9	65.0	4.3	7.4	7.7	8.2	5.3	20.0	2.1	11.5	0.7	45.0	20.7	2.7	4.8	5.7	0.1	17.1	0.3	1.5	0.3	0.8	0.8	0.0	1.0	0.1	0.3	6.3	1.9	0.1	0.0	0.1	0.1	0.1	0.7	0.1	29.8	0.7	0.3	0.1	1.6	0.0	0.1	0.6	0.8	4.0	0.2	0.1	3.8	0.8	6.9	1.7	2.8	0.2	0.1	0.0	0.0	4.9	0.1	2.0	0.0	0.7	0.4	1.0	0.1	1.4	53.0	43.9	1.2	0.9	0.2	0.5	3.2	0.9	2.8	0.1	0.0	0.1	0.2	6.3	0.1	13.2	3.1	15.6	1.9	1.1	0.2	0.0	0.8	0.0	0.2	1.5	0.7	0.1	0.3	0.6	17.1	0.1	0.8	0.5	0.3	0.3	0.1	0.8	0.3	0.8	6.4	11.0	5.1	9.2	7.3	6.3	9.5	6.1	7.5	11.5
DERA	"CGI-26, DEOC"	ENSG00000023697	"Deoxyribose-phosphate aldolase"	Q9Y315	12	15911172-16037282	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055897			Supported	Nucleoplasm			180000	Nucleoplasm		"HPA055897: "	"unprognostic (3.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.17e-2)"	"prognostic favourable (3.64e-5)"	"unprognostic (3.66e-2)"	20.3	12.0	10.5	10.8	10.8	7.5	11.5	5.2	7.7	11.3	30.3	11.4	12.7	20.2	21.5	14.7	20.0	8.2	11.1	11.7	10.1	9.1	40.9	51.5	13.6	14.1	12.5	6.5	5.8	16.9	6.6	27.5	12.3	11.3	9.2	21.2	11.0	11.4	11.3	15.3	12.4	46.7	10.4	14.6	14.6	10.5	5.5	11.0	13.8	26.6	16.7	14.3	10.1	13.1	12.4	30.2	14.1	28.2	17.1	14.9	15.7	19.9	16.5	13.0	11.4	8.8	20.2	26.6	11.7	11.0	15.9	20.5	19.9	37.1	13.6	10.4	14.9	14.2	14.1	15.0	28.3	22.8	8.2	12.0	8.3	18.7	12.7	12.7	8.2	13.4	17.4	13.0	26.7	22.9	1.7	4.2	29.0	7.3	9.4	10.6	28.4	8.2	14.4	28.6	8.5	39.9	7.2	9.5	16.0	22.0	7.3	22.9	39.7	15.9	22.6	17.0	11.2	7.7	12.4	4.5	6.6	23.5	21.8	12.8	12.5	5.4	24.4	14.1	7.2	27.1	7.9	12.4	7.8	7.7	30.2	11.4	8.6	6.9	6.5	17.1	28.2	16.5	14.9	15.7	10.5	10.8	5.2	7.7	10.1	9.1	12.5	6.5	11.3	11.0
DERL1	"DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577"	ENSG00000136986	"Derlin 1"	Q9BUN8	8	123013164-123042423	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 133.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016562, CAB037269"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB037269: AB_609868, HPA016562: AB_1847611"	"prognostic unfavourable (2.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (5.66e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.35e-1)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	31.2	34.3	12.7	24.5	14.6	43.4	31.6	18.6	19.5	17.3	23.9	16.6	21.4	22.9	21.3	17.0	23.4	17.5	20.2	23.8	11.7	12.4	25.4	73.3	23.4	42.3	14.1	11.5	23.5	33.6	11.7	23.0	25.0	14.9	16.4	21.5	17.9	21.9	24.4	48.0	16.3	32.6	16.9	14.4	35.3	18.1	22.4	13.0	17.9	25.2	20.9	31.2	23.3	18.3	34.0	26.6	32.8	35.1	34.6	47.3	35.1	20.1	15.0	9.0	11.7	16.3	12.3	7.4	17.0	11.6	11.3	14.0	9.5	20.3	23.3	21.3	14.0	17.0	8.4	11.0	16.1	27.1	9.4	24.3	10.4	7.9	14.9	9.4	18.2	11.1	14.4	12.3	14.9	10.0	14.4	31.1	12.6	40.2	10.3	5.9	6.8	13.5	10.7	7.4	39.1	28.7	14.5	9.8	14.4	17.2	133.0	10.8	15.6	8.6	11.5	13.5	25.4	11.9	15.8	39.3	65.7	21.0	22.3	11.8	12.6	27.3	28.8	32.8	45.1	35.1	47.3	34.0	30.6	37.1	23.4	26.2	21.6	33.3	19.8	34.6	34.2	26.6	36.6	35.1	12.7	14.6	18.6	19.5	11.7	12.4	14.1	11.5	14.9	13.0
DERL2	"CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa"	ENSG00000072849	"Derlin 2"	Q9GZP9	17	5471251-5486811	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB037287, HPA048957, HPA056551"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB037287: AB_1078641, HPA048957: , HPA056551: "	"unprognostic (2.54e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.83e-2)"	"prognostic favourable (7.26e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.91e-2)"	12.2	18.9	8.8	11.6	10.7	22.4	13.5	8.1	9.7	11.9	10.7	10.5	17.0	10.9	12.4	23.6	13.4	11.5	13.2	9.6	10.6	6.8	18.1	28.7	12.8	18.8	12.5	4.4	13.1	49.1	12.2	14.7	16.6	11.5	11.0	9.5	10.7	30.3	19.4	9.5	9.5	15.9	11.3	11.0	14.9	13.5	21.0	11.3	11.4	22.1	7.6	16.7	13.8	10.5	33.4	36.6	39.3	36.3	29.5	40.6	53.3	16.5	21.5	10.1	17.0	17.4	13.2	13.0	23.6	19.3	16.3	19.9	14.6	14.9	11.5	21.5	15.0	18.6	7.0	13.6	16.3	15.2	14.8	5.6	14.1	15.7	24.1	4.1	13.8	12.2	11.4	22.0	19.1	16.8	6.1	20.2	22.0	8.6	8.8	6.4	9.8	8.6	10.8	14.4	8.5	17.5	8.5	4.3	12.6	14.4	10.0	24.8	13.3	6.2	12.6	19.4	13.0	11.8	22.5	14.1	15.6	10.2	20.3	10.4	15.2	31.4	34.4	39.3	36.5	36.3	37.8	33.4	35.4	38.6	25.7	29.3	28.1	34.8	32.3	29.5	27.8	36.6	40.6	53.3	8.8	10.7	8.1	9.7	10.6	6.8	12.5	4.4	11.5	11.3
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426739	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 17.6;LHCN-M2: 35.2;RH-30: 81.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 45.7"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"			1300000	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	9.1	2.5	0.1	35.1	0.2	0.1	1.9	0.1	0.3	41.3	238.3	0.4	69.1	12.6	95.6	80.2	209.7	33.0	149.8	531.0	0.1	0.1	2.1	0.3	4.8	3.0	0.3	0.8	20.3	0.7	0.0	0.1	2.4	0.8	101.0	11.2	3.8	11.9	104.2	600.8	4.2	43.2	439.9	0.3	0.6	72.6	10.9	0.0	0.0	9.4	161.2	12.5	343.7	34.4	0.0	0.2	0.4	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.3	17.6	0.0	0.0	0.0	0.0	0.6	0.0	35.2	0.0	0.0	9.2	0.1	0.0	0.0	81.8	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.7	0.1	0.2	0.1	0.3	0.1	0.1	0.3	0.8	0.8	0.0
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472526	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	17.8	19.9	22.9	15.6	23.0	7.9	20.9	20.4	20.7	16.6	15.1	22.5	19.1	16.5	18.4	14.4	24.2	18.6	15.3	17.2	20.7	19.9	23.7	18.9	15.5	15.6	26.4	18.9	22.5	19.8	25.7	17.2	27.2	26.1	17.0	17.3	15.0	16.3	18.4	16.8	14.8	14.7	22.4	24.1	14.8	16.8	13.4	21.9	16.7	18.0	13.0	21.4	18.7	26.1	14.1	10.7	7.2	9.9	14.1	14.4	8.9	14.3	14.4	12.4	14.1	10.5	10.0	6.0	20.6	13.3	21.5	16.0	34.3	19.1	30.8	13.3	17.3	11.9	23.9	24.4	21.8	12.2	16.5	15.3	14.9	13.7	17.2	18.7	10.2	12.5	12.3	33.8	27.3	16.3	27.4	7.0	15.2	18.3	18.4	8.5	10.9	16.8	15.9	14.8	15.5	19.3	11.1	14.7	14.3	19.1	16.8	22.6	10.7	6.5	17.0	10.1	13.8	18.5	13.5	8.7	12.1	44.9	10.7	17.8	15.2	1.3	9.9	7.2	14.4	8.0	10.9	14.1	9.7	12.4	9.2	13.7	10.2	12.3	1.5	14.1	9.7	10.7	13.5	8.9	22.9	23.0	20.4	20.7	20.7	19.9	26.4	18.9	26.1	21.9
DGKD	"DGKdelta, KIAA0145"	ENSG00000077044	"Diacylglycerol kinase delta"	Q16760	2	233354507-233472104	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 22.1;U-698: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027530, HPA049101"	Approved		Supported	Cytosol				Cytosol		"HPA027530: , HPA049101: "	"unprognostic (1.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavourable (1.69e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (4.07e-8)"	"unprognostic (1.78e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.94e-3)"	5.9	3.6	10.0	10.9	12.4	26.3	5.3	34.3	7.9	3.7	7.8	8.9	12.4	8.1	5.8	12.6	2.7	5.5	8.0	6.4	9.6	4.3	3.1	3.3	9.3	14.0	11.7	4.3	8.6	3.0	2.3	3.7	8.9	7.2	6.0	8.4	6.2	4.9	8.0	25.4	2.9	10.9	7.3	11.1	10.3	19.4	17.4	8.3	4.5	7.6	1.3	13.5	5.6	10.1	6.6	1.0	5.9	2.0	1.8	3.4	2.5	3.2	8.0	4.7	3.0	2.2	2.2	7.2	1.9	1.7	1.8	1.9	13.8	3.2	5.8	1.0	3.0	3.2	5.1	2.3	3.0	8.7	4.8	8.1	22.1	4.7	2.8	7.0	8.8	3.1	4.9	2.3	4.4	2.0	5.7	1.3	1.9	3.1	5.7	7.3	2.5	4.5	11.4	8.7	4.7	1.4	3.8	7.2	5.2	6.5	3.5	3.4	1.5	12.5	1.9	3.9	7.2	2.3	5.8	4.7	2.9	22.4	3.4	10.9	3.0	1.7	2.0	5.9	3.3	0.8	1.6	6.3	1.0	2.9	1.0	6.6	2.3	3.4	2.0	1.8	1.4	0.6	0.5	2.5	10.0	12.4	34.3	7.9	9.6	4.3	11.7	4.3	7.2	8.3
DGKZ	"DAGK5, DAGK6, DGK-ZETA, hDGKzeta"	ENSG00000149091	"Diacylglycerol kinase zeta"	Q13574	11	46332905-46380554	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051336	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA051336: "	"unprognostic (2.85e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.66e-3)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (1.48e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.84e-3)"	8.6	6.7	34.5	11.8	27.4	28.0	6.8	22.6	50.7	7.5	7.4	8.5	2.5	21.0	6.1	4.3	7.1	6.3	6.7	16.0	48.0	9.2	5.3	3.3	8.3	20.7	9.4	26.7	5.0	17.3	7.0	18.6	8.4	7.5	5.9	4.2	4.8	24.1	7.0	42.8	8.3	23.2	5.6	7.2	15.6	9.9	5.0	7.5	14.2	4.1	9.1	9.9	7.6	5.0	0.9	12.3	11.2	11.8	7.7	7.5	8.1	11.7	10.5	7.1	10.7	3.8	4.2	33.2	9.2	6.9	9.8	8.6	12.5	5.5	15.1	6.7	9.5	13.7	8.6	13.3	3.5	15.1	20.0	9.9	7.7	9.1	6.8	18.6	19.9	5.7	6.3	5.3	7.3	10.7	13.8	9.4	6.9	31.0	17.9	29.2	20.8	16.2	21.4	12.4	6.4	3.0	11.6	49.0	8.3	10.5	35.3	7.2	25.4	23.5	12.0	12.9	14.0	20.3	16.5	6.2	7.0	12.4	17.6	16.9	11.9	11.2	11.8	5.8	7.5	6.1	4.5	0.4	4.7	6.3	12.3	0.9	4.9	5.0	9.8	7.7	5.9	5.9	4.5	8.1	34.5	27.4	22.6	50.7	48.0	9.2	9.4	26.7	7.5	7.5
DGLUCY	"C14orf159, FLJ39975"	ENSG00000133943	"D-glutamate cyclase"	Q7Z3D6	14	91060333-91225632	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 57.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041423, HPA052932"	Approved		Supported	Cytosol				Cytosol		"HPA041423: AB_10795540, HPA052932: "	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (4.28e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favourable (9.48e-5)"	"unprognostic (3.56e-1)"	"prognostic favourable (7.28e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.77e-15)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.57e-3)"	12.5	18.7	23.4	15.9	23.1	10.7	9.3	27.3	22.6	14.6	16.7	18.1	16.0	13.8	16.8	13.1	16.0	21.9	12.5	63.9	18.8	16.6	20.1	13.1	13.7	11.2	20.1	19.2	13.4	9.3	29.3	14.2	9.2	19.0	13.3	17.0	11.3	17.4	22.3	82.9	13.9	12.3	20.0	18.5	17.3	18.9	12.2	21.6	11.2	16.8	29.1	14.1	19.4	11.4	9.4	19.8	57.9	19.3	5.6	12.0	7.0	2.7	7.4	3.8	9.1	15.5	14.7	9.9	2.8	8.0	8.9	9.2	4.8	21.4	18.5	21.5	8.5	8.2	10.4	11.3	3.7	10.2	4.3	12.4	3.7	6.1	22.8	12.6	18.1	22.6	4.9	4.9	1.9	15.8	6.2	25.3	8.4	0.7	9.9	12.0	7.6	0.7	17.1	7.4	13.4	15.1	11.7	10.5	5.3	4.8	8.3	3.4	14.7	10.7	11.3	2.7	2.3	8.0	2.6	14.5	10.3	6.2	13.9	16.6	1.7	13.7	13.6	8.1	8.8	19.3	9.0	9.4	5.9	7.2	19.8	7.0	4.9	6.0	57.9	5.6	15.5	6.2	12.0	7.0	23.4	23.1	27.3	22.6	18.8	16.6	20.1	19.2	19.0	21.6
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	Cytosol	"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favourable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (5.67e-4)"	8.0	40.1	12.1	5.6	14.5	19.0	16.8	5.3	22.8	5.5	9.3	27.9	8.8	20.8	4.0	27.3	14.6	5.2	5.8	10.7	13.7	13.2	7.1	64.8	12.0	2.7	20.6	12.3	21.5	7.3	14.0	7.0	3.7	23.4	10.0	6.6	16.6	10.0	3.9	5.4	22.9	15.8	4.5	20.5	5.9	8.5	17.7	15.5	2.8	5.4	12.1	7.7	4.3	7.4	6.3	6.2	3.5	1.9	4.6	12.1	5.7	21.6	19.6	19.2	21.2	9.0	14.0	6.0	8.9	23.8	7.6	20.8	73.0	71.1	15.1	14.3	8.5	41.6	22.8	48.3	8.1	5.7	17.1	5.7	16.6	31.2	23.1	10.8	2.8	16.2	21.4	28.6	19.7	11.2	27.0	32.3	7.6	58.1	8.9	12.2	27.5	11.7	8.1	27.0	65.0	28.6	32.7	26.1	9.7	8.5	28.2	20.3	27.3	5.9	10.6	2.1	11.6	0.6	10.7	10.7	12.9	16.1	6.1	19.2	8.6	3.5	1.9	1.7	9.7	1.2	11.8	6.3	8.2	9.0	2.5	5.4	10.5	12.1	1.0	4.6	1.2	6.2	5.1	5.7	12.1	14.5	5.3	22.8	13.7	13.2	20.6	12.3	23.4	15.5
DHFR		ENSG00000228716	"Dihydrofolate reductase"	P00374	5	80626228-80654983	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Methotrexate resistance, One-carbon metabolism"	"Oxidoreductase, RNA-binding"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB037129, HPA051465"	Uncertain		Supported	Mitochondria				Mitochondria		"CAB037129: AB_439683, HPA051465: "	"unprognostic (1.44e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.91e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	17.7	6.1	16.0	11.6	13.9	28.3	10.9	10.2	14.0	7.5	12.6	18.1	11.7	14.5	5.9	9.0	9.8	4.7	6.9	9.7	17.3	14.4	13.1	35.5	8.6	23.2	18.9	9.4	7.5	4.9	9.6	7.2	8.5	13.0	5.9	15.5	8.6	8.0	8.4	10.4	5.9	14.5	7.3	25.3	9.1	7.4	10.5	11.5	13.4	9.2	2.3	22.8	7.9	6.1	2.4	3.3	3.5	2.6	2.1	4.0	2.1	19.6	13.6	34.6	25.6	6.6	6.9	12.7	15.7	12.1	27.4	31.7	12.9	23.7	39.8	6.9	9.1	13.8	44.4	20.3	44.4	17.6	27.4	19.1	22.6	12.0	1.4	22.2	8.5	4.8	2.1	24.5	2.7	13.2	21.4	30.6	27.7	19.7	54.7	9.0	17.4	8.0	35.5	67.9	39.4	15.7	12.5	28.3	19.8	22.2	10.4	11.2	20.5	22.0	7.9	8.7	13.2	24.3	30.0	14.4	28.8	43.1	19.4	45.2	22.3	0.8	1.2	1.1	2.3	2.6	1.1	2.1	2.7	3.2	1.9	2.4	2.1	2.7	3.5	2.1	1.7	3.3	4.0	2.1	16.0	13.9	10.2	14.0	17.3	14.4	18.9	9.4	13.0	11.5
DHFR2	"DHFRL1, DHFRP4, FLJ16119"	ENSG00000178700	"Dihydrofolate reductase 2"	Q86XF0	3	94047836-94063389	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA051465	Uncertain		Supported	Mitochondria				Mitochondria		"HPA051465: "	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (2.30e-6)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-2)"	6.6	8.0	9.7	5.2	10.9	2.2	7.7	5.2	13.2	9.8	6.3	15.2	2.8	5.8	11.7	9.9	5.3	9.4	7.6	5.1	9.8	8.1	10.6	9.3	7.1	7.3	10.2	6.9	15.3	10.8	15.4	13.1	4.5	12.2	9.5	6.7	6.2	6.6	8.9	2.8	5.8	10.1	9.0	12.6	9.4	6.6	8.2	8.6	16.9	10.3	4.8	6.4	7.3	6.2	5.0	4.1	3.8	3.3	2.8	7.3	2.5	4.2	6.6	5.1	5.1	7.0	8.9	2.0	6.6	7.2	3.3	3.8	1.3	7.0	2.8	4.5	3.5	5.9	3.8	4.6	5.2	9.4	2.1	3.5	3.1	3.7	7.2	2.3	4.1	9.0	6.3	3.9	5.1	3.4	1.8	6.5	4.3	5.1	12.0	1.4	4.1	8.1	3.1	6.6	4.6	4.6	2.2	6.3	6.4	9.5	2.5	10.7	6.5	3.5	5.3	5.3	8.9	2.1	2.4	4.8	4.8	4.0	5.2	6.1	7.1	3.6	2.2	3.8	3.8	3.2	7.3	3.8	5.1	6.1	1.4	5.0	6.9	6.2	3.5	2.8	3.3	4.1	6.1	2.5	9.7	10.9	5.2	13.2	9.8	8.1	10.2	6.9	12.2	8.6
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 72.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	5.9	4.2	4.7	8.8	5.1	2.9	5.0	2.7	5.0	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3.0	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4.0	2.6	5.2	3.9	4.8	5.9	6.0	4.4	11.7	4.0	3.0	7.5	4.0	3.5	3.4	4.3	5.4	4.0	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.3	15.4	4.5	7.4	2.4	3.2	8.5	6.3	2.5	9.6	7.4	12.1	6.8	16.6	8.6	3.4	7.8	8.8	6.8	11.3	3.7	8.3	9.1	7.5	11.8	6.8	12.6	6.7	3.1	7.0	11.6	12.2	6.9	13.9	3.0	5.8	19.6	11.9	12.1	10.1	6.0	15.1	5.9	17.5	5.8	4.9	5.3	6.3	8.5	9.1	4.1	8.1	6.4	3.0	8.8	5.5	8.3	9.2	5.8	10.8	28.1	4.6	13.8	8.0	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9.0	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5.0	4.3	3.0	4.8	2.7	5.2	5.4
DHRS12	"FLJ13639, SDR40C1"	ENSG00000102796	"Dehydrogenase/reductase 12"	A0PJE2	13	51767993-51804157	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.3"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB034238, HPA057028, HPA058315"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB034238: AB_2091845, HPA057028: , HPA058315: "	"prognostic favourable (1.41e-4)"	"unprognostic (1.98e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.98e-1)"	"prognostic favourable (2.22e-16)"	"unprognostic (2.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.44e-1)"	15.6	6.4	6.9	4.1	7.1	3.9	11.1	5.2	10.9	9.5	7.6	13.8	7.1	5.5	8.4	16.0	7.7	7.5	7.4	8.3	6.0	6.0	14.2	15.8	8.7	4.8	5.8	6.2	10.4	37.6	11.1	10.0	7.3	8.0	7.7	4.7	14.0	11.5	13.0	10.4	10.1	12.2	8.3	7.2	8.3	7.3	3.9	6.5	4.4	10.2	6.9	9.2	6.4	5.7	6.0	4.5	36.3	7.3	1.6	11.6	5.7	0.9	3.1	5.6	7.6	2.5	5.3	5.2	1.7	3.9	2.2	1.2	3.5	15.6	3.9	1.2	3.2	1.9	0.1	0.8	0.3	3.6	2.7	1.2	1.0	3.2	6.7	0.7	1.1	3.4	6.0	0.7	3.2	5.2	1.6	4.4	2.5	4.5	1.5	3.2	6.7	0.5	0.5	0.7	6.4	8.8	2.6	3.4	7.1	2.6	5.7	6.8	5.9	3.9	9.1	1.3	1.9	0.3	1.8	2.1	1.5	1.9	4.0	2.1	4.9	2.9	7.3	0.2	6.4	6.2	11.6	6.0	9.9	8.0	4.0	5.6	8.8	6.2	36.3	1.6	7.0	4.5	8.6	5.7	6.9	7.1	5.2	10.9	6.0	6.0	5.8	6.2	8.0	6.5
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 48.8;RT4: 58.4;SK-BR-3: 285.8;U-2 OS: 93.6"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA053915: , HPA069551: "	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	19.7	1.5	0.1	0.0	48.8	0.0	0.2	1.7	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	2.2	0.1	0.4	0.1	0.0	58.4	0.2	0.3	0.4	285.8	0.3	0.2	0.0	0.0	0.1	93.6	0.5	0.2	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068972-12123225	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.5"	"Cell line enhanced"	"Detected in all"		"T-47d: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Approved		Supported	Mitochondria				Mitochondria		"HPA037949: , HPA037950: AB_10673650, HPA066098: "	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	5.7	6.3	6.5	4.7	6.6	2.2	5.0	5.7	7.2	5.5	5.7	9.8	5.0	4.5	4.7	5.0	5.1	4.2	4.5	7.7	5.3	4.8	23.8	69.5	4.2	6.9	7.5	5.2	7.1	16.6	5.4	4.1	4.7	6.2	7.6	6.3	7.2	9.7	7.1	10.5	3.6	4.3	3.5	6.1	5.1	6.1	4.4	6.6	10.1	6.8	6.7	8.0	5.2	4.1	9.5	12.5	16.8	11.0	10.2	4.1	3.3	11.2	8.7	13.0	10.3	8.1	4.8	15.7	5.7	3.7	10.2	9.1	5.5	6.7	8.1	1.9	3.5	16.1	13.6	4.4	11.7	4.5	6.1	4.4	3.4	4.2	7.9	1.7	1.7	5.9	3.5	5.9	2.4	5.5	6.9	6.6	2.7	21.8	5.9	3.2	7.2	2.0	10.1	4.2	6.8	6.6	2.7	3.4	15.3	11.2	20.1	6.7	44.2	6.4	2.4	3.3	2.4	6.9	4.1	5.9	4.1	5.2	4.3	3.1	5.5	16.8	4.8	10.7	3.2	6.8	3.4	9.5	2.5	2.1	8.6	7.8	2.5	3.3	14.0	10.2	11.0	12.5	4.1	3.3	6.5	6.6	5.7	7.2	5.3	4.8	7.5	5.2	6.2	6.6
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584550	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"			30000	"Nuclear speckles"		"HPA047047: "	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favourable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	34.3	29.6	23.2	32.1	27.5	42.5	33.0	38.0	27.6	31.1	31.9	29.5	24.1	22.8	37.5	23.4	40.8	30.6	22.9	32.6	22.8	18.8	30.0	29.5	31.2	34.7	29.4	17.7	36.5	35.9	42.5	32.8	39.2	27.4	28.2	37.7	22.4	34.1	24.9	36.5	36.0	30.7	30.7	22.8	32.4	32.4	21.0	27.9	58.3	33.5	31.6	43.0	35.4	35.7	20.3	26.7	31.4	24.1	24.5	28.8	17.7	29.6	29.1	48.3	23.9	23.7	23.2	28.8	34.6	30.5	36.6	36.4	29.5	36.0	54.5	21.4	28.3	24.9	62.0	41.6	57.0	20.0	29.4	47.3	31.9	23.8	14.0	48.7	32.7	19.4	25.1	35.6	24.1	30.5	44.3	22.1	41.4	22.4	63.8	32.6	52.5	26.5	42.1	56.7	25.5	43.6	42.7	41.5	26.0	26.8	25.9	24.3	28.3	25.3	27.8	31.0	20.4	23.4	40.3	16.7	28.1	65.2	20.8	39.8	36.9	31.4	20.2	18.8	21.1	20.6	28.8	19.9	23.6	24.5	26.7	20.3	24.9	23.7	9.7	24.5	24.1	17.8	25.8	17.7	23.2	27.5	38.0	27.6	22.8	18.8	29.4	17.7	27.4	27.9
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673037	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA051455: "	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	12.8	15.8	12.7	16.8	14.0	12.1	14.4	16.8	14.9	13.3	16.2	12.3	15.8	19.3	16.3	13.3	14.9	14.4	14.6	12.4	11.4	7.1	18.0	19.2	13.9	18.2	13.6	8.6	15.6	19.1	24.3	16.6	11.3	13.5	16.4	13.6	14.4	18.0	18.2	23.2	18.4	19.8	16.4	11.0	22.6	14.9	36.8	14.9	18.8	21.6	12.1	16.5	13.2	15.3	4.5	5.9	8.7	7.6	7.1	5.8	4.4	9.6	4.0	5.9	9.2	6.8	4.6	7.1	8.0	6.4	11.6	9.0	9.1	4.0	7.3	7.5	7.1	9.3	9.7	7.2	9.3	10.3	8.0	7.2	7.4	5.1	5.9	18.2	9.7	4.2	7.1	9.4	8.1	3.5	12.0	7.2	5.7	8.0	5.2	9.2	5.6	5.6	8.7	6.3	7.9	6.1	7.6	7.1	5.7	8.9	9.4	6.5	7.2	5.5	3.8	7.5	5.1	7.2	11.7	8.6	13.3	7.2	3.6	10.0	9.5	6.0	6.0	8.7	5.8	7.5	5.3	4.4	5.3	4.8	5.9	4.5	4.4	5.0	5.8	7.1	7.6	4.8	5.1	4.4	12.7	14.0	16.8	14.9	11.4	7.1	13.6	8.6	13.5	14.9
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favourable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	18.4	18.7	22.1	18.5	31.1	23.6	18.3	31.2	43.5	22.3	17.8	26.9	15.5	17.3	23.3	14.8	21.0	24.8	17.9	21.3	19.1	19.8	18.6	19.3	16.7	22.0	20.4	28.0	27.1	21.2	37.3	24.8	20.6	23.6	20.4	13.0	22.0	20.4	23.6	27.1	26.2	16.1	18.8	15.3	21.2	18.7	54.4	18.4	23.8	20.1	15.2	16.9	18.6	17.6	9.9	13.0	9.8	10.5	8.2	16.1	11.6	8.1	20.7	20.5	21.1	9.5	7.9	14.0	15.4	13.2	26.6	19.2	23.8	17.4	26.5	12.1	15.0	12.5	30.3	21.5	9.5	18.0	36.3	23.1	30.5	23.2	16.5	21.5	24.0	13.8	13.7	28.1	19.8	17.3	32.5	17.1	12.4	22.0	27.3	23.6	22.8	35.4	18.2	11.0	23.5	13.3	20.7	16.9	22.5	15.0	21.4	11.1	15.0	22.6	12.0	16.1	20.9	18.1	28.2	20.7	25.8	24.1	16.7	18.8	19.9	9.8	10.1	7.2	15.0	10.3	13.0	9.9	12.7	16.1	13.0	9.3	12.1	13.0	1.5	8.2	10.5	7.8	14.3	11.6	22.1	31.1	31.2	43.5	19.1	19.8	20.4	28.0	23.6	18.4
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440912-5469060	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli				Nucleoli		"HPA073875: "	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	10.0	10.4	11.6	11.0	14.6	7.0	12.9	15.8	22.0	9.0	8.7	14.1	8.6	8.6	12.4	7.9	11.2	11.2	9.2	7.7	9.7	7.0	8.2	13.4	8.0	10.1	11.0	13.2	11.1	12.1	16.5	7.3	11.5	10.3	10.0	10.7	11.3	10.4	10.8	13.9	12.5	8.7	11.1	8.0	11.1	9.6	10.1	11.7	8.4	9.5	9.4	10.3	9.6	9.5	3.7	3.4	2.6	3.5	3.0	2.5	0.7	10.3	15.3	9.8	17.5	4.1	8.4	12.2	10.2	6.4	15.8	12.8	9.6	4.5	25.3	7.2	8.4	12.3	19.9	16.0	20.2	8.1	19.1	10.0	12.5	16.2	8.2	13.4	9.1	7.0	9.8	16.8	23.1	11.7	13.3	12.6	8.6	7.3	13.5	7.3	21.7	7.8	18.2	14.4	13.7	7.2	8.0	8.6	12.4	10.7	9.2	15.8	7.2	7.0	10.8	10.9	11.5	8.6	21.6	4.7	5.0	13.0	7.8	16.0	15.6	0.6	3.5	1.8	2.2	1.4	2.1	2.5	2.5	1.4	1.4	3.7	2.5	2.4	2.6	3.0	1.3	3.4	1.8	0.7	11.6	14.6	15.8	22.0	9.7	7.0	11.0	13.2	10.3	11.7
DHX36	"DDX36, KIAA1488, MLEL1"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324497	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035399	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	16.3	14.0	11.5	14.1	27.5	12.6	15.7	19.0	21.3	17.9	14.7	10.3	12.4	10.7	20.4	10.6	14.5	14.3	13.7	23.9	13.4	12.7	16.7	17.1	14.6	17.0	12.2	15.0	20.0	13.7	34.0	36.2	16.4	20.1	15.7	12.2	9.3	15.5	20.5	53.4	14.7	14.3	15.1	13.7	18.9	13.4	28.3	11.3	24.3	20.4	13.4	17.1	20.7	15.6	6.3	5.9	3.1	5.7	4.8	6.9	1.1	26.7	18.3	24.9	14.3	11.7	16.5	12.4	17.5	17.6	20.0	23.9	18.6	21.5	26.0	28.4	15.3	17.3	23.4	14.8	31.5	24.9	15.5	18.8	15.7	10.5	19.9	26.1	16.5	18.6	12.6	21.4	26.3	17.1	17.7	15.0	18.4	13.0	21.6	5.7	33.0	17.6	22.5	20.9	37.4	14.3	19.0	23.3	24.8	18.2	19.4	25.4	19.9	13.3	19.3	21.0	13.2	19.6	34.9	28.1	18.1	37.5	17.0	13.7	22.2	1.9	2.7	3.1	6.9	2.8	4.4	4.7	6.1	4.7	2.3	6.3	5.8	6.0	1.1	4.8	5.7	5.9	5.4	1.1	11.5	27.5	19.0	21.3	13.4	12.7	12.2	15.0	20.1	11.3
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093562-72112912	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA041347: AB_10796571, HPA041604: "	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	21.8	16.5	21.1	22.2	25.0	35.1	20.5	36.0	29.4	18.6	19.5	23.5	19.4	20.1	24.1	13.5	21.1	19.9	18.1	19.2	24.1	13.7	17.3	20.8	20.6	26.1	24.1	20.7	29.0	17.3	36.6	18.7	19.3	20.9	18.3	17.2	17.9	20.4	16.4	33.0	27.2	23.0	23.5	22.5	27.3	19.4	17.5	27.8	24.6	20.8	23.2	23.1	20.5	21.4	10.4	8.1	8.3	10.6	11.8	14.9	6.3	14.4	21.5	15.7	8.7	13.7	10.6	20.6	13.1	12.8	19.6	15.1	26.1	14.5	19.3	11.8	19.7	19.1	18.1	18.0	15.2	9.6	19.5	14.8	18.3	35.5	12.7	17.4	26.9	14.7	16.6	26.4	19.1	16.9	21.9	9.2	12.0	44.6	16.6	19.7	19.7	12.4	21.5	10.8	19.1	9.4	13.8	14.1	15.5	16.8	8.0	9.3	14.6	14.5	19.1	18.9	16.8	13.7	14.3	22.7	17.9	37.1	17.8	12.1	14.7	7.4	7.9	8.3	14.9	10.6	13.7	10.4	9.3	10.7	8.1	8.2	10.4	10.8	8.2	11.8	6.6	7.4	10.9	6.3	21.1	25.0	36.0	29.4	24.1	13.7	24.1	20.7	20.9	27.8
DHX40	"ARG147, DDX40, FLJ22060, PAD"	ENSG00000108406	"DEAH-box helicase 40"	Q8IX18	17	59565525-59608345	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044350	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA044350: AB_10960560"	"unprognostic (1.58e-2)"	"unprognostic (3.10e-1)"	"prognostic favourable (4.05e-5)"	"unprognostic (4.09e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-1)"	22.4	24.2	16.2	14.0	18.1	19.5	24.8	21.7	18.4	21.4	16.5	17.5	23.7	12.8	27.0	25.0	19.3	24.8	16.5	19.8	17.1	19.5	29.5	13.1	16.7	16.8	17.9	14.7	29.7	21.0	51.3	45.8	21.9	19.0	21.6	15.4	13.7	19.3	27.8	20.4	21.3	12.3	18.9	19.9	15.6	17.2	28.4	16.8	26.1	28.2	16.0	15.5	26.0	19.7	5.4	6.9	18.8	6.6	4.2	10.6	6.1	11.5	21.3	27.1	17.6	16.6	17.2	14.9	10.5	20.1	16.1	18.2	8.3	11.6	15.2	29.5	15.0	8.6	19.3	14.8	25.0	12.0	28.2	13.9	16.0	9.2	13.0	16.7	6.5	13.1	13.7	13.6	13.2	17.1	11.6	14.1	10.9	21.0	20.5	10.3	10.3	15.6	19.7	19.0	16.6	16.1	9.3	19.3	47.5	18.9	7.5	19.2	24.4	9.8	13.9	19.4	24.2	6.9	10.2	17.4	19.1	9.8	22.8	11.7	13.2	8.5	6.6	10.5	8.1	6.5	10.6	5.1	5.9	5.8	6.9	5.4	5.9	6.9	18.8	4.2	4.4	3.5	6.0	6.1	16.2	18.1	21.7	18.4	17.1	19.5	17.9	14.7	19.0	16.8
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43544463	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			Nucleoplasm	"Nuclear bodies"	"HPA049285: "	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	21.9	18.6	17.5	17.0	22.9	47.8	22.3	21.6	29.8	20.3	21.0	25.3	17.2	17.1	26.1	28.4	26.6	17.9	16.7	18.5	18.1	18.7	18.5	20.1	19.8	21.0	20.8	19.7	19.5	17.4	35.4	23.0	21.7	22.7	22.1	24.6	20.1	21.7	21.7	25.2	32.9	22.0	24.6	19.2	27.3	19.5	34.6	20.6	40.8	20.5	17.8	28.9	19.4	22.6	11.5	16.3	23.3	20.4	9.5	14.9	9.8	12.3	35.1	19.1	23.7	19.0	19.5	10.6	13.0	27.5	28.8	27.7	16.0	12.6	17.1	12.1	25.5	16.8	28.6	22.9	33.8	17.9	22.6	14.5	26.8	24.7	16.3	25.1	22.0	9.7	19.4	23.6	26.0	25.4	16.1	16.9	22.2	13.4	31.8	22.4	15.5	13.4	19.4	36.4	17.6	19.5	25.9	16.5	24.9	14.6	8.4	11.7	19.5	24.8	17.3	22.4	12.2	16.1	19.4	12.7	15.1	19.4	18.6	15.7	17.9	23.3	15.2	17.2	13.7	20.4	13.6	11.5	11.4	14.9	16.3	10.6	11.2	10.9	19.2	9.5	19.6	8.4	11.7	9.8	17.5	22.9	21.6	29.8	18.1	18.7	20.8	19.7	22.7	20.6
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839369-182887751	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050"	Supported		Supported	Nucleoplasm			97000	Nucleoplasm		"CAB011819: AB_777725, HPA028050: AB_10603564"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	30.2	25.9	25.7	28.5	28.6	68.9	32.9	42.5	33.1	31.9	24.5	23.3	25.2	19.8	38.2	24.2	27.7	30.6	19.7	22.9	24.4	22.6	36.2	31.4	27.8	32.0	34.2	23.1	37.5	24.9	51.8	35.8	28.5	28.0	25.7	30.1	21.1	28.2	29.4	27.6	26.6	27.0	31.6	25.3	32.8	26.5	29.4	37.4	68.3	30.1	31.6	41.2	32.4	31.9	16.8	22.9	12.0	17.4	14.7	21.9	15.0	35.1	34.5	49.5	27.2	25.9	20.1	48.9	31.2	28.6	45.4	30.8	38.5	27.2	56.5	30.5	28.0	30.5	75.1	33.8	50.8	22.9	37.3	37.6	28.2	26.0	14.6	54.4	25.8	17.9	17.0	44.5	12.1	35.4	59.0	20.3	36.3	30.9	55.0	13.4	62.7	21.3	50.2	46.2	32.3	29.3	40.9	35.7	41.0	44.2	28.0	18.2	32.7	30.8	27.6	28.2	31.5	28.6	42.2	21.3	34.8	67.1	17.7	29.9	38.2	5.6	16.0	12.0	19.2	17.4	21.9	16.8	16.8	17.6	22.9	14.6	18.4	19.9	6.5	14.7	14.3	11.1	15.4	15.0	25.7	28.6	42.5	33.1	24.4	22.6	34.2	23.1	28.0	37.4
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122226568	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria			21000	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	17.2	29.7	21.9	15.5	24.0	26.7	24.8	21.9	30.1	20.4	25.9	29.0	14.3	20.6	22.2	36.6	23.5	21.8	19.2	20.3	21.2	26.8	31.7	37.2	15.8	20.9	28.3	23.6	22.4	32.6	22.9	30.6	28.5	27.0	21.1	24.2	22.4	22.2	20.2	25.8	18.2	21.3	21.8	29.2	18.5	19.8	62.7	21.8	23.2	26.9	23.0	22.8	20.5	17.9	32.8	35.0	27.5	29.1	29.9	32.1	26.8	19.0	37.8	26.7	18.1	19.2	18.8	20.5	19.8	19.5	23.3	21.0	32.6	10.0	23.3	18.7	17.9	19.0	29.0	23.7	27.7	20.1	22.7	25.5	15.6	29.9	27.4	27.4	10.6	26.0	16.9	27.5	41.3	26.9	29.2	9.9	22.6	28.4	22.4	40.3	21.5	35.5	20.4	26.6	25.6	26.3	29.7	25.3	25.8	26.5	10.6	21.5	35.8	19.3	18.3	18.0	22.2	20.4	17.8	21.6	36.1	33.4	23.0	21.1	23.6	23.6	28.9	27.5	30.4	29.1	29.1	32.8	28.4	28.4	35.0	26.0	27.9	28.2	12.7	29.9	26.5	26.8	32.1	26.8	21.9	24.0	21.9	30.1	21.2	26.8	28.3	23.6	27.0	21.8
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: , CAB068184: , HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	25.3	5.7	8.2	16.5	13.6	19.9	12.0	1.6	4.6	17.8	18.5	2.9	15.1	5.5	10.7	9.1	16.3	10.4	12.6	13.0	6.6	3.0	6.1	15.7	16.8	6.9	4.1	4.4	14.2	6.6	8.7	5.5	37.2	7.1	16.0	11.4	4.7	9.4	17.2	19.9	9.3	12.0	18.5	7.3	9.8	9.9	12.3	5.1	9.4	7.5	12.0	4.9	19.8	26.9	2.7	4.3	5.7	5.8	1.4	2.8	1.0	0.0	4.0	1.9	3.9	11.0	18.4	0.0	6.9	7.3	3.7	7.9	3.3	7.6	11.3	5.5	5.9	0.0	10.3	1.1	4.9	0.3	5.9	0.0	4.8	3.5	9.2	14.5	5.2	9.2	3.7	5.0	15.7	7.2	0.0	9.3	6.9	3.2	5.4	5.9	15.3	5.9	0.0	10.4	0.0	2.1	6.0	0.0	4.0	0.0	2.0	5.5	1.7	8.0	9.1	8.1	3.7	6.6	4.4	0.1	0.0	9.5	6.8	14.8	4.7	0.0	5.8	5.7	2.3	5.4	1.8	2.7	2.4	2.8	4.3	2.4	1.6	1.5	0.6	1.4	4.5	4.1	1.3	1.0	8.2	13.6	1.6	4.6	6.6	3.0	4.1	4.4	7.1	5.1
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163987	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.2;testis: 19.6"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA032151			Supported	"Plasma membrane,Microtubules"				"Plasma membrane, Microtubules"		"HPA032151: "	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favourable (9.04e-4)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	1.8	0.4	1.7	11.5	1.8	6.7	1.6	0.1	1.4	0.9	4.7	0.2	0.4	2.0	1.4	1.1	7.1	0.3	2.5	1.1	1.0	1.6	1.7	0.4	4.1	2.9	1.0	0.0	0.4	0.4	0.5	0.2	9.4	0.2	0.4	2.3	0.0	1.6	0.0	0.1	1.8	4.3	2.7	0.3	2.5	3.1	19.6	0.0	35.2	0.2	5.3	5.9	0.8	1.5	0.4	2.0	0.4	0.2	0.0	0.5	0.2	17.9	6.0	6.2	3.5	1.1	2.9	10.6	25.2	11.2	25.5	22.3	15.9	12.2	6.0	2.0	12.9	12.3	10.1	9.9	38.9	6.8	7.0	8.6	15.4	3.6	1.6	11.7	6.9	1.1	0.2	15.5	10.5	11.4	6.6	8.6	24.2	2.6	10.4	5.0	5.8	3.5	7.1	15.4	4.9	8.3	3.7	3.3	5.7	12.8	8.9	3.9	6.5	6.4	11.3	16.2	10.4	5.4	20.8	5.8	6.3	9.4	4.3	5.8	12.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	2.0	0.5	0.2	1.7	1.8	0.1	1.4	1.0	1.6	1.0	0.0	0.2	0.0
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol				Cytosol		"CAB068185: , HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	23.2	12.5	18.4	22.4	33.3	20.5	23.2	28.5	29.9	19.0	18.1	31.4	22.4	13.0	20.8	20.6	23.4	18.5	16.2	15.3	22.0	14.1	19.5	23.6	22.4	20.3	29.7	19.6	23.8	19.8	26.9	30.9	29.9	23.2	20.3	19.7	14.5	19.5	18.9	28.0	20.7	17.3	19.0	26.8	20.7	17.1	20.6	32.0	17.0	23.8	14.7	20.3	20.7	24.1	2.5	1.8	10.7	7.2	1.2	3.3	1.0	12.8	13.4	25.1	9.3	6.5	9.8	19.9	10.6	6.4	6.8	8.2	17.0	9.9	14.5	11.5	9.8	15.2	19.9	10.0	14.2	22.5	8.9	21.9	7.4	12.2	6.6	13.4	13.5	9.1	8.3	9.1	13.9	10.1	9.2	12.9	11.4	18.0	15.0	8.9	7.1	6.6	12.0	20.5	8.0	9.0	20.5	20.8	11.8	10.7	11.0	12.0	12.4	9.9	10.0	5.2	10.3	10.1	11.9	14.8	21.1	20.6	5.4	10.9	9.3	3.1	3.0	1.2	1.6	3.1	3.3	1.9	1.5	1.2	1.8	2.5	1.5	1.3	10.7	1.2	7.2	1.6	1.6	1.0	18.4	33.3	28.5	29.9	22.0	14.1	29.7	19.6	23.2	32.0
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIM1 dimethyladenosine transferase 1 homolog"	Q9UNQ2	5	62387254-62403939	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA042944: "	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavourable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.7	14.0	18.9	16.7	17.0	10.6	18.9	11.5	23.5	18.6	11.8	12.4	11.8	11.0	16.2	11.9	20.1	14.2	15.3	19.7	19.1	17.0	11.9	16.3	11.7	22.5	18.8	8.5	17.8	28.4	8.9	13.4	16.7	12.3	18.8	9.5	10.0	16.1	18.3	17.9	12.2	11.9	24.6	20.2	22.1	10.2	10.7	9.8	16.3	19.0	19.0	19.2	21.7	13.2	7.9	7.7	5.0	5.6	7.0	13.2	6.1	14.4	8.7	15.9	20.8	11.8	15.7	15.9	18.6	7.0	14.4	15.3	14.1	15.5	29.8	17.0	13.8	11.3	10.7	11.0	18.3	21.2	18.7	20.5	11.4	11.7	14.2	16.8	15.8	13.6	8.9	14.0	13.7	12.5	20.7	13.8	14.6	14.5	24.7	25.9	15.4	18.4	16.0	16.1	41.1	13.0	13.4	17.9	15.6	15.9	14.9	15.9	12.0	15.8	13.8	9.9	10.4	14.0	25.4	18.2	18.9	26.9	15.1	30.2	14.6	5.0	3.1	2.3	7.7	5.6	11.7	7.9	10.4	9.3	5.0	6.6	13.2	11.0	0.8	7.0	4.3	7.7	9.3	6.1	18.9	17.0	11.5	14.7	19.1	17.0	18.8	8.5	12.3	9.8
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197527-80387757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 67.7;thyroid gland: 128.7"	"Cell line enhanced"	"Detected in some"		"BJ: 26.1;fHDF/TERT166: 14.3;HeLa: 29.9;HHSteC: 14.9;SiHa: 54.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029544, HPA048002"			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029544: AB_10600804, HPA048002: "	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favourable (1.67e-4)"	"prognostic favourable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.3	1.8	13.0	0.9	12.3	0.7	6.1	1.0	19.7	67.7	1.2	1.6	1.9	1.2	15.6	1.1	36.1	0.9	2.5	4.7	14.2	2.7	2.4	0.7	1.2	1.0	4.1	7.6	0.7	1.3	0.9	35.9	5.9	13.2	5.0	1.3	13.1	17.7	12.4	3.0	3.3	1.2	2.4	1.2	0.9	2.5	2.5	1.4	0.0	128.7	15.8	12.0	2.6	13.7	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.4	0.0	26.1	5.5	2.3	0.3	0.0	0.1	0.0	0.1	14.3	0.5	0.9	0.0	1.9	0.0	0.0	0.0	29.9	0.0	14.9	0.0	0.0	1.6	0.0	0.5	0.0	0.5	0.0	0.2	0.1	0.6	0.0	0.0	0.5	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.0	54.7	11.4	0.1	0.0	0.0	0.3	0.1	2.4	5.5	6.6	0.8	0.0	0.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	13.0	12.3	1.0	19.7	14.2	2.7	4.1	7.6	13.2	1.4
DIRC2	"FLJ14784, RCC4"	ENSG00000138463	"Disrupted in renal carcinoma 2"	Q96SL1	3	122794795-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles				Vesicles		"HPA072579: "	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favourable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	7.6	7.8	6.5	4.0	7.7	7.9	6.8	5.2	8.8	5.0	6.2	10.0	4.4	3.0	4.2	6.1	8.8	5.0	5.9	9.9	6.4	6.3	7.5	9.2	8.0	6.9	7.5	4.5	4.9	12.9	18.4	7.6	34.8	6.7	7.8	6.9	11.9	7.7	6.0	27.0	9.7	6.1	6.7	7.8	5.8	5.9	4.2	3.8	3.1	8.0	11.2	7.4	7.4	5.4	0.6	0.3	4.2	0.8	0.0	0.5	0.1	5.6	4.7	4.6	2.6	6.0	4.9	15.6	2.4	5.3	3.9	4.0	11.0	6.3	0.8	3.1	2.7	8.2	3.4	4.3	3.7	1.2	2.5	0.9	2.6	4.7	4.5	0.5	0.6	4.1	11.9	2.8	4.7	4.4	0.5	1.0	4.9	2.5	0.7	0.6	4.2	7.7	1.5	10.5	1.2	5.5	6.6	4.8	3.8	7.1	3.2	6.3	3.8	1.2	6.1	6.1	2.3	3.7	2.0	1.1	0.9	0.3	3.1	1.0	3.3	0.0	0.7	0.1	0.5	0.8	0.0	0.1	0.0	0.0	0.3	0.6	0.5	0.3	4.2	0.0	0.7	0.0	0.1	0.1	6.5	7.7	5.2	8.8	6.4	6.3	7.5	4.5	6.7	3.8
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039281: AB_10795583, HPA058762: "	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	25.5	14.7	11.7	17.6	24.8	23.8	22.4	23.4	19.4	20.3	18.8	11.6	17.0	11.8	18.0	19.3	23.1	17.8	16.0	21.6	12.4	13.6	20.2	25.6	19.3	22.2	13.9	17.0	23.4	15.3	15.8	22.8	26.3	18.7	18.0	15.6	9.8	17.4	19.3	19.9	17.3	17.9	17.5	12.9	22.8	16.2	27.7	14.6	23.7	21.3	19.1	23.0	26.7	19.3	6.9	6.8	11.1	9.7	10.3	10.0	5.0	15.6	7.3	14.4	12.1	15.4	18.4	9.5	14.0	17.1	14.3	17.6	11.2	13.1	19.1	12.2	14.3	13.1	19.7	16.1	23.2	15.6	14.5	22.4	15.7	10.1	19.2	37.8	13.0	19.1	11.3	16.2	21.4	15.3	14.9	8.0	17.4	5.5	16.0	18.6	13.5	8.6	13.0	11.0	8.6	14.4	12.6	13.1	17.2	11.5	9.6	13.5	9.3	17.3	14.3	8.7	7.0	9.7	14.8	15.5	17.4	15.3	24.2	18.0	12.5	11.1	5.5	7.8	6.5	9.7	9.4	6.9	8.5	7.3	6.8	6.0	8.1	7.6	3.4	10.3	7.6	4.3	10.0	5.0	11.7	24.8	23.4	19.4	12.4	13.6	13.9	17.0	18.7	14.6
DIXDC1	"Dixin, KIAA1735"	ENSG00000150764	"DIX domain containing 1"	Q155Q3	11	111927144-112022584	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 23.1;TIME: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 8.6"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039658			Supported	Cytosol				Cytosol		"HPA039658: AB_2676611"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.11e-2)"	"prognostic favourable (6.89e-5)"	"unprognostic (4.10e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (4.19e-5)"	9.7	10.4	8.8	4.5	16.1	0.0	8.6	52.2	15.7	11.5	7.4	20.2	4.9	2.9	14.3	11.0	8.4	12.3	7.0	12.7	8.7	9.9	6.4	4.7	5.1	1.0	16.1	10.2	9.5	3.9	10.2	8.9	5.9	10.8	14.1	5.7	6.8	4.7	22.0	6.6	4.2	3.9	24.9	9.2	3.1	4.8	10.1	16.2	0.0	6.5	1.7	1.0	17.4	18.0	0.1	0.1	8.6	0.2	0.1	0.9	0.2	0.4	1.9	5.2	9.8	16.5	9.6	1.1	4.0	2.8	1.6	2.8	0.3	1.0	0.8	1.0	11.2	0.4	2.2	1.2	1.5	3.2	2.0	0.4	3.0	5.2	2.5	2.7	0.3	7.8	10.4	3.3	23.1	16.1	2.6	0.3	6.3	0.4	1.7	2.3	3.2	3.6	0.8	1.5	3.1	6.5	0.1	4.3	9.0	3.0	2.4	1.3	3.6	1.0	26.2	7.1	3.0	1.3	6.6	0.6	2.7	0.4	3.9	6.9	2.4	0.0	0.2	8.6	0.6	0.0	0.1	0.1	0.5	0.6	0.0	0.1	0.9	0.8	0.7	0.1	0.1	0.1	0.0	0.2	8.8	16.1	52.2	12.4	8.7	9.9	16.1	10.2	10.8	16.2
DKC1	"Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101"	ENSG00000130826	"Dyskerin pseudouridine synthase 1"	O60832	X	154762742-154777689	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Isomerase, Ribonucleoprotein, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000166, HPA000447, HPA001022, CAB033086"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"			40000	"Nucleoli fibrillar center"	Nucleoplasm	"CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: "	"unprognostic (9.87e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (2.94e-4)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (9.13e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (1.46e-9)"	"unprognostic (5.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.55e-1)"	17.6	18.1	17.2	22.5	17.3	42.3	25.8	19.6	20.7	16.6	20.3	14.8	20.7	17.4	19.7	17.1	33.6	18.5	15.9	16.9	15.4	16.3	15.2	22.5	15.2	26.8	15.6	16.6	23.9	38.7	22.6	24.6	19.1	17.0	17.1	26.2	13.7	20.8	18.7	40.8	25.5	18.5	18.3	20.9	25.8	17.6	33.1	16.7	31.3	26.6	28.7	33.2	16.4	20.8	23.5	18.5	16.7	15.5	20.8	26.8	14.8	36.1	20.2	12.5	17.8	7.8	8.0	18.5	13.8	9.8	20.7	19.6	25.4	18.1	69.3	36.4	11.6	19.5	38.0	22.8	31.2	16.7	21.1	35.3	21.2	22.0	11.0	46.4	21.3	7.6	21.9	22.8	52.1	14.3	31.8	17.4	14.0	21.0	31.2	35.7	20.8	25.3	27.2	28.0	35.8	13.0	20.6	27.5	13.6	12.2	21.4	18.8	10.8	18.7	11.4	14.9	22.4	19.1	45.6	32.2	44.5	113.1	10.2	49.2	16.1	4.8	13.1	16.7	21.4	15.5	26.8	23.5	17.6	22.7	18.5	17.1	23.3	22.2	4.0	20.8	14.9	13.4	13.4	14.8	17.2	17.3	19.6	20.7	15.4	16.3	15.6	16.6	17.0	16.7
DKK2		ENSG00000155011	"Dickkopf WNT signaling pathway inhibitor 2"	Q9UBU2	4	106921802-107283806	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 21.7"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB009727, HPA052611"	Uncertain		Supported	"Golgi apparatus"	"Secreted in other tissues"			"Golgi apparatus"		"CAB009727: AB_2091492, HPA052611: "	"unprognostic (3.14e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.58e-2)"	6.6	1.2	3.0	1.5	2.5	0.0	4.8	1.8	3.6	21.7	3.6	0.2	0.0	0.1	1.4	2.4	2.0	0.9	1.6	3.1	2.9	2.2	0.4	0.3	7.9	0.9	2.0	1.5	6.3	0.3	0.9	3.4	3.4	2.5	2.9	0.7	6.8	2.7	2.4	2.4	6.1	0.5	0.9	2.3	1.7	0.4	0.5	0.2	0.1	1.3	4.4	3.7	1.1	2.6	0.0	0.2	0.0	0.1	0.0	3.0	0.0	0.0	0.0	3.6	0.0	0.7	0.3	0.0	0.1	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.1	0.0	2.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.5	1.8	3.6	2.9	2.2	2.0	1.5	2.5	0.2
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11963106-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 94.7;heart muscle: 297.4"	"Cell line enhanced"	"Detected in many"		"BJ: 60.0;BJ hTERT+: 92.8;fHDF/TERT166: 86.9;TIME: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	90	"T-cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"		15000000	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	4.8	21.7	44.9	3.5	94.7	1.3	6.8	32.5	60.3	25.8	7.3	12.1	4.1	4.9	7.8	5.6	8.8	4.9	17.9	297.4	49.6	23.5	5.1	2.7	17.8	3.1	19.1	45.8	10.8	5.7	10.9	6.6	7.5	24.7	16.8	4.6	10.7	9.1	22.3	2.7	8.3	7.3	12.0	32.9	9.0	7.0	8.9	25.5	0.0	4.7	2.5	2.6	10.5	7.8	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.2	1.8	2.6	0.0	2.2	4.4	0.0	60.0	92.8	26.6	30.2	1.3	0.4	0.0	6.6	86.9	9.2	0.2	25.9	10.2	0.0	0.0	0.0	0.2	0.0	16.9	0.0	0.0	6.7	8.7	9.0	22.2	28.1	0.0	0.0	36.7	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	9.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	49.8	15.8	12.4	1.6	15.5	0.0	0.0	0.0	2.6	0.0	14.8	0.0	0.0	0.0	0.8	0.0	8.9	0.0	0.8	5.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	44.9	94.7	32.5	46.5	49.6	23.5	19.1	45.8	24.7	25.5
DLAT	"DLTA, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112024814-112064390	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 55.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Enhanced	Mitochondria				Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favourable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavourable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favourable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	14.1	10.7	10.6	8.8	11.9	4.8	10.9	10.5	14.2	6.7	13.3	6.3	7.8	12.4	6.3	8.1	12.2	7.2	6.4	55.4	10.4	13.5	19.1	12.0	6.6	8.7	11.2	9.7	7.9	6.0	15.8	7.8	8.3	13.0	8.3	13.5	7.6	10.4	9.9	41.0	7.2	13.0	6.6	7.3	6.9	8.1	7.3	4.2	12.7	10.7	22.1	8.8	7.5	6.7	9.2	9.1	7.9	8.9	7.2	10.3	8.0	6.0	6.1	8.1	10.8	11.4	8.5	9.7	8.3	4.8	9.2	10.4	19.3	17.8	24.8	16.3	7.6	13.0	16.9	8.9	10.5	8.9	10.5	15.7	6.5	11.9	8.2	19.9	9.0	10.3	9.8	9.2	9.3	8.4	25.7	11.9	10.8	4.7	9.0	23.9	9.5	11.8	14.0	11.0	27.9	16.9	6.4	15.6	9.5	10.0	28.3	6.3	21.0	12.4	5.6	9.2	10.0	9.2	10.6	3.9	6.2	37.6	2.6	21.8	7.2	7.9	6.6	4.7	8.3	8.9	9.5	9.2	8.2	8.9	9.1	7.5	10.3	8.3	0.5	7.2	8.9	7.4	8.8	8.0	10.6	11.9	10.5	14.2	10.4	13.5	11.2	9.7	13.0	4.2
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Supported	Mitochondria			16000000	Mitochondria		"HPA044849: "	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favourable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	39.9	32.4	18.0	31.0	25.9	22.9	20.4	23.0	19.4	26.8	20.8	37.9	22.4	39.1	39.7	24.4	26.6	36.2	32.4	40.5	26.1	21.5	27.5	43.0	27.0	19.9	45.2	28.4	26.1	23.6	28.4	15.5	32.1	68.6	29.2	29.0	44.9	36.9	32.8	21.4	23.5	26.6	28.8	53.0	36.6	59.8	22.4	23.7	37.7	63.7	33.8	24.2	38.7	20.3	29.6	24.3	57.6	34.9	22.1	42.1	26.3	27.9	48.3	30.6	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7
DLEC1	"CFAP81, DLC1"	ENSG00000008226	"Deleted in lung and esophageal cancer 1"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 23.2;testis: 28.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA019077	Enhanced		Supported	Cytosol				Cytosol		"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	0.8	0.3	1.3	0.7	8.3	1.1	0.5	0.0	0.6	3.3	0.6	6.1	3.5	0.7	1.1	21.1	0.3	23.2	1.3	0.3	1.7	2.5	0.3	0.3	10.0	1.7	0.5	0.2	6.3	0.2	0.6	14.2	0.3	9.8	0.8	0.6	0.8	0.6	1.8	0.2	0.7	0.7	0.3	0.6	0.7	0.6	28.9	1.7	0.0	0.8	0.0	0.6	0.4	0.1	0.2	0.1	0.9	0.4	0.1	1.1	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.1	3.4	0.0	0.0	0.0	0.2	0.1	2.8	0.5	0.2	0.3	1.7	0.5	0.1	0.3	0.0	0.0	0.4	0.3	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.8	0.2	0.4	0.2	1.1	0.0	0.1	0.1	0.2	0.0	0.9	0.1	0.1	0.1	0.2	0.1	1.3	8.3	0.0	0.6	1.7	2.5	0.5	0.2	9.8	1.7
DLG5	"KIAA0583, P-dlg"	ENSG00000151208	"Discs large MAGUK scaffold protein 5"	Q8TDM6	10	77790791-77926526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.0;NK-cell: 1.5"	"Group enriched"	"Detected in many"	6	"NK-cells: 1.5;T-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001746			Supported	"Cell Junctions"				"Cell Junctions"		"HPA001746: "	"unprognostic (1.36e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (5.38e-4)"	"unprognostic (8.48e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.13e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.74e-2)"	5.3	24.3	9.2	3.4	9.2	0.9	14.5	9.8	7.9	11.6	12.4	8.0	21.8	4.3	12.6	28.2	9.5	7.8	11.2	3.4	8.2	4.9	4.7	1.9	3.7	1.4	7.5	3.0	9.8	9.4	22.2	19.4	18.2	8.9	15.5	4.9	8.6	9.4	19.5	11.8	24.9	7.7	13.1	8.3	2.0	8.5	4.4	8.0	2.1	11.4	5.2	6.0	11.6	16.1	0.0	0.1	0.3	0.0	1.5	2.0	0.0	11.4	9.1	13.7	10.7	9.2	6.8	16.8	6.6	13.2	6.4	6.1	8.9	13.1	0.0	6.4	9.9	15.0	6.8	13.6	5.6	1.4	5.6	1.5	6.2	8.7	9.8	1.5	2.4	9.4	13.7	8.4	16.9	2.5	2.7	0.2	6.0	8.7	1.1	2.1	6.1	21.4	4.0	4.3	0.7	4.5	10.1	4.6	9.5	7.1	22.0	3.3	15.6	2.1	4.6	7.1	11.1	5.7	9.1	0.0	1.8	0.7	6.7	2.4	3.3	0.3	0.0	0.1	2.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.1	0.0	0.0	9.2	9.2	9.8	5.8	8.2	4.9	7.5	3.0	8.9	8.0
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191678	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 8.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.52e-6)"	"prognostic unfavourable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavourable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	1.4	0.9	0.3	11.4	0.4	16.2	0.5	0.3	0.5	1.3	3.3	0.2	0.2	2.9	0.9	1.0	8.7	0.3	1.3	0.7	0.2	0.3	1.1	0.8	2.1	10.6	0.3	0.2	0.7	0.4	0.0	0.3	3.3	0.3	0.5	4.1	0.3	1.5	0.2	0.5	1.9	4.1	1.3	0.3	6.6	2.2	13.0	0.2	65.1	0.4	6.4	11.4	1.7	2.4	1.1	0.4	0.4	0.0	1.3	8.3	1.2	37.0	14.7	38.8	17.4	0.9	3.9	12.0	21.5	14.2	31.9	30.4	12.0	20.5	21.6	11.9	12.5	23.1	24.8	17.3	41.9	25.9	12.2	22.1	13.8	10.3	0.1	21.6	13.6	0.7	0.6	14.9	7.2	35.1	17.9	21.6	29.6	17.8	27.3	11.1	20.0	15.4	21.3	37.5	9.9	10.4	12.1	19.8	11.1	22.9	8.6	8.5	19.3	8.1	13.6	14.3	37.4	13.8	24.7	5.3	11.5	28.6	10.0	15.4	22.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.1	2.3	0.4	0.1	0.5	0.2	0.4	1.3	0.0	0.0	8.3	1.2	0.3	0.4	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.2
DLX4	"BP1, DLX7, DLX8, DLX9"	ENSG00000108813	"Distal-less homeobox 4"	Q92988	17	49968970-49974959	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 14.7;skin 1: 6.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.9;CACO-2: 13.3;HAP1: 9.1;K-562: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059933	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA059933: "	"unprognostic (8.12e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.88e-13)"	"unprognostic (8.79e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.86e-2)"	0.4	0.3	0.2	1.2	0.7	0.4	0.7	0.3	0.8	0.8	0.6	0.8	0.2	0.2	0.2	0.6	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.5	0.2	0.2	0.2	0.7	0.1	0.2	14.7	1.4	0.5	0.3	0.5	2.7	0.6	0.2	6.0	1.5	0.2	0.2	0.8	0.3	0.5	0.2	0.2	0.6	3.8	1.2	0.4	0.8	0.1	0.9	0.0	1.3	1.0	0.8	0.3	0.4	1.1	0.0	0.1	0.1	0.0	18.9	0.1	0.1	0.0	0.3	13.3	0.8	0.5	2.7	0.2	1.8	9.1	0.3	0.0	3.6	4.8	0.3	4.5	1.4	0.0	0.7	3.1	0.0	2.3	0.1	0.0	0.0	10.5	0.0	0.0	2.3	0.3	4.7	0.2	0.0	0.0	4.3	0.4	0.1	0.7	1.5	0.0	0.3	1.6	0.8	3.3	3.2	0.0	0.0	0.9	0.2	0.0	0.8	0.1	0.0	0.4	2.5	0.0	0.0	0.3	0.0	0.8	1.3	0.0	0.0	0.0	0.4	0.7	0.1	0.2	0.0	0.0	1.0	1.3	0.9	0.0	0.3	0.2	0.7	0.3	0.8	0.2	0.2	0.2	0.2	1.4	0.2
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: "	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	12.7	31.7	21.5	17.6	22.4	12.5	12.6	21.3	31.5	12.8	13.8	20.4	15.6	13.5	14.0	14.9	12.9	19.8	11.7	20.3	20.7	18.3	14.9	16.1	12.9	17.2	18.0	19.4	23.3	19.9	25.3	15.7	14.3	17.9	13.9	11.9	19.2	21.1	15.2	30.5	18.0	12.7	17.0	15.8	16.7	13.8	13.8	17.0	15.2	18.1	14.3	13.6	12.7	11.4	18.6	15.4	23.2	14.8	26.5	23.1	15.0	12.4	13.3	18.8	9.9	9.8	9.3	21.7	11.1	14.9	26.8	23.2	21.7	15.7	18.7	15.1	17.8	10.3	16.7	14.3	14.3	15.0	27.0	17.2	23.7	21.4	17.7	16.8	13.1	14.5	15.9	22.1	12.8	17.2	11.9	17.2	15.6	14.5	23.5	21.2	26.7	17.0	23.9	19.0	20.4	14.1	15.8	17.5	14.4	20.8	14.9	21.1	12.3	19.5	16.5	7.6	23.0	17.4	22.3	21.0	12.5	15.0	14.4	16.8	12.5	23.2	14.8	14.1	21.2	13.1	21.6	18.6	21.4	21.8	15.4	18.6	19.6	19.3	6.4	26.5	10.5	12.4	23.1	15.0	21.5	22.4	21.3	31.5	20.7	18.3	18.0	19.4	17.9	17.0
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997606-79236038	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 50.2;liver: 81.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.6;Hep G2: 11.3;hTEC/SVTERT24-B: 3.5;Karpas-707: 3.6"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria			440000	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: "	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favourable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	2.8	2.2	0.8	0.8	1.3	0.0	1.5	0.4	0.6	0.5	0.5	0.7	1.9	0.1	0.9	5.9	0.4	0.4	0.6	1.3	0.8	0.8	50.2	81.8	0.1	0.1	0.8	0.3	1.0	0.5	0.3	2.1	0.0	1.1	0.9	0.1	2.7	0.4	1.1	0.6	0.2	0.3	2.0	1.7	0.0	0.4	1.2	0.2	0.0	1.5	0.8	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	1.4	0.4	0.3	5.6	1.3	2.3	0.0	0.1	0.0	0.4	1.7	0.0	0.1	0.0	1.8	0.3	0.0	0.0	0.0	11.3	3.1	0.0	0.0	2.7	3.3	3.5	2.5	0.0	0.0	3.6	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.3	0.4	0.6	0.8	0.8	0.8	0.3	1.1	0.2
DMTF1	"DMP1, DMTF, hDMP1, MRUL"	ENSG00000135164	"Cyclin D binding myb like transcription factor 1"	Q9Y222	7	87152361-87196337	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023846	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA023846: AB_1847779"	"unprognostic (3.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.26e-3)"	"unprognostic (9.77e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (4.39e-5)"	"unprognostic (6.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-3)"	16.8	14.2	22.5	17.8	27.2	24.3	19.1	35.2	24.2	19.2	17.8	19.2	22.3	15.0	23.7	35.0	12.3	19.6	14.0	14.1	23.0	15.1	14.5	10.6	18.4	17.2	28.9	20.0	27.1	14.8	24.9	41.6	16.4	23.1	17.0	18.3	14.3	13.4	16.9	10.0	17.9	17.7	19.9	23.6	17.5	13.5	42.0	32.4	29.4	25.0	7.0	16.6	18.2	17.0	10.3	5.9	13.6	5.1	6.6	10.0	3.5	12.8	6.6	28.8	23.9	8.2	14.3	12.0	16.0	6.2	9.5	15.2	5.8	11.9	16.1	11.7	10.2	7.3	20.4	11.2	18.5	8.5	10.3	11.8	18.0	8.7	8.2	10.9	12.8	13.4	8.9	18.6	18.3	12.1	20.1	18.8	15.3	11.9	19.3	13.5	22.6	11.9	16.8	15.6	10.4	8.6	11.3	19.8	24.6	20.6	7.8	12.6	11.7	6.8	15.5	17.6	8.7	22.4	14.3	14.8	20.8	29.4	9.9	8.7	15.3	13.6	4.4	8.8	10.0	4.8	9.2	10.3	7.7	7.0	3.6	9.3	9.2	8.2	6.8	6.6	5.1	5.9	9.1	3.5	22.5	27.2	35.2	24.2	23.0	15.1	28.9	20.0	23.1	32.4
DMXL1		ENSG00000172869	"Dmx like 1"	Q9Y485	5	119037772-119249138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036431, HPA036432"	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA036431: AB_10669791, HPA036432: "	"unprognostic (2.47e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.26e-1)"	"prognostic favourable (5.16e-5)"	"unprognostic (4.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.18e-2)"	17.8	10.4	9.3	14.0	14.1	29.3	16.1	14.2	15.4	12.0	11.6	15.4	9.6	8.3	15.7	8.5	13.0	12.0	10.3	10.2	8.9	5.6	18.8	9.6	13.9	12.5	11.5	11.4	17.4	20.1	21.3	14.1	9.5	18.9	35.9	9.8	13.3	13.6	10.9	10.9	21.4	13.1	13.0	10.9	11.5	12.4	9.2	13.1	18.1	17.9	6.8	13.8	14.3	12.4	11.2	9.5	4.6	9.0	1.5	3.8	2.6	9.5	7.4	8.4	8.6	9.1	12.1	9.0	7.9	7.9	7.9	9.4	8.9	5.9	18.6	8.2	10.1	5.8	9.3	9.4	10.4	14.3	9.3	13.1	12.9	3.1	7.6	8.5	11.4	9.6	5.3	9.2	7.7	10.4	11.0	12.6	6.4	6.0	11.4	4.9	4.6	4.5	9.0	15.6	7.2	6.2	11.1	7.9	8.0	13.6	4.9	12.2	8.2	9.9	10.0	9.5	8.0	9.5	8.3	11.9	8.4	16.2	11.8	8.4	7.6	4.6	5.5	3.9	2.9	4.9	3.6	9.7	2.3	2.4	3.8	11.2	3.8	2.1	4.5	1.5	9.0	9.5	2.8	2.6	9.3	14.1	14.2	15.4	8.9	5.6	11.5	11.4	18.9	13.1
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 49.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.5"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria				Mitochondria		"HPA037487: AB_10672493, HPA057526: "	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.6	1.2	2.0	13.7	2.4	7.0	3.0	6.2	3.8	1.6	4.5	1.1	0.8	3.5	3.0	1.8	3.2	1.0	2.4	2.0	2.5	2.2	3.4	6.2	3.3	8.4	2.9	5.0	1.9	2.4	1.1	2.3	4.0	1.7	3.0	5.0	0.9	2.3	0.8	2.3	2.9	5.2	1.9	3.0	5.2	2.6	7.0	1.4	49.1	1.5	5.1	10.8	2.3	2.0	0.4	0.1	0.9	0.1	5.5	0.6	0.1	13.7	7.1	16.3	11.5	1.8	1.3	11.5	6.8	5.7	9.8	12.1	17.0	9.0	14.1	2.6	2.1	8.5	9.3	3.6	11.8	8.7	7.0	8.6	4.4	6.5	0.5	14.7	9.3	1.0	1.4	7.0	2.0	4.4	12.5	12.8	5.6	4.8	22.7	10.7	11.5	13.4	17.8	11.3	4.5	4.2	6.4	7.4	8.9	9.4	11.9	2.2	9.2	6.3	1.8	3.8	11.7	4.8	12.9	6.5	7.3	21.1	3.2	14.1	4.9	0.0	0.0	0.9	0.2	0.0	0.2	0.4	0.2	0.6	0.1	0.4	0.3	0.3	0.1	5.5	0.1	0.0	0.4	0.1	2.0	2.4	6.2	3.8	2.5	2.2	2.9	5.0	1.7	1.4
DNAAF2	"C14orf104, CILD10, FLJ10563, KTU, PF13"	ENSG00000165506	"Dynein axonemal assembly factor 2"	Q9NVR5	14	49625174-49635230	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002894, HPA004113"	Enhanced		Supported	Cytosol				Cytosol		"HPA002894: AB_1078316, HPA004113: AB_1078315"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.25e-2)"	"prognostic favourable (6.74e-7)"	"unprognostic (6.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.44e-2)"	3.4	5.7	4.3	3.9	9.1	2.5	5.8	5.9	4.9	4.6	7.1	4.8	2.3	7.6	4.2	13.8	5.3	9.2	6.1	4.1	5.5	5.2	7.0	9.5	9.7	4.9	4.0	3.8	14.6	7.0	3.6	7.3	3.7	10.7	4.0	4.7	2.9	5.3	3.0	5.4	2.9	6.8	3.0	3.8	3.9	4.8	48.1	3.2	4.8	5.4	8.5	4.3	4.3	3.5	12.6	6.2	7.2	5.8	13.7	11.5	5.3	10.1	6.1	13.4	10.4	6.6	7.6	12.8	5.5	6.1	6.1	6.8	5.9	9.9	14.9	8.8	3.6	11.2	11.0	7.7	7.7	10.4	6.6	7.6	4.6	10.1	5.1	12.2	6.4	5.0	8.4	5.2	7.2	6.3	11.3	10.2	6.0	12.6	8.0	12.7	14.6	11.2	10.0	10.4	5.0	8.6	8.6	20.5	15.3	8.2	8.9	9.7	10.1	4.9	5.1	5.8	16.3	5.9	6.8	20.6	12.8	12.3	2.2	7.5	6.2	6.7	5.5	7.2	8.7	4.7	10.4	12.6	9.8	11.5	6.2	9.7	9.5	9.3	2.1	13.7	5.8	5.6	9.1	5.3	4.3	9.1	5.9	4.9	5.5	5.2	4.0	3.8	10.7	3.2
DNAH14	"C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277"	ENSG00000185842	"Dynein axonemal heavy chain 14"	Q0VDD8	1	224896262-225399292	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 32.4;testis: 29.9"	"Cell line enhanced"	"Detected in many"		"K-562: 25.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 3.5"	"Low lineage specificity"	"Detected in single"											"HPA027718, HPA028545, HPA031379"	Uncertain		Supported	Centrosome				Centrosome		"HPA027718: AB_10601210, HPA028545: , HPA031379: "	"unprognostic (1.16e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.09e-3)"	"unprognostic (9.94e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-9)"	"unprognostic (6.76e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	1.6	5.2	6.3	2.7	2.5	2.5	5.2	0.9	3.4	3.1	2.9	0.2	3.8	1.7	3.3	6.5	2.0	2.6	5.3	3.7	7.0	5.5	4.2	6.8	5.4	0.6	2.9	4.6	5.5	11.2	3.4	32.4	2.6	7.2	4.3	3.7	3.6	3.4	7.8	0.6	1.0	1.1	4.6	8.5	1.0	3.8	29.9	0.8	3.2	7.1	0.9	0.4	2.5	1.9	0.6	0.2	0.4	0.2	3.5	0.9	0.0	10.2	5.3	4.9	5.3	1.9	4.0	11.7	2.1	2.0	4.0	3.5	8.3	11.4	0.0	5.4	2.1	0.1	7.5	2.0	6.7	0.0	12.5	4.9	3.6	1.8	2.4	10.2	1.7	3.9	4.6	5.4	3.8	1.3	25.2	0.0	6.7	2.7	1.8	10.6	13.7	6.5	0.0	18.5	9.4	3.6	4.8	8.2	9.3	8.3	6.3	16.7	11.5	8.9	0.2	0.0	7.9	0.2	0.0	11.5	7.1	0.1	0.0	0.0	7.4	0.0	0.1	0.3	0.1	0.2	0.0	0.6	0.3	0.7	0.2	0.3	0.4	0.5	0.4	3.5	0.1	0.0	0.9	0.0	6.3	2.5	0.9	3.4	7.0	5.5	2.9	4.6	7.2	0.8
DNAH7	KIAA0944	ENSG00000118997	"Dynein axonemal heavy chain 7"	Q8WXX0	2	195737703-196068812	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7;fallopian tube: 19.4;pituitary gland: 25.2"	"Cell line enhanced"	"Detected in some"		"PC-3: 10.5;RPTEC TERT1: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"neutrophil: 2.0;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;granulocytes: 2.0"					"Low region specificity"	"Detected in many"			"HPA034724, HPA044070"	Approved		Supported	Cytosol				Cytosol		"HPA034724: AB_10670977, HPA044070: "	"unprognostic (1.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.98e-2)"	1.0	2.6	6.8	1.4	9.9	0.7	1.9	0.6	6.4	3.3	1.9	4.6	4.3	0.9	2.2	12.9	1.1	19.4	1.9	1.4	7.1	5.8	4.5	1.2	9.5	0.9	3.4	3.5	3.9	4.2	3.6	25.2	0.9	21.7	1.9	1.6	1.8	1.8	2.5	0.6	0.9	1.9	1.2	2.1	0.8	1.5	18.3	2.3	0.0	5.9	0.0	1.0	1.3	0.5	0.3	2.0	2.0	0.0	0.1	0.2	0.2	0.6	2.4	0.5	0.2	1.3	0.9	0.1	0.2	1.4	0.5	0.5	0.5	1.7	0.0	0.7	0.5	0.1	0.0	0.3	0.4	0.0	1.4	0.0	2.9	0.7	0.2	0.1	0.2	0.3	0.4	2.1	0.4	0.0	0.6	3.3	0.9	2.4	0.0	0.1	0.5	10.5	0.1	0.6	0.8	4.9	0.3	1.1	1.9	0.6	0.4	0.2	0.9	0.2	0.0	1.3	0.4	2.0	0.6	2.6	2.3	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.1	2.0	0.1	0.0	2.0	0.0	0.2	6.8	9.9	0.6	6.4	7.1	5.8	3.4	3.5	21.7	2.3
DNAJA1	"dj-2, hdj-2, HSJ2, HSPF4, NEDD7"	ENSG00000086061	"DnaJ heat shock protein family (Hsp40) member A1"	P31689	9	33025211-33039907	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 189.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001306	Approved		Supported	Microtubules,Cytosol				Cytosol	Microtubules	"HPA001306: AB_1079043"	"unprognostic (3.11e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.58e-2)"	"prognostic favourable (5.39e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (3.27e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.70e-2)"	29.0	46.7	46.5	26.1	47.2	42.7	57.2	31.6	53.3	30.4	18.7	20.7	25.5	14.4	27.6	27.9	17.1	34.8	28.2	22.2	42.5	51.7	36.0	71.9	30.7	23.8	56.5	30.8	30.7	19.5	47.3	40.2	35.0	49.6	29.8	21.7	9.0	18.9	23.0	14.5	13.1	15.9	29.0	42.4	22.3	20.8	42.2	51.5	24.1	47.0	15.3	28.1	27.9	189.5	36.6	60.0	50.0	69.0	31.6	37.2	49.5	38.0	68.3	55.3	19.2	38.5	25.0	31.7	39.4	31.8	70.9	55.2	45.3	17.7	39.1	30.2	26.7	17.4	79.6	23.7	61.2	55.0	23.2	31.3	84.1	57.3	18.5	36.0	36.8	15.4	24.4	26.7	8.5	42.2	48.7	17.1	40.5	31.1	60.0	79.2	53.8	47.7	44.2	19.8	20.0	39.7	22.6	35.2	38.4	53.0	34.3	17.5	16.0	35.0	36.1	25.3	43.3	28.8	52.2	11.0	34.0	41.3	33.2	31.4	21.7	33.3	40.1	43.3	28.5	56.0	33.3	36.6	35.6	31.4	35.7	32.7	37.2	34.7	50.0	31.6	69.0	60.0	30.1	49.5	46.5	47.2	31.6	53.3	42.5	51.7	56.5	30.8	49.6	51.5
DNAJA3	"hTid-1, TID1"	ENSG00000103423	"DnaJ heat shock protein family (Hsp40) member A3"	Q96EY1	16	4425805-4456775	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016095, HPA040875, HPA044229"	Approved		Enhanced	Vesicles,Mitochondria				Mitochondria	Vesicles	"CAB016095: AB_668801, HPA040875: , HPA044229: "	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-2)"	"prognostic favourable (1.79e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-1)"	10.8	26.6	10.7	11.3	15.5	6.2	13.0	15.3	20.8	10.0	14.0	13.9	11.1	17.3	11.3	8.7	15.6	12.6	12.5	28.8	13.9	12.6	19.0	44.8	9.1	13.4	13.0	13.0	13.2	18.1	21.6	12.1	13.7	14.2	11.5	13.4	10.6	14.4	13.4	46.7	12.8	13.2	11.4	12.6	11.4	12.8	15.1	11.1	13.6	16.1	16.2	13.3	13.4	11.2	10.4	6.5	2.2	7.0	7.8	11.9	7.9	8.9	17.9	6.3	11.8	7.9	6.9	11.7	11.8	8.9	16.5	13.6	14.9	12.6	17.6	11.0	7.6	13.6	20.4	14.0	9.6	12.1	17.6	9.0	15.5	14.3	19.5	15.6	8.6	8.4	16.8	14.5	24.3	7.9	23.1	14.6	9.3	20.4	14.6	11.3	13.7	16.6	18.2	10.0	32.9	12.3	9.6	15.5	6.7	12.9	29.6	19.5	16.9	13.1	7.4	12.3	8.4	29.6	14.7	15.1	20.2	24.0	6.6	15.1	14.4	0.7	4.6	2.2	9.5	7.0	11.0	10.4	9.1	8.9	6.5	8.9	11.9	9.2	0.5	7.8	5.2	4.6	7.4	7.9	10.7	15.5	15.3	20.8	13.9	12.6	13.0	13.0	14.2	11.1
DNAJB1	"Hsp40, HSPF1, RSPH16B, Sis1"	ENSG00000132002	"DnaJ heat shock protein family (Hsp40) member B1"	P25685	19	14514770-14529770	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 291.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 109.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017450, HPA063247"	Enhanced		Supported	Nucleoplasm			9600	Nucleoplasm		"CAB017450: AB_10631418, HPA063247: "	"unprognostic (3.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.17e-1)"	"prognostic favourable (5.96e-4)"	"unprognostic (2.20e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.77e-2)"	29.2	76.9	28.5	13.2	30.0	36.2	67.0	41.4	29.4	19.3	15.5	21.5	14.5	10.5	20.4	11.8	72.3	21.7	56.4	23.5	28.2	31.6	23.4	37.7	35.7	10.7	53.4	12.0	32.3	22.6	18.3	25.0	33.5	45.8	29.6	13.1	12.2	18.4	40.8	16.1	25.3	9.5	24.0	40.2	9.4	19.1	37.5	37.9	15.0	28.9	18.0	31.1	19.2	291.1	19.7	15.2	28.2	31.6	23.0	61.6	56.7	36.6	39.0	14.1	15.0	26.0	20.9	8.8	24.4	18.1	38.7	29.3	23.0	20.7	10.1	28.0	20.8	27.9	28.8	17.5	27.4	10.6	14.3	16.1	25.8	48.2	17.7	11.4	15.3	11.6	42.1	14.9	13.1	12.7	23.9	109.8	21.3	23.2	18.3	10.6	15.0	42.0	14.0	19.9	22.8	17.6	12.6	13.0	9.6	22.1	43.8	24.0	12.0	11.1	13.2	31.4	18.9	36.2	51.2	48.9	30.0	13.3	22.4	19.8	28.0	11.5	18.9	22.3	36.6	31.1	38.9	19.4	52.5	45.4	15.2	19.7	61.6	47.6	28.2	23.0	31.6	9.1	51.8	56.7	28.5	30.0	41.4	29.4	28.2	31.6	53.4	12.0	45.8	37.9
DNAJB11	"EDJ, ERdj3, HEDJ"	ENSG00000090520	"DnaJ heat shock protein family (Hsp40) member B11"	Q9UBS4	3	186567403-186585800	"Predicted intracellular proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA010814, HPA017051"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		18000	"Endoplasmic reticulum"		"HPA010814: AB_1078691, HPA017051: AB_1847792"	"unprognostic (4.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.86e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.05e-3)"	"prognostic unfavourable (3.44e-9)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-1)"	18.8	16.4	14.0	27.7	21.2	26.4	22.3	12.4	14.4	18.7	21.6	15.9	21.5	19.7	20.0	28.1	19.9	18.1	18.2	27.3	14.7	14.9	29.5	83.5	21.7	31.5	17.4	10.2	13.9	67.4	20.6	18.0	26.2	19.6	14.4	22.7	13.3	37.2	18.4	13.2	13.9	25.4	17.3	17.4	25.6	21.3	16.1	19.6	17.9	47.6	15.7	20.3	19.0	26.0	19.3	42.2	19.0	21.6	22.6	23.7	16.8	33.3	13.1	19.4	33.4	15.9	12.3	33.2	37.7	21.6	31.2	33.1	40.4	22.2	24.4	76.5	24.7	31.0	22.1	19.6	32.9	27.2	19.4	21.5	13.0	29.9	37.0	25.2	34.0	10.9	19.9	17.5	30.9	26.1	12.0	58.7	20.6	25.4	16.9	20.7	19.0	17.7	17.0	21.9	40.8	23.3	14.4	16.7	23.3	24.2	40.5	26.1	46.6	38.6	19.6	17.4	22.6	22.5	53.4	46.9	34.5	38.4	23.1	30.8	37.3	16.6	18.3	19.0	23.7	21.6	19.9	19.3	12.2	19.2	22.9	11.5	11.8	16.0	8.4	22.6	15.8	42.2	16.7	16.8	14.0	21.2	12.4	14.4	14.7	14.9	17.4	10.2	19.6	19.6
DNAJB12	"DJ10, FLJ20027"	ENSG00000148719	"DnaJ heat shock protein family (Hsp40) member B12"	Q9NXW2	10	72332830-72355230	"Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010642, HPA072702"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Nuclear membrane"	"HPA010642: AB_1078692, HPA072702: "	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (4.79e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (5.73e-2)"	"unprognostic (5.60e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.87e-1)"	24.9	31.7	18.6	20.1	20.6	27.2	32.6	24.0	28.3	24.1	21.8	29.9	26.4	25.0	26.8	31.0	23.8	21.1	28.7	25.3	18.0	17.3	25.6	34.3	26.8	27.5	19.9	19.4	25.4	33.1	38.4	26.2	36.0	20.2	24.5	17.5	27.5	32.4	44.8	40.3	28.6	27.4	22.8	22.3	26.9	24.3	29.2	18.2	20.8	25.5	25.8	23.5	21.1	21.2	7.6	15.5	23.3	19.8	8.3	8.7	9.9	15.5	16.1	10.2	17.0	13.4	13.6	12.9	15.6	27.1	21.5	20.1	18.9	27.1	11.5	12.6	18.8	26.1	9.4	14.0	11.4	12.5	12.8	6.1	9.6	12.2	29.5	12.4	23.5	17.5	29.1	19.0	24.1	14.9	9.6	17.3	17.8	15.0	10.6	10.6	4.7	4.7	9.8	7.7	7.9	15.8	9.1	7.0	10.1	8.5	31.6	15.2	12.1	14.3	16.7	10.8	14.8	12.0	19.5	14.7	10.9	6.7	17.8	13.7	7.3	9.1	18.1	11.0	8.7	19.8	7.8	7.6	8.6	6.5	15.5	7.3	7.2	7.1	23.3	8.3	16.8	10.5	8.7	9.9	18.6	20.6	24.0	28.3	18.0	17.3	19.9	19.4	20.2	18.2
DNAJB2	"CMT2T, HSJ1, HSPF3"	ENSG00000135924	"DnaJ heat shock protein family (Hsp40) member B2"	P25686	2	219279267-219286900	"Disease related genes, Predicted intracellular proteins"		Chaperone	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036268	Approved		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA036268: AB_10670793"	"unprognostic (2.02e-2)"	"unprognostic (3.69e-2)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.62e-3)"	19.9	34.1	48.9	10.1	51.3	14.0	20.9	43.1	62.6	18.4	14.9	51.6	19.8	13.9	13.7	29.0	15.7	25.6	16.3	26.9	52.6	46.8	23.2	16.6	19.4	13.8	65.7	43.4	26.2	41.3	27.8	28.7	16.4	50.0	24.3	10.2	17.2	36.1	23.7	57.5	37.7	14.3	10.3	71.3	14.6	20.7	24.1	54.0	5.2	27.4	10.9	12.1	13.4	41.2	3.8	1.8	5.2	2.9	3.5	2.6	1.1	13.3	5.5	8.8	8.2	18.7	9.0	11.8	12.9	10.8	11.6	9.8	25.6	8.3	8.2	15.7	12.2	19.2	11.1	14.3	6.6	17.3	4.6	16.1	9.7	12.2	12.5	2.7	14.6	8.7	41.4	12.6	15.5	5.1	2.8	9.4	8.5	6.9	4.3	3.2	5.2	10.4	5.1	7.2	4.8	12.6	9.5	8.1	9.4	14.9	15.3	24.5	11.4	5.3	6.6	16.8	32.9	4.8	11.0	10.5	3.1	13.5	16.8	2.5	12.3	0.0	1.1	5.2	2.2	1.0	1.7	1.7	2.1	1.9	0.7	3.8	2.6	2.6	1.2	3.5	2.9	1.8	2.2	1.1	48.9	51.3	43.1	51.0	52.6	46.8	65.7	43.4	50.0	54.0
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 89.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 42.5;LHCN-M2: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	23.3	39.0	19.2	8.4	20.7	4.9	16.6	22.7	24.1	21.3	12.7	7.2	9.3	5.4	20.8	10.1	25.0	11.7	25.2	42.0	18.0	16.8	16.0	15.5	21.7	7.0	25.7	9.1	15.3	18.5	16.4	19.1	19.5	23.8	19.4	9.4	5.1	7.0	12.2	33.3	7.6	8.8	23.0	29.5	30.3	11.9	7.8	22.5	2.8	35.1	29.4	5.1	22.1	89.8	3.6	5.0	4.5	1.9	3.1	7.2	2.6	1.4	2.7	3.5	2.0	15.0	28.0	1.6	27.2	6.9	12.1	13.7	0.9	1.8	2.0	4.6	12.9	2.1	4.4	2.4	20.7	2.3	1.2	1.0	8.2	6.6	20.3	0.5	0.5	11.6	6.6	15.7	4.5	42.5	4.4	1.4	72.3	0.1	0.6	1.5	2.1	1.3	1.1	6.0	1.3	2.9	0.7	2.5	0.8	3.1	2.3	2.6	0.9	0.8	20.3	17.1	4.2	12.1	3.5	1.2	0.4	1.8	2.3	1.2	2.9	4.5	1.7	2.7	2.6	1.7	4.4	3.6	3.2	3.1	1.7	3.0	7.2	5.1	0.4	3.1	1.9	5.0	4.2	2.6	19.2	20.7	22.7	24.1	18.0	16.8	25.7	9.1	23.8	22.5
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: "	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	24.0	23.1	38.0	17.9	35.0	51.3	40.5	42.2	41.3	17.1	25.5	21.7	19.1	14.5	23.3	38.8	33.2	20.9	17.3	37.0	31.7	32.2	24.5	16.7	19.4	16.4	37.6	32.2	22.8	18.8	17.2	20.2	24.4	37.7	19.5	17.2	15.3	20.1	25.6	96.9	34.2	15.6	31.7	33.9	17.2	16.8	38.3	35.2	12.2	17.9	23.5	21.9	23.4	51.9	32.7	30.4	74.3	48.1	35.5	42.1	55.0	38.0	23.1	28.2	28.5	28.6	26.0	26.1	42.8	35.1	39.9	43.8	31.4	38.5	14.6	80.7	31.6	24.4	19.1	29.9	62.0	29.4	26.1	26.2	13.9	22.2	26.3	19.4	22.1	22.7	29.1	30.2	14.4	29.6	42.5	14.7	51.0	25.8	48.4	38.2	56.3	30.9	26.1	20.3	20.4	32.9	23.4	17.0	44.9	33.4	26.2	31.3	19.1	27.6	36.9	25.2	19.2	60.0	36.8	28.2	40.1	17.2	35.8	44.7	31.8	70.6	41.5	48.8	36.2	41.6	36.1	32.7	33.2	37.2	30.4	28.1	42.1	39.3	74.3	35.5	48.1	27.6	38.9	55.0	38.0	35.0	42.2	41.3	31.7	32.2	37.6	32.2	37.7	35.2
DNAJC13	"KIAA0678, RME8"	ENSG00000138246	"DnaJ heat shock protein family (Hsp40) member C13"	O75165	3	132417526-132539032	"Predicted membrane proteins"	"Protein transport, Transport"	Chaperone	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036923, HPA036924"	Approved		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA036923: AB_10672480, HPA036924: "	"unprognostic (3.35e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavourable (7.49e-4)"	"unprognostic (3.68e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (8.36e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.81e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	23.3	17.8	20.4	15.1	14.4	20.5	16.2	18.0	19.9	20.8	23.1	8.1	23.3	14.5	25.0	18.7	22.3	16.8	13.1	20.5	19.9	11.0	23.6	12.1	17.7	14.9	11.5	17.8	20.1	12.2	21.1	12.3	22.9	17.3	17.8	18.8	10.2	16.1	24.6	20.0	13.7	20.1	26.3	12.5	19.4	16.0	10.3	16.4	13.0	20.6	13.8	13.6	24.5	32.4	2.2	5.7	3.4	7.0	1.7	2.1	1.6	14.6	8.4	11.5	5.8	26.8	23.9	7.0	15.9	29.9	15.5	17.2	9.4	9.3	7.7	10.2	21.6	12.0	10.7	11.6	21.6	8.7	3.0	9.5	8.4	6.2	14.1	9.5	9.3	17.4	8.5	14.0	17.4	21.6	5.3	12.8	21.9	11.2	7.8	4.5	6.7	7.6	7.6	8.2	6.1	14.0	15.5	4.1	6.8	15.2	8.0	17.2	12.5	9.0	20.1	17.5	9.0	17.0	6.8	7.3	7.1	10.4	18.3	6.7	12.8	3.4	5.2	0.7	1.9	4.3	1.8	2.2	2.0	1.7	5.7	1.4	1.5	2.1	1.2	1.7	7.0	2.7	1.1	1.6	20.4	14.4	18.0	19.9	19.9	11.0	11.5	17.8	17.3	16.4
DNAJC18	MGC29463	ENSG00000170464	"DnaJ heat shock protein family (Hsp40) member C18"	Q9H819	5	139408588-139444491	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 51.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036538, HPA060154"	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA036538: AB_10670802, HPA060154: "	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.73e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"prognostic favourable (5.89e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.97e-2)"	4.1	4.0	8.2	2.9	15.7	1.9	4.3	10.7	19.5	4.7	3.3	12.4	0.7	1.8	7.6	4.9	3.9	4.9	4.2	6.3	8.7	8.7	4.5	1.2	4.5	3.3	8.8	11.7	10.7	2.3	6.5	7.1	4.1	16.2	4.9	3.0	3.4	2.1	5.9	8.4	2.2	2.4	6.8	9.0	2.9	2.4	51.4	7.5	1.2	5.1	1.7	2.6	3.4	3.3	3.5	2.0	2.1	2.0	6.0	6.7	1.4	1.7	1.8	11.6	10.7	6.5	6.9	1.3	3.5	7.7	6.2	11.3	4.1	1.4	7.7	9.6	5.4	3.0	6.5	10.5	6.5	17.5	8.6	5.2	4.0	1.9	5.1	0.6	2.6	9.2	1.3	10.3	6.3	8.4	2.3	7.5	9.1	1.0	2.3	2.4	8.0	2.6	6.3	12.7	1.2	3.7	1.9	10.8	11.3	3.6	1.4	7.9	1.6	3.9	10.8	8.3	0.0	2.5	7.4	8.9	11.7	4.1	4.4	3.9	3.5	1.9	2.0	2.1	2.2	1.3	3.2	3.5	3.2	4.1	1.5	3.5	3.2	2.0	0.6	6.0	0.7	2.0	6.7	1.4	8.2	15.7	10.7	19.5	8.7	8.7	8.8	11.7	16.2	7.5
DNAJC2	"MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin"	ENSG00000105821	"DnaJ heat shock protein family (Hsp40) member C2"	Q99543	7	103312474-103344873	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chaperone, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020454	Approved		Supported	Cytosol				Cytosol		"HPA020454: AB_1859492"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.28e-1)"	12.8	12.5	12.8	21.5	14.2	37.0	13.6	12.9	16.8	13.3	15.0	5.1	10.7	14.3	13.4	12.5	13.6	11.8	11.5	13.6	11.4	11.0	16.2	25.2	10.7	15.5	13.3	12.7	16.4	13.2	12.2	28.5	13.8	16.1	12.0	13.0	5.6	12.6	9.1	29.4	12.7	18.6	13.1	12.2	19.7	12.8	30.6	15.7	17.6	13.0	12.0	13.6	16.6	16.5	9.1	7.1	28.6	9.1	10.0	8.8	3.7	17.3	12.6	7.2	13.8	5.8	8.1	14.8	12.0	8.7	13.4	10.0	18.7	12.8	24.6	19.3	8.2	11.8	19.5	8.7	20.5	13.1	16.1	18.2	11.9	15.8	10.5	32.0	14.5	7.0	7.6	15.6	14.0	8.7	42.1	16.1	10.9	29.1	30.5	33.1	25.8	19.5	19.6	14.9	22.9	7.9	8.3	14.2	13.2	16.2	22.6	12.5	9.6	16.3	10.3	13.3	21.3	28.7	23.4	17.1	22.5	49.3	9.5	33.4	16.6	28.6	6.0	5.5	7.6	6.5	8.4	7.8	7.6	7.9	5.9	9.1	8.8	8.8	2.4	10.0	9.1	7.1	8.1	3.7	12.8	14.2	12.9	16.8	11.4	11.0	13.3	12.7	16.1	15.7
DNAJC27	"RabJS, RBJ"	ENSG00000115137	"DnaJ heat shock protein family (Hsp40) member C27"	Q9NZQ0	2	24943636-24972094	"Predicted intracellular proteins"			Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 30.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036815, HPA036816"	Uncertain		Supported	Cytosol				Cytosol		"HPA036815: , HPA036816: AB_10673506"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.44e-4)"	"unprognostic (8.84e-2)"	"prognostic favourable (8.48e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.78e-3)"	6.0	5.6	6.7	3.4	13.8	5.3	5.9	9.4	15.7	5.6	4.1	6.8	1.9	3.2	6.6	8.1	3.7	5.7	4.8	7.3	6.7	8.0	6.1	3.1	4.4	4.1	9.5	6.5	10.9	3.6	7.6	10.2	4.6	19.0	5.5	4.6	4.9	3.2	5.2	6.5	4.5	3.3	5.0	8.3	4.1	3.7	30.4	8.2	3.6	5.3	2.4	3.9	4.1	6.1	1.4	0.8	2.9	1.2	4.5	1.9	0.9	4.5	2.0	4.3	4.3	6.1	5.2	3.3	3.5	5.2	3.8	3.3	2.1	2.1	4.3	0.8	2.5	3.6	3.2	2.2	3.8	1.9	2.6	2.7	2.3	1.9	3.9	2.4	3.7	3.9	3.7	3.0	5.9	1.5	1.8	4.0	4.0	1.6	4.3	4.1	2.8	1.8	2.7	8.6	2.3	3.6	2.5	1.6	5.5	3.3	2.6	4.9	2.2	1.8	1.4	5.0	3.6	2.5	3.2	10.3	3.6	5.1	2.5	4.0	2.1	0.0	0.8	2.9	1.0	0.5	1.9	1.4	1.2	0.8	0.8	1.1	1.6	1.8	0.2	4.5	1.2	0.4	1.1	0.9	6.7	13.8	9.4	15.7	6.7	8.0	9.5	6.5	19.0	8.2
DNAJC7	"TPR2, TTC2"	ENSG00000168259	"DnaJ heat shock protein family (Hsp40) member C7"	Q99615	17	41976433-42021376	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023015, HPA052395"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023015: AB_1847804, HPA052395: "	"unprognostic (3.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavourable (3.35e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.93e-3)"	22.9	24.2	42.0	27.6	49.3	24.7	28.3	36.6	44.1	22.2	30.5	25.0	21.0	21.5	18.6	32.3	31.4	19.3	19.9	30.6	36.5	38.6	36.9	30.8	21.8	30.1	38.1	30.5	26.4	29.0	37.7	38.2	24.4	48.2	20.4	29.0	21.0	21.0	22.1	44.3	28.0	22.4	18.9	28.9	23.7	22.0	25.2	32.9	31.8	26.5	29.0	40.9	24.3	33.5	15.8	48.1	14.0	21.2	17.8	16.2	13.2	19.4	33.3	31.2	23.3	19.1	32.2	26.6	20.0	28.5	38.0	30.5	38.4	19.8	30.1	23.9	29.1	29.3	49.1	36.0	45.4	26.8	68.8	24.2	28.4	53.3	27.4	35.1	22.0	26.8	21.2	35.0	32.8	29.9	37.1	21.3	32.1	16.3	37.9	29.1	30.5	24.3	26.5	35.6	26.5	28.5	25.5	30.4	23.9	16.9	49.9	24.5	28.0	29.3	23.5	20.9	19.7	21.8	33.2	15.6	35.2	27.8	22.6	25.7	22.1	14.0	20.6	13.6	13.2	21.2	14.6	15.8	14.6	15.1	21.6	15.0	14.4	13.8	8.9	17.8	20.4	48.1	16.2	13.2	42.0	49.3	36.6	44.1	36.5	38.6	38.1	30.5	48.2	32.9
DNAJC8	SPF31	ENSG00000126698	"DnaJ heat shock protein family (Hsp40) member C8"	O75937	1	28199456-28233025	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026275, HPA026283"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA026275: , HPA026283: AB_10600907"	"unprognostic (1.42e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.71e-2)"	"prognostic favourable (6.95e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.07e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"prognostic favourable (2.39e-4)"	"unprognostic (4.84e-2)"	27.3	26.9	35.9	27.8	40.1	27.5	27.7	33.6	40.7	26.3	27.2	33.6	15.8	22.6	33.1	25.9	24.5	23.6	22.5	30.5	31.2	31.7	29.0	29.1	23.4	38.5	34.2	32.5	32.0	15.0	20.0	23.8	32.4	38.2	30.0	25.4	21.4	20.7	26.1	26.4	21.8	21.8	36.0	33.0	30.3	22.3	15.7	36.0	30.8	35.1	19.9	42.8	29.6	27.7	31.9	34.8	29.6	30.8	29.6	37.0	44.0	24.6	12.7	20.2	23.1	24.4	20.1	18.0	20.6	25.7	41.5	38.1	13.4	20.1	28.3	21.4	22.8	15.3	29.5	20.2	44.0	22.2	21.9	36.3	19.5	23.6	22.0	35.8	30.1	15.3	18.1	26.1	13.8	27.4	33.9	20.0	30.2	14.3	27.2	25.1	36.4	14.8	30.9	29.8	27.1	26.3	20.4	7.3	18.9	26.9	11.6	24.2	16.6	29.2	21.0	18.5	20.1	41.4	30.5	19.0	24.8	44.5	24.8	43.7	25.1	29.6	30.5	27.8	37.0	29.3	37.0	31.9	33.5	36.1	33.1	30.7	33.6	34.1	16.2	29.6	30.8	34.8	35.1	44.0	35.9	40.1	33.6	40.7	31.2	31.7	34.2	32.5	38.2	36.0
DNAJC9	"JDD1, SB73"	ENSG00000213551	"DnaJ heat shock protein family (Hsp40) member C9"	Q8WXX5	10	73183362-73248862	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035215, HPA035216"	Supported		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA035215: AB_10603663, HPA035216: AB_2674522"	"unprognostic (4.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.45e-1)"	"unprognostic (6.83e-3)"	"unprognostic (2.43e-3)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavourable (7.07e-5)"	"unprognostic (5.61e-2)"	"unprognostic (3.08e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	3.1	4.0	4.0	5.0	4.3	24.2	4.6	12.9	5.8	3.0	4.6			4.2	4.0	3.9	6.8	2.9	1.7	2.7	4.2	5.2	2.8	3.5	2.9	7.7	3.5		5.2	2.6	3.6	4.3	5.4		3.6	5.8		3.6	3.9	3.4	5.3	4.1	3.8	3.1	5.9	3.4	4.3			2.9		9.9	3.1	4.4	15.6	9.4	13.2	4.9	10.6	16.5	8.8	26.2	16.3	21.0	17.4	5.0	4.9	9.2	21.3	12.6	21.5	22.5	27.8	18.4	18.2	7.0	9.4	17.9	21.0	14.2	24.3	21.0	14.5	38.6	16.6	18.4	3.5	33.9	15.6	4.0	7.8	22.5	19.7	14.1	34.5	21.2	16.9	24.4	32.8	25.7	7.7	45.5	24.4	18.4	9.9	10.6	12.7	10.1	17.0	15.6	25.7	11.2	13.4	15.9	10.3	14.4	25.5	15.3	32.6	9.9	14.9	29.2	14.4	33.8	9.2	7.3	1.8	13.2	13.0	4.9	14.4	15.6	15.9	14.1	3.0	12.7	15.6	13.8	2.1	10.6	4.7	9.4	16.5	8.8										
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 26.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"		160000	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.14e-4)"	1.5	1.4	1.5	2.6	1.6	1.7	1.5	3.8	2.5	2.2	12.2	1.8	1.5	14.9	1.5	2.2	3.4	1.2	2.5	1.5	1.5	1.2	11.4	1.5	1.5	4.4	1.5	1.5	2.0	13.7	1.6	12.2	1.9	3.1	5.1	2.1	1.5	3.3	1.5	1.5	3.9	26.7	1.5	1.5	2.3	6.0	2.7	1.5	1.5	1.6	2.6	3.8	1.9	2.3	4.5	2.2	9.2	2.0	1.9	3.4	1.0	2.4	5.7	10.0	5.2	2.9	2.5	4.8	4.0	0.7	3.2	4.7	6.8	6.0	10.5	3.2	0.6	4.2	3.6	1.1	3.5	4.6	5.5	3.7	8.5	4.5	1.5	2.6	8.5	2.0	4.2	4.3	1.0	2.1	9.2	4.7	2.7	10.2	5.2	11.3	6.1	3.1	12.4	4.6	5.1	2.7	2.1	7.1	6.6	2.9	9.1	1.6	9.0	6.5	2.9	6.0	4.5	3.8	2.2	4.2	6.0	18.2	1.7	4.8	5.8	4.3	2.0	5.3	3.0	1.3	1.9	2.5	2.3	2.4	1.0	4.5	2.7	3.4	9.2	1.9	1.2	2.2	2.4	1.0	1.5	1.6	3.8	2.5	1.5	1.2	1.5	1.5	3.1	1.5
DNLZ	"bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17"	ENSG00000213221	"DNL-type zinc finger"	Q5SXM8	9	136359480-136363789	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062738			Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA062738: "	"unprognostic (2.81e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.6	11.3	13.8	13.0	11.9	13.4	10.4	8.1	13.9	9.7	8.9	9.2	4.0	12.8	10.0	6.2	13.4	7.4	7.1	29.9	11.2	9.1	13.7	14.0	8.0	14.9	11.4	3.5	13.6	25.3	5.0	6.5	7.1	8.5	11.2	2.8	6.2	9.2	7.0	29.6	7.0	7.2	9.9	8.0	13.7	8.3	6.3	6.8	11.6	11.2	7.4	8.9	8.0	9.2	8.6	4.2	8.0	3.1	0.9	6.9	1.2	4.1	7.5	2.6	7.6	1.3	2.7	6.7	6.8	3.7	5.5	2.4	9.0	4.4	9.7	25.0	4.9	9.0	1.6	3.9	0.6	39.6	9.9	3.5	3.7	3.7	5.1	7.8	6.6	3.4	4.0	4.0	2.5	2.9	5.6	7.0	3.5	31.1	9.2	13.0	11.4	19.8	28.2	3.7	11.2	6.7	4.3	11.5	16.7	6.9	6.4	6.1	7.9	7.2	6.3	9.2	8.4	6.4	10.3	6.1	8.7	8.6	6.8	3.8	8.5	8.0	1.8	0.3	3.8	3.1	4.8	8.6	5.3	5.6	2.4	5.7	5.4	4.5	1.4	0.9	1.7	4.2	6.9	1.2	13.8	11.9	8.1	11.7	11.2	9.1	11.4	3.5	8.5	6.8
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 133.5"	"Cell line enhanced"	"Detected in many"		"A549: 48.8;U-87 MG: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910, HPA061801"	Enhanced		Supported	Nucleoplasm			440000	Nucleoplasm		"CAB005920: , HPA049910: , HPA061801: "	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	5.9	6.1	31.5	3.3	36.9	2.3	4.6	57.7	133.5	11.7	3.0	2.5	0.0	2.4	4.6	2.7	3.3	6.3	9.0	2.7	33.4	24.0	2.9	1.8	2.5	2.5	18.3	33.0	1.6	4.7	3.2	5.5	2.7	33.0	2.9	2.9	4.3	2.6	3.1	2.3	4.6	3.3	4.4	5.1	1.6	2.6	4.0	1.8	0.0	1.9	0.4	2.3	3.6	3.7	0.3	0.4	0.5	0.3	0.0	0.3	0.7	3.2	48.8	4.4	1.0	1.4	14.9	0.2	3.0	7.3	6.2	2.6	0.6	1.0	0.0	4.2	6.3	5.8	0.7	0.3	3.4	0.0	4.7	3.1	7.0	0.2	1.0	0.4	2.2	3.9	0.1	4.8	0.0	0.0	1.1	0.2	0.0	1.3	0.2	1.0	4.7	8.9	5.8	0.1	1.5	0.9	0.0	6.3	10.6	10.4	0.3	0.4	0.1	4.2	0.2	0.2	14.1	14.2	6.2	0.4	0.1	0.3	18.6	0.1	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.7	31.5	36.9	57.7	71.8	33.4	24.0	18.3	33.0	33.0	1.8
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009952, HPA039324"	Supported		Enhanced	Vesicles,Cytosol			10000000	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: "	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	15.4	16.2	24.9	14.8	34.4	22.3	14.3	40.5	37.8	13.0	14.5	12.4	14.9	12.3	16.5	16.5	19.8	13.3	11.9	25.4	26.1	28.1	19.4	12.8	11.2	13.8	23.4	23.2	14.1	9.8	28.7	18.8	16.0	27.9	19.3	16.0	12.1	11.1	21.1	25.6	11.8	11.0	21.7	21.7	11.6	12.2	23.1	14.9	13.4	15.2	17.4	15.8	16.9	12.2	5.9	17.0	5.0	14.6	7.2	7.9	7.1	22.1	22.1	23.2	23.8	18.8	19.3	44.9	24.9	19.2	23.5	21.8	31.0	17.0	29.8	17.5	22.5	19.9	24.4	28.6	28.3	15.7	19.9	33.9	21.3	17.0	15.5	24.0	17.9	17.4	14.5	24.9	25.7	28.4	24.5	12.9	26.9	8.6	9.6	20.2	48.9	10.8	16.2	43.7	20.3	19.8	30.5	20.3	20.8	26.5	18.2	19.4	20.9	16.4	25.6	20.1	20.2	47.1	23.1	9.1	24.6	31.1	19.5	16.1	15.2	5.0	9.7	3.1	5.6	14.6	6.8	5.9	6.0	5.9	17.0	5.2	7.3	7.9	1.7	7.2	13.6	5.4	6.1	7.1	24.9	34.4	40.5	37.8	26.1	28.1	23.4	23.2	27.9	14.9
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133345-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease mutation, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	12.1	7.6	9.8	20.2	10.8	31.9	11.5	27.1	14.4	12.0	8.6	10.0	4.3	8.1	12.1	8.0	12.0	11.5	7.8	8.0	9.3	8.1	6.9	9.2	11.8	29.7	12.5	7.9	11.1	6.2	10.2	8.8	32.5	8.7	8.3	10.7	7.8	9.3	6.5	6.8	10.8	11.3	11.2	9.1	11.0	9.0	19.9	12.6	31.4	9.5	8.8	28.8	11.4	9.7	12.6	19.0	10.2	13.4	25.0	18.2	6.8	24.0	15.2	19.5	16.5	7.3	7.5	41.8	16.3	13.0	23.5	23.6	14.7	13.1	40.3	10.2	10.0	15.9	21.4	12.7	24.1	15.8	31.9	58.4	13.6	7.6	3.1	23.8	23.7	5.0	2.4	20.5	8.1	12.7	23.1	24.9	17.5	16.0	34.7	32.4	25.5	22.2	35.2	20.4	22.2	7.4	15.3	20.8	16.1	19.8	8.9	6.4	9.3	12.1	9.6	39.5	13.5	23.9	24.1	20.4	21.2	47.7	11.5	22.2	30.6	10.2	13.4	3.3	18.2	13.2	15.9	7.9	14.6	12.5	11.3	12.6	16.6	12.3	3.1	25.0	7.9	19.0	12.9	6.8	9.8	10.8	27.1	14.4	9.3	8.1	12.5	7.9	8.7	12.6
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.5;REH: 25.1;SH-SY5Y: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favourable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	7.8	12.4	13.7	12.7	15.5	10.8	8.6	21.6	20.1	9.0	12.7	14.5	7.6	9.1	13.0	12.2	8.0	9.6	8.9	8.2	12.3	6.7	9.4	6.9	9.5	13.6	15.3	10.1	18.3	12.1	6.3	12.6	20.8	10.7	9.3	9.2	12.0	8.5	9.2	29.1	6.6	11.4	11.3	7.9	17.5	11.6	6.6	15.2	20.8	9.1	10.5	11.8	9.8	8.4	3.0	4.1	4.9	4.1	8.7	8.3	2.3	1.0	3.5	14.7	3.6	1.6	1.2	19.4	1.0	0.9	2.0	1.6	8.7	5.7	0.0	2.2	1.9	0.9	1.6	2.2	1.2	3.6	2.5	6.3	5.3	10.4	3.8	1.3	4.1	3.6	1.1	2.6	0.9	8.2	7.3	1.3	1.5	8.4	13.8	14.9	25.5	1.9	25.1	16.2	2.1	1.2	1.5	8.8	31.0	1.2	8.4	2.6	0.9	6.7	2.8	2.5	3.2	0.6	1.3	3.1	2.2	8.5	0.9	3.8	2.6	4.7	1.8	3.1	5.2	3.0	7.0	2.3	3.4	4.9	2.0	3.0	8.3	6.6	4.9	8.7	4.1	4.1	2.8	2.3	13.7	15.5	21.6	20.1	12.3	6.7	15.3	10.1	10.7	15.2
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7;testis: 23.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 55.9;CACO-2: 21.0;HEL: 22.0;K-562: 21.1;NB-4: 18.6;NTERA-2: 75.5"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	1.1	0.8	0.9	2.5	0.9	4.7	2.4	4.5	1.4	1.6	2.1	0.7	0.5	0.9	1.3	4.7	1.6	1.1	1.6	1.8	0.8	0.7	2.7	1.2	1.2	1.9	0.9	0.5	1.2	7.5	2.5	1.1	2.8	0.8	1.1	0.8	1.2	3.5	1.6	0.5	5.5	0.8	1.0	0.5	1.3	1.1	23.3	0.8	17.7	2.6	1.7	2.5	2.7	2.2	0.7	1.0	0.0	0.2	0.9	1.3	0.1	0.8	1.1	6.1	1.4	0.1	0.5	55.9	0.7	0.5	0.8	0.8	21.0	0.9	2.2	2.2	0.3	0.5	3.9	0.3	0.6	0.2	3.1	22.0	0.7	4.0	0.2	0.9	2.2	0.5	0.4	1.2	0.2	1.4	21.1	0.6	0.3	3.4	3.3	18.6	75.5	0.7	3.3	1.0	0.5	2.0	0.9	1.9	1.3	1.3	1.9	0.5	1.3	1.2	0.3	1.2	2.8	0.6	0.5	1.3	0.6	0.8	0.6	6.0	0.5	0.0	0.2	0.0	0.1	0.1	0.1	0.7	0.2	0.0	1.0	0.0	1.3	0.0	0.0	0.9	0.1	0.9	0.0	0.1	0.9	0.9	4.5	1.4	0.8	0.7	0.9	0.5	0.8	0.8
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219373527-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol			6200000	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	20.1	12.3	8.8	15.5	10.4	7.2	20.0	7.2	9.3	16.5	30.4	8.6	13.8	27.9	15.1	13.3	16.9	15.3	16.6	22.9	10.4	6.8	21.2	33.5	15.5	11.7	10.5	7.2	19.4	19.0	9.7	11.0	28.5	9.4	21.0	15.8	15.9	18.7	14.7	36.6	14.6	50.3	12.9	6.8	17.5	15.2	33.7	9.3	11.3	15.0	20.0	17.4	20.7	13.1	11.6	16.1	5.8	15.0	15.7	15.7	10.9	16.0	8.8	5.4	16.1	14.4	11.9	43.0	8.0	16.2	20.9	22.1	24.3	21.2	9.8	17.3	16.6	15.8	6.5	18.3	7.6	19.2	4.6	15.9	9.0	26.4	38.2	13.1	11.4	19.3	19.5	21.5	18.0	14.3	17.9	15.8	10.7	34.9	20.0	14.6	8.9	5.5	26.0	12.4	12.9	11.6	25.0	6.8	9.2	9.3	30.8	11.3	9.0	14.5	7.9	20.1	16.6	10.5	11.5	17.7	10.3	7.0	28.6	12.6	8.5	5.8	13.2	5.4	13.6	15.0	15.4	10.2	11.0	15.0	16.1	11.6	12.0	15.7	1.0	15.7	12.2	5.8	12.6	10.9	8.8	10.4	7.2	9.3	10.4	6.8	10.5	7.2	9.4	9.3
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304396-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Terminal addition"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 171.0"	"Group enriched"	"Detected in some"	420	"MOLT-4: 48.7;REH: 168.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"naive B-cell: 1.2;naive CD4 T-cell: 4.5"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036532: , HPA044194: AB_10960525"								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.1	0.1	0.3	24.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.7	0.0	171.0	0.6	0.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	168.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791937-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Group enriched"	"Detected in all"	7	"dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavourable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	15.2	16.3	15.8	19.0	18.0	31.6	16.0	15.5	19.9	16.4	24.2	15.4	20.5	14.0	23.3	21.3	18.8	20.6	18.6	20.6	14.6	15.3	15.6	18.7	18.2	17.7	14.5	17.6	20.1	24.1	18.2	17.8	18.3	15.1	23.5	32.0	16.1	21.0	21.6	45.0	21.8	19.6	32.6	13.8	21.2	20.7	36.9	11.8	25.2	21.1	19.4	21.7	30.1	16.1	3.2	14.2	41.0	16.6	1.0	3.4	4.5	20.4	10.9	11.3	10.7	8.7	9.4	11.8	7.7	12.5	25.0	22.7	34.6	33.6	8.5	25.3	11.2	15.5	9.9	16.5	16.7	4.6	12.4	9.2	11.5	22.0	17.7	18.0	15.4	9.4	15.6	16.3	15.8	14.6	8.5	8.7	14.8	27.2	14.7	27.9	7.6	74.6	11.9	14.0	8.8	12.5	9.8	10.6	9.6	15.7	12.8	16.1	12.7	28.9	8.5	15.0	11.2	14.5	18.4	9.5	6.1	10.5	32.8	11.6	12.8	4.8	16.6	21.6	1.4	6.9	1.4	3.2	1.9	2.4	14.2	2.7	3.4	1.6	41.0	1.0	4.2	5.5	2.7	4.5	15.8	18.0	15.5	19.9	14.6	15.3	14.5	17.6	15.1	11.8
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866283-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	Nucleoli				Nucleoli		"HPA044502: AB_10960277, HPA053707: "	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavourable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	14.0	8.5	10.7	7.3	11.4	27.6	10.9	12.0	12.5	12.4	9.4	5.8	7.9	6.1	9.4	14.1	15.1	9.7	9.7	11.4	9.4	10.3	14.5	15.1	12.1	10.7	10.4	10.5	15.9	8.3	9.9	12.1	15.5	17.7	13.0	8.1	4.6	9.0	7.3	24.6	11.7	11.7	11.0	13.2	16.2	9.0	12.0	10.9	15.9	16.2	12.6	10.7	17.3	15.5	11.1	7.2	15.8	11.6	11.9	11.6	8.0	12.4	6.0	6.7	7.1	6.5	5.8	10.3	8.4	6.0	10.1	8.7	6.6	5.6	16.7	11.2	8.8	7.0	10.8	10.0	14.4	10.1	6.1	13.7	9.8	9.6	6.7	15.3	4.9	6.4	11.0	10.8	9.1	7.2	16.1	5.8	13.6	5.4	10.7	10.0	13.0	9.7	6.2	14.3	6.4	10.3	9.7	8.1	7.3	8.8	13.2	9.1	5.6	11.1	6.8	8.2	8.6	9.3	14.0	6.1	8.1	13.7	4.8	12.1	5.4	10.9	7.9	15.8	9.6	11.6	11.6	11.1	8.9	8.7	7.2	10.5	8.2	10.4	12.1	11.9	10.7	5.0	8.8	8.0	10.7	11.4	12.0	12.5	9.4	10.3	10.4	10.5	17.7	10.9
DOCK1	"ced5, DOCK180"	ENSG00000150760	"Dedicator of cytokinesis 1"	Q14185	10	126905409-127452517	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.5;plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004378, HPA048692, HPA053277"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004378: AB_2094604, HPA048692: , HPA053277: "	"unprognostic (4.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.49e-3)"	"unprognostic (8.98e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.83e-2)"	17.1	7.7	27.4	8.1	36.8	1.0	17.4	6.9	25.4	23.5	12.5	27.4	14.3	12.2	18.3	18.0	13.8	17.6	16.2	12.9	24.4	17.8	18.9	9.0	12.8	8.0	34.5	11.4	24.2	12.1	38.6	5.3	17.9	25.0	16.1	13.0	9.4	15.4	18.3	9.7	30.0	13.6	21.2	25.4	8.7	11.0	6.6	32.3	2.2	25.1	9.1	5.5	14.5	18.5	0.0	2.3	0.0	0.7	0.8	0.0	0.0	6.4	12.3	24.2	17.1	12.4	16.7	5.3	12.9	27.4	9.3	9.8	7.7	7.4	0.0	4.3	19.1	7.4	7.6	9.6	10.9	0.1	7.4	4.0	8.1	8.9	12.2	0.0	6.0	13.4	2.9	9.6	20.8	21.1	0.0	0.0	13.9	6.5	0.0	0.0	5.9	5.6	0.0	15.8	0.1	9.2	7.1	1.4	10.2	13.5	7.7	12.0	1.9	0.0	22.1	16.7	6.7	4.2	12.3	0.0	0.0	0.0	13.3	0.0	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	27.4	36.8	6.9	25.4	24.4	17.8	34.5	11.4	25.0	32.3
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042445	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;lymphoid tissue: 27.6"	"Cell line enhanced"	"Detected in many"		"BJ: 20.0;HDLM-2: 22.7;TIME: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA058106: "	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.2	7.6	17.1	16.7	28.8	8.8	4.0	3.0	18.4	9.5	5.9	27.6	0.0	4.1	3.4	1.4	3.4	2.5	6.4	1.8	24.3	14.7	2.9	5.4	7.3	23.9	33.3	9.6	15.9	1.8	1.9	1.4	2.5	23.2	2.0	6.7	1.1	4.1	2.0	1.3	5.0	8.5	4.4	37.7	26.5	6.1	2.3	35.5	27.6	2.7	1.3	18.4	6.6	3.7	6.8	6.2	2.6	9.6	12.8	10.5	4.0	0.0	9.4	3.0	0.0	3.9	8.3	0.0	20.0	16.4	9.6	7.2	0.0	0.0	0.2	0.0	12.6	0.2	0.0	0.0	7.7	22.7	0.0	0.2	2.0	0.0	0.1	1.9	0.9	1.9	0.2	13.9	5.4	9.5	0.0	18.8	16.2	0.9	3.4	2.6	1.1	2.2	4.5	4.4	2.7	0.5	0.0	0.1	2.5	0.0	0.0	2.0	0.6	8.7	21.2	10.4	2.5	4.9	6.8	0.0	0.0	0.0	14.7	12.9	4.5	2.6	2.8	0.2	6.2	8.2	6.4	6.8	10.5	8.8	6.2	3.8	10.4	9.0	0.1	12.8	9.6	2.6	7.5	4.0	17.1	28.8	3.0	18.4	24.3	14.7	33.3	9.6	23.2	35.5
DOCK3	"KIAA0299, MOCA, PBP"	ENSG00000088538	"Dedicator of cytokinesis 3"	Q8IZD9	3	50675241-51384198	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.0;HAP1: 5.4;HEK 293: 5.5;HMC-1: 6.4;U-87 MG: 10.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037543, HPA037544"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA037543: AB_10672495, HPA037544: AB_10670383"	"unprognostic (1.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-3)"	"unprognostic (6.35e-8)"	"unprognostic (2.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.83e-5)"	"unprognostic (7.96e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.24e-1)"	1.6	5.5	15.3	1.7	19.8	1.6	1.7	24.2	38.9	1.7	2.3	11.6	1.9	1.7	2.1	2.7	4.2	2.2	1.9	4.6	11.5	9.8	1.9	1.3	1.8	1.8	9.1	17.6	1.7	2.0	15.8	9.2	1.5	13.1	3.8	1.9	1.8	3.2	5.0	4.3	4.0	1.7	3.1	8.5	1.8	1.7	9.0	10.7	0.0	17.4	0.0	1.9	2.0	0.7	0.7	0.7	0.2	2.0	0.6	1.3	0.0	0.1	0.2	0.2	8.0	0.0	0.0	3.5	0.1	0.2	0.4	0.3	0.2	0.5	0.0	0.7	2.5	0.5	5.4	0.0	0.1	4.6	5.5	0.1	1.3	0.1	0.1	0.2	6.4	0.1	0.2	0.3	0.0	0.1	0.0	0.1	0.6	0.3	0.0	0.0	2.6	2.5	0.0	0.8	0.0	0.4	0.7	4.9	0.0	0.4	4.5	0.1	0.1	0.0	0.5	0.3	2.2	0.3	2.8	0.3	0.0	0.0	10.6	1.0	0.1	0.0	0.1	0.2	0.5	0.4	0.5	0.4	0.4	0.2	0.1	0.7	1.3	0.5	0.2	0.6	2.0	0.7	0.1	0.0	15.3	19.8	24.2	25.3	11.5	9.8	9.1	17.6	13.1	10.7
DOCK5	FLJ21034	ENSG00000147459	"Dedicator of cytokinesis 5"	Q9H7D0	8	25184723-25418082	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017719, HPA056837"	Approved		Enhanced	Cytosol				Cytosol		"HPA017719: AB_1847820, HPA056837: "	"unprognostic (2.16e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.25e-2)"	"prognostic favourable (1.91e-4)"	"unprognostic (8.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.18e-3)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (1.18e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	5.5	4.3	12.1	10.4	30.3	26.2	7.2	3.3	18.2	6.3	11.5	38.8	12.1	14.9	6.3	7.8	4.3	7.6	9.6	8.0	15.1	7.6	4.8	16.2	10.7	4.7	35.0	9.4	10.4	5.7	6.3	10.8	15.6	18.8	9.4	13.4	10.8	7.9	14.3	3.3	7.1	17.0	5.3	17.0	21.9	9.2	7.8	33.8	0.6	18.5	2.3	2.7	5.6	5.8	0.0	1.6	22.0	4.6	0.3	0.3	0.2	10.2	21.5	2.1	0.2	5.0	5.4	7.8	25.0	12.7	6.1	4.8	3.1	7.4	0.3	2.3	19.3	17.9	2.4	15.8	9.8	3.3	3.1	10.3	18.5	7.5	5.8	2.4	11.4	3.7	6.4	6.8	10.0	5.2	0.1	0.5	5.9	5.9	0.3	4.7	2.2	6.8	0.1	4.8	0.2	4.4	6.1	1.5	0.7	13.1	7.2	2.3	2.3	2.2	15.7	10.5	7.4	13.0	8.9	0.5	0.1	0.2	13.6	5.5	13.2	7.6	1.9	2.6	0.3	3.8	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	22.0	0.3	4.6	0.2	0.0	0.2	12.1	30.3	3.3	18.2	15.1	7.6	35.0	9.4	18.8	33.8
DOCK6	"KIAA1395, ZIR1"	ENSG00000130158	"Dedicator of cytokinesis 6"	Q96HP0	19	11199295-11262481	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 32.5;TIME: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049423, HPA049424"	Approved		Supported	Cytosol				Cytosol		"HPA049423: , HPA049424: "	"unprognostic (2.69e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.72e-3)"	"prognostic favourable (9.09e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.95e-1)"	17.8	4.9	6.4	5.1	7.9	0.0	12.8	3.3	8.5	7.1	12.6	6.7	6.5	10.3	11.0	8.6	9.3	4.9	8.8	10.5	6.1	2.3	12.2	7.3	19.7	3.6	8.1	2.0	5.8	8.1	3.7	6.2	11.1	6.7	7.1	4.5	10.2	7.4	5.8	9.8	18.2	11.7	13.4	5.5	7.1	10.3	5.4	5.3	1.3	14.5	8.6	7.6	7.3	22.9	1.5	0.0	0.0	0.5	0.0	0.3	0.2	6.6	4.2	4.8	3.9	3.6	5.2	7.7	2.0	3.3	2.0	3.1	7.8	5.2	0.4	12.3	3.3	3.9	2.0	10.5	1.2	5.7	3.3	1.3	0.9	5.8	5.8	1.9	6.6	4.0	6.2	3.6	8.2	32.5	7.1	0.0	4.3	15.1	0.0	6.7	6.0	7.9	0.4	3.2	6.3	3.2	9.3	0.2	8.5	1.9	2.0	3.6	2.3	3.5	32.3	3.7	3.8	8.2	3.5	0.6	0.1	6.5	3.1	1.4	3.2	0.0	0.3	0.0	0.3	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	6.4	7.9	3.3	8.5	6.1	2.3	8.1	2.0	6.7	5.3
DOK1	p62dok	ENSG00000115325	"Docking protein 1"	Q99704	2	74549026-74557554	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004224, HPA048561"	Approved		Supported	Cytosol			74000	Cytosol		"CAB004224: AB_627447, HPA048561: "	"unprognostic (2.40e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.60e-1)"	"prognostic favourable (8.42e-4)"	"unprognostic (9.86e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.10e-2)"	"prognostic favourable (4.64e-4)"	"unprognostic (7.57e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (3.16e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-2)"	13.2	4.9	4.7	11.2	6.0	15.7	13.3	1.3	3.3	6.2	5.9	5.3	2.6	4.3	7.0	3.6	3.4	5.5	8.0	5.0	4.9	4.2	4.7	2.3	8.0	9.5	6.9	2.8	6.7	10.9	5.5	3.1	5.0	5.4	5.6	5.1	3.1	4.1	5.0	2.0	2.2	7.2	4.7	6.7	15.5	6.6	4.5	5.2	14.5	8.8	1.3	10.8	5.0	7.7	6.9	13.9	17.9	16.1	7.4	5.6	9.9	2.1	0.6	2.0	1.5	4.3	4.7	1.9	4.3	2.7	1.3	2.1	0.7	2.2	1.0	6.8	4.1	0.3	2.9	1.2	0.7	31.2	2.9	13.3	1.9	0.1	3.6	7.6	14.3	4.5	0.0	10.7	4.9	1.7	4.1	2.8	3.1	2.2	6.1	16.6	4.1	0.9	4.9	3.9	1.6	1.0	1.9	0.9	3.7	1.4	0.2	3.4	1.5	11.1	3.4	10.5	6.1	5.7	1.0	4.4	3.2	0.0	10.1	10.8	1.8	10.8	15.1	11.3	4.9	14.3	4.1	6.7	3.9	4.2	13.9	6.9	3.6	3.6	17.9	7.4	16.1	2.9	5.6	9.9	4.7	6.0	1.3	2.8	4.9	4.2	6.9	2.8	5.4	5.2
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463311-3501473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.1;skeletal muscle: 17.0"	"Cell line enriched"	"Detected in some"	4	"MCF7: 27.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Group enriched"	"Detected in some"	8	"cerebellum: 8.7;pons and medulla: 2.5"	"Group enriched"	"Detected in some"	14	"memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2"	"Group enriched"	"Detected in many"	15	"B-cells: 6.3;NK-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA059449: , HPA062780: "	"prognostic favourable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favourable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favourable (1.28e-4)"	1.2	0.5	0.1	0.2	0.2	0.2	0.5	8.7	0.7	1.5	0.3	1.4	0.1	0.1	1.3	4.7	1.1	5.0	3.7	19.1	0.4	0.6	1.4	0.4	1.7	0.7	0.1	0.1	1.3	4.3	0.0	9.7	0.1	2.5	0.7	0.1	2.4	2.0	6.4	17.0	0.3	0.1	0.7	0.1	0.6	2.2	5.3	0.4	0.1	0.6	1.8	0.6	0.6	0.1	6.3	0.0	0.0	0.0	3.2	0.3	0.2	2.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.9	0.0	1.0	0.0	3.4	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.3	27.1	0.0	1.1	0.2	0.1	0.0	5.3	0.2	1.8	2.3	0.4	0.1	2.2	0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	3.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	8.7	0.7	0.4	0.6	0.1	0.1	2.5	0.4
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947619	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Enhanced	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: , HPA068706: "	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favourable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (6.88e-5)"	"unprognostic (6.13e-3)"	11.0	20.2	7.9	7.8	13.8	1.4	9.5	7.0	18.6	9.8	8.6	14.9	7.1	8.8	12.4	16.8	10.9	10.8	10.8	12.0	7.6	9.9	17.5	22.0	10.6	10.6	8.1	6.7	13.2	16.9	19.2	8.0	19.5	16.3	12.3	8.0	14.2	15.5	12.8	7.9	11.4	10.9	11.1	5.9	11.6	12.4	22.4	6.0	12.5	11.0	11.9	12.1	10.4	7.3	9.4	14.2	5.6	16.4	9.8	13.7	9.0	5.1	19.1	6.8	10.0	20.1	10.6	9.2	10.7	17.4	13.2	9.8	15.0	8.1	2.8	5.7	15.5	36.4	9.2	13.4	6.8	4.7	8.1	3.5	13.1	10.8	20.3	3.8	6.3	14.6	12.4	14.2	7.8	12.8	8.5	4.5	14.2	25.2	3.1	3.2	8.7	11.9	3.1	9.0	11.1	11.8	7.7	6.2	7.0	14.2	11.7	6.3	20.5	5.0	10.6	11.9	4.3	14.9	8.8	4.3	10.7	2.8	11.2	3.5	9.0	2.3	13.5	5.6	10.2	13.3	9.1	9.4	9.2	11.2	14.2	9.2	12.1	12.3	2.1	9.8	16.4	8.1	13.7	9.0	7.9	13.8	7.0	18.6	7.6	9.9	8.1	6.7	16.3	6.0
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2164149-2232578	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA011875: , HPA071217: , HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favourable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	7.3	8.8	7.0	10.7	11.7	20.1	5.1	20.6	11.7	4.5	7.9	9.8	6.0	13.5	6.4	4.9	8.3	5.4	6.9	5.7	7.0	3.6	9.5	8.5	10.0	8.4	11.9	5.3	6.5	10.8	3.6	8.3	11.6	7.1	5.7	4.9	9.5	6.1	7.4	9.8	9.9	13.0	4.2	6.7	10.4	13.3	64.7	9.7	10.5	9.2	7.0	9.1	4.8	5.3	0.7	1.0	3.0	0.9	2.8	1.4	0.6	12.0	6.5	22.1	12.1	1.6	2.4	29.1	6.9	1.5	3.8	3.0	8.3	4.5	14.2	3.3	4.4	10.9	7.3	3.8	1.8	7.2	9.2	13.1	10.6	8.1	2.7	18.6	24.1	2.4	2.9	7.3	3.7	3.1	15.8	14.9	2.9	6.9	14.9	20.6	17.1	11.6	15.4	6.3	9.7	2.1	5.7	14.8	11.4	4.8	14.4	9.1	6.6	14.3	4.4	10.6	9.6	15.6	13.2	13.8	18.0	9.8	10.5	12.9	6.1	0.5	0.7	3.0	0.9	0.3	1.4	0.7	0.8	0.2	0.9	0.7	0.5	0.3	0.3	2.8	0.9	1.0	0.1	0.6	7.0	11.7	20.6	11.7	7.0	3.6	11.9	5.3	7.1	9.7
DPF2	"BAF45d, REQ, ubi-d4"	ENSG00000133884	"Double PHD fingers 2"	Q92785	11	65333754-65353249	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020880, HPA056786"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA020880: AB_1847845, HPA056786: "	"unprognostic (2.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.40e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	18.5	16.3	22.5	14.3	26.4	23.0	17.0	29.4	28.6	26.3	24.8	41.7	16.9	14.1	31.5	25.5	19.5	34.9	20.8	27.1	21.4	20.4	14.7	12.2	17.3	21.4	30.4	18.6	46.3	18.1	21.9	17.7	19.8	23.2	22.9	15.9	21.7	19.7	30.5	27.6	14.2	17.9	31.2	27.3	23.3	18.9	27.0	30.3	40.6	26.1	10.8	25.8	25.2	21.3	36.9	26.4	56.1	26.5	41.8	35.2	33.7	13.3	17.0	21.5	18.7	19.4	19.7	12.0	11.6	16.5	25.8	18.6	16.6	16.2	18.2	19.3	15.9	14.3	24.7	14.9	18.5	21.5	10.8	23.1	12.1	16.9	30.0	21.1	17.1	17.2	14.5	22.9	42.0	20.5	21.7	23.8	16.8	21.6	26.5	21.6	23.9	17.3	29.0	14.1	21.1	15.9	11.1	14.0	12.8	15.0	21.2	20.3	27.6	11.6	12.0	16.7	14.8	18.2	11.7	29.3	34.5	23.3	10.2	13.9	18.6	53.0	26.5	46.9	29.4	23.9	31.7	36.7	28.6	28.5	26.4	36.9	30.0	27.1	56.1	41.8	26.1	24.2	35.2	33.7	22.5	26.4	29.4	28.6	21.4	20.4	30.4	18.6	23.2	30.3
DPF3	"BAF45c, cer-d4, Cerd4, FLJ14079"	ENSG00000205683	"Double PHD fingers 3"	Q92784	14	72619296-72894116	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.3;skeletal muscle: 28.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.4;BJ hTERT+ SV40 Large T+: 9.2;HEL: 22.8;Karpas-707: 9.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 56.3"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA066790, HPA070601"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA066790: , HPA070601: "	"unprognostic (2.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.85e-3)"	"unprognostic (4.08e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-1)"	0.7	2.2	6.2	1.1	10.3	3.2	0.8	56.3	7.6	0.9	2.7	8.4	0.0	0.8	0.8	0.5	1.2	0.7	1.0	16.8	6.4	2.5	2.2	4.3	0.8	1.5	8.9	4.5	17.8	0.7	8.4	0.9	0.9	10.4	0.7	2.4	3.4	0.8	0.7	28.4	1.1	1.7	1.2	10.1	1.4	1.1	6.6	10.7	0.0	0.8	6.3	1.8	0.8	0.7	1.9	0.0	0.0	0.3	0.4	0.8	0.2	1.5	0.0	1.2	0.1	0.2	2.2	13.4	4.0	3.8	9.2	3.5	0.0	0.1	0.2	0.2	1.2	0.1	1.3	0.6	5.6	0.2	0.4	22.8	0.1	0.0	0.3	0.1	0.4	0.6	0.2	2.1	1.5	2.9	2.0	9.3	2.9	0.1	1.9	0.2	0.0	1.3	5.0	0.6	0.3	1.6	0.0	0.9	0.5	0.0	0.1	0.0	0.0	0.0	6.4	4.5	0.0	1.6	0.5	3.3	0.8	0.3	0.4	0.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	6.2	10.3	56.3	7.6	6.4	2.5	8.9	4.5	10.4	10.7
DPH3	"DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2"	ENSG00000154813	"Diphthamide biosynthesis 3"	Q96FX2	3	16257978-16264972	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035287	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA035287: AB_10604113"	"unprognostic (2.49e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.44e-2)"	17.6	13.9	15.7	10.6	14.8	8.0	21.3	10.7	15.0	12.6	15.3	8.9	8.2	12.4	13.2	13.0	12.6	11.5	12.1	15.4	14.2	17.3	17.9	27.4	12.5	10.0	19.3	6.9	15.8	9.1	7.6	19.3	17.3	18.6	11.0	10.4	5.6	7.2	13.6	33.2	5.4	32.8	17.3	17.4	15.3	12.0	13.2	12.6	12.8	14.4	10.1	9.0	15.3	12.8	7.3	11.3	25.6	15.6	7.2	10.6	8.7	5.2	7.7	16.6	10.2	30.7	22.4	13.3	15.2	12.2	14.4	16.9	9.5	3.3	5.0	5.1	18.8	3.3	15.2	9.7	17.3	25.2	10.4	8.4	6.2	10.6	19.3	12.3	8.3	15.5	12.9	19.6	8.5	13.1	14.3	8.7	20.4	6.9	9.2	8.1	13.4	8.1	6.5	10.9	7.7	12.8	4.2	3.6	10.6	7.1	3.5	17.4	6.8	12.2	15.3	12.4	7.7	21.8	12.6	6.7	22.4	6.6	17.8	13.9	10.7	15.3	12.0	17.8	8.6	15.6	10.6	7.3	9.2	10.4	11.3	6.6	7.8	9.1	25.6	7.2	14.4	4.5	8.1	8.7	15.7	14.8	10.7	15.0	14.2	17.3	19.3	6.9	18.6	12.6
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: "	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	13.3	12.7	8.0	6.8	16.1	6.4	15.3	11.6	15.8	14.7	9.2	15.5	10.8	8.5	23.9	17.1	14.7	11.5	10.5	14.4	7.8	7.2	14.7	11.2	8.7	9.3	9.7	12.0	16.7	19.5	15.8	31.7	11.1	13.4	8.5	10.2	14.6	11.5	14.7	24.9	15.2	8.7	16.8	11.1	8.3	9.6	11.3	10.6	7.1	15.3	16.5	10.0	11.0	11.3	8.4	6.3	0.3	6.5	13.2	10.8	4.4	10.5	5.6	9.5	8.1	1.7	7.9	9.3	4.0	7.0	9.7	5.0	7.6	9.9	3.2	9.7	3.6	12.1	11.0	11.4	11.6	2.5	6.9	12.2	6.5	11.9	10.2	6.5	7.9	6.6	14.5	3.8	18.7	9.2	13.4	13.3	8.8	4.1	8.0	6.1	8.4	5.2	9.9	8.9	4.5	8.3	13.4	7.0	6.8	7.4	8.4	6.4	28.8	9.1	2.8	9.4	9.2	9.4	6.3	12.0	18.8	8.2	8.1	11.2	8.9	0.0	6.5	0.3	6.2	6.0	7.7	8.4	8.3	8.6	6.3	6.5	10.8	9.5	0.3	13.2	5.6	5.4	5.4	4.4	8.0	16.1	11.6	15.8	7.8	7.2	9.7	12.0	13.4	10.6
DPP3		ENSG00000254986	"Dipeptidyl peptidase 3"	Q9NY33	11	66480013-66509657	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035780, HPA035781"	Approved		Supported	Cytosol			2600000	Cytosol		"HPA035780: AB_2674778, HPA035781: AB_10669529"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.85e-2)"	"prognostic favourable (1.34e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.66e-2)"	10.4	13.0	5.2	16.8	12.1	10.9	16.9	13.7	11.5	7.3	18.5	9.1	10.3	15.3	10.5	6.8	15.6	7.1	15.7	8.4	9.3	5.9	18.4	31.1	9.8	20.0	9.5	10.6	5.1	11.6	11.2	6.9	10.9	7.4	10.3	16.9	5.7	17.6	8.5	15.8	9.4	15.5	10.0	10.6	12.5	11.8	15.5	6.7	16.1	10.5	10.8	14.0	11.4	8.6	7.5	19.7	12.2	24.4	18.2	17.9	9.9	28.5	24.8	11.5	12.8	9.6	10.4	17.9	16.2	21.8	21.9	14.6	31.2	24.0	16.6	55.2	18.3	25.7	18.3	19.8	14.1	31.5	8.3	21.6	11.6	18.3	14.8	26.1	36.1	14.7	19.4	16.4	8.2	16.7	15.1	9.9	19.9	32.4	30.4	26.6	19.6	15.2	21.5	11.6	27.2	18.8	24.6	21.8	18.7	13.8	16.1	21.6	25.0	15.3	17.4	13.1	14.3	14.4	15.8	8.3	15.1	18.9	17.4	12.5	16.1	9.6	11.3	12.2	13.7	24.4	8.4	7.5	10.3	11.4	19.7	7.2	6.3	9.2	2.0	18.2	16.0	13.7	17.9	9.9	5.2	12.1	13.7	11.5	9.3	5.9	9.5	10.6	7.4	6.7
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110542-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 56.7;THP-1: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		1300000	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: "	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavourable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favourable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	28.1	45.2	23.7	23.4	35.3	31.8	20.8	23.5	27.5	21.5	22.0	24.9	40.7	23.2	17.5	35.8	19.1	27.0	30.2	44.7	24.6	29.2	21.0	29.9	25.6	34.8	29.7	25.9	14.3	55.4	23.3	42.5	21.9	24.2	28.8	6.9	32.8	73.1	41.6	25.3	26.9	17.8	22.8	21.7	29.1	24.4	30.9	26.8	18.9	41.2	17.5	24.7	21.3	16.6	20.0	60.8	12.2	43.1	19.2	36.8	38.2	6.8	10.9	0.9	0.9	13.5	10.8	1.4	10.4	17.0	6.9	4.5	10.3	5.7	13.6	11.4	6.8	14.9	8.0	2.0	0.3	13.3	0.5	6.2	15.0	0.3	30.2	16.8	34.9	13.3	8.3	3.0	6.2	9.0	13.6	10.6	4.6	19.0	8.4	16.0	3.7	10.7	12.4	0.1	56.7	11.0	7.7	17.4	12.1	12.0	31.6	29.4	11.3	54.5	10.9	17.7	6.0	11.2	7.2	13.0	7.4	3.6	21.2	10.2	7.9	6.8	43.1	12.2	34.4	37.6	35.5	19.7	31.1	29.6	41.7	20.0	28.1	25.1	2.6	19.2	22.6	60.8	36.8	38.2	23.7	35.3	23.5	27.5	24.6	29.2	29.7	25.9	24.2	26.8
DPP8	"DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141"	ENSG00000074603	"Dipeptidyl peptidase 8"	Q6V1X1	15	65442463-65517704	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008706	Approved		Supported	Cytosol				Cytosol		"HPA008706: AB_1078665"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.59e-1)"	15.6	16.1	16.4	14.9	18.8	16.2	13.9	22.9	24.9	15.5	14.5	15.0	12.7	18.0	15.9	13.9	13.1	11.1	12.4	18.8	15.1	14.6	16.0	9.9	13.3	16.0	15.4	11.8	16.2	11.7	22.2	14.5	15.9	21.7	13.5	15.8	13.9	15.6	20.8	30.5	14.2	16.5	16.2	17.5	17.2	13.2	29.9	15.8	22.5	17.4	12.5	16.0	16.2	13.2	10.7	8.1	20.0	10.8	6.1	10.3	5.3	9.4	15.3	10.1	10.1	11.4	16.4	8.6	15.3	18.1	13.7	13.2	6.6	8.2	16.7	12.1	19.1	17.7	19.5	11.0	16.8	14.1	12.1	16.1	11.8	6.3	11.9	20.7	15.9	12.2	10.5	11.1	10.5	15.0	10.9	15.6	16.8	7.6	11.0	7.6	6.9	7.9	14.7	18.7	16.2	11.3	20.6	7.2	12.7	9.9	10.1	15.4	9.3	12.4	18.9	18.4	12.9	8.7	16.3	20.2	26.4	17.0	13.9	20.9	13.2	20.0	9.1	11.1	9.9	9.2	10.3	9.2	8.6	9.5	8.1	10.7	8.6	9.2	18.3	6.1	10.8	7.5	8.9	5.3	16.4	18.8	22.9	24.4	15.1	14.6	15.4	11.8	21.7	15.8
DPP9		ENSG00000142002	"Dipeptidyl peptidase 9"	Q86TI2	19	4675224-4724673	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036059	Approved		Supported	Cytosol				Cytosol		"HPA036059: AB_10671240"	"prognostic favourable (4.96e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.03e-1)"	"prognostic favourable (6.21e-5)"	"unprognostic (5.67e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (3.38e-8)"	"prognostic favourable (7.72e-5)"	"unprognostic (1.55e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.80e-1)"	18.1	11.9	11.7	24.3	14.0	25.8	13.7	13.0	12.5	12.6	16.3	14.2	15.8	18.3	15.3	10.5	17.4	11.6	13.5	19.7	11.0	7.2	13.5	38.6	19.3	20.7	14.7	7.1	13.5	15.5	9.5	9.8	15.2	11.7	14.0	13.1	14.2	13.1	12.9	46.4	21.5	18.9	14.2	9.3	21.0	14.7	7.1	13.9	24.3	14.6	16.3	17.0	16.0	21.7	10.3	9.0	10.0	10.5	13.4	13.8	8.0	23.5	18.8	5.5	8.7	8.5	11.9	10.1	13.8	18.4	23.3	15.2	16.9	18.3	11.2	10.5	17.8	16.1	11.3	63.6	14.3	14.3	10.9	8.1	10.3	14.4	13.0	14.2	17.8	9.1	14.8	36.4	21.6	21.0	11.2	24.9	20.1	6.4	16.5	9.2	11.4	28.0	10.3	11.9	13.0	12.1	16.2	7.9	7.1	11.9	21.6	9.1	5.9	11.9	16.9	20.9	9.1	32.3	27.5	17.4	18.1	11.2	20.4	16.5	17.5	10.0	8.8	9.4	13.8	10.5	10.5	10.3	6.4	11.2	9.0	6.8	6.3	9.9	4.7	13.4	7.8	4.3	11.3	8.0	11.7	14.0	13.0	12.5	11.0	7.2	14.7	7.1	11.7	13.9
DPY30	"Cps25, HDPY-30, Saf19"	ENSG00000162961	"Dpy-30, histone methyltransferase complex regulatory subunit"	Q9C005	2	31867809-32039812	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043761	Supported		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA043761: AB_10960501"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (4.26e-4)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-1)"	20.3	41.8	38.2	22.6	34.8	14.6	34.2	30.1	36.0	30.5	25.8	19.4	28.9	23.1	25.6	44.3	31.8	49.7	23.8	23.9	35.4	44.2	42.1	44.7	23.6	24.6	40.4	33.1	24.5	25.8	21.4	39.4	23.4	38.6	32.0	25.6	17.6	34.7	35.1	24.5	26.2	24.6	26.8	41.4	19.8	24.2	13.4	31.0	22.1	49.1	26.9	25.3	26.4	25.4	57.8	35.2	50.6	37.2	34.4	67.7	43.5	52.5	36.4	27.5	21.2	24.2	36.1	36.9	27.3	24.5	22.2	21.9	52.2	42.6	32.5	28.0	24.0	21.4	25.1	31.7	24.2	37.9	40.3	29.2	26.6	58.5	21.4	29.5	18.3	24.3	37.0	23.8	21.1	35.0	34.0	23.2	33.7	57.1	33.1	59.8	37.9	38.0	27.1	32.5	40.8	38.7	36.3	44.5	31.8	27.1	38.2	36.6	26.6	21.7	26.8	20.4	32.9	18.8	33.0	27.4	40.4	42.5	21.4	32.3	24.7	46.0	37.2	50.6	36.3	34.0	43.8	57.8	51.0	44.4	35.2	46.1	45.8	43.0	41.4	34.4	37.0	32.1	67.7	43.5	38.2	34.8	30.1	36.0	35.4	44.2	40.4	33.1	38.6	31.0
DPYSL2	"CRMP2, DHPRP2, DRP-2, DRP2"	ENSG00000092964	"Dihydropyrimidinase like 2"	Q16555	8	26514022-26658178	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.4;Karpas-707: 62.2"	"Cancer enhanced"	"Detected in all"		"glioma: 89.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 25.5;monocytes: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002381, CAB018719"	Supported		Supported	"Plasma membrane,Cytosol"			3900000	Cytosol	"Plasma membrane"	"CAB018719: AB_2085366, HPA002381: AB_1847244"	"unprognostic (2.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (5.41e-5)"	31.6	21.7	53.5	13.4	48.1	3.0	21.3	51.8	137.0	14.6	12.2	54.7	3.9	7.1	14.2	8.1	12.0	14.7	18.0	27.2	52.9	48.6	12.1	11.2	45.3	9.9	56.5	45.4	25.8	7.5	5.1	7.2	25.6	46.9	9.8	12.4	8.2	6.5	10.3	10.9	10.2	9.7	19.9	70.1	19.0	8.5	7.5	44.9	5.8	7.7	5.2	12.3	14.0	13.1	3.2	25.5	0.6	26.7	4.0	4.6	8.8	4.7	22.7	22.4	11.9	60.4	27.9	2.2	9.2	21.4	8.8	11.5	8.8	6.8	7.0	6.7	28.7	4.6	23.5	9.2	8.4	15.8	2.0	7.9	8.6	12.4	38.7	1.7	3.2	34.5	13.3	24.0	14.0	17.6	0.2	62.2	8.8	3.0	13.5	1.7	17.5	4.4	18.0	9.0	4.6	14.7	5.4	10.2	21.5	11.2	0.1	6.0	1.7	3.2	31.7	20.0	8.1	16.5	4.0	8.8	9.0	5.5	28.9	10.4	10.1	0.4	24.0	0.2	3.5	26.7	1.2	3.2	3.1	2.3	25.5	1.7	1.6	2.1	0.6	4.0	16.2	15.1	4.6	8.8	53.5	48.1	51.8	68.4	52.9	48.6	56.5	45.4	46.9	44.9
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390811-147510056	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 91.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 34.8;SH-SY5Y: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Supported	Cytosol			170000	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (8.23e-4)"	21.7	7.2	22.9	18.9	20.4	0.5	14.1	6.7	31.0	26.8	39.7	20.9	31.4	6.8	38.8	28.0	28.8	20.1	33.9	18.5	23.7	24.7	2.5	1.8	16.2	6.1	16.7	15.2	33.0	2.2	1.0	4.2	7.1	27.0	40.0	14.3	32.3	7.1	61.4	22.1	7.3	12.9	91.4	24.7	9.1	15.0	12.1	15.9	0.3	7.2	15.5	9.6	45.6	18.9	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	6.0	10.9	0.0	0.4	11.1	0.2	5.7	27.4	12.2	16.3	18.8	0.5	0.0	1.6	16.6	0.6	2.2	0.2	13.7	2.6	4.9	0.0	5.2	0.0	11.0	0.0	0.0	2.1	0.1	26.3	10.4	34.8	0.0	0.2	6.9	0.0	0.0	0.1	23.1	9.0	0.0	23.1	0.0	10.7	2.3	8.0	117.8	0.0	0.0	1.8	0.0	0.1	15.2	8.9	6.7	21.6	21.0	19.5	3.4	0.0	8.2	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	22.9	20.4	6.7	12.5	23.7	24.7	16.7	15.2	27.0	15.9
DR1	"NC2-BETA, NC2B, NCB2"	ENSG00000117505	"Down-regulator of transcription 1"	Q01658	1	93345888-93369498	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050785, HPA055308"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA050785: AB_2681237, HPA055308: AB_2682779"	"unprognostic (1.46e-1)"	"unprognostic (9.62e-2)"	"prognostic favourable (4.79e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (9.95e-7)"	"unprognostic (8.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.60e-1)"	18.5	15.2	14.6	19.4	17.9	37.2	16.9	20.1	18.7	19.2	19.0	17.5	12.6	19.4	20.7	9.7	26.7	13.6	17.0	19.0	14.5	13.9	17.0	17.8	19.0	28.2	15.0	10.1	17.1	14.3	14.4	17.6	25.9	14.2	17.6	12.2	16.7	18.2	10.9	32.2	27.0	21.4	15.4	15.9	21.8	21.8	44.4	14.9	63.4	17.8	17.8	25.4	20.5	22.1	19.0	28.0	39.8	26.0	16.5	27.9	18.7	32.6	10.3	16.5	21.2	15.3	17.5	20.3	26.5	16.3	18.1	19.3	11.9	11.9	34.7	30.8	19.5	17.4	19.7	18.3	26.7	29.1	18.5	29.1	21.6	13.0	24.4	34.2	21.5	12.2	22.1	25.1	36.6	16.0	30.0	33.6	21.3	10.1	32.4	10.8	27.5	25.2	28.2	36.5	35.3	12.8	19.9	16.1	20.4	22.5	21.0	27.8	14.8	27.1	24.8	32.7	26.1	32.0	39.5	19.5	21.6	35.9	9.4	27.4	13.3	36.8	22.8	39.8	19.0	26.0	21.1	19.0	21.0	21.6	28.0	16.1	21.2	20.6	31.9	16.5	22.1	22.9	27.9	18.7	14.6	17.9	20.1	18.7	14.5	13.9	15.0	10.1	14.2	14.9
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117333-111140216	"Predicted membrane proteins"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 17.6;THP-1: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: "	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavourable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"	21.8	10.1	5.9	14.4	6.6	7.9	18.4	13.5	6.9	8.4	12.0	7.5	5.7	10.6	8.6	11.1	10.0	12.7	9.1	11.7	5.3	6.0	13.0	9.2	11.5	19.9	9.3	4.2	12.3	8.2	5.7	9.9	14.1	8.4	10.1	8.7	8.8	10.7	7.1	10.6	7.0	15.2	10.1	15.1	24.9	9.5	6.1	8.3	15.0	10.6	6.7	14.7	16.8	7.7	16.1	11.2	3.0	10.9	6.2	10.4	11.4	2.0	0.1	3.4	2.0	8.5	7.2	6.0	8.1	3.1	2.0	4.6	2.5	1.1	7.3	5.4	4.0	2.3	4.8	1.3	3.9	8.8	3.4	4.1	2.5	1.2	6.4	0.6	1.8	5.0	6.1	3.3	1.3	1.0	2.3	3.3	2.4	1.4	3.9	5.3	6.5	4.1	3.8	3.8	3.1	7.3	2.1	6.5	2.4	0.9	2.7	17.6	4.7	19.3	3.5	0.6	0.8	4.1	5.4	4.2	1.2	12.5	1.5	8.1	1.3	2.7	10.3	3.0	6.5	10.9	10.4	13.6	9.0	8.1	11.2	16.1	9.5	7.9	2.1	6.2	7.6	11.2	5.4	11.4	5.9	6.6	13.5	5.4	5.3	6.0	9.3	4.2	8.4	8.3
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399523-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 86.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001218	Enhanced		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	14.5	18.1	12.3	10.6	18.1	11.9	15.3	14.1	20.9	12.7	10.5	13.3	11.7	9.3	13.6	17.6	13.4	14.7	8.4	18.5	11.2	12.7	15.3	15.7	9.4	11.1	12.6	14.9	15.7	16.4	14.2	11.9	19.6	17.2	13.5	13.3	14.3	17.0	13.3	47.0	11.9	10.1	14.9	10.9	11.7	12.4	86.8	9.9	23.6	17.8	12.1	15.7	15.0	10.5	29.4	25.2	25.1	27.1	25.0	27.6	24.8	22.0	18.2	22.6	18.6	20.3	24.0	18.1	20.7	25.2	38.9	32.7	29.7	11.3	32.5	11.2	25.9	18.9	38.9	25.1	42.5	15.1	47.2	20.9	20.9	29.9	29.2	50.3	19.7	20.4	18.8	31.5	47.8	26.9	26.9	14.0	29.8	25.9	20.1	25.8	18.0	20.3	27.7	36.0	28.4	25.5	20.3	24.1	15.1	23.2	23.2	29.5	17.4	22.2	15.0	17.5	23.3	17.6	23.2	19.0	21.4	31.3	17.1	22.2	22.5	13.7	23.9	25.1	20.5	27.1	23.8	29.4	22.1	25.2	25.2	21.7	24.7	23.9	5.4	25.0	19.9	22.1	27.6	24.8	12.3	18.1	14.1	20.9	11.2	12.7	12.6	14.9	17.2	9.9
DRG2		ENSG00000108591	"Developmentally regulated GTP binding protein 2"	P55039	17	18087886-18107971	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007716	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA007716: AB_1078705"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"prognostic favourable (1.56e-4)"	"unprognostic (1.26e-3)"	"unprognostic (7.86e-2)"	"unprognostic (8.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.88e-3)"	"prognostic unfavourable (7.34e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	19.9	19.9	16.1	17.5	21.8	17.4	19.3	14.7	30.8	19.3	19.3	22.9	16.6	19.2	23.5	22.8	21.6	25.2	18.2	22.4	15.7	17.0	19.1	31.9	15.7	21.2	17.6	16.1	27.6	23.9	20.6	18.8	22.4	17.9	21.1	13.4	18.4	21.7	21.7	33.3	19.4	17.9	18.3	17.1	20.7	17.6	14.6	17.2	21.6	23.6	21.2	25.6	20.5	18.0	12.6	18.4	17.0	20.9	20.0	19.8	14.0	16.8	24.1	8.2	8.1	15.3	16.3	15.7	11.9	11.8	19.3	18.0	25.5	10.1	16.3	15.5	13.7	17.8	13.5	16.5	13.1	14.4	36.9	7.1	12.8	14.2	16.6	6.5	11.4	18.1	14.7	19.3	16.3	18.4	12.5	6.4	11.2	19.0	17.3	11.0	6.1	17.7	18.6	19.9	30.2	11.5	9.9	4.7	13.3	11.8	7.0	14.6	13.9	9.9	13.8	9.3	8.9	10.9	19.5	7.3	8.9	9.2	13.4	11.9	17.1	11.6	15.9	17.0	19.8	17.2	16.4	12.2	14.7	15.8	18.4	12.6	14.0	15.3	2.1	20.0	20.9	10.3	18.3	14.0	16.1	21.8	14.7	30.8	15.7	17.0	17.6	16.1	17.9	17.2
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30990008-31042815	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.3;hippocampal formation: 3.6"	"Not detected"	"Not detected"			"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"			2700000	"Plasma membrane, Cell Junctions"		"CAB037328: , HPA049265: , HPA073937: "	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.04e-5)"	1.5	0.0	0.0	0.6	0.0	0.0	10.4	0.0	0.0	11.9	1.0	0.0	0.4	0.1	2.1	1.4	73.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	2.4	0.1	16.0	0.1	4.5	0.0	0.0	7.2	0.3	0.2	99.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	2.2	0.0	92.4	28.4	1.0	14.4	0.7	0.2	1.0	0.5	0.4	0.4	0.1	4.4	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.4	0.0	16.0	0.0	0.0	3.8	0.2	1.3	0.1	2.6	0.0	0.0	2.7	41.1	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.7	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.3	0.2	0.2	0.4	0.3	0.2	0.0	0.7	0.3	0.4	1.0	0.4	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: "	"unprognostic (1.28e-1)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.4	2.2	7.8	7.3	21.1	14.0	8.8	12.3	29.0	15.5	22.7	0.0	2.9	0.2	1.1	21.4	19.9	1.1	28.9	20.3	10.7	4.8	0.7	3.3	0.1	23.6	0.4	0.5	29.6	12.5	17.1	16.8	9.1	0.2	4.8	7.3	0.3	1.3	0.6	4.2	0.6	1.8	7.2	4.9	10.2	0.7	2.6	2.0	11.9	0.0	0.2	0.1	1.2	3.4	15.6	4.6	3.9	9.8	1.0	0.3	0.5	8.3	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498043-31549008	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.2;HaCaT: 58.0;HBEC3-KT: 43.0;hTERT-HME1: 46.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"pons and medulla: 6.9"	"Cell type enriched"	"Detected in single"	10	"basophil: 9.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"			94000000	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavourable (8.22e-4)"	"prognostic favourable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavourable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favourable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	17.3	1.1	0.6	11.6	0.7	0.0	21.1	0.7	0.7	3.9	50.2	1.3	4.0	18.1	3.8	5.6	6.3	4.9	14.2	15.7	0.7	0.6	22.4	10.8	7.0	2.4	0.6	0.9	8.8	15.5	39.9	2.7	39.8	6.9	10.4	23.8	4.5	27.3	1.5	2.2	5.3	70.7	3.1	0.5	0.6	17.3	2.3	0.5	13.6	20.8	3.2	5.8	18.5	7.7	0.1	0.9	9.5	0.0	0.0	0.3	0.0	24.8	9.6	0.8	0.0	0.1	1.6	31.3	0.0	0.0	0.0	0.0	6.7	37.2	0.0	14.1	0.0	58.0	11.8	43.0	0.0	0.0	7.3	0.0	11.1	7.5	4.5	3.1	0.0	2.2	29.9	0.9	46.9	0.0	9.8	0.0	0.0	6.5	6.6	0.4	12.0	5.0	11.0	0.0	15.9	14.4	12.4	5.2	0.0	18.9	13.4	0.0	9.6	2.7	0.0	0.0	5.6	0.0	6.1	1.2	0.0	0.0	4.4	0.0	5.4	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.6	0.7	0.7	0.7	0.7	0.6	0.6	0.9	6.9	0.5
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 homolog, MIS12 kinetochore complex component"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Cytosol"	"HPA002813: AB_1078343, HPA030627: "	"unprognostic (3.60e-2)"	"prognostic favourable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavourable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	6.7	10.4	5.6	15.6	7.4	11.6	8.2	5.4	7.2	5.1	8.6	4.1	9.5	6.3	9.5	12.0	9.1	5.0	8.1	6.2	5.1	4.7	5.8	8.6	6.1	11.0	4.8	3.9	5.3	5.4	3.6	7.6	12.9	5.1	6.5	10.3	10.1	9.7	8.1	4.6	7.3	8.8	5.9	4.1	11.6	7.0	27.2	4.1	21.2	6.3	11.4	13.8	5.8	5.5	10.9	25.4	21.7	5.9	5.6	6.5	3.7	13.1	11.9	14.0	11.1	5.5	7.2	9.2	16.1	13.6	24.7	27.9	20.6	17.0	15.1	10.7	8.7	17.3	13.0	12.6	23.6	6.7	8.3	29.5	11.4	13.8	1.2	16.9	13.0	2.8	3.6	17.1	5.4	12.0	11.5	12.6	16.2	9.4	21.6	13.0	6.5	21.0	17.0	42.6	10.1	6.2	7.8	14.3	6.5	20.0	20.6	9.7	21.0	11.4	6.3	22.6	13.8	22.1	17.3	10.6	14.2	17.2	19.0	15.3	16.1	21.7	3.6	7.5	4.4	5.9	4.9	8.8	4.8	5.8	3.9	10.9	5.9	5.5	6.5	5.6	5.0	25.4	6.5	3.7	5.6	7.4	5.4	7.2	5.1	4.7	4.8	3.9	5.1	4.1
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541575-7586717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 138.3;skin 1: 136.5;tongue: 189.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.5;HaCaT: 49.1;HBEC3-KT: 35.3;hTCEpi: 111.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"naive B-cell: 5.8"	"Lineage enriched"	"Detected in single"	59	"B-cells: 5.8"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 12.8"	"Low region specificity"	"Detected in all"			"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"			110000000	"Cell Junctions"		"CAB037324: , HPA045840: , HPA054950: "	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favourable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavourable (1.82e-4)"	1.3	2.7	0.9	9.6	0.7	0.0	12.5	0.6	0.8	27.5	19.4	0.2	9.1	8.1	2.8	11.2	138.3	2.5	8.7	71.8	0.7	0.6	8.7	21.9	8.0	1.4	0.6	0.9	1.4	23.0	8.1	2.7	25.7	2.5	9.0	7.0	3.4	25.6	8.5	0.6	136.5	28.2	1.1	1.4	1.0	7.4	0.8	0.1	15.0	17.1	189.6	48.7	3.1	46.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	20.6	6.2	0.0	0.0	0.9	1.4	45.5	4.0	3.5	2.0	2.0	17.7	5.4	0.0	5.8	6.5	49.1	7.5	35.3	0.3	0.0	8.7	0.0	3.5	23.8	0.0	0.1	0.1	0.3	111.4	1.8	20.4	0.0	0.0	0.0	3.6	9.7	0.0	0.1	0.9	3.1	0.0	0.0	5.2	7.5	5.6	2.1	0.0	4.6	9.8	0.0	11.6	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.9	2.5	0.1
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: , HPA032031: "	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.5	10.7	18.4	9.2	1.1	2.3	9.0	15.8	9.8	14.9	22.3	6.6	11.1	9.5	5.9	6.0	9.8	24.2	13.3	21.6	11.5	11.6	15.2	14.1	8.1	0.0	19.9	9.5	1.0	0.4	24.2	12.9	6.8	18.1	19.4	17.2	5.0	26.6	9.1	21.2	12.4	21.1	32.4	18.4	4.2	8.7	11.5	18.0	15.0	14.4	6.5	12.2	9.1	3.7	15.0	11.2	15.4	17.7	7.1	11.1	22.0	7.6	13.2	14.5	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522801-15663058	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody				Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favourable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (8.72e-4)"	"prognostic favourable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	7.2	5.0	22.8	10.5	91.0	9.3	7.7	6.7	18.4	6.8	10.5	7.8	4.5	7.2	8.0	12.5	7.2	6.9	7.9	12.0	15.0	18.0	11.3	5.0	8.4	16.9	18.5	10.3	7.3	6.7	13.1	8.5	9.3	13.7	8.1	10.9	13.4	6.7	10.1	15.4	7.1	7.6	11.9	9.4	10.2	7.6	5.5	17.2	9.3	7.8	2.7	19.4	8.6	8.1	17.8	17.9	8.1	7.1	26.9	12.1	6.6	15.5	6.8	5.8	12.5	8.5	9.7	8.9	8.0	10.5	19.4	17.5	8.9	7.2	22.0	21.7	11.3	5.4	11.4	8.5	17.6	14.1	15.2	15.4	8.9	13.2	14.9	15.5	13.2	9.2	13.1	9.8	14.6	17.0	14.6	5.5	11.6	18.3	16.2	24.8	4.1	9.8	19.2	11.4	17.2	18.0	16.3	11.9	5.0	6.3	15.1	18.9	10.9	10.0	7.8	10.9	7.2	11.3	14.7	14.9	28.3	15.5	5.1	13.8	20.7	5.9	5.9	8.1	12.1	7.1	8.0	13.7	10.3	10.4	6.4	17.8	9.8	7.9	6.8	26.9	4.9	17.9	6.9	6.6	22.8	91.0	6.7	18.4	15.0	18.0	18.5	10.3	13.7	17.2
DTWD2	FLJ33977	ENSG00000169570	"DTW domain containing 2"	Q8NBA8	5	118837322-118988545	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053173, HPA054864"	Approved		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA053173: , HPA054864: "	"unprognostic (1.66e-1)"	"unprognostic (1.60e-1)"	"prognostic favourable (3.16e-4)"	"unprognostic (4.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.15e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (6.09e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.59e-1)"	5.9	8.2	8.5	4.5	8.6	1.9	6.9	10.9	8.9	9.9	6.7	8.7	7.3	6.0	5.5	4.8	8.3	4.9	6.9	14.3	7.1	6.0	14.7	9.8	4.7	3.8	6.0	7.4	4.0	8.5	14.1	6.2	3.5	6.6	7.0	6.7	7.5	7.4	10.0	18.4	5.7	6.6	6.4	8.0	5.9	5.2	5.7	7.2	5.3	17.7	8.2	6.7	7.0	5.2	3.9	2.7	2.8	2.2	3.1	3.3	1.7	6.0	3.8	4.7	6.7	2.8	1.2	5.7	6.1	3.9	8.2	9.6	2.4	4.3	5.2	11.8	4.1	6.3	7.8	6.1	9.6	2.1	7.3	6.4	6.8	3.3	2.3	7.6	9.1	2.3	9.6	3.4	3.7	2.6	6.1	7.5	4.4	6.4	6.4	3.7	5.3	3.0	2.4	4.7	2.4	9.3	9.0	2.6	4.3	6.3	5.3	7.2	13.4	4.7	3.0	8.9	7.5	3.2	8.2	5.5	9.9	4.1	5.2	4.3	4.6	2.8	1.9	0.9	1.4	1.5	1.5	2.6	1.5	2.1	2.3	3.9	3.0	3.3	2.4	3.1	2.2	2.7	0.7	1.7	8.5	8.6	10.9	8.9	7.1	6.0	6.0	7.4	6.6	7.2
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.7;lymphoid tissue: 13.3"	"Group enriched"	"Detected in some"	12	"Daudi: 40.0;REH: 16.4;U-698: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA051249: , HPA055275: "	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.7	2.3	6.1	8.9	7.0	3.2	3.9	7.3	8.3	0.8	0.7	1.1	0.5	1.6	2.0	0.5	1.2	1.7	1.0	2.7	5.4	5.9	1.7	6.4	0.5	13.3	3.7	4.2	0.5	2.0	0.0	2.2	0.9	4.6	0.8	0.2	1.4	3.2	0.5	0.5	0.5	2.2	0.5	1.1	9.8	1.0	4.9	0.5	0.5	1.3	0.5	8.1	0.5	0.5	2.3	0.0	0.0	0.0	1.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.7	0.0	16.4	0.0	0.9	0.0	0.0	1.0	2.7	0.1	0.1	0.9	0.0	0.1	0.4	0.0	1.5	0.0	0.0	0.2	0.0	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.2	6.1	7.0	7.3	7.1	5.4	5.9	3.7	4.2	4.6	0.5
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.1;esophagus: 19.2"	"Cell line enhanced"	"Detected in all"		"A549: 28.0;CAPAN-2: 46.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA042931: "	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	2.9	1.3	0.4	4.8	0.5	1.5	3.2	0.4	0.2	4.8	5.7			4.1	3.0	0.0	19.2	3.2	3.8	1.8	0.5	0.5	1.6	2.8	3.2	3.9	0.7		2.7	4.3	3.8	2.1	1.8		4.6	3.2		10.5	1.3	2.8	11.6	5.5	1.3	1.1	4.9	6.1	8.3			2.7		4.0	4.6	8.8	7.0	14.7	19.1	14.1	3.3	9.0	6.4	12.7	28.0	4.2	6.1	2.4	2.3	9.0	2.7	2.4	3.1	4.2	7.8	46.2	4.0	2.0	2.7	9.6	2.2	13.3	1.9	8.9	4.7	2.3	5.7	6.8	3.2	3.3	5.8	4.1	8.1	7.9	4.3	2.3	6.9	6.0	3.7	6.2	5.0	11.5	6.0	4.2	5.6	3.8	7.1	1.4	10.0	1.6	3.4	4.5	7.7	3.7	7.7	8.8	2.4	17.3	8.2	5.8	11.0	4.5	5.3	4.5	3.7	3.5	8.8	12.4	9.2	13.3	7.6	10.9	5.5	6.0	6.4	7.5	8.4	7.0	6.6	6.9	19.1	3.3	14.1	14.7	9.0	6.4										
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564238-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.3;BJ hTERT+ SV40 Large T+ RasG12V: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	32.3	13.0	5.9	22.7	8.4	8.1	11.2	2.0	6.8	14.2	18.5	5.9	6.0	14.8	14.0	12.8	17.9	12.0	15.1	21.5	5.0	5.1	17.3	39.2	21.3	18.3	6.4	3.3	21.7	18.5	10.3	13.9	22.2	6.5	20.9	12.1	7.6	13.9	9.8	14.6	6.2	31.8	10.8	9.7	35.2	12.4	4.9	6.9	24.8	23.9	8.0	18.3	17.0	22.1	6.4	6.5	21.9	13.6	7.8	10.2	6.7	11.4	3.5	1.0	3.0	4.7	10.9	3.9	3.0	11.1	35.3	43.7	3.4	11.8	1.3	5.9	4.9	11.6	3.5	4.8	7.8	9.7	1.3	10.0	2.6	3.6	9.3	5.1	7.9	9.4	5.7	5.3	3.0	6.6	1.2	7.2	2.6	3.5	12.4	3.6	0.6	6.5	13.8	8.1	2.2	9.0	7.4	1.5	1.6	6.2	2.8	22.3	3.2	6.5	8.1	4.0	5.7	0.4	3.8	2.6	1.4	6.1	7.0	6.7	4.1	12.5	8.5	8.7	9.3	13.6	10.2	5.9	7.8	10.0	6.5	6.4	7.1	7.6	21.9	7.8	13.5	0.7	7.4	6.7	5.9	8.4	2.0	6.8	5.0	5.1	6.4	3.3	6.5	6.9
DUS2	"DUS2L, FLJ20399, SMM1"	ENSG00000167264	"Dihydrouridine synthase 2"	Q9NX74	16	67987746-68079320	"Predicted intracellular proteins"	"tRNA processing"	"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042560, HPA043528"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA042560: AB_10965170, HPA043528: AB_10959753"	"unprognostic (2.21e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-1)"	"prognostic favourable (3.50e-5)"	"unprognostic (1.44e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.81e-1)"	6.9	8.2	7.0	12.5	11.3	8.6	6.7	7.6	15.0	6.4	9.2	12.8	5.1	6.1	10.1	5.4	13.6	6.1	5.8	5.9	7.0	6.2	7.0	10.3	7.6	18.3	9.2	10.5	6.0	5.1	11.1	6.6	10.3	9.5	6.2	9.1	9.9	7.2	5.7	10.3	11.6	11.2	8.5	7.9	18.4	7.1	32.2	10.8	6.9	6.3	8.8	21.0	8.5	8.1	23.9	8.7	34.2	13.7	7.9	5.1	6.1	9.5	15.2	6.3	10.1	5.2	10.2	11.7	9.3	9.0	19.9	13.6	15.9	17.4	23.1	8.8	9.9	13.9	16.1	16.5	16.1	3.5	9.7	8.1	9.2	12.4	8.9	8.4	10.3	9.2	12.1	16.9	16.3	13.1	9.0	4.1	9.7	15.0	9.3	12.0	7.0	8.5	15.6	8.0	15.7	10.3	6.8	7.8	7.2	18.7	6.4	4.1	14.9	4.1	8.1	9.2	8.5	7.8	7.8	10.8	14.3	21.4	6.3	11.9	5.1	4.9	11.8	34.2	4.0	10.3	3.9	23.9	2.7	4.3	8.7	17.3	4.0	3.6	11.1	7.9	13.7	3.3	5.1	6.1	7.0	11.3	7.6	15.0	7.0	6.2	9.2	10.5	9.5	10.8
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favourable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	7.4	4.7	6.0	7.1	11.2	23.2	8.2	5.9	11.1	5.7	10.8	21.1	0.3	2.1	4.9	2.7	7.0	8.5	7.6	3.8	7.2	4.0	2.8	35.4	8.0	9.0	14.0	5.6	2.8	18.3	1.8	2.5	4.5	8.4	3.6	4.9	8.5	9.5	1.7	21.0	8.0	6.2	9.7	10.1	6.4	4.5	3.9	14.1	5.6	5.3	10.6	8.6	8.5	4.1	0.8	5.4	4.6	4.2	15.1	12.7	1.6	6.0	2.6	0.2	0.1	18.8	9.7	0.2	4.0	10.6	6.7	5.2	0.1	1.6	4.7	1.4	10.4	41.5	0.9	3.9	5.8	12.0	0.5	8.1	1.1	0.7	4.4	3.6	5.5	13.5	2.9	7.2	7.3	0.2	0.8	1.6	6.4	0.1	0.7	2.7	0.6	0.2	0.4	11.5	0.3	2.3	3.7	15.5	1.2	0.5	0.5	17.2	0.9	2.1	1.4	3.4	0.9	5.1	4.9	2.8	2.0	2.5	5.3	1.6	3.6	4.6	4.2	0.2	3.6	3.7	3.3	0.7	2.5	2.5	5.4	0.8	0.8	1.5	0.3	15.1	1.4	0.2	12.7	1.6	6.0	11.2	5.9	11.1	7.2	4.0	14.0	5.6	8.4	14.1
DUSP11	PIR1	ENSG00000144048	"Dual specificity phosphatase 11"	O75319	2	73762184-73780157	"Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021052			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge"				"Nucleoplasm, Nucleoli fibrillar center"	"Cytokinetic bridge"	"HPA021052: "	"unprognostic (2.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.28e-3)"	"prognostic unfavourable (2.10e-7)"	"unprognostic (7.20e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.84e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.46e-1)"	19.6	16.1	15.1	15.1	17.9	29.5	21.4	31.8	21.5	23.1	16.8	16.4	16.2	16.3	29.9	19.8	38.7	37.4	15.2	15.2	17.2	13.9	19.3	16.5	17.2	21.5	12.7	15.8	26.4	14.9	11.6	28.2	19.1	14.0	18.2	16.8	16.5	22.3	20.3	16.2	27.9	19.7	18.9	13.4	21.5	15.4	19.7	13.8	28.7	16.8	16.2	29.3	20.4	27.3	29.9	20.9	42.6	19.1	28.0	37.6	29.2	19.0	8.3	8.9	9.4	16.2	20.3	16.0	14.0	18.4	18.3	18.7	11.9	14.5	24.8	9.1	15.1	13.4	11.0	28.2	17.7	17.1	11.5	15.2	6.3	18.1	17.0	17.1	14.3	16.4	34.3	16.3	22.7	20.2	16.1	14.6	20.2	10.5	16.4	18.2	14.4	11.4	6.6	24.0	22.3	14.8	15.9	13.3	7.2	13.0	15.5	16.5	8.2	9.1	11.4	13.1	16.1	15.0	16.5	15.6	12.3	32.8	12.1	17.4	12.7	24.7	19.1	42.6	26.8	16.9	34.6	29.9	31.7	31.6	20.9	28.1	33.9	31.8	29.1	28.0	16.9	15.9	37.6	29.2	15.1	17.9	31.8	21.5	17.2	13.9	12.7	15.8	14.0	13.8
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavourable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	15.6	12.1	15.0	16.0	17.2	37.8	21.2	27.2	20.3	14.0	14.2	13.9	16.6	11.7	19.5	14.0	12.7	15.6	12.1	11.9	12.6	12.7	14.0	11.4	14.1	18.5	18.6	13.1	18.4	16.7	10.7	18.7	16.4	14.7	13.6	16.0	15.2	13.8	15.1	8.6	12.6	14.4	16.5	12.0	17.4	13.8	8.2	19.4	11.1	15.9	9.4	18.4	14.4	14.1	16.0	17.8	18.7	15.4	23.1	19.4	10.6	18.0	17.0	18.6	12.5	9.9	10.8	17.6	14.4	18.8	22.2	17.2	24.1	15.8	10.9	15.0	17.5	13.0	14.4	17.7	21.7	14.2	12.8	9.8	15.5	15.6	21.1	20.8	9.8	14.6	19.4	19.3	34.8	15.4	17.3	12.0	15.9	16.8	12.1	23.6	29.7	24.7	17.9	18.2	17.9	12.5	22.2	11.9	25.3	12.2	20.5	23.8	17.8	24.0	10.7	19.2	17.9	14.9	30.6	20.3	16.8	26.1	11.9	21.1	18.9	18.7	13.9	10.2	16.1	15.4	19.4	15.5	18.1	15.3	17.8	16.0	17.5	19.1	5.5	23.1	9.2	8.2	15.3	10.6	15.0	17.2	27.2	20.3	12.6	12.7	18.6	13.1	14.7	19.4
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12474210-12562383	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 24.2;RT4: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favourable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	6.4	32.8	6.3	14.8	7.5	3.4	12.5	16.4	7.1	8.8	13.1	6.7	9.5	13.6	11.0	9.1	9.5	6.8	12.3	5.8	6.7	5.4	6.6	34.2	17.0	13.2	8.0	3.6	8.5	13.9	11.6	31.4	21.3	7.7	13.9	11.7	9.2	17.4	9.5	8.3	7.9	20.1	5.7	9.1	12.2	9.9	8.6	9.2	40.7	10.8	6.8	16.7	10.9	13.4	0.1	0.2	1.4	0.1	0.1	6.9	0.5	2.7	4.1	5.2	2.7	1.8	2.4	8.7	1.7	3.7	4.1	6.0	12.2	5.3	0.2	0.9	1.8	1.8	9.2	1.5	5.9	8.9	4.6	0.4	4.4	13.6	3.9	0.8	1.9	1.9	4.6	3.3	10.9	3.2	2.4	7.5	0.3	6.0	1.0	0.6	24.2	1.3	1.2	1.7	5.0	2.6	22.0	7.9	7.6	6.6	8.9	4.4	3.4	1.5	2.8	1.9	5.5	1.2	1.9	5.3	6.1	0.9	2.5	1.8	2.6	0.0	0.0	0.0	1.1	0.1	4.6	0.1	3.2	1.5	0.2	0.1	1.1	0.7	1.4	0.1	0.0	0.0	6.9	0.5	6.3	7.5	16.4	7.1	6.7	5.4	8.0	3.6	7.7	9.2
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667890	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB034070: AB_2094867, HPA051349: "	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	5.2	3.9	10.1	7.1	9.7	4.9	5.3	4.1	8.3	5.6	10.1	11.4	4.6	7.8	6.1	8.4	7.5	18.5	8.0	3.8	8.7	7.8	5.5	2.3	9.9	7.2	8.4	3.9	4.4	6.6	5.2	19.5	3.6	9.5	4.6	11.5	4.7	6.1	4.3	2.0	7.9	11.0	6.4	9.0	6.9	8.3	30.8	10.2	8.0	5.8	3.4	7.6	6.0	6.1	6.4	11.2	21.7	13.9	4.3	8.1	4.7	5.2	5.7	2.6	6.4	6.4	12.9	2.5	5.0	5.7	5.1	5.5	3.1	5.6	3.5	3.5	6.2	3.9	1.6	4.0	5.7	9.8	6.3	1.7	2.0	2.0	2.8	7.3	5.8	3.6	5.7	8.5	3.1	15.5	1.8	3.2	5.5	4.5	4.0	1.8	1.0	3.5	2.9	1.7	1.3	6.1	3.7	6.6	3.8	5.2	2.1	3.7	4.6	2.1	11.2	10.5	5.7	2.7	2.9	2.3	2.6	1.7	11.8	1.3	5.2	18.3	10.4	19.4	5.9	12.5	4.6	6.4	6.8	5.4	11.2	6.2	4.6	5.5	21.7	4.3	13.9	6.4	8.1	4.7	10.1	9.7	4.1	8.3	8.7	7.8	8.4	3.9	9.5	10.2
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143166-96145440	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 151.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.3;HeLa: 13.9;Karpas-707: 17.4;NB-4: 14.4;RT4: 17.3;SCLC-21H: 15.5;U-698: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 46.1"	"Group enriched"	"Detected in all"	10	"NK-cells: 29.6;T-cells: 46.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"HPA071920: "	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	6.4	3.1	2.0	13.1	4.3	51.3	2.9	1.3	4.3	4.8	3.9	1.9	7.9	0.8	4.3	18.3	4.1	3.0	8.8	7.4	3.0	1.4	5.5	3.4	15.9	19.0	1.8	0.8	3.0	1.7	0.4	14.6	0.6	2.0	10.7	1.1	2.8	2.0	151.1	1.8	9.8	4.7	3.7	1.6	16.4	2.1	3.3	0.7	43.4	2.4	2.6	12.2	24.6	14.1	3.9	2.3	1.4	2.2	29.6	46.1	7.5	1.5	0.0	0.1	0.1	0.2	0.3	2.2	1.9	0.0	2.8	2.7	4.4	0.3	15.3	5.5	2.1	1.1	3.8	0.0	0.5	0.2	0.0	0.3	13.9	0.0	1.0	6.3	1.3	0.5	1.0	0.4	0.0	0.0	0.0	17.4	0.1	2.6	12.4	14.4	3.4	5.4	0.0	0.2	12.1	0.1	17.3	15.5	0.8	0.7	0.2	2.8	1.0	7.2	0.0	0.0	4.1	0.0	0.8	1.2	1.8	21.0	0.0	6.9	0.1	0.5	0.9	0.2	46.1	2.2	22.6	3.9	11.4	41.4	2.3	2.6	7.8	23.9	1.4	29.6	1.8	0.6	3.4	7.5	2.0	4.3	1.3	4.3	3.0	1.4	1.8	0.8	2.0	0.7
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.0"	"Cell line enhanced"	"Detected in many"		"HSkMC: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA028211: , HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavourable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	25.0	28.0	7.6	9.3	10.5	11.2	27.3	4.4	9.0	15.5	15.9	5.9	6.6	17.2	12.2	15.0	21.2	10.9	12.6	14.9	7.8	5.2	88.0	80.8	12.1	15.4	8.5	4.6	12.3	21.5	12.5	4.3	7.4	9.6	18.0	9.1	9.5	37.8	10.9	32.8	15.8	16.1	7.7	9.6	8.7	11.0	9.7	7.3	5.7	27.0	17.4	11.4	10.5	19.1	13.6	59.7	49.9	43.2	21.3	24.0	24.0	12.2	13.2	0.1	0.0	12.9	11.0	0.1	5.0	4.1	5.9	4.6	5.3	14.0	0.0	29.9	5.4	0.5	3.4	4.5	3.2	3.0	1.5	16.8	4.7	0.0	19.2	10.1	12.9	46.6	12.2	3.8	13.8	22.4	7.6	6.1	8.2	22.1	1.0	0.4	22.7	18.8	0.0	0.0	5.7	7.1	2.1	5.7	12.7	9.0	19.9	23.2	12.8	15.9	16.4	4.9	0.2	0.6	0.0	4.3	10.3	0.1	8.3	8.2	3.7	20.0	43.2	49.9	24.0	33.4	13.3	13.6	18.1	22.5	59.7	9.8	11.0	16.4	43.2	21.3	22.1	13.6	15.7	24.0	7.6	10.5	4.4	9.0	7.8	5.2	8.5	4.6	9.6	7.3
DUSP26	"DUSP24, MGC1136"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591332-33600106	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 147.1"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 45.1"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"B-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	1.3	9.3	11.5	1.4	13.1	1.1	1.2	18.2	14.8	1.1	1.7	4.2	0.0	2.4	1.5	3.4	3.0	2.3	1.5	20.1	9.1	15.9	1.6	1.0	1.7	1.1	10.6	8.8	15.1	2.2	1.0	14.0	1.0	7.6	2.6	1.5	4.4	1.5	1.3	147.1	1.0	1.9	2.0	10.0	1.2	2.6	1.6	3.8	0.0	1.1	27.0	1.3	1.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	45.1	10.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	13.1	18.2	14.8	9.1	15.9	10.6	8.8	7.6	3.8
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766121-43778988	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol			1300000	Nucleoplasm	Cytosol	"HPA063616: "	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favourable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	17.1	17.8	23.1	10.2	20.8	4.6	22.0	14.3	28.6	12.8	28.4	11.1	16.7	13.4	17.5	18.7	23.6	10.6	19.3	64.0	21.5	18.1	27.1	39.9	17.2	9.0	17.6	19.1	9.1	19.2	27.5	11.4	15.0	17.1	22.6	13.1	14.3	11.1	36.6	106.9	8.9	15.2	31.1	12.7	14.5	19.6	8.0	10.8	1.2	13.9	22.8	6.5	20.7	24.1	1.7	19.5	5.2	17.0	0.9	1.7	5.8	10.9	19.8	7.6	8.1	22.3	12.0	6.5	8.3	19.9	19.4	23.5	19.0	7.4	1.7	13.2	15.5	9.5	11.8	10.2	20.5	3.7	9.0	5.5	9.1	15.5	27.3	0.6	5.7	11.1	18.4	14.9	13.1	13.5	4.9	1.9	22.6	7.8	2.8	2.8	3.5	14.5	3.6	23.0	4.1	26.9	11.5	4.3	7.7	9.7	6.5	24.4	29.1	15.4	14.0	22.0	14.9	31.2	13.7	10.2	13.4	0.4	26.1	7.7	7.3	5.2	17.0	3.5	1.0	8.9	1.7	1.7	1.5	1.2	19.5	1.6	1.2	1.1	4.1	0.9	10.8	8.2	0.9	5.8	23.1	20.8	14.3	28.6	21.5	18.1	17.6	19.1	17.1	10.8
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350668	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 30.0;SK-MEL-30: 46.2;WM-115: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"T-reg: 9.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm				Nucleoplasm		"HPA061967: "	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	10.9	3.4	1.2	3.6	1.1	3.4	17.1	4.8	2.7	4.6	1.7	1.0	46.7	0.8	3.2	0.7	1.6	1.3	13.1	1.5	4.6	0.8	0.7	0.4	3.7	1.8	0.8	0.8	1.2	78.6	0.1	3.7	17.7	0.7	4.3	0.9	17.1	8.9	63.5	2.7	3.5	1.3	1.5	1.1	0.6	20.6	1.7	0.2	3.9	1.2	2.0	4.7	7.4	3.0	0.0	0.5	0.0	0.0	0.2	9.6	0.1	11.1	30.0	17.8	0.8	2.3	0.0	1.5	2.3	12.8	7.0	3.1	0.3	5.7	0.0	6.3	1.0	3.6	0.2	7.7	4.2	0.3	0.6	0.0	1.0	0.2	0.0	0.1	14.6	1.4	5.1	2.2	13.1	5.7	0.1	1.3	14.0	12.6	0.0	2.1	3.1	18.4	0.3	0.6	2.3	16.1	5.9	0.1	9.9	3.2	15.2	46.2	3.2	0.3	16.0	5.2	0.0	0.0	1.6	3.6	0.4	0.0	15.6	2.6	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	9.6	0.1	1.2	1.1	4.8	2.7	4.6	0.8	0.8	0.8	0.7	0.2
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 80.6;NB-4: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favourable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.0	80.6	20.8	17.7	0.0	8.7	11.1	1.7	1.3	7.0	1.2	0.0	2.0	3.7	9.3	0.1	21.6	2.5	0.1	0.1	3.6	0.2	11.2	14.7	15.5	39.5	3.4	7.6	15.3	14.3	40.1	0.0	3.8	5.5	0.5	0.5	57.8	14.6	19.7	39.3	3.0	1.5	24.8	23.3	0.4	17.1	0.2	0.1	45.9	1.2	8.6	10.7	5.9	0.1	1.1	4.1	0.6	3.1	0.0	24.5	10.9	37.4	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA054422: , HPA060360: "	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	26.9	32.9	23.2	51.1	31.8	69.0	31.9	31.7	27.6	26.8	26.3	24.4	27.2	14.5	29.8	31.8	33.7	26.9	28.2	35.5	23.2	26.5	25.4	19.8	25.7	44.7	25.3	23.6	33.4	22.2	23.7	30.7	26.0	22.5	30.3	24.3	28.1	27.5	26.1	25.6	27.3	22.6	25.6	23.9	30.1	25.8	31.9	20.7	120.3	40.5	37.7	43.2	23.5	28.4	34.5	32.3	17.0	24.5	22.2	40.2	24.3	25.6	8.1	19.7	18.7	13.8	14.8	11.7	27.2	17.4	25.2	31.3	9.3	17.7	71.6	14.7	14.9	35.3	20.6	18.6	24.7	50.4	21.3	58.4	21.3	12.6	7.7	61.2	27.8	9.0	12.7	17.0	9.0	16.7	31.6	40.7	18.5	10.4	54.7	72.1	12.4	15.6	44.6	43.2	75.2	16.5	17.4	28.6	29.1	20.2	16.4	23.3	23.1	48.9	13.8	26.4	25.5	31.4	35.7	32.9	68.3	70.5	20.0	105.1	28.9	11.3	19.5	17.0	21.7	19.3	28.1	34.5	38.9	34.2	28.2	31.6	40.2	26.5	11.1	22.2	24.5	32.3	34.4	24.3	23.2	31.8	31.7	27.6	23.2	26.5	25.3	23.6	22.5	20.7
DVL2		ENSG00000004975	"Dishevelled segment polarity protein 2"	O14641	17	7225341-7234545	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009312, HPA021611, HPA022914, HPA064732"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB009312: AB_639776, HPA021611: , HPA022914: AB_1847683, HPA064732: "	"unprognostic (7.63e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (4.34e-6)"	"unprognostic (5.66e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.97e-2)"	"prognostic favourable (3.85e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.45e-2)"	14.6	16.7	16.9	11.0	24.6	12.5	14.2	22.3	16.2	20.2	15.7	20.0	12.3	12.6	24.3	12.3	22.6	18.0	15.3	12.8	14.5	8.2	13.2	7.8	12.2	14.8	16.7	12.3	30.6	12.7	15.7	26.3	14.9	12.5	18.9	8.6	18.9	14.4	19.3	11.9	21.2	12.9	18.2	10.9	12.7	11.4	14.5	17.0	24.6	16.1	9.5	16.3	16.7	19.7	11.7	7.8	11.6	5.4	7.2	12.1	6.9	12.9	18.9	22.8	22.7	17.5	15.8	9.9	9.1	16.6	22.0	28.3	16.1	11.0	18.5	13.8	10.0	18.7	18.9	12.3	8.4	18.3	21.6	12.0	20.1	16.9	30.7	6.7	10.4	23.6	21.1	20.8	11.4	9.1	10.2	8.8	13.2	12.2	25.6	6.7	7.8	7.3	37.7	14.8	11.3	12.1	11.6	10.1	20.5	16.5	8.3	19.8	11.9	9.3	7.5	12.4	11.3	23.1	16.8	13.7	11.4	8.5	14.5	10.1	19.2	11.6	4.7	10.7	12.1	5.4	10.1	10.4	8.3	10.7	5.6	11.7	9.9	10.1	2.1	7.2	5.1	7.8	5.0	6.9	16.9	24.6	22.3	16.2	14.5	8.2	16.7	12.3	12.5	17.0
DYM	"DMC, FLJ20071, SMC"	ENSG00000141627	Dymeclin	Q7RTS9	18	49041474-49461347	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043551, HPA049187"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA043551: , HPA049187: "	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.58e-2)"	"prognostic favourable (2.76e-5)"	"unprognostic (3.89e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.26e-3)"	"prognostic unfavourable (5.26e-5)"	17.7	19.5	13.6	19.4	15.2	17.0	29.4	23.9	17.9	20.3	17.5	15.1	21.4	12.9	19.5	18.8	20.9	15.8	15.7	18.9	13.3	15.0	17.4	16.5	16.9	21.6	16.8	12.0	24.9	63.2	20.1	19.4	12.9	18.7	19.7	14.2	20.3	26.8	26.9	42.0	16.7	12.0	29.7	17.3	14.4	16.9	33.1	14.1	32.5	26.5	13.5	17.9	23.8	25.9	13.5	21.5	23.0	19.3	21.0	21.3	14.9	12.0	7.3	11.6	17.8	22.1	25.0	9.2	12.0	15.8	14.4	14.1	5.4	7.7	37.4	10.7	22.2	15.4	18.0	15.7	17.7	14.0	9.3	8.7	6.9	15.8	22.1	30.1	15.8	19.4	18.7	16.8	43.4	22.1	9.1	22.8	11.5	12.8	20.3	12.9	3.7	5.7	10.6	14.8	17.6	13.2	13.7	21.6	13.8	8.1	9.8	11.1	13.8	10.9	12.0	13.6	6.5	5.8	6.9	25.8	18.5	21.0	7.3	19.0	15.1	11.9	19.3	23.0	15.8	17.3	21.3	13.5	15.4	14.7	21.5	11.2	15.6	12.2	8.8	21.0	14.1	6.1	15.4	14.9	13.6	15.2	23.9	17.9	13.3	15.0	16.8	12.0	18.7	14.1
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964510-102056443	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol			120000	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavourable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	23.3	17.2	24.3	13.9	42.9	21.1	12.7	43.9	53.4	16.9	18.4	35.0	10.2	13.9	18.6	12.5	18.3	15.5	16.1	26.6	26.1	26.6	11.2	9.4	14.6	14.0	29.1	23.4	24.7	15.4	28.1	16.4	14.8	51.5	16.7	11.9	15.5	18.0	18.6	44.5	42.0	13.8	17.7	30.3	15.4	15.5	17.2	12.6	15.1	18.1	11.1	12.9	19.1	12.8	2.7	6.3	4.5	6.0	7.8	4.7	3.3	23.8	35.7	19.7	15.1	44.1	28.8	12.0	20.7	19.3	24.4	21.5	15.2	12.1	13.7	17.0	28.2	21.8	19.2	23.1	8.9	11.8	11.6	9.8	23.3	24.6	20.1	14.4	10.2	18.7	12.2	57.6	43.0	26.7	8.4	15.7	27.7	23.4	9.4	3.6	11.9	44.2	8.9	20.7	7.8	19.7	38.0	22.4	18.1	27.3	13.9	18.0	11.5	6.1	58.6	29.0	12.4	40.0	28.2	10.8	10.9	9.2	39.9	8.6	17.8	3.6	3.4	2.5	4.6	6.0	4.7	2.2	3.0	4.0	6.3	2.7	3.6	4.2	4.5	7.8	3.9	3.3	3.0	3.3	24.3	42.9	43.9	53.4	26.1	26.6	29.1	23.4	51.5	12.6
DYNC1I2	"DIC74, DNCI2"	ENSG00000077380	"Dynein cytoplasmic 1 intermediate chain 2"	Q13409	2	171687409-171748420	"Predicted intracellular proteins"	"Host-virus interaction, Transport"	"Motor protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033836, HPA040619, HPA053987"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol"			33000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Microtubules"	"CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.19e-1)"	"prognostic favourable (8.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.42e-2)"	33.4	32.9	39.6	22.5	53.2	10.8	35.5	30.1	50.0	36.1	33.0	50.0	20.1	28.8	43.1	29.3	37.5	26.5	32.0	34.3	45.2	38.3	43.5	21.8	27.3	18.5	59.3	37.9	40.6	23.3	35.8	29.9	40.2	58.7	33.7	35.8	15.1	28.3	34.7	41.3	27.9	27.7	43.7	92.7	25.8	26.5	28.6	49.2	27.9	31.2	23.5	24.3	36.7	31.8	23.5	35.3	51.7	30.8	18.9	19.9	11.5	19.9	12.8	39.9	14.6	36.9	35.6	22.6	35.0	27.3	29.5	32.2	22.3	19.9	18.3	30.8	41.6	20.2	31.3	33.6	38.7	6.9	14.1	16.0	16.5	25.1	18.5	18.2	17.2	27.6	32.0	36.4	23.5	51.6	25.2	5.0	58.2	12.5	15.5	14.8	18.3	13.1	15.7	35.9	13.2	39.2	32.1	25.0	28.1	19.4	15.6	20.7	15.2	17.8	55.9	45.0	22.3	17.9	20.9	6.3	12.0	14.8	30.6	14.8	32.9	51.7	30.8	14.7	16.9	30.1	18.0	23.1	19.5	19.6	21.4	23.5	17.6	16.7	1.8	18.9	29.4	35.3	19.9	11.5	39.6	53.2	30.1	45.7	45.2	38.3	59.3	37.9	58.7	49.2
DYNC1LI1	DNCLI1	ENSG00000144635	"Dynein cytoplasmic 1 light intermediate chain 1"	Q9Y6G9	3	32525971-32570874	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035013	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA035013: AB_10600807"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.38e-2)"	"prognostic unfavourable (9.19e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-2)"	16.1	11.6	15.8	14.8	18.6	27.5	18.9	24.5	28.0	13.4	13.8	12.7	9.2	11.6	17.0	11.6	13.9	14.7	14.1	40.1	16.3	23.4	18.4	15.9	16.3	15.8	18.3	16.4	15.2	18.6	16.8	18.9	14.9	26.5	18.6	14.2	14.1	12.0	12.9	41.1	32.1	13.0	19.7	16.6	18.1	13.8	34.0	11.7	19.3	12.8	16.6	17.2	15.5	13.5	6.2	15.3	29.8	25.1	7.5	6.1	10.7	13.1	14.2	22.1	13.8	12.7	15.0	61.0	20.3	28.0	36.7	30.2	15.0	11.3	16.4	13.8	20.5	6.8	22.1	15.9	35.1	15.5	15.3	21.7	10.4	13.4	15.6	24.6	12.8	12.1	12.7	25.8	20.3	23.6	25.1	15.2	19.6	10.5	18.8	10.9	22.8	19.1	16.6	11.8	17.1	14.9	12.0	9.5	14.0	14.3	17.7	15.3	14.7	14.4	17.5	20.2	17.0	17.5	20.3	11.0	27.7	26.6	11.3	21.3	15.7	11.3	13.3	11.7	5.2	16.8	5.4	6.1	5.6	5.7	15.3	6.2	3.9	5.0	29.8	7.5	25.1	8.4	6.1	10.7	15.8	18.6	24.5	28.0	16.3	23.4	18.3	16.4	26.5	11.7
DYNC2H1	"DHC1b, DHC2, DNCH2, DYH1B, hdhc11"	ENSG00000187240	"Dynein cytoplasmic 2 heavy chain 1"	Q8NCM8	11	103109431-103479863	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 35.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.9;T-cells: 2.2"	"Low region specificity"	"Detected in all"							"HPA039015, HPA039016"	Approved		Supported	Mitochondria				Mitochondria		"HPA039015: , HPA039016: AB_10673410"	"unprognostic (3.11e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.13e-2)"	"prognostic favourable (8.49e-5)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.11e-3)"	7.3	5.7	6.3	3.8	8.9	1.4	8.4	13.2	9.3	11.5	4.8	5.5	11.0	4.1	11.3	9.6	3.9	14.6	7.8	3.7	7.1	7.1	8.5	2.6	10.2	2.6	4.8	7.9	11.4	5.1	24.2	35.7	3.9	11.2	7.6	2.6	6.2	4.5	10.7	1.6	5.7	3.4	7.8	5.1	4.8	4.2	14.3	5.2	1.1	10.7	3.0	2.4	6.1	6.6	0.5	0.4	0.4	0.2	2.9	2.2	0.0	1.0	2.1	5.7	2.7	7.9	17.9	0.3	3.2	5.2	5.3	5.8	1.2	1.1	0.0	4.4	6.2	4.3	4.4	5.9	4.3	0.0	4.0	0.8	3.7	0.1	7.6	1.7	1.0	11.1	2.3	12.0	13.8	2.1	0.1	0.0	6.9	4.1	0.5	0.4	1.5	6.0	0.0	4.7	0.1	5.7	0.7	4.1	2.9	5.0	1.4	2.3	5.3	1.1	5.0	6.4	2.6	6.0	2.1	0.0	0.0	0.0	1.9	5.2	1.9	0.4	0.2	0.0	0.9	0.1	2.2	0.5	0.7	1.1	0.4	0.3	0.8	1.1	0.0	2.9	0.1	0.2	0.0	0.0	6.3	8.9	13.2	9.3	7.1	7.1	4.8	7.9	11.2	5.2
DYNLT1	TCTEL1	ENSG00000146425	"Dynein light chain Tctex-type 1"	P63172	6	158636474-158644739	"Predicted intracellular proteins"	"Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046559			Supported	Nucleoplasm				Nucleoplasm		"HPA046559: "	"unprognostic (1.80e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-2)"	20.2	34.2	20.2	16.6	23.6	8.2	29.6	16.0	22.0	29.3	33.5	17.4	31.1	27.0	30.8	38.5	44.2	42.7	28.7	36.0	18.4	15.1	45.6	25.5	32.3	23.9	26.5	16.9	24.7	19.5	14.2	27.6	25.6	32.5	28.8	33.6	16.0	37.8	31.0	44.9	14.1	55.5	42.4	29.3	27.2	26.7	52.5	22.8	15.7	32.8	30.8	28.9	32.1	27.7	10.8	27.7	99.5	56.5	12.0	20.3	30.9	31.8	22.7	37.5	36.6	38.9	39.7	15.5	33.1	26.8	41.0	48.6	26.9	28.9	7.7	13.8	68.7	29.4	23.5	35.7	49.9	10.9	32.8	12.1	22.2	30.8	41.0	5.6	8.5	34.1	38.7	33.7	33.9	51.7	23.2	9.2	60.1	28.4	2.4	14.6	20.5	18.6	5.0	20.2	6.9	57.0	21.9	75.2	37.6	46.6	38.2	13.4	26.0	12.6	44.9	20.4	25.7	21.8	29.7	5.6	6.9	12.8	29.0	23.5	22.0	17.9	56.5	5.4	16.4	52.5	18.1	10.8	17.6	18.5	27.7	6.6	14.6	15.2	99.5	12.0	38.9	13.6	20.3	30.9	20.2	23.6	16.0	22.0	18.4	15.1	26.5	16.9	32.5	22.8
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.1"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.1;SH-SY5Y: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA028522: , HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favourable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	4.8	7.9	7.4	3.7	10.2	5.0	4.0	10.1	13.1	4.5	4.2	7.4	6.1	6.2	6.4	12.3	6.7	8.0	4.6	9.0	6.6	6.1	6.1	3.2	5.4	5.1	4.4	6.7	6.1	5.2	7.1	12.3	3.8	6.4	5.5	3.4	6.7	5.5	5.8	89.1	6.3	5.1	3.9	3.4	5.9	5.2	28.8	4.6	11.2	6.4	25.3	5.3	5.6	4.1	4.7	8.3	4.8	3.2	6.2	7.0	2.6	0.4	8.6	8.3	5.9	4.7	4.5	0.7	2.7	1.7	2.5	2.2	0.8	3.3	1.3	10.6	3.2	2.9	1.2	1.9	2.2	4.9	7.2	0.6	5.3	0.8	4.0	0.3	1.8	6.0	1.2	0.8	2.8	0.6	1.3	1.9	0.4	4.2	1.9	0.7	2.0	1.9	0.9	0.1	0.6	5.4	2.1	12.1	13.7	4.2	4.2	0.2	4.1	0.5	4.2	1.1	1.9	0.9	0.8	3.1	1.0	0.9	7.1	0.8	0.4	1.2	3.1	3.2	5.9	3.2	7.0	4.7	4.0	5.9	3.5	3.5	2.2	3.5	4.8	6.2	2.9	8.3	4.2	2.6	7.4	10.2	10.1	13.1	6.6	6.1	4.4	6.7	6.4	4.6
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: "	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	12.2	5.3	4.5	20.1	4.8	8.6	8.1	4.4	6.6	10.1	21.3	4.1	8.3	13.7	14.6	9.6	9.6	9.1	16.9	26.1	4.7	3.2	6.3	4.6	10.1	17.9	4.0	3.3	7.6	8.5	3.6	4.4	13.0	5.0	7.1	15.3	6.6	7.2	6.6	23.7	9.4	26.0	11.2	5.3	10.3	14.0	4.4	3.9	34.3	7.6	12.5	17.2	11.1	12.2	2.7	1.9	5.9	1.3	6.9	6.8	1.6	13.5	7.7	11.5	8.3	5.8	7.9	9.2	13.8	9.0	6.8	3.9	10.1	7.5	25.4	17.1	20.0	15.9	9.2	5.4	7.3	10.9	12.0	4.1	5.1	3.8	2.2	9.2	8.9	6.5	7.8	18.2	14.6	3.8	5.0	13.3	8.6	7.8	7.9	4.5	10.0	12.4	21.1	11.4	11.2	7.9	17.1	15.2	18.0	5.8	7.8	8.0	5.3	7.8	5.6	10.8	10.2	7.4	10.9	6.3	1.0	14.1	10.4	6.3	11.1	3.2	0.5	5.9	5.2	1.3	4.0	2.7	3.9	6.8	1.9	2.7	3.3	6.1	0.7	6.9	1.3	0.8	3.1	1.6	4.5	4.8	4.4	6.6	4.7	3.2	4.0	3.3	5.0	3.9
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA075041			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA075041: "	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6.0	3.4	3.4	7.4	5.0	1.6	2.6	2.0	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3.0	2.1	2.0	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3.0	1.7	5.4	7.6	0.0	6.1	0.0	0.1	0.0	0.3	0.0	2.5	3.4	0.8	4.8	8.6	7.7	0.1	8.1	17.9	7.4	9.6	0.2	1.2	3.7	1.2	9.5	0.7	4.2	6.5	7.9	0.0	2.8	5.4	4.4	0.8	13.7	3.7	3.5	5.4	4.2	12.8	35.2	5.7	10.3	0.7	11.4	0.9	8.1	2.1	6.8	6.4	20.2	2.6	0.0	2.3	0.1	4.9	3.6	7.3	0.3	9.9	0.9	0.9	4.3	15.5	5.9	7.5	6.7	2.9	1.0	4.4	9.2	4.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	4.2	3.5	1.3	2.7	6.0	3.4	2.6	2.0	4.6	3.1
DYRK4		ENSG00000010219	"Dual specificity tyrosine phosphorylation regulated kinase 4"	Q9NR20	12	4562204-4615302	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	9	"testis: 85.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028065, HPA056073"	Enhanced		Enhanced	Vesicles				Vesicles		"HPA028065: AB_10601212, HPA056073: AB_2683028"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (6.52e-6)"	"unprognostic (1.86e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	1.6	2.1	2.3	2.1	1.8	1.6	2.8	1.9	2.3	2.6	2.1	2.2	2.3	1.7	2.5	9.1	1.6	2.0	1.7	1.7	1.8	1.8	1.9	2.0	2.2	2.5	1.9	2.5	2.2	2.3	2.9	2.7	2.9	2.3	2.3	2.7	2.4	2.3	3.4	1.6	1.9	2.4	2.1	2.7	4.3	1.7	85.9	2.1	1.6	4.3	1.6	2.0	2.4	1.6	7.6	2.7	1.3	5.2	1.1	1.6	1.6	1.9	3.0	3.9	4.2	5.9	7.2	4.6	2.3	4.7	5.3	5.8	0.6	3.1	5.8	0.3	6.6	4.0	2.9	4.3	4.2	4.4	6.6	4.0	0.8	3.3	16.6	3.5	3.2	4.9	9.3	3.7	12.3	7.5	1.6	6.6	4.8	4.0	3.2	8.6	5.2	1.8	0.7	2.8	2.5	6.5	1.9	0.0	1.5	0.4	2.3	3.3	1.8	3.1	0.5	6.3	4.9	0.6	2.9	1.9	2.3	3.4	3.3	5.4	3.2	0.6	2.8	1.3	1.0	2.2	1.1	7.6	1.5	1.6	2.7	5.8	1.6	1.6	0.1	1.1	5.2	1.4	1.1	1.6	2.3	1.8	1.9	2.3	1.8	1.8	1.9	2.5	2.3	2.1
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 39.9;skeletal muscle: 53.3"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 32.4;LHCN-M2: 29.4;RH-30: 31.1;TIME: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 19.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"				"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	6.6	2.1	1.1	7.2	1.3	18.6	7.9	1.2	2.0	1.9	6.4	0.0	3.9	1.6	4.2	4.9	5.1	3.6	3.3	20.8	1.2	2.0	4.7	13.4	9.1	17.8	2.1	0.7	4.1	1.4	2.0	2.1	39.9	7.0	4.8	1.9	3.3	1.9	3.6	53.3	1.7	3.3	12.1	1.4	26.5	3.2	1.5	0.3	0.8	4.9	8.3	1.0	8.7	11.9	0.0	0.0	19.9	2.6	0.3	0.3	0.7	0.4	0.0	1.3	1.1	0.0	0.0	2.4	0.0	0.3	0.8	0.6	0.1	0.3	0.0	4.8	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.9	4.2	32.4	3.1	0.0	29.4	0.0	0.0	2.1	3.2	0.3	0.0	31.1	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	0.1	0.3	21.2	0.1	1.5	0.1	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.6	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	19.9	0.3	0.1	0.0	0.0	0.7	1.1	1.3	1.2	2.0	1.2	2.0	2.1	0.7	7.0	0.3
DZIP1	"DZIP, KIAA0996"	ENSG00000134874	"DAZ interacting zinc finger protein 1"	Q86YF9	13	95578202-95644703	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054891, HPA057272, HPA070194"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				"Nucleoplasm, Cytosol"	"Centriolar satellite"	"HPA054891: , HPA057272: , HPA070194: "	"unprognostic (6.74e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.89e-3)"	5.0	6.3	17.2	4.4	17.4	0.4	3.7	13.9	16.1	11.5	6.7	4.1	3.8	2.2	16.2	10.7	6.2	10.7	8.5	3.8	13.1	18.1	16.2	1.7	4.0	3.6	8.7	13.5	24.2	9.6	0.9	8.9	4.6	8.8	7.7	3.7	5.8	3.2	13.3	1.7	1.1	2.6	12.3	5.6	2.8	3.6	27.3	4.5	0.6	1.7	1.8	3.5	5.0	5.2	0.4	0.2	1.2	0.2	0.3	0.3	0.0	1.4	5.2	17.5	17.8	13.6	16.9	3.5	12.6	14.6	14.1	17.0	0.1	0.0	0.0	2.9	10.1	0.0	11.6	4.6	16.0	0.9	10.3	16.1	4.0	10.9	9.4	0.0	0.1	11.9	0.4	4.3	5.8	9.5	0.0	0.0	10.3	0.0	0.0	0.0	7.9	0.4	0.0	12.0	0.0	13.6	1.8	4.3	11.4	9.6	0.0	0.5	0.0	6.0	0.7	14.1	6.8	1.9	10.3	0.0	0.0	0.0	3.7	0.0	2.5	1.2	0.2	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.0	0.4	0.1	0.3	1.1	0.3	0.1	0.2	0.1	0.0	17.2	17.4	13.9	16.1	13.1	18.1	8.7	13.5	8.8	4.5
DZIP1L	"DZIP2, FLJ32844"	ENSG00000158163	"DAZ interacting zinc finger protein 1 like"	Q8IYY4	3	138061990-138115818	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"classical monocyte: 1.8;eosinophil: 1.7;intermediate monocyte: 1.3;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	17	"dendritic cells: 1.5;granulocytes: 1.7;monocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030404	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"				Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA030404: AB_10601548"	"unprognostic (3.65e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.47e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.72e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.77e-2)"	5.3	2.0	2.2	6.1	2.5	10.9	5.5	12.1	3.3	17.4	5.1	5.3	3.1	2.9	14.8	6.5	4.3	15.2	7.9	3.8	2.4	2.1	5.1	1.2	6.4	2.0	2.6	1.6	12.4	8.3	6.2	5.6	2.7	6.1	9.3	2.1	10.9	2.5	5.0	1.7	10.4	2.3	11.3	3.4	3.1	10.0	4.2	3.4	0.1	4.2	4.2	2.5	8.0	17.8	0.0	1.5	1.7	1.8	0.0	0.0	0.4	5.2	3.0	6.2	5.1	3.9	5.3	1.4	8.5	5.1	5.1	6.4	2.0	0.4	0.0	4.4	7.8	1.7	4.5	2.0	2.4	1.1	4.4	2.3	6.3	0.3	3.2	1.7	4.0	5.6	2.1	5.5	2.7	2.8	1.7	0.0	6.9	0.3	0.0	0.7	7.4	1.0	0.0	7.1	0.0	2.3	8.3	2.2	4.9	8.7	0.0	4.4	2.3	3.6	2.1	12.6	5.7	6.0	4.4	0.0	0.0	0.1	5.0	2.5	4.8	0.0	1.8	1.7	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	2.2	2.5	12.1	3.3	2.4	2.1	2.6	1.6	6.1	3.4
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Enhanced	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: "	"unprognostic (7.46e-2)"	"prognostic favourable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	15.9	15.5	18.0	14.0	1.8	1.3	13.7	15.3	7.4	19.6	16.5	27.4	16.5	29.4	15.5	6.8	12.0	8.7	8.1	8.8	8.8	12.5	24.0	23.1	15.9	0.1	11.2	15.2	1.0	0.5	10.7	1.9	5.0	6.3	20.8	12.1	14.1	23.8	23.8	5.4	22.3	23.8	49.1	12.1	3.3	9.8	26.9	18.9	18.6	13.0	7.6	16.3	14.2	2.7	22.9	13.4	15.8	21.7	20.3	13.7	24.2	19.0	6.7	13.5	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401906-20493715	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: , HPA065012: "	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	9.5	8.4	7.6	12.2	13.4	22.1	10.8	1.7	10.1	4.8	7.1	2.9	3.2	6.8	6.3	6.9	8.0	4.9	9.9	11.1	8.3	6.8	14.6	6.1	7.8	19.7	5.8	7.3	4.0	3.6	2.9	3.2	7.4	7.9	5.0	8.6	5.1	4.7	4.5	15.1	4.3	8.0	7.9	5.0	16.9	5.0	8.9	3.1	17.7	11.4	10.2	12.0	9.2	4.8	0.7	3.7	10.3	3.1	4.8	3.6	1.5	6.7	5.5	15.9	17.0	5.3	5.9	11.0	9.1	7.9	8.8	9.7	6.8	4.2	15.1	17.7	8.5	7.1	18.1	8.2	14.8	5.9	12.8	27.5	9.1	7.5	5.7	18.0	16.5	4.7	6.1	8.6	10.5	6.0	30.4	9.4	9.9	6.9	20.4	20.1	11.9	5.7	22.2	14.0	17.4	10.5	11.8	11.5	21.0	8.5	11.7	12.0	6.0	10.9	8.0	14.2	8.9	7.0	14.5	5.9	18.7	19.0	3.5	11.2	20.1	6.9	3.1	1.4	2.3	2.3	3.1	0.7	1.5	3.6	3.7	0.7	1.3	2.8	10.3	4.8	1.5	1.6	2.2	1.5	7.6	13.4	1.7	10.1	8.3	6.8	5.8	7.3	7.9	3.1
E2F4	E2F-4	ENSG00000205250	"E2F transcription factor 4"	Q16254	16	67192169-67198918	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054128			Supported	Nucleoplasm				Nucleoplasm		"HPA054128: "	"unprognostic (1.74e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.05e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-1)"	19.9	20.4	19.0	23.1	22.5	51.1	24.9	15.9	22.0	17.0	21.7	15.5	17.2	19.8	23.4	14.6	24.8	20.5	16.8	18.7	14.6	10.9	18.4	16.7	20.8	29.1	20.9	13.4	21.6	26.4	21.5	22.3	27.2	17.6	20.3	20.3	18.6	16.6	18.6	25.2	17.5	22.8	20.8	11.5	31.1	21.4	19.5	20.3	21.1	18.7	15.4	26.0	19.9	17.8	6.9	15.5	10.6	12.5	8.5	11.0	7.5	19.0	15.4	13.2	16.0	19.3	16.8	47.4	14.3	21.4	26.4	25.5	27.3	20.9	23.7	17.4	15.1	28.0	20.4	20.2	17.3	10.0	21.6	16.0	8.8	27.7	23.4	31.3	33.9	19.7	16.0	21.0	23.5	22.9	30.1	7.9	13.8	32.8	35.8	25.9	32.3	14.0	43.5	27.6	31.5	12.4	14.8	16.0	19.1	39.1	14.7	16.4	14.9	31.5	16.3	18.8	17.8	13.7	22.3	19.7	16.9	60.8	22.1	21.7	17.8	1.2	12.5	10.6	9.6	11.1	8.1	6.9	8.8	11.0	15.5	6.8	7.2	6.5	8.0	8.5	8.2	6.9	4.2	7.5	19.0	22.5	15.9	22.0	14.6	10.9	20.9	13.4	17.6	20.3
E2F5		ENSG00000133740	"E2F transcription factor 5"	Q15329	8	85177225-85217158	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 27.0;Daudi: 53.1;U-698: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 13.3;naive B-cell: 7.6"	"Lineage enriched"	"Detected in many"	9	"B-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055723, HPA065441"			Enhanced	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA055723: , HPA065441: "	"unprognostic (8.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (1.89e-6)"	"unprognostic (2.88e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.95e-3)"	3.0	9.0	6.4	22.2	8.1	1.5	5.9	2.6	5.3	5.0	5.9	4.0	3.4	4.6	5.4	7.4	4.7	7.2	6.6	3.2	5.6	5.6	9.0	4.5	5.1	22.4	4.6	2.7	8.3	14.6	12.7	10.6	4.3	3.8	5.1	7.2	3.4	5.7	5.9	1.1	1.7	7.3	3.8	4.5	9.9	5.1	10.5	3.2	13.6	10.2	3.0	26.0	6.0	7.6	13.3	1.4	0.0	0.0	1.1	0.6	0.6	4.8	5.2	27.0	10.0	0.5	0.7	8.7	0.9	2.1	0.8	2.3	3.1	5.7	53.1	3.8	1.1	1.0	15.7	1.3	1.0	5.5	7.2	5.3	2.9	7.3	4.3	1.6	0.0	1.0	2.1	1.0	3.8	0.8	11.2	0.4	1.4	3.1	5.4	3.5	8.7	4.6	4.3	1.1	5.7	8.7	3.4	3.3	10.4	0.6	1.8	8.0	11.3	1.7	0.0	1.3	1.0	1.5	3.5	10.0	6.7	25.4	1.5	1.3	2.6	0.0	0.0	0.0	0.1	0.0	0.0	13.3	0.0	0.0	0.1	7.6	0.2	0.4	0.0	1.1	0.0	1.4	0.6	0.6	6.4	8.1	2.6	4.5	5.6	5.6	4.6	2.7	3.8	3.2
E2F6	E2F-6	ENSG00000169016	"E2F transcription factor 6"	O75461	2	11444375-11466177	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 8.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075185			Supported	Nucleoplasm				Nucleoplasm		"HPA075185: "	"unprognostic (7.13e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.58e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	8.4	6.6	4.4	5.0	5.9	5.0	6.2	7.8	8.0	4.1	4.9	7.4	4.7	4.2	8.4	6.6	3.6	7.4	5.0	8.9	4.3	4.9	4.0	6.2	4.5	3.3	5.6	3.8	6.7	5.3	3.9	12.4	5.4	5.0	5.3	3.5	4.7	4.7	6.5	17.7	3.9	4.8	10.6	9.0	5.0	5.7	4.2	7.3	2.9	6.7	4.4	3.7	6.3	4.9	0.0	0.3	8.3	0.3	0.0	0.8	0.2	3.1	3.9	8.3	4.6	3.8	3.1	6.3	3.0	5.5	3.6	3.3	7.7	4.6	7.0	3.5	3.5	2.3	5.8	4.5	3.8	7.8	8.4	11.1	3.0	9.7	7.5	11.4	11.4	5.3	4.2	3.9	4.6	3.2	8.3	11.8	2.8	7.4	6.5	12.5	11.8	5.2	11.6	9.4	6.2	3.9	2.8	7.1	15.0	3.5	5.2	13.6	4.7	5.8	2.7	5.2	6.6	3.3	6.8	17.1	12.6	15.1	5.7	10.8	7.9	8.3	0.3	0.1	0.2	0.0	0.8	0.0	0.1	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	4.4	5.9	7.8	8.0	4.3	4.9	5.6	3.8	5.0	7.3
E2F7		ENSG00000165891	"E2F transcription factor 7"	Q96AV8	12	77021247-77065580	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 42.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 5.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"midbrain: 7.6;pons and medulla: 7.4;thalamus: 12.1"	HPA064866			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA064866: "	"unprognostic (1.21e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.67e-5)"	"unprognostic (1.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-1)"	1.3	0.4	0.6	4.7	0.7	8.4	0.4	0.5	0.8	1.1	1.7	1.2	0.5	1.3	1.2	1.4	5.0	1.2	1.3	0.8	0.7	0.6	0.5	0.5	1.4	2.7	0.5	0.0	0.7	0.7	0.5	1.8	2.1	0.6	0.7	3.0	0.4	0.9	1.0	0.3	2.1	2.3	0.9	0.6	2.4	1.2	6.1	0.2	42.0	0.4	2.3	6.3	1.4	1.7	0.6	5.0	1.2	0.0	0.2	1.0	0.0	9.5	4.5	12.8	5.0	0.4	1.3	15.5	13.4	14.6	7.1	8.6	6.2	3.2	5.3	2.7	2.6	7.4	7.6	14.5	13.7	2.1	5.1	4.7	13.2	3.5	3.0	4.0	4.4	0.4	3.8	18.6	11.5	6.9	4.8	4.4	14.5	4.8	15.0	0.0	9.0	10.8	10.9	11.1	3.0	1.7	8.1	8.1	5.3	11.1	3.9	3.2	6.2	4.2	19.1	26.9	13.6	11.4	17.6	4.7	2.6	3.4	9.7	1.8	16.7	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	5.0	1.0	0.0	0.6	0.7	0.5	0.8	0.7	0.6	0.5	0.0	0.6	0.2
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: , HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	1.0	0.4	0.4	7.2	0.2	11.5	0.3	0.2	0.4	1.6	3.6	0.2	0.2	3.3	1.2	1.4	8.2	0.9	2.0	3.4	0.2	0.2	0.4	0.5	0.8	6.1	0.2	0.2	0.7	0.3	0.0	0.2	4.0	0.2	0.6	4.8	1.2	1.8	0.9	11.5	2.6	4.6	0.7	0.2	2.4	5.1	4.7	0.2	30.3	0.3	8.0	12.5	3.4	2.1	0.0	0.1	0.0	0.0	0.0	2.9	0.4	14.2	4.3	4.4	6.1	0.2	0.6	18.9	7.9	2.2	9.3	10.1	14.7	4.7	14.1	3.3	2.5	12.6	10.8	1.0	8.5	9.5	8.7	4.9	2.4	4.0	0.0	7.5	11.9	0.2	0.0	1.9	0.6	13.1	10.3	13.7	3.7	6.9	14.6	9.3	4.1	6.0	15.9	8.3	9.6	4.0	9.7	3.8	4.3	3.5	7.0	0.8	4.8	8.0	2.5	4.5	5.6	11.0	7.1	4.7	9.5	17.9	5.7	14.7	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.4	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2
E4F1	E4F	ENSG00000167967	"E4F transcription factor 1"	Q66K89	16	2223566-2235742	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052042, HPA069007, HPA071325, HPA072309"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA052042: , HPA069007: , HPA071325: , HPA072309: "	"unprognostic (3.05e-1)"	"prognostic favourable (9.13e-4)"	"unprognostic (7.31e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.89e-1)"	"prognostic favourable (1.10e-4)"	"unprognostic (9.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.49e-3)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.12e-1)"	"unprognostic (8.93e-3)"	12.4	12.8	18.1	13.8	15.4	21.0	21.0	26.1	18.9	10.8	10.7	11.9	9.3	13.4	14.8	10.4	11.4	10.9	13.5	9.8	14.3	10.7	11.7	12.9	10.0	13.4	16.7	16.4	13.8	17.0	11.6	14.8	12.0	12.8	15.5	5.0	8.7	20.7	13.7	26.7	23.2	14.7	10.3	9.8	18.8	15.9	14.6	17.2	13.3	17.3	9.3	10.6	10.5	13.4	11.5	11.6	15.2	14.2	8.5	14.7	9.3	6.1	11.7	5.0	9.7	2.9	2.6	11.8	8.5	4.0	6.0	4.0	18.8	9.5	9.0	9.3	3.3	8.4	4.1	4.4	1.1	9.7	14.6	6.4	18.9	10.1	5.7	8.1	11.3	4.0	5.0	5.4	2.5	4.0	14.8	6.3	2.2	17.0	10.5	17.2	11.1	10.9	19.6	5.4	15.5	3.7	4.4	12.5	9.2	10.4	13.1	6.0	11.3	11.5	7.1	7.1	9.4	7.0	7.2	12.3	5.9	18.1	3.0	5.7	7.2	7.5	10.7	14.6	14.7	13.1	12.5	11.5	12.0	13.6	11.6	11.5	13.2	11.9	15.2	8.5	14.2	7.0	14.1	9.3	18.1	15.4	26.1	18.9	14.3	10.7	16.7	16.4	12.8	17.2
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427355-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytokinetic bridge"				"Nucleoplasm, Nuclear bodies, Vesicles"	"Cytokinetic bridge"	"HPA059516: , HPA060569: , HPA069538: "	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	15.6	11.5	13.9	12.2	20.0	55.7	11.4	18.1	19.1	9.8	11.7	13.3	11.5	12.7	10.1	9.9	13.1	9.4	12.9	7.6	14.3	18.1	13.7	22.2	12.0	12.4	14.7	13.0	8.0	11.8	13.0	17.6	18.9	18.6	12.7	12.4	9.6	9.5	15.4	8.6	15.9	12.5	10.4	13.7	15.1	13.7	9.7	10.1	14.0	13.0	9.1	12.9	11.9	9.0	5.1	9.9	7.1	7.4	8.1	15.4	4.3	3.9	6.4	6.8	7.0	4.0	3.4	55.0	5.8	4.1	6.7	6.5	8.8	4.4	11.0	3.7	4.2	3.3	8.9	5.1	7.7	9.0	6.4	9.5	5.8	8.0	9.0	8.9	7.7	4.5	9.1	9.6	6.5	6.6	10.1	8.2	5.5	8.1	8.8	5.0	12.2	6.7	8.1	5.6	6.1	5.8	6.9	7.0	12.3	7.1	6.6	6.7	9.9	7.1	6.4	7.0	5.2	6.2	8.3	10.8	21.6	11.6	6.8	10.7	8.3	7.1	7.4	4.5	12.0	5.4	15.4	5.1	10.1	9.3	4.3	3.8	6.0	9.8	6.7	8.1	6.5	9.9	10.5	4.3	13.9	20.0	18.1	19.1	14.3	18.1	14.7	13.0	18.6	10.1
EARS2	"KIAA1970, MSE1"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23522014-23557731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favourable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	8.4	19.0	11.0	8.5	19.0	2.7	13.6	13.4	16.8	11.1	10.0	10.8	12.7	6.4	11.4	10.2	10.5	13.1	7.8	14.9	10.9	11.9	14.5	18.3	7.3	8.1	9.9	14.0	12.0	18.9	32.7	10.9	12.4	10.3	11.3	11.0	8.8	16.4	11.7	17.3	11.1	6.9	8.3	9.3	7.6	9.2	12.6	10.4	6.3	14.5	9.0	11.0	8.6	16.9	3.0	6.2	0.5	5.5	10.6	7.9	3.3	8.1	16.4	7.7	12.4	5.4	7.8	9.4	9.0	6.9	11.2	9.4	11.9	8.2	11.3	9.3	8.3	9.1	29.1	16.6	10.7	4.5	14.1	6.5	10.1	20.2	8.7	7.2	8.2	8.3	9.9	10.0	14.2	5.0	20.3	6.0	7.9	17.1	7.2	5.2	20.4	5.7	12.9	8.9	21.7	14.1	7.0	13.8	10.1	7.1	13.4	7.2	18.1	8.2	4.0	8.8	7.8	9.7	11.4	11.0	10.4	9.1	9.0	10.1	13.0	0.0	2.8	0.3	4.2	3.6	7.9	3.0	4.7	4.3	6.2	3.0	4.6	4.5	0.5	10.6	5.5	4.5	3.4	3.3	11.0	19.0	13.4	16.8	10.9	11.9	9.9	14.0	10.3	10.4
EBAG9	"EB9, RCAS1"	ENSG00000147654	"Estrogen receptor binding site associated, antigen, 9"	O00559	8	109539711-109565996	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021153, HPA021154, CAB072810, CAB072811, CAB072812"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"CAB072810: , CAB072811: , CAB072812: , HPA021153: AB_1856151, HPA021154: AB_1856152"	"unprognostic (3.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.72e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.71e-2)"	17.1	23.7	24.4	19.8	23.4	10.7	24.1	24.2	25.6	28.1	20.3	13.3	24.9	16.9	17.0	34.2	15.6	20.7	16.0	23.9	21.4	21.5	27.1	31.9	22.7	19.2	20.2	21.9	18.2	32.1	24.1	27.4	19.2	18.2	21.2	23.2	15.1	29.0	36.3	34.1	12.9	21.0	16.1	20.8	20.7	19.0	17.4	15.5	17.0	42.4	20.1	18.7	22.5	15.0	21.8	13.0	7.8	10.3	15.4	20.2	7.9	16.2	11.5	11.7	8.0	7.3	11.9	9.1	8.9	6.7	12.6	11.9	11.6	17.4	23.2	15.5	6.2	11.5	11.2	14.2	13.4	25.6	12.3	25.5	7.5	17.6	16.3	8.8	7.5	9.5	28.1	10.8	22.2	11.8	26.2	17.1	11.0	24.8	25.5	14.0	7.3	11.6	13.7	9.3	19.4	14.5	10.7	12.9	10.3	9.7	10.4	12.1	20.6	11.5	7.9	9.8	7.1	8.8	6.5	25.7	16.5	21.8	10.0	23.7	9.0	2.7	7.4	7.8	11.3	10.3	19.8	21.8	15.9	15.6	12.2	20.2	20.2	17.8	1.5	15.4	8.9	13.0	17.1	7.9	24.4	23.4	24.2	25.6	21.4	21.5	20.2	21.9	18.2	15.5
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	18.9	24.8	30.2	22.8	41.1	19.3	27.6	17.7	35.7	18.1	23.6	19.0	15.6	15.4	22.4	40.6	27.8	30.4	15.6	24.9	26.3	25.2	34.0	66.0	18.5	21.9	25.1	29.8	21.8	30.7	24.5	30.0	26.0	29.2	20.3	26.0	16.6	22.3	22.3	28.4	22.8	16.9	24.3	21.6	18.4	19.7	24.8	27.4	18.2	28.8	31.3	25.8	21.5	19.8	26.9	29.6	10.2	22.8	24.1	25.1	17.8	61.1	35.7	13.4	38.7	10.8	12.2	27.7	42.6	21.4	68.2	42.9	39.9	38.3	40.6	33.9	31.0	43.5	28.9	39.5	74.6	19.2	28.5	27.7	32.1	35.0	19.6	48.0	21.3	9.7	40.0	50.1	40.5	37.3	41.8	13.7	33.1	33.6	36.4	28.7	58.1	33.1	26.8	30.4	45.9	25.0	26.7	26.6	28.6	24.6	46.1	42.8	18.9	26.3	28.7	26.4	49.8	42.2	69.3	20.4	40.2	50.3	21.9	49.8	53.0	7.5	20.1	10.2	24.0	22.8	25.1	26.9	24.5	24.9	29.6	26.7	22.8	22.8	1.8	24.1	21.6	28.3	24.6	17.8	30.2	41.1	17.7	35.7	26.3	25.2	25.1	29.8	29.2	27.4
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"Emopamil binding protein (sterol isomerase)"	Q15125	X	48521158-48528716	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease mutation, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003130	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	3.7	33.2	5.3	4.3	5.7	10.5	10.5	10.1	6.3	8.6	19.6	2.8	3.4	17.2	4.0	3.7	20.6	3.9	4.5	21.7	4.7	4.3	12.8	74.1	14.9	13.0	3.5	8.0	4.8	11.7	6.0	3.7	4.2	8.8	8.6	15.7	5.2	8.7	4.8	3.5	9.1	30.0	5.6	7.0	7.9	8.1	5.4	2.8	9.0	4.6	9.8	10.4	5.0	10.0	17.1	22.9	21.5	12.6	13.3	29.9	18.1	33.0	7.0	18.6	11.1	10.4	7.7	6.0	8.5	7.1	11.3	16.3	13.9	55.3	17.9	6.0	5.9	37.3	31.1	45.9	8.6	13.7	15.5	9.0	9.4	11.9	7.6	33.2	22.4	7.5	16.7	15.1	11.2	7.5	11.5	17.0	9.2	14.5	18.4	20.4	18.6	23.0	12.8	1.8	50.7	27.6	5.9	15.8	8.0	31.3	16.1	4.4	17.7	7.9	7.8	5.8	9.8	22.4	9.2	7.3	11.4	18.1	13.5	33.5	5.5	17.4	8.9	21.5	29.9	11.7	25.1	17.1	22.2	27.5	12.3	12.6	20.1	25.5	1.8	13.3	12.6	22.9	22.4	18.1	5.3	5.7	10.1	6.3	4.7	4.3	3.5	8.0	8.8	2.8
EBPL	EBRP	ENSG00000123179	"Emopamil binding protein like"	Q9BY08	13	49660723-49691475	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA049891	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA049891: "	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavourable (7.18e-8)"	"unprognostic (1.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	10.2	32.6	5.8	13.4	5.7	11.1	17.1	4.5	8.6	21.5	13.9	4.7	8.8	10.1	21.1	7.0	32.9	13.0	7.2	6.8	4.8	7.1	12.8	64.8	14.5	17.9	6.1	5.0	21.8	46.4	6.6	5.9	7.3	9.4	22.4	11.7	8.2	21.0	14.6	4.9	15.5	8.8	13.5	6.0	13.7	13.6	8.4	3.7	11.1	22.2	21.8	19.7	14.7	22.6	7.0	6.7	9.3	4.8	5.5	10.4	1.7	14.9	12.0	7.8	32.0	9.8	24.0	12.6	15.5	11.6	11.8	8.6	23.2	21.8	18.3	7.1	8.4	31.4	14.2	16.5	16.1	14.5	40.5	15.8	8.4	33.0	27.8	22.9	11.9	27.9	34.2	8.6	24.4	19.1	11.2	7.9	14.5	10.0	8.9	43.5	25.4	25.2	18.8	4.5	29.4	23.7	5.0	6.7	17.6	6.1	21.7	7.1	18.7	18.6	9.4	8.1	8.2	6.8	12.8	5.0	12.4	15.4	3.5	22.9	7.5	2.8	4.0	1.1	3.4	4.7	10.0	5.8	7.3	7.2	6.7	7.0	10.4	5.8	9.3	5.5	4.8	4.5	4.9	1.7	5.8	5.7	4.5	8.6	4.8	7.1	6.1	5.0	9.4	3.7
ECD	"GCR2, hSGT1"	ENSG00000122882	"Ecdysoneless cell cycle regulator"	O95905	10	73130155-73169055	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006465	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA006465: "	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.71e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.55e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.84e-2)"	23.2	22.3	22.2	22.4	23.8	34.8	23.2	34.7	27.0	20.4	18.6	21.8	20.0	15.6	23.7	20.9	21.2	17.0	20.6	18.8	17.9	16.9	22.4	23.6	17.7	21.4	23.4	16.7	24.1	21.1	32.5	32.1	23.4	25.5	21.8	18.1	16.7	21.4	21.3	19.9	23.3	16.8	19.9	19.4	20.5	18.5	25.4	23.1	32.7	24.2	18.7	22.4	22.1	20.7	20.4	16.8	23.3	26.3	25.4	27.2	15.7	18.5	13.4	15.2	23.1	14.0	13.9	12.5	14.5	22.8	23.7	27.8	24.3	19.5	14.6	14.3	14.1	15.6	16.2	17.2	24.4	11.8	15.8	18.4	11.0	17.3	21.2	21.9	12.3	15.5	14.4	19.9	25.0	25.2	19.0	10.2	22.3	15.7	19.6	12.2	15.6	38.8	14.6	16.9	7.9	19.0	13.8	6.7	12.6	13.1	29.9	18.6	17.1	10.6	15.5	10.3	20.9	11.1	16.6	11.9	8.1	24.9	19.3	18.4	8.8	15.0	19.3	20.9	21.8	20.5	23.2	20.4	20.6	21.4	16.8	18.6	27.2	19.4	23.3	25.4	26.3	11.5	19.7	15.7	22.2	23.8	34.7	27.0	17.9	16.9	23.4	16.7	25.5	23.1
ECH1	HPXEL	ENSG00000104823	"Enoyl-CoA hydratase 1"	Q13011	19	38815422-38832005	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002907, HPA005835"	Supported	Supported	Enhanced	Mitochondria			5700000	Mitochondria		"HPA002907: AB_1847964, HPA005835: AB_1847965"	"unprognostic (1.91e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.73e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (3.54e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.74e-2)"	33.0	52.0	17.6	21.7	20.9	14.7	29.6	11.4	19.8	14.8	34.1	19.5	19.8	25.8	16.8	15.4	30.2	18.9	30.6	130.6	18.6	15.5	40.0	105.8	16.9	19.6	22.2	17.2	16.0	36.5	11.5	11.3	32.8	17.5	20.9	27.1	20.8	27.4	15.2	130.9	18.7	24.4	27.0	13.3	28.1	24.8	26.2	20.6	15.9	24.5	43.5	21.5	21.3	19.3	68.7	60.7	49.9	61.1	61.4	72.6	83.3	12.8	56.5	8.8	14.5	34.2	17.8	12.8	6.3	11.1	5.6	5.7	36.2	25.5	20.1	24.9	15.0	6.1	14.6	15.1	4.4	69.6	8.1	24.3	17.2	29.2	34.8	25.8	24.7	23.6	39.2	7.3	12.7	13.2	11.5	33.6	12.3	24.1	17.9	14.9	5.8	13.7	20.4	26.4	40.0	35.3	29.3	11.0	14.1	33.2	16.5	17.5	22.2	58.0	11.1	9.9	8.5	9.7	5.9	25.5	29.5	19.2	15.0	33.3	18.9	49.1	61.1	49.9	51.9	46.8	48.9	68.7	50.9	51.2	60.7	62.2	45.7	51.4	8.1	61.4	38.3	41.4	72.6	83.3	17.6	20.9	11.4	19.8	18.6	15.5	22.2	17.2	17.5	20.6
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria			1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.7	36.1	19.7	49.1	28.6	18.4	18.0	21.2	28.0	29.6	25.1	79.2	28.0	21.7	18.4	23.8	27.0	25.5	21.5	21.4	16.6	44.8	21.6	21.8	56.3	24.0	28.0	15.4	20.5	18.6	19.6	25.1	26.2	19.5	19.1	28.8	68.2	13.9	54.7	13.7	43.4	24.0	23.9	11.6	36.5	36.9	12.7	20.2	21.9	36.4	27.5	28.3	27.0	21.0	13.4	19.4	27.7	27.9	14.4	8.8	24.6	31.7	15.3	11.0	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239395-2252300	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria			11000000	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favourable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favourable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	15.7	12.5	12.5	9.8	10.8	9.1	16.8	12.8	11.3	10.9	27.6	9.7	20.3	30.9	10.6	16.7	15.5	13.4	17.3	56.4	10.1	10.3	36.5	57.4	10.3	10.7	12.4	8.8	10.8	30.4	11.1	11.9	10.6	13.0	13.4	8.4	16.3	40.9	19.1	90.3	10.4	31.2	14.1	10.1	8.0	17.2	8.4	9.6	10.4	38.7	25.4	10.5	14.4	11.5	7.6	6.5	3.9	7.1	5.8	6.7	1.7	7.3	17.5	6.7	27.6	2.6	3.6	25.3	7.4	5.1	6.1	9.0	30.9	22.5	10.6	18.6	4.6	18.1	7.9	7.0	0.8	18.4	40.4	3.2	16.4	38.1	23.6	9.5	1.5	6.8	16.7	5.0	11.0	6.1	17.6	22.6	2.0	30.2	0.9	14.3	15.6	17.8	33.4	7.3	51.1	11.6	8.3	23.2	14.7	17.9	33.9	22.4	21.8	17.0	5.0	4.8	18.0	5.1	8.2	25.0	14.7	17.3	6.3	8.9	6.7	3.2	6.8	2.7	3.8	7.1	6.0	7.6	5.5	2.9	5.5	7.4	6.7	5.6	3.9	5.8	4.2	6.5	6.7	1.7	12.5	10.8	12.8	11.3	10.1	10.3	12.4	8.8	13.0	9.6
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria				"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favourable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.4	20.5	30.5	2.0	25.3	26.0	27.7	24.8	7.3	2.7	0.7	31.9	27.5	9.4	18.5	14.7	40.3	6.7	21.2	9.4	13.8	39.3	11.9	8.5	4.7	21.0	9.1	23.5	13.2	57.6	30.8	6.9	26.2	7.1	24.0	21.2	11.0	34.9	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.4	24.5	4.0	58.1	20.9	11.5	18.4	15.0	10.6	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3
ECPAS	"ECM29, FLJ22036, KIAA0368"	ENSG00000136813	"Ecm29 proteasome adaptor and scaffold"	Q5VYK3	9	111360692-111484745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 92.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021646, HPA059795"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA021646: , HPA059795: "	"unprognostic (1.64e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.05e-1)"	21.0	17.2	16.4	12.9	29.0	13.2	19.4	18.4	18.1	16.6	16.6	14.1	20.8	17.1	18.9	17.2	13.6	14.3	13.2	19.9	27.4	13.7	16.0	16.6	12.7	13.8	15.1	12.8	17.9	19.2	28.5	20.8	12.8	15.7	19.2	16.4	13.7	14.9	23.3	92.6	15.3	17.8	19.5	11.5	13.9	15.7	18.3	11.5	8.7	17.7	23.7	14.5	17.8	18.5	5.6	11.6	4.0	8.6	6.6	8.2	3.6	20.6	19.1	12.8	13.8	30.7	30.8	21.2	25.5	21.9	21.0	14.5	17.7	12.9	21.0	12.1	22.4	30.2	16.4	17.0	19.6	23.0	10.3	12.9	23.1	25.4	22.8	24.0	14.1	27.9	18.0	21.1	31.4	21.3	29.6	29.7	17.1	17.6	0.1	14.0	25.2	16.0	11.8	39.5	12.6	17.9	18.7	24.6	11.7	21.8	23.5	15.9	18.5	12.9	23.2	14.2	16.2	21.1	23.3	26.3	49.1	25.7	20.7	9.9	13.1	4.0	8.2	2.7	6.9	8.6	8.2	5.6	7.4	8.0	11.6	5.3	4.5	7.6	2.6	6.6	6.2	5.3	5.8	3.6	16.4	29.0	18.4	18.1	27.4	13.7	15.1	12.8	15.7	11.5
ECSCR	"ARIA, ECSM2"	ENSG00000249751	"Endothelial cell surface expressed chemotaxis and apoptosis regulator"	Q19T08	5	139448556-139462743	"Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	121	"EFO-21: 48.5;HUVEC TERT2: 122.6;TIME: 90.6"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.7"									HPA063337			Supported	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	Nucleoplasm	"HPA063337: "	"unprognostic (5.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.91e-1)"	14.8	1.9	0.8	5.7	1.6	0.0	17.5	0.4	0.7	13.7	6.1	1.0	5.1	1.9	14.3	14.4	11.0	7.9	8.6	26.9	0.8		5.6	4.3	23.4	26.9	1.4	0.7	7.9	1.0	1.3	0.4	19.6	2.9	9.3	4.3	6.8	3.6	5.5	13.4	2.9	3.4	14.3	4.3	12.1	1.1	6.8	1.1	0.1	11.5	14.5	4.6	13.2	13.1	0.6	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	122.6	0.0	0.0	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	90.6	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.6	1.1	1.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.6	0.0										
ECSIT	SITPEC	ENSG00000130159	"ECSIT signalling integrator"	Q9BQ95	19	11505916-11529174	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042979	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042979: AB_10964063"	"unprognostic (9.88e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.08e-2)"	"prognostic favourable (1.48e-9)"	"unprognostic (2.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.95e-2)"	15.3	16.8	13.8	10.7	15.5	12.9	12.8	20.0	24.5	13.5	21.0	9.5	11.1	24.2	13.1	6.8	19.7	16.2	13.8	49.5	12.9	11.6	15.6	27.7	8.4	9.9	13.5	10.8	27.2	28.5	14.7	10.5	6.4	12.5	16.3	12.0	13.2	26.8	11.0	64.2	11.8	17.9	12.9	9.1	10.1	18.4	8.2	11.9	13.8	21.4	29.5	12.7	14.1	14.2	21.4	22.3	6.2	20.9	13.1	18.6	15.2	14.9	13.6	8.2	12.0	12.7	14.6	9.2	8.0	10.9	17.5	14.2	20.2	10.5	22.4	17.2	10.4	20.3	20.8	17.1	6.2	12.8	17.0	20.9	8.8	18.3	12.4	11.9	17.5	15.2	18.7	14.3	15.9	12.9	22.6	23.4	6.5	20.7	20.8	17.8	22.3	36.5	20.9	8.8	29.9	9.5	9.7	31.6	19.9	9.6	16.1	16.1	18.3	18.2	6.6	18.3	12.7	25.9	14.9	20.9	40.3	11.2	15.3	17.9	13.0	2.1	17.2	6.2	15.2	20.9	17.3	21.4	16.5	14.1	22.3	20.3	18.6	16.9	3.5	13.1	18.6	12.6	18.1	15.2	13.8	15.5	20.0	24.5	12.9	11.6	13.5	10.8	12.5	11.9
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036363: , HPA053261: "	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (6.82e-6)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	6.4	6.0	5.4	9.9	7.2	16.3	7.4	11.1	7.6	9.0	11.0	2.6	2.1	9.1	4.6	2.8	14.9	3.2	6.6	4.2	5.4	5.0	10.1	4.3	8.9	9.6	6.7	5.8	3.2	4.1	4.0	6.1	11.1	10.2	4.1	16.1	2.4	9.0	2.7	2.9	7.0	7.6	7.2	8.4	8.7	9.2	14.7	6.8	50.8	5.7	9.3	10.8	8.0	6.5	2.8	2.6	10.4	3.2	1.3	3.6	1.0	46.0	32.9	25.9	13.4	2.7	5.6	13.0	20.4	16.8	30.7	29.8	18.2	48.9	11.4	31.1	11.9	20.3	20.9	13.1	42.0	16.3	11.5	7.1	18.0	9.3	1.1	11.0	8.3	1.8	2.2	18.2	18.7	13.2	7.4	16.8	24.2	16.3	11.2	8.3	21.2	17.9	8.1	25.5	14.7	23.3	10.8	17.4	11.1	25.8	29.4	10.4	48.9	8.2	11.4	14.9	14.3	20.0	42.4	8.3	11.1	21.6	13.2	9.7	19.4	6.8	3.2	1.3	1.8	2.8	1.9	2.2	2.4	1.6	2.4	2.8	1.2	1.8	10.4	1.3	1.2	2.6	3.6	1.0	5.4	7.2	11.1	7.6	5.4	5.0	6.7	5.8	10.2	6.8
EDA	"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED"	ENSG00000158813	"Ectodysplasin A"	Q92838	X	69616067-70039469	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.6;Hep G2: 18.2;Karpas-707: 5.1;RPMI-8226: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Group enriched"	"Detected in many"	6	"monocytes: 3.0;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037972, HPA037973"			Supported	"Vesicles,Lipid droplets"	"Intracellular and membrane"			Vesicles	"Lipid droplets"	"HPA037972: , HPA037973: "	"unprognostic (3.76e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.25e-4)"	"unprognostic (4.33e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.01e-1)"	"prognostic favourable (1.04e-9)"	"unprognostic (8.63e-4)"	"unprognostic (7.64e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.79e-1)"	6.8	11.7	2.2	3.1	3.0	0.3	3.9	0.9	2.4	10.3	3.4	3.9	7.4	0.9	6.3	5.7	5.0	4.4	7.0	13.3	2.6	2.1	6.9	3.1	4.3	5.8	4.3	2.0	7.9	6.3	18.4	1.9	2.7	2.9	8.3	1.7	5.0	5.4	10.4	3.3	5.4	1.6	5.4	4.6	2.0	4.7	2.7	2.3	0.8	8.9	5.0	1.2	4.4	8.1	0.0	0.0	0.0	3.0	0.6	4.0	0.3	0.0	0.6	0.3	2.9	0.6	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.3	5.6	0.2	0.4	4.0	1.5	0.0	0.0	4.6	0.0	0.1	18.2	1.1	0.0	1.2	2.4	1.4	0.0	1.0	0.5	0.0	5.1	0.0	1.2	0.0	0.0	3.0	0.4	0.0	1.3	6.1	0.1	0.0	1.6	0.0	0.1	0.4	0.1	0.3	0.1	0.5	1.9	2.4	2.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	3.0	4.0	0.0	1.8	0.9	0.0	0.0	1.1	0.2	0.0	0.6	2.0	0.0	0.0	0.3	2.2	3.0	0.9	2.4	2.6	2.1	4.3	2.0	2.9	2.3
EDC3	"FLJ21128, hYjeF_N2-15q23, LSM16, YJDC, YJEFN2"	ENSG00000179151	"Enhancer of mRNA decapping 3"	Q96F86	15	74630558-74696292	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040650, HPA044206, HPA066137"	Uncertain		Supported	"Cytoplasmic bodies"				"Cytoplasmic bodies"		"HPA040650: , HPA044206: , HPA066137: "	"unprognostic (4.22e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (7.80e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.81e-2)"	12.4	9.3	12.5	14.1	18.0	7.5	14.2	21.7	19.5	14.0	11.9	21.4	11.0	10.5	23.7	13.1	16.0	17.2	11.6	9.9	12.0	10.3	11.1	11.6	10.8	14.0	13.3	12.4	19.7	12.2	17.9	20.1	14.0	13.4	14.9	14.5	12.2	21.6	11.8	14.5	15.6	12.7	17.4	11.5	14.0	12.1	33.7	13.9	20.6	15.6	10.2	18.8	13.0	15.0	10.3	7.9	5.4	6.6	14.9	12.8	7.7	11.4	9.8	18.7	16.9	12.1	11.2	17.3	12.3	14.5	20.5	19.8	27.4	14.4	18.3	11.8	17.1	23.9	46.9	19.6	14.5	15.9	25.7	18.9	22.3	14.1	14.5	21.7	11.8	11.9	18.0	17.7	18.9	18.9	26.8	14.5	14.5	18.4	14.8	13.0	18.8	10.8	18.8	20.5	18.5	9.5	20.1	20.6	18.8	18.3	16.0	19.7	16.6	16.0	11.4	17.9	9.9	10.6	17.8	15.3	29.3	20.7	14.5	21.7	14.1	5.4	6.6	4.8	12.1	6.6	12.8	10.3	8.6	9.7	7.9	8.4	8.7	9.3	2.4	14.9	5.7	7.8	9.3	7.7	12.5	18.0	21.7	19.5	12.0	10.3	13.3	12.4	13.4	13.9
EDC4	"Ge-1, HEDLS, RCD-8"	ENSG00000038358	"Enhancer of mRNA decapping 4"	Q6P2E9	16	67873023-67884503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041164, HPA043038"	Supported		Enhanced	"Nucleoplasm,Cytoplasmic bodies"				"Cytoplasmic bodies"	Nucleoplasm	"HPA041164: , HPA043038: "	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (7.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.17e-1)"	11.3	12.6	14.4	13.2	20.2	25.2	12.1	33.3	27.0	11.9	18.5	17.5	11.2	16.5	15.5	13.0	14.3	15.4	15.2	11.9	12.8	11.9	12.8	10.8	12.9	18.0	14.4	15.2	19.7	18.6	23.6	18.4	13.1	15.6	13.2	14.3	15.0	13.4	13.4	22.0	19.1	15.0	13.5	10.7	15.4	15.8	18.1	15.1	25.6	12.9	6.8	19.2	15.9	11.4	6.2	6.6	4.4	11.0	9.1	12.2	6.4	9.3	13.1	9.1	8.2	8.6	6.3	17.9	8.7	7.2	17.5	14.1	21.4	8.9	15.4	9.5	11.8	13.1	18.0	6.8	9.2	5.9	22.8	11.0	8.3	11.3	10.1	13.0	12.3	8.5	9.4	17.7	8.5	13.2	19.1	2.8	10.4	14.2	17.1	33.9	9.0	7.6	26.2	11.0	16.5	6.8	6.9	15.7	8.5	22.9	6.4	6.3	11.8	18.1	8.7	7.1	10.4	6.6	11.5	14.8	8.5	37.7	5.5	16.0	6.6	0.7	5.9	4.4	10.2	7.0	9.5	6.2	9.0	9.8	6.6	5.4	9.0	6.4	2.9	9.1	11.0	4.8	12.2	6.4	14.4	20.2	33.3	27.0	12.8	11.9	14.4	15.2	15.6	15.1
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219957	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.5;lymphoid tissue: 89.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.9;U-698: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"				"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	6.5	7.6	5.3	13.1	6.7	26.3	7.0	4.8	6.3	6.7	7.6	4.5	5.1	5.9	8.4	6.4	10.5	7.0	6.2	4.8	4.3	3.1	6.6	57.5	14.2	16.9	3.9	5.0	8.6	20.3	10.2	6.5	14.2	4.2	6.6	7.6	5.5	9.7	5.7	3.7	10.1	11.8	5.4	3.7	15.4	7.8	7.8	4.0	89.4	7.8	5.5	23.5	8.8	8.1	9.9	10.3	4.3	5.8	2.9	8.9	2.8	4.7	4.8	3.0	3.0	4.0	9.0	9.7	7.8	10.6	5.4	7.1	2.2	6.3	25.5	4.2	7.7	3.8	3.3	10.7	8.3	48.9	1.9	8.7	4.5	4.9	18.8	10.2	25.5	8.1	13.1	11.5	12.7	10.7	2.2	35.3	6.6	2.8	20.5	3.9	1.5	3.6	29.9	5.4	23.5	6.2	10.0	0.4	4.0	5.6	8.1	11.5	4.1	32.9	10.4	10.4	7.3	8.8	8.9	20.8	12.6	43.9	17.3	9.9	8.6	3.5	3.8	4.0	5.8	5.0	8.4	9.9	8.8	6.5	4.6	6.8	7.9	6.2	4.3	2.9	5.8	10.3	8.9	2.8	5.3	6.7	4.8	6.3	4.3	3.1	3.9	5.0	4.2	4.0
EDF1	"CFAP280, EDF-1"	ENSG00000107223	"Endothelial differentiation related factor 1"	O60869	9	136862119-136866286	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035642	Approved		Supported	Nucleoplasm,Cytosol			140000	"Nucleoplasm, Cytosol"		"HPA035642: AB_10611959"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	49.5	68.5	77.7	58.3	67.3	55.6	71.0	68.2	75.2	51.6	68.7	35.1	75.3	106.6	55.0	60.9	68.4	57.3	66.7	83.2	66.5	61.8	65.4	107.5	47.2	75.3	64.9	64.2	72.1	273.4	44.5	64.4	47.7	62.3	64.1	46.5	38.2	123.3	96.5	175.4	69.4	102.3	64.3	71.9	48.8	61.9	49.5	44.8	43.6	64.5	75.1	51.5	51.9	57.7	78.2	116.5	58.0	70.5	68.6	83.6	85.4	63.5	85.6	47.7	48.4	47.6	50.2	93.9	73.5	49.8	59.6	46.6	69.2	44.6	55.9	68.5	63.9	77.0	37.1	56.3	22.0	60.4	45.2	38.9	107.7	94.0	94.7	66.3	53.3	49.6	72.5	46.7	54.4	57.3	56.3	72.6	51.0	139.4	59.0	105.5	50.3	73.5	52.0	69.7	113.0	79.1	68.0	61.2	58.8	76.7	108.1	74.4	104.4	93.2	69.4	65.2	49.3	70.5	68.3	41.9	69.9	47.1	85.2	39.9	59.6	45.7	70.5	58.0	69.9	59.9	77.2	78.2	74.8	72.1	70.8	71.9	66.9	68.8	28.2	68.6	48.9	116.5	83.6	85.4	77.7	67.3	68.2	75.2	66.5	61.8	64.9	64.2	62.3	44.8
EDNRB	"ETB, HSCR, HSCR2"	ENSG00000136160	"Endothelin receptor type B"	P24530	13	77895481-77975529	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.5"	"Cell line enhanced"	"Detected in some"		"AF22: 24.6;ASC diff: 18.7;SK-MEL-30: 22.6;U-266/70: 14.8;WM-115: 47.1"	"Group enriched"	"Detected in all"	7	"glioma: 41.1;melanoma: 127.7;renal cancer: 28.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 2.0;intermediate monocyte: 2.1"	"Lineage enriched"	"Detected in single"	21	"monocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017842, HPA027546"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB017842: , HPA027546: "	"unprognostic (7.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.59e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (4.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.01e-2)"	"prognostic favourable (7.20e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.77e-3)"	25.4	23.2	22.2	10.3	29.8	0.8	23.1	10.3	30.7	8.1	7.2	13.6	2.3	10.9	7.7	3.6	4.9	6.0	8.5	23.7	16.7	16.4	22.3	26.5	28.4	15.6	24.2	8.1	4.9	6.4	7.7	6.3	67.5	33.2	14.9	7.7	51.0	13.4	4.4	6.7	5.1	11.9	7.4	33.4	16.0	5.8	3.1	12.4	0.0	17.6	2.0	2.9	10.9	8.2	0.0	0.0	0.0	2.1	0.0	0.0	0.4	1.9	0.0	24.6	0.0	18.7	0.7	0.3	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	22.6	0.0	0.1	0.1	0.2	0.0	0.0	0.1	14.8	8.3	0.0	0.4	0.0	47.1	0.0	2.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.2	29.8	10.3	11.9	16.7	16.4	24.2	8.1	33.2	12.4
EEA1	ZFYVE2	ENSG00000102189	"Early endosome antigen 1"	Q15075	12	92770637-92929331	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB005861, CAB018782, HPA038158, HPA038159"	Supported		Supported	Vesicles				Vesicles		"CAB005861: AB_2262056, CAB018782: AB_2277714, HPA038158: AB_10966710, HPA038159: AB_10962356"	"unprognostic (5.38e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.75e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.65e-1)"	26.4	11.1	10.9	14.9	13.5	5.3	13.7	20.5	12.4	18.4	12.2	7.7	8.3	10.2	14.4	9.5	20.9	11.0	11.4	13.4	12.0	9.8	10.6	14.7	12.9	8.0	12.5	11.8	17.6	9.3	16.9	14.3	23.6	16.7	14.2	11.0	7.3	13.7	12.3	23.1	16.7	10.3	15.7	14.3	15.3	10.7	7.8	12.5	6.9	12.6	15.2	8.2	19.2	17.9	2.2	2.0	2.2	3.3	0.7	3.4	0.9	8.9	3.0	4.4	3.1	19.2	19.4	10.4	17.7	10.2	9.4	6.7	10.3	2.4	9.1	3.2	12.4	10.9	9.9	5.0	14.6	6.2	4.9	9.7	3.5	9.4	10.7	6.9	4.6	12.6	7.4	10.0	15.2	16.5	7.3	3.1	9.7	4.1	4.9	4.7	4.5	6.8	5.6	11.4	6.1	4.9	12.4	3.8	2.9	13.0	8.6	7.9	11.3	6.1	21.0	13.3	5.1	10.6	6.7	3.4	5.8	6.4	4.9	6.1	7.2	0.1	2.5	0.7	1.7	1.8	1.8	2.2	2.0	1.8	2.0	2.0	3.4	2.4	2.2	0.7	3.3	2.0	0.7	0.9	10.9	13.5	20.5	12.4	12.0	9.8	12.5	11.8	16.7	12.5
EED	"HEED, WAIT-1"	ENSG00000074266	"Embryonic ectoderm development"	O75530	11	86244544-86278813	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012211, HPA060089, HPA061140"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (1.80e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.19e-3)"	"prognostic unfavourable (1.36e-7)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic favourable (2.27e-5)"	10.9	12.0	20.1	20.6	19.8	9.7	14.0	33.4	26.5	13.4	14.4	10.4	19.2	15.6	20.0	20.1	16.7	13.5	14.5	10.8	17.7	12.7	13.7	15.1	13.0	31.1	18.3	17.7	16.9	14.1	16.2	21.6	17.6	17.7	15.5	15.0	9.8	13.7	13.8	11.8	14.6	14.6	12.5	18.2	19.5	13.7	12.5	20.5	17.0	14.6	11.9	36.2	14.9	22.8	21.5	6.7	11.3	7.6	8.9	27.3	9.2	12.0	13.9	14.6	6.2	8.1	6.8	16.9	17.9	7.5	15.8	15.9	43.4	23.2	27.2	18.9	5.0	15.1	17.2	9.4	15.1	28.1	8.2	18.2	13.9	12.9	7.0	18.8	12.2	4.4	6.3	16.8	7.1	7.1	20.0	5.8	13.4	19.7	17.5	19.0	10.7	6.8	19.3	18.0	13.2	10.3	19.9	10.1	8.2	22.9	10.8	5.1	18.0	8.0	7.1	17.4	16.5	25.6	15.4	3.4	10.9	22.0	5.0	16.5	13.0	11.3	4.5	7.1	13.3	7.2	11.6	21.5	17.4	16.6	6.7	18.8	14.0	15.8	1.9	8.9	7.6	4.4	27.3	9.2	20.1	19.8	33.4	26.5	17.7	12.7	18.3	17.7	17.7	20.5
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73515750-73523797	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol				Cytosol		"HPA051759: , HPA053862: , HPA056990: "	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	134.1	124.1	80.2	136.0	75.6	140.9	182.0	103.3	106.2	149.6	133.3	94.9	93.7	81.7	152.0	127.3	136.4	143.1	102.4	88.2	71.5	58.0	130.9	123.1	169.6	135.6	74.3	93.2	240.8	227.6	106.3	111.2	89.1	79.7	115.0	114.7	105.0	133.3	123.6	51.3	139.8	101.6	121.6	108.6	111.3	121.5	129.9	71.6	125.1	132.4	143.1	169.7	151.1	134.8	258.9	209.7	54.6	187.6	184.6	366.8	517.5	111.1	141.0	200.2	273.4	410.7	679.5	159.4	166.6	430.1	213.7	205.1	218.7	153.9	454.1	222.8	281.5	118.0	244.5	318.4	206.0	79.2	153.0	169.5	115.0	243.6	356.6	315.0	185.1	587.0	541.5	157.3	530.9	289.4	313.2	143.7	258.2	148.2	134.8	330.2	214.2	98.0	268.8	337.3	509.0	274.5	235.6	164.3	182.4	83.5	196.4	329.6	133.5	509.2	240.4	91.3	130.0	67.6	189.1	161.4	143.4	106.6	94.8	261.3	143.4	54.6	187.6	20.8	198.7	165.4	366.8	258.9	288.8	250.9	209.7	199.5	323.8	277.8	17.0	184.6	169.0	161.7	202.9	517.5	80.2	75.6	103.3	106.2	71.5	58.0	74.3	93.2	79.7	71.6
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488012-63499322	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 298.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 55.3;HBF TERT88: 27.8;MCF7: 45.7;SCLC-21H: 29.1;T-47d: 23.7;U-2 OS: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Supported	Cytosol			55000000	Cytosol		"CAB034019: AB_1562672, HPA051759: , HPA053862: , HPA056990: "	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	2.2	8.0	21.3	2.3	23.5	1.9	2.2	41.1	51.3	1.9	2.3	2.3	0.1	2.2	2.0	2.3	4.1	2.1	2.6	51.9	23.0	21.0	2.0	2.0	2.0	2.1	13.9	31.0	2.0	3.5	6.1	16.6	2.0	23.1	3.7	2.1	1.8	3.4	2.2	298.6	2.2	2.3	2.1	4.8	2.0	3.6	2.3	3.6	0.0	2.0	23.9	2.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.3	0.1	10.6	0.2	2.5	0.0	0.1	1.3	2.1	0.3	10.5	3.5	1.4	7.0	0.0	18.6	0.1	5.0	55.3	0.1	27.8	0.1	2.5	0.0	4.0	0.4	0.6	0.0	2.5	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.1	45.7	0.1	0.1	1.9	17.8	1.3	0.0	1.7	0.4	0.5	29.1	17.7	16.8	1.9	0.1	23.7	0.6	0.0	0.0	32.4	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	21.3	23.5	41.1	51.3	23.0	21.0	13.9	31.0	23.1	3.6
EEF1D	"EF-1D, FLJ20897"	ENSG00000104529	"Eukaryotic translation elongation factor 1 delta"	P29692	8	143579697-143599541	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"DNA-binding, Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045101, HPA051002"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"			900000	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045101: AB_10963077, HPA051002: "	"unprognostic (9.34e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (8.56e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (2.58e-5)"	"unprognostic (3.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.14e-1)"	58.0	47.7	25.2	48.0	23.6	67.6	61.7	20.1	25.9	56.4	54.7	35.0	50.8	33.8	57.2	50.8	63.0	39.5	68.6	58.5	24.5	20.5	43.0	89.4	49.1	123.8	27.3	18.7	95.0	258.8	23.3	27.8	34.6	22.3	70.7	25.3	50.2	98.6	48.3	95.1	56.2	45.4	65.7	31.2	60.1	49.9	33.4	23.3	73.4	76.4	82.3	77.4	57.8	94.6	122.6	75.1	35.9	46.3	69.1	128.4	143.7	46.8	68.5	30.6	26.4	27.7	34.2	34.0	36.4	46.9	58.1	46.3	93.5	44.7	36.0	38.5	40.6	46.8	31.6	58.8	25.3	28.4	52.0	35.3	120.8	91.0	41.4	21.9	30.0	65.6	86.0	35.1	40.0	38.8	33.0	53.5	32.9	151.4	85.4	55.8	32.3	90.9	38.0	22.0	70.5	49.7	79.7	30.4	32.9	31.8	78.1	76.2	58.4	56.2	30.1	33.9	99.6	50.3	78.3	36.4	14.0	37.5	38.1	44.9	29.4	19.5	46.3	21.3	80.0	41.6	103.1	114.0	102.4	83.8	53.3	122.6	128.4	103.5	35.9	69.1	36.6	75.1	96.2	143.7	25.2	23.6	20.1	25.9	24.5	20.5	27.3	18.7	22.3	23.3
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102578	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: "	"unprognostic (9.39e-3)"	"prognostic favourable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favourable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	10.5	21.8	20.1	14.2	26.9	34.0	18.5	20.0	24.6	10.8	12.2	13.5	12.3	8.2	13.6	19.2	15.9	10.3	9.5	12.5	19.4	27.0	34.9	19.2	9.9	19.7	26.9	16.2	10.8	26.6	19.8	28.6	11.7	41.2	12.5	15.2	9.6	13.5	13.4	14.4	8.4	8.4	13.3	21.3	11.8	14.8	36.3	19.4	9.9	13.9	15.8	20.3	11.6	9.3	20.9	29.6	6.8	15.0	14.0	21.3	13.5	27.7	14.7	23.7	16.3	7.8	13.1	14.4	23.4	14.8	21.1	21.8	24.0	11.6	30.5	51.6	15.2	11.6	26.7	26.9	35.6	17.0	34.8	24.6	19.4	41.6	14.5	48.6	18.1	10.9	25.4	25.1	26.1	29.8	58.7	8.5	20.2	11.6	20.8	39.5	21.3	23.6	25.6	13.9	47.8	34.5	21.5	35.2	10.9	9.9	22.5	27.8	17.9	16.7	15.3	17.7	17.5	16.0	33.9	13.3	60.2	43.3	9.9	20.6	28.0	6.2	11.0	6.8	13.5	15.0	19.1	20.9	18.1	17.8	29.6	20.5	20.3	20.6	1.1	14.0	11.2	13.0	21.3	13.5	20.1	26.9	20.0	24.6	19.4	27.0	26.9	16.2	41.2	19.4
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985469	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			9700000	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (5.47e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.75e-1)"	"prognostic favourable (1.81e-6)"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (4.46e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.86e-2)"	104.2	84.9	64.0	66.7	57.1	92.7	77.5	55.7	96.2	93.4	91.3	55.8	80.8	95.4	100.1	75.1	115.1	83.4	88.6	104.1	51.6	44.4	65.5	161.0	67.7	108.9	51.4	38.3	167.1	395.7	45.1	72.3	63.7	47.5	105.6	41.3	67.7	191.3	64.4	260.8	87.2	100.9	112.3	46.8	85.4	98.5	70.9	32.4	123.4	127.1	112.5	108.3	111.8	94.7	84.9	60.0	10.0	58.4	48.3	76.3	83.7	95.2	68.4	39.8	105.1	106.7	192.3	57.3	74.9	101.4	71.7	70.6	107.8	44.2	199.0	44.6	69.1	72.3	62.8	116.0	38.0	49.6	104.2	50.8	65.7	110.7	156.0	109.1	88.4	248.2	122.7	63.1	97.7	74.2	99.1	146.7	43.6	138.2	97.9	83.7	105.3	69.2	109.1	59.2	126.5	59.0	85.2	109.0	101.3	47.1	94.3	135.0	91.9	132.7	88.9	51.4	53.7	104.4	115.2	157.4	105.6	99.0	76.6	137.2	67.0	10.0	58.4	8.3	38.6	45.8	68.7	84.9	67.7	50.8	60.0	70.7	76.3	59.4	6.1	48.3	43.8	50.5	58.4	83.7	64.0	57.1	55.7	96.2	51.6	44.4	51.4	38.3	47.5	32.4
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 29.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	4.1	2.8	2.9	12.2	3.4	3.4	6.5	2.8	3.8	6.5	4.7	2.3	3.5	4.8	8.9	4.4	2.4	4.2	4.1	3.5	2.3	1.5	7.5	4.0	3.1	4.3	3.6	0.4	5.5	2.8	8.4	7.6	5.4	3.2	9.3	3.4	2.6	5.4	2.0	1.3	2.2	6.3	9.9	3.5	4.6	3.5	20.0	2.7	2.4	14.9	0.7	4.3	5.5	29.9	5.6	1.0	5.3	2.1	0.8	2.6	0.8	0.9	3.9	1.7	0.2	2.1	7.2	3.0	2.2	0.5	0.6	1.1	1.7	5.6	0.3	6.5	0.8	1.0	0.0	0.4	3.9	0.2	0.6	5.1	3.2	0.5	2.0	3.9	0.6	1.3	1.9	2.7	0.0	4.4	1.5	9.7	2.4	0.1	1.7	2.2	0.9	3.1	4.6	1.2	1.8	9.1	3.2	1.2	0.6	1.2	0.1	2.6	6.5	4.7	1.6	0.2	1.3	0.4	1.0	10.0	6.9	0.9	6.2	7.7	4.2	5.3	2.1	0.6	1.1	1.2	0.9	4.3	0.9	0.6	1.0	5.6	2.6	1.2	0.0	0.8	0.7	0.4	0.1	0.8	2.9	3.4	2.8	3.8	2.3	1.5	3.6	0.4	3.2	2.7
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 64.8;HUVEC TERT2: 263.9;TIME: 233.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"		1800000000	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: , HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (6.68e-5)"	63.1	14.1	13.6	14.1	35.1	0.1	45.5	8.0	12.8	14.8	20.4	22.0	16.6	6.2	20.1	31.9	22.0	38.6	37.1	55.4	8.2	9.7	16.3	3.5	38.5	24.5	12.5	15.5	52.9	10.9	3.3	6.6	84.5	25.8	47.5	22.9	116.9	26.8	40.5	15.6	13.8	12.0	29.9	8.6	10.1	12.6	9.3	13.5	0.9	57.4	18.1	7.3	45.5	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.2	0.4	0.0	20.1	13.0	0.0	12.5	13.4	1.5	1.1	0.0	1.2	0.0	8.1	15.1	21.0	0.0	15.0	0.5	0.0	0.0	0.0	5.3	0.0	55.1	0.0	0.0	64.8	6.9	1.5	17.3	263.9	0.0	0.0	5.6	2.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	17.4	6.5	0.0	20.2	0.0	233.7	0.1	7.0	25.9	8.0	0.7	0.0	0.0	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	35.1	8.0	8.8	8.2	9.7	12.5	15.5	25.8	13.5
EFHD1	FLJ13612	ENSG00000115468	"EF-hand domain family member D1"	Q9BUP0	2	232606057-232682781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.0;breast: 83.4;kidney: 75.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 29.7;RPTEC TERT1: 16.0;SK-BR-3: 70.9;T-47d: 55.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 100.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.1;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049331, HPA056959"	Enhanced		Supported	"Nucleoli fibrillar center,Golgi apparatus"				"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA049331: , HPA056959: "	"unprognostic (9.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.57e-2)"	"unprognostic (9.99e-2)"	"prognostic favourable (2.93e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-3)"	16.1	4.0	32.0	2.3	71.3	1.1	83.4	4.1	39.1	37.2	3.9	85.0	0.8	2.7	22.2	16.5	5.1	16.7	6.0	13.5	42.0	24.5	75.9	24.2	4.0	2.3	85.0	25.2	32.1	39.3	4.8	3.5	55.2	43.2	8.0	3.4	12.9	10.1	13.8	13.5	5.9	3.8	10.3	66.0	20.7	3.7	7.3	80.1	0.0	6.8	3.6	1.8	5.0	9.3	0.8	0.7	6.1	0.7	0.3	1.6	0.3	0.0	0.8	1.3	0.3	0.5	0.0	29.7	6.2	0.4	0.5	0.4	0.2	0.1	0.0	0.4	2.6	0.0	4.4	0.0	0.0	0.1	2.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.1	0.0	1.9	0.0	0.1	1.7	0.1	16.0	0.1	0.0	0.7	2.1	70.9	4.2	55.5	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.1	1.9	0.7	0.4	0.7	0.3	1.2	0.8	1.0	1.0	0.3	0.3	1.6	1.6	6.1	0.3	0.2	0.7	0.3	0.3	32.0	71.3	4.1	35.5	42.0	24.5	85.0	25.2	43.2	80.1
EFNB1	"CFNS, Elk-L, EPLG2, LERK2"	ENSG00000090776	"Ephrin B1"	P98172	X	68828997-68842147	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.4;hTCEpi: 27.6;PC-3: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB031489, HPA067188"	Uncertain		Supported	"Plasma membrane"			790000	"Plasma membrane"		"CAB031489: AB_631414, HPA067188: "	"unprognostic (2.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (3.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (4.29e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.86e-2)"	36.5	13.2	5.0	11.5	4.5	1.3	26.5	2.3	4.7	19.5	21.1	4.7	13.1	14.0	15.2	14.9	17.4	15.2	33.7	16.0	3.6	2.7	25.5	15.3	23.0	5.2	4.7	3.5	21.6	4.5	15.0	6.4	34.3	3.9	15.9	10.1	14.9	7.0	13.2	9.1	26.4	24.0	12.3	2.6	15.3	13.3	7.4	4.2	4.8	11.9	22.0	11.2	16.7	14.8	0.5	7.1	0.6	3.4	1.3	1.0	1.0	3.7	1.9	15.6	5.7	8.3	5.1	8.2	3.2	3.5	1.4	1.0	1.7	6.9	0.9	21.2	1.2	19.8	14.7	35.4	0.8	1.5	3.7	0.9	0.8	3.0	7.6	0.7	8.0	9.5	27.6	3.5	16.0	10.8	1.0	0.0	1.2	3.0	1.5	0.7	10.8	26.2	6.6	1.6	5.9	5.9	13.1	5.8	2.8	2.4	0.7	0.9	0.6	1.3	18.1	2.7	3.3	7.2	1.2	0.0	0.8	0.9	1.3	4.0	1.7	0.0	1.3	0.6	1.0	3.4	0.6	0.5	0.9	0.9	7.1	0.4	0.8	0.4	0.3	1.3	2.1	1.0	0.4	1.0	5.0	4.5	2.3	4.7	3.6	2.7	4.7	3.5	3.9	4.2
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489731-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 49.4;SH-SY5Y: 24.8;U-87 MG: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol			760000	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavourable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavourable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	15.7	4.9	11.2	8.2	11.0	0.8	21.8	8.3	14.0	13.2	23.1	5.8	13.1	13.9	10.8	5.2	11.4	13.6	11.2	11.8	10.4	6.5	9.3	11.8	50.1	7.8	6.2	11.5	8.4	3.7	5.7	6.1	27.7	5.2	11.8	18.4	15.2	12.7	20.6	6.6	14.3	20.6	10.5	5.0	9.3	21.3	7.2	5.9	7.3	11.2	8.8	5.9	7.7	12.4	0.2	0.0	0.4	0.0	1.5	0.0	0.0	11.8	1.1	49.4	0.0	0.1	0.4	0.2	5.4	3.4	5.3	3.1	11.9	18.1	0.0	5.2	1.6	14.1	1.8	6.9	5.8	0.0	10.6	0.0	4.1	0.0	1.0	3.9	0.3	2.3	12.4	0.2	10.6	6.7	0.0	0.0	5.8	2.0	0.1	0.0	2.6	2.4	9.9	2.0	0.0	7.6	1.5	3.5	24.8	2.0	1.0	0.0	0.6	0.1	5.2	10.6	0.0	0.3	12.1	0.1	0.0	0.0	22.2	0.2	2.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	11.2	11.0	8.3	14.0	10.4	6.5	6.2	11.5	5.2	5.9
EFR3A	KIAA0143	ENSG00000132294	"EFR3 homolog A"	Q14156	8	131904088-132013642	"Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022859, HPA023092, HPA023402"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA022859: AB_1848029, HPA023092: AB_2293240, HPA023402: AB_1848031"	"unprognostic (4.79e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-3)"	14.7	16.0	21.6	13.6	21.4	8.0	46.8	48.6	52.2	20.4	19.2	7.1	15.0	15.0	18.0	26.5	18.6	16.5	14.6	22.7	28.2	18.5	20.2	28.9	18.8	22.4	20.7	24.4	13.6	13.8	29.2	12.9	13.3	63.3	18.7	12.5	13.9	14.6	20.8	37.1	13.8	15.2	28.1	11.9	14.5	14.8	13.8	7.6	18.7	25.4	9.8	17.7	18.1	14.1	9.5	12.0	11.8	25.8	10.0	12.1	9.5	20.9	18.9	5.9	4.9	24.3	28.1	11.9	15.0	21.1	12.5	16.6	4.1	15.7	12.9	14.2	33.7	6.9	9.3	20.5	15.4	29.6	5.1	12.8	9.4	8.3	23.3	4.9	13.6	23.7	11.7	12.3	19.6	15.7	7.0	17.4	22.1	13.7	13.6	4.5	3.3	11.9	5.5	11.6	6.1	15.1	13.1	4.0	13.8	29.8	4.2	11.6	13.5	8.4	21.8	22.3	20.5	10.8	15.6	12.4	10.6	8.1	16.5	11.9	11.3	5.4	11.7	11.8	12.1	16.4	10.8	9.5	9.8	9.8	12.0	8.3	9.0	9.1	7.2	10.0	25.8	2.8	7.7	9.5	21.6	21.4	48.6	52.2	28.2	18.5	20.7	24.4	63.3	7.6
EFR3B	"FLJ37871, KIAA0953"	ENSG00000084710	"EFR3 homolog B"	Q9Y2G0	2	25042130-25159137	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;retina: 21.1;skeletal muscle: 25.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.9;BEWO: 10.4;SH-SY5Y: 9.3;SK-BR-3: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038089, HPA071831"	Uncertain		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"HPA038089: AB_10672618, HPA071831: "	"unprognostic (9.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.49e-6)"	"unprognostic (4.83e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	1.9	3.2	13.1	1.7	22.9	1.3	1.3	15.5	30.5	1.4	1.7	9.4	0.0	1.4	1.8	8.4	1.3	1.8	1.5	6.9	11.4	8.7	1.4	1.1	4.4	1.3	8.7	13.5	1.4	1.3	2.4	4.1	3.2	29.9	1.5	1.8	21.1	1.1	2.0	25.1	1.7	1.3	2.6	7.8	4.3	2.2	3.5	9.0	0.0	4.5	0.2	1.1	1.4	0.7	1.0	0.6	4.4	0.5	1.0	0.7	0.1	0.1	7.0	8.2	8.9	0.5	0.1	10.4	0.8	0.2	0.4	0.1	5.6	0.3	0.1	0.5	1.2	0.5	6.5	0.0	0.1	1.3	1.6	1.3	0.3	0.5	0.0	0.1	0.7	0.1	0.0	2.0	0.1	0.2	0.1	0.4	0.2	0.8	0.2	0.4	1.6	5.6	0.6	7.9	0.2	0.1	0.2	3.5	9.3	1.0	15.6	5.0	0.8	0.1	0.5	0.5	2.4	3.6	1.7	0.6	0.7	0.1	6.4	0.1	1.7	4.4	0.4	1.1	0.7	0.3	0.5	0.6	0.4	0.6	0.3	1.0	0.4	0.7	1.7	1.0	0.5	0.6	0.2	0.1	13.1	22.9	15.5	22.7	11.4	8.7	8.7	13.5	29.9	9.0
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell line enriched"	"Detected in many"	12	"A-431: 337.7"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"		93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: , CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavourable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	337.7	4.3	1.1	1.5	6.9	4.3	1.1	3.3	4.5	2.0	1.6	0.8	3.7	0.2	0.8	2.8	13.5	0.0	14.9	2.5	0.1	0.2	0.0	1.8	0.2	1.8	0.0	0.0	2.1	13.7	5.2	27.9	0.2	0.0	0.0	4.4	0.2	0.0	0.0	0.3	2.2	0.0	0.6	0.0	2.5	3.6	0.0	1.3	2.8	3.4	0.6	0.3	0.7	1.0	1.9	0.5	14.6	3.1	0.0	0.3	0.1	2.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9
EGLN2	"HIFPH1, PHD1"	ENSG00000269858	"Egl-9 family hypoxia inducible factor 2"	Q96KS0	19	40798996-40808433	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056649			Supported	Nucleoplasm				Nucleoplasm		"HPA056649: "	"unprognostic (1.11e-2)"	"prognostic favourable (2.88e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.81e-4)"	"unprognostic (7.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.38e-3)"	27.4	24.3	24.8	24.7	28.5	23.3	33.5	22.6	28.9	22.2	21.2	21.9	26.4	17.8	24.2	17.8	16.7	18.6	23.4	18.6	25.5	18.7	18.4	19.1	31.6	29.0	21.8	25.7	22.8	16.6	10.6	16.9	42.5	16.9	20.9	15.3	16.5	19.4	25.7	15.5	13.4	16.8	28.1	15.0	42.4	18.0	74.1	18.0	14.4	29.7	17.2	22.7	19.6	25.1	25.1	16.3	68.2	21.5	15.1	30.2	26.5	16.3	44.5	20.7	20.0	26.9	19.7	13.5	17.9	15.0	25.6	28.2	36.7	16.6	14.6	15.3	21.4	10.6	26.0	20.4	13.8	18.2	14.7	19.4	26.0	13.9	28.9	14.9	26.6	24.2	21.8	24.4	14.1	31.5	27.5	13.7	26.9	11.6	27.5	24.7	17.9	15.5	25.7	10.2	9.9	27.6	25.2	19.1	17.4	29.3	23.2	23.6	30.6	40.8	29.0	32.2	23.2	13.2	21.1	6.9	10.0	25.7	23.5	21.8	23.7	20.9	19.1	46.8	24.1	21.5	25.3	23.2	28.5	24.9	16.3	25.1	30.2	25.2	68.2	15.1	19.9	11.9	25.6	26.5	24.8	28.5	22.6	28.9	25.5	18.7	21.8	25.7	16.9	18.0
EGLN3	"HIFPH3, PHD3"	ENSG00000129521	"Egl-9 family hypoxia inducible factor 3"	Q9H6Z9	14	33924231-34462774	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 49.6;skin 1: 44.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;RPTEC TERT1: 15.2;RT4: 47.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 50.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 19.0"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064895			Supported	Cytosol				Cytosol		"HPA064895: "	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.75e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.38e-2)"	"prognostic unfavourable (2.14e-5)"	"unprognostic (1.39e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.30e-2)"	6.3	0.8	12.9	4.8	10.6	0.4	6.0	3.0	11.9	7.3	14.3	13.4	4.9	19.3	5.9	2.8	10.4	5.4	7.8	49.6	10.9	7.3	6.1	2.4	3.0	3.0	10.7	8.1	2.5	6.5	0.4	1.5	19.6	9.9	9.9	11.3	3.5	4.2	11.3	9.7	44.1	21.7	11.7	9.7	2.8	19.9	1.0	12.5	3.4	1.2	1.3	5.3	25.6	16.1	0.0	19.0	1.2	0.0	0.8	1.0	0.6	11.8	3.1	0.3	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.2	0.0	4.0	0.0	0.3	5.9	11.5	0.0	1.2	3.1	3.2	8.7	0.4	0.0	0.0	0.1	1.6	5.8	0.0	0.0	0.0	6.3	0.0	0.1	1.0	0.2	0.0	9.6	1.1	0.0	17.8	4.2	15.2	47.8	2.5	2.8	0.8	4.6	1.2	4.7	0.0	0.0	0.1	1.3	0.0	0.6	0.1	2.5	0.0	2.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.8	1.9	0.0	0.1	0.0	0.1	0.8	0.0	19.0	0.0	0.6	12.9	10.6	3.0	9.8	10.9	7.3	10.7	8.1	9.9	12.5
EGR1	"AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225"	ENSG00000120738	"Early growth response 1"	P18146	5	138465490-138469315	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.2;hTCEpi: 57.1;U-266/84: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.5;intermediate monocyte: 5.1;neutrophil: 9.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 9.9;monocytes: 5.1"	"Group enriched"	"Detected in all"	6	"amygdala: 88.4;basal ganglia: 148.1;cerebral cortex: 237.4;hippocampal formation: 138.8;olfactory region: 126.1"	"Low region specificity"	"Detected in all"			"CAB019427, HPA029937, HPA029938"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB019427: AB_2097038, HPA029937: , HPA029938: "	"unprognostic (5.47e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.74e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	78.7	47.9	5.5	114.3	23.3	18.3	28.7	23.7	25.0	61.8	40.5	31.6	8.0	6.8	51.7	15.6	47.2	187.3	158.4	42.9	7.0	8.1	22.0	68.8	39.7	18.6	4.9	7.0	130.9	23.0	15.8	43.3	24.3	17.8	45.2	21.7	56.1	18.7	100.5	19.4	54.2	29.8	60.8	4.4	8.8	46.1	14.7	2.8	19.4	76.6	67.5	26.6	43.2	20.3	0.9	0.9	9.9	5.1	0.1	0.2	0.4	4.1	0.1	8.9	13.2	24.2	39.2	1.0	7.1	4.4	9.6	7.8	5.0	3.6	0.2	1.1	15.4	1.9	0.5	14.4	4.4	0.2	0.6	0.5	1.7	1.4	3.1	1.5	11.4	3.0	57.1	8.5	1.9	0.8	20.9	5.1	2.8	20.5	0.6	6.4	0.8	0.0	0.1	1.3	0.7	7.3	2.5	11.2	1.2	8.6	23.9	18.5	0.3	1.2	0.3	3.5	4.5	1.7	2.7	11.9	86.2	1.7	4.0	19.6	1.0	0.0	3.5	0.4	0.2	5.1	0.0	0.9	0.1	0.1	0.9	0.3	0.2	0.2	9.9	0.1	1.4	0.0	0.2	0.4	5.5	23.3	23.7	25.0	7.0	8.1	4.9	7.0	17.8	2.8
EGR2	KROX20	ENSG00000122877	"Early growth response 2"	P11161	10	62811996-62919900	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 57.1"	"Cell line enriched"	"Detected in some"	6	"U-87 MG: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5;non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"amygdala: 2.5;basal ganglia: 3.8;cerebral cortex: 4.9;hippocampal formation: 4.1;olfactory region: 3.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.7;cerebral cortex: 6.6;hippocampal formation: 5.1;midbrain: 3.0;olfactory region: 9.8"	HPA031165			Supported	Nucleoplasm				Nucleoplasm		"HPA031165: "	"prognostic favourable (7.30e-5)"	"unprognostic (1.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.11e-3)"	9.4	4.7	1.8	8.3	9.2	2.7	7.8	1.2	9.9	8.5	2.9	18.7	0.5	0.7	5.8	25.5	3.5	6.1	13.1	16.1	3.3	1.6	3.0	5.2	15.7	5.3	6.0	1.2	7.6	2.2	3.9	10.6	4.9	7.5	7.6	1.5	7.8	3.1	1.3	1.2	15.9	3.1	6.7	3.1	3.6	3.0	4.3	0.7	22.7	57.1	5.0	11.5	8.2	2.4	1.2	1.1	1.5	5.5	0.5	0.4	0.6	0.0	0.2	2.4	1.0	1.8	2.4	0.4	0.5	0.2	0.5	0.8	0.0	0.3	0.6	0.0	0.6	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	3.8	0.3	0.6	1.3	0.2	0.1	0.2	0.8	0.1	1.2	0.0	1.7	0.2	1.3	0.1	0.2	0.4	0.0	0.2	0.1	0.3	0.2	0.8	3.9	0.0	0.5	0.1	0.6	0.4	0.2	0.3	1.4	0.6	0.3	22.4	0.4	0.4	0.0	1.1	0.4	0.4	5.5	0.0	1.0	0.0	0.2	1.1	1.2	0.0	0.4	1.5	0.5	5.3	0.0	0.0	0.6	1.8	9.2	1.2	9.9	3.3	1.6	6.0	1.2	7.5	0.7
EHBP1	"KIAA0903, NACSIN"	ENSG00000115504	"EH domain binding protein 1"	Q8NDI1	2	62673851-63046487	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035468, HPA035469"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA035468: AB_10671513, HPA035469: AB_10601365"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (8.78e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (1.95e-8)"	19.6	12.6	19.8	10.2	15.4	4.0	12.0	27.5	22.5	22.5	22.3	8.0	7.5	6.8	22.3	6.0	20.9	12.7	18.2	7.8	16.0	15.9	12.3	36.9	8.1	5.7	17.1	13.0	35.1	10.9	9.7	14.5	8.2	12.8	12.6	10.4	8.6	10.2	14.0	5.4	7.4	8.5	21.4	9.3	5.4	11.1	24.1	9.8	5.4	10.4	7.5	7.0	12.3	12.7	8.4	5.4	3.5	3.6	4.7	6.8	2.8	18.3	25.4	10.4	6.2	18.2	35.2	10.5	16.4	16.1	12.1	10.0	30.2	13.8	12.7	6.0	30.0	11.2	13.4	11.6	20.1	13.5	6.3	10.9	9.0	35.6	12.5	6.3	8.4	16.2	21.0	12.3	24.1	7.7	7.5	7.3	19.4	7.1	7.3	4.0	10.1	9.9	6.6	13.0	5.4	8.1	6.0	11.3	9.2	13.5	10.0	16.3	4.8	6.3	5.6	13.1	13.6	21.5	8.6	8.4	5.7	12.1	13.0	9.9	26.1	0.2	3.4	3.5	6.3	3.6	6.3	8.4	6.8	6.0	5.4	7.3	6.7	5.7	1.3	4.7	1.9	3.5	3.7	2.8	19.8	15.4	27.5	22.5	16.0	15.9	17.1	13.0	12.8	9.8
EHD1	"FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1"	ENSG00000110047	"EH domain containing 1"	Q9H4M9	11	64851642-64888296	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751, HPA067747"	Approved		Supported	"Plasma membrane"			19000000	"Plasma membrane"		"HPA049890: , HPA049986: , HPA066751: , HPA067747: "	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (2.81e-5)"	"unprognostic (1.46e-3)"	"unprognostic (9.10e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.37e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.59e-2)"	17.5	10.4	7.3	33.3	7.4	57.5	12.3	27.2	11.3	11.1	13.5	18.2	8.0	14.7	13.1	10.8	15.5	12.5	15.2	11.3	8.2	9.4	14.5	9.3	18.7	41.1	13.8	5.9	10.0	5.2	5.1	3.4	34.8	16.7	9.0	6.6	8.0	11.9	10.0	13.2	14.1	22.9	12.4	13.1	43.1	12.7	65.8	10.4	21.3	12.3	13.6	33.6	13.5	10.3	10.6	3.5	38.0	13.1	10.2	17.2	10.2	26.4	18.4	6.6	7.3	8.1	13.2	3.9	27.0	24.5	22.9	13.4	23.8	16.6	34.9	9.7	32.2	21.6	6.9	27.2	8.9	21.8	3.8	23.2	9.6	12.0	9.6	7.5	6.3	5.9	5.8	35.4	11.1	22.6	9.5	62.0	17.3	14.1	15.0	12.5	4.4	24.1	6.0	21.3	12.1	21.7	8.8	4.7	4.2	15.1	27.8	12.3	37.8	5.4	31.8	10.2	9.1	27.0	12.9	25.5	11.2	26.8	26.6	9.8	5.5	6.7	5.0	38.0	16.9	6.7	17.2	10.6	11.9	14.6	2.9	8.2	7.2	9.8	23.6	10.2	13.1	3.5	12.9	10.2	7.3	7.4	27.2	11.3	8.2	9.4	13.8	5.9	16.7	10.4
EHD2	PAST2	ENSG00000024422	"EH domain containing 2"	Q9NZN4	19	47713343-47743134	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 58.6;fHDF/TERT166: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047394, HPA049890, HPA049986, HPA066751"	Approved		Supported	"Plasma membrane"			580000	"Plasma membrane"		"HPA047394: , HPA049890: , HPA049986: , HPA066751: "	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavourable (8.75e-4)"	"unprognostic (5.49e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (6.59e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.06e-3)"	82.2	17.8	6.7	14.5	6.1	0.6	62.0	4.3	7.5	35.2	29.1	5.0	10.0	6.7	40.2	21.2	33.0	20.7	34.3	19.3	5.4	2.9	8.3	4.5	28.1	13.5	5.4	3.4	34.0	11.1	3.1	3.8	22.8	6.4	28.2	7.3	11.6	9.7	25.1	17.3	15.3	14.3	40.7	4.5	19.0	17.5	12.9	5.7	1.8	15.0	24.6	8.3	35.0	52.6	0.6	0.4	2.4	0.6	0.2	0.5	0.9	11.1	26.1	0.0	0.3	58.6	44.7	0.0	43.7	20.7	15.8	12.9	1.7	5.6	0.0	0.0	46.1	14.1	0.2	22.7	9.6	0.0	0.1	1.4	15.2	0.1	37.1	0.0	3.1	43.2	20.1	13.3	13.1	30.5	4.6	0.0	16.6	2.0	2.2	0.1	0.3	4.7	0.2	1.8	0.0	12.6	0.5	0.0	0.1	38.3	1.4	1.1	3.6	0.7	34.7	23.8	5.3	20.9	9.3	0.0	0.0	0.0	22.1	0.5	5.0	1.0	0.4	0.6	0.3	0.3	0.3	0.5	0.3	0.4	0.1	0.6	0.5	0.5	2.4	0.2	0.6	0.4	0.3	0.9	6.7	6.1	4.3	7.5	5.4	2.9	5.4	3.4	6.4	5.7
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34661057	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 34.7;HaCaT: 23.9;HBEC3-KT: 26.3;RT4: 53.1;T-47d: 53.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			Nucleoplasm	"Golgi apparatus"	"HPA050923: , HPA060734: "	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavourable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.8	1.0	0.8	9.3	0.9	0.0	32.1	0.7	0.7	19.3	16.0	0.5	152.4	6.9	4.5	21.4	69.0	23.0	22.1	0.7	0.9	0.9	11.6	1.6	9.9	0.1	1.5	0.3	4.7	10.5	0.2	0.9	0.5	1.4	20.7	22.3	0.2	118.0	161.8	0.7	12.8	10.1	1.7	3.3	0.7	10.1	1.4	0.5	0.4	1.2	50.3	59.7	13.7	30.3	0.0	4.9	0.0	0.4	0.0	0.0	0.2	11.4	6.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	34.7	0.0	4.4	0.0	23.9	0.0	26.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.2	4.7	53.1	0.0	0.0	0.1	3.6	0.0	53.8	0.1	0.0	0.0	0.3	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.7	0.7	0.9	0.9	1.5	0.3	1.4	0.5
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618963-137870016	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060022			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA060022: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favourable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favourable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	16.6	18.3	16.4	23.2	22.3	24.9	17.1	23.7	20.4	16.3	20.7	21.6	20.4	17.1	22.0	13.0	17.9	18.5	20.0	12.1	12.8	9.6	12.7	14.9	14.9	25.0	27.8	12.1	21.4	13.6	15.1	16.2	17.9	18.6	16.9	12.4	19.1	16.5	18.0	23.1	17.3	17.9	21.5	12.5	22.1	16.4	30.8	21.5	22.3	18.9	11.0	22.2	19.2	15.7	20.0	19.0	25.0	13.7	13.1	15.6	6.9	11.0	22.1	24.8	22.9	10.5	10.9	20.7	14.6	9.2	10.7	8.7	14.4	13.8	33.8	14.2	11.0	23.7	14.8	15.9	8.5	18.9	10.5	14.3	22.1	9.2	9.2	21.7	17.1	9.8	11.2	12.9	12.6	17.5	21.4	11.7	7.6	25.5	25.4	10.8	24.1	14.7	32.7	21.3	19.5	8.9	20.3	21.9	17.8	27.7	19.5	6.3	21.9	17.5	16.4	12.6	13.1	19.3	13.8	7.5	20.8	27.8	9.3	11.6	13.6	13.6	13.7	16.3	15.6	11.7	10.0	13.3	13.5	13.3	10.4	20.0	13.3	11.8	25.0	13.1	12.0	19.0	11.1	6.9	16.4	22.3	23.7	20.4	12.8	9.6	27.8	12.1	18.6	21.5
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 10.2;NTERA-2: 15.5;U-266/84: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"			"Nuclear speckles"	Nucleoplasm	"HPA050550: , HPA060259: "	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	9.4	12.2	13.1	9.6	21.4	7.6	6.3	17.1	17.5	8.0	7.7	12.3	8.4	14.6	15.0	11.7	18.0	7.6	8.1	7.6	12.3	12.4	5.3	4.4	8.5	6.9	12.6	10.6	10.6	13.2	2.2	8.1	6.0	10.3	10.4	4.3	7.2	5.6	9.6	5.2	5.5	10.1	9.6	8.4	9.1	9.8	7.6	14.9	14.6	9.5	4.8	7.2	8.7	7.6	0.3	0.6	0.0	0.7	0.1	1.1	1.3	0.0	3.5	6.3	0.0	2.8	1.5	4.0	2.7	2.2	3.1	2.6	0.0	0.0	0.0	6.2	4.5	0.0	0.0	6.8	1.5	4.1	9.4	0.0	0.0	0.0	0.0	10.2	0.0	3.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	15.5	0.0	6.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	5.2	0.0	0.0	3.0	3.3	2.6	5.6	0.0	9.0	12.2	2.9	3.8	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.1	0.8	0.6	0.3	0.3	1.1	1.1	0.0	0.1	0.7	0.6	0.2	1.3	13.1	21.4	17.1	16.5	12.3	12.4	12.6	10.6	10.3	14.9
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24, autophagy associated transmembrane protein"	O14681	11	125569216-125584687	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 164.6"	"Cell line enhanced"	"Detected in all"		"HEL: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	13.4	10.2	13.3	8.9	16.2	4.6	16.7	11.2	22.1	12.7	17.0	14.4	13.8	11.3	13.6	12.9	22.7	12.1	15.8	16.4	10.6	10.7	14.6	55.5	12.1	11.2	12.0	11.1	13.1	34.2	164.6	9.2	11.9	11.0	13.7	18.9	13.2	20.9	14.3	26.5	17.2	16.1	15.9	9.2	10.5	17.7	10.4	10.5	9.9	12.0	14.2	13.0	16.2	12.9	8.5	15.5	5.4	7.3	6.5	10.0	4.9	24.5	18.7	21.4	25.8	35.2	26.8	26.8	25.2	19.1	17.4	15.7	28.4	49.6	24.7	42.9	23.7	28.4	32.5	53.0	22.6	6.5	20.6	117.8	13.4	26.6	26.2	26.5	12.8	25.0	48.6	26.1	38.6	36.7	53.4	10.1	24.4	17.3	12.1	13.6	28.2	20.5	17.8	25.3	21.0	29.0	44.0	20.0	19.2	29.5	35.2	9.5	71.9	26.5	30.5	22.4	15.2	15.6	20.3	6.3	12.7	32.2	9.8	40.8	29.8	4.1	7.3	5.4	8.2	7.0	8.1	8.5	6.5	10.0	11.6	7.3	9.4	7.6	0.9	6.5	5.1	15.5	9.0	4.9	13.3	16.2	11.2	22.1	10.6	10.7	12.0	11.1	11.0	10.5
EID1	"C15orf3, CRI1, EID-1"	ENSG00000255302	"EP300 interacting inhibitor of differentiation 1"	Q9Y6B2	15	48877886-48880183	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051122, HPA051123"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA051122: , HPA051123: "	"unprognostic (1.38e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (9.99e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-3)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (2.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-1)"	42.6	75.4	69.7	33.0	66.6	18.4	38.1	65.0	77.2	56.1	47.9	36.9	33.6	30.4	58.1	46.0	41.2	46.8	52.9	95.4	63.4	73.2	53.0	42.5	35.1	35.1	58.6	63.7	71.7	38.3	42.0	71.7	32.7	67.6	56.2	24.6	44.9	34.4	53.3	92.7	19.9	29.1	55.3	59.8	39.6	33.4	26.9	44.4	32.8	48.3	38.0	26.9	57.1	35.0	36.4	72.7	55.3	62.9	43.9	65.0	73.4	20.5	17.5	39.9	37.4	35.2	47.0	2.7	54.2	44.9	33.1	43.6	15.1	9.3	27.6	50.4	30.8	18.5	19.2	19.3	36.0	75.9	19.9	47.4	38.8	0.6	27.6	28.5	21.7	41.0	16.5	22.3	13.3	37.2	28.1	26.5	36.6	29.6	20.5	24.0	0.0	15.4	29.0	49.6	45.0	41.0	22.7	38.1	38.1	33.8	12.9	61.4	23.5	37.7	42.1	52.8	29.4	50.0	47.2	34.3	93.6	19.7	43.7	63.0	37.1	55.3	62.9	53.7	47.8	56.6	45.1	34.0	54.6	49.5	72.7	36.4	39.9	36.6	8.3	43.9	56.0	72.2	65.0	73.4	69.7	66.6	65.0	77.2	63.4	73.2	58.6	63.7	67.6	44.4
EID2	"CRI2, EID-2, MGC20452"	ENSG00000176396	"EP300 interacting inhibitor of differentiation 2"	Q8N6I1	19	39538705-39540333	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045477	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA045477: AB_10959785"	"unprognostic (5.91e-2)"	"unprognostic (6.37e-3)"	"prognostic favourable (9.73e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.88e-3)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	12.1	19.8	18.0	10.1	18.9	6.5	10.6	16.7	24.5	10.1	9.2	9.5	7.7	8.2	10.9	10.3	8.7	8.9	7.9	9.7	17.8	20.8	15.4	12.8	10.1	9.9	16.2	17.9	10.8	9.3	13.6	14.4	20.6	24.0	11.3	8.2	9.2	8.6	10.5	10.3	8.5	9.3	11.8	10.9	10.5	9.1	9.2	9.4	13.1	12.9	6.0	9.7	8.0	8.6	1.9	1.4	1.8	1.5	0.8	4.2	1.1	13.4	18.3	17.5	11.8	14.2	8.8	2.5	16.3	12.2	12.6	13.1	11.5	4.3	13.7	13.3	11.2	5.8	16.1	11.7	16.4	13.3	20.3	6.2	10.2	13.6	14.1	10.7	9.1	10.3	7.4	10.5	8.1	14.7	9.9	9.7	11.0	8.8	15.4	9.4	9.8	7.7	14.4	16.7	6.3	15.9	12.4	16.4	11.6	17.6	7.1	10.9	9.5	7.0	10.6	8.1	28.9	10.7	12.1	15.3	17.7	17.2	7.6	10.0	6.6	0.0	1.2	1.8	2.4	1.5	2.5	1.4	3.0	3.1	1.3	1.9	3.1	4.2	0.5	0.8	1.2	1.4	0.6	1.1	18.0	18.9	16.7	24.5	17.8	20.8	16.2	17.9	24.0	9.4
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 69.1"	"Cell line enhanced"	"Detected in many"		"A549: 10.0;BJ: 9.3;BJ hTERT+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 7.7;HeLa: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5"	"Low region specificity"	"Detected in single"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059367: "	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	1.7	1.7	2.0	2.9	2.7	3.0	1.7	4.0	2.6	1.6	1.8	1.5	0.2	0.6	2.1	1.9	1.3	1.8	1.8	1.2	1.9	1.9	1.2	0.9	1.8	3.7	1.2	2.3	3.4	1.7	0.9	5.3	1.1	2.2	2.7	0.6	1.7	1.3	4.1	1.5	1.6	1.6	1.6	1.2	1.9	1.4	69.1	1.6	2.3	1.0	0.4	2.5	1.5	1.3	2.9	0.5	0.7	1.5	6.6	9.5	2.6	0.3	10.0	0.3	1.0	2.2	2.3	1.9	9.3	7.6	4.5	7.7	0.2	0.5	0.1	0.1	2.1	0.2	0.3	0.8	6.6	0.6	0.1	1.8	8.4	1.5	3.3	0.1	0.5	3.1	0.0	2.8	0.6	0.7	0.1	0.6	2.8	0.1	3.3	1.4	0.5	2.0	0.2	0.0	0.1	2.5	0.3	0.1	0.0	6.2	0.4	0.2	0.0	0.0	1.4	0.1	0.3	2.2	0.4	0.4	0.2	0.1	0.2	0.0	0.9	0.0	0.3	0.5	5.2	1.5	5.5	2.7	6.6	6.2	0.3	2.9	9.5	5.7	0.7	6.6	0.9	0.5	7.6	2.6	2.0	2.7	4.0	2.6	1.9	1.9	1.2	2.3	2.2	1.6
EIF1AD	"haponin, MGC11102"	ENSG00000175376	"Eukaryotic translation initiation factor 1A domain containing"	Q8N9N8	11	65996545-66002176	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054991, HPA058735"	Uncertain		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA054991: , HPA058735: "	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (3.59e-5)"	"unprognostic (1.30e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavourable (8.63e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.96e-1)"	16.8	18.4	15.5	17.9	18.8	38.7	16.3	21.8	23.7	16.0	15.3	15.4	19.9	15.0	18.3	16.4	22.1	16.0	15.3	15.6	15.1	16.1	15.2	18.5	16.2	21.1	18.8	11.1	21.5	23.7	22.0	24.0	25.5	17.7	15.8	14.8	17.5	17.8	16.2	27.1	23.4	17.6	14.9	18.2	22.2	16.6	22.3	19.9	21.2	16.0	18.1	27.0	15.5	23.8	14.8	16.1	28.2	15.5	11.6	14.7	9.4	22.3	19.5	16.4	16.4	13.2	13.8	15.5	16.4	16.2	21.0	17.9	18.8	21.5	17.0	28.8	18.8	15.5	19.5	21.9	19.5	15.7	10.2	24.1	22.4	20.2	16.5	21.9	18.9	11.5	19.2	31.5	21.5	14.0	35.8	24.8	29.8	29.8	20.3	24.4	12.4	21.4	22.4	16.7	33.3	11.8	14.0	12.1	14.9	18.5	25.3	19.1	24.6	13.7	16.7	27.4	18.6	22.4	15.8	30.4	35.8	35.7	19.9	15.4	18.2	28.2	15.5	10.0	14.7	12.7	11.3	14.8	12.6	10.7	16.1	14.5	12.0	11.0	10.6	11.6	15.3	9.7	11.3	9.4	15.5	18.8	21.8	23.7	15.1	16.1	18.8	11.1	17.7	19.9
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022244-6059230	"Enzymes, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: "	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	21.0	38.2	31.7	25.4	32.7	62.8	26.9	23.9	41.1	22.8	34.5	31.0	20.8	26.5	22.6	28.6	28.4	23.4	21.5	40.0	29.9	30.0	32.0	46.3	22.1	23.3	33.3	30.3	23.0	32.4	61.9	25.4	43.9	33.4	26.4	34.9	23.4	46.4	26.3	31.6	28.9	29.9	17.8	35.6	25.4	34.7	16.3	22.6	37.1	29.0	17.4	29.6	22.4	20.1	11.7	7.5	17.4	7.4	10.4	10.6	4.8	41.1	25.9	20.8	31.6	20.0	18.0	27.4	21.2	19.4	19.0	24.1	23.7	27.8	32.2	23.3	23.3	29.1	27.0	19.3	24.5	19.9	41.5	33.2	28.2	35.7	16.4	28.2	30.3	14.5	24.4	17.9	19.3	20.1	53.1	31.2	17.8	41.1	15.4	36.0	26.1	29.3	34.0	21.9	37.8	24.1	20.1	25.9	46.6	40.8	54.5	18.1	41.0	34.6	19.2	10.9	40.7	19.2	22.4	31.7	31.6	32.8	22.0	37.2	31.6	10.6	7.4	17.4	9.5	5.9	6.4	11.7	7.4	10.6	7.5	7.7	8.6	7.7	4.1	10.4	6.5	6.6	8.8	4.8	31.7	32.7	23.9	41.1	29.9	30.0	33.3	30.3	33.4	22.6
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157065	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol				Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: "	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	25.5	14.2	15.9	16.3	15.5	36.4	13.9	16.4	19.0	14.7	13.7	9.9	9.3	14.5	17.2	21.5	12.1	12.8	15.4	10.7	13.7	19.2	12.2	11.5	13.7	10.7	14.3	15.0	18.7	11.7	19.2	21.1	18.2	17.3	15.0	12.8	10.2	23.0	17.8	7.1	6.7	15.2	16.2	14.0	15.5	14.3	5.1	12.8	14.1	13.6	8.1	10.6	14.8	15.5	8.8	6.9	27.6	10.8	8.6	9.9	3.3	24.9	12.8	7.9	10.0	8.7	11.9	15.6	13.2	19.0	41.8	40.3	14.6	14.9	13.3	17.2	14.4	14.8	13.6	13.4	18.8	29.3	7.2	14.6	9.8	9.5	8.6	14.0	0.1	9.7	5.3	16.7	12.2	10.3	10.1	13.4	9.4	11.1	17.9	7.2	8.2	9.2	18.1	19.4	6.6	7.8	9.6	8.9	9.4	16.1	11.7	25.4	6.0	4.0	13.4	17.0	18.0	7.2	21.2	9.9	16.3	0.2	8.1	9.5	14.8	17.1	8.2	11.1	8.9	10.6	9.0	8.8	7.5	8.1	6.9	7.0	6.1	7.5	27.6	8.6	10.8	4.7	9.9	3.3	15.9	15.5	16.4	19.0	13.7	19.2	14.3	15.0	17.3	12.8
EIF2B1	"EIF-2B, EIF-2Balpha, EIF2B, EIF2BA"	ENSG00000111361	"Eukaryotic translation initiation factor 2B subunit alpha"	Q14232	12	123620406-123633766	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034258, HPA049509"	Approved		Supported	Cytosol			8500	Cytosol		"CAB034258: AB_2095995, HPA049509: "	"unprognostic (2.14e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (6.75e-7)"	"unprognostic (5.65e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (1.78e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.40e-2)"	27.9	29.5	24.0	27.8	29.0	27.5	27.6	35.6	33.4	24.1	26.4	25.7	24.6	24.3	32.3	27.3	30.2	27.3	27.2	21.1	22.6	20.3	22.8	30.2	21.3	32.7	29.9	28.0	32.7	29.2	22.0	29.0	29.8	26.8	25.8	28.0	21.7	25.6	28.0	34.9	44.3	27.6	33.8	24.3	30.1	24.9	29.1	26.9	33.3	25.2	30.5	36.6	28.0	27.3	23.2	35.6	42.3	38.2	22.6	26.6	32.6	18.8	16.6	17.7	18.6	16.3	16.4	18.5	23.2	13.1	22.5	16.3	21.0	11.9	35.7	27.8	17.2	19.0	27.2	17.7	23.7	29.0	29.7	25.6	23.6	18.6	15.3	36.0	32.2	14.8	21.9	19.3	13.7	20.6	45.6	12.0	20.5	16.7	28.9	37.2	29.1	21.8	30.4	21.6	27.0	14.9	15.8	22.0	25.0	17.1	17.2	21.4	31.2	21.7	19.7	15.6	19.0	22.3	21.5	32.5	34.1	52.7	22.8	24.5	22.4	32.5	32.7	42.3	22.5	38.2	20.4	23.2	22.9	23.1	35.6	20.3	23.7	21.8	3.6	22.6	34.5	22.4	26.6	32.6	24.0	29.0	35.6	33.4	22.6	20.3	29.9	28.0	26.8	26.9
EIF2B3	"EIF-2B, EIF2Bgamma"	ENSG00000070785	"Eukaryotic translation initiation factor 2B subunit gamma"	Q9NR50	1	44850522-44986722	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024213, HPA024218, HPA024219"	Supported		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069"	"unprognostic (2.12e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavourable (1.73e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.80e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.73e-2)"	16.5	18.3	12.9	9.2	14.6	7.1	16.1	22.2	16.5	11.6	10.1	13.1	11.2	6.6	13.1	10.1	11.8	9.6	7.5	22.5	10.7	11.1	11.9	20.7	8.8	9.9	13.7	11.1	12.3	18.5	23.3	26.7	7.3	16.0	10.6	10.6	12.3	17.9	11.9	52.1	10.5	6.6	14.8	12.1	9.8	9.1	13.7	12.3	11.1	9.8	13.7	12.4	12.2	10.9	11.3	21.9	2.3	21.4	14.1	15.4	12.5	13.8	11.3	12.5	10.6	15.3	18.4	15.0	22.4	17.1	23.0	21.8	16.3	8.3	36.2	16.5	16.9	8.2	26.3	19.0	28.2	12.5	24.1	17.9	12.5	15.6	19.5	27.5	10.2	12.7	10.4	25.1	28.7	21.1	41.1	12.6	24.9	9.5	26.4	12.0	17.4	22.5	21.4	20.9	25.8	11.8	6.5	22.6	8.2	22.6	26.0	14.3	10.1	12.8	11.3	15.0	17.9	21.9	29.0	13.1	14.7	27.0	11.6	23.1	17.8	1.0	14.3	2.3	12.2	21.4	14.4	9.5	12.0	13.5	21.9	11.3	15.2	15.4	1.2	14.1	18.5	15.4	9.9	12.5	12.9	14.6	22.2	16.5	10.7	11.1	13.7	11.1	16.0	12.3
EIF2B5	"EIF-2B, EIF2Bepsilon"	ENSG00000145191	"Eukaryotic translation initiation factor 2B subunit epsilon"	Q13144	3	184135038-184145311	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015412, HPA064370, HPA069303"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB015412: AB_831253, HPA064370: , HPA069303: "	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.33e-2)"	"prognostic unfavourable (3.38e-8)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	15.2	20.1	15.3	15.4	20.2	10.6	21.5	24.5	25.8	15.1	18.8	17.8	24.3	17.3	16.3	14.9	24.3	15.4	14.0	21.5	13.0	16.1	17.5	27.5	15.6	20.1	20.8	15.1	16.0	19.1	27.0	21.2	20.6	17.7	20.4	23.7	15.3	23.2	21.0	47.2	22.8	18.2	17.5	14.7	21.1	19.6	11.9	17.3	20.9	17.4	16.9	26.9	19.1	18.3	12.7	10.3	10.9	8.4	11.2	17.2	6.5	24.5	11.3	13.9	15.1	14.0	11.5	15.0	14.7	15.7	21.5	18.3	18.5	12.4	22.4	17.0	14.4	19.0	24.9	17.2	22.1	20.1	20.4	36.6	11.5	16.2	10.9	27.6	19.4	9.6	15.5	13.0	13.5	15.4	19.7	19.6	15.2	20.6	20.2	19.3	18.7	20.9	21.9	16.7	25.2	19.6	21.7	15.0	16.6	12.6	39.9	16.3	37.0	27.3	14.3	13.1	15.3	12.4	28.2	16.9	23.3	28.5	15.6	29.6	16.3	7.2	8.4	10.9	7.6	7.4	10.5	12.0	11.9	12.7	10.3	12.7	17.2	10.7	1.6	11.2	7.7	5.0	9.5	6.5	15.3	20.2	24.5	25.8	13.0	16.1	20.8	15.1	17.7	17.3
EIF2S1	"EIF-2alpha, EIF2, EIF2A"	ENSG00000134001	"Eukaryotic translation initiation factor 2 subunit alpha"	P05198	14	67359997-67386516	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011663, HPA064885"	Supported		Enhanced	Cytosol			52000	Cytosol		"CAB011663: AB_2096478, HPA064885: "	"unprognostic (1.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavourable (4.73e-7)"	"unprognostic (4.14e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.68e-2)"	"prognostic unfavourable (4.97e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (7.11e-4)"	35.5	26.2	18.7	24.8	26.3	18.9	22.5	18.9	30.6	17.8	25.7	16.3	16.1	18.5	22.9	18.0	34.8	18.4	19.1	27.9	21.9	17.0	23.8	45.0	21.1	24.1	19.9	20.8	22.9	27.8	21.3	16.3	28.0	24.1	24.4	24.2	12.6	19.9	21.0	52.0	23.8	18.4	30.9	18.9	22.8	22.9	29.1	15.1	27.3	29.0	29.9	28.0	31.1	23.1	26.6	32.9	17.3	32.7	25.7	29.2	30.2	67.2	22.5	15.8	24.3	15.3	17.4	34.0	30.1	18.0	34.0	29.8	26.2	24.1	30.4	15.3	22.6	26.1	36.5	28.7	51.9	22.1	13.6	19.6	21.9	17.9	16.1	20.8	19.2	14.0	16.7	30.3	46.4	27.6	33.2	23.6	33.5	33.4	28.4	16.4	16.1	37.6	21.8	26.3	21.6	20.9	31.0	22.9	16.2	21.6	25.5	23.2	43.4	18.1	21.0	45.1	48.6	21.7	31.8	20.5	22.3	45.9	26.1	37.3	28.9	17.3	24.2	14.8	23.9	32.7	29.1	26.6	27.9	25.7	32.9	21.3	26.0	26.5	3.3	25.7	27.4	22.5	29.2	30.2	18.7	26.3	18.9	30.6	21.9	17.0	19.9	20.8	24.1	15.1
EIF2S2	"EIF2, EIF2beta, PPP1R67"	ENSG00000125977	"Eukaryotic translation initiation factor 2 subunit beta"	P20042	20	34088298-34112332	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034415, HPA041262, HPA041332"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"CAB034415: AB_2095998, HPA041262: , HPA041332: "	"unprognostic (5.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (3.23e-5)"	"unprognostic (9.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavourable (9.64e-10)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"	25.9	30.1	32.8	23.3	40.7	21.4	38.1	20.2	37.7	21.1	24.3	10.9	27.1	21.2	21.2	22.4	36.3	17.0	18.3	36.3	30.1	20.4	22.0	40.1	27.2	37.7	40.0	26.2	19.9	45.4	18.7	22.4	29.9	35.8	20.4	24.7	7.4	26.3	25.5	101.8	21.2	20.4	37.0	50.2	23.0	28.1	19.6	35.6	18.2	24.1	32.7	30.1	25.0	30.7	38.8	48.5	28.1	39.3	32.4	42.4	27.3	38.9	26.2	19.9	24.0	19.5	29.7	38.0	35.7	34.3	35.6	36.0	92.0	27.4	35.0	26.3	32.2	36.9	32.3	58.7	43.3	11.2	17.6	69.3	21.6	47.0	50.4	44.3	22.6	30.3	50.1	35.2	52.7	37.2	40.6	33.5	29.2	25.0	41.0	37.0	19.3	47.9	23.7	33.9	32.3	28.1	32.7	20.3	13.8	39.5	24.0	73.2	36.3	52.5	25.0	40.8	25.1	25.5	33.4	31.5	27.7	36.5	38.3	34.5	29.5	21.2	37.0	28.1	26.9	39.3	32.9	38.8	38.2	37.6	34.7	31.8	36.4	36.5	21.9	32.4	35.6	48.5	42.4	27.3	32.8	40.7	20.2	37.7	30.1	20.4	40.0	26.2	35.8	35.6
EIF3A	"EIF3, eIF3-p170, eIF3-theta, eIF3a, EIF3S10, KIAA0139, TIF32"	ENSG00000107581	"Eukaryotic translation initiation factor 3 subunit A"	Q14152	10	119033670-119080823	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038315, HPA038316"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA038315: AB_10672588, HPA038316: AB_10673168"	"unprognostic (8.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.07e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.89e-2)"	36.7	27.4	19.6	29.4	20.2	41.4	42.4	22.4	22.3	27.8	29.2	21.7	32.3	26.0	33.4	26.0	35.7	22.7	25.0	36.7	19.9	18.6	28.2	41.5	24.6	39.0	24.2	20.1	29.2	61.9	35.8	33.2	33.7	25.5	26.9	26.4	14.4	31.4	31.6	92.3	36.0	29.2	49.3	29.8	29.8	34.1	18.6	22.6	45.8	28.6	33.6	28.7	40.5	38.9	15.0	20.2	21.6	29.7	14.2	27.6	13.9	50.8	38.5	31.8	43.4	34.6	50.2	24.7	46.4	48.2	29.9	30.1	36.2	33.7	59.7	17.3	38.2	51.2	41.3	35.6	42.6	32.8	34.0	51.3	29.8	40.2	39.5	75.0	38.2	43.3	40.1	44.0	75.9	33.8	52.5	39.4	38.6	30.1	31.0	35.5	30.4	19.7	32.1	68.7	28.5	28.6	43.0	14.8	31.5	36.5	34.3	48.0	22.0	48.0	49.6	29.0	26.8	30.3	67.0	34.2	37.5	58.8	30.8	74.0	19.9	21.6	21.2	12.6	16.5	23.9	19.1	15.0	19.9	14.9	20.2	13.3	13.9	15.0	5.7	14.2	29.7	11.6	27.6	13.9	19.6	20.2	22.4	22.3	19.9	18.6	24.2	20.1	25.5	22.6
EIF3C	"eIF3-p110, eIF3c, EIF3S8"	ENSG00000184110	"Eukaryotic translation initiation factor 3 subunit C"	Q99613	16	28688558-28735730	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB034045, HPA047097, HPA049495, HPA050112"	Supported		Supported	Cytosol				Cytosol		"CAB034045: AB_1122487, HPA047097: , HPA049495: , HPA050112: "	"unprognostic (2.42e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-3)"	30.0	24.4	22.2	20.9	33.5	21.2	30.2	24.3	34.8	24.4	31.8	18.1	14.5	23.6	41.5	26.5	30.1	31.0	32.0	32.3	35.9	20.8	30.1	51.7	22.8	21.8	20.9	33.4	42.3	38.1	63.8	21.4	20.0	26.9	20.3	29.3	18.8	54.7	27.9	114.0	32.3	25.0	33.3	19.8	20.7	25.4	47.2	17.5	25.6	32.8	46.4	29.3	24.9	23.6	28.5	50.5	20.6	49.1	37.9	36.1	52.5	25.7	40.8	56.7	68.5	50.7	62.1	87.5	65.4	48.9	77.5	55.6	81.5	48.8	60.7	85.9	41.8	31.8	47.8	80.6	87.5	26.4	48.3	69.6	66.4	105.5	62.9	107.6	53.7	71.3	48.8	49.3	79.4	88.6	75.4	57.6	41.6	94.9	85.8	31.3	94.6	63.9	87.5	87.0	59.8	41.0	56.7	53.5	82.1	55.3	76.7	63.4	76.5	44.3	78.4	55.1	54.7	25.9	42.6	50.0	38.1	122.3	58.3	42.6	56.2	10.7	44.9	20.6	31.1	47.8	36.1	28.5	32.9	33.0	50.5	27.4	33.3	30.3	3.8	37.9	49.1	23.7	34.0	52.5	22.2	33.5	24.3	34.8	35.9	20.8	20.9	33.4	26.9	17.5
EIF3D	"eIF3-p66, eIF3-zeta, eIF3d, EIF3S7"	ENSG00000100353	"Eukaryotic translation initiation factor 3 subunit D"	O15371	22	36510850-36529436	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045882, HPA063330, HPA066216"	Approved		Supported	Cytosol				Cytosol		"HPA045882: , HPA063330: , HPA066216: "	"unprognostic (4.98e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (8.10e-5)"	"unprognostic (1.47e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.98e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.78e-2)"	49.5	28.2	15.7	30.2	21.3	38.1	47.9	22.6	23.6	51.6	43.1	25.7	27.6	27.0	46.1	32.7	57.8	42.1	30.1	27.2	15.0	13.4	35.3	36.6	29.8	55.0	19.6	17.6	60.7	87.2	32.7	20.9	42.3	18.0	50.3	35.7	27.7	40.7	28.8	55.5	49.1	41.1	46.7	19.8	51.3	39.7	28.9	20.7	65.9	55.4	41.2	61.9	52.7	38.6	70.5	72.2	19.2	51.5	51.6	82.8	93.2	51.1	29.4	31.5	34.5	42.1	82.8	49.3	39.6	53.8	55.6	54.1	45.7	29.1	67.2	29.5	45.6	39.7	54.8	64.1	58.4	36.2	52.6	37.3	27.5	34.8	75.0	86.7	38.0	74.0	74.7	61.6	88.6	60.0	40.5	33.8	63.4	31.6	29.9	44.6	33.6	23.3	54.3	51.1	51.0	55.9	37.4	25.3	33.9	26.9	54.6	54.6	35.0	78.1	41.4	44.6	39.1	33.6	55.4	42.2	28.5	55.5	44.5	54.1	42.0	19.2	51.5	18.7	46.8	47.2	74.9	70.5	67.3	55.4	72.2	68.4	82.8	66.9	13.5	51.6	44.5	41.6	79.7	93.2	15.7	21.3	22.6	23.6	15.0	13.4	19.6	17.6	18.0	20.7
EIF3E	"eIF3-p48, eIF3e, EIF3S6, INT6"	ENSG00000104408	"Eukaryotic translation initiation factor 3 subunit E"	P60228	8	108201216-108435333	"Cancer-related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023973	Approved		Supported	Cytosol				Cytosol		"HPA023973: AB_1848083"	"unprognostic (8.18e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.52e-3)"	"unprognostic (6.93e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (3.06e-7)"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-2)"	88.2	44.0	27.6	49.2	38.2	57.8	75.1	41.5	25.2	101.6	73.6	14.6	47.2	34.4	55.5	47.6	111.2	45.4	41.0	39.5	23.9	22.4	51.8	63.6	60.3	75.3	33.0	19.5	127.6	90.2	29.2	72.5	54.6	28.9	100.1	40.3	22.8	56.9	45.5	100.4	46.7	56.3	73.7	38.4	63.9	49.7	52.7	31.5	100.5	93.8	70.8	50.7	121.7	69.2	49.0	51.7	14.0	39.5	38.7	78.1	59.4	62.0	30.6	41.0	50.7	69.9	147.9	28.0	32.4	50.6	48.2	50.4	38.3	62.5	106.9	42.6	36.4	38.6	54.0	63.6	64.2	42.0	55.0	85.3	32.4	54.6	56.0	50.8	40.0	111.7	94.1	36.4	101.0	73.3	71.8	44.4	54.2	61.3	65.8	96.3	40.9	48.9	61.2	50.8	83.2	63.0	37.4	46.4	42.3	18.2	15.4	72.2	65.5	73.7	46.5	28.2	48.7	29.2	40.7	33.5	25.0	61.2	34.9	88.8	31.4	14.0	39.5	7.4	26.6	36.2	52.0	49.0	52.6	37.7	51.7	40.4	78.1	56.1	3.7	38.7	33.6	27.3	45.2	59.4	27.6	38.2	41.5	25.2	23.9	22.4	33.0	19.5	28.9	31.5
EIF3G	"eIF3-delta, eIF3-p44, eIF3g, EIF3S4"	ENSG00000130811	"Eukaryotic translation initiation factor 3 subunit G"	O75821	19	10115017-10119918	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 175.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041997	Approved		Enhanced	Cytosol			12000	Cytosol		"HPA041997: AB_10804123"	"unprognostic (1.80e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (3.94e-4)"	"unprognostic (4.90e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.43e-1)"	41.6	29.0	20.2	34.2	21.5	34.1	36.1	18.1	28.4	41.1	41.2	27.0	30.3	29.8	40.2	34.6	37.7	34.1	47.0	52.3	19.0	18.4	30.5	45.0	28.2	40.1	22.6	18.5	63.6	88.6	30.9	24.8	34.9	19.3	41.9	17.6	25.6	57.1	35.5	141.1	40.2	30.1	39.1	24.3	36.7	38.9	51.0	23.4	46.4	42.3	49.7	40.3	46.2	48.7	47.1	58.4	31.4	60.6	80.3	70.8	74.7	25.1	21.4	16.4	21.6	21.8	28.0	21.1	21.5	30.2	34.0	31.6	35.0	13.6	25.9	30.9	25.7	19.3	19.9	32.4	14.1	23.3	60.6	45.9	21.6	34.9	36.4	36.0	24.2	33.6	24.0	23.9	23.0	24.2	41.1	30.8	20.3	33.7	39.2	175.1	40.1	46.1	31.7	16.1	34.1	21.6	22.1	21.3	41.3	14.3	18.8	33.7	16.5	31.9	23.8	29.4	16.7	31.9	40.8	91.1	66.2	28.9	22.1	39.5	28.0	31.4	60.6	25.3	54.6	44.4	70.8	46.7	59.0	59.1	58.4	47.1	60.3	54.1	11.7	80.3	35.6	45.9	64.9	74.7	20.2	21.5	18.1	28.4	19.0	18.4	22.6	18.5	19.3	23.4
EIF3J	"eIF3-alpha, eIF3-p35, eIF3j, EIF3S1"	ENSG00000104131	"Eukaryotic translation initiation factor 3 subunit J"	O75822	15	44537057-44563029	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050977	Approved		Enhanced	Cytosol			8600	Cytosol		"HPA050977: "	"unprognostic (4.47e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.76e-1)"	"prognostic unfavourable (4.96e-5)"	23.7	17.8	24.7	21.0	21.9	16.4	22.8	16.6	23.1	15.6	18.4	13.2	20.5	17.7	15.8	17.2	28.0	11.9	14.8	36.8	22.8	23.7	23.3	46.3	14.7	18.3	26.3	19.2	15.0	35.1	17.3	22.9	22.9	31.6	17.1	20.0	6.9	27.0	25.4	134.3	18.9	16.6	18.6	29.0	20.9	18.4	14.7	20.9	17.0	19.2	27.3	24.9	23.0	20.6	26.7	33.2	22.6	19.2	28.2	23.9	6.4	22.3	11.9	19.5	12.2	13.9	14.1	23.9	35.4	10.5	24.7	16.8	37.7	13.7	20.7	41.7	14.8	42.4	31.3	22.6	30.3	23.1	15.9	47.1	29.4	23.9	26.2	50.4	21.0	12.5	30.3	17.0	33.4	26.5	61.2	27.3	22.1	15.7	25.3	34.4	11.9	19.5	29.6	33.5	30.7	28.1	26.8	26.4	16.2	32.7	31.1	19.6	26.1	41.9	31.2	26.9	31.9	28.8	47.6	32.5	61.1	52.2	18.7	55.1	25.3	22.6	19.2	16.8	17.4	18.3	21.0	26.7	23.2	22.3	22.2	24.7	22.8	23.9	7.7	28.2	16.3	33.2	23.6	6.4	24.7	21.9	16.6	23.1	22.8	23.7	26.3	19.2	31.6	20.9
EIF3K	"ARG134, eIF3k, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001"	ENSG00000178982	"Eukaryotic translation initiation factor 3 subunit K"	Q9UBQ5	19	38619082-38636955	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045446, HPA054590"	Uncertain		Supported	Cytosol				Cytosol		"HPA045446: AB_10962716, HPA054590: AB_2682534"	"unprognostic (7.07e-3)"	"prognostic favourable (1.31e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.26e-2)"	"prognostic favourable (5.43e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.69e-2)"	37.7	30.1	33.1	39.0	32.8	47.1	43.3	23.9	48.6	34.0	53.7	29.5	36.8	46.1	34.0	37.2	48.2	39.9	39.0	84.0	29.4	28.0	58.2	45.6	28.1	47.5	34.1	25.0	43.2	57.2	36.3	31.0	27.4	32.5	37.8	54.0	43.7	50.8	38.6	111.4	45.2	57.1	43.4	26.6	39.5	42.8	17.5	19.4	50.6	42.1	92.9	55.7	42.9	36.6	52.1	72.7	26.3	57.7	37.7	58.7	74.9	25.7	80.1	21.6	34.7	36.0	37.1	26.2	19.0	32.5	41.7	38.7	52.0	22.7	52.8	22.3	32.1	23.3	42.0	49.4	32.6	25.5	36.1	35.9	27.6	36.3	39.1	57.9	33.1	40.0	43.3	28.7	49.6	40.6	38.7	48.0	35.3	39.6	31.6	29.9	20.4	40.8	41.7	35.3	42.1	40.7	57.9	27.4	27.4	20.9	72.8	31.6	27.9	48.9	22.7	26.4	26.6	16.3	35.3	47.6	48.2	46.3	22.3	58.1	29.6	25.6	52.5	26.3	39.4	57.7	49.7	52.1	48.4	45.8	72.7	44.1	50.5	44.7	14.5	37.7	56.6	42.4	58.7	74.9	33.1	32.8	23.9	48.6	29.4	28.0	34.1	25.0	32.5	19.4
EIF3M	"eIF3m, FLJ29030, GA17, hfl-B5, PCID1, TANGO7"	ENSG00000149100	"Eukaryotic translation initiation factor 3 subunit M"	Q7L2H7	11	32583798-32606262	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031063	Approved		Supported	Cytosol			48000	Cytosol		"HPA031063: AB_10602128"	"unprognostic (4.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (1.28e-9)"	"unprognostic (5.79e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.42e-2)"	44.3	46.1	25.4	36.8	30.9	41.0	47.1	19.3	32.2	49.0	35.1	17.3	26.5	26.2	40.2	38.9	48.7	52.0	29.1	34.3	23.3	23.0	50.0	54.5	30.8	47.7	23.4	21.9	80.9	60.6	34.0	33.1	44.7	28.3	44.3	35.0	18.8	32.5	30.3	48.8	35.1	37.8	39.2	26.4	45.0	37.1	43.5	19.6	84.1	55.1	54.7	48.1	59.8	34.6	36.5	64.0	15.4	53.2	33.3	38.5	39.4	28.4	36.8	29.4	37.3	39.2	56.6	43.4	29.7	41.2	45.7	44.6	47.4	21.0	73.9	20.5	33.7	36.3	51.1	53.9	57.3	24.9	63.3	33.3	29.9	50.0	56.9	77.3	47.9	50.6	61.2	30.8	75.7	51.2	65.5	25.8	50.0	33.5	38.5	81.3	32.2	57.0	31.6	74.2	34.5	49.8	53.8	22.7	35.1	21.1	39.9	45.5	44.3	46.3	23.9	28.7	32.7	60.6	89.2	31.7	39.8	54.0	25.8	47.1	28.1	14.3	53.2	15.4	26.5	45.8	36.3	36.5	36.6	33.4	64.0	29.2	38.5	34.8	6.3	33.3	33.3	38.4	37.9	39.4	25.4	30.9	19.3	32.2	23.3	23.0	23.4	21.9	28.3	19.6
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80135214-80147183	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm			73000	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favourable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (1.68e-5)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	27.3	37.0	19.6	23.6	21.5	71.7	22.0	20.3	19.8	24.2	23.8	16.9	19.2	16.2	24.9	18.0	41.5	29.4	17.1	24.2	17.8	12.3	24.5	20.3	21.6	25.4	16.8	19.7	37.5	16.8	17.1	21.9	38.3	13.1	24.7	20.9	14.7	22.1	31.2	19.8	31.2	18.6	18.5	13.7	25.5	20.4	35.1	19.3	30.7	26.9	26.4	30.6	28.9	25.8	38.7	80.4	33.1	41.9	30.2	38.9	48.3	47.5	42.7	28.2	20.9	21.7	13.3	24.7	25.3	18.0	35.9	28.9	45.5	22.3	43.6	17.0	22.1	31.8	38.7	27.0	40.0	16.1	40.5	27.3	33.8	49.0	21.4	49.1	28.6	20.3	13.9	30.0	24.4	29.3	36.3	28.3	21.2	36.4	44.3	25.0	30.3	39.6	36.7	57.2	34.4	17.5	40.8	39.4	21.5	34.8	68.1	29.2	44.5	33.1	20.1	22.3	28.6	32.8	39.8	24.8	21.4	80.5	18.0	31.1	22.8	25.7	41.1	33.1	26.7	41.9	34.5	38.7	34.5	30.8	50.3	31.6	32.0	30.7	24.4	30.2	32.9	80.4	38.9	48.3	19.6	21.5	20.3	19.8	17.8	12.3	16.8	19.7	13.1	19.3
EIF4B		ENSG00000063046	"Eukaryotic translation initiation factor 4B"	P23588	12	53006158-53042209	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039072, HPA046164"	Approved		Enhanced	Cytosol			50000	Cytosol		"HPA039072: , HPA046164: "	"unprognostic (1.91e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.44e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.69e-1)"	"unprognostic (8.20e-3)"	35.6	36.9	20.1	21.5	25.4	26.4	34.5	29.5	30.2	41.0	27.9	35.4	26.8	26.7	35.8	18.8	30.9	40.1	33.6	25.0	21.6	15.2	27.8	29.4	22.5	28.7	23.1	27.9	94.9	55.8	31.0	37.2	22.2	24.3	25.9	24.5	27.0	39.1	21.0	76.9	31.9	24.4	37.9	25.7	27.5	31.1	31.9	29.5	27.2	32.9	33.6	39.0	35.7	33.5	27.2	26.0	10.5	24.0	25.4	46.3	33.9	25.3	41.3	28.1	36.6	51.3	95.5	37.3	24.7	58.4	22.7	20.8	42.3	41.2	154.5	37.1	36.3	28.4	50.1	55.5	28.5	30.4	29.9	59.8	56.7	45.6	38.4	85.4	35.0	96.4	56.2	26.9	82.8	44.4	65.2	63.6	37.0	55.6	51.5	53.2	51.9	21.6	53.0	40.0	64.3	31.0	41.9	29.9	40.1	25.9	56.3	49.1	64.4	55.1	40.8	15.8	34.6	17.3	21.7	55.8	61.8	39.4	26.6	36.9	22.0	9.1	20.0	10.5	30.0	20.8	43.1	27.2	36.3	33.1	26.0	19.6	46.3	42.6	5.4	25.4	24.0	16.3	29.3	33.9	20.1	25.4	29.5	30.2	21.6	15.2	23.1	27.9	24.3	29.5
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98871684-98930637	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004077, CAB016316, HPA051311"	Supported		Enhanced	"Cytosol,Cytoplasmic bodies"			580000	"Cytosol, Cytoplasmic bodies"		"CAB004077: AB_823488, CAB016316: AB_627502, HPA051311: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	22.3	26.8	25.7	20.1	35.3	25.2	23.1	40.8	38.4	21.4	27.2	23.3	19.1	19.8	21.7	21.4	39.6	19.9	18.8	23.0	26.0	29.9	29.3	26.2	18.8	24.4	27.7	28.4	18.8	16.1	24.7	25.6	21.8	35.3	19.9	33.2	15.4	23.2	21.0	29.8	19.1	19.5	24.8	31.0	19.4	20.6	39.1	23.4	22.4	33.4	27.1	34.2	22.1	24.2	31.3	25.4	36.6	32.0	32.6	32.2	30.0	25.6	22.5	38.4	25.5	21.9	23.0	23.0	48.9	30.7	40.5	30.5	30.2	32.5	52.0	15.8	30.0	13.0	52.8	36.8	49.5	34.3	15.3	35.4	15.7	27.5	18.8	50.8	26.8	16.4	23.5	31.2	24.7	31.1	58.8	24.3	35.8	22.0	47.0	19.7	30.2	21.0	29.7	26.0	23.1	35.7	22.9	32.5	21.4	22.8	48.4	15.8	23.6	20.1	22.8	29.3	31.5	26.3	39.4	18.2	46.1	47.0	26.1	26.1	33.1	23.3	22.3	36.6	26.3	25.9	30.5	31.3	29.2	27.0	25.4	26.9	32.2	31.9	16.2	32.6	32.0	21.4	28.7	30.0	25.7	35.3	40.8	38.4	26.0	29.9	27.7	28.4	35.3	23.4
EIF4E2	"4EHP, EIF4EL3, IF4e"	ENSG00000135930	"Eukaryotic translation initiation factor 4E family member 2"	O60573	2	232550052-232583644	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019253, HPA077074"			Enhanced	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA019253: AB_1848092, HPA077074: "	"unprognostic (3.44e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (1.42e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.38e-2)"	19.0	22.9	27.9	24.0	24.4	25.4	19.4	27.1	38.1	17.6	30.7	18.4	17.0	24.4	26.2	18.2	32.1	18.5	20.0	21.3	25.8	14.8	29.8	43.2	20.4	21.0	18.6	27.2	22.0	26.2	16.3	25.0	26.8	26.3	19.9	35.7	16.1	27.3	15.9	77.6	23.8	25.2	25.3	27.0	25.4	26.7	25.2	21.5	18.1	19.1	24.8	27.1	20.0	21.2	13.5	38.9	49.6	46.8	14.1	24.1	29.7	27.6	22.9	28.1	20.7	20.6	28.2	43.3	37.2	20.2	25.6	26.3	25.2	26.1	27.1	10.6	36.2	23.5	31.6	32.3	32.3	24.2	26.0	37.0	24.7	33.5	25.1	51.6	35.0	24.2	24.3	26.9	19.5	41.6	34.7	9.2	28.9	44.5	21.0	43.9	44.7	19.1	18.2	62.4	17.7	51.4	32.9	27.3	37.4	19.8	23.0	23.7	21.9	36.3	38.0	24.0	31.7	25.1	27.4	17.3	16.3	35.6	26.9	28.5	20.8	49.6	45.1	40.7	14.8	46.8	11.8	13.5	15.1	15.4	38.9	12.2	12.9	13.1	29.5	14.1	41.7	15.2	24.1	29.7	27.9	24.4	27.1	38.1	25.8	14.8	18.6	27.2	26.3	21.5
EIF4EBP1	"4E-BP1, PHAS-I"	ENSG00000187840	"Eukaryotic translation initiation factor 4E binding protein 1"	Q13541	8	38030341-38060365	"Cancer-related genes, Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 94.7;salivary gland: 109.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005032, CAB005039, HPA023501"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095"	"unprognostic (1.55e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (8.86e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.18e-3)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.72e-3)"	17.7	3.4	2.5	4.9	3.6	9.2	21.7	1.8	3.2	5.5	15.4	2.0	7.7	6.2	5.3	2.1	22.2	5.0	7.0	9.4	2.2	1.8	6.0	39.6	6.9	7.4	4.3	1.4	9.3	94.7	1.7	2.2	8.7	2.8	7.4	4.6	2.8	109.8	8.0	38.4	4.9	9.0	7.1	4.2	9.3	10.6	3.0	2.7	2.7	3.7	12.6	9.2	11.3	11.1	16.3	41.3	31.3	53.5	4.0	7.6	28.0	20.4	10.6	3.1	18.4	4.0	3.5	13.6	22.7	10.6	12.3	19.7	7.0	5.3	8.0	15.9	11.3	10.9	10.3	18.5	7.3	6.1	33.5	46.8	4.7	9.6	41.8	15.1	7.5	9.8	30.2	13.6	25.5	19.7	25.5	21.4	5.1	12.8	13.2	36.8	22.9	42.7	11.6	13.0	28.2	4.6	2.0	43.2	32.8	4.6	7.5	53.4	10.0	17.8	18.5	7.4	24.3	21.9	17.2	30.8	16.7	9.2	17.3	26.8	16.0	5.1	53.5	31.3	3.9	41.2	3.5	16.3	4.5	4.0	41.3	13.5	3.6	3.6	4.7	4.0	31.4	31.3	7.6	28.0	2.5	3.6	1.8	3.2	2.2	1.8	4.3	1.4	2.8	2.7
EIF4ENIF1	"2610509L04Rik, 4E-T, Clast4, FLJ21601"	ENSG00000184708	"Eukaryotic translation initiation factor 4E nuclear import factor 1"	Q9NRA8	22	31436977-31496108	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001619, HPA002078"	Enhanced		Enhanced	Vesicles				Vesicles		"HPA001619: AB_1078727, HPA002078: AB_1078728"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"prognostic favourable (1.57e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.45e-2)"	10.9	10.9	18.8	13.4	18.9	12.6	10.8	19.4	20.8	11.9	15.9	14.4	12.3	11.8	14.9	14.5	12.6	13.3	8.6	13.2	16.3	11.8	11.9	7.6	10.7	12.3	12.5	15.7	16.9	10.9	18.1	12.2	14.3	16.2	12.5	12.6	12.7	11.2	15.2	17.4	13.7	10.3	13.8	11.8	11.4	11.3	43.6	14.8	8.8	13.3	7.7	15.3	14.1	12.9	6.6	6.5	3.1	10.7	1.7	5.7	3.0	13.3	8.2	20.9	11.3	11.8	10.5	8.4	9.7	11.8	15.3	14.3	9.3	4.8	17.4	5.7	14.4	13.2	18.8	8.7	14.1	13.6	19.4	7.1	13.2	10.6	12.3	27.6	12.7	12.4	12.0	11.4	12.9	12.8	17.1	18.7	14.3	15.8	18.1	13.4	9.6	6.8	21.2	17.5	17.9	15.5	10.1	16.2	15.1	13.4	10.8	10.0	11.6	10.9	14.2	10.2	13.4	10.1	10.7	13.8	13.3	17.0	9.8	10.1	11.9	2.0	3.5	1.6	5.4	4.2	5.7	6.6	3.0	5.1	3.2	3.3	3.1	5.1	3.1	1.7	10.7	6.5	2.0	3.0	18.8	18.9	19.4	20.8	16.3	11.8	12.5	15.7	16.2	14.8
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol			17000	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: "	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	30.2	33.1	18.3	26.4	18.9	26.3	30.3	18.0	23.2	24.1	25.2	19.6	33.6	21.9	24.5	30.5	45.2	20.9	31.1	33.0	16.9	16.9	40.6	108.0	26.0	21.0	19.4	15.9	29.3	46.4	47.5	21.9	34.6	18.3	24.0	21.8	19.9	31.4	34.1	103.7	39.0	31.6	26.8	15.7	33.1	27.1	30.8	18.0	25.8	30.0	46.2	34.3	28.6	27.6	8.8	15.9	5.5	17.0	8.1	11.4	9.1	90.2	37.9	31.8	36.1	35.5	35.1	55.1	49.8	35.2	55.4	42.2	80.3	29.5	57.8	66.4	61.8	48.9	54.9	61.1	43.2	61.0	57.7	52.2	38.8	35.5	30.8	52.2	36.6	35.4	35.6	50.4	48.2	48.3	37.9	45.8	36.6	67.1	35.4	18.8	62.6	30.7	36.4	31.3	46.3	29.3	55.1	33.4	29.7	42.5	70.4	33.8	75.0	37.4	60.4	39.4	39.8	51.5	93.3	35.7	43.1	106.8	44.3	45.9	43.0	4.8	13.6	5.5	11.4	13.9	11.0	7.6	7.7	9.2	12.2	8.8	7.1	7.0	5.1	8.1	17.0	15.9	5.4	9.1	18.3	18.9	18.0	23.2	16.9	16.9	19.4	15.9	18.3	18.0
EIF4G2	"DAP5, NAT1, p97"	ENSG00000110321	"Eukaryotic translation initiation factor 4 gamma 2"	P78344	11	10797050-10809110	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005163, HPA006773, HPA016965"	Approved		Enhanced	Cytosol			25000	Cytosol		"CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100"	"unprognostic (1.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (6.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.74e-1)"	86.2	86.5	81.0	73.8	78.4	124.4	122.8	76.8	84.8	94.3	102.2	64.5	70.2	57.5	108.8	85.3	125.4	83.5	82.4	199.1	83.8	85.7	121.2	115.8	84.6	71.3	92.0	66.4	81.3	76.1	117.7	118.9	187.1	96.8	90.8	90.2	69.5	84.4	97.1	162.7	84.2	102.0	113.1	104.8	120.0	83.9	60.5	65.5	110.6	110.0	81.9	96.5	107.8	98.9	48.4	57.5	87.4	72.2	44.5	52.7	114.7	104.7	85.7	116.0	63.1	79.0	87.9	78.5	97.3	104.8	91.4	61.1	90.3	124.9	60.2	58.5	120.8	62.8	126.6	90.9	119.0	97.7	53.2	76.6	54.3	66.0	67.5	117.1	65.9	70.8	68.4	54.0	69.0	98.0	59.2	67.8	109.0	52.0	87.3	40.1	81.0	83.7	80.6	67.8	38.5	71.8	158.5	43.3	69.8	113.8	76.0	58.7	66.8	51.1	94.6	110.8	72.7	93.7	81.4	32.7	99.7	92.3	64.2	67.3	117.3	50.2	60.0	87.4	42.3	70.9	52.7	48.4	45.7	47.8	57.5	40.6	40.4	41.6	42.9	44.5	72.2	28.5	50.3	114.7	81.0	78.4	76.8	84.8	83.8	85.7	92.0	66.4	96.8	65.5
EIF5		ENSG00000100664	"Eukaryotic translation initiation factor 5"	P55010	14	103333544-103345025	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 123.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000867, CAB004226"	Supported		Enhanced	"Plasma membrane,Cytosol"			21000	Cytosol	"Plasma membrane"	"CAB004226: AB_627507, HPA000867: AB_1078731"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.47e-3)"	"unprognostic (6.33e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.70e-2)"	"prognostic favourable (5.67e-7)"	"unprognostic (2.76e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.14e-2)"	35.7	31.9	36.5	20.8	41.1	67.7	34.4	31.5	47.2	21.3	32.5	25.5	18.8	31.7	27.6	23.5	34.0	27.6	26.2	34.1	37.9	34.2	37.9	78.4	27.3	37.2	37.1	33.3	24.7	32.1	30.1	26.7	31.9	39.3	23.4	32.5	19.2	28.5	32.8	59.4	22.7	31.5	39.5	36.9	31.1	28.2	39.1	27.0	29.6	40.1	30.5	31.1	29.1	37.9	96.7	96.6	90.1	74.3	86.8	90.5	102.2	21.4	25.2	29.3	13.3	25.5	22.6	31.0	31.7	34.4	32.7	24.9	37.1	22.9	22.3	20.1	28.4	28.9	36.9	32.1	55.9	18.2	14.7	19.9	13.3	19.5	26.6	35.8	17.1	24.2	21.6	28.9	39.6	32.8	41.1	21.4	27.0	30.8	24.4	11.9	15.3	48.1	20.7	38.2	13.9	19.3	70.0	26.2	18.4	31.7	23.8	25.7	22.8	16.5	24.9	26.2	17.9	33.4	33.0	64.1	123.4	46.8	25.8	25.2	30.5	83.4	74.3	90.1	74.1	73.2	82.6	95.9	76.0	69.3	70.7	96.7	90.5	76.1	80.3	86.8	73.8	96.6	62.3	102.2	36.5	41.1	31.5	47.2	37.9	34.2	37.1	33.3	39.3	27.0
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005042, HPA061298"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB005042: AB_562281, HPA061298: "	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavourable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	69.0	55.6	37.9	57.0	40.4	83.1	44.5	35.0	59.8	44.6	54.8	37.5	39.8	47.4	47.2	45.5	107.0	38.1	52.9	55.8	35.6	33.6	58.5	192.9	46.6	67.2	34.3	35.9	50.3	126.0	26.0	34.1	73.9	34.0	38.0	57.2	40.7	87.7	40.7	100.6	71.1	49.0	45.4	29.5	65.5	42.9	56.8	24.2	77.9	57.9	105.4	79.0	48.6	50.7	64.7	87.7	44.4	75.7	75.2	79.3	64.3	133.0	166.1	51.2	102.5	39.6	51.0	72.0	100.5	66.3	135.9	95.1	99.3	56.8	129.0	65.1	77.2	91.0	111.3	129.5	123.7	71.7	161.6	77.6	137.6	127.2	70.2	58.9	80.3	54.1	68.0	100.3	136.3	87.2	106.7	36.1	91.9	82.5	69.2	85.2	97.2	82.0	68.5	62.3	118.9	82.0	74.0	59.6	77.5	64.4	78.5	62.2	62.1	45.4	81.7	95.8	69.0	63.6	158.7	30.4	41.5	83.4	90.6	88.7	109.1	44.4	56.0	38.9	65.1	75.7	79.3	64.7	67.1	57.7	85.8	62.6	62.3	62.6	25.1	75.2	68.6	87.7	58.9	64.3	37.9	40.4	35.0	59.8	35.6	33.6	34.3	35.9	34.0	24.2
EIF5A2		ENSG00000163577	"Eukaryotic translation initiation factor 5A2"	Q9GZV4	3	170888415-170908693	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029090	Approved		Supported	Vesicles				Vesicles		"HPA029090: AB_10671359"	"unprognostic (2.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.05e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (7.42e-4)"	"unprognostic (1.11e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.29e-3)"	5.6	3.9	3.6	4.1	8.4	4.9	4.2	1.9	14.4	4.4	4.6	4.3	2.0	2.5	6.2	2.0	4.1	3.6	4.9	5.4	4.3	5.8	6.8	3.4	3.2	3.6	6.7	6.2	6.4	4.5	2.2	5.2	2.5	21.6	4.8	3.8	3.4	2.7	4.2	1.9	3.0	2.6	9.6	5.1	3.0	11.0	31.2	2.5	6.1	3.1	2.6	4.2	6.3	6.2	2.6	0.9	10.2	1.3	6.9	11.2	4.3	11.8	6.2	2.3	3.2	12.2	8.0	5.4	8.9	11.7	9.6	13.4	12.6	7.8	7.5	16.8	12.5	4.0	7.2	3.2	12.2	8.3	3.1	3.5	2.5	3.9	8.2	9.3	10.9	8.7	4.7	14.3	11.9	4.6	2.9	0.0	15.6	3.8	4.2	4.1	4.3	3.9	0.0	6.6	0.0	4.0	2.1	1.8	3.5	9.5	2.5	7.5	5.5	6.3	6.5	11.8	8.3	24.2	20.5	11.8	0.1	17.1	4.0	3.3	8.4	10.2	1.2	1.2	11.2	1.3	7.7	2.0	7.7	10.6	0.9	2.6	4.6	7.6	0.6	6.9	1.2	0.8	9.2	4.3	3.6	8.4	1.9	14.4	4.3	5.8	6.7	6.2	21.6	2.5
EIF6	"b(2)gcn, EIF3A, ITGB4BP, p27BBP"	ENSG00000242372	"Eukaryotic translation initiation factor 6"	P56537	20	35278911-35284985	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA040873	Enhanced		Supported	Nucleoplasm			150000	Nucleoplasm		"HPA040873: "	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (7.25e-5)"	"unprognostic (9.94e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.18e-2)"	"unprognostic (8.15e-2)"	21.5	24.9	13.7	21.7	13.1	14.3	21.4	12.4	20.3	26.9	29.5	13.4	15.7	33.7	22.5	19.4	59.9	25.2	29.7	14.4	13.1	14.3	39.9	63.7	18.3	27.9	13.1	15.8	22.1	35.6	17.7	15.6	30.8	13.7	21.2	29.0	14.7	27.0	22.7	14.9	40.6	43.2	22.8	11.1	21.4	20.6	24.1	10.9	31.0	30.7	49.7	43.8	24.1	29.8	51.3	64.0	70.4	60.4	47.4	39.3	60.5	36.7	54.0	13.5	15.4	16.9	20.3	17.4	24.5	29.5	51.9	39.4	100.1	34.6	26.5	28.9	30.2	29.1	27.8	78.3	32.9	6.3	18.5	42.9	21.3	72.0	32.0	22.6	20.9	20.4	50.7	40.4	79.4	35.5	27.8	13.1	54.6	36.1	13.1	30.0	16.2	45.3	18.3	22.3	23.1	67.0	26.1	22.7	19.2	18.8	74.8	26.7	36.3	17.7	27.9	56.6	24.1	28.7	32.8	14.3	15.3	21.9	27.9	24.2	31.3	70.4	55.8	46.1	36.7	55.8	39.2	51.3	35.6	39.3	64.0	49.7	29.1	34.2	18.8	47.4	60.4	59.6	38.1	60.5	13.7	13.1	12.4	20.3	13.1	14.3	13.1	15.8	13.7	10.9
EIPR1	"EIPR-1, TSSC1"	ENSG00000032389	"EARP complex and GARP complex interacting protein 1"	Q53HC9	2	3188925-3377882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031231, HPA031232, HPA031233, HPA031234"	Approved		Supported	"Nucleoplasm,Nucleoli,Intermediate filaments"				"Nucleoplasm, Nucleoli"	"Intermediate filaments"	"HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: "	"unprognostic (2.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (3.67e-7)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.83e-2)"	7.3	12.3	20.1	17.3	24.4	14.2	9.0	26.0	22.9	8.3	11.9	12.1	10.0	10.7	7.7	18.4	14.5	12.0	7.9	10.3	17.7	19.3	12.4	11.4	7.9	15.2	15.1	14.5	5.8	11.6	14.2	20.8	8.0	13.6	7.7	10.9	10.5	9.9	7.4	10.9	9.2	9.3	9.4	12.4	12.0	9.3	9.9	11.5	14.5	20.4	15.5	15.3	11.1	7.7	15.7	23.4	13.9	13.3	16.3	16.9	14.0	11.1	20.9	11.2	12.6	7.1	9.6	25.3	11.7	12.1	14.1	10.8	13.9	14.1	19.4	20.7	11.8	11.4	8.7	16.8	7.8	15.1	16.5	17.2	13.0	32.2	13.5	16.8	21.5	8.7	15.3	14.2	18.5	17.8	19.1	13.5	12.9	20.7	15.5	24.5	12.9	16.7	18.2	11.8	26.1	17.4	15.4	24.4	28.3	8.2	13.8	12.7	12.8	15.7	12.4	11.3	5.9	9.3	15.6	15.5	37.5	16.1	13.4	17.5	10.4	13.9	11.8	9.4	16.1	13.3	16.3	13.9	13.4	16.8	21.3	15.7	14.7	15.8	5.0	16.3	11.9	23.4	16.9	14.0	20.1	24.4	26.0	22.9	17.7	19.3	15.1	14.5	13.6	11.5
ELAC1	D29	ENSG00000141642	"ElaC ribonuclease Z 1"	Q9H777	18	50967991-50988121	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040867, HPA066483"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040867: AB_10697716, HPA066483: "	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.75e-2)"	"unprognostic (8.61e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.67e-3)"	"unprognostic (6.36e-2)"	"prognostic favourable (8.43e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	8.7	15.0	7.7	7.7	9.7	3.3	9.4	7.1	11.9	8.0	9.1	12.8	12.1	7.6	11.3	20.1	7.5	10.0	9.6	7.2	7.3	8.3	12.4	15.2	7.6	11.2	7.6	7.2	8.8	19.5	17.1	15.7	12.3	8.7	9.9	10.8	13.7	20.1	12.2	6.8	7.7	11.7	8.3	7.1	10.8	10.1	16.7	3.9	10.1	15.6	7.0	9.9	8.7	6.6	14.2	12.4	7.8	9.1	16.1	15.7	8.1	6.9	4.8	12.7	10.8	14.3	6.1	5.4	7.6	10.1	7.2	5.1	1.8	6.6	5.4	5.3	7.0	7.0	3.9	8.0	4.9	11.7	1.0	6.6	1.8	1.2	8.4	16.7	4.8	7.6	6.4	3.8	8.9	7.4	6.7	13.5	12.6	3.1	5.7	5.0	6.3	2.1	6.6	4.5	10.0	8.3	3.0	7.5	8.6	6.3	1.1	12.1	5.9	12.8	6.5	9.4	4.9	2.7	5.1	12.7	10.6	7.2	8.7	5.6	11.8	4.1	7.8	7.8	13.2	9.1	14.6	14.2	12.7	12.9	12.4	13.6	12.4	15.7	0.9	16.1	8.7	10.4	10.0	8.1	7.7	9.7	7.1	11.9	7.3	8.3	7.6	7.2	8.7	3.9
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12992391-13018187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	20.3	35.9	15.2	17.2	23.5	13.8	18.6	16.9	30.0	17.5	21.2	24.6	17.9	15.8	22.1	13.1	25.9	19.5	19.6	28.1	14.2	14.3	23.5	34.8	14.2	19.4	18.2	19.5	20.3	24.5	27.5	14.0	21.2	20.5	20.7	25.1	19.4	19.1	26.2	49.2	20.7	18.7	26.6	15.6	25.5	22.8	29.5	17.1	28.1	20.7	20.1	25.9	23.0	16.3	19.9	23.5	9.4	20.4	24.0	25.1	20.9	20.2	32.2	22.4	24.9	17.9	17.5	13.6	22.2	17.9	36.3	24.4	25.9	10.8	36.7	24.2	21.1	27.4	40.5	25.7	36.3	19.0	40.8	21.4	25.2	17.0	13.3	18.3	29.7	15.6	21.9	28.2	26.3	25.4	29.3	11.2	27.5	18.0	32.3	18.3	18.5	21.6	22.7	38.2	23.0	20.5	18.2	11.5	16.8	28.2	18.4	11.4	18.3	8.0	24.7	44.9	14.9	17.7	32.6	7.0	13.0	14.8	17.8	19.6	16.3	9.4	14.7	9.3	21.4	20.1	23.0	19.9	20.7	21.3	23.5	17.4	21.5	19.2	2.2	24.0	20.4	13.3	25.1	20.9	15.2	23.5	16.9	30.0	14.2	14.3	18.2	19.5	20.5	17.1
ELAVL1	"Hua, HuR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958579-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			210000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: "	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favourable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	19.7	23.8	28.0	22.4	34.1	17.2	22.4	35.4	28.0	23.1	21.4	21.2	19.6	17.9	27.5	19.7	24.4	25.7	16.9	25.2	23.6	17.6	20.8	21.4	19.4	26.5	27.5	22.2	25.7	20.4	29.4	25.4	23.3	26.5	20.4	20.2	19.7	21.2	23.0	27.6	19.2	18.4	30.4	17.7	21.9	19.7	46.7	26.5	40.4	20.6	18.7	30.7	23.4	32.2	17.1	17.6	24.3	14.7	23.2	19.6	9.4	35.6	23.7	39.8	29.9	15.6	15.7	22.4	26.6	22.4	39.7	31.1	34.2	20.8	43.0	37.5	29.2	24.9	44.3	30.5	33.6	38.4	41.2	37.7	17.4	31.8	22.9	35.7	30.2	19.4	18.3	27.6	16.8	30.3	38.7	32.3	27.3	26.5	59.6	28.8	35.5	30.2	67.1	26.0	28.3	25.2	26.4	28.6	20.9	25.2	25.5	20.1	29.1	28.2	22.7	37.2	26.1	34.4	45.8	33.0	31.8	45.2	20.8	43.0	32.0	16.4	13.0	24.3	12.2	11.7	12.9	14.0	17.8	19.6	17.6	17.1	16.1	12.4	3.8	23.2	14.7	8.8	13.5	9.4	28.0	34.1	35.4	28.0	23.6	17.6	27.5	22.2	26.5	26.5
ELF1		ENSG00000120690	"E74 like ETS transcription factor 1"	P32519	13	40932028-41061440	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 129.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001755, CAB005172"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB005172: AB_631428, HPA001755: AB_1078732"	"unprognostic (1.21e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.20e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.72e-2)"	27.7	11.5	6.0	37.9	12.5	51.4	22.6	3.4	7.7	19.9	23.4	9.0	12.0	14.5	20.9	15.6	25.1	17.0	19.3	15.8	7.0	4.5	16.6	13.8	28.0	34.8	14.9	3.4	16.7	20.0	12.7	13.9	15.9	11.1	17.4	14.0	10.9	22.0	16.8	13.0	23.8	34.6	14.8	15.1	44.8	15.2	8.5	11.1	129.5	19.4	18.6	44.4	26.7	23.4	20.1	17.1	64.6	26.3	20.7	27.2	20.6	7.9	4.7	3.6	3.5	16.6	17.5	13.5	8.2	20.0	11.5	13.3	11.8	21.1	45.9	5.2	13.8	18.2	0.7	10.4	7.3	10.1	5.5	41.0	3.9	8.0	12.5	23.3	64.6	18.1	18.3	7.8	15.0	16.2	10.0	12.1	7.6	7.2	30.3	13.5	2.8	3.7	40.7	6.0	13.1	12.0	12.5	1.3	5.0	7.1	7.1	14.5	5.1	30.2	14.4	5.0	3.0	4.1	2.9	5.6	3.2	30.2	6.9	14.9	10.6	64.6	17.7	38.1	21.9	19.5	23.1	19.1	25.1	24.2	17.1	20.1	27.2	24.0	28.8	20.7	26.3	11.3	24.7	20.6	6.0	12.5	3.4	7.7	7.0	4.5	14.9	3.4	11.1	11.1
ELF2	"EU32, NERF, NERF-1A, NERF-1B, NERF-2"	ENSG00000109381	"E74 like ETS transcription factor 2"	Q15723	4	139028112-139177218	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006057, HPA071166"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA006057: AB_1078733, HPA071166: AB_2686351"	"unprognostic (7.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	35.3	12.6	13.2	17.4	24.9	34.3	24.2	29.7	21.6	23.4	22.4	15.2	25.7	12.7	22.9	17.5	18.8	19.0	15.7	20.3	16.1	11.6	15.6	17.4	18.6	19.8	29.3	10.2	25.5	19.5	19.5	23.6	22.8	17.7	23.4	16.9	14.2	21.0	22.4	27.6	19.1	17.9	30.0	23.4	22.8	16.2	30.1	25.1	31.1	21.6	22.4	17.6	25.2	35.0	19.3	19.1	12.5	8.0	10.6	14.8	4.8	9.2	6.8	17.1	12.3	17.2	20.9	16.2	11.1	19.3	12.0	13.8	12.8	18.3	18.6	11.2	14.8	9.6	25.3	14.9	12.5	11.6	10.9	17.0	15.8	10.9	13.2	18.6	13.5	18.5	15.1	11.4	13.9	17.7	27.2	10.8	10.1	15.4	20.9	15.7	10.6	7.5	20.6	22.2	16.9	14.5	16.1	17.2	19.3	13.5	16.8	10.0	11.4	21.3	14.8	11.0	9.6	10.0	7.2	24.2	27.0	16.4	8.2	19.0	9.9	8.6	8.0	12.5	12.4	6.4	12.9	15.3	11.8	10.5	8.8	19.3	14.8	13.4	8.0	10.6	6.4	19.1	9.3	4.8	13.2	24.9	29.7	21.6	16.1	11.6	29.3	10.2	17.7	25.1
ELF3	"EPR-1, ERT, ESE-1, ESX"	ENSG00000163435	"E74 like ETS transcription factor 3"	P78545	1	202007945-202017188	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Inflammatory response, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.8"	"Cell line enhanced"	"Detected in some"		"A549: 40.4;CAPAN-2: 57.6;RT4: 41.4;SK-BR-3: 79.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003316, HPA003479"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA003316: AB_1078757, HPA003479: AB_1078756"	"unprognostic (9.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.05e-3)"	"unprognostic (7.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (9.92e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-3)"	0.3	0.1	0.1	16.0	0.2	0.0	34.0	0.2	0.2	13.2	80.7	0.2	12.5	34.4	3.8	8.9	59.3	8.6	67.7	1.1	0.1	0.1	38.1	33.3	24.6	0.1	0.1	0.1	5.8	38.4	1.1	1.7	16.7	0.3	39.9	31.3	0.7	37.9	11.3	0.7	3.5	100.8	9.5	0.3	0.2	29.9	1.9	0.1	0.6	5.7	25.5	43.5	44.7	22.7	0.3	0.8	2.0	0.3	0.2	0.3	0.0	10.5	40.4	0.0	0.0	0.0	0.0	12.6	0.0	1.5	0.0	0.0	9.0	57.6	0.0	4.7	0.0	10.5	0.0	0.0	0.0	1.2	0.0	0.0	7.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.1	0.6	3.4	0.0	0.0	0.5	15.3	41.4	0.0	0.0	0.4	79.9	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.8	0.3	0.2	0.1	2.0	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.1
ELF4	"ELFR, MEF"	ENSG00000102034	"E74 like ETS transcription factor 4"	Q99607	X	130064874-130110716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058595, HPA060277"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA058595: , HPA060277: "	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.43e-3)"	"unprognostic (7.86e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavourable (6.49e-6)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (1.42e-4)"	16.9	3.6	2.0	18.1	2.5	27.6	16.9	0.5	3.0	7.7	10.8	3.1	7.0	8.4	10.5	8.1	10.5	9.5	11.0	7.3	3.1	1.2	5.9	2.5	21.9	33.3	3.8	0.9	12.7	4.5	3.8	4.2	23.5	3.0	6.6	10.9	3.6	5.4	7.9	5.7	9.1	16.3	6.4	4.2	18.9	12.3	3.5	2.9	18.1	3.9	7.4	11.5	11.7	14.4	3.9	6.1	9.4	10.3	8.4	10.3	5.1	22.5	8.4	1.5	0.1	3.9	8.4	22.0	10.5	13.4	12.8	14.2	11.6	16.1	11.6	21.1	14.2	14.7	8.4	12.4	12.6	12.4	7.0	22.7	11.2	5.4	8.7	19.8	29.1	8.7	13.9	20.5	20.3	12.3	8.7	3.2	6.9	13.1	3.2	11.3	1.0	8.3	7.0	2.7	4.9	7.8	26.1	5.8	2.5	9.4	9.1	2.9	4.5	19.1	11.4	9.0	7.1	16.7	19.4	1.7	0.7	9.3	10.6	18.2	2.0	1.6	5.4	7.8	10.3	10.3	8.3	3.9	6.2	8.8	6.1	3.5	6.2	7.2	9.4	8.4	7.0	3.7	6.3	5.1	2.0	2.5	0.5	3.0	3.1	1.2	3.8	0.9	3.0	2.9
ELK1		ENSG00000126767	"ELK1, ETS transcription factor"	P19419	X	47635521-47650604	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003808, HPA036084, HPA064381"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB003808: AB_562282, HPA036084: , HPA064381: "	"unprognostic (2.25e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (3.25e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.67e-2)"	12.1	20.9	37.2	10.8	52.2	11.5	8.2	32.6	32.9	11.1	9.4	4.9	14.6	8.1	11.4	17.5	8.5	13.1	9.9	12.4	23.3	11.6	7.7	19.0	8.9	10.4	5.7	22.7	37.7	9.8	12.0	7.5	13.7	6.7	9.3	9.8	7.4	9.8	11.3	17.9	8.6	8.5	10.8	4.4	14.3	7.5	19.1	11.2	8.7	6.9	8.3	11.5	8.9	6.7	7.4	11.7	3.9	9.5	4.2	12.7	6.3	17.1	13.6	7.0	19.3	12.1	14.7	9.7	14.5	17.3	17.8	18.4	9.4	13.0	13.6	8.0	15.7	10.5	18.4	15.5	16.9	15.1	17.5	11.3	12.5	8.5	26.8	12.3	19.9	14.1	14.1	28.5	19.2	10.2	23.4	16.1	14.5	22.7	13.0	14.1	16.2	28.8	14.1	17.6	21.3	9.5	7.5	15.1	12.6	24.4	8.7	20.5	22.1	7.9	8.1	20.4	21.1	26.5	13.5	26.7	36.7	14.1	22.6	22.4	12.7	2.0	8.1	3.4	7.4	9.5	8.6	7.4	9.5	8.6	11.7	6.7	8.4	6.8	3.9	4.2	7.8	8.2	12.7	6.3	37.2	52.2	32.6	32.9	23.3	11.6	5.7	22.7	6.7	11.2
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ELK3, ETS transcription factor"	P41970	12	96194382-96269835	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavourable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	36.9	9.3	5.0	20.9	6.7	8.3	23.5	12.9	4.5	29.2	12.6	7.3	12.0	4.6	45.2	15.6	25.7	15.0	16.3	15.5	4.8	5.1	13.3	8.2	17.1	20.6	6.1	2.8	13.3	5.8	6.6	6.0	15.9	8.9	18.1	7.5	15.7	14.1	8.6	10.5	8.7	11.1	20.8	13.1	32.7	9.1	8.6	6.3	17.4	19.7	25.1	32.1	15.9	20.9	11.3	9.4	4.1	12.8	10.5	24.1	6.3	12.8	7.7	7.9	4.2	20.2	38.0	2.0	16.4	31.4	13.1	10.1	0.4	9.6	2.0	5.6	18.3	4.6	0.8	26.2	23.1	5.6	3.0	0.6	3.2	2.9	6.1	6.2	1.5	22.3	4.9	26.9	20.4	31.2	1.5	8.6	44.1	1.9	1.2	4.2	9.7	10.3	10.2	13.4	2.3	11.2	3.4	0.4	8.4	5.3	2.4	8.2	1.3	3.4	19.2	36.0	14.1	22.1	14.2	16.6	13.7	0.5	12.7	7.3	24.9	3.3	12.8	0.3	6.2	6.9	24.1	11.3	14.7	8.4	9.4	9.9	8.9	6.5	4.1	10.5	5.9	3.8	23.4	6.3	5.0	6.7	12.9	4.5	4.8	5.1	6.1	2.8	8.9	6.3
ELK4	SAP1	ENSG00000158711	"ELK4, ETS transcription factor"	P28324	1	205597556-205631962	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028863	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA028863: AB_10602492"	"unprognostic (2.08e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (4.65e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (2.94e-6)"	"unprognostic (2.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-3)"	14.1	7.1	10.0	14.7	12.7	12.0	13.8	16.2	10.4	10.1	8.9	10.4	8.6	7.3	11.3	9.2	11.7	9.5	11.4	10.8	10.6	5.0	15.2	15.6	13.8	19.1	10.0	6.9	13.1	12.4	13.6	16.8	9.5	9.5	32.6	8.7	12.2	12.4	8.2	14.7	17.6	13.5	10.5	8.2	18.3	9.4	8.4	11.0	24.4	10.8	8.3	19.6	15.1	13.2	2.2	1.5	8.7	1.1	1.2	3.1	0.6	8.2	7.4	2.9	7.6	7.0	9.1	7.5	5.5	5.8	4.4	5.2	3.2	8.3	17.4	5.2	6.9	10.3	6.2	6.8	7.7	19.8	4.4	7.5	12.1	6.7	9.6	14.1	30.1	7.9	8.4	7.0	14.3	18.4	6.9	14.7	6.1	11.1	11.6	5.3	4.9	4.5	8.6	18.2	14.2	5.9	18.0	3.4	4.1	14.3	7.9	9.4	7.3	4.7	13.3	8.9	10.5	7.9	10.5	11.0	10.0	11.8	7.8	5.8	10.4	8.7	0.8	1.2	1.6	1.1	2.1	1.4	1.8	2.1	1.1	2.2	2.2	3.1	0.4	1.2	0.6	1.5	1.8	0.6	10.0	12.7	16.2	10.4	10.6	5.0	10.0	6.9	9.5	11.0
ELL2	MRCCAT1	ENSG00000118985	"Elongation factor for RNA polymerase II 2"	O00472	5	95885098-95962071	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 64.2;HDLM-2: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013569			Supported	Nucleoplasm				Nucleoplasm		"HPA013569: "	"unprognostic (1.18e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (1.31e-4)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-2)"	24.4	9.1	7.1	12.2	13.5	18.1	16.4	5.2	19.3	9.8	7.5	11.5	26.0	6.3	4.2	3.7	27.5	6.4	16.3	17.2	10.5	8.1	7.5	37.1	14.3	10.0	11.4	8.3	11.8	41.3	9.4	14.3	12.5	15.8	18.2	6.0	2.8	43.9	55.7	14.0	25.9	6.8	9.1	13.3	14.9	18.3	6.5	11.9	1.4	7.7	15.4	9.3	12.3	14.8	5.3	0.6	8.7	1.6	2.2	1.5	0.9	6.1	2.4	0.7	0.1	9.3	11.6	0.9	64.2	11.0	21.4	18.2	4.6	1.4	0.2	1.4	34.1	7.9	1.9	20.4	26.3	56.5	1.5	3.9	10.5	10.1	5.9	0.9	6.8	11.3	14.2	12.9	39.3	3.3	2.2	24.3	19.9	0.6	0.0	1.0	0.9	3.3	0.6	3.8	4.8	4.0	5.9	1.3	0.4	23.5	1.2	1.3	0.7	0.7	6.9	28.3	5.7	6.4	11.6	17.1	40.7	0.3	14.6	0.4	1.8	8.7	1.1	7.6	0.9	1.6	1.5	5.3	1.3	1.3	0.6	2.6	0.9	0.7	2.5	2.2	1.1	0.4	1.4	0.9	7.1	13.5	5.2	19.3	10.5	8.1	11.4	8.3	15.8	11.9
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772600-43777543	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.3;lymphoid tissue: 24.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.8;U-698: 18.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.3;naive B-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.5"	"Region enriched"	"Detected in single"	11	"olfactory region: 2.4"	"Low region specificity"	"Detected in all"			HPA028938	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA028938: AB_10795352"	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.7	1.1	1.0	24.2	0.6	0.4	2.5	4.7	0.6	2.3	10.6	0.5	1.6	4.8	1.0	1.0	5.5	1.3	0.9	0.6	1.0	0.6	1.8	0.5	0.9	7.5	1.3	0.0	1.3	0.7	0.6	1.2	0.8	2.6	2.1	1.8	0.8	2.0	0.7	1.0	7.0	13.3	0.9	0.6	1.5	1.1	12.3	0.5	0.8	1.1	2.8	16.7	1.3	1.7	8.5	1.0	0.1	0.1	0.1	1.2	0.6	0.6	0.1	0.6	0.2	1.6	0.1	0.1	0.2	0.5	0.8	1.2	0.1	0.5	7.8	0.1	0.7	2.8	0.3	0.0	0.5	0.7	3.3	0.3	2.6	0.8	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.3	0.3	0.0	0.0	1.2	0.2	0.8	0.0	0.8	0.8	0.1	0.1	0.2	0.0	3.5	0.2	0.3	1.5	0.3	3.5	0.2	0.1	0.2	0.0	0.3	0.2	0.0	0.0	18.8	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	5.3	0.5	0.2	0.0	8.5	1.2	0.3	0.1	0.1	0.0	1.0	0.3	0.6	1.0	0.6	4.7	0.6	1.0	0.6	1.3	0.0	2.6	0.5
ELMO2	"CED-12, CED12, ELMO-2, FLJ11656, KIAA1834"	ENSG00000062598	"Engulfment and cell motility 2"	Q96JJ3	20	46366049-46432985	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018811	Approved		Supported	Cytosol				Cytosol		"HPA018811: AB_1848126"	"unprognostic (1.19e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (8.81e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.92e-1)"	"prognostic favourable (6.10e-4)"	"unprognostic (4.53e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.20e-2)"	12.6	14.9	23.8	11.9	30.0	28.1	10.6	39.8	32.6	14.8	9.9	34.8	5.2	7.8	12.7	17.5	18.0	13.5	9.4	13.1	25.4	17.1	12.6	8.5	13.7	15.5	21.5	16.8	11.6	17.5	30.1	13.9	13.2	20.6	18.1	9.3	13.8	11.6	22.8	16.8	18.6	9.3	19.5	20.4	17.5	9.1	18.5	22.6	12.3	13.0	7.0	16.3	11.4	13.8	5.3	13.4	38.3	27.6	21.9	22.3	15.6	4.8	14.3	17.1	14.0	29.9	19.3	8.8	11.3	15.5	15.9	15.5	19.3	5.5	6.0	18.1	18.8	11.5	14.4	16.8	12.4	9.9	6.5	9.8	9.3	14.1	22.7	5.4	20.9	18.9	15.0	16.8	12.0	12.7	9.7	20.1	14.7	12.8	10.7	14.1	6.5	14.1	9.1	16.6	12.1	15.5	11.2	10.3	9.3	16.3	14.5	21.8	11.2	21.8	14.7	32.8	18.6	13.4	7.3	8.1	12.2	6.2	13.6	8.8	9.9	38.3	10.1	16.3	18.4	19.3	22.3	4.3	16.5	17.4	9.6	5.3	10.7	12.0	11.1	21.9	27.6	13.4	10.8	15.6	23.8	30.0	39.8	32.6	25.4	17.1	21.5	16.8	20.6	22.6
ELMSAN1	"C14orf117, C14orf43, LSR68"	ENSG00000156030	"ELM2 and Myb/SANT domain containing 1"	Q6PJG2	14	73715122-73790285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003111	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA003111: AB_1078329"	"unprognostic (1.54e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.36e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-1)"	17.8	8.1	11.2	18.7	10.1	18.8	17.4	17.8	9.9	17.3	13.7	14.5	9.7	11.2	16.8	11.1	14.0	12.7	15.8	11.2	8.3	6.3	7.7	7.8	13.9	12.9	7.6	8.2	18.6	8.7	21.4	7.6	12.8	9.4	14.2	6.0	16.8	13.1	13.1	13.4	26.1	14.1	13.9	7.6	18.8	12.6	8.2	11.8	8.8	11.0	9.5	20.0	16.1	15.0	2.9	4.4	3.1	1.9	2.1	1.8	1.3	6.7	7.6	2.7	5.1	2.6	4.4	5.3	2.7	4.8	3.9	3.5	6.7	8.1	9.9	3.1	3.7	10.4	4.5	7.8	1.6	13.0	2.7	15.7	6.5	2.4	4.2	2.7	34.4	5.9	4.9	3.4	4.2	6.1	8.0	9.1	1.8	15.8	6.2	4.4	0.9	6.4	7.3	14.9	2.5	5.8	7.3	3.5	2.9	10.4	14.5	5.8	11.1	5.8	12.2	8.0	9.2	5.9	3.0	7.2	3.4	10.9	6.5	3.4	9.3	2.1	1.9	0.7	1.2	0.9	1.8	1.8	0.6	1.3	2.1	2.9	0.7	0.8	3.1	2.1	1.1	4.4	1.4	1.3	11.2	10.1	17.8	9.9	8.3	6.3	7.6	8.2	9.4	11.8
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB017042: , HPA047752: , HPA054197: "	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavourable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavourable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.5	18.7	32.8	59.9	87.1	50.6	14.0	29.9	33.6	24.2	34.0	16.5	29.7	29.1	21.7	31.0	15.2	32.3	27.3	36.3	24.5	22.7	28.7	17.4	23.0	47.9	22.6	21.0	46.7	21.5	24.2	30.4	26.8	35.8	16.9	17.4	2.8	67.2	20.1	17.7	14.3	26.2	22.5	10.1	45.5	15.3	30.6	21.1	24.7	12.9	25.0	29.5	21.2	25.4	26.6	23.6	47.3	39.3	14.3	13.1	22.1	13.8	33.0	18.8	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108867517-108934116	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Low region specificity"	"Detected in all"							"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB021340: , HPA049677: , HPA050686: "	"prognostic unfavourable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	10.4	33.0	18.7	10.6	22.9	10.8	13.1	37.6	19.9	13.0	11.5	17.2	11.4	8.2	15.7	17.3	9.8	15.1	10.3	15.3	14.8	15.2	13.0	14.7	11.2	12.8	20.9	17.3	26.4	12.9	41.3	42.3	11.2	20.5	13.1	12.6	15.0	12.0	12.8	11.6	15.7	11.2	14.4	16.7	13.3	11.3	11.7	19.3	12.1	15.4	8.3	13.2	10.4	13.4	2.1	2.7	26.9	2.6	4.0	4.2	1.9	9.1	17.6	15.2	9.8	16.7	16.1	12.5	15.0	10.4	15.3	12.2	16.6	6.7	16.8	6.8	13.4	23.6	23.3	18.7	16.9	15.8	14.6	9.8	27.4	44.9	12.5	19.1	8.8	12.3	13.2	21.3	20.1	13.1	23.1	11.8	14.0	15.6	16.3	11.8	19.4	17.7	14.2	20.5	10.5	11.6	11.8	18.4	14.8	16.5	16.5	10.2	21.4	8.6	12.5	8.8	10.1	19.6	14.9	11.2	25.2	8.5	14.7	12.7	11.9	26.9	1.7	2.5	3.1	2.0	4.2	2.1	3.0	4.0	2.7	1.4	2.9	3.6	0.3	4.0	2.6	1.3	2.4	1.9	18.7	22.9	37.6	19.9	14.8	15.2	20.9	17.3	20.5	19.3
ELP2	"FLJ10879, STATIP1, StIP"	ENSG00000134759	"Elongator acetyltransferase complex subunit 2"	Q6IA86	18	36129444-36180556	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002996, CAB020835"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB020835: , HPA002996: AB_1857552"	"unprognostic (5.51e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (6.66e-3)"	"unprognostic (4.33e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.74e-3)"	"unprognostic (7.31e-3)"	"unprognostic (7.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.97e-2)"	21.3	19.8	16.5	21.0	22.4	10.5	32.9	23.2	23.6	23.2	19.8	21.6	29.6	14.0	32.3	29.7	15.0	27.2	18.7	21.0	15.8	16.2	17.8	41.0	16.1	17.1	18.6	18.0	46.3	26.7	22.0	43.6	18.7	21.3	28.0	15.4	22.5	19.7	27.4	34.7	23.7	15.6	22.5	18.0	18.1	18.3	19.4	21.7	23.5	20.2	14.1	20.5	25.2	19.5	17.1	14.2	13.4	18.2	17.3	18.8	11.1	10.1	7.3	13.8	12.4	19.6	29.6	15.3	21.1	30.7	17.8	23.9	7.7	9.5	21.4	14.8	17.6	14.5	17.6	15.7	25.4	9.7	9.5	8.3	12.7	13.3	21.5	26.8	8.9	24.0	18.1	17.7	28.9	19.9	13.9	11.4	18.9	12.3	12.9	11.6	16.4	5.6	21.1	16.6	14.9	16.2	23.8	11.0	21.0	19.8	7.8	30.9	10.0	13.6	11.7	16.2	9.4	5.9	10.8	13.7	10.8	19.9	13.6	14.4	13.9	13.4	9.7	7.7	10.9	14.3	15.3	17.1	14.7	12.8	14.1	14.3	18.8	16.4	1.6	17.3	18.2	14.2	14.4	11.1	16.5	22.4	23.2	23.6	15.8	16.2	18.6	18.0	21.3	21.7
ELP3	"FLJ10422, KAT9"	ENSG00000134014	"Elongator acetyltransferase complex subunit 3"	Q9H9T3	8	28089673-28191156	"Enzymes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation, tRNA processing"	"Acyltransferase, RNA-binding, Transferase, tRNA-binding"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025297, HPA025812"	Uncertain		Supported	Cytosol				Cytosol		"HPA025297: , HPA025812: AB_10601369"	"unprognostic (1.29e-2)"	"unprognostic (1.26e-2)"	"prognostic favourable (9.25e-4)"	"unprognostic (3.49e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.46e-2)"	"prognostic favourable (1.31e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	14.8	15.3	18.7	11.5	23.4	6.7	19.4	20.0	27.4	33.4	14.8	21.8	35.2	10.8	27.3	14.4	12.8	18.6	17.5	16.0	17.7	19.0	19.1	22.8	13.6	15.4	17.6	13.6	18.9	12.6	14.3	17.4	12.7	23.3	15.9	18.0	13.9	11.1	36.1	28.8	13.4	12.3	16.0	15.8	16.1	12.1	15.0	15.5	16.0	19.9	13.8	20.3	14.7	12.0	16.2	12.2	11.6	18.2	15.8	20.8	11.0	14.3	15.1	11.5	11.0	17.0	14.9	8.2	7.4	13.4	17.4	15.6	12.5	6.1	27.1	11.7	14.2	9.8	12.6	17.6	20.6	4.9	5.2	18.2	10.0	20.6	15.2	9.8	13.6	15.7	27.2	12.0	18.5	16.3	20.4	16.8	17.8	8.8	20.8	16.7	12.9	5.3	15.8	11.2	10.4	17.4	11.8	6.9	12.0	8.4	7.2	14.1	13.7	11.3	11.4	12.0	15.7	12.4	10.7	7.1	11.4	20.8	11.9	11.0	12.2	11.6	10.1	8.2	19.4	14.4	20.8	12.5	16.6	18.3	11.8	16.2	15.0	17.0	2.8	15.8	18.2	12.2	15.6	11.0	18.7	23.4	20.0	27.4	17.7	19.0	17.6	13.6	23.3	15.5
ELP4	"C11orf19, PAXNEB"	ENSG00000109911	"Elongator acetyltransferase complex subunit 4"	Q96EB1	11	31509700-31790328	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038572, HPA038573"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA038572: , HPA038573: "	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.63e-2)"	14.7	14.6	19.8	12.0	19.6	12.9	12.2	55.1	17.6	13.9	15.3	15.2	8.5	8.1	13.9	15.3	15.7	12.5	12.8	17.0	18.5	13.2	18.6	16.0	12.5	15.1	15.7	13.2	13.6	17.5	16.5	19.0	13.3	16.2	12.1	13.8	15.2	11.6	13.6	13.9	16.7	11.1	13.2	17.8	14.6	11.5	14.5	19.1	28.0	11.8	12.3	13.8	13.1	12.2	12.6	12.8	10.2	12.3	9.5	13.6	8.7	9.1	8.0	8.8	10.7	8.2	11.3	3.1	8.3	9.0	12.3	13.6	7.3	8.3	12.5	7.1	7.3	16.7	11.4	10.3	13.6	10.3	13.2	4.2	10.2	11.0	8.5	8.7	8.3	11.2	6.4	5.3	14.5	14.8	18.8	11.4	7.8	14.6	14.9	10.4	5.0	9.9	9.0	18.9	8.5	18.4	9.2	10.2	4.8	15.1	9.9	6.7	18.6	12.9	6.0	11.3	9.9	18.4	10.7	4.5	8.5	15.2	8.0	12.4	9.7	7.7	11.1	10.2	9.5	12.3	12.1	12.6	11.2	11.4	12.8	9.0	12.5	11.1	3.3	9.5	12.0	11.2	13.6	8.7	19.8	19.6	55.1	17.6	18.5	13.2	15.7	13.2	16.2	19.1
ELP5	"C17orf81, DERP6"	ENSG00000170291	"Elongator acetyltransferase complex subunit 5"	Q8TE02	17	7251416-7259940	"Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023279, HPA052411"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023279: AB_1847613, HPA052411: "	"unprognostic (3.73e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.60e-2)"	"prognostic favourable (2.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.30e-2)"	12.4	18.2	14.0	13.6	14.0	11.8	10.4	14.1	17.8	11.1	15.5	12.2	13.3	11.4	13.1	13.5	10.9	12.6	11.9	23.0	13.2	12.0	16.5	21.3	9.1	15.0	13.6	12.8	15.2	10.6	9.6	15.9	12.6	12.5	14.0	11.0	16.4	20.9	12.7	28.3	7.8	14.6	18.0	11.2	14.1	10.7	103.3	12.4	23.6	15.7	17.2	16.1	11.6	11.0	31.1	36.7	16.3	29.3	27.6	34.7	21.5	12.3	35.1	15.8	14.3	27.8	22.0	6.9	11.1	13.2	17.9	16.6	35.0	8.2	24.6	12.3	17.6	9.3	39.9	26.2	12.9	15.2	56.3	22.7	11.8	31.8	13.8	16.0	9.0	15.5	19.7	12.2	24.1	15.2	15.6	6.6	27.7	20.9	40.7	30.7	13.0	24.4	35.0	17.8	13.3	19.8	11.7	7.7	15.4	21.6	6.6	17.1	9.4	11.7	17.2	10.3	12.1	19.7	17.6	7.7	10.3	28.6	18.8	15.7	13.3	16.3	25.3	12.4	27.9	29.3	34.7	31.1	24.9	25.5	30.0	31.0	26.4	31.2	4.4	27.6	19.3	36.7	33.8	21.5	14.0	14.0	14.1	17.8	13.2	12.0	13.6	12.8	12.5	12.4
EMC4	"FLJ90746, MGC24415, PIG17, TMEM85"	ENSG00000128463	"ER membrane protein complex subunit 4"	Q5J8M3	15	34224999-34230156	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026868, HPA053440"	Approved		Supported	"Focal adhesion sites"				"Focal adhesion sites"		"HPA026868: , HPA053440: "	"unprognostic (8.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.97e-2)"	36.3	34.3	43.5	23.4	48.3	25.4	35.2	34.9	54.3	33.5	32.2	31.0	25.7	27.5	33.5	54.3	36.2	35.4	28.4	38.5	39.4	40.6	39.1	47.5	27.1	24.5	41.7	42.8	35.3	45.2	29.1	29.5	41.5	48.6	32.5	30.1	32.8	38.9	34.7	95.1	29.6	27.9	30.1	36.7	27.2	31.2	26.4	32.0	26.9	34.6	41.2	29.0	28.9	32.6	71.6	53.3	65.7	59.4	60.3	65.9	78.0	31.5	66.4	27.9	36.2	36.5	33.2	25.7	36.3	41.6	44.8	39.0	43.2	28.2	12.5	48.0	41.8	60.9	28.4	35.6	32.2	38.2	27.5	23.7	61.2	39.6	44.1	35.9	23.8	33.3	33.9	32.6	36.7	37.0	29.5	50.0	39.0	36.0	28.5	38.5	31.3	43.5	26.4	25.5	35.5	42.7	49.7	36.9	45.0	27.0	39.6	19.2	26.5	42.7	28.1	41.2	28.2	35.4	36.9	44.3	62.7	32.0	50.1	42.8	34.7	65.7	52.3	54.5	53.0	54.0	57.9	71.6	59.5	63.4	52.2	54.6	60.8	59.8	29.1	60.3	59.4	53.3	65.9	78.0	43.5	48.3	34.9	54.3	39.4	40.6	41.7	42.8	48.6	32.0
EMC8	"C16orf2, C16orf4, COX4NB, FAM158B, NOC4"	ENSG00000131148	"ER membrane protein complex subunit 8"	O43402	16	85771758-85799608	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049476	Approved		Supported	Cytosol				Cytosol		"HPA049476: "	"unprognostic (2.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (8.49e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-3)"	"prognostic favourable (6.39e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	16.8	17.4	18.8	17.1	19.8	26.9	39.3	12.4	21.0	14.5	16.6	16.3	14.1	18.9	18.2	14.4	17.3	14.0	16.8	23.0	17.7	15.5	19.1	22.5	14.2	16.2	18.0	12.4	16.2	16.2	20.5	14.6	20.9	14.0	14.5	16.2	13.4	16.6	17.0	25.6	13.3	16.3	17.0	17.3	17.9	15.5	15.5	13.3	24.3	19.5	18.2	16.5	14.8	12.3	12.8	20.9	21.2	15.8	16.3	13.9	9.5	12.7	15.0	9.6	8.7	10.4	10.0	18.7	12.7	12.6	21.2	9.5	23.9	14.8	11.1	14.7	12.7	14.7	14.2	13.3	19.0	4.7	20.3	9.1	8.3	21.7	15.8	9.2	6.2	10.9	9.1	16.1	18.9	12.1	20.6	4.3	13.0	21.7	14.6	26.4	19.1	19.3	21.5	7.8	9.4	13.3	9.1	16.3	9.7	23.3	7.6	14.0	15.1	16.5	10.5	12.8	13.0	11.2	16.1	12.0	11.5	44.4	11.0	17.9	13.4	12.5	15.2	21.2	9.9	15.8	11.7	9.6	11.0	13.5	20.9	12.8	13.9	13.2	6.6	16.3	15.7	15.5	10.2	9.5	18.8	19.8	12.4	21.0	17.7	15.5	18.0	12.4	14.0	13.3
EMD	"LEMD5, STA"	ENSG00000102119	Emerin	P50402	X	154379197-154381523	"Disease related genes, Predicted membrane proteins"		Actin-binding	"Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000609, CAB001545, CAB002029, CAB058694, CAB062552"	Supported		Enhanced	"Nuclear membrane,Endoplasmic reticulum"			520000	"Nuclear membrane, Endoplasmic reticulum"		"CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: , CAB062552: , HPA000609: AB_1078736"	"unprognostic (2.92e-1)"	"unprognostic (6.59e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.99e-1)"	25.0	17.5	14.0	17.6	16.0	21.0	26.5	15.8	21.8	24.8	21.3	13.7	22.3	14.0	32.3	25.7	22.9	27.2	28.7	29.5	13.1	14.1	18.2	21.2	22.0	37.4	13.3	16.5	35.9	29.4	20.5	22.8	15.4	11.9	25.5	11.4	20.7	24.5	29.1	62.0	18.1	13.7	40.4	13.1	17.6	20.1	16.1	9.7	16.6	28.1	24.4	18.3	31.7	20.6	23.2	30.5	24.5	19.7	14.7	26.9	15.8	31.2	11.8	8.2	9.0	7.4	14.9	14.7	15.4	16.5	19.7	20.7	10.5	6.1	24.9	23.5	15.8	17.4	15.6	19.1	8.4	14.6	34.1	11.7	17.4	6.2	20.2	11.2	12.9	13.0	15.2	17.6	21.9	13.7	9.6	10.8	13.4	13.3	19.6	20.6	13.7	37.0	16.3	12.2	23.7	10.6	6.0	10.4	12.9	8.0	13.4	18.8	9.3	8.4	12.3	9.8	18.7	22.1	22.1	35.1	26.0	44.9	11.9	19.0	10.6	16.6	16.9	24.5	26.9	19.7	25.0	22.5	25.7	25.7	13.5	23.2	23.1	22.4	18.1	14.7	14.0	30.5	23.9	15.8	14.0	16.0	15.8	21.8	13.1	14.1	13.3	16.5	11.9	9.7
EMG1		ENSG00000126749	"EMG1, N1-specific pseudouridine methyltransferase"	Q92979	12	6970893-6979941	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA039304, HPA039666"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039304: , HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	8.1	10.1	4.9	12.4	6.6	7.3	8.8	3.6	6.3	5.8	7.5	4.8	11.5	7.5	6.9	9.9	8.1	5.8	7.4	11.6	5.0		7.2	8.3	6.4	8.8	6.4	4.2	8.9	9.4	2.7	5.6	12.6	6.2	7.2	6.8	5.1	8.6	11.4	14.9	5.6	6.7	6.3	5.5	7.7	6.0	4.8	6.1	9.0	8.7	9.5	10.8	7.5	8.7	33.3	20.5	7.7	29.6	20.8	30.1	28.5	16.8	16.8	6.5	8.0	5.1	3.7	27.1	12.6	5.6	10.0	6.8	33.0	18.1	17.0	4.7	7.7	12.4	5.9	14.4	11.3	12.3	9.6	23.6	16.6	30.4	6.6	23.9	15.3	6.0	8.6	14.5	16.6	4.3	11.6	3.8	9.4	19.9	12.4	14.7	53.9	8.8	17.2	13.2	13.5	6.3	21.4	3.8	11.4	13.2	13.9	12.0	3.8	17.8	9.1	10.5	13.6	8.5	28.5	4.6	5.2	29.6	11.2	10.4	16.6	4.4	16.6	7.7	24.0	23.8	24.8	30.7	25.5	26.3	18.8	33.3	30.1	27.7	2.3	20.8	29.6	20.5	24.1	28.5										
EML4	"C2orf2, ELP120, ROPP120"	ENSG00000143924	"Echinoderm microtubule associated protein like 4"	Q9HC35	2	42169350-42332548	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036687, HPA036688, HPA065337"	Enhanced		Supported	"Intermediate filaments,Microtubules,Cytosol"			41000	Microtubules	"Intermediate filaments, Cytosol"	"HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	11.3	17.3	5.8	29.3	6.8	19.2	10.5	4.6	5.2	9.4	21.6	6.7	6.8	20.3	13.6	11.6	10.7	8.7	20.3	6.5	5.1	3.9	11.7	26.4	19.3	27.7	4.6	4.0	12.5	37.8	10.8	11.6	26.9	6.5	8.5	12.8	12.1	17.7	8.9	4.3	17.9	33.5	9.2	5.0	30.9	11.7	14.2	5.3	17.4	13.2	6.9	30.0	14.0	9.0	11.5	4.2	10.0	11.0	9.4	17.5	5.9	14.4	25.1	14.6	11.6	5.3	8.8	16.0	9.0	7.1	10.0	9.7	26.2	18.2	13.2	6.2	8.8	7.5	12.6	8.6	17.5	25.8	10.5	12.1	7.8	60.0	6.8	9.1	12.5	9.6	3.3	13.2	9.0	6.9	12.0	13.4	10.7	8.5	8.6	2.4	14.9	7.2	8.9	23.2	7.8	8.2	21.0	14.5	29.2	8.8	9.2	6.8	4.8	3.7	8.0	10.2	13.7	8.1	8.1	15.1	10.5	11.4	8.9	8.8	7.1	4.4	3.9	7.7	7.8	10.9	16.3	11.5	13.0	12.7	3.3	7.9	11.4	8.3	10.0	9.4	11.0	4.2	17.5	5.9	5.8	6.8	4.6	5.2	5.1	3.9	4.6	4.0	6.5	5.3
EMSY	C11orf30	ENSG00000158636	"EMSY, BRCA2 interacting transcriptional repressor"	Q7Z589	11	76444923-76553025	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012234, HPA050777"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB012234: AB_449325, HPA050777: "	"unprognostic (1.69e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.74e-2)"	14.5	12.1	13.7	12.8	22.7	19.7	15.6	39.4	22.2	17.7	14.3	17.2	12.6	9.0	21.7	14.0	11.5	15.8	11.4	17.2	13.6	10.6	13.1	10.7	17.8	14.3	23.8	10.8	20.9	15.3	23.2	23.1	25.8	16.2	14.6	15.7	14.7	14.0	14.4	18.3	11.6	13.5	18.0	24.8	14.7	13.9	14.4	26.7	22.6	15.1	8.5	14.3	14.2	17.1	7.0	6.2	11.8	5.1	5.0	8.4	4.4	4.9	6.9	16.0	9.8	6.0	6.0	7.0	7.9	7.8	10.3	11.4	11.7	6.8	6.7	7.6	8.5	9.8	12.9	7.6	16.1	10.7	4.8	10.5	10.2	5.0	3.8	11.3	9.4	5.4	5.1	11.8	9.9	9.3	7.2	11.9	8.3	13.1	15.1	6.8	6.9	9.2	9.7	29.4	9.4	7.1	5.8	10.0	4.3	11.1	7.6	2.4	15.3	7.0	6.9	9.8	13.3	25.0	5.5	6.6	7.1	19.3	3.2	6.9	7.1	11.8	5.1	10.3	7.2	4.8	6.7	6.4	6.7	8.4	3.8	7.0	6.3	5.8	10.8	5.0	3.8	6.2	6.5	4.4	13.7	22.7	39.4	22.2	13.6	10.6	23.8	10.8	16.2	26.7
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8;kidney: 27.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;CACO-2: 5.6;HEK 293: 12.5;HMC-1: 2.5;RPTEC TERT1: 2.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6"	"HPA006230, HPA006421"	Approved		Supported	Nucleoli				Nucleoli		"HPA006230: , HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.3	5.2	0.2	3.1	0.1	0.1	0.1	14.8	0.1	0.5	0.0	0.8	1.4	0.1	6.0	0.2	0.1	0.1	0.2	5.0	0.4	27.4	0.2	0.1	0.2	0.4	1.5	0.2	0.4	4.8	0.2	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.2	0.2	1.1	0.1	0.1	0.1	0.3	2.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.5	0.0	0.0	1.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.1	0.1	14.8	5.0	0.4	0.4	1.5	0.0	0.0
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847678	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;ASC TERT1: 6.4;fHDF/TERT166: 11.1;HSkMC: 11.9;PC-3: 6.6;U-138 MG: 8.6;U-2197: 9.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Group enriched"	"Detected in some"	10	"midbrain: 11.4;pons and medulla: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 5.9"	"Region enriched"	"Detected in some"	5	"midbrain: 23.9"	"CAB014884, HPA073141"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB014884: , HPA073141: "	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	5.6	0.1	0.0	0.1	0.4	0.0	2.7	0.9	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	11.4	0.0	0.1	0.0	0.1	0.0	0.0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10.0	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.5	0.2	14.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.4	0.5	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	8.6	0.8	9.6	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	0.2	0.1	11.4	0.0	8.8	0.1
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.5"	"Cell line enhanced"	"Detected in some"		"AF22: 26.9;AN3-CA: 9.9;HAP1: 5.8;HEK 293: 16.3;SK-MEL-30: 7.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	8	"cerebellum: 31.1"	"Region enriched"	"Detected in some"	6	"cerebellum: 71.6"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA045646: , HPA069809: "	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavourable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.3	0.2	0.1	0.0	0.1	0.0	0.1	26.5	0.1	0.0	0.0			0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3		1.3	1.2	5.0	0.0	0.0		0.0	0.0		0.0	0.0	0.8	1.1	0.0	0.0	0.4	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.4	26.9	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	5.8	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.2	3.4	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.2	0.0	0.0	1.9	0.0	7.9	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ENAH	"FLJ10773, MENA, NDPP1"	ENSG00000154380	"ENAH, actin regulator"	Q8N8S7	1	225486835-225653142	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA028448, HPA028696"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites,Cytosol"			18000	"Plasma membrane, Focal adhesion sites, Cytosol"		"HPA028448: AB_10600766, HPA028696: AB_10611249"	"unprognostic (2.56e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.71e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.93e-2)"	19.2	17.4	15.8	11.9	17.0	0.6	11.1	7.6	17.6	17.8	24.4	15.3	39.9	9.3	21.9	19.9	16.7	11.8	29.0	18.2	16.7	15.3	5.8	5.9	13.8	3.5	13.7	11.3	24.3	16.7	22.5	10.3	13.5	12.7	26.4	8.0	3.3	14.5	44.9	20.2	8.2	8.0	61.4	13.4	17.3	21.0	18.5	17.2	5.3	6.8	11.4	3.5	35.3	21.9	2.1	0.4	1.0	0.3	0.5	0.4	0.0	20.2	16.2	20.1	18.2	7.9	10.4	26.0	22.5	10.8	13.6	10.3	10.4	7.5	8.6	60.0	34.7	17.9	23.5	8.5	12.9	0.1	14.5	8.9	14.4	14.0	23.6	1.0	0.3	16.1	10.3	17.6	22.6	10.7	0.6	0.4	13.4	3.9	4.0	1.0	33.9	14.7	6.1	28.5	0.2	6.2	15.7	19.8	16.0	44.2	16.9	14.9	20.1	1.3	20.8	35.3	26.0	29.3	44.6	0.9	2.5	5.8	19.4	1.1	18.0	1.0	0.3	0.2	0.4	0.1	0.3	0.6	0.4	0.3	0.0	2.1	0.4	0.4	1.0	0.5	0.2	0.4	0.2	0.0	15.8	17.0	7.6	13.7	16.7	15.3	13.7	11.3	12.7	17.2
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815012-127854756	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 66.9;TIME: 136.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"			260000000	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: , HPA011862: AB_1846217, HPA067440: "	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (6.61e-4)"	"prognostic favourable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavourable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	40.3	19.3	6.4	26.6	10.5	5.5	52.7	3.9	8.6	26.3	14.0	7.6	18.5	11.2	27.0	25.2	17.2	23.2	28.3	105.4	8.0	5.0	40.8	26.8	66.7	44.1	10.6	7.0	66.4	9.6	8.6	12.5	60.2	10.1	23.1	6.4	35.5	9.9	51.7	24.1	10.1	14.5	23.1	8.7	52.4	11.6	37.2	7.7	6.7	35.4	19.3	11.0	20.3	44.8	1.1	6.4	0.3	17.7	4.6	2.3	4.6	0.1	0.1	0.9	0.0	16.8	11.5	29.6	19.5	14.0	10.4	6.1	0.0	0.1	0.1	9.5	35.8	0.3	0.0	3.1	3.4	0.0	0.0	5.5	11.0	0.6	13.1	2.6	0.0	19.7	0.7	13.5	4.9	66.9	0.0	0.1	12.1	0.1	0.0	0.2	0.2	0.5	8.7	1.7	0.1	0.0	0.0	0.1	0.2	10.3	9.0	2.6	1.8	3.9	136.5	34.1	1.8	22.2	0.0	0.7	0.1	0.1	9.2	6.8	11.2	0.0	12.2	0.3	1.3	17.7	0.4	0.4	2.1	2.3	6.4	1.1	1.3	2.0	0.3	4.6	13.0	2.4	0.8	4.6	6.4	10.5	3.9	8.6	8.0	5.0	10.6	7.0	10.1	7.7
ENKD1	"C16orf48, DKFZP434A1319"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Centrosome, Cytosol"	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favourable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	8.5	7.7	4.9	5.9	7.0	3.8	6.6	5.0	6.9	10.4	11.7	6.1	18.6	4.7	11.2	14.2	8.2	14.5	11.0	6.1	5.4	5.2	10.9	4.7	8.9	2.9	4.5	4.4	10.9	38.8	23.7	12.0	4.8	8.3	12.7	3.6	7.9	11.7	12.6	6.0	7.2	5.1	12.9	4.3	6.1	7.3	19.6	6.4	7.1	20.4	5.2	4.9	12.9	6.4	0.6	4.2	3.0	1.3	0.7	1.5	0.5	6.9	4.8	11.3	5.2	3.8	3.9	5.6	5.5	3.3	4.3	5.4	3.4	10.7	2.6	9.4	3.4	8.1	2.9	6.5	5.4	4.0	6.6	2.5	14.4	8.1	6.0	4.6	3.6	3.4	4.7	6.0	5.4	3.5	4.2	1.6	2.2	3.5	5.0	19.2	5.3	1.9	17.8	1.2	19.1	4.6	0.7	11.4	12.4	11.6	1.1	5.9	10.2	6.5	9.2	5.4	7.5	10.0	0.0	12.5	5.6	2.7	8.1	6.8	1.6	0.0	1.3	0.0	0.3	0.5	1.5	0.6	1.2	0.7	0.5	0.0	0.8	1.1	3.0	0.7	0.7	4.2	0.0	0.5	4.9	7.0	5.0	6.9	5.4	5.2	4.5	4.4	8.3	6.4
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879250	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394"	Supported		Enhanced	"Plasma membrane,Cytosol"			490000000	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: "	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	68.6	57.7	92.7	94.9	109.6	121.8	73.4	46.6	119.4	47.3	63.8	74.6	21.7	71.3	44.9	24.2	138.2	52.2	55.0	45.2	79.1	70.7	180.4	165.4	64.8	80.3	74.9	62.7	58.2	31.6	52.7	35.5	70.5	88.6	38.6	66.4	62.6	106.1	69.1	45.0	74.6	70.3	84.0	56.4	80.0	44.3	31.7	48.8	98.8	55.4	91.0	119.3	73.5	62.9	38.7	114.1	22.1	105.4	55.5	63.7	159.3	180.7	158.0	76.2	65.2	63.8	71.3	69.1	98.3	109.0	211.8	199.1	101.1	105.0	130.3	131.2	118.2	89.2	129.4	262.3	216.0	88.9	136.7	110.0	160.5	125.6	95.9	219.2	67.8	73.6	79.6	167.7	255.0	135.6	120.5	51.0	137.3	89.5	82.6	117.4	83.1	158.6	85.6	113.6	212.8	250.7	43.1	103.1	63.7	115.3	167.9	121.2	84.1	65.7	123.9	146.7	129.9	125.1	167.1	145.5	103.2	197.7	227.8	179.8	123.1	13.9	105.4	20.8	52.3	75.8	59.1	38.7	55.8	53.8	114.1	32.7	45.6	47.8	22.1	55.5	72.4	31.2	63.7	159.3	92.7	109.6	46.6	119.4	79.1	70.7	74.9	62.7	88.6	48.8
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 119.2"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5"	"Group enriched"	"Detected in many"	7	"B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"			89000000	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: "	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	4.2	20.7	31.2	8.3	48.0	4.0	4.9	115.2	119.2	7.6	7.9	10.9	2.6	4.9	11.7	6.3	5.9	9.4	8.0	10.3	30.2	39.2	3.5	2.0	10.1	10.5	29.6	47.4	3.7	4.1	19.1	15.5	4.8	47.7	8.0	7.4	28.6	3.1	15.3	2.1	5.8	6.0	15.2	15.7	5.8	6.4	3.2	13.3	1.7	14.2	0.3	10.3	7.1	5.0	5.6	1.0	6.2	0.2	0.4	10.8	4.5	14.0	8.9	3.2	0.1	4.8	5.2	0.2	10.9	7.0	16.2	25.0	1.7	1.1	19.8	1.8	4.7	2.1	33.7	3.0	24.6	39.6	3.1	27.3	9.1	11.8	3.5	1.6	32.9	2.6	0.1	11.9	2.4	3.4	1.8	0.2	10.8	1.9	12.8	1.7	17.1	5.0	14.2	2.7	4.3	7.9	1.9	25.9	18.2	2.8	0.2	18.6	0.9	0.8	4.3	14.2	15.0	19.1	14.1	14.5	14.5	2.9	81.3	0.0	2.9	1.3	0.0	0.1	8.2	0.0	9.7	5.6	10.8	9.6	0.0	3.3	7.1	7.4	6.2	0.4	0.2	1.0	5.5	4.5	31.2	48.0	115.2	91.3	30.2	39.2	29.6	47.4	47.7	13.3
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 638.2;tongue: 320.3"	"Group enriched"	"Detected in many"	4	"HDLM-2: 70.1;HeLa: 30.0;HMC-1: 29.6;RH-30: 48.2;RPMI-8226: 25.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"			100000000	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: "	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.6	0.3	0.2	0.6	0.2	0.7	0.5	0.6	0.2	0.2	0.4	0.0	0.1	0.8	0.4	8.5	8.6	0.4	0.1	38.3	0.2	0.1	0.5	5.0	0.4	0.5	0.2	0.0	0.4	0.3	0.3	0.5	0.2	0.1	2.1	0.1	1.2	11.8	0.1	638.2	0.3	0.7	0.4	0.2	0.8	0.4	0.5	0.0	0.6	4.8	320.3	10.5	0.3	0.3	13.3	21.0	27.1	24.8	18.5	23.3	36.0	2.8	6.2	2.8	2.6	2.4	0.6	6.8	5.0	0.6	0.3	0.3	3.0	1.9	5.2	6.8	0.4	3.6	1.0	0.4	0.2	70.1	5.7	5.1	30.0	4.4	0.9	1.5	29.6	4.1	1.0	0.5	1.0	0.3	2.3	9.7	1.5	1.5	1.8	6.2	3.6	2.6	8.3	48.2	25.2	0.7	1.9	1.8	6.8	3.2	2.8	3.6	2.5	1.6	1.5	3.0	5.5	1.3	3.7	6.9	3.8	4.3	1.7	5.0	2.9	13.5	15.6	27.1	21.8	22.5	14.7	13.3	18.7	20.3	21.0	11.1	12.3	19.7	19.7	18.5	24.8	16.6	23.3	36.0	0.2	0.2	0.6	0.2	0.2	0.1	0.2	0.0	0.1	0.0
ENOX1	"cCNOX, CNOX, FLJ10094, PIG38"	ENSG00000120658	"Ecto-NOX disulfide-thiol exchanger 1"	Q8TC92	13	43213518-43786908	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 12.6;RH-30: 17.5;TIME: 12.6;U-2197: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038355	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA038355: AB_10673171"	"unprognostic (9.64e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.88e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.42e-2)"	5.7	2.2	10.7	4.5	14.8	0.8	2.8	2.1	17.0	5.2	8.5	15.0	0.2	1.3	7.2	2.0	2.1	4.7	3.1	8.3	10.3	6.0	6.1	1.0	1.9	3.5	9.4	10.6	11.2	2.5	0.7	2.3	7.8	15.6	5.6	3.1	3.2	1.3	6.9	11.0	1.4	2.2	8.8	7.7	1.5	3.5	14.5	15.0	0.1	1.4	0.3	2.6	4.8	3.7	0.2	2.3	0.9	0.3	0.3	0.2	0.1	0.1	0.2	2.5	0.0	2.5	9.8	0.5	1.1	2.7	4.1	4.0	1.7	0.3	0.0	0.1	3.6	0.1	0.5	0.3	1.8	2.9	4.0	0.5	2.9	0.0	1.6	0.1	0.6	9.4	0.8	12.6	6.3	0.3	0.0	0.6	2.5	0.2	4.0	0.1	2.7	1.1	0.0	17.5	0.0	2.2	0.5	8.6	3.3	1.5	2.5	0.6	0.5	0.0	12.6	1.4	0.4	13.0	1.3	0.0	0.0	0.0	6.0	0.0	9.1	0.9	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.1	2.3	0.1	0.2	0.1	0.3	0.3	0.3	0.3	0.2	0.1	10.7	14.8	2.1	17.0	10.3	6.0	9.4	10.6	15.6	15.0
ENOX2	"APK1, COVA1, tNOX"	ENSG00000165675	"Ecto-NOX disulfide-thiol exchanger 2"	Q16206	X	130623369-130903317	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Growth regulation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000514, HPA003027"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA000514: AB_1078558, HPA003027: "	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.27e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.09e-5)"	"unprognostic (6.42e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.38e-1)"	13.1	14.6	13.5	14.8	17.6	4.7	11.4	7.6	11.0	13.2	11.6	13.9	10.7	8.0	15.6	12.9	13.3	13.2	11.2	18.9	14.6	13.1	10.4	23.6	8.8	16.0	14.7	8.8	14.6	7.4	12.5	12.3	11.7	12.2	12.9	9.3	8.5	10.3	15.1	11.2	8.6	11.1	14.5	13.4	17.7	9.2	9.7	17.7	17.4	11.0	11.7	15.9	14.2	9.7	12.8	11.9	15.0	16.7	11.3	13.3	9.7	12.3	9.1	14.0	5.8	12.0	11.4	5.6	10.5	12.1	7.1	4.4	4.3	10.7	8.7	25.4	8.8	8.7	9.1	9.7	8.8	11.5	10.0	20.2	6.2	5.7	9.3	14.7	14.2	9.0	16.6	7.7	9.6	10.6	12.4	7.1	5.5	17.2	9.2	3.2	7.3	12.7	6.6	8.7	9.6	8.2	8.7	4.2	8.5	9.1	6.0	14.7	3.9	8.1	8.6	6.8	4.1	10.9	21.3	7.4	3.6	5.7	19.8	15.4	11.5	8.0	12.0	15.0	10.4	16.7	11.1	12.8	12.2	10.8	11.9	11.6	13.3	11.7	2.1	11.3	7.8	5.7	13.2	9.7	13.5	17.6	7.6	11.0	14.6	13.1	14.7	8.8	12.2	17.7
ENTPD4	"KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase"	ENSG00000197217	"Ectonucleoside triphosphate diphosphohydrolase 4"	Q9Y227	8	23385783-23457695	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA017655	Supported		Supported	Vesicles			28000	Vesicles		"HPA017655: AB_1848181"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.72e-2)"	16.3	11.5	15.0	21.9	19.8	25.7	15.3	20.3	27.4	15.2	18.5	14.7	15.7	17.0	18.8	17.9	13.3	12.7	14.4	21.0	14.5	12.8	13.0	14.4	19.9	26.0	16.2	12.2	14.7	26.5	30.4	25.2	19.3	20.6	17.6	20.2	18.0	19.5	13.7	14.9	12.2	26.1	16.1	14.5	26.9	19.1	18.7	15.8	17.0	15.8	9.3	30.7	16.7	16.7	9.7	8.0	15.9	9.5	4.4	10.7	6.8	9.9	13.7	17.2	11.9	15.1	19.2	17.6	15.9	15.2	10.8	16.9	19.6	13.2	16.8	11.5	16.0	12.1	7.8	14.4	20.8	4.0	5.4	8.9	8.5	6.8	12.3	4.7	17.7	11.7	17.5	14.4	15.4	15.4	6.1	15.5	18.2	4.5	6.8	5.7	10.0	5.0	6.8	17.2	5.1	13.8	11.8	13.7	13.1	6.0	8.7	11.7	6.4	6.7	19.1	19.7	19.4	22.0	11.7	12.4	5.2	22.0	26.3	5.6	19.7	14.9	6.0	13.7	8.5	9.5	10.0	9.7	8.3	9.1	8.0	6.7	10.7	8.3	15.9	4.4	6.9	7.3	6.5	6.8	15.0	19.8	20.3	27.4	14.5	12.8	16.2	12.2	20.6	15.8
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6 (putative)"	O75354	20	25195693-25226729	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"		18000	"Golgi apparatus"		"HPA015491: , HPA069555: "	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	12.7	19.7	21.8	11.3	46.5	6.7	12.8	33.1	49.1	9.8	31.3	12.1	12.8	31.6	9.4	10.1	9.0	12.5	18.3	27.5	24.9	25.0	13.4	12.9	11.0	7.4	15.1	29.2	16.1	25.6	11.7	20.5	13.2	15.4	25.5	24.5	9.0	36.8	9.7	15.1	6.8	32.2	9.9	8.2	8.3	24.7	16.1	10.5	9.4	10.4	6.1	8.3	10.2	7.1	7.2	17.1	3.0	16.0	8.8	17.9	12.9	20.4	32.4	8.9	17.0	11.2	14.1	19.1	16.8	12.2	14.6	13.5	17.3	15.8	12.4	25.4	16.2	26.8	10.8	25.6	9.7	7.6	9.7	10.1	4.9	39.1	16.8	13.4	15.5	13.2	14.3	18.4	14.0	11.7	13.1	21.7	10.8	19.6	12.5	8.3	5.6	25.4	7.1	27.8	28.4	18.3	12.8	14.2	7.4	4.6	28.5	75.7	20.8	11.3	12.7	17.1	17.8	14.0	19.8	13.6	11.0	5.4	12.2	8.9	32.0	0.0	16.0	3.0	12.7	10.7	17.9	6.1	11.4	10.4	17.1	7.2	12.2	10.6	0.7	8.8	4.8	12.0	10.6	12.9	21.8	46.5	33.1	49.1	24.9	25.0	15.1	29.2	15.4	10.5
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41091786-41180079	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favourable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	16.8	14.8	19.1	13.9	15.5	45.3	14.5	33.0	20.6	14.8	16.8	15.6	18.9	11.1	18.1	11.6	16.8	15.7	16.5	10.7	16.6	8.3	11.5	12.2	14.1	12.9	16.9	12.7	20.2	15.7	26.4	14.5	27.7	13.8	13.2	12.2	12.3	15.3	17.9	19.5	18.2	17.4	13.8	12.7	15.9	14.7	20.6	18.6	29.3	16.9	10.9	14.1	18.7	22.5	4.3	4.4	9.8	3.9	5.7	3.9	2.3	15.5	11.2	19.0	11.8	12.1	13.0	17.0	7.5	10.9	11.3	10.8	14.2	5.7	16.2	6.6	14.8	12.5	27.4	10.3	12.5	15.8	18.2	12.2	12.8	11.1	13.7	28.8	13.8	12.7	10.8	16.3	13.6	12.5	12.8	22.3	8.9	5.7	8.3	9.0	13.7	7.8	17.1	8.9	10.1	10.7	20.7	6.1	6.4	26.6	13.6	13.0	9.6	16.8	16.1	11.3	13.7	8.0	10.6	15.3	7.2	25.3	8.3	8.9	10.7	5.0	3.2	3.0	3.7	3.9	3.2	4.3	3.6	3.9	4.4	2.9	3.1	2.6	9.8	5.7	2.1	3.0	2.6	2.3	19.1	15.5	33.0	20.6	16.6	8.3	16.9	12.7	13.8	18.6
EP400	"CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12"	ENSG00000183495	"E1A binding protein p400"	Q96L91	12	131949920-132081102	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 6.7;dendritic cells: 7.3;T-cells: 2.8"	"Low region specificity"	"Detected in all"							"HPA016704, HPA049013"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA016704: AB_1854888, HPA049013: "	"unprognostic (2.28e-1)"	"unprognostic (4.04e-1)"	"unprognostic (4.33e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.24e-1)"	14.1	15.5	19.3	23.9	21.9	20.0	16.5	27.4	24.0	17.3	15.6	17.6	13.4	11.4	19.2	25.8	14.0	17.1	18.0	11.1	16.6	12.6	12.3	11.9	13.9	18.9	15.6	17.6	24.6	14.0	24.6	17.9	13.3	13.7	15.6	13.2	14.4	16.1	22.6	19.2	27.9	14.7	16.3	12.0	19.4	13.4	27.0	16.8	22.5	18.0	11.8	16.9	16.0	20.9	6.7	7.3	1.0	1.2	0.8	2.8	0.9	14.5	19.3	18.3	9.1	11.0	10.9	14.4	8.2	6.3	6.3	5.5	11.5	4.5	12.4	7.7	10.2	11.1	8.8	8.3	8.6	5.1	13.1	17.7	6.6	12.9	9.1	19.0	13.9	9.3	7.9	11.7	10.6	10.8	17.2	3.5	9.1	18.3	14.3	26.0	14.6	16.8	15.2	12.2	4.9	8.5	17.8	14.8	12.5	9.5	6.7	9.2	11.2	15.0	16.0	10.2	15.9	11.4	11.8	9.1	7.0	12.7	10.6	10.6	10.2	1.0	1.2	0.9	1.9	0.9	2.0	6.7	1.7	1.5	0.9	6.4	2.0	2.8	1.0	0.8	0.8	7.3	1.1	0.9	19.3	21.9	27.4	24.0	16.6	12.6	15.6	17.6	13.7	16.8
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386703	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 200.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.9;HHSteC: 57.5;RT4: 56.9;TIME: 56.7;U-138 MG: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 14.9;eosinophil: 7.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA031200: , HPA069697: "	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favourable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	71.2	14.2	12.5	17.1	15.7	0.8	101.7	5.3	13.9	24.9	20.9	8.9	11.3	12.0	28.8	13.0	21.6	24.8	35.2	40.0	12.8	11.0	35.2	31.2	200.8	27.2	14.3	11.1	20.2	15.5	18.1	9.4	119.6	18.4	20.7	11.5	41.2	13.3	18.7	25.2	13.0	15.6	19.2	12.5	20.5	12.8	13.8	8.0	1.1	43.8	15.2	10.3	32.2	39.3	0.0	0.0	14.9	0.1	0.7	0.1	0.1	5.2	5.6	0.3	0.4	27.0	17.4	45.9	16.6	45.2	9.5	10.4	0.9	0.9	0.0	4.1	31.5	2.5	0.1	13.3	7.1	0.1	0.2	0.0	1.8	11.7	57.5	0.0	3.4	25.5	18.3	18.6	13.1	32.7	0.5	0.0	5.8	4.5	0.1	0.1	0.2	3.1	0.1	0.6	1.7	5.9	56.9	0.2	11.8	13.0	29.9	3.6	2.0	2.3	56.7	49.3	1.4	6.5	1.3	0.0	0.0	0.0	36.0	0.9	1.2	14.9	0.1	7.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	12.5	15.7	5.3	12.6	12.8	11.0	14.3	11.1	18.4	8.0
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell line enhanced"	"Detected in many"		"HEL: 39.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"			3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: , HPA028096: , HPA028412: , HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavourable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.3	1.7	18.3	8.6	1.5	0.2	6.1	1.8	2.8	2.3	2.9	4.9	8.8	13.6	4.9	2.5	3.3	22.8	1.7	2.5	24.5	7.0	39.0	5.5	7.9	2.8	13.2	26.0	0.5	5.4	2.2	3.9	4.0	36.7	10.8	0.0	2.5	21.4	8.6	19.2	2.8	32.9	8.0	19.5	2.2	9.3	24.7	18.3	5.7	5.4	12.4	4.1	5.1	0.3	0.1	3.8	3.6	3.8	16.3	21.1	24.3	3.5	13.6	2.0	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9
EPB41L1	"4.1N, KIAA0338"	ENSG00000088367	"Erythrocyte membrane protein band 4.1 like 1"	Q9H4G0	20	36091504-36232799	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 40.3;HaCaT: 59.3;SK-BR-3: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 3.9"	"Low region specificity"	"Detected in all"							"HPA054104, HPA056817"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA054104: AB_2682380, HPA056817: AB_2683244"	"unprognostic (2.01e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (6.46e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavourable (9.30e-4)"	"unprognostic (1.78e-1)"	"prognostic favourable (4.39e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.26e-2)"	23.1	57.8	36.0	3.5	39.5	0.3	10.9	21.5	56.8	18.4	14.0	28.8	7.3	6.2	13.1	14.7	21.5	21.4	18.3	9.4	31.2	34.6	30.5	3.9	13.5	1.9	35.2	39.4	20.2	13.2	16.8	8.7	9.8	45.2	12.9	9.8	9.4	23.9	20.8	4.8	6.5	7.4	12.7	22.3	3.6	27.9	8.2	23.7	0.0	11.4	4.6	6.1	14.9	11.1	0.2	3.9	0.0	0.0	0.0	0.2	0.0	12.8	40.3	14.4	5.3	9.4	5.9	13.6	4.2	9.3	8.8	7.0	26.6	23.3	0.7	6.9	12.8	59.3	6.6	4.8	6.6	0.1	3.8	0.1	13.5	25.9	2.8	0.0	4.9	5.1	2.3	8.2	0.6	2.1	0.6	10.3	7.5	8.3	0.4	0.2	5.5	12.6	0.6	4.0	15.9	7.5	20.8	5.1	6.3	18.5	46.5	1.6	11.4	0.5	1.8	10.5	11.4	5.3	0.9	13.6	4.6	0.1	18.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	36.0	39.5	21.5	56.8	31.2	34.6	35.2	39.4	45.2	23.7
EPB41L2	4.1-G	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"			170000	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	50.2	16.5	29.6	17.3	42.8	3.9	21.1	6.5	40.1	20.5	23.1	32.3	7.2	12.3	23.0	13.7	13.2	25.6	18.0	22.8	33.4	24.6	11.5	12.1	24.4	15.4	50.5	33.1	44.4	9.1	8.2	8.4	26.2	34.8	11.2	23.2	52.0	10.1	15.8	16.0	7.1	21.4	20.6	59.5	25.3	11.7	32.2	51.9	6.8	15.2	14.6	11.6	15.2	16.6	10.5	8.6	0.5	8.8	1.0	2.5	1.3	8.3	8.7	19.8	27.2	13.8	22.1	6.1	14.1	17.8	14.4	20.1	16.6	11.8	10.1	26.5	19.3	4.3	7.6	13.0	28.8	43.0	17.5	18.1	10.4	9.5	8.1	0.0	22.2	10.8	0.2	25.4	9.8	22.1	49.1	29.1	9.1	2.1	14.1	3.1	18.3	9.5	22.1	23.8	0.9	24.2	7.9	2.1	0.0	5.9	0.1	11.4	3.0	18.9	26.7	17.0	32.0	28.6	42.3	24.1	0.4	9.5	11.6	0.1	25.8	0.1	3.1	0.5	1.0	8.8	0.9	2.9	1.0	1.2	8.6	10.5	1.7	0.7	0.0	1.0	3.3	2.3	2.5	1.3	29.6	42.8	6.5	39.6	33.4	24.6	50.5	33.1	34.8	51.9
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 17.6;ASC TERT1: 20.5;HUVEC TERT2: 18.5;SCLC-21H: 20.7;TIME: 50.8;U-2 OS: 18.5;U-2197: 18.0;U-251 MG: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 11.6"	"Lineage enriched"	"Detected in many"	4	"monocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"			140000	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	17.1	19.4	12.0	16.4	32.1	2.5	8.9	35.9	36.3	5.1	10.6	36.2	1.4	29.8	5.8	7.1	6.8	8.8	6.0	6.0	11.3	16.6	21.0	3.1	8.8	8.8	46.4	15.9	7.8	4.4	14.7	9.0	12.7	46.8	4.0	8.4	3.8	3.6	5.0	4.6	3.5	27.9	8.3	27.2	10.5	3.2	35.9	36.6	0.9	4.0	1.5	2.6	5.6	5.8	0.0	2.5	0.7	11.6	0.0	0.6	0.7	0.0	0.3	1.2	0.0	17.6	20.5	13.8	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	12.0	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	1.4	10.7	0.0	3.8	0.0	18.5	0.1	0.1	0.0	0.0	0.1	0.2	2.5	3.9	0.0	0.0	0.0	0.1	1.4	20.7	0.1	0.0	0.1	8.2	0.2	1.4	50.8	0.1	18.5	18.0	21.8	0.0	0.0	0.0	0.0	1.6	2.1	0.0	4.5	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.6	0.0	0.7	0.0	11.6	0.0	0.0	0.7	12.0	32.1	35.9	27.7	11.3	16.6	46.4	15.9	46.8	36.6
EPB41L5	"BE37, FLJ12957, KIAA1548, YMO1, YRT"	ENSG00000115109	"Erythrocyte membrane protein band 4.1 like 5"	Q9HCM4	2	120013005-120179119	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.8;MCF7: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037563, HPA037564"	Uncertain		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA037563: AB_2675546, HPA037564: AB_2675547"	"unprognostic (1.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (5.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.20e-2)"	"unprognostic (9.51e-2)"	"prognostic favourable (2.28e-6)"	"unprognostic (1.99e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.61e-1)"	4.6	5.0	7.4	6.0	11.6	1.1	13.3	19.4	12.6	7.4	8.6	6.9	4.3	10.6	7.2	4.9	7.0	10.2	6.2	4.9	8.5	7.4	25.6	42.3	36.3	3.8	7.6	6.5	9.4	20.3	13.0	15.8	7.5	12.2	9.9	7.0	7.1	10.8	6.6	8.6	6.6	9.5	7.5	14.8	2.2	7.0	22.0	6.1	2.9	25.2	6.4	5.0	5.3	8.4	4.7	0.4	1.8	1.4	1.5	3.2	1.4	7.9	2.7	11.0	8.5	7.7	5.6	9.6	1.7	1.7	3.6	3.2	24.8	5.3	0.1	6.0	2.1	5.5	14.8	6.8	5.4	1.6	4.6	2.3	1.3	13.8	9.0	1.0	2.5	5.0	12.8	6.7	4.8	10.1	5.4	0.6	7.1	37.1	1.8	3.5	9.9	2.5	0.0	3.3	2.2	11.3	7.7	5.7	10.9	7.5	13.4	3.7	6.4	1.9	8.3	0.3	5.3	5.7	1.7	0.8	1.5	4.1	0.9	0.0	2.0	0.3	1.4	1.5	1.1	0.3	0.3	4.7	1.2	1.1	0.4	3.6	3.2	2.4	1.8	1.5	0.9	0.0	0.5	1.4	7.4	11.6	19.4	12.6	8.5	7.4	7.6	6.5	12.2	6.1
EPC1	Epl1	ENSG00000120616	"Enhancer of polycomb homolog 1"	Q9H2F5	10	32267751-32378798	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005811			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA005811: "	"unprognostic (6.94e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.93e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.73e-2)"	"prognostic favourable (6.40e-4)"	"unprognostic (1.80e-2)"	"unprognostic (3.83e-3)"	"unprognostic (7.43e-2)"	"unprognostic (5.55e-2)"	"prognostic favourable (6.02e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-3)"	17.3	10.0	13.2	19.9	14.3	35.0	19.4	45.3	16.3	20.1	18.0	15.6	13.6	10.6	21.4	15.1	11.7	17.3	12.4	13.5	13.0	10.5	12.3	13.9	13.7	20.5	14.1	10.1	25.4	19.9	20.4	35.7	12.5	12.6	17.2	16.1	15.8	15.1	14.7	22.0	16.8	15.5	21.5	14.3	18.9	13.2	10.2	17.8	41.2	17.9	14.4	19.9	19.1	17.8	12.7	11.1	16.1	6.1	6.6	9.1	3.1	7.8	8.2	16.8	14.1	8.0	11.4	6.6	9.3	5.6	10.1	9.9	5.6	9.4	14.5	6.2	9.3	7.6	8.9	7.3	7.5	11.9	8.4	12.5	6.9	6.8	8.8	8.4	14.2	9.5	12.2	6.7	4.9	9.3	10.4	18.1	9.6	7.8	15.7	6.1	3.7	3.2	17.7	13.7	6.9	8.3	7.5	12.9	13.3	8.2	6.1	12.4	5.9	14.1	9.5	7.3	10.5	5.1	7.5	7.8	5.9	15.3	7.1	13.6	6.7	14.6	6.1	10.9	8.6	4.0	9.1	10.7	8.6	7.8	3.9	12.7	8.9	8.1	16.1	6.6	5.8	11.1	8.7	3.1	13.2	14.3	45.3	16.3	13.0	10.5	14.1	10.1	12.6	17.8
EPCAM	"17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 303.2"	"Cell line enhanced"	"Detected in many"		"A-431: 58.3;CACO-2: 75.6;CAPAN-2: 106.4;RPTEC TERT1: 45.4;SCLC-21H: 41.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: "	"unprognostic (6.79e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.40e-1)"	"prognostic favourable (3.30e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (1.04e-6)"	"unprognostic (6.38e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-3)"	"unprognostic (6.08e-2)"	0.4	2.1	1.8	49.8	3.0	0.2	8.9	0.6	1.0	10.8	155.8	0.7	31.5	66.8	4.4	35.2	2.8	10.2	41.6	0.4	1.7	2.7	60.2	1.2	22.6	0.4	1.2	0.4	3.8	54.1	19.8	38.7	2.2	0.9	9.0	70.5	0.7	47.2	25.0	0.5	2.0	303.2	1.7	1.4	0.5	15.3	5.5	0.9	1.7	83.6	4.2	4.1	4.1	2.1	0.2	1.9	0.4	0.2	0.0	0.0	0.6	58.3	0.6	0.0	0.1	0.0	0.0	37.0	0.0	0.0	0.0	0.0	75.6	106.4	0.0	16.4	0.1	27.5	0.5	6.9	0.2	0.0	6.7	0.0	0.3	29.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	17.4	0.0	0.0	29.8	0.0	2.8	19.1	3.8	0.0	0.0	14.8	45.4	25.8	41.1	0.3	0.4	21.7	0.0	18.3	0.1	0.0	0.0	0.7	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.6	1.8	3.0	0.6	1.0	1.7	2.7	1.2	0.4	0.9	0.9
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 41.9;EFO-21: 40.4;PC-3: 48.0;U-251 MG: 49.2;WM-115: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	115	"dendritic cells: 11.4"					"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	6.7	3.4	1.3	3.1	2.6	0.0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31.0	2.8	3.4	12.7	13.1	2.7	3.0	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	15.4	31.3	8.7	4.2	0.6	0.7	5.1	9.3	13.3	17.0	10.8	13.0	41.9	0.0	40.4	5.3	6.3	2.0	21.6	5.9	0.0	1.4	0.0	9.1	8.3	11.1	0.0	0.0	1.0	8.1	9.2	20.5	18.1	0.0	0.0	10.7	4.9	0.0	0.0	4.2	48.0	0.0	7.9	0.0	18.0	8.0	0.0	1.3	18.2	4.4	1.2	0.6	0.1	22.3	6.1	16.3	0.4	49.2	0.0	0.1	0.1	4.7	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Cell line enriched"	"Detected in some"	6	"AF22: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.8	0.0	0.0	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;ovary: 13.2;testis: 15.5"	"Group enriched"	"Detected in some"	6	"HEK 293: 8.0;U-266/70: 24.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA007397: AB_2667821, HPA058047: "	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.8	0.5	8.7	0.5	9.8	0.3	0.8	27.9	9.9	2.2	5.8	1.1	0.3	0.6	2.2	1.0	2.1	4.2	2.1	1.1	15.4	1.3	1.3	0.5	0.5	0.4	1.1	6.8	13.2	1.4	0.7	0.6	0.5	5.7	2.5	1.8	0.2	0.6	1.7	0.4	0.5	1.1	3.2	0.8	0.4	1.7	15.5	2.8	0.0	4.3	0.0	0.5	2.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.0	0.0	2.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.1	0.0	0.8	24.3	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	9.8	27.9	9.9	15.4	1.3	1.1	6.8	5.7	2.8
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 22.8;HUVEC TERT2: 31.1;TIME: 30.7;U-251 MG: 26.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"		290000	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: "	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (4.98e-4)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	16.7	7.1	6.8	10.9	0.6	0.6	0.0	3.9	0.2	11.8	2.5	2.4	6.7	0.2	8.4	1.7	15.8	4.6	22.8	3.1	0.0	1.6	0.0	0.7	0.0	7.1	0.0	1.7	2.3	7.3	21.1	0.1	31.1	0.6	0.0	2.3	2.5	0.3	0.1	1.6	4.6	2.0	7.0	0.3	5.8	1.6	7.4	7.8	6.8	0.2	0.1	0.4	0.2	30.7	4.7	12.4	11.9	26.8	0.0	0.1	0.0	8.8	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3
EPHX2		ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490779-27545564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.9;liver: 87.6"	"Cell line enhanced"	"Detected in many"		"K-562: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 39.2"	"Lineage enriched"	"Detected in many"	24	"T-cells: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Approved		Enhanced	Cytosol			720000	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favourable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favourable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	4.8	25.1	4.8	14.3	6.0	0.4	8.3	5.6	3.3	7.6	56.2	6.1	21.8	29.8	10.3	15.1	15.2	11.3	9.4	7.8	4.1	4.8	44.2	87.6	4.6	5.0	5.8	3.2	11.4	25.3	11.6	14.6	2.9	10.5	17.9	15.6	13.3	18.0	22.7	8.5	11.5	83.9	13.1	4.5	3.5	6.7	5.4	3.9	45.7	7.5	13.2	11.7	7.0	7.4	1.6	0.0	0.0	0.0	1.4	39.2	7.6	8.4	5.7	3.6	4.7	0.2	0.0	2.7	0.7	0.5	0.4	0.1	4.5	5.8	0.0	3.4	2.1	6.1	0.6	1.4	0.3	0.0	2.7	12.5	0.6	13.7	2.0	0.0	2.6	5.1	6.2	0.0	0.7	0.3	28.2	0.1	0.0	2.6	8.1	0.3	5.8	9.9	0.0	0.0	0.2	5.1	1.2	3.0	9.4	6.9	8.2	8.2	12.5	2.3	0.1	0.0	2.3	1.0	0.1	7.3	5.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.9	0.0	4.0	1.6	12.5	4.5	0.0	0.9	39.2	18.0	0.0	1.4	0.0	0.0	9.4	7.6	4.8	6.0	5.6	3.3	4.1	4.8	5.8	3.2	10.5	3.9
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A, laforin glucan phosphatase"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation, Epilepsy, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA053643: , HPA055468: "	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favourable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.4	6.0	8.8	1.9	9.0	2.2	3.6	4.0	8.9	3.9	11.1	8.6	2.5	3.4	4.8	4.8	8.9	4.3	3.9	19.4	9.6	8.7	8.0	5.7	3.5	3.4	11.9	5.5	5.9	2.9	5.5	3.3	2.0	9.6	6.2	3.4	5.6	3.1	9.2	60.9	2.4	3.3	13.9	13.6	2.5	4.6	3.3	7.1	3.7	4.2	15.7	2.9	10.4	6.0	1.4	1.0	0.3	1.4	5.4	2.4	1.0	1.1	1.7	3.2	6.2	8.0	2.5	1.4	2.9	3.4	2.7	3.4	1.5	1.6	19.9	2.5	3.5	1.7	1.2	1.2	2.5	7.7	1.6	3.2	2.3	2.5	4.9	11.0	2.0	2.0	6.6	1.6	0.5	1.9	1.4	5.1	3.4	2.6	7.3	2.4	3.3	1.7	4.2	2.9	5.8	2.4	1.6	6.0	5.9	5.2	3.1	6.8	1.8	6.4	4.2	2.8	1.3	2.6	2.3	3.7	3.7	8.0	2.4	2.7	4.3	0.0	0.1	0.1	0.4	1.4	1.1	1.3	1.1	0.9	1.0	1.4	1.2	2.4	0.3	5.4	0.3	0.9	0.2	1.0	8.8	9.0	4.0	8.9	9.6	8.7	11.9	5.5	9.6	7.1
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB009729, HPA061136"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB009729: AB_2277865, HPA061136: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	26.7	23.4	34.2	20.6	31.4	15.7	31.4	26.3	47.1	13.5	32.7	17.2	18.1	67.7	13.7	19.8	21.3	15.4	28.2	56.0	28.0	18.6	23.1	36.0	16.5	25.5	17.5	25.9	23.2	54.5	12.1	14.3	15.0	15.8	19.3	13.8	13.5	24.8	22.7	84.7	22.2	59.7	12.2	14.3	26.9	55.1	20.2	13.1	11.2	15.3	26.3	14.6	13.1	16.2	2.2	3.6	4.6	6.9	0.7	2.0	2.4	24.6	34.1	8.5	17.4	9.8	9.4	17.5	18.4	10.5	13.1	13.1	14.2	15.6	15.2	12.5	14.7	18.9	7.4	14.0	4.7	5.2	70.5	11.1	18.2	16.8	13.6	7.1	10.7	12.2	12.4	11.3	8.2	12.5	16.5	12.9	8.6	13.9	11.3	11.7	19.5	48.2	7.6	11.6	26.6	9.9	14.6	12.3	29.9	17.0	18.5	12.1	13.9	25.0	20.8	36.5	17.6	13.1	26.5	14.2	12.9	10.9	26.8	14.4	18.0	2.4	3.5	4.4	1.4	4.5	1.0	2.2	1.4	1.3	2.4	2.0	1.4	1.3	4.6	0.7	6.9	3.6	2.0	2.4	34.2	31.4	26.3	47.1	28.0	18.6	17.5	25.9	15.8	13.1
EPN2	"EHB21, KIAA1065"	ENSG00000072134	"Epsin 2"	O95208	17	19215615-19336715	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049809, HPA053360"	Approved		Supported	Vesicles				Vesicles		"HPA049809: , HPA053360: "	"unprognostic (1.38e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (9.13e-5)"	"unprognostic (1.32e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (8.15e-5)"	6.5	5.1	16.3	6.2	11.8	3.4	4.4	9.9	34.8	7.0	5.2	4.3	3.6	2.9	9.9	7.0	13.9	7.7	4.8	10.7	16.7	10.5	4.5	3.6	6.1	3.6	14.9	13.1	7.2	4.3	8.4	3.6	7.7	8.5	7.3	3.0	5.6	5.0	9.2	9.8	18.4	3.6	8.7	14.7	4.5	3.2	6.7	10.6	3.6	4.4	8.1	3.6	5.4	6.9	2.9	0.7	19.9	1.1	0.6	1.5	0.4	14.8	14.9	21.9	9.6	11.5	18.6	17.1	14.3	9.3	8.9	7.7	9.7	4.5	2.3	14.0	14.2	14.1	9.7	10.7	11.0	11.1	10.8	1.6	9.4	4.8	12.1	0.7	6.6	10.4	9.7	14.0	11.4	19.0	4.2	2.0	7.8	10.8	0.6	1.0	5.6	9.8	3.4	9.3	3.9	10.5	4.1	6.5	14.5	10.1	6.8	7.4	10.2	1.9	17.3	9.9	11.4	15.4	6.2	3.3	2.0	1.9	27.0	0.2	15.1	7.1	1.1	19.9	1.5	0.7	1.0	2.3	1.1	1.2	0.5	2.9	1.3	1.2	7.3	0.6	0.8	0.7	0.9	0.4	16.3	11.8	9.9	34.8	16.7	10.5	14.9	13.1	8.5	10.6
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532543-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.4;HBEC3-KT: 17.2;hTCEpi: 9.7;MCF7: 27.5;RT4: 21.6;SK-BR-3: 11.2;T-47d: 24.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 6.8;pons and medulla: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2"	"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA055546: , HPA063224: "	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favourable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.4	7.7	0.5	1.9	0.7	0.4	1.9	1.1	6.8	5.3	7.8	1.5	24.0	5.1	0.7	3.8	26.2	6.0	12.6	6.6	0.5	0.7	10.9	0.4	0.7	0.0	2.0	1.4	10.3	18.3	9.6	0.9	8.4	17.8	9.3	3.4	0.3	16.7	18.7	0.4	19.7	5.1	0.5	0.6	0.3	23.8	2.2	0.0	3.4	1.2	15.9	21.9	8.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.1	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	6.3	5.4	0.0	0.1	0.0	12.4	0.0	17.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	9.7	0.0	1.3	0.0	0.0	0.0	0.0	27.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	21.6	0.2	0.0	0.0	11.2	0.0	24.9	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.1	6.8	0.5	0.7	2.0	1.4	17.8	0.0
EPOP	"C17orf96, LOC100170841, PRR28"	ENSG00000273604	"Elongin BC and polycomb repressive complex 2 associated protein"	A6NHQ4	17	38671703-38675421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.7;Hep G2: 18.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055190, HPA056555"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA055190: , HPA056555: "	"unprognostic (9.08e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.78e-10)"	"unprognostic (8.97e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	1.2	2.0	2.5	1.5	5.1	0.4	1.1	0.0	13.5	0.3	0.2	0.0	2.5	0.2	0.7	0.7	0.7	0.4	0.8	0.4	1.1		0.3	3.4	0.4	2.4	0.3	3.2	0.1	3.6	3.0	0.0	1.2	0.4	0.7	0.3	0.2	0.5	1.2	0.1	1.0	0.2	0.5	0.8	0.6	0.5	5.8	0.8	1.7	0.1	1.1	3.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	2.9	3.4	2.2	15.7	0.5	0.1	3.8	0.6	0.2	0.6	1.1	3.4	1.1	5.5	3.8	0.4	2.3	7.3	1.5	1.2	5.7	5.6	1.2	0.6	18.0	1.0	0.6	3.0	0.3	2.6	0.7	1.5	0.5	3.7	8.5	0.4	4.6	4.9	1.6	0.5	3.1	11.8	1.3	12.0	0.4	0.7	3.4	5.3	1.9	2.6	0.6	3.7	2.3	0.8	0.6	0.7	0.7	0.6	4.5	4.9	7.0	1.3	8.1	2.3	0.0	0.0	0.0	0.4	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
EPOR		ENSG00000187266	"Erythropoietin receptor"	P19235	19	11377205-11384342	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins"		Receptor	"Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA077654			Supported	"Nuclear speckles,Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Nuclear speckles"	"HPA077654: "	"unprognostic (9.13e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (9.00e-2)"	"prognostic favourable (3.17e-5)"	"unprognostic (6.37e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.01e-3)"	5.5	8.6	2.1	1.1	2.9	14.7	2.6	1.3	1.7	3.9	3.3	2.8	13.3	1.0	3.6	11.6	2.4	3.2	1.8	11.2	1.9	1.4	12.1	8.4	8.5	6.9	1.9	1.6	1.9	9.2	28.1	5.2	12.7	2.3	3.1	1.4	3.3	8.7	18.3	2.0	1.1	1.7	1.5	4.0	8.0	3.7	2.2	1.0	1.6	21.5	1.0	1.5	1.9	2.1	2.6	2.5	12.2	7.7	0.9	4.8	2.9	3.4	1.1	3.5	4.1	5.3	3.4	2.1	2.2	6.8	3.5	4.5	1.2	1.3	2.4	3.9	3.9	0.9	2.7	1.3	4.1	1.9	1.6	13.0	1.1	2.0	3.8	2.7	5.4	2.5	0.5	4.7	3.3	8.2	11.4	11.6	3.9	3.1	2.5	3.2	1.9	9.3	6.7	5.9	5.2	3.3	1.8	1.4	10.9	1.4	2.0	6.0	3.5	4.7	3.4	1.9	2.6	6.5	1.9	5.9	4.3	2.6	10.3	2.6	2.0	8.1	4.2	3.3	2.1	5.1	4.5	2.6	4.2	3.1	2.5	1.6	4.8	2.8	12.2	0.9	7.7	0.1	3.7	2.9	2.1	2.9	1.3	1.7	1.9	1.4	1.9	1.6	2.3	1.0
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"		8	143857324-143878464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.9;EFO-21: 10.2;HaCaT: 10.1;HeLa: 16.9;MCF7: 14.6;SK-BR-3: 7.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"HPA066808: , HPA067357: , HPA069333: "	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.0	0.0	0.0	3.0	0.0	0.0	1.1	0.7	0.0	0.4	7.8	0.0	7.2	3.1	3.4	2.4	6.0	1.4	2.3	0.0	0.0		0.8	0.0	4.2	0.9	0.0	0.0	1.0	1.9	0.6	0.0	2.8	0.5	2.9	0.8	0.0	14.8	4.9	0.1	14.1	12.1	15.7	0.1	1.5	1.2	2.3	0.0	0.0	0.0	7.2	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	5.4	0.4	0.0	10.2	0.0	10.1	1.0	0.1	0.0	0.0	2.6	0.0	16.9	3.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.6	1.7	0.0	1.6	7.0	0.0	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.0	0.2	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0										
EPRS	"EARS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase"	P07814	1	219968601-220046658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol			29000	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavourable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (2.62e-4)"	25.0	20.4	16.8	18.6	22.2	13.2	20.6	24.2	26.3	19.3	20.4	15.4	13.6	15.8	17.8	15.3	25.2	15.9	11.9	20.1	15.9	18.0	23.3	31.6	17.4	20.8	21.7	16.1	21.3	32.7	47.1	38.6	15.7	34.9	14.3	23.2	9.4	64.0	16.3	42.9	19.6	23.3	18.9	24.7	22.3	20.1	13.2	20.8	28.0	25.1	25.7	23.4	18.3	16.3	14.7	15.4	6.4	16.6	14.2	19.8	10.7	30.1	19.2	13.9	37.9	29.6	32.8	34.8	39.4	27.6	25.7	28.8	22.7	24.3	57.8	22.0	41.5	32.2	34.8	31.8	34.6	28.3	22.1	31.4	25.9	19.3	32.3	52.1	26.9	23.6	40.8	32.7	41.0	28.0	54.0	45.6	25.0	14.8	22.3	12.7	26.8	39.7	23.7	24.5	56.5	23.5	13.2	33.1	26.0	23.0	38.2	40.2	35.3	56.9	24.9	12.2	22.6	37.5	36.7	30.9	35.1	48.9	28.3	37.5	38.7	4.2	11.9	6.4	14.0	16.6	19.8	14.7	14.1	15.6	15.4	11.5	15.9	16.3	0.4	14.2	13.7	5.0	13.5	10.7	16.8	22.2	24.2	26.3	15.9	18.0	21.7	16.1	34.9	20.8
EPS15	"AF-1P, MLLT5"	ENSG00000085832	"Epidermal growth factor receptor pathway substrate 15"	P42566	1	51354263-51519328	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008451, CAB010164, HPA061431"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"		67000	"Vesicles, Cytosol"		"CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: "	"unprognostic (1.45e-2)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (1.05e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	39.0	26.9	35.5	25.3	27.8	13.2	19.3	22.2	41.0	25.7	16.7	35.7	16.2	11.4	21.8	21.3	19.6	14.1	19.3	18.9	40.7	26.0	21.0	19.1	24.4	30.7	36.2	11.2	22.4	10.9	17.0	14.6	22.8	20.3	22.5	15.5	25.7	24.3	16.4	30.9	18.1	19.3	18.2	36.8	33.8	15.2	32.4	33.1	25.0	20.3	23.4	32.1	25.3	17.0	16.1	10.8	14.9	12.2	10.7	18.7	8.0	14.7	4.4	9.6	9.0	22.2	22.2	23.9	10.3	16.4	8.5	12.6	6.0	8.2	30.2	10.7	16.2	14.1	12.4	9.9	12.9	34.1	7.8	26.9	7.6	7.2	20.9	15.2	24.8	18.0	9.2	14.8	20.2	15.8	16.6	13.8	12.9	7.2	12.2	8.3	13.1	7.2	10.0	14.5	6.6	11.2	18.4	6.6	9.2	12.3	21.9	17.9	8.9	10.8	21.8	7.9	8.5	15.8	8.6	16.5	16.7	20.4	11.7	17.3	6.9	14.9	10.1	11.6	10.1	10.7	15.3	16.1	12.2	15.6	10.8	10.0	7.3	10.5	7.8	10.7	12.2	7.1	18.7	8.0	35.5	27.8	22.2	41.0	40.7	26.0	36.2	11.2	20.3	33.1
EPS8L1	"DRC3, FLJ20258, MGC23164, MGC4642"	ENSG00000131037	"EPS8 like 1"	Q8TE68	19	55072020-55087923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.9;placenta: 45.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.1;BEWO: 31.9;SK-BR-3: 9.8;T-47d: 15.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041851, HPA043545"	Uncertain		Supported	Cytosol				Cytosol		"HPA041851: , HPA043545: "	"unprognostic (1.91e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (7.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.63e-1)"	1.2	0.0	0.2	2.1	0.3	0.0	1.7	0.3	0.4	7.6	2.1	0.2	1.5	2.0	1.3	1.8	40.9	6.2	6.9	0.2	0.2	0.0	4.1	0.2	1.8	0.2	0.2	0.2	1.6	4.0	1.1	1.1	45.0	0.3	2.9	0.5	0.3	6.6	2.5	0.4	18.7	1.5	0.7	0.2	0.4	23.2	0.9	0.2	1.0	6.2	12.1	16.9	1.9	12.1	0.1	3.5	5.1	0.4	1.7	0.8	0.5	9.1	0.4	0.3	0.2	0.0	0.0	31.9	0.8	0.0	0.0	0.0	2.9	7.6	0.1	1.9	0.0	4.6	0.2	0.5	0.0	0.2	0.9	0.7	0.3	0.2	0.1	1.4	6.4	0.0	1.4	0.0	0.0	0.0	3.4	0.0	0.0	4.2	0.5	1.4	0.5	0.0	0.1	0.0	3.0	0.7	0.7	0.1	2.3	0.6	9.8	0.4	15.5	1.8	0.7	0.0	0.4	0.0	0.0	1.4	1.7	0.9	2.0	0.5	1.2	2.6	0.4	5.1	0.8	0.1	0.7	0.0	0.4	0.8	0.0	0.1	0.1	0.0	0.0	1.7	0.0	3.5	0.7	0.5	0.2	0.3	0.3	0.4	0.2	0.0	0.2	0.2	0.3	0.2
EPS8L2	"FLJ21935, FLJ22171, MGC3088"	ENSG00000177106	"EPS8 like 2"	Q9H6S3	11	694438-727727	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 73.3"	"Cell line enhanced"	"Detected in many"		"A-431: 45.8;BEWO: 45.3;CAPAN-2: 43.2;SK-BR-3: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 6.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 13.6"	HPA041143	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041143: AB_10794985"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.03e-2)"	1.7	3.0	2.0	6.4	3.3	0.0	12.4	6.9	2.5	11.6	31.5	1.2	23.9	38.7	4.6	10.1	53.3	5.3	21.7	1.0	1.3	1.6	30.4	38.3	18.0	0.4	1.7	0.5	3.9	11.6	1.8	4.3	39.6	3.6	8.4	6.0	2.7	26.2	17.6	0.7	22.8	73.3	2.4	2.4	0.5	18.0	7.2	1.5	0.9	29.5	29.4	33.7	6.9	19.2	0.2	6.4	0.7	0.1	0.1	0.1	0.1	45.8	14.0	0.0	0.3	0.5	3.1	45.3	4.0	4.2	6.0	2.6	10.5	43.2	0.1	16.8	4.3	24.3	0.1	24.3	1.4	0.1	0.9	0.0	5.2	18.8	3.4	0.0	0.0	1.6	16.3	1.7	4.2	0.0	0.3	0.2	0.6	14.7	0.1	0.2	0.5	4.5	0.1	0.1	0.3	21.2	11.4	0.1	0.1	14.3	53.0	0.1	20.0	0.0	0.3	2.4	5.7	1.5	0.3	0.1	0.2	0.1	1.3	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	6.4	0.0	0.1	2.0	3.3	6.9	2.5	1.3	1.6	1.7	0.5	3.6	1.5
ERAL1	HERA-B	ENSG00000132591	"Era like 12S mitochondrial rRNA chaperone 1"	O75616	17	28854938-28861067	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021425, HPA024423"	Supported		Enhanced	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA021425: AB_1848228, HPA024423: AB_1848229"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.37e-3)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (8.20e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.79e-2)"	16.2	24.8	24.1	13.3	31.6	12.7	19.4	25.1	47.9	18.4	20.9	27.1	15.8	18.0	21.5	19.2	20.6	22.2	17.2	24.5	23.0	22.0	24.9	33.7	14.8	16.0	21.3	20.2	22.0	18.1	29.3	15.4	24.7	27.6	18.0	23.4	17.3	28.2	21.2	34.1	18.3	19.7	21.8	18.4	17.0	18.2	17.3	15.5	20.4	20.3	21.5	23.8	16.1	14.8	20.1	29.0	11.1	23.1	20.8	18.2	14.9	15.9	31.1	18.2	20.6	20.1	13.8	17.8	12.8	18.3	38.9	32.0	30.3	10.3	20.6	15.6	22.0	17.8	33.3	29.2	32.5	20.3	39.0	16.5	20.7	30.6	25.8	19.6	15.1	18.0	26.0	31.5	29.9	31.7	32.8	13.0	21.6	25.1	20.4	30.4	16.8	14.9	18.9	28.9	26.6	23.5	18.2	19.4	15.6	20.9	51.5	16.5	36.2	23.1	12.7	15.9	17.9	17.5	26.9	10.5	19.0	22.0	17.2	17.2	16.1	11.1	17.9	7.1	17.8	23.1	13.4	20.1	15.2	13.0	29.0	18.6	17.6	18.2	1.4	20.8	15.6	15.0	16.3	14.9	24.1	31.6	25.1	47.9	23.0	22.0	21.3	20.2	27.6	15.5
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	27	"SK-BR-3: 263.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.8"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Supported	"Plasma membrane,Cytosol"			430000	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: , HPA001060: , HPA001338: , HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavourable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favourable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	5.8	2.4	5.2	10.4	7.0	0.1	20.1	4.2	7.0	19.1	46.5	9.1	55.2	21.6	14.9	18.7	40.9	22.7	26.6	24.8	6.3	3.1	37.5	21.5	17.6	3.7	5.1	5.6	19.3	16.2	27.7	8.1	60.8	7.5	23.6	16.6	15.9	28.7	58.1	8.9	35.3	47.2	10.9	4.5	4.0	17.1	6.5	3.7	2.8	35.7	20.8	22.9	19.7	20.3	1.3	0.3	2.1	0.4	0.9	8.8	2.2	3.1	3.8	4.2	2.7	5.1	3.6	5.7	2.2	3.7	4.9	4.2	2.8	8.6	0.2	4.6	5.1	9.8	0.2	5.1	2.3	0.4	3.2	0.1	3.0	4.5	3.0	0.0	0.0	3.5	4.8	3.0	1.8	2.0	0.4	0.1	3.6	4.8	0.5	0.2	7.6	0.9	0.3	1.7	0.4	5.0	9.8	0.8	0.2	4.2	263.9	1.3	7.4	0.1	0.2	2.5	3.3	3.2	1.4	0.4	0.2	0.2	0.2	0.0	8.2	1.6	0.4	0.8	8.8	0.3	0.7	0.9	0.5	2.5	0.3	1.3	1.0	2.5	2.1	0.9	0.2	0.2	0.4	2.2	5.2	7.0	4.2	7.0	6.3	3.1	5.1	5.6	7.5	3.7
ERBIN	"ERBB2IP, LAP2"	ENSG00000112851	"Erbb2 interacting protein"	Q96RT1	5	65926475-66082549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048606, HPA059863"	Approved		Supported	"Nuclear speckles,Plasma membrane"			250000	"Nuclear speckles, Plasma membrane"		"HPA048606: , HPA059863: "	"unprognostic (4.34e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.45e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.62e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.81e-2)"	20.1	8.7	33.2	28.5	32.7	13.3	13.0	5.4	15.9	16.1	21.1	10.6	16.3	12.1	14.5	22.1	17.2	10.5	17.2	12.6	29.5	22.5	15.8	24.1	20.1	21.1	32.5	7.4	11.1	13.7	15.4	6.9	10.4	16.0	18.2	13.8	11.1	17.3	26.0	16.4	16.9	37.4	15.3	31.0	27.6	20.3	13.3	17.6	40.2	19.6	16.3	19.6	20.7	14.9	6.2	4.5	13.5	7.6	5.0	7.1	3.6	30.2	10.2	13.3	15.9	10.0	12.1	10.1	19.5	20.0	27.8	31.1	9.6	36.2	25.5	19.0	30.1	10.1	8.5	14.2	49.3	11.2	3.8	8.8	12.9	7.6	13.2	6.8	8.6	13.1	9.5	15.2	22.3	10.3	8.9	17.6	18.7	10.3	17.9	7.8	3.3	2.9	16.5	10.7	14.1	16.3	20.7	6.5	6.0	20.7	7.0	14.7	12.1	16.7	9.4	15.8	28.1	9.5	25.0	15.2	9.4	21.9	10.4	11.3	9.0	13.5	5.2	6.7	7.1	7.6	6.5	6.2	5.5	6.3	4.5	4.9	6.5	6.7	11.9	5.0	6.0	2.9	4.8	3.6	33.2	32.7	5.4	15.3	29.5	22.5	32.5	7.4	16.0	17.6
ERC1	"CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2"	ENSG00000082805	"ELKS/RAB6-interacting/CAST family member 1"	Q8IUD2	12	990509-1495933	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019513, HPA019523, HPA024130"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavourable (7.01e-4)"	12.6	11.4	10.3	12.5	14.7	7.4	15.1	41.7	10.4	11.2	11.9	8.5	9.2	4.3	17.1	11.0	13.7	9.8	9.9	14.7	10.0	11.2	11.2	8.0	8.8	5.4	9.0	6.4	12.5	8.6	24.3	19.4	13.2	10.7	11.4	7.5	10.1	9.3	14.4	9.2	9.9	6.4	22.1	8.5	7.3	8.6	11.0	9.9	9.8	15.3	7.2	8.6	15.7	15.3	8.6	2.9	2.1	3.8	1.1	3.5	0.5	2.9	7.3	3.9	2.6	10.4	8.8	5.4	9.2	7.4	6.3	5.8	6.4	3.6	4.5	1.3	11.9	5.0	8.3	7.1	8.8	9.5	4.2	11.1	7.3	3.2	7.9	5.7	2.6	7.1	6.2	11.1	20.8	8.1	3.3	9.0	4.7	3.2	1.8	1.2	6.2	3.5	3.6	14.8	1.4	6.2	5.3	2.3	4.6	14.4	3.3	5.2	3.4	2.4	15.0	10.9	11.1	8.0	8.6	2.4	4.5	6.7	7.1	3.4	4.8	1.4	2.8	2.1	1.6	1.0	2.2	8.6	2.4	2.4	2.4	5.6	3.5	2.6	2.1	1.1	3.8	2.9	2.2	0.5	10.3	14.7	41.7	10.4	10.0	11.2	9.0	6.4	10.7	9.9
ERCC1	RAD10	ENSG00000012061	"ERCC excision repair 1, endonuclease non-catalytic subunit"	P07992	19	45407333-45478828	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cataract"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004390, HPA029773, HPA050182, CAB072859, CAB072860"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004390: AB_2278023, CAB072859: , CAB072860: , HPA029773: AB_10602129, HPA050182: "	"unprognostic (1.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (2.57e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (9.00e-5)"	"unprognostic (6.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	25.0	28.2	25.9	20.2	27.5	20.8	30.6	28.4	34.8	26.4	21.5	35.4	20.6	20.8	27.4	34.6	28.6	30.9	24.0	63.5	24.7	24.4	22.9	24.2	21.3	26.3	28.3	25.0	37.6	42.9	31.6	32.0	20.3	27.4	29.1	17.1	29.1	53.8	24.4	43.3	43.5	20.4	26.1	23.5	24.3	22.4	21.6	26.7	22.6	28.4	25.7	25.1	22.0	26.0	16.6	69.0	5.3	29.7	12.6	14.2	17.9	13.7	23.7	20.1	29.4	13.8	26.3	6.4	20.6	27.6	25.1	33.4	2.6	13.5	8.1	5.8	21.9	10.6	6.4	65.7	15.5	17.7	6.5	12.1	9.0	8.0	28.9	12.2	22.8	19.6	14.1	26.2	23.7	27.2	7.4	16.3	39.3	9.2	11.5	9.8	4.7	9.4	17.4	9.4	10.9	18.4	8.8	8.6	18.2	13.1	11.2	18.0	13.6	23.4	15.6	22.6	21.6	13.8	20.8	12.1	9.7	8.7	26.0	10.6	68.1	4.7	29.2	5.3	14.2	29.7	9.6	16.4	8.7	11.0	29.3	16.6	7.0	11.3	4.0	12.6	21.8	69.0	10.2	17.9	25.9	27.5	28.4	34.8	24.7	24.4	28.3	25.0	27.4	26.7
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: , HPA069266: "	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	7.4	15.6	11.4	10.6	17.7	6.7	7.1	9.5	23.8	9.4	8.1	11.7	7.8	7.9	11.7	6.0	6.7	10.0	10.1	7.9	9.4	9.1	8.7	13.2	6.5	9.9	8.2	10.5	9.5	13.1	12.9	10.9	7.2	14.0	8.2	6.4	12.5	9.5	11.8	15.9	10.7	7.1	11.2	5.3	9.7	8.3	17.2	7.8	10.8	10.2	5.1	8.3	9.3	6.6	7.8	17.2	5.0	13.9	11.3	9.8	8.7	12.3	6.0	12.6	17.7	7.5	8.9	6.7	17.6	12.1	22.8	17.5	14.0	8.5	4.4	10.1	17.1	6.4	8.8	14.8	8.7	10.6	14.5	7.5	11.5	14.7	15.9	11.9	13.3	10.2	2.3	26.0	14.8	13.2	18.2	5.0	15.7	6.0	7.0	7.9	5.8	10.6	13.5	8.9	3.7	6.5	10.9	7.4	8.0	15.6	11.1	6.2	10.5	15.8	17.1	21.8	11.9	9.2	39.1	11.6	6.7	6.4	6.4	7.3	9.6	0.0	13.3	5.0	7.7	13.9	9.8	7.8	7.4	7.4	17.2	5.8	7.1	7.4	0.4	11.3	10.9	8.3	7.4	8.7	11.4	17.7	9.5	23.8	9.4	9.1	8.2	10.5	14.0	7.8
ERCC3	"BTF2, GTF2H, RAD25, TFIIH, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294176	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB037153: AB_796181, HPA046077: "	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavourable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	17.4	20.0	26.1	23.8	28.9	20.5	21.0	35.9	32.0	22.1	19.4	19.7	17.1	11.5	21.6	15.7	19.1	23.6	20.4	20.4	23.2	18.8	17.5	17.4	19.4	23.1	19.7	25.8	23.3	22.4	32.0	26.4	16.3	21.5	20.1	17.1	18.3	18.0	21.8	30.1	19.7	17.3	26.1	16.0	24.5	17.4	39.5	20.1	24.1	19.3	15.8	25.9	22.4	20.8	11.8	13.9	7.2	9.7	18.8	16.2	11.7	21.8	15.1	18.6	19.7	20.8	14.2	23.1	20.1	26.2	32.6	31.6	22.9	16.0	16.6	16.7	18.3	19.6	28.4	21.2	28.4	25.9	25.4	20.8	18.4	24.2	15.4	18.1	22.7	14.7	19.9	37.7	16.1	20.9	20.2	10.9	20.5	21.6	25.7	19.5	27.1	23.5	21.2	21.4	13.7	18.2	20.4	22.6	24.4	17.2	26.2	26.3	14.1	20.8	16.6	19.6	22.5	17.8	23.9	19.5	38.1	26.0	17.3	8.7	20.9	6.6	9.5	7.2	16.0	9.7	16.2	11.5	11.8	13.5	13.9	11.8	15.8	10.9	3.1	18.8	7.9	11.3	16.1	11.7	26.1	28.9	35.9	32.0	23.2	18.8	19.7	25.8	21.5	20.1
ERCC4	"FANCQ, RAD1, XPF"	ENSG00000175595	"ERCC excision repair 4, endonuclease catalytic subunit"	Q92889	16	13920157-13952345	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Disease mutation, Dwarfism, Fanconi anemia, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000156, HPA045828"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"				"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"CAB000156: , HPA045828: "	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.41e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.88e-4)"	8.4	12.7	8.6	7.0	11.3	5.3	6.4	8.9	9.7	8.1	6.7	9.9	6.0	4.1	8.5	6.8	6.7	8.5	6.8	7.8	7.2	7.1	6.9	7.2	6.9	6.8	10.5	8.8	9.9	7.6	13.3	13.0	5.9	9.6	8.3	5.4	7.1	6.4	7.0	31.3	6.9	5.7	8.5	10.3	7.7	6.6	14.2	8.9	13.7	9.7	5.6	6.4	9.1	7.8	8.4	7.9	8.3	6.8	8.9	7.4	2.6	5.4	7.0	6.4	9.2	10.7	10.1	5.0	7.2	7.7	6.5	8.3	2.4	5.4	9.1	10.4	6.3	6.9	9.5	4.9	10.1	12.3	5.6	4.5	7.8	6.0	9.8	6.0	5.1	7.6	6.9	8.6	7.3	8.6	7.0	10.7	9.1	4.5	8.0	4.1	4.7	3.7	9.2	13.0	11.2	4.0	3.7	5.3	6.3	8.8	7.2	6.7	9.1	4.6	9.7	9.6	7.1	8.6	6.3	9.5	11.1	6.3	9.2	7.3	9.7	8.3	6.2	5.4	6.8	6.8	7.4	6.2	6.4	5.1	5.5	8.4	6.4	6.9	7.2	8.9	5.7	7.9	5.8	2.6	8.6	11.3	8.9	9.7	7.2	7.1	10.5	8.8	9.6	8.9
ERCC5	"ERCM2, XPGC"	ENSG00000134899	"ERCC excision repair 5, endonuclease"	P28715	13	102807146-102876001	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045845, HPA050126, HPA050374"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA045845: , HPA050126: , HPA050374: "	"unprognostic (1.28e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.19e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.77e-3)"	"unprognostic (5.76e-3)"	"prognostic unfavourable (2.96e-6)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (6.82e-4)"	22.3	19.1	15.9	16.1	17.8	23.7	20.1	26.4	20.8	19.7	27.0	17.9	27.0	25.0	22.1	25.7	21.0	15.1	21.1	15.4	14.6	13.1	18.7	28.1	19.9	26.4	17.1	16.2	22.9	22.3	15.7	25.6	17.9	19.0	20.1	23.1	15.9	20.5	24.7	14.6	25.8	31.1	17.0	19.4	30.6	21.9	14.0	17.8	40.8	21.8	16.6	26.0	22.4	19.6	10.1	10.8	23.4	17.4	17.7	17.5	12.0	14.7	5.4	10.8	6.7	21.5	20.2	6.5	14.9	19.9	8.7	11.3	8.2	20.6	9.3	7.5	15.1	15.4	9.5	13.7	9.1	14.0	5.3	13.8	15.6	7.2	10.5	28.0	18.0	19.2	13.2	10.0	15.6	15.1	6.4	8.5	15.2	4.0	15.1	19.5	4.6	7.5	8.2	8.0	9.3	17.9	8.2	7.2	10.7	7.8	13.2	8.0	11.8	26.2	15.2	6.7	3.4	5.6	9.4	12.4	3.7	4.7	26.2	11.4	8.4	23.4	9.8	18.3	16.7	12.3	15.5	9.6	15.5	17.5	10.8	10.1	16.6	16.1	7.2	17.7	17.4	7.7	16.6	12.0	15.9	17.8	26.4	20.8	14.6	13.1	17.1	16.2	19.0	17.8
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239047	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 5.3"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: "	"prognostic unfavourable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.4	0.5	0.2	3.1	0.2	6.0	3.0	0.9	0.8	1.5	2.2	0.2	0.2	1.5	0.9	0.8	4.6	0.6	1.0	0.2	0.2	0.3	0.5	0.5	0.8	4.7	0.7	0.2	1.2	0.5	0.0	0.6	0.9	0.9	0.7	2.5	0.2	1.1	0.2	2.6	1.3	2.1	0.5	1.3	4.0	1.5	2.0	0.2	13.1	0.5	2.8	5.6	0.7	1.6	0.5	0.3	0.5	0.2	5.3	1.1	0.4	10.9	9.6	8.9	5.6	0.6	1.1	4.9	11.8	5.4	10.4	10.9	7.8	6.9	17.8	4.5	4.2	9.1	16.6	8.8	18.5	10.1	12.1	6.1	3.3	4.6	0.0	11.9	8.6	0.1	0.5	14.4	2.7	5.7	8.0	4.4	10.5	8.6	11.3	7.0	16.1	14.9	9.5	15.9	3.1	2.6	6.8	7.3	5.2	8.7	5.9	2.2	4.5	2.6	3.5	7.0	11.3	13.2	7.7	3.4	5.3	15.3	4.9	8.3	7.0	0.0	0.2	0.5	0.1	0.1	0.6	0.2	0.5	0.1	0.1	0.5	0.4	1.1	0.3	5.3	0.2	0.3	1.1	0.4	0.2	0.2	0.9	0.8	0.2	0.3	0.7	0.2	0.9	0.2
ERCC6L2	"C9orf102, FLJ37706, RAD26L"	ENSG00000182150	"ERCC excision repair 6 like 2"	Q5T890	9	95875701-96014571	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021260, HPA022422"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021260: AB_1859544, HPA022422: "	"unprognostic (6.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (8.70e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.39e-2)"	13.5	13.9	14.6	12.7	17.4	7.6	13.6	21.8	19.3	17.7	12.9	13.2	13.9	10.4	18.7	11.8	11.6	11.4	11.8	13.3	14.0	9.7	12.4	11.7	12.7	15.0	15.3	12.2	21.7	10.6	26.2	22.0	11.7	16.1	15.5	11.5	11.0	11.2	12.7	13.9	10.1	13.5	16.1	12.1	15.8	13.4	12.5	15.4	29.7	20.3	7.1	12.4	17.4	13.8	7.3	12.7	4.3	5.3	5.1	12.9	4.0	11.3	14.3	17.0	12.2	6.7	11.4	8.2	10.1	10.3	10.2	11.7	11.0	5.0	12.8	5.6	14.3	14.0	16.4	7.0	15.2	9.1	7.9	11.5	10.9	7.1	6.5	14.6	11.5	10.1	7.2	12.6	10.0	9.5	14.9	7.2	10.6	9.1	12.2	5.5	12.7	8.7	11.4	22.2	4.5	8.7	10.3	15.9	12.2	7.1	7.4	7.2	7.0	7.6	10.1	11.5	14.7	14.2	11.9	4.8	7.3	6.2	11.1	7.0	16.6	3.2	4.4	4.3	8.7	5.3	8.4	5.7	8.3	9.3	4.8	7.3	12.9	9.4	2.7	5.1	4.2	12.7	9.9	4.0	14.6	17.4	21.8	19.3	14.0	9.7	15.3	12.2	16.1	15.4
ERF	"PE-2, PE2"	ENSG00000105722	"ETS2 repressor factor"	P50548	19	42247572-42255157	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058532, HPA067952"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA058532: , HPA067952: "	"prognostic favourable (8.07e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.27e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.54e-2)"	29.0	18.1	17.8	17.5	22.0	11.2	20.4	8.3	29.6	27.0	23.5	48.3	14.9	28.4	29.8	15.5	18.4	34.6	42.1	21.5	17.6	12.0	20.2	27.2	22.8	15.2	26.7	13.7	41.0	24.1	14.1	25.0	15.5	22.7	21.0	8.8	23.7	15.2	15.7	10.1	23.3	28.1	17.4	17.7	19.0	17.5	20.8	25.2	18.0	22.9	18.4	16.2	25.0	18.1	0.6	1.0	3.1	0.2	0.0	0.5	0.1	18.0	44.0	19.0	21.4	4.3	11.0	5.3	17.2	12.2	17.7	18.0	19.9	21.1	15.0	10.9	15.8	19.9	13.7	40.1	13.0	7.4	9.4	9.0	24.7	25.3	11.6	10.3	15.0	12.3	13.6	13.6	15.1	14.7	19.1	12.6	9.6	36.7	11.8	7.8	15.9	9.5	14.7	6.9	6.3	10.9	15.7	8.8	17.9	19.2	14.2	19.8	14.2	18.7	17.4	26.1	37.8	9.0	31.6	14.3	16.0	11.9	25.5	11.2	35.2	0.0	0.2	1.7	0.2	0.1	0.2	0.0	0.1	0.1	1.0	0.6	0.3	0.3	3.1	0.0	0.0	0.1	0.5	0.1	17.8	22.0	8.3	29.6	17.6	12.0	26.7	13.7	22.7	25.2
ERGIC1	"ERGIC-32, ERGIC32, KIAA1181, NET24"	ENSG00000113719	"Endoplasmic reticulum-golgi intermediate compartment 1"	Q969X5	5	172834275-172952685	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018666, HPA018900"	Enhanced		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA018666: AB_1848241, HPA018900: AB_1848242"	"unprognostic (8.86e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.71e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.06e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.22e-2)"	30.2	56.5	14.2	20.6	13.8	12.0	44.6	25.5	18.1	42.9	30.5	12.3	35.6	24.6	26.4	24.9	22.6	23.7	30.3	20.7	14.2	11.4	36.4	120.8	28.6	29.3	14.5	11.4	22.5	55.5	15.6	18.9	25.5	13.5	48.1	32.9	19.2	51.5	29.3	27.1	16.7	32.6	22.0	10.8	30.8	36.5	15.8	13.2	29.1	41.5	20.9	25.8	21.3	45.8	6.6	4.2	20.8	9.2	8.5	3.8	3.0	20.3	19.5	16.8	37.3	64.3	48.1	9.3	41.6	31.5	18.8	17.6	27.7	21.0	19.7	29.8	70.2	7.5	12.3	55.2	22.1	15.6	12.1	12.1	28.7	14.8	47.1	5.6	3.9	40.8	23.1	27.7	26.0	30.1	7.2	27.6	31.1	25.5	16.1	9.7	10.0	18.1	55.6	11.2	60.4	43.9	11.9	9.5	17.1	14.5	41.5	20.8	17.2	6.4	22.9	30.7	12.6	29.4	16.9	44.0	49.0	8.2	42.7	13.5	13.4	2.1	4.9	12.1	2.3	7.1	3.8	6.6	1.2	1.5	4.2	4.9	1.0	1.6	20.8	8.5	9.2	2.1	0.7	3.0	14.2	13.8	25.5	18.1	14.2	11.4	14.5	11.4	13.5	13.2
ERGIC2	"Erv41, PTX1"	ENSG00000087502	"ERGIC and golgi 2"	Q96RQ1	12	29337352-29381189	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049695	Approved		Supported	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoli	"HPA049695: "	"unprognostic (1.62e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.19e-3)"	"prognostic unfavourable (8.06e-6)"	"unprognostic (3.70e-2)"	"unprognostic (2.32e-2)"	"prognostic favourable (8.18e-4)"	"prognostic unfavourable (7.02e-6)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (3.76e-6)"	"unprognostic (6.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.64e-1)"	26.6	21.0	24.4	21.9	32.8	5.5	29.9	28.1	36.1	25.4	22.7	14.6	25.8	21.2	23.1	33.1	32.5	16.6	21.2	33.7	25.3	22.6	27.7	36.2	18.6	18.9	29.8	24.2	24.9	32.6	27.3	40.1	40.9	31.2	29.5	21.4	12.1	28.8	23.8	29.2	15.6	24.3	31.4	31.0	25.6	21.1	32.8	30.7	25.7	28.6	21.6	25.8	33.4	20.6	27.0	39.0	59.2	30.1	22.1	40.8	27.5	24.6	22.7	18.6	12.5	26.9	31.7	45.4	40.2	33.9	25.2	27.3	29.9	41.7	13.6	40.1	31.9	25.9	17.7	26.6	40.4	29.1	19.1	22.1	32.5	17.3	15.8	30.7	18.7	22.4	21.4	31.8	32.2	19.5	18.0	38.7	33.6	13.3	15.3	33.3	26.2	64.2	14.2	51.3	27.6	21.4	36.2	7.1	11.6	20.5	23.3	23.8	45.0	25.2	21.6	34.4	29.3	45.4	43.3	28.5	36.0	27.2	28.7	23.0	27.8	24.2	17.0	22.1	29.7	25.3	35.8	27.0	38.1	34.8	17.8	22.3	38.4	32.3	59.2	22.1	30.1	39.0	40.8	27.5	24.4	32.8	28.1	36.1	25.3	22.6	29.8	24.2	31.2	30.7
ERGIC3	"C20orf47, CGI-54, Erv46, NY-BR-84, PRO0989, SDBCAG84"	ENSG00000125991	"ERGIC and golgi 3"	Q9Y282	20	35542021-35557634	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015242, HPA015968"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA015242: AB_1848238, HPA015968: AB_1848239"	"unprognostic (4.36e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (2.20e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (9.81e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.64e-2)"	35.5	43.7	23.7	29.5	25.7	29.9	38.3	18.9	35.2	45.3	45.2	28.6	52.7	26.5	42.1	104.8	43.2	72.4	52.2	31.1	22.1	23.8	45.6	60.6	33.2	33.3	20.7	19.3	54.2	86.8	36.0	22.8	59.0	21.4	43.9	42.1	33.6	86.1	46.1	31.7	36.5	42.1	32.1	21.6	28.4	37.1	55.8	13.7	37.8	74.4	40.8	46.2	35.0	34.2	43.9	62.0	27.6	50.5	36.9	46.2	54.4	22.8	44.1	22.6	38.9	80.2	60.8	29.7	31.6	70.2	53.7	53.5	104.6	48.4	17.0	30.9	68.1	34.3	19.0	51.7	39.7	8.4	35.4	35.9	32.9	63.8	41.4	31.2	26.9	67.0	81.8	33.3	42.7	35.0	24.8	55.3	42.9	52.6	24.6	48.6	12.8	43.0	18.8	52.4	48.6	45.4	40.6	22.1	31.7	48.1	39.6	37.5	38.5	53.4	28.0	61.0	24.0	24.4	27.6	22.9	13.8	13.8	64.4	17.2	32.3	22.2	50.5	27.6	33.9	47.8	40.8	43.9	40.3	37.2	62.0	38.5	40.1	40.5	16.8	36.9	40.3	61.5	46.2	54.4	23.7	25.7	18.9	35.2	22.1	23.8	20.7	19.3	21.4	13.7
ERI2	"EXOD1, KIAA1504, MGC16943, ZGRF5"	ENSG00000196678	"ERI1 exoribonuclease family member 2"	A8K979	16	20780193-20900349	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 11.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.8"	"Low region specificity"	"Detected in all"							"HPA035384, HPA035385"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA035384: AB_10602316, HPA035385: "	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.28e-3)"	18.5	14.3	9.2	7.5	10.4	8.5	15.0	7.8	11.9	8.3	11.2	12.0	9.3	12.2	8.2	12.1	12.4	9.1	8.9	8.4	9.0	7.9	12.7	19.4	8.2	5.3	11.7	7.4	9.9	14.4	19.2	14.9	10.1	11.1	12.0	15.7	8.1	10.3	11.0	7.0	10.7	12.1	11.8	12.2	6.4	12.7	21.3	9.7	10.8	9.7	12.1	6.6	9.6	15.1	0.6	2.4	11.8	2.9	0.7	0.9	0.6	10.8	5.2	14.3	6.2	4.4	5.6	8.6	8.5	5.1	7.8	9.9	6.5	11.3	3.0	9.9	4.7	8.2	14.2	8.9	14.6	9.6	7.5	7.4	6.1	11.2	4.0	14.1	6.2	5.1	11.1	10.5	8.8	4.7	23.3	9.0	13.1	9.6	2.0	12.6	8.8	2.9	16.2	11.7	6.7	7.2	8.5	7.3	8.9	5.5	10.6	6.5	22.2	15.7	3.5	8.4	4.7	8.1	11.4	5.5	8.4	1.8	7.9	11.5	11.5	11.8	2.3	2.0	0.6	1.7	0.4	0.6	0.5	0.6	2.4	0.1	0.4	0.3	0.1	0.7	2.9	0.8	0.9	0.6	9.2	10.4	7.8	11.9	9.0	7.9	11.7	7.4	11.1	9.7
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100188334	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	12.9	8.0	5.4	6.9	10.1	23.2	13.9	6.7	6.1	11.3	18.6	5.7	7.0	13.8	11.9	6.6	17.9	11.2	6.8	6.8	6.2	3.7	12.3	81.4	8.7	10.1	7.3	3.8	13.9	17.7	5.9	8.8	24.2	4.7	9.2	13.5	8.2	9.8	5.7	5.5	10.8	18.9	7.7	4.1	9.7	12.7	17.4	5.4	8.6	11.8	10.3	14.3	14.7	14.6	6.2	12.6	18.2	16.0	7.5	9.0	7.0	23.1	23.1	11.8	21.4	28.5	28.0	24.1	36.9	34.3	30.5	35.2	15.4	27.1	10.3	14.9	34.1	24.2	10.5	21.7	42.3	6.2	9.4	8.9	10.4	19.5	11.8	31.0	9.8	15.8	13.2	26.7	32.4	22.0	8.7	6.3	32.1	9.4	7.9	11.4	8.4	9.6	6.8	19.4	7.5	13.1	9.2	4.8	7.7	21.0	5.9	13.0	14.7	25.7	24.9	30.6	23.6	18.2	38.7	4.9	8.3	14.1	26.9	49.1	15.0	4.3	16.0	18.2	8.5	11.7	7.6	6.2	6.6	7.0	12.6	5.5	6.8	9.0	11.6	7.5	8.6	2.9	3.8	7.0	5.4	10.1	6.7	6.1	6.2	3.7	7.3	3.8	4.7	5.4
ERLIN2	"C8orf2, Erlin-2, NET32, SPFH2, SPG18"	ENSG00000147475	"ER lipid raft associated 2"	O94905	8	37736599-37759101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002025, CAB014894"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"CAB014894: , HPA002025: AB_1080077"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-1)"	"prognostic favourable (5.16e-4)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (4.51e-4)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.78e-3)"	"prognostic favourable (6.67e-6)"	"unprognostic (4.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.33e-1)"	14.5	17.7	15.6	9.5	17.6	8.9	17.5	11.0	13.8	16.6	16.2	21.4	26.9	11.8	18.1	23.1	19.5	21.8	20.6	11.9	13.1	11.3	28.5	31.1	12.0	16.5	13.2	16.0	22.3	45.7	34.2	12.9	26.8	15.2	21.2	17.9	23.3	23.2	18.9	13.0	12.4	19.1	22.8	15.3	12.0	16.6	15.9	12.5	13.8	32.4	14.8	14.0	20.5	13.5	4.9	8.7	14.8	9.8	2.8	5.8	3.5	16.1	17.0	18.5	12.4	20.7	15.4	19.4	24.3	23.1	13.7	14.8	8.5	20.6	7.9	41.1	26.8	16.8	14.0	21.0	22.6	4.5	10.4	11.3	10.8	9.4	13.7	7.2	16.3	18.9	21.2	20.4	21.5	14.3	21.0	7.6	20.7	8.0	10.4	5.7	18.7	7.1	7.3	13.1	5.8	16.6	17.7	3.5	9.0	15.7	4.8	14.4	26.5	10.9	12.8	13.1	11.7	24.4	13.0	10.1	16.4	9.9	23.5	11.8	17.8	1.7	7.5	14.8	5.2	7.5	4.3	4.9	3.5	4.2	6.0	2.8	5.4	4.8	9.6	2.8	9.8	8.7	5.8	3.5	15.6	17.6	11.0	13.8	13.1	11.3	13.2	16.0	15.2	12.5
ERRFI1	"GENE-33, MIG-6, RALT"	ENSG00000116285	"ERBB receptor feedback inhibitor 1"	Q9UJM3	1	8004404-8026308	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 141.1;pancreas: 133.6"	"Cell line enhanced"	"Detected in many"		"HHSteC: 93.0;LHCN-M2: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027206, HPA076543"			Enhanced	Cytosol				Cytosol		"HPA027206: AB_10600908, HPA076543: "	"unprognostic (2.13e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.03e-3)"	38.6	8.8	4.4	6.3	6.3	0.6	27.8	9.6	7.0	17.5	13.6	5.4	8.4	6.8	15.9	9.6	13.6	12.2	27.3	8.8	4.7	2.5	32.6	141.1	15.5	7.7	7.5	3.7	29.7	133.6	7.7	41.9	33.7	8.1	9.3	5.1	12.0	14.5	5.9	68.3	20.2	26.5	22.9	12.5	2.1	22.3	7.4	5.2	0.6	19.4	4.7	3.8	20.0	19.5	0.4	0.3	0.2	4.9	0.0	1.3	0.2	13.2	7.8	3.3	4.5	32.0	23.9	35.1	13.0	3.8	2.4	2.8	3.4	35.0	0.2	7.8	4.3	2.8	0.9	23.0	11.2	0.4	2.5	0.2	2.3	40.4	93.0	0.1	0.5	32.5	23.2	8.0	19.5	6.1	0.9	0.1	71.0	5.7	0.0	0.8	8.0	19.5	1.1	37.9	0.2	11.2	4.2	2.3	1.3	2.5	5.9	4.0	4.0	0.3	8.6	9.4	5.5	7.9	18.3	0.2	0.1	0.2	36.4	0.6	8.7	0.0	0.4	0.0	1.3	0.1	0.2	0.3	1.2	1.3	0.2	0.4	0.9	1.2	0.2	0.0	4.9	0.3	0.6	0.2	4.4	6.3	9.6	7.0	4.7	2.5	7.5	3.7	8.1	5.2
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"				"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: , HPA053679: "	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	1.0	1.7	0.5	7.1	0.5	5.5	1.0	0.4	0.6	1.2	9.6	0.1	0.5	11.9	0.6	1.0	5.0	0.3	1.8	1.1	0.7	0.5	1.6	1.4	1.1	4.2	0.5	0.6	0.6	1.0	0.3	0.3	1.5	0.5	0.5	4.5	0.1	1.4	1.4	0.4	1.1	23.2	0.4	0.8	4.7	2.4	10.3	0.2	39.8	0.5	5.3	5.7	1.0	1.8	1.3	1.9	0.8	1.5	0.9	4.6	0.8	24.8	18.9	8.5	10.3	1.1	1.8	4.7	15.0	6.3	13.9	15.9	6.7	4.9	9.2	7.9	3.9	13.8	10.3	4.1	21.2	7.1	4.4	10.9	8.5	7.0	0.1	5.5	10.2	0.3	0.4	8.1	2.0	5.1	8.7	14.1	8.0	4.8	22.3	2.5	5.7	6.4	9.9	25.4	6.7	4.5	15.1	3.7	5.4	7.5	9.1	3.8	6.2	6.1	2.2	8.6	17.8	17.3	11.7	1.9	5.0	11.4	4.7	9.3	11.9	0.1	0.7	0.4	0.3	1.5	0.1	1.3	0.7	1.0	1.9	0.1	0.5	0.4	0.8	0.9	0.4	0.2	4.6	0.8	0.5	0.5	0.4	0.6	0.7	0.5	0.5	0.6	0.5	0.2
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.9;lymphoid tissue: 30.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (2.01e-5)"	"prognostic unfavourable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favourable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.7	0.4	0.2	7.1	0.4	7.2	0.3	0.2	0.5	3.9	2.3	0.4	0.8	4.2	0.6	0.7	17.9	0.2	0.5	1.0	1.1	0.1	1.0	0.9	0.7	4.1	0.2	0.2	0.3	0.2	0.0	0.2	3.0	0.6	0.4	1.5	0.6	2.6	0.2	0.2	2.7	4.4	0.5	0.2	3.0	0.8	10.9	0.3	30.3	0.3	2.5	7.8	0.7	6.2	0.0	0.0	0.4	0.1	0.0	1.8	0.0	12.4	12.7	13.7	11.2	0.3	1.2	8.4	8.2	4.2	14.1	9.0	6.9	11.0	22.5	4.6	3.3	10.4	15.8	4.8	7.4	7.0	16.0	15.1	11.5	5.3	0.0	9.4	12.5	0.4	0.3	8.2	4.0	7.2	20.2	20.4	4.2	13.0	14.8	8.1	11.0	6.9	13.9	14.6	9.3	2.0	5.2	9.8	7.6	6.9	10.2	5.3	16.8	6.3	3.3	7.1	13.8	6.0	11.2	15.1	14.0	15.2	4.1	8.9	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.8	0.0	0.2	0.4	0.2	0.5	1.1	0.1	0.2	0.2	0.6	0.3
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 65.1"	"Cell line enhanced"	"Detected in some"		"A-431: 33.5;BEWO: 25.7;CAPAN-2: 35.3;HaCaT: 20.5;hTCEpi: 57.7;RT4: 24.5;T-47d: 27.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: "	"prognostic unfavourable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favourable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.6	0.5	0.5	15.1	0.5	0.0	7.6	0.5	0.6	9.7	18.1	0.2	18.7	7.7	3.3	21.3	43.1	6.6	14.5	0.6	0.5	0.5	6.4	0.7	15.5	0.8	0.5	0.2	1.8	65.1	11.8	10.1	18.5	0.3	8.9	20.8	0.2	38.2	15.1	0.5	24.8	12.7	1.9	0.5	0.5	12.1	1.0	0.2	1.4	20.2	30.4	28.9	9.0	16.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	33.5	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	10.9	35.3	0.0	0.9	0.0	20.5	0.9	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.7	0.0	0.3	0.0	0.0	0.0	0.0	16.3	0.4	0.1	3.1	0.8	0.0	0.0	4.4	4.4	24.5	9.0	0.0	0.0	5.3	3.4	27.3	0.2	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.6	0.5	0.5	0.5	0.2	0.3	0.2
ESRP2	"FLJ21918, RBM35B"	ENSG00000103067	"Epithelial splicing regulatory protein 2"	Q9H6T0	16	68229111-68238102	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.2;pancreas: 41.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.1;MCF7: 35.4;RT4: 19.0;SK-BR-3: 19.0;T-47d: 29.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040751, HPA048597, HPA048618"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA040751: , HPA048597: , HPA048618: "	"unprognostic (3.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (1.30e-6)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.75e-3)"	0.4	0.2	0.2	7.6	0.5	0.0	3.9	0.6	0.3	4.7	8.0	0.6	4.1	4.6	1.2	10.2	30.1	2.1	12.4	0.6	0.3	0.1	13.4	45.2	15.6	0.2	0.2	0.2	1.3	41.5	7.0	2.5	11.3	0.7	6.6	5.6	0.8	17.3	5.0	0.3	17.6	8.5	0.6	0.2	0.2	12.8	7.0	0.3	3.0	18.4	25.7	17.1	6.4	9.4	0.0	0.0	0.0	0.8	0.0	0.8	0.0	12.2	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.0	0.0	0.1	11.5	6.1	0.0	0.5	0.0	12.7	0.0	9.4	0.0	0.0	8.3	0.0	3.4	9.2	0.1	0.0	0.1	0.0	13.4	0.0	4.4	0.0	0.0	0.0	0.0	35.4	0.0	0.0	1.3	4.1	0.0	0.0	0.0	4.8	19.0	1.3	0.0	6.1	19.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.3	0.3	0.1	0.2	0.2	0.7	0.3
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305572-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053785			Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"				"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	8.2	9.6	6.0	8.9	7.7	7.9	17.8	9.8	9.4	4.3	32.4	4.9	18.3	43.1	4.6	6.2	17.1	4.1	15.7	45.2	6.8	5.0	21.4	26.9	8.7	9.2	10.4	5.2	2.5	20.5	10.1	4.6	11.0	8.0	7.5	12.6	6.0	28.7	14.9	78.3	10.5	46.4	7.1	7.4	9.3	14.1	2.2	6.0	6.0	8.2	27.1	10.0	8.5	12.0	4.1	4.2	8.5	8.4	2.6	5.4	2.4	9.7	15.6	3.9	9.4	5.3	5.1	21.2	9.6	4.7	3.6	3.6	14.4	11.9	13.4	18.0	5.1	25.1	6.5	12.9	1.4	9.0	8.4	8.6	18.5	11.3	7.3	14.6	21.8	7.2	19.7	8.1	10.7	5.0	14.5	7.4	5.9	21.9	7.1	20.8	10.8	29.7	7.7	7.6	29.9	12.0	20.6	8.2	10.1	4.9	32.7	30.9	10.1	14.5	10.8	6.6	7.9	18.5	9.7	11.4	9.4	8.8	10.7	14.4	5.2	0.3	4.7	7.1	4.4	8.4	4.4	2.9	3.8	3.1	4.2	4.1	4.1	5.4	8.5	2.6	7.5	3.2	5.1	2.4	6.0	7.7	9.8	9.4	6.8	5.0	10.4	5.2	8.0	6.0
ESX1	"ESX1L, ESXR1"	ENSG00000123576	"ESX homeobox 1"	Q8N693	X	104250038-104254933	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	99	"testis: 25.4"	"Cell line enriched"	"Detected in some"	11	"TIME: 23.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051992	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA051992: "															"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
ESYT1	"FAM62A, KIAA0747, MBC2"	ENSG00000139641	"Extended synaptotagmin 1"	Q9BSJ8	12	56118250-56144671	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016858, HPA076926"	Approved		Supported	"Endoplasmic reticulum"			2600000	"Endoplasmic reticulum"		"HPA016858: AB_1848404, HPA076926: "	"unprognostic (5.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.29e-1)"	"prognostic favourable (3.86e-4)"	"unprognostic (3.04e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.98e-2)"	49.8	25.9	10.8	17.6	11.5	7.8	40.3	14.3	16.5	22.8	25.1	15.9	13.7	8.3	33.7	16.4	21.7	24.4	21.1	15.2	10.1	11.3	17.8	27.6	21.8	20.2	11.3	10.8	28.9	25.8	24.7	8.6	19.1	28.1	25.4	18.4	15.9	18.4	24.7	23.4	15.7	18.5	36.6	9.2	23.6	19.1	19.7	12.7	24.3	17.9	18.1	23.5	27.1	22.0	11.7	15.2	70.9	13.4	13.6	29.2	26.3	22.5	16.7	13.7	34.5	20.3	15.2	11.8	25.6	28.1	30.0	21.0	15.3	24.8	8.6	20.5	42.9	25.8	15.9	25.8	26.9	12.3	11.7	52.4	13.0	12.1	28.1	40.9	83.0	17.2	27.2	32.3	18.1	25.4	32.1	57.8	26.7	16.8	14.5	23.8	17.3	22.2	22.4	18.9	22.4	24.9	19.1	11.5	12.0	38.1	11.5	17.1	24.4	26.8	33.6	23.3	21.4	13.1	18.2	13.8	20.6	12.6	21.8	16.9	24.3	63.2	6.2	70.9	23.4	12.0	29.2	11.7	24.2	23.7	15.2	9.5	19.5	22.5	1.7	13.6	13.4	5.1	23.9	26.3	10.8	11.5	14.3	16.5	10.1	11.3	11.3	10.8	28.1	12.7
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein alpha subunit"	P13804	15	76215355-76311472	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria			6300000	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favourable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	18.8	39.9	12.8	16.4	13.6	10.7	26.1	7.6	13.4	8.6	26.4	7.3	9.6	27.5	10.1	11.1	18.9	7.7	12.6	84.4	13.3	8.5	36.4	78.3	9.8	15.7	11.9	12.9	7.8	28.1	7.6	11.0	24.0	11.8	11.2	26.0	9.4	15.8	10.8	84.0	12.3	29.2	17.3	11.8	11.7	18.5	9.7	10.8	10.8	11.9	37.9	12.8	14.8	11.5	24.6	50.7	25.2	38.8	36.0	29.3	39.4	21.7	35.9	23.8	24.9	26.8	28.6	37.5	26.3	30.5	34.2	30.7	31.7	40.7	36.5	26.5	26.1	55.9	92.3	36.6	39.9	43.8	18.0	39.7	26.1	36.6	21.9	37.9	29.7	21.4	34.7	17.3	28.9	34.5	37.5	38.0	35.0	34.3	7.8	31.7	18.5	10.8	34.3	29.6	48.8	37.6	70.1	24.9	12.6	39.9	91.2	36.1	46.8	40.2	20.2	33.4	22.7	29.2	31.7	18.5	38.0	45.0	24.0	50.5	23.6	11.2	38.8	25.2	22.1	34.5	20.8	24.6	20.8	22.7	50.7	20.2	17.0	21.1	9.9	36.0	28.4	20.3	29.3	39.4	12.8	13.6	7.6	13.4	13.3	8.5	11.9	12.9	11.8	10.8
ETFB		ENSG00000105379	"Electron transfer flavoprotein beta subunit"	P38117	19	51345169-51366418	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.6;liver: 106.6"	"Cell line enriched"	"Detected in all"	4	"Hep G2: 185.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria			640000	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favourable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favourable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	35.8	28.7	26.1	12.0	30.7	14.3	16.7	9.4	19.5	9.1	27.2	17.7	11.3	33.2	9.8	10.1	24.2	13.2	31.5	108.6	22.2	19.2	32.1	106.6	10.2	12.3	27.9	17.1	11.1	23.0	12.8	11.7	10.5	18.1	12.9	10.1	18.4	46.7	10.2	72.9	13.6	30.6	16.6	22.2	10.6	19.1	7.7	15.9	17.7	14.2	47.7	14.6	11.4	9.9	66.0	62.5	27.0	49.3	46.2	50.7	31.9	13.2	34.2	4.7	13.0	15.2	17.8	7.5	9.0	6.9	7.3	7.3	28.7	21.8	13.2	9.2	14.5	11.7	9.4	19.2	2.2	19.7	36.6	10.4	20.9	185.6	16.7	9.9	7.8	27.6	5.7	9.9	10.2	6.2	15.6	14.9	9.4	26.8	10.3	9.4	3.0	42.3	11.5	12.8	24.7	10.0	15.2	10.6	5.1	19.9	5.7	10.3	14.9	9.6	8.7	7.6	8.0	8.2	8.2	22.9	13.9	11.8	39.0	14.8	19.6	26.7	46.9	27.0	26.4	49.3	34.4	63.9	39.6	33.7	53.5	66.0	42.2	35.0	23.6	46.2	36.6	62.5	50.7	31.9	26.1	30.7	9.4	19.5	22.2	19.2	27.9	17.1	18.1	15.9
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1, persulfide dioxygenase"	O95571	19	43506719-43527244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria			13000	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	7.7	10.5	5.2	28.3	6.3	13.1	8.8	4.5	6.7	10.9	80.7	4.6	9.6	27.4	7.1	12.2	28.2	7.1	18.4	8.9	4.4	4.1	19.0	21.3	11.4	15.5	5.6	4.9	7.4	12.7	3.0	7.2	16.7	5.1	12.0	72.1	5.6	18.5	6.7	9.4	9.1	40.3	11.8	4.5	11.0	13.2	3.3	4.7	12.0	26.2	23.3	24.4	10.9	13.3	7.9	35.8	7.4	24.3	9.9	20.2	15.1	13.4	17.7	3.6	12.6	19.8	13.5	1.4	20.9	57.0	18.0	18.5	5.3	13.8	0.0	15.7	20.0	11.0	5.2	31.5	4.8	6.7	1.7	3.4	7.7	14.7	9.0	5.0	4.7	13.8	24.8	6.9	19.5	13.3	2.2	22.6	8.8	9.1	5.8	4.6	0.9	8.6	6.6	1.6	3.0	39.1	28.0	0.0	4.5	5.3	19.2	12.5	5.8	8.4	11.2	2.9	12.4	3.5	3.8	6.4	5.0	0.3	12.6	20.8	15.0	7.4	24.3	0.6	17.2	12.7	20.0	7.9	20.2	16.3	35.8	3.4	15.6	14.8	0.7	9.9	8.5	7.1	19.4	15.1	5.2	6.3	4.5	6.7	4.4	4.1	5.6	4.9	5.1	4.7
ETNK1	"EKI, EKI1"	ENSG00000139163	"Ethanolamine kinase 1"	Q9HBU6	12	22625075-22690665	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010712, HPA029407"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA010712: , HPA029407: "	"unprognostic (2.06e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (3.98e-3)"	"unprognostic (8.30e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.53e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-1)"	"prognostic favourable (1.75e-4)"	15.7	17.7	15.2	41.1	19.4	13.7	16.9	19.7	22.2	12.9	33.2	16.4	14.6	27.2	16.6	24.1	14.7	13.1	27.3	10.4	15.6	23.9	22.0	30.2	19.6	18.5	17.2	15.8	17.2	14.9	15.8	30.6	13.4	18.9	13.8	19.5	15.9	16.7	14.7	8.2	17.8	24.5	10.0	17.1	18.3	53.7	22.3	17.5	33.4	17.6	8.2	16.5	14.2	18.6	16.2	10.7	28.1	17.6	14.0	15.7	13.4	6.7	14.0	15.5	14.3	11.2	11.4	11.6	8.0	6.0	8.3	8.5	10.8	17.0	20.0	7.2	5.2	5.1	13.6	3.8	14.9	16.6	11.0	16.5	6.1	9.2	10.7	15.8	15.2	7.4	3.7	11.1	9.5	10.2	19.8	8.5	10.9	4.6	17.2	32.2	30.0	9.1	15.6	13.8	16.1	13.7	9.1	5.0	8.8	8.7	7.5	12.5	11.8	15.3	8.8	6.6	10.6	8.9	12.0	6.2	7.7	21.5	8.4	10.3	11.0	28.1	11.7	12.1	12.9	17.5	12.7	16.2	14.1	11.9	10.7	13.0	15.7	15.5	11.5	14.0	17.6	9.7	15.3	13.4	15.2	19.4	19.7	22.2	15.6	23.9	17.2	15.8	18.9	17.5
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 122.5"	"Cell line enhanced"	"Detected in many"		"HEL: 60.8;U-698: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002575: AB_563721, HPA063230: "	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	33.2	6.3	4.1	45.9	4.7	6.4	24.0	1.6	3.3	13.3	15.0	3.1	4.9	5.3	18.0	9.3	12.6	8.1	13.6	19.1	4.2	3.7	12.4	9.9	36.7	53.9	4.7	2.9	14.1	6.2	6.7	4.1	11.6	4.2	11.7	6.6	12.7	11.7	5.7	12.9	7.5	19.1	7.9	4.3	68.0	8.8	6.0	2.3	122.5	16.7	9.2	51.4	17.5	18.8	6.0	3.0	20.5	0.4	12.5	17.3	4.7	14.9	2.7	13.0	0.0	5.6	9.1	0.0	11.5	24.8	14.5	14.0	0.8	16.2	53.9	11.8	19.1	5.2	1.2	33.3	30.7	11.4	0.2	60.8	1.1	0.0	15.1	6.2	0.7	17.8	2.7	12.4	45.8	12.0	0.1	11.2	17.4	0.0	31.3	4.6	4.8	9.7	8.6	21.2	4.2	11.5	16.7	0.1	0.9	6.0	0.1	12.7	0.0	3.0	22.0	32.7	10.2	6.3	18.9	8.4	1.5	81.3	5.8	11.8	28.7	20.5	0.0	3.0	10.4	0.1	14.6	6.0	14.0	12.6	0.1	4.9	17.3	13.5	0.5	12.5	0.4	3.0	15.5	4.7	4.1	4.7	1.6	3.3	4.2	3.7	4.7	2.9	4.2	2.3
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805307-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 59.3;hTCEpi: 54.3;hTERT-HME1: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: "	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	33.6	10.4	25.8	29.6	12.8	44.7	28.5	5.5	36.5	28.4	38.1	7.3	13.7	39.7	27.0	20.3	30.1	21.8	42.6	42.9	16.2	10.8	21.2	75.5	58.3	56.9	13.8	18.2	23.6	11.7	20.0	19.7	23.2	14.2	31.4	50.6	12.9	17.6	17.4	64.2	72.4	59.0	43.3	13.6	68.7	25.8	8.3	11.0	7.2	21.5	28.4	13.7	40.8	35.5	0.2	16.5	18.5	14.9	0.1	2.5	3.6	22.9	4.9	3.4	1.1	3.9	13.3	9.2	5.4	31.4	7.2	9.5	4.4	6.5	5.0	2.6	4.8	6.8	5.8	14.5	13.7	4.6	2.3	59.3	29.8	10.8	40.4	3.6	5.8	7.9	54.3	10.1	44.3	5.7	6.0	0.0	3.1	3.4	11.0	3.9	11.1	3.3	36.1	2.2	4.6	10.1	14.9	2.7	3.6	15.3	6.3	1.2	0.3	6.7	6.1	17.2	2.5	11.0	11.8	0.1	0.0	5.0	4.1	12.3	14.3	10.1	9.2	3.3	1.7	12.3	2.0	0.2	1.6	2.5	16.5	0.2	1.6	1.6	18.5	0.1	14.9	4.0	0.1	3.6	25.8	12.8	5.5	36.5	16.2	10.8	13.8	18.2	14.2	11.0
ETV3	PE-1	ENSG00000117036	"ETS variant 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004794	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA004794: AB_1078761"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	15.2	7.0	8.9	9.2	10.1	17.8	10.9	9.0	9.3	14.2	12.7	10.2	13.1	13.0	13.1	10.6	20.8	10.8	11.3	9.4	8.6	7.7	6.4	7.4	13.0	8.1	8.9	5.7	11.8	7.2	25.9	7.5	19.5	9.9	12.7	8.6	9.7	11.0	8.1	9.9	37.2	15.1	13.2	7.1	10.7	10.4	8.9	11.0	14.4	8.4	13.6	17.0	14.0	14.3	4.4	7.4	8.9	8.1	6.6	10.8	3.8	6.9	6.8	7.1	6.0	10.7	7.1	6.0	6.4	6.8	6.5	6.1	7.2	6.8	8.3	8.3	7.9	10.7	7.8	9.9	8.5	18.1	4.9	6.9	7.1	3.8	6.4	10.9	11.0	7.9	11.8	9.7	8.1	6.6	8.0	6.1	7.2	9.1	3.3	6.1	23.1	5.3	5.0	8.4	9.5	4.9	25.9	5.9	11.6	7.0	16.8	17.1	8.5	12.0	11.1	8.2	7.3	7.9	8.1	15.0	7.8	10.1	9.5	6.4	27.0	8.3	8.1	5.4	7.9	6.7	10.8	3.8	6.9	7.8	7.4	4.4	7.2	6.3	8.9	6.6	6.2	2.2	5.2	3.8	8.9	10.1	9.0	9.3	8.6	7.7	8.9	5.7	9.9	11.0
ETV4	"E1A-F, E1AF, PEA3"	ENSG00000175832	"ETS variant 4"	P43268	17	43527844-43579620	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 38.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 45.0;Hep G2: 42.2;SK-MEL-30: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005768	Approved		Supported	Nucleoli				Nucleoli		"HPA005768: AB_1848294"	"unprognostic (2.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (1.58e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.08e-2)"	"prognostic favourable (7.60e-4)"	"unprognostic (1.69e-1)"	0.6	2.4	1.4	0.9	1.4	0.0	6.8	1.6	8.3	3.6	3.3	0.4	1.3	5.7	3.4	2.2	9.9	2.4	38.4	2.6	1.8	1.3	7.8	1.4	2.5	0.4	2.3	1.1	1.2	23.8	19.3	19.7	11.6	2.7	4.7	1.6	1.7	4.9	4.5	1.3	6.7	3.8	1.2	1.8	0.5	3.6	1.3	0.5	0.3	6.6	15.0	12.1	3.1	5.3	0.2	0.0	1.3	0.2	0.0	0.6	0.1	5.9	16.7	20.5	45.0	0.8	5.3	4.5	1.9	5.3	3.8	3.9	9.4	8.5	0.0	1.1	1.0	10.9	0.6	10.0	3.4	0.2	0.1	0.5	2.6	42.2	1.1	11.4	5.3	0.9	0.3	14.5	9.0	8.1	11.7	0.0	7.8	2.3	0.0	20.2	29.6	28.0	24.4	2.4	14.3	8.4	4.3	0.0	18.3	0.5	1.1	48.7	0.2	3.4	3.7	2.7	13.4	4.0	5.4	1.8	11.2	0.0	4.9	2.2	15.8	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.6	1.3	0.0	0.0	0.0	0.0	0.1	1.4	1.4	1.6	3.6	1.8	1.3	2.3	1.1	2.7	0.5
ETV5	ERM	ENSG00000244405	"ETS variant 5"	P41161	3	186046308-186110318	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 55.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009590, HPA063065"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB009590: AB_2101008, HPA063065: "	"unprognostic (3.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (7.85e-9)"	"unprognostic (3.52e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.84e-3)"	5.8	30.3	13.2	5.5	21.7	1.6	11.3	12.1	35.2	4.7	3.0	15.7	1.3	5.1	6.8	6.2	3.8	4.6	4.8	8.8	13.6	9.4	7.1	6.2	21.9	8.9	9.9	11.0	2.5	25.4	55.3	28.1	24.3	11.5	6.3	3.1	7.4	5.5	5.1	9.8	5.3	2.8	6.1	9.6	10.0	11.9	7.2	6.1	2.0	16.6	1.7	3.6	3.6	3.6	0.6	1.8	0.9	3.1	0.1	0.3	0.5	12.8	8.9	11.4	24.8	7.0	7.3	0.8	11.0	12.4	8.7	9.5	9.7	7.9	0.3	14.8	10.7	2.2	0.2	8.4	13.0	2.8	0.3	3.7	0.3	10.9	11.7	9.3	7.0	6.4	1.3	13.9	17.1	12.8	3.4	4.6	14.9	5.9	1.2	14.3	17.0	10.1	26.2	11.4	8.6	7.2	3.0	0.5	14.7	2.7	0.1	55.7	0.0	5.2	12.3	4.8	7.8	12.1	21.6	3.5	14.4	0.0	14.7	7.5	28.6	0.0	0.3	0.1	0.3	3.1	0.0	0.6	0.0	0.0	1.8	0.1	0.0	0.0	0.9	0.1	1.5	1.6	0.0	0.5	13.2	21.7	12.1	31.7	13.6	9.4	9.9	11.0	11.5	6.1
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.7;BJ hTERT+ SV40 Large T+: 8.2;BJ hTERT+ SV40 Large T+ RasG12V: 15.7;HDLM-2: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA029033, HPA049689"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA029033: AB_10601375, HPA049689: "	"unprognostic (1.67e-2)"	"prognostic favourable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favourable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favourable (2.95e-6)"	2.3	2.5	1.7	7.9	1.7	0.9	1.8	0.9	1.5	2.3	15.1	0.9	2.1	14.4	2.0	2.1	4.7	1.9	7.5	0.9	0.9	1.0	3.0	3.6	7.5	4.2	1.1	1.7	3.7	2.4	3.1	9.9	7.2	3.0	5.3	2.2	3.0	8.1	1.5	0.8	15.1	22.2	4.5	1.5	3.3	5.5	1.1	1.3	3.7	5.3	5.5	8.0	4.3	9.8	2.8	0.7	15.4	4.4	0.4	12.0	1.8	2.1	0.3	0.5	1.3	0.0	0.1	15.7	0.2	5.1	8.2	15.7	1.1	4.6	0.7	0.8	0.1	2.6	0.2	0.9	0.4	32.6	0.6	1.1	0.3	1.2	1.0	0.5	0.6	0.7	1.4	0.4	0.1	0.2	0.2	0.9	0.2	0.4	0.7	0.6	1.2	0.1	3.4	0.3	0.3	0.1	1.2	0.8	0.5	0.8	1.8	0.5	2.8	0.9	0.6	0.8	0.9	0.4	0.5	0.3	0.5	0.7	0.3	1.8	0.9	0.0	2.9	0.2	1.4	4.4	3.3	2.8	4.5	1.8	0.7	1.1	0.9	1.2	15.4	0.4	1.4	0.0	12.0	1.8	1.7	1.7	0.9	1.5	0.9	1.0	1.1	1.7	3.0	1.3
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.4;pancreas: 32.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;U-138 MG: 36.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	0.6	0.3	0.3	0.7	0.5	0.0	1.2	0.3	0.2	3.7	0.6	0.1	11.4	0.5	1.6	5.1	0.5	1.3	0.4	0.6	0.3	0.3	23.6	69.4	15.2	0.1	0.8	0.0	0.8	32.3	0.8	0.8	26.6	0.5	0.6	0.2	5.7	14.3	13.5	0.9	1.5	1.1	0.7	0.4	5.9	0.4	2.2	0.3	3.3	1.2	0.8	0.8	0.3	0.6	0.8	0.0	0.0	0.0	0.0	1.1	0.7	0.3	4.6	0.5	0.1	1.0	7.1	0.5	21.7	14.6	19.3	9.9	0.1	0.4	0.0	2.0	27.1	3.0	0.5	4.6	12.2	0.0	0.3	0.0	0.8	14.3	0.7	0.0	0.0	5.0	2.7	23.8	11.0	12.0	0.0	0.0	14.8	0.0	0.0	0.0	1.0	7.5	2.4	0.0	0.0	10.7	0.1	0.3	0.5	2.0	0.1	16.5	0.0	0.1	9.8	36.4	15.3	0.6	22.6	0.2	0.0	0.0	20.6	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.3	0.3	0.8	0.0	0.5	0.3
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027452	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 24.1;MCF7: 15.8;RT4: 34.9;SK-BR-3: 17.4;T-47d: 22.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"CAB002220: AB_563701, HPA053969: "	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	0.2	0.0	0.0	2.3	0.1	1.1	1.2	0.0	0.3	11.6	5.7	0.1	2.8	4.8	1.9	1.3	69.9	0.9	4.1	0.0	0.0	0.0	4.8	0.0	5.7	0.2	0.0	0.0	0.4	2.4	1.8	1.1	2.3	0.1	3.2	0.7	0.7	10.9	4.5	0.5	43.7	7.8	2.1	0.2	0.1	1.9	0.3	0.1	0.4	6.3	43.1	46.1	5.0	21.6	0.4	1.7	1.9	0.3	1.6	1.4	0.0	11.0	9.3	0.0	0.1	0.1	0.0	3.9	0.1	0.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	24.1	0.0	3.1	0.0	0.0	0.0	0.2	6.9	7.0	0.0	0.0	1.7	0.0	5.0	0.1	0.0	0.0	0.0	0.4	0.0	15.8	0.4	1.5	0.0	4.2	4.5	0.0	0.1	7.3	34.9	0.4	0.0	4.6	17.4	0.0	22.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.0	1.0	0.3	0.7	0.6	0.3	0.7	0.2	0.2	0.5	0.1	0.4	1.4	0.6	1.9	1.6	0.2	1.7	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavourable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	35.3	43.2	45.3	41.3	51.3	67.5	32.1	58.2	48.6	32.4	39.8	43.2	31.3	41.0	45.1	38.5	40.8	37.6	25.9	40.7	40.1	32.8	33.0	48.5	33.4	50.5	32.7	49.9	38.4	32.0	47.2	44.3	34.0	41.7	35.0	39.9	41.5	32.3	38.2	52.8	34.8	36.6	40.5	33.8	44.1	34.5	85.6	32.5	39.9	32.5	30.9	55.4	36.4	34.5	52.0	65.8	50.6	81.1	58.4	67.8	76.1	56.4	44.0	60.5	47.0	30.9	25.6	41.6	34.4	55.0	57.1	49.0	50.1	29.3	77.2	21.8	52.7	44.4	86.2	70.4	58.8	52.5	61.5	58.3	39.0	47.9	46.2	89.6	41.7	39.1	29.7	47.6	77.3	44.1	43.6	34.9	42.2	56.7	90.0	34.4	42.5	33.5	63.2	58.3	46.6	52.5	60.0	49.6	47.4	42.8	50.2	37.1	32.2	48.8	45.0	34.9	38.8	21.9	49.9	45.4	36.4	71.6	33.2	39.9	42.4	48.4	57.9	50.6	60.2	81.1	60.7	50.4	56.6	59.6	65.8	52.0	55.8	53.6	43.3	58.4	78.6	35.3	67.8	76.1	45.3	51.3	58.2	48.6	40.1	32.8	32.7	49.9	41.7	32.5
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA053079: , HPA069738: "	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavourable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavourable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	2.1	1.0	0.9	10.3	1.0	15.6	1.0	0.3	1.3	1.3	3.1	0.3	0.1	2.9	0.7	0.8	6.2	0.4	1.3	1.5	0.7	0.6	0.9	1.3	1.5	5.6	0.6	0.3	1.3	1.3	1.8	0.4	4.6	0.7	0.7	3.9	0.3	1.4	0.1	1.0	1.7	4.2	1.0	0.6	5.7	1.5	14.8	0.1	31.3	0.6	4.0	8.1	1.6	2.0	1.4	0.6	2.9	0.7	0.9	3.3	1.0	15.0	10.0	16.5	10.9	1.0	2.7	14.0	20.0	6.7	17.9	19.6	12.5	8.5	16.4	9.8	4.6	15.0	20.9	8.3	21.3	25.4	18.3	15.2	10.7	6.3	0.3	21.7	11.3	0.6	0.4	17.9	4.8	5.5	30.5	21.7	14.3	6.9	23.4	12.3	22.6	9.9	17.0	15.5	17.5	3.7	9.6	18.5	23.5	13.1	10.6	7.1	9.8	13.5	2.0	17.4	15.3	16.3	27.0	16.0	21.1	26.4	6.0	17.7	20.8	2.9	0.7	0.0	1.1	0.0	0.0	1.4	1.1	1.1	0.6	1.3	0.6	0.2	0.3	0.9	0.0	0.1	3.3	1.0	0.9	1.0	0.3	1.3	0.7	0.6	0.6	0.3	0.7	0.1
EXO5	"C1orf176, DEM1, FLJ21144"	ENSG00000164002	"Exonuclease 5"	Q9H790	1	40508741-40516556	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028429			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA028429: AB_2092105"	"unprognostic (9.44e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (9.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.91e-3)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (9.95e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.53e-1)"	8.6	9.1	9.9	8.6	12.4	6.5	16.9	13.9	10.4	8.6	8.4	5.5	11.1	6.9	11.7	8.9	8.5	8.4	7.5	10.3	8.5	5.9	9.9	10.7	8.3	12.3	6.4	10.2	7.5	8.1	8.4	6.9	8.1	6.5	8.9	8.4	7.3	9.0	11.8	6.2	8.2	10.0	12.5	6.1	13.8	7.2	10.1	7.5	15.7	7.3	5.8	16.9	8.6	10.8	11.8	7.9	16.4	9.8	8.6	14.9	7.0	5.4	1.9	4.9	8.1	3.3	3.0	3.4	7.4	1.9	6.7	8.1	3.5	6.6	7.3	4.6	4.7	6.8	4.7	4.9	8.0	2.4	3.0	6.4	9.3	4.8	4.0	0.0	6.4	3.1	3.1	9.2	3.4	4.2	7.3	0.0	9.5	2.3	10.0	5.0	7.3	0.7	7.7	16.6	2.9	3.3	8.4	5.9	5.2	9.5	3.4	6.0	4.8	56.5	4.6	4.6	13.8	10.3	7.1	2.2	6.8	0.0	0.6	2.0	9.1	7.5	6.6	16.4	14.9	9.8	12.3	11.8	10.4	10.7	7.9	9.8	12.8	12.4	11.3	8.6	7.2	6.4	13.4	7.0	9.9	12.4	13.9	10.4	8.5	5.9	6.4	10.2	6.5	7.5
EXOC2	"FLJ11026, SEC5L1, Sec5p"	ENSG00000112685	"Exocyst complex component 2"	Q96KP1	6	485133-693111	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032093			Supported	Vesicles			5300	Vesicles		"HPA032093: AB_10611964"	"unprognostic (1.61e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.20e-1)"	15.9	13.8	16.6	18.2	19.9	8.8	16.7	17.0	20.8	16.4	13.5	22.2	9.3	12.8	14.3	12.5	18.7	10.5	13.6	16.7	17.0	19.0	14.5	15.3	16.8	18.2	19.7	11.6	12.6	11.0	22.8	22.0	26.4	22.4	12.5	15.5	24.4	13.4	12.9	15.7	17.5	14.5	14.1	22.2	18.4	13.4	25.7	17.1	24.8	21.5	12.2	20.2	16.5	14.5	12.5	12.1	8.9	13.6	12.2	18.8	11.4	10.4	8.1	13.5	14.7	12.4	11.2	8.3	9.5	11.1	11.4	13.6	10.3	5.6	7.8	23.4	11.3	9.1	15.1	16.5	13.6	24.3	16.1	9.9	9.7	10.2	15.5	10.5	9.9	9.7	13.5	8.1	9.5	19.0	19.4	5.7	14.1	9.1	14.0	10.3	13.7	7.8	13.3	11.7	15.6	10.2	11.4	13.3	7.8	7.5	4.6	14.9	12.0	6.5	27.6	10.3	7.6	12.8	8.7	14.2	28.3	8.3	10.5	8.8	31.5	8.9	7.8	8.6	15.7	9.5	18.8	12.5	15.9	16.4	12.1	12.0	15.2	14.5	2.5	12.2	13.6	9.9	17.2	11.4	16.6	19.9	17.0	20.8	17.0	19.0	19.7	11.6	22.4	17.1
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92834713-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: "	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favourable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	9.7	19.4	15.3	8.5	16.9	11.6	9.4	18.9	16.2	7.4	9.6	4.5	5.1	8.3	7.3	7.5	4.9	6.3	10.3	7.0	15.5	8.6	7.0	10.8	12.0	16.7	6.1	12.8	5.4	12.5	8.2	17.8	34.6	8.1	9.4	10.8	3.5	7.2	5.0	29.3	6.2	9.8	12.8	6.7	12.6	7.6	10.0	8.1	13.5	29.1	10.2	8.2	9.5	8.2	4.9	7.6	21.2	3.4	1.8	2.5	1.7	8.4	10.6	11.3	7.4	0.6	0.7	4.0	3.9	10.8	3.5	4.4	3.9	7.2	9.6	8.2	1.8	5.4	9.1	2.4	4.5	8.5	9.2	13.9	3.7	5.0	4.4	15.1	12.5	1.0	1.3	3.2	2.1	46.2	11.7	6.4	1.7	4.5	6.3	9.8	1.5	3.1	9.6	4.9	5.0	7.7	5.7	3.8	5.3	4.0	4.1	5.0	8.0	8.0	9.4	0.2	3.7	3.3	6.3	4.8	5.1	7.8	1.2	17.0	4.0	3.7	3.4	10.1	2.2	2.7	2.2	4.7	2.5	2.1	3.4	4.9	2.1	2.4	21.2	1.8	2.6	7.6	2.3	1.7	15.3	16.9	18.9	16.2	15.5	8.6	6.1	12.8	8.1	8.1
EXOC8	"EXO84, Exo84p, SEC84"	ENSG00000116903	"Exocyst complex component 8"	Q8IYI6	1	231332753-231337852	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027438	Approved		Supported	Cytosol				Cytosol		"HPA027438: AB_1848318"	"unprognostic (3.85e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	12.1	9.3	10.4	11.2	9.6	22.1	10.3	14.8	12.8	8.6	8.6	9.9	9.5	8.8	9.3	7.6	11.1	8.5	7.7	9.0	9.2	10.3	9.2	11.2	9.5	12.6	9.1	9.9	11.2	11.2	17.1	11.9	14.4	11.9	8.7	7.3	6.7	9.5	9.9	26.7	12.2	11.4	6.8	9.0	13.0	10.1	6.7	9.3	16.9	12.9	9.2	13.3	7.7	9.9	1.8	2.1	6.0	3.8	2.0	3.5	1.2	7.3	8.1	5.0	5.0	13.0	10.6	12.1	9.0	7.6	6.8	6.5	7.7	7.4	8.4	8.1	9.0	12.1	7.1	9.7	7.5	10.8	17.4	5.0	10.3	4.8	7.3	8.8	14.1	10.6	10.7	10.1	9.7	8.3	9.3	20.0	10.8	3.8	8.2	5.5	7.6	7.0	5.5	7.7	10.7	8.6	8.5	6.6	7.1	9.1	12.0	8.8	11.5	12.9	11.3	9.2	6.6	12.3	15.8	15.0	8.6	9.1	10.6	8.0	11.6	4.5	1.8	3.3	1.3	2.3	1.6	1.2	1.7	1.5	1.3	1.8	2.0	3.5	6.0	2.0	3.8	2.1	1.5	1.2	10.4	9.6	14.8	12.8	9.2	10.3	9.1	9.9	11.9	9.3
EXOG	"ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b"	ENSG00000157036	"Exo/endonuclease G"	Q9Y2C4	3	38496127-38542161	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012531, HPA071050"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA012531: , HPA071050: "	"unprognostic (2.88e-1)"	"unprognostic (5.81e-3)"	"unprognostic (3.55e-3)"	"unprognostic (2.77e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.10e-2)"	"prognostic favourable (1.92e-5)"	"prognostic unfavourable (4.90e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	7.4	9.9	14.1	12.8	14.2	8.1	6.6	18.5	14.1	8.2	8.0	10.5	6.6	5.4	9.7	8.9	5.2	7.4	9.0	22.8	11.7	9.1	7.2	5.8	7.2	12.9	11.1	11.0	8.0	7.4	7.6	16.8	7.3	8.7	9.4	8.2	6.8	5.9	9.3	9.5	4.8	8.1	11.2	8.0	10.8	6.6	9.7	11.2	11.5	8.7	4.0	11.0	9.0	6.4	24.5	6.8	2.1	5.2	12.0	13.6	2.6	3.7	6.6	7.6	6.6	5.2	7.6	3.1	11.9	7.7	10.4	11.8	6.0	3.7	12.9	3.2	4.8	3.8	9.6	4.2	8.8	14.4	8.6	9.7	10.0	6.3	6.3	10.5	8.1	5.9	4.6	9.3	4.9	14.0	4.4	8.6	16.5	2.4	7.3	3.5	7.3	8.5	4.8	4.2	5.7	5.4	5.0	3.5	1.8	7.4	1.8	3.2	2.6	5.0	11.7	8.7	6.1	9.2	9.6	4.8	8.2	11.8	6.5	9.1	6.2	0.4	5.0	2.1	13.6	4.4	11.9	24.5	13.0	13.0	3.4	22.4	13.1	13.0	0.2	12.0	5.2	6.8	5.8	2.6	14.1	14.2	18.5	14.1	11.7	9.1	11.1	11.0	8.7	11.2
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099881	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favourable (5.27e-4)"	"unprognostic (1.33e-1)"	28.2	21.8	30.4	22.1	31.9	30.8	27.9	58.8	34.7	24.8	22.0	31.9	22.4	18.5	27.0	22.9	27.6	22.7	18.3	18.3	27.8	16.2	22.4	18.2	20.8	26.0	31.5	26.3	31.2	24.2	23.1	32.1	23.5	24.3	22.1	25.9	20.4	24.6	20.5	27.3	33.2	22.7	25.6	23.2	26.0	25.2	20.3	32.7	28.2	20.8	12.5	29.9	23.6	24.6	21.0	21.6	24.8	26.4	27.5	25.9	22.3	23.1	14.8	31.1	12.0	16.6	18.4	17.8	22.9	16.9	40.4	36.8	21.8	33.9	23.4	14.9	21.7	23.1	34.3	25.5	37.2	26.2	34.4	34.0	29.1	22.2	16.3	27.6	27.1	14.4	22.1	39.6	23.4	25.1	35.6	21.6	22.2	13.1	27.1	25.5	20.6	17.8	28.0	26.5	20.4	23.7	11.9	20.1	19.6	24.7	21.4	27.4	18.7	25.5	22.7	21.6	22.5	19.3	26.8	13.1	20.5	46.3	22.0	41.2	25.8	24.8	18.2	14.6	22.2	23.4	25.9	21.0	23.1	22.1	21.6	19.9	19.8	22.0	3.6	27.5	26.4	11.0	21.8	22.3	30.4	31.9	58.8	34.7	27.8	16.2	31.5	26.3	24.3	32.7
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA021756: , HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	13.0	14.2	14.4	18.6	17.0	12.7	17.9	22.7	18.0	16.1	14.3	15.8	13.6	11.0	18.7	10.1	16.6	19.0	11.7	12.5	15.8	12.5	14.3	18.4	11.1	16.7	18.5	17.3	22.1	25.0	19.6	12.6	13.1	13.9	13.9	17.4	14.6	14.1	13.7	22.3	13.1	11.5	18.7	12.3	14.0	13.4	8.4	17.6	17.3	14.2	15.7	21.3	15.8	13.9	11.0	10.4	5.6	7.9	16.8	11.7	7.7	13.7	28.2	16.9	14.9	6.1	6.9	12.3	20.7	10.0	20.8	16.1	22.7	12.0	27.4	11.4	11.1	25.2	26.9	20.7	23.0	16.2	13.1	21.9	27.6	15.8	11.5	33.0	14.5	8.8	7.8	29.1	34.1	14.7	23.8	11.9	14.4	24.5	23.2	9.2	20.9	18.3	18.3	31.0	29.9	9.7	12.8	10.4	11.6	24.2	18.5	10.9	19.2	11.9	8.9	20.5	15.9	18.2	29.2	6.1	24.0	41.6	14.6	19.3	16.0	1.5	7.7	5.6	10.9	7.9	11.2	11.0	11.0	9.2	10.4	10.4	11.7	10.0	2.0	16.8	5.4	6.8	9.9	7.7	14.4	17.0	22.7	18.0	15.8	12.5	18.5	17.3	13.9	17.6
EXOSC3	"CGI-102, hRrp-40, hRrp40p, p10, RRP40, Rrp40p"	ENSG00000107371	"Exosome component 3"	Q9NQT5	9	37766978-37801437	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020485	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA020485: AB_10960685"	"unprognostic (7.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (7.01e-5)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (7.39e-4)"	"unprognostic (1.71e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	14.5	18.2	14.9	18.8	16.3	11.5	16.7	29.2	19.2	14.2	14.0	14.3	12.9	16.1	14.8	13.2	20.6	12.2	8.6	11.5	13.5	13.2	13.2	16.3	10.8	20.6	17.4	8.2	16.0	11.3	13.0	18.1	13.6	14.1	15.9	13.0	13.2	13.5	14.6	14.9	11.9	12.0	17.9	11.7	16.0	15.8	26.9	18.7	23.1	14.6	13.3	22.5	12.9	15.7	34.5	32.6	22.9	33.7	24.4	32.9	33.7	25.7	18.5	9.9	12.7	6.8	5.4	13.2	15.0	5.9	12.5	11.8	24.1	4.4	20.1	11.3	5.5	10.1	11.0	10.4	14.5	27.9	18.1	16.2	22.4	22.2	7.8	24.6	14.9	3.9	5.4	9.8	6.2	6.5	40.0	9.4	8.9	15.7	21.9	19.7	26.9	20.8	20.0	12.3	10.8	7.0	8.9	14.5	14.6	8.5	7.0	9.4	9.3	18.1	7.5	10.2	18.5	12.5	23.3	6.6	16.5	26.6	10.1	19.4	11.2	17.8	29.8	22.9	25.0	33.7	31.9	34.5	30.3	32.9	27.7	30.5	30.6	29.5	18.2	24.4	29.8	32.6	32.1	33.7	14.9	16.3	29.2	19.2	13.5	13.2	17.4	8.2	14.1	18.7
EXOSC4	"FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p"	ENSG00000178896	"Exosome component 4"	Q9NPD3	8	144078626-144080647	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024792	Approved		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA024792: AB_1848325"	"unprognostic (2.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.36e-2)"	"prognostic favourable (2.23e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.11e-2)"	12.3	16.7	12.8	11.4	17.6	13.8	8.9	13.9	20.6	8.1	12.0	10.5	13.6	15.8	9.8	10.4	14.5	10.0	9.3	16.5	11.4	11.2	14.9	21.5	8.7	11.4	11.5	13.0	10.3	15.0	8.0	10.2	11.5	12.0	12.1	6.5	11.6	28.0	14.7	12.1	12.7	11.1	6.7	9.3	13.4	13.9	45.0	9.7	14.8	10.8	10.4	11.1	8.7	7.8	24.7	38.2	19.0	31.8	17.1	16.1	18.8	10.2	22.5	4.0	9.6	3.5	2.6	11.0	8.0	3.3	6.3	6.4	15.7	7.2	6.2	11.7	3.3	8.4	7.4	8.8	1.8	8.1	25.0	8.9	16.8	17.4	5.8	6.6	10.6	3.8	9.0	7.3	5.8	3.2	13.9	4.2	5.1	37.2	10.2	13.1	10.4	90.3	4.5	6.6	16.0	6.0	10.4	12.6	16.7	10.0	13.0	18.5	14.7	10.0	3.2	6.5	14.2	15.5	13.6	11.2	13.4	7.7	9.4	10.6	10.1	19.0	31.8	12.5	15.9	29.4	16.1	22.0	12.4	15.4	29.8	24.7	15.9	15.4	9.2	17.1	16.1	38.2	13.7	18.8	12.8	17.6	13.9	20.6	11.4	11.2	11.5	13.0	12.0	9.7
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397479	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA053150: , HPA055677: "	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	9.1	14.3	12.6	12.3	16.6	13.1	11.1	7.6	21.3	8.8	12.1	10.8	9.0	10.0	8.1	6.0	14.6	13.6	6.4	11.6	12.0	10.3	7.9	25.1	5.7	17.0	13.4	9.9	13.2	46.9	3.2	4.9	6.5	10.3	9.5	6.6	6.3	14.0	8.1	30.9	18.5	9.5	6.6	14.0	12.7	9.8	7.5	11.8	16.8	15.1	15.7	12.2	11.3	8.6	22.9	36.8	3.3	23.7	17.1	21.1	13.5	17.8	33.5	4.7	13.8	3.0	3.8	11.0	7.6	3.6	12.4	10.3	19.5	13.2	27.9	19.7	3.7	6.8	9.3	8.5	3.9	17.8	32.1	12.4	12.6	14.8	9.6	22.4	12.3	4.7	19.1	10.0	9.6	5.8	16.6	20.1	4.1	23.4	19.3	15.8	16.6	16.6	18.3	12.9	25.1	5.0	12.8	18.1	13.6	10.9	18.3	18.5	8.5	27.7	4.6	13.1	11.0	8.3	23.3	31.7	40.5	30.3	10.2	32.3	11.1	3.3	21.7	0.6	13.2	23.7	15.8	21.1	14.4	13.3	34.1	22.9	21.1	18.5	1.5	17.1	14.0	36.8	11.1	13.5	12.6	16.6	7.6	21.3	12.0	10.3	13.4	9.9	10.3	11.8
EXOSC7	"EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p"	ENSG00000075914	"Exosome component 7"	Q15024	3	44975241-45036066	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036182, HPA057980"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA036182: AB_10673346, HPA057980: "	"unprognostic (1.69e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.67e-3)"	"prognostic favourable (2.69e-4)"	"unprognostic (4.33e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.20e-1)"	13.2	37.1	11.2	14.2	18.8	13.0	17.2	16.5	17.6	17.7	11.9	15.8	14.2	10.5	17.7	17.8	21.1	14.8	12.5	23.4	17.4	12.9	17.0	18.8	12.1	15.6	13.3	15.5	16.1	18.6	11.3	17.6	13.9	15.8	14.7	10.0	16.2	14.4	17.8	30.3	33.2	10.8	15.7	9.3	12.9	15.6	26.0	11.9	14.8	18.2	19.6	18.3	16.5	17.1	27.4	27.6	3.0	17.7	22.7	23.6	17.8	18.5	17.3	14.1	11.4	14.8	16.4	12.8	8.0	13.1	17.8	18.5	28.7	14.9	23.6	12.8	14.0	10.5	17.4	22.4	14.5	15.8	15.4	20.4	19.7	27.7	29.0	28.5	8.4	14.3	14.3	19.4	39.7	17.1	31.9	11.7	12.5	19.2	20.3	50.9	16.9	24.6	10.3	13.1	35.7	15.9	26.4	6.5	9.9	11.5	9.9	11.9	14.6	23.7	12.1	9.1	13.7	15.0	21.9	14.9	13.8	28.0	13.5	40.2	8.0	2.0	17.7	3.0	17.2	17.1	19.1	27.4	20.0	17.8	27.6	20.9	23.6	18.9	0.9	22.7	12.0	16.7	18.9	17.8	11.2	18.8	16.5	17.6	17.4	12.9	13.3	15.5	15.8	11.9
EXOSC8	"bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p"	ENSG00000120699	"Exosome component 8"	Q96B26	13	36998816-37009613	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034240, HPA039702, HPA043942, HPA075230"	Uncertain		Supported	"Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center, Vesicles"		"CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: , HPA075230: "	"unprognostic (8.67e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.32e-3)"	"prognostic unfavourable (8.39e-7)"	"unprognostic (9.58e-3)"	"unprognostic (7.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.51e-1)"	15.1	14.5	16.0	18.0	15.7	24.5	20.1	15.4	16.3	17.3	17.1	16.7	13.5	13.0	15.6	15.2	18.8	16.3	10.1	16.8	14.9	12.7	16.5	22.9	15.5	22.8	19.8	15.5	19.4	14.5	6.9	15.3	21.6	15.2	18.3	19.8	12.6	13.1	14.4	22.5	16.2	20.0	19.3	18.5	20.0	14.9	30.4	19.6	31.5	18.9	21.1	24.6	20.4	14.5	27.6	23.5	9.3	16.0	18.0	30.7	21.3	12.8	9.8	28.0	18.9	8.6	9.1	21.4	20.1	14.1	27.7	22.6	21.3	26.4	18.7	8.8	11.2	18.1	27.3	19.6	32.7	27.2	23.0	50.9	10.8	25.8	11.1	41.0	17.5	5.4	14.9	18.8	30.3	21.0	24.1	11.8	19.4	16.7	20.8	33.4	29.2	12.9	13.6	28.6	15.2	15.4	9.2	7.2	13.8	10.9	12.5	17.8	9.6	32.8	10.4	10.1	14.5	12.3	26.5	6.9	8.2	39.8	16.0	29.3	18.6	9.3	13.0	9.2	19.2	16.0	19.9	27.6	24.6	22.7	14.3	22.9	30.7	28.5	2.8	18.0	15.7	23.5	22.2	21.3	16.0	15.7	15.4	16.3	14.9	12.7	19.8	15.5	15.2	19.6
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801317-121817021	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: "	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	12.5	12.7	10.1	18.9	14.7	29.7	13.9	16.8	18.6	11.2	9.7	8.1	12.5	7.5	12.5	12.4	13.3	11.8	7.8	13.1	13.5	11.3	11.3	14.0	11.9	19.8	11.3	12.2	12.6	10.4	14.2	15.5	12.1	12.9	10.3	12.0	9.6	10.9	8.9	17.6	12.1	10.3	10.6	11.7	14.2	10.4	36.7	10.0	33.7	9.2	15.4	18.9	12.2	10.5	19.9	15.9	20.1	17.7	11.6	23.6	14.0	19.2	9.1	24.6	14.6	3.9	7.9	12.0	25.1	14.5	36.0	27.8	9.8	16.2	33.9	6.2	15.6	6.9	26.5	11.7	32.1	15.0	12.2	17.0	14.0	12.6	8.1	28.8	15.8	6.0	6.1	25.1	7.2	17.7	29.1	13.4	33.6	11.3	44.0	22.2	12.9	10.7	24.6	41.2	15.2	12.3	6.3	15.7	16.5	9.2	13.7	15.2	11.7	18.6	10.7	16.1	23.8	13.5	24.2	19.6	14.8	40.7	16.7	20.1	10.6	12.0	13.3	20.1	18.7	17.7	18.4	19.9	20.5	23.6	15.9	19.9	23.3	20.7	3.3	11.6	17.0	15.7	21.6	14.0	10.1	14.7	16.8	18.6	13.5	11.3	11.3	12.2	12.9	10.0
EXT2	SOTV	ENSG00000151348	"Exostosin glycosyltransferase 2"	Q93063	11	44095549-44245429	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078409			Supported	"Golgi apparatus"			20000000	"Golgi apparatus"		"HPA078409: "	"unprognostic (5.87e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.77e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (5.36e-6)"	"unprognostic (7.07e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.36e-2)"	24.5	19.5	11.6	17.2	18.5	6.6	25.8	14.5	23.0	26.8	25.0	15.5	17.5	17.6	37.1	25.5	16.7	26.0	23.4	22.7	11.7	13.0	19.2	36.3	22.3	16.8	11.8	12.3	29.3	21.8	25.7	17.3	58.0	16.2	23.7	20.6	22.9	24.7	22.8	16.9	20.2	34.0	35.0	12.2	18.7	19.3	20.0	11.4	16.2	24.7	16.7	13.0	20.2	23.2	6.7	14.9	13.0	12.0	17.8	17.6	9.8	12.9	17.9	9.7	30.2	44.8	33.0	13.4	40.2	50.3	23.8	32.4	12.7	8.9	8.9	18.3	47.0	20.6	10.4	28.5	28.8	17.9	14.3	8.2	9.4	9.7	17.7	8.2	17.8	25.6	18.9	14.4	22.5	33.8	11.0	16.2	17.3	9.9	5.7	5.0	10.4	12.8	7.2	27.8	4.5	13.7	12.3	7.0	7.8	25.4	10.4	6.7	17.3	8.8	30.5	32.2	21.1	31.5	25.7	7.3	9.5	6.5	21.2	6.4	34.3	9.3	11.9	13.0	15.6	12.0	17.6	6.4	12.5	14.4	14.9	6.7	11.9	11.7	2.6	17.8	8.5	5.1	9.6	9.8	11.6	18.5	14.5	23.0	11.7	13.0	11.8	12.3	16.2	11.4
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 45.5;pituitary gland: 30.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.4;RH-30: 12.7;SH-SY5Y: 31.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"NK-cell: 9.8"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028917			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA028917: "	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	1.0	1.1	2.8	0.6	16.8	0.5	0.6	0.2	6.8	4.0	0.6	1.9	0.0	0.7	0.6	2.2	1.0	2.5	0.8	4.6	2.8	2.2	0.6	0.5	1.0	0.6	2.9	2.8	0.8	0.6	45.5	30.8	0.6	4.2	12.4	0.7	15.3	1.2	4.6	3.2	0.6	0.7	3.9	0.4	0.7	0.9	1.3	5.1	4.4	0.9	2.9	0.6	3.5	5.7	0.8	1.9	1.8	2.3	9.8	2.3	0.2	0.1	0.0	3.7	16.4	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.9	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	1.2	0.9	0.0	12.7	5.4	0.0	0.0	1.3	31.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.2	1.8	0.3	0.6	0.9	0.9	1.9	0.8	0.7	1.9	0.7	0.8	1.3	1.4	1.6	9.8	2.3	1.9	2.3	0.2	2.8	16.8	0.2	2.8	2.8	2.2	2.9	2.8	4.2	5.1
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 47.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 13.4;SCLC-21H: 20.4;U-266/70: 38.0;U-266/84: 46.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"memory B-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"B-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol				Cytosol		"HPA027024: AB_1848334, HPA059291: "	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favourable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	10.5	2.0	6.5	2.6	7.4	0.8	13.4	2.4	6.5	47.4	6.4	3.8	21.0	1.0	15.7	10.7	25.9	28.2	2.2	4.3	7.0	4.1	5.2	1.8	2.3	1.3	6.3	4.9	5.2	2.4	11.5	4.7	5.9	9.1	18.5	3.2	15.4	28.6	27.3	2.1	4.2	1.1	2.3	7.2	1.1	8.2	4.9	5.1	14.3	21.4	3.6	14.0	5.5	17.3	2.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.1	13.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.3	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	20.4	0.0	0.0	9.1	0.0	1.8	0.0	0.0	0.0	1.6	0.1	3.0	38.0	46.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	7.4	2.4	6.5	7.0	4.1	6.3	4.9	9.1	5.1
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088696	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA052432: , HPA062889: "	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favourable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	12.8	10.0	14.9	24.0	12.9	8.6	13.3	21.9	13.8	14.7	10.2	14.4	12.8	10.7	14.4	12.4	19.4	11.8	8.1	11.7	10.6	11.8	21.6	11.3	12.5	15.6	11.1	8.8	12.4	12.9	20.9	29.2	13.8	12.9	11.8	11.7	16.4	11.8	13.1	14.5	16.3	12.2	10.5	10.1	14.2	10.0	20.6	13.7	17.4	17.3	12.2	25.0	10.7	13.8	8.6	12.4	10.5	11.2	10.4	12.1	2.6	10.4	4.4	8.9	6.6	10.4	8.1	5.0	7.6	7.3	9.0	8.9	4.3	6.4	16.5	8.5	5.2	10.2	16.4	6.3	10.7	8.7	9.2	18.8	8.9	7.6	6.2	18.1	17.3	4.9	5.7	9.9	6.7	11.5	17.2	6.5	8.0	4.5	11.5	12.1	18.7	5.8	8.8	16.4	10.5	10.6	5.8	10.3	5.7	8.2	5.2	7.3	4.2	4.8	11.0	10.8	5.8	9.9	6.3	9.6	9.6	15.3	7.8	17.6	4.7	7.5	11.2	10.5	12.1	10.4	10.8	8.6	9.5	8.7	12.4	7.6	8.3	9.4	9.7	10.4	8.3	7.7	8.2	2.6	14.9	12.9	21.9	13.8	10.6	11.8	11.1	8.8	12.9	13.7
EZH1	"KIAA0388, KMT6B"	ENSG00000108799	"Enhancer of zeste 1 polycomb repressive complex 2 subunit"	Q92800	17	42700275-42745049	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005478, HPA077684"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA005478: AB_1848340, HPA077684: "	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.74e-2)"	21.7	10.4	15.0	10.1	25.0	9.9	18.7	39.6	26.1	18.4	15.1	21.4	10.0	9.7	29.8	21.2	10.6	18.8	9.7	17.2	19.0	11.2	13.6	5.3	12.6	14.0	13.7	22.0	38.2	8.1	20.0	19.1	9.3	25.6	13.1	12.1	21.5	10.7	19.3	25.4	16.0	14.0	16.4	19.9	16.0	10.6	8.6	16.7	11.9	15.0	7.5	14.9	16.0	15.9	6.2	6.0	18.8	5.4	4.8	8.3	2.3	5.4	5.8	7.9	5.4	31.7	19.2	6.7	8.8	8.1	7.3	7.5	2.7	6.8	8.3	5.5	9.3	12.4	5.1	5.9	10.6	9.2	9.2	2.8	10.7	3.3	10.9	6.2	6.9	10.9	10.7	5.5	13.4	5.9	7.5	11.7	6.4	2.3	10.0	7.9	2.1	3.0	6.6	8.0	8.8	7.6	5.8	5.4	4.3	4.9	2.4	5.8	8.4	4.0	6.1	7.9	3.3	9.2	5.5	12.3	6.2	4.9	5.6	6.4	4.0	10.2	5.2	6.9	5.9	5.4	8.3	5.7	5.2	6.0	1.9	6.2	7.7	5.7	18.8	4.8	3.3	6.0	5.7	2.3	15.0	25.0	39.6	26.1	19.0	11.2	13.7	22.0	25.6	16.7
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavourable (8.18e-12)"	"prognostic favourable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	16.9	7.9	27.1	18.0	0.8	1.4	14.8	13.2	5.3	10.9	11.0	11.9	19.6	29.9	6.4	4.9	10.4	13.9	4.5	13.9	42.8	13.9	12.7	9.8	9.2	2.2	28.4	10.5	1.2	2.6	8.1	4.3	6.4	27.1	19.9	9.7	19.2	55.1	23.7	21.5	10.7	34.1	15.2	18.5	5.0	8.1	25.9	16.5	16.6	12.6	4.3	9.2	12.2	3.9	11.6	5.4	23.1	23.6	17.9	19.4	30.1	10.6	19.4	22.7	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819412	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"			75000000	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: , HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favourable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	22.8	56.4	30.9	31.2	31.4	24.7	13.3	4.0	21.5	18.0	45.5	28.2	35.2	33.8	9.8	25.8	71.8	25.1	30.2	34.3	37.6	13.9	53.5	16.2	44.3	36.7	14.8	19.0	20.7	33.0	77.1	14.6	125.1	23.5	21.7	22.8	37.0	27.4	32.0	13.6	47.5	87.9	22.8	12.8	26.0	55.4	21.4	22.2	41.6	37.1	34.4	75.6	38.2	25.3	81.7	30.0	24.3	31.2	20.7	61.7	41.1	87.0	47.6	11.8	16.9	1.3	1.4	68.9	27.4	9.0	30.9	26.1	55.7	48.3	87.7	27.2	31.3	66.8	23.2	30.5	35.9	30.6	15.0	1.8	28.9	24.6	31.4	21.7	13.5	2.3	23.7	29.1	28.3	20.2	17.3	43.0	17.9	22.9	30.7	26.2	19.6	15.9	23.1	5.5	19.9	63.5	26.5	21.4	17.5	47.9	69.1	5.2	16.8	28.7	26.1	10.0	32.1	13.7	42.1	29.7	27.0	75.2	6.2	11.2	11.9	24.3	14.0	16.4	34.8	31.2	41.0	81.7	36.7	42.9	30.0	67.5	19.9	26.5	6.1	20.7	30.6	14.0	61.7	41.1	30.9	31.4	4.0	21.5	37.6	13.9	14.8	19.0	23.5	22.2
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021348	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;HaCaT: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 44.5;neutrophil: 32.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"			41000000	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: "	"unprognostic (1.60e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.72e-3)"	"unprognostic (5.01e-2)"	20.7	13.3	3.0	9.6	3.6	6.4	11.8	2.0	3.5	14.5	36.3	3.9	21.4	20.5	8.6	11.2	41.5	12.3	30.5	10.0	3.4	3.2	35.9	69.8	55.0	10.4	3.6	1.8	10.9	37.9	18.5	16.3	61.8	5.3	17.8	19.5	5.7	59.3	23.7	9.0	22.0	59.8	4.9	4.0	27.0	18.8	11.0	3.3	8.1	52.2	25.8	29.9	16.8	19.7	1.3	7.0	44.5	8.9	2.2	3.8	6.6	28.5	3.7	1.1	0.3	0.8	0.0	23.3	0.1	0.0	1.0	1.0	26.4	37.7	2.1	19.4	0.0	49.4	5.8	24.5	1.5	1.6	4.3	6.0	1.5	12.0	1.1	5.6	17.8	0.3	31.0	0.1	8.2	23.2	8.1	0.6	0.1	12.3	1.7	3.2	19.7	5.3	2.6	0.0	9.2	16.6	21.7	8.2	2.1	6.9	29.7	6.1	32.3	10.0	13.9	0.1	0.7	0.1	0.2	6.9	13.6	0.7	4.4	5.5	1.8	7.6	8.9	44.5	3.8	4.5	2.0	1.3	3.5	2.3	7.0	0.9	3.4	2.7	32.2	2.2	3.4	5.3	1.5	6.6	3.0	3.6	2.0	3.5	3.4	3.2	3.6	1.8	5.3	3.3
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888860-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.4;breast: 30.7;lung: 33.0"	"Group enriched"	"Detected in some"	7	"HEL: 24.3;HMC-1: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favourable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	69.4	3.3	0.2	2.6	0.4	1.3	30.7	0.2	0.6	1.3	16.9	0.4	0.5	1.9	1.3	1.9	4.3	1.0	4.5	9.7	0.5	0.2	5.0	0.8	33.0	2.6	0.2	0.3	3.9	12.3	0.5	2.3	1.1	1.4	1.4	1.5	1.3	1.0	0.8	6.5	2.2	4.4	1.1	0.2	3.0	5.4	2.5	0.2	0.3	27.1	2.3	1.5	3.4	1.9	5.3	4.3	5.8	2.5	3.9	3.3	3.2	0.2	0.2	0.7	0.3	0.1	0.2	0.7	0.4	0.0	0.2	0.1	0.4	0.7	0.5	0.5	0.2	0.6	0.1	0.2	0.2	0.3	0.3	24.3	0.9	0.4	0.2	0.3	9.8	0.0	0.1	0.3	0.2	0.8	1.9	1.0	0.1	0.3	0.3	2.4	0.3	0.2	0.2	0.2	0.7	0.2	0.5	0.4	0.2	0.2	0.1	0.1	0.5	1.6	0.9	0.5	0.5	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.4	5.8	2.5	1.6	2.2	1.4	2.1	3.9	2.4	1.9	0.8	5.3	3.3	3.1	5.3	3.9	1.8	4.3	1.7	3.2	0.2	0.4	0.2	0.6	0.5	0.2	0.2	0.3	1.4	0.2
FAAP100	"C17orf70, FLJ22175"	ENSG00000185504	"Fanconi anemia core complex associated protein 100"	Q0VG06	17	81539885-81553961	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023954, HPA024626, HPA026532"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (1.00e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.24e-1)"	11.4	10.0	7.7	21.1	8.6	9.8	13.4	33.2	10.9	9.0	12.2	13.4	9.6	13.0	11.1	13.6	11.7	11.0	22.6	9.0	6.9	7.1	11.7	19.3	9.6	20.0	8.4	7.6	12.7	20.1	9.7	14.1	9.6	6.9	12.5	5.5	12.8	15.9	11.9	9.4	16.8	14.0	14.0	7.0	23.8	11.1	11.3	5.9	16.7	15.1	14.5	15.5	9.9	9.2	6.1	6.5	2.3	6.1	4.7	5.3	3.6	7.6	13.8	6.3	17.6	7.5	7.9	9.6	7.8	3.6	9.3	5.7	9.0	9.2	13.6	6.3	9.8	9.9	3.1	9.2	2.2	3.9	10.1	9.2	13.8	12.2	7.7	9.9	11.0	9.5	7.0	6.8	7.8	17.6	13.4	11.0	4.6	14.6	15.3	16.1	7.4	6.0	13.9	6.4	12.2	6.8	13.5	13.8	11.4	5.6	16.0	6.6	17.4	13.1	14.8	20.3	13.0	5.3	12.4	12.8	1.0	6.4	5.5	6.3	9.4	0.0	6.1	2.3	5.3	5.6	4.1	6.1	3.4	3.6	5.9	4.7	3.2	2.5	0.9	4.7	2.8	6.5	3.6	3.6	7.7	8.6	33.2	10.9	6.9	7.1	8.4	7.6	6.9	5.9
FAAP20	"C1orf86, FLJ31031"	ENSG00000162585	"Fanconi anemia core complex associated protein 20"	Q6NZ36	1	2184461-2212720	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA038829	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"				Nucleoplasm	"Nuclear bodies, Cell Junctions"	"HPA038829: AB_10673476"	"unprognostic (1.36e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"prognostic favourable (2.88e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.55e-2)"	33.1	18.8	15.4	14.3	12.1	15.2	20.5	15.4	16.4	17.8	19.1	13.8	19.1	14.6	17.8	17.7	20.3	12.6	14.2	17.0	15.4	14.8	27.7	20.9	15.0	22.5	14.9	10.3	16.9	17.2	8.0	26.4	11.7	13.3	21.8	7.3	20.9	21.4	23.9	27.3	28.1	14.9	15.0	14.3	24.4	30.5	20.2	11.5	35.1	30.5	11.4	16.5	17.1	19.3	13.2	22.0	31.0	8.7	5.1	12.6	5.6	10.2	1.6	2.3	2.8	1.4	1.9	13.7	11.7	4.3	3.8	5.1	2.5	6.8	12.0	17.3	1.8	5.0	1.6	1.7	1.9	25.7	23.7	10.0	2.7	5.2	5.4	6.9	9.7	3.2	3.8	2.3	2.5	4.6	13.7	2.8	2.6	4.2	10.0	21.6	8.1	21.6	13.5	7.1	11.2	1.8	1.6	18.7	25.0	7.6	3.3	20.0	3.2	2.8	9.8	5.9	14.1	7.3	6.6	27.1	14.4	17.6	11.1	4.3	2.4	3.6	8.7	31.0	10.1	8.1	10.0	13.2	9.2	10.9	8.8	13.1	12.6	10.4	11.2	5.1	7.5	22.0	7.8	5.6	15.4	12.1	15.4	14.1	15.4	14.8	14.9	10.3	13.3	11.5
FAAP24	"C19orf40, FLJ46828, MGC32020"	ENSG00000131944	"Fanconi anemia core complex associated protein 24"	Q9BTP7	19	32972209-32978222	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041168	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA041168: AB_10960496"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (6.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.54e-2)"	"prognostic unfavourable (4.00e-7)"	"unprognostic (4.37e-3)"	"unprognostic (5.30e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.15e-1)"	3.7	3.5	1.8	4.1	2.1	5.3	3.9	2.3	2.9	3.0	2.9	2.4	3.3	2.8	3.3	4.6	4.8	2.6	6.7	1.9	1.5	1.7	4.3	2.5	2.3	4.6	3.8	0.9	4.2	2.4	0.2	2.0	6.1	3.1	9.6	4.0	3.3	3.2	1.9	1.0	4.6	5.1	2.2	2.6	6.1	2.8	16.9	2.0	8.7	3.0	3.1	8.6	3.6	2.7	7.2	7.7	16.0	8.0	7.7	6.2	3.7	5.0	12.6	5.2	8.1	2.6	5.5	4.2	6.5	6.8	12.5	16.4	8.9	8.3	6.0	9.6	2.7	3.6	9.9	4.8	10.0	16.1	5.1	12.9	5.7	6.7	1.5	4.5	6.6	3.1	3.1	7.8	4.8	5.0	6.7	6.1	9.1	5.7	9.4	5.9	2.3	5.7	8.5	4.7	3.2	2.5	3.1	5.5	4.3	7.3	8.5	5.3	5.9	11.2	3.0	12.5	6.0	5.2	5.9	4.9	9.9	8.1	8.9	9.8	8.1	10.8	6.4	8.7	3.9	7.3	4.4	6.6	4.7	5.6	4.0	7.2	4.3	6.2	16.0	7.7	8.0	7.7	6.0	3.7	1.8	2.1	2.3	2.9	1.5	1.7	3.8	0.9	3.1	2.0
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 92.9;MOLT-4: 90.8"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"		28000000	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: "	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.7	16.5	10.1	0.0	48.4	4.5	0.0	11.8	0.6	9.2	11.7	0.1	7.9	92.9	6.8	2.9	5.4	24.6	18.9	7.9	47.2	53.4	33.5	11.8	25.0	4.3	32.0	8.7	3.5	38.9	11.4	23.5	53.0	9.6	10.1	5.5	5.6	90.8	16.4	13.4	64.3	40.5	0.0	9.8	14.8	71.8	42.0	15.9	5.7	1.9	4.4	0.0	16.5	7.5	0.0	26.3	0.1	0.1	12.5	4.9	66.2	4.2	30.7	14.8	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6
FADD	"GIG3, MORT1"	ENSG00000168040	"Fas associated via death domain"	Q13158	11	70203163-70207390	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001464, CAB010209"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB010209: AB_2100622, HPA001464: AB_1848348"	"unprognostic (2.08e-1)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (6.91e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.89e-1)"	"prognostic unfavourable (8.22e-5)"	"unprognostic (7.25e-3)"	"prognostic unfavourable (2.21e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"prognostic favourable (3.45e-4)"	"unprognostic (7.29e-2)"	16.1	20.2	7.9	13.3	8.9	7.1	13.5	10.9	11.8	13.7	16.2	10.9	20.8	13.5	18.0	18.7	18.8	13.3	19.7	11.4	7.8	8.0	17.9	17.4	11.0	19.2	10.5	6.6	12.9	24.9	9.1	9.3	26.3	7.9	12.5	12.7	10.1	14.4	14.5	10.3	13.7	16.9	10.1	8.3	18.8	14.0	8.7	7.4	33.5	16.9	12.4	19.8	14.6	15.1	18.6	17.6	42.7	19.5	16.6	24.6	16.0	81.8	13.8	6.9	6.2	8.4	6.8	6.2	14.1	11.1	12.3	8.3	11.8	13.4	12.2	13.6	9.3	12.1	6.7	12.5	9.6	11.3	7.4	5.5	7.9	6.0	7.5	6.9	7.4	6.7	8.9	13.3	16.9	11.6	9.0	6.3	10.8	12.0	8.4	12.2	10.9	22.9	6.5	16.7	11.6	12.1	6.0	6.1	5.8	10.4	9.8	28.9	10.6	7.7	12.9	9.6	9.4	14.7	13.4	8.8	6.7	7.1	14.0	7.0	13.5	15.0	17.1	12.7	21.0	17.7	24.1	18.6	22.3	24.6	17.6	16.4	23.2	20.9	42.7	16.6	19.5	16.0	20.7	16.0	7.9	8.9	10.9	11.8	7.8	8.0	10.5	6.6	7.9	7.4
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960263	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	16.0	13.6	11.6	18.0	13.4	17.4	16.7	20.0	16.3	14.1	14.6	19.1	14.5	12.2	17.2	12.9	16.9	13.3	12.2	22.3	11.1	10.8	13.2	14.7	13.3	14.9	16.4	13.3	17.0	21.3	22.8	21.5	12.0	13.1	13.9	13.0	12.5	18.0	17.3	58.4	19.0	15.8	17.3	13.1	10.6	14.5	29.7	15.7	29.6	15.6	19.6	17.8	19.4	14.0	5.6	5.4	7.3	5.0	6.1	9.1	2.4	14.3	10.6	9.2	15.6	9.2	8.8	13.6	14.0	12.7	21.8	19.9	11.8	10.3	23.2	10.4	11.9	10.7	14.8	13.0	18.7	15.4	13.3	19.3	14.1	12.2	15.0	20.7	11.5	8.1	11.8	22.9	28.2	11.7	22.4	0.0	11.1	5.7	21.4	16.5	12.2	7.6	20.1	20.4	0.0	21.9	12.9	0.1	11.5	12.7	26.0	21.3	8.1	24.8	7.1	12.3	15.1	15.1	0.1	18.2	19.0	27.0	0.0	30.2	14.1	1.4	3.4	7.3	6.6	4.1	8.7	4.0	5.9	6.4	5.4	5.6	7.0	4.7	1.2	6.1	5.0	4.5	9.1	2.4	11.6	13.4	20.0	16.3	11.1	10.8	16.4	13.3	13.1	15.7
FAF2	"ETEA, KIAA0887, UBXD8, UBXN3B"	ENSG00000113194	"Fas associated factor family member 2"	Q96CS3	5	176447628-176510074	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065968, HPA071246, HPA073828"	Approved		Enhanced	"Endoplasmic reticulum,Lipid droplets"				"Lipid droplets"	"Endoplasmic reticulum"	"HPA065968: , HPA071246: , HPA073828: "	"unprognostic (6.25e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.02e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavourable (1.79e-4)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (6.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.74e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.48e-1)"	21.1	27.7	17.5	16.5	28.5	21.7	20.8	25.4	28.3	21.5	19.2	24.4	17.4	17.2	22.3	21.5	23.0	21.0	18.0	15.1	16.8	18.9	20.5	34.2	17.8	17.2	16.4	15.9	29.3	25.9	32.4	31.5	32.0	25.5	22.3	23.1	24.6	20.1	18.6	15.3	25.5	22.6	22.2	14.5	21.0	18.8	31.9	14.2	30.0	23.1	15.2	24.3	20.7	17.5	7.2	10.9	10.0	14.9	12.4	13.1	7.5	13.9	15.9	15.8	17.5	22.4	17.9	21.6	18.3	21.0	20.9	22.7	20.6	25.3	12.2	20.7	19.3	21.6	22.6	46.4	29.0	48.6	12.4	8.0	16.2	10.0	22.9	17.3	10.5	23.5	20.5	25.5	21.3	17.3	11.4	16.7	19.9	23.2	15.1	9.2	12.7	13.5	15.0	13.7	13.6	17.7	18.5	14.0	15.0	22.3	19.4	20.2	22.8	13.8	19.3	28.8	15.6	15.8	24.4	14.4	15.3	16.0	18.2	12.4	25.1	10.0	9.2	6.1	10.0	7.6	12.2	7.2	8.2	10.5	10.9	7.0	10.7	9.5	7.8	12.4	14.9	7.5	13.1	7.5	17.5	28.5	25.4	28.3	16.8	18.9	16.4	15.9	25.5	14.2
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favourable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	10.4	17.0	10.4	6.7	9.9	6.5	9.2	8.6	12.7	6.8	21.7	9.3	8.2	26.7	9.8	10.9	14.8	5.8	10.2	15.8	10.9	11.4	46.8	43.6	5.6	5.2	10.1	9.4	7.9	17.4	9.0	11.1	10.4	9.9	8.1	11.1	8.5	9.1	9.8	20.2	12.4	24.8	6.9	8.8	6.3	14.9	6.9	9.5	4.7	12.5	19.0	5.7	9.9	7.9	18.5	23.1	8.6	27.5	19.6	16.0	13.7	8.3	18.8	9.0	15.8	12.0	8.7	5.6	13.7	6.8	9.2	10.1	12.0	8.7	5.3	11.6	8.5	17.2	7.0	11.0	8.3	8.0	16.6	4.8	16.2	27.6	11.7	8.2	9.2	11.4	14.5	8.4	5.6	11.9	4.9	5.6	11.5	38.2	4.4	12.5	5.3	14.1	10.2	12.2	15.0	32.9	10.5	17.6	14.6	17.9	14.4	21.5	21.2	5.6	17.4	15.1	10.8	8.8	7.4	8.1	17.0	6.3	9.6	6.0	6.4	6.5	23.5	8.6	14.4	27.5	13.0	18.5	14.5	15.7	23.1	16.9	16.0	14.9	2.0	19.6	19.1	17.9	14.7	13.7	10.4	9.9	8.6	12.7	10.9	11.4	10.1	9.4	9.9	9.5
FAM103A1	"C15orf18, HsT19360, MGC2560, RAM"	ENSG00000169612	"Family with sequence similarity 103 member A1"	Q9BTL3	15	82986207-82991057	"Predicted intracellular proteins"	"mRNA capping, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041923, HPA041948"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA041923: AB_10796467, HPA041948: AB_10797270"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.45e-1)"	16.1	16.2	16.7	12.8	19.5	21.8	23.2	18.9	25.4	16.4	15.4	11.6	18.9	12.0	16.6	27.8	27.5	17.4	13.1	13.3	15.7	17.9	22.1	23.2	10.9	17.5	16.0	14.4	18.9	21.4	12.5	21.7	29.0	22.7	16.3	17.1	16.3	20.9	14.1	27.0	21.8	18.9	14.6	12.4	16.2	17.6	17.0	11.3	25.8	20.8	19.9	23.9	16.7	17.1	24.9	21.7	46.3	23.4	26.4	26.3	22.5	13.5	18.3	18.0	11.4	11.7	8.8	14.1	14.3	14.4	16.5	13.5	20.5	18.2	7.1	19.1	12.0	15.9	31.6	13.6	18.1	16.9	23.9	22.0	9.8	24.0	15.5	15.1	19.2	15.3	26.9	12.7	16.8	10.3	26.3	14.4	17.3	14.7	11.2	20.0	22.1	9.4	13.5	15.9	11.1	21.0	26.6	17.9	18.4	14.6	15.6	33.8	25.1	20.2	7.8	12.2	14.6	11.2	19.8	21.5	40.3	16.7	10.8	21.1	14.2	40.4	23.4	36.3	20.1	22.2	21.8	24.9	23.3	22.0	21.7	21.6	23.3	23.2	46.3	26.4	22.2	20.1	26.3	22.5	16.7	19.5	18.9	25.4	15.7	17.9	16.0	14.4	22.7	11.3
FAM107A	"DRR1, TU3A"	ENSG00000168309	"Family with sequence similarity 107 member A"	O95990	3	58564117-58627610	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Stress response"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 149.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 11.4;HUVEC TERT2: 34.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 110.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055888	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA055888: "	"unprognostic (1.20e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.80e-3)"	"prognostic favourable (3.38e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.95e-3)"	22.4	4.6	119.4	4.7	86.5	1.3	8.4	32.4	149.7	17.0	7.6	68.6	1.7	3.6	9.4	25.1	13.9	39.6	8.4	15.8	91.5	52.0	12.4	3.5	18.1	2.4	66.6	44.3	4.3	11.1	4.1	12.0	13.8	33.5	16.3	8.4	10.7	17.5	19.4	7.5	3.5	5.8	19.8	77.5	12.0	5.8	2.5	87.2	1.2	9.9	1.4	4.8	6.5	10.2	0.3	0.3	1.3	0.9	0.7	0.6	0.1	0.0	0.0	0.5	0.0	11.4	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	34.8	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	1.3	0.4	0.5	0.3	0.4	0.6	0.2	0.3	0.2	0.2	0.3	0.2	0.3	0.6	0.7	0.9	0.3	0.3	0.1	119.4	86.5	32.4	80.7	91.5	52.0	66.6	44.3	33.5	87.2
FAM107B	"C10orf45, FLJ45505, HITS, MGC11034"	ENSG00000065809	"Family with sequence similarity 107 member B"	Q9H098	10	14518557-14774897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 63.7;HDLM-2: 76.1;Karpas-707: 54.6;THP-1: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"granulocytes: 17.3;NK-cells: 14.5;T-cells: 32.4"									"HPA039661, HPA058814, HPA073195"	Approved		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA039661: AB_10794751, HPA058814: , HPA073195: "	"unprognostic (1.24e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.82e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.53e-2)"	15.0	15.2	30.0	27.5	44.7	48.7	19.3	13.1	21.7	15.0	20.2	56.3	85.8	10.4	15.7	7.0	8.3	7.0	21.8	5.9	44.1	23.8	40.1	47.4	20.8	45.7	49.7	14.6	3.5	40.7	16.4	10.7	17.2	38.5	10.0	14.0	3.9	27.7	85.7	2.1	8.4	17.8	10.5	66.3	15.4	37.9	11.6	44.7	7.5	6.2	4.1	41.9	15.5	9.8	3.5	1.4	17.3	3.7	14.5	32.4	19.2	10.2	22.3	8.9	0.5	1.3	0.3	3.7	10.3	15.0	6.4	4.6	13.7	8.7	63.7	9.4	4.7	3.2	2.8	6.3	11.4	76.1	2.4	1.7	10.1	16.1	4.8	22.9	4.1	0.7	4.9	2.6	1.3	27.0	0.1	54.6	4.9	2.6	5.6	6.7	2.2	4.9	40.8	6.9	23.4	14.6	6.7	3.3	9.5	4.1	2.1	6.7	8.1	50.5	8.8	6.6	5.5	20.9	3.4	24.2	21.5	41.2	1.1	20.1	1.7	11.5	1.7	17.3	29.8	2.0	29.1	3.5	24.0	25.1	1.4	3.1	32.4	32.0	7.2	14.5	3.7	1.0	21.1	19.2	30.0	44.7	13.1	21.7	44.1	23.8	49.7	14.6	38.5	44.7
FAM110A	"bA371L19.3, C20orf55"	ENSG00000125898	"Family with sequence similarity 110 member A"	Q9BQ89	20	833715-857463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 83.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7"	"Group enriched"	"Detected in all"	9	"granulocytes: 83.4;monocytes: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034110, HPA069240"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles, Cytosol"		"CAB034110: AB_1562838, HPA069240: "	"unprognostic (6.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (4.42e-4)"	"unprognostic (9.64e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.42e-3)"	"unprognostic (4.21e-3)"	5.2	3.6	1.7	17.7	4.2	7.4	7.7	1.9	3.9	6.5	8.8	2.0	7.7	10.0	4.0	6.1	22.1	1.9	6.9	4.8	1.7	2.5	4.8	3.9	15.2	18.7	2.1	1.9	2.6	3.5	9.3	5.1	11.1	3.6	11.1	3.4	3.1	12.7	10.5	3.7	39.9	9.2	1.3	1.6	15.1	5.5	2.8	1.3	22.9	7.7	8.0	18.9	7.8	9.7	1.9	5.8	83.4	37.7	1.0	6.4	3.2	12.4	3.4	1.9	3.5	2.1	0.9	13.2	3.9	2.2	2.5	2.2	7.3	7.9	4.1	1.7	2.4	20.3	1.5	10.3	2.1	3.3	1.1	8.4	2.1	1.9	0.9	2.3	3.0	0.5	12.8	3.4	3.4	1.7	4.5	10.1	2.3	7.5	6.4	6.2	2.5	5.8	6.4	3.3	5.3	1.9	9.1	3.6	4.3	3.3	39.7	1.7	16.4	3.4	2.2	6.0	4.4	5.4	4.3	3.7	3.2	1.7	0.9	6.0	4.3	83.4	4.4	24.8	2.2	25.1	2.0	1.1	4.0	4.6	5.8	1.9	4.9	4.7	2.5	1.0	37.7	0.6	6.4	3.2	1.7	4.2	1.9	3.9	1.7	2.5	2.1	1.9	3.6	1.3
FAM110B	"C8orf72, MGC39325"	ENSG00000169122	"Family with sequence similarity 110 member B"	Q8TC76	8	57994509-58204279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.0;RPTEC TERT1: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 13.1;intermediate monocyte: 3.6;non-classical monocyte: 6.4"	"Group enriched"	"Detected in many"	11	"granulocytes: 13.1;monocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008318, HPA011781"	Uncertain		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA008318: AB_1853892, HPA011781: AB_1853891"	"unprognostic (2.07e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (3.88e-8)"	"unprognostic (4.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.72e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (1.06e-2)"	"prognostic favourable (4.31e-8)"	"unprognostic (2.23e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.15e-4)"	6.5	3.1	15.7	4.1	12.2	4.1	9.9	23.7	18.4	8.8	6.1	5.0	24.3	2.3	8.9	6.8	3.0	9.1	7.9	21.7	10.3	14.4	6.6	6.0	4.1	2.0	8.0	5.9	8.2	3.0	16.7	4.1	5.0	7.9	10.0	3.2	9.5	8.5	19.8	17.1	3.0	3.3	10.4	11.5	30.8	5.5	14.7	4.9	0.0	8.6	3.4	2.1	7.9	9.4	0.3	0.9	13.1	6.4	0.0	0.2	0.5	0.0	1.1	4.1	0.1	1.8	0.7	1.6	7.7	9.0	5.4	2.5	0.0	0.1	0.0	1.5	5.5	0.0	3.6	0.0	4.2	0.0	3.8	0.7	1.2	4.5	6.2	1.0	0.2	6.6	1.5	0.2	3.4	0.0	0.0	0.1	4.1	0.1	0.0	2.7	3.9	1.7	0.0	4.6	0.0	13.4	0.8	3.9	4.3	0.0	0.5	0.2	3.6	0.4	0.0	3.8	2.5	0.0	2.6	1.7	0.0	0.0	1.8	0.0	4.4	0.0	1.4	13.1	0.0	3.6	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.2	0.5	0.0	6.4	0.0	0.1	0.5	15.7	12.2	23.7	11.8	10.3	14.4	8.0	5.9	7.9	4.9
FAM114A1	Noxp20	ENSG00000197712	"Family with sequence similarity 114 member A1"	Q8IWE2	4	38867677-38945739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.2;ASC TERT1: 44.2;BJ hTERT+: 50.5;fHDF/TERT166: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.1;intermediate monocyte: 6.3;myeloid DC: 4.3;neutrophil: 3.8;non-classical monocyte: 2.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.3;granulocytes: 3.8;monocytes: 6.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA067948, HPA069104, HPA069701"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA067948: , HPA069104: , HPA069701: "	"unprognostic (2.13e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.40e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (3.63e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-3)"	15.8	27.3	4.4	11.8	7.3	0.3	17.9	2.5	5.1	23.3	18.9	8.0	17.1	9.0	34.1	23.5	19.9	11.4	24.1	14.1	7.0	4.2	9.6	31.8	14.5	6.1	5.8	5.0	21.7	33.4	8.8	18.7	19.1	6.5	22.0	14.0	13.0	59.9	12.6	9.3	10.1	15.8	36.7	6.2	6.3	13.9	10.8	5.8	1.5	11.5	16.7	15.1	29.1	17.8	0.7	4.3	3.8	6.3	0.1	0.2	1.3	8.6	6.2	3.8	4.5	42.2	44.2	1.2	34.4	50.5	14.6	22.4	1.6	6.8	0.0	4.8	55.7	2.4	0.0	11.0	17.0	0.0	0.9	0.6	6.6	8.1	15.1	0.0	1.2	26.1	3.5	21.2	4.9	20.9	0.6	0.0	21.3	2.2	0.0	0.4	0.8	3.2	0.1	19.0	0.6	4.9	1.7	0.1	1.9	6.9	0.1	7.0	4.3	0.7	31.9	15.9	7.4	19.9	8.0	0.1	0.0	0.0	26.1	0.6	13.0	0.8	5.1	0.1	0.2	6.3	0.1	0.7	0.2	0.1	4.3	0.3	0.2	0.2	3.8	0.1	2.2	0.5	0.1	1.3	4.4	7.3	2.5	5.1	7.0	4.2	5.8	5.0	6.5	5.8
FAM120A	"C9orf10, KIAA0183, OSSA"	ENSG00000048828	"Family with sequence similarity 120A"	Q9NZB2	9	93451722-93566107	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019734, HPA055800"	Approved		Enhanced	Cytosol				Cytosol		"HPA019734: AB_1848369, HPA055800: "	"unprognostic (5.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (5.03e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.71e-3)"	"prognostic favourable (1.08e-7)"	"unprognostic (8.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	25.7	35.1	23.3	28.6	19.1	15.7	23.0	22.1	21.8	26.1	27.0	14.9	32.2	21.3	33.2	17.2	26.0	24.2	24.1	22.1	20.5	11.0	21.2	33.2	25.7	26.4	18.4	12.6	25.5	34.4	40.6	16.8	24.6	20.0	17.4	26.0	15.9	27.7	22.4	71.5	17.6	23.6	23.3	17.7	21.7	25.3	7.5	17.7	19.5	19.8	23.8	17.6	46.5	33.1	4.7	6.6	15.2	9.2	4.2	7.5	3.5	48.3	39.7	9.0	25.9	27.1	34.0	28.3	34.0	30.1	26.2	19.3	12.8	30.1	31.6	19.5	42.9	52.3	24.0	39.8	20.4	31.4	17.5	17.2	35.5	20.3	30.4	29.2	23.6	33.0	24.8	29.7	47.6	37.3	19.7	26.5	28.3	54.2	28.6	16.6	11.5	37.2	16.7	24.1	26.4	31.8	29.2	24.2	14.9	38.4	46.8	23.2	25.4	19.2	38.5	28.5	20.5	34.8	37.1	21.0	20.5	12.2	30.8	26.4	25.2	3.0	7.1	5.0	5.4	8.1	5.1	4.7	5.2	5.6	6.6	4.1	3.6	5.1	15.2	4.2	9.2	4.6	7.5	3.5	23.3	19.1	22.1	21.8	20.5	11.0	18.4	12.6	20.0	17.7
FAM126A	"DRCTNNB1A, HCC, HYCC1, hyccin"	ENSG00000122591	"Family with sequence similarity 126 member A"	Q9BYI3	7	22889371-23014130	"Disease related genes, Predicted intracellular proteins"			"Cataract, Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042873	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042873: AB_2678207"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-4)"	"unprognostic (1.35e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavourable (6.04e-7)"	"prognostic unfavourable (5.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (9.03e-4)"	15.6	6.1	12.4	13.6	16.9	4.6	14.3	1.7	10.2	10.5	10.5	9.3	1.5	9.6	10.9	4.7	16.1	7.3	12.3	12.2	11.9	6.4	6.1	8.6	15.0	16.8	12.0	5.2	8.6	7.9	1.5	13.2	16.6	10.0	9.7	5.2	11.3	8.4	6.0	28.4	6.0	10.7	13.1	8.6	14.7	6.0	22.3	11.4	12.8	8.1	10.3	14.3	10.6	15.0	9.5	5.9	16.3	12.1	3.6	5.3	3.3	9.5	4.0	19.6	7.9	18.6	29.6	3.0	28.9	29.4	12.8	19.2	6.3	3.6	8.7	5.2	23.5	3.7	19.8	6.5	21.1	4.2	7.0	7.5	6.7	4.4	16.1	12.9	8.8	12.9	4.8	26.3	25.8	14.9	16.1	26.3	23.1	2.7	7.9	10.2	19.2	8.5	8.6	19.4	4.5	3.7	3.3	6.5	0.0	11.7	0.2	12.0	5.7	9.3	14.6	44.0	5.9	22.7	15.5	36.1	14.0	30.4	28.4	6.9	38.4	3.9	4.6	16.3	2.3	9.5	1.8	7.6	3.3	2.1	5.9	9.5	1.8	2.4	0.9	3.6	12.1	2.2	5.3	3.3	12.4	16.9	1.7	9.4	11.9	6.4	12.0	5.2	10.0	11.4
FAM126B	"HYCC2, MGC39518"	ENSG00000155744	"Family with sequence similarity 126 member B"	Q8IXS8	2	200973718-201071671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036166, HPA036167, HPA067307"	Uncertain		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA036166: AB_10696651, HPA036167: , HPA067307: "	"unprognostic (7.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.52e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	10.5	6.9	9.8	8.7	17.2	22.1	7.3	28.7	21.1	5.9	10.3	6.5	5.9	9.8	6.8	6.3	12.1	5.8	6.4	6.5	9.3	9.2	12.0	10.9	9.4	7.9	7.3	11.6	7.8	7.1	9.8	16.6	7.2	15.1	5.8	9.6	8.8	7.0	4.9	5.6	10.2	9.3	5.8	8.1	10.6	11.0	6.3	6.4	8.3	10.3	2.9	8.7	5.5	8.1	2.1	1.2	20.3	1.9	2.3	3.4	1.5	3.2	1.7	2.5	2.6	2.6	3.5	5.4	3.1	1.8	2.5	2.4	4.4	3.9	3.0	3.1	3.1	4.0	5.0	1.9	3.9	4.3	3.1	8.7	4.6	4.1	2.1	10.5	7.6	1.5	2.4	3.4	2.1	2.4	8.0	11.2	2.5	2.0	6.3	6.9	1.7	2.9	3.7	3.7	2.7	2.4	3.6	4.9	2.5	3.3	3.8	2.8	2.6	4.6	4.8	4.7	3.4	2.3	2.8	8.3	34.6	6.4	2.8	4.1	3.2	1.7	1.4	5.1	3.1	1.8	3.4	2.1	2.6	2.4	1.2	2.0	2.6	3.1	20.3	2.3	1.9	0.9	1.7	1.5	9.8	17.2	28.7	21.1	9.3	9.2	7.3	11.6	15.1	6.4
FAM129A	"C1orf24, GIG39, NIBAN"	ENSG00000135842	"Family with sequence similarity 129 member A"	Q9BZQ8	1	184790724-184974550	"Cancer-related genes, Predicted intracellular proteins"	"Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 129.1;urinary bladder: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 32.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"			40000	"Plasma membrane, Cytosol"		"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (4.52e-4)"	10.1	3.5	1.1	16.9	1.8	2.3	7.8	0.8	1.3	13.0	39.3	1.0	14.9	2.5	14.6	11.0	32.3	10.7	30.4	52.2	1.1	1.1	1.8	1.2	6.1	10.7	3.0	0.5	8.0	27.3	0.8	1.9	2.9	1.7	34.6	5.1	13.8	59.3	14.7	21.4	4.1	8.3	129.1	2.1	6.5	30.0	4.1	1.3	4.9	4.7	14.7	8.7	90.3	20.3	0.5	2.3	32.7	1.5	2.6	5.3	0.8	13.6	0.1	0.0	0.0	9.8	14.9	0.5	7.0	14.4	6.1	7.7	0.0	5.8	0.0	4.6	18.0	15.4	0.8	0.5	9.8	27.2	1.1	5.7	2.9	0.0	22.8	18.5	6.5	13.6	22.3	17.7	21.5	0.0	1.3	28.9	0.1	0.0	0.6	3.2	3.7	1.4	4.3	3.3	0.2	8.4	0.2	0.7	0.7	0.1	0.0	10.0	3.0	5.9	1.1	12.1	0.0	2.1	14.4	24.3	9.6	2.9	23.7	7.7	11.8	7.1	1.5	4.7	2.5	0.9	2.1	0.5	2.2	2.3	2.3	0.1	0.2	0.9	32.7	2.6	0.3	0.2	5.3	0.8	1.1	1.8	0.8	1.3	1.1	1.1	3.0	0.5	1.7	1.3
FAM129B	"bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Family with sequence similarity 129 member B"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 95.6;placenta: 103.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			1200000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	7.8	17.9	4.5	8.4	5.6	5.1	6.7	6.5	4.2	19.1	13.9	4.2	12.3	11.9	9.6	7.3	95.6	8.9	22.9	8.2	4.8	4.1	9.9	5.5	24.0	5.1	6.9	3.1	9.3	24.8	6.8	5.7	103.7	9.1	12.8	7.2	9.4	23.6	11.7	4.1	17.3	17.1	10.5	7.0	6.8	13.8	5.4	4.2	1.3	39.8	44.6	48.8	11.8	28.3	0.0	2.4	0.5	3.7	0.0	0.5	1.7	22.1	25.3	5.1	6.7	15.5	30.3	24.0	44.0	40.9	24.3	15.1	8.0	24.5	0.0	17.5	49.7	36.9	4.4	32.6	8.0	4.2	4.7	3.7	37.5	8.3	30.7	0.1	10.8	33.2	20.5	40.0	14.1	36.6	7.1	0.2	46.1	26.1	0.2	6.2	5.3	33.3	2.6	17.3	11.6	20.9	17.8	8.2	3.8	35.9	25.6	15.6	16.8	1.2	47.3	25.0	10.9	31.4	36.3	0.4	0.8	0.0	70.5	3.6	46.3	0.5	3.7	0.0	0.2	1.3	0.0	0.0	0.5	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.7	4.5	5.6	6.5	4.2	4.8	4.1	6.9	3.1	9.1	4.2
FAM131B	KIAA0773	ENSG00000159784	"Family with sequence similarity 131 member B"	Q86XD5	7	143353400-143362770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.1;NTERA-2: 16.5;PC-3: 15.9;SCLC-21H: 16.2"	"Cancer enriched"	"Detected in many"	11	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021371, HPA029992"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021371: AB_1852341, HPA029992: "	"unprognostic (1.70e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-2)"	1.5	2.1	10.0	2.0	12.4	0.9	1.2	37.2	47.1	2.7	2.0	15.1	0.0	1.7	4.4	1.0	1.7	1.6	1.4	1.1	9.1	6.8	1.1	0.9	1.5	1.3	14.6	12.3	1.0	0.9	6.4	0.4	0.9	13.8	1.0	2.2	0.0	0.9	1.0	7.7	0.8	2.1	5.6	18.6	1.1	1.4	1.2	11.3	0.0	0.9	0.0	1.1	1.2	0.5	0.0	0.2	0.0	0.5	0.1	2.1	0.2	0.0	0.1	4.9	0.0	4.0	5.1	0.0	0.2	1.2	0.8	0.2	10.1	0.0	0.0	0.0	0.3	0.2	2.0	0.4	0.7	2.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.3	16.5	15.9	0.0	0.0	0.0	0.0	0.0	16.2	0.5	0.2	1.1	0.0	0.0	0.0	0.7	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.1	3.2	0.1	0.0	0.3	0.0	2.1	0.5	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.2	10.0	12.4	37.2	25.0	9.1	6.8	14.6	12.3	13.8	11.3
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560793-92590394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA066175: , HPA069513: "	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	10.5	11.7	18.5	11.1	23.6	32.1	15.1	25.7	23.3	13.6	10.4	8.2	12.0	11.9	13.0	22.5	11.4	10.4	9.2	9.2	13.8	9.1	11.2	14.3	11.2	14.1	15.3	13.2	15.1	13.6	13.4	21.3	12.9	18.0	12.0	11.7	7.5	11.4	10.5	17.1	12.8	10.8	15.7	18.5	12.1	10.6	7.3	17.3	15.9	12.5	7.5	12.8	10.6	12.0	22.5	23.2	9.8	11.7	10.7	17.0	5.9	12.8	6.7	18.8	28.8	11.0	11.8	11.3	14.6	15.8	14.3	17.5	10.7	14.4	21.1	14.2	9.9	10.4	14.8	9.2	22.0	11.8	19.4	17.1	9.8	21.4	11.6	18.8	14.8	7.8	9.8	11.0	13.7	8.4	22.4	26.8	15.3	15.7	29.5	29.3	25.7	8.6	21.4	18.9	17.5	14.3	13.8	18.3	17.7	12.6	16.0	17.0	14.9	13.8	9.7	16.5	26.2	19.2	16.3	7.0	7.4	37.8	9.9	24.8	21.2	9.5	11.7	9.8	10.7	10.5	13.9	22.5	13.6	13.2	9.6	18.8	17.0	14.4	4.9	10.7	7.8	23.2	14.3	5.9	18.5	23.6	25.7	23.3	13.8	9.1	15.3	13.2	18.0	17.3
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA058113"	Approved		Enhanced	Mitochondria,Cytosol			29000	"Mitochondria, Cytosol"		"HPA035856: AB_10611965, HPA058113: AB_2683609"	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favourable (3.93e-4)"	13.6	32.8	24.9	18.6	49.9	14.1	18.7	10.7	44.8	21.8	57.8	11.5	19.6	22.7	17.0	25.5	58.7	13.8	25.4	54.2	40.2	21.7	35.9	78.1	12.2	16.5	23.6	27.7	30.2	71.5	24.6	16.1	7.3	31.0	27.3	61.3	16.2	17.7	23.1	56.6	29.2	21.2	27.2	24.4	10.9	25.7	16.9	18.8	8.6	17.9	48.6	16.7	34.6	36.0	26.8	29.4	25.3	24.4	16.4	33.1	12.9	30.4	6.5	9.7	18.1	17.9	16.6	5.0	12.5	11.2	11.9	30.5	16.3	14.0	33.2	21.8	4.3	21.4	17.6	30.4	31.9	17.1	13.2	26.9	11.3	29.1	11.8	26.2	9.6	19.2	16.0	11.3	24.0	15.8	18.1	13.3	17.0	11.9	26.7	31.9	14.3	34.7	16.1	13.9	43.2	34.5	74.4	14.6	11.7	9.3	22.2	25.5	13.9	13.0	11.1	11.8	8.5	6.9	12.9	26.5	9.0	33.7	35.1	25.7	5.4	2.6	9.3	25.3	21.7	23.0	32.1	26.8	29.8	27.1	29.4	23.9	32.6	33.1	3.0	16.4	24.4	24.6	27.1	12.9	24.9	49.9	10.7	44.8	40.2	21.7	23.6	27.7	31.0	18.8
FAM169A	"KIAA0888, SLAP75"	ENSG00000198780	"Family with sequence similarity 169 member A"	Q9Y6X4	5	74777574-74866951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;epididymis: 23.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.1;Hep G2: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041574	Enhanced		Supported	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA041574: AB_10794382"	"unprognostic (3.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.75e-4)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	0.7	4.2	9.9	1.4	13.5	1.5	1.1	11.0	21.8	1.7	1.9	5.2	2.9	0.7	3.8	23.6	0.9	3.8	3.0	2.2	9.4	14.2	6.7	3.1	0.8	2.5	9.6	10.3	3.4	2.0	10.7	8.3	1.2	10.4	6.4	3.0	11.3	1.9	7.0	0.8	0.7	1.0	1.0	11.1	2.5	2.1	15.5	4.6	3.7	9.6	0.0	2.5	4.1	1.1	1.4	0.5	0.0	0.0	0.8	4.0	1.2	5.2	4.7	3.3	4.5	0.0	0.0	23.1	0.7	1.7	3.5	3.6	2.1	3.5	0.0	2.4	0.0	3.7	6.9	10.4	3.7	3.9	7.9	1.4	0.8	15.7	0.1	0.0	0.0	0.1	11.0	0.8	5.2	0.0	0.0	0.0	2.1	1.5	4.9	0.0	8.4	2.6	7.2	2.1	0.3	3.3	8.3	2.0	2.7	8.7	3.9	0.6	3.7	1.0	0.0	0.2	3.4	0.0	3.8	12.8	11.9	0.0	0.4	0.0	0.4	0.0	0.0	0.0	2.7	0.0	4.0	0.8	1.6	2.5	0.0	1.4	3.5	3.4	0.0	0.8	0.0	0.5	0.9	1.2	9.9	13.5	11.0	17.1	9.4	14.2	9.6	10.3	10.4	4.6
FAM172A	"C5orf21, DKFZP564D172"	ENSG00000113391	"Family with sequence similarity 172 member A"	Q8WUF8	5	93618069-94111699	"Predicted intracellular proteins, Predicted secreted proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012299, HPA045505"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"HPA012299: AB_1845724, HPA045505: "	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.03e-2)"	18.4	15.4	24.2	17.8	21.8	9.8	19.3	28.8	20.8	19.9	14.4	15.5	13.9	11.2	19.1	16.1	17.7	18.8	14.3	14.0	21.0	19.9	18.5	8.0	14.9	22.4	18.9	13.0	23.0	18.2	20.7	28.4	15.1	15.6	19.4	12.3	12.6	14.3	22.6	6.2	11.8	12.9	26.2	20.8	13.6	13.7	8.3	16.6	16.1	22.8	9.5	16.1	19.0	15.7	9.8	7.1	13.1	7.3	12.3	11.9	6.4	4.5	5.3	13.1	14.7	15.8	19.1	6.8	9.8	7.6	4.2	4.2	3.6	6.4	6.6	7.4	11.5	4.0	3.9	13.8	10.0	4.5	4.7	8.7	11.2	2.4	6.7	6.7	10.2	16.7	7.9	3.9	7.5	9.7	1.7	2.0	17.4	5.0	5.6	5.1	2.0	4.4	6.3	13.8	6.2	6.7	8.9	11.7	20.9	7.9	3.3	7.2	8.1	8.2	9.5	10.2	9.2	6.6	11.5	8.5	12.3	7.5	16.0	7.5	18.6	13.1	5.4	7.0	11.9	7.3	11.9	9.4	8.9	8.7	7.1	9.8	10.1	10.2	13.0	12.3	5.1	6.8	9.2	6.4	24.2	21.8	28.8	20.8	21.0	19.9	18.9	13.0	15.6	16.6
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.4"	"Cell line enhanced"	"Detected in many"		"AF22: 16.4;HEK 293: 9.6;K-562: 13.4;SCLC-21H: 10.7;SH-SY5Y: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: , HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	4.0	2.8	14.2	3.7	13.7	0.6	6.1	13.9	16.0	2.8	3.0	4.6	0.4	3.8	3.9	3.6	2.6	3.9	2.3	2.4	11.3	10.5	6.7	6.4	15.3	4.9	9.1	10.0	7.1	5.1	14.2	15.4	31.4	11.9	4.0	1.9	2.7	2.9	4.1	1.2	2.3	2.6	3.1	4.6	1.0	1.7	23.2	7.1	0.1	8.5	1.1	5.8	2.1	2.0	0.5	0.0	0.0	0.2	0.3	1.9	0.0	0.1	0.3	16.4	1.6	0.2	0.2	0.0	0.5	0.3	0.5	0.8	2.1	1.3	1.1	0.0	0.2	0.0	5.0	0.0	0.2	1.3	9.6	0.5	1.5	7.2	0.1	0.0	1.5	0.3	0.2	0.1	0.0	0.0	13.4	0.6	0.2	0.3	0.3	0.0	5.5	1.2	0.0	0.0	0.0	0.1	0.1	10.7	7.9	0.5	0.5	1.6	2.2	1.9	0.2	0.8	0.5	0.2	4.1	4.1	4.4	0.3	1.3	0.0	2.1	0.0	0.0	0.0	0.2	0.2	0.6	0.5	0.2	0.0	0.0	0.1	1.5	1.2	0.0	0.3	0.0	0.0	1.9	0.0	14.2	13.7	13.9	12.9	11.3	10.5	9.1	10.0	11.9	7.1
FAM185A	MGC35361	ENSG00000222011	"Family with sequence similarity 185 member A"	Q8N0U4	7	102748971-102809225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020470, HPA029883"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA020470: AB_1853890, HPA029883: AB_10601903"	"unprognostic (8.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.03e-1)"	"prognostic favourable (9.36e-5)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.25e-2)"	3.7	4.6	6.6	3.0	4.9	3.6	3.8	9.3	6.3	5.6	4.3	4.4	4.1	2.3	3.8	3.1	4.4	3.1	3.4	4.2	4.2	2.3	4.0	9.4	4.8	2.3	5.1	6.0	4.7	3.7	8.7	4.8	2.8	4.0	5.2	4.3	6.1	5.1	8.4	9.5	4.6	3.1	3.7	4.5	3.0	5.9	2.2	5.1	3.0	3.8	2.4	2.7	4.4	4.0	3.3	2.6	7.5	3.0	1.2	2.2	0.9	1.3	3.5	1.6	4.1	0.6	1.7	4.2	0.9	1.7	1.6	0.5	3.4	2.9	0.0	2.2	1.2	3.6	2.3	2.4	1.6	1.7	2.0	0.2	0.4	4.1	1.0	2.9	0.4	0.0	2.7	0.9	1.2	2.0	2.1	1.5	1.6	2.7	1.4	0.3	1.7	0.0	0.3	0.1	10.1	0.8	2.5	1.4	2.9	3.4	5.3	0.4	3.2	0.0	3.5	0.4	1.7	2.5	0.5	4.8	1.5	0.6	0.7	0.9	0.0	0.0	3.0	3.3	2.1	2.2	0.9	3.3	1.4	2.2	2.6	1.9	1.3	1.5	7.5	1.2	1.0	2.4	1.6	0.9	6.6	4.9	9.3	6.3	4.2	2.3	5.1	6.0	4.0	5.1
FAM189A1	"KIAA0574, TMEM228"	ENSG00000104059	"Family with sequence similarity 189 member A1"	O60320	15	29120254-29570723	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.3;parathyroid gland: 6.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HDLM-2: 15.2;REH: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA009410, HPA010637"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA009410: AB_1852332, HPA010637: AB_1852333"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.12e-1)"	0.8	1.5	12.8	0.6	7.9	0.4	0.6	4.2	9.5	0.4	4.0	1.5	0.0	1.0	1.1	0.8	0.6	1.5	0.5	0.7	15.3	4.7	1.7	0.5	1.5	0.5	3.5	3.4	0.4	3.3	6.5	0.0	0.7	4.0	0.8	3.0	0.0	1.1	0.5	0.4	0.8	3.2	1.0	0.7	1.3	0.6	2.3	0.3	0.0	1.9	0.0	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	15.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.5	0.0	3.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.8	7.9	4.2	9.5	15.3	4.7	3.5	3.4	4.0	0.3
FAM189B	"C1orf2, cote1"	ENSG00000160767	"Family with sequence similarity 189 member B"	P81408	1	155247205-155255483	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006659, HPA050674"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA006659: AB_1078339, HPA050674: "	"unprognostic (1.56e-2)"	"prognostic unfavourable (4.98e-4)"	"unprognostic (1.44e-2)"	"prognostic unfavourable (9.59e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.86e-3)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (2.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (3.43e-7)"	"unprognostic (4.16e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.25e-2)"	18.7	13.5	18.8	12.0	17.3	6.4	20.1	18.3	18.4	11.2	16.9	5.6	16.6	14.4	14.8	6.9	14.7	10.9	13.9	10.3	15.2	11.0	11.0	10.1	10.1	7.8	10.1	16.3	11.6	11.8	15.9	13.2	11.0	19.7	12.3	8.1	7.2	13.9	18.7	41.1	12.9	12.5	17.1	13.0	9.7	13.6	10.3	11.2	3.8	8.9	10.8	7.2	18.6	19.3	0.2	0.2	0.1	0.3	1.2	0.8	0.3	12.4	9.4	8.5	15.9	8.1	11.1	2.5	10.7	8.0	8.0	6.9	10.5	6.7	10.7	16.6	8.1	12.6	10.1	10.2	3.8	15.2	22.7	7.7	7.9	6.1	10.9	2.4	8.9	10.3	6.4	8.1	7.6	10.6	6.4	4.5	6.2	6.7	11.1	3.9	10.6	22.7	11.4	6.3	12.1	5.4	3.4	12.2	16.2	5.0	17.8	12.4	14.6	9.6	9.0	7.4	10.2	8.5	11.4	9.7	9.6	5.8	9.0	4.6	6.1	0.0	0.3	0.0	0.1	0.3	0.8	0.1	0.4	0.2	0.2	0.2	0.0	0.2	0.1	1.2	0.0	0.2	0.0	0.3	18.8	17.3	18.3	18.4	15.2	11.0	10.1	16.3	19.7	11.2
FAM192A	"C16orf94, NIP30"	ENSG00000172775	"Family with sequence similarity 192 member A"	Q9GZU8	16	57152466-57186116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054382, HPA059652"	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA054382: AB_2682469, HPA059652: "	"unprognostic (1.69e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-3)"	21.2	23.1	39.3	31.3	42.5	60.4	31.0	38.0	45.6	22.4	33.4	41.8	19.1	30.3	25.2	31.0	28.0	25.4	21.9	25.8	37.2	36.3	26.9	27.0	25.3	39.6	44.8	32.5	26.1	33.9	52.1	31.1	28.4	36.7	28.1	41.1	24.7	24.8	24.6	31.8	40.7	32.4	25.4	40.8	42.0	27.5	41.4	40.0	47.2	33.2	21.9	42.6	23.1	23.9	26.6	30.4	48.5	38.1	17.9	22.2	20.8	31.0	39.8	44.4	29.8	19.5	24.2	41.9	36.7	27.6	45.5	29.5	37.6	33.0	47.1	41.4	28.0	41.8	30.8	36.9	46.2	20.9	24.8	32.8	35.7	38.9	28.2	40.1	46.8	24.1	36.9	43.2	35.0	32.5	43.8	15.2	29.9	23.1	43.6	37.5	28.6	30.0	53.7	64.8	45.6	30.7	25.7	32.0	36.8	67.1	28.6	24.7	23.7	27.9	32.1	33.8	28.3	24.6	27.3	36.5	28.6	60.6	34.5	29.1	32.2	48.5	26.6	40.1	17.3	30.6	16.8	26.6	16.7	16.0	30.4	23.9	17.4	18.0	36.8	17.9	38.1	21.0	22.2	20.8	39.3	42.5	38.0	45.6	37.2	36.3	44.8	32.5	36.7	40.0
FAM193B	"FLJ10404, IRIZIO, KIAA1931"	ENSG00000146067	"Family with sequence similarity 193 member B"	Q96PV7	5	177519788-177554541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035847, HPA035848"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA035847: , HPA035848: AB_10601320"	"unprognostic (6.58e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (3.71e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.15e-1)"	"prognostic favourable (1.30e-5)"	13.5	9.5	18.5	16.5	17.2	35.6	15.8	37.9	20.4	18.1	13.5	13.6	17.2	15.4	19.8	11.6	13.8	13.3	12.3	9.1	18.4	8.0	16.3	18.5	17.0	20.5	17.3	18.3	22.1	22.1	10.3	15.2	15.2	17.0	19.0	11.6	17.1	14.3	14.6	11.6	34.9	18.7	12.7	10.9	27.8	14.9	14.0	16.2	11.7	16.9	9.5	15.3	13.7	23.1	1.3	1.6	2.9	1.8	2.0	2.8	0.9	5.2	7.1	15.7	13.6	7.8	7.5	33.9	4.8	5.2	8.0	7.6	18.9	10.3	10.1	7.5	4.6	9.2	7.1	10.1	5.9	22.2	7.4	7.1	11.1	9.0	4.5	6.9	14.7	7.4	11.3	6.7	7.4	8.0	6.8	10.0	5.7	17.7	12.6	20.2	10.9	5.6	20.6	3.5	8.5	7.6	15.1	14.6	9.3	5.6	16.1	4.7	15.7	9.6	9.9	8.9	7.4	5.7	5.7	10.9	4.5	8.1	7.1	11.3	7.3	0.0	1.8	0.7	2.8	0.2	1.8	0.7	1.4	2.0	1.1	1.3	0.7	1.0	2.9	2.0	1.1	1.6	0.9	0.9	18.5	17.2	37.9	20.4	18.4	8.0	17.3	18.3	17.0	16.2
FAM198A	"C3orf41, DKFZP434B172"	ENSG00000144649	"Family with sequence similarity 198 member A"	Q9UFP1	3	42979267-43060211	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.8;RPMI-8226: 6.1;SK-BR-3: 4.2;T-47d: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047726	Approved		Supported	Vesicles	"Secreted - unknown location"		440000	Vesicles		"HPA047726: AB_10960554"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.81e-1)"	8.9	3.5	6.2	3.7	8.3	0.1	5.4	4.1	6.8	10.8	3.5	6.1	2.4	1.3	11.7	9.4	4.0	13.8	13.0	2.0	7.2	2.6	1.3	12.1	3.8	1.1	5.1	5.5	9.4	3.0	0.3	2.6	3.2	11.2	2.7	1.8	4.0	4.1	3.8	1.4	1.8	2.5	9.2	5.2	1.2	4.3	3.1	6.8	0.0	2.0	1.1	0.6	3.8	4.2	0.0	1.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	5.8	0.2	0.0	1.7	0.3	0.6	0.0	0.0	0.2	1.8	0.0	1.8	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.9	0.0	0.0	1.3	0.5	2.1	1.2	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	6.1	0.0	0.8	0.1	0.4	0.0	4.2	0.0	11.7	1.4	0.0	0.7	1.2	2.3	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	0.0	6.2	8.3	4.1	6.8	7.2	2.6	5.1	5.5	11.2	6.8
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297930-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038182, HPA062025"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: "	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	31.2	17.5	30.0	18.5	31.6	40.3	28.1	18.9	37.8	24.9	26.8	20.0	19.6	17.9	27.4	29.5	26.1	19.2	19.2	29.5	25.4	21.7	25.0	24.8	21.4	22.4	23.4	25.9	26.2	21.4	19.1	31.3	19.1	30.4	21.1	21.6	19.4	21.9	20.7	36.3	17.1	18.5	34.0	31.2	24.1	20.8	39.9	20.9	19.8	26.0	21.9	23.0	32.8	18.4	27.4	32.4	36.6	35.1	17.5	27.2	28.7	21.4	9.7	16.0	22.3	16.0	17.5	9.1	17.0	32.1	24.7	22.4	11.4	20.1	15.3	10.6	18.3	18.6	13.4	17.8	22.5	24.0	16.6	12.7	10.0	10.0	23.9	32.8	18.1	12.0	21.8	18.1	38.1	21.0	13.2	18.1	20.4	12.0	20.1	30.6	11.3	8.7	17.3	31.0	11.2	22.3	11.0	10.3	16.3	11.7	10.9	25.0	17.4	23.8	14.6	13.0	12.2	11.5	25.8	13.0	11.5	22.0	25.4	35.6	13.1	29.8	31.7	36.6	21.7	34.4	22.7	27.4	24.6	19.8	32.4	20.2	21.3	24.7	17.6	17.5	35.1	23.5	27.2	28.7	30.0	31.6	18.9	37.8	25.4	21.7	23.4	25.9	30.4	20.9
FAM206A	"C9orf6, CG-8, FLJ20457, Simiate"	ENSG00000119328	"Family with sequence similarity 206 member A"	Q9NX38	9	108934181-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035917, HPA035918"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Cytosol"	"Cytokinetic bridge"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	12.0	11.4	16.8	9.0	28.8	12.9	17.8	12.3	19.2	11.6	13.3	12.8	10.3	13.8	12.6	22.9	16.0	18.9	9.9	13.3	16.2	16.0	14.1	12.6	12.0	9.9	16.7	20.0	13.7	13.7	23.3	28.5	10.6	16.0	11.9	15.1	7.6	16.9	13.5	12.2	22.9	15.1	14.4	16.6	7.5	13.0	16.7	14.8	8.4	20.9	10.2	10.6	10.5	11.7	10.6	23.6	24.4	20.7	12.4	16.1	11.9	8.7	9.5	10.4	11.4	18.5	25.7	13.9	9.0	9.7	8.4	6.9	14.1	4.8	8.6	5.0	8.0	21.4	8.3	8.7	8.4	5.2	8.6	5.2	12.9	13.2	15.5	18.8	7.4	13.5	16.6	10.2	23.6	11.4	18.4	8.9	9.9	24.8	13.4	7.6	11.7	13.9	6.7	16.8	9.0	10.9	9.8	13.4	7.3	12.9	11.3	14.1	15.4	10.2	7.4	4.7	8.6	20.8	10.6	7.3	18.9	6.3	15.0	7.5	6.8	19.9	20.6	19.0	9.9	20.6	15.2	10.6	15.8	13.1	22.6	6.9	16.1	12.1	24.4	12.4	20.7	23.6	13.0	11.9	16.8	28.8	12.3	19.2	16.2	16.0	16.7	20.0	16.0	14.8
FAM208A	"C3orf63, KIAA1105, RAP140, se89-1, TASOR"	ENSG00000163946	"Family with sequence similarity 208 member A"	Q9UK61	3	56620133-56683237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006735, HPA017142"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006735: AB_1852384, HPA017142: AB_1852382"	"unprognostic (1.46e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-3)"	"unprognostic (9.31e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.74e-1)"	10.3	11.6	11.4	10.9	14.7	8.0	9.8	13.8	11.6	9.9	10.1	14.3	10.5	7.3	12.6	5.8	11.2	11.1	9.0	9.9	9.2	5.4	8.1	5.8	8.5	14.6	15.2	7.1	11.9	12.6	22.9	19.2	7.0	10.5	7.6	9.6	8.6	11.4	7.6	7.4	8.2	10.4	16.9	11.6	10.5	10.2	21.1	13.0	13.8	14.6	4.1	14.2	14.3	12.9	4.1	3.3	3.7	2.6	2.9	4.4	2.0	22.7	9.0	14.1	11.0	7.7	13.4	7.1	10.2	10.5	9.8	10.3	7.4	17.1	36.1	3.8	10.2	9.1	14.0	11.9	14.3	17.7	7.1	14.2	13.2	3.3	5.4	14.8	22.4	6.4	10.1	9.5	17.2	12.6	13.6	20.8	12.4	8.0	18.1	2.9	7.8	13.9	9.7	14.0	12.0	9.4	16.8	9.4	11.6	22.2	8.9	11.1	14.7	17.2	13.5	12.7	11.7	11.5	15.5	19.0	26.5	18.3	14.7	21.9	16.7	1.8	2.6	3.7	4.3	2.0	2.8	2.8	3.8	4.4	3.3	4.1	4.1	4.2	0.8	2.9	2.3	2.5	3.3	2.0	11.4	14.7	13.8	11.6	9.2	5.4	15.2	7.1	10.5	13.0
FAM208B	"bA318E3.2, C10orf18, FLJ20360, KIAA2006"	ENSG00000108021	"Family with sequence similarity 208 member B"	Q5VWN6	10	5684838-5763740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038042, HPA038043, HPA061547"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: "	"unprognostic (3.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.25e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.12e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (2.39e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.23e-2)"	15.4	15.5	10.1	22.9	13.6	16.1	16.4	18.9	13.4	18.7	15.0	11.8	13.6	8.6	21.2	20.7	14.6	19.6	13.4	16.9	12.0	9.3	13.6	15.9	15.1	20.5	15.0	10.6	23.8	19.4	26.2	24.3	16.0	12.6	15.9	15.8	12.9	15.6	17.0	26.9	12.7	16.4	17.4	12.8	16.7	15.7	29.7	14.0	19.5	22.6	14.1	21.1	17.4	22.0	4.3	2.2	1.8	2.4	8.6	3.2	0.8	17.2	14.7	9.5	16.0	12.2	14.6	13.3	14.8	9.4	12.7	16.2	15.5	10.3	35.4	9.5	14.5	13.7	27.0	15.1	20.7	6.9	18.2	16.5	11.4	10.4	12.2	12.1	9.9	11.1	17.0	20.7	17.7	14.7	26.5	8.3	14.2	11.7	15.7	4.3	11.5	9.5	11.7	13.2	12.4	7.7	15.8	11.7	13.2	14.7	13.4	10.5	17.5	9.6	14.7	16.2	17.5	31.1	20.1	10.2	9.6	31.6	8.0	12.0	8.5	1.4	2.4	0.5	2.4	2.3	2.2	2.1	1.8	2.3	1.4	4.3	1.8	3.2	1.8	8.6	0.9	2.2	2.4	0.8	10.1	13.6	18.9	13.4	12.0	9.3	15.0	10.6	12.6	14.0
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B, glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076562	"Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"			280000	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	18.2	21.3	17.7	12.8	20.9	8.8	26.0	16.1	26.4	15.8	20.8	10.8	13.3	8.7	18.5	14.7	17.5	14.7	17.3	32.9	17.1	17.2	16.2	14.8	14.6	9.1	16.1	19.9	19.0	10.1	22.5	16.9	15.2	15.2	15.6	13.4	14.5	9.9	18.8	19.0	11.4	10.6	25.9	13.6	10.5	14.4	6.8	9.4	7.3	16.5	7.7	9.4	17.6	28.7	4.9	3.6	2.3	2.3	4.4	4.1	1.5	17.7	16.2	12.6	13.3	22.5	23.8	14.0	14.8	17.0	10.4	9.4	8.1	17.7	9.1	19.5	26.0	13.0	12.8	10.9	15.3	11.6	8.6	29.2	15.3	10.3	11.3	19.3	18.5	13.8	11.9	14.2	11.1	12.8	32.5	13.5	16.6	9.9	8.4	7.0	16.6	3.5	10.3	13.3	12.2	8.7	20.1	16.9	41.4	15.6	17.7	15.1	15.3	14.2	13.5	16.7	14.7	22.9	19.9	11.0	20.1	8.0	16.5	9.4	16.5	2.3	2.0	0.6	3.8	1.7	4.1	4.2	2.4	3.5	2.2	4.9	3.5	3.2	1.9	4.4	2.3	3.6	2.7	1.5	17.7	20.9	16.1	26.4	17.1	17.2	16.1	19.9	15.2	9.4
FAM212B	"C1orf183, FLJ31105, INKA2"	ENSG00000197852	"Family with sequence similarity 212 member B"	Q9NTI7	1	111680630-111739424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 17.9;U-87 MG: 36.7;WM-115: 13.9"	"Cancer enhanced"	"Detected in many"		"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	13	"neutrophil: 19.2"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 19.2"									"HPA027809, HPA027811"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA027809: AB_10599616, HPA027811: AB_10600872"	"unprognostic (1.92e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.81e-2)"	"prognostic favourable (4.51e-5)"	"unprognostic (9.96e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.50e-3)"	"unprognostic (9.92e-5)"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.07e-2)"	12.1	1.4	14.9	4.6	11.5	4.0	8.6	5.5	22.4	2.6	3.7	2.9	1.5	1.8	4.9	1.8	11.1	7.9	4.7	12.9	13.1	3.5	3.9	1.4	6.9	2.4	4.8	13.4	3.2	1.7	4.5	0.9	9.4	3.9	4.6	3.3	1.8	2.7	6.3	8.3	8.8	2.9	8.1	3.9	6.3	4.9	4.3	3.7	0.5	3.8	3.5	2.9	3.1	3.9	0.4	0.8	19.2	1.4	0.0	0.0	0.4	1.2	1.1	2.1	1.6	10.5	3.8	0.9	0.9	1.9	1.6	4.0	2.0	0.0	0.9	0.4	0.8	1.1	1.1	2.4	1.5	2.2	1.1	7.2	0.7	1.9	3.5	0.3	1.1	2.5	10.5	17.9	0.8	4.4	0.0	1.6	2.0	1.1	0.4	0.3	0.3	1.0	1.1	9.7	0.3	0.4	1.7	5.5	1.6	0.5	0.0	4.8	1.4	1.1	1.7	3.7	5.8	1.9	0.7	10.5	1.9	0.8	36.7	1.8	13.9	0.0	1.3	1.0	0.0	1.1	0.0	0.2	0.0	0.0	0.8	0.4	0.0	0.0	19.2	0.0	1.4	0.3	0.0	0.4	14.9	11.5	5.5	22.4	13.1	3.5	4.8	13.4	3.9	3.7
FAM217B	"C20orf177, dJ551D2.5"	ENSG00000196227	"Family with sequence similarity 217 member B"	Q9NTX9	20	59933764-59948680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041021, HPA056698"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA041021: AB_10959734, HPA056698: "	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.04e-8)"	"unprognostic (2.78e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	5.5	5.2	17.7	7.2	18.2	14.7	6.2	18.7	29.6	6.4	5.4	10.7	5.0	6.2	8.6	7.3	5.9	7.2	5.1	11.7	15.5	14.3	6.8	2.8	6.5	10.3	14.4	19.1	13.7	4.0	5.9	14.3	7.7	14.1	9.6	4.6	4.7	5.8	11.8	16.5	4.3	7.1	5.8	10.7	7.4	5.6	10.8	11.6	8.5	8.5	4.9	10.4	7.0	6.8	7.2	8.0	13.8	7.0	9.3	13.5	6.9	5.2	3.6	8.5	5.8	4.1	6.2	6.8	7.6	6.5	8.4	6.1	18.9	11.6	11.8	12.9	3.1	13.2	9.2	6.3	8.3	6.5	5.8	11.0	9.1	10.8	2.6	17.4	14.9	3.6	7.9	6.2	2.0	2.4	7.8	5.0	5.4	9.7	30.4	9.6	8.3	7.5	7.4	8.4	11.4	3.2	8.4	8.7	10.4	10.2	13.2	11.1	12.8	12.5	3.4	7.1	8.3	7.2	4.0	8.5	14.4	14.0	9.8	11.5	4.6	9.6	7.0	9.5	11.0	4.6	13.5	6.6	10.6	10.0	8.0	7.2	11.0	11.6	13.8	9.3	4.3	6.4	9.1	6.9	17.7	18.2	18.7	29.6	15.5	14.3	14.4	19.1	14.1	11.6
FAM219A	"bA573M23.5, C9orf25, FLJ39031"	ENSG00000164970	"Family with sequence similarity 219 member A"	Q8IW50	9	34398184-34458570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.9"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019338, HPA052909"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA019338: AB_1845819, HPA052909: "	"unprognostic (9.96e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (1.98e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.95e-1)"	"prognostic favourable (2.46e-4)"	"unprognostic (3.46e-3)"	"prognostic unfavourable (5.54e-5)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.76e-1)"	13.6	10.3	27.8	10.9	27.0	4.9	7.1	26.3	56.9	7.5	6.3	23.3	3.7	7.2	13.2	8.6	6.3	6.5	7.6	17.5	25.4	27.6	6.1	5.0	11.0	7.8	30.8	31.0	10.7	8.4	9.4	10.6	16.3	34.0	9.2	6.6	5.4	7.1	9.7	28.6	12.3	6.7	15.0	25.2	9.8	7.2	6.9	25.6	2.9	7.2	4.0	6.6	6.5	6.4	0.5	0.6	3.8	0.7	0.7	1.5	0.3	12.4	4.8	11.4	6.5	10.7	4.1	11.2	7.6	5.7	6.6	8.4	3.3	2.9	2.7	7.8	7.3	5.2	9.0	4.8	6.6	43.0	5.2	1.1	6.2	3.6	6.0	2.7	6.4	4.3	4.9	9.8	5.5	10.8	2.7	13.8	5.1	2.5	4.2	3.8	7.4	7.2	5.4	1.9	2.4	4.7	2.7	3.6	11.6	6.5	4.8	3.8	2.4	2.7	12.8	7.3	5.7	15.1	10.4	3.6	5.2	2.4	20.9	6.3	12.8	2.3	0.6	3.8	1.5	0.4	0.8	0.5	0.8	0.4	0.5	0.4	0.6	0.8	2.0	0.7	0.7	0.6	1.4	0.3	27.8	27.0	26.3	40.8	25.4	27.6	30.8	31.0	34.0	25.6
FAM222B	"C17orf63, FLJ10700"	ENSG00000173065	"Family with sequence similarity 222 member B"	Q8WU58	17	28755978-28855232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051840, HPA062239"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA051840: , HPA062239: "	"unprognostic (4.11e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavourable (3.45e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.18e-2)"	9.6	7.6	12.0	11.5	13.4	7.9	9.4	25.4	15.3	10.6	14.0	12.3	9.2	15.3	9.7	10.5	13.9	9.4	11.1	10.6	11.6	9.5	11.6	8.7	9.3	7.6	11.5	10.3	11.4	9.2	15.0	15.2	12.4	13.9	10.5	13.0	16.4	16.8	12.2	42.4	8.5	13.4	9.7	9.5	7.8	10.5	39.4	10.9	10.1	11.1	4.4	9.2	13.3	12.5	7.8	5.7	13.6	8.5	4.1	10.2	4.2	8.1	16.2	13.8	16.0	11.9	8.4	15.2	5.9	5.6	8.3	8.4	20.8	8.1	8.3	11.8	6.6	10.5	11.6	13.2	6.9	11.5	15.3	9.3	8.1	15.7	13.8	5.9	15.2	8.7	13.1	11.7	10.5	16.5	17.6	6.0	17.5	10.5	10.5	4.9	15.8	6.1	4.9	13.1	8.4	14.8	10.5	15.2	10.7	8.0	15.8	20.7	12.3	5.8	18.3	5.4	11.4	6.0	9.1	12.2	14.8	5.3	7.6	4.2	9.8	13.6	4.2	11.1	8.2	5.9	10.2	7.8	6.8	8.3	5.6	6.4	9.6	7.9	6.1	4.1	8.5	5.7	5.9	4.2	12.0	13.4	25.4	15.3	11.6	9.5	11.5	10.3	13.9	10.9
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145397-112195256	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 49.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA062443: , HPA069294: "	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavourable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	43.2	4.8	3.3	11.9	3.0	7.0	49.5	3.6	3.1	6.9	9.5	4.6	10.7	3.1	8.9	6.0	7.6	5.2	6.2	18.5	4.3	3.0	6.4	6.9	10.2	7.2	5.6	1.8	5.2	3.8	7.1	6.3	12.6	3.4	9.7	3.2	2.8	22.3	17.2	11.6	7.2	4.7	9.0	4.3	9.7	8.3	7.7	3.6	6.3	8.5	7.3	6.0	9.3	24.7	2.7	2.8	5.7	1.7	1.7	1.7	0.7	3.9	1.6	1.6	1.3	8.4	4.8	2.5	3.4	0.8	0.6	1.1	1.1	5.0	25.9	3.2	1.8	1.9	2.5	3.5	1.2	12.2	4.2	2.8	3.8	2.1	5.0	6.4	1.7	5.2	5.7	0.9	6.0	17.9	5.2	12.6	2.0	4.1	2.3	4.6	2.0	3.7	5.3	2.7	5.3	2.7	3.8	3.0	2.4	3.1	5.8	1.6	4.1	2.7	11.3	2.0	6.2	1.3	1.2	5.2	6.8	12.0	4.8	3.2	2.6	5.7	1.7	1.6	1.5	1.3	1.3	1.5	1.6	1.1	0.9	2.7	1.5	1.7	4.2	1.7	1.6	2.8	1.7	0.7	3.3	3.0	3.6	2.4	4.3	3.0	5.6	1.8	3.4	3.6
FAM32A	"DKFZP586O0120, OTAG-12"	ENSG00000105058	"Family with sequence similarity 32 member A"	Q9Y421	19	16185380-16192046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051712	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051712: "	"unprognostic (3.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.49e-3)"	37.2	42.9	56.2	34.0	37.6	53.1	43.9	33.4	56.2	29.0	39.9	18.7	33.1	50.5	37.2	35.1	41.2	30.9	35.4	32.5	51.6	35.7	39.8	54.9	31.7	35.5	34.9	45.9	30.3	32.5	25.1	24.8	51.1	41.5	30.4	38.8	18.6	34.6	33.4	52.0	42.7	56.7	35.2	45.8	43.2	40.4	24.1	34.3	32.8	33.5	29.8	37.5	40.3	38.9	27.9	41.5	94.9	65.7	27.6	32.2	51.5	29.1	22.4	35.3	22.7	41.7	32.1	33.4	28.4	32.3	35.1	38.8	30.7	35.4	19.4	49.7	36.6	22.6	36.0	31.0	31.0	25.5	39.6	36.0	20.2	27.2	33.8	45.2	42.3	37.1	32.6	28.1	25.9	37.8	28.1	28.7	34.6	38.8	34.9	47.3	50.7	55.5	36.9	24.4	32.0	38.4	29.3	30.5	46.3	24.0	22.9	30.4	19.5	51.8	35.1	27.4	16.2	49.9	35.5	34.3	56.6	30.6	39.8	55.1	23.6	41.0	47.8	94.9	24.7	60.1	26.1	27.9	23.7	26.7	41.5	27.8	28.8	31.4	41.0	27.6	65.7	28.5	32.2	51.5	56.2	37.6	33.4	56.2	51.6	35.7	34.9	45.9	41.5	34.3
FAM3C	"GS3876, ILEI"	ENSG00000196937	"Family with sequence similarity 3 member C"	Q92520	7	121348851-121396364	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 13.9;naive B-cell: 11.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043376, HPA050548"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted in other tissues"		59000000	"Golgi apparatus"		"HPA043376: , HPA050548: "	"unprognostic (9.44e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.38e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	18.1	18.0	38.0	13.7	29.8	3.2	16.3	26.5	46.6	38.6	27.1	8.2	12.8	65.6	20.9	23.0	15.5	14.3	13.7	24.6	23.4	20.0	24.3	20.7	15.9	15.3	20.6	42.0	15.7	35.5	20.6	15.8	21.7	30.6	12.3	21.2	11.1	20.4	13.2	9.0	14.5	60.8	16.9	14.1	16.8	21.9	9.0	12.7	6.4	42.8	11.4	16.2	17.3	15.9	13.9	1.1	0.6	0.9	2.3	1.8	0.7	16.5	4.2	7.9	8.3	13.3	22.1	7.1	17.8	7.9	5.4	6.9	3.3	163.3	15.7	8.4	9.2	10.9	4.5	9.9	11.5	1.9	8.9	4.3	2.6	3.4	9.7	7.2	8.2	22.1	6.8	7.6	7.5	9.6	2.8	19.8	42.1	2.7	2.7	5.6	14.1	5.9	4.3	8.0	6.4	33.5	9.6	5.1	5.0	5.3	21.8	9.7	3.1	4.0	22.9	14.1	4.5	30.6	12.1	19.0	8.4	6.2	15.2	7.5	25.2	0.0	0.9	0.6	1.8	0.9	1.7	13.9	0.8	1.4	0.8	11.9	1.0	0.8	0.2	2.3	0.7	1.1	0.4	0.7	38.0	29.8	26.5	46.6	23.4	20.0	20.6	42.0	30.6	12.7
FAM50A	"9F, DXS9928E, HXC-26, XAP5"	ENSG00000071859	"Family with sequence similarity 50 member A"	Q14320	X	154444126-154450654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003585	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA003585: AB_1080603"	"unprognostic (1.95e-1)"	"prognostic favourable (2.05e-4)"	"prognostic unfavourable (9.52e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.64e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-1)"	33.0	29.9	31.4	23.3	46.1	21.7	22.6	42.7	45.3	23.0	27.0	25.6	22.2	24.8	22.2	38.1	18.9	16.4	17.4	31.9	32.6	23.5	24.7	23.2	23.1	16.6	43.5	29.5	20.3	25.1	32.1	41.3	30.5	35.6	23.1	20.2	24.3	27.9	26.6	54.7	16.1	22.9	26.5	31.4	24.1	23.1	7.0	42.9	11.7	25.6	12.4	16.9	24.8	39.9	16.5	24.5	19.4	35.1	19.6	30.3	14.6	26.0	32.4	10.8	15.4	40.5	29.2	21.5	33.8	30.7	33.2	50.6	29.5	12.2	1.3	35.2	35.7	10.2	25.5	23.6	25.8	18.9	16.3	8.3	38.9	18.6	59.3	7.5	24.8	33.4	17.0	51.0	26.3	27.1	10.7	21.3	32.1	17.8	8.9	10.0	7.3	20.3	13.0	27.2	18.7	20.9	26.3	19.5	13.9	12.3	20.0	40.5	17.3	14.8	32.9	22.9	18.7	37.4	41.4	49.4	28.3	9.3	30.9	26.4	25.4	14.2	26.6	19.4	22.5	33.9	30.3	16.5	23.4	21.5	24.5	14.0	13.2	18.0	14.4	19.6	35.1	18.8	24.9	14.6	31.4	46.1	42.7	45.3	32.6	23.5	43.5	29.5	35.6	42.9
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849386-3851317	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.7;MCF7: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067817	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"				"Nucleoplasm, Cytokinetic bridge"		"HPA067817: "	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favourable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	7.2	9.5	13.4	5.7	20.6	3.1	5.7	18.7	16.7	6.7	6.8	11.0	8.4	10.1	8.3	6.7	5.5	11.2	8.1	16.0	12.8	14.2	12.9	12.0	6.2	7.1	11.4	14.9	14.4	12.7	5.8	7.7	3.4	9.7	8.2	3.0	5.9	15.2	9.8	41.1	7.9	6.9	10.2	10.8	7.7	7.9	10.2	9.9	5.8	11.8	5.7	5.5	7.5	13.3	14.9	10.1	3.4	9.1	19.4	20.5	5.6	3.1	4.2	0.0	0.0	2.5	2.4	0.2	3.7	1.8	2.5	3.2	0.0	5.7	3.3	4.0	2.7	2.4	0.0	1.5	1.9	41.7	2.2	0.0	10.0	0.0	2.6	0.0	0.0	2.6	2.9	2.0	0.5	2.5	0.0	0.0	2.2	13.1	0.0	4.6	0.9	2.0	0.0	0.0	0.0	1.2	0.0	5.9	5.2	6.0	3.8	0.2	4.1	3.7	3.5	0.0	0.4	5.0	0.0	0.0	9.0	0.0	1.4	0.3	6.9	3.4	4.7	2.4	7.1	6.1	16.8	14.9	13.6	9.2	6.1	12.9	11.3	7.1	1.9	19.4	9.1	10.1	20.5	5.6	13.4	20.6	18.7	16.7	12.8	14.2	11.4	14.9	9.7	9.9
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;smooth muscle: 69.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"				"Mitotic spindle"	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA049333: , HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (5.44e-6)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	0.5	0.5	0.5	4.9	0.8	7.9	0.7	0.4	1.2	1.7	29.6	0.4	0.7	3.4	0.8	1.5	39.0	0.2	5.6	1.5	0.5	0.1	2.2	1.4	2.6	1.5	0.3	0.5	0.7	0.2	0.0	0.3	2.2	0.7	7.6	3.6	1.2	3.1	1.0	0.4	4.1	16.2	69.8	0.4	1.0	22.8	3.8	0.2	9.2	0.5	8.6	17.9	24.5	6.4	1.6	0.1	0.0	0.4	2.4	4.6	1.2	31.2	19.3	15.3	12.8	1.7	1.9	27.4	14.1	8.8	27.9	17.1	29.4	14.4	7.9	14.0	9.2	26.9	20.8	24.1	26.2	2.6	8.2	9.2	14.8	21.2	1.4	4.0	4.8	1.0	1.2	16.0	9.3	15.3	8.1	11.5	15.8	16.8	6.2	5.9	12.6	24.6	6.0	28.1	4.4	8.0	8.0	7.1	11.8	41.1	34.3	6.1	21.4	4.2	7.3	18.5	22.7	21.0	30.9	3.5	5.3	8.2	8.3	6.0	13.5	0.0	0.0	0.0	0.7	0.4	2.3	1.6	2.4	2.7	0.1	1.6	2.7	3.4	0.0	2.4	0.1	0.0	4.6	1.2	0.5	0.8	0.4	1.2	0.5	0.1	0.3	0.5	0.7	0.2
FAM96A	"CIA2A, FLJ22875"	ENSG00000166797	"Family with sequence similarity 96 member A"	Q9H5X1	15	64072559-64094018	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: "	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	13.6	32.3	11.2	19.1	12.8	17.0	13.9	9.0	10.3	8.5	24.3	13.6	17.7	31.3	8.1	14.9	13.6	8.3	14.0	20.6	11.2	10.8	39.4	89.7	18.1	22.7	15.2	8.0	7.8	27.0	10.6	15.4	25.2	11.2	17.2	20.2	10.7	16.5	15.7	28.2	7.6	45.5	6.4	14.9	25.2	17.9	8.9	13.8	20.5	30.1	18.3	19.3	14.6	9.0	51.8	63.7	23.7	48.6	11.8	21.3	38.2	19.5	28.7	17.6	10.9	14.9	18.3	11.6	15.4	17.2	20.6	21.8	28.3	31.7	32.5	27.1	9.7	21.6	34.3	15.1	17.5	26.5	18.5	26.5	26.0	26.6	11.8	42.9	22.9	14.4	15.2	13.4	12.0	20.8	36.2	25.2	14.5	33.1	16.3	37.1	25.4	15.2	26.2	23.2	72.0	26.5	23.0	18.8	14.2	12.3	28.1	29.8	20.6	44.8	12.5	16.3	23.2	18.6	33.1	24.4	57.5	29.2	19.8	77.6	15.5	16.2	48.6	16.9	10.1	44.1	12.4	51.8	15.3	13.5	42.6	48.8	12.3	11.6	23.7	11.8	36.7	63.7	21.3	38.2	11.2	12.8	9.0	10.3	11.2	10.8	15.2	8.0	11.2	13.8
FAM96B	"CGI-128, CIA2B, MIP18"	ENSG00000166595	"Family with sequence similarity 96 member B"	Q9Y3D0	16	66932055-66934423	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041501, HPA041736"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041501: AB_10795123, HPA041736: AB_10793932"	"unprognostic (2.49e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.12e-2)"	22.5	34.2	38.7	26.5	38.2	17.7	31.9	26.8	34.5	19.6	28.8	30.3	19.8	26.3	20.4	27.5	43.5	28.6	25.0	58.0	36.7	33.6	41.6	57.8	27.4	30.6	39.4	27.4	29.5	38.3	23.2	30.0	27.3	30.7	22.0	25.6	16.6	21.9	22.2	89.6	14.2	29.4	22.3	41.4	25.3	24.3	32.2	28.5	24.1	41.2	40.8	25.3	25.7	37.0	51.8	92.7	46.3	52.7	40.7	61.2	44.8	25.3	57.5	19.5	24.4	24.7	23.5	23.8	23.2	26.1	35.6	44.8	60.6	29.5	23.0	30.2	27.4	33.6	27.9	28.0	25.5	28.5	39.3	14.0	17.1	70.6	47.0	20.7	55.9	23.1	27.2	42.0	36.9	24.0	23.5	15.4	28.8	48.7	35.2	49.9	26.0	70.0	30.1	20.9	44.2	52.6	22.9	34.4	38.5	49.8	13.5	35.2	14.8	34.6	20.4	26.8	31.8	15.0	32.1	33.8	27.1	58.4	47.4	21.5	34.7	41.5	47.0	46.3	43.2	51.2	42.3	51.8	46.3	46.9	51.7	44.4	37.3	41.5	23.0	40.7	52.7	92.7	61.2	44.8	38.7	38.2	26.8	34.5	36.7	33.6	39.4	27.4	30.7	28.5
FAM98A	DKFZP564F0522	ENSG00000119812	"Family with sequence similarity 98 member A"	Q8NCA5	2	33583658-33599382	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036250, HPA036251"	Uncertain		Supported	Vesicles				Vesicles		"HPA036250: , HPA036251: AB_10673124"	"unprognostic (7.25e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (4.86e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (8.18e-5)"	"unprognostic (6.01e-2)"	19.5	18.5	17.6	13.5	19.7	4.5	11.6	15.0	27.1	16.4	13.8	23.5	9.3	9.6	16.1	14.0	16.4	9.6	11.7	26.6	22.5	16.3	19.2	19.1	9.6	11.6	20.9	17.9	13.8	11.8	57.7	26.4	26.6	26.0	16.8	12.3	8.4	24.8	12.4	38.4	11.5	9.9	24.8	23.4	11.5	13.5	36.3	16.5	8.2	14.8	17.7	14.8	12.6	10.1	12.0	6.8	3.0	8.9	4.4	10.0	4.6	25.3	12.6	7.3	12.3	28.9	31.6	11.6	63.0	22.6	17.3	22.7	13.2	5.2	39.0	11.7	27.4	11.4	23.2	17.3	23.6	17.9	15.6	32.4	13.5	18.4	13.9	25.8	12.6	16.6	11.7	23.4	15.1	22.7	22.1	12.1	30.3	12.3	14.2	7.5	18.1	16.9	11.3	23.6	13.9	18.1	19.4	12.9	7.3	16.4	25.5	7.5	10.5	4.2	38.0	11.1	19.0	23.5	24.7	23.0	27.7	38.7	26.4	18.7	15.6	1.3	4.9	3.0	8.0	8.9	8.3	12.0	6.6	6.8	6.8	7.2	8.8	6.9	0.1	4.4	4.8	4.2	10.0	4.6	17.6	19.7	15.0	27.1	22.5	16.3	20.9	17.9	26.0	16.5
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	15.6	15.6	20.4	16.9	21.0	10.8	17.0	27.3	24.4	13.7	19.3	12.7	8.7	12.5	17.9	12.9	14.9	14.5	11.0	15.8	20.1	19.6	17.7	10.1	10.6	16.3	18.6	20.3	15.6	10.6	27.5	18.3	20.1	17.7	16.5	15.7	9.3	11.2	14.2	16.2	11.5	12.8	17.4	21.0	13.8	12.0	13.0	14.0	27.4	15.7	12.3	16.8	14.8	13.4	3.5	2.5	3.7	1.1	3.8	6.6	0.7	13.5	7.2	35.8	18.3	6.6	12.2	17.5	17.4	12.8	17.2	17.4	16.0	6.6	9.4	19.3	14.4	14.4	21.5	17.8	24.3	9.6	11.7	27.6	16.7	12.3	9.6	26.1	16.0	11.2	11.2	15.4	17.9	17.7	19.8	11.8	16.4	6.1	22.0	14.0	19.2	10.1	23.5	19.3	7.8	14.9	17.9	22.1	22.7	19.2	12.3	8.4	15.1	16.2	14.7	19.7	24.0	13.0	19.5	22.0	19.7	34.1	10.7	17.3	20.4	3.7	0.9	2.5	5.3	0.8	4.6	2.8	5.4	4.4	1.1	3.5	6.6	5.1	0.8	3.8	1.1	2.5	3.3	0.7	20.4	21.0	27.3	24.4	20.1	19.6	18.6	20.3	17.7	14.0
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30903852-30943108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: "	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favourable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	5.9	8.9	11.6	6.9	17.4	6.3	12.7	19.6	18.4	15.0	11.4	17.7	11.9	4.6	11.6	22.9	6.5	8.5	8.5	13.0	12.6	11.0	14.7	14.4	6.9	5.5	18.5	11.8	12.5	18.2	7.2	17.0	10.6	15.4	16.4	9.7	8.6	17.3	8.3	16.8	9.3	6.7	11.5	13.0	7.3	8.5	9.4	15.0	5.1	14.3	6.3	5.8	9.0	9.1	4.0	3.6	0.6	1.7	4.5	5.4	1.6	6.4	11.0	3.6	2.0	13.0	11.6	2.4	4.5	1.9	4.8	5.1	7.5	3.3	1.5	8.1	4.9	13.0	6.1	9.5	4.7	5.1	2.9	1.1	11.2	1.3	5.6	0.9	6.1	3.5	7.0	2.9	7.7	2.3	5.5	10.1	7.8	1.4	10.0	4.4	2.8	2.5	8.5	11.9	2.8	7.1	5.1	8.3	5.8	9.9	6.8	3.5	6.1	7.6	8.3	15.1	3.6	4.2	5.8	13.9	9.7	1.7	6.6	4.8	1.3	0.1	0.8	0.6	3.7	1.3	4.7	2.8	3.5	1.7	2.7	4.0	5.4	2.8	0.3	4.5	1.7	3.6	3.2	1.6	11.6	17.4	19.6	18.4	12.6	11.0	18.5	11.8	15.4	15.0
FANCA	"FA-H, FAA, FACA, FAH, FANCH"	ENSG00000187741	"Fanconi anemia complementation group A"	O15360	16	89737549-89816657	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6;testis: 28.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063236			Supported	Nucleoplasm				Nucleoplasm		"HPA063236: "	"unprognostic (5.99e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.45e-4)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.48e-4)"	"unprognostic (7.82e-10)"	"unprognostic (3.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.62e-1)"	2.1	2.0	2.2	16.5	3.7	17.1	1.7	5.7	6.6	1.7	5.1	1.1	0.6	5.0	1.7	3.1	6.6	1.9	1.6	1.7	1.8	1.4	2.1	5.8	3.3	11.1	1.3	2.7	1.6	1.8	2.3	1.9	11.2	2.4	1.7	6.3	1.5	2.2	0.5	0.7	5.0	5.4	2.0	1.6	6.9	3.5	28.8	0.8	20.6	1.7	4.6	17.6	2.9	2.5	7.4	6.5	9.9	9.2	7.5	9.5	4.2	9.2	14.2	17.0	14.9	1.1	2.2	13.0	11.5	6.3	19.5	8.2	12.4	15.4	22.7	5.4	3.9	14.2	11.4	8.6	20.6	5.3	19.2	6.7	18.2	25.4	0.7	6.8	7.4	0.7	0.9	15.8	5.0	6.1	16.1	7.0	10.1	21.4	13.6	29.5	11.0	8.9	24.8	13.7	4.1	4.8	8.7	15.3	8.3	17.2	5.1	2.2	9.3	12.3	4.5	15.7	16.5	8.7	12.0	6.3	7.3	22.6	7.4	15.3	14.8	2.6	7.9	9.9	4.7	8.8	3.3	7.4	2.8	4.1	6.5	5.5	0.7	3.0	9.8	7.5	9.2	0.4	9.5	4.2	2.2	3.7	5.7	6.6	1.8	1.4	1.3	2.7	2.4	0.8
FANCC	"FA3, FAC, FACC"	ENSG00000158169	"Fanconi anemia complementation group C"	Q00597	9	95099054-95426796	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 29.7"	"Cell line enhanced"	"Detected in all"		"RH-30: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017793, HPA030771"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB017793: , HPA030771: "	"unprognostic (1.48e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.00e-3)"	"unprognostic (3.19e-2)"	"prognostic favourable (6.03e-6)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.71e-2)"	4.9	2.7	4.3	8.6	7.0	3.6	4.6	29.7	7.7	4.6	6.4	4.9	5.1	7.1	6.3	4.1	4.5	3.6	5.2	3.2	4.0	2.7	10.0	25.7	6.7	3.7	7.3	1.6	3.3	5.4	2.9	12.1	4.3	6.7	4.4	6.1	4.0	4.0	4.2	4.5	7.7	8.1	2.9	6.4	3.4	4.4	19.6	7.3	7.9	4.3	3.2	6.0	3.5	4.0	1.0	1.3	10.4	1.7	0.3	1.5	0.7	13.4	9.1	12.0	10.5	1.2	3.2	7.6	5.9	3.8	9.4	8.7	10.4	5.7	7.7	4.1	4.3	16.5	12.2	5.1	5.1	7.3	5.7	6.0	10.2	5.3	2.0	6.0	6.8	2.7	2.1	7.5	3.3	5.2	9.0	3.4	6.7	9.5	5.6	3.5	5.8	5.2	12.1	31.2	3.6	3.9	3.5	17.5	9.3	11.1	4.0	3.4	4.1	5.1	2.5	8.3	12.0	9.0	8.3	3.5	6.5	4.0	4.4	5.5	9.7	10.4	0.4	0.0	1.3	0.8	1.3	1.0	0.7	1.5	0.4	1.0	1.2	1.0	0.1	0.3	1.7	1.3	1.3	0.7	4.3	7.0	29.7	7.7	4.0	2.7	7.3	1.6	6.7	7.3
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: "	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavourable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.5	9.1	17.5	4.9	0.9	1.3	45.3	7.9	3.5	11.4	9.3	6.8	8.5	16.8	3.7	2.6	7.5	18.0	6.1	11.4	8.0	12.2	23.0	14.0	6.5	0.1	17.0	14.4	0.4	1.0	12.8	7.1	6.8	14.0	19.3	8.5	9.9	14.2	6.5	21.1	6.4	15.5	14.2	11.9	3.9	9.7	4.9	9.6	9.7	7.6	3.1	11.6	10.8	3.9	9.4	10.8	5.7	11.4	8.2	16.0	28.5	5.4	17.5	16.1	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6
FANCE	"FACE, FAE"	ENSG00000112039	"Fanconi anemia complementation group E"	Q9HB96	6	35452361-35467103	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											CAB014893	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB014893: "	"unprognostic (2.66e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.73e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.80e-3)"	"prognostic unfavourable (2.08e-9)"	"unprognostic (8.90e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.14e-2)"	7.2	2.1	2.6	7.0	3.8	7.2	8.5	5.5	3.9	6.7	4.1	4.8	1.5	3.1	6.1	4.7	10.0	4.9	5.4	4.1	2.8	3.2	2.4	1.7	5.5	5.4	2.4	1.8	10.8	6.9	2.7	4.0	21.3	3.9	6.7	4.1	3.7	5.3	4.0	20.8	16.8	4.7	4.1	3.7	4.6	3.8	12.1	3.5	3.0	5.9	10.1	8.5	6.7	15.0	2.4	1.8	1.0	1.0	2.6	3.6	0.9	5.6	2.8	7.7	17.3	5.6	10.0	20.7	6.8	5.8	8.9	7.8	6.6	3.2	19.3	4.5	4.2	4.2	8.6	5.8	8.6	6.5	7.5	13.5	6.7	4.3	3.0	7.9	5.5	6.3	17.5	10.9	16.8	5.2	12.4	7.2	7.4	6.6	3.7	9.9	3.2	4.4	10.9	7.3	7.2	2.0	6.2	7.7	7.2	3.9	5.5	6.1	5.4	25.8	3.2	10.8	9.0	6.9	10.6	4.8	16.6	7.0	2.4	14.6	10.1	0.7	1.0	1.0	2.2	0.6	3.0	0.7	2.8	3.6	0.6	2.4	1.9	1.9	0.6	2.6	0.6	1.8	1.7	0.9	2.6	3.8	5.5	3.9	2.8	3.2	2.4	1.8	3.9	3.5
FANCF	FAF	ENSG00000183161	"Fanconi anemia complementation group F"	Q9NPI8	11	22622519-22626787	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 15.2"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA008899			Supported	Nucleoplasm				Nucleoplasm		"HPA008899: "	"unprognostic (1.16e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.84e-2)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (4.29e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.64e-3)"	1.2	4.1	2.9	3.1	2.8	1.1	3.2	1.0	2.7	3.1	3.4			5.3	3.0	6.0	3.0	6.1	1.7	1.9	2.9	3.9	3.2	4.2	1.8	4.9	3.3		4.2	9.0	3.4	4.5	1.5		2.9	3.7		3.8	3.1	0.4	3.1	4.9	1.1	3.5	5.4	4.6	4.3			3.6		4.8	2.6	2.0	15.2	9.7	11.5	5.7	10.0	15.1	7.3	1.4	4.3	5.6	6.1	2.9	3.5	2.3	2.8	3.3	3.2	3.5	2.8	2.2	7.2	0.7	2.8	6.2	4.5	4.6	1.6	11.7	2.1	2.7	1.8	4.9	3.4	4.9	2.9	3.4	9.0	1.1	4.9	5.0	6.8	9.4	2.0	4.5	12.5	4.6	6.4	5.4	10.9	2.6	8.0	6.0	5.6	20.9	9.8	1.5	4.9	4.8	9.9	4.5	3.6	3.3	3.5	5.9	4.0	5.4	6.9	2.1	5.4	2.0	7.6	5.7	5.4	11.5	11.5	5.5	13.5	11.8	10.8	10.8	6.4	15.2	15.1	12.4	0.8	10.0	5.7	9.7	7.3	7.3										
FANCG	"FAG, XRCC9"	ENSG00000221829	"Fanconi anemia complementation group G"	O15287	9	35073835-35080016	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008105, HPA045335"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"CAB008105: AB_2231542, HPA045335: "	"unprognostic (9.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (2.38e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	5.8	5.0	4.4	7.1	6.5	14.9	7.5	13.9	8.5	6.2	5.9	5.3	8.4	6.7	6.8	3.2	9.2	8.6	4.7	5.9	7.6	4.0	5.2	4.5	5.1	9.9	8.7	4.4	9.2	17.0	6.7	4.8	7.6	6.6	7.0	5.5	3.5	8.7	9.7	2.9	8.9	6.5	6.4	4.2	8.6	5.8	8.9	7.6	25.6	9.3	4.8	9.2	6.8	6.9	6.8	4.8	8.9	2.5	8.8	9.2	3.4	15.7	19.5	14.3	13.2	3.2	5.1	12.0	11.1	8.0	21.8	20.9	9.3	9.9	15.6	7.7	3.5	9.7	11.9	10.2	8.3	18.2	7.2	11.1	20.9	5.7	0.9	11.3	12.9	4.2	2.0	19.0	8.6	11.1	7.3	21.0	10.9	14.0	19.1	15.5	14.9	15.1	19.8	16.9	11.0	5.1	6.7	6.9	12.6	7.3	10.4	4.1	13.5	8.1	6.7	10.3	20.7	13.2	14.9	5.7	10.8	9.4	9.2	8.4	14.1	8.9	0.8	7.7	7.4	2.5	6.5	6.8	6.1	5.7	2.2	6.5	4.8	5.0	1.3	8.8	2.3	4.8	9.2	3.4	4.4	6.5	13.9	8.5	7.6	4.0	8.7	4.4	6.6	7.6
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"Fanconi anemia complementation group I"	Q9NVI1	15	89243949-89317261	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.4;testis: 28.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA039972: AB_10673265, HPA040379: "	"unprognostic (6.88e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (6.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.59e-3)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (2.71e-13)"	"unprognostic (2.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	3.7	3.2	1.7	11.1	3.3	16.5	3.3	1.8	5.6	3.8	5.9	3.0	2.7	3.3	3.3	3.3	10.7	2.1	1.8	2.8	2.5	1.5	2.4	2.0	3.5	13.4	5.0	2.6	3.1	2.3	1.8	1.5	7.1	2.9	2.8	7.6	2.3	4.0	1.7	1.3	5.4	4.9	3.8	2.8	6.7	4.6	28.3	3.2	44.4	1.7	9.2	15.4	3.9	4.6	3.8	3.9	17.7	3.8	4.6	10.6	3.0	24.2	27.9	29.9	20.1	2.6	3.8	18.4	23.3	13.5	29.2	35.8	22.0	22.1	44.9	12.7	7.7	33.3	45.5	15.8	27.5	28.6	28.5	44.5	41.0	10.3	0.4	32.1	22.7	2.1	1.6	20.5	10.5	11.9	30.7	33.1	19.4	13.8	33.5	11.1	23.4	10.3	29.2	43.4	19.3	6.7	44.8	22.2	19.0	24.0	17.1	10.8	18.9	14.6	8.1	24.3	24.7	22.2	35.3	22.0	45.7	34.6	9.1	28.6	24.3	17.7	2.4	2.8	5.2	3.0	2.9	3.5	5.0	6.8	2.1	3.8	4.1	6.0	3.7	4.6	3.8	3.9	10.6	3.0	1.7	3.3	1.8	5.6	2.5	1.5	5.0	2.6	2.9	3.2
FANCM	"FAAP250, KIAA1596"	ENSG00000187790	"Fanconi anemia complementation group M"	Q8IYD8	14	45135940-45200890	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055144			Supported	Nucleoplasm				Nucleoplasm		"HPA055144: "	"unprognostic (8.40e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.13e-2)"	4.7	3.9	3.9	4.4	8.4	9.8	5.7	8.2	7.9	5.7	3.5	4.9	4.9	2.6	6.7	4.8	4.5	4.2	3.7	3.8	3.4	3.3	4.1	3.1	3.3	6.6	3.2	3.6	6.2	3.3	4.5	4.5	4.4	9.3	3.5	3.8	4.8	4.1	4.8	4.2	5.2	3.5	3.8	3.4	8.9	3.2	15.4	4.2	15.2	3.3	2.9	6.4	3.8	4.3	6.7	3.2	7.6	3.6	2.0	4.1	1.1	7.7	6.7	8.0	7.5	6.4	4.0	6.5	10.2	3.9	8.0	10.4	10.9	6.0	10.3	5.8	2.4	10.5	9.4	4.3	11.0	7.5	5.2	4.7	7.6	6.0	1.1	12.2	6.0	2.2	1.6	8.1	5.1	6.8	8.5	9.0	6.7	7.7	9.0	8.8	3.2	11.5	8.4	12.5	4.7	3.3	5.5	7.3	1.9	9.0	7.4	3.8	8.0	5.7	5.4	11.7	11.0	10.7	7.7	4.6	8.2	10.2	2.3	7.6	7.0	7.6	1.3	4.6	4.0	3.6	2.2	6.7	2.5	1.5	1.0	4.2	4.1	3.5	2.1	2.0	1.7	3.2	1.7	1.1	3.9	8.4	8.2	7.9	3.4	3.3	3.2	3.6	9.3	4.2
FANK1		ENSG00000203780	"Fibronectin type III and ankyrin repeat domains 1"	Q8TC84	10	125896539-126009592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.3;fallopian tube: 24.7;testis: 44.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.2;HaCaT: 8.4;hTCEpi: 8.9;RPTEC TERT1: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	14	"T-reg: 28.3"	"Lineage enriched"	"Detected in single"	284	"T-cells: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038413			Supported	Nucleoplasm				Nucleoplasm		"HPA038413: AB_10697249"	"unprognostic (4.25e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (3.83e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.02e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.44e-1)"	0.5	2.4	4.1	1.3	8.3	0.7	3.4	0.8	1.8	2.5	2.2	4.0	3.8	1.6	2.3	18.5	2.2	24.7	4.9	0.5	4.9	6.4	4.5	0.1	4.0	0.8	2.7	1.3	5.6	3.1	2.3	7.8	2.0	14.1	1.5	3.3	2.0	1.5	2.9	0.2	3.9	1.9	1.3	2.1	0.3	3.5	44.7	2.4	0.4	5.8	1.1	1.7	1.7	1.4	0.0	0.0	0.0	0.0	0.0	28.3	0.1	6.2	2.1	0.5	3.6	2.8	2.8	4.0	2.4	1.7	0.6	0.6	0.1	17.2	0.0	0.4	1.8	8.4	0.0	3.0	0.5	0.2	0.1	0.0	0.7	0.0	1.1	0.3	0.6	0.8	8.9	2.4	0.8	0.9	0.3	0.0	1.0	5.2	0.0	1.2	0.4	0.2	0.0	0.2	0.5	12.3	1.7	0.4	1.8	1.9	4.0	0.5	0.6	0.3	0.8	1.2	2.0	1.7	0.1	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.1	4.1	8.3	0.8	1.8	4.9	6.4	2.7	1.3	14.1	2.4
FAR1	"FLJ22728, MLSTD2, SDR10E1"	ENSG00000197601	"Fatty acyl-CoA reductase 1"	Q8WVX9	11	13668670-13732346	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Cataract, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017322	Approved		Supported	Peroxisomes				Peroxisomes		"HPA017322: AB_1848424"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"prognostic favourable (2.27e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	16.3	11.1	19.0	14.2	28.2	42.7	13.7	24.4	24.0	17.3	20.9	33.8	11.1	24.7	17.4	17.1	38.1	12.7	9.2	13.9	20.4	16.1	9.7	3.3	13.9	12.2	32.8	24.0	16.7	15.8	25.1	16.5	15.8	30.0	14.1	25.1	10.0	14.6	10.9	11.4	8.0	13.4	20.2	47.8	13.9	39.4	12.8	32.2	13.2	13.2	17.2	15.0	16.7	22.1	2.8	15.8	21.8	13.7	5.0	4.5	4.0	26.9	17.6	17.5	13.6	16.7	19.3	9.5	24.2	9.7	17.9	19.0	18.5	23.3	34.7	10.8	19.2	29.5	25.7	24.4	27.5	10.2	20.9	14.8	16.1	0.1	16.1	29.7	12.0	14.6	25.2	12.9	38.8	17.4	23.1	10.4	14.6	13.6	22.0	8.9	9.1	25.6	19.4	22.3	9.7	17.3	43.9	13.5	9.8	22.9	21.8	11.8	13.4	18.6	21.6	24.7	21.1	22.6	20.1	5.8	19.7	29.5	15.7	9.1	14.9	4.6	13.7	15.0	4.5	11.9	3.1	2.1	2.2	3.8	15.8	2.8	2.0	3.4	21.8	5.0	9.4	2.4	2.8	4.0	19.0	28.2	24.4	24.0	20.4	16.1	32.8	24.0	30.0	32.2
FARP1	"CDEP, MGC87400, PLEKHC2, PPP1R75"	ENSG00000152767	"FERM, ARH/RhoGEF and pleckstrin domain protein 1"	Q9Y4F1	13	98142562-98455176	"Predicted intracellular proteins"		"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.7;Hep G2: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000760			Supported	Cytosol				Cytosol		"HPA000760: AB_1078816"	"unprognostic (4.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (1.39e-5)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.18e-2)"	10.4	16.5	21.3	9.1	14.6	1.4	28.3	4.6	19.0	18.3	22.9	11.2	16.0	6.5	16.5	26.2	5.9	15.4	15.1	10.7	16.0	13.1	43.4	38.4	29.3	9.2	11.7	20.0	11.0	32.7	14.1	17.5	22.2	17.2	23.9	10.6	16.8	27.2	21.9	14.0	8.0	8.0	18.8	19.7	9.5	17.2	8.1	10.6	1.5	28.7	3.9	3.6	17.7	18.7	2.2	0.1	0.3	0.2	0.0	0.8	0.2	0.2	3.3	14.9	21.0	4.3	8.5	7.2	22.4	14.7	12.7	11.2	25.8	10.0	0.0	8.6	38.7	0.4	6.3	6.2	21.4	0.4	6.4	0.1	11.7	39.7	11.5	0.0	0.2	9.9	2.8	3.7	0.8	8.3	0.0	0.2	8.7	5.6	0.8	0.1	7.1	3.9	7.7	5.8	0.4	28.0	14.4	6.4	13.9	2.7	5.9	15.9	8.5	0.0	7.9	13.7	5.3	9.2	11.3	0.2	0.2	0.1	6.4	0.4	9.5	0.3	0.1	0.0	0.3	0.2	0.0	2.2	0.8	0.6	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	21.3	14.6	4.6	19.0	16.0	13.1	11.7	20.0	17.2	10.6
FARSA	"CML33, FARSL, FARSLA"	ENSG00000179115	"Phenylalanyl-tRNA synthetase alpha subunit"	Q9Y285	19	12922479-12934037	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001911	Approved		Supported	Cytosol			11000	Cytosol		"HPA001911: AB_1848427"	"unprognostic (1.52e-1)"	"prognostic favourable (8.23e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (9.22e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.45e-3)"	"prognostic favourable (8.32e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.84e-2)"	18.0	20.7	24.8	23.6	29.5	23.5	15.4	24.6	49.2	17.7	24.0	18.3	14.9	22.1	16.1	13.1	26.6	21.2	16.3	24.9	23.9	30.1	23.0	39.6	13.4	27.6	25.6	28.1	19.1	26.7	17.8	21.0	22.9	29.1	18.5	15.0	14.8	25.1	20.4	33.3	27.8	18.8	15.3	17.2	21.2	18.9	17.1	18.6	32.7	24.4	15.2	22.0	19.5	15.2	34.7	42.2	28.9	41.2	38.3	40.2	39.7	29.1	27.6	11.1	23.8	7.7	7.3	20.0	21.0	13.6	30.1	23.7	33.7	12.4	32.2	33.8	11.8	22.4	27.0	24.0	11.0	18.9	40.7	25.3	24.3	26.7	25.0	48.7	33.4	10.0	17.7	23.2	18.7	16.3	38.1	6.8	12.6	39.1	57.8	60.7	34.6	46.9	30.0	11.5	41.4	15.8	17.2	34.8	31.9	14.1	24.4	14.9	19.2	29.7	15.6	24.5	10.8	37.2	39.0	45.2	38.5	33.5	22.2	44.1	25.2	17.3	39.2	28.9	32.5	41.2	40.2	31.9	32.0	30.2	42.2	34.7	32.9	31.2	2.5	38.3	30.4	34.1	29.4	39.7	24.8	29.5	24.6	49.2	23.9	30.1	25.6	28.1	29.1	18.6
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase beta subunit"	Q9NSD9	2	222570536-222656337	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036677: , HPA036678: AB_10673504, HPA061398: "	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (1.25e-4)"	15.7	10.8	11.9	12.6	23.5	11.5	16.0	15.1	28.5	11.6	17.3	13.7	5.9	15.9	14.2	11.7	19.1	10.8	7.2	13.4	13.7	15.1	11.7	18.3	9.0	12.0	11.6	18.0	16.7	18.6	15.0	15.7	8.8	29.4	11.2	20.7	9.6	12.3	11.5	33.2	14.1	11.5	14.9	9.7	10.3	13.9	15.6	11.2	15.6	11.9	17.1	14.2	11.8	12.0	16.3	16.0	1.2	11.4	18.5	20.0	14.6	22.0	13.0	15.1	19.7	13.8	19.9	23.3	22.5	14.2	22.2	18.2	32.8	12.2	10.8	17.1	16.4	18.6	29.1	25.2	32.8	16.2	15.1	24.8	14.7	20.9	21.6	36.1	10.3	13.3	19.8	25.4	39.0	21.0	37.3	22.3	27.0	20.6	21.6	20.4	19.3	16.2	21.3	36.4	35.0	18.2	14.4	24.6	8.0	9.4	16.5	19.4	15.3	15.2	11.4	19.1	15.7	27.3	27.1	10.7	10.7	39.5	14.9	24.3	19.9	0.2	8.5	1.2	11.4	10.3	16.8	16.3	15.4	14.0	16.0	14.0	20.0	17.2	0.9	18.5	11.4	8.0	13.3	14.6	11.9	23.5	15.1	28.5	13.7	15.1	11.6	18.0	29.4	11.2
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990582-89015785	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 40.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 40.1;T-cells: 30.9"					"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"		450000	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	13.5	26.3	6.1	17.3	7.7	12.4	10.6	2.1	7.2	15.6	14.2	6.1	7.0	5.9	15.7	16.6	14.1	14.2	14.5	8.9	8.2	2.7	11.7	21.9	28.6	15.6	6.0	3.9	24.7	4.1	4.5	4.6	9.0	7.5	22.3	21.3	4.4	7.1	8.5	4.3	9.6	16.3	12.5	10.2	15.3	5.0	7.3	5.1	12.5	10.0	15.8	14.4	14.8	21.4	3.0	4.0	40.1	6.8	1.2	30.9	3.9	8.5	3.3	1.7	5.5	14.2	21.0	0.0	18.9	19.1	0.7	3.7	0.0	9.3	1.7	7.3	17.7	1.3	0.3	15.8	1.3	27.5	2.7	0.1	1.8	5.6	13.6	0.9	0.4	26.0	14.2	11.8	25.5	1.6	0.0	43.8	19.2	0.7	2.7	1.4	0.2	0.9	0.1	0.1	1.7	26.5	2.7	0.1	0.1	2.7	0.0	0.3	6.0	0.3	4.1	6.0	3.4	5.6	4.3	17.2	1.7	0.1	5.0	3.4	1.8	11.3	3.2	9.4	3.3	3.9	4.8	3.0	10.4	7.2	4.0	0.7	1.2	3.4	40.1	1.2	6.8	0.0	30.9	3.9	6.1	7.7	2.1	7.2	8.2	2.7	6.0	3.9	7.5	5.1
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078333-82098332	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 147.6"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 152.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			1600000	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavourable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	147.6	7.8	8.2	14.2	11.5	11.1	57.5	19.1	23.0	6.6	27.7	17.0	14.1	8.2	4.7	14.2	17.1	4.3	19.4	6.3	7.9	6.7	3.7	30.8	26.8	9.8	7.3	11.5	6.4	10.4	6.7	15.3	8.4	21.7	28.8	3.4	7.6	16.9	10.8	7.5	17.2	6.5	4.6	8.4	5.1	11.9	6.6	8.8	1.9	5.1	10.7	5.4	8.0	6.6	0.5	1.4	0.0	0.8	0.2	1.9	0.8	23.1	24.3	11.3	7.8	18.3	12.4	24.2	4.6	6.0	4.9	9.0	25.4	15.8	7.7	3.8	3.5	19.4	10.9	21.3	0.9	3.6	47.4	16.0	18.2	33.9	5.2	8.6	2.4	11.9	5.6	12.5	2.9	5.5	24.1	6.9	1.7	40.1	9.4	13.7	21.9	14.2	8.3	6.4	15.3	5.5	29.7	28.1	15.6	6.8	152.8	12.4	27.2	16.5	9.6	7.2	14.8	5.9	11.0	9.3	2.0	8.0	4.3	9.4	10.6	0.0	0.8	0.0	1.2	0.5	0.7	0.5	1.9	1.4	1.4	0.2	0.7	0.6	0.0	0.2	0.4	1.1	0.6	0.8	8.2	11.5	19.1	23.0	7.9	6.7	7.3	11.5	21.7	8.8
FASTKD2	KIAA0971	ENSG00000118246	"FAST kinase domains 2"	Q9NYY8	2	206765357-206792509	"Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067191			Supported	Mitochondria				Mitochondria		"HPA067191: "	"unprognostic (1.19e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.36e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.69e-3)"	"prognostic unfavourable (8.29e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.57e-2)"	17.2	20.0	12.8	11.2	24.2	9.4	17.1	18.7	23.9	15.5	15.0	9.0	13.1	14.1	19.7	12.7	20.9	15.5	11.2	23.9	12.1	8.4	19.0	27.4	12.8	12.4	10.4	18.1	16.9	15.1	16.6	29.4	12.3	21.2	13.5	17.0	10.3	15.5	11.5	42.0	17.1	14.5	15.6	11.0	14.0	16.3	10.8	11.8	14.2	17.7	19.4	16.0	16.7	14.2	13.4	19.6	5.1	13.9	19.2	19.5	12.8	14.9	13.7	12.8	14.5	14.6	17.5	24.0	17.5	14.9	30.1	17.2	24.3	16.4	18.9	19.7	18.2	20.5	15.9	24.7	26.7	5.8	10.3	14.7	14.1	23.4	17.8	31.8	13.8	18.8	25.3	22.8	25.1	20.2	27.8	9.6	22.1	12.8	13.5	13.6	22.9	26.3	11.8	19.9	19.4	20.8	25.1	18.7	12.0	13.5	23.0	20.8	10.8	16.7	15.7	18.4	16.5	12.6	18.2	9.7	15.9	24.4	21.4	14.8	15.1	5.1	13.9	3.2	13.1	13.5	14.4	13.4	14.6	13.7	19.6	10.8	19.5	17.5	0.8	19.2	9.8	9.4	11.3	12.8	12.8	24.2	18.7	23.9	12.1	8.4	10.4	18.1	21.2	11.8
FASTKD3	"FLJ23274, MGC5297"	ENSG00000124279	"FAST kinase domains 3"	Q14CZ7	5	7859159-7869037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068525, HPA074462"	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA068525: , HPA074462: "	"unprognostic (5.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"prognostic unfavourable (1.87e-5)"	"unprognostic (6.66e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"prognostic favourable (8.53e-4)"	7.1	15.5	8.6	9.7	13.3	7.6	12.3	9.1	15.0	8.3	10.7	8.6	7.9	10.4	8.8	10.2	8.9	7.5	6.5	7.2	8.7	7.3	17.8	14.5	8.3	10.0	9.2	13.7	9.3	8.4	13.0	10.8	6.4	8.0	8.6	13.5	8.1	11.1	15.8	10.2	9.0	12.1	7.8	8.8	12.0	9.1	6.0	7.4	12.2	8.9	7.4	12.2	9.1	7.0	9.6	6.7	7.4	7.3	4.8	10.3	4.7	7.0	6.2	6.1	7.9	3.8	4.9	12.0	6.0	5.1	9.3	7.2	9.3	7.6	24.6	12.0	6.2	7.5	14.9	8.3	13.3	6.7	7.7	8.5	20.3	7.3	5.2	14.0	7.1	5.5	3.6	8.7	5.4	5.1	11.6	4.3	7.0	5.1	9.4	8.2	5.6	8.8	11.0	7.5	5.6	7.6	7.6	4.3	4.0	17.8	7.9	8.7	7.1	6.5	3.5	9.3	9.4	9.6	9.7	5.0	4.7	15.7	6.2	13.0	7.5	3.8	5.4	7.4	6.1	7.3	8.2	9.6	9.4	6.5	6.7	6.8	10.3	9.7	0.2	4.8	5.7	3.8	10.2	4.7	8.6	13.3	9.1	15.0	8.7	7.3	9.2	13.7	8.0	7.4
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU, ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120628-65122473	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059015	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: "	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	79.7	95.0	90.6	84.9	76.2	186.7	95.4	50.9	80.9	103.6	134.8	77.6	63.4	77.8	84.0	80.5	115.2	100.0	87.2	133.9	70.0	58.9	88.0	162.9	77.5	182.6	78.9	40.8	176.0	202.8	27.5	56.1	73.2	46.6	123.5	53.0	67.8	97.3	76.7	190.8	86.8	93.8	97.5	72.4	130.9	79.2	53.6	53.2	126.8	121.5	83.6	149.5	122.0	136.6	291.3	169.7	90.9	119.0	116.3	253.8	346.5	78.1	51.5	45.5	72.1	44.6	66.6	62.4	44.6	43.5	62.6	39.7	58.2	78.5	93.1	121.2	38.4	69.1	42.2	59.5	26.1	68.3	64.6	75.1	54.1	79.9	82.0	89.0	82.8	82.1	99.1	53.7	73.2	48.2	70.0	110.4	33.1	97.7	102.7	179.6	125.2	85.8	100.0	36.4	182.7	57.6	44.2	63.4	63.6	34.7	100.3	139.4	89.7	123.4	45.6	56.6	65.3	87.3	71.3	120.1	114.1	158.5	68.6	69.3	64.0	90.9	119.0	70.6	128.9	107.0	176.1	291.3	212.1	165.5	132.1	281.7	253.8	198.1	78.9	116.3	92.8	169.7	153.8	346.5	90.6	76.2	50.9	80.9	70.0	58.9	78.9	40.8	46.6	53.2
FBF1	"ALB, FBF-1, FLJ00103, KIAA1863"	ENSG00000188878	"Fas binding factor 1"	Q8TES7	17	75909574-75941140	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023677			Supported	Centrosome				Centrosome		"HPA023677: AB_1848440"	"unprognostic (7.40e-3)"	"unprognostic (9.90e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.14e-3)"	"unprognostic (7.88e-4)"	"unprognostic (5.76e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.31e-5)"	"unprognostic (6.76e-2)"	"unprognostic (1.08e-9)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.77e-1)"	4.5	5.5	9.0	4.8	14.9	6.5	3.8	6.1	11.8	3.6	3.1	9.1	8.4	4.0	5.8	11.8	6.4	8.3	5.9	2.7	11.1	6.0	3.9	1.9	4.5	5.5	10.0	8.6	4.9	5.3	5.3	9.8	3.2	10.3	6.4	3.2	5.6	6.0	7.0	2.5	18.0	5.1	3.0	9.4	6.6	3.6	40.4	11.1	5.2	14.0	2.1	5.5	3.6	6.1	0.8	1.9	0.5	1.4	1.1	2.2	0.7	9.5	12.7	3.8	7.1	3.6	2.5	10.6	5.5	1.0	3.9	2.8	3.2	5.6	4.7	3.6	2.6	6.1	2.2	3.9	2.9	2.7	4.2	4.2	7.7	2.4	1.8	1.4	6.6	2.5	4.8	6.4	4.3	2.9	7.7	5.4	2.6	10.7	11.8	4.7	3.2	5.5	9.5	6.2	4.1	1.9	1.6	4.4	4.0	7.8	6.0	3.1	16.6	3.4	1.7	8.5	6.7	4.3	5.0	9.4	2.4	1.9	5.3	3.1	8.1	0.5	0.4	0.4	1.9	1.4	0.5	0.8	1.3	2.0	0.1	0.0	1.5	1.8	0.2	1.1	0.8	1.9	2.2	0.7	9.0	14.9	6.1	11.8	11.1	6.0	10.0	8.6	10.3	11.1
FBL	"FIB, FLRN, Nop1, RNU3IP1"	ENSG00000105202	Fibrillarin	P22087	19	39834458-39846414	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001514, HPA049546"	Supported		Supported	"Nucleoli fibrillar center"			190000	"Nucleoli fibrillar center"		"CAB001514: AB_367009, HPA049546: "	"prognostic favourable (1.65e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.69e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavourable (4.52e-6)"	"unprognostic (4.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	29.1	20.3	16.3	50.3	15.9	40.0	43.2	15.1	18.0	46.3	42.7	13.9	24.7	20.2	34.7	24.7	50.0	43.2	38.0	32.6	13.7	11.8	20.3	25.0	29.7	82.7	15.5	13.6	70.5	67.8	19.9	16.7	24.8	11.8	37.7	34.2	17.9	27.3	40.1	47.7	49.0	25.4	36.2	16.5	42.5	24.5	28.3	14.5	56.3	35.4	52.9	58.2	43.8	54.5	26.9	23.9	1.8	13.0	26.5	33.7	20.9	37.9	79.2	33.3	37.3	13.4	23.3	20.1	21.9	19.3	37.8	36.1	45.5	22.3	86.8	20.3	18.7	15.4	48.8	46.5	47.3	15.6	61.3	34.9	28.8	41.7	17.4	81.3	27.0	18.7	17.0	30.6	64.3	29.2	54.7	36.0	21.1	50.0	70.4	35.0	32.7	23.7	39.1	33.8	43.2	20.7	44.0	45.0	26.3	21.0	33.1	13.2	16.9	29.6	15.6	18.1	28.7	24.9	50.1	25.0	26.1	58.5	18.2	53.2	16.5	0.5	13.0	1.8	23.2	10.8	33.2	26.1	24.5	22.7	23.1	26.9	33.7	31.8	1.0	26.5	11.4	23.9	17.1	20.9	16.3	15.9	15.1	18.0	13.7	11.8	15.5	13.6	11.8	14.5
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 53.1;TIME: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"				"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: "	"unprognostic (4.10e-2)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavourable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	11.6	6.0	1.7	12.8	1.4	0.0	10.1	0.8	1.3	21.5	36.6	1.4	26.8	24.6	30.3	15.8	17.8	16.5	60.2	21.7	1.2	1.0	18.2	3.0	14.7	16.1	1.8	1.6	36.0	13.0	13.9	3.8	21.5	2.3	26.7	15.7	9.0	13.0	26.5	4.1	6.2	62.8	18.7	1.3	22.7	18.9	22.3	0.9	1.3	10.3	7.4	6.3	24.7	16.9	1.8	1.3	4.6	1.2	1.6	1.2	0.3	6.4	3.6	3.2	0.1	0.8	1.7	4.4	11.0	17.6	8.2	6.5	1.2	9.7	0.0	23.9	17.6	12.5	2.3	25.2	4.0	0.0	1.2	0.0	0.9	6.2	21.1	0.0	0.1	8.4	16.8	6.8	16.1	53.1	0.2	1.6	2.7	0.1	0.1	0.1	3.3	4.7	0.0	0.0	0.2	10.2	4.5	0.0	7.8	5.8	0.7	1.2	1.3	0.1	82.8	10.8	1.4	0.1	5.0	0.1	0.2	0.1	1.6	0.0	0.1	4.6	1.2	1.0	0.7	0.5	0.6	1.0	0.7	0.7	0.4	1.8	1.1	1.2	3.5	1.6	0.7	1.3	0.4	0.3	1.7	1.4	0.8	1.3	1.2	1.0	1.8	1.6	2.3	0.9
FBLL1	LOC345630	ENSG00000188573	"Fibrillarin like 1"	A6NHQ2	5	168529116-168530634	"Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 18.9;SH-SY5Y: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049546			Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA049546: "	"unprognostic (2.75e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.18e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.8	6.2	10.3	0.9	12.1	0.7	1.1	10.6	24.9	1.0	0.9	0.9	0.0	1.4	0.8	0.8	0.8	1.4	1.1	1.3	11.0	18.4	1.1	0.9	0.9	0.7	9.7	8.5	1.2	2.1	1.8	7.4	1.0	7.9	1.4	0.9	0.5	1.4	1.3	0.9	1.5	1.6	1.1	3.0	0.8	1.4	5.1	1.7	0.0	0.8	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.4	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.4	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	18.9	15.8	1.6	0.0	0.8	0.0	1.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.1	10.6	16.9	11.0	18.4	9.7	8.5	7.9	1.7
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549131-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 73.8;fHDF/TERT166: 48.4;HMC-1: 58.9;HSkMC: 42.8;U-2197: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.2;naive CD8 T-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	7	"olfactory region: 15.4"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"		28000000	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	58.5	2.7	1.8	8.0	2.2	0.1	34.3	0.8	3.2	21.4	11.5	1.3	9.5	2.1	11.6	23.6	32.7	7.2	21.9	80.5	1.6	1.7	2.1	1.2	7.8	5.1	2.4	1.4	6.3	3.2	1.1	0.9	31.8	2.3	22.1	4.2	7.9	10.8	3.3	20.1	20.8	6.1	42.9	1.5	2.3	6.9	41.8	0.5	4.8	20.7	23.8	8.5	34.2	36.3	2.2	9.2	0.0	0.0	0.4	5.4	1.1	0.0	0.2	9.5	0.0	73.8	10.0	4.5	23.0	18.4	23.1	15.3	1.4	0.0	0.0	1.1	48.4	0.0	0.0	0.1	4.3	0.0	0.0	18.2	0.4	0.0	5.0	0.0	58.9	42.8	0.3	3.6	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.1	2.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.3	9.2	2.2	0.0	5.4	0.0	0.4	0.0	0.7	0.0	1.1	1.8	2.2	0.8	3.2	1.6	1.7	2.4	1.4	2.3	0.5
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869412-91947987	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 85.9;ASC TERT1: 44.9;BJ: 40.2;BJ hTERT+: 37.7;fHDF/TERT166: 71.8;HSkMC: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.5"	"Group enriched"	"Detected in many"	19	"granulocytes: 8.5;T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Supported	"Plasma membrane"	"Secreted to extracellular matrix"		4500000	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favourable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	48.3	23.5	3.4	11.5	9.5	1.8	49.5	2.2	5.6	52.4	26.6	5.3	20.3	6.0	51.7	36.0	22.6	32.2	97.4	54.5	2.5	2.6	38.9	12.1	50.5	8.6	7.0	4.1	36.5	14.6	7.6	3.9	21.0	9.4	41.2	6.4	40.6	18.3	23.8	24.7	17.5	12.8	51.8	6.8	48.2	18.8	43.9	2.1	1.2	30.3	15.1	9.4	56.4	51.1	0.2	0.1	8.5	0.3	0.0	2.8	0.6	0.0	0.2	0.0	0.0	85.9	44.9	4.5	40.2	37.7	1.1	0.8	0.7	0.0	0.0	0.8	71.8	0.0	1.8	0.1	0.2	0.0	0.4	0.0	0.8	0.0	14.3	0.0	0.0	41.2	0.0	0.7	2.6	1.8	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.2	0.0	0.0	0.0	2.2	0.1	0.5	0.5	0.0	0.3	0.5	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.2	3.5	1.2	0.2	0.7	0.1	0.5	0.1	0.0	0.2	1.7	2.8	4.1	0.0	0.3	0.1	0.1	0.6	3.4	9.5	2.2	5.6	2.5	2.6	7.0	4.1	9.4	2.1
FBXL17	"DKFZP434C1715, Fbl17, Fbx13, FBXO13"	ENSG00000145743	"F-box and leucine rich repeat protein 17"	Q9UF56	5	107859035-108382098	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036410, HPA036411"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA036410: , HPA036411: AB_10669603"	"unprognostic (8.15e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.30e-2)"	"prognostic favourable (4.60e-8)"	"unprognostic (1.86e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (3.35e-2)"	13.7	13.8	22.2	7.8	27.4	5.4	13.3	18.0	27.4	11.5	9.8	7.9	12.0	10.3	10.1	9.3	12.0	9.3	10.4	25.1	18.5	19.0	16.8	13.6	9.8	12.0	16.8	17.1	9.7	9.8	27.5	12.5	6.1	11.7	12.0	10.5	12.4	9.6	14.4	46.1	9.6	10.5	11.6	12.3	10.4	9.6	8.2	8.9	16.8	23.8	9.7	10.0	10.8	9.0	2.0	1.9	3.3	1.3	1.0	2.3	0.5	6.5	6.5	7.5	13.7	12.6	13.3	5.0	8.0	18.0	6.6	8.9	1.3	13.8	7.3	12.7	12.9	2.9	5.9	9.1	10.3	7.3	5.4	6.9	7.6	3.2	6.6	4.6	8.0	9.4	13.8	6.1	4.5	7.8	0.9	9.5	14.3	4.9	4.0	5.9	1.0	6.1	5.6	10.0	9.4	9.2	9.1	6.4	11.0	10.4	9.3	9.8	7.3	11.0	8.4	15.0	4.7	4.6	10.3	7.5	10.4	5.4	13.2	7.1	9.7	0.4	0.9	3.3	2.1	1.3	2.2	1.1	1.9	2.3	1.1	2.0	2.0	1.6	1.7	1.0	0.7	1.9	1.3	0.5	22.2	27.4	18.0	27.4	18.5	19.0	16.8	17.1	11.7	8.9
FBXL20	"Fbl2, Fbl20, MGC15482"	ENSG00000108306	"F-box and leucine rich repeat protein 20"	Q96IG2	17	39252644-39402523	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044748, HPA050397"	Uncertain		Supported	Microtubules				Microtubules		"HPA044748: , HPA050397: "	"unprognostic (7.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	9.1	12.9	12.7	11.0	13.3	15.4	9.9	23.6	13.9	10.3	10.4	11.1	9.3	7.6	9.6	8.0	9.8	9.2	8.1	8.0	12.7	11.7	9.4	9.9	8.7	7.4	10.1	10.2	11.0	9.4	12.2	12.3	11.6	10.1	8.5	9.2	8.7	8.2	10.2	10.8	11.7	8.0	11.0	10.7	9.1	8.2	25.1	11.3	15.2	8.7	4.2	8.5	9.4	9.8	4.2	3.6	18.7	4.2	5.4	5.3	1.5	2.3	4.8	4.8	5.0	6.2	4.4	2.7	3.2	4.4	3.8	4.6	1.5	5.4	3.6	7.3	4.2	5.4	5.5	3.8	5.5	6.8	7.3	3.8	4.2	4.5	4.5	5.3	4.9	3.7	4.5	3.7	4.3	4.5	7.5	2.7	3.6	3.4	5.3	3.8	1.2	2.0	2.6	9.5	2.4	1.9	3.6	3.0	2.3	6.2	39.2	4.1	6.1	5.2	3.4	4.2	4.2	3.1	3.0	4.7	4.9	3.0	5.3	2.5	3.3	15.4	3.8	11.8	3.0	3.1	2.7	2.5	2.9	2.7	2.8	4.2	2.6	2.6	18.7	5.4	4.2	3.6	5.3	1.5	12.7	13.3	23.6	13.9	12.7	11.7	10.1	10.2	10.1	11.3
FBXL3	"FBL3, FBL3A, FBXL3A"	ENSG00000005812	"F-box and leucine rich repeat protein 3"	Q9UKT7	13	76992598-77027195	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"		"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053283, HPA065626"			Enhanced	"Nuclear bodies"				"Nuclear bodies"		"HPA053283: , HPA065626: "	"unprognostic (3.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-1)"	41.8	19.9	29.5	19.4	28.3	44.7	35.1	36.7	29.0	30.4	20.7	17.7	27.4	18.1	31.8	22.2	22.7	27.1	18.6	23.7	23.2	18.9	29.6	23.3	22.5	23.8	31.3	24.0	35.9	15.9	18.1	16.5	30.4	23.2	26.0	19.5	11.8	22.5	28.3	28.8	23.2	21.9	25.8	26.4	22.6	17.9	26.2	28.5	28.7	37.3	19.8	23.0	24.8	28.8	4.1	2.9	11.9	4.4	2.8	7.2	2.3	20.6	5.3	10.6	7.2	25.6	25.6	8.4	23.8	19.3	14.1	18.1	7.6	14.6	13.3	15.9	20.8	15.6	10.4	12.6	20.2	26.6	28.0	17.5	16.5	6.8	17.1	21.9	13.6	21.4	16.9	11.1	15.4	18.3	6.5	10.3	16.6	7.4	15.7	11.8	4.0	9.9	12.9	12.0	8.0	15.0	10.9	12.6	10.3	15.2	14.7	13.3	8.2	24.3	22.5	13.6	8.9	9.2	11.4	13.4	15.3	12.4	23.5	15.9	14.7	11.9	2.8	6.4	3.3	4.1	4.3	4.1	5.9	3.3	2.7	4.0	7.1	4.7	7.4	2.8	4.4	2.9	7.2	2.3	29.5	28.3	36.7	29.0	23.2	18.9	31.3	24.0	23.2	28.5
FBXL4	"FBL4, FBL5"	ENSG00000112234	"F-box and leucine rich repeat protein 4"	Q9UKA2	6	98868538-98948006	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029140, CAB033362"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB033362: AB_2103974, HPA029140: AB_10611967"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.62e-1)"	13.7	18.9	9.2	11.2	13.1	7.9	18.4	10.7	14.2	12.7	10.9	14.2	14.4	9.9	12.9	19.2	11.9	13.2	11.6	13.5	10.1	11.1	22.3	24.9	13.2	16.4	15.2	8.4	14.4	21.7	26.8	17.4	11.3	13.8	13.9	11.8	11.5	14.9	14.8	21.2	11.9	12.2	15.2	20.1	10.5	12.5	6.9	13.2	19.9	20.3	7.5	12.2	12.6	12.6	6.8	3.9	16.5	5.7	4.1	6.7	3.9	4.6	7.4	6.4	8.6	10.8	19.9	6.9	10.5	8.9	6.2	8.8	3.4	8.8	10.6	9.8	8.7	6.7	7.3	7.6	9.4	17.3	6.0	7.5	5.3	7.5	8.4	9.1	7.6	11.3	13.9	5.6	15.7	7.9	10.0	8.4	11.1	4.5	3.4	4.5	3.3	4.6	11.8	4.4	8.5	11.8	6.7	8.1	6.5	5.5	7.5	9.8	5.5	6.7	10.9	7.2	3.2	10.0	7.5	2.9	2.6	4.5	8.9	8.5	8.5	16.5	4.8	12.6	5.1	4.5	6.7	6.8	5.1	5.0	3.9	6.7	6.6	6.0	6.1	4.1	5.7	2.5	6.1	3.9	9.2	13.1	10.7	14.2	10.1	11.1	15.2	8.4	13.8	13.2
FBXO11	"FBX11, UBR6"	ENSG00000138081	"F-box protein 11"	Q86XK2	2	47789316-47905793	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002690			Supported	Nucleoplasm				Nucleoplasm		"HPA002690: AB_1848448"	"unprognostic (1.18e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	18.0	13.8	18.6	15.7	18.8	17.5	26.1	42.2	31.7	21.3	15.3	12.7	15.1	10.4	28.9	16.8	14.5	16.3	15.0	14.1	16.9	13.6	14.3	17.0	22.3	15.0	17.4	21.7	28.9	12.4	25.2	14.4	14.5	19.7	15.3	13.3	12.0	15.6	16.5	22.9	14.5	13.5	19.9	16.4	14.5	13.3	25.1	16.0	14.6	17.3	9.8	17.2	19.3	21.9	4.7	4.3	8.2	2.7	4.8	6.6	2.0	25.5	13.3	32.0	27.2	22.5	21.2	19.1	17.9	24.7	16.8	16.6	11.2	13.1	16.6	23.5	25.2	12.8	21.8	18.9	24.8	11.0	10.9	15.4	11.0	17.8	21.5	16.0	16.4	20.6	21.4	14.9	25.3	21.5	15.0	17.2	20.5	12.3	15.4	15.7	19.5	13.2	20.1	29.7	12.3	24.0	20.9	22.6	26.7	17.0	15.9	26.2	7.4	13.7	23.1	20.8	19.2	14.0	19.6	14.9	7.7	30.2	14.1	15.1	21.2	8.2	2.3	4.3	3.8	2.7	3.8	4.7	3.4	4.1	3.1	3.6	6.6	4.1	4.1	4.8	2.4	4.3	3.6	2.0	18.6	18.8	42.2	31.7	16.9	13.6	17.4	21.7	19.7	16.0
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114087-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003289			Supported	"Nucleoplasm,Focal adhesion sites"				Nucleoplasm	"Focal adhesion sites"	"HPA003289: "	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	17.4	13.1	16.4	14.9	19.7	12.1	19.6	22.5	21.6	18.7	15.9	15.0	13.1	13.3	16.2	13.3	22.2	14.1	15.1	15.0	15.3	15.6	21.4	26.6	14.0	14.9	15.9	13.6	18.7	13.4	25.7	16.2	15.8	20.2	16.5	17.1	11.9	16.6	14.9	24.6	32.3	14.4	15.7	15.6	16.1	13.7	11.9	15.5	19.4	15.7	13.1	16.1	17.5	20.0	10.3	10.0	14.7	8.9	10.9	11.0	5.7	14.0	6.2	9.7	10.4	10.2	11.8	16.0	14.2	11.7	9.7	9.2	8.6	11.1	6.8	14.8	13.0	12.4	14.3	13.8	16.7	9.6	16.0	8.6	7.9	6.2	12.7	16.2	11.4	11.4	16.7	14.0	25.5	16.0	14.0	9.8	17.3	4.6	8.4	8.2	23.2	13.4	9.0	13.9	12.8	18.2	9.4	15.8	17.0	14.8	22.8	15.8	12.0	16.3	18.3	12.0	9.1	15.0	26.8	10.6	12.5	10.6	14.9	7.9	23.3	8.9	8.7	14.7	7.8	8.1	10.1	10.3	8.2	9.6	10.0	10.2	8.3	9.1	5.3	10.9	8.9	4.7	11.0	5.7	16.4	19.7	22.5	21.6	15.3	15.6	15.9	13.6	20.2	15.5
FBXO32	"ATROGIN1, Fbx32, MAFbx"	ENSG00000156804	"F-box protein 32"	Q969P5	8	123497889-123541206	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 200.5"	"Group enriched"	"Detected in some"	5	"HDLM-2: 59.7;U-251 MG: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058955, HPA065209"			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA058955: , HPA065209: "	"unprognostic (2.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (8.58e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-3)"	3.5	1.5	2.4	4.9	5.1	0.8	13.2	1.0	3.8	5.6	31.1	8.9	14.4	2.6	25.3	5.8	8.1	15.8	16.6	26.1	2.9	2.1	1.5	1.0	1.7	4.1	10.2	2.5	9.5	2.0	0.9	5.6	4.9	7.3	19.7	8.0	4.2	8.0	23.1	200.5	3.7	6.5	36.9	8.8	1.7	10.8	3.5	7.6	0.2	9.0	15.1	3.1	24.8	16.1	0.6	0.2	2.9	0.3	4.4	7.6	1.4	1.8	0.3	0.0	0.0	3.8	0.9	0.6	0.3	4.0	0.2	0.4	0.0	1.0	0.0	1.1	2.9	0.1	0.0	0.3	0.3	59.7	1.4	0.0	2.1	0.0	5.2	0.0	0.2	7.7	2.6	0.9	1.1	0.2	0.1	0.5	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.6	0.6	0.1	0.4	0.4	6.8	6.9	6.6	0.1	0.2	1.1	0.3	0.4	17.9	6.2	0.8	0.1	4.5	0.0	0.8	2.9	0.3	0.0	3.7	0.2	3.6	0.6	5.1	5.4	0.2	0.6	6.0	7.6	0.2	4.4	0.2	0.1	4.5	1.4	2.4	5.1	1.0	3.8	2.9	2.1	10.2	2.5	7.3	7.6
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: "	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	23.2	19.3	13.8	17.7	21.2	12.6	20.6	20.8	21.1	22.3	18.4	20.0	20.4	13.8	25.2	18.2	17.6	16.7	16.9	24.1	18.8	13.8	19.2	25.7	20.7	19.0	16.3	18.8	19.2	16.9	29.2	34.1	19.7	24.6	22.2	19.3	16.4	19.4	18.7	28.5	19.3	18.4	18.2	17.8	24.8	18.8	20.0	18.9	26.9	18.1	17.1	21.7	21.7	18.0	5.5	8.1	13.7	14.8	8.0	7.9	4.9	8.4	9.0	14.1	10.3	15.9	17.9	7.4	11.1	21.3	15.9	21.8	13.3	10.5	12.4	11.0	18.0	12.0	14.7	14.0	19.2	13.5	9.4	7.3	13.3	9.0	15.9	19.8	12.1	17.3	12.0	15.2	15.0	21.3	8.1	13.4	15.5	3.4	12.4	9.3	6.6	13.8	11.2	20.6	12.3	15.4	9.9	12.6	12.3	14.8	9.9	14.3	10.5	14.4	13.9	14.5	5.3	7.6	12.3	16.5	16.6	10.6	14.5	11.3	11.0	13.7	6.3	9.0	5.9	8.6	6.3	5.5	5.5	5.7	8.1	4.8	5.7	7.2	12.0	8.0	14.8	3.9	7.9	4.9	13.8	21.2	20.8	21.1	18.8	13.8	16.3	18.8	24.6	18.9
FBXO5	"EMI1, FBX5, Fbxo31"	ENSG00000112029	"F-box protein 5"	Q9UKT4	6	152970519-152983579	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 29.3;lymphoid tissue: 69.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008106, HPA029048"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB008106: AB_828450, HPA029048: AB_10602132"	"unprognostic (1.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.25e-9)"	"prognostic favourable (8.65e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-1)"	4.2	2.9	2.7	13.7	3.1	29.3	3.5	6.6	3.3	5.3	6.1	1.8	1.8	3.5	5.8	3.7	6.1	4.4	3.0	2.4	2.8	2.3	3.0	4.1	3.8	10.8	4.4	1.6	5.1	3.1	2.0	3.4	8.2	3.5	3.9	4.1	1.6	6.9	2.4	1.6	3.3	5.0	3.9	2.4	10.6	3.5	4.2	3.9	69.0	5.6	4.8	11.2	3.5	4.5	6.8	5.3	0.0	3.5	8.8	7.9	3.2	11.0	5.7	24.2	16.3	1.8	3.8	7.7	26.8	12.1	20.2	22.8	11.8	6.6	27.0	8.2	7.1	10.6	19.1	8.9	24.3	14.4	17.1	27.1	8.5	12.7	3.6	24.1	16.7	2.7	1.7	13.6	10.7	9.2	28.5	25.4	18.3	8.4	27.5	15.6	14.1	8.5	23.3	19.4	17.4	7.1	6.0	15.9	16.5	19.0	10.3	5.0	7.4	22.7	6.9	15.2	19.8	17.5	31.2	8.5	9.4	39.9	11.0	18.0	18.3	0.0	2.4	0.0	3.8	3.0	5.4	6.8	6.3	6.9	4.6	6.0	6.2	6.4	0.0	8.8	3.5	5.3	7.9	3.2	2.7	3.1	6.6	3.3	2.8	2.3	4.4	1.6	3.5	3.9
FBXO7	"Fbx, FBX7, PARK15"	ENSG00000100225	"F-box protein 7"	Q9Y3I1	22	32474676-32498829	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032113, HPA032114, CAB034296"	Uncertain		Supported	Nucleoplasm,Cytosol			430000	"Nucleoplasm, Cytosol"		"CAB034296: AB_2102563, HPA032113: , HPA032114: AB_10696202"	"unprognostic (3.99e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (1.08e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.53e-1)"	"prognostic favourable (2.66e-10)"	"unprognostic (3.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.79e-3)"	22.9	27.8	25.5	16.2	28.6	92.9	27.7	14.5	30.6	23.7	22.5	55.9	17.0	20.1	22.5	29.6	18.5	28.3	18.8	16.3	29.3	26.2	43.3	51.2	24.9	26.0	39.9	18.2	27.7	26.9	27.6	23.2	31.8	33.4	23.0	22.7	35.9	18.6	23.6	12.4	20.7	28.4	24.0	52.7	29.5	20.6	42.1	24.4	33.3	77.6	16.4	24.4	19.7	26.3	22.0	25.4	60.4	21.7	28.6	33.0	24.9	21.3	15.0	19.6	22.1	30.3	28.9	14.2	18.3	33.1	29.0	34.6	14.8	14.6	19.6	15.3	31.3	14.3	28.5	23.4	29.8	33.7	25.8	27.0	16.4	22.9	36.9	35.3	24.1	24.1	37.9	25.5	19.6	31.2	21.4	25.5	31.4	15.7	17.5	22.1	7.7	11.2	17.3	20.8	23.6	33.2	22.3	28.7	18.8	22.8	18.4	64.7	10.2	18.7	21.8	15.2	21.7	14.7	14.3	18.0	19.1	18.8	28.5	18.0	60.6	60.4	18.9	39.8	27.6	21.7	33.0	22.0	25.3	27.0	25.4	19.6	22.4	24.3	7.2	28.6	20.7	16.7	30.7	24.9	25.5	28.6	14.5	30.6	29.3	26.2	39.9	18.2	33.4	24.4
FBXW7	"AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10"	ENSG00000109670	"F-box and WD repeat domain containing 7"	Q969H0	4	152320544-152536063	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 60.1;skin 1: 45.0"	"Cell line enhanced"	"Detected in all"		"U-266/70: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013793, CAB029987"	Supported		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB013793: AB_2533451, CAB029987: AB_2246842"	"unprognostic (3.32e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.32e-3)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.17e-3)"	9.2	6.8	27.0	8.9	27.9	11.1	9.8	27.2	60.1	5.5	6.1	3.6	3.8	4.9	6.0	18.3	9.8	10.6	6.3	10.9	21.4	10.1	4.1	7.3	6.9	9.8	9.1	40.5	6.4	8.0	6.4	7.3	6.2	37.2	5.1	6.9	2.8	7.6	5.3	15.8	45.0	6.5	6.1	6.4	10.1	8.0	13.7	5.7	6.5	6.8	10.6	12.3	7.9	6.5	2.9	2.2	16.6	3.4	7.8	5.0	1.3	4.9	3.9	10.2	7.4	7.1	5.1	8.4	7.1	6.5	4.4	4.2	7.9	6.3	12.7	2.0	6.8	2.9	8.7	16.0	6.2	7.2	4.1	5.9	4.8	5.6	7.2	14.4	5.4	8.1	25.3	7.6	12.9	7.7	9.3	13.6	5.5	6.9	16.5	5.7	5.0	3.1	16.6	4.3	2.5	5.4	8.5	6.5	5.6	4.5	6.2	3.9	3.4	6.8	8.1	6.0	6.8	3.1	4.0	37.4	21.3	12.4	4.8	4.7	4.3	16.6	3.1	1.7	5.0	3.4	3.3	2.9	3.7	3.2	1.8	2.4	3.9	3.2	5.5	7.8	2.5	2.2	3.3	1.3	27.0	27.9	27.2	60.1	21.4	10.1	9.1	40.5	37.2	5.7
FBXW8	"FBW6, FBW8, FBX29, FBXO29"	ENSG00000174989	"F-box and WD repeat domain containing 8"	Q8N3Y1	12	116910956-117031148	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038850, HPA038851"	Supported		Supported	Cytosol				Cytosol		"HPA038850: , HPA038851: AB_10673479"	"unprognostic (2.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.55e-1)"	10.5	10.6	8.5	16.2	9.5	5.6	10.4	8.2	9.5	13.1	9.0	12.3	14.7	6.2	16.4	14.1	9.5	11.5	15.5	8.9	6.8	6.6	8.1	8.8	9.2	9.3	6.8	6.2	15.5	18.4	17.3	21.5	16.7	8.2	10.4	8.9	11.7	18.4	11.8	8.6	11.3	8.7	11.0	7.5	9.0	11.1	12.4	7.3	11.3	17.4	7.9	13.8	10.6	10.3	5.3	2.2	3.9	1.9	6.8	3.0	1.5	5.8	10.7	9.3	6.7	8.8	12.7	6.1	12.5	11.3	7.8	7.9	3.4	3.9	9.3	4.5	13.7	6.3	6.4	3.8	6.6	14.6	5.6	4.5	4.4	3.3	14.1	5.6	3.6	11.8	3.6	7.3	16.1	8.8	5.8	4.0	7.4	14.0	4.2	3.9	10.8	6.9	7.0	4.4	7.9	6.0	9.6	8.6	24.6	8.2	2.6	5.0	10.4	4.9	11.5	7.0	3.4	7.8	3.5	15.2	8.8	8.4	10.8	3.6	11.3	0.3	1.6	3.9	3.0	1.6	2.7	5.3	1.6	1.9	2.2	4.4	1.1	1.9	0.2	6.8	1.9	2.2	2.4	1.5	8.5	9.5	8.2	9.5	6.8	6.6	6.8	6.2	8.2	7.3
FCAR	CD89	ENSG00000186431	"Fc fragment of IgA receptor"	P24071	19	54874248-54890472	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"IgA-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.6;neutrophil: 6.1"	"Group enriched"	"Detected in many"	44	"granulocytes: 6.1;monocytes: 2.6"					"Low region specificity"	"Detected in many"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA014050: AB_1846338"	"unprognostic (1.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.19e-6)"	"unprognostic (9.23e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.04e-3)"	"unprognostic (9.81e-2)"	4.0	0.6	0.4	1.5	4.4	28.1	0.8	0.1	1.0	0.6	0.6	0.7	0.0	0.6	0.6	0.6	0.6	3.8	0.6	8.2	2.0	0.4	0.6	1.8	19.5	15.9	1.2	0.0	2.2	0.6	0.6	0.3	1.5	4.3	0.6	0.6	0.9	0.6	0.6	0.6	0.6	0.6	0.7	2.7	14.9	0.9	2.1	0.0	1.0	0.6	0.3	0.6	4.4	4.8	0.0	0.0	6.1	2.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.7	0.4	4.4	0.1	1.0	2.0	0.4	1.2	0.0	4.3	0.0
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 182.8"	"Cell line enhanced"	"Detected in some"		"HEL: 14.0;HMC-1: 28.2;K-562: 8.3;NB-4: 7.9;THP-1: 30.0;U-937: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 182.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 182.8"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"			55000000	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: "	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	36.8	12.6	13.2	44.6	19.2	18.6	8.2	2.2	10.1	9.1	7.1	10.0	0.0	3.8	4.7	6.6	5.5	11.6	17.0	11.3	17.0	8.9	11.5	7.1	44.1	50.0	25.9	1.7	8.0	5.8	2.8	6.1	47.5	19.6	7.0	9.9	10.8	8.3	4.8	7.3	3.0	7.3	17.6	30.9	43.4	5.9	4.8	19.2	3.2	6.3	2.5	4.4	19.3	4.5	0.2	7.0	182.8	27.2	0.0	0.0	10.6	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.2	0.0	0.3	4.0	28.2	0.3	0.0	0.0	0.0	0.0	8.3	0.2	0.0	0.0	0.2	7.9	0.0	0.6	0.1	0.6	3.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	30.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	12.9	3.5	0.1	27.2	31.6	0.0	20.7	0.0	0.2	0.0	0.0	7.0	0.1	0.0	0.0	182.8	0.0	16.7	0.2	0.0	10.6	13.2	19.2	2.2	10.1	17.0	8.9	25.9	1.7	19.6	19.2
FCHO1	KIAA0290	ENSG00000130475	"FCH domain only 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 27.9;RPMI-8226: 19.2;U-937: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: "	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	2.3	13.6	13.7	18.9	18.9	1.9	11.4	15.2	1.1	2.7	30.2	0.0	3.7	1.8	1.8	1.5	1.9	4.5	1.1	17.8	11.7	1.0	2.7	3.4	22.6	23.0	10.0	2.2	0.9	0.8	2.6	1.4	10.8	1.4	2.6	0.6	2.7	1.2	0.9	13.4	4.0	2.1	15.9	13.7	3.5	4.3	23.3	16.4	1.2	0.0	17.3	5.1	1.0	9.9	10.4	25.7	9.5	4.1	5.7	4.4	0.4	5.4	3.5	2.5	0.1	0.1	3.5	0.5	0.1	0.1	0.2	0.7	0.6	27.9	8.0	0.2	1.1	1.7	1.0	0.1	12.3	0.9	2.2	0.7	2.8	0.3	6.9	4.7	0.0	0.1	0.1	0.2	0.7	10.9	13.4	0.0	7.7	15.8	12.4	1.7	13.3	13.5	0.1	19.2	0.1	0.5	0.6	1.3	0.1	2.8	0.4	2.7	6.9	0.5	0.1	2.0	0.5	0.2	8.5	3.8	15.1	0.4	17.2	0.3	6.9	6.6	6.5	5.2	9.5	4.5	8.8	5.7	4.5	9.7	9.9	5.5	4.4	25.7	4.1	7.2	10.4	5.2	4.4	13.6	18.9	11.4	15.2	17.8	11.7	23.0	10.0	10.8	23.3
FCRLB	"FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2"	ENSG00000162746	"Fc receptor like B"	Q6BAA4	1	161721563-161728143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.9;lymphoid tissue: 5.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.0;Daudi: 7.3;fHDF/TERT166: 10.7;HMC-1: 9.3;PC-3: 5.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 7.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"basophil: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB026139	Uncertain		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"CAB026139: "	"unprognostic (1.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (5.77e-3)"	"unprognostic (7.49e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.14e-2)"	0.5	0.2	0.2	3.4	0.3	0.0	0.3	1.0	0.8	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	1.4	0.6	0.3	2.4	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	1.2	0.0	0.2	0.7	2.7	0.2	0.3	0.8	0.2	0.4	1.5	0.2	0.2	0.2	0.2	0.3	0.2	5.0	0.8	0.2	4.9	0.6	8.9	0.2	5.3	2.7	0.6	0.7	0.1	0.0	0.3	0.5	0.7	0.0	4.5	6.0	1.5	1.5	0.1	0.2	7.3	0.2	10.7	0.1	0.2	0.4	3.9	0.1	0.3	0.2	0.1	0.2	0.2	0.0	9.3	1.4	0.0	2.7	0.2	1.3	0.3	0.3	0.2	0.4	0.0	2.5	0.2	5.4	0.0	0.5	0.3	0.2	0.2	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.8	1.6	0.7	1.7	0.8	0.0	0.0	2.9	3.2	0.4	0.8	8.9	0.1	2.4	2.7	0.1	1.0	4.6	1.6	1.5	0.6	4.9	0.8	1.2	1.5	5.3	0.2	0.0	0.0	0.6	0.2	0.3	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2
FDFT1		ENSG00000079459	"Farnesyl-diphosphate farnesyltransferase 1"	P37268	8	11795573-11839309	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008874	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA008874: AB_1078844"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (4.92e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.57e-1)"	"prognostic favourable (6.59e-9)"	"unprognostic (2.28e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.06e-1)"	20.8	44.3	26.3	22.7	27.7	30.6	57.5	19.5	43.6	27.6	41.7	45.9	20.0	44.6	26.9	29.1	59.4	27.5	19.9	27.1	29.8	32.1	24.9	45.9	30.7	23.4	36.2	34.4	22.9	18.0	17.1	18.2	22.1	47.4	38.8	32.9	32.4	46.5	20.6	71.2	38.4	30.2	18.0	56.5	18.4	35.4	41.3	40.5	25.9	24.7	32.2	25.4	25.8	34.2	44.0	30.5	42.2	19.6	22.6	31.0	29.0	21.6	10.5	47.1	18.8	10.2	17.5	14.3	8.5	14.5	9.0	18.7	14.7	26.8	30.1	4.2	8.5	18.0	23.3	71.0	7.3	5.0	24.9	14.1	8.0	35.0	21.7	7.3	9.9	15.7	18.0	20.1	10.0	11.3	20.3	39.7	8.8	14.1	25.7	17.4	41.2	6.2	15.8	10.9	61.8	41.8	78.8	15.1	9.4	7.4	12.6	21.3	20.7	21.3	14.1	4.2	10.5	1.9	5.3	8.2	20.7	32.8	7.4	24.8	12.4	42.2	19.6	22.6	21.6	17.2	20.8	44.0	22.7	21.2	30.5	35.3	21.5	20.3	18.6	22.6	11.7	22.7	31.0	29.0	26.3	27.7	19.5	43.6	29.8	32.1	36.2	34.4	47.4	40.5
FDX1	"ADX, FDX"	ENSG00000137714	"Ferredoxin 1"	P10109	11	110429883-110464881	"Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.9;seminal vesicle: 55.6"	"Cell line enhanced"	"Detected in all"		"U-698: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041630, HPA062087"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA041630: AB_10793970, HPA062087: AB_2630366"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.48e-2)"	"prognostic favourable (3.58e-7)"	"prognostic favourable (2.53e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.80e-1)"	5.5	113.9	3.9	4.7	4.5	3.9	5.6	2.7	4.0	3.2	7.5	5.2	33.7	7.9	3.2	3.9	5.1	3.0	5.6	9.6	3.6	4.3	10.7	22.8	7.8	4.7	4.5	2.5	3.5	8.6	3.5	3.7	48.4	3.1	4.8	4.2	4.2	4.1	55.6	7.3	3.3	12.3	3.6	3.4	3.9	5.0	5.3	2.6	5.2	8.7	5.0	3.5	5.6	5.4	10.7	6.9	3.4	5.8	4.4	8.7	2.9	5.2	3.7	5.7	6.2	5.6	10.0	12.8	4.9	6.0	4.3	7.4	12.6	8.9	12.4	14.4	6.3	6.3	6.6	7.4	5.9	11.8	8.4	6.2	6.5	7.7	9.8	6.5	10.2	17.3	6.1	3.9	9.3	8.8	6.2	18.5	9.2	5.8	9.2	14.6	5.1	7.0	13.7	5.4	11.4	9.4	9.5	7.8	4.0	9.3	10.6	6.2	6.2	4.5	5.2	4.4	5.4	5.3	5.2	4.2	3.2	37.2	3.3	13.4	5.6	1.8	5.7	3.4	5.3	4.2	5.8	10.7	7.3	7.4	6.9	7.5	8.6	6.1	0.7	4.4	5.8	5.3	8.7	2.9	3.9	4.5	2.7	4.0	3.6	4.3	4.5	2.5	3.1	2.6
FDXR	ADXR	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 93.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;Hep G2: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria				Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favourable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	1.7	93.9	2.6	2.1	3.1	1.3	1.8	8.4	2.7	2.1	4.6	3.2	6.4	2.6	2.6	23.8	8.7	6.6	6.1	1.9	3.4	1.7	2.7	4.1	4.4	1.7	2.9	3.5	7.1	3.9	2.3	1.5	2.6	3.6	3.3	2.1	0.9	5.3	4.2	7.9	5.6	2.5	2.0	4.4	9.7	2.2	32.1	3.0	3.9	2.0	7.7	3.7	3.0	3.0	5.4	7.4	4.8	6.4	10.0	15.2	5.6	3.9	21.1	3.1	3.5	2.3	3.0	29.5	4.7	5.2	2.8	5.7	5.9	3.5	9.4	0.8	2.0	8.1	2.3	5.9	0.8	8.9	4.9	7.1	3.5	54.0	6.4	1.5	25.0	9.9	6.7	2.9	1.0	14.4	11.3	1.5	4.3	16.7	6.1	3.3	1.7	4.6	3.3	5.3	5.0	2.3	6.7	1.7	4.0	3.2	7.1	3.4	15.4	1.5	6.7	1.9	17.6	3.1	2.3	4.4	0.7	2.0	5.3	2.4	6.6	1.8	6.4	4.8	6.2	4.3	5.3	5.4	5.6	7.3	7.4	2.8	4.9	6.1	2.1	10.0	3.2	1.4	15.2	5.6	2.6	3.1	8.4	2.7	3.4	1.7	2.9	3.5	3.6	3.0
FEM1A		ENSG00000141965	"Fem-1 homolog A"	Q9BSK4	19	4791681-4801273	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 103.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016565, HPA063622"			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA016565: AB_1848489, HPA063622: "	"unprognostic (4.62e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (6.18e-5)"	"unprognostic (3.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.70e-2)"	3.0	2.4	3.3	2.2	4.4	3.3	4.0	4.1	5.0	2.0	2.7	3.0	0.9	2.2	2.7	4.0	4.2	2.1	1.9	8.6	3.3	2.6	2.2	4.4	2.3	3.8	3.2	2.5	2.1	4.2	4.4	2.3	4.5	3.1	2.8	2.0	2.7	3.1	2.1	103.9	6.9	2.3	2.3	2.2	2.7	2.2	2.2	3.2	4.2	2.1	18.6	3.0	2.5	2.3	7.2	6.8	9.1	8.2	6.8	6.9	4.2	7.2	5.0	4.7	10.2	5.3	3.1	6.8	4.3	3.6	7.0	4.9	7.8	3.4	8.2	4.5	5.4	7.5	8.2	7.2	4.6	9.7	9.4	8.0	4.0	5.8	7.9	13.2	10.3	4.5	11.1	5.4	7.8	5.0	11.7	15.8	4.8	7.3	11.0	4.9	14.5	12.2	10.3	6.1	8.7	6.3	9.3	15.3	10.9	5.7	10.8	8.1	8.3	11.5	7.0	6.5	4.6	10.0	11.4	18.4	15.2	7.1	6.6	9.6	9.0	9.1	7.3	7.1	6.9	8.2	6.0	5.3	5.5	6.3	6.8	7.2	5.0	5.7	6.6	6.8	7.3	6.6	3.9	4.2	3.3	4.4	4.1	5.0	3.3	2.6	3.2	2.5	3.1	3.2
FEM1B		ENSG00000169018	"Fem-1 homolog B"	Q9UK73	15	68277803-68295865	"Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041920, HPA042192"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041920: AB_10796788, HPA042192: AB_10796574"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.67e-2)"	13.4	10.5	13.1	11.2	17.0	38.1	17.7	23.0	22.9	14.8	14.6	14.1	13.6	11.1	23.2	12.6	18.5	14.1	11.1	16.9	13.7	13.7	10.4	14.6	11.9	14.2	17.8	16.1	17.4	8.5	14.0	12.9	13.7	17.2	15.0	12.4	12.4	12.3	16.6	42.9	18.7	14.2	22.3	14.3	11.9	10.4	55.4	15.4	12.9	12.9	11.4	13.1	18.7	17.8	4.4	4.4	4.0	7.9	6.5	6.9	3.0	7.2	13.4	13.8	13.0	12.6	11.7	9.3	10.4	10.9	10.7	9.9	9.0	9.8	16.8	7.6	14.1	26.5	28.7	13.1	9.0	8.0	11.4	18.4	15.9	5.7	10.9	14.9	11.5	10.7	28.8	13.0	31.6	8.4	15.4	20.6	9.1	8.5	10.7	7.7	14.1	4.3	15.5	15.6	21.6	6.9	26.5	18.6	11.7	10.7	11.2	28.8	10.0	14.0	10.9	18.8	16.5	6.5	9.5	13.5	28.9	17.9	10.7	16.4	11.1	0.0	5.1	3.6	5.7	7.9	5.8	3.7	5.7	6.2	4.4	4.4	6.9	5.0	4.0	6.5	6.3	3.2	3.0	3.0	13.1	17.0	23.0	22.9	13.7	13.7	17.8	16.1	17.2	15.4
FEM1C	"EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785"	ENSG00000145780	"Fem-1 homolog C"	Q96JP0	5	115520908-115544894	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059919, HPA060977"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA059919: , HPA060977: "	"unprognostic (1.14e-2)"	"unprognostic (3.02e-1)"	"prognostic favourable (1.83e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.99e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	18.2	6.8	15.9	8.6	19.4	58.5	14.6	21.1	19.6	15.1	14.2	12.2	10.7	12.1	11.3	7.5	16.4	8.7	13.8	28.6	13.9	8.6	8.7	16.8	15.3	7.3	12.9	17.1	10.7	12.1	6.9	8.2	7.2	14.9	11.5	13.7	6.4	8.5	9.9	24.3	13.1	17.4	12.2	15.3	9.0	14.2	14.1	14.5	4.1	9.5	15.4	7.4	16.5	10.2	3.3	6.1	6.4	10.9	3.0	5.5	3.6	8.2	5.0	7.2	11.1	13.0	18.2	5.8	13.1	10.5	9.9	11.5	5.5	7.4	8.5	9.0	9.6	6.5	5.7	10.9	14.6	13.0	5.5	4.4	7.1	4.1	8.6	2.9	6.0	11.9	9.2	12.3	11.2	9.6	2.8	11.2	14.8	3.6	7.6	4.9	5.0	6.3	6.5	13.1	9.1	11.0	15.7	5.9	4.8	8.4	5.9	14.1	7.7	5.9	16.9	17.0	8.9	15.5	11.6	8.8	6.4	6.8	9.9	8.2	6.8	2.5	6.1	6.4	3.8	9.4	5.5	3.3	4.0	2.8	6.1	1.9	4.6	3.7	6.4	3.0	10.9	1.6	4.4	3.6	15.9	19.4	21.1	19.6	13.9	8.6	12.9	17.1	14.9	14.5
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792637-61797244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli			38000	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favourable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavourable (5.73e-6)"	"prognostic favourable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	4.8	9.6	7.9	14.6	8.5	23.9	7.4	16.9	14.9	4.9	11.0	8.5	5.0	8.1	5.0	6.6	13.3	4.2	7.0	4.6	8.6	8.5	4.9	9.3	5.0	22.5	8.3	9.8	3.9	6.3	5.2	7.9	11.2	12.6	4.7	12.0	7.3	9.3	4.6	11.2	6.8	8.2	6.4	7.1	12.3	7.2	16.2	5.9	36.3	3.5	10.6	25.5	6.1	4.2	11.5	18.1	14.5	9.4	13.3	18.0	7.3	31.0	28.6	31.4	16.9	3.1	3.9	20.0	27.5	15.7	33.7	38.4	25.0	23.4	44.9	21.5	11.7	32.9	44.2	24.1	34.6	23.6	24.3	23.7	39.1	25.4	2.4	36.8	24.5	2.7	3.3	31.1	8.3	13.1	35.8	32.5	28.0	39.1	51.2	33.1	34.5	28.1	35.2	36.4	46.3	13.4	29.5	35.8	29.7	18.3	24.1	15.8	34.9	25.9	8.8	30.0	37.9	38.2	27.7	25.7	39.9	46.6	20.9	24.7	25.8	14.5	5.0	10.2	12.4	9.4	13.1	11.5	10.0	11.8	5.8	11.5	11.2	11.3	2.1	13.3	8.8	18.1	18.0	7.3	7.9	8.5	16.9	14.9	8.6	8.5	8.3	9.8	12.6	5.9
FER	"PPP1R74, TYK3"	ENSG00000151422	"FER tyrosine kinase"	P16591	5	108747822-109196841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007641, CAB022464"	Approved		Supported	Cytosol				Cytosol		"CAB022464: , HPA007641: AB_1078845"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.05e-2)"	"prognostic favourable (5.55e-4)"	"unprognostic (3.83e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-3)"	13.4	5.7	5.5	6.1	13.4	1.8	5.2	6.0	5.0	9.7	6.7	1.4	16.8	2.5	6.5	19.3	8.2	4.6	5.3	4.6	4.8	4.8	7.2	3.6	12.2	1.9	4.9	2.2	7.2	3.0	18.5	15.9	5.7	3.1	6.8	3.6	5.0	4.5	21.9	5.0	6.6	3.5	7.2	6.2	8.1	4.1	15.9	2.6	3.9	10.2	12.8	2.8	7.7	9.0	10.5	5.4	8.0	5.1	1.2	2.8	1.1	4.6	1.6	5.7	9.0	3.4	5.2	3.6	5.6	5.5	3.3	3.9	9.5	2.9	7.5	3.5	6.7	3.3	3.1	7.0	7.5	3.1	4.2	4.9	7.2	3.4	2.3	2.7	4.2	3.1	3.9	7.9	9.0	4.9	6.1	5.6	4.2	1.3	2.1	0.8	0.8	3.3	1.7	5.5	44.2	3.2	1.6	1.9	2.8	9.2	0.5	6.0	2.2	1.2	7.2	6.4	4.9	3.2	4.4	4.8	7.1	2.9	4.0	0.8	3.0	8.0	5.1	5.4	1.7	3.1	2.8	10.5	1.0	1.8	2.8	3.8	1.6	2.0	0.4	1.2	2.4	5.4	2.1	1.1	5.5	13.4	6.0	4.2	4.8	4.8	4.9	2.2	3.1	2.6
FERMT2	"KIND2, mig-2, PLEKHC1, UNC112B"	ENSG00000073712	"Fermitin family member 2"	Q96AC1	14	52857268-52952435	"Predicted intracellular proteins"	"Cell adhesion, Cell shape, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	39	"T-cells: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040505	Uncertain		Supported	"Nucleoplasm,Focal adhesion sites"			58000	"Nucleoplasm, Focal adhesion sites"		"HPA040505: AB_10673300"	"unprognostic (4.38e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.73e-3)"	45.9	7.2	15.5	12.3	14.3	0.1	24.4	7.9	12.8	24.1	36.6	12.7	16.0	4.2	41.6	14.2	20.6	22.2	22.2	21.8	18.3	7.5	18.4	35.3	18.1	5.4	15.0	9.1	23.3	6.7	5.8	7.2	37.9	10.7	24.1	11.5	11.0	7.1	41.3	14.5	5.0	11.0	56.7	12.9	11.7	21.4	10.2	15.5	0.6	13.3	6.2	2.1	49.5	16.5	0.0	0.0	0.0	0.0	0.0	3.8	0.0	4.8	4.2	22.5	10.3	36.8	30.3	18.7	32.2	20.9	38.3	24.2	7.2	3.8	0.0	11.0	32.9	2.0	17.5	2.4	28.8	0.0	4.9	6.7	19.3	8.5	47.3	0.1	2.8	29.1	5.1	21.0	28.0	19.8	0.1	33.9	28.6	5.8	1.6	0.1	14.2	11.1	0.8	22.9	0.0	13.4	4.4	1.3	28.9	34.1	7.6	7.9	6.6	0.2	24.6	30.2	20.7	23.9	11.9	5.0	6.0	0.1	6.9	0.0	7.2	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	14.3	7.9	12.4	18.3	7.5	15.0	9.1	10.7	15.5
FEV	Pet-1	ENSG00000163497	"FEV, ETS transcription factor"	Q99581	2	218981087-218985657	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1"	"Group enriched"	"Detected in some"	6	"HMC-1: 18.7;SH-SY5Y: 23.9"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"midbrain: 2.3;pons and medulla: 0.9"	"Group enriched"	"Detected in some"	34	"midbrain: 7.3;pons and medulla: 3.9"	HPA067679		Supported	Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA067679: "			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favourable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	4.1	0.0	1.2	3.5	0.0	0.0	0.0	2.6	0.0	2.0	0.7	0.0	7.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	5.4	0.0	6.9	4.0	3.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	6.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.6	1.1	0.2	0.2	0.0	6.9	1.0
FEZ1	UNC-76	ENSG00000149557	"Fasciculation and elongation protein zeta 1"	Q99689	11	125445745-125496317	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 123.4"	"Cell line enhanced"	"Detected in many"		"AF22: 39.9;HBEC3-KT: 38.6;NTERA-2: 36.5;SCLC-21H: 39.0"	"Cancer enriched"	"Detected in all"	10	"glioma: 68.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 30.8;MAIT T-cell: 18.0;memory CD8 T-cell: 8.9;naive CD8 T-cell: 7.7"	"Lineage enriched"	"Detected in many"	14	"T-cells: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038490, HPA076844"	Approved		Supported	Microtubules,Cytosol				Microtubules	Cytosol	"HPA038490: AB_10672647, HPA076844: "	"unprognostic (5.68e-2)"	"prognostic unfavourable (9.06e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	6.6	5.6	48.3	4.4	50.1	1.3	4.3	28.2	121.4	6.4	5.1	58.8	0.2	2.9	6.9	4.0	5.9	4.1	9.4	12.4	54.2	38.2	2.7	7.4	10.0	3.5	68.2	29.8	6.0	1.4	5.0	2.3	6.0	43.4	6.6	5.3	1.4	2.4	12.9	1.7	3.5	3.5	13.0	123.4	3.9	2.5	7.2	51.4	0.0	2.2	0.0	2.9	16.8	2.1	0.0	0.4	2.1	0.5	1.0	30.8	5.0	0.0	0.0	39.9	0.0	26.3	24.0	0.0	6.2	8.0	1.5	0.3	0.0	0.0	0.0	7.3	11.7	0.1	18.1	38.6	0.8	3.2	0.2	18.3	0.0	0.0	22.2	0.0	0.1	19.6	8.9	7.2	19.1	17.6	2.4	0.2	1.9	0.9	0.1	0.0	36.5	0.4	0.0	0.0	0.0	0.0	14.0	39.0	4.1	0.1	0.0	0.6	2.9	17.9	15.8	0.1	1.0	0.0	5.2	0.4	0.1	0.0	4.3	0.0	16.8	2.1	0.5	0.0	30.8	0.1	18.0	0.0	1.1	8.9	0.4	0.0	0.4	7.7	0.6	1.0	0.0	0.0	0.0	5.0	48.3	50.1	28.2	97.4	54.2	38.2	68.2	29.8	43.4	51.4
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301394-122310691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.7;testis: 11.0"	"Group enriched"	"Detected in some"	10	"NTERA-2: 57.4;SCLC-21H: 25.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 13.7"	"Region enriched"	"Detected in single"	9	"hypothalamus: 6.9"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA064639: , HPA073693: "		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.6	0.2	6.4	0.2	4.9	0.2	0.2	0.0	2.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	1.0	16.7	0.2	0.2	0.2	0.2	2.0	0.0	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	1.4	0.6	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	11.0	3.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	57.4	1.0	0.0	0.0	0.0	0.0	0.1	25.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.9	0.0	2.0	1.0	16.7	2.0	0.0	0.0	3.5
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154562956-154571086	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"liver: 1908.6"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 75.9"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"		120000000000	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavourable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	1908.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	75.9	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGD4	"CMT4H, frabin, FRABP, ZFYVE6"	ENSG00000139132	"FYVE, RhoGEF and PH domain containing 4"	Q96M96	12	32399529-32646050	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039235	Approved		Supported	"Actin filaments"				"Actin filaments"		"HPA039235: AB_10673420"	"unprognostic (6.73e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"prognostic favourable (7.16e-5)"	"unprognostic (9.50e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.41e-3)"	28.9	6.1	12.4	7.7	13.8	16.0	13.2	3.8	12.4	8.8	23.6	13.2	11.8	11.6	5.3	7.4	11.4	8.3	13.7	8.5	12.8	6.8	14.8	21.5	14.7	5.3	15.1	6.8	31.1	12.2	21.8	8.5	13.6	13.0	6.7	13.3	14.3	11.8	15.0	17.3	12.4	27.4	5.1	21.2	11.0	33.6	15.3	17.3	0.4	8.5	6.3	4.6	8.3	9.7	1.8	4.1	9.6	6.5	0.8	0.5	1.3	4.0	1.9	4.5	1.4	17.1	10.5	6.7	3.0	15.3	0.8	0.3	5.6	5.8	0.6	2.0	0.2	3.7	3.6	5.3	0.5	0.7	2.0	3.2	2.0	1.6	3.1	0.8	0.0	6.2	7.8	4.1	9.1	8.1	0.4	3.7	10.7	1.3	0.0	1.2	14.1	0.1	0.3	4.9	10.7	5.8	3.6	5.2	6.0	3.4	3.1	4.4	5.1	0.2	9.9	0.1	1.3	12.9	0.5	1.3	3.0	2.0	0.0	1.9	3.7	3.1	4.6	9.6	0.4	6.5	0.4	0.7	0.4	0.3	4.1	1.8	0.4	0.5	7.8	0.8	5.9	0.4	0.3	1.3	12.4	13.8	3.8	12.4	12.8	6.8	15.1	6.8	13.0	17.3
FGD5	"FLJ00274, FLJ39957, ZFYVE23"	ENSG00000154783	"FYVE, RhoGEF and PH domain containing 5"	Q6ZNL6	3	14810853-14934565	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 40.4;TIME: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014436, HPA014536, HPA019191"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519"	"unprognostic (2.57e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.32e-2)"	"prognostic favourable (7.50e-4)"	18.9	3.7	2.2	10.7	2.7	0.0	18.9	1.2	4.0	11.0	9.2	1.9	8.3	7.3	17.7	9.5	5.7	8.1	14.3	12.3	2.3	2.2	10.3	2.5	27.3	8.1	2.7	1.9	7.2	6.5	2.8	3.9	14.3	3.1	8.3	3.8	8.4	4.5	4.0	7.9	6.0	8.6	9.6	2.4	29.3	5.2	7.1	1.6	1.0	8.6	8.4	3.6	7.2	20.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	33.0	0.0	2.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.7	1.2	4.0	2.3	2.2	2.7	1.9	3.1	1.6
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 65.0;heart muscle: 35.5;kidney: 41.5"	"Cell line enhanced"	"Detected in some"		"BJ: 19.3;BJ hTERT+: 14.4;BJ hTERT+ SV40 Large T+: 16.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.2;HBF TERT88: 28.8;hTEC/SVTERT24-B: 20.1;LHCN-M2: 13.4;U-2 OS: 14.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 33.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"			Nucleoplasm		"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (1.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (2.59e-5)"	"unprognostic (3.72e-4)"	"unprognostic (2.49e-1)"	"prognostic favourable (3.45e-5)"	"unprognostic (3.01e-4)"	7.3	3.5	44.2	2.0	43.1	1.5	9.7	10.5	59.9	1.8	1.7	65.0	0.0	1.6	3.1	8.7	2.3	2.1	2.7	35.5	47.4	33.0	41.5	2.0	2.9	1.4	62.6	13.8	1.5	1.4	3.4	1.6	2.3	36.3	2.2	1.8	0.8	5.8	2.6	2.3	2.0	1.7	2.6	57.7	5.5	1.1	2.2	48.6	0.0	4.9	0.8	2.2	1.7	0.4	1.2	1.0	1.8	0.6	0.1	2.3	0.2	2.3	0.1	0.1	0.7	0.5	1.5	0.8	19.3	14.4	16.0	20.2	0.1	0.1	0.5	1.4	6.6	0.3	0.0	1.5	28.8	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.2	0.7	0.5	20.1	1.2	0.0	0.0	0.7	13.4	0.3	0.0	0.4	0.6	0.6	0.1	0.6	0.2	0.6	0.1	0.5	1.0	0.0	0.4	0.2	0.0	0.1	0.4	2.6	14.4	0.3	9.1	0.3	0.1	0.1	3.6	0.1	0.7	0.3	0.3	1.8	2.3	0.1	1.8	0.4	0.8	0.9	0.2	1.2	0.9	1.9	1.7	0.1	0.6	1.0	0.5	0.2	44.2	43.1	10.5	22.6	47.4	33.0	62.6	13.8	36.3	48.6
FGF13	"FGF2, FHF2"	ENSG00000129682	"Fibroblast growth factor 13"	Q92913	X	138614731-139222777	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;parathyroid gland: 44.3;skeletal muscle: 37.0"	"Cell line enhanced"	"Detected in some"		"AF22: 19.5;fHDF/TERT166: 16.8;HAP1: 17.8;RPMI-8226: 15.1;U-2197: 31.4;WM-115: 16.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002809			Supported	Cytosol				Cytosol		"HPA002809: AB_1078855"	"unprognostic (3.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (9.92e-3)"	"unprognostic (2.97e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (5.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.96e-4)"	"unprognostic (4.36e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.48e-2)"	11.1	1.9	30.0	1.9	29.5	2.7	4.2	0.9	22.9	7.9	3.1	1.5	2.4	2.7	7.0	2.8	4.4	2.6	4.1	1.3	36.7	22.3	4.9	1.4	1.7	3.1	19.7	12.9	6.0	0.9	44.3	2.4	8.4	7.8	11.6	3.3	4.8	6.5	3.5	37.0	1.1	3.1	4.5	3.3	3.8	2.9	2.7	4.1	0.0	3.6	7.9	1.6	3.5	5.7	0.5	0.9	7.4	0.5	0.2	0.3	0.1	0.0	0.2	19.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	16.8	1.2	17.8	0.0	0.0	0.2	5.0	0.1	0.1	0.7	0.7	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.7	5.6	2.0	0.1	0.0	0.1	2.0	6.4	2.9	1.2	15.1	2.8	0.1	0.1	0.0	0.0	0.1	11.9	0.0	0.1	0.4	0.6	0.8	31.4	8.3	7.4	4.1	0.0	7.0	5.6	16.8	2.7	0.5	1.6	0.2	0.3	0.1	0.5	0.2	0.1	0.1	0.4	0.3	0.2	7.4	0.2	0.5	0.9	0.2	0.1	30.0	29.5	0.9	22.9	36.7	22.3	19.7	12.9	7.8	4.1
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 56.5;BJ hTERT+: 33.1;fHDF/TERT166: 61.3;hTERT-HME1: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"			"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	28.1	3.8	19.4	6.9	21.3	0.7	12.1	6.5	15.3	10.2	14.2	10.3	1.9	2.6	17.9	6.3	6.4	10.1	9.4	5.6	17.1	11.0	5.5	2.9	8.3	2.5	9.9	10.7	16.8	2.4	10.1	4.0	8.1	18.6	10.3	5.6	7.5	4.6	11.9	2.0	2.3	4.1	16.2	17.3	1.9	7.6	3.0	12.3	0.0	3.1	3.8	2.7	7.5	14.5	0.8	0.8	0.5	0.5	0.3	1.0	0.0	1.2	3.1	1.7	6.8	4.3	7.2	0.0	56.5	33.1	23.7	13.8	0.0	0.1	0.0	6.6	61.3	0.2	1.8	0.1	23.9	4.4	0.8	0.0	6.4	0.0	12.8	0.3	0.0	3.9	0.3	23.4	33.8	2.6	1.7	1.9	6.1	0.0	0.0	0.0	5.1	1.3	0.0	0.9	0.0	7.5	0.0	1.0	0.9	10.9	0.0	0.4	0.0	0.1	2.3	19.6	3.8	7.2	4.8	3.3	3.6	0.0	5.6	0.0	2.0	0.5	0.5	0.4	0.3	0.4	0.2	0.4	0.5	0.4	0.2	0.8	0.7	1.0	0.4	0.3	0.4	0.8	0.7	0.0	19.4	21.3	6.5	15.3	17.1	11.0	9.9	10.7	18.6	12.3
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell line enhanced"	"Detected in some"		"BJ: 19.7;BJ hTERT+: 37.4;fHDF/TERT166: 26.9;HBF TERT88: 28.1;LHCN-M2: 25.2;U-138 MG: 34.9;U-251 MG: 16.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: "	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.1	0.1	0.1	1.7	0.1	0.5	0.1	38.2	1.3	0.1	3.1	0.0	0.0	0.4	0.4	0.1	1.3	0.1	9.2	0.3	1.6	0.2	2.3	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.3	0.1	4.1	0.2	0.1	0.0	0.1	0.0	0.5	0.4	2.8	2.4	0.3	0.1	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.7	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	1.9	7.1	0.0	19.7	37.4	5.2	3.8	0.0	0.0	0.0	0.0	26.9	0.0	0.0	6.9	28.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	2.0	0.0	15.3	7.3	1.7	0.0	0.1	25.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	6.4	34.9	1.4	1.7	16.7	0.0	0.0	0.0	2.0	0.0	0.7	1.7	0.3	0.3	0.4	0.2	0.5	0.2	0.3	0.4	0.2	0.7	0.5	0.5	0.9	0.2	0.2	0.7	0.2	0.0	0.1	0.1	38.2	1.3	1.6	0.2	0.2	0.2	4.1	0.1
FGFR1OP	FOP	ENSG00000213066	"FGFR1 oncogene partner"	O95684	6	166999182-167094789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071876			Supported	Centrosome				Centrosome		"HPA071876: "	"unprognostic (9.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (7.32e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	6.2	12.2	11.2	12.9	12.5	9.8	10.2	11.9	13.0	10.1	9.5	6.9	11.8	10.8	13.6	14.1	8.8	19.1	7.9	6.4	10.8	9.1	12.2	24.9	6.7	9.4	6.4	11.5	11.8	10.2	8.2	17.2	6.6	9.4	7.4	12.1	8.9	8.1	11.6	5.8	7.9	13.0	7.4	7.4	9.4	7.8	50.3	8.0	14.5	12.5	6.2	11.8	7.0	8.2	6.8	10.0	24.1	4.1	3.5	6.8	3.0	12.0	6.7	17.0	11.6	10.0	7.5	20.7	15.6	10.5	12.8	12.4	24.9	10.3	14.4	8.9	9.5	11.4	14.9	11.0	24.1	9.0	12.9	9.9	12.1	27.0	5.4	17.6	10.5	4.1	8.2	26.2	12.3	8.8	32.3	12.4	16.3	11.1	14.1	25.8	14.5	5.2	16.3	11.6	11.9	13.3	6.5	12.7	12.8	12.7	13.7	5.4	11.2	21.8	5.7	12.8	21.3	15.2	19.5	10.6	14.5	14.6	14.4	16.5	15.6	0.2	4.1	13.5	3.3	3.6	4.9	6.8	3.9	3.1	6.5	5.0	2.3	3.7	24.1	3.5	3.6	10.0	6.8	3.0	11.2	12.5	11.9	13.0	10.8	9.1	6.4	11.5	9.4	8.0
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 57.8;BEWO: 19.4;CACO-2: 15.1;HaCaT: 17.4;HAP1: 18.7;NTERA-2: 18.5;T-47d: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favourable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.0	57.8	0.0	0.0	19.4	0.1	0.0	0.0	0.0	15.1	0.3	0.0	4.1	0.9	17.4	18.7	4.0	0.0	0.0	4.0	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.4	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.5	0.0	0.0	0.0	2.2	5.6	4.9	0.1	0.1	0.1	10.6	0.0	15.5	0.0	0.0	0.1	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 131.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 19.1;HaCaT: 14.9;Hep G2: 32.1;NTERA-2: 15.6;RT4: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		670000	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: "	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.5	1.5	24.7	1.7	30.3	1.6	4.2	10.2	22.0	4.1	4.9	15.8	3.4	9.9	1.8	2.7	26.9	2.0	5.0	2.0	21.6	11.7	9.6	7.4	4.5	1.3	17.6	21.5	1.1	23.0	1.2	3.0	5.6	15.1	3.7	3.8	1.7	3.8	9.0	1.7	131.7	7.4	1.3	9.0	2.1	4.9	8.1	10.6	0.1	1.3	8.5	7.3	8.5	10.1	0.1	0.6	0.1	0.1	0.2	0.3	0.0	0.0	1.5	9.0	2.6	0.0	0.1	9.2	1.0	0.1	0.4	0.2	19.1	0.4	0.0	7.6	0.3	14.9	2.6	0.1	0.1	0.1	9.6	5.9	1.5	32.1	0.0	0.0	0.1	0.0	5.0	0.1	0.0	0.0	6.4	0.0	0.0	9.5	0.3	0.2	15.6	0.0	0.5	0.5	0.1	1.3	19.1	2.6	0.7	0.8	1.6	0.0	8.9	1.1	0.4	0.0	0.9	0.2	0.6	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.6	0.1	0.0	24.7	30.3	10.2	22.0	21.6	11.7	17.6	21.5	15.1	10.6
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026897	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 51.1"	"Cell line enhanced"	"Detected in many"		"U-251 MG: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.5;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026019, HPA068828"	Approved		Supported	Vesicles				Vesicles		"CAB026019: , HPA068828: "	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	21.8	22.9	16.0	6.1	20.5	5.8	21.5	13.8	20.6	8.1	6.6	9.1	5.3	6.6	6.6	5.0	4.7	19.7	9.8	12.2	16.6	3.6	11.5	25.1	6.4	4.0	8.8	8.4	14.0	51.1	12.6	9.0	3.1	17.0	7.6	4.8	12.7	29.3	3.1	9.6	3.7	6.0	4.1	14.0	5.3	15.0	3.2	11.1	1.0	33.8	3.9	3.6	6.2	11.5	0.4	0.3	1.2	3.6	0.1	1.2	0.4	8.5	11.6	4.2	12.8	4.5	4.7	1.1	15.2	2.3	4.8	3.2	8.4	17.7	0.9	19.8	23.1	2.2	8.1	5.1	4.5	3.2	7.9	0.1	15.2	22.1	9.2	4.9	2.1	9.9	4.4	8.4	3.6	4.6	9.3	3.3	2.9	11.1	5.7	13.5	5.3	31.6	9.4	6.2	6.0	8.5	1.3	0.4	0.8	14.0	0.3	5.6	8.4	4.3	9.9	26.2	10.7	13.2	36.8	3.6	4.8	1.3	6.9	5.7	8.4	1.2	0.1	0.0	0.7	3.5	0.1	0.4	1.2	0.2	0.3	0.1	0.2	0.5	0.0	0.1	3.6	0.3	0.1	0.4	16.0	20.5	13.8	20.6	16.6	3.6	8.8	8.4	17.0	11.1
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria			2800000	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.2	24.5	23.3	21.0	22.9	27.0	36.9	36.3	28.5	41.0	25.8	35.1	18.3	18.6	24.1	27.8	41.7	35.6	27.0	35.8	21.2	11.5	17.4	26.0	29.9	20.5	40.7	15.9	19.5	16.8	23.0	26.0	25.2	53.0	24.1	29.8	14.6	35.1	27.2	24.7	52.7	29.0	25.5	83.5	39.5	24.9	30.0	25.9	30.6	36.3	23.2	27.6	27.7	24.7	18.4	23.8	32.5	60.5	21.6	23.1	22.6	20.6	46.8	26.4	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 557.6;tongue: 239.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.7;fHDF/TERT166: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 20.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4"	"Low region specificity"	"Detected in all"							"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"			18000000	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavourable (2.11e-4)"	61.9	4.1	7.6	11.0	9.5	0.7	30.6	6.3	7.2	31.5	30.6	3.9	10.0	5.0	25.5	27.7	43.2	14.2	11.7	79.0	6.1	8.1	3.3	2.5	13.7	2.5	5.5	8.1	6.7	2.4	13.4	5.0	13.5	4.4	23.4	10.0	13.5	16.5	30.1	557.6	4.9	11.4	77.7	4.3	2.5	22.1	5.7	3.0	0.6	18.2	239.4	22.1	47.0	14.3	3.4	12.5	0.7	0.4	20.6	11.4	6.2	0.0	9.4	13.1	12.3	28.5	11.5	0.2	36.7	57.7	7.3	17.8	0.0	2.7	0.1	12.8	52.2	0.1	25.3	31.3	6.2	0.1	29.2	0.1	7.8	0.0	26.7	0.0	6.1	21.4	5.1	8.9	28.1	7.7	0.0	5.5	17.2	0.4	5.1	0.3	4.0	11.1	14.4	0.5	7.8	0.2	0.0	9.2	13.8	1.3	0.0	2.6	0.0	0.5	21.6	34.1	15.8	1.3	9.2	1.4	3.2	0.2	2.5	0.2	3.8	0.0	0.4	0.0	3.2	0.0	8.6	3.4	11.4	4.5	1.8	2.3	7.6	2.3	0.7	20.6	0.0	12.5	1.2	6.2	7.6	9.5	6.3	7.2	6.1	8.1	5.5	8.1	4.4	3.0
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 312.0;ovary: 80.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 79.9;RPTEC TERT1: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;T-cells: 4.6"	"Group enriched"	"Detected in many"	4	"amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3"	"Low region specificity"	"Detected in all"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"				"Actin filaments, Focal adhesion sites"		"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	8.3	9.8	1.5	5.7	3.6	1.5	8.9	0.8	5.6	16.3	10.5	1.4	5.1	6.0	14.8	12.1	9.2	6.8	16.5	312.0	2.5	0.4	5.5	7.8	2.1	2.7	0.9	3.0	80.7	1.6	0.2	4.1	16.7	1.1	12.8	7.4	18.5	6.2	8.7	9.4	5.6	16.9	11.9	0.8	3.9	12.7	13.4	0.7	3.1	6.6	16.9	5.1	18.1	7.6	1.4	1.3	7.8	0.8	1.5	4.6	2.6	22.5	5.3	3.1	0.1	10.1	12.8	29.6	42.8	11.3	27.5	33.1	9.5	35.3	0.0	3.6	52.1	7.0	4.6	38.9	31.4	0.9	3.5	15.8	6.5	7.1	40.0	0.0	3.5	26.6	21.4	43.3	28.8	56.0	4.1	1.3	79.9	0.8	3.6	0.1	6.5	16.7	0.0	4.8	0.6	73.7	16.0	0.1	1.0	16.0	7.2	11.1	9.0	0.5	26.9	20.0	20.3	22.1	34.4	0.4	0.0	0.1	31.9	0.0	20.6	7.8	0.8	1.0	2.2	0.4	1.5	1.1	1.8	3.6	0.7	1.4	1.4	2.9	4.5	1.5	0.3	1.3	4.6	2.6	1.5	3.6	0.8	5.6	2.5	0.4	0.9	3.0	1.1	0.7
FHOD1	FHOS	ENSG00000135723	"Formin homology 2 domain containing 1"	Q9Y613	16	67229387-67247658	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.0;skeletal muscle: 61.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024468	Approved		Supported	Cytosol			2500000	Cytosol		"HPA024468: AB_1848568"	"unprognostic (6.53e-3)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (1.90e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-3)"	"unprognostic (4.70e-2)"	8.3	7.5	2.5	5.1	4.4	2.9	7.9	4.7	2.8	4.2	5.3	2.5	3.8	3.3	3.9	4.7	2.5	3.4	5.6	3.7	2.3	1.3	4.8	2.3	12.5	4.4	4.0	0.7	12.9	3.4	2.5	2.5	5.8	4.2	4.2	2.6	4.0	5.7	4.0	61.1	2.5	3.9	3.5	5.6	38.0	2.9	2.2	3.0	2.7	8.2	11.1	5.8	2.6	3.5	0.5	2.0	2.2	3.0	1.3	1.4	2.1	4.3	11.9	4.4	3.6	18.1	10.9	15.0	9.2	7.6	10.6	10.3	8.2	5.7	5.2	6.7	6.7	5.3	5.2	7.5	5.3	4.1	8.3	23.2	4.6	8.9	4.8	9.5	42.6	13.5	0.9	16.2	1.5	16.4	12.0	3.2	6.6	14.9	6.4	17.1	6.7	3.8	7.4	10.0	12.3	3.3	1.7	1.4	7.4	14.5	8.3	8.4	8.9	7.6	19.0	14.4	8.4	8.8	7.4	11.1	11.3	7.6	29.6	9.0	13.1	1.5	3.0	0.5	1.1	1.2	1.4	0.1	1.3	1.0	2.0	0.5	0.8	0.6	2.2	1.3	1.0	1.2	1.2	2.1	2.5	4.4	4.7	2.8	2.3	1.3	4.0	0.7	4.2	3.0
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;parathyroid gland: 10.7;testis: 9.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 21.9;RPTEC TERT1: 17.0;THP-1: 8.4;U-2 OS: 11.7;U-251 MG: 9.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	11	"hippocampal formation: 19.2"	"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 5.7"	"Lineage enriched"	"Detected in single"	11	"monocytes: 5.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 18.2;hippocampal formation: 75.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 81.5"	HPA055353	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA055353: "	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.0	8.5	1.7	0.1	1.1	0.0	1.1	0.1	3.0	0.0	1.8	0.3	0.0	0.5	0.0	1.4	0.4	0.0	5.0	2.0	19.2	1.2	0.0	0.0	5.3	0.0	0.6	0.0	0.4	0.0	10.7	0.0	1.7	1.5	1.0	1.4	1.1	1.6	0.0	0.0	0.0	1.6	2.1	0.0	0.8	0.1	9.5	0.8	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.2	0.3	2.4	0.8	0.0	0.0	0.0	0.0	5.2	6.1	0.3	0.8	0.0	2.6	0.0	1.9	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.2	0.2	0.0	0.1	2.8	0.0	0.0	0.6	0.0	0.0	21.9	0.0	2.3	1.5	0.5	0.0	4.6	0.3	17.0	0.0	0.1	0.0	0.7	0.0	0.6	1.4	8.4	0.0	0.9	11.7	0.1	9.5	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	1.7	1.1	0.1	1.0	19.2	1.2	0.6	0.0	1.5	0.8
FIBP	FGFIBP	ENSG00000172500	"FGF1 intracellular binding protein"	O43427	11	65883741-65888539	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011729	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA011729: AB_1848579"	"unprognostic (1.70e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.89e-2)"	17.9	27.8	33.8	20.0	33.4	21.4	18.8	27.2	53.7	21.6	20.6	22.4	16.4	23.2	21.1	23.7	19.9	29.5	17.9	34.5	31.5	31.3	26.1	29.7	17.7	29.8	29.9	27.8	19.7	23.9	28.4	18.4	22.7	36.8	17.2	21.6	20.0	15.7	20.5	30.8	24.2	27.1	23.9	22.2	25.2	20.0	40.7	17.4	35.2	25.0	28.5	31.3	21.0	15.3	33.3	56.7	34.7	46.0	31.6	32.4	33.9	18.1	25.7	14.9	35.9	22.7	28.6	11.2	16.8	33.9	22.6	19.1	10.7	24.9	23.6	30.0	36.7	19.8	14.5	36.1	15.0	27.4	19.5	23.5	26.7	15.6	31.3	29.9	20.6	23.2	20.9	16.4	35.8	28.3	7.9	42.6	29.6	56.0	24.7	25.6	14.6	40.7	30.8	14.4	57.3	26.8	23.4	26.9	24.8	18.3	34.0	33.0	34.5	17.1	25.1	24.8	21.2	40.0	11.8	23.6	25.6	14.3	31.7	21.9	9.2	34.7	41.8	32.1	26.3	44.7	26.4	33.3	24.7	23.7	56.7	28.4	19.8	21.2	7.3	31.6	46.0	29.1	32.4	33.9	33.8	33.4	27.2	53.7	31.5	31.3	29.9	27.8	36.8	17.4
FIP1L1	"DKFZp586K0717, FIP1"	ENSG00000145216	"Factor interacting with PAPOLA and CPSF1"	Q6UN15	4	53377643-53460861	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037475, HPA058202"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA037475: AB_10696933, HPA058202: "	"unprognostic (3.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (1.87e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-1)"	25.7	24.4	20.2	27.6	25.8	35.8	24.0	23.0	25.1	24.5	18.0	19.4	16.1	16.0	27.4	17.7	23.4	22.4	16.2	19.7	17.1	16.6	19.7	19.0	20.3	24.5	20.1	26.0	32.2	16.9	26.6	26.6	28.2	20.9	21.7	21.0	16.2	21.5	18.0	33.9	24.5	20.0	23.5	19.4	24.5	20.4	40.2	22.4	42.4	22.7	17.8	29.2	26.6	22.6	26.5	32.7	36.5	24.0	33.7	32.4	21.3	17.9	11.8	21.7	13.0	16.4	16.8	27.7	22.7	28.7	18.6	14.4	17.2	16.7	33.0	17.7	24.3	11.3	23.5	16.9	24.1	11.4	12.8	26.0	9.8	15.9	26.1	38.6	22.3	19.1	15.4	23.5	24.1	13.6	29.9	15.4	14.6	13.2	34.8	17.8	14.2	11.7	31.2	9.8	14.5	15.1	16.2	16.9	18.3	15.9	18.4	26.1	10.4	14.3	14.4	19.1	16.6	17.7	27.2	19.4	11.2	41.6	16.5	24.2	33.9	25.8	16.9	36.5	25.7	17.8	29.2	26.5	25.8	25.1	22.6	24.2	28.9	25.4	20.7	33.7	24.0	32.7	32.4	21.3	20.2	25.8	23.0	25.1	17.1	16.6	20.1	26.0	20.9	22.4
FIS1	"CGI-135, Fis1, H_NH0132A01.6, TTC11"	ENSG00000214253	"Fission, mitochondrial 1"	Q9Y3D6	7	101239458-101252316	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017430	Approved		Supported	Mitochondria			590000	Mitochondria		"HPA017430: AB_1848608"	"unprognostic (1.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.47e-2)"	"prognostic favourable (1.08e-7)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	35.1	46.8	53.4	22.3	49.9	32.7	35.8	26.0	60.0	30.3	34.4	57.9	38.0	30.0	31.1	42.7	35.6	47.0	39.4	78.6	52.6	44.8	39.6	58.3	27.8	23.6	65.3	37.8	41.2	56.6	39.5	37.1	34.0	45.1	29.3	26.3	28.8	45.2	43.8	120.5	29.7	29.2	32.4	87.9	28.1	31.1	30.4	44.1	21.3	47.1	48.8	22.6	30.5	29.3	73.0	73.4	63.6	67.4	55.6	72.8	87.9	24.7	29.2	21.9	31.4	25.3	33.9	15.0	26.9	32.8	24.6	21.2	20.1	40.8	24.3	36.0	36.9	14.6	15.3	43.5	13.8	18.8	22.2	11.0	42.5	26.6	30.2	20.5	17.1	32.2	41.0	17.2	26.4	44.5	23.1	33.4	37.0	113.9	31.9	37.0	24.3	28.4	15.6	12.3	53.2	37.2	28.7	28.4	33.3	12.8	61.9	18.2	20.6	23.3	36.4	28.9	18.6	29.9	28.6	28.3	21.6	14.0	26.8	23.3	37.7	58.9	67.4	63.6	63.2	65.5	65.1	72.2	61.0	59.7	73.4	73.0	60.7	63.5	51.4	55.6	59.0	61.4	72.8	87.9	53.4	49.9	26.0	60.0	52.6	44.8	65.3	37.8	45.1	44.1
FKBP3	"FKBP-25, PPIase"	ENSG00000100442	"FK506 binding protein 3"	Q00688	14	45115600-45135319	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol			980000	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	11.7	13.2	28.1	10.2	40.7	9.8	15.5	25.1	32.1	12.0	14.6	11.4	8.3	13.2	9.9	20.4	14.6	8.8	9.1	31.3	26.0	24.4	16.5	20.5	8.0	14.6	23.2	23.8	9.9	10.9	15.0	17.1	14.0	22.9	17.9	15.2	6.6	10.7	12.2	113.3	11.3	13.9	12.8	19.6	9.9	10.6	13.5	22.4	12.7	12.4	24.2	16.5	12.7	9.3	19.5	27.5	13.5	17.4	15.4	19.4	13.0	36.9	41.2	60.0	31.5	26.7	29.2	23.7	22.7	26.1	36.0	39.7	36.0	31.8	19.7	24.0	25.6	30.8	44.5	29.3	51.3	28.5	26.6	16.2	32.0	46.5	26.4	28.0	17.6	27.5	30.6	20.9	19.5	46.8	23.4	14.9	42.6	45.2	44.8	37.5	30.4	39.1	43.2	44.2	23.9	57.5	42.8	36.6	14.3	36.4	22.7	34.8	53.1	21.0	30.1	27.5	47.6	14.4	17.4	25.1	44.6	30.7	16.6	19.3	25.6	11.6	14.6	13.5	13.0	17.2	15.7	19.5	17.5	17.6	21.8	13.6	16.8	18.8	2.3	15.4	17.4	27.5	19.4	13.0	28.1	40.7	25.1	32.1	26.0	24.4	23.2	23.8	22.9	22.4
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FK506 binding protein 4"	Q02790	12	2794953-2805423	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"vagina: 209.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Approved		Enhanced	Nucleoplasm,Cytosol			110000	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: "	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.12e-5)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	16.2	21.6	26.0	13.7	30.7	13.3	40.7	50.4	31.9	19.9	22.6	22.8	36.2	13.1	20.1	30.7	34.2	25.7	16.4	20.4	25.0	32.5	31.6	31.3	15.8	11.7	44.7	23.4	23.9	30.3	30.1	19.5	32.0	39.4	30.2	25.3	11.5	30.1	31.6	33.5	25.3	16.1	26.4	25.2	11.5	25.3	36.0	42.1	15.6	47.1	16.5	18.5	17.4	209.6	13.8	6.0	10.9	13.7	8.4	14.0	9.9	15.5	34.6	10.0	16.8	12.5	7.4	48.1	15.3	5.5	25.3	17.2	34.4	19.0	20.8	4.4	9.8	21.3	62.3	20.7	30.5	38.0	39.9	22.9	25.5	12.2	9.6	17.9	6.2	6.7	19.0	29.9	30.0	14.7	21.0	29.7	10.1	44.7	31.3	16.2	85.5	25.0	18.8	17.6	12.4	21.3	19.9	14.5	20.8	17.7	48.4	7.7	65.3	12.1	7.8	12.5	39.3	14.0	38.5	7.4	11.3	30.7	11.1	26.7	12.7	10.9	10.8	5.9	12.5	9.8	14.0	13.3	11.1	11.8	6.0	13.8	11.8	13.7	1.5	8.4	13.7	5.3	10.1	9.9	26.0	30.7	50.4	31.9	25.0	32.5	44.7	23.4	39.4	42.1
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FK506 binding protein 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 277.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 101.4;ASC TERT1: 63.1;HHSteC: 79.4;HSkMC: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: "	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	78.8	20.7	9.5	14.2	15.6	4.9	36.7	2.4	10.9	16.5	29.0	5.1	29.8	2.2	18.6	16.9	29.2	19.4	17.9	26.3	10.6	4.2	44.9	30.7	19.7	55.9	15.7	3.6	27.2	43.7	8.6	33.8	6.0	13.1	18.3	8.2	11.8	30.4	25.1	277.2	20.2	36.7	18.6	18.2	32.3	25.0	14.3	12.4	20.1	24.2	9.8	16.8	22.5	18.4	4.0	30.6	24.9	31.2	11.8	42.3	39.9	4.9	2.1	9.5	14.2	101.4	63.1	0.1	2.7	0.1	1.7	4.1	3.7	0.8	24.5	2.5	0.5	0.0	5.6	11.9	4.2	9.6	5.3	10.5	1.8	5.2	79.4	6.6	1.0	95.9	48.2	3.1	29.1	10.3	11.2	10.0	18.6	3.1	27.3	12.4	2.4	1.6	12.2	2.4	11.9	7.9	3.0	3.6	2.2	2.2	2.5	0.5	14.0	7.8	22.7	2.5	2.2	0.3	3.7	4.5	5.2	31.1	0.8	12.9	0.9	13.7	31.2	19.4	20.0	27.0	23.8	3.0	28.2	20.8	30.6	4.0	42.3	30.2	24.9	11.8	12.0	9.2	10.3	39.9	9.5	15.6	2.4	10.9	10.6	4.2	15.7	3.6	13.1	12.4
FKBP7	FKBP23	ENSG00000079150	"FK506 binding protein 7"	Q9Y680	2	178463664-178478600	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.9;ASC TERT1: 32.2;HSkMC: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.6	4.6	1.5	4.3	4.1	0.7	11.1	3.5	2.3	20.5	6.9	1.0	10.0	1.8	21.4	21.9	8.4	12.4	12.8	12.1	1.5	1.5	5.5	7.4	6.8	5.2	4.0	1.8	34.6	4.3	1.5	11.1	8.2	2.9	19.5	4.2	7.1	4.9	9.7	4.4	4.0	3.9	19.9	3.9	3.0	5.3	8.3	2.2	2.2	8.7	8.0	2.3	15.5	9.9	2.8	5.8	0.2	1.6	1.2	2.8	0.8	0.0	0.6	6.0	8.9	51.9	32.2	0.5	10.7	17.8	1.9	6.3	0.1	0.6	1.7	2.4	19.5	0.1	2.2	0.9	3.4	1.3	1.2	1.7	2.4	1.7	8.0	1.0	1.2	21.6	0.4	7.9	1.1	6.3	0.7	1.1	8.2	0.1	1.9	1.9	1.2	0.9	2.5	10.5	2.3	2.7	0.2	3.2	10.4	2.3	0.0	1.8	0.1	2.0	5.9	3.7	2.2	4.2	1.0	2.1	2.1	0.8	6.6	2.7	7.9	0.0	1.1	0.1	2.3	1.6	2.8	2.8	2.0	1.6	5.8	1.7	2.2	2.4	0.2	1.2	0.0	4.5	2.2	0.8	1.5	4.1	3.5	2.3	1.5	1.5	4.0	1.8	2.9	2.2
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FK506 binding protein 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 32.5;neutrophil: 31.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"				Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: "	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	44.3	38.1	75.9	27.5	82.1	82.5	26.5	43.4	113.7	35.2	31.9	41.2	34.6	31.1	31.4	27.2	48.7	39.3	34.5	43.4	69.6	62.1	28.9	42.7	34.3	31.1	55.3	54.3	56.1	60.4	28.8	42.2	36.6	51.2	36.5	12.9	31.9	73.1	46.1	56.7	35.1	31.6	34.6	46.3	36.7	31.9	49.5	26.9	32.1	38.8	24.2	30.7	36.3	45.8	4.3	4.3	32.5	6.9	3.1	6.6	9.1	36.6	26.3	20.6	39.1	21.3	33.5	51.7	29.7	31.6	22.7	31.5	24.9	50.0	21.0	48.3	36.4	19.9	12.7	41.3	6.4	25.6	60.3	19.6	34.3	29.9	36.7	19.4	43.2	43.7	39.9	20.4	13.0	23.3	41.1	50.0	19.7	61.0	35.2	58.1	42.1	38.2	37.0	17.1	71.8	30.5	24.0	22.9	41.7	20.8	17.2	37.0	20.2	56.7	27.1	28.4	26.0	55.4	22.5	38.3	21.9	24.4	64.3	31.2	25.2	6.3	5.6	32.5	6.0	5.8	5.5	4.1	6.1	6.6	4.3	4.3	4.7	5.3	31.0	3.1	6.9	4.3	6.0	9.1	75.9	82.1	43.4	113.7	69.6	62.1	55.3	54.3	51.2	26.9
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavourable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	16.5	16.5	20.3	15.5	18.9	12.1	17.4	15.9	20.8	14.1	16.4	19.3	14.7	19.6	15.9	21.2	19.8	16.7	11.8	16.1	18.2	10.4	19.0	36.5	13.5	20.0	20.8	15.6	14.5	19.0	13.6	12.0	18.5	15.9	18.7	19.0	16.1	16.2	16.3	26.3	23.3	23.9	17.6	12.4	22.9	16.1	19.1	18.9	15.7	20.8	18.4	22.0	15.5	15.4	25.1	24.5	15.2	24.1	14.9	26.4	22.7	13.1	21.2	13.5	23.0	11.8	8.7	25.7	10.0	8.3	14.6	12.5	18.8	16.3	15.4	20.2	9.2	17.3	25.8	20.7	9.5	16.0	19.4	12.5	16.8	13.2	16.1	18.0	16.3	12.4	27.2	16.6	17.8	16.9	20.0	12.5	12.3	28.4	12.4	12.6	29.4	22.0	20.9	6.7	35.3	13.9	18.4	22.8	31.3	15.6	35.4	19.7	30.3	27.4	10.7	9.2	12.7	11.8	15.7	19.6	24.3	26.5	11.1	14.7	14.7	15.2	23.0	14.8	24.0	20.9	26.4	25.1	22.1	22.7	24.1	20.5	20.5	20.2	5.2	14.9	24.1	24.5	23.3	22.7	20.3	18.9	15.9	20.8	18.2	10.4	20.8	15.6	15.9	18.9
FLCN	"BHD, MGC17998, MGC23445"	ENSG00000154803	Folliculin	Q8NFG4	17	17212212-17237188	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB015158, HPA028760"	Supported		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB015158: AB_2231645, HPA028760: AB_10601323"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.90e-1)"	"prognostic favourable (4.49e-4)"	"unprognostic (6.45e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.65e-1)"	11.9	15.3	23.6	10.8	41.6	15.6	13.9	49.4	26.9	18.0	21.3	18.5	10.4	25.0	22.1	15.8	11.0	14.5	17.6	17.2	17.2	8.6	9.6	15.5	15.6	11.6	24.2	13.5	25.2	13.7	6.1	20.3	13.3	18.1	15.4	10.7	14.8	10.5	14.8	22.7	12.6	20.2	15.4	14.8	16.5	15.3	12.5	29.1	6.6	15.8	3.9	8.0	15.0	14.8	6.0	2.4	10.5	6.8	4.5	5.0	3.1	6.4	15.7	5.8	7.5	18.9	10.8	8.5	5.8	9.7	9.2	12.8	11.9	5.4	3.2	8.1	7.0	7.5	7.0	3.6	4.8	6.1	5.9	6.5	4.6	6.8	17.5	2.4	18.3	15.8	12.4	14.4	10.7	7.5	8.9	8.3	8.8	8.3	4.3	4.1	5.9	3.9	8.6	26.8	3.7	5.5	7.1	7.0	4.5	6.1	3.7	10.1	5.6	4.5	8.8	21.7	9.4	29.9	7.6	4.1	3.9	3.0	13.7	5.5	8.5	3.6	4.7	2.8	2.9	6.8	4.1	5.3	3.5	2.5	2.4	6.0	3.9	3.4	10.5	4.5	2.2	2.4	5.0	3.1	23.6	41.6	49.4	26.9	17.2	8.6	24.2	13.5	18.1	29.1
FLG		ENSG00000143631	Filaggrin	P20930	1	152302175-152325203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 21.9;skin 1: 109.7;tongue: 38.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;NTERA-2: 4.4;TIME: 3.0;U-2 OS: 3.4;U-2197: 3.6"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"			500000	"Cytoplasmic bodies"		"CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.8	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.4	109.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	38.6	7.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	14.0	0.0	0.0	0.0	1.5	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	3.0	1.2	3.4	3.6	2.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.2"	"Cell line enhanced"	"Detected in many"		"HEL: 40.2;HUVEC TERT2: 22.3;REH: 18.8;TIME: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073099			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA073099: "	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	14.7	2.5	3.5	15.8	4.4	10.6	9.9	1.4	3.2	6.7	5.1	3.8	2.1	3.3	7.8	6.5	4.8	5.3	6.0	7.5	3.8	3.1	4.2	3.6	17.4	24.4	6.2	1.6	4.0	3.2	2.5	2.0	11.4	3.8	4.3	3.1	4.8	4.2	3.3	5.2	3.2	6.9	5.7	6.6	40.2	4.1	2.7	4.6	26.8	5.7	2.8	17.9	6.2	6.7	4.5	13.1	20.1	12.0	7.8	8.8	11.6	0.0	0.0	2.0	0.0	0.2	0.4	0.0	1.2	3.4	1.4	1.2	0.0	0.0	6.8	12.2	4.0	0.0	0.3	5.0	1.6	3.2	0.1	40.2	0.2	0.0	2.4	4.8	5.7	0.3	0.4	2.9	6.8	22.3	0.0	8.8	0.3	0.0	4.8	2.7	0.6	1.2	18.8	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.8	23.1	0.2	0.0	0.1	1.2	2.8	5.9	5.9	0.0	11.7	1.8	20.1	9.5	16.1	7.2	10.3	8.8	4.5	6.2	5.8	13.1	3.6	2.6	5.6	7.8	7.8	12.0	2.2	7.4	11.6	3.5	4.4	1.4	3.2	3.8	3.1	6.2	1.6	3.8	4.6
FLII	"FLI, Fli1, FLIL, MGC39265"	ENSG00000177731	"FLII, actin remodeling protein"	Q13045	17	18244836-18258916	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007084, HPA008903, CAB016132"	Approved		Enhanced	"Nucleoplasm,Centriolar satellite,Cytosol"			1800000	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	21.2	16.8	8.6	16.9	12.4	16.6	21.7	11.7	11.4	17.5	18.5	12.8	14.3	14.6	17.3	16.3	25.9	13.7	15.6	28.3	9.3	7.4	19.0	18.8	17.3	13.4	15.0	6.1	15.3	20.0	15.4	13.5	15.8	13.6	17.2	10.7	11.0	21.3	17.0	78.4	14.4	18.9	19.1	11.1	20.0	15.4	15.6	11.9	21.2	15.1	25.4	17.5	21.5	16.3	5.3	16.0	12.9	24.9	5.2	7.2	10.3	58.9	21.3	6.0	9.3	14.0	12.7	9.1	16.4	19.9	18.5	11.5	27.1	13.5	11.5	17.2	18.8	26.3	8.1	27.3	10.9	9.6	12.6	6.3	15.7	10.7	15.8	7.0	13.4	11.4	16.7	15.1	22.8	17.9	5.1	4.7	10.8	17.6	10.3	5.8	6.3	11.2	10.1	27.2	14.3	13.8	16.7	2.1	3.2	19.1	16.3	8.8	27.7	5.5	21.9	16.5	17.0	31.7	19.3	4.9	3.6	3.5	15.6	6.8	8.9	4.8	13.6	12.9	7.0	21.4	7.2	5.3	5.8	7.2	16.0	3.6	4.3	4.6	12.0	5.2	24.9	4.7	6.6	10.3	8.6	12.4	11.7	11.4	9.3	7.4	15.0	6.1	13.6	11.9
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374638	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 396.7;urinary bladder: 276.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"			2900000000	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: , HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.88e-4)"	42.8	8.8	2.9	46.4	3.9	22.9	30.7	2.0	5.2	106.5	204.2	6.3	86.0	13.1	158.9	54.4	140.2	79.9	121.0	18.8	3.2	2.2	17.2	5.5	29.1	21.1	3.4	5.9	77.4	7.3	1.6	4.8	20.0	9.4	129.3	13.4	19.0	12.6	98.8	13.7	15.0	50.2	396.7	3.6	25.5	82.7	29.9	2.9	12.1	11.7	16.3	15.1	276.1	64.5	6.3	13.1	7.1	19.7	5.9	22.6	24.1	87.2	67.8	23.9	30.8	20.9	27.7	39.4	58.4	65.1	53.6	47.7	43.9	16.2	7.5	151.6	90.7	50.1	21.5	51.2	15.1	30.8	7.5	24.2	88.7	15.2	38.5	28.6	31.8	26.5	12.4	79.8	31.9	39.8	6.8	52.3	38.3	20.0	13.6	9.9	25.2	45.1	13.7	21.7	6.7	20.8	18.2	5.3	12.1	48.8	7.9	39.3	7.6	9.0	95.2	61.2	59.0	62.0	107.6	32.8	19.2	15.2	56.9	19.2	61.2	4.1	11.5	7.1	22.6	15.2	14.3	6.3	10.5	18.7	13.1	3.0	4.0	9.1	2.6	5.9	19.7	1.7	12.8	24.1	2.9	3.9	2.0	5.2	3.2	2.2	3.4	5.9	9.4	2.9
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 70.2;TIME: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"			37000000	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favourable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	24.7	17.8	7.8	25.3	10.6	2.2	30.0	12.6	7.4	21.3	33.5	17.2	49.6	19.4	36.1	47.4	18.6	17.3	16.0	7.7	10.6	8.5	20.6	29.2	14.1	9.4	16.1	5.3	22.9	22.4	25.6	7.8	36.0	13.2	35.8	28.5	20.1	25.5	44.0	7.7	28.9	50.2	39.7	24.3	12.1	21.2	11.7	13.5	49.3	28.2	12.0	13.0	32.8	34.7	3.8	15.9	7.4	1.2	5.9	4.9	1.2	19.8	34.0	3.4	5.0	2.3	4.0	59.9	7.4	6.0	16.5	16.9	34.0	34.0	3.2	2.8	26.0	32.7	6.4	47.2	16.1	17.9	3.1	2.7	28.9	16.5	17.1	2.3	9.8	6.3	20.5	22.9	70.2	55.8	4.5	1.0	10.2	4.3	7.2	5.7	5.3	29.4	3.2	0.9	2.8	22.1	33.9	3.8	3.6	37.5	20.6	4.1	17.0	6.6	79.1	4.3	13.5	51.5	26.3	0.7	0.2	2.6	16.0	4.3	4.5	7.4	0.3	4.2	0.5	0.8	2.6	3.8	1.6	0.7	1.2	1.6	4.9	3.5	0.1	5.9	1.2	15.9	1.7	1.2	7.8	10.6	12.6	7.4	10.6	8.5	16.1	5.3	13.2	13.5
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830377-128859274	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 546.8"	"Cell line enhanced"	"Detected in many"		"BJ: 78.6;fHDF/TERT166: 35.8;hTEC/SVTERT24-B: 38.9;U-2 OS: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006135	Enhanced		Supported	"Plasma membrane,Cytosol"			54000000	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (3.73e-5)"	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1.0	5.2	24.4	1.4	18.4	1.9	14.0	10.1	16.0	4.8	13.3	70.0	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1.0	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1.0	5.2	69.0	4.7	0.3	10.0	1.3	0.6	0.0	4.7	40.0	2.2	39.6	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	7.1	8.6	0.8	78.6	14.9	22.4	10.8	24.4	0.2	0.0	13.3	35.8	0.0	4.8	0.1	13.3	0.0	2.6	0.0	4.0	0.0	9.0	0.0	0.0	16.3	0.0	38.9	0.0	13.9	9.4	0.0	15.2	0.0	0.0	0.3	13.1	4.5	0.0	26.0	0.2	0.0	0.0	0.4	1.4	0.1	0.0	0.0	0.1	0.3	28.8	7.8	33.6	2.0	0.0	0.0	0.0	0.0	26.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6
FLOT2	"ECS-1, ECS1, ESA, ESA1, M17S1"	ENSG00000132589	"Flotillin 2"	Q14254	17	28879335-28897679	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001396, CAB004395, HPA071038"	Supported		Supported	"Vesicles,Plasma membrane"			1900000	"Plasma membrane"	Vesicles	"CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: "	"unprognostic (6.04e-2)"	"unprognostic (8.76e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.15e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.20e-2)"	26.1	19.5	21.5	28.3	21.9	47.8	21.1	17.3	35.9	17.3	20.7	14.4	13.7	11.1	15.7	14.3	25.9	21.0	15.0	24.5	17.3	18.7	36.4	52.5	24.7	40.1	15.3	17.8	19.8	18.5	18.8	9.1	30.4	31.9	27.6	14.8	20.9	24.3	29.5	21.1	17.7	19.2	25.5	12.8	49.6	17.5	8.4	12.3	17.4	21.8	14.5	33.1	36.7	34.4	25.7	29.4	84.8	21.3	14.8	21.4	24.1	14.7	25.2	19.6	16.8	10.0	12.7	21.2	11.5	15.9	17.0	20.1	26.0	12.7	20.6	22.4	12.8	17.5	21.1	19.1	7.3	65.3	24.9	25.0	23.7	18.7	13.2	20.3	4.2	15.4	14.8	14.1	18.9	26.9	23.5	18.1	7.8	22.3	5.6	15.3	17.2	6.7	8.7	19.7	50.4	30.0	46.3	17.3	29.0	27.0	19.3	20.9	20.1	36.6	21.9	6.1	11.0	9.8	17.4	10.3	17.7	10.6	17.0	19.6	11.3	28.0	21.3	41.2	21.4	19.5	15.8	21.4	16.4	18.1	29.4	25.7	12.3	15.2	84.8	14.8	20.8	8.0	19.3	24.1	21.5	21.9	17.3	35.9	17.3	18.7	15.3	17.8	31.9	12.3
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322988-14337616	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.1"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;hTCEpi: 28.9;RPTEC TERT1: 9.7;WM-115: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"		240000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: "	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favourable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	7.3	4.3	3.4	2.2	7.4	0.1	2.7	27.5	18.9	3.8	5.0	0.7	3.2	12.4	2.6	5.5	2.5	2.7	5.6	1.6	9.3	4.1	43.1	28.9	26.2	0.2	2.3	5.3	11.9	2.3	4.6	2.1	2.0	2.9	12.7	1.0	1.9	1.5	16.4	2.1	6.9	6.0	3.9	2.3	0.8	9.7	1.7	0.7	4.8	8.5	1.8	0.4	12.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	15.3	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	8.4	3.1	0.0	0.5	0.3	4.3	0.0	4.5	0.1	0.0	0.9	0.0	0.2	0.1	1.3	0.0	0.0	2.7	28.9	0.0	5.4	0.0	0.0	0.1	2.9	0.2	1.9	0.0	5.0	0.0	0.0	0.1	0.0	9.7	1.8	0.3	3.1	0.0	0.0	4.8	0.2	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	7.4	27.5	18.9	9.3	4.1	2.3	5.3	2.9	0.7
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related tyrosine kinase 1"	P17948	13	28300344-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"placenta: 155.3"	"Cell line enhanced"	"Detected in some"		"BJ: 17.0;BJ hTERT+: 13.5;HMC-1: 84.6;HUVEC TERT2: 15.3;WM-115: 30.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.7;granulocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	875697	54000	"Plasma membrane, Actin filaments"		"CAB068189: , CAB068190: , HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	18.9	4.0	9.9	4.0	14.3	1.2	13.5	8.0	15.9	7.1	4.6	3.5	1.7	3.5	7.2	2.2	3.4	4.0	6.9	18.3	11.4	7.3	10.3	7.6	12.3	2.5	10.3	3.2	5.1	5.4	13.4	3.7	155.3	13.8	5.1	3.1	9.1	3.0	5.0	12.5	2.6	3.4	7.3	9.6	7.2	4.6	6.8	10.2	0.0	19.1	3.8	2.8	7.6	9.2	3.7	0.5	2.1	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	17.0	13.5	6.2	3.6	0.0	0.0	0.0	0.0	2.2	0.0	1.6	0.0	11.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	84.6	0.1	0.0	0.0	0.2	15.3	0.4	0.0	0.0	0.0	1.0	0.8	9.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.1	0.0	30.3	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.0	3.7	0.4	0.4	2.1	0.2	0.1	0.5	0.2	0.2	9.9	14.3	8.0	15.9	11.4	7.3	10.3	3.2	13.8	10.2
FLYWCH1	DKFZp761A132	ENSG00000059122	"FLYWCH-type zinc finger 1"	Q4VC44	16	2911937-2951208	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040753, HPA041001"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA040753: AB_10794880, HPA041001: AB_10794259"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-2)"	15.6	16.6	13.1	12.6	17.2	12.5	10.2	24.4	27.4	13.6	12.2	17.7	9.5	14.7	14.3	13.4	11.8	11.9	15.0	16.7	12.1	15.9	10.1	5.9	10.7	11.6	15.8	18.5	21.4	12.2	22.6	12.2	9.5	18.8	13.9	4.7	25.3	14.4	15.6	28.1	22.8	14.4	14.1	16.2	19.9	11.0	5.1	10.9	8.5	11.5	8.4	10.3	17.1	15.7	4.6	1.6	2.3	1.6	0.9	5.5	2.1	5.0	17.9	4.1	12.1	6.7	6.8	12.5	9.4	7.4	4.8	4.9	2.9	16.5	12.4	25.1	7.2	10.6	3.4	6.3	0.9	20.6	10.2	4.1	15.1	9.9	15.0	5.5	14.5	6.1	20.1	10.0	7.4	6.7	9.2	13.2	3.6	12.1	12.5	6.6	6.7	12.3	22.0	6.1	22.2	5.6	3.4	8.9	8.2	9.9	10.8	12.6	8.4	10.0	12.6	8.0	7.3	15.5	6.3	19.6	16.7	11.1	8.8	9.0	9.3	2.3	1.6	0.6	3.0	0.7	4.9	2.0	4.5	5.5	1.6	4.6	3.9	3.4	0.2	0.9	0.8	1.0	2.2	2.1	13.1	17.2	24.4	27.4	12.1	15.9	15.8	18.5	18.8	10.9
FMN1	"DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289"	ENSG00000248905	"Formin 1"	Q68DA7	15	32765545-33194733	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 21.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 9.3;RH-30: 12.5;SK-MEL-30: 13.0;T-47d: 11.4;U-138 MG: 7.3"	"Cancer enriched"	"Detected in many"	9	"melanoma: 14.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005465, HPA046786"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005465: AB_1859515, HPA046786: AB_10963545"	"unprognostic (1.57e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (7.61e-2)"	7.0	2.1	3.7	3.9	5.3	2.2	4.9	0.6	12.1	8.9	8.5	1.8	2.6	2.6	2.2	4.8	3.9	5.1	4.0	2.4	3.3	2.0	4.7	1.4	7.7	3.3	5.9	7.3	1.1	2.5	2.6	8.0	5.1	4.6	3.8	6.9	21.9	6.4	2.5	2.2	9.2	4.3	3.7	6.4	3.0	11.7	12.4	4.6	1.8	4.7	1.5	2.0	2.7	6.8	0.6	1.8	2.8	0.7	0.1	0.7	0.1	1.6	1.8	0.3	0.2	0.0	0.2	2.0	2.3	1.8	0.6	1.7	0.2	2.2	0.2	0.8	2.7	1.4	0.0	1.5	1.7	0.0	0.1	1.2	0.3	0.1	0.1	0.0	0.1	0.7	0.0	2.7	0.0	0.0	0.0	9.3	4.1	1.7	0.0	0.0	0.5	0.1	0.2	12.5	2.2	0.8	0.6	0.1	0.3	0.0	1.5	13.0	11.4	0.0	1.6	7.3	1.2	6.6	0.6	0.0	0.0	0.4	3.5	0.0	4.5	2.8	0.7	0.0	0.3	0.0	0.5	0.0	0.7	0.6	1.4	0.6	0.4	0.0	0.1	0.1	0.0	1.8	0.1	0.1	3.7	5.3	0.6	12.1	3.3	2.0	5.9	7.3	4.6	4.6
FMNL3	"DKFZp762B245, MGC45819, WBP3"	ENSG00000161791	"Formin like 3"	Q8IVF7	12	49636499-49708165	"Predicted intracellular proteins"	Angiogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002552, HPA023201"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"				"Golgi apparatus, Vesicles, Plasma membrane"	Cytosol	"HPA002552: AB_1078862, HPA023201: AB_1848575"	"unprognostic (2.97e-1)"	"unprognostic (2.77e-3)"	"unprognostic (4.97e-3)"	"unprognostic (7.19e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.37e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	18.3	6.4	10.1	19.9	10.7	5.0	13.8	8.5	11.2	9.3	8.0	23.2	6.3	6.0	13.5	20.8	5.1	7.5	13.0	12.6	10.6	9.0	10.1	3.1	18.0	22.5	14.0	7.7	18.9	3.8	3.7	5.0	14.4	12.9	7.5	6.2	9.8	5.0	5.1	6.3	4.8	10.7	12.3	14.2	13.0	6.7	10.5	11.3	16.2	15.0	5.1	27.9	9.6	7.7	1.7	8.6	3.6	0.7	1.1	1.5	0.7	4.4	1.3	10.0	3.3	2.8	11.3	0.1	5.5	11.3	7.6	6.7	5.1	1.2	9.6	10.7	6.6	0.2	5.1	2.3	7.0	8.4	1.9	10.5	1.5	0.2	4.9	2.1	13.8	7.1	0.3	11.8	5.0	20.0	2.3	7.1	11.1	3.3	8.5	3.1	3.3	2.9	4.1	12.5	1.4	7.1	0.6	1.7	4.7	3.2	0.4	6.5	0.8	3.1	25.2	18.9	6.6	0.3	9.5	3.7	0.2	5.2	11.7	6.5	7.9	3.6	0.3	1.2	1.5	0.7	0.7	0.4	0.5	0.9	0.4	1.7	0.8	0.9	0.0	1.1	0.6	8.6	0.3	0.7	10.1	10.7	8.5	11.2	10.6	9.0	14.0	7.7	12.9	11.3
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 28.4;HMC-1: 6.4;THP-1: 7.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favourable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.0	1.9	0.5	0.6	0.4	0.3	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.3	0.0	0.0	0.0	1.0	0.1	1.1	0.0	28.4	0.6	0.9	6.4	0.9	0.1	0.3	0.0	0.4	0.1	0.1	1.1	0.9	0.2	0.5	2.0	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	1.9	0.9	1.4	7.2	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0
FMR1	"FMRP, FRAXA, MGC87458, POF, POF1"	ENSG00000102081	"Fragile X mental retardation 1"	Q06787	X	147911951-147951125	"Disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation, Mental retardation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012444, HPA050118, HPA056084"	Approved		Enhanced	Cytosol				Cytosol		"CAB012444: AB_732400, HPA050118: , HPA056084: "	"unprognostic (4.11e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.89e-3)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.98e-2)"	14.9	13.3	24.8	14.9	21.1	28.3	14.3	32.6	25.7	16.0	14.5	17.7	14.4	13.3	21.2	33.2	13.9	18.3	12.3	15.0	22.2	19.0	26.5	30.3	15.3	15.7	23.3	22.8	23.4	11.5	27.8	20.5	49.9	18.9	15.4	15.0	14.0	12.7	19.6	7.8	17.7	15.9	18.3	23.1	20.1	13.2	14.5	19.2	21.7	29.0	9.8	16.1	17.1	27.3	5.3	3.4	7.3	3.5	4.9	7.4	2.4	14.8	13.3	13.9	9.3	8.6	6.9	11.1	8.0	8.5	12.9	23.4	14.6	14.1	29.6	33.3	9.9	25.7	22.1	9.9	14.5	11.6	15.4	8.3	24.8	13.7	8.8	9.2	5.2	7.5	5.7	10.9	10.2	10.7	5.2	19.6	11.5	19.3	10.3	6.7	6.2	7.5	11.6	39.8	12.5	15.1	39.8	12.2	8.0	9.2	8.4	11.9	7.5	8.3	10.2	10.5	9.1	12.9	20.1	21.2	21.0	31.8	9.5	15.8	5.5	2.8	2.7	6.6	6.0	3.5	7.4	4.7	3.9	6.6	3.4	5.3	5.0	5.8	7.3	4.9	3.2	2.8	4.7	2.4	24.8	21.1	32.6	25.7	22.2	19.0	23.3	22.8	18.9	19.2
FNBP1L	"C1orf39, FLJ20275, TOCA1"	ENSG00000137942	"Formin binding protein 1 like"	Q5T0N5	1	93448131-93554661	"Predicted intracellular proteins"	"Autophagy, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065273	Approved		Supported	Cytosol				Cytosol		"HPA065273: "	"unprognostic (1.83e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic favourable (4.72e-7)"	"unprognostic (3.59e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.78e-1)"	22.8	6.8	17.8	8.3	36.0	1.7	27.0	20.3	11.3	15.7	24.3	5.4	27.3	16.5	14.2	15.9	7.6	11.4	11.9	16.3	13.0	13.7	29.9	10.9	18.0	3.3	10.5	10.3	12.2	15.0	16.0	15.6	13.7	14.0	14.5	14.5	5.6	32.2	23.2	23.4	10.3	27.5	10.3	13.9	2.6	19.0	12.0	16.1	2.5	26.3	7.1	3.3	15.2	24.2	0.9	2.2	11.1	0.1	0.1	0.4	0.2	10.2	5.7	30.0	16.7	6.5	4.7	33.5	5.1	3.5	3.9	5.4	7.1	3.2	0.0	10.8	5.0	5.2	7.2	5.9	5.6	6.6	5.4	5.5	8.3	10.3	3.2	0.9	0.1	8.4	9.8	3.6	5.4	18.5	2.1	0.0	9.2	4.7	3.9	0.4	22.8	5.8	8.7	22.9	2.6	17.1	16.5	12.0	17.0	16.1	31.6	8.9	12.0	1.4	18.3	9.2	11.7	0.2	3.5	3.2	2.6	0.1	0.9	0.1	6.2	11.1	0.1	1.1	0.0	0.0	0.1	0.6	0.4	0.0	0.5	0.9	0.0	0.4	0.1	0.1	0.0	2.2	0.4	0.2	17.8	36.0	20.3	11.3	13.0	13.7	10.5	10.3	14.0	16.1
FNBP4	KIAA1014	ENSG00000109920	"Formin binding protein 4"	Q8N3X1	11	47716517-47767443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039485, HPA040029"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA039485: , HPA040029: AB_2676808"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavourable (7.33e-5)"	"unprognostic (5.58e-3)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (6.35e-4)"	"prognostic unfavourable (1.91e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-1)"	"prognostic favourable (7.23e-5)"	21.7	19.0	14.0	33.0	16.7	31.9	25.3	33.8	18.4	29.6	21.1	19.7	21.5	17.2	32.2	23.8	20.2	21.5	19.3	15.7	12.6	9.8	16.1	17.7	22.5	26.8	18.0	14.6	31.1	23.4	21.8	25.9	20.2	18.3	21.8	17.4	20.7	21.9	28.2	29.4	28.0	24.5	21.8	19.6	30.7	18.3	10.9	18.4	29.6	26.6	16.7	31.5	26.0	23.2	9.0	9.1	5.4	3.7	2.8	6.6	1.4	7.7	6.1	13.1	9.1	7.6	9.0	9.2	9.2	9.3	8.3	9.7	6.0	10.1	16.9	4.7	10.1	16.3	11.5	7.3	12.2	14.3	21.8	13.2	18.5	10.1	10.7	13.7	12.5	10.8	12.1	7.2	16.5	9.5	14.1	14.3	7.8	6.8	21.9	16.3	12.2	6.7	15.7	12.8	9.7	8.0	9.2	5.8	10.1	13.6	11.3	7.2	9.2	6.5	11.4	9.7	10.8	14.0	12.6	14.6	10.2	19.1	7.3	8.9	6.7	5.1	3.7	5.4	6.6	2.5	5.1	7.6	4.6	4.6	2.2	9.0	4.8	5.1	3.5	2.8	3.5	9.1	6.2	1.4	14.0	16.7	33.8	18.4	12.6	9.8	18.0	14.6	18.3	18.4
FNIP2	"FNIPL, KIAA1450, MAPO1"	ENSG00000052795	"Folliculin interacting protein 2"	Q9P278	4	158769138-158908049	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 60.9;U-266/70: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.8;myeloid DC: 3.1;non-classical monocyte: 9.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.1;monocytes: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042779, HPA052758, HPA072420"	Approved		Supported	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA042779: AB_10794386, HPA052758: , HPA072420: "	"unprognostic (3.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (3.96e-11)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.10e-2)"	23.6	8.6	12.5	7.4	15.5	5.8	11.3	10.9	16.0	10.4	15.7	17.5	11.4	5.6	9.3	9.8	11.0	7.6	15.3	20.9	15.1	9.1	35.5	44.0	21.8	12.0	14.1	14.4	8.5	14.2	13.0	5.2	21.7	11.1	8.5	16.8	8.0	10.0	14.7	15.3	11.4	8.1	13.3	12.9	9.6	16.3	7.2	15.0	5.5	13.9	8.3	4.1	9.3	9.5	0.0	3.1	0.6	9.4	0.9	1.0	0.5	1.3	1.5	6.8	3.5	5.1	3.2	7.5	3.0	3.2	3.1	3.4	1.8	1.4	0.0	0.7	10.8	1.3	6.4	3.1	3.8	60.9	2.3	6.4	0.8	2.5	3.2	2.6	12.8	2.3	2.6	2.1	2.7	3.4	3.8	0.2	5.1	0.4	6.2	0.3	2.1	1.6	3.6	3.3	1.7	2.5	3.5	4.4	3.9	1.6	1.1	6.8	1.4	1.5	4.3	5.0	3.1	3.4	2.2	20.6	8.6	1.3	5.0	3.3	3.5	0.6	1.1	0.3	0.7	4.8	0.4	0.0	0.4	0.3	3.1	0.0	0.4	1.0	0.2	0.9	9.4	0.6	0.1	0.5	12.5	15.5	10.9	16.0	15.1	9.1	14.1	14.4	11.1	15.0
FOPNL	"C16orf63, DKFZp686N1651, FLJ31153, FOR20, PHSECRG2"	ENSG00000133393	"FGFR1OP N-terminal like"	Q96NB1	16	15865720-15888625	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040599	Supported		Supported	Centrosome				Centrosome		"HPA040599: AB_10794036"	"unprognostic (1.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.78e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.45e-3)"	12.0	21.6	15.6	13.4	17.3	13.2	21.4	13.1	19.5	14.2	16.0	14.5	9.5	13.7	11.7	9.3	21.3	12.8	15.4	15.4	14.0	14.7	19.4	18.3	11.3	23.8	16.5	11.3	16.8	14.3	15.5	16.4	14.7	17.9	14.3	15.3	14.5	11.4	13.2	32.7	18.3	12.5	13.1	12.9	13.9	11.4	21.7	13.0	25.7	36.0	22.1	16.4	20.5	13.0	13.9	14.9	23.7	12.9	16.0	15.3	13.6	15.2	16.4	5.9	0.9	13.5	16.8	0.7	8.5	9.9	8.8	10.4	8.8	1.5	11.1	11.1	2.1	12.4	14.6	1.1	18.6	11.7	10.8	1.6	3.9	3.3	11.4	3.1	12.3	1.5	20.0	1.9	13.6	14.8	29.8	1.4	2.3	11.6	9.6	11.8	14.6	0.9	2.1	13.9	1.1	1.1	4.7	5.3	0.4	0.8	11.1	18.3	1.3	1.3	5.0	1.2	1.1	17.3	29.9	4.0	12.8	18.4	16.0	25.9	12.9	23.7	12.9	6.0	11.7	12.7	15.2	13.9	14.4	13.8	13.4	13.7	15.3	14.1	3.7	16.0	10.5	14.9	13.6	13.6	15.6	17.3	13.1	19.5	14.0	14.7	16.5	11.3	17.9	13.0
FOS	"AP-1, c-fos"	ENSG00000170345	"Fos proto-oncogene, AP-1 transcription factor subunit"	P01100	14	75278774-75282230	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"hTCEpi: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 84.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 84.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA018531	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA018531: AB_1846576"	"unprognostic (1.18e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.55e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (7.81e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-2)"	104.8	58.4	17.0	143.7	30.0	157.6	40.7	24.0	21.3	132.3	48.7	52.3	22.1	17.4	79.7	50.5	93.6	239.5	271.8	56.8	17.5	21.4	22.7	47.9	70.7	31.0	23.9	10.6	94.5	32.7	40.9	52.9	130.2	44.6	60.6	49.3	64.4	42.8	255.8	37.5	156.2	44.1	98.1	43.7	18.5	60.7	33.2	26.8	10.1	77.5	226.7	28.1	60.8	54.0	0.0	11.6	84.5	12.3	0.7	0.1	3.3	0.4	0.3	1.5	2.2	13.2	4.0	9.1	1.3	0.5	0.9	0.7	0.9	2.6	0.1	0.4	9.2	0.6	0.7	15.9	0.2	0.2	0.2	0.2	3.8	0.3	6.1	0.5	9.3	9.9	98.7	0.8	6.0	0.5	0.4	4.2	0.2	5.4	0.1	2.6	1.6	0.5	0.4	0.3	4.8	4.1	4.3	11.3	0.7	2.0	18.3	7.8	0.3	1.9	1.3	0.1	1.2	0.8	0.4	11.4	11.9	2.0	0.6	1.6	1.2	6.0	12.3	14.6	0.0	3.5	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.0	84.5	0.7	0.4	0.2	0.0	3.3	17.0	30.0	24.0	21.3	17.5	21.4	23.9	10.6	44.6	26.8
FOSB	"AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291"	ENSG00000125740	"FosB proto-oncogene, AP-1 transcription factor subunit"	P53539	19	45467995-45475179	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 14.6;hTCEpi: 9.1;Karpas-707: 7.5;SK-BR-3: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.1;basal ganglia: 4.2;cerebral cortex: 5.3;hippocampal formation: 4.5;olfactory region: 8.8"	"Low region specificity"	"Detected in many"			"CAB010267, HPA054663"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB010267: AB_640583, HPA054663: "	"unprognostic (7.22e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.72e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.04e-2)"	72.7	13.0	2.3	111.4	7.4	39.2	10.0	5.5	7.7	62.9	9.0	14.9	2.2	1.7	32.1	6.1	18.9	135.1	102.6	14.1	2.5	2.9	3.4	8.6	22.9	6.0	2.0	1.2	29.1	12.2	8.1	8.1	129.0	8.5	12.2	7.9	38.6	8.7	59.1	2.2	59.5	10.8	36.3	2.5	2.6	30.5	21.7	1.3	4.0	33.6	114.5	8.2	16.7	4.4	0.2	1.7	9.0	1.6	0.2	0.7	0.2	0.4	0.8	0.2	0.3	1.3	0.3	2.4	2.5	1.1	0.8	0.7	0.5	1.0	2.1	0.4	1.6	0.9	0.5	1.7	0.5	0.3	0.8	0.6	0.8	0.4	0.9	1.2	14.6	0.5	9.1	1.9	2.1	1.0	0.8	7.5	0.2	0.2	0.2	1.2	0.5	0.4	0.6	0.1	1.4	0.7	1.4	3.4	0.4	1.5	10.7	1.3	0.6	0.8	0.2	0.6	0.7	1.2	0.8	5.6	0.7	0.6	1.2	0.8	1.4	1.5	1.6	1.7	0.3	0.2	0.7	0.1	0.4	0.3	1.7	0.2	0.0	0.0	9.0	0.2	0.1	0.1	0.1	0.2	2.3	7.4	5.5	7.7	2.5	2.9	2.0	1.2	8.5	1.3
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.2;tongue: 46.8"	"Cell line enhanced"	"Detected in many"		"PC-3: 92.9;U-2197: 62.3;WM-115: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 6.9"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004396, HPA030728"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.80e-4)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	22.4	3.7	1.5	8.2	3.1	17.9	3.6	1.1	2.8	5.4	2.8	1.5	0.2	0.8	2.1	2.0	35.2	4.4	24.4	5.8	2.3	1.3	2.2	4.4	7.7	1.7	2.6	0.5	2.6	9.9	0.4	2.0	3.2	6.5	3.1	1.7	0.6	5.4	1.0	6.6	9.2	2.0	3.6	3.5	1.6	8.7	1.5	2.3	0.3	2.1	46.8	16.5	16.6	4.6	0.0	6.9	1.0	1.6	0.0	0.6	1.1	36.0	5.3	0.6	2.4	5.4	5.4	5.2	33.8	31.0	29.3	16.4	1.6	30.1	0.0	7.4	23.4	6.8	2.2	27.2	25.2	1.1	0.0	2.2	0.5	4.0	6.8	1.4	0.8	2.3	2.7	22.9	34.7	9.4	5.2	0.2	38.4	1.5	0.0	3.0	2.5	92.9	0.1	2.9	0.1	13.6	2.4	0.0	0.0	2.0	0.0	25.4	0.1	1.3	23.3	34.7	7.1	62.3	49.5	0.0	0.1	0.1	48.8	0.6	140.9	0.0	1.6	0.0	0.3	1.1	0.2	0.0	0.6	0.3	6.9	0.0	0.6	0.0	1.0	0.0	0.5	0.8	0.0	1.1	1.5	3.1	1.1	2.7	2.3	1.3	2.6	0.5	6.5	2.3
FOSL2	"FLJ23306, FRA2"	ENSG00000075426	"FOS like 2, AP-1 transcription factor subunit"	P15408	2	28392448-28417312	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 23.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004817, CAB013460, HPA061417"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB013460: , HPA004817: AB_1849014, HPA061417: "	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.41e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.79e-2)"	62.8	66.9	7.3	24.6	11.2	74.5	22.5	5.4	11.9	34.4	35.4	7.0	15.0	11.4	43.8	16.3	49.6	26.6	42.0	30.3	12.0	4.7	17.2	12.6	32.2	4.4	10.2	3.6	62.0	14.1	4.1	14.2	20.8	15.9	36.4	15.9	11.4	16.2	22.1	56.3	31.1	37.2	40.8	20.0	20.4	25.4	13.8	8.0	2.1	13.6	16.2	14.5	47.1	79.7	0.0	2.5	23.0	6.2	2.7	5.1	2.8	12.3	8.5	0.5	6.6	7.0	12.4	17.9	10.6	10.8	17.0	14.9	10.0	9.8	0.0	15.7	13.6	11.9	0.7	14.0	15.4	2.9	0.9	1.2	15.8	1.7	11.0	2.1	5.4	19.7	35.8	19.9	17.6	8.9	0.1	3.6	11.3	2.0	0.2	6.7	1.0	4.2	0.5	16.5	1.1	27.3	42.9	4.5	0.6	17.2	10.1	3.1	1.1	9.9	26.5	35.9	24.2	20.8	15.3	5.5	2.0	0.0	23.8	12.1	6.1	8.8	6.2	5.4	5.1	4.7	5.0	0.0	1.1	2.5	2.5	0.0	0.3	1.7	23.0	2.7	3.8	0.8	0.7	2.8	7.3	11.2	5.4	11.9	12.0	4.7	10.2	3.6	15.9	8.0
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589984-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 47.0;prostate: 44.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 16.3;MCF7: 35.4;PC-3: 24.7;RT4: 33.1;SK-BR-3: 33.5;T-47d: 47.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 127.0"	"Region enriched"	"Detected in single"	6	"midbrain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"hypothalamus: 1.0;midbrain: 1.3;thalamus: 1.1"	"Region enriched"	"Detected in some"	6	"midbrain: 6.1"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: "	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favourable (1.00e-4)"	0.1	0.0	0.1	6.1	0.1	0.0	23.5	0.1	0.3	1.5	9.4	0.1	0.1	4.6	0.1	0.5	7.2	1.3	6.5	0.1	0.1	0.3	0.4	47.0	13.2	0.1	2.0	0.1	0.6	0.2	0.0	1.1	0.1	0.2	44.4	6.0	0.2	9.4	0.7	0.1	0.7	5.1	2.4	0.1	0.1	13.0	0.6	0.1	0.2	0.1	4.4	9.9	12.5	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.3	0.9	0.0	0.5	0.0	8.2	4.6	1.1	0.0	0.0	8.1	0.0	1.4	16.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	35.4	0.0	0.1	0.0	24.7	0.0	0.3	0.1	3.4	33.1	4.2	0.0	1.6	33.5	0.0	47.5	0.1	0.0	0.3	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.3	2.0	0.1	0.2	0.1
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22581005-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.4;pancreas: 47.9;stomach 1: 20.7"	"Cell line enhanced"	"Detected in some"		"A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;PC-3: 15.1;SCLC-21H: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	7	"midbrain: 4.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: "		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favourable (6.28e-4)"	"prognostic favourable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.2	0.0	0.2	1.3	0.2	0.0	0.2	0.2	0.3	9.7	4.5	0.2	0.2	2.2	1.8	0.2	0.2	3.8	13.1	0.2	0.2	0.1	0.2	44.4	15.9	0.2	1.4	0.2	3.4	47.9	0.0	0.4	0.3	0.4	0.5	6.0	0.2	0.2	0.2	0.2	0.0	1.8	0.2	0.2	0.2	20.7	0.3	0.2	0.2	2.2	0.2	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	0.0	0.0	0.0	11.7	0.0	0.0	0.7	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.3	0.0	7.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.5	0.0	26.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	1.4	0.2	0.4	0.2
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609972-1613897	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"retina: 32.7;salivary gland: 86.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.9;HEK 293: 37.9;RPTEC TERT1: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040670	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	7.7	4.4	2.6	1.3	3.4	1.0	9.4	2.3	3.4	6.6	1.4	2.8	3.2	1.2	2.4	3.8	3.8	3.4	9.8	9.5	3.2	2.1	12.9	1.4	3.8	1.6	4.5	2.3	4.8	2.8	2.2	6.5	3.1	6.5	6.0	1.3	32.7	86.6	4.9	3.6	7.1	1.2	2.1	3.9	0.9	1.1	4.6	2.6	2.8	3.7	4.2	2.9	5.7	4.6	0.0	0.0	0.2	0.1	1.4	0.0	0.0	7.2	0.8	0.2	38.9	1.8	2.0	1.2	3.6	4.3	2.3	1.8	2.7	1.5	0.0	4.2	2.1	8.2	3.7	2.7	1.9	2.2	37.9	1.5	2.2	1.3	1.2	0.5	2.5	6.8	3.7	3.1	3.6	3.3	1.0	0.0	0.9	1.5	0.0	0.8	0.1	3.1	0.0	1.6	0.2	15.2	5.5	1.4	3.4	4.5	0.0	2.6	1.1	0.6	0.8	4.9	3.0	2.5	3.8	0.1	0.3	0.0	1.4	1.8	4.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	2.6	3.4	2.3	3.4	3.2	2.1	4.5	2.3	6.5	2.6
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86567251-86569728	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 17.6"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 15.7;HUVEC TERT2: 12.0;LHCN-M2: 19.3;TIME: 21.4;U-138 MG: 11.5;U-2197: 19.3;U-87 MG: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA056302			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA056302: "	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	4.8	5.7	1.1	1.6	1.4	0.5	6.4	1.1	3.4	6.2	2.0	2.2	0.1	1.1	1.6	5.3	3.0	3.9	5.6	8.8	1.1	1.1	9.1	0.9	4.9	5.4	4.3	2.6	4.0	1.3	0.6	3.7	0.9	9.9	2.1	1.0	17.6	4.2	2.9	3.2	1.5	0.9	2.1	8.5	0.5	1.1	7.7	0.7	0.0	3.3	1.0	0.9	4.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.0	0.0	6.4	8.8	5.0	0.9	0.0	0.0	0.0	0.9	0.8	0.0	0.1	2.0	4.4	0.0	0.3	0.0	4.8	0.0	1.7	0.0	0.0	0.8	2.1	15.7	5.0	12.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	21.4	11.5	0.0	19.3	0.0	0.0	0.0	0.0	15.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	1.1	3.4	1.1	1.1	4.3	2.6	9.9	0.7
FOXJ2	FHX	ENSG00000065970	"Forkhead box J2"	Q9P0K8	12	8032703-8055503	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008723	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA008723: AB_1078903"	"unprognostic (1.68e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (9.01e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.02e-2)"	19.6	9.7	7.6	9.2	8.6	14.8	14.2	23.7	14.6	20.8	14.7	11.7	17.3	8.1	20.5	11.6	12.3	14.7	13.3	17.3	9.4	5.8	8.5	6.5	12.9	8.4	8.8	8.4	19.9	11.0	21.0	10.2	12.1	7.3	15.4	9.0	11.7	12.4	19.7	25.7	18.1	10.8	17.9	8.4	11.7	12.5	6.7	9.8	13.0	12.0	13.5	13.2	17.0	14.7	4.2	4.5	6.9	3.5	7.3	5.0	2.4	7.3	6.3	6.9	8.7	8.1	8.9	15.2	10.7	11.0	10.5	7.8	8.9	8.2	0.1	2.0	12.9	8.1	6.2	7.1	11.3	12.8	4.2	9.8	7.2	3.0	10.1	4.4	27.6	7.8	10.8	13.5	19.9	7.5	7.1	5.0	8.4	5.8	6.2	4.0	7.9	4.2	6.7	10.7	3.6	4.4	5.0	2.9	3.9	13.4	9.4	4.7	2.1	5.3	6.7	12.8	15.8	9.0	6.4	4.0	4.0	5.0	8.3	3.6	7.6	6.3	3.4	5.1	4.0	2.7	5.0	2.3	4.0	4.6	4.3	4.2	4.7	4.1	6.9	7.3	3.5	4.5	3.1	2.4	7.6	8.6	23.7	14.6	9.4	5.8	8.8	8.4	7.3	9.8
FOXK1	IMAGE:5164497	ENSG00000164916	"Forkhead box K1"	P85037	7	4682309-4771443	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017998, HPA018864"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA017998: AB_1849077, HPA018864: AB_1849079"	"unprognostic (3.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (2.54e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-1)"	13.0	16.7	15.5	12.7	16.0	24.7	10.3	18.1	23.8	14.1	15.4	18.4	9.5	10.1	16.9	8.3	12.4	14.4	11.7	13.6	14.4	13.7	10.7	8.4	14.3	11.9	19.3	13.9	15.5	17.6	10.6	22.2	9.9	14.2	11.7	9.3	13.8	12.6	14.0	27.4	21.0	11.3	15.5	12.1	15.6	11.9	14.7	19.9	12.5	9.2	9.5	11.0	14.9	19.0	3.2	2.8	1.9	4.0	3.7	6.5	2.9	8.7	11.2	7.2	14.3	7.2	5.4	9.0	4.0	3.5	2.9	3.3	11.1	9.9	14.8	4.7	6.4	14.3	7.8	9.8	2.9	4.3	4.8	6.9	11.6	6.2	7.0	8.6	8.0	10.3	5.5	6.9	9.6	5.5	14.9	3.3	3.4	10.0	3.3	15.5	10.9	5.7	12.4	7.2	9.4	4.2	13.0	6.5	8.2	6.1	13.3	4.7	7.3	11.5	16.9	5.0	15.9	7.7	8.5	9.2	7.5	9.8	6.8	10.1	7.9	1.9	2.4	1.0	4.6	4.0	6.5	3.2	4.5	4.3	2.8	3.2	5.1	4.7	1.4	3.7	3.7	2.3	2.2	2.9	15.5	16.0	18.1	21.4	14.4	13.7	19.3	13.9	14.2	19.9
FOXK2	"ILF, ILF1"	ENSG00000141568	"Forkhead box K2"	Q01167	17	82519713-82644662	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027523, HPA073491"	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria				Nucleoplasm	"Vesicles, Mitochondria"	"HPA027523: AB_10601013, HPA073491: "	"unprognostic (2.39e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.24e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	16.8	21.2	17.5	14.3	19.2	8.7	19.1	21.3	30.5	17.7	17.1	17.1	16.9	11.2	22.2	13.7	24.2	14.6	13.4	17.1	14.9	14.9	13.0	13.6	15.2	13.6	13.7	17.2	17.6	19.2	25.4	19.8	18.6	15.6	14.9	11.7	13.8	17.1	16.3	41.5	21.6	12.6	19.9	10.3	13.2	15.5	32.3	15.8	21.8	18.6	12.4	13.9	16.4	16.4	4.0	5.9	4.1	2.9	4.1	4.4	1.6	21.4	22.9	21.5	23.4	12.4	13.7	14.3	12.6	14.5	22.1	22.5	22.2	13.8	18.3	9.2	15.6	12.5	22.9	14.5	21.0	12.5	21.9	18.9	15.1	21.9	19.6	21.0	12.7	12.9	26.7	23.4	26.7	22.3	25.2	18.8	12.1	12.8	35.8	13.4	12.3	17.6	23.5	18.4	15.1	10.1	18.1	35.6	26.3	12.5	31.9	29.7	22.4	24.4	17.4	29.2	20.5	19.5	25.4	21.7	19.2	23.7	15.8	17.6	15.3	4.1	2.9	3.3	4.4	2.2	3.5	4.0	3.3	4.2	3.3	2.8	2.6	2.9	0.5	4.1	2.3	5.9	3.4	1.6	17.5	19.2	21.3	30.5	14.9	14.9	13.7	17.2	15.6	15.8
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947140	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3"	"Cell line enhanced"	"Detected in some"		"A-431: 5.4;fHDF/TERT166: 6.3;HEL: 9.0;hTCEpi: 8.3;K-562: 9.2;SiHa: 6.4;THP-1: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA069613	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"HPA069613: "	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	1.5	0.3	0.0	1.2	0.0	0.0	0.3	1.0	13.9	0.0	0.6	0.0	0.0	10.0	0.4	0.1	6.4	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.4	55.5	0.6	15.3	13.1	1.4	0.8	0.2	0.0	1.7	0.0	0.4	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	2.1	0.3	3.9	0.1	0.0	1.7	0.2	0.0	0.4	0.1	0.0	0.4	0.0	2.6	6.3	1.2	0.0	0.0	0.1	0.0	0.0	9.0	1.1	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	9.2	0.0	3.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	6.4	0.0	0.0	0.0	6.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.3	1.0	0.4	0.2	0.3	0.4	0.8	0.2
FOXL2NB	"C3orf72, FLJ43329"	ENSG00000206262	"FOXL2 neighbor"	Q6ZUU3	3	138947234-138953451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 51.6;parathyroid gland: 25.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.4;fHDF/TERT166: 10.5;HEL: 10.4;hTCEpi: 4.9;SiHa: 8.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"											"HPA061017, HPA071790"			Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA061017: , HPA071790: "	"unprognostic (3.32e-1)"	"unprognostic (1.13e-1)"		"unprognostic (3.86e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.40e-5)"		"unprognostic (3.30e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-10)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-2)"	0.1	1.0	0.6	0.1	1.4	0.2	0.1	0.2	0.9	15.3	0.1	0.5	0.1	0.0	12.6	0.9	0.2	7.3	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.5	0.4	51.6	0.4	25.0	9.4	3.2	1.0	0.1	0.0	1.3	0.1	0.5	0.1	0.3	0.1	2.5	0.3	0.1	0.0	0.4	0.3	0.1	0.4	0.3	0.1	0.4	2.3	0.6	0.5	2.8	0.4	0.7	0.4	0.0	2.1	1.4	0.7	5.4	0.3	0.1	2.3	0.1	0.0	0.2	0.0	0.2	0.4	0.2	1.1	10.5	0.5	0.2	0.1	0.2	0.1	0.3	10.4	3.2	0.1	0.0	0.1	0.4	0.2	4.9	0.2	0.1	0.0	4.0	0.2	2.6	0.2	0.1	0.3	0.3	0.1	0.1	0.0	0.0	0.5	1.5	0.2	0.2	8.1	0.2	0.0	0.2	3.0	0.2	0.3	0.2	0.3	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.3	0.4	0.3	0.4	0.3	0.2	0.4	0.3	0.3	0.2	0.6	0.4	0.3	2.8	0.7	0.2	0.5	0.4	0.0	0.6	1.4	0.2	0.9	0.3	0.2	0.5	0.4	1.0	0.3
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857681-2877155	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.5;testis: 40.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB017832	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavourable (1.95e-6)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.7	1.7	1.0	9.3	0.9	13.8	2.4	0.4	1.2	2.0	6.5	0.4	1.1	6.0	1.2	2.1	13.5	0.4	4.1	1.2	0.8	0.6	1.3	1.6	2.8	6.6	0.8	0.3	0.8	0.6	0.0	0.5	3.9	0.9	0.9	8.2	0.6	2.6	1.1	0.7	3.7	7.1	4.4	1.2	5.0	3.2	40.1	0.4	47.5	0.6	11.4	11.6	2.0	3.7	0.7	0.6	1.0	0.6	0.4	1.9	0.1	28.6	29.1	22.6	20.7	3.4	4.5	28.8	18.7	18.5	38.1	34.5	36.7	25.7	18.5	4.0	26.8	22.3	33.8	17.2	37.3	34.6	18.1	20.9	27.9	15.7	0.5	16.8	17.1	2.3	1.9	35.3	24.9	26.8	11.7	41.7	29.9	26.9	22.8	8.0	49.8	21.7	16.6	34.3	9.7	9.0	18.4	12.7	20.2	24.0	20.1	11.0	19.7	18.8	10.7	30.9	47.0	36.1	65.0	5.5	9.1	26.8	14.3	16.1	32.7	0.4	0.6	0.1	0.4	0.2	0.4	0.7	0.5	0.4	0.2	0.7	0.9	0.3	1.0	0.4	0.1	0.6	1.9	0.1	1.0	0.9	0.4	1.2	0.8	0.6	0.8	0.3	0.9	0.4
FOXN2	HTLF	ENSG00000170802	"Forkhead box N2"	P32314	2	48314637-48379294	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 45.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003485	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA003485: AB_1078905"	"unprognostic (5.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.65e-3)"	"prognostic favourable (3.85e-4)"	"unprognostic (4.00e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (2.81e-5)"	"unprognostic (2.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.12e-2)"	17.7	6.2	12.7	13.9	17.4	45.5	13.6	23.6	13.8	8.1	7.4	25.0	3.2	8.2	8.2	4.6	9.1	6.5	9.8	8.3	16.1	9.5	6.8	18.7	10.6	17.4	23.3	12.8	6.2	8.4	9.8	7.0	12.6	19.0	6.2	8.0	2.9	7.1	4.7	8.0	5.9	10.1	9.5	23.6	17.2	7.4	6.1	26.0	17.8	7.9	6.9	15.7	10.9	8.2	7.6	11.3	42.3	11.3	8.3	9.9	5.6	6.9	10.6	12.2	10.8	9.7	7.2	13.5	7.7	8.5	6.5	7.4	9.3	8.7	15.1	10.4	9.1	8.8	7.4	8.8	9.6	11.7	6.5	29.6	7.6	9.3	17.0	16.2	23.5	6.4	3.8	7.0	12.4	6.9	14.0	18.1	10.6	5.3	17.9	10.7	9.3	5.5	9.0	25.6	12.4	5.7	8.8	6.9	7.0	3.8	7.2	13.7	3.2	9.6	8.0	9.0	9.0	8.5	8.2	9.8	7.3	21.9	7.9	14.9	12.1	35.1	11.1	42.3	8.7	8.9	9.9	7.5	8.3	7.9	11.3	7.6	6.4	6.4	14.1	8.3	11.3	7.0	9.5	5.6	12.7	17.4	23.6	13.8	16.1	9.5	23.3	12.8	19.0	26.0
FOXO1	"FKH1, FKHR, FOXO1A"	ENSG00000150907	"Forkhead box O1"	Q12778	13	40469953-40666597	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.9;Daudi: 20.0;HSkMC: 25.2;U-698: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001252, CAB022326"	Approved	Approved	Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB022326: , HPA001252: AB_1078906"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.33e-5)"	"unprognostic (1.93e-1)"	"unprognostic (5.44e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.63e-2)"	41.6	6.9	7.0	18.4	11.2	8.0	35.5	2.3	5.0	21.4	13.4	8.4	7.7	3.5	27.4	9.8	9.5	17.2	13.3	9.9	7.8	3.9	8.3	25.6	15.3	22.4	8.3	3.9	46.0	12.2	3.8	6.2	9.5	6.5	7.9	6.8	5.7	7.5	9.3	85.9	12.3	7.6	18.6	9.7	10.8	7.4	12.3	9.0	9.4	13.1	9.0	15.6	14.4	16.2	6.1	0.5	2.8	1.6	1.1	7.1	1.0	0.3	0.6	5.6	0.1	18.9	3.7	5.4	0.8	1.1	0.2	0.1	1.4	1.3	20.0	3.7	0.5	4.8	4.4	2.4	0.3	9.1	4.6	0.0	0.6	4.4	9.0	0.1	0.5	25.2	16.4	0.1	3.1	14.2	0.3	6.4	1.4	0.7	0.0	0.2	8.2	1.4	14.2	6.5	1.5	10.5	2.5	1.2	0.3	0.7	3.8	0.8	0.6	0.5	8.3	0.1	1.1	0.0	0.5	3.6	1.3	25.9	0.5	0.9	2.6	0.9	0.8	0.5	1.5	1.0	2.3	3.2	3.9	2.2	0.5	6.1	7.1	5.3	2.8	1.1	1.6	0.0	5.5	1.0	7.0	11.2	2.3	5.0	7.8	3.9	8.3	3.9	6.5	9.0
FOXO3	"AF6q21, FKHRL1, FOXO2, FOXO3A"	ENSG00000118689	"Forkhead box O3"	O43524	6	108559835-108684774	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004074, HPA063104"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004074: AB_2106672, HPA063104: "	"unprognostic (3.42e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.68e-2)"	29.6	7.7	11.5	12.2	12.6	36.7	35.4	28.0	18.1	19.9	16.1	12.6	9.8	7.8	17.4	16.1	22.3	16.5	18.0	12.9	9.7	7.7	10.7	14.0	21.1	16.8	12.4	14.0	28.8	52.3	14.3	8.8	13.1	10.3	13.8	11.0	14.3	21.2	10.5	54.7	20.3	11.3	13.9	7.9	14.2	14.8	13.1	13.2	11.6	13.1	12.7	10.2	17.1	20.3	1.8	2.7	15.7	4.6	3.4	4.0	1.0	8.9	3.3	5.9	9.5	18.3	21.9	7.4	7.5	7.9	6.6	9.1	5.8	8.2	5.8	6.4	8.7	6.6	6.1	9.1	9.8	5.2	8.8	14.4	2.9	4.4	21.3	3.4	10.6	24.9	18.4	13.4	18.5	4.9	9.7	39.3	11.9	5.1	4.8	5.3	3.8	4.9	5.5	16.7	19.3	13.0	6.8	10.4	27.1	6.3	5.2	7.4	5.7	11.5	7.9	11.2	6.3	6.8	9.6	0.7	6.7	5.5	6.1	6.9	7.6	6.7	2.9	5.7	3.6	1.5	4.0	1.0	1.9	3.0	1.7	1.8	1.7	2.3	15.7	3.4	4.6	2.7	1.8	1.0	11.5	12.6	28.0	18.1	9.7	7.7	12.4	14.0	10.3	13.2
FOXO4	"AFX1, MLLT7"	ENSG00000184481	"Forkhead box O4"	P98177	X	71096197-71103535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 98.6"	"Cell line enriched"	"Detected in many"	5	"BEWO: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039560, HPA040232"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA039560: , HPA040232: "	"unprognostic (4.64e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.79e-2)"	"prognostic favourable (4.61e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.16e-2)"	"prognostic favourable (3.46e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-3)"	8.5	13.2	21.7	3.8	21.5	9.9	5.1	9.1	15.6	4.8	8.4	9.1	11.9	6.3	6.8	10.2	7.3	7.7	5.8	9.7	21.4	14.5	5.2	3.6	5.5	3.6	22.8	8.4	13.4	6.8	8.7	3.0	98.6	9.2	7.0	4.7	4.9	8.5	11.3	33.8	5.5	6.6	9.4	17.3	6.0	5.2	13.9	13.1	4.4	5.9	7.5	4.2	7.5	11.0	0.9	0.2	3.4	0.6	1.0	1.8	0.9	1.7	0.5	1.4	1.8	3.3	2.3	60.0	1.4	1.6	0.7	1.7	1.2	2.4	2.3	1.8	1.8	0.8	3.6	1.6	0.8	2.3	5.5	3.4	11.2	1.9	1.9	1.9	2.7	1.9	3.8	0.6	0.4	1.8	6.9	4.6	0.3	0.3	3.0	3.1	6.5	2.1	2.1	3.5	3.6	1.2	1.0	1.0	2.9	2.9	0.4	3.1	0.7	1.2	1.7	0.4	0.9	3.1	0.3	3.0	1.6	0.4	1.6	5.2	0.5	0.2	0.6	3.2	0.9	0.6	0.3	0.8	0.5	0.9	0.2	0.9	0.4	1.8	3.4	1.0	0.3	0.0	1.3	0.9	21.7	21.5	9.1	15.6	21.4	14.5	22.8	8.4	9.2	13.1
FOXP1	"12CC4, hFKH1B, HSPC215, QRF1"	ENSG00000114861	"Forkhead box P1"	Q9H334	3	70952817-71583993	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003876, CAB011501"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB011501: AB_732428, HPA003876: AB_1078907"	"unprognostic (2.31e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	24.6	5.1	7.0	30.2	19.2	32.7	21.9	7.2	13.1	16.3	29.3	8.7	10.3	10.1	19.8	9.9	19.6	13.1	19.3	15.5	8.4	5.9	7.6	12.9	26.1	34.0	7.6	10.2	30.3	14.7	7.2	25.7	11.4	7.4	21.6	21.6	11.3	24.6	11.2	12.7	12.2	16.7	34.3	7.9	18.6	20.4	11.7	10.1	38.1	19.8	13.1	27.0	28.5	31.8	29.9	8.4	14.4	9.9	9.2	29.6	11.2	3.7	2.8	7.0	4.7	3.3	9.4	3.3	11.2	12.9	9.8	7.2	20.9	4.4	10.1	1.7	5.0	2.6	12.9	9.6	16.6	3.1	5.3	5.2	7.0	19.7	8.1	9.8	12.8	9.6	4.0	39.5	17.5	14.6	5.2	14.9	4.4	16.5	4.8	3.9	8.6	18.3	14.6	12.0	1.8	8.0	11.9	5.9	10.7	11.7	3.2	0.7	2.3	7.2	18.4	13.6	5.9	19.0	15.5	3.7	2.8	14.3	8.7	12.5	2.9	14.4	5.7	6.0	8.3	5.7	9.3	25.8	18.3	10.3	5.3	29.9	29.6	18.9	8.3	9.2	9.9	8.4	15.9	11.2	7.0	19.2	7.2	13.1	8.4	5.9	7.6	10.2	7.4	10.1
FOXP2	"CAGH44, SPCH1, TNRC10"	ENSG00000128573	"Forkhead box P2"	O15409	7	114086327-114693772	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 48.4;urinary bladder: 31.5"	"Cell line enhanced"	"Detected in many"		"AF22: 14.7;RH-30: 27.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000382, HPA000383, HPA001679"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: "	"unprognostic (1.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.69e-4)"	"unprognostic (2.04e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.04e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.84e-1)"	"unprognostic (9.81e-2)"	"unprognostic (4.19e-2)"	1.7	1.5	0.9	9.4	2.9	0.0	2.0	0.6	2.8	9.4	20.4	0.7	3.6	2.7	18.1	2.1	12.4	3.5	7.7	1.2	0.7	2.9	1.5	2.9	1.4	0.6	2.0	1.0	11.1	4.5	0.0	0.9	0.7	1.8	13.3	5.7	1.4	2.8	1.5	4.6	3.3	4.2	48.4	0.9	0.6	4.6	0.9	0.9	0.6	5.3	3.2	1.2	31.5	5.4	9.4	16.5	11.1	7.2	6.3	10.3	16.3	0.2	2.1	14.7	0.0	3.4	4.6	0.9	2.3	2.5	0.5	0.3	1.0	0.2	0.2	0.5	0.8	0.3	0.5	0.0	0.1	0.1	5.0	5.5	3.3	4.5	0.0	0.3	0.3	1.1	0.6	0.0	0.0	0.6	1.2	2.1	0.5	1.0	1.2	0.8	0.7	0.7	0.3	27.0	5.2	0.3	5.9	3.8	1.5	0.0	0.9	0.7	0.7	8.0	1.1	0.9	0.4	1.4	0.4	5.3	0.4	0.5	1.1	0.5	0.4	7.5	5.2	11.1	6.2	7.2	6.3	9.4	7.0	6.8	6.8	7.3	7.2	8.1	5.6	6.3	5.9	16.5	10.3	16.3	0.9	2.9	0.6	2.7	0.7	2.9	2.0	1.0	1.8	0.9
FOXP3	"AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID"	ENSG00000049768	"Forkhead box P3"	Q9BZS1	X	49250436-49264826	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.9;lymphoid tissue: 23.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 8.1;SiHa: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	11	"T-reg: 25.9"	"Lineage enriched"	"Detected in single"	260	"T-cells: 25.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB026301, HPA045943"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB026301: , HPA045943: "	"unprognostic (2.46e-2)"	"prognostic favourable (1.91e-4)"	"unprognostic (4.95e-3)"	"prognostic favourable (7.02e-4)"	"unprognostic (2.55e-4)"	"prognostic favourable (4.90e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.73e-14)"	"unprognostic (5.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-1)"	0.4	0.4	1.4	20.2	1.3	1.4	0.6	2.2	1.2	0.7	0.8	0.5	1.0	0.6	1.1	7.2	2.6	0.3	3.3	0.4	1.3	1.0	1.1	4.7	1.9	23.3	0.9	0.4	0.6	0.4	0.1	1.2	0.4	0.4	0.9	0.6	0.6	4.0	0.6	0.4	2.5	4.0	0.4	0.7	4.7	1.8	2.7	0.4	23.3	0.8	1.8	20.6	4.9	0.6	0.0	0.0	0.0	0.0	0.0	25.9	0.4	0.3	0.5	0.5	1.2	0.2	0.0	1.5	0.3	0.0	0.4	0.1	0.4	0.3	0.9	0.4	0.4	0.4	0.9	0.0	0.3	3.0	0.4	0.4	0.6	0.1	0.7	0.7	0.9	0.3	0.5	0.7	0.8	0.0	1.5	0.8	0.1	8.1	0.3	0.6	1.2	0.8	0.6	0.3	0.6	0.4	0.5	0.7	0.4	4.8	0.5	3.0	1.8	0.7	0.1	0.1	1.6	0.8	0.2	0.8	1.6	1.0	0.5	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	25.9	0.4	1.4	1.3	2.2	1.2	1.3	1.0	0.9	0.4	0.4	0.4
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312440-1314748	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 65.5;vagina: 39.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.4;CAPAN-2: 9.9;HaCaT: 19.2;Hep G2: 40.4;RT4: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059700			Supported	Nucleoplasm				Nucleoplasm		"HPA059700: "	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favourable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.6	0.5	2.3	0.6	4.0	0.5	1.4	1.6	5.9	7.1	1.9	3.2	0.0	6.9	1.1	0.7	7.2	3.2	31.8	0.5	2.2	1.9	7.1	3.6	5.8	0.5	2.7	1.5	0.5	10.1	0.5	1.8	1.2	3.8	18.2	0.8	7.5	35.8	1.3	0.6	16.8	0.8	6.6	1.9	0.5	65.5	0.6	0.8	0.8	3.1	7.8	11.7	26.3	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.5	0.0	0.0	0.0	0.0	0.0	0.3	6.6	0.0	0.0	16.4	9.9	0.0	0.2	0.0	19.2	0.0	0.8	0.0	0.0	0.5	0.0	3.5	40.4	0.0	0.0	1.0	0.0	7.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	17.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	4.0	1.6	5.9	2.2	1.9	2.7	1.5	3.8	0.8
FOXR2	"FOXN6, MGC21658"	ENSG00000189299	"Forkhead box R2"	Q6PJQ5	X	55623400-55625325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	10	"testis: 6.0"	"Group enriched"	"Detected in some"	114	"NTERA-2: 11.4;SH-SY5Y: 10.1;U-266/70: 6.7;U-266/84: 17.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA034487, HPA057358"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA034487: AB_10795354, HPA057358: AB_2683418"															"unprognostic (3.81e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOXRED1	H17	ENSG00000110074	"FAD dependent oxidoreductase domain containing 1"	Q96CU9	11	126269055-126278131	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039620, HPA046192"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA039620: , HPA046192: "	"prognostic unfavourable (7.36e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (2.01e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	7.2	12.3	14.6	8.5	14.9	10.4	7.8	12.6	19.2	6.1	11.7	9.2	6.4	10.3	6.8	6.9	7.7	7.7	7.5	20.1	11.1	11.7	14.6	36.2	5.1	9.2	12.9	18.2	4.3	7.5	9.2	7.7	7.1	13.6	5.8	13.0	8.0	7.5	11.9	15.0	6.1	8.2	8.0	8.7	9.5	8.8	6.8	11.7	8.3	6.2	9.8	10.0	8.0	4.9	7.5	16.5	5.3	12.4	8.5	8.9	7.7	9.5	11.0	8.1	10.1	6.1	2.8	11.2	5.0	6.2	9.4	9.4	16.3	9.8	15.6	13.9	4.0	16.0	21.6	13.0	5.9	8.3	5.9	32.5	7.2	19.2	8.0	8.0	7.0	2.6	5.0	6.2	11.2	10.3	18.6	8.5	7.9	13.1	9.1	14.0	6.7	19.0	14.9	14.4	18.4	8.5	4.9	10.5	9.0	9.9	15.0	5.4	36.2	13.4	3.7	5.6	4.6	10.1	8.0	5.2	7.4	12.8	6.9	27.3	7.7	1.6	9.7	5.3	6.9	12.4	7.1	7.5	5.5	8.9	11.8	6.2	7.9	6.9	1.9	8.5	8.9	16.5	7.6	7.7	14.6	14.9	12.6	19.2	11.1	11.7	12.9	18.2	13.6	11.7
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell line enhanced"	"Detected in many"		"RT4: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025217, HPA030479"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB025217: , HPA030479: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favourable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	1.5	2.2	0.8	3.0	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9.0	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2.0	41.4	2.5	2.4	1.0	5.5	1.8	0.5	1.2	1.0	5.2	7.4	5.0	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	3.2	5.3	0.8	1.3	0.4	0.4	1.0	0.8	0.2	0.1	0.1	4.1	5.1	1.3	4.9	0.8	7.7	0.4	1.5	0.2	4.4	0.5	1.8	4.6	3.5	0.3	1.2	1.1	0.3	2.2	0.5	0.6	0.3	0.9	3.3	1.3	1.8	1.0	0.8	1.4	0.9	1.5	4.6	1.6	6.5	10.1	1.1	1.2	1.1	6.8	0.7	2.1	1.0	1.3	1.5	1.6	1.2	0.8	5.0	3.5	2.3	1.5	0.8	1.0	3.2	1.0	1.0	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1.0	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5
FSBP		ENSG00000265817	"Fibrinogen silencer binding protein"	O95073	8	94372170-94436952	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 10.5;hTERT-HME1: 11.0;SK-MEL-30: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.3;naive CD4 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	22	"T-cells: 5.3"									"HPA025059, HPA026509"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA025059: , HPA026509: AB_10602307"																		2.2	3.7	3.4	1.6	5.6	2.1	4.1	7.1	7.6	6.7	2.0	2.7	11.0	1.5	3.7	9.6	4.3	14.1	3.1	4.6	3.0	2.4	5.1	4.2	2.6	1.8	3.4	3.6	7.7	4.3	3.2	23.7	2.9	6.4	5.3	2.4	16.4	4.7	15.4	4.4	3.7	1.8	5.3	2.9	1.9	4.6	5.6	3.7	2.3	3.2	3.2	2.6	8.7	4.2	0.2	0.0	0.0	0.0	0.1	5.3	0.7	0.0	1.8	10.5	4.5	1.6	2.8	0.0	0.3	2.3	0.2	2.8	2.5	3.4	0.1	9.2	1.0	1.9	4.6	1.7	0.9	0.0	2.8	1.4	0.8	3.5	4.7	0.0	0.9	2.8	1.9	2.4	11.0	3.1	1.7	4.3	2.5	2.0	0.9	0.7	4.9	2.2	0.4	0.0	2.8	6.1	7.7	0.1	2.1	0.0	0.0	10.5	2.6	1.7	2.3	1.9	0.1	0.0	0.3	0.0	2.3	0.4	2.1	1.9	4.0	0.0	0.0	0.0	1.0	0.0	5.3	0.2	1.3	0.3	0.0	0.1	3.7	2.8	0.0	0.1	0.0	0.0	0.2	0.7	3.4	5.6	7.1	7.6	3.0	2.4	3.4	3.6	6.4	3.7
FSCN1	"FLJ38511, p55, SNL"	ENSG00000075618	"Fascin actin-bundling protein 1"	Q16658	7	5592823-5606655	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 80.6;K-562: 67.5;NB-4: 76.7;PC-3: 67.5;SH-SY5Y: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000121, HPA005723, CAB035991, HPA050654"	Enhanced		Supported	"Plasma membrane,Cytosol"			4500000	Cytosol	"Plasma membrane"	"CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: "	"unprognostic (1.91e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (8.15e-7)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.93e-3)"	26.3	13.3	23.7	29.6	30.1	6.3	8.1	5.5	56.9	9.9	5.5	35.1	0.0	5.4	11.7	2.3	22.3	5.9	8.9	10.6	27.7	16.8	5.5	7.1	11.3	15.2	26.9	23.6	21.8	5.1	2.3	7.0	29.4	20.1	4.1	3.0	8.1	11.0	3.9	7.8	17.3	6.6	7.0	29.6	39.3	7.6	15.9	28.3	9.3	8.5	15.9	11.4	14.7	12.3	0.2	5.4	1.0	1.9	0.0	0.1	1.4	7.8	18.3	12.2	43.7	4.7	9.1	80.6	18.9	8.4	3.2	3.5	12.7	2.0	0.1	23.2	8.3	30.0	7.0	30.4	0.2	9.0	3.8	0.5	19.4	59.7	2.5	0.0	1.5	5.6	9.0	6.1	5.0	15.9	67.5	0.1	4.2	0.8	0.2	76.7	31.9	67.5	17.8	2.9	0.3	4.7	0.7	9.8	64.8	15.9	0.2	0.6	0.4	4.8	32.3	22.5	39.6	13.0	19.4	0.1	0.1	0.0	14.5	0.0	42.2	0.0	1.9	0.1	0.0	0.5	0.0	0.2	0.1	0.0	5.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	1.4	23.7	30.1	5.5	41.3	27.7	16.8	26.9	23.6	20.1	28.3
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA methyltransferase homolog 3"	Q8IY81	17	63819433-63830012	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	Nucleoli				Nucleoli		"HPA055544: , HPA062628: "	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.1	19.9	14.2	15.8	18.2	12.5	16.4	13.6	15.2	17.5	17.4	22.4	25.0	12.9	22.7	19.4	17.6	17.3	16.8	19.2	14.8	9.2	24.4	24.9	13.9	17.5	18.9	9.5	22.3	14.6	30.6	13.3	15.4	16.2	19.3	17.1	17.4	16.5	18.1	25.1	21.2	16.2	21.5	17.7	19.8	16.5	13.0	17.8	31.1	22.4	19.7	26.0	18.0	16.8	9.8	13.3	6.5	12.8	12.3	15.1	9.0	20.3	32.2	12.5	17.7	20.1	17.3	19.4	20.4	15.0	23.5	18.7	26.8	13.7	27.3	8.4	12.0	14.2	23.3	19.5	30.3	4.7	23.2	24.5	22.9	24.9	14.7	30.9	17.9	12.2	15.4	36.4	17.6	19.5	24.3	11.2	15.6	34.4	27.2	10.1	33.6	32.9	24.3	34.3	19.1	15.4	18.6	11.6	45.3	24.1	20.6	13.9	19.5	10.4	17.5	17.5	24.6	19.5	37.8	27.1	38.1	27.2	15.7	20.6	16.9	4.5	10.8	6.5	11.4	12.8	15.1	9.8	12.2	14.9	13.3	9.8	9.8	12.0	2.4	12.3	9.2	10.1	14.2	9.0	14.2	18.2	13.6	15.2	14.8	9.2	18.9	9.5	16.2	17.8
FUBP1	"FBP, FUBP"	ENSG00000162613	"Far upstream element binding protein 1"	Q96AE4	1	77944055-77979110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006149	Supported		Enhanced	Nucleoplasm			200000	Nucleoplasm		"HPA006149: AB_1849172"	"unprognostic (4.17e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavourable (9.83e-9)"	"unprognostic (2.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.80e-3)"	"unprognostic (9.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.46e-2)"	23.9	35.5	21.8	42.4	26.9	56.8	27.0	34.0	31.8	24.3	19.6	18.1	23.0	21.8	29.4	35.0	23.5	25.2	18.4	27.5	22.0	22.3	26.6	16.3	27.2	37.6	17.5	28.8	44.4	31.6	36.0	41.5	27.3	26.3	22.4	28.3	22.0	28.2	35.6	27.4	21.3	24.0	22.7	31.3	28.6	22.6	17.6	19.9	64.9	35.0	26.2	40.3	24.0	29.1	16.1	11.3	10.8	16.1	23.5	22.2	12.8	21.8	19.2	45.6	18.1	7.1	8.9	37.4	22.6	13.5	21.7	15.8	19.5	24.4	39.1	10.6	16.8	21.8	30.5	24.9	29.1	43.0	15.5	25.0	32.0	28.6	15.3	42.8	10.5	11.7	20.6	23.2	18.4	17.3	28.6	17.4	17.1	22.1	34.0	20.7	35.6	13.8	41.7	36.1	15.0	22.5	21.5	24.1	22.7	21.0	19.9	17.8	24.3	15.5	22.2	21.0	30.7	5.9	27.0	16.7	18.0	50.7	9.1	18.9	21.4	3.8	9.6	10.8	18.7	15.7	22.2	16.1	18.3	19.4	8.7	13.1	17.9	20.9	4.0	23.5	16.1	11.3	21.3	12.8	21.8	26.9	34.0	31.8	22.0	22.3	17.5	28.8	26.3	19.9
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868592-90883458	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"liver: 118.4;placenta: 158.9;salivary gland: 337.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009499	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"		41000	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095"	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	8.3	3.3	3.0	7.5	3.6	16.6	5.9	5.0	4.4	4.1	6.6	2.8	3.5	5.7	4.9	10.8	4.7	4.4	3.9	6.9	3.1	1.8	6.4	118.4	9.5	3.1	2.8	2.7	4.2	22.5	3.8	7.2	158.9	3.5	9.3	2.2	3.0	337.9	4.7	8.7	9.0	5.9	3.1	3.0	8.2	6.0	5.3	2.9	4.8	8.9	5.5	4.1	4.4	4.3	1.5	3.3	10.3	3.3	3.1	1.9	2.0	14.1	8.6	1.9	8.7	14.3	9.2	22.2	17.8	13.6	7.4	5.2	12.6	15.5	0.5	45.9	12.9	25.5	3.9	9.2	1.6	40.7	10.1	24.8	15.5	16.5	7.6	3.4	40.9	10.4	10.4	8.4	3.8	23.6	18.9	2.5	4.9	9.7	1.3	11.2	6.2	2.5	2.2	7.5	3.2	11.5	10.8	3.9	2.6	15.1	8.2	12.6	2.9	9.1	34.7	8.3	17.8	12.7	26.1	4.4	25.1	1.1	15.9	11.2	16.8	7.5	3.3	10.3	1.9	1.1	1.4	1.5	1.2	1.2	2.1	1.0	0.6	0.8	7.4	3.1	0.7	3.3	0.9	2.0	3.0	3.6	5.0	4.4	3.1	1.8	2.8	2.7	3.5	2.9
FUS	"ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS"	ENSG00000089280	"FUS RNA binding protein"	P35637	16	31180110-31194871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008784, CAB033036, CAB058691"	Supported		Enhanced	Nucleoplasm			190000	Nucleoplasm		"CAB033036: AB_2105208, CAB058691: , HPA008784: AB_1849181"	"unprognostic (3.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	44.0	24.2	35.0	47.1	43.3	41.7	29.9	64.1	59.0	39.7	32.4	48.6	22.6	28.0	54.5	44.7	29.6	48.6	35.9	32.0	32.7	34.6	30.3	24.4	27.7	51.3	31.1	39.0	66.7	28.8	41.7	24.8	44.1	39.2	29.1	30.2	39.3	27.6	30.5	43.6	24.3	28.7	46.5	33.7	36.2	27.7	40.7	30.7	66.3	29.1	40.1	49.6	30.3	31.4	16.4	22.3	24.2	29.0	14.2	24.8	9.4	47.8	41.5	54.7	35.5	13.5	11.5	58.2	64.4	23.4	29.5	22.5	56.0	32.2	73.7	46.0	32.5	20.9	54.5	41.7	28.2	43.8	35.4	62.3	31.4	56.4	22.5	66.2	42.9	23.2	11.5	42.5	28.9	28.1	66.0	25.1	36.6	58.6	48.1	58.6	83.3	45.6	79.0	72.8	42.2	32.9	35.1	35.7	64.0	42.3	29.9	31.9	36.0	73.7	34.8	47.2	47.4	31.1	68.1	23.4	44.7	103.8	26.4	45.1	57.0	5.6	17.5	24.2	24.8	29.0	24.0	12.8	17.4	21.8	19.3	16.4	20.3	21.1	14.9	14.2	25.1	22.3	13.9	9.4	35.0	43.3	64.1	59.0	32.7	34.6	31.1	39.0	39.2	30.7
FUT4	"CD15, ELFT, FCT3A, FUC-TIV"	ENSG00000196371	"Fucosyltransferase 4"	P22083	11	94543840-94549898	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 71.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 20.4;NB-4: 13.2;THP-1: 25.8;U-937: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000014, CAB016129"	Enhanced		Supported	Vesicles				Vesicles		"CAB000014: , CAB016129: AB_626918"	"unprognostic (6.36e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (3.64e-4)"	"unprognostic (7.26e-2)"	"unprognostic (4.14e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.10e-3)"	5.5	2.4	5.5	6.1	6.2	71.3	6.3	3.0	6.0	4.4	8.3	6.7	4.7	10.9	5.9	2.5	3.0	4.6	7.5	3.7	6.2	2.2	4.1	3.0	6.0	5.4	8.1	2.5	4.9	11.4	1.4	2.9	3.4	4.8	3.4	8.3	3.8	6.3	2.9	1.7	1.9	10.1	5.8	5.7	6.5	9.7	2.9	4.5	10.4	2.9	1.9	3.1	4.4	3.0	0.7	1.9	2.5	3.9	0.8	1.9	0.8	1.6	0.8	1.0	0.0	3.1	2.8	5.1	1.4	0.7	1.3	1.5	6.9	2.2	0.0	3.5	2.4	0.8	1.6	0.1	1.2	10.5	1.6	5.2	1.1	0.1	1.6	20.4	4.6	2.4	0.0	1.7	0.0	2.0	5.2	0.0	1.5	0.7	4.2	13.2	1.9	1.9	3.8	0.0	0.0	1.4	1.1	1.4	0.5	0.8	2.1	0.8	1.2	25.8	1.9	1.0	2.9	0.0	0.5	0.6	0.3	0.0	0.9	18.3	0.6	2.0	3.1	2.5	1.1	1.5	0.7	0.6	1.0	1.3	1.8	0.7	1.1	0.7	1.7	0.8	3.9	1.9	1.9	0.8	5.5	6.2	3.0	6.0	6.2	2.2	8.1	2.5	4.8	4.5
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830610-5839731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0"	"Group enriched"	"Detected in some"	7	"Hep G2: 14.6;RPMI-8226: 5.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.7;NK-cells: 2.1"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA043707: , HPA046966: "	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favourable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.2	0.2	0.2	7.2	0.2	0.1	0.8	0.2	0.2	9.2	26.4	0.0	9.5	15.6	0.7	7.6	40.8	0.6	25.4	0.2	0.2	0.2	27.2	6.5	1.3	0.2	0.2	0.0	0.2	2.2	0.0	0.8	0.0	0.0	0.3	6.9	0.0	37.0	19.1	0.2	0.2	44.4	0.2	0.2	0.2	2.8	0.3	0.0	0.0	0.2	16.4	33.9	0.2	12.4	0.4	0.3	3.7	0.3	2.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.2	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	5.4	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.1	3.7	0.3	0.4	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.4	0.3	0.2	1.2	2.1	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA040863, HPA043410"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA040863: , HPA043410: "	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	7.2	7.6	16.2	12.0	21.1	3.3	9.4	24.1	18.1	6.7	9.8	29.1	16.1	15.4	8.7	5.0	6.5	14.0	10.1	5.2	19.8	12.9	6.2	2.9	7.0	11.2	20.5	11.2	7.2	10.5	6.2	5.2	18.8	17.3	5.4	10.4	7.1	33.7	13.7	3.5	4.9	15.1	9.5	39.8	8.5	27.6	13.1	23.6	8.4	7.5	2.4	15.2	14.4	5.6	13.5	2.2	0.5	1.7	12.0	8.2	2.5	34.9	6.9	3.3	30.7	14.8	11.2	20.8	11.2	17.2	7.8	8.7	5.4	12.9	9.3	9.6	11.1	2.6	7.9	3.1	12.0	34.5	3.4	9.4	2.5	7.0	7.6	2.1	7.7	28.1	2.0	10.8	5.1	19.8	3.4	7.9	5.6	18.0	9.9	5.1	4.5	24.2	6.8	2.9	5.3	14.0	9.8	7.1	5.3	6.0	2.8	2.4	2.8	3.4	43.1	10.3	11.0	4.5	9.1	15.9	6.0	22.2	20.8	3.7	3.2	0.5	1.7	0.5	3.5	0.6	3.5	13.5	5.6	5.1	2.2	6.8	6.1	6.0	0.2	12.0	1.1	2.2	8.2	2.5	16.2	21.1	24.1	17.3	19.8	12.9	20.5	11.2	17.3	23.6
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035259-69120427	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"CAB022164: , HPA068304: "	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	8.7	19.9	10.8	9.1	9.8	21.9	11.8	13.9	11.0	8.3	9.3	12.3	11.6	6.6	12.4	11.7	9.2	9.6	7.2	20.2	8.7	10.1	10.2	40.2	9.5	12.8	11.7	8.5	16.8	25.9	18.8	8.6	8.4	10.5	9.9	11.6	12.1	11.9	13.6	25.1	5.2	7.2	16.6	8.9	12.9	9.2	13.3	9.7	3.7	11.1	9.5	9.6	10.5	7.9	15.8	17.7	2.0	18.5	24.2	28.3	19.1	11.2	9.6	15.7	7.5	7.2	10.7	15.2	8.2	7.2	12.5	9.7	5.1	7.3	20.2	6.3	8.5	12.4	18.5	18.7	15.8	23.6	21.1	28.5	6.3	37.5	12.3	20.8	12.4	11.8	15.1	12.5	13.6	16.7	21.3	19.8	11.6	11.0	5.9	9.1	21.2	19.1	14.0	10.8	13.8	14.4	9.4	12.1	5.4	8.4	5.5	8.5	6.2	6.4	9.9	8.2	14.3	10.7	11.8	5.6	4.8	12.0	3.8	17.2	8.2	2.0	16.7	0.1	21.5	18.5	16.3	15.8	22.0	21.2	17.7	10.3	28.3	27.1	0.8	24.2	14.1	15.0	17.0	19.1	10.8	9.8	13.9	11.0	8.7	10.1	11.7	8.5	10.5	9.7
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 215.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol				Cytosol		"HPA018246: AB_1849204, HPA055475: "	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	12.4	13.8	13.0	7.6	16.1	13.7	11.7	14.8	15.0	11.5	14.3	10.5	11.4	7.5	14.7	10.1	13.4	11.7	8.9	36.1	13.7	14.3	10.1	11.3	8.5	9.4	19.4	9.6	16.9	11.4	11.4	17.3	12.7	18.1	13.1	7.4	6.5	10.2	11.8	215.4	7.7	7.9	12.3	23.4	9.1	10.5	39.1	19.4	17.2	16.2	22.7	10.0	15.6	28.8	13.8	14.9	11.4	14.0	11.0	21.8	9.4	37.8	17.6	38.1	29.6	29.3	33.5	17.2	30.1	30.8	33.9	33.6	25.9	19.1	19.3	49.9	20.7	18.3	30.7	18.5	47.5	25.5	20.7	19.7	23.3	29.5	31.3	12.2	16.3	35.3	21.2	17.1	41.0	34.1	15.7	23.5	42.6	13.7	23.2	20.5	43.0	19.4	16.1	48.7	20.6	26.1	11.9	16.1	20.6	26.1	30.4	38.9	42.2	23.5	27.2	25.6	28.6	16.0	59.2	22.0	27.5	23.0	26.7	17.6	32.5	8.9	12.9	10.0	12.9	14.0	13.6	13.8	13.8	11.7	14.9	9.5	17.6	14.4	11.4	11.0	10.2	10.5	21.8	9.4	13.0	16.1	14.8	15.0	13.7	14.3	19.4	9.6	18.1	19.4
FXR2	FMR1L2	ENSG00000129245	"FMR1 autosomal homolog 2"	P51116	17	7591230-7614871	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 55.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011205, HPA022997"	Supported		Supported	Cytosol				Cytosol		"CAB011205: AB_476964, HPA022997: AB_1849208"	"unprognostic (9.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.49e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.67e-2)"	10.4	13.6	15.9	7.4	22.5	5.8	7.5	21.2	25.2	9.6	9.5	14.5	11.2	9.2	9.7	8.3	11.1	9.0	7.4	31.9	16.1	18.1	11.1	9.6	10.5	8.5	18.8	18.5	10.2	11.2	19.2	13.9	10.6	22.4	11.8	8.0	13.5	10.9	13.2	55.0	9.1	8.5	11.7	15.1	8.4	7.8	13.5	18.2	8.3	9.4	9.5	9.8	8.9	8.3	2.4	3.1	6.0	2.2	2.1	4.6	1.9	15.3	20.4	18.9	19.7	16.2	11.1	14.6	23.1	19.3	33.5	23.3	11.3	5.0	14.4	15.4	15.6	16.9	24.8	10.5	22.5	16.1	26.7	8.1	17.8	6.5	15.8	0.1	17.4	10.4	15.5	25.4	24.7	11.6	14.4	4.9	16.5	7.7	11.1	7.9	11.3	11.0	16.1	11.4	8.7	12.3	5.4	11.3	21.0	15.7	10.5	15.7	10.8	6.0	10.7	15.7	10.0	10.3	27.3	8.3	7.4	6.4	18.0	6.6	20.6	6.0	2.0	5.8	2.4	2.2	3.2	1.1	3.8	4.6	3.1	2.4	3.1	3.3	5.1	2.1	1.4	2.1	3.8	1.9	15.9	22.5	21.2	25.2	16.1	18.1	18.8	18.5	22.4	18.2
FYCO1	"FLJ13335, ZFYVE7"	ENSG00000163820	"FYVE and coiled-coil domain containing 1"	Q9BQS8	3	45917899-45995824	"Disease related genes, Predicted intracellular proteins"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 105.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035526, HPA057966"	Uncertain		Enhanced	Vesicles				Vesicles		"HPA035526: AB_10672867, HPA057966: "	"unprognostic (2.45e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.85e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.98e-1)"	"prognostic favourable (3.33e-11)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.99e-2)"	11.6	7.8	4.1	11.4	4.7	3.1	11.6	1.4	3.5	13.5	20.2	7.3	11.4	4.2	19.8	11.1	12.6	7.9	22.0	29.1	4.2	2.7	5.7	6.2	7.9	5.0	4.7	3.5	14.8	15.9	11.4	4.9	4.3	6.1	14.5	5.6	16.2	9.5	11.6	105.8	9.9	7.7	39.9	6.4	6.4	11.6	5.0	5.3	8.5	10.4	25.5	9.5	23.3	27.0	0.6	2.8	1.1	1.1	3.0	6.0	1.3	6.3	6.2	1.8	8.0	17.6	13.9	3.0	6.2	14.4	8.3	9.1	3.4	5.6	4.8	3.5	8.7	4.8	5.2	10.4	9.8	2.0	5.5	6.7	5.1	3.7	12.0	5.1	4.9	15.4	10.4	13.0	12.9	16.3	4.4	6.9	5.8	3.9	5.2	3.2	2.8	5.9	1.8	5.1	2.6	9.9	22.5	1.3	2.1	3.9	12.3	10.7	6.0	3.4	12.5	3.1	3.7	10.5	3.4	3.9	2.5	1.6	10.8	6.6	5.8	1.1	1.0	0.6	4.4	1.1	6.0	0.6	2.6	4.6	0.4	0.6	1.1	1.8	0.9	3.0	0.7	2.8	2.6	1.3	4.1	4.7	1.4	3.5	4.2	2.7	4.7	3.5	6.1	5.3
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"NK-cells: 15.3;T-cells: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"			2000000	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: "	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favourable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	29.1	7.2	49.2	29.0	38.4	16.3	18.1	33.9	62.1	25.7	12.1	33.7	4.1	10.1	21.8	21.4	10.2	32.0	19.4	21.2	39.4	34.0	9.5	12.2	25.2	57.2	35.7	23.1	18.6	4.4	15.0	12.5	17.7	25.6	9.6	10.0	11.0	6.4	8.4	7.0	16.5	19.0	24.2	30.9	39.8	15.4	10.1	31.3	34.8	27.5	5.6	38.5	22.6	19.3	1.6	1.7	0.7	1.5	15.3	43.2	10.7	1.9	0.2	34.2	5.7	26.2	16.1	0.6	5.4	17.1	4.6	8.3	0.2	0.3	3.8	3.5	10.4	0.2	4.8	7.5	9.1	0.1	12.6	10.5	2.5	0.5	15.5	3.5	3.6	15.4	11.3	17.4	14.9	18.8	0.8	26.8	16.4	0.2	16.7	3.2	4.9	3.4	5.3	4.6	0.2	0.0	1.7	24.0	9.7	1.0	0.4	22.8	0.2	10.6	11.9	14.0	2.6	103.1	3.4	3.8	3.5	5.9	26.4	8.2	24.3	0.2	1.5	0.0	34.1	1.2	43.2	1.1	21.2	37.5	1.7	1.6	7.0	18.7	0.7	15.3	0.9	1.0	17.6	10.7	49.2	38.4	33.9	35.3	39.4	34.0	35.7	23.1	25.6	31.3
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054474			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA054474: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	12.0	10.2	12.8	13.6	13.1	14.5	24.5	20.5	13.9	11.3	11.9	6.9	13.3	6.6	13.2	10.2	19.0	13.2	10.3	19.4	11.0	12.5	11.1	12.0	11.8	13.5	11.1	10.9	13.3	17.0	13.8	13.2	13.9	13.4	11.0	9.2	6.0	10.0	13.9	82.6	11.6	10.1	21.8	17.1	11.4	10.3	16.7	10.7	10.5	12.6	15.8	15.3	15.7	21.8	11.2	15.9	23.7	16.6	32.5	22.7	21.5	29.6	6.6	13.0	12.3	15.3	17.0	4.0	14.5	14.9	22.6	18.5	10.2	10.2	19.1	53.5	17.2	10.7	16.4	14.9	24.1	4.2	7.4	28.5	10.0	4.6	15.0	21.2	13.9	12.2	19.3	12.2	17.6	17.7	12.8	41.1	19.9	24.9	23.0	5.1	2.8	12.1	21.4	15.9	13.4	16.4	19.5	24.7	10.7	22.4	17.8	16.5	41.7	11.3	15.6	11.6	11.6	14.6	15.3	25.0	37.9	22.9	12.3	30.7	11.9	23.7	14.2	13.6	18.3	16.6	22.7	11.2	17.6	20.1	15.9	9.9	19.4	18.7	4.6	32.5	15.2	8.9	15.5	21.5	12.8	13.1	20.5	13.9	11.0	12.5	11.1	10.9	13.4	10.7
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264364-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 61.2"	"Cell line enhanced"	"Detected in many"		"AF22: 16.3;HSkMC: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in many"	4	"monocytes: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favourable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.8	4.6	2.6	4.9	3.5	0.9	10.7	8.2	2.8	17.6	8.5	4.1	9.3	4.9	10.1	9.9	7.8	6.1	11.0	12.3	6.1	1.8	15.3	3.9	10.5	1.4	2.0	3.2	15.0	7.9	2.5	4.6	10.0	5.7	12.3	3.7	11.1	9.2	17.5	3.1	10.7	8.3	7.2	4.6	3.4	4.5	4.4	3.5	1.4	61.2	6.5	2.9	10.4	13.9	0.1	1.3	0.2	5.4	0.0	0.0	0.4	0.5	1.6	16.3	1.7	13.3	11.5	3.0	5.9	3.8	2.2	1.5	0.7	2.8	0.0	1.4	3.8	3.0	2.5	1.3	1.4	0.0	3.2	0.1	3.1	0.8	0.9	2.6	0.7	21.8	2.3	5.0	1.6	0.5	0.9	2.3	6.3	3.9	0.4	0.7	4.2	2.7	3.2	10.0	0.2	3.5	7.6	2.2	4.3	4.5	3.7	0.9	1.9	2.4	2.4	9.3	7.0	9.8	2.4	2.2	1.5	0.2	10.0	2.2	10.7	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	5.4	0.1	0.0	0.4	2.6	3.5	8.2	2.8	6.1	1.8	2.0	3.2	5.7	3.5
FZD7	FzE3	ENSG00000155760	"Frizzled class receptor 7"	O75084	2	202034587-202038445	"G-protein coupled receptors, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 25.2;CAPAN-2: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059979, HPA069165, HPA076183"	Approved		Supported	Vesicles				Vesicles		"HPA059979: , HPA069165: , HPA076183: "	"unprognostic (3.44e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.44e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (7.71e-5)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.05e-3)"	4.8	1.6	3.2	4.7	6.5	0.0	9.9	23.3	4.5	8.5	17.8	2.0	3.3	3.9	9.7	9.4	9.1	8.6	3.7	8.7	10.8	0.7	4.1	0.8	3.0	4.0	0.8	6.2	17.4	0.8	0.0	4.9	3.2	3.8	12.4	3.4	6.1	13.4	16.2	13.5	5.3	5.6	17.3	3.0	2.0	3.1	3.2	3.0	0.8	2.6	4.3	3.2	13.1	8.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.6	2.5	17.2	5.5	5.7	4.2	7.3	19.6	25.2	6.3	7.4	16.1	31.4	0.0	11.7	13.4	5.0	3.1	0.7	7.3	2.3	4.1	0.5	1.1	1.3	3.8	0.9	1.0	4.1	0.5	3.3	2.0	0.0	1.3	1.3	5.1	2.1	0.0	2.8	17.9	1.7	1.9	3.2	0.5	1.0	3.0	2.8	6.2	2.5	0.2	3.2	1.8	1.2	0.0	12.2	4.3	7.5	2.5	1.2	0.9	0.0	2.5	0.2	8.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.5	23.3	4.5	10.8	0.7	0.8	6.2	3.8	3.0
FZR1	"CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242"	ENSG00000105325	"Fizzy and cell division cycle 20 related 1"	Q9UM11	19	3506273-3538330	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043536	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA043536: AB_10968058"	"unprognostic (2.78e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (1.15e-1)"	"prognostic favourable (2.57e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.04e-1)"	10.3	16.9	15.4	12.0	19.9	37.2	10.6	39.1	23.1	13.3	13.8	17.7	11.0	29.0	14.6	10.1	14.6	12.3	14.5	10.3	13.0	16.6	12.0	13.8	10.7	12.6	11.7	14.3	16.4	20.6	13.2	22.5	15.4	16.1	12.3	5.0	14.9	24.6	15.1	18.1	15.7	18.0	12.0	10.7	15.3	16.3	29.7	14.1	18.9	15.6	9.3	15.8	10.6	12.9	3.0	1.7	5.7	2.1	3.3	3.5	1.5	23.2	14.2	12.1	11.8	3.4	5.6	10.5	14.7	7.6	14.3	11.3	14.3	11.5	12.9	7.6	9.5	13.9	6.7	12.3	2.9	17.6	13.0	6.2	10.0	13.9	7.5	11.1	13.1	5.0	6.5	8.8	5.1	9.2	11.0	20.7	7.7	12.2	19.6	7.9	11.3	11.1	14.6	11.5	12.6	7.2	11.8	11.5	14.0	13.1	9.3	7.2	9.7	8.7	13.9	9.8	12.1	23.7	25.1	24.1	5.6	9.9	13.4	21.7	11.9	3.5	1.9	5.7	3.5	2.1	2.0	3.0	3.4	2.4	1.7	2.6	1.8	2.7	3.7	3.3	1.5	1.4	2.4	1.5	15.4	19.9	39.1	23.1	13.0	16.6	11.7	14.3	16.1	14.1
G3BP1	"G3BP, HDH-VIII"	ENSG00000145907	"G3BP stress granule assembly factor 1"	Q13283	5	151771045-151812785	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, Transport"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004052, CAB037068"	Supported		Supported	Cytosol			150000	Cytosol		"CAB037068: AB_1840864, HPA004052: AB_1849348"	"unprognostic (1.31e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (3.33e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.88e-2)"	36.7	27.5	21.1	29.1	23.7	12.2	29.7	24.3	21.4	28.5	23.4	27.7	19.6	18.1	29.9	19.3	40.7	26.5	20.7	24.8	21.7	21.2	30.7	44.1	25.9	36.8	31.8	16.7	38.2	30.6	29.9	29.9	27.9	24.9	24.5	27.2	22.6	24.1	19.7	66.4	25.3	22.8	27.0	27.4	28.9	20.6	27.4	25.8	57.1	28.9	37.0	42.3	27.7	34.8	25.6	19.9	19.5	19.1	29.4	40.0	32.1	37.4	29.3	36.1	15.8	46.0	24.9	41.7	37.2	33.8	48.0	57.0	53.8	48.6	69.9	54.7	34.5	35.6	54.5	72.2	63.0	19.3	26.2	43.2	27.1	36.0	26.2	54.1	28.6	24.9	39.4	41.7	41.4	39.5	33.8	34.5	47.0	20.1	45.6	24.0	40.3	30.0	41.8	45.6	33.3	31.5	37.2	34.1	24.7	35.2	51.3	53.8	41.0	30.1	43.1	34.7	40.4	32.8	67.5	21.5	29.6	55.0	26.1	41.6	62.6	19.5	13.9	13.0	25.7	19.1	40.0	25.6	34.4	28.7	18.0	21.9	33.0	32.9	6.1	29.4	16.8	19.9	34.0	32.1	21.1	23.7	24.3	21.4	21.7	21.2	31.8	16.7	24.9	25.8
G3BP2	KIAA0660	ENSG00000138757	"G3BP stress granule assembly factor 2"	Q9UN86	4	75642782-75724525	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018304, HPA018425"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA018304: AB_1849350, HPA018425: AB_1849352"	"unprognostic (2.42e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.88e-2)"	"prognostic favourable (6.65e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.99e-2)"	22.7	24.7	28.2	21.9	48.4	31.6	23.9	52.2	55.6	24.3	28.6	21.5	18.7	24.5	25.1	18.7	24.5	26.9	23.3	23.0	29.3	46.3	32.3	33.7	21.3	24.8	31.3	30.0	20.4	18.8	31.0	27.6	17.7	57.9	37.7	27.3	16.3	22.0	24.2	69.7	15.3	27.8	25.9	35.2	22.9	22.0	27.4	19.6	29.9	35.4	28.1	26.6	26.9	17.9	18.8	20.4	32.5	28.2	31.9	41.4	24.7	27.3	28.4	46.4	38.2	40.0	40.9	15.4	42.1	40.3	27.0	28.7	36.7	38.3	52.5	37.7	33.5	18.5	47.8	49.0	39.5	31.1	19.7	54.5	28.4	41.3	35.3	49.9	40.6	32.3	42.1	32.7	33.9	48.6	39.9	40.0	42.9	17.6	58.0	18.0	48.6	13.2	44.0	57.2	27.4	31.9	33.6	38.1	40.9	30.9	44.5	54.5	21.4	25.2	49.2	27.5	22.3	30.7	23.4	39.0	37.2	53.9	39.3	34.3	35.5	32.5	17.0	30.7	26.8	23.1	41.4	18.8	26.1	28.8	20.4	14.6	26.3	28.4	16.6	31.9	28.2	9.9	22.1	24.7	28.2	48.4	52.2	55.6	29.3	46.3	31.3	30.0	57.9	19.6
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA067052: "	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favourable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	25.4	38.1	25.8	15.6	25.4	11.1	23.4	12.9	35.3	25.3	17.8	37.8	28.3	21.1	22.0	50.9	14.4	27.7	20.5	22.2	25.4	37.8	42.8	15.3	18.7	29.8	32.9	21.3	28.1	29.1	38.4	37.7	22.2	34.0	26.1	15.2	37.4	27.7	33.8	22.9	9.9	17.7	17.8	33.1	19.7	18.2	20.7	16.0	18.5	35.1	11.4	14.8	21.4	14.0	5.9	33.4	3.1	19.0	7.2	6.1	6.5	10.0	60.3	21.1	34.0	22.5	16.7	14.8	11.6	23.8	27.1	18.2	24.9	16.4	23.2	16.7	25.8	17.4	16.1	24.7	13.0	11.9	24.7	12.7	40.8	45.4	23.4	11.4	16.2	22.0	11.9	25.7	18.1	22.5	13.1	29.7	20.2	28.1	5.6	17.7	26.4	39.3	11.8	13.2	53.8	36.8	23.8	25.4	22.5	12.8	15.3	14.8	42.3	11.7	22.4	26.9	14.3	7.2	16.1	19.7	14.1	6.6	29.9	10.0	34.1	1.2	15.2	3.1	4.6	19.0	5.6	5.5	3.6	4.4	24.6	5.9	4.6	6.1	0.5	7.2	11.1	33.4	3.5	6.5	25.8	25.4	12.9	35.3	25.4	37.8	32.9	21.3	34.0	16.0
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.1"	"Cell line enhanced"	"Detected in all"		"A549: 225.5;MCF7: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 77.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 77.3"					"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"			12000000	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	21.9	29.4	10.4	15.6	10.7	51.4	18.2	8.4	14.7	12.2	7.5	13.6	4.8	7.2	14.0	13.2	29.0	11.0	24.7	10.1	8.8	10.1	15.4	3.7	20.8	31.0	10.3	8.0	19.8	7.9	5.9	20.7	9.2	10.9	11.3	7.3	17.8	13.9	8.6	4.4	11.3	7.3	17.5	11.1	20.3	9.9	83.1	9.5	22.5	24.6	44.8	25.7	24.1	19.0	3.6	7.6	77.3	16.2	12.7	10.3	11.8	15.4	225.5	4.6	17.8	19.5	26.7	4.1	10.8	31.0	11.0	19.1	10.3	5.8	10.0	16.8	24.7	13.8	7.2	18.3	5.7	10.2	5.0	10.6	51.0	23.2	38.2	10.6	36.4	12.9	5.4	21.6	4.6	22.9	6.3	4.4	19.9	85.5	6.8	7.6	3.3	16.7	6.7	2.6	10.9	33.2	19.3	4.7	5.9	10.8	42.1	9.0	6.3	8.9	27.2	7.0	24.7	9.7	16.6	5.3	6.9	17.1	19.4	7.0	14.3	29.3	16.2	77.3	10.3	13.6	6.6	3.4	2.7	7.4	7.6	3.6	3.5	5.9	27.1	12.7	11.1	3.5	3.5	11.8	10.4	10.7	8.4	14.7	8.8	10.1	10.3	8.0	10.9	9.5
GAB2	KIAA0571	ENSG00000033327	"GRB2 associated binding protein 2"	Q9UQC2	11	78215297-78418348	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 49.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.4;neutrophil: 16.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.3"									"HPA000271, HPA001368, CAB022159"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB022159: , HPA000271: AB_1078925, HPA001368: "	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.99e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (9.32e-5)"	"unprognostic (6.95e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.67e-2)"	15.5	8.4	31.1	12.0	26.9	32.9	11.6	5.7	21.5	10.2	8.9	49.1	1.6	13.7	16.8	4.6	8.2	13.5	9.1	13.6	30.4	21.3	5.2	4.5	16.1	6.8	31.5	14.8	20.0	5.9	10.4	7.0	14.6	24.7	6.5	10.9	6.6	5.4	7.3	5.2	8.8	10.1	17.1	35.4	11.8	7.4	5.5	26.0	9.4	6.5	3.0	5.6	9.3	12.3	0.5	1.7	16.3	3.4	0.0	0.1	0.7	1.7	1.5	4.4	0.5	6.4	2.8	19.4	2.7	3.3	2.0	1.6	11.4	0.9	0.5	12.4	3.8	2.8	10.3	0.2	2.6	17.2	1.1	6.9	2.7	2.0	3.2	2.6	1.4	3.0	0.9	7.7	1.2	11.5	18.1	0.6	3.3	0.7	1.3	6.5	1.4	2.1	13.0	4.2	0.2	3.6	6.5	3.8	31.0	0.7	1.4	7.1	6.5	7.5	9.4	0.9	2.2	7.5	0.6	4.8	0.7	0.3	0.7	4.1	8.2	9.4	2.4	0.7	0.0	1.4	0.0	0.5	0.0	0.0	0.8	0.3	0.0	0.0	16.3	0.0	3.4	1.7	0.1	0.7	31.1	26.9	5.7	19.3	30.4	21.3	31.5	14.8	24.7	26.0
GABPA	"E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A"	ENSG00000154727	"GA binding protein transcription factor alpha subunit"	Q06546	21	25734570-25772460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003258, CAB004411, HPA028791"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598"	"unprognostic (5.50e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (3.97e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.73e-3)"	25.3	15.2	11.6	17.0	16.9	13.6	18.3	15.9	15.4	17.6	17.1	11.4	18.8	12.7	19.5	15.9	15.1	15.4	13.6	18.6	12.5	9.5	14.6	18.8	13.3	18.8	12.9	9.0	20.4	13.3	19.4	20.3	34.5	12.5	18.0	14.2	10.8	14.2	15.4	18.2	11.5	17.0	15.8	18.4	20.0	12.3	19.5	16.3	37.7	27.3	10.3	19.0	18.4	35.3	8.9	6.6	12.0	8.2	10.8	10.3	6.1	12.6	5.2	15.5	11.0	15.9	21.6	12.0	10.1	11.4	8.4	8.4	6.6	10.8	27.1	8.0	11.7	5.8	17.2	10.3	14.0	15.3	15.9	18.8	7.0	6.2	10.8	20.0	12.8	15.8	10.1	11.2	10.6	15.5	17.2	16.4	14.0	6.3	21.6	8.7	21.4	7.3	18.1	22.3	16.6	9.8	8.4	9.5	12.9	18.1	11.6	12.4	10.3	15.5	15.2	10.2	9.4	11.1	8.3	13.1	11.3	24.0	10.6	15.4	12.2	12.0	6.8	11.5	7.4	8.2	9.9	8.9	8.6	8.7	6.6	8.4	10.3	8.7	8.7	10.8	6.0	3.4	8.6	6.1	11.6	16.9	15.9	15.4	12.5	9.5	12.9	9.0	12.5	16.3
GABPB1	"E4TF1-47, GABPB, GABPB2"	ENSG00000104064	"GA binding protein transcription factor beta subunit 1"	Q06547	15	50275392-50355408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019653, HPA067444"	Supported		Supported	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	"Cytoplasmic bodies"	"HPA019653: AB_1849370, HPA067444: "	"unprognostic (7.79e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.54e-3)"	"prognostic unfavourable (2.53e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-3)"	15.4	12.6	8.1	13.8	16.8	31.7	14.3	16.0	14.0	12.7	9.5	8.4	8.6	8.1	14.1	10.8	13.8	12.0	12.6	10.3	8.8	7.2	9.1	16.2	15.2	25.7	9.1	8.7	12.1	10.6	8.7	11.5	15.1	7.3	11.4	11.8	10.7	12.1	8.1	15.2	10.4	12.8	13.9	7.3	17.1	11.2	17.3	9.9	35.7	16.2	12.5	20.8	13.4	11.9	23.1	16.8	26.8	15.0	19.1	21.1	14.3	11.7	13.5	19.8	15.4	5.2	7.4	26.4	15.4	12.2	18.3	16.1	22.9	9.7	15.4	9.4	12.6	19.3	17.7	13.2	23.3	21.3	10.6	18.2	14.1	15.6	12.6	17.4	14.1	9.7	13.0	17.1	22.3	31.9	16.7	19.4	12.1	26.6	25.7	15.7	13.5	9.2	31.8	14.4	14.6	11.0	14.9	18.7	15.5	13.7	13.0	15.6	11.3	17.3	15.1	16.7	13.9	29.2	27.5	13.9	18.9	27.1	10.3	16.1	16.8	26.8	12.2	23.6	15.9	15.0	21.1	23.1	15.7	16.9	16.8	21.3	14.6	16.8	12.4	19.1	11.1	13.3	20.4	14.3	8.1	16.8	16.0	14.0	8.8	7.2	9.1	8.7	7.3	9.9
GABPB2	MGC29891	ENSG00000143458	"GA binding protein transcription factor beta subunit 2"	Q8TAK5	1	151070578-151125542	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028471, HPA058483"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA028471: AB_10602319, HPA058483: "	"unprognostic (1.21e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.76e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.65e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.98e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-3)"	9.9	8.3	9.5	9.3	13.3	12.2	10.9	12.3	12.2	10.0	8.5	14.8	10.7	7.0	10.1	8.0	8.7	10.2	10.7	11.0	11.6	5.8	7.9	6.4	7.7	9.9	14.4	9.7	17.6	7.8	15.1	12.8	6.5	11.4	9.4	9.8	11.0	7.6	12.6	10.0	13.9	8.1	12.0	10.2	10.1	9.8	20.2	15.2	15.7	10.0	11.6	9.8	9.9	16.6	4.7	5.0	4.7	5.1	2.6	4.8	2.6	6.8	2.4	1.7	2.1	6.0	8.9	2.2	6.3	3.9	3.7	2.6	0.7	5.1	7.1	2.4	6.0	6.0	3.6	3.2	5.4	2.6	1.4	1.9	3.7	0.1	4.0	7.7	4.0	4.8	3.8	5.1	7.5	1.3	4.7	5.0	4.4	9.7	10.6	1.4	0.8	2.7	3.2	2.8	3.3	3.1	1.9	3.0	1.2	8.0	2.8	2.4	7.1	8.5	4.0	0.9	3.2	6.5	5.1	2.7	1.3	26.0	3.0	5.9	4.3	3.6	2.8	1.6	4.4	3.3	2.7	3.1	4.8	3.9	2.5	4.7	4.3	4.7	4.7	2.6	5.1	5.0	1.7	2.6	9.5	13.3	12.3	12.2	11.6	5.8	14.4	9.7	11.4	15.2
GABRA5		ENSG00000186297	"Gamma-aminobutyric acid type A receptor alpha5 subunit"	P31644	15	26866363-26949207	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 52.6"	"Group enriched"	"Detected in some"	12	"A549: 25.8;HAP1: 8.9;NTERA-2: 10.7;U-2 OS: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA077031, CAB079022"		Supported	Supported	"Plasma membrane"				"Plasma membrane"		"CAB079022: , HPA077031: "	"unprognostic (6.33e-2)"			"unprognostic (8.94e-3)"	"unprognostic (1.04e-1)"			"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.57e-1)"		"unprognostic (7.63e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.44e-2)"		0.8	0.8	12.0	0.8	48.2	0.8	0.8	0.1	52.6	0.8	0.8	0.8	0.0	0.8	0.8	0.7	2.5	0.8	1.5	0.9	20.9	6.0	0.9	0.8	0.8	0.8	2.3	15.2	0.7	0.7	0.7	0.1	0.8	1.0	1.0	0.7	0.0	0.7	0.9	0.7	0.8	0.7	1.4	0.3	0.8	1.1	1.4	2.0	1.3	0.9	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	8.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	48.2	0.1	26.0	20.9	6.0	2.3	15.2	1.0	2.0
GADD45A	"DDIT1, GADD45"	ENSG00000116717	"Growth arrest and DNA damage inducible alpha"	P24522	1	67685061-67688338	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 86.7;skeletal muscle: 102.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 59.4;hTERT-HME1: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;T-cells: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA053420			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA053420: "	"unprognostic (1.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.76e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.21e-2)"	"prognostic favourable (8.06e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.93e-1)"	29.6	6.8	10.7	8.2	20.9	46.2	20.9	1.7	15.8	11.7	10.8	5.8	18.8	10.1	23.3	13.8	12.2	8.8	16.7	12.9	18.1	9.8	86.7	66.9	17.1	4.9	11.4	4.1	13.8	8.3	4.1	5.1	10.8	21.2	16.5	9.0	9.4	9.5	15.6	102.1	14.8	20.4	16.1	15.5	7.4	14.1	9.2	7.5	9.2	26.2	10.1	10.9	23.9	11.1	1.1	2.2	24.9	3.2	3.1	9.3	4.8	21.9	1.4	3.7	1.1	6.7	7.0	35.4	39.1	18.2	13.0	14.2	7.7	3.7	9.5	12.0	6.3	13.2	0.4	33.4	24.6	6.9	3.8	11.8	3.5	7.7	59.4	3.4	1.1	11.8	16.9	16.5	91.6	9.3	25.3	16.9	15.3	0.7	1.0	4.2	4.8	15.5	2.5	29.1	9.7	6.7	16.6	16.2	2.8	8.2	2.3	23.4	0.4	3.7	9.6	13.6	18.3	14.4	27.3	43.3	8.4	17.2	6.0	1.6	13.3	7.2	3.2	24.9	3.7	1.5	3.0	1.1	2.5	3.0	1.4	0.7	0.7	1.2	4.1	3.1	1.0	2.2	9.3	4.8	10.7	20.9	1.7	15.8	18.1	9.8	11.4	4.1	21.2	7.5
GADD45GIP1	"CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6"	ENSG00000179271	"GADD45G interacting protein 1"	Q8TAE8	19	12953119-12957236	"Predicted intracellular proteins, Ribosomal proteins"	"Cell cycle, Host-virus interaction"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055205, HPA065048, HPA071910"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA055205: , HPA065048: , HPA071910: "	"unprognostic (5.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-1)"	23.9	31.8	32.7	22.3	29.1	28.1	19.3	17.2	31.4	16.9	18.9	11.2	17.9	21.1	19.2	20.0	22.3	17.5	25.0	41.9	26.4	27.6	24.3	31.5	15.3	21.0	26.0	23.6	20.7	29.6	10.1	18.5	21.3	17.7	18.7	9.7	13.1	36.2	21.7	85.5	18.4	19.2	19.5	19.3	19.8	20.0	17.2	17.1	14.8	27.0	37.9	14.8	17.5	21.5	34.2	17.7	4.8	14.1	16.1	23.6	10.6	19.8	17.0	7.1	10.0	5.0	6.5	10.0	14.7	7.4	14.7	12.1	23.4	8.1	14.4	24.6	8.8	14.0	8.7	14.4	3.8	9.3	42.7	10.2	22.9	26.2	12.2	16.9	15.6	7.7	11.7	10.2	8.4	8.5	15.4	5.6	9.1	29.3	26.7	35.6	19.7	53.7	19.8	7.2	23.0	11.3	11.8	22.0	20.1	11.0	14.8	16.6	11.6	16.0	13.8	28.6	10.0	24.8	27.0	22.4	15.6	14.9	19.8	21.3	16.4	4.1	14.1	4.8	14.4	13.4	14.5	34.2	22.1	22.8	17.7	28.0	23.6	17.4	0.9	16.1	11.3	16.9	17.5	10.6	32.7	29.1	17.2	29.1	26.4	27.6	26.0	23.6	17.7	17.1
GAK	DNAJC26	ENSG00000178950	"Cyclin G associated kinase"	O14976	4	849276-932373	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-3)"	"prognostic favourable (1.70e-6)"	"unprognostic (1.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"prognostic favourable (7.41e-4)"	16.5	18.9	16.8	42.2	22.7	29.9	16.7	32.4	27.7	18.0	32.5	19.7	18.6	48.2	22.4	18.6	23.7	20.5	26.8	11.4	16.2	13.9	25.0	22.1	22.2	22.4	17.6	19.4	21.1	33.0	19.5	18.9	16.6	17.9	20.3	15.2	16.9	70.8	20.6	26.2	25.6	41.1	15.2	14.3	30.9	39.2	28.6	18.5	23.6	19.7	19.2	22.3	18.9	18.9	4.7	7.1	10.8	19.3	4.0	8.5	6.9	15.7	12.7	7.8	13.2	7.8	6.7	20.1	15.0	9.0	10.3	8.6	16.0	22.6	13.5	10.2	9.0	13.8	8.0	12.4	4.9	13.7	14.1	15.6	12.8	12.0	14.7	15.8	24.5	9.7	10.7	10.4	5.1	11.2	16.8	17.1	6.9	15.2	26.8	40.9	13.9	23.3	22.2	9.0	12.0	8.3	12.9	13.4	14.5	8.7	11.1	10.4	17.8	13.6	18.4	14.4	8.4	14.6	20.0	27.8	18.6	15.0	16.2	19.4	13.1	2.6	9.0	10.8	8.5	8.9	7.4	4.7	5.6	5.7	6.0	4.0	3.2	4.7	6.7	4.0	19.3	7.1	5.0	6.9	16.8	22.7	32.4	27.7	16.2	13.9	17.6	19.4	17.9	18.5
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"pituitary gland: 149.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 46.9;HEK 293: 21.9;K-562: 24.3;NB-4: 86.7;SH-SY5Y: 35.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"hypothalamus: 18.8"	"Cell type enriched"	"Detected in single"	15	"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	60030		"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: "	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	2.8	0.2	0.1	14.8	0.5	0.4	4.5	0.6	2.0	0.2	6.0	0.1	0.4	1.7	0.2	0.7	0.7	0.2	0.3	0.6	1.3	18.8	0.3	0.2	0.2	0.1	0.2	0.6	0.2	2.9	0.0	149.9	0.9	2.2	0.7	4.1	0.6	0.5	1.8	0.3	4.5	2.2	9.7	0.3	0.2	1.5	0.5	0.4	0.7	0.2	0.4	0.3	1.5	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	4.4	6.6	0.0	0.1	0.0	46.9	1.7	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	21.9	1.1	14.1	0.0	0.2	0.6	0.0	0.3	0.7	0.0	0.0	1.1	24.3	0.0	0.0	13.3	0.0	86.7	11.2	4.2	0.0	0.0	8.9	0.1	0.0	9.1	35.0	4.6	0.2	0.0	0.2	10.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.7	1.3	18.8	0.2	0.6	2.2	0.4
GALNT2	GalNAc-T2	ENSG00000143641	"Polypeptide N-acetylgalactosaminyltransferase 2"	Q10471	1	230057990-230282124	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 140.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011222	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"		11000000	"Golgi apparatus"		"HPA011222: AB_1849446"	"unprognostic (1.26e-1)"	"prognostic unfavourable (1.22e-6)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.70e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (8.48e-8)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.79e-13)"	"unprognostic (3.79e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	19.5	25.6	11.1	19.6	10.1	6.9	20.4	7.7	12.5	11.7	12.7	9.1	10.5	11.3	13.7	11.5	11.5	13.2	17.0	13.9	12.5	8.5	17.5	140.3	13.2	20.4	8.4	9.0	24.8	35.9	4.3	7.3	16.6	12.6	10.8	7.5	10.5	11.1	9.6	42.2	8.4	11.3	14.6	13.6	9.5	18.0	12.7	8.2	28.4	10.7	10.7	7.0	14.9	13.1	6.7	13.5	3.5	10.1	2.7	5.3	6.3	15.9	21.3	12.6	14.9	24.2	20.7	26.0	30.3	18.8	12.3	11.8	9.2	30.4	4.0	22.5	15.9	31.2	8.3	25.4	10.4	40.3	10.8	12.3	47.7	10.2	13.2	4.7	24.2	29.6	12.6	16.4	6.6	14.4	15.3	6.2	13.6	4.4	24.3	4.7	17.2	20.4	27.1	18.0	12.4	12.1	19.0	4.0	14.9	30.7	1.6	18.4	9.7	8.8	34.1	12.1	23.3	27.2	24.0	20.7	11.9	9.0	31.2	9.4	89.5	1.1	10.1	3.5	4.7	9.6	3.6	3.8	2.9	4.7	7.9	6.7	2.8	5.3	3.2	2.7	9.6	13.5	3.4	6.3	11.1	10.1	7.7	11.8	12.5	8.5	8.4	9.0	12.6	8.2
GALNT3	"GalNAc-T3, HFTC, HHS"	ENSG00000115339	"Polypeptide N-acetylgalactosaminyltransferase 3"	Q14435	2	165747591-165794682	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.5;HaCaT: 37.5;HBEC3-KT: 25.3;hTCEpi: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA007613	Enhanced		Supported	"Golgi apparatus"			88000	"Golgi apparatus"		"HPA007613: AB_1078941"	"unprognostic (1.95e-1)"	"prognostic unfavourable (2.08e-4)"	"unprognostic (1.16e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (4.10e-4)"	"unprognostic (4.13e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-1)"	1.5	1.7	1.5	6.3	1.7	14.6	12.0	2.2	1.7	11.9	21.3	3.6	6.5	15.5	2.4	8.8	23.4	15.7	26.4	0.9	1.9	2.1	15.1	2.1	15.3	0.6	4.2	1.2	6.4	31.2	3.0	23.0	7.0	4.2	13.8	21.2	1.7	35.7	5.4	0.7	6.7	37.4	0.5	4.8	23.3	28.9	17.6	3.3	1.5	37.6	15.1	20.8	11.7	9.3	3.3	7.5	21.1	5.7	5.8	5.3	2.3	20.1	0.0	0.1	0.0	0.0	0.8	13.4	4.4	1.7	1.7	4.5	12.4	32.5	0.1	0.0	0.0	37.5	0.0	25.3	3.8	0.2	3.6	0.0	3.7	0.1	0.1	3.7	0.1	0.1	35.7	0.0	9.5	0.0	0.0	16.7	1.4	14.4	0.1	1.5	0.0	2.0	0.0	0.0	0.6	6.7	16.9	2.0	0.0	0.0	18.2	4.1	8.1	0.1	0.1	0.0	0.3	0.0	0.0	8.6	4.2	0.3	0.0	3.9	0.1	21.1	3.1	13.8	5.3	4.5	4.1	3.3	1.7	3.3	5.3	3.1	0.6	1.9	10.5	5.8	5.7	7.5	2.9	2.3	1.5	1.7	2.2	1.7	1.9	2.1	4.2	1.2	4.2	3.3
GAN	"GAN1, KLHL16"	ENSG00000261609	Gigaxonin	Q9H2C0	16	81314952-81390884	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skin 1: 46.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011825, HPA049473"	Approved		Supported	Microtubules				Microtubules		"CAB011825: AB_732515, HPA049473: "	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.91e-3)"	"unprognostic (3.12e-3)"	"unprognostic (5.93e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.86e-2)"	3.1	2.8	7.5	2.9	7.6	2.8	6.2	8.0	7.8	3.9	4.0	10.9	3.2	3.0	3.3	3.7	8.4	2.6	2.8	2.9	10.8	5.0	2.5	2.5	3.0	2.8	5.5	7.5	3.0	3.5	4.1	2.9	3.1	7.5	3.9	3.9	2.7	4.1	3.0	4.0	46.9	3.0	4.3	8.1	3.0	4.2	3.2	7.7	2.0	3.1	6.2	4.0	3.3	6.6	2.2	3.3	2.4	1.6	3.2	3.7	0.6	2.1	3.1	2.0	2.6	2.6	1.3	13.2	1.8	1.2	1.4	0.7	6.3	2.4	3.3	2.1	2.1	3.9	4.1	1.7	3.0	0.9	1.8	2.9	2.5	4.9	2.5	2.7	3.2	1.5	4.8	1.9	4.6	2.4	3.7	1.5	1.5	11.1	2.4	3.5	5.1	1.1	4.6	2.0	1.3	2.1	6.9	2.3	1.3	6.3	5.3	1.7	3.8	2.4	3.3	3.0	3.9	1.2	2.4	2.8	3.6	8.1	1.6	2.9	2.4	2.4	1.6	0.8	3.1	1.4	2.8	1.7	3.1	2.5	0.9	2.2	2.9	3.7	1.3	3.2	1.3	3.3	2.2	0.6	7.5	7.6	8.0	7.8	10.8	5.0	5.5	7.5	7.5	7.7
GAP43	"B-50, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623324-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 132.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.4;NTERA-2: 34.8;SCLC-21H: 22.4;SH-SY5Y: 16.8;U-87 MG: 7.8"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"naive CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"				"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	1.8	5.0	48.8	5.2	38.3	1.4	1.9	31.2	132.7	1.6	4.1	4.3	0.0	2.7	1.5	1.5	1.9	1.5	3.8	3.6	29.0	56.6	1.4	1.4	1.5	1.5	30.6	42.2	1.4	1.8	1.4	1.5	2.2	25.7	1.7	4.0	0.8	2.2	1.5	1.4	1.4	4.3	3.6	6.1	1.4	1.5	1.6	5.7	0.0	1.5	0.0	1.6	1.7	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	22.4	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	48.8	38.3	31.2	75.7	29.0	56.6	30.6	42.2	25.7	5.7
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"			2200000000	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavourable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	196.0	345.9	99.8	155.5	97.4	160.6	217.5	149.0	212.2	218.1	227.7	244.1	134.6	229.2	29.5	175.6	111.7	92.7	345.6	151.4	201.0	100.7	126.8	217.1	207.3	131.3	204.9	102.1	134.3	112.9	214.3	242.1	240.0	68.1	48.3	247.7	391.1	233.5	107.9	368.8	115.3	189.9	177.7	109.1	248.1	239.9	70.7	113.5	131.5	343.1	197.9	53.6	144.8	149.7	170.2	205.7	87.8	257.4	109.8	79.8	295.4	360.8	129.9	266.3	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9
GAPVD1	"DKFZP434C212, KIAA1521"	ENSG00000165219	"GTPase activating protein and VPS9 domains 1"	Q14C86	9	125261794-125367207	"Predicted intracellular proteins"	Endocytosis	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029386, HPA029387"	Uncertain		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA029386: AB_10599604, HPA029387: AB_10600311"	"unprognostic (8.43e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.82e-2)"	17.6	16.2	16.0	14.9	18.6	26.6	16.9	25.7	21.3	17.5	16.1	20.9	18.0	10.8	19.1	14.0	24.3	16.0	13.7	15.4	15.5	14.1	17.6	14.5	20.5	15.1	21.1	15.6	18.9	14.1	30.3	20.2	23.3	20.1	14.7	13.2	16.4	15.9	17.2	31.6	23.5	14.6	17.4	15.3	17.3	14.6	32.1	20.2	18.6	24.8	12.2	19.9	16.2	17.7	10.4	14.8	19.2	17.8	13.6	14.8	10.0	11.5	12.0	11.4	10.6	13.8	15.1	16.6	12.9	14.8	15.0	12.6	19.1	8.3	15.4	7.0	16.2	23.5	23.6	13.5	16.0	14.1	14.1	17.5	29.5	9.4	16.3	20.8	29.6	10.8	13.2	17.8	14.4	17.8	33.9	8.5	12.5	16.9	15.5	9.1	11.5	13.7	13.6	24.9	14.9	8.6	11.9	15.2	10.2	18.8	17.4	10.3	21.4	10.8	18.6	10.6	7.8	18.9	13.8	11.0	20.7	15.8	13.0	11.8	13.6	18.6	15.0	18.0	13.7	15.6	13.4	10.2	14.2	14.8	14.8	10.4	14.2	14.7	19.2	13.6	17.8	5.6	10.9	10.0	16.0	18.6	25.7	21.3	15.5	14.1	21.1	15.6	20.1	20.2
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: "	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	16.6	18.9	15.2	19.5	19.9	34.7	22.4	11.0	16.5	14.6	20.9	12.4	15.5	17.0	24.3	14.8	26.6	17.2	17.8	11.6	14.2	13.3	15.6	20.0	13.7	17.2	15.5	17.1	20.2	24.1	15.7	19.1	24.8	13.8	17.3	21.0	14.5	23.3	17.5	13.8	25.4	16.3	19.0	18.1	18.8	15.1	27.7	16.3	29.5	17.3	27.6	22.4	15.5	15.5	11.3	9.3	7.4	9.3	9.5	10.7	4.3	15.6	18.2	12.5	16.9	6.7	9.6	10.9	16.3	8.8	13.5	10.9	28.4	19.9	38.3	10.7	12.3	7.5	23.0	16.2	22.5	11.3	22.6	22.8	16.4	31.0	16.3	48.8	12.1	8.7	17.0	16.7	12.0	16.3	54.4	11.7	16.6	33.5	30.1	33.7	20.4	22.1	20.4	20.5	14.2	17.8	22.1	18.5	18.9	10.3	26.8	14.5	9.5	14.5	14.1	13.5	18.9	9.9	20.8	14.9	24.2	47.3	9.6	23.9	14.6	7.4	5.9	3.3	9.7	9.3	10.3	11.3	9.2	9.8	9.3	10.0	10.7	9.9	1.0	9.5	8.0	9.2	9.6	4.3	15.2	19.9	11.0	16.5	14.2	13.3	15.5	17.1	13.8	16.3
GARS	"CMT2D, DSMAV, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase"	P41250	7	30594681-30634033	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		660000	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavourable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavourable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavourable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavourable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavourable (3.04e-5)"	25.8	27.3	24.5	26.2	28.5	24.6	32.4	31.1	44.7	21.5	23.7	17.0	11.5	17.2	24.1	23.3	43.7	18.6	18.4	25.7	21.1	26.8	27.6	57.2	27.9	28.0	22.9	28.4	35.4	49.4	44.4	33.3	24.3	37.6	17.2	30.2	14.1	28.7	21.6	35.6	33.2	18.1	30.1	17.6	23.5	30.5	29.7	14.9	28.6	31.4	33.9	38.4	22.8	25.7	22.5	26.4	21.2	27.2	15.3	27.6	21.2	33.0	16.4	14.5	51.5	27.2	40.9	27.6	49.5	44.8	25.5	51.7	21.8	16.5	55.7	14.9	60.2	26.2	36.2	31.4	44.9	13.3	16.9	25.7	13.4	18.3	86.4	37.8	22.8	38.9	55.2	36.6	43.5	32.7	50.9	64.9	40.4	20.3	32.9	26.2	39.2	31.4	16.7	12.8	43.2	29.2	14.9	17.6	29.4	13.2	37.0	70.3	33.0	58.0	30.0	12.1	40.7	24.3	31.2	64.2	53.8	65.5	42.3	57.3	56.9	21.2	19.0	17.7	23.2	25.8	23.7	22.5	23.7	25.1	26.4	19.3	25.5	27.6	5.6	15.3	27.2	18.0	25.9	21.2	24.5	28.5	31.1	44.7	21.1	26.8	22.9	28.4	37.6	14.9
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786554-48794311	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 78.3;bone marrow: 37.0"	"Group enriched"	"Detected in some"	9	"HEL: 49.6;HMC-1: 51.2;K-562: 52.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 78.3"	"Lineage enriched"	"Detected in single"	784	"granulocytes: 78.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.7	0.2	0.1	2.4	0.7	37.0	0.3	0.0	0.3	0.7	0.3	0.0	0.0	0.6	4.9	2.4	0.4	0.3	0.6	2.3	0.1	0.3	0.4	0.8	5.6	0.2	0.6	0.0	0.1	0.1	0.1	0.5	2.8	0.3	1.4	0.4	1.6	0.3	0.2	0.1	0.6	0.8	2.4	0.3	4.9	0.5	3.1	0.0	1.5	0.6	1.1	0.6	0.9	0.6	0.0	0.0	78.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.0	52.8	0.1	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	78.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.7	0.0	0.3	0.1	0.3	0.6	0.0	0.3	0.0
GATA2	NFE1B	ENSG00000179348	"GATA binding protein 2"	P23769	3	128479427-128493185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Phagocytosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.2;ductus deferens: 85.8;seminal vesicle: 209.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 55.8;HEL: 68.8;HMC-1: 37.2;SH-SY5Y: 65.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 36.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	339	"basophil: 81.2"	"Lineage enriched"	"Detected in single"	813	"granulocytes: 81.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005633, CAB024847"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB024847: , HPA005633: AB_1078954"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.61e-2)"	"unprognostic (8.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.96e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.04e-1)"	"prognostic favourable (2.04e-4)"	"unprognostic (2.50e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (5.22e-5)"	7.0	6.2	2.1	1.5	2.4	2.5	7.9	1.2	1.9	22.4	2.8	1.4	85.8	2.5	20.6	5.4	3.2	23.0	9.7	4.8	1.5	1.0	7.6	0.6	16.1	2.2	1.8	1.1	4.6	5.8	3.4	4.5	51.8	2.4	27.8	1.8	6.1	1.9	209.1	3.5	4.1	3.4	8.4	1.4	5.1	2.9	2.7	1.5	0.4	3.3	2.7	1.5	22.4	12.4	0.0	0.0	81.2	0.0	0.0	0.0	0.4	4.6	1.1	0.2	3.1	0.4	0.1	55.8	10.4	8.9	3.6	1.3	1.9	2.0	0.1	2.9	6.1	4.9	2.9	0.0	1.5	0.0	1.6	68.8	7.6	3.0	0.8	6.9	37.2	0.0	0.0	0.1	0.0	5.6	18.0	0.1	0.0	1.7	0.0	14.1	0.2	0.3	0.0	1.3	0.0	0.1	4.1	4.3	65.0	2.6	13.8	0.4	2.6	2.8	10.0	0.2	0.1	2.5	1.4	0.0	0.0	0.0	0.1	0.4	0.7	81.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	2.4	1.2	1.9	1.5	1.0	1.8	1.1	2.4	1.5
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 97.8;skin 1: 61.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 32.6;MCF7: 77.8;RT4: 31.8;SH-SY5Y: 27.3;T-47d: 101.3"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	42	"gdT-cell: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9"	"Group enriched"	"Detected in many"	54	"NK-cells: 16.6;T-cells: 18.9"	"Region enriched"	"Detected in single"	6	"midbrain: 7.3"	"Group enriched"	"Detected in some"	46	"midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB016217: AB_2108591, HPA029730: AB_10601907"	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	2.0	2.0	0.3	3.4	0.3	0.9	17.8	0.3	0.3	1.8	0.5	0.1	44.4	0.1	0.4	13.5	0.8	0.4	0.4	0.9	0.3	0.4	12.9	0.7	1.6	2.7	0.8	0.0	0.3	0.4	55.0	3.8	53.4	1.4	8.1	0.0	1.8	8.9	97.8	0.8	61.7	1.2	3.4	0.4	2.7	0.5	0.8	0.1	42.4	3.3	0.6	3.4	26.9	16.4	0.2	0.0	0.3	0.0	16.6	18.9	3.0	5.4	1.3	0.0	0.0	0.0	0.0	32.6	0.1	0.0	0.0	0.0	2.0	4.9	0.0	0.0	0.0	4.7	0.5	0.1	0.0	15.6	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.3	2.5	0.0	0.0	0.0	77.8	8.5	0.0	0.5	0.7	0.4	0.4	0.1	0.0	31.8	1.6	27.3	0.0	4.4	0.0	101.3	0.0	0.0	0.4	1.0	0.2	0.6	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	9.7	0.0	13.3	0.2	18.2	14.1	0.0	0.0	10.0	9.0	0.3	16.6	0.0	0.0	18.9	3.0	0.3	0.3	0.3	0.3	0.3	0.4	0.8	0.0	1.4	0.1
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 42.5;intestine: 29.9;ovary: 63.4;pancreas: 49.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 14.9;HHSteC: 17.4;SH-SY5Y: 16.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB013125: AB_2533804, HPA073899: "	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	16.8	0.1	0.0	13.4	0.5	0.4	0.1	1.0	15.4	42.5	0.0	0.0	0.0	26.5	0.1	0.8	0.0	0.0	63.4	49.9	0.0	0.1	4.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	13.8	18.3	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	14.9	17.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.3	16.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169443-22202528	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 77.2"	"Group enriched"	"Detected in many"	4	"BEWO: 27.3;CACO-2: 33.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB011581: AB_732529, HPA066629: "	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavourable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	9.7	26.6	0.2	8.4	0.2	0.0	9.4	0.2	0.2	9.8	24.7	0.9	1.5	12.5	19.5	10.3	3.3	15.3	51.3	40.4	0.2	0.2	3.9	15.5	14.9	11.1	0.2	0.1	77.2	52.2	0.1	0.5	5.2	0.7	24.3	6.0	0.4	1.5	1.1	1.5	0.9	43.5	32.2	0.4	18.9	26.9	9.7	0.0	0.1	6.3	0.7	0.6	30.3	16.5	0.0	0.0	5.7	0.0	0.0	0.4	0.0	4.7	0.7	0.0	0.0	1.0	0.5	27.3	0.1	0.2	0.4	0.5	33.2	1.8	0.0	1.6	0.5	5.3	0.2	2.1	0.7	0.0	6.7	0.0	2.1	2.8	7.2	0.2	0.3	0.2	4.3	6.0	4.5	4.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	4.7	0.0	0.5	0.1	0.2	1.3	0.4	0.0	5.1	3.0	1.3	0.8	0.0	0.3	0.7	0.8	5.6	0.8	0.0	0.0	0.0	3.1	0.1	4.8	5.7	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.7	0.0
GATAD1	"FLJ22489, ODAG, RG083M05.2"	ENSG00000157259	"GATA zinc finger domain containing 1"	Q8WUU5	7	92447448-92459432	"Disease related genes, Predicted intracellular proteins, Transcription factors"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006105, HPA072785"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA006105: AB_1078956, HPA072785: "	"unprognostic (8.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-3)"	"unprognostic (6.43e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.98e-3)"	20.1	20.9	14.7	13.7	32.1	8.7	21.1	19.5	23.5	23.1	18.2	32.9	20.8	17.6	23.2	29.8	13.7	21.7	20.0	14.9	18.3	13.4	21.5	17.5	22.5	12.4	37.7	21.4	32.9	27.3	19.7	22.5	19.3	22.1	21.7	18.3	19.5	17.0	21.2	10.4	15.3	16.9	22.2	28.9	18.9	21.1	11.5	31.8	6.5	28.1	8.0	11.3	21.4	18.7	4.5	3.8	7.3	3.8	3.1	3.0	1.1	8.8	5.6	11.4	11.9	15.0	17.2	9.2	8.8	13.2	9.3	12.8	6.1	13.7	6.6	12.2	6.5	10.6	7.8	6.0	9.9	11.5	8.5	8.4	5.6	8.4	20.8	10.0	22.9	13.0	14.4	7.1	20.9	10.5	17.0	14.2	10.2	12.7	3.9	14.3	15.4	10.8	5.2	13.6	8.6	10.0	9.9	10.2	16.2	11.6	12.3	16.5	6.9	13.6	9.6	15.0	11.5	22.6	11.2	11.4	3.9	7.3	12.6	6.6	20.5	7.3	3.8	3.4	2.6	2.3	2.5	2.8	2.0	1.6	2.0	4.5	2.1	3.0	3.9	3.1	2.5	3.8	2.0	1.1	14.7	32.1	19.5	23.5	18.3	13.4	37.7	21.4	22.1	31.8
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	19.2	16.1	14.7	24.4	15.3	30.5	25.9	11.1	14.2	12.9	22.2	12.2	20.4	24.8	16.7	16.1	23.3	13.1	17.4	16.3	16.2	11.3	21.2	28.7	22.3	29.9	12.8	10.1	16.0	28.5	13.8	16.2	26.9	15.3	11.7	13.0	18.1	16.7	20.2	17.9	29.9	26.4	13.1	14.8	28.1	19.5	42.0	11.4	34.1	16.1	15.3	24.6	16.3	23.0	3.2	4.9	12.3	4.9	3.7	5.2	2.7	18.5	16.0	14.9	22.1	6.2	6.5	31.4	14.7	10.1	15.4	14.7	28.9	19.8	36.5	22.5	14.7	15.6	13.9	13.0	9.0	12.5	15.1	26.9	16.0	15.9	15.2	29.8	23.3	10.2	9.7	16.0	13.0	15.3	42.7	11.9	8.9	21.1	35.1	11.8	31.4	14.6	37.5	15.0	17.0	8.0	24.7	28.3	15.8	12.7	15.5	18.6	14.0	12.5	29.8	29.3	14.1	34.2	27.4	14.8	18.5	39.1	18.2	25.2	17.0	5.6	4.9	4.5	5.2	2.3	3.1	3.1	3.1	4.2	2.1	3.2	2.3	2.6	12.3	3.7	4.5	4.9	2.1	2.7	14.7	15.3	11.1	14.2	16.2	11.3	12.8	10.1	15.3	11.4
GATAD2B	P66beta	ENSG00000143614	"GATA zinc finger domain containing 2B"	Q8WXI9	1	153789030-153923360	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017015	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA017015: AB_1854905"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (4.43e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.17e-2)"	12.9	9.6	16.5	16.2	19.8	22.2	13.6	33.2	24.4	12.0	12.4	22.2	10.5	10.7	15.7	9.0	14.6	13.1	9.6	19.3	16.3	11.0	8.8	10.5	15.9	18.4	15.1	12.3	17.1	16.0	19.4	11.1	14.4	14.7	10.8	9.6	12.3	10.7	14.6	20.2	17.2	11.9	17.6	13.9	14.6	11.6	24.6	17.9	29.5	19.1	7.6	17.7	12.1	14.4	1.3	2.9	6.7	1.1	1.5	1.4	0.7	4.7	9.1	8.1	8.9	1.7	5.3	4.9	2.9	7.2	9.5	11.2	4.4	7.5	9.4	7.1	6.7	9.7	11.2	5.8	7.8	8.5	7.8	9.2	9.9	1.8	5.5	5.5	13.1	4.2	4.1	10.6	21.1	9.0	6.8	13.0	1.9	8.9	19.9	1.5	3.5	4.5	20.3	4.1	10.3	1.9	6.7	9.4	9.9	11.1	13.7	5.9	12.6	4.7	8.0	9.3	8.3	5.1	6.3	17.6	11.9	14.5	5.2	3.7	8.0	6.7	1.1	0.9	1.3	0.5	1.3	0.7	0.6	1.4	0.3	1.3	0.5	0.6	6.4	1.5	0.5	2.9	1.1	0.7	16.5	19.8	33.2	24.4	16.3	11.0	15.1	12.3	14.7	17.9
GATB	"PET112, PET112L"	ENSG00000059691	"Glutamyl-tRNA amidotransferase subunit B"	O75879	4	151670504-151761023	"Predicted intracellular proteins"	"Protein biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042610	Uncertain		Supported	Mitochondria				Mitochondria		"HPA042610: AB_10797502"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.17e-2)"	"prognostic favourable (1.20e-10)"	"unprognostic (1.91e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-1)"	11.2	17.0	12.3	10.5	13.6	8.2	9.2	10.7	19.8	7.3	9.7	11.2	6.4	5.8	5.9	8.9	10.1	9.1	7.0	31.3	10.7	10.8	21.4	21.8	5.3	6.8	15.8	11.1	12.1	6.8	14.6	8.4	9.9	10.6	5.9	9.9	7.8	7.7	7.1	22.7	8.5	6.3	8.1	22.6	6.9	7.4	7.8	10.4	10.5	7.7	18.9	9.3	8.0	5.8	9.1	17.0	1.5	13.2	6.8	6.8	8.3	8.6	6.8	9.8	9.4	14.3	13.7	8.5	11.5	15.1	20.5	16.0	11.4	14.3	11.8	3.0	12.0	8.1	20.9	22.0	22.0	6.6	12.8	5.4	9.5	23.6	14.0	11.1	5.4	14.2	14.2	19.7	6.9	15.2	21.1	10.4	15.7	9.6	13.9	12.1	10.0	12.8	11.8	9.3	9.3	18.5	7.3	10.1	11.3	9.2	12.8	13.5	10.8	8.1	8.3	10.3	5.6	7.1	7.9	12.4	16.1	9.8	14.5	9.9	7.5	0.7	9.4	1.5	4.0	13.2	6.3	9.1	5.3	5.6	17.0	8.2	6.8	6.4	0.9	6.8	9.4	6.7	5.4	8.3	12.3	13.6	10.7	19.8	10.7	10.8	15.8	11.1	10.6	10.4
GATD1	"FLJ34283, PDDC1"	ENSG00000177225	"Glutamine amidotransferase like class 1 domain containing 1"	Q8NB37	11	767220-777488	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008812	Uncertain		Supported	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm		"HPA008812: AB_10962724"	"unprognostic (3.39e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.23e-3)"	"unprognostic (4.89e-3)"	"prognostic favourable (3.79e-5)"	"unprognostic (2.84e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.61e-3)"	16.7	36.5	26.6	16.3	24.9	10.6	19.1	30.9	29.8	15.1	15.0	20.7	19.8	23.3	17.7	22.4	16.6	18.8	20.0	16.7	27.0	26.2	19.8	18.6	15.3	15.6	25.8	19.4	21.9	16.6	15.5	22.9	16.4	22.0	18.6	10.5	15.8	20.0	23.8	19.2	27.2	21.5	12.6	21.7	17.2	19.1	17.5	21.5	12.8	17.0	13.0	11.5	11.9	14.3	4.0	9.5	1.3	8.7	1.7	4.7	2.8	16.5	9.6	9.3	9.9	4.3	6.7	9.0	9.9	4.3	9.2	8.1	6.9	26.0	9.0	3.6	6.5	17.8	6.9	8.8	4.6	11.5	49.8	5.5	14.4	14.5	7.5	10.3	11.8	9.5	9.8	3.9	6.0	7.0	13.5	8.3	5.1	4.8	11.6	11.1	8.8	17.7	12.8	6.3	11.3	8.0	3.7	24.0	9.4	9.6	13.6	6.7	11.8	6.8	12.8	9.9	7.5	5.3	7.6	10.0	5.0	11.5	15.0	13.8	8.0	1.3	7.0	1.3	4.7	8.7	3.4	4.0	4.5	4.4	9.5	3.5	3.9	2.6	0.7	1.7	3.5	5.5	2.1	2.8	26.6	24.9	30.9	27.7	27.0	26.2	25.8	19.4	22.0	21.5
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 186.3;liver: 252.2;pancreas: 286.1"	"Group enriched"	"Detected in some"	4	"RH-30: 55.9;RT4: 14.7;U-266/70: 34.5;U-266/84: 43.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	6	"B-cells: 12.8;dendritic cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria			620000	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	1.8	2.5	18.5	1.6	14.7	0.6	2.9	11.4	16.2	1.5	3.1	24.9	0.3	17.8	1.3	2.2	3.0	1.7	5.0	5.5	15.2	10.3	186.3	252.2	1.2	2.1	20.6	14.3	17.6	286.1	0.7	1.2	7.8	14.5	1.7	1.7	1.5	5.5	2.1	13.5	13.9	10.8	2.7	26.1	3.5	10.0	8.0	18.4	0.7	6.6	2.5	3.1	2.2	2.0	12.8	6.9	0.3	1.5	0.1	1.5	0.8	3.4	1.7	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	5.7	8.8	0.3	0.0	0.6	4.4	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.2	5.1	0.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.1	3.1	0.0	0.1	55.9	0.4	0.9	14.7	6.5	1.1	1.8	0.1	0.3	0.7	5.8	0.0	0.0	0.1	0.0	1.7	34.5	43.6	0.2	0.4	0.1	0.3	0.0	1.1	0.3	0.3	1.5	0.0	12.8	0.0	0.3	6.9	5.9	0.0	1.5	0.0	0.1	0.6	6.8	0.0	0.8	18.5	14.7	11.4	16.2	15.2	10.3	20.6	14.3	14.5	18.4
GBF1	"ARF1GEF, KIAA0248"	ENSG00000107862	"Golgi brefeldin A resistant guanine nucleotide exchange factor 1"	Q92538	10	102245532-102382899	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037759, HPA037760"	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA037759: AB_10671884, HPA037760: "	"unprognostic (5.97e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.74e-3)"	"unprognostic (7.02e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.09e-2)"	19.8	21.8	15.8	19.5	27.2	27.4	19.2	32.6	35.8	22.0	22.7	21.0	29.6	21.2	26.4	21.7	21.7	20.0	18.9	24.0	15.8	15.6	21.7	29.1	20.3	16.6	16.3	17.3	23.2	24.7	43.2	39.0	31.2	22.3	24.2	26.1	26.1	36.7	23.4	43.0	25.9	24.8	25.4	17.4	22.3	20.6	34.8	14.7	24.9	26.2	21.3	28.4	21.4	20.1	4.9	7.0	7.3	8.0	3.9	7.7	4.2	7.7	17.1	14.1	12.1	31.4	22.0	10.5	18.0	25.6	19.9	23.8	17.9	16.3	9.1	11.6	26.2	16.4	20.7	23.2	20.8	15.1	15.3	13.9	17.6	13.0	11.7	16.5	22.3	19.2	12.7	27.1	27.0	19.0	8.8	24.1	18.4	13.1	10.5	10.8	5.8	11.5	13.9	33.7	7.2	18.1	12.4	6.1	6.7	12.8	8.1	8.6	23.3	9.1	26.5	13.1	11.3	16.0	20.4	14.5	11.1	10.1	13.8	16.0	7.9	7.3	5.5	4.0	7.7	8.0	6.6	4.9	5.3	7.3	7.0	4.0	4.8	5.7	4.1	3.9	5.1	3.4	6.9	4.2	15.8	27.2	32.6	35.8	15.8	15.6	16.3	17.3	22.3	14.7
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.5;HDLM-2: 25.9;RT4: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042682, CAB045975"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"				Nucleoplasm	"Actin filaments, Cytosol"	"CAB045975: AB_10584474, HPA042682: "	"prognostic favourable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavourable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favourable (1.10e-5)"	40.1	39.4	4.7	24.4	14.3	8.9	31.9	2.3	11.0	38.2	35.7	3.3	9.5	11.0	29.0	20.6	39.0	17.5	18.5	12.6	4.6	4.1	21.6	17.9	42.8	21.3	14.3	2.9	35.5	4.9	39.8	5.9	17.3	12.2	48.7	13.8	12.4	14.2	15.4	20.1	19.5	39.6	48.1	26.7	27.5	20.2	13.0	6.0	7.7	22.0	18.2	15.3	63.1	40.3	3.1	8.5	78.9	44.2	20.1	61.2	22.2	6.0	0.5	0.0	0.0	17.4	15.2	4.5	1.5	15.7	2.6	6.0	0.1	9.6	0.0	23.5	10.4	1.1	0.0	0.2	1.4	25.9	0.0	0.1	4.4	1.3	4.6	0.7	1.1	15.8	0.1	3.9	0.0	17.7	0.3	0.9	7.2	0.0	0.0	5.7	0.0	0.4	0.1	6.6	0.0	4.9	32.4	0.0	0.2	7.6	2.2	0.2	0.2	1.0	12.0	1.9	0.4	2.8	1.6	18.8	0.0	0.0	6.0	0.1	0.3	12.2	20.5	6.6	24.6	31.2	32.6	3.1	26.3	27.1	8.5	2.7	18.0	18.9	78.9	20.1	44.2	0.5	61.2	22.2	4.7	14.3	2.3	11.0	4.6	4.1	14.3	2.9	12.2	6.0
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181148-89198932	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.8;HDLM-2: 7.9;HEL: 10.4;REH: 8.8;RT4: 14.8;U-266/70: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"				"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favourable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	25.4	4.4	3.9	18.4	5.9	3.6	9.4	2.1	5.0	7.8	5.8	4.4	2.9	8.0	10.5	7.4	7.9	6.3	5.7	9.2	4.6	4.4	8.5	9.8	34.7	20.5	5.8	4.4	12.8	2.4	9.3	4.8	9.1	6.9	12.7	4.8	17.4	4.8	4.8	12.0	3.2	11.0	5.1	7.4	23.4	7.4	2.6	2.7	8.1	23.3	5.7	15.2	9.3	7.7	3.3	2.0	5.1	12.6	12.2	7.6	4.4	0.6	0.0	0.1	0.2	0.1	0.1	0.5	1.5	6.2	6.7	6.1	0.1	9.8	0.5	0.8	1.8	0.7	0.0	0.3	0.3	7.9	0.1	10.4	0.3	0.3	0.9	0.2	0.3	0.3	0.0	0.1	0.0	1.5	0.3	1.9	0.0	0.1	5.1	0.3	0.4	0.1	8.8	0.2	0.3	0.1	14.8	0.2	0.5	0.2	0.5	0.2	0.5	1.1	0.4	0.2	1.4	0.2	0.1	13.3	0.2	0.3	0.3	0.1	1.8	0.4	3.8	0.4	6.6	12.6	5.8	2.3	7.3	7.3	2.0	3.3	5.5	5.1	5.1	12.2	11.5	0.7	7.6	4.4	3.9	5.9	2.1	5.0	4.6	4.4	5.8	4.4	6.9	2.7
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 41.1;neutrophil: 112.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 112.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"			890000	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	13.1	6.8	13.4	24.8	21.3	116.0	7.8	6.9	15.8	6.0	7.7	15.3	3.2	8.2	4.6	11.0	5.0	7.2	9.7	11.2	15.9	13.0	8.5	7.6	15.6	51.8	26.0	9.7	4.4	11.5	4.8	8.1	10.6	24.6	5.7	8.6	3.7	6.9	4.9	2.2	3.7	7.8	7.7	30.2	50.0	10.3	10.7	20.8	5.8	7.4	2.5	10.3	10.0	6.3	3.1	8.9	112.7	18.2	0.3	1.3	8.4	1.3	2.1	5.8	0.0	1.4	1.2	0.2	2.1	6.1	3.4	6.2	4.8	16.3	1.9	15.0	0.1	0.8	2.2	6.9	4.2	9.1	9.2	17.1	1.5	9.1	1.7	21.4	5.0	1.5	2.4	3.1	0.7	0.4	0.3	6.6	0.2	16.8	0.4	12.4	3.7	8.3	7.4	1.4	9.6	17.9	9.6	3.8	6.5	2.8	12.6	10.6	8.6	9.6	0.4	0.8	6.2	9.7	3.2	6.3	11.7	0.3	5.3	8.4	4.0	4.4	18.2	41.1	0.4	10.7	0.5	3.0	0.6	0.6	8.9	3.1	1.1	0.7	112.7	0.3	8.0	2.2	1.3	8.4	13.4	21.3	6.9	15.8	15.9	13.0	26.0	9.7	24.6	20.8
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 81.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA020460	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"				Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	2.9	6.0	8.9	2.4	8.8	8.1	4.2	8.3	12.3	4.5	4.7	5.2	8.0	3.5	3.0	4.0	6.3	3.9	6.0	21.5	8.6	8.4	8.1	19.1	2.3	2.1	10.1	7.4	4.0	81.6	3.5	3.7	2.2	7.4	12.2	3.5	4.3	12.0	5.0	10.3	3.2	3.2	3.1	6.3	1.1	4.4	5.9	4.3	2.8	10.7	9.3	4.3	3.3	2.2	0.3	2.5	0.8	1.3	2.3	7.1	2.8	8.7	2.3	5.9	33.6	12.2	9.9	4.1	12.6	13.3	9.6	8.2	5.1	1.0	2.7	5.9	5.6	5.1	5.9	8.9	2.2	1.2	10.7	6.1	7.3	20.1	19.9	10.8	8.0	11.6	5.4	6.3	14.0	7.8	15.6	3.2	4.5	7.7	11.3	20.0	2.5	9.4	11.9	1.2	16.1	12.1	6.9	12.2	8.3	9.8	15.9	6.7	12.8	5.3	5.9	9.7	5.3	6.4	4.3	10.7	5.2	5.7	6.7	10.1	10.1	0.2	1.3	0.8	1.5	1.2	0.6	0.3	3.4	1.0	2.4	0.1	7.1	2.9	0.6	2.3	0.8	2.5	3.3	2.8	8.9	8.8	8.3	12.3	8.6	8.4	10.1	7.4	7.4	4.3
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580618-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	11.5	14.1	13.4	11.0	13.7	17.7	14.2	13.9	12.8	11.6	10.2	12.8	8.6	9.6	13.2	10.3	14.1	10.7	12.2	9.0	10.2	7.9	9.8	17.8	10.4	12.3	19.8	7.6	13.6	12.7	14.8	14.5	13.6	13.0	11.5	9.6	8.4	13.8	11.0	12.5	14.5	12.9	8.4	12.1	15.5	12.7	20.7	17.9	15.7	11.8	9.5	14.4	10.3	29.2	8.4	7.9	15.6	9.1	10.2	11.6	8.8	8.2	11.2	5.0	10.7	11.1	7.7	6.9	7.3	8.5	7.3	9.2	9.3	5.7	7.6	4.4	6.7	9.2	7.1	8.0	7.9	10.7	6.5	5.6	6.1	4.9	16.5	9.7	9.4	7.2	21.9	7.8	15.5	6.9	9.1	8.8	8.2	8.3	9.3	8.4	10.3	8.8	6.7	5.4	8.7	6.3	6.4	7.9	11.4	7.8	37.2	14.5	6.3	7.0	8.8	10.9	3.5	9.4	8.3	24.2	10.5	4.9	10.7	9.9	11.0	5.8	8.1	15.0	9.1	8.2	11.6	8.4	8.2	8.9	7.9	8.0	6.8	6.7	15.6	10.2	9.1	4.6	7.6	8.8	13.4	13.7	13.9	12.8	10.2	7.9	19.8	7.6	13.0	17.9
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108448561-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: "	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	10.9	10.6	12.0	15.2	21.6	20.5	13.1	5.0	16.8	11.9	13.6	3.9	26.7	13.4	10.9	32.0	9.5	12.4	13.2	8.0	9.3	5.8	12.8	8.3	14.2	13.0	7.8	15.6	17.6	13.1	11.5	24.3	8.6	15.0	14.6	13.6	4.3	14.9	32.3	9.6	9.3	18.1	8.4	11.4	11.7	18.1	15.5	10.5	11.1	13.8	6.1	10.0	16.3	11.3	14.3	17.6	20.3	8.8	7.9	23.0	4.5	7.5	5.8	7.6	2.7	5.6	13.5	13.2	10.5	12.4	4.0	6.7	11.2	9.3	8.8	12.5	7.2	6.2	4.3	7.4	8.5	10.7	7.5	11.9	9.8	7.4	6.2	15.4	8.7	14.2	7.1	10.4	8.8	6.9	15.2	7.2	7.5	4.6	6.4	8.0	12.2	7.6	6.5	8.9	8.2	4.6	12.6	7.9	9.0	11.8	8.7	9.0	4.4	5.0	11.9	8.2	12.4	7.8	4.0	9.5	16.7	10.5	9.2	3.9	5.1	20.1	5.2	13.7	15.4	4.6	14.9	14.3	16.9	16.0	4.0	13.6	23.0	19.7	20.3	7.9	8.8	17.6	12.3	4.5	12.0	21.6	5.0	16.8	9.3	5.8	7.8	15.6	15.0	10.5
GCDH	ACAD5	ENSG00000105607	"Glutaryl-CoA dehydrogenase"	Q92947	19	12891026-12914207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043252, HPA048492"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA043252: AB_2678390, HPA048492: AB_2680418"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.79e-3)"	"unprognostic (8.07e-3)"	"unprognostic (8.20e-3)"	"unprognostic (3.14e-2)"	"prognostic favourable (7.28e-5)"	"prognostic favourable (3.35e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.46e-2)"	"prognostic favourable (6.79e-8)"	"unprognostic (7.09e-3)"	"unprognostic (3.42e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.59e-1)"	12.5	12.1	11.4	8.6	13.3	8.2	9.5	11.5	14.0	9.5	10.5	15.5	8.6	9.1	11.7	7.3	9.1	10.5	7.5	19.8	9.3	8.0	20.2	62.6	6.3	12.1	15.5	14.1	13.7	12.3	7.9	8.7	4.9	9.7	10.4	6.9	9.6	14.7	9.7	17.5	6.6	8.1	8.2	8.7	8.6	11.3	4.9	11.8	13.0	10.9	13.7	9.0	12.0	6.6	10.9	14.5	7.2	8.1	21.7	20.6	12.3	11.2	6.2	6.7	12.4	9.9	4.9	6.2	8.4	5.0	9.8	7.4	11.5	4.8	16.3	15.8	4.6	7.1	9.3	7.2	4.9	14.0	9.9	10.4	10.9	14.1	11.3	19.6	8.3	6.3	9.0	6.9	7.5	8.4	25.3	5.1	4.8	12.3	23.0	17.2	7.6	16.2	22.0	6.9	31.6	5.7	5.1	14.9	9.0	11.8	10.3	7.2	8.0	13.0	5.9	8.0	6.0	14.8	8.0	27.3	13.8	17.1	5.6	22.5	6.9	7.2	8.1	4.6	11.7	7.1	11.6	10.7	15.0	13.7	14.5	10.9	20.6	15.5	2.0	21.7	5.3	8.6	12.5	12.3	11.4	13.3	11.5	14.0	9.3	8.0	15.5	14.1	9.7	11.8
GCFC2	"C2orf3, DNABF, GCF, TCF9"	ENSG00000005436	"GC-rich sequence DNA-binding factor 2"	P16383	2	75652000-75710989	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077882			Supported	Nucleoplasm				Nucleoplasm		"HPA077882: "	"unprognostic (1.98e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (9.59e-4)"	"unprognostic (5.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (3.09e-4)"	"unprognostic (6.07e-2)"	13.7	10.0	10.3	10.8	11.2	9.7	14.8	12.7	12.2	17.6	9.9	11.2	11.9	5.6	14.7	16.8	14.9	12.9	8.8	15.4	10.7	10.2	15.5	24.3	8.6	11.1	10.2	12.0	16.9	13.8	9.0	14.9	12.2	10.4	13.5	5.9	8.8	11.8	13.7	34.0	22.1	11.9	9.7	10.9	11.8	9.5	10.9	11.4	20.9	15.9	11.7	9.7	13.5	10.6	14.3	11.0	3.0	7.3	3.9	12.7	7.5	8.7	8.7	5.3	6.4	3.0	4.3	8.1	5.7	4.8	6.1	5.8	10.3	6.3	8.6	8.5	3.9	3.3	7.4	4.0	8.0	12.6	16.0	6.6	8.5	27.3	5.4	11.3	6.4	4.3	5.1	3.0	8.9	7.4	9.8	4.9	5.7	7.0	11.8	19.4	9.6	9.9	13.8	12.7	21.2	10.3	9.4	11.0	14.5	7.9	8.4	9.9	6.6	5.1	7.1	5.1	7.8	8.3	11.5	6.0	10.2	6.6	5.5	6.9	12.5	0.5	6.7	3.0	9.1	4.3	10.5	14.3	8.8	10.6	7.8	9.9	12.7	11.6	0.4	3.9	7.3	11.0	9.3	7.5	10.3	11.2	12.7	12.2	10.7	10.2	10.2	12.0	10.4	11.4
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902852	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.8;liver: 58.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;Daudi: 13.2;SH-SY5Y: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 15.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favourable (8.69e-4)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (6.67e-4)"	4.8	5.2	1.3	5.7	4.5	26.8	2.1	0.6	1.1	2.2	5.5	1.2	1.5	7.5	1.8	1.9	3.8	1.3	1.6	1.5	1.6	4.3	7.9	58.2	11.6	6.7	2.9	0.7	1.4	3.2	0.3	2.5	2.5	2.8	2.9	4.0	5.2	2.5	4.7	1.4	2.5	9.1	2.0	1.7	10.0	4.2	3.6	1.1	13.0	2.3	2.0	8.5	2.9	2.5	1.6	3.0	0.4	11.5	2.3	3.2	1.3	1.9	0.6	0.7	3.5	0.0	0.0	11.6	0.0	1.2	0.8	2.2	0.9	0.6	13.2	3.3	0.1	2.0	5.7	0.9	0.0	5.1	4.9	0.3	0.2	1.9	5.6	0.0	1.2	1.4	1.6	1.9	0.0	0.4	0.8	0.0	0.0	6.8	7.1	0.2	1.1	4.5	5.8	1.4	0.0	1.6	2.7	5.8	29.3	2.4	1.5	0.7	5.6	1.6	0.2	0.1	1.9	3.7	2.3	5.6	4.2	3.2	2.4	4.5	0.0	0.0	3.0	0.2	3.0	6.3	2.5	0.8	1.6	2.1	3.0	1.6	3.2	1.8	0.4	2.3	11.5	0.1	2.3	1.3	1.3	4.5	0.6	1.1	1.6	4.3	2.9	0.7	2.8	1.1
GCHFR	"GFRP, HsT16933"	ENSG00000137880	"GTP cyclohydrolase I feedback regulator"	P30047	15	40764020-40767710	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 32.0;RPTEC TERT1: 41.1;SCLC-21H: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebellum: 11.6;midbrain: 14.1;pons and medulla: 9.8"					HPA046258	Enhanced		Supported	Nucleoplasm			59000	Nucleoplasm		"HPA046258: AB_10967205"	"unprognostic (2.50e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"prognostic favourable (5.62e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.03e-3)"	"unprognostic (9.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.55e-1)"	9.0	4.9	3.8	6.6	6.0	7.9	37.6	9.7	5.0	7.2	16.5	1.5	0.9	18.3	2.0	2.7	13.4	5.1	6.2	8.1	4.6	4.1	16.3	73.4	16.4	10.5	2.8	2.3	7.1	3.9	1.5	5.1	4.7	8.8	5.0	3.4	6.5	6.0	1.7	1.9	7.3	31.7	1.3	3.1	3.5	4.4	3.4	1.3	10.3	5.0	4.0	12.6	4.4	6.1	13.0	25.4	27.1	21.0	33.1	38.6	27.0	0.1	2.1	1.7	9.3	2.7	0.9	4.7	0.6	2.2	1.0	2.1	24.4	13.8	12.4	8.8	0.5	1.7	4.5	0.8	0.2	9.7	7.6	12.2	18.5	32.0	2.2	7.9	4.2	2.3	1.1	0.4	0.1	4.0	6.1	3.8	0.3	4.5	2.1	16.2	4.5	15.9	17.5	0.1	7.6	41.1	6.5	36.8	0.5	5.5	26.3	2.8	7.1	8.1	0.0	0.1	0.3	0.6	0.1	0.2	1.6	7.6	1.4	17.7	1.1	4.3	21.0	27.1	22.7	6.4	38.0	13.0	20.1	21.0	13.6	9.6	20.8	13.5	3.3	33.1	5.6	25.4	38.6	27.0	3.8	6.0	9.7	5.0	4.6	4.1	2.8	2.3	8.8	1.3
GCN1	"GCN1L, GCN1L1, KIAA0219"	ENSG00000089154	"GCN1, eIF2 alpha kinase activator homolog"	Q92616	12	120127203-120194710	"Plasma proteins, Predicted intracellular proteins"	"Stress response, Translation regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018799, HPA019648, HPA024367"	Enhanced		Enhanced	Cytosol			40000	Cytosol		"HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569"	"unprognostic (7.36e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (1.87e-8)"	"unprognostic (5.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.43e-1)"	23.1	14.6	7.9	14.3	14.4	15.7	14.4	18.3	20.6	15.3	15.2	22.3	9.7	11.5	31.2	10.2	20.2	14.8	11.3	12.6	7.7	7.8	14.7	19.1	14.0	16.0	11.5	6.8	18.9	19.9	23.8	21.4	24.4	14.9	15.1	12.2	16.8	33.3	13.2	36.0	20.9	15.5	14.4	9.7	18.3	17.2	16.0	10.3	22.2	20.6	14.3	27.4	15.9	15.1	4.3	4.9	2.2	6.5	3.1	7.8	3.1	16.7	33.1	12.0	13.4	19.0	11.5	42.0	15.0	13.2	15.7	12.9	28.3	11.6	22.3	17.1	21.5	16.6	27.7	21.3	9.8	14.8	22.6	27.6	21.6	19.6	12.4	25.4	17.7	14.1	12.4	18.5	17.6	14.3	32.3	5.7	13.1	16.9	16.0	19.3	21.2	20.3	19.5	12.3	22.1	10.8	57.5	19.7	19.7	24.7	10.8	8.9	22.9	14.4	19.5	12.9	14.3	8.4	15.5	22.7	20.8	22.6	12.3	13.4	12.9	1.2	3.1	2.2	6.4	3.2	7.8	3.9	5.0	5.3	4.1	4.3	3.8	4.0	0.1	3.1	6.5	4.9	4.6	3.1	7.9	14.4	18.3	20.6	7.7	7.8	11.5	6.8	14.9	10.3
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1, core 2"	Q02742	9	76419850-76507416	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.0;parathyroid gland: 57.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 25.8;HSkMC: 21.9;U-2197: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"cerebellum: 8.2;olfactory region: 30.1"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"			72000	"Nuclear speckles"		"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (4.96e-4)"	5.6	1.1	1.6	7.9	3.9	2.2	8.2	10.9	2.7	5.3	24.5	0.7	3.0	23.2	5.2	1.2	2.1	1.8	4.1	3.1	2.1	1.4	1.4	1.0	4.5	9.2	1.6	2.1	0.9	2.0	57.8	1.9	3.9	1.0	4.9	4.6	0.5	9.1	1.8	0.8	1.5	32.0	2.5	1.2	7.6	18.6	1.4	0.6	2.8	16.9	1.2	6.4	2.4	3.3	9.4	4.7	16.8	6.4	4.7	1.9	1.6	2.4	0.2	0.1	0.0	3.1	14.9	3.6	10.0	4.5	8.1	5.8	2.5	0.6	1.7	1.0	7.4	2.1	5.0	4.1	9.1	1.2	0.8	4.2	0.2	0.4	25.8	3.1	1.4	21.9	1.1	7.9	8.5	7.4	0.0	1.7	8.1	3.7	1.6	5.0	4.7	0.6	2.8	5.0	0.8	9.5	4.4	1.0	0.0	1.2	1.3	0.0	0.0	2.1	3.0	5.1	3.3	18.3	4.4	2.6	0.4	0.0	10.3	5.3	1.2	4.3	2.7	16.8	1.3	6.4	0.4	1.3	1.5	1.3	4.7	9.4	0.2	1.0	0.9	4.7	5.7	2.3	1.9	1.6	1.6	3.9	10.9	2.7	2.1	1.4	1.6	2.1	1.0	0.6
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 26.2;Hep G2: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 54.8"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Supported	"Golgi apparatus"			560000	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	2.0	0.9	2.5	7.9	2.8	0.7	12.7	7.6	1.9	6.0	13.0	2.0	0.9	7.8	5.6	1.3	3.7	1.7	2.8	11.8	2.2	2.4	19.6	14.3	10.4	3.3	2.4	0.4	0.9	5.5	1.0	6.2	3.1	4.0	21.9	3.7	8.1	7.4	0.9	2.3	2.5	25.1	2.6	2.2	4.2	8.3	9.0	2.9	0.9	2.4	1.2	7.2	2.0	3.0	2.1	2.5	4.2	3.1	0.5	0.4	0.7	4.2	3.5	1.2	2.9	0.0	0.0	3.5	0.0	3.1	0.8	0.2	6.2	3.1	2.4	26.2	0.0	0.1	0.3	3.2	1.8	1.6	0.9	0.5	1.8	10.9	0.0	1.1	2.9	0.0	0.0	0.3	0.0	6.9	0.3	0.0	0.3	0.0	0.0	2.2	3.9	2.4	0.1	2.4	3.8	9.3	2.3	2.6	1.8	0.0	9.2	8.8	0.1	0.4	5.9	0.5	0.4	0.0	3.4	0.0	0.0	1.7	0.5	0.2	1.4	4.2	3.1	1.3	0.3	2.3	0.1	2.1	0.3	0.4	2.5	1.3	0.4	0.4	0.2	0.5	0.8	0.6	0.2	0.7	2.5	2.8	7.6	1.9	2.2	2.4	2.4	0.4	4.0	2.9
GCNT4	C2GNT3	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4, core 2"	Q9P109	5	75025346-75030899	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.6;intestine: 13.1;stomach 1: 10.4"	"Cell line enriched"	"Detected in some"	5	"RT4: 26.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Group enriched"	"Detected in many"	54	"granulocytes: 13.6;T-cells: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favourable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.6	0.6	0.3	1.0	0.7	0.0	0.9	0.0	2.3	1.1	1.1			13.1	1.4	0.6	1.3	1.1	2.5	0.3	0.3	0.1	1.8	0.4	1.0	1.7	0.1		0.9	3.0	8.4	0.1	3.0		1.0	0.2		0.5	2.4	1.0	1.5	10.8	0.7	0.0	0.6	10.4	1.0			0.5		1.1	6.4	2.0	0.0	0.0	13.6	0.1	0.2	11.6	1.6	0.2	0.1	1.0	1.6	1.8	0.6	0.1	2.0	5.2	1.0	0.9	2.5	0.1	0.0	0.2	1.5	0.7	1.0	1.8	0.2	0.0	0.0	0.8	0.2	0.2	0.8	0.0	0.0	0.3	2.9	0.1	0.3	0.0	0.0	0.3	0.1	0.0	1.4	0.0	0.4	0.0	0.0	0.0	2.6	0.2	26.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	13.6	0.0	0.0	0.9	0.0	3.5	0.0	8.1	2.6	0.0	0.0	8.1	5.9	0.1	0.2	0.1	0.0	11.6	1.6										
GDAP1	"CMT2K, CMT4, CMT4A"	ENSG00000104381	"Ganglioside induced differentiation associated protein 1"	Q8TB36	8	74321130-74488872	"Disease related genes, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.3"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014266, HPA024334"	Enhanced		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA014266: AB_1849581, HPA024334: AB_1849583"	"unprognostic (3.19e-2)"	"unprognostic (1.52e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.72e-2)"	"prognostic favourable (2.68e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.17e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.99e-2)"	"prognostic unfavourable (4.54e-4)"	"unprognostic (2.73e-1)"	2.8	11.2	19.2	3.8	25.9	2.1	5.6	24.9	48.3	3.2	2.9	7.6	1.1	3.2	5.4	5.7	5.3	3.7	3.4	2.8	17.6	21.4	5.3	2.0	3.2	3.7	16.5	19.2	8.2	10.8	12.3	16.4	2.3	23.3	5.6	3.6	3.7	2.9	5.4	2.6	2.1	3.0	3.9	14.6	2.9	3.2	5.4	9.6	0.7	7.5	0.5	3.4	3.8	1.8	2.7	1.7	2.8	7.2	1.9	4.6	1.4	2.3	7.7	11.9	2.7	1.0	0.9	1.1	1.0	5.6	6.0	6.9	4.0	2.7	9.1	1.4	1.3	3.9	6.4	3.9	11.8	7.9	2.0	4.8	4.3	7.8	1.3	3.9	9.8	2.8	1.3	2.9	6.1	0.7	2.3	0.1	3.6	2.9	7.9	0.6	13.7	10.5	4.0	5.6	1.7	2.0	7.2	11.7	28.7	7.0	2.6	5.9	11.8	1.3	0.1	8.8	4.1	2.0	2.8	6.0	5.6	4.4	4.0	0.2	9.2	0.0	1.7	2.8	1.5	4.3	1.8	2.7	1.6	1.9	1.7	1.9	1.3	1.6	0.0	1.9	7.2	0.0	4.6	1.4	19.2	25.9	24.9	25.8	17.6	21.4	16.5	19.2	23.3	9.6
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 463.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 70.7;Hep G2: 36.4;HHSteC: 98.3;TIME: 35.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"pons and medulla: 6.5"	"Cell type enhanced"	"Detected in some"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.3;monocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	1258667	890000	"Golgi apparatus"		"CAB062554: , HPA011191: AB_1078962, HPA070957: "	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	13.4	2.2	0.4	1.0	0.6	0.0	13.1	0.4	0.5	3.9	13.0	1.0	1.9	1.8	5.9	1.9	2.4	1.1	13.1	1.2	0.5	0.0	64.7	24.1	12.6	0.8	0.4	0.5	2.9	21.9	0.3	2.4	463.0	6.5	25.5	11.0	1.6	2.4	5.1	13.6	1.1	1.8	4.8	1.2	1.4	12.0	2.5	0.4	0.4	5.2	0.5	0.8	47.0	2.7	0.2	0.8	6.3	2.3	0.0	0.0	0.3	0.3	15.8	1.5	0.5	3.8	3.2	70.7	5.5	3.0	0.2	3.2	0.7	4.9	0.0	10.0	0.4	0.1	0.0	2.0	0.8	0.0	0.3	0.2	1.5	36.4	98.3	0.0	6.1	8.4	23.8	15.4	10.0	16.7	24.3	0.1	3.8	3.8	0.0	0.1	0.9	8.9	0.0	0.6	0.0	11.7	15.6	0.1	0.1	0.0	0.9	19.8	0.4	0.0	35.3	0.0	1.3	0.3	0.2	0.2	0.6	0.0	8.9	0.0	4.6	0.0	1.8	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.3	0.4	0.6	0.4	0.5	0.5	0.0	0.4	0.5	6.5	0.4
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142330-96160792	"Disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.8;placenta: 16.9"	"Cell line enriched"	"Detected in some"	8	"LHCN-M2: 26.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"			Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	2.5	0.2	1.4	1.5	0.9	0.0	0.8	0.1	1.7	0.3	1.4	0.3	1.5	0.6	3.0	0.7	0.8	1.0	6.6	11.8	0.9	1.0	0.4	0.7	0.4	1.9	0.9	0.1	2.2	1.3	0.1	0.3	16.9	1.1	0.6	0.5	2.9	0.1	2.7	0.8	0.0	1.6	1.8	0.2	0.1	1.4	1.1	1.1	0.1	1.4	0.1	0.1	3.2	2.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.5	3.2	2.1	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	26.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.9	0.1	1.7	0.9	1.0	0.9	0.1	1.1	1.1
GEMIN2	SIP1	ENSG00000092208	"Gem nuclear organelle associated protein 2"	O14893	14	39114223-39136973	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015426, HPA046570, HPA057114"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB015426: AB_629517, HPA046570: , HPA057114: "	"unprognostic (4.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (3.88e-6)"	"unprognostic (8.62e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.78e-2)"	10.0	8.2	13.2	8.1	16.9	15.2	13.3	15.7	15.2	10.1	9.5	10.9	5.2	11.4	9.3	12.5	10.2	9.9	7.2	12.4	13.8	10.1	8.2	9.2	9.1	14.1	11.0	13.8	11.3	8.5	4.3	16.1	9.0	13.4	8.4	10.9	8.9	7.7	7.7	18.9	10.4	8.0	12.6	12.4	9.5	8.4	13.2	12.8	11.9	9.8	9.9	13.3	11.3	9.6	17.1	15.8	8.9	12.6	11.6	15.5	8.7	11.4	16.5	16.3	11.9	5.7	6.7	8.4	5.5	4.4	14.7	14.7	14.4	13.6	17.0	11.5	4.7	8.8	21.8	9.3	15.5	8.7	12.7	9.9	10.1	35.8	11.7	15.0	6.5	3.6	8.9	9.3	13.4	12.8	11.8	12.5	8.2	22.8	16.4	14.5	11.4	18.6	15.4	17.8	10.7	8.2	7.6	16.0	3.2	11.5	8.9	6.0	20.3	6.6	5.2	6.8	10.1	6.6	8.9	13.1	20.3	24.9	3.3	16.0	9.5	8.1	12.3	8.9	14.3	12.6	10.1	15.4	13.2	14.0	15.6	17.1	14.9	15.5	3.4	11.6	10.4	15.8	11.4	8.7	13.2	16.9	15.7	15.2	13.8	10.1	11.0	13.8	13.4	12.8
GEMIN4	"DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97"	ENSG00000179409	"Gem nuclear organelle associated protein 4"	P57678	17	744414-753999	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065699, HPA067891"	Uncertain		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA065699: , HPA067891: "	"unprognostic (1.85e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.56e-3)"	10.8	6.5	6.4	5.9	5.1	10.5	10.1	15.0	7.2	11.1	6.9	5.4	11.3	6.1	10.5	5.9	12.0	9.5	9.9	9.1	5.5	3.3	5.4	9.9	8.0	12.8	5.8	4.0	13.5	8.5	4.1	5.2	7.6	5.4	11.2	5.0	6.8	9.1	8.8	10.5	29.5	7.6	8.7	4.2	11.4	10.7	36.7	6.5	20.5	20.1	8.7	11.4	10.4	9.9	11.7	8.3	1.5	9.6	6.9	13.4	8.4	18.6	33.1	11.1	16.6	7.1	8.9	13.8	10.7	7.5	19.4	17.3	18.8	10.1	32.8	14.3	9.2	23.7	20.9	20.1	15.6	12.3	31.1	11.8	17.6	10.5	5.0	12.4	16.2	8.6	10.2	15.9	11.3	10.9	16.3	13.8	10.3	13.2	20.4	7.0	10.7	14.3	22.2	5.3	15.4	8.3	13.8	11.5	9.3	11.0	11.3	5.0	12.0	9.1	8.6	12.0	10.9	15.5	25.8	2.3	5.0	18.8	10.3	17.6	13.7	1.5	6.1	0.3	7.6	8.5	13.4	11.6	8.2	8.0	8.3	11.7	10.0	9.8	0.8	6.9	9.6	4.8	5.5	8.4	6.4	5.1	15.0	7.2	5.5	3.3	5.8	4.0	5.4	6.5
GEMIN5		ENSG00000082516	"Gem nuclear organelle associated protein 5"	Q8TEQ6	5	154887416-154938209	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037392, HPA037393"	Uncertain		Enhanced	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA037392: , HPA037393: AB_10672489"	"unprognostic (1.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.41e-3)"	"prognostic unfavourable (6.23e-5)"	"unprognostic (5.44e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.40e-3)"	"unprognostic (5.01e-2)"	17.7	10.5	9.4	13.8	13.2	6.4	17.0	11.2	11.7	12.9	10.8	16.5	12.1	7.0	14.4	10.2	11.3	13.2	8.6	14.8	9.5	10.4	10.3	12.3	9.5	14.9	14.0	10.5	18.3	15.4	17.1	15.1	9.9	10.4	12.8	10.1	9.1	10.4	13.3	23.0	15.3	8.6	14.6	11.4	11.0	9.6	13.8	12.5	19.7	11.9	11.0	14.5	12.4	10.9	6.1	4.6	2.9	4.0	4.5	7.3	3.4	8.6	12.9	8.4	19.3	9.0	7.7	10.8	8.4	5.1	14.8	11.0	21.2	7.8	22.8	10.7	8.0	9.2	24.8	15.4	20.3	4.5	11.6	13.8	8.4	12.7	5.0	24.0	8.1	5.8	7.2	20.5	12.3	12.0	21.8	5.6	11.0	11.8	12.9	9.6	11.7	10.1	16.8	16.4	19.0	6.2	5.9	11.0	7.6	9.7	10.9	6.8	12.8	5.5	7.3	13.4	9.6	10.0	18.9	5.6	8.6	17.9	5.7	19.8	11.7	0.0	3.1	2.9	4.5	4.0	7.3	6.1	4.2	4.3	4.6	5.0	6.3	6.6	0.3	4.5	3.9	3.4	3.9	3.4	9.4	13.2	11.2	11.7	9.5	10.4	14.0	10.5	10.4	12.5
GEMIN6	FLJ23459	ENSG00000152147	"Gem nuclear organelle associated protein 6"	Q8WXD5	2	38751534-38785000	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035726, HPA035727"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA035726: AB_10669528, HPA035727: "	"unprognostic (1.97e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-2)"	9.2	17.0	10.8	12.8	11.7	4.8	12.0	8.2	13.1	9.3	10.2	8.4	8.1	12.7	12.0	15.5	11.8	13.2	8.1	8.1	9.6	10.5	17.7	21.0	8.1	13.9	9.9	11.0	14.8	18.8	9.2	11.7	10.5	9.7	9.2	12.6	8.5	11.0	8.0	15.8	7.7	10.7	12.5	11.9	12.9	11.1	29.2	13.1	12.7	13.5	11.0	16.9	10.6	9.3	20.5	14.8	4.6	17.1	15.0	18.4	12.9	18.2	14.9	10.5	12.2	13.7	12.1	18.0	15.6	7.9	13.9	11.6	15.8	8.8	25.1	18.1	8.0	8.7	16.3	15.2	20.3	21.5	20.6	16.3	8.9	25.7	9.4	13.5	8.5	8.2	11.2	18.5	9.3	14.5	16.6	8.8	13.8	12.9	16.3	17.4	18.0	18.0	11.3	18.5	13.7	12.5	6.5	13.2	20.8	4.0	15.2	11.7	7.8	4.7	7.9	13.5	17.2	10.5	23.3	18.1	35.3	24.4	10.9	20.6	13.4	1.6	15.5	4.6	13.0	17.1	14.2	20.5	13.4	13.2	14.8	18.9	16.5	17.0	2.4	15.0	15.2	10.9	18.4	12.9	10.8	11.7	8.2	13.1	9.6	10.5	9.9	11.0	9.7	13.1
GEMIN7	FLJ13956	ENSG00000142252	"Gem nuclear organelle associated protein 7"	Q9H840	19	45079195-45091524	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052075			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA052075: "	"unprognostic (3.32e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.00e-2)"	"prognostic unfavourable (5.86e-5)"	"unprognostic (7.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (9.64e-11)"	"unprognostic (7.01e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.83e-1)"	"prognostic favourable (8.00e-4)"	9.7	10.6	8.9	13.0	12.2	18.3	12.3	22.1	19.0	8.1	13.6	10.0	8.2	18.9	10.0	8.7	18.5	9.0	9.6	13.3	9.8	9.7	12.4	20.2	10.3	21.6	10.0	9.0	8.5	24.1	6.1	20.4	12.9	12.8	11.9	13.2	12.7	16.8	9.5	20.7	14.7	16.5	9.7	6.9	24.3	17.4	5.3	10.5	12.8	12.5	14.7	17.1	13.1	11.7	28.4	22.9	15.2	14.3	29.6	32.0	18.9	20.7	27.7	16.2	19.9	12.4	13.0	12.6	16.0	11.8	24.6	27.4	16.8	13.4	20.9	11.1	13.8	13.0	23.5	19.0	14.9	16.6	30.6	23.0	12.7	21.8	17.4	18.3	13.8	19.4	15.7	13.7	9.9	23.9	24.0	21.9	9.6	30.7	17.5	19.0	15.2	14.4	21.1	7.5	27.0	18.6	15.4	16.2	11.3	12.5	27.2	14.1	18.3	19.7	12.8	9.1	17.4	5.9	21.0	22.8	33.6	33.3	14.6	18.5	14.6	10.7	14.3	15.2	32.0	11.5	30.2	28.4	23.6	29.4	20.1	23.7	18.3	23.8	7.9	29.6	8.3	22.9	19.8	18.9	8.9	12.2	22.1	19.0	9.8	9.7	10.0	9.0	12.8	10.5
GEMIN8	"FAM51A1, FLJ20514"	ENSG00000046647	"Gem nuclear organelle associated protein 8"	Q9NWZ8	X	14008279-14029893	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028613	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028613: AB_10602905"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (7.78e-5)"	"unprognostic (3.87e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.75e-2)"	"prognostic favourable (7.73e-5)"	13.4	13.5	14.5	12.9	17.0	12.0	19.9	12.3	20.0	16.5	13.9	24.0	27.3	9.0	21.5	16.9	13.2	22.8	16.4	15.5	14.8	14.0	16.7	12.9	14.5	16.0	16.6	14.7	28.9	22.2	18.7	27.4	10.3	21.0	13.1	11.9	16.8	24.7	30.2	7.6	15.7	10.0	17.1	23.3	12.5	13.6	8.2	12.7	14.6	21.3	7.9	13.2	12.7	13.0	11.3	15.4	0.8	6.9	9.9	15.2	7.5	6.3	6.3	7.5	1.8	12.2	18.7	3.7	5.9	6.6	5.2	3.6	3.3	11.0	14.8	14.2	4.8	8.5	4.6	10.4	5.0	7.9	9.5	3.8	4.7	7.4	7.1	9.0	8.0	15.0	17.2	9.0	15.7	11.2	6.6	13.1	7.8	8.5	9.0	14.1	8.1	3.7	13.8	5.2	26.3	8.7	6.2	7.4	20.5	6.3	11.9	7.0	16.3	9.0	8.5	3.8	2.2	11.1	2.4	8.9	4.4	9.3	8.8	5.5	2.2	0.6	6.7	0.2	9.4	6.4	11.6	11.3	15.2	8.9	12.2	9.8	13.1	9.8	0.8	9.9	6.9	15.4	8.4	7.5	14.5	17.0	12.3	20.0	14.8	14.0	16.6	14.7	21.0	12.7
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Golgi to ER traffic protein 4"	Q7L5D6	7	876552-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	13.7	39.8	22.4	14.8	21.4	28.5	15.3	22.1	23.5	10.3	15.5	20.9	19.0	21.8	12.3	23.8	18.8	14.6	12.8	18.7	16.4	15.4	27.8	37.5	12.2	15.1	22.9	21.5	16.5	32.6	11.3	32.9	21.7	18.9	16.8	9.9	15.2	25.0	21.9	53.7	29.7	20.9	12.6	18.9	16.9	22.2	32.0	22.7	12.5	16.0	21.8	12.5	14.3	17.3	23.3	31.5	28.9	30.7	24.9	27.3	21.9	26.0	12.8	9.0	13.3	4.6	3.2	28.5	7.3	5.1	9.3	9.3	34.9	32.6	9.6	7.6	4.1	16.6	10.1	7.9	4.0	3.9	17.3	5.3	10.1	19.7	10.3	9.0	9.8	4.9	9.5	8.1	5.3	7.3	34.1	8.9	5.2	19.8	6.8	21.7	32.3	19.3	14.4	1.5	10.3	8.2	15.4	16.3	17.6	6.7	24.6	10.5	18.7	16.0	7.3	6.9	15.4	15.8	9.9	13.5	8.4	12.4	7.1	15.5	17.3	16.8	27.4	28.9	24.2	24.7	23.7	23.3	26.5	24.0	27.7	23.2	26.0	27.3	21.1	24.9	30.7	31.5	24.5	21.9	22.4	21.4	22.1	23.5	16.4	15.4	22.9	21.5	18.9	22.7
GFAP	FLJ45472	ENSG00000131095	"Glial fibrillary acidic protein"	P14136	17	44903161-44916937	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"brain: 595.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 9.5"	"Cancer enriched"	"Detected in some"	368	"glioma: 2468.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000039, HPA056030, HPA063513"	Enhanced	Supported	Supported	"Intermediate filaments"			220000000	"Intermediate filaments"		"CAB000039: AB_10013382, HPA056030: , HPA063513: "	"unprognostic (1.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.12e-5)"	"unprognostic (4.08e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.35e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.75e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	3.0	2.9	122.2	3.2	105.4	5.8	3.0	33.9	595.5	2.7	3.0	171.0	0.0	2.8	2.9	3.0	3.6	3.2	3.1	4.0	143.0	175.1	3.0	2.8	3.0	3.1	227.0	67.3	3.0	3.0	3.4	1.3	2.8	212.7	3.0	2.9	0.0	3.1	2.9	3.2	3.3	2.8	2.9	482.0	3.0	3.0	2.9	119.0	0.0	3.0	0.0	2.9	3.4	0.0	1.1	0.8	9.8	1.2	2.9	0.8	0.3	1.7	1.1	2.0	3.8	0.0	0.8	0.5	1.7	2.0	2.4	2.0	2.1	2.4	3.5	3.1	0.9	4.3	2.2	0.7	3.0	4.3	1.9	2.8	2.9	1.4	0.1	0.8	4.2	0.2	1.3	1.7	0.0	0.0	1.3	8.3	0.6	2.2	2.9	4.1	2.7	5.2	1.2	1.2	2.8	1.1	1.5	2.7	2.9	0.5	3.4	0.3	2.2	2.2	1.2	2.1	1.6	1.9	2.5	1.2	2.3	2.7	9.5	3.4	3.3	1.9	1.2	0.5	0.5	1.1	0.4	0.4	0.5	0.7	0.3	1.1	0.6	0.8	9.8	2.9	0.7	0.8	0.4	0.3	122.2	105.4	33.9	69.4	143.0	175.1	227.0	67.3	212.7	119.0
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984207-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Intracellular and membrane"			"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: "	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	9.7	12.2	9.7	15.2	9.9	10.7	14.8	15.2	12.5	8.1	24.8	10.8	15.2	29.6	10.1	10.2	11.0	10.2	16.1	17.8	9.8	9.7	13.7	33.5	17.1	18.1	10.7	9.7	9.4	43.8	19.2	10.9	18.0	8.0	11.9	18.0	10.5	22.5	12.5	27.5	8.3	33.2	9.2	9.6	15.2	12.8	20.0	7.8	7.7	15.1	15.0	11.4	12.4	17.1	16.1	9.1	9.8	12.7	7.8	17.7	7.7	11.3	18.1	14.9	12.1	6.3	12.6	19.3	13.2	12.9	18.6	15.2	26.0	19.0	6.4	18.0	9.8	17.1	11.3	17.4	11.8	19.7	23.1	8.8	17.8	29.5	11.4	12.7	16.6	8.1	13.5	16.2	14.6	8.7	13.7	21.4	13.5	26.7	14.5	13.8	23.8	18.1	31.8	11.4	20.7	18.9	8.9	13.1	12.5	17.8	38.0	14.1	18.1	13.6	8.1	18.1	20.2	10.1	22.6	36.3	19.6	18.3	6.0	8.7	15.2	3.1	12.6	9.8	9.2	10.5	9.9	16.1	12.6	15.6	9.1	13.4	11.5	7.9	1.1	7.8	12.7	4.0	17.7	7.7	9.7	9.9	15.2	12.5	9.8	9.7	10.7	9.7	8.0	7.8
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 71.0;bone marrow: 29.2"	"Group enriched"	"Detected in some"	5	"HEL: 54.3;HMC-1: 35.2;K-562: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"basophil: 31.2;eosinophil: 71.0"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 71.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004420, HPA006291"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.2	0.0	0.2	2.2	0.2	29.2	0.1	0.1	0.2	0.9	4.2	0.2	0.0	0.8	0.4	0.7	0.8	0.2	3.5	0.8	0.2	0.1	0.3	0.4	2.5	0.0	0.1	0.0	0.1	0.2	0.0	0.1	1.2	0.0	4.2	0.3	0.2	0.1	0.1	0.3	0.8	6.3	1.0	0.2	3.3	0.3	4.0	0.0	1.0	0.2	0.0	0.5	0.4	0.2	0.0	0.3	71.0	2.7	0.1	0.1	2.4	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.1	7.6	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	54.3	0.1	0.0	0.0	0.0	35.2	0.0	0.6	0.0	0.1	0.0	16.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	31.2	0.0	71.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.1	2.7	0.1	0.0	2.4	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719421	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favourable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favourable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	9.0	9.4	9.6	7.7	13.8	13.4	8.6	42.9	18.9	10.7	10.6	5.0	9.4	10.7	8.1	5.9	21.8	12.2	8.4	6.8	10.1	12.4	9.8	24.4	7.9	6.9	8.2	11.1	5.6	9.0	14.1	11.7	19.4	10.8	7.4	8.7	6.4	8.7	7.2	6.5	14.1	8.1	8.6	5.7	12.8	7.5	8.3	5.1	6.1	9.7	13.2	12.8	9.0	16.4	9.1	6.5	10.6	5.5	6.4	10.2	4.1	9.3	15.1	9.3	19.1	9.4	7.1	10.9	7.8	10.0	14.6	14.9	12.8	8.5	15.7	7.3	9.0	11.8	9.5	8.9	12.4	9.4	11.7	4.0	8.0	18.3	7.2	6.5	7.8	5.9	10.4	19.2	5.8	20.9	8.2	3.1	8.1	19.8	10.5	7.7	12.6	8.2	17.0	5.4	12.2	8.9	13.2	19.0	11.1	19.2	6.5	5.9	9.8	4.3	16.1	11.3	11.3	10.0	7.6	8.0	11.2	17.1	7.0	9.5	8.1	0.7	5.5	5.7	5.6	3.5	9.0	8.0	9.5	9.6	5.6	9.1	8.4	6.6	10.6	6.4	3.4	6.5	10.2	4.1	9.6	13.8	42.9	18.9	10.1	12.4	8.2	11.1	10.8	5.1
GFPT2	GFAT2	ENSG00000131459	"Glutamine-fructose-6-phosphate transaminase 2"	O94808	5	180300690-180353387	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 65.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.0;ASC TERT1: 41.2;HSkMC: 26.4;hTEC/SVTERT24-B: 49.0;U-87 MG: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 7.1"	"Lineage enriched"	"Detected in single"	49	"T-cells: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056892, HPA059910"	Uncertain		Supported	Vesicles				Vesicles		"HPA056892: , HPA059910: "	"unprognostic (3.48e-1)"	"prognostic unfavourable (9.09e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (3.05e-1)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (2.58e-14)"	"unprognostic (3.67e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (1.52e-3)"	65.6	3.9	4.5	15.8	5.6	0.9	11.0	17.0	9.2	10.0	9.2	9.3	5.4	2.1	9.0	16.7	5.9	15.9	14.6	16.4	7.1	3.8	2.8	2.6	11.0	3.1	6.2	6.8	17.5	11.1	3.5	2.5	6.0	8.4	7.7	3.6	2.9	4.0	8.0	6.0	4.0	5.0	10.0	17.2	1.7	6.6	6.3	7.7	0.0	5.6	5.4	3.5	14.3	14.6	0.0	0.1	0.0	0.0	0.1	7.1	0.2	0.0	5.3	4.2	5.4	24.0	41.2	0.4	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.2	4.4	0.0	2.3	0.0	0.2	0.5	0.8	0.0	2.6	0.0	10.0	0.0	0.0	26.4	0.2	49.0	0.1	7.9	0.0	0.0	21.0	0.7	0.0	0.0	9.0	2.4	0.1	0.0	0.0	0.0	0.0	0.2	0.3	8.3	0.1	0.3	0.3	0.0	3.7	13.5	2.1	8.7	9.9	0.0	0.0	0.0	85.2	0.0	0.3	0.0	0.0	0.0	1.4	0.0	7.1	0.0	0.8	2.4	0.1	0.0	0.8	1.1	0.0	0.1	0.0	0.1	0.0	0.2	4.5	5.6	17.0	9.2	7.1	3.8	6.2	6.8	8.4	7.7
GGA1		ENSG00000100083	"Golgi associated, gamma adaptin ear containing, ARF binding protein 1"	Q9UJY5	22	37608475-37633564	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048280, HPA051016"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA048280: , HPA051016: "	"unprognostic (1.64e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (4.86e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.16e-3)"	10.7	15.8	13.5	12.2	14.0	17.3	10.8	21.8	18.4	11.6	10.6	19.3	14.5	13.1	12.9	14.1	13.3	13.8	11.8	10.2	12.5	10.6	12.0	14.1	10.9	14.0	17.7	13.2	18.1	13.9	20.6	19.4	12.5	13.5	12.0	9.6	17.7	16.7	16.7	17.1	17.1	12.0	9.3	14.2	15.8	12.8	83.8	16.6	12.1	15.4	9.9	14.2	10.6	11.0	6.4	5.0	4.9	7.7	7.6	18.0	7.6	18.2	12.8	16.0	15.6	14.1	11.6	17.6	15.1	12.1	13.3	14.8	11.3	10.4	28.0	10.3	10.8	17.0	14.2	16.8	12.2	23.9	23.6	11.1	22.9	12.1	13.7	27.2	21.6	14.0	15.0	18.9	12.0	12.5	22.3	18.2	13.7	17.4	12.1	29.2	12.6	13.2	13.4	12.9	12.0	13.7	14.8	14.8	26.2	9.6	20.2	23.3	21.0	19.8	14.9	18.2	17.8	16.4	12.0	39.3	15.7	29.0	20.4	16.5	15.9	4.9	7.7	4.3	14.0	7.6	17.3	6.4	5.6	18.0	5.0	4.1	4.2	13.0	3.3	7.6	5.5	4.3	5.8	7.6	13.5	14.0	21.8	18.4	12.5	10.6	17.7	13.2	13.5	16.6
GGA2	"KIAA1080, VEAR"	ENSG00000103365	"Golgi associated, gamma adaptin ear containing, ARF binding protein 2"	Q9UJY4	16	23463542-23521995	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 50.3;U-698: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034422, HPA043313, HPA063634"	Approved		Enhanced	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"CAB034422: AB_2110748, HPA043313: , HPA063634: "	"unprognostic (1.27e-1)"	"prognostic favourable (1.71e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.91e-2)"	"prognostic favourable (9.70e-5)"	"unprognostic (1.68e-1)"	"prognostic favourable (1.68e-4)"	"unprognostic (7.82e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.55e-2)"	"prognostic favourable (3.91e-5)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.08e-1)"	16.4	25.7	9.0	39.7	13.8	20.0	13.7	26.0	14.8	15.0	11.1	7.5	18.5	6.7	16.2	15.1	13.9	12.6	13.0	13.1	8.5	9.9	18.7	13.4	21.9	42.4	7.3	10.1	25.1	37.2	25.5	18.9	14.5	9.7	18.7	11.1	37.6	35.2	24.1	18.3	13.8	22.4	10.6	7.6	31.8	16.0	11.1	6.9	26.0	28.3	12.8	52.4	15.3	13.1	15.3	12.9	5.3	3.5	2.6	3.8	2.3	5.9	7.5	10.1	9.3	6.4	7.1	8.6	7.1	7.0	5.6	6.5	10.0	6.0	50.3	10.5	7.5	9.5	17.4	8.9	7.2	8.0	15.4	9.5	9.5	16.7	5.6	15.3	6.0	6.5	8.7	6.9	4.0	7.1	16.0	7.6	6.9	9.8	5.7	10.0	13.9	6.6	33.9	13.4	14.1	9.0	8.3	7.8	9.2	6.0	9.7	8.9	8.3	19.1	7.6	6.2	6.7	7.0	6.4	14.7	13.1	52.8	6.2	10.8	7.1	0.1	3.2	5.3	2.8	3.5	3.0	12.9	3.4	3.3	4.0	15.3	3.6	3.8	0.5	2.6	3.0	12.9	3.2	2.3	9.0	13.8	26.0	14.8	8.5	9.9	7.3	10.1	9.7	6.9
GGA3	KIAA0154	ENSG00000125447	"Golgi associated, gamma adaptin ear containing, ARF binding protein 3"	Q9NZ52	17	75236599-75262363	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022945, HPA024645"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA022945: AB_1849639, HPA024645: "	"unprognostic (9.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (8.26e-4)"	"unprognostic (1.20e-1)"	"unprognostic (4.60e-3)"	"prognostic unfavourable (2.77e-6)"	"unprognostic (6.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (3.41e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.68e-3)"	14.0	12.0	18.4	16.8	23.0	16.1	13.2	19.2	30.9	15.1	15.4	16.6	9.5	12.2	14.6	9.1	20.0	13.5	15.1	13.7	16.4	11.4	13.6	14.0	17.2	19.5	16.7	14.7	20.0	14.9	19.8	14.5	18.2	20.3	12.6	16.0	14.9	15.5	11.6	26.4	18.5	17.7	15.3	12.7	24.6	15.2	16.7	15.8	20.8	12.7	8.4	24.3	14.8	14.2	9.0	10.8	11.7	11.1	12.8	9.4	9.3	10.8	10.2	11.9	6.4	15.5	11.9	14.1	11.4	10.7	15.8	13.5	14.0	10.3	12.7	5.3	9.7	7.4	12.7	6.3	20.9	10.4	14.6	21.3	11.7	10.8	7.8	18.4	16.4	8.7	11.4	10.7	17.4	20.2	20.6	9.7	11.6	9.0	26.7	4.3	9.9	9.9	10.3	15.4	10.0	10.3	12.5	7.8	13.7	12.6	21.0	9.6	14.5	10.8	17.7	13.7	10.4	10.3	11.4	13.0	10.2	17.3	12.7	13.9	10.4	5.5	11.1	4.5	9.4	10.0	8.5	6.8	8.7	7.6	10.8	9.0	7.5	7.8	11.7	12.8	8.9	9.6	8.8	9.3	18.4	23.0	19.2	30.9	16.4	11.4	16.7	14.7	20.3	15.8
GHITM	"DERP2, HSPC282, My021, PTD010, TMBIM5"	ENSG00000165678	"Growth hormone inducible transmembrane protein"	Q9H3K2	10	84139440-84153245	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016464, HPA061664"	Approved		Supported	Mitochondria				Mitochondria		"HPA016464: AB_1849656, HPA061664: "	"unprognostic (6.26e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (5.71e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.71e-2)"	"prognostic favourable (2.32e-10)"	"unprognostic (2.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	28.7	50.7	46.0	21.9	53.3	25.3	26.0	30.9	62.7	21.4	45.5	20.2	23.9	43.3	21.2	24.5	30.0	19.9	21.8	94.9	40.8	42.8	80.5	71.6	19.2	23.2	45.2	42.4	20.7	25.1	29.9	24.0	20.9	62.8	22.6	46.0	24.3	26.0	24.5	87.6	19.9	35.6	28.9	24.6	20.1	30.1	41.7	17.5	21.5	29.3	47.6	26.6	26.1	19.1	46.8	63.7	60.6	67.5	44.4	51.6	106.0	41.2	43.0	18.4	42.1	31.6	28.2	32.7	28.5	50.3	37.1	34.7	52.2	34.4	32.7	32.1	37.7	37.3	39.0	37.3	35.9	32.6	29.6	23.2	44.9	51.3	59.9	72.2	38.1	31.7	73.4	38.2	111.5	32.0	53.8	61.2	34.0	36.0	25.5	57.8	18.5	38.3	23.3	16.9	49.1	51.4	33.3	15.1	17.6	28.8	25.3	57.6	51.6	46.4	27.0	18.0	24.3	26.2	45.8	43.3	47.1	36.7	47.4	67.0	12.5	52.6	64.3	60.6	42.2	67.5	47.1	46.8	44.2	44.9	63.7	37.2	41.5	44.4	51.3	44.4	59.6	33.0	51.6	106.0	46.0	53.3	30.9	62.7	40.8	42.8	45.2	42.4	62.8	17.5
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Group enriched"	"Detected in some"	5	"HSkMC: 13.3;T-47d: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	2200000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: , HPA057705: "	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.0	2.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.3	4.3	0.0	0.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.1	33.9	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.5	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2
GID8	"bA305P22.1, C20orf11, FLJ20602, TWA1"	ENSG00000101193	"GID complex subunit 8 homolog"	Q9NWU2	20	62938119-62948475	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049929, HPA055047"	Approved		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA049929: , HPA055047: "	"unprognostic (1.35e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.90e-2)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (1.19e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.22e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.87e-2)"	14.0	14.1	23.0	15.4	18.7	35.5	21.5	20.7	23.5	20.8	18.6	14.3	21.0	15.1	18.2	19.5	55.9	23.0	19.0	15.9	17.4	10.9	15.6	29.6	15.2	24.2	15.5	22.9	30.6	30.0	22.2	15.7	15.1	14.7	17.8	16.1	17.7	21.2	17.7	19.7	34.0	17.1	19.8	14.1	19.6	20.1	22.4	17.2	23.6	20.6	26.0	24.6	22.8	28.7	9.3	9.8	16.0	10.4	12.9	15.0	8.3	15.6	10.0	15.0	13.5	12.4	9.8	14.7	8.8	7.3	25.2	11.4	48.2	15.3	19.7	15.1	11.3	18.2	13.7	18.2	15.3	5.2	6.7	18.3	13.0	23.0	9.8	21.2	15.5	10.7	20.3	10.8	12.6	12.2	14.0	8.5	8.6	22.0	25.2	19.0	15.1	15.0	20.0	28.2	11.7	9.2	22.1	15.6	12.8	20.7	20.4	12.7	28.3	20.5	12.2	15.1	18.9	11.8	11.8	9.0	10.3	20.5	10.2	10.4	9.5	5.8	10.4	16.0	11.7	8.7	13.7	8.4	12.3	13.0	9.8	9.3	13.6	15.0	15.2	12.9	8.1	7.4	10.6	8.3	23.0	18.7	20.7	23.5	17.4	10.9	15.5	22.9	14.7	17.2
GIGYF2	"GYF2, KIAA0642, PARK11, PERQ2, PERQ3, TNRC15"	ENSG00000204120	"GRB10 interacting GYF protein 2"	Q6Y7W6	2	232697299-232860575	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050899, HPA054612, HPA059918, HPA065064"	Approved		Enhanced	Cytosol				Cytosol		"HPA050899: , HPA054612: , HPA059918: , HPA065064: "	"unprognostic (7.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.61e-2)"	"unprognostic (8.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.40e-3)"	"unprognostic (8.01e-2)"	"prognostic favourable (6.97e-5)"	"unprognostic (7.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.66e-1)"	22.8	22.1	20.7	16.5	19.4	15.2	19.7	33.0	21.7	17.9	17.5	25.0	21.2	15.9	23.7	15.0	18.6	17.8	13.7	21.3	19.2	15.7	23.1	13.7	15.7	15.4	21.4	15.6	24.6	26.5	47.5	38.1	18.1	21.5	19.4	16.9	18.1	21.4	21.7	41.5	23.4	17.2	22.3	27.5	18.9	18.2	53.4	22.0	19.2	22.4	17.7	17.3	20.8	20.5	10.1	9.8	21.5	14.6	9.8	9.9	5.2	15.9	15.4	18.0	18.6	24.5	23.6	20.1	20.1	17.3	14.8	15.9	14.4	13.3	9.6	5.4	15.0	16.9	21.5	16.2	18.2	22.3	16.0	35.3	15.9	21.7	15.4	28.6	22.6	14.8	16.7	17.8	25.4	16.5	32.9	10.6	16.9	16.9	18.7	10.2	18.3	11.4	19.0	35.6	13.1	13.8	24.5	16.0	13.3	20.3	14.8	15.6	14.3	19.9	23.9	15.7	13.3	17.6	15.5	21.7	14.5	18.9	14.2	16.8	15.2	21.5	8.6	10.8	7.9	6.7	9.9	5.6	6.5	7.2	9.8	10.1	7.8	5.9	11.2	9.8	14.6	7.6	9.6	5.2	20.7	19.4	33.0	21.7	19.2	15.7	21.4	15.6	21.5	22.0
GIMAP1	"HIMAP1, IAN2, IMAP1, IMAP38"	ENSG00000213203	"GTPase, IMAP family member 1"	Q8WWP7	7	150716557-150724284	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 16.5;MOLT-4: 9.5;TIME: 4.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA044887, HPA053441"	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA044887: AB_10960351, HPA053441: "	"unprognostic (1.60e-2)"	"unprognostic (6.58e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-3)"	"prognostic favourable (1.09e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (6.12e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-1)"	18.9	3.6	3.5	11.5	4.9	1.3	10.3	1.2	4.1	8.5	4.1	2.8	3.6	4.2	12.4	5.5	6.2	5.5	5.9	7.4	3.8	2.9	5.3	4.6	11.2	23.8	4.1	2.1	2.6	3.7	1.8	2.2	8.3	4.4	6.3	3.0	5.2	3.6	2.8	6.4	3.6	8.2	4.9	4.6	28.9	3.8	2.9	3.8	6.7	7.9	5.4	12.0	4.9	11.5	0.2	5.1	1.0	11.5	14.6	27.4	11.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	9.5	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.9	11.5	0.0	17.2	10.4	20.3	0.1	18.8	21.4	5.1	0.2	27.4	22.2	1.0	14.6	10.4	0.3	11.8	11.4	3.5	4.9	1.2	4.1	3.8	2.9	4.1	2.1	4.4	3.8
GIMAP1-GIMAP5		ENSG00000281887	"GIMAP1-GIMAP5 readthrough"		7	150716668-150743646	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 37.5"	"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 8.4;MOLT-4: 13.1;THP-1: 3.2;TIME: 6.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"monocytes: 15.5;NK-cells: 21.5;T-cells: 37.5"									HPA053441			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA053441: "																		12.2	2.1	1.8	12.9	2.7	1.0	6.4	0.0	2.2	5.2	2.2	1.3	1.8	7.0	7.8	3.1	3.6	2.1	3.3	3.8	1.9		3.0	2.5	6.2	15.5	2.0	0.8	1.6	1.9	0.7	0.0	4.6	2.3	3.6	0.5	2.9	2.2	0.9	4.4	0.2	3.1	2.7	2.5	16.4	3.0	1.3	2.0	3.9	4.7	3.0	7.6	2.5	7.2	0.2	4.8	1.5	15.5	21.5	37.5	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	15.5	0.0	23.3	13.5	27.9	0.2	26.4	34.0	4.8	0.2	37.5	30.2	1.5	21.5	9.8	0.3	16.4	20.1										
GIMAP7	"IAN7, MGC27027"	ENSG00000179144	"GTPase, IMAP family member 7"	Q8NHV1	7	150514830-150521073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 155.1"	"Group enriched"	"Detected in some"	12	"HUVEC TERT2: 39.0;MOLT-4: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"monocytes: 41.1;NK-cells: 65.0;T-cells: 155.1"					"Low region specificity"	"Detected in many"			"HPA020266, HPA020268"	Enhanced		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA020266: AB_1849680, HPA020268: AB_1849682"	"unprognostic (4.85e-3)"	"unprognostic (1.65e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.71e-1)"	"prognostic favourable (7.43e-4)"	"prognostic favourable (8.98e-5)"	"unprognostic (6.49e-3)"	"unprognostic (5.24e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	32.2	7.3	6.2	30.1	9.8	1.9	19.7	4.3	8.0	19.9	9.5	2.1	5.3	7.6	13.4	11.9	12.2	10.2	9.4	14.6	9.3	6.4	20.1	10.5	22.8	54.7	10.0	3.3	7.0	4.7	3.3	4.9	12.5	7.2	13.5	8.8	6.2	10.7	4.6	17.0	4.6	20.5	12.4	8.1	51.5	7.7	6.7	8.2	18.7	16.7	11.3	34.9	13.4	11.0	0.4	18.0	3.4	41.1	65.0	155.1	131.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	41.1	0.5	79.6	36.9	77.6	0.4	118.6	95.4	18.0	0.3	155.1	108.0	3.4	65.0	38.6	1.0	64.7	131.0	6.2	9.8	4.3	8.0	9.3	6.4	10.0	3.3	7.2	8.2
GINS2	"Pfs2, PSF2"	ENSG00000131153	"GINS complex subunit 2"	Q9Y248	16	85676198-85690073	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.2;testis: 21.3"	"Cell line enhanced"	"Detected in many"		"U-698: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA057285	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA057285: AB_2683398"	"unprognostic (3.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.70e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.60e-1)"	0.9	1.5	3.5	15.9	3.7	13.2	3.6	3.8	2.1	1.9	6.5	1.9	1.5	4.7	1.8	2.6	7.1	0.9	2.2	1.6	4.8	1.5	1.3	3.3	1.4	8.7	2.2	1.5	1.9	4.4	2.6	1.4	4.6	1.6	2.6	7.4	1.9	2.0	0.7	3.2	3.1	5.9	1.5	2.3	7.6	2.1	21.3	1.8	25.2	1.8	8.0	13.3	1.9	3.0	1.4	1.7	1.5	3.3	4.3	11.1	2.4	13.2	9.5	18.6	7.8	0.5	1.8	4.9	9.1	3.6	13.5	8.3	12.5	8.8	15.6	5.0	3.1	10.1	19.6	7.4	13.1	5.4	17.0	7.7	7.3	14.1	0.1	5.3	4.3	0.5	0.9	8.1	3.1	5.7	21.0	3.7	7.7	27.6	18.7	20.1	10.4	7.3	26.3	11.3	8.6	4.3	5.5	25.7	8.1	13.1	2.7	2.6	27.1	7.3	3.4	8.8	11.8	8.3	10.4	7.0	12.3	70.7	5.1	11.3	10.0	0.7	0.3	1.5	1.4	1.3	0.2	1.4	4.7	3.1	1.7	1.0	2.2	1.6	1.2	4.3	3.3	1.0	11.1	2.4	3.5	3.7	3.8	2.1	4.8	1.5	2.2	1.5	1.6	1.8
GINS3	"FLJ13912, PSF3"	ENSG00000181938	"GINS complex subunit 3"	Q9BRX5	16	58295080-58406144	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041216, HPA048209"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA041216: AB_10794989, HPA048209: "	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.34e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.14e-7)"	"unprognostic (9.76e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.07e-2)"	5.5	10.6	3.3	5.6	11.4	9.9	4.4	20.4	4.7	5.9	6.6	3.2	13.2	4.3	5.6	5.5	11.5	3.4	3.3	8.2	3.5	3.6	5.3	4.2	6.1	10.0	5.8	1.5	2.8	2.3	6.0	4.2	6.3	4.5	3.5	6.0	3.3	4.8	10.0	3.9	5.4	5.0	5.1	4.1	11.9	3.4	8.0	4.9	17.5	4.9	14.3	13.1	3.8	7.9	4.7	10.9	0.5	2.4	5.0	4.1	2.1	7.1	8.1	9.8	5.3	1.1	1.4	4.9	8.2	3.6	13.1	10.0	6.0	7.2	12.5	6.6	2.8	6.9	9.0	6.9	14.9	7.0	11.1	7.4	4.6	7.3	0.6	9.3	12.7	1.6	1.3	6.8	2.3	9.0	11.6	5.3	5.5	7.4	16.9	8.5	9.2	16.8	29.5	10.9	16.0	4.8	4.6	11.4	7.5	13.6	9.0	4.5	4.7	7.6	3.7	8.9	10.4	5.3	10.2	5.4	7.0	52.8	6.2	9.4	10.8	0.2	2.4	0.2	2.9	2.2	2.1	3.5	2.4	4.1	5.5	4.7	2.3	3.6	0.5	5.0	1.2	10.9	3.2	2.1	3.3	11.4	20.4	4.3	3.5	3.6	5.8	1.5	4.5	4.9
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529206-41545046	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	2.0	3.0	2.3	6.2	4.7	9.0	2.7	1.6	3.7	2.7	3.4	6.8	0.0	2.5	2.4	3.0	6.0	1.6	2.4	5.7	3.7	1.8	2.2	2.2	2.5	7.9	5.9	3.3	2.6	1.3	1.6	1.2	4.8	2.8	1.8	5.1	1.9	2.6	0.8	3.7	3.4	3.7	2.4	4.7	5.0	2.1	8.6	5.6	14.0	2.1	5.7	9.6	2.1	3.0	5.8	5.2	3.9	1.4	2.7	6.7	1.7	9.5	13.8	19.6	8.7	1.2	1.5	8.1	13.7	8.3	14.2	16.7	12.7	8.4	13.3	5.6	6.9	7.3	15.7	11.3	21.0	4.9	8.7	19.3	10.2	8.6	0.3	4.2	10.0	0.8	0.5	23.5	5.3	7.0	9.5	4.5	9.9	6.6	17.4	4.8	10.8	7.6	16.3	18.2	5.6	5.1	9.1	6.0	4.7	9.7	4.3	3.9	11.2	4.7	4.8	9.7	14.7	17.8	13.7	5.3	7.7	15.9	6.9	9.9	23.4	2.4	1.4	0.5	3.0	1.3	1.7	2.4	4.8	2.0	0.7	5.8	3.1	2.0	3.9	2.7	0.7	5.2	6.7	1.7	2.3	4.7	1.6	3.7	3.7	1.8	5.9	3.3	2.8	5.6
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573469-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"			53000	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	13.0	8.5	34.0	11.1	38.1	8.0	9.4	18.9	43.4	7.8	9.8	15.6	2.2	11.6	10.0	5.3	13.2	14.0	10.2	12.2	41.5	16.4	7.0	3.7	12.0	12.6	19.2	21.8	13.6	14.3	10.2	8.1	13.8	15.0	8.4	6.9	7.8	11.9	10.3	10.0	20.2	10.9	8.7	11.9	11.1	9.5	42.9	19.8	10.8	11.0	4.5	9.7	9.8	7.5	1.8	4.7	3.0	6.0	5.6	4.9	3.6	17.1	28.8	14.2	25.2	11.3	7.2	16.5	8.5	8.4	10.3	9.2	11.6	6.4	13.0	13.7	11.1	28.4	14.9	21.9	5.3	16.8	17.8	9.4	14.1	10.4	13.8	11.8	7.7	8.7	25.2	11.8	18.5	19.0	7.6	11.3	7.3	17.7	37.3	16.0	10.5	6.9	28.4	19.0	19.5	9.3	9.5	29.9	25.6	12.0	28.0	42.0	13.7	15.8	23.5	9.8	14.2	21.5	17.1	9.4	12.9	14.2	16.1	10.2	16.5	0.3	3.6	3.0	4.7	6.0	2.2	1.8	4.5	4.9	4.7	1.7	3.7	2.7	1.2	5.6	3.7	4.0	2.9	3.6	34.0	38.1	18.9	43.4	41.5	16.4	19.2	21.8	15.0	19.8
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435692-121449727	"Cancer-related genes, Disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.8;HUVEC TERT2: 61.6;NTERA-2: 62.7;TIME: 45.3;U-87 MG: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: , HPA047551: , HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavourable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	19.7	65.2	78.6	5.5	69.7	0.4	14.2	32.4	44.4	64.5	4.0	23.8	6.1	4.2	23.5	5.5	17.3	7.8	23.0	36.0	87.3	25.5	3.6	2.5	15.2	4.4	42.9	39.9	10.5	4.5	94.7	5.7	63.8	53.7	20.0	4.8	26.3	7.1	35.7	3.4	86.3	4.4	25.6	38.7	1.1	6.4	8.3	64.3	0.5	38.9	9.9	7.6	14.8	32.2	0.5	0.5	0.4	0.5	0.0	0.4	0.0	0.0	7.2	32.1	0.0	17.5	10.9	0.0	24.0	48.8	8.1	19.8	0.1	0.0	0.0	2.7	9.3	3.1	0.8	14.7	26.4	0.0	8.8	0.3	2.9	0.0	21.9	0.0	0.0	29.0	15.9	29.6	10.7	61.6	0.0	0.7	1.6	1.3	0.0	12.9	62.7	8.0	0.0	0.0	0.6	32.4	3.5	0.0	0.5	0.0	0.0	0.0	2.5	0.0	45.3	25.0	6.9	21.1	15.5	0.0	0.0	0.0	61.0	0.0	3.5	0.4	0.5	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.5	0.4	0.4	0.0	0.0	0.1	0.5	0.1	0.0	78.6	69.7	32.4	42.8	87.3	25.5	42.9	39.9	53.7	64.3
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A-431: 25.9;CAPAN-2: 36.9;HaCaT: 30.0;HBEC3-KT: 25.6;hTCEpi: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"		"HPA074472: "	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	3.5	0.0	30.0	0.0	25.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.1	0.0	10.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	6.7	0.0	0.0	0.0	12.5	9.9	0.0	0.0	3.9	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759741-34763724	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.1;skin 1: 26.2"	"Cell line enhanced"	"Detected in some"		"A-431: 6.6;HaCaT: 9.8;HBEC3-KT: 6.4;hTCEpi: 4.2;RPTEC TERT1: 3.8;RT4: 4.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"				"Cell Junctions"		"HPA055112: , HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favourable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavourable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.1	0.1	0.1	1.2	0.1	0.0	1.5	0.1	0.1	1.7	0.3	0.0	2.9	0.0	0.1	11.1	2.9	0.1	8.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	3.4	0.0	2.0	0.2	0.0	0.8	2.0	0.1	26.2	0.3	1.2	0.1	0.1	0.2	0.7	0.0	0.1	0.1	1.6	2.4	3.2	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	6.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	1.0	0.0	9.8	0.0	6.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
GJB6	"CX30, DFNA3, ED2, EDH, HED"	ENSG00000121742	"Gap junction protein beta 6"	O95452	13	20221962-20232395	"Disease related genes, Predicted membrane proteins"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.5;esophagus: 97.1;tongue: 43.6"	"Cell line enriched"	"Detected in some"	9	"RT4: 63.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 145.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Lineage enhanced"	"Detected in many"		"T-cells: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014846			Supported	"Cell Junctions"				"Cell Junctions"		"HPA014846: AB_1847135"	"unprognostic (5.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"unprognostic (7.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.96e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.14e-11)"	"unprognostic (8.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.35e-3)"	"unprognostic (5.04e-2)"	1.2	1.0	15.3	1.1	17.0	50.5	3.3	9.0	15.9	16.9	1.0	1.9	0.0	1.0	1.6	1.1	97.1	1.2	1.8	1.0	16.3	7.9	1.0	1.0	1.1	1.4	11.1	11.3	1.0	1.0	1.0	0.7	1.0	9.2	1.1	1.1	0.0	8.7	1.0	1.0	18.7	1.0	1.0	3.7	1.1	1.2	1.7	6.0	7.9	4.1	43.6	15.7	6.3	30.9	1.4	0.0	1.2	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	63.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	1.4	2.7	1.5	1.2	0.0	0.0	0.0	5.7	0.6	15.3	17.0	9.0	15.9	16.3	7.9	11.1	11.3	9.2	6.0
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149852-228159826	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 34.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;SCLC-21H: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.4	1.9	4.6	1.2	10.0	0.5	2.0	2.2	14.8	2.8	2.6	34.3	0.0	0.6	4.5	2.0	1.7	4.8	1.4	1.6	9.3	5.3	0.6	0.5	3.1	1.2	27.2	5.6	3.4	0.9	2.9	0.6	1.2	18.3	2.1	0.8	0.0	1.5	4.0	1.5	2.4	1.2	3.8	32.6	1.9	1.2	1.0	15.7	0.0	0.9	0.0	0.7	1.3	1.8	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.2	0.5	1.3	0.7	1.8	1.4	0.4	0.6	0.7	0.9	1.2	0.2	9.7	2.6	0.9	0.3	0.3	0.3	0.3	1.5	0.3	2.4	2.1	2.5	0.0	0.0	0.4	0.2	0.8	0.5	0.2	1.0	0.3	0.4	0.5	1.8	0.6	0.6	1.9	0.4	0.3	0.1	0.8	0.0	5.1	3.0	0.4	0.1	0.3	0.1	0.3	4.5	1.3	3.7	4.4	1.5	0.3	0.6	0.2	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	4.6	10.0	2.2	10.4	9.3	5.3	27.2	5.6	18.3	15.7
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: , HPA069503: "	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favourable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.6	9.8	6.3	7.6	39.1	20.3	136.7	9.1	24.7	11.7	15.1	13.9	13.6	2.8	8.1	18.6	5.5	6.0	11.6	8.7	16.0	5.0	10.9	5.9	7.1	20.1	7.6	11.2	23.4	11.2	10.6	6.3	18.0	9.8	10.6	12.8	6.6	4.5	5.0	4.3	4.3	3.9	4.2	13.0	12.6	8.4	1.9	6.6	11.7	19.0	11.4	12.6	19.9	10.5	7.5	5.2	10.3	7.7	8.4	13.4	0.9	15.9	11.0	5.7	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 36.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.1;HaCaT: 25.3;HMC-1: 14.0;SCLC-21H: 17.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.8;NK-cell: 5.8"	"Group enriched"	"Detected in many"	23	"NK-cells: 5.8;T-cells: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054808, HPA059955"	Uncertain		Supported	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm		"HPA054808: , HPA059955: "	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6.0	13.5	4.5	8.7	3.6	20.5	6.6	3.0	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7.0	0.3	1.4	15.0	5.2	2.6	5.1	2.9	0.2	0.0	0.0	0.0	5.8	5.8	0.8	7.4	0.7	4.0	2.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.3	24.1	0.0	8.0	0.0	25.3	12.2	0.2	0.0	0.0	11.5	0.0	3.2	0.3	1.1	0.0	14.0	0.1	0.3	0.0	0.0	0.0	12.1	0.0	0.0	7.2	2.0	1.4	2.3	8.8	0.0	0.0	0.7	6.8	5.2	17.2	6.4	5.5	6.9	0.0	8.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	0.0	0.0	5.8	0.0	2.3	0.0	1.3	2.3	0.0	0.2	1.6	2.6	0.0	5.8	0.0	0.0	0.0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532464-6645783	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 22.3;liver: 40.3;placenta: 10.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 65.3;CACO-2: 15.5;HMC-1: 14.2;RPTEC TERT1: 27.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria			570000	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: "	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavourable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.2	0.3	3.9	1.0	3.4	0.4	0.4	3.1	5.6	0.3	0.8	1.6	0.0	0.7	0.4	4.2	1.4	0.6	0.6	0.1	2.9	2.2	22.3	40.3	0.8	1.1	1.9	2.9	0.3	0.1	0.0	1.7	10.6	2.1	0.4	0.3	3.2	0.9	0.8	0.9	1.5	0.6	0.1	1.9	0.8	0.8	1.1	1.8	0.0	2.6	0.0	1.9	0.8	0.0	2.9	0.7	2.3	0.5	0.8	0.6	1.1	0.1	1.3	0.5	7.0	0.0	0.1	65.3	0.0	0.0	0.0	0.0	15.5	0.1	0.1	1.5	0.0	0.1	0.0	0.1	0.0	0.3	3.7	0.0	0.0	10.3	0.0	0.0	14.2	0.0	0.0	0.5	0.0	2.7	0.0	0.1	0.3	0.3	0.2	0.0	7.6	1.2	0.3	0.0	0.1	27.0	0.3	6.2	3.2	0.0	6.0	0.0	1.4	0.0	0.9	0.1	0.2	0.7	0.3	0.3	8.9	0.0	0.2	0.7	1.5	1.5	0.5	0.5	0.5	0.3	0.5	2.9	0.6	0.4	0.1	0.9	0.4	0.5	2.3	0.8	0.5	0.7	0.2	1.1	3.9	3.4	3.1	5.6	2.9	2.2	1.9	2.9	2.1	1.8
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1, RNA export mediator"	Q53GS7	9	128504700-128542288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"				"Nuclear membrane"	Nucleoli	"HPA041689: , HPA043538: , HPA061560: "	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favourable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	12.5	17.0	11.1	13.5	13.2	12.2	14.7	22.1	13.8	13.1	15.7	16.5	17.6	14.6	13.8	11.4	18.5	13.5	12.6	13.2	10.5	8.9	13.1	20.4	11.3	23.0	11.2	9.9	15.7	21.1	20.8	16.3	16.4	10.6	13.4	17.2	13.1	13.6	16.7	23.3	18.3	14.9	12.0	9.8	17.5	12.1	42.8	11.8	27.2	12.4	14.6	20.0	14.3	13.5	16.0	19.2	26.2	22.5	22.6	20.5	15.8	10.8	20.4	10.0	17.0	9.9	10.1	13.3	11.0	9.4	15.4	11.0	13.6	7.6	22.0	8.9	12.3	38.3	17.3	15.6	13.4	20.8	11.3	11.2	22.4	12.7	11.2	18.1	14.9	7.1	15.2	17.5	18.8	8.7	16.1	19.4	17.7	25.1	17.8	12.8	8.4	17.7	18.3	24.6	29.0	10.4	9.7	11.9	8.9	26.8	16.2	9.6	30.0	12.8	6.3	16.4	11.0	19.2	15.2	19.6	47.0	17.2	15.4	13.9	17.7	26.2	18.1	20.3	20.5	22.5	16.7	12.0	16.0	18.1	19.2	16.0	14.4	16.6	15.4	22.6	22.0	11.4	18.3	15.8	11.1	13.2	22.1	13.8	10.5	8.9	11.2	9.9	10.6	11.8
GLG1	"CFR-1, ESL-1, MG-160"	ENSG00000090863	"Golgi glycoprotein 1"	Q92896	16	74447427-74607144	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010815	Supported		Supported	"Golgi apparatus"			1600000	"Golgi apparatus"		"HPA010815: AB_2232486"	"unprognostic (3.70e-2)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-3)"	"unprognostic (5.13e-3)"	"unprognostic (9.45e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.85e-2)"	"prognostic favourable (1.56e-7)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (7.97e-4)"	30.8	30.4	24.0	23.9	38.8	13.9	29.9	25.8	35.9	40.2	27.3	43.4	27.2	22.2	44.1	29.7	22.8	33.3	40.8	38.1	23.3	26.3	37.5	28.2	28.3	28.9	32.0	28.9	55.7	44.9	72.8	28.0	55.9	31.8	32.8	24.7	27.0	27.5	36.3	38.3	25.3	25.1	41.2	31.4	25.9	26.0	37.5	31.8	35.6	37.0	17.2	25.1	30.6	30.7	10.2	15.6	11.5	14.2	13.8	25.7	13.4	17.7	20.9	18.9	20.3	62.2	46.6	16.0	22.5	30.1	20.6	28.4	19.1	44.3	9.5	31.5	50.4	27.1	12.8	27.4	27.5	4.6	7.8	6.7	14.6	24.6	27.7	10.9	5.6	33.6	15.8	28.8	25.7	42.3	7.6	12.2	20.1	29.3	6.2	9.5	18.0	6.8	15.2	12.7	23.9	14.6	8.8	8.1	11.8	35.1	11.7	10.1	15.3	13.9	41.2	23.1	19.4	17.9	14.2	17.5	14.9	18.4	34.2	10.7	20.2	2.2	14.1	11.5	17.0	13.6	17.2	9.2	22.4	19.0	15.0	10.2	25.7	19.8	7.5	13.8	14.2	15.6	17.6	13.4	24.0	38.8	25.8	35.9	23.3	26.3	32.0	28.9	31.8	31.8
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57460135-57472262	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.9;BJ hTERT+: 7.6;NTERA-2: 7.7;RH-30: 35.1;U-266/70: 9.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: , HPA068903: "	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	3.2	1.7	4.0	2.1	2.5	0.6	2.1	8.2	4.4	14.4	3.5	0.0	3.0	3.7	12.8	8.3	0.7	4.7	8.3	2.7	2.9	1.9	3.2	1.8	2.0	1.3	1.5	2.0	4.7	1.0	0.1	1.2	0.6	3.3	5.6	4.9	9.6	2.9	4.3	3.1	2.4	3.7	3.8	2.8	1.2	2.4	6.2	2.5	0.6	3.3	3.4	1.4	4.8	4.6	0.9	0.4	5.2	0.2	0.1	0.5	0.1	0.0	5.5	1.6	11.9	0.2	0.0	0.2	0.7	7.6	1.3	1.3	0.2	0.4	1.9	0.0	0.3	1.0	0.9	0.7	0.2	2.1	0.1	0.0	0.6	0.1	1.2	0.3	0.6	0.5	0.2	1.3	0.4	0.2	0.4	4.0	0.6	0.0	0.3	0.2	7.7	0.5	0.6	35.1	0.8	1.5	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	1.3	4.4	0.4	0.2	9.7	0.4	3.2	1.2	0.8	2.1	2.2	0.2	0.9	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.4	0.4	0.3	5.2	0.1	0.1	0.4	0.5	0.1	4.0	2.5	8.2	4.4	2.9	1.9	1.5	2.0	3.3	2.5
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 23.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.2;NTERA-2: 11.7;U-2 OS: 19.9;WM-115: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: "	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	2.1	1.6	3.6	2.9	5.3	0.2	2.3	3.1	3.4	8.0	4.4	1.9	1.5	0.9	8.6	2.6	3.9	5.8	8.8	3.3	3.7	1.0	1.7	0.8	2.9	0.7	1.3	1.5	23.3	0.8	0.7	2.6	1.7	3.6	6.2	1.4	5.9	1.8	2.4	1.6	3.7	3.2	4.5	1.6	2.0	3.9	5.4	2.1	1.7	1.6	4.7	2.6	4.3	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	19.2	3.8	2.1	4.1	0.0	7.3	1.6	3.2	2.1	0.0	0.6	0.0	0.8	3.6	0.3	5.3	0.0	1.6	0.0	3.4	0.5	4.7	0.0	4.6	0.0	1.5	2.1	0.0	10.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	11.7	5.9	0.0	2.1	1.2	0.0	0.0	0.8	3.3	3.4	0.0	0.5	0.0	0.2	5.8	0.0	19.9	2.0	0.0	0.0	0.0	0.0	7.2	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.3	3.1	3.4	3.7	1.0	1.3	1.5	3.6	2.1
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 57.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.2;HSkMC: 23.0;RPTEC TERT1: 14.3;U-251 MG: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA056426: "	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	5.6	2.8	5.6	4.4	7.4	1.0	2.9	3.5	9.5	13.4	2.9	10.7	33.5	1.6	6.1	6.5	1.5	15.0	14.7	4.7	8.9	4.5	11.4	5.1	5.7	2.6	7.7	3.8	10.4	17.3	6.4	8.8	2.8	16.3	5.3	4.0	4.6	5.2	57.8	2.1	1.4	2.2	5.1	26.7	3.8	3.2	4.6	10.2	0.0	29.3	1.4	1.7	5.6	8.8	0.0	0.0	1.8	0.9	0.3	0.7	0.0	0.6	6.6	2.0	0.0	2.6	7.3	0.2	5.0	15.2	2.2	3.3	1.1	2.4	0.0	4.0	3.7	0.0	1.3	0.0	4.7	1.5	1.0	0.0	0.3	0.0	8.0	0.7	0.0	23.0	0.0	7.0	0.7	0.4	0.0	0.1	1.9	0.2	0.0	0.9	0.1	0.9	0.0	4.6	0.0	14.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.0	2.6	0.6	2.6	11.9	0.0	0.0	0.0	7.0	0.0	2.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.7	1.1	0.3	0.9	0.0	0.1	0.0	5.6	7.4	3.5	9.5	8.9	4.5	7.7	3.8	16.3	10.2
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703141	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 244.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			1600000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: "	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	22.2	30.5	42.1	19.5	42.3	11.4	32.0	25.4	42.3	27.1	42.1	19.7	22.9	48.1	25.3	49.2	28.2	31.5	17.8	39.2	37.8	37.7	37.1	65.3	30.7	31.6	38.9	29.7	37.6	25.9	33.2	12.6	26.7	40.6	74.0	22.7	21.7	21.7	28.2	57.5	31.3	64.3	28.9	37.6	25.6	21.3	12.9	21.4	19.8	32.6	42.5	24.3	28.6	24.7	25.9	28.6	8.5	15.6	10.8	24.4	14.7	18.1	8.4	24.2	24.0	11.5	20.8	21.4	15.8	15.0	22.3	23.2	20.5	7.0	20.2	12.5	12.6	12.0	20.7	20.4	28.3	18.3	32.0	29.9	10.9	19.1	17.3	11.3	244.2	17.7	12.6	21.1	15.1	24.0	23.5	13.4	20.8	15.3	17.7	14.4	17.4	16.5	15.4	29.3	13.2	20.3	13.7	18.9	19.1	11.1	15.5	29.8	18.0	57.1	9.9	17.4	16.0	15.0	25.0	10.6	20.0	55.5	6.3	29.4	27.9	8.5	9.8	6.9	18.0	15.6	24.4	24.7	18.1	18.3	18.3	25.9	17.1	17.9	1.2	10.8	12.1	28.6	15.7	14.7	42.1	42.3	25.4	42.3	37.8	37.7	38.9	29.7	40.6	21.4
GLP2R		ENSG00000065325	"Glucagon like peptide 2 receptor"	O95838	17	9822206-9892102	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 32.7"	"Cell line enriched"	"Detected in some"	5	"HeLa: 41.8"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.1"	"Group enriched"	"Detected in some"	4	"basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 2.1;hippocampal formation: 2.6"	"Low region specificity"	"Detected in many"			"CAB022690, HPA049244"	Supported		Supported	"Plasma membrane"				"Plasma membrane"		"CAB022690: , HPA049244: "	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.63e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.40e-8)"	"unprognostic (9.53e-5)"	"unprognostic (5.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.48e-3)"	7.9	0.7	0.6	2.0	2.9	0.0	2.6	0.3	4.3	6.6	14.5	0.0	1.7	12.4	1.9	0.4	5.3	1.4	32.7	0.9	0.6	0.5	0.4	3.2	1.4	0.7	0.6	1.6	0.8	2.1	0.0	0.3	1.5	0.5	8.4	7.5	0.8	0.4	0.2	0.3	0.3	15.4	15.6	0.6	0.3	4.9	1.1	0.2	0.0	0.5	0.1	0.4	13.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.3	4.1	0.6	0.5	0.6	1.6	0.5	0.2
GLRX2	"bA101E13.1, GRX2"	ENSG00000023572	"Glutaredoxin 2"	Q9NS18	1	193090866-193106114	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023087, HPA057224"	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA023087: AB_1849778, HPA057224: "	"unprognostic (4.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavourable (3.30e-7)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.21e-2)"	"unprognostic (4.48e-2)"	14.1	17.9	13.8	9.7	12.2	10.7	16.3	7.4	22.0	7.8	14.9	6.6	7.4	14.7	6.7	14.5	13.1	5.1	8.8	23.5	13.0	13.3	14.3	28.2	7.8	6.1	16.5	13.1	5.4	10.4	4.6	9.9	9.5	22.3	21.8	11.7	7.4	8.6	11.6	28.5	8.9	12.7	10.9	12.3	7.6	10.3	27.9	8.7	2.3	7.7	11.6	9.0	9.6	10.2	10.8	17.4	19.6	21.4	11.6	14.1	10.9	13.8	17.0	4.3	9.7	16.1	10.5	7.8	20.4	8.8	16.8	14.0	10.5	13.2	6.2	11.4	8.4	13.5	5.1	11.6	17.3	13.6	9.6	11.9	11.5	12.2	17.3	9.7	12.0	7.1	10.1	23.1	11.6	10.6	17.6	6.5	20.3	19.1	7.7	17.9	5.1	12.5	7.1	7.0	14.0	16.2	9.1	4.2	3.7	8.2	24.4	68.9	10.6	11.0	6.4	13.2	3.3	28.6	20.9	13.2	13.6	11.8	12.6	11.2	18.3	7.8	15.2	19.6	10.8	17.9	11.9	10.8	11.3	9.7	17.4	8.2	10.2	11.4	7.6	11.6	21.4	7.3	14.1	10.9	13.8	12.2	7.4	22.0	13.0	13.3	16.5	13.1	22.3	8.7
GLRX5	"C14orf87, GRX5, PR01238"	ENSG00000182512	"Glutaredoxin 5"	Q86SX6	14	95533503-95544724	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042465, HPA063716"	Approved		Supported	Mitochondria				Mitochondria		"HPA042465: AB_10794048, HPA063716: "	"unprognostic (2.57e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.28e-2)"	"prognostic favourable (1.08e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (7.83e-10)"	"unprognostic (1.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	13.7	24.1	19.3	11.2	16.9	54.8	9.7	10.5	17.3	7.4	16.6	7.7	8.1	17.6	9.1	10.8	10.7	8.4	12.6	45.3	16.1	14.5	22.5	43.3	7.7	8.4	15.5	9.5	15.8	19.1	8.3	9.4	27.3	10.4	9.9	9.9	13.3	11.6	11.0	68.8	7.9	15.7	12.6	8.3	9.1	12.8	24.2	7.1	19.9	14.8	25.6	9.7	10.0	10.8	6.0	9.9	5.5	4.5	4.8	8.7	3.0	13.9	18.7	8.6	11.4	8.5	6.2	39.0	10.3	6.7	8.9	8.5	24.4	15.3	20.1	15.3	5.2	14.1	12.8	10.3	7.5	13.2	19.3	17.2	12.0	36.5	9.7	27.5	18.5	7.6	8.6	6.4	9.0	8.9	20.4	15.8	6.3	39.2	21.6	27.9	14.7	20.9	39.5	30.6	12.0	9.9	16.8	22.9	14.3	9.9	12.5	14.1	19.2	11.8	10.6	5.7	12.6	13.8	14.5	8.6	10.2	15.3	12.4	16.6	13.1	1.0	3.5	5.5	5.2	4.5	6.1	6.0	6.4	7.7	5.4	5.8	5.9	5.8	2.2	4.8	2.7	9.9	8.7	3.0	19.3	16.9	10.5	17.3	16.1	14.5	15.5	9.5	10.4	7.1
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880827-190965552	"Enzymes, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 127.9"	"Cell line enhanced"	"Detected in all"		"EFO-21: 138.9;RPTEC TERT1: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"		25000	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	16.5	37.3	37.8	20.4	24.7	10.7	34.3	43.8	47.3	11.9	13.1	5.8	8.9	36.9	14.6	11.9	7.6	11.0	17.7	15.7	23.3	22.8	127.9	5.3	22.6	25.4	20.6	36.8	14.1	17.0	26.4	10.1	14.8	35.1	9.4	13.1	10.8	9.0	13.9	7.4	13.0	40.9	15.5	11.7	19.3	8.7	6.9	12.1	15.0	17.7	8.0	22.9	14.1	16.1	5.2	5.0	6.0	2.1	3.9	9.4	1.5	6.2	7.0	4.9	6.4	15.4	10.7	12.7	18.8	14.3	13.7	15.8	8.5	6.2	12.9	138.9	39.7	8.2	8.6	7.4	20.1	31.8	5.6	21.4	10.3	10.5	14.1	12.5	10.1	9.7	7.7	10.8	7.4	17.8	9.9	26.4	30.5	3.3	8.4	12.1	13.1	11.5	10.7	12.7	11.2	63.8	11.6	6.8	7.1	25.7	5.7	23.9	2.2	7.7	12.6	19.9	14.6	9.9	22.8	8.5	19.4	17.8	7.1	10.3	15.7	6.0	1.5	2.5	5.5	2.1	9.4	4.8	6.5	7.0	2.2	5.2	6.8	8.1	3.0	3.9	1.4	5.0	5.6	1.5	37.8	24.7	43.8	47.3	23.3	22.8	20.6	36.8	35.1	12.1
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.1;bone marrow: 25.4;liver: 24.7"	"Group enriched"	"Detected in some"	7	"MOLT-4: 12.2;NTERA-2: 17.6;SCLC-21H: 8.3"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 23.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	3.0	0.6	7.0	7.0	12.4	25.4	0.6	7.1	15.5	1.8	0.6	1.2	0.2	0.5	4.1	1.4	0.9	2.1	2.1	1.2	6.3	10.5	1.2	24.7	2.2	4.5	5.8	6.4	0.6	1.2	0.4	1.0	1.0	7.6	1.3	0.7	2.6	0.4	1.9	8.2	1.3	0.6	3.6	1.6	9.2	0.6	14.7	1.3	0.1	2.0	0.0	0.8	1.7	0.6	0.0	1.4	23.1	3.8	0.0	0.3	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.1	0.0	1.1	1.4	0.0	0.8	7.0	12.4	7.1	15.5	6.3	10.5	5.8	6.4	7.6	1.3
GLTP		ENSG00000139433	"Glycolipid transfer protein"	Q9NZD2	12	109850943-109880488	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 82.0;lymphoid tissue: 78.0;skin 1: 84.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056461	Approved		Supported	Cytosol			280000	Cytosol		"HPA056461: "	"unprognostic (1.18e-1)"	"prognostic favourable (2.01e-5)"	"unprognostic (7.46e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (7.68e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (4.17e-6)"	"unprognostic (3.28e-2)"	7.0	5.8	11.4	6.1	16.4	6.6	10.5	4.7	19.3	21.8	13.2	31.3	6.6	5.4	5.4	13.4	82.0	4.9	5.4	6.4	15.9	9.7	13.7	4.5	9.2	7.0	22.4	8.9	5.9	7.7	5.7	3.4	7.9	14.8	8.0	11.8	4.0	21.2	8.0	6.1	84.3	8.2	7.1	48.7	7.4	7.6	4.0	24.7	6.2	8.9	60.6	78.0	10.8	38.5	11.8	23.2	16.7	32.3	21.2	26.7	17.2	14.0	10.0	5.8	6.2	13.9	16.0	4.3	17.4	21.7	13.6	11.4	4.0	5.4	12.4	9.4	21.4	17.3	9.0	20.6	19.3	12.6	8.0	8.1	6.1	6.0	12.2	8.6	9.6	11.8	25.9	24.2	17.2	22.7	3.7	8.6	19.8	19.5	11.7	7.1	10.5	13.6	10.5	13.8	13.0	7.6	42.3	7.4	7.4	11.0	28.6	9.3	13.3	3.1	31.0	15.5	8.3	22.8	13.1	11.4	9.4	8.5	31.3	9.1	9.6	16.7	32.3	16.5	26.7	30.8	16.2	11.8	16.1	23.3	23.2	11.4	10.5	18.8	15.8	21.2	24.8	3.7	17.6	17.2	11.4	16.4	4.7	19.3	15.9	9.7	22.4	8.9	14.8	24.7
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050486-87094866	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.4"	"Cell line enhanced"	"Detected in all"		"Hep G2: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"		26000000	Mitochondria		"HPA042492: , HPA044839: , HPA061369: "	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavourable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favourable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	15.5	21.5	57.8	9.9	54.5	5.9	23.2	13.4	37.9	12.1	14.5	19.9	5.5	18.4	10.9	7.5	17.0	11.5	12.6	16.7	44.1	35.3	56.2	182.4	13.1	11.5	40.6	30.8	17.5	15.2	8.7	6.6	13.5	31.1	26.5	14.6	8.1	10.0	13.3	9.2	15.3	19.8	14.0	22.7	10.2	12.2	6.4	33.2	12.6	16.1	8.7	13.1	14.0	9.5	9.2	15.8	9.2	14.6	13.7	11.9	5.9	24.0	19.5	15.3	25.9	29.1	35.9	16.7	19.0	33.0	18.5	20.3	44.9	23.6	27.1	15.6	27.7	38.0	19.9	19.2	19.8	19.5	15.7	13.1	11.7	106.0	65.0	30.7	19.1	24.7	36.2	20.5	61.4	22.0	13.2	24.5	19.9	17.5	27.6	27.6	17.4	15.7	21.0	19.5	17.6	53.1	19.7	7.9	14.8	17.1	13.6	24.3	18.6	21.6	21.8	9.6	8.5	19.4	19.3	14.7	15.1	32.4	23.2	35.2	5.7	5.5	13.8	9.2	8.7	11.1	10.9	9.2	11.8	10.6	15.8	8.8	10.6	8.5	1.3	13.7	14.6	5.9	11.9	5.9	57.8	54.5	13.4	37.9	44.1	35.3	40.6	30.8	31.1	33.2
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047588-121050080	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.3;testis: 31.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.8;K-562: 8.6;SK-MEL-30: 11.1;THP-1: 5.5;WM-115: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA042492, HPA044839, HPA061369"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA042492: , HPA044839: , HPA061369: "	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	3.1	2.5	4.8	0.8	7.3	0.5	1.6	2.2	3.5	1.1	0.7	2.0	0.6	0.6	1.0	5.2	0.7	1.0	1.6	1.5	5.7	1.8	4.7	11.3	0.9	0.9	2.7	6.2	0.7	1.5	0.7	0.7	2.7	4.3	0.8	0.6	0.2	0.9	3.1	0.7	0.8	1.0	1.0	1.5	0.5	0.9	31.9	4.1	0.0	1.4	0.0	0.8	0.8	0.6	0.8	1.2	0.7	1.1	1.2	0.7	0.4	0.0	2.1	0.5	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.3	0.0	1.1	0.0	0.8	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	1.7	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	11.1	2.7	5.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.5	0.6	0.8	0.7	0.4	1.1	0.7	0.8	0.7	0.7	1.2	0.4	0.7	0.5	0.0	1.2	1.1	0.2	0.7	0.4	4.8	7.3	2.2	3.5	5.7	1.8	2.7	6.2	4.3	4.1
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182381704-182392206	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 138.5;ASC TERT1: 97.9;HSkMC: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 92.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 92.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	Mitochondria,Cytosol			28000	"Mitochondria, Cytosol"		"CAB008636: AB_1616669, HPA007316: AB_1078981, HPA007571: AB_1078980"	"prognostic favourable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	173.3	19.2	83.7	37.2	91.0	47.6	63.1	48.5	80.7	41.9	20.4	49.9	9.4	6.2	20.5	29.7	54.0	31.6	26.2	23.5	74.0	48.7	15.6	64.9	39.5	36.9	71.0	48.8	66.2	49.0	7.4	8.9	41.8	70.6	17.4	23.3	39.3	30.4	25.5	159.8	27.9	16.4	30.5	51.3	36.1	71.4	24.0	55.2	8.6	63.9	15.5	24.2	34.7	32.2	2.5	11.0	92.2	21.1	3.4	6.3	18.6	2.9	1.2	13.7	0.0	138.5	97.9	10.1	5.0	16.2	3.0	2.7	7.2	3.0	2.5	5.4	9.7	6.8	5.9	35.6	2.5	6.8	16.6	33.5	5.7	14.0	7.3	14.7	26.8	84.6	42.8	3.8	45.4	6.1	28.2	1.5	10.7	1.6	22.9	14.1	10.1	6.4	8.3	3.6	4.3	5.3	13.0	9.4	6.2	1.4	18.3	1.9	17.8	18.7	4.5	0.1	0.2	0.0	1.1	0.5	0.3	0.0	2.6	8.4	0.5	43.6	21.1	54.9	6.3	20.5	2.6	1.6	4.5	5.2	11.0	2.5	2.3	3.9	92.2	3.4	17.1	6.1	1.7	18.6	83.7	91.0	48.5	80.7	74.0	48.7	71.0	48.8	70.6	55.2
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847342	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favourable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	24.1	33.2	39.1	29.4	37.4	27.5	22.5	26.3	44.8	24.8	32.6	31.0	32.8	30.7	30.0	20.6	32.1	33.9	26.1	28.3	29.8	24.8	39.0	30.5	24.5	27.6	27.0	33.1	22.2	27.4	53.4	34.7	24.1	37.1	30.4	32.3	28.5	29.9	29.4	41.6	24.3	29.9	30.1	27.3	30.7	33.9	17.4	26.0	27.6	29.6	17.2	30.0	35.3	22.7	7.6	8.3	22.2	14.5	5.2	7.5	5.5	12.9	14.4	23.8	14.8	21.0	16.9	22.9	24.4	18.3	18.8	16.1	20.3	23.1	21.1	23.3	22.5	14.3	29.8	20.5	16.9	34.2	17.9	21.7	17.4	14.2	11.9	35.0	40.4	16.0	16.3	17.6	13.1	23.8	36.2	18.2	20.3	21.0	28.4	19.4	28.3	10.9	36.8	18.7	25.9	23.0	19.4	29.2	14.8	26.5	24.8	11.3	27.8	37.1	26.3	12.9	14.5	57.9	15.2	15.2	21.1	44.1	9.2	17.4	26.2	6.3	10.9	5.7	7.5	9.8	6.5	5.1	4.9	7.1	7.3	7.6	5.2	4.6	22.2	5.2	14.5	8.3	4.9	5.5	39.1	37.4	26.3	44.8	29.8	24.8	27.0	33.1	37.1	26.0
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668732-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA044811: AB_10959666, HPA052975: "	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favourable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	8.3	6.6	8.0	14.0	6.5	21.1	8.7	13.5	9.0	8.8	8.0	8.4	6.4	5.4	10.9	8.0	10.4	8.5	8.0	6.8	7.8	4.9	6.6	7.3	8.7	11.3	5.8	7.0	12.1	7.5	8.6	8.8	16.4	5.8	7.2	8.4	8.0	7.4	6.8	10.3	9.3	8.6	9.1	6.3	11.5	7.4	11.4	6.4	25.3	7.5	7.0	14.1	7.9	12.4	10.8	9.7	14.4	12.7	10.6	12.8	6.3	9.2	6.7	11.4	10.3	3.8	7.0	8.1	9.9	7.2	6.4	9.6	2.1	7.4	17.0	5.2	9.2	3.6	10.1	7.7	8.4	19.4	6.2	15.9	7.0	4.1	5.7	13.1	8.2	5.6	5.5	15.5	10.1	8.8	9.5	13.8	7.7	8.1	8.2	4.4	15.2	4.5	5.5	7.8	7.9	4.8	7.6	8.4	6.9	9.4	6.4	6.4	4.9	6.8	8.8	4.4	10.6	7.5	13.3	6.1	10.4	9.6	5.3	12.3	6.9	10.0	8.2	14.4	11.1	10.2	8.4	6.6	10.6	12.8	9.7	10.8	8.8	9.3	11.8	10.6	12.7	7.2	8.9	6.3	8.0	6.5	13.5	9.0	7.8	4.9	5.8	7.0	5.8	6.4
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627041	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: "	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	9.3	8.2	7.4	9.0	9.8	29.8	8.4	13.5	11.5	8.7	10.5	7.7	6.9	9.6	10.6	6.1	10.0	11.0	9.5	7.4	8.1	6.2	7.7	9.3	8.7	11.5	6.0	6.5	11.5	17.6	9.6	9.5	14.5	7.2	9.9	5.1	9.8	16.0	7.5	10.1	10.0	11.0	10.3	7.1	12.1	8.8	18.8	5.7	24.7	18.0	9.5	10.4	9.2	13.8	3.0	2.6	4.4	5.6	1.9	4.5	2.2	10.7	6.6	8.1	7.0	3.9	3.6	10.8	7.5	4.8	12.1	6.4	20.4	8.0	8.6	7.9	6.5	15.4	6.3	11.0	5.4	4.6	7.1	6.6	9.6	9.8	5.3	6.3	11.0	5.2	10.5	7.8	9.8	5.3	9.7	6.2	4.2	11.6	15.3	13.8	5.8	10.7	16.7	8.3	7.9	4.9	9.6	12.2	10.0	13.5	12.0	7.8	14.6	10.4	6.5	13.3	7.3	7.9	8.2	11.9	9.8	13.6	8.0	5.9	8.6	0.0	1.9	3.2	4.5	2.6	4.3	2.1	4.0	3.9	2.1	3.0	4.5	3.9	4.4	1.9	5.6	2.6	2.7	2.2	7.4	9.8	13.5	11.5	8.1	6.2	6.0	6.5	7.2	5.7
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643667	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: , HPA045481: "	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavourable (3.97e-5)"	"prognostic favourable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (5.15e-4)"	6.1	2.8	3.5	20.3	4.9	31.0	4.0	0.9	4.1	2.9	6.9	4.3	2.7	7.0	2.7	3.2	6.2	4.4	7.9	3.3	4.3	3.4	4.2	3.9	11.7	28.0	4.2	2.5	2.4	4.6	10.6	3.0	3.9	3.4	4.1	4.6	2.7	6.0	4.5	1.5	4.9	15.3	2.9	4.9	40.0	11.1	2.2	3.1	26.8	6.2	2.7	23.2	6.1	4.5	6.6	6.7	32.7	13.9	4.2	6.4	4.6	4.4	2.0	2.7	3.0	3.0	1.6	11.0	2.8	2.4	1.7	1.6	1.6	5.9	10.8	5.7	1.9	5.3	1.7	3.0	1.1	3.7	2.8	3.4	3.2	1.7	0.9	9.6	43.0	2.0	2.1	1.8	0.9	3.8	2.3	3.9	1.8	6.5	6.0	15.9	1.6	3.7	10.4	1.2	6.2	3.2	10.5	2.3	7.1	3.8	4.0	1.6	3.7	13.8	6.8	3.1	1.8	3.5	2.0	2.0	0.8	8.9	2.0	12.6	2.1	2.9	8.3	21.5	6.4	10.6	5.9	5.9	4.0	5.7	6.7	6.6	4.5	4.6	32.7	4.2	13.9	6.1	4.5	4.6	3.5	4.9	0.9	4.1	4.3	3.4	4.2	2.5	3.4	3.1
GMNN	Gem	ENSG00000112312	"Geminin, DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 95.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: , HPA054597: "	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favourable (4.13e-4)"	"prognostic unfavourable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	4.5	3.9	10.7	11.2	19.0	24.1	10.7	15.6	9.4	4.9	17.1	3.2	9.7	7.6	5.3	6.3	8.0	7.3	4.7	3.7	11.0	10.2	10.8	8.4	4.4	12.0	13.6	9.8	7.2	95.0	2.6	7.5	7.9	10.7	18.4	18.9	3.4	4.2	11.6	3.7	17.3	7.4	5.7	7.9	12.6	9.7	19.6	11.9	26.1	13.2	11.0	9.7	15.2	7.4	8.5	9.2	15.8	6.7	5.3	15.2	5.6	24.5	14.6	37.0	15.2	5.2	5.6	24.7	24.1	12.8	29.0	31.9	28.2	8.8	24.7	30.8	7.7	14.4	31.9	17.7	31.3	9.1	33.4	33.8	25.9	46.2	4.9	26.2	12.4	4.5	5.8	17.6	6.9	14.2	42.5	13.1	20.4	19.2	49.2	28.4	20.2	11.5	28.7	28.9	31.7	12.2	21.4	29.7	18.3	10.8	17.8	21.2	18.7	16.1	7.0	17.8	18.0	20.5	40.8	14.6	45.0	46.3	5.4	49.6	25.5	5.3	5.3	15.8	4.6	6.7	5.8	8.5	8.9	7.1	7.4	4.5	6.6	7.3	3.0	5.3	4.7	9.2	15.2	5.6	10.7	19.0	15.6	9.4	11.0	10.2	13.6	9.8	10.7	11.9
GMPPB	KIAA1851	ENSG00000173540	"GDP-mannose pyrophosphorylase B"	Q9Y5P6	3	49716844-49723951	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014657	Uncertain		Supported	Nucleoplasm			10000	Nucleoplasm		"HPA014657: AB_1849852"	"unprognostic (3.48e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.77e-2)"	"prognostic favourable (6.19e-6)"	"unprognostic (1.01e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.73e-2)"	"prognostic favourable (3.17e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	7.5	17.1	7.6	17.5	8.1	7.4	9.7	4.3	9.6	14.4	13.2	7.2	28.7	12.1	11.5	23.2	15.3	12.6	13.3	10.9	5.2	4.7	13.1	41.3	12.9	15.9	8.3	6.8	10.1	32.0	8.9	23.0	15.3	6.9	16.6	11.3	7.9	50.8	37.2	7.2	8.2	12.2	7.9	4.3	16.8	18.1	6.9	5.8	16.5	16.8	8.6	17.5	8.8	9.3	13.4	34.5	10.1	11.1	5.5	11.2	8.1	17.6	17.2	12.5	7.6	10.0	7.6	12.9	20.4	12.1	20.7	19.7	11.2	13.1	10.3	9.1	12.7	10.2	10.4	22.0	7.0	9.3	8.6	7.4	19.1	13.2	23.1	11.2	11.9	5.3	9.5	29.3	23.4	18.7	5.5	17.1	11.9	13.3	15.1	5.7	6.9	20.8	5.3	6.4	17.7	11.5	16.6	8.3	8.8	9.3	22.7	6.7	12.9	7.3	12.9	14.9	14.5	20.2	21.8	19.7	5.3	7.3	15.8	7.9	17.1	10.1	8.6	3.7	10.8	11.0	11.0	13.4	9.5	11.2	8.2	10.3	7.3	8.8	2.2	5.5	11.1	34.5	6.3	8.1	7.6	8.1	4.3	9.6	5.2	4.7	8.3	6.8	6.9	5.8
GNA12	gep	ENSG00000146535	"G protein subunit alpha 12"	Q03113	7	2728112-2844324	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010046	Approved		Supported	Cytosol				Cytosol		"CAB010046: AB_2263416"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavourable (1.20e-6)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.45e-3)"	"unprognostic (7.90e-2)"	"prognostic unfavourable (4.71e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.27e-4)"	19.4	15.0	26.5	12.3	22.8	10.5	11.9	12.9	22.5	13.7	11.9	19.4	5.2	5.9	13.8	5.9	9.2	12.1	11.0	17.6	22.9	19.3	7.6	7.3	10.4	14.2	25.2	11.4	21.9	13.4	9.5	13.8	27.2	22.1	11.4	7.4	7.4	8.8	14.2	5.4	4.4	8.5	16.8	24.4	11.7	9.1	11.5	18.2	4.6	7.7	3.9	11.4	13.3	12.8	4.7	4.3	2.5	3.1	0.2	1.8	0.9	15.5	8.6	8.9	13.3	14.3	11.5	24.7	13.1	15.3	14.3	16.5	8.2	11.1	3.3	9.0	15.5	7.0	6.1	13.6	9.7	39.6	6.1	6.7	4.7	8.6	16.7	1.1	6.0	11.1	7.4	16.7	11.3	15.1	7.5	10.5	12.8	7.3	1.8	6.2	12.4	15.0	11.8	10.3	6.7	5.2	10.6	7.1	10.2	7.4	11.1	5.5	6.2	9.3	17.8	15.6	18.8	15.2	21.5	7.4	8.7	3.0	16.8	10.0	15.3	2.5	1.3	0.2	0.6	3.1	0.9	2.7	1.5	0.8	1.1	4.7	1.4	0.2	0.3	0.2	0.8	4.3	1.8	0.9	26.5	22.8	12.9	19.7	22.9	19.3	25.2	11.4	22.1	18.2
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65010715-65056839	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol			4000000	Cytosol		"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	28.2	17.4	16.4	25.3	17.5	75.6	15.1	15.1	15.0	14.2	19.1	23.0	13.0	14.0	12.9	12.1	13.2	12.1	17.7	15.4	16.8	13.3	12.4	17.4	27.6	27.5	18.5	9.4	16.3	10.0	12.1	10.0	25.0	14.8	16.8	17.3	10.7	10.5	13.9	35.0	11.4	17.5	15.9	32.1	22.5	13.6	11.3	20.4	34.9	11.9	9.0	27.5	28.3	26.0	5.7	5.5	15.8	13.4	7.8	11.2	4.4	11.6	13.2	12.1	8.2	12.6	11.4	12.5	9.1	10.6	12.5	14.3	7.4	7.8	47.6	6.0	9.8	8.1	12.9	11.1	19.3	12.3	7.5	24.8	8.0	14.5	18.2	18.5	16.5	9.6	17.0	12.0	16.6	18.8	10.0	29.7	14.4	11.0	28.4	6.7	7.5	9.8	16.5	24.3	17.3	12.6	19.1	8.9	18.8	6.6	13.8	15.6	14.2	18.1	13.4	20.8	18.3	8.9	11.9	22.0	26.1	54.0	7.6	12.0	11.0	7.1	6.4	8.5	7.2	13.4	7.3	5.7	8.9	8.5	5.5	4.8	5.2	5.7	15.8	7.8	8.3	2.5	11.2	4.4	16.4	17.5	15.1	15.0	16.8	13.3	18.5	9.4	14.8	20.4
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	80133955-80219402	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 20.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome			9000000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: "	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	33.2	23.4	17.2	5.4	26.2	1.5	14.4	14.4	33.7	9.4	10.5	36.9	3.0	6.9	10.0	3.0	16.6	9.0	8.6	5.7	23.8	18.3	25.9	13.1	10.3	3.4	40.3	21.9	14.3	5.4	2.5	7.3	30.4	26.2	10.1	9.0	2.8	4.9	9.5	4.2	32.4	5.3	12.2	49.7	5.7	8.3	11.1	32.0	0.9	11.1	3.2	4.6	15.5	9.0	0.1	3.7	2.1	1.5	20.0	2.3	0.7	2.9	20.5	18.8	0.1	23.4	15.0	8.6	12.5	15.1	11.1	13.7	0.0	3.2	0.1	4.0	13.4	3.0	10.4	12.8	14.7	0.1	9.6	17.6	18.1	1.2	23.7	2.2	3.8	16.1	32.4	5.9	17.1	7.4	1.4	0.0	20.7	0.5	0.1	0.1	5.4	7.4	8.2	7.2	8.8	33.1	9.9	13.8	9.5	13.4	0.2	10.6	2.5	0.4	13.1	24.8	17.5	5.7	4.7	0.1	0.0	0.1	6.5	1.3	11.0	2.1	0.7	0.7	0.1	0.7	0.0	0.0	0.3	0.2	3.7	0.1	2.3	0.9	0.3	20.0	1.5	0.3	0.2	0.7	17.2	26.2	14.4	25.5	23.8	18.3	40.3	21.9	26.2	32.0
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259355	"Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			53000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favourable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	81.9	37.8	50.8	69.5	47.2	102.5	53.4	17.7	45.3	56.2	47.9	67.2	34.5	22.6	51.4	41.1	44.4	47.1	55.5	57.0	44.6	48.0	34.1	50.9	72.8	78.7	53.3	34.3	54.0	21.4	24.9	42.1	81.3	46.8	44.3	22.5	38.5	25.8	60.0	29.6	29.0	35.7	53.6	81.8	96.7	30.1	28.5	45.9	70.0	37.7	32.4	55.5	60.7	49.8	5.3	14.2	35.8	19.4	6.1	8.4	5.6	15.1	8.2	24.8	24.8	30.5	38.3	4.5	33.0	53.3	47.6	49.1	9.2	21.4	18.1	14.5	74.4	12.1	17.7	46.1	30.5	38.5	6.2	45.5	22.3	14.3	30.1	41.5	60.6	37.1	20.6	43.1	17.7	111.5	3.0	39.3	47.5	19.6	35.1	44.9	13.3	32.1	22.0	11.9	26.4	30.6	17.1	6.1	10.4	24.1	7.3	15.2	11.5	43.1	97.0	41.1	24.1	38.7	33.0	24.9	31.7	15.9	46.3	56.7	49.2	2.6	16.5	23.4	8.4	19.4	4.9	5.0	6.3	7.6	14.2	5.3	5.0	5.7	35.8	6.1	15.0	11.7	6.6	5.6	50.8	47.2	17.7	45.3	44.6	48.0	53.3	34.3	46.8	45.9
GNB2		ENSG00000172354	"G protein subunit beta 2"	P62879	7	100673531-100679174	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010032, HPA040736"	Approved		Supported	"Plasma membrane"			36000000	"Plasma membrane"		"CAB010032: AB_2263466, HPA040736: "	"unprognostic (1.55e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.98e-1)"	49.9	45.9	43.8	41.6	58.4	60.9	88.8	31.7	40.9	40.5	43.1	22.3	39.4	34.8	41.1	39.7	74.6	49.6	44.0	54.0	38.9	36.1	39.1	72.9	49.1	94.9	32.5	42.3	47.5	45.6	33.5	45.9	38.0	35.6	47.7	29.0	28.8	77.8	42.5	39.2	59.9	38.3	39.1	23.6	50.7	42.2	31.9	33.9	43.7	40.9	45.8	35.1	37.8	50.1	6.3	9.9	42.7	14.8	5.2	7.9	4.0	51.1	39.5	33.3	40.4	26.0	31.0	28.8	30.8	43.0	44.3	36.8	30.0	49.5	22.9	33.8	45.6	35.8	26.3	45.9	15.7	32.0	22.5	17.3	30.3	24.5	43.5	22.5	37.6	39.8	43.8	45.7	37.2	50.8	32.1	45.3	40.1	138.2	35.6	64.0	25.8	42.9	33.7	20.4	36.6	35.3	42.6	35.3	57.3	40.8	67.1	28.4	28.7	28.0	47.9	47.6	52.7	92.4	38.4	13.1	15.7	33.9	36.0	50.3	65.6	7.8	10.6	23.6	6.5	14.8	6.1	4.8	6.8	5.7	9.9	6.3	4.5	4.7	42.7	5.2	12.2	8.5	7.9	4.0	43.8	58.4	31.7	40.9	38.9	36.1	32.5	42.3	35.6	33.9
GNB4		ENSG00000114450	"G protein subunit beta 4"	Q9HAV0	3	179396089-179451590	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018383, CAB018737, HPA040736"	Supported		Supported	"Plasma membrane"			18000000	"Plasma membrane"		"CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: "	"unprognostic (2.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavourable (1.39e-6)"	"unprognostic (1.90e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.80e-3)"	16.6	5.3	11.9	16.7	9.9	20.7	12.4	3.2	16.6	10.4	11.1	13.9	2.2	4.4	11.3	10.7	16.1	10.2	11.9	11.0	9.8	6.2	5.0	6.3	14.3	12.6	10.1	8.0	6.3	3.7	2.1	4.3	16.6	9.9	5.1	7.2	6.6	8.8	3.6	4.3	27.0	7.7	16.9	19.4	14.9	10.6	3.7	9.4	5.6	8.8	9.6	8.6	9.5	11.9	8.2	13.6	7.0	15.3	1.8	0.3	4.2	10.3	4.5	12.5	0.2	8.3	14.3	14.5	14.7	10.0	16.3	19.4	0.1	1.1	19.2	3.4	16.0	0.2	11.0	13.3	17.4	41.0	8.2	21.7	17.4	0.1	8.1	19.0	5.1	11.6	2.0	12.9	6.5	17.9	5.7	0.2	14.6	0.4	9.3	7.7	6.3	5.5	18.7	16.0	8.1	12.1	0.5	2.0	6.6	11.8	11.2	19.5	22.0	8.6	14.6	16.0	8.9	4.0	19.5	0.0	0.2	0.2	8.7	17.0	11.1	2.2	11.5	5.4	0.1	15.3	0.1	3.6	0.2	0.1	13.6	8.2	0.2	0.1	7.0	1.8	12.6	6.9	0.3	4.2	11.9	9.9	3.2	14.7	9.8	6.2	10.1	8.0	9.9	9.4
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.0;salivary gland: 45.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol				Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favourable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	7.7	6.7	6.0	6.5	8.3	8.3	16.6	11.1	12.1	7.9	20.7	7.0	4.6	2.9	8.0	3.9	7.6	6.7	5.2	7.6	7.8	6.8	6.8	55.0	5.5	6.0	6.0	7.8	9.8	8.4	4.1	7.0	20.2	10.2	10.1	30.1	4.8	45.3	5.0	10.5	3.7	7.2	11.7	10.9	4.5	4.9	3.4	5.3	3.2	4.6	4.2	7.9	8.6	7.9	3.9	2.2	1.2	2.7	2.4	4.2	1.8	4.4	19.9	8.9	7.6	10.1	10.1	12.9	6.2	7.9	8.6	11.1	4.8	14.2	5.8	6.6	10.3	1.7	6.7	2.0	9.6	10.9	0.6	5.0	11.7	6.6	6.9	0.1	14.3	6.6	2.0	14.3	13.5	3.6	6.3	12.1	8.3	0.7	8.1	2.6	5.1	11.2	6.7	7.5	1.6	47.6	8.2	7.6	6.9	6.6	2.3	5.7	2.1	5.1	5.2	5.7	5.9	6.8	5.4	5.3	11.3	3.2	7.8	4.3	8.1	0.7	1.7	0.9	2.7	2.2	1.8	2.4	3.4	2.9	1.4	3.9	4.0	4.2	1.2	2.4	2.7	2.2	1.5	1.8	6.0	8.3	11.1	12.1	7.8	6.8	6.0	7.8	10.2	5.3
GNL1	HSR1	ENSG00000204590	"G protein nucleolar 1 (putative)"	P36915	6	30541377-30557174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033575, HPA043338, HPA050455"	Uncertain		Supported	Vesicles				Vesicles		"CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132"	"unprognostic (2.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.32e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.78e-1)"	14.2	9.2	15.6	12.9	18.6	7.7	13.4	18.8	29.2	13.3	7.9	12.1	7.6	4.3	15.2	15.1	8.4	17.4	10.6	6.9	14.6	14.1	13.5	9.3	12.8	9.7	13.1	17.3	25.9	13.0	40.3	11.6	11.1	14.3	9.0	13.2	9.3	10.1	15.3	8.0	13.8	7.8	16.9	13.9	8.8	8.8	31.7	12.5	12.8	13.5	7.6	16.7	11.1	10.6	1.4	0.3	0.8	0.7	1.2	3.6	1.7	7.9	1.7	4.6	13.3	8.8	10.4	0.3	2.4	5.0	2.1	3.2	11.5	5.0	3.6	4.8	8.0	5.3	12.0	9.8	3.5	1.3	6.9	5.9	5.7	1.1	0.0	1.0	3.9	8.9	7.9	16.0	5.3	0.9	10.3	0.4	5.0	1.8	2.8	0.2	2.6	1.3	6.1	2.9	4.0	6.9	3.4	4.0	3.8	3.2	2.4	1.4	2.3	3.7	4.8	8.3	2.4	1.5	2.8	6.2	6.7	7.3	0.2	5.0	10.1	0.8	0.5	0.7	2.7	0.7	3.6	1.4	2.9	3.4	0.3	1.2	0.6	1.1	0.7	1.2	0.7	0.3	1.7	1.7	15.6	18.6	18.8	29.2	14.6	14.1	13.1	17.3	14.3	12.5
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595935	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA027163: AB_10601655, HPA060026: "	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favourable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavourable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	24.1	17.4	13.8	24.1	15.0	30.7	21.9	11.2	14.2	15.9	15.7	11.7	16.8	12.4	20.2	18.3	21.8	16.4	14.8	17.9	12.5	11.3	18.0	26.9	18.7	19.6	21.2	11.5	19.6	17.4	15.2	21.6	24.5	15.8	16.4	18.7	10.1	19.4	18.9	40.3	22.2	16.3	17.4	15.0	21.8	17.8	21.4	15.2	24.3	17.1	27.5	22.2	20.5	19.8	18.4	25.2	14.4	22.7	20.7	17.4	12.2	19.3	10.0	19.4	20.3	15.6	18.0	31.6	29.5	20.5	27.3	27.9	27.3	22.9	31.8	19.3	21.8	18.3	31.7	24.1	37.8	18.0	24.8	31.9	20.1	21.9	20.9	41.9	22.9	11.3	22.1	37.2	44.7	19.6	42.3	22.9	26.4	17.1	22.5	25.3	50.9	19.6	24.1	35.3	36.1	22.8	21.2	23.8	22.0	22.3	22.5	21.9	16.1	24.5	15.8	18.5	26.1	39.1	40.9	21.5	19.3	55.4	21.3	33.8	23.6	10.3	17.1	14.4	15.3	22.7	17.4	18.4	14.3	16.5	25.2	13.5	15.1	14.5	1.8	20.7	20.7	18.5	16.9	12.2	13.8	15.0	11.2	14.2	12.5	11.3	21.2	11.5	15.8	15.2
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694492	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli,Nuclear bodies"				Nucleoli	"Nuclear bodies"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavourable (6.11e-4)"	"prognostic unfavourable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	27.7	28.0	14.8	21.8	17.5	13.0	40.5	17.2	25.4	25.0	27.0	10.0	22.8	21.6	22.2	17.5	41.8	17.4	16.1	20.5	21.6	15.9	19.3	50.4	19.5	26.6	18.4	15.7	27.2	45.1	14.1	43.3	24.7	23.4	28.3	27.0	8.8	30.3	27.3	52.2	24.1	21.2	19.5	19.6	32.0	22.7	15.0	16.9	18.3	18.1	34.3	35.8	44.3	24.9	16.2	21.6	1.8	8.9	13.6	19.4	10.0	21.2	15.9	23.4	25.0	22.3	22.7	35.8	26.3	20.9	28.1	21.1	24.0	15.6	49.8	8.7	20.2	15.5	38.4	25.1	37.8	31.1	27.4	38.0	27.2	36.8	46.4	54.1	28.3	20.1	44.7	30.4	47.5	22.1	41.8	26.6	19.1	15.2	32.4	30.2	40.2	31.3	19.3	19.0	61.6	22.1	29.8	16.7	21.4	16.4	37.7	36.8	14.9	30.7	17.0	18.8	20.0	27.4	54.9	29.4	47.5	75.5	20.1	39.5	29.7	0.6	8.0	1.8	11.3	8.9	19.4	16.2	15.3	13.4	13.9	13.5	17.7	16.6	1.0	13.6	6.4	21.6	9.7	10.0	14.8	17.5	17.2	25.4	21.6	15.9	18.4	15.7	23.4	16.9
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530211-54561071	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	12.7	12.9	10.3	16.1	12.3	19.2	12.5	8.6	13.1	10.8	10.2	14.8	10.5	8.5	15.2	10.2	16.3	11.0	10.1	15.3	8.1	8.0	12.0	12.5	13.0	15.5	13.0	10.8	13.2	17.5	15.9	16.9	12.0	10.2	10.6	13.3	12.3	13.3	12.4	24.0	13.2	13.5	15.0	11.5	17.6	11.7	5.9	13.9	20.5	18.0	12.0	18.6	13.7	13.1	17.2	11.4	20.2	15.2	21.8	17.7	11.5	11.1	27.7	5.7	11.8	5.9	4.0	10.6	6.7	4.9	7.5	6.0	23.4	9.2	15.7	12.9	9.6	10.9	19.2	8.4	10.4	10.8	9.9	15.7	22.2	11.0	4.5	24.4	15.5	5.8	4.0	17.6	10.6	8.1	10.3	15.8	7.5	21.7	13.8	5.1	16.6	15.6	14.9	13.1	15.2	5.7	17.7	9.4	5.6	21.8	13.5	6.3	17.8	6.2	11.5	13.7	13.7	13.2	11.3	11.9	15.2	20.2	7.1	20.2	15.2	18.9	14.2	15.1	17.7	12.6	16.1	15.0	16.2	15.4	11.4	17.2	12.4	13.0	20.2	21.8	15.2	9.6	8.6	11.5	10.3	12.3	8.6	13.1	8.1	8.0	13.0	10.8	10.2	13.9
GNPTAB	"GNPTA, KIAA1208, MGC4170"	ENSG00000111670	"N-acetylglucosamine-1-phosphate transferase alpha and beta subunits"	Q3T906	12	101745497-101830938	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cancer-related genes, Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014558, HPA042343"	Approved		Supported	"Golgi apparatus"			47000	"Golgi apparatus"		"HPA014558: , HPA042343: "	"unprognostic (6.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.71e-3)"	"prognostic favourable (8.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.98e-2)"	15.2	6.5	21.9	11.9	23.0	15.2	12.2	13.9	25.6	14.0	21.3	10.3	5.9	10.3	9.0	6.5	11.7	7.1	11.0	15.9	17.9	13.7	11.0	7.3	19.6	20.3	14.4	13.0	6.6	11.4	29.9	9.0	10.8	10.9	15.6	22.5	11.3	37.6	10.2	10.8	18.1	14.5	11.7	13.1	15.4	15.2	7.4	10.8	24.5	10.5	8.6	12.6	14.7	14.8	3.9	5.8	5.9	3.4	14.2	16.4	2.7	8.3	8.1	3.0	5.1	25.6	12.2	9.4	11.9	24.6	11.8	15.5	6.2	5.9	17.5	8.6	16.3	10.9	14.0	15.3	18.5	8.2	7.3	7.5	7.5	8.8	4.8	6.8	15.2	9.4	8.5	11.2	6.6	20.7	11.6	5.2	11.0	12.7	20.4	9.6	10.4	5.9	4.8	15.5	23.5	19.0	21.7	6.6	5.4	19.8	14.1	28.0	14.5	4.5	20.3	11.2	6.1	9.3	6.6	14.3	14.6	10.0	12.7	10.1	6.9	5.9	3.1	3.4	16.4	2.9	5.4	2.4	3.6	8.9	5.8	3.9	4.6	7.1	1.2	14.2	3.4	5.8	2.6	2.7	21.9	23.0	13.9	25.6	17.9	13.7	14.4	13.0	10.9	10.8
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878357-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: , HPA050555: "	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	13.2	16.2	11.2	13.6	16.0	7.7	12.1	11.0	15.3	11.8	15.1	22.0	16.9	15.0	19.3	9.6	15.2	12.3	11.5	14.9	13.6	9.1	11.8	16.0	12.0	11.5	17.3	13.2	13.6	15.8	16.8	15.1	14.2	16.6	13.1	14.5	19.3	13.4	13.4	20.0	16.4	14.7	21.4	16.9	13.7	13.5	30.0	15.7	8.7	12.5	11.2	12.9	18.2	12.5	5.5	6.7	11.5	5.2	4.1	6.9	1.8	6.3	11.4	6.9	7.3	12.1	10.6	8.8	10.4	11.3	11.2	8.3	7.5	7.6	4.2	5.2	11.7	16.7	5.5	8.9	8.2	6.1	5.5	4.6	14.7	9.9	13.9	5.3	10.8	7.2	6.6	10.8	13.2	10.0	7.3	7.4	7.9	13.3	3.8	6.2	2.5	10.7	2.4	10.1	9.2	5.7	8.7	4.0	7.6	12.7	10.5	6.9	19.9	3.8	11.5	10.4	5.8	13.3	9.6	9.3	14.3	4.9	13.2	5.7	10.9	10.4	5.2	6.1	6.4	5.0	5.2	4.6	4.0	6.9	4.7	5.5	4.2	3.9	11.5	4.1	3.9	6.7	3.7	1.8	11.2	16.0	11.0	15.3	13.6	9.1	17.3	13.2	16.6	15.7
GOLGA2	"GM130, golgin-95"	ENSG00000167110	"Golgin A2"	Q08379	9	128255829-128275995	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB015421, HPA021178, HPA021230, HPA021799"	Enhanced		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"CAB015421: AB_831377, HPA021178: AB_1849837, HPA021230: AB_1849839, HPA021799: AB_1849841"	"unprognostic (2.88e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (3.70e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.21e-2)"	"prognostic favourable (9.77e-5)"	"unprognostic (3.92e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.27e-2)"	23.3	21.2	21.2	15.4	27.0	15.5	23.4	23.0	30.5	37.7	20.0	23.4	35.0	15.3	30.7	32.6	34.7	23.6	22.1	32.2	18.9	21.4	23.9	30.5	22.5	11.5	16.9	20.5	30.7	47.1	54.2	66.6	34.8	26.3	29.6	23.5	27.6	31.3	38.2	27.6	33.0	23.5	30.4	33.3	15.4	24.5	16.1	18.6	11.3	26.8	27.4	27.9	28.9	30.9	5.3	8.8	21.1	5.0	5.0	4.6	1.8	14.4	14.5	15.5	16.2	39.2	45.0	14.4	29.1	37.6	23.4	21.1	17.5	13.2	6.8	11.0	44.1	28.4	8.8	13.7	22.1	9.9	8.4	7.3	34.0	14.1	26.1	11.3	22.5	28.7	21.8	23.5	24.3	18.6	23.8	17.1	22.5	30.0	9.4	9.5	4.8	26.1	9.7	17.5	11.7	18.7	12.1	8.9	10.5	18.2	15.3	12.8	36.0	9.2	26.0	31.5	16.5	20.4	15.0	13.1	14.5	8.6	27.7	5.7	20.4	15.7	4.7	7.9	4.6	3.5	2.9	3.9	3.0	2.4	1.8	5.3	3.2	4.3	21.1	5.0	5.0	8.8	2.3	1.8	21.2	27.0	23.0	30.5	18.9	21.4	16.9	20.5	26.3	18.6
GOLGA3	"GCP170, golgin-160, MEA-2"	ENSG00000090615	"Golgin A3"	Q08378	12	132768909-132828858	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039809, HPA040044"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA039809: AB_10962348, HPA040044: AB_10981600"	"unprognostic (1.93e-1)"	"unprognostic (7.91e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (1.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-2)"	"prognostic favourable (3.87e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (6.47e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-1)"	17.5	14.2	14.7	17.6	17.0	13.8	14.5	23.7	21.4	20.1	19.9	17.6	20.6	12.3	18.2	20.0	18.3	14.3	20.7	17.0	14.6	16.7	11.2	18.7	15.5	16.0	15.8	13.2	20.5	39.1	16.1	32.1	18.8	16.2	18.0	16.8	14.3	26.9	19.8	20.5	21.4	15.5	24.6	12.9	18.2	22.2	13.9	14.1	9.8	15.3	15.4	18.2	17.1	16.1	7.3	8.0	5.1	4.6	7.3	7.5	3.5	9.7	19.8	7.1	11.9	25.0	16.9	13.1	16.7	12.7	10.5	9.2	18.8	4.4	13.2	9.0	24.6	10.2	7.7	10.1	7.2	3.5	8.9	13.3	20.0	12.2	14.6	14.6	19.6	12.7	12.3	14.2	14.4	10.2	12.9	5.2	10.9	15.0	12.6	13.5	7.3	13.4	10.1	7.9	4.7	6.7	23.2	9.0	5.7	13.8	12.4	7.9	16.1	10.8	20.8	12.4	9.2	13.9	10.7	16.2	13.5	18.0	15.6	8.7	15.8	5.1	4.2	3.6	7.5	4.5	6.6	4.6	5.5	5.9	4.1	7.3	6.3	6.6	3.2	7.3	4.6	8.0	4.5	3.5	14.7	17.0	23.7	21.4	14.6	16.7	15.8	13.2	16.2	14.1
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favourable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	22.3	20.6	16.7	14.0	29.0	11.4	30.6	26.9	27.1	19.1	25.1	14.5	29.1	23.9	12.8	18.4	22.0	11.3	16.7	34.3	18.1	12.3	22.1	32.7	15.2	12.2	30.5	12.8	14.8	27.7	27.1	42.8	34.5	18.9	21.1	18.1	20.2	24.8	24.4	64.6	29.8	29.1	19.0	23.9	14.8	21.2	26.0	24.9	10.3	29.9	22.6	11.8	20.5	24.8	10.0	9.9	19.8	11.0	13.0	14.9	3.2	23.4	16.2	8.4	10.6	22.2	19.2	21.4	30.2	25.3	11.9	14.4	13.9	13.1	8.1	7.9	25.6	13.8	13.3	21.4	24.8	10.3	9.8	10.9	14.4	22.1	22.3	11.5	8.0	10.2	20.5	18.8	36.6	17.2	13.3	12.7	19.1	10.0	8.8	5.0	9.1	15.5	2.0	25.5	8.5	14.8	24.7	5.4	7.1	18.7	20.2	23.1	29.7	8.4	20.7	12.2	14.2	23.5	21.5	15.7	11.0	7.1	21.7	10.1	14.3	19.8	5.5	12.0	14.9	6.4	12.5	8.1	9.2	10.3	4.5	10.0	9.6	7.2	7.7	13.0	11.0	9.9	6.0	3.2	16.7	29.0	26.9	27.1	18.1	12.3	30.5	12.8	18.9	24.9
GOLGA5	"golgin-84, GOLIM5, ret-II, rfg5"	ENSG00000066455	"Golgin A5"	Q8TBA6	14	92794231-92839963	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000992, HPA063876"	Enhanced	Supported	Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA000992: AB_1079009, HPA063876: AB_2685140"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.49e-2)"	20.8	20.3	16.8	15.7	17.3	6.5	24.4	11.6	17.5	24.9	20.4	17.2	25.5	16.5	18.2	41.7	21.2	15.3	17.5	18.3	17.5	15.6	21.5	51.0	16.6	18.2	18.6	14.6	18.9	26.8	23.6	27.2	44.4	16.4	23.4	23.7	12.7	24.3	30.2	20.6	18.9	25.6	18.9	19.4	16.9	23.0	23.5	17.6	13.5	24.8	17.8	16.4	20.7	15.8	9.7	9.7	22.2	12.7	8.1	12.4	6.3	12.6	11.6	10.5	9.6	22.1	30.0	18.1	17.5	32.3	17.1	20.2	8.5	17.4	8.2	14.4	27.8	13.3	9.3	14.3	23.3	10.0	4.4	7.7	5.8	11.4	25.7	9.0	13.0	23.0	26.0	12.0	24.9	16.8	6.8	11.1	18.7	23.4	6.9	7.8	6.5	12.5	5.4	15.5	8.2	17.4	15.4	7.5	10.6	15.9	12.0	17.8	20.6	10.0	13.9	9.8	6.5	12.7	8.7	13.6	10.5	7.2	22.6	7.2	16.4	9.1	9.8	22.2	10.9	12.7	12.3	9.7	11.1	11.1	9.7	9.2	9.9	8.6	8.7	8.1	10.8	9.1	12.4	6.3	16.8	17.3	11.6	17.5	17.5	15.6	18.6	14.6	16.4	17.6
GOLGB1	"GCP, GCP372, giantin, GOLIM1"	ENSG00000173230	"Golgin B1"	Q14789	3	121663199-121749767	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011008, HPA011555"	Enhanced		Enhanced	"Golgi apparatus"			35000	"Golgi apparatus"		"HPA011008: AB_1079011, HPA011555: AB_1079010"	"unprognostic (2.56e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.90e-3)"	"unprognostic (9.05e-2)"	16.7	22.3	17.6	12.5	24.0	12.8	25.7	22.3	28.0	24.6	16.8	8.2	27.1	12.7	16.5	35.0	15.9	14.0	14.0	16.6	16.8	10.3	19.7	17.2	13.4	8.5	26.1	14.5	20.9	23.4	26.2	39.4	24.4	17.7	28.0	18.4	12.5	21.5	29.3	11.7	20.5	20.6	21.3	30.6	14.8	16.6	12.1	20.7	9.0	19.3	12.9	10.1	17.2	13.6	3.6	5.8	16.4	4.4	3.9	5.0	1.5	12.4	10.0	10.0	6.5	19.3	21.0	6.3	8.1	17.9	7.9	8.9	8.8	4.6	2.7	6.8	15.1	5.8	5.9	8.8	9.3	3.9	11.3	7.7	12.1	12.1	11.5	8.5	10.6	17.1	21.0	4.9	12.4	9.9	3.5	6.2	8.2	8.9	2.5	6.2	6.5	10.6	3.4	7.9	6.4	11.7	12.9	7.1	7.9	10.0	7.1	10.5	8.8	9.6	13.7	7.5	4.6	3.3	5.8	11.7	6.9	4.6	10.2	4.2	2.8	1.7	4.4	4.3	5.0	2.2	4.0	3.6	4.0	3.6	2.7	3.2	3.7	4.0	16.4	3.9	1.7	5.8	3.8	1.5	17.6	24.0	22.3	28.0	16.8	10.3	26.1	14.5	17.7	20.7
GOLIM4	"GIMPC, GOLPH4, GPP130, P138"	ENSG00000173905	"Golgi integral membrane protein 4"	O00461	3	168008677-168095975	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001677, HPA002315"	Enhanced		Enhanced	"Golgi apparatus"			730000	"Golgi apparatus"		"HPA001677: AB_1079017, HPA002315: AB_1079018"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-3)"	13.0	7.1	25.5	10.8	25.6	4.2	9.3	12.4	24.2	11.3	28.0	18.6	7.4	34.8	15.6	7.1	9.3	9.7	16.2	28.5	31.3	13.8	17.1	31.7	15.6	5.5	24.6	23.2	11.6	8.8	13.3	10.3	12.0	26.8	10.2	28.0	13.3	8.9	7.9	15.5	6.1	44.2	14.6	36.2	11.7	13.0	4.9	30.9	1.8	11.0	12.0	5.0	10.7	12.2	2.0	4.5	11.7	3.3	6.0	0.8	0.7	6.6	9.8	14.0	8.8	23.8	17.7	4.2	39.0	21.0	10.6	9.8	10.9	8.2	14.5	46.9	23.4	12.2	12.8	11.4	16.2	22.7	16.5	23.5	29.5	13.5	9.6	22.3	13.4	18.4	6.1	9.8	9.7	12.1	12.0	42.4	12.0	10.9	0.0	6.0	13.6	10.6	0.0	14.0	20.2	5.9	2.4	12.6	16.3	23.9	7.2	7.8	8.9	10.1	22.6	34.0	13.1	23.7	31.0	16.5	11.8	31.3	16.9	13.4	15.1	3.0	3.0	11.7	0.8	3.3	0.2	1.5	0.2	0.6	3.7	2.0	0.0	0.3	0.1	6.0	2.5	4.5	0.0	0.7	25.5	25.6	12.4	24.2	31.3	13.8	24.6	23.2	26.8	30.9
GOLM1	"bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73"	ENSG00000135052	"Golgi membrane protein 1"	Q8NBJ4	9	86026146-86100173	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 83.7;stomach 1: 114.2"	"Cell line enhanced"	"Detected in many"		"U-266/70: 78.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 343.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010638, HPA011929, CAB015341"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"		70000000	"Golgi apparatus"		"CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (8.14e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.40e-3)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (4.89e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.23e-1)"	6.1	53.6	23.3	15.6	18.2	1.9	11.6	23.1	27.7	21.0	53.1	16.5	6.0	62.8	11.9	9.3	4.2	11.1	83.7	4.0	24.7	26.3	22.0	6.6	4.4	2.8	17.4	20.4	11.1	19.5	7.8	15.1	5.3	22.3	39.9	45.5	10.9	43.0	3.5	2.6	4.6	16.5	8.4	25.5	11.3	114.2	5.0	16.4	5.0	19.5	7.9	36.6	11.6	11.0	1.2	2.2	7.2	5.9	1.2	5.7	2.5	29.3	28.7	21.6	24.4	27.9	16.2	22.8	13.4	9.7	21.1	17.2	14.1	58.8	0.6	13.3	25.9	22.7	13.2	13.2	15.3	1.0	21.0	9.1	19.2	0.7	16.6	13.4	7.4	24.4	7.2	19.8	7.2	36.0	5.7	0.9	11.9	13.8	1.6	10.1	34.0	20.8	8.6	24.6	4.4	35.2	12.6	24.4	15.3	18.2	39.6	15.0	22.3	13.8	22.9	5.5	15.5	16.7	15.8	78.9	7.4	0.2	23.9	6.0	12.0	2.1	5.5	0.8	5.7	3.9	0.7	1.1	0.5	0.8	0.7	1.2	0.7	1.3	7.2	1.2	5.9	2.2	0.3	2.5	23.3	18.2	23.1	20.8	24.7	26.3	17.4	20.4	22.3	16.4
GOLPH3	"GOPP1, GPP34, MIDAS, Vps74"	ENSG00000113384	"Golgi phosphoprotein 3"	Q9H4A6	5	32124704-32174350	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044564, HPA055841"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA044564: AB_10795169, HPA055841: "	"unprognostic (1.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	26.7	22.0	17.9	21.8	17.4	7.9	24.9	19.9	20.6	27.9	40.5	22.1	25.0	20.9	24.3	28.3	24.6	19.4	36.0	23.1	17.7	17.8	30.7	75.0	24.3	22.6	20.9	12.6	26.6	37.2	27.2	22.9	35.6	19.0	36.0	28.2	22.3	35.8	24.9	20.6	19.0	34.0	33.0	19.6	21.3	28.1	16.0	19.1	26.4	30.0	19.3	26.0	25.4	27.9	11.9	9.5	18.9	11.1	8.7	13.2	4.2	15.6	10.5	17.0	18.4	32.3	31.0	48.8	21.6	28.9	20.3	19.4	14.2	28.3	14.1	21.4	29.1	14.7	21.0	15.2	25.7	18.3	12.5	15.5	35.9	27.0	26.0	23.9	18.2	23.6	21.9	19.9	23.0	16.2	16.1	34.4	22.5	15.7	15.2	31.2	14.6	10.8	14.3	24.5	14.5	25.3	19.9	13.0	14.5	50.2	52.7	21.2	21.5	26.6	15.6	18.0	16.8	14.1	15.1	38.7	47.4	17.1	16.1	34.4	21.3	7.3	8.4	18.9	8.9	11.1	7.8	10.8	9.7	11.5	9.5	11.9	11.1	8.4	8.6	8.7	10.8	7.3	13.2	4.2	17.9	17.4	19.9	20.6	17.7	17.8	20.9	12.6	19.0	19.1
GOLT1B	"CGI-141, GOT1, YMR292W"	ENSG00000111711	"Golgi transport 1B"	Q9Y3E0	12	21501781-21518408	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055909, HPA066383"	Approved		Supported	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA055909: , HPA066383: "	"unprognostic (1.22e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.37e-3)"	"prognostic unfavourable (1.99e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (4.83e-10)"	"unprognostic (3.13e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.04e-1)"	21.1	26.0	18.3	18.2	24.4	23.4	20.4	31.9	30.4	22.3	14.7	18.9	13.8	12.0	16.9	18.9	15.3	14.6	16.4	17.0	19.1	22.4	23.2	40.1	19.9	16.0	20.1	16.2	14.1	30.9	11.3	34.9	31.1	23.8	19.0	16.8	16.1	17.4	15.3	15.9	14.5	13.0	19.6	22.2	17.8	15.3	11.6	17.5	13.5	19.1	11.6	15.6	22.5	14.2	17.7	22.2	26.7	22.9	14.8	21.1	19.4	11.5	12.3	10.1	13.1	20.4	32.0	17.2	45.7	17.5	14.5	23.8	16.0	17.2	7.0	11.8	23.7	11.3	8.4	9.5	25.4	10.2	8.0	10.2	8.0	11.2	22.9	13.2	13.2	16.2	18.4	17.4	32.0	13.1	6.4	7.8	22.2	10.9	5.9	21.9	28.0	8.8	5.0	24.8	14.7	12.0	7.1	2.7	8.5	18.7	7.3	24.9	10.1	14.9	14.6	17.1	18.7	21.1	24.8	7.6	16.5	18.6	23.5	12.7	23.0	26.7	20.6	14.8	17.9	22.9	21.1	17.7	21.1	19.5	20.2	16.5	19.3	19.2	5.6	14.8	20.9	22.2	20.4	19.4	18.3	24.4	31.9	30.4	19.1	22.4	20.1	16.2	23.8	17.5
GON4L	"FLJ20203, GON-4, GON4, YARP"	ENSG00000116580	"Gon-4 like"	Q3T8J9	1	155749662-155859400	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA006986, HPA057305, HPA074504"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA006986: AB_1080620, HPA057305: , HPA074504: "	"unprognostic (3.16e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (9.85e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.26e-2)"	"unprognostic (5.83e-2)"	17.4	12.5	13.5	16.1	18.9	13.6	18.3	30.1	21.6	17.6	15.7	14.4	18.7	11.8	25.8	18.3	13.7	15.9	12.0	14.0	14.8	10.2	14.9	12.7	16.7	18.3	14.8	13.0	17.2	16.3	26.0	22.3	15.9	15.3	16.1	15.4	16.3	15.2	15.8	18.8	17.8	17.5	18.3	16.5	21.1	15.1	14.1	16.0	25.1	18.8	11.4	24.8	16.9	16.0	7.0	5.2	10.2	4.7	8.4	6.6	2.5	11.5	9.6	18.6	11.4	11.7	14.8	11.7	10.4	13.0	13.6	13.3	11.4	10.5	13.3	11.5	13.8	13.4	13.7	12.2	15.8	12.4	9.7	13.3	11.8	6.4	11.1	15.6	12.4	13.1	10.8	15.0	14.3	16.1	16.9	5.2	11.4	11.8	13.5	9.4	20.5	11.0	12.5	11.8	14.8	10.0	14.0	10.4	17.5	12.8	13.0	10.1	14.2	18.8	18.0	11.1	9.2	11.2	13.0	20.9	13.9	22.4	9.7	9.4	12.2	5.0	4.7	4.0	6.6	3.7	4.4	3.7	4.3	4.6	4.7	7.0	4.5	4.1	10.2	8.4	3.1	5.2	4.2	2.5	13.5	18.9	30.1	21.6	14.8	10.2	14.8	13.0	15.3	16.0
GON7	C14orf142	ENSG00000170270	"GON7, KEOPS complex subunit"	Q9BXV9	14	93202894-93207094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA051832	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051832: "	"unprognostic (2.28e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (3.40e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.47e-3)"	"unprognostic (7.37e-2)"	"prognostic favourable (3.08e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.77e-1)"	7.3	15.5	11.4	8.7	13.2	5.4	11.0	11.3	13.4	14.6	14.2	4.9	21.5	12.5	6.8	20.5	7.5	33.8	9.8	18.6	10.9	13.6	21.1	14.7	10.1	13.7	10.4	11.3	7.6	11.5	9.5	14.8	6.1	13.2	8.7	12.9	7.6	9.4	12.1	13.2	5.1	17.4	6.4	8.2	10.3	9.3	8.9	9.5	13.6	14.6	9.5	11.8	8.3	8.8	14.2	14.8	10.7	10.8	10.6	17.6	8.8	5.0	6.9	7.2	7.4	6.4	7.7	5.7	6.4	6.0	9.4	10.8	4.4	7.9	15.8	4.9	4.1	7.2	7.9	5.7	11.2	9.2	6.2	4.1	10.0	10.5	4.8	15.7	7.8	4.7	5.3	7.2	5.9	7.0	9.7	10.6	8.4	17.0	10.6	13.7	4.7	13.5	15.2	9.2	8.2	9.2	6.6	11.8	8.0	5.8	7.5	10.6	9.7	11.1	4.6	4.8	5.8	8.5	5.1	11.7	26.2	14.9	10.0	9.6	5.8	10.7	9.7	8.1	9.6	10.8	12.5	14.2	11.0	10.1	12.3	9.8	10.4	11.4	3.5	10.6	9.8	14.8	17.6	8.8	11.4	13.2	11.3	13.4	10.9	13.6	10.4	11.3	13.2	9.5
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	18.4	15.6	17.2	21.1	22.2	6.5	21.5	30.0	27.8	26.9	19.3	17.0	25.7	12.7	25.3	20.1	15.1	20.3	17.3	22.8	18.9	17.8	15.6	19.2	14.1	19.0	18.6	21.8	28.3	16.9	32.6	34.2	21.2	21.2	18.0	21.8	10.7	17.5	24.6	17.6	19.5	17.3	20.7	18.7	18.5	15.5	17.6	18.3	32.1	25.3	13.2	17.4	18.7	26.4	9.9	11.0	9.8	5.5	10.6	11.9	4.9	5.8	6.3	8.3	11.0	18.1	21.5	13.1	24.3	17.9	13.3	13.8	9.6	6.6	17.6	10.6	13.6	13.2	15.9	11.7	18.8	8.8	8.9	16.1	16.5	15.5	19.0	21.4	10.8	25.5	32.7	9.8	28.9	11.3	15.0	7.2	26.8	5.3	8.9	16.7	7.1	6.8	13.7	16.0	12.7	10.1	5.4	11.8	9.2	24.4	8.5	6.5	6.1	20.9	13.4	0.9	12.2	12.3	26.0	13.0	11.6	15.0	16.6	18.2	10.2	9.8	5.0	3.8	8.4	4.5	11.9	9.7	9.1	8.9	6.6	9.9	10.7	10.8	3.7	10.6	5.5	11.0	8.9	4.9	17.2	22.2	30.0	27.8	18.9	17.8	18.6	21.8	21.2	18.3
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532129-170553446	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027208, HPA027250, HPA027746"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favourable (1.39e-4)"	"prognostic unfavourable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	7.7	14.7	8.4	9.4	9.2	0.5	10.6	8.7	9.5	10.7	9.4	4.8	7.0	4.8	8.8	10.5	6.3	6.8	6.7	8.2	7.4	7.8	7.2	11.1	6.8	9.6	6.3	8.1	12.6	9.7	6.5	20.6	9.4	8.7	11.1	10.4	6.3	8.8	13.1	3.3	6.5	7.0	6.4	11.1	10.4	5.6	8.6	7.3	8.7	10.5	4.2	9.7	10.4	10.0	6.2	7.3	1.2	7.4	7.9	9.4	5.5	5.1	5.0	9.6	3.6	12.8	9.5	6.3	7.8	12.0	6.9	7.1	3.2	8.7	7.5	8.9	7.8	6.5	9.5	4.6	9.2	8.0	2.9	5.0	6.5	4.0	8.6	6.6	5.1	8.3	4.5	7.3	6.9	5.4	6.8	3.7	7.3	1.2	9.4	6.0	8.5	6.3	5.7	6.4	9.9	6.2	3.8	2.4	5.3	6.4	7.8	18.1	5.0	11.6	6.8	10.9	5.8	4.3	10.7	6.7	7.2	6.6	9.1	6.0	9.8	1.0	7.4	0.0	4.7	7.4	7.4	6.1	8.3	7.2	7.3	6.2	7.3	6.2	1.2	7.9	5.7	4.6	9.4	5.5	8.4	9.2	8.7	9.5	7.4	7.8	6.3	8.1	8.7	7.3
GORASP1	"FLJ23443, GOLPH5, GRASP65, P65"	ENSG00000114745	"Golgi reassembly stacking protein 1"	Q9BQQ3	3	39096659-39108363	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056283	Supported		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA056283: AB_2683085"	"unprognostic (1.06e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.92e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (2.13e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.73e-3)"	"prognostic favourable (1.91e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.24e-3)"	13.8	12.5	14.7	12.2	18.1	10.2	19.5	19.6	26.7	29.6	21.6	26.5	25.7	10.4	18.3	18.4	20.3	20.3	17.9	14.7	16.3	15.1	18.0	24.0	18.5	11.5	18.5	20.9	13.9	22.0	26.7	15.6	21.6	19.9	21.6	27.7	18.0	21.0	31.5	11.8	16.9	17.5	24.7	16.3	21.2	18.0	19.6	18.2	8.2	22.8	12.4	17.2	17.6	14.0	8.5	7.8	4.8	9.3	1.4	3.5	3.9	4.2	1.6	8.1	5.8	23.1	16.0	3.4	5.4	15.6	12.0	11.4	2.3	6.6	4.5	3.0	20.0	8.4	9.4	12.2	10.1	5.2	4.9	6.5	5.1	5.3	7.1	4.4	6.7	10.7	22.3	12.6	15.1	16.7	4.1	6.7	13.4	6.8	1.6	7.4	2.4	5.1	2.0	1.1	8.4	12.8	8.2	1.1	2.1	5.2	14.8	3.9	11.9	8.7	6.2	5.1	2.9	7.8	3.7	3.1	3.0	1.4	4.6	5.2	5.6	1.3	6.4	3.7	1.6	6.7	2.8	8.5	2.5	1.8	7.8	7.5	2.7	2.4	4.8	1.4	9.3	5.3	3.5	3.9	14.7	18.1	19.6	26.7	16.3	15.1	18.5	20.9	19.9	18.2
GORASP2	"GOLPH6, GRASP55, GRS2"	ENSG00000115806	"Golgi reassembly stacking protein 2"	Q9H8Y8	2	170928464-170967129	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 120.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035274, HPA035275, CAB075758"	Enhanced		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"CAB075758: , HPA035274: AB_2674546, HPA035275: AB_10602600"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavourable (7.32e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.38e-8)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-1)"	6.6	9.4	6.6	6.6	6.9	4.0	7.3	6.6	6.6	12.1	6.9	6.6	9.6	7.2	9.1	15.5	9.0	6.5	6.6	10.1	6.6	7.1	6.6	10.3	6.6	6.6	6.6	6.6	6.7	13.6	6.6	13.1	10.4	6.6	7.4	7.1	6.6	12.8	9.8	7.1	7.5	6.6	7.2	7.0	6.6	7.5	120.2	6.6	6.6	8.7	6.6	6.6	7.5	6.9	12.3	16.9	11.7	10.7	16.0	23.7	14.2	11.7	9.7	13.8	11.2	27.1	20.5	16.9	19.5	21.6	17.2	21.9	25.5	15.9	17.6	11.1	27.0	14.8	15.6	18.1	20.5	10.3	21.4	19.9	9.0	39.9	27.4	16.6	12.9	15.5	20.4	17.2	29.0	18.9	17.3	13.4	15.7	19.4	15.3	26.6	14.6	12.1	12.9	12.7	21.8	25.1	16.9	12.5	11.3	11.0	19.5	19.5	12.4	15.8	17.1	16.6	11.1	15.9	10.6	14.7	9.4	21.1	17.2	11.9	18.8	11.7	10.0	6.4	15.2	10.6	23.7	12.3	17.2	18.1	12.6	10.2	17.4	14.5	2.4	16.0	10.7	16.9	14.5	14.2	6.6	6.9	6.6	6.6	6.6	7.1	6.6	6.6	6.6	6.6
GOSR2	"Bos1, GS27"	ENSG00000108433	"Golgi SNAP receptor complex member 2"	O14653	17	46923075-46975524	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB017456, HPA048956, HPA054472"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"CAB017456: AB_10532285, HPA048956: , HPA054472: "	"unprognostic (3.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.29e-2)"	22.4	24.6	27.9	18.7	27.8	12.5	22.6	22.2	31.1	24.1	25.3	28.9	38.0	43.9	25.9	30.0	19.7	19.6	21.4	28.7	25.2	26.5	37.4	39.7	21.0	23.8	27.0	22.8	27.5	33.6	26.8	40.6	27.6	23.5	22.0	25.1	25.8	28.4	29.8	34.4	19.2	38.2	27.1	27.8	31.5	20.6	38.8	18.4	23.6	24.9	15.2	30.7	20.9	21.0	16.9	15.5	15.1	37.0	13.9	17.6	15.5	18.1	20.5	14.6	17.8	25.0	17.9	17.0	26.1	25.8	28.5	25.8	26.0	11.4	16.2	14.9	32.9	13.2	19.0	21.2	35.3	34.6	14.5	24.5	16.9	25.4	27.6	19.0	19.7	18.7	20.9	23.2	33.2	23.3	23.9	22.0	20.6	20.1	20.6	10.3	13.6	29.2	17.7	28.5	18.8	18.0	15.6	12.9	27.3	14.3	8.6	20.2	24.0	13.2	27.2	27.0	17.4	21.0	24.9	28.5	16.0	25.6	25.5	12.2	29.5	15.1	15.5	13.1	16.8	28.9	15.5	14.8	15.0	13.8	15.5	16.9	14.9	13.0	1.8	13.9	37.0	14.0	17.6	15.5	27.9	27.8	22.2	31.1	25.2	26.5	27.0	22.8	23.5	18.4
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol			130000000	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favourable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	16.9	9.4	11.1	28.0	8.6	7.4	31.4	13.9	25.6	24.3	26.5	21.3	13.8	16.6	4.8	11.7	21.3	25.3	18.3	26.8	5.7	10.8	6.3	12.1	27.7	45.6	18.0	10.8	11.6	19.8	20.6	55.9	11.7	16.2	26.0	15.5	15.3	9.6	13.5	7.1	13.1	10.5	10.6	17.3	42.4	9.3	4.8	7.1	10.5	14.9	51.9	28.5	6.2	5.4	6.2	13.8	6.7	15.9	18.6	21.9	16.9	16.3	9.4	8.2	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7
GPATCH11	"CCDC75, CENP-Y, CENPY, FLJ38348"	ENSG00000152133	"G-patch domain containing 11"	Q8N954	2	37084451-37099244	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038231, HPA038232"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA038231: AB_2675904, HPA038232: AB_10675788"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.31e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.16e-2)"	26.0	8.5	14.4	9.4	15.8	11.0	11.1	16.0	17.5	9.9	6.0	10.7	4.0	6.2	7.3	5.2	6.8	5.1	5.9	6.9	14.3	13.9	7.3	7.3	8.0	14.8	16.1	16.2	8.2	4.4	6.6	11.2	7.3	15.3	5.6	6.6	4.9	5.2	5.8	7.3	7.6	6.4	5.7	22.7	9.7	6.2	14.1	15.5	8.6	8.5	2.8	14.3	8.0	8.2	9.3	12.9	5.9	2.8	7.3	4.9	1.5	6.3	3.8	6.5	5.1	14.0	6.5	7.0	11.4	4.6	7.0	5.7	4.8	2.7	7.3	6.4	4.3	4.6	7.7	2.8	10.4	12.5	8.5	13.4	5.2	4.8	4.5	15.9	14.6	4.2	4.9	9.5	5.4	6.1	12.5	34.9	8.1	3.2	10.2	8.8	2.8	5.4	8.5	14.0	20.5	3.0	2.7	7.9	7.4	6.0	3.9	5.6	4.0	7.4	6.7	12.7	7.0	9.2	12.6	13.7	14.1	11.2	9.0	13.5	11.1	5.9	2.8	2.3	4.9	2.0	4.9	9.3	3.7	4.1	3.8	7.8	4.0	4.1	0.9	7.3	0.8	12.9	2.6	1.5	14.4	15.8	16.0	17.5	14.3	13.9	16.1	16.2	15.3	15.5
GPATCH2	"CT110, FLJ10252, GPATC2, Pfa1, PPP1R30"	ENSG00000092978	"G-patch domain containing 2"	Q9NW75	1	217426992-217631082	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027181, HPA027322"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA027181: AB_10602601, HPA027322: AB_1848645"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (9.99e-6)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	11.0	10.4	14.6	13.7	19.0	6.7	17.1	12.2	19.9	15.1	12.4	10.6	19.4	11.4	15.9	19.2	13.4	12.2	14.8	11.6	12.9	13.7	12.7	11.4	10.4	11.0	11.0	13.4	13.6	12.5	18.2	27.7	14.6	12.8	17.0	11.2	8.5	12.2	19.5	13.0	12.0	13.8	12.3	11.5	11.7	11.2	16.6	12.2	20.6	16.5	11.7	12.7	12.2	13.3	5.2	9.0	6.6	6.0	4.8	6.0	2.7	6.9	7.9	8.6	6.7	7.6	7.7	7.1	6.5	8.0	9.1	8.6	6.9	9.1	7.4	6.7	5.6	8.2	9.6	7.7	10.7	5.5	5.5	4.9	6.5	4.4	9.4	7.4	5.8	6.8	11.3	10.6	17.5	6.2	11.9	0.1	6.6	6.5	9.9	5.3	15.5	8.7	4.9	19.6	8.9	6.4	15.1	10.1	14.4	11.6	10.7	8.5	10.0	7.3	6.4	8.6	6.0	12.0	6.0	7.8	5.5	7.1	6.5	4.9	6.1	6.6	6.0	1.9	5.1	3.4	3.5	4.6	6.0	3.5	6.1	5.2	5.3	4.8	0.9	4.8	4.9	9.0	5.1	2.7	14.6	19.0	12.2	19.9	12.9	13.7	11.0	13.4	12.8	12.2
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594487-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: "	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	18.2	13.3	14.7	16.9	27.7	9.4	15.1	6.9	22.5	10.0	12.1	8.3	3.9	9.7	13.8	10.0	14.0	11.6	7.2	11.9	12.6	12.1	18.0	23.1	10.0	15.7	15.3	12.4	15.3	12.9	19.6	16.2	10.0	24.2	12.6	14.6	5.7	11.5	11.9	47.1	10.9	10.0	15.1	10.2	16.6	12.5	8.8	13.2	8.0	10.3	19.0	19.1	12.5	10.1	16.6	10.1	0.3	11.2	10.7	15.9	7.6	17.1	23.6	10.0	14.3	9.2	7.0	12.9	21.2	8.5	16.6	9.7	24.1	13.0	41.2	17.6	14.8	12.0	22.6	18.7	18.4	12.2	22.4	24.6	23.1	18.4	8.3	54.8	15.9	8.0	15.8	31.4	27.8	11.6	40.2	10.4	13.4	31.9	22.5	13.3	43.6	24.9	22.5	17.0	28.5	11.4	20.3	15.7	23.7	20.3	44.7	13.1	14.6	26.7	17.7	15.8	21.5	16.4	37.9	19.0	20.9	53.2	14.3	28.5	23.9	0.0	5.4	0.1	13.3	10.5	13.4	16.6	13.5	14.7	10.1	16.6	15.4	15.9	0.3	10.7	11.2	6.4	8.5	7.6	14.7	27.7	6.9	22.5	12.6	12.1	15.3	12.4	24.2	13.2
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435671-240468078	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 142.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030571	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"		6500000	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (5.78e-5)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	13.6	22.8	32.4	7.2	21.0	1.9	8.1	42.7	33.6	11.5	8.1	10.1	9.5	5.4	9.6	9.8	26.3	7.8	7.1	40.7	26.5	11.9	8.5	11.0	7.4	4.0	8.8	22.5	14.1	18.1	5.8	14.4	20.2	13.6	29.5	4.0	6.3	16.3	17.6	62.9	142.6	4.9	12.0	8.3	5.2	6.5	20.0	10.5	1.7	4.5	24.3	10.7	10.5	15.2	0.9	0.1	0.0	0.0	0.1	0.8	0.3	16.0	22.1	5.2	13.7	16.0	15.4	21.3	38.6	19.2	4.5	5.2	7.9	18.0	0.4	5.3	40.8	44.4	2.8	27.4	0.9	7.7	2.3	0.0	20.3	9.7	23.0	0.3	1.5	13.5	17.9	10.0	5.2	2.3	0.1	0.8	11.4	8.4	0.2	0.1	8.2	4.9	2.8	23.9	3.7	3.6	26.0	5.2	3.5	25.2	22.3	2.3	7.0	1.6	10.8	24.0	40.7	11.4	15.9	0.1	0.1	0.1	17.1	0.4	26.8	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.3	32.4	21.0	42.7	33.6	26.5	11.9	8.8	22.5	13.6	10.5
GPC3	"DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1"	ENSG00000147257	"Glypican 3"	P51654	X	133535745-133985895	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 262.7"	"Group enriched"	"Detected in some"	8	"HAP1: 53.1;Hep G2: 209.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 269.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7"	"Group enriched"	"Detected in many"	12	"NK-cells: 1.7;T-cells: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006316			Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA006316: AB_1078994"	"unprognostic (2.06e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.51e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.92e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.81e-3)"	"prognostic unfavourable (4.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	30.1	5.9	0.4	3.6	0.7	0.0	50.2	0.6	0.4	3.3	4.5	0.5	2.2	0.5	2.5	11.7	2.0	3.4	9.2	8.0	0.4	1.1	21.2	1.1	37.0	1.9	1.6	0.4	6.0	4.6	0.3	16.9	262.7	1.6	3.6	1.0	6.3	3.8	2.3	4.1	5.5	1.8	3.3	2.1	0.9	4.0	2.1	0.3	2.3	7.2	11.2	3.0	7.6	8.0	0.0	0.2	0.0	0.0	1.7	5.0	0.6	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	2.4	0.0	0.1	209.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	14.5	0.6	1.7	4.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.2	0.0	5.0	3.5	0.0	1.7	0.0	0.0	0.0	0.6	0.4	0.7	0.6	0.4	0.4	1.1	1.6	0.4	1.6	0.3
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.1	107.4	9.4	73.5	30.9	23.0	22.5	29.4	23.2	37.1	44.8	60.5	27.0	50.2	43.7	28.8	53.1	56.8	63.9	42.2	55.8	22.9	64.5	51.8	63.6	20.0	83.5	42.0	31.5	26.4	43.9	22.8	34.6	32.8	39.8	26.1	64.6	36.3	29.2	25.4	38.0	34.0	24.9	94.8	46.5	51.3	51.4	29.9	59.3	104.6	21.4	23.7	26.6	29.8	14.0	30.9	39.8	45.3	73.5	41.7	45.5	46.8	63.5	28.4	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0
GPKOW	"GPATC5, GPATCH5, Spp2, T54"	ENSG00000068394	"G-patch domain and KOW motifs"	Q92917	X	49113389-49123801	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000287, HPA001894"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000287: AB_1079015, HPA001894: AB_1079014"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	14.9	14.6	20.1	11.8	23.1	15.0	13.8	24.3	25.3	14.5	14.8	22.6	11.7	15.3	15.5	13.4	14.7	17.0	11.3	17.0	17.6	20.1	12.3	15.8	12.8	14.1	22.9	28.9	14.3	11.5	22.4	15.8	14.7	20.0	13.8	13.9	12.1	13.4	19.3	31.9	16.9	14.1	15.3	20.3	14.0	13.5	8.0	22.3	15.7	14.2	9.0	14.9	14.8	12.1	21.3	17.0	20.7	24.8	17.8	29.5	14.6	20.3	21.7	14.5	12.1	12.9	11.2	15.8	13.2	14.9	21.1	22.4	15.7	20.4	8.5	10.2	16.2	14.5	16.1	15.6	13.8	17.9	17.1	8.9	18.2	11.1	15.4	10.5	18.9	12.2	20.0	16.8	17.2	15.8	10.9	13.4	13.7	33.1	14.3	17.5	10.3	17.3	18.0	16.0	23.1	10.8	26.0	12.2	14.2	15.4	14.7	14.2	28.1	13.8	17.5	12.2	18.6	17.7	12.4	20.8	14.1	11.6	15.7	17.5	18.8	19.3	16.8	20.7	29.5	23.1	24.0	15.4	23.2	22.0	17.0	21.3	19.7	18.5	13.3	17.8	24.8	15.5	22.7	14.6	20.1	23.1	24.3	25.3	17.6	20.1	22.9	28.9	20.0	22.3
GPN1	"ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1"	ENSG00000198522	"GPN-loop GTPase 1"	Q9HCN4	2	27628247-27651508	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036793, HPA036794, CAB037303"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230"	"unprognostic (9.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (2.88e-5)"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavourable (1.71e-5)"	"unprognostic (3.50e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	24.3	24.3	18.8	18.7	23.2	28.1	26.3	22.9	27.2	18.3	21.6	20.7	13.7	19.3	21.3	21.2	26.7	21.0	18.2	21.5	17.2	22.1	29.7	29.2	18.2	29.2	20.0	16.1	24.6	35.4	19.8	18.5	31.1	23.3	18.8	25.6	14.3	23.0	17.6	30.9	25.0	25.3	22.1	16.4	26.6	20.8	30.2	15.9	29.0	26.9	22.5	28.3	21.5	24.3	29.1	35.8	28.5	28.2	39.6	38.6	29.7	32.1	18.3	17.2	12.5	16.3	16.7	17.5	18.0	17.9	25.5	18.9	19.9	16.9	20.1	17.5	19.6	14.0	23.9	22.3	25.9	18.7	16.7	23.0	14.7	24.2	21.2	33.6	12.1	17.1	19.7	26.2	24.6	26.6	28.5	18.9	30.1	18.7	20.3	25.2	29.8	18.0	20.5	51.1	21.0	20.6	18.6	15.4	24.4	19.7	22.2	20.0	13.3	19.5	21.6	22.3	32.9	11.0	42.1	21.9	23.5	54.1	32.0	29.2	18.3	28.5	24.7	21.1	33.4	28.2	36.0	29.1	31.1	38.6	35.8	25.2	27.7	34.1	3.7	39.6	26.3	18.5	30.3	29.7	18.8	23.2	22.9	27.2	17.2	22.1	20.0	16.1	23.3	15.9
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 19.1"	"Group enriched"	"Detected in some"	4	"HHSteC: 52.5;hTCEpi: 23.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.7;pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	2.3	5.0	0.5	0.6	10.7	0.1	1.7	0.4	1.2	4.1	0.6	4.8	1.6	0.2	1.3	0.7	6.6	1.1	2.7	3.8	1.6	0.5	0.7	0.0	0.5	3.1	0.2	0.3	3.2	0.1	0.0	0.4	19.1	6.6	0.7	0.6	1.1	1.5	0.4	1.5	6.7	0.5	2.3	0.3	0.2	0.2	1.6	1.0	0.0	0.7	2.2	1.2	3.1	7.7	0.5	0.1	1.4	0.2	0.5	0.2	0.6	0.8	0.1	0.7	0.0	0.1	2.9	0.2	5.4	9.3	3.3	2.8	0.0	0.0	0.0	0.3	2.7	0.1	0.2	0.0	1.1	0.0	0.1	0.0	1.8	0.0	52.5	0.0	0.0	2.1	23.7	4.8	7.7	0.0	0.0	0.0	6.7	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	2.3	1.1	0.0	0.0	0.0	0.0	0.1	4.1	1.8	4.7	0.4	0.0	0.0	0.0	1.4	0.0	0.1	1.3	0.2	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.5	0.2	0.2	1.4	0.5	0.1	0.1	0.2	0.6	0.5	10.7	0.4	1.2	1.6	0.5	0.2	0.3	6.6	1.0
GPR156	"GABABL, PGR28"	ENSG00000175697	"G protein-coupled receptor 156"	Q8NFN8	3	120164645-120285094	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 7.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 3.0;PC-3: 3.0;SiHa: 7.9;U-2 OS: 4.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028642, HPA028644"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA028642: AB_10599711, HPA028644: AB_10600441"	"unprognostic (2.85e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.62e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.03e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.71e-2)"	0.9	0.5	0.8	1.6	2.2	0.0	1.0	0.1	1.0	1.4	0.7	0.0	0.0	0.0	1.2	0.0	1.9	3.4	1.3	0.2	0.4	0.3	0.3	0.0	0.2	0.0	0.3	0.0	1.4	0.0	0.0	1.4	1.2	0.7	1.9	0.2	0.4	2.4	1.5	0.1	0.3	0.2	1.6	1.5	0.1	0.3	7.7	1.2	0.0	0.1	0.0	0.4	2.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.8	0.1	0.9	1.3	0.1	0.6	0.0	0.8	3.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	2.0	0.0	0.8	0.2	0.0	1.9	0.2	0.4	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.9	3.0	0.0	0.0	0.0	0.0	0.0	1.0	1.5	7.9	0.0	0.9	1.0	0.1	0.2	0.2	4.4	0.0	0.3	1.0	0.4	0.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.1	1.0	0.4	0.3	0.3	0.0	0.7	1.2
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037929-170085403	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.0"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 30.4;SK-BR-3: 24.2;THP-1: 47.8;U-266/70: 52.8;U-266/84: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA006970	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.61e-4)"	7.0	1.4	3.1	21.7	2.5	23.6	8.2	0.9	1.8	2.6	31.2	1.5	7.9	18.0	1.9	21.5	2.6	1.8	16.2	3.0	1.9	1.7	27.4	2.1	23.2	25.6	2.7	0.4	1.6	14.7	71.0	3.5	2.9	1.8	10.7	18.1	11.8	14.2	4.7	2.0	1.8	43.2	0.9	4.7	17.9	18.0	2.9	2.4	6.6	3.8	1.0	10.7	9.1	6.9	11.2	2.9	10.1	1.1	0.3	3.0	1.2	15.6	0.3	0.0	0.1	0.0	0.1	3.9	0.1	0.1	0.1	0.5	2.8	2.0	7.2	3.3	0.1	0.1	2.1	0.1	0.2	11.0	4.3	4.7	0.2	5.8	0.0	9.2	6.4	0.0	0.2	0.5	0.5	0.3	1.5	18.8	0.1	10.0	0.6	1.9	2.5	0.6	1.3	0.3	30.4	8.2	21.6	1.5	0.4	0.1	24.2	1.1	14.2	47.8	0.4	0.0	0.1	1.8	1.1	52.8	30.3	12.7	0.2	10.0	0.7	1.5	1.1	8.1	0.5	0.4	0.9	6.8	0.9	0.4	2.2	11.2	3.0	1.1	10.1	0.3	0.1	2.9	0.3	1.2	3.1	2.5	0.9	1.8	1.9	1.7	2.7	0.4	1.8	2.4
GPR20		ENSG00000204882	"G protein-coupled receptor 20"	Q99678	8	141356500-141367267	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 6.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 3.7;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 5.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.3"	HPA071337			Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA071337: "	"unprognostic (4.47e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.23e-2)"	"unprognostic (4.07e-1)"	2.8	0.5	0.7	2.7	1.4	0.1	2.5	0.2	2.0	10.6	9.1	1.0	4.3	2.2	6.7	1.9	3.4	3.9	6.1	2.1	0.8	0.4	1.1	0.4	3.5	0.3	1.4	0.9	3.7	0.5	0.5	0.5	3.2	2.1	2.2	1.0	1.1	0.5	3.0	2.1	1.0	10.5	4.5	0.5	0.8	4.3	1.6	0.7	0.0	1.4	1.5	0.5	1.7	3.4	0.0	0.3	0.3	5.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	6.9	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.1	0.7	1.4	0.2	2.0	0.8	0.4	1.4	0.9	2.1	0.7
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 10.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in single"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA049862: , HPA054678: "						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0
GPRASP1	"GASP, GASP1"	ENSG00000198932	"G protein-coupled receptor associated sorting protein 1"	Q5JY77	X	102651366-102659083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 6.7;REH: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.2"	"Group enriched"	"Detected in many"	5	"B-cells: 1.4;T-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000161, HPA031061"	Uncertain		Supported	Cytosol				Cytosol		"HPA000161: AB_2247872, HPA031061: "	"unprognostic (3.92e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.42e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.82e-1)"	"prognostic favourable (1.77e-5)"	"unprognostic (3.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (1.23e-2)"	3.5	16.6	19.0	3.7	34.3	2.5	4.0	28.2	37.0	8.9	7.2	4.3	1.6	1.9	18.2	8.1	3.3	8.7	5.5	10.6	19.9	18.3	5.2	1.4	3.8	6.2	7.9	30.3	29.9	3.0	22.4	16.1	2.2	20.6	12.0	3.5	4.0	5.1	13.4	4.0	2.2	4.1	11.7	6.6	6.8	3.5	2.9	5.6	0.9	11.9	0.8	5.4	6.3	6.3	1.4	0.6	0.0	0.0	0.3	5.2	1.0	0.4	0.8	2.6	1.6	2.6	2.6	1.5	2.7	0.2	4.0	6.7	0.3	0.5	0.0	0.6	5.5	0.7	0.8	0.1	5.8	0.0	0.3	0.2	0.7	0.7	2.1	0.3	0.3	3.4	1.0	4.9	0.4	0.4	0.5	0.2	6.3	0.6	5.2	0.2	1.8	0.8	8.0	2.5	0.0	0.4	0.6	2.5	4.1	0.9	0.4	0.7	0.3	1.3	0.7	1.3	1.6	0.8	0.4	0.4	0.6	0.0	0.6	0.4	1.7	0.0	0.0	0.0	1.3	0.0	2.9	0.6	2.4	1.0	0.0	1.4	5.2	4.8	0.0	0.3	0.0	0.6	1.8	1.0	19.0	34.3	28.2	37.0	19.9	18.3	7.9	30.3	20.6	5.6
GPRC5A	"PEIG-1, RAI3, RAIG1, TIG1"	ENSG00000013588	"G protein-coupled receptor class C group 5 member A"	Q8NFJ5	12	12890782-12917937	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 155.0"	"Cell line enhanced"	"Detected in many"		"A-431: 41.8;CAPAN-2: 161.0;HaCaT: 42.2;SiHa: 59.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 3.1"	"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA007928, HPA046526"	Enhanced		Enhanced	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA007928: AB_1849318, HPA046526: "	"unprognostic (4.79e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavourable (4.63e-6)"	"unprognostic (3.81e-1)"	"prognostic unfavourable (9.02e-5)"	"unprognostic (9.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.49e-1)"	9.8	1.4	0.2	6.0	0.6	0.4	5.4	0.1	0.3	12.1	19.8	0.5	2.0	6.2	4.3	1.9	9.1	3.0	15.5	7.1	0.1	0.2	5.1	0.6	155.0	0.1	0.5	0.1	18.5	1.1	0.0	0.9	20.1	3.1	10.4	16.9	4.8	9.6	1.5	1.1	2.0	36.9	14.2	1.1	0.1	11.4	4.8	0.3	0.1	54.2	14.9	11.5	32.1	14.0	0.6	0.6	3.1	0.3	0.5	0.4	0.0	41.8	33.5	0.0	0.1	0.4	0.2	2.1	12.6	4.8	8.2	6.3	5.8	161.0	0.0	1.0	10.0	42.2	0.1	6.1	12.6	0.0	0.5	0.0	13.8	0.2	3.0	0.0	0.0	0.2	8.2	3.4	0.8	5.0	0.0	0.0	0.3	29.3	0.0	0.0	0.1	5.2	0.0	0.9	0.0	16.3	8.3	0.0	0.0	59.2	4.5	1.9	1.3	0.1	0.5	0.3	10.7	19.2	0.5	0.0	0.0	0.0	4.3	0.0	0.2	3.1	0.3	0.4	0.3	0.2	0.3	0.3	0.2	0.3	0.1	0.6	0.4	0.4	1.3	0.5	0.2	0.6	0.3	0.0	0.2	0.6	0.1	0.3	0.1	0.2	0.5	0.1	3.1	0.3
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 108.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 38.4;HHSteC: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive CD4 T-cell: 6.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles				Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"	12.6	4.4	45.2	3.2	55.9	1.0	7.3	22.8	108.0	5.4	2.9	95.1	4.9	4.0	7.1	9.3	5.5	12.7	9.2	22.3	47.8	28.7	12.1	2.7	3.9	4.6	63.1	34.9	13.7	12.7	9.5	3.8	9.3	38.6	6.3	2.3	3.8	20.8	11.5	35.1	2.5	3.3	5.1	61.6	2.2	22.7	19.6	63.1	0.0	7.2	2.6	2.7	6.2	3.0	0.0	0.0	0.0	1.5	0.0	6.5	1.3	0.4	12.3	12.3	2.2	12.7	0.8	2.2	0.1	3.1	1.2	0.8	11.3	0.4	0.0	38.4	0.4	0.6	9.0	0.0	0.7	0.0	3.3	0.0	0.0	0.0	26.2	0.0	0.0	1.1	0.0	2.1	0.0	6.0	2.5	0.2	2.8	0.6	0.0	0.0	13.4	5.8	3.5	0.0	0.0	0.4	5.7	9.5	0.8	1.4	0.8	11.0	0.0	0.2	1.1	0.0	1.4	6.0	0.3	0.1	0.0	0.0	0.6	0.1	0.7	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.3	0.0	0.0	1.3	45.2	55.9	22.8	40.5	47.8	28.7	63.1	34.9	38.6	63.1
GPRIN1	"GRIN1, KIAA1893"	ENSG00000169258	"G protein regulated inducer of neurite outgrowth 1"	Q7Z2K8	5	176595802-176610133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 28.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.3;SCLC-21H: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036478, HPA070892"	Enhanced		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA036478: , HPA070892: "	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.06e-1)"	"unprognostic (4.76e-6)"	"prognostic unfavourable (6.83e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-3)"	"prognostic unfavourable (2.79e-7)"	"unprognostic (4.24e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.32e-3)"	1.3	3.2	16.9	1.8	6.4	0.9	0.9	16.9	28.2	1.1	1.6	0.2	0.0	6.4	1.3	0.6	1.1	0.7	1.1	0.7	11.1	11.1	0.7	0.7	1.1	1.7	3.6	11.4	0.5	1.5	0.7	5.8	1.0	4.4	0.7	1.3	0.7	0.7	0.6	0.7	1.5	4.0	1.7	1.9	0.9	1.9	2.2	0.7	0.0	0.8	0.0	2.3	0.9	0.1	0.9	0.0	0.0	0.0	0.5	0.3	0.0	3.6	3.9	4.9	7.1	1.1	2.4	4.2	4.9	2.5	3.8	4.9	4.7	2.4	8.3	10.0	2.6	3.2	3.1	3.4	3.3	27.3	2.1	0.1	2.1	1.6	0.4	0.2	2.1	1.1	2.6	4.1	0.6	2.7	4.3	12.1	3.1	9.5	0.8	0.0	5.0	7.7	15.4	5.5	4.9	4.3	3.8	30.3	17.4	5.6	1.6	8.5	3.7	3.1	3.3	7.1	8.2	2.7	7.1	0.2	1.0	2.3	6.1	0.4	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.9	6.4	16.9	14.3	11.1	11.1	3.6	11.4	4.4	0.7
GPS1	"COPS1, CSN1"	ENSG00000169727	"G protein pathway suppressor 1"	Q13098	17	82050691-82057470	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047448, HPA052848"			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA047448: , HPA052848: "	"unprognostic (1.96e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favourable (3.06e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.07e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.15e-1)"	23.5	23.9	27.2	19.3	28.2	23.6	18.8	27.7	47.2	20.5	18.7	33.3	19.8	22.4	21.5	21.1	22.2	24.5	19.2	33.4	28.7	26.7	29.6	39.9	17.2	21.6	28.7	25.9	25.3	34.4	23.2	22.3	20.8	28.0	23.2	12.0	25.1	37.1	28.9	67.1	26.5	19.7	16.8	23.7	20.7	21.9	36.0	18.2	32.3	25.3	29.8	20.6	19.5	17.0	26.1	37.3	25.2	34.5	29.7	44.0	36.0	26.7	50.1	18.7	24.3	13.2	12.8	26.4	18.0	14.5	28.7	23.8	43.8	16.7	13.3	16.2	18.0	20.4	17.7	23.1	9.8	8.8	63.3	22.4	28.1	48.5	21.9	24.4	21.8	18.2	16.9	25.3	15.1	29.8	21.0	15.4	15.8	52.9	41.6	27.7	23.7	37.5	25.6	25.6	21.5	17.6	27.9	32.0	50.2	18.3	34.0	26.6	38.5	22.1	16.9	28.7	34.0	22.1	28.9	28.3	11.8	14.0	22.4	15.8	25.7	19.6	34.5	25.2	33.0	31.7	34.5	26.1	34.8	33.0	37.3	24.5	25.0	31.2	5.4	29.7	28.6	25.7	44.0	36.0	27.2	28.2	27.7	47.2	28.7	26.7	28.7	25.9	28.0	18.2
GPS2		ENSG00000132522	"G protein pathway suppressor 2"	Q13227	17	7311324-7315564	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067540	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA067540: "	"unprognostic (1.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (7.50e-5)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (3.42e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.28e-3)"	21.8	22.8	21.1	17.6	20.9	27.8	25.0	18.2	25.4	18.5	23.4	19.1	14.4	14.4	20.0	15.5	24.6	19.9	15.5	35.3	19.9	17.1	28.7	30.1	18.5	15.2	19.5	16.9	20.9	23.0	26.6	21.1	21.9	16.5	17.5	20.2	14.3	19.7	21.5	72.4	23.0	25.7	18.2	21.2	20.6	18.0	45.8	22.1	21.2	22.4	21.0	21.1	19.2	25.0	55.2	48.3	58.1	46.4	28.2	57.0	38.8	19.4	37.8	12.1	16.5	24.1	13.6	13.9	14.1	16.7	28.6	24.7	26.2	10.0	22.0	10.7	19.4	26.7	15.3	27.5	22.2	26.8	24.1	20.4	35.9	32.4	17.1	12.2	23.7	12.8	19.1	39.3	10.5	16.7	12.3	5.2	29.6	16.4	23.7	12.9	16.5	15.8	18.2	22.4	22.5	21.2	22.0	16.1	27.0	23.0	14.8	19.3	14.5	11.9	10.0	13.4	13.8	18.5	32.8	17.2	24.4	14.7	20.1	14.4	23.4	44.1	35.3	58.1	40.8	43.0	38.4	55.2	45.5	45.8	29.5	43.3	42.5	38.5	56.4	28.2	46.4	48.3	57.0	38.8	21.1	20.9	18.2	25.4	19.9	17.1	19.5	16.9	16.5	22.1
GPSM1	"AGS3, DKFZP727I051"	ENSG00000160360	"G protein signaling modulator 1"	Q86YR5	9	136327476-136359605	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042199, HPA060736"	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA042199: AB_10959329, HPA060736: "	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.07e-4)"	"unprognostic (4.07e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.48e-2)"	7.8	10.2	15.2	5.6	8.3	5.6	4.2	38.6	23.0	10.5	5.3	12.8	4.8	4.7	13.4	10.1	2.6	7.1	8.3	25.5	8.8	11.6	5.5	1.8	13.8	3.2	8.8	14.2	16.4	28.1	4.4	6.6	8.8	10.5	12.7	2.2	20.4	7.7	8.6	2.8	12.0	4.6	9.0	9.1	8.0	6.1	12.0	9.9	2.8	3.9	3.7	2.0	5.0	8.2	0.4	0.7	0.0	2.0	0.0	2.1	0.3	1.6	2.7	6.6	11.5	3.8	6.6	5.5	19.0	7.9	5.4	2.9	5.5	1.8	0.0	8.0	11.5	1.2	1.0	3.9	1.2	14.9	11.2	2.2	8.9	1.0	16.2	0.1	2.8	10.7	2.6	4.9	2.8	5.4	5.7	0.1	3.5	6.2	1.0	2.1	6.9	10.0	35.4	11.8	5.5	1.4	1.2	16.1	20.0	3.5	0.4	5.9	8.0	3.8	8.7	10.0	8.0	11.6	3.8	3.4	0.1	0.0	6.0	0.0	9.4	0.0	0.3	0.0	0.7	2.0	0.8	0.0	1.2	0.1	0.7	0.4	0.5	0.3	0.0	0.0	0.0	0.0	2.1	0.3	15.2	8.3	38.6	18.8	8.8	11.6	8.8	14.2	10.5	9.9
GPSM2	"DFNB82, LGN, Pins"	ENSG00000121957	"G protein signaling modulator 2"	P81274	1	108875350-108934545	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 35.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007327, HPA008408, CAB018962"	Uncertain		Supported	Cytosol				Cytosol		"CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939"	"unprognostic (1.97e-1)"	"unprognostic (6.80e-2)"	"prognostic favourable (7.86e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.57e-6)"	"unprognostic (7.12e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (7.55e-3)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (6.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.00e-2)"	3.8	4.0	16.6	4.4	17.9	13.9	8.5	10.1	20.6	7.5	13.6	17.9	2.5	8.0	6.9	4.3	30.4	2.9	3.1	3.0	15.2	14.1	2.6	1.9	6.6	5.8	19.7	9.0	2.4	2.4	4.0	2.1	7.6	19.6	6.3	15.4	1.3	7.0	5.7	8.0	35.6	10.1	10.6	25.1	2.0	5.3	11.4	18.8	14.1	2.3	23.5	12.1	6.5	10.6	1.8	1.6	8.6	1.2	0.7	4.4	0.4	40.7	5.9	13.4	10.6	13.5	8.1	10.1	8.2	20.8	10.2	15.7	6.3	10.5	9.3	2.2	11.4	8.9	8.6	21.5	13.1	9.6	5.8	6.9	11.4	6.9	1.8	9.2	6.3	1.5	44.0	11.0	43.9	10.8	5.2	14.1	21.8	12.7	7.3	4.7	3.4	9.9	6.5	21.7	2.5	8.8	6.4	10.2	8.9	11.2	22.9	8.6	9.0	8.9	6.7	7.8	12.3	20.8	15.4	6.3	5.8	9.2	12.5	15.3	36.2	0.1	1.2	8.6	0.8	0.9	0.5	0.7	0.6	1.1	1.6	1.8	1.1	0.8	1.6	0.7	0.4	0.7	4.4	0.4	16.6	17.9	10.1	13.6	15.2	14.1	19.7	9.0	19.6	18.8
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"		220000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: , HPA058546: "	"unprognostic (8.42e-3)"	"prognostic favourable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favourable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	163.0	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119.0	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47.0	56.7	64.0	85.2	85.2	28.4	58.5	110.5	28.3	32.3	46.7	98.7	141.7	84.0	52.0	22.5	81.3	42.9	43.8	65.9	38.5	10.3	24.6	45.5	32.0	27.3	32.6	21.0	57.6	49.3	19.4	29.0	92.9	82.4	22.7	31.1	83.3	49.7	21.7	36.6	60.0	27.1	25.9	35.4	72.9	38.4	39.0	44.2	52.1	53.3	6.3	29.7	46.6	70.6	40.3	25.5	44.1	41.9	45.8	40.9	55.6	50.8	45.7	30.4	78.3	28.2	91.1	61.7	24.0	43.0	45.6	26.2	75.6	85.2	85.2	37.0	62.0	43.0	56.7	54.3	38.6	64.0	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160118-55167071	"Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 51.7;fHDF/TERT166: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA036720	Enhanced		Supported	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA036720: "	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavourable (5.13e-9)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	12.6	7.1	0.8	5.8	1.0	0.0	12.2	0.5	0.7	31.4	6.8	1.7	17.3	1.3	23.6	34.5	13.3	13.2	11.2	12.1	1.0	0.9	13.7	2.6	7.3	5.6	1.1	0.9	31.5	5.0	4.5	3.2	40.9	4.0	24.2	4.7	17.8	7.3	16.7	5.0	5.1	4.4	14.1	3.3	7.5	4.9	10.2	0.5	0.7	28.4	11.0	5.4	15.8	19.7	1.0	0.7	2.4	0.5	0.6	0.9	0.2	6.9	5.9	12.7	12.4	33.7	38.4	7.0	35.6	51.7	20.0	40.1	0.6	15.9	0.0	38.0	48.4	6.0	7.6	10.3	27.5	0.0	3.2	0.3	10.4	1.2	10.7	0.0	0.0	27.1	10.3	12.2	6.4	23.3	0.2	0.0	22.7	2.2	0.0	0.0	5.8	8.2	0.0	7.3	0.0	12.3	0.2	0.0	0.3	12.0	0.8	12.6	11.4	0.7	20.9	10.7	11.8	15.9	19.1	0.0	0.0	0.0	17.0	0.0	23.2	1.4	0.5	0.3	0.5	0.3	0.5	0.6	0.5	0.5	0.2	1.0	0.9	0.9	2.4	0.6	0.3	0.7	0.2	0.2	0.8	1.0	0.5	0.7	1.0	0.9	1.1	0.9	4.0	0.5
GRAMD1A	"FLJ90346, KIAA1533"	ENSG00000089351	"GRAM domain containing 1A"	Q96CP6	19	34994784-35026471	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008852, HPA012570"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA008852: AB_1079203, HPA012570: AB_2112577"	"unprognostic (3.09e-2)"	"unprognostic (4.62e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (7.95e-12)"	"unprognostic (2.04e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.36e-2)"	15.6	19.1	14.6	21.4	14.0	17.1	19.4	13.8	18.1	16.8	13.2	10.4	17.4	13.0	16.9	12.9	7.8	17.2	13.8	17.2	15.9	12.0	13.3	11.0	27.5	42.0	13.7	12.2	21.8	44.1	11.5	14.9	14.1	16.6	15.6	7.5	11.5	45.3	17.2	35.7	6.8	10.9	21.3	12.8	21.1	16.1	11.7	12.1	17.9	12.7	11.5	12.1	17.3	21.4	1.1	4.1	13.1	14.9	3.8	5.5	2.5	5.4	42.3	8.3	16.4	9.7	11.1	6.9	6.6	10.9	8.9	8.8	16.0	4.7	3.1	13.2	9.9	3.6	8.6	13.0	3.4	13.1	15.0	9.1	10.5	14.7	19.5	6.4	14.5	19.6	8.1	6.3	10.8	28.8	9.9	2.1	6.1	5.2	14.6	7.9	13.0	4.7	13.9	2.6	3.8	9.5	1.0	12.5	25.2	6.7	5.1	10.9	7.7	7.1	15.6	14.3	7.4	2.9	9.4	2.3	7.8	7.5	9.4	7.1	10.5	13.1	4.5	3.6	2.9	7.3	5.5	0.5	3.9	2.1	4.1	1.1	2.9	4.2	9.8	3.8	14.9	1.4	3.1	2.5	14.6	14.0	13.8	18.1	15.9	12.0	13.7	12.2	16.6	12.1
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2-related adaptor protein 2"	O75791	22	39901082-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 138.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.4;HEL: 18.1;K-562: 17.3;MOLT-4: 47.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 22.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			260000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.6	0.4	0.3	7.7	0.7	7.6	1.5	0.3	0.4	1.1	2.3	0.6	0.4	2.9	2.3	1.6	1.6	1.2	3.5	2.8	0.6	0.4	1.2	1.8	6.4	12.6	0.9	0.4	1.0	0.8	0.0	0.6	1.1	0.6	2.4	1.9	1.2	2.4	1.2	0.5	1.4	6.2	2.0	2.2	13.2	2.9	2.4	0.3	138.0	1.3	1.5	11.3	3.0	1.9	2.1	0.4	2.5	0.2	1.7	22.5	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	18.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.2	0.0	19.5	0.1	14.4	1.0	14.4	21.1	0.4	2.1	12.2	22.5	2.5	1.7	0.1	0.3	12.0	25.9	0.3	0.7	0.3	0.4	0.6	0.4	0.9	0.4	0.6	0.3
GRB10		ENSG00000106070	"Growth factor receptor bound protein 10"	Q13322	7	50590063-50793462	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 65.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"basophil: 11.4;eosinophil: 3.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019423, HPA027502, HPA031818"	Approved		Supported	Vesicles				Vesicles		"CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: "	"unprognostic (2.82e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.31e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.73e-3)"	"unprognostic (8.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (8.50e-2)"	14.3	14.6	14.7	4.9	26.7	6.5	18.8	22.0	20.9	9.7	10.5	14.6	2.0	12.3	8.9	8.0	7.3	9.0	15.6	19.1	13.8	14.8	19.8	15.6	8.3	4.3	19.8	10.7	6.5	65.8	6.0	21.5	10.6	20.9	10.6	5.1	16.5	7.0	11.7	35.7	3.7	8.4	13.0	9.9	15.9	7.2	11.4	16.9	0.4	18.3	4.2	3.2	12.7	17.3	0.0	0.1	11.4	0.2	0.0	0.4	0.1	0.1	10.6	17.4	7.0	8.2	6.3	9.2	4.3	3.7	8.3	10.1	6.4	0.1	0.2	7.6	5.4	1.0	17.9	4.5	4.1	0.1	7.2	18.3	10.8	4.6	17.4	11.4	28.3	16.3	7.1	12.8	12.7	21.2	34.5	0.2	6.3	1.2	2.0	15.4	19.0	18.4	5.3	0.0	0.1	5.5	4.2	7.6	0.0	0.5	2.7	22.7	9.2	23.2	25.9	7.4	10.1	15.0	16.2	0.7	0.2	0.1	23.4	10.4	24.9	11.4	0.1	3.5	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.1	14.7	26.7	22.0	20.9	13.8	14.8	19.8	10.7	20.9	16.9
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Enhanced	Nucleoplasm			1900000	Nucleoplasm		"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	29.0	29.2	36.1	48.2	40.3	56.3	23.6	42.2	41.6	18.5	27.8	28.2	19.1	29.2	28.3	19.4	27.0	22.1	22.5	32.2	34.7	33.9	24.9	32.2	33.7	54.8	30.9	29.2	21.8	16.7	21.8	21.8	33.1	26.9	21.4	27.9	21.8	21.2	25.6	27.8	18.6	30.5	30.6	42.6	56.7	22.8	10.8	27.1	45.8	20.4	15.6	53.1	29.8	19.2	24.7	25.0	64.9	42.8	12.0	13.4	20.7	24.8	21.7	14.9	18.0	16.5	15.5	34.0	26.3	21.4	27.7	26.6	18.6	16.7	32.5	15.6	24.0	14.9	21.5	18.9	28.8	16.0	19.7	34.8	14.3	27.1	14.9	40.0	68.0	14.3	19.8	28.9	14.5	33.2	23.5	22.6	20.1	31.0	46.8	38.7	10.3	22.1	28.1	32.0	23.5	21.1	18.6	18.0	26.0	22.2	21.7	27.7	24.0	64.7	21.1	26.6	20.2	21.0	26.7	41.5	31.9	52.2	20.5	31.3	19.0	25.1	32.1	38.5	13.4	38.4	11.7	23.7	12.1	13.2	25.0	24.7	12.7	12.0	64.9	12.0	42.8	16.7	13.2	20.7	36.1	40.3	42.2	41.6	34.7	33.9	30.9	29.2	26.9	27.1
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9"	"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 89.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 7.4"	"Cell type enriched"	"Detected in single"	20	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Region enhanced"	"Detected in some"		"cerebellum: 9.3"	"Low region specificity"	"Detected in all"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: "	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (3.10e-4)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favourable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	2.9	0.1	0.1	2.8	0.6	0.0	16.1	7.4	1.2	6.7	12.7	0.3	25.0	6.7	2.6	8.1	53.9	14.5	16.3	0.8	0.2	0.1	23.4	5.2	12.3	0.1	0.1	0.4	3.1	20.5	5.8	3.7	42.6	1.6	10.2	6.4	0.7	14.0	25.5	0.5	19.1	12.4	2.0	0.1	0.3	7.2	2.3	0.3	0.5	8.5	6.5	17.2	7.2	11.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.0	0.0	0.0	4.4	0.0	0.2	0.0	0.1	10.4	5.9	0.0	0.9	0.1	5.6	0.0	3.9	0.0	0.0	0.5	0.0	1.3	9.0	0.0	0.0	0.0	0.0	3.4	0.0	0.9	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.2	0.8	0.0	0.0	4.1	4.6	3.3	2.3	0.0	4.5	89.5	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	7.4	1.2	0.2	0.1	0.1	0.4	1.6	0.3
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.3;skin 1: 34.4"	"Group enriched"	"Detected in some"	4	"BEWO: 64.8;SK-BR-3: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 4.8;neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	1.7	0.6	1.5	0.2	2.4	2.8	15.9	2.0	1.6	10.2	0.9	0.2	10.8	0.3	0.9	3.8	40.3	0.7	1.0	1.6	1.9	1.2	2.5	4.9	2.3	0.2	0.7	1.4	0.5	1.5	12.9	2.6	31.0	0.8	6.1	0.2	1.8	17.5	9.7	0.9	34.4	0.7	5.1	0.6	0.6	1.3	1.6	0.4	0.4	2.8	22.3	25.3	6.7	16.9	0.1	0.2	4.8	0.2	0.5	0.6	4.5	3.1	0.0	0.3	0.9	0.1	0.1	64.8	0.3	0.4	0.2	0.3	0.2	2.2	0.4	0.1	0.0	1.9	3.9	0.4	0.9	0.9	1.7	0.1	0.6	1.2	0.0	0.2	0.3	0.1	1.7	1.8	0.0	0.3	0.6	1.2	0.0	4.1	0.6	0.5	0.2	0.7	0.2	0.3	0.5	0.4	12.3	0.7	0.5	0.6	34.1	0.7	4.1	0.1	0.3	0.2	0.8	1.0	0.3	0.8	0.4	0.4	0.1	0.5	0.5	0.0	0.2	4.8	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.6	4.5	1.5	2.4	2.0	1.6	1.9	1.2	0.7	1.4	0.8	0.4
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492432-101669726	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 47.9;seminal vesicle: 42.4"	"Cell line enhanced"	"Detected in some"		"A-431: 15.5;CACO-2: 11.3;HaCaT: 18.9;hTCEpi: 14.8;MCF7: 13.0;RT4: 27.9;T-47d: 32.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA004820: AB_1857928, HPA062839: "	"prognostic unfavourable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.4	0.3	0.4	3.3	0.4	0.0	11.3	0.3	0.4	6.0	9.9	0.0	34.7	2.1	1.6	16.4	18.7	5.2	10.3	0.4	0.4	0.4	6.4	0.7	11.3	0.0	0.4	0.0	1.5	22.1	7.1	1.5	47.9	0.1	15.2	5.6	0.1	15.0	42.4	0.4	18.0	8.6	1.6	0.4	0.4	5.9	0.6	0.0	1.7	12.7	14.3	12.2	7.4	8.4	0.0	0.0	0.0	0.0	1.2	0.2	0.0	15.5	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	11.3	7.7	0.0	0.0	0.0	18.9	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.5	0.0	0.0	6.2	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.0	0.1	0.0
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9"	"Cell line enhanced"	"Detected in some"		"HEL: 9.1;NTERA-2: 9.0;REH: 24.8;SCLC-21H: 7.1;SH-SY5Y: 15.8"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA074001: "	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.7	5.4	9.6	2.3	12.2	3.4	2.4	17.2	23.9	2.7	6.9	4.9	1.3	1.2	3.8	2.7	2.4	4.5	2.6	5.6	21.7	8.9	3.8	0.3	0.6	2.6	5.0	5.3	5.3	3.5	17.8	9.1	0.3	5.5	4.5	1.6	5.8	0.7	8.9	1.0	1.1	1.4	6.7	7.6	1.8	2.7	13.6	3.5	1.0	10.3	0.3	1.0	2.2	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	9.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	9.0	0.0	24.8	0.0	0.1	4.1	0.0	7.1	15.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	12.2	17.2	12.7	21.7	8.9	5.0	5.3	5.5	3.5
GRK4	"GPRK2L, GPRK4"	ENSG00000125388	"G protein-coupled receptor kinase 4"	P32298	4	2963608-3040747	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028737, HPA057023"	Approved		Supported	Vesicles				Vesicles		"HPA028737: , HPA057023: "	"unprognostic (1.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.89e-1)"	3.4	3.6	5.4	1.6	5.1	1.7	4.8	12.5	5.9	3.0	2.1	4.2	1.0	1.5	2.7	3.1	2.4	2.0	3.0	5.6	5.2	4.8	2.8	2.3	2.4	1.6	5.3	5.3	3.4	7.9	3.9	6.2	2.2	5.9	2.4	2.0	3.1	4.0	2.9	5.0	2.9	1.7	2.8	5.4	1.9	2.5	41.2	3.7	1.6	4.1	1.6	1.7	2.5	3.3	1.2	2.5	4.5	2.0	1.6	1.7	1.0	2.4	0.9	3.0	8.5	7.3	7.0	1.8	4.8	2.1	2.7	2.4	2.4	0.8	5.5	2.1	7.6	0.8	3.9	4.0	2.4	3.8	3.9	6.0	3.4	2.8	4.3	2.4	2.2	4.7	6.2	4.8	2.3	5.1	5.6	7.2	6.4	2.8	5.1	5.1	2.3	6.7	6.5	3.8	2.2	2.6	3.1	17.3	5.3	2.9	1.3	4.3	6.5	3.7	5.9	7.4	1.9	5.0	4.2	7.4	4.2	4.2	3.7	5.3	2.5	4.5	1.1	2.1	1.1	2.0	1.4	1.1	0.7	0.7	0.3	1.2	1.7	1.6	4.0	1.6	0.7	2.5	0.4	1.0	5.4	5.1	12.5	5.9	5.2	4.8	5.3	5.3	5.9	3.7
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207589-119459742	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 36.5;HUVEC TERT2: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"				"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: "	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	15.9	8.3	3.4	16.8	7.8	2.7	10.2	6.5	5.0	12.5	18.8	3.9	4.5	12.4	13.4	12.2	8.1	7.7	19.5	45.4	4.2	4.2	4.3	5.7	27.6	8.8	3.7	2.5	16.5	3.5	26.2	6.3	24.0	4.5	7.5	6.4	5.6	5.0	6.7	12.8	4.7	10.4	10.8	4.8	17.0	13.9	3.5	4.7	9.8	8.9	10.7	8.6	9.5	13.6	9.3	2.2	6.5	3.7	0.2	11.3	4.2	4.0	2.3	6.0	6.1	13.8	13.3	1.8	7.8	36.5	4.9	2.7	1.9	5.9	4.3	1.8	12.2	1.0	2.6	8.6	3.2	17.1	2.1	0.7	5.0	7.7	9.5	0.2	2.2	1.8	1.3	9.8	1.4	28.8	0.4	4.2	1.7	0.6	4.0	3.9	0.9	6.0	1.4	0.8	1.0	0.8	1.6	2.0	5.5	2.7	1.2	7.5	0.1	1.0	8.7	2.6	1.9	15.8	3.0	0.9	4.6	2.6	5.5	4.8	2.5	0.9	3.7	6.5	5.3	3.2	0.4	9.3	7.7	3.8	2.2	9.1	11.3	5.0	5.0	0.2	0.9	0.0	9.2	4.2	3.4	7.8	6.5	5.0	4.2	4.2	3.7	2.5	4.5	4.7
GRN	"CLN11, PCDGF, PGRN"	ENSG00000030582	"Granulin precursor"	P28799	17	44345086-44353102	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 138.4;intermediate monocyte: 80.4;myeloid DC: 109.8;neutrophil: 61.8;non-classical monocyte: 36.4;plasmacytoid DC: 95.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 109.8;granulocytes: 61.8;monocytes: 138.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008763, CAB019394, HPA028747"	Uncertain		Enhanced	"Endoplasmic reticulum,Endosomes,Lysosomes"	"Secreted to blood"		91000000	"Endoplasmic reticulum, Endosomes, Lysosomes"		"CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (7.41e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	66.8	27.1	8.2	31.2	10.2	76.4	30.1	5.2	13.9	29.1	45.0	16.6	46.2	23.2	29.8	76.5	104.7	18.8	51.4	46.9	7.8	9.5	39.3	43.2	74.9	81.1	10.5	9.3	20.7	21.6	11.6	18.0	116.4	11.4	28.7	25.1	23.8	54.5	42.1	15.2	37.3	42.9	21.1	13.4	76.3	25.6	21.0	9.7	23.5	31.4	46.3	52.1	34.8	38.5	13.0	109.8	61.8	138.4	2.1	3.8	83.8	17.2	28.2	8.6	23.2	70.5	37.1	26.4	21.2	67.6	35.0	46.5	12.2	42.6	51.1	45.5	34.2	26.9	12.3	49.5	15.8	8.4	26.6	5.4	14.8	25.7	35.8	8.8	72.0	49.1	65.7	29.1	19.2	39.8	10.4	7.7	23.7	25.6	5.0	25.4	6.5	47.7	14.3	26.9	60.1	39.1	20.6	8.2	10.9	28.4	13.4	52.3	30.6	33.4	47.7	65.6	15.8	44.8	14.6	17.0	46.4	17.4	39.6	20.9	18.1	12.5	138.4	11.9	2.7	80.4	2.1	13.0	2.9	2.4	109.8	8.2	2.2	2.1	61.8	2.1	36.4	95.5	3.8	83.8	8.2	10.2	5.2	13.9	7.8	9.5	10.5	9.3	11.4	9.7
GRPEL1	"FLJ25609, GrpE, hMGE"	ENSG00000109519	"GrpE like 1, mitochondrial"	Q9HAV7	4	7058906-7068197	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036647	Supported		Supported	Mitochondria			1900000	Mitochondria		"HPA036647: AB_10672359"	"unprognostic (6.13e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-2)"	"prognostic favourable (2.00e-6)"	"unprognostic (9.61e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.30e-2)"	14.7	35.8	11.5	7.3	10.8	20.7	11.4	10.6	15.2	7.9	9.9	9.3	8.5	8.9	7.8	8.8	11.4	8.7	7.6	22.8	10.9	11.6	22.6	46.8	8.1	9.0	12.5	10.9	10.9	12.9	9.6	7.7	11.0	14.8	8.3	9.9	7.2	9.1	8.5	38.0	10.2	10.4	8.4	11.4	17.2	10.7	14.2	11.7	8.1	9.4	15.8	10.7	11.2	8.3	17.6	22.9	24.8	16.8	15.8	21.5	15.8	9.9	9.4	5.4	10.7	10.6	8.9	6.7	13.2	10.6	15.0	11.1	16.6	13.1	21.6	8.9	10.1	10.2	21.5	15.1	17.6	5.2	13.5	23.1	8.6	17.9	12.3	23.3	11.8	8.8	20.1	13.2	16.0	13.1	13.5	9.1	17.5	10.1	18.3	28.9	8.1	31.5	12.4	20.4	9.0	14.9	10.5	15.4	7.5	10.4	10.3	11.2	9.2	13.6	11.2	10.0	6.2	14.2	22.9	9.8	14.0	14.6	13.6	15.2	7.9	6.3	16.0	24.8	15.3	16.8	21.5	17.6	16.7	17.3	22.9	12.8	21.4	16.4	5.5	15.8	13.4	13.9	16.3	15.8	11.5	10.8	10.6	15.2	10.9	11.6	12.5	10.9	14.8	11.7
GRPEL2	"DKFZp451C205, FLJ23713, Mt-GrpE#2"	ENSG00000164284	"GrpE like 2, mitochondrial"	Q8TAA5	5	149345430-149354583	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018173, HPA023211"	Uncertain		Enhanced	Mitochondria				Mitochondria		"HPA018173: AB_1850358, HPA023211: AB_1850360"	"unprognostic (3.13e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (3.87e-5)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (6.16e-8)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-1)"	7.4	5.1	5.4	6.5	6.4	5.3	9.8	10.9	8.9	13.3	4.8	3.7	3.9	6.0	5.4	5.8	43.1	5.1	4.3	6.3	5.5	5.6	7.5	5.7	10.2	8.1	5.1	5.2	7.5	6.8	7.2	6.5	8.5	8.4	5.1	4.8	3.7	7.2	6.7	7.8	5.4	5.8	4.3	4.4	5.9	6.1	4.9	5.1	7.4	7.9	14.4	12.8	6.1	11.5	3.5	3.8	8.2	2.5	3.7	13.5	4.6	9.0	4.9	7.1	25.5	4.5	4.7	14.3	8.0	6.8	7.8	11.0	12.0	6.1	9.4	8.5	4.2	7.0	11.3	11.7	10.0	5.0	9.5	11.9	9.4	6.8	13.6	11.1	6.0	6.9	14.4	9.7	15.2	4.7	10.3	23.2	5.8	6.4	7.2	9.5	9.4	17.9	9.1	9.9	12.4	5.0	8.4	14.7	12.2	8.1	15.0	23.9	13.1	13.3	5.3	8.5	9.4	6.1	11.8	8.6	11.4	9.1	8.6	16.2	7.7	8.2	2.5	3.3	5.1	2.4	6.2	3.5	7.7	5.7	3.8	1.9	10.3	7.7	1.9	3.7	2.5	1.0	13.5	4.6	5.4	6.4	10.9	8.9	5.5	5.6	5.1	5.2	8.4	5.1
GRPR	"BB2, BB2R"	ENSG00000126010	"Gastrin releasing peptide receptor"	P30550	X	16123556-16153021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 24.5"	"Group enriched"	"Detected in some"	10	"PC-3: 17.6;T-47d: 22.0;U-138 MG: 30.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 6.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069604			Supported	"Plasma membrane"				"Plasma membrane"		"HPA069604: "	"unprognostic (3.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.86e-2)"	0.5	0.4	3.4	4.7	2.3	0.2	3.5	0.3	3.5	3.7	1.4	0.0	2.5	0.2	1.0	2.8	7.5	0.3	0.2	0.5	3.5	0.4	0.3	0.3	0.4	0.2	0.3	1.9	0.3	24.5	0.4	0.3	0.2	1.1	0.7	0.6	2.0	0.4	0.4	0.4	0.3	0.5	1.2	0.4	0.3	2.1	0.4	0.0	0.0	0.4	0.0	0.2	0.4	0.4	0.6	0.2	0.4	1.9	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.5	0.0	2.3	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.2	17.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	22.0	0.0	0.1	30.1	0.3	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.4	0.0	1.6	0.1	0.0	0.4	3.4	2.3	0.3	3.5	3.5	0.4	0.3	1.9	1.1	0.0
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815782-70839945	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favourable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavourable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favourable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	17.9	33.4	21.3	22.3	19.9	8.8	29.0	19.1	42.5	16.8	22.7	19.7	15.0	18.1	17.2	18.2	21.7	18.9	22.9	33.3	22.9	22.6	23.9	23.6	23.7	24.6	24.8	20.2	17.3	26.9	19.6	13.7	18.3	23.6	17.7	27.1	12.0	32.1	20.9	101.8	18.7	17.2	18.1	24.1	17.3	22.5	13.6	19.1	37.0	19.7	31.1	21.7	21.1	15.4	5.7	20.0	7.6	11.6	14.3	11.7	5.6	31.9	21.8	25.7	26.7	27.3	31.9	36.9	38.8	24.6	29.3	24.1	22.2	32.9	46.2	29.7	39.9	12.2	45.4	30.3	39.3	25.1	14.9	24.3	22.4	30.7	33.7	35.5	14.0	26.8	29.2	29.6	20.6	30.1	27.8	26.9	40.7	34.2	58.3	25.0	27.4	23.1	24.1	40.0	19.6	36.2	40.0	26.8	24.2	18.3	52.2	64.0	22.6	17.4	27.5	27.4	29.0	22.6	24.4	22.4	17.8	29.7	22.7	23.1	26.7	7.6	11.6	5.2	7.6	8.8	9.5	5.7	11.2	11.7	20.0	4.9	11.2	9.5	1.6	14.3	10.5	19.3	9.3	5.6	21.3	19.9	19.1	42.5	22.9	22.6	24.8	20.2	23.6	19.1
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445773-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.9	15.5	9.2	15.7	11.1	14.8	15.5	12.9	14.1	13.6	14.1	10.4	11.9	15.6	18.7	12.8	20.0	15.0	16.2	16.9	7.8	8.6	13.0	26.3	12.5	17.5	11.0	10.3	19.3	35.5	16.5	10.3	14.7	9.5	13.8	8.0	12.0	18.6	14.4	29.1	18.3	11.5	13.3	8.2	19.4	14.7	13.1	10.9	18.6	17.3	19.0	17.3	14.1	18.0	21.1	18.4	1.4	17.8	17.4	22.6	16.5	16.8	44.7	7.6	14.3	6.2	6.2	6.5	13.2	6.3	19.1	15.9	25.1	12.5	24.1	11.5	8.2	14.4	18.9	20.4	7.5	18.1	25.6	22.0	15.2	17.8	7.2	20.7	14.1	7.4	11.3	18.0	9.1	9.4	30.7	15.2	7.9	17.5	21.8	52.1	20.7	13.1	27.1	8.6	17.3	7.9	20.9	17.2	9.5	14.9	21.1	6.6	10.4	10.5	10.0	17.8	15.0	7.8	31.3	15.5	35.5	22.6	5.9	18.7	20.6	0.1	11.0	1.4	19.6	17.8	22.6	21.1	18.1	19.5	18.4	20.4	21.3	19.7	0.8	17.4	13.5	13.6	15.6	16.5	9.2	11.1	12.9	14.1	7.8	8.6	11.0	10.3	9.5	10.9
GSAP	"LOC54103, PION"	ENSG00000186088	"Gamma-secretase activating protein"	A4D1B5	7	77310751-77416400	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lung: 33.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 11.2;U-937: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA023994			Supported	Vesicles				Vesicles		"HPA023994: AB_1855386"	"prognostic favourable (3.36e-4)"	"unprognostic (3.70e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.53e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.36e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (3.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (9.49e-2)"	"prognostic favourable (4.15e-5)"	5.7	6.3	3.8	19.9	3.9	7.0	5.7	1.7	6.6	3.5	6.4	4.4	2.8	2.0	3.9	6.7	5.0	5.7	8.0	7.3	4.2	5.4	6.2	13.9	33.1	24.0	4.5	2.2	4.0	5.4	9.4	14.0	3.6	4.2	5.8	4.1	5.6	5.6	5.3	2.5	3.7	10.1	8.0	5.5	21.5	6.9	1.9	3.3	3.8	9.4	3.4	14.8	5.5	3.4	13.7	11.7	1.3	9.7	11.2	6.6	5.7	3.2	1.7	0.0	0.0	0.5	2.2	0.3	2.0	6.8	1.1	2.9	0.5	4.7	0.7	0.2	0.0	1.6	0.1	1.6	3.0	2.1	1.3	3.5	0.2	9.0	3.0	0.3	0.0	0.8	6.2	5.5	11.2	0.5	0.0	0.3	9.1	1.8	0.0	6.9	0.5	2.4	0.0	0.1	0.1	6.1	2.7	0.2	5.1	2.2	1.1	5.3	2.0	2.9	0.0	1.7	1.2	0.2	6.1	1.3	0.0	1.2	7.9	14.7	1.4	0.0	9.7	0.9	6.6	8.9	3.9	13.7	2.2	4.5	11.7	12.3	2.9	4.8	1.3	11.2	6.4	0.3	0.1	5.7	3.8	3.9	1.7	6.6	4.2	5.4	4.5	2.2	4.2	3.3
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977766	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 35.7;tongue: 19.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.1;hTCEpi: 4.9;hTERT-HME1: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 5.6"					"Not detected"	"Not detected"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"			7100	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	2.1	0.4	0.2	0.4	0.1	0.0	2.2	0.1	0.1	1.1	0.6	0.0	0.0	0.1	0.4	8.6	1.9	0.3	0.3	2.0	0.2	0.2	0.4	0.2	0.7	8.5	0.2	0.7	0.2	0.2	1.0	0.9	0.9	0.1	0.2	0.6	0.0	0.6	0.0	0.9	35.7	0.3	0.5	0.2	0.3	0.2	0.9	0.0	0.8	0.2	19.4	7.8	0.8	1.1	0.6	0.5	1.9	0.4	0.6	5.6	1.0	0.4	0.1	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.0	7.1	0.0	0.1	0.5	0.9	0.6	0.4	0.0	0.3	1.6	0.0	4.9	0.8	9.6	0.0	0.2	2.3	0.0	1.0	0.0	0.2	0.1	0.1	0.6	0.0	0.8	0.2	0.6	0.0	0.2	0.2	0.3	0.0	0.5	0.1	0.1	0.3	0.7	0.1	0.1	0.3	0.1	0.6	0.4	0.1	0.0	1.7	0.4	0.4	4.8	0.2	5.6	0.3	3.1	1.8	0.2	0.6	1.6	2.5	1.9	0.6	0.3	0.5	1.1	1.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.7	0.1	0.0
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786888	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2"	"Cell line enhanced"	"Detected in some"		"A-431: 8.2;HaCaT: 5.8;hTCEpi: 3.0;HUVEC TERT2: 3.2;TIME: 8.5"	"Group enriched"	"Detected in many"	6	"cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA023670, HPA024767, HPA026317"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.2	25.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.4	0.0	0.0	14.1	0.0	0.0	0.2	25.0	0.0	0.0	0.0	0.1	0.1	19.2	17.5	1.4	5.9	0.3	0.3	1.2	0.1	0.4	0.3	0.0	8.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.1	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GSDMD	"DF5L, FLJ12150, GSDMDC1"	ENSG00000104518	"Gasdermin D"	P57764	8	143553207-143563062	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004656, HPA044487"	Uncertain		Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"CAB004656: AB_426076, HPA044487: "	"unprognostic (1.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavourable (1.43e-4)"	"unprognostic (8.51e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.77e-3)"	15.1	13.3	4.8	19.7	5.9	18.6	19.2	2.2	4.6	12.1	25.4	3.9	17.2	23.3	13.9	15.6	14.5	13.7	22.4	11.6	5.1	2.6	21.7	64.6	19.0	28.1	6.8	2.8	14.8	18.3	6.9	6.9	17.0	6.8	13.6	7.2	10.9	17.9	15.0	8.7	5.8	31.7	13.0	5.3	42.9	13.2	4.1	5.0	17.2	20.0	9.8	15.9	11.5	13.1	19.6	22.9	20.8	32.3	19.6	30.4	21.6	11.3	6.6	0.1	0.0	4.1	4.6	8.5	5.3	11.0	14.1	13.5	3.4	15.1	5.2	9.2	5.5	4.5	0.2	8.6	4.3	15.0	1.0	10.8	2.2	6.4	5.0	3.0	0.5	9.7	0.8	5.1	3.0	11.4	0.5	13.6	0.6	0.4	23.1	3.8	0.1	20.5	10.4	1.3	13.9	6.1	14.8	0.2	0.2	16.9	10.4	11.2	19.4	6.9	5.3	0.1	17.5	1.2	6.8	4.5	6.8	0.1	8.3	7.0	5.8	20.8	21.9	20.0	26.5	32.3	22.8	19.6	24.5	26.5	22.9	17.2	18.9	20.9	18.9	19.6	26.7	13.2	30.4	21.6	4.8	5.9	2.2	4.6	5.1	2.6	6.8	2.8	6.8	5.0
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698351-24758113	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 8.7;myeloid DC: 6.9;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Enhanced	Cytosol				Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	8.1	6.5	7.7	2.2	10.3	0.5	6.1	5.9	12.1	12.0	14.5	7.8	0.5	6.1	18.4	12.8	4.2	9.9	6.7	7.4	7.5	8.8	10.7	3.6	4.0	4.0	9.3	4.5	14.1	2.3	2.2	4.5	27.1	10.1	5.9	2.1	9.0	2.0	17.7	5.1	1.8	31.3	12.2	25.4	1.5	2.7	9.9	5.0	0.8	11.7	4.0	2.9	9.5	7.0	8.7	6.9	0.0	2.1	0.0	0.1	0.7	9.8	7.2	3.1	13.4	17.2	9.7	5.4	7.7	20.6	8.0	11.4	7.5	0.3	0.1	6.9	21.2	6.7	1.8	33.8	14.2	0.0	0.7	0.2	12.7	15.1	14.4	0.0	0.5	10.6	24.8	14.2	34.2	13.7	0.9	1.7	17.9	0.1	0.6	0.2	3.3	5.2	0.0	11.0	0.0	24.4	6.9	0.1	19.8	12.1	0.2	13.4	0.7	0.9	9.2	7.6	13.4	10.3	9.2	0.8	0.2	4.7	23.1	0.0	1.9	0.0	2.1	0.0	0.0	0.2	0.0	8.7	0.1	0.0	6.9	8.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	7.7	10.3	5.9	9.5	7.5	8.8	9.3	4.5	10.1	5.0
GSK3B		ENSG00000082701	"Glycogen synthase kinase 3 beta"	P49841	3	119821323-120094417	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016263, HPA028017"	Approved		Supported	Nucleoplasm			81000	Nucleoplasm		"CAB016263: AB_2279451, HPA028017: AB_10600708"	"unprognostic (1.09e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (8.20e-5)"	"unprognostic (3.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.79e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.16e-1)"	17.6	17.6	17.4	13.8	21.3	25.0	13.7	32.7	28.3	15.8	16.0	15.6	7.1	15.5	14.5	12.6	20.3	12.4	14.4	20.8	17.1	22.4	15.7	21.7	17.1	17.5	17.0	22.6	14.0	14.9	25.0	19.2	24.1	18.1	13.9	17.9	14.9	18.5	11.7	23.9	21.6	18.2	17.1	13.4	26.3	13.3	30.8	14.4	46.5	17.4	8.4	14.1	14.2	15.7	1.7	2.0	10.6	3.1	1.4	3.0	1.0	28.3	13.7	23.0	13.3	15.3	15.6	22.3	16.0	30.8	15.4	14.1	14.8	11.6	11.5	9.8	22.8	19.4	10.8	31.1	23.9	7.8	3.0	16.8	10.3	11.0	17.5	17.2	22.5	15.7	20.9	16.4	33.5	16.9	7.1	22.4	20.1	15.3	18.3	4.8	12.5	14.2	7.3	19.6	11.1	11.2	20.3	17.3	10.7	18.8	13.7	18.5	17.0	11.6	21.6	22.1	24.9	6.9	9.5	14.9	13.7	22.2	13.7	11.5	17.6	4.3	2.9	7.5	2.4	2.6	2.1	1.1	2.0	3.0	2.0	1.7	2.0	1.5	10.6	1.4	3.1	1.6	1.3	1.0	17.4	21.3	32.7	28.3	17.1	22.4	17.0	22.6	18.1	14.4
GSN	DKFZp313L0718	ENSG00000148180	Gelsolin	P06396	9	121207794-121332843	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cilium biogenesis/degradation"	"Actin capping, Actin-binding"	"Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 167.4;HaCaT: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010823, CAB016728, CAB036009, HPA054026"	Supported		Supported	"Actin filaments"	"Secreted to blood"	111500000000	510000000000	"Actin filaments"		"CAB010823: , CAB016728: , CAB036009: , HPA054026: "	"unprognostic (3.25e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (1.79e-5)"	187.8	23.1	14.1	23.7	21.4	26.6	186.2	7.3	20.0	81.9	69.6	53.7	48.0	22.3	88.1	64.7	99.6	57.8	59.6	235.1	17.6	11.9	14.8	3.9	30.6	12.9	42.8	16.5	40.8	20.4	7.4	25.7	17.5	33.4	74.0	29.0	83.0	44.8	63.2	48.1	55.6	32.7	154.8	33.4	12.4	45.0	32.5	29.9	5.6	67.7	46.4	20.9	113.5	109.0	2.2	43.3	133.9	15.2	24.4	0.4	11.8	5.8	8.0	5.9	16.9	167.4	55.1	3.8	19.5	43.1	4.7	9.5	8.1	17.5	0.4	5.3	25.7	66.5	0.4	13.4	2.7	1.0	1.0	4.7	7.4	18.4	4.6	1.0	22.9	20.5	12.8	7.8	4.9	17.0	1.4	0.6	21.0	10.5	0.0	34.3	2.0	6.2	1.1	2.0	0.5	22.2	9.0	0.9	1.5	8.8	9.5	25.6	37.7	20.9	30.9	13.7	4.8	1.2	1.9	0.2	0.2	0.4	15.2	2.3	37.7	30.2	15.2	133.9	0.2	10.2	0.1	2.2	0.1	0.1	43.3	0.6	0.0	0.0	37.0	24.4	2.6	28.7	0.4	11.8	14.1	21.4	7.3	20.0	17.6	11.9	42.8	16.5	33.4	29.9
GSPT2	"eRF3b, FLJ10441"	ENSG00000189369	"G1 to S phase transition 2"	Q8IYD1	X	51743431-51746232	"Predicted intracellular proteins"	"Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.0;PC-3: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044769, HPA074588"	Approved		Enhanced	Cytosol				Cytosol		"HPA044769: AB_10963577, HPA074588: "	"unprognostic (8.55e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.39e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.07e-1)"	8.6	11.1	11.6	8.6	17.6	3.6	9.3	14.1	18.3	8.2	7.3	6.5	3.4	4.8	8.3	11.5	4.2	8.8	7.6	9.8	11.5	19.5	9.6	16.0	7.9	12.0	9.2	13.0	15.3	7.3	7.1	14.9	3.6	8.8	10.5	5.5	6.7	8.9	9.7	7.8	4.0	7.6	8.0	6.7	9.0	6.5	18.4	8.8	18.4	9.1	3.8	12.1	7.7	4.1	9.5	9.7	2.7	4.1	7.2	8.3	4.2	0.0	5.1	10.4	0.0	7.3	6.4	0.0	5.9	1.0	4.2	5.3	3.2	5.2	14.9	0.0	5.0	1.6	0.0	2.7	4.9	0.0	6.6	0.2	0.0	0.0	5.4	0.0	6.5	8.4	1.3	3.7	3.7	6.1	3.9	1.1	7.4	0.0	1.3	0.9	25.0	28.1	7.1	9.8	0.0	7.6	5.4	0.0	8.8	0.0	0.0	5.0	0.0	4.8	3.8	4.2	8.6	3.9	3.8	0.0	8.5	0.0	5.6	1.0	4.6	2.7	2.9	1.8	5.7	4.1	5.7	9.5	5.1	5.3	9.7	9.5	8.3	7.1	0.3	7.2	3.1	8.2	6.4	4.2	11.6	17.6	14.1	18.3	11.5	19.5	9.2	13.0	8.8	8.8
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678061-30727999	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632"	Approved		Supported	"Plasma membrane,Cytosol"			110000000	Cytosol	"Plasma membrane"	"CAB008632: AB_1616690, HPA001538: AB_1078986"	"unprognostic (1.23e-1)"	"prognostic favourable (3.37e-4)"	"prognostic favourable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favourable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	8.9	14.4	6.8	10.7	9.1	7.9	6.2	9.1	11.8	18.6	18.7	7.1	18.4	20.4	13.2	12.0	19.4	8.8	17.3	11.9	5.0	5.7	27.9	17.8	10.8	9.7	4.9	6.0	11.8	17.6	22.9	7.2	8.9	6.8	16.4	17.2	10.9	12.0	17.4	14.7	6.5	31.8	9.3	4.5	13.6	17.7	7.9	4.2	17.0	9.2	11.8	12.0	23.9	14.5	2.5	4.7	19.0	5.7	2.6	7.3	2.1	12.0	51.0	8.3	6.4	8.9	10.0	8.0	5.4	11.8	7.7	10.3	15.0	6.4	23.6	26.7	6.9	13.6	12.5	11.7	8.4	6.1	11.6	23.7	17.6	50.1	24.0	7.2	38.3	16.6	7.4	11.5	4.6	10.9	19.6	10.5	17.3	11.0	25.5	8.5	14.7	9.1	9.8	9.5	11.4	15.2	30.6	6.3	8.1	7.4	17.3	12.9	7.5	8.2	14.7	3.2	8.9	7.6	8.0	5.8	6.4	15.1	10.2	10.2	10.5	19.0	4.6	11.5	4.2	4.2	7.3	2.5	3.8	4.6	4.7	2.0	2.4	3.1	6.5	2.6	5.7	2.9	3.2	2.1	6.8	9.1	9.1	11.8	5.0	5.7	4.9	6.0	6.8	4.2
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928433-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm			23000000	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavourable (7.21e-5)"	"unprognostic (2.90e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.64e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (7.31e-6)"	"unprognostic (3.35e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.52e-1)"	12.9	29.8	14.7	13.2	21.0	16.0	16.2	9.2	27.6	12.7	26.9	17.2	28.9	20.0	11.5	47.5	25.6	18.5	18.3	14.6	15.0	15.9	30.5	30.9	12.1	11.7	15.1	15.1	11.6	10.3	17.5	15.6	27.2	15.3	18.6	27.6	15.4	19.1	19.4	10.7	19.1	21.4	12.9	13.3	13.3	15.7	16.8	9.2	17.0	18.0	12.0	21.0	14.4	13.9	7.3	24.3	7.9	21.3	15.2	18.3	14.9	18.0	21.9	10.8	15.1	12.6	13.1	15.4	15.4	14.3	24.3	20.2	40.3	22.1	12.8	20.6	15.8	17.2	15.7	39.3	20.6	5.9	8.9	50.4	14.0	40.0	17.7	12.7	17.8	13.7	42.1	22.9	38.7	17.2	24.4	10.5	29.5	19.9	20.2	18.0	6.4	28.4	18.6	21.7	30.4	34.8	18.5	21.2	12.4	27.2	25.5	20.3	31.3	11.6	13.5	28.0	15.9	18.4	13.3	10.7	9.9	14.1	23.8	14.0	16.6	7.9	20.3	4.6	18.0	21.3	16.1	7.3	14.5	18.3	24.3	5.2	16.9	14.3	5.3	15.2	19.0	13.5	17.5	14.9	14.7	21.0	9.2	27.6	15.0	15.9	15.1	15.1	15.3	9.2
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 87.7"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol		"HPA004342: AB_1078987, HPA048934: , HPA053817: "	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	87.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750089-52763569	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 63.4;liver: 192.2;pancreas: 54.1"	"Group enriched"	"Detected in some"	20	"CACO-2: 20.3;Hep G2: 15.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol		"HPA004342: AB_1078987, HPA048934: , HPA053817: "	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.2	1.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	6.4	0.2	0.2	13.4	0.2	0.3	0.2	0.0	9.9	0.2	0.2	0.0	63.4	192.2	5.3	0.2	0.2	0.2	0.3	54.1	0.0	0.2	0.3	0.2	0.7	0.0	0.2	0.3	0.2	0.2	0.0	27.6	0.2	0.2	0.2	1.5	14.1	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	20.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	15.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909685	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;BJ hTERT+: 1.1;CACO-2: 1.5;HAP1: 2.8;HEK 293: 1.5;SK-BR-3: 2.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol				Cytosol		"HPA004342: AB_1078987, HPA048934: , HPA053817: "	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.2	36.5	0.2	0.2	0.6	0.0	0.7	0.3	0.2	0.9	0.2	1.0	0.2	0.0	0.3	6.6	0.2	32.4	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	0.2	0.2	3.8	0.2	1.1	0.2	51.9	2.1	0.2	0.0	0.5	0.6	0.2	0.2	12.5	0.2	0.2	0.2	0.2	1.0	6.4	0.3	0.2	0.2	0.9	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.2	0.2	0.2	0.2	0.2	2.1	0.3
GSTCD	FLJ13273	ENSG00000138780	"Glutathione S-transferase C-terminal domain containing"	Q8NEC7	4	105708778-105847728	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 11.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046160, HPA061782"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA046160: AB_10961048, HPA061782: "	"unprognostic (4.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.44e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.38e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.02e-2)"	6.5	6.1	7.6	7.2	10.1	9.3	11.2	11.0	9.7	8.2	7.3	8.4	5.7	5.2	9.3	10.0	10.0	8.8	7.7	5.6	7.4	7.8	10.3	5.7	6.3	9.4	7.5	6.5	7.2	6.3	7.6	13.1	7.2	10.0	8.2	8.3	14.4	7.4	7.6	5.6	6.9	5.9	8.4	10.5	6.9	6.6	20.5	6.4	15.1	10.7	5.4	9.8	7.1	7.1	2.0	1.9	11.4	1.9	1.9	2.2	0.9	7.6	7.0	15.9	13.8	4.1	5.4	12.0	10.8	5.6	13.5	12.2	6.4	14.8	9.2	5.6	4.6	6.4	18.1	11.4	19.0	13.7	5.4	7.7	6.7	8.7	1.8	14.1	5.3	2.9	5.8	12.2	9.5	8.2	14.8	8.4	11.3	6.3	14.7	5.3	8.7	8.8	10.2	9.4	5.2	14.7	5.6	13.0	5.8	8.4	12.0	4.6	10.8	5.7	6.1	10.0	10.5	6.2	8.4	3.1	6.7	5.2	6.2	7.3	13.6	0.9	1.4	0.6	1.3	1.7	1.5	1.5	1.2	0.4	1.4	2.0	1.4	2.2	11.4	1.9	1.9	1.9	0.2	0.9	7.6	10.1	11.0	9.7	7.4	7.8	7.5	6.5	10.0	6.4
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006311, HPA022904"	Supported		Supported	Peroxisomes			1300000	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favourable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favourable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	38.0	45.3	14.0	45.3	19.9	29.0	43.0	5.6	19.6	30.4	69.0	19.9	35.7	58.0	24.8	39.8	37.8	27.4	55.2	56.4	15.0	13.1	67.6	97.1	35.4	52.2	24.3	16.3	22.7	39.9	46.2	20.7	41.5	23.9	28.0	43.5	34.4	72.9	35.8	38.9	30.0	91.0	22.2	17.5	58.5	34.8	18.9	20.8	27.1	48.0	56.6	50.3	29.4	26.6	32.8	57.1	35.7	75.4	22.3	99.0	95.2	27.1	19.6	2.7	24.4	43.3	62.2	13.0	16.1	27.6	14.4	28.8	11.8	69.8	15.5	23.0	23.2	41.2	10.7	25.2	12.6	29.8	11.6	12.6	14.7	18.5	29.8	15.2	20.6	56.1	31.0	16.6	11.8	38.2	17.6	18.9	38.5	20.9	15.5	27.6	6.5	29.7	13.4	0.4	30.6	49.9	15.0	11.3	15.4	29.5	48.1	24.4	23.1	21.3	22.5	7.8	7.3	20.5	13.6	32.4	15.2	3.5	28.3	61.3	16.1	35.7	67.9	25.8	41.1	74.8	39.6	32.8	76.4	52.4	57.1	21.9	39.5	38.1	21.2	22.3	75.4	23.9	99.0	95.2	14.0	19.9	5.6	19.6	15.0	13.1	24.3	16.3	23.9	20.8
GSTM3	GST5	ENSG00000134202	"Glutathione S-transferase mu 3"	P21266	1	109733932-109741038	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 115.3;testis: 96.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 44.8;T-47d: 94.8;WM-115: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.1;T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017130, HPA035190, CAB040583, HPA055972"	Enhanced		Supported	Cytosol			560000	Cytosol		"CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: "	"unprognostic (2.13e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.48e-2)"	7.5	11.3	21.4	2.9	27.8	0.9	23.1	8.5	18.4	15.4	11.7	9.9	51.0	12.6	9.0	67.2	11.1	8.8	12.3	27.6	14.0	14.4	54.0	5.3	5.2	2.4	9.6	22.0	32.3	26.5	7.3	9.4	5.8	30.7	13.6	5.6	13.4	4.5	115.3	15.5	15.0	7.5	15.9	13.3	3.3	14.2	96.0	6.4	0.1	15.8	15.6	3.3	17.4	12.0	0.6	0.8	4.1	0.3	1.0	11.1	1.4	0.0	1.3	9.7	0.0	13.2	8.1	1.6	10.5	1.8	11.5	11.2	4.2	0.3	0.0	6.1	5.3	0.5	1.9	4.3	16.0	0.0	2.9	9.8	31.8	6.3	14.1	0.0	22.8	8.1	5.3	17.3	0.0	14.2	0.8	0.1	5.1	5.7	2.6	0.2	1.0	18.2	0.0	6.2	0.4	3.2	22.5	17.1	9.2	21.9	44.8	2.0	94.8	14.3	11.1	0.1	4.2	11.8	6.9	1.5	2.4	0.0	0.1	0.0	36.8	0.8	0.3	4.1	4.2	0.1	1.2	0.6	5.3	3.1	0.1	0.6	11.1	5.5	2.0	1.0	0.2	0.8	2.3	1.4	21.4	27.8	8.5	18.4	14.0	14.4	9.6	22.0	30.7	6.4
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583595-67586656	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol			120000000	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	24.2	25.3	20.2	23.8	21.7	46.2	39.5	15.5	19.8	51.8	51.9	23.5	125.4	35.2	43.5	41.9	181.6	60.8	51.1	45.3	18.3	23.5	44.2	5.9	61.0	39.4	25.5	19.9	33.4	60.7	44.1	33.8	57.9	46.0	37.0	17.9	59.9	50.2	110.8	33.7	58.5	34.0	30.1	22.8	25.1	48.5	15.4	15.4	29.8	91.6	131.5	75.6	40.8	79.5	25.3	191.4	12.4	168.2	70.1	40.7	167.2	68.1	93.0	45.3	70.5	35.1	39.6	41.9	29.8	40.0	45.6	35.5	170.8	71.7	0.1	68.4	47.1	99.7	122.4	131.2	12.9	47.5	44.5	3.3	67.7	0.0	52.1	22.4	39.9	49.1	298.4	36.3	35.1	68.3	73.9	19.0	35.6	0.2	51.3	62.5	86.7	39.9	47.9	7.6	0.2	72.5	0.2	15.4	44.0	41.8	13.6	135.0	0.2	37.7	36.8	21.0	53.4	44.0	21.6	11.8	73.8	25.0	23.9	37.1	43.6	2.3	168.2	12.4	40.7	125.7	15.0	25.3	18.4	33.3	191.4	24.3	15.3	27.3	7.0	70.1	79.4	76.2	18.3	167.2	20.2	21.7	15.5	19.8	18.3	23.5	25.5	19.9	46.0	15.4
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B (gene/pseudogene)"	P0CG30	22	23957414-23961186	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"breast: 83.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.4;HHSteC: 33.0;SK-MEL-30: 22.8;T-47d: 25.2"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favourable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	1.6	11.7	2.7	0.7	1.9	0.0	83.4	0.0	4.2	2.6	1.5			0.1	1.7	2.9	2.6	1.4	1.1	2.4	1.7	2.9	1.3	6.1	2.0	0.1	2.5		3.1	3.2	0.9	3.6	0.8		6.1	0.2		1.2	2.5	1.3	11.4	0.7	2.7	1.4	0.9	2.6	0.5			2.5		0.1	0.7	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.4	0.3	0.0	22.4	0.4	0.5	0.9	3.1	1.8	4.6	4.8	9.6	0.0	0.0	5.1	7.8	9.4	0.0	9.9	2.1	0.0	0.8	0.3	12.6	1.5	33.0	0.0	3.6	13.6	1.6	13.1	2.7	3.6	0.0	0.0	2.7	0.1	0.0	0.0	0.1	4.7	0.0	16.7	0.0	10.1	0.0	0.4	9.4	3.1	0.0	22.8	25.2	0.3	12.2	3.8	2.5	0.5	2.4	0.0	0.0	0.0	2.4	0.0	9.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
GTF2A1	TFIIA	ENSG00000165417	"General transcription factor IIA subunit 1"	P52655	14	81175452-81221377	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000869	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000869: AB_1080253"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.88e-2)"	16.9	14.9	18.2	15.7	23.3	8.7	17.1	32.6	23.4	15.7	12.9	17.7	12.7	12.2	16.0	20.1	17.9	12.5	13.1	12.7	17.0	17.8	15.3	18.4	11.6	18.9	16.2	17.0	17.6	14.7	21.0	20.6	24.5	19.9	14.8	14.7	14.0	14.5	13.1	20.3	14.7	12.4	16.2	18.5	17.2	13.4	23.9	16.7	36.3	30.4	11.3	18.5	15.9	15.0	1.3	3.2	9.3	3.9	1.5	2.3	0.8	10.5	10.6	22.3	14.9	12.7	10.7	8.1	12.8	13.3	11.8	10.7	15.7	10.7	17.3	10.4	10.6	8.0	15.3	9.7	21.0	14.6	4.6	15.7	12.2	9.3	12.5	11.0	16.3	9.9	7.5	16.2	21.2	12.0	9.6	23.9	15.1	17.7	28.0	6.5	12.1	10.2	15.1	19.5	10.7	7.9	21.7	21.1	12.5	30.2	12.4	13.5	18.5	9.4	15.0	12.0	9.2	16.6	13.3	19.2	20.5	18.0	9.6	12.9	19.0	9.3	1.2	2.1	2.3	0.9	2.0	1.3	2.1	1.3	0.7	1.2	1.9	2.1	2.0	1.5	3.9	3.2	1.1	0.8	18.2	23.3	32.6	23.4	17.0	17.8	16.2	17.0	19.9	16.7
GTF2A2	"HsT18745, TFIIA"	ENSG00000140307	"General transcription factor IIA subunit 2"	P52657	15	59638062-59657541	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 117.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056239			Supported	Nucleoplasm				Nucleoplasm		"HPA056239: "	"unprognostic (2.18e-2)"	"unprognostic (3.21e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	20.7	25.7	19.3	22.6	27.5	26.3	35.2	19.1	21.8	17.4	26.6	14.3	18.3	17.5	20.6	24.3	27.0	18.3	18.6	38.6	21.0	20.3	22.3	24.2	24.1	28.3	22.5	18.3	21.4	23.8	13.0	26.1	18.6	24.9	18.2	22.6	16.1	26.3	25.3	26.7	14.6	18.2	20.0	28.8	19.4	18.2	117.1	15.9	20.8	21.8	26.3	21.2	18.2	24.7	41.1	65.0	53.2	44.1	36.2	41.8	39.2	31.1	44.4	29.8	28.5	18.2	15.1	34.3	35.2	16.2	28.8	29.1	47.8	12.6	28.9	32.9	22.6	26.8	29.9	21.1	21.2	50.3	24.5	32.9	34.5	30.1	24.1	35.8	29.6	14.4	20.4	24.3	20.7	18.8	46.9	29.6	23.7	21.9	23.3	27.5	39.8	26.1	21.9	31.4	35.4	28.1	36.9	32.2	34.6	32.7	37.6	32.8	26.1	37.9	26.0	28.1	49.7	31.2	63.0	29.5	85.6	62.9	31.9	60.4	33.9	45.3	44.0	53.2	31.0	44.1	32.2	41.1	36.3	34.3	56.6	33.0	31.3	34.1	22.9	36.2	40.8	65.0	41.8	39.2	19.3	27.5	19.1	21.8	21.0	20.3	22.5	18.3	24.9	15.9
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852932-88891944	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA061626: "	"prognostic favourable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	23.7	27.0	22.2	27.1	29.8	54.9	30.2	25.7	30.0	24.2	21.9	12.5	19.2	18.8	23.4	32.9	26.4	23.0	24.6	16.0	22.0	21.7	23.7	34.8	22.8	30.6	24.3	17.9	28.2	23.8	21.6	25.9	30.2	23.8	19.2	24.7	13.8	24.9	20.8	21.6	26.4	29.3	21.6	20.6	30.0	22.5	15.2	23.5	44.4	27.6	24.0	30.8	22.6	22.7	28.6	31.6	51.1	28.2	25.8	34.4	23.8	19.6	7.4	18.9	9.3	28.6	20.1	22.8	16.6	22.0	24.9	26.6	9.7	13.6	22.7	18.9	15.5	11.8	20.0	17.8	21.9	22.4	18.7	23.9	12.2	16.2	18.6	27.6	14.7	17.7	18.2	21.8	12.6	13.1	21.3	19.7	26.1	6.9	28.1	25.0	14.5	16.1	18.0	23.2	17.3	26.5	21.9	14.2	12.5	15.8	19.7	29.0	8.4	27.3	11.6	10.6	13.0	18.4	19.9	19.3	13.3	30.2	7.0	23.4	8.9	37.9	25.5	39.3	25.6	28.2	29.1	28.6	28.5	27.2	31.6	24.2	34.4	29.5	51.1	25.8	28.1	21.3	34.2	23.8	22.2	29.8	25.7	30.0	22.0	21.7	24.3	17.9	23.8	23.5
GTF2E1	"FE, TFIIE-A"	ENSG00000153767	"General transcription factor IIE subunit 1"	P29083	3	120742637-120783069	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009884, HPA056359, HPA066881"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009884: AB_2279381, HPA056359: , HPA066881: "	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.29e-3)"	"unprognostic (4.94e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.97e-1)"	11.1	18.0	8.6	10.7	9.9	6.6	10.0	9.1	9.9	9.2	8.5	11.6	7.3	7.8	13.3	8.1	9.4	7.6	6.4	8.5	8.8	8.3	12.9	12.7	8.4	14.0	9.3	7.6	10.5	14.5	8.4	12.9	11.9	9.1	8.2	10.4	7.9	18.7	10.2	12.8	7.8	9.8	10.0	11.9	14.0	7.8	16.3	8.9	25.6	9.6	10.0	14.9	9.2	9.5	10.9	10.5	16.8	12.9	11.9	12.0	8.7	9.1	12.8	16.1	9.8	12.2	5.7	14.1	6.2	5.6	9.7	10.5	15.3	6.7	15.1	10.8	4.6	11.1	14.9	8.1	13.6	10.4	3.4	19.4	9.4	12.7	9.5	17.4	11.8	7.4	8.8	7.2	10.3	14.8	13.5	7.9	10.2	10.5	14.3	8.8	15.3	12.0	11.9	19.0	11.2	9.6	5.9	3.4	10.7	9.3	8.1	8.3	10.3	13.5	12.9	9.1	10.0	2.9	6.9	7.0	7.7	21.6	9.6	17.7	8.7	16.8	8.5	13.0	8.5	12.9	11.1	10.9	10.1	12.0	10.5	9.1	11.1	10.7	6.2	11.9	11.7	4.9	11.4	8.7	8.6	9.9	9.1	9.9	8.8	8.3	9.3	7.6	9.1	8.9
GTF2E2	"FE, TF2E2, TFIIE-B"	ENSG00000197265	"General transcription factor IIE subunit 2"	P29084	8	30578318-30658251	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004816, CAB009603, HPA025065"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009603: AB_2114537, HPA004816: , HPA025065: AB_10601658"	"unprognostic (4.84e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.38e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (5.82e-7)"	"unprognostic (8.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.24e-1)"	19.0	21.9	11.4	16.2	17.0	7.5	26.7	21.2	13.1	16.4	19.1	10.7	15.1	16.8	17.7	15.8	20.0	12.3	11.7	12.7	11.1	10.9	14.7	21.1	13.4	20.3	11.6	12.2	24.2	44.6	14.1	22.5	14.5	11.9	14.2	14.4	12.1	12.6	13.8	9.9	14.8	26.2	16.3	11.6	17.2	20.9	31.0	11.7	21.4	17.2	10.6	22.0	16.9	27.5	16.4	8.0	5.6	4.2	8.7	7.9	2.6	21.4	17.4	12.0	12.7	32.5	29.1	9.1	23.4	21.2	19.2	24.5	10.4	15.4	27.8	19.9	20.8	15.2	19.8	21.8	25.6	12.4	11.7	13.8	12.2	24.6	31.6	6.6	12.2	21.2	28.9	20.6	21.0	26.4	26.6	17.1	30.1	14.5	32.5	16.7	13.6	21.0	17.1	13.0	13.8	20.7	14.7	9.3	12.0	12.9	8.7	18.2	8.4	8.2	20.1	12.7	13.2	10.7	15.9	17.5	23.8	30.1	20.0	11.4	16.7	3.0	4.2	5.6	3.9	3.3	4.2	16.4	6.0	7.9	7.2	9.3	5.9	5.9	2.2	8.7	3.3	8.0	6.7	2.6	11.4	17.0	21.2	13.1	11.1	10.9	11.6	12.2	11.9	11.7
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379569-6393981	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA022793: AB_1857946, HPA028707: , HPA070752: "	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favourable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favourable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	24.9	26.0	32.5	26.6	33.1	41.1	22.6	60.7	47.3	25.5	24.7	18.8	26.1	35.2	31.7	22.6	30.8	29.9	26.5	22.9	28.9	25.9	24.4	21.7	19.8	34.9	23.9	36.3	59.8	40.7	31.8	33.4	19.9	26.6	24.6	16.3	22.3	33.9	24.4	25.6	21.8	31.9	27.6	26.4	26.7	26.4	39.4	23.1	23.6	36.4	19.7	22.2	26.0	39.8	24.4	21.5	28.4	21.4	19.0	23.8	14.1	38.0	28.1	20.4	32.5	13.8	22.4	16.1	26.8	25.2	33.5	32.0	29.4	15.1	23.3	37.7	17.5	34.7	19.2	17.0	16.4	35.4	24.4	32.2	20.9	26.1	24.0	37.4	26.2	23.5	22.8	23.9	18.2	19.7	39.4	31.6	18.5	26.5	37.1	21.3	37.0	35.8	34.3	22.7	29.7	18.6	21.9	25.1	34.5	27.7	21.3	29.5	27.0	29.8	27.8	26.3	22.2	45.3	37.7	56.1	63.0	25.1	32.7	39.2	29.4	7.0	21.4	14.0	20.5	20.6	23.8	24.4	18.4	19.5	16.9	23.3	21.7	18.8	28.4	19.0	19.1	21.5	17.6	14.1	32.5	33.1	60.7	47.3	28.9	25.9	23.9	36.3	26.6	23.1
GTF2F2	"BTF4, RAP30, TFIIF"	ENSG00000188342	"General transcription factor IIF subunit 2"	P13984	13	45120515-45284909	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006912	Supported		Supported	Nucleoplasm,Microtubules				Nucleoplasm	Microtubules	"HPA006912: AB_1080256"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavourable (1.65e-5)"	"unprognostic (3.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (6.44e-3)"	15.1	24.7	23.5	21.1	23.6	22.5	20.9	12.0	21.0	16.3	21.8	14.8	18.5	14.9	16.8	23.4	21.8	12.0	15.9	27.5	21.4	21.1	18.3	16.0	15.1	17.5	22.9	19.0	17.3	14.6	16.5	27.5	23.9	18.2	16.7	21.2	18.2	20.8	20.2	32.0	31.5	12.9	28.2	19.5	17.8	15.2	22.2	24.2	22.6	19.2	27.7	19.9	20.5	19.0	15.4	16.3	24.9	15.3	16.1	12.9	8.5	15.4	5.8	11.0	8.1	6.7	9.9	9.1	17.0	11.2	17.3	17.0	9.7	24.2	15.5	9.6	12.4	17.2	16.4	13.6	25.4	11.7	14.2	18.3	7.8	12.6	10.8	20.2	10.5	8.3	21.0	12.9	21.9	11.0	12.9	5.9	46.6	8.6	14.8	23.4	13.0	14.2	14.0	8.3	8.9	37.7	5.4	5.9	9.8	8.6	8.5	14.1	6.9	16.6	8.7	14.6	12.4	11.5	28.9	3.8	5.1	15.5	17.0	13.1	15.2	12.0	14.2	24.9	9.7	14.1	11.5	15.3	11.3	11.5	16.3	15.4	12.9	12.6	19.8	16.1	15.3	12.7	12.3	8.5	23.5	23.6	12.0	21.0	21.4	21.1	22.9	19.0	18.2	24.2
GTF2H1	"BTF2, P62, TFIIH"	ENSG00000110768	"General transcription factor IIH subunit 1"	P32780	11	18322295-18367044	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004637, HPA046660"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004637: AB_425470, HPA046660: "	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (5.98e-9)"	"unprognostic (7.71e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.42e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.94e-1)"	27.1	26.4	24.1	18.2	28.8	10.5	33.0	32.6	35.7	21.5	21.6	19.3	24.1	18.0	23.5	23.1	26.2	18.6	22.9	21.4	24.1	20.4	25.9	25.0	19.1	23.7	19.6	22.2	27.2	24.3	27.1	32.4	24.3	27.4	22.5	20.9	21.2	25.8	26.0	20.8	32.4	21.7	20.6	21.1	23.4	20.5	38.5	23.3	22.7	29.3	21.7	25.7	22.9	22.2	12.0	11.8	20.3	12.1	15.9	13.9	8.8	12.2	11.4	9.5	13.6	21.9	17.5	12.0	18.4	19.8	16.3	18.9	11.8	4.8	20.5	7.4	18.9	17.1	15.6	16.8	21.2	9.0	15.5	13.3	11.6	11.9	31.3	25.5	14.5	19.7	20.2	10.1	32.1	14.4	20.4	10.9	23.5	11.4	12.8	20.3	8.4	16.4	13.2	20.3	9.5	13.4	16.9	11.0	11.8	15.2	14.7	22.7	7.7	15.0	10.6	22.1	10.7	39.5	14.9	5.6	13.2	15.1	19.1	20.0	21.0	20.3	10.9	11.3	9.1	11.0	9.8	11.7	11.5	10.1	11.8	12.0	13.9	11.1	7.9	15.9	12.1	6.5	11.0	8.8	24.1	28.8	32.6	35.7	24.1	20.4	19.6	22.2	27.4	23.3
GTF2H2	"BTF2, BTF2P44, p44, T-BTF2P44, TFIIH"	ENSG00000145736	"General transcription factor IIH subunit 2"	Q13888	5	71032670-71067689	"Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 15.1"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA047001			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA047001: "	"unprognostic (7.40e-3)"	"unprognostic (4.71e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-3)"	"unprognostic (3.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.62e-1)"	3.9	3.0	1.5	1.3	1.6	1.4	2.0	1.3	2.2	5.0	3.1			0.1	3.3	3.0	3.7	2.8	1.5	1.8	1.4	1.8	4.4	2.8	2.1	6.4	1.4		4.0	4.2	2.1	1.6	0.9		3.1	1.3		2.2	0.7	3.2	2.2	2.2	7.4	1.4	3.6	2.2	3.9			4.6		0.1	2.4	2.0	2.9	1.8	6.2	1.8	1.2	2.1	0.6	3.4	0.0	3.3	0.0	8.0	9.5	10.5	0.4	0.1	0.2	0.5	8.5	0.3	13.1	6.3	7.0	2.3	0.4	0.1	0.2	10.4	10.2	7.9	0.2	0.7	9.0	0.5	0.0	0.0	1.9	0.3	0.0	0.0	0.2	2.4	0.0	4.9	5.0	4.3	0.2	0.1	4.6	2.3	8.5	15.1	0.0	0.3	3.4	8.1	1.0	8.6	5.8	5.7	3.3	3.9	1.0	0.6	6.5	0.2	0.5	3.8	0.3	0.8	7.7	1.1	1.8	0.7	1.9	1.0	0.7	1.5	2.0	1.9	0.9	2.9	2.1	1.7	6.2	1.2	1.1	1.8	0.3	0.6										
GTF2H3	"BTF2, P34, TFIIH"	ENSG00000111358	"General transcription factor IIH subunit 3"	Q13889	12	123633739-123662606	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004844, HPA053562"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA004844: , HPA053562: "	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (6.72e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.68e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.80e-2)"	15.8	15.8	17.4	15.2	22.0	12.2	19.7	23.2	23.8	16.1	17.2	21.4	9.3	13.0	18.4	18.1	22.5	19.4	12.3	13.5	16.9	17.3	15.8	25.3	12.1	18.8	16.7	19.8	16.9	10.8	16.1	24.0	16.1	24.6	17.1	21.1	14.8	15.6	15.4	16.1	16.1	13.7	18.2	17.9	17.3	14.6	17.9	16.1	23.6	17.2	23.1	19.4	15.7	15.2	7.4	8.6	10.5	8.6	12.8	11.7	5.2	18.7	9.9	12.9	16.4	15.9	17.9	18.2	14.2	17.6	22.1	14.9	10.5	9.7	21.8	17.6	19.5	12.8	21.3	25.8	26.6	18.4	15.0	17.8	9.3	15.0	22.4	35.9	11.9	18.9	19.7	17.8	40.6	15.7	26.6	7.3	19.8	12.2	17.8	12.1	16.6	18.4	18.5	19.7	12.3	11.3	18.2	11.6	10.2	18.8	9.2	14.3	25.7	21.7	10.4	13.9	10.6	21.4	22.8	13.5	18.3	21.5	15.9	18.4	15.8	10.5	5.6	7.2	9.9	8.6	10.0	7.4	8.1	10.4	8.6	7.3	11.7	10.5	0.8	12.8	7.8	7.3	8.1	5.2	17.4	22.0	23.2	23.8	16.9	17.3	16.7	19.8	24.6	16.1
GTF2H4	"P52, TFB2, TFIIH"	ENSG00000213780	"General transcription factor IIH subunit 4"	Q92759	6	30908184-30914106	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074336			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA074336: "	"unprognostic (7.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.79e-4)"	"unprognostic (7.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.66e-4)"	"unprognostic (7.74e-3)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-2)"	11.2	13.8	13.4	16.1	13.3	10.5	17.8	27.3	17.7	12.2	9.8	9.7	9.1	7.1	12.4	12.8	13.0	11.8	11.2	8.4	12.6	8.4	13.3	18.6	10.2	11.6	10.3	14.8	14.6	9.9	8.5	12.9	9.8	11.2	9.6	10.0	7.5	13.4	16.8	10.9	12.1	12.9	10.4	13.4	11.3	10.7	9.9	12.4	13.1	12.7	8.9	9.5	9.5	10.4	2.3	3.4	5.5	2.2	1.3	3.0	1.7	7.4	3.7	6.4	7.2	5.7	4.0	6.1	2.0	1.8	4.1	3.4	5.9	3.8	6.9	3.3	5.5	6.1	7.8	9.9	2.7	6.3	6.3	5.5	5.0	3.8	3.5	0.0	5.3	5.2	6.9	5.7	0.0	3.7	14.7	2.8	4.4	6.9	5.7	8.2	5.1	1.5	9.8	4.8	3.6	10.4	3.3	2.7	1.8	3.7	2.8	2.6	7.4	3.9	3.1	5.6	6.9	4.9	9.5	4.4	6.2	7.6	2.8	8.8	3.4	5.5	2.2	1.4	2.1	1.7	1.7	2.3	2.1	2.1	3.4	2.2	2.5	3.0	0.0	1.3	1.3	2.8	2.5	1.7	13.4	13.3	27.3	17.7	12.6	8.4	10.3	14.8	11.2	12.4
GTF2I	"BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6"	ENSG00000263001	"General transcription factor IIi"	P78347	7	74657667-74760692	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004595, HPA026638"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004595: AB_628345, HPA026638: AB_1857959"	"unprognostic (3.47e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.28e-1)"	"prognostic favourable (6.35e-6)"	"unprognostic (7.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.88e-2)"	10.2	14.3	12.6	10.2	14.3	4.0	11.5	13.1	15.2	11.3	8.6	15.4	6.0	9.1	10.5	9.6	9.9	12.5	10.8	8.6	12.8		13.5	10.2	10.2	8.8	18.1	9.7	12.1	8.5	29.0	12.4	9.8	12.9	12.1	6.9	12.1	11.7	10.3	13.4	10.9	7.9	11.1	8.8	7.5	12.0	4.3	16.0	21.2	22.3	6.3	11.6	10.3	7.1	16.8	14.8	10.9	6.9	14.2	13.2	5.8	30.3	25.1	52.0	51.0	28.8	25.7	10.8	19.3	17.7	21.3	21.2	17.4	37.1	36.7	7.8	23.6	26.7	51.0	23.2	27.6	27.6	26.9	18.7	29.8	24.2	17.4	35.3	28.0	23.7	19.9	16.1	16.6	28.5	36.4	17.6	25.6	28.3	29.4	31.7	55.7	15.7	32.3	18.1	30.0	28.0	52.9	43.6	55.8	35.1	52.7	17.6	27.0	23.4	25.4	29.3	15.8	14.6	24.5	20.7	18.2	58.3	16.7	21.4	29.2	5.1	6.9	10.9	8.3	5.1	13.2	14.6	11.3	12.9	10.5	16.8	13.1	12.9	2.8	14.2	4.2	14.8	5.7	5.8										
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602604	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 62.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	4.6	7.6	4.3	5.1	6.8	0.6	6.3	4.4	7.8	9.4	8.2	8.2	9.2	7.0	7.4	8.7	16.4	7.0	8.6	7.7	3.9	5.5	9.3	3.6	7.2	2.6	8.5	5.3	8.6	10.0	21.1	25.3	5.3	6.6	8.2	5.5	21.6	11.3	8.3	62.8	15.6	5.2	12.1	5.6	1.6	8.8	4.5	5.7	1.3	16.4	12.9	7.3	10.5	13.2	0.6	1.8	2.7	0.5	0.6	0.7	0.1	9.3	5.9	12.9	14.1	10.4	5.1	0.1	4.0	10.6	7.8	8.2	10.2	13.5	2.4	3.0	8.0	5.4	10.2	4.7	5.8	0.1	6.1	0.4	19.9	11.5	33.4	0.1	0.3	7.1	19.2	5.5	22.7	4.0	6.9	0.0	8.7	11.8	1.2	8.2	10.3	6.1	12.6	7.5	8.8	14.9	6.5	10.7	14.5	9.8	17.9	8.7	10.6	9.4	2.2	8.1	8.3	5.2	9.0	0.5	1.4	3.9	3.3	0.1	6.5	1.2	0.5	0.5	0.3	0.2	0.3	0.4	0.7	0.2	1.8	0.6	0.3	0.4	2.7	0.6	0.1	0.6	0.2	0.1	4.3	6.8	4.4	7.8	3.9	5.5	8.5	5.3	6.6	5.7
GTF3A	"AP2, TFIIIA"	ENSG00000122034	"General transcription factor IIIA"	Q92664	13	27424544-27435823	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007990	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA007990: AB_1857960"	"unprognostic (9.88e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavourable (3.43e-6)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.41e-1)"	28.1	19.5	33.8	23.4	32.4	36.9	39.1	20.4	29.4	16.7	21.0	13.6	17.5	14.0	14.5	27.1	20.4	16.6	21.5	88.6	30.6	19.3	23.6	59.9	19.2	42.5	26.0	12.6	13.0	53.5	8.3	15.6	13.5	16.2	16.5	20.2	14.6	35.2	19.0	60.2	14.0	17.4	19.1	22.5	36.8	20.9	11.5	18.0	50.6	15.9	39.7	42.1	21.6	16.9	58.8	57.7	29.0	33.7	45.2	72.2	82.3	18.0	14.5	14.4	28.6	20.3	22.7	18.2	19.1	18.7	25.5	16.6	21.2	28.9	53.2	13.4	23.6	12.7	28.7	27.8	35.9	55.8	16.1	44.1	14.5	23.3	23.4	82.0	30.4	18.1	29.4	23.5	31.0	22.7	34.2	19.2	29.5	30.9	65.2	89.7	24.1	37.0	30.5	33.5	50.4	28.7	7.3	32.4	16.8	13.2	20.0	28.0	15.1	43.1	12.8	13.3	13.7	9.9	19.9	12.1	21.4	61.1	14.1	52.9	24.1	18.9	33.4	29.0	53.0	33.7	72.2	58.8	54.7	57.5	42.8	48.0	42.4	48.0	7.3	45.2	30.9	57.7	66.5	82.3	33.8	32.4	20.4	29.4	30.6	19.3	26.0	12.6	16.2	18.0
GTF3C1	TFIIIC220	ENSG00000077235	"General transcription factor IIIC subunit 1"	Q12789	16	27459555-27549913	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"gdT-cell: 20.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051617	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA051617: "	"unprognostic (6.46e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (8.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.32e-2)"	"prognostic favourable (9.56e-4)"	"unprognostic (2.10e-1)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.06e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.23e-3)"	13.6	18.4	19.4	12.1	25.9	17.3	10.6	25.3	31.2	17.3	12.8	21.0	18.8	11.0	19.0	12.0	39.3	19.9	16.5	23.7	15.8	16.2	16.9	13.2	14.1	13.5	14.3	19.1	20.7	24.0	33.8	33.2	13.5	15.8	35.4	12.4	22.3	15.3	16.9	29.5	41.5	11.7	19.3	12.8	14.2	15.7	24.4	17.1	25.2	35.8	18.8	21.0	12.3	20.7	1.9	4.2	2.1	2.1	7.8	20.6	3.6	12.7	28.2	20.8	24.2	18.7	15.1	11.8	13.9	15.7	19.4	16.6	21.1	12.1	14.1	20.6	17.0	14.4	26.3	17.7	16.0	6.3	25.2	11.6	23.9	30.0	10.5	13.3	15.5	18.5	13.5	23.8	10.5	19.2	14.3	11.6	15.2	31.5	14.7	16.0	27.9	13.5	27.5	25.7	14.4	12.2	13.4	26.3	17.6	14.0	11.9	8.6	21.4	10.1	20.3	19.6	11.8	12.3	14.2	12.4	11.1	14.3	8.1	14.8	14.3	1.0	2.1	2.1	20.6	1.9	15.2	1.9	2.4	10.3	2.7	1.6	2.5	6.7	1.6	7.8	2.0	4.2	2.5	3.6	19.4	25.9	25.3	31.2	15.8	16.2	14.3	19.1	15.8	17.1
GTF3C2	"KIAA0011, TFIIIC110"	ENSG00000115207	"General transcription factor IIIC subunit 2"	Q8WUA4	2	27325849-27357034	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA008274, HPA035836"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA008274: , HPA035836: AB_10601813"	"unprognostic (1.76e-1)"	"unprognostic (9.64e-2)"	"unprognostic (9.89e-2)"	"prognostic unfavourable (8.25e-5)"	"unprognostic (1.33e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavourable (1.21e-8)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.00e-1)"	16.5	23.7	15.4	21.9	19.8	17.0	18.1	22.5	22.5	19.4	22.1	25.0	25.3	18.7	19.8	25.1	30.6	21.3	21.7	19.0	13.3	11.9	21.7	17.9	20.5	20.5	15.5	12.5	19.5	27.4	30.8	19.0	22.8	19.4	18.6	24.1	26.3	26.5	19.2	28.8	27.9	24.5	20.2	12.4	25.2	20.9	24.8	15.2	28.3	25.3	21.6	30.1	20.0	18.4	12.7	14.9	23.2	17.1	12.0	15.6	17.4	29.2	26.4	22.2	21.4	13.2	12.9	32.5	10.7	14.7	14.2	12.1	19.5	18.8	25.8	19.3	14.8	17.7	32.6	20.5	13.6	20.2	28.4	21.6	17.7	25.8	12.1	23.4	21.6	16.1	18.6	16.1	20.9	18.1	30.1	19.4	13.6	24.1	21.7	17.2	41.8	16.7	26.9	24.6	28.8	20.0	22.1	20.7	36.4	11.5	27.8	19.6	14.9	13.5	13.9	17.3	19.0	13.1	19.9	21.5	23.4	57.8	17.3	19.1	18.9	23.2	16.0	13.3	14.4	14.8	15.6	12.7	12.8	15.3	14.9	12.7	13.2	12.4	8.6	12.0	17.1	9.5	8.2	17.4	15.4	19.8	22.5	22.5	13.3	11.9	15.5	12.5	19.4	15.2
GTF3C3	"TFIIIC102, TFiiiC2-102"	ENSG00000119041	"General transcription factor IIIC subunit 3"	Q9Y5Q9	2	196763032-196799725	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069179			Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA069179: "	"unprognostic (1.44e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.64e-2)"	"prognostic unfavourable (1.26e-6)"	"unprognostic (1.92e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-2)"	19.3	20.3	14.9	14.3	20.0	34.6	23.4	17.3	21.2	17.3	15.3	16.3	14.1	13.1	19.7	18.7	18.1	17.5	21.5	16.1	12.6	11.7	16.2	16.6	15.1	20.0	20.9	16.4	20.3	23.5	21.5	30.8	20.4	23.4	17.2	18.3	11.8	17.7	15.0	22.6	23.9	20.1	18.3	22.3	19.4	18.0	17.5	20.3	29.8	18.6	19.1	18.7	19.5	25.4	14.3	11.8	16.3	15.0	12.6	14.3	7.4	11.1	12.0	21.6	16.4	10.5	14.4	23.9	18.6	12.5	18.6	17.6	26.4	17.6	23.1	14.6	11.9	16.3	21.6	18.1	24.0	26.1	20.5	29.0	33.6	24.0	18.1	25.0	22.2	20.1	18.9	15.6	21.2	17.5	32.9	33.7	10.1	20.5	24.7	20.6	14.1	22.3	20.1	17.9	15.8	13.9	26.8	16.0	17.1	14.4	11.9	15.5	11.3	19.1	15.2	15.9	13.2	12.8	16.5	20.5	25.0	17.0	17.9	18.6	14.6	16.3	11.0	10.8	11.2	10.5	13.4	12.6	11.5	12.2	11.8	14.3	14.3	12.9	7.1	12.6	15.0	10.4	12.4	7.4	14.9	20.0	17.3	21.2	12.6	11.7	20.9	16.4	23.4	20.3
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694955	"Enzymes, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA069369: "	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favourable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	6.9	8.5	12.3	6.6	11.6	7.8	11.6	23.8	13.9	10.8	8.0	7.0	5.6	5.3	10.2	9.3	11.4	9.5	7.4	7.8	8.7	8.1	8.7	7.4	8.9	10.9	9.4	11.6	15.0	8.4	16.6	10.1	9.7	8.9	8.9	7.7	7.6	11.3	8.4	11.6	14.5	6.6	8.6	5.6	6.3	8.1	16.9	6.4	11.6	13.3	5.3	9.3	8.8	7.9	2.3	2.1	1.5	1.5	2.1	3.1	0.9	8.3	12.0	15.3	13.0	7.6	8.9	11.0	8.1	10.7	11.5	8.5	14.6	6.3	13.1	5.5	10.5	19.5	23.3	13.2	12.8	7.9	9.6	11.0	17.3	6.2	7.4	16.2	7.0	6.9	10.1	11.7	15.4	9.8	17.9	6.7	8.3	13.7	9.9	7.6	19.3	11.7	9.8	18.5	11.5	8.5	7.1	21.2	14.4	14.5	14.8	9.0	20.6	6.7	10.2	19.1	10.7	8.7	12.1	2.8	6.3	14.6	8.1	10.3	11.7	0.1	1.5	1.2	2.5	1.3	2.0	2.3	2.2	3.1	1.2	2.2	2.3	2.4	1.5	2.1	1.2	2.1	2.0	0.9	12.3	11.6	23.8	13.9	8.7	8.1	9.4	11.6	8.9	6.4
GTF3C5	"TFiiiC2-63, TFIIIC63, TFIIICepsilon"	ENSG00000148308	"General transcription factor IIIC subunit 5"	Q9Y5Q8	9	133030675-133058503	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067063, HPA069805"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA067063: AB_2685773, HPA069805: AB_2686201"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.73e-2)"	21.2	24.6	20.1	18.2	30.4	33.3	21.8	38.7	30.6	21.9	25.0	39.6	20.6	24.7	23.1	21.9	28.0	25.7	16.2	24.5	20.8	17.3	20.9	25.1	18.8	23.1	31.9	19.9	41.3	24.6	24.4	26.0	24.9	22.7	24.0	18.5	21.3	26.4	20.1	36.7	31.2	23.6	20.6	23.0	23.9	20.4	24.2	30.8	43.5	22.1	29.3	29.2	19.5	22.5	11.2	12.0	28.4	13.2	13.8	17.0	11.5	13.0	24.5	21.4	20.0	11.8	10.2	28.6	12.8	14.5	24.8	17.6	25.8	21.9	22.2	12.2	14.1	32.2	25.6	23.2	14.1	22.5	21.2	25.3	28.1	23.8	18.0	20.5	54.4	14.3	15.5	26.0	18.1	21.8	32.7	21.8	12.9	44.0	32.9	28.6	27.8	24.7	34.9	21.4	28.0	16.3	15.5	25.7	19.0	21.2	23.5	13.6	30.1	29.4	13.3	29.9	23.1	18.4	21.3	8.4	17.0	24.0	14.9	15.2	20.1	28.4	11.0	14.9	11.8	13.2	17.0	11.2	12.2	15.3	12.0	10.8	14.0	12.4	6.6	13.8	10.7	11.6	13.4	11.5	20.1	30.4	38.7	30.6	20.8	17.3	31.9	19.9	22.7	30.8
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958560-110967890	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA056179: , HPA061345: "	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	17.0	21.6	26.4	14.3	25.3	12.8	14.6	10.9	17.4	15.8	22.1	14.2	12.7	17.4	12.3	12.9	17.3	16.4	23.0	32.1	21.2	20.1	31.1	23.5	10.9	15.6	24.8	17.8	15.6	14.7	21.6	15.5	11.0	18.1	32.7	18.4	12.1	14.7	16.1	95.8	10.4	17.5	15.7	21.4	19.7	18.1	20.3	20.3	17.9	13.2	30.7	18.7	17.2	13.1	36.2	38.8	19.0	37.6	23.4	63.5	33.3	14.7	27.7	19.5	20.5	9.7	19.1	26.7	24.9	18.2	24.0	19.5	40.1	11.0	20.9	23.9	22.2	6.3	21.8	21.3	18.1	31.5	36.7	39.3	25.7	51.6	19.6	55.7	32.1	19.3	17.2	18.3	17.5	26.5	47.2	11.3	34.8	28.6	27.4	57.8	26.9	22.3	27.5	14.9	17.5	31.2	32.5	17.3	24.5	18.0	2.4	18.6	9.0	30.0	28.1	6.0	18.2	43.9	37.7	10.0	20.3	35.8	6.3	33.5	29.8	19.0	26.9	14.9	25.1	37.6	27.9	36.2	31.6	30.9	35.6	26.3	24.8	29.2	4.3	23.4	29.9	38.8	63.5	33.3	26.4	25.3	10.9	17.4	21.2	20.1	24.8	17.8	18.1	20.3
GTPBP2		ENSG00000172432	"GTP binding protein 2"	Q9BX10	6	43605316-43629162	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031418, HPA031419"	Approved		Enhanced	Vesicles				Vesicles		"HPA031418: , HPA031419: AB_10600709"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (1.08e-6)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.31e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavourable (1.44e-15)"	"unprognostic (1.13e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	26.8	19.8	21.4	28.0	19.7	27.9	23.5	27.5	26.1	20.1	22.4	19.9	29.6	22.7	19.0	20.5	38.2	14.5	18.6	20.5	19.1	10.8	20.5	22.5	29.1	21.4	15.0	17.4	20.4	26.2	30.9	26.8	24.1	17.9	20.7	20.7	19.9	29.0	25.3	19.2	19.8	21.9	21.0	17.0	28.8	23.8	17.2	20.1	28.2	30.0	13.3	29.6	25.7	25.2	3.0	2.8	7.0	2.5	1.2	3.4	4.4	17.5	4.6	12.3	8.3	9.5	10.3	14.2	16.7	18.0	19.6	22.5	5.3	7.4	6.3	7.1	8.9	9.5	4.6	6.7	13.5	17.3	10.0	15.6	11.7	4.7	38.1	10.1	17.4	12.1	47.5	21.6	55.7	10.1	21.8	32.5	9.7	6.0	7.5	14.6	3.7	5.4	6.5	8.9	7.1	9.1	10.7	10.6	11.0	5.6	5.2	21.3	10.0	15.7	11.1	9.9	11.1	6.2	11.1	22.2	10.5	8.6	14.2	9.3	10.3	7.0	2.5	5.0	3.4	1.4	2.0	1.7	0.9	3.0	1.3	3.0	2.4	2.8	3.7	1.2	2.0	2.8	1.5	4.4	21.4	19.7	27.5	26.1	19.1	10.8	15.0	17.4	17.9	20.1
GTPBP3	"FLJ14700, GTPBG3, MSS1, MTGP1, THDF1"	ENSG00000130299	"GTP binding protein 3, mitochondrial"	Q969Y2	19	17334920-17342735	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042158	Approved		Supported	Mitochondria				Mitochondria		"HPA042158: AB_10964400"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (2.81e-4)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.79e-1)"	8.0	13.8	8.1	12.0	14.7	10.0	9.3	11.7	12.6	9.6	8.2	7.4	9.8	12.5	10.2	6.9	13.0	9.8	12.4	7.9	11.3	10.7	9.2	13.7	7.5	13.4	7.8	11.6	11.3	12.3	14.8	11.0	8.0	11.4	10.6	7.2	10.3	13.2	15.6	14.3	22.9	10.6	8.6	6.7	13.2	11.0	3.5	6.3	16.7	9.2	10.9	16.2	8.5	10.0	6.6	9.3	1.3	4.4	6.3	7.3	3.7	9.1	5.5	5.1	6.6	1.7	1.6	25.0	4.3	1.8	4.0	3.9	7.6	7.4	13.9	11.1	1.6	8.2	6.5	3.7	3.2	11.5	30.2	8.4	8.0	9.9	2.2	8.9	5.5	1.7	5.4	3.7	4.8	3.1	15.8	6.3	2.0	7.2	10.6	7.9	10.8	24.8	12.7	4.0	13.1	3.6	4.2	12.0	10.7	4.6	7.2	5.9	6.3	3.7	3.4	6.2	5.5	13.6	7.6	10.7	16.6	16.8	4.8	11.7	4.7	0.5	3.1	0.6	7.1	4.4	5.8	4.5	6.5	6.1	4.8	6.6	7.3	6.8	1.3	6.3	2.4	9.3	4.4	3.7	8.1	14.7	11.7	12.6	11.3	10.7	7.8	11.6	11.4	6.3
GTPBP4	"CRFG, FLJ10686, FLJ10690, NGB, NOG1"	ENSG00000107937	"GTP binding protein 4"	Q9BZE4	10	988019-1019936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039618, HPA056468"	Uncertain		Supported	"Nuclear membrane,Nucleoli"				Nucleoli	"Nuclear membrane"	"HPA039618: AB_10795292, HPA056468: "	"unprognostic (2.11e-3)"	"unprognostic (3.10e-3)"	"unprognostic (7.77e-3)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavourable (8.85e-12)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (2.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.67e-2)"	19.0	24.6	11.3	13.9	14.9	24.8	14.2	11.6	15.0	11.0	10.5	12.2	10.3	9.6	14.8	10.1	12.2	15.8	8.9	11.9	14.1	11.8	11.8	14.0	9.5	13.8	14.0	10.1	16.3	22.8	12.7	18.3	13.8	15.3	11.1	12.2	8.9	10.3	9.9	24.8	11.4	11.0	14.4	18.1	13.5	12.7	22.9	12.2	14.2	11.9	16.3	16.3	11.6	10.4	10.5	11.3	10.7	14.2	15.8	14.2	7.7	21.0	17.2	14.5	12.7	10.2	12.3	10.4	19.8	6.9	24.3	20.7	25.4	16.4	30.5	6.0	15.7	16.7	28.6	18.1	28.4	15.0	17.8	33.5	12.4	15.4	16.2	14.5	18.1	15.9	15.4	26.6	18.6	13.2	34.2	12.7	22.2	19.4	22.2	13.7	21.1	11.8	22.1	12.7	21.1	14.4	13.4	7.3	21.9	13.0	16.7	22.9	23.9	14.5	11.4	11.5	6.4	27.7	23.9	16.4	31.5	38.4	13.0	15.4	9.5	10.7	8.4	3.0	11.6	14.2	13.6	10.5	11.0	11.7	11.3	9.9	12.2	11.8	1.4	15.8	10.8	7.4	14.2	7.7	11.3	14.9	11.6	15.0	14.1	11.8	14.0	10.1	15.3	12.2
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990918-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA034831: AB_10671506, HPA058631: "	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favourable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	7.5	9.3	7.4	7.3	7.8	9.5	7.3	8.5	10.1	7.1	11.9	9.2	8.3	8.0	8.3	5.2	12.2	6.4	7.4	20.0	7.6	7.6	12.2	8.2	6.2	13.2	7.6	8.3	10.4	12.1	13.0	12.1	9.3	9.5	8.2	9.3	6.6	9.6	5.2	25.3	6.5	11.8	7.4	11.7	9.3	9.1	22.7	8.9	25.4	13.4	14.3	10.2	9.6	8.0	6.7	12.2	6.7	7.0	11.9	15.8	7.8	19.2	8.8	11.7	13.1	7.1	12.4	9.3	13.3	11.6	13.7	17.1	15.4	8.3	12.6	7.9	7.3	13.2	15.5	12.9	15.8	5.6	10.8	34.5	8.9	8.0	6.8	22.0	8.5	9.8	9.3	7.5	5.4	12.6	12.2	15.0	13.2	7.6	14.0	10.8	24.0	16.7	12.0	10.7	8.0	9.6	12.2	13.5	13.7	10.8	8.5	17.7	9.6	15.0	7.5	10.0	14.8	3.6	12.4	9.8	12.8	17.7	10.0	18.3	11.0	6.7	7.0	4.5	10.4	4.6	9.1	6.7	11.9	10.0	12.2	5.9	15.8	10.3	1.0	11.9	3.9	5.8	8.2	7.8	7.4	7.8	8.5	10.1	7.6	7.6	7.6	8.3	9.5	8.9
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666711-155732349	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 55.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.0;Karpas-707: 8.5;MOLT-4: 15.6;RPTEC TERT1: 10.7;RT4: 12.5;SH-SY5Y: 7.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.6;non-classical monocyte: 9.2;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 11.6;monocytes: 9.2;NK-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm			6100	Nucleoplasm		"CAB010887: AB_259901, HPA056004: , HPA058617: "	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	10.9	5.3	12.4	10.2	19.9	0.9	11.1	3.4	11.6	13.7	31.2	7.3	2.8	5.6	14.7	6.0	7.0	6.8	8.3	21.0	9.0	7.2	11.6	5.1	13.2	7.3	4.7	12.5	5.4	8.5	55.2	5.8	16.3	6.3	17.2	6.9	39.7	7.0	9.8	4.5	3.6	10.1	18.8	6.6	8.5	12.9	2.1	8.5	4.5	8.1	7.3	5.9	6.4	10.6	0.1	11.6	0.3	9.2	7.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	6.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	15.6	0.0	0.0	0.2	3.5	0.0	2.6	10.7	12.5	2.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	7.6	9.2	11.6	0.0	1.0	12.4	19.9	3.4	11.6	9.0	7.2	4.7	12.5	6.3	8.5
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982314	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"		48000	Vesicles		"HPA036322: AB_10670796, HPA036323: "	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	23.5	12.0	3.7	7.9	5.5	20.7	25.4	5.7	4.4	10.4	14.6	7.7	22.0	10.0	10.4	12.2	9.3	7.6	11.1	8.0	3.7	2.9	11.8	50.4	15.3	12.3	6.3	3.1	8.6	17.1	9.0	7.3	30.0	4.5	12.1	11.4	9.9	17.2	11.8	5.9	10.0	16.1	8.3	3.9	17.5	11.0	7.9	5.8	14.7	17.7	5.9	13.0	9.2	7.4	9.7	27.7	22.1	36.0	15.2	11.5	15.8	16.8	6.5	6.4	14.3	21.9	13.1	9.3	5.3	14.9	11.8	10.9	9.3	17.4	7.7	8.4	6.8	6.9	4.1	6.4	7.0	7.2	8.4	10.5	9.8	6.4	10.7	22.4	17.5	9.0	6.9	6.8	8.9	10.2	15.9	55.9	7.6	12.2	8.2	24.1	4.3	5.5	8.5	14.8	43.7	7.4	10.2	9.4	8.3	14.3	33.6	18.7	18.7	22.4	7.2	14.4	13.1	5.4	13.3	31.8	38.1	13.0	10.8	29.9	17.5	7.4	28.1	22.1	11.5	36.0	10.3	9.7	9.0	10.2	27.7	7.8	6.2	7.3	4.5	15.2	30.0	11.3	11.3	15.8	3.7	5.5	5.7	4.4	3.7	2.9	6.3	3.1	4.5	5.8
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991341-149027668	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030497	Approved		Supported	Vesicles				Vesicles		"HPA030497: AB_10602326"	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	10.8	7.9	7.0	8.5	8.5	55.7	10.0	9.2	7.5	10.6	31.0	6.0	11.9	4.8	15.6	15.4	18.1	11.1	12.0	32.0	8.0	9.0	8.5	6.3	9.1	14.7	11.6	7.1	13.3	14.3	6.5	7.8	6.5	10.0	16.3	7.6	7.7	11.3	19.4	113.0	4.7	8.4	32.5	8.1	13.6	12.8	47.3	7.4	4.2	9.4	39.6	8.5	28.7	14.6	7.0	26.7	16.8	26.7	17.7	32.5	17.5	18.5	12.0	9.0	10.0	24.9	26.1	12.2	27.4	22.8	40.0	37.4	15.7	19.0	0.0	13.6	31.7	5.7	23.5	12.1	40.4	6.2	10.1	14.2	5.7	17.8	22.5	14.4	21.4	14.3	19.8	13.2	16.7	22.9	8.7	33.8	22.9	32.6	2.8	11.5	10.7	9.8	7.9	13.6	26.6	11.0	17.4	7.4	3.5	14.4	19.9	15.5	19.8	15.4	19.0	20.5	6.1	14.6	20.0	30.7	17.1	13.2	17.3	22.2	6.6	7.2	23.4	16.8	17.4	24.5	32.5	7.0	11.6	18.1	26.7	5.1	6.3	10.7	11.6	17.7	26.7	10.7	15.9	17.5	7.0	8.5	9.2	7.5	8.0	9.0	11.6	7.1	10.0	7.4
GYPC	"CD236, CD236R, Ge, GPC, GYPD"	ENSG00000136732	"Glycophorin C (Gerbich blood group)"	P04921	2	126655933-126696670	"Blood group antigen proteins, CD markers, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 61.5;K-562: 45.7;SK-MEL-30: 90.3;U-266/70: 51.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 66.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008965, CAB009445"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB009445: AB_2116251, HPA008965: AB_1078455"	"unprognostic (1.63e-2)"	"unprognostic (7.14e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.00e-3)"	44.5	21.7	3.9	34.5	5.3	95.0	99.8	1.3	4.3	20.7	24.8	5.9	9.8	5.0	20.3	26.0	22.9	18.5	21.4	61.2	4.4	3.4	15.2	6.3	29.5	75.8	8.0	3.7	37.4	18.7	1.7	5.5	17.5	5.6	24.5	5.5	13.8	13.0	15.5	48.9	11.3	15.2	34.8	8.3	41.1	13.5	13.4	4.6	28.5	11.6	29.9	22.5	37.1	38.8	21.2	9.9	4.2	7.7	14.7	41.4	21.8	0.1	0.0	22.1	0.0	16.4	14.4	0.0	3.3	25.6	4.0	11.9	0.0	0.0	0.0	0.0	9.2	0.0	12.0	0.0	1.3	10.5	0.0	37.1	0.0	0.0	61.5	12.9	0.1	32.3	0.0	3.2	0.0	0.1	45.7	30.7	9.6	0.0	0.0	20.5	6.6	0.0	2.4	1.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	90.3	0.0	35.3	8.9	15.2	0.1	1.0	0.1	51.0	33.0	0.0	7.3	18.8	13.7	0.1	5.9	0.4	32.3	7.7	36.4	18.9	29.3	39.1	9.9	21.2	41.4	40.4	4.2	14.7	4.7	5.5	35.1	21.8	3.9	5.3	1.3	4.3	4.4	3.4	8.0	3.7	5.6	4.6
GZF1	"dJ322G13.2, ZBTB23, ZNF336"	ENSG00000125812	"GDNF inducible zinc finger protein 1"	Q9H116	20	23362182-23373063	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024520	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA024520: AB_10963938"	"unprognostic (3.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavourable (9.81e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-1)"	7.6	25.8	12.3	7.1	12.5	35.7	6.6	14.1	17.2	8.8	7.1	14.9	8.0	5.4	9.0	7.6	6.1	8.2	7.5	15.6	11.5	10.6	9.2	8.7	7.1	6.5	13.0	10.4	11.4	7.8	12.0	9.8	8.4	12.9	8.3	5.9	7.1	7.7	11.2	10.0	5.8	5.6	10.7	12.4	6.7	6.6	16.5	13.0	7.4	9.6	5.3	6.3	9.3	9.8	3.2	4.4	3.4	4.5	1.3	3.2	2.4	5.5	9.8	6.3	6.3	7.4	7.3	5.1	6.8	6.3	7.0	6.6	7.4	4.5	11.3	6.0	5.8	9.9	7.2	9.2	8.0	1.9	4.7	10.5	4.0	10.0	9.7	6.2	6.4	7.3	6.8	7.5	11.6	4.7	7.1	17.7	10.0	7.3	9.6	7.8	4.7	13.5	6.4	15.1	7.8	5.3	5.6	9.7	5.6	6.0	10.8	14.2	7.1	9.1	6.0	11.4	6.6	8.6	7.2	14.5	5.9	10.0	3.3	28.6	6.1	0.0	4.5	2.0	2.0	2.7	1.5	3.2	3.0	3.1	4.4	1.6	3.0	3.2	3.4	1.3	3.2	3.7	0.9	2.4	12.3	12.5	14.1	17.2	11.5	10.6	13.0	10.4	12.9	13.0
H1F0	"H10, H1FV"	ENSG00000189060	"H1 histone family member 0"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 158.1"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"				"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favourable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	21.7	13.6	27.5	14.7	24.9	158.1	32.3	35.7	41.7	48.2	37.9	20.4	11.3	35.8	42.7	18.5	66.0	31.7	38.5	30.3	23.5	17.6	33.2	90.6	22.8	15.0	16.0	23.8	48.5	43.5	20.2	25.6	33.6	23.5	43.7	34.0	28.3	43.2	12.4	53.5	53.2	59.2	28.0	18.6	16.3	34.6	15.2	18.8	56.3	36.1	33.4	32.0	24.9	45.2	0.1	6.3	12.5	9.0	0.1	2.4	4.7	20.7	9.0	28.0	12.4	7.4	6.8	39.8	16.9	35.3	49.5	70.7	36.6	33.1	0.0	4.2	14.0	40.6	0.0	11.6	35.3	0.1	2.0	35.1	3.3	24.4	25.9	0.0	0.1	6.3	20.8	24.8	28.0	13.1	0.0	0.0	3.8	34.3	5.8	3.4	10.8	44.5	9.7	16.7	7.1	7.8	5.6	6.4	36.1	46.6	31.8	61.5	24.8	21.9	8.7	3.7	113.0	16.6	3.4	0.0	2.3	0.1	4.6	12.6	10.7	12.5	7.6	11.3	0.1	9.0	0.1	0.0	0.8	0.2	6.3	0.1	2.4	0.3	4.2	0.1	7.7	5.7	0.2	4.7	27.5	24.9	35.7	41.7	23.5	17.6	16.0	23.8	23.5	18.8
H1FX	"H1X, MGC15959, MGC8350"	ENSG00000184897	"H1 histone family member X"	Q92522	3	129314771-129316277	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"bone marrow: 381.6;lymphoid tissue: 238.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012235, HPA040099"	Supported		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB012235: , HPA040099: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	23.1	13.1	11.9	19.0	14.5	381.6	33.7	29.0	22.9	30.9	21.0	9.6	13.4	21.1	26.0	19.6	34.5	25.1	24.0	27.5	11.3	11.2	12.9	24.9	30.9	44.2	6.7	16.3	39.0	22.4	18.4	20.5	15.0	6.9	26.2	7.8	18.4	32.3	16.3	30.8	40.5	26.0	19.1	9.6	29.9	29.0	14.2	6.3	238.6	21.9	18.1	20.5	35.6	25.0	5.7	10.8	15.9	5.3	4.8	8.3	2.2	19.6	10.4	19.8	8.5	2.0	2.4	18.8	8.6	6.3	10.3	10.9	6.2	10.8	2.5	9.6	3.0	19.8	8.3	5.5	1.6	18.0	16.1	7.5	8.1	8.5	8.5	8.6	2.0	4.8	7.6	4.1	9.5	5.9	11.5	44.8	1.4	20.6	40.1	17.2	18.5	11.8	28.9	8.4	23.4	3.1	4.1	31.6	36.6	9.1	4.6	26.2	17.9	17.6	5.8	8.0	41.9	7.8	7.2	137.4	52.5	21.2	6.5	8.2	8.7	0.4	5.3	15.9	4.3	3.7	4.0	4.4	6.7	5.1	7.4	5.7	8.3	4.3	1.2	4.8	3.3	10.8	5.1	2.2	11.9	14.5	29.0	22.9	11.3	11.2	6.7	16.3	6.9	6.3
H2AFX	H2AX	ENSG00000188486	"H2A histone family member X"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 135.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: , HPA051647: "	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	5.9	10.1	10.7	17.9	9.4	24.0	4.2	9.4	13.9	5.0	12.0	15.2	2.5	15.4	5.7	2.8	9.8	5.5	4.0	4.7	10.6	10.1	6.4	5.0	7.1	17.0	13.3	5.3	8.0	9.2	3.8	8.1	12.8	9.3	6.4	5.4	6.3	5.8	6.3	7.2	10.8	13.7	4.2	13.6	11.1	12.6	28.3	9.5	135.1	5.9	11.3	23.2	4.8	6.6	2.0	3.4	7.4	2.4	3.8	3.4	1.8	26.1	15.8	25.0	14.9	2.3	1.7	26.4	29.8	9.1	16.8	14.8	25.0	11.3	18.0	18.0	6.8	27.2	11.8	8.5	4.5	26.5	33.1	36.4	4.3	25.7	2.4	17.9	22.7	1.4	1.8	7.1	4.4	8.4	29.4	29.6	8.0	66.7	40.9	53.6	18.2	33.5	40.0	29.5	8.4	7.6	11.4	26.7	31.7	23.6	13.8	4.1	20.6	13.6	10.3	16.3	43.1	13.2	22.1	8.1	7.9	18.2	3.7	29.2	31.8	7.0	2.4	7.4	3.4	1.1	1.8	2.0	3.4	3.4	3.4	1.8	2.3	2.0	1.2	3.8	1.5	1.5	2.8	1.8	10.7	9.4	9.4	13.9	10.6	10.1	13.3	5.3	9.3	9.5
H2AFY	macroH2A1.2	ENSG00000113648	"H2A histone family member Y"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm			4700000	Nucleoplasm		"HPA041189: , HPA050962: "	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	34.9	26.0	24.8	32.2	27.2	75.1	21.7	37.6	27.6	22.5	40.0	19.7	14.0	40.2	22.0	21.8	60.7	22.4	38.8	41.9	21.4	28.8	23.8	24.1	36.7	39.4	24.1	26.5	21.8	16.6	24.2	25.8	30.0	21.0	20.2	43.2	24.4	28.3	14.0	34.9	33.4	52.0	21.9	21.8	33.8	28.5	21.4	16.9	76.9	22.2	40.7	47.2	28.7	29.6	16.0	51.8	23.8	45.6	21.5	15.9	30.1	44.8	31.7	48.9	33.5	23.0	13.7	44.0	18.9	20.4	33.6	23.9	49.9	45.2	53.4	32.3	15.3	30.7	36.6	80.1	25.3	28.8	36.5	63.6	37.4	33.5	16.8	30.2	28.0	14.5	21.7	28.0	30.2	21.5	22.1	22.0	19.1	39.3	86.8	57.6	19.1	17.0	78.6	27.8	37.7	41.7	51.3	68.9	43.4	36.8	35.9	30.3	42.5	83.7	17.4	29.6	24.9	21.7	38.5	10.6	42.8	50.0	24.6	68.2	20.7	4.1	45.6	20.5	10.8	30.1	9.1	11.7	14.0	13.4	51.8	16.0	13.6	11.2	23.8	21.5	19.0	37.3	15.9	30.1	24.8	27.2	37.6	27.6	21.4	28.8	24.1	26.5	21.0	16.9
H2AFY2	macroH2A2	ENSG00000099284	"H2A histone family member Y2"	Q9P0M6	10	70052796-70112280	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 48.3;AN3-CA: 28.0;SCLC-21H: 35.8;SH-SY5Y: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 12.6;monocytes: 5.4;T-cells: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035865, HPA041189"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA035865: AB_10672099, HPA041189: "	"unprognostic (1.62e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.17e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.66e-2)"	4.7	3.7	9.3	9.0	9.8	2.0	11.3	21.8	12.1	16.1	10.9	12.2	26.0	9.8	22.5	14.8	18.7	18.1	17.9	13.9	7.3	9.8	12.6	10.2	6.3	5.9	6.6	9.2	18.3	12.5	14.3	18.8	2.6	6.3	19.7	12.1	10.6	11.7	23.5	15.6	11.4	10.6	16.7	9.3	3.4	9.2	18.9	7.4	6.9	15.3	11.7	9.9	14.1	12.5	0.0	12.6	0.4	5.4	0.9	6.4	3.1	1.3	7.1	48.3	28.0	0.5	1.5	0.0	2.2	0.0	4.2	2.9	0.2	14.4	0.0	6.1	0.8	7.3	3.6	11.7	1.3	18.8	17.5	0.0	0.0	14.8	2.9	0.5	0.4	1.9	8.5	1.5	2.4	0.0	0.0	0.0	4.0	10.0	0.0	0.0	20.0	12.3	0.0	0.0	0.0	8.6	8.9	35.8	34.7	7.3	0.0	0.1	10.8	5.5	0.0	0.0	8.4	3.4	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	3.6	5.4	4.5	0.0	4.8	4.3	12.6	0.0	5.0	6.4	0.4	0.9	3.3	0.1	3.4	3.1	9.3	9.8	21.8	12.1	7.3	9.8	6.6	9.2	6.3	7.4
H2AFZ	"H2A.Z, H2AZ"	ENSG00000164032	"H2A histone family member Z"	P0C0S5	4	99948086-99950388	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB022549, HPA057236"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB022549: , HPA057236: "	"unprognostic (1.21e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.03e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.74e-3)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.99e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (3.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	23.5	22.5	28.9	40.7	40.4	113.9	31.1	39.5	38.0	26.3	45.0	13.9	26.9	33.2	40.4	23.1	53.5	24.0	27.9	32.1	28.6	28.1	37.1	26.9	32.4	70.6	32.9	26.2	32.6	19.8	14.5	30.3	32.0	26.1	30.2	43.2	29.5	29.4	27.2	28.3	30.1	34.0	46.2	26.7	46.1	37.4	32.2	31.3	139.8	29.7	47.9	81.0	51.6	29.9	46.7	54.1	139.3	87.0	41.3	80.9	120.4	86.1	60.7	126.6	65.2	26.1	22.1	41.7	91.5	66.0	94.6	89.1	62.3	100.8	153.4	33.3	46.5	31.4	110.6	89.2	102.7	67.3	77.0	78.6	71.8	70.6	15.8	140.0	66.3	17.4	39.1	72.8	40.9	93.2	77.3	93.5	107.9	119.7	115.9	116.5	73.1	58.2	100.1	92.7	64.1	52.6	52.4	82.6	63.7	56.5	108.0	105.5	55.1	108.4	48.7	61.1	116.5	41.7	116.8	54.0	79.9	183.1	68.4	93.7	95.6	61.8	63.2	120.2	38.1	68.7	42.2	46.7	60.5	49.8	54.1	39.3	56.9	47.2	139.3	41.3	87.0	36.1	80.9	120.4	28.9	40.4	39.5	38.0	28.6	28.1	32.9	26.2	26.1	31.3
H2BFS		ENSG00000274559	"H2B histone family member S"		21	5972924-5973383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"blood: 16.0"	"Cell line enhanced"	"Detected in many"		"K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "										"unprognostic (3.37e-2)"				"unprognostic (2.63e-1)"				0.4	0.3		0.5		1.0	0.0		0.0	1.0	0.9			1.4	1.3	2.9	3.3	2.8	2.8	0.0			0.0	2.2	0.3	2.3			0.2	1.2	0.0		0.8		3.7	0.9		1.9	0.0	0.0	0.0	1.8	0.7		0.6	1.1	0.9			1.6		1.0	1.2		7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.0	3.2	0.6	0.9	2.2	0.8	2.3	2.5	1.3	3.2	1.9	4.5	1.0	0.5	8.6	0.8	2.4	0.2	0.7	0.9	2.1	3.5	0.5	4.9	0.2	0.3	0.9	4.4	2.4	0.4	0.6	0.0	0.3	23.2	2.7	0.8	6.0	1.0	2.2	0.3	2.6	0.8	0.5	8.5	0.6	0.7	3.4	2.4	10.2	3.1	2.0	10.9	1.4	0.9	1.7	22.9	1.1	0.6	7.4	23.3	4.9	1.1	11.6	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2										
H3F3A	"H3.3A, H3F3"	ENSG00000163041	"H3 histone family member 3A"	P84243	1	226061851-226072001	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 258.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 258.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011481, CAB037178, HPA042570"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: "	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.74e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.21e-6)"	"unprognostic (3.66e-2)"	"unprognostic (8.03e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.03e-2)"	39.0	43.4	37.2	83.4	33.4	126.8	67.9	45.0	42.8	44.6	54.0	31.6	62.9	47.9	43.4	60.6	66.3	42.4	49.6	59.4	36.1	31.2	45.9	59.2	73.2	217.9	37.8	23.2	44.4	79.7	30.8	34.8	59.1	29.2	38.4	59.4	42.7	49.0	49.7	37.0	47.1	50.0	42.0	48.6	71.9	41.4	87.6	31.7	148.9	38.5	71.0	84.1	43.5	47.6	39.2	44.6	258.7	56.9	23.6	34.9	60.5	53.7	30.7	119.8	67.6	33.3	38.8	90.0	25.5	31.0	41.4	32.8	32.0	89.7	51.8	56.8	31.3	51.6	59.2	46.5	40.8	32.0	102.3	64.0	45.5	42.8	33.0	65.7	77.8	35.5	53.9	29.0	38.2	61.3	90.1	88.6	47.1	31.1	136.4	122.3	162.5	60.9	92.4	87.5	133.4	85.8	57.5	117.0	174.0	72.8	92.1	63.1	104.4	154.2	34.5	30.2	42.1	40.7	73.9	39.5	50.5	90.4	28.8	62.8	64.5	40.0	56.9	80.8	23.1	44.9	23.6	39.2	25.0	24.9	44.6	36.0	23.7	25.7	258.7	23.6	50.8	36.6	34.9	60.5	37.2	33.4	45.0	42.8	36.1	31.2	37.8	23.2	29.2	31.7
H3F3B	H3.3B	ENSG00000132475	"H3 histone family member 3B"	P84243	17	75776434-75785893	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 570.8;bone marrow: 441.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 570.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 570.8"									"CAB037166, CAB037187, CAB037221, HPA042570"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: "	"unprognostic (1.66e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-1)"	57.2	41.2	38.1	58.9	48.6	441.9	71.4	60.2	47.0	86.6	44.6	65.9	42.7	37.9	60.5	77.7	93.2	70.2	75.8	35.1	38.5	33.9	42.8	48.1	64.2	62.3	50.4	41.2	141.0	90.9	33.0	41.5	58.5	42.7	60.5	26.6	65.8	58.4	55.4	71.1	114.0	58.0	63.7	51.8	65.9	45.1	66.9	46.2	78.6	58.9	69.1	55.7	78.5	71.9	78.9	88.1	570.8	98.4	80.0	77.2	203.5	118.3	105.1	43.9	43.3	25.1	39.4	60.7	56.1	49.7	68.9	55.3	112.5	84.2	59.3	53.6	32.6	46.6	34.7	77.5	39.3	32.3	78.2	52.9	56.1	95.2	56.7	87.8	68.1	42.9	48.0	70.6	91.1	51.7	74.8	106.6	35.4	174.1	126.0	73.7	35.2	117.5	93.8	80.4	64.6	54.4	70.3	89.1	99.0	56.9	83.5	120.3	65.4	94.8	48.2	123.7	109.4	53.3	148.4	129.0	76.3	71.2	65.4	83.8	67.4	182.8	98.4	259.3	74.4	86.9	70.2	78.9	71.8	70.5	86.7	65.3	77.2	64.5	570.8	80.0	78.9	88.1	76.0	203.5	38.1	48.6	60.2	47.0	38.5	33.9	50.4	41.2	42.7	46.2
HABP4	"IHABP4, SERBP1L"	ENSG00000130956	"Hyaluronan binding protein 4"	Q5JVS0	9	96450201-96491336	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055969	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA055969: "	"unprognostic (1.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"prognostic favourable (1.10e-7)"	"unprognostic (2.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.62e-2)"	13.2	11.9	31.2	6.1	44.8	1.7	6.5	14.1	40.6	7.9	5.5	12.4	1.5	3.0	8.2	6.8	7.2	5.3	8.1	19.1	26.1	24.9	23.5	5.7	6.1	6.8	27.1	20.5	11.7	4.8	13.8	7.4	3.4	31.6	8.3	4.2	8.4	4.1	10.6	9.4	6.1	3.3	10.6	19.4	5.0	5.0	21.8	13.0	0.4	11.2	2.2	4.9	7.6	6.5	4.1	0.1	0.3	0.8	1.0	4.0	0.7	7.4	8.5	10.8	11.6	24.1	20.6	7.7	10.1	11.3	7.6	8.4	12.7	12.5	3.8	5.0	15.1	5.5	9.0	1.9	6.2	4.6	5.4	1.5	4.0	21.1	12.2	0.3	1.6	8.3	3.5	8.7	6.9	5.4	1.7	11.3	13.7	7.6	0.1	2.3	5.0	8.3	3.9	9.5	0.1	13.0	3.3	6.9	4.7	5.4	3.3	16.1	2.3	1.6	9.2	10.6	2.4	19.3	8.5	7.1	7.0	1.6	8.4	3.0	15.5	0.0	0.1	0.0	1.4	0.3	1.4	4.1	4.0	3.2	0.0	1.7	2.8	2.8	0.3	1.0	0.8	0.1	3.0	0.7	31.2	44.8	14.1	33.8	26.1	24.9	27.1	20.5	31.6	13.0
HACD3	"B-ind1, HSPC121, PTPLAD1"	ENSG00000074696	"3-hydroxyacyl-CoA dehydratase 3"	Q9P035	15	65530418-65578352	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014837, HPA060347"	Enhanced		Enhanced	"Endoplasmic reticulum"			27000	"Endoplasmic reticulum"		"HPA014837: AB_1855914, HPA060347: "	"unprognostic (1.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.57e-1)"	"prognostic favourable (3.09e-5)"	"unprognostic (3.44e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.04e-2)"	9.6	37.4	31.0	7.4	36.0	6.2	33.3	28.6	37.6	18.5	12.5	24.2	10.1	12.2	13.1	19.4	8.4	14.3	14.7	5.9	29.2	44.8	35.0	50.0	12.7	7.2	36.5	26.0	21.7	12.6	22.5	33.9	15.9	45.9	18.5	15.1	17.9	11.6	15.8	3.3	11.7	12.0	12.2	41.5	8.5	29.0	13.9	19.7	8.9	30.7	5.6	8.3	18.8	10.4	13.0	9.0	2.7	6.1	11.7	19.9	11.2	19.6	44.0	49.0	24.4	30.9	18.7	23.2	21.8	18.9	24.8	28.1	33.7	29.5	24.8	19.1	23.6	54.4	78.9	18.2	22.3	13.7	44.0	19.6	22.1	36.8	15.7	24.3	15.1	19.1	13.6	17.0	12.3	24.1	25.7	9.4	40.0	23.4	18.0	19.0	41.7	15.0	20.4	41.5	27.9	35.4	34.2	29.6	26.1	23.5	26.5	24.6	26.9	12.9	19.1	31.6	27.8	15.5	30.2	18.4	54.5	34.9	21.0	23.8	18.9	2.7	3.9	1.2	17.6	5.8	19.9	13.0	16.1	16.6	6.8	13.0	18.9	18.5	0.4	11.7	6.1	9.0	12.4	11.2	31.0	36.0	28.6	34.1	29.2	44.8	36.5	26.0	45.9	19.7
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728093-104859919	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 41.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: "	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (1.75e-1)"	6.4	5.4	12.7	3.7	16.1	4.3	6.1	15.5	13.1	6.6	4.8	6.8	2.5	3.6	8.5	2.9	8.1	5.4	5.0	5.2	7.5	8.6	9.4	2.9	5.7	3.5	8.8	9.6	6.4	3.8	12.0	7.4	41.9	10.2	6.1	3.3	7.7	6.2	6.9	4.4	4.8	3.6	6.5	9.5	4.1	3.9	14.1	8.9	5.4	7.1	2.7	3.9	6.4	5.8	2.9	2.4	2.2	2.9	2.2	3.9	1.6	3.5	2.5	10.7	13.4	6.4	8.5	12.7	7.2	11.1	4.6	6.9	2.3	2.1	2.0	3.2	5.4	2.4	2.7	4.9	9.7	8.2	6.8	7.1	2.3	3.1	6.4	6.1	2.3	5.7	4.5	5.9	5.0	7.5	6.8	2.3	9.0	2.6	4.5	3.6	4.7	2.4	7.2	12.2	0.8	3.7	6.1	5.8	8.7	3.9	4.1	2.1	2.6	8.4	7.9	3.7	3.1	9.9	6.8	3.3	3.6	6.9	3.9	5.8	6.7	0.0	1.9	2.2	3.7	2.9	3.9	2.9	3.7	3.6	1.9	2.7	3.9	3.0	0.4	2.2	1.5	2.4	1.2	1.6	12.7	16.1	15.5	13.1	7.5	8.6	8.8	9.6	10.2	8.9
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Supported		Supported	Mitochondria			8700000	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	36.6	19.5	8.5	15.6	9.2	6.1	41.7	5.4	9.7	15.2	29.7	10.6	9.4	23.3	18.3	13.3	20.5	15.7	12.4	98.3	7.8	8.1	37.2	60.3	10.6	8.8	10.0	7.0	17.1	17.8	9.8	6.8	5.1	9.2	15.6	25.0	11.6	20.4	12.5	64.6	9.0	37.1	19.6	10.2	8.0	19.1	12.6	7.2	40.9	16.1	38.0	13.1	14.2	10.6	18.6	22.6	5.6	10.7	20.2	13.0	8.9	8.8	8.3	18.0	13.1	43.3	13.9	8.7	13.0	19.4	14.2	14.0	5.9	16.7	50.4	7.0	10.7	11.9	23.9	18.1	15.7	15.4	12.5	11.7	15.9	13.2	6.9	24.7	5.5	14.5	9.7	10.0	9.2	9.5	14.5	26.8	16.0	16.1	41.9	9.9	8.5	11.1	32.0	25.2	25.2	15.3	36.1	21.7	12.5	12.6	45.1	12.8	21.5	19.6	5.3	10.0	5.7	14.1	7.1	15.2	17.6	21.9	13.6	16.8	7.7	0.0	6.1	5.6	10.1	7.8	12.5	18.6	11.4	12.1	19.7	15.5	13.0	13.0	0.7	20.2	10.7	22.6	10.0	8.9	8.5	9.2	5.4	9.7	7.8	8.1	10.0	7.0	9.2	7.2
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria			2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: "	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.3	20.8	13.7	22.4	54.5	34.1	11.7	18.3	19.8	18.9	16.4	26.3	22.7	15.4	12.0	32.1	14.9	24.0	35.5	17.1	34.5	29.4	23.1	22.1	43.8	18.8	29.1	17.0	34.8	23.3	26.8	26.9	31.6	31.4	31.3	24.3	28.6	12.7	32.6	11.7	40.2	11.7	29.6	33.1	21.6	28.2	9.7	19.3	21.5	22.4	24.8	11.9	28.2	28.9	11.0	16.3	16.4	13.4	10.3	20.3	27.4	17.1	34.5	13.2	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria			1100000	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favourable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	22.7	18.0	12.6	22.5	77.7	43.0	12.7	19.2	29.4	19.8	19.4	21.5	22.2	11.4	13.5	31.4	18.0	20.9	27.1	24.3	25.7	18.2	26.2	10.7	42.0	33.3	21.1	20.1	41.6	44.8	20.5	33.5	36.6	21.9	18.5	41.2	16.7	11.8	40.8	8.7	19.6	13.1	41.6	21.7	40.7	32.4	6.0	20.7	32.9	37.5	50.4	23.2	37.8	25.3	18.7	19.5	17.5	13.8	13.9	20.9	20.1	21.5	33.8	18.5	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 61.4;placenta: 62.9"	"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 117.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"hippocampal formation: 0.3"	"HPA019591, CAB025576"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB025576: , HPA019591: "	"unprognostic (4.11e-2)"	"unprognostic (7.50e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-1)"		"unprognostic (3.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.39e-3)"	4.2	24.2	0.2	10.9	0.2	0.0	4.7	0.4	0.2	34.3	42.7	0.2	7.5	1.9	42.7	7.9	16.6	9.7	61.4	54.1	0.2	0.2	0.2	8.2	0.2	0.1	0.2	0.0	13.4	3.8	0.0	0.3	62.9	0.0	13.1	3.6	5.2	1.1	4.2	0.6	1.7	13.5	37.5	0.2	1.8	19.9	5.4	0.0	0.0	1.5	2.7	2.2	25.7	12.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.7	3.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.3	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.8	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0
HAP1	"HAP2, hHLP1, HIP5, HLP"	ENSG00000173805	"Huntingtin associated protein 1"	P54257	17	41717742-41734644	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.5;stomach 1: 23.3"	"Cell line enriched"	"Detected in some"	7	"REH: 45.1"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076992	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA076992: "	"unprognostic (2.84e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	"unprognostic (8.76e-2)"	"prognostic favourable (4.26e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.29e-2)"	0.7	3.2	11.7	1.1	16.2	0.8	2.0	5.6	13.1	4.8	1.3	3.8	2.2	5.2	4.6	3.5	0.9	2.8	3.1	0.6	10.1	30.5	1.1	1.2	1.4	0.9	6.6	6.6	1.0	2.2	0.5	6.8	3.1	15.5	1.6	1.4	0.4	3.4	3.0	1.0	1.6	2.5	1.7	8.3	3.3	23.3	3.4	2.2	0.0	7.2	0.0	1.0	0.9	1.2	1.2	0.8	2.6	0.6	1.5	1.0	0.1	0.1	1.5	0.7	1.5	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.9	0.1	0.1	0.5	0.1	6.2	3.2	0.2	0.0	0.0	1.6	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.8	0.4	45.1	0.0	1.7	0.3	0.5	0.2	0.0	0.3	0.2	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.6	0.6	0.5	0.6	0.3	0.4	0.5	0.5	0.6	0.2	1.2	0.8	1.0	2.6	1.5	0.6	0.8	0.8	0.1	11.7	16.2	5.6	9.3	10.1	30.5	6.6	6.6	15.5	2.2
HAPLN1	CRTL1	ENSG00000145681	"Hyaluronan and proteoglycan link protein 1"	P10915	5	83637805-83721613	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 41.8"	"Group enriched"	"Detected in some"	37	"PC-3: 44.7;TIME: 28.2;U-2 OS: 46.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019105, HPA019482, HPA025238"	Enhanced	Approved	Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: "	"unprognostic (5.74e-4)"	"unprognostic (2.94e-2)"	"unprognostic (6.58e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.76e-3)"	"unprognostic (6.01e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"prognostic unfavourable (4.81e-9)"	"unprognostic (6.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.91e-2)"	0.1	0.0	5.4	1.5	3.9	0.0	0.1	0.6	4.7	0.1	4.7	0.1	0.1	3.8	0.5	0.1	1.2	0.0	0.5	1.8	3.4	1.3	0.4	0.1	0.9	0.1	1.7	0.7	0.2	0.2	0.0	0.1	41.8	1.5	4.9	5.8	1.5	0.9	0.1	0.1	0.5	9.3	0.3	0.6	0.1	2.4	0.1	0.1	0.1	0.3	0.5	0.3	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.2	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.4	3.9	0.6	4.4	3.4	1.3	1.7	0.7	1.5	0.1
HARBI1	"C11orf77, FLJ32675"	ENSG00000180423	"Harbinger transposase derived 1"	Q96MB7	11	46602861-46617909	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038671, HPA045457"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038671: AB_10675947, HPA045457: "	"unprognostic (1.29e-1)"	"unprognostic (6.82e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.23e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.13e-1)"	3.3	5.9	6.3	3.3	13.9	7.5	3.7	2.6	8.5	3.8	4.4	11.8	5.4	4.0	3.6	5.4	4.4	3.3	3.7	3.7	6.0	4.4	4.6	4.9	3.2	4.6	16.6	4.2	2.6	4.8	5.4	8.3	5.9	9.2	3.6	5.3	3.4	4.5	3.0	4.9	5.0	4.1	4.5	7.7	4.3	6.2	19.2	13.0	4.8	4.1	0.6	5.0	4.4	3.1	6.7	8.2	20.3	10.2	6.0	10.1	4.5	3.7	6.1	5.1	4.8	10.1	6.2	6.0	5.4	5.2	7.5	9.4	4.2	4.3	6.5	3.5	4.4	7.3	5.4	4.7	7.0	7.6	6.4	6.6	4.7	4.7	11.7	6.1	9.0	7.7	12.7	4.9	9.7	4.6	10.3	8.2	6.1	7.9	7.5	2.6	13.7	7.4	5.1	7.1	11.5	5.8	4.4	4.8	4.0	6.4	6.9	7.7	11.5	5.4	4.4	7.5	5.8	9.8	4.8	7.8	8.3	7.0	5.7	3.7	7.6	20.3	7.5	10.2	10.1	10.2	7.1	5.0	8.3	7.5	6.2	6.7	8.1	8.9	11.1	6.0	9.2	8.2	9.8	4.5	6.3	13.9	2.6	8.5	6.0	4.4	16.6	4.2	9.2	13.0
HARS	USH3B	ENSG00000170445	"Histidyl-tRNA synthetase"	P12081	5	140673904-140691862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol			52000	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	22.4	24.5	28.5	21.1	35.5	18.1	21.0	41.1	46.3	20.6	22.7	20.0	23.6	17.4	21.6	23.5	26.9	23.7	17.5	25.1	29.5	35.9	20.6	34.2	16.7	22.4	36.9	33.0	24.7	25.2	29.5	38.7	15.0	38.2	21.7	24.8	13.6	22.1	27.9	27.1	33.9	16.4	28.0	21.0	18.3	18.8	16.6	23.5	17.6	19.4	20.3	28.5	19.9	20.9	16.8	22.1	10.7	22.9	25.2	29.4	23.4	20.5	30.0	18.1	39.5	23.1	25.1	19.1	33.1	23.9	38.3	35.9	54.7	17.4	27.4	29.2	37.1	21.6	27.5	53.3	36.1	23.2	34.0	19.7	39.0	34.6	28.7	30.9	16.9	26.6	16.7	41.7	23.8	38.4	17.2	22.7	39.8	35.3	22.0	28.8	14.2	19.8	20.3	26.3	22.3	30.8	26.2	28.5	27.5	27.4	40.0	26.1	29.5	17.4	32.0	36.0	13.8	20.2	44.6	22.9	27.2	27.7	27.3	26.0	24.5	6.7	14.1	10.7	29.4	20.8	26.3	16.8	25.8	27.3	22.1	14.8	28.2	26.9	4.3	25.2	22.9	15.6	22.1	23.4	28.5	35.5	41.1	46.3	29.5	35.9	36.9	33.0	38.2	23.5
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 49.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA067602: "	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	11.7	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	49.8	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA027422: AB_10601812, HPA030698: "	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	1.2	0.3	0.3	11.8	0.6	7.5	1.8	0.5	0.3	0.5	1.5	0.2	0.0	2.2	0.3	0.4	2.8	0.6	1.3	0.6	0.2	0.2	0.8	0.4	2.6	5.8	0.4	0.0	0.4	0.5	0.0	0.3	1.3	0.2	0.7	1.5	0.2	1.0	0.0	1.2	0.9	3.6	0.4	1.2	4.9	1.7	26.7	0.3	26.7	0.7	1.7	7.3	0.8	1.0	2.8	1.5	2.1	0.6	0.0	1.2	0.4	7.5	8.2	7.6	8.6	0.5	1.0	6.4	6.9	5.3	13.7	13.5	6.4	3.1	18.5	4.0	3.8	12.3	13.7	6.7	13.1	0.1	11.5	9.2	6.7	3.8	0.3	5.3	9.5	0.6	0.5	10.3	6.4	6.2	8.1	16.3	6.9	3.9	10.7	3.1	6.7	5.7	11.1	9.6	5.0	2.0	5.3	3.1	4.5	6.1	4.2	2.4	4.2	5.0	3.2	6.1	7.0	6.8	12.1	3.1	3.5	9.0	3.6	7.7	7.3	0.4	0.6	2.1	0.2	0.5	0.2	0.7	0.8	0.0	1.1	2.8	1.2	0.2	0.2	0.0	0.0	1.5	0.1	0.4	0.3	0.6	0.5	0.3	0.2	0.2	0.4	0.0	0.2	0.3
HAT1	KAT1	ENSG00000128708	"Histone acetyltransferase 1"	O14929	2	171922448-171983682	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036788, CAB037191"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB037191: AB_477070, HPA036788: AB_10672267"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.39e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (5.72e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.69e-2)"	24.3	23.7	14.3	20.8	21.4	30.9	25.7	18.4	16.7	17.6	18.2	14.0	17.7	11.8	20.7	15.6	21.3	17.7	14.8	26.2	16.7	13.0	27.5	22.1	18.8	26.9	21.2	12.9	21.8	23.0	22.3	32.2	21.1	21.4	20.8	19.3	13.1	25.5	15.6	53.9	18.6	15.8	22.9	20.5	22.5	20.2	15.9	21.5	35.4	26.1	31.8	27.8	22.1	16.9	21.0	16.0	29.9	32.1	25.9	28.1	19.2	34.0	16.3	28.8	26.3	15.3	15.9	20.3	35.6	23.8	39.3	41.1	37.7	23.6	38.2	23.1	21.5	27.1	31.1	29.1	60.8	21.5	30.9	33.7	26.9	34.0	7.5	42.5	21.2	9.5	16.9	51.8	17.4	24.8	34.8	25.1	44.6	23.8	33.3	38.9	23.9	17.1	26.7	36.3	25.9	23.4	34.4	18.4	15.1	29.8	16.7	30.2	23.2	43.2	12.5	35.4	27.3	29.7	35.8	11.0	25.4	45.0	23.8	30.5	30.5	23.8	21.1	29.9	20.8	24.5	25.8	21.0	22.1	21.3	16.0	18.4	22.2	24.2	24.0	25.9	32.1	8.2	28.1	19.2	14.3	21.4	18.4	16.7	16.7	13.0	21.2	12.9	21.4	21.5
HAUS1	"CCDC5, FLJ40084, HEI-C, HsT1461"	ENSG00000152240	"HAUS augmin like complex subunit 1"	Q96CS2	18	46104332-46128333	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040601, HPA040652"	Supported		Supported	Centrosome,Cytosol				Cytosol	Centrosome	"HPA040601: AB_10794743, HPA040652: AB_10793966"	"unprognostic (1.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (1.39e-1)"	"unprognostic (4.76e-3)"	"prognostic favourable (1.55e-4)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (6.76e-4)"	"unprognostic (5.97e-3)"	"unprognostic (5.40e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.96e-2)"	15.2	11.8	10.3	14.6	13.1	23.1	14.5	15.8	12.2	14.3	13.4	6.2	13.1	9.9	15.5	28.4	15.9	13.8	11.6	9.3	10.3	8.0	14.4	12.1	10.9	22.9	13.6	6.8	20.4	12.0	6.5	18.1	13.0	12.0	14.8	16.3	7.3	11.4	14.4	7.1	8.6	13.4	12.2	14.4	17.9	12.2	11.8	15.4	38.4	14.3	14.4	26.1	13.9	12.3	28.1	23.4	13.0	18.2	19.3	34.9	19.3	18.4	11.2	42.5	22.9	10.9	16.9	11.4	18.1	18.1	28.9	28.8	10.9	10.5	35.3	10.9	12.9	19.7	25.4	15.3	31.9	19.8	17.0	25.9	12.0	20.6	9.2	47.2	15.9	8.2	6.1	17.8	9.2	31.5	18.4	10.1	25.8	10.8	37.4	22.6	27.1	6.6	37.5	30.5	25.2	22.8	13.0	20.0	20.8	16.8	5.8	13.6	8.5	23.0	17.8	17.0	11.5	7.3	18.8	11.8	17.9	32.7	10.8	40.1	19.4	4.4	18.2	13.0	16.0	16.4	17.7	28.1	21.6	18.9	21.6	23.7	15.4	18.1	2.0	19.3	12.7	23.4	34.9	19.3	10.3	13.1	15.8	12.2	10.3	8.0	13.6	6.8	12.0	15.4
HAUS4	"C14orf94, FLJ20424"	ENSG00000092036	"HAUS augmin like complex subunit 4"	Q9H6D7	14	22946228-22957161	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA029803, HPA071195"	Approved		Supported	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA029803: AB_10601428, HPA071195: "	"unprognostic (8.47e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.47e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (2.24e-4)"	17.2	16.7	11.0	28.8	15.0	29.8	22.3	9.9	15.6	20.3	24.0	13.8	22.3	15.3	17.8	20.7	25.4	16.9	30.6	19.5	12.3	8.3	16.8	17.9	24.0	30.6	17.7	9.2	33.8	29.1	17.5	9.8	12.1	13.4	19.1	16.9	14.2	22.0	19.2	14.4	21.7	24.9	23.3	17.6	24.5	19.3	12.2	17.4	33.7	23.2	17.2	21.2	18.9	19.5	14.0	35.3	34.5	28.2	7.8	15.4	15.3	25.6	17.5	20.2	20.0	14.9	18.7	30.4	12.9	17.2	14.1	19.9	12.5	30.7	49.6	6.2	7.7	26.0	10.7	15.4	11.9	13.4	8.1	16.7	12.3	30.5	13.6	21.4	27.8	12.7	29.9	6.0	18.4	24.5	11.6	24.8	15.1	19.8	23.3	19.0	10.6	17.8	22.4	24.3	19.1	12.2	14.1	8.1	13.2	18.5	19.2	11.3	16.7	17.3	13.5	12.9	16.7	9.3	11.3	26.3	22.6	23.0	6.1	24.2	7.3	2.1	28.2	5.8	5.8	18.3	7.8	14.0	10.9	8.3	35.3	11.6	15.4	11.8	34.5	7.8	11.3	9.9	14.6	15.3	11.0	15.0	9.9	15.6	12.3	8.3	17.7	9.2	13.4	17.4
HAUS6	"dgt6, FAM29A, FLJ20060, KIAA1574"	ENSG00000147874	"HAUS augmin like complex subunit 6"	Q7Z4H7	9	19053143-19103119	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020960, HPA020965"	Approved		Supported	"Nuclear speckles,Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"	"Nuclear speckles"	"HPA020960: AB_1848393, HPA020965: AB_1848394"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (6.04e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (3.13e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.03e-1)"	8.7	9.6	10.9	9.2	13.1	17.5	11.1	10.8	10.3	7.7	7.0	9.9	5.6	4.9	8.9	8.0	7.0	7.4	6.4	7.1	10.5	7.3	5.2	11.0	7.1	12.8	15.0	8.9	11.1	6.3	5.8	8.5	8.4	12.4	7.6	7.9	5.6	7.1	7.4	7.2	9.8	7.2	8.9	13.5	10.0	5.8	27.1	13.6	27.3	6.6	3.8	12.7	7.0	7.1	3.6	2.6	10.9	2.2	7.2	6.1	2.5	10.8	7.4	15.3	11.9	5.9	7.1	8.3	11.7	8.3	10.8	16.7	3.8	5.0	12.7	4.3	6.7	4.5	14.0	6.8	16.8	11.6	6.7	67.7	13.5	8.7	3.9	8.9	15.5	4.4	7.1	10.2	22.3	7.8	9.2	8.4	12.4	3.5	17.4	15.2	16.3	7.5	13.6	10.4	5.2	5.8	6.3	8.9	12.3	5.2	4.8	7.4	3.8	11.3	7.7	9.7	5.9	8.3	13.4	3.3	7.3	12.6	9.1	7.6	4.2	10.9	2.2	2.2	4.5	2.2	6.1	3.5	4.3	5.6	2.2	3.6	5.2	4.6	3.5	7.2	2.0	2.6	5.4	2.5	10.9	13.1	10.8	10.3	10.5	7.3	15.0	8.9	12.4	13.6
HAX1	"HCLSBP1, HS1BP1"	ENSG00000143575	"HCLS1 associated protein X-1"	O00165	1	154272511-154275875	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055141, HPA075289"	Approved		Supported	Mitochondria				Mitochondria		"HPA055141: , HPA075289: "	"unprognostic (1.32e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.96e-1)"	24.0	25.4	28.6	16.0	33.9	12.2	29.2	15.1	36.6	24.9	24.8	21.9	22.9	18.6	20.2	42.7	27.7	24.5	20.2	59.5	24.7	26.3	32.1	61.7	17.3	20.3	25.8	20.3	29.3	47.8	21.0	35.2	18.4	23.5	26.1	25.0	26.6	52.0	26.3	90.4	17.8	27.8	25.1	22.6	23.2	23.9	31.3	17.0	23.8	32.4	45.8	27.7	27.0	18.6	39.1	34.9	59.1	39.6	30.9	51.8	42.8	20.4	17.5	14.9	32.5	18.4	20.6	24.1	19.5	32.0	41.4	38.5	23.2	23.0	29.8	28.3	33.0	17.7	34.0	27.0	32.0	30.5	25.5	14.5	14.4	20.0	41.0	30.2	31.5	19.1	49.9	31.1	37.3	23.0	28.3	44.6	26.6	49.3	30.2	25.0	16.4	38.4	21.5	10.9	57.3	21.8	11.5	22.8	22.8	17.4	42.3	58.9	34.9	83.4	11.4	17.2	23.2	18.0	26.8	52.0	54.2	55.9	26.2	27.9	28.4	58.3	28.4	59.1	34.2	33.5	39.1	39.1	43.1	38.7	34.0	38.2	51.8	41.2	17.2	30.9	39.6	34.9	50.8	42.8	28.6	33.9	15.1	36.6	24.7	26.3	25.8	20.3	23.5	17.0
HBP1		ENSG00000105856	"HMG-box transcription factor 1"	O60381	7	107168961-107202529	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020225, CAB032824"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB032824: AB_2114615, HPA020225: "	"unprognostic (9.00e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.43e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.49e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.50e-1)"	"prognostic favourable (7.70e-5)"	"unprognostic (7.39e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.26e-2)"	28.7	26.2	17.5	14.2	19.2	33.7	27.9	33.6	20.7	27.0	21.1	17.3	23.9	13.1	36.5	16.9	28.8	18.8	16.7	23.8	16.3	8.9	21.0	27.4	25.8	13.8	29.4	12.3	27.8	18.0	18.5	14.4	37.1	19.8	26.4	14.6	14.5	23.7	19.4	40.8	34.3	17.6	21.5	23.5	17.9	18.5	25.9	27.5	24.5	33.5	19.0	17.8	30.9	32.5	11.6	12.9	47.2	19.5	16.6	17.2	24.7	5.1	5.8	10.5	6.7	21.7	20.4	5.2	8.5	19.0	6.2	10.9	2.3	12.6	4.7	11.3	11.6	6.1	4.1	5.2	7.6	3.9	3.9	3.1	9.8	4.3	12.4	2.4	9.4	23.7	15.5	5.9	7.3	19.9	5.8	11.8	7.8	8.5	4.0	7.9	6.6	6.4	3.6	7.5	11.6	10.9	6.2	4.0	12.6	9.7	14.4	13.2	4.7	7.0	19.2	8.3	6.4	12.2	2.8	13.6	16.0	4.6	7.9	5.3	7.7	41.3	19.1	24.7	13.0	19.5	12.2	11.6	13.7	12.4	12.9	11.2	16.0	13.4	47.2	16.6	18.9	6.6	17.2	24.7	17.5	19.2	33.6	20.7	16.3	8.9	29.4	12.3	19.8	27.5
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703343	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 50.9"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 50.7"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 50.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 50.9"									HPA028660	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	16.1	0.2	0.4	6.4	0.5	13.2	8.3	0.2	0.7	5.8	3.6	0.3	6.2	0.4	0.8	1.6	26.0	0.4	1.1	1.2	0.8	0.2	1.9	1.8	11.3	0.7	3.3	0.2	1.2	0.2	4.4	0.9	8.2	1.0	8.6	0.0	0.3	9.7	10.7	0.7	17.8	0.7	0.4	0.9	16.5	0.8	2.8	1.1	1.1	0.4	13.5	21.5	3.5	8.3	0.0	0.5	50.9	6.6	0.0	0.0	0.3	1.8	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	50.7	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	9.0	0.6	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	50.9	0.0	6.6	0.0	0.0	0.3	0.4	0.5	0.2	0.7	0.8	0.2	3.3	0.2	1.0	1.1
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123078	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavourable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	10.6	14.2	8.8	9.0	12.7	11.8	9.6	11.0	17.7	6.7	15.5	7.4	8.0	17.2	8.5	5.5	15.8	6.9	9.8	36.9	8.4	8.3	15.9	19.0	9.5	10.1	8.2	11.1	10.0	11.4	11.5	10.0	12.8	10.6	7.8	15.2	9.3	12.8	8.0	41.6	13.8	14.4	10.4	6.3	12.3	12.2	10.5	6.0	10.3	10.8	16.4	11.8	11.4	17.3	18.1	28.4	13.3	29.7	8.4	11.1	8.7	23.2	26.8	12.5	12.0	11.8	11.4	13.3	23.5	17.9	29.7	25.5	31.1	17.0	14.5	12.1	18.8	21.6	25.9	22.4	29.0	13.5	20.3	14.5	34.4	15.5	20.9	15.8	17.7	11.1	17.5	28.2	19.3	21.0	26.8	16.8	19.9	31.5	11.4	12.8	22.7	29.0	11.2	25.2	28.4	20.0	18.3	9.1	10.7	23.4	25.5	15.0	19.7	11.4	20.6	19.3	10.4	49.2	20.0	12.4	12.6	19.2	15.5	12.7	18.4	10.1	22.5	13.3	9.9	29.7	9.5	18.1	9.7	8.9	28.4	15.5	8.5	11.1	6.2	8.4	24.8	25.9	10.4	8.7	8.8	12.7	11.0	17.7	8.4	8.3	8.2	11.1	10.6	6.0
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947553-153971807	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018312			Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA018312: AB_1850522"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	16.0	19.2	18.2	23.7	18.5	48.3	14.2	24.4	23.3	13.9	20.0	17.3	14.1	16.8	26.3	13.6	18.2	18.8	20.8	14.7	17.0	12.7	15.6	17.2	19.0	24.9	14.6	16.1	20.4	15.6	21.9	26.4	13.8	15.8	17.7	11.2	13.8	21.5	20.6	27.8	18.2	18.3	19.7	20.0	25.2	18.0	15.3	17.9	52.3	16.4	15.6	17.6	17.4	18.3	4.8	8.0	1.7	5.6	2.8	6.7	3.5	15.2	19.9	13.5	17.1	5.7	4.1	19.9	6.3	4.9	7.5	6.8	21.0	10.3	27.8	16.2	8.1	12.6	14.6	10.3	3.9	14.7	17.2	16.6	15.9	16.5	3.9	20.4	27.6	6.3	6.7	13.0	5.7	7.9	23.1	17.6	5.2	21.4	28.2	26.4	17.6	12.2	33.0	11.1	16.8	5.6	14.2	15.1	16.4	11.6	12.1	6.4	11.1	18.5	10.4	14.3	17.6	12.3	20.2	28.1	38.3	34.8	11.6	19.9	13.4	1.7	4.0	1.7	6.0	5.6	4.3	4.8	4.8	4.6	4.5	4.4	4.9	6.7	0.8	2.8	4.0	8.0	3.2	3.5	18.2	18.5	24.4	23.3	17.0	12.7	14.6	16.1	15.8	17.9
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064457-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	11.5	10.0	11.9	4.7	13.2	3.2	12.9	3.8	11.1	11.5	14.4	9.1	8.7	7.2	12.6	7.5	9.1	8.5	8.1	7.7	9.3	5.8	8.5	10.2	9.1	5.9	12.5	8.1	11.8	9.1	10.4	14.3	10.6	10.0	10.8	6.3	6.8	8.0	14.6	17.5	7.4	7.5	19.0	10.2	6.8	9.9	19.2	11.0	9.1	10.1	5.1	5.0	12.8	10.3	1.8	2.2	2.8	5.0	2.5	3.2	1.7	1.9	2.1	2.2	1.9	12.4	12.4	1.6	8.5	3.9	6.5	3.8	1.0	0.9	1.9	3.0	6.6	2.1	2.7	1.5	7.1	3.2	2.6	1.9	2.0	0.9	8.4	1.6	3.1	7.7	4.2	4.1	3.4	5.0	2.2	4.0	11.6	1.7	2.8	3.7	0.4	4.4	2.3	7.3	1.2	2.9	1.3	3.2	2.4	4.2	3.0	3.2	4.8	1.7	7.5	10.4	1.4	5.3	2.8	5.1	1.5	1.7	4.9	2.1	4.1	1.3	2.0	2.8	2.6	3.7	3.1	1.6	2.5	3.2	2.2	1.8	3.0	3.2	0.5	2.5	5.0	1.2	2.8	1.7	11.9	13.2	3.8	11.1	9.3	5.8	12.5	8.1	10.0	11.0
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 149.7;lymphoid tissue: 110.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 42.3;HMC-1: 60.1;THP-1: 41.9;U-266/70: 59.5;U-698: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"			200000	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	24.7	10.7	7.8	44.9	14.7	35.5	9.1	1.3	7.4	6.3	10.4	8.5	2.2	5.5	5.6	8.2	4.8	9.1	10.1	7.5	6.7	5.0	10.5	10.1	18.7	59.4	12.9	3.2	4.6	5.1	1.4	6.1	15.4	10.9	6.1	8.6	4.9	7.4	3.1	7.0	4.6	23.0	8.9	15.1	110.1	7.1	3.6	11.6	41.0	6.1	4.4	61.5	12.5	5.6	33.4	59.6	149.7	84.9	24.3	44.1	103.5	0.1	0.0	0.0	0.0	3.5	1.9	0.9	0.6	0.6	0.1	0.2	0.0	0.0	42.3	20.6	0.0	0.0	1.1	1.6	0.1	18.8	0.0	27.4	0.0	0.0	1.9	30.1	60.1	0.3	0.0	0.0	0.3	24.9	5.4	39.1	0.0	0.0	21.3	25.4	0.0	0.7	21.6	0.0	40.2	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.0	41.9	32.5	0.0	0.3	0.0	0.1	59.5	18.1	59.5	0.3	29.0	0.0	26.6	64.1	104.2	40.2	80.6	32.9	33.4	33.3	36.8	59.6	29.4	28.5	33.0	149.7	24.3	84.9	18.5	44.1	103.5	7.8	14.7	1.3	7.4	6.7	5.0	12.9	3.2	10.9	11.6
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902480-35904377	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1"	"Cell line enhanced"	"Detected in some"		"HEL: 51.7;HL-60: 29.8;HMC-1: 34.5;THP-1: 39.1;U-937: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"				"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	29.4	4.0	6.5	19.9	5.2	84.0	5.9	1.4	3.1	3.9	4.9	4.8	0.5	4.5	5.4	6.0	3.0	4.5	6.3	7.3	5.7	5.9	5.6	6.9	38.4	79.1	7.7	2.2	3.4	2.9	0.7	4.3	10.6	4.9	5.5	3.6	7.1	6.2	3.7	2.4	2.8	10.9	4.5	12.7	49.5	5.6	1.7	4.4	56.8	3.4	3.3	26.7	5.2	3.6	6.1	66.6	15.9	57.0	96.4	134.0	89.5	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.2	5.6	0.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	51.7	0.1	0.1	0.1	29.8	34.5	0.3	0.0	0.0	0.0	0.0	0.4	7.4	0.1	0.0	3.4	11.6	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.1	39.1	0.1	0.3	0.4	0.0	0.0	0.3	0.2	8.5	0.3	58.7	0.0	7.3	57.0	7.9	134.0	42.0	99.3	6.1	57.4	108.5	32.6	3.7	48.3	96.4	15.9	96.4	23.0	66.6	48.5	89.5	6.5	5.2	1.4	3.1	5.7	5.9	7.7	2.2	4.9	4.4
HDAC1	"GON-10, HD1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292086-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB005017: AB_2248344, CAB068191: , HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	13.8	22.8	12.8	33.5	14.8	15.0	21.1	5.1	13.0	21.9	35.7	16.0	34.8	22.2	24.6	17.5	40.6	21.0	43.8	12.4	12.5	8.5	21.1	21.5	17.2	33.3	14.7	8.6	27.7	20.5	17.2	27.1	24.4	12.2	25.2	33.9	18.0	27.8	31.3	6.6	16.9	32.7	22.1	13.3	32.6	27.8	20.0	16.7	59.4	36.8	21.2	51.1	26.0	25.1	47.7	32.1	59.8	44.6	42.4	49.2	54.7	29.5	18.0	11.6	23.1	6.8	8.1	24.2	20.9	23.5	28.1	26.0	33.0	53.3	45.6	38.9	23.1	34.6	35.7	28.5	31.2	42.6	35.5	31.4	21.7	25.3	16.1	55.6	45.6	14.7	15.7	21.7	14.4	21.3	41.1	18.2	12.3	22.5	63.3	31.3	26.9	46.2	43.8	27.6	20.3	30.4	42.8	9.1	11.5	35.0	23.6	44.0	27.8	43.3	24.6	18.7	22.0	5.7	51.0	11.1	23.8	62.5	15.4	46.2	24.3	37.0	27.7	59.8	43.2	35.5	35.4	47.7	42.4	46.1	32.1	44.3	49.2	45.7	19.9	42.4	44.6	20.1	42.5	54.7	12.8	14.8	5.1	13.0	12.5	8.5	14.7	8.6	12.2	16.7
HDAC2	"RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavourable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	25.8	33.8	25.8	30.1	31.3	34.9	58.7	32.8	36.5	32.1	30.7	25.6	32.2	22.0	38.7	36.7	36.3	32.7	23.3	27.6	26.5	26.9	31.6	22.2	29.9	41.5	29.6	26.5	39.2	31.5	31.7	45.1	38.1	27.9	32.1	36.1	17.5	29.3	39.0	33.9	30.8	26.1	36.1	31.1	30.7	29.9	47.4	27.4	64.0	35.1	31.3	32.5	33.1	47.3	27.0	35.7	28.2	32.6	26.3	32.6	24.3	24.2	16.7	78.2	44.9	20.2	23.0	32.8	28.9	23.7	34.2	41.0	44.3	17.9	20.0	24.2	26.0	19.1	53.0	29.3	57.6	28.5	36.6	48.2	21.7	25.6	26.9	48.9	21.8	18.6	19.7	36.4	34.2	39.8	62.0	20.4	56.5	20.3	43.8	44.3	44.2	23.1	29.8	39.0	18.4	35.3	29.3	52.3	44.4	22.9	21.6	24.1	15.7	57.1	32.1	21.8	25.1	22.8	47.9	16.2	21.3	47.9	18.5	47.2	36.9	23.1	27.6	28.2	21.1	26.6	28.1	27.0	25.9	22.7	35.7	22.3	32.6	29.7	16.3	26.3	32.6	30.9	24.5	24.3	25.8	31.3	32.8	36.5	26.5	26.9	29.6	26.5	27.9	27.4
HDAC3	"HD3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636870	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: "	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favourable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favourable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	15.9	28.8	19.6	12.2	17.6	18.1	18.6	22.6	20.8	15.6	14.1	11.2	13.1	10.6	17.3	17.6	22.8	16.3	14.0	16.8	18.0	8.9	14.5	23.3	24.4	36.4	13.4	14.2	17.3	24.7	20.9	17.3	14.3	18.8	13.6	14.4	13.6	17.5	13.7	24.5	26.7	15.2	17.2	10.8	20.1	15.5	11.9	12.6	18.5	14.4	9.6	23.7	17.5	17.0	22.1	46.7	16.4	22.6	14.1	23.1	16.9	21.1	14.3	26.6	40.4	25.8	20.6	17.3	15.4	33.9	35.0	50.2	30.7	18.1	30.7	20.0	20.0	18.3	26.8	36.1	43.4	26.2	28.8	24.0	13.2	17.4	18.2	28.9	22.0	17.5	23.3	20.3	26.4	22.5	23.4	16.4	22.1	20.0	32.0	25.0	23.5	11.4	23.2	27.9	22.1	18.7	21.3	22.3	18.1	20.4	21.2	25.4	22.6	18.3	11.3	21.7	13.6	16.6	25.2	13.4	16.4	28.9	18.3	27.5	18.6	13.2	22.4	16.4	15.9	22.6	20.8	22.1	19.8	19.2	46.7	20.1	21.7	18.0	9.5	14.1	19.0	23.9	23.1	16.9	19.6	17.6	22.6	20.8	18.0	8.9	13.4	14.2	18.8	12.6
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 28.3;monocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004431, HPA048723"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoplasm, Cytosol"	"CAB004431: AB_627706, HPA048723: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.33e-4)"	"prognostic favourable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	7.9	6.8	6.1	6.8	5.2	17.1	4.6	6.4	12.3	11.3	21.4	4.6	4.3	2.5	10.2	6.4	8.8	9.0	24.6	5.2	5.0	6.0	3.2	3.1	4.2	4.3	6.1	5.4	8.5	5.8	4.9	8.3	2.5	5.2	7.5	4.8	8.3	3.7	7.3	54.6	6.9	6.5	15.8	4.2	5.4	7.0	8.1	4.3	6.5	4.8	13.2	5.6	10.2	4.6	0.5	1.7	28.3	7.4	2.1	1.2	0.4	4.3	4.3	5.5	6.6	3.1	5.3	6.5	4.5	3.1	3.6	3.4	2.0	7.8	2.0	1.8	3.9	4.3	3.8	1.8	1.8	12.0	2.0	3.2	5.3	6.3	4.2	4.9	2.9	3.6	4.6	6.6	5.3	3.8	4.5	4.6	1.7	5.3	31.6	6.7	4.3	2.2	8.2	10.4	3.2	4.1	5.5	4.4	7.8	6.3	2.8	11.1	1.5	13.4	6.1	4.2	0.3	7.2	6.1	3.3	3.1	3.9	6.1	6.8	8.3	10.5	7.4	1.1	0.9	2.4	1.1	0.5	0.9	0.8	0.8	0.5	0.5	1.0	28.3	2.1	1.0	1.7	1.2	0.4	6.1	5.2	6.4	7.5	5.0	6.0	6.1	5.4	5.2	4.3
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"				"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favourable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favourable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	15.6	17.6	24.9	7.9	15.8	13.2	18.1	35.9	25.8	16.5	8.8	19.6	9.5	8.4	15.0	11.9	20.1	16.9	11.3	24.4	22.1	24.2	8.6	6.3	13.6	8.8	24.7	22.1	24.5	16.1	28.2	17.5	23.0	19.3	13.6	5.5	11.7	14.2	11.9	42.6	34.0	9.7	12.4	20.5	13.8	9.3	10.3	18.1	7.6	15.0	9.8	8.2	14.9	20.4	7.6	9.4	17.9	13.6	3.5	4.9	5.0	3.5	2.3	6.4	1.5	12.4	9.7	23.1	9.6	24.0	4.8	7.9	5.1	3.8	5.6	3.9	22.8	2.9	7.5	4.1	2.0	8.7	12.2	10.9	7.7	11.7	5.3	3.5	15.4	13.7	7.1	5.5	6.9	3.9	8.1	11.4	27.8	2.7	5.8	10.7	7.0	5.5	22.5	17.9	14.4	0.5	1.6	16.7	8.8	2.8	11.8	13.0	16.8	20.7	2.1	12.1	7.8	2.8	4.8	18.8	15.7	6.7	7.0	4.4	5.7	7.1	7.3	7.7	4.9	11.6	3.5	6.6	3.9	4.9	9.4	7.6	4.1	3.5	17.9	3.5	13.6	8.3	3.5	5.0	24.9	15.8	35.9	25.8	22.1	24.2	24.7	22.1	19.3	18.1
HDAC6	"FLJ16239, HD6, JM21, KIAA0901, PPP1R90"	ENSG00000094631	"Histone deacetylase 6"	Q9UBN7	X	48801377-48824982	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003714, CAB004236, HPA026321"	Supported		Supported	Nucleoplasm			39000	Nucleoplasm		"CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546"	"unprognostic (9.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (3.34e-4)"	14.6	13.7	23.4	12.8	29.8	19.0	14.4	34.2	30.1	12.7	14.1	24.4	14.9	16.9	16.0	14.7	13.1	15.7	11.7	11.9	21.7	24.8	32.8	43.3	15.1	13.9	27.2	22.4	18.7	15.5	26.7	24.4	15.1	27.0	12.3	15.9	15.1	12.2	15.3	18.2	11.3	16.1	15.0	20.9	15.3	14.2	24.7	22.4	19.0	15.7	9.5	14.0	11.7	12.1	5.7	9.7	6.3	12.4	4.0	5.8	5.0	16.0	13.6	26.7	10.2	10.8	9.8	18.1	7.7	6.5	14.8	14.6	13.1	13.7	15.4	7.4	8.7	11.5	16.2	8.2	12.8	14.4	10.2	21.1	16.2	13.4	10.2	9.7	32.7	14.2	13.3	11.6	14.0	12.3	23.1	17.1	9.3	5.6	13.8	15.3	9.9	13.0	11.9	28.8	15.9	8.5	6.9	13.8	13.6	15.4	4.6	9.2	19.3	9.1	10.0	11.5	14.9	15.8	7.3	15.8	15.6	11.2	11.7	12.5	11.4	0.0	5.8	6.3	5.8	9.7	4.1	4.3	4.0	4.2	8.6	5.7	3.9	3.7	2.9	4.0	12.4	9.7	4.4	5.0	23.4	29.8	34.2	30.1	21.7	24.8	27.2	22.4	27.0	22.4
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 85.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol				Cytosol		"HPA004775: AB_1850548"	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (4.65e-4)"	26.0	21.6	8.2	22.7	10.8	17.3	24.4	8.4	10.7	28.2	20.7	8.7	15.4	8.0	27.9	21.5	19.2	25.2	22.1	16.5	10.3	4.3	17.7	5.1	27.6	21.1	8.2	8.0	25.4	8.9	23.7	11.5	17.5	10.0	20.1	4.1	17.6	16.3	18.9	12.5	19.7	13.9	24.9	10.3	23.1	14.9	9.5	11.5	85.8	20.9	12.9	21.0	24.8	25.0	1.4	0.6	10.5	1.9	1.7	1.5	1.8	14.0	9.6	10.0	16.3	7.8	21.9	9.0	13.9	10.8	10.1	6.6	12.8	13.4	28.3	46.2	12.6	13.1	2.3	10.8	3.7	13.2	4.8	9.6	9.4	2.9	8.5	3.0	0.4	14.3	3.8	10.0	5.4	20.8	10.2	11.6	6.4	6.1	27.8	7.5	14.0	10.7	21.4	5.3	10.2	4.3	9.2	2.8	6.8	10.6	4.9	5.0	4.6	4.1	23.5	20.7	22.5	16.8	9.8	26.2	19.0	22.5	8.5	14.3	6.7	0.0	1.9	0.0	1.5	0.8	1.5	1.4	1.3	1.1	0.6	1.1	1.5	1.0	10.5	1.7	0.7	0.5	0.6	1.8	8.2	10.8	8.4	10.7	10.3	4.3	8.2	8.0	10.0	11.5
HDGF	HMG1L2	ENSG00000143321	"Heparin binding growth factor"	P51858	1	156742107-156766925	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Growth factor, Heparin-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026035, HPA048728, HPA053422"	Enhanced		Enhanced	Nucleoplasm			300000	Nucleoplasm		"CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146"	"unprognostic (2.80e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (9.06e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (2.43e-8)"	"unprognostic (9.80e-3)"	"unprognostic (2.34e-2)"	"prognostic favourable (9.84e-4)"	"unprognostic (2.45e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.86e-2)"	27.6	24.0	24.4	26.4	24.6	78.7	51.5	26.7	22.1	29.7	57.9	22.4	23.9	40.6	22.1	22.9	53.0	34.9	38.1	41.7	23.5	18.3	64.5	92.6	38.0	32.6	23.7	12.9	29.0	35.3	25.6	19.0	49.1	20.4	21.3	37.5	15.9	26.5	30.6	57.2	39.2	83.1	21.7	25.5	30.0	25.6	11.8	22.4	79.0	38.3	64.8	44.0	30.9	29.6	7.5	14.5	10.4	12.3	6.1	9.7	7.8	76.0	37.7	43.4	20.6	25.1	34.6	47.9	25.2	64.5	59.2	38.8	42.6	81.2	51.4	49.9	50.2	53.8	64.4	56.7	58.9	41.6	45.7	44.0	54.8	37.2	33.5	64.4	37.2	24.8	54.3	46.3	90.4	43.5	57.5	43.1	48.1	55.9	53.0	71.4	76.5	53.5	59.9	25.9	68.7	65.0	25.7	64.7	70.4	60.2	79.7	30.4	63.6	100.1	38.4	29.9	46.5	37.9	64.0	58.2	72.3	89.5	39.9	51.2	38.1	6.0	12.3	10.4	8.5	10.4	6.3	6.7	7.3	7.5	14.1	7.5	6.6	6.2	7.1	6.1	11.4	14.5	9.7	7.8	24.4	24.6	26.7	22.1	23.5	18.3	23.7	12.9	20.4	22.4
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472287-4502211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favourable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	10.3	9.6	15.4	10.0	13.6	8.1	10.3	15.3	21.0	9.7	8.8	9.0	8.0	10.1	12.3	10.4	6.6	10.2	9.9	8.5	16.6	13.5	9.8	9.9	7.3	10.2	11.9	13.2	15.9	10.6	8.3	10.2	9.6	10.5	10.1	5.0	7.8	11.3	16.8	39.4	10.9	9.2	12.0	8.8	10.3	9.2	49.1	9.5	13.6	7.3	6.2	7.4	7.7	9.0	7.0	2.2	3.6	1.8	2.3	2.4	0.8	27.4	16.2	28.2	26.1	12.3	12.6	19.7	22.2	12.0	24.4	21.8	18.5	12.0	24.2	13.0	16.3	15.8	18.7	20.2	14.4	27.1	29.7	14.9	12.2	24.4	15.9	14.6	21.3	17.9	11.0	16.8	8.2	22.3	17.1	30.6	11.8	19.5	33.1	29.4	32.2	29.2	33.0	23.2	15.6	15.2	14.1	31.2	30.8	21.6	12.4	17.9	12.2	23.3	29.4	15.5	21.1	29.0	20.9	38.0	19.8	17.0	21.7	23.6	16.3	0.0	1.8	3.6	1.4	1.1	0.4	1.1	1.5	1.1	1.6	7.0	2.4	0.9	0.5	2.3	0.6	2.2	1.8	0.8	15.4	13.6	15.3	21.0	16.6	13.5	11.9	13.2	10.5	9.5
HDGFL3	"Hdgfrp3, HRP-3"	ENSG00000166503	"HDGF like 3"	Q9Y3E1	15	83112738-83208018	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040719	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA040719: AB_2677097"	"unprognostic (1.28e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.85e-1)"	9.5	12.9	30.0	6.8	18.8	5.4	9.3	16.0	28.8	11.0	10.6	11.6	4.8	3.7	13.2	17.9	8.5	9.7	9.1	11.8	25.1	24.2	7.9	2.9	8.1	6.3	20.0	19.0	11.3	4.4	42.3	12.9	7.1	13.1	11.2	6.7	7.7	4.3	10.9	5.7	5.0	4.5	11.6	20.2	7.5	5.2	18.5	12.3	5.4	13.9	4.3	5.5	12.3	14.4	0.7	0.7	2.6	0.9	5.1	1.6	0.4	4.4	3.9	11.7	6.0	4.9	6.8	3.9	4.3	7.6	4.6	4.8	0.3	8.5	0.1	5.3	1.1	1.8	12.8	6.5	6.7	21.2	6.7	7.3	2.1	0.1	6.9	0.2	1.1	4.0	5.5	5.2	9.1	10.9	5.5	0.2	8.5	4.6	4.4	0.4	8.7	2.2	0.1	11.4	0.0	6.8	9.3	14.8	11.3	6.5	1.6	5.5	1.8	0.8	9.5	9.6	7.2	1.9	13.1	1.4	0.5	5.5	4.4	3.5	6.4	1.6	0.9	2.6	1.6	0.4	0.2	0.3	0.5	0.3	0.5	0.7	0.6	0.7	2.4	5.1	0.3	0.7	0.1	0.4	30.0	18.8	16.0	28.8	25.1	24.2	20.0	19.0	13.1	12.3
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 54.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favourable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favourable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	4.9	54.7	5.1	10.1	8.4	3.3	12.7	6.2	8.5	6.0	29.8	5.6	10.6	38.2	6.4	15.5	13.8	5.8	18.1	9.1	4.6	5.3	17.7	36.6	4.4	6.3	4.5	9.4	7.2	23.7	20.5	9.1	6.5	7.3	10.6	16.8	8.3	24.4	12.5	2.8	11.4	47.1	8.0	4.8	6.0	17.7	4.5	4.0	8.0	18.2	6.1	6.8	7.0	6.9	12.1	10.6	5.9	2.9	5.6	12.3	5.8	3.6	10.5	2.3	6.3	5.7	2.5	19.2	2.7	5.2	4.4	4.9	19.2	18.4	8.1	3.4	1.5	14.4	3.6	4.2	1.5	11.3	8.2	11.2	5.7	11.9	6.6	0.6	8.6	3.9	9.0	3.6	10.3	2.3	8.8	2.0	2.1	23.9	5.1	3.2	5.1	8.2	4.2	0.0	6.5	5.6	7.7	5.7	3.6	4.7	20.3	6.8	12.7	2.3	2.3	0.9	0.0	0.7	0.9	5.0	9.7	3.3	1.1	0.0	0.6	0.1	2.9	5.9	9.9	1.6	11.2	11.3	11.5	9.0	4.5	12.1	12.0	8.9	1.9	5.6	0.2	10.6	12.3	5.8	5.1	8.4	6.2	8.5	4.6	5.3	4.5	9.4	7.3	4.0
HDLBP	"HBP, VGL"	ENSG00000115677	"High density lipoprotein binding protein"	Q00341	2	241227264-241317061	"Plasma proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 210.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004189, CAB026457"	Enhanced		Supported	Cytosol				Cytosol		"CAB026457: , HPA004189: AB_1079044"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.58e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (6.39e-5)"	"prognostic unfavourable (4.12e-4)"	38.2	38.7	18.1	18.1	27.7	15.9	37.4	18.1	27.0	39.6	30.4	24.7	38.2	22.5	34.8	43.2	35.3	38.7	30.9	37.5	17.9	15.9	33.9	92.0	29.9	20.9	19.8	16.6	40.1	210.4	40.5	40.0	44.4	22.5	35.9	29.4	26.1	105.2	34.3	80.2	27.6	36.1	29.9	18.5	23.0	39.2	39.6	19.3	20.8	39.0	45.7	34.7	31.9	31.0	10.9	22.4	11.6	28.8	10.1	12.3	12.4	33.8	27.3	28.6	45.5	73.0	89.6	40.6	84.6	86.8	38.5	55.0	24.4	34.7	10.3	10.3	122.4	27.2	42.5	55.4	63.1	16.4	26.3	32.9	34.4	59.5	71.5	23.5	28.8	66.2	45.0	55.9	63.0	52.4	31.3	13.9	60.0	35.3	13.5	12.3	27.6	18.1	12.6	55.5	20.5	31.4	40.4	23.8	27.3	36.9	38.9	33.0	30.7	23.0	65.8	47.1	30.0	65.0	35.4	16.4	13.5	18.3	59.7	17.6	43.1	11.6	20.0	9.1	9.3	21.9	12.3	10.9	10.6	11.1	22.4	7.4	9.6	8.9	11.5	10.1	28.8	14.7	9.8	12.4	18.1	27.7	18.1	27.0	17.9	15.9	19.8	16.6	22.5	19.3
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604504	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"			120000	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: , HPA062200: "	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	14.1	11.0	9.2	14.7	11.3	15.2	13.8	15.0	13.9	10.7	10.6	8.6	8.3	7.6	15.9	9.4	14.7	12.5	8.1	9.4	10.0	5.8	9.9	13.2	10.6	16.5	12.9	6.9	15.8	17.2	13.5	12.8	10.5	11.6	11.1	10.8	8.2	12.6	9.5	12.7	14.5	11.6	13.1	6.6	16.1	11.5	20.3	13.2	18.3	12.0	12.8	17.9	12.7	12.8	9.9	5.9	1.8	4.5	6.4	10.0	2.4	14.5	17.5	9.2	13.8	12.9	14.5	20.6	11.7	7.6	13.5	12.1	17.5	12.4	23.9	13.3	10.8	17.7	20.8	12.6	18.4	12.0	24.0	16.9	12.4	14.9	11.6	30.2	11.0	11.8	11.4	20.5	17.7	15.5	38.3	8.1	13.4	7.8	14.3	8.3	36.6	7.2	16.0	13.3	22.4	8.7	14.7	8.6	19.2	14.2	10.2	12.1	12.1	11.4	14.7	13.6	12.9	17.5	29.0	15.4	19.1	28.3	12.2	17.0	20.3	1.8	3.6	1.1	7.3	4.5	6.6	9.9	7.2	7.9	4.3	8.1	10.0	9.4	0.5	6.4	4.3	5.9	5.9	2.4	9.2	11.3	15.0	13.9	10.0	5.8	12.9	6.9	11.6	13.2
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: "	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	22.0	22.3	14.2	21.0	16.8	22.0	18.5	22.3	18.9	19.4	17.9	15.2	20.2	11.5	17.6	15.7	30.4	16.1	15.2	26.2	13.5	14.3	18.0	35.2	15.0	14.1	14.5	14.5	18.2	15.1	34.8	20.5	27.0	18.8	16.8	15.5	16.8	18.9	16.4	88.5	24.3	16.3	15.6	13.7	16.4	18.8	18.9	14.4	16.7	24.8	23.0	18.6	18.6	22.3	10.6	9.3	12.6	8.6	8.9	8.1	3.3	28.4	17.8	15.7	9.8	49.6	26.0	15.0	17.4	17.6	15.6	13.5	13.3	15.4	22.3	18.5	31.8	19.3	20.8	15.7	23.7	13.6	8.5	22.8	14.7	53.1	23.1	23.7	16.8	22.8	21.8	17.5	27.5	28.6	16.4	10.4	24.2	23.3	9.2	10.1	11.9	16.2	17.0	18.1	9.7	24.3	29.5	11.6	13.6	25.5	17.7	15.4	18.6	15.3	28.6	18.1	14.2	13.0	14.7	11.4	16.1	25.2	8.6	12.0	15.2	12.6	8.6	11.3	7.1	7.1	8.1	7.2	8.0	6.3	9.3	10.6	6.7	6.6	4.4	8.9	5.3	7.8	8.0	3.3	14.2	16.8	22.3	18.9	13.5	14.3	14.5	14.5	18.8	14.4
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112599-43566001	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;kidney: 15.4"	"Cell line enhanced"	"Detected in some"		"A549: 5.5;U-266/70: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Approved		Supported	Cytosol				Cytosol		"HPA007203: , HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.7	0.5	10.3	0.8	12.1	1.4	0.8	13.6	24.0	0.6	0.8	1.1	0.0	0.4	0.8	1.7	2.6	0.5	4.0	0.4	3.9	4.1	15.4	0.6	0.6	1.3	3.8	15.5	1.0	0.4	1.7	0.4	0.6	10.2	3.2	0.5	0.6	1.0	0.8	1.8	2.1	0.6	0.7	1.4	0.6	1.0	3.7	1.6	0.0	1.5	0.0	0.8	1.2	0.6	2.4	1.6	7.0	1.7	1.6	0.7	0.1	0.1	5.5	0.6	0.8	0.0	0.0	0.0	1.6	2.8	0.1	0.6	0.0	0.0	0.2	3.0	2.7	0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.4	0.2	0.2	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	2.3	0.9	0.5	0.0	0.0	0.0	0.1	0.2	0.7	0.5	0.1	0.0	0.4	0.0	0.0	0.8	1.1	1.3	0.4	15.6	0.5	0.0	3.5	0.4	0.0	6.4	1.7	1.1	0.7	1.0	0.5	1.0	0.7	0.3	0.2	2.4	0.6	0.7	7.0	1.6	0.9	1.6	0.2	0.1	10.3	12.1	13.6	24.0	3.9	4.1	3.8	15.5	10.2	1.6
HEMGN	"CT155, EDAG, NDR"	ENSG00000136929	Hemogen	Q9BXL5	9	97926791-97944856	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 71.1;placenta: 20.2;testis: 32.5"	"Cell line enriched"	"Detected in some"	4	"K-562: 75.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.2"	"Group enriched"	"Detected in many"	27	"granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2"					"Region enriched"	"Detected in all"	5	"cerebellum: 55.9"	"HPA019572, HPA019604, HPA019606"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591"	"unprognostic (1.94e-1)"				"unprognostic (3.15e-3)"			"unprognostic (2.50e-2)"		"unprognostic (9.00e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-4)"	"unprognostic (2.77e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.25e-1)"		0.3	0.2	0.2	0.4	0.2	71.1	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.3	1.0	0.2	0.2	0.3	0.9	5.4	0.5	0.2	0.0	0.6	0.2	0.0	0.3	20.2	1.1	0.2	0.0	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.3	2.8	0.2	32.5	0.0	17.1	0.3	0.2	0.5	1.4	4.8	0.0	0.1	2.1	0.1	2.9	8.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	2.1	0.1	0.0	0.4	0.1	0.8	0.0	2.3	1.1	0.1	0.0	8.2	3.3	1.0	2.9	0.0	0.0	1.2	4.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	1.1	0.0
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188586-93226524	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 43.4;kidney: 24.5;pituitary gland: 16.1"	"Cell line enriched"	"Detected in some"	37	"SCLC-21H: 61.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"			89000	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favourable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.2	0.2	8.5	0.2	0.6	3.4	0.1	0.1	0.1	29.4	0.1	5.3	11.8	0.1	0.4	0.2	0.1	0.8	0.3	0.2	0.2	24.5	0.2	0.4	0.1	0.2	0.1	0.1	5.5	0.0	16.1	0.4	0.2	0.7	38.9	0.1	4.1	1.2	0.1	0.1	43.4	0.4	0.2	0.2	4.0	1.4	0.1	0.3	0.1	0.1	2.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.1
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 32.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: , HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favourable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	2.5	3.3	3.2	2.2	4.5	3.9	3.1	7.0	5.7	3.2	4.6			2.7	4.4	1.7	2.8	4.1	2.1	4.6	3.5	3.6	3.3	1.6	2.5	2.1	3.8		8.5	3.6	9.2	3.5	2.7		3.0	3.0		2.3	3.3	8.2	3.1	3.1	4.1	4.1	2.3	3.4	3.2			5.6		2.4	3.3	2.3	1.0	1.1	0.5	0.4	0.2	1.1	0.4	5.1	10.1	7.0	2.9	5.9	4.4	2.0	3.7	4.4	4.8	4.6	5.2	0.6	5.1	4.5	6.3	5.2	7.4	3.6	3.5	3.1	4.8	32.6	11.7	1.7	2.2	7.6	2.6	3.7	2.9	5.7	7.1	6.3	12.5	2.1	4.5	2.3	1.7	2.5	2.1	4.4	6.1	10.0	0.4	1.6	11.1	7.8	4.5	8.9	2.5	2.9	3.0	9.0	9.4	8.9	5.8	3.4	5.5	1.4	1.9	4.8	4.1	3.6	4.7	0.0	0.4	0.5	1.1	0.1	0.6	0.5	0.2	0.5	1.1	1.0	0.9	0.5	0.0	0.2	0.3	0.9	0.4	0.4										
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075348	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 55.1;fHDF/TERT166: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: "	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	25.3	29.4	21.9	28.0	28.4	14.6	22.7	30.5	24.9	24.2	20.5	22.2	26.7	20.0	28.1	24.3	22.2	19.2	20.2	20.5	21.9	22.7	20.6	24.5	20.6	30.2	30.9	14.8	24.5	17.1	25.2	35.6	23.8	26.8	19.4	23.9	17.8	17.7	24.1	19.6	20.9	25.8	23.0	28.7	27.0	17.3	22.2	33.6	23.6	19.5	13.8	28.3	24.7	47.9	7.7	10.4	13.5	9.3	9.9	11.5	6.5	22.4	8.0	5.1	8.5	13.2	18.1	4.6	55.1	34.1	20.7	13.4	4.5	10.6	7.9	4.3	61.8	11.9	5.6	8.1	28.0	5.2	2.7	3.6	13.3	3.5	7.0	4.4	6.5	8.9	9.5	11.0	9.8	12.8	3.8	4.0	31.9	9.6	3.1	5.2	3.0	14.0	4.2	2.1	2.8	9.4	6.4	2.4	2.8	17.9	7.7	7.8	4.8	5.6	17.4	10.9	6.1	26.8	9.4	2.8	3.3	5.0	20.0	8.6	3.7	13.5	9.3	11.1	8.2	7.9	11.5	7.7	9.1	9.8	10.4	7.5	8.8	9.0	11.7	9.9	7.6	2.7	10.6	6.5	21.9	28.4	30.5	24.9	21.9	22.7	30.9	14.8	26.8	33.6
HES1	"bHLHb39, FLJ20408, HES-1, Hes1, HRY"	ENSG00000114315	"Hes family bHLH transcription factor 1"	Q14469	3	194136145-194138732	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.7;hTCEpi: 33.5;SK-BR-3: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 19.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066929			Supported	Nucleoplasm				Nucleoplasm		"HPA066929: "	"unprognostic (1.79e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.04e-5)"	31.0	10.9	8.4	7.9	9.3	0.6	30.1	5.5	8.1	28.4	18.9	14.1	36.1	17.2	21.2	15.9	47.8	9.9	11.5	21.2	9.5	6.0	22.1	27.4	37.9	3.7	6.3	8.8	15.7	21.2	19.7	15.1	23.5	8.8	35.1	20.5	58.7	31.0	89.6	32.8	56.0	12.6	9.7	8.4	10.7	23.9	11.7	8.0	2.3	36.3	29.7	40.3	26.3	39.8	0.5	0.1	19.5	4.8	0.0	0.0	0.1	3.1	0.9	7.4	9.5	2.2	0.0	1.8	1.5	4.2	0.3	0.1	12.5	9.1	0.4	26.7	0.5	18.0	1.4	8.4	0.1	2.6	15.5	11.3	1.2	3.2	0.0	0.0	10.8	0.8	33.5	0.3	3.9	10.1	5.4	0.4	0.0	14.9	15.9	15.5	6.9	6.2	0.0	0.5	0.3	9.9	24.6	0.4	0.5	7.3	28.0	12.5	7.8	0.8	7.7	0.8	8.0	0.1	10.7	0.0	0.0	0.0	0.6	0.0	15.3	0.0	0.1	19.5	0.0	3.1	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.1	8.4	9.3	5.5	8.1	9.5	6.0	6.3	8.8	8.8	8.0
HEXIM1	"CLP-1, EDG1, HIS1, MAQ1"	ENSG00000186834	"Hexamethylene bisacetamide inducible 1"	O94992	17	45148502-45152101	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008926, CAB011625"	Supported		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB011625: AB_2233058, HPA008926: AB_1079048"	"unprognostic (2.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.26e-2)"	14.8	25.3	30.0	12.6	25.3	30.4	13.7	41.4	37.4	16.2	21.0	10.7	18.5	17.8	17.0	17.2	18.6	18.2	18.6	16.0	31.1	15.6	20.9	19.0	15.8	11.8	24.9	19.2	14.8	15.6	12.2	24.4	56.7	27.5	19.9	10.8	12.6	16.4	25.2	29.7	22.6	20.2	19.5	31.4	20.7	17.3	17.1	21.7	8.9	17.2	14.3	12.3	17.8	30.6	3.7	3.4	15.9	6.7	3.8	4.6	2.3	12.9	41.2	8.6	12.4	14.3	7.7	21.1	11.5	10.4	9.5	10.7	19.3	18.4	5.6	35.6	12.1	10.5	5.2	11.3	7.7	11.6	12.3	17.6	22.7	23.5	12.5	10.9	23.4	8.9	9.7	7.0	3.1	4.7	7.7	13.8	7.1	17.3	11.4	12.7	7.9	12.5	4.8	7.5	6.9	25.0	23.0	4.6	3.5	17.3	19.6	18.6	20.4	8.6	9.0	9.6	13.3	5.5	21.3	12.6	4.0	3.7	8.8	10.3	10.9	15.9	4.3	6.6	4.5	6.1	2.7	3.3	4.6	4.0	3.3	3.7	4.2	4.4	10.5	3.8	6.7	3.4	3.9	2.3	30.0	25.3	41.4	37.4	31.1	15.6	24.9	19.2	27.5	21.7
HEXIM2	FLJ32384	ENSG00000168517	"Hexamethylene bisacetamide inducible 2"	Q96MH2	17	45160700-45170040	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.4"	"Cell line enhanced"	"Detected in all"		"Hep G2: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023323, HPA028455"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA023323: AB_1850651, HPA028455: AB_10602603"	"unprognostic (9.03e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.01e-2)"	"prognostic favourable (2.53e-4)"	"unprognostic (2.36e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (9.85e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-2)"	4.0	7.7	8.3	4.2	8.0	3.6	3.4	9.0	11.8	4.3	4.8	5.0	6.5	8.8	4.3	5.6	4.2	5.1	7.9	6.3	6.7	6.2	9.3	9.6	4.1	5.6	7.8	6.7	5.7	9.3	7.5	6.1	3.0	6.6	5.1	2.5	6.9	9.9	5.5	36.4	5.6	6.4	4.3	5.4	5.2	6.9	27.7	6.4	6.4	9.1	6.6	3.0	4.7	4.7	9.7	13.2	10.0	12.2	7.3	8.6	13.3	4.9	17.9	4.0	8.8	4.4	7.3	7.6	2.8	3.4	4.5	5.0	6.7	13.3	3.1	14.5	1.9	8.2	3.9	3.4	1.4	7.1	6.2	2.3	16.7	30.4	3.2	2.0	5.1	6.3	3.2	3.9	1.4	2.2	2.5	7.7	2.0	8.6	3.1	4.2	4.3	7.9	4.2	6.0	9.3	5.7	4.9	4.8	4.1	2.5	5.0	11.5	13.3	3.4	2.1	8.2	4.4	5.4	6.5	12.0	12.6	2.9	6.4	3.6	6.1	8.4	12.2	10.0	5.4	9.7	8.6	9.7	3.8	6.1	10.3	6.5	3.0	5.3	8.3	7.3	3.0	13.2	4.6	13.3	8.3	8.0	9.0	11.8	6.7	6.2	7.8	6.7	6.6	6.4
HFE	HLA-H	ENSG00000010704	Hemochromatosis	Q30201	6	26087281-26098343	"Disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: "	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	7.2	13.7	2.2	4.4	2.7	0.0	6.2	1.2	2.5	6.7	7.1	3.5	10.3	4.2	6.8	13.9	7.6	5.2	13.3	8.9	2.0	1.4	5.4	12.8	9.0	16.1	2.3	2.0	8.1	16.2	14.6	2.2	7.6	4.3	12.6	5.3	13.7	7.0	8.1	3.1	3.2	5.8	10.4	3.2	14.4	6.1	4.9	1.2	2.0	7.7	3.9	5.0	8.6	5.2	3.5	4.6	1.9	10.5	0.2	2.2	3.4	8.1	18.7	0.3	9.1	13.8	10.6	0.0	5.8	14.0	7.5	11.9	1.5	16.6	0.8	15.9	9.6	5.2	0.0	6.9	9.6	2.1	0.1	0.2	4.4	1.2	2.7	0.0	0.3	11.0	2.0	8.2	0.7	5.1	0.3	0.2	6.4	3.3	0.0	0.1	0.4	0.0	1.1	0.0	0.1	6.2	5.4	0.0	0.0	3.5	0.0	5.0	26.6	0.8	3.9	5.3	0.5	5.3	5.1	0.1	0.1	0.1	7.9	0.1	11.4	1.2	10.5	0.0	1.7	10.2	1.3	3.5	1.7	2.2	4.6	1.5	0.4	1.2	1.9	0.2	8.2	0.3	0.3	3.4	2.2	2.7	1.2	2.5	2.0	1.4	2.3	2.0	4.3	1.2
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"HFM1, ATP dependent DNA helicase homolog"	A2PYH4	1	91260766-91404869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;testis: 19.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;AN3-CA: 4.8;K-562: 4.9;SCLC-21H: 3.1;SH-SY5Y: 3.8;U-266/70: 4.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA035036: , HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.8	0.7	2.6	0.3	4.1	0.4	0.8	11.3	4.4	1.7	0.9	1.5	2.7	0.6	3.7	2.5	0.4	1.2	0.6	1.0	2.3	0.9	1.3	0.4	0.5	1.6	0.7	1.4	6.4	1.2	0.1	7.8	0.9	3.9	1.1	0.7	2.7	1.0	2.0	2.3	0.4	0.5	1.7	4.7	0.7	0.6	19.9	1.5	0.0	2.7	0.5	0.4	0.7	2.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.1	4.8	0.0	0.2	0.1	0.5	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.1	0.2	1.1	0.0	0.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.6	0.2	2.4	0.0	0.3	1.4	0.1	0.0	0.0	3.1	3.8	0.0	0.0	1.2	0.0	0.8	0.1	0.0	1.0	0.9	0.1	4.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	4.1	11.3	4.4	2.3	0.9	0.7	1.4	3.9	1.5
HGH1	"Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236"	ENSG00000235173	"HGH1 homolog"	Q9BTY7	8	144137769-144140843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042470	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA042470: "	"unprognostic (2.13e-2)"	"prognostic unfavourable (3.12e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (3.72e-5)"	"unprognostic (4.62e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.48e-1)"	13.4	12.3	6.3	7.7	5.5	4.6	7.6	7.3	8.6	5.5	11.8	5.2	4.9	5.0	6.5	3.8	8.7	5.1	5.5	5.1	5.2	3.6	8.2	15.1	5.1	9.5	5.7	7.3	9.7	12.8	6.8	4.4	3.8	6.1	8.6	4.5	5.9	10.5	6.4	13.2	8.9	5.9	5.8	3.8	8.8	15.7	7.9	4.7	11.3	11.0	4.7	8.6	4.9	7.7	2.1	0.9	0.0	0.9	2.2	2.9	0.6	4.7	1.6	1.2	2.1	1.6	1.1	2.9	8.2	0.6	1.7	1.2	2.1	1.2	14.0	11.3	1.5	5.0	2.3	1.1	0.5	6.7	8.7	5.3	1.3	1.0	1.6	2.9	3.5	0.7	3.5	1.9	1.2	0.8	15.1	0.5	1.1	4.0	10.1	2.7	3.3	27.9	12.6	1.0	2.1	1.0	1.1	2.5	2.6	3.8	2.0	2.7	1.7	1.1	2.9	1.0	8.6	3.0	9.7	8.4	5.4	3.4	1.0	5.0	1.7	0.0	0.6	0.0	1.5	0.9	0.9	0.5	1.9	2.9	0.9	2.1	1.8	1.3	0.0	2.2	0.7	0.7	0.6	0.6	6.3	5.5	7.3	8.6	5.2	3.6	5.7	7.3	6.1	4.7
HGS	"Hrs, Vps27, ZFYVE8"	ENSG00000185359	"Hepatocyte growth factor-regulated tyrosine kinase substrate"	O14964	17	81683326-81703138	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA004872, HPA007728"	Uncertain		Enhanced	Endosomes,Lysosomes,Cytosol			250000	"Endosomes, Lysosomes"	Cytosol	"HPA004872: AB_1079053, HPA007728: AB_1850681"	"unprognostic (6.52e-2)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (5.61e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (4.31e-7)"	"unprognostic (3.69e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	26.8	33.5	34.7	31.9	44.7	66.5	28.9	35.7	45.6	25.4	31.1	35.2	24.5	33.2	27.3	37.2	42.1	32.8	29.1	25.4	32.7	30.4	34.2	31.3	29.4	34.3	39.8	44.2	33.2	39.7	21.8	31.7	32.4	40.7	31.9	31.1	23.6	38.2	27.9	36.3	57.5	32.5	32.6	28.5	38.5	35.6	53.1	38.1	22.2	26.2	25.9	32.5	24.9	34.6	12.2	14.6	28.9	20.2	17.2	18.7	18.8	33.2	27.1	20.5	25.4	18.5	20.9	22.5	25.0	24.3	29.3	22.6	22.8	23.8	9.3	17.1	33.8	28.3	17.3	27.4	20.7	7.9	28.9	20.0	34.1	28.7	27.9	17.2	26.4	23.3	30.0	32.7	46.6	36.7	21.8	17.1	30.8	20.1	18.9	39.8	14.8	28.8	20.6	16.4	14.7	28.7	25.2	29.3	34.9	19.0	48.4	22.2	29.7	33.4	30.5	57.1	33.6	28.2	46.4	21.9	7.7	11.8	35.1	22.5	30.0	25.2	17.4	22.3	18.7	20.2	12.4	11.4	13.5	13.0	14.6	12.2	10.1	11.7	28.9	17.2	19.1	12.4	14.9	18.8	34.7	44.7	35.7	45.6	32.7	30.4	39.8	44.2	40.7	38.1
HIC2	"HRG22, KIAA1020, ZBTB30, ZNF907"	ENSG00000169635	"HIC ZBTB transcriptional repressor 2"	Q96JB3	22	21417404-21451463	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.0;K-562: 48.2"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 17.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031884, HPA059399"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA031884: AB_10602234, HPA059399: "	"unprognostic (2.37e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (7.42e-5)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (4.83e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.33e-1)"	"unprognostic (3.86e-2)"	"unprognostic (5.64e-2)"	4.0	2.8	3.7	5.2	9.1	8.1	8.1	4.9	6.3	4.0	4.1	4.3	5.0	3.7	6.5	5.6	4.4	3.7	2.5	3.0	3.5	3.8	2.8	2.9	3.3	3.9	2.7	6.8	6.2	5.9	4.3	5.9	15.1	4.3	2.7	2.6	3.2	6.1	2.3	12.3	2.4	4.3	2.3	4.4	4.6	4.7	11.4	3.1	2.2	4.2	3.0	2.6	2.3	4.9	1.3	2.2	0.7	1.1	0.6	1.5	0.4	0.8	1.0	5.8	1.7	0.4	0.4	28.0	0.5	0.2	0.5	0.4	10.6	0.3	1.9	0.5	0.3	2.3	4.0	0.3	0.3	1.3	6.0	2.6	1.3	5.7	0.5	2.3	1.2	0.4	0.2	0.8	0.3	0.4	48.2	0.8	0.3	0.8	1.0	2.3	6.1	0.8	2.5	2.5	0.3	0.3	1.4	1.6	2.8	0.7	0.8	1.0	0.4	3.5	0.7	0.9	2.2	0.8	0.6	1.7	1.3	2.1	0.7	0.9	0.5	0.0	0.8	0.4	0.3	0.5	1.5	1.3	1.3	0.5	0.5	0.5	1.5	0.8	0.7	0.6	1.1	2.2	0.3	0.4	3.7	9.1	4.9	6.3	3.5	3.8	2.7	6.8	4.3	3.1
HID1	"C17orf28, DMC1, HID-1"	ENSG00000167861	"HID1 domain containing"	Q8IV36	17	74950743-74973166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 34.7;SH-SY5Y: 18.0;SK-BR-3: 53.2;T-47d: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.8"	"Group enriched"	"Detected in many"	34	"B-cells: 1.5;dendritic cells: 5.8;T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031406	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA031406: "	"unprognostic (7.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.47e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.37e-1)"	"prognostic favourable (3.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (1.34e-4)"	5.4	3.8	10.1	3.9	21.2	1.3	8.9	62.3	22.2	12.2	9.2	19.9	21.3	21.9	7.1	17.3	2.4	11.3	16.7	5.4	12.8	13.3	4.7	2.0	7.5	3.0	21.3	12.2	1.3	49.4	9.0	16.9	11.4	15.8	19.7	10.4	4.1	46.7	20.0	2.6	2.9	15.3	4.0	10.5	6.4	31.2	2.6	17.1	0.7	8.5	1.4	3.7	7.4	3.8	1.5	5.8	0.0	0.0	0.0	2.8	1.3	1.5	3.4	0.4	4.8	0.0	0.0	0.8	0.0	0.2	0.3	0.3	3.1	1.8	0.0	0.3	0.0	1.6	4.4	0.3	0.2	0.0	3.5	0.0	0.1	3.0	0.8	0.0	0.3	0.0	1.8	0.0	0.7	7.9	0.2	1.2	0.0	34.7	0.2	0.0	0.1	2.1	0.0	0.0	6.5	4.5	13.5	6.5	18.0	0.0	53.2	0.0	31.4	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	1.5	2.3	1.8	0.0	0.4	2.5	2.8	0.0	0.0	0.0	5.8	0.0	1.3	10.1	21.2	62.3	22.2	12.8	13.3	21.3	12.2	15.8	17.1
HIF1A	"bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8"	ENSG00000100644	"Hypoxia inducible factor 1 alpha subunit"	Q16665	14	61695513-61748259	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 47.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000907, HPA001275, CAB017442"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB017442: AB_10621732, HPA000907: , HPA001275: AB_1079057"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.35e-2)"	"unprognostic (3.88e-2)"	31.9	62.0	15.6	45.2	17.8	125.2	24.9	22.7	18.5	45.7	15.3	12.3	23.5	10.8	17.7	31.3	31.2	21.7	50.0	19.4	17.5	16.5	76.4	42.7	42.8	27.3	18.3	11.0	34.5	12.7	13.7	26.8	24.2	25.1	17.6	13.9	14.0	24.6	36.2	8.0	17.4	16.9	18.7	27.2	57.3	16.0	21.1	12.4	24.7	26.9	18.4	28.8	37.8	21.5	6.6	6.0	47.8	6.8	6.2	7.9	5.1	37.6	15.0	15.1	43.2	24.0	38.7	20.5	31.3	37.8	39.5	35.6	6.5	12.5	9.2	23.6	38.7	8.9	9.7	51.5	49.4	4.0	5.0	5.6	13.8	11.2	53.6	2.3	6.2	67.6	16.3	28.9	31.0	24.8	3.8	0.0	117.8	7.8	7.3	2.9	13.6	19.8	0.5	34.0	2.7	50.9	25.1	12.7	14.1	58.8	8.4	20.7	8.8	4.5	14.7	89.7	20.1	29.7	26.3	4.9	7.2	10.4	47.3	4.7	24.2	11.2	6.8	47.8	3.8	5.5	4.9	6.5	5.0	4.4	6.0	6.6	7.9	5.1	18.2	6.2	5.6	2.9	3.4	5.1	15.6	17.8	22.7	13.2	17.5	16.5	18.3	11.0	25.1	12.4
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 alpha subunit inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: , HPA065302: "	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	8.8	12.7	11.6	11.9	10.8	7.6	12.9	9.5	14.1	9.2	10.7	11.5	8.8	9.7	11.6	10.4	11.1	9.6	12.5	16.0	10.2	9.4	10.3	8.8	9.3	12.3	13.0	9.5	14.5	14.3	17.1	10.6	10.2	10.8	10.7	9.3	9.2	10.6	12.1	46.8	13.3	10.6	14.9	9.7	11.1	10.0	17.9	10.3	13.5	8.1	14.8	12.3	10.8	10.8	9.7	8.5	16.9	14.0	10.1	11.3	9.3	9.2	9.8	13.2	13.2	20.5	8.5	11.5	9.8	23.8	14.6	17.3	15.1	7.9	9.9	9.0	14.7	10.8	11.6	8.8	16.0	10.9	7.0	9.5	8.6	11.5	10.6	11.3	12.6	8.3	9.0	14.2	15.6	8.2	4.1	5.6	16.4	9.7	12.1	7.4	4.3	4.7	8.8	16.3	4.8	10.2	12.3	5.1	8.3	8.5	5.2	9.2	17.8	6.2	6.9	7.5	9.8	7.3	9.8	7.7	7.7	7.7	12.4	9.3	5.6	13.1	8.8	16.9	9.8	12.4	9.6	9.7	10.1	9.0	8.5	7.5	9.8	9.9	9.3	10.1	14.0	3.1	11.3	9.3	11.6	10.8	9.5	14.1	10.2	9.4	13.0	9.5	10.8	10.3
HIF3A	"bHLHe17, IPAS, MOP7, PASD7"	ENSG00000124440	"Hypoxia inducible factor 3 alpha subunit"	Q9Y2N7	19	46297046-46343433	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.1;HHSteC: 16.5;HSkMC: 14.5;TIME: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041141	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041141: AB_10803997"	"unprognostic (9.20e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (6.90e-9)"	"unprognostic (4.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.41e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-4)"	"unprognostic (5.98e-2)"	15.8	7.7	17.9	4.9	9.8	2.5	8.7	10.6	11.1	15.8	16.1	4.7	6.7	3.1	8.1	10.3	11.6	9.8	9.2	31.2	21.4	6.8	4.5	2.1	13.5	5.2	10.8	8.3	17.7	5.1	2.1	12.1	42.4	9.8	9.7	4.5	10.0	4.3	13.1	12.3	3.6	7.0	26.9	11.2	21.7	14.1	3.3	11.4	0.0	3.2	5.6	2.0	18.8	14.6	1.0	1.3	3.3	1.1	0.5	0.7	0.1	0.0	0.0	1.3	0.3	3.8	8.1	0.4	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	16.5	0.1	0.6	14.5	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.1	13.3	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.1	0.0	3.3	0.4	0.8	0.4	0.4	0.4	0.5	0.4	0.4	0.2	1.0	0.6	0.7	3.1	0.5	1.1	1.3	0.2	0.1	17.9	9.8	10.6	11.1	21.4	6.8	10.8	8.3	9.8	11.4
HIGD1A	"DKFZP564K247, HIG1, RCF1A"	ENSG00000181061	"HIG1 hypoxia inducible domain family member 1A"	Q9Y241	3	42784298-42804531	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 89.9"	"Low lineage specificity"	"Detected in all"											HPA043336	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA043336: AB_10795039"	"unprognostic (6.46e-2)"	"unprognostic (3.72e-3)"	"prognostic favourable (2.12e-4)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.45e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.94e-2)"	"prognostic favourable (3.99e-8)"	"unprognostic (7.37e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	27.7	30.4	50.1	15.5	43.4	9.6	20.4	20.3	56.4	18.3	63.8	25.2	10.8	35.2	15.7	24.8	36.7	13.5	18.8	68.6	43.2	43.3	45.9	78.4	15.3	16.0	54.4	35.9	12.8	12.8	14.7	29.2	17.2	50.9	24.4	67.3	21.8	16.6	26.8	34.9	15.0	28.4	22.8	58.8	13.0	31.6	14.7	20.7	8.9	28.1	30.6	16.9	20.1	25.0	11.9	89.9	25.9	26.6	12.3	18.8	30.1	26.9	15.2	33.7	27.6	86.3	51.6	32.8	36.4	29.9	35.7	32.8	26.7	27.5	16.5	21.9	31.8	16.3	27.0	40.2	44.7	23.7	29.8	51.0	27.2	49.4	39.4	29.2	24.0	53.5	44.2	27.4	38.2	31.3	50.3	17.7	49.8	11.0	16.1	10.7	28.2	36.9	13.2	23.9	11.7	88.2	67.0	14.2	18.5	32.0	24.2	34.4	24.3	22.1	27.4	21.1	19.2	59.1	37.6	16.5	34.0	34.1	27.8	31.2	16.3	16.9	14.7	25.9	15.4	22.7	13.7	11.9	15.1	15.1	16.3	8.5	12.9	15.3	14.9	12.3	26.6	89.9	18.8	30.1	50.1	43.4	20.3	56.4	43.2	43.3	54.4	35.9	50.9	20.7
HIGD2A	"MGC2198, RCF1B"	ENSG00000146066	"HIG1 hypoxia inducible domain family member 2A"	Q9BW72	5	176388747-176389771	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042715	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA042715: "	"unprognostic (9.24e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-2)"	37.2	38.5	31.4	33.5	36.0	34.9	37.5	21.4	33.2	26.8	43.8	22.5	29.7	36.7	25.7	31.1	47.0	31.5	39.4	80.0	28.5	26.6	46.3	56.1	30.1	54.1	30.3	20.0	33.2	42.6	36.6	28.8	26.4	21.0	41.2	30.9	31.2	64.0	32.6	115.9	27.8	38.1	43.3	25.9	37.3	31.6	28.8	15.0	63.1	42.3	53.8	34.3	42.1	28.7	70.4	104.6	25.5	107.7	31.1	67.6	88.9	17.6	31.2	18.6	31.6	19.6	37.4	48.9	11.1	21.2	32.4	40.8	32.5	37.3	32.1	27.1	20.2	22.7	28.2	49.8	13.0	75.2	44.3	15.8	32.1	44.5	27.5	24.6	43.1	47.4	41.4	18.2	22.2	27.2	17.5	64.7	23.7	58.2	28.0	31.4	22.0	34.2	27.2	13.9	58.1	50.6	29.4	19.6	26.2	12.7	53.6	54.5	32.0	41.6	17.0	22.1	22.9	20.3	23.1	30.1	35.9	26.1	28.6	44.2	13.8	25.5	84.5	23.8	46.3	106.5	45.8	70.4	64.9	53.5	104.6	52.2	59.6	55.6	14.4	31.1	107.7	68.6	67.6	88.9	31.4	36.0	21.4	33.2	28.5	26.6	30.3	20.0	21.0	15.0
HIGD2B	HIGD2BP	ENSG00000175202	"HIG1 hypoxia inducible domain family member 2B"	Q4VC39	15	72675783-72686149	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	12	"testis: 11.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019016, HPA042715"	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA019016: AB_1850711, HPA042715: "	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"		"unprognostic (2.24e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.80e-2)"	"unprognostic (6.11e-4)"	"unprognostic (6.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.6	0.2	0.0	0.7	0.0	1.3	0.7	1.1	0.0	0.0	0.4	0.0	0.6	0.6	0.8	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	1.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.8	0.7	0.0	0.0	0.0	0.3	0.3	0.2	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
HILPDA	"C7orf68, FLJ21076, HIG-2, HIG2"	ENSG00000135245	"Hypoxia inducible lipid droplet associated"	Q9Y5L2	7	128455849-128458418	"Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4;esophagus: 71.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010515	Approved		Supported	"Nucleoplasm,Lipid droplets"	"Intracellular and membrane"			"Lipid droplets"	Nucleoplasm	"HPA010515: AB_1850710"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.30e-11)"	"unprognostic (9.20e-3)"	"unprognostic (4.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.15e-2)"	"prognostic unfavourable (2.05e-7)"	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	24.5	5.2	25.3	5.5	34.2	14.1	16.2	8.6	53.9	15.7	14.4	6.4	2.8	4.7	9.1	6.3	71.4	7.9	7.2	16.7	25.1	8.5	10.4	10.3	13.2	4.9	22.4	3.1	22.9	5.0	3.0	4.2	25.7	46.5	7.0	6.2	2.8	7.7	6.1	5.2	14.4	4.4	6.9	66.4	3.0	6.4	10.1	21.1	1.7	5.6	6.9	6.0	60.5	18.6	9.2	5.9	31.7	3.6	6.9	3.3	2.0	11.0	23.2	12.7	13.8	17.4	6.4	23.9	4.0	5.0	8.5	9.4	5.8	10.1	7.5	3.2	6.0	7.1	7.1	8.6	10.9	4.1	6.5	4.6	4.9	5.2	3.9	7.2	6.3	10.6	7.5	6.7	4.5	6.9	6.6	3.1	8.4	13.5	21.7	13.2	15.7	10.3	16.4	5.9	11.7	4.7	16.4	12.2	11.2	6.3	44.1	7.8	35.9	7.1	5.0	10.9	5.4	8.2	5.0	3.1	2.2	9.6	20.6	11.2	9.4	9.2	3.5	31.7	2.3	3.6	3.3	7.8	2.9	2.8	3.4	9.2	3.0	2.9	1.4	6.9	2.7	5.9	1.9	2.0	25.3	34.2	8.6	53.9	25.1	8.5	22.4	3.1	46.5	21.1
HINT1	"HINT, PKCI-1, PRKCNH1"	ENSG00000169567	"Histidine triad nucleotide binding protein 1"	P49773	5	131159027-131171735	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044577	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			3600000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA044577: AB_10795618"	"unprognostic (2.00e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.49e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.68e-1)"	28.5	46.5	56.6	46.2	51.6	50.5	64.7	42.9	78.4	29.8	53.3	20.4	49.1	36.5	30.6	43.8	44.3	42.3	36.7	61.4	47.3	43.9	65.4	124.4	38.9	54.7	48.7	50.6	32.2	62.9	43.9	39.6	24.6	40.8	41.3	50.0	22.6	44.4	41.8	84.0	38.3	41.3	37.9	37.5	32.5	32.5	30.5	25.1	29.4	47.5	56.6	39.4	29.1	45.1	26.6	46.5	19.2	25.3	20.9	40.3	52.9	37.5	55.0	43.2	88.5	30.8	33.4	39.9	28.6	26.8	28.9	33.6	53.7	52.7	51.7	57.1	36.7	23.2	34.4	75.4	26.8	45.2	63.3	19.9	77.9	68.7	64.5	31.0	6.4	44.6	66.6	34.7	58.3	36.2	30.2	113.2	37.1	41.4	52.4	78.1	41.9	43.9	37.9	43.2	93.5	54.3	48.5	53.0	33.2	37.9	25.9	45.1	31.4	45.4	39.7	38.2	21.7	30.3	58.1	32.6	41.6	44.9	53.6	50.2	35.2	19.2	25.3	9.6	21.7	12.8	29.7	26.6	40.3	28.6	39.2	25.7	32.0	25.3	5.0	20.9	12.9	46.5	27.0	52.9	56.6	51.6	42.9	78.4	47.3	43.9	48.7	50.6	40.8	25.1
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"		1100000	Mitochondria		"HPA020961: AB_1850715, HPA059109: "	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favourable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favourable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	18.4	27.2	16.0	14.5	15.5	10.3	15.6	9.5	16.5	10.0	16.4	11.0	26.1	15.3	8.9	24.1	12.6	14.4	21.7	33.7	13.3	13.3	34.8	68.7	15.2	14.2	15.3	13.6	6.8	30.8	21.0	14.1	12.8	12.5	10.8	16.4	12.2	20.2	31.0	30.9	10.3	15.8	17.0	12.3	11.3	16.7	10.3	8.2	16.8	14.9	29.8	11.8	10.4	7.5	24.6	62.0	7.8	20.3	15.1	25.5	18.5	9.7	26.8	16.7	16.1	10.7	9.0	11.0	9.2	13.8	15.1	16.7	17.6	10.9	12.7	10.7	8.8	9.8	7.6	14.4	16.0	27.7	13.8	13.9	23.4	15.8	24.8	7.8	14.0	10.0	13.2	14.4	23.5	11.7	8.1	41.5	12.0	20.8	19.5	9.8	7.4	46.2	19.7	11.1	17.5	21.6	7.6	13.3	15.9	12.0	14.9	16.0	16.1	15.1	5.3	8.1	12.8	10.5	11.6	36.1	40.1	18.3	18.0	10.8	12.7	7.8	20.3	1.1	18.5	14.3	16.7	24.6	19.9	18.5	28.6	23.8	15.4	15.9	1.9	15.1	13.0	62.0	25.5	18.5	16.0	15.5	9.5	16.5	13.3	13.3	15.3	13.6	12.5	8.2
HIP1	ILWEQ	ENSG00000127946	"Huntingtin interacting protein 1"	O00291	7	75533300-75738962	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation"	"Actin-binding, Activator"	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013606, CAB015334, CAB016402, HPA017964"	Enhanced		Enhanced	Vesicles				Vesicles		"CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719"	"unprognostic (8.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.73e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.09e-1)"	16.5	8.7	14.6	7.2	25.9	5.1	13.5	13.2	20.8	13.2	5.3	34.4	4.9	2.9	13.4	10.1	5.7	13.8	8.7	9.2	17.5	11.9	14.6	9.6	17.7	4.6	27.2	11.8	8.1	4.0	4.9	3.6	20.0	16.1	6.8	4.5	9.9	4.0	12.4	3.9	10.8	4.6	12.6	24.8	10.8	4.6	18.5	29.7	1.6	15.8	5.7	4.6	9.7	8.8	0.5	4.0	8.8	1.1	3.3	1.5	0.3	2.5	27.3	18.6	17.5	7.9	10.7	5.6	4.8	3.1	3.1	2.3	1.5	2.4	1.8	5.6	11.8	3.1	18.8	3.9	4.2	1.5	3.5	1.4	3.2	2.5	7.8	0.4	7.4	8.2	2.4	10.2	2.1	13.0	1.9	1.8	5.0	10.4	1.2	10.6	20.2	3.3	2.1	7.8	0.1	2.4	9.7	0.9	8.2	4.4	2.8	6.3	17.2	6.7	4.6	9.2	7.1	3.1	6.6	2.0	0.2	4.4	9.2	3.9	6.2	8.8	1.1	7.6	1.1	1.1	1.0	0.4	0.2	0.9	1.6	0.5	0.1	0.7	7.7	3.3	0.8	4.0	1.5	0.3	14.6	25.9	13.2	16.9	17.5	11.9	27.2	11.8	16.1	29.7
HIP1R	"FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655"	ENSG00000130787	"Huntingtin interacting protein 1 related"	O75146	12	122834453-122862960	"Cancer-related genes, Predicted intracellular proteins"	Endocytosis	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.5;naive B-cell: 12.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017187, HPA038135, HPA038136"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852"	"unprognostic (4.52e-1)"	"unprognostic (6.39e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.72e-2)"	"prognostic favourable (6.50e-7)"	"unprognostic (2.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.54e-3)"	"prognostic favourable (7.26e-4)"	9.8	14.5	24.6	13.2	26.5	11.6	8.0	11.5	31.6	4.6	11.6	40.5	19.7	29.2	4.0	9.1	7.0	4.0	7.8	10.8	29.5	21.7	16.2	9.0	6.3	15.3	31.4	20.6	3.2	27.7	7.4	15.6	5.2	18.0	8.6	5.4	2.9	52.0	24.1	5.7	26.5	21.3	3.0	27.4	11.1	30.4	4.0	30.6	8.1	8.1	5.9	12.6	7.4	6.5	12.3	0.0	2.7	0.0	0.6	3.2	1.6	17.3	5.0	3.8	15.6	1.1	3.0	18.7	2.7	4.5	2.8	2.2	7.7	5.2	16.5	9.2	2.0	15.0	4.6	10.0	0.2	2.6	6.6	0.3	5.7	8.1	3.5	1.3	11.8	1.8	7.1	3.8	6.4	19.3	4.3	0.9	1.6	24.9	7.8	4.0	3.5	6.0	4.1	4.8	5.7	9.4	21.0	3.8	8.5	3.2	8.5	4.5	17.4	0.7	15.2	1.8	13.4	5.5	2.6	11.9	6.3	9.8	2.9	2.8	1.5	0.0	0.0	2.7	2.9	0.0	1.7	9.5	1.8	2.2	0.0	12.3	3.2	2.0	0.2	0.6	0.0	0.0	0.4	1.6	24.6	26.5	11.5	19.8	29.5	21.7	31.4	20.6	18.0	30.6
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777778	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 17.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favourable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.6	9.8	58.8	7.4	53.6	14.4	12.6	8.5	39.8	5.5	7.4	54.5	5.2	8.2	4.7	5.2	10.2	9.9	5.5	30.5	60.0	39.9	28.2	17.5	8.6	5.3	66.1	16.4	6.6	12.3	17.2	7.6	10.8	26.4	10.7	5.8	9.4	11.5	7.1	21.6	3.2	6.2	4.8	56.2	7.3	15.4	2.6	38.6	1.7	10.4	2.8	4.9	6.8	7.4	0.6	0.5	17.8	2.9	0.2	1.4	0.5	4.1	18.2	8.4	5.2	20.7	14.8	1.0	2.2	2.2	2.5	2.6	1.3	2.2	0.0	5.3	4.2	0.2	3.8	5.9	6.4	42.0	1.6	18.7	3.0	6.5	11.6	5.1	5.1	22.6	3.9	11.7	17.6	6.3	10.8	5.2	19.5	3.1	6.4	3.7	2.1	12.5	7.7	4.6	0.5	11.6	0.7	5.1	4.7	5.1	0.1	2.6	2.9	2.1	21.2	8.9	4.3	10.3	11.1	25.4	15.1	3.7	18.3	2.7	4.8	17.8	1.1	2.7	0.2	0.9	0.3	0.6	0.5	0.1	0.5	0.3	1.4	0.4	1.5	0.2	2.9	0.2	0.0	0.5	58.8	53.6	8.5	25.2	60.0	39.9	66.1	16.4	26.4	38.6
HIPK3	"DYRK6, FIST3, PKY, YAK1"	ENSG00000110422	"Homeodomain interacting protein kinase 3"	Q9H422	11	33256672-33357023	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028069	Approved		Supported	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA028069: AB_10601815"	"unprognostic (2.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-3)"	"unprognostic (7.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	46.3	13.4	12.7	15.9	15.9	12.7	49.2	11.7	13.7	23.6	24.8	11.9	15.9	9.9	28.3	22.8	22.9	24.1	18.8	69.0	13.4	11.8	23.4	21.1	20.2	20.9	15.5	8.2	23.6	15.4	49.7	21.2	20.5	15.2	23.2	12.8	15.6	18.8	18.1	45.9	18.7	25.0	32.9	15.9	20.1	20.5	14.7	14.2	15.2	37.9	26.0	14.4	33.6	34.6	3.1	11.3	17.6	10.1	3.3	4.4	3.7	9.4	9.0	6.8	7.7	31.6	20.0	6.8	10.0	11.6	8.1	6.9	9.9	6.9	10.2	8.5	12.2	12.1	5.1	11.2	11.5	14.8	8.0	10.3	10.2	7.5	13.1	11.0	6.5	18.7	22.0	3.1	9.2	9.9	3.2	20.5	13.1	4.9	9.1	7.7	1.7	5.5	12.3	24.2	10.2	13.4	14.8	1.0	5.7	13.6	15.6	9.3	17.5	20.4	12.7	12.8	8.8	14.7	7.1	11.3	17.7	10.8	6.2	11.7	11.9	6.6	10.1	4.8	3.5	7.6	4.4	2.4	3.2	3.7	11.3	3.1	2.9	3.5	17.6	3.3	8.6	1.4	3.2	3.7	12.7	15.9	11.7	13.7	13.4	11.8	15.5	8.2	15.2	14.2
HIRA	"DGCR1, TUP1, TUPLE1"	ENSG00000100084	"Histone cell cycle regulator"	P54198	22	19330698-19447450	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 50.0"	"Cell line enhanced"	"Detected in all"		"K-562: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB039243, CAB039244, HPA050714, HPA052902"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB039243: , CAB039244: , HPA050714: , HPA052902: "	"unprognostic (1.32e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.50e-1)"	"prognostic favourable (8.11e-4)"	"prognostic favourable (3.97e-4)"	"unprognostic (9.05e-2)"	"prognostic favourable (5.18e-6)"	"unprognostic (4.84e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.32e-3)"	9.9	9.8	14.8	10.0	13.6	19.9	7.4	16.7	16.3	8.0	11.7	10.9	9.4	12.4	11.9	8.4	9.7	11.5	10.0	9.2	13.4	11.6	12.8	15.0	9.1	11.4	11.3	10.0	10.8	11.3	25.6	11.4	7.6	9.8	7.6	9.4	8.9	8.6	8.7	15.3	10.8	12.1	10.3	8.3	10.2	10.1	10.5	10.6	20.3	50.0	4.6	10.0	8.9	18.2	8.2	2.9	6.1	1.2	3.6	2.4	1.2	8.0	7.0	9.9	10.3	9.7	6.4	7.0	6.7	7.8	11.1	11.1	16.0	4.6	15.5	3.3	8.6	9.4	14.1	8.5	7.2	9.6	16.3	14.3	7.5	14.5	10.6	33.2	10.6	7.7	8.3	8.7	8.5	8.0	73.7	8.3	6.3	9.9	16.3	11.8	9.0	7.1	13.0	14.1	4.6	6.4	8.9	14.6	9.7	7.7	7.7	9.2	4.9	11.6	9.2	7.7	11.4	7.8	7.9	8.9	8.7	16.3	8.9	10.7	6.3	6.1	1.2	5.0	2.3	1.2	2.4	3.7	1.3	2.3	1.5	8.2	0.6	1.7	2.2	3.6	0.6	2.9	0.6	1.2	14.8	13.6	16.7	16.3	13.4	11.6	11.3	10.0	9.8	10.6
HIRIP3		ENSG00000149929	"HIRA interacting protein 3"	Q9BW71	16	29992321-29996436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051897, HPA063205"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA051897: , HPA063205: "	"unprognostic (6.99e-2)"	"prognostic favourable (2.74e-5)"	"unprognostic (4.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (8.53e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.35e-2)"	9.4	11.3	16.8	9.2	26.8	15.0	10.0	23.4	17.9	10.9	11.3	20.7	10.0	9.6	11.3	10.8	9.5	12.5	9.0	17.6	16.4	14.6	10.6	13.6	12.8	12.7	22.9	13.6	18.2	11.4	20.0	14.2	8.4	15.3	10.1	7.5	11.5	12.8	15.5	29.0	13.3	9.2	13.3	20.1	10.8	8.5	34.0	23.9	21.0	11.8	9.0	11.9	10.3	12.4	13.9	14.6	10.8	13.9	9.7	16.6	8.3	11.0	11.9	18.2	12.4	5.8	6.4	6.3	8.9	7.3	9.7	8.2	9.9	12.1	19.7	18.6	5.8	8.4	11.9	10.9	6.3	19.5	14.3	21.1	15.8	11.2	5.4	18.7	18.6	3.4	8.3	9.2	13.6	5.6	10.9	25.1	5.0	8.2	27.0	11.8	6.1	7.5	29.5	20.4	22.6	6.2	4.8	13.2	15.9	8.4	7.5	6.2	10.7	13.4	5.5	12.9	9.7	9.1	8.7	17.4	12.2	13.5	12.0	17.6	17.4	3.5	5.9	10.8	13.4	9.2	9.3	13.9	15.3	12.4	4.9	11.7	16.1	14.9	2.7	9.7	13.9	14.6	16.6	8.3	16.8	26.8	23.4	17.9	16.4	14.6	22.9	13.6	15.3	23.9
HIST1H1B	"H1.5, H1b, H1F5, H1s-3"	ENSG00000184357	"Histone cluster 1 H1 family member b"	P16401	6	27866849-27867529	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 342.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.7;NB-4: 7.5;U-698: 5.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4"									"CAB012241, HPA055907"	Approved		Supported	Nucleoplasm			510000	Nucleoplasm		"CAB012241: , HPA055907: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.4	0.4	22.9	0.5	18.2	2.1	0.5	0.4	1.7	7.3	0.0	0.0	0.3	0.5	1.0	10.2	0.3	1.9	0.6	0.5	0.5	0.4	0.6	3.9	10.7	0.5	0.0	0.4	0.4	0.3	0.4	6.4	0.0	0.4	0.5	0.0	0.8	0.3	0.4	1.4	7.0	0.3	1.7	14.4	1.3	1.7	0.0	342.6	0.6	10.5	26.0	2.0	0.7	13.0	12.7	0.7	1.1	1.8	3.4	2.1	2.2	0.0	0.8	0.0	0.0	0.0	1.7	0.7	0.6	1.0	0.6	0.7	1.5	2.6	0.4	0.8	0.8	0.0	0.0	0.1	0.8	0.9	3.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.9	2.6	1.9	0.1	0.4	13.7	7.5	2.1	0.0	4.2	0.0	0.0	0.4	0.0	1.9	1.1	2.3	0.3	0.0	1.0	2.4	0.8	1.4	0.1	1.3	1.0	2.8	0.0	5.8	1.9	0.9	1.3	0.0	0.9	0.0	3.3	0.9	1.7	4.8	3.1	3.4	5.1	13.0	1.7	1.8	0.7	1.8	1.1	12.7	3.4	2.1	0.4	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.0
HIST1H1C	"H1.2, H1c, H1F2, H1s-1"	ENSG00000187837	"Histone cluster 1 H1 family member c"	P16403	6	26055787-26056428	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 353.5"	"Cell line enhanced"	"Detected in many"		"K-562: 48.9;SiHa: 46.5;U-2 OS: 91.7;U-266/70: 101.7;U-266/84: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 79.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 79.7"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	Nucleoplasm,Nucleoli			1800000	"Nucleoplasm, Nucleoli"		"CAB011507: AB_2117984, HPA055907: "	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favourable (8.06e-5)"	25.1	17.4	10.1	32.1	10.2	94.7	36.0	23.8	12.8	29.8	23.3	8.1	14.3	15.0	24.7	21.0	48.6	16.6	27.4	37.6	9.3	7.3	23.8	43.1	31.4	37.2	8.2	8.7	34.4	46.6	2.3	5.8	29.1	6.9	44.3	21.2	26.5	22.0	9.5	69.1	21.0	21.1	22.9	12.5	28.4	25.6	33.7	5.4	353.5	21.7	28.5	39.7	38.8	28.0	14.9	5.9	79.7	3.2	3.3	8.6	4.2	5.7	4.2	3.1	3.3	8.0	1.6	0.1	2.9	4.8	13.8	14.7	2.2	4.2	0.4	16.8	3.8	2.5	1.0	2.2	3.9	5.6	3.6	2.4	4.6	2.5	2.3	1.1	5.8	11.2	3.1	1.8	3.0	2.1	48.9	36.8	6.8	2.6	2.9	2.6	1.7	6.4	1.5	1.4	18.7	8.1	4.2	8.0	2.7	46.5	8.0	3.2	9.9	1.7	0.9	6.3	91.7	1.8	1.3	101.7	96.6	4.4	4.6	38.1	2.1	35.8	2.6	79.7	3.8	2.6	4.8	9.8	6.3	4.1	5.6	14.9	5.8	4.4	43.0	3.3	3.2	5.9	8.6	4.2	10.1	10.2	23.8	12.8	9.3	7.3	8.2	8.7	6.9	5.4
HIST1H1E	"H1.4, H1e, H1F4, H1s-4"	ENSG00000168298	"Histone cluster 1 H1 family member e"	P10412	6	26156354-26157107	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 56.4;bone marrow: 102.3;lymphoid tissue: 123.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 9.7;U-266/70: 11.8;U-266/84: 13.2;U-87 MG: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB011506: AB_470256, HPA055907: "	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	6.7	3.6	3.1	14.3	3.5	102.3	10.3	8.1	9.0	10.7	7.7	4.7	4.2	4.1	6.8	7.5	13.7	4.0	11.3	7.4	4.0	3.5	6.6	6.7	13.1	18.4	3.4	2.4	19.3	17.1	3.7	9.0	7.3	3.5	10.2	4.4	9.8	10.0	4.0	4.1	14.4	9.0	7.4	6.8	14.6	5.3	5.9	0.7	123.9	4.6	10.0	18.4	14.3	10.7	39.6	14.6	56.4	12.9	19.2	24.4	9.4	2.4	0.3	0.4	5.2	0.1	0.0	6.3	0.0	0.4	1.1	0.8	0.1	1.5	1.2	0.7	0.1	1.1	0.3	0.7	0.5	1.7	1.5	0.8	0.5	0.4	0.1	0.7	1.0	0.1	0.3	0.3	0.5	0.5	3.9	6.7	0.1	0.5	7.7	7.1	1.8	0.8	3.6	1.2	9.7	0.3	0.0	3.8	0.9	3.1	0.8	1.1	1.0	2.5	0.4	2.4	3.6	1.4	2.4	11.8	13.2	5.3	12.1	2.1	1.1	56.4	12.7	30.0	21.1	12.9	24.4	21.4	16.7	19.2	14.3	39.6	12.7	11.6	18.6	19.2	10.9	14.6	16.4	9.4	3.1	3.5	8.1	9.0	4.0	3.5	3.4	2.4	3.5	0.7
HIST1H2AE	"H2A.1, H2A/a, H2AFA"	ENSG00000277075	"Histone cluster 1 H2A family member e"	P04908	6	26216975-26217483	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 139.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 26.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB012242, HPA041189"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB012242: AB_470265, HPA041189: "	"unprognostic (4.26e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.36e-2)"	0.3	1.8	0.9	19.1	0.9	13.5	33.8	4.9	6.2	3.7	3.8	0.2	3.2	2.8	2.2	13.6	7.2	3.0	2.4	2.2	0.5		0.8	1.5	1.9	11.4	0.0	3.0	2.0	1.1	0.4	0.0	2.9	0.5	10.6	1.6	1.4	2.7	2.5	0.1	2.4	3.4	2.0	3.5	5.9	2.0	5.1	0.0	139.6	2.0	7.4	11.4	2.3	0.0	6.1	15.4	11.4	2.1	4.0	4.2	10.1	2.8	0.0	2.1	0.0	3.5	0.7	0.5	0.9	1.4	3.1	2.1	1.4	2.3	0.1	7.7	0.3	2.3	1.0	1.4	1.2	3.0	2.5	1.8	4.1	1.7	0.6	0.2	2.9	6.1	0.7	1.3	0.1	1.5	7.6	2.1	0.2	5.1	6.2	5.4	2.5	2.6	5.0	1.7	9.8	1.3	1.6	8.5	3.6	7.6	2.6	1.7	10.5	2.8	0.0	0.1	0.6	1.3	1.2	26.4	0.0	0.0	1.1	3.7	1.8	11.4	2.0	6.3	2.7	2.1	3.8	4.3	3.0	4.2	5.0	6.1	1.6	2.1	9.4	4.0	1.2	15.4	3.6	10.1										
HIST3H3	"H3.4, H3/g, H3FT, H3t"	ENSG00000168148	"Histone cluster 3 H3"	Q16695	1	228424845-228425325	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	194	"testis: 107.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;MCF7: 1.3;THP-1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001386, CAB003812, HPA042570"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB001386: , CAB003812: AB_365490, HPA042570: "	"unprognostic (4.45e-1)"				"unprognostic (4.66e-2)"			"unprognostic (1.36e-1)"		"unprognostic (3.78e-3)"	"unprognostic (1.75e-2)"		"unprognostic (4.04e-2)"	"unprognostic (1.39e-2)"			"unprognostic (2.26e-2)"	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	107.8	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.8	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.2	0.0	0.8	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0
HIST4H4	MGC24116	ENSG00000197837	"Histone cluster 4 H4"	P62805	12	14767999-14771131	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 36.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.7"	"Low lineage specificity"	"Detected in all"											"CAB011503, CAB037279, HPA042201"	Supported		Supported	Nucleoplasm			30000000	Nucleoplasm		"CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: "	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-3)"	7.1	4.6	2.3	7.4	7.6	2.5	4.7	6.7	4.9	6.9	6.2	1.1	3.3	5.0	5.4	7.1	8.9	6.0	5.4	5.9	2.8	2.5	11.0	3.3	6.3	7.2	2.5	2.1	8.3	36.7	2.1	5.1	7.1	2.1	16.0	4.8	6.1	12.7	5.5	2.8	6.4	8.9	3.3	3.1	21.8	10.1	6.6	1.7	16.9	9.9	6.8	18.6	6.6	6.8	5.5	3.6	19.7	2.1	2.1	3.4	1.1	2.1	0.8	0.1	2.6	2.8	0.0	1.5	1.3	0.1	1.0	0.9	1.4	7.9	1.9	0.5	0.7	1.3	0.0	1.0	0.6	2.5	1.1	0.0	5.1	2.0	0.8	0.5	1.9	2.0	0.6	0.2	1.1	0.0	0.0	2.5	0.1	1.1	0.5	0.7	2.7	0.3	2.2	0.0	3.9	0.0	5.8	1.0	1.4	5.2	1.3	0.3	0.9	1.0	1.7	0.5	4.2	1.1	1.6	2.8	1.6	5.8	1.9	0.0	1.3	0.0	1.9	0.2	2.0	2.1	3.4	4.1	2.3	2.2	2.1	5.5	2.0	2.2	19.7	2.1	0.7	3.6	3.2	1.1	2.3	7.6	6.7	4.9	2.8	2.5	2.5	2.1	2.1	1.7
HIVEP1	"CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A"	ENSG00000095951	"Human immunodeficiency virus type I enhancer binding protein 1"	P15822	6	12008762-12164999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050724	Approved		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria"				Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA050724: AB_2616457"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.65e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.38e-1)"	22.3	5.5	6.4	20.1	5.6	20.5	13.1	8.0	10.0	11.5	12.6	5.4	13.9	7.0	10.0	10.6	12.9	9.2	10.6	8.8	5.6	7.1	7.3	17.1	13.3	12.4	5.3	6.7	11.6	11.7	23.3	12.2	8.7	7.8	10.5	9.5	7.7	10.9	17.6	8.2	14.1	11.8	12.9	5.9	15.2	7.2	7.3	5.0	23.8	7.7	14.2	16.2	17.3	23.1	5.6	9.6	12.9	4.9	3.6	4.6	0.7	5.2	3.9	5.1	2.8	4.0	5.1	4.9	4.2	3.7	3.5	3.9	2.5	2.8	4.4	9.3	5.1	5.0	4.9	6.1	4.9	9.4	2.9	2.0	3.7	2.4	3.2	2.3	1.7	3.5	6.2	7.2	11.1	10.3	20.9	5.0	7.7	3.9	3.8	2.1	4.3	2.0	2.0	6.6	6.9	2.1	5.7	4.8	3.5	10.5	8.6	2.9	5.1	3.1	16.7	8.9	4.0	8.3	4.8	20.3	16.9	7.8	2.7	3.1	3.7	2.4	2.2	2.2	1.4	2.2	1.0	3.4	2.3	0.9	1.3	5.6	4.0	2.3	12.9	3.6	4.9	9.6	4.6	0.7	6.4	5.6	8.0	10.0	5.6	7.1	5.3	6.7	7.8	5.0
HIVEP2	"HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B"	ENSG00000010818	"Human immunodeficiency virus type I enhancer binding protein 2"	P31629	6	142751467-142956698	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055954			Supported	Nucleoplasm				Nucleoplasm		"HPA055954: "	"unprognostic (1.35e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.10e-1)"	11.3	9.7	13.9	13.6	17.4	4.2	9.2	29.8	30.1	6.3	7.2	5.9	3.8	6.1	8.6	7.3	11.7	15.9	13.5	10.5	15.7	10.4	8.5	7.7	10.6	14.9	9.3	12.8	18.5	13.4	19.0	8.7	9.6	12.7	7.3	6.3	7.1	10.9	8.6	24.3	10.6	8.0	10.1	13.5	10.4	6.5	2.7	8.5	18.6	11.2	9.6	15.5	12.5	12.0	2.1	1.1	2.3	0.6	1.7	3.9	1.2	3.6	0.7	0.8	3.2	7.2	8.1	2.6	5.3	13.6	3.3	4.0	0.3	3.0	5.8	3.3	23.3	2.3	1.4	10.8	8.2	2.2	1.7	1.5	2.4	1.4	5.4	5.0	0.0	7.4	10.8	13.6	15.6	1.8	0.1	5.3	5.6	4.1	6.6	2.1	0.8	5.3	8.7	5.9	0.5	3.0	6.4	8.9	3.8	7.0	5.8	3.9	1.0	3.0	1.9	11.2	2.8	9.4	4.6	11.1	1.8	12.5	3.1	3.9	5.2	0.0	0.3	0.0	1.6	0.6	3.6	2.1	3.9	3.2	1.1	1.3	3.9	3.0	2.3	1.7	0.5	0.5	2.9	1.2	13.9	17.4	29.8	30.1	15.7	10.4	9.3	12.8	12.7	8.5
HIVEP3	"FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C"	ENSG00000127124	"Human immunodeficiency virus type I enhancer binding protein 3"	Q5T1R4	1	41506365-42035925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3;lymphoid tissue: 16.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.5;hTEC/SVTERT24-B: 9.1;Karpas-707: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005728	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA005728: AB_10612117"	"unprognostic (2.87e-3)"	"unprognostic (2.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	4.2	1.5	7.5	5.4	5.7	3.8	3.6	20.3	11.7	1.2	1.4	5.1	0.0	1.2	1.1	1.1	3.2	1.3	2.0	2.1	6.1	3.0	1.4	1.2	4.6	4.1	4.8	4.7	1.6	2.4	2.3	8.3	1.8	6.5	2.2	1.5	0.5	3.7	1.1	1.6	11.7	1.3	2.2	5.0	2.9	1.9	1.4	5.1	16.6	2.9	1.8	5.4	1.9	1.6	1.0	1.5	0.1	3.7	0.2	2.1	1.1	1.8	0.6	0.2	1.7	2.2	1.0	0.0	0.9	0.2	2.3	4.0	0.1	0.3	3.8	0.6	0.9	2.5	0.4	0.4	3.0	17.5	0.5	0.2	0.8	0.0	0.4	0.3	0.3	5.5	0.4	9.1	1.0	0.5	0.0	10.6	1.7	1.1	2.8	0.7	0.5	2.2	1.8	2.7	2.0	1.4	0.3	2.0	0.6	2.5	0.6	0.5	0.8	3.2	3.2	2.0	2.1	0.6	4.3	3.2	1.3	2.5	7.9	0.2	7.1	0.1	1.7	0.0	2.1	3.7	0.5	0.6	0.9	1.0	1.5	1.0	0.2	0.8	0.1	0.2	3.1	0.3	0.3	1.1	7.5	5.7	20.3	11.7	6.1	3.0	4.8	4.7	6.5	5.1
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2"					"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli"	Mitochondria	"HPA008436: AB_1850757, HPA027261: "	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.37e-5)"	"prognostic unfavourable (2.46e-4)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavourable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	1.4	0.9	0.1	12.2	0.4	27.4	2.2	0.1	0.7	1.1	3.7	0.3	0.1	2.6	0.6	1.8	8.0	0.3	0.7	1.1	0.1	0.2	1.0	1.2	2.0	8.1	0.2	0.1	0.6	0.4	0.0	0.2	3.1	0.2	0.7	3.6	0.3	1.5	1.0	0.2	2.6	4.8	1.1	0.4	5.8	2.4	20.9	0.1	51.1	0.4	3.0	11.6	1.0	2.8	0.5	0.3	1.2	1.3	0.5	4.2	1.7	17.0	23.0	22.6	10.6	0.8	1.8	14.1	25.6	12.3	18.3	20.0	16.2	18.6	5.3	2.9	10.1	19.9	18.0	13.2	24.4	12.5	6.7	20.5	18.5	15.7	0.1	16.9	14.2	0.6	0.5	14.9	10.3	11.4	17.4	13.3	33.6	17.2	23.7	18.6	19.2	16.0	18.3	33.8	9.4	9.4	10.3	13.0	8.1	14.7	11.2	10.5	8.4	13.1	8.3	19.8	21.5	14.5	27.6	12.7	10.0	21.4	11.8	12.5	49.2	0.6	0.2	0.2	0.3	0.2	0.2	0.4	0.7	0.6	0.3	0.5	0.3	0.5	1.2	0.5	1.3	0.2	4.2	1.7	0.1	0.4	0.1	0.7	0.1	0.2	0.2	0.1	0.2	0.1
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052, HPA011956"	Supported		Supported	Mitochondria			16000000	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049, HPA011956: AB_1850758"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	17.5	10.5	21.1	19.9	30.4	23.5	15.8	40.0	48.6	16.6	16.9	10.1	7.6	6.3	13.5	9.4	44.8	15.2	12.6	61.6	19.8	23.3	10.8	4.4	17.2	14.3	19.8	31.3	9.0	4.6	12.5	14.7	22.6	31.3	25.5	15.4	21.2	21.5	26.8	62.1	30.7	8.6	25.6	9.7	13.3	20.3	28.9	10.6	18.9	33.6	32.6	23.0	25.8	23.1	11.4	25.5	17.8	39.3	8.9	23.0	29.6	17.4	9.9	13.3	12.7	14.9	11.2	8.5	17.4	45.8	23.3	25.2	2.9	1.9	1.2	13.8	29.1	15.3	12.4	38.9	22.3	11.6	9.7	43.4	10.6	0.2	17.0	0.8	32.9	16.9	22.7	33.3	74.5	24.1	72.3	9.2	31.9	28.9	5.0	2.2	20.4	44.3	7.7	8.1	0.1	16.1	20.6	13.7	16.1	19.9	38.7	11.5	21.1	2.8	24.7	34.8	15.9	19.1	24.2	11.0	7.2	3.0	45.1	22.8	10.0	17.8	27.3	13.4	14.0	39.3	23.0	11.4	16.2	15.8	25.5	6.8	14.5	11.5	6.6	8.9	39.3	2.9	17.8	29.6	21.1	30.4	40.0	48.6	19.8	23.3	19.8	31.3	31.3	10.6
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell line enhanced"	"Detected in some"		"A549: 14.7;CACO-2: 20.9;CAPAN-2: 41.4;EFO-21: 12.8;Hep G2: 12.1;RPTEC TERT1: 30.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA011956, HPA064198, HPA064230"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA011956: AB_1850758, HPA064198: , HPA064230: "	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.9	41.4	0.0	12.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.1	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	"P16188, P04439, P13746"	6	29941260-29945884	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 154.8;fHDF/TERT166: 41.4;HBEC3-KT: 42.5;RPMI-8226: 40.3;U-266/70: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB078470			Supported	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favourable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favourable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	69.4	57.5	16.0	69.1	18.2	41.2	40.8	9.1	20.7	54.4	92.6	20.4	28.6	105.7	38.4	76.2	48.4	27.8	92.3	59.1	14.6	16.6	80.5	47.6	112.0	90.5	19.5	8.9	57.2	30.0	22.5	33.3	38.7	22.7	64.1	38.5	52.4	28.3	19.2	44.0	110.4	129.4	30.3	22.8	150.0	115.9	26.6	12.3	71.1	62.3	38.5	97.7	86.4	41.0	23.0	10.9	65.8	25.2	25.9	46.7	45.4	154.8	3.9	0.0	0.0	25.0	23.6	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.4	0.0	41.4	3.8	0.0	42.5	0.0	0.3	1.5	27.0	1.2	0.8	1.4	0.0	1.8	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	2.4	0.3	0.4	3.3	0.3	40.3	29.0	31.8	0.0	1.4	3.5	0.0	1.4	0.1	3.6	0.5	2.3	0.1	0.7	0.4	41.3	10.5	8.7	0.0	22.8	0.0	65.8	25.2	35.4	38.3	17.9	28.8	23.0	29.6	34.4	4.1	14.9	21.7	29.7	47.9	25.9	19.8	10.9	46.7	45.4	16.0	18.2	9.1	20.7	14.6	16.6	19.5	8.9	22.7	12.3
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941070	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"CAPAN-2: 7.2;Daudi: 10.1;EFO-21: 4.8;U-266/70: 3.8;U-698: 12.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 19.9;dendritic cells: 11.5;monocytes: 11.9"									"HPA012298, HPA077524"	Supported		Supported	Vesicles				Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favourable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"	12.0	13.0	5.9	20.2	7.5	4.3	7.9	0.4	4.9	8.1	9.7	8.8	2.1	1.2	6.2	10.2	3.3	12.6	6.0	8.0	5.7	4.2	13.1	5.4	20.8	24.0	10.2	2.3	7.4	5.0	1.2	3.2	6.2	8.1	6.3	10.5	6.3	7.8	3.2	2.9	4.5	31.8	1.9	14.5	35.6	6.1	2.1	7.3	10.5	33.7	3.8	34.5	10.6	3.2	19.9	11.5	2.2	11.9	2.2	1.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	10.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.3	12.3	0.0	0.0	0.0	0.0	11.9	2.2	0.3	10.1	0.4	15.1	0.2	0.5	11.1	19.9	0.1	0.5	0.5	2.2	3.5	11.5	1.0	10.3	5.9	7.5	0.4	4.9	5.7	4.2	10.2	2.3	8.1	7.3
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 59.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.4;HDLM-2: 47.5;REH: 12.1;U-698: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 16.3;intermediate monocyte: 37.8;memory B-cell: 30.0;myeloid DC: 59.5;naive B-cell: 26.7;non-classical monocyte: 23.2;plasmacytoid DC: 17.1"	"Group enriched"	"Detected in all"	8	"B-cells: 30.0;dendritic cells: 59.5;monocytes: 37.8"									HPA017967	Enhanced		Supported	Vesicles			92000	Vesicles		"HPA017967: AB_1853929"	"unprognostic (8.93e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.06e-1)"	25.2	12.8	3.3	13.3	3.6	4.7	16.3	3.5	3.3	11.8	6.8	3.1	4.3	8.6	8.5	15.9	8.5	5.7	14.7	11.1	4.2	6.2	12.4	9.7	35.9	20.2	6.2	3.8	3.8	5.4	3.8	5.2	6.5	4.8	7.4	7.3	7.5	7.4	15.7	4.1	5.8	14.7	6.4	20.4	37.6	5.6	8.6	4.1	10.9	14.2	9.5	21.5	8.5	17.8	30.0	59.5	1.3	37.8	4.0	5.6	20.3	0.0	0.0	0.0	0.0	0.3	0.5	0.5	0.2	0.1	0.2	0.0	0.0	2.1	15.4	2.2	0.3	0.0	0.0	0.0	0.0	47.5	1.0	2.5	0.0	0.0	0.0	0.0	5.0	0.7	0.0	0.9	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	12.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	1.1	3.4	0.0	0.0	0.0	2.4	0.3	11.1	5.4	0.1	1.8	0.3	16.3	1.3	4.6	37.8	1.2	30.0	2.1	5.0	59.5	26.7	0.7	3.4	0.6	4.0	23.2	17.1	5.6	20.3	3.3	3.6	3.5	3.3	4.2	6.2	6.2	3.8	4.8	4.1
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 74.6"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.8;intermediate monocyte: 24.1;memory B-cell: 30.9;myeloid DC: 68.2;naive B-cell: 35.6;plasmacytoid DC: 21.4"	"Group enriched"	"Detected in all"	6	"B-cells: 35.6;dendritic cells: 68.2;monocytes: 27.8"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"				"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	23.9	10.0	3.5	40.4	3.0	9.0	17.0	1.0	4.9	11.0	18.8	8.8	4.5	0.0	9.9	42.6	9.6	8.0	21.7	12.7	4.1	5.3	35.4	9.9	61.2	61.1	6.1	4.2	6.3	4.0	0.0	9.2	4.0	7.9	11.3	10.7	13.5	11.8	5.6	7.8	12.4	27.6	4.6	15.5	74.5	32.7	4.6	2.9	63.5	13.3	7.9	74.6	37.9	7.4	35.6	68.2	4.6	27.8	1.5	7.1	31.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.4	0.0	3.6	0.0	3.6	0.0	111.8	2.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.6	2.0	0.0	0.0	0.1	0.1	0.0	13.4	0.3	12.3	9.3	0.0	0.0	0.0	27.8	4.6	2.4	24.1	1.1	30.9	1.2	3.7	68.2	35.6	0.0	1.1	1.9	1.5	6.6	21.4	7.1	31.9	3.5	3.0	1.0	4.9	4.1	5.3	6.1	4.2	7.9	2.9
HLCS	HCS	ENSG00000159267	"Holocarboxylase synthetase"	P50747	21	36750888-36990236	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017379	Approved		Supported	Cytosol				Cytosol		"HPA017379: AB_1850768"	"prognostic unfavourable (7.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.02e-1)"	6.3	9.6	7.1	9.8	10.3	2.9	10.6	12.2	8.5	7.7	7.2	10.3	12.1	5.7	6.4	9.4	7.1	8.1	9.9	5.3	8.4	8.0	9.1	16.4	6.7	5.8	10.2	6.0	5.5	15.6	23.3	23.9	9.9	9.4	12.8	6.4	11.7	9.9	11.6	13.5	4.3	8.1	7.3	10.6	4.5	7.6	7.7	5.1	4.9	14.3	6.1	8.0	9.2	4.9	3.9	5.3	3.2	10.0	8.5	7.8	2.9	17.6	6.5	9.9	7.2	11.8	10.8	9.7	10.8	10.4	4.9	5.5	7.1	8.4	9.6	5.2	15.5	6.0	5.0	8.2	4.4	19.0	10.3	14.1	6.4	4.5	14.1	7.6	7.4	8.5	12.7	7.4	19.9	6.2	15.3	24.5	12.4	10.7	3.4	3.5	15.5	9.2	6.0	5.6	7.8	7.6	17.8	7.0	7.2	14.2	6.6	10.8	11.5	7.8	8.3	7.1	2.2	6.5	5.8	23.8	14.5	5.9	10.2	9.6	8.2	3.2	2.1	1.6	7.8	4.0	6.1	2.6	4.5	5.2	2.0	3.9	5.4	5.5	2.7	8.5	10.0	5.3	2.7	2.9	7.1	10.3	12.2	8.5	8.4	8.0	10.2	6.0	9.4	5.1
HLF	MGC33822	ENSG00000108924	"HLF, PAR bZIP transcription factor"	Q16534	17	55265012-55325065	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"liver: 78.8"	"Cell line enriched"	"Detected in some"	6	"Hep G2: 58.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 2.4;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA068156: , HPA071210: "	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favourable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favourable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	9.5	15.2	13.3	2.0	26.2	1.0	10.8	15.2	38.0	10.5	10.6	6.4	2.4	1.7	10.3	8.5	18.1	9.3	6.1	15.9	12.6	6.9	9.2	78.8	9.5	2.1	6.6	24.5	34.6	2.7	2.8	8.0	1.5	12.3	9.9	3.1	23.7	15.9	9.5	5.3	11.6	3.0	14.3	5.5	5.7	4.7	3.4	6.3	0.0	23.4	7.1	5.6	9.2	5.2	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	9.7	0.2	0.0	0.0	58.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.9	0.0	0.1	0.1	4.8	0.0	4.1	0.2	0.0	2.6	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	1.9	1.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	13.3	26.2	15.2	38.0	12.6	6.9	6.6	24.5	12.3	6.3
HLTF	"HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3"	ENSG00000071794	"Helicase like transcription factor"	Q14527	3	149030127-149086554	"Enzymes, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015284, HPA049001"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA015284: AB_1857263, HPA049001: "	"unprognostic (3.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.07e-2)"	10.2	22.1	12.6	8.4	17.6	9.0	12.4	29.3	23.8	11.1	11.0	12.4	6.2	4.8	12.4	9.6	7.1	10.8	8.6	16.5	15.8	16.6	15.6	16.3	7.1	9.8	15.7	19.0	17.6	12.0	16.5	25.1	7.3	29.9	14.7	7.0	11.3	9.3	11.1	9.7	5.1	6.6	12.7	19.0	7.5	8.7	37.7	14.0	17.1	19.0	4.8	9.6	10.0	7.8	8.4	9.2	8.8	2.3	5.4	10.4	3.5	24.6	12.0	17.1	13.3	11.4	14.9	1.7	16.7	10.0	12.4	14.5	9.7	17.2	15.9	20.4	7.7	0.7	22.9	6.6	20.7	8.7	11.2	38.2	9.4	3.9	7.1	10.0	15.8	9.4	3.6	9.2	5.4	7.1	13.3	10.4	16.9	12.4	20.5	15.4	12.9	15.1	23.7	19.3	2.5	10.2	8.0	16.9	10.0	25.3	11.7	22.9	35.2	9.8	5.0	14.5	8.8	20.5	18.1	15.3	8.6	20.8	14.3	13.7	5.6	8.8	1.3	4.0	5.6	2.1	10.4	8.4	4.9	7.2	3.9	5.4	7.2	7.4	0.2	5.4	2.3	9.2	4.4	3.5	12.6	17.6	29.3	23.8	15.8	16.6	15.7	19.0	29.9	14.0
HM13	"dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1"	ENSG00000101294	"Histocompatibility minor 13"	Q8TCT9	20	31514428-31577923	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045089, HPA056062"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA045089: AB_10962054, HPA056062: "	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.87e-3)"	"prognostic unfavourable (1.95e-5)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-2)"	"prognostic unfavourable (4.64e-12)"	"unprognostic (3.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.17e-2)"	25.2	34.3	9.2	20.1	11.1	19.8	36.4	10.2	17.5	37.9	17.0	13.2	64.7	18.1	23.3	40.7	39.2	21.4	24.1	17.9	9.3	13.0	30.2	121.3	25.5	38.7	10.8	9.8	20.8	132.3	24.4	28.6	45.9	14.5	22.4	16.3	15.4	149.6	84.3	13.1	15.0	17.8	17.9	11.0	22.0	25.3	11.7	9.0	15.5	33.5	21.5	30.5	18.1	21.4	16.7	48.2	50.1	65.3	19.4	29.8	52.6	24.6	26.0	10.5	15.5	47.9	30.8	36.2	42.2	39.5	28.9	29.8	51.6	29.7	15.9	56.9	46.0	45.1	14.7	28.4	19.0	8.0	19.9	35.2	19.0	31.0	53.3	20.0	14.1	28.1	18.5	24.4	33.4	22.3	15.5	63.3	26.7	29.1	17.1	14.4	12.1	44.6	10.9	49.5	74.2	27.8	13.2	13.8	16.7	43.2	41.6	34.1	32.3	19.1	27.0	43.9	23.4	44.2	23.7	40.9	24.3	12.6	59.9	72.2	38.7	18.4	65.3	31.8	21.7	64.0	29.8	16.7	20.5	20.9	46.0	12.6	13.8	16.2	50.1	19.4	58.6	48.2	18.1	52.6	9.2	11.1	10.2	17.5	9.3	13.0	10.8	9.8	14.5	9.0
HMBOX1	"FLJ21616, HNF1LA, HOT1, PBHNF"	ENSG00000147421	"Homeobox containing 1"	Q6NT76	8	28890394-29064764	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055855, HPA058586, CAB070418"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB070418: AB_11154826, HPA055855: , HPA058586: "	"unprognostic (2.68e-3)"	"unprognostic (2.30e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-1)"	10.8	23.1	16.4	10.5	15.5	21.2	10.4	18.6	15.8	9.2	8.4	13.9	8.5	6.7	14.9	8.6	9.6	8.7	9.4	12.7	14.6	8.2	10.1	10.0	15.9	11.0	16.6	10.1	13.9	10.9	13.5	13.6	14.6	15.9	7.6	8.8	9.9	11.7	12.5	9.7	12.1	10.2	11.6	20.0	11.8	9.3	16.8	18.2	13.0	13.7	5.6	12.6	10.4	14.3	6.6	4.8	5.0	9.0	2.2	5.5	2.6	5.0	5.5	6.1	7.0	5.7	6.0	5.1	2.2	2.9	3.4	3.9	2.5	3.2	12.3	5.4	3.8	4.3	11.8	4.4	4.8	4.5	2.1	12.8	10.3	3.4	4.5	4.3	8.6	2.9	6.3	4.5	8.5	7.6	18.1	12.3	4.8	2.9	7.9	2.2	4.2	1.3	6.5	6.0	2.9	2.4	9.3	2.6	7.8	4.2	3.2	4.6	3.2	3.9	10.9	3.1	14.6	3.3	3.0	3.7	3.8	4.8	4.2	5.3	4.5	5.0	4.8	2.0	4.0	4.9	5.5	6.6	3.9	3.5	4.8	5.7	5.0	4.8	2.7	2.2	9.0	3.8	1.7	2.6	16.4	15.5	18.6	15.8	14.6	8.2	16.6	10.1	15.9	18.2
HMG20B	"BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL"	ENSG00000064961	"High mobility group 20B"	Q9P0W2	19	3572777-3579088	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 79.8;WM-115: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050220, HPA053157, HPA069832"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA050220: , HPA053157: , HPA069832: "	"unprognostic (2.97e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"prognostic favourable (1.72e-7)"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.84e-1)"	"prognostic favourable (2.89e-5)"	22.2	19.0	14.4	19.2	17.1	18.7	22.8	7.1	15.0	23.7	24.5	18.5	28.3	20.4	27.0	22.6	26.0	20.6	28.9	17.4	16.3	8.2	25.0	23.3	17.4	13.0	20.3	9.9	19.0	21.7	19.3	9.8	35.2	14.8	33.6	12.9	18.8	36.6	23.5	12.5	25.9	24.6	22.6	14.6	18.6	24.2	19.0	16.2	44.8	29.4	14.0	25.0	24.0	24.4	18.6	32.7	31.1	35.2	27.7	22.9	24.8	18.2	7.9	7.1	16.9	8.9	8.0	13.0	11.8	8.6	10.8	8.2	2.8	6.7	10.0	11.1	8.5	8.9	4.1	8.0	6.5	8.8	9.4	4.9	25.6	7.4	5.7	6.6	24.1	6.8	9.7	6.2	4.1	10.8	8.1	16.6	7.1	24.8	12.4	12.0	8.1	15.9	8.3	12.5	13.6	8.0	11.7	4.4	13.5	16.5	28.7	79.8	21.7	18.0	15.5	5.7	13.0	20.4	10.0	15.7	8.2	6.9	14.9	16.9	82.2	19.1	34.5	31.1	21.2	33.6	18.9	18.6	18.3	22.9	32.7	15.9	19.7	18.9	19.0	27.7	35.2	29.5	19.9	24.8	14.4	17.1	7.1	15.0	16.3	8.2	20.3	9.9	14.8	16.2
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824131-65966295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.3"	"Cell line enhanced"	"Detected in many"		"AF22: 66.0;NTERA-2: 38.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"CAB017809, HPA039076"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB017809: , HPA039076: "	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavourable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (2.86e-4)"	6.5	0.3	0.5	3.8	0.8	8.1	2.1	0.2	0.6	2.5	7.6	0.4	0.0	2.4	2.7	0.1	1.1	2.4	3.3	0.5	0.3	0.4	1.0	0.4	0.5	0.1	0.3	1.3	2.1	1.7	0.0	1.7	0.3	0.6	0.5	4.6	0.4	0.5	1.8	2.0	0.7	5.1	0.7	1.7	0.8	2.1	25.3	0.0	0.8	1.1	3.0	0.1	0.8	2.8	0.7	0.3	3.8	2.1	1.3	0.7	0.1	9.5	4.2	66.0	9.4	3.1	17.3	0.0	30.5	13.9	5.4	5.4	5.4	4.0	0.0	19.8	1.4	4.2	10.9	26.2	25.7	0.0	11.4	0.0	0.1	33.0	1.7	0.9	0.1	13.1	1.6	11.5	20.8	21.1	0.0	0.1	30.5	0.0	0.1	5.4	38.7	19.0	2.6	3.2	0.0	14.2	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.1	24.6	19.4	5.8	14.8	9.1	0.0	0.0	0.0	23.4	0.0	4.4	3.8	1.0	0.7	0.5	0.6	0.3	0.3	0.4	0.5	0.2	0.7	0.4	0.7	2.5	1.3	2.1	0.3	0.3	0.1	0.5	0.8	0.2	0.6	0.3	0.4	0.3	1.3	0.6	0.0
HMGB1	"DKFZp686A04236, HMG1, HMG3, SBP-1"	ENSG00000189403	"High mobility group box 1"	P09429	13	30456704-30617597	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003506, CAB005873"	Supported		Supported	Nucleoplasm	"Intracellular and membrane"		2000000	Nucleoplasm		"CAB005873: AB_444360, HPA003506: AB_1079070"	"unprognostic (9.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.28e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.97e-2)"	52.0	40.0	71.2	57.0	86.8	147.8	57.6	69.6	66.1	56.0	55.0	59.6	45.1	47.6	69.7	48.8	58.5	50.2	39.4	40.3	71.2	58.7	42.4	61.1	43.6	104.8	90.3	57.3	56.1	34.5	28.4	53.3	42.7	70.6	47.5	67.3	40.0	43.0	51.7	62.6	41.2	51.6	70.3	85.8	53.8	44.8	27.1	91.2	68.8	48.9	48.3	120.9	51.0	79.5	90.8	78.1	133.2	74.8	87.6	102.9	132.3	50.7	39.4	91.6	68.4	25.7	25.6	36.1	64.9	35.4	62.8	42.6	62.3	85.6	103.4	33.9	58.7	56.9	95.7	52.3	108.6	54.3	40.1	108.6	28.7	57.1	14.1	155.8	66.3	16.9	27.9	46.6	43.4	83.9	71.9	37.2	55.3	94.3	198.6	167.4	77.1	44.2	167.4	126.1	60.8	58.8	50.5	83.0	75.0	59.5	44.3	33.0	43.4	117.1	52.0	42.2	61.1	45.0	75.2	33.7	43.4	221.7	17.2	103.3	88.3	127.3	74.8	133.2	75.5	60.7	84.2	87.9	86.6	84.5	78.1	90.8	78.6	74.9	96.4	87.6	57.4	77.3	102.9	132.3	71.2	86.8	69.6	66.1	71.2	58.7	90.3	57.3	70.6	91.2
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"		380000	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: "	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.3	8.2	70.9	31.6	8.8	8.8	27.2	25.6	19.5	28.2	25.3	23.3	48.0	116.2	5.8	14.3	13.4	46.5	14.0	44.2	71.1	21.7	127.7	20.9	34.1	8.6	112.9	49.3	8.5	4.3	14.1	32.2	29.0	48.1	163.7	25.9	28.7	168.3	104.8	25.8	14.3	85.1	36.4	43.1	16.3	14.7	61.4	55.4	25.9	15.0	11.5	20.8	82.4	16.6	12.7	37.6	15.7	38.4	52.9	29.6	133.0	10.8	82.6	33.0	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43289395-43313512	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 117.0"	"Cell line enhanced"	"Detected in all"		"AF22: 123.5;HBEC3-KT: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			310000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: , HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favourable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	6.0	16.5	13.3	8.1	24.4	4.3	12.8	8.4	38.2	16.9	15.5	16.9	9.5	27.8	6.8	11.5	53.0	4.1	7.5	5.1	19.4	18.8	10.5	117.0	26.9	6.2	10.4	20.7	15.4	8.4	10.8	5.0	6.9	59.3	12.9	14.2	13.0	18.5	7.7	5.0	25.2	17.1	6.3	25.8	4.4	13.4	9.8	8.1	3.3	7.5	58.1	23.3	6.1	21.4	9.3	7.8	6.9	7.7	6.7	7.9	3.3	15.3	7.4	123.5	14.2	7.2	28.7	8.4	2.4	9.7	3.5	7.0	12.8	22.2	16.3	5.5	3.5	12.1	30.7	71.2	3.7	3.4	36.9	6.0	6.8	17.3	11.3	13.1	4.3	15.6	8.6	18.5	7.4	3.6	10.7	44.6	2.9	7.1	11.8	16.0	22.1	3.9	8.5	17.3	18.0	54.7	23.8	10.6	5.1	12.6	6.3	3.7	9.9	17.5	4.3	2.6	13.3	2.8	2.3	6.0	9.1	22.2	2.3	15.8	2.3	5.5	4.0	3.7	5.6	7.4	5.6	9.3	6.2	7.9	7.8	7.5	5.3	7.3	6.9	6.7	7.7	6.5	5.7	3.3	13.3	24.4	8.4	32.1	19.4	18.8	10.4	20.7	59.3	8.1
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119747996-119768905	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 257.0"	"Cell line enriched"	"Detected in some"	16	"RT4: 66.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA027423, HPA027442, CAB032906"	Enhanced		Supported	Mitochondria			820000	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favourable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favourable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	0.3	0.1	0.3	8.7	0.3	0.0	20.6	0.3	0.3	0.3	30.8	0.4	0.3	13.8	0.3	0.3	0.7	0.1	4.4	42.0	0.4	0.0	7.4	257.0	0.8	0.3	0.3	0.3	0.3	1.4	0.0	0.3	0.8	0.7	3.8	19.8	18.9	5.1	0.3	1.4	1.8	12.2	1.9	0.3	0.3	8.1	6.1	0.3	0.4	0.3	0.6	2.1	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	66.2	0.0	0.2	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.3	0.7	0.3
HMGN1	"FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425"	ENSG00000205581	"High mobility group nucleosome binding domain 1"	P05114	21	39342315-39349647	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012260, HPA048694"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB012260: AB_304786, HPA048694: "	"unprognostic (4.49e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.21e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (5.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavourable (8.74e-7)"	"unprognostic (3.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.84e-2)"	"unprognostic (8.98e-3)"	16.8	24.5	18.1	56.3	18.0	37.4	27.0	11.1	21.3	27.3	28.5	14.4	30.6	26.3	21.4	38.9	46.4	21.3	28.2	25.5	17.0	17.5	33.0	30.4	42.3	76.6	15.8	13.6	28.7	44.1	26.9	29.1	30.9	19.1	27.7	28.9	36.4	37.1	27.1	10.1	25.6	32.0	27.4	23.4	41.7	26.0	42.5	15.9	58.5	31.2	24.4	63.1	23.3	26.7	46.9	60.2	55.0	16.5	33.8	43.9	42.2	52.0	12.3	44.0	29.1	8.0	15.6	31.0	27.6	19.6	26.9	24.8	23.0	42.3	115.8	26.4	25.1	11.1	32.2	38.8	35.8	47.5	34.3	89.1	18.3	29.6	20.9	78.7	30.9	17.3	36.7	26.9	33.0	41.3	69.8	20.0	43.0	63.7	77.6	67.0	82.1	25.3	84.6	24.0	45.6	45.1	24.3	41.0	36.1	60.2	35.9	31.3	48.0	78.9	24.5	13.2	13.7	10.3	27.8	24.6	39.1	71.8	18.6	84.8	34.8	14.6	16.5	55.0	30.1	14.0	33.6	46.9	38.6	31.3	45.3	41.6	43.6	38.0	11.0	33.8	12.9	60.2	43.9	42.2	18.1	18.0	11.1	21.3	17.0	17.5	15.8	13.6	19.1	15.9
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472450-26475972	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: "	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavourable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	30.6	34.9	36.0	52.4	32.3	169.1	37.6	30.8	39.1	51.3	43.4	30.3	53.6	30.0	46.1	60.6	44.1	50.1	51.6	37.6	30.5	32.0	35.9	37.1	62.9	100.2	32.7	30.5	64.7	59.4	16.7	52.7	49.6	26.0	48.0	49.9	42.5	58.9	51.9	41.1	33.9	41.3	68.1	40.4	50.0	33.2	29.9	31.1	104.6	48.6	52.5	83.2	43.7	38.7	60.4	81.4	157.4	73.6	38.6	83.4	103.5	82.5	28.7	83.1	34.9	7.7	17.9	32.4	40.9	23.6	80.1	61.8	29.5	77.4	93.0	39.1	33.2	47.7	104.7	40.6	68.2	57.2	74.2	99.8	34.0	28.8	14.5	211.2	58.3	18.8	21.3	43.8	25.9	37.2	78.9	44.7	41.9	60.9	150.6	96.0	69.5	53.3	104.8	130.4	56.9	25.2	22.6	82.9	51.4	122.9	34.6	45.2	56.7	100.2	27.7	40.0	74.7	76.5	68.1	54.6	74.1	103.5	25.7	222.3	79.2	30.3	59.9	157.4	34.2	69.0	32.0	60.4	46.8	41.4	60.9	59.1	51.5	41.7	53.1	38.6	73.6	81.4	83.4	103.5	36.0	32.3	30.8	39.1	30.5	32.0	32.7	30.5	26.0	31.1
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: "	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favourable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	26.6	57.2	53.6	22.9	52.7	18.8	37.2	73.1	84.6	26.1	28.3	22.6	28.4	27.7	29.9	55.4	29.0	66.8	26.4	68.6	53.3	33.4	52.5	44.6	34.4	35.5	70.8	36.1	34.9	27.8	38.7	66.8	35.4	53.0	27.4	23.5	28.0	47.4	30.6	41.8	24.8	22.3	33.0	53.2	27.7	31.0	24.8	63.5	21.9	36.1	37.9	32.8	26.1	25.6	28.0	52.3	7.7	38.3	32.8	29.4	36.4	14.1	12.9	45.2	19.5	18.2	15.0	10.2	9.8	10.6	11.1	16.3	72.1	12.0	0.1	18.3	8.0	9.1	29.3	11.2	10.9	41.7	24.6	49.9	40.4	37.5	11.7	40.8	7.6	18.1	12.5	7.3	4.0	24.6	29.2	40.0	17.9	12.9	18.7	78.8	33.1	32.4	32.1	69.1	14.5	75.9	20.6	18.5	24.8	18.8	21.7	13.8	12.3	68.9	10.7	3.0	13.5	10.7	21.7	34.5	50.8	0.2	1.7	0.1	14.8	7.7	38.3	3.2	29.4	36.2	25.5	28.0	20.6	24.6	44.8	23.2	24.3	29.2	1.8	32.8	33.3	52.3	21.9	36.4	53.6	52.7	73.1	84.6	53.3	33.4	70.8	36.1	53.0	63.5
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113701-81201942	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 44.5;Karpas-707: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favourable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	5.2	11.4	14.7	3.1	15.6	12.5	6.5	6.0	12.0	8.6	10.6	5.1	12.3	10.2	7.7	30.9	9.8	7.5	4.8	5.4	16.1	14.3	16.2	9.9	3.9	2.0	13.2	10.1	9.5	5.6	11.9	39.8	2.0	10.4	7.0	7.9	3.5	5.6	9.3	3.6	5.2	10.8	7.3	22.1	8.2	5.9	48.6	19.6	10.9	8.1	8.6	2.7	7.8	6.0	6.5	11.0	2.8	3.1	3.4	10.2	3.4	0.2	2.2	5.8	28.5	5.0	1.5	1.2	1.6	2.5	0.4	0.7	0.7	10.8	44.5	5.0	0.7	1.9	34.4	4.1	1.0	26.0	13.7	18.6	21.0	0.3	0.5	30.9	18.4	1.2	1.1	1.7	1.7	2.2	24.5	65.6	2.9	1.0	28.1	11.0	25.9	7.5	1.0	24.3	21.0	7.0	0.8	0.2	0.6	0.2	0.6	1.9	3.5	7.3	2.6	0.9	7.6	4.5	6.0	4.6	1.9	7.2	2.7	12.2	1.6	2.0	3.1	1.4	8.5	1.6	7.7	3.6	5.2	4.6	5.3	6.5	10.2	8.7	2.8	3.4	2.5	11.0	1.7	3.4	14.7	15.6	6.0	12.0	16.1	14.3	13.2	10.1	10.4	19.6
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491945	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.5;testis: 16.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol				Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: , HPA043926: , HPA061524: "	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (5.52e-4)"	"prognostic unfavourable (1.93e-7)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	1.6	1.4	0.6	13.4	0.6	11.4	2.4	0.4	0.9	1.7	5.0	0.6	0.6	4.5	0.6	2.3	6.4	0.5	0.9	1.6	0.8	0.7	1.4	1.8	2.5	10.9	1.0	0.4	0.6	1.1	0.6	0.5	6.9	1.1	0.7	5.6	0.4	1.6	0.2	1.4	2.3	4.8	1.4	1.9	8.6	2.6	16.7	0.3	54.5	0.7	5.6	10.8	1.8	2.1	1.2	1.8	0.6	0.7	1.5	4.8	0.8	21.1	13.3	27.1	14.5	1.4	2.6	20.2	20.1	9.8	25.2	22.9	27.0	40.8	35.1	19.2	6.2	24.4	31.3	19.0	43.0	31.8	9.7	21.0	9.5	13.1	0.4	18.6	19.4	0.7	1.1	23.6	18.5	14.3	19.8	28.8	26.2	7.7	19.6	10.6	23.4	14.5	21.4	36.3	17.6	9.8	5.7	22.7	12.6	29.9	9.4	11.4	27.6	14.9	9.3	18.1	15.3	14.4	26.9	15.5	25.9	28.3	11.9	28.8	17.3	0.5	0.7	0.0	0.5	0.3	0.9	1.2	1.0	0.6	0.9	0.9	0.4	0.7	0.6	1.5	0.0	1.8	4.8	0.8	0.6	0.6	0.4	0.9	0.8	0.7	1.0	0.4	1.1	0.3
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"intestine: 24.2;kidney: 17.2;liver: 15.6"	"Group enriched"	"Detected in some"	7	"A549: 6.2;CACO-2: 20.6;Hep G2: 22.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB010430: AB_2116746, HPA035231: "	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	17.3	0.1	0.1	13.7	0.1	1.5	0.1	0.8	5.1	0.1	0.1	0.0	17.2	15.6	0.1	0.1	0.1	0.1	0.2	6.3	0.0	0.1	0.1	0.1	0.1	2.1	0.1	0.1	0.1	0.1	0.0	24.2	0.5	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.5	1.8	0.3	0.3	0.4	0.2	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.2	0.2	0.3	0.2	0.3	0.4	0.4	0.1	0.5	0.4	0.4	1.6	0.3	0.3	0.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686432-37745247	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.7;kidney: 66.2;pancreas: 18.6"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 52.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"					"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.0"	"Group enriched"	"Detected in some"	5	"basal ganglia: 0.7;hypothalamus: 2.3"	"Low region specificity"	"Detected in some"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB068192: , HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favourable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favourable (2.51e-6)"	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.1	4.5	0.0	4.8	3.8	0.9	7.8	0.0	2.8	34.7	0.0	0.0		66.2	7.7	3.7	0.0	0.0	0.0	0.8	18.6	1.6	0.0	0.6	0.0	1.6	3.4	0.0	0.0	3.8	0.0	0.0	5.5	0.3	0.0	0.0	3.7	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.8	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	52.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 65.5;kidney: 30.5;liver: 57.3"	"Group enriched"	"Detected in some"	9	"CACO-2: 51.6;Hep G2: 37.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.2	0.2	13.4	0.2	0.0	0.2	0.2	0.3	0.2	54.0	0.2	0.1	33.0	0.2	6.2	0.2	0.4	15.7	0.2	0.2	0.2	30.5	57.3	0.3	0.1	0.2	0.1	0.3	22.7	0.0	0.2	0.1	0.2	0.2	14.4	0.2	0.2	0.1	0.2	0.2	65.5	0.3	0.2	0.2	7.1	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.4	0.4	0.6	1.2	0.8	0.8	0.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	51.6	2.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.4	0.4	0.4	0.7	0.8	0.8	0.6	0.3	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.1
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566843	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 139.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;CAPAN-2: 17.3;Karpas-707: 4.9;PC-3: 5.3;THP-1: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005438: AB_1850822, HPA010610: "	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.2	0.5	5.0	0.5	0.0	0.3	0.3	0.3	0.6	56.2	0.1	0.3	35.9	0.4	1.1	0.4	0.3	12.6	0.2	0.3	0.3	6.1	12.1	0.4	0.0	0.4	0.2	0.2	10.9	0.0	0.2	0.0	0.3	0.6	6.9	0.2	0.4	0.6	0.2	0.2	139.6	0.2	0.3	0.2	2.6	0.9	0.1	0.1	0.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	4.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.3	17.3	0.0	2.5	0.0	0.0	2.2	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.3	0.3	5.3	0.0	0.0	0.3	3.0	0.1	0.3	1.7	0.4	0.1	0.0	0.3	5.8	0.0	0.4	0.2	0.1	0.0	1.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.3	0.3	0.4	0.2	0.3	0.1
HNRNPA0	"hnRNPA0, HNRPA0"	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754376	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm			110000	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: "	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favourable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	25.6	30.9	18.1	31.8	21.4	40.7	62.9	35.2	43.8	27.0	21.2	11.5	17.2	21.0	38.1	26.3	25.7	29.3	29.5	29.1	15.7	18.0	17.4	18.5	40.4	61.2	16.5	22.5	42.7	34.8	15.1	20.4	30.7	16.6	22.1	17.2	20.0	18.6	20.8	38.1	23.2	23.1	33.4	16.8	24.2	24.3	25.7	13.6	50.1	26.2	22.5	21.6	24.8	24.2	5.2	6.1	8.0	4.4	7.8	7.1	1.5	14.6	14.7	28.6	28.8	14.1	9.0	29.4	11.3	9.4	10.2	11.7	27.4	11.6	26.7	16.4	9.6	13.5	15.4	17.5	12.4	13.4	21.5	17.2	9.4	16.6	13.0	15.8	18.4	14.6	12.4	8.0	9.3	14.0	14.0	17.9	10.2	19.0	29.5	21.2	22.3	10.8	35.4	20.9	13.4	10.0	16.9	36.4	29.6	14.5	10.2	19.1	12.8	18.3	13.6	16.3	13.9	9.0	21.4	18.2	14.6	18.9	10.5	18.3	16.0	4.2	2.4	8.0	5.9	4.1	7.1	4.2	5.6	5.9	4.2	5.2	6.1	6.0	2.6	7.8	4.4	6.1	3.2	1.5	18.1	21.4	35.2	43.8	15.7	18.0	16.5	22.5	16.6	13.6
HNRNPA1	"ALS20, hnRNP-A1, hnRNPA1, HNRPA1"	ENSG00000135486	"Heterogeneous nuclear ribonucleoprotein A1"	P09651	12	54280193-54287088	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001609, HPA001666, HPA005812, HPA007185, CAB010894"	Supported		Enhanced	Nucleoplasm			10000000	Nucleoplasm		"CAB010894: AB_261962, HPA001609: , HPA001666: AB_1850836, HPA005812: , HPA007185: "	"unprognostic (1.38e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.54e-3)"	36.4	33.3	31.7	55.6	37.4	99.5	45.1	48.3	43.0	52.2	38.9	38.4	33.9	35.2	54.1	41.6	41.3	39.5	20.4	31.9	29.7	28.5	40.5	76.2	29.7	51.7	33.1	23.1	123.6	46.1	34.4	36.7	49.9	42.6	35.3	38.7	28.1	33.4	31.5	40.5	37.3	35.6	34.9	40.1	59.5	34.1	69.6	33.3	88.7	42.1	62.0	62.7	37.5	45.8	61.6	72.5	17.9	51.1	86.6	98.1	105.8	83.6	77.1	164.9	130.5	51.0	81.6	89.7	77.2	88.6	85.6	72.6	115.4	92.4	221.1	75.9	53.5	75.6	110.1	110.7	104.1	86.4	83.9	122.8	110.6	198.7	27.1	174.6	80.8	72.6	42.9	56.5	84.4	93.7	135.8	93.3	71.3	108.6	190.0	188.8	173.7	54.7	185.4	131.6	107.7	92.8	126.5	92.6	127.0	57.2	117.9	85.5	73.6	109.5	79.1	63.9	85.8	64.3	98.8	83.7	84.7	148.2	41.9	110.1	55.9	12.0	39.5	17.9	61.9	51.1	96.1	61.6	82.7	72.3	72.5	55.2	98.1	89.4	4.2	86.6	41.3	55.9	70.9	105.8	31.7	37.4	48.3	43.0	29.7	28.5	33.1	23.1	42.6	33.3
HNRNPA2B1	HNRPA2B1	ENSG00000122566	"Heterogeneous nuclear ribonucleoprotein A2/B1"	P22626	7	26189927-26201529	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001666, HPA005812, CAB012403, HPA065537"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"		11000000	Nucleoplasm		"CAB012403: , HPA001666: AB_1850836, HPA005812: , HPA065537: "	"unprognostic (1.19e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.04e-3)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (1.25e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (5.12e-4)"	"prognostic unfavourable (8.01e-5)"	"unprognostic (6.74e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	82.2	97.4	85.1	105.3	106.3	90.9	74.4	123.3	87.4	77.1	85.7	89.4	68.7	87.5	92.6	71.9	90.4	75.1	51.7	87.9	82.4	71.8	113.4	103.7	76.2	127.7	118.6	57.0	121.0	75.7	107.2	121.2	100.7	96.3	75.5	98.6	64.4	71.4	66.5	167.2	58.7	94.8	73.7	139.7	116.5	74.1	73.1	135.4	180.3	81.9	104.4	140.7	74.2	128.8	33.7	46.5	35.1	52.4	32.1	42.5	36.0	122.0	104.2	151.7	113.7	39.0	35.7	70.2	78.3	61.1	86.5	78.4	96.2	88.9	223.1	74.9	72.5	85.2	162.2	102.3	122.0	69.4	98.9	135.2	125.7	115.0	32.8	145.5	92.7	33.7	53.6	82.3	75.1	89.3	159.0	73.0	87.4	98.7	155.7	170.3	134.3	80.3	144.7	123.3	93.5	99.9	106.8	88.6	108.7	94.1	92.7	57.2	103.9	126.8	77.1	48.7	100.8	65.9	133.6	97.0	192.2	212.4	62.7	166.0	91.7	17.4	38.7	35.1	42.5	52.4	38.6	33.7	35.5	36.6	46.5	29.2	35.6	35.6	13.0	32.1	48.4	43.6	36.1	36.0	85.1	106.3	123.3	87.4	82.4	71.8	118.6	57.0	96.3	135.4
HNRNPA3	HNRPA3	ENSG00000170144	"Heterogeneous nuclear ribonucleoprotein A3"	P51991	2	177212563-177223958	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001666, HPA005812, HPA066381"	Supported		Enhanced	Nucleoplasm			1500000	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: , HPA066381: "	"unprognostic (2.85e-2)"	"prognostic favourable (4.87e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.95e-5)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.65e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (9.57e-7)"	"unprognostic (6.95e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-2)"	22.9	17.6	24.7	29.5	28.0	29.8	19.5	22.3	29.3	24.3	24.8	16.1	13.7	18.0	26.5	26.9	33.8	20.8	20.9	16.7	20.8	14.2	23.9	20.3	23.7	29.9	40.4	17.7	35.6	19.3	20.6	20.1	27.0	26.5	19.0	28.7	14.9	20.0	28.4	28.0	23.2	23.5	23.4	35.0	24.8	19.7	22.2	27.3	23.0	30.7	18.4	40.6	20.5	28.2	15.2	26.4	7.4	15.8	15.6	18.7	9.3	62.7	42.4	93.0	47.5	24.6	21.9	71.4	48.1	22.7	37.9	36.1	84.2	32.4	126.6	36.7	37.1	36.2	91.8	60.2	71.4	58.1	56.0	94.3	64.2	166.5	26.5	101.3	58.7	24.5	27.0	56.5	42.1	51.6	67.4	43.6	48.1	84.5	70.6	40.8	50.8	39.9	90.5	79.0	39.6	52.9	124.1	54.5	49.1	71.6	22.3	29.0	32.3	63.7	57.2	48.7	54.3	33.7	69.3	39.7	70.4	108.3	29.0	67.4	31.4	4.9	15.3	7.4	18.7	15.8	15.0	13.9	15.0	16.5	16.4	15.2	13.8	13.9	6.6	15.6	14.9	26.4	17.3	9.3	24.7	28.0	22.3	29.3	20.8	14.2	40.4	17.7	26.5	27.3
HNRNPAB	"ABBP1, FLJ40338, HNRPAB"	ENSG00000197451	"Heterogeneous nuclear ribonucleoprotein A/B"	Q99729	5	178204507-178211163	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046688	Approved		Enhanced	Nucleoplasm			380000	Nucleoplasm		"HPA046688: AB_10964924"	"unprognostic (2.23e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.17e-3)"	"prognostic favourable (9.79e-4)"	"unprognostic (9.12e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavourable (1.35e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.08e-1)"	34.9	41.7	16.5	47.8	18.4	44.6	32.5	17.9	19.1	30.0	54.0	20.4	24.9	37.0	33.9	23.0	50.9	27.3	38.6	44.4	15.4	17.8	50.0	72.4	29.8	36.5	20.6	12.4	39.1	39.1	25.5	20.5	36.7	16.8	26.8	47.1	19.4	31.3	26.7	53.3	43.4	55.0	38.7	18.9	53.5	31.9	26.5	15.9	75.6	34.6	46.3	41.3	38.7	36.8	5.9	11.4	15.1	7.2	5.7	6.6	2.2	45.5	38.0	58.7	56.8	21.7	19.2	84.9	51.4	23.8	41.2	44.4	70.1	34.3	73.9	47.4	27.5	30.2	50.8	69.8	51.1	114.3	59.9	46.5	30.6	42.8	21.8	58.7	39.6	18.9	33.0	36.9	37.2	36.8	37.8	33.8	41.2	122.8	70.7	56.7	53.8	54.8	57.8	35.4	43.7	34.7	49.0	54.1	42.1	40.0	56.0	36.2	33.5	36.0	33.0	50.3	42.5	35.4	70.2	39.7	46.3	86.9	20.3	65.1	40.8	2.8	4.8	15.1	5.5	7.2	6.2	5.9	4.6	6.6	4.6	5.0	4.5	5.3	0.9	5.7	7.1	11.4	4.8	2.2	16.5	18.4	17.9	19.1	15.4	17.8	20.6	12.4	16.8	15.9
HNRNPC	"hnRNPC, HNRPC"	ENSG00000092199	"Heterogeneous nuclear ribonucleoprotein C (C1/C2)"	P07910	14	21209136-21269494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005223, HPA051075, CAB075755, CAB075756"	Supported		Enhanced	Nucleoplasm			1400000	Nucleoplasm		"CAB005223: AB_2117508, CAB075755: , CAB075756: , HPA051075: "	"unprognostic (1.92e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.21e-3)"	"prognostic unfavourable (7.72e-5)"	"unprognostic (8.66e-3)"	"unprognostic (5.96e-3)"	"prognostic favourable (1.19e-4)"	"unprognostic (3.31e-3)"	"unprognostic (5.30e-3)"	"prognostic unfavourable (7.29e-5)"	"unprognostic (7.36e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.28e-3)"	"unprognostic (5.42e-2)"	41.1	53.9	51.8	51.1	64.0	71.6	55.1	72.1	65.5	49.6	41.9	45.3	47.3	35.3	51.0	51.1	53.4	54.3	38.0	41.1	47.9	45.1	50.0	51.9	43.0	76.7	54.8	42.1	72.8	57.8	38.3	63.3	54.7	43.7	45.2	47.8	43.9	36.0	44.5	44.5	39.8	39.5	57.6	54.8	55.8	37.4	62.4	52.4	49.3	53.0	37.9	75.6	45.3	45.9	78.3	104.6	119.0	73.3	64.8	89.1	142.9	92.8	77.7	117.1	66.7	77.8	72.0	82.5	59.3	72.1	100.2	85.5	73.2	70.6	165.1	37.7	74.6	70.2	161.0	100.4	136.7	107.5	85.9	82.8	61.3	109.1	88.5	126.6	69.2	74.6	82.1	73.9	176.6	105.2	127.1	70.5	79.2	89.3	151.0	120.5	121.8	72.4	121.1	93.4	81.3	106.8	84.4	64.9	60.4	72.0	69.6	65.6	65.4	113.7	68.0	36.0	65.1	42.8	85.2	64.0	95.8	161.1	33.6	103.2	70.6	57.8	73.3	71.2	65.9	63.5	86.1	78.3	78.0	70.2	104.6	68.7	89.1	75.0	119.0	64.8	59.7	67.5	80.3	142.9	51.8	64.0	72.1	65.5	47.9	45.1	54.8	42.1	43.7	52.4
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm			550000	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	45.5	40.0	35.4	58.8	46.1	88.0	49.4	49.1	40.6	55.2	49.8	37.2	40.5	45.1	56.2	39.1	55.5	47.9	48.5	40.8	28.4	27.4	36.4	40.6	43.2	72.2	26.5	37.1	64.5	48.9	51.6	38.7	51.9	32.9	44.9	45.8	41.5	52.9	48.6	51.6	49.5	49.9	53.1	27.9	61.4	46.7	30.4	30.7	136.1	41.5	53.7	80.4	58.2	49.9	17.8	21.8	18.0	11.9	12.4	17.5	5.9	59.0	23.4	101.2	32.1	13.4	17.4	47.8	46.5	35.9	53.7	46.3	41.9	52.5	121.0	33.8	31.5	29.3	80.4	34.8	84.4	22.5	41.5	86.7	32.3	56.8	27.3	114.8	44.7	21.3	15.6	43.3	43.9	48.5	95.3	41.9	45.5	22.8	139.8	79.8	84.1	21.8	103.5	102.8	50.2	44.8	36.2	51.1	55.2	45.9	39.9	23.2	29.8	45.8	40.9	41.5	56.7	31.9	59.8	44.5	35.0	140.8	31.9	59.4	47.2	18.0	10.8	10.8	13.2	11.3	14.5	17.8	15.9	16.5	12.3	14.4	17.5	14.5	13.1	12.4	11.9	21.8	17.2	5.9	35.4	46.1	49.1	40.6	28.4	27.4	26.5	37.1	32.9	30.7
HNRNPDL	"HNRPDL, JKTBP, laAUF1"	ENSG00000152795	"Heterogeneous nuclear ribonucleoprotein D like"	O14979	4	82422564-82430408	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056820, HPA063147"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA056820: , HPA063147: "	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.30e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.03e-2)"	60.5	43.9	52.0	58.8	82.9	98.2	58.8	67.6	79.7	50.1	51.9	60.4	42.9	41.8	73.7	57.8	45.3	53.5	42.4	47.7	49.0	44.7	43.0	37.4	52.9	64.4	86.9	74.2	101.7	66.0	43.5	41.0	46.2	79.0	49.8	44.5	31.6	46.4	52.3	89.7	46.0	47.8	60.6	69.4	55.7	51.1	32.8	80.8	48.3	49.0	59.2	51.3	44.9	51.5	27.7	20.3	14.4	31.1	17.6	35.6	19.9	51.8	27.4	102.4	20.2	38.4	21.1	33.7	56.2	61.1	50.1	47.7	37.6	43.0	96.7	35.8	60.9	40.4	77.2	51.9	58.9	21.3	55.9	55.9	44.5	67.6	18.1	95.1	41.8	37.1	15.0	56.0	50.2	39.7	72.6	40.1	48.5	21.6	88.9	66.8	70.2	32.5	79.8	82.8	44.2	58.3	34.0	43.6	75.3	35.0	45.2	33.0	47.3	54.1	33.2	50.6	62.5	33.0	67.0	47.2	45.2	106.5	44.2	55.7	42.5	14.4	15.7	13.2	28.5	25.7	23.3	27.7	25.5	26.0	12.6	26.8	35.6	30.6	6.7	17.6	31.1	20.3	19.4	19.9	52.0	82.9	67.6	79.7	49.0	44.7	86.9	74.2	79.0	80.8
HNRNPF	HNRPF	ENSG00000169813	"Heterogeneous nuclear ribonucleoprotein F"	P52597	10	43385617-43409166	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016884, HPA069667"	Supported		Enhanced	Nucleoplasm			2500000	Nucleoplasm		"HPA016884: AB_1856444, HPA069667: "	"unprognostic (9.93e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (1.51e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.22e-1)"	48.1	34.0	19.9	41.2	34.9	43.3	56.1	23.2	22.3	31.1	44.5	31.6	26.9	41.1	34.9	32.6	50.4	39.2	35.7	26.2	21.7	18.3	42.3	68.3	40.4	55.9	33.7	13.9	54.2	39.7	22.5	28.1	37.5	32.5	35.4	37.8	26.2	36.9	25.0	40.0	40.6	57.5	41.6	27.5	58.7	39.2	66.4	31.2	77.5	40.6	42.3	56.9	46.2	57.4	58.3	59.7	52.0	62.5	63.2	75.8	89.4	46.1	49.2	30.6	46.2	37.5	41.1	44.8	36.2	61.0	51.0	60.3	45.9	64.6	93.1	23.3	39.1	65.6	81.5	59.2	42.0	39.0	48.8	59.3	30.5	59.0	46.3	86.8	60.3	49.9	47.0	39.5	73.1	43.7	59.8	42.3	38.5	72.1	84.8	47.6	23.1	41.5	71.5	28.7	44.2	52.1	71.7	37.7	37.9	36.9	67.8	54.9	75.5	42.5	32.5	23.6	44.7	38.4	57.1	38.1	64.3	56.5	38.2	83.6	22.9	38.5	54.4	52.0	62.3	62.5	75.8	58.3	65.5	68.6	59.7	48.1	55.7	52.5	36.5	63.2	55.5	33.4	72.6	89.4	19.9	34.9	23.2	22.3	21.7	18.3	33.7	13.9	32.5	31.2
HNRNPH1	"hnRNPH, HNRPH1"	ENSG00000169045	"Heterogeneous nuclear ribonucleoprotein H1"	P31943	5	179614178-179634784	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, HPA016884, CAB032820"	Supported		Enhanced	Nucleoplasm			2100000	Nucleoplasm		"CAB032820: AB_2248257, HPA000914: , HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (9.01e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (7.85e-4)"	"prognostic unfavourable (3.29e-7)"	"unprognostic (7.99e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.72e-3)"	40.1	36.2	26.8	86.3	31.0	90.5	45.4	73.4	33.2	55.6	38.2	26.6	54.7	30.2	52.4	44.3	41.7	37.7	45.3	30.3	25.6	23.3	36.5	42.3	37.0	59.8	33.0	30.3	60.1	41.3	24.4	46.1	43.6	28.9	40.8	34.7	34.4	53.5	60.3	51.3	44.3	43.0	61.6	31.3	65.2	34.4	42.5	34.3	113.2	47.5	61.5	62.0	57.3	54.4	26.3	34.7	18.4	27.7	24.3	36.8	13.8	51.0	38.9	61.6	40.3	22.1	12.2	49.9	30.4	15.8	39.8	26.3	52.7	33.9	84.9	27.5	22.1	32.7	57.4	35.8	35.8	71.1	41.2	46.2	64.2	66.2	26.0	60.3	44.5	12.7	26.1	38.8	24.5	21.6	57.9	44.9	23.6	35.0	91.8	56.2	71.4	28.6	81.8	70.1	50.3	20.4	60.8	58.8	50.1	59.0	40.4	53.1	38.4	78.3	35.4	58.3	41.5	26.6	68.7	36.9	79.8	89.0	31.6	57.7	68.1	18.4	18.0	17.5	26.0	27.7	34.3	26.3	27.8	27.9	26.6	22.7	35.5	36.8	3.5	24.3	20.8	34.7	31.7	13.8	26.8	31.0	73.4	33.2	25.6	23.3	33.0	30.3	28.9	34.3
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408295-101414133	"Disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004436: AB_627737, HPA000914: , HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favourable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	49.5	44.2	43.4	34.6	51.9	38.3	42.7	49.1	53.9	37.0	32.2	33.8	33.3	34.1	36.6	39.7	36.7	32.7	28.2	35.9	40.3	42.4	49.8	46.1	34.5	30.1	37.1	46.4	47.8	28.4	77.5	50.0	44.9	48.8	37.9	35.9	25.0	30.4	45.2	54.8	40.0	43.6	39.7	36.7	42.2	30.6	18.9	34.2	44.0	44.1	39.9	39.9	41.7	34.4	16.7	28.8	65.9	32.1	22.1	19.4	22.6	31.2	21.7	42.7	25.6	37.6	32.9	20.4	26.7	37.3	25.3	51.6	18.4	28.0	32.2	27.3	37.4	28.7	48.6	36.9	34.6	31.3	23.8	23.9	52.7	24.8	32.2	29.5	23.4	33.3	34.0	24.9	24.5	34.2	24.1	46.5	38.3	39.9	24.2	26.0	26.9	21.3	23.2	45.5	31.3	54.4	41.7	19.6	35.8	39.8	19.0	30.1	24.2	28.3	37.2	14.1	25.9	40.2	10.9	15.7	22.5	22.7	29.1	34.3	17.5	29.3	29.4	43.2	18.1	32.1	19.4	16.7	17.7	18.2	28.8	15.6	18.7	19.2	65.9	22.1	30.4	12.1	16.3	22.6	43.4	51.9	49.1	53.9	40.3	42.4	37.1	46.4	48.8	34.2
HNRNPH3	"2H9, HNRPH3"	ENSG00000096746	"Heterogeneous nuclear ribonucleoprotein H3"	P31942	10	68331174-68343191	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038264			Supported	Nucleoplasm			560000	Nucleoplasm		"HPA038264: AB_10697246"	"unprognostic (1.72e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (6.17e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-3)"	44.9	41.8	47.1	37.9	53.2	51.3	42.8	57.3	48.1	45.1	39.2	49.8	33.2	33.4	58.2	29.2	38.2	42.4	27.8	40.3	45.0	42.3	42.7	34.4	34.6	43.7	57.3	42.2	71.4	27.0	41.2	61.5	50.4	45.6	53.1	40.4	30.4	28.1	39.7	50.4	38.5	41.9	61.1	81.9	38.0	33.7	40.5	65.3	48.9	60.5	31.6	45.8	55.4	78.7	13.6	17.4	29.0	19.3	17.5	22.7	10.6	41.5	40.4	64.7	20.1	25.4	15.7	41.7	36.7	19.3	34.5	28.6	68.9	36.9	65.9	20.2	24.2	28.0	51.9	35.4	53.4	40.5	27.5	51.1	36.5	41.6	22.3	58.3	28.2	10.3	32.5	39.2	69.9	26.1	63.1	22.9	38.1	57.7	51.5	63.3	42.9	48.0	43.2	54.2	21.4	27.7	34.6	29.2	31.8	39.0	27.0	38.3	28.7	29.8	28.4	31.8	53.8	16.8	49.4	27.9	37.5	67.3	17.8	28.9	25.0	14.7	15.3	29.0	15.0	17.0	15.5	13.2	17.8	17.2	17.4	13.6	22.7	18.6	19.8	17.5	19.3	14.3	15.8	10.6	47.1	53.2	57.3	48.1	45.0	42.3	57.3	42.2	45.6	65.3
HNRNPK	"CSBP, HNRPK, TUNP"	ENSG00000165119	"Heterogeneous nuclear ribonucleoprotein K"	P61978	9	83968083-83980616	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004435, HPA007644, CAB016225, HPA044105"	Supported		Enhanced	Nucleoplasm			5000000	Nucleoplasm		"CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: "	"unprognostic (4.84e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-3)"	"prognostic unfavourable (6.68e-5)"	"unprognostic (3.46e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.82e-1)"	79.0	92.0	70.0	80.7	81.7	146.9	97.2	88.0	104.8	77.9	70.0	68.8	80.9	74.5	96.3	69.0	95.8	79.6	67.5	80.4	68.2	71.5	76.0	90.9	77.7	125.0	80.9	72.9	96.5	102.8	91.4	74.5	92.3	67.3	69.4	75.2	58.6	76.5	104.6	101.4	78.7	76.7	100.9	86.3	96.1	72.5	60.3	78.6	162.5	79.9	80.8	106.9	81.0	77.1	59.7	76.1	92.7	71.0	75.6	73.2	136.4	120.8	83.6	143.7	85.1	69.1	76.5	115.4	85.5	106.3	107.2	100.9	69.9	86.6	143.6	58.9	89.5	93.0	143.6	103.8	130.9	98.7	84.6	100.8	73.3	99.1	91.5	124.8	100.1	77.8	79.4	91.3	121.6	109.1	102.4	73.8	105.4	106.0	154.7	85.6	127.6	81.4	135.3	114.5	95.7	103.8	99.8	93.3	110.7	89.9	96.0	85.2	95.1	106.2	89.2	74.7	88.0	75.6	111.4	77.7	101.7	104.3	71.3	101.2	105.5	77.4	71.0	90.1	53.9	69.2	67.3	59.7	62.5	61.2	76.1	56.8	65.1	59.3	92.7	75.6	65.8	45.2	73.2	136.4	70.0	81.7	88.0	104.8	68.2	71.5	80.9	72.9	67.3	78.6
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836388-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm			130000	Nucleoplasm		"CAB016326: AB_627736, HPA051748: , HPA052661: "	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	44.1	43.3	32.8	47.1	37.1	102.7	40.6	48.9	47.6	38.9	46.2	42.5	35.9	43.7	47.8	34.8	50.1	36.2	42.0	39.7	31.8	31.9	39.9	52.9	43.2	48.0	36.2	32.5	41.6	41.6	36.1	28.1	47.9	34.7	34.6	49.1	35.6	37.5	39.8	44.7	50.7	48.1	49.4	34.3	44.8	38.2	34.9	39.4	102.8	53.0	36.8	67.6	37.9	40.5	3.1	6.2	3.5	3.8	2.2	3.6	1.9	45.7	36.2	46.0	29.6	18.3	21.6	43.5	38.1	26.3	35.4	33.7	38.8	35.2	72.6	31.2	24.4	28.1	56.6	42.7	52.7	55.9	30.8	60.0	23.1	34.5	19.5	55.4	40.7	23.5	20.2	35.7	35.3	39.1	58.1	37.7	36.9	36.2	57.3	34.2	54.1	25.1	74.4	52.6	45.7	39.7	34.4	38.6	35.8	38.2	30.0	15.4	39.4	30.8	34.9	35.5	40.5	31.2	54.7	36.2	48.5	81.8	22.9	49.0	38.7	1.1	2.6	1.7	3.5	3.8	2.7	2.2	2.5	2.1	3.5	3.1	2.7	2.2	3.5	2.2	2.8	6.2	3.6	1.9	32.8	37.1	48.9	47.6	31.8	31.9	36.2	32.5	34.7	39.4
HNRNPM	"CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1"	ENSG00000099783	"Heterogeneous nuclear ribonucleoprotein M"	P52272	19	8444767-8489114	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016113, HPA024344"	Supported		Enhanced	Nucleoplasm			170000	Nucleoplasm		"CAB016113: AB_627739, HPA024344: AB_1850879"	"unprognostic (2.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (1.80e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (6.91e-3)"	"unprognostic (4.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	41.1	38.3	43.2	57.1	44.8	83.6	39.3	66.1	56.7	41.0	45.8	32.8	45.7	42.0	51.5	35.5	54.5	40.7	41.2	38.3	40.4	29.0	38.9	53.9	37.9	55.7	36.4	35.5	56.3	36.0	57.6	42.2	44.8	37.5	37.9	41.1	35.7	40.4	52.4	98.8	43.4	40.8	48.7	39.6	50.1	38.3	41.0	45.4	91.7	41.4	40.0	64.7	37.9	64.3	26.0	32.4	16.5	35.0	30.6	36.6	28.2	61.4	41.8	79.3	31.7	18.2	20.3	50.5	37.1	27.9	46.4	35.3	59.5	18.9	90.9	49.6	33.5	37.9	80.8	46.4	58.4	56.7	66.7	80.6	42.5	56.9	18.9	82.3	43.1	20.9	23.6	39.2	16.4	41.5	80.8	26.1	36.7	41.8	79.0	71.3	68.2	50.9	89.2	68.8	43.0	24.4	59.7	43.6	48.5	62.5	33.7	34.8	40.1	49.1	48.1	40.5	49.0	42.5	69.3	38.4	70.7	105.4	30.3	67.2	43.9	6.9	28.2	16.5	36.0	35.0	36.6	26.0	31.4	35.9	32.2	24.6	34.0	33.0	7.7	30.6	25.7	32.4	31.6	28.2	43.2	44.8	66.1	56.7	40.4	29.0	36.4	35.5	37.5	45.4
HNRNPR	"hnRNP-R, HNRPR"	ENSG00000125944	"Heterogeneous nuclear ribonucleoprotein R"	O43390	1	23303771-23344336	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011687, HPA026092"	Supported		Enhanced	Nucleoplasm			50000	Nucleoplasm		"CAB011687: AB_2295532, HPA026092: AB_1850885"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (2.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.28e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.12e-1)"	27.1	30.4	31.2	36.1	34.7	33.8	31.2	41.0	32.2	32.4	27.4	34.3	29.5	26.5	42.2	23.7	33.2	32.7	20.3	25.6	29.1	27.9	25.1	25.1	28.1	39.6	35.0	27.9	44.3	32.8	40.5	40.9	40.9	27.5	27.3	31.3	26.5	28.1	27.7	31.1	27.8	26.8	41.0	34.1	28.8	24.9	20.3	40.0	68.3	29.9	29.7	40.9	29.0	29.4	21.9	23.6	20.8	23.2	26.1	28.5	19.8	36.1	22.6	46.3	27.3	16.5	16.6	21.8	24.6	25.1	34.7	25.1	15.5	25.1	44.3	12.1	29.9	20.9	47.7	31.9	45.6	30.7	32.4	42.3	29.8	27.8	16.7	52.3	28.5	18.4	19.7	32.5	26.4	25.7	38.0	30.9	26.7	20.8	59.8	15.2	26.1	20.8	42.8	45.2	31.2	23.5	17.7	29.6	30.8	32.2	27.4	19.9	21.9	23.4	26.1	23.3	31.9	28.6	29.1	19.6	29.2	59.7	17.6	44.8	25.4	8.7	18.5	20.8	25.4	22.5	27.7	21.9	24.3	25.2	23.6	20.1	26.3	24.4	6.6	26.1	23.2	13.9	28.5	19.8	31.2	34.7	41.0	32.2	29.1	27.9	35.0	27.9	27.5	40.0
HNRNPU	"C1orf199, FLJ30202, FLJ37978, hnRNPU, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A"	ENSG00000153187	"Heterogeneous nuclear ribonucleoprotein U"	Q00839	1	244840638-244864560	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011532, HPA041057, HPA058707"	Supported		Enhanced	Nucleoplasm			840000	Nucleoplasm		"CAB011532: AB_732983, HPA041057: , HPA058707: "	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (8.88e-5)"	"unprognostic (2.26e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.87e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.62e-1)"	55.6	57.5	55.3	55.3	68.1	87.3	60.9	80.2	61.7	53.4	47.9	57.7	49.6	38.9	61.4	74.9	53.3	55.9	48.0	47.4	53.3	51.5	68.5	61.2	45.1	52.2	60.5	51.8	76.0	51.7	85.9	48.6	55.4	47.2	56.5	51.1	43.9	49.0	54.3	69.7	43.9	50.3	58.0	55.4	62.3	49.4	47.8	64.5	121.5	61.7	41.5	64.3	57.5	97.9	17.3	25.1	17.0	11.7	15.1	21.7	7.3	47.2	38.0	50.5	39.6	26.5	22.9	49.6	33.9	21.9	31.2	27.8	36.4	31.5	74.7	31.7	28.6	37.2	67.6	38.4	49.5	31.4	45.3	64.4	33.7	55.4	27.9	73.6	39.2	25.8	23.2	33.9	36.0	31.8	83.8	27.8	41.9	33.8	78.3	76.6	87.6	34.6	78.6	63.0	40.6	50.1	34.8	42.3	41.6	53.3	35.3	40.9	48.6	83.1	38.3	31.2	46.0	33.2	59.7	45.9	50.0	72.9	25.6	63.2	44.6	14.1	11.7	15.5	15.3	10.1	16.2	17.3	18.6	18.4	12.4	17.0	21.7	18.3	17.0	15.1	11.0	25.1	15.8	7.3	55.3	68.1	80.2	50.4	53.3	51.5	60.5	51.8	47.2	64.5
HNRNPUL1	"E1B-AP5, E1BAP5, FLJ12944, HNRPUL1"	ENSG00000105323	"Heterogeneous nuclear ribonucleoprotein U like 1"	Q9BUJ2	19	41262496-41307598	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046290, CAB046477, HPA049475"	Enhanced		Enhanced	Nucleoplasm			20000	Nucleoplasm		"CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783"	"unprognostic (5.52e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.39e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.39e-1)"	44.8	37.1	31.0	40.7	32.2	72.3	40.4	35.9	40.3	48.9	48.0	47.3	38.1	38.6	50.3	33.3	43.6	41.4	43.6	52.9	28.9	24.6	29.1	28.4	39.0	45.5	30.8	26.7	58.8	44.9	34.3	33.7	27.9	28.8	38.3	35.8	40.8	45.4	44.7	50.9	48.4	40.1	55.5	29.7	41.2	39.6	54.3	34.5	85.2	39.6	45.9	50.2	52.7	44.1	9.4	13.0	13.2	6.7	11.5	19.3	4.8	57.5	76.5	45.5	41.9	22.5	26.8	17.4	35.1	40.3	43.8	40.1	44.5	44.3	51.6	24.0	42.0	18.9	42.9	39.6	49.7	50.4	37.3	57.0	35.4	34.6	26.2	53.2	52.9	28.6	25.0	39.0	36.3	40.6	40.7	48.9	38.7	43.9	67.6	31.3	34.7	28.0	44.1	36.9	28.6	32.1	60.9	36.3	33.2	77.5	44.6	20.0	34.2	59.2	40.3	49.3	48.0	22.4	65.0	57.5	37.0	48.5	31.3	43.3	64.9	9.0	5.9	9.4	12.3	6.2	19.3	8.6	14.9	12.6	6.7	9.4	10.1	8.0	13.2	11.5	6.7	13.0	9.8	4.8	31.0	32.2	35.9	40.3	28.9	24.6	30.8	26.7	28.8	34.5
HNRNPUL2	"DKFZp762N1910, HNRPUL2"	ENSG00000214753	"Heterogeneous nuclear ribonucleoprotein U like 2"	Q1KMD3	11	62712630-62727349	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041632, HPA056696, HPA067699"	Supported		Enhanced	Nucleoplasm			23000	Nucleoplasm		"HPA041632: AB_10960896, HPA056696: , HPA067699: "	"unprognostic (3.06e-3)"	"unprognostic (2.31e-1)"	"unprognostic (7.48e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.45e-2)"	26.6	17.3	35.3	24.5	42.1	22.1	25.8	52.1	42.3	28.1	32.2	23.5	22.9	26.8	27.6	37.0	28.5	23.7	27.2	23.7	31.9	29.6	24.2	19.5	24.0	30.1	32.8	35.2	26.3	25.3	33.1	19.5	26.9	27.7	26.3	27.8	21.6	28.0	31.2	38.8	35.1	28.6	34.2	26.7	29.5	24.0	17.1	28.4	36.6	20.8	14.8	34.6	26.6	31.3	4.0	5.0	4.4	3.8	2.6	5.1	1.7	35.5	17.0	28.6	17.2	16.2	19.9	4.8	23.0	14.2	18.4	14.3	11.7	12.5	42.0	11.8	19.6	20.1	17.8	22.7	24.8	17.7	9.2	39.4	22.0	13.1	14.4	41.3	26.5	15.3	17.9	17.4	21.8	22.4	14.9	16.0	21.1	21.4	40.9	37.5	13.4	13.7	28.9	26.2	20.0	23.0	22.4	17.0	18.9	23.8	20.2	24.2	14.8	18.0	24.3	21.4	9.4	26.5	24.2	20.1	16.7	41.6	19.2	19.9	19.5	3.2	2.9	4.4	5.1	1.9	3.7	3.4	3.7	4.3	1.7	4.0	2.9	3.6	3.8	2.6	3.8	5.0	3.3	1.7	35.3	42.1	52.1	42.3	31.9	29.6	32.8	35.2	27.7	28.4
HOMER2	"CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2"	ENSG00000103942	"Homer scaffolding protein 2"	Q9NSB8	15	82836946-82986153	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 80.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 21.1;Karpas-707: 37.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040134, CAB079014"	Uncertain	Supported	Supported	Cytosol				Cytosol		"CAB079014: , HPA040134: AB_10795272"	"unprognostic (7.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.75e-4)"	"unprognostic (3.31e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.16e-4)"	"unprognostic (2.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.45e-3)"	0.7	2.9	3.9	0.5	3.8	1.6	9.9	5.1	6.5	8.9	1.4	4.6	2.7	3.2	3.4	13.0	8.0	9.6	12.9	12.5	5.0	3.1	2.8	19.4	2.5	1.0	2.5	4.2	1.7	80.9	2.7	4.5	0.4	13.2	21.8	0.6	12.7	34.5	2.0	36.0	15.9	0.6	0.7	5.4	2.3	17.8	2.3	2.0	0.2	13.4	14.2	5.0	0.8	4.3	1.4	4.1	1.6	0.6	0.4	1.1	1.0	6.4	2.7	2.9	7.6	0.0	0.0	0.4	0.4	0.0	0.7	0.2	0.5	4.6	0.0	3.6	3.3	3.6	21.1	9.9	0.5	17.5	13.4	4.1	0.1	3.2	0.2	0.1	13.3	0.7	15.2	0.2	0.8	0.0	0.1	37.4	2.8	18.8	1.2	0.4	4.6	2.0	0.8	4.6	2.2	10.2	7.9	20.7	5.3	7.4	5.7	6.9	6.9	1.4	0.1	7.0	13.0	0.5	5.9	4.8	2.2	0.7	11.9	0.1	2.5	0.3	0.6	1.5	0.4	0.5	0.3	0.7	0.8	0.2	4.1	1.4	0.6	0.4	1.6	0.4	0.3	1.8	1.1	1.0	3.9	3.8	5.1	6.5	5.0	3.1	2.5	4.2	13.2	2.0
HOMER3	HOMER-3	ENSG00000051128	"Homer scaffolding protein 3"	Q9NSC5	19	18929201-18941261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 61.2;THP-1: 73.6;U-266/84: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 14.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.1;monocytes: 14.7"	"Region enriched"	"Detected in many"	6	"cerebellum: 212.2"	"Low region specificity"	"Detected in all"			"CAB032656, HPA040999, CAB079015"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"				Cytosol	"Plasma membrane, Cytoplasmic bodies"	"CAB032656: AB_2120801, CAB079015: , HPA040999: "	"unprognostic (3.41e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (4.24e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (4.93e-5)"	"unprognostic (1.07e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	11.4	8.3	11.1	6.5	16.0	12.4	31.0	42.3	12.2	8.7	6.7	17.6	2.1	4.9	8.2	5.2	7.6	4.8	10.9	11.9	15.8	9.0	21.2	4.1	7.0	5.5	19.4	7.2	8.2	5.3	13.6	2.4	9.7	15.5	8.1	4.5	15.4	8.4	7.0	49.2	10.9	5.5	7.6	24.2	64.8	6.5	3.4	14.6	2.2	19.6	7.8	3.3	12.3	16.8	2.4	1.2	5.1	14.7	0.0	0.7	3.6	19.3	5.0	9.6	7.9	8.9	9.0	4.7	19.2	17.0	19.3	9.8	2.5	7.4	0.1	9.1	21.5	12.1	3.3	24.9	10.8	0.6	2.0	0.0	1.6	4.7	8.3	3.7	0.3	7.3	16.1	10.7	14.5	23.4	0.5	5.1	14.0	5.2	0.3	61.2	4.9	20.7	9.5	2.9	9.0	6.9	5.0	0.0	8.1	4.7	5.6	13.5	2.5	73.6	18.6	17.2	7.7	20.7	23.0	49.9	63.2	16.1	27.1	47.3	12.4	0.1	14.7	2.6	0.1	5.1	0.0	2.4	0.7	0.3	1.2	1.7	0.1	0.0	5.1	0.0	1.4	0.2	0.7	3.6	11.1	16.0	42.3	12.2	15.8	9.0	19.4	7.2	15.5	14.6
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favourable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (3.23e-1)"	7.6	8.3	6.6	7.2	6.8	1.7	9.2	4.6	6.6	9.3	8.5	12.1	18.5	8.1	8.4	11.2	14.4	9.1	12.7	8.9	6.4	5.1	11.6	8.8	7.2	6.4	6.5	5.4	12.5	11.0	8.0	7.0	6.6	7.2	11.1	7.6	12.2	13.6	22.0	12.0	9.1	8.4	8.6	7.6	8.1	9.9	39.9	7.4	16.0	14.7	6.3	11.3	12.9	8.3	4.3	7.4	10.8	7.2	3.6	6.3	3.9	4.3	4.5	8.6	8.3	13.5	5.9	9.6	4.9	6.2	4.6	5.7	1.9	9.6	9.6	3.9	4.4	14.8	11.5	11.8	5.7	5.2	3.9	3.3	3.6	8.9	16.9	4.8	2.9	9.3	12.1	3.4	7.8	8.7	9.3	4.0	8.0	9.9	3.7	3.4	3.4	2.6	5.8	6.5	4.2	8.7	18.5	2.8	3.5	4.5	13.1	5.1	7.9	6.0	9.2	3.2	1.4	3.9	2.1	16.2	6.9	3.3	1.7	3.6	4.7	4.1	7.2	10.8	5.7	7.1	4.6	4.3	4.9	4.8	7.4	3.9	5.4	6.3	1.4	3.6	4.9	4.7	6.2	3.9	6.6	6.8	4.6	6.6	6.4	5.1	6.5	5.4	7.2	7.4
HOOK2	HK2	ENSG00000095066	"Hook microtubule tethering protein 2"	Q96ED9	19	12763003-12872740	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4;RT4: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043519, HPA050351"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA043519: , HPA050351: "	"unprognostic (4.26e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (7.59e-5)"	"prognostic favourable (3.28e-4)"	"unprognostic (3.27e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-2)"	18.6	6.6	14.9	5.7	13.5	1.9	15.5	21.9	17.5	8.5	14.5	4.2	32.7	25.5	8.0	24.9	18.5	8.9	16.8	15.5	12.2	6.9	16.0	15.0	8.1	4.1	10.2	8.4	8.7	31.9	28.4	49.1	11.3	12.9	17.3	12.2	6.6	22.9	35.9	29.8	26.4	27.1	5.3	10.8	6.0	18.1	7.4	12.1	3.5	33.5	15.8	11.4	10.1	12.0	3.9	3.7	2.2	2.7	2.6	6.8	2.4	15.3	3.8	4.7	3.2	5.0	4.8	16.6	4.6	2.2	2.6	3.4	12.8	18.3	2.8	8.7	4.6	20.4	4.8	14.0	2.7	8.8	3.4	3.0	7.1	4.3	2.9	1.5	4.8	5.8	13.4	3.7	5.4	1.5	5.0	2.5	5.3	34.4	1.6	2.9	2.2	4.0	5.1	2.8	7.0	5.5	39.8	12.5	6.0	3.3	10.4	3.1	15.1	4.0	3.1	6.0	3.5	8.8	1.7	9.7	9.5	1.8	5.6	5.8	3.9	0.8	1.6	0.0	3.4	2.7	2.1	3.9	4.0	1.5	3.7	3.1	6.8	4.4	2.2	2.6	1.6	1.3	1.0	2.4	14.9	13.5	21.9	17.5	12.2	6.9	10.2	8.4	12.9	12.1
HOOK3	HK3	ENSG00000168172	"Hook microtubule tethering protein 3"	Q86VS8	8	42896932-43030539	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024756	Approved		Supported	"Golgi apparatus,Centriolar satellite,Cytosol"				"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA024756: AB_1850913"	"unprognostic (1.84e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.73e-1)"	"unprognostic (8.61e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.13e-1)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.12e-2)"	15.5	9.3	11.3	10.1	15.1	13.1	16.3	16.0	19.2	13.5	11.3	10.3	14.1	10.2	13.7	12.0	14.8	11.7	20.0	9.5	11.2	11.3	9.9	10.7	14.6	10.3	14.7	11.7	13.4	13.9	13.4	14.4	12.0	13.1	17.7	10.9	6.8	17.1	15.2	24.1	11.0	11.9	19.3	17.5	11.6	12.8	14.5	14.3	7.4	37.5	8.9	10.1	19.2	17.6	1.8	3.8	10.2	3.2	2.0	2.0	1.8	7.3	7.3	17.8	9.6	13.2	11.7	6.8	9.3	7.8	7.8	7.3	9.6	8.6	9.1	9.6	12.4	4.1	14.7	6.3	12.7	6.2	4.2	17.2	6.0	6.6	7.4	1.8	10.2	9.5	4.6	10.5	9.1	11.2	9.4	10.7	9.4	1.8	13.9	3.4	6.4	2.2	8.2	18.6	2.3	5.8	10.9	4.5	7.2	10.6	4.5	4.9	8.2	6.2	20.0	11.7	9.2	14.1	5.9	10.6	11.5	12.0	9.9	6.6	17.3	10.2	3.2	3.1	2.0	3.2	0.8	1.6	1.9	1.5	3.8	1.8	1.1	1.5	3.8	2.0	3.1	2.4	1.4	1.8	11.3	15.1	16.0	13.1	11.2	11.3	14.7	11.7	13.1	14.3
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170591-27180261	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 48.2;endometrium 1: 45.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 54.8;THP-1: 28.8;U-937: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 7.8;NK-cell: 12.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;NK-cells: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB019384	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB019384: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	5.9	2.7	0.3	4.6	0.4	1.2	2.5	0.3	0.3	48.2	15.9	0.3	4.0	0.0	45.6	5.4	0.3	3.4	0.5	0.3	0.3	0.0	7.9	0.3	0.3	0.5	0.3	0.3	1.3	0.3	0.0	0.3	7.7	0.3	22.2	5.3	0.3	0.6	6.6	28.0	2.4	3.1	19.2	0.4	0.3	0.0	3.4	0.3	2.2	0.3	0.3	0.3	19.0	7.6	0.2	1.2	7.8	0.1	12.7	2.3	0.3	6.0	1.3	0.0	18.3	9.3	8.9	0.0	12.1	8.3	5.6	5.2	1.8	5.4	0.0	3.4	9.5	6.8	4.7	0.0	4.1	2.8	54.8	6.4	4.7	0.1	0.2	2.8	9.7	5.6	0.3	0.4	0.0	8.4	0.2	0.0	4.0	0.0	0.0	18.6	0.0	5.7	0.5	1.2	0.0	10.7	2.9	14.5	0.0	4.2	0.0	0.0	0.0	28.8	0.0	0.0	5.0	6.5	0.0	0.1	0.0	0.0	0.0	29.9	0.1	7.8	0.1	0.3	2.3	0.0	0.0	0.1	0.0	0.2	1.2	0.2	0.0	0.0	0.0	12.7	0.0	0.4	0.0	0.3	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181510-27185223	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.5;HEK 293: 24.6;THP-1: 17.6;U-937: 22.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA006770: , HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	1.5	0.4	0.0	1.7	0.0	0.0	2.0	0.0	0.0	35.7	9.3	0.0	5.7	0.0	60.9	8.8	0.0	0.7	0.0	0.2	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	9.0	0.0	16.5	2.4	0.0	0.1	6.3	4.9	0.7	0.2	27.3	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	20.1	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.1	0.0	6.7	8.2	5.8	0.0	14.5	17.5	10.3	7.4	0.1	0.8	0.0	3.3	12.2	1.6	8.6	0.0	7.5	0.8	24.6	3.0	6.0	0.3	0.5	6.1	0.8	3.7	0.3	0.0	0.0	7.4	0.1	0.0	1.1	0.1	0.0	4.7	0.0	7.2	0.3	0.0	0.1	4.9	4.2	3.2	0.0	3.5	0.0	1.0	0.6	17.6	0.0	0.1	7.1	1.6	0.7	0.0	0.0	0.0	0.1	22.9	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200106	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 48.5;prostate: 25.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.2;HEK 293: 21.1;PC-3: 10.5;RT4: 23.5;THP-1: 10.0;U-937: 11.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA069061			Supported	"Nucleoplasm,Intermediate filaments"				Nucleoplasm	"Intermediate filaments"	"HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	48.5	6.9	0.0	7.1	0.0	5.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	16.5	0.0	25.1	8.6	0.0	0.1	17.9	1.2	0.4	0.1	15.7	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	12.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	1.4	0.1	0.0	0.0	7.4	8.2	2.9	1.9	1.5	0.1	0.0	0.9	3.5	0.0	15.2	0.0	2.5	0.0	21.1	1.0	4.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	10.5	1.5	0.3	0.0	0.0	23.5	0.4	0.0	1.8	0.0	0.1	0.0	10.0	0.0	0.2	2.7	0.1	0.1	0.0	0.0	0.0	0.0	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HOXA3	"HOX1, HOX1E"	ENSG00000105997	"Homeobox A3"	O43365	7	27106184-27152581	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.6;CACO-2: 12.1;CAPAN-2: 32.2;HEK 293: 14.4;WM-115: 17.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"pons and medulla: 6.6"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	31	"pons and medulla: 2.9"	"Region enriched"	"Detected in single"	55	"pons and medulla: 5.0"	HPA029157	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA029157: AB_10601020"	"unprognostic (1.32e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.61e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavourable (2.52e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.82e-2)"	5.3	2.6	0.5	11.0	0.5	0.0	8.9	0.5	0.5	3.9	13.7	0.7	9.8	3.9	7.5	7.2	6.9	16.0	4.7	4.7	0.5	0.0	9.9	1.5	5.2	3.5	1.3	0.5	5.5	0.6	5.4	0.5	0.5	6.6	5.6	4.9	0.5	0.5	4.2	7.2	3.8	7.8	3.6	4.7	2.5	6.3	2.7	0.5	6.7	2.5	9.8	2.7	9.4	6.0	0.5	1.3	3.8	1.1	1.3	0.5	0.3	5.5	6.6	0.0	18.6	0.0	0.0	0.0	0.2	0.1	0.0	0.1	12.1	32.2	0.9	9.3	0.5	7.6	0.3	0.8	0.0	0.2	14.4	0.2	0.1	9.6	0.6	0.3	0.3	1.2	0.0	1.5	1.8	1.7	0.6	0.1	0.7	0.2	0.0	0.4	0.0	4.2	6.6	2.1	0.0	5.5	2.6	2.8	0.0	1.0	0.0	2.7	0.5	0.3	7.9	0.0	1.0	1.9	1.5	0.0	0.0	0.3	0.6	1.2	17.2	1.7	0.2	0.7	0.5	0.2	0.0	0.5	0.3	0.5	1.3	0.1	0.0	0.3	3.8	1.3	1.1	0.1	0.5	0.3	0.5	0.5	0.5	0.5	0.5	0.0	1.3	0.5	6.6	0.5
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130799	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.7;HEK 293: 14.3;REH: 13.1;WM-115: 18.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	18	"pons and medulla: 26.7"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	47	"pons and medulla: 11.9"	"Region enriched"	"Detected in single"	60	"pons and medulla: 24.6"	HPA060088	Approved		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA060088: "	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	8.9	6.2	0.4	2.2	0.3	0.2	11.6	0.3	1.2	2.7	7.5	0.4	8.2	3.5	3.9	10.3	27.5	18.1	5.7	4.8	0.3	0.0	9.6	2.0	10.5	3.0	1.4	0.3	8.8	1.1	17.6	0.3	0.5	26.7	4.1	1.7	0.3	0.7	5.6	29.8	3.5	5.2	4.9	25.8	5.5	9.3	1.6	0.4	0.3	2.3	3.4	1.2	5.5	10.9	0.9	1.4	0.1	0.5	0.1	0.3	0.2	5.8	2.0	0.0	18.7	0.0	0.0	1.2	0.5	0.6	1.9	2.0	3.7	1.2	1.5	0.1	1.8	2.5	0.7	0.3	1.5	0.0	14.3	0.0	0.6	8.5	2.2	2.0	3.5	2.1	1.6	6.6	0.5	6.6	0.0	0.0	6.4	1.6	0.0	7.0	0.0	4.6	13.1	2.9	0.1	9.4	1.4	0.9	0.0	1.8	0.0	6.9	0.4	1.0	8.6	0.0	3.0	4.9	0.1	0.0	0.0	0.7	4.0	3.2	18.7	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.5	1.4	0.0	0.2	0.4	0.3	0.3	1.2	0.3	0.0	1.4	0.3	26.7	0.4
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.4"	"Group enriched"	"Detected in some"	9	"AN3-CA: 28.6;HEK 293: 39.0"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 5.9;NK-cell: 2.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.9;NK-cells: 2.0"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.5"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favourable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.2	2.9	0.0	1.2	0.0	0.0	2.3	0.0	0.0	1.6	5.4			0.0	6.7	4.6	0.1	10.4	0.0	0.0	0.0	0.0	5.9	0.0	2.3	0.8	0.0		0.0	0.0	0.5	0.0	0.0		2.5	1.5		0.0	2.2	1.0	3.2	4.2	1.4	1.0	0.0	1.2	0.0			0.0		0.0	4.3	1.3	0.1	0.5	5.9	0.1	2.0	0.2	0.0	0.5	0.9	0.0	28.6	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.6	3.3	0.6	1.0	0.2	1.3	0.7	0.0	0.0	0.8	39.0	0.4	0.5	0.3	0.0	0.6	1.0	2.3	0.0	0.0	0.3	1.3	0.2	0.0	0.3	0.3	0.0	0.1	0.0	1.0	3.7	0.0	0.0	2.8	1.8	3.0	0.0	1.3	0.1	0.6	0.3	0.3	0.0	0.0	0.4	1.5	1.0	0.0	0.0	0.6	0.0	2.8	2.8	5.9	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0										
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.8"	"Cell line enhanced"	"Detected in many"		"HAP1: 19.4;RPTEC TERT1: 24.0;SCLC-21H: 19.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"pons and medulla: 9.2"	"Cell type enriched"	"Detected in some"	5	"NK-cell: 7.7"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 7.7"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	10	"pons and medulla: 2.9"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA074048: "	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	6.5	14.5	0.2	4.8	0.2	0.0	11.2	0.3	0.6	7.3	10.0	0.2	7.9	0.0	5.0	15.4	3.0	12.2	0.5	0.2	0.2	0.0	25.4	0.4	2.6	3.5	0.2	0.2	6.2	0.2	0.3	0.2	1.3	9.2	8.2	7.2	0.2	0.2	8.9	27.8	8.2	6.1	8.1	14.3	3.7	3.2	2.7	0.2	1.6	0.9	0.2	1.1	11.4	6.7	0.2	0.9	0.0	0.0	7.7	1.6	0.2	6.8	2.4	0.0	7.4	0.0	0.0	0.4	2.4	4.2	5.1	5.9	3.6	2.7	4.7	6.8	1.9	4.8	19.4	0.0	3.1	0.0	12.2	0.3	2.7	0.1	0.5	0.4	0.2	4.1	0.2	0.6	6.9	9.7	0.0	0.0	1.9	1.2	0.0	1.0	0.2	0.7	2.4	4.5	0.0	24.0	4.7	19.4	0.0	13.3	0.0	0.0	0.2	1.9	0.8	0.0	4.6	13.8	2.3	0.0	0.1	0.1	0.0	9.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	7.7	0.0	0.6	0.4	0.2	0.2	0.2	0.3	0.6	0.2	0.0	0.2	0.2	9.2	0.2
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162435-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 35.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 42.7;PC-3: 14.9;RPTEC TERT1: 14.7;SCLC-21H: 39.7;U-937: 14.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7"									HPA061982	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA061982: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	3.2	3.4	0.2	8.8	0.1	2.4	8.7	0.1	0.2	15.5	12.8	0.2	4.1	0.0	10.4	16.8	1.4	12.2	0.3	0.1	0.1	0.0	35.1	0.1	0.8	0.7	0.1	0.1	2.0	0.1	0.0	0.1	1.4	0.4	16.6	4.5	0.2	0.5	5.6	21.0	13.3	8.2	13.1	0.7	1.0	0.0	2.4	0.1	2.6	0.3	0.3	0.3	16.2	11.4	0.5	6.0	5.4	1.0	11.7	1.5	0.5	12.4	0.0	0.0	6.3	2.1	1.6	0.0	5.0	4.0	0.4	0.4	0.8	0.5	0.1	0.5	2.7	11.7	8.1	0.0	0.4	0.0	42.7	0.1	0.3	0.0	0.2	0.0	0.1	2.1	0.0	0.0	0.0	10.5	0.0	0.0	0.4	0.0	0.0	0.3	0.0	14.9	2.7	0.0	0.0	14.7	0.2	39.7	0.0	5.3	0.0	0.1	0.0	10.5	0.4	0.0	4.0	4.8	0.0	0.0	0.0	0.0	0.0	14.2	0.0	5.4	1.0	0.0	1.5	0.2	0.2	0.2	0.0	0.1	6.0	0.5	0.3	0.1	0.9	11.7	0.4	1.9	0.2	0.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.4	0.1
HOXB13		ENSG00000159184	"Homeobox B13"	Q92826	17	48724763-48729178	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 18.6;prostate: 38.3"	"Cell line enriched"	"Detected in some"	13	"PC-3: 57.6"	"Cancer enriched"	"Detected in many"	17	"prostate cancer: 187.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004438, HPA062852, HPA065019"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.73e-11)"	"unprognostic (1.39e-2)"	"unprognostic (4.50e-2)"		"unprognostic (1.12e-1)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	2.4	10.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.4	0.1	38.3	18.6	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	3.6	2.4	0.1	0.2	1.3	0.1	0.1	0.1	0.0	0.6	2.0	0.0	4.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.8	1.0	0.0	1.0	0.0	0.0	2.9	0.0	0.0	0.3	1.4	0.9	0.6	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.0	57.6	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.4	0.0	0.2	0.0	0.2	1.7	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
HOXB2	"HOX2, HOX2H"	ENSG00000173917	"Homeobox B2"	P14652	17	48540894-48544989	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 53.1"	"Cell line enhanced"	"Detected in many"		"AF22: 20.6;EFO-21: 19.9;HEK 293: 22.5;HMC-1: 45.0;WM-115: 19.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	6	"pons and medulla: 12.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	34	"pons and medulla: 4.7"	"Region enriched"	"Detected in single"	31	"pons and medulla: 5.4"	HPA047857			Supported	Nucleoplasm				Nucleoplasm		"HPA047857: "	"unprognostic (8.58e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.89e-1)"	9.2	11.0	0.2	6.3	0.3	1.9	24.2	0.3	0.2	14.5	15.4	0.4	53.1	2.4	6.9	32.5	19.3	12.2	12.8	4.5	0.5	0.1	25.6	2.8	6.4	4.4	2.0	0.3	6.4	1.6	8.9	0.9	1.7	12.9	8.2	1.7	0.8	0.6	33.2	6.1	3.7	6.4	7.5	19.4	6.8	6.7	2.7	0.2	2.4	3.0	3.9	2.6	7.9	16.3	0.8	6.0	5.0	0.4	2.2	9.5	1.3	0.0	0.7	20.6	0.0	4.7	5.5	0.0	1.8	0.0	0.0	0.0	0.2	0.1	0.0	19.9	5.6	0.0	3.1	0.0	0.0	0.1	22.5	7.8	0.8	0.0	8.3	0.0	45.0	3.4	0.0	8.9	3.5	3.2	15.2	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	14.7	1.8	0.0	0.0	1.5	0.0	11.8	10.7	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	8.0	0.0	19.7	5.0	0.4	0.0	4.2	0.4	1.3	0.2	6.2	4.7	1.9	0.8	9.5	3.9	0.0	2.2	0.3	6.0	7.3	1.3	0.2	0.3	0.3	0.2	0.5	0.1	2.0	0.3	12.9	0.2
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.2;EFO-21: 17.7;HEK 293: 21.4;RPTEC TERT1: 16.6;U-251 MG: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	40	"pons and medulla: 9.3"	"Region enriched"	"Detected in single"	29	"pons and medulla: 12.9"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB009860: AB_2119262, HPA064990: "	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (8.45e-6)"	8.3	4.5	1.0	7.3	1.1	0.2	8.0	1.0	1.0	11.3	16.4	1.0	56.7	2.3	10.1	44.9	5.5	17.7	3.6	1.7	1.0	0.0	16.3	1.6	4.8	1.6	1.0	1.0	2.8	1.7	6.7	1.0	3.8	2.6	4.1	4.9	1.0	1.0	68.4	4.0	2.9	11.3	3.5	4.8	6.5	7.8	3.7	1.0	1.0	1.8	1.0	1.1	6.4	5.2	0.1	2.8	1.7	0.9	1.4	1.1	0.4	3.2	6.8	4.6	2.1	3.8	5.4	1.2	0.1	0.0	0.1	0.1	3.2	20.2	1.6	17.7	14.5	0.1	0.9	0.3	0.0	5.2	21.4	5.0	3.0	0.0	6.3	0.0	13.3	6.2	0.0	6.0	0.4	6.3	6.8	0.1	3.7	0.1	0.3	0.1	0.1	0.7	0.0	3.3	0.6	16.6	3.0	0.0	0.0	0.7	0.0	3.3	6.5	1.4	7.0	2.2	7.0	1.2	19.1	1.7	2.0	0.1	4.5	0.0	3.7	1.7	0.1	0.0	0.9	0.1	0.4	0.0	0.5	1.1	0.3	0.1	0.8	1.0	0.0	1.4	0.9	2.8	1.1	0.4	1.0	1.1	1.0	1.0	1.0	0.0	1.0	1.0	2.6	1.0
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575513-48580111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 13.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 23.0;HEK 293: 11.1;HMC-1: 14.1;K-562: 11.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	36	"pons and medulla: 3.7"	"Region enriched"	"Detected in single"	61	"pons and medulla: 7.5"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA057432: "	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	4.4	2.4	0.0	1.5	0.0	0.0	2.9	0.0	0.0	4.2	8.1			1.2	2.3	13.3	2.7	8.5	1.5	0.4	0.0	0.0	5.7	0.7	3.6	0.6	0.0		0.0	0.7	1.8	0.0	1.0		0.6	1.1		0.0	4.8	0.8	0.9	4.3	2.0	2.4	3.0	3.9	0.5			0.6		0.2	1.3	1.7	0.3	2.4	0.0	0.1	0.6	0.7	0.1	0.1	0.3	0.0	0.1	4.8	3.8	1.8	0.0	0.0	0.2	0.1	2.1	1.9	3.1	23.0	1.4	0.1	4.0	0.0	0.0	7.9	11.1	7.5	0.6	0.0	4.9	0.0	14.1	3.7	0.0	5.6	0.0	6.4	11.2	0.2	5.5	0.0	1.8	0.0	0.0	0.0	0.0	4.3	1.5	4.5	1.9	0.0	0.0	0.6	0.0	2.8	0.4	1.4	2.5	0.3	0.2	0.8	0.2	1.9	3.9	0.7	1.5	0.0	2.1	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.2	0.5	0.0	0.1	0.2	0.1	0.0	0.6	0.0	2.4	0.0	0.1										
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593961	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 21.1;RPTEC TERT1: 15.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enriched"	"Detected in single"	33	"pons and medulla: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	90	"pons and medulla: 24.0"	"Region enriched"	"Detected in single"	100	"pons and medulla: 14.7"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA043851: , HPA074454: "	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favourable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favourable (8.59e-5)"	3.4	3.1	0.2	2.1	0.2	0.0	5.0	0.2	0.7	5.4	10.5	0.2	25.9	1.5	2.2	18.5	0.6	7.2	0.2	0.7	0.2	0.0	16.0	0.4	5.2	0.8	0.2	0.2	1.9	0.5	0.9	0.2	1.2	25.4	1.3	4.7	0.2	0.6	27.6	0.2	0.5	9.5	1.6	22.5	2.0	4.3	0.7	0.2	0.2	0.7	0.2	0.2	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.7	0.0	2.4	2.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.1	2.6	0.0	0.2	0.0	0.0	0.0	21.1	0.9	5.4	0.0	4.1	0.0	1.2	1.3	0.0	2.8	0.0	1.4	1.6	0.0	3.2	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	15.7	1.6	0.0	0.0	0.1	0.0	2.3	0.4	0.0	5.2	0.7	2.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	25.4	0.2
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 73.7;seminal vesicle: 56.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 13.1;HEK 293: 36.2;RPTEC TERT1: 24.6;TIME: 13.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.5"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.0"	"Region enriched"	"Detected in single"	60	"pons and medulla: 10.6"	"Region enriched"	"Detected in single"	62	"pons and medulla: 14.6"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	5.2	4.3	0.3	18.1	0.3	0.0	3.8	0.3	0.3	12.0	8.5	0.3	73.7	0.5	7.2	30.5	0.4	8.7	0.3	0.3	0.3	0.0	26.6	0.4	3.4	0.3	0.3	0.3	0.6	0.6	1.9	0.3	1.5	0.9	4.3	3.8	0.3	0.3	56.7	1.0	0.6	8.2	1.8	10.0	1.7	5.9	1.8	0.3	0.3	0.3	0.3	0.3	4.2	10.0	1.5	0.2	0.0	0.0	0.0	1.0	0.3	2.3	5.4	0.0	2.8	2.5	2.7	0.0	0.0	0.0	0.0	0.0	2.9	3.5	0.0	13.1	6.4	0.0	0.6	0.2	0.0	0.1	36.2	3.2	9.0	0.0	3.8	0.2	8.4	3.2	0.1	5.2	0.1	2.4	2.0	0.0	7.2	0.1	0.0	0.1	0.0	2.1	0.0	6.1	0.3	24.6	1.1	0.0	0.0	1.9	0.0	3.5	0.9	1.1	13.6	0.5	2.8	2.2	10.0	0.0	0.0	0.0	0.4	0.0	4.4	0.0	0.0	0.0	0.7	0.0	0.2	1.4	0.4	1.0	0.2	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.9	0.3
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607227-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 62.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 30.8;RPTEC TERT1: 24.5;SK-MEL-30: 29.2;WM-115: 21.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	45	"pons and medulla: 6.0"	"Region enriched"	"Detected in single"	13	"pons and medulla: 1.5"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favourable (2.39e-4)"	8.3	8.3	0.0	7.3	0.3	0.1	17.2	0.1	0.6	10.0	8.1	0.1	24.1	0.5	4.1	62.3	0.8	4.2	0.3	1.1	0.0	0.0	23.7	0.8	1.7	2.4	0.1	0.3	2.3	0.6	0.4	0.5	4.1	4.1	5.2	7.0	0.1	0.1	22.1	2.4	2.2	12.4	3.5	20.1	2.2	4.6	3.0	0.2	0.1	0.5	0.1	0.6	5.8	15.1	2.2	1.8	0.0	0.0	2.0	4.7	0.5	17.1	7.5	0.0	0.2	5.4	8.1	0.0	0.0	0.0	0.1	0.3	11.4	0.3	0.3	30.8	7.2	2.5	0.0	0.0	0.0	7.9	5.5	2.6	5.9	0.0	4.5	0.0	5.5	5.3	2.3	5.3	0.0	16.2	2.8	0.1	17.0	4.4	0.3	0.1	0.0	0.0	0.0	14.6	2.0	24.5	5.7	0.0	0.0	5.8	0.0	29.2	1.4	1.7	13.9	0.0	9.4	7.6	13.2	0.9	2.2	0.0	0.1	0.0	21.5	0.0	0.0	0.0	3.8	0.0	1.9	1.9	0.7	2.1	0.0	2.2	0.0	1.4	0.0	2.0	0.0	1.8	4.7	0.5	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.3	4.1	0.2
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48614939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.6;HDLM-2: 9.2;HEK 293: 21.2;LHCN-M2: 10.8;RPTEC TERT1: 22.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enriched"	"Detected in single"	82	"pons and medulla: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	48	"pons and medulla: 6.8"	"Low region specificity"	"Detected in many"			HPA075905			Supported	Nucleoplasm				Nucleoplasm		"HPA075905: "	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	3.5	4.3	0.0	1.6	0.0	0.0	2.5	0.0	0.0	7.7	2.1	0.0	45.4	0.0	2.1	39.2	0.0	0.9	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.2	8.2	1.9	0.8	0.0	0.1	34.6	0.2	0.4	4.0	1.1	49.3	0.0	4.3	2.8	0.0	0.1	0.1	0.0	0.0	5.0	6.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	3.2	0.0	0.4	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	20.6	3.2	0.0	0.0	0.0	0.0	9.2	21.2	0.5	0.0	0.0	0.2	0.0	3.1	0.6	0.0	0.0	0.0	1.3	6.1	0.0	10.8	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	22.5	0.5	0.0	0.0	0.3	0.0	3.0	0.2	0.0	5.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0
HOXC10	HOX3I	ENSG00000180818	"Homeobox C10"	Q9NYD6	12	53985065-53990279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 16.2;skeletal muscle: 53.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 76.4;ASC diff: 22.6;ASC TERT1: 20.8;fHDF/TERT166: 17.6;T-47d: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053919	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA053919: "	"unprognostic (1.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.56e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.98e-1)"		"unprognostic (1.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.60e-3)"	"unprognostic (3.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.91e-1)"	8.0	0.7	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.5	0.3	0.0	0.4	0.0	1.6	6.8	0.1	2.5	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.8	0.0	0.0	3.4	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.3	53.2	6.8	0.8	0.5	0.9	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.8	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.0	76.4	22.6	20.8	0.1	2.6	6.4	3.6	3.4	0.1	0.2	0.1	0.7	17.6	8.2	1.1	0.0	1.7	3.8	1.4	0.7	9.5	0.0	0.1	0.0	0.9	9.8	0.1	0.2	0.0	0.0	0.5	0.0	2.5	0.4	0.0	1.9	0.0	0.3	0.0	0.1	0.0	8.1	0.0	0.0	1.0	1.8	2.6	3.9	26.0	0.5	0.0	2.1	2.7	0.0	3.4	0.3	0.0	0.0	0.0	0.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 7.0;skin 1: 9.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 23.0;BJ hTERT+: 11.6;HaCaT: 10.1;T-47d: 18.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	4.8	0.0	0.1	0.1	0.1	0.0	1.2	0.1	0.1	2.5	0.1	0.1	0.1	0.8	2.0	1.0	0.1	0.7	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.7	0.1	0.1	0.5	0.1	0.0	0.1	0.6	0.3	0.5	0.0	0.1	0.1	2.0	7.0	9.2	2.7	0.4	0.1	0.1	0.0	1.6	0.1	0.5	0.1	0.1	0.1	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.7	0.0	23.0	2.2	3.3	0.0	3.3	11.6	4.9	3.6	0.2	0.9	0.0	0.2	3.1	10.1	4.4	0.0	2.2	0.6	0.1	0.1	7.5	0.0	0.0	0.1	0.1	0.6	0.9	0.0	0.3	0.0	0.9	0.0	3.1	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.8	0.0	0.1	2.1	5.2	2.0	18.1	0.0	0.0	0.0	4.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
HOXC4	"HOX3, HOX3E"	ENSG00000198353	"Homeobox C4"	P09017	12	54016931-54056030	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.7;ovary: 31.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.8;HEK 293: 19.6;SH-SY5Y: 16.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	27	"pons and medulla: 29.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	24	"pons and medulla: 9.9"	"Region enriched"	"Detected in single"	13	"pons and medulla: 3.7"	HPA053910			Supported	Nucleoplasm				Nucleoplasm		"HPA053910: "	"unprognostic (2.78e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.96e-6)"	"unprognostic (3.30e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.37e-2)"	"unprognostic (7.81e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-4)"	"unprognostic (9.82e-2)"	16.2	4.4	0.7	3.2	0.7	0.0	17.9	0.7	0.7	1.3	2.3	0.6	1.4	0.9	11.5	17.8	6.0	20.9	1.0	1.0	0.7	0.7	15.4	0.8	0.9	3.2	1.1	0.0	31.6	0.7	0.0	0.7	5.8	29.7	2.4	0.0	0.3	0.7	1.3	8.1	4.2	9.2	4.4	10.5	1.2	2.6	8.3	0.9	0.0	1.0	0.0	1.8	2.1	3.4	1.1	0.5	0.0	0.0	0.0	1.1	0.0	3.0	3.1	0.0	13.8	5.8	3.0	0.0	1.4	1.4	1.4	1.0	0.1	2.6	12.0	0.1	10.6	2.7	0.2	0.3	0.8	17.8	19.6	0.1	1.4	0.0	0.6	1.4	0.4	7.6	1.4	8.3	1.4	0.2	0.6	0.0	5.3	0.1	1.6	0.3	0.1	0.0	3.9	4.4	0.0	5.9	0.0	0.0	16.7	2.1	0.7	7.8	10.4	0.7	0.0	7.3	4.2	0.5	7.4	3.2	3.4	6.2	0.4	1.3	7.6	0.0	0.0	0.0	0.8	0.0	0.8	1.1	0.0	0.8	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.5	0.6	0.0	0.7	0.7	0.7	0.7	0.7	0.7	1.1	0.0	29.7	0.9
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54032853-54035358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.8;ovary: 13.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;ASC TERT1: 6.1;HSkMC: 5.7;SH-SY5Y: 9.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Region enriched"	"Detected in single"	14	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.9"	"Region enriched"	"Detected in single"	40	"pons and medulla: 4.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.8	1.6	0.2	1.0	0.2	0.0	1.8	0.2	0.6	0.2	1.6	0.2	0.2	0.3	0.5	5.3	1.7	8.0	1.5	0.2	0.2	0.0	1.5	0.2	0.2	0.3	0.4	0.2	13.4	0.2	0.0	0.2	1.4	8.8	0.2	0.0	0.8	0.2	0.2	4.2	2.1	4.6	2.5	2.6	0.2	3.9	2.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.9	2.1	0.0	8.3	5.0	6.1	0.0	0.5	0.4	0.9	0.7	3.5	0.4	0.0	0.6	2.5	1.3	0.1	0.0	0.3	2.6	2.9	0.0	1.0	0.1	0.2	0.0	0.1	5.7	0.6	4.1	0.4	0.0	0.0	0.0	1.8	1.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	9.1	0.6	0.2	4.3	1.7	0.1	0.0	1.4	0.9	3.1	0.3	0.0	0.0	0.0	0.2	0.1	3.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.4	0.2	8.8	0.2
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 31.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.3;fHDF/TERT166: 18.6;HDLM-2: 31.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	17	"pons and medulla: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	23	"pons and medulla: 1.5"	"Not detected"	"Not detected"			HPA054981			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054981: "	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	10.9	11.2	0.4	1.2	0.4	0.0	16.3	0.4	0.4	0.7	1.9	0.6	0.4	0.0	3.9	14.8	3.1	13.5	0.4	2.0	0.4	0.0	11.3	0.4	0.9	3.0	0.4	0.4	31.2	0.4	0.0	0.4	4.0	7.0	0.8	0.0	0.4	0.4	0.4	11.0	7.6	8.8	6.1	8.1	1.0	0.3	3.3	0.4	0.4	0.6	0.8	0.4	0.7	2.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.4	1.7	0.0	37.3	13.7	13.0	0.3	1.9	1.9	3.1	2.8	1.5	2.8	1.1	2.5	18.6	4.2	1.4	0.2	2.8	31.2	10.8	1.9	4.8	0.0	1.5	0.2	4.7	12.3	2.0	6.1	2.2	0.1	1.3	0.0	10.8	0.5	0.0	1.2	0.0	1.6	0.0	1.4	0.0	9.4	0.1	0.0	4.6	2.8	2.7	7.6	6.6	0.5	0.0	3.9	8.4	4.2	2.6	0.3	0.3	0.0	1.4	0.3	7.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	7.0	0.4
HOXC8	"HOX3, HOX3A"	ENSG00000037965	"Homeobox C8"	P31273	12	54009106-54012362	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.7;ovary: 25.2;skeletal muscle: 12.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.7;ASC TERT1: 15.5;fHDF/TERT166: 27.6;HSkMC: 18.9;LHCN-M2: 20.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028911, CAB037020"	Uncertain		Supported	Nucleoplasm,Microtubules				Nucleoplasm	Microtubules	"CAB037020: AB_1840935, HPA028911: AB_10602236"	"unprognostic (1.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.26e-6)"	"unprognostic (4.89e-2)"	"unprognostic (5.20e-4)"	"unprognostic (5.34e-3)"		"unprognostic (2.43e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.47e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.14e-2)"	5.2	5.4	0.4	0.7	0.2	0.0	7.1	0.2	0.3	0.5	0.5	0.2	0.2	0.0	0.3	16.7	0.4	6.3	0.6	0.6	0.2	0.0	7.0	0.2	0.2	2.2	0.2	0.5	25.2	0.2	0.0	0.2	1.9	0.4	0.3	0.0	0.2	0.2	0.2	12.8	2.6	4.8	7.9	2.5	0.2	0.0	2.6	0.2	0.3	0.7	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	8.3	23.7	15.5	0.1	1.5	0.0	2.8	1.8	2.5	1.2	0.0	0.2	27.6	1.0	2.2	0.7	3.2	2.8	3.0	0.4	1.0	0.0	2.9	0.0	3.2	18.9	2.1	8.9	5.2	0.2	0.3	0.0	20.6	0.7	0.0	0.2	0.0	0.4	0.0	0.0	0.0	3.1	0.0	0.0	1.1	2.8	0.5	7.2	0.8	0.0	0.0	0.5	4.4	3.8	0.9	0.0	0.0	0.0	0.5	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.0	0.2	0.5	0.4	0.2
HOXC9	"HOX3, HOX3B"	ENSG00000180806	"Homeobox C9"	P31274	12	53994895-54003337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.9;skeletal muscle: 28.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.4;HDLM-2: 18.3;HEK 293: 22.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063965, HPA072160"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA063965: , HPA072160: "	"unprognostic (2.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.23e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.53e-1)"	18.9	2.5	0.0	1.2	0.0	0.1	12.8	0.0	0.1	0.5	0.2	0.0	0.4	0.1	1.7	7.8	0.3	6.3	0.1	0.1	0.0	0.0	12.2	0.1	0.1	4.3	0.0	0.0	5.6	1.0	0.1	0.0	2.0	0.0	0.9	0.1	0.0	0.5	0.2	28.3	5.7	4.4	1.2	0.5	0.1	0.1	4.3	0.0	0.1	0.2	0.2	0.3	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	2.2	0.0	14.4	5.8	4.8	1.0	1.5	1.3	1.9	1.2	0.6	2.2	0.0	1.1	5.7	2.6	0.3	1.5	1.6	18.3	22.3	0.4	3.3	0.5	0.6	0.0	3.3	5.4	2.5	2.8	1.3	1.8	4.5	0.0	3.8	1.6	0.0	1.3	0.0	0.2	0.2	2.8	0.0	4.3	1.4	0.0	4.2	5.2	2.8	5.7	4.3	0.2	0.0	3.4	6.1	1.0	1.7	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188579-176190907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.7;Hep G2: 5.9;RPTEC TERT1: 18.3;RT4: 14.1;SCLC-21H: 4.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA040062: , HPA056900: "	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	2.4	0.6	1.5	1.1	3.5	0.3	2.0	0.6	3.9	0.5	5.2	18.8	11.8	0.7	0.8	14.1	0.9	8.8	1.4	0.3	4.1	2.2	6.8	0.2	5.7	0.9	9.8	1.3	1.2	0.5	0.2	0.2	0.3	15.5	1.7	3.7	0.3	1.0	20.4	0.3	1.2	4.4	0.9	18.9	1.5	0.7	2.2	6.3	0.0	0.4	0.0	0.5	4.6	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	18.3	14.1	4.9	0.8	0.0	0.0	0.9	0.0	0.0	3.3	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.5	0.6	3.2	4.1	2.2	9.8	1.3	15.5	6.3
HOXD11	"HOX4, HOX4F"	ENSG00000128713	"Homeobox D11"	P31277	2	176104216-176109754	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 15.8"	"Cell line enhanced"	"Detected in some"		"HEK 293: 20.3;SCLC-21H: 6.2;U-251 MG: 4.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055155			Supported	Nucleoplasm				Nucleoplasm		"HPA055155: "	"unprognostic (1.99e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.48e-1)"		"unprognostic (1.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (6.73e-2)"		"unprognostic (5.00e-2)"	"unprognostic (2.11e-8)"	"unprognostic (2.09e-3)"	"unprognostic (2.49e-2)"		"unprognostic (2.27e-3)"	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	5.4	4.2	0.0	0.0	0.0	15.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.3	5.7	0.9	0.0	0.0	2.9	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	1.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.1	0.0	20.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	6.2	0.3	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 7.9;HSkMC: 9.3;RPTEC TERT1: 9.7;SCLC-21H: 13.8;SH-SY5Y: 9.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"pons and medulla: 3.8"	"Region enriched"	"Detected in single"	30	"pons and medulla: 6.7"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA051831: , HPA063671: "	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	6.2	1.1	0.4	3.2	0.4	0.2	19.6	0.2	0.2	8.7	3.6	0.0	22.5	0.3	25.9	36.4	1.1	4.8	2.0	0.4	0.8	0.5	8.5	0.2	0.3	0.8	1.5	0.0	7.0	0.3	0.2	0.2	0.2	0.5	2.1	0.4	0.0	0.6	22.6	0.7	0.7	0.4	4.0	7.2	1.9	0.3	3.6	0.0	0.0	0.4	0.2	0.3	1.7	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.9	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	9.3	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	9.7	0.5	13.8	9.3	0.1	0.1	3.9	0.0	0.0	0.6	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.8	0.5	1.5	0.0	0.5	0.0
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151222-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.0;seminal vesicle: 26.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.1;HEK 293: 21.6;RPTEC TERT1: 16.0;SK-MEL-30: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	31	"pons and medulla: 8.2"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA054383: , HPA070349: "	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	3.4	4.9	0.5	0.5	0.5	0.0	4.0	0.5	0.7	2.8	3.4	0.5	13.8	0.2	15.6	21.0	0.5	7.9	0.5	0.5	0.5	0.0	10.2	0.5	0.5	0.6	1.1	0.5	9.7	0.5	0.0	0.5	0.5	7.6	1.5	0.8	0.5	0.5	26.2	1.3	1.0	3.5	5.3	3.7	4.4	0.4	1.5	0.5	0.5	0.8	0.5	0.5	2.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	1.7	0.0	0.1	0.4	0.0	0.6	0.5	0.0	0.0	9.1	1.6	0.1	1.5	0.0	0.2	0.0	21.6	0.2	0.0	0.0	0.3	0.0	0.0	4.9	1.4	0.0	0.2	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	16.0	2.5	1.3	2.1	0.3	0.0	6.0	0.0	0.0	2.7	0.2	0.1	1.4	1.1	0.0	0.0	0.0	1.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.0	1.1	0.5	7.6	0.5
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122720-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.6;HEK 293: 12.0;RPTEC TERT1: 14.1;SH-SY5Y: 16.4;SK-MEL-30: 9.0;TIME: 12.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068683			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA068683: "	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favourable (9.58e-4)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	4.1	2.7	0.2	1.7	0.4	0.0	11.4	0.2	0.2	13.1	10.8	0.2	10.4	0.0	26.2	12.0	1.6	5.1	2.6	0.5	0.2	0.0	19.7	0.2	0.7	2.4	0.2	0.2	8.9	0.2	0.0	0.2	1.6	0.4	13.0	2.2	0.2	0.4	16.0	3.8	3.9	1.1	12.6	0.6	3.7	0.1	9.8	0.2	0.3	2.2	2.2	1.3	2.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	1.2	0.8	1.0	0.8	0.0	0.0	0.0	8.6	1.1	5.6	0.0	0.0	0.6	0.0	12.0	0.0	0.6	0.0	0.1	0.0	0.0	2.8	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	14.1	5.2	3.2	16.4	4.1	0.0	9.0	0.0	0.0	12.4	0.0	2.8	4.0	4.3	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2
HP1BP3	HP1-BP74	ENSG00000127483	"Heterochromatin protein 1 binding protein 3"	Q5SSJ5	1	20742661-20787323	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028215, HPA054295"	Supported		Supported	"Nuclear speckles"			50000	"Nuclear speckles"		"HPA028215: AB_10601021, HPA054295: "	"unprognostic (3.90e-3)"	"unprognostic (6.83e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-2)"	40.1	41.4	52.6	41.2	59.0	62.2	39.0	53.3	60.0	52.8	46.8	45.8	41.2	34.1	65.7	32.2	46.9	38.6	36.9	35.9	49.1	33.7	42.4	31.7	39.7	41.4	47.6	41.2	70.8	36.5	54.6	46.7	55.1	46.7	41.6	44.2	32.5	39.5	44.5	48.7	41.7	43.9	49.7	50.1	41.9	39.6	27.9	58.6	58.1	52.7	30.9	42.9	48.0	62.9	21.9	18.9	60.5	17.0	18.3	27.3	14.0	43.4	23.1	58.4	35.1	35.0	42.3	35.0	49.2	41.3	36.3	38.4	20.8	50.5	45.1	25.0	39.3	37.3	30.4	28.8	47.1	64.9	28.0	63.3	45.1	18.6	23.0	43.6	40.8	31.8	21.4	35.4	48.4	36.5	35.1	55.6	41.3	13.8	67.0	20.1	15.4	28.2	53.1	56.6	46.9	25.9	14.1	39.3	40.5	60.7	25.2	39.9	25.9	30.8	42.3	39.7	36.7	40.0	29.9	31.8	38.3	50.7	34.0	47.3	44.8	25.5	17.0	60.5	19.4	13.9	20.0	21.9	20.9	20.7	15.5	19.0	27.3	18.6	21.8	18.3	15.8	18.9	21.3	14.0	52.6	59.0	53.3	60.0	49.1	33.7	47.6	41.2	46.7	58.6
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326905-45328533	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 38.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 46.3;HL-60: 13.1;NB-4: 16.3;SK-BR-3: 29.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8"	"HPA031997, HPA057346"			Supported	Mitochondria				Mitochondria		"HPA031997: AB_10602909, HPA057346: "	"prognostic favourable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favourable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.9	0.7	2.7	3.1	4.2	3.6	1.0	7.6	3.4	2.0	8.4	2.4	0.0	5.4	1.0	1.3	3.6	1.0	1.8	3.0	2.7	2.4	0.7	0.2	0.8	2.6	2.5	1.8	1.0	0.3	0.2	0.4	5.1	3.1	1.7	7.1	38.4	1.3	0.6	3.3	1.1	4.7	0.9	2.2	2.8	7.8	1.4	0.6	6.4	1.0	4.2	2.3	0.8	1.6	3.1	0.7	0.0	0.3	2.1	1.5	0.8	0.0	0.4	0.1	0.0	0.0	0.1	46.3	0.6	0.0	0.8	0.1	11.5	3.0	2.3	0.1	0.5	2.8	0.0	0.1	0.2	0.0	0.1	0.2	5.0	0.0	0.3	13.1	0.3	0.5	0.1	0.4	0.0	0.9	0.0	2.1	0.1	5.7	8.4	16.3	0.2	0.0	2.5	0.0	7.6	0.1	0.1	9.1	0.6	5.8	29.3	4.5	0.0	2.4	0.4	0.0	0.1	0.4	0.0	0.3	0.1	8.2	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	1.5	3.1	0.7	1.2	0.7	0.3	0.9	0.8	0.0	2.1	0.0	0.0	0.4	0.8	2.7	4.2	7.6	3.4	2.7	2.4	2.5	1.8	3.1	0.6
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell line enhanced"	"Detected in some"		"A549: 27.3;ASC diff: 16.9;HEL: 59.7;RT4: 92.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favourable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.3	0.0	0.0	16.9	1.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	59.7	2.0	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.4	2.8	0.0	0.2	5.6	92.8	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5
HPRT1	"HGPRT, HPRT"	ENSG00000165704	"Hypoxanthine phosphoribosyltransferase 1"	P00492	X	134460153-134520513	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets, Gout"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006360, CAB012200"	Enhanced		Supported	Cytosol			15000000	Cytosol		"CAB012200: AB_297217, HPA006360: AB_1079082"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (1.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	7.9	14.9	31.0	12.6	30.2	25.3	11.3	24.2	49.8	7.5	13.7	5.8	9.8	11.0	7.9	36.2	10.3	9.4	8.1	12.8	27.6	37.3	18.4	24.7	7.3	15.9	23.5	28.9	9.8	20.2	9.9	18.6	8.8	34.4	8.8	13.2	9.7	7.1	9.5	10.7	8.0	14.2	9.5	9.8	8.7	17.1	39.7	4.9	13.7	12.3	8.6	15.9	10.8	7.5	13.5	19.7	10.1	18.5	19.9	29.3	12.6	31.0	15.0	4.2	8.7	9.5	13.7	12.8	16.6	16.0	21.3	28.0	13.4	19.9	35.2	37.9	10.8	19.1	27.4	22.8	36.8	29.2	51.3	19.1	21.3	13.6	9.4	41.0	17.6	10.1	8.6	18.9	30.3	24.5	14.6	0.9	16.6	31.7	31.6	35.6	8.7	40.3	19.0	21.6	36.1	25.6	15.1	26.9	14.7	12.0	9.7	11.3	8.3	17.2	12.1	14.5	10.9	41.4	41.2	13.4	23.2	0.2	17.8	45.6	7.9	2.2	11.6	10.1	11.6	18.5	16.7	12.3	17.3	15.3	19.7	13.5	14.3	15.1	2.9	19.9	17.2	8.2	29.3	12.6	31.0	30.2	24.2	49.8	27.6	37.3	23.5	28.9	34.4	4.9
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.8;neutrophil: 12.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;monocytes: 17.8"	"Region enhanced"	"Detected in some"		"olfactory region: 4.5"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"		9700000	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	4.9	5.1	3.0	6.8	3.5	2.2	1.2	0.8	2.4	3.6	6.2	7.1	0.0	2.3	2.9	2.8	14.5	5.7	3.0	5.8	3.2	1.5	3.0	5.6	8.2	16.1	7.1	1.4	7.5	1.1	15.5	2.3	11.3	3.4	1.1	7.0	0.7	12.5	2.1	0.7	6.9	3.6	2.1	7.0	19.0	2.4	6.0	2.8	1.6	1.4	16.9	9.7	2.4	4.9	0.3	1.9	12.8	17.8	1.4	3.4	4.8	8.1	0.4	0.0	1.1	1.9	0.6	0.0	1.0	4.5	2.0	8.7	0.2	6.1	0.2	1.4	2.2	7.9	10.3	1.4	3.6	0.8	0.9	2.2	5.8	0.1	1.1	1.4	4.9	0.8	3.1	1.4	9.8	10.8	0.0	24.7	0.9	1.7	0.1	0.1	0.4	1.5	0.0	0.3	0.3	5.7	0.2	5.8	0.0	11.3	6.2	0.9	0.8	1.9	12.6	0.9	2.8	0.8	1.0	0.3	3.8	0.1	6.5	6.6	1.5	0.2	17.8	0.0	1.0	6.7	0.7	0.2	1.9	0.7	1.9	0.3	1.4	1.2	12.8	1.4	0.9	0.1	3.4	4.8	3.0	3.5	0.8	2.4	3.2	1.5	7.1	1.4	3.4	2.8
HR	"ALUNC, AU"	ENSG00000168453	"HR, lysine demethylase and nuclear receptor corepressor"	O43593	8	22114415-22133384	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Oxidoreductase"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 50.5;tongue: 23.8"	"Cell line enhanced"	"Detected in some"		"A549: 10.0;EFO-21: 9.9;HaCaT: 38.4;SiHa: 13.3;T-47d: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054888			Supported	Nucleoplasm				Nucleoplasm		"HPA054888: "	"unprognostic (9.11e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.68e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	2.6	1.8	3.8	3.2	6.1	0.8	4.7	19.8	17.0	2.1	7.5	9.6	0.1	5.5	1.5	0.9	12.1	1.9	6.7	1.9	5.3	4.0	0.9	0.8	1.2	1.0	6.1	6.8	0.8	1.3	0.7	1.7	0.9	4.9	2.3	4.0	6.7	3.4	5.4	1.1	50.5	5.3	2.3	3.8	1.1	8.4	5.2	6.6	0.0	2.6	23.8	4.4	3.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	9.9	0.7	38.4	0.0	0.9	0.0	0.0	0.0	0.0	8.1	0.0	2.2	0.0	0.0	2.0	6.2	0.0	0.6	0.0	0.0	0.1	0.0	5.7	0.6	0.1	0.0	7.7	0.8	0.0	0.2	0.1	2.6	0.4	2.2	13.3	3.0	3.0	14.2	0.0	0.0	0.2	8.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	6.1	19.8	17.0	5.3	4.0	6.1	6.8	4.9	6.6
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.4;hTEC/SVTERT24-B: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	9.1	4.4	7.3	4.6	4.4	0.2	9.6	0.5	10.6	8.0	13.5	1.3	2.4	3.8	6.2	7.2	5.7	10.6	9.9	7.0	5.1	4.0	3.3	1.1	8.2	1.8	2.2	2.1	8.7	2.1	1.7	1.2	5.5	3.2	7.2	7.2	2.0	3.4	6.1	3.0	8.0	10.5	9.2	8.6	1.4	3.3	2.4	2.0	0.1	2.5	7.2	3.1	11.2	16.2	0.1	0.3	1.2	0.2	0.1	3.5	0.1	1.5	3.4	0.0	0.0	1.6	17.4	2.4	2.6	8.7	7.8	5.3	0.6	12.5	0.0	7.8	6.0	9.8	0.0	3.5	10.6	5.5	0.0	0.8	5.6	0.0	5.2	2.4	1.4	6.0	2.2	17.5	6.2	10.8	0.0	0.0	3.4	0.0	0.0	1.1	0.0	3.2	0.2	0.9	0.3	13.9	2.0	0.1	0.0	3.7	2.7	0.0	0.0	1.9	16.1	8.8	5.5	8.9	13.0	0.0	0.9	0.0	13.4	2.2	7.5	0.4	0.2	0.0	0.1	0.2	0.0	0.0	1.3	0.5	0.3	0.1	0.1	0.1	1.2	0.1	0.0	0.1	3.5	0.1	7.3	4.4	0.5	8.4	5.1	4.0	2.2	2.1	3.2	2.0
HSCB	"DNAJC20, HSC20, Jac1"	ENSG00000100209	"HscB mitochondrial iron-sulfur cluster cochaperone"	Q8IWL3	22	28742031-28757515	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018447, HPA031518"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"HPA018447: AB_1853867, HPA031518: "	"unprognostic (8.19e-3)"	"unprognostic (6.48e-2)"	"unprognostic (9.62e-3)"	"prognostic favourable (3.78e-4)"	"unprognostic (3.30e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.38e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (8.38e-4)"	9.6	18.8	13.1	9.2	13.9	4.9	12.4	13.7	12.9	14.1	11.6	9.1	20.3	13.7	11.5	8.8	11.8	10.4	11.4	9.6	12.3	8.3	12.9	29.5	7.3	15.5	15.8	9.0	16.5	15.2	6.2	16.1	8.7	10.6	15.9	7.7	8.2	28.2	17.5	14.6	9.2	10.0	8.9	12.2	10.9	12.8	6.0	13.2	6.9	14.4	8.1	10.3	15.0	10.5	12.9	11.3	7.7	14.4	9.7	8.5	5.8	9.3	6.0	2.5	3.8	4.6	11.8	4.8	6.9	9.7	10.2	6.3	2.6	3.4	10.5	3.3	3.8	6.6	4.8	4.5	4.9	10.0	19.4	3.6	4.7	7.4	9.8	6.6	5.4	7.9	9.9	5.7	9.0	7.8	5.6	9.3	4.0	13.5	3.0	6.1	6.0	14.8	5.9	7.7	11.9	11.1	2.7	8.5	7.7	3.8	14.6	18.4	6.0	4.0	4.1	14.1	7.3	13.3	6.2	13.1	10.6	9.1	9.8	4.9	9.3	7.7	7.9	3.6	6.3	14.4	7.6	12.9	6.4	7.4	11.3	9.9	7.0	8.5	0.4	9.7	11.0	5.9	4.8	5.8	13.1	13.9	13.7	12.9	12.3	8.3	15.8	9.0	10.6	13.2
HSD11B1L	"SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 34.4"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"			Vesicles		"HPA049078: "	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favourable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	8.8	34.4	2.1	19.2	4.7	5.0	10.3	29.7	3.9	2.9	5.4	3.7	2.6	3.6	8.5	2.2	7.6	4.8	3.8	25.4	16.1	6.7	3.5	4.4	2.3	11.7	20.4	6.1	6.2	5.8	8.5	2.5	10.7	4.0	1.9	3.2	9.1	6.9	15.0	6.9	2.9	2.7	6.0	2.6	3.3	4.3	7.5	0.0	6.6	1.3	1.8	2.5	2.2	2.5	4.8	2.5	5.8	1.4	4.5	1.7	3.0	2.9	10.7	2.0	5.1	5.5	2.2	2.3	4.6	1.1	4.7	1.3	3.0	0.7	5.1	2.0	1.5	1.3	1.7	1.0	2.5	3.3	2.0	2.6	1.9	3.5	0.8	7.3	5.4	3.7	1.7	1.5	1.7	1.9	2.9	4.3	0.4	1.8	2.1	2.9	3.4	3.4	0.4	2.6	8.9	0.7	2.9	17.8	0.5	1.5	11.4	2.5	0.7	2.9	2.7	4.8	4.5	1.8	7.2	2.3	0.8	7.4	1.1	2.1	1.7	2.5	0.2	1.2	5.8	1.6	1.2	3.2	3.6	2.3	2.5	4.5	3.9	2.5	1.4	2.9	4.8	0.9	1.7	34.4	19.2	10.3	29.7	25.4	16.1	11.7	20.4	10.7	7.5
HSD17B1	"EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1"	ENSG00000108786	"Hydroxysteroid 17-beta dehydrogenase 1"	P14061	17	42549214-42555213	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 217.6"	"Cell line enriched"	"Detected in many"	8	"BEWO: 87.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA021032, HPA065296"	Enhanced		Supported	Cytosol				Cytosol		"HPA021032: AB_1844345, HPA065296: AB_2685457"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.88e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-2)"	"unprognostic (5.09e-1)"	"unprognostic (4.98e-1)"	"unprognostic (1.32e-2)"	2.8	1.5	2.0	1.7	2.1	1.1	1.8	2.7	3.1	1.3	1.3	1.3	1.3	1.9	1.5	1.3	4.3	1.4	1.3	1.4	2.4	1.4	1.4	1.3	1.3	1.6	2.4	1.3	5.8	2.6	0.2	1.4	217.6	1.3	1.5	0.2	1.3	2.9	1.3	3.5	4.1	1.9	1.3	1.9	2.1	2.0	2.3	1.3	1.3	1.8	1.3	1.3	1.3	1.8	6.0	5.5	7.5	8.6	6.1	5.4	5.5	1.6	1.7	0.9	4.5	0.6	0.1	87.6	1.2	0.0	0.0	0.0	1.0	0.9	0.0	1.1	0.0	2.6	0.1	0.7	0.0	2.4	2.8	1.2	1.1	1.5	0.2	1.0	1.4	0.2	2.5	0.1	0.5	0.0	1.6	0.3	0.0	1.5	1.3	1.1	0.4	0.8	1.3	1.1	0.7	0.1	1.3	1.2	1.8	0.7	8.9	1.4	10.7	0.8	1.4	1.4	1.7	0.9	0.8	2.5	1.4	0.6	0.5	0.9	1.0	3.6	7.6	7.5	4.9	8.6	5.3	5.6	5.4	5.1	5.5	6.0	5.1	4.4	7.2	6.1	5.3	4.3	3.7	5.5	2.0	2.1	2.7	1.5	2.4	1.4	2.4	1.3	1.3	1.3
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336610-87391386	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1;intestine: 81.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 100.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 100.1;monocytes: 25.8"	"Low region specificity"	"Detected in all"							HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"		14000	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	22.0	23.8	11.1	15.5	8.4	23.6	18.9	23.8	12.8	19.6	58.3	7.2	9.5	53.0	19.1	15.7	6.5	14.6	26.3	9.0	10.1	6.4	18.1	57.4	25.3	14.7	14.2	7.9	18.0	24.5	3.0	12.6	11.4	9.7	15.5	36.2	5.7	6.7	9.0	6.4	6.2	81.3	15.2	14.2	12.2	11.6	11.6	10.6	15.8	8.1	8.4	8.2	21.0	15.9	7.7	14.2	100.1	25.8	10.4	10.3	18.7	0.2	10.6	5.2	13.0	16.0	22.1	7.4	5.7	9.1	3.8	7.0	8.8	68.2	0.0	11.2	5.9	0.2	15.1	1.2	4.2	16.8	3.2	14.7	5.9	29.8	9.1	26.1	27.3	15.6	0.4	5.2	1.8	7.3	15.2	7.6	6.9	0.4	5.3	32.0	8.9	1.7	14.6	4.8	17.2	10.5	16.3	1.7	16.7	11.3	0.3	19.4	0.0	25.5	6.1	2.6	11.7	10.4	2.9	3.7	1.5	1.6	4.8	18.5	17.7	61.0	25.8	55.9	8.7	18.4	10.3	7.7	8.8	9.0	14.2	6.6	8.1	9.0	100.1	10.4	15.2	4.8	9.9	18.7	11.1	8.4	23.8	12.8	10.1	6.4	14.2	7.9	9.7	10.6
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 41.9"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 4.9;HEL: 4.3;U-2 OS: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Supported	Vesicles				Vesicles		"HPA056833: "	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	0.5	0.4	1.0	0.5	1.0	0.4	0.5	0.5	0.9	0.8	0.5	0.5	0.5	0.4	0.5	0.5	0.5	1.3	0.5	0.5	1.7	0.5	1.0	6.3	0.5	0.5	1.6	0.5	0.5	1.3	0.4	0.5	0.5	0.5	0.8	0.4	0.5	0.5	0.5	0.5	0.5	1.1	0.5	1.9	0.5	0.4	41.9	0.5	0.5	4.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.0	1.0	0.5	0.9	1.7	0.5	1.6	0.5	0.5	0.5
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452443-119637199	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes			6900000	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favourable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	25.1	42.4	22.1	15.5	21.3	6.4	46.0	12.3	23.6	27.8	30.1	24.1	83.8	28.6	16.2	20.7	24.6	15.1	20.6	27.3	23.8	21.2	31.3	116.3	30.5	16.7	27.0	21.7	15.1	29.9	33.2	20.5	19.0	23.9	20.9	25.2	10.7	20.0	86.2	20.7	19.2	30.5	15.6	33.6	16.9	20.7	8.1	25.5	10.8	48.9	17.3	14.5	24.1	25.3	6.1	11.1	31.4	13.6	3.2	4.2	5.3	17.7	15.3	28.8	38.1	71.9	33.8	15.2	17.3	23.3	16.4	29.9	12.6	29.5	23.7	35.6	18.7	17.8	21.1	37.6	25.6	25.9	19.5	31.2	16.6	24.1	18.3	9.8	48.9	29.4	15.8	17.6	16.5	28.0	10.6	13.8	17.8	15.4	15.0	6.4	21.3	10.8	19.2	28.8	25.6	26.2	49.0	21.7	18.7	40.6	6.4	18.9	23.6	16.6	19.9	16.1	11.0	17.7	14.1	7.0	14.7	8.7	18.3	26.3	15.8	31.4	13.6	24.7	3.4	8.0	4.2	6.1	3.2	2.9	11.1	5.8	3.1	2.9	2.4	3.2	7.8	6.9	2.0	5.3	22.1	21.3	12.3	23.6	23.8	21.2	27.0	21.7	23.9	25.5
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.0;Hep G2: 22.7;HMC-1: 35.2;U-2197: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 24.5;eosinophil: 13.5"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050521, HPA060847"	Uncertain		Enhanced	"Lipid droplets"				"Lipid droplets"		"HPA050521: , HPA060847: "	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	21.6	11.2	2.5	7.5	4.7	1.8	7.3	2.7	4.0	4.9	8.3	4.6	2.8	11.2	5.3	6.4	9.4	4.4	7.4	5.2	3.1	1.6	25.6	74.1	6.4	5.6	3.5	1.4	9.3	17.7	5.6	2.6	6.1	3.7	5.9	3.2	2.9	4.5	2.6	5.1	7.8	13.3	6.7	4.8	8.3	4.8	3.6	3.7	1.0	2.9	4.5	4.6	8.0	3.9	0.1	0.8	24.5	0.8	0.2	0.0	0.3	6.9	8.0	0.8	4.0	2.9	10.5	0.5	8.7	13.7	1.7	3.6	0.5	12.1	0.4	2.9	10.6	2.1	0.7	1.2	0.9	31.0	1.9	0.5	6.3	22.7	2.7	0.1	35.2	5.0	2.1	8.3	1.6	0.7	1.6	0.3	6.5	14.8	0.2	4.9	0.6	1.1	0.8	2.8	7.6	5.3	0.4	3.0	1.5	1.1	5.6	0.7	11.0	0.5	4.0	3.6	1.0	34.3	0.9	0.6	5.0	0.4	14.0	0.8	0.3	24.5	0.8	13.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.3	2.5	4.7	2.7	4.0	3.1	1.6	3.5	1.4	3.7	3.7
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112379937-112472410	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favourable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favourable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	31.0	26.3	18.3	5.8	17.7	4.1	13.8	5.7	12.1	10.1	14.1	11.9	6.2	15.2	11.0	5.0	14.4	8.8	7.6	52.1	16.1	13.7	29.3	70.5	11.4	7.8	17.9	10.8	21.3	11.4	7.9	7.7	9.9	12.4	12.2	11.0	10.2	7.3	6.9	54.1	12.5	18.3	13.3	12.9	10.1	9.9	5.9	14.5	5.7	13.2	27.7	6.9	14.2	10.7	3.6	4.6	23.3	5.0	2.6	4.1	2.4	15.2	13.7	10.3	5.2	17.9	17.8	11.9	10.5	6.5	7.5	6.3	26.3	17.2	9.8	5.8	15.3	17.6	11.1	14.7	9.3	41.2	7.3	10.2	22.2	25.7	11.2	5.7	6.6	18.9	10.7	11.2	8.1	8.7	14.1	6.6	20.4	10.1	14.2	5.3	6.0	17.8	9.2	31.2	14.4	15.9	13.9	7.4	5.3	26.3	17.5	8.8	24.7	7.0	9.8	10.8	10.1	30.2	10.2	7.8	19.2	4.6	13.4	8.5	6.3	21.9	4.0	15.2	2.3	3.9	3.5	3.3	2.5	2.6	4.5	3.6	3.0	3.1	23.3	2.6	5.0	4.6	4.1	2.4	18.3	17.7	5.7	12.1	16.1	13.7	17.9	10.8	12.4	14.5
HSF1	HSTF1	ENSG00000185122	"Heat shock transcription factor 1"	Q00613	8	144291591-144314722	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004239, HPA008888"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004239: AB_627753, HPA008888: AB_1079088"	"unprognostic (7.08e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.07e-2)"	"prognostic unfavourable (8.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (5.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	24.7	22.9	17.4	21.0	20.9	20.8	30.8	24.4	23.6	21.3	26.9	18.3	17.7	18.9	23.3	16.7	25.5	28.5	22.9	42.8	17.0	17.5	21.2	19.5	20.3	23.6	17.4	15.9	32.4	36.8	25.8	21.8	22.8	17.8	26.7	15.2	20.7	26.4	24.6	55.2	20.3	17.8	35.1	14.4	20.3	23.6	42.6	17.8	23.2	29.9	24.2	19.8	30.3	33.9	16.9	20.3	20.3	24.2	12.9	18.4	14.2	14.6	19.9	8.6	7.3	14.5	13.6	14.3	11.0	10.0	10.9	9.5	13.3	12.9	16.9	16.2	15.2	10.7	13.1	15.8	7.0	10.7	15.1	21.2	20.4	18.1	22.9	6.1	16.4	13.2	14.9	15.3	28.3	14.7	14.0	10.2	10.9	29.7	20.6	9.4	11.0	57.4	13.4	7.5	21.4	7.8	14.9	13.0	10.5	16.8	13.5	19.4	15.2	12.6	14.8	11.2	25.4	17.6	18.0	7.1	5.4	14.5	16.0	11.5	10.7	10.6	18.9	20.3	14.5	19.9	15.2	16.9	15.7	18.4	20.3	15.5	15.6	13.9	8.1	12.9	24.2	10.3	18.1	14.2	17.4	20.9	24.4	23.6	17.0	17.5	17.4	15.9	17.8	17.8
HSF2		ENSG00000025156	"Heat shock transcription factor 2"	Q03933	6	122399546-122433119	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016067, HPA031455"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB016067: AB_627754, HPA031455: AB_10670702"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.51e-6)"	"unprognostic (3.40e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (9.27e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	9.6	13.7	9.0	6.7	14.7	20.6	11.4	17.8	19.4	12.7	9.3	9.9	9.2	6.3	14.4	9.8	8.7	11.1	6.9	20.3	9.2	11.3	6.4	4.9	7.7	11.5	9.7	15.5	14.3	5.9	13.5	18.5	7.3	18.0	10.4	6.5	9.7	7.7	12.1	37.9	10.2	7.8	12.6	9.2	8.5	8.5	31.7	9.3	14.3	8.3	15.9	10.7	13.1	8.6	6.6	3.8	4.0	4.2	7.0	21.3	7.7	4.2	4.5	23.3	19.0	10.5	8.4	6.5	7.7	18.4	14.2	22.3	6.6	3.6	16.5	6.8	9.6	5.5	15.6	7.4	20.0	16.5	19.0	16.0	4.3	13.6	10.7	11.8	8.3	10.6	11.4	11.7	13.5	8.5	17.2	8.2	13.3	5.7	19.3	15.5	7.2	6.5	17.9	9.5	5.3	10.7	4.9	25.0	16.8	8.0	6.6	7.4	5.6	12.9	5.1	7.7	8.9	8.5	11.6	12.0	11.4	21.0	8.3	7.8	10.0	3.4	2.7	4.0	8.5	3.2	9.1	6.6	8.1	7.4	3.8	5.4	21.3	16.0	0.4	7.0	4.2	2.6	8.8	7.7	9.0	14.7	17.8	19.4	9.2	11.3	9.7	15.5	18.0	9.3
HSF4	CTM	ENSG00000102878	"Heat shock transcription factor 4"	Q9ULV5	16	67164681-67169945	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 11.6;U-266/70: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048584			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA048584: "	"unprognostic (1.90e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavourable (8.24e-5)"	"unprognostic (9.20e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavourable (2.19e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (8.74e-3)"	6.9	16.8	11.8	2.5	14.7	2.6	5.5	16.4	20.2	7.1	4.6	2.6	16.0	6.4	6.5	13.7	7.5	7.9	5.3	8.7	11.6	5.5	6.4	8.3	6.0	2.6	19.3	16.9	7.1	17.4	10.2	12.3	5.0	11.5	12.2	3.4	19.1	16.4	4.3	36.8	13.2	6.3	26.8	11.7	3.4	16.1	3.4	15.1	0.3	7.4	10.6	1.9	10.9	8.4	0.0	0.5	0.0	0.9	0.0	0.4	0.2	1.4	0.9	0.0	1.1	0.5	2.8	5.1	0.6	0.5	0.2	0.0	2.1	2.6	0.0	2.3	1.0	5.0	0.4	0.6	0.2	1.6	2.0	0.8	1.9	3.0	2.1	0.3	3.6	1.5	4.3	0.3	2.3	0.8	1.4	4.8	2.0	1.3	0.6	1.3	0.1	1.8	2.4	1.8	5.9	3.8	2.2	2.8	5.9	4.1	2.7	6.2	11.6	4.0	1.2	1.5	1.7	5.6	1.6	21.2	3.0	1.3	3.1	1.5	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	11.8	14.7	16.4	20.2	11.6	5.5	19.3	16.9	11.5	15.1
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080738-102139699	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 519.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol			94000000	Cytosol		"CAB002058: "	"prognostic unfavourable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavourable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favourable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	50.8	75.3	96.1	46.7	106.8	64.1	118.6	81.3	113.4	51.0	47.3	50.7	43.0	31.0	40.7	55.5	40.9	94.7	61.0	70.9	99.6	113.3	75.6	62.5	51.7	48.1	134.4	58.6	53.4	40.1	94.9	121.6	67.2	143.6	63.2	53.3	23.4	57.0	57.0	65.2	35.6	38.9	51.0	139.7	35.7	41.3	84.6	132.7	53.5	91.5	34.3	59.5	54.2	519.3	30.7	46.9	31.8	29.9	57.7	63.1	21.9	86.3	118.1	75.4	52.0	45.8	38.8	100.2	96.1	46.2	117.9	66.5	71.7	81.2	106.2	90.5	61.8	95.9	216.5	94.0	215.1	80.3	71.3	82.0	67.5	91.5	22.7	122.0	63.3	36.4	40.0	75.3	27.8	65.0	113.2	54.6	106.6	116.8	130.4	56.1	78.4	111.7	125.8	102.5	45.8	68.4	111.7	99.4	71.7	121.5	91.5	53.6	117.6	48.7	46.0	82.5	53.4	122.6	182.5	51.7	161.1	157.1	78.1	75.4	99.4	31.8	19.9	24.0	47.8	29.9	63.1	29.6	40.5	49.0	23.9	30.7	30.1	43.5	13.5	57.7	27.5	46.9	39.2	21.9	96.1	106.8	81.3	102.7	99.6	113.3	134.4	58.6	143.6	132.7
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		62000000	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favourable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	79.9	116.1	88.0	65.9	105.0	74.6	107.8	92.1	118.2	92.3	60.4	61.7	80.9	40.6	113.3	107.6	71.6	138.4	63.8	115.0	89.0	110.5	72.0	70.7	76.2	73.8	109.7	94.4	238.4	113.9	151.6	95.3	83.6	133.7	93.5	76.4	52.7	64.8	100.3	197.1	67.9	49.0	102.1	93.9	57.5	77.3	45.9	100.2	58.3	133.8	89.8	102.5	86.2	223.4	75.9	50.5	7.2	45.7	55.7	82.5	74.9	138.6	89.0	79.1	97.1	54.3	56.9	82.8	62.7	61.5	116.1	81.8	133.0	42.5	177.7	68.0	65.2	80.9	192.3	93.3	143.7	58.8	77.8	138.3	50.4	173.8	39.3	138.0	95.8	52.5	63.2	91.2	78.8	111.1	184.5	66.3	78.9	140.0	114.9	83.3	92.2	68.2	110.9	80.8	97.5	78.5	84.4	115.8	70.8	48.7	70.6	87.9	91.8	69.1	69.6	69.3	116.0	56.6	143.1	76.8	120.4	321.0	75.3	101.5	78.9	7.2	30.2	6.8	49.3	45.7	82.5	75.9	55.2	56.4	50.5	63.2	75.2	71.3	3.7	55.7	43.3	31.4	42.6	74.9	88.0	105.0	92.1	118.2	89.0	110.5	109.7	94.4	133.7	100.2
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953645	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 325.1;thyroid gland: 338.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"		410000000	"Endoplasmic reticulum"		"CAB005224: AB_2119181, CAB078151: , HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	49.0	57.1	26.9	50.0	32.0	45.9	60.3	16.5	25.5	45.7	43.4	17.5	108.5	32.1	42.2	127.2	34.3	42.0	32.4	67.0	27.1	32.0	74.0	325.1	46.6	49.2	31.5	26.0	53.9	95.5	47.1	50.0	123.6	29.4	46.9	46.9	15.8	43.8	136.8	25.4	19.2	54.4	45.0	37.8	89.3	37.0	25.7	27.9	44.5	338.5	24.0	36.9	66.1	106.1	25.6	81.0	22.2	23.8	40.2	53.3	33.9	79.2	43.0	86.8	89.1	88.9	84.0	117.8	133.6	101.0	71.2	95.1	76.6	74.3	23.2	106.3	140.2	55.4	85.4	143.5	96.1	54.8	32.6	62.3	48.5	79.0	137.1	62.8	48.9	49.2	64.0	87.6	125.8	136.9	49.8	88.2	94.0	28.5	37.7	70.3	71.3	51.8	34.4	56.0	96.9	95.2	50.0	25.8	61.8	83.4	86.3	84.3	70.2	93.3	78.7	53.9	46.2	43.8	55.7	90.3	84.5	42.9	107.4	46.5	83.4	22.2	21.2	6.9	45.6	23.8	53.3	25.6	26.7	39.3	28.0	15.9	18.0	31.3	4.9	40.2	19.3	81.0	16.4	33.9	26.9	32.0	16.5	25.5	27.1	32.0	31.5	26.0	29.4	27.9
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133051962-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Supported	Nucleoplasm,Cytosol			10000000	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavourable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	20.6	35.0	26.6	25.6	27.6	20.5	39.0	25.9	35.6	19.4	20.5	18.7	19.9	17.4	23.3	20.2	42.0	19.2	18.9	32.9	26.4	31.9	30.3	31.1	17.2	28.9	30.9	24.5	23.2	19.5	37.1	32.8	24.5	34.3	18.9	23.9	16.0	20.3	19.2	48.3	19.6	18.5	23.6	25.9	20.0	20.9	39.8	29.5	27.3	26.8	24.8	38.6	24.5	77.1	27.7	17.9	15.5	23.0	14.1	14.9	11.5	34.2	47.2	33.0	53.7	31.4	26.5	59.9	37.6	28.3	36.5	45.3	88.6	36.0	57.0	39.6	36.1	30.6	57.2	62.2	52.9	26.3	32.8	42.0	31.7	48.5	25.1	26.0	36.9	26.3	26.3	47.0	30.9	34.8	43.9	17.7	39.8	30.2	36.6	19.4	45.2	21.9	33.6	40.4	30.3	33.0	45.2	26.3	21.6	35.8	18.8	50.0	27.6	25.6	30.4	33.3	47.9	28.4	44.5	20.3	45.0	43.8	28.5	43.3	33.0	14.8	14.4	15.5	12.6	23.0	14.9	22.6	11.6	13.0	17.9	27.7	12.1	11.2	9.6	14.1	16.4	6.8	11.3	11.5	26.6	27.6	25.9	35.6	26.4	31.9	30.9	24.5	34.3	29.5
HSPA9	"GRP75, HSPA9B, mot-2, mthsp75, PBP74"	ENSG00000113013	"Heat shock protein family A (Hsp70) member 9"	P38646	5	138554882-138575444	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000898, CAB005219"	Supported		Supported	Mitochondria			3100000	Mitochondria		"CAB005219: AB_647720, HPA000898: AB_1079032"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.86e-1)"	"prognostic favourable (4.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.29e-1)"	26.4	76.4	30.9	22.1	33.2	39.8	27.7	24.3	39.5	20.0	28.7	30.4	24.0	27.8	23.1	29.7	28.5	19.1	19.3	55.0	28.2	32.5	59.9	117.7	20.5	22.8	35.5	31.3	28.9	31.9	56.7	25.5	24.6	43.7	25.3	32.7	20.6	26.0	26.4	84.2	24.0	25.7	24.0	29.3	24.6	27.7	18.6	32.0	21.1	41.0	32.8	29.1	23.7	33.1	19.3	24.1	6.6	20.9	20.5	28.3	23.3	32.7	41.5	23.7	45.4	24.9	16.3	48.8	34.8	30.9	39.1	42.6	79.1	35.0	62.8	47.8	25.8	27.8	63.1	46.6	54.3	31.5	30.9	34.6	37.3	52.7	67.3	34.8	38.5	27.7	70.8	43.1	97.4	18.5	43.2	54.1	30.8	40.2	36.5	30.0	34.7	34.5	41.0	34.3	48.6	43.9	47.3	28.5	21.7	40.3	64.2	131.7	36.9	40.9	17.7	38.4	24.3	32.0	55.1	66.8	47.8	63.2	47.3	61.5	38.2	6.6	16.9	6.5	24.0	20.9	28.3	19.3	20.6	23.0	24.1	14.1	23.0	22.8	3.9	20.5	20.6	14.1	18.2	23.3	30.9	33.2	24.3	39.5	28.2	32.5	35.5	31.3	43.7	32.0
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302544-76304295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 565.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 162.0;MCF7: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			57000000	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavourable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	67.6	41.7	23.0	42.9	22.8	7.3	186.2	10.1	21.3	127.6	84.9	10.8	89.2	27.1	126.5	65.9	410.5	57.7	52.2	164.8	21.4	22.5	85.4	26.3	43.3	25.1	25.7	14.3	63.4	34.7	16.6	15.5	106.9	32.8	99.6	12.0	31.1	50.5	101.3	439.2	164.4	24.6	139.7	27.3	17.8	37.6	22.0	23.4	31.9	72.9	207.3	126.8	146.2	565.5	27.8	17.8	4.1	27.9	23.2	36.8	14.4	72.6	54.0	5.8	43.1	35.1	31.1	0.3	30.9	16.3	16.8	21.1	4.8	42.6	0.6	23.9	40.0	66.7	25.3	18.1	5.4	40.5	8.5	3.3	41.7	22.8	18.8	4.9	30.5	38.6	162.0	25.3	3.7	55.4	26.4	74.3	19.2	227.6	8.3	33.6	29.6	47.3	25.7	11.9	59.0	24.9	27.7	0.4	33.1	21.7	88.6	27.6	104.4	34.8	29.9	50.5	75.3	15.7	77.9	5.2	8.6	0.7	36.9	15.2	36.7	4.1	4.5	2.8	18.6	21.1	9.6	27.5	30.6	20.2	11.1	27.8	36.8	31.5	1.7	23.2	27.9	17.8	19.7	14.4	23.0	22.8	10.1	21.3	21.4	22.5	25.7	14.3	32.8	23.4
HSPB3	HSPL27	ENSG00000169271	"Heat shock protein family B (small) member 3"	Q12988	5	54455601-54456384	"Disease related genes, Predicted intracellular proteins"	"Stress response"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 106.0;skeletal muscle: 46.1;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 37.1;fHDF/TERT166: 16.6;HSkMC: 7.3;LHCN-M2: 5.4"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 7.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062124			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA062124: "		"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-3)"		"unprognostic (1.13e-1)"	"unprognostic (4.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"		"unprognostic (2.73e-1)"	"unprognostic (2.82e-2)"		"unprognostic (7.15e-2)"	0.7	0.1	1.1	0.1	1.0	0.0	0.5	0.0	2.7	0.2	1.0	0.0	0.1	0.1	1.8	4.3	3.7	0.7	0.1	106.0	0.5	0.4	0.0	0.0	0.5	0.0	0.1	1.1	0.3	0.0	0.0	0.9	0.0	0.2	2.0	0.5	0.1	2.1	0.2	46.1	0.5	0.2	2.4	0.0	0.2	0.2	0.3	0.0	0.0	0.1	22.3	0.9	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	37.1	0.0	0.0	0.1	0.0	0.0	0.1	16.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	7.3	2.2	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	1.0	0.0	2.7	0.5	0.4	0.1	1.1	0.2	0.0
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754569-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 356.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 184.7;ASC TERT1: 77.9;HHSteC: 62.6;HSkMC: 72.9"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"		86000	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: , HPA054811: "	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (1.43e-6)"	95.3	39.5	3.9	18.3	8.1	1.1	40.5	1.1	6.1	49.7	48.4	3.8	18.6	5.7	42.6	57.4	24.6	33.3	80.6	132.0	4.4	2.4	6.2	3.5	8.7	7.2	5.4	2.8	53.4	5.8	1.7	1.2	12.7	8.1	42.1	8.7	18.2	8.6	35.8	356.8	2.5	14.3	128.2	10.2	1.9	32.4	22.6	4.9	0.0	11.0	153.5	16.4	121.6	23.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	184.7	77.9	0.1	8.2	0.1	0.5	0.9	0.1	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	62.6	0.0	0.0	72.9	0.0	1.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	1.7	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	8.1	1.1	6.1	4.4	2.4	5.4	2.8	8.1	4.9
HSPB8	"CMT2L, E2IG1, H11, HSP22, HspB8"	ENSG00000152137	"Heat shock protein family B (small) member 8"	Q9UJY1	12	119178642-119221131	"Disease related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 152.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 29.1;HeLa: 21.7;MCF7: 38.2;U-87 MG: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015876	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA015876: AB_1850458"	"unprognostic (1.52e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (2.98e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.17e-2)"	12.2	4.4	19.3	8.2	22.7	0.7	6.8	2.0	18.1	15.3	52.7	34.1	13.1	2.8	18.6	7.2	42.9	9.6	12.0	107.9	17.4	17.6	16.3	1.7	13.4	3.3	27.4	14.7	5.7	7.7	73.3	3.0	64.3	24.5	40.1	11.9	21.7	11.4	79.4	152.6	10.0	7.9	65.5	35.0	13.6	20.6	3.6	19.3	5.4	8.0	42.1	26.7	55.6	18.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.4	4.9	0.2	0.0	5.7	4.5	19.1	10.7	9.5	2.2	0.1	12.0	0.2	0.0	29.1	14.8	0.8	0.1	0.0	0.3	0.0	0.4	0.0	21.7	1.0	3.9	0.0	0.0	5.0	1.7	7.2	0.7	4.4	0.0	0.0	5.3	38.2	0.0	0.1	2.2	7.0	0.0	7.9	1.0	15.7	2.0	0.1	0.3	4.1	0.5	2.2	9.9	0.0	6.1	5.3	13.4	6.9	0.5	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.7	2.0	16.0	17.4	17.6	27.4	14.7	24.5	19.3
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486581-197516737	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 162.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria			53000000	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	28.5	125.2	28.7	23.4	31.8	21.0	55.9	18.2	24.3	17.4	30.3	17.8	23.3	28.9	17.5	18.5	27.2	25.3	16.3	24.0	24.2	27.8	67.1	147.5	22.4	25.3	35.5	16.1	30.2	50.6	32.5	25.9	27.1	33.6	25.9	37.2	11.9	17.6	21.0	36.4	13.7	32.0	23.6	32.4	22.7	25.2	10.9	35.8	22.7	38.7	29.4	30.3	33.3	162.6	25.6	30.3	6.2	29.3	23.1	33.5	22.2	40.4	49.8	41.8	37.5	28.7	30.0	60.8	42.2	22.3	50.8	37.3	167.0	24.4	123.1	55.1	22.0	41.4	163.6	46.5	72.1	30.2	65.6	87.4	80.6	193.3	27.0	96.8	27.5	33.9	54.0	45.0	79.4	39.8	107.6	48.3	37.3	51.8	60.1	98.0	82.6	104.2	72.3	51.6	88.9	53.4	42.3	54.8	31.0	42.3	45.8	54.1	31.7	57.5	17.7	31.6	43.8	40.6	66.6	27.1	59.6	102.2	37.1	58.5	33.9	4.5	19.7	5.3	15.5	29.3	28.8	25.6	25.0	21.8	30.3	21.0	33.5	29.0	6.2	23.1	25.8	20.2	19.7	22.2	28.7	31.8	18.2	24.3	24.2	27.8	35.5	16.1	33.6	35.8
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134974-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"vagina: 286.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol			820000	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.90e-4)"	"prognostic unfavourable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	13.7	19.8	36.6	12.2	57.1	9.8	33.7	11.7	44.0	14.7	10.6	9.8	13.0	6.1	13.3	21.7	13.9	31.0	18.1	14.2	34.8	40.3	16.6	14.8	15.9	17.4	36.5	16.3	13.4	10.1	15.1	24.1	19.8	32.7	14.5	14.5	3.6	7.0	17.3	10.5	11.0	6.4	15.7	34.8	9.0	12.2	35.0	34.6	12.1	22.5	7.8	23.8	17.0	286.1	9.0	6.8	2.1	14.6	13.7	12.8	5.5	14.5	27.8	23.0	2.2	22.1	12.6	15.3	25.2	22.4	39.2	18.3	32.7	22.6	37.7	15.8	17.5	28.2	88.5	22.4	50.6	29.5	11.1	32.7	15.4	28.8	7.3	22.6	26.1	7.9	51.8	26.1	15.0	22.6	27.3	6.0	27.4	19.8	32.4	25.9	32.7	20.8	25.6	18.8	12.5	29.5	17.7	23.8	19.8	22.9	22.6	11.6	7.5	22.0	13.7	13.5	17.2	19.4	27.8	4.7	15.4	32.3	11.2	27.5	22.5	1.0	3.9	2.1	6.6	9.6	8.1	9.0	8.4	10.0	6.8	7.8	12.8	11.9	0.4	13.7	14.6	5.3	5.3	5.5	36.6	57.1	11.7	44.0	34.8	40.3	36.5	16.3	32.7	34.6
HTATIP2	"CC3, FLJ26963, SDR44U1, TIP30"	ENSG00000109854	"HIV-1 Tat interactive protein 2"	Q9BUP3	11	20363685-20383783	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Differentiation, Host-virus interaction"	"Developmental protein, Oxidoreductase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006417, HPA024321"	Approved		Supported	Cytosol				Cytosol		"HPA006417: AB_1079091, HPA024321: AB_1851288"	"unprognostic (8.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.79e-3)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavourable (6.18e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (8.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	16.3	28.1	8.5	11.9	16.3	6.3	26.3	3.2	10.6	9.4	50.4	16.2	10.8	52.2	6.8	13.0	23.1	5.7	17.6	9.5	10.8	9.9	21.5	41.8	19.5	16.2	24.3	8.0	6.8	11.9	17.9	27.4	22.9	12.4	13.9	32.2	3.3	16.5	9.2	19.4	14.8	74.6	12.1	15.0	19.6	29.4	10.6	14.6	6.6	23.9	17.2	12.1	17.8	26.7	16.4	17.4	69.4	30.6	13.5	30.6	23.8	23.4	38.9	0.8	0.0	12.0	9.1	8.7	10.3	10.1	7.9	9.5	22.5	20.7	5.3	21.0	12.7	33.0	0.0	6.2	7.6	61.1	4.8	6.6	38.5	0.0	28.8	2.4	31.5	13.1	44.1	6.4	10.1	22.6	16.2	7.0	14.7	22.0	0.0	1.5	12.6	19.4	5.0	0.0	19.3	10.8	13.1	10.6	0.1	33.2	13.2	15.6	27.6	12.4	27.4	5.7	12.5	11.4	0.2	7.5	9.3	0.1	0.1	16.7	24.4	43.7	30.6	37.3	15.5	27.5	17.5	14.9	18.0	16.5	17.4	16.4	15.8	15.5	69.4	13.5	28.3	5.1	30.6	23.8	8.5	16.3	3.2	10.6	10.8	9.9	24.3	8.0	12.4	14.6
HTATSF1	TAT-SF1	ENSG00000102241	"HIV-1 Tat specific factor 1"	O43719	X	136497079-136512346	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000504	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000504: AB_10752094"	"unprognostic (3.56e-2)"	"prognostic favourable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-2)"	"prognostic favourable (8.13e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.05e-1)"	14.5	40.9	26.2	11.8	24.7	18.3	19.6	29.5	22.2	15.2	13.4	19.4	12.9	9.6	15.9	24.7	12.3	14.5	11.5	25.2	23.8	29.9	17.5	12.7	10.4	12.1	26.9	17.6	25.5	10.9	25.6	71.7	21.2	21.4	15.1	14.2	11.9	10.6	16.6	72.2	13.6	9.8	14.4	28.1	10.2	12.4	15.8	19.0	14.5	19.4	22.6	13.3	12.7	12.9	17.1	14.1	19.2	16.1	23.6	24.9	13.1	42.8	22.9	29.1	20.6	21.7	16.4	25.7	19.9	17.7	17.0	16.6	13.6	19.3	32.3	48.4	19.3	18.6	35.2	14.8	22.2	24.6	29.9	20.1	29.0	16.7	12.0	37.8	16.4	14.5	19.4	18.7	11.5	17.3	18.5	23.9	21.9	31.9	37.6	32.5	16.8	34.1	29.7	36.2	29.4	18.3	30.4	20.6	32.0	18.8	15.8	15.6	11.7	27.2	16.6	20.8	15.7	23.5	35.6	14.0	19.2	26.9	13.3	53.9	14.6	19.2	10.1	16.4	21.9	10.5	24.4	17.1	24.1	22.2	14.1	15.9	24.9	22.2	3.4	23.6	16.1	10.3	24.0	13.1	26.2	24.7	29.5	22.2	23.8	29.9	26.9	17.6	21.4	19.0
HTD2		ENSG00000255154	"Hydroxyacyl-thioester dehydratase type 2"	P86397	3	58306262-58318574	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA066812			Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA066812: "	"unprognostic (1.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	7.9	8.9	9.0	6.6	13.9	6.9	9.4	17.0	11.5	7.4	9.2	6.4	7.1	11.3	8.6	8.5	9.4	7.8	7.1	15.9	7.9	9.3	12.1	16.2	6.9	8.2	8.5	10.7	11.0	12.9	8.8	14.2	6.7	7.8	9.6	10.1	9.7	9.2	9.4	35.2	7.2	9.7	12.6	6.0	9.7	8.6	9.8	6.4	6.8	10.7	19.8	9.2	7.8	8.1	23.9	21.6	23.7	20.4	21.3	26.5	13.5	8.0	6.1	9.4	6.7	8.0	9.0	12.1	11.5	8.7	14.3	12.6	13.4	6.1	16.0	3.4	8.3	7.1	15.8	10.4	14.8	8.9	11.0	9.6	13.6	11.3	8.7	12.6	9.1	11.1	10.7	15.2	9.2	12.5	9.4	15.2	9.0	4.7	8.1	6.4	12.2	14.0	5.7	6.0	11.4	9.6	11.9	5.9	8.8	7.1	6.6	13.1	8.9	11.1	7.3	12.2	8.6	11.0	14.0	11.6	20.9	12.5	9.8	9.4	7.4	13.5	17.3	23.7	18.7	20.4	20.1	23.9	18.7	23.5	17.5	23.8	26.5	20.2	18.4	21.3	16.7	21.6	13.4	13.5	9.0	13.9	17.0	11.5	7.9	9.3	8.5	10.7	7.8	6.4
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77461753-77463773	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;placenta: 14.2;stomach 1: 10.2"	"Group enriched"	"Detected in some"	15	"HUVEC TERT2: 40.8;TIME: 18.0"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 11.8"	"Cell type enriched"	"Detected in single"	17	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 34.5"					HPA028808	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA028808: "	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	2.2	1.5	1.3	1.1	11.8	0.3	2.4	0.4	3.7	2.9	0.6	0.1	0.0	0.6	1.1	1.0	1.4	0.8	2.8	0.4	1.0	2.1	0.9	0.3	1.1	0.3	1.2	0.9	1.1	0.5	0.3	0.5	14.2	3.0	1.6	0.4	0.3	1.3	1.2	0.9	0.5	0.4	4.1	0.6	0.4	10.2	1.5	0.6	0.0	0.5	0.0	0.3	2.6	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.4	1.0	40.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	11.8	0.4	3.7	1.0	2.1	1.2	0.9	3.0	0.6
HTR2B	"5-HT(2B), 5-HT2B"	ENSG00000135914	"5-hydroxytryptamine receptor 2B"	P41595	2	231108230-231125118	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 26.0"	"Group enriched"	"Detected in some"	4	"HHSteC: 6.8;HSkMC: 13.0;SK-MEL-30: 23.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 3.8;T-reg: 2.9"	"Group enriched"	"Detected in many"	29	"granulocytes: 3.8;T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012867, HPA063658"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA012867: AB_1856710, HPA063658: "	"unprognostic (1.86e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.42e-3)"	"unprognostic (7.44e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	2.3	17.9	0.2	5.8	0.3	0.7	4.1	0.3	0.6	17.8	7.3	0.2	1.7	1.0	14.9	9.5	5.7	1.9	0.8	4.6	0.3	0.3	5.6	2.5	1.8	0.5	0.3	0.4	4.3	0.3	0.3	0.4	26.0	0.9	2.6	1.5	1.8	0.5	1.0	0.2	0.2	6.3	12.8	0.3	0.4	5.2	3.3	0.3	2.4	6.8	1.0	0.4	4.9	0.8	0.0	0.1	3.8	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.1	0.4	3.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.8	0.1	0.2	13.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	23.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	2.9	0.0	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.4	0.9	0.3
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90857698	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.8;testis: 14.3"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.1;hTCEpi: 7.3;hTERT-HME1: 24.5;LHCN-M2: 9.8;U-87 MG: 7.5;WM-115: 9.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"myeloid DC: 4.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: "	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	1.0	0.5	2.4	1.1	2.5	0.5	0.7	0.3	4.3	0.6	0.8	1.7	1.2	0.8	0.4	0.3	1.0	0.4	1.3	0.6	9.9	5.1	0.3	0.6	0.5	0.7	1.7	1.8	0.4	1.4	30.8	0.2	0.5	3.1	1.0	1.2	0.4	0.6	0.3	1.7	0.9	2.2	3.6	1.5	1.3	1.5	14.3	1.0	0.0	0.3	0.1	0.6	3.5	2.1	0.0	4.6	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.2	0.5	0.7	0.0	0.9	0.0	0.0	0.1	3.3	0.9	8.1	2.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.4	5.8	7.3	2.4	24.5	0.0	0.0	0.0	9.8	0.0	0.0	0.1	0.9	1.2	0.7	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	3.8	0.0	0.2	0.2	4.5	0.0	0.0	6.8	0.0	0.0	0.0	7.5	0.0	9.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.1	0.1	2.4	2.5	0.3	4.3	9.9	5.1	1.7	1.8	3.1	1.0
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122461525-122514908	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 198.9;ASC TERT1: 73.9;fHDF/TERT166: 67.4;HSkMC: 129.7;LHCN-M2: 98.6;U-87 MG: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;memory CD4 T-cell: 1.6"	"Group enriched"	"Detected in many"	20	"monocytes: 2.4;T-cells: 1.6"	"Low region specificity"	"Detected in all"							HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	24800000	2600000	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (5.62e-6)"	40.8	21.8	64.5	9.1	79.0	0.5	48.2	16.2	62.8	50.4	19.3	60.8	7.2	5.6	47.6	67.0	15.6	19.5	78.7	28.7	50.8	35.4	34.7	60.4	14.6	9.1	62.7	32.5	111.3	14.5	37.6	26.9	114.1	41.9	19.5	14.0	20.7	19.3	31.5	7.5	29.6	9.3	40.5	46.5	10.5	12.9	9.8	49.5	1.7	13.3	8.5	7.1	41.5	27.3	0.0	0.0	0.0	2.4	0.0	1.6	0.7	0.0	3.4	1.5	0.4	198.9	73.9	0.0	8.5	15.6	3.5	1.9	0.0	0.0	0.0	2.3	67.4	1.0	0.6	9.7	0.5	0.0	0.3	0.0	5.7	0.0	10.1	0.0	0.0	129.7	35.7	2.0	16.6	16.3	0.0	0.1	98.6	1.7	0.0	0.0	1.6	5.4	0.0	0.1	0.0	22.5	0.1	0.1	0.3	21.4	0.0	9.2	0.6	0.0	10.7	25.1	0.3	11.3	7.2	0.0	0.0	0.0	81.4	0.0	11.7	0.0	2.4	0.0	0.6	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	64.5	79.0	16.2	54.6	50.8	35.4	62.7	32.5	41.9	49.5
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529377-74533348	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria				Mitochondria		"CAB004004: AB_326421, HPA006602: , HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	16.4	12.7	10.6	14.9	11.3	18.9	12.9	10.7	17.7	12.3	12.8	12.6	9.7	12.6	12.9	6.9	10.7	10.6	9.0	12.9	11.6	8.7	13.1	11.4	11.3	13.2	10.8	11.9	18.7	12.9	10.5	9.0	10.4	13.5	11.6	5.5	10.2	13.1	9.2	17.6	9.0	12.6	11.8	9.1	17.3	11.8	13.9	12.6	12.2	16.8	12.6	9.3	10.4	15.2	12.9	9.4	5.9	8.1	5.5	7.8	7.0	7.9	4.9	5.7	4.9	7.9	3.2	15.2	6.9	3.6	4.2	2.4	9.1	3.5	7.2	5.4	3.9	9.0	6.7	7.9	1.1	16.2	13.4	14.4	4.7	8.0	7.4	6.7	10.6	3.8	5.3	7.9	6.7	5.2	18.9	10.7	3.1	5.2	12.4	14.2	4.7	14.2	8.5	16.1	7.9	3.4	3.2	6.6	7.9	3.7	8.5	13.2	3.9	6.6	3.7	7.3	9.0	14.7	15.4	13.1	4.3	4.7	6.3	10.7	5.8	5.9	8.1	4.8	7.3	6.2	7.8	12.9	7.3	6.2	9.4	11.6	6.3	6.4	3.2	5.5	4.7	6.6	7.4	7.0	10.6	11.3	10.7	17.7	11.6	8.7	10.8	11.9	13.5	12.6
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3074681-3243960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favourable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	12.9	13.8	19.4	16.6	18.3	14.1	12.3	24.7	32.3	10.0	13.6	11.6	11.0	10.5	11.5	15.9	16.3	11.6	9.4	8.9	19.7	12.1	11.3	13.1	21.5	18.1	11.8	19.5	13.0	27.0	29.5	13.0	12.0	12.8	10.5	11.4	13.3	10.2	11.4	19.1	25.4	12.8	12.0	10.4	17.4	12.0	14.9	10.4	17.4	13.3	7.3	15.6	11.7	9.6	2.9	3.5	2.8	4.5	2.9	4.3	1.9	12.3	8.6	12.1	7.1	22.3	12.7	12.3	5.8	7.1	8.7	8.3	11.4	8.1	19.0	6.2	13.9	7.1	14.3	10.5	8.8	5.0	10.5	18.1	12.3	12.2	5.2	12.1	26.5	8.8	6.5	17.1	8.0	10.1	11.8	6.8	7.7	11.9	12.9	11.5	14.8	14.0	11.6	11.6	3.7	9.3	12.8	13.3	9.4	10.3	3.9	10.1	10.7	7.6	14.0	12.2	7.7	8.4	12.9	5.3	6.2	15.1	9.1	11.2	8.7	0.0	2.6	2.8	3.5	3.4	2.4	2.9	2.7	4.3	3.5	2.4	2.0	2.4	0.4	2.9	4.5	2.6	3.5	1.9	19.4	18.3	24.7	32.3	19.7	12.1	11.8	19.5	12.8	10.4
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase"	Q7Z6Z7	X	53532096-53686729	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol			3400	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	24.6	28.2	27.7	23.8	43.3	22.4	28.0	37.0	41.1	31.8	25.9	34.3	26.6	17.1	31.9	52.4	27.4	26.5	23.1	27.1	28.0	31.8	30.3	26.2	20.3	23.1	30.0	30.2	43.3	27.8	59.8	34.2	27.2	34.6	27.3	22.7	25.6	26.4	29.6	59.1	50.1	22.1	33.9	23.9	26.6	25.7	28.4	27.7	32.4	27.6	20.7	28.6	27.0	22.9	5.1	7.2	8.2	7.0	6.9	8.9	3.5	50.1	30.9	20.1	14.2	35.3	21.1	24.8	15.1	19.5	15.9	16.7	23.5	16.2	26.3	10.3	27.4	24.1	45.4	25.3	21.8	37.9	20.1	20.9	27.7	18.3	32.5	31.3	12.9	20.1	19.0	38.2	43.9	27.5	20.8	17.1	20.6	30.9	16.9	17.5	27.5	22.3	15.7	27.8	15.9	26.4	34.8	16.8	12.1	42.6	19.0	13.6	27.2	15.2	35.0	14.7	21.1	20.9	19.2	15.0	14.7	23.0	15.7	30.7	21.1	4.0	4.7	8.2	7.2	3.8	8.9	5.1	6.9	7.6	6.7	5.1	4.9	4.9	4.2	6.9	7.0	7.2	5.7	3.5	27.7	43.3	37.0	41.1	28.0	31.8	30.0	30.2	34.6	27.7
HYLS1	FLJ32915	ENSG00000198331	"HYLS1, centriolar and ciliogenesis associated"	Q96M11	11	125883614-125900648	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041210	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041210: AB_10794987"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (3.28e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.56e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	4.3	4.3	6.5	3.6	8.8	2.8	5.2	12.3	11.6	5.9	5.5	2.7	6.0	7.0	5.3	8.3	5.7	5.0	3.2	5.7	6.7	7.2	8.7	7.2	3.1	6.7	5.0	8.6	5.0	3.4	3.4	5.5	5.1	7.6	6.2	6.0	2.2	3.9	7.6	3.7	5.7	6.7	7.1	3.5	5.6	6.2	28.6	4.3	7.6	5.1	4.6	9.6	5.0	3.8	11.8	14.3	3.2	6.0	4.6	10.3	4.7	4.6	10.4	3.8	2.8	7.5	5.1	6.6	12.0	4.8	11.2	7.6	0.1	7.8	2.0	5.0	10.5	7.1	5.4	4.2	13.1	11.5	3.8	1.5	1.1	2.1	5.6	5.3	8.0	3.3	4.9	11.1	12.7	8.1	2.6	12.8	14.6	7.9	3.8	15.9	8.4	17.5	8.1	0.0	6.9	12.0	7.9	5.4	3.3	12.7	9.8	4.7	24.2	11.7	7.3	0.8	9.8	8.9	2.0	4.7	4.7	4.9	2.4	11.6	9.8	3.2	5.5	1.1	8.1	6.0	7.6	11.5	10.2	9.4	6.7	11.8	10.3	7.4	0.9	4.6	4.2	14.3	10.3	4.7	6.5	8.8	12.3	11.6	6.7	7.2	5.0	8.6	7.6	4.3
HYPK	"C15orf63, FLJ20431, HSPC136"	ENSG00000242028	"Huntingtin interacting protein K"	Q9NX55	15	43796142-43803043	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055252	Uncertain		Supported	Nucleoplasm,Microtubules				Nucleoplasm	Microtubules	"HPA055252: "	"unprognostic (2.89e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.39e-3)"	"unprognostic (6.52e-7)"	"unprognostic (2.05e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.78e-4)"	7.5	11.3	10.8	10.1	13.7	22.1	7.3	29.4	11.1	7.0	8.3	8.4	7.0	8.4	8.5	8.8	8.2	7.9	7.3	17.3	9.3	6.5	13.2	30.5	13.7	11.3	13.3	9.7	10.4	18.0	6.7	11.9	8.1	14.1	13.3	13.5	5.7	11.0	7.1	36.8	13.4	10.2	7.4	8.6	11.1	14.4	14.0	12.0	6.0	11.1	13.1	11.0	8.3	10.8	7.8	3.9	8.3	8.9	4.4	9.6	1.5	1.5	1.9	5.6	3.4	4.7	5.4	3.5	3.0	1.3	2.2	1.6	4.9	1.8	2.5	1.7	1.5	5.2	4.7	3.6	2.1	2.5	3.3	3.5	9.0	2.7	2.4	2.0	2.7	4.2	6.7	1.6	3.0	2.3	3.9	4.9	2.3	4.1	2.5	5.1	1.8	4.1	3.2	1.8	2.9	3.7	5.4	3.5	2.5	2.4	5.0	0.7	5.0	2.4	4.4	6.1	3.6	4.1	2.8	5.8	6.0	5.8	4.8	5.8	2.4	6.2	4.4	4.2	5.4	3.2	8.0	3.2	7.5	6.3	3.0	7.8	9.6	7.8	8.3	4.4	8.9	3.9	5.2	1.5	10.8	13.7	29.4	11.1	9.3	6.5	13.3	9.7	14.1	12.0
IAH1		ENSG00000134330	"Isoamyl acetate hydrolyzing esterase 1 (putative)"	Q2TAA2	2	9473658-9496543	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040523, HPA076040"	Approved		Supported	Nucleoplasm			160000	Nucleoplasm		"HPA040523: , HPA076040: "	"unprognostic (1.51e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.41e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (3.64e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.91e-2)"	27.3	34.5	27.3	21.0	27.0	19.6	28.7	19.6	35.3	26.7	25.6	21.9	19.9	18.3	22.3	30.5	22.8	24.2	24.2	46.2	24.5	25.1	31.4	40.4	20.9	24.6	23.7	24.6	27.0	24.7	24.1	23.0	21.2	25.5	23.2	27.0	19.7	20.8	28.0	28.7	15.4	25.2	30.3	25.9	18.6	20.7	49.9	17.9	21.2	26.9	23.7	27.6	24.6	20.8	27.2	36.4	20.2	25.5	23.2	30.4	15.8	12.2	12.4	1.3	0.1	23.1	43.4	0.2	10.9	23.3	15.4	14.5	0.1	13.6	6.3	5.2	31.5	8.3	4.6	9.2	14.8	25.4	12.6	8.1	4.9	7.0	43.5	0.0	6.1	25.9	27.8	10.9	12.9	14.6	0.1	3.9	30.3	12.0	29.8	0.9	1.8	12.1	7.4	0.0	1.9	23.2	6.5	8.9	18.1	8.2	10.7	15.0	11.7	13.7	11.9	11.8	5.1	5.2	16.1	3.2	0.2	2.2	16.5	4.9	13.0	13.9	25.5	20.2	22.7	23.2	24.0	27.2	25.9	24.9	33.9	22.4	20.8	23.5	13.9	23.2	25.3	36.4	30.4	15.8	27.3	27.0	19.6	35.3	24.5	25.1	23.7	24.6	25.5	17.9
IARS	"IARS1, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Supported	Cytosol				Cytosol		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	20.6	31.0	19.1	21.1	28.5	13.8	24.8	24.5	32.1	22.8	23.7	17.5	25.8	13.6	31.9	24.8	29.7	23.8	15.1	26.0	21.4	18.5	24.5	29.9	24.4	24.1	21.6	20.6	28.4	42.8	57.4	29.0	21.1	31.6	23.6	26.7	17.1	25.2	27.7	47.4	25.4	18.8	32.6	20.0	23.1	29.0	18.7	16.9	25.1	52.3	26.7	28.8	22.1	20.5	14.5	15.3	1.9	7.3	18.6	18.6	9.7	35.9	37.3	20.9	32.8	34.4	38.8	33.0	38.2	36.5	30.3	37.1	13.1	23.2	48.9	15.0	58.9	45.0	64.3	49.7	38.3	30.7	23.9	29.8	32.1	23.2	72.7	40.6	22.0	37.8	55.9	52.8	87.4	31.8	52.5	44.5	42.5	26.2	37.5	15.8	33.8	34.5	26.3	31.7	23.5	25.0	18.1	26.7	22.1	25.9	28.5	36.0	22.8	25.4	23.4	22.4	28.0	36.9	31.0	32.6	41.6	25.9	52.4	31.3	41.3	1.9	6.7	0.5	14.7	7.3	18.6	14.5	14.5	14.9	15.3	10.7	14.7	15.3	0.8	18.6	6.2	6.2	12.9	9.7	19.1	28.5	24.5	32.1	21.4	18.5	21.6	20.6	31.6	16.9
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094102-220148041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria			26000	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	25.9	39.3	18.0	17.9	16.9	6.7	31.9	15.1	20.8	16.9	26.2	14.8	24.3	18.9	21.5	16.8	23.8	18.8	16.5	40.0	17.5	12.6	29.5	37.3	16.8	25.9	15.6	16.0	20.5	20.5	42.5	15.3	26.2	17.4	18.5	24.9	15.0	22.4	22.3	57.8	22.2	23.4	17.7	15.7	16.1	18.5	15.7	13.7	19.5	17.8	25.9	20.1	24.9	18.7	16.8	20.0	17.2	19.0	18.5	22.6	16.8	37.7	35.4	20.4	20.0	30.8	31.1	49.1	23.0	24.8	25.5	20.7	34.0	39.5	34.9	31.2	28.5	36.7	28.2	28.7	29.5	24.1	34.0	17.3	29.0	38.2	19.1	27.5	18.8	22.4	29.3	27.5	28.5	24.7	42.7	20.3	33.3	20.9	21.6	19.8	26.4	23.5	19.2	40.6	55.8	36.7	25.4	11.0	30.9	34.8	54.1	35.8	62.6	31.1	25.3	25.1	21.0	33.7	38.5	17.4	26.7	25.4	26.6	21.6	27.8	17.2	16.7	15.1	16.8	19.0	22.6	16.8	18.4	22.0	20.0	13.6	20.8	19.0	3.3	18.5	14.5	7.3	19.7	16.8	18.0	16.9	15.1	20.8	17.5	12.6	15.6	16.0	17.4	13.7
IBA57	"C1orf69, FLJ12734"	ENSG00000181873	"IBA57, iron-sulfur cluster assembly"	Q5T440	1	228165815-228182257	"Disease related genes, Predicted intracellular proteins"	"Heme biosynthesis"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030555, HPA030556, HPA030557"	Approved		Supported	Mitochondria				Mitochondria		"HPA030555: AB_2673522, HPA030556: , HPA030557: AB_10670433"	"unprognostic (3.00e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.01e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.61e-1)"	"prognostic favourable (1.71e-9)"	"unprognostic (4.94e-2)"	"unprognostic (5.02e-1)"	"unprognostic (5.04e-3)"	"unprognostic (7.14e-2)"	5.2	7.5	4.7	5.3	5.5	8.2	6.1	7.8	5.1	4.7	4.5	4.1	3.8	4.5	5.3	4.2	4.7	3.8	6.8	7.9	4.9	3.2	5.8	9.5	6.3	12.7	3.5	4.5	5.9	18.3	7.4	2.9	6.4	5.2	4.5	3.9	4.9	5.3	3.1	22.9	8.0	5.7	4.9	3.5	4.9	5.3	3.1	3.2	5.0	5.2	6.4	4.7	3.6	3.7	2.8	3.4	4.7	1.7	2.8	3.5	0.9	3.3	3.4	3.8	1.7	2.0	2.3	4.6	2.0	1.0	1.6	0.9	7.3	2.9	7.2	4.5	2.1	6.2	2.9	4.4	1.4	1.5	6.3	4.2	4.3	3.5	1.7	4.8	4.8	3.1	2.7	1.8	2.2	2.2	7.1	3.4	1.5	2.6	4.8	2.9	2.8	4.0	6.0	4.3	1.2	2.3	6.9	5.8	4.0	3.4	10.4	2.6	8.3	6.6	5.1	4.3	4.0	2.9	5.1	2.5	1.2	3.6	1.9	2.0	3.2	4.7	1.7	0.8	2.3	1.4	3.5	1.5	1.9	1.8	1.2	2.8	2.8	2.6	2.7	2.8	1.5	3.4	1.7	0.9	4.7	5.5	7.8	4.6	4.9	3.2	3.5	4.5	5.2	3.2
IBTK	"BTBD26, BTKI, DKFZP564B116"	ENSG00000005700	"Inhibitor of Bruton tyrosine kinase"	Q9P2D0	6	82169983-82247754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023826, HPA048438"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA023826: AB_1851378, HPA048438: "	"unprognostic (3.13e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.27e-2)"	"unprognostic (9.78e-2)"	12.8	26.4	8.7	11.0	13.3	4.8	13.2	15.9	16.0	13.9	12.0	14.9	16.7	11.7	14.3	10.9	14.7	12.9	8.9	13.9	8.8	8.7	16.3	39.1	12.1	15.5	11.8	7.7	13.9	20.4	19.9	22.2	9.0	14.5	11.5	15.1	11.2	14.6	17.6	30.9	7.2	16.5	15.1	12.9	12.7	15.8	6.2	10.8	13.6	14.9	14.5	10.0	13.5	10.1	3.9	4.3	3.0	4.6	2.2	6.0	1.9	5.5	11.6	8.5	7.1	10.3	14.2	3.8	13.1	14.5	10.9	11.8	6.1	6.5	11.0	8.4	15.5	6.0	6.7	7.3	13.1	14.8	5.0	11.8	6.2	9.5	14.4	13.6	7.2	12.2	12.3	10.4	25.6	10.6	10.8	6.9	11.4	8.5	4.7	4.4	3.8	6.2	6.8	17.9	4.3	16.4	12.8	5.7	6.3	8.8	11.1	6.9	10.5	8.3	8.6	6.3	4.7	7.9	10.4	7.1	11.1	5.1	7.0	9.0	8.1	3.0	2.7	2.1	4.4	2.5	6.0	3.9	4.3	3.9	4.3	2.6	4.4	4.0	0.0	2.2	4.6	3.2	5.9	1.9	8.7	13.3	15.9	16.0	8.8	8.7	11.8	7.7	14.5	10.8
ICA1	"ICA69, ICAp69"	ENSG00000003147	"Islet cell autoantigen 1"	Q05084	7	8113184-8262687	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 58.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.2;MCF7: 15.2;RT4: 17.8;SCLC-21H: 24.9;SH-SY5Y: 41.0;SK-BR-3: 19.5;T-47d: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"T-reg: 20.8"	"Lineage enriched"	"Detected in many"	8	"T-cells: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017646, HPA061452"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA017646: AB_1851382, HPA061452: "	"unprognostic (1.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.83e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.62e-1)"	"prognostic favourable (4.23e-8)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.08e-2)"	8.9	6.1	12.6	4.2	15.3	11.7	13.0	19.4	24.2	10.7	13.2	2.5	8.7	7.7	5.5	8.5	5.8	8.1	10.4	25.7	7.7	7.8	9.1	5.3	9.2	6.9	4.8	12.4	1.6	58.6	13.2	13.5	4.6	10.5	13.7	14.3	2.5	21.2	8.3	2.8	7.0	10.4	3.7	2.8	7.6	17.9	16.0	3.2	0.8	8.1	4.1	5.5	9.6	4.1	0.3	1.7	2.4	1.6	0.7	20.8	1.1	0.0	0.3	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.3	16.2	0.1	1.6	0.0	0.0	0.3	0.7	0.0	0.0	2.4	3.4	0.3	0.0	0.1	2.8	0.5	0.0	1.1	0.0	0.0	11.8	9.5	0.0	0.0	15.2	0.1	0.0	3.7	0.1	0.0	0.0	7.0	6.9	17.8	24.9	41.0	0.0	19.5	0.2	15.8	5.1	6.9	0.0	0.3	0.0	0.3	5.1	2.4	0.0	0.0	2.2	3.4	0.5	1.6	0.1	0.2	0.5	0.4	0.2	3.9	0.3	1.7	0.3	0.2	0.1	2.4	0.7	0.2	0.4	20.8	1.1	12.6	15.3	19.4	24.2	7.7	7.8	4.8	12.4	10.5	3.2
ICA1L	"ALS2CR14, ALS2CR15"	ENSG00000163596	"Islet cell autoantigen 1 like"	Q8NDH6	2	202773150-202871985	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042507	Approved		Supported	Mitochondria				Mitochondria		"HPA042507: AB_10797016"	"unprognostic (4.14e-3)"	"unprognostic (3.60e-3)"	"unprognostic (5.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.05e-4)"	"unprognostic (1.66e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.50e-4)"	"unprognostic (4.15e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.58e-3)"	3.3	7.3	11.6	2.2	15.6	5.4	3.8	24.8	19.8	5.8	5.2	8.5	4.1	2.3	10.1	8.9	4.2	12.6	5.5	6.5	11.1	12.1	3.3	1.2	3.2	2.2	7.3	14.0	9.4	3.2	15.2	22.6	7.6	9.1	8.8	2.7	5.8	1.9	9.5	8.1	3.0	2.0	7.6	7.2	2.2	3.6	11.9	7.8	1.0	7.8	1.8	2.1	4.5	3.2	5.3	4.6	4.2	5.3	6.7	4.2	1.6	1.5	1.1	2.8	8.3	2.8	5.0	20.5	2.7	3.6	1.9	2.4	1.6	0.6	1.6	0.8	3.2	0.8	4.0	1.3	2.5	1.9	3.1	3.2	1.6	1.8	1.6	4.0	2.1	2.0	2.4	1.9	1.5	2.3	2.8	1.5	2.3	0.7	3.4	5.4	7.8	2.8	4.1	4.0	0.7	1.6	3.7	7.9	7.9	4.1	0.2	1.7	1.0	3.1	1.6	7.3	1.7	1.5	4.0	5.7	7.9	4.7	4.0	1.2	1.4	2.2	2.6	1.5	2.6	2.7	2.2	4.0	1.9	2.1	4.6	5.3	3.1	4.2	4.2	6.7	5.3	2.8	1.8	1.6	11.6	15.6	24.8	16.9	11.1	12.1	7.3	14.0	9.1	7.8
ICE1	KIAA0947	ENSG00000164151	"Interactor of little elongation complex ELL subunit 1"	Q9Y2F5	5	5420664-5490234	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054452, HPA061934"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA054452: , HPA061934: "	"unprognostic (1.45e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.39e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.33e-1)"	14.3	13.2	16.3	13.2	17.3	17.4	18.1	26.7	20.6	17.7	15.1	10.3	13.4	10.6	18.3	14.2	11.6	15.0	10.8	12.3	14.4	13.3	15.5	11.3	12.0	15.5	15.5	16.8	21.7	14.2	27.3	22.5	18.5	17.1	13.5	12.0	8.8	12.9	14.0	28.2	12.8	13.4	20.0	16.3	14.0	13.6	10.7	14.2	21.6	15.5	13.8	16.2	15.5	17.8	3.4	3.8	3.6	2.3	3.4	3.9	1.2	9.2	11.8	13.5	12.9	13.2	13.0	17.5	8.1	9.7	9.8	10.8	9.0	6.9	12.6	11.3	11.6	8.9	18.5	9.5	16.5	17.4	9.4	10.2	35.6	6.5	8.0	23.0	8.4	10.3	10.2	11.6	18.1	12.0	14.5	10.6	10.1	8.1	16.7	8.3	11.4	10.0	19.7	12.3	8.5	8.2	10.6	8.8	9.1	28.1	9.2	10.8	7.9	7.3	13.5	12.7	16.3	16.3	12.5	11.6	13.6	21.4	10.7	17.5	10.7	1.5	1.8	3.6	3.3	2.3	3.9	3.4	3.0	3.1	1.7	3.0	2.7	3.2	0.5	3.4	1.2	3.8	3.5	1.2	16.3	17.3	26.7	20.6	14.4	13.3	15.5	16.8	17.1	14.2
ICE2	"BRCC1, FLJ11896, NARG2"	ENSG00000128915	"Interactor of little elongation complex ELL subunit 2"	Q659A1	15	60419609-60479160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040058			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA040058: AB_10795686"	"unprognostic (3.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.71e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.74e-2)"	12.1	11.5	7.7	9.2	11.5	6.7	11.0	9.8	9.2	11.4	9.1	10.2	14.1	6.1	11.9	8.0	9.6	10.3	8.8	8.2	8.2	6.0	10.6	9.2	8.6	10.9	13.3	6.3	15.4	9.1	44.0	25.6	10.2	9.7	11.7	9.6	7.7	9.4	9.9	10.7	9.1	8.6	10.8	10.1	10.0	9.0	8.6	13.4	19.5	14.0	8.1	12.3	10.7	11.3	10.9	6.6	5.9	7.4	4.4	11.7	6.9	8.7	15.6	13.1	12.6	10.0	11.0	6.9	5.2	8.1	8.4	9.1	12.1	6.5	15.4	11.5	5.6	16.8	17.4	7.0	11.6	18.5	7.8	15.5	11.0	7.1	5.4	17.0	11.0	5.4	8.5	6.9	12.4	13.7	23.6	14.5	10.3	3.8	13.4	4.5	16.3	10.5	16.2	10.4	13.5	6.7	10.9	14.9	14.3	7.3	7.5	9.2	12.2	8.8	6.4	11.7	10.3	9.8	16.0	6.8	18.3	22.5	7.6	19.6	10.7	4.5	5.1	5.9	7.1	7.4	11.7	9.1	8.7	9.2	6.6	10.9	11.6	11.2	0.8	4.4	6.0	5.6	8.9	6.9	7.7	11.5	9.8	9.2	8.2	6.0	13.3	6.3	9.7	13.4
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 163.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 75.1;HaCaT: 71.6;Hep G2: 59.5;PC-3: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"CAB025915: , HPA051456: , HPA058518: "	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	28.6	12.3	8.2	15.2	9.1	4.4	33.2	5.6	13.8	36.3	33.3	15.4	38.5	36.4	25.9	11.6	78.0	25.1	19.0	33.5	8.7	8.4	22.3	23.4	57.4	17.9	10.0	7.9	12.3	5.8	4.0	25.7	22.1	14.3	56.4	13.1	34.9	10.5	163.1	23.0	16.5	40.6	16.9	8.1	15.3	48.6	7.8	4.0	2.4	78.8	36.2	21.0	80.0	26.4	0.4	0.7	3.9	0.7	0.3	0.5	0.5	10.5	35.1	0.4	7.1	4.6	2.1	27.4	45.0	1.8	8.3	0.9	18.5	16.0	0.0	75.1	12.0	71.6	5.8	2.5	1.3	0.8	3.7	5.8	30.4	59.5	6.3	0.1	0.3	8.6	10.2	0.0	0.6	5.0	12.9	0.3	15.9	13.8	1.5	0.2	25.2	74.9	0.1	29.3	0.5	1.6	29.4	13.7	12.8	37.4	13.4	0.3	8.2	1.0	26.8	22.3	43.5	7.1	30.2	0.8	0.8	0.6	26.0	5.6	3.0	0.0	0.6	0.9	0.1	0.2	0.0	0.1	0.1	0.0	0.7	0.4	0.0	0.5	3.9	0.3	0.7	0.0	0.0	0.5	8.2	9.1	5.6	13.8	8.7	8.4	10.0	7.9	14.3	4.0
ID3	"bHLHb25, HEIR-1"	ENSG00000117318	"Inhibitor of DNA binding 3, HLH protein"	Q02535	1	23557918-23559794	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Myogenesis, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 117.9"	"Cell line enhanced"	"Detected in many"		"U-698: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 47.4;naive B-cell: 42.9"	"Group enriched"	"Detected in many"	37	"B-cells: 47.4;T-cells: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021353, HPA024677"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB021353: , HPA024677: "	"unprognostic (6.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.19e-2)"	"prognostic favourable (1.27e-5)"	"unprognostic (5.58e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.37e-3)"	"unprognostic (8.36e-2)"	33.5	12.2	13.3	18.9	15.5	6.0	41.6	2.4	14.4	22.0	25.9	16.6	31.4	18.9	21.7	17.8	20.6	33.8	22.9	42.2	21.1	12.4	21.3	11.1	25.8	15.3	16.6	9.1	27.2	10.2	4.2	31.1	31.3	17.7	38.9	13.0	42.6	9.1	117.9	17.0	14.2	17.0	13.3	16.9	12.4	21.6	6.9	20.7	20.5	82.8	19.3	10.7	35.0	72.1	47.4	0.9	0.5	0.2	0.0	24.9	6.1	3.2	20.0	6.9	24.0	3.1	0.4	8.0	24.1	2.1	13.5	1.7	1.2	0.1	21.4	24.9	9.0	27.6	8.5	3.2	1.3	0.1	8.8	0.3	26.1	10.7	9.7	0.0	0.0	10.1	16.9	0.3	0.2	12.0	0.1	0.2	12.2	7.9	2.8	0.0	6.0	5.0	26.7	12.7	0.7	0.1	7.6	10.1	7.9	23.0	17.1	1.7	4.4	0.5	24.7	19.1	10.2	9.5	12.5	6.7	6.0	82.5	4.2	0.2	11.1	0.0	0.2	0.0	0.6	0.2	0.2	47.4	10.9	2.1	0.7	42.9	18.2	7.2	0.5	0.0	0.2	0.9	24.9	6.1	13.3	15.5	2.4	14.4	21.1	12.4	16.6	9.1	17.7	20.7
ID4	bHLHb27	ENSG00000172201	"Inhibitor of DNA binding 4, HLH protein"	P47928	6	19837386-19840684	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"thyroid gland: 154.6"	"Cell line enhanced"	"Detected in some"		"AF22: 16.9;AN3-CA: 22.2;EFO-21: 50.7;HEK 293: 28.4;SCLC-21H: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060800			Supported	Nucleoplasm				Nucleoplasm		"HPA060800: "	"unprognostic (3.25e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	"prognostic favourable (2.49e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.57e-3)"	33.1	2.1	29.3	5.3	29.6	1.1	16.9	13.2	31.1	21.1	5.1	29.0	7.2	4.9	22.9	7.0	12.1	34.1	6.8	25.2	32.3	20.6	11.7	2.4	14.6	3.5	14.5	19.0	22.9	11.8	2.0	13.1	13.2	24.9	18.7	4.6	5.7	16.0	26.6	1.8	31.3	4.0	14.2	12.5	11.4	11.9	10.8	20.0	0.0	154.6	4.4	3.5	10.5	11.5	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	16.9	22.2	0.5	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	50.7	5.7	8.6	0.0	0.0	0.2	0.0	28.4	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.0	3.0	6.0	45.8	0.6	0.0	0.7	2.9	1.4	0.0	0.0	0.1	2.6	0.0	0.7	0.0	0.0	0.5	0.7	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	29.3	29.6	13.2	19.2	32.3	20.6	14.5	19.0	24.9	20.0
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial"	P48735	15	90083045-90102504	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.2;skeletal muscle: 190.7"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria			53000000	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favourable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	5.4	2.0	14.9	10.1	16.6	22.6	8.8	4.9	19.1	6.4	16.2	13.8	12.4	16.1	5.9	15.3	23.7	6.0	9.4	126.2	10.2	9.3	25.0	93.2	6.9	15.8	14.4	12.0	3.0	25.1	8.4	3.3	15.1	11.9	13.3	14.5	6.0	28.0	21.9	190.7	11.0	13.9	15.8	11.0	7.5	27.9	1.2	7.6	28.2	3.4	69.0	13.6	11.0	8.6	16.8	32.8	17.2	56.3	22.2	29.5	31.2	10.2	5.8	30.2	30.0	4.2	5.2	25.7	12.8	19.5	12.1	13.0	2.7	8.9	12.2	3.6	10.6	3.5	4.4	3.9	5.8	23.9	2.9	20.8	2.2	20.3	5.1	14.2	21.1	10.8	2.2	2.9	2.3	24.8	3.1	10.5	9.3	29.8	68.3	22.1	9.0	2.4	57.9	21.7	36.3	18.7	12.3	43.6	22.1	15.9	63.6	5.1	51.3	43.9	5.9	21.7	3.1	2.8	5.9	17.3	3.2	1.4	6.9	30.0	12.5	9.0	26.4	17.2	26.1	48.0	12.4	16.8	18.7	29.5	32.8	9.8	10.2	18.2	5.1	22.2	56.3	17.8	15.9	31.2	14.9	16.6	4.9	19.1	10.2	9.3	14.4	12.0	11.9	7.6
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase 3 (NAD(+)) alpha"	P50213	15	78131498-78171949	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 47.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria			2000000	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favourable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	14.6	18.1	18.0	13.0	25.3	6.5	7.7	16.1	29.5	9.9	17.6	11.9	6.1	24.5	11.2	5.9	12.0	8.4	6.5	41.5	16.6	16.8	15.2	10.4	8.8	11.0	20.6	18.1	8.0	9.2	18.5	12.4	8.4	29.0	10.1	18.8	10.4	11.2	11.9	47.7	11.1	23.8	11.9	18.1	10.1	8.9	11.5	13.8	16.2	8.1	26.5	16.4	11.1	10.3	10.1	47.2	6.1	17.0	5.5	6.0	7.4	15.9	21.9	4.0	13.9	10.0	10.2	8.7	19.0	9.3	15.5	11.8	15.5	9.7	34.0	14.1	11.1	24.1	36.9	14.7	14.4	14.9	12.2	13.1	23.7	7.0	8.5	25.4	18.8	7.7	9.1	15.1	15.9	9.7	16.8	14.0	9.8	15.2	18.6	6.8	4.9	8.2	10.8	17.0	10.6	12.9	21.7	15.9	6.1	21.8	31.2	17.6	12.4	13.8	10.0	18.3	17.0	24.1	30.6	16.0	35.6	18.1	12.9	24.3	14.3	4.2	9.4	2.7	5.3	17.0	5.7	9.2	5.2	4.8	14.2	10.1	5.6	6.0	6.1	5.5	16.6	47.2	5.6	7.4	18.0	25.3	16.1	29.5	16.6	16.8	20.6	18.1	29.0	13.8
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase 3 (NAD(+)) beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favourable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	19.5	20.0	19.4	15.5	31.7	20.6	18.5	32.1	30.5	16.4	23.9	16.9	14.5	30.5	19.2	16.7	20.7	17.9	19.2	57.3	19.8	20.0	29.7	25.2	15.1	17.6	24.0	29.4	20.2	15.2	27.6	12.2	17.0	31.2	15.4	25.6	16.2	19.3	19.5	75.5	20.9	24.9	21.5	17.1	19.2	19.9	19.6	16.0	19.7	19.1	37.7	22.5	16.7	17.4	34.7	49.4	25.8	44.7	29.5	38.6	33.9	26.1	35.5	16.2	14.1	18.0	14.2	18.8	14.1	18.0	33.3	26.6	45.7	27.6	29.6	12.9	19.3	37.0	29.9	45.7	30.6	8.1	23.5	35.9	13.8	47.3	17.6	39.0	7.8	18.8	17.6	31.1	16.4	19.6	45.3	16.6	20.2	14.4	33.9	44.8	31.5	33.7	27.8	29.6	33.2	19.1	24.6	29.3	21.2	17.3	57.7	29.7	28.9	17.4	17.4	26.0	16.4	8.8	32.3	22.6	51.6	31.2	12.2	40.4	24.6	22.2	41.7	25.8	33.9	44.7	25.6	34.7	29.4	30.7	49.4	30.6	34.4	29.8	11.9	29.5	38.3	22.9	38.6	33.9	19.4	31.7	32.1	30.5	19.8	20.0	24.0	29.4	31.2	16.0
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 35.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol				Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favourable (5.27e-4)"	"prognostic favourable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.4	2.5	0.1	0.3	0.0	35.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9
IDUA	MPS1	ENSG00000127415	"Iduronidase, alpha-L-"	P35475	4	986997-1004506	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		130000	Vesicles		"CAB025901: , HPA046979: , HPA054254: "	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavourable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favourable (8.04e-5)"	11.0	15.0	14.7	12.0	15.3	10.8	12.9	36.5	15.7	12.4	9.2	10.9	16.9	17.1	13.0	13.4	7.7	12.1	15.9	8.9	13.4	6.5	13.4	10.7	12.8	11.2	11.6	10.0	14.6	22.6	13.0	15.2	4.0	12.8	14.5	6.0	14.1	20.2	15.8	6.2	16.8	11.8	7.3	9.0	15.3	21.3	4.7	12.6	7.6	14.0	3.4	10.0	10.4	11.2	0.8	4.1	0.0	3.8	3.1	4.5	1.1	3.0	5.7	0.0	2.4	13.2	4.7	8.7	8.3	7.3	2.8	1.7	2.0	9.8	1.3	9.3	5.6	1.9	0.3	1.1	0.6	8.3	0.4	4.9	5.9	0.7	5.5	4.0	13.2	9.0	4.1	2.3	0.0	2.0	2.4	0.1	2.7	3.3	2.7	4.2	1.9	5.4	7.5	0.0	1.4	4.6	6.1	0.1	3.8	0.9	0.0	4.7	6.7	3.4	8.6	15.4	1.7	8.6	2.2	32.0	3.6	1.6	7.5	5.4	3.7	0.0	3.5	0.0	3.3	2.7	4.5	0.6	2.7	2.6	4.1	0.8	3.4	2.0	0.0	3.1	3.8	2.5	1.3	1.1	14.7	15.3	36.5	15.7	13.4	6.5	11.6	10.0	12.8	12.6
IER2	ETR101	ENSG00000160888	"Immediate early response 2"	Q9BTL4	19	13150415-13154908	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 120.1"	"Cell line enhanced"	"Detected in all"		"NB-4: 56.3;U-266/84: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055387, HPA060574"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA055387: , HPA060574: "	"unprognostic (3.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.01e-1)"	34.1	24.4	11.5	13.4	16.1	68.2	19.1	13.3	16.8	16.4	20.3	10.1	28.7	12.6	20.3	13.0	22.3	66.8	16.4	16.2	14.1	5.9	16.8	19.9	25.4	14.0	19.2	13.7	33.9	21.6	15.1	17.0	19.9	14.9	26.4	10.0	11.6	34.4	27.1	4.2	45.6	13.7	24.1	15.3	17.1	25.3	7.0	14.2	6.7	29.0	6.7	11.9	18.3	26.4	23.8	14.3	120.1	27.5	28.4	38.4	30.3	13.7	8.2	6.4	9.8	4.3	5.8	14.3	10.7	5.8	7.4	4.3	7.0	8.3	8.1	10.8	7.7	9.3	3.0	6.2	3.7	4.8	5.6	10.7	14.0	5.8	5.3	13.4	12.0	2.9	15.3	7.9	4.9	8.6	26.9	11.0	2.8	22.5	8.0	56.3	12.3	35.6	15.7	6.5	9.7	6.6	8.1	8.0	11.5	11.9	36.9	24.2	4.3	8.1	15.5	15.6	10.7	12.9	30.8	32.4	72.1	8.4	8.4	26.8	12.0	40.5	23.4	37.6	38.4	27.5	33.1	21.3	27.0	30.7	14.3	23.8	18.1	22.7	120.1	28.4	24.7	6.5	25.3	30.3	11.5	16.1	13.3	16.8	14.1	5.9	19.2	13.7	14.9	14.2
IER3IP1		ENSG00000134049	"Immediate early response 3 interacting protein 1"	Q9Y5U9	18	47152834-47176374	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Diabetes mellitus, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA010027	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA010027: AB_1079098"	"unprognostic (6.13e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (6.47e-6)"	"unprognostic (9.86e-2)"	"unprognostic (5.13e-2)"	"prognostic favourable (8.59e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.53e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.27e-3)"	16.9	21.7	13.1	13.7	12.9	15.0	33.1	22.4	21.4	15.7	17.7	7.3	18.4	20.3	15.6	19.6	19.2	12.8	17.9	40.2	12.3	15.3	38.1	45.7	28.3	25.7	12.5	9.1	15.7	30.6	16.3	30.5	29.7	13.9	17.7	16.4	13.3	29.8	17.9	33.8	16.7	27.7	17.7	11.3	22.7	19.0	17.0	7.6	16.4	19.7	24.8	17.6	17.9	15.9	14.2	24.5	10.7	12.4	11.5	18.6	11.8	12.6	7.3	11.2	10.0	15.3	17.1	7.8	30.2	14.8	15.1	16.0	5.9	10.9	12.5	9.6	13.4	15.5	10.5	10.6	16.5	20.4	9.5	10.9	11.5	17.9	16.4	32.8	16.3	13.4	13.6	13.5	10.2	12.9	8.9	19.4	16.0	7.0	11.6	15.8	5.6	9.0	11.6	17.6	17.8	15.2	12.4	13.0	14.5	10.3	8.8	17.8	8.7	18.9	18.6	22.5	11.5	10.8	16.4	28.1	30.7	13.3	17.5	21.0	18.0	8.3	12.4	10.7	18.6	11.2	16.6	13.2	16.0	16.0	11.7	14.2	15.3	15.9	1.3	11.5	11.6	24.5	15.8	11.8	13.1	12.9	22.4	21.4	12.3	15.3	12.5	9.1	13.9	7.6
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA002134, CAB016293"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099"	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	64.2	21.0	10.9	42.5	18.0	10.2	34.8	6.7	11.4	28.5	18.6	9.6	7.8	7.5	32.5	21.8	32.8	25.0	33.4	24.8	16.5	7.5	13.3	10.2	32.1	51.0	19.5	6.3	32.6	5.5	3.2	7.0	21.4	18.0	23.0	15.2	10.9	33.6	11.2	14.6	23.7	21.6	29.1	32.2	63.2	11.8	14.2	16.0	81.8	19.1	24.2	41.8	30.9	27.6	28.9	20.8	51.2	21.0	27.9	24.6	16.9	6.9	0.5	2.4	0.1	16.8	55.6	0.0	14.8	39.7	41.7	55.5	0.0	8.9	40.9	12.8	9.0	20.3	0.3	15.0	16.7	12.6	0.1	10.5	3.1	0.0	31.4	3.6	0.7	52.3	26.9	21.3	30.4	43.8	0.2	30.0	23.1	0.0	48.0	3.3	6.4	5.4	22.7	15.4	47.2	5.8	2.6	1.1	0.0	19.4	0.1	42.1	0.0	4.2	24.7	10.7	5.1	30.2	6.2	28.0	13.1	38.4	30.8	11.8	25.8	2.5	21.0	0.1	18.9	20.5	16.9	27.6	18.1	19.3	20.8	28.9	11.5	14.6	51.2	27.9	18.5	15.6	24.6	16.9	10.9	18.0	6.7	11.4	16.5	7.5	19.5	6.3	18.0	16.0
IFI30	"GILT, IFI-30, IP-30, IP30, MGC32056"	ENSG00000216490	"IFI30, lysosomal thiol reductase"	P13284	19	18173162-18178117	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 348.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 75.3;RPMI-8226: 81.6;SK-BR-3: 55.1;U-266/84: 90.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 348.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5"					"Low region specificity"	"Detected in many"			HPA026650	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"		89000	"Vesicles, Cytosol"		"HPA026650: AB_10602237"	"unprognostic (4.66e-2)"	"unprognostic (1.25e-4)"	"unprognostic (2.35e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (9.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.29e-11)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.59e-3)"	104.2	31.0	5.8	85.5	10.8	28.3	13.9	1.2	5.2	5.3	17.4	6.5	3.2	23.3	5.0	13.7	9.3	15.9	13.1	16.2	5.0	4.0	37.5	60.4	109.7	139.5	12.0	0.8	15.0	14.6	2.0	7.6	123.2	11.0	8.6	18.2	9.2	18.7	4.3	7.2	10.1	28.5	18.9	13.3	140.6	19.4	5.7	7.9	20.6	15.6	9.6	41.2	24.5	8.2	24.3	145.5	95.4	348.5	1.7	1.0	213.4	12.7	6.7	0.0	4.4	1.3	1.8	12.1	1.4	1.8	3.9	10.1	15.2	22.8	75.3	11.6	4.3	10.0	8.0	2.9	0.4	20.0	5.7	0.8	12.5	21.5	12.8	2.2	5.8	7.8	6.8	6.4	2.2	0.2	10.6	47.3	1.9	24.9	1.0	0.2	2.5	6.7	7.3	0.5	81.6	11.6	0.4	0.6	0.8	23.4	55.1	1.3	3.7	0.9	0.3	6.7	4.0	13.8	1.4	1.6	90.3	42.9	18.7	14.9	1.0	2.0	228.9	95.4	1.0	348.5	1.0	24.3	0.7	0.8	145.5	16.8	0.5	0.6	52.5	1.7	230.0	4.3	1.0	213.4	5.8	10.8	1.2	5.2	5.0	4.0	12.0	0.8	11.0	7.9
IFIT1	"G10P1, GARG-16, IFI56, IFNAI1"	ENSG00000185745	"Interferon induced protein with tetratricopeptide repeats 1"	P09914	10	89392546-89406486	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 113.0;BJ hTERT+ SV40 Large T+ RasG12V: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 47.8;monocytes: 13.5"									"CAB045980, HPA055380"	Approved		Supported	Cytosol				Cytosol		"CAB045980: AB_11125836, HPA055380: "	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.35e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.82e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.75e-3)"	"unprognostic (6.40e-3)"	17.4	25.1	21.8	4.6	18.4	10.5	8.7	38.8	29.8	9.2	8.1	9.9	3.5	4.1	8.0	13.7	7.6	10.3	17.5	15.6	16.5	24.0	23.7	28.7	16.8	3.4	20.1	22.6	10.3	6.8	19.5	13.5	12.4	28.8	9.6	6.4	10.6	46.4	8.2	18.3	3.3	4.7	10.1	24.9	20.8	4.5	5.2	18.3	5.0	7.9	7.7	2.9	9.6	6.2	2.2	2.7	47.8	13.5	1.3	4.5	5.2	3.1	0.3	0.7	5.5	2.8	5.8	0.0	3.7	23.6	113.0	111.5	0.3	3.3	0.2	1.2	4.8	2.4	0.3	0.3	5.5	0.1	0.3	0.4	2.7	0.2	3.2	0.4	0.3	4.7	0.0	2.1	0.0	0.1	0.0	2.5	1.2	0.0	0.7	2.1	0.0	2.0	0.9	0.2	0.6	2.7	0.3	0.0	0.1	0.9	0.4	22.0	0.2	0.3	0.1	0.5	0.5	0.7	0.4	0.2	0.3	0.1	0.7	0.7	0.1	6.8	8.9	10.6	1.2	11.0	2.1	2.2	3.2	2.2	2.7	2.2	4.5	2.7	47.8	1.3	13.5	0.1	3.4	5.2	21.8	18.4	38.8	29.8	16.5	24.0	20.1	22.6	28.8	18.3
IFIT3	"CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G"	ENSG00000119917	"Interferon induced protein with tetratricopeptide repeats 3"	O14879	10	89327894-89340971	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 80.0"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 34.4;BJ hTERT+ SV40 Large T+: 80.5;BJ hTERT+ SV40 Large T+ RasG12V: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 80.0"					"Low region specificity"	"Detected in all"			HPA059914	Approved		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA059914: "	"unprognostic (2.81e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.09e-2)"	50.5	15.7	14.9	11.3	17.3	22.1	10.6	6.9	17.0	6.8	9.7	7.6	4.1	14.5	8.8	16.8	6.2	10.9	15.1	8.9	14.2	12.9	19.3	17.0	25.9	10.0	13.5	12.4	11.3	4.3	3.8	5.5	22.9	23.0	9.7	5.4	9.2	19.6	8.1	8.1	5.0	11.3	11.1	18.4	26.0	7.2	5.1	12.1	14.3	14.9	5.5	2.9	11.0	5.9	1.6	2.5	80.0	18.4	0.3	2.6	3.2	6.2	0.4	0.1	1.7	7.3	7.9	0.0	4.0	34.4	80.5	93.5	0.3	9.1	0.5	1.7	6.4	5.6	0.1	0.8	5.9	0.9	0.0	2.4	1.8	0.2	4.2	0.7	2.0	4.9	0.1	7.0	0.5	0.4	0.1	1.4	2.0	0.0	1.5	1.9	0.1	2.0	1.5	0.5	0.4	2.3	3.0	0.0	0.0	0.7	0.1	15.8	0.2	0.8	0.6	1.3	0.2	2.2	1.0	2.2	1.8	0.1	1.8	3.0	1.3	15.2	7.5	26.6	0.7	16.0	0.1	1.6	1.1	0.5	2.5	1.4	0.7	0.8	80.0	0.3	18.4	0.5	2.6	3.2	14.9	17.3	6.9	17.0	14.2	12.9	13.5	12.4	23.0	12.1
IFIT5	RI58	ENSG00000152778	"Interferon induced protein with tetratricopeptide repeats 5"	Q13325	10	89414586-89421001	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 30.1;BJ hTERT+ SV40 Large T+ RasG12V: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037957, HPA062180"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA037957: AB_10672499, HPA062180: "	"unprognostic (2.17e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.73e-1)"	26.6	14.5	15.6	9.7	14.8	11.5	13.1	16.1	15.2	11.9	10.0	11.4	5.5	8.9	11.7	10.9	12.4	10.9	11.9	13.4	15.6	18.1	13.0	14.2	16.8	11.9	17.6	12.3	16.1	8.8	30.2	12.1	13.1	20.6	12.5	8.9	8.4	11.0	10.3	6.6	5.8	11.7	12.8	16.7	20.1	8.8	7.0	15.4	11.1	15.3	5.5	10.1	13.7	14.0	9.1	5.5	21.2	10.4	3.6	8.0	5.0	9.8	2.7	4.0	14.5	13.2	13.1	0.5	7.1	17.1	30.1	36.0	0.1	4.8	0.4	3.0	10.2	8.2	5.5	5.4	7.8	4.5	3.1	1.1	2.1	1.6	14.9	0.1	0.9	11.3	2.4	6.9	6.0	1.6	0.0	7.7	9.6	1.9	2.7	1.4	0.5	4.7	2.6	5.1	0.9	8.3	1.2	0.5	3.2	3.7	1.7	16.1	1.5	1.0	4.0	3.8	2.8	6.5	5.1	1.0	0.1	0.0	6.5	0.9	3.2	8.1	6.3	8.2	6.2	10.0	7.6	9.1	6.9	6.0	5.5	7.4	8.0	6.6	21.2	3.6	10.4	0.4	6.3	5.0	15.6	14.8	16.1	14.0	15.6	18.1	17.6	12.3	20.6	15.4
IFITM1	"9-27, CD225, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	313506-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 120.0;BJ hTERT+ SV40 Large T+ RasG12V: 215.2;HMC-1: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1"									"HPA004810, CAB017615"	Enhanced		Supported	Cytosol				Cytosol		"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	81.1	14.2	17.4	36.7	24.5	41.2	57.0	11.9	23.1	71.0	28.2	12.9	20.6	17.2	48.3	152.4	44.4	67.2	31.2	62.6	19.8	13.9	59.8	34.5	44.1	159.7	34.8	14.7	100.2	16.3	22.3	23.3	36.3	27.3	38.7	22.1	49.5	27.4	41.6	38.7	23.6	33.0	46.0	37.9	112.9	20.5	29.4	20.1	42.7	48.3	28.0	50.3	39.3	52.8	13.0	4.3	106.8	18.6	164.4	128.1	147.7	6.2	0.1	52.2	4.2	3.8	13.4	0.3	11.1	51.9	120.0	215.2	0.1	43.5	0.1	8.3	11.6	14.8	1.6	1.1	2.4	13.2	2.7	6.4	4.0	0.4	34.6	9.3	66.4	25.1	0.0	1.3	0.1	0.2	22.7	52.7	0.0	0.9	4.6	17.9	14.8	1.6	1.2	0.1	1.2	32.1	0.0	0.0	0.0	5.8	0.6	10.6	2.1	0.8	0.3	0.1	0.1	0.0	0.0	3.7	2.0	0.3	0.1	14.0	0.1	15.6	2.3	56.6	120.0	10.9	80.7	13.0	128.1	121.4	4.3	11.3	123.5	123.4	106.8	164.4	18.6	1.2	70.4	147.7	17.4	24.5	11.9	23.1	19.8	13.9	34.8	14.7	27.3	20.1
IFT122	"SPG, WDR10, WDR10p, WDR140"	ENSG00000163913	"Intraflagellar transport 122"	Q9HBG6	3	129440036-129520507	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 84.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041815	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA041815: AB_10804118"	"unprognostic (7.16e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.67e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.33e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.20e-3)"	7.4	5.7	11.1	4.9	14.0	6.4	9.1	13.3	13.1	10.2	5.6	7.6	6.4	3.5	10.2	9.6	5.4	18.5	5.0	10.0	7.8	6.4	8.8	6.7	6.7	4.5	4.4	9.2	19.0	9.6	13.1	18.9	7.7	7.2	5.7	5.2	10.5	6.3	6.7	3.7	9.9	4.1	7.6	4.2	3.7	6.7	84.7	5.7	7.6	9.6	2.0	4.2	5.3	6.9	4.7	6.0	8.3	5.7	2.8	5.5	3.8	10.8	16.5	14.3	9.4	20.8	14.8	7.6	5.8	8.8	10.2	9.9	7.9	7.2	7.0	6.9	7.5	7.0	5.5	5.1	9.3	3.8	5.9	5.3	13.5	6.7	5.7	14.7	5.0	17.3	3.9	7.8	6.1	13.7	5.4	15.1	8.2	12.0	12.0	7.6	9.5	4.7	10.7	5.5	5.0	10.9	2.0	18.2	7.4	16.7	5.6	5.0	15.3	11.8	6.0	7.2	6.2	9.3	6.9	10.3	7.2	6.1	6.5	7.5	5.5	8.3	5.7	6.6	1.9	3.9	3.3	3.8	3.3	4.5	6.0	4.7	3.7	4.5	2.7	2.8	1.7	1.4	5.5	3.8	11.1	14.0	13.3	13.1	7.8	6.4	4.4	9.2	7.2	5.7
IFT43	"C14orf179, FLJ32173, MGC16028"	ENSG00000119650	"Intraflagellar transport 43"	Q96FT9	14	75902136-76084585	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Ectodermal dysplasia, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003438	Approved		Supported	"Microtubules,Centriolar satellite"				Microtubules	"Centriolar satellite"	"HPA003438: AB_1078327"	"unprognostic (1.64e-2)"	"unprognostic (5.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.07e-2)"	13.9	16.0	17.1	10.2	21.2	3.4	18.5	11.6	17.8	19.2	18.1	17.9	18.1	16.2	20.0	36.8	12.7	46.0	17.2	28.9	14.9	14.4	22.3	30.7	12.9	7.3	12.8	13.8	15.3	24.2	15.4	27.9	15.0	16.8	17.5	14.2	19.8	12.7	23.0	8.2	9.2	21.6	20.1	11.5	12.2	13.7	23.5	13.5	9.8	25.6	7.5	11.7	15.5	11.9	21.9	15.2	19.5	11.6	10.9	19.5	10.4	12.1	13.7	10.0	15.4	12.6	20.5	7.1	8.0	15.3	12.2	12.4	5.1	12.5	1.3	8.8	14.0	12.9	9.4	14.7	13.9	6.3	9.3	0.6	7.9	0.0	35.6	1.3	2.9	18.1	16.1	13.5	17.8	18.8	3.3	5.5	14.7	24.4	4.9	2.1	5.2	17.6	3.2	8.1	3.8	28.0	10.7	9.7	11.7	15.7	10.9	10.8	28.0	3.6	8.6	7.2	9.1	10.5	6.9	7.3	6.3	1.5	28.4	0.5	7.4	19.5	8.9	14.2	11.0	11.6	13.6	21.9	12.0	11.1	11.8	16.1	19.5	18.6	4.3	10.9	11.4	15.2	13.9	10.4	17.1	21.2	11.6	17.8	14.9	14.4	12.8	13.8	16.8	13.5
IGF2BP1	IMP-1	ENSG00000159217	"Insulin like growth factor 2 mRNA binding protein 1"	Q9NZI8	17	48997412-49055650	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"placenta: 17.6;testis: 17.8"	"Cell line enhanced"	"Detected in many"		"AF22: 35.9;CACO-2: 56.5;Hep G2: 26.5;K-562: 28.6;NTERA-2: 28.7;REH: 32.7"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 28.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA021367, HPA062273"	Enhanced		Supported	Cytosol				Cytosol		"HPA021367: AB_1851480, HPA062273: AB_2684733"	"unprognostic (6.79e-4)"	"unprognostic (2.76e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.30e-6)"	"unprognostic (1.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.80e-6)"	"unprognostic (2.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.47e-1)"	0.1	0.1	0.0	0.9	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.1	0.3	0.5	0.1	0.3	0.1	0.1	0.0	0.1	17.6	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	17.8	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	35.9	0.0	1.3	1.9	25.7	2.0	0.0	2.9	4.9	56.5	0.9	2.9	0.2	0.2	0.0	22.1	0.0	5.2	0.0	13.0	21.4	7.7	26.5	1.7	11.3	5.7	2.6	0.0	0.7	0.0	6.0	28.6	0.0	4.0	0.2	0.0	9.5	28.7	0.0	32.7	11.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	3.1	0.1	0.0	0.3	3.0	0.0	0.0	0.0	19.3	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643739-185825056	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 43.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB017126: , HPA035145: "	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavourable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	7.9	8.9	1.0	6.4	1.9	7.6	4.9	8.6	1.6	6.5	16.4	1.6	1.5	11.3	7.6	4.8	3.7	8.3	8.1	9.9	1.7	1.4	8.0	2.6	14.0	4.0	2.8	0.7	6.7	11.3	7.6	2.9	43.0	4.5	4.9	11.6	16.9	9.0	1.6	3.2	4.3	21.4	3.3	3.7	5.8	9.9	5.1	1.5	2.4	8.6	3.2	3.3	6.2	12.5	0.0	5.5	0.9	3.3	1.3	0.0	1.2	28.2	2.4	27.6	5.2	15.1	23.9	16.9	14.9	21.1	23.2	27.9	20.3	8.0	0.0	22.2	12.6	12.9	12.9	21.7	37.7	0.0	13.4	8.0	0.1	14.0	32.3	0.2	0.0	17.5	11.5	15.4	60.0	21.3	7.8	0.0	17.0	0.2	0.0	6.8	20.2	10.2	2.9	11.0	8.4	15.0	0.1	1.7	0.2	1.1	0.0	26.6	2.2	18.9	32.3	8.1	17.6	10.1	17.1	0.1	0.0	0.0	8.0	0.0	11.3	0.9	3.0	0.5	0.0	2.8	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.2	1.3	3.3	1.0	0.0	1.2	1.0	1.9	8.6	1.6	1.7	1.4	2.8	0.7	4.5	1.5
IGF2BP3	"CT98, IMP-3, IMP3"	ENSG00000136231	"Insulin like growth factor 2 mRNA binding protein 3"	O00425	7	23310209-23470467	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 74.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 52.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002037, HPA076951"	Enhanced		Supported	Cytosol				Cytosol		"HPA002037: AB_1851483, HPA076951: "	"unprognostic (5.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.02e-5)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.43e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.87e-4)"	"unprognostic (7.51e-3)"	0.4	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.3	0.4	0.3	0.4	0.1	0.0	0.2	1.3	4.8	0.7	0.1	0.5	0.3	0.2	0.2	0.3	1.2	3.4	0.2	0.0	0.2	1.5	0.0	0.2	74.0	0.7	0.2	0.0	0.3	0.7	0.1	0.2	0.2	0.3	0.0	1.2	1.0	0.2	6.5	0.0	11.4	0.6	0.2	6.0	0.2	0.6	1.2	0.4	1.5	1.5	0.0	0.2	3.0	14.5	4.3	32.7	9.7	5.2	13.8	20.0	2.4	11.0	6.1	7.6	13.8	11.6	11.0	13.2	6.5	9.6	14.1	10.8	10.8	1.7	5.6	5.8	11.7	11.5	16.1	10.5	4.1	14.1	7.6	4.7	2.0	52.3	26.4	0.0	14.8	0.0	6.4	7.1	26.1	13.4	9.9	10.9	14.1	12.1	1.3	8.6	18.8	1.4	0.1	12.2	0.0	2.0	21.0	5.9	0.3	12.8	6.3	0.0	4.6	17.3	23.5	11.8	22.6	0.0	1.5	0.0	0.1	0.8	0.0	1.2	0.0	0.0	0.4	0.9	0.2	0.0	1.5	0.0	0.0	0.0	0.0	3.0	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.0	0.7	0.0
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969099-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 59.6;hTERT-HME1: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"			150000000	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavourable (3.01e-4)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (6.08e-4)"	28.0	22.2	6.8	13.5	8.1	16.7	39.4	6.4	8.2	14.9	17.3	9.5	13.0	9.4	19.6	16.0	16.7	13.1	17.9	27.9	6.7	6.2	20.6	26.6	32.6	44.7	12.3	3.6	18.0	19.6	23.5	13.6	15.5	10.0	14.1	13.3	13.9	18.2	13.5	62.0	15.9	15.4	16.5	7.6	30.2	14.4	13.8	9.0	37.9	18.5	17.3	14.1	16.3	26.9	0.4	2.9	13.3	2.0	1.0	3.6	0.9	7.7	7.0	12.4	17.4	45.3	25.0	16.8	12.2	26.4	10.1	17.4	10.6	12.2	3.2	13.7	13.4	10.4	9.3	59.6	17.0	16.8	6.6	1.4	12.2	19.1	26.8	7.4	12.1	19.9	19.1	21.0	60.7	6.5	13.9	17.4	15.9	5.7	3.4	7.4	5.5	7.5	8.0	8.5	16.3	14.3	7.8	4.1	9.1	16.5	14.8	16.5	6.2	21.0	9.8	9.8	10.3	21.1	22.3	10.3	14.4	3.3	18.9	10.2	15.1	0.1	2.0	1.1	3.6	0.8	1.4	0.3	1.2	1.7	0.3	0.4	1.0	2.4	13.3	1.0	1.4	2.9	0.7	0.9	6.8	8.1	6.4	8.2	6.7	6.2	12.3	3.6	10.0	9.0
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu binding protein 2"	P38935	11	68903842-68940602	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004092, HPA060994"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA004092: , HPA060994: "	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favourable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	7.2	6.0	6.9	8.1	11.0	13.8	9.4	17.7	14.9	8.1	14.6	8.3	14.3	9.7	12.0	5.4	8.8	8.5	7.8	7.7	6.6	5.3	6.7	8.7	7.3	7.9	4.6	7.0	9.4	9.6	7.7	6.0	6.5	6.6	9.0	6.1	7.9	12.7	10.0	12.2	11.7	9.4	8.1	4.1	8.9	9.1	36.9	5.7	10.0	7.3	5.9	8.8	8.8	8.3	5.0	3.3	4.7	12.1	2.7	5.1	2.7	8.0	9.2	5.5	8.8	4.5	3.5	8.4	8.0	5.0	10.0	6.6	18.7	8.0	7.0	11.4	4.1	12.8	9.2	5.0	4.2	8.2	7.8	10.0	10.9	6.0	5.2	7.5	9.5	2.6	6.0	10.6	5.4	5.1	11.7	9.0	3.4	6.3	11.9	13.5	4.8	9.8	9.9	8.4	8.5	4.7	7.3	8.8	6.4	9.5	8.2	19.0	12.6	5.7	6.9	8.6	7.5	11.5	8.3	10.1	7.7	8.1	6.0	7.3	7.8	0.0	3.9	2.2	5.1	3.3	4.7	5.0	3.4	4.0	3.3	3.3	2.4	3.3	4.7	2.7	12.1	2.5	4.0	2.7	6.9	11.0	17.7	14.9	6.6	5.3	4.6	7.0	6.6	5.7
IGSF8	"CD316, CD81P3, EWI2, PGRL"	ENSG00000162729	"Immunoglobulin superfamily member 8"	Q969P0	1	160091340-160098943	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.2"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011917, HPA075970"	Approved		Supported	Vesicles			190000	Vesicles		"HPA011917: AB_1851536, HPA075970: "	"unprognostic (4.08e-1)"	"prognostic unfavourable (7.32e-4)"	"unprognostic (1.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.75e-3)"	9.9	10.4	25.2	9.0	30.3	2.4	11.1	40.9	54.2	9.6	11.8	53.5	6.4	18.2	8.6	16.6	7.0	13.9	8.5	11.6	32.4	24.1	10.4	19.3	10.1	10.3	32.2	29.9	15.1	19.1	9.0	8.7	7.8	25.9	13.8	7.4	11.2	21.0	14.0	6.0	34.0	14.4	5.1	42.6	10.6	9.8	11.5	25.3	6.2	10.0	5.9	6.2	6.0	6.9	14.3	5.6	1.2	4.0	4.7	15.6	6.4	8.8	5.3	6.9	17.6	4.1	2.6	14.6	4.3	5.7	9.3	8.7	6.0	6.1	13.0	16.3	6.3	17.0	2.8	6.4	1.3	15.5	5.0	1.6	5.9	10.3	6.8	4.4	14.5	3.1	13.0	6.0	1.9	1.9	2.2	7.5	2.1	8.4	11.0	10.3	14.6	8.5	6.3	3.5	9.4	8.5	9.2	2.9	12.6	5.0	16.2	58.0	11.5	5.7	1.9	4.1	8.9	7.4	3.5	20.6	22.8	5.8	14.5	1.7	10.7	0.0	2.9	1.2	13.3	4.0	11.7	12.2	11.0	15.4	3.3	14.3	14.8	15.6	0.8	4.7	2.4	5.6	14.9	6.4	25.2	30.3	40.9	54.2	32.4	24.1	32.2	29.9	25.9	25.3
IK	"RED, RER"	ENSG00000113141	"IK cytokine"	Q13123	5	140647058-140662479	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048798	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA048798: "	"unprognostic (9.90e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavourable (2.32e-7)"	"unprognostic (1.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.83e-1)"	42.0	37.7	35.6	35.3	45.6	61.3	36.9	56.3	41.6	40.2	38.8	44.1	31.3	29.7	44.3	41.0	45.8	79.4	28.9	40.1	36.6	35.6	40.7	36.7	37.0	43.3	34.2	39.2	48.3	27.4	42.3	47.8	39.6	41.6	43.8	38.9	31.0	37.2	41.6	71.4	39.6	40.0	48.3	39.4	45.6	34.1	54.4	45.4	69.5	42.0	37.8	49.4	55.4	37.4	54.3	39.2	76.6	50.0	53.9	76.4	60.5	32.6	35.4	31.7	46.0	35.3	31.1	38.0	38.7	41.2	43.2	43.6	49.5	37.3	38.0	50.0	40.1	33.8	47.1	52.9	50.3	55.8	37.3	37.7	59.6	31.4	37.7	59.9	39.1	34.0	34.7	43.1	38.7	36.5	38.6	35.8	38.3	28.8	52.2	59.0	21.1	37.7	39.5	47.6	37.9	32.6	30.8	29.5	32.7	47.8	44.7	45.7	51.1	46.4	39.2	36.3	25.0	30.5	46.3	51.8	78.4	53.5	41.4	45.4	27.5	76.6	39.2	65.6	57.0	44.0	50.3	54.3	61.8	58.0	39.2	50.1	65.7	61.1	66.1	53.9	50.0	37.3	76.4	60.5	35.6	45.6	56.3	41.6	36.6	35.6	34.2	39.2	41.6	45.4
IKBIP	"FLJ31051, IKIP"	ENSG00000166130	"IKBKB interacting protein"	Q70UQ0	12	98613405-98645113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038677, HPA038678, HPA061541"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (4.00e-5)"	"unprognostic (6.28e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (4.60e-9)"	"unprognostic (7.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.16e-2)"	21.0	8.9	3.7	12.2	4.6	3.6	13.6	1.1	4.0	17.0	12.3	1.7	6.0	3.3	9.5	10.2	8.5	7.3	11.0	23.6	4.0	3.7	17.0	25.3	16.1	14.0	4.2	1.7	12.8	5.8	4.1	12.6	22.1	6.3	12.2	6.1	3.6	7.6	6.7	10.0	3.2	6.2	13.3	5.2	30.6	5.3	5.8	3.8	15.2	19.8	6.2	7.8	15.1	26.2	3.3	3.7	19.8	4.3	3.7	2.4	1.1	3.2	10.1	11.5	7.1	27.7	29.3	10.1	53.2	32.7	14.1	18.0	2.1	3.2	10.7	9.1	32.7	7.0	4.4	20.4	23.9	3.1	6.8	4.1	6.5	15.1	10.6	7.5	8.2	21.9	4.4	16.2	14.6	19.8	6.2	4.2	34.6	2.9	3.4	17.5	4.3	8.7	3.0	16.6	5.4	23.2	3.7	1.7	5.5	15.2	1.0	8.4	3.3	9.5	18.5	30.1	10.7	13.2	13.6	4.6	4.8	8.0	8.9	7.0	21.6	6.0	4.3	12.6	2.1	3.3	2.4	3.3	1.3	2.1	3.7	2.2	1.4	1.5	19.8	3.7	3.7	2.6	1.6	1.1	3.7	4.6	1.1	4.0	4.0	3.7	4.2	1.7	6.3	3.8
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	"Inhibitor of nuclear factor kappa B kinase subunit epsilon"	Q14164	1	206470476-206496889	"Enzymes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.8;lymphoid tissue: 19.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 25.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015788, CAB025983"	Approved		Supported	Cytosol				Cytosol		"CAB025983: , HPA015788: AB_1851566"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.78e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (5.34e-7)"	"unprognostic (1.48e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.84e-2)"	2.1	0.9	1.0	17.3	3.4	4.3	1.4	1.1	1.7	2.2	4.8	1.5	1.7	3.9	2.0	3.9	6.1	1.2	3.6	1.1	2.9		1.5	0.6	3.7	13.6	2.1	0.7	1.0	1.5	0.0	0.8	2.5	1.9	1.8	4.3	1.5	8.3	2.9	0.1	8.9	4.2	1.0	2.9	12.8	4.0	0.0	2.4	18.8	2.6	4.4	19.5	4.4	0.4	12.9	4.6	4.2	15.9	10.8	24.8	12.3	8.8	7.0	1.9	0.2	3.5	5.0	2.0	3.6	11.3	4.9	5.5	5.5	14.4	17.5	9.7	7.2	12.0	0.0	9.1	1.0	2.8	1.7	2.4	4.2	3.8	4.6	14.9	8.0	6.5	1.6	4.0	0.8	7.1	1.1	5.4	5.1	1.8	9.5	25.1	2.8	5.4	5.1	2.1	14.0	5.8	15.1	0.0	0.0	1.5	12.0	2.2	7.2	10.6	13.7	4.9	3.0	3.5	4.0	1.8	0.8	11.4	9.2	12.5	2.0	4.2	15.9	0.3	10.5	11.2	7.5	12.9	16.7	15.2	4.6	7.4	13.3	13.6	1.1	10.8	6.4	1.5	24.8	12.3										
IKBKG	"FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9"	ENSG00000269335	"Inhibitor of nuclear factor kappa B kinase subunit gamma"	Q9Y6K9	X	154541199-154565046	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"		"Disease mutation, Ectodermal dysplasia, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000426, CAB010373"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB010373: AB_2124846, HPA000426: AB_1851572"	"unprognostic (7.53e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.37e-3)"	"unprognostic (9.77e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.36e-2)"	6.5	5.8	5.2	10.2	6.1	15.1	5.0	5.4	9.2	5.2	4.5	9.1	5.9	7.5	5.2	6.2	6.3	4.5	7.7	5.1	4.9		3.9	16.3	6.5	10.4	6.9	5.1	5.1	6.1	3.5	2.0	6.8	6.7	5.0	3.9	5.6	5.7	3.9	4.6	11.4	6.6	8.1	3.7	10.8	7.4	4.2	6.2	6.9	5.0	6.9	9.9	4.9	6.2	11.3	13.7	28.8	21.8	13.8	17.9	13.5	15.9	16.4	4.0	13.0	9.1	7.7	11.0	10.7	13.9	11.4	16.5	11.6	9.6	12.8	27.1	12.0	15.0	5.8	9.8	4.9	15.3	8.2	10.5	23.7	21.7	14.0	10.3	36.8	9.1	8.3	16.0	6.5	13.6	5.8	12.8	9.1	15.5	10.6	17.3	3.7	27.3	11.7	6.3	13.6	11.3	10.2	7.1	7.1	13.3	12.5	7.7	7.2	11.5	13.8	10.6	12.4	28.3	25.6	25.2	17.8	24.0	15.8	18.7	15.4	10.5	15.4	28.8	17.9	20.5	12.3	11.3	11.4	13.0	13.7	10.1	9.5	11.3	25.4	13.8	21.8	12.2	13.0	13.5										
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757715-39864188	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.7;lymphoid tissue: 55.1"	"Group enriched"	"Detected in some"	4	"Daudi: 26.5;Karpas-707: 14.0;U-266/70: 16.9;U-266/84: 18.8;U-698: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 8.3;T-cells: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024377, HPA073266"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favourable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favourable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favourable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.7	0.7	0.5	41.7	0.5	3.1	1.0	0.5	0.5	1.1	4.5	0.0	0.6	1.8	1.2	0.6	3.6	1.2	2.4	0.9	0.6	0.6	1.5	1.4	5.3	30.5	0.6	0.0	0.9	0.9	0.0	0.7	0.4	0.1	1.5	1.7	1.2	5.5	1.3	0.6	0.8	11.3	1.2	0.9	41.0	3.3	2.6	0.1	55.1	1.6	1.8	54.1	4.0	1.3	8.3	0.3	0.7	0.1	2.6	17.7	4.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	26.5	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.1	1.6	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	14.0	0.0	0.1	2.3	0.9	0.1	0.0	0.1	0.1	4.8	0.0	1.6	0.1	0.1	0.5	0.2	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.0	16.9	18.8	43.1	0.0	0.1	0.0	0.5	0.1	0.4	16.3	0.1	17.7	8.3	6.7	12.1	0.0	7.7	2.8	7.5	0.7	2.6	0.1	0.3	10.6	4.1	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.0	0.1	0.1
IKZF4	"Eos, ZNFN1A4"	ENSG00000123411	"IKAROS family zinc finger 4"	Q9H2S9	12	56007659-56038435	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 1.3;T-reg: 5.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046270, HPA049016"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA046270: , HPA049016: "	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.63e-3)"	"prognostic favourable (3.46e-4)"	"unprognostic (2.42e-1)"	"unprognostic (5.43e-2)"	"prognostic favourable (4.37e-4)"	"unprognostic (6.52e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.74e-3)"	5.6	14.5	7.7	7.4	8.5	6.7	8.1	13.9	7.6	7.2	6.9	6.5	7.1	3.4	7.7	8.5	4.1	10.0	5.9	5.6	6.3	6.3	5.6	4.1	7.3	4.2	5.9	9.8	16.2	5.7	20.8	22.1	5.9	9.2	8.1	4.3	9.2	3.7	8.6	16.8	4.1	4.5	10.8	8.4	4.1	5.7	9.1	5.9	5.2	8.8	4.5	4.5	6.4	14.0	0.3	0.3	0.0	0.4	0.1	5.3	0.3	1.2	1.5	9.0	3.0	1.9	2.0	2.1	1.4	2.4	1.7	2.4	4.6	1.9	0.8	1.6	2.2	0.8	1.1	1.2	3.7	27.6	1.4	5.1	1.5	2.2	2.1	2.4	2.1	3.3	1.7	1.7	1.4	1.7	8.0	4.4	2.7	1.5	3.0	1.2	3.9	1.1	2.6	2.5	1.0	2.4	1.4	3.5	2.9	1.9	0.6	3.2	2.3	2.5	0.9	1.4	2.5	1.4	1.1	2.7	1.6	1.3	2.9	2.4	1.9	0.0	0.3	0.0	0.3	0.3	0.5	0.3	1.3	0.0	0.2	0.2	0.3	0.4	0.0	0.1	0.4	0.3	5.3	0.3	7.7	8.5	13.9	7.6	6.3	6.3	5.9	9.8	9.2	5.9
IKZF5	"FLJ22973, Pegasus, ZNFN1A5"	ENSG00000095574	"IKAROS family zinc finger 5"	Q9H5V7	10	122990806-123008817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015297, HPA051574"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA015297: AB_1855183, HPA051574: "	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.15e-2)"	11.7	11.7	20.3	9.2	23.5	38.0	16.6	24.9	20.5	12.0	9.2	22.1	7.5	8.8	12.5	13.6	9.4	9.9	8.4	9.4	18.0	14.5	11.8	14.7	10.6	13.4	28.9	13.5	19.3	14.8	14.2	22.9	10.7	21.2	11.6	9.8	11.2	10.6	8.8	12.3	13.7	10.8	9.8	21.8	11.6	9.9	13.4	26.8	14.7	13.6	7.0	12.4	9.4	11.1	7.6	6.7	8.2	8.0	9.7	13.4	6.7	5.9	3.0	6.0	10.2	9.7	8.9	6.6	5.0	10.8	6.7	8.2	4.8	7.0	15.0	3.7	6.1	8.2	10.6	7.5	9.9	8.4	9.4	9.6	4.9	7.1	6.5	11.6	8.8	7.0	10.4	8.0	17.4	7.3	13.1	10.1	7.2	4.3	10.5	12.7	5.5	4.2	8.6	7.5	8.6	5.5	4.1	6.6	5.9	4.2	5.1	9.7	4.2	7.5	7.5	4.9	4.1	7.1	8.0	9.4	5.1	14.2	6.2	20.4	2.9	7.5	6.3	8.2	9.4	8.0	10.9	6.2	8.6	9.0	6.7	7.6	11.9	13.4	6.1	9.7	7.7	4.7	10.9	6.7	20.3	23.5	24.9	20.5	18.0	14.5	28.9	13.5	21.2	26.8
IL12RB2		ENSG00000081985	"Interleukin 12 receptor subunit beta 2"	Q99665	1	67307364-67396900	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.2;pancreas: 15.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.4;SCLC-21H: 8.7;SK-MEL-30: 21.9;THP-1: 12.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 18.2"	"Group enriched"	"Detected in many"	42	"NK-cells: 18.2;T-cells: 6.1"	"Region enhanced"	"Detected in single"		"olfactory region: 1.8"	"Low region specificity"	"Detected in all"			HPA024168	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA024168: AB_1851629"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.90e-1)"	3.8	1.0	1.8	3.1	3.6	1.5	3.7	0.6	7.7	2.4	1.0	0.0	0.0	0.7	0.8	1.1	3.2	0.9	1.1	5.2	9.6	1.1	1.5	1.4	1.8	4.3	1.0	6.0	0.8	15.0	0.9	0.8	14.1	1.6	1.2	0.9	1.3	7.2	1.7	11.4	2.1	1.4	1.0	1.0	2.5	1.0	2.3	0.0	1.1	1.1	3.2	1.6	1.4	1.2	0.0	0.0	0.2	0.0	18.2	6.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.1	2.0	1.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.4	0.0	0.0	21.9	0.0	12.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	2.7	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.2	18.2	0.0	0.0	3.9	1.0	1.8	3.6	0.6	7.7	9.6	1.1	1.0	6.0	1.6	0.0
IL15	"IL-15, MGC9721"	ENSG00000164136	"Interleukin 15"	P40933	4	141636599-141733987	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.5;Karpas-707: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB004457, HPA037738"	Approved		Supported	"Nucleoplasm,Nuclear speckles"	"Secreted to blood"	20753		"Nucleoplasm, Nuclear speckles"		"CAB004457: AB_2124575, HPA037738: "	"unprognostic (1.10e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	7.7	3.7	1.1	21.3	1.5	2.9	9.2	1.8	2.2	6.0	8.8	0.8	2.2	6.3	11.3	7.4	5.6	4.6	9.9	9.3	1.1	1.5	6.9	3.7	14.4	18.8	2.3	1.6	3.2	3.1	0.5	4.5	9.9	2.1	7.7	5.7	5.9	6.9	3.6	9.1	3.2	14.2	7.1	2.6	17.0	5.3	2.6	2.0	9.8	18.1	5.9	11.0	9.8	16.9	3.7	4.6	8.1	14.0	2.6	4.5	4.4	2.4	5.2	0.2	0.5	0.8	4.7	1.3	5.6	5.3	5.8	4.7	2.8	6.8	2.3	7.3	4.8	3.6	0.1	3.0	3.2	15.5	1.4	0.4	13.7	0.4	3.9	1.6	1.1	1.7	1.2	3.8	0.4	3.7	3.8	15.2	3.7	0.8	3.4	0.3	2.6	1.6	0.9	13.4	0.3	7.6	0.6	0.5	1.3	2.4	3.7	2.7	0.9	0.2	5.5	5.9	3.8	1.7	3.4	10.7	1.3	0.7	6.3	0.6	2.1	8.1	14.0	0.8	2.5	12.4	4.5	3.7	2.9	2.2	4.6	3.4	1.2	1.3	1.0	2.6	12.5	0.1	1.5	4.4	1.1	1.5	1.8	2.2	1.1	1.5	2.3	1.6	2.1	2.0
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.7;lymphoid tissue: 97.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.2;HEL: 12.9;HMC-1: 23.3;RPMI-8226: 22.1;U-266/70: 27.7;U-698: 11.4;U-937: 15.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 40.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"cerebellum: 61.1;hippocampal formation: 29.7"	"Region enriched"	"Detected in single"	38	"cerebellum: 96.7"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Midbody ring,Cytosol"	"Secreted to blood"	125370	14000	"Nuclear speckles"	"Plasma membrane, Midbody ring, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	8.8	2.4	4.1	48.0	5.8	19.5	7.8	40.1	4.3	4.7	4.8	4.6	0.9	3.8	5.4	2.9	3.4	9.7	5.6	5.1	4.9	2.1	2.5	3.9	14.7	58.0	5.8	2.3	3.7	1.7	0.7	1.4	3.0	6.7	3.5	5.9	3.4	13.5	1.5	1.8	6.1	19.2	3.3	7.8	38.2	5.0	2.2	5.5	97.9	3.7	2.4	54.8	8.7	5.4	43.3	37.1	75.7	35.0	49.3	60.5	66.5	0.0	0.0	0.0	0.0	8.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.0	0.4	9.1	23.3	0.4	0.0	0.0	0.2	0.1	1.3	4.9	0.0	0.0	0.7	9.7	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	2.0	0.1	0.1	0.1	0.4	0.0	27.7	2.3	11.4	0.8	15.5	0.7	52.7	27.4	75.7	43.1	35.0	48.6	43.3	45.1	47.1	37.1	39.9	60.5	48.6	69.1	49.3	33.7	28.0	47.0	66.5	4.1	5.8	40.1	4.3	4.9	2.1	5.8	2.3	6.7	5.5
IL17RD	"FLJ35755, IL-17RD, IL17RLM, SEF"	ENSG00000144730	"Interleukin 17 receptor D"	Q8NFM7	3	57089982-57170306	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 10.4;AN3-CA: 28.1;NTERA-2: 16.2;SH-SY5Y: 42.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039577, HPA043550"	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA039577: , HPA043550: "	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.25e-1)"	"prognostic favourable (2.92e-9)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.58e-3)"	2.7	1.3	5.2	1.8	6.5	0.4	8.9	2.8	6.1	14.7	7.7	7.6	7.4	0.9	18.5	13.7	3.4	8.4	6.1	3.0	4.8	3.6	7.1	0.5	1.1	0.7	4.0	2.4	12.6	1.4	20.8	14.0	0.7	5.7	8.1	2.5	10.2	7.2	10.8	1.0	2.6	1.8	14.7	7.2	3.1	2.2	11.2	3.1	0.0	1.0	2.2	1.4	8.9	5.2	0.6	0.6	1.5	0.5	0.6	0.4	0.0	1.5	0.3	10.4	28.1	0.0	0.2	1.7	0.1	0.1	0.1	0.3	0.2	0.7	0.0	0.0	0.5	0.1	2.0	0.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.2	0.4	0.0	0.0	0.5	0.2	0.0	0.0	16.2	0.8	0.0	3.7	0.0	2.1	0.4	0.2	42.7	0.4	0.6	1.2	0.3	0.0	0.3	0.5	0.7	0.5	1.6	0.0	0.0	0.0	0.2	0.0	0.7	1.4	0.5	0.3	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.6	0.4	0.4	1.5	0.6	0.3	0.6	0.3	0.0	5.2	6.5	2.8	4.0	4.8	3.6	4.0	2.4	5.7	3.1
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Group enriched"	"Detected in some"	6	"HHSteC: 54.1;HMC-1: 80.5;HUVEC TERT2: 39.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	19074133	1700000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	3.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.5	0.1	0.1	54.1	0.4	80.5	1.1	0.3	1.3	8.7	39.3	0.1	0.1	0.1	0.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 55.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.8;PC-3: 10.4;RT4: 5.5"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"					"Cell type enriched"	"Detected in single"	28	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 2.8"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	76703		"Nucleoplasm, Vesicles"		"HPA054371: , HPA057950: "	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.4		0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.9	0.0	0.8	0.1	0.0	0.0	0.2	0.4	4.8	0.3	0.5	0.4	0.5	0.0	0.5	0.3	0.1	0.2	0.8	1.5	0.3	0.0	1.8	0.2	0.8	0.0	0.0	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.1	1.1	0.0	0.0	1.4	0.5	10.4	0.1	0.0	0.0	0.0	5.5	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0										
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 35.8;HBEC3-KT: 34.4;U-698: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 34.4"	"Group enriched"	"Detected in all"	6	"B-cells: 34.4;granulocytes: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"		49000	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"CAB004451: AB_626889, HPA050124: , HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	20.7	14.8	8.7	31.6	10.6	36.9	12.0	4.4	7.7	20.8	30.3	5.9	11.5	10.9	18.0	12.8	24.7	13.6	25.1	12.3	6.7	4.4	13.3	39.1	40.9	44.8	10.8	1.7	14.7	11.3	3.8	5.5	16.1	10.1	18.8	15.1	12.3	7.7	11.5	7.2	9.9	18.6	39.6	13.6	31.8	21.1	10.4	9.8	9.1	8.6	13.7	38.4	31.6	15.4	34.4	1.6	11.9	2.6	3.3	4.0	1.8	11.3	3.0	1.9	3.9	0.9	4.5	4.1	7.2	8.3	2.9	2.3	6.1	31.4	35.8	9.0	11.3	12.1	2.1	34.4	2.5	31.0	1.0	6.7	1.8	9.3	13.0	1.8	19.1	6.9	13.9	13.2	7.9	15.4	2.9	3.0	4.6	5.0	0.1	5.4	2.4	2.6	0.1	14.9	2.9	13.3	13.0	0.6	0.3	1.0	6.9	1.5	2.6	6.9	23.0	6.5	2.9	5.8	5.0	1.8	0.5	33.3	0.7	6.0	0.0	0.5	2.6	4.7	1.7	1.1	1.3	7.7	2.6	1.7	1.6	34.4	4.0	1.9	11.9	3.3	0.6	1.6	1.8	1.8	8.7	10.6	4.4	7.7	6.7	4.4	10.8	1.7	10.1	9.8
IL6ST	"CD130, GP130"	ENSG00000134352	"Interleukin 6 signal transducer"	P40189	5	55935095-55994993	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.0;BJ hTERT+: 58.0;HHSteC: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 21.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"		100000000	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	44.8	34.2	24.7	25.5	23.4	8.8	76.9	15.9	22.9	38.1	23.9	15.0	29.0	8.7	26.1	24.9	22.7	23.1	31.1	31.9	21.9	19.7	37.2	71.2	36.3	70.0	25.8	14.7	42.1	16.4	35.8	36.2	97.0	22.5	31.9	17.1	20.0	26.3	33.0	27.1	12.5	20.6	36.6	33.8	35.5	19.7	13.7	20.3	19.4	37.6	12.5	18.7	33.7	51.1	0.7	2.1	0.9	3.8	0.8	21.0	4.0	9.4	11.8	3.8	9.1	27.3	57.0	15.8	28.2	58.0	15.2	22.7	16.5	9.0	0.3	21.1	17.4	4.1	3.0	8.4	31.2	0.8	3.0	2.2	9.7	13.6	64.9	0.2	4.5	49.9	4.6	33.0	16.1	34.7	1.6	39.8	17.5	1.6	0.4	0.4	0.6	3.9	0.5	10.7	5.4	8.3	5.6	2.0	3.4	11.4	3.8	11.6	19.0	1.5	55.7	5.9	6.7	23.8	14.8	9.8	4.2	0.3	15.8	0.4	15.3	0.2	3.8	0.1	0.8	3.5	0.4	0.7	4.9	0.8	2.1	0.6	21.0	5.9	0.9	0.8	0.6	1.8	3.4	4.0	24.7	23.4	15.9	22.9	21.9	19.7	25.8	14.7	22.5	20.3
IL7R	CD127	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1"	"Cell line enhanced"	"Detected in many"		"BJ: 21.7;fHDF/TERT166: 40.7;HBF TERT88: 37.4;REH: 84.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1"	"Group enriched"	"Detected in many"	33	"NK-cells: 19.1;T-cells: 70.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			CAB010215			Supported	"Plasma membrane,Centriolar satellite"	"Intracellular and membrane"		180000	"Plasma membrane, Centriolar satellite"		"CAB010215: AB_673727"	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"	6.7	3.6	0.7	34.0	0.7	3.1	4.8	0.5	0.6	4.8	20.6	0.3	0.9	3.5	1.8	2.9	6.6	3.7	8.5	1.9	0.7	0.7	7.0	2.7	52.6	133.1	0.8	0.1	2.5	1.7	0.0	1.5	1.2	0.8	3.3	5.4	1.7	13.2	1.8	0.9	1.8	34.0	1.2	1.5	32.3	7.8	3.0	0.4	130.9	5.1	5.3	42.9	12.6	4.6	0.4	0.3	1.3	0.2	19.1	70.3	12.7	0.1	0.0	0.1	0.1	0.1	0.1	0.2	21.7	11.0	19.6	11.6	0.1	0.1	2.1	0.0	40.7	3.5	0.0	1.3	37.4	1.8	0.2	0.6	2.3	0.0	0.3	0.1	1.5	0.3	0.0	4.2	0.9	0.5	0.1	0.3	15.4	0.0	0.5	0.2	0.1	1.0	84.6	1.1	0.1	0.0	1.2	0.0	0.0	3.6	0.3	0.0	0.1	0.0	1.5	7.7	13.1	3.3	2.8	0.1	0.0	2.4	3.9	2.0	5.9	0.5	0.2	0.1	19.2	0.2	70.3	0.2	39.9	28.0	0.1	0.4	34.5	22.5	1.3	19.1	0.2	0.3	6.7	12.7	0.7	0.7	0.5	0.6	0.7	0.7	0.8	0.1	0.8	0.4
ILF2	NF45	ENSG00000143621	"Interleukin enhancer binding factor 2"	Q12905	1	153661788-153671048	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007484	Supported		Supported	Nucleoplasm			3800000	Nucleoplasm		"HPA007484: AB_1079137"	"unprognostic (1.97e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-3)"	"unprognostic (9.70e-2)"	"prognostic unfavourable (5.71e-8)"	"unprognostic (2.64e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (2.61e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.09e-1)"	35.9	39.2	26.3	32.8	27.1	58.1	43.7	25.6	32.8	34.8	33.8	32.7	23.5	24.2	37.8	39.6	46.0	33.9	27.8	32.0	24.7	28.4	64.1	45.4	35.3	38.1	33.2	29.2	46.5	52.8	38.4	36.8	53.3	30.8	29.9	40.4	25.0	50.4	28.3	49.1	38.5	27.7	34.3	26.7	39.8	33.9	58.0	28.5	117.0	58.5	45.5	54.0	32.1	30.9	49.5	55.4	34.5	39.9	52.4	52.5	76.4	48.4	37.8	66.9	46.9	28.1	26.5	53.5	36.2	41.2	65.4	47.2	55.7	39.6	67.2	55.9	36.0	37.2	79.6	38.5	63.4	36.4	51.7	50.4	30.8	47.6	25.8	78.0	37.4	24.2	22.1	49.9	54.3	60.9	63.1	31.9	54.3	64.6	104.2	34.9	95.5	57.7	75.9	57.9	63.4	31.4	47.0	60.2	55.9	42.2	52.6	42.7	57.5	67.6	37.0	33.8	43.3	30.3	59.6	55.5	77.3	135.6	28.3	48.4	50.9	34.5	39.9	28.7	39.8	38.3	50.1	49.5	46.4	42.9	55.4	40.7	52.5	45.6	3.7	52.4	30.3	53.6	51.0	76.4	26.3	27.1	25.6	32.8	24.7	28.4	33.2	29.2	30.8	28.5
ILF3	"DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Supported	Nucleoplasm,Nucleoli,Mitochondria			1100000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavourable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	31.0	39.0	29.6	45.5	26.8	88.2	34.5	48.3	35.2	34.2	30.2	30.8	35.2	30.3	45.4	31.7	40.5	41.9	32.5	34.0	25.5	20.0	28.1	25.6	34.1	44.9	24.7	27.8	52.8	36.8	34.9	34.9	31.8	32.3	34.9	27.3	35.5	35.1	46.2	50.1	37.7	37.2	33.2	33.3	44.5	32.6	54.3	28.0	58.6	43.4	32.4	41.1	38.5	32.1	18.7	18.7	11.5	14.3	15.4	19.4	8.0	45.4	37.0	60.0	54.9	13.0	17.9	34.9	29.1	24.7	48.9	38.3	42.4	26.4	56.8	29.0	26.1	40.8	64.8	39.3	44.1	36.3	57.7	73.7	32.7	39.5	18.7	53.0	36.8	16.9	17.6	38.8	43.5	41.7	62.9	44.7	28.4	37.4	87.9	85.3	72.0	40.7	64.8	57.2	39.3	19.4	48.3	66.3	48.2	37.5	29.8	21.6	25.2	34.1	33.4	40.1	38.2	41.5	57.4	38.4	52.4	69.0	22.4	56.7	43.2	11.5	13.4	7.1	19.4	10.4	16.1	14.7	15.9	17.3	16.8	18.7	15.7	16.0	2.1	15.4	14.3	18.7	15.0	8.0	29.6	26.8	48.3	35.2	25.5	20.0	24.7	27.8	32.3	28.0
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Focal adhesion sites"			130000000	"Cell Junctions, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: "	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favourable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	20.9	17.6	11.0	22.3	11.9	7.5	37.0	9.4	14.6	40.2	75.1	14.7	41.9	13.5	75.4	25.2	35.7	33.2	41.1	35.1	11.1	9.2	21.6	15.1	21.9	18.9	11.5	14.0	24.2	22.3	20.4	10.9	22.2	11.5	39.9	24.6	19.3	19.4	89.9	18.5	12.4	22.2	103.5	10.6	20.2	33.2	14.2	11.0	8.2	17.5	14.1	13.6	60.8	25.9	19.5	45.9	76.5	49.4	45.3	25.8	63.7	23.8	18.4	29.1	10.0	44.9	31.9	13.2	35.1	69.4	41.6	50.8	19.2	28.1	9.0	9.3	57.4	19.2	16.2	29.7	41.8	15.7	14.8	12.9	17.6	14.9	30.1	10.3	14.8	30.6	14.0	28.1	21.5	39.6	11.8	10.7	54.2	17.9	9.1	17.7	18.3	21.6	9.6	15.2	9.5	30.5	19.1	5.0	11.4	16.6	23.0	19.3	16.0	11.8	45.8	52.2	23.6	21.6	17.0	7.8	4.8	12.6	38.7	15.6	24.3	48.3	49.4	76.5	25.8	47.9	25.1	19.5	23.3	24.4	45.9	17.1	14.7	18.5	31.7	45.3	44.4	18.5	25.7	63.7	11.0	11.9	9.4	14.6	11.1	9.2	11.5	14.0	11.5	11.0
ILKAP	"DKFZP434J2031, FLJ10181, PPM1O"	ENSG00000132323	"ILK associated serine/threonine phosphatase"	Q9H0C8	2	238170401-238203729	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004752, HPA056099"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA004752: AB_1851753, HPA056099: "	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (9.89e-6)"	"unprognostic (6.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-1)"	17.0	17.1	19.4	31.3	22.2	34.6	24.2	34.1	23.4	18.7	23.4	29.5	22.0	20.5	23.0	22.7	19.4	19.0	21.8	20.9	20.6	19.8	17.8	20.8	27.1	25.7	23.9	21.4	22.1	24.1	17.5	24.7	18.1	22.7	21.5	18.9	20.2	19.0	24.9	32.8	19.4	19.0	26.5	19.8	22.2	18.1	21.2	25.5	23.9	22.6	19.0	24.8	18.1	26.1	18.9	20.7	24.1	18.1	17.4	23.8	16.2	17.7	11.6	17.1	16.7	13.3	8.9	17.5	18.8	12.8	19.0	16.6	10.7	9.5	11.4	4.9	13.6	15.2	22.1	15.6	19.4	20.2	21.9	29.4	11.4	23.5	20.6	18.8	23.3	9.3	10.8	20.2	20.4	14.2	22.6	7.4	16.2	21.3	18.9	25.6	15.9	11.1	23.1	34.9	10.4	14.0	8.5	25.2	12.4	12.7	13.7	30.0	10.7	19.6	12.8	18.6	16.9	24.9	19.9	13.2	13.2	20.5	15.2	21.1	15.7	24.1	15.1	19.6	22.5	18.1	20.1	18.9	20.0	21.0	20.7	18.5	23.8	18.6	5.3	17.4	15.1	15.8	22.4	16.2	19.4	22.2	34.1	23.4	20.6	19.8	23.9	21.4	22.7	25.5
IMMT	"HMP, Mic60, MINOS2, P87, P89"	ENSG00000132305	"Inner membrane mitochondrial protein"	Q16891	2	86143932-86195770	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022439, HPA036164, HPA036165"	Supported		Enhanced	Mitochondria			240000	Mitochondria		"CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980"	"unprognostic (3.83e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (5.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (3.51e-6)"	"unprognostic (2.06e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	20.0	36.9	15.6	17.0	23.5	15.3	15.4	17.5	27.1	13.6	24.8	16.0	15.4	25.1	16.5	13.6	19.1	13.9	12.3	67.3	15.1	18.0	37.5	35.1	14.3	17.7	18.4	18.8	13.3	23.1	31.4	17.6	21.6	32.2	12.8	26.3	17.3	16.7	21.2	78.6	15.4	25.6	17.9	12.1	20.0	22.0	28.3	15.0	29.1	16.2	38.3	19.9	18.0	14.1	10.9	21.5	7.6	21.6	13.2	16.1	14.4	34.0	33.7	30.5	14.0	29.8	27.5	31.2	24.5	25.7	33.2	30.2	48.4	27.1	52.3	24.6	25.9	25.4	39.1	35.4	40.7	21.1	31.9	41.3	21.3	57.2	30.3	39.8	28.4	31.4	25.8	31.2	37.4	37.4	40.2	29.8	32.0	29.3	39.6	41.6	36.4	26.9	26.5	65.4	47.0	37.8	38.7	37.2	27.6	25.1	38.2	37.4	21.7	28.3	28.0	23.9	26.3	34.5	30.4	23.7	29.9	35.9	27.2	47.6	28.9	7.5	18.6	7.6	16.1	21.6	14.6	10.9	14.4	13.3	21.5	8.8	13.1	15.5	2.5	13.2	19.9	11.1	14.9	14.4	15.6	23.5	17.5	27.1	15.1	18.0	18.4	18.8	32.2	15.0
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP3, U3 small nucleolar ribonucleoprotein"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA060955: , HPA061177: "	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	21.2	28.4	21.9	23.0	24.0	18.9	34.3	20.1	28.8	19.4	31.0	15.4	17.5	27.5	14.7	24.5	35.6	20.1	25.2	21.7	21.1	19.7	28.2	49.7	21.1	28.5	17.6	19.6	23.0	29.1	12.6	17.3	16.9	16.7	23.3	19.2	17.5	28.3	25.4	37.6	29.3	31.5	11.0	15.5	28.5	25.9	12.4	13.3	33.7	30.0	37.5	27.9	19.6	21.8	40.7	34.0	23.0	31.1	33.3	47.2	48.1	20.1	22.8	11.1	19.2	19.8	11.3	16.5	17.0	13.6	13.9	16.1	17.5	17.8	24.1	18.6	8.8	33.5	36.4	27.6	12.4	18.1	43.7	25.3	18.8	30.3	14.6	25.6	17.6	10.4	22.8	11.2	13.9	9.1	32.6	19.7	12.6	24.2	20.2	62.6	29.8	24.1	22.1	13.6	26.4	18.9	27.4	18.9	19.6	14.4	25.1	30.9	21.9	23.8	10.3	18.2	14.6	13.0	22.9	26.9	49.5	27.0	20.1	41.6	11.9	18.5	31.1	23.0	42.0	23.9	45.1	40.7	40.5	40.4	33.4	38.7	47.2	44.5	4.0	33.3	23.0	34.0	38.7	48.1	21.9	24.0	20.1	28.8	21.1	19.7	17.6	19.6	16.7	13.3
IMP4	"BXDC4, MGC19606"	ENSG00000136718	"IMP4, U3 small nucleolar ribonucleoprotein"	Q96G21	2	130342225-130347810	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066222, HPA066673"			Enhanced	Nucleoli				Nucleoli		"HPA066222: , HPA066673: "	"unprognostic (8.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.18e-3)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.10e-2)"	19.0	15.7	13.1	19.5	15.7	17.9	14.2	6.6	25.1	9.4	12.2	11.7	9.2	15.6	11.1	7.4	20.1	9.2	12.7	30.5	11.8	10.1	13.5	29.1	10.6	22.2	14.9	12.7	9.0	36.3	2.6	7.4	10.5	15.4	9.5	3.4	7.1	26.0	12.5	52.3	10.8	15.5	12.5	8.5	11.2	16.4	9.1	13.7	8.5	12.0	10.9	11.5	17.1	9.7	34.8	31.6	7.0	26.8	26.6	25.4	26.7	19.3	17.7	0.8	14.8	2.9	3.5	13.8	11.8	5.6	8.4	8.8	38.0	12.3	51.8	18.5	5.6	11.7	1.6	12.4	0.3	11.8	13.3	15.8	5.0	32.0	15.7	14.9	11.4	5.8	7.6	15.1	6.8	8.4	17.7	16.0	2.2	35.9	11.1	6.3	13.4	23.4	15.5	6.2	26.4	3.7	13.7	9.1	10.2	9.0	27.5	9.8	10.5	10.7	9.4	15.9	15.1	16.8	24.4	16.2	20.0	42.9	12.2	9.5	22.4	2.4	25.5	7.0	25.4	26.8	22.6	34.8	22.4	21.9	29.3	30.7	22.4	22.2	2.9	26.6	25.1	31.6	21.5	26.7	13.1	15.7	6.6	25.1	11.8	10.1	14.9	12.7	15.4	13.7
IMPAD1	"FLJ20421, gPAPP, IMPA3"	ENSG00000104331	"Inositol monophosphatase domain containing 1"	Q9NX62	8	56957933-56993844	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"			560000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	30.6	33.9	17.8	13.9	23.7	9.6	17.6	23.6	33.1	24.7	17.7	30.9	17.8	11.7	23.2	15.2	17.7	15.6	18.0	25.2	19.9	21.6	21.3	32.6	16.5	10.3	23.6	21.1	16.0	25.2	30.4	20.4	23.3	27.2	28.8	16.2	25.2	28.7	22.5	41.4	13.4	12.3	23.0	21.7	13.0	14.7	19.0	19.5	12.0	24.4	18.1	13.0	17.2	14.9	1.9	2.0	6.1	4.6	6.8	2.4	0.6	17.1	14.3	11.0	11.3	33.9	23.3	15.2	26.1	25.4	18.7	16.4	7.1	12.2	10.7	20.0	27.7	14.1	13.3	17.6	27.9	14.7	9.5	20.9	10.1	12.7	21.1	13.2	14.9	18.7	17.7	16.8	27.4	24.8	9.0	19.5	20.5	9.1	16.1	8.0	8.2	5.3	11.3	9.9	12.1	19.5	10.2	4.3	12.0	14.6	18.1	14.8	16.1	9.7	20.7	25.4	14.7	25.0	18.7	20.2	16.8	11.5	34.8	11.1	15.6	2.9	1.9	1.1	2.0	1.2	1.6	1.3	1.3	1.2	1.4	1.9	1.5	2.4	6.1	6.8	4.6	2.0	0.9	0.6	17.8	23.7	23.6	33.1	19.9	21.6	23.6	21.1	27.2	19.5
IMPDH1	"LCA11, RP10, sWSS2608"	ENSG00000106348	"Inosine monophosphate dehydrogenase 1"	P20839	7	128392277-128410252	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 21.6;eosinophil: 20.2;intermediate monocyte: 26.2;myeloid DC: 15.1;neutrophil: 49.9;non-classical monocyte: 31.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 15.1;granulocytes: 49.9;monocytes: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001400	Approved		Supported	"Cytosol,Rods & Rings"				Cytosol	"Rods & Rings"	"HPA001400: AB_1079139"	"unprognostic (2.84e-1)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (2.23e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (7.31e-5)"	"unprognostic (6.03e-2)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (1.24e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (1.78e-12)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (3.72e-5)"	26.0	7.4	7.5	20.7	8.5	24.5	37.1	7.7	10.2	11.3	10.9	3.6	12.4	5.2	8.5	6.5	14.6	9.1	7.6	12.6	7.6	5.0	7.5	3.5	14.8	31.2	5.1	5.8	10.7	20.3	5.2	12.0	7.2	9.9	12.1	6.3	19.5	20.6	11.4	3.5	11.9	8.8	12.3	6.4	25.1	20.6	7.1	5.6	3.9	5.5	11.2	9.7	14.2	9.9	4.1	15.1	49.9	31.0	2.8	6.4	11.7	25.1	21.6	3.2	24.2	13.7	10.0	9.2	17.2	10.9	14.8	9.6	15.7	8.1	16.0	5.9	25.6	19.3	18.3	24.3	7.4	5.8	20.4	10.6	16.0	11.1	12.5	13.9	5.0	11.8	11.6	15.0	14.9	17.4	10.5	12.1	4.9	17.3	9.7	37.4	18.3	25.4	11.7	6.0	33.2	6.5	8.1	13.0	13.1	11.1	88.5	15.6	10.0	27.0	15.9	24.9	9.1	13.0	12.2	9.1	8.4	20.6	12.7	30.9	15.1	2.3	21.6	20.2	5.9	26.2	6.4	4.1	4.7	5.1	15.1	2.4	2.8	3.4	49.9	2.8	31.0	1.5	5.2	11.7	7.5	8.5	7.7	10.2	7.6	5.0	5.1	5.8	9.9	5.6
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029408	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001400, CAB020717"	Approved		Enhanced	"Cytosol,Rods & Rings"			19000	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.47e-2)"	25.0	21.5	16.1	25.7	15.4	23.9	47.0	9.7	21.1	34.7	24.9	15.1	19.1	18.9	29.5	19.8	40.1	51.9	33.3	29.3	13.0	11.2	21.4	29.4	19.9	52.5	18.1	13.0	89.0	88.8	19.1	16.6	23.2	15.6	33.2	31.7	10.8	22.1	22.2	61.4	40.7	17.8	34.1	15.2	23.7	22.2	15.3	15.4	31.2	29.8	51.3	33.4	30.3	32.1	31.6	18.8	6.2	16.8	21.6	34.8	16.0	39.6	22.9	31.8	32.8	47.6	86.9	30.9	27.5	44.6	66.4	56.6	39.8	35.8	72.4	19.7	33.1	27.7	65.6	55.9	58.2	19.0	21.9	53.6	33.8	36.4	40.8	56.8	22.1	77.2	61.6	63.4	115.3	46.6	32.0	41.0	53.4	32.2	48.0	39.5	41.2	46.3	21.0	33.5	71.0	37.8	25.7	20.6	20.3	29.9	33.8	49.7	41.9	25.3	23.4	29.1	54.0	70.7	70.5	39.8	28.7	34.7	33.6	63.4	28.4	6.2	10.1	4.0	17.0	16.8	31.7	31.6	23.3	19.6	18.8	31.1	34.8	28.6	4.4	21.6	13.9	14.5	15.5	16.0	16.1	15.4	9.7	21.1	13.0	11.2	18.1	13.0	15.6	15.4
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123973-62153163	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.9;NK-cell: 4.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.9;NK-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Midbody"				"Nucleoplasm, Nuclear bodies, Midbody"		"CAB013292: AB_2533405, HPA051339: , HPA070550: "	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (1.25e-4)"	"prognostic unfavourable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavourable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	5.1	5.0	6.9	9.2	8.2	23.8	7.7	19.3	13.6	6.9	6.5	5.7	2.8	9.5	5.7	11.7	22.2	5.3	4.7	4.1	5.9	5.0	3.9	3.8	5.0	14.1	6.9	7.9	5.3	5.4	6.0	3.1	5.7	6.9	4.2	5.3	4.9	10.6	4.6	6.7	9.8	7.5	4.9	5.1	7.5	6.4	12.3	6.4	36.1	8.5	8.5	13.2	5.9	8.6	0.2	0.0	2.9	0.3	4.0	0.5	0.0	26.9	25.8	19.6	16.7	2.6	3.1	10.5	16.9	7.4	15.8	10.1	13.6	18.3	25.0	14.0	5.8	26.4	19.4	10.2	12.4	22.1	13.5	16.3	25.4	11.0	1.0	18.7	23.3	1.6	2.2	15.2	8.8	9.5	17.2	20.8	8.7	21.9	30.1	15.3	21.1	12.6	28.3	24.7	18.8	4.5	13.6	15.0	16.2	17.0	11.1	10.5	17.3	6.8	10.6	15.6	19.9	22.3	18.0	11.2	17.1	28.0	8.7	12.4	18.7	2.9	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.2	4.0	0.1	0.0	0.0	0.0	6.9	8.2	19.3	13.6	5.9	5.0	6.9	7.9	6.9	6.4
ING2	"ING1L, p33ING2"	ENSG00000168556	"Inhibitor of growth family member 2"	Q9H160	4	183504994-183511096	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019486, HPA021517"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA019486: AB_1851780, HPA021517: AB_10601914"	"prognostic favourable (5.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (8.87e-4)"	"unprognostic (7.47e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.30e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.82e-2)"	6.1	28.5	7.8	4.4	12.2	20.0	7.6	8.3	10.3	6.2	13.0	6.0	5.9	10.1	4.2	11.6	15.7	8.0	8.1	5.0	8.0	8.9	10.4	9.4	6.1	6.0	9.9	6.0	34.4	17.3	6.3	18.8	11.5	9.5	6.0	6.3	6.5	6.8	6.7	16.2	7.4	23.1	6.8	11.0	7.2	7.5	16.9	7.2	11.5	9.1	10.9	6.8	10.3	9.4	11.4	7.4	21.8	7.9	3.5	10.7	3.9	14.5	7.7	12.6	10.2	20.0	13.1	10.9	16.3	13.8	12.8	11.7	7.5	14.7	11.3	3.6	11.9	6.2	7.5	13.9	18.4	7.9	6.8	16.7	8.9	8.9	5.8	12.9	19.0	9.9	11.1	13.4	5.2	6.5	10.2	40.2	10.3	14.2	18.1	15.5	9.1	10.3	8.5	6.3	17.5	14.7	7.2	11.9	8.1	9.5	13.3	3.9	6.3	9.7	4.5	8.6	14.6	6.7	9.5	8.5	5.6	7.1	16.6	11.8	6.0	13.1	6.2	21.8	3.6	6.3	5.5	11.4	7.6	6.5	7.4	8.1	10.7	9.0	7.4	3.5	7.9	7.0	5.6	3.9	7.8	12.2	8.3	10.3	8.0	8.9	9.9	6.0	9.5	7.2
ING3	"Eaf4, FLJ20089, MEAF4, p47ING3"	ENSG00000071243	"Inhibitor of growth family member 3"	Q9NXR8	7	120950749-120977216	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004762, HPA067388, HPA067575"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA004762: , HPA067388: , HPA067575: "	"unprognostic (1.35e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.09e-3)"	"unprognostic (4.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.64e-2)"	9.6	9.1	7.4	8.8	9.9	57.7	9.6	21.5	13.8	9.0	9.6	5.5	11.1	7.3	11.1	9.7	8.0	9.7	7.7	7.6	7.3	7.3	8.8	8.4	12.3	11.9	7.6	12.2	11.9	12.1	7.9	17.7	13.0	11.1	9.5	10.6	6.7	10.0	11.5	7.7	6.1	12.9	11.4	8.8	16.4	10.4	8.6	9.6	19.0	12.6	10.4	11.2	8.3	8.4	15.8	15.0	32.7	19.5	18.5	16.9	9.8	9.2	2.7	12.5	7.0	4.7	3.8	4.2	6.3	5.0	9.2	10.7	3.6	10.7	14.9	2.9	5.5	4.5	12.0	4.9	10.5	10.4	21.0	10.8	10.4	2.0	6.5	20.8	12.9	2.7	2.6	8.0	5.7	14.3	24.1	24.2	8.7	3.2	17.0	12.5	15.0	5.1	8.4	8.9	12.4	9.2	9.5	11.3	12.2	6.5	13.5	6.7	3.0	8.2	5.0	9.3	3.5	20.0	11.4	11.1	7.1	22.5	4.7	14.0	7.7	22.3	19.1	16.5	13.9	19.5	13.4	14.4	14.1	12.6	15.0	15.8	14.4	13.1	32.7	18.5	19.1	11.2	16.9	9.8	7.4	9.9	21.5	13.8	7.3	7.3	7.6	12.2	11.1	9.6
ING4	"my036, p29ING4"	ENSG00000111653	"Inhibitor of growth family member 4"	Q9UNL4	12	6650280-6663148	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Chromatin regulator"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031817, HPA057338"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA031817: , HPA057338: "	"unprognostic (2.95e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.65e-2)"	"prognostic favourable (5.16e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.42e-2)"	15.0	17.7	30.7	13.0	27.6	9.3	25.9	36.7	34.3	20.0	20.2	22.3	18.9	16.2	23.8	29.5	17.1	25.5	16.3	18.9	27.9	21.0	19.0	20.7	16.6	22.2	30.2	24.8	26.7	17.9	21.1	18.7	19.5	29.9	21.1	20.3	15.5	20.2	22.5	15.6	26.2	16.9	21.4	25.0	24.9	17.6	13.3	29.0	29.5	24.2	10.2	21.3	20.0	18.3	29.4	23.9	19.4	33.1	25.1	29.1	25.2	4.8	6.5	19.3	9.1	15.1	15.0	12.3	6.4	10.3	10.7	12.8	2.9	21.8	8.3	4.2	8.9	7.6	9.5	7.4	11.9	16.1	14.0	11.9	11.8	5.9	8.8	4.6	5.6	15.1	17.3	5.6	7.2	15.9	5.5	4.8	10.1	3.4	16.9	7.1	28.4	6.2	16.0	10.1	8.6	13.2	5.5	8.0	20.8	9.9	3.3	11.7	4.4	13.0	12.0	4.4	8.9	4.9	4.0	5.8	7.9	11.0	11.8	7.3	4.4	19.4	22.0	17.7	25.0	29.3	22.7	21.9	20.8	21.0	23.9	29.4	29.1	24.8	14.1	25.1	33.1	18.5	20.7	25.2	30.7	27.6	36.7	34.3	27.9	21.0	30.2	24.8	29.9	29.0
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin beta E subunit"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 127.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 14.8;Karpas-707: 22.3;U-266/70: 75.2"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"		1400000	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	127.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	1.0	0.9	3.1	0.6	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.8	2.1	0.0	2.6	0.1	0.0	1.0	0.5	0.2	0.1	0.5	0.0	0.3	4.9	0.0	0.0	0.0	3.2	14.8	0.6	0.6	1.4	1.5	0.3	3.3	0.0	1.3	22.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	2.3	0.0	0.0	5.5	0.2	0.0	0.0	2.1	0.1	2.4	0.0	0.0	1.2	0.0	0.1	75.2	2.3	1.0	0.4	0.1	0.1	1.9	0.5	0.5	0.3	0.4	0.4	0.9	0.1	0.2	0.1	1.0	0.2	0.5	3.1	0.6	0.6	0.9	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0
INIP	"C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C"	ENSG00000148153	"INTS3 and NABP interacting protein"	Q9NRY2	9	112683926-112718236	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020382	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA020382: AB_1845840"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.67e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.47e-3)"	"prognostic favourable (2.00e-8)"	"prognostic favourable (2.53e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.26e-1)"	9.0	11.3	16.1	9.8	17.3	11.4	14.7	18.7	22.9	10.9	12.4	21.0	4.4	12.8	9.6	11.2	12.6	10.4	11.0	9.3	16.8	15.6	15.1	13.7	10.5	16.6	18.6	14.4	11.0	8.1	11.1	18.4	7.5	20.6	8.9	14.8	7.8	10.2	8.6	7.6	11.4	13.4	9.7	19.3	12.5	8.7	8.2	18.2	17.3	13.6	6.1	17.1	12.6	9.2	15.0	21.2	25.1	23.0	13.1	19.5	14.8	8.4	8.3	11.5	16.4	10.0	10.7	11.8	12.0	6.6	10.6	10.5	9.9	7.0	22.8	7.5	8.2	12.0	11.3	5.3	14.1	27.0	6.6	9.4	9.9	9.3	6.4	19.0	7.2	5.3	8.0	11.1	9.1	9.8	16.1	14.8	11.4	13.8	16.8	9.8	5.9	15.5	18.9	24.4	9.8	12.0	11.6	15.1	11.3	15.1	9.7	7.7	14.5	11.9	8.1	8.5	13.4	16.5	11.4	7.4	31.0	19.2	10.9	11.1	14.2	17.7	19.7	25.1	13.4	23.0	17.5	12.5	17.2	19.5	21.2	15.0	19.0	16.3	16.0	13.1	19.8	7.5	15.8	14.8	16.1	17.3	18.7	22.9	16.8	15.6	18.6	14.4	20.6	18.2
INO80	"hINO80, Ino80, INO80A, INOC1, KIAA1259"	ENSG00000128908	"INO80 complex subunit"	Q9ULG1	15	40978880-41116354	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"	"Actin-binding, DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041417, HPA041484"			Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA041417: , HPA041484: "	"unprognostic (5.39e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.69e-2)"	"prognostic favourable (6.30e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.47e-2)"	14.0	10.6	11.8	13.9	13.4	20.7	13.9	29.5	13.0	12.3	13.2	17.4	11.5	11.3	14.9	13.4	15.1	12.6	12.4	10.6	12.8	7.8	12.1	12.9	14.8	13.4	10.2	10.3	15.4	17.8	18.8	13.3	16.4	12.1	12.5	13.9	13.8	11.9	15.7	23.0	16.4	13.2	13.3	9.5	14.5	12.3	13.9	11.6	18.1	13.3	12.6	15.8	13.9	13.3	5.2	2.3	0.9	2.7	5.7	3.4	1.5	9.1	9.1	7.9	7.7	12.5	10.5	9.2	8.5	14.0	13.0	11.3	11.1	7.7	9.8	6.9	13.0	18.0	14.5	14.9	13.8	11.3	7.5	12.2	12.7	8.4	12.0	12.0	12.0	10.4	13.8	10.4	27.7	12.4	13.6	8.5	8.7	7.6	8.7	8.0	8.3	10.0	13.5	8.4	7.9	9.8	19.3	10.6	7.2	6.2	13.8	5.8	7.8	14.6	14.2	10.3	9.4	13.1	13.7	9.4	6.4	16.0	12.2	17.8	8.5	0.9	2.7	0.6	2.7	1.7	3.3	3.2	3.4	3.0	2.3	5.2	3.4	3.2	0.9	5.7	1.2	1.8	2.6	1.5	11.8	13.4	29.5	13.0	12.8	7.8	10.2	10.3	12.1	11.6
INO80B	"hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4"	ENSG00000115274	"INO80 complex subunit B"	Q9C086	2	74455023-74457960	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA070644			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA070644: "	"prognostic favourable (2.89e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (1.56e-5)"	"prognostic favourable (8.44e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-3)"	18.7	22.4	31.0	20.5	33.4	21.4	22.6	31.3	48.6	23.3	16.2	15.6	24.8	24.0	28.5	23.4	22.6	26.8	21.5	19.7	39.3	20.0	20.3	22.5	18.7	22.5	19.6	32.6	39.8	31.8	36.6	32.3	14.0	38.2	25.6	16.7	15.5	32.1	37.6	28.1	39.7	18.0	20.0	49.6	19.3	22.1	28.3	25.0	21.3	30.0	15.9	24.7	20.6	23.8	4.9	6.5	6.8	5.4	4.4	3.8	1.3	12.8	14.3	3.9	5.7	8.2	13.3	11.9	12.2	9.9	8.4	7.4	9.2	14.2	22.1	15.0	8.0	13.7	3.7	8.3	8.0	20.9	14.2	16.6	6.7	9.0	8.4	16.1	7.4	12.1	14.7	12.0	14.7	10.9	9.3	7.2	7.2	15.5	18.4	21.3	2.8	19.8	10.7	15.8	20.1	10.3	9.0	7.3	15.3	6.3	16.2	5.4	5.5	5.1	9.7	6.9	12.5	14.1	8.7	28.6	22.1	8.0	15.3	9.6	7.0	3.9	5.4	2.0	2.7	3.7	3.2	4.8	2.9	1.5	3.1	4.9	2.7	2.3	6.8	4.4	2.8	6.5	3.8	1.3	31.0	33.4	31.3	48.6	39.3	20.0	19.6	32.6	38.2	25.0
INO80E	"CCDC95, FLJ90652"	ENSG00000169592	"INO80 complex subunit E"	Q8NBZ0	16	29995294-30005793	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043146	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA043146: AB_10794923"	"unprognostic (5.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.38e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-3)"	26.7	30.0	31.2	37.1	31.6	27.5	29.1	28.8	37.9	32.9	35.4	35.1	37.7	18.0	33.8	34.0	31.7	43.8	29.2	25.0	30.1	26.1	30.1	31.0	28.5	30.2	30.7	30.0	39.7	29.2	44.7	29.8	24.8	27.8	32.2	39.5	26.3	33.9	39.3	28.1	28.3	38.9	43.0	33.8	30.6	28.6	28.3	28.0	39.1	35.9	24.6	46.9	34.1	28.3	4.5	4.8	4.2	5.4	2.6	4.8	15.3	23.1	27.7	18.3	27.6	17.4	15.3	17.3	20.7	24.0	31.4	30.7	16.2	26.4	31.3	32.1	23.5	15.2	23.4	35.0	27.0	32.1	21.7	15.2	17.7	22.4	20.5	20.0	17.3	17.3	29.2	35.6	29.2	37.7	19.3	16.5	29.2	33.9	42.1	24.0	37.7	13.6	55.7	22.6	30.0	22.7	12.0	28.9	35.5	11.4	19.4	25.4	25.0	16.7	20.0	20.9	15.2	18.6	25.7	15.9	35.4	28.8	23.4	29.1	29.7	0.7	4.7	4.2	3.9	3.2	3.4	4.5	2.9	4.8	4.8	2.9	2.5	3.0	2.7	2.6	5.4	4.0	4.3	15.3	31.2	31.6	28.8	37.9	30.1	26.1	30.7	30.0	27.8	28.0
INPP5F	"hSac2, KIAA0966, SAC2"	ENSG00000198825	"Inositol polyphosphate-5-phosphatase F"	Q9Y2H2	10	119726097-119829278	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.7"	"Cell line enhanced"	"Detected in many"		"AF22: 36.0;SH-SY5Y: 28.5;SK-MEL-30: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042605			Supported	Vesicles				Vesicles		"HPA042605: AB_10793886"	"unprognostic (2.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.21e-2)"	4.6	12.3	17.5	5.9	50.4	3.2	5.7	37.0	52.9	10.9	5.0	5.5	2.2	3.1	11.8	18.0	4.5	4.2	5.5	4.1	24.6	53.1	7.3	2.0	4.2	7.6	23.7	29.1	9.8	4.6	8.9	34.0	8.2	69.7	8.3	6.1	3.4	7.1	8.4	7.5	10.4	3.8	10.8	19.2	4.1	3.8	10.1	7.3	1.4	8.4	1.4	9.3	5.3	4.5	12.2	7.4	1.5	4.5	3.8	6.7	2.2	4.6	3.3	36.0	5.2	3.9	4.0	3.1	6.5	3.6	3.1	3.0	4.8	5.9	3.0	2.5	8.1	5.2	3.9	3.8	4.7	1.9	3.6	2.0	1.6	4.8	5.5	1.3	6.7	4.8	3.5	6.1	6.1	10.4	1.8	4.8	7.3	2.6	1.8	5.4	3.4	4.1	2.4	6.4	0.8	5.2	2.4	2.6	28.5	7.2	2.2	54.3	1.5	1.4	6.9	3.1	4.1	4.0	6.3	5.4	2.4	1.4	3.9	4.6	12.6	1.1	4.0	1.5	1.3	3.5	1.6	8.1	2.8	1.9	7.4	12.2	3.2	1.4	1.0	3.8	4.5	1.8	6.7	2.2	17.5	50.4	37.0	50.5	24.6	53.1	23.7	29.1	69.7	7.3
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239105	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	20.9	23.7	22.2	20.4	19.5	25.1	18.6	11.1	18.9	25.2	32.0	22.7	28.8	19.8	24.7	18.4	17.4	24.3	29.6	29.5	24.1	10.3	23.9	17.1	24.9	19.0	27.6	10.4	30.1	22.7	21.6	26.9	31.9	20.4	28.7	13.5	30.7	27.5	24.2	60.0	17.7	23.0	34.7	27.5	28.3	24.5	11.8	24.3	16.0	29.1	19.3	18.3	25.0	18.1	2.6	5.2	7.0	7.6	4.2	4.5	3.3	6.4	13.8	16.6	11.3	8.2	9.8	29.6	29.8	13.9	18.7	11.9	18.9	16.3	18.4	30.5	22.8	24.6	13.6	8.4	6.4	23.8	14.2	19.1	70.0	6.9	16.1	12.6	42.8	13.9	8.9	18.1	7.2	10.0	13.4	7.9	10.2	17.4	9.3	51.0	16.9	21.6	43.9	37.7	4.1	21.7	10.8	8.1	11.8	32.0	19.3	41.6	20.4	23.9	16.9	20.1	23.5	30.7	9.7	22.9	3.8	17.9	5.7	12.0	10.8	5.2	7.6	7.0	4.5	4.4	3.7	2.2	3.7	3.0	5.2	2.6	2.7	3.7	5.2	4.2	7.0	3.9	3.3	3.3	22.2	19.5	11.1	18.9	24.1	10.3	27.6	10.4	20.4	24.3
INTS11	"CPSF3L, CPSF73L, FLJ20542, INT11, RC-68"	ENSG00000127054	"Integrator complex subunit 11"	Q5TA45	1	1311585-1324691	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028379, HPA029025"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA028379: AB_10599598, HPA029025: AB_10600425"	"unprognostic (7.54e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavourable (7.44e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-3)"	"unprognostic (5.14e-2)"	"unprognostic (5.62e-3)"	21.4	22.5	22.8	25.4	24.9	23.2	26.9	50.8	30.4	26.5	31.2	32.1	24.1	29.1	33.1	39.8	25.3	39.1	24.8	29.8	23.7	19.8	23.5	26.7	19.7	25.7	25.9	25.8	34.1	33.5	24.1	26.9	25.8	21.0	29.5	19.9	20.4	33.8	28.0	52.8	28.6	25.4	34.0	20.0	27.3	27.9	57.8	25.9	28.5	23.3	23.5	22.5	27.5	25.7	24.6	37.7	22.0	42.2	28.4	35.2	32.4	21.1	21.9	12.4	23.7	21.3	17.3	13.4	11.7	19.7	27.2	20.2	19.7	26.9	23.7	17.0	23.8	15.6	18.4	26.2	12.1	22.2	24.0	18.2	29.8	26.5	32.8	14.4	20.1	29.2	14.3	24.7	37.2	28.4	21.6	21.6	13.4	19.1	28.4	19.6	15.0	23.6	22.4	11.7	34.1	19.1	10.8	17.5	16.2	11.8	31.9	33.2	17.2	21.1	20.4	16.9	15.4	19.2	14.9	33.9	36.3	30.8	23.7	25.6	8.3	22.0	32.3	20.8	31.7	37.2	33.8	24.6	28.1	29.3	37.7	20.3	26.5	24.9	15.3	28.4	42.2	24.5	35.2	32.4	22.8	24.9	50.8	30.4	23.7	19.8	25.9	25.8	21.0	25.9
INTS13	"ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30"	ENSG00000064102	"Integrator complex subunit 13"	Q9NVM9	12	26905181-26938326	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039543, HPA040109, HPA073020"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"				Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA039543: AB_10795150, HPA040109: , HPA073020: "	"unprognostic (2.09e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavourable (1.17e-10)"	"unprognostic (5.22e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.75e-3)"	"prognostic unfavourable (3.16e-6)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.78e-2)"	10.0	20.9	10.5	11.5	14.7	15.3	11.5	11.4	11.4	10.5	10.0	22.3	4.6	9.0	10.6	10.4	14.1	8.1	7.5	10.2	12.3	9.8	12.6	14.3	8.0	14.1	18.8	7.4	9.2	11.9	9.3	17.6	9.2	22.4	10.1	10.4	8.9	9.4	6.6	16.9	11.4	8.5	11.6	30.2	17.9	14.1	10.9	14.1	26.6	10.7	11.6	15.1	16.9	9.6	7.4	6.8	5.1	5.4	16.4	18.7	7.1	9.3	10.3	6.3	13.3	9.0	14.5	8.9	13.0	7.8	12.3	13.9	15.4	12.3	23.5	13.6	7.2	13.3	15.3	12.2	20.9	10.8	9.4	18.4	12.8	12.7	16.2	31.1	11.3	7.9	9.4	20.0	42.6	15.9	19.4	9.3	13.4	10.7	16.2	57.1	27.3	18.5	11.5	18.3	31.4	10.5	8.5	5.0	4.8	11.4	9.0	13.0	12.2	6.8	10.4	14.6	10.8	24.4	15.7	4.9	5.5	34.4	9.7	21.6	10.2	4.2	5.4	5.1	10.5	3.7	15.5	6.8	13.1	12.9	6.8	7.4	9.4	11.5	1.8	16.4	3.2	4.6	18.7	7.1	10.5	14.7	11.4	11.4	12.3	9.8	18.8	7.4	22.4	14.1
INTS4	"INT4, MGC16733, MST093"	ENSG00000149262	"Integrator complex subunit 4"	Q96HW7	11	77878720-77994678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042378	Uncertain		Supported	Nucleoli				Nucleoli		"HPA042378: AB_10797388"	"unprognostic (2.72e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (9.44e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.20e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.20e-1)"	"prognostic favourable (9.66e-4)"	"unprognostic (9.39e-2)"	15.8	17.7	13.6	15.7	16.5	21.4	17.0	23.9	17.5	17.1	13.6	27.7	13.0	12.2	31.0	16.3	14.8	13.9	12.1	12.1	13.6	12.1	14.4	18.7	14.0	20.6	20.0	12.1	20.0	19.6	22.9	24.4	20.8	19.3	17.3	16.1	17.7	23.1	13.5	12.1	16.0	16.7	14.6	18.0	23.2	14.4	11.7	17.6	33.6	15.9	8.6	28.1	14.5	16.6	12.5	13.8	10.9	13.7	14.6	17.1	10.0	6.0	10.1	13.2	15.8	11.1	9.8	11.0	7.3	8.1	9.4	8.6	21.0	17.2	10.5	15.6	12.8	15.3	14.4	14.3	15.2	15.6	9.0	16.2	13.5	12.0	9.8	16.3	9.9	10.0	7.8	19.4	16.7	14.7	15.6	16.2	14.4	12.6	15.5	26.8	12.6	11.0	15.0	12.2	20.1	11.7	12.2	9.4	13.6	12.8	8.5	5.3	16.2	9.5	9.9	13.1	17.5	34.2	9.4	17.8	17.2	23.7	4.9	11.2	12.9	10.9	12.6	6.7	12.2	13.7	16.9	11.8	12.6	14.3	13.8	12.5	17.1	13.2	3.2	14.6	12.0	5.5	15.7	10.0	13.6	16.5	23.9	17.5	13.6	12.1	20.0	12.1	19.3	17.6
INTS5	"INT5, KIAA1698"	ENSG00000185085	"Integrator complex subunit 5"	Q6P9B9	11	62646848-62653302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046181, HPA056915"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046181: , HPA056915: "	"unprognostic (2.87e-1)"	"unprognostic (9.51e-2)"	"unprognostic (9.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-2)"	"prognostic favourable (8.44e-5)"	"unprognostic (7.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.35e-2)"	13.8	13.2	9.1	14.0	8.9	6.5	17.2	9.7	16.5	12.8	11.0	7.0	14.3	10.9	16.0	10.6	16.0	19.1	14.0	14.3	7.4	6.7	12.0	19.9	11.6	22.3	7.8	7.6	15.4	21.3	17.4	9.5	12.1	6.9	12.4	8.5	11.0	16.0	17.4	17.3	15.7	11.2	11.9	5.5	14.8	12.4	9.4	6.6	26.0	16.4	10.8	12.8	12.6	15.7	7.6	7.2	5.1	6.2	10.1	14.3	7.0	11.2	13.9	8.2	7.6	16.2	11.9	7.7	9.3	9.6	12.7	9.1	9.8	12.6	21.5	17.0	11.8	17.7	16.4	21.7	6.1	13.4	11.4	11.1	11.1	6.6	14.7	12.2	10.7	13.7	17.1	13.5	11.7	12.5	16.9	12.7	10.8	23.1	13.9	14.3	12.5	17.7	14.4	11.1	25.8	9.7	7.4	11.1	9.4	10.5	14.7	14.5	21.0	8.4	10.3	12.2	9.4	18.6	8.4	17.9	13.7	15.4	14.0	9.3	11.4	5.1	6.2	4.8	8.7	4.6	14.3	5.8	8.2	7.7	7.1	7.6	9.6	8.7	2.6	10.1	5.1	7.2	6.1	7.0	9.1	8.9	9.7	16.5	7.4	6.7	7.8	7.6	6.9	6.6
INTS6	"DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2"	ENSG00000102786	"Integrator complex subunit 6"	Q9UL03	13	51354077-51454264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA001846"	Supported		Supported	"Nucleoplasm,Actin filaments"				Nucleoplasm	"Actin filaments"	"HPA001552: AB_1078659, HPA001846: AB_1847669"	"unprognostic (1.99e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.26e-2)"	13.3	13.7	12.9	14.4	14.6	11.3	23.9	23.8	15.8	12.5	11.9	10.6	17.4	9.5	12.1	10.9	16.4	10.3	12.3	13.0	14.1	8.9	11.1	24.5	13.6	15.7	16.9	9.1	14.6	44.2	14.4	24.1	11.5	13.2	12.2	9.5	8.5	12.3	19.2	10.6	13.3	13.9	12.2	12.3	11.4	12.9	46.4	17.8	21.7	13.0	9.5	13.4	12.3	15.9	6.1	6.5	7.8	2.8	6.7	9.2	3.2	7.7	6.2	15.0	7.2	8.5	18.5	9.9	15.1	15.1	16.0	12.0	7.9	19.4	9.6	3.4	12.7	13.9	19.5	9.3	23.8	17.5	5.6	16.7	9.9	9.6	20.9	19.8	16.1	13.6	18.2	16.6	26.4	14.8	11.2	14.2	17.4	6.1	13.7	15.0	11.3	7.5	9.4	10.0	7.6	12.7	5.1	8.9	9.6	15.7	12.3	12.1	7.1	22.6	10.2	8.6	7.1	10.2	9.9	14.0	8.8	14.9	7.8	11.9	14.6	7.3	2.8	4.2	7.9	1.8	8.9	4.9	5.9	7.1	2.8	6.1	8.4	9.2	7.8	6.7	2.0	6.5	6.3	3.2	12.9	14.6	23.8	15.8	14.1	8.9	16.9	9.1	13.2	17.8
INTS7	"C1orf73, DKFZP434B168, INT7"	ENSG00000143493	"Integrator complex subunit 7"	Q9NVH2	1	211940399-212035542	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072611			Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA072611: "	"unprognostic (1.25e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.37e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavourable (1.42e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.44e-2)"	6.7	8.6	10.2	7.3	14.2	8.6	8.4	15.6	11.6	6.9	7.7	9.4	3.5	7.1	6.1	8.6	12.5	5.8	5.7	6.5	8.0	6.9	5.6	13.4	6.6	10.3	10.5	5.7	6.1	8.2	3.9	21.5	7.1	10.0	7.2	9.8	7.9	7.1	4.1	8.7	9.3	6.4	8.7	9.1	7.9	6.5	24.7	14.5	19.4	8.6	7.9	12.0	7.9	8.3	8.7	9.8	8.2	8.2	19.3	12.9	6.7	16.1	14.4	11.6	9.2	8.5	9.4	14.0	13.3	8.5	16.0	20.3	13.6	14.1	18.9	7.2	9.6	15.0	17.3	10.7	13.3	18.1	14.8	16.4	16.1	9.9	9.3	29.1	15.4	8.3	13.2	25.5	19.5	9.5	24.0	16.9	13.1	9.4	23.3	8.5	21.2	14.5	14.6	21.6	27.7	9.2	12.3	19.8	15.5	17.3	18.8	11.1	15.6	14.1	6.7	13.1	14.1	11.9	19.7	7.4	12.3	22.7	11.5	12.0	14.6	8.2	6.7	5.3	8.4	6.8	7.0	8.7	8.5	9.8	9.8	8.1	5.3	6.4	0.7	19.3	8.2	6.9	12.9	6.7	10.2	14.2	15.6	11.6	8.0	6.9	10.5	5.7	10.0	14.5
INTS9	"CPSF2L, FLJ10871, RC-74"	ENSG00000104299	"Integrator complex subunit 9"	Q9NV88	8	28767661-28890242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051615, HPA066822"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA051615: , HPA066822: "	"unprognostic (2.19e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.79e-2)"	"prognostic favourable (9.45e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.91e-3)"	"prognostic favourable (7.71e-4)"	"unprognostic (3.64e-2)"	"unprognostic (5.01e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.48e-3)"	"prognostic favourable (1.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	10.8	28.8	10.5	14.1	13.4	8.1	11.0	14.2	16.5	11.3	11.7	15.5	7.7	9.3	16.4	16.1	14.1	13.7	9.1	13.0	9.5	7.6	12.8	9.3	11.4	17.9	15.2	8.1	11.4	12.5	13.4	24.0	11.4	12.1	11.6	12.9	17.9	15.5	10.6	14.1	12.4	11.9	12.8	13.5	20.4	11.7	15.2	13.3	28.4	17.2	8.5	23.1	13.2	11.2	17.6	24.3	15.5	19.3	19.9	17.0	9.3	13.2	9.3	11.2	11.9	14.0	6.5	5.0	6.1	8.4	10.7	11.9	6.5	7.4	13.2	8.6	6.2	11.1	21.7	12.5	14.9	5.5	8.9	13.2	5.3	11.3	10.1	6.6	10.2	7.4	8.9	12.9	9.2	13.1	27.6	7.6	7.1	7.3	30.4	11.9	15.2	6.0	19.6	13.1	6.9	7.5	9.2	8.1	14.9	6.3	8.3	11.0	8.0	7.4	7.6	6.2	15.9	10.4	7.7	3.9	2.7	16.3	9.5	11.0	8.7	12.1	17.7	15.5	15.4	19.3	14.3	15.4	13.7	17.0	24.3	17.6	12.5	13.1	7.2	19.9	13.7	12.8	16.3	9.3	10.5	13.4	14.2	16.5	9.5	7.6	15.2	8.1	12.1	13.3
IP6K1	"IHPK1, KIAA0263"	ENSG00000176095	"Inositol hexakisphosphate kinase 1"	Q92551	3	49724294-49786542	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040825	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040825: AB_10960426"	"unprognostic (6.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (2.08e-4)"	"unprognostic (9.97e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic favourable (6.85e-4)"	"unprognostic (1.29e-2)"	"prognostic favourable (5.77e-5)"	"unprognostic (8.75e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.64e-2)"	14.2	17.5	23.5	12.9	26.9	12.1	15.8	38.6	40.4	17.7	16.1	20.7	16.1	13.6	21.4	14.5	19.6	20.0	14.7	13.7	23.8	23.5	16.3	15.9	16.9	16.3	17.9	18.3	30.2	21.9	30.3	16.7	18.3	21.2	14.3	13.2	18.6	18.3	21.1	9.0	18.2	12.7	19.5	16.9	16.9	13.7	27.3	14.8	22.3	17.1	8.4	14.4	16.3	15.6	6.8	4.1	24.0	4.8	6.9	9.7	6.0	12.3	15.0	17.6	20.6	18.4	14.2	14.2	16.5	17.4	27.1	23.8	19.4	12.9	10.8	10.7	18.2	9.2	24.8	14.9	15.4	21.6	19.7	24.4	23.0	13.1	20.3	14.9	17.1	16.5	18.6	29.2	17.7	22.6	15.9	12.7	13.3	11.0	18.1	15.6	18.9	25.0	11.5	12.5	21.6	17.5	18.9	9.5	19.0	21.0	13.7	18.9	11.0	22.0	20.2	15.2	15.3	20.8	19.1	15.5	20.8	11.5	13.9	17.3	15.5	2.5	4.8	8.2	8.7	3.9	8.8	4.6	8.0	9.6	4.1	6.8	9.7	9.5	24.0	6.9	4.8	2.9	8.2	6.0	23.5	26.9	38.6	40.4	23.8	23.5	17.9	18.3	21.2	14.8
IPMK		ENSG00000151151	"Inositol polyphosphate multikinase"	Q8NFU5	10	58191517-58267934	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 6.4;monocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037837, HPA057542"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA037837: AB_10670166, HPA057542: "	"unprognostic (4.52e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.22e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavourable (9.96e-7)"	"unprognostic (1.79e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.02e-3)"	12.2	4.1	5.4	6.8	5.6	2.8	6.7	8.7	5.6	5.9	19.4	3.5	2.1	9.5	3.2	5.6	10.8	3.8	8.6	7.4	5.2	5.5	5.3	21.3	11.0	13.8	4.9	3.3	4.8	6.0	22.5	6.1	13.8	4.3	4.4	7.5	4.8	6.4	4.4	9.8	9.0	28.1	4.9	6.0	14.1	4.4	2.9	3.8	11.7	5.9	4.9	5.9	10.4	12.3	0.7	1.0	6.4	2.1	0.4	0.9	0.4	14.6	3.7	5.6	5.4	5.4	6.4	4.8	3.9	8.3	3.3	6.7	7.5	9.4	11.7	7.9	4.6	4.5	4.7	5.1	10.7	5.3	3.5	2.9	3.8	7.2	3.3	4.5	6.7	7.0	4.7	5.6	11.4	7.1	1.9	6.0	5.8	3.6	6.2	8.8	3.5	3.6	0.4	12.0	5.4	6.2	3.8	3.9	6.7	5.0	13.4	3.9	11.2	5.5	6.1	3.6	7.0	7.6	4.9	13.0	7.6	9.3	6.9	4.8	1.4	2.3	1.5	3.3	0.4	1.6	0.4	0.7	0.4	0.2	1.0	0.4	0.9	0.3	6.4	0.4	2.1	0.4	0.1	0.4	5.4	5.6	8.7	5.6	5.2	5.5	4.9	3.3	4.3	3.8
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	25.5	15.3	13.6	14.2	17.1	8.8	22.2	18.4	18.3	19.5	13.7	14.2	17.4	10.4	19.9	13.9	18.6	16.1	16.4	20.0	15.2	13.4	18.5	16.9	12.8	14.2	14.9	13.7	18.6	14.4	23.9	20.9	24.4	17.1	15.9	13.7	13.2	14.8	16.6	19.0	14.0	12.3	17.0	14.4	26.3	13.7	30.9	13.3	18.8	21.7	15.7	15.0	19.8	24.4	4.2	3.6	12.2	5.6	18.0	5.3	3.2	11.7	11.1	10.3	15.9	8.4	11.4	14.0	12.7	9.7	13.3	15.0	12.4	9.3	20.2	10.2	12.9	9.7	21.3	14.8	21.1	7.6	11.2	9.4	11.4	11.1	6.1	10.6	5.4	8.1	8.6	16.0	17.2	50.4	17.7	6.6	13.3	11.1	11.2	13.8	13.2	6.8	13.7	15.2	18.3	8.3	11.6	11.0	6.4	11.1	8.8	9.0	11.3	7.4	22.7	8.0	8.9	8.9	11.6	5.2	8.5	14.0	10.0	14.8	9.6	12.2	2.1	1.8	3.5	3.4	4.2	3.1	3.7	3.6	3.6	4.2	5.3	3.8	2.1	18.0	5.6	2.3	2.3	3.2	13.6	17.1	18.4	18.3	15.2	13.4	14.9	13.7	17.1	13.3
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024297	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol			92000	"Nucleoplasm, Cytosol"		"CAB009110: AB_2264985, HPA040983: , HPA056548: "	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	26.3	13.8	16.5	14.5	18.3	13.0	23.5	16.3	20.2	20.2	19.7	15.9	13.5	9.6	21.1	13.4	19.4	18.9	12.4	23.9	15.7	12.7	18.9	23.2	14.1	16.0	20.8	15.9	33.5	60.7	12.5	13.0	14.3	15.3	19.1	16.6	11.0	13.9	20.2	65.0	13.5	11.3	25.5	24.3	14.9	18.9	79.5	19.4	23.3	23.0	24.1	21.1	21.8	23.9	8.0	11.0	1.1	7.3	10.3	12.3	6.1	28.2	19.1	35.8	32.8	24.4	62.1	22.0	41.6	32.8	58.7	41.8	39.1	21.8	81.8	14.6	50.0	24.6	74.4	28.5	81.2	20.6	23.4	44.5	36.2	30.6	17.4	48.0	15.9	34.8	18.8	47.6	40.1	33.4	30.7	11.0	50.1	7.7	36.2	13.0	36.0	22.9	46.6	40.7	24.2	14.1	18.6	26.6	21.7	21.4	25.0	15.6	18.9	26.5	23.4	39.7	20.0	19.8	37.8	14.8	18.2	25.5	41.0	30.5	27.1	0.5	4.4	1.1	7.1	7.3	12.3	8.0	8.3	8.8	11.0	7.6	11.6	9.6	0.6	10.3	5.1	5.4	8.5	6.1	16.5	18.3	16.3	20.2	15.7	12.7	20.8	15.9	15.3	19.4
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384622-9448126	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol			26000	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: "	"unprognostic (1.92e-1)"	"prognostic unfavourable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	23.9	20.6	21.8	18.6	24.4	12.3	36.0	24.1	30.6	24.3	27.4	14.4	19.3	17.0	25.7	19.3	29.0	20.3	20.3	37.7	22.8	23.4	26.5	24.7	22.0	23.2	23.3	17.4	23.4	25.9	33.1	19.1	26.5	24.8	24.4	22.1	12.0	21.4	22.4	88.2	17.1	16.1	53.4	25.7	16.6	21.5	9.7	16.8	20.8	34.3	28.5	20.9	43.7	33.9	3.8	5.8	1.3	6.3	6.9	5.4	1.6	37.3	29.2	34.4	27.3	34.9	45.1	27.6	45.5	29.3	33.7	36.5	25.3	34.4	35.1	16.6	35.0	29.4	48.8	35.3	56.3	16.7	40.3	29.0	33.2	25.3	21.8	44.3	22.1	28.8	38.3	22.1	52.2	39.7	43.4	21.1	43.8	15.2	26.7	21.7	33.9	34.0	28.1	54.2	15.8	27.8	35.3	13.7	26.9	20.3	40.3	32.8	18.5	22.3	31.1	41.5	28.6	42.7	48.6	6.1	23.4	24.2	27.2	23.9	22.5	0.1	2.5	0.6	2.7	4.8	5.4	3.8	3.1	3.9	5.8	3.1	3.9	3.2	1.3	6.9	6.3	2.7	2.8	1.6	21.8	24.4	24.1	30.6	22.8	23.4	23.3	17.4	24.8	16.8
IPO8	"IMP8, RANBP8"	ENSG00000133704	"Importin 8"	O15397	12	30628988-30695986	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018439, HPA023765"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA018439: AB_1851771, HPA023765: AB_1851773"	"unprognostic (1.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (2.66e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (8.62e-5)"	"unprognostic (9.75e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.24e-1)"	15.7	20.9	21.2	17.3	22.5	10.0	15.4	19.8	22.6	17.4	25.2	12.3	15.9	17.9	22.4	16.0	22.9	17.2	18.3	18.9	17.9	14.5	22.5	23.3	15.6	17.5	14.8	20.3	21.1	23.9	54.4	27.8	17.2	19.0	18.4	22.6	11.9	16.7	18.5	19.8	16.6	22.6	21.3	15.9	20.4	17.8	27.5	14.6	24.8	22.1	13.1	18.0	21.6	20.4	8.0	3.6	7.3	6.0	6.0	7.5	2.8	17.1	20.2	19.3	14.2	18.2	21.0	27.1	19.0	18.3	15.2	17.9	13.8	17.9	22.2	16.7	23.2	11.2	21.4	20.6	22.2	25.8	15.0	18.1	24.2	12.5	12.0	26.2	14.3	16.9	13.0	24.1	20.7	25.0	16.1	16.7	21.4	8.7	19.7	16.2	37.6	7.7	16.2	40.6	17.9	19.1	23.7	12.0	14.7	19.9	14.6	10.5	23.3	9.5	22.3	14.6	12.8	31.4	16.5	16.5	22.3	33.6	17.8	15.8	25.2	7.2	4.5	5.4	4.8	6.0	7.1	5.6	5.4	5.2	3.3	8.0	5.9	7.5	7.3	6.0	5.5	3.6	6.1	2.8	21.2	22.5	19.8	22.6	17.9	14.5	14.8	20.3	19.0	14.6
IQCB1	"KIAA0036, NPHP5, SLSN5"	ENSG00000173226	"IQ motif containing B1"	Q15051	3	121769763-121835079	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding	"Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042028	Approved	Approved	Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"				"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA042028: "	"unprognostic (3.82e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (3.08e-5)"	"prognostic favourable (3.67e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-3)"	11.5	10.8	9.9	25.1	12.6	16.6	21.9	14.7	16.8	14.4	11.8	8.8	16.9	11.0	14.7	19.4	13.1	15.9	11.5	10.4	10.1	10.1	10.6	9.0	15.0	20.6	12.5	14.5	19.8	22.7	13.9	20.7	12.1	12.4	16.2	15.6	10.9	14.4	30.2	11.4	14.2	14.0	14.6	11.4	19.3	11.2	40.1	12.5	16.2	11.4	9.5	23.0	16.7	14.1	18.9	7.6	8.9	10.4	8.6	10.0	4.9	13.7	3.7	18.4	20.7	3.0	4.5	21.6	6.6	4.0	7.4	9.0	12.7	6.7	27.9	9.2	3.7	10.6	11.3	5.3	11.1	5.4	9.1	18.5	7.3	10.4	7.7	22.9	5.6	2.8	10.2	5.1	11.5	5.6	11.0	10.4	8.3	6.9	14.9	16.2	15.5	6.8	14.8	8.8	8.9	4.3	6.1	9.9	8.0	6.3	4.5	11.4	4.0	17.9	4.7	7.1	8.5	3.4	8.5	25.2	16.0	47.4	6.8	10.5	6.4	2.5	5.2	8.9	6.3	9.9	9.0	18.9	8.3	7.6	7.6	17.5	10.0	6.3	2.1	8.6	10.4	7.2	8.7	4.9	9.9	12.6	14.7	16.8	10.1	10.1	12.5	14.5	12.4	12.5
IQCC	FLJ10547	ENSG00000160051	"IQ motif containing C"	Q4KMZ1	1	32205661-32208687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028602, HPA028686"	Approved		Supported	Vesicles				Vesicles		"HPA028602: AB_10600298, HPA028686: AB_10601985"	"unprognostic (1.45e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (7.81e-6)"	"prognostic favourable (5.65e-4)"	"unprognostic (4.97e-2)"	"unprognostic (2.97e-2)"	"prognostic favourable (8.23e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.12e-3)"	"prognostic favourable (3.79e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.66e-1)"	2.2	4.2	5.0	3.3	8.2	4.4	5.0	9.7	11.7	3.8	3.5	5.1	4.4	2.5	5.5	10.2	3.1	8.3	3.4	2.8	4.0	4.3	4.3	1.9	2.9	3.5	3.1	5.9	5.4	8.1	5.6	9.5	2.7	3.4	4.3	3.5	4.7	4.8	5.7	4.1	4.9	3.1	3.0	3.1	3.2	4.4	26.6	4.6	4.4	8.3	1.0	3.7	2.8	2.9	5.1	2.8	3.4	1.1	3.9	3.8	1.2	7.6	2.5	6.2	5.8	1.1	2.3	3.9	4.4	5.0	9.2	8.6	6.1	6.8	2.7	4.8	1.3	6.4	6.3	3.8	7.8	4.1	7.1	4.9	5.9	2.6	1.5	5.2	3.3	1.6	4.1	8.1	3.7	1.9	8.5	0.7	4.1	5.3	8.5	5.3	3.9	5.7	12.0	3.8	6.2	3.4	2.9	8.8	3.4	8.7	5.0	4.6	6.1	5.4	2.6	3.4	6.3	4.9	7.4	3.5	2.5	2.4	4.8	4.9	7.0	1.6	1.0	0.4	3.3	1.0	3.1	5.1	3.4	2.5	1.8	2.5	3.8	2.2	3.4	3.9	1.1	2.8	3.7	1.2	5.0	8.2	9.7	11.7	4.0	4.3	3.1	5.9	3.4	4.6
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388218-90502243	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			890000	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	46.2	23.2	9.9	27.8	17.1	23.7	31.7	5.9	11.2	41.8	26.7	18.1	19.7	12.3	50.8	28.8	41.3	27.4	22.0	17.6	12.0	9.1	25.9	9.8	38.3	45.3	17.5	6.6	31.3	16.4	27.6	19.1	53.7	15.5	28.9	27.1	12.0	37.8	22.0	23.1	32.7	25.8	37.6	17.4	48.0	20.3	11.4	15.4	39.5	32.7	29.6	34.9	43.0	40.8	5.9	9.9	39.3	12.4	11.5	9.9	6.3	31.6	17.5	8.8	10.3	22.8	29.7	51.4	30.3	28.2	27.9	30.1	20.1	33.1	17.7	14.8	50.6	57.2	17.6	33.9	33.9	22.5	12.5	11.8	33.9	7.4	27.6	21.6	25.4	17.5	31.4	32.9	47.0	38.3	10.2	25.0	42.6	16.4	11.7	6.5	11.5	10.0	14.3	23.7	15.5	28.8	50.4	11.1	8.4	42.2	21.6	22.5	18.9	18.7	48.5	31.9	16.6	26.7	31.2	9.7	13.8	17.9	29.0	21.3	17.1	10.5	11.6	8.1	9.9	10.9	8.9	5.6	6.2	8.5	9.9	5.9	3.8	6.6	39.3	11.5	12.4	6.0	6.7	6.3	9.9	17.1	5.9	11.2	12.0	9.1	17.5	6.6	15.5	15.4
IQSEC1	"ARF-GEP100, BRAG2, GEP100, KIAA0763"	ENSG00000144711	"IQ motif and Sec7 domain 1"	Q6DN90	3	12897220-13073117	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.2;U-266/84: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038143, HPA038144"	Uncertain		Supported	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA038143: AB_10697241, HPA038144: "	"prognostic unfavourable (3.03e-5)"	"unprognostic (1.80e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (9.07e-4)"	"unprognostic (4.42e-1)"	"prognostic favourable (3.58e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.65e-2)"	17.8	14.1	27.8	12.3	27.0	32.5	7.1	31.9	41.5	9.5	6.7	18.5	3.5	4.8	8.0	4.7	6.1	8.5	7.4	16.0	25.0	17.8	7.0	11.5	12.4	14.8	16.4	24.8	12.3	13.0	25.7	7.8	13.4	36.7	11.6	4.8	17.0	9.3	10.0	21.0	6.2	7.7	8.4	10.6	20.6	6.9	5.6	15.5	2.6	6.3	4.3	14.0	7.8	5.9	6.2	6.8	12.9	4.0	1.8	3.6	2.3	4.9	6.7	6.0	6.8	5.1	7.1	34.2	5.6	4.6	3.7	2.9	4.6	4.4	10.5	6.4	10.5	2.8	4.6	2.9	2.8	7.1	9.7	6.2	4.0	19.6	5.6	0.1	2.6	7.0	5.4	7.6	4.3	3.4	17.5	11.2	2.5	15.8	3.9	6.6	6.3	13.8	5.3	2.0	15.1	2.2	6.4	5.3	9.7	4.0	14.1	3.3	6.0	4.3	9.2	4.1	10.4	3.5	0.7	22.3	30.6	4.1	7.7	3.1	3.3	5.0	3.8	4.8	3.6	4.0	2.7	6.2	2.4	2.7	1.9	6.1	2.4	3.0	12.9	1.8	3.9	6.8	1.7	2.3	27.8	27.0	31.9	41.5	25.0	17.8	16.4	24.8	36.7	15.5
IQSEC3	"KIAA1110, MGC30156"	ENSG00000120645	"IQ motif and Sec7 domain 3"	Q9UPP2	12	66765-178460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8"	"Cell line enhanced"	"Detected in some"		"HEL: 9.4;U-266/70: 12.7;U-266/84: 3.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039025			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039025: AB_10672768"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.83e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-2)"	5.6	1.3	5.6	0.7	4.2	0.8	0.4	19.8	15.5	1.6	0.4	0.5	0.0	0.5	2.0	0.5	0.4	5.2	2.2	1.9	6.5	5.1	2.4	0.2	2.9	0.5	3.7	4.7	2.1	1.2	0.0	2.2	1.3	5.0	1.5	0.2	0.4	0.2	4.5	1.3	0.2	0.7	1.9	1.4	0.3	0.6	1.2	0.8	0.0	0.3	0.0	0.2	1.3	0.6	0.0	2.1	0.0	0.0	0.5	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.7	3.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	1.2	0.0	0.5	0.0	2.1	0.0	0.4	5.6	4.2	19.8	12.4	6.5	5.1	3.7	4.7	5.0	0.8
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010500-154019980	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: "	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	22.3	23.7	12.1	25.0	11.4	48.3	38.5	7.7	14.8	11.1	24.8	10.8	13.4	29.9	13.2	12.4	25.5	12.2	23.1	14.1	9.9	12.3	23.7	46.9	18.5	37.5	12.6	7.9	15.1	34.6	8.1	15.2	14.3	11.9	18.0	11.0	10.1	31.9	15.9	32.6	15.9	34.6	11.5	12.7	34.0	19.3	14.3	9.8	17.0	12.6	20.4	26.7	17.2	15.3	10.0	13.0	6.7	10.6	6.3	6.7	3.4	76.3	29.7	4.2	34.3	8.4	6.7	18.3	11.4	10.8	17.6	16.4	23.5	34.0	32.6	64.3	12.2	20.9	9.7	18.6	6.9	25.6	29.0	11.9	26.7	14.0	19.4	28.1	20.5	9.3	16.4	16.8	18.6	10.5	20.9	37.8	12.3	28.1	11.5	25.1	10.4	59.3	30.0	21.3	54.8	11.7	14.5	23.6	17.0	13.6	15.2	22.5	5.9	29.9	14.3	21.4	33.9	48.9	70.7	47.6	30.4	59.8	31.3	33.8	22.2	1.3	8.7	6.7	6.7	10.6	5.9	7.5	5.3	5.3	5.4	10.0	3.1	6.1	5.9	6.3	8.1	13.0	2.5	3.4	12.1	11.4	7.7	14.8	9.9	12.3	12.6	7.9	11.9	9.8
IRF1	MAR	ENSG00000125347	"Interferon regulatory factor 1"	P10914	5	132481609-132490798	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 103.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011662, HPA063131"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB011662: AB_775784, HPA063131: "	"unprognostic (1.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.09e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.53e-3)"	19.7	8.5	4.1	64.2	9.9	43.8	21.0	3.9	4.6	10.6	27.3	4.0	4.4	31.1	11.4	9.9	12.4	11.8	18.1	11.8	4.2	3.5	14.2	20.9	49.3	41.0	6.8	1.4	11.5	14.5	2.8	8.8	24.7	10.3	18.9	13.6	10.3	13.2	10.3	14.0	8.4	52.1	11.3	8.0	51.7	17.5	5.7	4.9	36.6	26.5	14.7	33.0	14.7	26.7	12.1	16.2	103.0	42.1	21.3	28.5	21.3	8.9	7.2	0.6	2.5	7.1	6.2	14.7	4.3	18.3	13.7	17.2	3.7	26.7	8.9	5.8	6.4	12.5	2.2	10.4	4.6	18.8	2.4	11.9	3.4	2.7	46.9	5.8	10.2	11.6	2.6	10.1	9.7	6.4	2.1	34.3	3.8	4.9	31.6	9.7	0.8	5.1	36.7	7.7	10.8	7.0	10.1	1.3	1.1	4.5	10.2	4.4	1.7	8.0	4.0	7.8	2.8	4.5	6.3	27.2	6.8	6.3	9.0	9.3	5.6	23.1	26.2	40.2	28.5	40.0	19.4	12.1	18.7	22.9	16.2	11.5	11.5	16.0	103.0	21.3	42.1	8.2	20.2	21.3	4.1	9.9	3.9	4.6	4.2	3.5	6.8	1.4	10.3	4.9
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387713-184474580	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 49.8;Karpas-707: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"				Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: "	"prognostic favourable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favourable (8.34e-5)"	"unprognostic (1.31e-3)"	27.5	30.6	15.2	31.0	19.3	11.3	21.0	21.5	16.4	21.5	23.7	28.8	16.6	21.2	19.8	16.5	20.5	18.1	17.3	16.1	15.3	12.1	15.3	26.1	24.0	38.7	22.8	9.7	28.0	14.9	12.4	24.5	19.7	17.8	20.5	20.4	16.8	22.1	16.1	21.9	18.1	27.7	21.2	22.4	39.4	21.3	8.4	22.0	36.1	24.0	12.6	34.5	28.8	26.4	22.2	16.2	83.9	27.5	18.1	21.9	17.2	6.0	4.4	5.5	3.6	12.1	12.4	3.3	4.4	13.9	10.9	11.5	1.3	11.6	3.7	2.3	6.6	5.6	3.7	8.4	7.1	49.8	2.0	10.3	2.5	8.0	12.0	6.2	8.7	13.3	7.8	6.2	16.1	8.3	2.0	52.0	4.5	4.2	12.0	7.7	1.2	3.3	15.9	2.1	16.5	8.3	9.3	2.3	3.6	6.2	5.2	9.1	4.0	5.7	6.8	3.1	3.4	3.5	3.9	14.9	11.9	3.2	6.6	6.1	5.5	17.7	19.4	34.5	16.4	25.3	16.9	21.2	16.3	17.6	16.2	22.2	17.5	17.3	83.9	18.1	27.5	4.1	21.9	17.2	15.2	19.3	21.5	16.4	15.3	12.1	22.8	9.7	17.8	22.0
IRF2BP1	"DKFZP434M154, IRF-2BP1"	ENSG00000170604	"Interferon regulatory factor 2 binding protein 1"	Q8IU81	19	45883607-45886170	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042164, HPA049480"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA042164: , HPA049480: "	"unprognostic (5.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.01e-1)"	"prognostic favourable (2.32e-4)"	"unprognostic (2.60e-1)"	"prognostic favourable (3.85e-5)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.07e-3)"	14.2	11.9	12.2	9.0	14.1	6.7	8.7	23.1	26.2	12.7	11.2	12.6	10.6	14.4	15.3	8.1	8.2	12.4	12.6	10.8	11.8	11.7	12.0	14.8	10.0	9.5	13.2	12.8	20.3	18.5	12.4	15.6	8.6	12.5	13.5	4.8	12.6	19.6	15.2	33.4	13.4	12.4	9.3	8.7	15.6	16.4	8.0	12.8	17.4	13.7	8.0	8.6	12.0	8.7	2.7	2.0	1.4	1.7	2.4	3.6	1.6	8.2	12.6	3.1	6.9	2.7	1.7	5.1	6.1	3.5	4.9	4.3	4.7	3.9	6.7	4.6	3.1	7.8	2.2	2.3	1.4	8.4	21.9	6.7	3.6	5.9	5.4	6.9	6.3	2.3	3.1	2.5	1.8	3.0	10.5	5.3	1.8	6.4	14.0	37.8	5.8	11.3	16.1	3.6	5.7	3.4	4.6	9.3	16.0	6.4	8.5	7.7	7.0	12.9	4.3	4.2	8.6	3.2	8.6	14.6	16.1	3.9	5.7	6.6	6.1	0.0	1.2	0.4	2.8	1.7	2.8	2.7	2.5	2.3	1.1	2.3	3.6	2.2	1.4	2.4	0.7	2.0	2.3	1.6	12.2	14.1	23.1	26.2	11.8	11.7	13.2	12.8	12.5	12.8
IRF2BP2	IRF-2BP2	ENSG00000168264	"Interferon regulatory factor 2 binding protein 2"	Q7Z5L9	1	234604269-234609525	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 73.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027815, HPA062269"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027815: AB_10609994, HPA062269: "	"unprognostic (1.15e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	17.9	14.5	11.3	21.1	12.9	48.0	29.9	16.5	17.6	19.8	19.3	13.8	10.9	13.9	20.3	13.1	17.3	17.1	31.6	19.6	12.7	11.5	12.3	20.4	35.0	30.3	11.1	10.6	25.3	22.6	15.9	10.8	11.1	13.9	18.5	18.1	16.8	19.6	12.9	18.8	25.2	20.0	11.6	15.0	16.2	17.0	23.9	11.3	28.6	21.1	14.6	19.5	17.4	19.4	4.0	17.4	8.9	4.5	2.8	5.1	2.3	7.4	11.4	8.3	12.7	17.4	13.8	9.9	5.9	5.1	3.6	4.1	6.6	9.2	0.0	14.1	5.7	10.3	4.4	7.8	5.6	12.1	10.4	7.2	9.0	19.4	14.1	26.4	25.2	16.2	18.3	8.0	15.0	9.0	6.2	15.3	9.1	2.2	6.6	28.2	7.5	4.4	13.1	3.8	17.5	6.8	6.2	16.5	11.7	9.6	12.8	18.8	12.3	73.8	10.0	12.9	5.4	9.6	11.2	34.0	8.8	2.4	6.4	24.1	17.4	8.9	4.5	7.6	4.1	3.4	4.2	4.0	5.0	4.8	4.5	3.9	5.1	4.3	2.3	2.8	1.8	17.4	3.7	2.3	11.3	12.9	16.5	17.6	12.7	11.5	11.1	10.6	13.9	11.3
IRF2BPL	"C14orf4, EAP1, KIAA1865"	ENSG00000119669	"Interferon regulatory factor 2 binding protein like"	Q9H1B7	14	77024543-77028699	"Plasma proteins, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050862, HPA061333"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA050862: AB_2681258, HPA061333: AB_2684481"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (8.78e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	24.2	21.6	12.7	13.7	13.0	7.9	24.4	20.3	17.9	21.0	21.0	9.8	18.2	11.0	19.3	13.3	16.3	26.3	23.4	21.3	12.9	12.3	19.7	16.3	15.6	12.7	13.8	7.4	36.9	18.2	35.8	17.2	13.7	15.7	20.2	6.0	19.7	26.2	20.2	15.9	17.0	11.1	18.4	13.5	18.4	13.9	15.3	13.4	27.4	27.6	7.1	9.8	21.8	24.6	2.1	12.2	9.9	2.4	6.5	3.4	0.7	6.7	5.9	14.8	16.5	4.5	4.1	21.1	7.1	5.9	2.0	2.7	2.7	11.2	2.4	5.2	6.1	10.6	2.5	5.3	1.7	11.3	8.7	3.0	5.8	3.7	5.9	0.8	13.6	5.5	4.2	3.6	3.1	2.7	4.5	27.1	2.5	18.5	9.1	6.3	6.6	31.0	1.9	4.2	5.6	7.0	10.0	11.5	16.6	10.1	10.6	17.6	7.3	1.5	4.6	9.4	9.2	3.1	4.5	10.5	11.2	4.0	14.5	2.1	11.6	1.5	1.6	1.4	3.4	2.2	3.2	1.7	3.0	3.1	1.4	2.1	2.5	2.6	9.9	6.5	2.4	12.2	2.9	0.7	12.7	13.0	20.3	14.1	12.9	12.3	13.8	7.4	15.7	13.4
IRF3		ENSG00000126456	"Interferon regulatory factor 3"	Q14653	19	49659569-49665875	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004895, CAB013018"	Approved		Supported	Cytosol				Cytosol		"CAB013018: AB_2533904, HPA004895: AB_1851887"	"unprognostic (5.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.17e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.91e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.52e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavourable (1.56e-7)"	"unprognostic (1.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (3.47e-2)"	"prognostic favourable (3.61e-4)"	14.8	17.0	13.4	33.2	22.1	21.8	17.1	16.9	20.1	23.4	18.9	14.1	30.1	18.3	20.0	16.3	18.7	18.9	22.0	15.9	17.7	11.2	20.5	21.3	19.4	36.3	22.2	10.9	23.5	18.5	13.4	22.3	21.2	18.7	23.1	11.7	18.1	26.3	37.7	8.6	19.9	25.4	20.0	17.4	37.3	21.4	7.6	20.0	23.7	22.6	11.8	31.0	19.0	20.6	17.8	13.4	21.8	14.7	20.3	35.4	17.4	29.1	32.1	11.2	16.6	8.5	13.6	25.4	12.9	19.5	22.3	29.4	22.6	34.4	17.2	14.7	11.9	23.9	11.9	33.1	10.0	23.3	21.2	16.1	12.4	20.6	9.8	11.8	16.4	12.9	23.7	29.5	8.9	17.6	17.7	18.8	11.8	28.4	18.5	33.7	13.2	29.8	21.4	11.2	29.8	16.3	25.0	6.3	7.9	23.5	25.7	12.7	11.1	23.3	12.2	13.3	12.5	10.0	16.5	25.8	26.4	16.5	15.1	27.6	13.1	8.8	12.6	21.8	28.5	12.7	25.4	17.8	27.9	26.6	9.8	16.2	24.9	22.5	16.1	20.3	14.7	13.4	35.4	17.4	13.4	22.1	16.9	20.1	17.7	11.2	22.2	10.9	18.7	20.0
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391739-411447	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 49.1;Karpas-707: 45.6;RPMI-8226: 44.1;U-266/70: 41.3;U-266/84: 30.7;WM-115: 25.0"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8"	"Group enriched"	"Detected in many"	5	"B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favourable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	7.1	0.5	0.4	36.6	0.4	18.4	4.0	0.4	0.4	17.4	13.9	0.1	0.4	5.0	2.2	0.7	6.4	1.2	4.1	1.6	0.4	0.5	1.4	5.6	4.2	31.5	0.5	0.0	1.9	0.7	0.0	0.7	0.5	0.1	1.5	4.8	15.8	21.3	1.9	0.7	4.5	11.1	0.3	0.6	33.8	4.6	1.7	0.1	15.2	1.3	2.4	48.7	8.4	4.2	9.7	10.4	0.0	1.6	0.2	4.8	1.3	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	45.6	0.0	0.0	0.0	0.0	0.2	0.0	5.8	0.0	44.1	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	30.7	13.4	0.0	0.0	25.0	0.0	1.6	0.0	0.6	1.2	0.0	9.5	0.9	0.9	9.0	9.7	1.6	0.7	0.0	0.2	1.2	10.4	4.8	1.3	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.0	0.1	0.1
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785623-209806175	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 16.0;HaCaT: 58.3;HBEC3-KT: 21.3;hTCEpi: 47.0;hTERT-HME1: 23.5;RT4: 20.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 8.6;pons and medulla: 4.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.0	6.3	1.1	4.1	1.0	0.3	13.3	8.6	0.9	11.7	12.9	1.0	38.6	9.2	3.9	31.4	63.7	7.6	17.5	10.3	1.1	0.8	12.9	18.4	8.8	0.3	0.9	0.7	3.9	13.9	10.3	6.8	26.7	4.4	21.8	11.3	1.5	24.8	34.6	0.6	45.6	20.3	3.1	1.1	1.2	9.5	4.3	0.3	13.0	22.1	32.3	33.8	15.0	19.1	0.9	0.5	2.0	1.0	0.6	2.8	0.7	16.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.1	0.0	0.0	3.4	5.7	0.0	0.0	0.0	58.3	0.0	21.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	0.0	23.5	0.9	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	20.8	5.2	1.7	0.4	9.3	0.5	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.2	0.1	2.0	2.8	1.0	1.9	0.6	0.6	0.9	0.5	0.9	2.1	1.1	0.1	0.6	0.1	0.2	0.0	0.7	1.1	1.0	8.6	0.9	1.1	0.8	0.9	0.7	4.4	0.3
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85898803-85922609	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 197.4;lymphoid tissue: 64.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 34.7;THP-1: 58.7;U-698: 137.6;U-937: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 197.4"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 197.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	12.4	4.0	6.8	36.1	8.8	19.2	6.7	2.6	5.3	2.3	7.8	8.3	6.8	12.3	2.3	3.0	3.7	2.9	5.6	2.9	5.8	3.3	5.6	9.9	11.7	60.4	9.3	3.1	2.1	3.1	0.2	2.2	2.7	6.7	3.3	10.0	2.2	6.1	8.9	1.5	2.6	36.4	3.6	10.9	64.4	6.5	2.2	8.8	18.4	3.6	2.3	63.3	8.3	2.1	31.8	197.4	0.7	10.8	8.9	0.3	9.8	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.7	0.0	34.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	0.1	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.7	0.0	0.0	1.6	0.0	0.1	0.0	0.0	137.6	0.0	19.4	0.0	0.5	10.7	0.2	0.2	10.8	0.3	29.3	0.1	0.1	23.7	31.8	0.3	0.2	0.7	8.9	7.2	197.4	0.0	9.8	6.8	8.8	2.6	5.3	5.8	3.3	9.3	3.1	6.7	8.8
IRF9	ISGF3G	ENSG00000213928	"Interferon regulatory factor 9"	Q00978	14	24161053-24166565	"Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.4;BJ hTERT+ SV40 Large T+ RasG12V: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001862	Approved		Supported	Cytosol				Cytosol		"HPA001862: AB_1079153"	"unprognostic (4.96e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.84e-3)"	"unprognostic (8.17e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (7.58e-8)"	"unprognostic (1.56e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.40e-2)"	"prognostic favourable (9.92e-4)"	34.4	20.9	23.4	35.0	25.3	21.5	15.8	10.1	19.5	19.1	19.1	22.5	15.1	19.2	23.5	31.3	18.6	22.6	27.4	13.5	17.7	24.6	27.4	26.8	23.8	22.7	22.1	18.4	26.5	13.6	13.9	17.5	25.4	22.1	21.7	11.8	17.8	36.0	16.2	8.1	14.7	20.3	20.4	23.8	37.0	22.4	9.3	20.1	26.4	29.2	12.0	28.3	30.1	21.9	28.4	21.4	57.8	30.9	19.5	29.0	25.4	1.6	1.5	1.5	0.6	7.7	8.1	0.9	3.0	16.5	34.4	26.7	2.9	9.5	2.2	3.4	8.3	2.9	1.0	0.7	8.7	10.1	0.3	4.7	1.6	2.8	11.7	0.5	6.4	7.7	2.5	4.3	1.0	3.7	0.8	12.5	4.5	2.3	1.0	1.9	0.5	3.0	0.7	1.1	1.2	7.8	1.7	0.4	1.4	3.0	1.9	16.3	0.7	4.3	7.0	3.5	2.6	2.3	0.9	13.3	10.4	2.1	4.1	0.8	3.2	45.6	24.3	30.8	21.5	30.9	18.4	28.4	22.7	19.3	19.4	25.5	20.1	18.1	57.8	19.5	29.2	21.4	29.0	25.4	23.4	25.3	10.1	18.5	17.7	24.6	22.1	18.4	22.1	20.1
IRGQ	"FKSG27, IRGQ1"	ENSG00000167378	"Immunity related GTPase Q"	Q8WZA9	19	43584369-43596135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043254, HPA050338"	Approved		Supported	Vesicles			18000	Vesicles		"HPA043254: AB_10794178, HPA050338: AB_2681094"	"unprognostic (1.98e-1)"	"prognostic favourable (5.17e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.20e-3)"	"prognostic unfavourable (9.60e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.48e-2)"	"prognostic favourable (3.57e-5)"	"unprognostic (9.24e-2)"	"prognostic favourable (3.92e-4)"	"unprognostic (2.82e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.65e-2)"	5.1	6.1	9.0	4.9	8.7	17.4	4.5	17.2	16.0	6.4	4.9	6.5	9.4	5.0	6.7	6.0	5.2	5.7	6.3	9.2	8.2	8.4	9.5	8.9	6.5	3.3	6.7	13.0	8.5	5.8	10.8	7.9	5.4	9.2	6.6	4.6	5.6	5.9	5.8	15.4	5.5	4.7	5.5	6.1	6.6	6.6	4.7	6.5	2.7	5.2	4.5	4.9	5.5	5.4	1.1	1.6	5.4	1.7	1.1	1.2	0.8	3.2	5.4	4.5	9.1	5.0	3.6	4.6	3.0	1.9	3.4	3.5	4.2	2.1	2.0	4.8	3.6	4.7	4.3	2.3	2.1	3.8	3.1	2.8	6.6	4.0	3.1	3.9	4.2	3.6	4.7	4.5	2.4	4.2	4.2	4.3	3.2	2.7	4.8	2.8	2.4	3.0	8.8	4.3	1.7	2.8	6.8	8.6	7.8	7.9	8.3	2.4	5.3	3.5	6.7	11.4	8.4	2.9	4.0	4.5	3.7	3.6	7.0	1.7	9.0	5.4	1.7	0.9	0.9	1.4	0.6	0.8	0.7	0.8	1.0	1.1	1.2	0.7	3.5	1.1	1.4	1.6	0.8	0.8	9.0	8.7	17.2	16.0	8.2	8.4	6.7	13.0	9.2	6.5
IRS1	HIRS-1	ENSG00000169047	"Insulin receptor substrate 1"	P35568	2	226731317-226799759	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.0;naive B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005261, HPA046433"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005261: AB_649615, HPA046433: "	"unprognostic (2.20e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.55e-3)"	7.0	9.9	3.1	5.0	2.7	0.6	11.7	9.6	5.4	13.3	14.2	1.4	3.9	4.0	17.2	5.0	3.8	13.9	11.5	6.3	3.9	2.2	5.2	12.0	5.0	2.5	2.3	2.6	21.9	7.1	3.4	2.5	9.1	4.2	9.8	2.9	5.5	3.3	7.5	23.3	5.1	6.5	11.7	2.6	3.3	5.8	2.4	1.7	17.1	23.4	5.6	2.5	14.6	15.8	1.2	0.4	0.0	0.2	0.0	0.3	0.2	3.2	14.7	10.8	0.4	14.9	8.9	0.0	8.8	7.0	11.9	7.7	8.4	8.2	1.3	1.5	6.0	5.6	0.7	8.5	6.8	3.2	0.6	0.0	0.9	3.9	7.4	0.3	0.0	12.3	4.7	9.3	8.5	0.0	1.6	13.1	8.0	12.6	2.7	3.7	4.3	8.2	0.6	14.0	0.1	5.4	10.7	1.9	0.3	2.8	2.0	4.7	7.9	0.1	0.7	15.7	14.4	12.1	8.5	6.1	2.5	1.9	15.5	0.3	4.6	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.1	1.2	0.2	0.1	0.0	0.0	0.0	0.4	0.3	0.2	3.1	2.7	9.6	5.4	3.9	2.2	2.3	2.6	4.2	1.7
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752698-109786568	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 18.0;SH-SY5Y: 18.9;THP-1: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol				Cytosol	Aggresome	"CAB016944: , HPA054664: "	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	38.9	24.3	27.6	10.9	25.2	70.1	33.5	19.6	30.6	13.5	10.9	13.0	6.7	8.7	14.4	12.2	7.1	7.7	8.4	13.5	23.6	14.6	7.7	24.6	11.6	5.3	24.2	22.1	27.1	7.9	6.1	23.0	13.6	19.5	20.0	7.5	9.3	11.5	12.2	20.9	15.3	9.7	9.7	25.1	9.0	8.3	6.3	21.3	2.0	10.7	4.7	5.3	8.4	17.8	0.5	0.1	6.9	1.4	0.2	0.5	0.2	2.6	3.0	1.9	0.0	16.5	3.3	1.0	2.9	3.4	1.7	1.5	0.2	3.2	0.0	1.8	2.0	1.2	1.0	2.6	2.2	1.0	13.6	1.2	4.3	0.0	16.7	4.7	1.5	6.9	13.9	0.5	18.0	0.6	0.8	0.0	17.0	1.3	0.0	13.9	2.1	0.6	5.9	1.8	1.2	4.9	0.7	2.9	18.9	1.5	0.0	11.6	0.3	28.3	0.0	3.7	0.0	0.2	3.8	0.0	1.3	0.9	2.7	4.6	6.3	2.7	1.4	1.9	0.2	0.3	0.3	0.1	0.4	0.1	0.1	0.5	0.5	0.4	6.9	0.2	0.4	0.1	0.5	0.2	27.6	25.2	19.6	30.6	23.6	14.6	24.2	22.1	19.5	21.3
ISCU	"hnifU, IscU, ISU2, NIFUN"	ENSG00000136003	"Iron-sulfur cluster assembly enzyme"	Q9H1K1	12	108562582-108569384	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006329, HPA038602, HPA057592"	Approved		Supported	Cytosol				Cytosol		"CAB006329: AB_425907, HPA038602: , HPA057592: "	"unprognostic (1.72e-1)"	"prognostic favourable (4.90e-7)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.49e-2)"	"prognostic favourable (2.73e-7)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-3)"	"prognostic favourable (6.12e-4)"	37.3	91.2	44.7	25.2	62.2	23.6	44.5	27.4	61.6	37.4	39.7	20.1	32.7	25.2	36.5	44.7	25.2	32.5	34.6	121.6	37.5	56.1	86.7	33.1	29.6	34.1	54.9	58.9	48.5	28.3	41.7	48.5	31.4	65.8	36.6	33.1	34.7	33.9	59.6	87.3	21.4	27.2	50.5	27.4	33.6	32.9	29.9	21.9	30.3	53.2	39.1	37.6	36.3	42.1	86.6	34.7	85.9	34.3	29.6	61.9	53.8	9.9	24.4	17.3	10.3	62.4	48.0	42.2	20.0	33.0	15.3	14.6	18.1	14.3	10.0	17.3	27.4	14.6	16.5	23.0	13.9	30.9	17.7	10.9	13.3	40.0	36.4	25.9	13.0	46.4	51.6	16.6	33.2	23.3	20.3	32.6	32.1	21.6	20.3	47.3	16.7	36.0	13.5	11.5	43.1	44.6	28.7	14.9	13.8	14.5	8.6	21.9	22.3	21.1	19.8	15.6	13.1	12.4	10.1	38.9	42.3	31.0	24.3	19.4	15.7	62.3	29.4	84.0	37.2	30.2	44.0	86.6	49.1	48.0	19.9	73.7	61.9	51.7	85.9	29.6	34.3	34.7	49.7	53.8	44.7	62.2	27.4	61.6	37.5	56.1	54.9	58.9	65.8	21.9
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498850	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"placenta: 193.8"	"Cell line enriched"	"Detected in some"	15	"BEWO: 89.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"			Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.7	0.0	0.2	0.2	4.2	0.0	0.1	0.1	0.3	1.1	0.2	0.1	0.3	0.1	2.7	0.9	0.2	0.5	0.1	0.1	0.1	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.5	193.8	0.2	3.2	0.0	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.2	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.1	0.3	0.1	0.8	0.1	0.1	0.2	0.2
IST1	KIAA0174	ENSG00000182149	"IST1, ESCRT-III associated factor"	P53990	16	71845996-71931199	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041802, HPA054532"	Approved		Supported	Vesicles			45000	Vesicles		"HPA041802: AB_10794491, HPA054532: "	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (4.55e-4)"	"unprognostic (1.64e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.43e-3)"	"prognostic favourable (8.88e-4)"	43.9	41.2	40.4	36.4	48.5	54.9	43.2	42.4	50.8	41.5	51.7	63.2	36.6	39.9	48.1	35.4	44.9	49.6	37.1	40.0	39.9	38.6	54.9	36.4	43.9	45.4	53.4	36.8	49.6	49.8	91.6	55.5	52.1	41.7	40.2	50.0	45.1	39.2	38.4	64.6	45.7	46.5	48.4	56.4	55.8	40.5	45.9	48.9	50.6	47.3	32.8	60.6	44.6	42.6	52.4	52.1	87.3	56.5	52.7	67.6	71.8	16.8	24.9	35.1	22.6	35.4	25.0	29.7	21.1	26.8	29.7	31.2	27.0	23.6	24.1	26.4	24.5	25.5	34.3	22.6	37.9	15.9	16.6	20.2	15.0	43.4	26.8	19.7	28.8	29.5	31.5	26.5	25.7	37.0	27.6	8.9	30.5	28.2	25.5	16.5	40.2	15.5	40.4	19.2	29.4	24.7	24.7	26.5	19.8	23.5	12.4	19.2	22.7	24.6	18.4	22.5	22.3	13.7	16.8	23.4	41.4	66.2	19.1	17.7	27.0	55.5	56.5	67.7	49.0	53.0	53.0	52.4	47.0	51.2	52.1	51.8	50.7	47.4	87.3	52.7	49.6	36.2	67.6	71.8	40.4	48.5	42.4	50.8	39.9	38.6	53.4	36.8	41.7	48.9
ISX	RAXLX	ENSG00000175329	"Intestine specific homeobox"	Q2M1V0	22	35066136-35087387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"intestine: 22.2"	"Group enriched"	"Detected in some"	15	"CACO-2: 3.4;Hep G2: 9.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA060328			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA060328: "			"unprognostic (5.02e-2)"				"unprognostic (2.68e-1)"				"unprognostic (2.23e-1)"	"unprognostic (3.33e-1)"		"unprognostic (3.86e-1)"	"unprognostic (2.55e-1)"			0.1	0.0	0.1	2.0	0.1	0.0	0.1	0.1	0.1	0.1	16.3	0.1	0.1	22.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	15.8	0.1	0.1	0.1	0.1	0.0	19.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ISY1	"fSAP33, KIAA1160"	ENSG00000240682	"ISY1 splicing factor homolog"	Q9ULR0	3	129127415-129161293	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA006312, HPA016995"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (2.20e-2)"	"prognostic favourable (2.46e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (7.25e-4)"	"unprognostic (4.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	20.7	17.1	16.4	21.8	18.1	43.4	22.2	21.8	19.5	18.8	22.5	13.9	15.9	15.2	25.0	20.0	25.2	16.9	17.7	20.9	16.0	13.2	15.6	13.6	16.8	28.3	14.8	15.9	22.5	24.1	12.3	15.3	21.6	12.6	15.6	17.4	14.4	17.4	18.1	31.6	22.8	17.6	22.1	13.7	21.8	17.5	15.4	16.7	25.5	17.0	20.4	28.2	20.7	31.3	28.7	32.3	46.9	30.0	41.6	36.1	26.7	18.6	7.2	10.8	15.0	13.1	13.7	12.5	14.0	12.7	16.9	16.3	14.3	14.1	23.6	15.2	11.5	16.0	20.3	11.3	24.0	22.6	9.3	27.3	12.3	11.4	12.1	41.9	19.5	8.5	8.0	14.8	23.0	13.4	19.5	12.1	9.0	18.8	25.3	23.4	11.8	11.3	22.5	24.4	16.5	6.3	11.9	17.1	12.9	25.8	5.7	14.7	11.0	34.8	16.1	12.3	12.3	18.1	14.6	14.7	8.8	46.7	11.3	24.3	14.0	35.7	30.0	46.8	30.3	28.5	33.7	28.7	30.9	32.0	32.3	26.8	34.3	30.8	46.9	41.6	24.3	28.1	36.1	26.7	16.4	18.1	21.8	19.5	16.0	13.2	14.8	15.9	12.6	16.7
ISY1-RAB43		ENSG00000261796	"ISY1-RAB43 readthrough"		3	129087575-129161036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA006312, HPA016995"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (1.09e-1)"	"unprognostic (5.42e-2)"			"unprognostic (1.52e-1)"	"unprognostic (9.05e-3)"		"unprognostic (2.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"		"unprognostic (5.67e-2)"	"unprognostic (1.87e-1)"	14.4	15.8	11.8	17.9	13.1	11.9	16.2	15.9	14.2	15.0	14.7	9.9	11.5	7.9	17.8	14.6	11.7	12.9	12.8	11.5	11.6	7.7	15.9	22.5	19.1	17.0	10.6	11.5	19.1	17.6	17.7	13.3	13.0	9.0	15.3	14.4	10.3	13.7	17.2	18.2	10.6	13.3	16.1	9.2	20.4	13.1	11.1	12.0	18.6	17.1	14.8	16.8	12.6	23.0	0.6	0.7	2.3	1.8	2.1	3.3	1.9	15.8	3.6	8.2	7.5	10.3	6.1	3.6	7.6	17.9	12.3	15.3	1.8	8.2	0.5	11.2	13.7	6.1	3.2	12.9	7.7	6.0	1.1	1.5	1.5	6.3	17.9	6.5	8.1	14.1	6.9	7.7	4.9	16.0	2.5	6.2	10.7	6.6	9.8	4.8	5.6	4.3	8.3	3.6	5.4	13.4	6.1	0.6	3.6	3.6	8.2	11.4	4.1	6.2	12.9	6.1	5.1	8.6	3.4	9.1	4.1	2.8	6.9	0.7	8.4	0.4	1.8	0.5	2.4	0.9	2.6	0.2	2.2	3.0	0.7	0.6	3.3	2.5	2.3	2.1	1.6	0.6	1.8	1.9	11.8	13.1	15.9	14.2	11.6	7.7	10.6	11.5	9.0	12.0
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363235-34511393	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: "	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	20.7	16.7	18.9	15.4	26.9	20.5	17.5	19.8	26.7	23.9	18.2	37.9	15.2	16.9	18.4	15.1	35.9	14.5	14.5	17.9	20.4	15.9	21.1	46.5	18.5	16.8	29.2	16.5	19.3	17.1	21.6	26.3	26.9	29.0	17.5	20.4	16.7	20.1	18.4	24.0	19.2	20.3	19.8	30.4	17.3	17.3	34.8	32.3	22.3	22.7	13.0	23.6	19.6	21.0	7.3	11.4	19.6	6.2	6.2	11.4	2.7	20.0	13.2	13.5	9.7	14.9	21.3	16.2	16.3	18.7	20.4	20.0	37.2	30.9	9.8	15.8	20.8	25.4	20.5	32.9	24.9	7.4	6.6	28.4	11.2	22.2	15.6	11.6	12.9	10.8	16.8	17.2	27.0	15.3	16.1	17.0	15.9	10.0	17.0	6.2	6.5	15.7	14.3	28.5	22.6	12.1	34.8	8.3	6.1	30.5	11.9	18.3	14.3	10.5	14.8	24.4	14.7	15.9	12.0	13.5	14.1	14.3	15.1	7.5	14.3	3.6	5.8	6.1	10.8	6.2	11.4	7.3	3.8	5.7	4.5	6.9	3.3	4.9	19.6	6.2	3.8	11.4	4.8	2.7	18.9	26.9	19.8	26.7	20.4	15.9	29.2	16.5	29.0	32.3
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 74.7;hTERT-HME1: 64.9;RPTEC TERT1: 65.8;U-138 MG: 65.1;U-87 MG: 112.1;WM-115: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"			180000	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (3.24e-3)"	"prognostic unfavourable (6.75e-4)"	"unprognostic (9.51e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (8.28e-3)"	"unprognostic (2.76e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (5.95e-5)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.35e-2)"	15.7	15.8	4.1	8.6	5.1	0.1	8.7	7.7	6.5	10.9	20.9	2.3	8.9	17.1	11.6	11.6	12.8	14.5	32.6	8.4	4.2	5.4	36.0	1.7	37.6	3.2	3.2	6.7	10.7	8.0	13.0	11.2	26.4	4.3	12.0	8.9	11.6	10.0	9.7	6.6	17.3	37.3	11.6	3.3	6.5	13.7	3.9	1.5	3.3	36.1	13.3	8.3	19.0	8.1	0.2	0.0	0.0	0.0	0.0	1.1	0.2	20.5	27.2	0.1	0.8	0.5	2.1	4.4	9.6	20.8	14.6	11.1	0.6	32.1	0.0	60.9	7.0	14.6	0.2	74.7	8.9	2.5	0.4	0.0	6.9	0.1	12.9	0.0	0.6	2.6	36.9	14.6	64.9	10.7	0.0	0.3	27.4	5.9	0.0	0.0	0.6	16.5	0.0	1.4	1.5	65.8	35.8	1.1	0.4	10.5	1.4	24.1	2.4	0.2	23.1	65.1	20.5	0.6	37.5	0.9	1.5	0.6	112.1	0.2	67.6	0.0	0.0	0.0	0.8	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	1.1	0.2	4.1	5.1	7.7	6.5	4.2	5.4	3.2	6.7	4.3	1.5
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32900319-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"			540000000	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: , HPA069003: "	"unprognostic (3.07e-2)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	95.2	30.6	13.7	32.1	19.7	9.7	107.7	6.5	14.8	55.1	61.3	17.0	80.2	20.2	84.2	56.2	59.9	45.0	49.8	68.7	15.0	14.4	47.3	85.8	55.4	34.5	23.0	11.1	47.4	37.4	17.6	35.2	83.3	19.5	53.1	32.2	18.6	30.3	76.2	58.0	19.5	42.3	109.3	30.1	59.8	45.4	26.9	18.8	12.7	36.8	27.6	19.4	92.7	47.4	31.3	9.1	4.3	27.1	21.9	68.4	26.2	47.4	69.7	37.6	41.7	90.9	78.3	32.8	159.7	92.6	76.1	69.6	15.6	111.2	12.8	28.9	133.9	33.2	11.3	90.9	84.9	12.6	9.2	15.4	33.2	18.2	64.0	3.4	15.3	79.3	49.7	80.0	32.6	93.4	10.6	5.7	125.4	7.8	5.9	3.5	8.4	35.4	3.9	27.9	2.3	108.5	13.8	8.9	22.3	49.8	8.5	35.8	11.4	12.4	104.5	98.0	56.9	69.6	53.2	5.2	1.1	7.2	72.2	14.6	38.4	1.6	9.8	4.3	25.5	17.8	6.0	31.3	54.6	37.5	9.1	8.6	7.1	19.1	2.3	21.9	27.1	3.7	68.4	26.2	13.7	19.7	6.5	14.8	15.0	14.4	23.0	11.1	19.5	18.8
ITGB1BP1	"ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B"	ENSG00000119185	"Integrin subunit beta 1 binding protein 1"	O14713	2	9403475-9423547	"Predicted intracellular proteins"	"Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067348, HPA071538"			Supported	"Nucleoplasm,Nuclear bodies,Centriolar satellite,Cytosol"				Nucleoplasm	"Nuclear bodies, Centriolar satellite, Cytosol"	"HPA067348: , HPA071538: "	"unprognostic (2.21e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (4.39e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavourable (4.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (7.10e-5)"	"unprognostic (3.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.08e-3)"	61.1	15.0	19.0	11.6	29.2	16.1	73.0	17.6	24.0	24.5	16.3	9.9	10.2	7.7	18.0	16.6	13.3	15.0	14.4	23.9	17.1	15.6	23.6	7.7	13.4	12.1	19.7	18.7	14.3	7.6	14.8	9.7	14.1	19.4	11.1	14.8	11.4	7.7	15.1	16.0	16.6	8.6	22.1	19.2	8.6	11.2	5.6	17.0	10.2	11.2	12.1	14.8	12.8	33.6	20.7	29.5	35.2	27.3	24.1	31.3	24.9	16.0	11.5	13.6	15.5	48.5	41.2	7.4	29.4	20.2	26.6	20.7	15.3	10.0	17.7	13.3	40.3	15.2	20.7	19.2	29.4	47.7	10.5	16.1	13.6	19.0	16.9	12.4	17.6	23.2	15.9	24.3	17.4	23.2	9.0	14.7	32.9	14.3	21.9	8.1	11.0	19.3	12.6	18.6	16.4	26.9	13.2	14.8	14.3	16.4	12.6	19.8	9.3	9.4	14.7	23.9	17.6	31.8	32.6	14.7	31.6	25.9	32.7	17.1	16.5	35.2	23.0	27.9	30.4	27.3	28.9	20.7	26.5	29.4	29.5	17.5	20.6	26.5	5.0	24.1	20.0	26.6	31.3	24.9	19.0	29.2	17.6	24.0	17.1	15.6	19.7	18.7	19.4	17.0
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6"	"Group enriched"	"Detected in some"	5	"THP-1: 114.8;U-937: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"			2500000	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	59.1	9.8	9.0	47.5	16.8	91.4	8.4	1.7	8.0	5.6	7.4	12.2	1.2	6.3	4.9	9.0	4.8	10.7	10.3	9.7	7.2	6.4	8.1	7.0	32.9	73.8	14.3	2.9	6.6	5.1	1.1	3.3	12.7	12.1	6.9	4.2	5.2	8.8	2.7	3.0	4.1	13.2	12.3	18.3	75.6	7.6	4.2	12.2	53.5	4.5	2.2	29.0	15.7	4.2	9.5	76.0	104.6	122.9	41.0	57.4	159.7	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.4	19.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.3	0.0	0.4	0.0	15.0	3.9	0.2	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.5	17.0	18.0	0.0	0.3	0.2	3.5	9.3	0.7	0.0	0.0	0.2	0.5	0.3	0.3	0.0	114.8	0.3	0.0	1.0	0.0	0.5	0.1	0.8	0.4	0.0	85.3	0.1	10.5	122.9	85.7	57.4	84.1	25.8	6.7	28.4	39.5	76.0	9.5	19.1	32.0	104.6	41.0	81.0	11.6	20.7	159.7	9.0	16.8	1.7	8.0	7.2	6.4	14.3	2.9	12.1	12.2
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253846-47311816	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 45.5;HEL: 40.3;RPTEC TERT1: 26.2;U-87 MG: 20.6;WM-115: 65.7"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"basophil: 2.8;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.8"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"		710000000	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	10.0	0.6	1.0	6.2	2.5	2.7	7.0	0.4	1.6	4.6	13.6	0.9	2.4	2.2	9.7	5.7	6.4	6.4	2.8	8.5	0.7	0.6	16.0	3.7	5.2	1.2	2.3	0.1	4.6	0.6	0.7	1.6	23.5	1.6	6.4	4.8	1.8	2.5	11.5	4.9	2.4	5.0	17.0	1.8	9.5	3.6	2.6	0.6	0.2	36.6	1.9	0.9	11.0	7.8	0.1	0.0	2.8	0.1	0.0	0.0	9.5	0.0	0.4	0.1	0.0	2.3	1.0	0.0	1.2	6.0	2.6	2.4	0.0	0.0	0.1	45.5	0.3	0.0	0.0	0.0	3.4	0.8	0.0	40.3	0.1	0.0	1.9	0.0	0.0	0.9	0.0	15.2	0.3	11.3	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	26.2	0.0	0.0	0.1	1.5	0.0	8.2	0.0	0.0	12.3	0.5	0.6	0.3	2.8	0.0	0.0	0.2	20.6	0.0	65.7	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	9.5	1.0	2.5	0.4	1.6	0.7	0.6	2.3	0.1	1.6	0.6
ITGB3BP	"CENPR, HSU37139, NRIF3, TAP20"	ENSG00000142856	"Integrin subunit beta 3 binding protein"	Q13352	1	63440770-63593721	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA028463	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA028463: AB_10601435"	"unprognostic (4.98e-2)"	"unprognostic (5.88e-3)"	"unprognostic (6.28e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.58e-1)"	"prognostic favourable (4.32e-4)"	"prognostic unfavourable (7.24e-5)"	"unprognostic (2.68e-2)"	"unprognostic (7.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.97e-3)"	"prognostic unfavourable (8.45e-6)"	"unprognostic (1.34e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.34e-3)"	"unprognostic (6.14e-2)"	8.3	11.3	10.9	11.2	14.2	8.3	12.8	17.6	16.3	11.8	8.6	3.1	4.4	6.5	10.1	13.8	13.6	11.3	9.0	6.5	12.5	3.6	13.2	7.1	8.1	13.8	17.6	3.6	15.5	12.6	15.1	29.4	8.3	13.7	10.7	8.9	4.5	12.5	6.4	6.1	8.6	8.7	9.6	16.5	12.0	9.6	17.1	15.0	17.6	11.6	9.0	13.6	11.0	11.5	13.5	6.8	7.1	3.3	11.6	10.2	5.7	23.8	11.5	13.5	11.1	3.3	10.4	12.6	11.6	7.0	20.2	24.9	6.4	11.0	21.8	8.9	2.9	17.2	10.7	11.1	24.9	16.1	25.7	16.6	16.1	12.9	3.5	22.6	10.9	2.5	8.7	11.4	9.3	10.3	19.1	29.1	2.7	10.0	24.3	21.0	17.8	12.9	15.9	24.3	32.2	13.3	6.9	18.0	10.9	13.3	7.6	18.4	7.7	7.6	6.3	6.9	10.2	14.3	17.4	14.6	23.7	20.5	11.3	28.4	10.6	7.1	3.3	0.9	5.8	2.4	9.5	13.5	9.0	8.7	4.0	12.8	10.2	8.7	1.0	11.6	2.9	6.8	9.5	5.7	10.9	14.2	17.6	16.3	12.5	3.6	17.6	3.6	13.7	15.0
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 117.5;HaCaT: 45.0;HBEC3-KT: 100.3;hTCEpi: 34.3;RT4: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			79000	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (6.39e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	6.3	3.4	9.7	10.9	9.7	1.4	13.7	4.7	7.7	14.3	32.1	15.6	10.0	35.3	9.7	8.8	24.0	13.7	47.8	4.3	9.4	7.9	4.8	1.5	7.4	3.7	10.1	9.1	4.7	6.7	3.1	5.7	50.0	17.2	19.7	10.4	9.8	52.3	13.2	2.4	47.0	58.5	7.4	10.7	17.0	41.0	3.9	9.8	1.8	3.2	22.1	15.9	17.2	20.5	2.4	8.2	1.3	0.7	0.0	2.2	0.8	21.8	19.3	0.0	0.2	0.0	0.1	26.6	0.1	0.0	0.0	0.1	2.0	117.5	0.0	4.2	0.0	45.0	0.1	100.3	0.0	0.1	0.0	0.1	4.9	2.1	0.1	0.0	0.2	0.1	34.3	0.0	21.4	0.7	0.0	2.0	0.0	12.2	0.2	0.2	0.1	16.8	0.3	0.5	0.2	26.8	33.0	0.0	0.2	0.6	2.0	0.3	8.4	0.2	2.2	0.6	1.0	0.0	0.2	0.7	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.0	0.7	0.7	2.2	1.4	0.3	1.0	0.1	2.4	0.9	0.6	1.3	0.0	0.0	8.2	1.4	0.8	9.7	9.7	4.7	7.7	9.4	7.9	10.1	9.1	17.2	9.8
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48233158-48270357	"Disease related genes, Predicted membrane proteins"			"Amyloidosis, Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 346.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 108.7;RPTEC TERT1: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 236.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 236.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Approved		Enhanced	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		2600000	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: "	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favourable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	89.3	79.6	60.6	41.3	61.6	25.0	79.6	87.2	65.8	72.6	58.3	64.9	93.4	83.4	61.2	346.2	71.5	53.2	59.4	86.9	75.9	61.4	198.7	65.1	80.2	75.9	71.7	49.8	100.7	48.5	27.0	63.1	132.0	50.2	66.5	36.0	80.8	75.1	99.8	30.9	73.5	81.0	53.1	90.0	78.5	64.5	44.7	48.3	35.0	73.1	63.0	47.7	63.3	74.5	13.3	23.3	236.4	46.6	17.2	31.7	73.7	8.6	7.5	12.7	23.8	48.5	29.4	18.9	22.9	29.0	11.5	14.6	5.3	41.5	2.3	19.5	16.7	35.3	6.8	16.5	9.7	6.7	16.1	16.4	6.1	14.6	20.9	16.1	108.7	17.6	14.8	6.7	7.5	14.8	4.2	19.9	14.0	5.8	25.9	35.6	34.8	10.2	11.7	12.6	11.7	154.6	40.9	4.3	17.1	20.3	16.7	11.8	10.9	17.1	23.8	9.6	9.6	12.5	11.1	7.8	7.2	0.3	14.0	9.4	21.4	136.9	46.6	141.3	21.3	35.7	28.1	12.0	29.8	26.5	23.3	13.3	31.7	26.5	236.4	17.2	35.5	10.3	28.7	73.7	60.6	61.6	87.2	58.0	75.9	61.4	71.7	49.8	50.2	48.3
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			69000	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	17.7	27.5	18.6	24.7	21.2	20.4	17.7	10.2	22.7	21.3	21.4	18.3	20.6	22.9	18.1	17.3	31.0	26.6	19.6	25.9	18.1	13.5	22.9	20.3	22.7	30.6	20.5	24.1	16.5	43.8	17.6	10.2	17.0	16.2	14.6	16.8	13.2	19.9	21.5	19.5	23.4	19.0	16.3	16.3	20.6	19.3	16.7	19.5	15.2	24.9	29.0	24.1	14.6	17.7	19.3	30.7	11.3	31.0	24.7	24.1	18.2	33.1	26.2	13.0	13.4	8.6	12.7	8.6	15.0	21.0	19.8	17.4	21.0	30.9	14.3	13.8	13.8	28.9	17.8	22.6	13.9	9.3	26.6	35.8	10.9	31.8	16.3	15.3	12.2	12.1	17.3	18.7	11.6	15.1	24.5	9.9	17.8	15.2	18.0	44.4	21.7	26.5	17.3	18.1	37.5	27.1	10.5	19.7	23.2	11.9	41.7	27.6	17.3	25.6	10.6	22.3	12.4	14.6	31.8	14.7	18.4	27.0	10.4	28.4	24.2	11.3	25.7	8.8	20.7	31.0	18.0	19.3	18.9	21.8	30.7	17.8	14.2	17.2	1.4	24.7	21.9	28.3	24.1	18.2	18.6	21.2	10.2	22.7	18.1	13.5	20.5	24.1	16.2	19.5
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717103-40740860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA050760: , HPA053003: "	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	26.0	8.2	6.6	9.8	10.9	2.4	13.4	4.4	7.7	14.2	9.3	3.7	7.6	8.5	8.8	5.2	46.8	11.0	17.1	10.8	13.2	3.7	7.3	7.7	18.4	6.9	4.4	2.7	6.8	16.4	6.4	9.9	10.8	23.8	12.1	5.2	6.0	15.4	8.4	8.1	21.6	9.8	11.9	17.8	6.5	11.4	3.8	5.2	3.2	7.8	31.4	28.0	10.6	17.1	3.3	2.3	3.9	3.2	0.9	3.5	1.7	6.5	6.2	3.8	6.0	17.5	15.2	6.2	3.9	8.3	4.1	3.6	8.9	6.8	1.8	4.5	5.0	6.9	3.8	16.9	1.7	3.4	3.9	1.4	2.2	6.2	17.3	1.5	1.9	21.1	24.7	3.8	14.2	9.9	5.3	3.2	3.9	8.0	2.2	2.3	1.9	2.8	2.4	1.9	2.5	6.3	11.1	2.7	3.4	3.9	16.1	3.6	7.4	3.9	6.3	2.6	3.9	1.7	2.6	1.8	0.4	1.9	4.1	1.5	2.8	3.9	3.2	1.7	3.5	1.6	1.4	1.4	2.7	1.9	1.5	3.3	1.9	2.2	1.6	0.9	2.2	2.3	2.6	1.7	6.6	10.9	4.4	7.7	13.2	3.7	4.4	2.7	23.8	5.2
ITPR2	"CFAP48, IP3R2"	ENSG00000123104	"Inositol 1,4,5-trisphosphate receptor type 2"	Q14571	12	26336515-26833198	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell line enhanced"	"Detected in many"		"TIME: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059144, HPA062260"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoplasm	"HPA059144: , HPA062260: "	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.76e-1)"	8.8	20.6	12.8	14.5	13.8	6.1	18.5	9.3	15.0	7.9	9.9	7.8	3.7	6.0	7.2	7.8	12.0	7.3	8.0	7.1	14.2	6.0	14.4	47.1	6.5	8.1	12.8	4.6	8.0	9.2	17.4	9.9	11.9	13.0	6.6	7.8	4.8	17.6	3.8	4.7	13.3	8.9	5.4	20.3	12.5	5.9	3.4	15.3	35.3	5.3	6.6	10.7	5.5	8.1	4.3	9.0	17.3	5.2	3.6	3.1	0.7	2.6	1.1	1.6	2.6	4.9	5.0	1.7	2.5	3.4	1.7	1.8	0.1	1.4	9.2	1.6	3.3	2.9	8.6	5.2	2.3	2.2	2.8	7.4	2.4	14.8	4.5	6.6	3.3	4.7	0.7	3.7	6.8	16.3	3.2	2.9	2.2	2.2	4.6	8.8	7.1	0.8	1.5	3.8	5.8	4.0	4.2	0.5	2.6	11.2	2.0	6.2	4.2	3.3	35.6	3.5	1.3	3.4	3.1	2.7	2.1	17.2	3.2	3.0	2.2	17.3	5.2	7.1	2.4	2.2	2.0	4.2	2.1	1.9	1.0	4.3	2.5	2.2	13.5	3.6	3.0	9.0	3.1	0.7	12.8	13.8	9.3	15.0	14.2	6.0	12.8	4.6	13.0	15.3
ITSN1	"ITSN, MGC134948, MGC134949, SH3D1A, SH3P17"	ENSG00000205726	"Intersectin 1"	Q15811	21	33642400-33899861	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 42.4;NTERA-2: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 5.9;eosinophil: 7.2;intermediate monocyte: 4.1;myeloid DC: 1.8;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;granulocytes: 7.2;monocytes: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018007	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA018007: AB_1851836"	"unprognostic (2.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.64e-2)"	47.4	14.9	24.9	8.9	24.5	5.7	21.7	24.2	24.8	15.5	11.2	10.2	12.3	8.3	17.9	11.8	11.0	13.6	18.5	18.3	24.6	12.1	10.7	23.1	9.5	5.9	12.1	20.4	19.2	4.9	8.4	7.7	22.0	21.1	14.2	10.6	11.4	6.9	21.9	18.0	11.0	9.0	17.4	11.1	13.4	10.3	11.2	15.0	2.4	9.3	4.0	3.9	13.1	12.5	0.0	1.8	7.2	6.3	0.1	0.7	1.1	12.7	5.3	25.8	8.5	12.1	11.7	42.4	12.9	12.5	7.6	7.3	20.2	9.7	3.0	10.5	15.4	4.9	15.3	8.9	8.2	1.2	6.7	3.6	11.0	9.4	9.2	2.5	3.6	11.5	8.1	14.2	7.9	20.0	4.7	2.1	12.1	2.9	3.5	3.4	38.2	4.1	4.6	12.4	6.2	11.3	5.2	4.9	5.3	18.5	3.8	4.6	4.7	2.5	18.0	8.5	11.6	6.6	4.4	2.6	7.1	2.8	7.7	8.1	9.4	0.0	5.9	7.2	0.4	4.1	0.5	0.0	0.7	0.2	1.8	0.0	0.3	0.1	0.3	0.1	6.3	0.4	0.0	1.1	24.9	24.5	24.2	24.8	24.6	12.1	12.1	20.4	21.1	15.0
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405795-40435947	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria			66000	Mitochondria	Nucleoplasm	"HPA041391: , HPA044250: "	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favourable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	12.3	32.0	15.4	13.2	20.6	6.7	24.3	14.4	18.0	12.7	13.7	20.5	23.3	12.3	11.8	16.6	8.9	17.2	22.7	30.4	13.8	16.1	28.9	71.9	14.2	10.4	16.1	15.9	19.4	18.9	19.5	23.9	7.4	16.3	21.0	13.0	14.4	11.8	31.9	30.6	3.5	9.8	13.7	14.7	11.0	14.4	11.2	15.7	8.6	55.7	12.2	9.0	11.2	7.9	11.6	34.1	14.3	29.8	14.7	13.5	8.6	8.7	5.3	9.6	17.3	15.4	13.5	0.4	13.5	13.1	17.3	10.7	19.7	7.6	0.3	25.7	16.9	10.3	18.4	19.8	10.6	12.5	14.8	22.6	15.4	18.9	27.0	9.2	22.5	20.5	6.9	9.6	20.1	17.0	1.0	1.1	15.4	13.7	11.4	14.2	8.1	16.8	16.7	13.3	10.4	20.4	23.6	16.5	9.2	18.5	40.4	8.1	34.7	40.6	14.5	14.3	9.4	10.1	10.7	21.8	14.9	0.3	13.5	9.1	14.1	5.8	10.2	14.3	13.5	16.1	12.6	11.6	7.5	11.4	22.3	9.9	8.4	11.7	1.3	14.7	29.8	34.1	9.7	8.6	15.4	20.6	14.4	18.0	13.8	16.1	16.1	15.9	16.3	15.7
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 97.1;tongue: 152.1"	"Group enriched"	"Detected in some"	25	"HaCaT: 77.0;RT4: 20.2;SK-BR-3: 23.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"			8000000	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: "	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	39.0	0.1	0.0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	1.8	0.1	0.0	18.7	0.1	0.2	34.2	0.1	1.0	0.0	0.1	0.1	0.1	0.0	1.9	0.1	152.1	49.1	4.9	43.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	77.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IVNS1ABP	"HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP"	ENSG00000116679	"Influenza virus NS1A binding protein"	Q9Y6Y0	1	185296388-185317329	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 171.2"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003405	Approved		Supported	Cytosol				Cytosol		"HPA003405: AB_1079141"	"unprognostic (4.11e-3)"	"unprognostic (9.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.18e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.28e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	23.7	8.7	9.9	19.8	35.8	171.2	29.0	9.9	13.8	12.5	17.0	19.2	28.5	16.2	10.2	12.9	17.1	9.0	15.9	19.3	10.9	8.6	38.7	10.2	26.5	29.9	23.0	7.8	12.7	17.1	11.6	11.9	15.8	16.8	12.6	21.5	9.2	36.2	38.8	13.5	19.5	14.3	7.9	19.3	12.8	18.3	9.0	20.8	13.1	17.3	16.0	16.3	11.5	22.5	4.6	9.1	24.5	8.1	7.4	7.9	8.1	6.8	7.6	22.3	8.9	8.0	2.6	21.0	13.6	4.2	8.6	7.8	8.1	11.0	11.0	11.3	6.6	9.6	8.1	8.9	9.2	8.1	7.8	10.4	11.4	6.5	3.1	7.2	4.1	1.9	10.1	6.5	21.1	11.0	6.9	6.2	15.4	5.2	11.9	5.1	14.0	1.7	7.1	5.9	5.9	73.0	9.2	15.6	13.3	12.0	10.0	8.1	4.5	3.5	7.5	12.0	7.3	3.0	9.6	8.9	7.1	6.5	8.9	7.4	5.3	5.1	8.1	7.7	7.9	5.9	7.0	4.6	6.0	5.7	9.1	3.3	6.7	6.3	24.5	7.4	7.2	2.5	6.1	8.1	9.9	35.8	9.9	13.8	10.9	8.6	23.0	7.8	16.8	20.8
IWS1	"DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319"	ENSG00000163166	"IWS1, SUPT6H interacting protein"	Q96ST2	2	127436207-127526886	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035719, HPA061866"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035719: AB_10669527, HPA061866: "	"unprognostic (3.11e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.81e-2)"	18.6	16.5	21.7	24.5	30.8	25.4	22.9	32.7	25.3	19.6	18.6	23.6	19.1	21.2	21.7	23.1	19.6	18.3	17.8	30.8	24.3	21.4	18.9	27.0	19.1	24.2	32.4	21.8	16.7	18.8	26.8	30.6	35.6	24.9	21.1	22.6	13.4	19.9	19.1	40.5	17.2	20.1	21.0	27.9	23.4	18.4	20.3	32.3	31.4	18.8	24.8	25.2	19.1	23.0	15.7	13.6	18.3	16.4	15.0	13.2	9.2	21.8	14.9	30.2	19.6	23.2	19.3	31.6	31.9	21.9	29.7	25.1	34.9	16.8	20.6	17.0	25.5	18.1	28.9	25.0	35.6	21.3	19.6	28.9	21.6	38.6	27.3	32.5	24.0	18.9	19.2	31.5	28.4	25.3	30.4	16.3	28.2	20.4	32.1	26.5	40.3	20.1	29.1	23.7	18.9	29.9	26.7	23.6	15.3	22.9	28.8	25.2	12.9	22.8	28.7	29.6	22.4	17.8	18.7	12.6	13.9	28.1	16.4	23.1	19.6	3.8	13.8	18.3	11.2	14.9	13.2	12.0	12.5	13.0	13.6	15.7	11.8	12.3	14.5	15.0	16.4	12.2	11.1	9.2	21.7	30.8	32.7	25.3	24.3	21.4	32.4	21.8	24.9	32.3
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"thyroid gland: 212.3"	"Group enriched"	"Detected in some"	6	"CACO-2: 3.3;SK-BR-3: 8.2"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"hippocampal formation: 8.1;thalamus: 2.6"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA059627: "	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favourable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	8.2	0.1	0.1	3.6	0.1	0.3	0.1	0.1	6.7	0.1	0.1	0.1	5.4	6.8	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.1	1.2	0.0	0.3	0.0	0.1	0.2	13.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	212.3	0.0	0.1	0.1	0.1	1.4	1.0	5.9	1.3	2.3	0.7	2.3	0.2	0.0	0.2	0.3	0.1	0.9	0.5	0.0	0.0	0.1	0.0	3.3	0.6	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.5	0.8	0.3	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.5	0.0	0.4	0.3	0.2	0.3	0.2	0.2	0.0	0.8	0.4	0.2	0.0	8.2	0.0	0.8	0.1	0.2	0.2	0.2	0.3	0.0	0.3	0.1	0.1	0.5	0.3	0.2	3.3	1.3	0.7	0.7	1.1	0.5	0.6	0.6	0.5	0.1	1.4	0.6	0.7	5.9	2.3	0.5	1.0	0.5	2.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.0
JADE2	"JADE-2, KIAA0239, PHF15"	ENSG00000043143	"Jade family PHD finger 2"	Q9NQC1	5	134524312-134583230	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025959, HPA055789"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA025959: AB_1855289, HPA055789: "	"unprognostic (8.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavourable (4.42e-4)"	"unprognostic (1.58e-2)"	"unprognostic (3.49e-2)"	"prognostic favourable (5.36e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.87e-2)"	15.6	19.8	16.7	16.1	22.0	9.7	13.9	22.8	21.7	16.0	13.4	15.3	9.2	12.7	13.9	8.4	11.8	20.6	13.2	13.4	17.8	14.5	14.8	4.7	15.0	25.8	30.8	16.0	28.4	14.0	30.9	14.4	8.5	20.1	12.8	8.2	16.4	15.0	16.9	12.0	11.5	17.8	13.0	16.8	22.9	12.9	8.1	30.8	13.0	20.6	6.0	19.2	20.0	22.7	7.3	2.0	6.8	3.0	3.1	6.2	2.4	28.1	20.1	0.6	0.8	7.0	8.5	9.2	5.1	13.4	9.4	11.1	15.2	21.9	31.0	11.4	6.6	6.0	3.6	26.9	4.7	18.7	1.4	7.3	14.0	4.1	7.0	8.0	1.1	5.7	13.1	11.4	14.4	7.1	4.5	11.7	5.7	10.1	13.7	7.2	6.6	10.5	12.3	0.6	12.1	8.8	7.8	4.3	2.8	12.6	0.4	18.0	5.5	9.9	9.9	6.6	6.0	18.7	12.7	5.4	22.5	28.7	10.3	14.3	9.3	6.8	1.2	4.4	6.2	1.1	6.0	7.3	5.7	5.6	2.0	5.5	5.6	5.6	1.3	3.1	3.0	1.2	5.8	2.4	16.7	22.0	22.8	21.7	17.8	14.5	30.8	16.0	20.1	30.8
JAG2		ENSG00000184916	"Jagged 2"	Q9Y219	14	105140981-105168824	"Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.0"	"Cell line enhanced"	"Detected in many"		"HaCaT: 32.3;SCLC-21H: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025481, HPA030636, HPA050567"	Approved		Supported	Vesicles,Cytosol			120000	Vesicles	Cytosol	"CAB025481: , HPA030636: AB_10602607, HPA050567: "	"unprognostic (6.74e-2)"	"unprognostic (4.49e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.17e-1)"	11.5	2.5	5.4	3.5	6.3	1.3	11.4	6.4	8.4	4.2	3.0	3.5	5.2	3.2	7.5	8.4	8.1	5.0	4.4	9.5	5.6	6.4	3.0	1.5	6.6	2.4	4.5	5.3	2.7	5.8	4.3	15.9	6.8	8.7	7.1	1.7	5.9	12.2	6.9	16.8	36.0	4.3	3.2	2.9	3.7	3.8	4.2	3.0	2.7	4.2	11.0	4.1	5.2	5.6	0.0	0.0	0.0	0.0	0.5	0.3	0.0	8.4	3.4	0.2	0.8	0.0	0.0	10.5	0.1	0.1	0.0	0.0	2.8	10.5	0.0	7.3	0.0	32.3	2.1	10.8	0.0	1.1	5.0	0.0	9.3	0.0	0.1	0.0	2.0	0.1	5.3	0.0	1.2	2.6	2.0	0.0	0.0	3.8	0.0	0.0	1.0	1.2	2.6	2.0	3.6	0.1	2.2	16.6	0.5	2.9	0.7	0.1	8.2	1.2	8.9	0.0	0.9	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	5.4	6.3	6.4	8.4	5.6	6.4	4.5	5.3	8.7	3.0
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"ASC diff: 18.9;HDLM-2: 26.7;HEL: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 40.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"				Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: , HPA043870: "	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	19.8	8.8	11.5	19.0	10.5	19.0	17.7	14.7	14.4	17.8	10.6	7.0	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7.0	10.5	15.9	6.7	10.1	7.5	12.0	10.0	12.0	7.4	9.4	7.2	7.4	14.4	19.0	12.3	10.4	11.7	21.5	14.1	10.1	9.0	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.4	1.4	2.5	18.9	4.9	0.4	3.4	2.9	2.6	1.7	0.1	0.8	0.1	0.8	2.0	0.8	1.5	2.1	1.9	26.7	0.5	54.8	2.9	0.7	3.9	3.7	2.8	4.0	0.9	1.1	1.8	2.4	3.9	6.4	4.7	0.9	0.9	5.2	1.3	1.7	1.9	2.7	0.7	2.0	1.3	1.6	0.9	1.0	1.5	1.0	0.7	6.5	5.0	4.0	1.3	4.1	2.4	1.2	2.2	0.5	5.2	1.8	2.0	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7.0	10.5	10.0	9.0
JAKMIP2	"JAMIP2, KIAA0555"	ENSG00000176049	"Janus kinase and microtubule interacting protein 2"	Q96AA8	5	147585439-147782848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.9;Karpas-707: 25.8;RH-30: 26.1;SCLC-21H: 12.3;SH-SY5Y: 8.5"	"Cancer enriched"	"Detected in some"	6	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 8.9;MAIT T-cell: 6.3;memory CD4 T-cell: 3.5;memory CD8 T-cell: 6.4;naive CD8 T-cell: 5.6;NK-cell: 7.4"	"Group enriched"	"Detected in many"	6	"NK-cells: 7.4;T-cells: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046929, HPA065023"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA046929: , HPA065023: "	"unprognostic (3.69e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.20e-8)"	"unprognostic (1.54e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	1.3	6.5	12.0	2.5	10.4	1.7	1.1	44.0	35.0	1.8	1.7	8.7	0.0	1.6	2.6	1.4	3.1	1.1	3.2	1.2	12.4	10.0	1.3	5.1	4.2	2.3	11.4	9.0	1.2	2.2	0.9	14.8	1.0	10.2	1.7	1.9	1.0	1.4	1.6	1.0	1.3	1.9	3.4	10.8	2.1	1.9	5.3	16.5	8.7	1.0	0.0	2.3	1.6	0.3	0.8	1.2	0.7	0.2	7.4	8.9	1.6	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	1.0	0.0	0.0	0.2	0.0	3.1	1.3	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	2.6	0.0	6.2	0.1	1.0	26.1	8.3	0.0	0.0	12.3	8.5	0.0	0.1	0.0	0.0	0.0	0.0	1.9	2.2	0.0	0.5	1.8	1.0	2.5	4.9	0.0	0.0	0.0	0.0	0.4	8.9	0.0	6.3	0.8	3.5	6.4	0.2	0.4	0.9	5.6	0.7	7.4	0.2	1.2	1.5	1.6	12.0	10.4	44.0	16.4	12.4	10.0	11.4	9.0	10.2	16.5
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639272-25717562	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.7"	"Cell line enhanced"	"Detected in some"		"AF22: 18.9;BJ hTERT+: 12.0;HDLM-2: 11.8;U-138 MG: 13.6;U-87 MG: 10.0"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"			17000	"Plasma membrane"	Nucleoplasm	"HPA028789: , HPA077346: "	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	16.6	17.2	13.8	8.4	18.9	1.5	14.6	9.9	23.4	18.1	14.7	14.5	8.0	7.5	20.5	13.5	13.3	12.0	14.4	21.9	13.5	12.5	6.5	3.5	17.1	4.6	17.6	13.5	18.9	3.9	5.8	7.7	66.7	18.5	12.0	9.7	11.1	5.5	18.0	8.4	6.9	9.2	21.8	23.0	2.8	9.7	25.8	12.2	0.6	9.5	10.1	6.3	13.5	15.1	3.1	1.9	1.9	0.7	2.8	1.1	0.4	0.0	0.0	18.9	0.1	0.7	0.2	0.4	0.5	12.0	1.5	5.7	0.0	0.0	0.1	0.0	0.2	0.1	1.6	0.0	3.5	11.8	0.5	0.1	0.0	0.1	0.0	0.0	0.1	1.1	0.0	1.3	0.0	0.0	0.0	0.2	5.8	0.1	0.3	0.1	6.0	0.0	2.2	3.9	0.1	0.0	0.0	0.3	2.8	0.1	0.2	0.0	0.7	0.1	0.0	13.6	1.3	0.1	1.9	1.5	0.0	0.0	10.0	0.1	0.5	1.4	0.7	0.3	0.4	0.5	0.6	0.3	0.4	0.9	0.4	3.1	0.7	1.1	1.9	2.8	0.6	1.9	0.2	0.4	13.8	18.9	9.9	20.5	13.5	12.5	17.6	13.5	18.5	12.2
JAM3	"JAM-C, JAMC"	ENSG00000166086	"Junctional adhesion molecule 3"	Q9BX67	11	134068925-134152001	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 77.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 29.1;RH-30: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.2"	"Group enriched"	"Detected in many"	7	"B-cells: 8.2;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003417, HPA050434"	Approved		Enhanced	"Golgi apparatus"	"Secreted to blood"		570000	"Golgi apparatus"		"HPA003417: AB_1851981, HPA050434: "	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (3.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavourable (2.68e-4)"	14.0	14.9	17.6	7.9	34.1	2.2	9.9	7.0	28.7	15.5	23.4	77.0	6.9	5.9	25.0	12.9	16.3	11.9	17.8	21.4	26.1	16.9	6.7	3.0	13.7	6.2	40.3	17.4	32.0	4.4	14.5	19.5	68.8	29.6	26.2	9.7	17.5	9.4	32.5	4.1	9.1	11.7	29.7	34.8	8.7	12.0	24.8	34.1	5.1	7.6	4.6	5.6	22.7	22.6	8.2	0.2	0.8	0.1	0.1	4.0	2.9	0.2	0.4	28.0	14.4	26.2	19.4	23.5	11.9	14.1	4.5	4.4	0.3	0.2	0.3	12.3	15.5	0.4	20.2	0.2	8.5	0.2	10.0	0.8	0.1	1.8	7.8	0.5	12.4	13.2	0.0	3.1	2.8	29.1	0.3	0.2	19.2	0.3	8.6	1.0	6.6	1.2	0.2	38.3	0.1	0.2	0.1	18.9	10.6	0.1	0.3	0.4	0.3	0.3	0.2	8.4	6.1	13.1	8.1	0.1	0.1	0.2	9.3	1.1	16.0	0.4	0.1	0.3	2.2	0.0	2.6	8.2	2.8	1.6	0.2	4.8	4.0	2.6	0.8	0.1	0.0	0.2	0.1	2.9	17.6	34.1	7.0	28.7	26.1	16.9	40.3	17.4	29.6	34.1
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: "	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	6.2	4.3	17.9	10.3	2.2	2.2	17.7	1.8	4.3	2.3	3.0	4.5	4.9	3.3	6.5	3.6	3.2	4.1	10.4	2.2	6.4	6.4	11.7	5.1	5.8	2.4	11.8	13.8	3.1	6.6	3.5	14.0	2.5	15.2	5.6	1.4	6.2	23.5	22.3	19.1	2.0	10.5	5.4	9.3	2.2	6.6	13.8	7.9	3.7	13.0	16.3	4.5	12.8	4.3	11.0	6.1	6.0	6.2	3.6	8.6	5.9	3.7	11.1	13.8	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5
JAZF1	"DKFZp761K2222, TIP27, ZNF802"	ENSG00000153814	"JAZF zinc finger 1"	Q86VZ6	7	27830573-28180743	"Disease related genes, Predicted intracellular proteins"	"Lipid metabolism, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019271, HPA066967"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"CAB019271: , HPA066967: "	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-2)"	11.9	65.2	18.7	13.4	13.1	16.7	17.7	26.9	19.2	50.1	23.0	8.5	12.8	3.4	34.1	18.4	8.4	11.9	9.9	17.0	14.0	14.8	4.8	12.2	9.9	10.8	8.9	16.9	11.6	5.7	5.6	19.0	12.3	11.1	23.6	7.3	4.8	4.2	28.1	5.6	5.9	6.7	29.7	12.2	11.0	7.4	14.3	10.0	6.3	12.1	5.5	11.9	18.7	24.3	4.6	12.5	17.6	3.7	4.3	4.6	2.4	0.7	0.6	2.4	0.6	18.3	22.3	0.0	5.7	14.4	9.5	11.6	0.0	3.8	16.5	11.6	11.5	0.3	3.1	4.2	7.6	2.4	5.1	5.9	4.1	0.0	12.5	2.4	1.6	10.0	5.2	7.1	4.7	5.8	0.1	27.1	5.1	0.7	0.7	8.6	5.2	3.8	1.8	1.1	5.0	3.3	0.1	1.5	2.6	4.5	0.1	5.9	1.7	2.9	5.7	15.1	5.9	4.1	6.3	4.9	1.4	6.4	4.8	6.1	8.2	17.6	3.7	5.5	4.6	3.0	1.3	2.9	1.4	3.1	3.3	4.6	0.6	3.1	3.2	4.3	3.2	12.5	2.9	2.4	18.7	13.1	26.9	18.7	14.0	14.8	8.9	16.9	11.1	10.0
JCAD	KIAA1462	ENSG00000165757	"Junctional cadherin 5 associated"	Q9P266	10	30012800-30115494	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 14.8;HUVEC TERT2: 15.3;LHCN-M2: 12.8;TIME: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017956	Enhanced		Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"		"HPA017956: AB_1852408"	"unprognostic (1.78e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.37e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.09e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (2.54e-4)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.34e-2)"	27.0	7.5	6.2	9.1	12.4	0.5	18.0	2.2	8.8	10.1	29.4	3.2	5.4	1.7	16.5	8.1	5.9	10.8	9.9	16.3	6.2	4.7	6.0	2.0	22.3	3.2	6.7	8.9	11.3	15.7	4.7	4.8	30.5	8.9	14.1	4.1	24.4	2.5	9.7	9.2	3.7	3.7	27.8	6.8	1.2	5.0	13.0	4.4	1.4	13.0	3.9	2.0	18.3	22.8	0.2	0.1	0.8	0.0	0.3	0.2	0.0	7.5	3.4	3.1	0.0	1.9	0.4	4.5	4.1	4.3	0.6	1.0	1.3	0.0	0.0	0.3	14.8	0.1	0.8	0.2	1.7	0.8	1.8	0.0	0.0	0.0	8.5	0.0	0.5	4.8	0.1	10.3	0.7	15.3	0.0	0.0	12.8	0.2	0.0	0.3	0.6	5.2	0.0	1.7	0.0	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.7	34.4	7.8	1.9	2.4	0.3	3.2	0.4	0.0	1.8	5.2	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.0	6.2	12.4	2.2	8.7	6.2	4.7	6.7	8.9	8.9	4.4
JHY	"C11orf63, FLJ23554, Jhy"	ENSG00000109944	"Junctional cadherin complex regulator"	Q6NUN7	11	122882528-122959798	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 51.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039612, HPA040344, HPA077658, HPA077748"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA039612: AB_10674424, HPA040344: , HPA077658: , HPA077748: "	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"prognostic favourable (7.94e-5)"	"unprognostic (9.97e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.97e-1)"	"prognostic favourable (8.77e-4)"	"unprognostic (6.46e-3)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (7.79e-2)"	3.6	0.9	1.9	1.6	2.1	0.2	2.3	1.6	2.2	2.1	2.4	1.2	1.0	0.7	1.5	2.5	1.0	5.1	1.5	1.6	1.5	2.6	5.3	1.0	2.8	1.0	1.7	1.4	2.1	1.5	6.3	4.2	2.3	1.7	2.3	0.8	1.9	1.0	1.5	2.4	1.0	1.2	1.0	2.2	1.3	1.0	51.0	1.3	1.4	3.4	1.5	1.2	1.7	1.2	2.4	4.9	0.3	0.6	4.3	4.1	1.1	2.8	3.9	2.3	0.1	0.6	0.4	0.7	6.0	7.0	2.5	1.1	0.2	10.5	0.0	1.5	9.2	2.4	2.7	1.4	1.2	9.3	2.8	0.1	1.9	0.1	0.9	1.6	4.9	2.9	7.7	0.4	0.6	3.8	0.0	0.0	1.9	1.7	0.0	0.6	0.3	3.6	0.9	0.0	1.2	7.2	3.2	6.0	4.3	7.2	3.9	2.6	4.8	0.6	1.2	8.3	1.0	0.2	4.8	0.1	0.0	0.0	2.2	2.1	5.5	0.3	0.6	0.1	2.9	0.1	4.1	2.4	3.0	3.9	4.9	1.4	2.1	2.1	0.3	4.3	0.0	1.1	0.6	1.1	1.9	2.1	1.6	2.2	1.5	2.6	1.7	1.4	1.7	1.3
JMJD1C	"DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8"	ENSG00000171988	"Jumonji domain containing 1C"	Q15652	10	63167221-63521850	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056175, HPA066195"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA056175: , HPA066195: "	"unprognostic (7.72e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.13e-1)"	31.7	10.9	8.7	26.0	10.9	25.9	16.2	43.0	11.1	21.8	16.6	5.4	11.8	12.2	18.1	17.4	16.4	13.1	18.5	11.7	10.8	8.1	14.1	16.7	29.9	20.9	9.6	6.5	19.2	12.6	27.1	18.6	10.3	14.1	14.1	9.2	13.8	15.3	15.6	13.4	11.0	22.2	11.7	17.6	29.1	12.9	10.9	13.3	27.2	15.6	20.1	15.3	21.9	11.8	4.8	4.2	15.2	2.8	1.7	3.1	1.1	10.9	5.5	13.1	10.0	7.0	12.8	4.6	7.6	15.8	6.9	9.5	9.4	11.7	14.9	4.7	7.1	9.0	3.7	7.3	12.3	4.0	4.7	5.6	5.7	6.8	8.5	12.0	2.1	12.7	7.6	12.2	35.7	12.3	9.9	11.2	16.2	2.9	9.2	6.5	13.9	19.5	16.0	28.4	7.0	7.0	7.9	7.1	11.6	11.5	7.2	11.0	7.1	22.0	14.8	6.4	9.1	5.6	9.5	10.1	8.0	14.1	7.8	7.2	5.7	0.6	2.8	3.1	2.0	1.9	3.1	4.7	2.2	2.1	2.4	4.8	3.1	2.6	15.2	1.7	1.6	4.2	1.9	1.1	8.7	10.9	43.0	11.1	10.8	8.1	9.6	6.5	14.1	13.3
JMJD6	"KIAA0585, PTDSR, PTDSR1"	ENSG00000070495	"Arginine demethylase and lysine hydroxylase"	Q6NYC1	17	76712832-76726799	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004548, HPA059156"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB004548: AB_628185, HPA059156: "	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.14e-3)"	"prognostic unfavourable (5.75e-6)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"	"prognostic favourable (5.71e-4)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (7.59e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.82e-1)"	14.9	15.9	10.7	12.6	14.9	80.6	14.3	20.5	18.7	9.9	17.5	8.5	10.5	11.7	12.2	6.6	12.2	11.5	14.7	26.0	11.9	7.3	9.7	11.1	14.6	11.0	17.8	7.8	16.7	13.7	10.6	13.3	12.3	16.9	11.9	8.6	8.3	9.7	10.2	19.6	8.6	10.5	13.7	13.8	12.7	14.7	11.2	18.6	5.4	11.0	8.6	10.0	16.1	57.5	13.4	17.3	25.2	24.8	8.6	20.4	12.8	16.7	23.0	8.1	10.6	10.5	9.1	7.9	15.4	11.9	22.4	21.9	23.3	8.4	10.9	6.8	16.6	12.8	25.6	7.6	21.7	7.9	20.4	16.3	16.2	23.5	16.9	8.5	25.0	10.8	12.0	24.6	8.4	18.6	24.2	20.5	16.6	10.4	14.7	12.2	7.1	27.9	11.6	15.3	16.9	7.6	5.2	14.1	13.9	13.4	19.8	18.4	17.8	12.7	12.0	26.2	15.4	13.5	28.5	22.7	12.1	10.1	25.3	7.5	14.5	25.1	19.4	25.2	17.6	24.8	17.0	13.4	20.4	19.5	17.3	9.2	17.0	15.8	15.4	8.6	23.7	14.9	19.5	12.8	10.7	14.9	20.5	18.7	11.9	7.3	17.8	7.8	16.9	18.6
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321328	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 97.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.2;RT4: 9.0;SK-BR-3: 24.3;T-47d: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favourable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	1.7	0.6	1.8	0.7	5.7	0.5	0.8	13.7	3.1	0.8	1.9	0.8	0.4	0.8	1.5	1.7	1.8	0.6	0.6	3.3	2.1	0.7	0.8	0.5	2.2	0.5	1.0	4.2	0.5	3.5	1.1	0.4	1.1	2.4	1.8	2.8	0.0	1.3	0.8	97.2	0.7	0.9	1.4	2.4	0.5	0.9	0.9	2.3	2.4	1.2	21.5	1.4	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.4	0.1	3.1	0.0	1.0	0.0	4.6	3.9	3.1	1.0	0.0	5.9	0.0	3.7	0.0	0.5	2.0	0.2	0.6	2.6	0.0	2.9	0.0	0.5	0.0	0.3	2.8	10.2	0.0	6.8	2.0	5.2	3.9	0.0	0.1	9.0	5.2	0.7	0.0	24.3	1.2	17.3	0.1	0.0	1.2	1.7	0.4	1.0	0.0	0.0	0.0	2.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.7	13.7	3.1	2.1	0.7	1.0	4.2	2.4	2.3
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 109.4;testis: 101.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 109.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavourable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	8.0	18.5	15.6	25.9	22.2	23.0	8.1	30.7	25.4	9.4	43.3	4.6	7.7	37.5	6.1	5.4	52.8	4.3	23.7	6.1	17.9	19.6	15.5	12.8	13.9	26.3	11.1	15.0	5.6	6.5	1.2	6.6	29.2	13.7	7.0	23.7	3.3	15.9	17.6	23.7	9.3	51.3	7.3	8.3	26.2	42.5	101.3	4.9	32.6	5.8	28.9	28.7	17.9	17.0	15.4	14.5	109.4	28.4	10.2	28.7	14.6	91.6	91.4	48.1	47.7	10.2	10.5	38.4	48.3	14.4	47.5	36.6	74.8	55.0	25.8	31.0	38.6	54.8	44.9	60.1	35.8	25.8	56.4	41.5	36.3	74.0	24.0	31.1	40.1	16.0	28.8	38.6	39.8	86.2	23.4	53.2	43.4	66.4	99.7	30.4	28.0	120.5	63.7	57.5	40.0	50.7	57.6	59.8	48.6	69.1	36.6	25.7	98.1	19.1	49.6	27.2	76.9	38.1	56.0	20.8	33.5	38.6	23.7	29.2	31.0	27.5	18.5	51.6	12.4	26.6	8.9	15.4	17.2	14.9	14.5	8.0	8.2	12.0	109.4	10.2	28.4	9.6	28.7	14.6	15.6	22.2	30.7	25.4	17.9	19.6	11.1	15.0	13.7	4.9
JPT2	"C16orf34, FLJ13092, HN1L, KIAA1426, L11"	ENSG00000206053	"Jupiter microtubule associated homolog 2"	Q9H910	16	1678256-1702280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA041888, HPA041908"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041888: AB_10793937, HPA041908: AB_10794160"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-3)"	"prognostic favourable (7.85e-4)"	"unprognostic (3.60e-1)"	"unprognostic (2.37e-2)"	"prognostic unfavourable (9.14e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.78e-2)"	10.6	11.3	6.7	10.4	24.3	4.9	19.9	11.1	12.3	22.5	16.7	24.1	12.6	11.3	11.5	11.1	28.6	34.4	12.4	10.1	10.5	8.7	18.5	37.3	12.0	11.7	33.8	6.2	12.3	31.0	13.2	10.1	33.6	37.7	26.3	16.5	6.8	15.7	12.7	12.8	16.2	12.8	12.4	72.4	8.7	14.8	14.1	17.3	20.3	16.1	15.7	16.8	16.9	16.8	9.7	8.2	4.7	4.6	7.5	10.0	5.4	31.2	32.1	37.3	20.7	5.4	9.0	33.8	31.1	9.9	26.3	22.5	41.8	41.1	20.3	24.0	15.4	30.8	49.0	42.3	30.3	16.3	29.5	16.7	18.4	23.7	8.3	19.6	10.0	6.3	26.8	25.8	33.6	16.6	39.2	8.2	15.1	36.2	24.4	9.7	40.9	24.4	45.1	35.3	29.2	41.0	17.7	34.8	19.2	46.8	45.4	14.2	55.0	12.7	19.1	25.6	45.1	12.1	30.3	7.0	27.9	42.3	8.0	15.2	37.3	2.6	4.6	4.7	7.1	4.1	10.0	6.3	7.8	5.6	3.6	9.7	8.5	7.1	0.4	7.5	2.0	8.2	7.0	5.4	6.7	24.3	11.1	12.3	10.5	8.7	33.8	6.2	37.7	17.3
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58780788-58784327	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA059474"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, HPA059474: "	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"	64.5	29.4	26.7	33.7	17.2	68.4	61.7	19.5	20.6	60.0	32.7	30.8	28.4	13.3	40.5	21.8	34.1	72.6	48.5	31.3	20.2	12.4	21.2	39.3	55.1	14.3	15.3	12.0	49.8	48.7	15.0	16.7	21.6	24.1	48.6	16.7	40.5	59.4	39.3	32.2	51.3	28.6	40.7	17.6	22.9	47.0	18.2	18.1	9.0	61.0	35.2	23.3	41.5	33.1	7.4	1.3	4.0	5.1	3.2	2.5	1.2	16.0	2.3	5.2	1.0	8.3	9.4	0.1	20.5	7.5	14.5	8.8	4.2	1.2	0.6	9.9	12.7	5.6	0.4	6.6	9.2	12.7	37.3	0.2	0.9	4.7	6.8	1.1	3.7	10.1	17.1	18.7	7.8	10.8	5.6	9.3	5.6	3.0	1.0	9.0	4.1	14.6	0.4	71.1	3.2	13.6	1.5	14.4	4.2	14.2	14.9	6.0	5.3	0.6	19.0	33.1	15.0	12.0	25.6	20.7	3.3	1.2	34.5	2.1	9.4	1.2	5.1	2.0	2.4	1.1	1.3	4.1	1.2	2.5	1.3	7.4	0.3	1.7	4.0	3.2	0.4	0.2	0.9	1.2	26.7	17.2	19.5	20.6	20.2	12.4	15.3	12.0	24.1	18.1
JUNB		ENSG00000171223	"JunB proto-oncogene, AP-1 transcription factor subunit"	P17275	19	12791496-12793315	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 104.3;U-266/70: 44.7;U-266/84: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 101.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 101.1;monocytes: 27.0"	"Group enriched"	"Detected in many"	5	"amygdala: 25.2;basal ganglia: 16.8;cerebral cortex: 31.3;hippocampal formation: 24.3;olfactory region: 15.1"	"Region enriched"	"Detected in single"	19	"cerebellum: 17.1"	"CAB004464, HPA019149"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB004464: AB_2130023, HPA019149: AB_1852053"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-2)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.02e-1)"	83.4	95.3	8.7	57.2	16.6	153.1	29.0	8.3	16.0	57.6	33.1	29.2	13.0	20.7	26.6	23.7	84.8	128.6	103.5	46.4	10.2	9.9	20.4	54.5	76.2	23.1	10.3	7.1	108.1	25.0	10.5	43.8	44.4	21.5	63.8	9.7	47.3	37.8	84.3	54.3	66.0	32.9	33.6	15.7	25.7	39.7	15.3	11.6	12.2	27.1	71.9	53.3	71.7	37.9	4.7	12.7	101.1	27.0	2.6	6.5	12.7	8.7	1.7	0.4	1.1	2.0	4.9	1.7	3.8	3.3	1.9	1.7	1.1	5.1	3.0	13.5	1.4	16.6	0.4	5.8	0.2	104.3	1.7	3.0	6.7	1.4	2.6	4.0	14.0	6.2	17.0	1.7	1.3	0.9	7.8	5.6	0.6	26.4	2.7	24.4	0.3	6.8	3.7	1.3	6.2	1.2	11.0	4.1	6.2	16.7	10.3	4.8	1.8	4.5	2.9	5.6	3.2	11.1	4.8	44.7	66.3	2.7	6.6	10.4	1.5	3.5	17.4	18.5	5.2	27.0	5.3	4.7	5.7	6.5	12.7	4.4	4.1	4.3	101.1	2.6	24.7	1.1	5.5	12.7	8.7	16.6	8.3	16.0	10.2	9.9	10.3	7.1	21.5	11.6
JUND	AP-1	ENSG00000130522	"JunD proto-oncogene, AP-1 transcription factor subunit"	P17535	19	18279760-18281622	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 204.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005268, HPA063029"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB005268: AB_2130177, HPA063029: "	"prognostic favourable (6.15e-5)"	"unprognostic (4.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.99e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.49e-1)"	75.7	52.7	35.4	38.9	32.4	204.7	51.5	34.7	56.5	42.4	49.5	42.6	21.1	35.7	43.4	31.0	31.7	55.7	43.5	35.9	31.5	32.1	26.9	66.5	55.7	17.2	21.6	22.6	78.1	64.3	21.7	47.8	80.3	27.0	45.5	21.0	35.2	39.0	33.3	29.2	44.5	61.8	34.4	31.5	39.3	46.2	34.9	19.2	32.0	27.2	33.7	23.1	41.7	30.8	8.6	10.7	19.0	7.8	4.5	6.3	1.7	22.0	9.3	9.3	10.5	7.4	8.3	41.2	9.2	11.1	5.2	7.1	10.1	19.9	11.4	10.9	9.4	12.0	2.2	2.1	2.7	22.6	20.2	16.8	7.6	21.8	16.5	7.8	22.0	8.0	9.4	5.6	7.3	4.2	22.9	33.3	1.4	29.3	23.1	24.5	19.3	13.4	8.5	5.8	23.9	7.6	3.4	50.7	20.8	11.4	12.6	30.0	10.5	11.8	14.4	3.2	15.2	20.3	5.6	46.6	18.5	9.2	11.3	11.9	7.4	8.0	6.4	5.8	4.9	7.8	3.8	7.4	6.3	4.4	4.6	8.6	4.7	4.9	19.0	4.5	7.4	10.7	5.1	1.7	35.4	32.4	34.7	56.5	31.5	32.1	21.6	22.6	27.0	19.2
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 146.3;skin 1: 126.1;tongue: 122.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 126.0;hTCEpi: 63.6;RT4: 77.4;SK-BR-3: 76.5;T-47d: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"			61000000	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: "	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favourable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	12.5	2.6	2.8	9.5	4.5	3.3	13.0	6.5	3.7	34.5	17.9	8.7	12.3	15.6	12.2	9.6	146.3	13.0	19.0	34.5	3.3	1.6	31.6	11.7	13.2	4.0	5.3	2.2	12.5	12.8	3.6	5.8	42.4	4.0	14.0	8.8	8.3	34.3	14.3	17.6	126.1	36.1	4.3	3.2	4.5	15.4	3.6	4.6	10.8	27.9	122.8	84.8	12.5	55.4	7.9	7.8	14.8	20.6	0.3	0.1	2.9	30.2	25.1	2.5	2.1	0.0	0.0	39.3	1.7	10.4	0.7	0.6	37.9	33.5	0.6	18.7	1.1	126.0	3.6	28.0	0.1	0.0	8.9	1.3	20.0	8.3	4.2	0.8	13.4	0.0	63.6	0.1	5.2	11.2	11.1	11.0	0.0	38.8	0.2	10.9	4.9	4.2	35.4	0.0	22.7	19.4	77.4	6.2	4.6	3.9	76.5	0.2	63.8	0.9	17.6	0.0	1.8	0.8	0.5	0.9	3.4	0.6	0.1	1.4	0.3	1.7	7.6	14.8	0.0	12.8	0.0	7.9	0.0	0.1	7.8	7.4	0.1	0.1	0.3	0.3	20.6	2.5	0.0	2.9	2.8	4.5	6.5	3.7	3.3	1.6	5.3	2.2	4.0	4.6
KANK1	"ANKRD15, KANK, KIAA0172"	ENSG00000107104	"KN motif and ankyrin repeat domains 1"	Q14678	9	470291-746106	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005539, HPA056090"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA005539: AB_1078164, HPA056090: "	"unprognostic (6.59e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	28.9	5.3	23.9	8.7	23.2	1.4	15.5	17.7	18.2	18.2	17.4	28.5	7.6	8.8	26.5	10.3	33.7	12.7	13.2	46.5	21.9	10.4	19.8	39.4	10.0	6.9	21.4	14.8	16.9	17.0	9.5	14.7	18.2	16.5	23.4	11.2	14.8	17.9	24.4	24.2	20.0	9.2	27.6	21.3	3.9	10.7	12.1	23.5	2.8	16.2	8.2	8.8	28.9	26.3	1.5	7.1	0.0	0.2	0.2	4.4	1.0	2.0	4.3	1.4	26.8	22.2	8.5	7.4	13.6	9.6	1.1	1.4	10.9	0.9	16.6	3.3	16.8	4.5	5.8	11.1	2.0	8.0	3.0	0.0	6.3	34.4	3.1	3.9	0.0	4.8	15.6	1.2	13.5	11.5	0.8	21.0	8.6	5.1	1.6	16.8	1.9	3.3	0.6	2.9	3.0	9.1	13.2	0.6	0.0	1.3	4.0	18.1	2.6	3.1	16.9	3.1	1.1	4.0	6.2	3.6	21.5	0.0	2.1	7.6	5.8	0.0	0.2	0.0	0.2	0.2	0.0	1.5	2.3	0.8	0.7	1.2	4.4	1.4	0.0	0.2	0.0	7.1	3.0	1.0	23.9	23.2	17.7	17.6	21.9	10.4	21.4	14.8	16.5	23.5
KANSL1	"CENP-36, DKFZP727C091, KIAA1267, MSL1v1, NSL1"	ENSG00000120071	"KAT8 regulatory NSL complex subunit 1"	Q7Z3B3	17	46029916-46225389	"Predicted intracellular proteins"		"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006874, HPA007208"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA006874: AB_1852393, HPA007208: AB_1852395"	"unprognostic (2.46e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavourable (3.74e-4)"	"unprognostic (1.54e-2)"	"unprognostic (9.28e-2)"	"unprognostic (7.79e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-2)"	14.2	11.0	8.9	11.3	12.6	18.2	17.2	24.6	12.1	15.3	11.7	19.6	7.7	6.5	20.3	14.9	14.7	14.0	11.0	9.7	8.1	8.3	13.9	7.8	13.0	18.8	13.2	6.5	19.5	16.8	13.9	11.4	13.4	14.7	13.7	13.3	13.6	12.6	7.8	15.9	17.8	15.6	16.2	18.2	18.8	13.3	25.6	14.6	42.8	14.2	5.5	14.2	16.8	26.6	2.1	1.1	1.8	0.6	1.7	2.6	0.7	1.7	1.5	6.6	3.3	1.0	2.6	4.3	1.4	2.6	3.3	3.9	6.7	0.5	6.5	2.5	7.0	3.9	13.6	4.9	6.6	7.3	6.7	0.9	2.8	8.4	11.0	0.7	2.4	2.6	10.5	7.3	11.2	8.1	2.6	7.4	7.1	2.6	24.3	1.2	2.1	8.6	14.1	12.2	11.7	4.6	4.2	3.4	8.3	9.0	0.3	5.8	10.3	13.3	6.9	14.4	8.4	5.5	1.7	12.7	8.4	10.3	3.9	3.6	9.9	0.1	0.6	1.7	1.6	0.4	1.6	2.1	1.6	2.6	0.2	1.0	1.6	1.3	1.8	1.7	0.6	1.1	1.8	0.7	8.9	12.6	24.6	12.1	8.1	8.3	13.2	6.5	14.7	14.6
KANSL2	"C12orf41, FLJ20436, NSL2"	ENSG00000139620	"KAT8 regulatory NSL complex subunit 2"	Q9H9L4	12	48653401-48682238	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038497, HPA038498"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038497: AB_10674685, HPA038498: "	"unprognostic (3.87e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (4.98e-4)"	"unprognostic (5.46e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-3)"	"unprognostic (4.19e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"prognostic favourable (4.32e-4)"	11.4	12.3	9.8	9.0	14.0	41.3	14.5	19.7	14.7	12.0	10.7	15.6	8.9	8.9	14.9	14.3	13.7	12.0	9.0	12.8	8.6	8.6	13.8	10.2	11.0	16.8	13.0	11.2	17.4	14.3	10.6	21.0	18.2	11.3	12.5	11.3	14.1	13.2	10.4	36.3	13.1	11.6	13.5	11.2	14.0	10.8	16.5	12.7	20.1	16.4	12.6	16.5	11.8	12.8	23.6	21.3	28.2	18.4	19.8	26.8	18.7	9.4	12.7	11.5	5.5	12.8	11.4	24.1	10.7	8.6	17.5	10.0	22.4	12.2	15.3	19.1	12.7	9.5	18.6	12.5	14.6	13.7	11.1	17.9	11.4	6.2	14.4	19.8	7.0	11.8	15.9	13.3	23.3	8.5	20.7	10.3	12.7	8.8	19.4	15.1	14.8	12.8	16.7	11.3	17.5	9.5	13.1	13.1	9.1	20.8	15.4	12.7	20.3	19.4	7.2	13.3	9.8	5.7	9.7	15.5	22.9	22.4	6.6	45.1	6.8	28.2	16.8	19.3	23.0	17.4	22.0	23.6	22.9	23.8	21.3	21.1	26.8	25.5	7.7	19.8	18.4	17.3	25.1	18.7	9.8	14.0	19.7	14.7	8.6	8.6	13.0	11.2	11.3	12.7
KANSL3	"FLJ10081, KIAA1310, NSL3, Rcd1"	ENSG00000114982	"KAT8 regulatory NSL complex subunit 3"	Q9P2N6	2	96593170-96642787	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035017, HPA035018"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA035017: , HPA035018: AB_10601763"	"unprognostic (2.19e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.35e-3)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-3)"	"unprognostic (4.99e-3)"	15.3	15.2	8.2	15.4	10.8	15.9	16.9	10.6	13.3	16.6	14.0	13.6	17.8	9.9	21.5	15.3	12.7	17.2	12.1	9.2	7.5	4.8	13.2	9.8	13.7	9.9	10.9	7.3	20.1	17.5	17.0	13.7	12.4	9.6	16.5	9.3	20.2	16.6	19.8	15.7	14.2	15.7	18.0	6.1	15.0	13.4	36.0	8.4	14.8	18.1	10.5	11.0	20.1	14.8	3.6	1.4	4.2	2.6	5.7	5.9	2.8	9.2	5.6	18.9	14.3	7.9	4.3	8.5	7.4	11.8	14.8	16.1	10.5	6.2	13.6	10.8	11.6	6.0	13.3	7.0	12.8	9.0	10.6	18.7	5.8	11.8	10.6	12.8	7.4	10.9	4.9	9.9	8.4	8.2	12.9	9.7	9.2	5.2	23.0	10.1	9.2	9.6	18.3	12.8	7.4	8.7	9.4	20.2	12.4	8.8	9.7	8.6	8.4	4.8	12.2	10.3	9.0	7.6	6.6	8.1	5.0	11.5	5.5	14.4	9.5	4.2	2.6	0.8	5.8	2.6	4.3	3.1	3.5	5.9	1.2	3.6	2.6	4.5	0.2	5.7	2.2	1.4	2.5	2.8	8.2	10.8	10.6	13.3	7.5	4.8	10.9	7.3	9.6	8.4
KARS	"DFNB89, KARS1, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	25.4	21.1	19.2	29.2	22.0	24.6	28.0	17.5	19.5	26.3	28.3	15.2	28.1	20.6	23.4	26.7	35.8	24.1	27.5	49.6	16.3	18.6	31.7	47.1	25.8	26.6	18.8	16.2	34.9	62.6	28.5	22.4	30.4	19.6	30.7	29.7	20.1	31.7	23.2	80.0	26.6	32.3	28.4	17.1	37.3	26.3	33.6	14.5	41.3	34.4	43.6	34.7	38.6	33.4	32.8	39.0	35.5	44.2	35.0	62.4	39.5	26.7	31.3	22.9	31.5	24.6	24.9	45.1	22.7	27.9	50.0	37.8	55.3	35.3	48.4	25.1	30.2	38.6	46.1	41.5	54.7	14.1	23.7	26.5	27.4	57.2	45.0	39.9	29.9	29.2	29.8	44.2	72.0	40.7	44.2	11.6	37.7	61.9	41.0	42.7	48.4	23.1	54.0	20.5	59.0	40.0	22.8	34.5	28.0	57.0	20.9	25.3	28.2	37.8	22.4	27.7	28.6	21.1	32.4	24.9	28.5	115.3	24.2	34.1	33.7	20.9	31.5	35.5	34.1	44.2	62.4	32.8	42.3	40.2	39.0	27.6	40.1	36.1	7.2	35.0	43.2	24.6	43.5	39.5	19.2	22.0	17.5	19.5	16.3	18.6	18.8	16.2	19.6	14.5
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526"	Supported		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"CAB004526: AB_2128417, HPA002470: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	3.9	2.2	3.6	9.0	8.4	5.1	5.0	7.4	5.3	7.8	1.1	2.6	13.4	2.1	9.4	1.1	5.4	1.6	4.5	12.2	5.1	11.8	6.2	0.4	4.2	1.8	15.3	3.6	2.9	4.6	3.0	5.0	7.5	19.0	7.5	1.8	3.8	3.5	0.9	3.9	5.1	4.1	2.8	7.2	8.0	1.1	2.4	2.8	4.5	17.0	4.7	8.0	4.8	9.0	3.6	3.3	5.7	7.3	15.1	3.2	8.2	7.8	18.9	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1
KAT5	"cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5"	ENSG00000172977	"Lysine acetyltransferase 5"	Q92993	11	65711996-65719604	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016953	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA016953: AB_1851277"	"unprognostic (2.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (1.10e-13)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-2)"	18.5	19.5	21.2	16.0	27.4	34.3	21.6	29.4	37.1	22.1	24.1	28.2	22.3	16.5	30.1	24.8	21.2	32.9	24.5	21.1	18.3	19.2	22.6	16.1	20.8	18.3	19.0	25.7	29.5	23.2	38.8	22.0	32.7	24.6	21.2	19.4	29.3	23.6	27.5	24.6	27.6	19.2	25.2	20.1	22.0	21.9	30.7	22.8	26.9	26.5	19.1	22.1	24.4	22.0	25.0	24.0	40.4	23.6	24.8	28.6	23.3	19.1	23.4	21.3	16.2	16.9	17.9	22.4	13.9	22.7	23.3	20.3	17.0	22.9	17.6	19.9	24.3	16.2	26.5	23.3	14.1	22.9	17.0	25.8	19.3	20.1	24.3	28.1	31.0	19.0	26.1	15.3	31.4	14.6	26.6	27.6	22.0	34.8	23.8	32.9	18.6	15.1	19.6	14.1	32.2	21.3	29.1	19.9	20.9	13.2	25.0	26.5	24.5	18.2	18.7	18.9	16.7	14.9	14.9	21.2	21.8	25.9	16.3	13.8	15.4	23.4	23.6	40.4	25.7	22.3	22.1	21.1	22.5	25.5	24.0	25.0	28.6	23.3	26.1	24.8	23.3	14.5	21.5	23.3	21.2	27.4	29.4	37.1	18.3	19.2	19.0	25.7	24.6	22.8
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788555-49835030	"Enzymes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	15.8	14.3	16.9	16.2	25.9	44.4	17.5	37.0	35.0	19.5	17.3	23.8	17.9	13.1	27.3	18.6	18.8	19.5	14.6	25.3	16.8	21.8	18.7	11.3	13.9	15.3	17.0	23.6	21.9	13.6	44.4	19.8	19.8	21.9	20.4	14.9	20.8	18.9	23.3	31.7	22.7	14.7	21.8	17.9	15.8	15.5	63.7	19.1	25.9	28.6	14.5	20.6	22.7	17.4	13.0	12.7	15.2	11.4	20.6	20.7	14.2	13.0	18.4	17.8	12.5	8.4	11.2	21.6	11.4	13.3	20.5	14.7	28.4	9.3	15.0	18.5	12.1	11.5	17.0	11.9	24.2	16.3	16.8	17.8	13.4	11.8	12.6	18.2	14.8	10.6	11.9	18.4	23.0	15.1	19.7	14.9	19.1	19.9	25.8	13.1	44.3	16.1	16.3	28.5	12.9	9.6	14.8	19.4	16.5	11.6	7.0	10.7	25.6	16.1	9.0	26.0	14.1	11.3	14.7	21.9	23.9	17.6	11.8	10.9	16.2	15.2	11.0	15.1	16.9	8.9	20.7	13.0	16.3	17.1	12.7	12.2	20.6	16.2	13.1	20.6	11.4	6.6	14.3	14.2	16.9	25.9	37.0	35.0	16.8	21.8	17.0	23.6	21.9	19.1
KAT8	"FLJ14040, hMOF, MOF, MYST1, ZC2HC8"	ENSG00000103510	"Lysine acetyltransferase 8"	Q9H7Z6	16	31115754-31131393	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 17.8;neutrophil: 17.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066324			Supported	Nucleoplasm				Nucleoplasm		"HPA066324: "	"unprognostic (8.58e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-1)"	"prognostic favourable (6.34e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.77e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.41e-1)"	18.4	21.7	22.7	29.4	23.6	26.6	29.7	48.9	30.8	28.0	24.8	18.3	27.5	15.7	29.8	48.3	16.7	35.0	28.2	32.7	23.0	21.2	20.8	18.9	26.3	29.0	20.2	21.0	52.8	31.4	38.0	22.2	31.5	16.8	21.2	17.7	22.1	35.1	26.2	39.8	22.1	19.7	25.9	20.5	27.4	18.6	27.3	18.4	30.2	31.7	22.6	22.2	20.2	26.6	2.1	4.1	17.8	4.6	1.7	2.9	1.9	7.6	11.8	14.8	4.4	17.6	13.2	15.2	6.8	13.1	11.0	12.1	5.9	16.7	18.1	10.8	8.5	9.1	23.6	11.5	10.9	15.1	16.0	7.8	8.7	18.7	15.8	12.9	14.2	12.4	23.1	8.2	23.8	10.5	20.8	14.9	5.6	22.3	19.9	24.4	16.7	7.2	32.1	12.1	21.2	8.9	4.6	15.6	15.8	4.1	11.5	5.8	12.5	21.5	6.2	4.7	9.9	5.2	4.9	14.2	14.3	10.2	7.1	17.3	7.0	3.9	4.4	17.8	1.9	2.4	2.4	2.1	2.2	2.6	4.1	1.8	2.9	2.1	17.4	1.7	4.6	1.4	1.3	1.9	22.7	23.6	48.9	30.8	23.0	21.2	20.2	21.0	16.8	18.4
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"				"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.5	7.8	9.3	11.9	9.8	14.2	11.7	13.0	9.5	13.8	12.1	15.0	6.0	7.6	15.3	10.3	12.5	10.9	10.1	11.3	9.1	6.7	13.7	8.4	10.8	11.8	10.4	7.9	18.7	9.6	5.7	12.1	11.0	15.0	12.7	9.5	17.5	10.1	10.5	21.2	12.0	10.8	12.4	8.9	12.2	10.4	36.7	12.0	22.5	13.9	10.3	14.0	15.1	12.7	19.6	19.4	23.5	20.8	12.7	24.2	14.9	11.3	4.1	9.3	20.4	11.3	18.1	14.5	14.2	12.1	15.1	20.0	9.8	6.0	15.8	8.3	14.2	9.0	18.3	9.4	19.7	14.5	15.5	21.0	8.7	13.5	15.6	29.4	7.9	11.4	11.2	17.3	13.7	13.8	21.8	11.6	13.3	15.7	20.1	19.2	9.2	6.9	13.9	17.1	7.7	10.7	6.4	7.6	10.7	26.0	7.5	10.0	7.6	28.7	11.8	7.9	12.0	20.7	16.4	10.8	9.9	21.8	10.4	21.0	12.8	23.5	15.2	21.0	19.9	20.8	17.5	19.6	20.2	20.0	19.4	14.2	17.2	17.3	7.0	12.7	18.0	16.7	24.2	14.9	9.3	9.8	13.0	9.5	9.1	6.7	10.4	7.9	15.0	12.0
KATNB1		ENSG00000140854	"Katanin regulatory subunit B1"	Q9BVA0	16	57735730-57757250	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041165, HPA041839"	Enhanced		Supported	"Plasma membrane,Microtubules,Cytosol"				"Plasma membrane, Cytosol"	Microtubules	"HPA041165: AB_10795584, HPA041839: AB_10795598"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (9.24e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (2.89e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.54e-1)"	6.9	9.1	15.3	9.3	21.4	18.7	6.3	13.2	29.0	7.0	7.4	8.8	6.7	9.4	6.6	5.8	11.0	18.7	5.9	8.5	16.0	14.5	5.8	10.3	8.0	8.8	9.3	14.1	7.0	9.4	9.5	8.0	7.9	10.6	6.3	5.2	6.2	11.9	8.0	7.1	21.4	8.5	6.0	6.9	8.0	9.1	32.7	8.1	10.8	7.2	10.3	8.6	7.4	6.4	5.8	9.8	24.6	11.6	8.4	12.4	10.5	7.4	13.6	7.5	9.6	4.1	3.7	13.3	5.3	7.0	13.9	7.7	11.3	6.7	6.1	10.6	3.3	10.1	10.0	10.5	6.3	4.1	28.6	7.9	7.6	15.5	4.4	17.2	29.8	3.8	6.5	10.9	6.4	8.2	15.5	3.0	5.4	8.0	24.9	22.4	13.2	23.7	20.0	9.3	22.0	4.1	3.6	38.0	11.4	8.5	10.4	6.2	3.9	8.9	5.8	9.7	8.5	8.5	11.4	6.9	5.5	7.4	13.5	13.4	5.9	24.1	10.1	24.6	12.4	11.2	12.4	5.6	10.5	9.9	9.8	5.8	10.1	10.0	15.5	8.4	11.6	7.4	10.9	10.5	15.3	21.4	13.2	29.0	16.0	14.5	9.3	14.1	10.6	8.1
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 75.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"				"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: "	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavourable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	13.2	7.9	16.2	14.0	22.6	9.1	22.7	16.7	26.0	11.7	12.2	10.7	10.5	9.6	13.5	12.5	28.8	10.9	10.2	9.0	11.2	9.0	9.1	10.9	20.2	10.7	13.8	10.3	10.9	14.3	8.7	10.4	75.0	15.0	11.9	13.6	8.9	10.5	9.0	7.4	19.7	9.4	16.1	17.8	12.0	11.0	11.0	12.8	7.5	8.3	8.6	12.3	10.2	19.1	9.1	10.2	46.0	6.8	4.3	8.9	4.5	17.9	15.7	25.1	16.8	20.3	20.4	18.7	24.4	14.9	19.6	19.6	8.9	10.0	8.8	16.1	15.8	23.7	12.2	14.0	23.2	18.0	6.6	15.5	16.6	10.5	14.2	16.2	16.8	12.1	20.7	13.3	26.2	35.0	16.5	18.4	26.6	8.7	10.1	13.3	18.4	12.5	15.7	15.3	8.2	18.1	24.2	14.2	12.7	15.0	11.0	7.2	13.6	19.4	20.0	26.7	13.7	23.6	19.3	11.5	15.4	18.0	23.9	17.7	19.8	16.5	6.8	10.3	7.0	6.3	8.9	8.5	7.7	7.2	7.4	9.1	8.6	7.6	46.0	4.3	4.0	10.2	6.3	4.5	16.2	22.6	16.7	26.0	11.2	9.0	13.8	10.3	15.0	12.8
KAZN	"FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.7;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 6.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 6.9"									"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: , HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favourable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	8.0	11.0	13.4	3.0	17.4	1.2	7.6	41.1	21.9	8.0	3.8	27.5	5.7	4.6	3.1	11.1	18.8	11.0	7.0	4.1	12.4	12.4	13.2	5.2	8.5	1.5	25.1	12.1	10.4	8.0	22.9	2.7	11.0	15.0	4.1	4.0	10.5	16.8	7.2	1.7	14.2	4.9	3.7	25.0	64.9	4.9	4.1	18.9	0.0	6.6	7.0	6.3	7.9	9.4	0.3	0.0	6.9	0.0	0.0	0.0	0.0	7.8	1.4	8.6	39.7	3.8	3.9	2.9	3.8	3.2	7.1	5.1	1.8	4.2	0.0	9.9	8.1	2.8	1.9	6.2	3.5	0.2	3.9	4.5	4.7	11.8	2.8	0.0	2.3	5.5	8.3	1.6	1.1	0.0	1.8	9.2	5.6	5.7	0.0	0.4	2.4	1.2	2.7	0.2	4.8	11.9	2.4	4.6	3.3	0.6	21.6	14.8	1.2	3.0	0.0	5.8	5.5	9.2	4.5	1.5	1.3	0.0	5.4	7.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	13.4	17.4	41.1	21.4	12.4	12.4	25.1	12.1	15.0	18.9
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavourable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavourable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	19.2	13.3	17.9	20.2	16.0	23.6	26.1	13.4	18.6	15.0	20.2	10.7	20.3	15.4	16.3	18.8	28.5	12.8	17.9	30.4	16.5	12.0	14.8	20.7	16.4	18.8	13.7	11.1	17.2	48.6	14.7	18.7	20.5	14.4	17.5	21.4	14.0	19.4	15.7	67.2	17.6	20.6	25.7	10.3	16.7	16.8	29.0	11.5	19.7	18.7	21.8	22.5	23.9	34.0	4.0	4.2	8.1	3.4	2.8	8.8	1.5	27.1	21.4	19.1	14.7	20.2	19.5	32.5	29.1	27.1	28.0	18.7	26.1	29.4	29.6	29.3	39.4	18.1	14.8	28.2	36.9	22.1	10.4	18.9	16.1	26.6	39.5	20.7	18.1	20.1	44.6	27.4	76.0	21.0	18.7	23.6	27.9	25.1	20.0	11.5	20.8	18.0	14.4	26.8	18.5	25.3	23.9	18.4	13.8	16.9	21.6	28.2	10.0	13.2	17.9	28.6	27.9	26.6	30.2	26.9	33.2	30.0	21.5	15.3	21.4	5.0	2.6	8.1	4.5	2.2	3.6	3.5	3.2	3.4	2.2	4.0	2.8	3.1	7.5	2.8	3.4	4.2	8.8	1.5	17.9	16.0	13.4	18.6	16.5	12.0	13.7	11.1	14.4	11.5
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209868	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 39.3"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.5;prostate cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB022571: , HPA019664: AB_1855578"	"unprognostic (2.01e-1)"				"unprognostic (1.14e-1)"		"unprognostic (2.68e-1)"				"unprognostic (5.58e-3)"	"unprognostic (4.46e-2)"		"unprognostic (3.39e-2)"				0.7	0.7	8.7	0.7	12.9	0.7	3.3	0.4	39.3	0.7	0.8	1.9	0.0	0.7	0.9	0.9	0.7	0.7	0.7	0.7	7.4	10.4	0.7	0.9	0.7	0.7	4.7	13.5	0.7	0.7	0.7	6.0	0.7	19.1	4.4	0.8	1.3	1.1	0.7	0.7	0.7	0.8	0.7	1.0	0.7	0.7	1.0	0.6	0.0	0.7	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	12.9	0.4	27.3	7.4	10.4	4.7	13.5	19.1	0.6
KCNH1	"eag, eag1, h-eag, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134180	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 20.2"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.2;RH-30: 7.1;RPTEC TERT1: 4.1;SH-SY5Y: 9.0;SK-MEL-30: 8.5;T-47d: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA014551, HPA019445"	Enhanced		Supported	Vesicles				Vesicles		"HPA014551: , HPA019445: AB_1852118"	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.9	2.3	6.3	1.3	13.3	0.7	0.6	19.1	20.2	1.0	1.3	3.3	0.2	1.2	1.5	1.0	0.9	1.2	1.0	0.7	3.8	1.7	1.0	0.7	0.7	0.7	1.1	7.5	0.8	0.9	0.9	0.8	1.1	1.7	1.3	1.3	0.0	0.8	0.9	0.7	0.9	1.0	1.0	2.1	0.6	1.5	2.4	1.5	0.0	0.8	0.0	0.7	0.9	0.7	0.1	0.7	0.7	0.1	0.1	0.3	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.6	0.1	1.4	1.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.1	0.0	0.0	7.1	0.0	4.1	0.0	0.3	9.0	1.6	0.1	8.5	6.3	0.0	0.0	1.1	0.1	1.3	0.8	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.7	0.1	0.0	6.3	13.3	19.1	20.2	3.8	1.7	1.1	7.5	1.7	1.5
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148454-19535646	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.3;pituitary gland: 16.1"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.6	7.0	8.4	1.6	22.0	1.4	2.4	1.3	11.4	1.3	1.9	31.3	0.0	2.2	1.2	1.2	0.7	1.4	2.2	1.0	11.8	5.7	0.7	0.7	0.8	3.2	16.4	10.2	0.7	2.7	0.8	16.1	0.6	15.0	2.2	2.5	0.1	3.3	1.4	0.6	1.9	1.8	1.1	9.9	2.6	5.9	4.0	18.1	0.0	1.1	0.0	3.2	0.9	0.5	4.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	8.4	22.0	1.3	11.4	11.8	5.7	16.4	10.2	15.0	18.1
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.1;RPMI-8226: 13.3;RT4: 22.5;U-266/84: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.2	1.1	2.7	5.6	3.2	0.4	14.8	0.5	5.1	6.8	7.9	4.8	1.3	3.1	4.5	2.4	7.2	3.3	5.3	4.6	3.9	3.4	4.2	2.6	17.6	1.2	6.8	1.4	1.1	7.7	1.9	0.8	8.3	15.2	4.4	4.1	9.9	7.6	2.8	54.4	3.7	4.3	9.7	4.7	1.1	7.0	3.9	1.4	0.2	2.4	19.0	3.6	5.0	4.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.3	0.0	0.8	0.4	1.8	1.3	4.0	0.8	1.0	0.0	8.1	0.0	0.4	1.4	1.2	9.8	0.0	0.9	0.0	2.5	0.0	0.1	0.0	4.0	0.1	0.3	0.3	6.2	0.0	0.6	0.2	0.2	0.0	0.5	1.0	0.0	0.0	4.8	0.1	1.1	33.1	13.3	0.8	22.5	9.8	0.3	0.0	2.5	2.7	1.3	0.0	0.0	1.3	0.0	0.1	9.9	0.0	15.4	0.0	7.4	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.2	0.5	5.1	3.9	3.4	6.8	1.4	15.2	1.4
KCTD10	"BTBD28, MSTP028"	ENSG00000110906	"Potassium channel tetramerization domain containing 10"	Q9H3F6	12	109448656-109477544	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014273	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA014273: AB_1852159"	"unprognostic (7.21e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (5.32e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	29.1	16.2	10.4	16.3	17.1	8.4	21.3	10.6	20.0	25.3	26.9	14.1	15.1	8.5	30.5	15.6	24.4	18.1	23.2	16.1	11.0	16.4	23.2	9.3	20.5	13.9	11.7	8.4	16.7	7.9	14.6	12.7	19.2	16.9	19.8	22.2	29.4	14.4	29.8	9.9	19.3	14.1	36.4	9.6	17.5	19.4	13.5	12.6	12.8	30.8	15.4	17.5	27.8	19.0	6.2	10.4	7.9	14.0	20.8	12.7	11.8	9.1	9.7	28.4	9.4	23.0	32.9	6.3	20.0	26.3	13.3	13.2	9.1	7.5	8.9	11.7	45.6	7.3	10.0	16.5	12.8	8.6	6.8	10.3	6.2	5.7	14.7	7.5	9.0	31.3	10.2	17.5	9.6	31.0	6.9	3.9	23.1	4.8	9.7	10.2	16.8	12.0	9.6	12.4	6.9	13.3	15.8	10.1	15.1	12.0	12.5	12.5	15.4	6.2	22.9	14.1	5.4	8.0	11.0	8.7	16.4	12.4	16.0	6.6	20.7	7.9	8.1	5.4	12.7	12.4	9.3	6.2	7.6	9.2	10.4	6.2	8.4	10.5	5.9	20.8	14.0	7.9	8.4	11.8	10.4	17.1	10.6	20.0	11.0	16.4	11.7	8.4	16.9	12.6
KCTD13	"FKSG86, PDIP1, POLDIP1"	ENSG00000174943	"Potassium channel tetramerization domain containing 13"	Q8WZ19	16	29905012-29927035	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Autism, Autism spectrum disorder, Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043524	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA043524: "	"unprognostic (6.97e-2)"	"unprognostic (9.06e-3)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"prognostic favourable (9.05e-4)"	"unprognostic (3.92e-3)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.49e-3)"	5.7	5.4	20.4	12.3	28.4	9.5	5.6	11.4	26.0	6.0	6.6	16.0	6.2	11.5	7.2	13.2	5.8	6.3	13.1	3.8	24.4	11.4	6.1	4.2	4.3	13.5	15.7	14.7	8.0	5.7	9.2	11.9	5.3	10.5	7.4	10.6	6.1	6.9	9.6	3.1	15.1	9.9	4.3	9.7	9.7	9.2	33.9	15.7	6.4	10.5	3.6	11.0	5.6	5.7	3.9	2.5	8.8	2.8	2.9	5.7	1.6	5.9	10.8	3.4	7.3	1.8	2.7	7.8	3.1	0.6	0.9	3.1	4.7	11.3	11.9	3.9	2.7	10.0	3.2	3.4	2.2	5.0	7.3	2.7	7.6	2.5	0.8	4.2	6.7	4.2	5.5	6.1	1.4	2.2	5.7	6.4	4.0	6.8	5.2	4.9	4.1	2.4	9.4	3.6	3.2	2.4	6.6	9.3	3.1	3.4	4.9	8.5	5.1	2.6	5.3	4.4	3.3	8.6	4.9	6.1	2.3	4.6	3.5	8.0	6.2	4.9	2.8	7.4	3.0	2.3	3.5	2.2	5.7	4.6	2.5	3.9	5.0	4.0	8.8	2.9	2.7	2.1	4.0	1.6	20.4	28.4	11.4	26.0	24.4	11.4	15.7	14.7	10.5	15.7
KCTD9	"BTBD27, FLJ20038"	ENSG00000104756	"Potassium channel tetramerization domain containing 9"	Q7L273	8	25427847-25458476	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042468, HPA047902"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"				Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA042468: , HPA047902: "	"unprognostic (4.18e-2)"	"unprognostic (3.90e-2)"	"prognostic favourable (7.88e-4)"	"unprognostic (7.04e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.97e-3)"	14.4	5.8	7.4	17.3	7.7	11.5	14.6	17.7	10.1	15.7	14.1	5.4	16.8	12.4	15.6	12.2	18.2	11.3	12.8	48.4	5.9	5.2	9.6	6.6	10.3	6.9	7.4	5.3	12.4	8.3	7.3	11.2	7.4	14.6	11.8	14.8	9.4	14.6	18.4	19.0	15.0	10.9	16.7	10.8	8.6	10.6	11.2	6.6	11.8	8.7	11.7	8.7	19.1	14.8	2.2	3.2	3.7	2.9	0.9	3.8	1.5	17.9	12.8	14.0	4.8	18.2	24.2	11.5	27.3	24.6	18.0	18.3	9.1	13.2	11.8	11.7	27.2	12.1	12.2	12.8	21.7	6.0	7.3	13.7	12.5	8.4	22.1	4.8	10.2	18.6	15.6	16.3	13.6	15.1	14.4	9.3	20.3	4.8	18.4	8.3	6.8	6.8	7.2	16.2	4.3	18.3	10.3	3.5	4.6	20.9	9.3	14.1	7.1	5.5	16.7	19.9	11.6	38.1	14.7	2.7	4.9	15.6	13.9	8.5	14.3	2.6	1.7	3.7	3.4	2.5	3.8	2.2	3.6	3.6	1.1	1.2	2.2	3.6	1.8	0.9	2.9	3.2	3.5	1.5	7.4	7.7	17.7	10.1	5.9	5.2	7.4	5.3	14.6	6.6
KDELC1	"EP58, MGC5302"	ENSG00000134901	"KDEL motif containing 1"	Q6UW63	13	102784281-102799007	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.5"	"Group enriched"	"Detected in many"	4	"NK-cells: 6.5;T-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020780, HPA043946, HPA064398"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"		7400	Nucleoplasm		"CAB020780: , HPA043946: , HPA064398: "	"unprognostic (1.97e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (2.24e-4)"	"unprognostic (6.68e-3)"	"prognostic unfavourable (4.81e-4)"	"unprognostic (4.34e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (4.73e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.60e-3)"	7.0	4.6	6.7	4.0	8.2	1.9	7.1	14.8	8.6	8.8	5.6	4.5	6.1	1.8	18.8	5.9	4.9	7.0	10.9	8.4	6.1	2.6	10.0	10.1	5.8	2.9	8.4	3.2	9.8	3.2	2.5	10.5	15.8	5.7	6.0	3.9	5.7	3.4	7.1	1.7	3.3	3.5	16.4	6.3	4.7	4.4	2.6	7.1	3.0	5.2	1.9	2.5	9.0	6.2	0.4	1.2	0.0	0.0	6.5	4.5	0.5	3.8	2.8	18.0	17.2	18.5	14.4	4.4	10.2	7.9	9.6	16.6	8.1	5.5	0.0	8.2	8.4	6.4	12.8	5.2	9.7	1.6	10.7	4.6	8.6	8.7	16.1	11.8	16.9	13.6	6.0	7.2	7.0	20.8	7.5	0.0	5.0	4.2	5.2	9.5	11.4	8.6	0.0	12.8	4.4	26.3	0.3	2.7	16.6	10.1	2.7	5.7	7.8	5.1	6.3	6.3	4.6	7.2	10.2	3.6	6.6	0.0	12.4	0.0	10.9	0.0	0.0	0.0	2.7	0.0	4.5	0.4	1.5	2.2	1.2	0.0	0.5	1.4	0.0	6.5	0.0	0.0	1.7	0.5	6.7	8.2	14.8	8.6	6.1	2.6	8.4	3.2	5.7	7.1
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382570-48391553	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (3.49e-4)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	46.9	49.3	22.6	23.4	21.5	14.5	60.6	16.1	28.8	51.8	43.3	24.4	64.8	47.7	44.0	45.2	41.3	40.3	56.5	42.8	20.9	20.4	57.3	81.3	38.0	44.6	18.6	20.4	68.9	61.0	63.5	45.7	81.4	20.9	44.8	47.7	39.7	65.8	69.9	31.8	37.4	59.9	39.6	26.0	33.7	42.5	33.2	18.6	26.2	75.5	32.9	42.3	53.2	54.4	10.6	26.5	6.8	23.3	11.6	12.8	9.3	30.1	43.7	25.4	26.9	57.1	66.8	18.6	29.8	52.8	36.4	41.8	28.8	34.5	12.6	19.6	65.2	27.1	30.5	31.9	34.8	10.1	32.6	10.5	15.5	53.6	49.7	11.7	19.7	63.1	39.4	24.7	26.5	33.8	18.2	23.5	48.3	24.3	11.0	120.2	18.4	17.8	15.7	15.1	19.7	46.2	25.2	25.5	19.8	26.1	23.5	15.6	18.4	14.4	26.1	25.8	21.3	21.3	25.3	66.5	52.0	8.5	16.3	15.8	26.2	5.9	23.3	6.8	11.2	19.8	12.8	10.6	11.0	12.1	17.7	9.6	9.2	9.9	5.9	11.6	16.5	26.5	11.7	9.3	22.6	21.5	16.1	28.8	20.9	20.4	18.6	20.4	20.9	18.6
KDELR3		ENSG00000100196	"KDEL endoplasmic reticulum protein retention receptor 3"	O43731	22	38468062-38483447	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 48.5;salivary gland: 57.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.8;BJ: 36.3;BJ hTERT+: 37.4;fHDF/TERT166: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043477, HPA076405"	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA043477: AB_10962952, HPA076405: "	"unprognostic (1.76e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (6.05e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.07e-2)"	10.5	4.0	1.3	3.4	1.4	0.2	11.6	0.9	1.3	15.7	7.7	1.8	5.3	6.6	6.2	14.8	5.5	5.7	20.9	14.2	1.5	1.1	10.9	44.5	8.6	5.8	1.0	1.2	7.2	48.5	9.3	12.4	11.6	1.8	9.2	10.3	5.5	57.2	7.1	2.1	3.6	15.1	6.6	2.2	3.0	15.5	4.1	0.9	1.1	6.7	6.5	16.9	6.8	6.5	1.2	4.3	0.9	0.1	0.3	2.4	0.3	6.9	2.2	1.8	7.7	30.6	57.8	1.3	36.3	37.4	8.9	22.3	3.9	9.2	0.0	7.7	59.0	1.0	1.8	2.2	10.8	0.0	4.1	0.5	1.9	11.0	13.5	0.0	4.9	21.3	1.7	11.2	1.2	10.7	1.7	0.0	14.7	11.4	0.0	0.2	0.4	6.3	0.0	0.5	2.3	10.8	0.9	0.1	0.9	9.3	0.5	4.6	2.7	0.4	8.2	9.6	6.0	33.0	3.6	0.3	0.1	0.0	15.5	0.0	13.3	0.0	0.1	0.0	0.8	0.1	2.4	1.2	0.8	0.2	0.2	0.4	0.8	0.8	0.9	0.3	0.1	4.3	0.7	0.3	1.3	1.4	0.9	1.3	1.5	1.1	1.0	1.2	1.8	0.9
KDF1	"C1orf172, FLJ34633, RP11-344H11.3"	ENSG00000175707	"Keratinocyte differentiation factor 1"	Q8NAX2	1	26949562-26960406	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 13.6;BEWO: 12.0;CAPAN-2: 12.9;HaCaT: 12.1;HBEC3-KT: 16.7;hTCEpi: 21.9;SK-BR-3: 14.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.6"	"Group enriched"	"Detected in many"	36	"B-cells: 3.7;T-cells: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA028639, HPA068312"	Uncertain		Supported	"Nucleoplasm,Cell Junctions,Mitotic spindle"				"Cell Junctions"	"Nucleoplasm, Mitotic spindle"	"HPA028639: AB_10599191, HPA068312: "	"unprognostic (2.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.91e-1)"	"prognostic favourable (3.04e-13)"	"unprognostic (1.38e-3)"	"unprognostic (7.83e-2)"	"unprognostic (8.03e-2)"	"prognostic favourable (4.40e-4)"	0.2	1.1	0.6	3.8	0.7	0.0	7.9	1.5	3.6	2.9	11.9	0.4	13.6	9.3	1.0	17.3	16.1	5.5	4.2	0.5	0.8	0.1	7.9	3.5	7.5	6.7	0.2	0.6	1.0	23.8	6.6	9.0	12.4	0.8	6.0	5.1	2.0	14.3	11.5	0.2	13.3	12.5	0.2	0.2	1.0	7.7	5.8	0.5	1.6	14.5	7.2	8.6	5.2	6.0	3.7	0.1	0.0	0.0	0.0	8.6	2.4	13.6	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	6.8	12.9	0.0	0.5	0.0	12.1	0.0	16.7	0.0	0.0	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.0	21.9	0.0	1.8	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.9	0.1	0.0	0.0	2.0	3.0	6.5	8.5	0.0	0.1	14.3	0.0	9.2	0.2	0.1	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.5	3.5	5.9	4.2	0.1	3.7	8.6	5.1	0.0	0.0	0.0	0.0	0.3	2.4	0.6	0.7	1.5	3.6	0.8	0.1	0.2	0.6	0.8	0.5
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: "	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	15.1	19.0	19.7	16.8	23.2	24.9	19.3	28.0	26.6	20.0	20.6	15.1	21.0	16.2	28.9	30.6	20.9	22.0	15.7	18.6	16.4	18.9	15.9	14.8	15.1	19.5	13.8	25.4	27.4	21.4	24.6	28.7	19.3	20.3	20.9	21.6	16.4	21.3	19.9	24.8	23.3	16.9	19.1	10.7	16.2	17.1	78.4	12.1	48.1	20.9	19.1	22.1	18.7	21.9	9.1	9.7	5.7	6.9	3.8	7.4	1.9	30.0	15.6	44.5	39.3	11.8	15.1	31.7	12.8	16.2	26.2	23.4	14.6	29.3	22.4	18.4	21.0	33.8	41.2	24.4	33.3	20.3	25.0	31.5	26.0	35.5	15.1	24.2	13.9	14.0	17.6	27.8	19.7	32.6	34.4	10.6	18.6	17.9	52.8	18.6	29.0	22.7	50.7	29.4	15.1	22.0	19.4	55.7	42.1	57.8	15.3	19.0	15.3	18.1	26.4	11.7	19.8	21.6	17.4	13.8	10.8	26.1	12.2	28.8	16.6	2.8	3.7	5.7	5.9	5.9	5.2	9.1	5.4	5.7	4.4	3.3	7.1	7.4	0.3	3.8	6.9	9.7	5.8	1.9	19.7	23.2	28.0	26.6	16.4	18.9	13.8	25.4	20.3	12.1
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223853	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;granulocytes: 7.6;monocytes: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favourable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	7.3	10.5	19.1	12.2	17.8	27.9	13.4	13.5	14.6	8.6	15.6	10.6	7.2	9.8	7.5	8.2	11.7	17.5	7.5	8.1	13.8	9.6	10.0	8.9	12.1	11.4	15.1	12.0	8.8	7.8	3.9	9.8	5.5	13.5	7.0	15.9	7.1	7.6	6.4	19.1	13.3	10.3	10.0	13.0	10.5	7.1	18.7	13.8	16.0	33.5	7.6	11.5	9.2	10.0	1.6	4.2	7.6	9.6	0.3	0.8	1.2	8.4	5.1	7.2	14.9	9.5	15.3	14.2	7.9	8.4	5.2	7.4	8.7	4.9	21.4	19.2	13.1	10.3	12.0	14.4	11.6	17.9	9.6	10.3	5.6	9.0	4.8	14.5	11.5	7.5	16.8	13.2	12.4	5.4	24.6	3.0	9.0	7.7	8.3	6.2	2.1	8.4	16.6	13.9	15.5	7.5	11.1	19.8	7.6	6.4	15.6	14.8	15.4	11.8	4.2	10.5	5.5	7.6	9.2	3.0	8.4	12.0	4.2	11.0	24.2	1.3	5.3	7.6	0.6	9.6	0.4	1.3	0.6	0.6	4.2	1.6	0.6	0.2	5.6	0.3	7.5	1.8	0.8	1.2	19.1	17.8	13.5	14.6	13.8	9.6	15.1	12.0	13.5	13.8
KDM3A	"JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA"	ENSG00000115548	"Lysine demethylase 3A"	Q9Y4C1	2	86440647-86492716	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055543, HPA065162"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA055543: , HPA065162: "	"unprognostic (1.97e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.32e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavourable (2.15e-6)"	"unprognostic (2.01e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.50e-3)"	"unprognostic (4.44e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-2)"	21.5	12.5	21.5	14.6	27.2	52.9	18.5	17.2	18.7	18.9	25.9	19.6	17.3	17.0	21.2	24.8	20.3	16.8	14.7	21.3	22.7	11.4	13.2	11.9	17.2	14.8	17.8	15.2	20.6	15.7	16.3	20.3	19.5	17.8	19.7	14.9	14.6	19.2	19.1	20.7	34.7	19.1	21.0	22.1	15.7	14.5	42.9	23.6	30.1	18.6	12.8	17.3	29.0	22.1	4.8	4.9	14.4	3.4	4.9	9.1	4.1	18.9	7.6	18.1	4.7	9.3	9.6	16.9	9.2	9.2	8.7	10.8	9.6	8.1	11.1	17.6	7.7	12.1	13.5	9.3	17.0	14.9	11.2	17.9	7.0	13.7	7.0	14.2	11.4	10.4	14.1	7.8	14.4	10.7	11.4	18.2	9.1	4.8	19.7	19.9	16.2	11.6	13.4	24.5	23.9	7.8	10.7	14.1	14.9	12.2	8.8	16.8	5.1	9.3	11.9	17.8	7.4	18.2	10.5	19.1	18.0	16.6	22.5	14.8	21.7	11.9	3.2	5.9	7.6	3.4	8.0	4.8	8.4	7.3	4.9	4.1	9.1	7.8	14.4	4.9	2.3	4.4	8.6	4.1	21.5	27.2	17.2	18.7	22.7	11.4	17.8	15.2	17.8	23.6
KDM3B	"C5orf7, JMJD1B, KIAA1082, NET22"	ENSG00000120733	"Lysine demethylase 3B"	Q7LBC6	5	138352596-138437028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016610, HPA057202"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA016610: AB_1852004, HPA057202: "	"unprognostic (1.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"prognostic favourable (6.67e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.60e-2)"	13.5	12.8	10.0	10.9	12.6	12.2	14.9	20.2	14.9	14.0	14.2	18.4	13.5	9.9	20.0	18.0	13.0	14.7	12.5	11.8	14.7	8.6	12.8	8.4	11.4	11.5	12.0	9.6	19.8	17.4	27.9	15.1	11.7	11.3	13.6	14.4	18.5	16.3	16.3	29.6	16.5	14.0	21.5	10.7	13.3	12.6	10.4	12.2	25.2	16.1	9.0	16.4	21.9	19.4	4.1	5.1	9.3	4.6	7.4	5.7	2.2	11.8	16.6	31.3	28.7	14.5	12.1	24.3	8.2	13.2	14.6	16.4	18.5	13.0	23.6	14.9	15.5	12.2	25.4	18.2	16.7	15.4	15.6	20.2	14.7	14.0	12.9	16.3	22.1	14.4	19.9	11.3	13.5	17.4	15.9	12.6	17.5	15.2	21.2	20.1	15.5	6.9	25.9	24.1	15.4	20.9	16.4	16.6	18.1	14.0	13.7	12.1	13.0	20.6	16.7	8.7	9.1	9.1	14.2	17.5	8.3	20.9	5.8	23.0	12.3	0.3	4.6	6.5	4.2	3.6	5.7	4.1	5.0	5.2	4.1	3.9	4.4	4.2	9.3	7.4	3.6	5.1	2.8	2.2	10.0	12.6	20.2	14.9	14.7	8.6	12.0	9.6	11.3	12.2
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153595	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.1;dendritic cells: 2.5;granulocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062872			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA062872: "	"prognostic favourable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (2.74e-4)"	"prognostic favourable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"	13.3	16.0	14.8	15.1	13.4	22.0	20.0	26.1	18.7	19.4	12.6	18.3	24.3	12.1	24.2	18.1	15.9	18.4	12.0	12.6	13.3	9.2	10.4	18.2	11.8	19.2	13.8	12.9	18.5	19.0	12.1	17.9	29.4	11.2	24.8	6.0	18.8	16.5	22.6	38.0	21.1	12.9	16.2	13.3	21.2	12.0	19.9	13.8	14.6	28.9	8.8	13.7	13.3	21.9	7.1	2.5	6.9	0.9	1.3	0.8	0.5	8.8	3.1	7.3	8.7	4.2	4.2	14.7	4.4	3.3	3.9	4.9	5.2	2.5	12.3	4.7	5.0	5.0	4.4	5.2	2.4	5.5	11.2	4.1	5.3	4.3	7.9	4.1	9.6	6.5	5.6	3.2	2.7	5.2	10.1	7.6	3.5	4.5	4.7	6.3	6.4	7.7	8.0	5.5	10.2	3.9	5.8	13.6	10.4	5.7	6.4	7.0	34.9	10.9	7.5	5.8	3.3	7.1	4.4	20.9	8.6	9.5	11.5	8.3	3.3	1.6	0.9	2.6	0.5	0.3	0.3	6.1	0.4	0.4	0.4	7.1	0.6	0.8	6.9	1.3	0.4	2.5	0.5	0.5	14.8	13.4	26.1	18.7	13.3	9.2	13.8	12.9	11.2	13.8
KDM5A	"JARID1A, RBBP2"	ENSG00000073614	"Lysine demethylase 5A"	P29375	12	280129-389454	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006201			Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"HPA006201: AB_1079160"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.81e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.69e-2)"	13.6	14.4	10.6	13.7	13.0	41.6	13.1	21.8	13.2	11.8	10.3	14.8	11.3	7.8	14.2	8.1	13.6	11.2	10.0	10.1	11.5	5.7	9.0	10.7	13.1	14.9	15.1	9.1	15.2	11.5	16.8	13.8	12.4	11.3	10.6	10.9	10.6	12.9	8.6	9.7	20.3	13.0	10.4	10.1	15.5	10.6	21.2	14.8	28.8	11.4	7.1	16.1	13.1	18.8	17.2	16.8	33.7	14.1	18.6	18.1	10.1	7.6	13.7	10.1	7.8	9.1	8.7	11.2	6.8	9.0	10.2	11.1	8.1	9.3	12.8	2.1	11.3	7.2	10.5	7.7	12.3	20.1	8.7	15.6	14.4	4.8	7.4	20.3	12.3	9.4	7.3	12.5	16.8	10.3	9.3	18.0	8.6	5.1	14.5	5.8	15.7	4.3	13.6	26.4	6.0	4.9	17.6	3.9	11.4	13.3	6.0	7.2	6.5	12.8	14.1	6.7	9.7	7.5	11.3	6.4	7.0	29.4	8.7	8.9	9.9	30.2	11.3	22.2	17.7	13.1	18.1	14.1	13.8	14.2	11.8	17.2	15.1	12.9	33.7	18.6	14.1	16.8	10.5	10.1	10.6	13.0	21.8	13.2	11.5	5.7	15.1	9.1	11.3	14.8
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724491-202809470	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB068193: , HPA027179: AB_1851987, HPA053723: "	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	7.7	7.1	5.9	8.2	7.8	14.8	12.3	12.7	9.0	12.9	9.6	5.1	9.7	5.0	13.6	9.4	17.6	8.6	8.4	5.7	6.1	4.5	6.0	4.6	9.0	5.4	3.7	7.3	13.3	9.0	9.8	8.6	23.1	5.0	11.3	9.0	16.0	11.1	8.8	4.3	19.5	7.3	10.1	4.9	6.9	8.2	74.0	5.2	25.8	9.1	6.2	10.4	12.2	12.6	4.1	3.0	16.0	5.2	7.3	4.4	2.6	11.1	4.6	30.4	14.6	14.4	13.1	25.7	7.7	11.9	8.1	8.6	3.8	11.9	0.0	5.3	12.1	17.3	14.4	12.6	10.5	0.1	5.5	6.1	4.3	6.1	12.4	19.0	8.1	13.5	21.0	11.6	15.3	18.0	19.0	0.0	8.2	11.4	5.3	22.7	20.6	8.0	22.4	0.0	0.0	11.7	19.4	9.3	20.5	16.3	10.1	13.6	20.6	13.6	13.3	7.2	5.4	0.9	4.5	1.2	0.8	4.7	6.3	7.0	2.9	16.0	2.9	6.4	3.7	3.4	3.1	2.8	3.3	2.7	3.0	4.1	4.2	1.8	9.5	7.3	5.2	2.1	4.4	2.6	5.9	7.8	12.7	9.0	6.1	4.5	3.7	7.3	5.0	5.2
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038244: , HPA046147: "	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	19.5	22.9	22.4	22.6	24.7	26.3	17.9	43.0	31.7	25.9	19.5	23.4	16.7	22.2	29.2	13.3	26.9	24.8	15.2	17.6	21.6	15.3	17.0	18.8	20.6	25.8	24.6	21.8	33.1	22.5	37.7	31.8	34.0	22.8	18.7	13.5	17.0	25.6	17.1	36.6	28.4	22.2	23.6	16.0	25.0	19.4	10.6	26.2	29.0	22.2	11.3	24.5	21.5	26.4	4.5	4.3	4.8	4.0	2.8	6.1	3.8	17.3	23.8	25.5	19.5	17.7	16.2	18.1	10.9	12.8	14.8	13.8	16.0	11.4	16.2	14.2	14.3	15.6	28.8	23.3	11.3	12.1	42.6	15.7	25.3	11.3	21.8	18.6	31.4	12.7	17.2	28.9	35.6	21.8	30.6	10.8	10.8	22.3	13.6	20.9	21.6	22.3	15.4	15.2	17.6	9.4	16.7	19.2	24.8	33.1	30.7	12.4	21.5	16.4	14.9	16.5	14.3	14.8	10.5	15.7	12.8	12.4	21.4	22.1	12.2	3.0	3.8	2.7	6.1	3.6	5.1	4.5	3.7	5.7	3.1	3.2	4.5	2.9	4.8	2.8	4.0	4.3	4.3	3.8	22.4	24.7	43.0	31.7	21.6	15.3	24.6	21.8	22.8	26.2
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078259-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 31.8;TIME: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB004028	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"		7400000	"Plasma membrane"		"CAB004028: AB_2212507"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	19.7	6.2	1.8	4.4	3.1	0.4	20.5	1.1	2.2	11.4	6.0	1.8	11.5	2.3	28.8	10.2	5.2	9.5	6.2	12.1	2.3	1.7	7.8	10.4	13.2	14.1	3.1	2.9	6.0	8.1	8.0	6.8	34.5	3.9	9.5	1.4	27.6	7.1	10.3	5.3	3.0	3.8	7.7	2.6	4.4	4.2	5.3	1.2	0.5	20.0	5.3	3.0	4.4	12.0	0.1	0.1	0.7	0.0	0.2	0.2	0.1	0.0	0.0	1.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.7	0.0	0.0	0.3	0.0	0.0	0.2	31.8	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.8	3.1	1.1	2.2	2.3	1.7	3.1	2.9	3.9	1.2
KEAP1	"INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454"	ENSG00000079999	"Kelch like ECH associated protein 1"	Q14145	19	10486120-10503741	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005558, CAB025337"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				"Nucleoplasm, Centriolar satellite"	Cytosol	"CAB025337: , HPA005558: AB_1079175"	"unprognostic (1.98e-1)"	"prognostic favourable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.06e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	16.0	13.7	13.5	10.4	14.3	9.1	12.4	13.2	15.1	13.1	15.7	15.4	13.8	13.6	11.0	12.7	26.3	15.1	12.7	19.7	13.9	13.7	13.2	22.0	10.8	15.5	16.7	7.4	11.8	14.3	11.1	10.2	11.5	14.3	13.9	8.8	11.8	11.3	13.9	63.9	16.8	13.8	11.6	16.5	11.3	10.6	12.2	13.8	13.1	14.5	29.1	16.1	14.5	11.2	14.6	23.7	21.3	19.8	21.0	30.8	19.6	17.2	31.7	8.8	11.7	18.1	15.5	9.4	14.7	11.0	15.1	13.6	22.5	17.4	24.6	38.8	16.3	15.5	17.4	11.5	7.5	23.8	19.1	37.2	9.4	26.6	17.5	19.4	20.2	16.0	15.6	17.0	7.9	14.3	22.7	45.6	13.1	23.9	14.1	53.4	25.6	26.7	25.6	11.0	28.7	9.8	20.7	24.2	12.6	20.5	13.8	12.7	11.9	26.0	17.6	24.4	13.1	27.3	17.8	26.6	33.3	24.1	18.8	23.2	17.9	16.1	19.8	21.3	30.8	17.0	29.3	14.6	21.5	28.3	23.7	5.7	13.5	19.1	10.9	21.0	16.6	16.3	25.4	19.6	13.5	14.3	13.2	12.8	13.9	13.7	16.7	7.4	14.3	13.8
KEL	"CD238, ECE3"	ENSG00000197993	"Kell blood group, metallo-endopeptidase"	P23276	7	142941114-142962681	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 21.1;testis: 36.4"	"Group enriched"	"Detected in some"	12	"HEL: 14.9;K-562: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA064442			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5.0	2.0	0.2	0.2	0.2	0.0	0.2	1.1	0.3	0.2	0.0	0.3	2.5	0.2	0.2	0.0	0.5	0.2	4.4	3.8	0.0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2.0	0.2	0.3	0.3
KHDRBS1	"FLJ34027, p62, Sam68"	ENSG00000121774	"KH RNA binding domain containing, signal transduction associated 1"	Q07666	1	32013829-32060850	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005355, HPA051280, HPA056813"	Supported		Enhanced	Nucleoplasm			20000	Nucleoplasm		"CAB005355: AB_631869, HPA051280: , HPA056813: "	"unprognostic (1.31e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavourable (3.68e-5)"	"unprognostic (5.01e-2)"	"unprognostic (2.51e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-3)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.03e-2)"	34.5	31.7	31.1	49.7	34.2	42.0	35.9	56.6	41.5	42.0	38.8	35.1	30.1	33.3	51.5	37.8	37.0	39.5	51.2	34.9	29.7	30.1	30.0	30.9	38.3	52.5	27.3	35.9	63.2	31.3	40.4	29.5	33.9	25.9	36.5	31.7	32.2	31.1	35.5	39.0	30.6	32.4	44.2	31.4	36.0	31.0	42.7	23.7	69.9	35.1	41.0	50.0	40.2	34.4	11.4	10.2	6.4	10.2	8.2	14.4	3.5	43.8	26.7	61.2	44.9	21.3	26.8	35.9	26.6	33.9	50.1	42.2	29.6	39.4	65.7	29.9	33.6	30.8	49.3	36.4	51.4	39.1	42.1	41.4	26.3	40.4	28.1	54.8	27.9	29.4	20.9	38.0	30.2	47.2	53.3	30.2	38.4	28.5	80.6	46.9	62.1	32.2	64.7	51.8	55.4	34.8	44.5	41.9	54.8	38.7	33.2	33.4	39.5	39.9	35.3	32.6	35.4	34.7	44.4	31.7	34.3	64.7	33.9	43.9	24.9	4.6	6.7	6.4	9.6	10.2	14.4	11.4	11.5	9.9	9.0	9.3	12.5	11.8	5.9	8.2	8.2	10.2	10.3	3.5	31.1	34.2	56.6	41.5	29.7	30.1	27.3	35.9	25.9	23.7
KHDRBS3	"Etle, etoile, SALP, SLM-2, SLM2, T-STAR"	ENSG00000131773	"KH RNA binding domain containing, signal transduction associated 3"	O75525	8	135457457-135656722	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.4;testis: 79.1"	"Cell line enhanced"	"Detected in many"		"REH: 30.9;RPTEC TERT1: 27.8;WM-115: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"eosinophil: 4.1"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000275, HPA000500, HPA000981"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (7.16e-6)"	"unprognostic (6.63e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.33e-3)"	8.0	9.6	16.4	3.3	16.6	1.7	5.8	7.1	34.4	10.3	5.3	8.0	0.9	2.7	4.3	13.4	3.9	4.2	6.8	5.6	16.7	9.8	11.0	7.0	4.5	1.9	11.1	21.7	5.8	5.4	3.5	4.2	1.6	8.7	5.2	5.4	2.6	6.4	7.6	14.7	3.1	3.6	5.1	12.5	1.9	3.7	79.1	7.9	0.9	3.1	1.5	2.7	6.8	4.5	0.1	0.0	4.1	0.0	0.0	0.1	0.0	0.1	0.6	11.3	0.6	2.4	4.5	4.5	7.4	10.3	7.0	3.6	3.9	1.6	0.0	4.0	7.0	0.9	7.0	7.5	9.6	1.5	12.2	0.0	4.2	8.0	1.9	2.0	25.7	1.0	1.0	3.8	5.9	5.7	0.9	18.6	12.5	2.6	0.7	0.4	2.3	12.3	30.9	15.4	7.9	27.8	0.2	14.5	12.3	0.5	1.6	8.0	0.5	0.6	0.4	8.8	15.1	0.1	15.9	6.6	0.0	0.0	5.3	0.0	30.8	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	16.6	7.1	34.4	16.7	9.8	11.1	21.7	8.7	7.9
KHSRP	"FBP2, FUBP2, KSRP"	ENSG00000088247	"KH-type splicing regulatory protein"	Q92945	19	6413348-6424794	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034739, HPA056518"	Supported		Enhanced	Nucleoplasm			740000	Nucleoplasm		"HPA034739: AB_10601582, HPA056518: "	"unprognostic (2.16e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.27e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.56e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.84e-2)"	40.3	34.3	31.4	34.5	37.2	49.9	27.6	53.8	54.2	38.9	35.6	51.4	23.9	49.5	48.0	27.5	41.5	39.2	33.3	27.4	31.3	27.7	31.0	49.2	27.0	39.3	31.7	29.8	51.0	45.3	18.4	31.4	43.4	28.1	35.0	25.6	39.2	44.4	35.9	43.7	41.8	44.8	30.3	30.3	37.9	36.1	56.3	29.2	73.9	37.8	35.0	33.4	37.7	33.7	8.9	11.5	4.9	7.6	3.1	6.3	3.5	71.7	36.1	34.5	33.5	15.0	16.4	60.1	29.5	19.6	35.0	36.1	73.2	19.6	71.2	46.3	17.1	38.8	39.3	27.8	28.0	0.3	73.8	45.8	22.3	50.7	26.3	51.4	44.3	21.2	12.6	28.8	23.6	27.2	85.2	30.2	21.1	45.8	63.0	50.8	67.2	51.1	66.6	33.8	45.6	16.2	36.9	40.9	45.3	36.3	25.3	32.1	30.1	48.0	29.5	28.8	36.1	60.8	58.0	60.4	46.8	54.3	25.3	73.1	33.7	3.2	6.9	4.5	5.7	7.6	6.0	5.9	6.0	6.3	6.4	8.9	4.2	4.5	4.9	3.1	6.3	11.5	4.1	3.5	31.4	37.2	53.8	54.2	31.3	27.7	31.7	29.8	28.1	29.2
KIAA0319L	"AAVR, KIAA1837"	ENSG00000142687	"KIAA0319 like"	Q8IZA0	1	35433490-35557950	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 27.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072692	Supported		Supported	"Nucleoli,Golgi apparatus"			870000	"Golgi apparatus"	Nucleoli	"HPA072692: "	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (5.92e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.79e-1)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-1)"	10.6	23.5	20.3	10.6	29.0	9.9	20.1	21.9	37.2	19.2	17.7	24.1	17.0	18.1	19.7	19.2	14.4	25.1	15.7	30.7	19.4	20.0	27.5	32.1	21.3	11.0	19.4	20.1	13.0	32.8	38.5	28.1	21.1	23.0	25.3	21.3	24.5	33.9	20.5	27.4	13.8	19.8	12.7	16.6	17.1	23.3	14.0	17.5	11.9	29.3	11.9	17.4	12.9	12.0	2.3	3.2	27.1	11.0	5.5	3.5	4.5	6.1	9.2	19.2	15.1	26.0	18.4	18.2	8.4	18.0	12.3	18.3	9.9	25.1	6.9	23.3	9.2	12.4	14.1	13.6	14.1	11.0	10.3	9.4	11.3	10.9	20.4	7.7	13.0	25.8	17.5	14.2	18.5	20.1	12.3	10.1	16.7	6.2	4.6	6.5	21.7	5.5	5.2	16.3	8.6	20.4	15.2	4.2	11.9	12.2	14.7	25.1	15.4	11.0	20.5	8.5	9.2	7.1	13.0	15.0	12.0	4.6	21.6	10.2	8.4	4.5	11.0	5.0	3.0	3.6	2.9	2.0	2.5	2.8	3.2	2.3	3.5	2.5	27.1	5.5	2.2	2.1	2.3	4.5	20.3	29.0	21.9	37.2	19.4	20.0	19.4	20.1	23.0	17.5
KIAA0391	"MRPP3, PRORP"	ENSG00000100890	KIAA0391	O15091	14	35121846-35277614	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA020459: "	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	13.9	26.1	18.8	17.6	20.1	12.5	17.5	23.1	21.9	17.4	22.4	20.6	15.6	16.6	13.0	19.4	26.1	14.7	13.2	16.7	17.6	16.3	31.1	29.5	20.9	29.5	20.2	17.7	10.8	16.5	29.8	27.4	13.4	19.2	14.1	24.9	15.8	18.0	21.8	22.2	23.0	16.5	15.0	23.0	18.7	15.8	17.1	20.9	31.2	18.9	21.3	24.8	18.2	16.0	10.0	9.7	10.9	5.4	12.1	25.5	12.4	22.7	18.1	12.6	16.7	13.9	16.4	11.1	15.3	13.8	19.6	17.0	17.2	14.1	25.0	19.9	14.5	17.6	23.2	26.5	22.1	19.6	7.2	11.2	14.0	36.7	14.3	13.8	12.3	17.5	20.4	18.5	17.1	28.4	18.1	7.3	23.9	25.7	20.9	15.2	13.5	18.0	20.0	21.0	14.5	27.5	23.3	11.8	13.3	19.8	22.0	12.7	32.0	11.4	21.5	15.1	13.6	11.7	13.1	7.9	18.5	26.2	7.7	15.0	15.8	10.9	5.4	3.4	15.4	5.2	22.4	10.0	23.8	16.6	7.2	7.0	21.2	15.6	6.3	12.1	4.3	9.7	25.5	12.4	18.8	20.1	23.1	21.9	17.6	16.3	20.2	17.7	19.2	20.9
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578148-6640927	"Disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023057, HPA023494"	Enhanced		Enhanced	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	6.5	7.0	7.5	11.7	12.8	4.5	9.9	7.4	9.4	10.1	7.7	7.3	20.1	4.4	17.8	15.6	8.5	13.4	10.7	5.0	8.3	7.7	8.7	4.3	8.3	6.6	4.9	7.9	15.4	10.5	26.4	26.0	7.4	8.0	9.6	9.2	9.6	7.0	13.6	5.4	7.4	6.4	11.5	7.2	9.0	7.9	20.1	5.1	13.7	12.1	4.1	6.8	8.4	7.7	2.3	1.8	5.5	2.2	1.1	2.0	0.7	15.6	12.1	15.8	11.0	6.0	10.4	6.0	8.5	8.0	12.1	10.6	8.9	3.6	5.6	5.7	7.8	14.6	14.9	7.7	19.4	5.6	11.9	3.2	10.5	6.3	8.9	5.5	7.2	6.8	10.9	12.1	10.0	8.8	7.9	0.8	9.4	5.5	6.0	4.8	9.6	6.4	8.8	5.3	1.8	10.8	10.2	5.9	10.6	11.2	2.9	6.5	5.0	3.6	8.1	11.4	5.2	5.9	12.5	1.3	1.9	2.4	8.0	3.2	7.6	0.0	2.0	1.7	1.8	2.2	2.0	2.3	1.5	1.6	1.3	1.4	1.2	1.1	5.5	1.1	1.1	1.8	1.1	0.7	7.5	12.8	7.4	9.4	8.3	7.7	4.9	7.9	8.0	5.1
KIAA1324	"EIG121, maba1"	ENSG00000116299	KIAA1324	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8;salivary gland: 169.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.1;SCLC-21H: 9.1;SK-BR-3: 11.0;T-47d: 37.8;U-87 MG: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favourable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favourable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.7	0.9	3.7	3.6	7.9	0.0	16.4	0.7	5.6	23.9	11.8	0.4	0.0	14.6	5.5	5.7	1.3	7.8	19.1	0.6	3.3	2.3	0.6	0.6	2.2	0.7	1.0	2.7	1.2	79.8	6.1	46.6	0.0	1.1	15.8	10.0	0.0	169.4	0.0	0.6	2.5	16.5	0.2	0.9	0.9	27.3	9.4	1.1	0.0	3.9	5.2	11.5	0.9	0.6	0.2	0.0	33.8	0.0	0.2	4.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	14.1	0.1	0.1	0.2	0.0	0.0	0.1	0.5	0.2	0.0	9.1	0.2	0.0	11.0	0.0	37.8	0.0	0.2	0.0	1.4	0.0	0.1	0.8	2.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.9	0.2	3.9	1.7	0.0	0.0	1.8	0.7	33.8	0.2	0.0	0.0	4.6	1.0	3.7	7.9	0.7	5.6	3.3	2.3	1.0	2.7	1.1	1.1
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741885-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;hTCEpi: 31.4;RT4: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: , HPA064839: "	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favourable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	3.7	39.4	12.1	8.6	8.7	0.7	14.1	1.6	15.8	8.7	25.9	2.7	27.8	28.1	5.4	8.7	33.8	13.5	28.8	2.3	6.4	4.5	23.1	5.9	13.4	0.8	2.4	6.6	18.0	32.8	21.7	4.8	19.3	7.3	18.5	17.4	10.0	36.9	44.6	1.8	33.4	36.0	6.8	1.6	1.1	25.5	2.9	3.0	3.1	19.2	17.9	20.3	15.0	22.3	0.0	2.1	0.0	1.0	0.0	0.4	0.2	19.0	10.0	1.6	2.8	0.7	1.4	7.5	2.3	4.6	2.7	2.7	10.9	37.7	0.0	9.9	3.4	28.5	3.1	20.2	1.4	0.0	4.0	4.0	14.3	8.8	1.2	0.0	10.2	0.5	31.4	7.2	8.7	5.6	5.7	0.1	1.3	15.8	0.1	0.1	3.3	6.3	2.5	2.0	4.9	26.1	34.9	1.4	1.4	14.7	21.3	2.9	22.6	1.2	5.3	4.6	12.4	4.2	5.0	0.2	0.1	0.1	4.7	0.7	5.2	0.0	0.6	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	12.1	8.7	1.6	15.8	6.4	4.5	2.4	6.6	7.3	3.0
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Intermediate filaments,Cytosol"				Nucleoli	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.9	5.3	9.2	3.5	4.2	5.0	13.7	3.6	3.6	2.6	2.8	20.0	19.6	14.3	9.0	3.0	4.0	12.6	2.4	3.7	10.5	1.7	20.0	2.6	2.6	8.2	14.4	32.4	2.7	3.7	2.9	4.8	20.2	11.4	22.8	2.7	1.4	20.2	6.0	19.6	2.2	9.4	8.8	6.2	2.6	5.5	3.7	3.3	4.7	2.4	2.5	8.4	16.0	12.7	2.7	4.4	4.7	3.8	13.9	14.7	17.6	1.5	8.1	3.0	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92593286-92655395	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 74.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"				Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: , HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (8.19e-7)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	2.3	1.6	1.0	20.2	2.6	14.3	1.6	0.7	1.5	2.4	4.6	0.7	0.5	3.7	1.4	1.9	11.5	0.8	2.6	2.0	1.1	1.2	1.1	1.1	2.8	12.1	1.0	1.0	1.1	1.1	0.5	0.7	3.1	1.4	1.0	5.4	0.5	2.7	0.2	0.6	4.2	4.4	1.6	1.8	5.2	2.7	10.5	1.1	74.2	1.2	7.5	13.4	2.2	3.8	2.4	0.9	2.5	1.2	3.5	3.9	1.0	30.6	13.7	31.0	28.8	2.2	3.4	7.7	22.1	19.3	24.6	24.4	12.0	20.4	33.9	11.4	10.3	22.2	22.1	11.3	28.9	20.2	12.7	21.2	13.1	12.5	0.4	34.1	19.8	1.1	1.0	19.0	17.7	15.2	15.0	39.7	18.5	12.3	29.0	19.2	12.3	9.5	31.3	30.7	12.0	6.4	9.0	9.5	13.6	17.3	7.8	9.0	21.2	10.9	8.6	11.2	16.2	11.4	29.0	11.1	17.0	34.9	9.1	24.7	15.2	2.5	0.5	0.5	0.4	1.2	1.1	2.4	1.4	1.9	0.9	1.0	0.5	0.7	1.4	3.5	0.4	0.4	3.9	1.0	1.0	2.6	0.7	1.5	1.1	1.2	1.0	1.0	1.4	1.1
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620734	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 9.0;lymphoid tissue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"				Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: "	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.4	0.6	0.2	2.7	0.4	9.0	2.6	0.3	0.3	0.7	2.0	0.4	0.2	1.8	0.4	0.5	3.8	0.2	0.2	0.5	0.3	0.3	0.4	0.8	1.2	4.7	0.2	0.2	0.3	0.3	0.0	0.2	2.8	0.6	0.6	1.8	0.4	0.9	0.2	0.2	1.4	2.4	0.8	0.6	2.0	1.1	4.5	0.2	34.4	0.3	0.6	4.9	0.8	1.3	0.5	0.1	2.4	0.2	0.7	1.9	0.2	15.5	9.2	14.6	8.1	0.4	1.7	8.1	10.7	6.3	10.3	9.3	5.5	8.1	9.4	3.8	5.1	12.4	11.6	7.1	14.8	11.5	6.1	15.1	13.1	5.4	0.0	23.6	8.6	0.3	0.3	11.4	9.8	7.2	22.6	12.3	12.7	6.3	13.8	7.4	12.3	8.1	12.7	19.3	12.0	3.4	4.4	6.9	7.7	15.1	5.2	6.2	7.0	6.1	5.9	8.1	9.7	8.8	18.6	4.5	4.5	13.8	4.7	12.7	16.5	2.4	0.1	0.1	0.1	0.2	0.1	0.5	0.5	0.4	0.0	0.4	0.2	0.1	0.5	0.7	0.1	0.1	1.9	0.2	0.2	0.4	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2
KIF18A	"DKFZP434G2226, PPP1R99"	ENSG00000121621	"Kinesin family member 18A"	Q8NI77	11	28020620-28108308	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.3;testis: 16.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA039312, HPA039484"	Approved		Supported	"Microtubules,Cytokinetic bridge"				"Microtubules, Cytokinetic bridge"		"HPA039312: AB_10794087, HPA039484: AB_10795252"	"unprognostic (3.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.09e-3)"	"unprognostic (3.80e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.72e-4)"	"unprognostic (4.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.50e-1)"	0.9	0.5	0.6	3.9	0.8	7.9	0.6	0.9	0.9	0.8	2.1	0.3	0.0	1.5	0.5	0.8	3.1	0.5	0.4	0.5	0.7	0.5	1.8	0.5	1.5	4.8	0.5	0.0	0.6	0.5	0.0	0.6	3.4	0.8	0.5	2.2	1.3	0.9	1.6	0.8	1.3	1.9	0.6	0.9	2.7	1.0	16.9	0.2	31.3	2.8	2.0	4.9	1.0	1.2	2.3	0.7	6.4	0.4	2.8	2.2	0.4	12.3	12.3	12.5	8.7	0.4	1.8	4.2	12.8	6.0	20.5	21.5	4.1	5.0	10.4	4.6	6.6	12.4	10.7	5.0	28.8	10.3	6.5	6.7	8.4	5.2	1.0	9.9	6.2	3.2	0.6	7.1	8.5	7.8	10.7	9.2	11.5	6.5	10.0	7.4	6.1	5.1	7.8	30.0	5.1	5.7	3.6	7.6	5.8	10.7	5.1	3.5	10.9	3.0	4.5	16.4	12.8	15.3	16.7	3.7	8.5	10.5	9.8	7.4	11.5	6.4	0.0	0.8	0.2	0.4	0.8	2.3	0.9	0.5	0.7	1.0	0.8	0.3	0.0	2.8	0.1	0.6	2.2	0.4	0.6	0.8	0.9	0.9	0.7	0.5	0.5	0.0	0.8	0.2
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947711	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 12.3;lymphoid tissue: 34.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"				"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.7	0.6	0.5	8.2	0.4	12.3	0.4	0.4	0.5	0.9	1.6	0.3	0.7	2.9	0.5	0.6	3.2	0.3	1.3	1.5	0.5	0.5	0.5	0.7	0.8	5.9	0.6	0.1	0.6	0.4	0.0	0.4	1.9	0.2	0.5	1.5	0.1	0.7	0.1	0.4	2.9	2.5	0.8	0.4	1.7	1.5	3.8	0.1	34.7	0.4	2.7	7.6	0.7	1.1	1.1	0.8	2.0	0.6	1.0	1.4	0.4	14.2	18.6	15.9	14.9	0.3	1.3	13.4	12.2	4.6	15.4	12.1	15.4	12.3	12.6	5.3	4.6	15.7	11.0	4.9	7.8	26.0	16.4	16.3	20.9	9.5	0.0	13.4	14.3	0.3	0.2	13.3	5.3	7.8	12.2	21.5	7.9	11.1	24.9	13.3	11.7	12.8	19.1	24.3	8.4	2.5	7.7	12.0	11.7	8.2	7.4	4.5	13.9	9.6	5.1	23.0	22.8	13.6	25.6	6.9	6.8	15.5	7.4	10.2	14.8	1.8	0.6	0.4	0.5	0.3	0.4	0.8	0.7	0.5	0.3	1.1	0.4	0.5	2.0	1.0	0.3	0.8	1.4	0.4	0.5	0.4	0.4	0.4	0.5	0.5	0.6	0.1	0.2	0.1
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187715	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.7;testis: 18.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 10.0;T-reg: 3.2"	"Group enriched"	"Detected in many"	64	"NK-cells: 10.0;T-cells: 3.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036909, HPA036910"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cleavage furrow"				"Nucleoplasm, Cleavage furrow"	"Cytokinetic bridge"	"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (2.14e-12)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	2.3	1.7	0.3	3.6	0.4	10.4	0.7	0.3	0.7	1.7	2.7	0.4	0.3	2.7	1.6	2.2	10.7	0.3	0.3	0.8	0.3	0.3	1.2	1.2	2.3	6.7	0.6	0.4	0.8	0.5	0.0	0.3	6.6	0.5	1.0	4.2	0.4	2.0	0.3	0.5	3.5	2.7	4.4	0.5	3.8	2.1	18.2	0.3	47.7	0.5	6.1	11.7	1.8	3.0	0.1	0.0	0.0	0.0	10.0	3.2	0.4	22.3	15.1	33.5	22.2	1.7	3.3	14.4	19.4	17.8	42.5	32.1	28.4	20.9	9.7	10.5	24.4	22.2	31.3	36.4	42.5	14.1	14.8	14.3	27.0	18.1	0.1	7.0	6.6	1.2	0.6	22.6	13.0	27.4	6.0	18.5	29.3	20.6	11.7	6.9	21.1	16.5	12.8	33.6	10.0	11.6	11.1	10.0	9.9	36.8	12.5	8.5	16.0	7.3	13.0	11.1	16.5	10.0	32.4	9.6	9.2	10.8	7.1	20.7	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.2	0.4	0.3	0.4	0.3	0.7	0.3	0.3	0.6	0.4	0.5	0.3
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701610-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031263, HPA050214"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"				"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA031263: AB_10602610, HPA050214: "	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	3.9	2.3	1.3	5.9	6.6	11.1	3.2	12.8	3.0	4.1	3.8	0.7	1.1	4.3	3.4	2.2	7.0	3.3	1.5	2.2	2.1	1.3	2.4	3.2	2.8	9.5	1.6	2.6	4.3	2.0	2.1	3.2	4.0	3.6	2.3	5.1	1.5	3.4	2.0	2.1	4.9	5.5	3.0	3.0	8.0	3.0	10.2	2.6	26.2	2.8	3.9	9.1	2.8	3.8	13.3	4.8	8.3	3.9	2.4	8.6	1.9	35.5	7.3	10.7	9.4	2.1	3.6	8.9	14.6	13.4	15.3	16.2	9.6	16.5	13.8	4.6	7.4	18.1	11.8	8.2	20.7	16.6	8.1	14.0	12.7	8.2	0.6	23.8	11.6	1.5	1.2	14.8	15.2	9.8	13.3	15.9	13.6	6.1	13.9	4.6	10.9	7.0	9.7	21.0	6.0	4.8	4.8	3.4	6.1	10.5	4.8	5.5	12.4	6.9	7.7	9.9	9.9	12.8	23.4	4.4	12.0	18.6	9.3	21.2	7.3	8.3	2.3	3.7	5.5	3.9	6.7	11.5	7.4	5.9	1.2	13.3	8.6	8.0	0.1	2.4	3.8	4.8	8.6	1.9	1.3	6.6	12.8	3.0	2.1	1.3	1.6	2.6	3.6	2.6
KIF21A	"FEOM1, FLJ20052"	ENSG00000139116	"Kinesin family member 21A"	Q7Z4S6	12	39293228-39443390	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.5"	"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	8	"NK-cells: 3.1;T-cells: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022079, HPA058432"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB022079: , HPA058432: "	"unprognostic (1.08e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-2)"	"prognostic favourable (8.07e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.34e-2)"	3.4	10.1	17.7	3.1	18.5	0.8	5.1	22.1	36.7	8.4	9.2	7.7	2.9	7.1	7.7	4.7	16.0	26.8	5.1	13.4	18.0	28.7	20.9	15.6	4.8	2.2	26.4	18.0	3.2	10.1	17.4	12.3	6.4	41.5	9.3	10.6	5.9	16.4	3.5	8.0	8.5	7.9	7.2	29.2	5.0	9.6	9.5	9.6	0.0	7.1	2.5	4.1	3.6	6.0	0.7	0.0	0.1	0.0	3.1	8.5	1.1	5.8	7.5	10.5	4.5	2.0	1.0	8.4	1.4	0.7	1.9	1.3	13.5	7.3	0.0	4.7	0.6	5.1	6.0	3.6	1.8	11.4	4.8	0.0	13.1	12.3	1.5	9.7	0.0	0.6	8.1	2.4	11.8	2.5	11.0	12.1	1.5	3.5	1.2	0.0	14.1	6.5	0.0	0.0	6.7	7.4	9.7	14.4	62.6	5.7	9.1	3.4	10.5	1.2	1.7	1.1	4.6	0.3	4.1	5.5	1.8	0.0	2.7	1.4	0.9	0.0	0.0	0.0	8.4	0.0	4.1	0.7	5.2	8.5	0.0	0.0	1.3	5.9	0.1	3.1	0.0	0.0	2.3	1.1	17.7	18.5	22.1	31.6	18.0	28.7	26.4	18.0	41.5	9.6
KIF22	"Kid, KNSL4, OBP-1, OBP-2"	ENSG00000079616	"Kinesin family member 22"	Q14807	16	29790719-29805385	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041076, HPA048213"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA041076: AB_10794540, HPA048213: "	"unprognostic (3.71e-2)"	"prognostic favourable (3.87e-8)"	"unprognostic (1.86e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	5.6	4.3	8.5	21.7	11.2	38.9	7.0	6.4	10.9	5.1	12.5	8.8	3.0	8.4	5.1	10.1	13.6	6.5	6.0	5.6	6.2	5.9	7.2	4.5	5.8	16.1	6.3	6.2	5.8	3.9	18.6	5.7	22.1	5.8	13.2	10.7	8.9	6.3	9.6	4.0	16.7	9.6	4.1	5.8	11.6	5.9	17.9	5.9	78.2	16.8	13.1	19.0	6.5	7.6	13.6	6.6	19.7	9.1	13.3	25.0	17.1	21.5	23.1	30.5	22.0	2.1	3.1	26.8	16.3	13.1	31.4	29.4	22.2	25.8	31.4	15.3	8.4	22.5	29.8	16.8	14.7	20.5	23.9	17.4	25.1	28.1	0.7	18.9	19.3	1.7	4.5	17.4	13.1	16.9	25.4	26.3	16.4	43.8	41.3	47.6	25.7	14.3	57.8	27.1	30.0	11.3	10.1	25.5	16.5	11.9	23.8	8.3	21.4	25.7	7.4	16.4	17.3	14.5	17.6	24.6	24.3	33.9	10.7	31.3	20.9	19.7	6.4	17.0	23.6	9.1	17.6	13.6	23.7	25.0	6.6	11.3	19.5	18.5	2.8	13.3	7.7	4.2	24.0	17.1	8.5	11.2	6.4	10.9	6.2	5.9	6.3	6.2	5.8	5.9
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.8;testis: 20.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 7.7"	"Group enriched"	"Detected in many"	12	"granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"				Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: , HPA068831: "	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavourable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavourable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.8	2.6	1.8	12.7	1.3	16.3	3.2	0.3	0.9	2.2	3.3	0.3	1.4	3.5	3.3	1.2	8.8	1.8	2.4	2.2	0.7	0.5	4.9	0.8	2.5	6.7	0.9	0.5	1.6	0.9	0.0	0.3	10.8	1.3	1.9	4.3	0.6	2.1	0.9	0.3	3.0	3.9	3.4	1.4	4.5	3.1	20.4	0.2	41.8	0.6	6.3	8.8	1.8	3.3	0.3	0.1	7.7	2.2	0.1	2.1	0.6	24.8	21.6	16.0	15.3	1.0	1.9	9.8	27.3	14.8	39.6	30.9	13.1	19.5	14.6	8.3	14.1	28.8	33.1	10.2	40.3	13.5	15.5	13.7	20.3	8.1	0.6	14.1	12.7	0.9	1.0	18.9	16.0	13.4	9.1	18.3	24.9	11.0	7.9	7.6	19.9	8.7	9.0	35.8	8.1	10.4	12.9	8.2	6.8	31.7	13.9	12.0	13.3	6.4	8.7	24.0	31.9	16.6	40.1	7.1	19.2	13.1	8.4	19.1	21.1	0.0	2.2	7.7	0.0	1.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.1	1.0	0.1	2.1	0.6	1.8	1.3	0.3	0.9	0.7	0.5	0.9	0.5	1.3	0.2
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62537249	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome			2100000	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: , HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (5.45e-4)"	"prognostic unfavourable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.3	9.3	25.4	21.9	26.4	12.4	15.5	15.4	40.1	19.7	13.5	19.4	8.0	10.3	12.9	7.6	14.3	17.5	13.7	7.2	26.2	24.1	8.2	5.8	10.6	29.4	24.9	24.6	13.0	12.3	15.2	14.3	27.8	37.0	10.2	14.5	6.8	10.7	11.9	7.4	7.9	15.8	13.5	34.3	17.4	9.6	39.2	26.4	28.7	13.0	5.6	26.7	17.4	14.8	9.0	8.4	7.1	3.0	15.8	25.4	9.7	17.2	17.3	28.9	25.6	10.9	15.4	23.6	18.5	15.3	20.2	25.6	18.6	18.9	42.8	20.4	16.3	11.0	21.9	14.9	27.0	42.9	15.3	43.0	16.2	10.1	12.9	23.4	16.4	12.7	9.8	19.6	17.8	18.4	30.4	26.1	16.8	13.0	39.1	11.6	16.8	10.9	28.9	22.9	23.6	9.0	21.0	25.9	21.5	25.1	10.6	13.0	13.8	13.2	15.9	12.0	19.9	13.9	18.4	24.7	35.6	45.2	13.9	28.2	14.7	7.1	3.0	3.4	20.2	2.6	22.8	9.0	20.3	20.6	4.0	7.8	17.9	18.4	5.3	15.8	1.8	8.4	25.4	9.7	25.4	26.4	15.4	31.2	26.2	24.1	24.9	24.6	37.0	26.4
KIF2B		ENSG00000141200	"Kinesin family member 2B"	Q8N4N8	17	53822901-53825213	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	261	"testis: 103.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023081, HPA023103, HPA024795"	Uncertain		Supported	"Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle"				"Microtubules, Cytokinetic bridge, Mitotic spindle"	Nucleoli	"HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.9;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006219			Supported	Nucleoplasm,Midbody,Centrosome				"Nucleoplasm, Centrosome"	Midbody	"HPA006219: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	1.1	0.7	0.4	8.7	0.4	12.7	0.8	0.5	0.5	1.2	2.4	0.4	0.2	2.1	1.3	1.4	4.6	0.6	0.7	0.9	0.6	0.5	0.7	0.6	1.6	6.7	0.4	0.2	0.7	0.4	0.3	0.6	2.2	0.6	0.6	3.2	0.4	1.1	0.2	0.4	2.3	2.2	1.1	0.4	3.3	1.4	61.4	0.2	39.9	0.8	4.7	12.0	0.9	1.7	1.3	1.5	0.0	0.2	3.9	5.8	1.0	28.7	11.2	25.0	20.0	1.3	2.9	16.8	21.6	15.4	44.2	38.6	18.9	20.8	33.1	10.4	10.6	13.7	25.4	14.5	40.5	21.4	10.9	39.2	19.8	15.7	0.1	28.9	18.2	0.7	1.4	31.5	15.4	14.2	30.9	28.4	27.9	11.2	30.4	17.5	24.4	14.1	24.4	37.8	20.8	7.4	10.4	17.2	12.3	28.7	20.5	18.1	11.8	22.0	8.4	16.1	31.9	17.4	37.8	15.1	15.3	47.8	10.3	28.2	30.9	0.0	0.0	0.0	1.9	0.0	0.1	1.3	3.4	2.6	0.3	0.2	0.7	0.5	0.0	3.9	0.2	1.5	5.8	1.0	0.4	0.4	0.5	0.5	0.6	0.5	0.4	0.2	0.6	0.2
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290090-70420832	"Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;lymphoid tissue: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"									"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: "	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.9	0.6	0.8	3.3	1.0	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2.0	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0.0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2.0	0.7	0.0	0.0	0.2	0.2	3.2	0.3	22.4	15.7	23.8	11.7	1.1	2.0	9.4	17.1	9.2	23.4	20.4	17.6	13.2	13.8	10.8	8.4	13.5	25.7	9.3	26.4	15.8	12.9	15.6	19.2	12.5	0.2	17.3	10.9	0.6	0.5	19.4	11.1	14.3	19.8	30.8	22.0	14.4	15.8	8.6	24.0	16.7	17.6	32.1	13.0	5.6	8.9	15.7	13.1	27.9	11.8	7.3	9.5	6.8	9.9	15.5	20.2	16.6	20.3	8.9	15.2	20.0	8.2	19.1	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	3.2	0.3	0.8	1.0	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009010-32056431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"			260000	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	26.3	19.9	55.7	20.2	55.5	34.1	23.0	22.2	42.4	23.8	34.2	21.7	20.9	23.5	25.7	17.8	28.0	20.3	28.0	48.4	51.5	39.3	21.1	15.3	23.8	16.5	62.9	26.1	18.2	18.9	56.8	22.4	27.7	38.3	31.8	30.0	8.9	20.1	25.6	34.3	17.6	28.6	37.2	80.4	21.1	23.1	27.7	43.7	25.0	23.5	21.5	16.1	33.8	28.1	13.8	27.6	30.0	18.9	13.4	16.5	9.2	29.4	25.1	34.0	23.8	24.4	26.9	14.5	40.7	19.3	31.5	26.9	27.5	32.6	20.2	17.7	48.3	24.5	31.0	26.0	42.3	17.4	16.9	25.7	23.5	26.8	28.1	17.8	28.3	21.8	37.0	36.3	25.4	40.2	30.9	21.3	43.5	17.7	18.6	10.1	5.5	11.5	24.4	63.4	8.3	24.3	20.7	33.1	24.2	31.5	12.6	30.3	15.2	25.6	33.5	32.1	30.1	37.1	30.1	6.4	7.4	23.9	30.6	36.9	30.1	20.8	15.2	24.2	11.8	18.9	11.4	13.6	14.9	12.5	14.2	13.8	13.3	13.0	30.0	13.4	18.9	27.6	16.5	9.2	55.7	55.5	22.2	42.4	51.5	39.3	62.9	26.1	38.3	43.7
KIFC2		ENSG00000167702	"Kinesin family member C2"	Q96AC6	8	144466043-144474202	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 36.2;skin 1: 48.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029264	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA029264: AB_10609999"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-3)"	"unprognostic (4.12e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.71e-2)"	4.2	5.1	18.7	4.2	28.4	4.5	3.4	36.2	35.0	3.1	6.3	2.3	6.6	8.8	2.7	5.2	7.0	2.9	4.4	2.2	13.5	7.2	4.7	2.8	3.8	4.8	4.4	16.8	2.1	7.9	9.8	7.9	2.5	8.3	7.2	4.8	2.2	7.5	6.5	2.3	48.2	7.9	2.1	2.6	8.1	8.7	5.2	6.6	1.6	4.1	1.3	3.5	5.0	4.9	0.8	0.1	0.1	0.1	0.0	0.8	0.1	7.9	6.8	3.3	7.2	4.8	2.9	7.8	4.8	3.4	2.6	2.6	2.7	9.9	8.3	2.7	2.7	16.3	3.3	4.3	1.1	8.4	2.9	5.0	16.7	3.5	6.2	1.3	14.8	3.7	15.5	2.6	3.4	1.7	5.4	8.7	1.9	13.6	6.0	4.2	0.5	10.1	15.1	0.2	4.9	10.8	12.5	10.4	9.5	3.4	10.6	3.8	27.9	2.7	4.6	5.1	15.4	5.4	4.8	4.3	2.0	2.3	9.9	7.0	2.8	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.3	0.6	0.1	0.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	18.7	28.4	36.2	35.0	13.5	7.2	4.4	16.8	8.3	6.6
KIN	"KIN17, Rts2"	ENSG00000151657	"Kin17 DNA and RNA binding protein"	O60870	10	7750962-7787981	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016339, HPA038700"			Enhanced	Nucleoplasm				Nucleoplasm		"CAB016339: AB_627860, HPA038700: "	"unprognostic (4.33e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.40e-3)"	"prognostic unfavourable (1.44e-7)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-1)"	"prognostic favourable (3.23e-5)"	8.5	8.6	9.0	8.2	9.7	9.4	9.0	19.8	11.9	9.5	7.0	10.2	9.1	7.8	11.3	9.9	6.5	8.1	7.2	8.6	7.5	7.8	10.1	12.9	7.4	10.4	9.7	8.2	10.8	10.2	7.7	15.5	10.0	10.6	10.0	7.7	8.4	8.4	8.6	9.1	11.5	10.0	9.1	9.0	10.8	8.1	6.9	9.7	13.6	11.1	7.7	9.7	8.8	8.3	7.0	6.9	13.8	5.1	5.9	5.0	1.8	6.9	4.4	6.8	4.3	5.6	6.8	5.5	6.2	2.8	7.5	8.1	8.5	6.9	5.4	3.3	3.8	6.7	5.7	3.8	8.7	6.1	6.6	8.5	4.5	8.1	7.9	3.0	6.8	5.6	4.2	5.7	3.8	5.6	8.4	5.2	5.8	6.2	6.0	4.7	6.5	2.7	7.7	4.9	4.9	6.3	3.9	3.0	6.4	4.9	5.0	9.9	9.1	6.1	4.0	4.9	5.5	8.6	5.0	6.8	7.2	6.7	6.2	4.7	3.3	13.8	4.8	8.0	4.7	5.1	4.7	6.5	4.2	3.9	3.6	7.0	4.8	5.0	10.8	5.9	4.6	6.9	3.4	1.8	9.0	9.7	19.8	11.9	7.5	7.8	9.7	8.2	10.6	9.7
KIRREL2	"DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1"	ENSG00000126259	"Kirre like nephrin family adhesion molecule 2"	Q6UWL6	19	35855861-35867109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"pancreas: 38.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.5;HMC-1: 25.0;U-937: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA071587, HPA074326"	Enhanced		Supported	"Centriolar satellite"	"Intracellular and membrane"			"Centriolar satellite"		"HPA071587: , HPA074326: "	"unprognostic (1.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-6)"	"unprognostic (1.72e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.62e-2)"	0.2	0.0	0.4	0.3	0.8	0.0	0.0	0.2	1.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.5	0.2	0.4	0.0	38.5	0.0	0.9	0.1	0.5	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.5	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.1	0.0	0.1	2.2	0.0	0.0	15.5	0.0	0.0	0.0	0.2	0.0	0.0	25.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	3.1	1.0	0.0	0.0	0.0	0.0	3.9	0.0	0.6	1.0	0.2	0.0	0.0	0.0	0.3	0.0	5.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.8	0.2	1.2	0.7	0.0	0.2	0.4	0.5	0.2
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921015	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;lymphoid tissue: 12.4"	"Cell line enhanced"	"Detected in some"		"K-562: 10.5;RPMI-8226: 25.7;SCLC-21H: 5.4;SH-SY5Y: 14.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;neutrophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: "	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavourable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.2	0.2	2.1	2.1	4.1	0.2	0.3	0.1	4.7	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.1	0.2	0.1	0.1	1.0	6.8	1.4	0.1	0.3	12.4	1.1	0.1	0.4	3.6	0.1	2.0	1.0	0.8	0.2	0.2	0.3	0.3	0.1	0.1	0.1	0.7	0.5	1.0	2.4	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.6	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	2.8	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.2	0.1	0.0	0.4	0.3	0.7	0.0	25.7	0.0	0.0	5.4	14.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.7	0.0	0.0	0.1	2.0	0.6	1.8	0.0	0.0	0.0	0.1	0.0	2.1	4.1	0.1	1.5	1.0	6.8	1.1	0.1	0.8	0.1
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.5"	"Group enriched"	"Detected in some"	13	"HEL: 47.7;HMC-1: 100.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.7;NK-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"			48000000	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: , CAB072867: , HPA004471: AB_1078431, HPA073252: "	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favourable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	8.1	1.6	9.5	6.6	11.8	3.7	65.5	18.3	12.0	12.1	10.3	6.5	10.2	5.8	8.9	4.2	9.9	2.5	15.5	2.4	36.0	4.4	9.4	1.1	13.8	3.8	3.6	6.0	28.5	2.1	1.3	2.3	6.2	5.7	9.6	10.4	20.7	12.9	6.9	1.3	14.6	8.9	10.2	3.9	3.2	12.8	4.0	4.5	0.4	28.9	4.3	4.9	9.8	12.5	0.0	1.8	12.7	0.9	9.7	1.9	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.6	0.9	2.5	3.2	0.0	0.0	0.0	0.0	1.4	0.0	0.5	0.0	2.1	0.0	1.1	47.7	0.0	0.0	0.0	0.0	100.2	0.0	0.0	0.0	0.0	5.6	0.6	0.1	0.0	0.0	0.2	0.4	1.3	0.0	0.1	0.0	0.0	0.0	4.7	1.2	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	12.7	0.0	10.0	0.1	0.0	1.9	0.0	0.3	0.7	1.8	0.0	0.0	0.0	0.8	9.7	0.9	0.0	0.0	0.1	9.5	11.8	18.3	12.0	36.0	4.4	3.6	6.0	5.7	4.5
KLC2	FLJ12387	ENSG00000174996	"Kinesin light chain 2"	Q9H0B6	11	66257294-66267860	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040416, HPA040434"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Mitochondria"	"HPA040416: AB_10795524, HPA040434: AB_10795367"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (3.16e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.57e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.08e-2)"	7.5	12.5	15.9	7.9	20.7	2.9	6.6	51.7	49.4	7.4	7.8	7.5	6.5	8.5	11.3	6.0	8.8	9.0	8.0	15.3	20.0	17.4	6.7	2.4	6.6	7.5	13.8	26.0	11.3	11.2	15.4	15.4	6.4	29.0	13.6	4.4	8.2	8.4	15.5	23.8	9.3	7.7	10.1	8.6	6.6	9.8	17.4	10.0	13.5	6.3	4.5	5.6	8.8	8.5	4.7	4.1	0.8	0.4	2.3	6.2	1.5	20.2	24.8	12.1	7.2	7.3	5.9	9.4	14.3	10.3	14.7	11.4	13.5	6.1	9.1	13.8	10.6	17.1	12.4	13.9	4.9	14.6	15.6	1.8	19.6	9.1	14.2	4.0	9.7	5.9	18.4	17.2	14.1	6.8	9.8	12.4	11.7	28.5	22.9	6.1	11.9	20.6	8.8	6.3	12.4	11.5	11.4	33.0	16.0	10.4	9.4	17.1	15.5	2.8	11.2	24.2	21.7	29.2	18.8	12.9	10.8	4.9	17.1	2.8	9.7	0.0	0.4	0.8	4.6	0.1	6.2	3.6	2.2	3.1	0.6	4.7	2.2	2.7	0.7	2.3	0.3	4.1	0.6	1.5	15.9	20.7	51.7	49.4	20.0	17.4	13.8	26.0	29.0	10.0
KLF1	EKLF	ENSG00000105610	"Kruppel like factor 1"	Q13351	19	12884422-12887199	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0"	"Group enriched"	"Detected in some"	28	"HEL: 22.6;K-562: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051850	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA051850: AB_2616460"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.44e-1)"	0.0	0.0	0.5	0.0	0.3	30.6	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	1.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.2	9.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	7.0	0.0	0.1	0.0	0.0	0.8	1.2	0.0	0.6	0.0	0.3	0.5	0.5	4.7	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.6	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.2	4.7	0.0	0.3	0.0	0.1	0.5	0.1	0.1	0.2	0.5	0.0	2.9	0.0	0.0	1.6	0.5	0.3	0.1	0.4	0.2	0.1	0.2	0.0	0.3	0.0
KLF11	"MODY7, TIEG2, Tieg3"	ENSG00000172059	"Kruppel like factor 11"	O14901	2	10042849-10054836	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058276			Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol"				Nucleoplasm	"Nuclear bodies, Focal adhesion sites, Cytosol"	"HPA058276: "	"unprognostic (9.66e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.63e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.24e-2)"	28.7	9.1	2.5	7.0	3.5	11.8	33.1	8.2	4.4	12.9	13.0	5.1	10.8	3.5	12.8	11.7	8.3	11.2	11.6	19.4	2.9	2.3	12.7	27.9	14.6	15.9	5.5	2.4	13.7	38.3	7.3	2.4	9.9	3.4	13.9	4.7	9.2	11.3	10.9	14.0	19.1	7.7	30.4	3.5	16.1	10.2	16.7	2.7	1.5	9.1	8.5	5.6	11.1	42.7	2.9	6.6	1.7	12.7	5.4	2.7	3.8	3.7	1.8	4.4	0.3	3.0	5.4	10.6	4.3	4.4	2.5	2.6	4.2	8.7	0.0	7.8	5.2	0.8	3.7	3.3	1.6	25.5	2.9	1.9	5.3	0.8	3.0	7.7	12.4	8.4	12.5	4.7	1.3	2.1	5.1	17.2	2.5	4.4	0.0	1.4	7.0	3.7	4.1	0.1	7.2	6.0	4.6	5.6	3.5	6.6	13.7	12.7	3.2	10.6	6.1	10.9	9.2	8.2	1.4	15.7	18.6	10.1	2.8	2.1	5.8	0.0	6.9	1.7	2.6	11.0	0.8	2.8	1.7	1.8	6.6	2.9	0.5	1.0	0.2	5.4	12.7	0.3	2.7	3.8	2.5	3.5	8.2	4.4	2.9	2.3	5.5	2.4	3.4	2.7
KLF16	"BTEB4, DRRF, NSLP2"	ENSG00000129911	"Kruppel like factor 16"	Q9BXK1	19	1852399-1863568	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052481	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA052481: "	"unprognostic (3.24e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (2.93e-5)"	"unprognostic (5.85e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.76e-2)"	10.5	9.2	19.5	11.8	32.2	20.3	5.7	7.0	20.8	3.9	12.9	6.2	5.0	15.8	5.8	4.1	9.9	5.1	10.1	4.8	20.6	8.8	7.1	15.1	8.6	14.8	7.8	10.2	10.8	10.1	6.2	10.2	7.0	7.3	5.0	5.6	5.3	6.0	4.7	4.9	9.2	14.2	6.2	6.6	15.9	12.8	6.4	5.8	7.7	3.5	10.1	11.8	4.4	4.2	2.5	9.1	4.8	2.3	0.2	2.1	1.1	16.4	8.8	4.5	9.3	2.6	3.2	9.8	12.7	2.9	5.3	4.8	7.0	7.4	12.3	11.0	8.2	15.2	6.8	11.4	3.3	18.7	12.0	12.8	4.5	8.3	6.1	12.1	21.7	4.8	6.9	8.7	10.9	4.6	15.6	9.6	4.4	12.5	11.3	15.1	14.7	12.7	17.6	4.2	13.3	5.5	5.6	19.6	16.5	4.4	6.9	14.4	6.5	15.3	11.0	8.7	13.1	19.7	17.2	13.5	15.4	13.7	8.9	10.6	9.1	1.7	2.3	2.2	1.5	1.9	1.8	2.2	1.8	0.9	1.8	2.5	1.6	1.1	4.8	0.2	1.8	9.1	2.1	1.1	19.5	32.2	7.0	19.3	20.6	8.8	7.8	10.2	7.3	5.8
KLF3	BKLF	ENSG00000109787	"Kruppel like factor 3"	P57682	4	38664196-38701042	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049512, HPA065054"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA049512: , HPA065054: "	"unprognostic (4.20e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	"prognostic favourable (4.36e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.10e-3)"	23.0	14.3	11.1	14.7	14.4	41.7	25.6	8.9	13.7	20.2	31.2	21.7	10.4	21.0	20.0	14.1	51.9	14.6	39.3	12.0	11.9	8.1	13.2	25.2	21.4	16.6	16.2	8.2	36.1	18.6	21.6	11.4	20.4	13.8	19.0	27.6	12.4	24.0	17.6	12.5	43.1	40.3	18.7	16.7	22.3	25.6	7.9	18.2	6.5	16.4	25.7	34.9	26.1	28.3	4.0	3.1	14.3	10.9	2.7	9.4	2.1	9.4	6.6	24.8	5.0	11.4	17.1	7.8	5.2	15.3	3.5	4.4	6.1	17.5	0.0	7.5	11.4	10.4	7.0	9.2	5.7	0.1	5.2	9.1	9.7	12.9	11.7	2.2	0.0	15.3	25.6	5.1	9.6	13.7	25.6	4.5	5.6	2.1	2.4	4.0	5.7	4.7	3.2	12.0	10.3	12.7	22.9	7.1	9.2	5.7	4.5	11.0	2.8	3.1	21.6	11.9	6.7	20.1	5.6	6.2	2.0	0.0	4.9	6.9	5.0	8.8	4.0	14.3	6.3	6.9	4.3	3.7	7.0	5.6	3.1	4.0	9.4	5.6	12.8	2.7	10.9	0.7	7.2	2.1	11.1	14.4	8.9	13.7	11.9	8.1	16.2	8.2	13.8	18.2
KLF4	"EZF, GKLF"	ENSG00000136826	"Kruppel like factor 4"	O43474	9	107484852-107490482	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 92.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.3;hTCEpi: 32.4;hTERT-HME1: 20.1;U-2197: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 5.2;intermediate monocyte: 7.4;myeloid DC: 4.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.4;monocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002926	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA002926: AB_1852541"	"unprognostic (2.06e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (3.93e-5)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.32e-2)"	29.2	8.5	2.7	23.8	3.9	14.4	23.7	1.8	3.5	39.1	28.9	5.6	5.5	10.2	17.8	18.6	34.9	22.0	32.4	18.6	2.4	2.2	4.8	5.1	35.6	4.4	2.7	2.2	18.6	2.3	2.7	2.8	41.0	6.2	11.3	29.6	11.7	11.9	6.5	13.6	92.1	39.4	16.0	3.3	21.8	22.2	11.2	2.0	1.9	7.8	81.1	30.7	16.8	24.1	0.0	4.4	0.4	7.4	0.1	0.0	1.3	5.6	2.3	0.2	0.0	6.0	15.3	2.2	2.0	10.5	2.7	3.1	0.8	7.2	0.0	0.3	2.6	4.2	2.6	1.4	1.0	0.0	1.1	0.0	4.0	0.1	8.9	0.0	0.0	2.0	32.4	5.4	20.1	0.2	0.2	0.0	1.4	3.7	0.0	0.6	1.7	11.4	0.1	0.6	0.1	0.8	1.6	0.1	0.1	1.5	4.8	6.0	0.7	2.5	1.2	1.6	0.0	49.3	0.8	0.0	0.0	0.0	1.5	1.0	2.7	0.0	5.2	0.0	0.0	7.4	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.4	0.1	2.9	0.4	0.0	1.3	2.7	3.9	1.8	3.5	2.4	2.2	2.7	2.2	6.2	2.0
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077542	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 88.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.8;HaCaT: 34.2;HBEC3-KT: 29.8;hTCEpi: 42.6;RT4: 36.0;SiHa: 30.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 22.2"	"Cell type enriched"	"Detected in single"	18	"basophil: 16.3"	"Lineage enriched"	"Detected in single"	106	"granulocytes: 16.3"	"Group enriched"	"Detected in many"	4	"amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3"	"Low region specificity"	"Detected in many"			HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	2.3	1.5	4.1	24.3	22.2	12.9	8.1	0.7	1.2	19.6	74.4	0.4	4.3	28.7	4.8	3.7	88.4	8.3	48.4	1.3	1.4	1.2	3.9	1.2	12.8	0.1	0.9	1.1	5.0	3.5	0.0	7.3	22.8	4.3	17.6	32.9	1.8	26.4	5.4	10.0	59.4	88.1	4.1	2.4	0.8	17.9	12.2	1.4	3.0	20.7	64.4	61.8	23.4	34.1	0.0	0.0	16.3	0.0	0.0	0.1	0.0	5.7	8.1	0.0	0.1	0.3	0.4	9.2	3.4	7.9	1.5	1.9	7.4	29.8	0.1	18.1	3.0	34.2	10.4	29.8	2.4	0.2	2.7	0.1	17.0	0.7	2.1	2.7	0.5	2.2	42.6	0.4	16.7	0.0	0.4	0.6	6.8	2.0	0.5	0.2	0.3	11.5	0.5	7.6	0.6	23.6	36.0	0.7	0.3	30.4	4.9	2.1	0.6	0.6	0.0	2.1	6.2	0.0	1.4	0.9	0.4	1.0	2.9	0.5	2.5	16.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	22.2	0.7	1.2	1.4	1.2	0.9	1.1	4.3	1.4
KLF8	"BKLF3, DXS741, ZNF741"	ENSG00000102349	"Kruppel like factor 8"	O95600	X	56232421-56287889	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 11.9;RT4: 10.4;SK-BR-3: 9.2;T-47d: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071740			Supported	Nucleoplasm				Nucleoplasm		"HPA071740: "	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-8)"	"unprognostic (2.96e-1)"	"prognostic favourable (3.32e-4)"	"unprognostic (6.56e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.15e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.60e-2)"	15.1	2.0	2.9	7.9	7.4	0.4	15.0	6.7	5.5	12.9	5.0	0.8	5.2	1.2	19.2	8.6	24.8	6.8	4.8	4.3	2.4	1.8	8.8	0.9	8.3	2.7	1.3	3.3	10.3	2.0	4.0	2.0	7.9	2.9	5.3	4.0	5.2	8.8	4.7	3.3	28.4	4.9	11.6	1.9	5.0	3.4	5.3	0.9	0.7	5.5	16.6	14.3	9.7	14.3	5.0	2.1	0.6	0.2	4.1	1.4	0.5	2.1	0.0	0.1	0.0	1.9	0.5	1.3	0.2	2.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	5.1	0.0	0.0	0.0	4.0	4.9	1.4	0.0	0.0	0.1	0.0	0.0	0.1	11.9	0.0	1.8	0.0	1.2	0.6	0.4	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.1	5.6	10.4	0.0	0.0	4.4	9.2	0.0	16.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.3	0.2	0.4	5.0	1.2	1.4	2.1	4.6	0.3	0.3	0.5	4.1	0.1	0.8	0.5	0.5	2.9	7.4	6.7	5.5	2.4	1.8	1.3	3.3	2.9	0.9
KLHDC1	MST025	ENSG00000197776	"Kelch domain containing 1"	Q8N7A1	14	49693105-49753152	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 8.8;ASC TERT1: 8.4;HSkMC: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020461	Approved		Supported	Cytosol				Cytosol		"HPA020461: AB_1852556"	"unprognostic (2.97e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-1)"	"prognostic favourable (1.94e-4)"	"unprognostic (3.42e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	8.6	9.7	8.5	8.0	14.5	3.3	11.0	13.4	15.2	10.9	8.7	15.4	8.6	4.5	13.3	13.3	5.3	8.9	7.2	9.9	9.2	10.0	7.2	5.9	6.6	7.5	12.0	12.2	18.2	6.7	11.0	13.2	6.0	10.7	10.2	5.6	12.4	7.1	14.2	14.1	11.3	6.5	11.0	12.9	7.9	6.5	11.7	11.7	2.9	12.5	4.4	6.0	7.1	8.5	3.0	3.7	2.5	2.2	1.6	4.8	1.7	1.0	0.5	0.9	0.7	8.8	8.4	0.0	2.3	3.1	0.7	0.6	0.0	2.8	0.5	0.5	0.9	0.7	0.3	0.0	0.7	2.3	0.8	0.4	0.2	0.0	4.6	0.2	1.0	7.0	0.4	0.3	0.3	1.8	0.4	0.0	3.4	0.3	0.6	1.1	0.0	0.4	0.6	0.7	0.0	1.7	0.2	0.3	2.3	0.4	0.0	0.9	1.0	1.8	2.6	1.9	2.2	0.7	0.2	0.8	0.1	0.6	1.9	0.3	1.1	1.4	1.0	2.5	2.1	2.2	4.2	3.0	2.8	2.4	1.1	2.1	4.8	4.0	0.1	1.6	1.1	3.7	0.9	1.7	8.5	14.5	13.4	15.2	9.2	10.0	12.0	12.2	10.7	11.7
KLHDC2	"HCLP-1, LCP"	ENSG00000165516	"Kelch domain containing 2"	Q9Y2U9	14	49767608-49786385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000628	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nuclear bodies"				"Nucleoplasm, Nuclear membrane"	"Nuclear bodies"	"HPA000628: "	"unprognostic (2.65e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.52e-3)"	"unprognostic (4.54e-2)"	"unprognostic (9.72e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-3)"	"unprognostic (6.77e-3)"	"prognostic favourable (2.75e-10)"	"unprognostic (2.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.34e-2)"	17.0	20.2	18.2	9.6	18.0	7.6	20.7	21.0	22.3	15.4	22.0	10.8	16.2	15.9	18.4	14.3	13.6	13.4	15.2	47.1	16.0	14.3	29.7	41.7	12.6	13.1	17.6	16.8	22.9	43.2	16.2	15.5	11.1	17.6	16.9	16.1	18.5	16.2	18.8	40.7	14.9	22.5	20.7	13.5	10.2	20.3	21.7	18.3	15.0	24.8	13.1	9.5	23.9	13.0	13.1	7.0	15.0	7.0	12.5	19.9	8.7	8.4	7.1	13.4	6.5	19.3	16.9	14.1	8.9	16.9	11.2	11.4	4.1	11.5	16.9	12.5	15.8	7.6	8.1	8.1	9.6	11.6	9.2	5.2	5.3	9.7	14.1	11.1	4.6	17.4	14.0	5.1	10.2	10.2	6.7	12.6	8.9	9.9	11.4	4.8	9.8	20.9	9.1	14.3	10.2	5.1	18.0	16.6	13.2	14.9	27.6	9.6	10.5	4.3	8.7	10.4	8.2	8.2	4.6	17.4	11.2	9.9	5.8	5.8	5.4	8.8	7.0	15.0	9.2	4.5	11.5	13.0	14.0	14.5	7.0	13.1	19.9	13.3	6.8	12.5	4.4	5.4	13.3	8.7	18.2	18.0	21.0	22.3	16.0	14.3	17.6	16.8	17.6	18.3
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favourable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favourable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	16.1	19.0	37.2	11.6	41.6	14.7	17.6	38.0	68.2	15.2	16.7	14.6	15.4	14.4	12.8	21.2	16.1	19.9	13.6	34.0	34.2	25.7	14.8	20.2	14.4	14.4	26.7	41.6	20.3	15.2	15.6	17.6	20.9	29.6	16.3	15.0	13.5	21.3	18.5	122.7	15.1	14.7	15.9	14.6	14.1	15.4	47.0	15.3	17.4	19.3	17.6	15.6	13.7	11.2	19.5	39.4	41.6	36.3	21.6	31.5	29.8	27.6	8.5	28.5	47.6	19.6	14.9	20.4	12.5	16.2	24.6	26.9	24.6	14.5	27.5	14.4	18.3	14.7	30.3	16.1	16.9	14.6	41.3	34.2	24.6	25.5	19.3	20.0	24.4	23.9	16.3	18.9	11.1	23.7	41.4	19.6	9.2	34.3	32.8	34.6	37.1	9.2	32.0	20.9	32.9	15.1	16.1	52.9	41.3	13.3	15.3	21.3	26.5	58.2	14.0	11.2	20.9	12.3	12.4	21.5	26.9	39.9	4.9	28.8	9.4	14.9	36.3	41.6	28.5	33.8	24.0	19.2	23.8	25.8	39.4	19.5	31.5	24.5	17.7	21.6	25.8	21.8	25.1	29.8	37.2	41.6	38.0	68.2	34.2	25.7	26.7	41.6	29.6	15.3
KLHDC8B	MGC35097	ENSG00000185909	"Kelch domain containing 8B"	Q8IXV7	3	49171611-49176486	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.4"	"Group enriched"	"Detected in many"	9	"granulocytes: 19.4;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008463, HPA014467"	Approved		Enhanced	Cytosol				Cytosol		"HPA008463: AB_1852563, HPA014467: AB_1852565"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.66e-1)"	"unprognostic (5.03e-3)"	"unprognostic (1.71e-3)"	"prognostic favourable (1.47e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	15.0	44.0	5.6	4.7	5.8	3.2	12.6	4.5	8.8	12.8	19.3	6.2	10.5	4.6	15.9	12.2	22.6	11.6	13.6	30.5	3.7	8.5	5.6	8.8	6.6	6.3	4.9	5.4	29.6	6.2	5.2	4.2	7.9	5.2	15.2	2.5	21.8	8.4	9.5	15.8	9.8	5.4	18.0	2.4	6.7	6.7	10.0	3.0	2.0	17.1	10.7	6.6	20.0	8.8	0.1	0.6	19.4	5.7	0.0	1.4	1.6	1.5	3.4	14.2	7.2	8.7	5.2	4.4	5.2	3.0	5.2	4.2	2.2	4.6	0.0	2.9	8.6	0.0	3.5	3.1	1.3	2.8	0.9	9.1	9.2	5.7	16.6	0.0	5.4	8.6	15.2	6.7	0.5	13.3	14.1	0.1	3.9	0.4	0.9	10.1	4.6	8.1	1.4	1.3	0.4	3.9	0.8	0.6	16.0	4.2	0.1	10.4	4.3	4.4	5.7	4.0	11.2	7.1	1.6	1.3	0.4	0.1	2.9	0.0	1.9	0.0	3.8	19.4	0.8	5.7	0.3	0.0	0.4	0.6	0.3	0.1	1.4	0.8	6.7	0.0	5.0	0.6	0.1	1.6	5.6	5.8	4.5	8.8	3.7	8.5	4.9	5.4	5.2	3.0
KLHL12	C3IP1	ENSG00000117153	"Kelch like family member 12"	Q53G59	1	202891100-202928636	"Predicted intracellular proteins"	"ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071324			Supported	"Vesicles,Centriolar satellite"			9600000	"Vesicles, Centriolar satellite"		"HPA071324: "	"unprognostic (1.69e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.11e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.22e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.87e-2)"	14.1	18.3	19.3	17.1	20.2	16.1	20.1	18.6	35.5	14.1	18.4	14.2	13.5	13.9	14.7	23.2	17.2	18.5	12.6	25.2	19.2	25.6	21.5	17.1	20.4	29.6	19.6	20.1	18.1	25.6	17.9	19.0	15.0	24.7	19.6	23.2	12.7	13.8	16.6	14.6	13.5	14.3	19.7	25.2	19.4	15.4	41.3	14.6	15.9	19.6	10.1	20.6	16.1	16.2	9.5	12.7	18.4	14.9	10.2	13.3	9.9	10.3	12.5	15.9	17.9	24.7	18.7	18.6	12.6	14.6	15.8	14.5	11.7	17.1	29.0	9.8	14.2	13.3	21.3	17.5	17.4	15.1	9.0	10.2	9.8	11.8	17.9	21.1	17.0	17.8	22.5	13.7	30.1	14.1	25.3	19.3	21.5	14.0	17.6	10.3	22.6	9.5	18.7	27.9	18.5	13.6	12.9	11.8	13.5	15.6	14.3	16.9	26.0	14.9	11.4	15.5	10.9	3.7	11.1	13.9	11.1	24.5	15.2	15.2	14.7	9.2	12.0	18.4	9.1	14.9	13.2	9.5	9.1	10.8	12.7	9.3	9.6	10.3	12.4	10.2	14.7	7.6	13.3	9.9	19.3	20.2	18.6	35.5	19.2	25.6	19.6	20.1	24.7	14.6
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672671-32773062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 14.6;seminal vesicle: 19.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;Hep G2: 16.4;REH: 4.4;RPTEC TERT1: 9.1;SCLC-21H: 3.5;U-698: 4.8"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	97	"memory B-cell: 10.7;naive B-cell: 8.5"	"Lineage enriched"	"Detected in single"	108	"B-cells: 10.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"hippocampal formation: 22.7;olfactory region: 20.4"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"				Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.6	0.1	0.4	1.0	0.4	1.5	0.6	0.4	1.0	2.4	0.4	0.4	14.6	0.0	1.5	1.4	0.4	6.3	0.4	0.4	0.4	0.3	4.3	0.4	0.4	5.1	0.4	0.4	1.1	0.4	10.3	1.1	0.4	1.5	1.6	0.0	1.0	0.4	19.3	0.4	0.1	2.3	0.4	0.4	9.5	0.1	2.8	0.4	0.4	11.7	0.4	3.8	0.4	0.7	10.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	16.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	4.4	1.4	0.0	9.1	0.0	3.5	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.4	1.0	0.4	0.3	0.4	0.4	1.5	0.4
KLHL20	"KHLHX, KLEIP"	ENSG00000076321	"Kelch like family member 20"	Q9Y2M5	1	173714941-173786702	"Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025034, HPA053704"	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA025034: AB_1852578, HPA053704: "	"unprognostic (2.97e-3)"	"unprognostic (3.11e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.62e-2)"	18.2	14.5	10.4	12.5	15.1	6.9	15.4	18.8	18.0	17.9	16.1	14.3	17.3	9.1	21.9	13.0	14.4	14.2	13.9	15.2	11.6	10.3	15.1	21.7	13.6	12.0	13.3	10.5	18.0	9.7	12.3	20.6	15.4	16.2	18.8	12.7	11.5	11.3	15.4	17.1	12.9	16.0	18.8	14.8	16.4	11.0	20.7	15.2	20.7	13.3	14.7	13.6	14.3	14.8	6.2	7.1	9.7	5.0	4.7	9.5	3.3	8.2	5.2	8.4	8.7	19.7	18.3	6.9	13.0	12.7	10.0	10.6	3.8	5.8	5.8	11.1	13.9	8.2	7.4	9.3	11.9	7.1	4.0	5.3	7.2	4.5	12.7	9.9	6.3	15.5	10.9	9.3	12.5	14.7	11.7	6.7	18.3	3.0	5.7	5.1	8.9	24.0	6.2	10.3	6.2	7.7	5.3	3.6	10.0	11.8	8.1	7.7	7.2	11.7	14.5	9.7	5.8	11.8	10.1	9.0	4.6	8.9	6.4	7.2	10.8	9.7	4.5	6.3	7.3	5.0	6.5	5.9	7.2	8.7	4.3	6.2	9.5	9.1	2.5	4.7	3.5	7.1	8.1	3.3	10.4	15.1	18.8	18.0	11.6	10.3	13.3	10.5	16.2	15.2
KLHL21	KIAA0469	ENSG00000162413	"Kelch like family member 21"	Q9UJP4	1	6590724-6614607	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 9.7;neutrophil: 31.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051364, HPA059307"	Uncertain		Supported	Centrosome				Centrosome		"HPA051364: , HPA059307: "	"unprognostic (6.13e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.33e-3)"	"prognostic favourable (1.71e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.19e-2)"	18.1	11.3	8.7	7.8	16.1	13.6	20.0	7.3	12.7	11.9	14.6	19.1	12.0	4.6	13.7	6.0	17.3	8.5	14.8	20.5	8.6	7.3	11.7	9.1	8.7	7.5	31.2	5.4	18.0	21.0	8.7	11.2	4.4	14.0	15.7	3.5	17.1	20.4	19.4	58.7	15.1	5.4	22.9	9.9	6.5	10.1	6.6	22.4	4.5	10.1	13.8	7.4	19.4	19.5	2.2	1.8	31.2	3.0	1.4	3.8	2.5	9.8	5.9	3.0	9.7	17.0	10.6	7.8	13.9	11.2	9.2	5.5	17.2	6.4	0.4	12.4	8.5	16.3	6.5	15.3	5.2	21.0	10.6	11.4	10.6	15.4	14.1	6.7	7.0	11.8	5.2	20.9	7.1	3.9	12.5	9.2	7.5	3.4	6.9	5.9	5.5	22.0	10.7	12.5	12.3	5.4	3.0	12.2	3.0	10.9	8.8	24.5	5.7	8.1	13.0	30.1	3.7	27.6	33.2	10.5	13.0	6.9	29.2	12.8	11.2	3.6	3.0	9.7	3.6	1.2	3.3	2.2	3.4	3.6	1.8	1.4	2.9	2.7	31.2	1.4	1.1	1.7	3.8	2.5	8.7	16.1	7.3	12.7	8.6	7.3	31.2	5.4	14.0	22.4
KLHL22	"FLJ14360, KELCHL"	ENSG00000099910	"Kelch like family member 22"	Q53GT1	22	20441519-20495883	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040766			Supported	"Golgi apparatus,Microtubules,Cytokinetic bridge,Mitotic spindle"				"Golgi apparatus, Mitotic spindle"	"Microtubules, Cytokinetic bridge"	"HPA040766: "	"unprognostic (4.15e-1)"	"unprognostic (9.34e-3)"	"unprognostic (5.37e-2)"	"prognostic favourable (4.88e-6)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.99e-2)"	"prognostic favourable (3.85e-6)"	"unprognostic (3.94e-2)"	"prognostic favourable (1.34e-8)"	"unprognostic (3.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.08e-2)"	10.8	12.4	15.2	11.2	17.8	8.6	9.6	26.9	24.0	15.4	10.7	11.8	13.1	6.5	17.8	15.7	8.5	15.1	15.9	11.2	14.2	14.9	13.7	9.0	11.1	13.1	11.5	16.3	19.8	16.3	20.7	14.7	13.2	10.9	16.6	9.2	17.0	11.3	16.2	16.3	9.9	8.0	19.0	7.8	12.5	9.9	8.3	9.6	5.0	18.5	6.8	17.1	11.1	12.3	7.1	12.9	15.1	6.6	13.7	16.0	5.1	8.9	8.8	19.8	16.5	16.9	19.5	4.9	11.4	18.9	11.7	12.9	4.5	3.4	5.9	3.8	20.1	11.5	13.7	5.1	10.5	12.1	7.4	5.6	8.6	4.5	15.6	1.4	6.6	15.1	7.7	10.1	7.1	16.3	16.4	6.3	11.3	14.0	1.2	8.3	3.5	6.3	12.3	7.3	0.3	6.8	10.9	10.7	11.1	11.8	9.2	8.3	8.1	5.0	7.2	14.2	6.8	9.5	4.8	3.6	3.6	4.4	7.5	5.5	9.2	5.4	3.6	15.1	7.3	5.1	5.7	7.1	9.3	6.6	12.9	6.1	7.3	7.3	8.7	13.7	6.6	4.9	16.0	5.1	15.2	17.8	26.9	24.0	14.2	14.9	11.5	16.3	10.9	9.6
KLHL4	"DKELCHL, KHL4, KIAA1687"	ENSG00000102271	"Kelch like family member 4"	Q9C0H6	X	87517749-87670050	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 34.4;brain: 16.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HHSteC: 8.2;HUVEC TERT2: 20.6;NTERA-2: 15.6;RH-30: 8.4;TIME: 22.6"	"Cancer enriched"	"Detected in some"	8	"glioma: 9.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029192	Approved		Supported	"Microtubules,Centriolar satellite"				Microtubules	"Centriolar satellite"	"HPA029192: AB_10602341"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (8.08e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.25e-4)"	2.3	34.4	6.8	1.0	12.1	0.5	1.9	1.1	11.2	2.4	1.0	16.3	0.9	0.7	4.8	1.4	1.3	3.7	2.5	1.5	7.0	4.0	2.1	1.4	1.8	1.0	15.9	7.4	11.7	0.9	0.6	0.6	0.6	11.9	1.1	1.1	0.0	0.5	2.8	0.8	0.6	0.9	8.0	12.7	2.4	0.9	9.7	16.2	0.0	1.4	0.2	0.7	1.9	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.2	0.0	2.9	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.2	0.0	2.0	0.0	8.2	0.1	0.0	1.3	3.9	4.2	1.0	20.6	0.1	1.7	5.6	0.0	0.0	0.0	15.6	4.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	22.6	0.0	4.8	0.0	0.3	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.2	6.8	12.1	1.1	11.2	7.0	4.0	15.9	7.4	11.9	16.2
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526262	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"skeletal muscle: 564.4;tongue: 157.3"	"Group enriched"	"Detected in some"	9	"HSkMC: 12.5;LHCN-M2: 19.8;RH-30: 31.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	12.0	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.1	0.1	17.8	9.8	0.2	0.6	10.2	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.5	0.1	0.0	3.9	0.1	0.0	6.6	0.1	564.4	0.2	0.1	2.3	0.2	0.1	0.2	0.5	0.0	0.0	2.0	157.3	5.0	2.1	0.1	0.2	0.5	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.1	0.0	12.5	0.2	0.1	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.1	0.0	31.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.0	0.0
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favourable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	7.5	14.6	9.2	5.6	13.0	8.2	10.3	12.6	15.1	8.8	5.7	7.9	4.7	5.9	9.1	9.9	7.7	7.4	7.6	37.1	8.1	8.7	9.2	7.7	6.4	5.8	8.3	9.7	9.6	5.9	7.1	6.1	6.5	15.9	8.1	6.3	8.6	7.2	6.8	7.4	8.6	5.8	8.1	10.6	5.8	5.2	40.7	6.2	9.6	7.2	5.1	6.7	6.9	7.1	5.5	5.5	32.0	8.7	4.2	8.0	6.0	10.8	9.3	25.7	30.3	12.6	11.0	9.4	9.6	14.3	14.2	16.6	11.3	7.9	10.7	7.8	11.7	11.8	9.8	6.8	12.0	2.8	7.1	7.0	8.1	14.5	9.4	14.2	5.5	9.7	8.8	16.2	13.4	18.0	12.3	11.7	23.1	12.5	11.8	22.6	35.4	11.2	10.5	14.4	9.8	13.3	9.4	15.5	15.1	20.9	10.4	9.8	8.6	7.5	7.7	12.0	12.5	26.3	11.4	18.5	15.0	25.5	7.9	15.1	14.3	18.7	7.8	32.0	6.8	8.7	7.1	4.5	7.3	6.4	5.5	5.5	5.5	5.4	7.4	4.2	7.5	4.0	8.0	6.0	9.2	13.0	12.6	15.1	8.1	8.7	8.3	9.7	15.9	6.2
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 56.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA013856: AB_1852594, HPA017762: "	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favourable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.8	7.3	6.9	5.6	8.1	3.0	12.0	10.0	10.7	9.2	7.5	5.3	3.8	7.3	8.3	56.2	5.3	5.4	5.0	7.4	7.7	7.2	11.4	10.3	9.0	8.1	6.3	5.6	6.1	6.3	7.1	14.2	6.6	7.3	5.7	8.5	4.6	6.5	7.7	23.4	4.8	8.2	6.6	8.0	6.9	5.5	4.2	6.5	7.0	17.3	2.9	4.7	6.8	10.9	3.8	10.3	8.6	12.1	8.7	4.9	5.0	6.5	5.7	10.4	4.6	9.5	7.0	5.6	8.4	4.5	5.6	6.6	9.2	5.0	9.5	6.8	6.1	2.8	11.0	8.3	12.2	9.0	6.9	11.5	4.3	5.4	8.1	18.9	7.3	8.7	6.0	8.6	8.6	6.6	14.9	8.7	5.8	7.2	22.6	9.6	2.6	2.3	8.5	8.9	5.8	9.5	6.8	21.9	7.6	5.5	13.5	6.2	4.6	14.0	6.2	7.1	8.8	7.5	6.9	13.0	8.5	16.9	5.4	9.0	7.8	1.9	12.1	7.3	3.0	9.2	4.9	3.3	2.4	2.5	10.3	3.8	4.4	4.3	8.6	8.7	9.0	2.7	0.9	5.0	6.9	8.1	10.0	10.7	7.7	7.2	6.3	5.6	7.3	6.5
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6;esophagus: 48.9"	"Group enriched"	"Detected in some"	14	"A-431: 68.4;CAPAN-2: 163.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 175.6"	"Group enriched"	"Detected in many"	8	"midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"		6800000	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavourable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavourable (1.27e-4)"	0.9	0.9	9.7	0.9	23.5	0.9	6.5	3.3	42.2	10.0	1.0	82.0	0.0	1.1	2.0	1.2	48.9	24.6	3.8	0.9	20.1	11.8	9.0	0.9	0.9	0.9	46.1	14.9	0.9	0.9	0.9	0.2	0.9	44.3	1.0	0.9	0.0	5.9	2.8	0.9	2.9	0.9	1.0	97.6	5.1	1.0	1.5	32.6	0.0	0.9	15.7	28.1	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.1	163.7	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.1	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	23.5	3.3	23.1	20.1	11.8	46.1	14.9	44.3	32.6
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976482-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 29.1;skin 1: 77.5;tongue: 90.2"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.6;HaCaT: 25.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"		960000	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	2.1	0.3	5.4	0.3	4.3	0.4	5.6	0.5	11.3	5.4	0.3	0.0	0.0	0.5	0.7	0.3	29.1	7.8	3.3	0.2	4.8	0.5	2.6	0.2	1.6	0.3	0.3	3.5	1.0	0.2	0.2	0.1	0.5	4.2	0.3	0.2	0.0	7.4	0.3	0.6	77.5	0.3	0.4	0.3	0.5	0.4	0.3	0.0	0.0	0.4	90.2	15.3	0.2	9.0	1.1	0.4	1.3	0.8	2.1	1.0	0.6	2.6	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	6.6	0.0	1.0	0.0	25.9	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	1.3	0.8	0.4	0.4	0.4	0.7	0.6	0.6	0.4	0.4	1.1	1.0	0.9	0.9	2.1	0.4	0.4	0.7	0.6	5.4	4.3	0.5	11.3	4.8	0.5	0.3	3.5	4.2	0.0
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859161-87863437	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 6.3;skeletal muscle: 7.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA074502			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA074502: "	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.7	1.5	1.2	0.8	1.9	0.6	1.4	2.0	1.4	1.3	1.6			0.7	1.2	2.0	0.6	2.9	0.6	0.7	1.0	1.8	1.7	1.7	0.5	1.3	1.1		0.7	0.6	1.3	1.9	0.9		0.6	1.6		0.4	0.8	7.4	0.4	0.7	0.8	0.9	1.7	0.9	2.4			1.3		1.4	0.9	0.9	1.7	1.4	6.3	1.6	1.7	1.2	0.5	1.4	1.6	2.0	1.4	1.0	0.6	1.5	1.2	1.6	0.9	1.2	1.0	4.4	3.4	0.6	0.5	1.7	1.2	1.3	0.7	0.9	0.5	1.1	2.6	1.1	1.1	2.4	0.9	1.1	1.5	1.2	1.5	0.5	0.8	8.7	0.9	2.9	6.6	2.7	0.8	0.8	4.3	0.3	4.2	0.8	1.4	0.8	1.7	1.5	1.1	0.2	2.8	2.0	0.5	1.0	0.5	1.7	0.6	5.1	5.2	4.9	1.7	4.8	1.0	3.1	1.0	1.5	0.7	1.4	1.1	1.2	0.9	0.9	0.8	1.7	1.2	1.1	6.3	1.7	1.6	1.4	0.7	0.5										
KLRG1	"2F1, CLEC15A, MAFA, MAFA-L"	ENSG00000139187	"Killer cell lectin like receptor G1"	Q96E93	12	8950044-9010760	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 83.1"	"Group enriched"	"Detected in many"	5	"HEL: 23.0;HUVEC TERT2: 8.1;NTERA-2: 15.8;U-937: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 71.3;MAIT T-cell: 83.1"	"Lineage enriched"	"Detected in many"	28	"T-cells: 83.1"	"Low region specificity"	"Detected in some"							"HPA051403, HPA076494"	Approved		Enhanced	Vesicles				Vesicles		"HPA051403: , HPA076494: "	"unprognostic (1.54e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.86e-2)"	15.4	3.9	4.4	7.3	5.8	5.6	5.7	12.3	5.0	3.2	3.5	7.1	0.8	1.7	5.6	4.2	2.2	2.6	7.7	5.1	4.4	5.8	3.2	6.4	5.5	17.3	8.3	3.4	2.7	1.9	1.5	5.6	1.5	5.5	4.8	4.7	5.6	3.5	1.8	3.1	2.2	5.0	3.9	5.5	19.0	3.6	2.2	6.8	6.8	2.9	2.3	11.1	8.3	2.6	0.5	1.3	2.4	0.6	2.9	83.1	14.0	0.1	2.2	1.2	1.7	2.0	0.4	1.1	0.3	0.3	0.2	0.7	0.7	0.7	3.1	0.1	0.3	0.2	2.8	0.3	0.3	2.2	1.4	23.0	0.3	1.2	0.5	0.7	1.2	1.4	0.3	0.3	0.0	8.1	1.0	0.3	0.1	0.5	0.5	1.6	15.8	1.5	0.9	0.7	0.0	0.3	0.3	0.3	3.1	0.7	0.4	0.9	0.2	1.0	0.5	0.5	0.7	0.4	1.0	1.0	2.7	1.7	1.4	14.5	0.2	2.4	0.3	0.2	71.3	0.4	83.1	0.5	15.8	43.4	1.3	0.5	4.3	29.9	0.9	2.9	0.6	0.5	1.2	14.0	4.4	5.8	12.3	5.0	4.4	5.8	8.3	3.4	5.5	6.8
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.8;lymphoid tissue: 30.7"	"Cell line enriched"	"Detected in some"	8	"U-698: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	39	"gdT-cell: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8"	"Group enriched"	"Detected in many"	47	"NK-cells: 50.8;T-cells: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"			33000	"Plasma membrane"		"CAB021896: , HPA068877: "	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	4.1	0.9	1.3	18.3	1.1	10.6	2.1	0.4	0.8	2.8	4.5	1.2	0.6	2.0	2.4	2.7	3.1	2.0	7.7	1.3	1.3	1.1	2.4	3.6	13.6	22.2	2.1	0.1	1.5	3.3	0.0	1.2	1.6	1.2	2.2	2.1	2.4	7.0	0.6	0.5	1.1	13.1	1.3	2.1	30.7	3.3	1.9	0.6	6.0	2.9	2.8	11.4	11.3	2.5	1.0	0.2	0.8	0.1	50.8	49.4	16.7	0.2	0.0	0.4	1.8	0.1	4.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	36.0	0.1	0.0	0.2	0.0	0.0	0.0	49.4	0.1	18.5	0.8	0.3	44.0	0.1	1.0	0.4	44.3	0.8	50.8	0.1	0.2	0.1	16.7	1.3	1.1	0.4	0.8	1.3	1.1	2.1	0.1	1.2	0.6
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: "	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	11.9	5.5	14.9	11.2	9.1	10.9	4.4	5.4	7.8	5.7	6.6	11.1	8.7	14.7	11.1	7.9	10.4	15.8	5.9	11.3	16.2	6.1	28.8	5.1	6.0	5.1	17.2	5.6	5.2	6.1	12.4	16.7	8.8	18.7	12.6	7.1	9.3	11.4	10.1	9.0	8.2	8.7	14.3	4.9	8.4	9.0	12.3	8.0	13.5	4.4	2.8	7.6	5.8	13.0	9.8	8.8	7.1	9.6	3.7	2.8	9.9	3.7	12.7	5.8	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm				Nucleoplasm		"HPA063648: "	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (9.30e-4)"	17.6	19.1	20.9	23.4	22.5	23.7	27.3	38.8	26.7	22.4	21.2	19.9	32.3	21.8	26.2	22.7	19.7	20.4	18.2	15.1	23.8	15.3	19.1	21.5	17.4	16.9	18.6	22.2	27.4	24.0	27.4	28.1	26.6	17.0	24.9	21.5	15.4	25.2	30.4	18.8	20.8	24.0	23.4	18.4	19.6	19.7	19.1	23.6	38.0	30.9	17.5	19.1	20.5	22.5	4.5	5.5	16.0	5.2	8.9	5.9	2.7	10.1	7.7	15.8	10.2	3.7	9.3	17.1	7.3	5.1	9.1	5.4	24.2	16.3	8.3	12.8	10.0	5.4	10.9	8.5	13.5	9.3	6.3	7.9	9.1	10.0	13.4	11.0	10.9	9.1	17.6	11.0	11.6	9.0	11.6	9.7	7.8	21.0	7.7	11.6	16.9	5.8	12.9	12.3	22.3	6.8	9.9	13.8	16.5	11.3	11.5	51.5	14.6	7.3	9.5	12.4	16.5	9.5	7.4	12.5	5.4	17.6	7.8	7.0	13.2	7.8	3.7	16.0	4.7	5.2	3.3	3.4	5.1	5.7	3.6	4.5	5.9	5.2	11.3	8.9	4.8	5.5	4.0	2.7	20.9	22.5	38.8	26.7	23.8	15.3	18.6	22.2	17.0	23.6
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"lymphoid tissue: 54.7;testis: 35.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: "	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.7	0.5	0.3	7.1	0.4	5.4	0.7	0.3	0.3	0.6	4.0	0.1	0.0	1.5	0.4	0.8	3.9	0.4	0.9	0.5	0.4	0.4	0.9	1.0	1.3	4.7	0.3	0.0	0.5	0.5	0.0	0.4	2.8	0.1	0.5	1.5	0.0	0.8	0.0	0.4	0.8	3.9	0.5	0.4	3.3	0.8	35.6	0.0	54.7	0.5	4.1	3.7	0.7	0.9	2.9	1.2	0.7	0.5	0.7	2.5	0.0	10.8	5.6	11.4	8.2	0.3	1.7	5.1	12.7	5.1	10.0	8.4	6.8	4.4	7.2	4.0	5.5	13.6	10.8	5.9	10.6	12.5	2.9	21.2	9.6	2.0	0.0	16.2	10.7	0.3	0.2	6.7	4.2	8.5	13.5	12.1	11.6	3.7	13.8	3.2	5.6	5.9	12.6	16.3	3.6	1.5	9.6	9.9	4.6	11.0	6.2	1.3	6.7	4.9	7.8	11.6	10.3	13.3	7.0	4.6	15.8	14.1	4.7	11.0	11.0	0.4	0.2	0.1	0.1	0.1	0.0	2.9	1.1	0.1	1.2	2.2	0.0	0.7	0.7	0.7	0.5	0.1	2.5	0.0	0.3	0.4	0.3	0.3	0.4	0.4	0.3	0.0	0.1	0.0
KNOP1	"101F10.1, C16orf88, FAM191A, TSG118"	ENSG00000103550	"Lysine rich nucleolar protein 1"	Q1ED39	16	19701934-19718235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041079, HPA066169"	Uncertain		Enhanced	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041079: AB_10962350, HPA066169: "	"unprognostic (6.55e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (3.75e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	6.9	7.1	13.9	7.6	34.7	3.9	13.8	11.1	23.7	7.1	9.5	20.9	8.5	8.2	8.5	10.9	10.1	8.1	7.3	6.9	17.0	10.5	6.2	7.6	5.5	9.4	33.1	9.1	12.8	19.6	17.2	6.4	10.3	18.1	8.1	11.1	4.9	13.9	9.8	15.2	15.0	8.2	5.8	21.2	6.4	9.3	10.0	33.2	4.9	7.3	5.8	7.5	8.4	7.7	7.0	5.2	1.6	8.0	4.5	12.8	4.4	12.2	18.9	21.1	15.9	5.2	4.9	10.8	7.6	4.2	7.3	7.4	13.3	10.7	14.6	31.1	4.6	11.4	16.3	10.4	7.1	9.8	11.4	8.6	10.7	17.4	9.5	13.4	6.8	3.1	14.9	9.5	7.9	7.7	26.4	6.6	6.8	16.0	11.9	11.2	40.9	7.5	25.6	11.3	17.0	7.7	11.7	18.9	16.0	9.5	12.2	12.4	14.2	9.2	8.8	11.4	11.8	7.0	10.0	9.8	20.1	18.4	6.2	10.4	11.1	0.4	3.5	1.6	4.8	8.0	7.2	6.6	6.9	4.8	4.2	7.0	12.8	7.2	1.0	4.5	7.0	5.2	4.4	4.4	13.9	34.7	11.1	23.7	17.0	10.5	33.1	9.1	18.1	33.2
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin/SPAG5 binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"				"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavourable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	5.5	4.4	6.7	5.5	6.3	7.3	9.0	8.1	7.0	3.3	4.5	4.0	8.0	5.3	3.9	7.8	6.2	3.4	2.5	4.1	6.0	5.3	4.2	7.0	4.1	8.0	4.6	7.1	3.4	3.5	6.0	4.2	7.4	6.8	4.4	6.3	2.5	6.4	5.0	7.5	4.2	4.1	5.9	4.3	4.8	6.2	40.1	4.5	18.4	59.8	6.0	9.1	3.8	3.7	5.9	11.0	10.0	26.2	5.5	5.5	4.0	31.1	14.7	29.3	19.2	6.5	10.1	15.3	21.7	16.9	44.8	39.6	31.4	13.8	12.1	11.1	14.5	36.1	31.2	20.1	40.6	21.4	15.2	35.8	33.0	19.8	6.1	19.2	18.7	5.2	11.6	22.6	22.6	25.1	25.8	21.0	37.6	15.8	16.6	15.5	18.4	22.3	17.1	22.1	14.0	15.6	13.0	28.6	19.9	18.1	19.9	4.8	20.9	13.8	12.8	21.6	22.2	22.0	29.9	18.0	29.1	21.7	13.4	25.7	17.6	4.8	10.3	10.0	4.8	14.5	4.4	5.9	3.6	4.4	11.0	5.4	3.5	3.6	5.9	5.5	26.2	7.5	5.5	4.0	6.7	6.3	8.1	7.0	6.0	5.3	4.6	7.1	6.8	4.5
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favourable (8.69e-4)"	"prognostic unfavourable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	5.6	5.6	4.5	15.3	5.4	28.9	5.8	7.5	5.6	5.2	6.4	2.7	3.9	7.0	5.4	5.5	9.6	4.9	2.9	2.9	4.6	1.8	4.9	4.5	5.8	11.8	4.0	3.8	6.7	4.9	3.5	5.9	8.1	3.6	5.3	9.7	3.9	6.1	2.8	1.6	11.7	10.9	7.7	3.1	14.1	5.5	23.2	2.8	39.6	4.0	7.0	15.6	4.4	6.6	4.8	2.1	5.0	2.6	2.2	3.6	0.8	13.0	10.9	31.5	7.2	2.5	4.5	14.2	12.1	7.9	12.0	11.4	10.3	11.0	15.6	6.3	5.8	18.0	13.6	7.6	16.0	11.1	9.4	19.2	20.4	10.5	0.8	18.9	13.3	2.4	1.7	12.4	8.3	8.1	19.2	11.8	9.0	9.7	15.6	43.8	15.9	13.8	21.4	15.3	17.3	7.2	14.0	9.8	12.6	22.0	4.7	6.5	17.8	10.9	5.9	13.8	13.2	13.4	14.1	15.9	16.0	24.1	8.2	12.3	15.7	5.0	1.4	4.6	2.0	1.9	1.8	4.8	3.3	3.6	1.3	3.0	2.5	2.9	4.4	2.2	2.6	2.1	1.4	0.8	4.5	5.4	7.5	5.6	4.6	1.8	4.0	3.8	3.6	2.8
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421949-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053627: , HPA063426: "	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	15.4	16.9	15.1	14.4	15.5	7.6	17.8	14.6	19.3	11.8	13.6	12.0	9.0	9.9	14.4	12.3	17.2	10.8	9.6	18.7	13.9	11.6	13.1	24.6	12.5	11.2	14.4	16.8	10.8	14.5	19.6	13.8	13.6	16.5	12.3	12.3	8.6	13.2	15.1	89.4	13.1	11.3	17.7	15.8	10.9	12.3	15.2	13.5	12.4	14.1	10.9	15.3	14.5	13.6	11.4	17.3	29.3	18.2	13.5	13.9	10.9	29.5	17.6	30.3	15.3	19.7	21.9	9.6	22.9	19.4	25.1	22.8	21.2	14.5	21.6	21.2	25.1	15.6	23.7	19.5	37.2	5.8	9.0	26.5	15.8	11.7	11.6	23.4	12.3	15.1	25.5	18.1	25.5	27.5	18.5	12.5	22.8	13.9	17.0	5.6	13.1	18.9	17.5	25.2	13.8	11.0	20.9	20.9	12.6	24.6	13.4	20.0	17.8	13.9	23.4	15.8	17.4	7.7	17.6	12.1	12.1	40.2	22.1	16.5	16.0	15.7	13.1	12.5	12.6	13.4	13.5	11.4	11.2	13.9	17.3	8.8	11.6	11.8	29.3	13.5	18.2	5.5	11.8	10.9	15.1	15.5	14.6	16.7	13.9	11.6	14.4	16.8	16.5	13.5
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035519-68046842	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol			38000	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: "	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavourable (2.12e-10)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (2.19e-4)"	10.6	8.3	10.2	19.5	12.0	38.6	11.9	6.1	13.2	7.4	11.5	6.6	4.3	10.1	8.3	10.4	21.1	6.3	7.9	8.9	11.6	13.2	10.9	11.8	9.1	25.5	10.3	10.3	5.3	4.7	4.5	8.4	16.4	11.4	4.6	14.5	4.0	8.2	4.7	7.2	8.7	10.2	13.2	8.5	14.8	9.7	103.9	9.0	56.6	5.9	20.3	36.8	10.0	8.3	24.6	28.1	16.4	22.6	20.3	17.7	15.0	61.9	81.5	77.8	31.2	11.5	11.2	49.4	54.7	42.5	88.4	69.0	56.0	29.0	58.2	17.3	31.5	34.4	86.0	42.7	101.8	23.4	50.7	51.5	39.3	53.4	12.2	44.3	35.5	6.9	8.1	50.8	31.4	85.0	40.9	42.1	78.4	57.8	55.2	28.5	52.5	42.3	30.5	71.0	31.9	34.9	29.1	30.9	34.4	30.7	99.2	32.1	57.8	22.3	33.1	49.1	60.6	34.5	73.5	35.0	49.9	58.1	23.9	38.1	52.6	16.4	16.1	6.6	14.1	22.6	10.9	24.6	10.3	14.4	28.1	19.7	7.9	12.3	1.2	20.3	18.9	21.4	17.7	15.0	10.2	12.0	6.1	13.2	11.6	13.2	10.3	10.3	11.4	9.0
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160494995-160565588	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm			250000	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	18.0	9.4	12.6	12.9	12.7	15.2	25.1	13.1	14.1	14.8	14.4	8.6	11.1	7.3	13.1	10.8	22.1	8.9	13.9	45.0	12.0	12.1	11.0	12.6	11.4	12.4	11.6	10.8	15.0	10.7	12.5	6.9	17.5	11.1	11.0	9.7	7.1	10.9	13.1	66.1	10.6	9.5	20.4	10.4	12.1	10.8	13.5	6.3	13.8	11.4	22.2	10.2	21.8	25.2	2.9	2.9	6.8	11.5	8.3	5.6	3.2	33.5	11.8	12.2	16.6	14.2	13.1	16.1	20.9	14.9	15.3	13.1	15.1	17.6	17.8	25.0	21.3	15.7	13.7	13.5	23.1	22.0	7.7	15.0	10.6	9.0	18.4	21.0	13.5	13.3	14.3	14.9	30.3	20.2	11.3	14.5	21.7	9.4	18.9	8.7	24.9	11.1	12.6	18.3	18.0	12.3	12.9	10.0	9.7	20.2	20.3	29.0	17.6	11.5	22.5	17.6	15.1	17.5	33.5	26.5	17.5	40.8	16.1	22.0	15.5	6.8	3.6	6.0	3.1	6.7	5.6	2.9	4.5	4.5	2.7	2.5	3.6	4.7	5.4	8.3	11.5	2.9	4.2	3.2	12.6	12.7	13.1	13.3	12.0	12.1	11.6	10.8	11.1	6.3
KPNA5	"IPOA6, SRP6"	ENSG00000196911	"Karyopherin subunit alpha 5"	O15131	6	116681187-116741866	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026464, HPA054037"	Enhanced		Supported	Cytosol				Cytosol		"CAB026464: , HPA054037: "	"unprognostic (9.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.56e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.98e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.43e-1)"	5.7	6.5	11.9	5.9	12.8	7.5	7.6	24.1	21.2	8.6	6.0	4.3	3.4	4.0	11.2	5.3	6.1	9.8	6.5	5.8	11.0	8.1	6.6	3.6	7.2	10.7	9.0	13.5	22.3	4.4	9.5	19.7	5.6	14.1	8.4	4.5	5.7	4.7	7.1	14.0	4.7	5.6	8.5	12.0	7.4	4.8	46.6	8.2	10.9	12.2	3.9	7.3	6.4	7.4	18.0	10.5	11.9	4.0	6.3	16.6	2.9	2.5	1.5	10.9	6.7	4.1	7.8	4.5	3.8	10.5	6.7	9.4	7.0	2.6	9.1	4.9	4.0	4.2	5.8	3.4	8.6	5.7	15.6	8.8	4.6	4.0	5.2	6.7	5.5	6.9	2.1	8.1	4.8	7.5	12.8	4.0	7.3	3.4	10.4	4.6	4.8	4.0	8.6	3.6	2.5	5.1	5.0	11.4	10.9	2.9	2.3	3.6	4.6	6.7	5.9	2.8	5.6	2.9	6.5	10.3	11.2	10.6	3.1	4.8	5.8	11.9	3.1	3.7	8.8	3.2	10.9	14.9	10.0	10.3	1.6	18.0	16.6	12.1	0.8	6.3	4.0	10.5	7.3	2.9	11.9	12.8	24.1	21.2	11.0	8.1	9.0	13.5	14.1	8.2
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 28.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"			5500000	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: "	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavourable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	38.0	42.1	31.9	46.1	30.7	22.1	33.3	32.9	33.5	37.6	37.9	29.7	39.9	24.5	39.3	35.4	51.2	33.1	35.0	43.5	28.1	30.5	33.8	48.8	35.8	50.5	31.6	35.3	47.2	32.3	42.3	29.4	34.6	34.9	36.1	39.3	23.7	35.2	45.9	74.6	31.7	32.1	40.7	36.6	50.3	35.7	62.4	34.8	47.6	37.0	34.3	62.8	50.8	47.5	5.4	4.0	28.2	3.9	3.7	6.3	2.8	43.2	73.6	46.9	42.6	22.7	39.5	47.1	51.5	46.2	67.6	53.1	128.4	25.7	55.7	35.2	48.0	30.6	84.6	47.5	102.7	34.2	51.6	61.6	59.4	40.2	23.4	69.6	40.6	32.0	21.0	77.6	76.0	44.5	69.6	38.2	52.2	47.0	64.6	20.9	44.6	46.6	40.0	82.9	32.4	27.7	61.9	41.2	38.3	35.2	18.9	29.8	41.0	26.9	37.0	73.9	45.9	38.4	62.4	46.7	54.0	79.9	31.5	33.7	54.1	4.3	3.5	7.1	4.9	3.6	6.3	5.4	5.5	5.5	2.1	5.1	5.2	4.9	28.2	3.7	3.9	4.0	4.0	2.8	31.9	30.7	32.9	33.3	28.1	30.5	31.6	35.3	34.9	34.8
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553078-10566037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA043110: , HPA043574: "	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	14.7	12.5	10.4	23.6	20.6	19.1	14.3	27.8	19.6	14.5	13.4	16.6	12.4	12.7	15.9	17.6	17.2	14.3	15.0	12.1	13.1	10.3	11.9	13.3	12.4	25.2	16.7	9.8	17.2	19.5	21.0	18.3	10.9	14.9	15.6	9.8	20.3	14.7	18.2	23.0	25.3	16.8	15.0	17.2	23.0	12.7	14.6	18.6	46.8	15.6	10.9	21.3	15.8	15.9	8.5	14.1	2.5	4.9	8.5	11.2	3.9	12.0	6.2	8.0	11.5	4.3	4.8	5.5	11.2	5.3	7.1	6.6	8.9	4.4	17.9	13.3	4.5	9.5	9.7	8.8	8.0	19.4	22.1	56.7	12.0	5.8	7.9	22.2	20.6	5.8	7.2	10.2	10.5	4.5	15.8	18.2	6.1	10.8	22.8	33.0	12.7	14.9	9.6	10.4	8.8	6.0	10.7	13.1	6.1	13.2	7.8	8.2	9.7	16.3	5.4	9.2	7.8	24.8	23.3	13.0	15.0	12.9	7.7	18.0	13.7	1.3	4.5	2.5	11.2	4.9	10.3	7.1	7.5	9.0	5.8	8.5	8.4	9.0	0.8	8.5	2.5	14.1	5.4	3.9	10.4	20.6	27.8	19.6	13.1	10.3	16.7	9.8	14.9	18.6
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1, small subunit processome component homolog"	Q13601	12	75490861-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA043433: AB_10960988, HPA051690: "	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	22.5	18.4	14.2	15.1	22.0	38.0	17.8	29.1	23.3	21.2	14.3	6.7	14.6	12.6	18.3	15.2	24.2	14.7	10.5	12.5	12.6	10.8	23.7	25.0	13.5	18.2	12.8	16.4	21.7	15.0	17.8	33.5	21.4	19.8	20.9	11.8	6.3	20.7	14.2	28.8	16.6	15.2	15.7	16.1	19.8	15.1	12.3	17.3	24.3	20.5	22.4	18.1	19.6	16.4	15.8	10.8	8.9	4.6	8.6	14.7	5.6	25.0	20.8	13.1	11.7	10.3	9.4	24.0	22.0	14.0	17.3	11.2	15.2	13.2	26.7	17.9	10.9	13.2	17.5	19.3	19.6	22.0	17.8	25.8	11.5	17.6	12.5	45.4	16.4	9.8	16.5	19.9	19.1	11.8	28.5	8.6	17.0	16.5	26.4	12.9	19.3	19.0	21.0	25.2	16.0	19.3	31.7	15.7	13.1	20.8	14.7	25.9	24.6	18.5	14.7	16.0	10.7	16.6	22.7	17.1	21.5	16.8	8.7	16.1	28.9	7.7	2.4	8.9	10.1	4.6	12.4	15.8	14.1	11.4	3.9	14.4	14.7	13.8	1.1	8.6	3.7	10.8	12.5	5.6	14.2	22.0	29.1	23.3	12.6	10.8	12.8	16.4	19.8	17.3
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8"	"Group enriched"	"Detected in some"	100	"A-431: 211.8;HaCaT: 141.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"			1100000000	"Intermediate filaments"		"CAB000133: , HPA030877: , HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	0.3	0.3	0.0	0.3	0.0	0.5	0.3	0.0	0.3	250.9	0.3	0.0	0.0	0.3	13.7	0.3	1075.6	0.3	0.6	0.5	0.0	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	2.4	0.3	0.1	134.9	0.4	0.4	0.3	0.3	1.7	0.0	0.3	0.3	0.4	0.0	0.6	0.3	499.8	404.8	14.9	222.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	211.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	141.5	0.0	0.0	0.0	0.1	0.0	0.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.7	0.2	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586921	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 439.2;tongue: 363.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 259.8;HBEC3-KT: 128.1;hTCEpi: 160.3;hTERT-HME1: 52.4;U-2197: 45.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 1263.1;head and neck cancer: 5910.5;melanoma: 1277.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"			2200000000	"Intermediate filaments"		"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favourable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	0.2	0.1	0.2	0.2	0.2	0.2	23.1	0.2	0.2	27.0	0.2	0.2	0.2	0.1	0.3	0.2	69.3	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	7.6	0.2	2.1	0.1	0.2	30.8	0.3	1.0	439.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	4.6	0.2	363.5	47.6	0.2	37.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	259.8	0.0	128.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	160.3	0.1	52.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	45.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513743-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6"	"Group enriched"	"Detected in some"	10	"HaCaT: 120.2;hTCEpi: 92.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"			580000000	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favourable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	0.6	0.0	1.4	0.6	1.5	0.0	37.4	0.6	1.1	14.6	1.1	0.6	0.6	0.0	0.6	0.6	115.3	2.7	10.6	0.6	1.3	0.0	1.1	0.6	2.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	3.0	1.1	16.4	0.0	1.4	15.1	0.6	0.6	119.3	3.5	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	1.9	6.2	0.8	38.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.6	2.1	0.0	0.2	0.0	120.2	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.4	0.0	92.9	0.2	0.7	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	10.2	0.3	0.7	0.2	0.0	0.1	1.7	0.1	2.3	0.0	2.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	1.5	0.6	1.1	1.3	0.0	0.6	0.6	1.1	0.6
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619437-41624842	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 109.0;tongue: 144.0"	"Group enriched"	"Detected in some"	7	"hTCEpi: 638.7;SiHa: 265.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"			750000000	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: "	"prognostic favourable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	0.7	0.0	0.7	0.7	0.7	0.1	52.3	0.7	0.8	12.6	0.8	0.7	1.2	0.0	1.0	3.1	38.6	0.9	0.9	0.7	0.7	0.0	0.8	0.7	3.7	0.7	0.7	1.0	0.8	0.7	0.0	0.9	4.1	0.8	15.0	0.0	0.7	26.8	33.4	0.7	109.0	0.7	1.2	0.7	0.7	0.0	0.8	0.7	5.1	0.8	144.0	19.7	55.6	25.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	6.4	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	64.6	0.0	66.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	638.7	0.0	49.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.2	0.0	0.0	265.9	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.7	0.7	0.8	0.7	0.0	0.7	1.0	0.8	0.7
KRT18		ENSG00000111057	"Keratin 18"	P05783	12	52948871-52952901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 268.7"	"Cell line enhanced"	"Detected in many"		"A549: 225.8;BEWO: 142.5;CACO-2: 248.3;CAPAN-2: 180.4;MCF7: 330.6;SK-BR-3: 182.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 10.0"	"Cell type enriched"	"Detected in many"	5	"basophil: 28.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000008, CAB000030, HPA001605"	Enhanced		Supported	Cytosol			140000000	Cytosol		"CAB000008: , CAB000030: , HPA001605: "	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.26e-3)"	"unprognostic (4.09e-3)"	"prognostic unfavourable (5.06e-4)"	"unprognostic (8.81e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	23.3	4.8	1.0	31.0	1.1	0.0	24.1	2.9	1.2	28.6	45.4	1.3	66.3	35.0	6.6	55.3	22.4	21.7	147.4	6.8	1.1	2.5	61.9	181.0	39.6	2.8	1.2	1.0	13.7	162.9	8.2	39.8	268.7	10.0	29.3	57.0	14.1	121.1	49.9	1.3	6.5	83.6	3.9	1.4	4.4	36.0	9.5	0.8	4.2	83.4	10.8	20.9	21.5	10.8	4.1	1.0	28.6	0.1	1.0	5.9	1.6	75.7	225.8	0.0	0.3	0.0	0.0	142.5	11.5	14.0	14.9	4.2	248.3	180.4	0.0	32.1	12.5	18.5	3.1	87.6	9.0	0.0	5.3	0.7	36.9	68.3	38.6	0.0	0.0	0.5	8.2	13.0	18.0	15.9	18.2	0.0	0.0	330.6	0.1	1.3	18.4	17.1	0.1	0.0	8.6	72.7	45.7	2.6	0.1	18.7	182.8	0.7	96.5	0.2	5.0	0.2	17.4	0.2	2.5	0.0	0.2	0.1	0.0	0.0	1.4	28.6	0.1	1.1	0.2	0.1	1.1	2.1	2.3	0.6	1.0	4.1	5.9	2.1	1.5	1.0	0.0	0.0	0.2	1.6	1.0	1.1	2.9	1.2	1.1	2.5	1.2	1.0	10.0	0.8
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 205.3;intestine: 184.9;placenta: 179.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 100.7;HBEC3-KT: 151.7;MCF7: 111.9;RT4: 161.1;SK-BR-3: 284.6;T-47d: 191.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.7"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"			330000000	"Intermediate filaments"		"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	9.8	1.6	0.7	22.8	0.9	0.0	50.1	2.9	0.8	37.4	126.7	1.0	38.0	37.8	9.9	53.0	102.1	19.5	205.3	2.3	0.8	0.2	35.0	2.1	50.6	0.7	0.8	0.8	16.7	7.5	1.2	2.6	179.4	1.3	39.2	40.1	1.8	103.0	46.3	0.7	15.8	184.9	11.7	0.6	0.6	69.1	6.4	0.7	33.3	4.9	21.2	89.2	77.0	35.4	0.0	0.0	0.0	0.0	2.7	0.6	0.2	0.1	17.6	0.0	0.3	0.0	0.0	61.6	21.2	0.0	0.6	0.1	50.6	100.7	0.0	20.8	10.1	53.9	0.0	151.7	0.1	0.0	0.5	0.0	11.4	34.6	1.6	0.0	4.3	0.0	27.6	0.4	0.0	1.3	7.3	0.1	0.0	111.9	0.2	0.1	0.9	25.6	0.1	0.0	0.3	69.5	161.1	2.1	0.0	0.1	284.6	0.0	191.7	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.7	0.9	2.9	0.8	0.8	0.2	0.8	0.8	1.3	0.7
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875941-40885227	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 232.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.3;BEWO: 2.6;NB-4: 2.3;RPMI-8226: 2.8;RT4: 7.2;SH-SY5Y: 2.2"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.7"	"Low region specificity"	"Detected in all"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol			34000000	Cytosol		"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	0.2	0.1	0.2	38.0	0.2	0.0	0.2	0.2	0.2	0.2	75.5	0.2	0.2	40.4	0.2	0.2	0.3	0.3	3.9	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.3	45.0	0.2	0.3	0.2	0.2	0.2	232.0	2.7	0.2	0.2	13.6	0.2	0.2	0.2	0.2	0.3	0.2	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	2.8	0.0	7.2	0.4	2.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814551	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 637.8;lymphoid tissue: 403.6;tongue: 174.6"	"Group enriched"	"Detected in some"	30	"HaCaT: 94.2;SK-BR-3: 38.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"			540000000	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: "	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (6.26e-4)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	25.5	0.1	0.0	0.0	0.1	2.5	0.1	637.8	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	48.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	174.6	403.6	0.2	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487174-52493257	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Allergen, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1"	"Cell line enriched"	"Detected in some"	4	"hTCEpi: 459.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"			7200000000	"Intermediate filaments"		"HPA045697: , HPA061168: "	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavourable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	0.2	0.2	0.0	0.4	0.0	0.2	0.8	0.0	0.3	209.2	0.2	0.0	0.0	0.2	6.8	0.2	422.1	0.3	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	19.8	0.0	0.3	0.2	0.0	37.6	0.2	0.2	19.0	0.2	0.3	0.0	0.2	0.2	0.2	0.0	2.7	0.2	620.2	86.8	0.5	179.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.7	0.0	111.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	459.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 117.7;HBEC3-KT: 262.1;RT4: 312.5;SiHa: 246.4;SK-BR-3: 143.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315"	Enhanced		Supported	"Intermediate filaments"			350000000	"Intermediate filaments"		"CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (9.42e-5)"	"prognostic unfavourable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favourable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	3.5	0.2	0.2	0.6	0.2	0.0	43.1	0.2	0.2	7.8	0.5	0.1	18.0	0.0	1.7	9.6	14.4	11.7	27.1	1.2	0.2	0.2	35.0	4.3	63.2	0.0	0.2	0.2	3.3	15.1	1.7	2.1	156.6	0.6	23.1	0.0	0.1	142.6	67.3	0.4	10.7	0.3	4.3	0.3	0.2	2.3	4.3	0.0	0.4	199.7	6.1	16.3	58.2	22.3	0.0	0.8	0.0	3.8	0.0	0.0	0.2	0.1	99.7	0.0	0.0	0.1	0.0	117.7	21.4	0.0	11.2	1.0	0.3	71.2	0.0	0.0	7.3	78.5	0.0	262.1	0.5	0.1	0.0	0.0	53.5	0.3	2.5	0.0	0.0	0.0	16.3	0.0	105.7	11.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.2	1.5	64.7	312.5	0.1	0.1	246.4	143.9	0.0	5.5	0.0	85.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0
KRT8	"CARD2, CK8, CYK8, K2C8, K8, KO"	ENSG00000170421	"Keratin 8"	P05787	12	52897187-52949954	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 102.9"	"Cell line enhanced"	"Detected in many"		"A549: 224.1;BEWO: 150.2;CACO-2: 278.9;CAPAN-2: 176.2;MCF7: 376.4;SK-BR-3: 191.3;T-47d: 160.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 13.7"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.9;granulocytes: 3.2;NK-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000131, CAB001696, HPA049866"	Enhanced		Supported	"Intermediate filaments"			920000000	"Intermediate filaments"		"CAB000131: AB_2281144, CAB001696: , HPA049866: "	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (8.99e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.19e-2)"	13.4	4.8	2.0	11.0	1.5	0.0	13.9	2.7	1.3	15.1	90.2	2.1	29.8	87.2	11.1	18.3	19.3	10.4	20.3	17.6	1.1	0.2	28.8	55.8	20.1	18.4	1.4	1.2	10.6	75.9	4.0	31.8	28.9	13.7	25.2	45.0	12.1	36.9	46.0	3.7	5.0	102.9	5.2	3.3	14.3	61.8	5.1	1.2	2.9	27.6	9.2	11.6	27.1	10.5	0.7	4.9	3.2	0.7	1.6	0.6	0.5	99.5	224.1	0.0	0.2	0.0	0.1	150.2	0.4	1.7	0.2	0.2	278.9	176.2	0.0	42.6	0.5	34.8	0.6	27.6	0.2	0.1	4.8	0.1	46.7	79.7	8.1	0.0	0.0	0.3	0.4	0.5	1.9	0.6	17.1	0.0	0.0	376.4	0.2	0.3	15.6	4.9	0.1	0.0	0.5	44.4	49.4	4.8	0.1	39.0	191.3	0.3	160.9	0.3	0.6	0.2	16.9	0.3	0.3	0.0	0.2	0.2	0.1	0.0	0.4	3.2	0.5	0.6	0.6	0.7	0.4	0.3	0.4	0.3	2.1	0.7	0.4	0.5	1.4	1.6	0.3	4.9	0.5	0.5	2.0	1.5	2.7	1.3	1.1	0.2	1.4	1.2	13.7	1.2
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192000	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8"	"Cell line enhanced"	"Detected in many"		"A-431: 44.0;MCF7: 62.9;SK-BR-3: 29.1;U-2 OS: 40.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"Low region specificity"	"Detected in all"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"			290000000	"Intermediate filaments"		"HPA077836: , HPA077918: AB_2686871"	"prognostic unfavourable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.2	1.9	0.1	0.0	0.2	0.0	3.9	0.0	0.1	5.7	0.5	0.0	1.5	0.0	0.5	4.2	20.4	1.4	1.8	0.2	0.0	0.1	2.7	0.2	1.5	0.0	0.0	0.0	0.6	9.0	7.3	0.2	17.5	0.0	1.8	0.0	0.1	22.1	1.6	0.9	64.0	0.5	0.0	0.1	0.1	0.2	0.5	0.0	0.8	0.4	41.8	43.9	3.2	10.7	0.1	0.9	0.3	0.9	0.0	0.1	0.0	44.0	14.8	0.0	0.0	0.0	0.0	12.4	0.6	0.4	3.5	1.0	1.0	19.3	0.0	21.7	0.5	22.0	0.0	0.2	1.2	0.0	0.0	0.0	23.1	0.5	2.3	0.0	0.0	0.2	2.7	0.7	5.3	5.2	0.0	0.0	1.2	62.9	0.0	0.0	0.0	2.2	0.0	18.1	0.6	19.8	7.9	5.6	0.3	11.2	29.1	0.2	5.4	0.2	3.0	0.0	40.8	0.0	15.8	0.0	0.0	0.1	4.1	1.6	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
KTN1	"CG1, KIAA0004, KNT"	ENSG00000126777	"Kinectin 1"	Q86UP2	14	55559072-55701526	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003178, CAB015331, HPA017876"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652"	"unprognostic (7.00e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.83e-5)"	"prognostic unfavourable (3.76e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.72e-2)"	"prognostic favourable (1.01e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	26.5	27.5	30.8	18.9	37.3	9.5	44.2	30.8	35.2	22.7	28.8	15.8	23.4	13.0	18.8	30.8	26.1	16.8	18.1	36.1	32.2	25.3	33.1	31.8	21.2	16.9	39.3	24.5	23.1	22.8	48.3	54.7	21.3	49.5	26.9	28.7	13.1	21.4	24.0	101.9	41.4	20.1	40.5	51.9	22.1	18.9	40.9	42.0	14.5	33.3	37.9	17.9	32.7	39.7	35.6	58.3	27.0	15.5	19.6	24.0	4.8	40.2	27.9	20.9	22.7	28.8	27.6	30.3	32.9	26.5	20.7	18.4	18.6	50.2	31.1	47.1	33.8	75.5	25.5	28.7	35.0	52.2	14.0	22.0	46.2	35.2	27.3	32.2	17.8	25.7	26.3	25.5	44.3	33.9	21.4	18.2	39.7	31.5	27.6	19.1	16.1	41.6	22.0	54.9	14.8	51.9	63.4	25.7	21.5	52.2	24.0	28.9	24.9	20.6	47.8	42.3	54.3	21.7	30.9	8.3	11.1	23.2	49.5	18.9	23.4	27.0	14.8	14.6	19.6	13.1	18.7	28.3	23.2	22.1	14.2	35.6	24.0	20.6	9.4	19.6	15.5	58.3	14.8	4.8	30.8	37.3	30.8	35.2	32.2	25.3	39.3	24.5	49.5	42.0
KYAT1	"CCBL1, GTK, KATI"	ENSG00000171097	"Kynurenine aminotransferase 1"	Q16773	9	128832942-128882494	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021176, HPA021177, HPA027736"	Approved		Supported	Cytosol			21000	Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"	"unprognostic (6.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	4.4	5.2	12.2	5.1	18.9	3.9	7.0	17.8	17.6	4.7	3.8	14.2	5.5	4.1	5.5	5.4	4.6	8.5	4.8	13.5	12.1	9.3	8.1	12.0	4.1	7.3	18.4	12.1	7.1	5.0	8.9	8.1	4.5	12.2	8.9	2.7	5.8	7.0	8.4	17.0	12.2	4.8	5.8	10.2	5.8	4.0	6.9	17.2	3.7	7.5	2.8	7.4	8.1	8.1	12.1	7.6	3.5	5.1	4.6	9.6	4.9	4.0	9.3	8.5	8.4	7.7	9.7	4.4	5.6	6.4	5.5	8.3	5.1	7.6	7.8	2.8	4.2	13.2	12.6	10.9	7.1	8.7	8.8	5.1	22.5	9.2	6.9	4.9	2.2	4.2	6.9	7.2	6.9	9.7	7.8	6.9	7.2	2.6	11.3	3.3	14.9	7.2	13.5	7.3	14.5	7.6	1.7	9.0	7.7	8.9	2.2	5.1	5.4	1.9	6.4	4.2	7.2	6.2	4.9	12.7	10.7	9.6	8.0	7.6	3.4	0.1	3.1	3.3	7.8	2.2	6.2	12.1	8.1	8.1	7.6	5.8	8.6	9.6	3.5	4.6	5.1	4.8	8.7	4.9	12.2	18.9	17.8	17.6	12.1	9.3	18.4	12.1	12.2	17.2
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;HeLa: 44.8;Hep G2: 27.2;hTEC/SVTERT24-B: 23.5;SiHa: 22.2;U-87 MG: 70.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol			360000	Cytosol	Nucleoplasm	"HPA031686: "	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	40.1	0.1	0.1	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.7	0.5	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	44.8	27.2	0.5	0.1	0.2	3.9	3.2	23.5	0.1	0.0	0.1	0.2	0.3	20.5	0.0	2.4	0.1	0.1	0.0	0.2	0.1	0.6	20.7	0.1	0.0	22.2	3.3	0.2	11.1	5.7	0.3	1.3	0.1	19.6	0.0	0.1	0.0	0.0	70.2	4.6	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA065409: , HPA069708: "	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favourable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	5.4	5.1	6.9	3.6	8.4	3.5	5.1	12.7	10.9	3.5	5.6	4.9	4.8	6.2	3.4	4.3	9.0	4.4	3.2	7.7	6.1	4.7	25.5	16.0	2.5	3.3	7.7	4.7	4.2	5.4	7.1	5.8	2.6	5.7	4.6	6.8	7.7	5.0	5.6	17.7	7.0	5.0	4.7	5.3	2.3	5.6	6.0	6.0	3.7	6.5	6.2	5.2	4.6	4.4	1.4	1.5	10.5	0.6	2.4	3.3	0.8	13.8	9.8	4.0	3.9	2.0	1.3	11.4	4.6	2.6	7.3	8.7	15.6	6.4	10.9	5.4	1.8	10.2	12.1	4.8	8.2	8.7	6.9	23.7	6.7	2.1	1.9	8.3	8.2	1.2	3.1	4.8	4.2	3.1	8.3	6.9	1.9	16.7	9.4	3.8	5.9	10.4	8.9	13.2	8.5	6.8	16.3	8.3	5.9	13.6	10.4	5.9	13.6	2.3	2.9	4.6	13.1	5.3	6.1	6.3	14.3	15.4	2.6	4.2	5.2	10.5	0.6	1.4	1.5	0.3	3.3	1.4	1.7	1.6	0.9	1.2	2.1	2.6	0.9	2.4	0.3	1.5	2.4	0.8	6.9	8.4	12.7	10.9	6.1	4.7	7.7	4.7	5.7	6.0
L3MBTL1	"dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3"	ENSG00000185513	"L3MBTL1, histone methyl-lysine binding protein"	Q9Y468	20	43507680-43550950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 11.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068051			Supported	Nucleoplasm				Nucleoplasm		"HPA068051: "	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.65e-4)"	"unprognostic (6.02e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-4)"	3.3	5.7	12.6	4.3	11.7	6.4	5.2	25.0	14.3	5.6	4.9	10.5	8.3	4.3	8.2	10.7	4.0	10.4	3.9	5.7	13.8	16.4	4.5	1.8	4.2	4.7	16.3	9.6	11.2	3.3	7.1	14.6	5.1	10.1	6.6	4.4	7.5	8.1	8.0	9.0	9.7	4.7	6.0	7.4	5.6	4.2	13.3	14.5	4.6	7.2	0.7	5.5	4.3	5.4	0.5	1.3	1.5	0.2	2.5	1.8	1.4	0.2	2.1	5.8	3.9	0.1	0.0	11.4	1.3	1.6	1.9	3.3	0.6	6.1	3.3	2.1	2.1	5.1	0.0	1.2	1.6	0.0	5.1	2.7	5.2	4.1	1.4	0.0	3.0	2.3	2.6	1.2	0.0	1.2	3.1	2.2	1.0	0.7	1.4	3.4	2.8	3.1	2.5	1.4	0.9	4.3	1.3	2.1	6.6	2.2	1.4	0.3	2.9	3.4	2.1	1.1	3.9	0.0	0.9	4.2	1.1	1.1	4.1	4.1	1.2	0.0	0.2	0.6	0.8	0.2	1.3	0.5	1.0	1.0	0.9	0.4	1.8	0.6	1.5	2.5	0.1	1.3	0.3	1.4	12.6	11.7	25.0	14.3	13.8	16.4	16.3	9.6	10.1	14.5
L3MBTL3	KIAA1798	ENSG00000198945	"L3MBTL3, histone methyl-lysine binding protein"	Q96JM7	6	130013699-130141451	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.9;HUVEC TERT2: 30.1;TIME: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044382, HPA053035"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA044382: , HPA053035: "	"unprognostic (2.33e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-2)"	8.8	16.7	5.2	16.4	8.2	7.5	7.5	2.4	7.7	17.1	5.6	3.6	9.3	3.1	17.5	14.1	5.7	7.4	6.0	4.1	5.4	5.8	6.1	6.4	7.4	11.4	5.2	5.9	12.1	3.8	8.1	17.0	6.5	5.7	10.3	5.7	4.8	5.8	7.5	5.3	4.3	7.6	9.9	5.4	18.5	4.6	7.5	3.9	25.5	10.2	4.3	12.8	10.4	11.6	10.7	10.8	3.9	14.1	1.7	4.2	0.6	0.8	3.1	7.3	1.1	5.0	6.8	1.5	3.6	7.5	1.5	2.7	3.7	3.9	1.3	5.3	4.7	3.1	4.2	6.5	2.3	2.8	4.2	8.5	1.5	0.9	2.6	5.0	30.9	4.2	4.7	1.7	5.0	30.1	6.1	3.4	3.7	0.3	10.6	0.8	3.4	1.6	4.0	2.0	0.0	4.8	1.2	0.2	1.0	1.4	0.3	2.9	7.6	4.4	20.5	2.4	3.4	0.4	2.3	0.6	0.0	2.2	1.2	2.1	2.5	3.9	3.5	3.5	2.7	4.0	2.7	7.6	2.7	3.8	1.3	10.7	2.4	3.0	3.7	1.7	14.1	10.8	4.2	0.6	5.2	8.2	2.4	7.7	5.4	5.8	5.2	5.9	5.7	3.9
LACTB	"FLJ14902, MRPL56"	ENSG00000103642	"Lactamase beta"	P83111	15	63121800-63142061	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protease"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036361, HPA036362"	Supported		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA036361: AB_10672244, HPA036362: AB_10670798"	"unprognostic (6.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.25e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.64e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.88e-3)"	26.5	22.7	9.2	13.1	12.2	31.5	9.3	7.3	9.1	6.8	11.4	6.3	4.0	12.5	7.0	6.9	9.8	5.7	9.2	24.9	7.9	6.1	20.5	38.3	18.8	12.9	8.5	6.1	7.2	9.3	6.7	10.4	7.4	9.5	7.6	10.4	5.8	9.3	4.7	37.3	10.1	19.6	8.1	8.0	21.6	8.3	13.2	9.8	8.3	8.4	11.1	9.0	11.5	12.8	3.3	10.4	5.8	8.9	2.3	3.1	2.0	21.4	13.5	3.8	2.6	19.5	10.5	3.2	9.4	14.5	16.2	30.2	3.4	13.8	2.8	11.6	13.6	6.0	13.1	6.1	20.3	19.7	3.2	5.5	4.6	8.4	18.2	5.0	9.6	14.2	13.0	16.6	13.7	16.6	5.2	8.2	27.3	8.1	3.8	6.0	5.8	4.2	2.8	9.9	6.5	8.7	33.6	3.5	1.6	6.8	7.7	20.2	5.8	8.2	29.7	21.8	17.1	9.8	11.8	8.6	7.5	0.7	16.7	14.1	10.0	3.6	8.8	4.6	1.3	8.9	2.0	3.3	1.1	1.0	10.4	2.9	1.0	1.6	5.8	2.3	7.6	0.9	3.1	2.0	9.2	12.2	7.3	9.1	7.9	6.1	8.5	6.1	9.5	9.8
LACTB2	CGI-83	ENSG00000147592	"Lactamase beta 2"	Q53H82	8	70635318-70669174	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.1;liver: 58.8"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044391, HPA053040"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"			24000	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA044391: AB_10965168, HPA053040: "	"unprognostic (6.33e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.60e-4)"	"unprognostic (3.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.93e-2)"	9.3	31.4	6.8	6.7	10.0	1.2	8.9	2.0	7.1	5.5	13.5	9.0	5.3	17.8	5.7	8.3	7.6	5.2	14.6	19.3	7.2	7.2	70.1	58.8	9.7	8.9	11.5	7.5	5.5	10.6	6.2	12.6	6.3	10.1	7.5	10.0	6.2	7.8	8.6	12.0	6.1	19.1	7.2	11.6	8.0	7.7	45.7	11.7	6.0	9.8	10.9	5.9	8.2	7.4	14.0	18.2	13.4	17.3	11.0	13.8	6.4	14.0	14.7	4.6	1.9	8.1	12.5	2.8	7.9	4.6	8.6	6.4	7.0	15.9	0.0	3.2	3.8	10.1	5.6	8.3	6.8	8.5	6.2	6.6	1.9	3.8	17.1	6.4	5.7	15.0	10.2	4.2	6.4	2.2	11.3	13.4	11.2	4.2	3.6	1.2	5.0	13.9	3.2	2.7	2.9	32.6	7.5	6.7	2.3	17.6	97.4	8.8	16.3	8.6	3.5	0.6	4.7	15.1	6.4	10.9	8.2	0.0	4.8	11.0	6.3	11.1	15.2	13.4	9.9	17.3	12.5	14.0	10.4	9.7	18.2	13.2	10.1	10.6	6.4	11.0	16.4	12.8	13.8	6.4	6.8	10.0	2.0	7.1	7.2	7.2	11.5	7.5	10.1	11.7
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201373244-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;tongue: 66.9"	"Cell line enhanced"	"Detected in some"		"A-431: 37.3;CAPAN-2: 33.1;HaCaT: 48.1;HBEC3-KT: 36.6;hTCEpi: 35.6;MCF7: 40.9;RT4: 35.1;SK-BR-3: 57.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"			"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.3	0.2	0.3	10.7	0.3	0.0	3.0	0.3	0.3	15.9	17.5	0.3	22.1	17.4	2.9	4.4	83.9	2.8	56.9	2.0	0.3	0.2	17.2	5.4	3.6	1.5	0.3	0.3	1.5	29.5	0.0	0.4	16.0	0.4	6.9	12.1	0.5	17.1	25.0	1.3	49.7	39.1	1.5	0.3	0.4	13.8	0.6	0.3	3.0	1.6	66.9	42.5	8.9	29.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	37.3	0.3	0.0	0.1	0.0	0.0	12.0	0.0	0.0	0.0	0.0	24.2	33.1	0.0	2.1	0.0	48.1	0.0	36.6	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	35.6	0.0	7.3	0.0	0.0	0.1	0.0	40.9	0.0	0.1	0.9	0.4	0.0	1.7	0.4	24.7	35.1	1.9	0.0	0.0	57.6	0.6	8.7	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3
LAGE3	"CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1"	ENSG00000196976	"L antigen family member 3"	Q14657	X	154477769-154479257	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA036122, HPA036123"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA036122: , HPA036123: AB_10601926"	"unprognostic (1.70e-1)"	"prognostic favourable (5.29e-6)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (7.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (8.63e-5)"	"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.88e-3)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (5.42e-5)"	"unprognostic (7.37e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	10.9	18.3	24.6	9.1	23.0	20.1	7.9	12.4	27.4	10.0	9.7	9.4	5.3	8.5	6.1	11.1	6.8	7.3	7.9	11.0	22.3	15.6	6.7	12.3	7.3	11.3	16.3	20.7	11.3	20.2	5.1	16.6	6.9	12.1	9.7	6.2	8.6	17.5	9.0	22.0	12.2	7.5	7.4	12.3	10.9	11.2	5.0	10.4	16.7	6.2	8.1	10.8	8.4	6.3	14.5	27.5	10.8	10.8	18.4	36.5	15.6	12.4	11.9	4.4	9.3	4.8	4.0	13.1	3.8	2.7	5.8	6.5	7.6	6.8	26.7	35.0	5.0	5.4	10.9	3.8	2.0	15.1	17.4	9.7	11.1	4.3	8.2	12.8	14.4	6.1	2.5	8.7	2.3	4.1	9.4	13.0	7.9	29.4	17.1	37.6	8.3	29.0	15.1	7.6	29.7	3.3	3.4	12.3	11.4	8.9	21.5	15.5	9.3	9.5	4.5	4.2	12.4	17.4	14.4	30.7	31.9	40.1	7.3	23.1	9.6	10.8	10.8	4.2	11.7	9.8	14.8	14.5	16.2	17.1	14.8	12.2	36.5	18.7	1.2	18.4	8.0	27.5	12.3	15.6	24.6	23.0	12.4	27.4	22.3	15.6	16.3	20.7	12.1	10.4
LAIR1	CD305	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.0"	"Group enriched"	"Detected in some"	5	"HMC-1: 6.5;Karpas-707: 16.7;THP-1: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA011155	Enhanced		Supported	"Plasma membrane"			130000	"Plasma membrane"		"HPA011155: AB_1852685"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (5.01e-5)"	"unprognostic (1.72e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.52e-2)"	"unprognostic (5.22e-2)"	12.7	7.0	4.5	10.9	9.9	13.5	6.9	0.5	4.5	2.7	5.1	6.7	0.2	2.7	2.2	6.8	2.5	3.6	4.4	3.9	5.2	4.2	3.8	2.9	16.5	33.1	10.2	1.9	2.0	2.4	1.4	2.8	7.0	7.0	3.0	2.0	3.1	3.9	2.2	2.3	2.3	7.6	7.8	11.9	28.6	2.9	3.1	7.4	39.0	2.0	0.5	6.1	3.7	1.7	6.0	10.3	12.4	8.8	5.8	8.0	5.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	2.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	2.1	1.5	0.0	0.0	2.1	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	2.6	0.2	12.4	4.2	10.0	8.0	8.3	4.6	2.3	2.4	4.3	0.1	6.0	3.8	4.9	0.6	5.8	8.8	10.3	1.6	5.7	4.5	9.9	0.5	4.5	5.2	4.2	10.2	1.9	7.0	7.4
LAMA3	"BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa"	ENSG00000053747	"Laminin subunit alpha 3"	Q16787	18	23689443-23955066	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 70.8"	"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 150.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009309, CAB010757"	Uncertain		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		810000	"Endoplasmic reticulum"		"CAB010757: AB_477162, HPA009309: AB_1079224"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavourable (3.58e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.91e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.13e-1)"	8.2	0.9	2.9	8.2	1.9	0.0	16.7	0.6	2.3	18.2	13.3	2.4	5.4	11.2	19.1	9.5	12.4	7.8	8.1	2.7	1.8	1.5	3.1	1.3	26.2	7.0	2.4	0.9	5.8	3.1	10.3	2.3	70.8	1.6	8.7	5.2	5.7	14.9	9.1	2.2	20.7	27.8	10.2	1.3	0.8	19.7	3.8	0.5	3.3	1.8	9.7	8.0	11.5	15.2	0.0	0.0	0.8	0.0	0.0	1.3	0.2	16.9	2.1	0.0	0.0	0.9	0.1	0.0	0.3	0.2	0.1	0.2	0.7	19.6	0.0	2.2	0.2	31.0	0.0	150.6	0.1	0.0	1.2	0.0	0.6	0.3	0.1	0.0	0.0	0.1	16.9	0.1	17.8	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	2.0	0.3	0.0	0.0	6.6	1.9	0.0	0.3	0.7	0.2	0.0	0.5	0.2	1.6	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.6	2.3	1.8	1.5	2.4	0.9	1.6	0.5
LAMA5		ENSG00000130702	"Laminin subunit alpha 5"	O15230	20	62307955-62367312	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 30.3;CACO-2: 41.8;EFO-21: 31.2;TIME: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054609, CAB078157"	Enhanced		Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"		1200000	Vesicles	Nucleoplasm	"CAB078157: , HPA054609: "	"unprognostic (8.01e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.90e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-3)"	"unprognostic (4.04e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.33e-2)"	22.6	5.9	5.6	8.1	5.9	2.5	16.8	24.0	6.6	16.7	28.0	3.1	18.6	7.6	23.2	13.8	18.0	14.2	27.4	13.7	4.7	2.9	17.0	7.3	19.7	4.4	3.7	2.3	6.9	13.9	8.3	6.0	33.3	5.5	17.4	2.6	18.6	12.7	25.0	9.4	45.2	9.0	25.0	4.5	8.8	13.3	4.4	3.4	2.0	18.4	11.8	10.4	19.4	24.9	0.9	1.2	0.2	0.0	0.0	0.0	0.0	3.9	30.3	0.6	4.0	0.7	8.6	23.3	1.1	0.6	0.9	0.1	41.8	15.7	0.3	31.2	0.0	28.4	0.8	12.1	0.0	0.1	1.7	0.9	27.3	11.9	2.7	0.0	4.5	0.4	8.1	2.1	2.1	4.0	1.8	0.4	0.0	5.8	0.0	0.1	1.9	17.7	0.0	0.3	3.3	7.8	18.5	0.3	12.1	16.7	16.8	0.3	16.6	0.2	36.6	0.4	11.6	0.2	4.9	0.2	0.0	0.1	8.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	5.6	5.9	24.0	6.6	4.7	2.9	3.7	2.3	5.5	3.4
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122213-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 123.9"	"Group enriched"	"Detected in some"	6	"EFO-21: 57.2;HDLM-2: 14.5;HHSteC: 21.2;hTCEpi: 19.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 7.6;T-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles			47000	Vesicles		"CAB025133: , HPA051467: "	"unprognostic (1.43e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.95e-2)"	"prognostic favourable (9.90e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavourable (1.89e-7)"	"unprognostic (3.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	0.5	0.7	0.4	14.1	0.4	0.0	0.5	0.3	0.4	1.0	0.6	0.1	0.6	0.4	0.4	1.0	2.5	0.5	0.8	0.4	0.4	0.4	0.8	0.6	123.9	11.2	0.4	0.1	0.4	8.3	0.0	0.6	1.0	0.6	1.0	1.7	0.2	6.8	1.9	0.4	1.9	1.4	0.8	0.5	2.0	0.8	8.4	0.0	21.3	8.3	3.1	11.3	3.3	0.9	0.4	0.0	7.6	0.1	0.8	6.6	1.1	3.4	0.1	0.0	0.5	0.0	0.0	2.8	0.0	0.9	0.6	0.1	0.8	1.8	0.0	57.2	0.2	0.5	1.2	2.1	0.1	14.5	1.7	0.0	0.1	0.1	21.2	0.0	0.5	0.3	19.4	0.0	2.5	2.6	0.1	3.4	0.1	0.0	0.8	0.1	0.1	0.8	0.0	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.1	1.5	1.1	0.1	2.7	0.0	1.0	0.1	0.0	1.2	4.3	0.1	0.0	0.0	0.0	0.4	0.1	7.6	0.4	0.0	3.2	0.1	2.7	1.7	0.0	0.4	3.5	2.0	1.9	0.8	0.1	0.0	6.6	1.1	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.1	0.6	0.0
LAMTOR1	"C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1"	ENSG00000149357	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1"	Q6IAA8	11	72085895-72103387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002997	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"			270000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA002997: AB_1845531"	"unprognostic (7.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	47.3	55.3	51.3	33.3	55.6	49.7	69.1	23.1	51.1	43.3	40.4	44.1	39.4	35.1	36.0	48.1	42.2	40.7	44.0	59.9	45.4	41.4	58.0	60.5	44.3	71.5	52.5	29.9	38.0	45.0	33.3	37.6	41.6	38.1	39.8	40.2	40.4	45.0	45.5	57.6	33.2	41.8	38.8	49.0	52.9	35.6	22.6	31.9	28.2	61.3	39.4	40.0	32.7	35.0	25.7	57.7	44.9	68.7	19.7	16.4	55.4	17.6	35.0	18.9	23.1	41.7	28.9	19.0	24.6	35.1	38.0	29.0	44.3	24.3	17.8	31.9	38.7	25.7	29.7	49.4	27.4	22.4	19.6	46.7	22.5	29.7	59.4	18.0	27.8	50.0	36.2	40.2	38.3	30.4	19.5	16.5	37.3	55.9	13.9	28.1	17.8	38.4	12.3	32.8	14.3	47.5	37.5	11.5	19.8	24.9	23.4	62.7	34.5	16.1	24.4	26.1	19.2	61.6	17.1	22.2	25.3	13.6	15.2	14.5	19.7	17.7	68.7	44.9	15.0	38.6	14.4	23.8	14.2	14.9	57.7	25.7	12.0	14.6	40.5	19.7	29.3	34.3	16.4	55.4	51.3	55.6	23.1	51.1	45.4	41.4	52.5	29.9	38.1	31.9
LAMTOR4	C7orf59	ENSG00000188186	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4"	Q0VGL1	7	100148907-100155944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 206.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 206.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020998	Enhanced		Supported	Vesicles				Vesicles		"HPA020998: AB_1845762"	"prognostic favourable (2.48e-4)"	"prognostic favourable (6.08e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.68e-2)"	31.0	30.7	43.8	36.0	40.2	54.7	43.2	20.9	70.6	28.5	41.8	27.9	26.5	28.6	25.0	35.3	32.9	35.9	36.0	42.2	39.5	35.1	36.3	24.9	32.0	44.7	49.5	30.7	30.0	36.9	19.3	28.5	26.8	38.7	30.8	34.5	31.2	35.4	27.5	44.4	84.7	27.2	31.3	47.8	41.5	29.7	21.3	35.2	15.7	37.3	33.1	26.6	31.3	39.6	31.4	35.1	206.0	53.2	17.6	26.5	46.2	19.0	46.3	24.5	30.9	26.1	30.2	19.9	11.4	28.3	21.4	26.5	21.4	30.8	30.8	38.9	17.3	20.1	23.2	29.5	9.2	31.1	65.7	24.5	43.9	36.8	24.6	19.0	35.4	36.1	29.3	22.3	27.7	32.6	23.0	49.6	29.0	90.9	18.4	76.6	26.0	37.3	19.4	20.2	54.7	24.2	23.3	17.3	32.0	21.1	49.8	37.9	20.0	37.7	21.8	20.4	30.5	42.1	18.3	30.1	40.1	57.0	32.6	53.4	29.0	52.0	53.2	183.0	19.6	46.9	16.3	31.4	24.8	20.2	35.1	27.7	25.5	20.5	206.0	17.6	43.4	29.7	26.5	46.2	43.8	40.2	20.9	70.6	39.5	35.1	49.5	30.7	38.7	35.2
LAMTOR5	"HBXIP, MGC71071, XIP"	ENSG00000134248	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5"	O43504	1	110401249-110407942	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006812	Approved		Supported	Cytosol			270000	Cytosol		"HPA006812: AB_1079040"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (9.97e-2)"	"unprognostic (7.58e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.80e-3)"	"prognostic favourable (5.52e-4)"	"unprognostic (6.66e-2)"	29.0	32.1	38.9	21.0	35.2	60.9	30.1	25.2	35.8	23.6	29.8	24.4	28.9	23.7	21.6	47.3	30.4	26.7	31.0	63.8	33.2	34.8	118.7	54.3	26.7	28.1	41.5	28.5	29.7	34.8	28.9	35.2	46.3	35.8	28.0	31.6	31.0	32.9	29.6	64.0	21.5	34.2	22.9	36.4	30.7	28.6	24.0	29.5	22.6	37.8	56.7	32.3	27.8	24.7	62.0	59.0	86.1	42.6	25.4	32.4	42.1	46.4	38.9	35.3	21.1	59.2	45.2	35.3	39.5	31.2	33.5	31.9	33.9	23.0	37.0	42.2	38.2	18.9	35.8	33.0	41.3	39.6	40.2	27.1	46.9	68.5	45.3	38.8	33.8	39.4	51.2	34.6	22.1	40.0	31.9	34.9	48.5	75.6	35.2	47.0	25.0	64.8	24.4	63.8	28.0	77.2	52.3	26.1	34.1	35.1	51.3	85.5	19.8	55.1	38.0	25.4	33.0	63.8	37.0	36.8	41.1	47.1	83.2	38.9	58.2	47.1	42.6	86.1	25.2	41.2	22.1	62.0	29.5	27.0	34.7	54.6	25.9	27.3	65.6	25.4	39.0	59.0	32.4	42.1	38.9	35.2	25.2	35.8	33.2	34.8	41.5	28.5	35.8	29.5
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365448-55433742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell line enriched"	"Detected in all"	7	"A-431: 57.1"	"Cancer enhanced"	"Detected in all"		"glioma: 52.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favourable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favourable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.1	4.9	20.4	2.3	17.0	3.1	5.9	9.9	28.5	6.1	4.6	19.8	1.8	5.0	9.6	5.3	3.5	5.6	3.8	3.9	17.2	11.3	6.0	4.8	3.0	4.0	12.9	21.1	9.6	3.4	10.4	4.2	3.9	10.1	5.9	4.7	2.4	3.3	6.9	5.7	5.3	4.2	7.0	10.8	2.8	3.5	5.7	13.1	3.3	6.6	0.3	2.7	2.8	2.7	2.7	4.7	0.7	4.5	3.6	6.0	2.6	57.1	2.0	4.0	2.7	1.2	2.1	2.2	2.6	3.1	4.0	3.4	2.0	1.6	4.0	2.4	3.7	2.6	2.1	1.4	2.5	1.7	4.2	1.4	1.6	2.0	2.2	4.4	2.7	3.8	1.5	3.0	1.0	2.0	2.5	2.6	3.7	1.7	1.1	2.0	7.7	2.5	1.7	1.8	2.0	2.6	4.5	7.0	6.7	3.7	5.6	1.5	2.3	4.7	3.3	2.5	3.5	4.8	5.0	2.5	3.0	4.3	2.0	1.0	4.8	0.4	3.6	0.7	2.6	4.5	4.5	2.7	3.4	3.9	4.7	2.6	3.1	2.7	0.5	3.6	3.0	3.7	6.0	2.6	20.4	17.0	9.9	28.5	17.2	11.3	12.9	21.1	10.1	13.1
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol			4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.8	9.5	9.1	8.6	18.1	22.1	0.1	17.1	19.3	62.3	75.7	17.3	20.7	42.7	11.4	13.1	6.7	34.2	12.1	23.7	16.3	9.8	23.7	10.5	22.6	21.1	21.3	15.2	22.4	7.7	20.4	10.7	21.6	22.9	30.5	14.6	11.7	18.9	29.2	19.0	18.2	29.4	8.7	21.6	16.2	12.7	13.5	11.1	15.7	9.7	33.5	8.2	8.2	14.0	15.8	10.7	16.6	29.7	28.1	42.9	36.9	21.4	35.5	15.3	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7
LARP1	"KIAA0731, LARP, MGC19556"	ENSG00000155506	"La ribonucleoprotein domain family member 1"	Q6PKG0	5	154712902-154817607	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: , HPA054819: "	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	24.9	30.1	30.5	21.9	31.9	18.9	20.3	25.7	46.5	21.3	20.4	27.3	23.2	21.0	26.5	23.0	29.2	25.4	18.5	28.5	27.8	29.1	25.6	22.6	19.9	23.1	26.8	29.7	28.4	81.2	55.9	23.6	25.1	29.2	18.2	21.3	18.9	38.8	21.4	41.7	24.7	22.3	23.8	22.2	21.5	24.4	27.8	27.4	26.1	33.5	16.4	25.8	22.1	28.7	5.2	6.4	2.8	7.9	10.1	5.8	2.5	26.0	36.5	28.5	32.7	24.8	20.2	31.6	26.5	27.1	31.1	30.4	57.3	31.4	68.9	37.7	33.1	26.3	51.9	48.8	36.0	22.8	29.3	49.8	38.0	26.4	31.6	66.5	23.1	24.9	28.3	38.6	49.4	27.3	40.9	47.8	28.8	25.7	39.4	26.0	30.3	18.4	44.1	27.1	32.8	19.1	32.5	51.7	27.8	36.0	57.8	31.9	34.4	31.4	36.1	39.1	24.5	29.5	47.5	42.8	30.7	58.7	26.0	36.9	27.3	2.8	4.0	1.1	4.5	4.9	5.8	4.3	5.4	5.3	4.0	5.2	4.3	4.7	2.4	10.1	7.9	6.4	3.4	2.5	30.5	31.9	25.7	46.5	27.8	29.1	26.8	29.7	29.2	27.4
LARP4	PP13296	ENSG00000161813	"La ribonucleoprotein domain family member 4"	Q71RC2	12	50392383-50480004	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039306, HPA039673"	Approved		Enhanced	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA039306: AB_10805362, HPA039673: AB_10795110"	"unprognostic (4.41e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.93e-3)"	"unprognostic (9.08e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.99e-3)"	15.1	22.5	12.3	13.5	14.4	9.4	15.0	12.2	13.1	12.1	13.8	8.1	17.7	13.0	12.4	11.6	15.1	10.7	10.4	14.7	11.3	10.4	28.5	47.8	13.6	11.3	15.6	9.0	11.5	17.1	18.3	23.1	17.7	14.8	13.1	11.7	13.4	17.3	14.7	31.3	10.2	14.8	15.7	17.9	10.9	13.2	11.2	13.5	14.0	15.9	11.2	11.8	14.0	21.4	11.8	15.6	8.9	14.6	10.9	12.1	8.9	14.8	21.1	14.0	10.2	13.1	11.0	23.9	18.3	10.9	18.1	14.5	41.2	17.3	34.9	22.6	11.4	14.2	30.5	12.4	23.9	21.6	12.5	28.3	19.9	14.7	12.3	31.4	16.8	9.9	11.9	21.4	23.1	15.9	40.7	16.7	16.8	13.2	25.7	10.6	20.3	18.5	19.0	22.4	20.7	9.8	22.3	16.7	9.8	32.4	16.9	18.8	14.7	12.7	22.9	12.0	17.9	13.9	17.2	16.4	43.7	31.0	16.7	12.9	10.0	8.9	11.6	7.7	11.4	13.0	10.8	11.7	10.1	6.4	15.6	11.8	12.1	9.6	6.5	10.9	14.6	13.5	9.8	8.9	12.3	14.4	12.2	13.1	11.3	10.4	15.6	9.0	14.8	13.5
LARP4B	"KIAA0217, LARP5"	ENSG00000107929	"La ribonucleoprotein domain family member 4B"	Q92615	10	806914-931705	"Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036566, HPA042738"	Approved		Enhanced	Cytosol				Cytosol		"HPA036566: AB_10673624, HPA042738: AB_2678137"	"unprognostic (3.02e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.13e-3)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (8.95e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.54e-2)"	17.5	23.1	16.5	27.7	20.7	17.9	17.3	23.8	23.8	15.0	19.7	21.2	20.9	21.7	19.1	23.6	30.9	17.0	19.4	22.0	15.8	13.0	17.6	17.0	25.4	23.0	16.0	16.7	18.2	21.0	22.3	18.6	27.1	18.3	20.0	18.4	18.9	22.1	28.1	37.1	25.1	21.7	16.0	14.4	25.2	25.3	22.9	15.9	29.5	25.8	16.8	21.8	18.3	20.0	8.3	12.2	13.5	13.6	7.7	9.8	5.2	21.4	18.3	9.4	10.6	8.7	8.9	13.8	14.6	6.8	15.8	15.5	24.6	24.4	26.3	5.7	14.3	22.9	16.9	12.1	13.9	17.7	12.2	21.6	12.5	14.4	14.2	16.1	19.5	9.6	14.2	16.0	9.3	10.8	28.7	17.1	12.8	21.3	23.0	14.3	10.2	8.5	16.7	8.3	17.7	12.7	16.5	9.4	13.3	14.1	27.4	10.8	25.7	15.3	15.1	12.1	3.3	38.6	14.4	19.6	23.4	26.0	13.6	13.1	7.7	12.9	12.6	13.5	8.7	13.6	9.0	6.7	9.5	9.8	10.8	8.3	9.2	9.8	12.0	7.7	11.1	12.2	8.6	5.2	16.5	20.7	23.8	23.8	15.8	13.0	16.0	16.7	18.3	15.9
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein domain family member 7"	Q4G0J3	4	112636964-112657592	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (4.33e-4)"	22.9	20.2	26.5	24.2	37.0	23.9	23.9	32.5	33.2	26.8	24.7	15.0	24.5	20.7	26.8	23.3	26.4	21.9	20.0	38.3	34.3	21.3	38.8	26.9	18.1	25.6	33.3	26.5	26.3	14.4	21.4	42.6	23.1	34.7	27.3	23.9	11.5	19.2	19.9	35.5	19.1	35.2	31.1	46.9	32.4	20.0	16.0	41.2	27.5	26.4	21.2	25.2	30.1	20.9	23.8	34.6	30.7	27.8	17.8	19.2	10.4	11.4	11.3	23.9	12.0	16.4	19.1	12.1	14.5	12.1	13.5	12.9	7.8	18.1	27.9	12.9	13.9	7.7	22.5	13.1	18.2	23.4	15.9	16.0	9.5	12.3	12.2	37.9	23.9	15.3	15.5	12.1	7.1	12.6	19.5	14.3	17.5	9.8	30.4	14.1	61.7	8.5	17.1	19.2	12.2	20.9	12.5	13.2	18.2	9.3	23.1	14.3	10.1	14.9	12.1	12.7	12.9	12.9	15.4	9.7	16.1	28.4	16.4	14.2	13.5	30.7	15.0	25.3	18.5	20.7	16.5	23.8	18.8	19.2	12.3	22.8	18.4	17.8	18.3	17.8	27.8	34.6	18.1	10.4	26.5	37.0	32.5	33.2	34.3	21.3	33.3	26.5	34.7	41.2
LARS	"FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase"	Q9P2J5	5	146113038-146182660	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Enhanced	"Nuclear bodies,Cytosol"			14000	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: "	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavourable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (2.98e-4)"	"unprognostic (2.96e-2)"	32.2	30.1	27.0	25.8	31.2	17.8	38.6	31.8	33.7	25.5	25.3	30.1	23.9	16.8	35.8	31.3	28.5	26.8	16.4	29.0	24.2	22.2	26.5	18.4	20.0	24.8	27.3	26.1	32.0	40.8	35.0	43.0	20.6	31.6	26.3	29.9	19.5	39.9	24.8	55.5	24.1	21.5	32.5	30.9	25.2	24.9	20.5	30.5	25.6	30.8	22.8	28.9	30.9	29.2	21.3	28.0	5.8	18.3	19.0	21.8	11.2	20.4	24.2	28.0	45.9	23.2	30.3	43.6	23.9	17.7	24.2	35.1	25.2	22.4	31.1	14.8	31.4	17.5	47.3	39.3	42.4	26.7	27.8	35.5	30.6	14.6	32.2	50.4	23.5	23.8	39.6	39.6	68.8	33.0	39.4	58.3	26.0	16.9	38.9	30.9	43.4	26.8	30.1	35.3	31.0	18.5	18.5	27.6	34.8	26.0	28.7	60.4	32.6	43.5	32.2	28.3	18.8	25.6	35.7	30.3	44.7	50.9	30.8	53.2	33.0	2.5	13.5	5.8	14.8	18.3	19.8	21.1	16.4	13.6	18.6	21.3	21.8	18.0	1.2	19.0	13.6	28.0	14.8	11.2	27.0	31.2	31.8	33.7	24.2	22.2	27.3	26.1	31.6	30.5
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388506-45549421	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: , HPA066085: "	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favourable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	9.6	14.3	18.8	9.6	21.8	6.7	8.1	11.9	17.9	9.2	14.8	13.1	8.3	9.6	9.8	8.9	10.4	11.2	8.4	14.2	14.6	13.6	18.9	17.2	7.0	10.3	15.7	9.5	10.2	8.2	20.0	14.0	10.6	12.3	10.8	15.3	10.0	8.7	9.8	14.1	7.8	8.8	11.0	8.8	10.0	8.9	7.3	11.8	16.1	10.5	8.3	12.8	11.3	7.8	5.1	5.9	2.4	3.3	8.4	6.0	3.7	6.2	7.9	9.2	8.7	8.4	9.5	9.9	9.8	10.1	18.3	13.7	14.0	8.8	13.0	8.4	11.4	6.8	34.2	20.5	13.9	11.4	8.6	14.1	12.8	13.5	8.8	20.4	5.2	12.3	12.7	17.5	9.2	11.4	21.9	7.4	11.4	6.9	14.6	7.5	23.0	14.6	8.3	9.2	14.5	16.3	15.2	7.3	9.1	15.6	8.8	8.1	14.0	12.0	10.0	11.2	8.3	9.3	11.7	5.8	10.6	13.9	13.2	13.9	9.9	0.6	2.8	2.4	6.0	3.3	5.8	5.1	4.4	5.4	5.9	4.0	4.8	5.4	1.2	8.4	3.0	4.5	3.9	3.7	18.8	21.8	11.9	17.9	14.6	13.6	15.7	9.5	12.3	11.8
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 124.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"			26000000	"Plasma membrane, Cytosol"	"Focal adhesion sites"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"	51.2	20.0	23.8	40.3	22.4	45.4	35.5	15.5	25.7	23.6	57.4	16.3	18.7	54.4	23.4	24.1	22.4	20.8	48.3	15.2	18.4	23.3	33.1	47.5	33.3	44.2	20.0	14.3	28.4	30.1	10.1	17.6	40.0	16.1	18.9	38.6	24.2	22.4	24.1	10.7	18.3	124.5	21.3	12.2	43.1	39.5	13.9	12.9	40.5	18.3	18.7	33.7	22.0	28.3	6.4	13.9	34.0	19.9	17.3	16.5	13.1	34.8	72.7	21.3	18.8	31.3	34.0	36.7	43.9	42.9	46.3	34.0	21.7	38.0	15.9	36.7	67.8	55.6	9.6	33.4	40.5	11.6	5.2	7.6	21.0	37.7	29.7	17.5	23.1	30.1	11.7	39.2	11.1	31.0	12.9	5.3	64.3	11.5	20.8	27.0	10.6	18.2	11.8	11.3	20.1	56.8	30.7	3.2	7.8	26.1	27.4	22.7	43.3	21.4	54.1	27.8	40.5	32.4	26.6	13.7	18.1	12.3	29.3	15.8	33.4	9.9	14.8	16.8	16.5	17.1	11.3	6.4	8.4	11.0	13.9	6.3	7.2	10.9	34.0	17.3	19.9	10.7	10.7	13.1	23.8	22.4	15.5	25.7	18.4	23.3	20.0	14.3	16.1	12.9
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990783	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"blood: 58.1;lymphoid tissue: 193.6"	"Cell line enhanced"	"Detected in some"		"HEL: 30.3;HMC-1: 128.1;MOLT-4: 43.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1"	"Group enriched"	"Detected in many"	134	"granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002223, HPA011157, CAB012978"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"		75000	"Plasma membrane"	"Golgi apparatus"	"CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	4.8	1.8	1.6	27.6	3.0	8.5	2.5	6.6	2.3	3.9	10.8	2.0	2.0	4.9	7.7	3.1	4.3	4.2	5.8	3.1	1.9	1.9	6.0	3.3	7.8	33.2	1.7	1.7	3.0	2.7	1.4	6.0	2.8	1.8	8.5	2.8	3.1	12.2	5.4	2.0	5.8	9.0	3.1	1.9	13.9	5.1	2.3	1.7	193.6	7.3	4.6	50.3	6.4	5.4	0.2	0.2	38.2	0.2	15.7	58.1	26.8	0.1	0.3	0.2	0.3	0.6	0.3	0.7	0.8	0.2	0.2	0.3	0.3	0.4	0.1	1.1	0.3	0.4	0.4	0.2	0.1	0.2	0.5	30.3	0.7	0.5	0.1	0.9	128.1	0.3	0.6	0.2	0.1	0.1	0.3	3.6	0.1	0.8	43.6	6.0	0.5	0.4	0.4	0.1	3.8	0.3	0.2	0.8	0.1	0.1	0.3	0.3	0.4	5.0	0.5	0.6	2.9	0.6	0.2	1.2	1.0	0.4	7.7	0.4	0.5	38.2	0.2	0.1	47.9	0.2	33.5	0.2	46.9	47.9	0.1	0.2	44.6	42.6	2.3	15.7	0.1	0.2	58.1	26.8	1.6	3.0	6.6	2.3	1.9	1.9	1.7	1.7	1.8	1.7
LAT2	"HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5"	ENSG00000086730	"Linker for activation of T cells family member 2"	Q9GZY6	7	74199652-74229834	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 98.4;lymphoid tissue: 36.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 45.6;REH: 51.8;RPMI-8226: 18.5;THP-1: 46.9;U-937: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 98.4"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003462	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA003462: AB_1079238"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (4.10e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	4.6	3.7	10.3	21.4	19.3	32.8	2.5	2.7	9.6	2.8	3.9	11.6	0.5	3.3	2.5	2.4	2.5	3.8	5.9	2.4	8.8	6.5	3.0	3.8	11.6	29.3	21.9	2.5	1.4	2.8	1.0	2.8	4.4	15.7	4.5	4.7	2.3	3.6	2.2	2.7	1.8	9.9	5.0	19.3	36.7	3.6	1.6	17.6	3.2	2.4	1.0	32.7	5.8	4.6	26.8	32.5	98.4	39.5	10.0	1.3	24.7	0.4	0.2	0.2	0.8	0.0	0.0	0.2	0.3	0.3	0.2	0.2	0.4	7.9	5.2	0.1	0.1	0.2	0.0	0.3	0.1	8.3	0.3	2.0	0.3	0.3	0.0	15.2	15.2	0.1	0.2	0.5	0.1	0.0	0.3	2.4	0.1	0.3	0.2	45.6	0.2	0.5	51.8	0.2	18.5	0.0	0.4	0.2	0.2	0.1	0.3	0.2	0.2	46.9	0.6	0.6	5.5	0.2	0.4	0.2	1.5	8.1	2.6	45.8	0.3	98.4	39.5	5.9	1.3	22.3	0.1	24.4	0.3	0.1	32.5	26.8	0.1	0.4	69.1	10.0	12.4	1.2	0.6	24.7	10.3	19.3	2.7	9.6	8.8	6.5	21.9	2.5	15.7	17.6
LATS2		ENSG00000150457	"Large tumor suppressor kinase 2"	Q9NRM7	13	20973032-21061547	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA039191: , HPA049037: "	"unprognostic (2.77e-1)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-1)"	"unprognostic (6.57e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-2)"	22.9	13.0	3.0	8.6	5.7	12.8	33.0	7.9	3.7	16.6	14.0	6.8	9.3	2.9	21.2	12.7	15.1	11.0	20.6	14.1	5.4	2.6	12.4	11.0	19.8	10.9	5.2	2.4	17.4	10.2	5.0	3.5	18.3	6.3	13.7	4.5	16.7	8.0	11.1	23.0	9.3	7.4	34.6	7.5	15.2	10.4	27.8	5.2	1.4	17.2	13.8	7.0	20.3	28.0	0.1	1.5	3.3	1.9	1.3	3.1	0.5	3.3	3.7	8.3	5.0	9.8	12.9	7.6	11.2	11.7	11.8	10.1	10.6	5.1	0.0	5.5	17.1	4.9	4.9	5.1	17.5	1.9	1.2	6.2	4.7	7.9	15.3	1.6	2.2	19.1	9.4	7.7	5.2	16.4	1.1	0.2	14.8	5.8	0.1	5.8	2.0	1.8	1.4	14.8	0.0	8.4	1.6	0.1	0.0	8.8	5.8	11.6	5.0	3.2	20.6	12.5	8.4	9.1	7.1	1.5	0.8	0.0	3.0	1.9	9.5	0.4	1.9	1.8	1.6	1.5	3.1	0.1	0.2	0.5	1.5	0.0	0.1	0.3	3.3	1.3	0.6	0.1	0.0	0.5	3.0	5.7	7.9	3.7	5.4	2.6	5.2	2.4	6.3	5.2
LAX1	"FLJ20340, LAX"	ENSG00000122188	"Lymphocyte transmembrane adaptor 1"	Q8IWV1	1	203765176-203776233	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 11.4;U-266/70: 14.1;U-266/84: 31.7;U-698: 12.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0"	"Group enriched"	"Detected in many"	19	"B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9"					"Low region specificity"	"Detected in all"			"HPA002461, HPA003887, CAB025358"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240"	"unprognostic (2.85e-3)"	"unprognostic (3.83e-3)"	"unprognostic (3.90e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.23e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	1.6	0.6	0.4	19.9	0.4	1.3	1.3	0.4	0.4	1.8	3.4	0.0	0.2	2.1	1.2	1.1	4.5	1.1	3.8	0.6	0.4	0.4	1.0	0.8	6.3	17.4	0.4	0.0	0.7	0.6	0.0	0.5	0.1	0.0	2.2	2.6	1.1	5.7	1.5	0.5	1.0	5.5	1.1	0.5	11.7	3.4	1.0	0.0	22.7	1.1	0.7	26.7	6.3	2.8	6.5	0.0	0.3	0.0	4.6	9.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	11.4	0.0	0.0	3.7	0.0	0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	31.7	12.1	0.0	0.9	0.0	0.0	0.0	0.3	9.9	0.0	7.4	6.5	5.7	7.3	0.0	1.5	4.5	5.9	0.0	4.6	0.0	0.0	6.0	2.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 88.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049840, HPA062236"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA049840: , HPA062236: "	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	16.7	4.2	5.6	22.9	7.8	37.0	14.6	5.5	7.2	23.4	37.7	14.5	10.8	16.8	31.4	19.5	17.2	21.8	11.1	7.2	6.5	6.1	15.4	18.9	12.3	31.0	9.9	4.2	14.3	11.8	2.4	5.0	11.2	9.4	19.6	19.7	6.2	8.2	16.6	6.8	7.3	20.4	32.8	9.9	25.4	21.5	8.0	8.9	88.7	8.7	6.9	28.1	28.8	16.2	14.1	13.1	70.9	15.0	12.2	19.9	20.2	24.7	9.7	32.9	14.6	13.8	8.6	16.6	6.5	8.2	13.6	14.7	19.5	42.7	51.0	14.6	6.8	18.9	23.5	6.9	20.7	29.7	24.4	12.7	9.5	16.6	8.6	55.1	22.5	7.5	4.5	12.4	11.0	17.3	38.5	34.7	9.1	3.4	50.5	31.1	29.7	3.3	34.1	30.0	47.5	15.6	11.6	8.8	11.7	11.1	8.2	5.4	11.3	36.4	11.3	3.8	19.7	10.5	23.4	12.5	17.0	57.0	5.1	24.9	12.8	22.2	15.0	21.1	15.3	10.1	17.1	13.8	14.6	16.2	13.1	14.1	14.7	17.4	70.9	12.2	7.8	6.6	19.9	20.2	5.6	7.8	5.5	7.2	6.5	6.1	9.9	4.2	9.4	8.9
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: "	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavourable (9.67e-4)"	"prognostic unfavourable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	7.7	9.7	7.0	13.7	8.7	12.3	7.1	10.2	10.1	11.6	10.7	5.2	12.6	15.7	18.7	15.0	13.0	9.9	12.6	21.7	7.5	9.2	15.2	13.8	10.0	12.5	6.1	6.0	15.4	16.7	10.8	21.8	5.7	7.0	10.7	10.6	9.7	9.5	16.3	10.9	9.4	25.0	11.3	5.5	8.0	8.4	12.1	4.2	20.7	17.9	11.9	11.7	9.1	10.4	9.6	2.8	10.5	3.9	4.1	12.6	2.8	10.9	14.6	7.9	13.3	1.8	4.2	11.2	8.0	7.9	8.5	7.2	14.6	13.0	7.1	7.4	12.3	12.5	26.0	10.7	8.4	8.9	8.9	13.0	9.1	14.1	8.4	18.4	10.0	3.2	8.5	9.0	12.5	5.9	11.9	6.8	6.5	8.5	10.5	10.9	8.6	8.4	10.3	15.8	14.5	6.7	16.2	9.2	14.2	17.8	11.9	10.3	8.6	6.3	6.7	15.5	12.8	8.2	12.5	4.9	10.2	16.0	15.8	13.5	11.8	10.5	2.5	4.8	5.6	3.9	6.6	7.5	8.7	7.1	2.8	9.6	12.6	12.1	7.4	4.1	3.5	2.2	4.0	2.8	7.0	8.7	10.2	10.1	7.5	9.2	6.1	6.0	7.0	4.2
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 271.0;EFO-21: 111.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"		870000000	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favourable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.5	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.0	0.0	111.0	0.0	17.7	0.0	0.5	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	4.9	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1
LCOR	"C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2"	ENSG00000196233	"Ligand dependent nuclear receptor corepressor"	Q96JN0	10	96832282-96995959	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031429, HPA057621, HPA077000"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031429: , HPA057621: , HPA077000: "	"unprognostic (5.61e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.24e-1)"	"prognostic favourable (2.16e-4)"	7.5	6.4	9.9	9.2	11.6	35.5	8.6	25.7	10.5	7.8	13.8	12.6	9.4	17.4	8.9	8.1	12.9	8.3	8.3	7.8	7.3	6.9	9.1	10.0	9.4	9.7	13.6	7.5	13.1	16.9	10.3	20.3	25.9	10.8	8.7	14.1	9.5	12.1	7.4	11.9	7.1	24.2	9.4	11.4	9.9	10.9	7.6	11.7	13.2	10.5	6.6	13.2	12.5	9.7	6.8	4.8	12.2	4.2	3.4	5.4	1.9	11.0	7.3	12.7	5.9	3.6	4.1	6.6	5.6	4.9	6.4	6.9	9.8	7.6	11.6	5.9	5.3	6.3	12.3	6.7	11.2	5.5	6.4	12.0	4.2	11.5	7.1	11.3	6.9	3.7	5.8	9.4	16.4	6.8	10.0	6.1	9.3	5.3	6.6	6.0	4.2	3.3	8.9	10.1	3.4	6.4	24.6	5.9	5.1	5.3	3.3	7.1	7.3	5.0	9.5	5.2	10.5	4.1	9.1	5.8	5.0	13.6	5.0	11.6	2.4	2.1	3.8	6.4	4.8	4.2	4.6	3.8	4.0	5.4	3.1	6.8	4.7	4.7	12.2	3.4	2.5	4.8	2.4	1.9	9.9	11.6	25.7	10.5	7.3	6.9	13.6	7.5	10.8	11.7
LCORL	"FLJ30696, MLR1"	ENSG00000178177	"Ligand dependent nuclear receptor corepressor like"	Q8N3X6	4	17841199-18021876	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028794, HPA028795, HPA060033"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"			Nucleoplasm	"Nuclear membrane"	"HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: "	"unprognostic (1.06e-1)"	"unprognostic (4.95e-2)"	"prognostic favourable (9.65e-4)"	"unprognostic (3.22e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.90e-4)"	"unprognostic (3.46e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	8.3	7.8	11.3	5.7	11.9	5.1	6.6	21.9	10.4	7.0	9.2	6.9	4.7	14.2	6.3	5.1	7.3	4.6	7.1	3.9	10.3	9.8	9.6	7.2	7.5	8.0	14.8	6.5	7.6	6.4	8.4	11.3	8.7	8.9	5.9	8.8	5.0	7.0	5.3	7.9	8.6	22.3	5.8	16.2	12.6	9.1	12.2	15.3	17.1	8.1	2.7	5.7	6.5	5.4	4.4	3.8	8.2	4.6	2.4	3.2	1.5	4.7	3.2	12.7	4.0	6.8	10.6	3.2	5.9	5.8	5.1	6.7	1.6	6.4	9.2	3.1	3.9	2.1	6.1	2.5	7.2	2.6	3.9	7.4	5.6	3.8	4.4	5.9	6.0	5.8	2.9	3.5	7.2	6.8	4.4	14.7	6.9	1.3	5.7	12.1	4.4	4.6	5.7	7.9	5.1	8.3	2.6	9.5	9.1	4.2	2.1	4.1	3.8	5.7	4.6	8.1	4.0	5.0	9.3	12.0	4.6	7.8	6.6	7.9	6.4	8.2	4.5	4.9	2.9	4.6	2.4	4.4	2.0	1.8	3.8	3.0	2.3	2.7	2.2	2.4	3.6	2.6	3.2	1.5	11.3	11.9	21.9	10.4	10.3	9.8	14.8	6.5	8.9	15.3
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 9.5;fHDF/TERT166: 9.6;HAP1: 17.6;HUVEC TERT2: 33.3;U-138 MG: 13.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7"	"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.1"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: "	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	27.9	9.5	14.5	4.6	30.3	0.4	26.8	1.1	45.3	27.1	6.8	2.7	8.0	4.0	54.9	14.4	9.5	15.6	18.3	18.5	16.6	4.8	14.9	15.0	31.3	6.9	5.5	21.7	11.9	4.6	15.2	5.6	33.7	3.4	10.4	5.4	15.4	6.1	8.6	7.5	5.4	6.8	32.8	4.2	32.9	6.7	6.4	3.4	0.7	17.8	7.5	3.0	14.7	13.3	0.2	0.0	0.3	0.0	5.1	0.0	0.6	0.0	0.0	9.5	0.0	5.5	9.1	0.0	5.2	4.0	0.6	1.4	0.0	0.0	0.0	0.0	9.6	0.0	17.6	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.1	0.0	6.5	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.4	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.7	13.4	0.0	0.6	0.0	4.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.6	14.5	30.3	1.1	45.3	16.6	4.8	5.5	21.7	3.4	3.4
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668449-86736068	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 6.0;SCLC-21H: 9.7;SK-MEL-30: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"			450000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: "	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0.0	4.9	0.4	4.2	9.9	9.9	1.3	1.0	213.9	1.7	1.0	0.3	0.2	0.4	0.2	2.6	0.0	1.5	0.3	0.3	0.1	0.5	0.0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0.0	0.0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0.0	0.3	0.3	0.4	3.2	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.3	0.6	0.0	0.4	0.2	0.0	0.1	0.9	0.8	0.7	0.9	0.1	0.1	0.1	1.7	6.0	0.5	0.1	0.0	0.0	0.3	1.9	0.3	1.6	0.4	0.2	0.4	0.3	0.0	2.0	0.1	0.0	1.1	9.7	1.8	0.3	0.2	4.7	0.3	0.2	0.0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.8	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0.0	0.9	1.6	0.1	0.6	1.7	1.0	2.6	0.0	0.0	0.0
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol			300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavourable (3.26e-8)"	"prognostic unfavourable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	66.1	48.6	48.0	131.1	34.9	70.0	53.9	19.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol			780000000	Cytosol		"CAB004641: AB_425525, HPA019007: "	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.7	88.0	77.4	50.9	55.5	61.8	90.0	45.8	45.8	64.1	63.5	139.3	0.1	116.1	30.1	30.8	16.5	106.4	84.9	81.7	29.7	74.1	119.5	84.1	0.1	53.1	111.5	51.7	70.6	30.4	56.1	76.4	73.1	65.3	17.5	70.5	0.1	94.7	135.0	223.2	38.2	85.6	108.0	93.6	318.2	146.3	24.9	57.7	21.0	32.6	79.0	0.2	87.5	28.4	43.2	56.7	30.7	86.3	15.5	20.9	152.5	47.9	53.4	51.2	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6
LDLRAD4	C18orf1	ENSG00000168675	"Low density lipoprotein receptor class A domain containing 4"	O15165	18	13217498-13652755	"Predicted intracellular proteins, Predicted membrane proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.4;lymphoid tissue: 49.2"	"Cell line enhanced"	"Detected in many"		"HEL: 15.5;MOLT-4: 47.4;REH: 14.3;U-698: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047633, HPA065246"	Approved		Supported	Vesicles				Vesicles		"HPA047633: , HPA065246: "	"unprognostic (2.52e-1)"	"unprognostic (4.31e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.94e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.18e-2)"	8.3	6.6	9.6	11.5	22.0	11.9	7.5	10.3	22.9	8.6	6.1	45.4	4.3	9.8	12.9	5.2	5.6	11.0	7.8	17.8	14.6	10.7	3.9	10.4	5.9	11.6	19.9	12.5	3.6	6.2	4.6	8.3	8.0	23.5	10.4	3.3	3.7	4.8	8.3	19.0	4.8	10.9	7.5	30.7	8.9	7.6	8.9	21.2	49.2	5.2	2.5	8.5	7.9	6.7	8.2	8.2	17.2	11.0	12.5	14.5	6.2	0.1	0.2	0.9	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.2	0.0	0.0	0.0	7.7	0.8	15.5	3.2	0.2	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.0	1.2	47.4	0.6	1.2	5.4	14.3	0.1	0.6	0.0	0.8	1.1	1.6	0.2	1.0	0.0	2.1	4.7	1.4	0.8	5.5	0.1	1.0	2.2	0.2	11.9	0.0	3.5	3.1	12.7	10.3	3.4	10.2	10.3	8.9	7.2	9.7	8.8	5.1	8.2	14.5	12.6	17.2	12.5	11.0	8.2	5.2	6.2	9.6	22.0	10.3	20.6	14.6	10.7	19.9	12.5	23.5	21.2
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1, regulator of NFKB signaling"	O95751	X	141175745-141177125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 29.2;MCF7: 39.3;PC-3: 49.3;U-251 MG: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 21.5"	"Low region specificity"	"Detected in all"			"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051768: , HPA061842: "	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	21.1	24.2	24.4	5.9	31.8	2.0	9.9	18.3	51.2	24.2	5.5	21.0	11.0	5.1	17.3	12.1	10.0	30.3	10.4	6.7	27.3	25.6	15.6	3.1	9.7	5.5	23.2	23.3	31.8	18.3	13.0	54.9	1.8	30.2	23.1	3.5	13.5	47.9	36.4	3.8	17.9	5.2	12.5	19.5	9.3	7.8	6.6	16.6	1.8	22.6	3.7	5.7	11.2	9.9	8.2	4.8	8.2	0.0	19.2	8.9	3.0	0.0	29.2	4.5	12.5	7.9	9.6	0.0	7.0	8.7	9.5	13.4	0.0	11.5	0.0	5.5	11.4	13.7	4.9	10.2	6.8	0.0	9.1	0.0	15.8	0.0	3.0	0.0	2.7	16.9	5.3	8.2	4.4	8.1	0.2	0.0	8.5	39.3	0.0	0.0	4.7	49.3	0.0	4.1	0.0	11.7	6.9	0.0	3.9	0.0	6.1	0.0	7.8	0.0	14.5	0.0	9.5	0.0	29.3	0.0	0.0	0.0	4.9	0.0	0.0	8.2	0.0	0.1	4.3	0.0	3.1	3.3	8.9	3.3	0.8	8.2	7.9	5.1	0.2	19.2	0.0	4.8	8.1	3.0	24.4	31.8	18.3	47.4	27.3	25.6	23.2	23.3	30.2	16.6
LEMD2	"dJ482C21.1, NET25"	ENSG00000161904	"LEM domain containing 2"	Q8NC56	6	33771202-33789136	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017340	Supported		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA017340: AB_2296925"	"unprognostic (9.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.29e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.12e-2)"	18.7	24.1	23.9	22.9	30.4	37.8	23.5	49.0	26.0	25.2	22.0	31.1	17.9	21.8	24.3	28.7	23.6	22.3	20.7	19.6	24.0	18.3	22.5	22.8	23.9	28.3	32.2	17.3	28.1	26.9	31.6	28.5	29.2	25.5	24.9	21.2	28.9	23.5	24.1	17.1	34.9	25.8	25.9	21.8	34.4	21.0	20.0	27.7	18.7	28.0	15.6	27.8	18.3	27.2	5.4	6.9	6.8	4.5	3.0	7.2	2.5	13.9	16.1	27.3	26.5	15.6	16.9	20.6	15.3	23.9	19.8	20.9	12.2	15.0	13.1	21.6	22.0	24.5	15.8	20.7	14.0	13.6	14.6	5.0	16.1	15.7	32.7	9.9	17.3	18.3	39.5	20.9	36.1	21.1	13.8	15.4	17.2	12.0	18.4	24.8	15.6	9.3	12.2	11.2	10.9	21.1	19.9	19.4	15.5	9.2	29.4	19.9	19.9	27.5	9.7	27.8	10.8	14.7	17.9	19.9	15.8	9.3	11.0	15.8	33.2	3.8	4.1	6.8	5.9	3.7	7.2	5.2	6.3	5.6	3.9	5.4	5.0	6.0	3.3	3.0	4.5	6.9	6.3	2.5	23.9	30.4	49.0	26.0	24.0	18.3	32.2	17.3	25.5	27.7
LEMD3	MAN1	ENSG00000174106	"LEM domain containing 3"	Q9Y2U8	12	65169571-65248327	"Disease related genes, Plasma proteins, Predicted membrane proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025078, HPA076986"	Uncertain		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA025078: AB_10601908, HPA076986: "	"unprognostic (2.10e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (2.30e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"	13.7	11.9	21.9	15.3	27.3	24.8	15.3	36.0	26.3	13.3	14.4	10.9	11.4	13.4	18.0	13.1	14.5	14.3	10.0	11.1	19.4	12.5	14.2	13.3	13.9	17.2	15.8	16.9	17.8	16.4	25.7	15.2	10.4	16.9	14.0	14.6	12.1	14.8	11.9	14.9	13.3	14.8	12.1	15.8	16.2	13.5	28.6	19.6	23.2	15.3	8.4	16.7	13.1	15.8	4.8	5.0	3.1	2.1	3.8	5.3	1.6	11.5	6.5	10.5	10.5	7.4	8.7	7.2	13.5	7.3	6.8	5.9	8.1	7.5	31.6	8.7	8.3	15.7	11.2	9.7	9.9	7.5	13.1	12.9	6.3	6.2	5.7	19.5	9.3	6.2	10.5	8.1	11.0	8.0	16.8	15.1	9.5	6.8	10.2	10.2	14.4	6.7	24.0	10.4	15.7	8.5	12.8	11.0	6.8	13.5	13.9	8.1	13.8	15.5	10.9	8.3	9.0	7.8	9.3	10.8	10.2	19.4	7.0	9.6	10.2	2.3	1.8	3.1	3.9	1.6	5.0	4.5	5.2	5.2	2.4	4.8	5.0	5.3	2.1	3.8	2.1	5.0	4.1	1.6	21.9	27.3	36.0	26.3	19.4	12.5	15.8	16.9	16.9	19.6
LENG8	"KIAA1932, MGC40108, pp13842"	ENSG00000167615	"Leukocyte receptor cluster member 8"	Q96PV6	19	54448887-54462037	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042004, HPA042056, HPA061571"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA042004: AB_10794642, HPA042056: AB_10795389, HPA061571: "	"unprognostic (2.09e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.42e-2)"	"prognostic favourable (7.59e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.45e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.85e-3)"	"prognostic unfavourable (3.30e-7)"	"unprognostic (3.64e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (2.73e-6)"	58.7	37.3	45.7	53.2	47.3	48.4	30.7	81.5	55.3	37.9	32.9	48.1	54.4	78.1	56.3	66.3	22.9	44.8	39.2	24.1	42.2	21.6	35.0	22.7	36.2	45.8	52.1	30.2	50.3	62.7	13.8	46.4	27.4	38.1	41.9	22.1	48.9	66.7	59.1	36.5	37.2	75.5	35.6	34.3	80.0	53.2	32.6	57.5	24.8	42.2	18.7	33.5	31.5	32.0	4.0	5.6	8.0	1.9	1.7	1.6	0.6	14.2	11.2	14.3	7.3	4.5	7.3	7.6	12.0	1.8	2.3	4.5	9.1	20.7	11.2	5.2	9.7	19.0	4.6	5.5	1.7	18.9	100.6	17.1	30.8	6.3	5.0	2.6	13.8	16.5	8.5	1.4	5.7	3.4	13.0	16.2	2.9	5.0	10.5	13.3	3.3	2.6	17.0	4.2	15.8	5.9	4.2	11.6	6.0	1.3	8.9	2.7	8.6	3.7	16.5	10.1	10.5	1.6	12.7	15.3	7.2	4.5	8.3	18.3	6.6	3.9	1.9	2.3	1.6	1.2	1.6	1.4	0.8	1.5	1.0	4.0	1.5	1.1	8.0	1.7	0.9	5.6	1.0	0.6	45.7	47.3	81.5	55.3	42.2	21.6	52.1	30.2	38.1	57.5
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971806	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"				"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.7	15.2	15.0	15.3	27.9	8.3	17.0	42.6	24.4	13.4	17.8	14.1	9.7	13.9	12.6	11.2	24.4	9.7	14.2	10.6	14.0	14.0	21.4	27.8	10.2	17.2	14.8	14.9	10.6	10.3	25.2	22.4	12.7	22.7	13.8	21.0	9.1	21.2	12.5	13.5	21.8	19.8	12.6	15.3	14.3	13.9	9.8	18.5	23.4	12.0	9.4	18.2	16.9	15.7	12.3	15.3	9.6	15.3	18.9	19.7	10.0	9.5	22.3	14.4	11.6	14.9	12.9	10.3	15.6	12.9	13.4	12.3	15.4	6.3	19.4	9.1	15.9	18.7	19.1	13.9	13.0	12.8	8.6	30.5	18.2	27.0	11.8	27.4	42.6	13.9	10.9	10.4	13.6	13.0	18.4	10.7	15.9	40.6	14.5	20.9	6.2	9.6	16.3	25.0	20.3	11.8	26.8	10.2	15.6	11.9	18.3	12.1	15.2	25.0	15.5	13.3	9.2	12.2	18.5	8.4	26.1	17.8	11.7	39.3	14.1	5.4	9.4	9.6	18.7	14.6	17.5	12.3	18.7	15.2	15.3	10.1	19.5	17.5	2.3	18.9	15.3	11.5	19.7	10.0	15.0	27.9	42.6	24.4	14.0	14.0	14.8	14.9	22.7	18.5
LETM1	SLC55A1	ENSG00000168924	"Leucine zipper and EF-hand containing transmembrane protein 1"	O95202	4	1811479-1856247	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011029, HPA011100"	Supported		Supported	Mitochondria				Mitochondria		"HPA011029: AB_1852804, HPA011100: AB_1852802"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.77e-4)"	"prognostic favourable (8.90e-4)"	"unprognostic (8.06e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.42e-1)"	16.9	15.3	11.9	11.2	13.1	9.9	16.8	17.3	19.9	6.7	23.7	10.0	7.5	20.3	8.5	6.9	22.0	8.1	15.0	18.9	10.2	10.2	16.2	20.4	9.4	10.7	10.6	10.5	9.5	19.7	13.0	8.7	7.6	10.7	8.2	16.3	9.2	9.7	7.2	17.2	18.5	19.4	8.0	7.7	10.6	15.6	12.6	9.0	50.7	10.9	19.9	16.6	8.0	9.7	5.0	14.7	3.8	5.6	6.7	7.1	2.1	12.1	20.6	6.4	19.9	9.9	7.0	11.5	12.0	5.9	12.1	9.5	19.0	13.5	20.0	8.6	12.6	12.3	16.4	17.0	7.5	13.3	17.1	20.5	16.8	13.6	12.9	20.7	16.9	11.3	12.2	13.8	12.3	10.4	26.9	12.6	8.3	13.3	29.9	23.7	16.8	23.8	17.2	9.0	11.7	9.5	16.9	16.4	14.5	13.7	17.4	7.2	16.3	10.9	15.6	13.9	8.3	11.7	20.0	11.0	16.9	16.0	12.3	18.1	11.1	3.8	4.5	2.1	7.1	5.6	7.0	5.0	6.0	6.1	4.7	4.6	4.0	5.9	0.7	6.7	5.3	14.7	4.6	2.1	11.9	13.1	17.3	19.9	10.2	10.2	10.6	10.5	10.7	9.0
LETMD1	"HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3"	ENSG00000050426	"LETM1 domain containing 1"	Q6P1Q0	12	51047962-51060424	"Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074361			Supported	Nucleoplasm,Nucleoli,Mitochondria				Mitochondria	"Nucleoplasm, Nucleoli"	"HPA074361: "	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.86e-2)"	"unprognostic (6.57e-2)"	"prognostic favourable (3.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.58e-1)"	"prognostic favourable (3.16e-4)"	25.7	27.5	23.0	18.1	31.2	17.1	27.1	23.1	37.5	18.6	26.8	18.8	21.5	31.9	22.9	22.4	16.2	30.0	23.5	16.4	21.2	19.0	29.3	35.1	16.6	18.5	20.6	21.3	34.3	38.6	28.5	20.2	12.3	21.6	19.1	26.1	22.6	28.2	24.0	23.8	18.5	28.5	18.7	21.4	17.5	22.6	15.5	14.3	19.9	34.1	10.7	20.1	20.3	14.8	11.3	7.2	2.9	11.6	8.6	17.1	9.3	7.4	6.7	5.0	13.5	22.8	37.5	5.1	7.7	12.8	8.2	9.2	16.2	15.4	19.7	9.6	8.3	13.9	10.3	10.4	9.4	7.1	12.9	14.1	9.3	12.7	15.1	12.7	10.3	31.5	33.7	9.6	22.8	8.2	14.7	14.3	11.1	11.6	8.9	12.3	3.4	18.3	7.6	6.1	10.7	10.2	11.4	15.1	6.9	5.8	13.1	17.6	20.7	11.6	6.2	5.1	5.5	8.4	4.4	13.0	20.2	8.4	9.5	8.3	3.6	2.5	7.3	2.9	8.6	7.8	12.5	11.3	14.2	10.6	7.2	8.1	17.1	15.5	2.4	8.6	11.6	6.4	12.6	9.3	23.0	31.2	23.1	37.5	21.2	19.0	20.6	21.3	21.6	14.3
LGALS14	"CLC2, PPL13"	ENSG00000006659	"Galectin 14"	Q8TCE9	19	39704306-39709444	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	34	"placenta: 110.8"	"Group enriched"	"Detected in some"	5	"EFO-21: 5.3;U-266/70: 12.6"	"Cancer enriched"	"Detected in single"	16	"liver cancer: 5.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"									HPA065180			Supported	Nucleoplasm				Nucleoplasm		"HPA065180: "										"unprognostic (1.95e-1)"								0.0	0.2	0.1	0.1	0.1	0.2	1.1	0.1	0.3	1.5	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.2	0.0	0.2	110.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.2	0.0	0.3	0.3	0.1	1.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	3.2	0.6	0.3	0.0	0.4	0.7	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.2	0.5	0.0	5.3	0.1	0.8	0.1	0.0	0.2	1.9	0.2	0.1	1.0	0.4	0.0	0.2	1.2	0.0	0.3	0.3	0.4	0.0	0.1	1.3	0.0	0.5	0.2	0.3	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.4	0.3	0.1	0.4	0.2	0.1	0.2	0.0	0.5	0.7	1.0	0.3	12.6	0.7	0.1	0.4	0.3	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.1	3.2	0.2	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.3	0.4	0.0	0.0	0.0
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145413	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.8;CAPAN-2: 74.5;SK-MEL-30: 175.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA003162, CAB005191"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		2300000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937"	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	95.7	11.0	10.4	50.9	13.6	29.8	53.2	6.5	11.7	54.1	127.1	6.1	42.4	75.7	50.3	30.7	76.1	26.1	83.9	42.3	8.4	5.7	19.9	3.9	65.5	16.6	8.5	9.4	58.9	24.2	0.5	11.0	78.7	5.5	51.7	93.7	25.7	78.3	51.7	31.3	76.1	182.4	48.2	8.7	11.1	36.9	20.4	5.7	5.5	18.0	65.7	41.7	41.1	44.4	1.3	41.7	3.6	67.4	2.5	25.9	37.2	22.4	7.2	0.2	0.1	46.8	93.8	27.4	18.0	37.9	5.0	8.9	15.5	74.5	0.0	9.5	20.9	22.5	0.4	18.8	2.8	26.6	0.3	0.0	8.0	7.1	35.5	0.0	0.0	29.3	28.7	5.7	12.1	7.8	0.1	21.7	11.3	15.1	0.0	5.4	0.4	20.2	0.0	0.9	1.6	46.8	30.0	0.6	1.7	42.1	0.0	175.1	18.5	2.4	14.2	23.7	3.3	8.8	0.3	12.1	38.3	0.1	34.1	1.4	2.5	1.7	67.4	3.4	1.8	55.4	11.4	1.3	6.8	5.1	41.7	0.4	0.3	1.0	3.6	2.5	44.2	1.1	25.9	37.2	10.4	13.6	6.5	11.7	8.4	5.7	8.5	9.4	5.5	5.7
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461834-124617888	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 106.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"			880000	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	9.6	14.2	37.3	6.0	34.0	6.9	7.9	11.9	34.2	12.3	13.6	29.7	8.2	17.9	7.5	11.0	12.7	8.1	8.3	9.8	43.0	31.5	18.6	33.8	6.6	8.2	62.7	19.3	5.5	12.2	6.6	5.6	7.2	20.5	6.9	6.7	6.7	13.3	10.6	6.5	8.9	15.7	8.1	106.0	8.2	12.4	14.2	19.5	7.1	20.5	3.6	11.2	8.7	5.7	24.7	20.0	13.3	16.1	3.9	17.2	12.9	14.7	7.3	3.0	7.5	11.6	9.5	7.9	5.4	11.1	3.4	6.3	1.3	13.7	14.6	12.6	8.1	16.0	0.9	2.8	3.6	3.2	10.5	10.6	2.3	6.7	11.8	2.1	17.3	7.0	12.5	3.4	8.2	5.4	5.2	5.8	4.2	14.6	7.0	6.8	5.3	4.1	7.5	3.3	18.6	7.4	1.9	1.6	9.0	3.8	13.9	4.9	10.5	0.3	2.5	5.3	7.9	4.4	1.4	4.9	1.5	4.7	4.9	4.1	1.2	4.6	16.1	13.3	9.5	13.5	12.4	23.7	11.1	10.1	20.0	24.7	13.7	9.6	2.7	3.9	14.9	7.5	17.2	12.9	37.3	34.0	11.9	25.0	43.0	31.5	62.7	19.3	20.5	19.5
LIF	"CDF, DIA, HILDA"	ENSG00000128342	"LIF, interleukin 6 family cytokine"	P15018	22	30240447-30246851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 35.5;U-138 MG: 39.6;U-251 MG: 28.6;U-87 MG: 31.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.7"	"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA018844, CAB025985"	Uncertain		Supported	Cytosol	"Secreted in other tissues"			Cytosol		"CAB025985: , HPA018844: AB_1852814"	"unprognostic (1.28e-2)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (6.78e-8)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.71e-3)"	20.3	1.7	1.4	21.6	3.3	0.6	5.2	0.9	4.3	4.4	3.9	1.8	1.6	3.7	6.9	2.6	2.0	7.3	28.7	14.2	1.2	0.6	5.7	3.4	17.4	3.8	2.2	0.5	7.9	7.5	0.2	7.3	1.3	11.7	8.6	4.7	3.5	3.2	1.2	1.9	6.0	5.2	4.6	4.3	1.6	4.1	2.0	1.8	0.9	3.4	2.2	5.4	20.8	1.7	0.0	0.0	0.0	0.0	1.2	0.2	0.1	8.7	14.7	0.4	3.3	0.0	1.2	5.4	1.2	5.3	1.6	3.8	2.3	14.3	0.0	3.2	0.0	2.2	0.3	4.0	2.1	2.0	0.6	1.1	5.0	3.2	1.4	0.0	11.5	1.4	0.7	35.5	1.0	0.0	0.2	0.0	6.9	6.5	0.1	0.0	0.5	9.1	0.2	5.0	0.0	12.7	3.4	0.0	0.1	1.4	0.1	2.6	0.3	0.1	0.1	39.6	14.6	14.9	28.6	0.0	0.0	0.0	31.3	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.4	3.3	0.9	4.3	1.2	0.6	2.2	0.5	11.7	1.8
LIG1		ENSG00000105486	"DNA ligase 1"	P18858	19	48115445-48170603	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037015, HPA041431, HPA048071"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB037015: , HPA041431: , HPA048071: "	"unprognostic (1.83e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.45e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.47e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.10e-3)"	"prognostic unfavourable (5.75e-5)"	"unprognostic (3.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	4.1	5.6	8.1	25.2	10.4	37.8	6.4	17.2	10.6	6.5	9.2	6.5	8.7	12.0	6.8	6.1	11.0	7.8	6.9	2.6	6.3	5.3	6.0	6.2	5.9	18.6	7.7	7.4	10.8	10.3	9.1	9.7	11.7	8.1	7.5	6.0	4.6	7.2	7.9	6.1	12.5	12.8	3.6	7.1	11.2	6.7	15.1	11.5	34.7	10.7	12.1	16.9	6.6	8.6	10.4	1.3	2.0	5.6	10.9	11.5	4.8	15.7	20.3	21.7	14.0	0.9	1.1	15.7	9.1	6.8	14.8	16.3	11.5	15.5	28.5	5.6	3.8	10.6	8.9	9.0	6.4	15.4	15.4	17.6	14.3	14.8	0.3	21.8	14.6	2.0	0.7	7.9	1.2	7.9	14.9	10.7	7.4	12.6	34.9	32.5	12.3	4.7	30.1	17.0	14.1	4.5	24.1	13.8	13.7	11.0	12.9	3.1	8.3	16.8	7.7	11.8	19.9	9.9	14.2	10.6	16.7	29.0	4.8	12.3	13.0	0.0	1.4	2.0	7.6	5.6	6.8	10.3	8.4	7.6	1.3	10.4	11.5	8.0	1.1	10.9	2.7	1.2	8.9	4.8	8.1	10.4	17.2	10.6	6.3	5.3	7.7	7.4	8.1	11.5
LIG3	LIG2	ENSG00000005156	"DNA ligase 3"	P49916	17	34980494-35009743	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006723	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA006723: AB_1847781"	"unprognostic (6.05e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.71e-2)"	8.8	11.5	10.7	9.8	17.0	9.2	12.5	15.9	18.3	14.7	11.5	15.8	11.4	8.4	21.5	12.3	14.2	17.3	7.9	11.0	14.2	8.0	9.8	11.8	9.8	9.6	9.1	11.7	17.8	15.4	22.9	13.3	16.5	9.3	16.5	13.1	11.8	14.3	13.9	17.0	13.9	9.8	14.7	8.0	14.3	11.6	27.8	10.9	20.8	14.5	9.7	13.9	13.6	12.7	4.6	10.1	4.8	6.3	11.1	8.4	4.5	8.1	16.3	19.7	17.3	3.9	4.9	15.1	7.9	5.8	10.8	10.8	7.9	4.5	13.4	6.6	10.3	7.6	22.3	10.2	13.9	6.3	14.9	14.0	7.8	11.4	6.2	21.9	24.9	3.7	9.0	7.9	12.5	13.0	22.0	15.4	7.8	9.1	27.5	7.0	18.9	6.9	15.0	18.1	14.1	5.3	8.9	16.1	11.5	11.9	9.7	7.7	17.6	11.0	6.2	7.0	8.8	8.6	12.7	13.9	14.9	17.4	5.0	10.4	13.4	0.6	3.8	4.8	5.9	6.3	8.4	4.6	4.0	5.2	10.1	4.0	5.4	3.8	0.3	11.1	3.2	6.0	2.5	4.5	10.7	17.0	15.9	18.3	14.2	8.0	9.1	11.7	9.3	10.9
LIG4		ENSG00000174405	"DNA ligase 4"	P49917	13	108207439-108218368	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001334, HPA057325"	Supported		Supported	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	"Cytoplasmic bodies"	"HPA001334: AB_1078689, HPA057325: "	"unprognostic (9.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.03e-3)"	8.8	12.4	11.6	10.4	15.9	4.3	9.1	14.2	20.6	5.4	7.1	10.2	7.8	8.9	5.8	11.4	8.1	5.9	8.7	8.8	15.6	14.4	11.2	16.7	8.7	12.7	15.5	10.6	7.9	8.3	17.0	20.3	8.3	19.6	7.5	8.7	3.8	6.7	7.1	9.5	6.6	8.6	8.4	14.4	12.6	9.7	11.7	13.6	18.6	10.0	5.4	10.2	8.1	5.3	3.3	2.1	6.8	10.7	2.7	2.7	1.5	9.4	3.6	9.8	6.5	8.2	8.8	3.5	9.4	7.1	7.2	8.7	4.3	4.3	16.2	7.7	6.1	3.9	6.5	6.3	12.5	9.4	6.2	7.6	8.3	2.2	9.8	10.2	8.1	8.0	10.5	7.0	6.3	8.6	2.7	3.0	11.1	5.1	16.8	7.4	2.5	2.3	15.5	3.9	2.6	9.4	6.1	6.2	6.4	2.1	5.8	7.1	4.9	15.7	12.7	4.3	4.7	4.8	8.4	8.0	5.2	26.3	16.6	5.9	9.7	0.8	2.3	6.8	1.8	3.8	2.5	2.6	2.0	1.9	2.1	3.3	2.0	2.7	3.2	2.7	10.7	1.4	2.7	1.5	11.6	15.9	14.2	20.6	15.6	14.4	15.5	10.6	19.6	13.6
LIMA1	EPLIN	ENSG00000050405	"LIM domain and actin binding 1"	Q9UHB6	12	50175788-50283546	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 83.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023871, HPA052645"	Enhanced		Enhanced	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"			160000	"Plasma membrane, Actin filaments"	"Focal adhesion sites, Cytosol"	"HPA023871: AB_1852875, HPA052645: AB_2681898"	"unprognostic (6.22e-2)"	"unprognostic (9.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavourable (1.76e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.28e-3)"	"unprognostic (6.27e-2)"	"prognostic favourable (2.79e-4)"	"unprognostic (7.12e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-1)"	50.3	19.8	6.6	22.3	6.8	0.9	34.1	73.6	6.6	30.9	49.2	10.4	21.3	35.2	31.1	22.1	25.0	18.0	31.1	12.6	6.6	5.1	29.3	11.1	23.3	11.8	7.2	4.1	21.1	12.4	12.4	18.6	42.0	15.4	28.2	42.8	20.7	27.0	22.1	10.5	16.3	90.5	33.8	10.4	23.6	30.3	11.8	6.0	12.1	17.0	20.7	18.0	41.8	21.4	0.6	4.4	1.3	2.1	5.8	13.6	2.7	24.0	0.7	7.7	11.3	35.4	35.6	29.1	60.5	42.6	48.7	39.0	9.1	35.4	1.0	5.6	83.2	27.4	6.9	55.8	42.7	15.3	7.3	10.0	2.7	3.2	22.7	3.6	14.3	23.8	16.5	17.1	49.3	17.1	7.0	4.9	15.6	4.1	4.4	1.1	3.9	3.3	4.4	18.8	0.3	11.3	28.7	5.7	12.4	8.2	16.7	25.9	7.9	2.2	26.6	20.9	16.1	19.3	9.8	2.7	0.3	4.4	22.7	4.0	8.9	0.1	0.2	1.3	6.4	1.0	2.5	0.1	8.1	7.8	4.4	0.6	3.3	5.9	0.1	5.8	2.1	1.1	13.6	2.7	6.6	6.8	73.6	5.6	6.6	5.1	7.2	4.1	15.4	6.0
LIMD1		ENSG00000144791	"LIM domains containing 1"	Q9UGP4	3	45555394-45686338	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064220			Supported	"Nucleoplasm,Focal adhesion sites"				"Nucleoplasm, Focal adhesion sites"		"HPA064220: "	"unprognostic (2.77e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.11e-3)"	"prognostic favourable (6.73e-5)"	"unprognostic (8.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.61e-3)"	12.6	7.0	4.8	14.9	5.5	6.2	13.9	2.5	6.0	10.2	9.7	8.1	13.0	8.4	14.4	12.0	10.4	9.6	10.9	11.5	5.1	4.1	8.3	16.6	24.8	17.1	9.2	2.2	7.6	24.5	11.3	5.5	11.7	9.4	12.1	9.2	20.2	19.1	8.2	25.2	8.3	12.2	12.5	6.8	16.4	11.4	6.2	6.4	20.3	17.9	10.7	24.9	12.9	18.9	6.7	8.8	4.1	5.5	1.1	1.6	1.0	7.3	14.0	5.1	6.9	4.5	8.9	10.3	7.1	10.0	7.6	6.7	6.6	3.9	0.9	4.7	6.5	5.0	10.9	5.8	6.3	15.5	6.7	8.2	11.1	5.4	4.6	7.3	10.6	3.7	4.8	11.3	6.0	6.6	6.8	23.2	7.5	4.9	8.9	4.6	8.3	13.5	4.4	6.0	11.2	4.0	13.2	2.4	4.6	6.0	10.9	7.2	6.6	6.6	11.8	8.4	7.7	8.4	7.5	22.2	28.5	3.7	18.2	6.7	9.1	4.1	1.4	1.4	1.6	3.1	1.0	3.9	1.3	1.4	1.4	6.7	1.4	1.4	1.6	1.1	5.5	8.8	1.3	1.0	4.8	5.5	2.5	6.0	5.1	4.1	9.2	2.2	9.4	6.4
LIMD2	MGC10986	ENSG00000136490	"LIM domain containing 2"	Q9BT23	17	63695902-63701172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 175.1;lymphoid tissue: 98.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 53.5;NB-4: 37.3;SH-SY5Y: 37.3;U-698: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062432, HPA075172"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA062432: , HPA075172: "	"unprognostic (2.90e-3)"	"unprognostic (2.89e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (5.36e-11)"	"unprognostic (1.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.08e-2)"	3.6	2.0	6.5	54.8	14.8	28.7	2.3	1.2	8.5	2.7	2.9	3.0	1.3	3.9	2.6	3.2	3.0	2.6	5.1	2.7	9.6	3.3	3.7	5.1	8.1	63.5	3.6	3.7	2.8	1.7	0.8	3.5	6.4	2.8	4.1	2.8	5.0	11.3	1.7	1.1	1.8	12.9	2.6	3.0	51.1	5.5	6.1	1.7	98.4	2.5	2.2	79.7	7.4	2.6	81.9	55.1	175.1	65.1	46.6	67.5	73.0	0.1	1.7	21.1	5.1	0.2	0.5	0.5	0.5	0.3	2.1	1.4	0.9	0.4	53.5	4.7	2.5	0.8	4.6	0.2	0.6	18.4	1.9	15.9	0.3	4.5	4.1	20.6	1.7	5.3	0.2	2.1	0.0	5.7	1.4	3.1	2.4	0.2	18.2	37.3	11.4	1.0	7.5	8.5	9.4	2.9	0.2	25.5	37.3	2.6	0.0	4.9	0.1	28.0	7.1	2.9	6.5	0.1	0.7	0.6	0.2	55.8	0.3	2.9	5.1	175.1	54.6	122.9	35.7	63.3	35.1	64.6	49.4	41.5	55.1	81.9	67.5	48.1	112.7	46.6	65.1	20.8	58.1	73.0	6.5	14.8	1.2	8.5	9.6	3.3	3.6	3.7	2.8	1.7
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.2"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028064, HPA028516"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA028064: AB_10600111, HPA028516: AB_10601751"	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	8.8	8.6	31.6	18.2	18.6	6.3	7.4	14.3	44.1	11.5	6.6	7.1	6.6	6.9	7.3	5.3	6.4	6.0	10.8	6.3	26.8	32.9	5.2	2.6	12.5	22.0	33.4	22.2	12.1	8.1	4.0	7.2	8.0	45.2	6.1	4.7	4.8	18.1	9.6	10.9	6.8	7.2	7.6	10.8	18.4	7.8	10.4	6.5	4.3	7.5	3.7	18.1	14.1	7.2	4.6	8.6	3.8	7.7	6.9	2.4	3.1	17.2	13.5	10.3	17.1	13.6	18.5	7.5	10.7	10.3	8.7	9.7	7.8	17.0	10.7	4.8	13.1	10.4	3.8	6.6	3.3	18.5	6.7	7.9	4.6	8.9	15.6	6.0	29.0	18.2	5.9	7.0	3.7	12.9	5.3	3.4	10.8	15.1	5.1	10.8	19.5	8.4	7.5	16.0	6.7	9.6	3.7	4.1	9.4	6.9	16.5	8.6	5.2	5.4	15.3	13.9	12.9	35.7	17.1	3.9	4.3	19.5	51.4	4.4	9.4	0.1	6.5	3.8	2.4	7.7	1.8	4.6	0.6	1.5	8.6	2.4	0.2	0.7	0.7	6.9	4.7	0.8	0.4	3.1	31.6	18.6	14.3	44.1	26.8	32.9	33.4	22.2	45.2	6.5
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 37.8;hTCEpi: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 14.7;neutrophil: 37.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB019313: , HPA008183: AB_1079252, HPA053882: "	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	9.4	6.6	23.5	23.6	26.2	29.4	17.0	9.9	16.8	11.0	20.9	15.6	10.7	13.1	12.9	8.7	33.7	22.1	28.7	6.0	15.4	10.7	15.4	19.9	21.6	18.1	20.8	7.2	11.4	19.9	20.0	12.8	64.3	23.3	17.1	22.1	10.1	25.7	16.2	9.7	36.7	13.3	10.1	28.3	17.4	18.5	16.8	17.9	12.4	25.8	15.6	15.3	13.1	20.0	1.0	1.6	37.2	1.9	2.4	5.6	1.6	7.0	1.1	4.9	2.7	2.1	2.5	37.8	4.7	2.2	4.7	4.0	6.1	3.3	6.9	8.4	7.0	14.4	5.7	24.6	3.0	5.0	6.2	5.0	5.6	6.5	3.2	9.2	9.2	4.0	70.1	3.8	11.5	12.0	2.8	5.0	6.4	5.5	5.6	3.2	4.6	1.8	7.5	8.3	3.8	5.5	16.8	6.3	5.7	3.5	22.7	9.4	18.9	3.7	7.2	4.2	6.6	2.3	4.3	2.8	4.1	6.0	2.7	4.4	1.8	2.1	1.9	14.7	1.3	1.3	2.4	0.8	2.3	1.7	0.7	1.0	2.3	1.8	37.2	2.4	0.5	1.6	5.6	1.6	23.5	26.2	9.9	16.8	15.4	10.7	20.8	7.2	23.3	17.9
LIMS1	"PINCH, PINCH1"	ENSG00000169756	"LIM zinc finger domain containing 1"	P48059	2	108534355-108687246	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA058455, HPA061230"	Approved		Supported	"Focal adhesion sites,Cytosol"			130000000	Cytosol	"Focal adhesion sites"	"HPA058455: , HPA061230: "	"unprognostic (1.79e-1)"	"unprognostic (8.82e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (7.51e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.11e-1)"	39.3	26.3	7.8	18.3	13.3	14.9	21.5	3.9	9.6	18.1	16.9	14.4	38.2	8.3	21.9	21.7	18.4	16.9	16.5	20.2	8.0	7.5	20.8	18.0	26.3	21.2	13.3	4.6	18.3	10.6	6.6	13.6	19.0	10.8	15.8	9.5	11.0	13.8	43.6	54.0	11.2	17.9	18.8	16.7	24.3	13.0	9.3	10.7	20.2	13.1	15.0	25.5	21.1	16.1	4.4	14.2	45.6	34.0	8.8	20.9	29.6	9.2	10.4	4.1	4.9	6.8	10.0	19.9	10.4	12.0	8.1	8.3	18.0	20.1	9.0	31.9	13.3	6.0	6.2	10.7	10.8	22.2	11.1	47.2	7.4	9.5	15.7	8.8	88.1	9.7	9.9	21.4	17.7	29.2	16.6	12.6	24.9	7.6	8.4	6.5	8.1	10.7	10.8	14.3	7.3	15.4	16.8	7.5	10.1	16.4	7.0	7.3	3.6	8.3	39.2	36.8	16.8	8.1	21.3	12.3	16.3	12.8	30.7	10.0	9.3	38.3	16.9	45.6	4.3	28.7	7.8	4.4	18.5	5.7	14.2	3.5	5.0	1.8	8.0	8.8	34.0	1.8	20.9	29.6	7.8	13.3	3.9	9.6	8.0	7.5	13.3	4.6	10.8	10.7
LIMS2	"PINCH-2, PINCH2"	ENSG00000072163	"LIM zinc finger domain containing 2"	Q7Z4I7	2	127638381-127681786	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 114.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 11.8;fHDF/TERT166: 13.0;HHSteC: 15.6;MOLT-4: 17.7;TIME: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 17.1"	"Group enriched"	"Detected in many"	14	"B-cells: 17.1;T-cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058340	Enhanced		Supported	"Focal adhesion sites"				"Focal adhesion sites"		"HPA058340: "	"unprognostic (2.51e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.49e-1)"	"prognostic favourable (6.53e-7)"	"unprognostic (3.98e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.86e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.00e-2)"	21.9	4.4	3.4	16.7	4.5	0.2	17.9	1.5	5.8	31.7	83.5	4.6	18.1	6.5	49.9	17.4	28.3	23.8	31.8	40.2	4.2	1.8	11.7	8.0	20.1	4.9	3.7	4.3	8.2	2.9	2.6	2.8	11.6	6.4	30.6	6.6	20.4	8.0	45.1	12.5	5.7	16.9	114.4	4.0	21.6	25.6	6.8	2.7	11.5	9.3	6.5	4.5	65.1	44.9	17.1	0.8	0.3	0.2	0.0	8.2	1.9	0.3	0.7	0.2	0.0	2.1	0.5	0.2	8.6	11.8	9.3	8.6	2.3	0.0	0.0	5.0	13.0	0.0	0.1	0.0	1.9	0.0	0.3	0.0	5.5	1.6	15.6	0.0	0.0	0.1	0.0	3.6	0.1	6.4	0.0	0.0	4.3	0.0	17.7	0.4	0.6	1.1	4.0	0.8	0.4	0.6	0.0	0.0	0.1	1.6	0.8	0.3	0.3	0.0	37.1	0.0	6.2	7.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.2	0.0	10.7	3.9	0.8	0.1	17.1	8.2	3.3	0.3	0.0	0.1	0.8	5.2	1.9	3.4	4.5	1.5	5.8	4.2	1.8	3.7	4.3	6.4	2.7
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410778-26429722	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 9.8"	"Cell line enriched"	"Detected in some"	10	"NTERA-2: 137.5"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"				Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.5	0.1	0.1	0.1	0.2	0.3	9.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.6	2.3	0.5	1.0	0.8	0.1	0.0	0.0	13.5	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.7	0.7	0.3	0.4	1.0	0.5	0.6	0.2	1.3	0.8	0.7	2.2	1.0	0.3	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 51.9"	"Cell line enhanced"	"Detected in some"		"AF22: 13.9;BEWO: 71.7;K-562: 23.2;NTERA-2: 12.6"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	1.2	0.0	0.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.0	0.1	0.1	0.1	0.5	0.8	0.0	0.0	0.0	1.0	51.9	1.2	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	5.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.7	2.1	0.4	0.2	0.5	0.3	0.0	0.9	13.9	2.8	0.0	0.0	71.7	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	6.7	9.9	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.3	0.0	0.0	1.4	1.6	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.3	0.0	0.0	1.1	0.0	2.9	0.3	0.0	1.5	0.0	0.0	4.2	5.9	0.0	0.0	0.0	0.0	1.6	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.7	0.1	0.2	2.1	0.2	0.4	0.7	0.2	0.3	1.2	0.8	0.1	1.3	0.9	1.3	0.5	0.8	1.2	0.4
LIN37	"F25965, lin-37, ZK418.4"	ENSG00000267796	"Lin-37 DREAM MuvB core complex component"	Q96GY3	19	35748361-35754519	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043253, HPA047809"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA043253: , HPA047809: AB_2680162"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.77e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.56e-1)"	"prognostic favourable (1.67e-4)"	"unprognostic (9.88e-3)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (2.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.35e-1)"	"unprognostic (5.14e-2)"	12.0	13.1	15.7	6.4	18.6	13.5	10.0	22.9	20.6	12.9	11.4	10.1	9.4	8.4	15.3	11.5	10.5	15.5	10.2	17.3	12.2	12.7	8.8	9.3	10.6	11.4	10.6	13.1	21.5	13.5	7.9	13.5	15.3	11.9	9.7	7.1	10.3	10.3	13.5	16.8	15.2	8.5	11.8	10.4	10.0	8.7	13.7	13.4	11.2	11.1	7.4	11.2	10.6	10.7	11.5	11.3	16.9	4.3	9.2	13.7	7.2	5.5	13.6	4.5	5.5	9.6	7.3	6.3	6.3	8.0	12.0	13.7	4.8	1.9	4.4	6.6	9.0	2.0	4.2	6.4	4.1	12.2	6.1	5.1	5.9	5.7	23.3	3.7	6.7	6.3	11.8	10.2	19.6	8.4	5.1	5.0	7.7	13.3	4.8	4.5	1.3	6.5	2.3	3.5	3.3	8.1	3.3	4.3	4.6	6.9	11.0	5.5	4.9	6.4	7.0	5.7	3.3	6.5	8.6	7.8	8.2	3.5	6.9	5.5	4.6	7.9	4.3	13.8	11.2	4.1	10.4	10.9	12.7	13.2	4.9	11.5	13.7	12.4	16.9	9.2	4.3	11.3	13.1	7.2	15.7	18.6	22.9	20.6	12.2	12.7	10.6	13.1	11.9	13.4
LIN9	TGS	ENSG00000183814	"Lin-9 DREAM MuvB core complex component"	Q5TKA1	1	226231149-226309869	"Predicted intracellular proteins"	"Cell cycle, DNA synthesis"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030241	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA030241: AB_10601542"	"unprognostic (9.90e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.51e-5)"	"unprognostic (2.80e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.26e-2)"	3.7	3.0	3.9	5.9	3.9	6.9	4.3	17.5	5.6	5.0	7.9	2.6	3.3	5.1	4.1	2.1	6.0	3.2	2.9	15.9	4.2	2.8	4.3	2.4	5.1	5.8	2.4	1.9	6.6	3.1	2.3	3.1	5.0	4.5	4.6	5.0	2.3	3.8	3.0	4.6	4.7	7.8	3.6	3.7	5.0	4.0	11.6	4.6	22.0	4.8	5.8	5.8	4.3	4.3	4.3	1.3	6.2	5.1	2.9	6.8	2.0	8.9	5.6	9.5	6.8	0.9	2.4	18.7	6.6	4.2	11.6	10.4	6.2	11.8	8.5	8.6	2.9	8.4	9.0	3.4	10.4	8.0	16.4	5.4	7.3	4.4	0.8	10.2	5.7	0.9	2.5	6.0	6.2	5.7	18.2	10.2	7.0	3.2	10.8	7.0	15.4	10.4	10.7	16.4	11.1	3.8	4.5	8.5	12.0	11.7	14.0	8.6	7.8	13.6	2.7	6.7	10.0	9.1	16.9	4.8	11.1	17.9	4.0	9.6	15.7	6.2	2.0	1.8	2.5	2.6	3.7	4.3	4.3	5.5	0.8	3.7	6.8	5.0	0.3	2.9	5.1	1.3	5.5	2.0	3.9	3.9	17.5	5.6	4.2	2.8	2.4	1.9	4.5	4.6
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 60.3;ASC TERT1: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.3;monocytes: 68.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		150000	Vesicles		"CAB034892: AB_784329, HPA057052: "	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	139.0	16.3	15.8	14.4	22.7	7.8	19.9	8.8	21.4	13.4	28.1	61.3	3.4	37.4	10.2	5.2	9.5	9.0	19.4	8.7	22.5	13.8	10.8	49.3	38.5	45.7	41.6	13.4	10.4	9.5	17.5	6.3	17.8	28.4	7.4	16.7	5.7	11.0	8.8	4.1	6.8	65.8	11.3	55.1	87.3	7.9	3.1	37.2	7.0	8.3	4.7	10.0	15.1	8.6	7.0	23.3	3.2	68.4	5.5	8.3	25.5	53.8	8.3	5.5	60.3	56.9	75.6	1.6	28.6	33.5	11.9	21.5	3.2	29.1	9.9	5.6	44.8	54.1	2.4	15.5	8.9	14.0	5.6	4.1	3.5	12.8	15.0	8.0	8.2	33.6	11.1	12.7	6.9	2.3	0.0	18.6	9.3	4.5	6.9	5.4	3.6	9.4	4.5	6.5	9.2	11.0	8.5	1.8	3.8	6.9	9.0	21.0	10.3	10.3	4.3	10.2	2.7	21.8	6.9	9.7	10.2	4.1	12.2	17.6	12.7	0.8	31.8	3.2	8.2	68.4	8.2	6.5	7.3	7.8	23.3	7.0	7.7	8.3	1.4	5.5	35.6	4.7	7.1	25.5	15.8	22.7	8.8	21.4	22.5	13.8	41.6	13.4	28.4	37.2
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401507-42427426	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 207.4;breast: 65.1"	"Cell line enriched"	"Detected in many"	7	"ASC diff: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol				Cytosol		"CAB017700: AB_2135504, HPA006567: "	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	207.4	6.0	3.2	2.9	9.4	2.1	65.1	2.0	6.8	1.2	6.7	19.6	0.8	2.4	1.7	1.3	2.2	1.6	3.6	4.8	6.2	4.2	1.5	1.1	1.4	2.7	18.0	2.3	1.5	2.2	2.2	0.8	1.7	9.9	1.7	1.3	3.7	5.4	1.7	3.7	2.9	3.4	1.7	19.2	3.1	1.6	9.0	10.8	1.7	1.5	1.8	1.9	2.0	3.7	6.1	4.8	10.8	12.1	4.1	5.2	4.0	4.8	3.7	2.4	0.9	56.0	0.5	0.0	2.3	1.2	3.7	3.4	0.9	1.8	8.0	2.5	0.7	2.1	1.4	4.5	0.4	1.5	2.4	2.2	1.8	0.1	1.1	0.0	5.5	0.4	4.3	0.6	0.8	1.0	1.0	5.1	0.4	0.0	5.6	0.2	0.3	1.1	4.6	0.4	2.6	1.0	5.1	3.4	3.5	2.0	2.3	2.1	0.6	2.9	1.8	1.0	3.2	0.4	2.0	3.8	3.1	5.9	2.5	0.2	3.4	10.8	12.1	4.7	3.6	6.0	3.3	4.8	4.6	5.2	4.8	6.1	4.1	3.7	2.0	4.1	3.3	3.9	3.9	4.0	3.2	9.4	2.0	6.8	6.2	4.2	18.0	2.3	9.9	10.8
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 202.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 202.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 202.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	55.0	14.1	18.0	49.2	42.4	53.3	65.7	5.0	18.5	50.4	36.4	45.2	20.2	13.9	42.7	28.8	19.6	34.0	35.3	31.5	20.7	15.7	48.9	66.3	73.0	80.6	28.6	13.2	43.1	26.3	15.9	17.1	46.2	42.8	36.2	36.7	26.0	57.3	32.2	18.6	28.5	24.1	41.6	52.1	57.9	26.3	11.0	19.0	18.7	53.3	18.8	36.4	47.4	41.6	14.1	16.9	202.5	10.3	20.2	37.6	35.6	13.7	25.6	16.2	7.8	2.5	1.9	16.4	17.9	55.1	17.0	25.4	10.6	37.1	6.9	22.9	15.1	17.0	6.8	30.0	16.3	52.7	7.1	0.5	22.3	53.7	38.0	2.1	2.3	5.7	58.3	13.9	38.2	0.0	4.2	26.8	0.2	13.1	0.3	31.8	26.4	0.1	2.1	3.5	39.6	14.3	19.4	4.0	12.2	30.9	39.5	31.8	22.1	11.7	0.1	7.1	12.0	4.1	4.1	10.5	23.1	17.7	8.1	16.8	40.5	32.2	10.3	20.8	37.6	9.8	22.8	14.1	23.5	33.5	13.6	13.9	26.8	31.7	202.5	20.2	5.7	16.9	26.2	35.6	18.0	42.4	5.0	18.5	20.7	15.7	28.6	13.2	42.8	19.0
LLGL2	"HGL, Hugl-2"	ENSG00000073350	"LLGL2, scribble cell polarity complex component"	Q6P1M3	17	75525080-75575208	"Predicted intracellular proteins"	"Cell cycle, Cell division, Exocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;CAPAN-2: 38.2;MCF7: 36.7;RT4: 26.1;SK-BR-3: 36.6;T-47d: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 6.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.2;NK-cells: 4.1;T-cells: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022913	Uncertain		Supported	Vesicles,Cytosol				Cytosol	Vesicles	"HPA022913: AB_1852930"	"unprognostic (1.18e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"prognostic favourable (9.25e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.49e-1)"	"prognostic favourable (6.00e-5)"	"unprognostic (6.22e-3)"	"prognostic favourable (6.14e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.56e-2)"	1.7	3.9	1.5	17.3	4.2	1.4	4.2	5.1	3.7	7.1	27.5	5.2	23.0	22.9	2.8	17.1	24.3	6.4	45.7	1.7	1.7	1.0	35.6	17.1	16.0	2.1	11.2	1.8	4.6	37.5	5.0	8.3	5.1	3.6	6.6	11.9	6.3	21.4	20.0	0.7	13.9	36.0	1.2	2.5	9.6	27.7	4.3	4.9	1.5	13.4	13.0	13.6	7.0	10.6	0.6	2.2	0.3	0.6	4.1	6.2	0.9	16.5	15.4	0.0	2.9	0.0	0.0	6.5	0.1	0.1	0.3	0.2	25.9	38.2	1.1	3.9	0.0	20.9	2.9	2.8	0.0	1.4	5.2	1.1	4.3	9.8	0.1	0.1	2.5	0.0	3.9	0.0	0.6	0.6	2.1	1.5	0.0	36.7	0.9	1.9	2.1	6.1	1.9	0.0	4.1	8.2	26.1	6.4	1.2	3.3	36.6	1.1	27.7	2.6	0.1	0.0	0.1	0.0	0.2	1.8	2.4	0.4	0.1	0.1	0.7	0.0	0.3	0.1	6.2	0.6	1.4	0.6	1.5	4.2	0.3	0.6	0.2	2.5	0.3	4.1	0.2	2.2	1.0	0.9	1.5	4.2	5.1	3.7	1.7	1.0	11.2	1.8	3.6	4.9
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation"	Q9BRT6	12	66116555-66130768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048920, HPA058786"			Enhanced	Nucleoli				Nucleoli		"HPA048920: , HPA058786: "	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavourable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	20.4	38.1	16.4	20.4	16.9	40.9	17.9	10.9	20.0	16.4	20.2	11.2	19.7	16.4	17.2	17.1	21.3	14.4	13.4	19.9	15.7	13.9	27.8	31.3	14.5	21.4	20.6	16.7	18.2	16.2	11.1	18.0	24.3	17.3	18.1	18.6	9.9	15.9	14.5	47.3	13.9	27.9	21.0	26.7	29.7	18.6	20.0	17.6	23.8	22.9	23.5	21.6	23.6	22.4	23.6	24.6	34.9	34.7	20.0	29.4	21.1	26.9	21.8	13.5	16.6	15.7	15.5	16.7	31.7	20.5	23.5	19.9	18.9	11.4	31.4	26.1	21.0	23.2	21.0	19.2	31.9	27.4	18.0	33.1	15.8	16.8	19.0	57.5	23.3	15.7	19.8	20.0	21.5	20.2	28.6	22.5	27.5	29.0	25.7	38.8	28.9	23.2	21.9	24.8	22.5	23.1	32.7	13.5	16.8	20.5	21.8	33.4	28.0	31.4	21.8	18.5	26.5	22.5	28.7	17.5	27.1	46.4	24.2	27.1	28.0	22.2	25.6	26.4	23.7	29.0	27.0	23.6	27.6	25.5	24.6	21.7	23.9	25.2	34.9	20.0	34.7	21.2	29.4	21.1	16.4	16.9	10.9	20.0	15.7	13.9	20.6	16.7	17.3	17.6
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501707-8574673	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 189.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 29.8;HSkMC: 41.7;hTEC/SVTERT24-B: 30.6;U-2197: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	38.6	3.3	1.6	10.1	1.8	0.0	36.4	3.9	1.9	11.7	4.4	3.8	5.2	1.9	22.3	20.8	8.3	11.9	15.4	15.9	2.3	1.7	5.5	2.2	25.9	3.8	2.4	1.7	17.9	8.5	5.8	2.0	14.1	4.5	16.1	1.6	4.6	19.2	7.0	189.9	5.7	3.3	72.9	3.7	14.3	10.6	9.3	1.3	0.8	4.6	34.3	7.1	29.4	15.7	1.8	2.7	0.0	0.3	0.0	17.0	0.2	2.9	16.6	2.8	2.1	20.7	11.7	2.9	12.1	6.2	6.7	16.5	12.2	3.7	0.0	1.4	14.0	0.2	1.6	3.1	2.7	5.0	1.1	3.6	1.1	2.4	29.8	0.0	0.3	41.7	0.0	30.6	0.2	3.2	0.0	0.0	8.6	2.1	0.0	0.0	5.4	0.7	0.0	9.2	0.0	6.1	1.1	0.1	6.9	2.0	10.1	6.3	13.2	0.0	1.5	6.7	13.5	27.0	8.1	1.6	1.9	0.8	1.3	0.9	8.7	0.0	0.0	0.0	0.0	0.3	0.1	1.8	2.6	0.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.9	17.0	0.2	1.6	1.8	3.9	1.9	2.3	1.7	2.4	1.7	4.5	1.3
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"				Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favourable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	3.9	4.9	5.2	2.5	11.0	2.3	4.5	6.1	9.1	6.2	3.5	5.8	14.3	2.2	4.8	20.3	3.5	9.3	5.1	5.9	5.7	7.4	6.6	3.7	8.1	3.5	5.6	8.9	6.5	6.1	8.8	15.0	3.9	11.6	4.6	4.1	5.4	4.2	11.7	3.7	6.5	2.3	4.0	5.5	3.0	3.9	27.0	4.4	1.2	7.6	3.0	2.6	3.5	3.7	1.9	1.9	0.8	2.4	1.8	2.4	1.2	6.5	2.5	3.0	3.5	5.9	8.3	2.5	3.4	3.1	6.2	5.1	2.4	2.4	2.1	16.0	2.4	2.5	2.8	2.7	9.0	0.3	2.0	1.2	2.1	1.8	3.7	3.7	1.8	3.9	6.1	7.7	5.0	2.7	6.3	4.0	5.9	4.9	2.2	3.2	3.3	6.0	2.5	0.7	2.2	6.4	1.7	4.8	1.4	4.8	4.3	3.4	11.1	2.8	5.7	7.6	1.1	9.2	5.7	7.1	13.8	0.6	10.9	6.4	6.9	0.2	0.6	0.5	1.2	2.4	1.7	1.9	0.8	1.6	1.9	1.1	2.2	2.4	0.8	1.8	0.9	0.5	0.0	1.2	5.2	11.0	6.1	9.1	5.7	7.4	5.6	8.9	11.6	4.4
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140089	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease mutation, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.4;memory CD4 T-cell: 8.9;myeloid DC: 34.8;T-reg: 35.4"	"Group enriched"	"Detected in all"	8	"dendritic cells: 34.8;granulocytes: 10.4;T-cells: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006660, HPA012078"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"			3200000	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB004022: AB_2136278, HPA006660: AB_1079231, HPA012078: "	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	64.0	37.3	7.4	51.4	11.8	21.3	88.6	9.0	10.8	62.8	32.6	21.9	27.2	28.6	69.1	52.3	62.2	40.1	77.7	62.5	8.8	7.5	25.9	26.6	51.8	39.6	15.7	11.2	60.3	30.9	15.2	17.4	73.3	18.1	34.0	15.2	32.7	37.5	26.4	36.3	68.7	29.9	63.0	10.3	22.4	36.7	30.2	12.9	9.4	31.5	140.0	35.6	46.4	51.2	1.1	34.8	10.4	3.5	1.7	35.4	6.4	58.6	58.2	6.4	17.3	32.6	56.6	19.9	63.4	80.9	47.9	33.2	14.7	58.1	0.5	37.7	97.5	68.7	9.4	49.2	12.4	19.9	5.5	18.5	46.9	34.0	29.5	3.2	54.7	33.9	21.4	38.9	26.8	42.7	9.9	4.5	52.4	46.3	0.1	10.2	4.8	74.2	0.2	22.6	17.2	47.4	28.2	6.6	13.2	42.8	46.5	58.9	39.3	15.3	76.1	45.7	29.1	56.4	51.2	4.4	1.1	1.2	74.7	3.0	136.2	10.4	3.5	0.1	1.2	0.8	1.0	1.1	8.9	3.4	34.8	0.0	0.1	0.3	0.8	1.7	0.1	0.3	35.4	6.4	7.4	11.8	9.0	10.8	8.8	7.5	15.7	11.2	18.1	12.9
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 93.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 23.4;pons and medulla: 6.3"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757"	Supported		Enhanced	"Nuclear membrane"			3300000	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: , HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	3.9	2.0	2.5	36.8	3.5	21.1	7.0	23.4	2.5	3.1	10.6	0.5	3.9	8.2	2.2	3.2	15.8	2.4	4.3	3.3	3.0	2.7	2.4	5.0	9.7	25.4	2.1	1.7	2.9	2.9	1.0	3.4	5.2	6.3	1.9	9.9	1.7	4.1	5.7	1.8	6.2	11.1	2.6	8.8	15.3	5.7	2.5	2.3	93.1	2.0	9.3	20.3	4.1	5.1	3.8	13.2	8.5	12.2	1.9	10.5	4.9	24.9	8.3	25.9	24.7	0.6	1.8	33.6	11.7	3.4	13.0	14.1	21.6	20.9	43.5	20.4	4.0	14.0	17.7	8.0	14.4	30.5	21.7	27.9	9.9	12.7	0.2	33.1	18.9	0.5	0.1	6.8	3.2	10.7	16.1	17.0	9.0	20.6	59.9	65.8	19.5	11.7	28.7	51.3	17.6	7.1	11.4	30.0	15.8	19.0	8.2	7.1	14.9	38.4	9.0	9.7	26.5	7.1	25.0	11.2	8.5	38.2	5.0	47.1	14.4	1.2	12.2	4.0	1.9	5.0	1.5	3.8	4.0	2.5	13.2	2.9	2.9	2.6	8.5	1.9	1.2	4.0	10.5	4.9	2.5	3.5	23.4	2.5	3.0	2.7	2.1	1.7	6.3	2.3
LMNB2	LMN2	ENSG00000176619	"Lamin B2"	Q03252	19	2427638-2456996	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022593, HPA047863, HPA062477"	Enhanced		Supported	"Nuclear membrane"			97000	"Nuclear membrane"		"CAB022593: , HPA047863: , HPA062477: "	"unprognostic (3.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (2.53e-3)"	"prognostic unfavourable (5.88e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.09e-3)"	"prognostic unfavourable (9.53e-5)"	"prognostic unfavourable (9.34e-5)"	"prognostic favourable (3.98e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-2)"	5.6	5.0	4.6	11.5	6.0	11.8	8.6	8.9	5.9	3.7	8.2	4.3	5.1	8.7	10.1	3.6	7.9	5.1	5.9	5.4	4.3	5.0	4.2	4.4	5.7	9.3	5.3	5.4	7.0	5.1	2.3	5.4	11.6	5.2	5.0	4.8	4.5	5.3	4.1	10.1	7.7	9.6	4.1	3.4	6.0	7.5	7.4	4.4	18.4	5.4	12.4	8.7	4.1	11.3	1.6	7.3	1.6	4.0	1.6	3.5	1.2	45.3	29.2	21.1	27.5	4.6	7.3	28.3	30.7	15.0	31.0	23.5	38.5	19.5	21.1	12.6	14.2	47.8	18.8	21.8	15.9	25.7	22.5	16.8	10.3	30.0	5.6	23.5	17.1	6.6	5.6	16.6	13.1	15.8	29.2	13.6	14.6	26.5	26.8	13.0	40.4	25.7	37.8	26.9	17.7	8.8	22.9	31.4	18.2	25.6	17.2	10.2	17.2	24.2	21.8	29.9	31.2	45.9	45.8	12.2	10.3	21.4	24.2	22.5	38.4	0.0	1.4	1.6	2.3	1.3	3.5	0.9	2.5	2.2	1.7	1.6	2.6	2.9	0.1	1.6	4.0	7.3	0.7	1.2	4.6	6.0	8.9	5.9	4.3	5.0	5.3	5.4	5.2	4.4
LMO2	"RBTN2, RBTNL1, RHOM2, TTG2"	ENSG00000135363	"LIM domain only 2"	P25791	11	33858576-33892289	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 22.8;HL-60: 22.7;K-562: 23.0;THP-1: 30.1;U-937: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 1.5;classical monocyte: 1.1;eosinophil: 3.0;intermediate monocyte: 3.1;myeloid DC: 4.3;neutrophil: 1.6;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 4.3;granulocytes: 3.0;monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016258, HPA029285, HPA070901, HPA070910"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016258: AB_2136572, HPA029285: , HPA070901: , HPA070910: "	"unprognostic (1.60e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-3)"	"prognostic favourable (3.12e-4)"	"unprognostic (1.73e-3)"	"unprognostic (8.95e-2)"	"unprognostic (5.76e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	18.2	6.1	13.8	13.6	15.6	28.8	14.5	5.2	18.4	9.4	5.5	10.3	6.4	6.2	9.7	9.9	6.9	8.6	9.1	6.4	15.8	12.2	12.9	5.5	15.9	22.2	14.2	7.2	5.1	3.9	4.2	8.3	8.5	11.9	8.3	2.7	14.6	4.5	4.0	25.0	4.2	5.5	6.6	13.9	22.0	4.4	3.6	11.1	1.0	10.7	8.1	13.3	11.1	14.8	0.5	4.3	3.0	3.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.9	0.5	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	22.8	0.0	0.0	0.1	22.7	7.9	0.0	0.0	0.0	0.0	4.4	23.0	0.0	0.0	0.1	2.1	9.7	0.4	0.0	6.4	0.3	0.0	0.0	0.3	1.9	0.0	0.1	0.2	0.0	0.0	30.1	0.3	0.0	0.1	0.7	0.0	0.0	0.1	0.2	2.1	10.6	0.1	1.5	1.1	3.0	0.0	3.1	0.1	0.5	0.0	0.0	4.3	0.0	0.0	0.0	1.6	0.0	3.6	0.3	0.0	0.5	13.8	15.6	5.2	9.5	15.8	12.2	14.2	7.2	11.9	11.1
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328468-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 102.8;T-47d: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"				Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: , HPA061638: "	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favourable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favourable (1.42e-4)"	"unprognostic (1.70e-1)"	19.3	7.5	39.8	11.7	36.4	8.0	13.9	10.3	102.4	22.7	16.2	9.8	10.9	11.5	19.4	18.1	22.2	13.7	21.0	17.2	62.3	18.0	12.8	14.5	16.6	11.5	21.0	50.9	18.4	10.4	11.6	13.3	27.5	13.0	26.0	14.3	11.2	36.2	37.9	18.4	17.1	21.1	15.3	16.5	15.8	38.6	12.0	11.0	4.4	14.2	12.5	36.3	15.4	21.4	7.8	7.2	18.9	8.2	15.3	6.9	3.6	9.2	7.3	5.7	102.8	17.5	20.8	14.4	8.4	6.7	7.9	8.9	17.8	5.9	21.7	10.7	9.8	7.7	2.2	5.8	7.9	11.5	5.6	19.8	15.8	5.4	16.8	10.6	26.8	10.8	13.5	12.3	7.1	5.3	4.4	19.3	4.2	3.7	0.3	6.9	20.8	6.8	12.3	7.9	4.7	9.8	35.5	4.7	0.3	33.8	5.0	24.9	65.4	29.3	3.4	37.3	7.0	8.9	27.4	17.6	11.6	4.9	4.6	2.3	5.3	18.9	6.8	13.0	6.0	8.2	6.9	7.8	5.4	6.1	5.0	4.4	1.4	3.5	10.9	15.3	7.7	7.2	1.4	3.6	39.8	36.4	10.3	102.4	62.3	18.0	21.0	50.9	13.0	11.0
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6"	"Cell line enhanced"	"Detected in many"		"BJ: 54.7;fHDF/TERT166: 90.2;LHCN-M2: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2"	"HPA020923, HPA050184"	Approved		Supported	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA020923: AB_1852963, HPA050184: "	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favourable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	2.2	2.2	10.1	6.3	32.6	0.9	2.5	2.7	13.2	6.7	24.3	0.5	2.4	17.5	2.3	7.8	42.5	4.0	16.3	65.6	9.8	2.5	21.7	19.9	57.0	2.6	2.3	8.8	5.5	6.8	6.2	3.1	10.9	1.1	7.6	8.9	2.7	14.3	7.0	44.4	8.6	55.0	2.1	2.0	1.5	16.7	4.7	4.1	16.2	25.7	36.3	23.7	4.6	15.4	2.4	1.1	3.0	0.5	0.5	14.1	2.6	12.1	6.9	0.2	0.2	14.4	10.2	2.4	54.7	27.0	13.9	15.1	16.9	15.7	1.0	4.2	90.2	11.8	3.0	2.6	16.1	16.3	0.7	7.4	36.7	15.8	4.1	2.3	3.9	7.0	5.1	6.0	6.9	5.8	0.2	0.0	84.9	4.7	1.8	1.0	0.3	10.4	1.1	25.5	0.2	5.9	2.8	0.8	1.9	9.9	1.7	2.2	2.2	1.7	8.8	34.4	6.4	4.1	13.3	3.7	2.7	4.3	10.1	2.6	15.6	3.0	0.2	2.4	0.7	0.5	0.9	1.1	3.2	1.0	0.4	2.4	14.1	8.5	0.1	0.5	0.3	1.1	1.2	2.6	10.1	32.6	2.7	13.2	9.8	2.5	2.3	8.8	1.1	4.1
LNPK	"KIAA1715, LNP, LNP1, Ul"	ENSG00000144320	"Lunapark, ER junction formation factor"	Q9C0E8	2	175923892-176002839	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014205	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoplasm	"HPA014205: AB_2234186"	"unprognostic (4.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.43e-2)"	14.2	10.8	13.4	8.4	16.0	29.4	11.3	12.9	26.5	15.0	13.3	13.4	7.1	8.6	11.9	7.7	15.1	8.2	9.1	13.6	13.8	16.1	9.8	16.3	8.1	7.6	19.9	14.2	12.8	6.4	16.8	22.8	9.4	21.1	12.0	11.9	10.1	8.6	10.1	33.5	13.5	8.4	11.3	26.2	6.6	8.9	25.4	14.6	16.4	10.3	14.8	8.7	12.2	15.1	7.1	6.7	11.6	7.3	9.7	11.6	5.2	8.5	4.3	10.3	14.6	21.8	13.6	5.1	25.3	12.2	11.8	16.7	6.0	10.1	8.6	14.5	11.2	9.5	9.7	6.7	16.5	13.0	9.9	9.7	5.6	5.3	5.1	16.4	12.0	11.2	6.4	11.5	5.7	2.1	9.9	11.5	16.2	5.6	10.8	6.5	3.3	8.4	10.9	10.4	6.3	5.0	7.9	11.9	12.1	11.1	6.4	8.5	9.5	5.4	3.2	58.8	8.7	19.6	11.8	6.8	12.4	7.1	18.2	5.4	10.9	5.7	6.6	11.6	8.1	7.3	9.5	7.1	7.2	8.9	6.0	5.0	7.2	11.2	5.6	9.7	6.7	6.7	11.6	5.2	13.4	16.0	12.9	23.3	13.8	16.1	19.9	14.2	21.1	14.6
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"			"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: "	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	16.9	2.5	11.8	1.7	24.6	0.8	13.2	4.4	33.3	5.9	7.2	1.5	11.2	8.3	4.5	3.2	21.7	5.6	4.8	6.9	6.1	5.5	10.0	3.7	2.5	1.8	3.8	11.6	2.1	12.9	10.8	5.0	21.6	4.8	5.1	5.6	2.0	22.1	10.0	5.1	10.0	8.2	2.8	1.3	0.9	8.0	4.1	2.0	0.7	15.0	5.7	7.8	5.8	7.7	1.4	1.1	1.5	1.9	3.8	1.6	0.6	1.6	0.6	1.9	1.0	3.5	7.3	9.2	1.5	0.7	0.0	0.0	2.7	8.4	2.1	1.2	4.2	1.6	0.0	0.3	0.0	0.5	4.6	2.9	1.7	1.6	1.4	2.7	0.8	5.4	0.3	0.5	0.0	2.8	1.7	1.0	6.6	4.7	2.4	1.8	4.8	1.0	1.5	0.7	0.9	6.3	8.8	2.3	2.6	0.7	9.7	1.0	5.2	1.4	8.0	10.5	3.1	3.4	1.8	3.9	0.6	1.4	9.6	2.4	1.9	1.5	0.5	0.3	1.0	0.5	1.5	1.4	1.5	1.5	0.8	0.9	1.6	1.2	0.4	3.8	1.9	1.1	1.3	0.6	11.8	24.6	4.4	33.3	6.1	5.5	3.8	11.6	4.8	2.0
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	15.8	78.3	16.4	12.8	19.8	12.5	13.9	16.1	22.8	11.3	13.6	15.8	13.3	13.7	10.5	13.8	12.7	12.7	15.7	27.3	15.4	15.3	19.9	49.6	10.3	14.5	17.7	14.9	15.5	17.7	17.6	16.8	16.6	16.2	11.7	8.5	12.7	18.5	14.7	38.0	14.7	13.9	11.5	12.7	15.5	13.5	9.8	13.3	13.8	21.2	15.3	11.8	14.7	12.5	6.7	6.5	6.0	6.2	4.0	7.2	3.0	23.0	23.9	7.9	25.3	9.4	6.7	24.7	14.7	11.7	15.9	19.5	20.4	8.3	29.0	20.6	15.4	9.8	20.4	17.8	7.7	17.1	16.8	16.0	20.9	26.7	43.7	36.4	16.8	12.6	25.6	15.1	29.9	12.7	42.3	57.8	7.3	15.3	18.0	21.7	28.3	31.6	19.0	11.4	31.2	8.8	13.7	21.1	21.1	12.9	18.9	51.6	11.1	45.7	9.0	8.1	8.9	22.5	21.4	60.9	37.5	25.7	36.5	39.9	14.6	6.0	4.1	0.8	6.4	6.2	4.1	6.0	5.6	6.1	4.3	6.7	7.2	4.8	0.5	4.0	2.4	6.5	4.0	3.0	16.4	19.8	16.1	22.8	15.4	15.3	17.7	14.9	16.2	13.3
LONRF2	"FLJ45273, RNF192"	ENSG00000170500	"LON peptidase N-terminal domain and ring finger 2"	Q1L5Z9	2	100273291-100322733	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.9;epididymis: 32.6"	"Cell line enhanced"	"Detected in some"		"A549: 6.5;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057366	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA057366: "	"unprognostic (9.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.72e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.86e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (6.42e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.66e-3)"	"unprognostic (6.34e-2)"	1.6	23.0	8.4	0.6	32.9	0.2	2.2	21.1	15.4	5.1	1.7	1.3	2.3	0.5	19.0	32.6	2.0	17.8	1.7	4.3	5.6	9.9	1.3	0.7	1.5	0.5	3.9	7.0	10.5	4.4	9.6	7.8	0.6	6.4	3.2	0.7	1.6	1.5	3.2	4.6	0.4	0.5	19.8	4.5	0.5	1.5	1.8	4.3	0.4	3.5	0.8	0.4	1.4	1.3	0.7	0.5	1.7	0.4	0.7	0.5	0.1	0.0	6.5	2.0	2.4	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.2	0.0	1.1	0.0	0.0	6.4	0.0	0.0	0.5	6.9	0.0	0.4	0.0	0.2	0.1	5.7	0.0	0.0	0.3	0.0	0.0	3.7	0.1	0.0	4.2	0.0	0.3	0.4	5.9	0.0	0.0	0.0	1.6	0.2	14.1	3.8	0.0	0.0	1.0	3.5	0.1	0.1	0.1	0.8	0.0	0.4	0.0	0.0	0.0	2.8	0.0	0.3	1.1	0.4	0.4	0.3	0.3	0.3	0.4	0.3	0.3	0.2	0.7	0.4	0.5	1.7	0.7	0.3	0.5	0.2	0.1	8.4	32.9	21.1	9.7	5.6	9.9	3.9	7.0	6.4	4.3
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 103.5;fHDF/TERT166: 157.7;HSkMC: 38.5;U-138 MG: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043930			Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		290000	"Endoplasmic reticulum"		"HPA043930: "	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavourable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.2	0.1	18.0	21.3	0.0	103.5	21.8	8.0	28.2	0.1	0.0	0.0	2.4	157.7	0.0	0.4	0.2	17.2	0.0	0.3	0.0	2.0	0.8	22.8	0.0	0.0	38.5	0.4	13.3	0.5	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.7	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.3	0.0	0.6	0.0	0.0	0.8	52.4	3.5	31.0	1.4	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23297189-23425328	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 107.9;BJ hTERT+ SV40 Large T+ RasG12V: 62.4;fHDF/TERT166: 69.9;TIME: 58.2;U-87 MG: 108.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 22.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"			Nucleoplasm		"CAB025848: , HPA036257: , HPA056542: "	"unprognostic (9.48e-2)"	"prognostic unfavourable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavourable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	37.8	2.7	1.2	14.5	1.6	0.6	22.4	2.9	1.6	16.9	18.4	1.0	12.2	5.8	11.8	9.1	11.5	4.1	5.4	7.2	1.2	1.3	4.3	4.1	6.2	7.5	1.9	0.7	15.6	4.4	1.3	2.2	38.0	22.7	8.4	3.8	1.6	5.6	9.7	6.2	4.3	10.7	27.3	10.9	8.3	7.7	4.1	0.7	1.6	4.3	8.0	8.6	19.1	6.4	1.9	1.3	3.0	0.7	2.1	2.8	0.7	6.2	16.6	5.0	4.0	13.7	22.7	2.2	107.9	34.9	49.5	62.4	0.1	0.4	1.2	0.8	69.9	5.2	0.2	9.2	26.2	0.2	0.9	0.0	2.3	0.1	27.8	0.0	0.4	20.1	0.4	18.4	2.4	41.3	0.0	0.2	16.3	3.4	0.0	0.1	3.2	2.6	0.2	4.1	0.0	14.4	0.0	0.1	1.3	13.5	0.7	0.9	0.1	0.1	58.2	46.1	12.2	18.7	14.2	0.4	0.0	3.3	108.2	0.1	47.9	1.9	0.7	3.0	1.6	0.3	0.8	1.9	0.6	1.3	0.5	0.9	0.8	2.8	1.6	2.1	0.6	1.3	0.2	0.7	1.2	1.6	2.9	1.0	1.2	1.3	1.9	0.7	22.7	0.7
LPAR3	"Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3"	ENSG00000171517	"Lysophosphatidic acid receptor 3"	Q9UBY5	1	84811602-84893213	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 32.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 13.0;HBEC3-KT: 16.0;hTCEpi: 17.2;NTERA-2: 14.5;PC-3: 16.2;SK-MEL-30: 15.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 24.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"olfactory region: 3.5"	"Low region specificity"	"Detected in many"			HPA013421			Supported	"Plasma membrane"				"Plasma membrane"		"HPA013421: AB_1847990"	"unprognostic (2.85e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (4.31e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.13e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	0.0	1.2	2.4	0.5	1.9	0.3	0.7	0.2	3.5	8.8	0.4	2.2	2.9	0.1	2.4	11.8	7.2	32.0	0.5	12.4	3.7	0.9	0.0	0.1	4.2	0.1	0.1	2.6	5.1	8.6	0.3	0.4	1.1	6.8	11.5	0.5	0.7	5.0	4.7	0.3	4.0	0.5	0.5	0.3	0.1	0.2	14.7	0.2	0.7	0.2	3.3	4.3	4.8	6.9	0.6	0.4	1.1	0.1	1.8	0.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.2	1.2	1.1	0.8	0.0	0.0	0.0	0.2	0.0	0.2	13.0	16.0	1.0	0.1	2.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	17.2	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	16.2	0.0	0.0	0.0	0.0	3.7	0.9	0.7	0.0	0.3	15.3	0.0	1.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.2	0.3	0.0	0.2	0.4	0.5	0.5	0.3	0.6	0.4	0.3	1.1	1.8	0.1	0.4	0.1	0.1	2.4	1.9	0.2	3.5	3.7	0.9	0.1	2.6	6.8	0.2
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 15.8;ovary: 10.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.1;NTERA-2: 16.4;RH-30: 6.9;U-937: 3.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"				"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: , HPA054951: , HPA055571: "	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	1.5	0.2	6.0	1.0	2.1	0.6	2.0	4.9	3.7	1.8	0.9	7.4	0.7	0.2	2.9	0.8	1.8	1.1	2.1	1.9	15.8	1.4	0.3	0.3	0.3	0.2	2.4	4.0	10.0	0.7	0.1	0.7	0.2	3.6	0.6	1.2	0.5	1.0	1.6	0.2	1.6	0.9	1.3	3.8	0.4	1.5	0.8	5.6	0.0	0.6	0.8	1.2	1.4	0.9	0.0	0.5	7.4	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.6	1.1	1.4	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	2.3	0.0	0.4	1.8	16.4	0.2	0.8	6.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.0	0.6	1.4	0.0	0.7	0.7	3.9	1.6	7.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	6.0	2.1	4.9	3.5	15.8	1.4	2.4	4.0	3.6	5.6
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523977	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 35.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 34.2;EFO-21: 32.9;PC-3: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Lipid droplets"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (5.33e-3)"	"prognostic unfavourable (7.11e-5)"	"unprognostic (3.11e-1)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (1.88e-8)"	"unprognostic (5.90e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.08e-2)"	"prognostic favourable (4.90e-5)"	"unprognostic (4.89e-2)"	"prognostic unfavourable (2.64e-7)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.03e-1)"	9.8	5.6	5.2	9.0	5.7	5.1	7.4	9.2	9.5	5.4	7.5	2.9	4.5	3.9	7.0	3.2	3.2	5.9	5.8	4.3	5.3	5.2	4.9	3.1	35.6	8.5	3.2	3.7	5.0	5.4	3.1	5.6	10.0	4.6	5.2	2.3	13.6	4.5	4.4	3.5	3.2	5.9	5.5	3.3	28.8	9.4	3.0	2.9	5.8	4.7	1.4	8.1	6.6	10.6	0.9	0.7	2.4	1.7	1.7	3.6	0.6	2.0	3.0	0.5	3.2	0.3	0.5	34.2	7.7	0.4	0.4	0.3	1.1	0.9	6.7	32.9	0.2	5.7	0.6	0.2	0.2	16.2	13.9	1.6	4.8	2.0	0.6	1.7	4.6	0.6	0.1	0.3	0.1	0.4	3.6	1.2	0.0	4.2	6.3	2.6	12.0	22.9	12.0	0.5	4.9	1.3	2.7	4.3	4.2	6.1	5.5	1.8	2.6	2.6	3.8	0.6	7.5	2.3	2.7	4.3	4.1	1.5	1.4	2.8	2.0	0.0	0.6	0.8	3.6	1.7	3.6	0.9	0.8	1.8	0.7	0.7	0.1	1.0	2.4	1.7	1.2	0.2	0.8	0.6	5.2	5.7	9.2	8.0	5.3	5.2	3.2	3.7	4.6	2.9
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55508998-55586670	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.5;HaCaT: 25.7;HL-60: 28.7;HMC-1: 47.8;WM-115: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 28.8;eosinophil: 49.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favourable (3.43e-4)"	"prognostic favourable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	10.5	7.5	10.5	8.0	16.2	43.5	9.9	1.7	7.5	11.0	5.2	18.2	36.5	4.3	17.0	21.5	7.2	8.5	6.2	5.7	9.6	6.3	6.7	2.4	7.4	10.3	18.6	3.1	11.0	3.8	12.7	1.9	9.0	16.1	8.2	5.5	5.1	7.7	33.2	3.0	10.2	5.4	8.9	30.7	8.9	5.3	4.6	14.9	0.9	49.0	5.2	2.6	8.5	8.5	0.0	5.4	49.4	9.3	0.0	0.0	1.4	9.4	1.2	1.0	0.1	3.3	1.2	1.7	4.0	3.9	2.0	2.0	2.1	33.5	0.0	13.8	5.7	25.7	0.6	5.5	3.2	2.5	2.8	9.6	3.1	4.9	1.2	28.7	47.8	0.6	5.6	2.2	1.8	15.4	0.4	0.1	3.3	0.6	0.0	11.6	1.5	0.1	2.9	1.1	1.4	1.9	3.7	0.6	7.4	7.7	3.1	5.6	1.3	7.3	17.3	0.3	0.0	2.0	2.7	0.1	0.0	0.0	0.8	14.0	34.0	28.8	4.5	49.4	0.0	6.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	12.1	0.0	9.3	0.1	0.0	1.4	10.5	16.2	1.7	7.5	9.6	6.3	18.6	3.1	16.1	14.9
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013315	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"				Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: "	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	6.8	5.6	13.0	10.5	18.4	9.2	7.7	11.9	16.5	6.6	25.2	10.4	2.4	31.6	6.7	3.9	5.9	6.3	14.3	5.1	11.0	14.5	20.7	83.9	11.8	11.8	11.2	9.8	8.8	9.0	9.7	8.2	16.3	15.3	5.8	7.4	6.8	4.4	5.3	2.2	2.7	43.3	6.1	9.6	10.7	15.6	13.5	9.6	6.3	7.5	1.5	10.0	6.8	6.7	1.2	1.1	20.8	2.0	10.1	9.5	2.1	4.9	6.7	10.6	3.7	18.4	17.1	6.3	11.9	14.6	11.9	11.6	8.7	4.2	3.6	7.3	18.3	0.2	8.7	3.7	9.4	7.0	1.8	9.2	5.2	9.9	17.2	7.3	10.1	17.2	2.5	11.8	10.3	14.8	8.3	1.9	16.6	3.7	9.1	6.3	3.4	9.6	16.0	9.2	13.4	9.5	11.1	8.9	6.2	11.2	5.3	3.8	0.0	10.0	20.8	15.4	18.7	19.7	8.8	3.5	5.3	7.8	13.6	7.5	5.4	6.5	2.0	6.1	9.3	1.3	9.5	0.9	7.1	5.3	0.8	1.2	7.3	4.7	20.8	10.1	0.6	1.1	6.3	2.1	13.0	18.4	11.9	16.5	11.0	14.5	11.2	9.8	15.3	9.6
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340920-41360582	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 6.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.8;NK-cells: 6.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol				Cytosol		"HPA051466: , HPA052667: , HPA070640: "	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	11.6	3.7	3.0	8.1	5.2	0.1	23.4	1.5	3.0	10.9	29.2	2.8	13.5	26.8	12.8	21.6	16.3	7.5	11.2	8.8	3.6	0.7	28.2	14.4	4.5	1.6	2.8	3.7	7.9	7.4	8.1	6.7	4.4	4.2	10.1	8.8	8.7	11.0	15.1	1.8	26.1	49.1	5.5	2.4	2.7	7.4	2.5	1.5	1.2	14.2	10.6	9.0	8.0	12.5	0.9	0.7	1.8	0.9	6.3	0.8	0.2	6.8	6.7	0.4	4.0	11.0	17.1	5.2	4.2	5.9	5.1	7.0	12.5	6.1	0.3	5.3	9.3	17.4	2.0	11.0	3.2	0.1	3.9	0.3	9.4	6.3	1.8	0.0	4.7	12.3	14.0	8.7	3.4	1.3	1.7	0.2	6.4	14.6	0.0	0.1	0.6	6.9	0.0	0.1	0.4	18.1	8.6	0.5	0.1	5.6	7.2	3.6	8.5	3.4	0.4	0.3	1.7	5.8	0.0	3.4	1.8	0.0	0.1	0.1	0.3	1.8	0.5	0.7	0.5	0.5	0.8	0.6	0.7	0.4	0.3	0.9	0.7	0.6	1.8	6.3	0.9	0.7	0.5	0.2	3.0	5.2	1.5	3.0	3.6	0.7	2.8	3.7	4.2	1.5
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell line enriched"	"Detected in some"	5	"AF22: 89.3"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in all"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"		880000	Vesicles		"HPA048749: "	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	89.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.2	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 127.8;urinary bladder: 105.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 28.8;EFO-21: 35.8;U-698: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Enhanced	"Focal adhesion sites,Cytosol"			520000	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	19.6	4.2	2.7	29.5	2.8	3.1	12.5	3.0	2.7	42.2	29.9	2.1	19.6	5.0	68.6	14.9	59.7	10.0	37.9	9.3	2.6	2.8	10.9	5.3	11.4	6.0	2.8	1.6	26.1	4.4	4.7	3.2	5.2	3.0	37.7	12.8	8.5	7.0	28.4	11.6	5.9	17.2	127.8	3.2	9.5	12.1	30.7	1.5	5.1	5.4	4.2	7.8	105.1	38.3	5.9	4.9	18.0	4.5	4.3	5.0	1.4	7.5	7.0	5.1	3.4	11.1	11.4	5.5	4.9	6.3	3.6	2.4	12.6	3.6	28.8	35.8	11.2	3.2	1.5	3.3	9.1	3.1	1.7	1.4	5.4	3.3	4.7	0.6	1.7	8.1	4.7	8.1	7.0	6.1	0.0	0.6	6.3	2.4	1.4	0.6	2.0	2.3	1.8	3.8	0.1	4.0	8.0	0.3	0.0	10.6	3.5	6.0	2.7	2.4	13.1	8.4	6.5	6.0	12.2	0.0	1.1	59.7	4.2	1.3	7.6	0.8	4.5	1.9	5.0	4.2	3.2	2.9	4.3	3.6	2.4	5.9	2.3	2.9	18.0	4.3	4.0	4.9	1.6	1.4	2.7	2.8	3.0	2.7	2.6	2.8	2.8	1.6	3.0	1.5
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.0;lymphoid tissue: 75.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 39.3;HMC-1: 65.8;Karpas-707: 56.4;U-2197: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"				"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	16.3	5.6	5.1	34.2	4.7	4.2	5.1	3.5	4.9	4.4	6.7	9.0	4.1	5.1	6.5	5.9	3.8	4.7	7.2	3.9	5.2	5.1	6.3	7.1	19.7	37.2	6.3	2.5	6.6	5.6	3.9	4.8	2.6	5.0	5.7	9.6	6.2	7.6	5.1	2.1	3.7	16.0	4.7	11.4	32.2	5.7	5.9	4.9	75.1	6.8	4.4	52.9	11.2	3.9	19.9	36.5	3.8	19.1	20.1	42.0	20.9	0.3	0.4	0.4	0.7	1.5	1.9	0.2	9.8	39.3	2.4	4.4	0.0	1.0	28.7	0.4	11.9	0.3	0.3	26.7	10.3	12.4	0.1	1.3	0.2	0.1	2.6	7.7	65.8	1.4	0.6	33.9	4.4	15.8	0.3	56.4	19.9	0.2	27.1	9.7	0.3	8.9	0.4	0.5	24.7	1.6	13.7	0.2	0.3	0.4	0.6	3.9	0.5	2.2	15.4	6.2	1.8	39.6	8.8	3.6	3.5	28.2	14.3	7.0	14.0	1.7	19.1	3.1	28.2	11.0	42.0	19.9	29.0	32.4	36.5	11.5	22.6	26.8	3.8	20.1	5.6	33.1	38.7	20.9	5.1	4.7	3.5	4.9	5.2	5.1	6.3	2.5	5.0	4.9
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA012380: AB_1853260, HPA017299: "	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	16.4	14.0	19.3	23.4	19.1	11.0	18.0	37.5	19.1	21.9	19.0	28.2	15.6	11.0	24.7	14.8	15.6	18.3	16.7	18.2	15.9	14.5	12.6	14.2	14.8	23.4	19.7	13.1	27.5	12.9	23.7	26.0	15.2	15.4	20.4	16.7	23.6	15.6	22.4	23.0	15.7	15.9	28.3	15.9	18.7	15.0	20.2	20.4	27.0	13.5	9.5	26.0	20.3	18.0	6.9	2.8	22.6	4.8	4.9	6.0	3.3	18.2	6.5	17.6	10.9	21.3	24.3	6.8	13.3	16.1	16.2	19.0	15.4	9.6	10.0	20.9	16.3	12.0	14.7	12.9	21.8	8.0	9.1	16.6	9.7	13.1	14.5	12.7	13.1	16.6	7.8	15.4	19.7	19.1	10.4	16.6	15.2	15.5	9.5	5.5	12.1	13.7	10.0	11.0	7.2	8.6	10.8	8.7	9.5	16.1	12.2	12.8	21.4	11.2	18.6	13.5	7.8	16.3	13.3	15.4	13.8	9.1	12.8	18.1	12.7	22.6	3.4	7.0	5.9	4.8	4.5	6.9	4.6	5.0	2.8	5.7	4.3	6.0	2.3	4.9	4.6	2.6	4.4	3.3	19.3	19.1	37.5	19.1	15.9	14.5	19.7	13.1	15.4	20.4
LRFN2	"FIGLER2, KIAA1246, SALM1"	ENSG00000156564	"Leucine rich repeat and fibronectin type III domain containing 2"	Q9ULH4	6	40391586-40587465	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 21.7"	"Group enriched"	"Detected in some"	5	"REH: 3.4;SH-SY5Y: 10.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.8;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;T-cells: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076660	Enhanced		Supported	Vesicles				Vesicles		"HPA076660: "	"unprognostic (1.93e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.58e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-4)"	0.5	1.4	5.9	0.5	7.6	1.3	0.6	4.5	21.7	0.5	0.8	0.0	0.0	0.5	0.6	0.4	1.8	0.6	0.6	0.4	5.0	5.2	0.5	0.4	0.4	0.5	2.3	7.4	2.1	0.7	0.4	0.6	0.5	0.9	0.5	0.7	2.7	0.4	0.4	0.4	0.5	0.5	0.5	0.8	3.1	0.7	2.5	0.5	0.0	0.7	0.0	0.6	0.5	0.2	0.0	1.3	0.0	0.0	0.3	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	3.4	0.0	0.0	0.0	0.3	1.4	10.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.4	0.0	0.3	0.0	1.3	0.0	0.2	5.9	7.6	4.5	21.7	5.0	5.2	2.3	7.4	0.9	0.5
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947185-110964079	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"				Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"	9.0	11.2	13.7	15.4	15.5	5.9	20.7	15.6	14.7	7.9	7.5	6.6	7.8	7.0	8.1	23.9	8.1	9.6	6.7	16.1	12.7	13.3	9.6	16.7	11.9	17.6	10.5	7.5	18.4	6.9	5.8	17.5	25.1	10.3	9.9	7.6	7.3	8.6	9.2	20.5	10.6	8.4	6.0	12.4	14.0	8.1	27.7	10.1	16.8	12.6	10.2	19.0	10.0	28.5	21.0	11.4	21.4	8.2	18.0	19.4	8.4	11.8	5.2	10.0	6.8	4.6	7.6	11.3	7.3	8.4	12.8	10.4	13.1	15.0	9.1	10.5	5.5	7.7	4.7	4.3	15.6	16.4	5.6	10.0	5.3	13.5	13.7	18.8	12.3	4.7	12.2	8.8	15.6	6.8	31.3	41.9	8.6	3.9	1.9	15.0	15.0	12.1	12.6	16.4	11.0	3.3	6.2	8.4	9.2	0.0	12.6	21.2	10.5	30.7	4.8	11.4	0.4	13.3	5.9	19.4	6.7	17.0	6.5	21.6	19.6	13.0	5.7	12.3	15.3	6.3	19.4	21.0	12.1	15.8	11.4	15.5	13.5	18.5	21.4	18.0	8.2	10.3	11.1	8.4	13.7	15.5	15.6	14.7	12.7	13.3	10.5	7.5	10.3	10.1
LRMDA	"C10orf11, CDA017, OCA7"	ENSG00000148655	"Leucine rich melanocyte differentiation associated"	Q9H2I8	10	75431453-76560167	"Disease related genes, Predicted intracellular proteins"	Differentiation		Albinism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 18.0;HMC-1: 14.0;NB-4: 25.9;SK-MEL-30: 36.5;THP-1: 19.4;U-937: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 23.6;myeloid DC: 27.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 27.3;granulocytes: 8.7;monocytes: 23.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047446, HPA050419"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047446: AB_2680050, HPA050419: AB_2756316"	"unprognostic (1.04e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (6.80e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.26e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.64e-2)"	12.7	35.3	4.6	4.7	6.4	13.2	6.1	2.6	3.6	7.1	4.6	8.2	12.5	3.1	12.5	34.9	5.3	5.7	8.9	13.2	3.7	5.1	11.5	19.1	13.1	5.6	7.4	3.1	8.6	21.0	6.8	9.7	6.9	6.7	8.3	4.0	19.8	10.7	8.8	2.2	2.3	4.5	5.3	8.1	7.8	8.6	5.8	5.0	0.1	13.2	6.9	3.9	5.5	5.3	0.0	27.3	8.7	23.6	2.6	0.1	6.7	0.1	2.5	0.1	0.0	1.2	1.5	0.0	0.2	0.0	0.1	0.2	3.0	5.4	0.0	10.6	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.6	1.3	18.0	0.5	3.6	14.0	0.7	0.5	0.2	0.0	0.5	0.0	0.6	0.0	0.3	0.0	25.9	0.1	1.1	0.0	0.1	0.0	0.2	3.3	0.1	0.2	3.2	0.0	36.5	0.2	19.4	0.3	0.1	1.3	0.9	2.0	0.2	0.0	0.0	9.4	17.4	4.6	2.6	23.6	8.7	0.0	11.2	0.1	0.0	0.0	0.0	27.3	0.0	0.0	0.0	1.3	2.6	6.4	0.2	0.0	6.7	4.6	6.4	2.6	3.6	3.7	5.1	7.4	3.1	6.7	5.0
LRPAP1	"A2MRAP, HBP44, RAP"	ENSG00000163956	"LDL receptor related protein associated protein 1"	P30533	4	3506376-3532559	"Disease related genes, Predicted intracellular proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008001, CAB025518"	Enhanced	Supported	Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"CAB025518: , HPA008001: AB_1853292"	"unprognostic (3.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (4.67e-11)"	"unprognostic (6.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.61e-2)"	9.4	11.3	13.7	8.7	34.4	17.4	8.5	11.4	22.1	10.1	9.3	9.1	15.5	10.6	11.1	16.7	7.2	10.5	11.2	28.1	11.6	13.1	17.7	16.5	10.8	9.9	10.6	14.5	13.2	28.8	20.0	18.1	35.2	9.9	11.2	7.6	11.5	23.0	18.9	12.5	10.9	10.3	8.4	7.2	10.9	10.7	10.9	12.0	4.8	11.6	6.9	6.5	8.6	8.0	6.2	8.8	37.7	15.9	7.3	7.1	15.1	4.2	8.9	6.5	9.5	9.2	4.8	14.0	7.0	7.9	6.3	5.1	17.6	8.6	2.3	7.4	6.7	6.9	4.1	7.4	3.7	1.8	9.7	3.2	8.9	11.6	5.7	5.2	15.0	6.1	5.8	5.0	2.7	7.8	5.6	8.8	5.5	6.9	3.3	19.9	5.4	9.4	4.5	5.0	8.4	6.8	9.7	5.9	5.2	8.6	3.5	9.1	7.6	9.6	6.3	6.1	5.7	4.7	9.0	4.9	3.2	3.2	7.3	15.4	8.3	11.2	15.9	37.7	6.5	12.5	5.6	6.2	6.0	6.1	8.8	5.9	6.7	6.1	13.3	7.3	11.4	6.6	7.1	15.1	13.7	34.4	11.4	22.1	11.6	13.1	10.6	14.5	9.9	12.0
LRPPRC	"GP130, LRP130, LSFC"	ENSG00000138095	"Leucine rich pentatricopeptide repeat containing"	P42704	2	43886508-43996005	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033786, HPA036408, HPA036409"	Enhanced		Enhanced	Mitochondria			16000	Mitochondria		"CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-3)"	"prognostic unfavourable (1.72e-5)"	"unprognostic (1.68e-1)"	"unprognostic (8.34e-3)"	"prognostic unfavourable (2.31e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.68e-2)"	"prognostic favourable (6.65e-6)"	"unprognostic (9.07e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.00e-2)"	20.6	25.5	20.2	27.7	24.8	26.7	37.2	34.3	51.8	16.4	31.7	15.1	15.9	21.8	21.5	19.2	22.5	18.6	15.2	36.6	24.3	21.9	41.7	31.6	26.3	38.0	21.9	22.9	23.6	28.0	33.3	19.7	17.6	29.2	18.9	32.5	13.6	17.8	22.8	63.2	22.4	19.1	32.6	17.9	18.0	20.7	20.7	16.0	25.4	20.5	30.5	19.9	20.4	17.8	15.8	15.5	5.5	11.7	13.2	18.1	12.4	30.1	24.7	15.6	19.8	15.4	20.5	26.8	20.1	14.6	21.9	17.0	39.6	16.0	43.3	19.4	12.4	25.6	29.1	21.5	29.4	26.1	18.4	39.2	19.5	52.4	22.7	56.3	17.8	20.3	18.9	20.3	32.9	17.6	57.7	17.6	19.3	16.7	29.5	65.2	26.0	17.6	33.1	34.9	35.2	24.0	27.7	27.6	26.8	22.7	30.5	36.5	22.4	34.2	15.1	15.8	21.7	16.7	21.4	17.9	20.2	37.8	15.2	35.0	13.6	5.5	10.7	1.8	9.5	10.8	18.0	15.2	12.8	12.6	15.5	15.8	18.1	15.4	0.8	13.2	11.7	6.2	10.5	12.4	20.2	24.8	34.3	51.8	24.3	21.9	21.9	22.9	29.2	16.0
LRRC1	"dJ523E19.1, FLJ10775, FLJ11834, LANO"	ENSG00000137269	"Leucine rich repeat containing 1"	Q9BTT6	6	53794497-53924121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 22.1;HAP1: 21.8;RT4: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031603, HPA031604"	Enhanced		Supported	Cytosol				Cytosol		"HPA031603: AB_10601753, HPA031604: AB_10601224"	"unprognostic (2.90e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.02e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (3.97e-1)"	"prognostic favourable (2.21e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-3)"	13.1	2.3	8.6	7.6	17.0	2.5	12.4	4.0	13.4	12.1	22.6	17.5	7.3	15.3	5.3	8.9	17.2	7.9	12.0	3.8	9.4	6.1	7.3	1.1	7.0	2.4	21.8	6.1	5.7	8.3	24.8	8.0	26.1	11.2	8.3	23.2	7.8	14.9	7.0	1.9	20.2	20.7	6.1	11.9	1.8	13.2	12.3	20.6	8.3	16.3	8.4	9.3	12.3	16.1	1.8	1.4	0.4	0.2	3.3	1.1	0.1	19.9	2.5	2.8	5.0	0.7	0.4	19.8	2.7	5.6	2.4	3.3	22.1	9.9	2.8	2.3	1.7	9.9	21.8	8.8	3.1	3.5	6.3	1.7	2.0	14.8	7.2	2.1	1.3	0.7	7.3	0.2	5.4	4.3	0.4	2.7	1.3	8.7	14.6	0.3	2.2	1.9	3.0	4.7	1.4	6.5	25.8	7.3	0.7	3.3	14.6	4.3	9.5	2.2	1.9	1.8	5.9	0.1	2.5	2.7	2.1	2.0	2.1	3.0	2.2	0.0	0.2	0.4	1.0	0.0	0.4	0.3	0.9	1.1	1.4	1.8	0.8	0.6	0.0	3.3	0.0	1.2	0.1	0.1	8.6	17.0	4.0	13.4	9.4	6.1	21.8	6.1	11.2	20.6
LRRC23	"B7, LRPB7"	ENSG00000010626	"Leucine rich repeat containing 23"	Q53EV4	12	6873569-6914243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"fallopian tube: 94.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037766, HPA057533"	Enhanced		Supported	Nucleoli				Nucleoli		"HPA037766: AB_10672609, HPA057533: "	"prognostic favourable (6.02e-4)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.25e-2)"	3.6	4.2	11.4	2.4	12.8	3.4	4.8	10.5	10.9	5.8	3.1	10.8	6.9	2.2	6.0	13.1	2.9	94.2	4.2	4.7	12.2	12.9	6.9	3.7	9.4	2.9	7.3	9.6	5.9	2.5	9.3	9.0	3.4	9.9	4.8	3.3	9.4	4.0	5.0	5.5	3.5	2.1	4.8	7.0	3.5	4.5	21.1	8.4	2.2	7.1	2.4	3.7	3.1	3.1	7.8	5.9	9.0	4.4	5.3	4.7	2.2	5.5	10.8	1.8	4.0	8.2	6.2	6.4	2.2	7.7	3.8	7.1	2.2	11.4	4.9	2.5	5.9	1.4	3.3	4.7	8.0	3.8	1.6	3.5	4.2	4.4	6.6	1.9	3.3	4.3	8.8	7.1	6.5	5.0	2.0	2.8	4.3	6.2	4.2	1.3	1.2	3.2	4.0	9.0	5.6	7.6	1.6	3.0	7.0	3.6	4.8	6.8	2.4	4.4	2.2	3.7	9.9	4.2	2.5	2.6	1.8	4.0	9.1	2.5	5.3	1.3	4.4	9.0	3.7	4.2	4.7	7.8	3.6	3.1	4.0	4.8	4.1	4.0	0.7	5.3	3.8	5.9	0.2	2.2	11.4	12.8	10.5	10.9	12.2	12.9	7.3	9.6	9.9	8.4
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 173.1"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 51.5"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	408	"plasmacytoid DC: 40.8"	"Lineage enriched"	"Detected in single"	408	"dendritic cells: 40.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"				"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: "	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favourable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favourable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.0	1.3	0.0	0.0	2.1	0.7	0.1	0.3	6.8	0.0	11.2	1.2	0.3	0.1	0.7	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.4	0.4	0.0	173.1	20.0	0.0	1.3	4.0	0.0	0.0	0.1	1.0	0.0	0.0	0.7	0.0	10.3	4.6	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	8.5	0.0	51.5	0.0	0.0	0.4	0.1	0.2	2.5	0.0	1.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LRRC32	"D11S833E, GARP"	ENSG00000137507	"Leucine rich repeat containing 32"	Q14392	11	76657524-76670747	"Predicted intracellular proteins, Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"ASC diff: 41.1;ASC TERT1: 25.3;HSkMC: 15.7;HUVEC TERT2: 17.8;U-2197: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"neutrophil: 1.0;T-reg: 3.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.0;T-cells: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA055775, HPA058434"			Enhanced	Nucleoplasm	"Intracellular and membrane"		19000	Nucleoplasm		"HPA055775: , HPA058434: "	"unprognostic (3.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavourable (3.93e-5)"	"unprognostic (7.99e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.22e-3)"	"prognostic unfavourable (2.64e-4)"	50.5	16.5	5.4	8.0	11.3	1.9	35.1	4.6	9.1	19.8	12.4	4.4	3.5	7.0	15.2	10.4	11.1	10.8	22.6	18.0	7.6	3.5	19.5	8.5	51.8	4.7	10.2	4.3	19.9	8.7	7.9	7.0	40.5	10.1	12.6	5.1	16.6	5.2	9.4	29.0	9.9	7.7	13.0	5.7	21.2	8.1	8.6	8.7	0.6	16.6	9.7	2.1	19.8	25.1	0.2	0.0	1.0	0.0	0.0	3.1	9.6	0.0	0.0	0.4	0.0	41.1	25.3	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.8	0.0	0.0	15.7	0.0	1.4	0.0	17.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	2.6	0.3	37.7	0.0	0.0	0.0	0.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	3.1	9.6	5.4	11.3	4.6	9.1	7.6	3.5	10.2	4.3	10.1	8.7
LRRC42	MGC8974	ENSG00000116212	"Leucine rich repeat containing 42"	Q9Y546	1	53946077-53968168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047458, HPA050537, HPA064581"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA047458: , HPA050537: , HPA064581: "	"unprognostic (3.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (7.95e-3)"	"prognostic unfavourable (3.88e-5)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.67e-2)"	12.0	27.1	11.8	9.8	14.7	8.7	20.3	8.8	10.5	15.1	13.1	7.9	18.5	10.7	17.5	19.4	18.8	15.1	16.6	14.0	9.1	8.3	16.1	23.1	13.1	12.9	7.7	10.0	17.9	11.5	12.4	23.1	32.3	10.5	15.8	11.9	17.9	15.0	21.2	14.9	18.0	10.2	16.1	13.6	10.2	14.4	24.0	9.9	16.6	21.8	14.9	13.1	18.3	17.8	6.5	10.5	7.6	4.5	6.4	8.9	4.1	25.8	9.7	24.5	14.4	12.8	17.6	16.6	20.5	28.8	27.4	37.5	31.8	17.5	14.5	16.6	25.2	22.9	20.7	29.3	32.1	11.5	12.4	13.5	15.5	20.6	23.4	8.4	13.0	15.8	40.9	23.6	26.2	17.4	16.8	3.9	26.6	9.0	15.4	11.7	20.8	15.1	26.7	25.9	10.2	19.8	19.5	14.6	15.7	27.5	15.7	22.5	23.2	10.1	14.1	21.0	26.8	18.6	12.7	10.9	12.5	21.8	20.4	8.8	11.1	0.1	4.5	7.6	7.6	4.4	6.4	6.5	6.5	8.9	5.6	4.1	6.9	5.0	6.8	6.4	3.3	10.5	7.0	4.1	11.8	14.7	8.8	10.5	9.1	8.3	7.7	10.0	10.5	9.9
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023302-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.1	4.9	7.1	7.0	9.3	12.0	4.5	20.3	10.8	4.6	7.0	5.7	9.5	11.1	4.4	5.0	8.0	10.5	5.8	3.1	7.7	3.9	5.9	12.9	5.6	6.5	8.3	4.7	3.7	15.5	4.5	4.8	4.9	6.5	6.6	3.6	4.9	13.6	5.0	4.3	10.2	9.4	5.2	3.3	7.6	10.4	3.1	9.9	7.1	9.8	6.8	6.5	5.0	5.1	2.3	3.3	5.0	3.2	2.8	4.6	3.1	9.7	11.1	3.4	6.9	1.4	1.9	13.2	6.8	2.8	4.1	3.5	9.9	6.7	7.3	6.2	1.3	11.4	3.2	4.1	0.9	4.4	20.9	4.6	20.2	13.3	1.1	5.4	11.6	1.8	1.7	2.4	0.6	6.0	3.2	3.2	1.0	16.5	12.1	18.1	3.5	14.9	10.0	6.6	4.0	2.6	9.0	10.5	10.2	3.1	16.3	5.7	13.3	6.3	3.5	7.2	9.1	11.4	11.5	6.3	1.6	1.1	3.9	4.7	7.5	5.0	3.2	3.6	3.9	2.4	4.0	1.5	4.5	4.6	2.2	2.3	2.4	3.1	0.2	2.8	1.0	3.3	3.8	3.1	7.1	9.3	20.3	10.8	7.7	3.9	8.3	4.7	6.5	9.9
LRRC59	"FLJ21675, PRO1855"	ENSG00000108829	"Leucine rich repeat containing 59"	Q96AG4	17	50375059-50397553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030827, HPA030829"	Enhanced		Enhanced	"Endoplasmic reticulum"			5400000	"Endoplasmic reticulum"		"HPA030827: AB_10602704, HPA030829: AB_10670045"	"unprognostic (4.73e-2)"	"unprognostic (2.15e-2)"	"prognostic favourable (2.60e-4)"	"unprognostic (5.63e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (1.00e-5)"	"prognostic unfavourable (3.12e-6)"	"unprognostic (1.88e-3)"	"unprognostic (9.95e-2)"	"unprognostic (5.62e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (3.68e-2)"	"prognostic unfavourable (1.19e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavourable (1.90e-5)"	20.7	40.5	10.6	21.8	14.5	28.4	16.3	11.5	21.6	28.2	30.0	11.4	28.8	19.6	17.2	24.9	23.5	15.8	22.8	17.4	10.2	8.8	22.1	74.7	23.0	15.9	12.7	11.5	15.8	87.9	15.4	11.6	35.3	10.8	17.7	31.5	10.0	48.6	26.2	16.0	11.2	27.3	22.0	8.9	19.0	30.7	18.2	10.4	18.0	22.8	22.4	20.8	13.7	17.0	8.6	14.9	14.4	19.6	5.9	9.1	9.0	62.1	47.4	13.7	20.5	23.2	27.4	24.5	51.0	28.5	47.8	42.3	108.4	18.0	27.2	35.1	58.1	22.7	33.9	43.5	57.1	14.4	49.4	47.6	26.9	57.9	48.8	46.8	22.7	24.1	35.4	51.2	59.6	35.2	44.0	25.9	31.3	42.3	32.9	22.2	15.4	69.6	28.2	43.9	52.0	26.0	31.8	33.5	27.8	17.6	19.8	25.9	33.4	25.5	37.6	55.5	23.0	51.2	66.4	39.1	32.0	35.2	37.7	31.8	34.8	14.4	15.7	13.4	7.4	19.6	9.1	8.6	7.5	8.9	14.9	6.4	5.0	6.3	8.0	5.9	18.6	12.1	7.5	9.0	10.6	14.5	11.5	21.6	10.2	8.8	12.7	11.5	10.8	10.4
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"	Q96NW7	1	69568398-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 29.1"	"Group enriched"	"Detected in some"	6	"HaCaT: 10.3;HEL: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 1.4;T-cells: 1.7"	"Low region specificity"	"Detected in many"							HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	1.0	1.3	20.2	1.0	29.1	1.0	0.8	0.5	21.9	1.2	1.9	5.0	0.0	1.0	1.2	1.0	1.3	0.8	3.2	2.8	15.4	5.8	2.8	1.2	0.8	0.9	4.4	17.6	1.0	2.7	0.7	0.4	1.2	2.4	1.5	2.4	0.2	0.9	1.1	2.8	1.1	1.3	1.2	2.5	0.8	0.8	5.8	7.6	0.0	6.7	0.0	0.8	0.9	0.5	0.0	0.1	1.4	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.3	0.0	10.3	0.2	0.0	0.0	0.0	0.5	30.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	20.2	29.1	0.5	19.2	15.4	5.8	4.4	17.6	2.4	7.6
LRRCC1	"CLERC, KIAA1764, VFL1"	ENSG00000133739	"Leucine rich repeat and coiled-coil centrosomal protein 1"	Q9C099	8	85107147-85146076	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012893, HPA075880"	Uncertain		Supported	Centrosome				Centrosome		"HPA012893: AB_1852434, HPA075880: "	"unprognostic (1.01e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.52e-1)"	5.2	5.6	10.8	9.8	10.7	7.0	7.3	2.3	7.2	7.0	10.8	5.6	5.1	7.3	7.1	7.3	6.1	5.2	4.8	5.3	10.4	9.0	9.7	4.4	6.1	4.9	12.7	6.0	9.4	4.8	6.0	2.7	2.5	8.8	8.9	10.1	3.4	3.6	6.8	2.0	6.5	10.0	11.7	15.0	5.3	6.5	33.1	9.9	11.4	10.1	3.4	3.9	8.0	22.1	1.3	2.9	0.1	1.2	2.5	3.6	0.6	4.3	0.9	8.2	1.9	4.0	3.5	6.5	4.7	2.9	1.0	1.8	2.2	6.3	3.2	0.7	2.8	6.0	9.7	2.7	1.6	25.3	0.8	12.7	2.5	3.2	1.2	4.8	3.4	2.0	0.7	2.8	0.6	1.1	14.3	3.0	5.2	1.6	14.5	3.8	2.8	2.1	10.7	5.2	2.2	2.8	3.3	1.1	2.8	2.2	4.3	1.6	9.8	10.5	1.4	4.0	5.4	4.2	6.1	4.1	4.0	6.4	3.3	12.6	7.7	0.0	0.8	0.0	1.8	1.2	0.9	1.3	1.4	1.9	2.9	1.2	1.6	2.8	0.1	2.5	0.9	1.9	3.6	0.6	10.8	10.7	2.3	7.2	10.4	9.0	12.7	6.0	8.8	9.9
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627576-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA006979	Approved		Supported	Cytosol			120000	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	27.2	9.9	11.2	28.6	9.4	28.5	31.3	8.8	14.5	28.0	30.9	5.4	16.4	13.7	36.3	24.1	30.1	18.5	23.3	30.7	11.1	12.0	32.1	27.6	29.9	25.5	7.7	10.0	18.0	10.4	31.3	14.2	16.8	12.2	27.5	16.3	8.2	20.2	14.4	52.7	12.6	19.8	56.8	7.4	27.9	21.5	7.3	5.8	27.6	19.0	23.1	19.4	49.3	39.5	12.8	17.6	71.6	33.1	9.3	19.9	10.6	22.2	11.5	5.5	11.1	7.9	15.7	18.5	16.8	16.1	9.1	9.1	4.4	15.0	1.9	6.7	25.8	18.7	12.6	23.2	19.5	72.9	8.2	17.7	13.1	12.4	15.9	23.3	16.9	7.0	48.8	21.1	51.9	18.4	13.0	18.3	19.5	10.8	13.5	17.8	7.2	10.6	20.1	32.3	18.1	29.1	32.6	11.3	7.5	7.8	17.9	21.2	10.1	29.4	32.2	11.0	10.7	11.8	17.6	3.7	3.1	12.5	16.0	23.6	12.0	14.3	22.8	49.4	16.5	19.7	12.4	11.0	19.9	17.1	17.6	12.8	10.6	11.8	71.6	9.3	33.1	15.5	15.3	10.6	11.2	9.4	8.8	14.5	11.1	12.0	7.7	10.0	12.2	5.8
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	"Leucine rich repeat kinase 1"	Q38SD2	15	100919215-101078254	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.1;Karpas-707: 17.0;U-266/84: 15.4;U-698: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010537	Uncertain		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA010537: AB_1079283"	"unprognostic (3.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (5.71e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.25e-2)"	6.1	1.9	4.5	26.3	3.9	6.5	5.0	2.1	8.1	6.4	8.0	5.9	2.2	2.9	7.9	6.0	5.4	7.1	4.2	3.4	4.0	1.5	2.7	1.0	4.7	15.0	4.5	4.0	6.3	5.3	2.8	2.3	4.4	2.5	7.1	6.5	2.8	7.7	6.8	1.6	7.3	8.5	5.7	3.7	11.1	3.9	5.1	3.4	1.2	3.5	2.1	17.4	7.5	6.7	2.3	3.3	3.2	1.1	0.0	0.0	0.1	0.8	4.7	0.0	0.0	7.3	7.5	0.0	2.8	2.1	2.6	1.8	0.8	2.1	23.1	1.0	7.7	4.7	0.6	0.5	1.3	0.4	1.1	7.0	1.0	0.0	0.5	3.7	5.4	5.9	1.0	1.7	1.5	4.7	1.1	17.0	0.5	0.0	0.0	2.3	0.2	2.0	1.6	0.4	6.3	0.0	0.0	0.0	1.6	1.8	2.7	5.3	0.3	4.5	5.4	0.0	0.8	1.0	0.0	8.7	15.4	15.0	0.3	0.5	4.3	0.0	0.7	3.2	0.0	0.3	0.0	2.3	0.0	0.0	0.9	1.5	0.0	0.0	0.8	0.0	1.1	3.3	0.0	0.1	4.5	3.9	2.1	8.1	4.0	1.5	4.5	4.0	2.5	3.4
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926006-67099830	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6"	"Cell line enhanced"	"Detected in some"		"AF22: 3.7;Daudi: 2.2;HAP1: 10.6;NTERA-2: 2.3;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.9	7.3	12.9	1.0	18.7	0.9	0.9	19.7	29.1	1.7	0.9	3.2	0.0	1.0	1.2	0.9	1.4	0.9	0.9	0.9	7.0	6.5	1.0	0.9	1.4	0.9	3.7	16.0	8.0	3.7	0.9	26.6	0.9	4.5	1.2	0.9	0.0	1.0	1.2	1.0	0.9	1.1	1.0	2.8	0.9	0.9	1.9	5.9	0.0	0.9	0.0	0.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.4	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	18.7	19.7	21.3	7.0	6.5	3.7	16.0	4.5	5.9
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464929-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 129.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles				Nucleoli	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favourable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	2.7	4.6	3.6	3.8	5.0	7.6	1.9	7.9	5.8	2.5	2.5	3.4	3.4	2.9	2.8	2.8	2.1	7.1	2.5	2.6	4.3	4.0	4.0	5.1	2.6	4.4	3.4	3.7	3.1	3.4	3.4	4.9	2.0	4.2	2.2	1.6	1.7	3.3	4.0	3.6	2.2	4.3	2.7	2.4	6.6	3.3	129.9	3.8	3.9	2.7	1.6	4.2	2.3	1.8	12.6	9.8	9.2	4.0	9.9	10.4	5.8	7.3	10.2	5.5	15.5	4.2	3.2	8.6	7.8	5.1	13.3	9.2	9.7	4.3	18.1	11.2	5.9	7.8	8.1	7.0	4.0	6.3	15.7	3.7	4.6	6.0	5.6	6.9	7.3	3.0	4.3	15.4	3.3	7.0	17.5	5.6	7.2	22.1	21.0	16.7	11.7	14.7	11.1	5.1	19.5	4.0	4.6	7.3	20.7	8.6	8.2	7.6	4.7	5.8	4.1	7.4	15.8	22.8	12.4	20.6	35.5	17.3	8.2	6.5	12.8	9.1	2.5	9.2	10.4	4.0	9.9	11.1	9.1	9.1	2.8	12.6	5.8	7.4	5.9	9.9	3.5	9.8	9.0	5.8	3.6	5.0	7.9	5.8	4.3	4.0	3.4	3.7	4.2	3.8
LSAMP	"IGLON3, LAMP"	ENSG00000185565	"Limbic system-associated membrane protein"	Q13449	3	115802363-117139389	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell line enhanced"	"Detected in some"		"AF22: 6.8;SH-SY5Y: 13.9;WM-115: 33.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054051, HPA076122"			Enhanced	Cytosol			200000000	Cytosol		"HPA054051: , HPA076122: "	"unprognostic (4.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.97e-3)"	"unprognostic (6.03e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.31e-2)"	2.3	12.7	21.9	4.3	23.7	1.1	1.6	43.4	48.4	17.8	5.5	16.6	0.0	1.9	4.4	2.8	3.4	2.9	11.3	2.1	23.7	18.8	2.5	1.0	8.5	4.0	17.6	21.5	4.8	11.1	0.6	3.1	1.2	18.3	21.1	3.5	1.2	1.7	6.2	0.7	4.6	1.9	3.3	13.1	1.7	3.2	3.9	21.3	0.0	4.2	0.0	5.2	7.3	3.4	1.6	0.4	3.0	0.8	0.3	1.0	0.3	0.2	2.2	6.8	0.2	0.7	2.1	0.7	0.6	0.3	0.2	0.7	0.2	0.4	0.5	0.2	3.5	0.1	0.1	0.1	0.3	0.5	0.1	0.2	0.7	0.3	0.1	0.5	0.3	1.7	0.0	0.8	0.1	0.0	0.3	2.3	0.0	0.2	0.7	0.6	2.6	0.8	0.2	0.1	0.1	1.7	1.6	1.6	13.9	0.0	0.1	2.1	0.2	0.8	0.1	1.5	1.3	1.7	0.4	1.4	1.8	0.2	0.4	0.2	33.8	3.0	0.8	1.4	0.9	0.5	1.0	0.7	0.6	0.5	0.2	1.6	1.0	0.7	2.8	0.3	0.6	0.4	0.5	0.3	21.9	23.7	43.4	23.7	23.7	18.8	17.6	21.5	18.3	21.3
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640788-194672477	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	20.4	17.8	14.2	17.9	20.7	28.8	21.8	14.5	18.9	17.7	18.5	19.2	16.6	20.4	21.6	24.8	22.5	18.3	15.3	17.8	13.3	15.1	20.4	30.6	18.2	20.2	19.9	13.3	21.9	25.6	20.6	24.4	24.2	23.8	21.0	22.3	15.9	19.8	22.2	30.1	26.0	20.0	18.0	16.3	22.2	18.5	18.6	15.9	25.0	23.5	15.8	28.1	18.7	20.3	13.2	14.0	10.7	10.6	17.0	14.9	8.2	20.5	13.7	8.3	13.9	13.0	7.1	16.9	12.4	12.0	17.0	15.1	18.0	9.5	16.3	37.3	11.3	15.0	26.2	14.1	20.7	21.0	12.6	17.4	14.2	10.2	9.3	19.1	16.9	6.9	12.2	17.6	16.4	18.4	14.5	18.1	14.0	28.7	17.2	11.4	22.6	25.2	20.9	13.7	18.4	9.1	17.9	15.8	10.9	16.1	14.7	15.0	34.7	12.5	14.0	13.0	14.8	18.2	25.3	20.0	26.2	38.7	10.4	24.7	20.0	2.8	8.1	10.7	13.5	10.6	14.9	13.2	11.0	11.9	14.0	11.0	12.9	11.5	1.1	17.0	7.1	7.4	12.2	8.2	14.2	20.7	14.5	18.9	13.3	15.1	19.9	13.3	23.8	15.9
LSM1	"CASM, YJL124C"	ENSG00000175324	"LSM1 homolog, mRNA degradation associated"	O15116	8	38163321-38176730	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024601			Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA024601: AB_1853379"	"unprognostic (1.19e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.97e-1)"	21.8	27.6	25.5	20.0	23.5	21.6	34.1	20.8	23.2	19.5	23.4	15.3	21.2	20.6	24.9	27.2	24.9	17.8	21.6	44.2	21.2	23.2	35.3	30.7	16.2	22.5	25.1	18.4	18.0	24.7	14.5	23.2	29.8	22.5	21.3	21.5	18.7	27.7	29.0	26.6	17.7	26.3	31.3	17.1	20.5	22.6	17.6	19.9	18.8	25.7	25.6	22.2	23.5	22.7	21.1	38.2	42.8	26.0	19.9	27.3	26.5	21.5	25.3	14.9	18.2	27.4	23.0	13.8	26.4	26.9	24.5	26.2	17.3	14.9	10.7	23.7	31.3	11.5	20.1	21.8	25.8	16.2	25.3	33.7	18.1	21.3	24.3	11.4	21.5	24.0	20.1	21.2	16.8	20.8	26.7	25.5	30.2	22.9	35.5	22.3	23.4	25.8	17.3	16.3	12.6	33.8	24.0	28.0	23.3	11.7	17.5	31.1	13.9	24.5	21.9	21.9	26.9	32.2	20.8	28.2	36.6	21.1	25.3	23.8	22.3	42.8	24.0	32.7	21.8	24.7	23.2	21.1	24.5	23.8	23.2	16.4	22.2	25.5	18.3	19.9	26.0	38.2	27.3	26.5	25.5	23.5	20.8	23.2	21.2	23.2	25.1	18.4	22.5	19.9
LSM10	MGC15749	ENSG00000181817	"LSM10, U7 small nuclear RNA associated"	Q969L4	1	36391238-36397892	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048469			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA048469: AB_2756307"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.90e-2)"	"prognostic favourable (4.89e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.40e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (8.54e-2)"	15.0	11.9	19.8	17.7	20.2	12.6	21.1	11.1	20.9	12.3	20.8	9.5	16.7	11.9	14.2	19.1	15.0	11.4	15.7	28.2	18.6	19.7	17.3	21.3	11.8	27.3	17.7	14.4	14.6	18.6	12.1	16.4	13.2	17.0	16.2	11.0	13.8	16.9	19.5	82.0	10.1	13.0	17.8	12.5	21.1	14.5	12.1	10.3	10.3	18.9	22.0	26.8	19.1	25.0	73.8	45.9	66.7	50.5	19.1	31.0	49.9	18.5	28.4	10.7	28.6	25.3	24.9	11.1	16.8	24.7	27.0	20.7	12.7	17.8	44.1	23.3	22.7	10.3	18.1	21.8	18.0	29.8	21.7	22.1	16.8	29.8	30.8	16.6	32.5	20.8	19.4	24.2	17.2	27.6	20.3	21.6	19.0	33.1	18.5	18.9	27.6	29.6	14.0	10.3	29.7	26.1	11.4	13.7	10.3	13.6	17.5	40.7	9.1	14.3	18.3	12.3	17.1	32.1	26.1	28.6	38.4	34.4	24.8	25.5	27.8	35.7	50.5	61.4	25.6	48.7	27.8	70.6	25.5	26.5	36.0	73.8	23.1	25.0	66.7	19.1	44.9	45.9	31.0	49.9	19.8	20.2	11.1	20.9	18.6	19.7	17.7	14.4	17.0	10.3
LSM11	FLJ38273	ENSG00000155858	"LSM11, U7 small nuclear RNA associated"	P83369	5	157743695-157760709	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039587	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA039587: AB_10796330"	"unprognostic (3.99e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.01e-2)"	3.4	3.7	10.8	3.6	4.7	2.9	6.4	13.6	11.8	5.3	8.9	1.9	4.9	4.6	9.1	3.2	4.7	4.6	4.7	2.4	5.1	6.1	2.8	2.7	3.1	3.9	4.7	9.2	7.3	3.7	5.0	4.2	4.2	5.8	9.2	5.4	2.7	3.4	10.2	2.5	4.4	3.8	21.0	3.3	3.1	4.1	9.0	1.4	1.9	2.6	2.6	4.2	15.0	8.0	1.0	0.6	1.6	0.9	2.7	1.8	0.5	3.7	2.7	7.5	7.9	3.4	4.4	6.5	5.1	2.3	4.3	5.7	8.1	3.8	8.2	6.0	3.0	4.4	9.6	5.6	4.7	5.8	9.1	3.4	9.6	5.1	1.2	9.9	4.3	1.9	3.7	5.3	5.4	7.0	6.3	4.4	4.6	3.5	5.6	5.8	2.2	8.3	9.0	9.3	3.4	2.2	3.5	4.4	7.0	3.4	4.6	4.5	3.8	6.2	5.1	8.5	3.3	4.9	8.0	3.6	2.3	8.2	3.4	10.5	3.7	1.6	0.9	0.5	1.4	0.7	1.8	0.7	1.8	1.4	0.6	1.0	1.6	1.5	0.7	2.7	0.4	0.4	1.2	0.5	10.8	4.7	13.6	11.8	5.1	6.1	4.7	9.2	5.8	1.4
LSM14A	"C19orf13, DKFZP434D1335, FAM61A, RAP55, RAP55A"	ENSG00000257103	"LSM14A, mRNA processing body assembly factor"	Q8ND56	19	34172504-34229515	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Repressor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017961	Approved		Supported	"Cytosol,Cytoplasmic bodies"				"Cytoplasmic bodies"	Cytosol	"HPA017961: AB_1845610"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.62e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.56e-1)"	22.7	22.9	20.8	28.4	23.7	78.7	36.1	33.4	24.9	26.4	26.2	20.3	21.2	13.4	31.5	51.6	22.2	21.0	20.8	22.5	21.3	18.9	33.9	30.7	25.6	32.7	24.6	19.3	30.3	18.2	32.1	18.5	38.1	23.1	27.8	21.8	21.0	20.2	30.2	38.8	38.3	25.9	29.0	25.6	23.2	17.9	20.1	25.7	42.1	37.9	21.5	23.2	26.6	25.3	8.2	10.7	16.4	10.1	10.9	12.0	7.6	1.0	0.4	1.6	1.9	0.7	2.1	0.8	0.7	4.6	0.6	0.9	1.6	1.1	2.0	0.6	1.3	0.2	7.0	10.1	12.9	0.9	1.2	0.4	2.9	1.8	11.5	1.2	0.8	8.3	6.4	1.2	2.0	1.5	0.8	0.0	9.8	3.1	5.8	8.3	9.9	0.1	1.6	0.4	4.8	8.0	0.1	1.0	2.9	0.6	13.0	7.9	1.4	27.6	0.5	1.7	1.4	0.0	0.6	0.4	4.1	4.4	10.0	4.4	0.6	11.2	8.2	16.4	10.5	10.0	12.0	7.8	9.1	8.5	10.7	8.2	10.4	9.6	6.1	10.9	10.1	2.8	8.9	7.6	20.8	23.7	33.4	24.9	21.3	18.9	24.6	19.3	23.1	25.7
LSM14B	"bA11M20.3, C20orf40, FAM61B, FLJ25473, FT005, LSM13, RAP55B"	ENSG00000149657	"LSM family member 14B"	Q9BX40	20	62122461-62135378	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041274, HPA061189"	Approved		Supported	"Nucleoli fibrillar center,Vesicles"				Vesicles	"Nucleoli fibrillar center"	"HPA041274: , HPA061189: AB_2684448"	"unprognostic (2.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (3.61e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.93e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.98e-1)"	13.6	19.6	21.4	17.3	24.4	20.2	24.0	50.0	38.6	19.5	16.1	15.9	11.9	20.4	21.9	15.6	20.1	16.8	16.1	28.7	20.8	18.9	14.9	15.1	15.3	18.9	17.3	28.2	30.6	26.5	19.4	16.9	13.2	20.4	18.2	13.2	16.8	20.2	16.9	55.5	23.4	19.5	17.9	18.6	18.1	18.3	35.2	12.2	28.8	16.6	20.1	16.7	19.1	17.7	1.4	1.3	5.8	1.1	0.1	1.2	0.2	13.9	13.3	21.2	20.3	9.7	10.2	18.2	14.7	11.0	30.8	13.5	39.0	9.7	14.7	17.1	10.1	20.2	10.2	12.8	15.4	6.0	7.4	35.4	17.0	23.2	13.4	15.1	21.5	8.7	23.2	12.8	11.9	7.8	18.9	10.6	10.7	18.4	25.1	22.8	13.1	19.7	32.8	42.0	11.6	8.3	16.5	29.2	25.3	26.9	23.9	18.9	29.7	19.2	10.1	43.9	30.1	22.6	14.9	13.5	15.9	18.2	19.3	10.1	14.0	0.2	1.1	5.8	1.0	1.0	0.4	1.2	0.7	1.2	0.9	1.4	0.8	0.8	1.8	0.1	0.5	1.3	0.5	0.2	21.4	24.4	50.0	38.6	20.8	18.9	17.3	28.2	20.4	12.2
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806984	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm			26000	Nucleoplasm		"HPA052805: , HPA066718: "	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	20.3	17.4	15.7	21.7	19.4	21.0	18.7	14.4	17.7	21.1	19.5	14.0	11.8	17.9	23.6	15.2	21.8	21.5	20.7	17.5	14.4	12.8	17.5	15.1	18.0	33.5	20.7	17.5	19.4	20.3	9.6	15.1	17.9	20.3	19.7	21.3	10.8	12.8	14.0	19.5	17.1	15.3	21.5	26.7	22.1	16.7	16.5	19.4	51.8	23.4	19.5	26.9	21.8	20.9	18.2	10.8	8.7	5.7	12.3	15.3	10.1	10.0	4.9	8.7	11.2	4.9	6.8	9.1	6.3	4.1	9.1	8.1	5.6	3.8	10.7	8.8	5.2	4.1	11.4	10.7	8.2	11.3	14.6	12.3	3.0	5.7	6.1	12.2	4.4	5.1	5.0	8.4	8.7	9.5	16.1	7.0	6.4	7.3	14.7	28.0	8.0	10.7	9.1	6.9	15.7	7.5	3.0	8.7	7.6	6.8	6.1	12.3	6.7	9.8	4.9	5.4	9.5	6.2	10.2	7.3	12.4	13.7	2.8	14.6	8.4	8.7	5.7	3.6	9.4	5.2	12.4	18.2	10.1	10.6	9.5	16.1	9.7	11.9	1.2	12.3	4.4	10.8	15.3	10.1	15.7	19.4	14.4	17.7	14.4	12.8	20.7	17.5	20.3	19.4
LSMEM1	"C7orf53, FLJ39575"	ENSG00000181016	"Leucine rich single-pass membrane protein 1"	Q8N8F7	7	112480853-112491062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 51.3;tongue: 19.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.6"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013753, HPA047988"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA013753: AB_1848926, HPA047988: "	"unprognostic (6.87e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.47e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.42e-2)"	1.1	0.7	0.6	0.6	0.6	0.8	0.9	3.6	0.7	0.6	0.6	0.6	0.6	1.3	0.6	1.7	0.7	0.4	0.6	2.1	0.7	0.8	1.4	3.5	1.8	0.6	0.7	0.6	0.6	2.8	0.3	0.9	0.6	0.6	0.9	0.8	0.6	1.9	0.6	51.3	0.8	0.8	0.6	0.6	1.9	0.8	1.1	0.6	0.6	0.9	19.2	1.5	0.6	0.6	0.0	0.1	2.7	0.1	0.0	0.2	2.2	0.8	1.3	0.7	2.8	2.8	3.1	0.1	1.3	0.9	0.6	0.5	2.2	1.8	1.2	1.9	0.3	0.7	0.8	0.9	1.2	0.6	0.8	0.8	12.3	2.2	1.3	1.2	0.6	2.2	3.7	0.8	0.8	0.7	0.9	2.8	0.4	1.0	1.0	3.6	0.6	0.9	0.4	0.2	0.6	2.4	1.4	2.6	1.4	2.2	1.1	1.5	0.4	0.5	0.5	2.8	1.0	0.8	1.0	0.8	1.7	1.1	0.8	0.8	0.8	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	2.2	0.6	0.6	3.6	0.7	0.7	0.8	0.7	0.6	0.6	0.6
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB022689: , HPA029680: AB_10603013, HPA072921: "	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	1.5	1.2	0.4	1.8	0.5	4.8	1.1	0.4	0.6	7.9	0.4	0.6	0.8	2.4	1.0	4.7	38.9	0.8	0.7	0.4	0.5	0.1	6.1	0.5	1.1	1.8	0.4	0.7	0.7	0.5	0.3	0.7	0.8	0.5	1.8	0.3	0.5	4.7	1.1	0.9	21.4	1.8	0.4	0.4	3.5	1.0	1.4	0.4	3.1	0.9	43.6	26.8	0.6	9.0	0.3	2.2	1.4	2.0	0.9	2.7	1.1	2.4	4.3	1.8	1.8	0.4	0.6	7.6	0.9	0.4	1.3	0.9	3.4	1.5	3.2	1.6	0.6	15.7	1.3	2.7	0.9	3.9	4.8	2.2	3.5	1.6	0.5	3.6	4.1	0.5	3.6	1.9	2.3	0.6	2.7	3.5	0.6	4.8	1.9	3.8	1.0	5.4	7.8	1.7	1.8	0.4	3.1	3.4	1.6	1.6	2.0	1.3	3.7	2.7	1.6	2.6	3.2	4.0	1.3	7.9	2.2	5.2	0.5	6.0	2.0	0.0	2.0	1.4	2.7	1.6	1.6	0.1	2.2	2.0	2.2	0.3	1.7	0.9	1.3	0.9	0.8	0.6	0.4	1.1	0.4	0.5	0.4	0.6	0.5	0.1	0.4	0.7	0.5	0.4
LTBR	"D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3"	ENSG00000111321	"Lymphotoxin beta receptor"	P36941	12	6375045-6391571	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 24.6;intermediate monocyte: 22.9;myeloid DC: 17.6;neutrophil: 15.8;non-classical monocyte: 16.4"	"Group enriched"	"Detected in many"	32	"dendritic cells: 17.6;granulocytes: 15.8;monocytes: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026202, HPA061617"	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB026202: , HPA061617: "	"unprognostic (2.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.24e-3)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (5.92e-4)"	"unprognostic (3.66e-2)"	"unprognostic (9.84e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.86e-1)"	32.7	24.8	6.0	13.6	8.1	3.6	77.6	2.7	4.8	25.0	25.1	4.9	31.3	18.9	26.7	19.5	34.9	18.1	29.8	15.2	9.5	3.3	39.4	85.2	38.7	21.7	8.1	2.6	28.3	79.8	18.1	10.6	27.0	8.4	31.3	13.7	16.9	31.3	27.0	19.1	25.2	43.6	28.2	12.5	23.3	24.5	14.3	5.7	4.2	45.8	33.6	19.1	27.0	23.0	0.0	17.6	15.8	24.6	0.6	0.1	8.0	17.4	23.6	0.0	7.6	46.9	35.3	16.3	12.1	28.2	18.5	19.1	10.8	27.2	0.0	7.4	26.4	20.2	0.0	25.6	7.3	0.0	0.0	10.3	9.7	6.1	75.2	0.7	17.4	51.7	47.5	13.1	37.1	16.8	9.8	0.1	21.1	16.2	0.0	4.9	0.2	13.0	0.0	1.2	0.0	27.5	20.1	0.1	0.1	11.4	22.7	25.5	3.8	18.9	10.4	6.5	7.4	23.9	12.9	0.0	0.0	0.0	2.7	6.4	23.8	1.4	24.6	0.1	0.0	22.9	0.0	0.0	0.0	0.0	17.6	0.0	0.1	0.1	15.8	0.6	16.4	4.2	0.0	8.0	6.0	8.1	2.7	4.8	9.5	3.3	8.1	2.6	8.4	5.7
LTN1	"C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294"	ENSG00000198862	"Listerin E3 ubiquitin protein ligase 1"	O94822	21	28928144-28992956	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029143, CAB034164, HPA055604"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: "	"unprognostic (3.67e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.38e-2)"	"unprognostic (5.40e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.52e-1)"	17.9	15.1	10.3	12.4	19.8	21.2	17.9	19.9	23.2	16.6	14.7	17.8	12.1	12.4	16.5	15.4	15.2	14.5	10.8	13.1	12.0	10.6	14.1	19.3	12.0	15.7	19.6	14.2	16.4	23.7	18.4	22.6	29.0	28.7	19.0	15.6	9.7	16.1	12.6	22.5	14.8	17.1	13.4	17.4	16.7	15.4	20.7	15.8	23.0	17.6	14.6	14.9	16.6	14.7	7.8	6.2	12.2	11.9	8.6	8.4	3.3	12.6	5.5	11.3	5.1	9.7	13.3	11.5	10.7	8.7	9.2	12.8	7.6	10.6	8.3	5.2	9.5	6.5	12.0	8.8	16.8	9.7	8.3	24.8	7.5	6.0	7.3	8.2	9.7	9.2	7.9	13.1	10.9	9.7	20.2	20.0	10.5	3.9	5.3	8.0	16.2	6.5	7.1	22.7	17.4	10.4	10.9	6.2	12.9	12.3	9.4	10.7	9.6	11.6	12.8	8.1	15.2	10.9	9.0	16.4	15.3	11.8	12.7	17.9	9.6	12.2	6.4	9.5	8.4	9.8	7.0	7.8	5.8	5.6	6.2	7.1	6.2	4.7	11.3	8.6	11.9	3.9	6.1	3.3	10.3	19.8	19.9	23.2	12.0	10.6	19.6	14.2	28.7	15.8
LTV1	"C6orf93, dJ468K18.4, FLJ14909"	ENSG00000135521	"LTV1 ribosome biogenesis factor"	Q96GA3	6	143843344-143863812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA030159, HPA030160, HPA030161"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001"	"unprognostic (2.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"prognostic unfavourable (4.95e-5)"	"unprognostic (7.09e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.70e-2)"	"prognostic unfavourable (6.01e-13)"	"unprognostic (2.94e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.41e-1)"	20.0	20.6	15.6	19.5	26.2	39.3	26.7	19.4	26.0	14.6	16.5	11.1	17.9	13.8	21.2	14.7	21.2	18.0	11.3	15.7	25.1	10.9	14.4	29.0	18.9	21.2	21.0	17.1	20.6	20.9	13.3	19.7	17.3	17.4	16.3	18.9	8.0	16.6	18.5	52.0	23.5	17.2	20.7	18.5	20.8	18.3	17.5	18.1	15.0	16.1	26.4	21.8	16.6	25.5	17.3	18.4	4.1	12.9	21.2	16.1	8.3	11.5	10.8	12.9	28.7	9.6	11.7	15.0	18.0	13.3	20.0	16.0	17.6	6.0	24.4	14.6	16.3	13.1	21.5	17.7	28.0	14.0	21.0	48.3	12.5	26.9	17.0	59.3	28.1	13.2	13.0	22.2	24.4	13.8	45.9	16.2	15.4	19.5	20.2	25.3	15.2	12.0	17.5	24.5	10.9	14.8	16.2	11.5	13.8	18.4	15.3	16.8	8.5	38.0	12.5	12.8	14.8	28.5	33.0	20.3	25.0	33.3	12.9	31.1	18.0	1.2	10.1	4.1	12.1	12.9	13.1	17.3	12.7	13.0	15.2	14.3	14.1	16.1	0.3	21.2	11.0	18.4	10.9	8.3	15.6	26.2	19.4	26.0	25.1	10.9	21.0	17.1	17.4	18.1
LUC7L3	"CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18"	ENSG00000108848	"LUC7 like 3 pre-mRNA splicing factor"	O95232	17	50719544-50756213	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018475, HPA018484, HPA020017"	Enhanced		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249"	"unprognostic (3.90e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.18e-2)"	"prognostic favourable (6.07e-4)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (8.41e-7)"	"unprognostic (7.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (5.35e-5)"	24.1	42.2	57.2	39.6	66.9	24.0	28.7	137.4	62.6	37.6	36.7	22.3	36.4	37.0	55.0	35.0	23.7	31.5	24.3	27.5	54.5	31.3	25.4	20.4	27.8	45.9	72.2	51.8	60.1	27.3	34.1	71.9	29.3	51.3	34.7	29.1	21.6	32.8	35.2	50.6	39.1	35.9	38.2	78.4	41.8	30.5	20.7	70.9	29.1	37.2	27.5	32.1	30.2	39.2	28.8	30.6	22.7	15.9	10.3	18.8	5.2	35.8	23.3	47.5	30.4	20.0	19.4	22.5	33.7	13.1	16.4	19.7	44.5	27.8	43.8	36.6	13.5	31.3	31.3	14.1	28.6	45.2	49.4	51.8	81.3	35.4	10.9	45.3	29.0	18.2	20.0	17.7	10.5	16.8	40.2	40.0	20.9	19.9	44.5	44.2	30.9	17.6	48.3	44.6	45.4	22.5	22.9	33.6	35.2	20.1	25.8	34.9	41.6	33.6	23.7	37.0	31.4	15.5	34.6	35.3	37.7	53.7	23.0	31.3	25.7	18.3	15.9	14.5	16.3	11.3	14.3	27.5	17.6	13.5	9.9	28.8	18.8	15.4	22.7	10.3	8.8	30.6	13.3	5.2	57.2	66.9	137.4	62.6	54.5	31.3	72.2	51.8	51.3	70.9
LURAP1	"C1orf190, FLJ25163, LRAP35a"	ENSG00000171357	"Leucine rich adaptor protein 1"	Q96LR2	1	46203334-46221261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 110.5"	"HPA030060, HPA030061"	Uncertain		Supported	Vesicles,Cytosol				Cytosol	Vesicles	"HPA030060: AB_10599997, HPA030061: AB_10601990"	"unprognostic (3.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.33e-1)"	"prognostic favourable (8.81e-8)"	"unprognostic (1.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.39e-2)"	3.0	7.3	7.1	2.2	13.2	3.4	3.9	12.7	12.7	5.8	3.8	15.2	2.2	2.0	5.5	4.9	4.0	4.0	3.7	8.7	6.7	5.8	7.4	1.1	3.2	1.6	18.8	6.0	7.2	1.1	21.5	3.2	2.3	11.2	7.5	2.5	4.7	5.2	9.8	2.5	4.2	1.9	5.6	17.5	3.5	3.7	10.8	13.6	0.0	19.6	0.0	2.1	5.6	5.3	1.0	0.7	6.2	1.1	1.9	0.8	0.3	0.2	0.2	3.0	0.2	4.1	5.6	3.1	2.1	5.4	2.9	3.5	0.1	0.2	0.2	0.1	5.1	0.3	3.2	6.8	2.4	0.6	1.5	0.2	0.7	0.3	1.2	0.2	0.1	2.9	4.6	5.7	2.7	4.2	2.6	0.6	1.7	0.3	0.3	0.3	1.1	0.5	1.1	1.5	0.0	7.6	0.1	0.4	1.2	0.1	0.2	4.9	1.5	0.3	0.2	1.8	2.3	1.5	0.4	0.3	0.1	0.3	1.7	0.3	0.4	1.3	1.1	0.4	0.3	0.5	0.8	0.5	0.4	0.3	0.4	1.0	0.8	0.6	6.2	1.9	0.5	0.7	0.1	0.3	7.1	13.2	12.7	12.7	6.7	5.8	18.8	6.0	11.2	13.6
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.3"	"Cell line enhanced"	"Detected in many"		"A-431: 28.2;BJ: 30.6;HeLa: 33.3;SiHa: 47.9;U-2197: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 5.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.3"									"HPA017770, CAB075742, CAB075743"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"			"Plasma membrane"	Nucleoplasm	"CAB075742: , CAB075743: , HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	6.6	0.4	1.4	0.3	1.8	0.4	7.6	0.9	3.8	1.8	1.6	0.1	9.8	0.5	0.7	0.8	10.9	0.8	1.2	1.2	1.5	1.9	2.0	0.2	0.6	1.9	1.7	0.0	0.7	0.4	0.0	0.3	6.3	1.0	1.1	0.1	0.1	1.4	7.0	6.3	4.3	0.2	0.6	1.1	0.3	0.4	39.3	0.2	0.2	1.1	4.5	6.8	1.0	3.2	0.1	0.1	5.3	0.2	0.4	0.2	0.0	28.2	0.5	0.0	1.5	0.6	1.9	0.3	30.6	3.6	9.5	5.7	0.0	0.2	0.0	2.6	3.4	2.5	0.0	1.7	8.0	0.3	0.0	0.0	33.3	0.0	0.4	0.0	0.0	2.8	5.0	7.0	9.1	0.8	0.0	0.1	17.8	0.2	0.0	0.0	1.0	0.4	0.0	0.1	0.0	1.5	0.3	0.8	0.1	47.9	0.6	9.3	0.1	0.0	1.2	0.4	2.8	64.7	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.5	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	5.3	0.4	0.1	0.1	0.0	0.0	1.4	1.8	0.9	1.7	1.5	1.9	1.7	0.0	1.0	0.2
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290169	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favourable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	11.1	5.7	6.8	11.9	10.1	10.9	8.2	7.3	8.0	6.6	6.9	4.3	4.1	5.7	6.9	5.5	11.2	7.1	5.4	10.1	7.0	4.6	5.0	9.9	7.7	13.8	10.9	4.5	11.1	6.3	4.4	15.6	7.1	8.4	7.8	6.8	3.7	5.4	6.4	15.1	5.9	6.2	9.1	7.9	18.2	5.8	60.2	12.0	10.0	6.3	11.9	10.9	10.1	10.4	7.3	7.1	8.9	12.9	10.7	32.8	10.3	13.1	6.9	6.2	9.0	5.4	6.2	10.6	12.0	4.1	12.5	8.6	21.6	17.3	35.3	8.7	5.1	8.4	23.1	12.5	16.4	6.3	17.0	35.4	6.6	24.2	9.2	40.8	9.6	4.8	8.0	14.3	24.5	10.8	47.3	11.8	8.7	13.3	13.8	52.6	30.8	22.6	21.3	11.3	17.0	5.6	9.2	14.7	6.3	6.5	7.1	12.2	7.4	12.2	10.0	12.5	9.9	16.2	37.7	8.4	12.6	56.4	8.5	34.5	10.1	8.9	9.7	8.5	28.6	9.6	32.8	7.3	18.9	30.8	7.1	5.7	8.9	19.0	2.8	10.7	12.9	5.3	8.8	10.3	6.8	10.1	7.3	8.0	7.0	4.6	10.9	4.5	8.4	12.0
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879813-56014168	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.9"	"Cell line enhanced"	"Detected in many"		"HEL: 56.8;HMC-1: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"			11000000	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	8.8	6.8	4.5	34.0	6.3	33.6	11.1	9.5	4.1	5.3	10.5	5.8	7.2	15.6	3.4	7.8	7.2	6.7	13.7	8.9	4.8	3.6	6.1	13.8	34.6	70.9	7.7	2.1	5.3	9.8	3.1	4.9	19.1	5.6	5.7	6.6	6.3	14.9	8.5	2.7	3.4	16.2	6.6	8.5	69.4	7.4	3.6	5.1	3.8	9.4	5.3	25.8	10.7	7.5	8.4	9.2	36.8	26.5	1.9	0.9	2.7	12.6	7.5	1.7	0.3	0.1	0.0	13.7	9.7	14.2	6.1	4.3	5.2	4.4	12.2	4.3	3.8	5.9	7.1	7.2	5.2	19.8	7.1	56.8	2.3	1.8	1.9	5.7	57.7	0.3	2.5	0.1	4.4	8.2	30.0	26.5	0.9	0.7	0.0	6.0	10.9	0.8	0.9	2.8	1.5	3.9	6.0	1.1	22.0	4.8	0.0	2.0	1.1	13.4	9.6	0.0	2.8	0.0	4.4	8.9	3.2	27.6	0.6	11.3	0.4	2.1	7.2	12.3	0.9	16.8	0.7	8.2	0.2	0.3	6.4	8.4	0.1	0.4	36.8	1.9	26.5	9.2	0.0	2.7	4.5	6.3	9.5	4.1	4.8	3.6	7.7	2.1	5.6	5.1
LYPLAL1	Q96AV0	ENSG00000143353	"Lysophospholipase like 1"	Q5VWZ2	1	219173844-219212865	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045806	Approved		Supported	Cytosol				Cytosol		"HPA045806: AB_10966647"	"unprognostic (1.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"prognostic favourable (1.31e-4)"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	10.7	22.3	19.0	9.4	17.4	2.1	12.4	15.2	13.2	10.6	7.2	14.4	4.4	10.7	19.4	5.9	10.0	7.1	10.5	39.7	17.9	15.4	46.6	29.9	8.9	9.5	19.5	12.3	12.5	12.9	14.6	25.0	9.9	14.9	16.3	7.7	16.1	9.9	8.6	12.0	11.5	9.2	15.6	28.2	6.5	7.7	10.6	17.0	7.3	19.3	9.9	10.3	9.0	12.9	12.8	6.8	8.9	9.6	4.0	7.3	5.3	6.6	6.6	3.0	0.0	6.0	12.0	7.7	3.7	4.4	3.5	3.9	3.1	8.9	7.1	11.2	3.3	3.5	6.0	8.6	5.1	10.0	6.9	4.1	3.5	6.8	24.2	8.6	3.0	13.9	7.8	3.7	8.8	10.2	12.1	7.0	7.9	4.3	4.0	7.4	5.8	10.8	2.3	7.7	12.0	13.8	4.9	7.2	4.7	4.4	11.8	13.2	11.1	11.1	6.2	2.9	2.0	5.8	4.6	6.5	3.7	5.2	9.4	7.1	6.3	2.4	8.6	4.7	3.6	6.3	5.7	12.8	4.9	4.2	6.8	7.6	7.3	5.7	8.9	4.0	9.6	6.0	4.8	5.3	19.0	17.4	15.2	12.9	17.9	15.4	19.5	12.3	14.9	17.0
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 101.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA059840: "	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favourable (9.50e-4)"	25.4	18.9	19.1	15.0	17.4	12.8	25.5	12.6	17.8	17.5	16.6	9.6	14.0	9.5	17.1	21.1	16.2	24.9	17.0	34.2	15.4	18.2	30.6	101.6	11.2	19.2	18.8	13.8	25.3	26.1	20.5	13.9	9.0	24.9	21.1	14.0	13.1	14.1	19.1	28.7	10.6	12.6	27.6	17.9	11.5	15.7	22.9	9.0	16.2	19.4	14.9	12.9	25.3	19.7	12.7	7.2	47.4	10.2	8.4	14.2	10.1	11.8	12.8	11.9	9.4	32.3	25.7	3.9	9.9	16.6	5.7	8.7	14.3	14.9	8.4	38.7	11.9	8.4	5.2	10.4	9.4	15.6	8.1	3.8	3.5	36.9	24.0	12.4	7.5	18.6	9.2	16.0	46.0	23.6	8.4	14.8	24.7	15.8	12.3	8.4	12.4	6.7	16.9	6.6	10.0	20.6	7.0	11.6	11.2	6.1	10.3	16.5	10.6	7.3	6.2	8.2	6.0	12.9	6.8	14.7	20.5	13.1	21.5	13.4	7.1	47.4	7.2	23.3	8.6	9.1	11.8	12.7	13.2	10.6	5.9	11.2	10.7	10.8	26.8	8.4	10.2	7.2	14.2	10.1	19.1	17.4	12.6	17.8	15.4	18.2	18.8	13.8	24.9	9.0
LYRM4	"C6orf149, CGI-203, ISD11"	ENSG00000214113	"LYR motif containing 4"	Q9HD34	6	5102593-5260939	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030362	Approved		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA030362: AB_10601546"	"unprognostic (2.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.23e-1)"	16.1	21.0	21.6	14.9	18.7	17.9	19.3	11.0	26.6	17.8	13.8	11.5	11.2	8.4	20.2	22.8	15.6	22.5	11.2	21.0	16.7	16.1	16.1	13.7	12.7	20.9	16.2	16.9	32.4	23.2	10.3	32.3	13.3	15.0	13.6	18.2	14.6	12.9	11.3	13.4	18.3	10.3	18.9	15.8	17.2	14.2	18.4	14.3	20.7	24.2	14.9	20.4	16.2	15.4	18.3	19.3	2.0	11.2	13.7	18.2	10.3	10.8	11.1	14.4	11.9	14.6	20.3	13.0	9.0	16.1	11.6	12.1	17.9	5.9	16.2	20.1	10.7	8.7	17.7	11.2	10.5	24.1	16.1	7.7	6.9	28.2	9.5	17.2	6.6	18.2	18.6	12.0	18.3	9.9	19.4	5.9	9.9	5.2	16.3	26.8	14.1	14.6	14.8	10.8	26.6	13.8	8.3	20.1	14.8	8.6	4.8	26.1	14.7	17.0	10.2	12.6	9.9	12.9	16.6	8.2	28.5	15.4	7.9	13.3	21.7	0.7	9.8	0.8	7.3	11.2	10.1	18.3	11.3	7.8	19.3	12.8	18.2	16.5	2.0	13.7	9.5	11.9	9.4	10.3	21.6	18.7	11.0	26.6	16.7	16.1	16.2	16.9	15.0	14.3
LYSMD1	"MGC35223, RP11-68I18.5, SB145"	ENSG00000163155	"LysM domain containing 1"	Q96S90	1	151159748-151165948	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028055, HPA064537"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028055: AB_10601912, HPA064537: "	"unprognostic (1.71e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.26e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.31e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.47e-3)"	"unprognostic (6.33e-2)"	8.2	11.2	9.0	4.7	11.2	2.1	10.0	20.8	13.4	11.0	9.3	13.0	10.7	10.6	12.1	7.9	8.6	11.4	8.7	13.2	8.8	9.1	9.4	9.3	5.9	5.2	8.5	9.9	19.8	10.9	13.8	14.8	13.2	11.0	10.6	9.8	11.1	9.0	15.4	20.6	9.2	8.7	12.4	9.3	6.3	8.2	7.3	10.6	8.2	11.1	6.4	5.7	10.0	8.8	3.6	3.3	7.2	2.1	3.1	3.5	0.7	4.1	4.5	9.9	7.7	5.8	6.5	7.7	6.1	5.3	7.3	6.6	2.9	5.1	5.6	7.6	3.9	7.4	7.7	4.3	5.4	10.6	8.5	3.2	7.5	3.0	9.1	3.2	5.2	9.0	9.5	6.8	9.9	3.0	6.3	5.4	5.0	6.7	8.5	4.2	6.3	5.8	6.0	7.2	3.2	5.4	1.9	11.9	14.6	4.6	14.0	7.9	8.6	11.3	3.0	5.7	3.1	3.5	7.9	17.2	13.0	2.6	4.8	1.3	5.2	3.8	2.1	3.0	2.1	1.3	2.4	1.7	2.5	1.4	1.6	3.6	3.3	3.5	7.2	3.1	1.7	3.3	3.3	0.7	9.0	11.2	20.8	13.2	8.8	9.1	8.5	9.9	11.0	10.6
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.4;SK-MEL-30: 12.4;THP-1: 43.9;U-937: 16.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.0;monocytes: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"				Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: , HPA055725: "	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	10.3	5.2	6.4	9.0	8.8	31.3	10.6	10.5	7.1	8.8	5.3	3.8	3.4	3.4	6.8	4.3	6.6	5.6	5.8	4.7	4.3	2.4	5.0	6.1	10.9	7.8	4.2	6.0	6.2	5.0	9.1	12.6	5.5	5.3	6.0	5.0	9.6	8.2	4.8	3.9	11.7	6.3	9.8	9.2	11.3	8.4	6.4	6.3	38.8	8.5	4.0	7.6	9.3	10.6	1.6	1.7	13.0	5.9	1.7	1.0	0.7	3.7	0.8	0.4	0.9	5.9	6.8	0.6	1.4	5.6	1.5	1.4	0.0	1.0	0.5	0.5	3.0	1.8	0.5	0.7	1.3	13.4	1.2	1.2	0.8	0.3	1.0	1.8	1.6	2.2	3.6	1.8	4.6	1.2	0.1	0.8	1.1	0.1	2.3	3.8	0.1	0.4	0.1	0.5	0.0	4.3	4.1	2.4	0.5	1.5	0.0	12.4	0.5	43.9	2.6	1.1	0.5	1.2	1.2	0.9	0.0	0.0	1.9	16.8	3.1	0.4	3.1	5.7	0.6	3.5	1.0	1.1	0.3	0.7	1.7	1.6	0.2	0.5	13.0	1.7	5.9	0.2	0.2	0.7	6.4	8.8	10.5	7.1	4.3	2.4	4.2	6.0	5.3	6.3
LZTFL1	BBS17	ENSG00000163818	"Leucine zipper transcription factor like 1"	Q9NQ48	3	45823316-45916042	"Disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043466, HPA048447"	Enhanced		Supported	Cytosol				Cytosol		"HPA043466: AB_2678491, HPA048447: AB_2680398"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.27e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.19e-1)"	5.8	7.2	12.3	5.0	14.9	4.8	13.6	9.3	21.6	14.5	6.9	4.4	10.4	6.0	14.4	16.6	6.1	20.8	7.3	5.3	10.2	11.6	12.9	10.1	9.7	4.4	6.9	13.4	12.8	8.6	14.6	30.7	6.2	10.1	9.0	6.8	5.6	7.5	10.4	3.6	6.4	6.8	8.7	6.1	5.8	6.3	27.7	5.6	55.7	20.4	4.3	5.7	7.3	6.4	7.2	4.6	1.9	2.5	2.3	4.0	2.7	6.7	3.5	5.5	3.5	5.2	12.5	2.6	3.6	6.0	7.5	9.8	1.0	5.1	2.0	2.2	4.5	3.2	5.9	6.0	10.5	0.0	4.2	1.3	4.9	2.9	6.8	6.6	1.9	6.7	20.9	9.3	6.1	4.2	6.2	4.3	4.1	1.0	18.1	6.3	5.7	2.9	2.5	0.5	7.1	10.3	2.6	3.7	7.7	4.4	4.1	8.8	4.9	11.6	6.8	3.2	2.2	8.5	4.7	12.3	6.4	0.0	10.1	7.8	2.6	0.0	1.9	0.7	2.8	2.5	3.9	7.2	2.5	2.4	4.6	3.7	4.0	3.3	1.9	2.3	1.6	4.5	3.5	2.7	12.3	14.9	9.3	21.6	10.2	11.6	6.9	13.4	10.1	5.6
MAB21L2		ENSG00000181541	"Mab-21 like 2"	Q9Y586	4	150581922-150584693	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.2;intestine: 59.8;smooth muscle: 15.2"	"Group enriched"	"Detected in some"	17	"HHSteC: 7.0;SH-SY5Y: 17.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Region enriched"	"Detected in some"	18	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049324, HPA059864"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA049324: , HPA059864: "	"unprognostic (1.12e-1)"		"unprognostic (3.67e-2)"		"unprognostic (4.03e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-2)"		"unprognostic (8.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.68e-1)"	0.6	3.1	0.2	8.6	0.4	0.0	0.1	0.2	0.2	0.2	59.8	0.1	0.0	6.8	0.1	0.9	0.9	0.2	0.5	0.7	0.2	0.6	0.1	0.5	0.1	0.6	1.0	0.0	0.1	0.2	0.0	0.3	0.0	19.2	0.2	8.1	9.0	2.2	0.0	0.3	0.2	14.7	15.2	4.5	0.1	0.3	0.1	0.0	0.2	1.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.6	1.0	0.0	19.2	0.0
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule-actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	Actin-binding	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"				"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: , HPA068103: "	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favourable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	24.1	22.6	41.4	21.4	44.0	21.2	25.2	62.6	54.0	37.1	42.2	35.3	22.7	11.9	66.5	33.6	20.3	28.0	31.5	39.0	35.9	32.7	27.2	24.4	53.5	21.2	41.1	28.6	41.5	25.0	46.2	37.1	22.8	40.5	26.3	18.2	23.3	26.0	32.0	40.8	59.2	18.4	56.7	37.0	29.7	22.9	17.7	39.0	13.3	34.5	17.9	16.0	28.0	34.8	4.8	2.6	4.9	2.8	6.4	13.7	2.0	12.4	15.2	18.8	8.4	16.6	17.2	8.1	17.2	23.3	10.7	10.6	9.1	15.1	6.5	18.1	24.4	8.3	3.3	12.3	14.9	12.5	9.2	11.6	11.3	14.7	19.0	10.7	5.0	11.7	12.7	29.6	15.9	37.7	17.0	8.9	41.8	4.1	6.0	13.9	25.9	9.0	11.4	28.7	1.2	55.7	13.5	10.4	10.6	6.8	4.6	16.4	2.0	10.6	42.4	17.5	14.1	8.3	30.1	5.3	5.1	7.8	28.6	10.1	16.0	4.9	1.5	3.8	13.7	2.7	6.7	2.3	6.8	8.6	1.9	4.8	5.4	6.8	1.3	6.4	2.8	2.6	2.9	2.0	41.4	44.0	62.6	54.0	35.9	32.7	41.1	28.6	40.5	39.0
MACROD1	LRP16	ENSG00000133315	"MACRO domain containing 1"	Q9BQ69	11	63998558-64166106	"Disease related genes, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 142.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 26.5;RPMI-8226: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA041031: AB_10794435, HPA071075: "	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favourable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	4.9	3.0	2.9	2.8	3.3	2.5	3.9	6.2	4.6	3.6	6.9	2.8	7.0	4.3	3.4	6.5	7.8	3.2	3.9	29.0	2.2	3.4	10.6	10.4	3.0	1.8	3.0	3.1	5.2	16.6	2.5	2.7	2.1	3.1	6.1	1.9	4.6	16.4	8.1	142.5	5.5	3.9	6.2	2.4	2.7	5.6	1.9	2.7	0.8	12.7	25.0	3.3	4.6	4.5	0.6	0.7	0.0	1.2	0.0	2.0	0.4	3.9	2.1	0.6	3.7	0.6	0.4	3.6	2.3	1.1	1.9	1.7	2.0	10.8	15.1	8.3	0.2	10.2	0.5	0.0	0.1	1.1	7.1	5.4	8.6	10.7	2.2	4.5	0.6	0.9	1.2	0.2	0.5	0.6	4.9	3.0	0.3	26.5	6.2	15.6	1.8	8.0	5.6	4.3	50.0	0.6	0.2	5.2	10.8	2.1	15.6	14.2	11.2	0.1	1.0	1.7	2.5	2.5	0.2	6.1	0.9	2.4	1.1	4.6	1.5	0.0	0.2	0.0	2.0	1.2	1.9	0.6	1.8	1.1	0.4	0.4	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.4	2.9	3.3	6.2	4.6	2.2	3.4	3.0	3.1	3.1	2.7
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"MACRO domain containing 2"	A1Z1Q3	20	13995369-16053197	"Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 14.5;Karpas-707: 17.9;RT4: 7.9;SCLC-21H: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8"	"Group enriched"	"Detected in many"	5	"B-cells: 14.1;granulocytes: 3.8"	"Low region specificity"	"Detected in all"							HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	2.8	5.1	15.2	3.0	47.5	2.0	4.2	20.8	13.6	6.4	2.7	3.7	2.0	1.4	12.1	3.9	2.3	10.3	4.1	1.9	10.5	8.2	5.6	2.7	15.7	5.5	7.6	8.9	4.5	4.2	5.4	12.0	1.8	10.5	7.1	2.1	4.0	2.4	14.9	3.1	3.9	1.8	5.8	6.9	6.9	3.4	7.9	9.9	0.0	4.1	0.1	7.2	10.6	3.1	14.1	0.5	3.8	1.8	0.3	0.6	0.5	1.0	0.6	2.7	0.9	0.9	0.8	0.5	0.5	2.0	1.1	0.6	1.0	0.7	1.9	14.5	1.4	1.4	0.4	0.6	1.8	0.9	0.8	1.1	1.1	1.8	3.5	0.3	0.3	1.6	1.1	0.0	0.8	1.1	1.3	17.9	3.0	0.4	0.5	0.7	0.9	0.4	1.1	0.5	3.4	2.1	7.9	9.9	4.3	1.5	0.1	0.7	1.0	1.6	0.8	1.5	3.0	0.2	0.1	1.5	0.4	1.8	0.9	1.0	1.8	0.3	0.6	0.6	0.4	1.3	0.4	7.4	0.3	0.4	0.5	14.1	0.4	0.6	3.8	0.3	1.8	0.2	0.2	0.5	15.2	47.5	20.8	12.8	10.5	8.2	7.6	8.9	10.5	9.9
MAD1L1	"HsMAD1, MAD1, PIG9, TP53I9, TXBP181"	ENSG00000002822	"Mitotic arrest deficient 1 like 1"	Q9Y6D9	7	1815793-2233243	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003635, CAB015338"	Supported		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"CAB015338: AB_627901, HPA003635: AB_1853472"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.26e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-1)"	11.8	7.6	11.4	17.3	29.7	19.1	9.0	15.7	15.0	10.0	9.3	12.1	6.1	8.8	10.4	8.5	12.3	9.2	10.9	11.4	12.3	10.0	7.9	17.6	13.3	23.2	14.8	13.3	10.3	10.7	7.8	10.7	9.3	10.5	9.4	6.8	12.0	10.3	8.3	16.8	17.4	9.8	10.3	11.9	21.2	9.8	15.4	11.0	25.9	10.5	7.2	19.1	11.3	11.3	25.4	21.9	25.8	21.6	6.7	46.8	18.2	16.9	6.8	8.4	12.9	6.0	5.2	11.2	12.6	7.9	13.6	11.0	13.4	10.3	10.6	4.8	7.5	13.6	7.9	9.2	7.8	5.4	8.0	11.8	10.3	20.8	7.8	8.1	23.3	6.6	7.6	14.8	7.6	6.7	13.4	8.2	7.1	17.1	3.4	32.0	13.9	8.1	18.3	9.1	7.9	7.5	9.8	5.9	16.2	10.0	10.2	28.9	7.8	28.0	8.3	9.8	27.5	27.8	12.6	12.9	12.0	13.0	8.6	25.7	33.4	25.8	12.1	8.6	27.9	21.6	26.0	19.7	27.2	27.1	21.9	25.4	37.7	26.2	3.4	6.7	19.6	8.1	46.8	18.2	11.4	29.7	15.7	15.0	12.3	10.0	14.8	13.3	10.5	11.0
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: "	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	12.1	16.6	11.0	13.3	14.4	35.7	13.8	16.5	24.4	12.2	21.3	10.1	6.3	18.1	12.9	14.1	17.0	13.4	13.2	19.2	11.9	12.1	18.3	18.9	11.4	18.2	11.0	12.6	11.3	18.5	11.5	12.8	12.6	14.0	12.6	22.0	13.6	24.2	11.3	25.1	11.9	22.0	12.4	9.8	17.5	16.8	17.6	7.9	29.0	18.9	13.9	19.9	14.3	13.2	27.9	27.6	39.7	22.2	26.8	39.8	21.4	19.1	8.9	14.0	15.5	12.2	13.3	8.5	11.5	18.7	25.6	24.0	18.1	7.8	14.9	6.6	13.5	12.6	21.7	16.0	19.8	13.7	16.9	18.4	9.8	15.5	13.2	10.8	11.2	13.4	19.7	19.0	11.7	19.1	23.6	8.1	17.7	18.0	9.6	20.1	8.6	11.5	11.2	10.9	14.1	18.2	15.4	16.7	16.9	8.3	12.8	54.2	15.0	28.9	10.4	13.7	11.5	9.0	18.3	10.4	8.8	35.0	12.5	18.3	15.0	39.7	22.2	25.0	25.7	22.1	25.8	27.9	30.8	28.4	27.6	25.6	32.3	29.0	18.6	26.8	19.9	18.3	39.8	21.4	11.0	14.4	16.5	24.4	11.9	12.1	11.0	12.6	14.0	7.9
MADD	"DENN, KIAA0358, RAB3GEP"	ENSG00000110514	"MAP kinase activating death domain"	Q8WXG6	11	47269161-47330031	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038568	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038568: AB_10795030"	"unprognostic (3.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.51e-3)"	"prognostic favourable (6.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.36e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.78e-2)"	"prognostic favourable (5.69e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	"prognostic favourable (8.25e-4)"	7.7	18.2	18.3	11.5	27.6	16.9	8.7	66.3	46.5	9.2	10.8	15.5	13.1	8.6	9.4	8.9	6.9	9.4	8.6	13.8	20.2	18.4	9.8	7.7	11.0	13.2	15.5	19.8	14.0	12.2	18.8	26.7	11.2	20.7	12.5	12.0	16.0	10.2	14.0	16.1	14.0	9.8	10.5	11.3	12.3	13.2	19.4	11.0	14.6	8.4	6.0	12.2	11.0	7.8	3.5	4.1	20.8	5.8	4.5	5.7	4.4	6.3	13.3	14.6	13.0	10.0	7.0	3.3	9.0	12.1	11.5	12.5	9.7	6.0	13.6	2.9	9.9	12.7	11.8	6.3	10.0	15.0	12.0	24.1	24.7	8.3	7.2	16.3	33.2	6.7	6.8	6.0	7.6	10.5	15.4	10.0	10.1	9.0	7.7	17.6	8.7	9.2	10.6	23.5	8.9	5.9	30.6	23.1	15.1	11.6	13.7	7.9	10.8	12.4	8.9	10.8	6.8	15.3	6.0	11.9	12.3	7.7	10.0	11.6	10.1	20.8	2.6	4.8	4.8	4.6	4.2	3.5	3.4	4.0	4.1	3.3	4.0	3.1	0.7	4.5	5.8	2.2	5.7	4.4	18.3	27.6	66.3	44.6	20.2	18.4	15.5	19.8	20.7	11.0
MAEA	"EMP, GID9"	ENSG00000090316	"Macrophage erythroblast attacher"	Q7L5Y9	4	1289851-1340147	"Predicted intracellular proteins"	"Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036886, HPA058185"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA036886: , HPA058185: "	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.03e-2)"	"prognostic favourable (5.34e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.94e-3)"	"unprognostic (4.65e-3)"	"prognostic favourable (1.90e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.51e-2)"	23.6	35.4	25.5	26.3	28.4	19.5	20.9	34.0	35.8	24.4	33.3	21.7	26.8	39.9	27.3	23.8	34.7	26.0	29.2	36.6	23.7	33.1	33.2	27.9	19.1	26.1	23.3	32.0	33.4	32.0	21.9	30.3	27.6	34.0	23.6	17.2	22.3	36.7	28.0	27.3	29.0	38.2	20.9	17.7	31.0	30.3	23.3	26.7	26.5	26.1	28.5	26.5	26.3	25.4	19.7	18.9	48.2	28.0	17.0	35.8	21.9	22.8	27.2	19.3	19.2	12.9	12.9	25.1	23.5	12.3	19.0	17.4	28.2	29.5	20.9	18.3	16.8	17.0	18.6	28.8	7.9	16.8	20.7	19.6	30.0	26.9	15.5	22.0	21.1	16.0	15.7	15.3	9.7	15.3	27.3	16.7	16.6	24.3	32.7	33.8	25.4	29.3	31.9	15.5	18.8	20.3	27.7	34.7	24.3	21.0	15.8	15.9	29.2	19.2	21.4	35.4	15.2	16.2	38.8	21.0	32.2	22.9	24.7	20.4	19.4	23.9	20.2	27.2	25.5	20.7	35.8	19.7	20.5	24.1	18.9	16.5	18.3	18.8	48.2	17.0	28.0	13.3	23.1	21.9	25.5	28.4	34.0	35.8	23.7	33.1	23.3	32.0	34.0	26.7
MAF1	DKFZp586G1123	ENSG00000179632	"MAF1 homolog, negative regulator of RNA polymerase III"	Q9H063	8	144104499-144107611	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024821, HPA058548"	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA024821: , HPA058548: "	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.67e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (6.12e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.02e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.99e-2)"	26.8	23.2	17.5	18.4	17.5	43.6	35.7	20.5	26.3	27.3	47.2	23.7	22.8	19.5	33.0	22.5	34.4	26.1	33.6	72.5	17.3	15.5	24.1	21.4	21.2	28.2	19.7	18.6	36.3	39.8	25.2	20.8	23.8	14.9	36.8	18.9	23.8	28.7	32.3	114.3	18.7	29.8	50.9	17.2	27.7	28.9	30.2	16.2	35.5	40.4	38.7	22.8	35.2	46.7	48.0	39.9	45.1	34.5	33.2	46.2	32.6	23.9	38.6	17.9	17.9	49.1	24.5	14.6	18.9	31.3	29.6	30.2	14.1	26.7	26.7	32.2	31.6	14.8	24.3	26.7	21.8	23.5	29.4	29.1	26.6	22.1	33.1	12.3	20.0	21.6	31.4	23.7	44.7	31.8	22.5	18.2	17.6	57.2	46.0	22.8	13.4	103.8	18.4	25.1	28.4	18.5	18.1	26.2	21.8	25.1	32.7	30.5	22.2	19.0	19.1	13.8	31.6	24.3	23.7	22.0	16.7	12.5	22.9	23.1	9.1	15.8	34.5	45.1	28.5	26.8	32.3	40.1	41.0	46.2	39.9	48.0	44.2	41.4	19.9	33.2	27.0	29.8	29.2	32.6	17.5	17.5	20.5	26.3	17.3	15.5	19.7	18.6	14.9	16.2
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530714-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 62.4"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB026820: , HPA060841: "	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	15.7	14.3	12.6	12.4	20.1	16.3	13.0	4.2	12.5	9.3	18.0	13.5	6.7	18.2	14.7	5.0	10.1	10.2	12.7	30.9	13.2	11.8	10.5	10.9	18.7	8.7	19.7	11.0	7.2	34.9	6.0	8.7	62.4	14.5	16.1	5.1	6.7	11.0	12.0	26.8	12.8	16.8	26.1	12.1	11.3	13.2	4.1	13.1	22.8	9.1	9.7	7.5	13.7	19.0	1.9	5.1	3.6	1.7	1.5	2.6	1.4	20.0	14.4	0.5	2.1	1.6	2.0	11.0	13.3	7.6	3.3	2.3	10.3	5.6	4.7	4.9	3.3	15.6	1.2	3.8	1.4	7.2	10.5	2.7	18.4	7.5	3.7	6.4	8.7	2.0	5.0	5.4	4.1	2.9	7.0	2.6	1.5	13.2	7.2	23.1	4.6	14.6	10.9	0.5	7.9	3.0	8.3	6.2	2.3	8.0	23.8	5.8	9.2	8.6	6.9	5.0	34.8	25.0	7.3	5.0	1.5	7.8	6.6	9.0	7.1	1.7	1.6	3.6	2.1	0.8	2.3	1.4	1.2	2.5	0.7	1.9	2.6	2.0	2.2	1.5	1.7	5.1	2.2	1.4	12.6	20.1	4.2	12.5	13.2	11.8	19.7	11.0	14.5	13.1
MAGEA1	"CT1.1, MAGE1, MGC9326"	ENSG00000198681	"MAGE family member A1"	P43355	X	153179285-153183880	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"HEL: 17.4;HMC-1: 30.3;RPMI-8226: 15.0;U-2 OS: 29.0;U-266/70: 43.3;U-266/84: 69.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB002620	Enhanced		Supported	Cytosol				Cytosol		"CAB002620: "						"unprognostic (8.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"				"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"		"unprognostic (2.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	3.2	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.1	0.0	0.0	29.0	0.1	0.1	43.3	69.0	0.0	2.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 48.7"	"Group enriched"	"Detected in some"	7	"PC-3: 9.3;SH-SY5Y: 5.9;U-266/84: 6.3;WM-115: 14.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: "		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	48.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.9	0.8	2.6	0.8	1.2	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.1	0.0	9.3	0.0	0.1	0.0	0.0	0.0	0.2	5.9	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.0	1.2	6.3	0.0	0.5	0.0	14.9	2.6	0.8	0.7	0.4	0.7	0.4	0.7	0.5	0.4	0.3	0.9	0.6	0.7	2.6	1.2	0.5	0.8	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
MAGEA11	"CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511"	ENSG00000185247	"MAGE family member A11"	P43364	X	149688228-149717266	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 36.5;testis: 9.3"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 22.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052687			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA052687: "	"unprognostic (4.06e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-2)"		"unprognostic (9.64e-2)"		"unprognostic (1.32e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.16e-1)"				"unprognostic (6.67e-4)"	"unprognostic (1.14e-1)"		"unprognostic (1.33e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	36.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	22.9	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MAGEC2	"CT10, HCA587, MAGE-C2, MAGEE1"	ENSG00000046774	"MAGE family member C2"	Q9UBF1	X	142202345-142205290	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	319	"testis: 31.8"	"Group enriched"	"Detected in some"	8	"K-562: 34.9;U-266/84: 39.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 19.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062230	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA062230: "					"unprognostic (1.25e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.82e-1)"						"unprognostic (1.04e-1)"		"unprognostic (4.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	1.5	0.0	0.0	0.1	2.4	0.4	4.8	0.0	0.0	39.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Supported		Enhanced	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favourable (2.88e-4)"	"prognostic favourable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavourable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	22.1	38.4	26.9	14.8	26.5	8.2	50.2	24.4	43.0	55.7	27.3	27.8	21.4	16.2	41.1	31.8	21.9	45.9	28.5	40.7	23.8	38.2	42.7	17.3	24.0	13.5	30.3	36.0	79.7	23.5	34.5	57.6	58.6	57.1	63.9	16.4	43.1	32.0	53.7	25.6	16.5	17.6	41.6	24.7	17.5	22.5	21.8	18.3	23.4	45.1	17.3	22.0	31.9	29.2	17.1	11.7	43.1	37.0	28.5	35.5	32.5	5.5	10.3	61.7	18.8	29.4	40.0	11.4	23.1	41.2	18.3	32.6	10.2	14.2	7.7	60.6	46.4	7.6	17.5	17.4	13.2	13.8	14.5	16.1	12.2	20.0	25.2	4.1	12.4	52.4	7.3	18.6	9.4	34.8	3.9	9.5	35.0	15.4	9.1	6.9	22.8	12.3	6.1	22.1	11.0	25.1	4.2	9.7	25.1	9.2	10.7	53.4	44.0	7.0	29.9	15.6	24.4	23.3	6.5	6.1	5.1	5.6	22.8	10.8	79.7	43.1	9.1	35.5	35.5	22.4	27.3	16.3	29.4	33.1	11.7	17.1	29.7	34.1	3.4	28.5	37.0	7.2	29.2	32.5	26.9	26.5	24.4	43.0	23.8	38.2	30.3	36.0	57.1	18.3
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031852, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031852: , HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favourable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	18.0	6.0	10.1	6.4	9.8	1.0	16.5	38.6	16.8	6.9	11.2	10.1	25.7	10.7	11.6	7.6	9.4	12.6	19.7	11.1	9.4	11.8	14.3	17.6	13.3	2.9	8.8	10.4	4.3	16.7	18.7	13.1	11.1	9.6	9.2	9.5	7.7	17.4	37.9	7.7	13.0	11.6	7.9	8.3	13.9	19.8	10.7	7.7	0.6	23.2	5.8	4.4	6.9	13.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.8	1.5	8.7	0.9	1.7	1.3	3.9	4.8	4.1	1.8	2.8	10.3	2.4	0.0	0.7	5.7	0.8	2.4	1.6	2.9	0.0	1.3	24.5	3.0	6.9	1.1	0.0	0.8	1.9	1.4	6.3	1.3	4.2	10.3	0.0	1.9	2.1	0.0	0.0	11.6	1.5	0.0	2.4	0.6	2.2	9.3	2.8	7.6	1.9	2.3	0.0	4.5	0.0	1.1	5.9	4.3	1.5	1.9	0.0	0.0	0.0	3.4	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	9.8	38.6	15.5	9.4	11.8	8.8	10.4	9.6	7.7
MAGI3	MAGI-3	ENSG00000081026	"Membrane associated guanylate kinase, WW and PDZ domain containing 3"	Q5TCQ9	1	113390749-113685923	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 50.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007923, HPA008444"	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA007923: AB_1853503, HPA008444: "	"unprognostic (4.07e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.80e-2)"	"prognostic favourable (4.29e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (2.60e-8)"	"unprognostic (1.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-2)"	4.4	4.3	9.5	9.0	6.2	0.4	11.6	11.3	11.9	4.9	15.3	1.3	1.7	7.4	6.2	8.7	10.0	4.8	6.3	4.2	6.6	9.5	9.6	8.0	50.7	2.6	8.0	7.9	8.0	13.3	7.1	8.2	9.2	5.2	5.5	10.5	5.9	7.8	3.6	2.4	3.1	25.1	5.9	5.4	3.6	14.6	4.9	3.9	3.9	16.5	9.1	9.0	4.5	9.8	0.1	0.7	1.1	0.2	0.8	1.8	0.2	8.3	9.7	9.2	4.1	4.3	6.3	2.7	5.9	2.7	4.5	5.1	8.5	2.5	0.4	4.4	5.2	3.7	8.3	4.4	5.6	9.0	8.9	3.6	8.4	3.9	1.0	2.9	5.4	3.3	2.2	4.7	10.5	6.2	4.5	7.9	6.1	5.4	4.7	0.8	3.4	6.0	6.8	14.8	1.0	5.3	3.7	8.5	8.8	6.8	11.6	2.0	6.0	1.5	10.8	7.4	9.4	6.8	8.1	3.2	2.6	0.0	3.9	1.5	5.9	0.4	0.2	0.0	0.5	0.0	0.5	0.0	1.3	0.2	0.7	0.1	1.8	0.1	1.1	0.8	0.2	0.2	0.0	0.2	9.5	6.2	11.3	11.9	6.6	9.5	8.0	7.9	5.2	3.9
MAGOH	"MAGOH1, MAGOHA"	ENSG00000162385	"Mago homolog, exon junction complex core component"	P61326	1	53226892-53238610	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015425, HPA043036, HPA047754"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB015425: AB_629914, HPA043036: , HPA047754: "	"prognostic favourable (1.85e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (1.45e-5)"	"unprognostic (2.01e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.75e-3)"	31.5	31.3	25.7	32.9	28.9	70.7	33.8	23.0	36.8	26.9	33.9	17.4	33.5	30.2	37.5	33.7	37.5	31.4	25.6	27.6	30.3	25.6	35.9	42.5	33.2	43.2	23.5	28.8	36.7	35.6	18.9	46.6	43.4	31.4	24.6	31.9	22.8	31.2	31.1	40.9	30.7	35.7	35.3	32.6	36.9	28.5	28.1	24.3	50.3	37.4	37.2	46.0	28.0	30.0	29.8	35.2	31.3	30.9	29.8	33.0	18.2	32.6	15.8	27.8	24.1	14.4	9.3	32.1	24.6	14.4	32.5	32.9	36.0	15.7	46.8	28.8	14.3	20.3	36.4	21.5	38.8	31.0	40.3	42.7	20.6	38.9	23.1	73.9	23.9	10.0	15.5	29.5	24.3	21.5	42.8	10.7	17.6	25.5	60.6	51.3	51.4	34.7	41.4	53.2	24.8	17.2	32.7	23.8	19.3	32.8	26.8	38.5	13.8	53.2	19.6	20.3	27.8	28.6	56.2	15.8	28.2	73.1	18.4	47.1	20.7	17.0	21.6	31.3	32.3	30.9	31.1	29.8	31.2	33.0	30.5	29.0	28.8	29.5	26.0	29.8	28.1	35.2	32.3	18.2	25.7	28.9	23.0	36.8	30.3	25.6	23.5	28.8	31.4	24.3
MAK16	"MAK16L, RBM13"	ENSG00000198042	"MAK16 homolog"	Q9BXY0	8	33484750-33501260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA044417, HPA050574"	Uncertain		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA044417: , HPA050574: AB_2681181"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.00e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	22.3	11.0	10.6	14.9	15.3	13.5	15.2	11.5	17.6	13.2	11.5	12.5	8.3	9.1	20.8	9.1	15.2	13.6	11.3	13.1	10.5	13.4	17.9	20.0	10.5	17.3	11.4	10.3	24.8	15.7	10.4	19.2	13.1	19.2	14.2	11.3	8.9	10.6	10.3	25.2	12.4	10.8	19.7	13.1	17.3	11.9	9.5	7.1	20.3	14.8	14.3	17.4	16.8	11.3	3.8	4.0	0.9	9.4	5.7	6.2	3.3	5.9	8.4	5.9	13.5	7.0	8.4	8.8	10.8	7.1	11.8	11.1	12.5	5.3	21.1	10.7	9.5	7.9	19.7	12.0	15.9	4.5	5.5	19.9	6.0	11.0	10.4	8.0	12.2	8.7	11.1	15.3	18.0	8.6	24.7	12.3	9.8	7.0	28.5	9.7	31.2	5.9	10.2	8.9	9.5	10.0	10.2	15.1	12.0	6.6	9.4	13.0	6.5	8.5	7.6	11.1	8.7	14.3	12.3	6.1	6.7	21.8	6.9	17.2	11.8	0.0	3.2	0.9	4.8	6.8	5.4	3.2	4.7	4.1	3.9	3.8	6.0	6.2	0.7	5.7	9.4	4.0	3.6	3.3	10.6	15.3	11.5	17.6	10.5	13.4	11.4	10.3	19.2	7.1
MALRD1	"bA265G8.2, C10orf112, Diet1"	ENSG00000204740	"MAM and LDL receptor class A domain containing 1"	Q5VYJ5	10	19048771-19790401	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"intestine: 60.5"	"Cell line enriched"	"Detected in some"	10	"Karpas-707: 31.2"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035732, HPA038106, HPA046848"	Uncertain		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA035732: , HPA038106: , HPA046848: "	"unprognostic (9.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-4)"	0.5	0.8	2.0	0.3	2.0	0.4	0.6	0.3	0.9	0.8	19.4	0.6	0.1	25.2	1.3	2.3	0.3	0.3	0.4	1.3	1.6	0.8	1.3	0.3	0.9	0.2	0.8	0.0	1.1	0.3	0.1	4.7	0.4	0.8	0.9	0.2	1.4	0.5	0.4	0.5	0.4	60.5	1.3	0.7	0.3	0.5	1.7	0.7	2.6	0.6	0.3	0.1	0.5	0.5	0.0	3.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	31.2	0.0	3.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	3.6	0.0	0.0	2.0	2.0	0.3	0.9	1.6	0.8	0.8	0.0	0.8	0.7
MALSU1	"C7orf30, mtRsfA"	ENSG00000156928	"Mitochondrial assembly of ribosomal large subunit 1"	Q96EH3	7	23298739-23311729	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020487, HPA052210"	Approved		Enhanced	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA020487: AB_1845757, HPA052210: "	"unprognostic (3.62e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.24e-3)"	"prognostic unfavourable (9.71e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.68e-1)"	7.9	11.3	9.5	6.9	9.4	7.6	11.0	8.6	11.1	7.9	8.4	8.3	5.8	5.1	9.2	10.2	12.3	10.1	7.6	29.8	8.8	9.1	12.5	21.2	8.2	10.2	8.9	7.2	10.3	10.1	8.0	7.8	12.6	12.7	7.9	7.8	17.2	10.6	10.3	20.1	6.7	7.0	8.9	8.1	6.9	7.5	13.7	5.6	8.5	14.8	14.9	8.0	9.2	7.5	6.1	4.8	3.5	5.4	4.2	7.3	5.1	5.0	6.3	4.6	27.2	4.6	3.2	4.7	3.9	2.8	3.6	3.3	10.6	4.2	5.1	4.2	2.4	5.2	4.5	2.4	4.4	2.5	8.2	3.0	8.6	16.3	3.0	6.6	1.8	2.7	3.8	3.0	3.4	3.3	9.0	1.3	4.5	3.5	4.6	20.8	8.5	17.0	3.9	3.9	6.7	3.5	4.5	4.2	5.1	3.2	5.1	8.0	2.6	3.9	5.7	2.9	2.6	5.5	6.8	2.0	5.0	8.8	11.0	8.2	9.0	3.4	5.4	3.5	4.4	4.0	5.0	6.1	6.1	4.9	4.7	5.7	7.3	4.9	3.4	4.2	3.3	4.8	5.7	5.1	9.5	9.4	8.6	11.1	8.8	9.1	8.9	7.2	12.7	5.6
MAML1	"KIAA0200, Mam-1"	ENSG00000161021	"Mastermind like transcriptional coactivator 1"	Q92585	5	179732850-179777286	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.5;BJ hTERT+ SV40 Large T+: 8.9;hTCEpi: 9.0;SK-MEL-30: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037687, HPA057531"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA037687: AB_10672604, HPA057531: "	"unprognostic (2.64e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (9.70e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (3.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.69e-2)"	8.5	8.9	8.5	9.5	9.6	15.8	8.2	27.2	9.3	35.4	9.3	10.6	3.9	12.5	11.2	18.8	8.8	9.5	6.8	6.4	7.9	3.3	7.5	5.8	11.9	9.7	9.9	5.8	13.0	8.8	2.3	9.2	11.7	8.6	9.2	10.9	10.4	7.8	4.7	13.1	9.2	25.1	13.4	6.4	10.1	8.0	5.6	10.6	20.8	10.8	3.4	9.1	9.9	9.6	2.4	0.8	3.3	2.0	1.1	1.7	0.9	0.0	0.0	0.0	0.0	7.6	7.5	0.0	4.6	8.5	8.9	6.6	0.0	0.0	5.4	6.5	0.0	0.3	0.0	0.0	5.6	0.0	0.0	0.0	6.6	0.0	6.7	0.0	0.1	0.0	9.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.2	0.1	0.0	0.0	0.1	15.5	7.0	0.0	7.0	0.1	1.1	0.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.3	1.7	1.2	0.8	2.4	0.9	1.4	0.6	2.4	1.0	0.8	3.0	1.1	2.0	0.8	0.5	0.9	8.5	9.6	27.2	9.3	7.9	3.3	9.9	5.8	8.6	10.6
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343180	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavourable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	26.3	5.5	10.2	16.1	8.1	4.2	19.7	27.8	13.4	15.8	9.2	10.4	8.4	4.3	11.2	8.5	9.3	11.7	10.8	8.9	10.5	6.9	13.8	3.5	15.0	10.9	6.9	3.4	11.7	8.2	13.3	15.2	18.8	9.3	12.3	8.9	10.8	16.6	12.3	4.4	14.2	8.9	10.2	14.4	16.8	6.5	4.3	10.6	21.2	11.8	4.8	13.6	16.0	15.3	2.1	1.2	4.7	1.1	4.2	6.4	2.0	5.5	1.1	9.6	2.5	10.0	11.6	2.1	6.4	9.6	4.2	4.4	0.6	11.8	1.2	15.2	14.8	5.1	1.9	6.2	5.9	27.4	0.7	0.7	2.0	2.1	5.8	0.0	0.0	16.9	0.6	7.5	4.5	2.4	3.1	1.7	7.5	0.4	0.1	1.5	1.0	1.8	1.9	1.8	6.4	6.3	7.8	0.1	0.8	2.4	1.0	2.7	0.9	0.2	10.4	7.5	1.8	2.5	4.0	1.2	0.2	1.8	3.6	1.1	13.7	0.1	1.1	0.0	1.5	0.6	2.6	1.9	3.2	4.1	1.2	2.1	6.4	4.3	4.7	4.2	0.7	0.9	1.2	2.0	10.2	8.1	27.8	7.0	10.5	6.9	6.9	3.4	9.3	10.6
MAML3	"CAGH3, GDN, KIAA1816, MAM2, TNRC3"	ENSG00000196782	"Mastermind like transcriptional coactivator 3"	Q96JK9	4	139716753-140154184	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 11.2;SCLC-21H: 11.9;SH-SY5Y: 18.1;WM-115: 15.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 29.1"	"Cell type enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA037717	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA037717: AB_10794323"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.89e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (7.60e-5)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.88e-1)"	5.9	5.5	6.0	10.3	4.2	3.9	6.4	29.1	4.1	10.0	6.3	5.4	8.3	6.8	19.4	11.5	10.5	8.4	11.2	3.7	3.2	3.6	4.2	4.8	6.8	6.0	4.9	2.8	13.3	11.3	7.4	16.7	7.2	5.8	8.4	5.7	5.5	15.3	16.2	2.5	12.9	6.2	9.2	7.8	4.9	6.0	6.5	5.1	13.5	6.2	5.9	6.8	8.9	8.9	0.6	1.8	11.0	1.9	3.9	0.6	1.3	0.3	6.0	4.1	2.0	1.6	3.4	3.7	0.7	3.3	0.3	0.2	2.3	1.7	1.3	0.3	0.6	0.1	1.6	1.4	0.2	0.0	0.9	4.2	1.3	0.2	0.3	2.0	6.6	3.3	1.1	0.1	0.7	11.2	1.1	0.0	0.2	0.6	0.4	0.9	1.0	2.6	2.5	0.4	2.6	1.8	8.3	11.9	18.1	0.0	3.2	4.1	1.7	0.6	9.6	0.5	1.1	0.0	1.3	2.2	2.5	0.0	0.6	6.7	15.1	11.0	1.9	3.5	0.0	1.3	0.2	0.0	0.0	0.0	1.8	0.6	0.6	0.5	4.5	3.9	1.2	1.5	0.0	1.3	6.0	4.2	29.1	4.1	3.2	3.6	4.9	2.8	5.8	5.1
MAMLD1	"CG1, CXorf6, F18"	ENSG00000013619	"Mastermind like domain containing 1"	Q13495	X	150361422-150514178	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 15.3;U-2197: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003923	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA003923: AB_10602034"	"unprognostic (4.18e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (9.76e-3)"	7.6	4.6	9.1	2.6	15.5	2.6	10.0	5.2	11.7	5.8	3.7	5.7	5.7	1.8	9.0	5.9	3.2	7.8	4.2	3.9	9.3	9.5	2.6	3.2	5.9	2.8	3.5	6.9	21.8	6.0	3.0	6.0	3.2	5.7	5.6	2.3	6.4	3.2	11.7	6.6	2.4	1.8	5.6	5.6	2.5	2.6	15.3	5.2	0.0	1.6	1.7	2.1	2.9	3.5	2.2	0.1	0.8	0.1	0.6	3.0	0.8	4.5	1.8	2.5	4.9	7.2	2.7	0.0	4.3	9.1	6.7	15.3	0.0	0.2	0.0	2.3	10.3	0.1	2.8	2.0	9.1	6.9	0.2	0.1	5.8	0.1	5.3	0.2	0.0	3.7	0.5	7.5	0.9	1.4	0.1	0.1	6.3	0.8	0.0	0.1	0.5	3.5	0.3	9.5	0.2	1.0	0.1	0.6	0.5	1.5	0.1	2.4	0.1	0.0	1.7	3.6	4.5	23.8	7.7	0.3	0.3	0.1	9.9	1.8	4.8	0.0	0.0	0.2	1.1	0.0	1.6	2.2	1.8	1.5	0.1	0.9	1.7	3.0	0.8	0.6	0.1	0.1	2.0	0.8	9.1	15.5	5.2	11.0	9.3	9.5	3.5	6.9	5.7	5.2
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177209-119349761	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 59.0;Hep G2: 41.4;Karpas-707: 46.2;U-266/70: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"			390000000	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: , HPA063561: "	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	41.8	19.8	5.8	10.5	17.4	8.1	32.2	1.5	7.9	12.3	23.3	3.2	3.6	17.4	11.3	12.0	10.6	9.5	22.0	10.4	5.0	3.3	23.4	74.2	16.4	16.8	2.8	5.7	10.3	22.0	3.4	6.4	26.1	3.7	14.7	9.9	10.5	41.0	5.3	7.1	9.6	36.3	19.7	3.5	20.9	10.0	8.7	3.7	8.8	15.2	10.3	9.1	21.2	36.4	1.4	5.5	6.0	1.1	1.9	4.7	0.6	0.0	0.0	0.7	0.0	59.0	26.1	1.4	1.4	8.6	1.0	2.6	4.0	0.5	8.8	0.0	5.4	0.1	1.5	0.0	1.3	13.0	4.0	7.3	0.8	41.4	5.9	0.0	3.7	17.8	1.1	8.8	5.4	0.7	25.5	46.2	8.3	1.2	0.3	0.0	0.4	2.1	2.4	0.9	13.3	2.8	7.3	3.0	4.4	0.0	0.1	0.0	2.1	0.9	5.1	3.6	3.3	6.7	3.2	62.4	8.8	17.4	10.7	0.1	2.1	6.0	0.6	2.0	2.4	1.1	4.7	1.4	1.3	1.3	0.6	0.9	0.8	1.9	3.8	1.9	0.9	5.5	1.4	0.6	5.8	17.4	1.5	7.9	5.0	3.3	2.8	5.7	3.7	3.7
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 122.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"			1100000	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: "	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favourable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	11.1	9.7	13.9	9.1	15.8	3.8	9.7	11.9	15.2	14.4	10.7	8.5	9.4	8.1	15.8	10.7	11.5	12.2	9.2	11.0	11.2	9.2	11.8	16.4	8.1	9.9	12.0	13.9	11.2	27.4	21.7	9.6	122.4	11.3	11.2	9.5	8.3	11.1	10.5	10.5	7.5	9.0	13.7	10.4	10.4	10.3	10.1	14.4	16.1	19.4	6.9	9.8	13.6	9.8	3.7	4.4	4.0	2.7	6.0	9.8	2.4	14.1	6.2	10.6	9.1	14.0	16.9	34.1	11.8	18.5	5.3	5.0	4.7	8.2	10.6	21.9	15.1	8.5	4.9	10.0	12.1	13.3	7.4	6.3	8.7	5.2	8.5	9.9	14.5	11.3	10.8	8.1	7.1	15.8	10.1	16.4	11.1	27.6	6.0	3.1	5.4	6.5	5.4	23.1	7.2	7.3	19.4	5.8	8.5	11.7	12.6	9.3	6.2	6.3	15.0	12.1	9.9	8.5	12.0	11.2	7.6	7.2	15.9	7.9	28.5	1.3	2.7	4.0	5.2	2.1	6.2	3.3	4.3	4.3	2.3	3.7	3.6	5.2	2.1	6.0	1.7	4.4	9.8	2.4	13.9	15.8	11.9	15.2	11.2	9.2	12.0	13.9	11.3	14.4
MAN2A1	"GOLIM7, MANA2"	ENSG00000112893	"Mannosidase alpha class 2A member 1"	Q16706	5	109689366-109869625	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022377, HPA026896"	Enhanced		Supported	"Golgi apparatus"			70000000	"Golgi apparatus"		"CAB022377: , HPA026896: AB_1853512"	"unprognostic (1.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.31e-3)"	7.6	17.5	10.9	7.7	21.8	5.7	7.4	1.9	13.2	8.4	11.2	46.8	2.4	17.2	9.2	1.8	7.7	6.2	10.6	4.2	11.7	4.8	9.5	20.7	8.5	7.8	29.9	10.4	7.5	16.7	20.1	3.4	8.7	19.8	4.7	11.9	5.6	9.0	6.0	8.7	7.0	14.4	11.2	23.1	6.9	8.9	7.5	30.6	15.0	9.0	1.8	7.8	10.9	6.2	3.3	2.7	5.8	6.7	0.9	5.5	1.6	7.2	6.7	8.4	3.6	16.1	14.2	31.4	16.1	26.6	9.2	16.6	7.9	11.7	5.2	10.4	20.9	8.6	4.5	16.7	20.1	5.6	3.4	10.6	5.0	7.2	9.1	4.8	5.8	12.1	6.9	14.7	19.5	18.1	2.8	30.5	21.6	3.6	9.0	1.3	6.0	2.4	3.5	13.1	23.0	7.3	11.5	1.2	1.1	7.6	6.8	4.6	6.7	4.2	19.3	18.2	8.0	9.8	10.4	16.3	21.1	4.4	14.0	6.2	10.1	5.8	2.9	0.9	3.0	3.8	1.9	3.3	4.5	4.9	2.7	2.9	5.5	4.8	2.1	0.9	6.7	2.5	4.1	1.6	10.9	21.8	1.9	13.2	11.7	4.8	29.9	10.4	19.8	30.6
MAN2C1	"MANA, MANA1"	ENSG00000140400	"Mannosidase alpha class 2C member 1"	Q9NTJ4	15	75355207-75368630	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040627, HPA067407"	Uncertain		Enhanced	Nucleoplasm			9000	Nucleoplasm		"HPA040627: AB_10795490, HPA067407: "	"unprognostic (4.68e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-3)"	29.9	28.8	22.6	20.4	26.0	30.0	24.6	27.5	25.5	25.1	25.1	26.8	23.8	22.9	27.8	27.5	20.2	24.2	23.3	28.2	18.3	12.9	22.9	21.4	25.2	17.0	23.0	28.3	32.8	22.3	28.2	30.6	22.4	18.3	24.9	14.2	30.8	25.6	20.2	37.9	30.9	27.7	20.0	15.0	28.1	23.0	28.8	19.9	21.0	34.7	15.3	19.5	21.1	21.3	2.3	15.7	2.6	16.2	3.9	7.3	8.5	5.4	13.1	10.9	7.8	12.5	10.9	13.6	12.7	12.0	6.7	5.6	9.1	18.8	2.6	7.5	9.3	16.9	6.0	8.6	4.3	15.0	13.2	17.2	24.8	8.9	18.5	11.0	2.7	12.9	8.7	6.3	7.9	15.6	9.9	14.2	5.4	10.6	5.4	12.5	4.6	5.5	7.6	5.5	16.4	8.7	25.5	6.5	11.8	8.1	12.3	5.7	12.2	12.9	30.4	14.1	9.8	9.8	12.5	14.2	3.5	4.3	9.1	12.7	13.9	2.6	13.3	2.0	7.2	16.2	6.8	2.3	5.3	5.2	15.7	2.0	7.3	5.1	1.4	3.9	12.4	6.4	7.0	8.5	22.6	26.0	27.5	25.5	18.3	12.9	23.0	28.3	18.3	19.9
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles	"Intracellular and membrane"		12000000	Vesicles		"HPA053478: "	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	12.7	23.5	8.5	12.2	11.9	8.6	17.1	13.4	8.4	12.1	9.9	12.9	11.7	8.1	11.6	13.6	9.3	11.0	15.5	12.1	8.7	8.6	11.8	10.3	17.7	20.2	15.1	6.2	16.7	18.1	25.1	18.4	25.0	10.8	12.0	10.8	12.4	27.4	11.4	5.4	7.8	14.0	14.2	15.3	21.3	14.4	4.6	13.5	9.4	19.2	3.6	12.8	17.9	12.6	3.9	9.5	25.2	11.6	3.6	3.1	3.9	7.3	4.1	2.0	1.9	39.0	18.1	5.1	5.1	10.1	2.2	4.4	5.3	8.5	7.9	6.9	7.1	3.5	5.2	11.3	1.8	5.5	2.1	4.5	4.6	8.1	11.9	8.3	20.5	15.4	19.3	9.5	7.9	4.1	7.5	8.2	8.0	3.3	2.0	8.0	2.8	3.4	4.1	4.7	2.2	6.4	8.7	1.3	1.0	6.1	10.5	7.9	15.0	5.7	3.1	6.1	3.0	13.6	2.7	4.3	9.0	0.8	11.0	3.7	4.4	6.2	11.5	25.2	1.8	10.6	1.4	3.8	3.1	2.0	9.5	3.9	3.0	2.0	10.1	3.6	11.6	2.3	1.6	3.9	8.5	11.9	13.4	8.4	8.7	8.6	15.1	6.2	10.8	13.5
MANEA	"FLJ12838, mandaselin"	ENSG00000172469	"Mannosidase endo-alpha"	Q5SRI9	6	95577543-95609457	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011046, HPA011069"	Enhanced		Supported	"Golgi apparatus"			87000	"Golgi apparatus"		"HPA011046: AB_1079303, HPA011069: AB_1079304"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"prognostic favourable (3.04e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.86e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.47e-2)"	18.0	8.1	6.0	6.7	6.9	2.4	14.4	8.3	6.0	9.6	9.5	5.0	5.8	7.7	7.5	8.2	11.5	7.2	7.1	9.3	6.5	6.2	14.6	44.9	9.8	12.3	8.9	6.7	10.4	8.0	10.9	13.5	7.4	7.8	9.2	8.0	4.5	8.1	7.6	3.8	5.9	9.5	6.0	11.6	13.2	10.7	7.1	6.9	17.9	11.7	5.9	9.7	11.2	7.5	6.6	3.4	8.5	5.7	3.8	10.4	3.3	3.7	3.2	12.2	9.9	20.3	23.9	4.7	10.6	9.7	6.2	9.3	3.6	9.5	7.2	13.2	6.8	6.2	8.4	7.0	14.2	12.4	7.6	9.8	3.0	5.9	7.1	12.7	8.7	23.6	8.2	7.3	5.1	14.4	15.0	16.8	13.1	2.6	7.4	5.4	1.8	3.2	8.9	12.2	10.7	9.4	6.6	9.8	5.3	5.9	4.3	3.7	6.8	12.0	13.0	6.2	4.4	11.1	10.3	12.6	7.4	8.9	11.0	11.2	14.0	8.5	3.3	1.9	4.8	5.7	6.8	6.6	5.9	5.5	3.4	3.3	6.9	4.6	0.7	3.8	4.9	1.3	10.4	3.3	6.0	6.9	8.3	6.0	6.5	6.2	8.9	6.7	7.8	6.9
MANF	"ARMET, ARP"	ENSG00000145050	"Mesencephalic astrocyte derived neurotrophic factor"		3	51385047-51389397	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011175	Approved		Supported	"Endoplasmic reticulum"	"Secreted to blood"			"Endoplasmic reticulum"		"HPA011175: AB_1845039"	"unprognostic (2.90e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"prognostic unfavourable (9.58e-6)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.10e-2)"	13.2	14.6	11.6	18.9	16.8	8.3	19.8	6.7	12.4	20.7	16.1	5.2	47.4	11.6	15.1	52.8	19.9	14.0	16.1	23.4	9.7	9.8	22.2	65.6	16.9	15.9	12.9	5.7	11.5	64.2	6.5	23.4	23.3	20.9	16.1	16.8	5.1	64.7	37.9	7.8	13.1	11.9	14.3	8.8	21.7	16.4	14.3	12.5	12.7	64.4	20.7	21.4	14.0	37.2	5.4	32.7	19.2	4.8	7.4	11.2	4.9	19.5	9.8	26.3	32.4	18.1	23.7	28.0	31.6	26.1	32.1	30.9	15.1	45.8	42.9	26.4	19.5	11.7	32.6	32.5	31.4	19.7	16.4	34.5	14.7	34.9	59.3	16.4	22.1	10.1	27.4	33.3	44.9	41.5	7.4	47.1	29.7	11.9	27.3	32.8	22.8	42.6	11.8	16.8	44.1	27.0	13.1	9.9	32.0	26.5	16.0	19.1	12.8	22.1	19.4	18.3	17.9	22.1	34.6	38.2	15.5	27.7	32.0	32.9	35.3	19.2	4.8	2.7	8.9	3.8	11.2	5.4	6.5	8.5	4.7	3.5	4.9	5.1	2.4	7.4	2.4	32.7	3.9	4.9	11.6	16.8	6.7	12.4	9.7	9.8	12.9	5.7	20.9	12.5
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 39.5;HHSteC: 74.2;HSkMC: 18.6;hTCEpi: 20.9;RT4: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol				Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: , HPA059299: "	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.3	39.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	1.4	5.3	0.0	0.0	0.5	1.6	0.1	4.2	74.2	0.0	4.0	18.6	20.9	0.0	10.9	4.7	0.0	0.1	1.3	0.6	0.0	0.1	0.3	1.2	0.0	0.0	0.1	5.3	30.6	0.7	1.8	0.0	0.0	0.0	0.1	0.0	2.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209570	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 102.5"	"Cell line enhanced"	"Detected in many"		"TIME: 64.1"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol			140000	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (8.22e-5)"	20.3	18.1	27.5	10.2	39.6	1.6	9.3	52.3	101.9	15.3	6.1	21.6	3.5	3.2	9.2	9.8	12.8	7.7	10.7	17.1	37.6	40.7	4.4	3.3	3.7	3.2	42.4	42.5	7.8	4.5	3.0	7.0	9.5	102.5	19.0	6.2	9.4	7.6	24.0	3.6	10.2	3.9	22.9	45.7	2.4	7.2	11.0	11.3	0.0	5.7	0.1	2.6	13.4	5.9	0.2	0.4	0.6	0.0	0.0	0.3	2.1	0.3	12.1	30.5	11.0	19.0	33.3	0.0	6.5	5.0	6.6	7.9	0.1	0.4	0.0	15.7	24.1	0.1	16.6	0.6	10.0	0.0	2.4	1.3	4.3	3.9	10.1	0.0	1.0	33.4	2.1	26.6	9.9	20.6	1.9	0.0	11.2	0.1	0.0	0.0	8.2	3.9	0.1	3.6	0.0	0.5	0.0	19.7	13.6	6.4	0.0	3.3	0.0	1.2	64.1	21.0	9.9	15.3	29.4	1.4	0.0	0.0	22.7	0.0	16.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.6	0.0	0.0	0.4	0.2	2.1	27.5	39.6	52.3	59.1	37.6	40.7	42.4	42.5	102.5	11.3
MAP1LC3A	"ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3"	ENSG00000101460	"Microtubule associated protein 1 light chain 3 alpha"	Q9H492	20	34546854-34560345	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.5;HSkMC: 29.5;SCLC-21H: 18.8;SK-BR-3: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 30.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007649, CAB037174, HPA042824, HPA052474, HPA052484"	Enhanced		Supported	Vesicles				Vesicles		"CAB037174: AB_1079382, HPA007649: AB_1853943, HPA042824: , HPA052474: , HPA052484: "	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.98e-1)"	"prognostic favourable (5.31e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.76e-1)"	29.8	15.1	38.3	10.3	33.6	10.7	16.8	45.6	59.8	15.8	22.7	17.8	9.6	24.2	16.1	15.8	13.6	16.1	18.7	30.3	39.0	46.8	15.3	31.9	11.8	20.4	41.6	46.7	11.9	20.7	17.8	26.6	9.7	38.3	16.9	16.2	13.6	14.2	15.4	29.7	23.3	26.8	18.8	29.0	12.1	13.5	15.7	18.2	1.1	17.6	10.2	24.5	13.0	13.5	3.4	1.4	30.6	1.6	1.1	4.0	1.0	0.0	1.6	1.8	0.0	12.7	17.7	0.0	9.3	8.9	7.0	6.6	0.0	0.1	0.0	0.1	9.4	1.9	0.0	3.5	1.3	2.1	0.7	0.0	6.7	0.0	19.5	0.0	4.2	29.5	0.4	4.7	1.7	4.1	0.0	0.0	7.4	0.0	0.0	0.2	0.6	1.8	0.0	0.0	0.0	0.0	0.0	18.8	10.8	10.6	26.1	0.0	0.1	7.8	7.2	14.9	0.1	2.9	4.0	0.0	1.9	0.0	9.8	0.0	6.1	1.3	1.3	3.6	1.9	1.6	1.4	3.4	2.0	2.0	0.4	1.6	0.6	1.2	30.6	1.1	0.6	1.4	4.0	1.0	38.3	33.6	45.6	59.3	39.0	46.8	41.6	46.7	38.3	18.2
MAP1LC3C	ATG8J	ENSG00000197769	"Microtubule associated protein 1 light chain 3 gamma"	Q9BXW4	1	241995490-241999073	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.0;ASC TERT1: 8.6;BEWO: 5.8;EFO-21: 5.1;LHCN-M2: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA072670			Supported	"Cytoplasmic bodies"				"Cytoplasmic bodies"		"HPA072670: "	"unprognostic (2.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.44e-3)"	"prognostic unfavourable (1.34e-7)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.73e-2)"	12.2	0.8	0.5	1.4	0.7	0.1	13.4	0.5	0.9	0.3	4.4	0.2	0.7	0.4	0.5	1.9	8.9	3.5	1.5	1.8	0.3	0.1	0.7	0.4	9.0	5.4	0.5	0.3	4.4	0.4	0.5	2.0	17.9	0.6	0.7	0.5	4.7	7.8	0.2	5.7	5.5	2.6	0.9	0.9	1.4	4.3	1.2	0.5	0.1	2.3	7.1	5.0	6.5	3.5	1.0	0.8	2.6	2.5	0.4	0.5	0.1	0.2	0.1	9.0	0.1	0.3	8.6	5.8	0.1	0.0	0.3	0.4	0.8	0.0	0.1	5.1	2.4	0.0	0.2	0.2	0.3	0.0	1.7	0.4	0.4	0.3	0.0	0.1	0.2	2.3	0.0	0.1	0.1	0.0	0.0	0.2	3.8	0.0	0.0	0.3	2.8	0.1	0.0	2.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	2.3	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	2.6	0.6	0.4	0.4	1.2	0.3	0.6	0.3	0.5	0.2	1.0	0.2	0.4	1.2	0.4	2.5	0.8	0.1	0.1	0.5	0.7	0.5	0.9	0.3	0.1	0.5	0.3	0.6	0.5
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734516	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Enhanced	Cytosol				Cytosol		"HPA050934: , HPA054637: "	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavourable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	14.7	7.1	18.9	14.0	27.0	14.9	13.4	15.4	42.1	12.3	11.5	15.5	4.9	12.5	13.4	9.8	11.6	11.1	13.1	9.3	17.2	12.9	8.3	6.9	17.6	13.2	11.4	18.1	16.8	13.8	8.9	11.9	16.1	14.3	10.0	4.7	8.4	12.6	12.1	21.2	6.0	10.5	8.8	10.3	14.2	16.0	34.1	13.1	13.2	8.5	4.3	8.6	12.6	7.6	13.1	20.7	24.9	17.7	9.4	13.3	12.5	12.8	20.3	6.2	8.0	5.2	7.7	15.5	8.5	4.3	5.4	6.1	27.5	7.4	7.6	15.8	5.4	7.1	5.0	7.0	2.2	9.5	28.4	6.9	18.0	18.0	11.0	7.5	9.9	8.4	4.0	8.2	5.1	10.8	10.6	4.4	2.9	18.1	9.2	19.1	13.5	23.8	15.0	4.7	7.7	7.0	19.8	10.8	12.0	4.7	7.3	8.5	4.6	8.3	16.7	10.0	8.6	19.3	12.7	8.3	9.9	7.7	11.5	12.0	11.7	13.3	17.0	19.2	13.3	17.7	12.8	13.1	10.4	13.1	20.7	13.1	8.8	11.7	24.9	9.4	13.1	16.7	9.5	12.5	18.9	27.0	15.4	42.1	17.2	12.9	11.4	18.1	14.3	13.1
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386817-66492312	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"			62000	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.92e-2)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.81e-3)"	"unprognostic (5.78e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.40e-3)"	28.6	16.9	33.9	19.1	54.1	29.0	23.6	32.5	48.4	12.5	12.1	8.4	10.2	10.0	11.8	16.5	22.0	10.6	14.4	19.1	49.2	26.4	15.3	53.1	16.4	23.3	17.6	31.2	13.5	11.7	23.4	12.0	15.4	17.2	14.4	12.9	9.1	13.2	12.4	39.5	12.3	10.9	16.9	17.4	14.5	10.8	7.8	12.6	12.6	12.3	9.7	27.9	13.6	18.7	4.6	16.2	5.5	8.2	8.4	7.9	2.7	33.1	15.6	31.5	13.1	19.0	14.3	18.2	24.1	20.6	26.2	23.4	23.5	27.3	30.5	29.9	19.8	29.6	29.4	35.2	30.8	24.5	17.5	9.8	16.4	12.7	15.4	12.9	14.6	11.0	21.8	18.9	28.1	20.4	17.3	39.0	38.1	12.8	10.3	16.8	16.1	13.7	11.7	19.5	27.1	25.4	14.3	19.4	10.8	19.5	15.3	20.2	13.8	11.0	28.1	34.1	20.9	24.0	35.7	24.2	43.0	19.4	36.0	22.8	15.9	3.2	8.2	5.5	7.4	8.2	6.7	3.0	6.6	6.9	8.3	4.6	7.9	4.9	3.9	8.4	7.3	16.2	4.9	2.7	33.9	54.1	32.5	46.9	49.2	26.4	17.6	31.2	17.2	12.6
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	"Mitogen-activated protein kinase kinase 2"	P36507	19	4090321-4124129	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB003835, HPA051993"	Supported		Supported	Cytosol				Cytosol		"CAB003835: AB_562312, HPA051993: "	"unprognostic (4.39e-1)"	"prognostic favourable (3.72e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.58e-1)"	"prognostic favourable (7.98e-4)"	"unprognostic (2.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (5.43e-5)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.90e-2)"	23.9	33.0	35.6	27.6	36.1	46.7	30.2	31.2	43.4	22.6	38.8	24.6	27.0	70.9	21.8	23.2	32.8	21.7	27.9	41.4	33.1	31.0	22.7	42.0	24.1	44.5	34.4	29.2	30.8	46.0	18.9	29.7	21.3	26.1	25.7	24.3	21.7	41.5	24.0	134.9	27.4	56.7	19.0	25.2	25.9	28.3	42.0	20.9	44.1	26.2	42.2	29.1	20.0	26.9	11.4	10.7	28.3	10.6	11.3	12.1	4.5	36.2	40.0	21.9	30.7	30.3	36.6	21.9	23.9	32.0	32.7	29.7	34.6	19.7	31.0	22.6	27.2	26.2	17.1	25.5	25.4	26.3	20.8	11.3	21.8	38.2	46.5	20.8	23.9	40.4	24.9	22.9	30.6	28.9	21.6	61.3	27.5	45.4	41.1	29.2	25.1	29.1	31.5	14.4	35.4	28.5	23.3	29.7	29.6	21.9	30.4	74.5	23.4	35.7	25.5	26.9	23.3	68.6	36.8	61.7	37.3	21.7	41.7	37.5	45.9	15.2	9.1	28.3	11.9	10.6	9.7	8.9	9.7	12.1	10.7	11.4	8.9	11.6	14.4	11.3	8.7	6.0	9.2	4.5	35.6	36.1	31.2	43.4	33.1	31.0	34.4	29.2	26.1	20.9
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315240	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	16.1	12.1	5.5	14.8	7.3	66.9	29.0	12.4	8.9	10.2	12.4	6.3	10.3	18.1	7.6	11.1	24.2	11.6	25.1	26.8	5.6	5.3	15.8	37.1	25.5	34.0	7.4	3.9	10.1	26.3	9.6	15.8	26.7	9.5	12.2	9.3	12.7	18.5	9.2	46.4	20.9	23.8	18.1	7.6	26.7	16.3	5.3	4.1	16.4	11.5	45.0	21.4	16.0	17.3	13.2	17.3	49.2	33.3	5.4	16.2	10.0	21.6	22.0	2.9	13.3	17.8	11.4	11.1	33.6	36.5	26.8	24.7	24.3	14.0	19.6	13.7	52.5	21.5	9.3	29.8	19.1	20.3	17.0	11.4	12.6	22.0	5.5	14.9	23.4	8.8	8.5	36.5	11.0	12.0	2.2	9.8	22.3	21.5	7.4	14.2	8.4	12.6	15.5	18.9	14.5	15.1	22.9	8.0	2.8	12.4	13.4	23.3	6.7	5.1	10.9	25.5	20.8	27.2	21.6	12.3	6.2	25.2	24.6	12.9	13.1	14.5	16.0	25.2	14.6	24.0	12.6	13.2	12.1	13.6	17.3	10.6	7.8	10.1	49.2	5.4	33.3	12.7	16.2	10.0	5.5	7.3	12.4	8.9	5.6	5.3	7.4	3.9	9.5	4.1
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414698-69553861	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.9;skeletal muscle: 55.6"	"Cell line enhanced"	"Detected in many"		"A549: 23.9;HUVEC TERT2: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favourable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favourable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	4.5	2.0	3.2	8.6	5.9	10.1	14.0	13.7	7.5	19.8	21.5	6.2	4.7	7.2	4.7	3.1	3.4	3.3	5.1	2.5	3.9	3.5	4.1	8.6	2.6	10.3	5.4	4.1	2.7	8.5	0.0	3.2	1.1	5.3	2.8	22.8	5.3	4.0	4.6	55.6	2.3	7.3	2.3	6.2	5.9	5.4	2.1	5.4	13.7	2.8	4.8	5.1	3.0	2.5	2.3	31.9	19.3	9.3	1.8	2.1	2.6	0.1	23.9	10.8	13.0	4.7	2.5	1.6	0.1	3.5	1.0	1.5	0.7	1.1	0.6	8.8	0.5	1.2	3.7	0.5	0.3	0.8	1.9	0.1	6.7	6.7	4.6	1.0	0.9	11.9	0.3	0.3	0.0	17.2	0.0	1.7	0.0	0.1	12.5	0.4	7.6	4.4	4.5	1.1	0.3	4.8	3.3	4.8	7.3	1.0	0.9	2.2	3.3	1.3	3.0	1.3	1.5	1.1	0.4	1.2	1.3	0.3	1.0	1.5	1.0	0.8	9.3	1.6	1.2	1.1	2.1	1.6	1.4	1.5	2.9	2.3	1.6	1.5	19.3	1.8	0.4	31.9	1.9	2.6	3.2	5.9	13.7	7.5	3.9	3.5	5.4	4.1	5.3	5.4
MAP3K11	"MEKK11, MLK3, PTK1, SPRK"	ENSG00000173327	"Mitogen-activated protein kinase kinase kinase 11"	Q16584	11	65597755-65615382	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 75.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010165	Approved		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"CAB010165: AB_631936"	"unprognostic (8.36e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.27e-3)"	23.2	10.8	11.4	23.7	21.2	14.2	27.4	7.9	13.8	8.6	15.8	29.8	6.1	31.9	11.0	8.1	14.7	11.6	12.0	11.6	13.3	8.1	16.1	31.2	21.1	14.4	30.9	8.2	8.4	12.5	8.3	10.3	14.7	16.7	13.4	8.2	15.4	13.5	9.5	11.9	13.7	31.9	8.6	17.7	28.8	16.9	8.6	19.0	8.9	13.6	7.6	12.7	8.9	75.8	2.3	7.6	13.8	12.0	1.8	3.5	5.6	16.5	14.6	7.9	8.4	2.5	3.2	8.1	6.4	4.5	7.7	5.3	14.6	16.0	6.2	23.7	5.0	14.4	4.7	6.9	2.8	13.6	6.0	17.5	10.0	17.4	7.0	10.0	26.5	5.0	6.7	5.7	5.2	21.5	7.5	12.5	4.0	20.4	11.7	18.9	8.6	18.7	19.5	5.1	12.6	7.2	14.3	7.1	8.0	7.5	21.8	37.5	17.4	16.3	23.9	11.8	12.8	17.2	11.3	8.0	9.0	5.5	13.8	11.6	27.3	4.3	7.7	9.2	2.4	12.0	2.4	2.0	2.6	3.5	7.6	2.3	2.0	1.5	13.8	1.8	11.7	2.3	1.4	5.6	11.4	21.2	7.9	13.8	13.3	8.1	30.9	8.2	16.7	19.0
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263121-45317040	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;HDLM-2: 22.6;U-251 MG: 22.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_10600302, HPA027270: AB_10600884"	"unprognostic (1.05e-2)"	"prognostic favourable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	3.7	3.4	3.0	14.7	4.0	3.4	2.7	4.9	3.6	5.0	7.3	4.5	3.5	6.0	5.5	3.3	6.8	4.2	6.2	4.5	3.0		4.4	5.1	4.9	12.0	3.0	0.6	3.5	5.7	3.5	7.7	1.5	4.6	5.2	3.5	4.3	7.5	4.8	14.5	6.1	9.6	5.2	4.1	8.4	4.0	4.5	4.5	7.1	2.2	6.9	18.0	4.9	2.8	9.5	4.8	7.7	3.6	5.6	5.2	2.3	9.4	22.0	2.2	3.9	1.5	3.7	5.6	2.6	1.8	8.3	5.1	3.4	11.6	4.2	13.3	2.7	6.6	1.0	3.5	4.3	22.6	1.7	0.9	6.0	1.5	4.0	0.7	4.4	5.8	2.2	4.1	2.2	1.6	1.8	18.0	4.2	3.4	3.9	1.5	1.2	3.1	5.2	6.7	9.5	6.0	1.9	2.3	1.9	4.0	2.7	2.8	1.7	0.4	3.5	3.8	5.9	3.2	22.1	17.2	6.4	2.2	2.1	2.4	5.1	1.5	3.4	1.6	3.5	3.6	2.0	7.6	2.4	2.5	2.3	9.5	2.6	2.5	7.7	5.6	2.2	4.8	5.2	2.3										
MAP3K2	"MEKK2, MEKK2B"	ENSG00000169967	"Mitogen-activated protein kinase kinase kinase 2"	Q9Y2U5	2	127298730-127388465	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 13.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021540	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021540: "	"unprognostic (5.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.97e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.11e-1)"	18.5	14.5	13.7	20.1	14.5	41.0	22.6	20.1	16.3	16.6	19.6	12.7	18.9	18.8	19.8	18.0	13.4	15.9	18.6	13.3	12.5	10.2	15.5	27.6	20.0	28.5	17.9	13.0	20.3	15.4	23.8	21.2	13.9	12.3	13.6	13.1	12.2	18.1	25.5	24.5	19.4	22.5	18.1	14.9	17.0	18.0	14.9	14.3	25.8	22.5	13.7	16.8	17.1	20.3	3.1	5.1	13.6	2.9	2.3	2.1	1.1	16.3	7.0	5.6	5.6	7.8	10.4	9.3	10.2	11.1	10.1	8.2	8.3	7.3	10.8	17.6	14.5	13.9	8.9	6.8	11.3	27.0	6.9	10.0	12.6	7.3	9.1	10.0	21.7	9.3	7.6	12.2	15.0	4.6	4.7	21.6	9.9	5.9	11.7	7.1	5.7	9.1	7.7	10.5	8.0	4.1	15.3	11.1	5.9	14.8	9.1	9.2	5.9	7.7	10.6	19.8	18.6	9.1	13.8	22.4	16.1	11.1	9.5	6.6	8.5	4.0	2.9	2.0	1.7	1.8	2.1	3.1	1.6	1.7	2.4	2.6	1.9	2.0	13.6	2.3	2.2	5.1	1.4	1.1	13.7	14.5	20.1	16.3	12.5	10.2	17.9	13.0	12.3	14.3
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268010	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.1"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 13.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 13.7;monocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol				Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	21.7	5.0	2.9	7.4	3.3	0.8	9.2	2.8	3.1	25.7	24.8	2.1	10.7	3.1	30.2	15.4	26.2	13.1	14.9	52.5	3.5	3.0	2.4	8.5	7.5	2.5	4.5	3.0	21.7	4.4	22.6	3.1	6.9	4.2	25.6	5.4	11.5	6.7	15.8	96.1	5.8	8.0	68.4	4.7	3.7	15.8	6.6	3.5	2.8	6.7	38.0	4.9	46.7	24.0	2.1	13.7	2.3	8.0	0.4	1.6	2.7	8.7	7.3	5.8	7.6	16.9	25.2	3.6	31.6	24.7	14.8	15.9	5.0	5.8	6.7	8.3	31.6	5.9	8.6	16.7	33.3	13.1	5.8	11.0	8.3	1.0	6.7	9.8	11.6	20.2	7.2	27.8	43.9	9.7	4.9	1.3	9.7	3.7	6.1	4.9	3.2	4.2	9.1	11.9	0.0	3.6	5.0	3.4	3.3	12.2	3.0	5.1	3.4	5.3	9.7	47.2	19.4	14.0	7.1	0.0	0.0	1.4	33.9	2.7	4.9	0.1	8.0	0.0	0.9	7.5	0.9	1.5	0.8	1.6	13.7	2.1	0.0	0.8	2.3	0.4	6.6	0.3	0.7	2.7	2.9	3.3	2.8	3.1	3.5	3.0	4.5	3.0	4.2	3.5
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557047-136792518	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol				Cytosol		"CAB007824: AB_598175, HPA063245: "	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favourable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	7.7	55.6	13.0	7.5	17.6	7.6	5.5	12.9	12.7	4.0	5.4	6.9	3.6	4.6	7.2	5.1	6.4	6.1	4.9	7.3	11.8	6.8	6.8	5.5	7.7	8.8	8.2	6.4	32.4	28.2	1.5	9.9	3.4	7.9	11.6	6.2	5.8	4.2	4.9	3.7	5.0	4.6	4.3	7.5	9.8	8.7	7.3	8.6	2.0	10.0	3.4	9.0	10.8	18.9	2.5	2.5	8.5	3.0	4.1	7.0	1.4	2.8	1.7	0.0	0.0	4.1	11.1	1.0	4.1	22.3	2.1	2.0	0.1	2.9	1.7	6.1	5.7	4.0	7.1	2.1	5.6	2.3	5.6	14.7	3.9	0.0	19.8	6.8	0.0	14.6	2.8	3.3	9.6	7.1	3.6	16.5	15.0	5.5	0.1	5.8	0.7	2.4	3.8	4.7	6.7	8.6	18.3	5.2	3.4	3.4	3.3	0.9	0.7	6.1	6.2	3.6	1.1	0.2	3.8	13.5	8.9	0.0	2.8	9.6	3.1	5.7	3.0	3.3	2.7	2.3	4.9	2.0	4.3	3.7	2.5	2.5	0.4	1.4	8.5	4.1	2.1	2.4	7.0	1.4	13.0	17.6	12.9	9.4	11.8	6.8	8.2	6.4	7.9	8.6
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20.0	22.2	22.9	16.4	25.0	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17.0	23.3	24.3	18.7	14.7	19.4	23.0	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.7	6.9	20.1	17.2	14.7	19.7	14.2	15.6	18.1	14.1	17.8	8.8	7.5	17.3	10.0	16.9	8.3	12.6	12.2	24.0	8.8	13.4	15.4	9.5	11.7	15.4	17.1	11.9	16.2	14.9	13.7	16.9	13.2	30.8	14.2	20.1	9.5	7.9	14.5	16.5	8.7	13.7	36.1	8.4	11.8	8.7	10.2	14.5	10.9	7.6	11.8	7.5	30.5	12.6	11.5	7.3	10.5	14.5	12.7	11.3	7.5	17.6	18.8	16.8	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16.0	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30433937-30461833	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 104.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol				Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	28.0	7.6	3.6	15.6	4.1	104.6	26.1	1.5	2.6	8.2	8.4	2.7	11.3	3.4	11.5	16.5	13.8	19.5	15.3	20.1	4.3	2.9	6.3	7.6	29.0	33.7	4.3	2.0	9.8	3.6	2.8	4.1	27.5	8.3	7.9	6.8	9.4	6.1	18.4	8.6	15.3	9.6	23.4	9.7	25.6	10.7	6.7	3.6	2.4	7.0	13.2	17.2	13.2	15.6	19.6	13.8	23.7	16.8	12.4	7.8	4.0	7.9	7.1	1.9	4.1	10.3	8.7	9.1	2.0	11.9	4.4	5.3	4.9	18.5	5.2	5.1	4.2	14.9	4.5	1.9	1.6	12.0	2.3	9.7	12.1	15.7	8.7	3.0	24.0	10.8	1.1	4.4	0.8	1.9	4.3	7.8	0.7	4.5	0.1	11.6	0.7	2.5	0.6	1.6	3.0	4.4	16.1	0.2	0.8	7.1	6.1	0.9	2.0	6.4	0.1	2.7	2.3	9.7	0.3	11.9	11.1	1.5	3.9	13.2	0.1	17.9	7.0	23.7	7.8	12.0	4.3	9.6	1.7	4.9	6.6	19.6	0.1	3.0	16.7	12.4	16.8	13.8	0.4	4.0	3.6	4.1	1.5	2.6	4.3	2.9	4.3	2.0	8.3	3.6
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.5;skeletal muscle: 197.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038149, HPA038150"	Enhanced		Enhanced	"Plasma membrane,Microtubules,Cytosol"			120000	"Plasma membrane, Microtubules, Cytosol"		"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	39.3	14.8	60.5	18.2	50.9	6.3	16.4	29.3	56.0	26.9	26.4	80.8	15.8	13.6	25.8	27.4	27.0	24.6	20.1	110.2	63.7	57.5	20.8	13.8	22.7	12.4	86.8	26.1	26.8	18.9	14.6	9.3	24.0	59.5	21.8	18.8	25.2	14.0	34.9	197.9	25.1	15.2	35.0	131.5	18.3	16.2	21.2	41.8	7.3	15.4	31.3	14.2	24.3	18.1	9.9	8.9	6.3	19.7	10.7	13.4	6.7	21.9	17.6	22.1	16.7	32.6	58.2	9.3	41.2	45.0	34.9	39.2	14.8	13.8	18.6	9.6	62.1	14.7	28.2	37.3	39.2	26.8	11.9	12.6	19.7	19.1	44.3	8.7	10.2	48.6	46.7	42.3	51.9	45.7	16.2	21.6	27.4	12.4	12.3	10.6	13.3	36.5	6.6	20.8	23.1	22.3	18.4	8.8	13.7	31.6	12.8	21.8	9.4	8.1	61.7	33.0	25.5	34.4	26.3	15.2	11.8	8.8	42.4	10.7	31.2	6.3	5.3	2.8	13.4	9.0	6.5	9.9	9.0	10.9	5.7	9.4	4.3	6.7	2.2	10.7	19.7	8.9	10.2	6.7	60.5	50.9	29.3	51.8	63.7	57.5	86.8	26.1	59.5	41.8
MAP7	E-MAP-115	ENSG00000135525	"Microtubule associated protein 7"	Q14244	6	136342281-136550819	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.7;HeLa: 25.9;MCF7: 31.8;RT4: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029712, HPA029713"	Enhanced		Supported	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA029712: AB_10600303, HPA029713: AB_10601339"	"unprognostic (8.68e-3)"	"prognostic unfavourable (9.70e-5)"	"unprognostic (2.33e-3)"	"unprognostic (4.35e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-1)"	"prognostic favourable (9.22e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.33e-1)"	"prognostic favourable (5.07e-7)"	"unprognostic (1.62e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.51e-2)"	2.2	6.8	24.1	3.6	41.3	3.4	10.4	36.9	29.3	5.2	18.5	49.8	6.0	21.8	2.1	15.7	11.9	7.9	6.5	1.5	30.7	18.3	25.3	13.3	5.5	1.3	47.6	16.5	1.5	19.0	18.9	13.8	5.3	26.2	15.8	18.0	6.6	14.0	8.2	1.1	13.0	19.7	2.1	55.4	1.5	14.4	17.1	52.7	0.4	12.6	4.3	3.9	6.3	6.0	1.6	5.9	13.0	2.8	0.7	0.6	0.7	9.1	14.3	0.1	0.0	0.1	0.0	15.2	0.2	0.4	0.1	0.2	21.7	9.7	0.0	2.0	0.3	14.1	4.1	12.7	0.2	0.0	9.1	9.6	25.9	0.1	0.1	9.3	1.1	0.0	11.9	0.0	0.9	0.1	6.5	0.2	0.0	31.8	0.1	0.9	1.9	2.1	0.0	0.3	1.7	8.9	25.0	9.2	1.9	10.1	19.3	0.2	7.6	0.9	0.2	0.0	0.7	0.1	0.6	1.7	2.2	0.0	0.2	3.7	0.2	3.0	2.6	0.0	0.0	1.7	0.3	1.6	0.6	0.0	5.9	1.2	0.1	0.0	13.0	0.7	2.8	0.0	0.2	0.7	24.1	41.3	36.9	29.3	30.7	18.3	47.6	16.5	26.2	52.7
MAP7D3	FLJ12649	ENSG00000129680	"MAP7 domain containing 3"	Q8IWC1	X	136213220-136256482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA035598, HPA058101"	Approved		Enhanced	Centrosome				Centrosome		"HPA035598: AB_10671108, HPA058101: "	"unprognostic (2.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavourable (9.00e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (4.16e-5)"	"unprognostic (5.35e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (7.91e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (5.38e-5)"	26.1	4.8	2.9	9.3	3.8	4.5	21.2	0.9	2.2	14.3	9.0	1.7	6.8	2.2	11.4	12.3	10.6	13.7	6.7	17.7	2.7	1.9	9.9	6.5	6.9	6.4	4.1	1.1	23.6	2.8	8.3	14.1	32.6	5.5	9.4	3.5	4.6	3.8	8.6	27.9	5.3	6.2	15.3	6.5	11.8	6.5	16.0	3.1	9.5	9.6	10.2	4.9	13.9	14.6	9.8	6.2	5.9	9.2	8.4	9.3	3.9	15.4	5.5	4.2	7.2	9.5	10.0	5.8	15.0	8.3	12.3	17.0	5.5	7.8	8.0	24.3	13.1	7.5	12.2	8.0	16.9	7.3	12.2	4.8	8.8	0.0	10.5	11.8	5.0	20.3	4.6	12.6	15.7	9.6	4.1	12.7	9.1	9.8	13.9	4.5	5.9	0.1	13.8	11.4	4.0	0.4	2.4	3.0	6.3	8.7	3.3	5.4	0.0	5.4	28.5	13.2	7.6	16.7	19.0	8.6	10.3	9.2	9.0	19.8	6.2	5.9	4.8	1.4	7.5	5.5	9.3	9.8	7.1	8.2	5.8	8.5	7.6	6.0	1.0	8.4	9.2	6.2	5.0	3.9	2.9	3.8	0.9	2.2	2.7	1.9	4.1	1.1	5.5	3.1
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 32.1;neutrophil: 12.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"			7100000	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	21.5	20.6	11.7	18.4	15.5	49.9	20.7	26.5	18.1	22.0	20.5	12.5	11.9	16.9	38.8	12.1	24.0	18.9	16.0	16.4	9.3	9.5	16.0	29.8	21.5	29.0	12.0	11.3	17.7	18.5	15.0	27.2	27.3	10.2	23.4	18.3	17.0	16.7	16.5	21.2	25.6	22.5	26.0	10.6	35.5	18.2	11.1	10.3	34.1	20.9	17.6	20.8	25.0	30.0	2.3	4.0	32.1	4.9	3.0	2.8	2.1	18.3	10.1	10.9	17.5	24.8	24.8	24.0	19.2	25.0	22.8	23.8	24.7	9.5	14.9	19.1	21.1	13.2	18.0	16.6	23.9	16.8	14.3	34.4	14.4	20.6	13.7	21.6	20.8	17.4	16.2	16.4	16.3	25.8	19.0	18.7	15.5	8.7	22.2	26.0	6.7	10.1	26.4	17.7	13.8	16.1	25.3	8.2	7.0	17.3	13.0	20.1	15.3	40.4	18.1	20.5	11.9	12.9	17.6	9.2	21.0	14.9	9.3	42.8	16.8	32.1	4.9	3.0	2.4	3.5	2.8	1.5	2.2	2.6	4.0	2.3	2.5	2.4	12.3	3.0	4.7	1.9	2.6	2.1	11.7	15.5	26.5	18.1	9.3	9.5	12.0	11.3	10.2	10.3
MAPK6	"ERK3, HsT17250, p97MAPK, PRKM6"	ENSG00000069956	"Mitogen-activated protein kinase 6"	Q16659	15	51952106-52067372	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005184, HPA030262"	Approved	Supported	Enhanced	Cytosol				Cytosol		"CAB005184: AB_2140298, HPA030262: AB_10601868"	"unprognostic (6.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.31e-2)"	11.8	7.4	14.4	10.9	23.2	25.6	13.7	33.0	24.5	16.3	18.7	12.5	9.3	16.3	15.9	13.3	32.3	8.2	17.0	9.1	13.3	15.9	14.4	32.6	12.6	9.4	13.1	16.8	11.5	8.5	12.2	15.3	13.9	23.8	10.5	18.1	9.5	17.9	11.4	27.1	24.0	26.2	17.8	14.2	9.2	15.7	25.7	13.0	11.7	13.4	22.7	12.4	18.9	22.4	4.9	4.2	3.0	4.5	6.5	7.9	3.6	8.7	11.8	23.3	8.9	7.2	11.9	17.0	12.5	12.6	11.6	13.7	14.1	5.3	12.6	8.8	16.0	12.4	17.9	23.9	15.9	7.7	5.6	18.8	7.0	22.3	17.4	14.0	40.2	12.7	43.9	14.0	36.4	10.9	24.3	21.5	14.7	19.7	9.8	11.0	8.2	5.7	8.6	15.0	20.2	11.1	36.9	11.4	10.8	10.1	8.2	18.3	7.5	20.9	10.8	13.9	15.0	9.0	16.7	11.2	32.9	15.6	17.2	20.6	17.0	3.0	4.5	1.2	3.8	4.3	4.7	4.9	5.6	4.3	4.2	2.6	5.4	3.8	0.6	6.5	2.8	1.9	7.9	3.6	14.4	23.2	33.0	24.3	13.3	15.9	13.1	16.8	23.8	13.0
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: "	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.5	15.0	6.4	7.3	7.6	9.2	11.8	12.5	7.9	13.4	15.3	7.2	6.0	9.2	13.1	14.1	17.3	9.4	11.8	8.2	5.9	4.7	10.8	4.8	9.9	9.2	8.2	5.2	25.4	5.7	7.3	7.5	12.5	6.7	14.0	6.9	10.5	7.8	12.3	7.5	13.1	11.2	13.8	7.1	13.2	8.0	13.3	7.5	4.5	8.6	11.3	10.6	12.7	15.9	2.2	2.6	11.5	7.4	5.5	4.7	3.0	4.1	6.5	5.4	4.2	27.1	11.3	6.3	5.6	5.2	7.8	7.2	7.5	0.7	2.5	4.6	9.7	4.6	6.3	5.1	4.9	4.3	4.8	1.2	4.7	3.3	11.7	1.1	4.2	11.9	3.6	11.8	4.2	5.7	2.2	0.9	7.7	2.7	8.3	4.4	6.2	4.3	4.5	7.9	1.7	2.6	2.3	2.4	7.2	5.7	0.5	2.9	3.5	1.4	3.2	8.4	6.2	9.2	3.8	1.6	2.4	0.6	9.7	1.0	5.0	1.0	3.6	11.5	4.7	7.4	2.5	2.2	2.2	4.1	2.6	1.4	2.1	2.6	1.3	5.5	6.5	1.7	1.0	3.0	6.4	7.6	12.5	7.9	5.9	4.7	8.2	5.2	6.7	7.5
MAPK8IP1	"IB1, JIP-1, JIP1, PRKM8IP"	ENSG00000121653	"Mitogen-activated protein kinase 8 interacting protein 1"	Q9UQF2	11	45885651-45906465	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 38.6"	"Cancer enhanced"	"Detected in all"		"glioma: 51.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058921, HPA070332"			Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA058921: , HPA070332: "	"unprognostic (3.96e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.25e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.20e-2)"	"prognostic favourable (1.23e-11)"	"unprognostic (7.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.80e-3)"	3.0	12.8	33.3	2.1	29.6	1.4	2.7	24.9	73.5	3.1	1.9	4.6	0.1	1.6	4.9	3.1	2.1	6.6	3.0	2.9	38.1	22.3	5.1	2.7	2.6	1.0	28.0	18.9	4.4	26.4	14.7	24.8	1.6	23.5	4.9	1.5	4.5	4.8	5.0	1.7	1.7	2.0	4.4	44.4	1.7	3.8	10.8	4.8	0.0	3.9	0.5	0.9	2.0	0.4	0.4	0.4	2.1	0.9	2.6	0.2	0.0	0.0	3.5	4.7	13.1	1.8	0.9	0.1	2.5	2.2	5.0	3.6	3.0	0.5	0.2	1.2	2.9	2.8	5.0	2.3	2.2	1.9	6.5	0.0	4.4	2.0	1.6	0.2	2.2	1.2	0.5	3.2	0.6	1.1	5.4	0.8	1.4	1.8	0.1	0.3	12.5	5.2	0.3	7.7	0.1	2.3	0.0	38.6	14.4	4.1	3.4	4.7	5.5	0.2	1.0	6.4	9.8	9.5	4.5	0.5	0.6	0.2	4.0	0.1	1.9	2.1	0.9	0.0	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.4	0.1	0.2	1.8	2.6	0.0	0.4	0.1	0.0	33.3	29.6	24.9	41.7	38.1	22.3	28.0	18.9	23.5	4.8
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"Mitogen-activated protein kinase associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favourable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	27.2	33.9	35.0	24.4	41.4	20.4	22.6	20.3	30.4	27.0	30.1	21.0	20.6	20.1	26.4	25.6	30.3	20.5	21.3	44.9	29.5	24.9	37.5	37.5	20.1	21.3	28.3	20.4	29.1	24.8	29.8	24.1	31.3	27.1	21.7	26.7	22.8	29.7	26.2	60.7	18.2	23.3	33.2	28.5	27.0	25.1	24.9	22.1	24.1	32.7	23.2	24.7	27.2	25.7	7.6	7.1	18.8	6.1	5.4	7.5	2.5	23.9	27.2	18.4	19.5	25.4	24.3	30.7	30.4	31.2	23.6	16.6	27.5	27.1	24.6	18.7	42.4	33.5	28.4	35.7	32.2	27.8	11.6	17.7	32.9	26.0	28.6	31.6	20.7	23.8	33.0	33.7	35.3	34.8	28.1	19.4	50.0	50.0	23.3	12.8	29.2	34.2	19.7	43.6	32.7	25.9	17.5	22.3	21.9	30.5	28.8	19.1	33.3	18.5	22.3	33.6	22.2	40.2	50.4	24.4	59.9	25.1	47.9	14.6	36.2	3.6	6.1	5.3	4.6	5.8	6.2	7.5	5.0	5.0	4.8	7.6	4.4	7.5	18.8	5.4	5.2	7.1	5.4	2.5	35.0	41.4	20.3	30.4	29.5	24.9	28.3	20.4	27.1	22.1
MAPKAPK2		ENSG00000162889	"Mitogen-activated protein kinase-activated protein kinase 2"	P49137	1	206684944-206734283	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: , HPA063708: , HPA064435: "	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	23.0	25.3	11.6	21.2	15.7	58.6	23.9	11.1	14.5	19.3	25.6	17.2	14.5	25.7	20.0	18.5	23.5	17.3	26.0	89.2	12.3	8.7	33.7	26.7	26.7	21.5	16.7	6.5	23.3	19.1	16.9	22.8	13.6	15.7	20.2	14.4	17.8	19.8	14.4	62.9	18.3	32.9	18.3	14.6	37.7	23.1	21.3	14.6	26.9	24.3	25.2	28.2	22.9	46.1	1.1	18.7	3.2	1.1	2.3	1.6	0.5	20.9	8.3	11.5	12.9	34.0	20.0	14.3	14.6	33.1	22.3	21.1	15.8	10.2	10.1	10.2	29.4	15.9	8.6	15.5	16.1	11.7	6.5	16.9	10.3	10.2	26.3	24.9	56.6	27.5	19.9	21.4	23.7	18.2	19.4	45.9	18.0	26.0	10.0	18.0	13.3	11.6	25.8	24.1	3.2	16.8	12.8	9.2	11.9	17.2	29.1	20.2	14.1	24.2	17.3	20.1	17.0	23.3	19.8	59.8	53.1	8.2	22.8	15.2	6.6	1.1	0.7	1.4	1.6	1.1	1.5	1.0	1.2	1.5	0.6	1.1	0.6	1.1	3.2	2.3	1.0	18.7	1.4	0.5	11.6	15.7	11.1	14.5	12.3	8.7	16.7	6.5	15.7	14.6
MAPKAPK3	"3pK, MAPKAP3"	ENSG00000114738	"Mitogen-activated protein kinase-activated protein kinase 3"	Q16644	3	50611520-50649297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 86.7;skeletal muscle: 70.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm				Nucleoplasm		"HPA058275: "	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	8.9	16.1	5.6	9.3	7.2	30.4	6.3	1.9	6.2	5.5	9.5	7.1	7.5	9.9	5.5	8.6	16.8	5.1	8.5	86.7	4.8	3.7	17.9	11.9	11.0	15.1	7.2	4.1	8.7	24.2	11.2	9.0	9.0	6.0	7.6	6.7	10.9	12.4	9.2	70.1	17.6	12.0	5.2	5.9	12.5	9.0	4.0	5.2	25.9	22.6	40.9	14.3	6.1	7.5	3.0	27.1	23.0	61.4	7.3	6.4	19.5	23.0	7.1	3.0	8.5	4.6	11.5	6.7	5.6	8.0	8.7	7.4	11.1	21.5	9.3	5.7	18.7	8.2	20.5	22.1	7.8	20.4	4.9	48.7	10.2	10.1	9.1	35.0	25.9	9.1	13.8	20.2	27.5	7.6	13.6	6.1	18.2	9.4	14.9	35.3	11.2	29.5	6.6	7.2	13.9	40.3	13.2	5.6	4.0	5.0	14.2	6.4	8.9	21.7	5.5	6.8	15.7	35.3	13.8	4.1	7.6	7.7	36.4	55.1	2.8	6.4	30.2	23.0	5.5	50.0	5.4	3.0	6.2	6.4	27.1	1.8	4.9	5.5	20.5	7.3	61.4	16.9	5.2	19.5	5.6	7.2	1.9	6.2	4.8	3.7	7.2	4.1	6.0	5.2
MAPKAPK5	PRAK	ENSG00000089022	"Mitogen-activated protein kinase-activated protein kinase 5"	Q8IW41	12	111841978-111902238	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	20.7	26.2	21.4	17.5	26.4	24.1	21.7	23.7	28.3	17.3	28.8	26.1	21.9	26.3	25.8	22.8	20.8	17.5	22.7	20.7	17.7	15.2	21.7	21.5	18.9	19.4	22.3	20.4	21.3	24.5	19.8	20.4	21.0	17.3	18.7	32.9	23.6	23.3	20.5	33.2	23.0	28.4	21.1	18.0	18.4	19.8	16.7	22.0	19.3	20.5	15.1	19.3	19.9	16.5	4.9	4.1	3.2	11.4	3.9	6.8	2.5	15.1	20.2	19.5	16.4	14.1	14.3	29.7	15.2	18.4	23.4	16.2	26.0	12.5	22.9	11.3	17.9	15.2	25.6	15.9	22.0	15.2	14.0	20.4	14.0	20.8	17.1	25.6	14.5	15.1	22.9	22.3	26.6	17.1	28.1	9.1	17.0	17.0	25.4	40.5	27.7	14.2	25.2	14.2	22.0	18.6	22.0	24.1	20.4	17.3	29.5	21.1	23.8	29.3	14.9	13.3	13.4	13.6	19.0	18.6	22.7	27.1	16.2	18.7	18.8	1.3	4.8	3.2	6.5	3.5	3.5	4.9	4.3	4.7	3.3	4.0	6.8	5.1	2.5	3.9	11.4	4.1	6.6	2.5	21.4	26.4	23.7	28.3	17.7	15.2	22.3	20.4	17.3	22.0
MAPKBP1	KIAA0596	ENSG00000137802	"Mitogen-activated protein kinase binding protein 1"	O60336	15	41774434-41827855	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030832, HPA030833"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA030832: AB_10601869, HPA030833: "	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.56e-2)"	"prognostic favourable (1.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (6.80e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	4.7	6.0	10.6	5.0	13.8	4.4	5.7	48.1	13.9	6.1	5.7	8.8	4.4	10.6	9.3	5.4	12.5	8.0	5.3	4.2	8.6	6.7	3.9	2.3	4.7	4.0	8.6	9.2	15.4	4.3	5.8	9.5	6.1	9.3	5.9	4.3	7.0	5.1	7.1	4.9	26.3	10.5	10.2	6.8	5.7	5.4	19.5	10.7	4.4	8.7	5.2	7.4	8.4	6.6	1.9	1.9	4.3	2.1	2.2	3.3	1.6	4.9	2.6	7.0	6.6	7.8	7.7	4.7	7.0	17.5	6.3	4.7	5.1	1.8	1.2	5.8	5.6	11.8	6.8	19.4	4.6	4.4	2.0	4.9	8.0	1.7	3.3	3.1	10.2	3.9	15.6	10.0	18.3	9.2	3.0	2.3	8.9	1.0	2.6	2.8	0.8	5.3	2.8	5.0	0.5	3.7	5.5	7.9	4.5	4.1	4.1	3.0	4.9	2.5	7.3	9.1	4.4	8.8	6.8	5.1	8.4	2.9	6.1	4.3	7.6	4.3	1.3	1.1	3.3	0.7	2.4	1.9	1.9	1.4	1.9	1.8	2.4	2.0	0.7	2.2	2.1	0.7	0.8	1.6	10.6	13.8	48.1	13.9	8.6	6.7	8.6	9.2	9.3	10.7
MAPRE1	EB1	ENSG00000101367	"Microtubule associated protein RP/EB family member 1"	Q15691	20	32819893-32850405	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003600, CAB009337, CAB019391"	Supported		Enhanced	"Centriolar satellite,Cytosol"			17000000	"Centriolar satellite, Cytosol"		"CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309"	"unprognostic (3.74e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (6.33e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.59e-3)"	35.4	23.4	30.9	30.9	28.7	77.5	27.2	12.3	25.3	26.1	39.3	34.0	25.9	18.3	40.0	29.8	30.0	28.4	27.4	31.7	26.9	25.0	33.6	14.2	30.3	31.9	36.6	17.5	29.5	22.1	19.7	20.0	35.2	27.9	29.1	28.1	24.7	22.0	35.3	20.4	19.3	25.8	42.5	37.1	38.5	29.1	31.7	24.1	48.4	35.2	26.1	31.0	39.1	30.0	19.7	25.7	66.8	41.4	27.3	30.3	42.1	30.5	28.1	31.5	18.0	17.1	15.5	44.9	30.0	18.7	46.8	34.6	81.2	28.5	46.7	30.2	26.9	28.1	37.6	33.5	51.4	15.7	14.6	89.9	19.6	43.4	18.1	32.3	40.0	16.7	16.8	38.2	25.6	29.1	40.4	26.7	41.0	19.0	44.2	28.3	22.7	26.1	29.8	55.9	25.0	25.5	21.2	19.7	20.7	53.8	23.9	30.8	34.5	24.1	25.7	52.8	28.5	26.3	38.6	23.6	32.4	50.3	28.0	74.1	29.3	55.1	33.6	66.8	28.1	39.3	29.1	19.7	26.9	25.9	25.7	18.9	27.3	30.3	36.8	27.3	41.4	23.6	27.0	42.1	30.9	28.7	12.3	25.3	26.9	25.0	36.6	17.5	27.9	24.1
MAPRE3	"EB3, RP3"	ENSG00000084764	"Microtubule associated protein RP/EB family member 3"	Q9UPY8	2	26970612-27027196	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 77.1;skeletal muscle: 62.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009263	Uncertain		Supported	Cytosol				Cytosol		"HPA009263: AB_1078716"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	14.4	17.3	38.5	5.7	46.6	1.7	10.0	39.5	77.1	7.3	9.7	13.4	6.5	5.8	12.0	8.4	7.3	30.2	9.6	22.2	34.6	40.9	9.3	11.3	9.2	4.5	27.7	46.0	22.1	9.6	17.9	25.9	8.2	32.8	12.0	7.8	8.8	7.7	11.8	62.3	17.2	4.5	9.9	15.7	5.7	10.3	25.4	15.9	0.5	9.8	6.3	5.2	6.6	6.0	1.4	1.7	7.0	3.2	1.0	1.5	1.3	10.4	8.1	7.5	13.0	13.7	7.7	2.1	8.2	6.6	7.0	7.2	2.9	13.9	0.0	8.0	10.2	5.4	4.1	8.7	4.1	8.6	10.1	1.5	4.4	0.7	12.6	1.2	20.1	6.3	15.7	3.5	6.6	1.7	10.0	8.2	4.2	4.7	0.0	0.5	3.2	13.0	0.0	0.2	1.1	4.8	6.9	19.0	9.4	5.7	4.2	5.7	4.4	0.7	1.7	6.2	6.3	8.7	7.2	6.3	2.2	0.0	22.2	0.8	12.2	0.2	2.8	0.5	1.5	2.9	1.0	1.4	0.8	0.5	1.7	0.7	1.3	0.3	7.0	1.0	3.2	0.0	0.2	1.3	38.5	46.6	39.5	57.3	34.6	40.9	27.7	46.0	32.8	15.9
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894382-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 89.9;skeletal muscle: 43.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 27.3;SCLC-21H: 9.8;T-47d: 12.4"	"Group enriched"	"Detected in many"	11	"breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: , HPA069524: , HPA069570: "	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	3.8	7.1	28.9	2.4	31.2	2.1	8.8	40.1	89.9	2.4	2.7	21.4	1.7	2.5	2.6	2.3	6.4	2.5	2.8	6.5	28.7	29.7	15.3	2.2	2.4	2.3	22.6	35.2	2.3	2.8	8.5	8.8	5.2	29.1	5.1	2.5	2.2	8.1	5.3	43.7	4.6	2.8	2.5	13.6	2.2	2.3	6.5	27.7	0.0	2.3	3.1	2.3	3.2	0.8	0.0	0.0	0.3	0.1	0.5	1.7	0.1	0.8	0.3	0.2	2.6	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.1	0.0	27.3	1.4	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.2	1.3	0.0	4.1	0.5	0.1	0.0	1.1	0.0	2.2	2.7	0.0	3.5	9.8	4.6	1.0	0.0	0.9	12.4	0.0	0.0	0.2	0.3	0.6	0.1	0.5	0.1	0.0	0.2	0.5	0.3	0.0	0.1	0.3	0.8	0.0	0.6	0.0	0.4	1.2	0.0	0.0	0.9	0.9	0.0	0.5	0.1	0.0	1.7	0.1	28.9	31.2	40.1	46.3	28.7	29.7	22.6	35.2	29.1	27.7
MARC1	"FLJ22390, MOSC1"	ENSG00000186205	"Mitochondrial amidoxime reducing component 1"	Q5VT66	1	220786759-220819657	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 71.3;breast: 81.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.0;HeLa: 21.7;Hep G2: 25.0;NTERA-2: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5"	"Group enriched"	"Detected in many"	32	"granulocytes: 28.5;monocytes: 20.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA028702	Approved		Supported	Mitochondria				Mitochondria		"HPA028702: AB_10601135"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.30e-1)"	"prognostic unfavourable (4.51e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-1)"	71.3	3.0	4.6	7.5	6.1	7.3	81.3	3.1	4.0	3.4	7.8	2.1	18.7	3.3	1.4	5.5	3.4	2.8	6.4	6.7	3.7	4.6	3.4	33.6	4.3	4.3	4.0	3.3	2.5	4.0	4.0	3.3	9.7	4.3	14.9	6.8	4.4	27.8	10.5	4.2	1.4	3.8	2.6	2.6	4.3	3.2	0.6	1.4	0.1	22.0	2.7	1.4	3.9	7.5	0.2	0.7	28.5	20.6	0.0	0.1	4.9	5.6	3.1	2.0	0.0	0.4	0.1	51.0	0.5	0.4	0.3	0.5	16.8	0.3	0.0	2.1	0.5	0.0	10.6	1.0	0.7	0.0	10.7	0.0	21.7	25.0	1.3	0.1	0.1	2.0	0.6	0.0	0.0	0.3	1.6	0.1	0.3	5.5	0.0	10.7	21.5	9.4	0.0	0.0	0.1	2.4	6.3	6.0	14.0	3.0	3.7	0.0	14.2	12.8	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.0	20.6	8.1	0.1	1.5	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	28.5	0.0	0.4	0.2	0.0	4.9	4.6	6.1	3.1	4.0	3.7	4.6	4.0	3.3	4.3	1.4
MARCH1	"FLJ20668, MARCH-I, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.4;lymphoid tissue: 32.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 9.4;U-266/70: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	95	"classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014600	Uncertain		Supported	Mitochondria				Mitochondria		"HPA014600: AB_1853573"	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	7.7	4.2	11.6	20.5	19.7	3.9	4.0	3.1	14.5	3.7	3.9	8.5	0.1	4.4	3.9	4.6	3.6	4.2	5.9	2.6	12.6	10.1	3.0	4.5	8.3	28.5	17.3	6.3	4.2	4.1	1.5	4.1	10.2	13.5	3.5	5.1	2.4	4.6	1.8	1.6	4.9	9.0	6.5	24.4	32.4	4.1	2.3	17.9	2.6	3.2	1.4	24.6	9.0	4.2	18.5	18.1	9.9	17.2	0.1	0.0	6.6	0.8	0.7	2.9	1.7	0.0	0.0	1.8	1.2	0.1	0.0	0.0	1.6	3.3	9.4	3.5	0.0	1.4	0.0	0.0	0.0	1.0	1.0	6.7	3.7	0.6	0.0	4.1	2.2	0.0	0.0	0.0	0.2	0.0	2.5	4.9	3.3	1.0	2.3	2.6	3.6	1.3	2.6	0.5	0.7	0.1	1.5	1.5	1.3	0.9	1.4	0.5	4.0	0.7	3.1	1.1	2.0	0.7	2.3	9.7	3.2	2.6	1.3	2.1	1.5	0.0	16.8	9.9	0.0	17.0	0.0	18.5	0.0	0.0	18.1	15.7	0.0	0.0	0.1	0.1	17.2	6.8	0.0	6.6	11.6	19.7	3.1	12.5	12.6	10.1	17.3	6.3	13.5	17.9
MARCH2	"HSPC240, MARCH-II, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavourable (6.48e-4)"	"prognostic favourable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favourable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favourable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	37.7	12.4	30.7	13.5	28.3	17.5	23.9	8.6	39.1	9.8	29.8	20.7	9.7	11.2	12.5	39.0	19.3	10.0	11.4	38.9	23.5	21.9	11.0	17.9	18.2	15.0	30.8	19.8	8.2	10.0	10.5	11.3	13.9	20.2	16.0	10.3	12.7	13.4	21.8	46.9	12.7	11.7	28.5	27.8	18.9	13.3	8.6	13.3	8.4	21.3	14.1	10.0	20.4	9.7	3.6	26.5	20.4	14.6	3.7	7.3	10.1	5.4	7.0	3.2	14.7	19.5	6.4	5.4	6.0	7.3	4.8	5.0	3.4	2.6	2.2	17.6	12.8	3.9	4.1	8.4	3.7	10.9	9.7	16.7	3.3	7.6	10.5	2.4	25.1	7.6	9.7	4.6	4.1	18.7	2.3	12.3	3.7	10.5	3.3	7.9	6.6	17.0	5.3	1.0	5.5	11.0	6.5	1.6	8.9	0.4	6.4	11.3	4.9	5.2	18.8	6.7	4.1	22.3	5.0	11.0	13.0	2.5	10.9	5.0	5.1	20.4	10.0	15.4	5.7	14.6	5.9	3.6	5.9	4.6	6.7	3.5	4.0	5.4	12.5	3.7	12.8	26.5	7.3	10.1	30.7	28.3	8.6	39.1	23.5	21.9	30.8	19.8	20.2	13.3
MARCH3	"MARCH-III, MGC48332, RNF173"	ENSG00000173926	"Membrane associated ring-CH-type finger 3"	Q86UD3	5	126867714-127030808	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 24.6;HUVEC TERT2: 16.4;TIME: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 8.8;naive B-cell: 13.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043406	Uncertain		Supported	Vesicles				Vesicles		"HPA043406: AB_10793947"	"unprognostic (5.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.75e-3)"	"unprognostic (9.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.60e-6)"	"unprognostic (7.74e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-1)"	11.3	6.0	5.6	11.0	9.4	6.6	6.2	5.3	4.8	2.0	10.8	8.2	0.5	2.4	3.7	3.6	3.4	3.2	10.4	15.2	7.8	6.8	2.0	1.9	5.2	5.2	9.5	2.3	4.0	5.0	1.7	10.8	4.0	12.3	2.9	11.8	9.7	11.2	1.1	11.9	11.5	5.2	6.5	16.0	3.7	5.5	14.2	7.6	2.1	3.6	3.4	5.8	6.5	6.7	13.1	0.7	2.5	0.4	1.9	2.6	0.7	0.3	1.2	2.3	1.2	2.1	2.0	0.7	8.4	3.5	6.8	10.0	1.1	0.5	2.2	0.8	1.3	0.7	2.9	1.5	9.6	0.5	2.7	7.0	1.9	1.1	3.4	2.8	1.8	1.4	0.5	24.6	2.9	16.4	2.9	0.4	5.5	0.8	0.3	1.2	2.0	2.8	0.9	9.4	0.6	0.5	1.2	0.7	0.5	1.9	0.3	1.0	1.7	2.9	19.9	1.3	1.0	7.7	0.9	1.1	1.3	1.3	5.0	2.3	1.1	0.0	0.2	2.5	0.5	0.4	0.1	8.8	0.6	0.3	0.1	13.1	2.4	0.5	0.8	1.9	0.3	0.7	2.6	0.7	5.6	9.4	5.3	4.8	7.8	6.8	9.5	2.3	12.3	7.6
MARCH5	"FLJ20445, MARCH-V, MITOL, RNF153"	ENSG00000198060	"Membrane associated ring-CH-type finger 5"	Q9NX47	10	92291163-92353964	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056596			Supported	Mitochondria				Mitochondria		"HPA056596: "	"unprognostic (4.00e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.33e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.02e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.85e-2)"	18.2	21.7	17.5	17.7	18.3	20.7	27.1	16.8	25.7	15.5	15.4	12.7	20.7	15.8	19.3	18.8	28.0	14.8	15.4	18.4	15.8	15.1	21.7	27.6	16.5	16.6	16.3	17.9	20.9	16.7	16.3	12.3	16.3	14.8	22.2	14.8	14.5	19.4	19.3	42.6	13.7	16.0	18.1	14.0	12.1	14.4	20.1	13.5	25.0	24.5	21.5	17.3	14.7	21.0	7.3	9.4	16.8	10.2	6.5	8.7	6.6	16.4	8.9	17.6	20.2	12.1	12.6	9.1	14.7	16.2	18.4	18.9	5.9	11.8	9.6	10.2	14.4	13.6	12.3	12.3	26.5	7.2	14.5	7.7	8.4	13.9	14.6	12.3	7.7	12.8	16.7	12.1	25.5	16.1	8.4	12.0	14.7	10.4	10.8	14.1	4.1	13.5	11.8	18.1	5.7	18.8	10.7	8.2	15.2	12.8	9.5	15.6	16.5	9.6	15.6	8.6	9.5	9.4	20.1	12.2	9.3	8.5	7.9	17.0	5.7	5.2	8.3	9.0	7.6	10.2	7.6	7.3	8.4	8.0	9.4	6.7	8.7	8.3	16.8	6.5	8.5	6.2	7.8	6.6	17.5	18.3	16.8	25.7	15.8	15.1	16.3	17.9	14.8	13.5
MARCH6	"MARCH-VI, RNF176, TEB4"	ENSG00000145495	"Membrane associated ring-CH-type finger 6"	O60337	5	10353703-10440388	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040841, HPA063246"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA040841: , HPA063246: "	"unprognostic (3.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.50e-3)"	22.5	25.6	28.6	21.2	25.5	57.0	62.4	42.0	53.8	21.4	23.0	24.0	18.3	28.6	24.7	24.2	22.8	25.1	22.0	35.5	27.6	23.7	31.9	28.9	35.0	33.2	29.8	39.1	34.0	41.5	56.0	27.4	20.3	33.4	21.4	18.4	20.3	28.0	23.4	49.8	23.9	32.1	27.4	38.6	31.2	26.0	25.6	26.9	18.0	26.8	17.1	20.3	24.6	36.4	13.4	7.3	15.6	12.1	9.9	15.7	9.4	12.4	18.7	31.4	24.3	18.0	14.5	25.7	19.7	18.4	17.0	21.8	17.8	33.3	13.1	30.1	18.4	17.3	16.6	12.8	23.1	27.7	15.1	17.1	62.2	12.1	12.7	20.2	19.2	16.9	14.2	17.1	18.7	15.8	20.4	29.6	15.5	14.2	10.9	15.6	11.4	13.2	17.0	13.1	18.9	13.3	24.2	13.5	19.6	36.7	20.1	12.9	16.7	11.0	15.2	20.7	20.2	10.2	14.7	20.8	29.8	18.7	15.2	14.1	14.7	15.6	8.5	13.6	13.5	9.6	15.4	13.4	13.4	13.4	7.3	11.5	15.7	14.6	13.7	9.9	12.1	5.6	11.7	9.4	28.6	25.5	42.0	53.8	27.6	23.7	29.8	39.1	33.4	26.9
MARCH7	"AXOT, MARCH-VII, RNF177"	ENSG00000136536	"Membrane associated ring-CH-type finger 7"	Q9H992	2	159712457-159771027	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014275, HPA022152"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA014275: AB_10599820, HPA022152: AB_10601107"	"unprognostic (2.42e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (1.84e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"	31.6	21.1	18.3	27.4	29.0	22.6	28.9	33.1	23.0	33.4	25.3	17.0	22.0	17.1	32.3	24.1	47.6	22.7	22.4	28.1	16.9	14.4	21.8	30.9	29.5	32.9	21.6	17.8	31.6	15.4	25.3	31.5	41.3	21.5	28.8	22.3	24.8	25.7	22.6	48.0	24.2	25.2	33.8	20.4	28.9	20.0	34.1	21.8	60.4	28.5	25.5	32.9	30.0	35.1	10.0	10.1	46.1	14.5	14.0	14.6	10.5	18.5	12.8	34.5	15.5	25.0	33.1	33.4	31.2	31.6	32.1	29.5	26.4	22.3	26.4	14.2	32.5	23.5	21.2	28.8	41.2	27.0	15.6	35.8	18.6	19.9	24.3	29.3	28.0	29.4	32.9	39.2	34.0	38.5	27.2	25.5	32.4	15.2	18.7	28.1	32.5	18.4	27.9	25.5	21.9	29.5	38.7	20.5	19.3	25.5	18.8	25.0	21.8	35.6	34.7	34.4	20.8	21.1	17.6	20.4	21.4	36.0	21.3	17.8	32.0	24.8	10.3	20.6	11.1	10.6	13.3	10.0	12.1	12.6	10.1	9.7	14.6	14.1	46.1	14.0	14.5	7.9	12.5	10.5	18.3	29.0	33.1	23.0	16.9	14.4	21.6	17.8	21.5	21.8
MARCKSL1	"F52, MacMARCKS, MLP, MLP1"	ENSG00000175130	"MARCKS like 1"	P49006	1	32333832-32336379	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 166.5"	"Cell line enhanced"	"Detected in many"		"AF22: 106.6;NTERA-2: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"eosinophil: 54.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 54.9"	"Low region specificity"	"Detected in all"							"CAB020787, HPA030528"	Enhanced		Supported	"Nucleoplasm,Actin filaments,Cytosol"			120000	Cytosol	"Nucleoplasm, Actin filaments"	"CAB020787: , HPA030528: "	"unprognostic (8.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.16e-3)"	"prognostic unfavourable (1.78e-6)"	"unprognostic (3.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-2)"	9.9	12.7	59.9	22.1	45.4	10.9	27.7	22.0	58.0	22.3	27.5	126.3	5.3	15.9	25.8	42.3	3.6	15.9	24.9	10.7	64.2	47.2	6.4	9.7	9.0	41.5	83.6	35.4	74.1	4.8	1.3	4.9	11.0	56.6	22.5	30.7	5.2	19.9	14.2	2.0	5.3	13.9	11.3	166.5	12.5	34.8	30.3	52.3	41.4	29.0	2.2	49.2	17.0	5.5	6.4	2.2	54.9	6.7	0.2	3.9	1.2	8.2	7.5	106.6	43.5	2.4	0.8	19.0	3.5	2.1	10.4	6.9	17.7	6.1	18.7	13.1	2.3	4.4	34.4	0.3	7.7	0.4	25.4	1.0	2.9	39.1	7.3	4.8	0.1	12.2	1.4	7.8	0.2	30.4	28.7	0.2	13.9	19.7	60.7	20.6	102.8	17.4	76.0	11.4	8.9	15.6	16.5	66.1	62.9	18.3	20.3	57.6	14.1	8.6	8.9	4.4	25.9	0.4	6.6	2.9	0.2	49.1	0.5	7.4	23.3	0.7	1.0	54.9	0.9	5.4	0.3	4.6	1.9	1.2	1.5	6.4	3.9	1.6	4.4	0.2	6.7	2.2	1.0	1.2	59.9	45.4	22.0	54.9	64.2	47.2	83.6	35.4	56.6	52.3
MARF1	"KIAA0430, LKAP, LMKB, Marf1, PPP1R34"	ENSG00000166783	"Meiosis regulator and mRNA stability factor 1"	Q9Y4F3	16	15594386-15643166	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.0"	"Group enriched"	"Detected in many"	4	"B-cells: 6.4;granulocytes: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017992	Uncertain		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA017992: AB_1852921"	"unprognostic (2.33e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.94e-2)"	12.2	9.1	22.4	12.3	17.7	16.7	11.2	25.9	40.0	16.9	17.2	12.0	7.6	8.9	15.2	7.1	10.7	15.1	11.0	8.8	20.7	15.4	13.0	9.0	10.8	17.2	15.1	18.4	20.8	12.0	18.8	12.0	9.3	16.5	12.8	12.8	9.1	12.4	12.8	20.4	11.9	13.0	15.5	13.6	14.6	12.0	6.8	14.0	11.8	15.5	4.2	26.1	18.8	13.9	6.4	0.8	12.0	1.9	0.8	2.1	0.8	4.2	8.0	10.3	7.4	9.5	13.6	4.2	4.8	6.6	4.4	7.7	1.3	5.9	19.4	9.6	9.5	3.0	6.1	6.7	8.1	6.6	4.2	8.2	7.3	6.1	7.9	9.2	10.8	8.1	7.4	9.7	11.7	11.3	7.1	7.3	8.8	4.0	7.5	4.2	2.8	4.0	10.4	13.5	4.8	3.9	8.2	5.9	7.5	7.1	4.6	8.7	4.9	8.1	11.7	6.6	4.3	11.4	3.9	8.5	7.9	11.8	9.0	6.0	8.6	2.4	1.6	4.3	1.4	1.4	0.8	4.2	2.1	1.4	0.7	6.4	1.9	2.0	12.0	0.8	1.9	0.8	1.9	0.8	22.4	17.7	25.9	40.0	20.7	15.4	15.1	18.4	16.5	14.0
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911019	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: "	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	9.7	11.6	16.5	16.3	21.4	18.5	13.8	24.7	26.1	15.2	20.5	20.0	11.1	21.3	13.6	7.5	48.4	13.6	14.4	14.7	17.0	10.1	11.9	12.4	15.4	16.3	18.1	13.7	11.0	17.3	21.8	22.4	21.1	15.0	14.9	19.8	10.6	20.7	14.3	15.7	35.8	26.9	13.3	13.3	21.6	16.8	9.8	18.7	22.9	15.9	13.6	23.5	14.8	21.3	2.9	1.9	9.8	1.9	3.3	4.5	1.2	22.4	15.0	12.3	12.9	6.7	8.9	17.1	9.1	8.8	13.2	10.2	16.1	23.7	16.6	16.2	9.5	29.0	11.8	14.3	11.5	11.4	9.3	18.2	11.8	10.4	7.6	19.8	24.1	4.9	19.5	12.1	10.5	10.8	15.5	19.1	8.7	27.6	20.7	14.1	14.0	10.9	17.1	9.1	18.3	9.8	18.6	17.0	11.4	15.8	40.4	10.6	29.4	11.8	10.3	14.0	8.8	18.0	10.1	11.6	12.0	16.2	9.5	10.4	11.1	2.7	1.7	4.4	2.9	1.5	4.5	2.3	3.2	3.1	1.9	2.9	2.6	2.4	9.8	3.3	1.9	1.7	1.5	1.2	16.5	21.4	24.7	26.1	17.0	10.1	18.1	13.7	15.0	18.7
MARK4	"FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D"	ENSG00000007047	"Microtubule affinity regulating kinase 4"	Q96L34	19	45079288-45305283	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039186	Approved		Supported	Cytosol				Cytosol		"HPA039186: AB_10796223"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavourable (8.31e-8)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (3.05e-5)"	"unprognostic (1.90e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.89e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.02e-2)"	11.8	13.0	19.4	10.3	26.0	8.4	15.2	21.9	28.6	11.4	10.2	9.0	12.9	6.6	14.0	17.5	13.5	12.9	13.4	14.7	22.2	15.7	8.7	13.5	11.7	10.5	14.3	21.6	21.0	16.8	13.7	12.9	12.1	15.0	12.2	6.3	14.1	12.1	14.2	40.7	20.6	7.5	14.1	10.8	12.4	10.3	32.1	12.3	11.2	10.5	11.5	9.4	13.7	17.9	1.0	2.8	3.5	2.9	1.8	4.3	1.2	8.8	3.8	15.0	10.9	10.7	17.1	4.2	6.6	10.3	9.8	9.2	2.3	5.1	4.3	5.6	12.0	6.0	10.6	9.6	5.5	7.8	8.7	8.5	4.6	8.2	19.7	2.1	7.4	21.2	13.7	8.2	9.5	13.1	10.8	10.7	10.6	7.4	7.5	6.7	6.4	3.3	29.3	4.9	2.8	9.3	7.2	28.1	12.4	9.7	8.6	5.0	4.1	12.4	10.6	8.8	6.7	6.0	4.2	12.0	9.5	4.8	9.4	4.0	7.0	3.5	2.9	0.7	3.4	2.2	0.7	0.9	1.2	4.3	0.8	1.0	2.3	2.6	2.9	1.8	2.0	2.8	2.4	1.2	19.4	26.0	21.9	22.7	22.2	15.7	14.3	21.6	15.0	12.3
MARS	"CMT2U, MetRS, SPG70"	ENSG00000166986	"Methionyl-tRNA synthetase"	P56192	12	57475445-57517569	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004125, CAB017097"	Supported	Approved	Enhanced	Cytosol			21000	Cytosol		"CAB017097: , HPA004125: AB_1079312"	"prognostic unfavourable (1.73e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (4.55e-7)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-2)"	23.8	26.7	35.1	27.3	29.1	23.0	19.8	25.1	36.0	17.4	23.9	23.1	23.9	17.3	23.3	36.3	29.5	17.9	16.1	25.0	28.0	29.5	20.5	45.9	24.3	25.1	40.1	25.5	25.8	48.3	35.7	34.0	22.2	30.9	25.6	24.7	19.8	26.0	30.0	24.5	18.4	20.1	33.7	30.7	30.7	31.3	29.6	30.9	21.4	26.9	22.3	34.3	24.3	27.9	12.9	29.3	19.0	27.0	14.1	18.9	15.5	16.5	23.0	15.4	26.7	17.3	10.5	28.4	23.7	27.8	25.1	26.9	24.7	18.4	29.1	15.7	28.7	18.8	35.1	30.6	26.3	25.2	15.2	20.5	8.6	13.9	38.5	30.9	23.6	15.3	47.6	28.7	74.4	17.9	31.7	62.4	17.4	22.9	27.6	23.3	29.1	25.4	24.0	116.3	30.1	18.9	13.0	20.6	20.9	12.3	18.9	32.8	25.0	40.5	13.2	9.1	26.9	13.1	14.0	57.2	57.8	35.1	22.3	23.5	31.0	12.1	14.6	19.0	18.9	27.0	17.2	12.9	12.9	17.1	29.3	7.7	11.1	15.2	7.2	14.1	21.8	28.4	13.1	15.5	35.1	29.1	25.1	36.0	28.0	29.5	40.1	25.5	30.9	30.9
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.1;CAPAN-2: 15.5;HaCaT: 12.1;RT4: 13.9;SCLC-21H: 16.3;T-47d: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"cerebellum: 8.8"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"				"Cell Junctions"		"HPA018119: , HPA061726: "	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favourable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.6	0.7	1.1	2.3	1.4	0.2	4.5	0.7	1.3	2.6	13.2	1.6	9.5	9.4	1.6	6.4	9.1	4.4	9.2	0.9	1.4	1.2	12.2	24.2	11.2	0.4	1.7	0.8	1.0	18.9	3.9	8.0	9.9	2.1	5.0	7.3	5.2	10.9	7.4	0.4	5.4	21.8	1.4	1.3	0.6	8.9	2.7	0.7	1.1	25.7	6.4	7.3	4.7	4.1	1.4	0.4	1.5	0.8	1.1	2.3	1.0	6.4	2.4	0.0	0.0	0.0	0.0	18.1	0.1	0.0	0.1	0.4	8.4	15.5	0.0	1.8	1.1	12.1	0.0	9.0	0.3	0.1	3.5	0.0	0.8	4.5	1.0	0.0	0.0	0.3	10.1	0.1	1.4	0.7	0.0	0.1	0.0	6.5	0.0	0.0	1.3	0.2	0.0	0.0	0.3	6.8	13.9	16.3	0.0	1.6	1.6	0.2	12.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.1	0.0	1.5	0.8	0.2	0.4	0.2	1.1	1.2	2.3	0.2	0.3	1.4	0.7	0.5	0.9	1.1	0.1	0.4	0.1	1.0	1.1	1.4	0.7	1.3	1.4	1.2	1.7	0.8	2.1	0.7
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Group enriched"	"Detected in some"	8	"BJ: 26.5;BJ hTERT+: 101.0"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	8673000000	1800000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favourable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	26.5	101.0	0.3	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047233	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	98	"liver: 185.1"	"Cell line enriched"	"Detected in many"	7	"Hep G2: 20.1"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	339700000	880000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favourable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0.0	0.5	0.3	2.9	1.6	0.0	0.1	0.4	0.8	0.0	0.0	0.0	1.3	1.1	2.3	0.6	0.0	0.7	0.0	0.0	0.0	0.6	2.3	1.4	2.5	20.1	0.0	2.1	1.6	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	0.6	0.6	1.1	0.4	0.6	1.8	1.0	0.5	0.0	1.4	1.8	0.7	0.9	0.5	0.5	0.6	1.3	1.1	0.9	0.6	1.0	0.6	0.7	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1.0	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0.0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27186924	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027175: AB_1853591, HPA054273: "	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	9.1	7.0	3.6	8.9	6.1	21.1	8.3	4.0	7.5	7.4	7.6	3.8	5.7	5.7	6.0	6.7	12.3	5.4	5.3	5.6	6.8	4.5	6.5	7.1	10.2	14.8	5.4	5.7	7.0	12.7	6.7	6.3	14.2	6.7	5.5	7.1	5.6	8.0	4.7	4.0	10.1	10.0	6.1	5.6	8.7	6.2	11.3	2.3	21.1	6.5	4.3	12.3	8.7	7.5	3.9	2.6	5.6	4.9	2.3	4.0	1.8	11.7	9.5	18.1	6.7	2.8	4.1	10.7	17.6	7.4	29.2	36.0	11.4	11.8	9.4	6.7	7.4	11.4	11.5	6.9	20.8	8.0	11.1	11.1	6.6	6.6	1.6	4.2	8.4	2.4	3.1	17.6	3.5	6.3	8.4	21.3	17.7	7.8	13.7	4.7	13.4	3.9	8.8	30.2	7.7	7.2	4.4	8.1	11.6	11.1	7.4	7.8	7.5	9.0	5.4	7.3	15.3	18.6	15.4	2.6	4.1	13.9	8.0	12.9	6.0	0.1	4.4	3.8	2.0	4.3	3.0	2.6	2.5	1.8	2.5	3.9	2.5	2.3	5.6	2.3	4.9	2.6	4.0	1.8	3.6	6.1	4.0	7.5	6.8	4.5	5.4	5.7	6.7	2.3
MAU2	"KIAA0892, mau-2, MAU2L, MGC75361, SCC4"	ENSG00000129933	"MAU2 sister chromatid cohesion factor"	Q9Y6X3	19	19320681-19358755	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059897			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			Nucleoplasm	"Nuclear bodies"	"HPA059897: "	"unprognostic (3.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.57e-3)"	"unprognostic (1.87e-1)"	"prognostic favourable (3.90e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-3)"	"unprognostic (5.56e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	15.3	15.2	17.5	17.4	23.6	24.5	15.8	30.5	21.1	15.7	15.0	28.2	18.9	16.9	18.9	21.6	20.8	20.1	16.9	19.9	15.7	14.4	14.8	12.7	19.5	26.5	28.3	13.1	25.2	19.3	17.8	20.9	15.9	18.3	16.6	10.5	17.2	16.8	20.4	43.6	25.0	15.9	17.8	19.7	22.0	14.1	18.0	25.9	20.6	16.6	12.2	18.6	15.3	16.0	7.0	6.8	14.1	13.4	8.2	9.8	7.4	8.5	6.5	11.7	10.4	9.7	10.2	16.2	8.0	8.3	10.9	9.9	9.4	12.0	10.5	17.5	8.6	10.0	9.9	8.2	5.1	5.5	25.5	8.2	10.2	8.1	11.3	14.6	12.9	11.2	9.3	7.8	9.0	10.4	11.0	13.1	7.2	9.7	15.0	20.3	10.1	18.8	16.8	7.5	11.3	7.7	11.0	17.0	15.5	9.9	10.4	10.4	9.0	20.6	9.2	17.1	3.9	16.7	12.1	17.1	14.3	10.6	8.3	15.5	12.8	4.1	7.7	5.5	8.7	6.5	9.8	6.9	7.5	8.0	6.8	7.0	8.3	7.6	14.1	8.2	13.4	6.8	7.1	7.4	17.5	23.6	30.5	21.1	15.7	14.4	28.3	13.1	18.3	25.9
MAVS	"Cardif, IPS-1, KIAA1271, VISA"	ENSG00000088888	"Mitochondrial antiviral signaling protein"	Q7Z434	20	3846799-3876123	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB009187, HPA049850, HPA053524"	Enhanced		Enhanced	Mitochondria			230000	Mitochondria		"CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177"	"unprognostic (1.30e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.95e-2)"	"prognostic favourable (3.81e-4)"	"unprognostic (1.92e-1)"	"prognostic favourable (4.13e-5)"	"unprognostic (4.97e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.39e-2)"	15.9	13.9	13.0	15.5	17.7	10.8	25.5	17.7	15.7	12.3	18.5	17.2	15.1	17.2	14.9	10.6	17.3	13.8	12.2	15.4	12.3	8.0	13.3	13.9	18.1	17.4	19.9	9.0	18.9	22.5	23.4	13.7	12.0	13.8	13.1	18.6	13.6	15.3	22.4	39.4	22.1	17.0	17.1	13.7	12.7	15.8	5.9	17.1	15.1	14.6	14.0	14.3	18.2	21.6	5.1	5.6	6.4	6.9	5.9	4.8	4.6	17.2	20.1	8.2	10.2	22.6	15.5	6.4	10.5	13.4	11.2	8.2	15.7	11.2	7.5	6.4	14.7	21.8	9.8	15.7	11.5	4.6	4.7	14.4	7.4	24.9	12.5	9.0	6.1	15.6	13.4	18.9	11.3	11.3	16.2	5.8	10.9	15.6	13.6	7.7	5.2	11.1	10.3	11.4	7.5	11.9	17.4	6.2	6.4	11.9	23.3	10.0	12.4	8.4	17.0	15.3	5.7	18.0	12.1	11.9	14.2	5.3	6.1	11.1	7.7	4.4	6.9	6.1	4.8	5.1	3.6	3.8	3.8	3.7	4.4	5.1	4.4	4.4	6.4	5.9	5.5	5.6	3.0	4.6	13.0	17.7	17.7	15.7	12.3	8.0	19.9	9.0	13.8	17.1
MAX	"bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8"	ENSG00000125952	"MYC associated factor X"	P61244	14	65006174-65102695	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000328, HPA003474"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB000328: AB_2281783, HPA003474: AB_1079317"	"unprognostic (4.50e-3)"	"unprognostic (1.51e-3)"	"unprognostic (4.08e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.68e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (6.03e-2)"	33.4	25.5	31.3	31.5	38.6	68.7	25.8	59.0	38.2	34.6	29.4	37.2	26.3	31.5	34.3	24.0	47.6	38.2	27.9	30.1	29.9	28.4	26.3	21.8	31.4	43.4	37.1	21.6	39.7	20.0	17.4	23.7	30.2	32.7	31.9	25.0	26.8	33.6	37.7	27.8	32.1	40.2	30.7	34.8	42.9	24.8	15.7	40.9	41.3	30.2	22.5	40.7	35.1	40.7	18.7	19.1	87.5	23.6	19.2	30.0	44.8	28.3	11.1	6.8	11.0	18.0	14.1	8.9	10.0	15.3	12.5	15.4	7.1	19.9	23.6	8.4	12.0	14.1	17.1	13.9	9.4	23.8	10.4	36.7	7.3	7.8	21.1	13.8	92.4	16.8	9.9	11.5	12.7	13.8	17.2	9.6	12.6	15.7	31.9	47.6	9.1	18.2	18.1	10.8	10.6	11.5	9.5	14.7	9.6	13.1	14.0	12.8	13.7	17.7	17.2	11.5	13.9	10.6	8.0	11.8	10.0	14.9	14.3	13.3	11.4	87.5	23.6	80.6	21.7	20.1	23.7	18.7	25.4	22.1	19.1	17.6	26.6	22.3	49.5	19.2	17.4	18.3	30.0	44.8	31.3	38.6	59.0	38.2	29.9	28.4	37.1	21.6	32.7	40.9
MAZ	"Pur-1, ZF87, Zif87, ZNF801"	ENSG00000103495	"MYC associated zinc finger protein"	P56270	16	29806106-29811164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048315, HPA059495, HPA065930"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA048315: , HPA059495: , HPA065930: "	"unprognostic (1.05e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.39e-3)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.22e-4)"	"unprognostic (7.08e-2)"	23.9	32.2	49.3	34.0	37.9	86.3	62.2	57.3	49.0	31.7	51.5	25.5	30.8	34.8	33.1	26.5	31.1	34.9	31.4	21.3	43.3	30.1	22.8	33.0	31.3	52.5	30.5	32.4	38.4	39.8	44.5	30.2	24.2	22.1	48.1	38.8	29.0	32.3	31.2	41.0	35.8	34.6	29.1	22.9	34.5	28.7	28.4	25.4	141.5	30.2	26.7	40.8	30.6	39.4	5.7	8.4	9.5	9.9	16.4	28.6	8.7	27.9	37.3	38.6	41.9	20.9	20.0	34.8	20.4	16.8	32.0	23.2	47.6	40.3	50.2	26.7	39.9	25.5	63.3	26.7	11.4	40.8	101.2	33.3	81.1	64.9	29.5	82.2	41.5	21.3	37.8	26.8	30.4	31.9	48.6	44.2	15.1	115.5	78.6	70.0	39.1	29.1	77.8	36.4	58.5	26.0	30.5	59.3	46.2	19.5	42.5	25.6	36.5	79.4	21.8	35.3	28.4	13.4	31.8	32.4	40.7	55.4	17.3	54.4	29.1	6.8	6.3	9.5	26.1	9.9	28.6	5.7	17.5	24.8	8.0	4.2	14.6	21.4	5.0	16.4	6.2	8.4	18.4	8.7	49.3	37.9	57.3	49.0	43.3	30.1	30.5	32.4	22.1	25.4
MBD1	"CXXC3, PCM1"	ENSG00000141644	"Methyl-CpG binding domain protein 1"	Q9UIS9	18	50266882-50281774	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009017, CAB036003, HPA068850"	Approved		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB009017: AB_2095559, CAB036003: , HPA068850: "	"unprognostic (2.12e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.85e-2)"	"prognostic unfavourable (5.08e-6)"	"unprognostic (5.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavourable (1.70e-6)"	"unprognostic (7.06e-3)"	"unprognostic (7.70e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	14.7	21.7	18.0	18.8	20.8	29.4	15.7	27.1	29.4	15.3	17.2	18.8	16.2	18.7	18.4	16.6	21.1	16.4	16.8	19.7	19.2	14.0	17.4	18.9	16.0	20.9	21.8	23.1	20.7	19.7	28.2	24.2	19.4	18.2	18.0	13.9	15.0	19.6	19.5	25.9	24.2	18.3	18.3	15.2	22.6	18.0	72.3	21.5	19.1	19.9	20.0	18.2	19.1	20.0	13.1	11.7	22.2	11.6	14.3	17.4	12.1	10.2	9.7	11.0	12.4	11.8	9.7	11.8	12.4	14.3	17.2	13.3	7.3	8.2	16.3	9.0	12.0	18.6	12.5	21.7	10.0	18.2	8.0	10.3	13.8	7.7	22.9	24.8	21.8	11.3	35.1	19.6	45.0	14.1	12.9	25.6	13.2	9.5	20.8	13.0	10.3	7.8	19.3	8.1	17.7	8.5	4.7	14.5	13.8	9.2	8.8	11.3	11.2	22.8	15.2	18.7	8.6	6.0	12.5	47.6	20.1	17.2	12.1	19.1	16.9	15.2	11.6	22.2	17.4	10.1	16.4	13.0	15.2	14.4	11.7	13.1	15.9	12.8	15.6	14.3	7.9	10.7	13.9	12.1	18.0	20.8	27.1	29.4	19.2	14.0	21.8	23.1	18.2	21.5
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151601-54224788	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 8.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB037282: AB_477234, HPA067582: , HPA067615: "	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favourable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	29.8	11.9	8.5	27.9	9.8	15.3	24.0	9.9	9.0	17.5	22.5	7.4	20.1	10.5	12.5	14.8	33.1	11.3	18.7	17.9	7.9	8.1	23.3	23.2	21.3	33.7	10.0	5.3	15.3	19.3	13.1	12.5	38.1	8.6	18.3	15.0	12.1	23.3	17.3	13.9	24.1	26.7	15.7	11.7	36.9	12.5	26.1	9.4	31.0	31.0	25.4	32.2	22.8	27.1	2.0	1.5	2.2	8.2	0.4	2.6	0.8	12.6	5.7	10.7	5.2	12.6	10.7	10.4	11.9	15.0	13.8	12.1	3.7	7.0	29.8	6.1	18.4	20.2	9.0	16.1	15.2	22.2	4.9	4.4	9.0	7.9	13.0	13.9	8.1	9.3	18.1	10.5	15.5	15.9	3.4	27.7	12.4	6.0	14.0	7.8	11.1	7.6	9.5	6.2	12.0	19.8	13.1	11.6	4.9	9.2	9.4	6.2	4.8	7.1	13.7	14.2	6.5	4.9	10.5	30.1	16.3	23.0	12.4	11.9	8.4	0.1	2.6	1.2	1.2	4.6	1.6	1.4	1.3	1.9	1.5	2.0	0.7	1.2	2.2	0.4	8.2	1.2	2.6	0.8	8.5	9.8	9.9	9.0	7.9	8.1	10.0	5.3	8.6	9.4
MBD3		ENSG00000071655	"Methyl-CpG binding domain protein 3"	O95983	19	1573596-1592801	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013265	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB013265: "	"unprognostic (1.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.44e-2)"	"prognostic favourable (5.08e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (2.99e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (1.76e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	19.4	14.8	27.3	18.2	21.0	19.9	19.7	18.9	25.1	11.8	14.9	12.7	18.8	17.1	14.4	12.0	14.8	13.4	18.3	21.5	26.5	16.5	17.2	19.1	13.1	18.2	18.2	16.9	17.2	25.4	17.7	18.1	27.3	13.1	19.5	7.5	12.5	28.0	17.1	41.4	28.5	14.5	11.4	14.9	18.3	14.1	21.1	11.0	23.9	17.2	14.3	15.4	12.3	26.8	3.1	7.0	2.3	3.7	1.2	3.7	2.0	28.0	31.9	13.4	22.9	11.0	9.6	19.9	17.3	10.5	18.5	17.3	29.7	12.8	28.3	13.6	12.6	23.3	14.9	16.7	4.9	37.9	30.7	16.6	34.4	22.0	15.9	21.2	23.6	13.7	14.2	17.9	8.2	16.9	30.5	24.2	9.1	31.9	25.4	29.4	22.3	21.0	30.4	16.6	21.2	9.3	27.2	37.5	30.4	17.2	15.2	12.9	16.9	26.2	16.8	26.0	19.0	38.6	40.9	23.6	19.6	25.9	21.1	29.6	26.6	1.2	3.7	2.3	3.7	2.0	3.3	1.6	3.0	2.0	3.4	3.1	3.3	2.8	1.5	1.2	1.7	7.0	0.7	2.0	27.3	21.0	18.9	25.1	26.5	16.5	18.2	16.9	13.1	11.0
MBD4	MED1	ENSG00000129071	"Methyl-CpG binding domain 4, DNA glycosylase"	O95243	3	129430944-129440179	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002031	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA002031: AB_1079319"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavourable (2.18e-4)"	"prognostic unfavourable (4.75e-4)"	"prognostic unfavourable (2.73e-6)"	"unprognostic (9.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.35e-2)"	18.1	14.5	14.9	41.9	19.0	26.2	22.8	22.1	16.3	24.0	17.2	14.2	11.2	16.0	16.6	17.8	14.1	15.3	17.4	22.0	15.3	12.8	24.1	30.1	19.0	41.6	17.6	13.7	26.5	18.9	14.8	23.8	17.4	13.6	14.7	16.2	8.4	16.2	16.2	18.2	16.0	21.9	14.7	15.9	34.2	18.7	11.3	15.4	30.4	16.0	14.7	47.8	18.3	18.0	40.3	8.7	19.6	9.5	9.3	15.1	8.7	19.3	11.8	14.3	16.0	16.5	14.8	16.6	16.8	16.0	16.1	19.3	14.4	13.1	27.4	13.7	10.4	17.6	10.9	10.4	19.7	15.4	7.2	16.4	13.5	10.3	26.4	29.8	21.8	17.6	14.9	13.7	12.2	15.2	18.2	20.7	11.9	18.0	17.2	21.0	12.6	10.1	16.2	8.5	18.8	17.9	9.7	16.1	9.0	21.2	11.1	17.6	14.1	26.5	10.0	15.4	11.8	16.4	11.1	14.1	8.5	48.0	13.1	17.0	12.6	19.6	8.7	11.6	11.5	7.8	8.7	40.3	12.3	11.3	7.3	36.0	15.1	12.6	15.4	9.3	9.5	8.7	10.5	8.7	14.9	19.0	22.1	16.3	15.3	12.8	17.6	13.7	13.6	15.4
MBD5	"FLJ11113, KIAA1461"	ENSG00000204406	"Methyl-CpG binding domain protein 5"	Q9P267	2	148021011-148516971	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035964			Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA035964: "	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.82e-1)"	8.5	11.3	13.9	14.1	13.7	6.8	9.0	26.1	14.7	13.7	16.3	10.1	8.9	7.2	12.6	8.7	9.9	9.6	13.4	10.3	11.7	10.6	13.7	6.9	8.2	8.7	9.3	9.9	14.2	5.7	25.5	24.7	10.4	11.3	11.5	8.1	10.8	7.5	11.6	9.9	6.6	8.2	15.7	11.8	9.8	9.1	11.0	12.5	17.3	12.8	6.0	8.6	15.1	10.1	1.3	1.1	3.6	1.2	1.0	2.2	0.7	1.4	1.5	9.0	6.5	6.5	7.4	4.0	6.7	7.3	4.5	3.8	3.4	4.5	2.5	1.7	5.7	1.0	4.7	7.4	6.4	2.2	2.2	5.4	4.9	1.7	2.7	0.7	0.8	5.6	6.5	6.0	4.0	7.5	2.0	6.1	7.6	3.4	2.9	3.9	3.0	2.4	2.9	1.5	0.9	6.0	7.2	5.2	7.3	4.3	2.3	4.5	2.9	4.5	5.5	5.3	2.2	0.7	2.8	4.4	1.7	2.2	9.0	2.5	6.1	3.6	0.4	1.9	1.6	0.3	1.1	0.7	1.8	1.5	0.9	1.3	1.4	2.2	0.6	1.0	1.2	1.1	0.6	0.7	13.9	13.7	26.1	14.7	11.7	10.6	9.3	9.9	11.3	12.5
MBD6	KIAA1887	ENSG00000166987	"Methyl-CpG binding domain protein 6"	Q96DN6	12	57520710-57530148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 14.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038948, HPA038949"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA038948: , HPA038949: AB_10671868"	"unprognostic (2.56e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.01e-2)"	16.0	21.1	15.2	22.1	18.4	35.0	18.7	20.2	15.2	22.3	22.1	19.6	35.2	27.9	24.9	22.6	18.0	21.7	25.2	13.1	15.2	7.6	21.0	21.6	17.6	16.3	18.0	11.1	24.3	22.4	24.2	60.6	35.1	14.0	19.9	14.3	34.8	23.7	37.0	22.5	25.1	22.8	14.6	16.1	34.4	28.6	31.1	18.7	16.1	48.2	14.0	21.9	19.0	20.3	1.4	0.5	14.7	1.1	0.7	1.3	0.6	8.5	12.2	9.5	10.2	6.6	4.7	13.4	9.9	6.0	6.4	4.8	12.6	13.7	8.7	7.7	5.3	12.1	8.7	7.4	4.6	17.1	8.7	15.2	11.9	8.6	8.0	9.1	39.5	8.2	13.1	6.9	9.8	8.5	9.6	23.0	5.1	8.9	9.3	9.1	9.1	9.0	9.3	46.0	6.5	5.5	17.0	13.2	8.0	7.9	15.9	9.7	17.8	14.6	8.4	7.1	11.7	7.2	6.6	24.0	8.0	5.9	9.2	5.7	11.9	0.0	1.1	0.4	1.3	0.9	0.6	1.4	0.2	0.4	0.5	1.0	0.6	0.6	14.7	0.7	0.4	0.4	0.2	0.6	15.2	18.4	20.2	15.2	15.2	7.6	18.0	11.1	14.0	18.7
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298558-36320676	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	10.4	11.7	11.4	5.7	17.0	15.4	12.9	16.4	14.9	15.4	12.2	11.5	3.6	8.6	14.0	11.3	14.0	9.1	8.6	7.2	10.7	13.0	19.5	15.0	46.2	8.1	9.9	8.9	20.0	9.0	10.4	25.1	9.8	13.3	13.8	11.7	10.1	7.7	8.9	6.0	14.3	13.2	11.0	13.6	9.8	19.0	8.8	11.8	14.4	61.2	4.0	7.9	12.4	9.3	12.0	10.4	5.1	9.3	8.3	17.9	9.6	16.5	8.7	18.5	18.6	18.6	18.0	14.0	14.2	17.7	18.8	19.8	17.7	16.6	15.7	21.7	18.2	12.6	19.4	13.1	23.2	22.6	14.6	9.2	8.6	30.0	20.3	18.7	10.2	18.4	20.2	12.2	15.9	11.7	15.6	19.6	13.8	15.9	17.9	15.2	15.6	25.8	8.6	16.2	10.9	21.2	12.8	27.7	11.0	11.6	11.3	18.7	18.4	12.2	9.1	21.0	13.7	15.3	14.6	16.3	18.7	24.5	8.0	9.6	14.5	1.4	9.3	2.0	11.2	6.8	14.1	12.0	13.7	13.8	9.2	8.7	17.9	14.5	5.1	8.3	5.3	10.4	16.1	9.6	11.4	17.0	16.4	14.9	10.7	13.0	9.9	8.9	13.3	11.8
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: "	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	55.9	17.5	14.5	50.8	17.0	28.5	43.8	11.8	14.5	46.4	44.0	10.8	18.0	15.2	41.1	23.6	33.3	22.3	27.5	29.9	14.3	12.9	18.6	16.5	39.6	45.6	18.0	9.1	30.5	12.5	12.5	16.0	10.4	12.6	30.5	26.0	12.7	18.3	25.1	87.6	22.8	29.5	59.8	22.1	39.6	23.1	14.6	17.4	71.9	18.5	34.5	46.0	64.4	29.3	25.0	30.7	38.2	27.4	33.6	39.9	40.2	27.7	22.9	3.7	8.4	29.5	30.5	2.7	34.8	28.3	23.0	19.4	10.1	16.3	28.6	17.8	48.9	12.8	6.9	20.1	34.1	22.2	9.4	31.2	11.6	4.7	16.5	37.3	22.8	14.2	10.9	26.5	20.7	47.2	15.8	39.0	22.3	9.6	34.7	13.7	1.5	18.4	35.5	11.5	35.8	11.6	14.0	3.0	3.4	15.1	8.2	14.7	11.4	56.9	39.6	31.6	12.1	20.9	30.0	40.8	23.3	32.9	18.4	46.6	17.0	32.6	22.7	38.2	37.2	27.4	39.9	25.0	30.5	30.9	30.7	24.1	38.9	33.3	35.4	33.6	22.8	11.1	27.0	40.2	14.5	17.0	11.8	14.5	14.3	12.9	18.0	9.1	12.6	17.4
MBNL2	"MBLL, MBLL39"	ENSG00000139793	"Muscleblind like splicing regulator 2"	Q5VZF2	13	97221434-97394120	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062685			Supported	Nucleoplasm				Nucleoplasm		"HPA062685: "	"unprognostic (8.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.17e-2)"	38.4	43.3	26.5	12.9	38.6	5.0	23.2	31.2	41.0	27.8	21.6	45.9	9.5	13.8	23.9	11.2	25.6	14.8	29.7	23.4	31.0	22.6	24.6	59.6	19.3	12.3	46.5	22.4	40.8	28.9	16.9	35.9	33.5	49.8	21.8	16.4	16.6	24.6	27.0	28.9	13.3	12.2	27.4	52.3	12.4	19.0	9.7	46.9	11.1	24.2	17.2	15.3	25.6	28.0	9.2	6.5	13.3	8.4	5.5	12.9	7.1	10.8	3.8	4.2	4.4	23.5	12.4	0.3	24.9	12.6	11.6	11.8	4.4	16.2	3.6	10.4	34.4	15.4	1.9	11.0	15.1	9.7	1.9	4.5	8.8	11.0	34.6	0.5	4.0	12.7	18.8	9.4	18.3	21.9	5.5	2.0	5.8	2.7	2.5	1.5	0.1	6.6	1.2	9.2	3.1	15.4	12.3	5.4	9.3	14.3	14.8	24.7	6.0	0.6	6.9	1.7	5.4	3.2	5.2	5.3	1.3	1.0	11.1	1.3	30.6	13.3	6.2	8.9	10.1	8.4	12.9	9.2	9.2	9.0	6.5	7.6	8.1	10.8	1.0	5.5	5.8	5.5	9.6	7.1	26.5	38.6	31.2	41.0	31.0	22.6	46.5	22.4	49.8	46.9
MBOAT4	"FKSG89, GOAT, OACT4"	ENSG00000177669	"Membrane bound O-acyltransferase domain containing 4"	Q96T53	8	30131824-30144686	"Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 23.9;stomach 1: 7.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;Hep G2: 8.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044509			Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA044509: "	"unprognostic (4.35e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-6)"	"unprognostic (9.87e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.66e-2)"	0.4	1.8	0.3	0.5	0.6	1.0	0.3	0.3	0.3	0.3	0.5	0.3	0.3	0.8	0.9	0.3	0.3	3.9	2.1	0.4	0.3	0.1	0.4	1.5	0.9	0.8	0.3	0.3	0.5	23.9	0.0	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	1.3	0.3	0.3	1.4	7.7	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.8	0.7	2.6	1.5	2.8	4.1	0.6	0.5	1.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	2.2	0.0	0.4	0.0	0.1	0.0	0.6	0.4	0.4	0.1	8.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.1	0.6	0.3	0.0	0.0	0.3	0.2	0.0	0.1	0.2	0.2	0.8	0.0	0.1	0.0	0.2	0.2	0.0	0.2	1.5	0.0	0.2	0.1	0.0	0.0	1.3	0.9	0.4	0.6	0.6	2.1	0.5	1.5	2.4	0.0	1.6	2.0	0.7	1.8	2.4	4.1	2.6	2.8	0.2	0.4	0.5	0.6	0.3	0.6	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3
MCAT	"fabD, FASN2C, MCT, MCT1, MT, NET62"	ENSG00000100294	"Malonyl-CoA-acyl carrier protein transacylase"	Q8IVS2	22	43132206-43143394	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003122, HPA035471"	Approved		Supported	Mitochondria				Mitochondria		"HPA003122: , HPA035471: AB_10670590"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-2)"	"prognostic favourable (5.53e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.86e-2)"	"prognostic favourable (2.18e-4)"	"prognostic favourable (3.89e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-1)"	10.4	18.2	13.3	8.2	17.2	11.0	12.8	10.4	24.6	10.6	11.9	9.4	10.7	9.5	11.0	17.2	12.3	20.7	21.4	12.9	14.4	14.2	25.6	24.3	8.6	7.1	12.0	12.0	14.4	16.2	20.3	14.3	9.2	15.1	12.8	10.6	9.9	14.5	10.2	17.7	11.7	9.7	8.6	6.0	7.6	12.1	19.6	5.2	18.4	20.1	14.0	9.9	8.5	8.1	10.2	13.9	2.5	9.5	11.6	10.3	5.6	7.1	9.4	6.7	11.7	5.6	6.0	6.8	8.0	7.1	10.8	10.1	9.4	7.3	12.0	8.3	5.9	12.0	12.6	10.6	8.1	4.1	37.3	4.5	10.8	10.4	9.0	21.3	5.4	4.5	10.3	10.5	8.4	7.7	10.5	4.9	5.2	13.2	9.9	23.2	6.4	16.7	13.2	6.6	19.0	13.5	6.2	8.8	4.7	8.6	16.8	12.1	8.7	13.8	4.6	4.7	9.3	10.2	11.2	8.8	9.0	8.6	10.1	8.1	5.6	0.0	9.5	0.7	7.7	9.1	10.3	8.3	8.6	10.1	13.9	10.2	10.1	7.1	2.5	11.6	5.5	13.7	5.5	5.6	13.3	17.2	10.4	24.6	14.4	14.2	12.0	12.0	15.1	5.2
MCC		ENSG00000171444	"Mutated in colorectal cancers"	P23508	5	113022099-113488830	"Predicted intracellular proteins"	"Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 49.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 27.7;hTCEpi: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA037390, HPA037391"	Approved	Approved	Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				"Nucleoplasm, Cytosol"	"Cytoplasmic bodies"	"HPA037390: AB_2675451, HPA037391: AB_10671248"	"unprognostic (6.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.70e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.90e-1)"	7.1	2.3	6.9	3.2	6.1	0.5	7.8	11.4	8.1	11.8	3.2	3.4	5.9	1.7	12.5	4.7	9.1	7.4	4.4	8.4	9.2	5.0	3.9	12.7	4.6	3.0	7.6	5.1	49.4	4.5	28.9	5.2	7.1	7.8	7.7	2.4	15.1	6.7	9.5	5.0	13.9	2.6	9.1	5.8	3.4	3.6	6.5	5.2	1.3	3.2	6.1	4.3	9.3	11.8	0.2	6.3	1.3	0.2	0.1	1.6	0.1	0.4	0.1	7.0	0.6	6.1	5.7	7.8	1.1	3.1	1.3	1.6	0.2	6.4	0.0	7.5	0.5	8.6	4.3	27.7	0.6	2.2	2.6	0.0	2.4	1.8	1.8	0.3	0.1	7.6	18.6	3.5	13.2	8.2	0.0	10.5	2.9	0.6	0.1	0.1	3.8	0.5	0.1	6.1	1.9	0.1	17.3	3.1	6.7	5.7	0.0	15.2	2.3	0.0	9.8	4.8	4.5	7.5	2.1	3.0	0.0	0.0	12.9	0.0	5.1	0.0	0.2	0.1	0.5	0.2	1.6	0.2	0.5	0.6	0.0	0.2	0.4	0.5	1.3	0.1	0.1	6.3	1.5	0.1	6.9	6.1	11.4	8.1	9.2	5.0	7.6	5.1	7.8	5.2
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favourable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	25.1	26.0	14.1	10.4	16.4	9.0	24.6	23.1	20.6	9.0	12.6	15.1	10.1	12.6	11.0	11.4	15.8	9.5	11.6	24.4	12.2	10.1	42.4	41.1	13.8	8.0	17.0	14.4	12.8	32.3	10.2	15.8	5.5	13.4	11.4	13.7	9.9	14.2	15.6	19.4	11.5	10.1	11.3	10.5	8.3	17.7	8.9	16.4	8.9	14.0	8.5	13.2	23.2	9.5	13.1	19.4	17.1	11.3	18.9	11.6	7.6	14.1	5.4	3.4	3.6	15.0	6.8	6.9	6.5	9.1	7.2	8.2	7.4	5.7	15.6	10.6	5.7	7.3	5.2	4.3	9.2	5.2	5.8	13.3	6.2	7.8	9.9	8.9	7.6	7.7	4.9	3.4	7.7	9.6	7.3	8.2	8.0	11.6	8.6	4.4	3.8	5.9	7.2	7.7	20.0	10.5	22.5	7.7	5.6	24.9	34.4	7.0	52.6	12.5	4.6	5.5	4.4	4.4	9.6	8.4	15.4	15.8	6.0	12.8	5.1	8.5	9.7	17.1	8.3	11.3	9.4	13.1	10.8	9.0	19.4	11.1	11.6	10.4	1.6	18.9	11.2	12.7	6.8	7.6	14.1	16.4	23.1	20.6	12.2	10.1	17.0	14.4	13.4	16.4
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 74.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favourable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favourable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	12.4	29.4	9.2	11.8	13.6	2.7	30.5	7.9	10.0	11.2	15.3	12.2	15.1	13.0	9.7	20.0	14.5	9.1	12.3	74.3	7.6	8.1	35.6	61.9	8.4	11.6	7.8	8.0	9.6	18.9	14.1	10.3	15.1	13.4	24.6	18.1	12.8	20.6	29.4	17.6	10.8	14.1	7.8	17.0	11.0	13.6	6.9	6.9	9.4	22.2	13.3	14.3	15.7	8.5	8.8	16.7	1.7	11.5	12.9	10.2	6.7	11.8	16.3	7.0	26.9	7.5	7.8	12.0	5.6	9.5	11.7	8.5	28.7	15.1	27.5	20.9	8.2	9.8	12.2	18.9	14.7	14.5	15.6	14.9	8.5	31.5	13.2	7.4	14.2	9.9	9.9	10.7	8.5	10.3	18.8	10.3	8.1	32.3	0.1	13.5	9.2	9.2	14.4	20.2	40.4	30.4	21.4	11.1	12.3	24.7	36.7	12.0	30.4	18.8	7.5	4.8	7.4	8.6	15.2	7.4	13.7	17.0	7.8	20.6	11.8	1.7	7.4	1.6	6.1	11.5	7.9	8.8	7.9	6.9	16.7	8.6	8.0	8.7	1.2	12.9	6.8	7.4	10.2	6.7	9.2	13.6	7.9	10.0	7.6	8.1	7.8	8.0	13.4	6.9
MCIDAS	"IDAS, MCI, MCIN"	ENSG00000234602	"Multiciliate differentiation and DNA synthesis associated cell cycle protein"	D6RGH6	5	55219614-55227315	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	Activator	"Ciliopathy, Disease mutation, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 2.6;stomach 1: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;CACO-2: 5.8;HEK 293: 4.8;U-2 OS: 3.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA049981, HPA058073"	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA049981: , HPA058073: "	"unprognostic (3.11e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.90e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.70e-2)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0		0.0	2.6	0.5	0.1	0.0		0.3	0.0		0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7			1.0		0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.5	5.8	2.7	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.1	4.8	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.2	0.9	0.1	0.0	0.5	0.5	0.0	1.8	0.0	1.6	2.1	0.6	0.0	0.0	3.4	0.6	0.2	1.9	2.4	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1, BCL2 family apoptosis regulator"	Q07820	1	150574551-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 328.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Approved		Enhanced	Mitochondria				Mitochondria		"CAB002781: , CAB068195: , HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	67.7	37.1	19.0	59.3	21.6	134.5	46.3	15.3	18.9	35.9	38.5	19.0	23.9	21.2	36.1	27.6	56.5	57.2	73.3	32.5	20.4	14.9	30.5	76.7	61.8	52.4	28.2	11.4	32.1	41.9	20.3	27.7	59.4	26.7	34.0	30.7	31.0	36.0	24.5	39.8	45.7	50.2	38.9	26.4	51.1	44.3	19.8	23.0	32.3	45.4	53.3	57.4	40.6	59.4	5.0	6.2	42.1	8.0	3.8	11.1	3.9	9.8	5.0	9.4	5.6	19.1	20.2	12.9	12.1	12.4	12.7	10.3	6.3	8.1	12.5	7.1	8.6	13.2	7.1	14.4	12.8	10.3	4.9	5.1	8.1	7.2	15.1	8.6	11.6	11.0	16.6	12.4	24.2	13.9	11.4	18.2	16.6	10.8	4.2	6.6	17.4	8.9	6.5	7.6	6.5	14.0	7.1	7.3	9.9	8.6	11.7	15.5	7.4	13.3	17.1	8.1	8.5	5.1	15.1	23.3	27.3	328.0	13.9	6.8	10.6	7.6	8.0	18.8	6.1	6.5	7.2	5.0	8.0	6.7	6.2	4.6	9.6	7.2	42.1	3.8	5.8	3.7	11.1	3.9	19.0	21.6	15.3	18.9	20.4	14.9	28.2	11.4	26.7	23.0
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161554-13211104	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 31.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: "	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	3.0	0.5	0.3	5.6	0.3	10.8	2.1	0.3	0.5	1.4	2.6	0.4	0.3	1.8	1.1	0.6	5.9	0.2	0.7	0.7	0.3	0.3	0.6	0.9	1.4	6.0	0.3	0.6	0.7	0.3	0.3	0.4	3.6	0.5	0.6	2.9	0.4	1.1	0.3	1.5	1.3	1.8	0.9	0.7	2.9	1.1	4.3	0.3	31.4	0.9	3.3	6.9	0.9	1.8	0.5	1.0	1.5	0.4	0.8	3.4	1.5	13.5	15.3	18.2	13.7	0.6	1.1	7.9	14.2	2.2	16.0	16.7	14.9	9.7	20.4	6.5	3.6	15.9	25.5	8.3	14.8	10.6	12.1	25.5	6.8	9.9	0.0	13.0	11.6	0.2	0.3	16.2	1.5	5.2	30.0	14.0	8.6	12.2	30.9	5.6	10.7	3.8	24.5	16.1	12.6	3.6	5.0	3.6	13.8	11.5	8.2	2.1	10.3	9.0	3.1	10.2	19.2	15.3	15.3	4.4	16.9	26.9	6.5	14.4	7.9	0.2	0.3	0.2	1.1	0.1	0.2	0.5	1.6	3.4	1.0	0.4	0.4	2.8	1.5	0.8	0.4	0.2	1.6	1.5	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.6	0.5	0.3
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598223-127622436	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 69.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000303, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm			8600	Nucleoplasm		"CAB000303: AB_322519, HPA031495: AB_2673904, HPA031496: "	"unprognostic (2.43e-1)"	"prognostic favourable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	2.9	3.7	2.1	24.3	4.0	32.5	3.5	6.7	3.2	4.7	7.1	3.3	2.2	4.7	4.7	5.9	11.2	4.8	5.4	3.6	2.0	2.3	3.9	3.4	3.4	14.6	2.2	3.5	5.1	3.0	2.4	2.4	26.4	3.0	3.2	6.0	2.5	4.7	1.9	7.0	6.0	7.1	2.9	2.9	13.3	3.8	20.3	3.9	69.9	4.1	16.6	20.7	3.4	5.1	10.4	3.6	0.9	1.4	5.8	10.6	3.4	24.8	21.2	23.2	20.3	1.4	3.0	22.7	13.1	8.4	26.3	28.7	35.1	16.5	26.8	12.8	6.4	20.0	41.5	15.0	16.4	22.1	25.9	44.3	28.4	25.5	0.9	41.4	19.4	1.6	1.7	17.8	2.7	8.2	22.1	24.6	9.6	33.0	38.3	30.4	34.0	18.7	43.1	33.3	38.4	5.4	19.3	28.9	21.9	33.5	10.0	3.4	21.4	32.5	4.2	20.5	17.5	25.2	17.6	25.5	28.9	66.6	14.2	31.4	7.8	0.0	0.6	0.2	4.7	1.4	5.9	10.4	4.1	5.5	2.8	9.2	3.9	5.0	0.9	5.8	0.3	3.6	10.6	3.4	2.1	4.0	6.7	3.2	2.0	2.3	2.2	3.5	3.0	3.9
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264009-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 82.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Enhanced	Nucleoplasm			29000	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (3.13e-5)"	"unprognostic (1.34e-2)"	17.3	10.9	8.5	29.7	10.5	22.3	15.3	10.7	9.7	15.9	17.2	9.5	20.2	9.0	21.2	13.0	21.7	15.5	15.8	15.4	7.4	6.6	16.1	12.6	13.7	30.1	8.9	5.8	20.0	13.8	16.0	7.4	24.7	10.0	15.9	19.2	12.7	12.6	23.4	12.1	15.0	17.8	17.7	9.5	23.2	15.3	16.1	10.5	82.5	12.9	20.1	35.7	19.1	15.3	21.1	12.9	11.4	13.3	22.2	29.4	18.6	30.2	20.1	35.1	33.1	7.6	6.9	23.1	22.5	17.3	38.4	39.5	41.2	16.5	33.1	22.6	13.1	24.1	46.3	27.5	38.9	37.2	43.8	62.5	40.5	58.0	2.0	61.3	25.6	4.1	6.4	28.2	7.9	19.6	50.8	76.3	19.8	20.0	61.7	47.4	29.1	14.2	54.8	53.8	44.2	17.0	32.2	35.7	27.3	23.6	13.6	20.4	26.8	43.5	10.0	26.3	28.3	27.1	33.6	22.6	25.8	58.9	22.6	53.2	30.7	11.1	8.0	11.4	22.9	13.3	19.7	21.1	23.3	23.0	12.9	19.2	22.6	24.0	1.1	22.2	7.4	8.3	29.4	18.6	8.5	10.5	10.7	9.7	7.4	6.6	8.9	5.8	10.0	10.5
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235126-46286297	"Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: "	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	19.4	16.7	14.2	21.5	25.3	19.5	19.0	26.6	29.2	18.3	17.2	27.7	19.3	15.4	24.8	18.0	18.1	21.1	16.3	17.9	14.4	13.2	15.5	13.3	18.2	21.9	16.5	14.6	23.7	17.5	25.7	20.6	18.2	18.2	17.7	17.6	21.3	22.1	21.4	52.9	18.2	19.9	19.5	15.1	20.7	18.7	15.7	15.7	31.8	19.6	15.7	26.0	21.1	16.4	4.8	4.8	3.8	4.9	3.0	6.9	4.1	15.7	15.6	18.2	19.7	15.0	18.7	16.6	17.4	21.4	16.6	13.4	14.1	9.4	22.5	14.4	18.4	9.4	24.0	14.6	14.5	23.0	21.8	36.9	14.9	11.1	13.5	16.7	20.9	14.5	12.7	22.5	15.6	17.5	43.9	17.2	19.0	9.0	17.9	11.3	31.3	13.0	23.3	11.5	20.3	8.1	14.6	15.4	16.4	22.2	14.7	17.0	20.1	17.4	22.1	17.3	13.2	14.3	13.0	31.4	34.7	14.0	15.6	16.2	22.4	1.5	4.7	3.8	6.1	4.9	6.5	2.9	3.7	6.9	4.8	4.8	3.3	3.4	2.9	3.0	2.7	4.2	4.4	4.1	14.2	25.3	26.6	29.2	14.4	13.2	16.5	14.6	18.2	15.7
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: "	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favourable (2.19e-4)"	"prognostic unfavourable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	4.9	8.7	6.7	18.4	12.6	33.1	9.3	13.9	14.8	6.7	11.9	6.9	3.6	8.3	4.7	7.8	21.6	5.9	6.8	8.3	6.6	7.1	8.0	6.6	4.4	20.3	5.9	7.7	5.3	5.5	4.3	4.1	29.2	7.7	4.2	13.2	5.3	9.0	3.1	8.7	16.2	10.3	5.9	6.4	10.1	6.3	39.0	4.1	56.6	4.0	21.8	23.7	8.0	9.5	5.1	4.9	3.4	4.3	4.9	12.9	4.5	34.1	21.2	39.4	14.4	3.9	6.8	17.4	26.0	17.1	32.8	37.2	22.5	31.0	37.0	14.6	12.9	25.2	49.6	21.1	37.1	11.6	32.8	63.4	25.5	24.9	1.0	33.8	13.9	4.1	4.2	26.1	9.3	11.5	34.9	30.8	22.6	21.1	74.8	24.7	42.7	9.2	47.6	30.9	24.1	11.9	30.6	37.8	18.2	52.7	22.0	7.8	26.3	17.8	7.7	25.1	24.4	28.1	23.8	10.1	24.2	75.5	20.1	31.4	22.4	3.4	2.1	1.5	5.5	3.7	2.7	5.1	5.0	6.8	4.9	2.1	4.6	3.4	0.1	4.9	4.3	1.7	12.9	4.5	6.7	12.6	13.9	14.8	6.6	7.1	5.9	7.7	7.7	4.1
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400063-35425430	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.0;lymphoid tissue: 60.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: "	"unprognostic (6.71e-2)"	"prognostic favourable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (1.78e-4)"	"prognostic unfavourable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	12.1	4.9	6.1	27.5	9.0	57.0	9.1	6.7	5.7	10.4	11.5	12.3	5.0	9.5	10.8	10.8	15.8	8.7	9.4	5.2	4.4	3.4	6.8	8.0	9.3	31.1	8.8	3.7	17.9	10.8	6.2	3.6	19.3	5.8	7.2	8.3	6.5	8.9	5.1	8.8	10.3	16.7	6.0	7.8	31.2	8.4	16.4	8.8	60.6	9.0	17.7	33.0	8.7	9.6	46.8	30.9	19.0	26.0	21.3	32.9	24.0	38.9	28.3	22.4	22.8	2.1	4.4	19.6	26.0	13.8	38.9	37.0	18.8	19.4	25.8	15.1	13.2	19.4	22.3	20.6	12.5	20.8	41.0	36.8	28.4	37.5	0.7	75.9	33.3	2.4	1.9	23.2	6.3	17.2	22.7	38.6	14.7	32.1	61.8	25.3	29.7	16.8	70.0	31.7	32.5	7.7	22.6	17.3	18.4	35.8	14.4	8.0	15.0	29.0	10.1	39.3	29.9	24.4	26.8	21.5	26.4	48.5	25.4	28.7	30.0	19.0	20.7	14.5	18.4	24.1	13.1	46.8	16.1	19.4	27.1	37.0	13.1	14.8	9.9	21.3	26.0	30.9	32.9	24.0	6.1	9.0	6.7	5.7	4.4	3.4	8.8	3.7	5.8	8.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876426	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 66.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavourable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	11.3	6.3	7.2	17.7	8.4	23.1	9.5	12.3	9.4	9.1	11.9	5.1	2.9	8.7	10.4	8.8	12.6	8.7	7.6	6.0	5.0	5.5	6.8	7.0	8.5	23.9	4.9	8.0	10.9	4.3	6.2	3.4	10.9	5.9	8.6	12.2	6.2	6.9	6.7	8.2	8.9	16.7	10.4	7.2	14.1	8.0	13.2	3.7	66.3	5.1	11.4	27.5	10.8	9.8	5.5	9.4	5.3	4.0	7.0	13.9	5.6	23.0	14.2	31.0	19.7	6.7	8.7	12.2	16.8	12.8	19.6	21.9	29.0	17.7	40.4	12.4	12.2	13.7	31.3	15.4	21.0	20.7	21.6	40.1	21.1	9.1	3.1	48.1	17.9	5.1	2.0	14.3	4.4	13.3	28.6	34.2	14.4	23.6	58.7	35.4	27.9	14.3	29.1	37.1	37.0	9.8	20.4	19.5	16.6	22.2	10.6	10.6	12.2	30.3	6.5	13.7	11.4	14.7	12.7	20.5	33.4	53.2	19.1	36.8	16.2	5.3	1.4	0.9	7.6	4.0	7.1	5.5	10.5	9.2	4.6	3.2	9.6	11.8	0.8	7.0	3.6	9.4	13.9	5.6	7.2	8.4	12.3	9.4	5.0	5.5	4.9	8.0	5.9	3.7
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favourable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	8.6	5.2	17.5	13.6	21.7	37.3	11.2	20.0	20.6	8.2	14.2	19.2	15.0	10.4	16.0	6.3	10.7	8.6	9.9	5.1	18.1	12.4	5.5	8.5	7.4	22.4	23.7	9.5	12.6	13.1	7.5	10.3	10.7	15.5	10.0	15.7	7.2	9.2	9.2	11.5	10.1	10.3	11.7	23.5	10.7	7.8	14.9	22.3	7.5	9.4	4.1	28.2	10.3	10.0	7.3	5.7	1.9	5.7	7.6	9.0	6.0	24.5	28.4	31.3	23.6	3.0	4.0	16.0	14.9	18.1	41.7	44.5	21.6	25.9	41.6	14.3	10.6	19.4	45.9	21.7	35.3	21.3	39.3	26.5	15.9	14.9	1.6	44.9	17.2	2.8	4.1	30.6	18.4	15.8	50.6	34.1	21.1	52.4	76.3	18.4	27.4	20.5	41.1	45.9	50.7	8.1	14.9	20.5	31.2	23.6	21.9	7.4	10.1	18.8	6.7	15.8	28.6	30.8	29.6	14.3	24.3	74.8	10.9	36.1	28.1	1.8	2.5	1.9	8.1	4.1	6.2	5.3	5.7	7.9	5.5	7.3	5.9	5.7	1.6	7.6	5.7	5.7	9.0	6.0	17.5	21.7	20.0	20.6	18.1	12.4	23.7	9.5	15.5	22.3
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045141, HPA066433"			Supported	Nucleoplasm				Nucleoplasm		"HPA045141: , HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavourable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	4.9	5.4	7.3	11.0	7.6	11.2	9.3	17.9	12.7	5.4	6.2	3.1	12.0	5.4	5.9	3.9	6.6	4.3	2.7	11.3	4.8	2.2	4.3	3.1	6.3	9.6	10.6	5.1	5.0	5.6	5.1	4.8	5.4	7.1	5.9	6.0	3.5	5.1	7.2	11.2	6.1	6.1	7.0	8.3	6.1	5.6	21.9	7.7	8.8	4.4	7.0	9.5	6.0	6.1	1.8	1.7	3.3	0.7	1.9	3.0	0.4	18.9	14.8	12.8	12.9	3.4	4.1	11.3	15.6	6.3	12.2	14.7	16.2	12.0	19.4	4.7	5.2	20.4	21.2	12.3	22.1	5.3	8.7	21.4	7.1	15.7	0.5	22.5	3.3	1.9	2.0	20.6	8.5	5.7	21.8	19.1	12.5	5.3	11.6	11.8	17.1	8.7	14.2	21.7	7.8	3.1	7.6	9.5	10.1	15.9	17.7	9.5	11.4	8.0	3.8	21.7	18.1	11.7	22.6	8.2	20.5	32.9	4.4	14.6	17.8	3.3	0.5	1.7	1.8	0.5	3.0	1.8	1.1	2.1	0.1	1.7	1.1	1.7	2.1	1.9	0.7	1.7	2.0	0.4	7.3	7.6	17.9	12.7	4.8	2.2	10.6	5.1	7.1	7.7
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"				Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavourable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	33.6	15.3	11.7	23.2	13.8	14.6	35.5	17.2	13.8	27.0	26.3	16.9	11.4	15.5	28.0	14.9	26.4	23.0	18.7	26.3	12.0	10.2	18.7	23.7	28.5	38.6	17.4	8.5	29.2	18.2	23.2	17.6	35.4	14.2	22.5	21.4	15.7	21.0	17.4	30.1	23.8	20.7	26.0	16.8	26.0	20.7	15.4	15.5	38.0	24.5	28.2	24.7	32.5	28.6	4.5	6.9	12.1	9.7	4.1	5.1	2.4	30.4	21.6	30.4	21.0	15.4	18.9	17.8	28.2	31.0	36.0	37.3	28.2	24.9	35.5	13.0	22.5	28.4	36.2	28.4	42.2	26.0	26.8	18.2	17.2	21.6	23.9	33.6	44.1	15.5	16.1	32.6	42.9	24.6	16.8	26.8	23.5	22.6	42.2	20.3	15.3	15.7	26.6	58.8	18.1	15.4	20.9	13.1	16.9	20.6	17.2	23.6	11.6	24.0	19.0	17.7	17.4	18.0	33.6	19.3	21.5	39.3	21.1	22.6	10.8	12.1	5.3	3.6	4.2	9.7	5.1	4.5	3.9	4.4	6.9	1.8	4.2	3.8	6.4	4.1	6.1	3.5	3.9	2.4	11.7	13.8	17.2	13.8	12.0	10.2	17.4	8.5	14.2	15.5
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522626-7534009	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 30.9;monocytes: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	18.9	27.5	10.1	10.3	11.9	10.0	10.3	8.2	19.7	7.7	9.6	11.2	7.2	9.6	8.8	9.5	11.2	8.4	11.7	11.7	9.0	9.2	11.5	20.6	17.9	20.6	10.6	10.0	7.8	10.5	9.8	26.0	17.9	13.6	8.8	6.9	9.7	9.2	8.0	14.2	13.9	8.0	9.5	10.4	38.3	8.9	6.5	9.4	7.0	6.2	7.6	5.1	12.5	8.7	1.3	6.2	30.9	28.9	2.8	2.7	4.4	6.3	6.5	3.2	10.8	18.7	6.0	9.2	11.9	9.6	14.4	12.5	5.0	5.6	3.5	14.7	8.0	2.9	5.4	4.1	4.3	6.9	11.9	3.1	6.4	4.0	16.4	3.6	14.0	8.5	9.6	13.8	2.4	6.1	5.9	15.9	8.3	2.1	4.9	3.6	7.1	14.1	6.8	5.4	7.6	5.4	5.5	8.3	10.2	5.1	9.0	15.0	5.4	6.3	7.5	6.9	3.9	27.8	8.8	12.3	18.8	2.5	11.1	5.0	10.3	30.9	13.7	29.7	2.3	27.5	2.0	1.1	2.0	1.9	5.6	1.3	1.9	2.0	12.2	2.8	28.9	6.2	2.7	4.4	10.1	11.9	8.2	19.7	9.0	9.2	10.6	10.0	13.6	9.4
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 13.8;HAP1: 9.9;HDLM-2: 16.4;THP-1: 19.7;U-698: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9"	"Region enriched"	"Detected in single"	5	"amygdala: 0.4"	"Low region specificity"	"Detected in all"			"HPA019114, HPA048999"	Uncertain		Supported	"Intermediate filaments"				"Intermediate filaments"		"HPA019114: AB_1853645, HPA048999: "	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	1.3	12.5	0.4	31.9	0.4	2.2	1.1	0.2	0.4	1.7	8.5	0.5	1.6	1.2	1.4	18.4	1.3	2.9	3.8	2.0	0.6	0.4	1.4	0.6	7.5	18.4	0.6	0.0	1.0	1.8	0.0	1.2	2.1	1.5	1.5	14.0	1.6	3.2	0.9	0.6	1.8	7.5	0.5	1.7	9.7	1.7	2.7	0.4	4.1	1.0	2.8	27.5	2.3	1.3	6.6	18.9	0.2	0.8	0.4	5.9	1.4	1.0	1.1	0.1	2.9	0.6	0.2	0.4	0.7	3.8	0.9	1.2	0.0	0.1	13.8	0.4	0.0	0.1	9.9	1.2	1.1	16.4	7.3	1.4	0.4	0.0	0.8	0.3	1.3	0.2	0.0	0.9	0.8	0.1	0.0	0.3	0.2	0.4	0.2	0.1	1.1	1.9	0.1	2.3	0.0	0.1	0.3	0.7	0.0	0.1	0.2	6.1	1.7	19.7	0.1	0.9	1.5	0.1	2.6	0.1	0.0	12.3	0.8	0.1	2.4	0.1	0.2	0.0	4.1	0.8	1.3	6.6	3.3	5.9	4.5	1.9	0.5	3.4	0.2	0.4	0.1	18.9	0.2	1.4	0.4	0.4	0.2	0.4	0.6	0.4	0.6	0.0	1.5	0.4
MCRS1	"ICP22BP, INO80Q, MCRS2, MSP58, P78"	ENSG00000187778	"Microspherule protein 1"	Q96EZ8	12	49556544-49568153	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039057	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA039057: AB_10794085"	"unprognostic (2.60e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.60e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.83e-3)"	"unprognostic (6.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.23e-1)"	"prognostic favourable (2.70e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.26e-2)"	16.3	20.3	20.2	19.5	23.3	24.4	16.0	20.1	41.7	19.8	21.0	28.3	16.5	19.1	21.7	20.6	22.5	23.2	22.7	47.6	20.0	15.5	25.0	21.5	17.3	19.7	19.0	24.7	17.8	25.3	23.8	16.6	25.7	21.6	19.7	19.4	24.1	26.8	21.0	32.3	19.9	29.0	20.4	21.8	22.2	20.6	33.2	23.1	30.2	29.9	30.2	22.7	19.4	17.6	22.8	38.6	38.6	39.0	41.0	34.8	31.7	15.4	23.0	23.9	22.6	12.9	14.9	27.3	15.0	14.8	35.2	19.6	38.6	27.5	26.9	29.4	26.7	18.4	38.2	34.4	15.7	21.5	34.6	28.1	17.0	13.0	24.3	31.9	29.8	18.6	25.6	26.2	21.5	27.7	34.1	18.6	20.8	22.1	21.0	18.0	35.7	17.8	26.9	20.2	31.5	25.1	11.4	24.5	24.3	16.1	19.9	12.9	33.3	32.4	20.3	18.4	22.1	16.5	20.7	18.6	18.4	26.3	24.3	17.1	11.6	38.6	29.9	34.7	33.0	39.0	25.3	22.7	28.6	34.8	38.6	22.8	25.5	27.1	15.4	41.0	29.2	26.5	28.7	31.7	20.2	23.3	20.1	41.7	20.0	15.5	19.0	24.7	21.6	23.1
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.6"	"Cell line enhanced"	"Detected in many"		"HEL: 14.2;HMC-1: 11.7;U-698: 15.5;U-87 MG: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA051176: , HPA070541: "	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	5.3	4.1	0.8	19.7	1.7	12.6	2.7	0.7	1.5	5.4	12.3	0.0	6.9	5.6	4.0	9.5	5.7	4.5	10.3	4.6	1.0	2.2	3.6	2.3	12.4	18.4	2.5	0.8	3.8	10.0	5.3	24.4	17.1	0.6	6.8	10.2	2.5	16.8	9.6	0.8	4.0	10.9	4.0	0.9	41.6	3.7	1.7	0.4	3.0	8.7	4.1	12.9	6.2	14.8	2.7	0.1	21.2	0.5	6.8	4.4	1.1	2.4	0.0	0.0	0.0	0.0	0.0	1.7	1.3	0.8	0.2	0.1	1.6	3.1	7.1	0.3	0.0	5.6	0.1	4.6	0.0	1.3	0.5	14.2	1.9	0.8	1.0	2.9	11.7	0.8	5.7	0.1	5.8	0.0	0.5	4.0	0.0	0.0	1.3	7.9	0.5	2.6	3.2	0.1	2.7	0.3	7.4	1.4	0.3	0.1	2.4	0.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	8.6	0.1	15.5	17.7	7.7	0.8	3.2	0.5	7.7	4.4	0.1	2.1	2.2	1.2	1.9	0.0	2.7	0.5	1.9	21.2	6.8	0.5	0.1	0.0	1.1	0.8	1.7	0.7	1.5	1.0	2.2	2.5	0.8	0.6	0.4
MCTS1	MCT-1	ENSG00000232119	"MCTS1, re-initiation and release factor"	Q9ULC4	X	120594010-120621074	"Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation"	"Initiation factor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001045			Supported	"Plasma membrane,Cytosol"			52000	Cytosol	"Plasma membrane"	"HPA001045: "	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (9.37e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavourable (3.27e-5)"	"unprognostic (2.94e-3)"	"unprognostic (9.59e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (4.35e-5)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	20.2	26.8	23.7	22.5	29.3	16.9	27.4	16.8	33.8	20.7	24.0	14.3	26.6	23.2	17.4	30.7	31.7	16.6	16.8	24.6	25.2	22.4	22.7	37.9	17.2	31.1	22.6	25.0	14.7	42.0	21.1	38.2	20.7	22.3	16.6	29.7	13.4	31.0	27.3	20.9	18.1	21.2	19.2	20.8	24.1	22.9	13.1	19.0	28.5	23.1	32.1	36.1	20.5	19.1	28.2	32.0	13.7	24.4	17.7	24.5	15.5	33.6	23.7	19.3	19.3	24.7	35.9	26.2	25.3	23.3	31.9	30.6	20.6	33.4	36.2	36.4	31.2	22.4	33.8	32.2	46.3	22.8	22.5	11.7	26.2	16.2	28.1	29.3	22.5	24.6	28.6	27.8	30.3	38.5	31.9	24.2	39.2	38.6	28.1	39.3	21.5	46.9	21.7	17.8	43.8	34.0	16.8	24.4	22.8	17.7	28.8	22.8	21.2	27.2	26.3	25.9	15.8	28.0	46.4	18.3	24.7	49.3	30.1	43.4	28.1	11.9	20.1	13.7	15.1	24.4	24.5	28.2	19.8	19.3	24.8	20.7	18.3	18.5	9.9	17.7	22.4	32.0	22.9	15.5	23.7	29.3	16.8	33.8	25.2	22.4	22.6	25.0	22.3	19.0
MCU	"C10orf42, CCDC109A, FLJ46135"	ENSG00000156026	"Mitochondrial calcium uniporter"	Q8NE86	10	72692131-72887694	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016480	Approved		Supported	Mitochondria			1400000	Mitochondria		"HPA016480: AB_2071893"	"unprognostic (2.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavourable (6.06e-5)"	"unprognostic (1.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (5.07e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.48e-2)"	8.2	6.5	6.3	9.4	6.1	12.3	9.8	41.0	6.8	7.0	19.8	4.1	8.5	19.1	10.9	7.4	13.4	7.8	11.5	6.9	4.8	4.3	11.1	7.2	10.1	7.4	3.4	4.1	5.8	12.1	8.2	5.5	8.8	5.5	4.6	21.9	5.1	9.5	5.8	41.4	9.0	23.0	11.0	3.8	4.9	29.4	4.7	3.5	4.9	5.4	14.9	7.3	10.1	15.0	3.4	5.4	16.6	7.6	1.9	4.6	3.6	19.7	32.0	8.3	6.0	12.7	14.3	8.5	12.2	17.4	12.2	13.0	19.0	18.9	8.4	9.8	14.8	18.0	10.9	14.5	16.3	9.2	10.2	10.5	12.0	10.5	9.9	26.3	8.9	14.5	12.3	10.9	23.4	14.6	6.5	6.3	11.3	11.4	7.1	5.7	9.1	6.7	7.4	17.8	2.2	16.5	10.8	8.9	3.9	15.0	16.8	3.6	3.3	6.9	11.8	5.9	10.2	12.7	8.1	4.7	5.9	5.9	7.9	13.2	4.5	1.7	6.1	16.6	2.9	6.7	3.1	3.4	3.0	3.5	5.4	1.7	2.3	2.6	8.2	1.9	7.6	1.9	4.6	3.6	6.3	6.1	41.0	6.8	4.8	4.3	3.4	4.1	5.5	3.5
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717889	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 15.4;AN3-CA: 12.1;HEK 293: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	10.8	3.6	5.7	9.5	5.9	4.9	5.5	10.2	8.0	6.9	6.3	8.5	3.8	3.8	9.9	5.1	3.7	8.3	5.0	5.0	5.2	2.4	5.1	6.2	5.1	5.4	4.9	3.7	11.3	5.7	3.1	12.5	3.1	6.0	6.4	2.9	9.4	5.5	3.5	11.1	11.7	6.4	6.1	5.5	7.1	7.7	26.7	5.3	11.4	11.9	2.4	13.0	5.2	5.4	2.0	1.8	0.4	0.2	3.8	1.2	0.3	15.4	1.0	1.2	12.1	3.9	3.8	1.0	1.3	0.7	2.7	1.0	1.0	1.7	2.6	6.6	7.7	1.6	2.4	4.4	2.5	2.1	29.3	1.9	2.9	0.6	0.4	1.1	1.4	0.9	0.9	4.1	1.9	0.4	3.8	2.9	0.4	1.4	0.7	0.2	0.8	0.8	2.2	1.3	2.9	4.5	3.3	2.6	1.3	0.6	3.1	0.5	2.8	2.2	0.9	1.0	1.5	2.0	1.4	1.9	7.2	6.7	0.3	4.3	2.1	0.4	0.1	0.3	1.1	0.2	0.9	0.8	0.9	1.2	0.2	2.0	1.0	0.8	0.1	3.8	0.1	1.8	0.0	0.3	5.7	5.9	10.2	8.0	5.2	2.4	4.9	3.7	6.0	5.3
MDFIC	"HIC, MDFIC1"	ENSG00000135272	"MyoD family inhibitor domain containing"	Q9P1T7	7	114922154-115019202	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030716	Approved		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			"Nucleoplasm, Golgi apparatus"		"HPA030716: AB_10671364"	"unprognostic (1.24e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.68e-2)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (6.13e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.55e-1)"	39.4	21.1	4.6	29.3	4.6	5.1	62.4	2.5	4.0	18.4	15.5	5.1	13.9	3.7	22.8	8.8	18.2	7.7	9.7	15.9	4.4	4.7	8.3	8.6	17.5	48.0	4.7	4.1	11.2	5.9	15.2	6.6	11.2	13.6	11.9	5.8	11.2	14.4	19.4	13.7	8.1	9.4	16.7	13.7	28.3	6.6	4.0	3.4	17.8	16.1	11.2	24.1	18.0	25.4	3.6	8.1	1.1	2.5	2.7	6.9	1.2	0.0	4.8	6.3	0.0	13.5	18.7	2.7	24.0	28.9	5.5	7.0	0.1	14.3	3.4	0.3	15.7	2.8	1.9	4.1	9.5	11.8	5.6	0.0	5.9	0.0	6.9	7.3	4.9	15.6	4.0	12.5	3.9	3.6	0.0	23.2	18.7	0.0	0.0	0.6	5.1	5.4	0.0	18.6	7.2	5.6	5.8	0.2	0.0	10.4	9.8	10.8	3.1	6.6	10.3	20.5	5.8	38.0	11.5	9.5	0.0	0.0	14.4	0.0	17.5	0.2	1.5	1.1	3.0	1.9	4.6	3.6	6.9	6.4	2.4	3.2	4.0	3.4	0.1	2.7	2.5	8.1	5.6	1.2	4.6	4.6	2.5	4.0	4.4	4.7	4.7	4.1	13.6	3.4
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 94.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.8;HaCaT: 8.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	17	"cerebellum: 94.7"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 3.1"	"Group enriched"	"Detected in many"	22	"B-cells: 1.1;T-cells: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031235, HPA050382"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"		490000	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: "	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	1.5	3.7	3.4	3.1	2.4	0.0	1.0	94.7	5.1	3.0	1.3	1.5	1.0	0.0	3.0	1.5	1.8	2.1	3.4	1.2	5.0	2.0	0.8	0.5	3.5	3.4	1.7	2.4	8.4	2.6	6.6	2.6	0.5	5.4	1.5	1.1	3.4	0.7	1.2	0.9	6.7	1.5	2.6	4.1	3.9	1.2	1.4	1.3	0.6	1.1	1.7	2.7	1.1	3.1	1.1	0.0	0.0	0.0	0.0	3.1	0.4	0.1	3.8	6.9	2.6	13.8	5.6	3.0	2.7	2.7	3.5	3.9	0.7	0.0	0.9	0.6	1.7	8.9	0.5	0.0	1.1	6.9	4.0	0.0	0.5	0.0	0.6	0.0	0.9	1.0	0.1	1.4	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.5	0.0	0.4	7.4	2.4	0.0	0.8	4.2	6.3	0.0	1.5	0.4	3.3	3.2	0.6	0.5	3.7	1.2	1.3	5.0	0.0	0.1	0.0	5.9	1.1	2.4	0.0	0.0	0.0	1.4	0.0	0.4	1.1	1.2	0.8	0.0	1.0	3.1	0.8	0.0	0.0	0.0	0.0	1.8	0.4	3.4	2.4	94.7	2.7	5.0	2.0	1.7	2.4	5.4	1.3
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol			63000000	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: "	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favourable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.0	36.1	48.8	31.9	69.4	51.4	50.6	34.7	51.3	52.9	53.7	42.7	39.1	55.5	20.6	45.4	38.8	54.9	64.3	75.9	33.6	42.4	52.1	33.8	67.8	38.1	59.9	41.3	50.9	43.9	49.5	29.3	40.3	28.8	40.4	69.5	26.5	52.4	60.5	28.6	45.0	41.9	57.5	54.4	87.5	41.8	45.3	27.0	29.1	46.9	66.5	34.2	62.5	23.4	40.6	39.8	33.7	43.6	50.4	44.2	67.9	50.1	54.2	33.5	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 175.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria			47000000	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favourable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	18.1	39.1	17.4	15.4	20.6	18.3	22.2	15.3	34.4	14.9	27.0	13.5	16.9	32.5	16.6	13.5	31.8	19.4	17.6	103.1	17.1	18.8	29.1	101.9	13.8	26.6	17.4	21.9	17.3	35.5	16.8	16.9	17.5	20.5	17.9	24.3	15.0	26.8	21.5	175.8	24.6	26.7	21.9	12.8	21.1	22.3	17.6	9.5	22.4	20.1	76.2	23.8	19.9	17.8	37.1	52.8	22.1	45.3	30.1	45.6	44.7	28.6	47.0	17.0	42.6	19.5	21.4	29.3	19.3	24.9	27.6	25.0	41.3	34.5	43.4	8.7	25.4	29.3	43.7	28.8	19.8	30.9	63.2	24.1	25.3	38.1	24.0	37.4	24.9	27.0	25.7	26.8	40.1	25.7	75.8	25.4	25.5	64.9	32.4	66.1	37.9	59.3	26.5	21.0	62.4	25.8	37.9	42.7	38.9	19.3	96.8	39.7	55.0	42.3	19.8	27.8	26.3	30.0	38.3	28.5	23.5	48.0	24.1	48.0	42.1	22.1	38.9	18.2	32.7	43.5	34.2	37.1	36.9	35.3	52.8	32.1	36.0	33.1	10.2	30.1	45.3	47.1	45.6	44.7	17.4	20.6	15.3	34.4	17.1	18.8	17.4	21.9	20.5	9.5
MDM1		ENSG00000111554	"Mdm1 nuclear protein"	Q8TC05	12	68272443-68332381	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA040411, HPA041594"	Uncertain		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA040411: AB_10805711, HPA041594: AB_10793968"	"unprognostic (7.41e-2)"	"prognostic favourable (6.01e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.63e-2)"	"unprognostic (5.23e-3)"	7.0	6.7	11.5	11.9	11.4	15.4	10.0	8.2	12.7	11.9	28.7	9.6	12.4	5.1	15.2	12.7	5.4	20.3	6.5	6.7	12.3	10.0	8.8	4.9	6.8	12.8	11.4	10.5	10.9	11.3	8.8	22.8	6.0	14.9	12.3	11.1	9.0	6.8	15.9	3.8	4.2	9.0	18.8	11.4	9.5	9.8	20.7	12.4	14.6	11.0	5.3	13.4	17.0	8.9	7.1	4.0	13.3	17.2	6.0	8.1	5.4	4.9	4.1	8.0	7.7	4.0	5.4	6.1	6.6	3.7	10.6	9.8	4.9	2.3	11.4	4.4	3.0	5.1	5.4	3.5	12.1	14.9	5.2	25.0	5.3	3.4	6.1	13.8	9.9	2.4	4.6	7.1	6.9	5.9	4.7	12.8	6.1	3.6	19.5	9.8	4.2	5.1	19.2	7.1	3.3	5.0	4.3	7.3	3.9	6.4	3.8	6.5	9.2	10.0	3.1	8.5	3.7	5.3	6.0	6.7	19.5	7.7	4.5	9.0	5.4	6.0	4.7	13.3	5.0	11.1	8.1	6.8	6.4	5.2	4.0	7.1	7.7	6.2	3.1	6.0	17.2	2.3	5.9	5.4	11.5	11.4	8.2	12.7	12.3	10.0	11.4	10.5	14.9	12.4
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808176-68850686	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 93.7;U-698: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB000086: AB_563872, CAB016303: AB_627920"	"unprognostic (1.16e-1)"	"prognostic favourable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favourable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"	16.6	15.3	11.1	12.5	10.8	23.1	12.5	12.0	11.3	13.1	16.6	13.6	11.9	5.2	8.8	9.4	14.2	12.6	12.3	9.0	8.8	8.6	11.2	25.7	15.9	13.3	14.2	7.1	11.0	21.4	11.4	10.4	24.5	11.9	12.6	21.5	7.8	10.5	11.1	19.5	9.8	7.2	10.8	10.8	15.3	9.8	6.5	11.5	29.5	13.6	10.8	14.1	13.5	12.6	4.9	4.0	19.3	6.4	3.6	4.4	3.0	3.1	7.3	7.7	3.9	10.0	9.3	39.4	8.7	8.7	4.6	7.4	4.4	1.4	32.6	2.4	5.7	1.8	5.2	93.7	7.5	8.6	3.7	6.0	6.2	19.8	9.8	5.3	5.5	14.3	8.0	18.4	12.5	12.9	6.1	7.9	8.8	5.0	7.0	1.7	6.5	1.4	24.8	5.3	2.7	2.8	26.1	5.9	3.4	5.5	4.3	1.9	10.1	3.5	13.8	3.5	6.7	2.9	3.1	12.1	7.6	90.1	5.4	2.1	14.4	5.3	5.4	4.8	4.4	4.0	3.9	4.7	3.7	4.1	2.8	4.9	4.0	3.7	19.3	3.6	6.4	4.0	3.8	3.0	11.1	10.8	12.0	11.3	8.8	8.6	14.2	7.1	11.9	11.5
MDM4	"HDMX, MDMX"	ENSG00000198625	"MDM4, p53 regulator"	O15151	1	204516379-204558120	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018919, HPA048821"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA018919: AB_1853694, HPA048821: "	"unprognostic (4.63e-2)"	"unprognostic (3.73e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (9.87e-4)"	"prognostic unfavourable (7.06e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.49e-2)"	"prognostic favourable (2.49e-4)"	12.7	8.8	14.4	21.1	18.0	59.1	14.6	19.7	16.4	12.2	10.6	20.4	15.8	7.6	12.5	23.6	10.4	12.3	10.3	11.3	13.7	8.0	11.1	12.3	15.4	21.0	20.5	9.5	19.0	16.7	11.1	19.0	12.4	13.4	13.1	12.4	14.2	11.3	15.4	12.0	23.7	15.2	18.5	13.5	19.9	11.9	19.6	19.4	55.8	15.1	9.5	21.0	13.9	12.7	15.1	9.0	8.1	4.8	4.9	7.8	2.4	3.5	7.0	7.1	9.7	5.0	5.5	33.5	2.6	2.7	3.4	5.1	3.6	4.9	12.2	2.6	3.7	3.8	4.7	4.0	4.7	3.7	3.3	9.7	15.6	4.2	3.8	7.5	9.6	5.6	2.6	5.6	10.0	3.3	5.5	17.8	3.0	11.8	4.6	6.7	9.7	2.9	5.5	5.8	4.0	3.4	17.2	3.2	7.1	2.7	5.3	5.0	10.0	4.4	3.4	3.9	7.0	2.5	4.3	9.0	3.2	10.1	2.7	3.3	5.6	8.1	4.7	6.2	7.2	4.8	6.0	9.0	5.4	5.0	4.1	15.1	7.8	6.5	7.8	4.9	4.3	9.0	3.0	2.4	14.4	18.0	19.7	16.4	13.7	8.0	20.5	9.5	13.4	19.4
ME2		ENSG00000082212	"Malic enzyme 2"	P23368	18	50878734-50954257	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008247, HPA008880"	Enhanced		Supported	Mitochondria			3400000	Mitochondria		"HPA008247: AB_1853704, HPA008880: AB_1853702"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (8.29e-8)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.09e-1)"	12.6	18.1	17.1	18.4	16.2	11.6	10.7	13.2	16.0	9.4	26.4	14.3	16.8	30.2	10.5	7.7	10.6	9.3	10.5	34.6	15.8	17.8	12.1	12.1	10.3	24.1	18.7	14.0	11.1	16.7	20.6	20.2	10.5	47.7	11.8	26.6	9.4	8.8	23.1	29.5	7.1	44.8	16.9	18.9	36.6	20.3	15.3	8.7	24.3	9.0	7.8	17.3	14.2	15.7	4.9	9.6	14.3	17.4	6.7	6.0	4.5	12.9	13.0	17.4	20.2	7.9	8.8	8.0	10.8	8.1	14.2	12.0	5.9	7.1	46.2	4.3	9.6	10.8	25.8	10.9	16.3	19.1	4.0	11.8	8.2	6.9	23.4	39.2	14.2	5.4	13.5	17.8	29.0	18.1	12.5	11.3	9.6	2.7	28.3	3.9	11.6	5.3	18.6	8.6	13.3	15.4	2.8	21.5	11.4	10.1	6.2	10.8	4.7	19.0	11.1	10.1	11.3	5.2	14.3	21.1	8.5	22.7	10.2	28.0	10.7	5.0	11.6	14.3	5.0	13.1	4.1	4.9	3.3	6.0	9.6	4.9	2.9	3.5	13.3	6.7	17.4	3.2	3.1	4.5	17.1	16.2	13.2	16.0	15.8	17.8	18.7	14.0	47.7	8.7
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663618	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 21.5;RPTEC TERT1: 27.6;RT4: 43.5;TIME: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046537	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA046537: "	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	25.9	0.7	3.3	5.7	5.6	0.3	9.1	3.4	5.3	13.5	13.9	1.6	22.1	11.2	15.4	5.7	10.4	14.3	8.1	8.2	3.3	2.9	32.2	2.6	30.0	1.5	4.6	1.4	6.2	27.8	1.1	5.3	10.0	4.7	9.3	17.5	4.2	5.9	25.3	16.0	2.3	5.9	5.6	5.8	6.4	39.4	2.7	3.5	0.2	4.7	3.3	3.5	18.1	18.5	0.3	0.0	0.6	1.5	1.8	1.0	0.0	9.6	0.1	0.2	0.0	1.3	1.0	0.1	1.3	1.5	0.5	0.8	3.8	9.9	0.0	15.2	0.2	5.1	4.0	5.9	1.1	0.5	6.3	6.1	1.6	0.1	0.1	0.0	1.9	2.1	0.8	0.3	4.5	21.5	4.6	0.7	3.8	1.0	0.0	0.0	0.2	2.5	3.6	4.9	0.2	27.6	43.5	0.3	1.1	0.4	2.5	0.1	2.9	0.0	20.4	3.8	2.5	1.0	6.4	0.5	0.1	0.3	1.9	0.0	0.5	0.3	0.0	0.6	0.4	0.2	1.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	1.8	1.5	0.0	0.1	0.0	3.3	5.6	3.4	5.3	3.3	2.9	4.6	1.4	4.7	3.5
MECR	"CGI-63, ETR1, FASN2B, NRBF1"	ENSG00000116353	"Mitochondrial trans-2-enoyl-CoA reductase"	Q9BV79	1	29192873-29230942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA022018, HPA022030, HPA028740"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.66e-2)"	"prognostic favourable (5.81e-6)"	"unprognostic (7.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (5.29e-4)"	16.4	11.9	16.0	6.6	17.0	6.0	12.3	7.8	17.7	13.0	9.7	8.6	7.1	7.8	10.5	8.4	9.4	10.9	8.5	24.8	15.7	11.5	11.0	13.7	8.3	10.0	14.7	16.3	11.7	14.3	8.1	10.0	10.8	12.8	7.5	8.9	10.8	12.6	10.0	45.5	11.3	5.9	10.2	10.7	5.4	8.1	8.2	10.5	4.4	8.3	12.8	7.6	8.0	7.2	8.3	14.7	0.3	11.5	11.6	13.1	6.5	10.3	9.9	4.8	22.5	4.9	8.8	17.8	7.8	8.9	10.3	10.0	7.5	21.2	13.6	15.8	7.7	12.9	6.1	16.0	6.4	9.3	12.6	11.8	6.3	9.5	15.4	13.0	6.0	8.7	14.2	5.4	20.1	11.3	10.1	14.1	12.8	11.6	11.0	7.2	13.0	12.7	6.8	8.2	24.0	10.9	6.0	7.4	11.4	11.6	16.5	14.5	6.1	12.6	11.4	7.5	8.1	11.7	11.6	13.5	5.6	10.2	20.2	17.4	14.1	0.1	7.0	0.0	8.3	11.5	13.1	8.3	7.8	6.7	14.7	7.4	8.4	8.5	0.3	11.6	7.0	8.6	6.3	6.5	16.0	17.0	7.8	17.7	15.7	11.5	14.7	16.3	12.8	10.5
MED1	"CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2"	ENSG00000125686	"Mediator complex subunit 1"	Q15648	17	39404285-39451286	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017696, HPA052818"	Approved		Supported	Nucleoplasm			170000	Nucleoplasm		"CAB017696: AB_1128703, HPA052818: "	"unprognostic (1.77e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.50e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.79e-2)"	16.4	13.8	11.8	14.8	13.7	15.5	15.1	19.8	16.5	16.9	14.6	18.8	9.3	10.3	17.9	9.7	15.0	14.3	10.9	12.8	11.6	10.5	13.0	13.3	12.3	17.7	12.0	10.3	22.2	16.2	34.5	21.1	16.5	14.5	12.5	14.2	16.5	13.4	11.6	19.5	16.1	14.1	17.1	14.0	20.4	13.0	15.1	12.1	34.1	13.2	12.1	22.5	16.6	13.4	6.6	4.9	4.4	4.0	5.0	6.1	2.7	8.0	10.7	13.5	9.2	9.9	10.1	10.9	9.8	10.6	13.5	13.2	10.3	8.0	21.5	11.2	12.2	15.9	16.1	9.7	21.5	20.7	13.5	13.5	10.2	10.2	10.7	24.1	14.3	9.5	9.8	16.6	24.2	11.4	17.3	11.7	10.9	4.5	22.4	9.1	8.7	6.4	16.9	18.2	9.2	7.9	9.3	8.6	9.8	13.0	85.6	11.2	15.8	13.8	10.1	10.5	13.1	11.6	17.2	10.7	14.3	22.2	10.3	11.9	12.8	3.2	4.0	4.4	5.2	3.9	5.8	6.6	5.5	5.8	4.0	6.4	5.4	6.1	3.3	5.0	2.6	4.9	3.3	2.7	11.8	13.7	19.8	16.5	11.6	10.5	12.0	10.3	14.5	12.1
MED10	"L6, MGC5309, NUT2, TRG20"	ENSG00000133398	"Mediator complex subunit 10"	Q9BTT4	5	6371881-6378594	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042795, HPA054188"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA042795: AB_10796679, HPA054188: "	"unprognostic (2.33e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-3)"	"prognostic unfavourable (2.65e-5)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (3.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.14e-1)"	19.8	15.8	28.8	16.9	23.2	37.2	16.2	20.6	31.4	13.9	22.7	19.3	17.1	15.8	15.1	20.3	22.2	16.7	16.6	24.6	29.9	31.2	14.7	17.2	16.2	25.1	27.7	21.1	17.7	31.4	10.6	13.8	16.5	23.9	15.9	10.4	13.7	17.1	19.6	21.5	21.3	18.7	24.0	26.6	17.4	16.9	21.1	17.5	15.1	16.4	12.3	21.6	19.6	22.9	34.4	24.4	37.4	17.2	24.9	40.0	35.2	17.5	19.5	7.8	14.4	12.4	13.7	22.3	22.3	20.0	23.7	17.4	29.6	14.1	22.8	18.1	18.5	13.1	13.4	16.4	21.3	37.7	15.6	15.0	30.6	14.7	38.4	18.0	13.4	15.7	21.7	22.4	32.2	18.8	22.0	13.5	18.1	22.1	26.3	27.3	13.3	51.4	15.2	13.9	9.5	16.0	18.6	14.9	22.3	42.4	17.5	33.7	12.2	16.2	20.6	23.7	26.2	21.7	23.5	22.1	21.7	32.7	21.3	28.6	17.5	37.4	15.8	33.1	28.7	16.4	35.2	34.4	36.2	30.9	13.3	31.5	40.0	33.6	11.4	24.9	17.2	24.4	31.8	35.2	28.8	23.2	20.6	31.4	29.9	31.2	27.7	21.1	23.9	17.5
MED13	"KIAA0593, THRAP1, TRAP240"	ENSG00000108510	"Mediator complex subunit 13"	Q9UHV7	17	61942605-62065282	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067939			Supported	Nucleoplasm				Nucleoplasm		"HPA067939: "	"unprognostic (7.26e-2)"	"unprognostic (4.50e-2)"	"prognostic favourable (1.43e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.30e-1)"	10.4	7.6	6.3	6.6	9.1	19.3	8.8	8.8	7.5	8.7	9.0	13.8	6.8	7.1	13.6	9.0	9.7	6.8	8.2	8.4	12.6	5.3	9.0	14.3	12.7	7.3	8.2	3.5	9.9	8.6	15.3	5.9	9.6	15.6	7.1	8.3	6.4	21.6	5.9	31.8	10.0	8.1	12.0	13.8	6.7	7.4	11.9	8.3	15.1	10.4	12.4	8.9	10.7	8.4	3.2	5.6	7.9	5.0	2.7	3.5	0.7	12.9	15.4	11.9	9.7	11.0	12.0	9.1	7.1	10.4	14.5	14.0	11.7	7.1	13.8	6.8	11.2	8.0	15.2	9.3	20.3	8.9	8.9	22.5	11.2	7.4	11.5	19.7	10.5	9.2	10.8	15.8	18.0	10.9	18.4	23.8	9.9	21.9	17.7	5.9	6.3	8.0	14.6	30.6	8.4	10.2	15.3	9.4	17.9	14.9	4.3	9.3	15.6	14.0	13.6	16.7	24.5	8.6	13.4	11.6	13.1	19.0	8.8	8.8	9.4	1.6	2.1	2.5	2.8	1.0	3.5	2.0	2.7	2.9	2.1	3.2	1.9	3.5	7.9	2.7	5.0	5.6	3.0	0.7	6.3	9.1	8.8	7.5	12.6	5.3	8.2	3.5	15.6	8.3
MED15	"Arc105, CAG7A, PCQAP, TIG-1, TNRC7"	ENSG00000099917	"Mediator complex subunit 15"	Q96RN5	22	20495913-20587632	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003179	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA003179: AB_1079581"	"unprognostic (7.98e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (7.30e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (9.09e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (1.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.57e-2)"	26.2	28.3	26.4	29.5	32.0	41.6	23.4	28.5	31.4	23.9	25.3	27.4	17.6	34.8	35.6	15.0	25.8	23.4	25.9	21.9	23.4	15.4	20.6	12.2	28.6	31.4	22.8	22.4	23.6	24.9	17.9	24.1	32.2	22.0	22.0	13.8	29.5	22.7	23.2	40.7	27.9	30.1	20.8	19.3	32.9	24.5	19.9	23.9	19.2	20.3	16.4	29.2	29.7	24.3	4.9	6.8	9.1	13.9	13.6	19.8	8.8	21.8	11.7	7.5	9.1	7.9	7.8	13.8	22.3	16.4	17.6	16.4	17.8	10.0	8.9	10.3	15.7	22.6	6.8	16.5	7.1	12.6	12.1	16.9	12.6	12.9	13.2	15.3	15.5	9.4	13.0	13.9	14.2	13.6	70.5	8.4	11.2	14.6	6.4	8.7	8.1	8.0	11.2	17.0	3.5	10.7	16.0	7.1	12.2	16.8	17.1	23.7	9.6	8.6	24.5	28.5	21.5	15.2	17.8	11.0	9.8	6.8	20.6	9.5	25.4	4.1	7.6	6.5	17.8	8.4	8.4	4.2	12.2	19.8	6.8	4.9	7.2	12.0	9.1	13.6	13.9	6.1	19.0	8.8	26.4	32.0	28.5	31.4	23.4	15.4	22.8	22.4	22.0	23.9
MED19	LCMR1	ENSG00000156603	"Mediator complex subunit 19"	A0JLT2	11	57703714-57712323	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039912, HPA040860"	Uncertain		Enhanced	"Nuclear bodies"				"Nuclear bodies"		"HPA039912: AB_10795262, HPA040860: AB_10794153"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (1.34e-6)"	"unprognostic (1.40e-1)"	"unprognostic (4.87e-3)"	"prognostic favourable (1.76e-6)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.38e-2)"	12.7	19.6	18.2	12.1	26.5	9.3	15.2	15.5	22.8	13.8	13.1	11.4	19.0	15.0	13.3	22.2	16.0	13.7	10.4	10.8	16.8	15.6	15.0	17.7	11.5	10.6	12.9	22.9	11.7	12.4	13.4	17.9	22.3	12.2	14.1	12.8	14.4	14.6	15.9	12.8	17.6	10.3	13.1	9.9	11.9	11.8	23.1	12.5	10.5	21.2	9.7	16.3	11.8	15.5	31.1	25.8	20.8	24.8	15.3	25.9	17.7	16.4	10.6	12.9	11.9	13.8	12.4	15.4	14.2	11.1	13.7	13.8	7.5	12.9	9.1	22.1	13.5	12.6	9.6	9.0	12.2	11.9	10.4	7.8	6.7	6.9	20.8	8.4	9.4	10.2	16.5	13.5	26.9	17.5	8.5	9.0	16.3	7.9	11.9	15.8	11.2	21.3	11.5	18.3	11.0	9.0	6.9	10.0	14.1	11.4	11.7	24.9	24.7	8.8	14.3	11.9	14.3	28.0	12.4	11.3	10.8	8.5	16.3	6.3	12.4	16.9	18.8	20.8	21.7	24.6	23.3	31.1	24.4	23.1	17.8	26.7	25.9	24.2	11.7	15.3	24.8	25.8	22.6	17.7	18.2	26.5	15.5	22.8	16.8	15.6	12.9	22.9	12.2	12.5
MED25	"ACID1, ARC92, DKFZp434K0512, TCBAP0758"	ENSG00000104973	"Mediator complex subunit 25"	Q71SY5	19	49818279-49840383	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068802	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA068802: "	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (6.67e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (9.85e-4)"	"unprognostic (1.02e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.04e-3)"	13.2	45.2	16.3	17.0	16.5	30.4	13.1	22.7	25.1	15.1	18.1	19.3	14.2	14.8	21.0	18.2	20.6	28.6	20.5	24.9	16.1	15.6	16.8	13.9	18.2	16.3	16.3	16.0	29.3	21.6	15.9	25.3	22.1	16.5	13.4	14.2	20.9	15.1	22.7	49.3	20.0	14.9	15.6	14.0	18.2	21.2	58.8	16.4	24.9	23.9	21.1	17.9	17.7	14.3	4.2	3.1	19.8	2.6	1.0	2.2	1.7	23.3	31.6	18.9	20.7	13.2	13.1	17.1	15.3	17.1	23.7	24.0	26.8	29.0	26.4	9.4	19.3	20.8	22.4	17.4	18.6	16.1	32.4	17.8	28.0	20.9	14.6	20.5	26.7	14.3	16.9	19.2	14.0	19.9	32.5	20.7	15.9	12.8	17.4	38.9	14.5	23.8	22.4	19.1	26.8	24.1	35.2	33.5	30.7	21.4	25.5	9.7	15.7	16.8	22.4	24.4	17.9	11.7	16.4	21.9	31.5	27.9	20.0	18.2	13.5	1.1	2.6	3.9	2.2	2.4	1.9	3.0	1.7	2.1	2.3	4.2	1.6	1.2	19.8	1.0	1.7	3.1	1.8	1.7	16.3	16.5	22.7	25.1	16.1	15.6	16.3	16.0	16.5	16.4
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131860107-132079908	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favourable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	11.1	12.1	18.0	9.5	18.1	15.5	11.5	14.0	21.4	10.9	11.7	19.5	10.1	7.8	18.6	23.5	15.5	13.9	9.5	17.5	17.5	11.2	10.4	7.5	10.9	13.5	18.6	19.1	12.7	7.9	10.6	17.8	12.7	17.4	12.7	10.7	16.0	17.7	14.4	15.2	15.7	8.6	16.3	16.1	11.7	10.2	14.7	14.0	17.9	13.2	9.6	15.8	12.3	10.5	12.9	19.8	13.4	18.6	18.0	19.7	11.8	16.0	15.8	18.2	14.4	13.1	12.1	15.4	16.7	22.2	33.4	26.2	23.5	13.0	15.9	11.3	17.3	29.1	25.2	23.7	21.9	17.0	14.9	11.9	16.6	14.0	19.6	21.3	15.0	13.3	16.3	26.4	27.0	17.4	17.3	13.2	24.3	25.5	22.8	12.4	18.6	26.8	20.2	25.7	19.4	13.4	8.9	34.1	13.8	21.5	11.1	11.1	17.6	10.0	14.6	34.1	15.0	25.2	25.0	5.4	16.5	28.1	18.9	14.9	23.1	3.5	12.2	13.4	18.9	18.6	15.3	11.6	14.8	18.5	19.2	12.9	12.7	15.5	4.8	18.0	16.0	19.8	19.7	11.8	18.0	18.1	14.0	21.4	17.5	11.2	18.6	19.1	17.4	14.0
MED28	"DKFZP434N185, EG1, magicin"	ENSG00000118579	"Mediator complex subunit 28"	Q9H204	4	17614631-17634105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035900, HPA035901"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA035900: AB_10673223, HPA035901: "	"unprognostic (1.14e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.07e-3)"	12.8	12.4	16.5	15.3	18.2	22.7	20.1	23.6	19.4	18.9	15.8	20.2	17.4	13.1	25.1	22.0	15.0	19.7	11.9	11.3	16.4	15.7	13.0	10.9	16.7	21.4	18.7	17.4	30.2	16.5	14.1	20.4	18.3	15.1	18.5	15.6	17.0	16.5	17.1	27.8	22.0	16.5	16.4	16.1	20.0	15.0	16.7	17.9	27.3	18.9	14.9	23.2	16.4	17.7	9.5	10.1	14.9	10.7	8.4	11.2	10.7	3.2	2.0	16.9	8.5	7.5	5.9	6.9	4.7	5.5	6.3	5.8	5.7	7.9	8.9	3.3	4.3	3.3	10.2	5.0	6.4	3.5	5.1	15.6	6.8	8.6	5.2	10.9	7.9	5.7	7.0	3.9	3.3	5.4	13.8	8.2	5.6	3.2	16.0	18.9	11.7	3.5	12.5	6.2	4.1	6.0	4.9	12.2	6.2	4.1	3.5	3.9	6.7	11.3	6.7	4.2	2.9	3.0	4.4	6.2	2.8	11.6	3.7	10.6	4.4	6.7	10.7	9.8	7.6	8.0	7.5	9.0	8.4	7.0	10.1	9.5	11.2	8.6	14.9	8.4	6.5	7.0	6.5	10.7	16.5	18.2	23.6	19.4	16.4	15.7	18.7	17.4	15.1	17.9
MED29	"DKFZp434H247, IXL, MED2"	ENSG00000063322	"Mediator complex subunit 29"	Q9NX70	19	39391303-39400637	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055956			Supported	Nucleoplasm				Nucleoplasm		"HPA055956: "	"unprognostic (3.30e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"prognostic favourable (5.15e-5)"	"unprognostic (9.51e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.87e-2)"	17.4	22.2	39.7	15.0	39.1	15.7	17.8	24.8	38.1	21.1	16.0	25.7	15.8	17.0	18.3	22.5	15.9	29.9	20.1	21.1	34.4	35.4	22.2	22.0	17.6	17.4	36.4	31.9	34.6	23.9	41.9	21.5	17.1	28.5	21.4	13.5	19.3	22.6	25.8	25.7	16.0	16.5	18.7	32.6	18.5	16.9	15.1	17.9	16.4	30.8	14.2	16.3	18.0	13.1	28.2	22.2	35.7	41.9	21.8	27.8	25.8	14.4	38.3	11.6	11.8	17.2	13.3	9.3	15.7	17.4	15.0	12.0	18.9	14.1	10.7	21.0	14.4	7.6	10.8	13.6	8.7	20.9	19.6	13.8	15.2	12.7	13.8	13.1	12.2	13.9	10.9	15.5	17.1	12.0	9.1	13.6	14.7	18.9	12.8	3.9	8.8	13.5	21.1	15.9	15.1	14.0	24.5	18.0	16.2	31.9	21.0	13.6	16.3	14.4	13.1	12.7	13.0	15.5	15.7	17.5	19.7	18.2	17.5	9.9	20.2	26.0	28.6	24.0	24.5	34.4	23.9	28.2	22.8	21.9	22.2	26.2	27.8	26.1	35.7	21.8	41.9	17.8	26.3	25.8	39.7	39.1	24.8	38.1	34.4	35.4	36.4	31.9	28.5	17.9
MED4	"DRIP36, HSPC126, TRAP36, VDRIP"	ENSG00000136146	"Mediator complex subunit 4"	Q9NPJ6	13	48053323-48095131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006232	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA006232: AB_1079351"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.79e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.34e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.84e-1)"	31.3	25.9	29.1	23.1	33.4	43.8	31.8	28.9	31.8	27.4	32.3	23.2	24.3	26.4	32.1	30.3	31.5	24.4	21.9	36.6	28.5	24.1	28.6	33.3	24.1	27.7	29.4	34.1	26.0	21.2	18.0	27.8	40.2	29.5	27.9	31.6	19.0	26.3	27.2	58.8	29.2	33.3	35.6	30.7	29.2	25.2	34.7	26.7	39.7	28.9	29.7	35.0	26.4	26.4	33.9	32.8	52.1	35.3	41.4	50.0	41.7	13.9	9.1	31.4	17.3	21.0	27.0	21.8	20.5	25.7	24.6	17.6	17.3	24.1	23.0	5.9	21.5	21.4	23.0	19.6	32.2	29.8	18.8	30.1	17.9	27.0	19.4	44.4	28.0	18.7	27.8	14.5	21.5	22.8	21.3	14.8	27.4	14.0	41.7	42.4	31.1	12.1	30.5	21.3	18.6	31.9	21.8	13.9	22.5	16.7	21.1	21.6	17.9	33.6	18.3	13.8	16.0	17.2	18.5	14.4	21.0	35.3	11.9	23.4	26.1	42.9	34.6	52.1	41.0	35.2	45.2	33.9	46.6	41.3	32.8	30.7	45.3	42.9	36.5	41.4	35.3	29.8	50.0	41.7	29.1	33.4	28.9	31.8	28.5	24.1	29.4	34.1	29.5	26.7
MED6	NY-REN-28	ENSG00000133997	"Mediator complex subunit 6"	O75586	14	70581257-70600690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030764, HPA069039"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA030764: , HPA069039: "	"unprognostic (1.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-2)"	16.7	19.7	20.3	16.5	30.7	22.7	21.9	42.0	30.4	17.6	15.7	19.3	16.6	14.2	23.6	22.9	24.5	19.7	14.8	17.1	20.1	19.5	14.7	20.2	15.5	26.9	17.4	23.0	25.7	15.6	13.5	30.0	22.9	21.9	15.2	16.5	20.5	17.4	17.4	29.9	24.1	16.2	18.9	19.6	21.6	16.4	16.6	20.5	21.0	19.4	18.9	30.2	18.5	18.8	19.9	18.5	23.5	21.1	21.3	24.8	14.2	36.6	20.5	26.6	11.5	14.5	15.4	21.2	18.6	19.7	28.6	28.1	20.2	22.8	28.1	11.0	15.8	17.7	31.0	18.8	30.9	19.6	16.5	20.4	15.8	27.1	17.8	17.8	16.5	17.4	22.0	20.5	19.0	21.9	18.8	17.8	20.7	27.4	25.5	24.2	19.7	25.0	21.3	24.7	14.6	17.8	19.6	18.1	19.6	19.4	20.9	21.6	32.5	22.5	17.4	23.6	34.3	11.9	17.0	19.0	28.1	39.5	20.7	15.5	16.4	17.4	16.2	23.5	18.7	18.2	22.2	18.9	24.8	21.3	18.5	19.9	23.1	23.3	15.8	21.3	21.1	13.9	23.1	14.2	20.3	30.7	42.0	30.4	20.1	19.5	17.4	23.0	21.9	20.5
MED7	"CRSP33, CRSP9"	ENSG00000155868	"Mediator complex subunit 7"	O43513	5	157137412-157159019	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067181			Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA067181: "	"unprognostic (1.63e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.81e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (2.37e-5)"	"unprognostic (7.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (8.69e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-3)"	11.4	16.0	15.0	9.9	19.4	11.2	15.4	24.2	19.7	12.1	12.3	14.2	7.2	7.5	11.7	17.4	11.7	10.1	8.9	11.1	14.5	13.0	16.3	12.0	9.5	13.8	19.4	17.4	13.5	9.4	10.3	13.4	10.4	19.7	13.0	12.9	8.5	8.9	8.9	14.0	7.0	11.1	14.9	15.9	16.0	11.3	29.7	17.4	10.0	14.2	9.0	12.7	14.3	8.7	24.5	11.9	23.2	24.0	18.0	28.1	16.1	9.3	11.2	14.7	10.4	12.5	9.1	11.5	14.5	8.5	11.4	14.5	13.7	17.2	15.5	13.2	11.0	11.3	8.4	17.2	16.5	7.0	7.7	6.0	10.7	8.1	12.0	8.5	8.1	10.4	11.7	10.2	11.3	14.6	5.3	12.7	18.0	9.0	8.2	7.6	4.1	13.2	7.8	12.1	9.1	23.6	12.4	10.5	8.4	10.3	10.4	13.5	25.6	9.3	10.1	15.6	13.0	8.3	13.1	12.5	12.9	7.8	10.2	12.3	12.3	23.2	17.1	22.0	15.3	17.7	18.0	24.5	18.8	19.2	11.9	23.0	28.1	20.1	14.6	18.0	24.0	11.0	20.0	16.1	15.0	19.4	24.2	19.7	14.5	13.0	19.4	17.4	19.7	17.4
MEF2A	"RSRFC4, RSRFC9"	ENSG00000068305	"Myocyte enhancer factor 2A"	Q02078	15	99565417-99716466	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004499, HPA046597"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB004499: AB_627921, HPA046597: "	"unprognostic (1.89e-1)"	"unprognostic (8.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (6.93e-4)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-3)"	28.9	17.4	17.4	19.1	24.3	12.0	20.1	22.9	31.6	21.9	19.7	20.1	18.2	9.5	30.5	24.7	16.6	20.5	16.6	62.0	14.9	12.7	18.8	17.5	26.0	16.7	14.0	21.9	23.0	11.7	32.0	10.2	18.8	16.1	19.9	11.4	14.5	15.5	18.4	46.1	38.4	16.3	31.2	23.6	22.2	16.3	10.7	15.8	17.6	15.2	19.6	17.3	25.2	15.9	12.8	10.7	11.3	14.2	5.6	4.5	4.3	8.7	5.0	8.4	4.2	10.7	13.8	4.2	8.9	20.5	7.3	10.0	5.1	12.2	11.0	12.6	19.0	9.6	8.5	7.0	9.6	7.4	12.5	22.1	11.1	4.6	18.4	8.7	10.9	9.2	11.8	9.8	20.4	13.3	7.8	21.1	13.6	3.6	14.3	13.0	4.6	7.3	21.0	18.4	8.9	15.1	12.4	5.4	7.6	13.5	5.9	25.0	5.5	8.0	21.7	20.5	11.2	10.1	10.7	11.5	13.1	24.0	14.3	9.7	19.4	6.2	10.3	11.3	3.4	12.8	2.9	12.8	3.2	3.0	10.7	10.4	4.5	3.4	10.2	5.6	14.2	6.6	2.1	4.3	17.4	24.3	22.9	31.6	14.9	12.7	14.0	21.9	16.1	15.8
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;HEL: 52.3;Karpas-707: 28.8;REH: 59.6;WM-115: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	5	"B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5"	"Group enriched"	"Detected in many"	7	"amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3"	"Group enriched"	"Detected in all"	4	"amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB068196: , CAB068197: , HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	13.9	10.8	17.0	15.0	26.7	3.8	10.7	4.3	52.8	8.2	6.8	6.1	1.5	2.8	10.9	5.4	5.0	6.4	9.8	11.2	11.1	6.8	4.5	4.0	8.3	19.3	6.6	28.0	12.3	2.9	5.2	6.5	14.8	4.8	7.1	5.7	4.6	6.6	6.6	154.8	3.9	7.4	10.8	8.3	16.0	4.5	3.6	4.4	1.6	9.6	3.5	24.0	8.9	5.8	48.2	23.8	5.8	19.5	4.0	0.1	7.2	0.3	0.0	1.7	0.0	1.8	1.1	0.0	0.5	1.0	0.0	0.2	0.0	0.2	23.7	0.1	2.7	0.7	2.2	2.1	0.0	7.2	2.9	52.3	3.1	0.0	0.6	2.3	0.1	5.2	0.0	0.0	0.0	8.2	2.7	28.8	2.1	0.0	0.0	0.0	0.5	1.9	59.6	15.0	11.4	0.0	0.2	0.0	2.0	0.0	0.1	6.9	0.0	13.3	9.4	1.3	0.2	0.1	1.2	21.9	2.5	14.3	0.3	16.2	34.1	0.1	17.2	0.0	0.0	19.5	0.0	32.6	0.0	0.0	22.3	48.2	0.0	0.0	5.8	4.0	15.9	23.8	0.1	7.2	17.0	26.7	4.3	52.8	11.1	6.8	6.6	28.0	4.8	4.4
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500828	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.8"	"Cell line enhanced"	"Detected in all"		"THP-1: 53.9;U-266/70: 47.4;U-266/84: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	18.1	19.6	14.9	15.7	27.5	47.6	15.5	27.0	40.3	23.8	21.1	12.1	10.5	11.0	28.6	12.9	13.8	19.5	16.6	26.3	11.8	9.6	10.4	10.6	20.0	13.9	8.6	21.1	26.7	22.4	21.4	15.0	16.2	11.6	17.2	10.6	22.3	11.3	18.8	97.8	17.5	14.8	22.0	8.4	17.2	16.1	9.9	9.9	17.2	14.7	19.4	15.6	21.9	19.3	1.7	8.5	8.1	2.0	1.5	2.3	0.8	4.5	8.5	1.8	2.7	4.3	6.0	2.7	6.0	7.8	3.2	3.4	2.7	6.2	10.6	6.9	8.0	4.5	2.1	3.4	1.9	14.4	2.8	2.5	10.4	1.5	5.3	6.2	8.4	6.7	5.8	5.5	7.5	6.0	1.8	18.7	5.0	4.3	4.1	14.3	2.6	4.3	20.4	3.9	12.2	2.7	2.2	2.9	4.6	5.8	12.6	10.0	3.4	53.9	10.0	7.5	7.1	5.5	4.4	47.4	48.8	20.3	6.4	4.9	4.0	1.3	2.0	2.3	1.9	1.1	2.3	1.7	1.4	1.7	1.4	1.7	0.7	1.3	8.1	1.5	1.9	8.5	1.6	0.8	14.9	27.5	27.0	40.3	11.8	9.6	8.6	21.1	11.6	9.9
MEFV	"FMF, MEF, TRIM20"	ENSG00000103313	"MEFV, pyrin innate immunity regulator"	O15553	16	3242028-3256627	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	Actin-binding	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell line enriched"	"Detected in some"	6	"THP-1: 11.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"											HPA077497			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA077497: "	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.58e-7)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	4.2	1.2	0.5	9.8	1.0	9.7	0.9	0.4	0.9	1.1	1.4	0.3	0.0	1.0	0.6	2.7	1.2	1.6	1.8	4.2	0.5	0.5	1.3	1.5	11.4	14.8	2.8	0.1	1.2	1.8	0.2	0.7	1.8	0.8	0.9	0.6	1.7	0.8	0.7	1.7	0.6	1.3	1.6	2.2	23.3	1.0	2.2	1.3	1.2	1.7	0.2	1.4	2.7	4.1	0.4	2.1	10.0	6.5	0.5	0.3	1.3	0.1	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.1	11.8	0.1	0.3	0.1	0.1	0.1	0.5	0.4	0.2	0.4	2.0	0.0	2.5	3.8	0.2	0.1	4.2	0.1	0.2	0.2	0.1	2.1	0.4	0.1	0.3	10.0	0.5	6.5	0.3	0.1	1.3	0.5	1.0	0.4	0.9	0.5	0.5	2.8	0.1	0.8	1.3
MEN1		ENSG00000133895	"Menin 1"	O00255	11	64803510-64811294	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030342	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030342: AB_10610138"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-2)"	"prognostic favourable (6.31e-5)"	"unprognostic (1.40e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	12.1	20.6	13.2	15.6	17.7	11.8	12.5	25.8	26.9	15.5	14.9	16.4	22.2	16.9	14.8	18.4	18.9	17.6	14.7	9.0	12.4	11.5	15.9	23.0	12.8	22.1	12.5	15.6	19.7	25.9	16.8	18.0	16.1	16.0	15.9	11.6	16.6	23.3	19.9	8.4	21.6	15.8	11.0	9.8	20.6	15.3	21.2	12.3	33.2	23.9	6.2	20.3	13.7	15.5	5.2	2.9	3.4	1.5	1.8	4.8	1.0	16.4	22.1	14.1	22.2	15.8	10.3	16.6	11.8	11.8	18.5	12.4	12.7	16.2	23.4	19.4	9.1	23.5	19.1	16.4	11.1	19.9	28.3	19.4	17.7	17.0	14.0	12.4	13.2	11.8	12.3	15.5	12.9	17.1	28.1	8.9	10.2	30.7	31.4	25.2	18.5	33.2	24.4	16.1	22.4	11.9	15.2	20.0	17.6	14.0	19.8	14.4	29.5	13.9	10.8	17.5	16.8	20.9	10.0	14.1	16.3	11.8	13.8	9.7	11.1	0.9	1.3	3.4	3.7	1.5	4.8	3.7	2.6	4.6	1.3	5.2	4.5	2.6	0.2	1.8	0.5	2.9	1.9	1.0	13.2	17.7	25.8	26.9	12.4	11.5	12.5	15.6	16.0	12.3
MESD	"BOCA, KIAA0081, MESDC2"	ENSG00000117899	"Mesoderm development LRP chaperone"	Q14696	15	80946289-80989878	"Predicted intracellular proteins"	"Wnt signaling pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039414, HPA041721"	Approved		Supported	"Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		690000	"Endoplasmic reticulum"	"Nuclear bodies, Cytosol"	"HPA039414: AB_10674981, HPA041721: AB_2756310"	"unprognostic (9.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.02e-2)"	"prognostic favourable (2.31e-4)"	"unprognostic (4.93e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.09e-3)"	"unprognostic (4.04e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.88e-1)"	15.5	19.5	15.5	19.7	17.6	5.7	23.5	15.6	14.4	21.1	15.8	15.3	31.3	14.0	14.5	48.3	17.1	14.3	16.2	15.5	14.0	17.6	16.4	28.2	17.6	23.8	20.9	13.4	22.2	34.7	12.8	23.4	32.1	17.0	20.8	16.4	15.0	20.4	37.6	14.2	12.3	13.7	13.9	22.4	16.2	16.5	13.6	17.8	13.0	37.1	12.7	14.3	13.7	17.1	19.0	25.6	17.7	15.0	24.7	25.1	16.0	12.3	18.7	16.7	10.7	28.3	16.2	25.9	19.0	22.6	20.7	25.3	16.7	34.8	10.4	22.0	15.2	20.9	25.8	19.4	19.7	22.9	16.5	13.1	16.2	28.4	21.7	15.5	14.5	16.7	22.5	17.4	20.8	19.6	15.7	26.8	17.6	15.5	9.5	13.0	20.2	7.7	14.7	10.3	27.7	17.1	17.0	14.5	8.5	20.8	14.1	31.0	16.3	12.5	15.2	20.1	19.1	10.7	24.2	16.9	21.5	14.3	18.8	27.9	20.9	17.7	15.0	10.3	21.6	13.8	25.1	19.0	22.8	21.1	15.3	18.1	21.5	21.6	4.5	24.7	11.6	25.6	22.8	16.0	15.5	17.6	15.6	14.4	14.0	17.6	20.9	13.4	17.0	17.8
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.1;prostate: 10.9"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;HDLM-2: 4.9;HEK 293: 4.9;PC-3: 9.3;SCLC-21H: 4.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 6.3;prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA069981: "	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	14.1	1.6	6.8	1.4	4.3	1.1	3.8	7.3	8.8	2.5	1.9	1.1	0.1	1.3	1.0	1.0	0.9	1.0	2.9	3.9	4.9	5.0	1.3	1.2	1.1	1.1	3.3	4.3	1.0	1.2	1.1	1.1	0.8	2.4	10.9	1.0	1.3	3.0	1.2	7.0	0.9	1.1	0.9	1.4	0.9	1.0	1.4	1.9	0.0	1.0	2.2	0.9	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	5.6	2.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.3	0.0	2.2	0.0	0.0	0.4	0.0	0.0	4.9	4.9	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.8	1.4	0.0	9.3	0.2	0.0	1.3	0.1	0.0	4.3	0.1	1.1	1.8	1.1	0.1	0.7	0.0	0.0	0.3	3.4	1.1	2.2	0.7	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.8	4.3	7.3	8.8	4.9	5.0	3.3	4.3	2.4	1.9
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 45.4;CAPAN-2: 49.6;EFO-21: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	178550000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: "	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.4	26.1	0.0	0.1	2.0	2.0	1.8	26.0	10.6	14.0	11.8	5.4	49.6	2.0	43.3	16.3	12.0	4.5	24.7	28.7	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.1	9.6	0.9	0.2	25.9	1.0	0.0	0.0	3.9	26.7	0.0	22.0	0.0	24.6	5.2	3.8	0.0	10.7	3.4	10.1	0.0	0.2	17.7	20.9	7.4	11.0	20.1	0.5	4.0	0.2	23.0	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"			22000	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	24.2	36.4	25.8	49.9	33.7	39.1	25.1	25.9	32.3	23.9	26.2	16.3	102.5	16.6	28.7	25.4	30.1	22.5	21.7	30.7	29.6	24.0	26.0	46.8	22.1	32.6	29.1	23.4	29.4	31.9	21.0	36.1	25.1	42.9	24.2	24.0	10.1	22.1	140.7	94.4	28.7	19.7	26.1	48.2	25.2	22.2	26.3	27.7	32.1	24.1	29.0	55.2	33.4	37.3	39.4	31.8	21.3	27.1	25.7	32.0	16.2	33.2	28.1	30.1	23.3	18.3	29.4	23.1	32.8	23.0	32.4	23.0	40.8	16.0	97.0	20.7	23.4	21.5	33.8	25.1	37.3	23.0	29.1	43.4	21.4	28.7	19.6	53.7	21.3	25.4	26.9	30.6	30.1	34.4	56.1	11.0	24.0	21.9	39.7	36.7	36.8	42.0	31.3	26.0	31.8	22.2	35.4	23.4	30.7	29.2	23.9	28.7	28.8	25.6	29.5	18.6	18.1	20.8	34.6	15.9	41.4	104.0	10.6	30.3	23.4	21.3	27.1	11.1	23.8	19.1	29.2	39.4	26.7	26.6	24.4	37.6	32.0	29.7	1.2	25.7	22.3	31.8	25.3	16.2	25.8	33.7	25.9	32.3	29.6	24.0	29.1	23.4	42.9	27.7
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"RH-30: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA020914: AB_1853830, HPA050450: "	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	12.2	16.6	6.7	13.8	8.8	8.4	12.3	2.2	6.9	7.6	7.6	4.5	10.8	3.3	9.4	21.2	10.3	9.0	10.7	8.1	5.8	5.0	20.9	15.3	7.7	8.8	7.4	4.6	17.6	34.9	10.9	10.6	8.3	6.5	11.0	10.3	5.3	17.9	17.2	20.4	8.5	5.7	10.5	5.0	8.2	7.3	11.4	5.4	4.5	15.1	15.6	9.8	8.8	7.8	6.1	12.6	0.7	6.7	7.3	18.6	5.1	5.9	11.0	4.6	4.2	6.2	4.3	6.3	6.5	5.8	10.9	5.9	7.6	8.4	7.2	12.0	7.8	7.2	7.1	10.0	10.6	4.3	8.2	8.4	4.2	9.3	4.4	9.1	4.4	3.8	9.1	12.2	8.5	5.7	7.7	7.3	5.5	11.7	6.3	10.9	10.8	11.0	5.6	77.0	10.7	9.5	7.5	4.9	4.4	6.7	7.5	6.0	9.8	8.6	4.3	4.4	4.9	7.7	8.5	3.4	2.5	8.8	6.2	6.5	9.1	0.0	4.7	0.0	5.3	6.7	18.6	4.7	6.9	6.5	10.3	6.1	9.5	9.2	0.7	7.3	1.1	12.6	3.3	5.1	6.7	8.8	2.2	6.9	5.8	5.0	7.4	4.6	6.5	5.4
METTL14	KIAA1627	ENSG00000145388	"Methyltransferase like 14"	Q9HCE5	4	118685368-118715433	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038002	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA038002: AB_10672401"	"unprognostic (4.48e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-3)"	"prognostic favourable (1.46e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.76e-3)"	17.3	16.4	15.5	12.4	19.2	25.8	18.0	25.9	19.4	21.8	16.1	12.8	11.7	13.4	19.1	17.2	16.4	15.9	12.0	12.3	13.3	11.3	17.4	22.0	13.9	15.9	16.4	16.0	22.6	14.6	17.1	34.5	13.6	16.0	20.0	13.0	12.3	13.7	14.9	13.5	16.4	15.4	14.5	17.3	17.3	14.2	26.6	18.4	24.1	18.7	10.6	16.2	23.0	16.1	18.9	12.3	24.1	17.5	17.1	18.4	10.7	14.4	6.7	14.6	13.7	9.2	11.7	10.7	12.9	9.9	9.8	11.3	9.6	17.3	16.4	7.7	9.0	7.1	12.4	10.6	12.6	12.9	7.5	13.7	8.4	10.6	10.5	22.1	16.4	10.3	12.3	11.3	7.5	8.8	14.6	14.0	13.3	9.7	21.6	18.6	12.5	5.8	12.4	18.3	8.3	10.6	9.6	12.0	13.5	9.1	16.9	12.3	7.7	21.1	11.9	14.2	13.0	12.6	10.2	11.8	12.2	18.7	10.1	12.4	11.5	24.1	10.6	22.3	14.7	15.6	16.6	18.9	15.4	15.1	12.3	18.1	18.4	16.6	8.5	17.1	17.5	9.8	16.2	10.7	15.5	19.2	25.9	19.4	13.3	11.3	16.4	16.0	16.0	18.4
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favourable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	12.7	14.0	13.1	11.0	15.2	13.1	14.1	22.5	14.4	14.9	13.1	19.8	11.2	8.6	21.6	10.6	11.0	16.5	9.6	12.4	12.6	9.7	11.5	6.9	12.2	13.1	18.3	9.7	22.5	13.5	19.7	22.8	7.5	13.6	13.5	10.4	18.3	12.1	13.1	14.2	14.7	10.4	16.5	14.6	11.1	11.2	11.0	17.5	15.7	16.5	8.8	17.5	15.3	12.7	5.7	3.1	2.3	3.2	2.0	8.1	2.0	6.0	16.1	9.1	8.8	6.9	8.7	8.5	7.7	6.6	8.8	7.3	21.3	3.9	18.9	8.3	6.9	8.7	21.0	10.5	12.0	7.2	13.3	9.7	13.2	9.7	7.5	8.9	7.9	7.3	10.0	12.1	17.8	9.0	12.6	10.2	5.8	6.5	12.7	5.3	10.4	6.8	21.3	9.6	8.5	6.3	5.4	4.8	7.6	11.4	6.3	6.7	7.9	5.7	6.5	8.0	5.2	11.3	11.1	6.0	7.3	13.5	10.9	7.5	10.9	2.3	3.2	1.2	5.7	2.1	7.2	5.7	5.6	5.5	2.2	5.0	8.1	5.9	0.1	2.0	1.5	3.1	3.5	2.0	13.1	15.2	22.5	14.4	12.6	9.7	18.3	9.7	13.6	17.5
METTL17	"FLJ20859, METT11D1"	ENSG00000165792	"Methyltransferase like 17"	Q9H7H0	14	20989770-20997035	"Predicted intracellular proteins"		"Methyltransferase, Ribonucleoprotein, Ribosomal protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002955, HPA059802"	Uncertain		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA002955: AB_2144183, HPA059802: "	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	11.4	35.7	15.8	15.8	18.4	25.4	14.4	24.9	16.6	16.4	22.1	14.2	25.6	19.7	14.9	15.8	23.4	15.2	12.2	20.6	17.3	10.0	20.7	20.4	17.5	18.5	21.1	11.8	15.6	19.8	11.6	18.9	16.0	16.1	13.4	25.0	14.2	23.1	26.1	20.2	16.0	21.6	21.0	16.3	25.0	17.6	21.9	20.2	17.9	15.1	22.1	22.3	12.7	15.2	7.9	10.3	17.6	5.3	6.2	9.2	4.3	14.4	17.8	18.8	7.1	11.6	5.2	14.5	9.6	13.5	29.3	24.1	14.1	18.9	31.0	9.7	12.5	24.1	23.8	18.8	21.2	10.9	19.7	16.2	13.2	18.4	10.9	27.0	18.8	10.8	16.6	15.0	11.2	11.7	14.9	14.9	13.9	10.7	18.0	28.1	18.6	22.7	23.1	16.5	20.4	15.6	14.2	13.5	15.9	12.7	16.7	9.6	11.6	23.9	6.5	10.2	29.9	9.9	13.1	12.9	20.8	22.0	5.9	19.4	12.3	17.6	5.3	5.0	8.6	4.9	4.8	7.3	9.1	8.4	10.3	7.9	8.9	9.2	0.0	6.2	3.2	6.2	7.1	4.3	15.8	18.4	24.9	16.6	17.3	10.0	21.1	11.8	16.1	20.2
METTL22	"C16orf68, FLJ12433, MGC2654"	ENSG00000067365	"Methyltransferase like 22"	Q9BUU2	16	8621683-8649654	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040803, HPA059882, HPA074173"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA040803: AB_10795479, HPA059882: , HPA074173: "	"unprognostic (1.74e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (2.79e-8)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.90e-2)"	8.4	10.6	5.4	10.5	8.8	12.5	8.0	17.1	10.2	9.6	10.9	10.9	13.6	9.2	13.0	12.2	7.6	8.6	9.8	15.0	7.0	7.3	7.1	9.5	6.5	10.8	7.9	6.8	10.8	10.6	7.3	7.6	9.4	9.3	10.5	7.9	10.2	9.5	15.6	45.2	15.7	6.4	11.4	6.3	8.1	9.8	27.8	9.3	10.4	10.1	10.0	9.1	9.7	9.9	1.1	2.8	12.6	3.0	1.8	1.6	1.4	3.7	7.7	8.8	8.4	3.3	8.5	7.6	6.4	3.4	7.7	8.7	7.5	8.7	5.8	5.8	5.6	7.1	5.5	10.2	5.1	8.5	7.5	6.0	13.5	21.2	10.0	6.1	4.6	8.5	7.4	8.4	9.3	6.1	8.1	6.0	5.8	13.3	6.3	14.8	4.7	7.6	9.6	6.6	12.1	3.8	4.0	10.8	7.2	5.6	6.6	4.2	7.2	5.1	4.7	9.1	8.0	7.4	2.9	8.1	4.3	9.1	3.3	8.2	4.2	1.4	3.0	2.4	1.3	2.3	1.2	1.1	1.1	1.3	2.8	1.1	1.5	0.7	12.6	1.8	2.5	1.6	1.6	1.4	5.4	8.8	17.1	10.2	7.0	7.3	7.9	6.8	9.3	9.3
METTL27	WBSCR27	ENSG00000165171	"Methyltransferase like 27"	Q8N6F8	7	73834590-73842535	"Disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.4;RPMI-8226: 39.9;T-47d: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA022420	Uncertain		Supported	"Focal adhesion sites"				"Focal adhesion sites"		"HPA022420: AB_2304370"	"unprognostic (6.70e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-1)"	"prognostic favourable (1.10e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.24e-2)"	5.7	2.7	1.5	1.4	2.6	0.3	5.2	4.2	3.9	10.2	3.6	3.8	14.5	3.3	5.3	4.4	5.8	9.3	12.4	0.9	1.4	1.3	9.2	2.7	4.7	6.0	1.2	6.0	5.2	11.1	10.0	4.0	8.7	2.8	8.0	1.3	2.4	20.3	12.4	2.3	2.0	4.5	1.3	1.3	5.1	1.7	10.6	0.8	3.0	6.6	0.9	3.1	4.3	3.6	2.4	1.4	2.0	3.4	0.0	9.2	0.3	6.2	7.7	0.0	0.6	1.2	3.4	1.3	0.0	0.1	0.2	0.2	0.4	9.4	1.5	1.4	1.3	0.6	0.0	2.5	0.1	1.0	0.1	0.0	2.3	2.3	1.3	0.0	0.0	1.4	0.6	4.0	1.9	1.5	0.1	1.3	0.9	1.7	0.0	0.0	0.1	2.0	0.4	1.7	39.9	2.1	1.2	0.7	0.2	0.8	0.7	0.7	11.7	0.3	1.7	2.5	0.6	4.8	2.5	1.8	0.6	0.0	0.5	0.0	0.7	0.0	1.0	2.0	0.1	3.4	0.0	2.4	0.6	0.0	1.4	1.0	1.2	0.8	1.0	0.0	0.8	1.0	9.2	0.3	1.5	2.6	4.2	3.9	1.4	1.3	1.2	6.0	2.8	0.8
METTL7A	DKFZP586A0522	ENSG00000185432	"Methyltransferase like 7A"	Q9H8H3	12	50923472-50932517	"Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 126.5;thyroid gland: 120.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 75.5;Karpas-707: 75.4;RPMI-8226: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 29.7;classical monocyte: 12.7;eosinophil: 25.8;intermediate monocyte: 14.2;memory B-cell: 13.6;myeloid DC: 11.5;naive B-cell: 14.7;non-classical monocyte: 20.2;plasmacytoid DC: 10.1"	"Low lineage specificity"	"Detected in all"											HPA017434			Supported	"Lipid droplets"			140000	"Lipid droplets"		"HPA017434: AB_1853835"	"unprognostic (2.31e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.48e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (8.64e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-2)"	38.3	35.2	25.3	10.3	32.1	4.4	44.8	22.7	21.5	21.4	36.6	17.8	15.6	18.3	16.1	13.0	19.9	29.1	25.2	12.8	27.1	12.6	43.0	126.5	26.4	24.5	29.3	22.2	29.0	35.6	11.9	10.5	7.9	26.5	13.6	20.0	13.0	19.0	14.2	16.1	10.9	22.3	19.4	32.2	16.0	28.1	17.3	25.9	3.6	120.3	9.4	16.0	29.1	15.8	14.7	11.5	29.7	20.2	3.8	3.7	5.4	0.2	0.0	1.8	10.9	75.5	21.7	23.8	0.2	1.8	0.1	0.3	0.9	1.0	12.8	0.9	0.8	1.5	1.1	1.2	0.0	1.3	2.8	3.1	2.3	7.3	16.4	0.7	6.6	22.6	0.1	0.1	0.0	5.0	1.8	75.4	0.7	0.0	0.6	3.3	8.9	0.0	0.7	0.1	41.6	3.5	13.5	4.2	6.9	0.2	7.4	0.2	21.6	0.7	2.9	0.1	0.2	0.9	0.0	3.8	0.6	5.7	1.4	1.5	0.0	29.7	12.7	25.8	1.0	14.2	0.6	13.6	0.4	0.8	11.5	14.7	0.1	0.7	0.8	3.8	20.2	10.1	3.7	5.4	25.3	32.1	22.7	20.0	27.1	12.6	29.3	22.2	26.5	25.9
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681546-55684611	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.8;CAPAN-2: 23.9;EFO-21: 17.9;Hep G2: 11.6;LHCN-M2: 19.8;THP-1: 17.5;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0"	"Group enriched"	"Detected in many"	56	"B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038644	Enhanced		Supported	Vesicles,Microtubules				Microtubules	Vesicles	"HPA038644: "	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (2.43e-1)"	1.3	0.9	1.2	2.1	0.9	0.1	0.5	0.5	2.2	0.4	15.2	3.0	0.0	15.2	0.4	35.7	0.3	0.7	8.1	46.1	4.6	0.6	12.6	82.4	0.8	0.8	1.8	1.5	0.3	1.2	0.0	1.3	4.3	3.2	0.3	6.0	1.4	0.4	0.1	2.7	0.5	44.7	0.4	1.0	3.1	1.0	0.4	0.6	0.0	1.0	0.1	0.0	0.3	0.3	2.5	8.6	0.0	5.4	0.0	0.0	0.4	0.2	9.1	0.0	0.2	1.9	6.7	0.1	0.3	1.3	0.1	0.6	11.8	23.9	4.8	17.9	0.5	0.0	1.7	0.1	0.3	0.0	2.3	0.4	1.5	11.6	0.0	0.2	0.0	1.7	0.0	0.4	0.0	0.0	0.1	0.0	19.8	8.2	0.0	0.1	2.4	1.1	0.0	0.6	1.1	0.2	0.0	0.0	0.1	0.9	0.0	1.6	1.6	17.5	0.0	1.3	1.6	0.2	1.2	0.0	0.2	1.4	18.2	4.1	0.1	0.0	1.0	0.0	0.0	5.4	0.0	0.7	0.0	0.0	8.6	2.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.4	1.2	0.9	0.5	2.2	4.6	0.6	1.8	1.5	3.2	0.6
MEX3A	"RKHD4, RNF162"	ENSG00000254726	"Mex-3 RNA binding family member A"	A1L020	1	156072013-156081998	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 7.2;ovary: 10.1"	"Cell line enhanced"	"Detected in many"		"AF22: 25.0;NTERA-2: 22.7;SCLC-21H: 23.6;SH-SY5Y: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062703			Supported	Cytosol				Cytosol		"HPA062703: "	"unprognostic (8.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (9.23e-8)"	"unprognostic (4.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.96e-2)"	0.4	0.2	1.8	1.0	1.8	0.8	2.5	3.3	5.1	2.5	1.3	1.4	0.2	0.7	7.2	0.7	1.4	1.7	1.1	0.2	3.5	1.0	1.1	1.8	0.6	3.4	1.9	2.1	10.1	0.6	0.4	0.4	0.8	2.2	1.7	1.0	1.0	2.0	0.6	0.2	0.7	0.6	1.7	1.0	1.4	0.5	3.1	2.0	3.6	1.5	0.2	1.1	1.9	1.4	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	25.0	6.2	0.3	0.4	2.9	0.6	0.1	1.0	0.9	1.4	0.3	0.7	2.9	0.3	0.5	10.8	0.4	1.2	1.2	2.9	0.6	1.1	2.4	0.5	0.3	0.5	0.7	0.8	0.5	0.4	4.7	5.6	0.0	1.4	1.6	2.8	0.4	22.7	3.2	9.2	2.0	0.1	0.8	1.1	23.6	43.1	0.7	2.8	1.4	4.8	1.8	1.6	1.5	3.9	0.4	1.4	0.5	0.4	1.3	0.1	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	3.3	2.0	3.5	1.0	1.9	2.1	2.2	2.0
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824802	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favourable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	23.7	32.9	23.8	25.4	25.0	12.5	24.3	35.5	29.2	22.5	19.5	17.7	20.0	15.9	25.2	27.2	28.0	21.2	16.8	21.9	24.6	21.2	28.1	20.0	16.8	26.7	21.5	30.9	29.2	20.0	38.5	33.0	25.2	24.0	26.3	20.7	15.5	21.9	21.8	33.3	24.4	19.3	21.5	26.7	23.9	21.0	21.7	27.3	33.9	28.2	19.2	34.1	24.1	28.2	21.2	20.3	34.3	21.5	29.6	26.0	15.1	15.2	15.9	27.7	18.2	23.6	14.9	17.1	24.7	17.2	20.1	23.5	24.7	10.0	16.4	23.6	15.2	27.8	24.6	20.1	23.8	27.7	14.8	39.8	28.7	18.5	18.5	23.6	21.3	13.8	22.1	19.1	17.4	19.6	35.9	14.1	23.9	11.4	19.2	17.9	19.5	13.9	28.2	27.8	10.5	20.8	22.9	17.6	17.3	21.7	18.6	10.0	28.0	15.2	18.5	20.4	14.5	22.4	19.9	17.4	41.9	35.9	17.2	22.6	14.9	21.4	15.8	34.3	23.4	21.5	22.9	21.2	23.4	22.0	20.3	18.6	24.1	23.5	14.4	29.6	17.1	16.7	26.0	15.1	23.8	25.0	35.5	29.2	24.6	21.2	21.5	30.9	24.0	27.3
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 14.3;RT4: 23.4;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306"	Approved		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"			Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: "	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favourable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.1	3.4	15.0	1.3	19.6	2.7	10.2	4.9	19.4	11.4	2.1	21.1	4.2	1.0	4.9	32.9	1.2	4.0	2.6	1.9	15.4	11.1	25.6	29.5	2.7	1.2	21.8	10.0	1.1	1.6	5.7	3.3	5.5	21.1	2.9	2.2	17.5	2.0	11.7	4.2	19.7	1.1	3.9	16.4	1.7	1.3	30.6	20.8	0.0	2.8	0.2	1.0	11.9	1.5	0.0	0.7	7.9	0.8	0.0	0.8	6.9	0.2	3.5	1.9	1.9	1.6	0.8	0.7	3.8	0.5	1.8	1.6	1.2	0.2	0.0	0.1	5.9	1.8	6.8	0.8	0.8	0.0	2.6	0.0	3.7	1.4	0.9	0.0	14.3	1.1	2.1	0.2	0.6	0.2	0.5	0.7	3.6	2.0	0.6	0.5	2.0	3.0	0.0	1.1	0.0	5.1	23.4	1.6	3.5	3.2	21.6	6.9	1.2	0.0	0.1	1.8	7.1	3.5	7.3	0.3	0.0	0.0	4.8	0.7	7.1	7.9	0.2	2.1	0.8	0.8	0.4	0.0	0.7	0.2	0.3	0.0	0.3	0.1	4.9	0.0	0.0	0.7	0.1	6.9	15.0	19.6	4.9	15.4	15.4	11.1	21.8	10.0	21.1	20.8
MFF	"C2orf33, GL004"	ENSG00000168958	"Mitochondrial fission factor"	Q9GZY8	2	227325151-227357836	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010968, HPA074625"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA010968: AB_1845714, HPA074625: "	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.22e-1)"	20.2	23.9	31.6	18.0	27.6	22.3	21.3	25.7	38.4	19.6	22.5	26.5	14.7	22.1	21.9	20.9	21.5	18.0	17.1	40.5	27.8	28.4	33.7	24.4	16.6	27.1	30.2	20.2	25.7	27.6	25.0	19.3	17.7	28.0	20.6	22.5	25.6	20.6	27.6	37.4	16.7	18.6	22.9	33.4	16.9	18.8	97.0	20.6	25.9	19.8	22.2	23.3	20.7	17.8	40.2	34.9	59.9	33.8	29.3	44.1	33.1	22.8	19.6	24.2	33.3	31.3	30.2	32.1	22.8	30.9	27.9	29.8	21.4	16.4	13.1	27.3	24.9	19.0	39.8	29.0	37.9	27.7	31.9	27.6	50.8	53.5	41.4	26.7	24.8	27.0	38.3	26.4	28.3	24.0	24.0	39.4	24.6	23.1	28.2	41.1	32.8	20.8	25.6	30.6	25.3	40.7	21.6	25.7	24.1	50.1	23.3	33.3	14.9	26.5	16.2	27.2	23.0	40.1	25.3	32.1	21.8	26.3	35.9	23.8	36.9	42.4	32.9	59.9	32.8	33.8	35.3	40.2	34.5	32.0	34.5	38.2	36.6	31.0	31.0	29.3	30.6	34.9	44.1	33.1	31.6	27.6	25.7	38.4	27.8	28.4	30.2	20.2	28.0	20.6
MFN1	FLJ20693	ENSG00000171109	"Mitofusin 1"		3	179347692-179394931	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033437, HPA059230"	Approved		Supported	Mitochondria				Mitochondria		"CAB033437: AB_2250540, HPA059230: "	"unprognostic (2.94e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavourable (6.70e-4)"	"prognostic favourable (6.11e-4)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (8.08e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.91e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.79e-2)"	13.7	16.5	12.2	12.1	17.2	9.9	15.4	24.3	22.4	18.4	16.5	15.9	19.4	12.0	19.6	21.3	19.6	18.5	13.4	31.1	12.0	11.4	17.9	14.9	12.3	16.0	16.9	14.5	16.6	29.9	18.2	22.3	12.4	21.5	17.7	14.6	12.8	17.4	17.4	21.7	19.6	16.6	15.7	16.0	18.2	17.8	11.8	17.0	16.9	14.5	20.1	19.6	17.6	15.1	10.5	4.1	8.9	4.5	4.1	7.3	2.1	16.7	5.0	9.7	15.7	13.9	13.0	12.9	10.4	10.8	11.0	13.2	12.4	6.9	5.7	11.0	15.4	9.9	13.6	10.3	19.4	8.9	10.5	9.3	11.6	6.8	11.4	4.9	8.9	9.0	9.1	11.9	8.4	14.0	6.8	7.6	15.4	8.9	7.2	3.7	11.5	9.3	5.1	15.3	21.1	10.5	17.7	9.2	13.1	9.8	26.3	14.2	36.0	3.6	11.7	9.7	10.8	15.0	15.2	10.2	11.0	9.5	10.8	8.3	10.4	5.5	3.8	8.5	4.3	4.5	7.3	7.8	4.9	4.4	3.4	10.5	4.6	5.1	8.9	4.1	3.6	4.1	4.4	2.1	12.2	17.2	24.3	22.4	12.0	11.4	16.9	14.5	21.5	17.0
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917732-127966034	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favourable (2.21e-4)"	8.9	9.6	9.1	11.7	15.4	5.3	13.0	19.6	15.4	12.2	12.1	14.6	9.4	17.1	19.0	11.9	10.3	9.8	9.2	7.5	8.9	10.1	12.6	19.1	9.1	9.7	9.3	11.8	13.2	14.5	16.7	21.5	18.0	15.8	10.2	15.6	14.8	10.9	9.7	7.2	11.0	15.0	12.4	11.8	13.5	12.0	9.4	10.2	12.9	13.6	7.1	15.0	9.9	10.5	7.0	5.8	7.1	8.2	5.4	8.3	4.1	8.3	6.9	7.2	4.0	6.4	5.7	6.2	6.2	8.0	8.1	8.2	4.3	11.9	3.9	12.2	11.2	6.9	8.4	6.3	11.8	9.0	6.7	4.7	7.8	6.6	7.1	5.0	5.9	6.2	2.1	7.6	5.8	8.6	8.1	5.2	11.5	7.6	4.3	1.7	1.4	4.6	4.6	0.5	4.5	5.8	11.8	7.3	2.6	7.8	7.9	3.3	4.6	3.4	4.5	2.7	2.8	10.1	5.8	11.4	18.9	8.8	8.7	4.3	7.3	4.6	5.6	7.1	7.1	6.2	6.2	7.0	7.9	6.6	4.5	3.6	8.3	8.3	6.3	5.4	8.2	5.8	8.0	4.1	9.1	15.4	19.6	15.4	8.9	10.1	9.3	11.8	15.8	10.2
MGA	"FLJ12634, KIAA0518, MAD5, MXD5"	ENSG00000174197	"MGA, MAX dimerization protein"	Q8IWI9	15	41621224-41773081	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042278, HPA058183"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA042278: AB_10794647, HPA058183: "	"unprognostic (5.78e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.97e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.82e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.89e-1)"	9.3	11.3	13.8	13.6	15.3	14.3	13.0	28.2	16.9	14.5	10.1	13.3	12.2	6.8	14.2	11.5	9.8	11.3	7.8	10.1	11.2	7.7	10.1	8.5	8.5	12.7	18.7	10.5	22.7	12.0	18.0	27.6	12.4	13.7	11.0	9.7	7.2	10.3	10.8	11.8	11.2	10.6	11.8	16.1	12.5	9.8	16.4	14.7	22.4	13.9	5.3	13.4	11.6	11.5	5.0	4.1	4.9	4.9	9.8	5.0	1.5	1.4	8.4	10.6	6.9	8.3	6.6	8.5	4.2	4.2	5.0	5.0	8.9	4.9	9.9	7.6	4.8	5.8	16.3	3.6	6.9	4.7	5.3	21.0	13.8	7.8	7.4	19.2	10.5	5.0	4.6	6.9	6.9	6.4	24.4	4.5	4.4	4.1	11.6	7.5	6.5	4.3	13.2	10.8	5.1	2.6	6.0	10.0	9.8	14.9	5.2	2.7	4.2	12.3	6.8	6.1	8.6	6.2	4.9	6.2	9.2	9.7	3.8	7.4	3.0	4.9	2.3	2.5	4.7	1.8	4.6	4.8	3.7	5.0	2.4	5.0	3.9	4.3	1.2	9.8	4.9	4.1	1.8	1.5	13.8	15.3	28.2	16.9	11.2	7.7	18.7	10.5	13.7	14.7
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266163-139280338	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 88.9;retina: 30.7"	"Cell line enhanced"	"Detected in some"		"BJ: 10.5;fHDF/TERT166: 15.6;HHSteC: 12.7;HUVEC TERT2: 31.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;cerebellum: 8.0"	"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in single"			HPA015994	Enhanced		Supported	Mitochondria				Mitochondria		"HPA015994: "	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"	3.2	88.9	1.0	0.5	4.5	0.4	1.2	8.0	1.2	3.6	1.0	2.1	1.1	0.4	2.6	3.0	0.5	0.8	1.3	6.1	0.8	1.4	1.0	0.4	0.5	0.6	1.0	0.0	20.1	0.5	0.4	15.3	0.5	1.5	2.0	0.5	30.7	0.4	2.0	0.6	0.5	0.4	2.3	0.7	0.6	0.4	5.9	0.5	0.0	0.5	0.0	0.5	2.1	1.0	0.5	0.0	0.0	0.3	0.5	1.7	0.3	0.0	0.5	0.3	0.2	0.8	0.4	0.0	10.5	0.0	1.5	0.0	0.0	0.1	0.0	0.1	15.6	0.2	2.2	0.0	0.9	0.0	1.0	0.0	0.0	0.1	12.7	0.1	0.1	3.8	0.3	1.7	0.1	31.7	0.2	0.2	2.6	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.2	4.4	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	1.7	0.4	0.0	0.3	1.6	0.7	0.0	0.5	0.2	0.0	0.3	0.3	1.0	4.5	8.0	1.2	0.8	1.4	1.0	0.0	1.5	0.5
MGAT2	GNT-II	ENSG00000168282	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase"	Q10469	14	49620795-49623481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043721, HPA056824"	Approved		Supported	"Golgi apparatus"			5000000	"Golgi apparatus"		"HPA043721: , HPA056824: "	"unprognostic (1.20e-2)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	14.0	17.0	7.4	14.0	7.1	5.0	12.3	7.3	8.4	11.7	16.5	7.8	16.5	13.9	12.9	14.1	11.7	11.4	16.8	10.1	6.2	6.6	13.2	34.4	10.3	20.5	6.1	7.2	15.3	27.9	4.8	8.2	14.1	5.8	9.4	13.7	10.7	34.9	19.1	5.1	6.3	29.1	9.7	7.1	20.9	12.3	27.7	5.8	18.2	9.0	7.2	14.8	11.6	9.1	15.5	28.2	22.1	22.8	12.0	24.7	23.2	18.7	9.3	7.1	12.0	17.0	16.5	4.6	20.8	20.7	19.3	17.5	11.2	14.3	19.0	17.8	18.9	15.0	10.0	12.0	20.9	19.4	8.9	12.1	6.9	11.0	13.4	27.8	28.4	12.6	9.7	11.4	16.2	23.1	9.2	52.6	20.3	7.1	9.6	17.8	7.3	15.0	10.9	20.8	16.4	15.1	10.9	7.4	8.0	14.9	3.9	11.7	12.0	19.0	23.9	17.6	19.1	12.7	14.8	56.9	27.3	17.0	8.5	13.9	11.8	21.7	22.8	22.1	23.0	20.0	24.7	15.5	21.3	20.7	23.6	10.4	12.6	17.3	6.8	12.0	21.6	28.2	18.2	23.2	7.4	7.1	7.3	8.4	6.2	6.6	6.1	7.2	5.8	5.8
MGEA5	"MEA5, NCOAT, OGA"	ENSG00000198408	"Meningioma expressed antigen 5 (hyaluronidase)"	O60502	10	101784443-101818465	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036141, HPA076501"	Approved		Supported	Cytosol				Cytosol		"HPA036141: AB_10672079, HPA076501: "	"unprognostic (4.34e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (8.69e-5)"	"unprognostic (4.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.23e-3)"	29.5	17.5	51.9	27.4	54.4	49.3	35.5	58.9	51.4	24.5	27.0	29.0	20.9	17.6	29.9	36.8	26.0	23.3	19.1	27.4	46.0	29.8	27.7	28.6	24.0	40.1	30.7	43.6	33.8	20.9	53.3	22.1	25.5	42.6	31.6	26.5	30.7	24.4	26.3	25.4	36.6	28.5	37.4	29.5	35.2	23.9	21.9	35.4	32.9	25.9	11.8	39.5	34.3	26.7	8.1	3.3	14.7	5.6	6.8	7.1	1.4	30.6	15.6	22.9	44.3	14.7	35.7	15.9	21.6	21.9	10.1	17.4	11.5	19.7	20.5	15.8	25.7	22.1	21.3	27.2	21.5	30.0	14.6	20.5	21.8	8.9	15.9	15.1	11.6	34.5	30.6	17.3	41.3	18.7	14.4	38.1	17.1	15.6	15.9	15.8	12.6	15.8	22.2	25.2	15.0	16.9	27.8	9.9	17.6	19.3	10.5	27.0	27.6	16.5	28.3	15.6	15.1	22.5	24.7	19.1	30.3	16.4	19.6	26.0	8.5	10.5	2.1	6.8	7.1	2.0	5.6	6.4	4.9	6.1	1.3	8.1	6.8	5.7	14.7	6.8	5.6	3.3	4.5	1.4	51.9	54.4	58.9	51.4	46.0	29.8	30.7	43.6	42.6	35.4
MGLL	"HU-K5, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-127823250	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 45.6;BJ hTERT+: 52.6;LHCN-M2: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm			4300000	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavourable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	72.2	6.7	29.4	22.6	29.7	7.5	39.0	32.8	36.9	13.3	36.3	8.3	8.4	16.5	8.7	10.8	63.8	16.3	24.1	35.5	23.6	10.2	22.6	32.1	32.4	6.0	15.4	17.8	3.9	3.6	1.7	5.0	18.9	10.2	10.6	27.6	10.0	31.4	13.6	40.9	11.9	22.3	13.6	12.2	19.2	17.5	3.2	15.5	2.4	6.4	33.4	19.7	14.4	14.5	1.8	30.4	11.6	28.5	0.6	0.9	6.0	11.0	9.9	0.0	0.0	17.4	20.6	1.3	45.6	52.6	10.1	16.3	0.3	4.5	2.8	12.7	15.4	0.4	0.0	6.0	5.6	4.9	0.1	0.3	7.1	0.0	6.3	0.0	0.3	7.7	3.5	18.9	20.7	21.4	0.0	0.5	42.0	1.1	0.0	0.1	0.0	15.8	0.0	5.4	23.4	37.9	1.2	5.8	0.4	7.8	15.5	2.7	0.7	0.4	27.4	11.1	3.3	26.7	6.2	0.0	0.0	9.3	23.0	0.6	34.3	4.2	2.8	11.6	0.2	28.5	0.9	1.8	0.2	0.3	3.1	0.2	0.0	0.0	0.5	0.6	18.3	30.4	0.0	6.0	29.4	29.7	32.8	36.9	23.6	10.2	15.4	17.8	10.2	15.5
MGME1	"bA504H3.4, C20orf72, DDK1"	ENSG00000125871	"Mitochondrial genome maintenance exonuclease 1"	Q9BQP7	20	17968913-17991122	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040913	Approved		Supported	Mitochondria				Mitochondria		"HPA040913: AB_10962835"	"unprognostic (5.81e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavourable (6.98e-8)"	"unprognostic (5.31e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavourable (1.13e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.89e-2)"	8.7	14.2	6.4	12.0	7.6	10.9	14.9	7.0	6.7	8.4	10.5	11.7	8.2	10.2	7.3	8.6	14.3	5.4	6.5	10.5	7.3	4.8	10.5	11.3	6.5	13.9	11.5	7.2	5.8	9.6	7.1	14.1	19.9	8.4	8.5	10.7	10.4	11.0	7.8	17.8	26.9	10.9	5.2	9.8	19.5	7.6	12.9	8.3	31.8	15.5	7.6	16.9	10.6	9.6	13.2	10.9	24.1	8.5	8.8	9.2	4.5	16.9	19.7	16.2	15.2	6.7	11.8	21.8	14.3	10.6	13.8	18.9	24.3	17.3	20.2	8.1	6.3	25.4	16.7	21.3	21.1	7.4	13.8	13.1	11.0	36.6	4.9	8.5	22.5	7.1	15.0	20.5	10.8	11.0	17.8	13.2	27.7	12.7	15.2	11.7	14.2	17.5	11.6	36.3	19.1	12.0	12.5	12.5	10.4	10.1	24.7	21.6	23.6	6.0	8.8	24.0	19.4	11.8	15.4	9.9	22.0	17.3	6.1	6.6	17.4	24.0	8.5	24.1	4.9	8.1	6.4	11.4	6.3	6.4	6.8	13.2	4.5	4.3	8.2	8.8	7.5	10.9	9.2	4.5	6.4	7.6	7.0	6.7	7.3	4.8	11.5	7.2	8.4	8.3
MGMT		ENSG00000170430	"O-6-methylguanine-DNA methyltransferase"	P16455	10	129467184-129768007	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002786, HPA032135, HPA032136, HPA069497, CAB069881"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002786: , CAB069881: AB_10002128, HPA032135: , HPA032136: , HPA069497: "	"unprognostic (1.10e-1)"	"prognostic favourable (9.42e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.81e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.54e-4)"	"unprognostic (6.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.32e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	11.7	11.3	7.4	15.5	7.6	7.1	11.3	3.5	9.1	8.3	12.2	10.0	19.6	10.8	15.3	17.1	9.9	15.2	14.1	10.5	7.1	7.1	12.6	45.6	7.5	11.6	8.6	6.6	12.3	16.5	5.7	5.8	4.5	9.2	11.2	3.4	11.8	14.9	24.5	14.4	9.2	9.6	10.9	8.1	8.6	9.9	11.7	3.9	16.0	10.2	14.9	14.7	12.6	13.0	20.3	17.7	6.5	15.3	18.2	21.2	16.6	0.0	2.6	2.8	13.3	5.8	12.1	10.4	5.9	6.6	4.3	4.2	16.2	17.3	12.1	9.5	7.6	7.9	1.7	6.3	1.9	0.0	1.0	2.4	5.9	10.3	9.0	0.2	6.9	7.7	0.0	2.5	0.0	0.0	0.0	8.5	5.3	21.8	9.5	12.4	0.6	10.4	11.0	0.0	4.7	7.9	5.9	2.8	7.0	7.1	2.9	0.0	11.4	9.4	0.0	5.7	2.9	0.0	0.0	0.0	0.0	6.1	0.0	3.9	0.0	2.6	15.3	6.5	19.1	14.8	18.6	20.3	17.5	17.8	15.8	19.9	17.6	18.9	1.8	18.2	13.7	17.7	21.2	16.6	7.4	7.6	3.5	9.1	7.1	7.1	8.6	6.6	9.2	3.9
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA family member 3, ER export factor"	Q5JRA6	1	222618086-222668012	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA055922, HPA056816"	Supported		Enhanced	Vesicles	"Intracellular and membrane"		750000	Vesicles		"HPA055922: , HPA056816: "	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	20.5	24.1	21.4	17.4	23.7	25.8	25.0	32.8	25.0	23.3	19.3	10.0	26.2	18.7	23.5	24.4	15.7	18.1	18.5	19.5	18.4	17.4	19.5	63.7	18.4	19.0	17.0	18.8	23.4	34.1	30.2	34.7	22.7	25.6	30.1	23.1	9.9	32.8	31.7	25.5	16.5	23.2	21.3	22.9	23.0	36.6	29.3	19.6	19.5	25.6	19.5	19.3	26.8	19.8	18.6	14.9	29.4	20.1	22.0	18.3	11.1	11.8	9.0	14.0	21.3	44.5	22.4	23.5	17.0	25.5	18.9	22.5	9.3	12.3	9.7	16.3	19.3	20.3	14.9	15.7	19.4	16.8	9.3	13.4	9.3	14.5	40.8	23.0	16.3	20.5	15.1	18.0	31.9	19.7	17.2	23.9	14.2	7.1	17.9	14.9	15.5	12.9	12.2	38.0	23.5	9.7	11.8	15.2	16.0	17.5	15.9	14.2	17.0	15.1	14.3	12.8	9.8	21.6	18.1	27.3	17.3	12.2	16.0	11.1	16.8	23.6	14.6	29.4	17.4	19.5	18.3	18.3	15.0	17.0	10.4	18.6	17.8	17.4	24.8	22.0	20.1	14.9	16.0	11.1	21.4	23.7	32.8	25.0	18.4	17.4	17.0	18.8	25.6	19.6
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	12.1	9.1	15.3	7.9	20.6	5.9	15.7	16.1	17.4	16.6	10.9	16.3	9.7	6.9	19.1	13.7	11.4	11.5	12.0	9.4	16.3	12.9	15.7	14.1	10.1	9.6	17.4	16.5	17.2	11.7	18.4	11.5	14.9	15.5	14.7	10.1	14.6	12.0	12.6	9.6	12.5	8.4	17.9	13.8	9.4	10.7	11.5	18.1	13.9	19.1	9.8	10.6	13.0	13.8	1.2	1.2	3.5	1.7	2.5	2.0	0.6	8.4	3.3	16.5	11.4	8.8	10.6	3.9	6.8	7.6	4.9	7.1	4.9	3.1	7.2	6.3	9.4	5.7	9.6	9.2	11.1	9.4	4.5	8.0	4.3	6.8	7.2	16.3	3.4	6.8	10.2	5.7	14.7	12.2	11.0	21.3	7.5	4.1	7.8	6.2	4.2	4.4	51.5	13.6	17.8	8.3	7.5	5.4	13.3	11.7	5.4	6.0	3.9	10.7	10.4	12.5	6.3	5.2	9.0	11.2	3.9	11.1	5.3	10.4	7.4	3.5	1.7	0.6	1.0	0.9	1.2	1.2	1.5	1.0	0.6	0.6	1.2	0.9	1.5	2.5	0.5	1.2	2.0	0.6	15.3	20.6	16.1	17.4	16.3	12.9	17.4	16.5	15.5	18.1
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024559	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2"	"Group enriched"	"Detected in many"	6	"B-cells: 5.2;granulocytes: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"				"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: "	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	10.1	9.0	15.4	20.7	19.2	10.2	9.6	62.2	25.0	12.8	22.4	30.0	8.8	8.3	30.3	14.0	13.8	28.6	9.5	23.7	15.4	13.8	8.7	16.8	6.1	15.2	21.6	15.6	20.2	10.2	30.4	11.0	11.9	19.4	11.8	16.5	14.2	8.0	14.8	28.0	14.7	13.2	26.1	20.9	12.2	11.1	15.7	22.6	3.0	10.4	7.8	20.8	14.7	15.1	5.2	0.3	10.0	0.1	1.3	1.1	0.2	13.7	15.1	8.0	13.0	6.0	7.8	9.7	12.1	13.2	17.2	13.6	14.4	1.9	15.4	6.2	16.5	15.9	11.8	14.0	16.7	14.9	11.2	16.0	16.1	6.0	4.0	7.1	8.6	6.3	11.2	18.1	19.2	10.0	17.5	9.9	6.3	12.3	6.7	4.4	5.5	9.9	9.4	12.0	0.7	13.8	9.7	21.2	8.3	17.1	10.9	25.8	4.3	3.0	17.6	17.7	11.4	12.1	25.2	6.5	11.5	20.6	15.4	3.2	50.7	10.0	0.0	0.1	0.5	0.1	0.8	3.3	0.6	0.5	0.1	5.2	0.3	0.2	0.2	1.3	0.0	0.3	1.1	0.2	15.4	19.2	62.2	25.0	15.4	13.8	21.6	15.6	19.4	22.6
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Uncertain		Supported	"Cell Junctions,Centriolar satellite,Cytosol"				"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: "	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	8.0	4.8	5.3	10.1	10.3	6.3	12.6	5.9	7.3	19.1	25.2	21.4	17.6	6.1	21.3	11.0	32.3	11.1	14.4	6.0	7.5	5.5	6.4	5.7	11.8	9.2	17.4	5.1	6.8	14.2	19.2	4.3	29.6	12.5	15.3	7.5	8.7	13.4	25.2	8.5	24.4	9.2	43.5	18.7	5.9	28.5	7.4	11.1	5.3	9.4	15.5	13.5	21.4	17.5	2.8	3.3	2.3	1.6	4.1	2.6	1.6	10.7	6.0	6.5	7.0	6.5	5.6	26.0	15.3	8.7	15.0	11.3	8.2	5.8	4.7	4.7	10.1	28.0	5.0	29.9	10.9	8.0	13.2	1.9	6.3	8.0	10.7	5.3	5.4	4.7	46.8	17.9	37.2	10.3	3.3	4.5	13.1	5.1	1.3	2.4	2.3	4.5	7.1	12.4	2.5	3.9	29.9	4.5	8.0	9.5	8.4	8.1	5.0	5.1	14.2	25.2	20.8	16.7	12.4	4.6	1.5	3.0	22.8	2.4	12.2	0.4	1.1	0.6	1.8	1.6	2.3	2.5	1.4	2.2	1.7	2.8	2.6	1.3	2.3	4.1	0.6	3.3	0.9	1.6	5.3	10.3	5.9	7.3	7.5	5.5	17.4	5.1	12.5	11.1
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favourable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	16.8	36.4	22.9	14.4	25.3	17.0	15.4	56.3	30.7	18.2	16.9	18.9	11.6	20.9	29.7	14.3	13.3	20.5	18.6	24.0	23.3	21.7	58.9	64.7	16.7	11.2	20.9	22.7	25.0	11.6	21.1	23.4	16.3	25.2	14.9	19.2	15.1	15.5	13.8	36.9	16.3	21.5	22.2	17.5	18.1	24.1	11.8	15.0	15.1	13.8	14.6	11.9	20.0	15.2	6.5	9.5	39.0	21.7	5.6	6.5	11.5	15.8	28.0	17.9	20.9	28.9	27.2	8.1	17.5	39.8	26.2	36.2	16.4	30.1	21.5	14.9	24.5	19.0	22.4	15.8	31.0	19.1	18.3	14.5	15.7	23.7	22.9	19.9	16.0	27.1	14.3	28.7	26.8	22.5	22.3	25.4	30.4	14.4	17.4	18.9	7.5	6.8	19.1	24.1	14.1	32.1	11.8	13.8	19.8	20.7	25.9	16.1	15.4	19.3	13.8	13.0	20.2	25.7	14.5	13.5	22.4	15.1	26.0	26.6	8.8	7.3	21.7	39.0	6.5	18.3	5.7	5.8	5.8	6.0	9.5	6.5	5.7	4.8	18.3	5.6	18.4	6.1	5.5	11.5	22.9	25.3	56.3	30.7	23.3	21.7	20.9	22.7	25.2	15.0
MIER1	"hMI-ER1, KIAA1610, MI-ER1"	ENSG00000198160	"MIER1 transcriptional regulator"	Q8N108	1	66924895-66988619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019589, HPA050306"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA019589: AB_1853953, HPA050306: "	"unprognostic (3.38e-3)"	"unprognostic (1.34e-1)"	"prognostic favourable (4.96e-4)"	"unprognostic (1.63e-1)"	"prognostic favourable (3.44e-8)"	"unprognostic (1.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.45e-2)"	23.5	20.0	13.9	23.2	14.8	70.3	19.9	15.9	14.9	22.2	22.9	10.8	18.8	13.2	19.3	17.9	16.0	15.0	19.0	12.5	13.3	12.9	16.0	20.7	19.4	22.2	14.8	10.9	22.9	11.8	11.2	20.2	18.5	13.3	19.9	20.7	10.8	12.6	22.5	14.0	14.1	22.3	25.6	15.0	23.0	16.1	15.9	13.9	30.4	17.4	13.9	16.3	23.9	34.3	8.5	7.6	24.3	12.2	9.6	14.9	5.3	14.0	8.3	10.1	18.2	21.0	14.5	11.3	14.9	16.8	15.2	16.5	6.7	8.8	14.2	5.6	16.7	9.3	12.6	16.0	21.8	16.6	9.6	31.1	22.2	10.4	17.0	24.4	18.5	14.3	12.2	16.9	17.6	16.3	16.3	12.8	17.4	4.4	35.4	8.9	14.2	5.3	15.6	24.5	9.8	12.7	16.1	6.2	11.8	22.1	13.6	14.5	7.3	16.2	19.1	17.4	12.4	17.0	13.6	15.9	14.7	20.6	14.2	10.7	10.5	21.6	7.4	16.6	12.8	8.0	14.9	7.5	11.6	11.3	5.5	8.5	12.0	11.7	24.3	9.6	12.2	7.6	9.5	5.3	13.9	14.8	15.9	14.9	13.3	12.9	14.8	10.9	13.3	13.9
MIER3	"DKFZp686L09111, DKFZp781I1119, FLJ35954"	ENSG00000155545	"MIER family member 3"	Q7Z3K6	5	56919602-56971675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058349, HPA065946"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA058349: , HPA065946: "	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.31e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-3)"	7.5	7.3	5.6	8.0	7.7	8.0	10.9	23.0	10.7	10.9	25.9	7.7	5.4	19.4	15.3	8.0	7.1	8.4	5.5	6.5	5.9	5.4	6.7	9.5	6.1	6.6	9.2	7.4	13.5	14.7	12.1	12.5	8.7	9.2	8.2	19.5	9.6	7.9	8.7	8.2	6.2	14.1	8.0	8.5	6.4	6.9	15.0	8.1	12.4	8.6	7.7	6.6	7.4	12.2	4.1	4.4	4.4	4.1	3.8	6.0	3.4	6.4	9.3	13.0	24.5	8.7	6.9	18.0	6.0	7.8	11.5	12.8	14.8	5.4	6.9	7.3	7.0	8.1	16.3	6.4	12.3	3.5	7.5	5.9	11.2	7.0	6.6	8.0	12.3	8.0	8.1	8.5	7.1	7.4	7.6	11.9	6.6	7.0	12.1	9.2	10.3	5.5	20.3	12.3	7.1	5.4	12.8	10.9	17.4	18.2	6.8	9.0	9.9	7.6	7.1	3.3	10.3	5.9	10.8	7.5	9.9	17.4	6.3	6.2	7.1	0.6	2.4	4.4	3.3	4.1	4.9	4.1	2.6	6.0	3.8	4.0	4.8	3.3	2.3	3.8	3.3	4.4	2.5	3.4	5.6	7.7	23.0	10.7	5.9	5.4	9.2	7.4	9.2	8.1
MIF4GD	"AD023, MGC45027, MIFD, SLIP1"	ENSG00000125457	"MIF4G domain containing"	A9UHW6	17	75266228-75271227	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 67.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051222	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA051222: "	"unprognostic (1.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.15e-2)"	"prognostic favourable (2.70e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.31e-2)"	19.0	13.9	10.4	14.5	11.1	30.5	13.3	7.4	14.6	11.9	12.9	20.8	14.2	10.3	16.8	12.8	18.3	13.9	20.4	20.4	10.2	8.2	16.0	15.1	15.1	30.4	12.0	9.9	12.2	16.2	18.2	7.4	15.9	12.0	12.0	11.7	15.5	15.4	11.5	34.4	18.6	14.1	20.4	15.4	22.0	11.7	12.6	10.9	21.8	15.0	20.7	20.9	16.6	12.2	14.1	67.0	11.3	21.5	14.5	17.5	14.4	11.8	21.0	4.7	10.9	7.6	2.2	6.7	3.0	8.6	6.1	4.2	7.4	13.4	18.5	5.5	4.8	9.5	5.7	10.6	4.6	9.1	14.4	9.1	9.1	6.5	8.4	8.0	10.7	2.1	16.7	4.2	17.4	12.6	12.0	22.6	1.6	23.1	25.5	19.1	2.1	10.3	16.6	6.0	25.2	12.3	6.5	7.0	10.3	6.2	16.4	15.2	30.3	18.7	4.8	3.1	7.6	3.9	6.1	33.1	8.5	15.6	5.8	14.2	4.1	5.7	21.5	11.3	15.4	11.0	16.2	14.1	12.5	13.7	25.4	13.0	11.4	12.0	3.8	14.5	13.1	67.0	17.5	14.4	10.4	11.1	7.4	14.6	10.2	8.2	12.0	9.9	12.0	10.9
MIGA1	"FAM73A, FLJ35093"	ENSG00000180488	"Mitoguardin 1"	Q8NAN2	1	77779624-77879539	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017589	Approved		Supported	Mitochondria				Mitochondria		"HPA017589: AB_1848409"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.31e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.75e-2)"	11.7	11.0	12.2	6.9	23.7	8.1	19.2	18.1	25.4	10.5	8.2	20.3	7.2	9.7	12.0	7.5	8.7	9.1	10.3	8.6	15.7	16.1	20.2	11.2	8.3	6.6	19.2	19.7	12.7	8.9	28.0	13.9	10.1	26.4	13.3	8.0	7.6	12.1	9.6	15.7	7.6	10.6	10.1	29.9	7.5	9.8	7.6	18.8	5.9	21.8	5.1	5.9	10.5	8.1	6.2	3.7	7.3	6.8	5.8	6.7	3.2	8.5	5.5	3.5	4.4	8.6	11.2	9.2	12.4	5.9	7.3	7.5	6.1	5.9	3.7	13.8	8.5	5.9	4.7	7.3	13.9	5.4	4.8	4.3	6.8	2.8	8.8	4.0	3.4	8.0	8.0	14.9	10.9	7.3	2.4	5.1	11.0	1.3	3.9	2.3	3.0	6.9	2.1	8.5	1.9	8.8	9.3	7.0	5.7	5.7	8.7	15.8	3.3	2.6	11.7	10.5	4.9	15.8	12.9	3.0	4.3	2.3	9.3	3.5	4.5	7.3	5.5	6.6	5.9	6.8	6.2	4.6	4.7	4.7	3.7	6.2	6.7	5.9	3.5	5.8	4.3	3.0	4.3	3.2	12.2	23.7	18.1	25.4	15.7	16.1	19.2	19.7	26.4	18.8
MINDY1	"FAM63A, FLJ11280, MINDY-1"	ENSG00000143409	"MINDY lysine 48 deubiquitinase 1"	Q8N5J2	1	150996086-151008375	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 26.3;eosinophil: 19.1;neutrophil: 30.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028351, HPA028358, HPA061086"	Approved		Enhanced	Nucleoplasm			240000	Nucleoplasm		"HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: "	"unprognostic (5.73e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.06e-1)"	"prognostic favourable (3.43e-8)"	"unprognostic (2.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.06e-2)"	9.2	9.7	14.0	6.7	31.1	5.6	13.0	18.4	21.2	13.1	13.5	53.8	14.8	14.0	14.7	6.5	24.1	14.4	11.8	24.5	17.6	10.1	26.6	12.2	10.9	5.2	37.5	13.5	19.3	37.3	26.2	12.3	5.9	25.0	11.7	14.8	16.9	25.3	21.0	11.9	17.1	12.1	13.7	34.1	10.7	15.9	14.7	35.7	0.9	39.9	7.9	10.3	12.3	13.0	0.6	4.0	30.4	3.2	1.5	2.2	3.4	6.0	4.0	4.3	6.0	7.7	6.4	3.6	2.0	5.0	2.8	4.5	8.5	14.5	0.3	4.7	2.5	3.0	3.4	3.7	1.3	4.6	5.1	5.9	7.3	7.2	1.7	1.7	2.4	5.2	3.4	5.0	1.4	7.1	3.6	15.3	2.9	9.3	0.3	4.0	2.0	1.4	4.4	0.7	18.7	13.2	12.1	7.4	5.4	3.8	6.9	4.2	27.6	6.0	6.6	2.4	3.1	1.2	1.7	5.6	5.1	20.4	5.8	3.9	11.3	26.3	3.2	19.1	0.1	1.5	0.1	0.3	1.3	0.3	4.0	0.6	2.2	0.7	30.4	1.5	0.9	0.6	1.6	3.4	14.0	31.1	18.4	21.2	17.6	10.1	37.5	13.5	25.0	35.7
MINDY2	"FAM63B, KIAA1164"	ENSG00000128923	"MINDY lysine 48 deubiquitinase 2"	Q8NBR6	15	58771192-58861900	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051103, HPA063669"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA051103: , HPA063669: "	"unprognostic (4.71e-2)"	"unprognostic (8.92e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (4.74e-2)"	"prognostic favourable (3.00e-8)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.77e-2)"	14.0	9.2	15.5	8.8	14.7	5.6	11.1	41.0	15.4	12.4	8.8	12.4	11.8	5.8	13.0	8.0	11.8	11.7	10.4	16.7	14.6	12.6	16.9	5.8	12.5	6.1	16.2	15.5	11.7	6.4	15.5	12.5	21.9	14.9	15.0	6.6	11.7	7.7	11.8	6.1	11.4	6.5	13.6	16.9	9.4	7.8	6.2	15.8	8.6	15.8	5.4	6.0	13.1	9.1	4.6	2.9	5.5	3.1	1.9	5.5	1.4	5.7	2.8	4.0	2.4	6.1	11.2	6.4	5.3	11.3	1.6	2.4	4.5	2.9	2.9	5.8	6.3	5.6	7.3	4.3	2.6	3.0	2.6	4.1	3.1	4.0	3.7	3.1	3.8	4.9	7.2	1.9	4.5	4.0	7.1	3.3	3.9	0.7	3.8	2.3	8.6	1.5	1.7	11.6	3.1	4.9	6.5	3.7	2.7	3.8	5.4	9.6	1.6	6.6	4.7	2.3	2.1	39.9	2.3	3.0	4.2	2.9	5.2	5.1	5.6	5.5	1.8	3.3	3.2	1.6	5.5	2.7	2.8	3.5	0.6	4.6	2.4	3.3	3.9	1.9	3.1	2.9	2.2	1.4	15.5	14.7	41.0	15.4	14.6	12.6	16.2	15.5	14.9	15.8
MINDY3	"C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042"	ENSG00000148481	"MINDY lysine 48 deubiquitinase 3"	Q9H8M7	10	15778170-15860520	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038400, HPA038406"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA038400: AB_10669724, HPA038406: "	"unprognostic (9.20e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.85e-2)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.19e-1)"	14.6	22.0	17.9	10.0	22.2	15.2	18.4	22.0	32.0	19.1	13.7	19.7	11.4	8.2	18.6	20.0	13.4	15.3	13.3	8.9	20.1	18.8	16.0	15.8	15.5	11.9	22.9	14.0	18.1	12.8	16.3	14.4	20.1	25.8	18.9	18.0	13.5	11.8	16.5	4.1	15.3	11.4	16.7	32.0	11.8	14.6	18.8	16.1	10.5	17.2	7.7	12.6	17.8	14.1	3.4	4.2	5.7	8.0	3.4	6.2	2.9	6.5	6.1	11.9	12.6	17.6	16.8	9.8	20.9	10.6	16.0	18.7	5.3	10.3	4.9	4.0	22.5	6.1	10.1	12.4	14.3	14.9	14.1	15.9	8.7	5.7	22.2	3.2	13.4	12.6	10.9	14.2	10.1	12.5	9.7	4.1	15.8	7.1	6.9	3.9	4.3	11.7	3.4	7.0	3.4	17.8	4.9	9.8	10.9	10.2	9.9	8.3	11.1	7.9	13.2	10.4	8.0	17.5	6.0	22.6	9.6	8.4	11.9	7.3	8.3	5.7	3.6	3.1	4.9	7.1	4.1	3.1	3.4	5.2	4.0	3.4	2.3	4.4	3.1	3.4	8.0	4.2	6.2	2.9	17.9	22.2	22.0	32.0	20.1	18.8	22.9	14.0	25.8	16.1
MINDY4	"C7orf67, FAM188B, FLJ22374"	ENSG00000106125	"MINDY lysine 48 deubiquitinase 4"	Q4G0A6	7	30771417-30892387	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 16.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;T-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019475, HPA030129, HPA030130"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	9.3	6.7	9.3	2.6	15.2	4.1	7.0	3.4	15.1	10.8	6.6	5.4	16.6	2.9	15.6	16.2	5.7	20.7	10.0	7.5	8.4	5.1	9.4	3.8	14.2	2.4	4.3	9.5	14.8	5.6	9.6	16.1	6.2	9.0	9.4	4.3	7.8	5.3	15.9	3.7	5.1	3.7	10.8	3.6	2.3	5.8	20.1	5.0	1.5	12.5	3.6	2.2	6.4	6.3	0.0	1.1	0.0	0.3	0.0	2.7	0.7	2.1	5.3	2.7	8.4	2.4	9.5	4.1	3.1	5.3	2.3	2.0	0.0	3.9	0.0	3.6	2.0	2.2	1.8	1.7	2.2	0.0	3.1	1.6	2.8	0.0	3.1	2.3	1.2	4.8	2.8	7.0	1.4	3.4	16.2	1.0	2.0	0.0	1.2	0.7	7.9	1.2	0.4	0.0	0.5	6.3	1.0	5.1	7.0	2.1	11.2	1.2	5.7	1.7	2.0	0.1	1.3	2.4	1.3	2.3	2.9	0.0	4.4	0.1	9.8	0.0	0.1	0.0	0.6	0.0	2.7	0.0	0.8	0.2	1.1	0.0	0.3	0.5	0.0	0.0	0.3	0.0	0.5	0.7	9.3	15.2	3.4	15.1	8.4	5.1	4.3	9.5	9.0	5.0
MINOS1	"C1orf151, FLJ36999, Mic10, MIO10, RP5-1056L3.2"	ENSG00000173436	"Mitochondrial inner membrane organizing system 1"	Q5TGZ0	1	19596977-19629821	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059930	Enhanced		Supported	Mitochondria				Mitochondria		"HPA059930: "	"unprognostic (3.84e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (2.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"prognostic favourable (8.11e-4)"	10.1	9.7	22.0	8.1	21.3	5.4	12.6	20.4	22.2	17.7	16.3	7.2	7.5	10.6	14.5	13.7	15.1	15.2	13.7	25.4	18.3	21.4	19.8	12.5	9.7	8.3	20.6	15.5	14.0	13.3	14.5	16.6	8.3	17.0	17.2	18.3	9.3	13.8	17.8	25.2	10.1	17.4	18.2	12.1	8.9	11.4	5.0	11.8	7.7	13.7	20.3	11.8	13.9	10.9	7.0	8.4	9.0	10.5	3.7	11.3	8.9	7.5	10.5	6.0	6.5	11.5	10.9	3.7	6.6	7.4	7.8	7.9	7.3	7.0	6.4	5.5	8.7	5.6	10.3	8.7	12.6	9.7	7.2	5.6	16.8	10.1	5.1	8.7	4.2	8.9	14.3	7.7	9.5	11.3	12.0	4.8	11.6	13.4	4.4	11.4	5.1	13.3	4.4	7.2	8.5	19.1	4.6	12.4	5.5	7.3	5.9	5.7	5.8	4.9	7.5	6.1	4.7	7.7	6.5	3.1	5.1	6.6	4.8	16.6	5.7	5.6	8.1	9.0	6.4	10.5	5.8	7.0	8.7	7.0	8.2	6.7	11.3	8.1	5.5	3.7	10.5	8.4	7.8	8.9	22.0	21.3	20.4	22.2	18.3	21.4	20.6	15.5	17.0	11.8
MIOS	"FLJ20323, MIO, Sea4"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566872-7608929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: "	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favourable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	9.9	7.8	6.7	14.4	9.5	10.3	9.6	11.7	10.3	9.9	7.0	7.3	10.3	5.5	8.8	8.7	17.1	8.1	6.4	8.0	7.3	5.6	12.0	11.2	7.4	13.9	5.7	7.2	9.0	16.2	24.6	14.9	11.0	16.8	14.7	8.7	10.9	12.3	14.3	67.7	15.3	8.9	8.0	8.8	15.2	10.6	11.9	7.8	14.0	6.8	14.6	19.0	9.3	12.2	10.5	8.3	8.9	11.0	6.4	7.5	4.2	19.1	8.6	10.4	12.4	8.2	17.6	8.7	15.1	12.0	9.6	9.7	10.6	7.5	16.9	4.7	8.9	17.4	10.5	11.0	12.8	6.8	9.2	4.2	10.3	7.0	11.5	18.1	4.8	14.6	13.9	8.5	21.6	8.6	21.1	13.9	40.6	13.3	4.0	8.3	21.0	9.2	12.6	15.9	16.2	8.7	9.8	10.9	17.7	7.9	22.9	8.9	12.5	16.4	7.4	15.0	16.1	8.3	12.7	12.5	13.7	15.2	13.1	10.6	17.4	0.0	5.9	8.9	5.1	11.0	4.3	10.5	5.5	4.7	8.3	9.5	7.5	5.8	0.6	6.4	5.3	5.0	5.4	4.2	6.7	9.5	11.7	10.3	7.3	5.6	5.7	7.2	16.8	7.8
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889419	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favourable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	7.3	14.9	6.2	7.1	12.2	4.4	11.0	4.7	10.3	8.1	12.2	12.9	12.1	8.4	9.6	20.4	14.4	17.1	11.7	16.9	8.8	5.3	24.7	12.0	8.2	8.4	5.1	8.0	8.5	14.7	8.1	15.4	5.3	9.1	10.9	13.1	9.1	12.9	10.1	16.2	22.0	8.9	11.5	4.4	6.5	9.8	13.9	4.9	8.9	10.9	15.7	11.1	11.2	8.6	9.2	6.5	1.2	10.6	9.7	10.0	3.9	8.9	10.1	5.0	11.7	11.5	15.5	10.7	6.5	10.1	9.8	8.2	13.4	17.8	10.5	6.6	5.2	22.6	11.5	13.6	12.2	6.1	7.3	4.6	4.8	11.5	9.4	10.7	2.5	7.6	17.1	10.1	9.0	12.2	8.8	1.7	15.2	6.6	7.6	6.0	6.9	10.2	8.5	13.5	9.1	21.8	6.0	11.8	3.9	6.9	11.4	13.6	11.7	6.0	6.7	6.0	5.0	9.8	6.9	1.7	2.4	5.6	10.3	5.5	7.4	0.0	3.0	1.2	7.9	3.7	10.0	9.2	7.7	7.1	6.5	7.7	7.4	7.3	0.0	9.7	10.6	5.6	5.1	3.9	6.2	12.2	4.7	10.3	8.8	5.3	5.1	8.0	9.1	4.9
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751126-764318	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"gallbladder: 24.6;intestine: 63.8"	"Cell line enhanced"	"Detected in some"		"A549: 37.1;HaCaT: 27.5;hTCEpi: 25.8;MCF7: 18.9;SK-BR-3: 41.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	0.5	0.1	0.3	7.9	0.3	0.0	0.7	0.2	0.2	1.5	42.8	0.2	0.2	45.9	0.7	0.8	0.4	2.4	24.6	0.2	0.5	0.2	6.9	0.4	6.8	0.2	0.3	0.3	2.2	2.0	0.0	4.2	2.1	0.2	2.2	13.0	0.2	0.5	0.5	0.2	0.3	63.8	0.7	0.2	0.2	5.8	0.2	0.2	0.3	0.2	0.8	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	37.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.7	13.6	3.2	3.6	0.0	27.5	0.0	11.5	0.0	0.0	0.0	0.0	14.6	3.9	0.0	0.0	0.5	0.0	25.8	0.1	1.4	0.0	0.0	0.1	0.0	18.9	0.0	0.2	0.0	7.6	0.0	0.1	0.3	9.3	10.3	0.4	0.1	13.1	41.8	0.0	9.1	0.0	0.0	0.0	4.7	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.5	0.2	0.3	0.3	0.2	0.2
MITD1	LOC129531	ENSG00000158411	"Microtubule interacting and trafficking domain containing 1"	Q8WV92	2	99161427-99181058	"Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036162, HPA036163"	Approved		Enhanced	Vesicles				Vesicles		"HPA036162: AB_10672236, HPA036163: "	"prognostic favourable (5.96e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavourable (1.47e-6)"	"unprognostic (1.39e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavourable (1.32e-11)"	"unprognostic (2.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.91e-2)"	"prognostic favourable (5.46e-8)"	18.8	19.1	19.6	26.3	34.2	11.7	18.8	20.6	30.2	16.6	17.6	13.5	14.4	15.6	17.7	15.5	20.0	16.6	14.2	13.6	21.1	12.5	17.9	17.1	15.2	33.6	29.0	12.5	18.4	13.8	6.6	28.9	16.8	21.6	14.9	21.0	12.7	15.5	13.4	12.8	15.9	18.9	17.8	30.2	25.9	17.4	7.0	33.1	20.2	17.7	14.0	28.4	16.5	26.7	25.0	24.0	22.9	20.8	19.2	21.5	10.3	24.6	6.6	13.5	5.1	16.0	20.8	18.6	11.8	16.7	16.6	22.7	8.1	20.9	17.2	13.7	9.6	18.7	13.2	13.1	27.9	24.4	9.0	15.1	9.9	17.2	23.9	25.4	9.0	16.4	11.3	14.6	14.1	18.7	12.4	10.6	15.0	5.9	24.3	37.7	11.4	13.2	13.7	19.5	14.7	20.9	13.9	4.4	6.6	11.6	10.7	14.6	5.6	20.3	14.0	10.3	13.5	10.8	14.5	12.6	9.8	23.4	18.8	21.6	10.2	12.9	20.8	14.3	15.2	18.1	17.0	25.0	21.5	18.0	17.6	24.9	20.9	16.7	22.9	19.2	16.2	24.0	18.2	10.3	19.6	34.2	20.6	30.2	21.1	12.5	29.0	12.5	21.6	33.1
MKI67	"MIB-, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2;lymphoid tissue: 81.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.4;T-reg: 1.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 1.1;T-cells: 1.4"									"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB000058: AB_2142367, CAB068198: , HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	1.8	1.2	0.2	9.9	0.5	25.2	1.8	0.3	0.5	1.5	5.0	0.6	0.2	3.6	0.7	1.4	13.4	0.3	1.2	1.3	0.2	0.2	1.2	1.0	1.9	8.8	0.2	0.2	0.5	0.4	0.0	0.4	2.9	0.5	0.7	5.8	0.5	2.2	0.6	0.5	3.9	6.2	1.3	0.8	6.5	3.5	2.5	0.2	81.5	0.4	5.2	10.0	1.3	3.5	0.0	0.0	0.0	0.0	1.1	1.4	0.4	47.3	24.1	25.1	17.8	1.0	2.1	7.8	18.0	13.3	17.1	15.3	19.7	19.7	35.7	5.2	12.3	28.9	26.3	13.5	25.8	37.6	12.7	30.6	17.8	12.3	0.0	43.0	16.6	0.5	0.6	17.6	18.0	16.7	14.0	34.4	16.9	18.8	25.6	13.1	10.0	11.0	19.1	32.9	4.7	6.2	13.3	8.7	9.5	25.5	9.2	4.4	7.5	9.2	15.4	9.1	18.2	12.8	48.6	15.7	12.4	43.3	7.5	19.7	7.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.4	1.0	0.0	1.1	0.0	0.0	1.3	0.4	0.2	0.5	0.3	0.5	0.2	0.2	0.2	0.2	0.5	0.2
MKKS	BBS6	ENSG00000125863	"McKusick-Kaufman syndrome"	Q9NPJ1	20	10401009-10434222	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Chaperone	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041071, HPA044233"	Enhanced		Supported	Centrosome				Centrosome		"HPA041071: AB_10960408, HPA044233: AB_10962986"	"unprognostic (9.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavourable (9.84e-5)"	"unprognostic (5.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.79e-9)"	"unprognostic (3.69e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.01e-1)"	13.1	15.9	24.3	11.0	26.8	3.1	15.7	31.0	31.6	18.3	19.6	9.9	18.7	21.8	13.9	18.1	15.0	16.1	16.0	25.3	23.7	22.4	33.2	30.6	12.1	11.9	22.4	21.5	17.5	15.2	27.6	16.1	11.7	21.8	16.3	23.0	11.5	18.7	23.8	29.5	11.3	22.0	17.0	16.8	12.1	13.5	20.6	11.6	8.3	20.1	24.0	12.9	13.2	12.9	15.1	22.6	22.6	22.0	13.5	20.9	20.0	12.0	15.1	12.7	18.9	14.4	11.8	4.7	8.6	8.6	9.8	8.3	5.0	6.7	9.2	3.7	7.3	15.3	15.1	15.8	11.9	1.6	6.6	20.7	4.2	16.2	11.1	13.4	4.8	11.4	26.7	9.8	21.2	8.3	11.6	7.1	12.0	5.4	12.5	11.8	9.5	10.2	8.3	13.2	9.5	15.5	5.9	18.4	12.3	7.3	35.4	18.7	10.0	9.7	4.0	8.7	8.4	10.7	14.5	5.7	20.8	4.7	7.8	14.6	9.3	22.6	22.0	18.8	15.9	19.9	18.6	15.1	18.0	14.2	22.6	10.7	20.9	19.5	10.9	13.5	19.5	17.7	13.5	20.0	24.3	26.8	31.0	31.6	23.7	22.4	22.4	21.5	21.8	11.6
MKL1	"BSAC, KIAA1438, MAL, MKL, MRTF-A"	ENSG00000196588	"Megakaryoblastic leukemia (translocation) 1"	Q969V6	22	40410281-40636702	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Actin-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 50.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 26.4;granulocytes: 50.9;monocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030782	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030782: AB_10600930"	"unprognostic (7.90e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavourable (1.58e-7)"	"unprognostic (9.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.98e-1)"	18.1	11.1	15.4	25.4	19.1	69.2	15.8	16.2	26.1	17.6	14.2	13.5	10.1	11.3	27.6	12.9	12.3	17.5	13.2	16.3	14.2	11.1	11.3	8.9	17.4	25.6	11.8	16.6	16.9	14.5	10.2	10.5	18.9	12.6	14.2	9.4	13.3	16.9	15.7	14.3	18.0	13.6	15.7	11.0	23.9	14.3	25.4	10.8	28.2	17.3	9.0	25.5	15.5	14.6	4.9	26.4	50.9	15.0	3.8	5.6	7.5	10.7	14.6	6.3	7.5	8.0	6.1	12.4	10.5	6.8	9.7	9.4	6.8	3.3	11.5	4.3	11.0	14.2	5.3	12.9	6.3	12.7	9.3	19.0	16.3	10.1	7.9	22.0	37.5	6.6	15.6	9.4	6.5	7.1	5.3	5.2	4.6	10.5	8.6	24.7	5.0	5.1	14.0	7.1	5.8	7.7	8.1	3.5	3.8	17.2	8.7	6.3	5.8	24.9	11.6	6.6	17.7	8.7	9.0	7.0	6.2	16.5	5.4	11.1	12.7	12.0	15.0	50.9	4.4	11.6	4.1	3.2	4.0	3.4	17.8	4.9	5.6	4.7	14.5	3.8	15.0	26.4	5.2	7.5	15.4	19.1	16.2	26.1	14.2	11.1	11.8	16.6	12.6	10.8
MKL2	"FLJ31823, MRTF-B"	ENSG00000186260	"MKL1/myocardin like 2"	Q9ULH7	16	14071321-14266773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011286	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA011286: AB_1853973"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (6.20e-4)"	"unprognostic (5.22e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.96e-2)"	25.2	9.8	32.5	7.7	44.9	5.5	22.0	7.4	47.8	19.0	9.1	5.1	9.2	8.9	18.1	8.8	13.7	13.5	12.4	13.2	18.3	9.0	8.2	8.0	16.2	7.0	7.7	26.8	8.2	10.9	28.2	16.4	19.6	8.5	15.2	10.5	8.3	15.0	15.4	11.1	15.9	9.6	14.7	9.9	4.7	10.3	15.4	12.1	2.6	16.3	6.8	7.4	14.0	15.1	7.1	3.7	0.9	1.5	2.3	5.0	1.2	12.8	13.3	14.1	10.1	4.5	8.6	6.4	3.7	10.3	5.7	8.6	5.9	12.6	7.1	9.6	6.2	10.6	9.7	10.8	10.5	16.8	5.3	4.8	10.6	9.8	6.4	3.2	4.2	7.0	11.5	9.8	6.6	11.0	5.8	8.7	4.4	11.0	9.6	2.4	4.5	3.9	15.3	10.5	6.5	5.7	13.3	4.9	8.5	17.9	7.7	3.7	13.7	2.6	7.5	11.9	11.6	3.4	4.8	5.9	6.2	6.7	12.8	5.4	8.9	0.4	1.0	0.3	2.7	1.4	3.6	7.1	4.0	2.0	1.5	3.9	5.0	3.0	0.9	2.3	1.5	3.7	1.8	1.2	32.5	44.9	7.4	47.8	18.3	9.0	7.7	26.8	8.5	12.1
MKNK1	MNK1	ENSG00000079277	"MAP kinase interacting serine/threonine kinase 1"	Q9BUB5	1	46557408-46616843	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: "	"unprognostic (4.05e-3)"	"prognostic favourable (7.05e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.38e-2)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (3.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (1.51e-5)"	"unprognostic (7.02e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.67e-3)"	17.6	12.0	10.7	16.2	10.5	16.8	12.1	13.7	12.3	9.2	12.6	11.0	9.6	9.7	11.9	13.3	12.2	11.1	11.4	12.3	10.8	7.0	9.4	10.8	16.1	16.3	9.9	9.8	10.7	72.3	8.6	11.3	15.4	11.0	9.9	13.3	11.9	10.6	7.7	12.8	10.2	12.7	13.3	8.1	25.6	11.7	7.6	8.7	12.5	8.8	15.8	10.9	10.9	14.5	4.9	6.0	33.3	12.1	5.0	22.0	6.1	19.3	13.1	8.7	9.6	7.8	11.6	11.6	9.8	9.8	11.9	16.2	15.1	8.0	12.8	12.1	9.8	23.5	14.5	16.0	12.7	21.9	12.9	27.0	15.0	12.9	12.2	14.4	22.0	15.2	11.1	15.5	8.5	13.9	14.1	9.4	6.4	12.7	10.3	12.9	5.9	15.6	9.5	18.2	12.8	12.7	20.3	6.1	5.5	18.9	17.1	15.8	11.5	16.1	11.2	4.3	0.9	13.5	10.9	8.0	13.3	10.9	8.4	18.6	7.9	3.9	12.1	14.3	7.5	11.5	22.0	4.6	6.6	6.8	6.0	4.9	4.8	7.0	33.3	5.0	8.1	4.4	4.4	6.1	10.7	10.5	13.7	12.3	10.8	7.0	9.9	9.8	11.0	8.7
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAP kinase interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.5"	"Cell line enhanced"	"Detected in all"		"HHSteC: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: "	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favourable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	30.3	15.6	7.6	24.2	8.5	31.9	31.1	16.6	9.7	12.5	22.7	6.5	21.4	13.1	9.3	18.4	42.1	11.0	21.7	33.3	7.5	5.7	10.3	22.0	24.5	16.9	10.3	3.3	13.8	53.1	8.3	13.4	16.7	9.2	18.8	8.4	14.2	35.2	32.5	207.5	19.3	15.1	13.0	7.0	27.8	16.7	9.1	9.1	16.0	32.3	47.1	32.8	21.2	63.6	10.7	5.9	26.9	8.0	6.1	7.5	2.2	13.1	14.8	6.3	13.8	46.9	17.0	14.2	7.8	5.6	5.6	5.7	9.5	23.1	18.6	10.8	15.7	16.3	7.9	22.8	2.5	25.3	7.4	7.5	12.5	10.1	78.8	14.7	13.6	18.1	55.5	10.6	22.6	13.2	12.9	33.3	3.8	7.7	8.8	12.3	16.5	16.2	16.9	1.8	23.5	9.9	8.6	8.7	10.4	18.3	27.1	33.4	11.2	18.3	19.8	2.0	8.0	8.2	9.3	54.3	21.0	18.2	16.5	11.1	3.7	2.7	6.1	5.7	5.6	6.3	5.1	10.7	5.8	6.2	4.8	10.2	3.7	4.5	26.9	6.1	8.0	5.9	7.5	2.2	7.6	8.5	16.6	9.7	7.5	5.7	10.3	3.3	9.2	9.1
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993332-37050918	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: , HPA060714: "	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	16.3	20.7	18.2	19.4	21.4	24.4	18.7	19.7	19.6	15.3	17.3	28.8	19.6	12.4	18.7	23.6	15.1	16.2	14.4	32.0	17.3	17.7	18.8	20.5	17.8	22.8	19.9	16.0	17.6	18.1	26.0	29.4	17.3	19.2	18.5	17.7	16.7	15.6	18.1	46.4	14.2	14.1	21.1	21.6	20.7	16.5	27.6	21.5	29.0	22.2	19.5	24.5	16.9	21.4	12.0	12.9	13.2	23.2	6.7	13.4	9.0	14.0	22.2	27.8	0.0	12.4	15.5	12.4	21.0	16.8	24.5	26.1	16.7	15.7	34.9	10.4	17.0	9.7	23.8	17.7	26.2	15.8	12.3	24.4	20.5	23.4	13.7	29.9	17.0	11.5	12.6	22.8	28.4	15.1	31.2	16.7	24.8	11.3	31.1	12.3	20.3	12.2	3.1	33.9	14.7	15.5	15.2	5.9	14.0	21.3	22.6	14.0	32.7	21.3	11.9	19.2	20.8	18.9	24.6	13.2	36.1	32.6	14.9	28.3	17.2	10.9	11.7	13.2	13.4	19.5	9.7	12.0	8.4	10.7	12.9	10.3	9.6	9.7	3.4	6.7	23.2	6.1	12.5	9.0	18.2	21.4	19.7	19.6	17.3	17.7	19.9	16.0	19.2	21.5
MLLT1	"ENL, LTG19, YEATS1"	ENSG00000130382	"MLLT1, super elongation complex subunit"	Q03111	19	6210379-6279948	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031166	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA031166: AB_10601874"	"unprognostic (3.21e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"prognostic favourable (6.03e-5)"	"unprognostic (1.30e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.93e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-3)"	20.1	13.7	21.8	17.1	23.4	8.8	12.9	32.7	28.6	17.7	16.8	16.8	17.7	13.4	22.1	15.5	13.1	25.5	19.3	18.2	16.9	14.3	10.7	12.8	16.7	10.9	13.0	18.5	29.8	22.4	26.2	10.7	45.2	14.6	17.2	6.8	18.7	21.7	18.8	23.5	18.8	13.1	15.0	10.6	13.9	15.1	10.7	13.7	10.8	18.9	12.1	10.2	20.6	23.6	1.5	5.2	4.9	3.5	1.9	2.5	1.6	24.4	12.0	14.9	17.5	11.7	10.1	17.3	15.2	9.9	12.8	13.2	19.8	8.3	17.8	19.9	19.9	15.3	11.8	14.9	7.7	14.9	18.4	22.1	32.6	14.9	22.5	14.3	20.3	16.3	13.1	12.2	10.0	14.5	21.3	20.8	8.4	13.5	24.4	13.7	18.1	25.4	21.0	11.1	14.2	6.9	15.2	25.9	23.5	15.7	17.4	18.8	15.7	17.0	15.1	18.0	14.0	27.8	20.9	25.6	19.8	14.0	20.8	24.7	25.5	0.2	1.9	0.4	1.8	3.0	2.5	1.5	1.3	1.7	1.4	1.4	1.1	1.5	4.9	1.9	3.5	5.2	0.5	1.6	21.8	23.4	32.7	28.6	16.9	14.3	13.0	18.5	14.6	13.7
MLLT10	AF10	ENSG00000078403	"MLLT10, histone lysine methyltransferase DOT1L cofactor"	P55197	10	21524675-21743630	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005747	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA005747: AB_1079393"	"unprognostic (6.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.31e-2)"	"prognostic favourable (8.75e-4)"	"unprognostic (1.03e-3)"	"unprognostic (9.56e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.85e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	16.3	12.1	11.7	18.4	14.3	21.9	12.8	25.4	13.6	19.0	17.0	12.0	13.6	8.5	26.3	12.8	14.7	14.5	13.7	15.8	10.2	8.5	12.3	13.5	12.3	11.6	10.5	9.9	21.4	12.3	16.6	23.2	20.3	11.8	12.6	11.3	14.6	13.2	16.3	13.4	18.7	12.1	18.7	11.2	10.6	11.4	71.2	14.3	14.6	18.1	9.7	15.2	18.5	19.6	5.5	6.9	12.0	6.8	5.3	7.2	2.8	14.3	12.2	18.9	13.1	12.0	15.1	20.7	9.1	5.8	11.4	11.2	13.0	15.4	17.2	5.1	10.1	13.5	20.8	12.2	11.5	11.9	12.0	26.6	10.6	18.7	14.8	0.6	17.2	11.2	14.6	9.5	11.0	15.1	28.4	13.4	9.0	11.1	20.7	12.5	7.7	3.9	18.0	10.1	14.4	11.0	6.8	6.6	18.4	12.1	14.5	20.4	6.8	18.5	13.6	7.2	12.6	14.3	9.0	11.7	13.4	19.2	8.3	10.3	5.5	10.6	6.8	12.0	5.3	4.6	5.2	5.0	6.2	5.7	5.6	5.5	7.2	6.7	5.8	5.3	5.2	6.9	4.6	2.8	11.7	14.3	25.4	13.6	10.2	8.5	10.5	9.9	11.8	14.3
MLLT11	AF1Q	ENSG00000213190	"MLLT11, transcription factor 7 cofactor"	Q13015	1	151057758-151068497	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.1"	"Cell line enhanced"	"Detected in many"		"AF22: 38.4;EFO-21: 29.2;SH-SY5Y: 42.1;U-698: 35.8"	"Cancer enhanced"	"Detected in all"		"glioma: 29.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000540	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA000540: "	"unprognostic (2.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (4.26e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (4.25e-12)"	"unprognostic (5.66e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-3)"	1.9	7.5	13.6	3.4	9.1	1.1	1.2	16.3	42.1	1.9	2.1	5.1	1.2	0.8	3.7	1.2	1.3	0.8	11.1	11.8	11.3	16.4	1.2	1.2	5.3	2.3	10.3	1.2	4.2	1.3	8.4	1.8	1.2	3.2	1.3	1.1	1.2	1.5	1.2	2.6	1.0	2.0	4.2	5.8	2.1	0.9	1.2	1.2	2.0	1.2	1.2	2.6	3.2	1.2	2.4	1.0	6.5	1.0	4.2	9.2	2.8	1.2	5.2	38.4	6.0	0.6	1.0	0.6	2.4	2.6	2.3	4.2	0.5	2.5	1.9	29.2	1.8	1.5	9.2	2.2	1.3	11.2	2.5	5.0	3.8	0.1	1.2	0.3	0.8	1.7	0.3	12.7	0.5	16.9	5.3	0.9	7.4	0.4	17.6	3.3	16.7	0.8	16.8	5.1	0.1	4.3	1.1	23.1	42.1	0.2	0.4	1.2	1.4	0.6	11.8	5.0	5.5	1.8	4.3	0.9	0.8	35.8	12.4	0.3	9.3	1.6	0.6	1.6	5.9	0.7	2.7	2.4	3.9	6.0	0.8	2.1	5.3	9.2	6.5	4.2	1.0	1.0	3.6	2.8	13.6	9.1	16.3	21.0	11.3	16.4	10.3	1.2	3.2	1.2
MLLT3	"AF-9, AF9, YEATS3"	ENSG00000171843	"MLLT3, super elongation complex subunit"	P42568	9	20341665-20622543	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.8;T-cells: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001824	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA001824: AB_1079394"	"unprognostic (3.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-1)"	8.6	17.3	18.0	10.4	25.8	19.7	11.4	34.6	20.3	12.3	20.9	7.2	10.6	7.2	13.6	7.9	10.2	11.5	12.7	8.6	18.0	12.8	10.1	2.1	10.7	9.1	14.8	13.8	10.5	4.6	18.3	24.7	10.3	13.2	11.7	22.8	7.4	21.3	12.1	9.1	7.9	12.3	13.5	12.0	5.9	15.3	3.6	21.4	22.1	22.5	6.1	6.5	12.9	10.4	1.4	0.7	1.6	0.3	3.8	14.4	2.8	2.5	7.1	2.5	2.9	5.9	3.7	1.6	6.7	11.3	3.0	3.4	6.9	2.4	9.8	3.6	3.1	1.3	2.4	11.6	2.7	20.2	6.2	72.2	21.9	3.2	4.3	1.3	6.1	2.7	4.5	1.0	7.3	3.0	0.0	12.7	6.3	1.9	7.0	4.2	1.6	2.1	0.0	4.6	2.6	13.9	3.8	8.2	2.9	5.4	2.7	2.9	2.8	1.9	1.9	0.0	1.7	1.7	2.3	5.7	5.2	4.0	0.0	3.1	1.4	1.6	0.3	0.5	3.9	0.2	3.6	0.5	7.0	5.3	0.7	1.4	14.4	8.3	0.1	3.8	0.3	0.4	7.3	2.8	18.0	25.8	34.6	20.3	18.0	12.8	14.8	13.8	13.2	21.4
MLX	"bHLHd13, MAD7, MXD7, TCFL4"	ENSG00000108788	"MLX, MAX dimerization protein"	Q9UH92	17	42567068-42573239	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025329, HPA052766, HPA064438"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB025329: , HPA052766: , HPA064438: "	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.55e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.25e-1)"	21.3	19.2	10.4	12.6	11.9	8.3	22.5	10.3	14.3	12.3	32.2	10.8	15.4	27.5	11.0	15.1	18.8	10.5	19.2	38.1	9.8	9.8	23.5	34.7	19.0	18.6	11.3	6.6	10.4	36.8	8.5	13.0	13.7	9.4	13.4	23.1	11.6	18.5	14.8	43.3	15.6	42.5	12.1	10.2	18.7	20.6	7.4	8.9	20.3	23.5	24.9	19.7	16.5	13.1	14.6	26.3	34.7	33.5	12.8	18.2	23.0	16.0	18.6	14.6	14.8	22.3	25.8	10.1	24.2	21.5	26.1	23.7	16.8	16.7	19.4	17.0	20.5	24.3	26.6	15.6	23.0	15.3	25.0	20.0	13.4	18.6	26.3	26.8	28.9	22.3	17.5	20.9	19.2	19.2	21.8	17.4	29.7	21.4	37.6	13.2	10.3	16.9	17.0	30.4	20.7	21.1	19.9	22.8	11.3	10.7	13.9	27.1	28.6	31.8	13.6	23.3	15.1	25.4	35.6	17.7	20.0	18.2	26.0	17.2	27.3	14.2	25.0	34.7	14.3	30.8	15.8	14.6	14.8	14.3	26.3	11.8	13.1	13.1	32.3	12.8	33.5	14.1	18.2	23.0	10.4	11.9	10.3	14.3	9.8	9.8	11.3	6.6	9.4	8.9
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 103.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 29.5;K-562: 8.8;SCLC-21H: 15.9;T-47d: 7.1"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Region enhanced"	"Detected in many"		"cerebellum: 20.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA064640: "	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	30.0	18.0	4.2	0.8	3.9	0.5	10.9	20.4	6.8	1.1	16.5	0.4	2.6	33.2	0.4	22.1	1.0	3.5	5.5	1.8	3.2	1.7	11.6	103.6	0.9	0.4	1.2	4.0	2.0	6.5	4.0	3.9	0.4	5.0	0.9	1.3	1.1	2.7	0.9	24.7	1.2	27.1	0.7	1.2	0.4	3.5	5.7	0.0	0.0	2.0	7.7	0.4	0.8	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.5	0.0	3.7	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	4.5	0.0	2.4	29.5	0.8	0.1	1.0	0.5	0.0	0.0	0.0	0.0	8.8	0.0	0.0	3.4	0.0	0.0	0.4	0.6	0.0	0.0	0.7	0.0	0.0	15.9	0.4	0.5	2.5	0.0	7.1	3.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.2	3.9	20.4	6.8	3.2	1.7	1.2	4.0	5.0	0.0
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria"	Q9Y4U1	1	45500053-45513382	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	3.5	7.4	5.8	3.3	10.2	2.2	6.1	3.6	12.2	5.4	6.3	11.8	3.2	5.6	4.1	5.6	4.0	6.2	2.9	11.1	6.2	5.1	7.6	30.1	2.7	3.1	7.3	6.9	6.4	9.8	9.5	5.4	2.9	8.5	3.9	7.6	4.0	11.9	7.5	14.7	3.8	4.1	4.2	6.7	3.6	4.5	7.3	5.7	4.1	4.4	3.7	3.6	3.9	3.1	2.1	3.6	5.0	6.1	2.6	3.9	1.1	6.8	3.6	6.1	9.3	5.8	3.5	7.6	5.3	3.6	9.7	8.8	7.3	4.3	10.7	7.0	4.4	5.7	11.2	12.7	8.9	2.9	10.3	8.3	5.9	8.2	5.5	11.8	3.0	5.0	7.2	10.7	11.8	4.6	9.4	6.1	7.4	7.3	7.9	3.8	10.0	8.3	9.8	2.5	11.9	5.7	5.4	9.8	5.0	8.0	13.3	17.4	7.7	4.3	2.1	6.9	9.4	7.7	2.9	9.2	7.4	6.3	5.0	5.7	6.3	5.0	1.6	1.6	1.7	2.4	2.8	2.0	2.0	1.4	1.7	2.1	3.9	2.0	3.5	2.6	6.1	3.6	1.4	1.1	5.8	10.2	3.6	12.2	6.2	5.1	7.3	6.9	8.5	5.7
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843803	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 177.5;salivary gland: 73.4"	"Group enriched"	"Detected in some"	17	"BJ: 98.9;BJ hTERT+: 269.1;fHDF/TERT166: 116.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"		170000	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	19.1	0.0	0.2	14.4	0.3	0.0	6.9	0.2	0.5	0.2	1.5	0.3	0.2	1.8	28.3	177.5	0.2	0.0	1.4	0.2	0.2	0.0	0.3	0.5	0.4	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.2	1.7	0.2	73.4	1.5	7.3	12.6	0.7	5.9	0.2	0.2	2.8	1.4	0.2	0.2	0.6	1.5	0.9	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.9	269.1	1.7	0.5	0.0	0.0	0.0	0.0	116.5	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.2	0.8	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2
MMS19	"hMMS19, MET18, MMS19L"	ENSG00000155229	"MMS19 homolog, cytosolic iron-sulfur assembly component"	Q96T76	10	97458324-97498794	"Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051936, HPA056299"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA051936: , HPA056299: "	"unprognostic (8.57e-2)"	"unprognostic (2.38e-3)"	"unprognostic (9.34e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (6.88e-4)"	"unprognostic (4.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.51e-2)"	"prognostic unfavourable (3.39e-4)"	17.5	16.4	26.5	16.6	25.5	17.1	23.0	38.0	35.7	18.9	18.2	26.2	17.1	16.8	20.8	23.4	23.1	23.7	15.9	25.6	24.8	18.4	22.8	16.2	20.2	24.2	21.0	24.8	28.3	20.6	19.3	31.4	24.5	22.3	17.3	21.8	23.1	19.5	20.6	26.7	38.2	18.4	22.0	18.6	23.7	17.8	33.7	24.7	27.6	19.2	19.4	26.4	18.0	21.9	8.1	11.0	9.8	8.5	6.7	12.7	7.7	15.4	14.9	18.1	25.3	17.8	21.4	10.8	12.6	25.4	19.2	22.7	19.8	20.4	24.1	13.8	17.1	17.8	29.6	34.1	18.2	10.4	22.4	12.6	12.4	20.6	13.4	16.7	12.4	17.6	14.8	17.0	36.3	32.3	18.0	13.5	18.7	14.1	15.9	30.7	10.2	12.3	12.8	13.8	10.7	22.8	11.3	7.3	12.1	7.2	9.7	18.7	19.8	15.3	18.3	8.8	11.2	6.0	14.2	12.2	13.7	14.0	13.2	25.2	7.1	9.8	7.2	5.8	7.5	8.5	12.7	8.1	10.1	9.4	11.0	7.0	12.2	9.5	1.6	6.7	6.5	8.3	10.0	7.7	26.5	25.5	38.0	35.7	24.8	18.4	21.0	24.8	22.3	24.7
MMS22L	"C6orf167, dJ39B17.2"	ENSG00000146263	"MMS22 like, DNA repair protein"	Q6ZRQ5	6	97142161-97283217	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067042			Supported	Nucleoplasm				Nucleoplasm		"HPA067042: "	"unprognostic (3.61e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.00e-5)"	"unprognostic (9.63e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.21e-3)"	"unprognostic (9.39e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	3.1	3.3	3.0	8.0	4.6	12.7	7.1	2.0	3.2	4.2	3.4	5.5	3.6	2.7	5.2	2.8	4.9	3.1	3.0	3.7	3.6	3.3	2.7	2.1	6.0	11.0	5.1	1.8	3.7	3.2	5.0	4.3	4.1	4.0	4.6	5.0	4.6	3.9	3.5	1.6	5.9	5.1	3.9	8.1	4.5	2.8	13.1	3.1	21.4	2.5	4.0	6.8	3.5	4.0	3.0	4.1	3.1	4.8	2.1	3.9	1.4	4.9	5.5	9.3	10.1	1.5	2.9	7.3	10.1	4.7	9.6	14.0	7.6	5.8	10.8	6.2	3.8	9.0	11.7	5.6	19.1	9.3	8.7	11.0	8.1	4.8	0.9	16.8	7.8	1.5	2.9	13.4	6.3	4.1	14.9	17.5	8.9	5.9	6.1	6.9	3.5	4.2	10.4	8.8	3.8	4.1	6.5	5.3	4.6	6.6	3.3	2.8	5.2	10.4	3.0	9.7	9.3	8.1	13.8	2.2	6.6	12.3	5.5	10.7	10.6	1.6	1.5	3.1	2.4	2.4	3.6	1.8	3.2	3.5	3.6	3.0	3.0	3.9	1.5	2.1	4.8	4.1	2.8	1.4	3.0	4.6	2.0	3.2	3.6	3.3	5.1	1.8	4.0	3.1
MNAT1	"MAT1, RNF66"	ENSG00000020426	"MNAT1, CDK activating kinase assembly factor"	P51948	14	60734742-60969953	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000701, HPA001154, CAB004495"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: "	"unprognostic (4.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.34e-2)"	"prognostic favourable (3.46e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.14e-3)"	15.3	14.9	14.6	10.1	18.9	9.4	19.6	29.2	20.2	16.9	11.4	11.8	12.2	6.8	17.3	15.0	13.7	18.9	10.8	15.2	14.0	14.2	19.8	17.0	10.7	9.4	13.8	15.4	16.2	10.3	42.8	33.2	13.7	18.7	16.3	9.9	11.6	18.4	12.8	53.0	8.4	7.1	14.6	15.0	9.2	11.5	8.8	11.8	11.8	14.0	15.9	12.5	13.6	12.3	14.7	25.7	11.6	5.1	18.9	10.8	3.9	59.8	11.6	14.5	10.2	16.9	18.6	15.8	22.1	23.9	27.0	21.9	9.2	21.1	14.4	16.8	16.1	19.1	16.1	25.4	38.9	17.9	16.8	9.7	11.3	13.5	21.0	22.5	5.2	11.3	18.7	17.4	19.3	25.7	14.4	13.9	30.0	20.5	14.0	14.2	7.9	25.9	14.6	39.5	9.1	31.8	28.3	13.0	8.8	16.9	14.3	20.5	22.1	11.0	19.5	20.8	22.0	9.8	16.5	6.1	5.1	20.7	16.8	3.8	15.0	4.7	3.6	11.6	8.5	4.6	8.8	14.7	9.1	8.9	6.6	11.3	10.8	10.7	0.3	18.9	5.1	25.7	7.5	3.9	14.6	18.9	29.2	20.2	14.0	14.2	13.8	15.4	18.7	11.8
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831317-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 289.8;bone marrow: 83.3"	"Group enriched"	"Detected in some"	15	"NB-4: 35.9;THP-1: 67.7;U-937: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 289.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 289.8"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	Nucleoplasm,Nucleoli			110000	"Nucleoplasm, Nucleoli"		"HPA034532: AB_10669677, HPA073215: "	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	17.6	6.3	5.4	24.4	7.9	83.3	3.0	1.4	5.8	2.1	2.1	3.2	0.2	1.1	1.7	3.4	2.3	4.7	8.4	6.3	4.9	3.2	3.9	4.2	31.3	32.2	10.7	2.6	3.4	2.4	1.1	2.2	9.9	6.8	2.6	2.5	5.0	3.6	1.2	2.0	1.9	3.6	6.2	18.6	57.3	2.6	4.0	6.3	5.5	2.1	1.4	4.2	9.1	4.9	1.6	29.7	289.8	60.9	0.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	0.0	7.1	60.9	11.1	0.1	25.4	0.1	1.6	0.0	0.1	29.7	0.6	0.0	0.0	289.8	0.1	12.0	0.4	0.0	40.2	5.4	7.9	1.4	5.8	4.9	3.2	10.7	2.6	6.8	6.3
MNT	"bHLHd3, MAD6, MXD6, ROX"	ENSG00000070444	"MAX network transcriptional repressor"	Q99583	17	2384060-2401118	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059532, HPA067578"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA059532: , HPA067578: "	"unprognostic (3.72e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.30e-3)"	"unprognostic (1.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.09e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.98e-2)"	18.0	14.7	12.6	15.2	15.2	29.8	11.8	13.3	22.8	17.3	16.8	12.1	9.9	14.9	16.9	11.3	19.5	15.9	14.4	9.0	12.1	11.6	11.2	9.1	11.9	13.2	8.6	13.6	17.9	15.8	14.2	18.9	15.1	12.0	13.8	8.4	15.8	12.4	17.2	10.7	15.3	13.6	13.4	11.4	14.5	13.1	16.2	9.3	14.2	13.3	11.5	14.4	25.5	13.8	1.0	1.1	4.1	1.7	0.6	1.2	0.6	7.1	8.8	7.7	9.7	9.6	10.9	7.0	4.7	6.3	2.7	3.0	5.8	7.0	9.9	5.0	7.2	11.3	5.5	10.4	2.0	5.3	8.0	7.0	14.6	4.9	6.3	2.9	13.0	17.3	9.8	5.7	7.7	4.6	5.9	9.0	3.0	5.1	6.9	5.1	3.6	5.8	8.0	3.6	6.5	5.0	10.2	8.2	11.7	5.5	5.4	12.7	4.5	5.7	8.4	6.6	4.5	10.3	3.8	7.7	3.8	3.9	13.4	6.0	4.2	1.5	1.2	2.9	0.6	1.7	1.2	1.0	0.8	1.0	0.5	0.7	1.0	1.0	4.1	0.6	1.3	1.1	0.1	0.6	12.6	15.2	13.3	21.6	12.1	11.6	8.6	13.6	12.0	9.3
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 57.3;urinary bladder: 51.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	9.2	4.2	2.4	17.0	2.5	3.0	12.1	2.5	3.2	14.9	30.9	1.8	6.7	2.5	12.5	8.7	17.3	13.8	26.8	8.1	2.8	1.9	3.2	3.0	4.1	8.2	2.1	2.1	8.6	5.8	6.8	1.8	4.2	2.9	21.2	6.7	4.3	12.9	20.1	7.1	9.4	10.6	57.3	2.5	3.7	9.9	4.2	2.0	2.0	4.3	3.2	4.4	51.8	21.2	10.6	10.8	11.2	12.5	11.6	17.3	9.0	13.9	15.2	9.4	7.6	23.6	16.6	8.7	11.0	16.1	21.3	16.8	9.7	19.2	10.3	8.5	25.9	17.1	14.6	24.8	13.0	13.8	21.8	7.8	5.5	12.3	15.9	10.2	12.3	13.4	29.8	11.3	13.4	22.5	12.6	10.7	10.8	9.9	13.2	17.4	11.6	14.2	9.6	9.7	10.7	17.7	13.4	17.6	18.8	13.7	17.2	13.3	7.9	10.3	18.5	13.0	6.6	4.2	7.0	10.6	10.3	10.7	9.0	9.9	9.9	8.2	8.6	11.2	17.3	8.7	14.6	8.2	14.9	13.8	10.8	10.6	12.5	10.5	7.1	11.6	12.5	6.9	12.8	9.0	2.4	2.5	2.5	2.5	2.8	1.9	2.1	2.1	2.9	2.0
MOBP		ENSG00000168314	"Myelin-associated oligodendrocyte basic protein"	Q13875	3	39467198-39529479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"brain: 194.3"	"Cell line enriched"	"Detected in single"	52	"HAP1: 20.2"	"Cancer enriched"	"Detected in single"	63	"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA035152	Supported		Supported	"Cytoplasmic bodies"				"Cytoplasmic bodies"		"HPA035152: AB_10603020"	"unprognostic (1.76e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.35e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.04e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	1.7	1.8	35.0	1.7	58.5	1.7	1.7	3.8	101.8	1.7	2.3	102.1	0.0	1.6	1.8	1.7	1.7	2.7	1.7	1.7	51.4	33.4	1.7	1.6	2.3	1.6	84.8	14.7	2.1	1.6	6.0	0.0	1.6	68.2	1.6	1.8	0.0	1.6	1.7	1.8	1.7	1.7	1.8	194.3	1.6	1.7	5.0	64.2	0.0	1.7	0.0	1.6	1.7	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	35.0	58.5	3.8	29.1	51.4	33.4	84.8	14.7	68.2	64.2
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187519-36272157	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.0;liver: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.4;hTERT-HME1: 25.1;SiHa: 26.9;SK-MEL-30: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA039412: , HPA047958: "	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavourable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	3.7	12.7	0.6	1.6	0.5	0.2	6.4	0.4	0.4	1.4	10.4	0.7	8.0	6.7	1.3	4.6	4.8	1.9	5.8	1.3	0.4	0.5	1.7	36.6	1.8	0.2	0.4	0.1	17.2	3.2	1.1	9.4	11.2	2.2	2.8	1.8	2.1	2.5	7.2	1.3	2.6	33.0	1.0	0.4	0.7	1.7	1.3	0.2	0.0	1.2	2.9	3.5	2.6	1.7	0.4	0.3	1.9	0.3	1.1	0.3	0.1	6.8	2.3	0.1	0.0	2.2	2.8	1.4	4.0	2.2	1.9	5.0	1.5	2.1	0.0	1.2	6.5	4.2	1.4	6.3	2.7	1.1	1.1	0.1	6.8	5.6	7.5	0.0	1.9	4.4	20.4	7.6	25.1	0.3	2.3	0.0	3.1	1.7	0.0	0.0	0.4	2.0	0.0	0.0	0.0	2.7	9.0	0.0	0.6	26.9	1.7	18.7	1.2	0.1	1.3	1.5	1.9	3.3	0.6	0.0	0.0	0.0	3.9	0.0	0.6	1.7	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.2	0.3	1.9	1.1	0.2	0.3	0.1	0.1	0.6	0.5	0.4	0.4	0.4	0.5	0.4	0.1	2.2	0.2
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"			88000000	"Endoplasmic reticulum"		"HPA011322: , HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavourable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	15.8	12.8	8.7	15.2	10.6	8.5	13.1	11.3	12.1	13.9	19.4	10.8	24.9	36.5	14.2	15.8	15.5	13.4	16.4	11.2	7.7	6.1	14.8	40.5	17.2	15.6	9.2	7.9	14.2	30.6	20.4	15.7	35.8	8.3	15.9	11.2	11.7	24.5	25.3	14.1	17.4	35.8	9.8	7.1	22.4	22.3	11.9	8.1	17.6	18.9	11.4	19.5	14.1	12.9	3.9	3.4	2.3	4.4	12.7	5.1	2.5	22.1	19.7	13.1	12.6	27.0	19.1	40.1	18.2	26.3	27.6	26.6	36.0	23.7	24.0	16.2	18.3	22.3	19.7	20.5	17.1	20.7	19.1	11.2	12.8	27.6	22.3	26.3	22.6	11.1	32.9	19.5	19.1	30.9	19.5	23.3	12.1	27.6	14.2	20.2	17.3	11.0	16.3	29.1	31.1	15.0	13.8	10.8	14.1	8.6	36.1	23.6	17.5	14.2	22.0	12.7	22.2	18.4	24.0	36.0	14.8	10.6	20.0	21.5	17.2	2.3	4.0	1.1	5.0	2.5	5.1	2.5	4.2	4.5	3.4	3.9	3.7	2.4	0.7	12.7	4.4	3.2	3.8	2.5	8.7	10.6	11.3	12.1	7.7	6.1	9.2	7.9	8.3	8.1
MOK	"RAGE, RAGE1, STK30"	ENSG00000080823	"MOK protein kinase"	Q9UQ07	14	102224500-102305200	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 45.0"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 28.0;hTEC/SVTERT24-B: 71.2;NB-4: 88.6;U-138 MG: 37.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027292			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA027292: AB_10600989"	"unprognostic (8.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.49e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.48e-1)"	5.9	6.8	12.9	2.7	17.3	3.7	7.8	9.7	15.9	7.6	3.6	8.7	6.2	4.7	7.6	10.2	3.9	26.4	6.4	8.3	13.5	10.2	7.7	3.6	6.1	2.5	6.0	13.7	12.4	8.6	9.4	22.1	3.6	16.6	5.1	3.0	15.2	6.1	5.4	1.9	8.6	4.1	5.9	6.2	3.8	11.7	45.0	6.2	0.4	11.7	2.3	2.2	6.2	3.9	0.7	3.9	0.9	1.1	10.6	2.4	1.3	3.3	3.0	0.4	1.7	0.7	2.5	0.7	6.8	2.0	9.9	11.9	0.2	8.3	2.5	0.5	1.3	0.7	0.6	3.5	28.0	2.8	2.5	0.6	0.3	2.2	3.0	0.2	3.3	2.1	0.9	71.2	6.6	0.3	0.6	0.1	6.4	2.2	0.2	88.6	0.1	7.2	0.4	0.1	0.0	4.0	0.1	1.1	0.7	1.2	0.4	19.2	2.0	0.2	0.2	37.6	1.9	1.4	2.1	0.2	0.4	0.2	7.5	0.2	17.0	0.0	1.1	0.0	0.7	0.7	1.2	0.0	0.5	1.9	3.9	0.7	1.1	2.4	0.9	10.6	0.1	0.0	0.0	1.3	12.9	17.3	9.7	15.9	13.5	10.2	6.0	13.7	16.6	6.2
MORC2	"AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1"	ENSG00000133422	"MORC family CW-type zinc finger 2"	Q9Y6X9	22	30925130-30968298	"Disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 10.3;MAIT T-cell: 9.1;memory CD4 T-cell: 14.3;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 8.9;T-reg: 17.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 17.7"					"Low region specificity"	"Detected in all"			HPA000436	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000436: AB_1079404"	"unprognostic (3.43e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.89e-3)"	"unprognostic (4.63e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (6.54e-8)"	"unprognostic (5.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.66e-3)"	6.7	5.3	4.6	6.0	7.0	5.2	16.9	6.4	7.5	6.8	7.1	6.5	14.8	4.7	7.4	5.9	6.1	6.3	4.7	7.7	4.7	5.0	5.3	9.6	6.3	8.8	4.8	4.1	8.1	7.5	9.4	8.1	7.7	7.7	8.0	4.5	7.7	11.0	7.9	9.8	10.4	5.6	6.7	5.3	7.3	5.9	50.5	5.0	5.5	6.6	6.1	6.6	6.8	9.7	1.7	2.2	0.8	2.0	1.2	17.7	3.9	18.5	17.0	20.1	22.2	21.1	15.6	15.2	13.8	10.8	14.2	14.6	22.1	9.0	16.7	12.4	12.0	16.0	18.0	8.5	11.8	13.1	21.9	17.4	13.5	25.9	18.2	14.2	18.0	14.9	12.6	14.8	19.3	14.2	22.8	17.3	14.8	30.3	15.1	29.0	18.6	12.6	28.9	11.8	21.4	13.7	17.0	18.0	14.1	14.6	23.9	10.5	12.8	24.1	14.2	17.2	17.0	12.1	12.1	15.5	19.0	18.8	12.6	10.1	12.2	0.5	1.1	0.8	10.3	1.9	9.1	1.5	14.3	8.3	1.2	1.7	14.7	8.9	0.3	1.2	2.0	2.2	17.7	3.9	4.6	7.0	6.4	7.5	4.7	5.0	4.8	4.1	7.7	5.0
MORC3	"KIAA0136, NXP2, ZCW5, ZCWCC3"	ENSG00000159256	"MORC family CW-type zinc finger 3"	Q14149	21	36320189-36386148	"Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018406, HPA034848"	Approved		Enhanced	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA018406: AB_1858988, HPA034848: "	"unprognostic (4.01e-3)"	"unprognostic (4.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	18.0	11.2	15.6	15.4	16.4	28.0	17.5	30.9	16.3	20.3	15.3	10.1	14.1	10.6	22.5	10.6	23.0	17.9	13.5	12.5	14.6	7.9	11.6	13.0	17.0	20.6	17.5	12.1	29.3	11.3	14.8	25.1	20.6	16.6	16.1	12.1	7.3	20.6	14.2	28.1	20.1	14.8	21.4	21.0	19.1	14.0	10.8	18.2	25.5	15.0	17.6	20.0	22.9	23.5	11.2	7.6	21.9	10.7	8.2	11.9	6.6	12.0	4.6	11.2	7.4	11.6	12.6	15.8	11.4	20.0	13.2	10.9	7.5	7.8	5.8	4.4	13.0	6.1	8.7	11.4	13.9	10.9	6.8	24.0	5.0	5.5	7.6	12.3	21.4	7.8	14.3	12.6	17.4	10.5	19.2	14.8	10.6	4.0	7.9	6.7	9.3	5.6	9.8	5.6	10.4	5.8	12.6	4.7	12.1	13.3	8.7	13.6	9.7	10.4	14.0	12.8	3.1	8.6	9.8	6.6	5.8	5.6	8.3	19.6	9.2	21.9	7.5	16.1	8.4	9.4	8.3	10.0	9.2	7.9	7.6	11.2	11.9	8.5	11.7	8.2	10.7	4.9	11.3	6.6	15.6	16.4	30.9	16.3	14.6	7.9	17.5	12.1	16.6	18.2
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000244	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 94.5"	"Cell line enhanced"	"Detected in all"		"A549: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: "	"prognostic unfavourable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	8.7	20.0	3.2	6.0	4.8	5.1	6.2	4.9	3.6	8.0	5.3	4.6	12.7	4.6	8.8	8.5	6.8	7.3	6.7	5.3	4.3	2.8	4.9	9.7	6.0	2.2	4.9	2.2	12.3	9.1	6.0	4.9	94.5	5.8	7.7	4.9	4.2	8.7	8.8	9.4	8.6	4.9	7.4	5.4	2.6	5.6	12.5	5.0	2.3	7.6	7.5	5.2	6.3	15.1	6.0	4.6	10.5	3.8	2.8	4.0	0.7	11.5	46.3	4.6	10.6	14.1	16.3	24.2	11.3	12.0	5.7	7.3	24.5	5.3	1.8	5.9	11.6	9.1	15.4	9.9	6.9	2.7	8.9	2.8	15.7	10.3	10.4	2.0	5.9	8.6	9.6	7.8	11.4	5.1	1.6	17.6	12.7	10.2	4.2	2.8	4.1	17.6	2.0	9.3	2.0	18.5	9.2	4.0	5.1	13.7	13.4	8.9	8.0	2.0	5.3	9.2	9.3	18.2	6.2	5.0	6.5	4.6	9.8	1.8	6.6	10.5	3.8	3.1	3.7	3.0	3.2	3.3	3.6	2.8	1.6	6.0	4.0	3.4	8.2	2.8	3.6	4.6	2.6	0.7	3.2	4.8	4.9	3.6	4.3	2.8	4.9	2.2	5.8	5.0
MORF4L1	"Eaf3, HsT17725, MEAF3, MORFRG15, MRG15"	ENSG00000185787	"Mortality factor 4 like 1"	Q9UBU8	15	78810487-78898133	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042360, HPA062010"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA042360: AB_10794275, HPA062010: "	"unprognostic (5.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.61e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-3)"	49.3	57.8	59.9	40.8	60.9	66.9	44.2	76.6	70.6	55.5	50.1	32.5	37.5	29.8	58.8	41.7	45.3	48.1	46.5	85.0	54.8	75.3	60.9	46.0	43.3	40.5	71.1	52.6	68.2	32.2	44.5	60.1	60.1	60.1	45.7	41.8	41.5	41.6	54.6	89.5	28.2	46.2	63.6	58.8	37.2	40.3	215.8	40.7	23.0	65.0	38.3	48.0	57.0	92.6	45.9	61.3	51.6	53.8	37.5	72.5	73.3	46.6	63.5	115.6	48.0	83.4	86.8	61.3	85.4	83.5	76.0	73.8	57.1	71.0	56.8	70.4	85.5	58.9	140.5	57.3	72.2	57.3	56.3	63.1	68.3	52.8	85.8	52.3	57.8	60.4	65.3	43.4	61.3	91.4	65.7	53.7	88.2	43.5	49.9	38.8	125.8	28.0	56.0	90.4	55.4	62.4	64.0	60.1	62.6	76.0	49.1	107.3	59.1	70.0	70.7	92.0	65.4	48.7	71.5	35.0	95.8	64.1	56.7	84.2	67.0	25.9	53.8	51.6	36.2	50.6	43.2	45.9	52.4	40.8	61.3	43.6	72.5	52.0	43.2	37.5	39.8	58.7	56.1	73.3	59.9	60.9	76.6	70.6	54.8	75.3	71.1	52.6	60.1	40.7
MORF4L2	"KIAA0026, MRGX"	ENSG00000123562	"Mortality factor 4 like 2"	Q15014	X	103675496-103688158	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031872, HPA054102"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031872: , HPA054102: AB_2682379"	"prognostic unfavourable (9.83e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.14e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (4.29e-5)"	"unprognostic (5.27e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (7.86e-7)"	"unprognostic (8.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-1)"	33.3	51.4	50.4	26.6	53.5	23.9	51.6	52.8	66.8	76.2	32.9	29.7	62.9	25.8	74.0	63.4	40.2	55.2	39.5	38.5	50.0	71.2	44.0	76.5	34.3	19.3	45.5	48.8	99.8	36.2	38.6	81.8	77.4	63.5	47.4	40.3	23.4	35.2	57.8	44.9	27.4	27.8	93.7	46.1	25.9	31.5	33.5	34.7	21.5	46.8	35.6	29.9	55.5	45.3	21.6	40.7	24.7	24.7	25.4	29.1	21.9	61.6	41.9	56.3	24.9	84.0	63.1	75.7	82.7	72.4	68.7	70.8	42.9	55.6	42.1	67.8	78.6	42.0	70.4	61.3	86.2	19.3	32.0	22.4	72.1	48.5	92.1	30.6	21.4	68.5	54.7	58.6	77.3	75.4	36.7	58.3	84.1	62.4	27.3	30.3	53.5	47.7	27.8	52.9	44.6	68.7	37.6	53.8	41.9	62.4	46.3	61.7	30.6	29.9	62.9	40.2	26.9	69.6	44.1	29.0	35.4	37.5	71.8	62.4	60.2	24.7	23.3	18.4	25.4	24.7	29.1	21.6	24.3	23.9	24.3	19.1	26.9	23.1	9.5	25.4	24.6	40.7	19.7	21.9	50.4	53.5	52.8	66.8	50.0	71.2	45.5	48.8	63.5	34.7
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA045119: AB_10960421, HPA055790: "	"unprognostic (3.30e-2)"	"prognostic favourable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favourable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	28.1	23.8	13.7	12.1	7.6	12.3	11.9	11.6	10.0	4.6	13.8	13.7	11.7	6.3	12.2	9.5	8.4	9.3	20.9	6.8	10.1	33.1	9.9	26.4	9.0	10.9	13.5	9.7	7.0	9.6	23.8	22.0	7.3	10.4	18.3	48.9	4.2	9.3	10.1	13.6	34.5	22.1	5.2	25.6	22.8	8.7	38.2	8.7	9.0	39.6	6.6	6.9	7.2	24.4	7.7	15.1	10.3	11.5	6.3	32.6	11.0	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8
MPDU1	"CDGIf, Lec35, PQLC5, SL15"	ENSG00000129255	"Mannose-P-dolichol utilization defect 1"	O75352	17	7583529-7592789	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014845	Uncertain		Supported	"Endoplasmic reticulum,Mitochondria"				"Endoplasmic reticulum"	Mitochondria	"HPA014845: AB_1854072"	"unprognostic (1.96e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.93e-1)"	15.4	24.6	12.6	10.3	16.5	16.6	16.7	9.1	26.2	16.0	27.3	22.8	4.6	18.5	8.2	15.3	20.5	14.2	16.4	9.1	11.6	10.3	36.0	80.1	15.4	12.3	12.9	8.4	10.8	24.3	21.0	9.3	27.4	15.7	15.1	30.0	17.3	17.2	9.6	11.0	14.7	39.0	11.8	13.3	23.8	20.3	9.1	10.9	17.6	21.4	12.5	17.5	15.5	11.3	7.5	19.7	5.5	26.8	6.4	10.0	8.7	12.3	25.8	18.8	12.4	23.9	21.9	11.4	20.4	30.0	38.7	28.5	13.4	20.8	7.3	14.8	35.3	23.9	28.5	35.0	33.0	15.3	26.1	13.4	17.1	22.9	29.8	11.1	20.8	22.3	28.9	36.1	21.4	29.3	21.8	9.5	41.9	17.6	7.3	6.9	20.3	12.2	16.9	14.6	12.5	38.8	12.1	11.8	21.5	26.6	18.5	7.0	21.6	9.0	19.7	16.0	8.2	9.3	25.4	4.8	8.8	6.1	22.9	14.4	22.7	5.5	16.2	4.8	6.7	26.8	5.5	7.5	6.5	9.0	19.7	7.5	6.7	7.6	2.6	6.4	24.2	18.5	10.0	8.7	12.6	16.5	9.1	26.2	11.6	10.3	12.9	8.4	15.7	10.9
MPG	MDG	ENSG00000103152	"N-methylpurine DNA glycosylase"	P29372	16	77007-85853	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006531	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006531: AB_1854075"	"unprognostic (1.78e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.99e-2)"	"prognostic favourable (2.82e-5)"	"unprognostic (8.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.86e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	20.8	32.1	18.4	21.1	18.4	25.3	33.2	18.3	32.1	19.5	20.4	12.6	24.6	21.0	22.6	30.5	21.5	18.5	28.5	37.4	16.7	15.1	16.1	32.0	20.1	39.7	15.8	18.2	23.8	36.5	8.0	21.7	19.0	16.5	23.2	7.2	15.2	47.1	24.2	33.6	19.0	19.4	19.2	13.6	25.6	27.3	10.9	11.2	18.3	29.2	22.4	22.8	27.2	25.2	33.5	38.8	27.2	27.4	41.2	31.1	22.4	13.8	20.3	5.5	17.0	10.2	23.3	13.9	20.0	27.6	13.0	14.3	12.8	18.8	9.9	17.5	11.3	17.9	3.8	8.7	2.0	17.0	14.7	6.4	10.4	19.0	29.5	6.7	39.8	22.4	12.2	14.6	6.0	22.6	14.1	17.9	16.9	48.0	11.6	30.9	10.0	22.2	22.2	6.7	37.7	10.8	5.0	4.5	11.6	10.5	11.4	25.1	16.3	34.7	19.8	10.6	13.5	14.4	9.8	17.4	5.9	12.6	19.6	19.4	37.8	14.2	27.4	27.2	22.7	19.2	20.6	33.5	21.8	22.6	28.5	30.6	16.8	17.2	14.0	41.2	15.7	38.8	31.1	22.4	18.4	18.4	18.3	32.1	16.7	15.1	15.8	18.2	16.5	11.2
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130314-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	Nucleoli				Nucleoli		"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: "	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	20.5	17.6	21.8	20.2	28.0	21.2	23.7	26.7	25.7	23.5	17.6	12.6	22.0	16.5	22.3	26.7	30.6	19.4	17.1	20.4	21.6	20.3	22.2	27.5	15.5	21.9	30.4	22.7	25.4	20.7	20.0	36.7	18.5	26.3	24.0	18.4	8.1	21.8	28.8	48.4	24.4	16.8	25.0	25.0	22.0	17.6	13.7	29.8	22.3	20.4	26.3	24.4	22.2	22.2	13.5	12.8	8.7	17.3	12.4	17.4	8.4	14.8	11.2	14.5	17.3	13.6	12.8	19.8	16.6	13.2	13.7	10.2	20.1	11.0	20.9	10.4	11.6	13.9	18.2	11.7	18.4	14.4	14.6	25.1	8.9	45.8	11.8	32.4	20.2	11.0	15.1	11.3	15.1	11.6	36.2	16.7	13.6	15.9	26.0	32.9	24.1	12.8	21.7	22.7	24.7	11.1	16.2	17.7	13.7	11.1	25.7	16.0	13.0	14.5	12.0	16.3	17.5	15.5	21.0	14.2	16.0	34.3	14.0	27.1	16.3	8.7	9.9	7.2	12.4	13.6	16.0	13.5	15.7	14.8	11.7	12.3	17.4	15.3	1.4	12.4	17.3	12.8	13.2	8.4	21.8	28.0	26.7	25.7	21.6	20.3	30.4	22.7	26.3	29.8
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170226	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavourable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favourable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	13.7	15.5	32.0	17.5	25.1	12.3	54.1	37.1	32.6	18.5	16.0	9.3	7.0	9.9	18.9	17.1	26.5	11.9	12.3	9.4	25.4	22.2	12.0	11.5	13.6	16.1	17.5	21.9	10.4	7.2	13.6	43.5	17.4	24.0	11.3	18.7	10.8	18.1	10.3	15.4	28.4	11.0	16.8	31.7	12.7	11.2	9.9	17.9	10.8	8.7	12.9	18.2	19.6	18.5	18.6	24.6	19.4	25.2	17.1	28.3	15.6	19.3	10.6	23.7	11.6	11.6	16.3	13.1	20.9	25.1	18.3	8.9	17.0	11.4	16.0	12.7	11.4	20.4	22.6	21.7	24.6	11.8	14.8	12.8	8.8	30.6	11.5	31.9	19.9	10.3	19.5	10.8	31.3	20.9	30.1	4.5	27.8	15.7	24.5	37.7	21.7	14.7	30.4	11.0	10.5	16.5	20.4	16.3	7.0	35.2	15.7	15.0	27.5	19.9	16.4	17.2	17.1	15.1	14.8	6.7	16.2	63.5	15.5	26.2	21.7	13.0	22.0	19.4	22.3	25.2	28.3	18.6	23.1	23.2	24.6	14.6	24.8	23.6	2.7	17.1	17.4	14.7	23.0	15.6	32.0	25.1	37.1	32.6	25.4	22.2	17.5	21.9	24.0	17.9
MPHOSPH8	"HSMPP8, mpp8"	ENSG00000196199	"M-phase phosphoprotein 8"	Q99549	13	19633681-19673459	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039701, HPA040035"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039701: AB_10805484, HPA040035: AB_10794207"	"unprognostic (4.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.90e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.02e-1)"	20.6	27.1	37.7	33.4	37.1	19.2	21.4	48.9	45.0	32.0	26.6	13.2	31.7	17.8	29.4	26.7	19.1	22.3	18.8	27.9	31.0	27.2	18.9	16.5	22.9	28.4	28.8	32.8	43.6	22.0	20.9	44.3	20.0	28.4	26.1	20.1	11.9	24.5	38.8	25.7	26.6	23.9	31.3	37.1	30.0	22.5	16.6	33.5	16.5	26.8	11.7	20.4	31.3	37.9	21.7	13.8	39.4	9.9	11.5	17.6	3.6	12.8	8.3	12.3	20.0	16.0	20.4	21.8	19.3	14.0	12.2	10.5	12.6	22.7	20.3	15.5	11.7	21.5	22.6	13.5	15.8	25.2	11.6	32.7	13.6	15.3	14.3	23.5	26.7	12.0	17.5	9.6	13.6	16.1	15.8	13.1	11.3	12.5	17.9	19.7	12.0	9.2	14.5	28.5	16.0	21.2	10.0	17.0	10.4	18.1	16.7	17.5	10.1	19.5	18.8	9.5	8.6	17.9	9.7	8.9	9.2	20.2	7.2	21.8	14.6	39.4	9.5	15.4	13.0	6.9	11.5	21.5	14.6	12.5	4.3	21.7	17.6	14.4	27.5	11.5	9.9	13.8	11.3	3.6	37.7	37.1	48.9	45.0	31.0	27.2	28.8	32.8	28.4	33.5
MPL	"CD110, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337849-43352772	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.6"	"Cell line enriched"	"Detected in single"	78	"HEL: 40.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Low region specificity"	"Detected in all"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"				"Plasma membrane"	"Nuclear membrane"	"HPA007619: AB_1854080"	"unprognostic (2.74e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.42e-1)"	1.1	0.3	0.9	0.5	0.8	2.0	0.9	0.5	2.2	0.6	0.6	0.5	0.5	0.3	0.9	1.7	0.9	2.1	0.5	3.9	0.8	0.6	0.5	0.5	2.0	0.5	0.9	0.5	6.6	1.1	0.6	0.6	2.2	0.5	1.5	0.7	0.5	0.5	0.7	0.6	0.4	1.2	2.1	2.5	8.6	0.5	2.1	0.5	0.5	2.2	2.4	0.5	0.9	0.5	0.0	0.0	1.6	0.3	0.0	0.0	4.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	40.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.0	0.9	0.8	0.5	2.2	0.8	0.6	0.9	0.5	0.5	0.5
MPLKIP	"C7orf11, ORF20, TTDN1"	ENSG00000168303	"M-phase specific PLK1 interacting protein"	Q8TAP9	7	40126023-40134652	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA058457, HPA065463"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA058457: , HPA065463: "	"unprognostic (5.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.08e-2)"	13.7	15.2	11.6	9.3	12.7	8.7	14.8	13.9	12.1	12.7	14.5	12.6	9.5	11.9	11.0	13.6	12.9	10.0	9.3	9.3	11.8	11.4	20.5	52.1	8.7	13.3	15.0	8.8	12.0	17.3	10.1	16.1	13.8	10.4	11.5	11.6	11.1	14.4	10.5	10.1	11.3	13.4	9.2	11.9	12.7	10.8	11.0	12.0	25.5	19.2	7.9	12.8	11.3	12.6	53.8	41.9	52.9	38.0	30.7	45.0	40.9	23.7	7.0	13.0	16.4	13.1	15.5	14.4	8.5	10.1	13.6	13.8	9.5	11.5	19.3	12.6	8.8	29.2	7.8	16.0	17.1	14.8	28.4	14.8	10.3	20.0	15.8	17.4	14.1	14.5	22.2	9.7	12.7	16.4	38.6	14.8	13.8	12.2	17.7	59.2	18.0	23.7	25.9	9.1	25.4	15.1	5.6	19.0	23.6	14.1	13.3	20.5	17.2	26.3	14.8	7.4	22.3	8.9	13.2	24.2	28.5	32.8	12.6	30.0	21.7	43.4	38.0	52.9	28.0	34.3	31.3	53.8	35.9	32.8	39.4	47.0	40.0	35.1	20.4	30.7	31.5	41.9	45.0	40.9	11.6	12.7	13.9	12.1	11.8	11.4	15.0	8.8	10.4	12.0
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269856-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 315.2"	"Group enriched"	"Detected in some"	93	"HL-60: 212.9;NB-4: 279.1"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0"	"Group enriched"	"Detected in many"	30	"dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"		15000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.2	0.1	0.5	0.1	0.8	315.2	0.1	0.4	1.0	0.1	0.1	1.4	0.0	0.1	0.2	0.2	0.1	0.1	0.1	21.5	0.6	0.8	0.1	1.4	6.9	0.8	0.6	0.0	0.6	0.1	0.1	1.0	2.9	0.4	0.2	0.1	0.2	6.3	0.1	0.7	0.5	0.1	0.1	0.4	17.8	0.1	0.4	0.2	19.7	0.6	0.0	0.5	0.1	0.0	0.0	3.2	2.0	7.6	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	279.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.1	7.2	0.5	0.8	0.4	1.0	0.6	0.8	0.6	0.0	0.4	0.2
MPP1	"DXS552E, PEMP"	ENSG00000130830	"Membrane palmitoylated protein 1"	Q00013	X	154778684-154821007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 58.4;REH: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 46.4;neutrophil: 45.3"	"Group enriched"	"Detected in all"	7	"dendritic cells: 12.7;granulocytes: 46.4;monocytes: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076675	Enhanced		Supported	"Plasma membrane,Centriolar satellite"			4300000	"Plasma membrane"	"Centriolar satellite"	"HPA076675: "	"unprognostic (2.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-3)"	"prognostic favourable (4.60e-6)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.67e-3)"	18.7	18.2	12.7	14.4	19.2	52.9	9.9	25.8	30.9	7.1	18.3	10.0	15.1	32.0	8.9	9.5	6.1	10.0	13.5	14.1	14.3	13.0	23.3	20.4	18.2	11.9	15.9	13.5	7.2	18.9	19.5	6.5	45.6	28.8	9.1	10.1	6.4	17.1	10.9	14.6	6.3	42.7	11.0	15.8	27.4	7.9	4.1	7.4	27.1	8.3	6.4	6.9	10.0	7.1	1.6	12.7	46.4	20.9	2.0	3.8	15.8	11.1	2.3	5.2	5.2	5.4	5.7	16.9	4.2	6.4	7.1	8.7	6.3	1.0	8.7	8.2	4.6	1.3	5.9	1.8	5.6	9.2	10.4	58.4	1.6	6.7	8.1	11.9	33.9	5.5	2.5	7.8	1.9	16.0	25.2	1.4	7.9	0.0	27.0	15.8	0.5	7.7	36.9	1.3	4.2	4.1	0.9	1.3	2.1	3.4	0.3	3.6	0.9	7.0	7.4	6.5	3.5	14.3	11.3	10.2	13.9	3.4	9.1	16.8	3.1	9.0	20.9	46.4	1.2	16.7	1.4	1.6	1.4	1.3	12.7	0.7	3.8	1.9	45.3	2.0	20.3	3.5	0.7	15.8	12.7	19.2	25.8	30.9	14.3	13.0	15.9	13.5	28.8	7.4
MPP4	DLG6	ENSG00000082126	"Membrane palmitoylated protein 4"	Q96JB8	2	201644870-201698694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 78.2"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;LHCN-M2: 41.4;TIME: 8.2;U-87 MG: 10.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057393			Supported	"Actin filaments,Cytosol"				Cytosol	"Actin filaments"	"HPA057393: "	"unprognostic (1.42e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.33e-16)"	"unprognostic (1.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	0.4	1.7	0.3	0.5	0.6	0.0	0.3	4.9	1.1	1.2	0.2	0.2	0.2	0.0	0.8	0.4	0.3	0.1	0.4	0.2	0.5	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.0	0.7	0.7	0.3	0.3	0.3	78.2	0.2	0.5	0.6	4.1	0.2	0.3	0.2	3.8	0.1	2.2	0.2	0.2	0.6	0.6	0.2	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	5.3	1.3	3.3	3.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	11.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	10.2	0.0	6.0	0.0	0.0	41.4	0.0	0.0	0.0	0.3	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	4.2	1.2	0.9	3.7	0.0	0.0	0.0	10.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	4.9	0.6	0.5	0.4	0.2	0.2	0.3	0.2
MPP7	FLJ32798	ENSG00000150054	"Membrane palmitoylated protein 7"	Q5T2T1	10	28050993-28334486	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 10.7;CACO-2: 20.2;CAPAN-2: 12.6;T-47d: 40.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037597, HPA037598"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA037597: , HPA037598: AB_10696941"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.64e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.31e-3)"	"prognostic favourable (5.88e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"prognostic favourable (2.79e-14)"	"unprognostic (2.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	1.9	1.2	1.9	3.2	1.9	2.6	3.7	3.2	3.0	2.3	6.3	1.9	1.9	1.8	1.9	3.7	16.3	4.6	2.0	2.0	1.9	0.6	4.9	1.9	3.7	4.6	1.9	1.9	1.9	11.3	1.8	7.8	4.2	2.2	2.8	3.5	2.6	5.0	1.9	4.7	11.2	3.3	3.0	1.9	2.4	5.9	33.2	1.9	1.9	5.7	1.9	3.0	3.4	5.4	0.7	8.1	9.0	8.2	4.9	9.2	5.3	2.6	0.0	0.2	0.0	0.0	0.0	10.7	0.5	0.4	2.2	3.5	20.2	12.6	0.0	0.1	1.5	4.7	1.8	3.4	5.1	0.0	3.4	0.0	0.6	1.2	0.0	0.0	0.0	0.1	5.3	0.3	0.2	0.0	0.4	0.0	2.8	4.8	1.0	0.0	0.6	0.9	0.5	6.1	0.0	0.2	8.5	0.5	0.0	1.0	5.2	0.0	40.8	0.5	0.0	0.8	5.9	0.0	0.4	0.1	0.0	0.0	0.0	4.8	0.0	0.0	8.2	9.0	4.3	2.7	6.3	0.7	4.7	2.9	8.1	0.6	9.2	6.4	3.3	4.9	1.4	0.1	1.1	5.3	1.9	1.9	3.2	3.0	1.9	0.6	1.9	1.9	2.2	1.9
MPRIP	"M-RIP, p116Rip, RHOIP3"	ENSG00000133030	"Myosin phosphatase Rho interacting protein"	Q6WCQ1	17	17042545-17217679	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 27.5"	"Lineage enriched"	"Detected in all"	6	"T-cells: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022034, HPA022901"	Enhanced		Supported	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA022034: AB_1854093, HPA022901: AB_2297761"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.81e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	46.5	38.7	46.7	33.7	58.8	27.7	47.4	47.7	62.0	48.4	35.3	45.8	31.9	36.1	54.9	40.9	51.6	32.9	38.2	63.7	46.9	39.7	30.2	31.3	40.2	34.5	46.8	44.9	33.5	46.6	55.0	35.8	37.4	36.5	33.4	29.0	41.0	34.0	46.8	66.7	35.1	32.9	63.0	38.2	35.3	45.9	31.4	47.7	19.9	38.4	30.1	35.4	39.8	55.3	4.4	4.8	1.5	1.2	1.9	27.5	5.0	62.6	45.9	19.8	16.1	20.9	15.7	29.7	32.5	22.3	25.6	19.2	35.6	46.1	24.7	33.3	47.4	60.3	25.0	43.0	27.0	25.4	13.3	13.4	39.4	12.4	14.2	7.1	10.7	15.0	26.0	28.7	22.1	26.4	8.3	13.9	40.9	20.7	28.8	24.2	9.5	53.0	25.6	32.1	9.1	19.5	28.9	11.4	18.5	34.4	28.2	15.5	13.2	11.1	25.5	23.9	27.0	63.3	55.3	10.9	8.6	11.4	43.2	12.8	56.9	1.1	1.2	1.5	4.5	0.8	9.2	4.4	17.5	7.3	1.1	3.8	12.6	6.0	0.5	1.9	0.8	4.8	27.5	5.0	46.7	58.8	47.7	62.0	46.9	39.7	46.8	44.9	36.5	47.7
MPV17L	"FLJ39599, MLPH1, MLPH2, MPV17L1"	ENSG00000156968	"MPV17 mitochondrial inner membrane protein like"	Q2QL34	16	15395754-15413268	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 33.1"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA041180	Uncertain		Supported	Vesicles				Vesicles		"HPA041180: AB_10794266"	"unprognostic (9.65e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.38e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.99e-3)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-3)"	"prognostic favourable (1.48e-11)"	"unprognostic (2.84e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.87e-2)"	3.1	4.9	6.2	3.7	8.7	8.3	16.0	6.8	8.0	7.1	4.5	10.5	1.6	7.1	4.5	3.1	2.5	3.3	5.7	3.7	7.4	5.4	8.2	12.2	2.3	4.7	5.8	6.1	4.8	33.1	10.6	11.7	1.4	6.3	3.7	2.9	9.7	10.1	5.0	16.0	9.1	5.6	9.4	7.2	3.7	4.1	2.7	7.0	0.0	5.2	1.3	1.6	4.8	2.4	4.0	2.2	5.7	3.6	3.6	2.5	1.2	0.8	1.5	0.6	0.6	0.1	0.1	1.0	0.4	0.0	0.0	0.0	1.5	2.9	1.2	1.2	0.5	1.1	2.9	0.0	0.0	0.8	0.8	5.8	3.5	3.0	0.2	2.7	29.7	0.2	0.3	0.1	0.2	0.0	1.8	2.6	0.0	1.5	0.9	1.7	1.5	1.0	1.5	0.4	1.1	0.4	0.6	4.7	1.6	2.4	6.8	0.2	1.5	2.0	1.9	1.1	0.6	0.9	0.8	1.1	0.4	1.3	0.6	1.3	0.4	3.9	3.6	0.6	2.3	2.7	1.9	2.1	1.5	2.4	1.2	4.0	1.5	2.5	5.7	3.6	1.0	2.2	1.2	1.2	6.2	8.7	6.8	8.0	7.4	5.4	5.8	6.1	6.3	7.0
MPZL1	"FLJ21047, PZR"	ENSG00000197965	"Myelin protein zero like 1"	O95297	1	167721192-167791919	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026966, HPA063538"	Approved		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA026966: AB_10600931, HPA063538: "	"unprognostic (6.54e-2)"	"unprognostic (9.26e-3)"	"unprognostic (4.59e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (4.27e-6)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (3.99e-7)"	"unprognostic (3.55e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (8.08e-4)"	"unprognostic (4.21e-2)"	34.4	19.1	13.6	21.4	13.9	3.2	42.0	14.3	13.7	32.2	27.3	15.4	15.9	18.5	34.8	25.2	32.1	30.1	34.3	29.2	12.0	14.0	22.2	20.9	22.2	20.7	14.4	10.0	38.3	25.4	13.7	24.3	34.0	14.3	28.3	28.2	28.0	51.7	19.4	11.0	17.7	26.6	30.5	13.0	19.6	21.3	27.7	10.9	9.7	29.0	25.8	28.0	33.6	35.0	4.2	12.5	51.4	8.9	2.9	2.4	3.0	18.1	26.5	20.8	16.1	67.2	30.5	65.8	28.4	36.7	18.6	23.2	48.9	25.3	6.4	33.3	35.9	30.6	20.7	31.4	15.8	14.5	11.2	5.3	14.1	11.7	41.8	6.2	3.4	27.9	39.7	29.6	33.4	24.7	19.7	13.5	22.0	6.0	20.9	7.4	13.2	11.4	12.8	17.9	28.3	28.5	17.6	12.0	19.9	25.2	26.3	14.6	14.2	3.3	28.0	21.4	9.6	27.3	15.3	20.2	31.3	29.8	30.6	7.3	3.3	1.9	8.1	5.4	0.8	6.8	0.4	4.2	0.8	1.2	10.9	2.5	2.4	0.8	51.4	2.9	8.9	12.5	0.1	3.0	13.6	13.9	14.3	13.7	12.0	14.0	14.4	10.0	14.3	10.9
MR1	HLALS	ENSG00000153029	"Major histocompatibility complex, class I-related"	Q95460	1	181033425-181061938	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048304			Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA048304: "	"unprognostic (6.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-2)"	10.5	13.8	5.3	10.2	7.1	7.7	8.3	1.7	5.5	8.6	8.2	5.3	6.8	5.3	10.4	10.9	12.6	8.6	13.2	8.9	5.2	3.1	10.5	10.7	16.6	16.2	5.9	5.0	13.9	5.1	12.4	17.6	11.5	5.1	13.2	6.3	12.3	8.1	8.6	3.8	10.1	7.8	9.6	6.1	14.9	6.7	5.5	6.2	23.2	13.6	7.1	18.4	16.4	9.6	12.9	15.6	24.0	22.2	14.9	14.3	11.1	3.6	2.5	0.0	2.2	15.8	19.2	6.7	7.3	20.1	6.1	10.5	1.0	15.0	4.5	15.3	13.1	9.7	0.3	8.6	5.4	13.6	2.4	6.5	2.9	4.5	5.3	5.3	19.6	12.6	23.9	9.1	9.9	0.6	12.1	12.2	11.8	4.0	5.5	3.8	0.0	0.4	6.3	0.1	12.5	6.7	10.8	0.1	0.2	3.9	7.1	5.1	7.5	11.3	3.8	6.0	0.8	10.4	3.6	20.3	6.9	8.4	5.6	7.1	0.5	24.0	17.9	18.1	14.3	22.2	12.7	12.1	13.0	12.7	15.6	12.9	9.7	14.3	13.4	14.9	18.7	8.4	13.6	11.1	5.3	7.1	1.7	5.5	5.2	3.1	5.9	5.0	5.1	6.2
MRE11	"ATLD, MRE11A"	ENSG00000020922	"MRE11 homolog, double strand break repair nuclease"	P49959	11	94415578-94493908	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Meiosis"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002691, CAB004081"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004081: AB_2145100, HPA002691: AB_1079409"	"unprognostic (5.59e-3)"	"unprognostic (4.35e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (7.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.66e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.06e-3)"	14.7	11.0	10.7	15.2	12.5	24.0	16.6	21.2	12.0	17.5	11.0	10.8	13.9	8.0	17.4	11.2	13.9	13.2	8.9	9.4	8.7	6.5	8.8	8.9	11.4	13.8	13.3	7.9	16.7	15.5	8.2	12.8	14.2	9.8	12.7	14.1	10.4	14.1	10.8	9.3	18.3	12.8	12.8	13.5	17.2	11.8	9.9	13.0	25.3	12.7	7.4	18.4	14.3	13.3	8.7	14.8	7.9	13.1	10.3	11.8	7.9	10.0	10.3	19.3	2.4	6.5	9.2	11.0	14.1	9.2	12.8	15.2	18.6	20.7	26.3	23.0	7.3	19.3	16.3	10.6	16.9	17.4	9.7	22.9	14.7	10.7	3.0	15.0	16.6	6.4	6.6	16.5	10.4	11.1	16.0	17.1	10.1	7.2	15.2	14.3	6.2	11.3	13.6	17.3	13.2	8.3	14.1	6.8	9.7	19.5	12.3	3.8	21.1	9.1	8.1	19.2	14.0	16.5	10.1	4.3	15.2	25.8	5.1	24.0	15.2	5.4	11.1	7.9	11.2	13.1	11.0	8.5	8.4	11.8	14.8	8.7	7.1	11.5	4.8	10.3	9.8	10.5	10.9	7.9	10.7	12.5	21.2	12.0	8.7	6.5	13.3	7.9	9.8	13.0
MRFAP1	"PAM14, PGR1"	ENSG00000179010	"Morf4 family associated protein 1"	Q9Y605	4	6640091-6642745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB042447, HPA056367"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB042447: AB_2145271, HPA056367: "	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.02e-1)"	"prognostic favourable (2.90e-7)"	"unprognostic (1.24e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	52.8	77.4	88.5	32.3	81.7	24.6	51.2	64.5	87.7	53.9	43.6	57.8	42.4	39.3	57.5	59.3	41.5	54.0	36.6	67.1	77.3	83.7	60.7	65.9	40.2	31.3	87.2	95.9	69.0	39.9	64.2	65.6	52.0	59.7	54.5	37.0	38.4	43.0	60.5	82.3	33.0	39.2	59.1	91.6	45.9	37.7	51.0	69.1	19.1	54.2	57.2	34.4	45.5	58.4	34.3	62.7	71.1	65.3	46.4	49.6	58.2	52.2	58.2	49.5	56.9	60.9	55.3	39.1	69.0	64.0	64.0	64.2	57.2	56.8	32.7	53.6	63.7	30.0	66.7	72.1	77.7	13.3	48.3	48.8	67.9	61.9	57.1	36.4	24.6	57.1	66.2	58.8	59.9	71.0	64.0	21.5	63.1	65.8	27.4	85.9	61.6	74.6	35.7	89.7	27.6	77.4	39.6	78.0	61.0	44.7	32.3	64.0	90.0	44.6	63.3	56.4	37.8	41.8	90.6	31.9	39.4	54.5	58.4	78.0	54.5	60.1	65.3	55.3	47.4	52.8	47.8	33.0	47.4	47.4	62.7	34.3	49.3	48.1	71.1	46.4	49.6	50.5	49.6	58.2	88.5	81.7	64.5	87.0	77.3	83.7	87.2	95.9	59.7	69.1
MRGBP	"C20orf20, Eaf7, FLJ10914, MRG15BP"	ENSG00000101189	"MRG domain binding protein"	Q9NV56	20	62796453-62801738	"Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 55.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017012	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA017012: AB_1845679"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (8.56e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavourable (3.80e-6)"	"unprognostic (2.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavourable (2.48e-6)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.01e-3)"	5.7	6.7	6.3	6.1	6.6	6.6	5.8	7.8	9.1	5.4	7.7	6.8	4.4	9.2	5.7	4.6	6.2	5.2	5.4	8.9	5.6	5.3	6.5	9.4	5.6	8.0	6.5	5.5	10.5	10.6	5.9	6.6	8.4	5.1	5.7	4.9	6.5	8.4	7.3	8.5	6.3	9.7	8.4	4.0	8.5	6.7	55.3	6.0	8.3	6.2	6.2	6.1	6.6	7.5	1.7	2.0	2.8	3.7	0.6	3.8	1.2	14.1	9.0	7.4	11.3	4.1	6.2	7.2	8.2	10.7	32.1	14.0	32.0	11.4	13.0	16.5	6.3	12.1	8.4	13.9	18.2	4.0	7.2	9.5	9.7	18.4	6.4	11.0	17.9	5.3	10.3	8.7	9.3	7.6	12.9	7.2	8.0	21.5	20.9	21.0	6.2	16.3	18.8	14.1	9.7	4.8	5.9	10.5	8.5	11.7	10.5	14.8	13.0	16.2	7.8	20.1	20.9	13.5	17.4	9.7	5.9	15.5	19.8	11.1	11.2	0.0	2.2	2.8	2.0	3.7	2.7	1.5	2.5	2.7	1.5	1.7	1.9	3.8	2.4	0.6	1.5	2.0	2.7	1.2	6.3	6.6	7.8	9.1	5.6	5.3	6.5	5.5	5.1	6.0
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013409	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 26.2;ASC TERT1: 11.7;BJ: 14.7;BJ hTERT+: 37.3;BJ hTERT+ SV40 Large T+: 14.0;U-2197: 17.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 16.6"	"Low region specificity"	"Detected in all"			HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"				"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	10.8	1.7	0.8	7.6	1.2	0.0	26.6	7.8	1.5	61.9	39.5	1.2	13.9	4.8	49.2	22.3	28.2	28.0	30.6	6.2	0.7	0.4	4.2	2.1	4.8	5.6	1.1	1.3	25.6	0.9	0.4	1.1	5.9	1.8	29.6	4.8	5.8	2.9	25.5	3.1	4.0	10.1	41.1	1.0	8.2	14.2	13.1	0.6	0.1	3.8	6.4	2.7	42.2	19.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	11.7	0.5	14.7	37.3	14.0	9.3	0.0	0.6	0.0	0.3	11.3	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.0	0.0	3.3	0.0	0.0	8.6	0.0	8.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	17.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	7.8	1.5	0.7	0.4	1.1	1.3	1.8	0.6
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764532-13774282	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"			2600000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: "	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	14.5	18.5	12.5	21.8	18.3	16.6	16.8	24.5	21.8	21.5	17.2	23.6	23.5	19.0	24.2	21.3	20.7	19.9	17.6	13.5	14.6	12.1	24.4	20.1	15.4	19.5	16.5	14.3	24.0	20.5	21.3	17.3	24.2	17.2	17.8	13.4	18.5	23.4	21.6	13.0	28.6	18.5	13.3	16.6	22.0	19.8	5.0	16.7	20.0	21.8	10.5	18.2	18.1	20.6	5.7	8.9	6.9	5.8	5.0	6.6	3.6	10.5	7.9	3.9	9.4	4.3	8.1	9.7	12.6	7.3	11.4	10.4	8.3	8.5	5.7	5.0	4.7	17.9	18.3	13.0	7.0	10.0	31.7	4.5	12.5	8.9	3.8	13.7	10.6	8.1	7.2	5.8	4.6	10.6	8.7	0.3	4.9	15.5	15.1	8.7	6.5	22.5	14.3	5.3	12.9	5.9	8.3	7.9	7.1	4.6	10.3	9.8	8.0	5.0	6.4	5.9	5.5	20.8	6.1	7.8	8.2	1.7	5.0	15.9	7.0	6.9	5.5	1.9	6.2	5.8	6.0	5.0	5.3	6.6	4.7	5.7	4.3	3.3	4.1	5.0	3.2	8.9	4.8	3.6	12.5	18.3	24.5	21.8	14.6	12.1	16.5	14.3	17.2	16.7
MRM1	FLJ22578	ENSG00000278619	"Mitochondrial rRNA methyltransferase 1"	Q6IN84	17	36601572-36608971	"Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 15.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021598	Supported		Supported	Mitochondria				Mitochondria		"HPA021598: AB_1854097"	"unprognostic (9.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.74e-2)"	2.2	6.8	2.9	3.9	6.4	2.9	3.5	1.9	4.9	1.2	4.2	5.2	3.2	5.9	3.2	3.4	3.6	4.0	3.4	3.8	3.7		2.4	4.0	2.2	4.6	6.5	3.0	4.2	4.1	0.9	0.9	1.0	2.8	2.1	5.6	2.4	2.9	4.7	5.9	2.2	4.5	1.2	3.4	5.2	2.5	1.5	3.5	0.9	3.2	1.8	3.8	3.4	0.0	6.7	3.3	0.0	4.4	7.3	7.6	3.7	0.9	6.2	0.0	3.6	3.2	3.9	11.9	0.2	0.0	0.0	0.0	0.4	0.1	0.4	7.2	0.0	15.3	0.1	0.2	0.0	4.7	2.2	10.7	3.5	6.5	1.9	5.2	5.5	3.0	0.3	7.6	0.0	3.8	6.3	4.0	4.4	0.1	10.6	3.2	0.1	0.1	8.5	0.0	13.7	3.1	7.2	2.9	1.9	0.0	4.5	4.6	4.7	1.8	1.8	3.6	6.1	4.2	0.0	9.4	10.9	4.6	0.0	6.0	2.6	0.0	2.9	0.0	4.3	4.4	7.6	6.7	3.6	4.1	2.9	6.1	5.5	5.8	0.0	7.3	1.8	3.3	2.8	3.7										
MRM3	"FLJ10581, HC90, RMTL1, RNMTL1"	ENSG00000171861	"Mitochondrial rRNA methyltransferase 3"	Q9HC36	17	782273-792509	"Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022534, HPA023031, HPA023292"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388"	"unprognostic (1.66e-1)"	"unprognostic (5.83e-3)"	"unprognostic (6.72e-2)"	"prognostic favourable (2.81e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.47e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (3.82e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.42e-2)"	10.0	13.8	7.2	12.4	11.9	16.4	10.5	12.8	11.8	7.1	9.1	7.8	8.0	8.6	8.6	8.2	12.0	9.4	10.1	14.7	7.1	7.2	11.1	20.5	6.5	11.9	9.7	7.7	10.3	21.2	8.3	9.2	7.6	10.1	8.2	8.9	7.0	11.4	8.6	31.0	14.6	8.2	8.7	4.8	10.8	12.4	21.4	8.9	12.2	10.1	13.8	10.1	8.7	10.8	22.1	14.8	8.0	14.2	17.6	20.2	14.8	13.3	27.9	6.1	10.4	9.0	7.7	12.0	7.2	6.8	14.5	12.4	16.3	6.3	24.2	7.5	5.7	11.4	17.9	6.4	14.1	8.1	29.2	9.3	16.2	14.2	9.1	8.0	8.5	9.0	8.9	15.5	13.5	11.1	15.6	10.9	7.8	14.4	13.7	10.5	8.9	14.7	16.8	4.3	12.8	9.7	7.3	8.1	9.3	10.3	8.7	13.5	10.8	7.2	8.6	7.8	6.0	11.3	19.8	4.2	6.0	9.7	9.8	11.2	10.5	4.9	14.2	8.0	15.2	11.3	16.4	22.1	16.6	18.5	14.8	20.9	20.2	17.6	1.1	17.6	10.9	11.8	17.2	14.8	7.2	11.9	12.8	11.8	7.1	7.2	9.7	7.7	10.1	8.9
MRPL1	BM022	ENSG00000169288	"Mitochondrial ribosomal protein L1"	Q9BYD6	4	77862520-77952790	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043656	Supported		Supported	Mitochondria				Mitochondria		"HPA043656: "	"unprognostic (9.03e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.14e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.22e-2)"	"prognostic favourable (3.35e-5)"	"unprognostic (7.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"unprognostic (9.17e-3)"	13.6	16.5	14.8	10.9	16.0	13.5	14.0	12.3	20.3	13.6	16.2	4.4	9.6	11.8	12.5	13.6	17.2	10.5	6.9	23.5	18.5	14.7	22.4	22.4	7.6	12.4	13.5	14.0	12.0	12.0	10.5	18.9	16.1	16.6	17.3	17.9	4.3	11.1	11.5	46.6	8.2	12.0	20.3	12.1	15.4	12.3	5.4	9.5	11.9	11.7	24.7	13.4	17.2	14.3	14.9	12.0	4.7	10.1	12.6	18.3	8.9	12.1	7.6	15.1	12.6	11.6	15.3	13.1	14.0	8.7	18.1	12.4	15.5	22.0	21.5	17.4	11.2	10.3	21.8	25.1	23.7	14.4	11.4	18.3	8.2	16.3	15.4	37.8	8.9	11.9	23.7	16.0	16.3	21.6	26.4	7.3	22.7	13.0	23.7	24.5	16.7	10.1	27.1	18.8	12.3	35.1	11.8	16.4	8.3	10.8	28.1	25.8	13.6	19.1	12.7	12.0	18.0	12.0	19.8	6.5	8.1	22.5	10.1	21.5	15.3	4.7	6.5	3.9	12.7	10.1	12.5	14.9	14.0	13.9	12.0	14.3	16.8	18.3	1.1	12.6	8.5	9.8	16.6	8.9	14.8	16.0	12.3	20.3	18.5	14.7	13.5	14.0	16.6	9.5
MRPL10	"L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8"	ENSG00000159111	"Mitochondrial ribosomal protein L10"	Q7Z7H8	17	47823272-47831534	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021234, HPA029885"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA021234: AB_1854098, HPA029885: AB_2673233"	"unprognostic (6.84e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-3)"	"prognostic unfavourable (6.67e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.87e-2)"	20.8	23.2	18.3	23.8	25.2	17.7	34.3	22.2	25.9	19.2	24.7	11.5	24.4	21.2	22.8	26.5	20.3	25.6	28.7	44.0	18.9	18.1	21.6	26.0	29.6	39.6	18.0	19.4	42.9	34.7	17.8	12.3	19.3	16.9	17.6	19.6	16.5	18.2	27.5	43.2	15.5	17.6	37.9	21.4	19.6	23.8	18.6	13.2	19.2	20.4	26.6	21.2	26.0	19.6	17.7	20.4	11.2	18.3	11.6	31.6	17.7	12.6	27.9	11.8	11.9	28.2	26.0	22.0	11.1	18.7	19.2	16.4	53.7	17.4	20.5	26.0	14.3	12.0	16.7	21.7	17.1	19.7	26.6	16.4	15.0	37.6	24.4	14.7	9.2	29.2	18.9	22.7	32.3	18.4	21.9	20.6	14.7	24.8	15.0	18.5	19.4	26.8	12.1	23.1	22.7	20.9	12.4	14.2	22.8	8.5	9.8	23.7	29.0	15.6	11.3	17.3	14.3	11.6	15.6	36.2	27.9	16.5	15.2	11.2	11.5	11.2	17.6	8.2	31.6	18.3	29.8	15.9	21.8	27.9	20.4	17.7	18.6	21.9	7.1	11.6	14.7	12.4	24.3	17.7	18.3	25.2	22.2	25.9	18.9	18.1	18.0	19.4	16.9	13.2
MRPL11		ENSG00000174547	"Mitochondrial ribosomal protein L11"	Q9Y3B7	11	66435075-66466738	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057685	Approved		Supported	Mitochondria				Mitochondria		"HPA057685: "	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	13.9	12.9	10.1	18.9	10.6	18.2	25.6	10.6	12.5	13.7	20.7	7.0	13.5	15.7	16.5	16.2	22.3	16.3	17.5	32.0	8.5	8.7	19.4	33.1	15.7	27.5	9.0	7.5	20.2	36.6	15.1	9.5	14.8	7.7	15.2	23.2	10.8	21.5	17.7	41.4	13.5	21.8	18.5	7.5	18.5	18.5	14.0	6.7	23.3	19.8	29.7	19.0	16.4	17.7	23.4	25.5	3.4	20.2	16.3	20.9	19.2	19.8	15.9	15.1	14.4	7.5	8.5	21.6	11.6	13.3	22.2	17.1	44.3	24.7	25.1	20.3	11.0	17.4	22.0	22.8	15.7	11.5	14.6	15.7	13.6	23.4	9.1	26.0	10.6	10.1	13.6	13.6	17.0	16.4	22.8	11.0	9.6	33.9	29.9	41.5	27.6	23.2	19.0	30.1	31.3	9.6	13.7	15.9	13.8	12.8	19.4	39.9	22.0	13.7	9.2	13.4	18.0	12.6	13.6	8.1	12.6	28.3	13.8	16.8	9.0	0.8	16.3	3.4	17.7	20.2	18.9	23.4	19.7	17.4	25.5	19.3	20.9	19.1	1.1	16.3	17.7	15.4	19.8	19.2	10.1	10.6	10.6	12.5	8.5	8.7	9.0	7.5	7.7	6.7
MRPL12	"MRPL7, MRPL7/L12, RPML12"	ENSG00000262814	"Mitochondrial ribosomal protein L12"	P52815	17	81703357-81707526	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022853, HPA023043"	Supported		Supported	Mitochondria				Mitochondria		"HPA022853: AB_1854099, HPA023043: AB_1854100"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.97e-2)"	"unprognostic (5.97e-3)"	"prognostic unfavourable (2.35e-4)"	"unprognostic (1.78e-1)"	"unprognostic (6.47e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.77e-3)"	"unprognostic (3.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.26e-2)"	15.7	18.6	15.3	14.5	16.9	14.4	27.7	13.6	18.6	9.8	27.2	8.3	14.9	25.2	10.7	8.6	24.4	12.6	14.8	63.7	14.8	13.7	22.8	64.9	15.4	20.4	17.8	10.5	8.9	40.7	13.3	10.7	12.8	13.1	11.6	20.5	9.3	19.6	13.9	79.1	12.6	18.2	11.4	9.4	17.2	15.2	14.4	7.5	16.1	12.2	50.4	16.0	10.9	11.2	24.7	34.6	5.0	30.0	14.7	20.5	17.7	27.7	47.6	12.8	14.8	9.7	10.7	23.6	21.8	13.4	33.0	24.6	39.8	13.4	43.3	13.2	14.3	23.6	16.4	28.0	16.8	10.1	82.0	33.0	25.4	44.5	14.4	36.1	17.3	12.3	20.5	22.6	25.4	27.3	32.1	14.4	16.3	35.0	30.7	53.6	20.0	62.0	29.3	20.8	32.0	24.3	23.2	32.7	42.0	16.0	69.2	35.6	35.1	33.1	14.2	25.1	29.8	19.6	44.1	27.9	9.5	24.6	17.2	26.2	18.8	5.0	24.1	3.2	15.0	30.0	20.5	24.7	15.1	16.6	34.6	23.1	16.0	14.3	2.6	14.7	17.3	28.4	12.9	17.7	15.3	16.9	13.6	18.6	14.8	13.7	17.8	10.5	13.1	7.5
MRPL14	"MRP-L32, RPML32"	ENSG00000180992	"Mitochondrial ribosomal protein L14"	Q6P1L8	6	44113454-44127457	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038769, HPA076790"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA038769: AB_10673288, HPA076790: "	"unprognostic (4.58e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.20e-2)"	"prognostic favourable (4.81e-4)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (7.46e-5)"	"unprognostic (7.13e-2)"	"unprognostic (1.65e-1)"	"prognostic favourable (1.08e-4)"	"unprognostic (3.27e-2)"	10.1	16.1	12.5	9.6	12.8	7.9	11.7	10.5	12.7	10.5	16.4	9.6	8.4	16.2	12.1	12.3	15.7	10.4	14.8	18.5	10.0	8.4	12.4	35.5	25.9	10.4	10.9	11.5	7.1	17.5	4.9	9.6	11.8	10.6	9.7	16.3	13.7	14.0	9.4	61.4	16.0	14.0	12.7	7.9	10.2	12.7	19.0	10.4	13.1	26.3	27.8	12.4	12.3	10.0	33.2	36.4	9.0	36.1	46.7	32.5	30.3	51.5	22.1	15.6	21.6	13.6	13.3	20.0	19.3	19.3	25.8	25.8	46.0	18.2	22.5	21.9	16.4	21.1	17.6	31.4	20.5	26.7	48.0	23.2	19.6	56.2	16.8	21.9	16.3	12.4	17.1	24.3	14.5	21.3	48.7	14.5	22.7	52.1	26.2	34.6	13.7	21.3	18.9	17.6	30.5	42.4	25.6	35.0	13.6	12.4	24.3	24.0	22.3	22.6	16.9	23.0	34.4	16.4	33.3	18.1	16.0	52.8	26.0	21.9	16.7	9.0	36.1	7.5	25.4	32.7	29.9	33.2	32.5	28.6	32.4	30.2	25.8	26.5	2.0	46.7	21.9	36.4	21.9	30.3	12.5	12.8	10.5	12.7	10.0	8.4	10.9	11.5	10.6	10.4
MRPL19	"KIAA0104, MRP-L15, RLX1, RPML15"	ENSG00000115364	"Mitochondrial ribosomal protein L19"	P49406	2	75646783-75690851	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046805, HPA056622"	Approved		Supported	Mitochondria				Mitochondria		"HPA046805: , HPA056622: "	"unprognostic (9.24e-2)"	"unprognostic (3.84e-2)"	"prognostic favourable (7.39e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.52e-3)"	"unprognostic (5.75e-2)"	"unprognostic (9.86e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.71e-3)"	"prognostic unfavourable (1.97e-5)"	"unprognostic (2.42e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	21.3	33.9	22.5	13.0	25.2	8.8	21.1	15.9	26.7	23.0	19.5	24.1	12.1	16.8	19.1	19.6	25.7	13.9	15.6	24.4	21.3	20.4	40.8	44.9	13.0	13.5	26.0	21.2	17.3	17.8	30.9	20.6	18.4	26.6	16.4	23.0	13.2	17.7	19.6	47.3	17.2	16.3	21.1	27.7	18.1	16.3	12.0	24.4	19.2	27.3	22.0	17.3	15.1	15.9	18.5	23.7	9.6	17.1	15.5	18.0	11.1	36.0	21.0	20.0	17.9	21.9	26.4	28.3	23.2	21.0	29.6	23.5	32.4	15.0	20.4	23.4	25.3	25.5	31.0	35.1	44.6	22.6	26.6	27.8	16.5	40.9	23.4	29.5	16.7	17.4	27.1	29.9	27.5	31.0	30.5	12.0	29.1	22.0	26.8	23.3	26.0	23.5	33.8	43.6	26.8	50.1	22.6	22.1	19.1	22.8	26.4	25.8	22.6	11.9	20.8	25.9	28.6	22.9	34.2	12.5	18.7	16.9	20.4	29.3	22.5	9.6	14.1	9.2	16.0	17.1	18.0	18.5	16.5	16.9	19.9	16.1	14.7	18.0	0.9	15.5	15.4	23.7	17.4	11.1	22.5	25.2	15.9	26.7	21.3	20.4	26.0	21.2	26.6	24.4
MRPL20	FLJ10024	ENSG00000242485	"Mitochondrial ribosomal protein L20"	Q9BYC9	1	1401908-1407313	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047074	Supported		Supported	Mitochondria				Mitochondria		"HPA047074: AB_10964064"	"unprognostic (4.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.64e-1)"	36.7	36.2	44.4	31.0	40.7	22.6	41.2	30.3	46.8	24.8	33.4	24.2	38.8	30.7	28.1	52.3	33.8	32.7	39.9	75.3	37.3	38.6	40.1	48.8	31.5	59.7	39.9	31.4	26.5	72.8	28.4	36.3	27.2	35.6	35.1	33.1	29.1	50.5	47.7	121.8	27.3	28.9	44.5	39.1	30.5	33.6	27.7	29.7	22.8	34.3	54.8	35.9	27.1	26.9	50.6	77.5	37.5	52.1	40.5	59.9	51.7	39.3	38.1	28.7	29.0	22.1	24.1	21.2	35.3	27.1	46.0	33.0	45.3	48.1	42.1	49.5	30.2	25.1	46.6	38.1	35.8	36.4	66.0	45.5	67.1	44.5	30.7	66.8	29.4	28.1	14.7	35.3	38.0	34.0	45.8	25.2	38.5	39.5	51.3	51.0	29.7	77.2	34.1	26.5	53.7	35.8	26.5	51.0	42.0	33.6	70.4	51.8	30.2	49.5	29.0	28.1	32.7	42.0	43.5	38.6	54.9	82.0	43.4	54.4	19.5	27.8	52.1	37.5	46.8	49.1	52.4	50.6	52.3	46.4	53.2	47.5	59.9	57.3	24.1	40.5	37.7	77.5	45.0	51.7	44.4	40.7	30.3	46.8	37.3	38.6	39.9	31.4	35.6	29.7
MRPL23	"L23MRP, RPL23L"	ENSG00000214026	"Mitochondrial ribosomal protein L23"	Q16540	11	1947278-1984522	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA050406	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"				Mitochondria	"Nucleoli fibrillar center"	"HPA050406: "	"unprognostic (5.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"prognostic favourable (3.97e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.33e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.08e-2)"	19.4	32.7	19.3	21.8	19.3	37.3	22.1	14.0	25.1	18.1	21.0	17.2	22.5	28.7	19.9	31.4	31.5	30.7	29.9	39.8	16.6	16.8	25.1	43.8	17.4	42.9	18.4	16.9	29.4	69.1	22.6	25.8	14.5	17.4	17.9	21.0	21.2	48.7	25.9	61.0	35.5	23.8	15.9	14.3	22.4	25.6	11.1	11.4	32.5	21.1	44.3	30.1	12.7	17.9	24.1	20.2	12.6	14.5	6.8	22.1	3.3	23.1	27.3	14.7	17.5	6.0	16.9	21.4	6.9	10.3	11.8	8.8	1.7	28.1	23.5	13.8	16.1	23.2	23.7	32.4	5.6	26.2	115.1	8.4	8.6	33.4	15.9	22.2	13.3	13.3	12.6	8.2	2.4	8.4	6.3	12.7	17.1	25.4	17.7	4.6	20.1	20.7	24.4	7.7	24.5	10.5	9.1	29.6	25.0	8.7	20.6	12.8	0.5	28.1	10.6	16.2	10.0	4.0	15.3	17.8	15.8	22.1	25.2	19.3	0.0	1.9	14.5	12.6	7.0	10.7	5.6	24.1	10.3	7.8	20.2	20.3	22.1	6.7	0.8	6.8	7.8	8.6	14.6	3.3	19.3	19.3	14.0	25.1	16.6	16.8	18.4	16.9	17.4	11.4
MRPL28	"MAAT1, p15"	ENSG00000086504	"Mitochondrial ribosomal protein L28"	Q13084	16	367384-370527	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030594, CAB033542, HPA055589"	Supported		Supported	Mitochondria				Mitochondria		"CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855"	"unprognostic (2.39e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.45e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.56e-2)"	18.3	21.7	32.2	18.6	36.6	25.1	19.5	17.9	38.4	15.3	26.0	19.1	14.6	21.7	16.8	21.3	21.1	21.2	20.0	49.6	30.9	22.5	26.9	35.5	15.1	24.5	24.9	20.9	15.7	21.4	23.6	15.5	15.8	17.7	16.2	12.0	16.8	21.7	18.4	42.1	16.0	19.2	19.6	16.8	18.1	15.8	25.7	10.4	24.9	20.3	36.3	20.4	16.9	14.7	38.0	47.1	48.2	42.0	28.0	47.7	33.7	17.6	41.3	17.7	21.2	10.0	12.9	24.2	20.7	27.1	37.5	37.1	50.7	24.6	26.0	23.6	20.9	23.2	27.0	43.7	20.0	23.4	65.6	19.1	31.9	41.6	32.3	23.7	25.8	19.4	21.8	34.8	28.1	27.4	35.0	19.5	23.3	71.5	37.3	27.0	28.4	26.4	46.6	21.6	37.4	30.7	10.9	30.5	27.8	25.6	26.2	21.2	33.7	24.7	21.5	23.1	32.2	18.3	23.0	30.9	23.8	34.5	15.5	17.3	36.1	30.4	42.0	45.8	30.1	40.8	24.6	34.3	26.2	28.4	37.7	38.0	18.6	23.8	48.2	28.0	40.7	47.1	47.7	33.7	32.2	36.6	17.9	38.4	30.9	22.5	24.9	20.9	17.7	10.4
MRPL36	"BRIP1, L36mt, MRP-L36, PRPL36, RPMJ"	ENSG00000171421	"Mitochondrial ribosomal protein L36"	Q9P0J6	5	1798386-1801366	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 90.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047238	Approved		Supported	"Nuclear bodies,Mitochondria"				"Nuclear bodies, Mitochondria"		"HPA047238: AB_10965331"	"unprognostic (2.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (8.53e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	16.8	20.7	14.3	12.9	14.8	8.2	17.9	9.3	15.4	12.3	15.9	9.0	13.7	14.1	13.5	15.1	20.8	12.7	19.0	32.4	13.5	13.0	22.4	44.6	11.6	13.6	14.2	8.6	16.5	28.9	9.0	10.1	13.9	12.3	17.0	10.5	9.6	27.3	12.3	52.5	11.7	16.2	16.1	11.9	11.5	14.4	46.0	11.1	14.1	18.1	35.8	15.3	16.3	14.4	24.5	90.2	12.9	20.3	18.4	25.8	24.1	22.9	34.1	15.9	30.0	29.4	24.3	20.9	20.1	17.8	24.0	23.0	24.7	18.7	30.9	36.6	21.5	25.1	35.7	33.1	17.4	33.7	39.8	15.0	75.8	39.0	37.6	19.4	11.8	21.4	25.6	26.8	34.9	23.3	22.7	20.0	34.1	42.1	22.7	43.9	15.4	42.0	18.3	11.9	37.3	21.7	18.8	17.7	12.2	43.8	34.2	20.9	20.1	21.1	14.0	20.9	22.7	14.1	22.2	19.2	23.9	40.8	26.2	36.0	28.4	12.9	20.3	12.5	18.6	19.4	22.1	24.5	21.0	22.4	24.3	17.9	18.6	22.1	5.8	18.4	16.5	90.2	25.8	24.1	14.3	14.8	9.3	15.4	13.5	13.0	14.2	8.6	12.3	11.1
MRPL37	"MRP-L2, RPML2"	ENSG00000116221	"Mitochondrial ribosomal protein L37"	Q9BZE1	1	54184041-54225464	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025767, HPA025826, HPA025951"	Supported		Supported	Mitochondria				Mitochondria		"HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107"	"unprognostic (2.00e-1)"	"unprognostic (6.81e-2)"	"prognostic favourable (6.99e-4)"	"unprognostic (1.71e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (6.45e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (9.25e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.67e-3)"	21.3	35.0	16.2	15.8	24.0	26.0	18.0	16.9	34.8	15.8	22.9	18.0	13.9	23.5	17.6	13.7	29.0	18.2	18.6	32.0	15.4	14.0	25.1	65.2	13.8	20.6	16.0	14.6	21.2	30.8	15.4	10.9	19.4	23.0	16.2	25.2	20.1	33.5	15.3	68.0	24.0	25.0	19.3	11.9	17.9	20.9	20.0	9.0	31.4	18.1	39.9	28.1	16.2	17.5	39.0	40.8	14.8	35.3	29.1	37.4	38.5	38.8	22.5	20.5	27.6	20.7	27.8	36.7	26.5	24.9	47.3	41.3	44.9	18.0	53.0	24.0	29.6	31.4	40.3	39.2	37.1	25.8	50.8	45.5	47.5	45.3	35.6	53.8	21.2	30.7	33.7	49.1	38.5	42.2	50.2	16.0	33.6	28.7	37.0	52.5	41.9	50.1	40.8	41.7	44.6	26.9	29.2	40.6	18.9	36.6	63.1	48.7	27.3	61.1	21.0	30.4	27.6	38.2	53.1	20.3	28.4	41.3	39.6	55.0	28.7	14.8	35.3	14.6	24.1	29.9	28.2	39.0	29.8	27.2	40.8	32.8	30.3	27.0	1.9	29.1	27.9	34.1	37.4	38.5	16.2	24.0	16.9	34.8	15.4	14.0	16.0	14.6	23.0	9.0
MRPL38	"HSPC262, MGC4810, MRP-L3, RPML3"	ENSG00000204316	"Mitochondrial ribosomal protein L38"	Q96DV4	17	75898643-75905413	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023054, HPA023135"	Approved		Supported	Mitochondria				Mitochondria		"HPA023054: AB_1854109, HPA023135: AB_1854110"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.24e-2)"	"prognostic favourable (4.23e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavourable (5.58e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.72e-1)"	"prognostic favourable (9.21e-5)"	10.8	14.1	12.4	6.7	14.8	6.0	8.2	8.4	20.8	9.6	11.7	23.3	6.5	10.6	9.5	7.8	11.2	15.4	10.2	21.2	11.7	9.2	11.7	17.6	8.4	8.1	15.7	18.1	12.0	17.5	8.7	7.7	7.3	14.8	8.7	8.2	8.8	17.1	13.6	41.8	9.5	8.9	17.9	11.3	8.8	10.3	15.1	14.7	8.3	8.8	14.1	9.5	10.9	7.5	28.5	29.4	9.9	21.8	24.0	24.6	21.3	17.6	24.8	5.0	6.1	7.3	6.0	20.4	6.0	10.5	23.3	16.9	30.3	10.6	17.1	7.1	10.2	12.5	17.8	16.2	6.1	5.1	33.5	11.4	7.0	27.0	18.4	15.1	10.2	8.8	18.5	15.0	12.2	22.6	14.2	7.8	8.3	36.9	18.3	15.0	6.4	24.6	13.7	17.2	18.4	17.3	8.8	9.8	11.0	11.2	26.2	24.2	24.4	15.1	6.9	8.9	15.3	7.0	15.8	10.1	6.3	4.9	10.8	11.7	8.1	4.5	20.0	9.9	23.7	21.8	23.8	28.3	24.5	22.2	29.4	28.5	24.6	23.7	1.6	24.0	17.5	20.9	24.5	21.3	12.4	14.8	8.4	20.8	11.7	9.2	15.7	18.1	14.8	14.7
MRPL40	"MRP-L22, NLVCF"	ENSG00000185608	"Mitochondrial ribosomal protein L40"	Q9NQ50	22	19431902-19436075	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006181	Uncertain		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA006181: AB_1079411"	"unprognostic (4.12e-2)"	"prognostic favourable (7.57e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.14e-2)"	4.0	6.6	5.5	2.5	6.6	1.3	3.9	5.1	5.4	4.3	2.6			2.9	3.0	5.0	3.7	5.0	2.9	11.8	4.6	4.7	6.1	10.3	2.2	3.0	5.1		4.7	7.0	6.4	4.9	2.5		4.6	2.2		8.7	4.2	14.8	3.6	2.3	2.4	5.0	2.7	3.1	2.8			8.2		2.8	3.7	2.5	28.1	21.6	10.3	15.1	10.9	16.4	16.6	13.2	9.2	2.2	8.4	13.7	12.7	7.0	10.0	11.6	14.1	17.6	10.8	7.7	11.6	10.4	11.0	13.1	13.9	15.9	11.8	11.7	21.2	10.5	6.5	13.3	20.2	14.9	7.0	13.1	15.4	10.3	18.5	9.4	42.4	11.0	13.6	10.1	7.8	8.9	3.6	12.5	7.3	14.5	5.3	16.7	5.5	7.6	7.0	15.3	12.9	19.1	11.4	8.7	11.7	18.8	17.3	7.4	9.6	10.6	14.2	16.9	12.2	10.2	13.5	5.9	13.8	10.3	13.0	15.1	14.0	28.1	13.2	13.5	15.0	25.5	16.4	14.3	1.6	10.9	12.0	21.6	15.0	16.6										
MRPL41	"BMRP, MRP-L27, MRPL27, PIG3, RPML27"	ENSG00000182154	"Mitochondrial ribosomal protein L41"	Q8IXM3	9	137551199-137552555	"Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 55.8;skeletal muscle: 60.6"	"Cell line enhanced"	"Detected in many"		"MCF7: 48.3;PC-3: 47.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024550, HPA027160"	Supported		Supported	Mitochondria				Mitochondria		"HPA024550: AB_1854112, HPA027160: AB_1854113"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	15.3	8.0	12.8	3.5	14.4	3.1	2.8	4.1	10.7	2.4	8.3			7.1	2.3	1.0	1.7	2.1	1.5	16.4	10.3	7.7	6.8	10.7	2.6	3.3	8.5		4.2	6.3	1.8	2.9	1.6		9.5	2.2		10.8	3.8	60.6	5.3	6.2	1.5	4.0	6.2	10.5	2.1			2.0		1.5	2.7	2.1	38.3	55.8	43.7	42.5	21.8	42.2	42.8	9.8	16.7	2.8	6.7	4.2	3.5	13.0	12.7	3.3	5.8	4.7	11.6	5.6	7.2	16.7	3.1	21.0	3.8	6.0	0.6	10.6	20.8	6.7	9.2	18.1	9.7	10.8	30.9	7.0	8.3	5.3	1.8	5.3	14.5	3.1	3.1	48.3	3.7	35.3	10.8	47.3	4.6	4.9	10.1	5.0	6.6	9.3	10.0	8.4	15.6	20.6	14.7	9.9	10.5	10.2	14.1	18.2	16.4	9.4	13.1	12.9	11.7	10.7	7.7	43.7	42.5	31.5	31.2	34.1	29.5	38.3	33.8	35.9	34.6	28.5	32.2	30.2	5.1	21.8	31.1	55.8	42.2	42.8										
MRPL42	"HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31"	ENSG00000198015	"Mitochondrial ribosomal protein L42"	Q9Y6G3	12	93467488-93516213	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039398	Approved		Supported	"Plasma membrane,Mitochondria"				"Plasma membrane, Mitochondria"		"HPA039398: AB_10673529"	"unprognostic (9.32e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (7.49e-4)"	"unprognostic (6.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (8.12e-4)"	18.4	35.6	16.7	13.9	23.6	14.6	22.5	23.2	24.4	22.0	21.5	16.6	16.3	17.0	18.7	16.5	26.7	20.5	15.1	24.2	16.8	16.4	31.0	28.9	16.0	15.3	21.4	16.7	18.4	16.3	26.1	35.8	18.5	26.2	19.3	26.4	13.7	17.8	19.0	15.1	15.8	18.4	19.8	20.4	18.8	18.1	34.5	17.1	25.7	19.5	14.9	21.5	19.1	21.0	29.9	18.8	23.3	23.1	29.3	32.0	21.0	17.0	18.3	29.5	23.9	17.6	26.6	25.0	21.1	21.4	32.2	26.2	24.6	13.7	24.0	9.2	19.3	15.4	38.0	28.5	49.5	28.1	29.3	27.7	12.6	30.6	24.2	32.0	13.9	19.6	31.2	28.0	41.5	31.2	36.5	13.1	36.7	18.1	35.9	25.1	44.1	33.8	29.7	14.9	29.3	35.6	35.0	36.2	19.7	18.1	30.2	22.7	29.9	17.7	15.4	23.7	13.5	15.0	28.3	15.7	22.8	26.5	9.3	25.3	35.5	18.0	17.7	23.3	19.0	23.1	24.4	29.9	24.9	20.9	18.8	23.9	26.1	26.8	7.4	29.3	21.5	13.3	32.0	21.0	16.7	23.6	23.2	24.4	16.8	16.4	21.4	16.7	26.2	17.1
MRPL45	MGC11321	ENSG00000278845	"Mitochondrial ribosomal protein L45"		17	38297023-38323218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 12.4;Daudi: 29.7;K-562: 18.0;REH: 14.5;U-266/84: 17.2;U-698: 21.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023373, HPA023385"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA023373: AB_1854114, HPA023385: AB_1854115"	"unprognostic (8.56e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.13e-2)"	3.1	0.6	1.4	2.6	2.4	1.8	4.9	1.8	6.3	9.6	3.6	1.4	0.7	0.3	10.3	1.1	2.1	0.4	5.8	3.7	1.2		5.9	7.0	2.6	9.6	1.7	1.7	3.9	9.1	0.3	2.4	2.5	2.7	7.7	6.9	1.8	3.8	1.1	11.1	2.4	13.2	1.4	1.8	1.2	1.4	1.7	1.3	1.2	2.6	2.8	10.5	0.9	1.5	6.1	9.3	1.6	5.9	6.9	8.7	4.3	0.0	0.1	12.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.5	29.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.3	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	14.5	0.0	11.0	0.0	11.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.1	0.0	0.0	0.0	8.6	17.2	21.9	0.0	0.0	0.1	0.4	5.7	1.6	4.7	5.9	5.5	6.1	7.0	3.7	9.3	5.2	8.7	5.3	0.1	6.9	1.2	3.3	5.2	4.3										
MRPL46	"C15orf4, LIECG2, P2ECSL"	ENSG00000259494	"Mitochondrial ribosomal protein L46"	Q9H2W6	15	88459476-88467419	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050166	Uncertain		Supported	"Nucleoplasm,Cell Junctions,Mitochondria"				Mitochondria	"Nucleoplasm, Cell Junctions"	"HPA050166: "	"unprognostic (1.42e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"prognostic favourable (2.09e-6)"	"unprognostic (7.73e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.63e-1)"	11.0	28.3	14.2	11.9	14.7	5.4	13.2	15.8	15.6	7.3	12.4	8.5	10.0	11.1	9.6	11.5	13.3	10.5	8.3	40.8	11.8	11.3	19.3	38.7	7.4	10.4	13.2	13.0	11.4	8.9	8.1	9.2	13.7	13.8	9.0	13.8	7.8	9.3	9.5	57.0	8.2	9.3	11.1	11.4	9.7	12.0	13.7	11.7	12.2	10.0	17.9	11.0	11.1	13.4	31.8	24.6	13.2	24.5	24.3	31.9	25.1	9.8	31.6	10.4	11.1	14.9	10.9	19.3	14.1	13.2	21.4	19.2	38.9	21.8	23.5	14.5	12.8	24.2	40.0	17.4	17.3	9.5	31.8	19.6	22.8	40.6	9.4	19.1	15.3	12.6	21.2	16.1	11.1	18.4	21.4	10.0	15.5	21.1	16.0	24.1	16.1	19.2	18.4	14.4	17.7	16.6	31.7	15.8	10.3	13.4	21.2	29.0	23.8	23.7	11.3	16.7	15.8	8.8	20.4	9.3	19.2	19.1	18.3	21.0	12.5	9.9	19.6	13.2	26.8	24.5	30.5	31.8	28.7	26.1	24.6	28.4	31.9	28.4	3.5	24.3	17.6	20.9	26.9	25.1	14.2	14.7	15.8	15.6	11.8	11.3	13.2	13.0	13.8	11.7
MRPL47	"CGI-204, NCM1"	ENSG00000136522	"Mitochondrial ribosomal protein L47"	Q9HD33	3	179588285-179604654	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037553, HPA047779"	Approved		Supported	Mitochondria				Mitochondria		"HPA037553: AB_10671375, HPA047779: "	"unprognostic (6.37e-2)"	"prognostic favourable (6.44e-4)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (3.15e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.84e-2)"	17.4	23.5	22.3	16.4	21.7	29.6	20.2	23.9	25.0	14.2	22.5	12.8	13.0	16.7	16.8	17.3	21.3	13.3	13.4	35.5	21.1	21.8	34.0	31.8	14.8	19.3	25.6	19.4	15.2	12.1	18.1	23.8	17.8	28.5	15.9	23.6	11.2	14.5	14.7	31.7	13.5	20.3	17.8	20.1	20.2	17.4	32.8	22.0	25.3	20.1	27.8	20.7	16.3	13.9	21.0	28.2	24.6	29.0	22.7	28.1	18.9	31.7	12.4	21.6	19.8	13.7	14.4	24.7	18.7	16.7	29.4	24.6	50.1	13.3	26.1	37.0	15.9	24.1	26.4	19.5	31.7	30.0	23.2	25.0	12.4	28.0	26.7	44.9	14.2	13.2	17.1	21.7	22.3	19.7	14.6	21.0	22.8	24.6	24.0	42.0	37.4	29.7	25.6	21.2	43.7	30.9	20.2	18.8	21.8	20.5	33.3	36.7	51.3	34.5	15.7	16.0	22.9	20.0	50.8	26.6	43.5	57.1	18.7	36.9	19.3	15.9	19.3	24.6	20.0	24.8	19.9	21.0	22.2	21.5	28.2	17.4	19.9	20.2	5.1	22.7	29.0	24.4	28.1	18.9	22.3	21.7	23.9	25.0	21.1	21.8	25.6	19.4	28.5	22.0
MRPL51	"bMRP64, CDA09, HSPC241, MRP64"	ENSG00000111639	"Mitochondrial ribosomal protein L51"	Q4U2R6	12	6491886-6493841	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039923	Approved		Supported	Mitochondria				Mitochondria		"HPA039923: AB_10795373"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.33e-2)"	21.4	32.4	36.3	30.4	31.8	24.4	29.1	14.7	29.5	21.0	29.2	18.8	27.2	20.7	22.0	35.2	35.8	20.8	26.8	48.9	29.3	29.6	38.5	50.1	18.1	29.8	36.9	21.3	20.9	52.7	18.8	26.2	26.6	28.4	23.2	30.0	15.8	36.2	28.7	74.0	19.5	24.3	21.5	28.9	27.3	24.0	46.6	25.8	37.5	32.8	52.1	36.7	21.7	26.7	58.4	85.4	59.7	56.2	50.2	61.2	69.5	36.2	44.4	52.6	35.6	34.5	31.4	56.5	25.4	31.4	38.3	37.1	61.3	48.6	45.0	17.8	38.3	32.4	36.6	41.4	58.3	55.4	46.2	31.1	64.5	52.0	32.0	42.3	30.9	30.3	32.9	35.4	46.1	35.1	22.1	16.9	49.4	56.7	49.6	68.1	106.9	45.1	34.4	51.2	38.6	35.2	49.6	18.9	33.7	39.1	53.8	44.1	16.3	48.5	26.9	34.6	48.6	27.8	56.9	16.7	24.0	115.9	44.1	32.3	46.0	49.1	56.2	59.7	52.2	51.2	58.7	58.4	56.4	57.5	63.4	54.4	57.6	59.4	21.2	50.2	49.6	85.4	61.2	69.5	36.3	31.8	14.7	29.5	29.3	29.6	36.9	21.3	28.4	25.8
MRPL52		ENSG00000172590	"Mitochondrial ribosomal protein L52"	Q86TS9	14	22829879-22835037	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012319	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA012319: AB_1854118"	"unprognostic (8.98e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.41e-1)"	24.3	29.4	31.8	31.8	36.8	27.8	54.5	18.8	34.7	22.7	35.5	13.5	31.4	43.7	21.3	23.5	37.5	20.8	39.2	73.7	28.3	31.0	34.1	41.9	36.9	55.9	35.5	27.8	17.2	58.5	21.6	20.7	20.9	40.1	22.4	22.4	12.7	41.6	43.0	79.5	24.3	35.1	22.9	37.0	27.6	39.9	30.6	24.0	27.8	27.4	38.4	25.2	15.6	31.6	43.9	50.6	25.4	39.0	21.9	30.7	29.7	43.7	34.4	18.8	23.3	11.7	13.8	45.9	30.6	22.1	27.4	26.1	42.2	61.4	33.4	33.7	21.0	40.0	15.4	42.3	20.7	35.3	25.3	24.8	13.7	95.7	35.8	39.0	35.7	20.7	29.3	35.4	30.2	43.4	25.4	33.3	20.0	61.5	31.5	59.3	34.7	76.2	39.0	23.5	39.3	28.5	26.2	18.8	24.3	23.7	23.2	32.5	22.3	37.3	33.4	28.7	33.6	35.8	46.3	32.9	38.9	40.6	26.1	26.8	45.7	25.4	36.0	18.0	25.4	39.0	23.2	43.9	27.9	22.9	50.6	37.7	26.4	25.3	6.1	21.9	28.7	41.9	30.7	29.7	31.8	36.8	18.8	34.7	28.3	31.0	35.5	27.8	40.1	24.0
MRPL53		ENSG00000204822	"Mitochondrial ribosomal protein L53"	Q96EL3	2	74471958-74473322	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034612, HPA056185"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA034612: , HPA056185: "	"unprognostic (2.22e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (7.36e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.06e-2)"	"prognostic favourable (1.37e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (1.16e-8)"	"unprognostic (8.76e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.45e-2)"	16.8	26.4	15.8	16.9	15.2	14.0	23.2	14.8	17.7	14.1	16.9	15.2	8.5	18.6	15.1	14.6	19.4	17.5	16.8	40.2	14.0	13.2	25.5	44.8	16.0	28.2	16.6	12.3	23.8	31.2	14.8	18.4	19.9	13.3	18.6	8.9	20.1	36.9	19.8	44.1	12.5	16.3	16.1	15.5	20.3	17.8	13.2	12.2	27.7	28.9	20.3	18.9	14.3	14.6	45.9	42.9	26.1	35.6	19.0	42.5	38.9	7.9	29.5	9.8	6.4	11.0	10.0	14.4	8.5	8.0	10.2	8.1	33.3	11.2	6.7	5.2	7.7	9.6	4.4	14.2	3.6	16.8	25.9	9.0	11.0	21.9	8.1	5.6	9.1	12.4	8.6	13.1	6.6	9.7	9.4	18.6	8.7	40.6	13.7	16.9	6.2	16.2	10.5	17.7	16.2	10.4	7.2	10.6	10.0	5.8	18.6	10.5	8.3	7.1	6.1	13.5	12.1	10.9	10.6	19.5	18.1	12.6	10.1	7.3	11.8	24.7	35.6	14.3	21.6	31.9	26.3	44.8	30.2	23.8	29.3	45.9	42.5	31.2	26.1	19.0	29.9	42.9	34.9	38.9	15.8	15.2	14.8	17.7	14.0	13.2	16.6	12.3	13.3	12.2
MRPL57	MRP63	ENSG00000173141	"Mitochondrial ribosomal protein L57"	Q9BQC6	13	21176645-21179084	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039779, HPA059370"	Supported		Supported	Mitochondria				Mitochondria		"HPA039779: AB_10673362, HPA059370: "	"unprognostic (1.00e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.68e-2)"	"prognostic favourable (8.35e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.78e-2)"	14.0	28.8	23.2	13.8	21.4	16.2	16.5	16.1	22.6	14.6	15.3	12.6	12.9	18.4	13.4	21.0	16.1	17.3	18.7	29.3	20.5	24.7	24.8	40.9	15.0	16.5	21.3	17.9	19.6	30.2	12.3	26.8	12.5	17.1	21.6	12.3	15.1	23.2	18.8	48.0	15.3	17.5	16.4	17.8	16.6	18.1	20.2	13.0	26.4	25.1	24.7	13.8	13.4	12.8	26.1	43.9	23.0	31.5	21.8	32.8	28.8	8.1	14.8	10.5	9.4	8.0	6.6	11.0	9.8	6.1	9.3	7.0	19.4	15.1	4.7	11.5	6.1	14.1	9.1	9.4	7.1	12.3	15.3	21.4	10.6	21.7	11.9	11.7	10.7	6.8	10.4	7.4	7.0	8.9	9.3	6.2	6.5	28.5	25.4	31.0	7.6	17.4	15.5	15.8	8.2	11.4	9.9	21.0	9.8	8.0	10.0	14.4	10.1	11.0	6.1	4.9	9.0	10.3	8.7	8.7	7.0	8.4	4.3	13.9	12.2	17.8	31.5	23.0	22.8	24.4	25.8	26.1	29.0	24.3	27.5	25.8	32.8	26.1	4.8	21.8	20.1	43.9	28.8	28.8	23.2	21.4	16.1	22.2	20.5	24.7	21.3	17.9	17.1	13.0
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003634	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA003634: AB_1851388"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	12.4	23.4	13.9	18.4	14.8	13.7	17.6	18.1	15.7	10.6	15.2	9.8	17.5	13.1	12.5	15.1	19.4	12.5	16.3	31.2	12.2	12.0	25.7	41.7	10.2	15.2	14.3	14.0	10.5	24.2	13.5	9.1	13.9	14.0	13.6	16.3	10.1	17.7	22.5	57.3	16.5	13.4	14.8	12.9	14.6	15.1	7.6	14.0	13.2	14.8	31.2	15.7	14.3	11.6	18.3	28.9	11.2	22.0	20.0	33.5	20.9	26.2	37.1	12.4	14.2	13.3	13.2	17.3	15.6	17.0	32.5	27.7	28.4	16.5	18.3	12.8	15.4	18.8	25.3	26.8	34.4	9.3	30.0	14.3	17.5	23.6	25.2	29.9	9.9	14.3	12.8	21.6	34.6	24.7	23.1	13.4	18.3	32.8	25.8	20.6	9.3	50.3	13.4	22.0	26.6	23.9	19.5	11.5	22.1	13.5	24.7	30.2	32.9	24.8	10.4	17.6	19.3	18.4	29.3	14.0	11.1	20.2	20.1	33.6	14.5	11.2	22.0	10.5	17.3	20.7	14.9	18.3	21.1	17.2	28.9	14.8	15.7	17.6	2.0	20.0	17.4	19.4	33.5	20.9	13.9	14.8	18.1	15.7	12.2	12.0	14.3	14.0	14.0	14.0
MRPL9		ENSG00000143436	"Mitochondrial ribosomal protein L9"	Q9BYD2	1	151759643-151763564	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008579	Approved		Supported	Mitochondria				Mitochondria		"HPA008579: AB_1079412"	"unprognostic (2.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.43e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (1.04e-7)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.30e-2)"	28.5	22.3	23.3	26.3	25.3	23.0	26.4	27.3	30.9	22.1	26.7	22.2	19.8	21.7	26.8	25.4	28.4	22.5	24.3	24.5	21.7	24.6	29.9	35.1	19.5	28.7	24.0	19.4	33.2	31.9	35.1	18.4	29.0	27.6	29.0	22.3	19.7	40.6	25.3	50.7	25.7	23.1	23.7	21.2	28.5	23.0	24.0	18.3	41.2	38.2	34.2	29.3	25.3	23.5	30.6	31.5	15.0	16.5	24.4	37.6	21.6	29.0	23.8	15.7	18.4	11.3	12.7	25.7	16.1	15.4	25.2	20.2	36.3	27.1	19.0	32.8	16.2	25.7	27.3	20.3	20.1	25.9	26.4	14.9	20.2	23.0	18.4	41.5	14.1	13.8	18.8	22.4	28.2	24.3	31.1	25.0	19.4	67.6	25.7	29.8	34.0	34.4	22.7	18.8	36.7	15.2	22.9	25.9	26.5	19.2	27.7	22.6	41.9	50.4	18.0	20.0	20.3	17.1	35.7	28.1	39.8	60.5	25.0	27.5	22.2	15.0	13.6	8.8	27.8	16.5	31.8	30.6	32.1	32.3	31.5	27.8	30.9	28.8	1.6	24.4	14.2	26.5	37.6	21.6	23.3	25.3	27.3	30.9	21.7	24.6	24.0	19.4	27.6	18.3
MRPS11	"FLJ22512, FLJ23406, HCC-2"	ENSG00000181991	"Mitochondrial ribosomal protein S11"	P82912	15	88467453-88480773	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043752, HPA050345"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA043752: AB_2678653, HPA050345: "	"unprognostic (2.66e-1)"	"prognostic favourable (3.60e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.45e-2)"	"prognostic favourable (4.75e-4)"	"unprognostic (8.31e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.44e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	12.4	19.1	19.5	9.0	18.3	6.1	13.5	11.2	19.6	7.0	13.4	8.0	11.0	17.6	7.3	9.3	15.1	11.4	10.3	31.0	19.1	17.3	16.5	28.5	8.2	10.5	18.3	15.0	6.0	22.5	9.6	9.3	9.0	15.8	8.9	8.6	8.0	11.4	10.4	44.3	11.5	13.1	10.0	13.7	9.5	10.7	9.9	10.4	12.9	17.7	12.9	10.4	9.7	7.9	18.5	23.0	18.9	19.0	20.9	24.4	17.4	5.5	22.1	3.1	5.7	7.7	3.9	9.1	4.7	7.9	5.8	6.4	15.2	8.6	5.0	9.4	3.7	7.9	9.2	6.2	2.9	6.7	24.1	6.8	14.3	16.5	9.2	2.4	4.5	7.5	6.1	5.0	5.0	7.9	5.0	2.2	9.7	23.6	4.7	9.8	9.2	23.5	10.1	6.3	11.9	8.2	15.1	11.1	5.4	4.9	11.6	18.0	11.0	13.4	3.6	8.4	9.3	5.5	6.5	4.7	8.3	5.8	10.5	5.7	8.7	18.9	18.4	13.2	11.7	19.0	13.3	18.5	13.3	13.6	21.2	12.9	14.1	13.7	6.7	20.9	12.1	23.0	24.4	17.4	19.5	18.3	11.2	19.6	19.1	17.3	18.3	15.0	15.8	10.4
MRPS14	HSMRPS14	ENSG00000120333	"Mitochondrial ribosomal protein S14"	O60783	1	175010789-175023425	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051087	Uncertain		Supported	"Nuclear membrane,Mitochondria"	"Intracellular and membrane"			"Nuclear membrane, Mitochondria"		"HPA051087: "	"unprognostic (9.24e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-2)"	17.7	23.6	31.8	11.8	27.6	4.5	23.7	19.6	26.3	19.5	14.9	22.9	18.3	13.8	20.1	25.6	15.4	18.0	15.8	16.6	26.9	26.5	23.4	29.7	14.7	16.0	32.7	14.5	21.8	19.1	28.3	26.1	17.1	22.5	23.6	18.1	15.4	18.4	20.4	13.7	12.7	14.7	17.2	33.5	17.4	15.3	15.8	24.5	22.6	26.5	14.5	16.2	14.3	11.7	14.5	13.6	6.5	12.9	14.3	19.2	11.6	11.1	9.0	21.4	7.6	24.2	17.4	6.8	9.8	12.0	16.7	17.4	11.7	9.9	14.2	12.0	13.1	9.9	13.2	11.4	17.8	15.6	18.2	11.7	17.6	13.3	10.2	12.9	10.5	19.0	14.1	9.8	6.9	13.8	14.1	12.6	11.6	6.1	14.1	9.4	11.6	4.8	12.3	11.3	16.9	11.5	9.0	18.0	12.7	14.2	13.2	9.4	15.6	13.8	11.2	5.7	6.3	11.9	8.8	13.9	11.8	17.8	8.1	12.3	11.9	6.5	12.9	6.2	13.4	12.7	18.8	14.5	14.2	14.1	13.6	13.5	19.2	16.2	4.5	14.3	9.7	11.8	15.1	11.6	31.8	27.6	19.6	22.6	26.9	26.5	32.7	14.5	22.5	24.5
MRPS15	FLJ11564	ENSG00000116898	"Mitochondrial ribosomal protein S15"	P82914	1	36455718-36464437	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028100, HPA028134, HPA067137"	Supported		Supported	Mitochondria				Mitochondria		"HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: "	"unprognostic (2.05e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (7.83e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.39e-1)"	22.6	20.7	17.8	16.9	17.3	24.0	23.8	9.5	16.0	13.2	19.9	9.3	13.7	14.3	13.3	23.0	23.0	10.4	16.6	43.2	15.0	15.2	30.6	61.7	16.6	23.3	17.5	10.6	13.8	23.3	14.3	14.3	23.7	18.3	15.0	18.2	13.8	24.0	14.7	89.5	14.1	18.4	15.7	12.3	17.3	18.8	65.5	10.6	20.3	19.1	41.3	19.3	16.0	12.9	24.5	40.7	7.0	28.7	20.3	28.1	28.6	40.2	22.4	24.5	29.9	24.4	35.4	60.9	22.5	32.3	55.8	51.3	39.6	43.4	37.3	36.8	29.6	35.5	35.7	56.8	50.4	24.2	45.3	38.1	29.1	43.2	45.7	47.1	27.0	32.6	50.8	49.7	40.3	45.5	41.1	29.5	34.4	27.6	45.3	50.5	44.0	39.5	35.1	43.1	54.5	49.3	33.9	36.4	20.1	31.2	39.8	57.7	24.6	32.4	21.4	31.5	33.4	38.8	47.4	29.7	40.7	52.1	35.8	32.1	43.9	4.9	26.7	7.0	22.0	28.7	27.2	24.5	25.2	25.0	40.7	21.6	23.9	23.2	1.8	20.3	18.9	27.7	28.1	28.6	17.8	17.3	9.5	16.0	15.0	15.2	17.5	10.6	18.3	10.6
MRPS16	CGI-132	ENSG00000182180	"Mitochondrial ribosomal protein S16"	Q9Y3D3	10	73248843-73252693	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050081, HPA054538"	Supported		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA050081: AB_2681007, HPA054538: AB_2682519"	"unprognostic (9.19e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (4.57e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.84e-2)"	16.6	28.4	16.4	16.9	15.8	15.8	28.6	12.6	26.6	13.3	22.1	12.4	18.0	20.8	16.3	16.8	22.7	16.5	20.8	42.2	17.6	15.7	23.4	35.1	17.7	30.0	16.2	16.0	16.5	37.0	15.7	15.5	17.0	15.9	15.4	21.1	14.4	18.4	19.0	53.2	16.8	18.4	18.0	14.7	18.4	18.3	13.7	9.8	32.7	16.9	26.1	20.1	15.5	13.9	30.0	28.3	17.0	24.2	17.7	22.3	24.3	22.5	32.7	12.7	16.7	10.1	8.3	18.6	10.4	18.2	14.6	15.2	38.6	22.2	27.4	11.6	11.0	21.2	14.5	20.8	9.2	15.4	14.2	17.2	17.6	29.2	17.2	22.2	15.4	12.6	15.9	14.9	35.8	15.9	25.1	15.4	15.1	25.1	23.9	20.5	15.3	61.4	21.7	17.0	19.7	15.3	13.5	8.5	15.7	11.9	49.4	22.9	34.7	11.8	12.6	13.9	24.3	15.0	20.2	23.1	24.5	21.3	15.2	25.8	9.4	16.7	22.7	17.0	19.0	24.2	20.5	28.7	20.8	17.8	18.5	30.0	22.3	19.6	10.4	17.7	19.1	28.3	20.6	24.3	16.4	15.8	12.6	26.6	17.6	15.7	16.2	16.0	15.9	9.8
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617709-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"				Mitochondria	"Cell Junctions"	"HPA043485: , HPA050334: "	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	17.1	18.9	9.9	10.3	10.7	5.4	16.0	8.5	13.1	11.6	13.4	12.8	11.9	12.8	9.3	15.5	15.5	16.5	12.3	26.6	9.0	8.0	22.4	49.1	10.5	17.3	13.1	9.3	16.4	21.8	17.4	10.2	11.8	9.1	10.9	16.4	10.1	17.1	18.0	55.4	13.7	14.0	10.4	12.4	14.4	13.5	10.2	11.2	13.5	21.5	31.1	15.6	11.2	9.3	15.7	8.9	6.3	10.2	12.4	15.2	11.2	9.5	5.8	4.6	6.6	7.0	9.5	8.5	3.6	8.2	11.2	7.0	9.0	4.6	9.8	8.3	5.5	7.7	10.7	10.0	11.0	5.9	11.4	9.5	4.5	10.5	6.2	8.9	4.2	8.2	12.6	9.3	25.5	6.3	14.4	9.5	10.2	7.3	5.9	5.5	3.3	7.4	7.8	6.3	18.8	10.4	4.0	10.1	3.3	3.2	13.4	13.5	17.2	4.7	3.6	7.4	7.1	4.2	6.1	8.0	9.6	8.3	3.5	13.6	10.8	6.3	8.0	4.0	9.1	10.1	12.3	15.7	12.1	9.8	8.9	14.7	15.2	12.2	0.6	12.4	10.2	8.1	11.4	11.2	9.9	10.7	8.5	13.1	9.0	8.0	13.1	9.3	9.1	11.2
MRPS2	CGI-91	ENSG00000122140	"Mitochondrial ribosomal protein S2"	Q9Y399	9	135499984-135504673	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029487, HPA057261"	Approved		Supported	Mitochondria				Mitochondria		"HPA029487: , HPA057261: "	"unprognostic (3.18e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.58e-2)"	"prognostic favourable (6.96e-9)"	"unprognostic (2.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.24e-1)"	18.5	31.7	15.6	14.8	18.4	17.7	32.1	17.9	28.9	15.2	19.6	12.6	31.3	20.9	19.7	15.7	20.7	33.3	20.6	43.6	15.0	15.5	24.5	48.6	17.8	32.7	15.4	15.1	25.6	37.1	21.7	15.5	16.5	14.1	18.3	16.2	15.0	25.7	29.3	43.0	19.7	16.0	22.0	12.8	18.4	20.6	12.3	10.6	18.5	22.5	28.4	18.2	18.5	15.7	20.6	16.2	7.3	15.8	14.5	22.3	13.7	16.2	27.0	9.9	13.5	11.3	12.7	17.1	12.0	10.9	20.3	15.1	40.6	15.4	20.7	16.4	11.0	37.0	24.9	28.1	7.9	12.7	39.1	10.2	27.4	27.2	19.8	20.7	12.6	16.9	21.9	22.1	15.9	18.9	33.6	15.3	11.8	50.1	20.2	36.2	22.7	43.7	22.2	16.3	43.5	16.8	13.9	30.0	15.8	16.3	31.3	17.2	26.0	16.5	11.7	14.9	16.8	25.6	21.5	16.9	33.0	22.9	15.3	18.9	13.7	4.8	15.8	7.3	18.0	14.9	20.4	20.6	18.1	19.2	16.2	20.3	19.7	19.6	1.3	14.5	12.2	13.9	22.3	13.7	15.6	18.4	17.9	28.9	15.0	15.5	15.4	15.1	14.1	10.6
MRPS21		ENSG00000266472	"Mitochondrial ribosomal protein S21"		1	150293720-150308979	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA078289			Supported	Mitochondria				Mitochondria		"HPA078289: "	"unprognostic (3.48e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.45e-2)"	"prognostic unfavourable (2.62e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.46e-1)"	10.5	17.7	10.8	8.6	16.5	8.6	14.2	8.7	18.8	9.7	8.5	8.1	9.7	10.1	10.4	15.1	9.5	12.1	9.3	15.0	8.9		13.3	12.2	8.1	10.3	8.4	16.7	16.4	11.5	10.9	13.6	8.3	15.9	9.3	7.5	10.0	9.9	12.2	16.9	9.0	8.6	10.3	7.9	9.6	9.9	10.3	9.3	6.2	13.8	11.7	11.7	8.7	9.4	37.8	43.7	15.7	25.8	21.2	36.9	30.3	26.6	22.3	28.8	14.6	27.7	27.4	23.8	19.7	16.8	19.6	19.0	4.6	25.4	27.2	13.6	21.5	25.5	24.7	21.0	17.5	18.3	31.8	15.8	33.1	32.5	22.0	23.6	13.9	30.3	22.4	23.5	26.8	24.7	26.0	36.0	26.0	61.1	19.9	21.6	49.2	39.1	18.3	15.0	46.3	22.5	19.6	22.3	47.0	16.6	33.7	31.9	18.4	34.5	17.4	7.6	14.4	20.3	21.6	31.2	32.9	27.1	9.8	13.1	14.4	11.8	25.8	15.7	24.8	24.5	29.7	37.8	32.2	28.3	28.6	33.1	36.9	31.3	6.0	21.2	21.9	43.7	30.1	30.3										
MRPS22	"C3orf5, GIBT, GK002, MRP-S22"	ENSG00000175110	"Mitochondrial ribosomal protein S22"	P82650	3	139005806-139357223	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006083, HPA007830"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA006083: AB_1854122, HPA007830: AB_1854123"	"unprognostic (8.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (5.22e-3)"	"unprognostic (5.45e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.49e-3)"	"prognostic unfavourable (1.55e-5)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (3.22e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.40e-1)"	17.6	45.3	16.9	14.5	24.9	22.1	18.3	15.5	26.7	16.3	22.7	14.6	12.2	24.0	17.0	14.7	26.7	14.5	13.8	39.2	23.4	15.0	24.9	43.3	12.9	20.2	18.2	19.7	15.7	22.4	13.6	15.2	16.9	22.6	11.6	22.0	8.8	15.3	15.8	50.8	17.2	21.1	16.8	18.1	14.0	19.0	21.9	19.9	15.3	15.1	31.0	16.0	16.5	16.9	24.9	27.9	21.7	31.6	21.1	27.8	20.9	30.5	13.2	11.2	13.6	16.9	14.3	25.9	17.9	23.2	32.3	26.5	41.9	22.0	21.1	33.8	21.8	34.7	20.3	24.5	31.1	11.9	18.8	33.7	11.4	29.1	18.8	31.4	18.4	15.3	19.2	19.4	20.2	19.6	46.5	13.3	19.5	22.5	15.7	24.7	20.1	23.3	19.9	19.2	29.5	23.3	18.1	13.4	12.0	29.1	42.8	45.6	29.9	28.5	14.0	12.9	13.7	25.6	16.9	20.6	11.3	37.7	16.0	22.4	12.5	21.7	24.0	21.2	22.9	31.6	27.6	24.9	24.7	25.7	27.9	21.6	27.3	25.3	5.4	21.1	30.3	17.8	27.8	20.9	16.9	24.9	15.5	26.7	23.4	15.0	18.2	19.7	22.6	19.9
MRPS23	"CGI-138, HSPC329, MRP-S23"	ENSG00000181610	"Mitochondrial ribosomal protein S23"	Q9Y3D9	17	57834781-57850056	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023453	Supported		Supported	"Nuclear membrane,Mitochondria"				Mitochondria	"Nuclear membrane"	"HPA023453: AB_1854125"	"unprognostic (3.84e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.06e-3)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (3.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.39e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.83e-1)"	15.1	28.5	23.0	19.0	27.5	16.0	19.9	16.4	32.0	13.4	16.4	17.6	28.3	18.1	18.0	23.1	18.1	19.3	17.2	53.5	22.5	22.1	36.6	19.9	16.5	21.3	23.6	26.2	16.3	29.9	17.3	16.7	15.5	23.7	28.3	16.0	15.3	16.9	24.7	39.2	14.1	15.5	17.0	19.4	17.4	25.7	21.9	17.2	14.8	28.4	19.8	19.7	15.3	16.5	25.1	30.8	33.4	26.7	23.5	24.3	22.8	32.1	32.5	17.6	18.5	10.7	12.5	20.3	20.9	15.8	29.2	22.6	24.4	19.4	40.8	62.3	16.0	16.0	27.7	24.6	24.5	32.4	32.1	29.5	13.6	42.2	20.5	38.7	28.6	11.4	22.2	21.6	22.6	18.4	43.7	14.8	22.8	27.5	35.7	22.3	21.3	34.0	26.1	29.5	34.1	22.6	15.5	23.6	36.8	15.8	13.3	41.6	41.4	28.8	15.6	24.8	31.7	24.8	44.2	32.4	68.4	45.5	23.7	24.3	22.8	24.9	21.8	33.4	22.4	26.7	23.4	23.6	22.4	22.6	30.8	25.1	24.3	24.0	3.5	23.5	18.8	29.0	21.4	22.8	23.0	27.5	16.4	32.0	22.5	22.1	23.6	26.2	23.7	17.2
MRPS25	"DKFZp313H0817, FLJ00023, MRP-S25, RPMS25"	ENSG00000131368	"Mitochondrial ribosomal protein S25"	P82663	3	15042460-15065335	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043490	Approved		Supported	Mitochondria				Mitochondria		"HPA043490: AB_10794888"	"unprognostic (3.98e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.68e-3)"	"prognostic favourable (3.60e-7)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.91e-3)"	14.8	18.5	18.7	18.4	28.3	12.0	14.3	24.9	21.9	11.7	20.9	13.1	15.2	31.6	16.8	15.8	15.6	15.4	15.0	41.7	15.2	16.5	18.4	27.5	14.4	17.7	16.3	24.0	18.1	24.1	18.1	21.4	11.4	16.8	14.9	23.3	20.3	14.9	17.4	47.6	18.8	26.4	24.5	13.2	17.4	17.3	33.3	15.0	10.2	28.5	15.7	18.6	14.8	13.5	21.1	16.1	3.6	18.6	6.8	15.3	9.4	8.4	12.5	10.3	14.3	10.9	9.4	32.8	11.6	4.5	9.4	8.1	14.3	9.2	22.2	6.2	5.1	11.0	14.8	11.0	8.1	8.8	20.9	18.4	25.8	17.7	7.7	16.2	14.1	11.3	10.5	14.7	4.5	8.7	19.5	13.4	7.0	27.0	12.6	15.7	10.7	19.8	17.2	8.9	22.9	11.6	14.7	8.2	12.3	8.5	16.2	16.6	21.9	14.1	10.6	8.5	12.5	11.6	14.4	13.0	13.8	15.9	8.6	20.9	7.9	1.1	15.4	3.6	10.1	18.4	11.8	21.1	9.6	10.4	16.1	18.2	15.3	12.5	1.0	6.8	18.6	13.3	7.4	9.4	18.7	28.3	24.9	21.9	15.2	16.5	16.3	24.0	16.8	15.0
MRPS26	"C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13"	ENSG00000125901	"Mitochondrial ribosomal protein S26"	Q9BYN8	20	3045945-3048254	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045472, HPA054610"	Supported		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA045472: AB_10962052, HPA054610: "	"unprognostic (1.53e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.14e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.93e-3)"	20.2	30.4	27.1	14.4	29.2	13.4	20.9	25.9	31.7	19.2	19.8	15.3	32.3	22.5	18.1	30.6	19.6	24.4	21.2	25.8	24.4	28.2	28.8	39.6	14.7	15.4	24.6	27.0	28.9	43.4	21.0	28.1	16.4	20.0	31.0	16.4	15.2	32.3	27.9	37.1	22.3	20.1	27.8	19.0	16.2	22.1	13.3	20.7	12.3	28.9	23.0	16.9	18.4	19.2	36.5	28.4	10.3	24.4	29.2	30.8	23.0	26.3	35.5	8.1	14.7	8.8	6.7	21.2	10.4	6.9	11.9	9.1	31.0	12.1	26.3	13.2	5.3	25.0	15.9	21.3	6.9	6.7	34.0	12.0	12.9	51.5	12.3	18.8	5.9	7.5	16.6	9.9	15.0	8.8	19.2	6.2	7.0	22.8	19.5	33.2	39.8	35.2	21.6	13.9	28.0	11.6	17.7	25.4	32.9	11.8	39.8	23.9	17.9	10.7	8.2	7.8	12.4	14.0	19.0	28.2	36.3	15.9	5.1	15.8	8.6	7.6	21.4	10.3	24.0	24.4	30.0	36.5	26.6	25.6	28.4	34.9	30.8	26.4	1.7	29.2	19.0	17.2	20.6	23.0	27.1	29.2	25.9	31.7	24.4	28.2	24.6	27.0	20.0	20.7
MRPS28	"HSPC007, MRP-S28, MRPS35"	ENSG00000147586	"Mitochondrial ribosomal protein S28"	Q9Y2Q9	8	79918717-80030289	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027202	Approved		Supported	Mitochondria				Mitochondria		"HPA027202: AB_1854126"	"unprognostic (3.63e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.55e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"prognostic favourable (1.20e-6)"	"unprognostic (4.48e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-2)"	18.1	36.9	27.4	13.2	26.7	10.9	19.9	16.7	23.3	14.1	20.9	20.5	10.9	13.4	11.5	16.5	18.1	14.7	12.0	40.4	24.0	24.7	32.5	44.2	12.2	13.7	32.2	17.9	13.4	19.1	20.6	20.2	18.7	21.9	13.1	17.2	16.7	14.2	14.8	56.9	11.8	12.7	13.4	27.8	12.6	14.0	9.7	19.0	18.1	22.4	27.8	15.7	14.0	11.7	19.6	41.7	26.0	28.1	25.4	26.7	18.0	20.3	20.3	18.4	4.3	15.7	20.4	20.2	22.8	21.3	31.2	26.5	17.7	16.5	25.7	26.5	18.5	16.8	25.4	26.0	25.1	20.3	22.4	31.2	18.5	27.5	17.6	13.9	14.1	17.2	22.4	18.2	24.9	20.1	22.0	10.8	30.8	19.5	31.7	22.6	7.5	34.7	21.7	14.7	14.8	39.2	19.7	8.7	14.7	10.1	89.7	21.2	21.6	16.7	14.4	11.7	29.4	20.4	20.0	11.7	18.7	22.9	19.9	16.1	9.0	26.0	20.7	10.9	19.0	28.1	20.7	18.7	21.4	23.8	36.7	19.6	25.9	24.9	4.5	25.4	24.9	41.7	26.7	18.0	27.4	26.7	16.7	23.3	24.0	24.7	32.2	17.9	21.9	19.0
MRPS31	IMOGN38	ENSG00000102738	"Mitochondrial ribosomal protein S31"	Q92665	13	40729135-40771173	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039083, HPA046344"	Uncertain		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA039083: , HPA046344: "	"unprognostic (9.62e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.54e-2)"	14.2	20.1	19.3	17.9	21.2	13.2	18.2	27.7	22.9	14.4	16.4	16.9	10.7	15.4	18.0	15.4	18.9	16.6	10.9	24.3	18.4	16.9	26.7	29.9	12.1	22.5	17.9	17.1	21.5	15.0	10.7	35.3	13.1	22.1	12.6	17.0	12.4	14.7	12.5	32.5	14.2	16.3	16.3	16.0	16.0	15.3	17.9	23.3	22.9	21.1	17.2	25.1	18.0	15.9	22.2	11.8	17.2	10.4	15.9	25.7	10.9	8.0	7.8	13.2	8.6	9.0	10.7	13.2	10.4	7.3	13.7	9.3	19.9	12.0	47.5	10.2	5.9	21.4	16.5	12.9	16.4	12.5	12.4	19.7	5.8	12.7	7.5	20.1	9.5	8.5	9.6	11.3	9.6	10.4	13.1	5.0	8.7	9.2	15.6	19.7	12.8	9.2	14.9	10.8	8.9	17.9	9.4	5.7	8.4	7.2	12.0	16.3	10.5	17.8	6.3	4.3	7.2	9.9	10.7	3.9	7.2	23.9	8.8	14.4	8.2	17.2	9.6	14.4	19.1	9.7	18.6	22.2	21.4	19.2	11.8	18.9	25.7	22.6	7.0	15.9	10.4	11.6	21.4	10.9	19.3	21.2	27.7	22.9	18.4	16.9	17.9	17.1	22.1	23.3
MRPS34	"MGC2616, MRP-S12"	ENSG00000074071	"Mitochondrial ribosomal protein S34"	P82930	16	1771890-1773155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042112	Supported		Supported	Mitochondria				Mitochondria		"HPA042112: AB_10796899"	"unprognostic (2.02e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.44e-2)"	26.8	30.5	15.6	14.1	18.3	21.1	17.8	20.2	26.8	11.5	28.0	14.7	19.2	28.4	15.1	13.6	24.7	13.7	17.9	21.9	14.0	13.1	22.5	27.7	12.9	14.8	14.0	13.1	12.6	42.0	13.0	15.5	12.6	16.3	21.2	7.0	12.5	46.6	19.4	89.8	21.9	23.6	10.8	13.6	25.8	36.5	8.8	15.1	21.5	21.0	28.1	21.1	14.7	15.7	55.5	54.6	27.2	50.8	41.0	51.9	45.5	14.0	15.6	2.2	5.4	1.8	2.2	18.0	15.4	3.0	5.3	4.1	10.6	8.2	17.7	24.7	1.8	16.5	3.1	7.4	0.7	12.5	74.4	12.4	13.9	11.2	4.1	22.6	13.2	2.0	3.6	3.2	1.4	4.1	20.7	3.7	1.5	22.6	12.3	40.4	20.9	47.9	27.7	10.6	38.6	2.0	3.9	27.6	20.7	17.2	8.6	14.8	11.1	9.2	10.3	5.7	18.4	7.7	12.6	32.1	22.2	28.1	4.4	12.9	7.2	15.7	50.8	27.2	41.0	44.0	43.4	50.5	45.8	43.5	54.6	55.5	43.7	39.2	11.0	41.0	37.4	51.0	51.9	45.5	15.6	18.3	20.2	26.8	14.0	13.1	14.0	13.1	16.3	15.1
MRPS36	"DC47, MRP-S36"	ENSG00000134056	"Mitochondrial ribosomal protein S36"	P82909	5	69217760-69230129	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035802, HPA056795"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA035802: AB_10600933, HPA056795: "	"unprognostic (1.19e-1)"	"unprognostic (6.78e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.90e-1)"	"prognostic favourable (5.02e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.84e-3)"	13.6	13.7	16.7	9.1	21.4	12.8	13.8	10.4	24.8	8.0	16.8	4.7	12.6	17.1	9.1	11.7	14.4	8.2	10.9	42.8	17.6	13.5	34.8	26.5	17.0	12.2	16.3	14.3	8.8	21.7	11.7	10.4	9.3	17.7	10.8	17.8	6.4	9.6	9.5	29.8	8.1	20.9	13.9	11.4	8.0	13.9	6.8	10.0	10.8	12.7	22.3	11.5	9.9	9.0	27.9	24.4	24.7	27.5	21.5	34.7	14.9	15.8	15.3	10.8	14.8	19.1	19.4	28.6	14.2	13.7	18.3	22.7	21.2	17.8	17.1	29.7	12.0	16.3	18.0	21.6	18.2	20.0	18.9	11.6	18.1	23.5	22.6	12.3	15.9	20.1	15.5	17.4	8.3	13.5	13.7	12.9	16.1	17.2	18.8	18.9	8.0	17.9	11.2	18.9	26.1	31.5	18.0	15.2	14.8	14.6	21.4	24.6	16.4	18.0	9.7	8.2	14.0	18.1	24.3	13.6	22.2	22.7	14.3	23.2	10.7	24.4	20.4	24.7	21.4	27.5	23.6	27.9	24.5	23.9	24.4	22.4	22.2	23.4	22.0	21.5	24.7	24.1	34.7	14.9	16.7	21.4	10.4	24.8	17.6	13.5	16.3	14.3	17.7	10.0
MRPS5	"MRP-S5, S5mt"	ENSG00000144029	"Mitochondrial ribosomal protein S5"	P82675	2	95087207-95149434	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055765	Approved		Supported	Mitochondria				Mitochondria		"HPA055765: "	"unprognostic (1.18e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (7.98e-7)"	"unprognostic (7.51e-3)"	"unprognostic (6.30e-3)"	"prognostic unfavourable (7.73e-5)"	"unprognostic (8.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (6.36e-4)"	"unprognostic (1.25e-1)"	17.7	25.0	17.6	16.2	24.1	24.0	15.3	31.7	22.7	14.8	24.7	22.6	15.0	27.2	17.6	14.9	23.8	17.3	12.7	36.7	17.9	17.7	30.9	40.4	16.8	17.2	23.4	15.9	18.5	21.2	20.7	30.1	14.7	20.0	14.6	27.8	14.3	19.1	18.0	45.6	12.8	22.0	18.6	19.3	18.2	19.6	13.3	24.5	20.8	19.9	20.4	20.6	17.2	22.8	24.9	29.3	17.5	38.4	19.3	30.5	20.7	36.4	23.1	16.8	14.5	14.8	19.2	31.5	19.6	8.9	17.3	18.0	45.8	21.6	29.0	16.1	16.1	23.9	24.6	20.3	24.5	24.4	30.5	20.3	21.0	41.9	23.9	27.2	16.2	18.9	16.7	23.7	25.4	21.4	28.6	14.7	17.6	22.4	38.5	31.1	15.9	36.4	22.8	16.5	37.2	28.6	30.5	22.9	14.8	15.5	29.1	32.8	13.7	25.2	18.2	21.1	26.1	28.0	29.0	18.1	15.8	26.3	16.4	29.2	18.0	13.4	33.7	17.5	21.9	38.4	21.3	24.9	27.1	23.0	27.5	23.6	24.2	24.1	6.3	19.3	34.7	29.3	30.5	20.7	17.6	24.1	31.7	22.7	17.9	17.7	23.4	15.9	20.0	24.5
MRPS6	"C21orf101, MRP-S6, RPMS6"	ENSG00000243927	"Mitochondrial ribosomal protein S6"	P82932	21	34073224-34143034	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007861, HPA008163, HPA049676"	Supported		Supported	Mitochondria				Mitochondria		"HPA007861: , HPA008163: , HPA049676: "	"unprognostic (2.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.16e-3)"	"unprognostic (4.01e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (5.51e-2)"	"prognostic favourable (1.06e-5)"	25.3	29.3	26.1	17.5	27.3	8.5	62.4	20.6	25.3	12.6	28.7	12.9	23.6	14.1	21.8	24.5	14.8	22.7	14.0	23.3	28.6	25.6	67.4	24.2	14.4	23.7	28.9	13.0	18.8	9.9	9.6	17.4	28.3	33.2	15.7	18.8	28.0	12.1	25.7	41.7	20.2	16.1	20.1	35.6	12.4	21.0	26.4	22.8	15.8	98.7	12.4	25.3	19.6	52.1	30.9	42.8	22.2	21.1	41.7	40.5	29.9	15.4	12.2	46.8	16.9	16.4	16.5	16.0	17.4	38.0	14.4	15.1	39.5	28.9	23.6	11.8	20.7	6.2	27.2	22.8	13.8	41.5	15.4	20.1	7.5	9.3	8.1	9.3	6.7	7.2	23.2	27.5	24.8	9.8	25.2	5.8	27.7	13.1	15.8	23.2	30.3	28.3	22.3	8.7	22.1	60.6	10.9	42.3	11.2	18.6	9.0	21.7	19.3	11.3	5.6	14.2	8.4	24.3	9.5	29.7	25.8	20.5	46.3	25.2	13.8	22.0	21.1	22.2	38.8	20.2	30.2	30.9	30.9	36.3	22.0	19.4	40.5	39.9	17.5	41.7	20.1	42.8	29.9	29.9	26.1	27.3	20.6	25.3	28.6	25.6	28.9	13.0	33.2	22.8
MRPS9	"MRP-S9, RPMS9, S9mt"	ENSG00000135972	"Mitochondrial ribosomal protein S9"	P82933	2	105037983-105099960	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043476, HPA048479"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA043476: AB_2678498, HPA048479: AB_2680412"	"unprognostic (8.10e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-3)"	"unprognostic (5.25e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	13.9	25.0	14.1	16.9	18.5	13.3	15.4	13.2	20.6	13.7	18.9	15.9	14.3	19.0	17.6	13.2	16.7	16.2	8.9	39.1	14.4	15.3	24.5	23.5	10.0	14.5	18.1	15.7	21.0	17.3	22.0	23.9	8.4	25.2	15.8	22.0	10.9	15.3	16.4	56.8	14.0	17.0	16.6	15.0	14.0	17.4	20.6	16.6	20.7	15.6	28.7	16.8	15.2	12.4	22.1	20.4	7.1	17.2	20.0	22.8	14.5	22.0	9.5	20.1	18.5	10.6	11.0	23.6	14.2	13.6	22.5	20.3	50.8	15.5	23.0	14.1	11.1	20.0	39.4	20.6	24.0	14.2	25.9	22.7	14.1	30.6	17.7	16.8	10.2	13.1	14.0	18.5	15.5	17.2	32.4	12.1	15.3	17.7	22.6	22.1	31.8	21.0	28.9	17.3	32.0	28.2	15.5	17.5	10.5	16.4	24.1	19.1	19.8	17.1	11.2	13.3	26.9	13.2	15.2	11.1	13.1	18.4	11.5	25.8	11.1	7.1	11.6	4.6	19.9	14.6	22.0	22.1	22.0	20.9	20.4	16.5	22.3	21.9	1.3	20.0	17.2	15.2	22.8	14.5	14.1	18.5	13.2	20.6	14.4	15.3	18.1	15.7	25.2	16.6
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455752-60470760	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1"	"Group enriched"	"Detected in some"	25	"Daudi: 120.0;U-698: 60.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	105	"memory B-cell: 77.7;naive B-cell: 77.7"	"Lineage enriched"	"Detected in single"	105	"B-cells: 77.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favourable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	1.6	0.3	0.3	79.0	0.3	3.6	0.6	0.3	0.3	0.5	2.0	0.0	0.0	0.2	0.4	0.5	7.0	0.4	1.3	0.7	0.3	0.3	2.0	0.9	2.7	81.2	0.3	0.1	0.3	0.4	0.0	0.4	0.4	0.1	1.1	1.7	0.6	14.5	0.2	0.3	0.3	46.1	0.1	0.4	90.7	2.6	0.6	0.0	15.7	2.5	2.7	134.1	6.4	0.8	77.7	0.0	0.2	0.0	0.7	0.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	77.7	0.3	0.6	0.0	77.7	0.0	0.2	0.2	0.7	0.0	0.0	0.0	3.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.0
MSANTD2	"C11orf61, FLJ23342"	ENSG00000120458	"Myb/SANT DNA binding domain containing 2"	Q6P1R3	11	124766498-124800673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038694, HPA038695"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA038694: , HPA038695: AB_10674693"	"unprognostic (2.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.77e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.65e-4)"	12.4	7.3	12.4	11.8	20.3	2.7	13.0	20.8	12.8	13.8	9.4	14.8	14.1	7.7	15.7	17.8	7.7	11.7	10.0	6.4	9.2	7.3	12.8	7.8	9.2	10.4	16.4	7.6	15.8	13.9	12.1	19.9	12.9	12.3	13.3	9.7	8.6	11.0	12.1	7.7	17.5	9.7	9.4	9.2	13.6	10.7	6.2	19.6	8.6	26.2	5.2	10.1	7.7	17.0	2.4	1.3	1.6	1.9	0.5	4.4	1.0	2.8	1.9	15.7	11.4	7.4	9.7	6.4	6.4	7.0	4.6	5.9	6.4	6.7	3.9	6.1	4.7	5.9	7.2	3.9	7.6	5.5	4.2	3.5	3.7	5.5	4.6	2.8	2.9	4.3	4.3	5.8	5.4	8.4	4.0	6.0	7.0	3.3	1.7	9.4	9.9	14.8	4.4	4.3	3.1	6.2	3.1	4.4	12.8	3.5	5.4	2.7	8.9	2.9	7.1	17.2	4.3	4.8	6.7	2.8	2.0	2.9	3.5	3.8	9.5	0.0	1.2	1.6	2.2	1.9	1.1	1.5	2.3	3.3	1.3	2.4	2.4	2.0	0.0	0.5	1.9	1.2	4.4	1.0	12.4	20.3	20.8	12.8	9.2	7.3	16.4	7.6	12.3	19.6
MSC	"ABF-1, bHLHa22"	ENSG00000178860	Musculin	O60682	8	71841549-71844468	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 56.3"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 129.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 18.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062878			Supported	Nucleoplasm				Nucleoplasm		"HPA062878: "	"unprognostic (2.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavourable (5.21e-4)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (4.83e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (1.07e-13)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.40e-2)"	9.9	7.6	2.0	10.1	1.3	2.8	56.3	0.6	4.4	4.8	1.6	0.8	0.4	1.9	4.8	2.9	3.3	3.4	10.5	16.3	5.5	0.2	5.2	3.0	6.6	14.1	0.8	1.2	7.3	4.7	0.0	2.6	15.1	1.9	4.8	0.9	15.9	3.7	3.1	2.6	3.0	3.8	3.8	0.9	5.6	3.8	3.1	0.6	1.8	3.6	3.4	4.8	10.3	6.5	5.0	4.3	0.1	0.2	0.0	18.5	2.1	0.0	1.0	0.0	0.0	4.7	0.8	0.0	0.1	3.9	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.0	129.1	0.0	0.0	0.0	0.0	8.4	0.0	0.4	1.8	0.0	8.1	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.1	0.0	0.0	9.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.1	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.8	0.0	0.0	3.4	0.0	5.6	0.0	0.0	0.0	3.9	0.0	5.2	5.0	6.8	18.5	0.1	2.8	0.1	6.4	0.1	0.0	0.2	4.3	8.6	2.1	2.0	1.3	0.6	4.4	5.5	0.2	0.8	1.2	1.9	0.6
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47402969-47663146	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: "	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavourable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	7.3	9.8	14.2	12.2	25.5	11.4	14.1	22.6	18.1	9.4	11.6	7.6	5.6	6.5	10.5	13.3	10.8	11.1	4.9	8.4	13.0	14.0	7.3	5.5	7.1	19.7	12.5	17.0	7.9	8.4	15.3	9.1	9.9	18.5	7.9	13.8	12.3	9.4	7.3	6.7	10.3	8.0	7.8	13.8	9.4	6.7	13.4	13.5	37.0	13.9	6.6	21.4	8.5	7.6	7.4	2.9	3.9	4.2	12.2	12.6	6.2	28.0	9.6	26.3	14.1	1.9	5.5	15.9	16.7	8.3	20.8	20.1	18.0	12.1	34.5	22.6	5.9	11.9	19.6	9.5	31.4	17.8	14.6	24.9	11.1	16.3	2.0	24.3	8.8	3.1	2.8	17.7	4.8	11.4	41.4	8.0	15.8	11.2	28.1	18.3	49.4	11.4	37.7	46.9	20.2	9.0	14.9	21.8	23.6	14.8	11.5	11.8	11.5	9.5	4.6	13.8	18.1	14.2	18.6	5.1	18.3	48.4	8.4	18.0	8.5	2.8	1.0	3.9	7.9	4.2	8.6	6.3	7.4	9.5	2.3	7.4	12.6	11.9	0.7	12.2	3.2	2.9	10.1	6.2	14.2	25.5	22.6	18.1	13.0	14.0	12.5	17.0	18.5	13.5
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810101	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavourable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	13.0	20.5	9.7	13.1	18.8	13.6	13.0	20.5	13.1	17.9	13.3	17.6	10.7	6.1	28.2	11.0	12.4	18.3	8.4	8.6	11.4	8.8	9.5	14.6	11.0	21.7	23.9	9.6	43.2	27.6	16.2	17.3	14.9	15.0	14.6	10.3	8.7	12.0	13.2	10.4	10.3	10.5	22.1	14.9	11.6	11.1	25.1	22.0	40.4	13.4	10.4	25.8	14.2	16.4	8.4	8.4	7.6	9.8	9.7	15.1	5.7	27.2	20.3	37.9	9.0	11.4	12.1	17.1	15.2	13.4	15.7	16.6	14.9	9.5	45.0	22.7	16.4	11.5	34.1	19.3	20.5	19.6	17.0	28.8	16.2	15.1	7.0	28.9	10.6	9.8	6.2	16.0	10.7	9.8	25.0	16.6	15.3	19.6	30.7	13.7	33.3	9.4	73.0	49.7	20.3	9.6	17.8	21.2	23.0	21.1	10.1	9.2	12.0	10.2	6.0	18.3	22.4	13.8	19.6	15.6	21.0	75.4	15.5	18.5	11.2	7.6	5.8	4.9	8.4	9.8	10.4	8.4	9.5	8.3	8.4	8.1	15.1	7.6	3.9	9.7	9.3	4.2	9.5	5.7	9.7	18.8	20.5	13.1	11.4	8.8	23.9	9.6	15.0	22.0
MSI2		ENSG00000153944	"Musashi RNA binding protein 2"	Q96DH6	17	57255851-57684685	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022300	Approved		Supported	Cytosol				Cytosol		"CAB022300: "	"unprognostic (4.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (9.22e-8)"	"prognostic favourable (2.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-3)"	3.4	34.7	20.0	22.4	21.5	8.4	8.8	18.0	25.3	9.7	14.4	7.7	14.2	5.0	6.7	36.3	4.6	11.1	23.5	28.5	13.9	16.9	18.0	3.6	6.9	9.6	21.0	6.4	22.8	6.1	41.4	23.1	10.7	19.7	10.5	7.4	14.6	9.8	48.5	25.6	3.6	5.4	4.6	14.8	8.7	7.7	7.5	9.5	23.7	12.4	8.4	8.6	11.6	5.0	1.9	3.0	4.8	1.5	1.9	4.1	0.5	3.4	5.8	20.1	7.7	2.3	2.2	15.8	3.8	4.4	5.0	3.0	6.9	5.8	15.8	13.5	2.3	3.4	12.8	5.1	9.3	22.0	8.9	6.9	12.9	15.8	5.0	7.6	7.0	2.8	6.7	0.6	8.2	5.1	15.0	11.9	17.5	7.9	34.2	2.1	7.2	9.4	48.0	30.1	12.5	12.2	22.2	22.3	41.5	6.2	5.9	17.7	10.6	5.9	6.5	3.2	8.3	2.8	6.5	16.5	14.0	19.2	8.4	4.6	19.3	4.4	0.4	4.8	2.0	0.3	1.5	1.9	1.9	1.8	0.6	1.1	1.8	1.7	0.4	1.9	1.5	3.0	4.1	0.5	20.0	21.5	18.0	25.3	13.9	16.9	21.0	6.4	19.7	9.5
MSL1	"DKFZp686P24239, hMSL1, MSL-1"	ENSG00000188895	"Male specific lethal 1 homolog"	Q68DK7	17	40122298-40136916	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022800, HPA023567"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA022800: AB_1853057, HPA023567: AB_1853059"	"unprognostic (1.94e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (2.92e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.61e-2)"	27.2	26.0	31.4	26.6	31.6	29.9	56.5	36.0	45.1	44.6	31.7	25.8	42.7	30.2	39.3	35.1	29.6	38.7	31.9	22.2	31.6	20.3	27.5	21.7	29.3	27.2	31.4	36.7	32.0	28.6	40.5	39.9	28.4	27.2	32.6	28.7	20.3	27.2	32.9	29.2	35.4	28.7	32.5	24.5	43.6	27.0	32.8	33.8	22.1	39.3	23.9	29.4	34.0	52.7	1.7	1.9	11.7	1.3	0.9	2.3	0.8	9.0	10.7	23.0	15.0	21.0	18.2	11.8	15.8	16.8	20.0	18.1	10.7	9.7	19.9	12.1	16.5	16.8	19.3	10.4	20.7	17.0	15.6	10.9	14.7	12.7	11.0	14.8	21.5	15.2	16.7	14.7	12.3	18.3	17.2	16.2	15.9	5.6	23.6	16.5	9.8	7.0	19.4	12.7	17.9	14.5	9.9	21.3	12.7	14.8	93.2	11.8	21.7	20.6	15.0	13.5	15.1	9.8	13.3	26.0	14.5	19.9	13.7	11.1	15.7	0.0	1.3	1.0	2.3	0.7	1.2	1.7	1.3	1.8	0.9	1.1	1.3	1.2	11.7	0.9	1.0	1.9	0.8	0.8	31.4	31.6	36.0	45.1	31.6	20.3	31.4	36.7	27.2	33.8
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760762-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 85.5;lung: 88.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 102.3;EFO-21: 15.8;HeLa: 31.2;hTCEpi: 22.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.0"	"Group enriched"	"Detected in many"	59	"dendritic cells: 9.0;monocytes: 2.6"	"Low region specificity"	"Detected in many"							"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"		14000000	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favourable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	36.5	0.0	0.4	6.7	0.5	0.7	0.3	0.1	0.4	5.4	5.4	0.8	26.8	2.1	4.8	18.9	3.1	85.5	9.6	4.3	0.4	0.3	2.6	0.2	88.5	0.4	0.6	0.0	22.3	0.4	0.0	0.6	13.7	0.9	1.9	1.2	0.2	14.4	33.1	0.0	0.5	0.7	1.0	0.8	0.1	3.7	2.1	0.0	0.1	0.1	0.6	7.8	1.4	1.3	0.0	9.0	0.0	2.6	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.5	1.8	0.4	1.4	102.3	0.0	15.8	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	31.2	1.1	0.9	0.0	0.0	0.0	22.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.4	0.5	0.1	0.4	0.4	0.3	0.6	0.0	0.9	0.0
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 6.0;placenta: 5.7"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 34.3;PC-3: 43.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.9"	"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in male reproductive system"			Vesicles	Cytosol	"HPA055174: "																		0.5	0.0	1.2	1.1	0.6	0.0	0.8	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.1	0.1	0.4	0.0	0.4	0.9	3.9	0.0	0.0	0.0	0.0	6.0	5.7	0.8	0.7	0.5	0.0	0.0	0.3	1.3	0.5	1.5	0.3	2.2	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.1	0.0	0.1	3.2	0.3	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	1.2	0.3	0.1	0.3	0.4	1.2	0.6	0.0	0.6	0.1	0.1	3.9	0.0	0.8	0.0
MSN		ENSG00000147065	Moesin	P26038	X	65588377-65741931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338"	Enhanced		Enhanced	"Plasma membrane"			340000000	"Plasma membrane"		"CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054"	"unprognostic (1.03e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (5.68e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.21e-2)"	"unprognostic (6.81e-2)"	36.3	17.6	10.2	40.7	14.4	38.5	98.2	8.6	18.6	25.1	21.3	19.2	7.6	6.5	33.4	14.2	15.7	21.8	20.2	53.8	11.5	10.4	25.6	29.5	102.8	85.0	17.5	5.4	28.8	19.4	5.7	10.2	24.2	30.0	23.1	13.0	16.6	16.3	21.9	13.6	19.5	18.3	41.4	21.8	31.6	17.3	9.0	12.9	18.7	26.2	17.6	38.1	22.7	28.9	16.0	36.4	54.1	69.0	28.0	37.1	81.8	27.8	21.4	21.0	17.3	25.2	33.3	0.1	70.7	45.8	39.2	30.4	0.0	4.9	23.4	63.2	62.5	19.2	22.1	50.4	51.2	43.3	6.1	64.9	37.1	0.0	23.8	78.8	105.1	24.9	10.9	72.1	63.8	86.5	31.4	73.0	62.0	0.0	46.5	59.1	26.0	40.7	24.4	37.7	17.8	41.9	0.0	0.1	0.0	56.8	0.4	22.5	0.2	42.9	137.0	44.7	28.4	60.1	46.8	26.5	40.1	25.4	32.7	100.1	49.7	30.8	44.4	30.0	37.1	58.9	27.9	16.0	20.4	29.1	36.4	13.9	14.0	21.3	54.1	28.0	69.0	5.2	15.5	81.8	10.2	14.4	8.6	18.6	11.5	10.4	17.5	5.4	30.0	12.9
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938210-1943326	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 195.6;liver: 94.8;pancreas: 107.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 85.8;neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 195.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB008650: AB_1619225, HPA043463: , HPA069557: "	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	7.9	4.0	5.2	9.0	6.3	27.3	5.1	3.2	6.1	5.2	13.1	5.6	7.5	8.7	7.9	13.5	16.9	9.6	13.5	13.7	4.7	4.1	24.9	94.8	9.6	15.6	5.5	4.1	7.3	107.2	2.9	3.9	11.6	4.1	11.0	5.1	6.2	4.7	9.4	20.5	8.0	17.0	14.3	4.3	18.2	9.6	8.1	3.6	3.7	5.5	19.8	4.5	14.8	4.8	1.7	10.9	195.6	26.2	2.4	2.8	12.2	6.6	17.0	6.3	14.9	11.8	5.2	10.8	8.3	10.4	12.1	10.5	27.2	7.4	6.5	27.1	9.5	11.0	10.5	7.2	3.8	36.3	11.9	5.0	6.3	43.4	10.8	14.1	11.9	9.6	6.4	8.7	1.7	12.1	7.8	3.6	6.4	36.8	7.9	23.2	8.6	9.7	11.6	8.7	30.5	18.9	11.2	6.1	8.1	9.3	10.4	5.0	11.3	25.1	7.2	3.7	10.2	7.2	4.8	9.6	15.2	12.4	3.8	13.4	6.4	26.0	26.2	85.8	2.2	12.0	2.1	1.7	1.8	1.8	10.9	1.7	1.4	1.6	195.6	2.4	10.7	4.6	2.8	12.2	5.2	6.3	3.2	6.1	4.7	4.1	5.5	4.1	4.1	3.6
MSX1	"HOX7, HYD1, OFC5"	ENSG00000163132	"Msh homeobox 1"	P28360	4	4859666-4863936	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 47.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 29.2;EFO-21: 13.6"	"Cancer enriched"	"Detected in all"	17	"endometrial cancer: 246.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB026198, HPA063895, HPA073604"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB026198: , HPA063895: , HPA073604: "	"unprognostic (1.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.39e-2)"	"prognostic favourable (1.64e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.16e-3)"	"unprognostic (4.07e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.18e-5)"	"unprognostic (4.35e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.33e-2)"	9.0	3.8	4.6	1.5	2.9	1.0	11.4	1.4	8.6	47.2	1.4	6.0	1.0	1.4	17.9	1.2	1.5	4.5	2.2	2.5	8.7	2.2	1.4	1.3	2.1	1.4	4.2	1.6	2.5	2.0	1.2	11.5	5.1	14.0	3.9	0.9	1.7	3.7	4.9	18.3	2.5	1.2	4.3	3.6	3.3	1.3	1.4	3.8	0.0	4.7	2.6	1.2	5.9	18.8	0.5	0.4	1.9	0.8	0.7	0.6	0.2	1.5	0.9	0.3	1.8	5.2	3.3	5.6	3.7	1.8	2.2	1.1	29.2	9.5	0.1	13.6	2.7	0.0	6.6	0.0	0.8	1.2	7.6	0.0	5.1	10.4	0.4	0.1	0.9	0.6	0.5	1.6	0.5	0.5	4.7	0.2	1.1	0.7	0.8	1.4	0.1	6.9	3.8	4.0	0.3	0.1	0.9	0.3	0.1	3.3	0.1	2.3	0.6	1.3	1.2	2.6	5.7	8.2	6.0	0.6	0.5	3.4	1.7	1.9	2.5	1.9	0.4	0.5	0.3	0.5	0.4	0.5	0.3	0.4	0.3	0.4	0.6	0.4	1.4	0.7	0.8	0.4	0.5	0.2	4.6	2.9	1.4	8.6	8.7	2.2	4.2	1.6	14.0	3.8
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724533-174730893	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.7;urinary bladder: 18.2"	"Cell line enriched"	"Detected in some"	6	"BEWO: 83.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 6.9"	"Low region specificity"	"Detected in single"			HPA005652	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.0	0.4	0.3	0.4	0.5	0.0	7.6	6.3	1.6	2.6	0.9	2.0	0.0	0.3	6.2	0.2	0.9	1.1	1.5	1.7	2.5	0.5	0.3	0.1	0.9	0.1	1.5	1.2	0.4	0.6	9.4	0.5	44.7	7.2	6.3	0.1	6.6	0.9	0.8	2.1	6.4	0.9	10.4	6.6	1.1	2.6	5.2	1.3	0.0	0.8	0.2	0.3	18.2	2.4	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	1.0	0.2	0.8	0.0	0.0	83.8	0.5	0.9	0.2	0.0	14.2	5.8	0.0	2.2	0.0	1.5	4.5	1.6	0.0	0.0	2.7	0.0	0.3	0.0	0.6	0.0	0.7	0.9	1.1	0.8	0.9	0.0	0.0	0.0	1.2	6.9	0.0	0.1	0.6	2.2	0.0	2.2	0.0	1.0	8.9	0.0	0.6	0.0	11.0	0.7	6.6	0.0	0.0	0.2	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	6.3	1.6	2.5	0.5	1.5	1.2	7.2	1.3
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7"	"Cell line enhanced"	"Detected in all"		"HeLa: 859.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria				Mitochondria		"CAB016241: AB_2229888, HPA069328: "	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favourable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	57.6	82.5	184.1	22.2	164.2	26.4	37.4	40.6	117.1	31.5	80.8			78.1	25.7	42.7	43.5	24.8	32.4	345.0	161.8	111.7	151.0	150.5	20.9	22.6	126.3		23.7	42.5	62.3	10.1	29.0		35.8	84.4		65.6	54.2	380.7	68.9	60.0	38.2	61.2	28.1	65.5	27.8			23.8		21.9	31.6	15.3	292.2	232.9	177.4	396.5	182.8	192.4	130.5	112.7	170.5	232.0	252.3	531.8	243.6	246.0	257.3	85.7	65.0	108.8	205.2	367.8	298.0	123.7	195.5	428.5	26.5	228.0	93.1	140.8	162.5	178.9	859.1	383.8	73.7	103.2	226.6	284.1	237.4	64.2	142.7	78.2	113.5	213.9	192.4	273.1	84.4	462.1	58.9	139.6	110.6	69.3	178.8	329.5	298.3	110.9	147.9	89.2	345.8	160.5	198.4	347.4	311.5	260.6	177.4	255.7	129.0	101.3	97.0	67.6	128.7	272.4	126.6	177.4	396.5	169.3	156.6	236.0	176.4	255.6	154.9	171.8	163.0	292.2	159.7	192.4	93.5	182.8	260.1	232.9	138.6	130.5										
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favourable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.4	20.1	22.4	24.7	24.3	22.0	22.9	33.8	23.4	17.9	18.9	21.9	22.5	22.3	22.1	21.3	14.9	22.5	20.0	27.7	22.1	17.3	14.8	15.1	20.1	22.3	22.8	18.4	31.4	31.1	15.7	26.5	16.1	19.4	21.9	10.6	22.2	28.7	24.8	29.1	20.0	19.8	27.1	15.0	23.6	18.9	31.4	24.1	27.3	21.1	16.1	16.3	19.3	20.5	1.8	3.7	2.8	0.9	1.8	1.8	0.6	13.1	10.5	19.6	19.5	7.5	12.9	17.4	10.5	8.0	10.4	10.1	13.6	17.8	25.8	11.0	7.6	18.2	14.2	10.0	7.1	16.9	23.9	13.4	9.5	13.9	16.6	16.8	10.4	14.4	12.7	7.4	17.0	14.8	15.2	11.3	5.4	23.6	30.3	33.4	28.3	22.3	28.7	11.9	8.4	8.3	10.3	31.7	33.0	14.1	16.5	15.0	14.8	16.1	10.6	8.5	9.0	13.9	10.9	23.0	11.1	16.4	10.5	11.4	14.7	0.5	0.9	2.8	1.4	0.9	1.2	1.5	1.2	1.1	1.1	1.8	1.5	1.8	0.2	1.8	0.5	3.7	0.9	0.6	22.4	24.3	33.8	23.4	22.1	17.3	22.8	18.4	19.4	24.1
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601840	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavourable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	26.3	20.4	16.6	28.0	17.9	28.7	20.5	21.6	24.8	23.9	22.0	31.5	15.6	17.1	23.8	16.9	45.1	19.9	23.7	18.8	15.8	12.4	19.0	23.6	21.8	35.5	19.7	12.7	35.0	13.7	22.5	19.8	22.3	20.9	21.9	27.3	21.2	22.3	22.1	12.7	41.1	23.5	25.0	23.8	39.4	19.9	25.7	18.9	64.6	19.3	20.3	49.1	21.7	27.8	12.9	12.0	8.4	13.2	10.4	17.3	4.4	24.5	21.5	34.3	44.8	15.4	14.5	23.7	20.8	29.3	41.8	30.7	20.3	21.5	35.0	22.5	27.3	33.1	46.2	57.5	35.6	34.6	23.2	37.3	23.2	20.4	24.0	42.0	48.0	16.1	32.4	29.4	43.9	38.7	41.1	27.9	29.9	47.6	53.3	53.6	29.6	25.1	51.2	24.4	40.9	29.6	36.9	27.4	25.1	21.7	31.1	17.6	36.4	28.8	27.0	23.5	21.7	26.5	23.9	20.9	27.0	49.5	17.2	30.8	22.6	5.6	6.4	8.4	17.3	11.0	14.6	12.9	14.4	12.5	10.2	9.8	13.7	13.5	2.9	10.4	13.2	12.0	11.6	4.4	16.6	17.9	21.6	24.8	15.8	12.4	19.7	12.7	20.9	18.9
MTA3	KIAA1266	ENSG00000057935	"Metastasis associated 1 family member 3"	Q9BTC8	2	42494569-42756947	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039433	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA039433: AB_10794747"	"unprognostic (5.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (4.69e-4)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.28e-2)"	8.8	35.0	19.2	16.7	21.0	1.6	14.6	11.4	23.7	14.5	12.5	10.2	16.8	9.0	17.2	25.0	16.7	14.1	11.3	11.1	18.3	14.0	14.5	7.6	8.3	11.5	12.3	14.6	33.3	15.0	18.3	15.8	16.1	12.5	15.0	14.1	12.6	10.6	20.8	9.8	15.4	8.7	14.3	10.4	6.4	12.5	21.0	9.3	74.3	13.0	7.7	15.0	13.5	13.4	2.9	3.2	7.7	1.9	3.3	8.8	3.3	7.7	8.1	12.1	7.3	9.7	13.6	24.0	4.8	8.7	10.9	9.3	10.2	13.4	25.3	8.4	10.5	4.8	25.6	11.5	16.0	9.3	8.7	4.5	4.7	16.0	10.5	2.7	15.5	14.3	12.9	7.4	7.9	14.6	8.2	2.9	11.9	11.4	17.6	8.5	43.2	4.9	10.2	10.6	0.0	10.9	6.3	6.4	20.9	7.5	23.5	9.9	12.7	3.5	9.1	5.2	8.6	3.9	4.7	6.1	2.8	37.1	6.9	2.8	6.7	7.7	1.9	0.0	4.1	0.7	5.7	2.5	4.4	6.2	3.2	2.9	8.8	5.9	0.3	3.3	1.2	1.0	2.2	3.3	19.2	21.0	11.4	23.7	18.3	14.0	12.3	14.6	12.5	9.3
MTCH2	SLC25A50	ENSG00000109919	"Mitochondrial carrier 2"	Q9Y6C9	11	47617315-47642623	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038390	Approved		Supported	Mitochondria			55000	Mitochondria		"HPA038390: AB_10669723"	"unprognostic (4.94e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (9.05e-6)"	"unprognostic (1.12e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	13.6	19.6	15.6	12.8	20.3	8.3	12.5	14.1	21.3	10.4	22.3	19.3	8.7	28.3	12.6	15.1	21.6	9.9	11.6	15.0	14.0	13.8	40.8	74.8	9.1	13.9	15.2	12.2	9.3	14.4	16.8	9.3	9.5	15.4	11.8	24.7	13.6	13.4	10.0	31.4	12.1	33.9	16.1	11.4	11.4	10.1	44.2	10.2	15.1	15.5	24.9	16.4	11.6	10.7	13.7	25.7	7.9	21.3	12.1	13.6	17.5	19.0	20.9	17.9	24.1	21.2	19.6	13.2	20.6	18.9	27.9	26.5	16.5	19.4	26.3	11.2	25.3	24.0	32.1	27.2	34.1	13.1	29.9	15.0	29.8	33.0	29.2	31.3	15.2	22.2	21.5	18.5	27.8	25.2	27.8	15.8	34.0	27.7	23.9	23.5	19.3	31.7	22.4	27.2	18.9	32.3	24.7	21.3	15.0	28.3	28.6	14.6	41.1	14.7	20.9	25.8	22.5	42.6	26.5	16.9	19.1	29.7	21.3	27.3	23.0	5.9	19.8	7.9	12.7	21.3	12.0	13.7	11.1	11.7	25.7	10.9	9.7	11.2	1.9	12.1	17.0	16.9	13.6	17.5	15.6	20.3	14.1	21.3	14.0	13.8	15.2	12.2	15.4	10.2
MTDH	"3D3, AEG-1, LYRIC"	ENSG00000147649	Metadherin	Q86UE4	8	97644179-97728770	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010932, HPA015104, CAB068204, CAB068205"	Supported		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB068204: , CAB068205: , HPA010932: AB_1079422, HPA015104: AB_1854173"	"unprognostic (1.01e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavourable (7.76e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (5.36e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (3.84e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	26.5	28.5	17.2	28.3	21.9	44.5	29.0	21.8	20.2	27.5	24.9	20.7	24.7	23.2	31.6	28.6	27.6	23.6	23.5	23.6	18.7	16.6	24.3	97.8	21.9	31.4	26.5	19.6	26.7	22.7	27.1	18.0	13.4	23.0	24.0	22.8	16.4	22.3	21.2	49.8	19.5	32.7	29.5	34.6	35.8	21.8	19.0	24.8	40.0	30.5	22.7	27.5	27.5	35.7	26.2	42.4	17.4	26.6	19.2	20.9	10.1	38.2	19.8	13.0	17.8	21.6	22.9	6.4	34.4	29.3	22.0	17.1	11.7	28.6	35.4	38.8	33.7	25.5	31.5	23.8	30.8	37.7	16.5	65.0	21.5	13.8	26.2	34.0	30.3	17.5	24.1	26.6	60.7	25.3	42.4	62.9	23.3	15.8	57.3	9.4	8.0	24.2	37.6	15.4	51.4	14.3	22.0	19.7	14.7	24.4	21.5	26.9	32.9	21.9	26.2	31.3	11.3	28.7	25.3	35.1	38.2	35.9	28.7	40.0	27.3	17.4	26.6	13.4	14.2	17.8	20.1	26.2	20.4	20.9	32.6	18.6	20.8	18.4	3.8	19.2	19.5	42.4	11.7	10.1	17.2	21.9	21.8	20.2	18.7	16.6	26.5	19.6	23.0	24.8
MTERF1	MTERF	ENSG00000127989	"Mitochondrial transcription termination factor 1"	Q99551	7	91692008-91880720	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044894, HPA069560"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA044894: AB_10966284, HPA069560: "	"unprognostic (5.57e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	8.9	11.5	16.1	10.9	18.1	13.9	14.4	23.2	18.9	10.4	11.8	12.1	10.0	11.5	11.6	11.0	13.4	9.8	8.3	8.7	15.2	10.5	13.2	17.6	8.3	19.4	20.3	13.1	14.7	11.4	10.0	18.0	10.6	18.8	11.6	12.1	8.5	12.5	9.2	9.3	9.9	13.6	9.7	22.7	17.6	12.5	10.0	18.5	11.9	12.2	10.3	19.0	12.0	11.4	15.0	9.4	24.8	8.8	9.8	19.0	10.0	10.3	9.0	8.7	5.8	8.5	8.9	7.6	8.8	9.0	9.5	11.8	10.9	9.9	21.3	7.3	7.0	9.2	13.0	7.9	13.6	1.2	9.5	9.7	9.8	8.5	7.6	17.0	10.7	10.6	10.5	10.5	11.2	8.2	17.5	8.9	11.1	13.2	17.8	19.5	13.1	10.1	5.1	11.6	14.6	9.8	11.3	8.1	15.4	8.9	18.8	17.8	6.6	12.2	5.3	11.3	13.9	15.3	8.9	12.7	12.8	28.9	8.2	5.6	15.8	24.8	8.8	11.9	10.6	7.5	12.7	14.6	13.8	15.2	9.4	15.0	19.0	15.1	4.2	9.8	8.2	7.4	13.2	10.0	16.1	18.1	23.2	18.9	15.2	10.5	20.3	13.1	18.8	18.5
MTERF3	"CGI-12, FLJ10939, MTERFD1"	ENSG00000156469	"Mitochondrial transcription termination factor 3"	Q96E29	8	96239398-96261610	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002966			Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA002966: AB_2147359"	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.56e-2)"	"prognostic unfavourable (5.88e-5)"	"unprognostic (8.67e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.74e-3)"	13.8	16.4	14.2	15.9	20.1	9.9	22.9	17.8	18.0	14.8	13.8	12.3	17.4	11.9	15.4	23.8	12.6	13.2	12.9	21.9	17.3	15.3	15.9	22.2	18.5	18.3	18.1	16.0	13.7	14.8	18.9	14.1	16.1	23.7	15.5	14.5	9.8	12.1	17.9	28.8	16.1	11.6	21.9	13.2	16.9	12.8	10.9	13.5	16.0	15.0	14.1	18.1	13.9	12.3	15.3	18.0	18.6	11.6	16.7	17.8	7.8	19.3	12.5	18.7	14.8	13.4	13.9	8.5	14.9	12.3	21.9	22.1	8.9	14.4	17.4	31.5	8.7	10.9	19.3	11.6	26.7	16.7	14.2	24.9	9.6	10.7	18.8	8.4	10.2	13.9	17.4	17.7	16.7	17.8	20.9	9.2	21.9	12.5	35.6	24.8	9.8	19.4	21.6	15.3	13.6	16.0	10.3	12.8	10.1	11.1	3.2	15.8	16.8	11.9	7.9	15.4	10.4	17.7	13.1	10.5	13.1	20.2	16.7	22.5	20.1	18.6	10.3	4.3	12.4	11.6	17.8	15.3	14.1	14.0	14.8	13.2	16.1	16.1	1.8	16.7	11.0	18.0	13.3	7.8	14.2	20.1	17.8	18.0	17.3	15.3	18.1	16.0	23.7	13.5
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027097	Uncertain		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favourable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	14.2	15.5	14.4	17.6	22.1	17.2	18.6	42.2	21.7	16.2	14.6	25.3	12.5	13.4	23.2	14.1	17.6	17.7	12.1	13.4	14.4	12.1	13.4	16.5	14.2	29.8	19.2	19.4	25.7	20.9	11.7	25.7	11.6	20.4	28.9	17.2	16.3	19.5	18.1	38.8	15.5	19.6	17.3	17.8	20.3	14.7	12.7	22.3	23.7	29.4	20.5	29.7	14.3	15.2	16.6	6.2	11.4	5.4	8.0	24.9	10.2	8.6	8.2	16.3	9.4	22.2	9.9	12.1	14.7	16.4	14.3	20.3	5.6	13.0	13.4	5.3	17.0	9.7	22.2	21.0	19.3	18.1	16.0	17.1	15.7	24.7	14.5	20.4	13.1	16.9	20.6	16.7	19.3	16.3	15.2	5.9	17.1	12.2	14.9	14.1	18.6	14.1	14.6	18.5	7.5	13.6	17.3	14.9	12.9	12.0	14.9	11.1	11.0	10.6	22.4	13.2	12.8	15.4	13.1	15.8	4.0	32.7	11.1	12.9	12.1	4.2	5.4	11.4	10.0	5.2	12.5	16.6	15.5	13.7	6.2	15.4	24.9	19.5	1.9	8.0	4.4	4.7	15.8	10.2	14.4	22.1	42.2	21.7	14.4	12.1	19.2	19.4	20.4	22.3
MTF1		ENSG00000188786	"Metal regulatory transcription factor 1"	Q14872	1	37809567-37859620	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028604, HPA028689"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA028604: AB_10600304, HPA028689: AB_10611384"	"unprognostic (5.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.19e-1)"	7.8	7.1	9.9	8.1	11.8	28.4	6.9	12.4	10.8	8.4	7.2	10.0	6.7	4.8	9.6	4.8	16.1	9.5	6.0	4.9	9.4	6.5	6.5	5.3	7.3	8.2	10.7	7.0	9.5	8.6	12.7	12.1	10.5	8.3	6.4	7.7	5.3	7.1	8.3	10.5	7.7	6.2	7.8	8.9	8.4	6.4	10.5	13.4	4.9	6.5	7.1	10.0	6.8	7.8	2.9	3.9	6.3	9.1	1.6	3.1	2.7	6.5	4.0	4.1	3.6	10.3	7.1	7.7	6.5	6.7	7.7	7.4	4.3	3.7	7.0	5.0	7.3	6.1	6.8	5.4	9.0	24.0	4.2	6.6	5.5	3.3	5.9	7.7	7.4	6.6	9.5	10.9	11.1	4.9	4.3	5.7	5.6	3.7	3.9	4.0	5.7	3.9	4.1	9.5	4.2	5.1	6.5	6.2	4.5	7.7	6.3	5.6	3.8	6.5	6.8	4.8	5.5	5.5	8.5	10.5	11.8	4.0	6.5	8.1	4.2	4.4	6.1	3.9	3.1	5.9	2.7	2.4	2.7	2.4	3.9	2.9	2.9	2.4	6.3	1.6	9.1	1.4	1.8	2.7	9.9	11.8	12.4	10.8	9.4	6.5	10.7	7.0	8.3	13.4
MTF2	"M96, PCL2, TDRD19A"	ENSG00000143033	"Metal response element binding transcription factor 2"	Q9Y483	1	93079235-93139081	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.4"	"Cell line enhanced"	"Detected in all"		"U-698: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069047, HPA069066"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA069047: , HPA069066: "	"unprognostic (1.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.88e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavourable (8.90e-7)"	"unprognostic (1.26e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavourable (1.05e-4)"	"prognostic unfavourable (2.47e-7)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	6.8	8.0	8.5	19.7	18.4	21.9	10.3	24.3	12.2	9.8	8.0	8.6	4.9	8.0	9.0	8.5	7.2	7.6	7.4	5.3	9.0	8.2	7.6	7.3	8.6	19.9	8.1	9.8	12.0	7.0	6.7	13.9	13.0	9.2	7.0	8.4	6.7	6.7	6.8	7.1	8.1	9.5	6.8	8.5	12.7	7.2	17.3	9.2	43.4	9.6	7.1	19.4	7.9	8.3	11.7	12.0	14.7	10.6	13.0	14.3	6.2	7.3	3.5	12.3	8.1	2.1	2.1	14.3	4.7	3.8	8.2	10.3	6.0	4.1	23.8	8.7	3.0	4.0	11.3	4.9	12.1	9.1	8.3	16.4	5.5	8.1	3.2	21.3	7.0	2.6	2.7	7.7	4.7	7.8	18.5	7.5	5.1	3.1	30.6	17.8	21.0	4.8	24.9	15.3	6.4	7.6	8.0	7.7	9.3	7.8	9.3	9.5	5.5	15.1	4.4	5.5	8.2	5.2	7.0	5.9	6.6	42.3	1.0	12.8	3.5	9.4	9.4	14.7	11.3	10.6	12.9	10.0	11.7	14.3	12.0	11.7	13.9	12.4	7.2	13.0	6.3	11.4	12.9	6.2	8.5	18.4	24.3	12.2	9.0	8.2	8.1	9.8	9.2	9.2
MTFR1	"CHPPR, FAM54A2, KIAA0009"	ENSG00000066855	"Mitochondrial fission regulator 1"	Q15390	8	65644734-65771261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023152, HPA056120"	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA023152: AB_1854176, HPA056120: "	"prognostic unfavourable (4.06e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.56e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.21e-4)"	"unprognostic (8.25e-2)"	10.7	17.7	6.6	5.5	11.7	3.9	9.5	10.1	8.8	9.7	10.7	10.8	14.2	11.1	9.9	11.9	12.3	7.2	6.2	8.7	6.8	5.5	28.4	37.7	7.1	3.9	10.3	5.4	7.9	19.1	8.0	15.0	16.2	9.7	8.1	11.2	14.8	11.0	11.5	11.7	8.3	16.2	8.8	11.3	6.5	13.2	16.8	11.7	5.4	13.0	11.2	9.3	10.5	9.7	1.7	3.1	4.3	2.8	0.8	2.9	1.7	14.4	10.8	8.5	10.0	12.0	11.7	6.9	9.5	8.8	11.9	12.5	9.2	15.1	8.1	3.1	9.2	9.5	19.5	13.0	16.1	2.9	10.5	10.0	8.0	18.4	14.9	2.6	4.9	8.0	14.0	15.2	48.7	14.4	13.6	8.4	13.7	13.0	8.8	6.1	9.1	9.7	4.5	11.8	6.7	14.6	13.1	3.8	5.7	9.6	16.3	12.6	17.9	5.7	10.8	7.2	10.0	17.1	8.2	8.2	5.3	5.9	8.8	10.6	9.5	4.3	2.8	1.2	2.0	2.5	2.9	1.7	2.6	2.2	3.1	1.4	2.6	2.9	0.7	0.8	1.2	1.9	2.5	1.7	6.6	11.7	10.1	8.8	6.8	5.5	10.3	5.4	9.7	11.7
MTG1	GTPBP7	ENSG00000148824	"Mitochondrial ribosome associated GTPase 1"	Q9BT17	10	133394094-133421307	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA037826, HPA037827"	Approved		Supported	Mitochondria				Mitochondria		"HPA037826: , HPA037827: AB_10670959"	"unprognostic (2.94e-2)"	"unprognostic (8.08e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-1)"	"prognostic favourable (5.08e-4)"	"unprognostic (4.63e-3)"	"prognostic unfavourable (6.79e-7)"	"unprognostic (3.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.19e-2)"	"prognostic favourable (1.03e-5)"	14.5	29.4	16.5	20.2	19.0	14.8	17.9	23.9	19.2	16.1	19.7	23.0	16.7	26.6	19.9	13.5	21.7	20.5	17.9	14.1	14.4	13.1	26.6	47.0	14.4	19.3	17.3	14.5	20.0	27.9	18.1	22.3	16.6	16.4	19.8	16.4	16.9	23.8	24.4	26.4	18.2	22.5	17.7	14.1	27.3	21.3	29.1	20.8	21.3	19.5	12.3	21.2	15.1	15.8	22.9	20.2	10.4	18.2	21.0	14.2	9.9	16.5	20.3	12.8	27.6	7.8	6.1	18.3	9.8	10.5	18.4	15.6	25.7	12.0	12.3	15.0	10.0	14.3	14.0	19.5	8.7	11.5	18.5	11.9	10.5	23.1	19.7	8.7	13.0	15.6	11.0	17.4	28.0	26.4	10.4	2.1	14.1	21.2	8.5	12.2	17.2	7.0	12.0	12.2	2.9	16.1	13.5	4.8	15.9	13.9	14.5	21.5	13.2	13.0	14.9	6.5	12.2	6.6	11.1	4.0	2.8	17.5	11.7	7.9	9.1	0.2	10.6	10.4	13.9	16.1	14.2	18.7	12.4	11.6	9.7	22.9	9.7	10.2	1.5	21.0	18.2	20.2	12.5	9.9	16.5	19.0	23.9	19.2	14.4	13.1	17.3	14.5	16.4	20.8
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"	P11586	14	64388031-64463457	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 121.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol			250000	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: "	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	18.9	9.0	8.1	8.4	18.1	9.7	12.2	5.7	15.9	7.1	9.3	9.0	4.0	7.5	8.5	6.9	12.0	6.7	6.4	10.6	8.4	6.5	20.5	121.6	6.8	9.2	8.0	10.4	10.1	13.4	13.1	5.6	5.6	10.0	5.5	11.4	9.3	11.6	5.6	26.5	7.6	7.3	8.8	6.9	8.3	7.9	2.3	7.4	15.6	8.6	14.0	12.5	8.7	7.3	21.1	12.8	0.5	13.2	12.8	14.9	8.4	72.1	41.1	15.6	34.0	16.8	13.7	25.3	28.3	19.5	36.8	36.5	39.9	33.3	30.4	13.4	16.8	35.5	48.2	28.2	43.1	30.1	31.7	37.6	41.2	30.2	12.4	28.8	20.5	10.7	9.1	32.8	17.8	22.9	28.0	25.0	27.8	59.9	46.4	16.9	28.6	43.6	37.1	54.3	27.5	27.6	42.3	33.8	13.1	47.4	25.8	14.2	40.1	14.6	14.1	27.8	48.1	25.5	33.9	16.7	20.5	53.5	25.4	33.4	31.4	0.2	8.2	0.1	8.1	13.2	10.9	21.1	9.0	9.9	12.8	11.6	7.6	10.1	0.5	12.8	10.3	3.2	14.9	8.4	8.1	18.1	5.7	15.9	8.4	6.5	8.0	10.4	10.0	7.4
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865549-151101887	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Supported	Mitochondria				Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: , HPA074911: "	"unprognostic (3.66e-2)"	"prognostic unfavourable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavourable (5.10e-4)"	"prognostic unfavourable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (8.69e-5)"	10.4	10.6	8.0	12.1	8.1	12.2	7.1	32.4	10.5	6.5	6.2	7.8	10.2	3.4	8.5	7.2	6.4	8.0	7.3	10.7	7.5	7.9	9.5	6.9	17.1	11.0	12.3	7.6	22.2	13.7	7.1	9.1	15.5	8.5	5.0	9.1	12.7	3.4	10.5	2.5	5.7	4.7	10.9	10.2	8.7	5.6	13.6	6.6	6.7	12.2	5.0	11.4	8.7	5.1	1.1	3.0	0.2	0.8	1.0	5.0	0.6	11.8	10.3	13.5	33.2	3.5	12.4	33.0	18.7	20.5	18.9	23.2	20.8	11.2	43.8	12.5	28.5	12.7	21.6	18.2	23.4	18.0	19.6	18.3	18.4	19.0	22.3	33.3	3.0	14.6	23.3	18.2	33.3	31.4	43.2	23.0	19.4	25.0	16.3	6.9	13.7	9.6	19.6	10.1	19.5	12.7	5.8	13.5	10.0	24.7	11.0	15.3	3.4	23.3	23.8	12.6	27.7	28.0	26.5	19.1	17.8	45.7	21.0	31.2	16.3	0.2	0.7	0.0	0.8	0.8	1.3	0.8	1.9	2.1	3.0	1.1	1.8	1.9	0.0	1.0	0.8	1.5	5.0	0.6	8.0	8.1	32.4	9.5	7.5	7.9	12.3	7.6	8.5	6.6
MTHFS	HsT19268	ENSG00000136371	"Methenyltetrahydrofolate synthetase"	P49914	15	79833585-79897379	"Enzymes, Predicted intracellular proteins"		Ligase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.7;liver: 120.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 88.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 88.7;monocytes: 25.4"									"HPA008067, HPA054177"	Approved		Supported	Cytosol				Cytosol		"HPA008067: AB_1078882, HPA054177: "	"unprognostic (4.57e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (9.13e-3)"	"prognostic favourable (1.29e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (2.04e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	10.0	6.6	4.5	7.6	4.4	2.5	5.7	3.9	2.8	4.4	12.4	3.7	6.8	8.3	4.3	6.2	4.5	4.0	7.9	5.2	4.1	5.0	27.9	120.9	6.4	5.4	5.5	1.7	3.3	18.8	11.4	9.4	13.9	3.9	8.6	3.7	6.5	10.6	7.6	6.0	1.9	18.3	4.4	6.1	7.6	6.3	5.9	3.3	5.3	12.0	3.1	5.7	4.0	9.9	9.7	9.3	88.7	25.4	12.4	12.6	13.8	11.0	27.9	2.5	1.4	9.9	8.3	11.2	7.7	10.2	13.6	10.4	21.7	21.7	13.8	23.5	9.6	17.8	23.8	7.6	10.4	14.4	15.8	11.9	16.2	25.7	17.1	5.6	0.4	12.6	22.3	5.6	14.2	5.1	26.3	11.4	10.7	23.7	8.6	23.1	11.9	10.5	9.4	13.7	21.0	24.8	20.7	6.8	3.3	21.5	12.9	28.4	16.5	10.3	3.3	5.2	11.1	2.4	5.1	5.7	18.5	14.0	2.6	22.0	4.0	9.8	16.6	43.5	7.7	19.0	9.9	9.7	10.8	9.0	9.3	8.7	12.6	9.7	88.7	12.4	25.4	7.0	11.2	13.8	4.5	4.4	3.9	2.8	4.1	5.0	5.5	1.7	3.9	3.3
MTIF2	IF-2mt	ENSG00000085760	"Mitochondrial translational initiation factor 2"	P46199	2	55236595-55269347	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006021, HPA061422"	Uncertain		Enhanced	Mitochondria				Mitochondria		"HPA006021: AB_2147687, HPA061422: "	"unprognostic (2.91e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (8.86e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.85e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-3)"	"unprognostic (1.33e-1)"	13.8	17.8	13.6	12.0	15.8	9.6	15.5	9.4	17.7	12.0	21.1	11.2	17.7	21.0	10.0	15.9	17.5	10.6	11.2	24.5	13.5	12.1	27.4	32.2	10.6	17.5	15.5	11.8	10.4	24.6	20.2	20.2	12.5	22.6	12.2	25.1	9.7	16.3	14.3	31.5	12.3	26.9	15.0	16.9	16.3	16.3	9.0	14.6	16.1	20.6	27.1	15.2	14.5	11.6	9.6	13.9	9.4	12.8	17.2	12.7	6.9	15.2	14.8	8.8	15.0	10.9	15.0	20.1	14.1	11.3	13.6	11.9	17.6	14.8	25.2	26.7	12.9	13.7	20.8	20.2	22.5	27.9	16.1	23.2	11.6	32.4	20.9	36.5	13.8	16.4	21.0	18.8	39.4	10.9	41.0	14.4	14.1	12.7	11.2	24.6	18.7	18.3	11.9	28.2	24.3	13.2	13.5	15.8	10.1	12.5	20.7	25.4	11.0	12.2	10.7	14.2	16.4	16.9	23.0	27.1	24.2	6.9	15.1	27.3	11.2	5.4	11.0	9.4	10.1	12.8	12.6	8.3	10.3	9.4	13.9	9.6	12.5	12.7	4.2	17.2	10.7	6.8	11.7	6.9	13.6	15.8	9.4	17.7	13.5	12.1	15.5	11.8	22.6	14.6
MTIF3	"IF-3mt, IF3(mt)"	ENSG00000122033	"Mitochondrial translational initiation factor 3"	Q9H2K0	13	27435643-27450591	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039791	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA039791: AB_10795296"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.27e-2)"	"prognostic favourable (8.41e-4)"	36.9	30.4	29.8	21.9	26.3	8.5	28.4	22.8	26.7	21.5	24.8	16.9	25.9	23.7	15.1	38.5	25.5	16.5	20.5	55.7	27.5	22.8	41.5	38.7	15.1	22.2	28.9	19.7	23.1	28.3	14.5	40.3	20.2	28.3	22.7	24.8	17.4	43.3	28.1	46.1	21.6	29.7	18.2	28.7	24.9	22.7	28.3	26.2	29.7	22.9	38.5	24.0	27.8	16.4	25.3	44.3	35.9	26.5	18.5	24.1	19.4	13.4	9.4	21.1	10.6	23.7	35.6	10.8	19.9	21.8	14.6	14.9	12.4	16.6	14.7	13.5	21.6	11.6	11.4	15.6	20.2	15.4	14.1	18.6	8.6	15.5	23.1	19.2	17.8	19.9	28.8	12.0	15.3	25.4	10.6	5.9	22.2	23.7	16.8	23.5	11.0	10.7	9.9	11.5	16.8	30.2	13.8	15.6	9.5	12.1	17.7	22.5	13.8	29.0	17.3	9.9	5.9	25.5	13.5	4.6	6.4	8.5	10.3	19.4	14.1	34.2	26.5	35.9	17.1	25.5	18.4	25.3	21.8	17.2	27.9	21.7	19.3	19.6	17.7	18.5	22.1	44.3	24.1	19.4	29.8	26.3	22.8	26.7	27.5	22.8	28.9	19.7	28.3	26.2
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568619-150673322	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favourable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	10.7	17.9	15.0	10.2	16.4	11.1	9.2	10.6	10.8	9.1	21.5	12.5	12.7	12.8	10.9	10.9	11.1	11.1	8.0	9.0	14.3	12.0	17.9	19.9	12.2	12.4	17.3	9.3	13.8	7.5	21.4	11.9	21.5	12.9	9.5	21.6	8.3	10.2	12.9	11.2	10.2	21.0	8.0	17.2	15.3	8.6	12.1	16.4	14.5	12.7	8.3	13.9	8.5	9.1	6.9	7.9	18.4	7.2	10.1	7.7	4.6	8.5	3.9	5.5	2.0	5.0	5.0	3.5	4.1	5.6	4.7	5.2	3.0	4.7	13.8	7.3	5.2	6.1	4.0	7.9	5.8	3.7	3.5	3.7	3.7	9.1	3.8	15.3	12.5	3.0	9.5	3.8	8.1	6.1	2.3	12.8	5.7	2.8	4.2	15.8	2.8	5.1	5.1	3.1	2.7	8.1	4.8	1.4	1.5	3.5	7.4	5.2	2.6	22.3	5.3	3.1	1.9	8.1	4.2	2.6	5.9	13.1	4.0	9.4	5.1	17.6	6.3	18.4	1.5	7.2	4.9	5.5	6.8	5.2	7.9	6.9	6.5	3.9	8.5	10.1	6.2	5.1	7.7	4.6	15.0	16.4	10.6	10.8	14.3	12.0	17.3	9.3	12.9	16.4
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95832882-95925315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles				Vesicles		"HPA049831: "	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	16.4	10.4	14.2	12.1	19.9	5.3	15.4	14.9	23.3	14.1	13.5	22.6	4.9	8.0	14.1	7.5	15.5	13.3	15.4	13.8	18.1	13.9	16.9	4.5	14.3	13.6	27.5	13.6	14.5	11.0	15.9	8.2	25.1	21.3	17.6	14.5	19.6	18.8	12.3	6.8	9.7	9.5	18.2	30.0	10.5	13.6	29.0	21.8	12.2	11.3	7.7	11.7	13.4	14.3	5.4	6.6	9.7	4.9	11.8	14.2	6.6	9.2	9.9	22.9	16.5	8.0	12.5	19.1	17.3	15.5	17.3	15.6	23.4	18.8	6.6	20.8	18.3	12.9	18.6	18.9	15.5	12.2	9.0	13.9	24.8	13.1	18.4	23.4	11.4	10.4	12.6	22.6	22.7	25.9	17.1	6.4	16.1	6.9	11.6	10.9	18.6	14.1	9.8	13.4	6.3	17.7	49.8	14.6	17.1	17.1	14.5	7.7	11.5	10.0	26.5	20.1	18.5	14.7	15.9	6.0	16.5	6.1	8.5	6.5	20.4	9.7	3.3	1.4	11.4	3.9	12.3	5.4	7.7	14.2	6.6	4.8	4.1	11.0	0.9	11.8	4.9	3.4	6.9	6.6	14.2	19.9	14.9	23.3	18.1	13.9	27.5	13.6	21.3	21.8
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883155-30030866	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	15.8	17.2	15.7	12.6	20.6	66.7	16.0	24.2	18.0	13.7	12.6	18.9	14.8	10.6	18.8	13.5	20.1	16.7	13.0	14.4	13.0	11.7	12.4	9.9	18.3	12.6	14.7	11.4	20.3	15.8	22.1	20.6	20.6	15.8	15.1	12.9	18.1	15.9	14.7	30.7	22.5	13.1	16.0	17.0	20.7	14.1	23.7	14.6	14.0	16.6	11.9	14.9	14.0	19.3	2.6	3.9	16.5	6.6	3.9	4.1	3.5	8.4	6.6	11.4	12.1	11.5	8.4	8.4	7.5	11.4	10.3	11.9	6.1	5.1	6.4	5.0	14.4	10.4	12.0	9.5	10.4	12.7	10.0	11.6	6.6	6.6	10.6	9.8	29.5	8.9	15.8	10.0	18.2	10.2	7.1	11.5	6.3	10.5	6.6	7.2	4.2	4.9	7.8	15.5	6.5	9.7	15.7	12.7	8.7	14.3	13.0	7.7	7.3	9.9	10.9	16.9	11.4	3.4	5.3	10.0	6.7	6.0	7.3	4.9	7.7	6.4	6.6	10.0	3.1	4.6	4.1	2.2	2.5	3.4	3.9	2.6	3.1	2.7	16.5	3.9	4.7	1.5	2.7	3.5	15.7	20.6	24.2	18.0	13.0	11.7	14.7	11.4	15.8	14.6
MTPAP	"FLJ10486, mtPAP, PAPD1, SPAX4"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria				Mitochondria		"HPA038620: AB_10673015, HPA058232: "	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	10.9	12.7	9.9	10.2	12.4	32.8	11.1	12.4	16.1	9.6	9.9	7.3	6.5	11.0	10.4	7.0	12.6	9.5	7.6	11.5	7.8	7.2	10.6	11.1	9.4	10.5	11.9	13.0	11.4	18.9	9.5	7.2	10.0	11.4	8.0	12.0	8.2	10.7	10.2	22.3	13.1	10.0	14.3	9.0	9.3	9.7	10.6	8.3	6.7	11.0	12.4	10.5	11.7	9.1	15.6	22.9	18.4	24.4	16.9	17.1	8.3	14.2	14.2	9.0	13.1	8.9	8.4	11.7	9.9	3.5	10.1	10.6	15.0	20.0	20.3	7.1	6.5	16.8	17.4	11.5	12.4	10.2	13.6	20.6	13.4	15.1	9.3	13.4	16.2	8.2	10.8	11.3	6.8	11.0	22.2	16.0	7.6	11.9	16.1	11.9	6.1	7.7	16.3	16.0	18.9	9.3	9.5	14.9	12.0	9.0	9.4	13.8	9.0	8.7	10.5	10.7	13.8	14.9	11.0	3.6	8.6	27.8	9.2	24.7	3.7	16.4	18.5	18.4	16.2	24.4	17.1	15.6	15.4	15.6	22.9	13.1	16.7	16.8	3.0	16.9	18.1	12.0	15.5	8.3	9.9	12.4	12.4	16.1	7.8	7.2	11.9	13.0	11.4	8.3
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795281-236903981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044474, HPA054915"	Approved		Supported	Cytosol				Cytosol		"HPA044474: AB_10966696, HPA054915: "	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (5.75e-4)"	"unprognostic (8.10e-2)"	14.5	11.4	9.9	13.2	13.5	7.6	13.6	14.8	14.4	16.9	16.4	16.2	16.0	7.5	18.1	27.3	10.4	18.4	16.3	21.9	9.4	9.8	21.2	9.5	11.7	14.3	12.6	12.8	24.7	20.8	27.4	12.4	17.5	13.0	14.0	8.9	17.7	11.1	17.3	27.0	15.4	11.7	23.3	12.1	13.9	14.9	20.1	12.1	20.8	22.4	11.1	13.2	18.4	14.4	3.3	1.6	3.0	2.0	2.3	5.8	2.1	9.9	6.7	8.2	6.8	15.3	14.1	9.7	8.7	7.8	9.6	10.0	6.3	7.6	22.1	8.1	9.8	6.9	10.6	7.8	11.5	10.2	9.1	13.0	8.9	11.6	10.3	20.6	8.1	20.1	4.9	12.7	12.2	12.7	18.7	10.4	8.0	6.9	10.7	6.6	11.0	3.6	11.7	14.6	14.2	6.9	11.5	6.7	18.7	9.8	7.2	8.8	10.2	8.4	16.4	15.9	6.1	12.2	11.2	22.6	7.0	12.9	10.3	13.0	15.6	2.7	1.6	3.0	3.2	2.0	5.8	2.7	4.2	4.5	1.5	3.3	5.0	4.0	0.1	2.3	1.5	1.6	2.9	2.1	9.9	13.5	14.8	14.4	9.4	9.8	12.6	12.8	13.0	12.1
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307760-55425581	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	23.6	23.6	26.1	24.9	24.0	18.7	24.1	40.6	31.2	22.0	19.3	15.2	28.8	27.6	26.2	17.8	23.3	20.0	22.4	24.3	22.0	16.0	21.2	22.7	19.7	24.7	21.1	21.5	25.9	25.8	35.8	45.0	19.0	26.6	25.6	21.7	10.4	21.8	28.7	71.3	23.8	24.3	20.9	37.5	20.9	20.6	22.3	21.5	29.7	29.3	19.2	21.7	24.4	23.4	9.8	10.9	5.8	10.3	5.9	10.4	4.0	14.2	20.0	14.6	15.5	12.3	13.0	19.6	13.1	10.0	14.8	18.8	21.3	18.7	27.6	15.5	11.5	9.8	28.3	17.9	22.2	4.9	23.5	18.9	18.8	16.3	11.4	11.1	12.5	10.2	12.3	15.6	19.0	12.8	22.3	16.0	14.2	12.9	11.9	14.6	13.2	19.4	14.6	16.3	12.1	16.0	20.8	18.0	11.1	14.9	8.4	12.8	20.3	16.1	11.5	3.8	9.6	10.6	21.9	11.8	12.3	23.8	9.7	25.4	14.7	4.9	6.6	5.8	10.4	6.1	10.0	8.8	7.7	9.7	7.9	9.8	8.1	8.3	1.9	5.9	10.3	10.9	7.5	4.0	26.1	24.0	40.6	31.2	22.0	16.0	21.1	21.5	26.6	21.5
MTSS1L	"ABBA, ABBA-1, LOC92154"	ENSG00000132613	"MTSS1L, I-BAR domain containing"	Q765P7	16	70661204-70686066	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 105.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 2.4;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.3;T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048531, HPA066469"	Approved		Supported	"Focal adhesion sites"				"Focal adhesion sites"		"HPA048531: , HPA066469: AB_2685671"	"prognostic unfavourable (2.85e-4)"	"unprognostic (8.85e-2)"	"unprognostic (7.01e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.25e-2)"	17.2	13.4	61.9	11.1	47.6	4.9	6.4	68.3	105.5	22.5	15.5	59.5	4.1	8.1	29.5	4.1	27.4	17.5	15.8	16.8	70.3	45.6	6.8	21.7	12.9	5.5	50.2	38.7	14.5	7.9	7.7	5.2	19.0	40.7	15.5	5.2	11.8	16.1	21.6	37.2	15.8	7.8	31.6	53.5	19.2	6.7	6.2	53.3	8.2	4.5	5.2	4.8	20.8	10.0	0.3	2.3	0.2	0.1	0.0	2.4	0.4	13.6	32.8	8.2	8.5	6.8	6.8	31.2	20.6	25.7	17.7	14.7	13.2	8.8	0.1	7.4	32.2	28.6	8.9	9.0	6.8	0.2	11.9	4.7	28.0	61.0	60.7	7.0	0.2	28.1	19.6	8.2	28.5	5.8	17.8	0.3	15.6	33.8	6.7	36.1	7.2	6.9	14.4	15.4	0.0	15.5	20.5	19.4	13.0	44.0	19.2	5.7	14.7	13.8	8.7	13.8	15.7	12.5	12.8	5.0	1.2	0.2	12.5	0.2	4.7	0.0	0.1	0.2	0.1	0.0	2.4	0.2	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.4	61.9	47.6	68.3	52.3	70.3	45.6	50.2	38.7	40.7	53.3
MTUS1	"ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1"	ENSG00000129422	"Microtubule associated scaffold protein 1"	Q9ULD2	8	17643795-17800917	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 29.1;AN3-CA: 25.6;HUVEC TERT2: 75.5;SK-MEL-30: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6"	"Lineage enriched"	"Detected in single"	21	"T-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067903, HPA069795"			Enhanced	Nucleoli,Microtubules				"Nucleoli, Microtubules"		"HPA067903: , HPA069795: "	"unprognostic (3.20e-1)"	"unprognostic (3.29e-1)"	"prognostic favourable (1.05e-4)"	"unprognostic (2.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (3.33e-1)"	"prognostic favourable (2.76e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.43e-1)"	45.0	20.8	20.9	6.8	38.2	0.4	21.8	51.0	27.7	19.8	19.0	56.5	9.9	16.9	16.9	12.6	20.3	12.8	20.0	44.3	27.4	17.3	14.4	29.3	20.9	4.4	34.7	18.0	28.2	47.1	43.8	15.0	36.1	33.7	17.5	21.1	10.3	24.3	14.0	49.7	12.2	17.4	20.5	48.3	8.2	21.4	6.5	49.3	0.7	15.7	10.9	7.5	21.4	26.7	0.2	0.0	0.0	0.0	0.0	4.8	1.0	5.3	29.1	4.7	25.6	0.0	0.1	8.6	0.2	1.9	0.1	0.6	2.1	1.9	0.7	2.2	0.0	5.6	7.8	2.7	0.2	3.9	3.3	0.0	5.0	13.8	1.7	0.0	0.1	2.4	4.2	0.6	8.6	75.5	0.0	11.1	0.0	1.4	1.0	1.4	6.8	0.7	0.0	4.3	2.8	1.5	11.1	2.4	0.5	3.7	6.8	21.4	4.9	0.0	15.4	0.0	6.4	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.0	0.2	4.8	3.6	0.0	0.0	0.0	0.0	0.0	1.0	20.9	38.2	51.0	27.7	27.4	17.3	34.7	18.0	33.7	49.3
MTUS2	"CAZIP, ICIS, KIAA0774, TIP150"	ENSG00000132938	"Microtubule associated scaffold protein 2"	Q5JR59	13	28820348-29505947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 46.8;pituitary gland: 19.3"	"Group enriched"	"Detected in some"	4	"HaCaT: 16.3;HeLa: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.9;intermediate monocyte: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.9;monocytes: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031473, HPA031474, HPA031475"	Enhanced		Supported	"Microtubules,Cytokinetic bridge"				"Microtubules, Cytokinetic bridge"		"HPA031473: , HPA031474: AB_10600109, HPA031475: AB_10600442"	"unprognostic (1.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.62e-2)"	0.6	0.8	2.3	0.7	6.1	0.7	0.6	12.2	8.8	1.1	0.8	0.1	0.0	0.7	2.1	0.6	0.8	1.4	0.7	46.8	3.4	1.9	0.6	1.1	0.7	1.0	1.2	4.6	8.2	4.7	0.5	19.3	0.5	2.3	0.8	0.8	2.0	1.0	0.7	0.6	0.7	0.9	1.7	0.7	1.0	1.5	1.6	0.9	0.0	1.1	0.0	0.6	2.6	0.7	0.0	1.3	1.9	1.7	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	16.3	0.5	0.0	0.0	0.1	0.7	0.0	6.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	1.2	0.0	2.8	2.1	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.3	0.1	0.4	0.0	0.0	0.0	0.2	1.9	0.0	1.7	0.1	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	2.3	6.1	12.2	8.8	3.4	1.9	1.2	4.6	2.3	0.9
MTX1	"MTX, MTXN"	ENSG00000173171	"Metaxin 1"	Q13505	1	155208699-155213824	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011543	Uncertain		Supported	Mitochondria				Mitochondria		"HPA011543: AB_1853824"	"unprognostic (2.57e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavourable (3.39e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-2)"	15.4	19.8	11.6	9.9	12.6	22.9	15.8	5.7	18.1	15.8	15.9	12.2	14.8	12.4	14.9	13.9	18.0	21.4	13.5	11.8	10.8	10.0	24.4	36.4	12.8	18.7	11.8	12.9	14.0	26.3	23.4	12.0	28.4	11.7	12.3	12.7	14.6	20.7	19.2	10.4	13.8	13.7	12.7	10.2	17.1	14.7	60.0	9.0	14.5	19.3	14.3	18.0	11.6	11.5	14.4	23.1	43.8	26.8	12.2	14.0	14.4	17.2	28.4	9.1	12.9	17.0	15.4	28.8	8.9	18.1	26.6	18.5	35.3	28.9	14.2	29.6	20.5	17.3	13.3	25.2	9.7	10.4	31.4	9.0	22.7	34.0	26.9	16.6	12.7	19.6	23.6	27.4	18.5	23.4	18.2	7.1	15.7	41.9	18.6	20.9	18.1	33.0	15.4	5.7	33.8	23.9	15.0	14.9	18.5	11.1	35.2	10.2	28.5	27.0	9.7	12.7	14.4	8.4	15.0	13.7	11.4	14.5	16.8	8.6	13.5	10.2	26.8	6.3	9.8	13.7	9.2	14.4	12.1	10.3	23.1	12.4	12.1	10.9	43.8	12.2	7.9	12.4	14.0	14.4	11.6	12.6	5.7	18.1	10.8	10.0	11.8	12.9	11.7	9.0
MTX2		ENSG00000128654	"Metaxin 2"	O75431	2	176269395-176338025	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031550, HPA031551, HPA031552"	Approved	Approved	Supported	Nucleoli,Mitochondria	"Intracellular and membrane"			Mitochondria	Nucleoli	"HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616"	"unprognostic (2.61e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (5.06e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-2)"	13.2	26.4	21.3	12.0	22.3	5.5	18.8	15.0	44.9	13.0	20.7	18.5	16.6	15.4	15.5	27.9	22.2	20.0	12.0	33.6	23.6	26.3	31.5	20.2	10.6	8.9	21.5	16.5	13.2	16.4	23.7	25.7	17.3	21.8	18.9	24.6	16.3	24.7	16.5	45.0	12.5	14.8	17.6	25.7	9.4	14.6	40.6	14.0	10.2	14.7	19.8	13.6	14.4	13.6	16.2	12.1	4.7	12.6	15.1	13.4	7.9	17.8	10.6	21.6	13.2	14.5	16.8	20.8	19.3	18.1	17.7	20.7	18.2	19.5	22.9	32.7	17.0	12.1	23.5	23.7	24.4	22.7	17.0	21.8	13.4	32.1	23.0	33.7	7.4	18.7	29.6	18.5	32.0	25.2	28.9	17.8	20.8	16.3	11.8	34.3	20.6	16.8	0.0	15.7	20.4	50.2	32.5	30.9	26.5	16.1	21.5	39.7	12.0	22.0	22.1	17.7	15.7	18.5	20.1	20.0	20.8	27.4	22.0	17.0	21.4	4.7	7.7	3.2	8.5	12.6	11.5	16.2	10.9	9.6	12.1	11.4	13.2	13.4	0.0	15.1	10.9	9.8	13.4	7.9	21.3	22.3	15.0	44.9	23.6	26.3	21.5	16.5	21.8	14.0
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 168.1;kidney: 158.5;lung: 143.5"	"Group enriched"	"Detected in many"	7	"CAPAN-2: 139.8;RPTEC TERT1: 107.3;T-47d: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Group enriched"	"Detected in many"	10	"granulocytes: 1.3;T-cells: 4.0"									"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"		4900000	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	1.5	0.7	0.8	12.6	1.2	0.9	12.6	0.4	0.7	31.6	15.9	1.2	2.4	2.9	10.5	9.8	51.8	18.7	168.1	0.8	0.5	0.3	158.5	2.0	143.5	0.3	0.5	0.3	14.9	74.2	0.0	4.7	15.5	2.1	6.1	16.1	0.8	17.0	5.9	0.8	1.8	3.6	2.8	0.7	0.6	105.0	4.3	0.5	0.7	15.7	10.5	47.8	12.3	5.2	0.0	0.2	1.3	0.1	0.0	4.0	0.2	1.8	0.9	0.6	0.5	0.4	0.5	0.2	0.6	1.5	0.7	1.9	0.0	139.8	0.0	10.2	1.1	2.8	0.1	0.0	0.2	1.2	0.1	0.2	11.8	0.0	0.3	0.0	4.4	1.2	0.2	0.3	0.2	0.2	1.0	1.9	0.5	14.2	0.1	0.1	0.4	0.2	0.2	0.0	3.4	107.3	0.1	0.6	0.2	3.4	5.9	0.1	47.1	0.6	0.2	0.4	0.8	1.3	0.1	2.2	1.1	0.0	0.7	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.8	0.0	2.3	0.4	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.0	4.0	0.2	0.8	1.2	0.4	0.7	0.5	0.3	0.5	0.3	2.1	0.5
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8"	"Cell line enriched"	"Detected in some"	7	"PC-3: 51.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"		590000	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.1	0.1	0.7	0.1	0.0	0.2	0.1	0.1	67.4	8.4	0.0	0.0	0.0	1.9	0.0	11.6	0.2	301.7	0.1	0.1	0.1	0.1	0.6	2.0	0.0	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.1	4.6	0.0	192.8	0.0	0.7	0.1	0.3	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.1	31.6	155.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MUS81	"FLJ44872, SLX3"	ENSG00000172732	"MUS81 structure-specific endonuclease subunit"	Q96NY9	11	65857126-65867653	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059530	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA059530: "	"unprognostic (2.34e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (6.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.86e-2)"	15.6	14.3	17.2	21.4	19.5	13.6	24.7	21.6	19.5	19.3	22.2	19.1	18.3	22.1	28.2	12.4	14.4	20.4	19.5	18.4	16.6	12.3	17.7	13.8	17.9	22.2	24.0	14.1	23.5	17.0	19.5	17.2	16.6	17.2	19.4	9.8	13.4	14.9	23.2	28.1	18.2	26.5	19.4	17.5	21.6	17.7	11.3	22.4	32.2	17.8	15.6	17.7	18.2	21.7	12.5	13.2	23.2	15.2	10.8	20.0	11.2	10.7	6.8	11.7	11.5	5.2	6.4	14.9	11.7	9.5	15.1	10.2	9.1	17.8	10.4	15.9	9.3	10.6	10.5	10.4	3.4	22.5	7.7	18.9	18.5	5.4	15.9	13.3	20.2	10.1	19.4	19.1	15.2	12.7	11.3	29.4	9.9	7.2	19.0	20.7	8.4	15.4	18.8	5.6	19.9	11.5	6.9	11.7	13.4	8.0	14.5	25.2	16.9	14.0	11.1	11.4	9.6	14.4	12.6	19.8	13.1	15.0	12.8	9.0	18.8	16.2	12.4	23.2	20.0	14.3	19.6	12.5	15.1	17.2	13.0	10.6	12.0	14.7	8.5	10.8	15.2	13.2	12.8	11.2	17.2	19.5	21.6	19.5	16.6	12.3	24.0	14.1	17.2	22.4
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340470	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008732	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavourable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	7.7	8.4	10.3	12.7	14.8	11.1	8.3	31.6	12.4	10.5	10.1	15.1	11.0	11.1	11.5	9.8	8.3	11.0	10.0	6.1	10.9	7.3	9.7	9.0	7.2	14.0	13.6	10.1	12.9	8.4	7.5	12.5	12.5	11.6	9.1	11.0	12.6	9.5	11.7	8.5	11.1	9.8	7.5	12.6	12.8	11.8	4.9	16.6	14.1	11.9	7.4	12.0	9.3	9.2	7.2	6.5	1.9	8.9	6.6	15.4	6.3	4.9	4.4	10.3	7.0	7.4	5.5	17.9	3.5	4.8	7.5	6.2	9.3	7.1	14.1	6.2	2.4	7.8	5.4	6.4	3.5	11.6	4.1	6.9	7.0	6.6	6.8	5.9	5.0	3.6	6.6	10.1	16.9	5.4	10.7	5.5	3.2	8.1	16.2	5.6	25.9	5.4	22.0	7.9	7.6	3.9	9.5	9.3	7.4	7.6	5.9	11.7	4.7	6.8	3.4	6.6	4.1	5.0	5.5	8.4	9.6	8.6	5.7	9.0	5.0	1.5	5.6	1.9	9.8	8.9	15.4	7.2	10.2	9.9	6.5	7.2	11.3	11.0	0.9	6.6	6.8	5.5	10.3	6.3	10.3	14.8	31.6	12.4	10.9	7.3	13.6	10.1	11.6	16.6
MVB12A	"FAM125A, FLJ32495"	ENSG00000141971	"Multivesicular body subunit 12A"	Q96EY5	19	17405722-17433724	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041885, HPA042231"	Approved		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA041885: AB_10964218, HPA042231: AB_10961043"	"unprognostic (1.34e-2)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.96e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.93e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.33e-2)"	18.4	24.6	9.4	16.2	9.8	14.1	21.1	10.1	12.3	13.4	16.3	13.3	22.2	19.0	16.4	15.2	24.0	16.8	17.1	10.4	8.2	6.1	17.4	16.6	12.4	21.1	11.8	7.1	33.8	16.8	9.6	7.2	15.1	8.8	12.5	9.5	15.6	17.0	17.3	11.4	20.0	20.4	9.0	9.2	17.7	14.2	10.7	11.3	19.6	29.5	12.4	22.8	15.6	15.3	13.8	28.2	24.6	30.6	17.7	26.3	17.4	16.3	9.2	4.3	12.9	6.0	9.6	23.7	5.1	10.2	13.8	17.1	8.5	24.4	13.1	17.0	11.2	7.9	8.4	12.6	3.7	13.9	23.4	2.9	19.1	19.8	18.6	5.2	12.6	10.6	9.7	10.7	6.7	15.2	9.2	25.6	5.5	12.3	9.3	8.1	6.2	26.0	11.8	4.7	19.2	11.4	9.1	8.2	12.2	7.4	11.1	26.5	14.6	10.9	7.4	10.5	5.5	11.2	6.1	18.2	22.6	14.3	10.9	18.4	12.8	24.6	30.1	19.2	17.3	30.6	16.2	11.9	17.5	16.3	28.2	13.8	14.7	14.4	17.6	17.7	23.8	25.5	26.3	17.4	9.4	9.8	10.1	12.3	8.2	6.1	11.8	7.1	8.8	11.3
MVK	"LRBP, MK"	ENSG00000110921	"Mevalonate kinase"	Q03426	12	109573255-109598117	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016961, HPA044110"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA016961: AB_1854220, HPA044110: "	"unprognostic (3.10e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.28e-1)"	4.7	14.3	6.8	5.9	11.7	6.8	11.2	6.3	13.1	7.1	7.8	16.7	5.1	11.5	4.2	9.5	23.0	5.1	5.3	6.7	7.8	9.0	16.5	33.1	8.7	4.9	12.5	8.3	8.5	9.3	7.0	6.5	5.5	22.5	9.0	6.3	6.4	8.1	5.8	6.3	19.5	6.9	3.7	18.0	3.8	6.1	17.5	10.5	2.8	11.9	8.5	8.8	5.5	9.9	11.5	7.4	3.4	5.9	8.3	12.2	5.4	12.3	10.4	12.7	6.3	4.1	10.1	6.8	4.5	8.4	11.8	12.9	15.0	15.1	8.7	3.5	4.5	15.1	13.5	21.2	5.7	8.5	9.6	4.6	7.1	22.4	12.7	4.9	5.9	11.0	17.9	21.4	5.8	8.0	8.0	8.3	5.3	15.6	5.0	15.7	10.7	16.1	4.6	9.7	17.0	27.2	18.4	11.8	10.2	8.8	25.1	6.2	23.1	8.6	7.0	5.4	7.1	5.2	5.7	7.0	9.2	12.8	6.5	12.7	7.4	0.7	5.9	3.4	12.2	5.8	9.9	8.4	7.4	11.6	7.4	11.5	11.7	8.3	1.7	8.3	3.7	6.2	6.2	5.4	6.8	11.7	6.3	13.1	7.8	9.0	12.5	8.3	22.5	10.5
MVP	"LRP, VAULT1"	ENSG00000013364	"Major vault protein"	Q14764	16	29820394-29848039	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	Ribonucleoprotein	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002321, CAB002752, CAB022717, HPA064740"	Enhanced		Supported	Cytosol			38000	Cytosol		"CAB002752: , CAB022717: , HPA002321: AB_1079277, HPA064740: "	"prognostic favourable (4.51e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.86e-1)"	"prognostic favourable (5.49e-5)"	"unprognostic (2.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.65e-2)"	32.4	55.4	6.8	37.8	17.9	13.9	20.7	5.4	11.4	20.5	49.5	12.0	11.7	48.7	29.5	29.0	28.6	21.0	46.6	27.8	6.6	6.0	58.9	43.6	57.9	59.4	20.4	4.9	42.7	37.2	8.9	14.6	22.8	13.2	18.3	32.6	14.5	23.3	14.8	16.9	17.6	81.5	24.4	14.6	38.8	34.2	27.4	13.5	17.4	27.1	23.5	23.3	25.4	21.6	10.1	28.7	41.1	53.1	17.6	22.4	33.3	10.4	31.0	0.9	1.0	36.9	48.4	4.5	26.6	43.8	16.2	21.0	4.7	35.5	1.9	21.7	38.9	13.5	1.5	23.3	7.8	25.3	1.6	0.6	13.4	13.9	33.3	1.0	11.4	63.2	18.3	36.0	10.6	47.1	0.7	15.1	28.6	5.2	0.5	2.7	1.0	3.8	2.4	1.6	6.6	39.1	17.9	3.7	2.0	7.6	9.8	5.5	2.3	3.7	68.7	21.1	10.5	20.3	10.6	11.9	8.4	1.1	49.3	1.9	4.4	9.7	33.8	13.4	19.3	53.1	15.1	10.1	21.8	19.8	28.7	7.1	16.8	14.9	41.1	17.6	47.5	17.5	22.4	33.3	6.8	17.9	5.4	11.4	6.6	6.0	20.4	4.9	13.2	13.5
MX1	"IFI-78K, MxA"	ENSG00000157601	"MX dynamin like GTPase 1"	P20591	21	41420304-41459214	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 117.5;BJ hTERT+ SV40 Large T+ RasG12V: 105.8;Karpas-707: 27.1;SK-MEL-30: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030917, HPA030918, HPA049724"	Approved	Approved	Supported	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862"	"unprognostic (3.62e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.88e-2)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (9.95e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.81e-1)"	19.3	7.5	8.6	19.8	22.5	25.7	11.6	3.1	15.5	14.4	12.8	9.4	4.7	14.7	13.2	19.3	19.2	12.4	19.0	8.1	12.4	16.2	20.8	11.9	28.4	17.3	14.3	11.4	16.3	7.2	7.5	16.2	9.7	20.5	7.2	5.4	15.9	54.0	8.4	3.7	5.7	15.4	11.3	13.1	34.5	16.2	5.2	4.8	33.7	16.9	14.5	20.7	15.6	11.5	22.8	25.0	36.5	27.0	9.2	29.5	17.0	2.3	0.0	0.1	0.2	0.1	1.0	0.0	0.1	3.7	117.5	105.8	0.7	4.9	0.0	1.0	0.4	0.3	0.1	0.1	2.3	0.7	0.1	0.2	0.4	0.3	1.1	0.1	0.1	1.0	0.3	7.0	0.2	0.4	0.0	27.1	0.0	0.2	2.0	0.4	0.4	1.1	2.0	0.0	3.7	0.5	1.5	0.2	0.1	0.1	0.2	35.4	1.6	0.9	0.2	0.1	0.1	0.0	0.1	6.0	5.6	0.2	0.1	0.4	0.3	13.7	24.0	14.0	10.9	27.0	14.6	22.8	16.0	12.7	16.9	20.1	14.5	10.7	36.5	9.2	22.0	25.0	29.5	17.0	8.6	22.5	3.1	15.5	12.4	16.2	14.3	11.4	20.5	4.8
MXD4	"bHLHc12, MAD4, MST149, MSTP149"	ENSG00000123933	"MAX dimerization protein 4"	Q14582	4	2247432-2262294	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053363			Supported	Cytosol				Cytosol		"HPA053363: "	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.54e-2)"	"prognostic favourable (2.21e-5)"	"unprognostic (1.64e-1)"	"unprognostic (5.94e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.39e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.12e-2)"	31.9	21.6	20.1	11.8	17.1	23.3	26.2	63.2	23.3	16.5	17.6	15.1	29.8	17.4	19.7	19.7	13.6	24.4	19.2	19.8	16.0	13.1	23.3	12.1	20.0	19.9	13.5	12.4	12.6	18.7	11.4	32.7	24.5	14.4	17.6	7.3	18.3	32.7	26.3	19.3	24.3	16.8	13.8	11.4	29.8	15.1	11.8	11.3	34.8	17.6	8.0	16.1	16.2	21.3	3.5	10.6	8.1	4.3	2.7	5.6	1.9	0.9	3.5	5.6	6.7	19.8	14.8	1.3	7.0	7.2	5.3	5.4	0.8	3.0	3.0	15.9	10.6	4.8	1.6	5.6	1.3	2.6	17.1	0.5	11.9	9.8	14.6	2.3	6.4	23.0	10.0	1.7	2.7	12.6	4.0	5.0	4.9	6.8	5.2	13.2	2.2	15.8	3.5	1.9	6.2	6.2	5.5	9.1	17.0	6.6	3.2	5.0	15.3	14.6	29.4	5.8	2.4	4.3	1.5	7.7	5.4	1.1	8.0	2.0	1.7	8.1	4.2	4.8	5.3	4.3	4.3	3.4	4.7	5.0	3.6	3.5	2.4	2.5	1.7	2.7	4.1	10.6	5.6	1.9	20.1	17.1	63.2	23.3	16.0	13.1	13.5	12.4	14.4	11.3
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 29.5;SK-MEL-30: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: "	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavourable (9.17e-4)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	16.9	19.4	37.2	7.5	34.9	32.7	26.5	56.4	36.9	20.3	26.4	33.9	20.1	12.0	26.0	23.8	39.5	19.1	17.4	36.0	35.1	26.6	23.9	30.5	16.5	7.1	37.0	25.9	46.4	23.1	25.6	12.1	14.4	26.2	24.5	22.1	15.8	41.2	32.7	22.8	25.4	22.5	18.2	44.7	7.8	14.7	13.5	38.1	7.0	29.2	13.4	9.8	32.8	33.9	4.5	2.2	11.0	4.7	1.4	8.6	2.3	5.5	2.2	5.7	11.4	9.0	6.8	2.5	3.2	11.0	2.1	6.8	1.0	10.0	7.3	5.2	5.6	7.2	6.8	7.7	5.7	3.7	9.2	1.9	4.5	4.1	5.9	3.9	4.4	7.2	29.5	3.7	15.0	2.1	7.3	15.9	3.5	3.6	2.6	7.9	2.4	6.8	1.6	7.5	11.6	7.5	0.5	9.7	15.9	3.2	2.4	53.2	2.7	12.7	2.1	3.8	6.5	4.0	1.7	13.2	6.9	2.6	10.1	14.5	4.0	2.2	3.1	11.0	3.1	2.5	5.8	3.9	6.7	3.6	1.7	4.5	8.6	2.2	7.8	1.4	4.7	2.2	5.0	2.3	37.2	34.9	56.4	36.9	35.1	26.6	37.0	25.9	26.2	38.1
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted - unknown location"			"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavourable (1.80e-5)"	28.4	46.7	14.7	18.2	43.2	1.8	32.4	15.6	30.5	31.0	44.0	14.6	16.9	6.6	44.5	40.4	33.2	28.0	28.1	93.3	15.1	13.1	14.1	5.1	24.7	13.3	16.2	16.3	36.1	16.4	40.1	7.8	21.1	20.6	32.8	14.5	41.9	15.0	61.7	13.9	10.8	13.3	59.9	15.8	31.4	21.9	20.7	10.0	6.4	51.0	9.3	6.6	44.7	31.4	2.9	3.6	1.9	3.9	7.8	7.0	4.0	2.5	7.6	11.4	21.5	60.5	55.3	5.7	36.0	29.3	26.4	25.8	10.1	0.4	0.0	16.4	49.9	10.3	12.7	20.0	43.2	0.1	12.6	6.5	5.7	16.9	36.9	3.0	0.8	34.3	23.9	30.6	25.1	38.7	4.6	0.1	60.8	0.7	0.3	2.1	3.6	21.6	5.7	44.9	2.1	21.2	0.6	4.0	29.1	10.7	0.1	20.5	7.1	3.9	47.4	59.7	12.7	24.2	37.8	3.4	0.6	0.1	93.6	1.3	8.6	1.5	3.9	0.8	6.3	1.2	4.8	2.9	3.5	7.0	3.1	0.7	2.3	4.9	1.9	7.8	0.4	3.6	0.8	4.0	14.7	43.2	15.6	30.5	15.1	13.1	16.2	16.3	20.6	10.0
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell line enhanced"	"Detected in many"		"HL-60: 38.9;MOLT-4: 70.8;NB-4: 36.9;REH: 43.7;THP-1: 61.8;U-937: 33.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favourable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favourable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	1.8	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	24.8	0.1	0.0	0.0	38.9	19.6	0.0	0.0	0.1	0.0	0.0	20.1	3.7	0.2	2.0	70.8	36.9	0.2	0.3	43.7	1.0	6.0	0.0	0.2	1.9	1.2	0.0	1.9	0.0	1.4	61.8	0.0	0.0	0.3	1.4	0.4	4.7	1.2	12.0	0.0	33.7	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555631	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (8.12e-4)"	"unprognostic (9.70e-2)"	14.1	11.6	13.8	16.5	14.6	13.2	16.2	15.0	21.5	11.3	10.2	14.9	11.1	12.9	15.4	11.7	17.1	15.8	12.4	11.5	11.7	9.2	8.7	21.5	11.6	16.0	15.2	11.1	15.3	23.7	10.5	13.1	7.2	13.0	17.0	7.2	12.7	24.5	15.3	30.8	25.0	12.8	10.9	7.3	15.0	12.9	9.3	12.6	14.6	11.7	18.2	17.6	15.4	13.2	5.3	4.9	0.4	4.9	4.3	5.9	3.8	19.4	31.2	4.1	18.8	5.3	6.2	14.0	13.5	6.0	13.7	10.6	23.0	8.0	26.6	15.8	8.0	24.7	17.0	20.4	6.4	13.3	45.8	12.8	19.3	20.3	8.5	15.0	11.7	9.0	11.7	20.1	10.0	9.1	20.9	12.3	5.8	16.9	17.5	5.9	18.8	16.3	22.7	6.9	17.6	3.2	15.7	8.7	16.7	13.8	9.7	9.1	9.3	6.1	11.7	11.9	10.7	11.1	38.7	11.1	7.5	10.8	11.3	17.6	15.2	0.0	2.8	0.4	5.1	2.7	5.9	5.3	4.2	5.5	4.9	3.3	4.5	4.6	0.1	4.3	4.9	3.5	1.8	3.8	13.8	14.6	15.0	21.5	11.7	9.2	15.2	11.1	13.0	12.6
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 28.6;BJ hTERT+ SV40 Large T+ RasG12V: 24.2;Daudi: 29.1;HBF TERT88: 39.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.9;MAIT T-cell: 3.5"	"Group enriched"	"Detected in many"	32	"NK-cells: 1.4;T-cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008791	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavourable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	2.1	1.1	2.6	25.6	5.1	2.5	2.2	6.5	3.8	1.6	2.1	4.0	2.6	1.7	1.6	2.9	1.5	1.8	3.3	3.9	3.4	2.2	1.4	2.4	4.5	21.7	6.4	2.8	1.2	0.7	1.3	1.2	4.1	6.3	2.6	1.9	1.8	1.2	2.2	1.3	1.6	3.9	2.7	6.5	11.0	2.2	12.7	4.4	4.7	1.5	1.0	18.0	2.2	1.9	0.0	0.0	0.0	0.0	1.4	4.9	0.3	11.6	4.0	1.3	3.4	0.3	0.7	0.9	16.1	7.4	28.6	24.2	0.5	11.8	29.1	1.4	13.5	3.3	1.1	1.3	39.5	3.5	1.8	0.6	4.4	0.5	0.0	0.2	1.1	0.2	0.1	7.8	6.6	0.9	0.1	9.7	17.4	1.0	1.9	0.4	0.9	5.4	0.6	4.8	0.7	6.7	0.4	2.8	1.1	2.8	1.0	2.9	17.3	0.7	4.9	17.2	3.9	3.8	14.7	2.8	3.9	8.6	4.5	1.7	6.8	0.0	0.0	0.0	4.9	0.0	3.5	0.0	0.9	2.0	0.0	0.0	0.1	0.8	0.0	1.4	0.0	0.0	0.0	0.3	2.6	5.1	6.5	3.8	3.4	2.2	6.4	2.8	6.3	4.4
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716496	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2"	"Cell line enhanced"	"Detected in many"		"MCF7: 101.9"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	30	"plasmacytoid DC: 35.9"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 35.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017114: , HPA030530: , HPA055416: "	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.7	0.7	0.2	48.3	0.2	33.0	1.0	0.2	0.2	1.0	4.4	0.2	0.1	2.7	1.1	1.1	8.4	0.3	1.7	0.9	0.2	0.2	1.0	1.2	1.8	22.3	0.3	0.1	0.8	9.4	0.0	0.4	4.0	0.2	0.7	2.7	0.3	2.9	0.1	0.3	1.8	6.4	0.6	0.3	43.9	2.9	12.6	0.1	49.2	0.6	6.4	33.8	1.9	2.1	1.1	35.9	0.0	0.0	0.0	0.4	0.3	25.8	16.5	14.6	15.1	0.1	0.5	19.0	11.7	4.0	37.1	27.4	80.9	16.3	52.3	6.8	5.1	15.8	26.4	8.1	13.9	9.8	16.9	24.5	16.5	21.8	0.0	22.3	17.0	0.3	0.7	14.1	3.2	9.9	24.4	65.1	3.2	101.9	45.3	31.4	16.8	14.5	31.6	30.1	30.0	6.8	5.3	13.5	19.6	34.8	35.0	3.5	23.1	24.5	4.6	2.3	37.4	16.4	20.1	22.6	46.5	82.3	4.8	19.1	14.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	35.9	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1
MYC	"bHLHe39, c-Myc, MYCC"	ENSG00000136997	"MYC proto-oncogene, bHLH transcription factor"	P01106	8	127735434-127741434	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000084, CAB010307, HPA055893, HPA066556"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000084: , CAB010307: AB_631274, HPA055893: , HPA066556: "	"unprognostic (1.45e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.41e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (5.19e-3)"	"unprognostic (9.86e-3)"	"prognostic unfavourable (5.49e-8)"	"unprognostic (7.85e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (4.96e-5)"	67.4	20.8	3.2	46.6	7.1	16.3	36.0	1.2	5.0	23.9	23.3	3.8	11.8	11.1	23.8	14.4	47.6	59.5	32.4	23.7	5.8	2.2	11.2	36.6	16.0	40.5	5.8	1.2	38.7	64.6	2.1	7.4	14.9	9.8	20.6	11.3	6.1	14.4	21.8	69.6	78.5	17.2	21.3	12.0	38.3	24.7	16.3	3.8	40.2	9.0	48.4	27.1	28.9	37.3	25.5	8.8	1.0	10.3	20.9	55.2	22.0	7.1	13.8	1.2	12.3	20.0	23.7	3.6	8.6	3.7	10.7	9.0	18.8	18.7	72.9	12.0	5.1	15.5	63.9	27.8	7.1	17.2	22.3	43.9	23.4	24.5	18.4	30.7	7.0	16.5	61.5	7.2	57.0	12.3	64.8	38.6	5.3	20.5	50.1	66.8	3.4	27.6	27.9	5.2	129.7	9.0	7.4	84.9	8.0	4.0	33.5	22.2	13.6	20.2	14.9	8.1	9.6	6.2	10.7	0.7	1.2	35.2	7.1	34.3	4.0	0.7	10.3	0.1	8.6	9.1	43.4	25.5	31.1	18.6	8.8	20.6	55.2	34.8	1.0	20.9	6.1	0.3	24.8	22.0	3.2	7.1	1.2	3.6	5.8	2.2	5.8	1.2	9.8	3.8
MYCBP2	"FLJ10106, KIAA0916, PAM"	ENSG00000005810	"MYC binding protein 2, E3 ubiquitin protein ligase"	O75592	13	77044655-77327050	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058807			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA058807: "	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"prognostic favourable (5.01e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	28.0	13.4	31.0	26.1	28.8	24.1	22.4	31.3	32.7	15.5	10.9	8.1	11.5	8.0	16.2	26.7	18.9	11.7	11.1	13.5	24.1	18.6	12.3	13.2	12.4	29.8	15.3	31.1	22.8	12.6	14.5	17.2	9.6	20.0	17.9	11.5	9.6	12.9	12.4	13.7	57.6	13.6	13.2	14.0	24.1	10.3	14.1	16.2	18.6	11.6	12.6	30.7	13.3	34.0	8.3	4.6	3.3	3.7	4.2	7.3	2.5	7.7	3.9	4.8	5.2	24.0	10.7	2.8	4.9	7.3	4.3	5.5	3.5	4.0	22.1	3.1	9.6	7.1	8.2	9.0	5.8	8.7	8.2	18.7	8.0	7.2	8.2	39.2	6.6	12.0	7.5	3.9	7.9	9.7	3.9	7.0	7.6	4.6	10.7	26.5	2.5	5.0	12.2	4.9	5.3	7.2	7.7	7.5	3.5	5.9	8.6	4.4	3.2	30.1	12.8	4.1	3.4	2.7	4.7	7.6	5.2	15.7	8.3	32.3	4.1	2.0	3.5	3.2	5.8	3.7	5.1	7.9	6.5	5.0	3.2	8.3	7.3	5.8	3.3	4.2	2.5	4.6	7.3	2.5	31.0	28.8	31.3	32.7	24.1	18.6	15.3	31.1	20.0	16.2
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 46.4;skin 1: 26.0"	"Group enriched"	"Detected in some"	7	"U-266/70: 94.1;U-266/84: 69.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 11.5;intermediate monocyte: 5.5;myeloid DC: 12.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	75	"dendritic cells: 15.4;monocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA063132: , HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favourable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.3	0.3	1.2	4.4	2.1	0.1	1.7	0.8	1.7	3.6	7.5	1.8	8.5	2.6	1.0	4.0	17.8	1.6	2.3	0.7	1.1	0.9	0.8	6.4	1.9	2.9	0.6	1.4	0.5	46.4	0.0	2.1	11.2	1.8	5.3	3.6	1.8	4.6	16.6	0.6	26.0	7.3	1.2	1.1	4.0	3.3	1.5	0.6	6.4	4.2	3.1	6.0	18.4	7.3	0.0	15.4	0.1	11.5	0.0	0.1	3.8	0.2	0.0	2.9	0.7	0.0	0.0	7.0	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.3	0.0	0.7	2.0	0.5	0.1	0.4	1.0	0.1	0.0	0.1	0.0	0.0	1.7	0.2	2.3	0.0	0.2	0.2	0.7	0.0	0.1	0.2	0.0	0.0	2.7	0.1	0.2	3.3	0.6	0.2	11.3	0.5	0.7	0.2	0.4	0.1	0.7	3.6	0.0	0.0	1.1	1.3	0.1	94.1	69.1	0.1	0.0	0.4	0.0	0.0	11.5	0.0	0.0	5.5	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.0	0.1	0.0	2.3	15.4	0.0	3.8	1.2	2.1	0.8	1.7	1.1	0.9	0.6	1.4	1.8	0.6
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 45.9;TIME: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	39	"eosinophil: 20.4"	"Lineage enriched"	"Detected in single"	190	"granulocytes: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047992			Supported	Nucleoplasm,Vesicles			69000	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	37.3	3.1	4.1	4.4	6.3	1.1	27.5	3.0	7.7	16.2	8.4	1.5	5.2	3.1	14.5	9.4	14.4	6.8	9.1	17.2	5.1	4.2	6.9	11.1	24.1	4.9	5.8	1.9	8.2	2.5	3.4	2.7	17.4	6.6	8.8	5.3	8.3	4.0	3.7	14.2	4.8	5.5	10.8	5.4	39.4	4.6	7.7	5.2	0.6	12.5	11.0	2.8	17.0	12.3	0.1	0.0	20.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	45.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.2	0.2	0.5	0.0	0.4	0.0	5.7	0.0	0.0	0.0	0.4	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	4.1	6.3	3.0	7.7	5.1	4.2	5.8	1.9	6.6	5.2
MYD88		ENSG00000172936	"Myeloid differentiation primary response 88"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 68.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol				Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favourable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	25.0	11.3	5.9	19.5	6.9	18.1	14.7	5.2	4.6	10.0	13.4	5.8	5.0	15.1	9.5	12.3	25.5	9.8	12.4	10.4	5.3	3.2	15.1	47.9	25.6	40.1	6.2	3.5	13.3	10.3	5.4	10.4	17.8	6.7	11.3	14.3	8.8	13.9	5.4	3.9	12.5	30.4	10.7	7.0	39.0	12.5	5.8	5.1	28.5	10.4	17.5	30.8	13.9	13.7	7.8	34.7	49.0	68.0	8.3	14.3	34.6	8.1	12.0	1.8	10.7	8.5	11.1	3.7	8.0	13.1	22.6	24.0	7.5	9.9	17.4	4.8	14.3	10.2	14.2	8.0	7.6	13.5	2.9	9.4	6.1	11.4	7.0	11.9	24.6	12.7	8.5	12.8	4.8	12.8	4.1	7.1	11.8	8.2	19.6	3.8	7.6	12.0	8.5	2.3	7.5	11.6	19.0	0.8	3.9	11.3	54.5	7.1	8.5	13.5	11.9	4.4	2.7	20.4	7.6	10.5	11.7	12.9	8.6	20.9	9.6	38.3	37.6	48.1	12.2	56.5	10.4	7.8	11.0	12.2	34.7	6.7	7.7	10.9	49.0	8.3	68.0	16.6	14.3	34.6	5.9	6.9	5.2	4.6	5.3	3.2	6.2	3.5	6.7	5.1
MYEF2	"FLJ11213, HsT18564, KIAA1341, MEF-2"	ENSG00000104177	"Myelin expression factor 2"		15	48134631-48178517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 34.0;SCLC-21H: 30.4;SK-MEL-30: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA004883	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA004883: AB_1079436"	"unprognostic (4.30e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.76e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.55e-5)"	"unprognostic (1.32e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.05e-1)"	5.2	17.0	18.7	6.5	18.7	2.0	8.7	23.1	31.9	2.6	9.6	12.7	15.7	4.3	6.7	11.6	3.3	13.6	7.9	9.5	18.3	17.8	19.9	1.1	6.6	7.3	19.0	18.5	2.6	15.3	19.3	26.5	2.1	19.3	10.3	5.9	8.6	6.9	14.9	2.0	5.1	4.6	8.8	20.8	6.6	8.7	28.2	11.4	7.6	6.4	0.9	8.3	5.0	2.2	1.8	1.1	0.0	0.0	1.9	1.4	0.2	0.1	9.8	34.0	21.2	0.3	0.0	0.0	10.3	2.7	5.2	2.3	3.9	4.2	7.1	13.5	2.3	0.0	14.2	0.6	7.1	19.3	5.4	4.3	0.0	1.6	1.7	4.9	3.5	0.1	0.4	0.0	0.7	9.4	0.7	10.1	4.2	5.6	7.5	0.0	14.6	1.7	0.0	2.6	0.2	17.1	1.8	30.4	23.4	0.0	3.0	29.7	16.3	6.3	6.0	1.6	8.2	6.3	23.8	4.5	17.1	0.0	3.1	0.0	6.6	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.5	0.5	1.0	0.2	1.4	0.5	0.0	1.9	0.0	1.1	1.0	0.2	18.7	18.7	23.1	24.0	18.3	17.8	19.0	18.5	19.3	11.4
MYF5	bHLHc2	ENSG00000111049	"Myogenic factor 5"	P13349	12	80716912-80719673	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"skeletal muscle: 23.1;tongue: 13.0"	"Cell line enriched"	"Detected in some"	22	"LHCN-M2: 102.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041691			Supported	Nucleoplasm				Nucleoplasm		"HPA041691: AB_10796780"						"unprognostic (2.65e-2)"												0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474205-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"			130000000	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: , HPA057198: "	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavourable (6.42e-4)"	18.3	12.3	12.6	5.4	24.7	7.9	9.6	15.6	30.8	16.9	7.3	5.4	5.3	1.9	19.9	12.4	5.0	18.0	18.2	25.7	15.1	12.9	23.7	13.0	40.0	4.2	9.5	16.7	21.8	6.9	14.7	18.4	35.9	19.2	12.9	3.1	8.6	4.7	19.6	3.3	5.1	3.9	15.7	4.9	3.3	7.1	5.3	5.9	2.7	9.7	2.6	3.0	9.8	7.4	0.5	0.2	2.8	0.1	0.0	1.1	0.2	13.6	9.0	57.2	19.1	7.5	9.0	25.7	11.4	10.4	13.8	14.9	24.2	2.1	0.1	7.6	11.3	1.3	28.4	13.7	15.6	0.3	23.1	15.8	5.8	21.0	17.5	1.3	1.1	12.8	5.0	17.9	6.9	22.3	21.9	0.0	8.6	5.4	16.7	0.4	26.9	2.0	26.8	17.0	0.0	15.7	5.7	4.7	25.7	17.9	0.9	18.3	4.8	0.9	0.7	13.0	9.6	0.1	9.8	2.2	2.6	3.4	0.0	1.3	29.2	0.0	0.1	0.1	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.2	1.1	0.5	2.8	0.0	0.0	0.2	0.3	0.2	12.6	24.7	15.6	30.8	15.1	12.9	9.5	16.7	19.2	5.9
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703172-15857033	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 507.4;urinary bladder: 394.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;NB-4: 3.8;U-698: 9.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 173.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 54.5"	"CAB002302, HPA014539, HPA015310"	Enhanced		Supported	"Plasma membrane,Cytosol"			130000000	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1854260, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	13.2	3.0	0.6	31.5	1.2	0.0	5.9	0.5	1.7	90.3	227.5	1.3	100.0	11.6	102.0	38.4	233.0	43.8	94.3	6.2	0.6	0.7	4.7	0.7	8.5	1.5	1.4	2.6	45.5	1.3	0.0	1.0	5.3	3.6	164.7	22.2	37.0	8.8	127.2	6.4	5.0	50.6	507.4	1.4	3.7	77.7	22.3	0.2	0.1	3.7	6.2	3.0	394.5	57.5	1.5	0.9	6.0	0.9	1.1	1.5	0.4	0.1	0.4	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.3	3.8	0.4	0.1	0.4	0.1	1.9	0.0	0.2	0.7	1.4	0.2	0.5	1.2	0.4	0.0	0.3	0.1	0.3	2.0	0.1	0.4	0.4	9.7	0.4	0.4	0.4	3.1	0.9	2.7	1.2	0.6	1.2	1.5	1.5	1.4	0.5	1.2	1.4	1.4	6.0	1.1	0.6	0.9	1.4	0.4	0.6	1.2	0.5	1.7	0.6	0.7	1.4	2.6	3.6	0.2
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281277-36388067	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"			3100000000	"Plasma membrane, Actin filaments"	Cytosol	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	115.5	26.1	11.9	43.7	12.9	55.6	59.0	9.3	16.8	67.1	44.6	18.0	26.4	26.9	120.8	39.7	48.3	45.6	66.9	39.2	11.0	8.1	45.0	42.8	74.4	57.7	15.1	9.2	56.4	43.9	19.0	15.4	65.7	17.9	47.6	23.6	32.4	66.2	27.2	36.9	40.3	49.8	46.7	13.5	91.5	37.1	25.8	11.9	76.0	42.5	38.4	65.0	56.0	53.7	6.9	8.2	28.5	11.5	4.2	16.6	19.3	60.6	28.2	9.0	7.6	16.8	21.1	45.7	40.7	52.7	58.2	43.7	30.4	17.5	15.7	24.2	68.1	42.1	13.1	79.7	60.0	35.4	12.4	30.3	30.3	25.9	51.5	34.4	48.6	24.9	24.6	78.6	66.8	47.9	6.6	21.3	46.5	16.1	12.2	20.3	5.3	17.4	23.3	27.9	14.6	32.9	59.1	13.5	5.5	57.2	22.5	26.2	16.8	17.8	137.0	129.1	39.2	24.7	73.5	14.1	11.1	13.3	48.9	17.4	37.4	26.8	10.4	28.5	16.6	9.6	14.7	6.9	12.0	13.2	8.2	6.4	9.6	10.1	19.7	4.2	11.5	3.8	12.6	19.3	11.9	12.9	9.3	16.8	11.0	8.1	15.1	9.2	17.9	11.9
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell line enhanced"	"Detected in many"		"BJ: 36.5;BJ hTERT+: 55.2;fHDF/TERT166: 45.0;HBF TERT88: 29.0;RPTEC TERT1: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"			3000000	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: "	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.1	1.3	2.1	0.4	0.9	36.5	55.2	23.6	17.0	1.6	1.4	0.1	8.2	45.0	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	11.0	0.1	1.9	6.8	0.7	4.6	6.9	1.8	0.2	0.1	17.5	0.3	0.0	0.5	2.2	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 176.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;RH-30: 13.2;RPMI-8226: 10.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA059704: , HPA059890: "	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favourable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	1.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	176.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	18.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.8	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	1.0	0.2	5.2	0.1	0.8	0.7	0.4	0.6	0.4	0.7	13.2	10.7	0.1	0.1	0.7	0.6	3.4	0.1	0.0	0.1	0.1	2.6	0.2	1.0	0.6	2.9	0.1	0.9	0.2	0.2	3.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MYNN	"SBBIZ1, ZBTB31, ZNF902"	ENSG00000085274	Myoneurin	Q9NPC7	3	169772831-169789716	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045149	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA045149: AB_10960839"	"unprognostic (7.13e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.36e-3)"	20.3	10.3	10.3	10.6	13.3	22.4	16.4	29.7	15.3	18.4	12.3	8.9	17.7	8.8	17.7	10.9	15.4	15.1	10.5	12.1	13.0	9.0	13.5	13.7	11.4	13.6	12.9	13.7	22.4	15.8	16.2	18.4	17.5	16.0	16.7	12.0	7.7	12.5	11.6	17.9	13.0	16.4	14.3	12.4	16.3	14.3	16.1	15.8	17.5	15.4	13.1	15.9	15.3	12.9	8.2	5.2	19.0	5.0	10.0	10.6	7.6	9.3	4.2	5.2	10.1	10.7	9.2	6.6	6.7	9.0	9.6	10.7	5.3	9.7	14.5	11.6	6.8	7.6	9.1	7.9	12.8	13.0	7.2	13.6	6.3	5.1	9.2	12.2	9.9	8.1	10.2	5.9	17.2	8.4	5.6	14.5	9.5	7.9	7.1	6.3	7.8	4.9	7.9	7.2	14.9	6.3	16.1	7.3	8.7	7.8	17.4	10.5	21.3	8.9	6.5	8.9	4.3	8.3	12.1	17.2	11.9	19.7	7.2	7.7	8.7	19.0	5.0	11.9	7.6	5.0	10.2	8.2	8.7	7.2	5.1	8.1	10.6	8.4	13.5	10.0	4.1	5.2	8.4	7.6	10.3	13.3	29.7	15.3	13.0	9.0	12.9	13.7	16.0	15.8
MYO10	KIAA0799	ENSG00000145555	"Myosin X"	Q9HD67	5	16661914-16936276	"Plasma proteins, Predicted intracellular proteins"	Transport	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 38.8;SK-MEL-30: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015224, HPA024223"	Enhanced		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"CAB015224: , HPA024223: AB_1854248"	"unprognostic (1.13e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (8.93e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.84e-1)"	10.5	3.4	28.1	5.1	30.1	3.0	8.0	8.9	39.7	6.3	15.3	17.3	6.6	19.5	5.7	4.3	7.7	3.8	7.7	3.7	26.2	10.9	13.3	7.1	14.5	1.6	14.6	15.3	12.1	22.0	10.4	16.2	22.0	10.6	5.4	15.8	19.7	9.8	7.4	6.6	13.4	14.6	4.3	11.1	10.9	24.2	12.4	18.5	0.5	28.6	3.3	2.3	6.6	7.1	0.9	0.5	1.1	6.0	0.5	0.6	0.3	13.1	20.9	8.7	4.1	6.4	3.5	8.0	23.6	16.7	6.6	5.4	13.2	2.2	0.4	16.2	10.7	7.0	38.8	15.5	12.3	0.0	3.9	0.0	34.9	3.7	23.6	0.1	0.4	7.1	6.8	15.9	19.0	22.0	0.0	1.3	6.4	2.6	0.0	0.1	22.5	7.6	5.3	2.2	13.9	6.6	10.2	1.1	0.6	5.1	2.6	45.3	1.7	2.1	26.6	16.0	5.9	0.2	12.9	0.2	0.1	0.1	7.9	2.5	15.9	1.0	0.6	0.5	0.3	1.5	0.4	0.3	0.4	0.3	0.5	0.9	0.6	0.6	1.1	0.5	6.0	0.4	0.3	0.3	28.1	30.1	8.9	20.7	26.2	10.9	14.6	15.3	10.6	18.5
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"		22	25742144-26031041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 141.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.6;REH: 10.9;RH-30: 23.3;U-2 OS: 10.3;U-266/70: 7.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.0	0.0	141.2	0.1	0.0	1.5	0.0	0.0	0.3	2.4	0.0	0.3	1.1	16.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	3.9	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.9	0.7	2.9	0.0	0.3	1.1	0.0	0.0	10.9	23.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYO19	"FLJ22865, MYOHD1"	ENSG00000278259	"Myosin XIX"	Q96H55	17	36495633-36543435	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059715	Approved		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA059715: "	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavourable (8.33e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.17e-2)"	5.2	1.9	3.1	5.4	6.2	7.8	4.7	2.7	6.5	4.7	7.7	7.0	6.8	7.5	4.3	4.1	9.8	3.4	4.1	1.4	4.7		5.7	7.0	3.8	5.2	6.1	3.1	2.9	5.8	9.8	7.2	8.1	5.0	2.8	11.2	4.8	9.5	9.3	6.3	13.1	7.9	5.2	5.4	3.0	8.3	8.0	5.7	5.8	4.2	5.6	7.2	3.3	2.8	2.2	3.4	1.7	1.7	3.7	3.9	1.4	13.8	17.0	8.1	9.3	4.5	4.5	9.9	13.8	11.0	22.0	22.5	16.8	14.5	8.7	5.5	9.4	21.0	19.2	14.5	15.8	6.2	13.0	13.9	18.6	10.5	3.0	13.5	15.2	4.2	7.2	15.7	17.2	9.8	16.3	9.2	11.1	10.5	9.4	11.0	9.0	10.0	10.9	13.1	10.3	10.3	11.3	14.0	8.7	18.4	11.3	5.8	18.5	5.5	6.3	12.4	14.0	16.8	24.3	7.1	14.0	8.0	7.7	8.3	14.4	1.7	1.7	1.7	3.8	1.2	2.8	2.2	2.4	2.6	3.4	1.7	1.7	3.9	0.1	3.7	0.5	1.9	2.0	1.4										
MYO1B	myr1	ENSG00000128641	"Myosin IB"	O43795	2	191245185-191425389	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 92.7"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.7;naive B-cell: 2.7;naive CD4 T-cell: 1.2"	"Group enriched"	"Detected in many"	4	"B-cells: 2.7;T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013607, HPA060144"	Approved		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA013607: AB_1854251, HPA060144: "	"unprognostic (4.11e-3)"	"unprognostic (7.36e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.83e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.85e-2)"	"unprognostic (4.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	18.8	2.5	3.3	5.9	4.3	0.2	21.8	1.4	4.7	8.2	8.0	2.1	21.6	4.2	11.8	8.2	9.0	4.9	8.9	11.6	3.6	3.1	12.2	92.7	34.5	6.6	3.6	2.3	7.8	34.3	15.0	3.1	15.7	4.4	8.5	7.4	5.8	7.5	18.6	9.3	7.5	5.4	6.7	2.7	6.6	5.0	3.6	2.0	3.6	9.3	10.4	4.8	10.3	9.9	2.7	0.4	0.0	0.0	0.0	1.2	0.0	19.9	10.3	16.8	5.0	4.6	20.0	15.2	38.1	18.9	26.4	26.3	12.6	1.8	0.0	6.3	43.7	44.3	5.5	32.8	33.3	0.0	4.8	0.0	4.8	16.1	10.9	0.4	0.1	8.0	22.7	27.5	74.3	4.8	0.0	0.0	24.3	8.4	7.6	2.4	10.9	16.4	9.8	10.7	1.5	10.3	8.5	8.5	22.4	12.9	2.2	11.5	2.0	0.6	5.8	25.3	12.7	15.2	4.4	0.1	0.0	0.2	15.3	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.3	4.3	1.4	4.7	3.6	3.1	3.6	2.3	4.4	2.0
MYO1C	myr2	ENSG00000197879	"Myosin IC"	O00159	17	1464186-1492812	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001768, HPA005924, CAB037023"	Enhanced		Enhanced	"Nuclear bodies,Plasma membrane"			30000	"Nuclear bodies, Plasma membrane"		"CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: "	"unprognostic (3.60e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (5.22e-4)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.47e-2)"	61.5	8.6	3.3	20.1	4.1	0.9	45.7	4.4	4.3	33.8	35.5	5.3	17.2	14.0	36.0	20.5	34.3	20.3	38.2	29.3	3.3	2.5	24.8	24.8	30.3	13.4	3.3	3.8	23.7	44.8	8.6	7.6	32.2	6.1	27.4	12.7	20.0	44.5	19.0	20.0	17.1	29.9	40.8	3.6	12.3	24.2	12.6	2.9	9.4	23.0	21.3	18.6	32.0	32.4	7.9	1.7	0.8	3.1	0.0	3.5	2.2	35.5	39.1	4.2	17.3	19.9	19.8	16.3	36.3	30.2	24.0	20.2	26.0	19.6	3.5	26.3	55.9	30.2	6.3	25.2	12.5	15.8	16.0	3.4	21.3	9.5	29.6	0.3	18.0	15.4	12.6	22.0	12.7	30.8	2.7	3.0	20.3	27.1	0.4	0.2	2.7	7.2	1.4	5.8	6.4	22.0	18.6	1.7	9.5	22.8	33.4	14.6	27.3	1.8	40.4	34.8	26.8	17.0	31.3	2.3	1.8	1.5	27.7	0.8	30.1	0.2	1.3	0.0	1.5	3.1	0.8	7.9	3.5	1.6	1.7	6.7	1.3	0.7	0.8	0.0	2.6	1.6	3.0	2.2	3.3	4.1	4.4	4.3	3.3	2.5	3.3	3.8	6.1	2.9
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.6;SCLC-21H: 2.4;U-2 OS: 4.3;U-698: 10.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA048951, HPA051893"	Approved		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"				"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA048951: , HPA051893: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	1.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8
MYO5C	MGC74969	ENSG00000128833	"Myosin VC"	Q9NQX4	15	52192322-52295798	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 13.1;MCF7: 23.4;RT4: 13.6;SK-BR-3: 17.9;T-47d: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020790, HPA032115, HPA032116"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB020790: , HPA032115: , HPA032116: "	"unprognostic (1.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-2)"	"prognostic favourable (5.18e-5)"	"unprognostic (2.94e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.82e-2)"	"prognostic favourable (2.47e-5)"	"prognostic favourable (5.82e-4)"	"unprognostic (9.15e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.32e-1)"	11.2	1.5	2.7	4.0	4.0	0.4	10.7	14.7	3.4	11.1	10.0	3.4	9.5	3.7	3.7	9.8	6.6	8.6	12.2	1.7	2.5	1.7	6.4	2.7	11.4	1.2	2.6	3.0	2.6	33.9	18.5	7.8	2.1	7.5	7.8	13.2	6.5	22.6	12.8	2.1	4.3	4.1	4.2	4.3	2.7	14.2	4.7	3.4	0.5	15.1	3.7	3.8	4.5	18.4	1.2	1.6	1.5	0.0	0.0	2.9	0.1	10.8	13.1	1.8	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	2.0	4.6	0.6	2.8	0.0	1.8	2.7	3.8	0.0	0.5	4.4	0.0	9.3	8.0	0.0	0.0	0.1	0.0	3.8	0.0	3.6	2.9	0.0	0.2	0.0	23.4	0.6	0.1	0.7	6.2	8.9	1.1	5.4	10.4	13.6	1.9	2.0	0.8	17.9	0.0	21.5	0.0	0.0	0.0	0.1	0.0	1.7	0.3	0.3	1.1	0.1	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.2	0.2	1.0	0.4	0.4	0.3	1.5	0.0	0.0	1.6	2.9	0.1	2.7	4.0	14.7	3.4	2.5	1.7	2.6	3.0	7.5	3.4
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 8.6;MAIT T-cell: 4.0;memory CD4 T-cell: 2.7;memory CD8 T-cell: 4.9;naive CD8 T-cell: 4.8;NK-cell: 3.3"	"Group enriched"	"Detected in many"	20	"NK-cells: 3.3;T-cells: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: "	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favourable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	8.4	9.1	18.2	9.0	27.0	0.9	26.9	17.1	24.1	16.2	18.9	26.8	28.7	30.0	7.5	25.9	28.1	10.0	23.1	4.9	19.1	12.2	44.0	13.8	20.5	4.5	24.0	17.9	4.6	18.5	42.2	24.2	7.1	19.0	16.0	17.3	11.9	23.3	33.7	4.2	14.1	27.7	8.0	21.2	6.7	23.9	14.3	28.2	0.9	13.4	9.1	10.9	16.1	13.1	0.2	0.0	0.1	0.1	3.3	8.6	1.2	22.3	6.0	4.9	3.4	11.7	9.5	19.2	7.9	8.4	5.9	7.7	9.0	20.2	0.0	7.8	8.9	17.7	5.7	11.4	6.7	9.4	11.7	6.4	2.0	5.5	10.0	0.0	9.3	6.7	8.3	8.0	6.3	16.4	8.4	3.3	6.0	21.5	0.0	0.2	3.2	1.6	0.3	11.6	0.4	21.9	42.7	10.0	6.6	2.0	20.1	3.4	8.6	13.1	23.9	6.5	5.6	0.3	7.1	6.8	6.8	0.0	4.0	0.0	2.3	0.1	0.0	0.0	8.6	0.0	4.0	0.2	2.7	4.9	0.0	0.0	0.6	4.8	0.1	3.3	0.1	0.0	0.1	1.2	18.2	27.0	17.1	24.1	19.1	12.2	24.0	17.9	19.0	28.2
MYO9B	CELIAC4	ENSG00000099331	"Myosin IXB"	Q13459	19	17075781-17214537	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, GTPase activation, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037190, HPA042043"	Approved		Supported	Cytosol				Cytosol		"CAB037190: AB_477214, HPA042043: AB_10796897"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (5.66e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.53e-2)"	17.4	14.3	14.3	34.7	30.2	59.3	16.0	16.2	25.0	12.7	15.3	40.1	10.6	12.5	16.2	12.8	11.0	10.0	14.9	11.2	16.0	11.8	9.4	12.9	25.0	37.4	38.8	10.7	8.2	9.0	6.7	9.2	15.2	18.8	15.6	11.1	14.7	12.3	10.7	4.8	13.5	20.3	17.2	27.8	55.9	15.2	21.8	28.2	17.4	9.2	5.4	24.8	17.2	16.2	3.3	4.4	14.4	4.7	2.9	3.9	1.9	18.9	8.8	11.8	13.8	8.6	9.1	34.2	18.0	9.3	11.4	10.0	7.1	9.7	17.7	10.1	15.8	11.9	5.0	8.8	8.6	31.5	10.3	21.3	10.4	6.7	11.0	16.6	34.4	8.3	4.6	15.7	6.2	11.9	8.7	12.1	7.8	7.9	22.5	31.0	8.9	19.6	24.7	8.9	5.0	4.5	16.1	4.0	9.1	11.2	8.9	23.2	8.8	17.5	22.9	21.3	9.5	32.8	15.1	17.4	11.0	11.4	21.0	21.8	26.4	4.2	3.8	6.6	3.4	4.7	2.1	3.3	2.5	2.7	2.2	3.0	1.6	2.4	14.4	2.9	2.8	4.4	3.9	1.9	14.3	30.2	16.2	25.0	16.0	11.8	38.8	10.7	18.8	28.2
MYOD1	"bHLHc1, MYF3, MYOD, PUM"	ENSG00000129152	"Myogenic differentiation 1"	P15172	11	17719568-17722131	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 31.8"	"Cell line enriched"	"Detected in some"	15	"RH-30: 101.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 0.5"	"HPA055436, HPA078647"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA055436: , HPA078647: "						"unprognostic (1.07e-3)"				"unprognostic (2.10e-1)"					"unprognostic (1.01e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	4.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	101.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0
MYOF	"FER1L3, KIAA1207"	ENSG00000138119	Myoferlin	Q9NZM1	10	93306429-93482317	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 15.9;non-classical monocyte: 18.0"	"Group enriched"	"Detected in many"	65	"dendritic cells: 6.2;monocytes: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014245	Enhanced		Supported	"Vesicles,Plasma membrane"			14000	Vesicles	"Plasma membrane"	"HPA014245: AB_1848495"	"unprognostic (3.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.17e-2)"	"unprognostic (9.18e-2)"	27.5	7.3	2.1	8.9	4.1	0.2	21.7	1.3	2.7	27.0	12.3	5.1	16.0	2.0	27.2	17.7	27.2	16.2	11.4	7.2	3.5	2.1	12.2	1.7	18.7	7.5	5.8	2.5	12.7	3.3	16.1	4.2	31.9	15.0	20.7	12.8	10.1	14.9	17.4	5.7	22.4	6.8	49.0	9.4	10.0	8.8	5.7	4.4	1.5	15.7	14.2	9.4	35.0	20.0	0.0	6.2	0.1	18.0	0.0	0.1	1.1	35.7	33.8	3.6	2.3	25.3	56.3	10.2	31.5	75.3	19.2	19.0	8.2	28.1	0.0	12.6	57.5	54.7	0.2	32.2	14.2	0.2	0.1	0.0	13.2	0.3	8.8	0.0	0.0	29.6	11.2	12.9	53.0	49.7	0.0	0.0	45.1	5.7	0.0	0.1	0.2	30.2	0.0	2.6	0.0	49.8	44.7	0.0	0.0	21.5	4.5	7.9	22.4	0.7	62.1	28.3	1.9	18.6	18.3	0.0	0.0	0.0	20.9	0.4	33.3	0.0	4.3	0.0	0.0	15.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	18.0	2.1	0.1	1.1	2.1	4.1	1.3	2.7	3.5	2.1	5.8	2.5	15.0	4.4
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083132-203086036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 60.0"	"Group enriched"	"Detected in some"	200	"HSkMC: 17.6;RH-30: 33.6"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028336			Supported	Nucleoplasm				Nucleoplasm		"HPA028336: "	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.0	0.0	2.4	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.7	13.3	1.7	0.0	0.0	0.8	0.8	2.3	1.3	1.8	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.8	0.4	0.7	1.0	0.8	0.5	0.6	0.3	0.6	0.9	1.0	1.4	1.8	1.3	0.8	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58654739-58700092	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA067133"	Approved		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA054291: , HPA067133: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favourable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	13.2	12.3	14.1	14.4	15.7	24.4	17.3	16.9	24.3	14.3	13.7	11.4	11.9	12.5	17.5	14.3	13.5	13.0	9.9	14.1	11.7	8.1	11.0	11.0	12.9	14.3	14.0	13.3	18.1	14.0	16.5	19.2	11.3	18.0	14.4	11.6	9.3	15.5	15.2	23.2	20.4	14.6	13.7	15.2	14.2	11.5	8.3	14.7	11.9	15.5	10.6	12.9	13.3	14.7	1.1	0.7	2.2	2.1	0.2	2.3	0.5	8.2	2.4	6.1	6.5	5.6	7.2	8.8	4.9	5.5	4.9	4.3	4.1	3.6	8.6	1.5	3.7	6.3	6.7	2.9	9.5	5.8	4.6	10.3	1.1	4.5	6.8	15.6	7.9	5.2	4.9	6.4	3.3	1.2	11.0	5.5	5.6	2.8	7.7	13.1	9.7	4.5	6.5	14.8	5.3	4.0	3.2	5.1	4.9	4.2	8.2	11.6	2.5	8.9	4.0	8.8	4.0	6.8	9.4	10.1	4.7	11.4	5.1	11.4	9.6	0.8	0.7	0.5	2.0	1.0	1.4	0.9	1.4	1.6	0.6	1.1	2.3	1.1	2.2	0.2	2.1	0.7	1.4	0.5	14.1	15.7	16.9	24.3	11.7	8.1	14.0	13.3	18.0	14.7
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 69.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;REH: 13.0;SCLC-21H: 16.2;SH-SY5Y: 4.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	13	"cerebellum: 69.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.4	7.4	4.3	0.5	5.0	2.4	0.4	69.5	11.0	0.3	0.7	2.7	0.0	0.9	0.4	0.5	0.3	0.6	0.5	0.8	4.2	5.3	0.6	0.4	0.4	0.4	3.7	2.2	0.4	4.7	0.4	3.7	0.4	5.1	0.6	0.6	3.7	0.3	0.4	0.3	0.4	0.6	0.4	2.0	0.5	1.0	2.1	4.8	0.0	1.4	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.6	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.4	0.0	0.7	0.2	13.0	0.0	0.0	0.0	0.0	16.2	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.3	5.0	69.5	3.1	4.2	5.3	3.7	2.2	5.1	4.8
MZF1	"MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6"	ENSG00000099326	"Myeloid zinc finger 1"	P28698	19	58561931-58573575	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 27.3;HeLa: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001757	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA001757: AB_1080718"	"unprognostic (8.25e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.16e-3)"	"unprognostic (7.15e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.62e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.03e-2)"	"prognostic favourable (7.97e-4)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (2.83e-8)"	"unprognostic (1.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.64e-2)"	"prognostic favourable (4.09e-5)"	7.8	14.2	16.9	10.9	17.4	9.4	8.1	20.3	18.8	12.5	9.4	12.4	24.8	19.6	13.6	13.4	8.7	16.6	13.5	6.7	15.4	9.7	11.7	9.8	12.5	9.9	13.9	14.8	15.9	15.2	17.5	26.0	6.8	13.7	13.8	7.8	12.4	16.7	21.5	9.7	11.6	17.0	9.6	9.6	11.7	14.7	9.0	16.1	8.3	18.1	5.2	9.4	11.0	9.8	3.5	2.3	2.3	1.2	6.6	9.0	3.4	4.6	12.1	5.0	3.2	2.9	2.6	6.0	4.2	2.2	0.7	1.5	2.5	5.7	3.3	2.1	1.2	5.2	1.3	3.0	0.4	5.8	27.3	3.5	20.9	1.4	1.8	2.7	6.1	1.7	7.8	1.1	3.4	2.6	2.9	4.3	1.1	5.2	1.5	1.4	1.8	4.8	4.1	1.2	6.0	2.7	10.2	4.7	6.7	2.0	4.1	2.6	4.2	3.5	2.9	8.0	2.5	1.4	2.1	7.3	8.3	2.8	6.4	2.9	1.9	0.0	1.2	0.6	3.3	0.9	4.9	3.2	5.4	3.8	2.3	3.5	9.0	5.6	2.3	6.6	0.9	0.6	3.2	3.4	16.9	17.4	20.3	18.8	15.4	9.7	13.9	14.8	13.7	16.1
MZT2A	"FAM128A, MOZART2A"	ENSG00000173272	"Mitotic spindle organizing protein 2A"	Q6P582	2	131464900-131492743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.9"	"Low lineage specificity"	"Detected in all"											"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA051758: , HPA052623: "	"prognostic favourable (3.04e-4)"	"unprognostic (3.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (3.04e-11)"	"unprognostic (1.51e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-1)"	17.7	17.1	34.7	22.1	22.6	31.3	17.1	9.6	25.1	17.5	20.3	7.6	23.0	30.0	11.9	22.3	23.5	14.0	17.5	57.5	28.0	20.7	14.4	15.9	7.5	15.6	18.9	16.4	20.8	55.4	5.6	7.2	5.3	8.8	16.4	3.4	9.3	48.5	19.7	40.7	12.6	22.8	17.3	12.0	15.5	24.0	11.1	5.5	28.3	17.8	23.8	17.0	16.2	12.8	11.9	5.4	31.9	1.0	2.6	9.3	2.2	35.6	19.2	0.4	7.4	0.5	1.3	7.7	12.1	2.8	4.7	4.6	47.2	12.3	23.1	15.7	0.5	16.1	1.2	8.1	0.1	9.1	58.8	9.5	21.6	55.8	2.9	16.6	3.6	3.7	4.4	3.0	1.4	3.8	18.7	24.4	1.1	32.2	23.0	70.0	12.5	44.1	19.6	6.7	51.7	2.9	16.5	28.0	3.5	12.3	8.4	22.0	13.1	30.0	10.6	12.3	29.8	5.2	11.8	22.8	16.9	18.6	17.2	10.8	7.3	6.9	1.0	31.9	3.8	0.6	4.2	11.9	8.5	4.9	3.4	6.2	9.3	4.5	0.4	2.6	0.3	5.4	8.4	2.2	34.7	22.6	9.6	23.1	28.0	20.7	18.9	16.4	8.8	5.5
MZT2B	"FAM128B, FLJ14346, MOZART2B"	ENSG00000152082	"Mitotic spindle organizing protein 2B"	Q6NZ67	2	130181737-130190729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA051758: , HPA052623: "	"unprognostic (8.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (9.65e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (9.37e-8)"	"unprognostic (1.67e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-1)"	28.9	39.1	50.8	23.9	33.5	63.4	23.8	19.5	35.1	24.3	31.3	14.4	27.7	34.2	24.7	24.0	30.6	19.4	26.7	56.6	33.7	29.3	22.5	31.1	14.4	27.8	32.8	33.3	31.0	104.2	10.9	17.1	16.2	19.7	28.4	11.6	18.6	63.6	24.9	87.5	20.9	32.1	31.8	21.7	26.8	33.8	26.1	15.4	35.3	36.0	27.1	22.2	24.4	34.9	15.3	21.7	31.7	9.3	12.1	13.3	4.9	40.8	17.3	4.4	21.0	1.7	6.4	20.4	19.6	7.3	7.6	5.5	35.3	21.3	22.5	30.6	4.4	23.2	2.3	6.4	1.2	33.3	53.5	12.1	25.3	38.5	7.5	16.0	12.1	6.9	9.1	5.1	2.5	8.3	16.0	33.7	5.4	47.4	35.8	93.1	14.0	31.7	41.8	11.0	70.6	4.5	13.5	30.5	37.2	11.8	21.4	31.8	25.3	47.3	14.8	21.9	35.5	17.5	18.5	41.1	25.6	27.7	33.0	23.7	15.8	0.1	9.3	31.7	7.7	9.1	6.2	15.3	11.3	10.7	11.2	14.8	13.3	10.7	4.6	12.1	8.4	21.7	8.7	4.9	50.8	33.5	19.5	35.1	33.7	29.3	32.8	33.3	19.7	15.4
N4BP3	LZTS4	ENSG00000145911	"NEDD4 binding protein 3"	O15049	5	178113443-178126087	"Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 7.9;MCF7: 10.6;RH-30: 10.7;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4"	"Group enriched"	"Detected in many"	18	"B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030972, HPA030973, HPA061387"	Approved		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: "	"unprognostic (1.84e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.88e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.55e-2)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	6.6	1.3	1.9	2.6	2.1	3.5	13.9	6.5	4.3	2.5	1.8	0.7	0.5	0.8	1.1	0.6	16.2	1.5	1.3	3.2	1.8	2.6	2.5	0.2	8.4	4.0	2.1	1.2	1.4	1.1	10.1	2.5	31.5	3.1	2.0	0.6	1.5	9.5	1.3	5.7	7.8	1.9	1.3	1.2	5.9	3.1	1.4	1.3	0.4	2.0	4.7	11.2	4.9	3.8	4.0	4.4	0.0	0.0	0.2	2.6	0.5	0.0	0.0	1.2	0.9	0.1	0.0	7.9	0.0	0.0	0.0	0.0	1.6	0.5	0.7	1.0	0.0	2.4	0.2	0.0	0.0	1.2	0.4	2.0	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	6.3	1.3	0.5	0.0	10.6	0.1	0.1	5.9	0.0	5.9	10.7	2.7	0.6	1.2	0.9	0.4	0.3	37.9	2.5	1.4	0.0	1.2	0.0	0.9	0.0	0.0	1.7	1.1	6.7	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.3	4.0	0.2	0.2	0.0	4.0	0.9	2.6	0.0	0.2	0.0	4.4	0.0	0.5	1.9	2.1	6.5	4.3	1.8	2.6	2.1	1.2	3.1	1.3
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: "	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	31.8	33.6	6.3	20.6	9.1	9.5	18.0	11.2	6.6	15.3	13.5	21.8	10.1	24.2	37.4	9.3	15.3	13.3	13.5	6.0	10.1	61.9	8.7	23.5	21.9	12.4	16.9	19.3	7.2	15.2	14.3	14.8	17.3	17.4	10.3	10.1	41.9	27.0	25.3	10.6	46.6	21.5	16.4	26.6	11.2	14.7	13.6	16.4	4.4	17.7	26.5	9.5	14.1	10.0	6.4	22.1	22.3	34.0	21.8	24.3	45.5	8.7	21.9	18.7	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N(alpha)-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326050	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	166	"placenta: 32.1;testis: 30.5"	"Group enriched"	"Detected in some"	6	"K-562: 9.1;U-266/70: 26.0;U-266/84: 8.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	32.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	30.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	26.0	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
NAA15	"FLJ13340, NARG1, NATH, TBDN100"	ENSG00000164134	"N(alpha)-acetyltransferase 15, NatA auxiliary subunit"	Q9BXJ9	4	139301455-139420033	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023589, HPA050661"	Approved		Enhanced	Cytosol				Cytosol		"HPA023589: AB_1854311, HPA050661: "	"unprognostic (6.25e-3)"	"unprognostic (5.95e-2)"	"unprognostic (7.80e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (2.16e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.58e-1)"	13.7	12.9	13.7	17.8	14.2	18.6	15.2	21.0	18.9	10.8	12.3	7.8	9.0	10.1	13.4	9.8	20.5	11.4	9.7	14.8	16.6	10.1	10.3	14.5	13.3	17.7	15.6	10.7	13.1	11.4	16.8	20.3	14.0	13.8	11.6	12.6	6.7	13.8	10.4	54.4	13.8	10.3	19.3	22.2	12.2	11.4	17.6	15.9	18.0	12.2	22.3	19.9	15.3	15.1	8.7	7.1	4.1	5.6	6.8	9.4	3.1	16.9	12.4	12.0	19.4	8.8	10.8	14.9	16.4	10.8	15.9	12.3	17.5	14.9	34.8	10.1	13.5	11.0	31.5	20.1	22.9	16.2	11.6	18.7	12.0	11.4	9.4	34.0	12.2	7.6	12.3	20.0	15.7	15.8	34.5	15.3	16.8	13.5	32.4	10.2	20.1	9.9	20.3	16.2	18.0	12.7	14.3	15.7	12.3	11.0	18.1	10.9	10.9	13.4	13.5	15.4	10.8	14.5	18.7	18.6	33.1	34.6	13.2	24.9	14.6	4.1	5.4	1.7	8.0	5.6	9.3	7.4	8.4	9.4	7.1	8.7	8.3	9.3	4.1	6.8	5.3	6.0	8.0	3.1	13.7	14.2	21.0	18.9	16.6	10.1	15.6	10.7	13.8	15.9
NAA16	"FLJ22054, MGC40612, NARG1L, PRO2435"	ENSG00000172766	"N(alpha)-acetyltransferase 16, NatA auxiliary subunit"	Q6N069	13	41311205-41377030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039761, HPA040157"	Approved		Enhanced	Cytosol				Cytosol		"HPA039761: AB_10795112, HPA040157: AB_10793917"	"unprognostic (2.09e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-2)"	7.2	6.3	8.4	6.1	9.6	25.5	6.7	20.0	13.2	7.7	6.0	5.1	5.3	5.6	10.0	4.3	7.9	9.0	5.0	5.3	7.5	3.7	4.4	4.0	6.3	9.0	8.5	5.8	8.0	25.7	5.1	9.6	5.0	6.6	6.5	4.4	4.5	7.0	8.3	8.3	7.9	6.5	10.0	7.9	5.5	6.7	9.2	9.7	8.3	5.7	4.0	5.1	8.7	21.1	3.0	2.7	4.8	2.4	5.4	8.2	2.2	6.5	5.4	13.5	9.9	4.8	6.2	5.3	8.0	6.7	8.0	7.1	6.4	5.1	10.9	3.9	6.4	9.1	7.0	5.2	9.8	6.6	14.2	13.3	5.3	6.3	5.2	14.9	9.0	4.2	3.7	3.3	6.2	7.8	6.0	6.0	5.1	5.2	15.4	4.2	11.6	7.4	11.5	5.6	8.9	6.3	5.9	4.6	10.7	7.3	7.1	2.8	4.3	8.2	5.7	5.5	4.5	8.7	6.2	4.2	4.8	12.7	7.0	6.4	6.5	4.3	2.4	4.8	3.9	1.3	3.8	1.6	4.5	4.1	1.3	3.0	8.2	8.2	1.3	5.4	1.8	2.7	3.3	2.2	8.4	9.6	20.0	13.2	7.5	3.7	8.5	5.8	6.6	9.7
NAA20	"dJ1002M8.1, NAT3, NAT5"	ENSG00000173418	"N(alpha)-acetyltransferase 20, NatB catalytic subunit"	P61599	20	20017116-20033655	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063344			Supported	Cytosol				Cytosol		"HPA063344: "	"unprognostic (2.94e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	15.9	20.0	14.2	10.0	21.4	17.4	23.2	15.5	34.1	17.3	12.7	12.0	22.7	9.7	20.5	17.7	58.4	15.8	12.3	24.1	14.7	14.1	24.6	25.0	15.7	19.0	13.1	18.3	12.9	43.2	24.8	20.0	18.5	19.4	14.4	12.2	11.2	22.0	20.6	35.2	15.6	11.0	17.3	13.1	11.0	14.5	43.7	10.2	9.5	23.6	37.5	22.1	14.0	23.7	18.6	28.3	20.4	27.5	17.7	25.8	26.4	40.2	24.5	8.8	13.8	18.7	19.7	13.3	29.8	20.4	26.9	25.2	12.5	29.3	21.9	16.2	20.1	32.0	15.1	47.8	21.9	9.8	16.4	16.4	6.5	18.7	26.8	17.3	12.2	22.4	31.5	27.2	27.5	23.0	26.5	22.6	23.4	31.6	24.3	18.0	6.9	40.0	13.4	34.8	29.0	26.4	9.3	16.8	11.4	18.0	50.9	24.9	31.4	27.9	25.0	22.3	13.1	26.8	27.3	24.6	30.7	23.6	13.6	15.2	15.9	8.0	27.5	20.4	17.6	27.5	25.8	18.6	20.5	20.2	28.3	16.5	19.9	22.0	3.6	17.7	23.2	22.9	20.8	26.4	14.2	21.4	15.5	34.1	14.7	14.1	13.1	18.3	19.4	10.2
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N(alpha)-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112109022	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavourable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	12.8	11.4	12.7	12.3	19.3	18.4	14.9	21.0	17.0	10.4	11.7	17.9	11.2	8.3	18.1	10.3	14.7	11.3	8.5	10.7	11.6	10.7	8.0	10.2	9.0	12.9	21.7	12.4	15.8	15.1	14.3	13.5	11.4	16.3	11.7	9.4	15.6	9.5	10.5	25.9	15.7	8.8	11.9	16.7	10.3	9.2	10.8	17.9	8.7	12.5	10.8	14.2	10.2	12.1	4.7	5.5	0.5	3.6	2.3	7.0	2.5	10.4	10.4	9.8	7.5	5.4	9.5	11.8	9.9	8.0	12.5	8.3	10.9	5.4	18.3	9.9	7.9	12.6	21.9	8.2	16.7	10.4	15.0	14.9	10.6	9.6	9.1	21.0	9.3	8.3	10.4	14.2	14.4	10.6	21.7	2.3	11.1	8.6	12.3	15.8	15.1	12.5	13.5	10.0	12.6	9.4	17.5	12.5	6.9	11.4	12.9	9.4	12.8	8.6	8.5	10.1	9.2	11.2	13.6	9.7	18.6	21.5	13.3	9.4	9.9	0.0	2.7	0.5	4.0	3.1	6.1	4.1	4.7	3.6	5.4	4.7	7.0	6.5	0.1	2.3	3.6	5.5	3.6	2.5	12.7	19.3	21.0	17.0	11.6	10.7	21.7	12.4	16.3	17.9
NAA30	"C14orf35, FLJ35355, MAK3, Mak3p, NAT12"	ENSG00000139977	"N(alpha)-acetyltransferase 30, NatC catalytic subunit"	Q147X3	14	57390544-57415917	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057824	Uncertain		Supported	Cytosol				Cytosol		"HPA057824: "	"unprognostic (5.13e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (1.25e-8)"	"unprognostic (1.77e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.63e-1)"	10.7	10.3	15.8	10.7	18.3	15.0	16.4	18.1	18.9	9.9	15.0	9.2	8.6	11.4	12.1	8.8	13.5	9.1	12.5	18.8	13.9	15.6	14.7	19.1	8.2	9.6	12.9	16.4	18.1	10.5	16.2	13.4	15.4	12.0	12.3	9.6	9.6	10.8	12.8	34.9	10.5	13.5	13.0	9.9	9.8	8.6	21.4	10.1	15.0	12.6	13.6	10.3	12.8	13.7	2.6	1.5	1.7	5.3	5.5	4.2	0.8	13.8	13.3	7.7	12.4	12.9	17.0	12.9	16.3	15.8	12.5	11.4	12.0	10.3	10.2	14.4	13.4	14.7	13.7	10.5	20.8	17.7	7.0	8.2	7.7	10.4	13.5	16.5	9.6	11.5	15.6	11.3	18.9	19.1	8.0	10.2	16.4	16.0	13.7	9.6	8.2	14.9	11.0	22.0	7.9	12.8	12.7	16.5	8.6	13.7	13.6	16.4	17.5	8.6	16.6	19.6	20.5	10.7	10.3	7.5	9.2	12.5	13.0	8.3	13.8	1.7	0.9	0.5	2.9	2.1	3.0	2.3	2.8	4.2	0.8	2.6	3.0	2.8	0.4	5.5	5.3	1.5	3.7	0.8	15.8	18.3	18.1	18.9	13.9	15.6	12.9	16.4	12.0	10.1
NAA35	"bA379P1.1, FLJ21613, FLJ22643, MAK10"	ENSG00000135040	"N(alpha)-acetyltransferase 35, NatC auxiliary subunit"	Q5VZE5	9	85941146-86022298	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021547, HPA051586"	Approved		Supported	Vesicles				Vesicles		"HPA021547: AB_1853505, HPA051586: "	"unprognostic (5.87e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (1.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-2)"	11.3	19.5	15.2	16.4	14.6	9.7	17.1	20.1	17.6	13.4	16.5	12.5	22.9	14.9	20.5	21.0	16.8	13.5	14.4	14.2	16.6	14.0	16.0	14.3	10.8	10.2	14.6	16.2	16.2	16.4	19.1	25.5	16.9	14.4	17.4	19.5	13.0	16.3	20.0	28.7	13.4	17.4	16.4	14.1	10.3	13.4	25.7	15.1	10.0	19.8	15.8	12.7	14.4	13.5	12.2	5.8	8.9	4.7	5.9	9.6	4.4	23.0	16.0	16.1	12.5	9.4	11.4	25.2	14.6	14.3	16.3	13.9	11.0	15.9	7.8	8.6	14.8	32.3	14.6	17.1	17.5	19.6	10.6	17.2	17.5	15.1	17.6	26.3	15.7	11.7	14.9	17.4	25.9	15.3	21.1	15.4	15.4	15.9	14.7	15.3	16.1	16.5	12.6	22.8	12.2	17.8	21.0	14.6	13.0	16.6	14.7	12.8	11.8	11.2	12.1	10.6	13.2	17.5	13.4	20.6	25.2	5.4	13.4	11.4	10.7	2.0	4.6	8.9	7.0	4.7	9.3	12.2	7.7	6.5	5.8	12.2	9.6	7.7	2.1	5.9	3.2	3.8	6.4	4.4	15.2	14.6	20.1	17.6	16.6	14.0	14.6	16.2	14.4	15.1
NAA38	"LSMD1, MGC14151, PFAAP2"	ENSG00000183011	"N(alpha)-acetyltransferase 38, NatC auxiliary subunit"	Q9BRA0	17	7856685-7885238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059189			Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA059189: "	"unprognostic (6.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.75e-2)"	24.4	38.7	55.9	20.5	51.0	41.8	23.8	25.1	60.7	22.1	27.0	18.7	16.2	20.1	17.2	22.9	19.8	30.1	28.1	34.2	41.4	37.2	26.1	27.6	18.4	26.3	45.9	36.2	15.8	33.3	17.9	21.3	15.0	32.1	26.7	18.1	19.7	37.5	33.2	74.5	16.5	18.2	23.8	34.2	22.3	22.2	26.6	25.6	14.6	18.7	39.8	20.0	18.0	15.9	66.0	84.4	68.7	71.8	35.5	52.1	70.5	27.6	51.0	28.6	29.1	16.0	17.8	9.9	12.9	15.0	24.0	20.1	19.1	11.9	19.1	22.0	13.6	22.8	15.3	23.9	6.0	28.3	69.5	29.1	57.7	27.7	15.5	8.1	22.6	25.8	13.3	15.7	10.3	23.2	6.0	21.0	13.9	33.3	29.2	19.3	6.4	59.4	30.1	13.2	12.6	21.9	15.6	12.7	24.5	10.1	24.4	18.3	15.0	21.4	12.4	16.1	11.6	13.0	36.1	8.7	8.8	7.0	27.2	33.8	15.7	68.7	71.8	47.6	47.7	59.1	43.6	66.0	50.9	48.6	84.4	57.1	46.1	47.8	51.7	35.5	56.4	76.8	52.1	70.5	55.9	51.0	25.1	60.7	41.4	37.2	45.9	36.2	32.1	25.6
NAALADL2		ENSG00000177694	"N-acetylated alpha-linked acidic dipeptidase like 2"	Q58DX5	3	174438573-175810552	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 29.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.5;BJ hTERT+: 4.1;fHDF/TERT166: 4.8;WM-115: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA012413, HPA017425, CAB025586"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275"	"unprognostic (7.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.29e-4)"	"unprognostic (3.44e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (3.66e-6)"	"unprognostic (7.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	4.9	2.3	2.2	4.6	3.7	0.8	7.0	1.9	2.7	8.3	8.3	5.4	23.8	2.4	9.7	10.5	2.3	5.0	8.9	5.4	2.5	1.8	7.0	3.7	3.3	1.3	2.3	2.0	5.4	3.9	20.6	3.0	6.4	4.0	9.6	3.3	4.4	17.0	29.3	1.8	3.2	6.6	6.0	3.6	2.6	4.5	1.9	2.9	4.9	3.5	2.6	1.7	8.7	5.0	0.1	1.7	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.2	0.0	3.5	11.5	0.1	2.3	4.1	0.5	0.7	0.1	1.2	0.0	0.4	4.8	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	3.2	0.6	0.1	0.0	0.4	0.0	0.1	2.3	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.1	1.7	0.2	0.0	0.0	0.2	0.2	0.8	3.1	0.1	0.5	2.2	0.1	0.1	0.5	0.0	0.0	0.0	1.5	0.0	4.5	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	1.7	0.0	0.0	2.2	3.7	1.9	2.7	2.5	1.8	2.3	2.0	4.0	2.9
NABP1	"DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2"	ENSG00000173559	"Nucleic acid binding protein 1"	Q96AH0	2	191678068-191696659	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054978, HPA067802"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054978: , HPA067802: "	"unprognostic (5.43e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.07e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (8.20e-7)"	"unprognostic (5.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.02e-2)"	20.8	4.9	2.4	26.0	2.3	4.2	22.2	1.1	2.1	4.4	14.1	1.9	1.6	13.3	6.7	9.2	12.1	4.9	8.1	6.9	4.7	2.0	8.8	8.7	18.6	39.6	3.9	1.3	4.9	6.3	0.8	4.4	28.0	6.1	4.7	5.2	2.6	6.2	3.9	3.1	4.3	30.6	4.7	5.3	40.0	4.6	18.4	1.5	7.4	3.6	12.1	23.0	8.7	8.8	3.8	2.2	18.6	7.7	1.6	14.2	1.9	14.7	2.3	0.3	0.4	11.2	13.6	3.9	23.0	18.9	14.3	8.6	12.2	8.3	0.8	18.3	13.8	4.2	2.1	9.8	15.8	7.7	1.9	7.3	4.7	3.1	8.2	3.4	8.4	17.8	12.3	20.5	14.7	5.4	10.3	32.6	22.3	1.2	1.1	3.9	1.3	11.6	2.5	2.5	6.9	21.4	10.9	0.5	0.1	7.9	2.7	6.4	0.7	2.2	13.6	12.0	10.1	6.3	14.4	10.7	4.4	3.0	9.9	4.1	2.1	2.5	4.0	1.9	6.4	6.7	8.7	3.8	8.6	6.6	2.2	0.6	2.2	3.8	18.6	1.6	7.7	1.4	14.2	1.9	2.4	2.3	1.1	1.9	4.7	2.0	3.9	1.3	6.1	1.5
NABP2	"hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1"	ENSG00000139579	"Nucleic acid binding protein 2"	Q9BQ15	12	56222015-56229854	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044615, HPA057213"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA044615: AB_10795884, HPA057213: "	"unprognostic (1.45e-1)"	"prognostic favourable (8.35e-6)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (7.44e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavourable (2.69e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-2)"	14.0	26.7	27.7	16.7	33.3	16.2	15.7	23.6	32.6	16.2	19.5	17.6	14.9	22.8	16.3	19.4	15.0	16.0	23.0	16.2	25.8	25.2	21.0	17.7	11.7	18.0	26.4	24.4	23.1	25.8	17.2	17.0	8.6	24.0	15.8	19.9	17.6	15.9	19.6	51.8	14.0	22.4	16.7	20.2	14.9	17.0	18.6	20.5	10.6	20.6	21.7	18.7	15.9	14.7	17.1	13.5	15.3	14.9	25.9	21.0	10.2	25.4	26.5	25.1	27.9	10.9	11.9	4.8	15.4	12.9	22.4	13.4	15.8	23.0	19.6	31.4	14.1	20.4	23.3	19.4	17.1	36.9	21.9	32.7	18.5	12.1	11.8	23.3	31.9	10.1	15.5	26.7	21.7	14.3	16.8	33.8	16.1	23.2	31.6	26.1	18.4	25.3	28.6	23.5	29.2	10.6	10.6	32.0	23.7	24.7	30.6	20.9	35.0	20.8	10.1	15.8	15.0	33.1	28.3	22.9	34.9	12.5	29.4	21.8	29.2	15.3	9.9	8.6	17.5	13.8	19.4	17.1	14.7	15.8	13.4	12.6	9.2	15.3	1.9	25.9	14.9	13.5	21.0	10.2	27.7	33.3	23.6	32.6	25.8	25.2	26.4	24.4	24.0	20.5
NACC1	"BEND8, BTBD14B, BTBD30, NAC-1, NAC1"	ENSG00000160877	"Nucleus accumbens associated 1"	Q96RE7	19	13118103-13141141	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021238, HPA062245, CAB069927"	Enhanced		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: "	"unprognostic (2.19e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.74e-2)"	12.5	13.7	27.2	18.2	22.3	10.0	6.7	19.8	38.7	10.8	16.6	20.1	11.7	16.6	12.8	10.0	17.9	10.5	9.4	13.2	23.6	14.2	10.8	15.6	11.3	14.9	17.1	14.2	7.8	16.8	10.5	10.6	15.4	16.0	11.9	8.4	7.8	15.3	15.6	17.6	10.9	18.3	9.2	17.2	15.2	16.1	18.8	15.4	10.7	9.8	9.6	9.9	13.2	7.9	0.7	0.9	1.8	0.8	0.6	1.3	0.5	27.9	34.0	7.9	17.6	4.5	5.6	21.6	13.7	10.3	13.3	10.4	34.3	12.0	14.0	30.8	11.4	14.0	10.2	25.0	4.9	24.8	16.2	8.9	27.8	24.0	10.7	14.0	25.2	8.5	8.3	13.0	7.1	15.1	19.5	5.6	6.5	57.8	22.5	11.1	35.3	31.5	13.9	9.1	14.0	8.1	30.7	17.2	10.8	13.3	19.6	12.1	17.4	12.9	21.5	28.3	17.7	20.8	24.1	15.5	24.2	11.6	30.3	14.1	17.6	0.1	0.5	0.0	0.8	0.8	0.6	0.7	1.3	0.8	0.9	0.4	0.4	0.7	1.8	0.6	0.6	0.8	0.2	0.5	27.2	22.3	19.8	38.7	23.6	14.2	17.1	14.2	16.0	15.4
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166921	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036241: , HPA036242: AB_10673616, HPA066090: "	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	13.3	12.3	8.6	9.6	19.8	8.7	11.9	10.7	18.9	12.9	10.6	14.7	6.4	6.2	18.8	8.6	11.0	17.3	10.9	11.7	10.5	7.8	9.5	10.5	10.9	10.7	7.2	9.1	20.1	11.1	15.7	18.7	8.8	10.1	12.0	11.4	13.4	10.4	12.5	36.4	14.3	8.3	12.7	7.4	10.0	11.3	17.2	7.5	12.3	14.0	12.2	12.2	12.5	10.4	2.5	2.4	0.1	1.6	1.2	3.5	1.4	8.9	7.6	9.8	10.0	5.8	9.2	11.5	10.6	7.1	9.3	9.3	8.6	10.7	23.3	3.1	6.5	7.5	19.9	11.4	12.3	10.2	12.3	24.6	6.8	7.2	10.1	15.9	8.8	8.7	10.2	11.3	9.2	8.2	27.6	12.4	12.4	8.8	18.4	9.1	12.8	7.6	15.3	7.3	12.2	9.3	4.1	10.7	8.0	7.0	12.8	7.6	6.9	6.9	8.6	11.2	9.6	8.7	11.9	7.8	10.8	17.9	10.6	9.3	11.0	0.0	1.5	0.1	2.2	1.6	0.9	1.9	2.5	3.3	2.4	2.5	3.5	2.3	0.0	1.2	1.5	2.4	0.7	1.4	8.6	19.8	10.7	18.9	10.5	7.8	7.2	9.1	10.1	7.5
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004546-44009063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.4;liver: 30.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.3;HHSteC: 6.4;TIME: 7.9;U-87 MG: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA027300: "	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.6	0.6	0.5	0.4	2.4	0.0	1.0	0.7	1.5	0.3	7.2	0.5	5.6	16.4	0.5	2.6	0.9	0.3	0.3	0.9	0.7	1.5	4.4	30.2	2.5	0.2	1.8	0.6	0.5	0.3	3.6	0.4	0.4	1.2	0.8	0.4	0.1	0.9	6.5	0.1	0.6	13.4	0.3	2.0	0.5	0.3	0.4	1.1	0.2	2.9	0.0	0.1	0.8	0.8	1.5	2.0	2.3	2.7	1.0	3.5	1.3	3.4	0.2	0.0	0.5	0.0	6.3	0.1	0.6	0.0	0.2	0.0	2.2	0.8	0.0	1.3	0.0	1.4	0.0	1.2	0.1	0.3	0.8	0.1	0.2	2.6	6.4	0.0	0.0	2.7	0.1	0.2	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.4	2.6	0.1	0.2	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.2	0.1	7.9	3.0	0.8	0.2	0.7	0.2	0.2	0.2	11.9	0.1	0.4	1.8	1.4	2.3	3.5	1.5	2.8	1.2	2.2	2.9	2.0	1.5	1.1	1.7	0.8	1.0	2.7	0.3	1.7	1.3	0.5	2.4	0.7	1.5	0.7	1.5	1.8	0.6	1.2	1.1
NANOS1	"NOS1, ZC2HC12A"	ENSG00000188613	"Nanos C2HC-type zinc finger 1"	Q8WY41	10	119029716-119033732	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.7"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 38.7;SK-BR-3: 22.2;SK-MEL-30: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB012219	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB012219: "	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.22e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.64e-4)"	"unprognostic (7.89e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.52e-3)"	8.5	10.5	8.1	1.0	7.1	1.0	6.4	6.5	4.8	4.9	2.1	4.5	1.3	1.2	2.1	4.4	2.1	1.5	1.0	16.7	5.0	6.7	3.5	1.0	1.3	1.1	3.4	2.4	0.9	3.3	0.9	2.2	8.2	6.0	3.5	1.2	8.8	1.5	2.5	40.7	1.7	1.4	3.4	6.7	0.9	3.1	2.9	3.0	0.1	9.3	0.3	1.0	3.3	9.8	0.6	0.5	3.2	0.3	0.6	0.3	0.1	7.5	0.6	1.0	0.2	3.6	0.5	4.6	0.1	0.2	0.2	0.1	0.9	2.6	4.0	1.0	0.0	2.7	1.3	1.3	0.3	1.2	3.1	0.1	1.9	0.8	1.7	0.4	0.0	0.7	5.6	0.0	0.7	0.1	0.7	0.5	0.2	1.0	1.0	1.3	3.4	0.6	0.0	1.3	2.7	1.5	0.6	3.0	38.7	2.2	22.2	16.8	3.5	2.1	0.2	0.0	1.7	0.0	0.3	1.1	3.8	1.4	0.3	1.0	0.0	3.2	0.3	0.4	0.2	0.1	0.1	0.2	0.2	0.2	0.0	0.6	0.3	0.2	1.3	0.6	0.2	0.5	0.1	0.1	8.1	7.1	6.5	4.8	5.0	6.7	3.4	2.4	6.0	3.0
NAP1L2	"BPX, MGC26243"	ENSG00000186462	"Nucleosome assembly protein 1 like 2"	Q9ULW6	X	73212299-73214848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.0;Karpas-707: 10.0;NTERA-2: 12.8;U-2 OS: 7.5;U-2197: 10.4;U-266/84: 20.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054050, HPA057065"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA054050: , HPA057065: "	"unprognostic (1.12e-1)"	"unprognostic (6.64e-5)"	"unprognostic (4.22e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.95e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-2)"	2.3	5.8	15.7	2.2	20.0	0.9	3.2	37.5	49.8	4.5	2.8	2.0	0.2	1.3	4.9	8.0	2.8	4.2	2.5	7.2	21.0	22.8	8.0	1.3	2.5	2.9	15.7	28.7	8.6	2.6	10.5	10.2	0.5	20.5	10.4	3.1	2.6	3.1	5.9	1.1	4.9	1.7	4.6	8.3	3.9	2.0	2.2	4.9	0.0	8.0	0.0	1.8	2.6	2.5	0.9	0.0	0.0	0.0	1.2	3.6	1.4	0.0	3.3	0.1	6.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	12.0	0.0	0.7	2.4	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	0.3	0.9	0.1	1.7	0.2	0.2	10.0	0.0	1.2	3.9	0.0	12.8	5.9	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.1	0.0	7.5	10.4	0.8	4.7	20.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	0.9	3.4	2.3	0.0	0.1	1.6	3.6	0.0	1.2	0.0	0.0	2.6	1.4	15.7	20.0	37.5	42.1	21.0	22.8	15.7	28.7	20.5	4.9
NAP1L4	NAP2	ENSG00000205531	"Nucleosome assembly protein 1 like 4"	Q99733	11	2944431-2992377	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011567	Approved		Supported	Nucleoplasm			5700000	Nucleoplasm		"CAB011567: AB_776638"	"unprognostic (1.61e-1)"	"prognostic favourable (9.77e-4)"	"unprognostic (8.99e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (1.68e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.55e-4)"	"unprognostic (1.54e-1)"	21.6	17.2	36.4	21.9	41.0	27.5	21.1	31.7	34.8	22.9	23.4	37.8	19.1	13.3	23.3	18.7	29.8	18.7	21.8	58.2	34.6	40.1	30.8	22.2	20.3	37.7	50.5	28.7	26.7	18.9	63.0	25.3	24.1	33.7	22.7	22.8	22.3	27.2	22.4	51.5	19.3	24.8	27.5	49.5	23.5	25.1	36.6	34.9	32.2	23.6	32.1	46.8	29.8	21.6	12.3	12.4	28.2	13.1	24.7	30.6	19.4	17.7	11.9	19.5	15.4	20.2	22.5	8.9	37.1	24.3	34.5	31.7	29.7	48.5	34.0	22.8	22.6	32.4	5.1	31.6	40.0	36.0	12.7	24.3	36.0	38.2	14.0	19.8	26.3	18.8	15.4	18.6	13.5	20.8	31.0	35.4	29.9	16.7	45.9	0.8	47.1	17.3	21.3	23.2	26.6	3.0	30.4	29.0	24.8	18.7	27.7	17.9	1.7	1.6	15.7	27.0	25.1	36.0	3.1	18.9	30.0	45.8	1.9	14.2	17.6	28.2	10.3	13.4	19.7	11.2	19.4	11.7	24.8	25.5	12.4	12.3	22.0	25.4	7.0	24.7	13.1	11.2	30.6	19.4	36.4	41.0	31.7	34.8	34.6	40.1	50.5	28.7	33.7	34.9
NAPEPLD	"C7orf18, FMP30, NAPE-PLD"	ENSG00000161048	"N-acyl phosphatidylethanolamine phospholipase D"	Q6IQ20	7	103099776-103149560	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019832, HPA024338"	Approved		Enhanced	Cytosol				Cytosol		"HPA019832: AB_1844422, HPA024338: "	"unprognostic (3.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.21e-1)"	"prognostic favourable (7.32e-6)"	"unprognostic (8.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.41e-2)"	3.8	5.3	8.6	3.8	14.0	3.1	3.9	13.9	18.5	5.1	8.8	17.2	3.7	15.9	4.9	3.5	2.6	6.5	6.1	4.2	6.4	5.5	15.1	7.4	4.3	3.8	15.0	11.6	9.7	4.1	8.5	6.2	2.9	10.3	5.4	10.1	5.0	4.2	4.1	5.0	5.7	10.8	4.5	9.7	6.6	11.2	11.1	16.7	5.3	8.8	0.9	3.8	6.9	4.6	7.9	3.7	5.7	4.6	2.9	7.6	2.5	4.6	6.2	4.0	3.6	3.6	3.9	0.6	3.0	2.8	2.1	3.4	2.7	6.2	4.2	5.1	2.3	4.3	2.8	1.0	2.5	6.5	3.9	1.7	3.7	1.2	0.9	3.7	1.8	2.2	1.2	1.9	0.0	3.4	2.0	4.5	4.0	1.7	4.4	2.0	3.7	7.3	2.8	1.8	2.2	7.6	2.2	2.9	3.9	8.2	2.6	1.8	1.7	2.1	3.0	5.9	4.2	12.0	3.7	5.6	6.1	3.6	4.2	2.7	11.3	0.2	3.1	5.7	4.9	4.6	4.4	7.4	5.3	5.8	3.7	7.9	7.6	5.6	0.3	2.9	3.0	2.7	4.7	2.5	8.6	14.0	13.9	18.5	6.4	5.5	15.0	11.6	10.3	16.7
NARF	"DKFZp434G0420, FLJ10067, IOP2"	ENSG00000141562	"Nuclear prelamin A recognition factor"	Q9UHQ1	17	82458180-82490537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053006			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA053006: "	"unprognostic (1.84e-1)"	"prognostic favourable (1.15e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.80e-3)"	"prognostic unfavourable (1.48e-10)"	"unprognostic (3.57e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.83e-2)"	13.7	10.6	21.2	15.7	20.2	35.0	17.4	24.2	23.5	8.2	13.1	10.1	11.1	13.8	9.5	11.0	13.1	11.2	10.6	28.5	15.7	12.3	10.1	21.3	11.8	15.1	16.4	15.0	11.2	13.8	9.0	11.9	10.2	16.3	10.9	9.0	14.7	13.6	12.0	44.4	15.4	11.0	9.8	10.6	17.7	13.6	35.4	18.1	12.4	11.7	11.2	11.5	11.7	12.4	11.6	10.1	50.6	10.6	15.9	13.6	11.5	8.5	8.1	13.8	21.7	6.5	6.4	7.8	5.1	5.4	8.9	9.1	9.3	3.1	5.5	5.8	4.1	7.7	10.1	6.5	6.1	5.8	22.4	11.6	11.6	11.5	5.8	11.8	20.6	9.6	10.8	7.0	2.4	16.7	26.3	4.1	3.9	7.4	20.6	19.1	5.8	17.6	17.2	14.0	8.8	4.2	8.9	16.8	23.9	13.5	9.1	15.7	7.8	9.7	8.3	11.5	9.8	9.4	8.7	38.0	14.4	12.2	10.5	8.3	6.8	24.4	10.6	29.5	11.6	9.4	12.7	11.6	11.4	11.2	10.1	11.0	13.1	10.9	50.6	15.9	7.0	8.3	13.6	11.5	21.2	20.2	24.2	23.5	15.7	12.3	16.4	15.0	16.3	18.1
NARS	NARS1	ENSG00000134440	"Asparaginyl-tRNA synthetase"	O43776	18	57600656-57622213	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034257, HPA040017"	Enhanced		Supported	Cytosol				Cytosol		"CAB034257: AB_2151043, HPA040017: "	"unprognostic (9.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.23e-7)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"prognostic favourable (1.73e-7)"	"unprognostic (1.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.51e-1)"	30.9	36.9	35.0	28.8	42.6	19.5	31.6	47.1	51.4	28.1	49.7	24.8	31.1	42.5	30.8	31.6	40.2	27.4	26.8	40.6	40.5	36.5	66.0	41.9	26.0	23.0	39.5	39.2	29.4	29.4	52.0	35.7	25.6	49.5	33.1	46.1	18.5	33.7	30.9	76.6	26.9	35.2	29.9	40.6	25.7	36.0	14.9	36.3	25.0	44.5	31.9	29.2	34.6	35.3	20.0	26.6	15.6	40.8	15.8	23.4	23.7	35.9	23.8	22.4	32.7	28.8	22.1	34.9	50.3	26.3	29.7	36.9	17.1	16.9	45.4	24.2	34.8	41.0	35.2	31.1	43.6	22.0	12.2	34.7	18.3	26.9	48.7	71.9	35.9	23.4	54.5	40.7	39.0	24.6	42.6	33.9	33.3	13.4	27.8	17.4	32.9	19.1	22.1	26.4	38.3	55.6	40.6	24.6	27.0	24.4	31.5	52.8	17.6	40.0	26.9	33.2	22.2	14.0	37.2	76.1	94.1	44.1	30.5	47.3	38.6	15.6	40.8	14.2	16.4	35.1	20.2	20.0	17.3	17.4	26.6	18.8	23.4	21.2	12.7	15.8	26.6	25.1	17.2	23.7	35.0	42.6	47.1	51.4	40.5	36.5	39.5	39.2	49.5	36.3
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavourable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavourable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	20.7	15.2	19.3	33.4	32.0	64.0	21.2	20.1	24.0	22.8	21.9	30.2	26.4	15.9	22.3	19.8	20.1	23.0	12.5	18.1	22.4	17.3	17.5	21.0	17.6	39.0	40.2	17.8	28.3	17.4	21.9	22.9	28.5	24.2	18.9	24.7	12.6	17.8	21.8	14.3	16.1	20.5	21.3	30.3	31.7	17.5	35.8	40.2	49.1	17.7	28.2	43.0	18.5	19.6	16.9	11.8	8.1	9.7	7.3	17.5	6.9	24.2	14.4	69.1	24.5	11.7	6.1	32.6	19.7	14.7	30.7	38.6	26.5	17.6	45.9	13.9	8.5	23.6	46.1	21.0	39.4	20.9	29.2	59.3	25.9	41.6	4.1	61.9	25.0	7.1	5.1	33.8	11.8	20.9	49.8	27.1	20.8	16.6	70.4	56.7	100.5	12.2	89.1	60.6	44.1	15.2	24.6	26.5	32.1	32.5	18.6	20.1	13.4	48.5	11.3	14.2	43.6	27.2	32.1	16.7	31.4	79.6	14.5	39.5	14.1	4.9	7.3	8.1	12.3	9.7	14.2	13.5	13.9	14.0	11.5	16.9	12.3	11.8	3.1	7.3	5.7	11.8	17.5	6.9	19.3	32.0	20.1	24.0	22.4	17.3	40.2	17.8	24.2	40.2
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105602-34147670	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody				Nucleoli	Midbody	"CAB035546: , HPA057576: , HPA071628: "	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (1.07e-4)"	"prognostic unfavourable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	18.5	22.8	20.5	21.9	27.5	23.6	20.8	21.9	29.9	18.1	17.6	24.3	16.4	13.7	30.6	19.8	25.2	21.7	14.7	16.4	17.2	18.6	15.9	21.8	15.1	28.7	16.9	19.8	26.4	24.9	31.5	23.1	20.1	23.4	19.5	21.7	23.0	22.5	17.8	23.4	31.0	16.6	21.5	15.1	23.6	18.0	30.9	16.9	31.2	18.3	19.4	35.3	17.8	19.7	10.4	12.8	2.2	11.1	11.8	13.7	6.9	12.2	17.3	9.3	19.7	11.2	10.0	10.8	12.2	9.0	15.5	12.4	19.4	7.1	39.4	9.1	10.3	18.7	34.9	18.6	19.9	10.9	22.4	17.9	14.2	18.1	10.2	44.7	13.0	10.1	12.8	10.1	28.6	11.8	38.9	13.8	12.9	23.3	36.4	20.3	13.3	20.9	27.4	31.5	16.4	8.9	21.5	13.8	10.5	16.4	17.5	7.3	17.5	12.3	9.5	13.9	11.0	20.3	22.6	15.1	18.1	37.6	14.0	18.6	13.7	0.5	6.6	2.2	10.3	11.1	13.7	10.4	11.1	11.7	12.8	9.6	11.5	11.2	0.8	11.8	9.7	9.7	9.6	6.9	20.5	27.5	21.9	29.9	17.2	18.6	16.9	19.8	23.4	16.9
NAV2	"FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1"	ENSG00000166833	"Neuron navigator 2"	Q8IVL1	11	19350724-20121598	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 64.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 34.8;SH-SY5Y: 31.7;TIME: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011755, HPA011891"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA011755: AB_1854319, HPA011891: AB_1854318"	"unprognostic (7.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.28e-2)"	14.8	3.1	7.9	4.7	12.5	3.1	13.8	13.8	16.1	10.2	17.6	16.1	8.6	5.1	9.3	13.4	7.8	5.7	3.2	64.6	9.9	7.0	12.3	18.7	11.2	3.0	16.5	11.5	4.7	10.8	10.1	6.6	16.2	23.5	7.9	6.3	8.6	16.5	11.8	3.4	7.9	4.7	13.0	32.2	2.5	9.9	2.1	12.6	0.0	20.1	1.8	5.3	6.0	8.6	0.3	1.9	0.0	0.5	0.0	0.3	0.0	5.9	1.7	3.9	0.4	13.2	8.5	4.2	5.0	8.6	6.6	5.0	6.7	0.8	0.0	0.2	7.5	0.7	0.2	3.9	7.8	1.0	0.4	0.1	8.8	7.6	2.4	0.0	0.2	5.5	10.2	3.1	34.8	8.8	0.7	3.0	19.0	6.3	0.0	0.0	9.2	5.0	0.0	18.0	0.9	5.6	1.7	6.8	31.7	3.8	3.0	5.7	0.1	0.0	24.5	15.5	2.3	18.3	4.7	1.0	0.5	0.0	5.3	0.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.0	7.9	12.5	13.8	16.1	9.9	7.0	16.5	11.5	23.5	12.6
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591762-156594299	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Isomerase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"		3300000	Nucleoplasm	Cytosol	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	19.1	29.9	31.6	14.4	28.5	12.1	22.6	17.6	42.5	23.0	30.0	31.0	17.4	28.4	28.5	57.9	23.4	29.4	25.8	46.3	28.5	25.0	41.6	41.0	17.2	16.9	33.2	29.3	29.3	37.3	36.3	29.0	21.8	28.8	27.9	26.6	23.0	29.5	36.3	30.9	20.2	25.9	25.0	29.1	17.4	25.0	29.5	22.2	17.7	32.4	19.5	20.4	20.8	18.3	52.4	53.8	12.4	26.5	31.6	32.5	40.6	31.4	41.8	13.4	23.9	17.8	12.2	16.0	10.9	16.6	18.6	19.7	34.8	21.2	21.4	33.0	13.8	30.7	13.3	26.0	13.2	22.5	29.1	17.7	23.8	22.9	20.4	22.2	18.2	12.3	33.6	23.7	22.1	25.3	18.0	19.5	19.0	56.0	24.4	27.0	16.6	32.7	24.6	12.5	56.5	25.2	26.2	32.3	30.8	26.1	49.8	38.3	48.3	32.7	14.7	13.4	20.9	19.0	23.6	50.6	30.5	20.4	18.5	13.2	20.6	4.9	24.1	12.4	31.6	26.5	31.3	52.4	29.2	32.2	21.7	41.7	32.5	30.9	2.9	31.6	20.6	53.8	25.5	40.6	31.6	28.5	17.6	42.5	28.5	25.0	33.2	29.3	28.8	22.2
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942287-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 41.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favourable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	3.9	11.9	12.2	2.7	20.6	1.0	8.2	32.6	28.5	7.4	9.8	3.9	10.9	2.7	10.3	6.2	6.2	9.4	5.4	11.7	13.5	10.6	6.6	1.7	3.6	2.6	6.9	22.2	10.4	5.7	9.3	25.0	1.5	14.2	11.9	4.8	13.3	7.0	14.2	8.5	2.0	3.8	11.4	4.7	5.1	4.8	7.7	6.0	6.1	9.6	0.7	2.4	7.1	6.4	1.1	1.3	0.0	0.5	0.4	1.4	0.1	0.0	2.3	5.4	3.0	0.4	0.0	0.1	3.4	5.3	4.0	3.3	0.0	0.5	1.4	0.0	5.8	0.1	1.8	0.7	8.5	0.7	1.8	0.0	1.6	0.5	0.3	0.9	2.2	0.9	0.6	0.0	0.4	0.7	0.0	9.7	0.5	1.0	0.5	0.0	2.3	0.9	0.6	2.3	0.4	4.6	1.0	3.1	41.2	2.5	0.0	1.7	0.9	0.2	0.0	1.0	0.6	0.0	0.7	0.9	0.2	0.7	2.6	0.3	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.2	0.0	1.1	1.4	1.3	0.0	0.4	0.0	1.3	0.0	0.1	12.2	20.6	32.6	18.4	13.5	10.6	6.9	22.2	14.2	6.0
NBR1	"1A1-3B, CA125, KIAA0049, M17S2"	ENSG00000188554	"NBR1, autophagy cargo receptor"	Q14596	17	43170481-43211689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022944, HPA022999, HPA023999"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				Vesicles	"Nucleoplasm, Nuclear bodies"	"HPA022944: , HPA022999: AB_1859532, HPA023999: AB_1859533"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"prognostic favourable (2.00e-5)"	"unprognostic (1.65e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	26.3	29.5	27.1	17.2	27.3	7.7	28.0	27.3	29.4	25.6	32.9	33.3	29.0	31.0	28.4	25.5	23.1	25.6	20.7	29.8	26.0	22.0	38.3	39.6	21.1	25.4	27.2	21.8	34.1	26.5	55.8	25.0	31.2	22.8	30.1	32.1	20.7	25.5	29.5	62.9	23.9	37.7	24.2	34.2	23.3	23.2	57.0	31.7	29.8	32.1	24.5	19.8	32.5	23.7	9.6	12.6	25.2	21.5	15.5	17.1	14.4	12.5	15.4	13.2	13.9	30.0	31.2	12.7	23.8	47.2	19.8	16.4	8.0	20.0	6.7	24.7	33.0	13.9	15.0	30.7	28.8	20.9	15.9	8.0	19.5	17.1	28.7	6.7	12.4	35.5	34.8	21.6	42.7	30.7	17.1	18.1	26.1	7.1	14.3	4.9	4.2	10.0	4.8	20.7	21.9	25.0	14.3	7.9	14.2	16.4	8.1	23.8	22.1	11.1	25.5	29.1	10.8	13.3	9.4	21.7	17.6	8.8	19.7	9.3	19.9	23.5	16.1	25.2	14.2	15.3	14.6	9.6	12.9	13.7	12.6	6.7	12.4	11.9	23.1	15.5	21.5	8.0	17.1	14.4	27.1	27.3	27.3	29.4	26.0	22.0	27.2	21.8	22.8	31.7
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.6;heart muscle: 67.7"	"Cell line enhanced"	"Detected in some"		"HEL: 19.1;RH-30: 43.1;SCLC-21H: 35.1;SH-SY5Y: 17.2;U-138 MG: 24.0;WM-115: 25.4"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"NK-cell: 27.2"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"		2800000000	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: "	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	3.5	36.4	22.7	3.0	35.7	1.8	2.1	20.2	110.6	13.3	9.0	55.8	0.3	3.4	24.7	3.0	4.8	8.3	3.6	67.7	22.5	19.2	2.3	2.6	2.0	1.7	45.0	27.1	21.9	2.3	1.1	9.1	1.4	38.8	8.4	4.6	5.5	2.5	10.9	14.6	1.8	5.3	25.6	27.6	3.4	6.7	2.9	39.2	0.0	16.9	0.7	1.7	7.0	6.5	0.0	0.0	0.4	0.1	27.2	2.0	0.9	0.0	0.0	6.7	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.4	0.1	0.1	0.9	6.0	6.3	0.1	0.0	0.0	0.0	0.1	3.8	19.1	0.0	0.0	0.7	0.0	3.1	4.1	0.0	0.0	6.1	0.0	0.0	0.3	6.7	0.0	0.0	1.6	0.5	0.1	0.0	43.1	3.1	0.0	0.0	35.1	17.2	0.0	0.1	0.0	0.0	0.2	0.0	24.0	11.2	0.1	10.0	0.0	0.1	0.0	2.7	9.0	25.4	0.0	0.1	0.0	2.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.4	27.2	0.0	0.0	0.1	0.9	22.7	35.7	20.2	41.6	22.5	19.2	45.0	27.1	38.8	39.2
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998315-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 15.9;brain: 52.7"	"Cell line enriched"	"Detected in some"	4	"T-47d: 44.1"	"Cancer enhanced"	"Detected in some"		"glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"			100000000	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: "	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	2.0	15.9	25.8	2.0	22.3	1.1	3.1	7.0	52.7	3.3	2.1	14.7	0.0	1.3	2.3	1.8	1.7	1.8	2.6	3.1	18.7	13.9	1.3	9.1	4.4	1.2	21.6	19.4	1.4	1.3	1.1	1.0	1.7	17.9	2.2	2.4	0.5	1.8	2.3	1.5	2.0	1.9	2.7	17.3	2.0	1.3	8.3	26.6	0.0	1.5	0.0	1.3	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.6	0.0	1.1	0.0	0.0	5.6	0.0	1.7	0.0	0.0	5.1	1.1	0.1	7.1	0.1	0.0	0.2	0.0	0.5	0.0	2.1	0.0	0.0	0.0	2.6	0.0	0.3	0.3	44.1	3.3	0.0	0.6	0.4	0.0	0.0	0.3	0.0	0.0	1.2	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	22.3	7.0	22.4	18.7	13.9	21.6	19.4	17.9	26.6
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 84.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavourable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	6.8	8.8	6.5	24.6	12.7	16.7	7.7	7.7	9.0	8.0	11.3	16.2	7.0	10.6	11.5	8.8	17.7	8.1	6.5	6.2	7.5	5.4	7.0	5.1	7.7	20.4	16.5	6.2	7.7	7.2	9.6	6.3	13.9	8.7	8.2	12.4	8.1	10.5	8.3	7.0	14.8	13.0	8.2	12.7	16.4	9.9	17.2	11.4	84.1	11.4	12.4	24.3	10.9	9.5	5.0	4.8	7.2	2.8	7.8	7.4	3.2	21.9	20.4	21.9	15.8	5.7	6.0	25.6	15.1	12.2	24.6	19.9	18.3	23.3	23.1	4.5	9.9	19.4	36.0	17.7	47.0	41.8	20.2	21.1	23.3	10.4	2.4	26.2	15.3	3.8	6.6	19.2	19.6	16.2	13.4	9.4	21.7	10.9	29.6	17.2	34.2	15.9	25.3	49.8	12.2	8.2	12.3	9.0	9.5	22.6	10.7	8.1	4.7	16.5	10.1	16.2	26.6	10.9	29.4	7.4	9.9	32.9	9.5	15.2	20.0	7.2	2.0	3.6	6.3	2.8	5.6	5.0	6.2	7.3	3.0	3.8	7.4	7.2	1.9	7.8	1.9	4.8	7.2	3.2	6.5	12.7	7.7	9.0	7.5	5.4	16.5	6.2	8.7	11.4
NCAPD3	"CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056"	ENSG00000151503	"Non-SMC condensin II complex subunit D3"	P42695	11	134150119-134225454	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 82.1"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 50.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040286			Supported	Nucleoplasm				Nucleoplasm		"HPA040286: "	"unprognostic (4.27e-2)"	"unprognostic (6.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.48e-1)"	4.9	6.4	4.9	8.3	7.4	13.7	5.4	8.9	6.2	4.0	5.4	8.5	5.0	5.4	4.7	5.9	7.8	4.2	5.4	4.5	5.5	4.3	4.3	12.1	5.3	7.6	9.0	3.3	4.1	5.9	6.8	9.2	6.0	6.1	82.1	6.1	4.9	6.0	6.6	3.8	9.0	5.6	5.4	6.8	8.5	5.3	14.8	7.1	30.7	6.6	5.3	9.8	4.5	5.4	6.9	11.2	2.6	5.6	5.8	10.4	3.8	13.0	11.6	12.8	19.2	5.2	3.8	8.5	15.4	9.8	14.2	15.7	22.7	20.6	24.3	20.7	7.9	21.8	23.8	13.3	15.5	21.9	20.7	41.6	11.7	10.0	2.4	25.7	22.6	2.6	2.2	18.8	6.1	9.2	22.1	14.4	10.6	10.9	29.6	16.7	8.7	20.6	17.4	15.1	14.0	5.5	16.8	25.6	12.0	22.4	17.9	3.6	28.3	14.8	7.4	18.4	7.8	12.5	19.2	6.2	6.2	22.8	5.3	30.7	15.4	1.7	5.6	2.6	9.5	5.0	5.6	3.7	6.4	7.2	5.1	6.9	8.9	10.4	2.2	5.8	4.1	11.2	9.4	3.8	4.9	7.4	8.9	6.2	5.5	4.3	9.0	3.3	6.1	7.1
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631311-158704829	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.91e-4)"	"prognostic unfavourable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	5.9	4.0	4.4	8.6	4.2	20.1	5.4	9.0	5.1	4.4	6.6	5.8	3.5	4.2	5.1	5.1	9.9	3.7	3.1	4.0	4.3	3.5	3.3	3.9	4.4	11.4	6.2	4.2	4.4	4.4	6.0	5.8	6.9	4.9	4.5	7.7	3.9	5.3	4.2	4.5	6.5	5.5	4.6	6.2	6.1	5.3	14.6	5.1	39.1	3.6	7.6	13.0	4.8	5.5	1.8	2.8	6.9	5.4	6.1	9.3	2.5	29.7	15.8	19.3	12.4	2.9	4.7	7.7	21.8	14.1	27.0	30.3	14.0	15.6	18.4	13.6	8.9	15.3	16.0	10.0	36.1	19.6	11.9	16.6	19.7	11.0	1.3	20.5	18.8	2.0	1.1	22.0	6.3	15.0	20.3	27.7	24.8	31.6	34.0	13.9	19.0	12.8	20.0	20.3	17.5	6.7	13.4	21.1	16.3	26.9	10.5	5.9	9.5	13.4	7.8	18.5	14.1	49.9	34.9	18.3	13.5	22.4	19.6	26.2	35.1	6.9	1.0	1.2	6.5	1.4	9.3	1.8	6.6	4.5	2.8	1.2	2.2	2.4	0.6	6.1	5.4	1.4	8.3	2.5	4.4	4.2	9.0	5.1	4.3	3.5	6.2	4.2	4.9	5.1
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335787-96373845	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 5.6;T-reg: 8.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.6;T-cells: 8.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavourable (9.53e-6)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.3	1.1	0.8	13.2	0.9	17.2	1.7	0.7	1.2	1.5	3.9	0.7	0.4	2.9	0.7	1.1	7.4	0.4	1.0	0.8	0.8	0.7	0.9	0.9	1.5	10.6	1.0	0.6	0.8	0.6	0.1	0.5	3.4	1.0	0.7	5.1	0.6	1.9	0.4	0.6	2.7	3.5	1.4	1.2	6.7	2.1	60.4	0.8	41.3	0.6	6.4	12.2	1.7	2.2	1.3	0.5	5.6	1.0	0.1	8.7	0.8	30.9	11.8	29.9	15.5	1.1	1.6	19.8	14.7	10.3	28.4	30.0	21.8	17.4	28.9	10.4	6.4	14.0	25.6	10.0	30.5	25.4	17.0	29.8	12.3	19.6	0.2	27.5	25.5	0.5	1.1	22.0	9.3	11.2	20.6	21.5	13.4	14.6	40.4	28.7	21.4	14.9	31.4	27.2	23.5	5.6	12.0	17.8	13.6	8.5	12.0	5.2	8.8	20.4	6.5	21.0	32.1	19.6	23.7	11.5	16.3	30.8	9.1	27.6	23.7	5.6	0.0	0.3	1.3	1.0	0.2	1.3	1.9	1.5	0.5	0.9	0.0	0.7	0.3	0.1	0.0	0.0	8.7	0.8	0.8	0.9	0.7	1.2	0.8	0.7	1.0	0.6	1.0	0.8
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508216-50523472	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"HPA067932: , HPA069056: "	"unprognostic (2.01e-1)"	"prognostic favourable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	15.7	12.4	24.5	17.8	18.8	57.4	14.7	33.5	29.4	14.5	14.2	17.4	14.6	15.6	17.5	15.7	18.0	17.2	11.4	18.2	20.0	19.6	14.5	13.8	17.0	22.2	17.8	19.2	22.8	22.6	16.3	22.0	20.0	19.0	15.2	10.8	16.8	22.4	16.6	20.2	23.2	15.7	20.5	15.7	18.4	15.7	26.1	20.4	25.2	16.3	16.8	21.0	12.0	14.5	13.7	10.1	14.5	11.6	11.3	20.9	12.8	19.8	10.8	18.8	19.2	5.6	6.5	24.4	15.8	10.9	28.5	31.1	21.9	13.7	23.0	8.7	11.3	15.8	17.1	15.1	8.2	13.1	28.4	13.2	27.3	19.6	6.8	29.3	23.9	5.9	9.5	22.5	7.6	9.1	16.6	44.8	11.5	27.4	20.0	33.4	13.3	12.9	33.6	24.4	25.3	8.3	13.1	12.3	16.1	12.4	18.5	14.7	12.6	28.8	5.9	22.3	26.8	18.2	23.3	23.4	13.0	34.1	16.7	15.0	20.9	10.6	8.4	14.5	17.1	10.4	20.9	13.7	17.7	17.4	7.0	13.2	18.7	15.5	10.2	11.3	11.6	10.1	16.8	12.8	24.5	18.8	33.5	29.4	20.0	19.6	17.8	19.2	19.0	20.4
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633626-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favourable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	18.5	17.2	19.8	27.4	26.2	37.2	23.6	25.5	27.1	17.0	21.9	18.7	19.8	18.0	19.2	15.3	21.7	15.9	16.3	20.4	23.7	17.8	17.9	22.7	17.3	25.9	16.6	23.8	22.8	22.0	17.1	26.9	20.3	22.6	18.4	25.7	18.1	18.3	17.7	25.5	22.4	19.3	16.3	18.7	20.5	19.4	26.8	17.8	36.1	22.5	15.1	25.0	18.5	19.4	7.6	13.7	12.9	14.6	14.9	10.0	7.7	24.5	16.9	19.0	17.7	13.4	13.5	18.6	18.8	10.9	17.2	16.2	22.6	12.8	21.2	8.1	16.9	27.8	30.2	21.4	24.7	14.1	9.7	19.5	25.5	14.1	13.1	26.0	20.3	10.1	10.7	20.0	15.5	17.8	28.7	11.9	28.8	17.7	18.8	13.8	20.6	18.3	18.1	44.1	8.5	14.0	18.3	24.2	16.3	18.8	16.5	9.8	10.2	15.9	14.9	13.5	12.6	26.8	19.3	11.5	14.1	11.0	12.4	20.2	17.7	12.9	11.4	11.0	8.7	14.6	9.9	6.5	9.9	9.1	13.7	7.6	8.7	10.0	3.5	14.9	14.3	5.9	8.6	7.7	19.8	26.2	25.5	27.1	23.7	17.8	16.6	23.8	22.6	17.8
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942597	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA044850: AB_10961012, HPA062483: "	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavourable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (4.75e-4)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	27.6	34.5	39.4	26.8	42.1	11.4	35.6	33.4	37.8	28.0	25.4	17.9	25.2	21.8	26.6	32.1	23.1	24.9	22.5	22.6	37.5	33.3	31.9	21.6	20.3	37.6	33.5	28.9	30.8	27.8	28.3	30.4	25.4	31.4	28.3	26.1	18.7	19.8	27.8	41.8	20.1	19.9	33.7	39.0	24.3	21.3	20.4	31.3	24.9	29.8	19.3	30.5	27.5	23.7	26.1	19.1	9.7	20.8	19.6	28.9	17.6	34.9	11.4	26.3	33.3	30.1	26.4	18.9	26.4	19.7	16.7	17.4	24.9	12.7	23.4	59.2	18.4	21.4	33.8	28.6	26.2	12.4	22.3	30.5	13.2	20.7	26.7	35.6	21.3	21.1	24.8	12.2	34.3	25.6	17.3	24.9	28.0	40.7	26.5	21.9	33.6	36.8	20.8	20.2	22.2	24.3	24.5	14.9	39.4	16.6	31.8	46.1	70.6	28.4	24.3	17.3	18.4	21.4	47.5	38.4	35.5	40.3	23.6	40.4	26.3	3.8	18.1	9.7	19.2	20.8	28.9	26.1	23.5	22.5	19.1	20.5	27.3	24.4	2.3	19.6	20.1	15.5	20.8	17.6	39.4	42.1	33.4	35.7	37.5	33.3	33.5	28.9	31.4	31.3
NCDN	"NCDN-1, NCDN-2"	ENSG00000020129	Neurochondrin	Q9UBB6	1	35557473-35567274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 144.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023676	Enhanced	Supported	Supported	Cytosol				Cytosol		"HPA023676: AB_1854325"	"unprognostic (1.15e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (4.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.36e-2)"	"prognostic favourable (3.73e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.34e-3)"	"unprognostic (5.88e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-2)"	5.2	11.3	33.4	6.0	144.3	3.4	3.6	28.7	104.9	9.9	3.5	8.7	1.2	3.9	6.2	4.8	4.5	8.1	6.5	12.0	45.4	25.0	4.0	2.5	4.5	5.9	15.8	32.3	9.2	6.1	6.2	5.5	4.7	26.4	7.1	2.9	3.6	6.7	8.0	5.3	5.6	3.2	6.5	10.7	5.0	4.7	5.8	15.6	0.8	6.5	0.6	4.6	6.0	2.4	5.9	2.7	0.8	4.5	3.0	6.5	5.5	8.7	10.6	8.9	14.0	12.9	16.0	6.1	11.6	12.1	12.2	9.8	10.6	13.0	10.0	11.3	10.7	13.5	8.7	14.1	4.5	9.7	18.0	12.4	15.6	5.4	17.9	11.2	14.3	15.3	11.8	21.6	8.7	6.5	13.4	16.0	9.9	15.7	10.2	7.2	39.9	18.7	8.4	4.9	12.9	8.2	9.8	11.1	16.0	13.2	12.2	16.3	11.7	7.4	8.8	15.6	11.2	11.4	15.8	22.6	15.9	7.4	19.4	18.0	14.2	0.0	4.5	0.8	3.1	2.6	3.8	5.9	4.8	4.8	2.7	2.7	6.5	5.3	0.7	3.0	4.2	1.6	2.7	5.5	33.4	144.3	28.7	61.4	45.4	25.0	15.8	32.3	26.4	15.6
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555563-183590876	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in many"		"A-431: 13.1;HMC-1: 11.4;hTERT-HME1: 27.4;U-2 OS: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 125.2;neutrophil: 80.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	15.3	3.1	2.0	23.0	4.5	53.0	3.9	0.7	2.8	2.9	2.8	3.7	0.2	2.3	1.8	6.1	4.1	5.2	7.2	6.4	2.0	1.8	2.9	5.4	39.5	42.7	6.8	0.4	3.5	4.2	0.6	1.9	11.5	3.8	3.4	3.7	4.2	4.4	0.8	3.5	7.1	3.8	5.8	5.5	45.4	2.6	3.9	3.2	4.2	2.0	5.6	5.5	7.3	3.5	1.4	24.3	125.2	45.7	0.2	1.0	22.7	13.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.2	1.8	0.8	0.1	0.4	1.6	2.3	0.4	7.4	0.0	9.7	1.6	8.2	0.0	0.0	3.3	3.0	0.0	1.0	11.4	0.0	2.1	1.7	27.4	0.0	0.0	2.9	3.0	0.1	0.1	0.5	0.2	0.7	3.5	1.1	9.9	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.4	4.6	0.6	0.0	26.6	0.0	2.4	0.5	0.7	0.2	0.2	5.2	0.0	15.5	45.7	125.2	0.1	34.4	0.1	1.4	0.4	0.1	24.3	0.8	0.2	0.1	80.6	0.2	29.7	1.3	1.0	22.7	2.0	4.5	0.7	2.8	2.0	1.8	6.8	0.4	3.8	3.2
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878015	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0"	"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 86.9;NB-4: 30.8;REH: 15.8;RPMI-8226: 30.6;THP-1: 29.0;U-937: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 130.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB010146: AB_627989, HPA036156: , HPA057975: "	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	10.4	5.8	4.4	24.8	5.6	69.0	5.6	0.7	2.8	3.4	7.4	2.5	1.2	5.0	2.2	8.1	4.4	5.9	7.2	8.0	3.9	2.2	4.4	4.2	17.5	21.2	8.0	1.0	3.3	2.1	0.6	2.6	10.3	4.6	5.1	5.3	4.2	6.5	2.2	2.6	2.3	16.0	4.3	7.7	66.0	3.9	3.0	5.4	5.0	3.5	2.8	22.2	9.0	7.1	12.6	10.0	130.3	19.5	0.4	10.8	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	18.2	0.0	0.0	0.0	2.6	86.9	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	30.8	0.0	0.0	15.8	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	16.1	0.0	58.0	19.5	76.4	0.2	9.6	1.1	12.6	3.9	0.8	9.1	8.9	0.2	0.2	130.3	0.4	6.4	10.0	10.8	10.2	4.4	5.6	0.7	2.8	3.9	2.2	8.0	1.0	4.6	5.4
NCK1	"NCK, NCKalpha"	ENSG00000158092	"NCK adaptor protein 1"	P16333	3	136862208-136949823	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005063, HPA030766"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB005063: AB_562169, HPA030766: "	"unprognostic (7.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.77e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (9.14e-5)"	"unprognostic (5.96e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.17e-2)"	44.5	15.7	11.5	24.5	13.4	19.3	38.9	22.6	11.6	23.7	18.3	8.4	16.5	10.2	20.8	19.2	35.9	14.6	13.9	16.8	11.8	11.1	14.0	20.9	22.4	33.0	13.9	12.1	19.6	14.3	17.9	17.7	22.7	13.5	26.3	19.5	10.8	24.0	15.8	29.0	27.3	14.3	24.0	13.5	18.7	12.8	14.7	12.7	41.1	23.8	23.5	29.0	27.3	43.3	8.5	13.3	26.8	27.1	11.2	20.2	11.9	19.6	8.7	11.5	9.5	26.8	26.1	12.9	14.5	26.2	16.9	17.7	12.7	19.6	19.3	30.2	17.0	15.2	16.2	14.8	22.6	13.9	6.6	16.7	12.4	9.9	43.7	12.1	11.6	23.6	19.5	16.4	32.8	25.9	10.0	17.3	17.7	10.7	27.3	9.7	11.0	11.1	14.9	10.8	18.5	15.8	13.5	8.2	8.0	26.2	11.8	23.4	16.9	13.3	12.8	11.0	7.2	15.6	8.3	17.3	13.6	23.9	11.7	10.9	11.7	26.8	12.4	13.2	19.7	27.1	20.2	8.1	15.6	19.8	13.3	8.5	12.6	15.0	7.2	11.2	13.4	5.2	15.0	11.9	11.5	13.4	22.6	11.6	11.8	11.1	13.9	12.1	13.5	12.7
NCKIPSD	"AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH"	ENSG00000213672	"NCK interacting protein with SH3 domain"	Q9NZQ3	3	48673844-48686364	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 39.6;parathyroid gland: 123.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019267, HPA050005"			Enhanced	"Plasma membrane"			42000	"Plasma membrane"		"CAB019267: , HPA050005: "	"unprognostic (1.55e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.50e-3)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.20e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"	11.7	11.9	14.4	4.9	18.5	4.4	7.8	17.9	39.6	7.0	7.9	10.3	3.5	7.3	7.8	8.6	7.8	9.6	9.3	17.8	12.9	16.0	8.7	6.8	7.4	5.9	11.1	17.8	17.7	8.5	123.9	10.0	8.0	16.9	8.1	7.4	9.6	8.9	11.7	6.4	9.8	7.3	8.7	9.2	5.7	6.2	8.4	10.9	2.9	7.7	1.9	5.4	7.7	6.5	4.9	8.5	1.0	5.3	4.8	6.4	4.7	11.6	10.2	10.5	10.7	14.3	8.7	14.6	11.7	13.1	13.0	16.6	15.1	7.1	8.6	6.4	6.9	7.9	13.3	15.5	7.5	9.6	16.3	15.4	38.1	11.9	12.5	10.4	17.4	8.3	13.5	18.0	11.3	7.3	5.2	11.5	10.4	8.6	9.4	8.8	12.1	18.2	4.8	4.8	14.4	7.1	12.0	11.0	8.9	12.2	11.5	9.8	10.2	12.7	4.1	11.3	12.7	13.3	15.4	10.4	7.6	9.6	12.8	13.9	17.2	1.0	4.6	0.2	3.5	5.3	2.6	4.9	4.2	4.1	5.8	2.6	6.4	4.1	0.3	4.8	2.8	8.5	4.6	4.7	14.4	18.5	17.9	39.6	12.9	16.0	11.1	17.8	16.9	10.9
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	Nucleoplasm,Nucleoli			600000	"Nucleoplasm, Nucleoli"		"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavourable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	71.2	68.2	59.6	67.7	77.0	96.6	71.0	72.8	69.2	72.1	63.0	79.2	46.0	48.1	80.3	63.7	85.2	65.7	45.9	55.9	57.7	53.3	66.7	94.7	55.6	78.4	67.4	51.8	93.9	77.5	94.8	83.4	69.5	79.8	64.6	75.4	47.1	58.1	51.8	120.6	70.3	56.9	70.9	88.4	80.2	59.4	41.7	76.4	118.9	67.8	82.6	105.5	79.9	60.6	40.8	41.3	20.4	36.4	52.6	53.9	40.8	62.2	58.2	70.7	51.7	41.7	45.4	72.7	70.5	47.8	66.5	58.9	96.1	44.8	82.8	60.7	54.3	61.1	141.3	94.6	114.1	48.3	59.3	138.0	55.3	129.6	45.8	157.2	52.3	43.0	54.9	83.0	87.5	69.7	122.9	28.4	58.5	84.6	137.7	97.6	105.2	41.8	102.8	127.4	72.6	48.8	82.7	61.2	43.7	47.1	54.1	62.2	40.7	79.7	59.2	53.3	55.2	62.3	92.5	53.8	52.8	178.1	38.8	102.7	55.2	9.5	27.9	20.4	47.4	33.2	53.9	40.8	41.7	42.6	41.3	38.9	46.6	42.1	6.0	52.6	36.4	35.5	34.4	40.8	59.6	77.0	72.8	69.2	57.7	53.3	67.4	51.8	79.8	76.4
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: , HPA070520: "	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	9.8	10.0	15.3	7.3	18.0	8.9	10.5	15.9	17.1	13.7	8.9	13.5	4.9	12.5	13.0	11.5	10.8	10.0	8.3	8.8	20.8	12.2	11.9	8.8	9.4	8.2	10.8	9.9	17.2	10.3	23.9	16.0	10.1	14.2	9.6	10.1	19.9	10.6	13.0	42.5	9.3	10.9	11.6	9.7	9.6	7.6	11.4	10.7	8.5	7.0	12.2	9.3	9.7	10.8	2.5	5.5	14.2	3.5	3.4	4.1	1.8	6.6	4.9	8.7	4.5	9.6	8.8	13.3	3.5	7.1	4.5	4.0	4.6	2.8	4.8	1.5	6.4	1.6	5.2	3.0	4.9	22.8	7.5	17.2	2.0	1.9	6.0	7.9	14.4	14.0	4.6	4.3	3.5	4.5	10.4	8.0	6.8	4.4	7.0	2.8	4.1	3.3	5.5	40.1	2.4	4.9	9.0	8.0	6.3	8.2	5.0	3.6	6.0	4.0	4.9	7.5	5.9	5.1	3.5	9.3	8.0	8.4	4.3	5.0	3.7	11.0	3.5	6.9	3.8	2.7	4.1	1.8	3.4	4.1	2.6	2.5	3.3	4.0	14.2	3.4	2.8	5.5	3.7	1.8	15.3	18.0	15.9	17.1	20.8	12.2	10.8	9.9	14.2	10.7
NCOA2	"bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2"	ENSG00000140396	"Nuclear receptor coactivator 2"	Q15596	8	70109762-70403805	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060243			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA060243: "	"unprognostic (9.79e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-2)"	"prognostic favourable (5.08e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-1)"	13.6	13.2	16.9	13.1	14.0	22.5	14.9	19.2	14.0	13.9	17.3	10.1	49.7	12.4	16.6	33.6	20.0	12.5	12.6	15.8	13.9	13.0	16.4	25.5	15.5	16.9	10.8	11.4	18.5	9.7	23.4	17.1	16.2	10.0	14.8	11.8	15.3	14.8	21.7	13.2	14.9	28.8	19.2	9.6	14.5	11.7	15.5	12.9	15.3	13.4	10.3	13.8	18.9	17.2	3.8	2.5	9.4	7.8	2.1	3.8	1.6	8.6	10.8	11.9	6.7	10.8	11.2	12.2	5.0	5.0	3.8	3.7	5.5	10.0	10.2	2.0	9.1	5.1	14.6	6.9	4.3	24.2	11.6	17.9	5.5	8.7	5.7	3.6	4.8	9.7	7.7	5.2	7.5	2.6	5.6	15.7	4.4	8.6	8.9	3.6	6.2	5.1	8.8	5.0	6.4	6.1	14.4	9.1	6.7	8.6	4.6	7.1	10.9	6.6	3.4	5.6	7.1	7.0	2.6	20.7	10.5	10.0	5.7	4.8	8.1	4.5	2.5	3.5	3.8	3.9	2.8	2.2	2.3	3.3	2.5	3.8	2.8	2.7	9.4	2.1	7.8	1.1	3.2	1.6	16.9	14.0	19.2	13.5	13.9	13.0	10.8	11.4	10.0	12.9
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501902-47656877	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	20.1	8.9	6.6	34.0	7.4	11.1	15.7	11.9	9.9	12.3	10.1	8.1	9.0	6.7	15.5	8.8	16.7	12.0	8.6	11.5	6.7	4.8	9.1	9.3	17.4	25.8	7.9	4.7	13.3	10.7	13.5	13.5	54.7	7.9	9.7	9.0	10.8	13.5	10.0	32.5	15.0	17.1	11.3	9.5	30.8	11.4	9.2	7.2	17.6	13.5	10.5	33.3	15.1	17.7	13.0	6.7	6.0	7.3	2.7	4.0	3.5	5.7	18.8	5.3	7.2	12.5	14.7	37.3	5.6	8.4	9.6	5.1	9.0	6.4	20.1	3.7	9.6	14.2	4.1	6.9	7.3	10.6	2.2	2.7	5.3	12.5	7.4	2.1	15.0	6.7	19.8	9.1	10.6	6.8	6.2	4.7	5.3	62.6	3.2	3.7	1.8	7.2	6.0	3.7	8.6	5.3	13.6	1.0	1.9	14.1	17.6	6.0	8.1	5.5	11.8	5.7	5.0	6.9	2.4	12.9	11.8	20.7	6.6	2.2	3.8	3.4	5.2	4.0	3.5	7.3	3.2	13.0	3.2	3.1	6.7	10.0	3.7	4.0	6.0	2.7	7.0	5.5	4.0	3.5	6.6	7.4	11.9	9.9	6.7	4.8	7.9	4.7	7.9	7.2
NCOA5	"bA465L10.6, CIA"	ENSG00000124160	"Nuclear receptor coactivator 5"	Q9HCD5	20	46060985-46089952	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050231	Uncertain		Supported	"Nucleoplasm,Actin filaments"				"Nucleoplasm, Actin filaments"		"HPA050231: "	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.41e-5)"	"prognostic favourable (8.07e-4)"	"unprognostic (2.32e-1)"	"unprognostic (7.75e-2)"	"prognostic favourable (1.09e-4)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.91e-2)"	16.0	15.0	20.9	25.8	18.5	8.1	55.1	31.2	25.6	19.3	17.7	12.0	18.5	14.0	23.4	20.3	16.5	21.1	15.8	13.8	19.3	13.1	14.1	12.9	21.7	23.0	14.6	16.2	29.8	27.0	23.4	26.2	18.4	15.7	19.2	16.5	14.7	18.5	23.6	22.8	19.4	18.1	19.8	13.6	23.3	16.5	44.4	16.7	23.8	19.2	14.2	23.8	18.2	42.5	17.4	18.5	10.7	8.6	7.4	14.0	5.4	19.2	17.1	24.2	24.8	11.6	12.3	19.4	13.4	12.1	21.8	17.9	23.6	15.4	31.6	22.7	12.9	25.8	19.9	16.7	18.8	19.1	10.0	18.9	17.0	19.9	12.3	26.0	18.5	8.8	22.4	11.5	10.5	15.4	17.6	25.8	17.1	24.9	35.7	20.1	22.0	21.1	27.2	16.0	13.8	12.8	21.9	21.8	19.7	21.4	26.2	18.7	20.8	30.7	14.3	23.1	17.5	13.8	20.7	16.9	23.8	21.3	16.0	15.3	14.6	3.3	8.3	10.7	12.2	8.5	14.0	11.6	12.8	12.3	8.3	17.4	12.3	11.1	6.0	7.4	8.6	18.5	8.2	5.4	20.9	18.5	31.2	25.6	19.3	13.1	14.6	16.2	15.7	16.7
NCOA6	"AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP"	ENSG00000198646	"Nuclear receptor coactivator 6"	Q14686	20	34689097-34825649	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004198, HPA050211"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA004198: AB_1078228, HPA050211: "	"unprognostic (2.48e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (4.65e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.51e-1)"	"prognostic favourable (8.78e-5)"	"unprognostic (9.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.42e-2)"	13.7	13.4	14.7	12.8	23.0	15.8	17.7	31.9	17.3	14.9	16.9	28.5	17.5	16.4	16.7	16.3	17.1	14.9	14.2	11.8	16.2	11.7	13.6	10.8	13.2	10.8	18.7	12.6	15.5	15.8	35.1	17.7	18.1	14.4	13.1	18.8	14.4	16.4	18.4	17.6	18.4	21.2	19.8	21.8	11.2	14.6	22.6	22.6	16.9	17.7	9.7	13.2	16.6	14.6	2.7	3.1	6.5	2.1	2.1	2.7	1.3	14.0	8.4	19.2	11.5	10.5	11.8	12.5	6.9	8.8	12.5	10.1	21.5	10.0	10.0	7.6	12.3	17.3	17.0	11.6	14.2	5.1	7.6	23.4	9.4	12.6	11.6	13.1	17.3	8.9	21.5	11.6	14.5	11.7	11.9	13.8	10.3	9.2	20.8	8.3	3.9	12.2	14.0	23.1	8.9	9.2	9.5	16.0	10.9	12.6	30.7	11.8	12.9	10.6	11.4	20.3	12.4	15.0	11.4	15.9	13.3	11.6	13.4	7.7	9.0	3.0	1.7	6.5	2.7	1.6	2.6	2.7	2.5	2.3	3.1	2.1	2.3	1.5	4.4	2.1	2.1	2.8	1.4	1.3	14.7	23.0	31.9	17.3	16.2	11.7	18.7	12.6	14.4	22.6
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB072830: , HPA043246: , HPA050288: , HPA051168: "	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favourable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	19.6	21.2	25.4	24.0	30.8	27.0	25.0	41.8	31.5	24.0	30.6	19.6	18.6	33.2	29.0	19.5	25.0	20.5	21.9	17.8	22.4	17.8	25.6	33.8	20.1	19.5	25.1	19.1	25.9	24.3	39.9	39.8	19.8	21.6	20.8	29.7	17.1	20.9	29.1	43.0	23.8	36.9	29.7	26.4	23.7	29.8	22.1	26.4	38.8	25.3	15.7	23.8	29.6	27.0	43.4	29.9	78.2	24.8	30.4	35.5	19.7	23.8	39.9	28.5	23.7	23.5	17.9	14.2	17.6	19.9	19.4	17.6	21.3	10.9	25.1	12.4	30.7	18.3	35.0	21.3	28.8	33.4	25.9	25.0	34.5	25.0	23.0	15.6	29.8	18.3	22.4	30.0	35.2	26.9	21.8	10.4	19.0	15.5	27.5	10.1	14.1	10.9	27.5	28.9	11.7	20.1	27.1	9.7	16.2	29.1	12.7	13.8	12.2	17.9	23.4	20.0	11.8	14.6	24.2	7.2	8.3	14.7	19.0	18.6	17.1	78.2	24.8	52.2	31.3	19.5	25.9	40.7	35.5	34.1	17.5	43.4	34.7	34.8	48.5	30.4	24.0	29.9	31.7	19.7	25.4	30.8	41.8	31.5	22.4	17.8	25.1	19.1	21.6	26.4
NCOR2	"CTG26, SMRT, SMRTE, TNRC14, TRAC-1"	ENSG00000196498	"Nuclear receptor corepressor 2"	Q9Y618	12	124324415-124567589	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001928	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA001928: AB_1079454"	"unprognostic (9.51e-3)"	"unprognostic (7.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.90e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.90e-2)"	24.0	22.0	21.3	21.3	19.0	16.8	18.3	33.8	33.5	24.5	17.2	24.3	17.7	16.4	21.3	19.0	15.7	16.3	21.5	18.2	22.0	14.8	16.0	11.2	23.4	11.9	19.0	15.6	28.6	30.0	13.8	39.5	13.2	28.3	21.3	7.6	32.7	29.2	24.5	62.4	22.8	22.2	17.4	12.2	17.4	24.0	10.8	22.0	9.3	16.7	25.0	7.6	16.3	14.7	0.6	1.7	8.1	4.0	0.2	1.9	0.4	19.4	36.7	10.5	10.0	6.1	8.3	31.4	20.2	10.1	11.8	5.3	19.5	14.4	19.8	15.0	16.4	18.5	4.1	21.5	4.8	20.8	8.1	15.9	34.6	11.8	12.3	11.9	20.2	13.3	8.1	14.7	8.8	11.2	20.4	5.9	10.5	16.8	42.9	13.8	14.6	35.8	13.9	17.5	10.0	5.6	22.8	27.7	20.2	24.8	21.0	12.7	17.1	15.1	53.9	27.5	47.6	27.1	42.9	11.3	11.4	12.1	15.6	8.9	25.7	8.1	0.7	1.6	1.9	0.4	0.5	0.6	0.5	1.5	0.3	0.4	0.6	0.5	1.6	0.2	4.0	1.7	0.0	0.4	21.3	19.0	33.8	28.4	22.0	14.8	19.0	15.6	28.3	22.0
NCS1	"FREQ, NCS-1"	ENSG00000107130	"Neuronal calcium sensor 1"	P62166	9	130172578-130237304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.2;MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018587, HPA019713"	Enhanced	Supported	Enhanced	"Plasma membrane"				"Plasma membrane"		"CAB018587: AB_649907, HPA019713: AB_1854404"	"prognostic unfavourable (5.40e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-3)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (1.61e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (1.65e-1)"	5.8	12.6	76.8	7.9	56.6	4.6	2.8	18.6	66.2	7.7	20.1	6.4	5.0	3.6	12.6	4.1	24.9	13.5	8.7	4.6	74.3	25.7	8.7	1.6	2.5	1.6	20.6	28.1	4.6	3.5	1.5	2.7	1.6	17.7	14.9	6.8	4.2	5.3	41.6	0.9	10.0	4.3	34.3	6.8	1.1	5.1	2.2	7.1	0.0	20.1	0.7	2.7	16.4	4.6	0.0	0.0	0.0	0.0	0.0	1.2	0.1	7.7	15.8	8.2	16.4	5.1	11.6	3.9	20.0	9.3	15.4	10.3	7.5	4.0	0.0	7.3	25.2	14.0	13.3	17.5	6.9	22.9	4.0	0.0	10.5	8.0	7.9	0.6	9.7	13.4	8.9	17.4	11.0	14.5	5.6	0.1	22.2	22.2	1.4	7.7	12.5	6.7	0.0	25.9	5.3	15.0	4.9	21.7	20.4	12.3	5.9	11.8	11.0	4.9	11.4	29.9	24.3	23.9	25.6	0.0	0.0	0.0	34.9	2.2	32.2	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	76.8	56.6	18.6	59.9	74.3	25.7	20.6	28.1	17.7	7.1
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765460-53838860	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"				"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: , HPA070882: "	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favourable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavourable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	8.8	6.7	3.3	8.6	5.7	4.9	12.9	10.9	7.7	4.8	8.4	5.1	1.9	6.2	6.0	5.4	11.0	5.3	2.9	5.5	4.3	2.8	4.9	11.7	4.4	10.6	8.0	1.5	4.6	6.0	7.6	5.5	5.5	6.6	4.0	10.7	5.5	6.4	3.7	7.1	6.8	6.5	5.0	7.5	7.1	5.8	17.4	7.5	9.1	5.8	6.7	13.0	6.4	5.8	5.5	3.8	2.0	7.2	4.0	8.2	3.4	19.6	10.4	14.2	14.5	5.2	5.3	16.7	13.5	10.1	21.2	17.2	15.3	13.2	38.9	8.9	6.0	23.8	23.9	14.1	30.1	9.7	17.2	18.9	15.3	13.0	4.9	30.4	10.8	3.2	5.6	20.9	12.5	12.8	21.6	5.6	11.6	7.1	14.8	12.1	33.6	16.6	16.8	22.9	21.3	9.9	13.6	8.6	10.9	12.1	23.6	11.6	18.3	16.1	7.4	11.1	11.1	15.2	24.2	6.2	15.3	27.7	9.2	23.1	13.8	0.0	3.2	2.0	4.5	7.2	6.9	5.5	4.3	4.0	3.8	4.1	8.2	6.3	0.2	4.0	4.5	3.3	4.7	3.4	3.3	5.7	10.9	7.7	4.3	2.8	8.0	1.5	6.6	7.5
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80, kinetochore complex component"	O14777	18	2571511-2616635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 51.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066330			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA066330: "	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	2.9	1.3	0.8	15.3	0.8	14.6	0.9	0.7	0.9	2.9	3.8	0.8	0.6	2.7	4.2	3.8	8.3	1.3	1.8	2.7	0.6	0.4	1.6	1.4	2.9	10.1	0.6	0.8	1.2	0.8	0.0	0.6	6.0	1.1	4.3	5.1	0.8	1.9	7.6	0.6	4.0	4.8	2.2	0.6	7.9	3.0	15.9	0.6	51.3	0.9	8.1	9.9	2.2	6.7	7.9	1.6	9.3	0.7	2.2	11.5	1.4	21.5	4.9	24.5	10.8	1.3	2.9	12.6	25.4	13.6	33.3	28.4	13.4	12.3	23.6	11.5	9.8	13.4	27.3	11.0	35.3	8.8	6.9	18.6	14.0	10.3	0.4	35.6	15.7	1.5	1.0	19.1	13.6	15.1	15.1	30.1	29.0	9.7	17.3	15.5	12.6	7.2	19.2	25.0	18.9	8.7	10.5	19.8	8.9	23.2	6.1	9.2	10.3	14.2	9.2	21.7	48.4	17.1	33.4	13.2	20.8	31.7	9.6	16.5	18.3	3.7	0.7	2.8	2.2	0.6	2.0	7.9	3.7	4.3	0.3	5.7	2.4	2.4	9.3	2.2	0.5	1.6	11.5	1.4	0.8	0.8	0.7	0.9	0.6	0.4	0.6	0.8	1.1	0.6
NDFIP2	"KIAA1165, N4wbp5a"	ENSG00000102471	"Nedd4 family interacting protein 2"	Q9NV92	13	79481124-79556075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 17.3"	"Group enriched"	"Detected in many"	18	"granulocytes: 17.3;T-cells: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009160	Uncertain		Supported	Vesicles				Vesicles		"HPA009160: AB_1079456"	"unprognostic (2.56e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.95e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (5.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.63e-2)"	"prognostic favourable (4.18e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.02e-1)"	8.0	13.0	15.3	6.7	28.4	1.2	12.8	8.7	39.6	11.8	24.0	12.0	10.5	27.9	5.8	12.9	36.4	9.4	11.1	13.9	23.6	9.6	25.2	24.7	9.5	6.4	11.6	27.3	4.8	16.9	8.8	7.5	29.7	20.4	12.8	25.8	4.8	15.8	9.3	18.2	39.4	36.1	5.0	12.7	6.1	13.7	9.4	13.8	7.3	10.7	15.7	10.7	16.8	18.8	0.3	0.1	17.3	0.0	0.6	5.0	2.1	36.0	6.2	6.5	8.2	7.9	14.7	12.3	13.3	18.6	14.1	23.6	13.5	40.5	1.5	9.2	17.5	49.4	5.6	23.4	21.4	18.7	15.8	1.6	20.6	7.3	14.5	28.4	5.0	11.6	30.9	9.4	15.0	6.7	7.3	2.8	15.8	5.2	2.3	6.4	4.7	6.3	0.1	12.9	6.7	34.6	21.1	6.6	9.4	15.1	14.7	10.5	12.2	23.9	5.6	4.5	5.8	8.7	8.9	10.7	11.6	5.6	18.6	0.1	18.2	9.7	0.0	17.3	2.6	0.0	2.2	0.2	2.4	2.1	0.0	0.3	5.0	2.8	0.1	0.6	0.0	0.1	2.4	2.1	15.3	28.4	8.7	39.6	23.6	9.6	11.6	27.3	20.4	13.8
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.6;retina: 41.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 22.7;U-266/70: 10.1;U-266/84: 38.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 12.6"	"Region enriched"	"Detected in many"	4	"pons and medulla: 7.6"	"Cell type enriched"	"Detected in single"	11	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.4;olfactory region: 41.7"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"			Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	3.8	1.3	1.2	0.4	1.0	0.0	14.2	0.6	1.5	7.2	3.5	1.2	1.7	1.3	3.1	2.2	5.7	10.0	6.9	4.9	1.2	1.5	12.5	0.5	91.6	0.1	1.8	1.2	21.3	0.6	0.4	8.2	28.0	7.6	26.1	4.0	41.0	2.1	2.2	7.5	1.8	3.9	2.6	5.5	0.4	2.2	8.0	0.8	7.0	1.6	9.0	1.4	8.9	11.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	5.1	0.0	6.8	5.6	0.1	0.1	0.2	0.1	0.2	0.7	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.5	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.0	0.1	0.2	10.1	38.7	0.0	1.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.6	1.5	1.2	1.5	1.8	1.2	7.6	0.8
NDP	"EVR2, norrin"	ENSG00000124479	"NDP, norrin cystine knot growth factor"	Q00604	X	43948776-43973504	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 40.4"	"Cell line enriched"	"Detected in some"	17	"U-87 MG: 40.3"	"Cancer enhanced"	"Detected in many"		"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"			Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15.0	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18.0	0.9	1.4	14.0	7.8	0.7	0.5	0.6	0.7	11.0	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0.0	1.2	0.0	0.7	1.0	1.7	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.9	0.0	0.1	1.0	0.7	0.0	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	40.3	0.4	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	18.6	14.6	15.0	14.0	7.8	11.0	10.9	13.1	12.2
NDRG1	"CAP43, DRG1, NDR1, RTP, TDD5"	ENSG00000104419	"N-myc downstream regulated 1"	Q92597	8	133237171-133302022	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 69.0;hTERT-HME1: 139.1;U-87 MG: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006881	Approved		Supported	Microtubules,Cytosol				Cytosol	Microtubules	"HPA006881: AB_1078392"	"unprognostic (6.96e-3)"	"unprognostic (3.31e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.47e-4)"	"unprognostic (3.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (4.13e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.28e-2)"	43.9	23.6	42.0	17.0	80.9	18.0	29.8	6.4	36.2	33.1	47.7	73.2	24.2	74.2	20.9	20.6	83.0	24.7	26.8	22.2	48.7	32.9	62.6	12.1	31.0	11.4	96.3	19.8	37.5	16.7	17.8	18.6	32.5	50.0	115.0	22.4	16.2	29.0	26.4	13.2	56.9	78.2	19.2	102.0	11.5	45.7	15.0	74.3	10.3	21.4	40.0	34.9	58.7	64.9	1.9	12.2	8.9	4.1	1.3	9.3	2.9	21.5	2.7	0.1	0.1	13.7	9.6	2.9	1.5	11.8	1.1	6.1	1.3	3.0	0.1	15.5	6.4	7.0	0.2	34.0	2.4	1.3	25.5	0.2	5.5	1.6	5.2	0.7	0.5	8.9	69.0	5.8	139.1	5.1	0.2	15.1	1.9	1.2	2.0	2.1	0.3	17.9	0.2	2.4	10.0	3.5	3.2	1.6	1.6	3.3	35.7	8.6	0.1	2.3	6.6	9.7	5.0	4.2	1.2	11.3	29.6	0.1	93.6	8.1	19.0	8.9	4.1	0.0	6.3	3.7	9.3	1.7	5.9	7.5	6.1	1.9	4.6	3.1	4.2	1.3	4.0	12.2	8.0	2.9	42.0	80.9	6.4	36.2	48.7	32.9	96.3	19.8	50.0	74.3
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871487-119876662	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 144.8;skeletal muscle: 138.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029768, HPA054359"	Enhanced		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA029768: , HPA054359: "	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favourable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	24.5	30.1	37.9	20.1	42.5	25.2	23.8	27.9	37.8	19.7	38.4	8.7	27.3	41.0	13.5	25.8	21.6	15.9	24.8	144.8	30.1	28.5	46.0	40.2	21.1	22.2	34.6	32.8	14.6	40.4	22.7	21.7	15.4	29.5	17.9	31.1	15.5	38.4	29.6	138.8	12.1	34.6	19.3	31.5	17.1	28.1	7.7	21.1	9.2	16.2	67.4	16.7	14.0	14.9	66.3	90.5	96.3	85.7	49.8	75.5	73.8	34.5	37.3	26.7	28.4	32.2	20.4	33.4	27.3	24.9	19.2	23.9	20.8	28.9	28.1	42.1	28.5	33.4	37.4	26.2	22.0	38.9	51.7	29.2	68.1	46.7	25.0	44.6	32.5	33.2	35.7	20.4	15.9	23.8	15.8	43.8	26.3	61.1	31.7	42.3	39.4	66.7	32.1	25.4	84.6	57.8	49.2	19.5	25.7	56.1	69.6	37.4	17.6	52.6	30.6	16.4	16.6	34.0	53.2	40.4	50.0	36.8	29.7	53.0	20.2	96.3	79.0	91.6	60.2	80.4	57.1	66.3	67.1	62.8	84.0	52.7	56.1	65.7	94.6	49.8	85.7	90.5	75.5	73.8	37.9	42.5	27.9	37.8	30.1	28.5	34.6	32.8	29.5	21.1
NDUFA10	CI-42k	ENSG00000130414	"NADH:ubiquinone oxidoreductase subunit A10"	O95299	2	239892450-240025402	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059529, HPA067045, CAB070846"	Approved		Supported	Mitochondria	"Intracellular and membrane"		12000	Mitochondria		"CAB070846: AB_11152346, HPA059529: , HPA067045: "	"unprognostic (2.12e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (2.09e-7)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.95e-1)"	19.0	37.5	19.7	18.2	30.4	20.3	19.5	26.2	31.5	14.5	31.0	24.5	18.6	30.4	14.8	18.4	28.5	18.8	17.1	66.0	28.6	18.7	36.3	40.6	13.1	13.8	21.4	27.7	19.8	23.5	25.1	15.5	15.9	33.4	13.7	34.7	16.2	20.6	26.7	67.0	26.1	24.3	18.6	27.0	13.8	24.9	15.4	19.8	13.2	16.9	34.1	20.2	19.3	17.7	24.6	35.7	11.0	27.7	21.2	24.6	24.5	16.8	16.6	12.3	20.7	14.9	24.8	20.2	14.3	18.5	20.7	20.8	16.5	21.1	12.5	6.6	15.9	22.6	27.8	25.7	26.5	16.6	18.4	16.4	15.6	35.3	22.5	22.4	13.3	24.1	21.0	16.5	22.6	26.2	24.9	8.8	22.1	25.8	21.2	23.0	14.5	18.0	21.7	27.5	21.9	29.3	33.1	19.5	12.8	14.1	32.0	22.3	29.8	22.7	16.3	14.8	15.0	18.7	15.9	15.2	6.8	19.9	16.0	20.5	17.6	6.3	26.1	11.0	18.9	27.7	24.6	24.6	19.1	20.5	35.7	18.3	19.0	19.0	5.8	21.2	23.4	12.7	22.0	24.5	19.7	30.4	26.2	31.5	28.6	18.7	21.4	27.7	33.4	19.8
NDUFA12	"B17.2, DAP13"	ENSG00000184752	"NADH:ubiquinone oxidoreductase subunit A12"	Q9UI09	12	94897055-95003770	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039903	Supported		Supported	Mitochondria				Mitochondria		"HPA039903: AB_10795516"	"unprognostic (2.76e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.27e-2)"	24.0	24.8	36.0	17.9	36.8	19.7	19.7	27.2	36.5	17.9	35.5	12.5	20.0	27.4	17.0	21.9	23.3	19.4	14.4	82.8	31.2	32.0	33.2	34.6	18.1	20.1	37.0	29.9	17.0	18.4	22.3	22.4	21.1	31.3	19.1	35.7	13.1	18.7	20.7	129.0	17.4	26.7	24.0	24.2	23.9	20.9	14.2	23.5	21.0	27.9	40.0	28.1	21.9	21.4	60.8	78.4	69.7	67.9	59.1	93.8	100.6	40.9	44.6	37.3	26.5	30.6	28.5	27.7	19.6	28.8	42.8	38.8	55.0	21.2	47.2	11.6	29.9	31.0	38.3	45.2	48.6	40.6	46.0	39.4	37.2	55.4	31.5	55.9	48.2	30.6	57.1	35.9	44.0	35.0	36.8	21.9	41.4	59.5	38.7	86.5	28.3	77.6	29.6	32.3	53.8	41.9	61.6	35.5	21.5	33.2	48.4	25.4	47.8	36.9	40.0	22.7	23.1	33.0	33.3	35.9	53.2	72.0	13.6	46.8	34.7	69.7	59.5	29.8	52.1	67.9	48.2	60.8	71.6	62.5	78.4	50.7	93.8	68.6	8.6	59.1	63.3	48.0	74.8	100.6	36.0	36.8	27.2	36.5	31.2	32.0	37.0	29.9	31.3	23.5
NDUFA13	"B16.6, CDA016, CGI-39, GRIM-19, GRIM19"	ENSG00000186010	"NADH:ubiquinone oxidoreductase subunit A13"	Q9P0J0	19	19515736-19529054	"Disease related genes, Predicted membrane proteins"	"Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 116.3;testis: 140.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041213	Supported		Supported	Mitochondria				Mitochondria		"HPA041213: AB_10794988"	"unprognostic (2.87e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.15e-2)"	17.9	16.9	20.0	11.7	23.9	15.4	14.4	20.7	25.2	11.0	19.2	8.7	16.5	16.5	9.7	19.6	12.2	11.7	12.9	68.0	16.4	13.9	18.9	20.8	8.4	11.9	19.9	22.3	10.6	17.8	10.6	12.1	12.1	20.0	12.9	11.9	9.8	15.2	15.5	79.7	9.5	14.9	12.1	13.4	10.1	15.0	140.2	16.2	7.6	11.3	28.1	8.4	9.6	10.2	73.7	74.9	61.4	76.8	44.8	72.7	116.3	33.7	24.9	46.0	45.8	47.0	38.2	43.2	40.2	44.5	45.3	44.3	40.3	50.7	44.9	94.6	48.5	27.4	32.6	43.6	18.7	27.4	73.7	34.3	39.7	49.4	42.1	64.4	48.4	51.2	39.7	31.8	36.7	32.6	37.8	64.3	36.0	67.1	76.4	64.0	46.9	69.4	43.9	29.9	68.6	66.1	48.5	43.8	55.4	40.9	48.2	40.0	29.8	88.7	33.9	44.5	15.1	51.8	49.9	45.8	36.0	48.3	39.2	50.0	32.4	61.4	76.8	57.8	51.2	72.9	45.5	73.7	58.9	56.0	74.9	60.5	56.9	51.1	26.9	44.8	60.8	61.2	72.7	116.3	20.0	23.9	20.7	25.2	16.4	13.9	19.9	22.3	20.0	16.2
NDUFA4	"CI-9k, MLRQ"	ENSG00000189043	"NDUFA4, mitochondrial complex associated"	O00483	7	10931951-10940256	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.9;skeletal muscle: 151.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055323			Supported	Mitochondria			18000	Mitochondria		"HPA055323: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favourable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	21.9	22.0	72.8	13.6	55.3	19.8	27.0	33.1	74.4	20.5	18.3	12.0	16.8	25.1	16.9	29.6	15.8	20.2	16.7	149.9	56.1	32.1	46.2	46.7	15.9	13.5	47.6	48.9	17.1	23.7	18.9	5.6	11.4	33.0	23.1	20.4	14.1	36.0	31.1	151.6	12.1	17.3	21.4	26.3	13.6	23.6	7.4	23.2	6.8	20.4	60.1	15.6	15.8	11.6	29.0	41.1	52.8	39.6	21.7	37.5	48.0	12.6	21.8	37.2	42.7	21.1	19.8	17.1	16.1	15.3	15.1	13.3	27.3	34.8	24.7	15.3	23.1	22.4	24.7	19.1	16.5	12.2	18.0	20.7	25.6	25.4	18.4	28.5	20.4	21.3	19.3	18.5	16.4	21.0	30.7	33.6	31.5	24.4	12.7	25.1	40.7	44.2	17.3	26.5	27.7	38.3	27.5	23.3	24.2	25.5	73.5	14.5	46.4	35.0	18.3	18.1	24.9	25.9	26.5	20.4	26.1	28.3	24.9	30.9	56.0	52.8	32.5	44.4	23.4	38.6	27.4	29.0	32.7	29.3	41.1	22.0	34.1	29.7	7.4	21.7	39.6	38.5	37.5	48.0	72.8	55.3	33.1	74.4	56.1	32.1	47.6	48.9	33.0	23.2
NDUFA7	B14.5a	ENSG00000267855	"NADH:ubiquinone oxidoreductase subunit A7"	O95182	19	8308768-8321396	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 110.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA059251, HPA071866"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA059251: AB_2683960, HPA071866: "	"unprognostic (6.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.35e-3)"	17.7	30.0	28.0	15.5	30.5	15.3	18.9	15.4	32.0	9.0	17.2	11.3	15.7	12.6	9.9	32.1	18.9	26.2	16.1	69.1	22.1	21.0	26.5	30.9	20.3	22.1	25.9	19.7	10.1	28.5	11.9	30.2	13.0	26.7	20.5	17.6	16.7	23.0	20.7	110.6	16.2	16.0	13.1	18.5	14.7	19.3	13.8	11.1	19.3	22.0	47.5	16.8	14.3	9.1	30.6	65.5	25.1	39.7	24.9	33.5	26.7	15.5	13.3	17.0	8.7	11.6	6.2	9.6	4.4	5.8	16.7	11.2	14.1	13.2	8.8	6.9	10.7	13.6	7.7	23.4	7.9	23.0	48.6	6.5	20.5	33.3	18.1	9.8	9.0	12.5	15.2	9.0	8.3	19.5	11.1	45.9	20.8	17.0	18.7	48.6	13.7	50.9	10.4	3.1	19.1	34.0	9.3	14.3	10.9	6.4	20.0	11.1	7.5	16.2	5.7	9.4	7.6	13.2	12.6	17.9	13.8	10.6	13.4	17.0	14.8	14.2	38.9	25.1	22.6	39.7	24.4	29.9	24.7	22.2	47.9	30.6	24.1	23.4	9.7	24.9	34.4	65.5	33.5	26.7	28.0	30.5	15.4	32.0	22.1	21.0	25.9	19.7	26.7	11.1
NDUFA8	"MGC793, PGIV"	ENSG00000119421	"NADH:ubiquinone oxidoreductase subunit A8"	P51970	9	122144058-122159819	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 105.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041510, HPA041600"	Enhanced		Supported	Mitochondria			14000	Mitochondria		"HPA041510: AB_10794379, HPA041600: AB_10796778"	"unprognostic (2.90e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.12e-2)"	"prognostic favourable (4.17e-6)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	15.4	20.0	35.9	9.5	40.5	7.3	16.5	18.8	36.8	14.2	23.4	12.4	19.6	19.4	12.6	26.9	17.0	18.9	16.9	105.4	32.3	27.5	29.0	23.6	10.9	11.2	31.3	30.3	11.3	16.8	21.8	15.3	14.1	22.4	17.9	26.6	14.6	25.1	19.7	68.3	11.1	17.4	22.0	19.1	10.9	18.0	25.1	16.8	10.0	18.5	30.9	15.8	15.6	15.3	29.7	39.7	22.2	34.3	25.5	30.8	24.3	19.4	36.0	23.9	31.4	25.8	23.7	29.6	22.6	26.9	31.1	26.2	45.6	19.4	28.4	22.4	26.4	48.9	45.2	48.9	30.6	27.8	31.3	22.4	60.4	39.3	27.8	39.5	23.1	25.9	47.9	31.1	20.0	44.6	34.1	21.4	35.4	49.4	24.5	25.7	21.8	69.3	19.6	37.7	41.4	44.7	27.0	41.4	16.3	35.6	42.3	28.1	44.8	19.1	28.9	17.3	17.4	32.4	25.3	24.2	39.0	28.1	36.0	25.6	28.5	5.1	29.4	22.2	29.1	34.3	27.8	29.7	27.0	28.4	38.1	29.3	29.0	30.5	4.8	25.5	28.8	39.7	30.8	24.3	35.9	40.5	18.8	36.8	32.3	27.5	31.3	30.3	22.4	16.8
NDUFA9	"CI-39k, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042268, HPA073212"	Supported		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA042268: AB_2677922, HPA073212: "	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favourable (5.75e-4)"	10.7	13.2	11.0	10.1	17.8	21.2	11.7	15.3	20.7	9.2	22.1	12.0	8.6	20.9	10.1	11.0	13.4	8.4	8.5	41.3	11.6	11.0	23.7	22.1	8.5	11.8	12.7	9.9	8.4	10.4	10.4	12.2	9.5	16.2	9.9	22.7	12.1	13.3	10.1	66.6	10.6	18.9	11.7	8.3	11.5	13.6	5.8	9.3	14.4	10.2	30.7	12.8	8.2	8.8	36.8	43.5	14.6	41.5	25.8	35.9	59.6	10.7	19.5	9.6	12.7	7.1	7.1	27.9	8.3	8.4	16.0	12.2	42.2	21.7	12.2	4.4	8.9	18.2	13.9	12.2	10.5	23.6	24.4	11.9	20.7	31.9	15.6	17.4	12.9	9.0	11.9	10.9	14.9	12.0	8.3	23.1	11.8	20.9	17.3	20.0	24.8	16.2	24.5	14.2	12.7	22.0	24.7	7.0	7.8	10.4	28.1	14.5	5.8	16.6	8.4	12.2	24.8	11.1	19.1	4.5	5.3	20.1	12.7	10.8	13.3	14.6	35.8	13.3	27.7	41.5	28.0	36.8	29.0	30.2	42.3	26.2	25.3	26.2	3.1	25.8	32.2	43.5	35.9	59.6	11.0	17.8	15.3	20.7	11.6	11.0	12.7	9.9	16.2	9.3
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581002-23596356	"Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 118.2;skeletal muscle: 112.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054364	Uncertain		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA054364: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favourable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	21.6	25.5	29.4	14.8	28.0	15.1	20.4	21.2	37.7	13.4	31.2	11.4	16.2	30.2	13.7	15.5	19.4	16.2	17.4	118.2	24.1	25.6	32.5	38.8	12.0	15.2	27.0	21.6	10.9	29.1	21.9	18.6	15.2	23.3	16.0	26.5	15.3	24.3	19.2	112.0	12.4	25.7	18.1	15.5	14.0	20.1	11.4	11.5	14.5	15.8	54.3	16.7	13.4	12.7	39.3	61.8	17.4	49.3	25.0	39.5	43.1	27.7	20.5	25.7	22.9	18.3	19.9	35.8	21.4	15.9	21.6	17.8	17.8	22.6	46.0	35.2	15.4	23.0	44.7	25.4	17.1	26.0	51.6	24.7	36.8	87.3	19.2	45.7	20.5	18.4	35.4	15.9	17.2	27.4	51.6	23.4	23.3	42.0	35.4	69.6	66.8	47.7	48.7	28.9	62.5	19.8	25.0	35.4	27.6	23.9	43.9	40.0	35.4	38.3	21.5	19.8	20.9	19.2	29.3	29.9	43.4	51.5	22.2	37.1	22.4	15.1	43.1	17.4	31.7	49.3	34.6	39.3	37.7	35.0	55.2	34.6	35.2	36.5	8.9	25.0	38.0	61.8	39.5	43.1	29.4	28.0	21.2	37.7	24.1	25.6	27.0	21.6	23.3	11.5
NDUFAF1	"CGI-65, CIA30"	ENSG00000137806	"NADH:ubiquinone oxidoreductase complex assembly factor 1"	Q9Y375	15	41387349-41402519	"Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039933, HPA040064"	Supported		Enhanced	Cytosol				Cytosol		"HPA039933: AB_10795265, HPA040064: AB_10795687"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (2.88e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"prognostic favourable (3.34e-6)"	"unprognostic (1.68e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	11.1	22.0	15.0	6.4	14.0	3.0	9.8	13.3	17.8	7.8	7.7	12.4	5.3	8.4	8.3	10.7	9.6	7.9	7.1	29.7	13.2	13.4	21.9	27.5	7.0	8.5	14.7	14.4	7.0	7.7	11.9	9.7	7.0	13.1	8.5	8.1	8.4	8.5	9.8	38.6	6.2	7.7	10.3	13.5	7.5	8.5	14.1	12.0	6.5	9.6	15.8	9.1	8.8	5.8	14.5	19.1	25.2	16.2	13.9	15.9	8.7	9.0	6.5	8.5	8.9	19.7	20.1	9.4	17.4	14.2	15.3	12.8	12.0	5.0	10.4	24.2	15.2	15.0	11.6	11.7	13.8	19.5	13.4	14.7	13.6	7.0	16.8	15.7	10.5	22.3	11.2	12.7	12.7	10.9	22.4	11.3	22.4	8.4	12.5	13.0	6.9	10.9	9.8	11.5	21.5	23.3	14.8	10.3	8.1	8.9	19.8	6.6	16.2	30.3	11.3	12.4	5.7	18.7	14.3	9.2	19.9	15.7	13.9	24.9	11.9	25.2	13.7	16.4	9.6	16.2	9.9	14.5	11.5	12.3	12.1	12.6	13.0	10.3	12.8	13.9	12.4	19.1	15.9	8.7	15.0	14.0	13.3	17.8	13.2	13.4	14.7	14.4	13.1	12.0
NDUFAF2	"B17.2L, mimitin, MMTN, NDUFA12L"	ENSG00000164182	"NADH:ubiquinone oxidoreductase complex assembly factor 2"	Q8N183	5	60945129-61153037	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048082, HPA054776"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA048082: AB_2680254, HPA054776: AB_2682598"	"unprognostic (7.28e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (2.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"	25.5	25.9	22.5	16.7	24.9	11.4	27.1	13.6	24.4	16.9	20.5	11.7	8.2	16.0	16.3	12.2	19.3	12.6	15.0	33.6	19.9	21.2	19.1	27.2	11.9	13.4	20.5	14.2	23.5	41.2	14.2	25.3	9.8	18.5	19.0	18.2	13.2	16.0	16.8	56.3	12.9	13.3	23.9	18.3	10.0	17.2	20.1	12.6	4.9	17.7	16.0	12.3	26.9	19.5	15.9	20.9	1.5	13.1	17.3	20.3	9.1	31.0	16.4	11.3	36.5	22.1	31.3	21.4	36.4	19.4	23.1	28.4	27.3	22.5	39.1	37.7	24.7	12.9	19.4	31.8	28.7	20.7	27.8	13.5	29.3	25.5	33.3	19.5	8.0	16.9	34.4	21.0	63.9	20.6	22.2	20.9	24.1	24.6	17.3	28.8	9.4	39.0	19.1	31.2	53.0	22.0	13.4	23.9	10.7	22.7	19.7	35.3	23.5	13.8	19.1	16.7	25.4	35.8	40.2	15.3	22.0	43.0	22.1	35.1	19.3	0.0	13.1	1.5	12.5	11.9	14.3	15.9	15.9	14.6	20.9	11.0	13.9	14.3	0.6	17.3	9.1	7.5	20.3	9.1	22.5	24.9	13.6	24.4	19.9	21.2	20.5	14.2	18.5	12.6
NDUFAF4	"bA22L21.1, C6orf66, HRPAP20, HSPC125, My013"	ENSG00000123545	"NADH:ubiquinone oxidoreductase complex assembly factor 4"	Q9P032	6	96889313-96897881	"Disease related genes, Predicted intracellular proteins"		Calmodulin-binding	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA046560	Uncertain		Supported	Mitochondria				Mitochondria		"HPA046560: AB_10966700"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	7.9	10.1	16.1	5.4	19.0	2.7	9.0	20.4	27.4	8.9	9.1	5.0	5.7	6.2	7.3	6.4	7.1	6.0	6.0	30.2	18.7	17.3	17.3	18.1	4.3	5.4	18.1	12.3	10.4	7.2	7.3	6.5	6.1	28.5	9.5	9.7	4.5	7.7	12.8	25.0	6.2	6.5	7.3	9.6	7.6	6.4	5.7	8.4	4.9	9.5	11.2	5.8	8.2	5.1	6.4	4.5	0.6	4.3	3.3	10.0	4.1	1.5	4.2	7.4	9.9	7.4	4.3	3.9	4.1	3.9	6.1	4.7	5.7	2.6	13.9	7.5	3.8	3.0	17.1	6.3	6.0	9.7	13.5	15.4	2.3	4.9	8.0	16.1	6.5	4.0	9.9	5.3	5.4	4.8	13.8	9.5	9.6	4.7	10.3	8.7	14.0	6.9	4.9	4.1	7.1	10.2	4.1	12.6	5.9	2.1	7.5	11.7	2.3	10.8	4.0	3.2	2.4	11.3	6.7	2.2	3.5	13.7	4.4	12.1	4.7	0.2	2.2	0.6	5.1	4.3	6.6	6.4	6.7	6.7	3.8	6.3	10.0	8.8	0.4	3.3	2.6	4.5	6.8	4.1	16.1	19.0	20.4	27.4	18.7	17.3	18.1	12.3	28.5	8.4
NDUFB1	"CI-MNLL, MNLL"	ENSG00000183648	"NADH:ubiquinone oxidoreductase subunit B1"	O75438	14	92116122-92121917	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 161.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA063737	Supported		Supported	"Nuclear speckles,Mitochondria"				Mitochondria	"Nuclear speckles"	"HPA063737: "	"unprognostic (1.12e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.74e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.15e-2)"	"prognostic favourable (1.31e-5)"	"unprognostic (7.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-3)"	38.3	48.3	47.8	22.4	43.1	30.2	22.1	30.9	53.6	12.4	39.7	13.4	28.1	36.4	14.8	39.2	23.2	15.9	20.0	142.2	38.4	35.7	51.2	64.6	28.1	24.9	40.6	36.0	16.5	48.5	9.9	30.6	13.2	41.8	19.3	26.9	22.9	54.1	35.9	161.6	12.6	32.9	25.9	31.3	19.3	29.4	10.0	26.4	11.9	21.6	48.9	21.3	17.1	16.3	61.7	98.6	116.1	93.9	45.1	70.1	95.0	27.9	56.7	46.1	29.7	30.2	22.6	21.1	34.5	19.4	20.5	19.0	34.1	47.6	25.3	32.1	19.3	35.0	26.3	28.0	18.5	39.7	60.3	48.9	89.0	40.7	24.0	38.6	28.0	27.8	17.0	21.4	19.0	18.2	26.5	52.0	28.0	105.8	38.1	34.6	23.3	69.5	34.1	43.8	37.5	51.0	69.3	30.8	22.4	67.6	41.1	43.8	61.6	60.4	40.7	13.0	24.8	26.1	23.0	41.1	64.2	56.1	39.3	28.6	26.9	58.1	93.9	67.8	43.7	63.5	50.2	61.7	64.7	49.8	82.6	52.0	65.4	60.4	116.1	45.1	58.1	98.6	70.1	95.0	47.8	43.1	30.9	53.6	38.4	35.7	40.6	36.0	41.8	26.4
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596309-120602500	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051739	Enhanced		Supported	"Nuclear membrane,Mitochondria"				Mitochondria	"Nuclear membrane"	"HPA051739: "	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.79e-4)"	25.5	68.2	37.6	20.1	37.7	22.4	59.4	40.7	51.6	25.6	37.2	19.1	25.6	33.6	23.2	32.2	30.2	24.3	27.8	130.2	32.5	30.8	53.3	46.9	25.4	42.0	37.3	29.4	25.8	36.5	34.1	32.8	18.5	36.7	26.8	34.8	24.6	33.9	29.5	195.7	27.3	30.6	37.6	32.4	22.6	28.7	26.6	25.6	31.1	25.9	64.8	25.4	32.3	29.1	64.5	73.4	52.1	60.5	39.1	79.7	49.0	51.9	37.9	45.3	45.4	28.7	34.2	36.9	29.2	38.8	38.0	42.0	36.8	39.9	26.4	59.3	32.7	50.3	34.9	37.2	28.7	40.4	40.3	40.8	39.8	37.0	17.4	35.8	48.3	30.8	49.7	18.5	24.4	47.4	24.1	40.6	40.8	40.7	70.8	51.9	36.1	103.9	41.0	25.9	58.0	61.6	32.5	51.1	52.4	34.2	38.4	62.2	64.7	57.2	36.3	33.7	44.3	14.2	40.7	50.2	45.2	79.8	53.1	50.4	45.5	46.2	46.2	52.1	45.5	60.5	47.4	64.5	63.5	51.3	58.4	47.2	54.8	53.4	28.1	39.1	60.5	73.4	79.7	49.0	37.6	37.7	40.7	51.6	32.5	30.8	37.3	29.4	36.7	25.6
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"			Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favourable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	32.2	39.6	41.3	16.0	44.6	12.1	27.2	20.0	45.7	23.7	32.3	22.0	21.2	43.7	16.2	15.4	26.4	20.0	20.5	86.9	34.1	31.7	48.1	42.3	17.8	21.7	39.4	33.6	22.1	23.2	31.1	18.7	21.3	37.6	19.6	29.9	24.8	35.8	21.3	96.3	17.5	38.5	21.3	30.9	20.4	24.9	21.8	18.4	22.7	27.7	47.3	18.5	26.5	17.3	27.7	41.4	19.5	44.9	14.6	25.0	26.7	23.2	6.5	16.3	19.7	21.5	29.0	22.1	14.8	18.7	21.2	21.4	19.6	17.0	20.4	44.9	12.5	25.8	17.6	19.6	21.4	42.1	14.7	21.9	11.9	16.3	19.8	26.1	17.4	26.7	25.4	11.9	19.9	24.3	18.4	29.7	22.7	16.6	15.0	20.3	23.5	26.5	16.7	18.9	63.1	38.3	18.0	11.6	19.5	9.0	50.6	34.9	77.1	42.6	15.6	14.0	13.3	19.1	35.2	39.5	40.9	30.1	22.6	28.0	19.9	19.5	29.9	14.4	13.9	37.6	22.1	27.7	20.0	17.0	41.4	19.5	20.8	21.0	6.7	14.6	44.9	24.0	25.0	26.7	41.3	44.6	20.0	45.7	34.1	31.7	39.4	33.6	37.6	18.4
NDUFB6	"B17, CI"	ENSG00000165264	"NADH:ubiquinone oxidoreductase subunit B6"	O95139	9	32552999-32573184	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044001, HPA053334"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA044001: AB_10959448, HPA053334: "	"unprognostic (4.09e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"prognostic favourable (7.47e-10)"	"unprognostic (2.70e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	21.9	26.8	33.9	17.7	31.8	16.0	18.7	22.6	28.3	13.7	21.9	15.5	17.3	26.5	16.8	17.4	18.6	15.4	15.9	58.6	27.6	27.9	32.8	36.6	13.9	15.4	28.4	27.2	14.1	19.5	15.4	17.8	15.5	22.9	15.1	18.2	14.6	22.7	16.1	87.2	14.6	25.5	16.4	25.9	13.5	20.0	28.9	17.1	19.2	22.2	34.4	14.5	14.1	13.5	26.0	38.8	77.4	27.3	22.2	27.5	26.5	29.8	18.4	20.5	23.4	13.9	13.0	13.1	20.0	16.4	18.5	20.5	18.0	13.5	22.3	20.9	13.8	17.0	19.3	22.1	14.0	30.6	30.9	53.0	28.2	18.5	13.6	26.4	13.7	13.4	10.8	16.7	12.7	16.7	16.9	25.2	20.7	17.3	35.5	62.4	21.6	40.9	24.5	17.2	20.6	20.7	11.3	20.6	23.3	23.2	26.7	13.5	25.2	20.5	14.8	20.3	30.7	22.3	29.4	11.2	21.0	36.2	33.9	18.6	9.5	25.0	25.8	33.3	21.0	23.1	20.2	26.0	22.4	21.6	27.6	21.8	23.0	24.3	77.4	22.2	27.3	38.8	27.5	26.5	33.9	31.8	22.6	28.3	27.6	27.9	28.4	27.2	22.9	17.1
NDUFB9	"B22, LYRM3, UQOR22"	ENSG00000147684	"NADH:ubiquinone oxidoreductase subunit B9"	Q9Y6M9	8	124539103-124568510	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 221.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 254.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042768	Approved		Supported	Mitochondria				Mitochondria		"HPA042768: AB_10797508"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.64e-1)"	"prognostic favourable (3.42e-5)"	"unprognostic (9.54e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.74e-1)"	26.9	20.8	61.0	19.6	45.1	43.7	33.3	26.9	63.7	20.7	40.4	15.0	25.4	35.5	17.4	30.0	27.9	19.4	23.8	125.1	44.2	39.0	50.1	52.9	23.8	38.2	60.0	49.1	16.8	51.7	20.6	16.3	15.8	46.7	20.6	37.5	13.4	39.9	24.0	221.3	18.0	26.1	31.3	44.8	15.3	28.9	44.1	31.1	13.5	27.7	80.7	19.3	16.7	16.5	53.8	52.7	52.1	54.4	37.5	71.2	64.2	28.8	26.7	20.5	27.7	21.4	18.2	17.2	14.2	16.2	25.9	19.6	35.1	27.9	28.6	36.9	16.3	32.9	29.7	22.6	24.5	33.2	40.5	69.6	19.0	42.0	28.5	21.6	19.0	21.2	33.0	23.7	51.4	23.5	43.0	24.1	20.7	90.2	34.0	43.3	20.6	59.4	23.0	15.6	39.0	34.1	24.4	28.6	22.4	30.9	254.7	30.4	35.0	29.3	18.7	15.1	39.4	14.1	33.4	31.1	41.4	32.8	26.3	43.3	19.9	52.1	54.4	27.5	48.3	37.2	47.9	53.8	64.0	53.9	52.7	42.5	63.4	52.2	11.2	37.5	27.2	39.6	71.2	64.2	61.0	45.1	26.9	63.7	44.2	39.0	60.0	49.1	46.7	31.1
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044556	Approved		Supported	Mitochondria				Mitochondria		"HPA044556: AB_10794402"	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favourable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favourable (7.25e-4)"	7.4	17.0	15.2	6.4	15.8	5.6	8.3	12.2	15.7	8.5	13.1	11.8	7.0	15.2	6.6	12.0	11.7	8.3	7.7	55.5	12.4	14.6	20.3	17.1	8.4	6.7	13.0	12.1	9.7	13.1	11.4	14.3	8.9	10.0	8.1	12.6	11.3	10.9	10.5	164.1	9.1	16.4	7.2	10.4	10.5	11.9	27.1	8.5	6.1	11.6	57.6	9.4	7.0	7.3	32.7	40.0	40.8	24.4	12.8	31.4	26.1	8.6	3.6	10.6	13.1	7.6	8.3	8.4	10.7	7.1	7.9	6.0	6.4	10.8	3.8	3.9	7.5	5.1	20.6	7.0	6.3	5.4	6.6	6.0	7.1	10.2	9.5	5.0	3.3	11.9	10.5	7.5	11.1	7.8	13.8	16.2	5.4	6.1	7.3	12.3	8.1	4.9	6.2	6.5	28.7	12.7	5.6	8.9	6.8	7.6	9.4	4.9	10.3	9.7	3.8	7.8	3.7	5.4	6.0	13.0	22.9	9.5	8.4	13.1	6.2	16.0	24.4	40.8	21.7	17.3	17.3	28.3	24.4	23.2	24.0	32.7	31.4	23.1	15.4	12.8	18.8	40.0	28.3	26.1	15.2	15.8	12.2	15.7	12.4	14.6	13.0	12.1	10.0	8.5
NDUFC2	"B14.5b, HLC-1"	ENSG00000151366	"NADH:ubiquinone oxidoreductase subunit C2"	O95298	11	78068304-78080219	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038873, HPA056195"	Approved		Supported	Mitochondria				Mitochondria		"HPA038873: AB_10673480, HPA056195: "	"unprognostic (7.32e-2)"	"unprognostic (5.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"prognostic favourable (5.00e-5)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.61e-3)"	55.0	70.8	40.8	23.3	44.4	32.3	46.2	51.4	58.4	22.5	41.1	31.2	68.0	63.4	31.8	32.8	41.8	35.6	31.9	60.4	41.0	44.5	37.5	89.6	30.1	36.4	43.2	47.0	27.3	48.4	25.3	34.7	31.8	40.8	27.3	20.3	29.7	79.5	59.0	122.8	29.0	55.3	23.7	41.1	24.5	36.6	28.6	23.2	26.9	63.5	43.7	23.3	31.9	24.1	50.3	78.2	70.3	73.2	44.5	46.3	81.2	36.1	45.2	24.6	15.5	23.4	14.8	30.3	44.3	26.6	35.2	25.1	121.1	40.7	21.7	81.3	20.9	38.2	18.5	26.0	13.5	41.1	52.3	23.3	46.9	95.3	40.0	50.9	23.2	20.4	24.2	27.0	10.2	23.9	45.9	36.6	19.6	62.4	33.2	91.8	27.7	57.1	29.1	46.8	73.3	26.6	54.5	34.8	30.8	31.5	65.0	22.8	51.5	42.3	31.2	34.3	42.3	81.7	37.9	33.7	66.1	49.9	19.5	30.6	32.8	65.8	73.2	70.3	39.4	58.2	36.2	50.3	45.6	41.5	77.2	45.5	39.6	41.3	21.0	44.5	48.0	78.2	46.3	81.2	40.8	44.4	51.4	58.4	41.0	44.5	43.2	47.0	40.8	23.2
NDUFC2-KCTD14		ENSG00000259112	"NDUFC2-KCTD14 readthrough"	E9PQ53	11	78016971-78079865	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.3;EFO-21: 8.4;RPMI-8226: 7.4;U-2 OS: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038873, HPA056195"	Approved		Supported	Mitochondria				Mitochondria		"HPA038873: AB_10673480, HPA056195: "																		7.1	11.3	6.3	5.8	7.9	9.7	8.9	13.8	11.7	9.6	7.4	5.5	13.8	27.3	8.8	5.9	9.5	9.7	5.6	11.3	7.7	7.1	6.9	18.7	6.6	6.7	6.4	9.1	6.6	8.8	5.4	5.6	5.6	7.7	8.4	6.3	5.1	18.0	11.8	10.1	5.7	10.6	5.9	5.9	5.9	15.9	4.9	3.7	4.5	12.7	8.3	4.8	4.6	6.1	30.7	37.7	30.7	33.7	16.5	33.2	39.7	0.0	2.1	0.6	0.6	0.6	0.0	1.3	1.5	0.9	1.2	2.9	10.3	1.2	0.2	8.4	0.0	0.3	1.7	0.0	0.7	5.9	0.0	1.2	0.0	0.0	0.7	0.8	2.1	0.0	0.3	0.3	1.8	0.9	0.3	0.1	0.2	0.0	3.0	1.1	5.2	0.3	1.0	0.1	7.4	0.0	0.0	1.5	2.3	0.0	1.1	3.3	0.6	1.1	0.9	0.5	12.9	4.2	0.0	1.2	1.4	2.9	0.8	0.3	1.4	22.5	33.7	30.7	24.5	24.1	19.3	30.7	22.8	23.0	37.7	23.7	20.5	21.5	10.0	16.5	25.7	37.5	33.2	39.7	6.3	7.9	13.8	11.7	7.7	7.1	6.4	9.1	7.7	3.7
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Approved		Supported	Mitochondria				Mitochondria		"CAB070844: , HPA064605: "	"prognostic unfavourable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	13.9	29.0	12.1	8.3	22.1	7.6	10.3	11.6	26.4	9.1	17.4	16.4	9.2	18.3	9.1	7.7	15.7	7.7	7.3	62.6	11.3	11.7	29.5	30.7	8.3	7.7	13.3	13.8	8.2	9.3	22.1	11.6	10.8	24.2	10.7	18.9	13.5	12.8	10.9	99.5	11.0	19.9	11.1	10.8	8.4	14.9	8.8	11.1	11.2	10.8	34.7	10.5	11.6	9.4	10.7	15.3	15.7	21.4	12.5	16.1	8.9	12.9	13.0	18.8	13.6	17.6	14.3	21.9	19.1	20.7	31.9	23.2	33.5	15.2	14.7	16.9	23.8	18.2	25.1	18.5	28.4	6.7	11.8	29.4	32.1	30.0	18.3	21.1	13.3	17.4	10.9	25.0	19.7	24.8	31.7	14.9	20.8	16.2	17.4	14.0	17.5	23.1	17.7	26.3	25.4	26.4	23.8	18.4	14.4	22.0	21.6	31.2	19.0	20.5	18.9	17.6	15.7	17.2	18.1	14.4	17.3	21.9	17.7	17.6	18.0	12.0	13.3	15.7	13.6	15.4	10.8	10.7	12.2	13.0	15.3	9.5	10.9	12.4	9.6	12.5	21.4	8.2	16.1	8.9	12.1	22.1	11.6	26.4	11.3	11.7	13.3	13.8	24.2	11.1
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214395	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria			16000	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	14.6	30.7	16.6	8.0	25.4	10.2	15.5	23.4	25.4	13.0	25.6	17.9	11.7	23.6	12.3	11.2	16.7	14.5	10.6	75.4	17.6	14.8	37.4	52.6	12.8	9.2	28.0	25.0	14.1	14.3	25.6	10.7	11.5	24.1	12.7	27.2	11.4	14.6	14.5	104.9	14.0	22.1	15.7	16.1	13.0	19.4	8.8	25.3	10.4	12.3	37.1	15.1	13.2	10.5	18.9	47.3	26.6	42.2	20.3	29.2	32.4	18.0	29.1	18.4	21.3	27.0	24.0	15.9	16.4	24.1	32.4	25.6	31.8	18.8	22.9	30.9	25.2	24.2	29.3	29.3	28.7	15.2	24.7	22.4	21.8	27.8	28.0	24.2	20.8	34.6	25.9	26.2	30.0	37.1	28.6	12.5	30.4	20.8	15.3	12.9	33.5	26.8	13.3	19.0	32.2	38.5	21.6	19.5	29.0	19.8	48.9	27.9	44.0	63.4	23.7	15.8	13.5	11.0	22.1	17.6	27.9	19.2	24.1	20.5	20.3	26.6	35.9	18.9	20.5	42.2	19.9	18.9	20.9	20.7	47.3	15.7	21.6	21.8	20.2	20.3	37.0	31.8	29.2	32.4	16.6	25.4	23.4	25.4	17.6	14.8	28.0	25.0	24.1	25.3
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004484	Approved		Supported	"Nuclear bodies,Mitochondria"				Mitochondria	"Nuclear bodies"	"HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favourable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	13.4	22.9	29.7	13.2	46.3	25.5	18.1	23.9	35.0	16.6	28.4	16.5	16.1	31.4	12.7	16.0	19.1	17.3	16.3	45.8	26.0	24.8	34.1	32.0	12.0	13.9	29.4	24.9	12.2	23.0	21.4	17.0	12.0	26.0	13.9	30.9	14.4	20.1	17.4	100.9	15.1	28.9	15.9	17.1	14.2	18.9	15.1	15.4	20.5	16.1	51.6	18.8	14.5	11.7	25.0	36.1	18.7	31.2	16.4	23.8	31.5	11.5	21.9	18.6	19.3	16.1	16.6	15.9	11.0	18.8	27.1	25.8	32.2	20.3	25.6	10.9	15.6	21.3	26.2	19.7	22.1	13.7	42.3	15.5	30.8	31.1	16.5	37.9	20.2	16.2	14.3	10.2	17.0	17.0	22.6	17.8	17.5	35.2	25.9	49.2	26.3	31.0	31.7	26.7	21.1	23.2	18.0	20.8	15.0	14.0	24.1	24.8	26.9	36.3	11.9	16.2	18.2	18.8	24.7	20.4	27.0	28.4	16.5	29.2	16.1	12.2	28.6	18.7	18.7	31.2	19.8	25.0	19.7	20.3	33.7	23.1	18.8	20.1	7.5	16.4	25.0	36.1	23.8	31.5	29.7	46.3	23.9	35.0	26.0	24.8	29.4	24.9	26.0	15.4
NDUFS4	"AQDQ, CI-18"	ENSG00000164258	"NADH:ubiquinone oxidoreductase subunit S4"	O43181	5	53560633-53683340	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003884	Supported		Supported	Mitochondria				Mitochondria		"HPA003884: AB_1079465"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.44e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.73e-3)"	"unprognostic (6.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.11e-1)"	"prognostic favourable (3.85e-6)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	27.5	26.5	29.8	15.7	35.7	14.3	34.0	23.3	35.3	20.8	30.0	12.9	21.3	27.6	24.0	24.2	27.0	22.9	20.9	65.1	24.4	23.2	45.3	48.1	18.7	14.9	28.5	34.4	35.7	19.5	22.2	24.9	20.7	26.7	22.9	30.5	16.4	24.4	26.3	105.5	23.0	25.5	34.3	27.0	13.6	24.1	20.9	24.6	12.9	25.1	67.3	19.3	21.7	22.4	24.3	41.0	6.7	32.8	24.5	25.2	21.9	30.0	26.7	53.2	31.4	36.4	52.8	44.8	36.6	35.8	40.8	50.0	32.5	39.6	21.4	48.3	31.2	22.2	18.8	43.7	47.1	19.8	36.0	14.7	26.6	29.2	38.8	35.4	25.6	43.8	50.6	28.1	49.6	35.4	12.5	23.4	37.2	28.1	26.6	29.7	16.1	30.2	32.1	30.1	42.1	43.4	29.1	24.6	26.6	25.1	24.4	43.0	39.1	37.3	27.0	25.1	26.7	18.2	47.8	18.0	22.4	25.8	26.7	52.0	36.0	6.7	28.9	2.4	17.5	32.8	19.5	24.3	22.2	20.2	41.0	16.5	25.1	25.2	2.4	24.5	32.4	31.0	23.5	21.9	29.8	35.7	23.3	35.3	24.4	23.2	28.5	34.4	26.7	24.6
NDUFS8	"CI-23k, TYKY"	ENSG00000110717	"NADH:ubiquinone oxidoreductase core subunit S8"	O00217	11	68030617-68036644	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018524	Approved		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA018524: AB_1854355"	"unprognostic (2.90e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favourable (3.27e-8)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.45e-2)"	26.0	62.0	29.9	16.9	40.5	21.0	19.1	18.4	50.1	18.6	24.7	19.7	24.3	34.7	18.2	15.1	28.3	19.0	22.7	82.4	26.5	27.5	50.3	47.6	16.3	19.1	28.3	22.4	20.8	41.3	25.4	26.7	18.0	25.9	22.9	18.3	30.1	41.3	32.2	156.6	17.3	26.7	19.8	18.2	20.3	25.0	21.1	15.7	29.6	29.2	53.9	24.2	19.1	14.8	37.3	66.6	23.6	46.1	59.0	39.6	42.6	26.8	66.7	18.5	25.1	13.8	12.4	24.3	19.1	16.6	29.6	23.0	62.1	28.7	20.8	34.8	16.5	33.2	21.2	23.2	10.6	24.8	48.8	18.9	42.5	32.6	33.0	17.7	20.9	15.6	24.1	21.7	24.9	19.8	19.4	22.6	19.3	63.7	38.9	37.9	22.7	56.6	27.1	17.9	67.3	37.2	21.8	23.2	18.9	13.9	32.2	67.5	44.2	19.4	15.3	28.7	25.3	41.6	26.3	30.9	32.5	17.6	46.2	21.3	20.0	15.8	46.1	23.6	39.6	45.1	37.0	37.3	34.2	36.0	63.3	30.2	33.0	36.7	4.4	59.0	24.9	66.6	39.6	42.6	29.9	40.5	18.4	50.1	26.5	27.5	28.3	22.4	25.9	15.7
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67606852-67612535	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 150.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Approved		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: "	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favourable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	23.3	28.9	27.3	20.7	33.9	20.3	18.9	32.9	48.8	18.5	33.0	23.1	19.2	40.6	19.4	21.5	25.5	22.5	23.4	93.0	26.5	24.1	39.0	41.5	15.9	20.6	31.5	40.5	24.6	38.3	49.2	18.8	15.7	34.8	16.1	25.1	17.6	27.3	27.0	150.8	28.4	30.3	22.7	23.1	21.5	28.2	30.2	24.3	18.3	23.4	67.9	20.3	18.7	18.6	23.8	41.2	13.5	30.7	36.2	28.2	24.3	26.2	28.2	14.4	28.8	18.0	18.1	26.9	16.4	15.8	25.7	17.2	53.3	31.8	48.5	34.6	14.1	35.4	30.3	25.6	8.1	24.6	23.9	19.9	38.3	26.3	25.5	27.0	22.2	26.8	24.8	20.9	18.7	22.7	36.1	39.7	15.6	39.4	31.5	53.5	14.1	35.5	36.6	27.9	78.7	20.8	19.7	22.9	21.6	20.7	72.5	54.7	36.8	27.5	18.0	24.9	18.6	35.4	17.2	38.8	22.1	24.2	29.0	28.6	23.9	12.6	26.7	13.5	25.9	30.7	28.2	23.2	21.7	24.5	41.2	23.8	20.2	25.1	4.8	36.2	17.4	26.5	27.8	24.3	27.3	33.9	32.9	48.8	26.5	24.1	31.5	40.5	34.8	24.3
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003404, HPA077896"	Supported		Supported	Mitochondria				Mitochondria		"HPA003404: AB_1079466, HPA077896: "	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	20.0	34.5	25.2	18.0	23.7	31.1	25.6	20.6	37.3	15.6	26.1	13.1	20.3	23.1	14.7	21.5	27.5	13.9	17.6	82.6	22.7	23.8	40.7	89.1	17.2	29.9	26.7	19.4	11.2	36.3	14.9	14.9	21.6	26.2	20.8	27.8	17.8	20.1	20.2	122.6	17.4	24.4	23.5	20.8	19.3	25.2	19.0	12.7	20.5	20.5	59.5	22.7	20.4	14.1	55.6	74.7	49.3	45.1	27.0	53.5	48.1	19.6	20.7	23.9	22.2	17.8	25.3	20.3	24.8	39.5	32.9	31.2	38.6	16.3	30.4	22.8	23.3	10.0	23.2	25.8	31.5	15.3	20.5	19.4	21.3	52.1	20.5	54.0	24.2	21.3	21.6	20.2	22.0	35.4	30.9	96.1	30.1	24.7	37.7	47.4	20.0	25.8	18.0	17.7	115.3	52.4	32.0	25.2	18.7	24.5	28.0	31.2	26.2	41.2	21.6	41.9	29.8	30.0	32.2	27.8	41.2	34.1	29.8	24.0	27.0	49.3	39.9	44.1	30.2	45.1	37.6	55.6	45.5	35.7	56.6	43.6	40.0	36.9	18.0	27.0	41.6	74.7	53.5	48.1	25.2	23.7	20.6	37.3	22.7	23.8	26.7	19.4	26.2	12.7
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria				Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	18.1	14.1	16.9	11.1	17.2	15.8	14.6	11.8	23.2	12.0	15.9	11.9	14.6	15.2	15.1	15.7	15.6	12.7	15.4	54.9	14.2	11.0	15.1	24.3	10.8	12.5	14.0	18.6	16.0	17.7	13.2	13.1	11.6	19.2	13.6	11.4	12.2	19.4	21.8	129.5	15.4	13.5	16.9	16.0	13.3	14.3	20.3	13.3	6.6	11.6	18.5	10.6	13.3	11.8	9.9	22.9	16.0	22.8	10.5	8.8	10.3	9.6	11.3	11.0	18.0	13.6	11.8	13.6	19.2	11.0	11.4	9.6	20.7	11.9	10.7	15.2	7.1	10.5	12.8	16.9	7.5	6.1	15.4	35.2	13.3	16.2	21.3	12.0	18.5	13.3	14.7	11.6	18.4	14.4	27.9	13.9	13.1	18.9	8.0	18.2	14.3	22.4	13.8	8.0	33.4	15.4	12.8	8.0	8.4	19.2	22.8	12.7	19.5	15.9	16.9	10.8	7.5	13.8	13.6	20.8	13.7	12.1	14.1	21.6	16.2	3.7	21.4	16.0	8.0	22.8	8.1	8.1	7.6	6.7	22.9	9.9	8.8	7.7	3.8	10.5	19.6	11.3	8.8	10.3	16.9	17.2	11.8	23.2	14.2	11.0	14.0	18.6	19.2	13.3
NECAB1	EFCBP1	ENSG00000123119	"N-terminal EF-hand calcium binding protein 1"	Q8N987	8	90791550-90959408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 56.4"	"Cell line enhanced"	"Detected in many"		"HEL: 6.1;MOLT-4: 6.4;U-266/70: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB068208: , CAB068209: , CAB068210: , HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815"	"unprognostic (8.09e-3)"	"unprognostic (3.78e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.96e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.39e-3)"	2.7	4.9	19.7	2.0	27.3	3.2	1.5	0.5	56.4	1.4	3.7	12.1	0.3	1.7	4.1	4.4	3.6	1.6	3.1	10.9	19.5	9.8	3.4	1.1	6.8	1.4	16.0	30.7	3.8	1.3	1.9	1.9	2.8	10.8	2.6	1.1	4.1	2.5	2.0	1.3	1.9	1.8	1.3	18.7	2.4	2.1	5.2	17.4	0.0	2.9	0.0	1.0	4.2	1.2	0.5	1.8	0.3	0.0	0.7	0.9	0.2	0.2	0.1	2.3	0.4	0.0	0.1	0.1	2.5	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.0	0.0	0.1	0.0	4.7	6.1	2.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	4.1	4.4	0.0	4.9	6.4	3.1	0.9	0.1	0.0	4.0	0.0	0.0	0.0	4.1	4.4	0.1	0.0	2.1	0.0	0.2	1.5	3.9	3.8	0.0	1.6	6.1	3.7	3.2	3.8	0.0	1.8	0.0	0.0	0.1	0.6	0.0	0.4	0.2	0.4	0.6	0.1	0.5	0.6	0.9	0.3	0.7	0.0	1.8	0.9	0.2	19.7	27.3	0.5	37.1	19.5	9.8	16.0	30.7	10.8	17.4
NECAB3	"APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51"	ENSG00000125967	"N-terminal EF-hand calcium binding protein 3"	Q96P71	20	33657087-33674463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 49.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044785, HPA070595, HPA071786"	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"HPA044785: , HPA070595: , HPA071786: "	"unprognostic (8.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (3.19e-5)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (7.81e-4)"	"unprognostic (6.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-1)"	7.7	29.1	13.9	5.6	10.5	2.3	6.4	3.8	30.0	5.7	8.1	7.1	9.4	14.6	4.9	8.4	6.5	6.9	5.5	30.5	13.2	10.0	6.4	6.3	11.9	2.9	11.3	15.0	22.4	13.6	10.9	5.5	4.9	15.5	23.8	5.4	6.9	13.7	9.7	49.7	3.3	8.3	7.4	6.8	3.4	13.6	6.5	5.5	0.4	10.6	10.8	3.3	7.7	7.8	1.2	2.6	3.5	6.5	2.4	3.0	1.2	4.4	3.9	2.8	5.8	2.3	4.5	13.9	6.2	2.3	4.0	3.5	18.1	2.9	4.9	14.8	3.6	5.3	2.9	1.8	1.5	1.7	4.3	4.7	16.3	21.0	6.1	1.1	4.5	5.7	2.7	3.7	1.2	2.6	6.7	2.6	5.1	6.8	1.7	4.7	1.2	9.8	5.2	7.4	8.5	3.7	3.3	18.2	5.1	14.3	16.0	6.3	20.3	5.6	2.2	4.9	7.0	6.4	6.9	10.0	4.1	8.9	9.7	2.2	2.1	0.0	2.7	3.5	0.8	2.5	1.9	0.5	1.3	0.7	2.6	1.2	1.0	0.3	0.1	2.4	6.5	0.1	3.0	1.2	13.9	10.5	3.8	30.0	13.2	10.0	11.3	15.0	15.5	5.5
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070995-161089599	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;placenta: 46.6;skin 1: 39.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.9;HaCaT: 18.0;MCF7: 11.2;SK-BR-3: 23.4;T-47d: 15.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"		11000	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0.0	0.1	0.0	0.5	4.4	0.0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2.0	0.1	0.1	4.5	0.2	0.0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0.0	5.1	0.1	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.1	0.0	18.0	0.0	0.6	0.1	0.0	0.2	0.0	0.4	5.2	0.0	0.0	0.3	0.0	7.2	1.5	1.8	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.1	23.4	0.0	15.2	0.0	0.0	0.0	1.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	1.2	0.2	0.0	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
NEDD8	Nedd-8	ENSG00000129559	"Neural precursor cell expressed, developmentally down-regulated 8"	Q15843	14	24216852-24232454	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol			5700000	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: , HPA060254: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	38.2	48.1	55.5	30.7	58.1	34.6	42.2	34.1	62.4	41.0	36.3	26.8	32.6	25.0	32.2	59.9	40.3	34.3	31.3	50.7	47.1	49.5	46.5	48.4	30.5	31.5	49.4	54.6	34.3	33.4	101.1	31.3	39.7	45.5	31.6	40.0	27.4	37.2	40.7	70.7	36.5	28.4	43.0	36.0	34.9	29.9	25.7	34.3	26.9	37.5	44.7	46.8	30.7	32.0	60.2	76.1	90.2	60.1	43.2	64.1	89.9	25.5	44.8	36.5	25.7	41.4	36.2	26.5	35.0	37.1	41.2	38.1	30.9	31.3	22.1	20.5	49.2	27.0	36.3	54.6	58.0	31.2	22.0	23.6	41.3	105.3	36.0	39.0	24.7	38.4	36.3	34.7	27.3	49.2	21.0	25.9	63.5	56.9	31.0	37.0	26.9	52.5	22.1	28.9	22.5	47.5	48.7	15.4	35.9	30.2	30.8	25.1	18.6	31.0	36.8	23.5	23.6	30.0	30.9	30.8	46.4	32.0	16.8	22.5	22.2	73.5	57.9	90.2	46.8	60.1	50.7	60.2	54.4	51.9	56.9	51.1	51.2	52.0	62.2	43.2	59.0	76.1	64.1	89.9	55.5	58.1	34.1	62.4	47.1	49.5	49.4	54.6	45.5	34.3
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913012-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 144.7"	"Cell line enriched"	"Detected in some"	23	"HEK 293: 286.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	1.5	18.9	20.3	2.0	24.2	1.3	1.3	10.9	87.6	9.7	2.0	5.6	0.0	1.3	3.8	1.3	4.7	1.3	1.4	1.3	36.1	25.0	2.2	1.2	1.3	1.3	52.2	22.4	2.0	2.5	1.2	3.3	1.4	144.7	2.5	1.9	3.4	1.3	26.9	1.9	1.3	1.5	3.3	26.7	1.3	1.5	12.4	4.9	0.0	1.3	0.0	1.6	1.3	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	286.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.3	24.2	10.9	71.9	36.1	25.0	52.2	22.4	144.7	4.9
NEIL1	"FLJ22402, FPG1, hFPG1, NEI1"	ENSG00000140398	"Nei like DNA glycosylase 1"	Q96FI4	15	75346955-75357114	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.7;memory B-cell: 4.0;naive B-cell: 6.5;NK-cell: 14.1"	"Group enriched"	"Detected in many"	12	"B-cells: 6.5;NK-cells: 14.1;T-cells: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054084	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA054084: "	"unprognostic (9.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (3.50e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.27e-3)"	7.1	14.8	12.9	28.2	14.5	6.8	9.3	24.4	15.4	10.8	8.3	4.9	23.2	10.1	8.4	11.6	6.4	10.0	10.2	5.3	12.8	5.7	7.9	9.1	9.3	9.8	6.0	9.8	11.0	10.8	9.1	9.0	4.6	8.0	10.4	2.4	7.1	25.0	24.2	13.6	11.7	9.5	4.3	5.9	6.8	9.9	3.8	7.0	15.4	8.2	5.2	13.3	7.5	8.5	6.5	0.2	0.7	0.5	14.1	4.7	1.0	2.1	3.6	2.4	1.5	0.7	0.8	4.5	1.3	0.0	0.5	0.1	0.6	4.0	11.4	2.1	0.2	6.3	1.4	0.4	0.0	5.6	9.3	1.9	9.9	1.8	0.9	2.2	2.7	0.3	1.8	0.6	0.0	1.4	1.2	3.4	0.4	2.9	0.4	6.2	2.1	0.8	2.1	1.4	0.5	2.1	2.4	1.4	2.8	2.2	1.0	3.1	4.2	3.3	6.2	1.3	2.5	1.9	1.1	5.3	5.2	9.3	1.2	9.3	1.2	0.0	0.5	0.0	4.7	0.1	1.3	4.0	0.8	1.0	0.2	6.5	1.4	1.4	0.7	14.1	0.1	0.2	0.2	1.0	12.9	14.5	24.4	15.4	12.8	5.7	6.0	9.8	8.0	7.0
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787346	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA073029: , HPA073916: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.05e-1)"	10.2	21.8	18.7	6.8	17.7	2.7	10.3	11.8	20.9	11.3	5.6	9.0	7.0	3.6	9.9	15.4	6.5	17.9	6.9	14.2	15.4	20.0	9.3	11.0	7.7	8.4	18.4	16.1	12.6	10.9	7.8	13.2	7.6	20.3	10.5	6.1	9.7	11.5	10.3	24.7	18.1	4.6	10.2	12.3	9.5	5.1	26.8	13.3	1.8	15.5	7.1	7.9	7.4	15.8	14.7	5.5	0.8	2.5	9.1	13.6	4.7	5.1	14.5	9.1	17.7	4.4	8.1	4.1	8.2	6.8	8.0	5.5	4.4	5.6	2.0	3.2	9.8	4.5	8.6	9.0	11.0	6.0	4.3	7.1	3.4	8.6	3.5	3.0	5.3	7.2	13.3	6.9	6.4	7.4	9.9	6.9	9.4	5.4	0.5	3.2	8.1	7.8	8.9	11.7	5.5	9.2	7.7	14.0	11.1	6.4	3.4	11.6	5.4	0.5	9.1	9.1	13.1	2.4	11.4	6.5	13.5	3.6	23.9	10.5	18.4	0.4	1.5	0.1	9.1	2.5	12.1	14.7	9.3	10.8	3.0	11.4	13.6	12.0	0.8	9.1	1.1	5.5	5.8	4.7	18.7	17.7	11.8	19.8	15.4	20.0	18.4	16.1	20.3	13.3
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309836-177362943	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 70.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.5;HL-60: 28.8;Karpas-707: 37.9;MOLT-4: 29.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065761			Enhanced	Nucleoplasm				Nucleoplasm		"HPA065761: "	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.5	0.4	0.2	7.4	0.2	9.3	0.7	0.1	0.2	0.8	1.5	0.1	0.1	1.5	0.5	0.1	5.6	0.2	0.3	0.5	0.2	0.2	0.4	0.4	0.9	5.1	0.2	0.1	0.3	0.2	0.0	0.2	1.6	0.2	0.2	2.1	0.2	0.8	0.1	0.2	3.4	1.7	0.5	0.7	1.5	0.8	3.5	0.3	70.8	0.2	1.1	5.0	0.7	1.3	0.2	0.3	0.8	0.0	1.6	1.6	0.2	7.0	5.9	6.3	3.1	0.7	1.3	3.1	8.8	3.2	9.8	5.8	2.1	6.2	7.8	1.3	2.3	3.3	6.6	3.5	14.2	26.5	4.3	5.4	4.6	5.6	0.2	28.8	3.7	0.1	0.2	10.1	2.2	3.7	5.5	37.9	6.3	3.1	29.2	11.1	2.9	4.3	5.9	4.3	2.5	2.5	0.9	4.9	3.4	4.4	5.1	2.4	4.1	7.5	1.7	5.9	4.6	3.0	8.8	2.6	1.7	12.4	3.9	10.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.2	0.0	1.1	0.8	1.6	0.0	0.3	1.6	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.3
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392857-169612629	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favourable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	9.6	10.5	13.5	9.2	15.8	6.0	8.7	20.7	14.5	13.6	8.4	12.5	7.1	5.4	12.4	9.1	7.9	15.7	10.2	11.4	13.7	13.2	10.2	6.9	7.7	8.0	15.9	11.3	16.3	6.6	15.3	16.5	7.2	16.0	11.6	7.7	8.9	6.4	10.6	7.1	4.7	5.7	11.1	18.2	8.0	8.1	18.3	14.8	14.7	13.3	6.4	7.4	10.0	8.2	4.5	3.3	6.7	3.3	2.2	5.3	1.3	4.2	1.9	7.8	8.4	12.1	13.6	2.5	9.0	8.1	7.2	6.9	2.4	5.1	11.3	1.7	7.8	1.4	7.3	7.6	8.2	12.4	5.0	7.6	7.8	2.9	7.2	7.7	6.1	10.8	4.4	7.3	12.9	7.0	13.5	21.6	9.2	2.7	9.9	3.4	2.5	4.5	6.1	5.1	3.6	7.6	5.0	8.5	9.7	6.5	3.2	6.0	4.0	3.4	8.4	4.6	4.2	4.8	6.0	8.7	13.4	8.7	7.6	3.8	8.0	6.7	2.1	1.8	4.4	3.3	4.8	4.4	3.4	2.7	1.5	4.5	5.1	5.3	1.1	2.2	1.6	3.3	3.2	1.3	13.5	15.8	20.7	12.9	13.7	13.2	15.9	11.3	16.0	14.8
NEK11	FLJ23495	ENSG00000114670	"NIMA related kinase 11"	Q8NG66	3	131026850-131350465	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016908	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA016908: AB_1854364"	"unprognostic (9.15e-3)"	"prognostic favourable (7.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"prognostic favourable (5.92e-6)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	3.9	5.8	9.3	2.7	11.1	0.5	8.7	2.7	7.6	7.3	2.8	11.2	8.4	2.0	6.5	16.0	3.2	26.9	6.0	2.9	9.1	10.0	8.2	1.1	5.5	1.7	7.8	5.4	8.7	2.8	5.0	9.3	4.6	17.3	4.0	3.3	3.0	3.8	6.7	1.7	2.8	2.6	4.3	7.3	1.8	2.3	17.8	5.5	0.2	12.3	2.5	1.7	4.2	3.0	0.9	1.0	1.1	1.3	0.3	2.9	0.3	5.8	2.4	1.7	5.1	6.9	10.4	1.0	2.9	5.4	4.4	3.4	2.2	8.2	0.3	2.1	5.1	3.2	0.5	5.0	6.2	0.5	0.7	0.8	0.4	1.0	2.3	0.6	1.5	4.3	8.4	4.7	2.1	0.9	0.2	0.9	7.4	4.1	0.1	0.5	0.5	2.3	0.0	0.2	0.1	10.1	2.3	2.2	2.4	1.4	0.1	1.9	4.8	0.1	0.9	4.6	2.2	3.6	1.3	1.3	2.3	0.1	3.2	0.2	0.8	0.0	0.3	1.1	0.6	1.3	1.2	0.9	2.9	2.6	0.5	0.6	1.0	0.8	0.9	0.3	0.9	1.0	1.5	0.3	9.3	11.1	2.7	7.6	9.1	10.0	7.8	5.4	17.3	5.5
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: "	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (9.47e-6)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.3	21.9	16.8	12.0	1.0	1.7	18.5	11.7	11.0	20.7	17.8	11.7	29.8	16.1	5.7	9.0	16.3	14.5	8.8	26.1	24.6	12.1	7.7	19.1	15.7	0.1	15.2	10.5	0.5	1.0	15.9	17.2	13.2	21.1	28.4	20.7	8.4	16.5	10.3	15.9	11.2	16.4	25.7	24.5	7.2	8.7	15.2	16.9	16.9	19.0	14.7	29.2	9.1	6.9	10.3	20.5	20.3	31.4	11.8	21.7	21.3	9.0	11.7	17.1	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708449-52770949	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol				Cytosol		"HPA015750: AB_1854367, HPA058543: "	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	7.2	10.7	15.5	9.1	15.7	7.3	11.0	20.2	16.1	10.6	8.4	10.6	9.6	7.6	10.3	10.7	8.1	15.8	7.5	7.4	12.5	14.2	11.6	12.4	7.7	8.8	12.7	8.6	15.8	10.2	13.4	17.6	8.7	11.9	9.4	9.7	9.1	8.5	11.3	10.8	5.3	6.6	9.5	10.7	7.9	11.0	47.7	12.4	11.1	15.5	5.0	10.4	9.3	10.7	5.1	6.4	12.4	11.8	4.6	5.2	5.5	12.8	10.0	13.7	10.8	12.6	9.1	14.9	9.1	12.3	17.1	17.3	8.7	9.6	13.2	4.3	8.9	6.0	16.7	10.7	23.0	13.1	7.0	10.3	12.2	11.1	7.8	25.1	10.4	5.6	9.9	21.9	14.6	6.4	12.8	10.7	10.7	10.9	13.5	9.2	11.9	9.9	11.9	12.0	9.7	9.6	18.5	10.1	6.1	19.1	11.8	9.0	11.0	15.2	5.8	11.5	11.7	18.3	16.8	12.0	17.5	13.0	13.1	11.9	12.4	12.4	11.8	5.8	4.6	7.3	5.2	3.6	4.0	4.8	6.4	5.1	4.9	4.2	1.8	4.6	4.8	3.2	3.1	5.5	15.5	15.7	20.2	16.1	12.5	14.2	12.7	8.6	11.9	12.4
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB045993: AB_2150651, HPA056828: "	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	14.8	5.3	26.1	22.2	29.1	12.8	18.8	7.2	21.2	20.5	15.6	13.4	4.3	12.5	9.2	7.5	6.8	8.5	18.4	7.0	17.1	16.6	12.9	51.9	17.0	18.1	19.4	13.3	11.2	20.5	1.6	6.4	21.4	14.7	14.8	16.6	18.5	16.9	13.2	5.5	5.1	18.2	23.4	13.0	11.3	19.0	5.8	12.9	4.0	6.3	1.9	22.0	17.7	10.1	21.9	11.5	29.0	18.8	8.3	3.8	7.6	7.7	12.7	12.3	4.8	23.4	30.4	15.3	9.7	15.6	15.1	12.6	12.1	14.5	9.4	15.6	18.8	1.5	6.3	28.3	10.3	10.3	5.6	25.9	10.7	21.1	27.9	4.6	65.0	40.6	4.6	14.3	14.9	16.4	4.6	0.4	27.0	8.1	0.2	5.1	3.1	11.6	10.0	9.2	4.8	16.2	2.8	5.5	1.9	3.2	6.1	13.8	13.1	19.1	32.1	11.1	11.2	7.6	6.6	2.1	2.6	5.4	13.9	10.6	14.7	10.2	18.8	29.0	3.8	12.3	2.4	21.9	2.3	3.2	11.5	9.0	0.4	1.6	23.4	8.3	14.7	10.6	2.8	7.6	26.1	29.1	7.2	21.2	17.1	16.6	19.4	13.3	14.7	12.9
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156963-198322420	"Enzymes, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 83.7;fHDF/TERT166: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	31.7	31.4	24.9	15.2	23.0	5.6	23.7	7.8	15.6	19.3	20.6	25.5	13.7	11.3	24.5	11.4	18.7	12.8	15.1	74.7	23.9	20.4	16.1	16.0	22.3	14.9	26.8	13.4	17.2	11.1	14.6	17.6	40.5	18.0	20.0	13.2	11.8	13.5	21.3	29.9	10.6	15.8	30.9	34.9	16.4	11.7	9.5	22.6	18.0	14.9	12.8	12.5	27.4	20.7	1.6	2.1	6.1	2.2	3.8	14.7	1.4	7.0	1.8	2.2	0.9	5.9	6.8	2.6	83.7	35.0	34.1	16.2	3.4	7.0	2.5	6.0	113.0	4.3	3.4	4.5	34.5	7.9	4.9	3.4	8.0	1.4	7.1	5.8	7.1	4.2	3.9	22.4	6.7	6.4	2.7	6.3	15.6	2.2	5.0	3.4	1.2	1.4	2.6	5.6	4.4	5.8	3.6	1.4	2.6	13.9	8.0	9.3	5.9	5.3	14.2	9.6	8.1	27.4	8.7	4.4	4.0	1.7	4.2	5.3	7.4	1.9	2.2	3.0	3.2	1.9	14.7	1.3	3.6	4.6	2.1	1.6	2.9	3.6	6.1	3.8	1.7	1.4	6.0	1.4	24.9	23.0	7.8	15.6	23.9	20.4	26.8	13.4	18.0	22.6
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982714-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: , HPA043931: "	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	14.8	13.7	18.3	17.2	19.0	20.0	16.5	36.4	23.2	17.0	15.1	22.5	15.7	21.6	19.5	15.1	26.1	21.0	11.4	10.8	16.8	12.2	14.7	10.9	11.4	15.8	14.1	12.0	26.9	27.0	12.5	19.1	16.8	13.6	15.7	8.3	16.2	28.6	28.4	17.4	23.4	21.2	13.3	11.9	18.4	20.6	26.5	18.3	18.0	16.8	10.9	21.6	18.1	19.5	20.5	14.9	12.0	14.0	13.1	18.5	10.3	10.6	9.9	8.6	15.7	3.6	3.7	17.1	5.7	4.1	6.9	5.5	16.3	18.4	18.8	8.3	3.7	10.1	8.7	7.2	3.4	9.6	13.4	12.4	7.3	15.4	5.2	12.8	12.7	3.2	6.4	4.6	4.9	5.2	23.4	9.1	3.0	12.4	24.7	36.8	24.9	14.9	22.6	7.5	11.8	5.0	9.0	23.5	14.6	6.6	7.9	9.7	15.1	9.8	5.9	7.0	8.0	8.1	12.6	19.4	19.9	20.9	8.0	13.5	8.7	6.0	12.3	12.0	14.2	14.0	17.1	14.6	16.3	12.6	11.9	20.5	14.2	11.0	4.7	13.1	11.2	14.9	18.5	10.3	18.3	19.0	36.4	23.2	16.8	12.2	14.1	12.0	13.6	18.3
NELFB	"COBRA1, KIAA1182, NELF-B"	ENSG00000188986	"Negative elongation factor complex member B"	Q8WX92	9	137255173-137273546	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020259	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA020259: AB_1847072"	"unprognostic (2.56e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (7.74e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-2)"	"prognostic favourable (4.31e-6)"	"unprognostic (6.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-2)"	21.9	16.5	28.2	20.1	27.8	21.2	17.1	20.2	41.6	19.2	20.6	20.6	17.0	23.7	19.6	10.6	24.7	21.8	17.9	28.8	25.8	21.8	20.1	17.9	19.9	25.8	23.0	27.6	27.3	33.7	14.8	14.6	19.4	24.0	20.6	12.6	19.2	29.6	18.4	29.3	29.0	24.9	26.9	17.3	22.6	22.6	19.1	21.1	17.7	21.5	13.0	23.1	20.7	34.2	6.8	8.3	9.2	6.1	7.1	8.0	3.6	18.4	32.0	16.2	21.1	14.3	10.6	23.4	15.3	11.9	20.1	14.3	33.4	22.3	26.7	23.0	16.1	35.6	17.0	19.0	6.2	25.5	21.3	17.2	39.4	26.4	14.5	25.2	21.1	12.4	19.5	18.4	10.7	18.5	29.2	23.1	11.7	44.9	18.4	32.2	25.1	31.8	30.3	29.6	43.1	11.1	17.7	23.9	21.4	21.5	23.5	14.4	31.5	28.7	23.0	28.9	21.1	44.3	24.4	11.7	20.5	22.1	22.7	18.1	25.3	2.3	6.1	9.2	8.0	4.8	5.4	6.4	6.8	6.0	5.2	6.8	6.3	6.6	3.2	7.1	4.4	8.3	7.2	3.6	28.2	27.8	20.2	41.6	25.8	21.8	23.0	27.6	24.0	21.1
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"		20	58981208-58995133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262"			Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: , HPA066262: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	9.1	11.1	10.2	9.4	13.0	8.8	12.7	18.1	13.7	10.2	10.8	15.2	9.2	8.4	11.2	8.2	14.6	12.5	8.6	9.2	10.9	8.2	16.4	15.9	7.9	11.2	16.7	13.4	15.4	10.3	19.1	18.1	12.1	12.5	10.2	8.9	9.4	14.7	9.1	12.0	11.9	8.8	8.1	11.8	9.2	8.9	26.1	12.4	17.4	14.4	10.0	13.6	9.8	11.3	22.7	29.6	9.4	27.7	19.4	24.6	20.5	12.5	14.5	17.5	18.6	6.0	10.7	11.2	10.2	10.0	31.0	18.0	48.0	18.1	16.6	16.1	10.2	22.0	23.4	25.8	25.1	5.1	16.6	21.9	18.2	37.5	7.2	15.6	15.0	11.3	8.3	11.3	7.9	17.8	29.0	12.7	14.1	49.9	33.7	23.6	10.1	32.2	18.9	14.5	30.7	13.0	19.5	19.3	28.7	31.9	38.5	21.2	41.5	18.3	7.1	23.9	22.7	9.3	16.9	10.1	18.6	16.9	14.2	13.9	20.6	7.2	20.4	9.4	20.3	22.8	23.9	22.7	19.3	24.6	29.6	20.0	18.9	19.9	2.2	19.4	27.7	15.0	17.6	20.5	10.2	13.0	18.1	13.7	10.9	8.2	16.7	13.4	12.5	12.4
NELFE	"D6S45, NELF-E, RD, RDBP, RDP"	ENSG00000204356	"Negative elongation factor complex member E"	P18615	6	31952087-31959110	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007187, HPA007594, HPA046502"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA007187: AB_1856161, HPA007594: , HPA046502: AB_2679677"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.68e-2)"	19.4	21.1	18.5	17.6	20.4	18.4	26.8	10.2	18.2	22.8	20.4	19.0	23.5	15.8	20.7	30.2	21.7	30.4	20.4	22.6	18.5	17.0	19.2	13.5	17.0	20.9	18.5	18.7	21.2	46.1	12.4	18.0	23.7	27.5	14.4	17.9	12.7	24.9	22.4	40.4	19.6	18.1	19.5	28.0	16.3	18.1	58.1	18.2	28.3	20.8	16.9	14.7	15.3	18.8	23.6	25.2	28.8	33.4	20.7	22.5	23.4	17.5	12.5	17.6	13.6	6.3	10.3	14.1	13.0	14.1	11.9	6.6	18.9	10.0	13.5	14.6	13.6	12.9	6.2	6.4	7.0	11.5	13.7	8.1	13.5	23.8	10.3	15.7	9.1	9.2	17.4	10.5	19.7	11.0	13.0	16.1	13.5	29.0	23.1	10.3	6.7	4.4	20.6	14.0	21.2	15.0	16.4	11.2	18.5	10.2	11.3	24.5	17.0	30.1	10.1	10.9	22.2	11.6	24.3	26.5	27.4	15.0	7.0	9.9	21.2	20.0	25.4	28.8	21.6	30.5	21.8	23.6	22.2	22.5	25.2	23.6	20.1	20.4	14.5	20.7	33.4	18.5	20.5	23.4	18.5	20.4	10.2	18.2	18.5	17.0	18.5	18.7	27.5	18.2
NENF	"CIR2, SCIRP10, SPUF"	ENSG00000117691	"Neudesin neurotrophic factor"	Q9UMX5	1	212432887-212446379	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026763, HPA028488"	Uncertain		Enhanced	Nucleoplasm	"Secreted - unknown location"		2400000	Nucleoplasm		"HPA026763: AB_1854379, HPA028488: "	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.80e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.99e-3)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.28e-2)"	21.9	19.9	33.5	10.1	47.7	12.8	44.4	16.2	30.6	41.9	23.9	45.2	24.0	12.7	24.1	42.2	19.4	27.6	19.6	50.6	31.3	31.4	32.0	25.8	18.0	20.4	38.3	21.3	38.3	43.4	21.0	47.1	17.9	23.6	26.7	23.9	19.8	22.1	36.1	53.6	16.5	12.2	29.7	49.5	13.2	16.8	9.6	24.5	6.5	23.6	26.0	16.2	19.3	19.9	7.2	13.3	1.9	6.7	0.8	9.2	2.5	22.6	11.9	6.5	29.3	47.9	36.2	11.6	11.4	28.2	20.5	20.2	14.0	14.5	8.7	8.9	27.3	14.7	16.1	16.7	16.8	13.3	32.2	5.6	7.7	4.0	18.1	5.6	20.3	25.9	24.6	14.2	11.9	13.2	17.3	11.8	17.9	9.3	12.9	26.4	11.3	37.6	11.5	11.7	14.6	20.9	4.0	13.0	22.7	11.8	27.0	20.5	20.6	21.8	2.5	16.1	14.9	22.3	21.1	11.0	17.7	6.7	17.6	7.9	12.2	1.0	4.8	1.9	4.1	6.7	7.3	7.2	4.9	9.2	7.7	5.1	6.5	6.5	0.5	0.8	4.5	13.3	5.7	2.5	33.5	47.7	16.2	30.6	31.3	31.4	38.3	21.3	23.6	24.5
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002440-113019861	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA069654: "	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	15.1	12.3	12.6	12.9	19.8	15.9	15.5	22.8	21.3	14.4	12.8	15.3	11.6	12.3	15.4	19.0	12.7	12.8	13.0	14.0	13.2	12.5	12.4	10.3	11.3	19.3	14.2	13.7	14.8	16.5	13.4	18.2	12.4	15.6	12.4	9.8	11.5	13.5	15.1	28.1	18.2	13.6	16.0	17.5	17.5	14.2	19.1	12.8	21.9	20.0	16.4	15.5	17.5	10.9	3.8	3.4	2.9	3.0	7.9	6.4	2.7	9.9	8.3	13.3	10.0	4.4	8.0	7.1	9.6	6.1	5.3	3.6	7.6	6.6	13.3	5.3	3.1	10.6	9.7	4.3	7.5	2.6	6.1	20.3	7.4	5.6	8.0	12.9	7.5	12.5	7.8	4.4	11.2	4.6	6.9	10.7	3.9	6.4	11.0	7.6	13.9	10.7	9.1	10.6	6.9	6.1	8.9	9.2	13.6	5.5	6.9	15.9	8.0	11.1	9.4	7.5	7.4	2.7	6.8	10.6	8.1	15.6	12.0	10.2	5.3	2.9	2.3	2.7	4.4	3.0	4.5	3.8	5.1	3.7	3.4	3.1	6.4	6.3	1.5	7.9	1.2	2.4	2.2	2.7	12.6	19.8	22.8	21.3	13.2	12.5	14.2	13.7	15.6	12.8
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677397	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.9"	"Cell line enhanced"	"Detected in many"		"AF22: 92.4;HUVEC TERT2: 46.7;LHCN-M2: 74.6;RH-30: 76.4;WM-115: 36.0"	"Group enriched"	"Detected in all"	6	"glioma: 147.0;melanoma: 101.4;testis cancer: 34.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: , HPA006286: , HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	22.1	4.2	6.2	7.1	7.6	0.4	13.8	6.0	13.3	16.9	5.9	13.0	7.5	3.1	23.4	12.3	10.0	12.5	8.9	77.9	6.5	5.1	15.7	4.5	16.0	4.2	8.2	5.1	13.2	2.2	7.5	5.6	8.9	12.8	14.6	4.0	12.2	3.8	20.0	25.3	3.2	4.9	16.1	12.0	26.8	4.2	5.3	6.2	0.4	8.0	16.8	3.5	12.7	17.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	92.4	19.7	0.2	5.0	0.0	22.3	17.6	0.3	0.5	14.6	0.2	0.0	5.3	2.1	0.4	9.3	0.0	0.2	0.0	0.1	0.1	1.3	6.6	0.8	0.0	5.4	4.3	0.0	0.8	0.0	46.7	0.6	0.0	74.6	0.6	0.0	0.0	15.0	12.8	0.1	76.4	0.0	0.0	0.0	0.2	14.9	0.5	0.6	17.1	0.2	0.1	33.8	0.1	5.2	0.6	1.2	0.0	3.3	0.0	2.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.6	6.0	6.3	6.5	5.1	8.2	5.1	12.8	6.2
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"			86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.9	3.0	3.0	6.9	10.1	3.8	5.9	2.7	9.3	8.1	11.8	17.4	3.3	1.0	7.0	3.6	1.7	6.3	2.5	3.1	2.5	4.2	1.5	1.8	20.3	18.1	1.9	8.5	6.3	4.7	9.7	5.0	7.2	3.2	7.2	4.1	5.3	1.6	2.9	2.3	2.4	2.1	1.6	10.4	13.3	6.5	2.3	1.3	3.0	4.0	7.1	7.7	8.7	3.0	5.3	3.1	7.4	4.8	8.9	14.2	2.1	3.9	4.8	3.7	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988134-75018893	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA038729: , HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favourable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	5.4	13.4	3.7	10.5	6.9	17.0	5.4	7.9	9.1	4.0	3.9	3.0	4.1	3.6	5.4	4.8	3.9	4.4	3.6	5.9	4.0	4.5	4.3	6.7	8.7	9.0	3.8	6.6	7.2	7.3	15.1	11.2	3.1	4.2	9.7	5.4	5.6	4.8	4.6	19.1	6.7	4.7	4.0	3.5	5.5	5.1	44.6	3.0	19.0	6.8	3.5	7.5	4.5	3.1	3.2	3.8	5.8	6.4	1.2	4.2	2.2	4.6	4.0	3.4	6.6	2.6	2.5	3.8	4.5	2.9	5.2	4.0	13.7	3.9	13.3	4.6	3.6	4.3	8.3	5.8	7.9	7.0	4.4	11.0	7.5	5.6	2.9	17.2	10.6	3.0	4.9	5.2	8.1	3.7	17.7	10.0	5.9	5.0	16.9	8.9	4.2	5.4	14.9	9.0	11.7	6.4	4.9	6.3	4.0	6.9	4.6	20.3	9.9	4.5	5.6	6.5	6.5	4.3	4.5	8.3	8.0	26.7	1.9	8.9	5.5	2.1	6.4	5.8	4.1	3.7	3.0	2.8	3.2	3.9	3.8	3.2	3.5	4.2	3.3	1.2	4.6	2.7	2.3	2.2	3.7	6.9	7.9	9.1	4.0	4.5	3.8	6.6	4.2	3.0
NEURL1B	"DKFZP761M1511, Neur2, RNF67B"	ENSG00000214357	"Neuralized E3 ubiquitin protein ligase 1B"	A8MQ27	5	172641266-172691540	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.0;T-47d: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037612	Approved		Supported	Vesicles				Vesicles		"HPA037612: AB_10795573"	"unprognostic (3.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.13e-3)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (3.00e-6)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.22e-3)"	26.6	11.8	7.5	10.3	3.2	1.5	23.9	0.6	7.0	21.4	17.5	5.6	31.2	5.7	26.7	24.7	14.0	15.8	23.0	19.2	10.7	4.2	7.6	4.4	10.5	7.8	3.1	3.2	20.9	4.8	4.1	6.0	5.1	2.7	20.7	11.6	6.1	4.9	28.4	12.3	14.7	12.1	29.1	1.5	0.6	5.9	6.6	2.8	3.6	7.2	13.9	5.4	16.0	30.8	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.4	2.3	1.2	5.6	0.4	0.2	0.1	5.0	2.2	2.7	3.9	8.5	2.0	0.0	1.4	3.2	1.3	0.5	2.2	1.8	8.1	0.3	6.1	8.1	0.0	0.4	0.0	1.9	0.0	9.7	0.6	2.7	0.4	0.0	1.9	5.7	4.9	1.4	0.1	0.8	0.2	27.0	6.0	0.8	0.1	1.0	1.0	5.8	4.8	7.6	0.2	12.7	0.9	0.8	2.0	11.9	1.4	3.1	0.8	0.2	0.0	5.8	0.1	1.7	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.5	3.2	0.6	7.0	10.7	4.2	3.1	3.2	2.7	2.8
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925485	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;parathyroid gland: 9.0"	"Group enriched"	"Detected in some"	9	"HAP1: 6.5;Karpas-707: 10.5;SiHa: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"				Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: "	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.6	3.0	5.4	0.7	6.2	0.4	1.3	10.2	9.4	1.7	1.9	0.7	1.0	0.6	1.7	0.9	1.8	1.3	0.5	0.3	5.0	6.2	2.4	0.2	0.9	0.5	1.8	5.0	1.7	4.4	9.0	7.5	0.5	1.9	3.2	1.1	1.1	2.5	2.5	0.4	1.8	1.1	2.6	1.2	0.6	1.6	0.9	1.5	0.0	1.5	0.0	0.5	0.7	2.8	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.3	0.1	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	9.3	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.2	10.2	6.8	5.0	6.2	1.8	5.0	1.9	1.5
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 110.8;skeletal muscle: 198.5"	"Cell line enhanced"	"Detected in many"		"BJ: 42.9;LHCN-M2: 39.4;RH-30: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA011185, HPA011904"	Approved		Supported	"Actin filaments"			12000000	"Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	8.9	4.3	0.4	10.4	0.8	0.0	5.0	0.5	0.4	14.1	17.0	0.2	12.5	1.9	16.6	12.5	24.1	9.9	8.7	110.8	0.4	0.5	4.0	1.2	6.2	3.8	0.6	0.5	8.2	2.0	0.3	0.5	2.6	0.7	13.1	3.2	0.9	4.1	14.8	198.5	1.4	5.5	45.8	0.8	3.9	10.6	4.2	1.2	0.0	5.1	40.1	1.0	29.7	10.3	1.4	1.7	2.9	3.4	0.6	0.6	7.0	7.0	0.4	1.2	0.0	23.2	22.5	3.5	42.9	19.0	8.7	5.9	1.2	0.0	0.0	2.4	15.5	0.9	0.9	4.0	15.7	0.2	0.9	1.7	2.2	0.4	17.4	0.3	0.0	16.8	0.9	12.1	6.8	6.6	0.0	0.0	39.4	0.0	8.0	0.5	6.8	5.2	6.7	31.2	0.0	10.2	0.3	0.0	0.3	3.7	0.0	0.2	0.0	0.9	6.7	21.0	15.4	8.9	21.3	0.0	0.0	0.0	1.1	0.8	0.0	0.0	3.4	0.0	0.4	2.0	0.1	1.4	0.3	0.4	1.7	1.1	0.6	0.2	2.9	0.6	1.4	1.2	0.0	7.0	0.4	0.8	0.5	0.4	0.4	0.5	0.6	0.5	0.7	1.2
NF2	"ACN, BANF, merlin, SCH"	ENSG00000186575	"Neurofibromin 2"	P35240	22	29603556-29698598	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003097, CAB005385"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB005385: AB_2298548, HPA003097: AB_1079473"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.66e-1)"	"prognostic favourable (2.89e-5)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.62e-2)"	11.8	12.4	23.6	11.1	20.1	10.0	15.4	20.8	28.1	10.8	9.7	9.0	11.8	7.8	10.5	11.3	14.2	11.3	8.0	19.7	26.6	16.4	13.5	11.1	11.9	24.1	18.0	13.5	11.0	12.9	46.8	8.6	6.9	11.4	10.2	8.7	9.5	9.3	15.4	25.7	12.1	8.5	11.9	10.7	10.4	8.8	21.6	10.1	14.9	15.6	11.5	9.9	10.6	10.2	8.5	13.6	6.6	17.3	11.6	15.0	9.8	26.3	10.6	3.7	24.3	7.3	7.3	3.6	21.4	12.1	23.5	20.3	10.5	6.5	7.0	17.8	22.0	9.3	7.7	12.4	21.1	10.2	6.1	8.3	7.9	7.5	7.8	11.9	9.9	6.7	5.7	16.6	20.3	16.5	4.0	6.5	22.8	11.0	7.2	4.7	2.8	10.1	7.5	20.0	6.7	23.8	12.3	5.8	4.0	12.3	8.3	4.8	5.3	4.8	30.6	35.0	39.9	15.2	36.1	10.2	8.1	8.4	9.3	4.7	22.3	6.6	9.5	3.6	15.0	13.5	12.8	8.2	11.3	10.1	13.6	8.5	9.8	9.2	2.3	11.6	17.3	9.3	9.4	9.8	23.6	20.1	20.8	28.1	26.6	16.4	18.0	13.5	11.4	10.1
NFAT5	"KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP"	ENSG00000102908	"Nuclear factor of activated T cells 5"	O94916	16	69565094-69704666	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057304, HPA069711"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA057304: , HPA069711: "	"unprognostic (2.71e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.08e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.42e-2)"	15.4	19.1	19.0	17.0	17.1	25.1	15.8	22.4	18.0	19.3	11.9	11.9	12.5	7.7	18.7	19.5	15.7	15.0	11.7	11.6	15.6	8.2	15.7	10.2	15.6	10.5	13.0	12.7	15.6	13.8	35.6	24.2	30.8	13.1	14.7	12.8	13.9	20.1	15.6	12.1	26.5	14.0	12.5	10.5	11.6	12.0	10.1	14.4	10.3	21.9	7.7	10.8	19.6	30.4	2.1	2.9	5.5	4.6	1.1	2.6	0.5	11.0	14.5	7.1	8.8	10.7	12.9	7.8	11.5	13.8	12.2	8.9	10.9	9.1	5.0	6.8	13.9	9.6	6.3	6.5	12.8	2.9	2.5	4.0	5.3	13.4	8.7	3.9	7.5	9.0	4.4	9.2	11.3	11.9	7.7	2.7	11.2	4.9	2.9	5.6	4.2	1.7	5.2	3.1	2.8	11.7	19.0	3.9	2.4	24.7	2.7	6.8	5.4	3.1	14.8	10.7	6.6	5.7	3.9	5.8	4.5	8.9	7.1	3.3	6.3	3.5	1.3	1.4	2.2	0.8	1.6	2.1	1.1	2.6	0.6	1.9	0.9	0.8	5.5	1.1	4.6	2.9	1.6	0.5	19.0	17.1	22.4	18.0	15.6	8.2	13.0	12.7	13.1	14.4
NFATC1	"NF-ATC, NFAT2, NFATc"	ENSG00000131196	"Nuclear factor of activated T cells 1"	O95644	18	79395856-79529325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004513, HPA071732"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"CAB004513: AB_628011, HPA071732: "	"unprognostic (3.53e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.08e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.85e-3)"	"unprognostic (7.02e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.11e-3)"	12.2	4.2	4.0	35.4	4.0	4.1	9.2	2.7	3.9	9.3	7.6	5.4	7.0	3.7	10.7	6.5	5.9	7.0	11.8	13.4	3.2	2.9	4.7	2.9	13.9	21.9	4.3	2.2	7.0	8.3	6.4	3.3	4.8	11.4	6.4	2.1	9.9	5.5	9.0	27.9	8.6	10.8	12.0	5.9	16.9	6.0	7.1	4.6	21.1	6.8	15.2	27.0	13.2	14.2	11.3	3.2	7.1	13.4	2.1	6.9	4.9	0.0	2.2	1.1	2.0	1.9	2.1	3.9	1.3	0.1	0.3	0.2	0.2	2.0	12.0	0.8	1.7	0.2	5.5	0.0	0.4	8.3	4.6	8.4	0.5	0.0	4.2	2.6	4.6	2.5	0.0	0.7	0.1	6.8	6.7	2.5	1.3	4.6	6.9	0.9	1.9	1.5	2.3	1.4	2.7	1.0	0.9	0.0	0.0	1.9	1.4	3.1	1.8	10.8	6.3	2.8	12.1	0.0	0.1	0.0	0.0	33.7	0.0	3.6	5.2	1.9	3.4	7.1	4.4	9.2	4.7	8.6	6.9	6.2	3.2	11.3	6.0	4.1	3.0	2.1	13.4	3.1	5.0	4.9	4.0	4.0	2.7	3.9	3.2	2.9	4.3	2.2	11.4	4.6
NFATC2	"NF-ATP, NFAT1, NFATp"	ENSG00000101096	"Nuclear factor of activated T cells 2"	Q13469	20	51386957-51562831	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.2;HMC-1: 16.3;WM-115: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008789, CAB018567, HPA024369"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413"	"unprognostic (2.69e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.59e-2)"	8.6	2.4	4.1	44.6	8.2	4.4	9.8	1.1	5.1	8.4	7.8	6.8	3.9	8.4	7.0	7.6	4.0	5.6	19.4	8.5	4.1	3.3	3.4	6.7	6.1	25.2	8.4	0.7	5.0	8.7	3.9	3.7	8.1	10.4	5.4	4.1	6.2	7.9	7.2	5.4	7.0	11.7	5.9	6.5	16.0	11.0	4.5	6.5	8.6	7.0	13.2	18.7	4.5	4.9	1.6	1.7	3.8	0.7	7.6	7.7	1.6	1.5	1.7	0.0	2.1	0.0	0.0	4.5	0.2	1.1	0.7	0.3	8.2	1.5	10.9	1.3	0.5	0.0	0.5	0.0	0.6	14.2	0.2	4.6	1.2	2.1	0.0	1.3	16.3	0.0	0.0	0.6	0.0	5.0	4.5	7.3	0.0	1.8	1.9	7.7	0.1	3.9	0.8	0.0	4.8	0.2	0.0	0.1	0.0	5.1	1.2	11.9	2.0	3.1	0.5	1.0	1.9	2.5	0.1	6.2	4.0	11.2	1.0	5.1	24.5	0.3	0.0	3.8	7.7	0.7	3.2	1.6	4.3	6.1	1.7	1.6	2.4	4.4	0.2	7.6	0.2	0.6	2.3	1.6	4.1	8.2	1.1	5.1	4.1	3.3	8.4	0.7	10.4	6.5
NFATC3	"NFAT4, NFATX"	ENSG00000072736	"Nuclear factor of activated T cells 3"	Q12968	16	68084751-68229259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 129.5"	"Cell line enhanced"	"Detected in all"		"HMC-1: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050665			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA050665: "	"unprognostic (1.19e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-1)"	9.6	6.8	4.3	16.0	6.6	12.0	7.8	7.5	5.8	9.8	11.0	9.7	7.6	7.1	12.2	6.5	7.7	8.3	7.6	7.0	4.7	4.0	8.2	12.1	11.3	14.2	8.7	3.5	10.0	7.0	18.7	6.8	6.6	5.1	10.5	6.1	11.1	7.9	7.6	27.1	14.0	12.0	9.0	6.7	12.3	6.2	25.9	5.8	129.5	11.0	8.1	16.0	10.2	14.1	6.7	3.1	12.0	7.1	13.4	15.6	9.0	4.9	5.8	9.4	10.3	8.4	5.4	8.6	3.2	4.0	9.1	7.9	8.4	4.4	16.5	4.9	5.3	7.4	11.7	5.5	8.9	3.4	7.6	16.2	6.1	18.9	5.6	14.5	42.7	4.1	7.1	9.2	5.0	7.6	20.9	4.7	6.7	9.9	22.3	19.7	6.1	3.1	12.7	9.0	17.0	3.9	5.7	7.1	7.6	24.0	6.1	3.1	8.4	11.0	4.8	4.7	5.1	5.4	4.8	6.5	11.2	30.0	3.6	13.5	6.5	12.0	2.4	5.3	15.6	3.7	14.8	5.2	8.9	15.2	2.9	6.7	9.1	14.0	3.3	13.4	7.1	3.1	6.0	9.0	4.3	6.6	7.5	5.8	4.7	4.0	8.7	3.5	5.1	5.8
NFATC4	NFAT3	ENSG00000100968	"Nuclear factor of activated T cells 4"	Q14934	14	24365673-24379604	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 19.7;BJ hTERT+: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA031641, CAB032859, HPA076526"	Uncertain		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: "	"unprognostic (3.51e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (5.84e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavourable (1.81e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-2)"	9.0	11.3	4.3	5.5	6.7	0.4	10.9	4.2	5.1	28.2	14.0	3.3	8.9	3.4	19.0	11.4	9.1	13.8	21.6	7.8	4.9	1.3	6.4	0.9	5.6	3.3	8.0	4.1	33.1	2.7	8.4	8.6	14.0	6.3	14.8	3.9	9.3	4.0	13.5	4.6	6.9	5.9	20.9	2.8	4.2	7.7	9.6	3.1	1.5	11.0	5.9	5.8	22.3	14.7	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	13.4	19.7	0.0	8.8	25.4	12.0	10.5	0.0	7.4	7.4	0.2	12.6	0.0	3.6	0.1	7.3	0.0	0.3	5.7	9.2	0.0	6.5	0.0	0.0	14.2	0.1	7.2	0.0	9.3	1.8	0.0	2.3	0.4	0.0	0.8	1.1	0.0	0.5	0.8	1.0	0.0	0.1	1.5	6.3	0.0	1.7	2.9	5.3	2.3	5.3	11.2	2.3	10.5	0.0	5.4	0.7	5.2	2.3	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	6.7	4.2	5.1	4.9	1.3	8.0	4.1	6.3	3.1
NFIA	"KIAA1439, NFI-L"	ENSG00000162599	"Nuclear factor I A"	Q12857	1	60865259-61462793	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.1;T-47d: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006111, HPA008884"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006111: AB_1854422, HPA008884: AB_1854421"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-2)"	"prognostic favourable (7.30e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.20e-2)"	"prognostic favourable (7.01e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (2.03e-4)"	29.1	17.7	21.9	17.0	19.1	15.9	28.5	42.1	16.9	23.1	20.1	17.1	19.2	9.1	17.1	16.3	27.9	20.4	18.7	25.7	18.2	13.7	13.7	48.4	11.3	8.7	16.9	13.0	22.1	17.2	24.5	14.1	6.5	21.9	26.0	12.8	16.4	25.3	26.5	30.8	11.6	12.3	44.0	25.8	11.7	14.9	11.1	15.9	2.9	36.6	14.9	8.8	35.6	30.9	1.3	2.4	5.2	5.0	0.7	5.6	2.8	3.4	3.2	0.4	37.1	15.6	10.3	0.1	0.7	2.5	0.8	1.5	0.2	2.5	5.7	2.7	1.6	4.4	1.4	9.2	0.4	13.1	3.0	0.3	8.3	2.6	3.6	0.7	1.2	12.9	7.4	3.6	15.1	9.7	3.5	10.7	0.7	1.7	0.1	0.1	1.6	3.3	0.5	3.8	9.4	2.0	6.8	3.6	2.8	2.0	15.6	5.1	19.7	0.2	9.2	0.6	5.3	8.5	1.6	0.8	1.5	0.0	0.9	0.0	0.7	5.2	5.0	2.3	3.7	3.4	5.5	1.3	4.5	5.6	2.4	0.5	4.4	5.3	0.2	0.7	4.3	1.7	0.1	2.8	21.9	19.1	42.1	16.9	18.2	13.7	16.9	13.0	21.9	15.9
NFIB	"NFI-RED, NFIB2, NFIB3"	ENSG00000147862	"Nuclear factor I B"	O00712	9	14081843-14398983	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 53.9;HBEC3-KT: 21.8;HUVEC TERT2: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003956	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA003956: AB_1854424"	"unprognostic (1.93e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-3)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.12e-1)"	"prognostic favourable (3.53e-4)"	"unprognostic (4.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.62e-1)"	29.3	9.5	22.6	9.2	12.9	1.0	39.7	30.0	22.9	14.8	17.0	13.6	34.1	11.3	16.8	22.3	11.5	17.0	18.0	24.1	22.0	9.3	18.8	22.3	16.3	9.8	10.8	15.5	18.7	17.5	8.2	6.0	14.7	13.7	21.3	10.4	9.2	40.0	41.3	20.8	23.6	16.8	24.2	14.9	10.4	14.2	7.6	15.6	2.7	18.8	13.9	7.7	27.4	23.4	0.3	0.3	2.4	0.4	0.5	1.0	1.3	6.3	4.5	2.8	53.9	13.6	7.9	0.1	0.1	0.0	1.3	4.7	0.0	2.6	0.1	4.2	0.4	1.4	2.6	21.8	2.3	0.9	2.6	19.4	10.1	0.6	4.5	0.5	0.1	6.8	3.0	4.9	18.1	21.8	0.6	0.1	1.8	2.9	0.0	0.1	1.0	5.3	0.0	2.5	0.0	4.0	2.3	4.5	16.8	4.6	5.7	1.8	11.5	0.0	21.2	4.2	6.3	3.2	4.0	0.5	0.4	1.5	3.7	0.0	5.3	1.3	0.1	0.2	0.3	0.2	1.0	0.2	0.2	0.2	0.1	0.3	0.2	0.1	2.4	0.5	0.4	0.3	0.5	1.3	22.6	12.9	30.0	18.8	22.0	9.3	10.8	15.5	13.7	15.6
NFIC	"CTF, CTF5, NF-I, NFI"	ENSG00000141905	"Nuclear factor I C"	P08651	19	3314403-3469217	"Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.7"	"Cell line enhanced"	"Detected in many"		"SiHa: 50.2;U-2197: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004300, CAB004674, HPA052625"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"CAB004300: , CAB004674: AB_425564, HPA052625: "	"unprognostic (2.59e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.11e-1)"	"prognostic favourable (1.52e-6)"	"unprognostic (8.38e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.80e-3)"	25.1	19.8	8.5	11.1	11.1	5.7	14.9	15.3	19.9	23.3	19.7	16.8	27.1	6.4	20.8	14.2	19.6	18.5	21.5	25.7	9.5	6.3	14.4	29.0	12.9	9.1	11.8	8.1	31.8	46.9	22.7	14.6	5.1	11.7	18.8	5.3	20.4	33.9	22.2	101.7	16.8	8.5	26.5	10.9	11.6	16.4	8.6	11.3	2.7	15.6	23.2	10.2	22.4	17.4	2.3	4.0	11.3	5.3	8.4	3.3	3.2	17.8	26.2	0.3	15.9	14.5	12.6	1.7	16.3	9.2	11.1	7.9	0.6	6.3	0.1	5.9	14.9	8.7	4.4	11.0	4.5	12.6	3.8	3.4	21.2	5.2	11.4	5.2	6.7	11.0	7.8	15.2	6.0	10.2	9.0	16.8	8.0	12.8	3.0	1.1	0.8	10.9	7.8	10.1	7.0	4.2	3.6	3.6	9.7	50.2	5.0	4.9	14.7	4.1	15.3	19.0	17.1	49.6	22.2	0.5	0.7	0.1	26.2	11.5	27.5	1.8	5.2	2.4	3.3	5.3	2.8	2.1	3.0	3.0	4.0	2.3	2.1	2.1	11.3	8.4	1.1	1.6	1.1	3.2	8.5	11.1	15.3	19.9	9.5	6.3	11.8	8.1	11.7	11.3
NFIX	NF1A	ENSG00000008441	"Nuclear factor I X"	Q14938	19	12995608-13098796	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 139.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.8;fHDF/TERT166: 49.4;U-138 MG: 47.1;U-2197: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007533	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA007533: "	"unprognostic (3.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.12e-2)"	"prognostic favourable (4.66e-4)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-2)"	28.6	6.6	21.3	8.0	23.8	5.8	15.5	57.0	60.8	25.1	17.9	41.0	8.9	9.2	29.9	12.4	29.2	29.2	21.8	24.1	27.3	15.0	4.6	8.9	20.3	3.1	21.6	29.8	31.8	10.2	6.8	7.0	5.3	22.1	35.4	8.7	19.5	56.6	26.1	139.7	39.7	10.1	27.6	28.3	5.0	14.6	7.2	23.4	1.2	12.8	29.1	8.1	15.6	17.7	1.1	0.6	0.6	0.8	0.1	2.6	0.5	9.1	3.7	0.2	28.9	27.4	36.8	0.3	11.4	16.2	11.0	7.7	0.3	0.8	0.1	3.3	49.4	4.2	3.0	8.9	4.8	6.0	4.8	4.6	1.8	4.0	13.2	1.9	2.5	24.5	2.6	10.6	5.9	2.9	1.5	1.4	6.9	2.8	3.4	1.4	0.1	31.8	9.9	5.4	5.2	0.1	1.9	4.3	11.6	8.5	0.0	10.6	5.4	4.0	2.9	47.1	6.0	44.9	15.9	1.1	0.4	0.0	12.1	2.9	14.7	0.6	0.4	0.0	2.4	0.8	2.6	0.1	0.1	0.0	0.1	1.1	0.9	0.2	0.5	0.1	0.2	0.6	0.0	0.5	21.3	23.8	57.0	60.8	27.3	15.0	21.6	29.8	22.1	23.4
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501329-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	19.8	14.7	8.2	37.7	12.0	44.5	26.6	12.4	10.3	18.2	17.1	10.4	10.4	10.7	17.5	11.2	20.5	16.4	20.3	14.5	7.5	5.1	13.2	15.8	26.9	46.0	11.4	4.8	17.5	14.3	10.2	8.7	13.7	10.0	18.8	14.6	10.8	17.7	13.5	17.1	19.6	16.7	16.0	10.1	30.0	14.6	9.3	12.5	37.5	14.7	16.3	26.7	18.4	22.7	5.8	10.4	5.5	7.1	14.3	10.6	3.5	16.9	9.5	5.1	7.8	16.0	14.4	6.3	9.7	28.8	12.1	12.4	10.5	24.3	27.7	8.8	15.3	13.5	10.2	17.0	16.7	25.0	6.0	11.8	7.7	11.3	15.0	21.0	25.1	11.9	12.0	11.8	16.4	15.2	11.4	20.4	8.7	11.9	1.8	11.5	3.1	8.8	14.8	12.2	12.5	11.3	23.9	3.5	5.8	17.9	25.0	9.8	5.1	15.7	19.4	16.5	8.6	8.9	13.6	9.0	6.2	26.9	10.5	10.8	23.3	5.2	5.4	4.9	3.4	7.1	6.0	5.6	8.4	5.6	10.4	5.8	10.6	8.9	5.5	14.3	5.9	7.4	4.5	3.5	8.2	12.0	12.4	10.3	7.5	5.1	11.4	4.8	10.0	12.5
NFKBIA	"IkappaBalpha, IKBA, MAD-3, NFKBI"	ENSG00000100906	"NFKB inhibitor alpha"	P25963	14	35401511-35404749	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 209.1"	"Cell line enhanced"	"Detected in all"		"RT4: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003815, HPA029207"	Approved		Enhanced	Cytosol				Cytosol		"CAB003815: AB_344886, HPA029207: AB_10603122"	"prognostic favourable (1.33e-5)"	"unprognostic (3.39e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.80e-2)"	49.0	38.5	14.9	63.7	25.7	209.1	60.8	16.1	27.8	33.8	32.8	10.3	36.7	13.5	21.3	15.6	50.4	30.5	34.3	30.9	18.8	10.5	30.6	45.1	73.0	47.7	29.7	7.8	57.4	22.1	6.5	25.3	25.5	21.8	28.7	18.6	19.5	44.2	64.6	33.1	48.2	42.3	24.9	23.0	47.4	26.1	19.6	23.9	35.0	27.8	46.2	38.1	41.8	45.2	45.3	55.0	118.2	58.3	33.2	37.3	51.7	12.9	11.5	4.3	3.9	25.7	17.1	15.6	5.4	52.0	11.7	10.5	3.6	7.8	7.8	14.5	8.5	17.1	8.2	22.4	16.9	47.8	3.2	3.9	8.3	21.2	15.4	6.1	3.2	18.6	22.7	7.9	20.4	10.5	3.2	12.7	8.3	15.2	8.0	14.8	4.0	7.1	18.3	5.0	6.5	20.1	83.5	3.9	6.8	14.4	25.3	6.0	14.3	13.1	19.6	16.1	5.8	4.6	8.6	15.5	15.7	13.4	13.4	4.6	3.3	35.8	58.3	36.6	24.2	33.4	37.3	34.0	29.3	25.4	55.0	45.3	25.6	21.7	118.2	33.2	22.1	29.7	19.5	51.7	14.9	25.7	16.1	27.8	18.8	10.5	29.7	7.8	21.8	23.9
NFKBIE	IKBE	ENSG00000146232	"NFKB inhibitor epsilon"	O00221	6	44258166-44265788	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002692, HPA005941, CAB010272"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478"	"prognostic favourable (1.72e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (1.37e-6)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (8.07e-4)"	5.8	5.2	7.6	24.6	5.4	24.0	5.2	9.4	7.8	3.7	8.0	4.2	3.2	6.7	4.7	5.5	6.9	3.0	9.8	4.6	7.9	5.5	11.5	8.7	15.9	17.1	6.0	4.1	6.1	7.1	3.5	4.1	6.0	4.8	7.1	5.9	3.6	7.7	4.1	3.7	7.4	9.5	3.6	5.0	29.6	6.3	7.9	3.7	14.5	5.5	4.6	22.7	6.7	6.7	8.1	8.2	7.1	10.2	0.8	3.5	1.6	14.4	3.7	5.1	8.0	2.0	1.5	2.7	2.5	12.6	8.0	8.4	7.8	6.8	7.8	9.2	2.6	3.1	5.4	8.1	9.0	13.4	3.0	4.0	1.5	8.7	6.2	13.2	12.2	3.9	3.6	7.4	4.6	5.4	3.7	20.9	2.0	7.4	2.5	27.0	2.7	2.0	4.9	4.5	7.2	18.4	15.8	3.3	4.1	1.8	6.7	10.5	4.6	15.5	9.5	4.5	5.3	2.8	8.0	13.3	5.6	14.4	4.0	14.7	8.5	7.1	8.1	3.8	1.8	9.4	3.5	8.1	2.4	1.6	6.8	7.3	1.1	1.7	3.2	0.8	10.2	8.2	3.0	1.6	7.6	5.4	9.4	7.8	7.9	5.5	6.0	4.1	4.8	3.7
NFKBIL1	"IKBL, NFKBIL"	ENSG00000204498	"NFKB inhibitor like 1"	Q9UBC1	6	31546870-31558829	"Disease related genes, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.9;ASC TERT1: 5.1;HBEC3-KT: 4.1;HEK 293: 21.0;U-266/70: 9.3;U-266/84: 7.8;U-698: 4.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006298			Supported	Nucleoplasm				Nucleoplasm		"HPA006298: AB_1079480"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.97e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.50e-2)"	19.3	20.7	7.9	8.8	8.8	4.9	16.4	9.8	13.7	9.8	13.0	7.4	11.4	4.9	9.2	23.0	15.1	24.5	12.8	6.5	7.1	6.9	8.5	8.7	16.1	9.8	7.4	7.3	16.1	18.6	4.9	10.1	6.8	6.7	11.5	4.9	7.0	11.8	13.9	24.3	28.8	8.8	11.2	6.8	19.1	16.7	12.9	8.3	6.3	12.7	7.6	5.1	13.8	11.3	0.3	2.0	1.6	1.7	1.5	0.9	0.5	0.0	3.6	0.0	0.1	4.9	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	4.1	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	7.8	4.9	0.0	0.0	0.0	0.6	1.7	0.6	0.9	0.4	0.5	0.3	0.1	0.5	1.6	0.3	0.3	0.7	1.6	1.5	1.3	2.0	0.6	0.5	7.9	8.8	9.8	13.7	7.1	6.9	7.4	7.3	6.7	8.3
NFKBIZ	"FLJ34463, INAP, MAIL"	ENSG00000144802	"NFKB inhibitor zeta"	Q9BYH8	3	101827991-101861022	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.3;RPTEC TERT1: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 20.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.8;monocytes: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010547, HPA075363"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA010547: AB_1854442, HPA075363: "	"unprognostic (2.20e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"prognostic unfavourable (4.30e-8)"	"unprognostic (2.69e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.52e-3)"	26.4	4.4	2.2	35.5	3.4	116.9	46.9	2.4	2.0	17.4	23.7	3.6	5.5	16.8	21.3	13.0	22.1	39.5	31.5	17.3	2.8	1.9	13.8	26.8	29.6	21.3	4.4	0.3	18.2	15.7	2.4	7.2	18.8	5.0	16.3	10.4	10.9	37.4	8.1	9.8	21.0	18.5	17.9	5.2	21.5	16.8	7.1	3.3	3.3	26.5	30.8	23.8	18.7	20.0	3.2	3.8	15.8	20.0	0.5	4.1	1.1	2.7	2.2	1.5	1.9	4.4	7.6	2.4	11.3	31.3	5.0	4.8	2.6	3.4	5.2	14.5	3.0	8.9	1.1	4.9	13.1	15.2	1.0	4.9	3.9	1.4	6.8	0.3	0.3	5.2	7.7	13.4	6.2	3.7	0.8	10.8	7.1	3.5	0.1	2.9	2.6	6.7	0.6	6.9	0.7	31.4	18.3	0.7	0.9	1.9	2.3	12.2	2.7	2.1	4.6	8.1	8.2	3.0	3.6	9.1	3.1	3.6	14.8	1.0	1.1	4.9	3.6	1.0	1.0	8.3	1.1	1.9	1.4	1.0	2.4	3.2	4.1	2.7	15.8	0.5	20.0	3.8	0.7	1.1	2.2	3.4	2.4	2.0	2.8	1.9	4.4	0.3	5.0	3.3
NFRKB	"DKFZp547B2013, INO80G"	ENSG00000170322	"Nuclear factor related to kappaB binding protein"	Q6P4R8	11	129863636-129895590	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007082, HPA007128"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA007082: AB_1079481, HPA007128: AB_1079482"	"unprognostic (1.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.15e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.93e-2)"	5.8	7.8	10.1	7.8	13.7	13.4	7.3	17.0	11.2	7.8	9.2	7.6	7.0	8.5	12.7	12.4	8.7	12.5	6.3	4.5	8.4	5.2	7.4	6.6	7.1	8.8	7.5	9.1	14.6	11.4	10.3	10.2	8.4	7.4	9.6	6.7	9.2	9.9	9.6	10.4	14.6	9.0	11.8	5.5	7.0	8.3	27.0	7.0	13.6	18.8	6.6	10.6	10.5	9.5	7.8	8.5	11.1	9.8	3.7	11.5	6.9	7.6	7.3	16.8	9.0	7.1	7.1	10.5	5.3	4.9	6.4	6.3	22.9	13.3	18.4	14.7	4.1	19.8	16.2	10.5	6.0	7.2	14.1	36.3	13.3	9.5	5.2	9.2	12.3	4.5	11.6	10.5	11.0	11.0	21.1	14.0	6.4	6.9	7.8	15.9	8.5	17.4	11.7	7.3	8.4	8.0	24.3	8.6	9.0	12.0	11.9	3.3	27.8	8.6	8.6	9.6	9.5	7.0	6.6	4.5	5.5	16.9	4.0	18.3	8.2	11.1	8.4	10.0	10.9	9.8	11.5	5.9	11.1	9.1	8.5	7.8	9.3	7.5	10.0	3.7	8.5	7.7	7.4	6.9	10.1	13.7	17.0	11.2	8.4	5.2	7.5	9.1	7.4	7.0
NFS1	"IscS, NifS"	ENSG00000244005	"NFS1, cysteine desulfurase"	Q9Y697	20	35668055-35699359	"Enzymes, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB034314, HPA051801, HPA054755"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594"	"unprognostic (1.72e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.93e-2)"	"prognostic favourable (4.72e-6)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.54e-2)"	10.2	28.0	16.9	6.7	19.3	3.7	9.7	15.3	20.8	11.2	11.7	12.0	10.0	11.0	8.4	9.9	10.1	11.7	9.9	19.2	14.6	14.0	36.9	33.0	7.8	7.0	16.5	15.5	12.5	14.0	20.7	14.8	7.8	14.3	9.5	13.0	12.2	12.6	12.2	19.7	9.5	9.6	10.1	12.4	6.6	10.3	25.3	15.8	4.9	10.2	8.4	10.4	8.1	7.7	10.4	11.2	7.4	8.1	12.8	11.4	6.1	13.3	16.7	5.8	6.1	15.9	14.6	11.8	10.2	10.8	15.5	10.1	30.0	7.6	11.4	20.1	9.5	16.9	19.9	20.6	14.0	5.1	9.3	24.4	17.8	23.3	13.3	10.2	4.7	11.7	19.8	12.1	13.4	11.5	17.4	7.7	10.8	20.5	11.5	10.8	6.7	25.1	4.6	18.9	19.2	15.7	9.1	7.3	6.7	25.5	24.7	16.6	22.1	9.2	8.4	17.5	8.3	10.2	10.0	11.1	15.2	10.4	14.8	11.1	8.6	2.5	8.1	7.4	7.6	7.7	9.7	10.4	8.8	11.2	11.2	7.6	10.3	9.3	3.4	12.8	6.0	5.6	11.4	6.1	16.9	19.3	15.3	20.8	14.6	14.0	16.5	15.5	14.3	15.8
NFU1	"CGI-33, HIRIP5, NifU, NIFUC"	ENSG00000169599	"NFU1 iron-sulfur cluster scaffold"	Q9UMS0	2	69395750-69437628	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035826	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA035826: "	"unprognostic (4.49e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.87e-1)"	32.3	26.0	24.9	14.7	23.5	14.9	59.9	19.7	40.4	14.7	20.0	12.1	16.0	15.9	17.1	31.8	13.9	17.6	15.9	83.2	21.4	23.6	32.8	20.0	23.0	20.8	24.1	29.7	18.5	21.7	22.9	23.0	19.1	23.7	17.5	20.8	12.2	19.1	19.8	69.3	9.7	16.3	28.9	24.8	13.9	18.7	16.5	16.8	7.8	21.4	28.3	14.4	19.0	19.4	18.2	17.7	16.0	17.5	12.9	18.2	8.0	20.0	18.6	19.4	19.4	24.8	23.5	21.2	21.6	19.1	19.0	14.3	40.3	17.6	12.2	11.3	17.8	9.1	19.9	20.3	26.6	25.6	19.5	13.6	15.9	36.7	25.4	24.8	20.7	19.6	11.9	20.5	14.1	24.3	23.4	14.9	34.2	4.2	13.0	42.5	17.7	20.9	14.4	30.4	4.9	29.1	21.2	15.7	12.4	11.8	10.9	33.7	13.1	17.3	23.9	24.2	17.3	18.8	29.0	19.6	16.5	8.0	18.3	25.1	18.6	13.5	8.5	16.0	12.1	12.4	11.8	15.9	12.3	14.4	8.6	18.2	12.8	14.4	2.8	12.9	17.5	17.7	18.2	8.0	24.9	23.5	19.7	40.4	21.4	23.6	24.1	29.7	23.7	16.8
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290511-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA056310: , HPA061382: , HPA073519: "	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	23.7	19.8	17.6	17.8	26.3	22.5	24.1	33.0	26.7	19.2	24.4	24.7	18.0	19.2	26.3	19.2	22.3	18.6	14.4	26.4	16.2	16.0	17.4	31.3	19.6	23.1	17.8	19.5	26.5	20.9	28.3	30.9	17.7	25.2	20.4	22.4	19.3	22.9	23.6	44.8	31.2	23.0	21.5	18.1	21.0	19.3	14.4	22.0	35.1	26.7	19.1	32.8	24.7	19.8	10.7	12.3	22.9	7.1	6.8	10.1	5.0	15.0	12.3	11.3	10.7	16.9	19.0	11.4	14.2	14.3	16.1	16.2	11.1	6.2	23.4	9.1	16.4	8.5	20.1	15.4	15.2	17.0	10.1	12.3	30.0	12.4	20.6	21.8	13.6	17.7	25.8	13.8	34.8	9.8	18.6	20.4	16.8	10.6	14.0	20.5	18.3	13.9	15.1	12.3	12.7	10.9	14.5	15.7	11.0	14.2	15.3	8.1	8.9	21.8	12.3	13.2	11.1	9.5	15.4	11.0	9.9	23.2	14.5	11.0	7.5	22.9	4.2	7.9	8.4	7.1	8.9	10.7	9.0	9.0	7.1	9.1	10.1	9.9	3.0	6.8	5.5	12.3	6.1	5.0	17.6	26.3	33.0	26.7	16.2	16.0	17.8	19.5	25.2	22.0
NFYA	"CBF-B, HAP2, NF-YA"	ENSG00000001167	"Nuclear transcription factor Y subunit alpha"	P23511	6	41072945-41099976	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009250, HPA050779"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009250: AB_2152107, HPA050779: "	"unprognostic (2.56e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.62e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	14.0	10.8	20.5	16.2	27.1	34.0	14.7	20.9	19.7	11.6	11.0	15.2	8.5	9.2	14.2	14.4	12.7	11.3	11.8	10.5	17.7	10.3	9.8	13.1	13.4	16.6	24.7	13.0	18.3	12.8	15.8	15.2	12.6	17.8	13.3	13.9	9.3	11.2	14.0	10.7	10.6	11.1	12.9	17.7	13.4	11.4	34.0	19.9	32.4	18.2	9.7	18.3	11.6	25.9	6.2	5.9	10.8	5.0	8.6	11.1	4.1	13.7	11.3	21.6	36.0	8.9	8.7	9.1	10.4	9.7	16.3	13.9	14.7	10.0	16.6	8.7	6.8	9.0	13.0	12.5	18.2	11.9	16.5	21.8	9.5	20.8	6.3	22.9	19.1	5.5	10.7	13.1	17.7	14.1	21.2	20.2	16.0	13.6	25.8	9.2	9.6	11.2	21.1	11.9	12.4	12.0	18.7	21.9	15.1	9.0	8.2	15.9	7.7	23.3	13.8	29.2	15.9	5.7	19.8	8.0	8.0	27.7	5.7	19.6	11.5	3.7	4.0	6.3	8.6	5.0	11.1	5.2	8.0	9.2	4.5	6.2	8.6	9.2	10.8	8.6	4.5	5.9	8.8	4.1	20.5	27.1	20.9	19.7	17.7	10.3	24.7	13.0	17.8	19.9
NFYB	"CBF-A, HAP3, NF-YB"	ENSG00000120837	"Nuclear transcription factor Y subunit beta"	P25208	12	104117077-104138289	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 107.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004211	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB004211: AB_628018"	"unprognostic (5.82e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (8.51e-2)"	"prognostic unfavourable (9.28e-5)"	"unprognostic (1.62e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.81e-3)"	16.1	23.4	22.2	13.9	21.3	10.8	17.5	18.5	17.5	16.1	28.2	13.6	107.1	9.9	16.8	25.8	13.7	16.0	13.7	20.0	22.6	16.9	15.4	21.8	16.0	17.4	21.9	12.4	15.9	11.3	17.3	19.0	16.3	15.6	23.5	14.4	10.1	10.3	53.7	18.5	11.2	10.6	20.0	24.9	10.1	13.8	13.7	20.4	21.4	19.2	13.5	18.5	20.2	27.9	15.6	7.4	22.8	10.2	15.1	21.1	10.7	13.6	11.8	22.5	13.7	15.2	16.5	21.2	13.7	11.3	15.2	10.4	8.8	6.4	18.3	6.7	12.2	9.1	18.0	8.7	16.5	12.5	5.7	11.1	13.2	8.0	16.0	15.8	7.7	23.9	11.9	6.1	11.9	9.8	10.7	7.4	12.6	15.5	19.9	15.8	21.2	12.8	18.6	13.0	8.0	10.7	13.9	13.5	11.1	24.0	59.9	7.7	22.4	16.2	7.3	8.9	6.1	8.0	9.8	14.3	12.2	20.4	5.6	9.7	9.2	17.3	7.5	22.8	16.3	9.5	21.1	15.6	15.7	17.1	7.4	11.3	17.5	17.4	10.5	15.1	10.2	6.8	20.5	10.7	22.2	21.3	18.5	17.5	22.6	16.9	21.9	12.4	15.6	20.4
NFYC	"CBF-C, NF-YC"	ENSG00000066136	"Nuclear transcription factor Y subunit gamma"	Q13952	1	40691648-40771603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055011			Supported	Nucleoplasm				Nucleoplasm		"HPA055011: "	"unprognostic (1.20e-3)"	"unprognostic (1.51e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (7.24e-4)"	"unprognostic (1.47e-2)"	"unprognostic (5.66e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-2)"	"prognostic favourable (1.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.12e-1)"	"unprognostic (7.75e-3)"	25.5	22.1	18.8	32.5	24.0	27.8	23.1	35.8	39.7	23.3	22.0	24.1	22.2	22.0	27.8	22.9	25.8	23.7	20.1	45.4	18.7	15.9	25.2	24.8	19.8	25.7	15.9	22.5	33.0	31.3	26.1	18.0	35.1	18.6	23.7	18.5	30.5	35.3	22.8	49.2	30.7	23.5	23.5	17.1	32.2	22.8	33.4	16.6	37.2	27.7	33.3	33.9	23.0	23.3	20.7	25.3	43.8	31.2	16.8	18.7	15.6	8.8	12.0	17.8	13.4	7.2	6.7	17.8	7.3	8.2	13.1	12.4	16.9	22.4	21.2	11.5	6.9	10.6	14.3	11.0	13.6	12.8	15.1	22.9	9.2	15.1	8.6	12.1	19.7	7.2	12.0	12.9	13.7	8.5	10.1	13.6	6.2	12.1	21.6	11.9	15.3	9.4	16.3	19.0	19.0	12.2	10.8	12.2	11.3	8.8	19.4	20.0	8.7	89.0	7.7	6.1	21.1	10.7	10.8	12.6	20.3	17.4	14.3	15.6	16.4	20.2	26.1	26.2	12.9	29.0	13.1	20.7	17.2	14.5	25.3	19.0	18.7	14.0	43.8	16.8	31.2	19.5	17.8	15.6	18.8	24.0	35.8	39.7	18.7	15.9	15.9	22.5	18.6	16.6
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90278141	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"			Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	13.3	21.3	49.2	11.0	43.2	19.4	18.7	27.6	61.5	18.5	15.6	13.8	8.4	9.3	18.9	21.0	13.1	15.2	14.1	19.1	38.9	42.2	11.2	13.3	15.3	11.9	38.9	37.7	19.4	18.9	21.1	17.1	12.3	30.9	15.5	12.1	11.4	14.4	14.5	47.6	17.7	11.3	12.4	25.7	14.0	13.9	13.8	14.0	3.8	23.3	15.4	11.4	12.7	15.4	5.2	2.4	6.0	3.1	4.2	4.8	2.5	2.9	7.2	9.6	15.1	8.4	3.7	1.2	4.1	3.2	3.9	2.9	3.5	1.7	4.6	2.8	4.9	4.8	9.3	2.3	5.7	1.9	8.6	4.4	4.4	5.3	5.4	5.1	3.3	5.0	8.5	3.7	4.7	3.5	5.5	5.7	2.3	3.5	4.8	2.1	4.5	4.3	7.4	5.4	2.2	4.1	12.8	9.6	12.1	8.0	6.3	3.5	2.6	7.3	5.7	9.4	4.0	6.1	7.3	3.7	19.6	4.9	4.1	5.3	7.6	6.0	2.3	3.6	3.2	3.1	4.0	3.5	3.1	2.7	1.2	5.2	3.7	4.4	5.0	4.2	1.9	2.4	4.8	2.5	49.2	43.2	27.6	61.5	38.9	42.2	38.9	37.7	30.9	14.0
NHEJ1	"Cernunnos, FLJ12610, XLF"	ENSG00000187736	"Non-homologous end joining factor 1"	Q9H9Q4	2	219075317-219160865	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB012334, HPA043869"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"CAB012334: , HPA043869: "	"unprognostic (5.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.29e-2)"	11.0	9.6	5.7	9.3	6.6	4.4	14.5	9.7	6.9	9.5	14.1	6.1	7.0	11.0	10.2	6.1	7.7	6.9	10.9	5.9	6.3	3.7	12.9	8.4	7.5	7.4	9.4	4.3	10.7	13.2	6.6	7.5	6.5	5.3	13.3	18.4	6.4	6.4	6.3	17.5	8.4	20.5	10.2	4.4	8.9	9.4	28.7	5.3	13.5	8.1	5.2	10.6	11.1	15.4	15.0	11.2	7.5	21.1	12.8	18.9	10.1	5.1	7.3	13.8	11.0	15.5	17.9	8.3	10.8	9.9	13.0	12.8	23.6	6.4	10.6	9.4	11.1	7.1	18.8	9.0	11.8	15.0	9.3	20.8	8.7	19.3	13.7	9.9	14.4	16.0	20.2	11.4	13.3	10.1	20.5	13.4	9.2	6.1	10.4	10.6	15.3	7.8	13.4	8.9	9.9	11.9	7.4	11.0	11.6	6.8	7.8	17.9	5.3	8.9	9.9	9.9	8.8	4.7	9.6	7.7	7.5	13.5	7.0	17.5	8.1	4.9	14.0	7.5	9.3	21.1	14.2	15.0	13.9	11.8	11.2	12.9	18.9	13.7	3.5	12.8	16.5	5.5	14.6	10.1	5.7	6.6	9.7	6.9	6.3	3.7	9.4	4.3	5.3	5.3
NHP2	"FLJ20479, NOLA2"	ENSG00000145912	"NHP2 ribonucleoprotein"	Q9NX24	5	178149460-178153967	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044171, HPA050400"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044171: AB_2678844, HPA050400: AB_2681113"	"unprognostic (1.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavourable (4.97e-4)"	"unprognostic (4.05e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (5.24e-4)"	"unprognostic (8.87e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.63e-2)"	35.4	41.0	42.5	37.5	46.4	44.2	37.9	26.2	54.2	27.1	37.3	23.7	26.2	29.0	31.9	34.4	59.4	37.6	33.6	52.3	37.7	33.6	31.3	57.1	24.9	60.3	37.1	29.3	38.2	62.1	15.1	25.3	25.0	26.7	28.0	22.4	18.6	40.0	35.5	50.9	39.1	26.7	34.2	34.1	29.9	30.4	26.9	25.6	40.6	34.5	61.9	32.9	26.8	33.4	50.8	78.2	7.1	38.9	37.9	43.8	51.2	32.3	48.9	15.8	45.8	10.8	14.3	55.2	25.2	12.2	27.0	23.5	28.6	27.6	46.4	46.8	14.0	20.3	23.7	52.3	14.4	88.2	79.8	24.5	38.1	32.1	18.5	41.8	26.5	17.2	24.7	21.2	19.1	25.3	24.6	30.0	15.1	140.2	57.8	29.0	24.4	75.7	39.2	21.8	69.3	20.2	20.6	40.8	47.3	19.0	51.2	44.0	26.3	29.6	25.6	28.4	31.9	23.9	56.6	37.8	76.0	55.2	29.6	55.3	31.1	7.1	35.3	4.8	31.6	38.9	43.8	50.8	39.2	36.3	48.7	50.0	40.8	42.0	2.7	37.9	27.0	78.2	36.3	51.2	42.5	46.4	26.2	54.2	37.7	33.6	37.1	29.3	26.7	25.6
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375420-17735994	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.9;RPTEC TERT1: 16.3;RT4: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"				"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: "	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	5.1	6.7	3.6	6.0	3.6	0.6	14.2	5.9	6.3	10.2	5.9	1.3	10.0	1.9	10.7	7.1	3.7	5.3	10.4	3.5	2.2	3.1	11.8	0.7	3.7	2.6	1.5	1.1	7.8	0.9	0.7	5.1	5.5	4.7	7.0	3.5	9.4	3.2	8.8	1.1	4.2	2.5	11.2	5.3	2.1	3.6	12.4	1.3	0.8	4.5	2.2	1.3	8.1	16.0	0.1	0.6	2.0	1.1	0.0	0.2	0.3	6.4	2.6	4.6	0.0	0.1	0.2	7.5	2.9	2.0	1.3	0.7	0.2	1.3	0.4	10.9	2.0	5.7	2.9	3.6	1.9	0.1	0.9	0.0	4.3	0.0	0.0	0.0	0.0	0.6	2.6	0.0	5.9	0.0	0.0	0.0	0.6	3.1	0.0	0.0	5.7	1.7	0.0	0.0	0.2	16.3	10.0	1.1	2.4	8.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.9	0.1	7.1	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	3.6	3.6	5.9	6.3	2.2	3.1	1.5	1.1	4.7	1.3
NICN1	MGC12936	ENSG00000145029	"Nicolin 1"	Q9BSH3	3	49422946-49429326	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA058014			Supported	Nucleoplasm				Nucleoplasm		"HPA058014: "	"unprognostic (4.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.88e-2)"	"prognostic favourable (1.11e-4)"	"unprognostic (2.46e-1)"	"prognostic favourable (8.81e-7)"	"unprognostic (3.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.96e-2)"	9.6	12.1	19.3	5.7	23.4	3.6	10.5	21.5	27.9	9.2	9.7	8.4	12.8	7.8	12.0	12.8	5.3	10.7	8.7	16.9	12.7	10.9	16.8	10.9	10.4	8.5	9.6	21.6	13.7	12.6	10.1	10.2	6.1	12.5	10.9	5.8	10.3	13.0	10.2	14.4	8.6	8.3	9.7	8.1	9.7	10.0	13.5	10.6	7.0	13.7	7.0	8.8	9.5	8.9	9.2	8.1	8.1	8.5	6.7	10.9	7.3	2.8	9.6	10.0	7.0	4.2	5.1	3.7	3.4	3.3	3.3	4.0	2.1	9.0	9.3	3.7	7.6	2.6	5.8	4.5	3.2	16.7	3.7	8.9	10.0	10.8	7.8	3.9	6.1	10.4	5.5	7.3	2.4	4.5	5.6	0.2	3.7	2.9	6.5	6.4	3.9	3.0	4.8	3.1	11.8	6.0	1.6	2.3	4.0	2.6	2.8	7.0	5.0	2.6	12.0	2.3	2.7	2.3	1.8	10.4	4.2	3.2	8.1	9.8	4.4	8.1	7.3	6.9	8.0	5.4	5.3	9.2	5.0	9.4	5.9	5.6	6.2	7.6	2.1	6.7	8.5	8.1	10.9	7.3	19.3	23.4	21.5	26.2	12.7	10.9	9.6	21.6	12.5	10.6
NID2		ENSG00000087303	"Nidogen 2"	Q14112	14	52004803-52069228	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 52.1;BJ: 27.2;BJ hTERT+: 23.2;HHSteC: 28.9;HSkMC: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052460, HPA058772"	Enhanced		Enhanced	"Plasma membrane"	"Secreted to extracellular matrix"		2500000	"Plasma membrane"		"HPA052460: AB_2681840, HPA058772: AB_2683815"	"unprognostic (6.51e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-3)"	"prognostic unfavourable (7.34e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (2.78e-4)"	15.0	5.1	0.9	5.3	1.8	0.1	7.6	0.9	1.7	12.9	8.5	5.1	9.0	1.0	9.5	7.6	9.8	6.0	10.2	17.5	1.2	0.9	6.4	2.9	5.1	3.0	1.3	1.2	16.8	13.9	10.2	2.4	32.5	2.5	13.4	3.6	17.4	4.3	8.9	3.9	1.8	3.0	11.4	1.5	1.1	6.6	4.4	0.8	0.7	18.8	3.6	2.2	10.7	5.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.6	13.6	0.0	52.1	20.7	0.0	27.2	23.2	2.6	2.7	0.0	0.0	0.0	4.0	3.0	1.8	1.7	0.0	0.7	0.0	0.3	0.0	0.4	0.0	28.9	0.0	0.0	107.9	0.0	10.6	0.0	1.4	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.9	4.0	0.0	0.0	3.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	9.9	0.1	5.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	1.8	0.9	1.7	1.2	0.9	1.3	1.2	2.5	0.8
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736923	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	Nucleoli				Nucleoli		"CAB015382: AB_2142390, CAB075728: , CAB075729: , HPA035735: , HPA035736: "	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavourable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	25.1	18.7	18.4	22.1	19.0	19.9	28.1	14.3	20.8	24.0	17.3	14.8	9.8	16.5	21.4	17.4	28.2	20.3	16.6	15.4	16.1	15.1	24.2	40.1	14.7	30.8	15.8	15.2	32.8	33.7	12.9	28.9	19.8	18.5	21.2	19.7	10.2	16.5	14.2	35.5	22.8	17.9	20.9	18.3	28.1	19.2	18.7	18.0	31.3	23.6	21.3	29.5	26.1	21.0	28.1	25.9	12.5	23.5	27.1	32.9	24.6	28.5	8.6	18.7	18.4	16.5	22.9	22.5	22.5	20.3	28.4	31.1	25.3	14.6	39.4	28.2	17.5	18.6	40.3	30.5	42.6	23.9	21.3	38.7	12.2	23.7	23.2	35.6	21.4	23.0	35.2	37.6	50.4	20.4	43.5	19.6	24.6	14.1	27.3	35.4	45.9	31.2	26.2	21.1	48.3	25.2	17.9	23.5	24.3	14.2	28.3	49.2	13.6	30.7	11.7	19.5	32.0	22.1	32.0	23.0	34.6	43.8	15.2	35.3	27.2	12.5	19.8	9.3	22.9	23.5	32.1	27.0	28.2	26.2	25.9	28.1	32.9	30.8	1.3	27.1	20.9	22.6	23.5	24.6	18.4	19.0	14.3	20.8	16.1	15.1	15.8	15.2	18.5	18.0
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA005939: , HPA070691: "	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	13.0	6.1	15.1	24.9	10.3	34.8	9.7	12.6	14.0	8.0	9.2	7.6	4.5	5.0	11.8	6.1	11.8	8.2	7.6	16.4	11.7	4.9	6.7	5.2	10.7	30.2	7.6	10.0	11.0	5.4	9.1	12.3	20.2	7.1	6.5	7.7	6.2	8.2	5.1	16.9	10.9	8.3	12.0	7.1	18.2	9.3	4.6	9.0	16.4	7.8	5.1	25.8	11.7	10.3	6.8	6.3	18.4	2.3	1.5	6.0	1.3	12.2	8.7	18.1	15.4	7.0	11.2	7.6	10.5	9.1	8.9	7.5	5.6	6.5	28.8	7.2	14.1	12.9	14.5	6.6	18.7	13.9	4.5	10.6	5.3	5.3	4.1	18.4	30.6	7.7	5.3	15.5	6.4	14.1	2.6	11.8	13.4	13.4	13.9	7.4	2.5	9.6	15.8	33.5	2.0	8.0	13.9	8.4	9.5	13.2	4.0	11.3	7.5	16.4	20.5	22.6	31.4	8.6	11.6	9.5	4.8	19.9	5.9	15.0	12.2	12.6	2.3	18.4	3.3	1.7	3.5	6.8	2.2	6.0	1.5	5.5	4.4	3.8	8.3	1.5	1.5	6.3	1.9	1.3	15.1	10.3	12.6	14.0	11.7	4.9	7.6	10.0	7.1	9.0
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"NIP7, nucleolar pre-rRNA processing protein"	Q9Y221	16	69339430-69343111	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA040856: , HPA059850: "	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavourable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.8	15.5	8.1	16.4	8.7	20.4	14.0	7.0	12.4	10.2	13.7	9.5	11.1	11.8	15.6	13.1	24.0	13.0	11.3	9.1	9.0	7.8	18.0	18.0	10.7	17.6	12.6	9.6	11.6	18.4	9.6	10.2	14.3	10.9	10.1	14.2	8.8	13.1	13.2	12.1	14.7	14.2	11.7	8.3	15.4	12.3	14.8	9.5	27.1	19.2	23.8	21.0	10.6	11.8	16.6	14.2	8.4	11.7	15.3	19.0	9.5	14.9	10.7	9.1	12.0	11.9	10.8	13.5	13.5	10.9	23.7	17.5	17.2	16.2	27.3	15.2	12.5	15.0	17.1	21.5	30.2	7.2	13.7	14.2	7.6	22.4	11.7	31.2	9.3	11.6	17.2	21.8	24.2	13.0	28.1	4.9	16.4	18.3	18.8	22.9	26.4	12.4	27.2	9.3	24.9	14.6	11.2	11.6	16.5	27.1	8.7	16.7	11.8	19.1	11.3	17.3	15.3	13.0	24.9	15.1	11.4	66.8	10.0	18.6	17.2	8.4	8.1	5.7	16.8	9.2	18.1	16.6	15.6	19.0	14.2	12.1	15.1	18.3	4.0	15.3	11.7	12.5	14.8	9.5	8.1	8.7	7.0	12.4	9.0	7.8	12.6	9.6	10.9	9.5
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL, cohesin loading factor"	Q6KC79	5	36876759-37066413	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: "	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	16.8	13.9	13.3	21.9	15.7	22.7	15.8	22.9	15.9	17.3	19.2	10.8	20.1	10.4	18.7	16.5	16.6	14.3	15.9	12.4	13.5	7.1	12.6	13.2	16.0	16.0	17.2	11.1	21.2	14.6	30.0	20.9	17.4	13.5	15.1	13.2	8.5	17.1	24.7	18.9	18.2	18.4	13.2	11.9	18.5	14.7	14.1	19.0	42.5	18.1	14.0	16.9	17.6	29.2	4.8	4.6	11.1	4.3	3.8	4.9	1.9	10.1	6.0	15.7	7.4	10.0	11.0	11.6	8.2	9.1	9.0	7.5	8.4	10.5	15.4	5.3	10.1	8.9	13.4	7.5	13.0	12.6	7.0	18.7	26.7	6.1	6.9	21.8	12.5	8.1	9.3	10.1	13.4	11.3	17.8	11.6	8.4	4.9	14.9	8.3	7.5	5.2	12.8	24.7	5.9	6.4	14.5	11.7	8.2	39.5	10.6	8.4	10.8	12.7	12.2	11.9	13.0	10.1	6.1	8.4	11.2	18.3	6.6	15.0	8.9	10.0	4.1	5.7	4.8	3.2	4.4	4.0	3.9	4.2	3.3	4.8	4.3	4.9	11.1	3.8	4.3	4.6	2.9	1.9	13.3	15.7	22.9	15.9	13.5	7.1	17.2	11.1	13.5	19.0
NIPSNAP2	GBAS	ENSG00000146729	"Nipsnap homolog 2"	O75323	7	55951793-56000181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 97.3;skeletal muscle: 144.4"	"Cell line enhanced"	"Detected in all"		"A-431: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063084	Enhanced		Supported	Mitochondria				Mitochondria		"HPA063084: "	"unprognostic (6.88e-2)"	"unprognostic (6.53e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.02e-8)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.65e-3)"	"unprognostic (3.59e-1)"	14.5	19.3	18.4	8.4	22.9	8.6	16.6	11.8	24.5	12.6	14.6	8.9	11.8	8.1	11.0	11.1	12.9	13.4	8.0	97.3	18.7	15.9	16.6	5.2	13.2	16.6	17.0	16.7	9.5	13.5	11.8	8.6	8.0	17.2	14.3	14.2	6.8	18.9	15.5	144.4	6.3	8.3	21.6	19.3	6.5	11.6	5.8	12.1	7.4	22.6	39.8	7.2	12.4	7.8	14.3	34.1	14.1	33.1	15.2	14.1	24.7	78.8	14.0	18.5	30.7	10.7	18.7	9.1	6.6	15.7	19.2	14.9	9.7	17.5	11.6	11.2	12.4	10.5	13.9	14.0	19.1	7.3	20.5	8.2	8.4	12.3	15.4	17.7	8.3	17.0	21.6	6.5	17.9	20.2	14.5	11.4	14.9	3.5	17.6	18.4	18.1	14.2	17.9	8.6	23.7	25.9	12.5	19.8	22.3	15.1	18.3	20.6	35.4	19.2	11.8	8.8	13.3	3.1	13.7	9.4	7.9	21.4	9.7	11.2	25.9	13.4	33.1	14.1	8.7	31.8	10.6	14.3	11.7	9.3	34.1	12.3	14.1	10.1	5.8	15.2	23.9	14.1	13.6	24.7	18.4	22.9	11.8	24.5	18.7	15.9	17.0	16.7	17.2	12.1
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036999	Approved		Supported	Centrosome,Cytosol			960000	Cytosol	Centrosome	"HPA036999: AB_10672105"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.1	8.9	12.1	6.2	4.1	6.0	9.7	9.2	8.4	11.2	9.9	6.2	5.8	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.8	4.7	4.9	7.6	16.7	5.1	8.5	6.1	3.3	8.0	11.8	9.4	3.1	4.3	4.4	15.0	3.5	4.2	9.7	16.0	6.2	6.9	3.2	5.6	9.6	6.1	7.1	4.4	4.4	6.1	2.5	2.9	3.5	4.9	5.4	8.5	9.6	7.9	7.6	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3
NKAP	FLJ22626	ENSG00000101882	"NFKB activating protein"	Q8N5F7	X	119920672-119943772	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000916	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000916: AB_1079486"	"prognostic unfavourable (4.20e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	13.9	17.5	12.2	11.2	16.8	15.9	14.0	11.6	16.9	13.0	13.2	15.6	9.9	10.1	16.2	12.4	12.0	15.2	14.0	15.5	12.9	14.0	14.8	19.5	12.6	14.1	14.5	9.7	23.9	13.5	14.1	21.7	18.1	16.6	16.0	8.5	10.3	13.9	15.0	23.9	13.5	13.7	12.0	19.5	15.8	12.3	11.8	16.7	20.1	16.4	11.6	12.2	17.9	15.3	11.8	9.7	16.5	8.0	7.0	8.1	4.4	6.2	7.5	6.1	5.4	4.9	8.2	8.2	4.8	4.5	6.1	4.6	4.5	4.9	6.4	7.7	4.4	4.5	11.3	4.5	5.4	8.8	10.8	3.0	5.3	4.0	6.4	7.2	6.2	5.7	7.9	5.8	4.9	4.2	7.4	6.2	4.7	7.7	7.9	10.3	5.9	9.7	8.2	6.6	8.3	3.4	2.4	6.8	8.3	9.6	4.6	9.9	4.1	6.5	6.4	4.4	2.2	10.3	6.2	7.9	6.3	7.3	6.1	6.8	6.4	11.3	8.0	10.8	6.9	5.9	6.8	9.7	8.1	6.5	6.0	11.8	8.1	7.5	16.5	7.0	6.6	9.7	7.5	4.4	12.2	16.8	11.6	14.6	12.9	14.0	14.5	9.7	16.6	16.7
NKAPD1	"C11orf57, FLJ10726"	ENSG00000150776	"NKAP domain containing 1"	Q6ZUT1	11	112074086-112085150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039493, HPA039892"	Approved		Supported	Cytosol				Cytosol		"HPA039493: AB_10795036, HPA039892: AB_10795372"	"unprognostic (5.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.41e-1)"	20.6	16.2	20.6	14.1	19.1	13.5	20.6	34.8	21.6	21.5	16.0	13.9	13.1	13.4	19.3	15.7	18.1	17.6	15.6	14.7	19.6	21.1	21.7	14.5	13.4	17.6	20.7	14.7	26.0	17.9	17.4	15.8	24.0	20.7	18.9	14.6	13.2	18.0	14.8	28.2	14.6	16.2	23.3	19.6	19.6	13.9	18.8	15.9	29.7	26.7	15.6	16.4	21.6	19.4	9.1	19.4	7.5	7.7	12.2	11.2	4.3	7.8	5.3	11.3	18.1	11.7	13.6	8.3	11.6	10.0	9.8	11.3	16.4	14.3	22.2	17.9	10.5	11.4	13.5	12.5	12.8	15.8	9.4	17.0	5.3	7.8	10.8	25.6	11.2	13.8	17.3	11.8	27.4	8.7	25.0	13.8	9.8	4.8	22.8	15.9	11.2	11.8	17.7	13.9	18.1	11.4	7.1	9.5	17.3	12.1	15.0	10.9	18.7	10.7	8.8	13.2	14.9	8.1	10.0	10.3	22.7	45.6	5.6	24.3	13.3	7.5	7.2	4.3	9.9	7.1	10.1	8.3	10.5	6.7	7.6	9.1	11.2	9.5	3.8	12.2	7.7	19.4	8.1	4.3	20.6	19.1	34.8	21.6	19.6	21.1	20.7	14.7	20.7	15.9
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119605895	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavourable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	3.8	7.9	14.5	6.2	24.3	7.6	6.5	11.4	34.9	4.9	4.0	4.4	1.1	4.7	4.8	5.6	5.6	5.2	4.1	3.8	15.4	14.0	6.9	6.9	4.1	9.7	8.1	24.6	7.4	3.9	8.3	6.5	7.5	25.7	4.9	4.5	2.9	4.6	4.3	4.8	6.4	4.4	4.7	6.0	6.4	4.0	1.9	3.5	7.4	5.4	1.4	9.7	5.2	4.8	3.8	2.7	2.8	2.2	1.3	5.5	1.7	10.8	11.1	6.6	7.6	5.7	5.8	10.0	6.6	5.4	9.0	9.7	11.8	9.4	19.4	11.7	5.7	12.8	27.4	10.2	11.0	9.7	18.7	10.2	13.2	7.8	5.4	19.7	7.9	6.1	8.4	10.4	12.2	9.1	11.0	8.2	8.0	16.8	12.6	15.8	14.6	12.5	9.9	9.4	19.9	11.9	8.1	10.8	9.0	9.3	14.5	9.8	6.1	12.0	7.4	5.8	6.2	12.2	16.6	6.7	8.1	20.5	5.9	22.2	6.4	2.8	1.3	1.5	3.3	2.2	3.1	3.7	3.6	3.7	1.3	3.8	5.5	4.8	0.2	1.3	1.1	2.7	4.3	1.7	14.5	24.3	11.4	34.9	15.4	14.0	8.1	24.6	25.7	3.5
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600614-42648741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: "	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favourable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (6.01e-4)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (1.05e-5)"	12.9	14.4	9.8	18.8	22.2	16.3	15.9	42.0	12.3	18.8	10.4	18.5	15.4	11.8	27.2	17.4	11.0	12.0	13.1	11.2	10.9	10.5	9.5	9.7	14.6	15.5	14.5	11.3	22.7	18.4	19.2	26.9	11.1	14.1	12.9	11.1	20.4	13.2	19.5	12.0	20.0	13.3	19.4	15.0	18.5	10.1	17.8	13.8	20.6	14.9	10.9	19.4	12.9	13.9	9.3	8.5	11.7	10.0	11.1	10.2	3.6	8.9	5.1	17.1	7.0	10.2	12.5	9.6	14.5	3.7	6.0	8.2	9.0	7.2	14.1	7.0	4.4	7.9	10.1	3.6	12.4	7.1	8.4	18.1	16.2	14.5	4.4	13.9	11.9	5.1	7.2	11.9	4.5	10.6	18.2	10.9	11.4	3.7	9.5	13.6	14.7	7.5	10.1	7.7	5.8	8.4	6.8	6.0	3.6	15.6	6.5	2.4	9.5	10.1	17.0	10.9	7.9	11.8	14.0	9.5	13.2	9.8	5.8	17.1	6.6	9.2	6.2	11.7	10.2	7.7	9.4	8.9	9.8	8.5	4.7	9.3	10.0	8.7	9.1	11.1	10.0	8.5	8.3	3.6	9.8	22.2	42.0	12.3	10.9	10.5	14.5	11.3	14.1	13.8
NKX3-1	"BAPX2, NKX3.1, NKX3A"	ENSG00000167034	"NK3 homeobox 1"	Q99801	8	23678693-23682927	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"prostate: 95.3"	"Cell line enhanced"	"Detected in many"		"SiHa: 17.5;U-138 MG: 17.8;U-251 MG: 15.2"	"Cancer enriched"	"Detected in many"	65	"prostate cancer: 392.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"eosinophil: 23.5;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 23.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025693, HPA078571"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA025693: AB_1854522, HPA078571: "	"unprognostic (1.47e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.56e-6)"	"unprognostic (6.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.69e-1)"	0.6	1.3	0.3	0.6	0.9	0.6	1.5	0.1	0.8	1.1	0.6	0.2	0.5	0.5	0.7	0.5	1.2	0.7	0.8	2.4	0.8	0.3	0.4	1.6	0.8	0.7	0.6	0.2	1.6	0.6	0.5	0.4	0.3	1.2	95.3	0.2	0.5	17.9	0.7	2.0	0.2	0.4	0.7	0.6	0.3	0.5	12.3	0.7	0.0	0.6	3.2	20.5	0.7	2.5	1.0	0.0	23.5	0.0	0.2	1.2	0.1	3.2	2.4	0.0	5.9	2.2	0.5	4.9	4.4	2.8	9.5	11.2	1.4	3.7	0.0	0.6	3.3	0.8	2.3	5.1	7.5	0.0	1.2	2.2	1.8	3.5	4.2	0.0	0.8	0.8	1.3	9.6	0.5	0.5	0.1	0.0	3.7	1.0	7.6	0.6	1.4	1.7	0.0	3.8	0.3	0.5	3.8	1.1	0.3	17.5	3.3	0.3	2.3	0.3	0.6	17.8	6.3	1.3	15.2	0.0	0.0	0.0	8.7	1.7	2.1	3.4	0.0	23.5	0.5	0.0	0.1	1.0	0.2	0.5	0.0	0.9	0.7	1.2	23.4	0.2	0.0	0.0	0.0	0.1	0.3	0.9	0.1	0.8	0.8	0.3	0.6	0.2	1.2	0.7
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491987-84498450	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 6.0;esophagus: 11.0;pancreas: 10.8"	"Cell line enhanced"	"Detected in some"		"AF22: 5.5;HAP1: 8.0;HEK 293: 7.0;HMC-1: 5.4;PC-3: 4.7;U-2197: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.7"	"Low region specificity"	"Detected in some"			"HPA036774, CAB070169"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.2	0.0	0.3	0.2	2.2	0.0	6.0	1.0	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	11.0	0.0	0.2	0.2	0.4	1.3	0.2	0.2	0.2	0.2	2.5	0.2	0.2	10.8	0.0	0.2	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	1.3	0.2	1.5	2.1	0.2	0.2	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.2	0.0	8.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	0.0	0.0	4.7	0.0	2.3	0.0	0.0	0.3	1.5	0.0	0.7	0.0	0.0	0.0	0.7	0.1	0.0	2.4	8.8	2.2	0.0	0.0	0.0	1.5	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	1.0	1.1	0.4	1.3	2.5	0.2	0.9	0.2
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128753-35142315	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 40.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (6.39e-4)"	6.3	6.9	7.0	8.2	7.6	6.4	11.4	7.6	9.1	5.6	5.8	5.4	3.3	5.1	10.0	5.5	7.9	10.0	8.3	4.8	6.0	6.4	4.8	6.9	4.5	9.1	5.6	7.7	16.3	40.3	5.1	4.2	6.1	5.4	9.2	5.3	6.2	9.1	7.5	8.8	7.6	5.1	10.2	5.1	8.3	6.8	7.2	6.4	10.0	10.0	6.6	8.3	6.3	5.4	6.4	4.5	0.4	3.2	2.4	9.1	3.0	8.1	19.9	6.7	11.9	4.2	6.2	10.7	7.3	6.9	13.1	10.9	13.7	7.9	18.1	10.2	6.1	10.9	15.1	18.8	9.1	2.9	23.6	8.1	9.5	17.1	5.6	15.6	6.5	7.0	10.1	13.6	20.8	8.5	21.8	6.6	7.7	11.2	23.9	12.7	12.6	8.8	19.3	11.7	19.9	7.7	7.9	13.8	8.4	7.0	7.1	8.7	17.4	11.3	7.5	7.1	10.0	6.8	24.5	5.2	4.0	15.1	5.0	12.9	13.6	0.1	3.0	0.0	5.7	3.2	9.1	4.8	5.4	6.0	4.5	6.4	7.4	5.1	0.4	2.4	1.6	1.0	3.0	3.0	7.0	7.6	7.6	9.1	6.0	6.4	5.6	7.7	5.4	6.4
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.9"	"Cell line enhanced"	"Detected in some"		"AF22: 10.9;NTERA-2: 7.9;SH-SY5Y: 4.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"			"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: "	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	1.4	8.9	16.3	1.6	19.4	2.2	1.3	11.5	45.9	3.2	1.6	30.0	0.1	1.1	4.2	8.1	1.5	6.0	2.4	2.1	15.7	9.7	1.2	0.9	1.3	1.2	12.7	13.1	6.1	1.2	1.4	1.1	1.5	15.2	7.9	1.4	1.6	1.6	16.0	0.8	1.6	1.6	2.9	12.9	1.4	1.5	3.8	12.3	0.0	1.0	0.0	1.1	1.5	1.3	0.2	0.1	3.3	0.3	0.3	0.5	0.0	0.1	0.8	10.9	0.3	2.6	1.1	1.9	0.3	0.1	0.0	0.2	0.1	0.5	0.8	0.8	0.1	0.2	0.4	0.0	0.2	0.7	1.3	0.5	0.5	0.1	0.0	0.2	0.9	0.6	0.1	0.3	0.0	0.1	0.7	2.1	0.1	0.6	0.7	1.7	7.9	0.0	0.9	0.4	0.5	0.0	1.2	2.7	4.3	0.3	0.0	0.9	0.0	0.5	0.3	0.2	1.3	0.4	0.0	1.7	1.5	0.6	0.3	0.4	0.6	0.3	0.3	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.1	3.3	0.3	0.0	0.1	0.1	0.0	16.3	19.4	11.5	23.1	15.7	9.7	12.7	13.1	15.2	12.3
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"basophil: 17.6"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions"				Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: "	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	6.4	30.5	19.4	10.9	14.1	7.4	7.5	7.5	38.2	6.2	6.7	8.3	14.4	8.3	5.7	8.8	4.5	5.1	8.2	8.5	18.2	12.0	13.0	8.2	7.1	11.7	15.2	23.6	4.6	11.5	20.8	9.4	9.1	7.0	6.7	7.1	12.7	5.8	17.4	4.9	4.5	8.3	4.6	15.3	10.1	7.0	17.4	7.5	10.9	13.2	3.7	11.0	7.2	4.4	0.5	0.3	17.6	0.3	0.1	0.5	0.2	4.6	5.4	13.0	4.5	2.8	3.6	5.7	4.6	4.7	7.8	6.0	27.0	4.2	6.3	7.1	3.8	4.4	9.1	8.5	9.0	14.5	5.8	24.7	5.0	4.6	4.7	5.2	25.5	4.7	5.2	5.1	6.1	9.1	9.5	7.6	7.1	5.4	13.3	6.0	5.0	2.7	11.2	8.4	4.6	14.1	5.7	9.5	3.5	7.1	6.8	29.0	10.6	8.3	9.3	5.6	7.5	4.6	9.3	9.0	8.6	6.1	5.4	5.6	6.1	17.6	0.2	0.2	0.3	0.3	0.1	0.5	0.4	0.4	0.2	0.3	0.2	0.5	0.1	0.1	0.3	0.3	0.4	0.2	19.4	14.1	7.5	38.2	18.2	12.0	15.2	23.6	7.0	7.5
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.2;HL-60: 12.9;HMC-1: 6.5;NB-4: 13.8;U-698: 19.9;U-937: 9.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"				Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: "	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	0.2	0.4	0.0	20.1	0.1	2.8	0.0	0.0	0.2	0.4	1.3	0.0	0.2	1.2	1.0	0.1	1.0	0.0	1.8	0.8	0.0		0.6	0.5	6.0	11.2	0.2	0.0	0.1	1.5	0.0	0.0	0.6	0.2	0.9	0.7	0.9	2.7	0.2	0.5	0.0	2.4	0.1	0.0	10.5	1.4	0.0	0.0	27.0	0.4	1.1	18.1	1.6	1.0	1.0	0.0	2.6	0.0	4.7	4.1	3.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.2	0.1	0.0	0.0	12.9	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	5.4	13.8	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	3.3	0.4	0.2	0.0	0.2	0.1	0.3	0.0	19.9	0.1	9.7	0.0	2.6	0.0	0.0	3.7	0.0	4.1	1.0	2.7	3.8	0.0	0.8	2.1	2.0	0.0	4.7	0.0	0.0	3.1	3.3										
NLRC5	"CLR16.1, FLJ21709, NOD27"	ENSG00000140853	"NLR family CARD domain containing 5"	Q86WI3	16	56989485-57083531	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 40.7;NB-4: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA059120, HPA060405"			Enhanced	Centrosome				Centrosome		"HPA059120: , HPA060405: "	"unprognostic (9.66e-2)"	"prognostic favourable (9.69e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.24e-2)"	"prognostic favourable (2.30e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.75e-3)"	10.0	5.7	3.4	26.4	7.0	24.9	6.0	1.6	6.2	5.4	7.0	4.2	2.9	4.9	10.8	4.4	6.4	4.9	8.9	3.7	4.3	2.4	5.5	5.5	12.8	21.3	7.0	2.0	3.9	3.6	2.1	20.2	2.3	6.0	5.2	5.6	4.7	8.9	3.0	3.5	10.9	16.1	5.8	7.8	24.6	7.2	1.3	6.3	9.4	5.9	6.6	29.7	7.3	7.0	5.4	1.7	13.2	4.0	2.7	7.0	2.7	4.8	0.9	0.1	0.3	0.3	1.6	0.0	2.7	4.2	8.6	8.4	0.0	8.4	9.9	2.0	4.4	3.2	1.1	0.3	1.0	0.4	0.3	40.7	8.6	0.9	3.0	1.4	2.4	3.2	0.1	7.0	0.7	3.3	0.0	2.0	1.8	0.1	2.2	22.3	0.0	0.9	10.6	3.1	4.1	0.9	0.4	0.3	0.3	5.4	0.5	1.1	0.6	5.3	4.2	4.1	1.4	15.1	2.2	4.0	2.1	10.1	7.4	3.0	0.7	6.4	4.0	13.2	7.0	2.2	4.2	5.4	4.0	6.6	1.7	3.1	2.6	2.7	9.8	2.7	2.5	1.3	4.6	2.7	3.4	7.0	1.6	6.2	4.3	2.4	7.0	2.0	6.0	6.3
NLRP1	"CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1"	ENSG00000091592	"NLR family pyrin domain containing 1"	Q9C000	17	5499427-5619424	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.3;Karpas-707: 41.2;U-266/70: 20.6"	"Cancer enhanced"	"Detected in all"		"glioma: 20.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB009189, HPA064431"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009189: , HPA064431: "	"unprognostic (4.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (7.57e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-2)"	19.5	2.5	2.4	39.9	3.1	15.1	16.4	0.9	2.8	19.1	6.1	5.3	5.6	4.0	16.2	10.2	12.4	7.6	15.5	8.6	4.9	1.8	6.3	3.4	19.1	31.2	4.2	1.9	4.5	2.3	2.2	2.9	8.3	5.2	10.2	5.7	6.3	8.1	11.3	17.8	35.2	18.3	13.1	6.8	34.4	4.4	6.9	3.2	15.9	13.7	11.9	30.8	17.5	16.8	5.3	4.6	16.8	7.5	3.8	7.0	3.7	6.2	0.0	0.0	0.0	3.3	4.6	0.7	2.6	2.5	1.0	2.2	0.1	2.4	2.2	9.7	2.5	2.8	0.0	10.1	1.6	23.3	0.0	0.6	2.0	0.2	3.1	0.0	0.7	2.8	6.4	8.5	6.2	10.8	5.4	41.2	5.0	0.0	0.0	1.8	0.0	0.1	2.4	1.6	9.7	0.0	2.0	0.2	0.0	0.0	0.1	0.2	0.0	0.2	10.5	2.1	1.3	1.3	0.4	20.6	6.6	1.6	3.5	0.2	0.1	13.8	6.3	4.4	6.0	4.5	6.6	4.4	4.9	6.1	4.6	5.3	5.5	5.0	16.8	3.8	7.5	0.4	7.0	3.7	2.4	3.1	0.9	2.8	4.9	1.8	4.2	1.9	5.2	3.2
NLRP11	"CLR19.6, NALP11, NOD17, PAN10, PYPAF6"	ENSG00000179873	"NLR family pyrin domain containing 11"	P59045	19	55785397-55836800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.2;RPMI-8226: 21.5;U-266/70: 38.0;U-266/84: 16.4;U-698: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			"HPA046402, HPA078027"	Uncertain		Supported	Cytosol				Cytosol		"HPA046402: AB_10962951, HPA078027: "	"unprognostic (2.36e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.95e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.61e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	4.0	0.1	0.3	0.2	0.1	0.1	0.0	0.7	3.3	0.1	0.6	0.1	0.1	0.9	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	1.2	0.1	0.1	0.3	0.5	3.6	0.1	0.1	0.1	0.1	4.5	0.1	0.1	1.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.7	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	38.0	16.4	27.6	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NLRP2	"CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2"	ENSG00000022556	"NLR family pyrin domain containing 2"	Q9NX02	19	54953130-55001142	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 25.1;K-562: 10.4;U-266/84: 11.4"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 78.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA021183			Supported	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles, Cytosol"		"HPA021183: "	"unprognostic (1.66e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.60e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.57e-2)"	0.6	0.9	1.1	5.0	3.8	1.7	1.4	0.6	2.7	2.6	2.6	0.9	0.2	2.5	2.1	3.7	10.8	1.0	3.7	0.7	2.0	1.8	4.7	0.9	2.2	5.0	0.8	0.8	1.0	6.1	0.3	1.7	8.1	2.9	2.1	1.2	2.4	4.1	1.6	1.4	3.5	2.9	1.1	1.0	3.0	3.1	14.3	0.9	4.2	3.1	0.2	3.5	4.7	5.6	3.8	1.8	0.6	0.9	3.4	2.6	0.8	2.3	3.9	2.0	0.4	0.1	0.1	25.1	0.1	0.0	0.2	0.1	5.0	0.5	2.6	0.2	0.1	4.1	0.0	4.3	0.2	2.5	0.2	2.5	0.3	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.1	0.0	10.4	0.3	0.0	0.3	0.2	1.0	3.0	0.0	2.8	0.0	1.5	2.3	0.9	2.4	0.6	0.1	1.1	0.0	3.4	0.8	0.0	0.2	0.5	0.3	0.3	2.7	11.4	0.9	0.3	0.7	0.1	0.6	0.7	0.3	2.6	0.9	1.5	3.8	1.1	1.0	0.6	2.6	0.8	1.5	0.5	3.4	0.5	1.8	1.2	0.8	1.1	3.8	0.6	2.7	2.0	1.8	0.8	0.8	2.9	0.9
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"			35000	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: "	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favourable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favourable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	4.8	6.1	1.9	3.3	3.7	3.6	3.6	2.5	4.9	8.9	5.1	2.9	8.0	2.9	5.6	5.3	34.9	6.7	4.9	8.7	2.9	1.6	4.3	4.4	3.4	3.4	1.8	2.7	2.9	6.2	5.6	2.5	3.3	3.0	4.4	2.0	5.4	5.6	4.8	14.3	11.6	3.2	4.6	2.4	4.5	4.0	3.2	1.3	3.8	4.3	38.9	37.5	5.3	8.5	0.6	2.0	14.3	3.3	1.3	1.3	1.9	4.0	12.0	1.3	9.6	4.1	4.8	1.9	5.4	6.3	2.7	4.7	0.6	10.1	7.3	16.7	6.9	10.2	3.7	3.1	0.9	9.4	3.9	9.6	4.1	6.5	6.3	3.3	5.6	5.3	13.0	3.5	6.9	5.5	0.1	4.9	2.8	10.8	5.6	8.1	5.9	6.8	11.1	1.6	2.4	6.5	5.2	1.8	6.3	8.0	4.3	3.5	13.9	9.9	6.4	5.4	4.9	4.8	2.8	1.7	1.9	2.4	0.8	10.3	3.8	2.8	3.3	14.3	0.9	1.5	1.0	0.6	0.8	1.3	2.0	0.4	1.0	1.1	8.1	1.3	1.3	0.9	1.3	1.9	1.9	3.7	2.5	4.9	2.9	1.6	1.8	2.7	3.0	1.3
NMBR	"BB1, BB1R"	ENSG00000135577	"Neuromedin B receptor"	P28336	6	142058330-142088799	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 2.5;fallopian tube: 3.3;testis: 5.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;RPTEC TERT1: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026665			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA026665: AB_1854527"	"unprognostic (6.24e-2)"	"unprognostic (3.05e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.88e-2)"			"unprognostic (3.54e-2)"		"unprognostic (8.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.94e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.45e-2)"	0.1	0.0	0.6	0.0	2.5	0.0	0.4	0.0	0.8	0.5	0.0			0.0	0.2	0.3	0.6	3.3	0.0	0.0	0.5	1.6	0.2	0.0	0.2	0.0	0.6		0.3	0.0	0.0	0.0	0.1		0.0	0.0		0.2	0.6	0.0	0.0	0.0	0.2	0.8	0.1	0.2	5.1			0.4		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.9	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.5	0.0	0.4	0.0	0.2	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.8	15.7	16.2	10.7	16.5	34.7	20.3	26.6	21.8	23.1	14.4	13.2	10.9	10.8	23.4	17.7	22.9	14.3	14.2	24.1	15.5	13.6	25.7	46.7	19.4	12.5	16.7	18.2	27.9	29.0	13.4	27.5	20.1	21.6	21.7	13.5	14.1	19.7	13.3	31.8	15.5	16.3	22.1	16.3	17.1	25.3	12.1	13.1	19.6	21.7	21.3	15.0	32.1	16.0	12.1	13.2	15.9	11.8	22.8	18.7	13.6	21.7	12.7	12.5	12.8	15.7	21.7	17.3	24.9	18.9	18.6	21.8	21.4	18.0	27.7	31.9	17.4	14.3	20.0	18.3	29.2	28.7	12.2	28.5	11.2	13.4	17.4	34.2	17.3	18.1	13.6	13.2	43.6	20.2	20.8	15.4	22.0	49.7	15.5	13.1	15.7	20.3	19.1	18.2	28.0	17.8	49.4	20.0	12.5	14.2	34.8	20.6	25.9	15.7	17.6	14.9	10.7	17.1	30.0	25.3	17.1	28.4	18.6	22.4	20.3	15.9	10.8	5.7	11.8	11.8	18.3	12.1	13.9	14.5	13.2	10.4	18.7	14.5	2.5	22.8	7.3	7.4	17.1	13.6	16.2	16.5	26.6	21.8	15.5	13.6	16.7	18.2	21.6	13.1
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: "	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	47.6	95.2	32.9	45.9	13.8	22.1	55.3	37.2	25.8	77.1	58.5	74.9	28.9	83.9	38.8	34.4	25.6	62.8	63.2	66.0	40.7	84.6	55.0	73.9	103.9	28.0	60.2	25.2	21.0	39.8	58.0	54.3	46.4	81.1	27.9	45.6	80.7	71.5	69.3	39.4	86.8	43.9	64.9	77.2	59.2	33.3	45.7	52.6	19.5	53.4	34.6	55.6	40.8	29.2	49.8	45.2	30.9	76.3	36.0	83.0	98.8	30.1	51.1	37.8	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171747	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB036213: , CAB036214: , CAB036215: , HPA041113: "	"unprognostic (7.21e-3)"	"prognostic unfavourable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavourable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	62.1	54.6	42.3	58.2	44.1	44.2	188.9	20.1	43.7	58.9	74.0	16.3	67.7	52.5	65.0	52.0	104.3	56.8	65.3	115.1	38.2	32.1	77.3	115.7	59.0	174.7	45.0	23.7	90.7	234.3	17.5	30.4	37.9	34.0	64.0	62.7	29.9	109.4	65.8	105.3	63.3	45.1	88.3	34.6	69.4	50.2	32.3	24.4	42.5	66.9	102.0	56.6	81.3	140.8	49.3	71.3	8.3	43.7	32.6	34.5	38.2	91.8	135.0	32.3	56.4	72.3	105.5	89.2	63.7	66.3	97.5	74.3	108.9	48.9	77.3	103.2	65.2	58.8	67.8	86.9	80.3	93.1	200.5	65.0	94.2	157.6	79.0	102.5	45.5	95.5	101.5	62.9	110.7	58.0	88.9	52.1	70.2	163.4	51.3	128.2	48.2	207.4	49.2	107.1	123.4	105.6	116.1	73.7	45.7	39.2	98.5	95.6	67.9	78.7	58.8	94.0	68.0	66.8	101.2	91.1	118.3	88.5	50.8	52.2	47.1	8.3	35.1	2.0	24.7	43.7	34.5	49.3	33.0	26.9	61.5	36.2	23.8	25.6	2.1	32.6	38.0	71.3	29.9	38.2	42.3	44.1	20.1	43.7	38.2	32.1	45.0	23.7	34.0	24.4
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria				Mitochondria		"CAB045997: AB_11126630, HPA072588: "	"unprognostic (3.27e-1)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavourable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	34.5	34.4	21.5	13.9	17.6	46.8	34.6	10.4	13.6	25.6	44.6	12.8	40.7	9.7	21.7	33.7	25.1	20.0	39.9	26.9	16.6	16.5	20.2	61.2	13.5	27.5	16.9	11.3	31.9	19.2	22.0	17.3	19.4	11.7	46.9	10.6	32.2	44.4	44.0	13.7	7.5	15.3	83.9	12.4	17.8	27.1	13.3	10.9	19.6	21.0	14.2	14.5	64.1	27.5	13.1	28.6	18.2	6.3	1.2	13.7	5.2	0.1	49.5	44.0	60.4	17.6	31.0	9.8	23.3	28.0	35.3	30.3	33.0	28.8	0.4	17.6	37.1	0.6	23.8	25.0	10.4	19.9	35.5	24.0	6.7	44.0	33.3	17.4	8.8	39.9	13.2	21.6	2.1	22.6	24.8	4.3	26.2	40.5	15.2	22.0	44.8	11.0	76.9	9.8	12.5	24.4	0.2	12.9	69.6	5.9	0.4	21.6	29.4	41.0	28.1	25.2	36.7	16.8	5.8	0.5	0.3	13.1	11.0	3.2	29.0	4.1	6.3	18.2	7.5	5.6	6.5	12.3	7.7	8.3	8.7	13.1	13.7	7.1	2.2	1.2	4.8	28.6	0.4	5.2	21.5	17.6	10.4	13.6	16.6	16.5	16.9	11.3	11.7	10.9
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270465-151290057	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Cell line enhanced"	"Detected in many"		"NB-4: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 75.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	12.0	14.2	5.0	18.6	7.1	26.4	14.0	1.3	5.8	8.9	15.0	3.4	11.1	13.2	8.6	10.4	16.1	9.8	14.7	8.7	5.9	3.8	13.0	20.4	18.5	26.9	5.1	2.7	14.8	8.4	2.9	6.5	24.6	6.9	13.6	10.5	5.0	9.8	7.9	5.1	7.3	26.0	13.1	7.7	30.2	10.2	5.3	6.4	36.7	14.9	10.2	14.2	10.4	10.3	10.8	17.0	75.1	26.9	14.3	12.5	14.9	10.7	5.3	0.2	0.0	3.0	8.4	10.5	3.1	7.4	15.1	23.0	1.1	24.6	10.5	11.7	4.7	6.1	1.1	2.8	3.9	22.3	0.6	29.5	5.5	0.6	12.9	28.0	8.5	5.4	3.8	9.0	2.0	18.7	14.7	2.6	2.8	8.3	23.4	41.8	6.2	7.9	25.3	0.6	9.0	12.5	9.3	1.5	0.0	6.6	7.2	4.0	1.1	32.0	10.1	2.2	5.0	7.1	4.5	0.4	0.3	0.6	5.2	33.7	2.3	31.6	19.7	21.6	10.8	26.9	12.5	10.8	11.3	10.7	17.0	9.1	9.2	9.4	75.1	14.3	24.4	6.9	9.7	14.9	5.0	7.1	1.3	5.8	5.9	3.8	5.1	2.7	6.9	6.4
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA059447: "	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favourable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	7.2	13.2	8.1	7.2	9.0	4.0	8.8	4.1	8.1	8.8	12.8	9.3	11.9	8.9	10.1	8.8	8.7	7.4	7.3	13.9	7.6	6.8	11.5	12.6	5.3	5.6	10.3	8.3	5.1	14.1	10.3	9.3	5.6	13.0	7.0	13.6	10.1	17.7	8.4	29.1	8.1	9.2	8.3	9.0	8.6	7.1	10.7	8.3	6.8	10.8	11.5	6.8	6.2	10.4	5.3	4.3	12.8	4.9	3.1	2.7	2.3	3.7	4.7	6.5	6.3	12.4	11.3	1.5	7.4	6.1	8.7	5.6	2.0	6.5	4.0	4.8	11.3	3.9	7.9	10.6	10.5	8.3	4.0	6.6	2.9	6.1	9.9	5.4	6.5	11.9	12.0	10.5	15.1	9.0	7.7	2.7	9.6	6.4	3.0	3.5	0.8	8.4	3.5	4.0	2.1	10.1	2.1	4.7	2.4	9.8	8.4	8.4	3.1	5.8	8.5	3.6	3.2	7.3	3.4	3.9	3.7	3.9	6.1	11.4	7.3	6.6	4.9	3.9	2.4	3.3	1.1	5.3	2.3	2.7	4.2	3.6	2.1	2.5	12.8	3.1	4.5	4.3	1.9	2.3	8.1	9.0	4.1	8.1	7.6	6.8	10.3	8.3	13.0	8.3
NMNAT3	PNAT3	ENSG00000163864	"Nicotinamide nucleotide adenylyltransferase 3"	Q96T66	3	139560180-139678017	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA039077, HPA057402"	Approved		Supported	Mitochondria				Mitochondria		"HPA039077: , HPA057402: "	"unprognostic (9.45e-3)"	"prognostic favourable (9.67e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.92e-1)"	"prognostic favourable (7.29e-5)"	"unprognostic (4.57e-2)"	"prognostic favourable (1.95e-5)"	"unprognostic (4.13e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.07e-1)"	6.2	6.3	9.9	7.0	9.8	14.1	10.8	7.7	9.8	7.4	7.4	6.8	2.7	7.8	7.9	7.3	6.5	11.6	7.9	12.6	11.9	8.1	7.9	6.2	4.7	3.6	7.7	14.0	17.9	10.0	6.2	6.6	1.8	6.7	7.6	6.4	12.7	7.5	4.8	21.9	14.9	6.5	7.3	7.0	4.2	4.8	16.8	8.4	2.4	8.3	9.0	4.8	6.3	6.8	7.2	4.2	11.9	5.0	6.1	5.1	2.1	6.8	2.9	3.3	3.7	0.8	0.7	4.4	2.9	0.3	0.5	0.4	3.9	5.2	4.8	8.7	0.6	3.5	2.2	1.0	0.7	4.3	3.9	22.2	6.3	5.0	1.8	4.2	4.3	1.2	5.8	0.9	1.4	0.4	3.8	10.5	0.5	4.7	3.9	3.7	7.4	2.9	3.5	3.7	3.2	0.9	5.2	7.2	4.4	6.8	3.8	2.5	9.5	11.1	3.9	4.7	10.3	5.6	4.3	17.4	8.3	3.3	3.1	6.7	4.3	11.9	5.0	3.0	4.1	4.5	3.0	3.6	3.6	3.4	3.6	7.2	5.1	5.1	10.8	6.1	4.4	4.2	2.2	2.1	9.9	9.8	7.7	9.8	11.9	8.1	7.7	14.0	6.7	8.4
NMRAL1	"FLJ25918, HSCARG, SDR48A1"	ENSG00000153406	"NmrA like redox sensor 1"	Q9HBL8	16	4461680-4495763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041353, HPA062287"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA041353: AB_10796343, HPA062287: "	"unprognostic (2.56e-1)"	"prognostic favourable (3.33e-7)"	"unprognostic (4.16e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	10.0	20.6	19.2	8.4	23.3	11.0	17.8	7.0	31.5	16.9	14.1	23.5	19.2	17.1	12.9	18.1	17.0	20.7	17.3	17.0	19.6	16.1	18.1	26.2	12.8	14.8	20.2	23.8	20.1	30.7	14.5	14.2	16.7	17.7	18.9	10.0	14.6	28.7	17.6	3.2	25.3	13.6	12.4	20.1	13.6	19.9	7.0	14.2	14.6	18.1	10.0	12.9	12.4	11.7	13.3	19.5	11.6	19.2	8.9	23.5	17.3	10.6	15.4	2.4	8.4	5.1	4.9	12.8	7.8	2.6	8.8	7.0	16.4	18.0	0.3	15.6	8.5	12.3	6.9	9.9	3.9	9.6	4.0	9.3	11.3	7.8	11.4	11.1	7.3	7.5	12.0	9.6	3.7	8.7	11.9	0.2	4.0	33.9	22.4	10.7	10.7	14.4	24.6	0.2	13.1	9.2	6.1	3.6	9.9	13.2	22.5	8.5	20.8	10.0	5.2	5.3	0.4	3.9	0.1	0.3	0.2	18.6	2.4	9.9	10.2	4.7	19.2	2.0	23.5	11.3	18.3	13.3	15.9	22.4	18.2	11.2	17.0	17.7	11.6	8.9	8.7	19.5	14.0	17.3	19.2	23.3	7.0	31.5	19.6	16.1	20.2	23.8	17.7	14.2
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"heart muscle: 271.6;skeletal muscle: 103.2"	"Group enriched"	"Detected in some"	7	"BEWO: 22.4;NTERA-2: 18.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA049909: , HPA054792: , HPA072450: "				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favourable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.0	0.0	0.0	271.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	1.0	1.9	0.1	103.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	18.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	45051610-45109016	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.8	32.6	44.9	28.2	37.3	12.0	26.1	34.5	64.3	23.7	24.4	17.2	22.9	23.4	27.3	29.3	26.6	30.9	17.3	26.8	37.7	29.6	28.8	36.6	26.7	27.2	27.7	43.6	29.3	21.8	41.6	23.7	32.7	38.1	23.7	23.1	18.1	34.9	30.1	75.5	28.8	24.8	30.1	36.6	28.2	23.4	26.1	34.0	20.7	29.4	18.6	30.9	25.1	43.3	10.2	18.2	7.6	9.3	7.4	10.0	3.3	16.9	22.4	19.4	17.1	35.1	22.7	20.4	18.9	25.0	36.8	30.4	25.0	14.6	20.4	27.4	26.0	16.0	33.3	26.5	34.2	51.8	23.2	20.3	15.0	24.7	23.1	26.1	24.5	28.6	24.1	27.4	21.8	24.7	32.2	10.4	20.5	14.5	31.7	17.8	18.1	23.5	21.7	28.9	15.5	29.1	15.7	16.2	14.6	11.9	10.9	17.1	23.6	20.7	19.8	22.5	17.3	18.1	25.1	16.1	22.8	20.4	24.1	14.7	23.8	6.5	8.1	7.6	7.9	9.3	7.2	10.2	7.8	9.3	6.6	7.6	10.0	7.6	5.3	7.4	6.9	18.2	7.5	3.3	44.9	37.3	34.5	64.3	37.7	29.6	27.7	43.6	38.1	34.0
NMT2		ENSG00000152465	"N-myristoyltransferase 2"	O60551	10	15102584-15168693	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 33.5;HMC-1: 28.0;TIME: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 8.7;eosinophil: 7.9;gdT-cell: 7.2;MAIT T-cell: 12.9;memory CD4 T-cell: 11.5;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 9.3;NK-cell: 12.9;T-reg: 17.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.7;NK-cells: 12.9;T-cells: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001303	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA001303: AB_1079494"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	29.3	5.4	18.9	6.5	17.3	3.8	19.2	35.6	25.3	12.0	9.9	6.0	4.7	7.4	14.5	5.0	8.2	8.9	8.1	9.6	12.8	9.2	10.8	18.5	7.2	9.0	8.8	15.0	18.2	7.1	28.5	7.9	5.1	10.3	10.7	10.7	8.3	5.8	9.4	18.8	11.5	11.9	12.5	10.3	10.1	8.8	14.5	9.9	23.7	6.9	4.5	8.9	10.1	20.1	1.9	0.3	8.7	0.5	12.9	17.5	3.9	2.7	3.6	4.1	3.1	11.4	12.3	0.8	6.1	5.0	5.6	7.7	3.5	12.6	0.1	4.3	33.5	3.5	3.7	3.4	9.6	3.7	4.8	7.5	1.7	4.7	7.6	0.5	28.0	10.9	3.6	8.0	2.4	21.8	3.5	0.5	21.0	3.4	5.7	1.4	3.0	3.5	4.3	6.1	0.5	4.2	0.6	1.2	4.8	7.4	1.2	2.0	3.8	2.3	48.6	5.6	8.3	24.8	4.4	4.3	4.5	0.3	6.9	2.0	4.1	8.7	0.3	7.9	7.2	0.4	12.9	1.4	11.5	8.3	0.3	1.9	14.7	9.3	1.2	12.9	0.5	0.2	17.5	3.9	18.9	17.3	35.6	25.3	12.8	9.2	8.8	15.0	10.3	9.9
NMUR2	NMU2R	ENSG00000132911	"Neuromedin U receptor 2"	Q9GZQ4	5	152391532-152433368	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.9;stomach 1: 5.0;testis: 8.0"	"Cell line enriched"	"Detected in some"	8	"EFO-21: 14.5"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 0.5;endometrial cancer: 0.6;pancreatic cancer: 1.8;stomach cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in all"			"HPA027800, HPA045836"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA027800: , HPA045836: AB_10968856"	"unprognostic (1.82e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.44e-3)"		"unprognostic (3.13e-1)"		"unprognostic (6.47e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.90e-5)"	"unprognostic (1.48e-2)"	"unprognostic (9.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.29e-1)"	0.1	0.5	0.6	0.7	1.0	0.0	0.1	0.2	1.2	0.4	0.2	0.7	1.1	0.6	0.9	0.2	0.4	0.1	0.6	1.4	0.9	2.8	2.0	0.1	2.9	0.1	4.3	0.4	0.1	0.0	0.0	0.7	0.5	1.6	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.3	0.2	8.9	0.0	5.0	8.0	1.4	0.9	2.5	0.0	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.2	1.2	0.9	2.8	4.3	0.4	1.6	1.4
NOA1	"C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3"	ENSG00000084092	"Nitric oxide associated 1"	Q8NC60	4	56963370-56978823	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 22.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035838, HPA035839"	Approved		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA035838: AB_10669531, HPA035839: AB_10669658"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (8.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.27e-2)"	4.5	4.7	2.6	3.0	3.2	5.4	5.3	4.3	2.8	4.3	5.3			7.0	5.9	3.8	6.1	6.0	2.9	3.5	2.5	2.1	3.6	2.8	3.3	5.1	2.1		5.6	13.9	3.6	2.1	2.3		3.8	4.9		5.9	3.7	10.5	6.8	4.9	3.2	2.6	3.8	6.0	1.7			4.0		5.8	6.7	4.5	20.2	16.5	7.0	14.1	20.3	22.3	14.3	7.5	6.9	5.2	9.1	9.5	17.0	14.2	5.9	10.7	6.8	6.9	11.9	14.0	26.8	10.3	5.0	8.1	9.8	10.5	6.5	4.9	12.6	6.7	6.2	12.8	7.4	12.2	7.3	15.8	12.8	6.3	11.1	11.4	11.3	9.7	9.2	10.8	17.4	16.3	6.7	10.7	12.2	5.5	10.1	9.8	11.2	11.9	10.1	6.1	24.8	8.8	11.1	8.7	7.5	5.5	13.3	6.7	11.0	12.5	5.2	14.0	5.7	7.8	7.0	6.2	14.1	7.0	12.2	13.0	18.3	20.2	18.2	15.2	16.5	17.0	22.3	18.4	4.8	20.3	11.2	13.3	21.1	14.3										
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944204-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	Nucleoli			420000	Nucleoli		"HPA044258: AB_10961284, HPA062195: "	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	17.7	15.6	13.4	20.5	17.8	23.8	18.2	23.7	27.4	15.0	15.3	15.6	13.5	16.8	19.0	13.5	27.7	18.3	21.8	23.0	15.3	15.3	15.2	36.6	14.0	19.3	18.7	19.0	16.9	26.8	20.8	15.3	15.9	16.7	16.6	11.1	14.0	22.0	16.5	40.0	32.4	14.6	14.7	13.6	17.5	16.4	21.1	18.0	22.7	19.8	29.5	21.8	17.5	18.0	14.3	20.2	11.3	29.0	18.8	18.4	16.0	27.6	27.6	4.9	32.0	9.0	8.0	18.1	20.6	9.7	28.9	15.9	36.5	27.1	31.2	29.4	13.7	25.4	36.6	30.9	12.3	19.5	41.7	16.5	35.6	31.6	20.3	36.3	16.2	13.1	8.7	31.8	21.2	14.0	46.5	14.4	12.7	43.7	23.3	21.9	28.2	32.7	29.2	20.6	37.7	13.3	11.6	34.6	34.0	27.4	41.4	25.3	18.5	19.9	16.0	17.3	24.7	18.9	35.2	24.8	26.7	56.3	21.5	51.5	14.4	7.2	17.0	11.3	14.2	25.7	18.4	14.3	13.8	13.6	20.2	11.9	14.3	11.1	1.6	18.8	29.0	13.0	10.9	16.0	13.4	17.8	23.7	27.4	15.3	15.3	18.7	19.0	16.7	18.0
NOC3L	"AD24, C10orf117, FAD24, FLJ12820"	ENSG00000173145	"NOC3 like DNA replication regulator"	Q8WTT2	10	94333226-94362959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063958, HPA067638, HPA070981"			Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA063958: , HPA067638: , HPA070981: "	"unprognostic (1.29e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.93e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.30e-1)"	16.7	13.2	9.2	11.2	14.5	3.7	14.4	10.8	12.7	13.5	8.9	6.0	8.4	6.7	14.1	8.5	14.3	12.1	7.3	8.8	9.3	6.6	11.0	15.0	9.7	14.9	16.4	7.7	15.4	7.8	12.5	18.2	11.0	14.5	12.5	8.2	6.3	9.7	8.9	18.8	11.6	8.4	9.8	16.6	19.8	8.1	14.1	13.1	12.8	15.7	13.6	16.0	16.1	10.6	13.7	4.3	0.5	4.1	7.5	5.8	3.1	17.6	9.7	6.6	21.2	6.9	11.2	7.8	14.2	11.3	19.5	22.7	16.4	12.6	19.2	10.4	7.1	12.8	18.7	8.5	31.7	13.1	14.0	13.0	8.1	10.5	13.8	20.6	5.9	6.4	8.4	20.5	20.7	8.6	20.1	9.7	19.1	6.0	12.9	15.3	13.9	10.7	5.8	15.1	10.6	11.5	5.5	4.7	11.7	10.1	5.1	15.7	13.2	8.0	8.3	12.5	12.6	11.3	23.8	9.3	18.5	26.7	11.4	20.0	9.3	0.0	2.4	0.5	4.3	3.9	5.4	13.7	4.4	5.4	4.3	12.6	5.8	5.1	0.1	7.5	4.1	3.8	4.0	3.1	9.2	14.5	10.8	12.7	9.3	6.6	16.4	7.7	14.5	13.1
NOC4L	"MGC3162, NET49, Noc4, UTP19"	ENSG00000184967	"Nucleolar complex associated 4 homolog"	Q9BVI4	12	132144448-132152473	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053424			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA053424: "	"unprognostic (9.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.79e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	11.9	10.3	9.0	14.2	11.6	18.8	11.1	11.5	17.2	9.9	9.2	14.1	7.8	14.8	11.5	6.4	12.0	10.7	10.4	8.6	8.0	7.5	11.2	15.6	9.2	13.7	14.7	8.5	13.6	16.8	7.1	10.4	9.7	12.1	9.8	6.9	10.3	16.2	8.8	22.5	15.7	11.9	8.2	9.2	15.5	12.5	28.4	10.6	15.7	10.5	13.2	12.3	9.5	9.5	13.9	18.8	5.9	16.1	7.4	11.4	8.1	12.3	22.9	5.1	7.9	2.5	2.7	26.0	8.5	4.3	10.5	5.8	18.6	5.9	18.9	9.4	4.3	11.1	9.0	9.3	2.3	7.4	24.7	12.7	7.6	12.2	6.8	14.8	14.9	4.0	6.5	8.2	6.6	7.4	21.5	4.4	4.3	14.5	14.0	34.8	14.9	18.2	18.3	5.7	16.5	5.4	9.2	12.5	9.9	7.3	9.9	6.3	13.9	9.2	9.8	6.3	15.9	10.0	14.2	11.1	6.8	16.6	9.6	12.8	13.2	2.5	11.8	5.9	11.4	16.1	11.0	13.8	10.6	11.3	15.8	13.9	9.3	8.9	1.7	7.4	12.1	18.8	8.7	8.1	9.0	11.6	11.5	17.2	8.0	7.5	14.7	8.5	12.1	10.6
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015789-139045939	"Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: , HPA053714: "	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavourable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavourable (6.23e-4)"	17.5	3.9	3.3	4.9	8.0	38.7	7.4	3.2	7.3	2.7	3.1	2.7	0.0	2.2	2.8	1.5	4.0	2.5	7.9	5.4	4.9	3.7	6.9	25.8	5.1	3.1	3.0	3.1	1.7	4.4	4.0	4.7	9.3	3.7	2.0	2.8	1.8	10.8	1.4	12.0	3.9	10.5	4.5	2.3	3.2	3.0	4.9	2.6	3.7	2.9	11.8	3.9	3.7	4.6	1.9	1.5	6.3	3.1	1.4	2.4	0.2	4.8	5.6	2.2	4.2	5.0	2.1	13.7	7.2	5.2	10.3	7.4	7.5	2.0	16.0	5.8	5.3	3.5	11.5	6.3	9.7	7.2	4.7	7.4	3.4	6.5	4.6	10.8	4.4	2.4	3.1	11.4	7.8	4.5	13.3	5.3	4.5	5.5	7.4	5.7	7.1	6.0	6.1	6.5	5.6	6.9	3.1	8.3	5.5	4.5	5.2	4.1	3.8	8.4	6.7	5.5	7.2	5.2	8.6	4.3	4.0	10.1	5.1	21.5	7.0	1.5	1.4	0.8	2.4	1.5	1.4	1.1	1.1	1.3	0.6	1.9	0.8	1.6	6.3	1.4	3.1	1.5	0.7	0.2	3.3	8.0	3.2	7.3	4.9	3.7	3.0	3.1	3.7	2.6
NOL10	"FLJ14075, PQBP5"	ENSG00000115761	"Nucleolar protein 10"	Q9BSC4	2	10570766-10689987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035286, HPA043075"	Approved		Supported	Nucleoli				Nucleoli		"HPA035286: , HPA043075: AB_10794652"	"unprognostic (6.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (1.43e-7)"	"unprognostic (1.25e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (7.51e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.87e-2)"	18.6	22.4	13.5	18.7	16.1	20.5	17.7	20.4	16.9	14.7	15.5	16.2	19.6	13.1	21.5	19.1	20.9	11.8	15.7	15.7	11.6	11.8	18.2	21.9	13.8	17.5	17.4	12.5	15.2	25.8	17.0	21.4	19.8	16.2	15.2	17.6	14.4	19.8	15.5	27.5	19.4	13.5	15.2	17.0	15.3	17.2	18.4	15.4	16.4	16.8	21.3	18.9	14.6	18.2	8.1	7.4	3.6	8.5	7.0	9.7	4.4	11.4	18.5	10.9	19.4	13.0	14.3	21.6	19.5	15.2	20.7	16.3	21.9	14.7	26.8	12.1	17.3	14.9	25.7	23.5	26.1	18.7	20.1	25.9	11.7	25.8	17.3	29.8	14.4	12.8	17.4	23.0	23.0	14.8	34.1	17.1	20.4	20.7	19.7	21.4	30.3	17.6	18.4	30.0	24.9	14.6	15.7	19.0	20.6	14.6	24.1	17.0	12.6	11.7	14.6	20.2	25.0	20.8	31.7	22.8	35.8	30.9	17.0	29.6	24.9	2.5	6.1	3.6	6.8	8.5	9.6	8.1	7.1	7.7	7.4	6.3	5.5	7.6	0.8	7.0	8.3	5.3	9.7	4.4	13.5	16.1	20.4	16.9	11.6	11.8	17.4	12.5	16.2	15.4
NOL11	DKFZP586L0724	ENSG00000130935	"Nucleolar protein 11"	Q9H8H0	17	67717833-67744531	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022010	Supported		Supported	Nucleoli				Nucleoli		"HPA022010: AB_2267158"	"unprognostic (6.81e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (1.00e-6)"	"unprognostic (3.07e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavourable (2.59e-6)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.77e-3)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.11e-1)"	17.3	15.1	12.2	14.3	13.4	17.0	14.5	19.8	11.6	15.2	12.9	10.2	11.9	10.3	17.2	11.7	18.1	13.9	10.4	12.8	9.5	7.6	18.9	22.1	10.4	17.5	14.4	5.4	19.5	16.9	18.4	17.0	19.8	10.8	14.6	13.9	10.4	14.1	10.7	26.8	13.8	13.8	13.6	11.1	16.6	14.4	10.6	14.3	32.1	13.6	16.4	20.1	14.5	13.4	9.7	7.0	7.4	5.8	10.0	14.7	7.8	14.5	17.0	14.3	9.3	6.8	8.1	15.6	10.1	8.8	22.6	18.5	16.1	11.2	24.8	7.9	11.0	11.4	34.8	16.8	33.2	7.0	27.6	16.3	10.3	14.3	7.9	21.7	10.7	6.3	10.6	16.9	11.6	21.0	27.2	7.6	17.9	14.3	26.6	9.1	15.7	23.8	18.4	30.0	17.4	10.2	17.3	11.8	10.9	9.4	26.5	12.3	18.0	12.2	7.2	19.7	13.3	6.7	21.0	4.8	12.3	26.7	8.4	15.2	11.7	7.4	5.2	3.6	8.5	5.8	8.8	8.8	8.9	10.2	7.0	9.7	14.7	10.8	0.8	10.0	5.3	5.3	9.6	7.8	12.2	13.4	19.8	11.6	9.5	7.6	14.4	5.4	10.8	14.3
NOL3	"ARC, CARD2, MYP, NOP30"	ENSG00000140939	"Nucleolar protein 3"	O60936	16	67170154-67175735	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009208	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009208: AB_634091"	"unprognostic (2.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (6.43e-5)"	"unprognostic (5.74e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (1.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.48e-2)"	16.3	22.6	13.0	3.2	19.6	1.3	9.4	7.3	14.1	8.4	7.1	10.8	19.7	5.3	7.5	10.5	15.4	7.8	15.7	29.1	11.1	8.3	10.1	12.8	10.1	2.6	15.9	12.3	6.8	12.3	22.8	14.8	8.6	12.7	19.8	6.1	13.8	18.0	13.3	76.1	39.7	5.2	10.6	11.6	3.7	11.1	2.7	15.8	0.6	9.6	27.7	6.3	9.4	9.2	0.0	2.1	1.5	6.8	0.7	3.4	2.5	6.1	10.1	1.7	9.5	8.5	6.5	9.5	5.0	5.3	5.4	3.2	2.1	16.3	0.1	16.6	5.8	10.3	2.3	7.7	1.3	5.5	3.5	0.2	8.0	3.2	5.3	0.5	1.2	3.9	14.4	4.3	3.0	2.3	2.2	6.6	10.2	16.1	0.1	0.8	1.6	24.9	5.5	3.5	12.3	9.2	1.9	13.5	7.2	21.0	15.2	2.2	32.5	1.7	5.2	7.2	6.2	7.0	4.3	9.6	3.0	1.7	20.4	1.5	2.4	0.0	6.8	0.0	0.3	0.6	0.1	0.0	3.4	0.3	2.1	0.0	0.0	0.5	1.5	0.7	0.2	2.1	0.0	2.5	13.0	19.6	7.3	14.1	11.1	8.3	15.9	12.3	12.7	15.8
NOL4	"CT125, HRIHFB2255, NOLP"	ENSG00000101746	"Nucleolar protein 4"	O94818	18	33851100-34224952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 12.5;testis: 14.5"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 28.2;SH-SY5Y: 7.5;U-698: 6.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046740			Supported	Nucleoplasm				Nucleoplasm		"HPA046740: AB_10960527"	"unprognostic (7.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.43e-7)"	"unprognostic (5.76e-2)"		"unprognostic (1.56e-2)"	"unprognostic (7.19e-2)"		"unprognostic (3.45e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.77e-2)"	"unprognostic (7.71e-2)"	0.0	2.4	3.3	0.0	6.2	0.0	0.0	8.9	12.5	0.7	0.3			0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	5.3	1.0	2.8	0.2	0.2	1.2		0.0	2.0	0.0	3.2	0.0		0.3	0.9		0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	14.5			2.1		0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.1	0.0	0.0	0.0	28.2	7.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0										
NOL4L	"C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424"	ENSG00000197183	"Nucleolar protein 4 like"	Q96MY1	20	32443059-32585074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 31.6;HEL: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041768, HPA043600"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA041768: AB_10964172, HPA043600: AB_10961001"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (3.10e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.88e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.08e-3)"	"prognostic favourable (2.63e-4)"	7.7	8.0	13.1	9.0	14.9	18.9	8.7	19.4	14.8	6.5	16.3	35.6	8.7	19.9	6.5	13.8	2.8	9.9	11.0	5.0	13.9	11.7	9.8	5.7	10.6	8.0	20.5	8.7	3.7	12.1	5.0	19.9	12.1	16.3	7.5	15.0	12.5	11.0	9.8	1.9	3.8	20.7	7.4	17.9	11.3	14.3	33.2	20.1	16.7	8.5	2.6	6.5	10.0	8.7	1.9	2.2	7.2	11.7	8.9	8.7	4.7	3.8	11.9	7.5	5.1	1.6	2.5	1.0	2.5	2.0	3.1	2.2	31.6	9.1	0.2	7.4	3.2	1.0	2.3	6.9	1.4	0.9	1.8	24.8	5.8	22.5	4.2	0.3	1.5	6.1	1.0	2.3	1.5	18.8	7.4	3.3	1.5	2.1	8.0	7.5	4.3	11.1	3.5	0.9	1.3	5.2	0.7	9.9	8.0	7.8	0.1	4.2	1.6	7.6	19.7	2.9	10.3	2.7	2.5	2.5	0.8	1.7	3.2	13.5	8.9	3.0	2.2	1.1	6.6	4.9	5.8	1.9	4.4	3.8	2.2	1.4	8.7	7.1	7.2	8.9	11.7	0.3	7.0	4.7	13.1	14.9	19.4	14.8	13.9	11.7	20.5	8.7	16.3	20.1
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461441-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA055891: , HPA061002: "	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (9.49e-4)"	"unprognostic (4.09e-1)"	15.3	14.9	13.3	17.7	19.7	21.0	14.9	16.8	30.8	16.0	11.4	14.6	9.0	10.3	15.3	11.9	21.1	12.8	18.2	13.1	12.4	10.6	13.8	41.6	13.5	15.8	10.1	11.4	20.5	20.5	22.7	18.2	15.4	19.2	17.5	14.8	12.5	15.5	15.5	23.4	23.5	11.3	17.0	7.3	17.6	13.0	19.0	7.8	13.8	13.2	19.7	20.9	12.4	14.5	4.2	7.1	0.3	8.4	3.9	6.0	3.4	15.5	22.5	8.6	19.4	13.5	9.3	14.7	17.4	13.1	20.4	17.2	24.8	5.7	27.2	8.0	19.5	10.9	24.9	25.0	21.6	17.2	10.3	14.0	26.2	13.7	13.3	31.8	20.5	10.2	20.8	27.0	26.1	13.3	22.7	10.5	16.2	13.7	17.8	32.0	31.0	20.6	15.4	8.5	14.1	15.8	18.7	10.2	14.0	14.5	18.8	6.2	7.6	18.6	14.9	12.6	17.0	15.8	30.3	10.0	13.9	23.0	11.1	16.9	14.4	0.0	4.0	0.3	5.4	8.4	6.0	4.2	4.1	5.2	7.1	3.6	5.1	4.8	0.2	3.9	7.9	3.8	4.0	3.4	13.3	19.7	16.8	30.8	12.4	10.6	10.1	11.4	19.2	7.8
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	Nucleoli				Nucleoli		"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	15.8	11.5	11.6	14.6	20.0	8.5	13.6	15.9	15.9	15.1	13.2	7.3	12.1	6.4	16.4	11.1	14.1	13.0	9.4	9.4	13.7	8.2	10.6	8.9	9.5	13.6	17.9	8.4	17.5	11.1	25.3	23.6	11.8	13.4	14.0	11.0	5.2	11.0	13.2	15.0	12.9	10.7	14.6	19.5	15.7	10.6	7.7	17.8	18.7	15.2	11.2	15.1	16.3	16.2	13.6	12.2	13.6	14.7	12.6	17.5	6.6	7.9	13.0	6.0	12.1	13.7	11.7	8.3	9.2	7.2	9.8	9.5	4.6	8.4	25.3	8.1	9.7	16.7	21.5	12.8	10.9	15.8	9.7	18.0	13.0	10.4	9.2	29.9	13.7	12.2	9.5	11.0	15.5	12.1	27.2	7.8	11.3	12.9	20.8	10.5	10.2	12.4	12.6	17.8	10.3	5.1	5.4	11.3	5.5	12.6	11.0	7.7	4.5	9.4	11.8	9.1	5.9	12.9	9.6	7.9	17.7	13.7	8.5	17.2	11.8	13.6	8.3	11.3	12.5	11.1	17.5	13.6	11.9	12.0	12.2	12.6	14.6	12.5	3.2	12.6	14.7	10.3	13.2	6.6	11.6	20.0	15.9	15.9	13.7	8.2	17.9	8.4	13.4	17.8
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554535	"Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"				Nucleoli	"Intermediate filaments"	"HPA036347: "	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	12.7	11.3	10.4	10.3	15.1	19.3	11.0	16.4	19.3	14.7	11.2	14.1	6.8	7.7	13.3	11.6	12.1	11.4	8.8	8.3	10.8	9.7	9.6	15.2	9.4	14.4	8.6	9.6	16.8	14.7	15.5	10.5	9.8	12.0	13.0	10.0	9.4	9.1	10.3	17.9	18.0	11.4	12.4	7.2	22.0	11.0	9.4	9.2	20.9	9.4	8.9	14.9	11.0	9.3	6.9	5.8	5.0	4.8	2.8	8.4	1.9	5.1	7.3	4.1	12.4	5.5	3.3	4.5	5.0	3.3	5.3	5.6	10.0	7.0	14.2	6.1	5.6	6.8	8.3	6.9	9.1	5.7	4.5	9.6	11.3	7.8	5.6	8.1	5.3	4.9	2.1	11.2	9.8	6.2	11.2	6.0	5.4	8.8	7.9	7.3	5.6	7.1	10.1	9.7	6.6	4.1	4.7	8.0	3.7	7.8	9.9	6.2	6.4	3.7	8.0	8.4	6.9	5.9	8.4	5.0	4.7	25.9	7.8	9.1	3.9	5.0	3.5	2.6	5.7	3.2	5.7	5.1	8.1	5.2	2.3	6.9	8.4	7.0	2.2	2.8	4.8	5.8	5.1	1.9	10.4	15.1	16.4	19.3	10.8	9.7	8.6	9.6	12.0	9.2
NOLC1	"KIAA0035, NOPP130, NOPP140, P130"	ENSG00000166197	"Nucleolar and coiled-body phosphoprotein 1"	Q14978	10	102152176-102163871	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032654, HPA037366, HPA050388"	Supported		Enhanced	"Nucleoli fibrillar center"			10000	"Nucleoli fibrillar center"		"CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: "	"unprognostic (3.23e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (9.19e-5)"	"unprognostic (3.15e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (8.25e-5)"	"unprognostic (7.68e-2)"	29.5	17.1	18.8	27.8	35.0	23.2	21.3	37.9	39.2	19.1	20.4	23.5	13.8	14.2	25.1	12.4	30.4	25.1	20.7	20.0	18.5	19.2	16.1	38.1	23.6	27.7	20.2	21.4	28.0	25.5	33.9	34.3	25.4	28.0	20.7	27.0	14.8	21.0	18.0	46.6	20.3	17.3	23.4	20.2	26.2	21.0	13.8	19.9	32.9	26.1	19.8	35.1	24.3	20.9	12.7	11.6	7.8	11.2	11.8	19.3	11.2	32.3	29.8	16.9	35.5	14.0	11.2	28.7	18.5	14.8	26.1	22.3	51.2	22.7	67.7	20.6	11.8	37.5	48.5	40.4	27.9	21.2	31.8	45.3	24.8	29.8	18.9	65.6	21.2	14.3	26.4	27.6	57.9	15.9	47.5	30.0	15.6	28.4	61.3	13.8	32.2	23.4	46.0	46.2	37.7	15.1	20.8	25.2	23.8	17.8	20.5	22.6	35.6	14.2	13.6	11.7	16.3	13.7	41.4	28.1	41.5	76.3	19.0	67.6	10.0	1.4	8.4	7.8	15.5	10.3	19.3	12.7	12.4	14.5	11.6	10.0	14.5	17.1	0.9	11.8	11.2	9.0	8.8	11.2	18.8	35.0	37.9	39.2	18.5	19.2	20.2	21.4	28.0	19.9
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949723-156973182	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA019866: , HPA051624: "	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	12.3	10.9	10.8	16.9	14.2	15.3	11.1	13.0	15.9	9.7	11.4	9.9	11.1	8.9	12.8	9.0	12.9	11.4	8.1	8.3	11.2	6.4	8.4	12.2	9.9	13.4	11.9	11.7	13.9	14.5	11.1	8.4	10.3	11.4	9.6	10.0	9.3	10.5	12.5	21.0	15.5	10.5	12.0	10.0	12.1	10.6	13.9	11.9	9.9	9.9	9.8	12.4	11.4	17.0	5.0	2.8	2.5	2.8	2.6	3.4	0.9	9.0	7.8	5.8	8.5	5.8	6.1	7.9	9.0	4.5	7.4	6.0	8.4	7.7	15.9	9.1	7.3	7.4	10.3	11.0	9.1	7.2	9.0	13.3	6.5	7.7	4.7	23.1	8.1	4.4	5.4	6.6	8.6	6.2	20.0	8.6	6.6	11.8	14.6	19.3	13.9	8.4	10.5	8.7	12.2	4.7	10.8	7.1	8.6	8.2	6.6	6.2	3.2	12.5	10.0	8.0	2.6	14.8	11.6	11.1	7.9	14.6	10.2	16.7	7.5	2.5	2.8	1.5	2.1	1.9	1.2	3.8	2.7	2.9	2.8	5.0	3.4	1.8	1.3	2.6	2.1	2.8	1.0	0.9	10.8	14.2	13.0	15.9	11.2	6.4	11.9	11.7	11.4	11.9
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71283192-71301168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"			150000	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	37.2	55.9	30.2	37.7	30.8	51.2	37.2	54.8	38.6	45.4	33.4	36.0	38.4	29.9	52.4	40.5	41.0	40.5	37.2	30.5	27.5	29.0	40.1	43.3	37.3	45.7	28.8	31.7	69.2	61.0	39.4	48.2	42.4	27.5	40.8	37.5	42.5	39.8	41.4	37.2	38.4	35.2	40.5	38.3	45.9	40.3	34.4	29.0	98.4	51.0	39.1	57.4	43.6	36.8	44.1	47.3	35.3	51.8	45.4	51.8	58.9	58.5	64.8	89.7	49.2	36.6	37.8	49.1	48.0	44.7	65.0	57.4	51.4	43.5	66.6	53.5	44.2	43.8	133.8	41.7	71.6	50.7	89.4	54.6	68.0	51.1	31.0	76.6	48.0	40.0	29.8	65.7	44.1	53.3	69.6	69.9	59.9	52.0	99.0	69.8	111.6	52.6	89.1	94.0	57.1	49.8	51.8	62.3	77.3	62.2	40.6	55.1	38.2	49.6	48.9	42.1	63.2	58.8	55.5	40.3	76.3	75.8	31.4	89.1	60.1	35.3	44.8	34.9	45.8	47.6	51.8	43.7	46.6	44.9	47.3	44.1	50.8	50.2	20.8	45.4	51.8	41.2	50.1	58.9	30.2	30.8	54.8	38.6	27.5	29.0	28.8	31.7	27.5	29.0
NOP10	"MGC70651, NOLA3, NOP10P"	ENSG00000182117	"NOP10 ribonucleoprotein"	Q9NPE3	15	34341713-34343177	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 210.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059198	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA059198: "	"unprognostic (2.65e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (1.48e-5)"	"unprognostic (3.12e-1)"	"unprognostic (2.39e-3)"	"unprognostic (8.11e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-3)"	39.1	45.3	29.8	33.1	34.7	45.7	73.3	17.3	41.2	31.8	40.5	14.8	34.3	28.2	28.7	74.7	51.4	30.8	31.1	73.6	29.9	26.9	46.1	59.6	78.1	77.3	31.1	27.2	19.6	64.7	21.2	28.2	31.5	30.7	27.4	52.3	17.0	34.7	33.1	49.4	30.7	34.2	41.0	29.5	51.2	34.1	22.3	27.5	39.5	33.2	58.7	51.9	30.3	34.8	52.4	61.9	210.0	66.4	36.8	50.3	66.7	25.3	56.4	40.5	25.3	64.9	55.1	21.4	34.5	56.3	67.4	86.1	42.3	24.5	17.5	41.4	54.3	36.0	72.2	60.1	63.8	25.9	41.3	55.4	51.4	60.5	90.7	36.0	28.8	63.9	56.5	62.2	72.5	94.3	48.4	25.6	82.3	34.5	27.6	57.8	39.8	54.7	30.3	28.0	28.7	90.7	56.1	26.2	35.0	24.8	26.3	25.6	29.1	75.2	40.4	37.1	27.7	52.1	29.1	25.2	47.1	47.0	47.5	58.3	26.3	64.6	66.4	64.3	29.5	62.3	31.2	52.4	38.6	35.0	47.8	46.9	41.3	36.2	210.0	36.8	48.2	61.9	50.3	66.7	29.8	34.7	17.3	41.2	29.9	26.9	31.1	27.2	30.7	27.5
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963385	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: "	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favourable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.3	16.8	9.8	22.4	13.2	19.0	16.2	21.1	15.2	12.0	12.6	9.0	12.6	12.0	14.3	11.7	19.0	12.1	14.7	14.8	8.9	7.1	13.6	34.0	12.9	20.8	10.0	8.7	20.7	26.8	13.9	15.5	12.8	10.6	12.3	12.8	11.1	14.7	14.6	38.6	21.4	13.1	12.4	9.8	18.0	15.1	9.8	11.4	17.9	15.4	16.3	20.9	18.1	18.9	5.2	4.9	1.3	3.8	4.4	8.4	3.0	16.1	13.7	8.2	16.9	11.0	12.6	14.4	14.9	10.6	15.6	12.9	17.9	17.1	45.8	10.6	12.1	11.2	22.6	19.4	16.8	8.7	21.6	36.4	13.0	16.2	14.6	39.5	15.9	12.7	17.5	17.6	16.1	13.1	32.9	16.3	11.7	11.6	41.6	29.8	21.3	22.6	27.0	12.4	15.2	7.8	26.1	17.0	10.0	12.4	9.2	11.6	17.6	15.6	16.2	13.1	7.6	15.9	27.4	12.2	19.7	39.5	13.6	29.3	13.5	1.3	3.2	0.6	4.8	3.8	8.4	3.4	5.8	7.0	4.0	5.2	7.0	5.2	0.5	4.4	2.5	4.9	3.8	3.0	9.8	13.2	21.1	15.2	8.9	7.1	10.0	8.7	10.6	11.4
NOP16	"HSPC111, HSPC185, LOC51491"	ENSG00000048162	"NOP16 nucleolar protein"	Q9Y3C1	5	176383938-176388975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036506, HPA058147"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA036506: AB_10672223, HPA058147: AB_2683620"	"unprognostic (4.55e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (5.75e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	17.1	12.8	11.0	15.3	12.7	13.2	13.5	6.1	10.4	8.5	13.3	4.9	8.4	12.0	9.5	8.1	23.2	9.6	9.9	18.2	8.0	8.2	18.2	34.3	8.7	15.0	11.0	8.8	10.9	16.2	5.8	7.2	9.5	14.8	9.1	11.8	3.2	8.8	7.7	50.2	15.6	9.5	8.7	6.8	14.7	11.2	12.2	9.5	9.4	11.3	29.3	17.1	11.1	12.2	26.8	30.3	2.7	26.6	24.1	22.6	13.7	17.5	26.9	6.7	28.5	9.9	10.4	26.0	14.6	8.6	21.2	18.4	36.8	17.8	29.3	20.0	10.8	16.6	31.3	48.4	14.8	37.3	25.6	15.1	19.8	31.2	19.9	30.9	17.9	10.7	21.8	19.4	24.1	15.5	29.6	15.1	15.3	51.2	23.7	42.8	23.6	34.2	19.8	9.4	31.2	19.8	15.0	20.1	17.0	8.6	34.8	19.4	15.5	22.7	14.0	16.2	16.6	15.1	36.4	19.4	22.9	32.6	12.7	42.4	13.9	2.1	16.8	2.7	17.4	26.6	22.6	25.1	19.6	18.7	24.9	26.8	21.5	22.5	1.7	24.1	13.0	30.3	13.6	13.7	11.0	12.7	6.1	10.4	8.0	8.2	11.0	8.8	14.8	9.5
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040119	Supported		Supported	Nucleoli				Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	16.5	12.7	14.8	21.7	17.1	30.9	15.3	14.8	14.9	10.8	12.8	6.9	7.3	14.0	15.2	11.4	19.5	15.0	11.2	12.8	11.9	8.7	12.8	31.2	14.0	25.9	14.7	8.9	14.5	21.5	12.1	15.1	12.3	13.8	17.4	14.7	9.0	21.3	9.4	32.6	19.1	15.7	14.7	8.9	23.1	13.4	19.4	13.2	24.7	16.8	18.5	27.2	11.5	17.1	12.6	16.5	3.3	11.5	11.9	20.3	10.9	16.1	26.0	7.1	24.3	9.1	7.8	38.6	14.7	9.5	17.4	15.0	31.7	16.5	34.5	4.0	7.2	20.0	27.2	16.2	16.9	40.7	25.5	33.8	24.8	18.3	12.2	33.3	19.5	7.9	16.0	21.0	32.8	11.7	23.7	5.5	13.8	20.0	17.8	29.0	59.4	14.5	25.4	20.7	16.9	12.7	22.3	5.5	10.9	23.0	25.1	12.1	4.1	16.0	11.0	12.0	16.1	15.5	33.7	7.7	11.2	51.5	11.0	19.1	20.8	1.4	8.2	0.9	14.8	11.5	20.3	12.6	14.1	16.6	16.5	10.1	17.3	17.6	3.3	11.9	10.0	14.5	9.7	10.9	14.8	17.1	14.8	14.9	11.9	8.7	14.7	8.9	13.8	13.2
NOP53	"GLTSCR2, PICT-1, PICT1"	ENSG00000105373	"NOP53 ribosome biogenesis factor"	Q9NZM5	19	47745522-47757058	"Predicted intracellular proteins"	"Host-virus interaction, Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 158.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 51.0;NK-cells: 20.5;T-cells: 52.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018999, HPA049600"	Approved		Supported	Nucleoli				Nucleoli		"HPA018999: AB_1849733, HPA049600: "	"unprognostic (2.08e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-3)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	35.2	34.8	13.4	35.1	19.7	39.3	40.6	21.0	21.6	44.4	36.9	15.4	30.7	35.9	41.4	30.8	37.2	32.2	36.1	24.5	12.7	10.2	24.8	24.7	22.6	48.7	18.2	19.7	90.1	92.0	18.6	19.8	20.3	16.1	42.3	12.7	22.8	67.3	28.2	51.6	54.7	32.8	50.2	16.4	49.8	39.0	31.9	17.4	49.7	54.9	33.8	40.9	39.6	68.7	51.0	8.8	4.8	7.2	20.5	52.7	2.9	12.0	12.7	11.5	27.0	14.3	24.0	21.8	7.5	13.9	7.3	10.9	11.8	24.4	53.0	10.9	8.8	17.2	6.6	11.0	3.9	15.5	21.9	17.4	10.8	13.7	21.2	24.9	34.1	21.1	25.5	6.4	17.5	11.6	21.1	26.1	6.5	10.5	67.9	158.3	26.2	7.4	45.5	20.4	24.5	14.0	18.7	12.1	42.6	6.3	41.8	37.7	19.7	60.9	14.2	7.2	19.3	6.2	15.3	38.2	34.1	14.4	9.1	17.8	11.6	3.6	4.8	4.8	12.0	7.2	16.7	51.0	23.9	21.2	6.9	36.0	52.7	24.0	0.7	20.5	5.0	8.8	22.7	2.9	13.4	19.7	21.0	21.6	12.7	10.2	18.2	19.7	16.1	17.4
NOP56	"NOL5A, SCA36"	ENSG00000101361	"NOP56 ribonucleoprotein"	O00567	20	2652145-2658393	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049918, CAB075757"	Supported		Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"CAB075757: , HPA049918: "	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.59e-7)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (6.77e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.87e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.42e-1)"	23.5	18.5	20.1	30.5	23.8	30.6	33.8	36.1	31.3	19.2	19.1	22.4	15.3	16.3	29.9	19.9	25.5	31.4	20.3	18.0	19.9	23.3	16.3	20.1	17.4	30.5	27.9	23.9	29.6	49.8	17.8	23.3	22.4	20.9	22.9	23.4	13.5	23.4	23.5	31.7	21.8	19.2	30.9	17.7	26.5	18.5	20.1	22.5	39.4	20.7	20.0	32.2	20.8	34.9	18.0	19.7	9.5	13.5	13.5	21.2	12.2	20.2	27.8	15.9	19.1	24.3	16.6	34.8	21.0	16.9	32.3	22.2	40.2	21.6	56.3	14.7	17.9	45.3	48.2	36.9	29.1	16.7	34.0	33.9	17.7	40.1	26.1	28.5	15.0	23.9	26.8	43.7	50.3	20.6	36.3	27.6	23.2	18.5	45.5	28.6	37.6	31.3	41.9	26.9	30.8	20.7	29.4	18.4	17.4	29.0	31.4	49.6	32.8	25.8	15.6	34.0	19.7	21.2	34.6	16.3	30.3	40.5	8.4	33.6	21.2	3.3	12.0	9.5	16.9	13.5	21.2	18.0	18.5	17.6	12.0	16.6	18.5	16.6	0.9	13.5	10.7	19.7	15.7	12.2	20.1	23.8	36.1	31.3	19.9	23.3	27.9	23.9	20.9	22.5
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265716-202303666	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	25.1	26.5	16.7	41.6	24.6	47.1	32.2	30.2	24.2	28.8	21.6	13.7	19.5	20.3	31.0	25.9	31.9	26.4	17.7	21.7	21.4	20.3	23.4	36.2	21.7	40.4	16.9	19.1	32.9	31.5	22.3	47.8	24.0	21.9	26.7	27.0	17.1	25.5	29.5	36.9	22.7	25.2	24.1	19.3	33.0	23.5	17.5	17.8	40.0	24.6	32.8	41.4	31.1	41.3	23.5	22.2	4.3	15.2	21.2	26.7	13.5	26.6	18.9	18.7	23.3	14.0	12.7	44.4	25.7	13.8	19.9	18.6	41.8	24.1	41.3	21.4	15.5	24.7	37.1	31.6	35.1	16.1	34.1	49.8	28.5	41.1	20.8	49.2	24.0	16.3	18.8	27.6	63.5	17.7	54.3	31.5	24.7	28.3	44.8	54.4	46.9	32.9	37.9	28.4	54.4	23.4	32.3	29.0	21.4	23.8	34.2	29.5	23.4	38.9	15.3	25.4	29.8	22.6	43.8	25.7	46.9	59.1	18.7	35.1	30.1	4.3	10.2	3.1	16.8	15.2	24.5	23.5	24.0	22.7	15.9	18.7	26.4	26.7	1.0	21.2	10.9	22.2	23.7	13.5	16.7	24.6	30.2	24.2	21.4	20.3	16.9	19.1	21.9	17.8
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 13.4;skeletal muscle: 36.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.2;RH-30: 12.8;RPTEC TERT1: 8.0;U-2 OS: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: , HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.5	0.6	3.8	3.5	13.4	0.7	0.6	4.4	4.8	0.7	2.0	1.1	0.0	0.5	0.6	0.7	1.3	0.8	0.5	0.5	2.8	4.4	1.9	0.5	1.4	0.6	2.4	1.6	0.5	1.9	0.4	0.8	0.4	5.9	1.6	0.9	0.6	3.8	0.6	36.3	2.2	0.6	0.8	1.2	0.5	0.5	0.9	3.0	0.0	0.6	0.0	0.5	0.9	0.6	0.9	0.6	2.1	0.5	0.8	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	6.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	1.4	0.0	12.8	0.1	8.0	0.0	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.5	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	2.1	0.5	0.5	0.5	0.4	0.4	0.7	0.4	0.3	0.2	0.9	0.5	0.5	1.9	0.8	0.5	0.6	0.3	0.0	3.8	13.4	4.4	4.8	2.8	4.4	2.4	1.6	5.9	3.0
NOSIP	CGI-25	ENSG00000142546	"Nitric oxide synthase interacting protein"	Q9Y314	19	49555711-49590262	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 119.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043464, HPA062132"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA043464: AB_10794284, HPA062132: AB_2684693"	"unprognostic (2.27e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-3)"	13.4	13.9	14.2	14.0	14.0	14.3	11.5	12.1	14.2	11.3	15.9	12.3	13.1	17.3	12.5	8.1	12.7	11.1	11.7	14.9	12.3	11.4	13.2	14.5	12.6	24.6	18.3	10.8	12.9	39.7	7.1	13.6	15.6	14.3	11.6	7.9	11.3	19.2	11.4	66.9	11.9	16.5	11.0	13.1	18.0	13.9	40.2	16.3	20.6	15.5	17.6	16.3	11.7	15.0	20.4	21.5	31.8	16.8	29.7	119.4	69.2	66.1	35.9	14.0	30.9	12.5	9.2	13.5	15.7	13.9	26.3	24.3	25.0	11.7	17.8	27.5	13.1	14.9	13.8	27.5	11.5	20.3	39.7	22.5	20.7	27.8	19.8	18.2	19.0	11.9	19.1	20.0	10.9	15.9	24.9	14.2	13.7	17.7	18.5	39.2	19.0	31.2	24.2	23.3	15.8	12.2	20.0	17.5	22.8	21.1	18.0	15.7	14.7	19.3	23.4	22.9	19.4	7.9	29.9	26.8	50.5	24.1	8.7	25.1	17.7	28.0	16.8	23.5	35.1	15.7	45.4	20.4	71.4	40.2	16.6	19.8	119.4	65.8	31.8	29.7	14.3	21.5	37.5	69.2	14.2	14.0	12.1	14.2	12.3	11.4	18.3	10.8	14.3	16.3
NOTCH2		ENSG00000134250	"Notch 2"	Q04721	1	119911553-120069626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"			67000000	"Nucleoplasm, Plasma membrane"		"HPA048743: "	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (5.24e-4)"	"prognostic unfavourable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	12.0	7.3	6.0	9.4	6.8	4.4	10.6	3.0	5.6	14.5	7.6	4.4	11.3	1.6	12.3	11.8	13.4	11.4	12.8	7.9	6.8	2.3	5.5	11.4	10.6	5.7	5.3	7.6	15.5	27.6	6.1	3.3	10.3	6.5	9.9	5.2	9.4	17.7	10.0	9.3	17.2	6.1	12.4	6.2	11.5	5.8	15.7	4.4	8.0	11.4	8.6	6.6	9.6	13.0	4.2	5.2	7.7	9.6	1.5	1.7	2.0	14.9	5.0	7.8	6.0	32.7	28.0	7.8	11.4	15.7	15.2	16.5	4.6	4.0	0.3	9.6	21.5	5.7	12.4	10.1	24.3	17.9	7.9	8.6	13.6	0.4	12.2	9.0	2.3	22.4	6.6	45.6	30.4	7.7	0.1	19.0	18.3	16.7	3.8	2.5	10.1	5.6	2.5	27.6	9.6	8.0	9.5	0.3	3.9	15.4	14.5	8.2	8.0	3.1	27.1	19.9	13.7	29.8	17.8	7.9	3.9	4.4	29.2	8.3	18.9	5.6	6.4	6.4	1.5	6.6	1.7	4.2	1.3	1.1	5.2	3.9	1.0	1.7	7.7	1.5	9.6	4.2	0.8	2.0	6.0	6.8	3.0	5.6	6.8	2.3	5.3	7.6	6.5	4.4
NOTCH3	"CADASIL, CASIL"	ENSG00000074181	"Notch 3"	Q9UM47	19	15159038-15200981	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 27.9;MCF7: 27.4;U-87 MG: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005393, HPA044392"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"			18000000	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB005393: AB_2151246, HPA044392: "	"unprognostic (4.97e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (5.92e-4)"	"unprognostic (9.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (2.53e-7)"	"unprognostic (3.35e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-3)"	35.9	3.7	4.7	6.4	6.4	0.5	53.7	2.7	7.5	25.9	7.3	6.2	9.2	3.7	22.9	23.1	33.8	14.6	22.7	25.0	4.6	3.6	9.2	1.6	16.2	11.7	5.0	6.4	14.1	6.9	10.1	4.9	37.3	6.4	13.4	3.0	8.3	11.4	11.4	16.6	48.3	6.2	11.0	2.8	11.8	5.5	10.1	3.9	44.4	14.9	36.7	10.3	14.9	24.6	0.1	2.4	1.0	0.1	0.1	0.1	0.0	5.2	3.3	27.9	12.7	3.9	3.2	12.6	4.2	0.2	0.2	0.1	6.3	5.5	0.1	3.3	7.7	6.2	5.0	0.1	0.2	0.0	1.3	0.1	5.2	1.4	1.9	0.0	0.5	3.6	3.1	6.5	0.7	0.3	0.2	0.2	0.5	27.4	6.3	0.0	16.3	0.0	0.0	1.6	0.1	0.0	16.9	0.8	9.0	0.0	15.9	0.0	16.9	0.0	0.0	0.8	9.1	0.1	0.1	0.0	0.3	0.0	19.5	0.1	0.4	1.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	2.4	0.0	0.0	4.7	6.4	2.7	7.5	4.6	3.6	5.0	6.4	6.4	3.9
NOV	"CCN3, IGFBP9"	ENSG00000136999	"Nephroblastoma overexpressed"	P48745	8	119416306-119424353	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 236.7"	"Group enriched"	"Detected in many"	5	"BJ hTERT+: 43.0;U-2197: 44.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 62.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	113	"eosinophil: 28.1;neutrophil: 14.0"	"Lineage enriched"	"Detected in single"	151	"granulocytes: 28.1"	"Group enriched"	"Detected in many"	7	"amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1"	"Low region specificity"	"Detected in many"			"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	269030000	2900000	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	6.3	236.7	2.2	1.4	7.9	1.0	5.6	3.1	12.3	5.0	2.0	3.6	3.6	1.5	5.8	2.9	1.9	3.0	2.0	5.7	3.5	1.9	4.9	0.9	2.9	1.1	2.1	15.1	1.8	2.7	2.1	13.4	0.8	7.4	5.6	2.2	1.2	1.2	5.0	1.6	3.6	1.5	2.5	2.5	1.0	1.6	2.6	0.0	0.0	6.9	4.8	1.1	3.3	2.5	0.0	0.1	28.1	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	3.9	1.0	0.0	5.7	43.0	5.2	3.0	0.0	0.1	0.0	4.5	7.2	3.6	0.2	0.0	1.7	0.0	0.1	0.0	3.3	0.0	0.1	0.0	0.0	0.2	0.0	2.0	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	8.6	0.0	0.0	0.0	5.5	0.0	1.3	0.0	2.1	0.0	8.0	0.0	0.0	0.0	3.7	5.7	44.5	1.1	0.0	0.0	0.0	5.9	1.8	4.3	0.0	0.1	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	2.2	7.9	3.1	12.3	3.5	1.9	2.1	15.1	7.4	0.0
NOVA1		ENSG00000139910	"NOVA alternative splicing regulator 1"	P51513	14	26443093-26597754	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Cell line enhanced"	"Detected in many"		"AF22: 25.6;ASC diff: 13.9;HAP1: 12.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004155	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA004155: AB_1079497"	"unprognostic (1.46e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.21e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.04e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.27e-4)"	"unprognostic (9.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-4)"	17.8	6.7	17.5	3.4	17.4	1.3	32.9	54.7	49.2	12.2	6.3	13.3	5.0	2.5	9.4	6.9	4.0	6.2	6.2	3.0	17.1	25.1	7.0	2.2	2.7	4.4	19.2	17.8	6.3	2.7	4.4	14.1	1.3	26.4	5.4	6.5	4.0	2.8	17.5	6.9	3.1	3.4	9.9	22.5	2.1	3.3	10.3	14.9	0.0	4.1	2.7	5.2	5.6	9.4	0.3	0.3	0.6	0.4	2.2	0.5	0.0	0.0	6.0	25.6	0.0	13.9	7.5	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.4	0.1	12.5	0.1	0.0	0.0	1.0	0.0	0.0	0.2	5.2	0.0	1.2	9.3	0.0	1.9	1.9	5.4	0.0	0.0	4.1	0.0	5.2	0.1	7.5	6.1	0.7	8.5	0.1	3.5	4.9	8.1	4.7	0.0	0.0	0.0	0.7	0.0	0.0	3.6	4.1	3.1	0.7	0.0	0.0	0.0	5.0	0.0	3.7	0.6	0.0	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.5	0.6	2.2	0.4	0.3	0.4	0.0	17.5	17.4	54.7	26.9	17.1	25.1	19.2	17.8	26.4	14.9
NPAS3	"bHLHe12, MOP6, PASD6"	ENSG00000151322	"Neuronal PAS domain protein 3"	Q8IXF0	14	32934933-33804176	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.8"	"Group enriched"	"Detected in some"	11	"AF22: 8.8;U-266/70: 21.8;U-266/84: 6.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 6.4;glioma: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002892, HPA075337"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA002892: AB_1079403, HPA075337: "	"unprognostic (6.02e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (3.27e-1)"	1.8	2.4	17.4	1.4	14.4	1.0	2.7	8.5	29.8	14.0	1.8	15.8	0.7	1.5	9.1	2.6	1.6	8.5	2.2	1.6	18.7	10.3	2.4	1.3	1.3	1.3	11.7	13.0	6.4	2.2	2.5	1.6	2.0	16.2	2.5	1.7	0.8	2.7	3.6	2.0	1.4	1.6	2.2	13.8	3.1	2.8	3.5	16.3	0.0	4.4	0.0	1.5	1.1	1.4	0.0	0.6	0.1	0.2	0.0	0.2	0.0	0.0	0.0	8.8	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	21.8	6.2	0.0	0.3	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.6	0.0	0.0	17.4	14.4	8.5	15.3	18.7	10.3	11.7	13.0	16.2	16.3
NPAT	"E14, p220"	ENSG00000149308	"Nuclear protein, coactivator of histone transcription"	Q14207	11	108157215-108222642	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045908, HPA066370"			Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA045908: , HPA066370: "	"unprognostic (6.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.93e-1)"	15.7	9.8	8.5	18.6	11.5	7.1	12.0	24.6	12.8	13.1	9.3	7.5	8.9	7.1	12.0	10.7	10.3	10.7	8.2	9.4	7.8	8.7	10.1	9.5	11.5	23.1	10.7	8.9	15.2	9.1	14.6	21.5	18.3	13.1	10.7	11.0	7.9	11.6	8.4	8.8	12.2	12.2	9.0	13.7	17.1	10.0	11.3	11.1	26.7	14.4	7.5	21.6	15.4	10.7	5.2	2.2	7.4	3.1	5.8	11.6	3.6	4.9	4.0	6.3	7.8	7.8	5.7	5.1	7.4	9.4	6.6	9.9	8.2	10.8	8.5	10.0	4.6	9.3	8.6	7.5	11.8	7.6	3.4	14.1	4.4	4.2	3.4	10.5	9.4	5.4	4.4	11.5	7.4	9.2	13.0	4.2	9.1	2.4	12.9	5.7	5.2	5.6	8.9	8.9	11.7	4.3	7.2	6.7	6.2	9.5	5.7	7.3	6.5	5.2	7.5	11.5	6.1	6.7	6.6	2.9	3.7	33.3	2.8	7.8	8.8	7.4	1.7	3.2	6.2	3.1	6.9	4.9	7.2	7.8	2.2	5.2	11.6	9.2	2.2	5.8	3.0	1.7	5.2	3.6	8.5	11.5	24.6	12.8	7.8	8.7	10.7	8.9	13.1	11.1
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586898	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 70.3;U-87 MG: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.7;T-cells: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles			27000	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	13.4	38.8	17.4	11.2	30.9	26.4	15.8	7.1	25.1	10.1	8.7	65.6	3.4	10.2	11.1	11.7	12.8	8.2	11.2	7.1	23.4	14.3	9.9	10.3	17.8	13.0	46.0	15.4	12.0	7.9	51.8	9.9	18.9	27.7	9.7	8.9	12.0	25.4	10.1	13.7	17.0	12.2	10.9	41.4	11.5	12.0	9.5	38.4	7.0	8.3	5.3	10.7	10.8	10.8	3.6	32.7	3.8	5.8	4.6	14.5	4.1	5.3	10.6	4.5	7.4	14.9	11.6	10.5	9.3	20.2	9.9	21.4	7.1	7.8	4.5	7.2	13.4	15.0	5.8	15.9	8.8	3.5	4.6	1.6	9.6	16.0	21.4	6.1	7.3	11.1	15.8	20.8	70.3	9.7	4.8	12.0	11.0	8.1	2.5	3.6	3.2	9.6	3.6	7.2	11.2	23.0	13.3	1.9	3.7	11.1	16.1	13.7	4.0	4.8	12.5	21.0	4.1	8.3	8.0	7.5	23.1	3.1	46.2	5.4	9.4	1.8	4.1	3.8	14.5	3.8	9.8	2.4	5.9	9.9	1.7	3.6	2.7	7.3	3.7	4.6	5.8	32.7	7.7	4.1	17.4	30.9	7.1	25.1	23.4	14.3	46.0	15.4	27.7	38.4
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47623276	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol			2100000	Cytosol		"HPA021453: , HPA045649: "	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favourable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	16.0	26.0	27.2	15.9	27.7	11.1	56.1	36.5	33.8	17.1	17.7	9.8	14.6	14.6	16.9	17.1	47.7	17.2	16.3	22.2	24.0	15.6	18.8	11.1	30.3	24.1	16.0	29.7	20.8	16.8	21.2	15.3	17.6	27.2	18.6	20.0	13.3	21.8	16.5	52.3	29.6	17.3	20.4	22.8	15.7	16.2	15.3	16.1	7.0	14.5	14.8	18.1	19.0	30.5	6.9	9.0	23.2	8.6	9.3	9.2	5.4	32.6	21.5	21.7	15.2	25.1	25.3	45.8	14.4	18.7	21.9	21.3	13.8	37.6	19.5	22.4	21.0	19.9	23.8	13.3	34.1	8.7	20.6	23.5	22.2	16.1	14.5	13.2	15.2	19.3	13.1	15.9	8.3	22.5	19.8	11.4	31.0	8.8	17.5	11.8	13.3	19.6	14.2	30.5	17.2	27.3	24.0	17.4	15.0	18.6	10.8	12.8	80.9	9.2	28.7	14.6	10.5	21.8	10.1	23.3	22.4	11.9	20.7	7.0	9.6	10.2	8.6	10.7	9.1	6.6	9.2	6.8	7.3	8.5	8.7	6.9	6.5	7.6	23.2	9.3	6.8	9.0	8.4	5.4	27.2	27.7	36.5	33.8	24.0	15.6	16.0	29.7	27.2	16.1
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	21.7	23.0	15.3	18.7	16.1	22.0	15.4	14.7	24.1	13.2	15.9	18.6	14.2	14.7	18.9	16.3	25.1	14.7	14.4	35.4	16.2	13.5	20.2	28.2	18.4	18.3	16.4	15.5	13.9	18.2	17.8	17.1	25.6	17.2	16.7	13.3	21.0	16.4	14.9	89.8	24.2	16.4	19.4	14.9	22.0	17.6	31.0	13.4	19.7	14.7	17.1	20.6	15.7	16.6	4.6	5.9	5.7	18.1	2.5	4.6	7.8	28.6	37.8	15.1	23.5	18.7	15.6	18.8	23.8	26.6	39.6	36.8	28.7	26.0	21.3	19.1	27.8	23.3	14.8	20.0	34.5	13.4	19.6	24.7	30.7	25.4	17.9	26.0	31.6	15.3	19.4	36.9	13.2	40.4	26.0	32.5	23.9	18.6	35.0	14.1	17.7	23.9	23.1	24.3	17.4	14.2	27.8	20.3	23.4	29.9	41.8	27.0	32.7	19.2	28.9	52.1	36.2	28.3	38.2	24.8	17.5	26.3	41.5	17.5	33.4	3.0	18.1	3.9	4.6	4.6	2.8	4.6	3.2	3.6	5.9	3.7	2.9	3.8	5.7	2.5	2.8	4.6	3.0	7.8	15.3	16.1	14.7	24.1	16.2	13.5	16.4	15.5	17.2	13.4
NPM1	"B23, NPM"	ENSG00000181163	"Nucleophosmin 1"	P06748	5	171387116-171411137	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011384, CAB012983"	Supported		Enhanced	Nucleoplasm,Nucleoli			810000	Nucleoli	Nucleoplasm	"CAB012983: AB_2533084, HPA011384: AB_1854692"	"unprognostic (1.84e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (7.48e-4)"	"prognostic unfavourable (4.82e-6)"	"unprognostic (1.86e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (2.89e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.24e-2)"	56.8	44.7	29.9	61.1	33.6	76.0	67.0	37.7	34.6	113.5	57.8	24.8	39.3	36.7	78.2	50.5	81.6	65.0	44.0	48.5	28.8	31.6	64.9	78.8	59.5	128.1	36.1	27.9	177.4	102.0	27.1	57.9	65.2	36.1	87.2	49.3	29.5	47.3	48.2	67.9	42.7	52.8	92.4	43.2	85.9	54.0	56.7	31.3	111.3	112.6	66.5	82.1	116.8	65.7	85.3	54.1	12.3	29.1	59.0	126.6	91.4	118.4	80.2	97.5	138.1	59.6	108.9	145.4	107.8	98.5	146.1	131.6	191.5	83.7	317.2	85.7	62.3	69.5	135.3	245.1	190.4	98.7	107.3	111.9	78.7	141.0	88.4	225.3	92.8	96.0	86.4	99.1	195.6	109.0	136.0	73.0	106.0	147.1	147.0	160.3	122.0	98.6	132.0	107.6	162.6	124.6	83.6	76.9	61.8	64.4	105.4	195.1	129.3	100.0	68.0	48.9	107.8	56.2	181.5	58.5	106.3	190.8	73.9	183.5	97.4	12.3	26.9	8.4	45.7	29.1	84.6	85.3	85.1	66.2	54.1	62.8	126.6	99.0	4.0	59.0	23.1	48.7	73.2	91.4	29.9	33.6	37.7	34.6	28.8	31.6	36.1	27.9	36.1	31.3
NPRL2	"NPR2, NPR2L, TUSC4"	ENSG00000114388	"NPR2 like, GATOR1 complex subunit"	Q8WTW4	3	50347330-50351091	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038196, HPA038197"	Approved		Supported	Cytosol				Cytosol		"HPA038196: AB_10675631, HPA038197: AB_10671523"	"unprognostic (7.25e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.06e-3)"	"prognostic favourable (1.59e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.06e-2)"	7.4	14.6	14.9	8.7	14.9	7.5	11.5	20.9	18.2	14.7	12.5	8.8	12.8	7.6	9.7	16.3	10.1	14.4	11.3	13.8	12.0	15.2	14.0	18.6	9.0	9.8	15.1	14.4	13.4	30.9	16.6	15.8	8.4	13.5	13.2	12.4	7.4	16.0	13.6	18.3	9.3	8.9	11.7	10.2	11.7	11.1	11.9	16.5	10.5	13.1	9.1	11.6	10.4	8.9	11.1	9.2	20.2	8.9	23.6	29.7	19.6	7.3	7.1	3.7	8.1	14.3	8.0	4.7	3.0	10.4	11.1	11.3	4.7	6.1	7.2	5.8	6.9	3.5	9.8	12.0	7.7	5.8	7.4	7.4	6.3	10.1	13.1	10.2	11.5	8.4	11.8	13.3	9.8	10.7	5.6	7.4	9.4	1.1	10.7	5.7	5.0	18.5	4.3	3.2	20.3	12.7	6.4	3.2	8.1	3.3	6.6	7.7	10.7	6.1	3.4	4.5	4.9	7.7	6.6	10.7	13.3	5.9	8.7	11.9	4.0	13.6	7.7	20.2	29.7	7.9	26.4	11.1	16.9	25.6	9.2	9.6	13.7	21.2	9.6	23.6	8.9	6.8	19.4	19.6	14.9	14.9	20.9	18.2	12.0	15.2	15.1	14.4	13.5	16.5
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284163-24291865	"Plasma proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 50.5;brain: 63.6;prostate: 131.2"	"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 121.1"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	30733800		"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: , HPA056798: "			"unprognostic (2.00e-1)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.6	50.5	27.2	5.5	63.6	2.8	1.0	0.1	55.9	1.0	1.8	2.8	1.4	4.7	1.1	1.1	2.5	1.0	1.4	1.0	11.9	20.6	1.1	1.0	1.1	1.0	2.6	18.3	1.0	4.0	1.0	0.5	1.0	1.9	131.2	1.7	0.0	1.0	14.7	1.0	1.0	5.0	1.4	1.4	1.0	1.7	1.3	13.9	0.0	1.1	0.0	1.0	3.9	4.5	0.5	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.4	0.0	0.1	0.0	0.0	0.1	121.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	27.2	63.6	0.1	31.2	11.9	20.6	2.6	18.3	1.9	13.9
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726951	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 142.1"	"Cell line enhanced"	"Detected in many"		"A549: 162.9;Hep G2: 143.8;SiHa: 185.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Enhanced	Cytosol			310000	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	31.3	24.2	12.8	6.4	20.7	0.6	77.1	2.7	9.1	7.6	23.2	7.8	5.7	29.5	3.9	8.6	36.3	8.2	77.2	9.3	9.9	7.5	44.7	1.2	17.2	6.9	11.3	6.0	3.7	2.5	7.0	3.7	3.5	25.5	9.8	20.8	20.2	10.5	7.6	7.6	2.3	17.7	22.7	10.4	6.0	142.1	3.8	4.9	0.1	25.7	69.7	16.2	21.2	18.9	5.2	3.2	0.9	3.2	15.1	12.3	4.4	14.3	162.9	13.7	61.0	34.1	49.4	5.1	24.3	43.7	25.1	38.8	19.8	93.0	0.4	28.9	125.7	15.0	5.3	27.4	12.9	5.8	0.2	0.7	40.4	143.8	45.2	3.4	11.7	11.6	17.4	43.5	5.0	62.2	5.9	1.0	134.1	46.5	0.6	6.3	7.2	15.9	1.1	2.9	6.6	50.0	52.2	4.9	1.1	185.1	26.3	108.3	42.5	11.4	42.1	25.3	10.5	9.4	19.1	0.8	3.2	0.6	32.4	1.8	125.1	0.6	3.2	0.2	5.7	0.3	2.9	5.2	6.6	7.2	3.2	2.1	2.1	4.7	0.9	15.1	0.3	1.2	12.3	4.4	12.8	20.7	2.7	9.1	9.9	7.5	11.3	6.0	25.5	4.9
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3028869	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol			6500000	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavourable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	24.7	45.6	18.2	11.0	17.6	27.2	21.9	44.3	28.1	12.9	11.5	8.9	8.8	15.6	10.4	15.4	12.1	11.2	12.8	38.2	16.0	13.3	82.9	47.0	11.7	17.5	17.0	23.5	13.5	18.4	12.1	9.3	12.1	24.5	12.7	9.0	18.0	24.5	13.5	41.3	20.2	15.5	10.7	11.8	15.3	12.8	7.7	12.5	7.0	11.9	13.9	7.9	10.4	11.0	3.2	16.6	62.1	25.2	7.3	9.3	13.1	12.6	21.4	13.0	28.7	23.1	13.7	14.0	12.3	15.8	11.3	12.8	22.5	4.8	11.1	44.9	21.1	9.7	13.4	8.5	8.9	25.8	11.4	6.8	26.3	22.5	18.8	6.8	21.8	8.4	10.2	13.8	12.8	11.0	38.9	6.6	9.4	28.1	7.8	12.7	17.7	17.8	14.6	15.6	32.4	17.1	6.8	2.8	5.1	18.6	8.0	39.0	10.9	4.7	19.0	10.7	4.2	14.3	5.3	14.5	32.8	3.4	12.6	20.8	21.1	5.6	25.2	13.5	9.2	15.7	6.6	3.2	8.3	8.3	16.6	2.1	5.0	5.7	62.1	7.3	13.9	1.7	9.3	13.1	18.2	17.6	44.3	28.1	16.0	13.3	17.0	23.5	24.5	12.5
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309598	"Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 23.9;testis: 36.0"	"Group enriched"	"Detected in some"	4	"A549: 34.3;RT4: 10.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"				"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: , HPA067207: "		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.4	23.9	1.0	0.0	0.8	0.0	0.2	0.4	1.1	1.3	0.1	1.7	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.1	0.0	0.5	0.6	3.5	2.1	0.0	1.6	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.6	0.1	0.7	36.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.1	0.9	0.9	0.5	0.6	0.6	0.7
NR1D1	"ear-1, hRev, Rev-ErbAalpha, THRA1, THRAL"	ENSG00000126368	"Nuclear receptor subfamily 1 group D member 1"	P20393	17	40092787-40100725	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 16.3"	"Group enriched"	"Detected in many"	6	"monocytes: 4.2;T-cells: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007935	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA007935: AB_10601277"	"unprognostic (1.38e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavourable (1.94e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.36e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.73e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.34e-1)"	19.4	15.1	12.2	7.6	14.7	6.0	30.5	30.7	32.5	45.9	13.9	6.4	17.3	15.2	16.5	6.1	16.8	10.7	8.2	43.7	8.8	5.2	9.8	14.8	12.7	8.8	4.7	11.7	33.3	8.3	4.8	10.9	7.3	6.1	15.5	5.5	28.0	53.0	18.6	51.2	79.3	8.8	27.3	6.0	7.8	7.9	7.3	6.8	1.8	13.9	11.7	10.6	28.0	25.4	1.8	1.1	0.1	4.2	0.8	16.3	1.5	2.8	4.1	0.8	3.3	4.9	3.4	1.2	6.3	10.3	2.1	2.6	2.7	10.3	3.4	3.8	7.2	8.1	2.2	9.4	1.5	2.9	2.3	2.5	4.1	6.9	8.0	3.7	3.7	7.4	6.8	7.1	15.2	2.6	3.7	32.2	2.0	2.0	5.5	3.3	1.6	6.5	3.9	1.3	10.6	2.8	2.6	2.8	1.6	3.9	5.2	6.4	2.5	3.1	2.5	9.3	9.2	7.6	4.9	11.7	17.8	1.4	12.6	2.1	7.1	0.0	0.4	0.0	3.9	1.6	16.3	1.5	4.9	5.7	0.9	1.8	4.5	3.2	0.1	0.8	4.2	1.1	6.5	1.5	12.2	14.7	30.7	32.5	8.8	5.2	4.7	11.7	6.1	6.8
NR1H2	"LXR-b, NER, NER-I, RIP15, UNR"	ENSG00000131408	"Nuclear receptor subfamily 1 group H member 2"	P55055	19	50329653-50382982	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005446, HPA056838, HPA070212"	Uncertain		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA005446: , HPA056838: , HPA070212: "	"unprognostic (1.31e-1)"	"unprognostic (5.35e-2)"	"prognostic unfavourable (9.86e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.69e-3)"	30.1	27.5	24.5	24.7	27.5	98.0	24.4	20.6	33.5	25.1	30.9	23.1	25.2	30.9	31.2	23.1	27.9	26.9	28.7	36.8	23.8	19.4	27.1	31.4	28.3	23.3	31.7	25.9	26.5	37.6	22.0	18.6	30.5	28.1	27.9	10.5	23.2	33.8	33.8	76.2	25.3	30.3	29.9	22.9	29.9	26.7	21.2	29.1	20.4	27.1	24.4	21.7	33.2	27.6	34.1	34.2	63.0	37.7	22.3	28.6	32.5	16.0	42.2	4.1	10.3	12.1	12.8	13.2	22.2	18.9	13.2	15.1	8.7	15.6	10.3	19.9	13.3	15.0	2.6	12.1	3.2	25.7	22.7	9.9	14.2	9.0	23.3	16.3	27.1	13.4	16.6	13.5	9.2	12.0	16.1	21.5	7.4	17.8	11.6	13.4	8.3	36.3	7.0	10.7	17.9	11.3	18.0	4.6	16.1	14.4	17.9	13.9	12.3	13.6	15.1	17.7	14.4	18.0	19.7	26.9	22.2	7.5	35.3	10.8	17.7	39.1	35.9	63.0	27.7	35.0	27.0	34.1	27.4	25.9	34.2	34.1	28.6	24.9	55.4	22.3	37.7	29.5	24.4	32.5	24.5	27.5	20.6	33.5	23.8	19.4	31.7	25.9	28.1	29.1
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818485	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 7.1;intestine: 15.4;liver: 22.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 17.3"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"					"Cell type enriched"	"Detected in single"	18	"NK-cell: 7.1"	"Lineage enriched"	"Detected in single"	18	"NK-cells: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA029309: , HPA055121: , HPA073926: "	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.6			15.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	22.2	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	5.5		0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.1	0.7	0.0			0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.1										
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073703	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"				Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: , HPA035041: , HPA067767: "	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favourable (5.62e-5)"	11.6	15.8	15.9	11.8	14.7	15.5	12.4	38.3	23.9	12.5	11.2	12.5	12.9	11.2	17.6	20.2	8.3	15.5	11.1	14.8	14.6	9.3	10.3	14.0	14.2	9.9	11.7	15.2	16.3	12.5	16.4	15.4	11.2	13.7	10.7	12.7	14.6	8.0	17.4	19.6	11.0	11.2	15.7	14.2	14.3	10.5	22.2	14.9	12.3	18.0	9.0	10.2	12.3	10.7	4.5	6.2	3.5	4.2	3.5	9.0	3.9	8.0	10.0	15.9	7.4	3.7	6.6	22.6	7.9	5.7	7.9	7.4	8.8	4.5	9.7	2.8	5.2	8.6	7.8	6.1	6.0	4.2	16.6	11.8	8.0	10.5	8.4	7.9	5.2	7.6	5.0	5.4	6.7	8.4	9.0	3.8	9.2	5.3	8.5	18.3	10.7	17.5	8.2	11.1	5.8	8.8	9.3	8.2	6.5	12.6	5.4	5.8	9.5	5.0	7.9	6.4	6.3	7.8	4.4	5.6	9.1	9.4	1.6	9.2	3.0	0.5	4.1	3.5	7.1	4.2	9.0	3.7	5.7	6.0	6.2	4.5	7.2	5.0	2.6	3.5	3.7	6.2	3.7	3.9	15.9	14.7	38.3	23.9	14.6	9.3	11.7	15.2	13.7	14.9
NR2C2	"hTAK1, TAK1, TR2R1, TR4"	ENSG00000177463	"Nuclear receptor subfamily 2 group C member 2"	P49116	3	14947584-15053600	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006313	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006313: AB_1079503"	"unprognostic (1.32e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (1.51e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.82e-3)"	13.2	13.1	22.5	17.0	17.5	17.1	16.1	30.5	26.4	11.9	14.0	12.8	14.1	18.5	17.8	11.0	13.6	12.6	12.3	14.5	18.3	12.0	12.4	12.6	18.7	16.9	12.6	20.4	18.8	14.2	18.0	23.2	11.9	13.1	12.3	12.2	13.7	13.0	21.5	31.5	19.6	18.1	15.7	13.5	18.8	14.7	29.2	13.3	26.0	19.4	9.0	15.5	15.5	17.8	5.1	4.2	6.2	3.4	2.7	4.9	1.5	10.0	11.4	13.1	10.1	9.3	11.2	30.1	14.6	11.8	11.9	12.3	7.3	9.9	15.6	7.6	13.0	10.1	12.1	7.5	12.4	20.5	17.1	20.4	24.4	6.6	7.9	14.9	15.8	8.8	10.0	14.9	7.8	13.3	14.4	10.7	10.4	8.9	22.8	11.8	8.7	11.8	18.4	15.6	10.4	5.7	15.3	8.4	20.9	13.3	11.1	13.4	11.1	14.9	17.2	18.4	21.9	16.7	19.9	16.4	21.2	16.9	13.3	14.3	16.1	6.2	2.5	1.9	4.9	3.4	4.4	2.3	2.7	2.9	2.6	5.1	3.9	3.5	3.5	2.7	3.0	4.2	2.5	1.5	22.5	17.5	30.5	26.4	18.3	12.0	12.6	20.4	13.1	13.3
NR2C2AP	TRA16	ENSG00000184162	"Nuclear receptor 2C2 associated protein"	Q86WQ0	19	19201416-19203424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042054, HPA055653"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA042054: AB_10965022, HPA055653: "	"unprognostic (9.54e-2)"	"unprognostic (2.93e-3)"	"prognostic unfavourable (8.53e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.81e-2)"	"unprognostic (6.26e-3)"	"prognostic unfavourable (5.63e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.65e-3)"	"unprognostic (5.89e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.99e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (2.10e-2)"	15.8	9.9	10.5	13.5	12.3	7.5	16.8	9.6	12.1	11.4	13.5	11.6	6.5	9.2	14.4	16.5	16.8	17.5	10.9	9.3	9.1	7.0	10.6	11.4	10.0	14.1	15.2	5.5	19.0	18.1	7.0	7.8	11.4	13.9	19.4	12.8	7.2	17.5	13.0	10.8	19.6	10.3	13.3	12.0	15.2	11.8	6.2	13.5	10.0	16.0	15.4	14.8	15.7	12.8	20.2	11.2	1.2	9.5	11.3	21.1	12.1	18.7	11.0	5.2	11.1	4.4	4.4	20.5	10.7	6.1	14.7	14.0	7.4	23.1	10.2	30.2	5.6	16.8	13.7	14.1	9.0	9.0	14.9	5.8	6.5	8.1	5.1	11.2	9.1	4.5	17.4	10.2	13.9	5.8	10.3	13.5	8.7	48.3	18.6	10.2	9.4	22.6	13.4	8.5	19.8	9.0	9.9	17.6	8.0	9.2	18.1	13.6	9.8	7.1	4.7	9.6	9.1	23.9	20.3	8.0	11.6	13.1	11.2	19.1	12.7	1.2	7.0	0.6	15.3	9.5	20.1	20.2	20.1	14.8	5.8	19.8	21.1	19.7	1.2	11.3	7.5	11.2	16.1	12.1	10.5	12.3	9.6	12.1	9.1	7.0	15.2	5.5	13.9	13.5
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavourable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	27.7	8.6	13.5	26.1	14.9	29.6	23.5	30.1	19.2	14.9	14.2	17.0	10.5	13.0	14.7	12.9	18.2	13.7	14.7	17.4	13.4	14.1	13.5	27.3	22.0	16.1	18.3	12.8	15.5	12.5	21.9	18.9	31.9	13.6	14.3	10.3	14.2	12.0	15.2	40.4	18.3	14.8	16.8	17.2	17.5	13.4	7.3	18.2	37.1	18.0	15.1	18.2	14.8	32.2	11.1	13.6	33.7	11.8	10.9	9.6	7.3	10.0	20.5	1.5	0.0	13.5	15.1	1.8	15.8	18.9	13.6	15.8	1.5	13.5	8.9	7.2	23.1	9.6	0.1	12.4	16.9	5.0	7.0	2.3	27.8	4.4	12.7	9.2	7.1	10.9	16.1	22.4	21.9	5.1	3.3	34.0	12.0	3.6	5.4	6.6	4.1	4.3	1.9	14.3	18.9	4.0	0.7	2.7	2.1	27.6	4.0	6.6	1.8	13.3	12.1	33.2	6.6	15.8	11.9	6.9	6.2	14.0	17.4	9.5	11.5	25.4	9.8	17.9	9.3	11.8	7.7	7.6	9.6	8.9	13.6	11.1	9.2	8.9	33.7	10.9	10.5	12.4	5.8	7.3	13.5	14.9	30.1	19.2	13.4	14.1	18.3	12.8	13.6	18.2
NR3C2	"MLR, MR"	ENSG00000151623	"Nuclear receptor subfamily 3 group C member 2"	P08235	4	148078762-148444698	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 7.1;Karpas-707: 7.7;PC-3: 7.1;RPTEC TERT1: 9.6;TIME: 9.4;U-138 MG: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 4.8"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009155, HPA074979"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009155: AB_2155949, HPA074979: "	"unprognostic (2.75e-3)"	"unprognostic (2.63e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.39e-1)"	"prognostic favourable (3.10e-11)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	7.0	5.6	9.0	12.9	9.5	1.5	7.2	16.8	14.5	8.2	23.4	8.2	6.5	9.7	7.2	4.8	3.8	7.1	10.2	9.7	12.7	6.5	13.8	9.6	8.2	4.2	7.5	7.7	17.0	8.6	22.5	16.7	2.4	5.7	5.9	28.4	12.1	16.9	9.6	12.1	4.6	26.5	8.6	6.5	5.7	9.0	4.8	6.5	2.2	21.7	7.6	5.0	10.7	5.6	0.8	0.0	0.0	0.4	0.1	4.8	0.4	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	0.1	0.0	0.5	0.0	0.1	1.6	3.0	1.2	0.0	1.6	0.8	0.1	0.3	2.9	0.3	0.7	0.0	0.1	1.9	0.4	0.1	0.0	0.1	0.0	7.1	0.0	7.7	2.4	0.0	0.0	0.0	0.1	7.1	0.6	0.0	0.1	9.6	0.1	0.1	0.1	0.0	1.6	0.7	0.9	0.0	9.4	5.1	3.0	0.2	0.9	0.0	0.0	0.2	1.7	0.7	1.2	0.0	0.0	0.0	1.5	0.0	4.8	0.4	1.8	1.2	0.0	0.8	2.9	2.9	0.0	0.1	0.4	0.0	0.5	0.4	9.0	9.5	16.8	14.5	12.7	6.5	7.5	7.7	5.7	6.5
NR4A1	"GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3"	ENSG00000123358	"Nuclear receptor subfamily 4 group A member 1"	P22736	12	52022832-52059507	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 25.3;MCF7: 28.8;SK-BR-3: 27.3;SK-MEL-30: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 18.2;non-classical monocyte: 24.4"	"Lineage enriched"	"Detected in many"	13	"monocytes: 24.4"	"Group enriched"	"Detected in many"	5	"amygdala: 35.3;basal ganglia: 43.1;cerebral cortex: 77.4;hippocampal formation: 65.3;olfactory region: 79.3"	"Low region specificity"	"Detected in all"			"HPA059742, HPA070142"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA059742: AB_2684119, HPA070142: "	"unprognostic (2.40e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (6.99e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-2)"	"unprognostic (8.89e-3)"	69.1	111.3	4.0	58.1	12.9	5.7	25.0	5.4	10.9	32.3	23.3	21.1	46.0	5.6	49.8	33.9	28.1	63.3	99.9	76.7	4.8	5.0	17.9	12.1	50.1	8.3	7.5	5.9	177.3	16.1	28.9	51.8	7.6	13.1	88.3	13.8	43.7	66.8	203.2	32.3	23.4	24.3	98.4	6.8	5.1	32.8	11.8	6.4	11.9	34.7	35.8	14.9	71.4	54.5	0.4	1.8	0.2	24.4	0.1	0.2	0.7	1.8	9.5	1.8	3.4	1.3	0.4	7.2	1.8	3.6	1.4	2.0	9.3	1.8	2.0	0.8	3.2	1.0	5.6	0.8	0.8	0.1	2.0	2.6	25.3	2.6	1.4	1.0	8.9	0.3	1.1	1.4	0.1	0.4	2.5	0.4	0.1	28.8	0.7	2.7	5.2	1.0	0.8	0.3	4.7	0.0	0.7	1.5	4.7	5.9	27.3	47.6	1.7	3.0	0.0	1.4	4.6	0.9	1.5	16.1	7.6	4.1	0.9	0.7	7.9	0.1	0.6	0.0	0.1	18.2	0.1	0.4	0.0	0.0	1.8	0.4	0.2	0.0	0.2	0.1	24.4	0.1	0.1	0.7	4.0	12.9	5.4	10.9	4.8	5.0	7.5	5.9	13.1	6.4
NR4A2	"HZF-3, NOT, NURR1, RNR1, TINUR"	ENSG00000153234	"Nuclear receptor subfamily 4 group A member 2"	P43354	2	156324432-156342348	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 102.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 14.2;HMC-1: 10.5;U-266/70: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000543, CAB010481"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB010481: AB_2298676, HPA000543: AB_1854631"	"unprognostic (4.26e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.11e-1)"	15.0	58.5	3.1	10.2	5.7	49.1	7.5	15.2	14.4	9.1	4.2	7.3	11.0	1.4	6.4	7.5	5.7	13.6	21.3	15.8	5.2	2.6	5.9	7.6	12.5	2.8	4.8	4.2	60.0	4.2	8.7	23.7	2.3	5.1	11.7	8.5	5.3	18.0	102.1	6.1	5.3	6.0	8.4	5.9	2.1	8.3	3.8	3.7	2.1	6.8	8.0	5.3	17.8	7.5	0.7	2.8	10.1	2.3	0.0	1.6	0.6	0.8	1.2	0.5	1.7	3.1	0.6	0.8	1.0	5.2	0.4	1.3	0.0	3.6	0.0	1.2	0.4	1.5	2.5	0.7	0.4	1.2	1.3	0.9	14.2	0.0	0.6	0.8	10.5	0.6	1.1	0.4	0.4	0.3	1.4	1.0	1.0	1.7	0.0	0.8	2.2	0.9	0.2	0.7	3.0	0.6	0.8	2.6	0.1	2.5	3.9	6.9	0.2	0.9	0.7	2.8	0.8	0.7	0.4	14.2	1.5	0.0	5.2	0.9	6.6	3.0	2.3	3.4	1.6	0.5	0.9	0.7	0.5	0.8	2.8	0.5	0.9	0.4	10.1	0.0	0.9	0.0	0.5	0.6	3.1	5.7	15.2	14.4	5.2	2.6	4.8	4.2	5.1	3.7
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771310	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 47.0;CACO-2: 10.8;Hep G2: 10.5;K-562: 13.8;NTERA-2: 16.7;U-266/84: 10.1"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: , HPA045145: "	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.6	1.0	2.9	1.4	3.4	5.5	1.8	5.8	3.5	0.8	7.9	1.2	1.3	2.5	0.9	1.4	2.2	1.0	0.9	1.0	3.3	1.3	1.9	2.8	1.8	0.7	2.1	2.4	0.6	3.3	1.5	2.2	4.2	2.2	1.7	2.3	1.7	1.5	1.4	1.9	2.6	5.3	0.8	2.3	1.1	0.7	28.2	2.8	0.0	7.3	0.8	1.1	1.3	1.4	0.3	1.0	8.6	1.2	0.1	0.0	0.1	0.5	1.2	6.2	0.8	0.1	0.1	47.0	0.0	0.4	0.3	0.5	10.8	1.2	2.1	0.4	0.0	1.1	0.6	0.5	0.7	0.5	2.0	1.6	1.7	10.5	0.0	0.9	3.1	0.0	0.6	0.5	0.6	0.1	13.8	0.3	0.2	0.2	0.0	1.3	16.7	0.5	0.5	0.6	0.9	0.2	0.8	0.9	0.3	0.0	0.3	0.4	1.1	0.5	0.0	0.6	1.3	0.4	0.3	1.4	10.1	1.9	0.3	0.9	0.3	0.1	1.2	2.0	0.0	0.9	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	8.6	0.1	0.6	0.2	0.0	0.1	2.9	3.4	5.8	3.5	3.3	1.3	2.1	2.4	2.2	2.8
NRBP1	"BCON3, MADM, MUDPNP, NRBP"	ENSG00000115216	"Nuclear receptor binding protein 1"	Q9UHY1	2	27427790-27442259	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029527, CAB033078"	Supported		Supported	Cytosol			38000	Cytosol		"CAB033078: AB_2154375, HPA029527: AB_10601379"	"unprognostic (4.95e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavourable (2.22e-5)"	"unprognostic (7.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (5.84e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.48e-3)"	30.8	27.6	20.9	30.8	25.9	49.8	29.1	31.6	38.4	36.3	35.2	21.3	27.5	27.3	40.6	34.2	52.2	28.7	29.9	27.7	18.0	26.0	24.6	38.8	27.1	25.6	21.5	26.2	36.6	28.2	23.0	27.0	58.7	33.9	30.3	25.4	30.6	31.6	34.7	62.2	36.6	31.5	40.7	18.3	29.1	28.9	46.9	20.6	24.4	25.4	39.4	37.6	34.2	37.7	20.6	29.1	57.9	37.2	27.5	33.7	32.9	30.0	30.2	25.0	33.1	38.7	38.7	30.4	28.6	36.1	41.0	31.9	30.5	12.3	8.7	21.5	45.5	20.8	24.8	25.8	26.5	17.0	15.4	17.3	12.3	40.0	32.5	9.7	23.3	31.6	32.5	41.8	28.0	45.0	9.7	13.8	35.9	45.3	12.7	23.3	31.4	19.1	9.9	53.4	9.7	29.1	20.9	6.7	19.0	33.9	24.5	17.8	13.4	10.8	35.5	36.2	36.0	21.6	23.1	29.2	29.0	10.4	28.3	16.9	18.1	53.6	28.5	57.9	33.2	37.2	29.2	20.6	28.6	29.9	29.1	18.1	26.3	27.0	38.2	27.5	33.3	18.6	33.7	32.9	20.9	25.9	31.6	38.4	18.0	26.0	21.5	26.2	33.9	20.6
NRDE2	"C14orf102, FLJ14051"	ENSG00000119720	"NRDE-2, necessary for RNA interference, domain containing"	Q9H7Z3	14	90267856-90332137	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047050, HPA050583"	Uncertain		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA047050: , HPA050583: "	"unprognostic (1.24e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.27e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-2)"	7.3	9.1	7.3	7.7	10.1	16.4	8.0	17.6	9.3	6.9	8.1	10.8	4.4	13.5	14.6	8.0	8.1	7.7	6.3	6.3	6.2	5.4	7.4	9.8	7.1	6.8	8.2	4.2	8.7	7.2	10.6	13.8	11.6	8.5	7.0	6.5	10.8	9.2	6.1	23.5	11.1	9.7	7.3	8.4	8.5	7.9	7.1	8.7	11.3	9.4	4.8	8.3	9.2	10.2	3.3	3.5	6.0	2.7	2.2	2.6	0.6	1.3	2.6	3.6	2.2	0.5	1.9	2.5	2.6	1.8	1.9	2.1	3.2	2.3	2.3	1.4	2.5	3.4	2.0	3.4	3.6	4.4	3.3	3.0	8.6	2.2	1.0	8.0	4.2	3.5	2.5	1.8	1.1	1.6	1.4	3.6	1.7	2.5	3.6	3.4	1.2	2.1	3.2	5.3	0.9	1.1	5.2	3.3	3.9	1.1	6.9	1.7	3.1	3.3	2.2	2.9	1.3	1.7	1.1	3.0	3.2	2.5	2.7	1.5	3.3	4.5	2.7	3.4	2.6	1.5	2.0	2.5	1.9	2.1	1.3	3.3	1.9	2.2	6.0	2.2	1.2	3.5	1.6	0.6	7.3	10.1	17.6	9.3	6.2	5.4	8.2	4.2	8.5	8.7
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611714-129757082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	14.8	7.3	10.9	18.9	13.0	20.3	18.2	22.2	11.1	15.4	10.3	12.6	16.0	9.0	15.7	10.4	10.1	18.7	10.0	12.3	11.5	11.1	10.0	7.8	11.2	18.7	12.1	7.7	24.4	15.2	13.5	10.9	12.5	11.5	11.5	9.9	11.7	13.8	13.9	19.3	12.2	10.7	14.0	9.6	14.2	8.7	17.2	15.2	29.2	13.8	11.4	16.1	12.8	19.2	8.8	7.0	13.1	7.0	5.8	13.3	6.2	11.6	9.6	13.8	12.2	8.4	6.7	11.0	8.1	8.5	12.5	9.8	11.6	7.8	13.4	6.0	9.2	8.9	14.9	8.2	12.8	12.8	10.6	11.1	8.1	7.8	6.1	13.5	11.1	5.7	7.8	12.3	11.9	9.2	13.4	10.4	7.6	10.6	26.5	12.8	12.9	8.5	17.0	11.2	11.9	7.1	8.5	12.0	13.1	12.3	12.8	8.2	7.9	13.0	7.0	7.1	9.8	8.2	14.9	11.3	11.2	23.8	7.5	12.6	13.6	6.1	5.5	13.1	11.4	6.9	13.3	7.7	8.7	10.5	7.0	8.8	9.6	8.2	11.4	5.8	7.0	4.7	9.1	6.2	10.9	13.0	22.2	11.1	11.5	11.1	12.1	7.7	11.5	15.2
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;Karpas-707: 5.5;PC-3: 14.5;RPTEC TERT1: 7.4;SCLC-21H: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"			Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: "	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	4.5	4.5	4.0	1.4	7.0	0.6	4.4	27.3	5.1	13.1	2.3	3.8	2.6	1.0	3.0	2.9	3.7	7.6	7.6	1.5	4.2	3.5	1.3	0.6	1.2	2.1	5.2	3.4	15.9	3.2	15.8	7.7	1.1	4.1	4.5	0.9	2.9	13.6	4.7	6.0	5.0	1.0	5.1	3.6	3.3	1.1	2.7	4.9	0.0	0.8	1.0	1.5	4.8	3.7	0.4	0.1	0.0	0.1	0.0	2.1	0.1	0.0	1.9	0.2	8.3	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.4	0.0	2.4	0.4	0.2	0.1	4.7	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.5	0.2	0.0	5.5	0.0	0.4	0.0	0.0	0.1	14.5	0.1	0.0	0.0	7.4	1.7	5.5	3.3	0.0	3.2	3.3	0.0	0.0	0.2	2.5	0.4	0.0	1.6	1.1	0.0	0.0	3.6	0.0	0.7	0.0	0.0	0.0	2.1	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.1	0.0	0.1	4.0	7.0	27.3	5.1	4.2	3.5	5.2	3.4	4.1	4.9
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: , HPA060036: "	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	29.0	15.0	10.8	12.6	7.5	19.6	18.4	20.8	10.5	23.1	21.2	6.7	8.5	14.5	16.6	13.4	13.1	18.8	9.0	11.8	9.3	5.8	16.0	22.7	9.3	8.9	5.9	7.3	14.4	15.8	8.3	11.2	16.8	7.2	13.9	15.8	12.7	10.3	7.7	36.5	7.6	30.3	17.3	12.9	17.0	8.4	6.8	7.7	22.1	7.3	12.4	5.9	13.0	14.9	2.6	1.7	0.5	1.4	1.2	5.6	0.7	9.6	20.4	16.1	0.0	8.1	5.2	5.7	11.5	5.1	7.6	5.8	3.8	7.6	0.0	6.5	10.9	5.0	1.0	6.8	15.4	0.0	4.4	14.5	7.1	11.7	4.8	7.2	3.2	6.4	9.5	7.9	9.3	5.6	10.3	8.0	5.0	5.4	3.3	0.0	6.5	6.1	40.9	12.6	0.3	4.4	16.6	1.4	0.0	9.5	5.0	3.8	12.2	5.5	9.7	6.2	4.2	9.6	4.6	3.8	0.0	0.0	13.6	0.0	3.1	0.0	1.4	0.5	1.0	0.8	5.6	0.9	1.0	1.1	1.7	2.6	1.7	0.6	0.3	1.2	1.4	1.7	0.5	0.7	10.8	7.5	20.8	10.5	9.3	5.8	5.9	7.3	7.2	7.7
NRL	"D14S46E, NRL-MAF, RP27"	ENSG00000129535	"Neural retina leucine zipper"	P54845	14	24080107-24115014	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"retina: 124.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026066, HPA064599"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB026066: , HPA064599: "	"unprognostic (2.71e-2)"	"unprognostic (8.17e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.88e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-5)"	"unprognostic (2.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	1.5	2.7	4.4	2.3	4.1	1.0	1.8	2.1	2.8	1.9	1.3	1.7	1.7	3.2	1.4	7.9	1.3	1.4	1.2	2.7	3.8	3.1	3.5	3.9	1.7	1.9	3.9	1.4	1.8	3.4	5.4	2.8	1.8	2.1	1.8	1.0	124.5	1.6	2.4	4.1	0.9	1.9	1.0	4.4	2.6	1.3	4.3	1.2	3.3	4.3	1.8	1.6	1.5	2.2	3.8	1.4	4.1	1.3	2.0	2.7	1.2	0.8	1.7	0.5	1.8	0.5	0.5	1.6	0.4	0.4	2.2	1.0	1.1	0.8	2.5	0.8	1.0	1.0	1.0	1.2	0.3	1.8	1.5	0.7	0.5	3.7	1.2	1.9	3.3	0.7	1.0	0.6	1.2	1.1	1.6	3.0	0.8	2.6	2.2	1.8	0.6	1.8	2.2	2.1	0.7	1.2	1.7	2.0	2.0	1.3	1.5	1.6	1.1	2.6	0.4	1.4	0.8	0.6	1.2	7.6	3.2	2.7	0.2	1.6	1.5	0.0	1.1	4.1	1.1	1.2	0.7	3.8	1.1	1.6	1.3	2.4	2.7	2.3	0.2	2.0	1.3	1.4	1.0	1.2	4.4	4.1	2.1	2.8	3.8	3.1	3.9	1.4	2.1	1.2
NRM	NRM29	ENSG00000137404	Nurim	Q8IXM6	6	30688047-30691420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA072545, HPA073982"			Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA072545: , HPA073982: "	"unprognostic (2.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavourable (3.52e-8)"	"unprognostic (3.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	14.2	5.6	1.4	6.5	2.4	10.0	11.4	2.2	2.5	16.2	6.6	2.9	5.8	2.6	15.3	5.3	11.4	7.7	7.4	7.5	1.5	1.4	7.3	3.0	8.1	15.7	2.1	1.5	13.7	5.7	3.6	1.7	11.3	2.4	10.4	4.2	5.4	4.2	7.0	4.5	9.0	6.0	7.4	2.4	9.6	4.2	9.7	2.2	23.3	5.0	14.4	11.9	9.9	9.2	4.2	3.7	1.6	3.8	0.8	1.6	1.0	3.8	3.6	6.8	4.7	1.1	3.7	0.8	1.9	3.8	6.1	5.6	3.9	2.7	6.4	1.4	3.9	5.9	3.7	6.4	1.8	8.8	2.0	3.9	5.2	5.0	1.4	3.0	6.0	2.3	2.3	5.9	2.2	4.8	3.4	5.9	4.2	3.4	4.7	3.3	1.4	2.2	11.5	4.5	7.8	2.6	1.9	2.6	2.2	2.2	2.7	1.2	4.4	3.0	1.9	5.6	3.0	3.2	3.5	2.2	4.0	2.3	0.8	8.2	7.2	0.9	3.8	0.2	1.0	1.1	0.8	4.2	1.1	1.6	3.3	4.1	0.5	0.6	1.6	0.8	0.4	3.7	0.8	1.0	1.4	2.4	2.2	2.5	1.5	1.4	2.1	1.5	2.4	2.2
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.2;HUVEC TERT2: 30.0;TIME: 28.6;U-251 MG: 58.5;U-87 MG: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039980, HPA054974"	Enhanced		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"		15000000	"Vesicles, Plasma membrane"		"HPA039980: AB_10795517, HPA054974: "	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavourable (7.80e-5)"	24.3	14.5	8.7	11.4	7.4	2.6	7.8	1.2	7.0	34.4	35.4	3.9	8.4	3.5	33.7	4.6	24.8	13.1	25.8	4.4	11.5	8.3	3.4	6.2	15.8	4.9	8.9	3.9	33.0	1.4	2.5	6.6	29.9	9.0	18.6	7.0	27.7	2.6	21.0	2.5	3.3	8.2	44.7	8.6	4.7	17.1	3.4	5.2	2.6	7.3	6.0	3.0	39.3	24.6	1.4	0.5	0.0	1.8	0.0	0.0	0.5	0.6	14.1	9.0	0.0	8.2	2.6	2.6	2.2	4.3	2.8	2.7	13.3	34.2	0.0	3.4	7.1	5.4	0.4	4.3	4.6	0.0	1.9	0.1	0.6	0.1	22.2	0.0	0.5	19.5	3.3	3.9	3.5	30.0	0.0	0.0	1.9	0.0	0.0	0.0	11.3	2.5	0.0	0.5	3.1	5.7	0.0	8.1	0.3	0.3	0.0	20.2	0.0	0.1	28.6	12.4	0.1	3.2	58.5	0.0	0.0	0.8	27.6	0.0	25.9	0.0	1.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.7	7.4	1.2	3.8	11.5	8.3	8.9	3.9	9.0	5.2
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918505-51225575	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 81.9"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 28.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"		620000	"Plasma membrane"		"HPA071400: "	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	2.1	3.2	22.4	2.1	20.3	1.4	1.7	56.5	81.9	2.8	5.1	3.0	0.5	2.1	2.1	3.7	3.0	1.4	2.2	3.8	16.9	13.8	1.5	1.6	1.5	1.4	8.3	25.9	2.1	2.3	1.3	4.8	1.1	12.6	2.5	3.8	2.0	3.5	9.3	1.3	2.0	3.1	2.1	6.5	1.3	2.3	6.5	4.7	0.0	1.4	0.0	1.4	2.0	1.6	0.0	0.0	4.4	0.1	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.0	28.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.4	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.3	0.0	0.0	0.0	0.0	22.4	20.3	56.5	33.2	16.9	13.8	8.3	25.9	12.6	4.7
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2, ribosome biogenesis homolog"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA043487	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA043487: "	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	25.4	32.6	17.4	26.8	29.3	28.3	24.0	14.0	29.4	31.8	25.8	8.0	18.0	26.2	26.5	22.6	27.9	22.9	13.5	27.7	20.8	13.6	27.4	35.4	27.0	42.5	16.7	19.1	54.2	31.2	13.5	35.4	25.4	20.3	27.8	20.6	10.4	33.8	17.9	51.1	17.3	22.2	23.1	28.5	28.5	24.3	44.5	15.7	26.4	27.2	21.7	26.1	36.7	26.1	17.0	11.1	4.4	11.9	13.1	19.3	6.1	20.3	11.1	13.8	18.5	8.6	15.8	21.0	14.6	7.6	9.3	7.4	18.4	20.0	16.5	31.1	8.0	12.6	10.8	16.1	13.2	11.2	16.8	8.6	21.7	21.1	8.0	14.9	20.2	10.4	15.2	12.4	9.2	7.7	8.5	13.9	9.9	15.4	25.1	37.6	9.1	9.7	18.0	16.1	31.0	11.7	22.5	14.8	19.3	8.8	17.1	39.3	16.0	42.6	8.9	7.1	21.7	13.5	41.8	13.9	18.5	26.9	18.0	26.5	10.7	4.4	7.2	4.2	10.5	11.9	15.1	17.0	16.0	15.8	11.1	12.4	19.3	19.1	1.3	13.1	8.8	10.4	15.8	6.1	17.4	29.3	14.0	29.4	20.8	13.6	16.7	19.1	20.3	15.7
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300215	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA048431: , HPA070333: , HPA073705: "	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	11.8	13.2	11.9	25.4	15.7	23.9	14.0	28.9	16.7	15.6	14.2	18.5	17.0	10.6	19.0	13.9	17.8	13.6	15.8	11.7	12.8	11.5	14.4	10.5	12.3	19.4	12.9	11.7	16.6	27.1	24.6	19.3	16.0	13.4	14.2	14.3	13.8	13.5	18.7	20.6	16.1	14.5	15.6	13.2	16.1	13.1	28.1	16.1	27.3	20.1	10.6	22.7	13.4	20.2	10.2	8.9	18.7	10.8	10.9	7.8	2.9	9.7	12.6	13.1	11.3	6.4	8.3	0.4	8.8	8.9	12.4	11.6	2.8	8.2	20.1	10.0	12.1	8.4	20.8	19.6	15.1	34.0	12.6	8.9	14.2	0.1	10.7	19.2	10.6	7.8	11.9	14.7	13.8	18.0	12.1	7.1	12.5	20.4	13.3	6.2	14.2	11.1	14.8	1.7	6.2	8.0	11.8	15.9	11.0	22.9	10.0	6.9	10.0	16.0	13.3	8.7	12.6	5.5	10.9	8.3	7.2	14.4	5.0	9.4	9.3	10.7	9.1	9.4	7.5	6.1	6.3	8.5	6.3	5.0	6.7	10.2	7.8	6.3	18.7	10.9	10.8	8.9	5.7	2.9	11.9	15.7	28.9	16.7	12.8	11.5	12.9	11.7	13.4	16.1
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871424-1982207	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB068246: , CAB068247: , HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	8.7	7.6	17.6	11.5	16.2	35.1	8.5	20.6	18.2	7.0	14.8	12.4	6.3	14.0	9.5	7.4	12.7	6.8	6.9	11.9	15.1	10.9	8.4	7.5	11.1	18.8	14.7	16.1	7.0	11.7	10.7	11.8	9.8	14.6	8.7	17.7	9.4	10.2	7.4	11.8	12.1	14.6	10.5	15.3	13.5	11.0	26.3	13.4	46.7	13.8	5.5	17.7	8.6	9.4	4.9	3.9	4.1	1.8	2.7	4.3	0.6	27.4	13.9	41.9	18.3	4.5	6.7	12.2	22.2	19.7	27.2	30.5	12.2	32.6	29.6	7.6	18.3	12.0	27.0	18.3	46.8	14.2	11.1	35.2	19.2	7.2	5.7	21.5	18.5	2.6	4.6	23.9	23.0	21.4	19.0	31.1	22.3	10.8	57.5	22.6	17.6	16.0	32.9	27.3	10.2	11.2	13.0	26.0	20.8	18.2	6.8	8.3	16.1	14.5	16.5	27.2	20.3	17.2	44.6	14.6	15.4	26.8	16.3	21.4	25.2	2.1	1.7	1.7	2.9	1.8	3.2	1.8	3.2	3.2	1.5	4.9	2.8	2.3	4.1	2.7	1.4	3.9	4.3	0.6	17.6	16.2	20.6	18.2	15.1	10.9	14.7	16.1	14.6	13.4
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favourable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favourable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	17.4	24.8	11.0	7.7	10.5	6.0	20.4	7.7	15.0	13.4	23.4	13.9	20.5	13.3	10.4	35.7	36.2	11.9	7.4	16.7	14.3	11.4	11.6	38.1	9.9	8.7	9.7	10.4	9.8	7.9	9.8	6.9	7.9	18.9	12.0	10.7	7.9	12.2	17.7	6.9	14.5	24.0	9.9	14.2	7.3	9.6	8.6	9.3	6.0	11.0	22.2	17.0	7.5	16.1	16.2	17.5	16.4	17.7	17.0	17.3	13.0	43.6	16.1	21.9	11.4	18.9	14.4	12.4	8.7	11.7	15.9	20.3	22.2	23.9	21.6	29.4	11.8	22.5	28.5	40.2	14.1	7.2	16.3	8.8	15.7	22.4	13.8	8.8	7.2	17.6	15.6	31.1	7.9	14.7	14.6	9.8	12.0	19.3	8.7	11.5	8.7	19.4	6.5	15.9	17.7	33.0	18.1	7.9	9.0	7.8	11.7	9.2	7.7	11.3	12.4	7.4	12.3	17.8	16.7	13.9	9.3	37.2	13.7	13.8	7.0	16.4	17.7	15.8	15.6	16.2	15.7	16.2	15.6	13.5	17.5	12.9	11.4	12.6	1.9	17.0	12.1	15.6	17.3	13.0	11.0	10.5	7.7	15.0	14.3	11.4	9.7	10.4	18.9	9.3
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Enhanced	Cytosol			6900	Cytosol		"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: "	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	1.9	3.6	11.2	2.7	19.1	1.6	2.6	14.1	35.4	2.5	4.0			1.4	1.9	2.7	3.9	2.2	2.8	1.5	13.9	14.4	3.4	2.5	2.2	3.1	12.6		1.3	3.5	6.5	5.5	2.6		2.8	5.5		2.4	2.1	4.3	2.4	3.2	2.2	3.1	1.6	3.0	3.1			3.6		3.4	3.3	1.0	7.2	15.5	10.4	13.3	6.7	11.1	8.8	6.1	13.6	9.1	0.6	5.4	7.6	7.4	8.4	9.8	8.1	7.9	9.3	0.0	15.0	15.1	18.6	1.1	10.2	3.1	13.3	5.3	13.3	0.5	9.8	12.7	8.0	0.4	3.3	6.9	4.3	16.4	6.8	12.7	10.0	8.2	17.9	12.0	10.0	3.9	5.1	16.2	7.2	8.8	14.0	9.2	12.8	8.4	9.5	12.4	0.0	5.9	15.5	18.6	10.3	22.9	8.1	12.1	12.5	17.6	10.1	8.8	6.4	8.1	16.1	10.4	13.3	7.8	8.2	12.1	8.9	6.8	8.2	10.5	15.5	7.2	6.9	8.1	6.0	6.7	12.1	6.2	11.1	8.8										
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			920000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	15.7	22.7	20.2	10.2	23.5	15.8	15.3	18.2	26.5	16.6	14.7	17.1	9.3	11.1	17.4	21.2	19.8	19.9	12.2	21.9	16.7	18.2	14.8	19.8	12.7	9.6	17.1	22.4	22.7	10.8	12.4	9.9	21.5	24.2	16.8	13.9	20.1	13.6	21.8	49.7	25.6	12.4	18.9	15.8	12.2	12.6	11.1	15.3	12.8	13.1	14.8	12.4	15.9	13.7	14.5	12.0	32.4	10.9	5.9	11.0	9.4	21.2	24.6	15.8	15.0	14.3	13.3	11.7	9.9	17.9	24.3	18.0	20.8	17.2	11.8	8.1	18.0	20.1	9.7	26.0	18.7	4.4	10.5	11.9	4.4	23.8	15.1	11.5	7.2	11.3	9.5	25.3	8.5	17.2	15.4	10.6	16.9	10.2	12.0	22.0	16.9	27.2	5.7	19.7	11.5	28.2	14.9	9.1	11.2	12.0	23.9	10.8	14.6	8.0	16.0	18.9	13.9	10.9	16.2	8.5	15.2	9.8	14.0	16.1	13.3	10.7	8.9	32.4	8.5	10.6	8.5	13.9	9.2	8.3	12.0	14.5	10.5	9.2	29.1	5.9	10.9	9.5	11.0	9.4	20.2	23.5	18.2	26.5	16.7	18.2	17.1	22.4	24.2	15.3
NSG2	"CALY3, HMP19, Nsg2"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045604-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 120.8"	"Group enriched"	"Detected in some"	58	"SCLC-21H: 21.3;SH-SY5Y: 34.3"	"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA046531: , HPA056191: "	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	1.7	23.1	31.6	3.0	92.4	1.4	1.4	19.7	120.8	1.4	3.6	5.0	0.0	2.8	1.4	1.7	1.5	1.4	1.6	1.6	27.3	40.2	1.6	1.4	1.6	1.4	20.2	27.6	1.4	2.0	1.4	0.9	1.4	22.5	1.4	4.1	0.8	1.4	1.5	1.4	1.4	3.8	2.5	4.6	1.4	3.3	5.0	11.7	0.0	1.8	0.0	1.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	92.4	19.7	49.8	27.3	40.2	20.2	27.6	22.5	11.7
NSL1	"C1orf48, DC8, DKFZP566O1646, MIS14"	ENSG00000117697	"NSL1, MIS12 kinetochore complex component"	Q96IY1	1	212726153-212791782	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA045761, HPA053721"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA045761: , HPA053721: "	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.44e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.66e-2)"	15.1	14.6	23.1	16.5	26.3	16.1	19.7	22.9	20.6	14.5	12.9	27.2	9.9	15.4	14.9	12.3	14.2	13.8	13.2	21.5	23.9	21.5	17.4	20.6	12.5	22.0	25.6	15.0	17.1	10.9	12.0	19.2	17.2	20.7	13.9	11.8	12.8	12.4	11.3	19.4	8.3	17.1	13.3	36.0	18.9	11.5	12.4	25.0	24.4	14.9	8.8	16.2	16.3	11.4	33.1	32.4	35.3	35.6	24.4	29.9	31.2	14.7	17.5	18.8	17.2	9.6	9.3	23.4	12.5	10.0	16.8	14.9	14.8	16.6	21.7	11.6	7.8	11.2	17.7	13.1	14.6	39.6	13.4	14.3	14.7	23.5	9.2	23.6	14.0	8.8	7.7	16.8	9.2	12.7	31.5	18.8	12.7	8.9	30.3	11.9	33.7	13.1	26.4	27.7	24.4	16.4	7.6	16.2	22.9	18.0	8.8	21.2	25.4	17.5	12.7	16.0	13.6	14.4	20.5	10.5	28.1	27.7	13.9	16.6	19.5	12.7	29.1	35.3	22.7	35.6	26.6	33.1	24.6	24.3	32.4	26.9	29.9	26.6	29.4	24.4	35.1	31.4	28.5	31.2	23.1	26.3	22.9	18.9	23.9	21.5	25.6	15.0	20.7	25.0
NSMCE1	NSE1	ENSG00000169189	"NSE1 homolog, SMC5-SMC6 complex component"	Q8WV22	16	27224991-27268794	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041567, HPA043091"	Supported		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA041567: AB_10964260, HPA043091: AB_10962722"	"unprognostic (6.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	24.0	37.3	26.7	33.3	27.4	16.9	30.1	16.9	27.2	22.2	24.7	31.4	30.8	14.1	23.1	32.5	34.7	36.0	36.7	21.7	24.3	26.3	30.9	37.4	27.1	36.7	31.9	20.9	29.5	45.3	46.7	20.5	21.4	27.1	33.8	21.2	26.0	37.2	31.5	22.5	19.5	23.8	35.4	32.4	20.9	26.2	55.4	19.3	41.5	33.9	25.7	29.3	27.6	20.4	42.0	38.9	31.8	27.7	60.4	41.6	32.6	14.4	20.8	14.3	15.5	23.2	31.2	11.5	15.5	15.8	11.8	12.3	16.1	35.3	28.5	37.2	23.5	15.6	26.7	46.4	15.3	34.8	18.5	13.1	19.3	30.8	40.5	15.3	9.9	30.5	32.4	29.6	56.7	15.8	17.5	9.0	21.7	24.4	20.0	17.0	12.6	14.4	17.6	17.6	44.5	34.1	9.4	15.1	13.7	10.5	14.7	26.4	24.3	18.4	9.8	14.3	9.0	16.3	14.8	27.0	19.4	21.9	30.8	15.2	6.1	31.8	27.7	25.0	25.2	24.3	27.8	24.1	36.0	30.6	38.9	42.0	41.6	32.6	9.0	60.4	22.5	37.7	32.8	32.6	26.7	27.4	16.9	27.2	24.3	26.3	31.9	20.9	27.1	19.3
NSMCE2	"C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7"	ENSG00000156831	"NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase"	Q96MF7	8	125091679-125367120	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway"	Transferase	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051614, HPA065734"	Supported		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA051614: , HPA065734: "	"unprognostic (1.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.65e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavourable (7.54e-4)"	"unprognostic (3.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.85e-2)"	22.4	22.3	17.6	16.4	20.2	26.2	23.8	21.0	22.6	18.2	19.9	17.1	17.6	12.3	28.3	19.5	18.6	14.3	16.5	22.9	13.7	12.7	18.5	17.2	16.3	19.4	20.2	17.3	21.3	14.9	11.2	32.0	19.1	16.1	15.0	17.8	16.7	19.3	17.4	36.5	18.1	13.4	21.9	18.3	16.6	18.9	19.1	20.6	18.5	18.2	16.8	24.9	18.8	21.2	12.6	12.6	35.3	12.6	11.1	18.8	12.5	16.1	14.0	16.7	10.5	13.2	20.0	8.1	13.0	24.5	23.1	26.9	8.9	15.5	20.3	15.3	12.3	12.1	13.0	10.9	23.6	22.7	12.7	28.6	8.5	12.9	19.1	8.5	8.7	14.7	15.3	13.3	17.0	20.8	16.5	13.4	20.1	27.9	21.9	7.9	3.7	18.8	12.3	11.6	18.3	13.9	12.3	11.1	11.8	15.5	46.8	21.6	19.9	9.8	12.9	8.9	25.3	11.0	18.4	17.9	31.9	25.5	13.9	16.6	13.8	5.1	12.6	35.3	12.2	10.9	13.5	12.6	13.0	13.7	12.6	11.5	13.4	14.6	6.1	11.1	10.9	7.4	18.8	12.5	17.6	20.2	21.0	22.6	13.7	12.7	20.2	17.3	16.1	20.6
NSMCE4A	"bA500G22.3, C10orf86, FLJ20003, NSE4A"	ENSG00000107672	"NSE4 homolog A, SMC5-SMC6 complex component"	Q9NXX6	10	121957088-121975217	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037459, HPA038412, HPA044872"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA037459: AB_10696932, HPA038412: , HPA044872: "	"unprognostic (1.16e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (2.72e-5)"	"unprognostic (3.16e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (1.64e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.01e-3)"	21.8	17.7	11.1	27.1	17.6	16.2	26.0	14.0	12.5	23.7	26.6	14.0	14.3	22.8	20.8	17.1	22.3	18.0	16.7	17.8	11.0	8.2	15.4	23.0	22.3	22.2	18.5	12.6	20.0	24.3	13.3	10.5	15.5	12.2	21.1	20.3	15.2	24.5	23.0	15.9	14.6	26.1	26.9	12.2	20.0	23.7	6.5	16.8	23.3	21.8	15.8	20.6	26.7	16.8	24.0	24.9	8.8	17.6	18.7	22.4	17.2	16.6	20.5	22.1	19.6	7.8	10.3	16.3	9.4	16.9	16.2	22.6	15.9	13.0	22.3	7.3	7.4	14.5	12.9	10.3	12.9	26.7	30.5	14.6	7.1	29.6	6.6	16.4	10.3	7.0	7.9	9.5	15.5	17.1	13.4	16.1	9.0	13.5	29.8	24.2	11.6	16.2	25.8	17.1	23.9	11.1	13.9	6.0	11.8	10.7	7.3	14.6	8.0	15.7	13.8	6.4	11.5	10.8	19.3	21.5	22.8	34.3	8.0	22.4	6.9	0.1	15.4	8.8	15.3	17.6	17.7	24.0	20.6	19.8	15.9	21.7	21.8	17.7	1.4	18.7	17.1	24.9	22.4	17.2	11.1	17.6	14.0	12.5	11.0	8.2	18.5	12.6	12.2	16.8
NSMF	NELF	ENSG00000165802	"NMDA receptor synaptonuclear signaling and neuronal migration factor"	Q6X4W1	9	137447573-137459334	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 96.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 12.1;non-classical monocyte: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.0;granulocytes: 3.1;monocytes: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044316	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA044316: AB_10964877"	"unprognostic (1.48e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.34e-3)"	"prognostic favourable (1.85e-6)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-2)"	8.8	8.8	61.7	6.9	34.4	6.1	5.3	6.4	67.3	6.0	8.1	18.2	2.1	16.9	8.6	6.6	6.6	7.2	5.7	5.0	96.4	21.8	15.3	6.2	5.2	6.9	20.4	30.2	5.0	14.7	10.8	13.7	4.2	12.1	9.0	6.3	5.4	11.5	8.7	4.0	9.7	13.7	8.2	9.6	6.8	9.6	7.8	15.0	2.4	5.1	1.3	5.8	6.4	3.8	0.2	6.0	3.1	12.1	0.0	1.5	1.4	7.7	6.3	11.2	16.7	26.4	12.5	9.7	7.5	10.0	7.2	5.6	16.8	4.7	9.7	10.2	11.0	23.7	16.5	10.1	4.3	12.7	17.8	7.5	14.9	22.3	14.3	5.1	17.3	14.2	19.3	8.4	19.7	7.6	17.3	1.6	9.6	18.0	0.2	22.3	14.3	17.0	4.7	17.8	21.6	5.0	3.9	47.2	38.5	18.0	10.0	11.3	7.1	10.7	19.1	12.8	10.5	31.0	12.7	3.4	5.3	14.8	7.3	6.9	11.7	1.5	2.0	3.1	1.5	12.1	0.2	0.2	0.5	0.9	6.0	0.1	0.6	0.7	0.3	0.0	10.5	0.2	0.7	1.4	61.7	34.4	6.4	62.9	96.4	21.8	20.4	30.2	12.1	15.0
NSRP1	"CCDC55, DKFZP434K1421, NSrp70"	ENSG00000126653	"Nuclear speckle splicing regulatory protein 1"	Q9H0G5	17	30115521-30186475	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015593, HPA015603"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA015593: AB_2072217, HPA015603: AB_1846157"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.43e-1)"	25.7	21.2	26.4	25.7	36.7	25.7	23.5	28.8	28.2	22.2	25.0	24.3	28.1	18.1	25.1	25.5	21.8	21.3	21.9	26.6	25.7	23.2	23.0	21.3	20.4	22.0	33.9	20.5	26.0	28.3	31.9	37.4	23.6	28.9	23.2	20.2	16.2	22.6	23.4	43.5	27.9	19.6	34.7	52.1	21.7	21.2	21.2	36.0	18.6	28.4	19.2	20.5	34.3	27.2	28.9	31.4	31.0	21.2	16.1	19.4	7.3	13.7	12.3	12.0	9.7	16.8	16.2	8.7	19.0	19.6	14.7	15.9	13.0	8.9	25.0	15.5	18.1	20.2	18.9	14.7	24.1	6.1	25.8	11.4	19.3	9.3	26.9	17.6	14.0	18.3	19.7	23.3	30.5	13.8	18.0	16.8	20.4	10.3	11.8	17.5	8.1	10.3	13.8	19.8	16.9	15.3	14.9	11.6	10.1	14.4	39.1	17.1	20.4	20.0	14.9	17.7	12.5	18.5	30.0	12.0	16.0	20.4	21.9	16.2	20.2	25.8	21.2	16.1	17.2	19.0	19.1	28.2	19.4	16.8	10.6	28.9	19.1	17.2	31.0	16.1	20.1	31.4	16.9	7.3	26.4	36.7	28.8	28.2	25.7	23.2	33.9	20.5	28.9	36.0
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase family member 5"	Q96P11	7	73302517-73308867	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: , HPA046867: "	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	9.0	7.7	11.2	13.1	12.8	40.9	8.7	12.9	14.4	8.5	10.3	15.0	4.8	12.6	12.3	6.9	10.8	12.0	8.1	9.4	10.8	9.3	9.4	9.8	8.0	16.1	19.4	11.9	10.6	19.6	9.5	8.3	8.3	13.6	9.7	6.2	7.7	13.6	9.7	27.1	11.8	12.1	10.9	11.6	15.8	9.6	14.6	13.6	23.5	10.6	11.2	12.1	10.6	8.9	33.5	21.2	18.7	14.4	16.8	22.3	15.3	12.0	16.7	4.7	10.3	2.0	2.5	17.9	5.8	3.4	9.0	9.6	22.6	9.0	19.9	3.9	2.9	10.4	8.8	5.8	2.9	13.1	20.6	7.5	12.2	12.9	7.6	16.6	10.2	3.3	9.7	7.7	6.5	1.1	24.5	4.7	4.3	29.0	14.0	34.0	19.0	12.9	17.1	3.5	28.5	3.9	6.0	12.2	20.4	10.2	27.2	13.1	17.5	13.2	1.9	0.1	13.1	13.0	3.9	19.0	24.5	28.4	0.2	23.3	0.9	14.2	14.4	15.0	14.0	12.5	11.0	21.5	15.9	14.3	16.5	33.5	22.3	18.8	18.7	16.8	9.3	21.2	17.3	15.3	11.2	12.8	12.9	14.4	10.8	9.3	19.4	11.9	13.6	13.6
NSUN7	FLJ14001	ENSG00000179299	"NOP2/Sun RNA methyltransferase family member 7"	Q8NE18	4	40749897-40809985	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.5"	"Cell line enhanced"	"Detected in some"		"A-431: 3.9;CAPAN-2: 8.6;Karpas-707: 6.3;MCF7: 4.1;RPTEC TERT1: 4.2;T-47d: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA020653	Uncertain		Supported	Vesicles				Vesicles		"HPA020653: AB_1848710"	"unprognostic (2.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.42e-2)"	"prognostic favourable (2.76e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-2)"	0.7	1.2	0.9	2.8	2.0	0.7	5.1	0.2	1.0	3.2	7.0	2.4	7.3	2.3	5.9	9.7	4.5	9.1	5.4	5.5	1.0	1.9	6.6	0.7	8.1	4.2	1.0	0.5	4.6	14.1	7.7	7.5	2.8	2.6	5.7	3.2	4.3	15.2	10.3	0.1	1.9	6.7	2.6	1.8	3.6	3.8	39.5	0.2	2.4	11.9	1.5	5.3	3.7	1.5	1.1	0.0	6.1	0.1	0.0	0.0	0.0	3.9	0.4	1.9	0.0	0.0	0.0	2.9	0.0	0.3	0.2	0.2	1.5	8.6	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	4.1	0.1	0.0	2.3	0.5	0.1	0.1	0.0	4.2	1.1	1.0	2.3	0.6	2.7	0.0	6.3	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.2	1.0	1.0	1.9	1.0	0.5	2.6	0.2
NT5C	"cdN, DNT-1, DNT1, PN-I, UMPH2"	ENSG00000125458	"5', 3'-nucleotidase, cytosolic"	Q8TCD5	17	75130225-75131795	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021581, HPA023632"	Approved		Supported	Cytosol			600000	Cytosol		"HPA021581: AB_1854663, HPA023632: AB_1854662"	"unprognostic (3.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"prognostic favourable (7.66e-4)"	14.5	16.7	10.7	32.5	10.5	14.4	15.2	16.0	13.8	16.3	27.3	18.5	16.2	25.1	18.0	18.7	21.6	15.9	21.0	16.7	9.6	11.0	21.0	13.5	19.9	30.1	12.3	11.0	19.7	28.0	10.4	9.7	11.6	10.9	17.5	14.2	18.0	17.9	17.7	27.1	16.0	30.1	16.7	13.7	20.5	24.5	11.4	12.0	17.2	22.0	30.4	24.5	20.5	17.1	30.7	16.8	46.7	15.8	22.7	14.3	9.7	21.1	33.2	10.9	11.4	3.3	6.9	15.0	12.6	11.1	12.8	8.2	12.4	25.0	14.8	9.2	8.8	14.9	7.6	15.7	7.3	6.9	23.9	16.2	25.8	20.7	16.6	15.7	7.4	10.0	7.5	9.1	25.6	14.1	15.7	7.2	13.0	21.2	11.4	15.9	11.3	22.0	10.4	14.3	20.5	16.6	11.4	13.0	26.6	12.2	15.0	17.4	21.0	11.6	8.2	11.1	27.5	4.2	16.7	14.4	2.1	16.4	10.3	9.6	17.2	46.7	10.2	15.2	13.8	15.8	9.7	30.7	9.0	11.6	12.7	29.1	7.9	11.9	4.6	22.7	15.5	16.8	14.3	9.7	10.7	10.5	16.0	13.8	9.6	11.0	12.3	11.0	10.9	12.0
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 108.8;TIME: 63.0;U-87 MG: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.4	2.9	5.0	0.1	11.5	36.7	0.0	35.5	38.9	17.5	32.9	0.0	54.5	0.0	12.8	31.0	2.8	0.0	35.7	41.7	0.0	0.0	0.0	0.8	0.6	5.7	0.0	0.0	9.4	0.4	35.7	22.8	14.5	0.0	0.1	108.8	0.9	0.0	0.0	0.1	3.9	0.1	1.1	0.1	37.9	2.4	0.0	0.6	0.4	2.2	12.0	0.0	0.9	63.0	14.3	0.1	18.0	57.7	2.7	1.7	0.0	98.1	0.0	44.8	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636131	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: "	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	10.2	25.7	11.9	11.5	13.1	13.8	10.0	13.2	15.3	8.9	10.7	9.0	14.4	11.7	8.8	13.6	10.2	7.8	16.6	31.8	11.5	11.5	11.7	16.8	8.9	11.5	15.7	11.3	8.8	19.5	9.4	10.8	12.1	13.8	10.2	7.4	9.4	13.0	11.4	54.6	10.7	10.2	13.6	10.3	13.1	10.5	56.2	10.7	10.8	12.3	22.1	9.8	12.3	14.5	27.1	28.4	20.3	34.2	14.8	26.6	19.4	16.6	34.5	14.3	24.2	9.1	13.6	15.4	31.7	18.8	32.1	27.8	28.3	21.9	21.4	16.3	22.6	32.5	30.0	27.9	20.2	16.5	16.1	8.9	31.1	28.5	29.3	18.0	13.6	14.5	14.2	33.6	16.8	17.5	32.8	16.1	16.7	55.1	20.3	24.3	18.7	30.2	19.3	16.9	43.0	12.9	9.5	29.1	15.2	15.6	29.3	21.6	24.4	9.4	11.8	38.6	19.6	35.8	33.2	12.7	15.1	32.6	17.6	18.7	22.1	15.1	27.3	20.3	25.2	28.7	24.8	23.4	25.5	26.6	26.4	27.1	26.4	22.0	7.6	14.8	34.2	28.4	23.4	19.4	11.9	13.1	13.2	15.3	11.5	11.5	15.7	11.3	13.8	10.7
NTNG1	"KIAA0976, Lmnt1"	ENSG00000162631	"Netrin G1"	Q9Y2I2	1	107140007-107483458	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 28.2;fHDF/TERT166: 13.7;RPTEC TERT1: 15.3;U-138 MG: 12.9;U-251 MG: 9.3;U-87 MG: 14.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065954			Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA065954: "	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.38e-5)"	"unprognostic (1.93e-3)"	"unprognostic (9.87e-3)"		"unprognostic (3.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-5)"	4.2	11.0	6.8	1.3	6.4	0.9	1.1	7.3	12.8	7.0	2.9	9.6	0.3	0.8	2.2	0.9	1.2	1.3	2.1	0.9	9.8	16.4	13.0	0.8	9.2	1.7	5.0	5.3	1.9	1.1	0.7	7.4	3.2	10.0	9.0	1.7	6.4	2.8	12.1	1.1	1.9	1.7	7.5	7.4	1.3	1.4	1.7	6.1	0.0	0.8	0.0	2.0	5.3	3.0	4.4	0.8	1.4	0.7	0.8	0.6	0.3	0.0	0.0	1.6	0.0	2.8	28.2	0.0	7.7	1.1	0.6	0.6	0.0	0.0	0.0	0.3	13.7	0.0	0.0	0.8	1.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	8.0	0.2	2.0	1.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	3.5	0.0	1.9	0.0	15.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	12.9	2.5	4.7	9.3	0.0	0.0	0.0	14.4	0.0	1.4	1.4	0.3	0.4	0.3	0.4	0.5	4.4	0.4	0.3	0.4	1.0	0.6	0.5	0.9	0.8	0.7	0.8	0.4	0.3	6.8	6.4	7.3	12.3	9.8	16.4	5.0	5.3	10.0	6.1
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8"	"Cell line enriched"	"Detected in some"	8	"U-138 MG: 47.4"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli"			11000000	Nucleoli	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: , HPA048065: "	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	20.8	7.4	22.0	2.5	28.1	1.5	6.2	30.4	41.8	7.0	4.0	8.4	1.3	2.0	12.4	6.7	3.4	9.5	3.9	5.5	22.0	11.1	5.1	2.0	5.7	3.1	11.2	18.7	5.1	2.9	1.6	7.9	2.8	14.7	6.8	4.7	8.0	11.5	8.7	1.9	2.9	2.5	7.7	13.7	4.1	3.0	13.8	13.7	0.0	2.5	0.7	4.3	7.1	4.8	0.7	0.4	1.3	0.5	0.5	0.8	0.0	0.0	5.9	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.9	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.1	1.2	0.5	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.1	0.7	0.4	0.4	1.3	0.5	0.1	0.4	0.8	0.0	22.0	28.1	30.4	28.9	22.0	11.1	11.2	18.7	14.7	13.7
NTSR1	NTR	ENSG00000101188	"Neurotensin receptor 1"	P30989	20	62708837-62762771	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.0;intestine: 15.1"	"Cell line enriched"	"Detected in some"	5	"PC-3: 35.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050299			Supported	"Plasma membrane"				"Plasma membrane"		"HPA050299: "	"unprognostic (4.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.87e-4)"	"unprognostic (9.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.16e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	0.3	0.1	3.7	2.5	3.6	3.8	0.1	0.1	7.0	0.1	15.1	0.0	0.0	0.4	0.2	0.1	0.1	0.1	1.4	0.1	2.0	1.1	0.6	0.2	0.3	0.3	3.3	1.0	0.4	0.1	0.2	0.3	0.2	1.4	0.2	0.5	1.2	0.3	0.1	0.2	0.2	1.5	0.8	0.8	0.6	0.5	0.5	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	6.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	1.6	0.1	1.5	0.2	35.0	1.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.7	3.6	0.1	7.0	2.0	1.1	3.3	1.0	1.4	0.0
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341699-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA021220: , HPA050722: , HPA053648: "	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	20.1	17.3	17.1	22.1	15.5	13.2	20.5	20.5	20.0	22.2	25.0	17.6	17.3	30.9	24.4	17.6	18.1	19.8	17.0	16.5	14.8	12.9	17.1	18.9	21.2	28.7	14.3	15.4	25.4	21.7	28.0	26.4	23.7	18.5	21.6	15.3	16.2	19.8	15.7	30.3	16.9	38.3	20.8	19.8	26.5	17.7	56.0	16.0	32.3	26.5	15.9	19.8	25.3	22.3	21.1	18.9	28.9	24.0	24.5	24.7	17.1	26.6	12.1	16.4	9.6	17.1	20.9	13.6	21.5	19.8	16.4	18.9	11.8	23.6	28.8	28.5	13.4	13.5	9.7	14.0	10.5	25.4	16.5	10.4	11.6	7.5	23.9	24.2	13.6	13.3	16.4	11.7	11.1	10.7	27.3	0.8	13.1	14.3	42.8	18.5	25.6	16.0	23.8	17.0	4.3	12.1	13.2	15.4	25.6	40.3	17.3	20.5	11.9	14.0	21.6	13.9	4.9	18.5	20.3	28.1	21.4	25.3	28.1	20.9	22.7	10.4	15.7	20.7	20.9	20.3	24.7	21.1	18.3	21.1	13.6	19.9	20.4	19.0	28.9	24.5	24.0	18.9	14.3	17.1	17.1	15.5	20.5	20.0	14.8	12.9	14.3	15.4	18.5	16.0
NUBP1	"NBP1, NBP35"	ENSG00000103274	"Nucleotide binding protein 1"	P53384	16	10743786-10769351	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041656, HPA041799"	Enhanced		Supported	Cytosol				Cytosol		"HPA041656: AB_10960278, HPA041799: AB_10960692"	"unprognostic (2.51e-2)"	"prognostic favourable (2.81e-5)"	"unprognostic (4.01e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.30e-3)"	"unprognostic (8.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.50e-1)"	"prognostic favourable (7.61e-8)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.69e-2)"	16.1	31.4	10.8	25.0	11.2	18.3	19.3	12.8	11.4	17.7	19.0	15.8	20.4	14.8	18.8	20.7	15.2	18.4	18.2	31.8	10.2	9.6	26.8	39.6	15.0	24.2	11.0	8.8	21.7	24.8	25.1	14.2	25.3	14.4	20.3	14.2	18.2	23.3	20.3	26.3	11.8	21.0	19.8	13.7	25.4	21.1	15.4	10.7	16.8	23.2	20.6	24.6	19.0	22.7	27.1	33.5	14.8	32.4	12.5	17.2	18.1	13.6	25.0	17.0	10.5	7.8	14.6	16.3	13.4	12.6	23.6	19.5	21.7	14.9	23.5	28.0	16.3	15.0	15.7	13.7	17.7	37.3	20.1	13.3	17.9	35.1	15.9	12.0	15.7	13.6	10.5	16.0	8.9	15.5	18.5	14.4	17.3	31.6	7.8	17.5	21.0	13.6	31.7	22.0	25.7	16.8	16.7	10.5	15.4	23.3	17.5	13.1	17.8	13.3	13.9	18.5	19.0	22.8	16.8	25.7	22.2	18.4	17.0	24.4	21.6	1.4	31.9	14.8	15.6	32.4	14.4	27.1	14.0	15.7	33.5	26.5	12.3	12.7	3.8	12.5	23.7	16.3	17.2	18.1	10.8	11.2	12.8	11.4	10.2	9.6	11.0	8.8	14.4	10.7
NUCB1	"Calnuc, NUC"	ENSG00000104805	"Nucleobindin 1"	Q02818	19	48900050-48923372	"Plasma proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008176	Supported		Supported	"Golgi apparatus,Microtubules"	"Secreted to blood"		15000000	"Golgi apparatus"	Microtubules	"HPA008176: AB_1845923"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.36e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.14e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.41e-1)"	49.5	32.2	18.1	30.5	20.2	19.3	50.1	17.9	36.0	31.0	42.5	24.8	32.5	51.6	36.7	46.8	33.1	30.7	47.2	58.8	16.8	20.3	56.7	144.7	42.6	48.4	20.5	25.2	40.0	37.4	42.7	21.3	46.9	29.1	36.6	15.3	31.0	37.8	29.7	46.7	26.0	51.8	36.7	20.7	32.4	33.4	19.0	15.9	17.1	48.0	29.0	23.2	36.4	58.2	19.1	42.3	39.2	47.7	24.4	40.2	40.1	10.1	32.9	15.8	34.0	57.4	44.4	18.2	39.3	34.7	19.1	26.9	16.5	36.8	9.8	29.9	47.8	24.1	9.0	19.2	8.1	35.7	16.4	25.5	23.4	21.3	27.8	15.4	33.9	52.2	8.5	18.2	12.1	29.3	31.0	52.3	18.6	12.1	7.4	9.6	7.8	17.1	13.9	23.7	20.6	14.1	24.2	11.3	23.4	45.9	28.4	15.6	14.5	20.3	44.1	32.4	22.1	20.0	18.5	39.5	90.7	6.7	24.9	9.7	37.9	31.6	39.6	37.6	40.2	47.7	30.4	19.1	27.3	30.5	29.9	15.5	22.9	22.7	39.2	24.4	40.7	42.3	27.0	40.1	18.1	20.2	17.9	36.0	16.8	20.3	20.5	25.2	29.1	15.9
NUCB2	NEFA	ENSG00000070081	"Nucleobindin 2"		11	17208153-17349980	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"salivary gland: 160.3"	"Cell line enhanced"	"Detected in all"		"HL-60: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA008395, CAB015931, CAB079781"	Approved	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	1245000		"Golgi apparatus"		"CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (8.27e-6)"	"unprognostic (5.24e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"prognostic favourable (1.98e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (3.94e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	10.2	13.9	9.5	7.5	13.1	66.4	17.9	13.5	7.5	18.3	7.8	3.8	79.5	6.6	11.4	59.6	29.7	13.7	7.3	25.0	7.5	10.9	10.8	51.1	12.5	13.5	8.5	7.6	15.4	92.8	58.9	69.7	35.8	10.3	13.4	8.3	5.8	160.3	104.9	7.2	4.2	6.8	11.3	9.4	9.8	11.4	18.7	6.1	86.1	22.7	17.7	10.4	12.1	11.0	3.7	71.7	28.8	7.6	45.2	49.5	20.1	12.1	5.1	5.6	17.1	12.8	17.6	6.9	27.2	39.6	12.2	21.7	5.0	2.8	18.7	6.8	25.8	5.2	3.5	6.9	19.1	12.9	8.0	13.8	6.4	8.6	37.0	187.4	25.4	7.6	9.2	8.8	21.5	14.9	11.9	38.0	12.0	10.7	66.0	67.8	1.3	5.3	24.4	13.8	1.5	5.4	3.8	6.7	3.8	11.9	12.0	6.0	9.8	51.0	13.3	13.0	12.0	39.2	11.5	7.5	4.0	10.4	15.0	66.2	11.1	28.8	7.6	27.6	17.1	5.0	22.3	3.7	16.3	31.5	6.9	2.4	46.0	49.5	7.0	45.2	4.0	71.7	7.0	20.1	9.5	13.1	13.5	7.5	7.5	10.9	8.5	7.6	10.3	6.1
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712819-205750276	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA062351: , HPA063843: "	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	25.6	25.3	46.9	17.3	55.5	12.1	31.3	45.0	49.2	33.0	24.2	38.3	18.8	12.5	36.5	27.8	25.3	32.1	22.5	40.6	43.8	35.6	30.9	43.9	20.6	29.4	43.6	47.6	49.1	17.4	50.3	21.0	20.8	32.8	31.9	21.1	21.9	19.0	32.7	43.1	21.7	14.6	42.9	49.1	22.6	17.9	14.2	38.9	35.3	42.5	20.6	24.8	32.0	22.6	7.8	7.4	4.5	4.9	10.7	11.8	4.0	40.6	25.0	67.4	26.6	18.7	25.9	31.8	29.3	30.3	41.2	33.3	13.7	46.9	45.1	17.0	28.5	30.1	51.2	24.6	47.4	21.5	25.6	29.3	22.1	14.9	13.8	46.0	10.5	20.5	22.3	24.5	42.7	32.2	47.0	14.5	32.1	47.0	41.7	23.2	68.8	18.7	43.6	83.1	25.9	23.1	25.1	28.1	51.9	43.3	34.7	23.5	53.0	34.8	32.1	31.7	28.2	36.1	51.8	13.3	15.7	36.4	21.7	26.0	42.6	4.5	3.4	3.7	9.9	4.9	9.6	5.8	9.2	8.6	4.7	7.8	11.5	11.8	0.6	10.7	4.0	7.4	5.5	4.0	46.9	55.5	45.0	36.6	43.8	35.6	43.6	47.6	32.8	38.9
NUDC	NudC	ENSG00000090273	"Nuclear distribution C, dynein complex regulator"	Q9Y266	1	26900238-26946862	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027183, HPA028105"	Enhanced		Enhanced	Cytosol			18000	Cytosol		"HPA027183: AB_10600086, HPA028105: AB_10601988"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.10e-2)"	30.7	57.9	49.9	25.8	44.9	31.8	30.9	40.1	59.0	30.5	35.7	32.0	31.7	25.8	30.0	53.0	26.6	69.2	28.2	41.8	39.3	41.0	28.2	46.8	26.4	27.3	39.6	49.7	34.5	44.7	36.7	32.3	29.2	38.6	34.2	23.7	25.0	35.0	43.9	65.6	30.8	22.9	39.0	32.9	29.2	36.6	41.4	35.9	30.0	36.8	24.8	29.5	37.6	84.4	73.7	69.0	63.1	62.8	57.9	71.8	64.8	42.5	44.6	23.4	32.5	18.7	16.9	26.6	34.2	21.1	46.1	34.1	40.8	29.8	35.8	30.3	23.4	33.5	49.7	45.1	35.7	27.7	51.6	44.5	45.4	69.9	33.1	46.8	32.9	18.1	29.5	55.5	35.9	33.8	63.3	20.2	31.1	36.9	47.0	60.7	61.5	57.9	49.4	29.7	36.5	39.2	16.9	39.1	29.3	37.2	23.8	30.1	23.1	29.0	33.3	33.0	39.4	41.2	43.8	40.5	63.7	43.2	35.6	66.3	37.0	63.1	60.3	57.5	69.1	62.8	69.7	72.0	70.4	65.3	59.8	73.7	70.0	71.8	41.0	57.9	60.0	69.0	66.5	64.8	49.9	44.9	40.1	59.0	39.3	41.0	39.6	49.7	38.6	35.9
NUDCD1	"CML66, FLJ14991"	ENSG00000120526	"NudC domain containing 1"	Q96RS6	8	109240919-109334385	"Predicted intracellular proteins"	Immunity	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023183	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023183: AB_1854695"	"unprognostic (5.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavourable (1.39e-5)"	"prognostic unfavourable (4.37e-5)"	"unprognostic (2.13e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (6.94e-4)"	"unprognostic (8.22e-2)"	"prognostic unfavourable (8.71e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	22.1	9.2	9.4	10.2	12.7	3.2	17.1	16.4	12.2	14.0	9.1	4.4	9.0	5.0	14.4	9.8	10.9	12.3	9.0	10.9	9.9	8.4	13.6	10.8	12.3	14.1	12.6	8.9	12.0	13.1	9.1	15.2	25.4	9.7	10.7	12.1	4.8	11.4	12.7	10.9	7.5	8.6	13.8	8.6	19.0	10.3	20.1	8.4	19.5	15.6	11.0	14.0	13.8	13.4	4.4	4.4	1.2	4.2	5.1	5.2	2.3	13.2	7.9	11.3	6.4	6.6	8.8	6.2	9.7	11.6	27.2	25.7	8.8	10.4	8.9	6.2	10.2	7.9	17.1	15.7	37.9	11.3	6.2	13.6	5.4	8.9	13.1	5.9	5.2	5.8	8.7	13.4	18.9	24.6	15.0	4.7	22.9	11.2	15.8	6.9	8.0	10.9	10.0	9.4	8.7	16.7	6.9	9.4	8.3	4.3	11.6	9.3	9.2	4.6	6.7	13.4	8.1	6.2	8.3	3.5	4.4	10.5	5.1	10.1	11.3	0.0	1.9	1.2	3.3	4.1	4.4	4.4	3.7	4.9	4.4	3.8	4.6	5.2	0.1	5.1	4.2	3.2	4.0	2.3	9.4	12.7	16.4	12.2	9.9	8.4	12.6	8.9	9.7	8.4
NUDT1	MTH1	ENSG00000106268	"Nudix hydrolase 1"	P36639	7	2242222-2251146	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012636	Approved		Supported	Cytosol				Cytosol		"HPA012636: AB_1854696"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (2.15e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (1.30e-7)"	"unprognostic (1.29e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.70e-1)"	8.8	3.9	7.4	12.6	13.4	37.1	10.8	5.0	10.8	5.9	9.0	8.7	2.2	9.1	8.2	9.2	13.1	6.0	8.1	11.3	8.7	4.7	4.1	2.9	7.2	18.9	8.2	7.0	4.8	4.0	0.7	1.8	5.8	7.2	7.2	6.3	4.0	5.5	4.2	12.0	18.8	9.3	10.5	11.9	11.1	5.5	26.7	5.3	30.7	4.1	14.4	17.2	6.8	8.1	18.3	59.5	11.9	21.3	10.1	20.4	13.0	21.5	34.8	19.1	25.3	7.0	9.7	14.0	9.5	8.3	13.1	15.3	18.7	16.3	22.8	7.8	10.4	26.4	14.5	14.5	7.7	10.1	24.7	17.8	29.3	15.8	1.7	13.8	18.0	6.4	3.8	18.9	6.7	7.0	14.0	25.5	14.5	55.0	25.7	53.8	41.0	21.5	35.9	28.4	19.1	7.1	12.2	19.2	26.6	9.8	28.9	4.4	19.1	36.7	6.5	12.6	48.1	29.0	22.6	19.7	14.9	23.6	12.7	34.4	45.2	9.0	17.5	11.9	12.9	21.3	10.2	18.3	15.1	13.6	26.6	18.0	15.1	13.1	4.6	10.1	17.4	59.5	20.4	13.0	7.4	13.4	5.0	10.8	8.7	4.7	8.2	7.0	7.2	5.3
NUDT15	"FLJ10956, MTH2"	ENSG00000136159	"Nudix hydrolase 15"	Q9NV35	13	48037567-48047222	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038968, HPA038969"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA038968: AB_10697402, HPA038969: "	"unprognostic (9.48e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.64e-2)"	"unprognostic (9.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.47e-3)"	"prognostic unfavourable (1.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-3)"	15.0	15.2	11.4	16.6	14.6	16.5	18.0	14.1	17.7	14.8	21.1	9.5	14.3	22.1	11.1	15.5	23.8	12.8	13.5	13.3	10.5	15.7	20.3	21.3	11.1	7.4	12.8	11.1	13.0	13.8	6.1	18.6	14.2	15.8	16.9	24.1	8.2	14.1	12.6	15.9	10.8	20.5	11.3	11.9	9.6	13.9	22.2	10.6	11.6	22.3	24.1	12.0	12.1	14.2	4.7	7.0	4.6	9.9	3.8	9.2	4.1	19.7	12.0	22.6	10.0	9.3	13.5	16.7	16.1	15.3	17.9	17.3	17.7	19.3	14.7	9.2	12.7	23.4	21.8	23.7	27.6	7.6	18.9	14.3	11.8	19.2	8.7	21.4	13.7	9.2	15.2	14.4	20.3	19.2	12.6	5.9	28.6	9.7	16.8	20.3	36.2	14.3	11.6	14.6	9.6	19.9	15.1	13.8	14.6	11.0	19.0	12.5	9.7	16.2	9.9	12.6	15.3	15.7	22.2	3.2	5.1	18.4	6.5	16.8	20.3	2.1	7.3	4.6	4.6	9.9	4.5	4.7	7.4	5.8	7.0	4.7	8.8	9.2	1.6	3.8	6.7	5.6	5.0	4.1	11.4	14.6	14.1	17.7	10.5	15.7	12.8	11.1	15.8	10.6
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5"					"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA060452: , HPA062492: "	"unprognostic (4.85e-3)"	"prognostic favourable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favourable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	25.9	13.4	22.1	13.1	22.0	8.7	13.1	13.5	20.5	11.1	32.8	23.9	13.9	20.2	11.7	11.6	8.7	14.0	13.6	22.2	21.1	19.6	25.9	23.1	16.2	31.1	27.7	16.9	23.0	18.3	32.9	9.7	7.6	20.1	13.4	18.4	13.6	11.7	13.6	20.3	6.8	37.5	18.5	30.4	22.2	13.8	9.5	21.6	2.2	17.1	11.5	9.1	12.4	8.4	4.3	13.6	18.8	24.5	3.7	4.3	6.7	12.7	6.8	11.2	5.8	22.6	20.5	5.2	10.4	9.6	7.0	7.3	10.4	5.7	2.1	9.1	9.6	9.3	9.9	6.5	11.3	6.3	7.2	5.4	8.7	10.0	14.5	9.1	9.9	18.3	5.8	4.6	12.7	10.9	6.1	11.1	6.8	13.2	0.0	2.4	8.7	10.1	7.1	8.1	16.0	7.0	10.3	5.5	9.7	6.2	6.3	9.5	13.8	7.2	10.7	11.5	5.0	21.0	8.0	11.0	10.8	0.3	7.4	7.0	6.3	2.2	18.2	18.8	2.6	21.9	2.7	4.3	2.7	2.4	13.6	4.2	2.4	2.4	14.6	3.7	24.5	1.8	4.3	6.7	22.1	22.0	13.5	20.5	21.1	19.6	27.7	16.9	20.1	21.6
NUDT18	"FLJ22494, MTH3"	ENSG00000275074	"Nudix hydrolase 18"	Q6ZVK8	8	22106872-22109419	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028581, HPA030125"	Approved		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA028581: AB_10601381, HPA030125: "	"unprognostic (9.90e-3)"	"prognostic favourable (1.43e-4)"	"unprognostic (4.88e-3)"	"prognostic favourable (2.49e-6)"	"unprognostic (1.29e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.67e-1)"	"prognostic favourable (2.47e-4)"	"unprognostic (1.43e-1)"	"prognostic favourable (8.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.32e-1)"	3.6	2.7	2.9	4.4	6.4	2.9	3.6	5.3	6.8	2.0	6.1	4.3	5.4	5.3	1.6	11.9	3.7	4.3	3.8	2.5	1.7		2.9	2.9	4.5	6.3	3.2	3.3	1.2	8.6	2.1	5.2	1.8	3.7	3.6	3.8	3.8	5.6	11.0	1.0	3.6	5.4	2.7	2.5	6.0	5.6	2.8	3.4	7.1	5.0	2.3	5.8	3.2	0.0	3.6	3.6	5.0	3.2	7.8	4.7	1.5	6.9	14.8	0.5	3.2	11.8	4.4	8.1	4.1	11.4	5.6	6.4	3.5	5.6	5.2	6.7	5.0	12.2	2.1	6.9	1.9	6.4	2.0	4.4	4.2	3.4	7.7	1.3	13.8	8.0	6.5	2.3	5.8	7.0	3.2	8.8	5.3	7.3	5.8	3.9	0.8	3.6	2.6	1.3	5.6	8.1	6.1	1.6	2.5	3.0	3.6	3.6	8.4	7.4	5.6	3.6	2.0	4.8	2.1	3.9	0.4	1.7	6.3	4.0	8.8	0.1	2.9	5.0	4.7	3.2	4.3	2.6	3.7	2.7	2.0	3.6	4.0	2.2	0.7	7.8	2.3	3.6	1.4	1.5										
NUDT2	APAH1	ENSG00000164978	"Nudix hydrolase 2"	P50583	9	34329506-34343713	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004684, HPA044903, HPA058623, HPA067639"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004684: AB_425306, HPA044903: , HPA058623: , HPA067639: "	"unprognostic (2.74e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.91e-1)"	12.0	18.0	21.6	9.6	21.9	10.2	20.6	14.0	25.5	14.9	14.9	26.0	15.4	12.8	15.7	30.2	14.5	20.5	12.3	16.0	17.3	18.6	10.7	17.5	11.2	12.2	19.5	19.0	28.3	20.9	12.0	19.0	14.1	20.5	16.5	15.3	15.7	16.1	13.0	30.8	13.9	10.1	14.7	20.7	11.3	13.0	8.6	19.1	18.6	3.8	13.2	13.8	14.4	12.1	16.6	15.8	14.3	12.2	14.3	22.2	11.2	23.6	9.8	12.7	4.5	8.8	16.2	9.2	11.4	25.9	13.3	13.9	6.7	11.2	6.6	9.5	14.2	10.4	11.5	28.2	13.5	24.6	10.3	14.2	18.4	12.5	25.4	10.9	5.8	16.3	18.2	17.1	32.2	27.3	4.0	26.9	19.3	14.7	11.3	10.3	7.8	28.1	14.7	7.9	16.6	13.0	7.7	2.6	10.4	18.5	7.0	10.7	5.7	11.8	17.6	11.5	10.3	7.5	11.9	6.1	9.8	11.6	14.3	10.5	14.2	14.3	12.2	9.7	11.7	10.3	16.7	16.6	19.2	15.2	15.8	15.0	22.2	19.6	4.5	14.3	10.7	14.7	19.7	11.2	21.6	21.9	14.0	25.5	17.3	18.6	19.5	19.0	20.5	19.1
NUDT21	"CFIM25, CPSF5"	ENSG00000167005	"Nudix hydrolase 21"	O43809	16	56429133-56452199	"Predicted intracellular proteins"	"Differentiation, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019863, HPA074228"	Uncertain		Supported	"Nuclear bodies,Centriolar satellite"				"Nuclear bodies"	"Centriolar satellite"	"HPA019863: , HPA074228: "	"unprognostic (4.95e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.80e-3)"	"unprognostic (6.87e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	26.8	33.0	31.6	33.3	36.0	41.9	31.9	41.7	58.2	32.6	29.4	24.5	21.7	37.7	30.7	22.4	36.6	28.8	22.2	28.9	31.8	39.1	33.6	27.7	23.0	40.8	30.3	38.9	44.9	33.2	34.5	31.2	29.0	34.8	23.8	31.6	24.1	26.1	34.5	27.6	25.6	25.8	27.1	30.2	26.1	25.7	54.0	20.9	46.4	29.3	29.0	47.9	28.9	26.7	17.2	18.9	23.1	19.8	17.5	35.8	15.7	32.2	18.2	33.9	27.2	18.8	26.7	30.9	22.3	26.1	32.1	22.5	38.3	33.9	44.0	23.4	20.7	30.1	44.1	26.9	48.9	15.1	18.3	28.7	17.6	32.9	15.4	41.0	29.5	15.7	19.5	26.8	19.0	29.5	30.5	16.1	25.8	19.9	43.6	29.2	41.8	30.9	64.6	46.2	37.3	22.2	27.9	38.2	25.2	42.8	20.6	17.7	25.0	24.5	17.2	25.5	36.4	21.9	23.9	24.3	26.1	82.8	16.9	26.8	23.2	19.4	18.1	23.1	21.8	19.1	21.7	17.2	23.5	20.4	18.9	16.5	22.0	21.6	20.8	17.5	19.8	14.8	35.8	15.7	31.6	36.0	41.7	58.2	31.8	39.1	30.3	38.9	34.8	20.9
NUDT22	MGC13045	ENSG00000149761	"Nudix hydrolase 22"	Q9BRQ3	11	64225941-64230686	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039334, HPA053464"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA039334: AB_10795174, HPA053464: "	"unprognostic (2.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.61e-2)"	"prognostic favourable (2.18e-6)"	"unprognostic (1.76e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.54e-2)"	9.2	16.8	8.1	16.0	9.2	14.3	9.8	7.3	12.8	9.2	24.2	9.1	30.9	29.6	9.1	16.9	17.8	9.0	16.7	23.4	8.3	7.0	21.1	30.1	10.2	15.9	10.5	8.4	7.9	26.4	13.8	12.2	14.7	8.6	12.3	8.5	9.0	28.6	35.2	24.9	12.9	23.7	11.4	7.8	20.5	18.5	7.8	7.7	19.5	15.4	15.7	19.6	13.5	9.4	30.0	49.1	20.0	33.9	19.2	25.0	20.1	14.5	9.3	2.3	9.7	3.6	4.4	8.9	6.1	6.4	4.4	4.1	6.0	12.4	6.9	16.3	6.1	15.2	1.4	9.7	0.6	8.8	3.9	9.3	6.8	6.3	10.7	6.0	15.4	6.7	7.3	4.7	5.0	7.2	4.5	7.6	5.2	21.8	8.3	11.1	3.7	19.7	10.2	3.9	25.6	7.7	8.1	5.4	8.6	5.4	20.6	24.5	21.0	6.8	6.7	7.5	7.1	23.5	5.2	28.5	11.3	4.3	25.7	7.0	8.7	13.8	28.7	20.0	23.0	33.9	20.5	25.3	20.3	22.4	29.1	30.0	18.0	19.6	17.3	19.2	31.8	49.1	25.0	20.1	8.1	9.2	7.3	12.8	8.3	7.0	10.5	8.4	8.6	7.7
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2, NDC80 kinetochore complex component"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.6;testis: 29.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059692, HPA076604"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA059692: , HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (1.04e-5)"	"prognostic unfavourable (9.16e-4)"	"prognostic unfavourable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavourable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	1.3	0.9	0.8	9.8	0.9	14.1	0.6	0.5	0.9	1.4	2.5	0.6	0.9	2.3	0.6	2.1	6.1	0.5	0.7	1.5	0.8	0.6	0.7	0.6	1.9	9.9	0.8	0.6	0.7	0.4	0.3	0.4	3.6	0.7	0.6	2.9	0.8	1.3	0.0	0.5	2.2	3.2	1.0	1.4	4.4	1.6	29.0	0.3	38.6	0.5	5.1	9.2	1.5	1.8	1.4	0.6	2.6	0.2	3.0	7.7	1.0	25.9	9.0	24.1	10.1	0.7	2.5	13.1	16.4	11.6	26.8	23.5	6.9	23.0	22.4	13.7	6.6	15.2	14.7	6.2	33.9	23.3	10.5	8.7	10.4	9.9	0.0	15.1	18.1	0.3	0.6	13.5	9.6	12.1	16.4	31.0	25.3	5.0	27.5	20.2	13.1	14.0	18.7	21.1	19.8	7.5	3.6	18.0	20.8	8.8	9.6	9.1	14.7	31.6	8.5	20.0	22.5	15.0	33.1	22.3	31.3	42.6	6.6	12.4	22.1	2.6	0.2	2.5	2.4	0.1	1.0	1.2	3.6	2.4	0.5	1.4	2.5	2.1	0.9	3.0	0.2	0.6	7.7	1.0	0.8	0.9	0.5	0.9	0.8	0.6	0.8	0.6	0.7	0.3
NUFIP1	NUFIP	ENSG00000083635	"NUFIP1, FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989483	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	8.9	9.8	10.4	10.7	16.4	17.4	11.6	11.0	17.2	9.8	7.8	10.8	4.8	7.1	11.7	14.4	9.2	9.2	6.3	6.4	12.7	9.6	10.2	13.7	11.2	8.5	8.9	12.6	13.7	11.5	9.3	9.6	7.7	7.9	9.1	7.9	6.3	8.6	8.8	17.0	10.1	6.4	10.3	10.0	8.4	8.6	14.1	8.8	11.4	10.1	6.8	9.3	8.9	8.3	6.6	6.3	1.1	3.7	8.3	6.9	2.5	5.4	4.3	7.3	6.0	5.0	5.2	8.7	6.4	5.6	12.0	7.7	11.5	8.7	15.9	5.4	6.0	8.6	13.5	9.1	15.7	4.8	10.6	12.1	2.9	10.3	8.3	15.5	4.9	5.4	8.5	8.1	12.3	5.9	9.6	2.7	8.4	6.2	12.8	9.8	17.2	7.1	12.7	6.9	9.7	7.2	4.7	4.0	8.9	5.5	7.6	6.9	5.7	8.7	4.5	6.2	5.3	7.9	8.8	3.7	5.7	20.0	6.9	11.0	8.6	0.0	3.7	1.1	3.9	3.7	6.9	5.9	4.3	4.1	4.7	6.6	6.8	5.1	0.2	8.3	2.3	6.3	2.4	2.5	10.4	16.4	11.0	17.2	12.7	9.6	8.9	12.6	7.9	8.8
NUFIP2	"182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1"	ENSG00000108256	"NUFIP2, FMR1 interacting protein 2"	Q7Z417	17	29255836-29294118	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067443			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA067443: "	"unprognostic (6.51e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.04e-3)"	21.6	20.6	25.0	25.4	28.6	83.5	25.1	38.8	39.0	17.3	18.0	15.5	17.4	19.6	17.8	15.9	27.1	17.0	17.7	21.8	24.1	15.6	16.9	28.9	31.5	22.2	24.2	15.5	20.0	19.8	26.2	40.8	44.4	28.9	18.4	16.6	13.9	25.4	27.5	43.7	17.9	20.3	13.3	30.5	24.6	22.0	17.0	27.2	18.3	20.2	15.6	22.9	19.0	42.6	6.9	9.8	21.2	6.9	4.1	6.1	1.6	15.0	24.6	14.4	10.0	12.5	14.6	24.2	15.0	9.1	11.6	10.7	27.1	8.3	24.5	22.5	10.3	21.4	11.5	10.5	14.8	26.2	20.6	18.5	22.4	7.0	11.5	23.5	20.1	12.6	12.9	12.7	13.8	8.5	30.1	18.3	11.8	12.5	24.7	10.7	14.8	9.1	20.3	24.8	10.5	9.7	24.7	13.9	8.8	26.9	50.6	16.4	17.4	15.9	13.9	22.3	22.3	12.9	25.6	25.6	23.5	28.4	14.7	12.6	18.9	8.8	5.2	6.2	4.9	5.0	3.7	6.8	4.7	5.2	4.1	6.9	6.1	5.0	21.2	4.1	6.9	9.8	2.4	1.6	25.0	28.6	38.8	39.0	24.1	15.6	24.2	15.5	28.9	27.2
NUMA1		ENSG00000137497	"Nuclear mitotic apparatus protein 1"	Q14980	11	72002864-72080693	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019841, HPA019859, HPA029912"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811"	"unprognostic (1.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"prognostic favourable (7.92e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.39e-1)"	29.7	33.5	23.6	20.6	28.1	26.8	33.1	38.4	31.8	51.9	37.7	55.6	40.1	25.5	58.3	30.9	34.1	37.8	31.2	21.2	21.6	19.4	23.0	13.1	28.3	23.3	37.6	24.8	51.4	30.0	70.7	29.5	26.0	28.3	50.3	24.2	41.2	35.3	40.1	43.7	41.9	30.2	45.3	29.5	23.0	31.2	25.9	39.5	39.4	32.6	22.5	31.8	50.5	37.2	10.3	12.9	4.9	5.7	7.0	9.7	6.6	18.5	23.6	29.6	19.9	26.3	27.5	15.1	25.1	29.1	26.2	22.9	24.5	34.4	25.3	22.0	30.7	39.9	27.0	25.4	24.0	26.0	12.7	31.0	37.1	18.6	21.2	23.4	22.6	29.0	16.8	25.6	25.9	22.1	18.2	30.6	17.8	35.8	30.2	13.1	18.4	17.0	37.1	51.6	19.5	19.6	29.1	35.8	50.8	40.0	37.1	37.3	49.9	13.7	30.4	27.8	21.7	39.2	16.6	19.8	19.6	35.6	18.6	11.1	15.8	4.9	5.6	2.5	9.7	3.5	7.4	5.2	6.0	7.5	4.9	10.3	7.5	5.2	4.6	7.0	5.7	12.9	7.2	6.6	23.6	28.1	38.4	31.8	21.6	19.4	37.6	24.8	28.3	39.5
NUMB	C14orf41	ENSG00000133961	"NUMB, endocytic adaptor protein"	P49757	14	73275107-73458617	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 64.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002874, CAB011478"	Approved		Enhanced	"Cell Junctions"				"Cell Junctions"		"CAB011478: AB_443023, HPA002874: "	"unprognostic (5.28e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.14e-2)"	"prognostic favourable (2.32e-6)"	"unprognostic (9.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.87e-1)"	27.3	21.5	26.2	24.5	23.5	21.3	26.4	37.1	27.0	24.2	35.9	17.3	26.1	31.3	30.8	23.9	30.1	28.8	28.8	23.3	23.3	14.1	30.3	35.5	40.5	23.0	18.9	20.7	29.2	26.8	31.8	28.3	29.9	23.4	23.7	29.4	22.3	34.2	23.9	16.4	24.6	45.3	38.0	26.1	32.9	25.1	19.0	19.8	20.1	27.7	17.0	26.2	30.5	26.9	5.2	15.2	64.9	20.9	2.7	3.8	11.6	20.9	14.4	10.4	9.4	21.1	32.2	14.2	19.9	27.0	16.1	17.2	17.4	26.5	9.6	12.5	24.6	13.9	12.3	20.5	24.5	14.7	6.9	7.7	9.5	11.2	22.4	7.0	18.1	17.9	22.1	39.6	23.7	34.7	13.9	11.6	20.3	18.9	12.8	9.8	4.8	15.5	8.3	14.5	6.4	22.3	32.2	4.3	11.2	24.9	16.9	10.1	25.3	10.4	33.2	24.2	13.6	15.5	8.5	9.7	11.2	8.8	48.6	8.3	10.6	16.3	19.8	20.8	3.0	17.1	3.1	5.2	3.0	3.3	15.2	5.1	3.1	2.8	64.9	2.7	20.9	2.8	3.8	11.6	26.2	23.5	37.1	27.0	23.3	14.1	18.9	20.7	23.4	19.8
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440260-229508341	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA059767: "	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	20.6	20.0	17.4	16.3	21.6	16.2	25.4	29.8	24.0	19.6	17.7	27.2	15.5	13.2	23.0	18.4	18.5	22.2	13.5	22.7	17.6	17.0	19.5	15.6	19.8	27.8	20.9	20.3	27.3	17.8	33.3	23.3	23.0	20.6	19.1	18.3	15.5	17.8	21.2	28.6	21.8	16.2	20.9	19.4	19.1	17.1	19.4	20.9	38.0	21.7	18.0	22.8	20.2	17.9	9.0	10.5	7.5	13.6	7.6	10.9	7.3	14.2	11.5	18.0	9.3	13.0	14.0	35.1	11.8	12.1	17.6	16.0	13.6	14.1	20.7	10.3	11.7	18.9	24.9	12.5	19.0	12.5	30.9	12.5	11.9	10.2	10.4	25.3	10.2	10.9	9.5	12.6	15.2	14.7	28.1	10.0	13.8	6.4	18.7	10.8	27.0	10.5	18.3	18.7	20.4	10.0	12.6	15.5	19.3	17.6	11.1	12.9	17.2	20.1	12.8	8.0	9.8	13.9	17.5	9.6	11.9	22.3	9.2	14.7	16.6	7.5	8.2	6.1	8.8	8.2	10.9	9.0	9.3	9.7	10.5	7.1	9.6	10.0	2.9	7.6	13.6	6.0	8.6	7.3	17.4	21.6	29.8	23.4	17.6	17.0	20.9	20.3	20.6	20.9
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706834	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898"	Supported		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682"	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	20.2	14.0	13.8	22.2	15.3	37.5	19.0	24.7	14.9	17.8	15.2	14.4	18.9	9.8	19.7	16.0	21.6	17.8	15.6	15.1	12.3	10.2	13.4	22.9	17.7	21.6	12.2	10.5	21.0	15.1	23.3	17.3	29.2	12.6	15.1	13.4	12.4	16.3	19.9	30.7	19.9	16.3	16.0	11.0	18.7	15.0	26.8	13.8	34.4	15.9	18.9	26.4	18.4	21.1	3.9	3.5	6.5	3.3	5.5	7.6	2.2	19.3	9.7	21.6	18.7	9.6	11.3	21.0	15.2	14.5	23.2	25.0	16.2	9.1	36.9	25.5	13.8	14.2	25.2	15.0	37.7	19.3	18.8	19.7	10.8	16.8	7.1	28.4	18.4	11.9	12.2	24.3	17.7	13.7	45.7	11.9	15.6	10.4	21.0	17.3	16.7	10.6	27.9	27.6	34.6	10.3	19.2	23.9	13.8	13.0	21.5	13.0	13.9	10.4	12.5	23.7	13.3	11.1	23.6	15.1	21.7	37.2	5.8	13.2	27.8	2.4	2.5	5.5	5.9	2.4	7.6	3.6	7.1	6.8	3.5	3.9	4.4	4.3	6.5	5.5	3.3	2.0	3.1	2.2	13.8	15.3	24.7	14.9	12.3	10.2	12.2	10.5	12.6	13.8
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371181	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"lymphoid tissue: 20.4;testis: 70.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"			"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	6.8	5.3	3.9	6.5	5.9	11.2	7.3	6.9	7.5	6.4	5.1	5.9	3.4	4.4	9.7	3.7	6.9	5.0	3.7	4.7	3.9	4.1	4.4	5.3	5.1	8.1	3.8	4.2	7.9	5.5	8.1	7.0	8.4	5.2	5.5	6.3	5.9	6.0	5.9	6.1	8.1	5.0	5.9	3.9	7.2	4.9	70.1	2.5	20.4	5.4	4.8	9.8	5.8	6.0	7.3	4.9	7.1	7.1	7.7	10.0	4.4	13.6	10.8	11.8	17.4	3.7	5.5	42.5	11.1	5.9	15.2	11.2	15.9	11.2	15.5	5.1	7.1	11.1	19.9	10.9	23.9	10.2	11.2	12.0	39.6	7.4	4.7	20.0	8.5	4.0	4.6	23.4	11.9	8.0	21.8	8.3	10.1	6.7	10.7	5.4	11.2	9.9	12.9	37.3	12.3	3.5	13.1	14.3	9.8	25.5	11.0	6.4	13.5	8.0	6.9	18.3	15.4	13.8	16.8	9.4	15.7	20.8	8.5	18.1	13.8	7.1	3.4	5.8	6.1	7.1	10.0	7.3	5.7	5.3	4.9	5.8	5.8	6.5	1.3	7.7	5.0	3.4	4.1	4.4	3.9	5.9	6.9	7.5	3.9	4.1	3.8	4.2	5.2	2.5
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"				"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favourable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	8.8	10.9	9.1	13.7	21.4	4.1	15.3	18.9	12.6	9.2	8.6	5.6	5.8	7.3	9.6	9.0	11.7	10.6	9.1	7.9	11.1	6.8	11.9	16.4	9.5	9.3	11.5	5.1	13.1	17.2	8.9	13.1	9.0	8.8	9.3	10.7	7.3	9.7	9.6	9.1	10.9	7.1	10.5	7.6	7.8	9.3	25.8	9.7	19.1	10.3	12.6	12.7	8.0	10.2	8.9	3.8	1.7	6.8	5.9	10.5	5.0	9.9	10.7	16.8	9.9	6.1	5.9	12.2	12.1	9.8	18.3	17.5	19.7	12.2	17.1	11.3	6.3	8.7	23.0	13.4	29.6	15.2	15.3	16.0	9.0	21.0	4.6	11.6	10.9	4.3	7.1	15.5	14.9	10.7	14.4	12.6	13.9	11.6	13.4	13.8	28.5	33.3	16.4	13.2	12.1	16.8	12.3	14.8	10.4	11.2	13.1	12.7	8.5	8.1	5.6	14.4	10.2	11.6	13.4	8.5	18.4	18.1	9.8	8.5	19.3	0.0	4.8	1.7	6.1	6.3	10.5	8.9	7.8	7.5	3.8	7.9	9.6	8.4	0.1	5.9	6.8	3.6	7.7	5.0	9.1	21.4	18.9	12.6	11.1	6.8	11.5	5.1	8.8	9.7
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163841-45188015	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	9.0	12.0	8.0	12.3	9.3	26.4	12.8	11.3	11.4	8.7	13.2	6.6	15.8	9.0	9.1	11.0	18.1	10.4	8.0	5.3	7.4	8.6	10.8	13.6	10.4	17.6	7.1	8.4	9.9	11.7	8.2	16.1	12.9	16.8	11.9	9.6	8.2	11.3	15.0	6.5	10.8	18.1	6.2	6.3	19.3	13.4	20.0	7.5	41.3	12.2	5.5	19.5	10.7	15.3	8.2	10.3	37.6	16.2	11.8	12.5	12.3	24.0	11.5	22.2	14.4	10.4	10.9	23.6	20.2	13.5	15.6	15.9	24.9	10.7	26.4	9.5	13.2	17.0	27.2	16.4	22.6	14.1	28.8	23.1	18.1	15.2	10.8	61.0	24.6	13.1	11.4	20.0	15.2	17.2	23.9	27.8	16.0	16.1	27.6	15.8	16.5	11.9	29.4	13.4	18.5	12.1	23.4	13.8	13.4	20.0	12.5	23.7	7.7	16.2	15.6	33.2	29.9	17.0	16.9	19.5	15.7	38.8	12.5	15.8	23.0	19.7	15.7	31.0	8.8	16.2	12.0	8.2	10.6	10.0	10.3	7.4	12.5	8.5	37.6	11.8	9.2	5.7	10.1	12.3	8.0	9.3	11.3	11.4	7.4	8.6	7.1	8.4	16.8	7.5
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.1	25.7	15.8	29.1	18.5	19.8	16.1	28.3	21.7	18.2	17.1	21.0	13.4	20.0	24.1	13.7	21.5	22.1	20.9	16.9	14.3	15.1	16.8	27.5	16.2	29.0	15.2	14.2	26.6	18.6	14.0	21.3	24.1	17.4	19.8	17.7	16.2	18.8	20.2	27.1	18.8	20.2	23.3	14.2	26.0	16.4	70.9	17.6	45.5	16.8	17.3	29.6	18.9	19.4	10.7	21.1	6.2	22.3	13.7	16.9	12.5	31.5	30.1	22.3	18.9	7.0	8.0	20.8	23.9	16.4	25.2	25.2	20.2	18.6	35.5	13.1	15.2	18.8	27.1	16.6	24.5	51.4	28.9	28.5	15.1	18.7	8.4	26.1	28.5	8.2	11.5	16.7	13.9	18.5	34.8	34.8	17.2	15.2	47.3	20.0	21.1	26.7	42.7	26.0	30.2	12.1	24.5	24.9	17.7	22.8	26.1	11.9	21.2	13.4	14.3	39.7	23.3	12.8	38.8	25.2	68.7	32.7	16.4	22.9	29.5	6.2	20.7	4.2	12.0	22.3	16.9	10.6	12.0	13.2	21.1	10.7	8.2	10.5	3.3	13.7	11.8	18.3	10.7	12.5	15.8	18.5	28.3	21.7	14.3	15.1	15.2	14.2	17.4	17.6
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA061910: , HPA062595: "	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	21.6	12.9	13.7	22.1	14.2	17.9	19.1	43.0	17.9	17.1	17.2	17.2	12.5	16.1	24.1	16.9	19.6	19.0	15.8	14.7	12.7	8.8	14.9	19.8	17.5	25.4	17.5	12.7	21.4	18.5	12.0	13.5	18.8	13.9	17.3	21.8	15.3	16.8	16.3	17.0	23.5	18.4	20.1	15.6	24.6	16.1	24.5	14.1	28.5	17.8	14.0	26.2	15.8	18.2	17.1	19.0	17.6	20.8	12.6	20.5	13.5	22.3	25.4	18.7	12.9	7.2	11.3	26.1	16.2	12.9	38.1	35.9	21.7	21.5	20.6	9.4	13.9	19.3	30.5	17.2	34.0	6.4	24.7	17.1	29.3	19.0	5.9	17.6	14.4	10.8	10.6	26.6	11.6	29.2	21.0	13.3	18.5	24.6	33.0	21.7	14.0	23.4	23.1	40.5	18.7	14.5	16.3	14.2	13.6	20.0	25.7	14.2	29.0	20.1	10.7	28.6	26.5	18.3	25.7	8.2	6.8	26.4	14.7	16.1	17.5	5.2	20.8	17.6	14.6	18.1	20.5	14.2	15.7	14.0	17.1	17.1	15.5	11.8	6.7	12.6	12.9	19.0	13.3	13.5	13.7	14.2	43.0	17.9	12.7	8.8	17.5	12.7	13.9	14.1
NUP98	NUP96	ENSG00000110713	"Nucleoporin 98"	P52948	11	3671083-3797792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074810			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA074810: "	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.08e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	20.2	13.5	8.7	23.5	11.7	40.8	23.5	14.2	13.2	18.0	15.3	14.6	17.8	11.2	19.2	17.5	18.6	17.3	17.1	18.2	7.8	8.0	12.8	20.1	20.7	17.4	11.4	8.7	25.5	19.0	25.7	23.6	20.7	12.7	18.6	15.2	17.8	17.4	25.0	35.2	18.5	15.7	20.8	10.4	18.3	16.0	57.0	10.6	27.5	20.9	15.0	26.6	22.6	19.3	8.9	9.9	24.9	10.0	6.1	13.2	8.7	29.8	23.4	19.3	21.3	21.4	17.6	17.0	21.3	24.9	29.3	26.4	25.7	37.1	29.2	10.1	25.5	32.2	33.9	21.0	40.0	20.7	24.5	31.3	19.2	17.6	18.0	39.9	26.4	20.0	14.5	16.1	29.4	22.7	38.9	23.5	31.1	12.2	40.1	13.0	24.4	18.0	24.5	23.5	14.0	16.7	23.6	17.8	11.9	30.9	25.1	14.2	15.4	15.7	16.6	23.5	20.4	25.6	19.4	14.2	24.2	31.0	15.9	17.2	24.7	19.1	7.9	15.5	11.0	10.0	11.0	8.9	10.7	9.7	9.9	7.8	12.2	10.5	24.9	6.1	6.3	2.7	13.2	8.7	8.7	11.7	14.2	13.2	7.8	8.0	11.4	8.7	12.7	10.6
NUPL2	"CG1, H_RG271G13.9, hCG1, NLP_1"	ENSG00000136243	"Nucleoporin like 2"	O15504	7	23181827-23201011	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049036, HPA057251"			Supported	Nucleoplasm				Nucleoplasm		"HPA049036: , HPA057251: "	"unprognostic (3.81e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-2)"	13.3	21.1	19.4	27.0	17.1	23.3	14.4	25.9	30.4	15.4	16.4	12.3	26.8	15.4	19.5	26.5	17.9	17.7	18.7	24.3	16.1	16.1	17.8	16.2	14.7	23.2	14.9	19.9	16.7	14.6	22.3	19.7	10.8	15.2	16.5	16.9	12.5	20.3	20.8	16.9	21.6	14.9	19.1	14.6	20.1	15.2	32.2	16.9	19.7	20.8	16.8	19.6	17.7	16.7	16.4	13.8	22.9	8.7	13.9	12.3	9.8	12.0	6.9	8.9	16.9	8.8	11.3	6.5	10.0	7.5	10.7	11.3	8.9	13.5	20.3	8.9	6.9	14.6	15.4	8.7	13.4	5.8	16.3	14.0	14.8	8.9	11.0	28.5	17.1	5.5	10.6	10.2	6.6	11.2	23.6	14.4	10.7	3.5	13.6	16.6	17.0	10.0	12.5	8.0	15.2	11.8	9.2	11.9	11.4	10.6	5.6	15.5	7.0	31.2	11.4	7.8	9.8	13.3	16.1	18.9	28.5	22.3	7.3	21.4	17.7	22.9	8.7	7.6	11.4	8.4	10.2	16.4	12.2	11.3	11.5	14.0	11.5	12.3	8.5	13.9	7.1	13.8	12.3	9.8	19.4	17.1	25.9	30.4	16.1	16.1	14.9	19.9	15.2	16.9
NUPR1	"COM1, p8"	ENSG00000176046	"Nuclear protein 1, transcriptional regulator"	O60356	16	28532708-28539174	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 297.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 50.0;hTCEpi: 82.5;SK-MEL-30: 59.0;T-47d: 35.1;U-87 MG: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 11.5;eosinophil: 4.2;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006349			Supported	Nucleoplasm				Nucleoplasm		"HPA006349: "	"unprognostic (2.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.72e-3)"	"unprognostic (5.77e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.80e-2)"	26.9	38.6	13.1	8.9	20.0	1.7	24.4	13.4	10.1	30.0	28.6	10.4	114.1	4.5	19.9	36.6	31.2	16.5	19.3	16.2	14.8	12.2	19.3	47.1	33.7	7.5	20.5	8.2	41.0	297.9	2.2	5.8	16.1	23.1	46.5	16.5	23.5	89.5	128.3	22.2	27.5	8.9	35.3	23.9	7.6	17.4	18.6	17.6	4.2	146.4	14.4	11.5	47.9	79.1	0.8	0.8	11.5	0.6	1.1	0.5	0.1	0.2	1.6	0.0	12.9	19.3	17.0	10.1	11.3	9.8	0.4	9.1	0.0	0.0	0.0	6.2	17.3	0.3	0.0	0.3	0.3	0.0	0.5	0.0	0.7	8.1	50.0	0.0	0.0	16.1	82.5	5.3	23.6	0.0	0.0	0.5	5.6	2.3	0.0	0.2	0.0	6.3	0.0	0.0	0.4	0.0	1.1	0.1	0.0	3.2	13.5	59.0	35.1	1.9	0.0	3.7	9.0	9.6	1.6	0.0	0.0	0.0	31.4	0.0	0.4	11.5	0.6	4.2	0.4	0.4	0.5	0.4	0.4	0.3	0.2	0.8	0.5	0.5	3.1	1.1	0.5	0.8	0.3	0.1	13.1	20.0	13.4	10.1	14.8	12.2	20.5	8.2	23.1	17.6
NUSAP1	"ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41332694-41381050	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 38.3;lymphoid tissue: 123.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.3"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042904, HPA074847"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA042904: , HPA074847: "	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavourable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	3.2	12.9	0.7	20.3	1.3	38.3	3.8	0.7	0.9	2.9	5.4	1.1	4.4	5.8	1.5	2.8	16.1	0.9	2.5	2.7	0.7	0.7	2.5	4.2	5.7	16.5	0.9	0.5	4.2	3.0	0.0	0.6	9.2	0.9	1.8	6.5	0.8	3.6	5.6	4.4	6.0	6.3	2.2	1.2	7.4	4.1	8.6	0.6	123.4	0.8	9.7	19.4	2.9	5.3	2.7	3.1	6.4	1.4	1.7	16.3	3.1	37.0	12.4	41.3	19.6	2.2	3.6	13.7	29.6	17.5	32.7	31.7	16.8	19.3	19.2	16.5	11.1	35.7	31.8	14.5	31.4	34.4	15.6	48.7	30.9	15.8	0.6	31.0	21.9	1.0	1.7	17.4	13.4	19.6	26.7	65.4	25.3	9.8	38.3	20.8	21.2	15.4	41.4	44.1	20.7	11.7	11.6	29.9	20.5	40.8	24.0	8.5	36.1	23.0	11.8	25.4	31.9	28.7	52.1	24.3	47.1	61.4	13.3	46.6	43.6	6.4	1.4	4.4	0.7	0.9	0.4	2.7	3.5	2.6	3.1	2.1	0.2	1.9	0.8	1.7	1.2	2.9	16.3	3.1	0.7	1.3	0.7	0.9	0.7	0.7	0.9	0.5	0.9	0.6
NVL	NVL2	ENSG00000143748	"Nuclear VCP-like"	O15381	1	224227334-224330387	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli				Nucleoli		"HPA028207: AB_10601382, HPA028219: , HPA028224: , HPA028654: "	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (5.77e-5)"	"prognostic favourable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	11.3	12.6	13.3	14.3	12.6	12.5	16.2	24.4	15.7	14.2	13.8	16.9	11.4	9.0	17.1	12.2	11.6	13.5	8.5	9.8	10.4	9.9	13.6	9.4	11.8	16.9	10.5	10.8	16.9	19.3	16.8	20.7	25.8	13.4	14.2	16.0	16.5	11.6	12.6	9.8	22.7	12.5	17.5	13.3	16.4	11.1	9.4	12.0	23.8	15.5	8.5	19.1	14.4	13.7	14.0	9.9	12.5	15.2	12.3	13.5	7.9	14.5	8.3	17.3	13.8	6.5	9.3	17.4	12.4	8.7	16.4	15.1	12.6	12.5	20.3	13.4	7.9	13.8	18.8	11.6	17.9	15.8	25.9	9.7	14.1	6.4	11.2	19.1	15.5	7.5	9.3	14.6	16.5	10.7	25.4	12.5	10.7	11.3	14.8	9.5	26.6	14.8	18.6	21.5	13.0	9.9	10.3	15.3	13.4	18.8	28.7	17.0	13.7	17.5	10.4	13.1	8.5	15.2	23.0	8.3	18.0	21.5	8.4	15.6	13.6	12.5	8.2	8.2	13.1	13.0	13.0	14.0	13.5	9.6	9.9	10.1	11.3	11.5	0.8	12.3	15.2	9.6	9.5	7.9	13.3	12.6	24.4	15.7	10.4	9.9	10.5	10.8	13.4	12.0
NXF1	"DKFZp667O0311, Mex67, TAP"	ENSG00000162231	"Nuclear RNA export factor 1"	Q9UBU9	11	62792123-62806302	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016327, HPA061593"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB016327: AB_627608, HPA061593: "	"unprognostic (2.45e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (4.08e-4)"	"unprognostic (4.33e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.25e-2)"	24.8	28.6	23.6	38.3	23.5	85.9	24.5	27.7	25.8	25.9	28.9	29.2	44.2	18.8	45.7	28.9	24.7	26.0	25.6	22.4	23.8	18.3	29.9	37.3	23.9	30.2	27.0	18.6	31.4	28.6	47.3	55.0	44.3	22.7	33.4	22.7	30.3	33.2	32.6	28.1	40.1	26.4	33.2	25.5	42.4	27.5	23.0	29.6	35.9	34.6	26.9	35.7	22.7	30.8	14.4	20.6	19.7	22.5	17.1	20.6	12.8	19.4	21.7	38.0	25.6	32.6	23.7	23.0	30.3	27.2	40.8	24.3	29.5	15.8	30.8	18.1	24.2	24.3	40.4	18.9	37.1	24.4	27.7	23.3	35.0	24.8	24.8	28.7	33.9	35.0	27.5	29.9	14.5	26.6	29.8	23.2	29.0	26.7	34.8	37.4	22.9	18.8	33.9	21.0	32.7	28.2	23.2	20.0	16.8	29.7	24.0	21.6	27.3	25.7	27.0	23.8	19.2	29.6	26.9	28.1	24.2	31.2	18.4	24.4	23.7	6.0	17.4	19.7	17.9	22.5	19.2	14.4	17.2	17.2	20.6	12.9	18.8	17.2	14.7	17.1	19.2	16.0	20.6	12.8	23.6	23.5	27.7	25.8	23.8	18.3	27.0	18.6	22.7	29.6
NXF3		ENSG00000147206	"Nuclear RNA export factor 3"	Q9H4D5	X	103075810-103093125	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 18.0;gallbladder: 16.4;testis: 50.0"	"Cell line enhanced"	"Detected in some"		"HEL: 16.4;HL-60: 15.5;NB-4: 14.5;THP-1: 11.2;U-2197: 47.7;U-937: 34.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA003132, HPA046757"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA003132: AB_1079514, HPA046757: "	"unprognostic (1.20e-3)"	"unprognostic (6.72e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.75e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.86e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-10)"	"unprognostic (1.90e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	1.3	0.5	0.1	0.0	0.3	2.4	0.2	0.1	0.2	0.9	0.3	0.0	1.0	0.2	0.2	8.2	0.6	18.0	16.4	1.1	0.2	0.1	0.7	2.1	5.7	1.3	0.3	0.0	4.4	0.7	0.0	0.1	0.2	0.1	0.3	0.6	0.4	4.2	0.3	0.1	0.1	1.9	0.2	0.3	0.4	0.2	50.0	0.0	0.0	0.2	0.9	0.2	0.2	0.3	0.0	0.0	0.5	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	16.4	0.1	0.0	0.0	15.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.0	0.3	0.0	0.0	14.5	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.0	0.2	34.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.9	0.1	0.3	0.1	0.2	0.2	0.1	0.3	0.0	0.1	0.0
NXN	"FLJ12614, NRX"	ENSG00000167693	Nucleoredoxin	Q6DKJ4	17	799313-979770	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.2;HHSteC: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023566	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA023566: AB_1854737"	"unprognostic (1.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.05e-3)"	11.9	4.9	5.8	11.5	5.9	1.0	12.8	5.0	5.0	21.7	27.1	4.7	16.9	4.0	21.5	19.2	14.0	13.8	14.5	7.6	6.0	4.2	5.1	3.8	15.8	7.2	3.9	3.1	13.9	23.1	1.1	3.2	10.0	5.6	18.9	3.6	12.3	10.9	19.0	48.9	10.6	8.1	25.8	4.4	2.9	13.0	6.4	4.3	6.0	5.7	17.4	11.8	20.8	26.3	0.9	1.2	1.5	0.2	1.8	1.6	0.3	4.3	6.5	25.7	16.5	1.7	0.3	1.4	13.8	9.1	14.6	23.5	15.4	4.6	0.1	26.5	17.6	31.2	16.5	25.8	11.7	0.2	9.6	0.0	4.1	13.5	34.4	0.1	0.7	10.4	23.9	1.9	11.5	13.1	2.2	0.0	3.8	1.7	0.8	0.3	12.3	0.4	1.9	0.6	0.1	10.3	6.3	6.6	4.3	6.5	0.0	0.3	4.6	3.9	0.0	0.3	6.2	0.1	3.8	2.3	1.5	0.1	0.1	0.5	0.2	0.8	0.2	0.1	0.2	0.1	0.1	0.9	0.4	0.2	1.2	0.3	1.6	0.2	1.5	1.8	0.1	1.2	1.4	0.3	5.8	5.9	5.0	5.0	6.0	4.2	3.9	3.1	5.6	4.3
NXT1	"MTR2, P15"	ENSG00000132661	"Nuclear transport factor 2 like export factor 1"	Q9UKK6	20	23350736-23354777	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047471			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047471: "	"unprognostic (6.44e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.15e-7)"	"unprognostic (2.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.11e-3)"	"unprognostic (9.31e-2)"	16.0	9.7	6.2	11.9	6.8	35.0	16.7	5.9	7.1	14.0	11.1	6.0	11.9	6.2	14.0	15.8	16.7	16.7	11.6	15.1	5.7	6.4	12.8	18.0	13.7	15.4	8.1	5.2	23.8	15.0	5.8	13.9	17.6	7.5	19.2	9.4	11.0	12.7	14.0	18.1	14.9	9.5	13.6	7.6	17.4	11.1	17.2	5.7	18.3	24.7	15.9	16.3	20.5	24.1	41.8	34.2	9.9	19.9	30.5	32.0	25.6	14.0	15.7	9.5	9.9	6.7	6.5	8.9	8.7	9.7	14.1	14.3	10.4	13.9	16.9	13.0	8.6	16.5	11.2	22.6	13.9	8.1	10.4	12.4	3.5	18.3	10.1	13.2	9.4	5.8	15.1	13.6	19.4	11.2	16.4	16.7	10.9	18.2	27.3	23.3	8.0	34.9	18.9	15.5	19.7	8.5	11.9	15.5	9.1	7.9	21.2	16.1	11.9	15.4	7.0	14.4	11.8	12.0	16.6	11.5	11.0	19.2	4.0	61.5	10.6	9.7	14.5	9.9	25.7	19.9	31.4	41.8	26.0	26.7	20.8	37.2	32.0	28.9	3.5	30.5	14.2	34.2	17.7	25.6	6.2	6.8	5.9	7.1	5.7	6.4	8.1	5.2	7.5	5.7
NXT2	P15-2	ENSG00000101888	"Nuclear transport factor 2 like export factor 2"	Q9NPJ8	X	109535781-109544690	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.7"	"Cell line enhanced"	"Detected in all"		"HL-60: 47.8;U-937: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024199, HPA072010"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA024199: AB_1854738, HPA072010: "	"unprognostic (1.72e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.59e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.90e-2)"	10.1	6.5	10.4	6.0	9.7	12.3	12.9	3.7	8.4	8.1	6.2	9.0	1.3	7.4	4.7	6.1	10.1	5.8	5.0	3.3	9.9	6.9	7.7	9.6	6.4	9.2	10.1	6.3	5.5	7.9	5.5	2.6	17.4	10.6	6.9	7.0	3.8	8.8	3.6	2.6	10.0	9.1	5.9	11.4	7.6	6.7	38.7	9.1	14.0	7.3	6.3	11.1	7.4	7.2	7.4	11.4	4.2	11.6	12.3	11.6	9.3	4.3	3.8	3.7	6.5	5.6	4.5	8.2	2.8	4.7	3.6	4.7	3.0	6.2	5.6	8.8	3.4	3.3	4.9	4.3	5.5	7.2	3.0	4.7	3.7	4.9	2.3	47.8	19.7	3.3	3.8	3.4	2.1	3.1	4.9	23.0	3.5	4.5	7.2	5.1	5.9	5.7	2.9	5.3	6.6	3.3	4.3	1.5	4.7	11.9	6.8	3.7	2.9	16.2	2.4	5.2	3.0	6.8	2.9	4.8	5.8	8.6	4.5	52.6	5.3	3.9	8.5	4.2	11.6	11.6	7.5	7.4	8.7	9.5	11.4	6.8	8.6	8.4	1.8	12.3	9.2	7.0	9.9	9.3	10.4	9.7	3.7	8.4	9.9	6.9	10.1	6.3	10.6	9.1
NYAP1	"C7orf51, FLJ37538, KIAA1486L"	ENSG00000166924	"Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1"	Q6ZVC0	7	100483927-100494799	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.8"	"Cell line enhanced"	"Detected in some"		"AF22: 4.4;HUVEC TERT2: 5.6;SH-SY5Y: 13.6"	"Cancer enhanced"	"Detected in some"		"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022251	Uncertain		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA022251: AB_1848915"	"unprognostic (6.59e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.65e-2)"	3.1	6.3	11.8	1.6	15.2	1.3	1.4	15.4	32.8	1.8	1.6	3.8	0.0	1.6	2.8	1.3	1.5	1.9	1.6	1.2	13.2	12.8	1.9	1.1	1.3	1.4	7.4	13.4	5.7	2.1	1.1	10.2	1.7	11.4	2.9	1.4	1.0	2.3	3.2	1.2	1.9	1.8	2.1	3.9	1.6	2.3	9.0	4.4	0.0	1.2	0.0	1.2	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.4	2.0	2.9	1.9	0.4	0.1	1.4	0.2	0.6	0.6	0.3	0.0	1.5	0.4	0.2	0.9	0.2	0.1	1.9	0.3	0.2	0.4	0.2	2.1	0.0	1.2	1.9	0.0	0.6	0.7	5.6	0.7	0.1	0.1	0.5	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.0	1.3	13.6	0.5	0.3	1.3	0.2	0.0	2.0	0.0	2.8	0.8	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	15.2	15.4	20.6	13.2	12.8	7.4	13.4	11.4	4.4
OAS1	"IFI-4, OIAS, OIASI"	ENSG00000089127	"2'-5'-oligoadenylate synthetase 1"	P00973	12	112906777-112933222	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 83.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 51.4;BJ hTERT+ SV40 Large T+ RasG12V: 73.9;U-266/70: 72.5;U-266/84: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 83.9"	"Low lineage specificity"	"Detected in all"											"HPA003657, CAB021104"	Uncertain		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"CAB021104: AB_10057722, HPA003657: AB_1854747"	"unprognostic (1.03e-1)"	"unprognostic (6.59e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.67e-2)"	"prognostic favourable (6.12e-6)"	31.2	7.3	6.1	16.6	7.1	5.7	8.4	2.1	6.0	16.4	25.4	11.0	2.6	23.6	5.8	21.0	39.1	5.1	10.7	5.1	4.2	5.7	18.3	23.3	20.7	17.3	5.9	5.3	7.4	3.2	4.3	6.1	18.8	8.6	11.5	20.5	11.7	31.8	4.2	2.9	6.3	27.2	7.6	9.4	30.1	22.7	4.2	6.2	21.6	9.4	13.5	27.3	20.9	13.0	18.2	24.4	4.1	83.9	4.5	16.8	29.0	1.0	5.8	0.0	0.0	2.0	1.6	0.4	0.0	7.6	51.4	73.9	3.3	6.2	8.0	2.3	0.0	2.6	0.0	0.7	0.7	5.9	0.0	0.2	10.5	1.3	0.6	0.1	0.4	0.1	2.2	1.9	0.0	2.7	0.0	3.5	0.0	0.1	0.2	3.6	0.3	5.1	1.7	0.0	3.3	2.6	16.6	0.1	0.3	0.8	1.0	19.6	0.2	1.3	10.1	0.0	0.1	0.7	0.1	72.5	55.0	5.5	0.6	2.3	0.4	1.0	40.9	0.5	4.9	63.6	4.6	18.2	6.5	6.1	24.4	13.6	2.5	3.3	4.1	4.5	83.9	22.1	16.8	29.0	6.1	7.1	2.1	6.0	4.2	5.7	5.9	5.3	8.6	6.2
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938352-112973249	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 64.0;BJ hTERT+ SV40 Large T+ RasG12V: 70.0;RT4: 17.5;U-266/84: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			21000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	36.9	4.9	5.1	11.2	5.4	18.3	7.0	2.9	5.5	10.5	6.8	5.5	3.2	7.3	10.0	11.8	17.9	4.2	9.4	6.7	4.5	5.3	10.3	7.1	19.9	13.3	5.1	5.1	6.1	3.2	3.3	4.6	19.3	8.7	5.6	6.9	8.9	24.7	3.4	3.3	6.0	9.3	8.3	6.2	22.0	9.5	3.0	3.3	21.3	9.9	6.7	13.5	9.9	8.2	2.6	4.8	10.1	14.7	5.0	3.8	3.9	6.3	9.5	0.0	1.5	0.3	1.4	0.8	1.2	8.3	64.0	70.0	7.2	5.8	0.4	2.3	2.9	5.4	1.2	7.7	5.4	4.7	0.3	4.9	4.4	2.3	1.2	1.7	2.7	0.5	2.5	9.1	0.5	3.3	0.1	1.0	0.8	4.1	2.7	0.9	0.5	5.5	3.9	3.4	0.1	3.0	17.5	0.2	0.0	5.8	2.2	5.7	7.6	0.5	2.2	1.7	1.2	1.5	2.6	0.5	19.1	0.1	1.4	4.8	5.2	0.9	7.9	1.6	2.0	8.6	2.5	2.6	3.0	3.0	4.8	1.3	2.2	2.6	10.1	5.0	14.7	0.2	3.8	3.9	5.1	5.4	2.9	5.5	4.5	5.3	5.1	5.1	8.7	3.3
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121019111-121039242	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;bone marrow: 33.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 51.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.5;hTEC/SVTERT24-B: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA001474	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavourable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavourable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	20.5	0.5	1.0	8.3	1.4	33.1	2.7	0.4	1.9	3.6	5.9	1.7	0.1	1.6	1.7	1.3	4.7	0.6	3.1	2.2	0.7	0.9	4.0	22.6	16.5	1.9	1.3	1.2	1.4	0.4	0.2	0.8	3.6	2.3	2.5	3.0	2.3	3.4	0.3	1.1	0.8	2.0	1.1	1.9	5.2	15.7	2.1	0.6	6.0	3.2	3.7	7.6	2.9	1.5	0.8	3.2	44.5	10.8	6.9	23.6	10.8	1.0	0.2	0.0	0.3	0.3	0.9	0.0	0.1	0.5	51.5	26.5	0.0	4.9	0.3	1.5	0.0	2.7	0.0	0.3	3.8	9.1	0.0	0.0	5.2	0.0	0.3	0.0	0.7	0.3	0.2	20.6	0.0	0.1	0.0	1.8	0.2	0.4	0.0	2.6	0.0	1.1	0.0	0.1	0.6	0.2	4.8	0.0	0.0	0.4	0.2	8.1	0.1	0.8	0.0	0.2	0.4	0.6	0.1	1.9	3.7	0.0	7.7	0.4	0.1	4.2	10.3	22.4	20.4	10.8	5.3	0.8	14.1	23.6	3.2	0.3	4.0	15.7	44.5	6.9	7.4	0.1	9.9	10.8	1.0	1.4	0.4	1.9	0.7	0.9	1.3	1.2	2.3	0.6
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 208.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: "	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	13.5	37.1	25.9	9.1	26.7	20.3	33.8	17.2	39.8	24.7	71.9	22.8	33.9	164.0	21.6	15.5	26.1	14.9	16.0	12.7	25.6	29.8	25.6	36.8	11.6	9.3	27.9	30.1	21.8	12.3	12.1	18.0	14.8	37.8	17.9	15.8	13.3	55.2	29.1	13.7	16.3	208.5	22.5	25.5	8.4	17.3	14.6	19.4	4.9	15.9	23.1	15.2	15.5	18.2	10.2	26.5	23.0	23.6	9.6	20.1	16.3	41.4	7.5	4.9	17.6	50.3	48.5	16.8	25.1	51.3	22.5	24.7	19.2	5.4	0.0	18.3	42.4	44.2	22.5	47.0	24.5	7.3	31.2	46.4	5.3	14.3	25.9	0.0	30.6	31.7	24.3	20.2	23.6	26.1	79.8	8.9	31.3	10.7	12.2	2.6	9.8	10.6	11.4	18.8	11.2	21.5	0.6	10.3	11.0	15.8	42.1	35.3	14.0	11.4	20.1	12.8	12.0	21.2	15.6	7.6	8.0	11.2	17.7	12.5	6.1	18.6	23.6	20.7	18.5	20.7	20.1	9.6	15.6	19.4	26.5	10.2	19.6	19.1	23.0	9.6	20.8	5.7	14.4	16.3	25.9	26.7	17.2	39.8	25.6	29.8	27.9	30.1	37.8	19.4
OAZ3		ENSG00000143450	"Ornithine decarboxylase antizyme 3"	Q9UMX2	1	151762899-151771334	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 102.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030136			Supported	Nucleoplasm				Nucleoplasm		"HPA030136: "	"unprognostic (2.12e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.05e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.36e-2)"	0.4	0.3	0.5	0.7	0.5	0.0	0.6	0.6	0.6	0.3	0.4	0.4	0.7	0.1	0.3	2.0	0.4	0.2	0.3	0.6	0.5	0.5	0.5	0.8	0.6	0.8	0.5	0.5	0.3	0.6	1.4	0.6	0.3	0.4	4.0	0.5	0.3	3.1	0.7	1.0	0.3	0.3	0.5	0.6	0.6	0.2	102.2	0.2	0.3	0.8	0.7	0.4	0.4	0.6	1.4	3.2	2.2	5.0	2.6	2.4	1.6	1.2	2.3	1.3	3.2	1.1	3.3	2.9	2.2	0.5	2.2	1.0	1.3	3.0	1.0	1.9	0.7	1.1	1.2	2.2	0.6	7.2	6.7	1.1	4.3	1.8	1.3	0.6	1.2	5.0	1.3	2.6	3.5	3.4	1.4	3.6	2.3	9.5	0.9	1.6	3.2	2.5	0.4	1.0	1.6	0.4	2.9	1.5	3.5	1.0	5.1	4.5	10.2	2.6	3.0	1.3	0.7	2.6	1.3	5.0	9.3	2.5	1.6	1.6	3.4	2.2	3.0	0.6	1.4	1.5	1.3	1.4	1.3	2.4	3.2	1.2	1.5	2.2	2.1	2.6	5.0	1.3	2.2	1.6	0.5	0.5	0.6	0.4	0.5	0.5	0.5	0.5	0.4	0.2
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.5;U-251 MG: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favourable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favourable (6.56e-4)"	"prognostic unfavourable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favourable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favourable (2.34e-4)"	4.0	10.7	24.5	15.7	18.3	4.7	8.1	3.7	14.0	7.2	23.0	1.9	14.0	41.6	8.9	19.5	12.4	7.7	22.3	7.2	19.9	11.7	51.6	43.6	6.6	10.7	9.7	9.9	3.7	13.2	9.4	18.7	2.9	8.8	8.8	17.3	6.6	18.3	12.9	1.8	9.0	37.5	5.2	4.1	5.2	27.9	4.1	5.7	24.9	14.9	5.8	13.3	9.3	8.5	29.7	22.9	32.7	0.6	27.1	60.8	26.1	34.6	18.4	0.2	0.0	0.0	0.0	0.5	9.0	4.1	4.9	4.6	0.0	43.0	6.0	40.3	5.1	11.2	5.1	56.5	5.0	14.1	3.8	0.0	13.6	0.0	4.6	16.9	0.0	2.7	25.8	0.0	11.0	20.2	0.0	3.0	5.2	13.0	28.5	11.5	17.7	25.0	6.4	0.0	10.0	50.2	22.8	40.0	12.1	13.0	4.4	0.9	4.5	4.2	33.6	0.0	37.4	0.2	67.1	8.6	9.8	19.1	28.8	0.0	0.0	32.7	0.6	12.4	20.4	0.2	27.0	29.7	38.4	29.2	3.4	27.0	50.2	33.6	2.1	27.1	0.2	22.9	60.8	26.1	24.5	18.3	3.7	14.0	19.9	11.7	9.7	9.9	8.8	5.7
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 20.9;CAPAN-2: 27.8;HaCaT: 22.4;MCF7: 22.1;RPTEC TERT1: 17.3;RT4: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"			"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: , CAB068213: , CAB068214: , HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favourable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.8	3.4	3.8	3.7	0.5	7.6	3.9	2.9	4.3	15.5	3.2	21.9	10.2	1.7	7.4	10.6	7.9	17.1	1.1	4.0	2.9	15.3	31.7	29.2	0.4	4.0	1.7	2.3	33.2	12.0	3.2	9.0	6.7	5.7	10.9	7.7	7.1	25.0	0.5	8.7	24.5	1.2	3.8	2.1	15.1	2.0	1.5	0.4	58.1	9.8	8.6	5.0	6.5	1.2	1.2	1.8	0.3	2.0	0.9	0.1	15.0	6.1	0.1	0.5	0.2	0.3	12.2	0.0	1.5	2.0	3.0	20.9	27.8	0.1	5.3	0.3	22.4	6.2	3.0	5.6	0.1	10.8	1.1	0.2	6.3	0.1	0.5	1.5	0.0	3.1	4.7	0.2	1.2	0.0	0.1	0.0	22.1	0.6	0.4	2.4	2.5	0.0	4.6	0.5	17.3	18.9	2.0	0.9	0.1	16.5	0.2	9.3	1.9	0.2	0.1	6.2	1.2	1.5	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.7	0.8	0.2	0.2	0.8	0.9	0.3	0.1	1.2	0.7	0.9	1.8	2.0	0.2	1.2	0.4	0.1	3.4	3.7	3.9	2.9	4.0	2.9	4.0	1.7	6.7	1.5
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"salivary gland: 157.7"	"Cell line enriched"	"Detected in some"	17	"Hep G2: 25.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.0	2.5	0.2	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.0	0.4	0.1	0.0	157.7	2.6	0.0	0.0	0.3	1.9	0.1	0.0	2.5	0.0	0.0	0.0	5.1	10.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
ODF2	"CT134, ODF84"	ENSG00000136811	"Outer dense fiber of sperm tails 2"	Q5BJF6	9	128455186-128501292	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 101.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001874, HPA048841"	Enhanced		Supported	Centrosome				Centrosome		"HPA001874: AB_1079522, HPA048841: "	"unprognostic (4.54e-3)"	"unprognostic (9.91e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (1.72e-4)"	"unprognostic (1.93e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.65e-2)"	6.2	4.8	5.6	9.9	6.7	10.2	7.0	14.3	7.7	7.1	5.7	6.7	5.4	4.0	9.7	6.4	5.2	8.8	5.7	5.7	6.3	5.1	4.7	6.7	5.8	8.9	6.2	4.1	6.4	5.1	7.6	18.2	6.0	7.5	6.6	6.0	5.4	5.3	8.3	3.7	7.2	5.3	8.0	5.2	7.3	5.7	101.1	7.1	18.4	5.5	3.7	9.6	6.4	6.4	8.3	8.8	16.0	16.3	11.0	14.6	9.1	14.5	17.7	29.6	33.6	11.8	14.2	23.8	24.6	11.5	20.5	10.8	17.4	10.8	26.2	9.3	19.9	38.4	21.5	14.6	20.9	17.3	10.0	23.3	26.8	14.5	6.8	25.1	29.4	11.6	9.3	21.7	15.4	17.8	27.4	14.8	19.3	44.7	26.6	30.7	11.5	12.8	24.4	28.5	20.3	10.6	11.3	17.8	15.2	23.0	22.1	8.0	20.6	18.3	16.9	25.6	15.8	29.4	23.8	27.7	39.8	18.9	11.7	22.9	22.2	16.0	8.9	9.8	12.4	13.4	14.6	8.3	10.9	12.9	8.8	8.2	7.9	10.0	3.1	11.0	16.3	8.4	8.0	9.1	5.6	6.7	14.3	7.7	6.3	5.1	6.2	4.1	7.5	7.1
OFD1	"71-7A, CXorf5, JBTS10, RP23"	ENSG00000046651	"OFD1, centriole and centriolar satellite protein"	O75665	X	13734745-13769353	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 31.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031102, HPA031103, HPA031104"	Approved		Supported	Microtubules				Microtubules		"HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655"	"unprognostic (3.10e-3)"	"prognostic favourable (9.62e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.20e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.04e-2)"	"prognostic favourable (2.76e-7)"	7.8	8.0	10.1	20.1	12.3	16.6	18.0	18.7	10.9	19.3	15.0	13.3	16.6	12.5	18.9	15.6	13.5	13.0	15.2	8.3	12.5	9.0	14.9	8.7	11.9	21.2	13.6	8.5	16.1	15.1	27.8	27.2	10.3	12.6	14.9	10.3	9.2	18.4	15.8	7.1	14.2	22.0	9.7	14.6	18.4	14.6	11.7	16.1	16.5	17.7	9.3	19.7	15.0	13.6	8.0	31.5	2.9	1.4	6.7	7.4	2.1	10.0	4.6	6.7	11.9	5.6	8.8	5.0	3.2	7.3	3.7	4.8	8.1	11.4	14.7	8.3	3.7	9.9	4.8	8.7	6.1	7.2	12.2	6.8	13.6	6.8	4.2	9.0	12.5	7.0	6.0	8.5	8.4	4.1	10.2	13.3	4.2	7.9	6.2	10.8	7.0	6.6	15.6	7.8	29.1	5.8	8.6	6.9	11.0	14.9	12.1	7.4	11.4	8.2	3.7	6.7	3.5	7.9	4.0	9.9	9.3	17.2	5.5	4.0	5.4	2.0	0.8	2.9	6.1	1.0	7.1	6.6	5.4	7.4	1.8	8.0	4.5	6.6	2.4	6.7	1.4	31.5	4.1	2.1	10.1	12.3	18.7	10.9	12.5	9.0	13.6	8.5	12.6	16.1
OGDH	E1k	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria			53000	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favourable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	18.9	20.8	12.3	14.5	18.5	8.7	11.0	14.3	23.7	10.1	19.4	15.9	13.5	29.0	16.2	11.1	19.5	11.1	11.8	73.9	11.3	12.8	28.8	14.8	13.0	11.1	14.2	11.7	9.8	13.0	25.5	11.0	14.5	22.2	12.3	13.3	22.3	23.7	15.9	99.3	15.6	35.5	16.4	10.1	12.1	14.9	11.3	11.0	11.3	17.8	39.8	15.8	13.0	10.8	7.2	13.4	7.5	20.4	11.2	25.7	11.6	10.8	22.8	13.7	20.8	21.2	23.3	13.4	17.0	16.6	19.4	16.9	20.8	22.5	47.8	20.2	24.7	33.8	27.0	25.4	18.9	27.9	7.1	14.5	46.2	10.2	10.8	17.9	16.3	21.6	19.3	27.4	19.7	26.2	16.7	14.3	20.4	15.3	17.7	10.3	12.6	25.8	17.0	9.6	53.7	22.2	32.4	23.4	11.2	24.6	34.1	10.6	20.2	18.0	20.6	14.0	12.6	24.2	19.6	13.0	24.9	26.4	25.3	20.3	25.3	4.8	12.1	7.3	11.7	17.7	12.8	7.2	13.5	11.7	13.4	5.9	5.8	7.0	7.5	11.2	20.4	6.6	25.7	11.6	12.3	18.5	14.3	23.7	11.3	12.8	14.2	11.7	22.2	11.0
OGFOD1	"FLJ10826, KIAA1612, TPA1"	ENSG00000087263	"2-oxoglutarate and iron dependent oxygenase domain containing 1"	Q8N543	16	56451490-56479100	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003215, HPA003722"	Approved	Approved	Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003215: AB_1078881, HPA003722: "	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.48e-3)"	"prognostic unfavourable (6.65e-4)"	"prognostic unfavourable (7.02e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.49e-2)"	"unprognostic (7.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-2)"	8.8	13.4	10.0	8.0	11.6	3.3	9.4	10.3	14.3	10.8	7.0	12.4	6.0	7.4	9.5	8.4	18.1	10.1	7.8	12.9	7.7	11.1	12.9	13.9	7.5	7.5	9.1	10.4	10.2	6.5	13.7	13.1	8.3	15.6	8.0	8.9	8.5	8.4	10.0	56.1	8.8	5.8	15.1	11.1	8.6	7.4	8.2	6.2	10.6	9.3	12.6	13.0	9.6	8.3	7.8	7.5	11.8	8.9	8.7	12.1	6.5	11.1	13.2	13.0	16.1	14.7	17.8	12.2	18.2	14.7	25.9	18.8	16.1	8.2	20.4	9.3	14.5	16.1	27.5	12.4	29.3	6.3	14.8	14.8	11.5	16.5	11.3	16.0	17.5	11.8	14.1	19.2	16.0	21.0	20.6	3.9	21.8	7.2	12.7	9.2	22.0	22.8	23.8	19.9	23.8	11.6	8.0	10.4	11.6	22.5	14.6	12.2	13.3	13.3	13.6	14.4	11.5	11.1	16.0	8.0	15.5	30.1	11.5	11.6	11.4	11.8	4.7	4.8	8.8	6.3	11.9	7.8	11.2	10.4	7.1	6.1	12.1	10.0	1.7	8.7	8.9	7.5	9.3	6.5	10.0	11.6	10.3	14.3	7.7	11.1	9.1	10.4	15.6	6.2
OGFOD2	"FLJ13491, FLJ37501"	ENSG00000111325	"2-oxoglutarate and iron dependent oxygenase domain containing 2"	Q6N063	12	122974580-122980043	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039448, HPA040306"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA039448: AB_10795035, HPA040306: AB_10794026"	"unprognostic (2.14e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	6.2	15.0	8.9	11.7	11.7	10.0	7.5	13.4	10.6	7.5	13.4	11.6	14.1	18.5	9.6	14.9	11.2	12.8	13.1	8.5	8.0	8.8	12.9	18.9	8.0	13.4	14.5	9.3	11.6	24.3	10.9	13.5	10.6	13.4	11.4	7.8	9.7	20.1	14.6	13.2	15.9	17.9	8.7	8.0	14.4	11.5	25.1	13.8	10.9	13.3	10.8	12.0	7.4	8.0	16.4	13.4	18.0	16.6	8.8	15.6	9.3	7.2	11.7	4.9	8.0	3.4	3.7	13.2	4.4	4.6	6.2	5.6	11.0	6.5	8.1	9.2	3.8	10.5	3.5	6.0	2.3	5.6	7.7	12.9	10.0	11.3	7.4	12.8	10.1	5.4	9.1	5.7	5.1	6.5	14.9	6.0	3.1	13.9	10.7	24.1	3.0	15.1	12.0	4.7	14.3	4.7	6.5	6.3	5.8	6.0	8.7	8.3	21.9	11.0	4.1	8.5	8.7	10.0	4.5	15.2	9.1	7.7	11.7	6.7	8.2	12.5	12.2	18.0	10.1	13.1	8.7	16.4	8.2	9.8	13.4	11.4	9.3	8.5	10.0	8.8	16.6	8.0	15.6	9.3	8.9	11.7	13.4	10.6	8.0	8.8	14.5	9.3	13.4	13.8
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	10.4	12.9	15.4	28.5	16.2	12.7	11.5	22.0	17.7	16.7	18.8	16.2	10.5	22.0	16.2	13.1	10.0	14.7	12.1	10.7	14.7	10.8	30.1	17.8	9.9	28.5	12.3	14.1	22.5	12.0	5.8	10.2	10.3	15.3	14.4	10.2	14.6	14.3	13.2	7.4	11.5	28.2	12.1	13.6	14.1	10.8	7.3	15.6	19.8	12.2	6.3	25.5	12.2	13.3	12.2	11.9	15.4	8.5	19.4	15.4	8.3	5.7	10.7	10.9	6.8	10.7	12.3	20.1	7.5	7.7	11.5	13.8	10.3	5.7	35.0	5.0	9.5	5.6	6.4	8.2	4.9	12.4	9.2	17.4	17.3	14.7	11.3	6.7	11.2	12.2	10.5	19.9	8.5	14.2	5.5	5.7	10.9	10.7	5.4	6.7	5.7	15.4	4.0	7.3	11.4	6.4	2.9	4.9	8.6	9.6	7.8	5.8	12.4	11.5	9.2	11.7	12.4	9.1	12.2	5.7	8.1	18.0	9.4	19.5	7.2	11.3	8.5	15.4	15.1	6.6	14.6	10.4	13.0	12.3	7.6	12.2	10.2	9.6	2.1	19.4	5.3	11.9	15.4	8.3	15.4	16.2	22.0	17.7	14.7	10.8	12.3	14.1	15.3	15.6
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383967-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 68.7"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 18.2;HSkMC: 8.1;MOLT-4: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"T-reg: 5.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"		190000000	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavourable (2.03e-4)"	35.6	3.9	0.7	7.1	1.3	0.0	14.7	2.0	2.2	47.8	15.2	0.7	11.7	1.5	25.2	19.8	11.7	12.9	47.5	27.6	0.9	0.7	1.9	1.0	7.8	1.3	2.8	1.6	26.1	1.9	68.7	7.1	9.7	2.9	27.7	5.7	10.7	2.9	4.9	2.4	1.6	5.9	31.1	6.0	0.8	9.4	10.7	0.8	1.3	5.9	7.0	1.5	32.0	10.0	0.6	0.3	0.0	0.0	0.4	5.1	0.2	0.0	0.0	0.0	0.0	3.9	18.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.5	0.3	0.6	0.1	0.1	0.0	0.4	0.0	0.1	5.1	0.2	0.7	1.3	2.0	2.2	0.9	0.7	2.8	1.6	2.9	0.8
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533083-71575897	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: "	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavourable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favourable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavourable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favourable (6.85e-7)"	26.1	24.0	33.3	39.7	36.6	38.7	33.7	75.7	43.8	25.0	23.0	22.0	31.1	22.5	36.7	48.3	24.3	33.4	21.2	25.1	29.3	15.4	27.4	20.3	31.0	47.9	30.2	25.6	42.8	46.1	26.5	34.5	19.5	26.6	34.2	30.3	29.9	35.9	30.9	35.0	45.4	38.4	31.1	32.3	56.7	28.2	11.8	36.6	35.7	34.1	27.6	41.4	24.9	31.0	9.7	7.6	3.2	7.2	12.5	9.9	6.0	14.3	13.5	17.5	15.3	18.9	17.4	11.8	11.0	19.9	12.0	18.5	14.2	16.5	17.1	7.8	13.5	17.9	19.1	10.8	14.8	14.6	19.6	10.8	32.1	10.1	14.3	22.2	17.9	16.6	22.0	13.1	24.8	11.1	10.9	59.5	11.4	12.2	17.1	26.7	11.6	18.4	17.0	19.6	21.9	18.5	16.7	9.0	7.9	17.1	11.4	10.6	8.4	15.1	12.9	13.0	10.6	13.5	6.4	16.3	11.7	20.6	9.1	23.4	7.9	3.2	5.3	2.3	9.9	7.2	9.0	9.7	8.3	8.0	7.5	8.5	9.7	9.5	2.4	12.5	6.5	7.6	7.6	6.0	33.3	36.6	75.7	43.8	29.3	15.4	30.2	25.6	26.6	36.6
OIP5	"CT86, hMIS18beta, MIS18B"	ENSG00000104147	"Opa interacting protein 5"	O43482	15	41309268-41332621	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.7;testis: 41.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052271, HPA059602"	Enhanced		Supported	"Nuclear speckles,Vesicles"				"Nuclear speckles, Vesicles"		"HPA052271: , HPA059602: "	"unprognostic (5.17e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.94e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.79e-4)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (9.34e-5)"	"unprognostic (5.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.84e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.86e-2)"	1.3	2.1	0.5	3.8	0.8	7.5	0.7	1.5	1.1	1.1	3.4	0.7	2.3	3.0	0.6	0.6	4.6	0.6	1.3	1.9	0.9	0.4	1.1	1.1	1.0	4.3	0.6	0.4	1.2	0.6	0.0	0.3	1.6	0.5	0.5	3.1	0.2	1.2	1.3	8.3	2.5	3.1	0.6	0.8	2.7	1.4	41.7	0.7	16.7	0.5	6.3	4.0	0.7	1.5	2.5	7.7	1.1	1.3	1.9	5.9	1.7	13.3	7.1	14.0	10.2	0.7	0.9	13.4	8.2	3.8	9.9	10.7	12.6	6.6	7.9	7.2	3.0	20.8	14.2	6.3	7.8	17.1	16.4	16.8	20.7	13.1	0.1	18.3	9.5	0.3	1.3	5.6	5.9	8.4	23.0	15.4	6.6	6.4	10.7	13.7	12.7	15.5	13.3	11.7	12.0	4.4	6.1	22.3	7.4	13.6	13.9	3.8	13.8	10.5	4.1	10.2	15.8	10.1	14.6	7.3	32.2	28.2	2.9	22.4	14.6	0.0	0.8	1.1	0.6	1.3	1.5	2.1	1.8	1.6	1.4	2.5	2.6	1.7	0.0	1.9	0.8	7.7	5.9	1.7	0.5	0.8	1.5	1.1	0.9	0.4	0.6	0.4	0.5	0.7
OLA1	"GTPBP9, PTD004"	ENSG00000138430	"Obg like ATPase 1"	Q9NTK5	2	174072447-174248698	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035790, HPA041443"	Approved		Enhanced	Cytosol			3600000	Cytosol		"HPA035790: AB_10601977, HPA041443: AB_2677483"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"prognostic unfavourable (9.73e-8)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.75e-2)"	28.5	23.1	39.3	18.0	40.6	23.0	29.1	39.4	52.4	18.5	23.5	14.7	12.2	24.9	17.9	20.6	29.9	19.8	20.0	27.9	35.4	34.3	28.4	33.3	14.7	26.1	28.8	27.9	17.1	31.1	19.7	23.8	20.7	45.3	21.5	27.3	15.1	18.9	18.2	50.1	25.9	24.0	18.8	27.0	18.7	19.2	23.1	16.5	36.1	31.9	27.2	25.6	21.9	18.4	12.7	24.5	9.6	16.3	16.7	16.6	13.9	39.9	19.0	31.2	51.8	16.6	36.5	56.2	32.3	32.7	45.2	34.5	44.9	23.8	55.1	32.4	25.8	31.9	37.8	37.3	53.4	25.0	32.2	51.4	18.4	46.5	32.1	58.0	21.0	32.0	46.7	47.8	51.0	39.8	55.9	18.9	39.0	25.8	52.5	60.3	36.6	62.2	40.0	50.4	37.8	56.5	43.3	50.7	29.0	21.9	32.6	45.5	23.2	49.3	28.8	29.8	37.7	29.6	46.9	17.7	44.2	41.9	29.2	40.2	26.3	9.6	16.3	4.6	11.5	16.0	16.6	12.7	13.4	14.6	24.5	11.1	15.8	15.1	1.4	16.7	12.4	15.0	16.6	13.9	39.3	40.6	39.4	52.4	35.4	34.3	28.8	27.9	45.3	16.5
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028759-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 280.2;pancreas: 105.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;BJ hTERT+: 15.2;HaCaT: 21.3;RPMI-8226: 4.7"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted in other tissues"			"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: "	"prognostic favourable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	0.3	0.0	0.3	18.1	0.3	11.4	2.5	0.3	0.5	50.3	132.5	0.4	0.2	121.4	0.8	3.3	0.5	0.9	6.0	1.1	0.3	0.1	7.5	0.3	1.6	0.4	0.3	0.2	0.7	105.8	0.0	0.2	0.9	0.3	16.2	58.9	0.2	2.9	0.2	0.3	0.1	280.2	5.6	0.2	2.2	2.4	1.4	0.3	1.8	0.3	0.4	0.3	18.4	40.9	0.0	0.0	1.4	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	4.4	1.9	15.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	4.7	0.1	0.0	0.9	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.9	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.2	0.3	0.3
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 83.1;ASC TERT1: 45.4;BJ hTERT+: 51.8;HSkMC: 83.1;LHCN-M2: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 5.4"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.4"	"Low region specificity"	"Detected in many"							HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"		1500000	Vesicles		"HPA027991: "	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	25.8	11.8	3.9	9.7	6.6	0.0	25.6	1.4	7.9	75.3	22.7	16.2	17.9	3.9	57.7	41.8	13.8	33.9	31.5	20.3	3.0	2.3	9.7	9.4	18.4	5.7	7.1	4.0	52.6	11.7	1.0	6.6	29.1	8.9	33.1	9.6	41.4	6.1	21.9	5.8	13.5	10.8	29.4	5.1	2.5	19.1	13.3	4.6	0.6	7.8	15.0	7.0	28.0	37.6	0.0	5.4	0.0	0.4	0.0	0.0	0.2	0.0	2.6	1.3	0.0	83.1	45.4	0.0	10.6	51.8	3.7	12.1	3.4	0.0	0.0	0.5	30.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	2.5	21.6	0.0	0.0	83.1	0.0	5.2	0.0	0.2	0.0	0.0	82.9	0.0	0.0	0.0	6.3	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.4	30.7	0.1	0.2	2.1	4.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.9	6.6	1.4	7.9	3.0	2.3	7.1	4.0	8.9	4.6
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lung: 46.8;placenta: 53.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 32.0;HaCaT: 16.8;HHSteC: 33.8;hTCEpi: 15.5;SiHa: 64.4;SK-BR-3: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5"					"Low region specificity"	"Detected in all"			HPA050798			Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"			"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050798: AB_2756318"	"unprognostic (2.30e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (8.24e-5)"	"unprognostic (6.34e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.42e-1)"	2.0	1.9	6.0	14.1	10.3	10.6	2.0	1.3	10.2	1.9	0.5	21.3	0.0	0.8	1.0	0.9	0.5	1.2	3.9	1.1	8.5	6.7	6.9	1.8	46.8	0.5	16.4	4.4	0.4	1.6	2.8	1.9	53.4	12.3	1.4	0.7	0.2	2.0	0.7	0.4	0.5	0.8	1.2	28.5	0.6	1.4	2.8	10.5	0.0	1.5	0.0	0.6	4.3	0.4	0.5	5.9	3.3	1.5	0.3	0.3	1.1	1.8	0.1	0.0	0.1	0.0	0.0	4.4	3.1	0.5	1.9	0.7	32.0	0.0	0.3	0.0	4.1	16.8	0.0	0.1	1.3	0.0	0.0	0.0	1.6	0.0	33.8	0.0	0.0	0.2	15.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	64.4	25.6	0.0	7.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	1.5	2.7	0.2	0.2	0.3	0.3	0.3	0.2	5.9	0.5	0.3	0.3	3.3	0.3	0.4	0.8	0.2	1.1	6.0	10.3	1.3	7.4	8.5	6.7	16.4	4.4	12.3	10.5
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435685-57491297	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.6;gallbladder: 60.7;intestine: 18.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 18.2;HeLa: 11.6;RT4: 6.2;SCLC-21H: 9.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"				Nucleoplasm	"Actin filaments"	"HPA057058: "	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.3	0.4	0.3	0.3	18.6	0.2	0.3	3.0	3.7	0.2	16.5	0.0	0.0	15.0	0.3	0.3	0.3	0.2	60.7	0.2	0.5	0.9	0.3	12.8	0.3	0.3	0.5	0.9	0.3	4.3	3.2	5.1	0.2	1.1	0.3	0.3	0.7	0.3	0.3	0.3	0.3	18.0	0.3	0.3	0.3	0.5	0.6	6.6	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	2.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	3.2	0.0	0.1	18.2	2.9	0.7	11.6	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	3.5	0.6	0.0	0.4	1.7	0.0	0.1	0.7	0.0	1.1	0.0	1.6	6.2	9.5	1.6	0.1	0.0	0.2	0.4	0.6	0.0	1.0	1.2	0.2	0.2	0.3	2.7	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	3.0	3.7	0.5	0.9	0.5	0.9	1.1	6.6
ONECUT3		ENSG00000205922	"One cut homeobox 3"	O60422	19	1752373-1780988	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"stomach 1: 9.4;testis: 3.8"	"Group enriched"	"Detected in some"	8	"HaCaT: 7.9;PC-3: 17.8"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.9"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.3"	HPA059936			Supported	Nucleoplasm				Nucleoplasm		"HPA059936: "	"unprognostic (9.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.08e-10)"	"unprognostic (1.18e-1)"	"unprognostic (9.86e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.21e-2)"	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0			1.2	0.0	0.1	0.1	0.0	1.3	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	9.4	3.8			0.1		0.0	0.0	0.0	0.6	0.4	1.6	0.4	0.4	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.3	0.2	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.3	1.6	0.4	0.4	0.4	0.1	0.0										
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria			13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: "	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavourable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	25.9	8.3	8.5	9.3	7.5	11.9	9.0	12.6	11.6	13.9	13.6	20.3	8.8	17.3	27.3	11.8	16.9	14.8	14.3	24.6	20.8	12.0	29.9	7.4	10.1	11.7	24.5	13.8	13.2	12.8	13.4	19.0	11.7	12.6	17.0	13.8	20.5	9.5	13.6	11.9	27.9	12.5	18.6	18.5	10.4	16.2	18.5	11.2	18.9	21.1	13.4	27.7	19.4	11.7	12.9	9.8	13.8	26.5	15.3	17.8	33.8	14.2	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225716-53251697	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.0;prostate: 6.7"	"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: "	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.7	0.7	15.9	0.3	18.0	0.4	0.3	2.2	8.8	0.4	0.4	0.3	0.0	0.4	0.4	0.6	0.5	0.7	0.4	0.8	4.5	6.2	0.3	0.5	0.8	0.4	1.7	5.8	0.4	0.3	0.4	0.8	2.8	3.1	6.7	0.4	0.0	0.3	0.4	3.8	0.4	0.5	0.5	0.5	0.6	0.3	2.8	1.6	0.2	0.9	0.0	0.3	0.3	0.1	0.2	0.8	1.2	0.2	0.1	0.4	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	1.2	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	15.9	18.0	2.2	8.8	4.5	6.2	1.7	5.8	3.1	1.6
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 170.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol				Cytosol		"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	19.3	21.4	16.1	8.4	15.4	9.6	17.9	17.1	20.4	9.5	11.8	9.4	5.8	14.3	9.4	6.9	14.5	7.3	10.1	32.5	11.9	13.6	16.6	16.7	12.0	9.5	16.2	18.0	22.1	8.2	8.9	9.9	13.0	21.0	9.9	13.4	5.8	10.2	10.2	170.7	17.6	16.0	10.3	16.9	12.4	12.7	16.0	12.5	4.9	6.4	24.5	8.4	11.0	19.8	6.0	1.8	11.9	1.1	16.0	34.5	9.2	18.5	5.3	3.0	4.1	41.1	42.4	3.5	22.4	25.6	17.0	28.2	9.3	24.9	0.1	8.9	30.5	17.4	3.9	21.5	13.0	43.2	2.1	3.8	7.4	5.0	42.1	0.1	14.0	22.7	17.0	16.2	17.0	14.4	4.7	28.8	22.8	3.9	1.8	0.5	1.2	2.4	0.3	5.9	1.9	20.7	13.3	0.8	3.2	19.4	5.9	14.5	12.7	2.6	39.2	14.0	6.9	18.9	6.2	14.9	5.1	0.1	21.0	3.2	2.6	11.9	0.8	0.1	19.7	0.5	15.0	6.0	24.9	22.6	0.1	3.4	10.1	12.3	0.7	16.0	1.1	1.8	34.5	9.2	16.1	15.4	17.1	20.4	11.9	13.6	16.2	18.0	21.0	12.5
OR8S1		ENSG00000284723	"Olfactory receptor family 8 subfamily S member 1"	Q8NH09	12	48525632-48528103	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"intestine: 1.2;ovary: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CAPAN-2: 1.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA045595	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA045595: AB_10964447"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			1.2	0.1	0.0	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.0			1.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 26.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 34.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016583, HPA061823"	Approved		Enhanced	Cytosol				Cytosol		"HPA016583: AB_1848720, HPA061823: "	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favourable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	4.3	1.3	0.0	6.2	1.1	3.7	7.1	0.0	1.3	2.1	9.8	1.7	5.0	10.6	2.3	2.2	3.4	1.7	4.8	3.5	0.4		4.9	9.6	7.5	14.1	2.5	0.6	4.8	5.9	1.4	0.0	4.6	5.6	3.3	0.1	10.6	6.8	3.0	26.0	17.0	14.0	4.4	0.9	11.4	3.9	6.8	0.9	8.1	6.5	7.0	9.1	3.8	2.3	6.9	5.6	6.3	4.3	4.9	14.4	5.1	6.1	12.9	1.4	5.9	1.5	1.9	6.6	7.3	1.2	3.4	2.2	11.2	4.9	4.4	12.1	1.3	11.2	1.1	5.1	0.0	14.6	3.0	8.0	2.2	4.9	4.2	4.9	14.9	0.6	2.1	5.1	0.2	5.4	6.4	1.0	1.0	13.4	14.2	34.8	6.1	15.4	6.4	2.3	7.0	2.5	3.3	5.4	0.8	2.7	3.8	5.5	8.6	1.9	6.5	7.7	3.5	9.1	5.6	3.7	2.5	1.8	5.1	8.7	5.8	6.3	4.2	5.7	14.1	4.3	10.9	4.4	11.5	14.4	5.6	6.9	11.2	9.8	5.2	4.9	3.7	1.4	10.0	5.1										
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404459	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.9;lymphoid tissue: 29.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favourable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.9	1.2	0.2	9.9	0.4	22.9	0.8	1.4	1.1	1.1	3.4	0.4	0.1	1.4	0.6	1.5	5.3	0.5	0.8	0.9	0.3	0.4	1.0	1.1	1.4	5.7	0.3	0.4	1.0	0.7	0.2	0.9	1.6	0.9	0.8	3.8	0.5	1.4	0.8	0.9	2.0	3.0	0.7	0.4	4.2	1.2	8.7	0.5	29.1	0.5	8.0	11.3	1.0	1.7	1.0	1.3	0.7	0.4	7.5	2.3	0.7	7.3	8.1	13.1	8.6	0.3	1.1	12.7	5.3	4.8	15.5	16.1	9.9	4.2	16.9	4.6	3.3	10.2	19.2	6.6	13.6	7.2	11.0	20.3	12.0	9.8	0.0	27.2	11.7	0.6	0.3	15.2	1.7	4.6	23.6	8.3	5.0	5.5	21.3	12.9	29.0	11.6	23.0	20.4	16.6	2.7	9.7	7.4	6.2	12.1	7.4	4.1	4.0	11.0	2.1	6.3	9.1	9.9	13.0	4.3	11.5	21.0	6.3	20.3	7.6	0.1	0.2	0.0	0.5	0.3	0.6	0.4	0.8	0.8	1.3	1.0	0.3	0.7	0.7	7.5	0.4	0.1	2.3	0.7	0.2	0.4	1.4	1.1	0.3	0.4	0.3	0.4	0.9	0.5
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908973-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: "	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	11.7	10.6	8.3	15.9	14.0	9.0	14.0	19.0	14.6	12.6	16.1	11.8	15.1	15.7	18.4	12.9	12.3	10.3	10.7	14.6	9.8	9.2	10.8	9.5	9.5	13.5	8.6	10.4	14.6	14.3	13.7	18.0	14.4	12.9	11.8	12.3	10.3	18.1	22.0	16.1	14.6	16.9	8.9	9.0	14.1	12.1	33.2	6.8	20.3	14.7	12.7	14.2	10.9	11.7	8.1	6.9	5.1	3.6	4.6	8.9	2.2	11.2	8.0	8.9	8.9	3.6	6.3	15.2	11.6	7.3	10.6	10.5	16.4	9.0	6.9	8.4	6.7	9.1	19.4	13.0	16.0	15.5	18.3	16.2	14.1	20.0	7.2	12.8	11.6	5.9	7.7	10.7	13.2	12.1	25.7	8.6	9.2	10.6	17.7	12.1	21.7	19.0	12.7	9.1	10.2	11.0	9.0	14.4	10.8	10.0	8.9	6.3	6.4	6.4	9.2	9.3	9.7	7.9	11.5	6.2	14.7	11.4	7.3	12.4	8.7	0.3	3.6	5.1	5.0	1.4	6.3	8.1	6.8	4.7	3.0	7.2	8.9	6.0	1.8	4.6	2.4	6.9	4.6	2.2	8.3	14.0	19.0	14.6	9.8	9.2	8.6	10.4	12.9	6.8
ORC3	"IMAGE50150, LATHEO, ORC3L"	ENSG00000135336	"Origin recognition complex subunit 3"	Q9UBD5	6	87590067-87667453	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039553, HPA053748"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA039553: , HPA053748: "	"unprognostic (9.38e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (8.63e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.09e-1)"	16.9	22.6	17.6	11.4	23.1	8.9	18.7	33.9	24.4	18.1	10.7	12.1	12.4	8.1	16.5	19.6	11.0	18.1	11.2	21.7	17.8	19.6	16.7	17.3	12.4	15.2	17.6	19.4	24.8	11.8	27.8	30.0	17.6	28.5	16.4	12.9	11.5	11.0	14.2	23.6	12.2	11.4	13.8	19.8	15.4	10.0	26.8	19.4	29.0	18.6	15.3	15.3	17.0	11.1	15.1	9.7	14.9	17.1	15.1	20.6	11.1	8.3	11.2	21.1	15.9	16.3	17.3	15.7	17.1	15.3	20.1	28.4	15.6	10.6	16.8	23.1	11.6	15.4	23.6	13.6	27.8	20.5	16.1	15.5	16.9	16.0	8.8	17.3	5.3	15.3	10.9	22.8	20.0	12.2	34.9	17.9	18.9	10.6	7.3	9.1	14.8	12.7	16.9	28.5	10.2	15.5	12.1	15.2	11.1	13.4	8.1	12.9	11.1	15.1	10.0	10.3	9.8	20.8	20.1	8.7	18.8	11.5	13.5	17.8	15.4	14.9	8.8	9.5	11.4	14.2	16.8	15.1	16.3	14.2	7.2	12.9	20.6	17.2	5.9	15.1	17.1	9.7	15.4	11.1	17.6	23.1	33.9	24.4	17.8	19.6	17.6	19.4	28.5	19.4
ORC4	"HsORC4, ORC4L, Orc4p"	ENSG00000115947	"Origin recognition complex subunit 4"	O43929	2	147930397-148021604	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015124, HPA064562"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB015124: AB_2157883, HPA064562: "	"unprognostic (5.04e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (4.98e-8)"	"unprognostic (5.55e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.19e-1)"	"prognostic favourable (4.10e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.95e-3)"	11.5	14.3	19.0	11.4	20.5	19.6	17.3	29.8	27.2	13.6	14.6	11.0	12.0	13.9	14.8	13.5	13.1	17.3	11.9	13.8	18.1	22.3	24.5	15.5	10.9	11.9	18.1	18.1	21.2	12.1	18.9	29.5	14.3	30.9	14.9	16.8	12.7	15.2	14.6	16.0	11.6	15.6	13.8	18.1	11.0	10.9	17.3	11.8	20.4	19.0	12.7	13.6	13.3	12.6	16.1	18.1	21.5	19.1	20.2	16.6	13.1	12.2	10.7	21.0	11.5	8.2	8.1	22.9	14.0	11.8	17.7	17.8	26.4	12.5	15.9	15.4	8.2	12.5	23.8	13.8	18.5	11.1	20.2	21.9	11.6	17.8	10.9	13.8	8.3	6.8	16.8	19.3	7.7	11.9	20.8	8.4	11.5	13.0	10.7	11.3	23.9	15.7	11.8	14.2	14.3	19.6	25.5	19.9	15.6	12.6	13.9	16.8	10.7	6.7	8.6	13.5	13.3	9.8	12.8	8.4	19.7	15.0	11.0	10.8	8.2	21.5	15.0	19.8	16.2	19.1	16.6	16.1	15.8	16.6	18.1	15.4	16.6	16.3	21.1	20.2	14.8	9.2	16.0	13.1	19.0	20.5	29.8	27.2	18.1	22.3	18.1	18.1	30.9	11.8
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication, Photosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	12.4	13.7	10.6	9.3	17.9	6.2	16.3	18.7	21.6	12.9	14.2	12.1	9.0	10.1	14.4	17.5	14.1	11.3	8.5	8.2	13.0	12.9	12.6	20.3	10.2	13.7	10.1	11.8	13.8	17.4	10.8	15.9	11.4	17.6	21.5	16.0	14.0	11.8	13.8	10.9	14.8	11.0	14.2	8.6	12.0	12.3	27.3	10.0	20.5	12.6	7.9	15.8	13.4	12.7	14.0	7.2	6.8	7.4	12.5	18.6	8.2	16.3	17.1	9.9	18.0	10.6	10.6	8.9	14.5	13.8	16.4	13.7	11.1	10.7	24.1	12.2	9.0	15.5	19.9	13.9	19.6	13.1	12.9	8.8	9.8	11.3	14.7	16.8	7.9	10.0	13.3	18.8	17.4	15.3	28.9	14.0	13.8	23.2	23.4	17.0	10.7	17.9	9.8	18.0	23.9	12.6	12.2	13.4	11.2	13.6	27.8	18.5	9.3	13.0	8.9	14.9	17.4	24.2	18.2	15.5	33.3	31.8	10.7	22.8	18.7	6.8	6.3	4.5	13.1	7.4	17.1	14.0	13.6	15.0	7.2	11.9	17.2	18.6	0.8	12.5	6.0	7.0	11.3	8.2	10.6	17.9	18.7	21.6	13.0	12.9	10.1	11.8	17.6	10.0
ORMDL1		ENSG00000128699	"ORMDL sphingolipid biosynthesis regulator 1"	Q9P0S3	2	189770323-189784371	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA065643			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA065643: "	"unprognostic (1.45e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.70e-3)"	"prognostic favourable (3.04e-5)"	"unprognostic (5.90e-3)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (5.84e-9)"	"unprognostic (2.62e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"prognostic favourable (1.49e-5)"	24.9	31.1	23.1	27.3	29.6	28.5	36.8	29.4	30.8	24.7	23.1	24.1	56.0	24.2	28.9	63.8	21.8	25.7	28.5	17.9	22.6	25.1	26.5	30.3	31.5	40.4	30.6	24.1	25.7	39.9	25.1	50.6	37.5	29.9	29.7	30.5	30.4	55.2	41.2	18.3	47.0	38.1	25.6	25.1	63.1	28.1	37.3	24.7	26.3	31.1	21.7	40.3	24.6	23.9	28.7	36.8	29.0	35.2	21.0	37.7	26.2	13.1	10.4	27.4	21.2	37.4	42.4	30.2	25.6	28.0	33.4	33.5	20.3	21.7	22.7	19.4	20.6	20.6	19.1	17.1	36.4	26.0	24.0	32.2	36.4	25.3	47.5	27.8	27.0	47.4	21.4	28.0	32.1	24.0	21.6	35.1	32.3	13.7	26.0	52.1	29.6	47.2	17.6	23.5	32.2	38.7	20.3	17.9	20.7	14.3	13.7	34.5	15.6	30.9	22.0	29.6	22.1	21.4	28.3	32.2	26.7	23.7	32.2	30.3	16.2	25.7	25.0	29.0	28.7	30.5	28.6	28.7	33.3	31.1	20.5	24.5	37.7	34.6	10.0	21.0	35.2	36.8	33.8	26.2	23.1	29.6	29.4	30.8	22.6	25.1	30.6	24.1	29.9	24.7
ORMDL2	"adoplin-2, HSPC160, MST095, MSTP095"	ENSG00000123353	"ORMDL sphingolipid biosynthesis regulator 2"	Q53FV1	12	55817919-55821879	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065643			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA065643: "	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	"prognostic favourable (3.30e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (9.75e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.68e-2)"	19.5	20.3	6.7	14.1	8.5	9.5	26.9	6.5	10.0	14.6	23.9	11.7	25.7	14.6	15.4	29.9	37.6	13.7	23.3	17.2	7.3	8.2	32.0	44.4	20.1	22.5	10.1	7.7	18.6	34.7	15.9	15.6	31.9	11.4	15.8	27.8	9.1	24.0	20.9	14.5	16.9	24.8	14.5	13.0	24.0	16.2	31.9	8.7	28.4	22.2	23.0	22.0	14.6	17.5	38.8	53.3	45.2	44.6	29.8	45.8	29.0	15.1	28.9	12.3	6.3	23.7	11.8	13.6	18.6	18.5	16.3	14.4	32.3	37.6	9.4	19.9	22.4	28.1	9.7	38.8	16.3	9.8	14.5	12.8	27.9	17.9	25.1	15.3	13.6	14.8	35.6	28.5	29.8	22.8	6.7	25.8	20.7	24.4	9.3	6.8	5.9	23.1	6.2	9.8	24.2	42.2	44.2	10.7	6.8	23.7	28.3	10.3	33.9	11.0	16.5	8.8	12.4	10.3	11.7	12.4	10.2	7.7	14.0	6.1	12.1	21.1	32.8	45.2	40.5	39.9	36.2	38.8	39.3	42.9	32.6	34.2	32.9	39.2	41.1	29.8	44.6	53.3	45.8	29.0	6.7	8.5	6.5	10.0	7.3	8.2	10.1	7.7	11.4	8.7
ORMDL3		ENSG00000172057	"ORMDL sphingolipid biosynthesis regulator 3"	Q8N138	17	39921041-39927601	"Disease related genes, Predicted membrane proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065643			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA065643: "	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.96e-1)"	"prognostic favourable (9.29e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.09e-3)"	"prognostic favourable (5.18e-4)"	48.9	12.4	16.1	19.9	20.6	11.7	36.1	14.9	18.2	14.9	17.4	12.6	29.9	17.2	15.3	23.8	10.9	10.4	17.3	21.6	16.1	12.5	14.1	83.0	16.9	17.3	14.6	16.3	15.7	68.4	14.9	21.0	28.6	12.6	17.0	13.7	14.4	24.4	24.1	13.5	15.4	16.2	14.1	13.5	15.5	16.9	18.1	16.1	29.7	20.9	11.0	24.9	17.8	10.4	11.9	8.8	24.9	4.3	7.4	24.8	15.9	7.0	8.7	9.2	7.6	24.0	9.2	8.4	10.4	12.1	11.2	10.8	9.9	7.9	5.2	9.9	12.8	12.2	6.5	8.4	10.5	90.5	11.6	5.1	4.8	23.9	9.4	5.9	9.0	10.0	8.8	7.7	4.4	4.9	6.4	42.9	6.1	6.3	17.7	6.7	5.1	4.4	15.1	8.3	16.5	6.2	17.3	8.1	8.3	6.9	43.3	6.9	15.5	6.6	4.0	6.1	7.6	5.2	7.8	23.1	19.5	7.3	6.3	5.9	4.5	3.5	2.0	24.9	17.5	3.1	12.5	11.9	17.8	19.3	1.7	10.8	20.9	24.8	3.3	7.4	4.3	8.8	11.3	15.9	16.1	20.6	14.9	18.2	16.1	12.5	14.6	16.3	12.6	16.1
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9, endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	8	"RH-30: 285.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	39.3	32.9	24.4	28.1	27.6	32.2	38.0	27.0	34.9	37.4	39.1	27.6	34.5	37.2	36.2	37.7	35.2	32.0	33.0	39.2	23.2	23.1	42.9	94.4	40.2	34.2	27.7	22.0	44.2	110.7	49.5	29.2	47.0	28.2	34.7	34.1	42.0	53.2	28.5	19.0	36.9	47.4	28.1	18.6	37.5	35.7	21.4	24.0	23.8	47.6	23.2	34.4	33.3	35.1	11.5	35.8	54.1	48.7	11.4	16.1	36.7	6.6	13.5	6.9	17.0	35.9	24.4	15.3	16.7	21.3	12.3	12.5	14.0	21.7	8.5	27.8	19.9	12.0	6.4	10.7	9.8	10.9	7.7	9.6	9.6	12.6	23.5	15.0	24.7	22.4	17.4	12.1	12.3	20.5	7.2	34.0	12.8	11.4	4.0	18.2	7.8	9.6	5.3	285.5	21.3	9.3	16.5	7.1	9.4	23.7	16.3	13.4	19.5	29.6	18.7	16.7	10.0	11.2	10.5	20.2	17.4	8.8	14.1	11.0	22.9	30.6	48.7	54.1	16.1	44.4	15.2	10.9	13.7	14.2	35.8	11.5	10.7	12.3	52.0	11.4	35.0	31.1	15.0	36.7	24.4	27.6	27.0	34.9	23.2	23.1	27.7	22.0	28.2	24.0
OSBP	OSBP1	ENSG00000110048	"Oxysterol binding protein"	P22059	11	59574398-59616144	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039227, HPA043625"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039227: , HPA043625: "	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"prognostic favourable (2.08e-5)"	"unprognostic (7.80e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.22e-1)"	"prognostic favourable (3.08e-7)"	"unprognostic (1.25e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	15.6	36.6	12.3	10.6	16.3	13.8	16.5	14.7	18.0	16.1	18.8	13.7	35.4	17.3	15.9	19.9	15.9	13.8	19.5	14.7	10.3	11.6	26.3	54.8	12.9	9.7	12.4	12.7	16.6	30.2	31.4	14.7	29.4	17.9	16.1	17.3	12.6	27.7	26.2	32.5	20.9	22.3	15.1	9.5	12.5	19.1	11.3	12.1	18.8	19.6	12.5	13.8	16.7	13.7	4.6	7.9	3.5	3.1	4.0	6.1	2.1	17.5	14.7	10.9	14.7	25.9	24.3	12.1	14.3	18.7	17.3	15.6	16.6	17.8	17.7	19.3	16.5	18.4	20.1	19.1	19.5	17.1	9.3	11.9	11.5	11.1	27.7	15.2	23.7	18.5	23.8	16.2	42.8	18.4	20.5	16.6	15.3	8.1	14.3	11.2	12.4	14.5	13.9	17.6	12.3	20.5	20.4	13.0	9.2	17.0	21.3	19.6	29.8	9.8	19.9	14.8	10.4	22.1	9.6	23.2	18.8	18.1	16.7	11.0	11.9	3.5	3.1	2.8	5.9	2.9	5.5	4.6	6.1	4.6	3.2	3.4	5.6	4.7	3.0	4.0	2.5	7.9	2.6	2.1	12.3	16.3	14.7	18.0	10.3	11.6	12.4	12.7	17.9	12.1
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796539-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: "	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	3.7	2.2	3.9	18.2	9.5	3.8	6.6	1.2	16.0	12.1	6.1	6.2	0.7	9.8	3.8	3.7	10.2	6.2	10.4	5.3	4.3	4.3	14.4	1.9	9.0	10.9	4.2	7.4	8.4	3.9	23.1	4.2	6.3	3.1	4.3	6.7	3.7	6.9	2.9	6.7	12.8	10.4	4.0	6.7	10.2	8.7	3.5	4.1	13.9	16.8	7.2	14.7	12.4	9.6	3.7	3.5	6.3	2.1	8.1	9.8	2.4	14.4	3.9	2.9	5.4	6.6	13.4	6.6	16.4	18.3	7.7	12.2	9.8	19.2	8.0	2.3	17.5	12.7	8.8	12.3	11.9	4.8	3.6	1.9	5.8	7.3	9.4	5.4	43.0	6.5	10.3	10.0	12.1	11.5	10.0	11.2	13.0	0.0	3.3	6.7	5.7	5.1	2.7	8.1	3.3	7.7	10.3	0.6	6.1	11.1	8.0	2.4	4.1	0.5	13.6	3.4	6.8	18.5	12.2	7.8	11.3	20.2	7.4	9.0	37.9	6.3	2.1	1.5	9.8	1.8	8.4	3.7	6.2	6.3	3.5	1.7	2.1	4.2	0.4	8.1	1.2	2.5	9.8	2.4	3.9	9.5	1.2	16.0	4.3	4.3	4.2	7.4	3.1	4.1
OSBPL5	"KIAA1534, ORP5"	ENSG00000021762	"Oxysterol binding protein like 5"	Q9H0X9	11	3087116-3166739	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.1;gdT-cell: 9.3;intermediate monocyte: 4.4;memory CD8 T-cell: 3.4;myeloid DC: 2.7;naive CD8 T-cell: 3.6;NK-cell: 10.0;non-classical monocyte: 10.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038335, HPA038712, HPA058727"	Approved		Enhanced	Vesicles				Vesicles		"HPA038335: , HPA038712: AB_10675949, HPA058727: AB_2683799"	"unprognostic (6.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.16e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	17.6	7.0	4.2	10.3	6.2	17.8	20.7	4.4	8.8	24.7	15.6	7.5	24.0	9.0	17.1	15.9	8.1	12.6	13.8	10.0	4.6	6.5	8.1	2.7	12.9	10.5	6.9	6.4	9.6	8.4	2.4	6.5	7.8	9.8	15.9	5.2	9.0	17.1	17.5	28.0	17.8	9.6	20.1	11.9	20.3	10.2	4.4	6.3	36.5	9.3	9.6	3.8	14.3	17.7	0.0	2.7	1.0	10.1	10.0	9.3	3.9	1.7	2.7	3.2	3.7	9.7	4.5	0.0	8.8	4.3	3.5	2.5	0.0	5.1	0.0	2.7	4.9	6.5	0.6	2.4	0.5	1.7	2.5	7.3	8.7	0.0	7.9	6.5	1.1	7.0	2.9	1.2	1.3	2.4	2.5	0.0	1.7	4.9	14.2	36.3	2.3	5.7	7.4	4.4	1.0	1.4	1.6	5.4	0.6	3.6	12.9	3.3	5.3	17.3	8.0	4.5	6.1	10.6	1.5	1.8	0.0	0.2	4.7	12.3	5.6	0.2	3.1	1.0	9.3	4.4	1.2	0.0	1.0	3.4	2.7	0.0	0.6	3.6	0.4	10.0	10.1	1.2	0.1	3.9	4.2	6.2	4.4	8.8	4.6	6.5	6.9	6.4	9.8	6.3
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	35.7	28.8	12.6	19.0	20.7	20.3	27.4	30.3	17.6	29.4	15.4	29.8	20.0	13.1	36.3	29.7	18.8	19.4	15.0	27.2	13.5	16.1	35.4	52.6	25.7	18.2	25.1	14.0	29.4	26.9	43.2	27.6	20.8	22.2	37.1	16.6	29.9	18.2	22.4	55.6	15.2	16.4	25.3	28.2	22.5	22.5	20.0	24.8	19.4	28.2	18.5	24.6	27.7	31.6	23.4	19.9	28.7	13.6	12.8	23.2	12.6	21.7	11.2	22.8	5.0	16.3	8.1	40.8	11.2	18.8	18.1	21.6	16.3	16.4	31.8	19.6	12.3	10.1	19.2	19.4	25.8	22.6	14.1	25.1	21.9	33.5	15.8	25.8	13.0	16.3	18.8	20.4	13.5	23.8	47.5	10.4	10.1	15.5	7.4	28.0	31.0	5.2	18.7	33.1	33.7	24.2	17.0	11.3	15.0	9.5	26.1	31.0	12.6	26.0	14.3	5.2	17.4	6.5	19.9	25.4	16.1	37.1	12.8	12.0	8.0	28.7	13.6	25.0	16.1	11.4	23.2	23.4	16.0	16.6	19.9	16.4	17.1	18.1	15.9	12.8	8.6	15.7	15.3	12.6	12.6	20.7	30.3	17.6	13.5	16.1	25.1	14.0	22.2	24.8
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446411-20455105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favourable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	11.2	14.2	13.2	13.1	14.5	10.7	14.4	21.3	18.3	14.3	15.6	18.6	11.6	8.8	16.0	19.2	12.9	13.1	13.6	15.8	13.4	10.2	12.3	22.2	12.4	16.9	13.4	12.5	12.4	12.4	10.6	20.8	13.6	15.5	10.8	14.0	14.5	12.4	18.6	19.6	9.9	12.4	16.8	12.3	18.8	13.6	5.7	15.2	16.2	15.7	9.6	18.7	16.6	11.0	24.5	28.8	23.4	19.1	13.0	14.2	15.7	6.3	10.3	3.4	10.0	5.9	4.1	10.5	5.0	6.6	12.8	12.4	14.2	7.5	13.3	6.5	6.3	5.6	10.3	10.1	8.0	10.5	13.2	8.4	8.7	18.2	4.4	14.4	12.0	3.1	3.1	15.3	8.1	8.4	8.1	7.6	10.0	11.9	14.1	6.3	5.1	20.4	22.5	6.4	7.5	7.2	7.3	13.3	2.6	8.9	9.4	6.8	6.3	13.7	3.9	5.4	13.2	6.8	6.0	2.3	12.5	18.2	3.3	22.5	6.5	5.1	19.1	23.4	13.7	17.6	11.9	20.5	14.2	12.0	28.8	24.5	11.3	12.9	8.7	13.0	13.6	12.4	12.9	15.7	13.2	14.5	21.3	18.3	13.4	10.2	13.4	12.5	15.5	15.2
OSGEPL1	"OSGEPL, Qri7"	ENSG00000128694	"O-sialoglycoprotein endopeptidase like 1"	Q9H4B0	2	189746660-189763227	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030693	Uncertain		Supported	Mitochondria				Mitochondria		"HPA030693: AB_10601978"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (4.18e-3)"	"unprognostic (1.06e-3)"	"prognostic favourable (3.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.51e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.55e-3)"	6.6	17.0	8.6	6.5	12.1	2.6	11.1	12.9	10.9	7.3	5.6	14.8	2.9	5.0	11.8	9.1	7.0	8.1	4.8	13.0	8.4	7.3	13.0	11.6	5.8	11.2	18.9	9.3	13.8	6.1	7.5	9.8	6.1	11.6	6.9	6.1	9.0	9.7	6.1	16.6	9.2	6.5	8.1	13.4	9.6	5.8	9.4	15.4	10.6	8.2	7.3	9.2	8.0	5.8	9.3	6.0	2.1	2.6	6.6	11.5	3.0	5.7	3.2	14.1	10.8	11.2	6.2	8.4	8.9	6.3	12.7	13.7	3.7	6.0	3.8	10.0	3.7	8.4	12.5	10.6	14.5	9.8	9.6	12.4	7.8	4.8	5.9	7.0	6.5	6.8	9.0	9.6	4.7	9.4	4.5	6.1	8.3	3.2	5.5	8.0	6.8	14.6	6.0	11.3	6.5	8.2	3.2	8.6	9.5	6.0	10.9	19.4	8.5	7.7	3.9	8.3	7.3	12.1	5.5	6.2	5.2	6.2	11.0	9.0	9.0	0.2	2.6	2.1	7.3	2.4	10.5	7.4	7.7	8.4	3.5	9.3	11.5	10.2	0.4	6.6	2.1	6.0	5.9	3.0	8.6	12.1	12.9	10.9	8.4	7.3	18.9	9.3	11.6	15.4
OSTF1	"bA235O14.1, OSF, SH3P2"	ENSG00000134996	"Osteoclast stimulating factor 1"	Q92882	9	75088543-75147265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020514	Approved		Supported	Cytosol			190000	Cytosol		"HPA020514: "	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.54e-2)"	"prognostic favourable (3.67e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.76e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	25.8	18.5	19.1	29.8	22.7	24.2	30.6	12.2	25.5	18.5	19.9	16.7	9.0	18.0	11.5	19.4	62.0	11.9	20.7	21.7	19.5	14.4	20.3	30.9	32.5	36.9	21.5	18.6	10.6	14.8	33.4	12.7	41.5	21.5	14.0	22.6	12.4	24.0	13.8	7.4	31.0	24.8	13.8	22.5	52.9	19.1	9.6	17.8	21.3	16.1	17.2	38.9	26.1	30.1	18.7	25.4	84.5	40.1	27.2	30.8	40.9	16.7	3.9	1.9	2.8	11.8	10.9	20.7	17.9	11.7	6.8	6.3	2.0	12.7	17.3	9.0	14.6	27.9	3.2	12.9	19.8	73.3	4.0	9.6	6.2	10.3	9.6	17.2	36.1	7.5	12.5	8.0	5.6	22.9	3.2	40.0	16.4	8.7	25.6	10.8	3.6	7.7	4.8	13.3	15.3	14.4	24.0	1.6	0.1	13.2	18.7	8.6	24.5	19.5	21.4	14.3	5.0	27.4	7.5	7.6	12.4	6.5	17.2	20.1	11.6	50.9	30.8	75.5	29.3	33.0	30.8	18.7	20.5	24.0	25.4	16.5	11.8	20.6	84.5	27.2	40.1	19.0	27.5	40.9	19.1	22.7	12.2	25.5	19.5	14.4	21.5	18.6	21.5	17.8
OTC		ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352545-38421450	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 59.1;liver: 90.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.8;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria			1800000	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			0.4	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.8	16.5	0.0	0.2	26.9	1.1	0.2	0.2	0.3	5.3	0.2	0.1	0.2	0.1	90.3	0.7	2.3	0.2	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.1	0.1	59.1	0.8	0.3	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.6	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0
OTUD4	"DUBA6, HSHIN1, KIAA1046"	ENSG00000164164	"OTU deubiquitinase 4"	Q01804	4	145110838-145180161	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036623	Uncertain		Supported	Cytosol				Cytosol		"HPA036623: AB_10696780"	"unprognostic (1.67e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-1)"	14.3	11.8	16.6	11.6	16.7	24.7	12.0	22.7	15.9	14.0	15.3	16.0	10.1	10.0	13.9	13.3	14.8	14.9	11.2	15.6	12.0	9.2	11.1	17.7	15.5	13.1	14.1	8.4	14.3	13.4	22.4	12.2	17.9	12.7	10.6	11.2	10.6	12.7	11.0	36.2	13.6	16.2	12.4	10.1	13.5	10.8	26.8	18.8	13.1	13.4	13.6	12.3	11.5	12.8	3.3	2.8	2.8	2.8	1.6	3.5	1.0	14.9	8.5	10.2	9.4	12.1	14.8	13.7	13.1	14.8	16.9	13.5	9.2	18.5	27.5	6.0	18.3	9.1	17.6	18.3	22.2	11.7	8.4	13.2	10.4	8.4	14.2	27.6	10.0	11.5	18.7	20.6	27.2	14.9	21.7	20.6	16.6	8.9	17.1	12.1	11.4	9.8	14.1	11.3	6.4	16.3	10.9	9.9	8.2	12.1	18.3	13.1	6.0	11.4	18.0	19.1	12.2	9.8	17.3	15.2	15.0	18.2	13.2	19.6	18.4	0.0	1.7	2.8	3.5	2.1	2.6	3.3	2.7	2.8	1.6	2.4	2.7	2.4	0.5	1.6	2.8	2.8	2.0	1.0	16.6	16.7	22.7	15.9	12.0	9.2	14.1	8.4	12.7	18.8
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56810479	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 27.7;retina: 78.2"	"Group enriched"	"Detected in some"	545	"HAP1: 62.7;NTERA-2: 52.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;pons and medulla: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.2	0.2	0.0	0.2	0.3	0.2	0.2	20.4	0.3	0.2	0.2	3.7	0.0	0.2	0.2	1.0	0.2	0.2	0.2	0.2	1.8	2.7	0.2	0.2	0.2	0.5	4.7	0.0	0.5	0.2	0.2	2.8	0.2	27.7	0.3	0.2	78.2	0.2	1.3	0.2	0.5	0.2	0.2	0.2	0.4	0.2	3.1	2.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.4	0.3	1.8	2.7	4.7	0.0	27.7	2.3
OVCA2		ENSG00000262664	"OVCA2, serine hydrolase domain containing"	Q8WZ82	17	2041936-2043430	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059002			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA059002: "																		17.0	25.7	13.6	22.3	16.4	23.1	14.4	11.2	17.2	15.4	20.5	12.1	12.1	20.0	12.2	19.1	23.6	12.0	28.4	17.6	12.2	11.3	31.0	46.4	15.6	37.2	11.5	11.8	14.2	25.5	9.6	21.7	26.5	13.3	16.6	17.5	24.5	30.2	21.1	20.4	18.5	32.1	12.4	8.3	28.9	19.0	28.1	9.6	29.7	22.3	34.8	30.3	22.0	12.6	26.2	30.7	12.5	30.7	29.9	43.0	28.4	21.2	21.0	8.8	17.8	10.9	14.5	14.3	14.1	15.4	15.6	14.7	24.1	14.0	4.6	14.4	19.1	16.6	9.4	22.6	11.4	11.2	23.9	10.5	12.8	8.9	29.8	7.1	21.6	18.8	20.4	15.0	10.2	26.0	5.8	22.7	23.1	14.9	10.3	11.9	7.6	13.4	8.7	8.9	7.2	23.7	14.1	5.8	21.6	9.2	14.5	19.0	16.9	14.2	20.5	22.7	7.3	16.3	27.4	13.7	14.0	4.0	20.4	15.9	22.3	8.5	30.7	12.5	26.8	26.6	26.9	26.2	26.7	28.3	26.5	21.5	18.5	18.0	8.6	29.9	20.4	30.7	43.0	28.4	13.6	16.4	11.2	17.2	12.2	11.3	11.5	11.8	13.3	9.6
OXA1L	"MGC133129, OXA1"	ENSG00000155463	"OXA1L, mitochondrial inner membrane protein"	Q15070	14	22766522-22773041	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003531	Approved		Supported	Mitochondria				Mitochondria		"HPA003531: AB_1079539"	"unprognostic (4.04e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"prognostic favourable (4.82e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.15e-3)"	27.8	36.0	11.9	21.2	15.5	25.1	28.4	13.5	23.0	25.4	30.9	18.5	24.3	27.2	22.7	23.9	30.2	21.5	30.6	48.3	12.9	13.0	31.9	58.4	25.8	45.0	15.2	10.9	31.4	59.6	30.0	12.3	18.3	17.9	25.3	24.2	28.1	24.9	27.5	76.3	24.9	32.8	23.9	13.5	32.9	29.9	17.0	10.3	32.7	37.3	49.0	38.3	31.3	22.3	22.1	39.9	7.2	29.4	16.3	22.6	19.9	20.9	29.0	13.0	21.8	37.0	55.2	24.1	16.0	33.7	23.3	26.9	21.7	24.0	39.4	21.5	18.6	30.0	25.1	31.1	23.5	16.4	16.2	19.5	20.0	79.3	41.5	36.3	24.3	54.0	34.6	19.2	29.8	66.9	14.4	32.2	25.5	30.8	21.5	14.1	13.2	36.5	22.1	21.6	30.0	29.7	26.3	8.9	17.2	23.2	51.7	30.6	22.1	29.5	21.3	13.9	16.2	25.3	18.3	24.3	19.3	18.5	10.9	21.0	14.9	4.8	27.9	7.2	13.4	29.4	16.3	22.1	19.2	16.9	39.9	21.9	21.9	16.3	6.3	16.3	22.9	11.3	22.6	19.9	11.9	15.5	13.5	23.0	12.9	13.0	15.2	10.9	17.9	10.3
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 56.1;SiHa: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"		1000000	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favourable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	21.9	8.0	17.3	7.5	30.3	5.8	9.5	26.6	36.8	6.7	9.2	8.3	10.7	4.4	8.6	8.7	13.1	6.9	7.5	108.8	19.3	15.2	25.3	1.2	4.2	9.5	13.1	25.7	7.2	3.0	20.9	8.4	2.8	21.2	12.5	10.4	6.6	8.5	14.7	13.4	10.7	6.5	17.0	8.9	5.2	14.6	6.2	5.3	22.8	13.0	10.7	11.8	8.0	7.5	8.0	4.6	3.3	1.6	7.5	15.6	5.1	7.8	0.3	6.5	7.7	20.1	10.8	0.0	14.1	8.9	11.7	7.1	1.2	5.4	20.4	3.5	10.7	4.6	17.8	12.7	13.8	17.4	2.0	14.3	56.1	2.6	8.8	27.7	4.8	10.1	3.4	11.5	19.4	10.7	2.9	26.3	13.4	1.0	23.1	1.3	1.4	5.6	18.4	18.2	15.4	9.5	0.6	6.5	6.7	72.9	0.0	8.6	0.1	6.0	6.4	9.3	12.2	15.9	11.3	4.3	3.6	0.8	14.1	20.4	7.1	1.0	1.0	3.3	9.1	1.1	10.9	8.0	9.2	9.8	4.6	6.1	10.8	8.9	0.3	7.5	1.6	1.8	15.6	5.1	17.3	30.3	26.6	36.8	19.3	15.2	13.1	25.7	21.2	5.3
OXGR1	"aKGR, GPR80, GPR99, P2RY15, P2Y15"	ENSG00000165621	"Oxoglutarate receptor 1"	Q96P68	13	96985719-96994730	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 7.0"	"Cell line enhanced"	"Detected in some"		"RT4: 7.6;SK-BR-3: 3.5;T-47d: 1.7;U-2 OS: 4.0"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	5	"myeloid DC: 2.9;plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 5.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA067673			Supported	"Plasma membrane"				"Plasma membrane"		"HPA067673: "	"unprognostic (1.83e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.97e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.52e-1)"		"unprognostic (8.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.68e-2)"	2.1	0.0	0.7	1.7	0.2	0.0	6.7	0.0	2.0	1.6	3.0			0.1	0.6	4.0	3.2	2.5	0.0	0.0	0.8	0.8	7.0	0.0	0.5	0.0	0.7		0.0	0.6	0.0	0.3	1.2		0.5	2.4		4.9	0.3	0.1	4.3	0.5	0.5	1.6	0.3	0.1	0.0			0.8		0.9	1.8	0.9	0.0	5.2	0.1	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.6	0.0	0.2	0.0	3.5	0.0	1.7	0.0	0.0	0.0	4.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.1	0.0	0.1	0.8	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.1	0.0	0.0	5.2	0.0	0.1										
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	"Oxidative stress responsive 1"	O95747	3	38165089-38255488	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol			21000000	Cytosol		"CAB017181: , HPA008237: AB_1079540"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.99e-3)"	17.6	16.8	9.4	18.3	13.4	24.2	15.9	17.4	14.9	16.8	15.4	9.2	35.7	12.4	14.9	14.7	31.6	11.6	18.9	15.5	11.9	9.0	18.3	17.6	14.6	13.9	13.6	9.3	16.7	12.3	23.7	15.3	21.4	12.3	16.5	16.8	13.0	15.1	23.9	32.6	17.4	21.4	17.0	12.9	15.8	14.0	11.2	13.2	26.2	14.2	24.1	19.6	23.5	19.2	2.3	4.4	10.1	4.8	5.0	4.7	1.6	17.5	8.0	16.1	11.2	11.2	13.0	18.3	15.6	21.4	22.5	24.5	10.3	11.5	19.5	7.9	18.6	10.9	21.6	16.0	29.8	20.6	8.8	21.3	17.1	11.3	13.5	13.1	13.0	10.3	18.9	20.8	33.7	14.0	16.1	11.2	38.5	4.9	25.3	9.5	16.9	9.6	8.8	13.5	15.0	13.9	13.4	8.4	12.9	17.0	43.2	10.6	14.2	8.6	12.7	14.2	14.1	21.5	23.0	8.6	10.2	14.3	19.4	16.4	28.2	10.1	2.8	6.1	3.3	4.8	3.5	1.9	4.0	3.1	4.4	2.3	3.0	3.7	5.5	5.0	4.1	2.5	4.7	1.6	9.4	13.4	17.4	14.9	11.9	9.0	13.6	9.3	12.3	13.2
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696404	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;Karpas-707: 15.5;RPMI-8226: 27.0;U-698: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"memory B-cell: 28.1;naive B-cell: 30.4"	"Lineage enriched"	"Detected in many"	19	"B-cells: 30.4"									"HPA021948, HPA067827"	Supported		Supported	Cytosol				Cytosol		"HPA021948: AB_1854878, HPA067827: "	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.6	0.3	2.2	32.0	4.9	4.8	0.5	4.1	5.1	0.3	1.4	0.0	0.4	0.9	0.2	0.2	2.4	0.2	0.8	4.9	1.8	3.0	0.8	0.4	1.0	39.1	1.5	2.1	0.2	0.8	0.1	1.2	0.2	1.7	0.5	1.2	0.0	5.4	0.1	11.4	0.2	12.0	0.4	0.6	29.6	1.8	0.6	0.2	9.3	0.5	1.9	27.6	2.2	0.3	30.4	0.1	0.7	0.0	0.0	1.6	1.6	3.8	3.2	0.0	0.0	0.1	0.6	0.0	4.0	1.8	0.4	1.3	2.4	4.7	24.0	2.4	1.9	2.0	8.6	0.0	0.8	0.4	1.5	1.2	8.5	2.9	0.6	1.6	2.1	1.0	0.9	0.1	5.6	0.0	0.2	15.5	8.7	0.0	10.8	3.6	2.4	9.7	0.4	0.0	27.0	0.1	2.9	2.0	0.0	3.3	1.1	1.8	1.0	1.5	0.0	0.0	2.2	0.1	0.7	5.5	11.7	22.3	0.0	2.3	0.2	0.0	0.0	0.7	1.1	0.0	1.6	28.1	1.0	0.8	0.1	30.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.6	2.2	4.9	4.1	5.1	1.8	3.0	1.5	2.1	1.7	0.2
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 36.0;RPTEC TERT1: 36.7;RT4: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 20.3"	"Lineage enriched"	"Detected in single"	104	"dendritic cells: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"	Nucleoplasm	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	2.4	22.6	2.9	4.0	3.9	0.2	3.1	0.7	2.2	14.3	11.8	6.2	11.5	1.2	15.0	13.5	8.9	4.6	8.4	3.8	2.8	2.1	74.5	3.5	22.5	3.6	8.1	1.0	11.2	3.9	1.4	6.1	11.0	5.6	19.9	5.3	10.3	2.7	14.3	0.6	8.6	3.6	16.3	7.6	33.7	12.0	2.8	5.3	2.0	1.7	6.3	2.7	5.7	9.8	0.0	20.3	0.1	0.1	0.0	0.0	0.1	14.9	5.9	11.7	0.0	0.2	0.4	14.0	15.9	6.3	2.6	4.2	4.8	5.9	0.0	9.1	2.8	36.0	0.0	21.3	5.5	0.1	2.0	0.0	4.0	0.0	12.1	0.0	0.1	5.7	7.2	5.0	1.8	0.4	0.0	0.1	4.0	0.3	0.0	0.1	3.6	1.2	0.0	2.3	0.8	36.7	25.1	0.8	0.1	21.6	1.2	9.5	0.0	0.2	7.9	15.5	5.8	0.1	2.8	1.1	0.0	0.1	3.6	0.0	19.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.1	2.9	3.9	0.7	2.2	2.8	2.1	8.1	1.0	5.6	5.3
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 105.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavourable (9.01e-4)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavourable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	16.8	14.4	16.5	10.4	20.2	7.0	47.6	9.9	18.2	18.5	10.9	11.3	7.4	5.6	14.8	12.2	11.6	22.4	14.1	23.9	17.0	10.9	19.0	39.9	18.1	7.5	33.5	4.9	22.3	13.1	11.1	8.6	33.5	25.4	17.9	9.4	8.6	8.5	10.4	63.5	10.3	7.8	15.1	45.8	9.7	11.1	9.7	30.9	4.1	19.4	7.5	7.3	34.4	105.7	6.9	14.8	10.2	17.3	3.4	7.3	6.1	17.3	4.5	13.0	25.3	40.2	30.9	10.9	51.0	46.2	19.7	47.4	7.4	13.5	5.9	19.5	50.4	19.7	8.2	18.6	43.3	7.5	3.1	5.0	4.3	8.8	16.7	9.2	3.5	18.7	10.9	16.8	22.3	9.3	7.8	3.1	17.0	4.6	3.6	8.9	4.6	19.8	3.4	8.7	10.6	11.1	7.5	1.2	7.3	10.4	30.8	12.1	4.7	8.7	8.8	24.2	10.0	6.7	11.8	17.7	6.4	2.8	43.4	13.5	11.7	0.8	13.5	10.2	5.2	16.4	6.7	6.0	6.2	6.0	14.8	6.9	4.6	4.7	7.4	3.4	17.3	11.8	7.3	6.1	16.5	20.2	9.9	18.2	17.0	10.9	33.5	4.9	25.4	30.9
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132191838-132295315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 61.3;U-87 MG: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"			"Endoplasmic reticulum, Vesicles"		"CAB062557: , HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (3.12e-4)"	10.2	5.6	7.1	6.5	5.4	0.8	12.2	9.5	7.8	14.4	12.5	4.6	6.1	9.8	20.0	35.3	11.6	13.7	9.7	26.1	6.6	7.0	34.4	6.3	16.0	4.3	6.3	4.2	6.7	42.5	6.7	15.8	15.1	9.5	9.3	14.6	15.1	21.1	8.4	7.1	9.3	17.1	23.3	5.1	6.3	12.6	5.1	4.4	4.1	12.2	10.8	5.4	11.3	34.5	0.2	1.0	3.1	1.3	2.6	2.6	0.7	10.1	6.2	2.0	9.9	27.9	33.3	11.3	47.5	40.6	20.2	50.0	14.0	8.9	0.2	14.0	50.8	12.8	6.2	24.8	32.0	7.5	2.1	0.0	9.1	8.4	61.3	0.0	6.1	20.1	36.7	23.9	22.0	10.6	3.6	0.6	24.7	4.0	0.0	0.0	0.5	5.1	0.1	0.6	1.5	5.6	1.9	1.0	2.8	12.1	4.0	8.0	5.0	0.7	16.3	30.7	12.0	9.3	10.2	4.3	4.6	2.0	59.2	0.0	8.5	0.0	1.3	0.0	2.6	1.1	2.4	0.0	1.4	0.4	0.6	0.2	0.0	0.4	3.1	2.6	0.2	1.0	0.0	0.7	7.1	5.4	9.5	7.8	6.6	7.0	6.3	4.2	9.5	4.4
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"		140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	57.7	50.3	18.6	60.0	50.4	59.3	44.2	112.8	72.8	49.2	66.6	36.9	50.6	23.3	49.6	72.5	41.0	20.5	44.1	28.5	15.0	34.7	34.9	52.9	150.1	66.3	110.1	57.7	44.7	30.0	39.3	41.7	81.0	24.7	100.7	35.0	52.7	31.5	87.5	14.6	45.8	25.8	33.3	46.2	38.2	69.8	22.4	24.8	56.2	162.4	58.5	73.4	129.7	62.9	92.4	46.3	52.4	55.0	72.4	52.4	22.0	121.4	42.4	70.4	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2
PABPC1	"PAB1, PABP1, PABPC2, PABPL1"	ENSG00000070756	"Poly(A) binding protein cytoplasmic 1"	P11940	8	100685816-100722809	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB011536, HPA045423, HPA067156"	Supported		Supported	Cytosol			2700000	Cytosol		"CAB011536: AB_777008, HPA045423: , HPA067156: "	"unprognostic (5.00e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-1)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (2.51e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (5.70e-12)"	"unprognostic (6.22e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.98e-3)"	"unprognostic (1.40e-2)"	85.6	49.6	33.6	66.1	38.8	94.2	80.5	35.8	32.5	84.2	80.7	41.9	57.2	64.1	85.3	48.8	195.5	54.6	56.4	35.1	32.3	19.3	43.6	83.2	72.8	156.2	40.6	24.3	111.1	106.9	31.8	34.1	50.6	36.8	88.2	71.5	43.4	192.9	79.0	35.1	95.4	104.0	89.9	65.2	135.3	73.4	98.7	37.6	137.2	65.4	63.0	157.9	120.9	116.4	70.8	98.4	32.3	106.7	65.9	106.0	90.6	180.2	45.1	35.3	64.1	66.2	131.6	61.0	44.1	63.9	47.5	51.8	53.9	84.9	228.8	172.1	77.6	70.0	55.3	86.3	81.3	69.9	36.5	118.0	34.0	69.3	82.1	50.5	83.5	122.2	136.7	44.2	217.6	74.2	99.1	88.1	70.4	52.5	251.4	105.3	79.1	64.1	83.0	42.9	82.6	57.4	117.4	49.3	54.9	29.4	46.0	103.0	82.8	83.8	69.1	42.8	79.9	62.8	74.2	86.4	59.8	128.2	50.4	113.5	43.0	27.6	83.3	28.8	39.7	99.9	84.2	70.8	78.3	64.4	98.4	62.6	106.0	85.1	32.3	65.9	106.7	65.5	67.4	90.6	33.6	38.8	35.8	32.5	32.3	19.3	40.6	24.3	36.8	37.6
PABPC4	"APP-1, iPABP"	ENSG00000090621	"Poly(A) binding protein cytoplasmic 4"	Q13310	1	39560816-39576790	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 137.3;skeletal muscle: 117.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027301, HPA056496"	Approved		Enhanced	Cytosol				Cytosol		"HPA027301: , HPA056496: "	"unprognostic (6.81e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (1.14e-7)"	"unprognostic (2.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavourable (3.00e-10)"	"unprognostic (1.87e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.08e-1)"	30.0	19.2	9.0	23.0	7.9	20.8	19.6	7.2	9.6	19.1	26.0	14.0	22.0	12.4	22.2	21.1	20.3	13.7	20.2	32.0	8.6	7.2	12.3	28.8	24.9	38.2	8.3	7.3	28.6	137.3	9.1	8.2	16.2	8.6	20.7	11.5	15.4	16.4	22.9	117.8	12.9	21.1	22.4	16.4	27.5	28.0	29.2	6.4	21.5	18.1	51.1	21.0	25.3	20.3	13.9	13.7	6.7	21.2	8.2	21.4	5.5	56.9	15.5	16.5	27.4	41.3	82.1	54.3	33.7	23.7	26.2	19.5	31.0	29.9	49.2	33.5	42.3	30.5	31.4	37.6	33.9	25.1	25.9	41.5	17.7	30.9	41.5	27.4	27.9	71.2	44.6	31.8	48.5	32.8	43.9	27.3	42.0	22.2	28.4	35.4	51.1	17.8	21.8	52.9	37.3	25.3	56.3	15.6	23.7	23.5	22.5	51.0	23.9	81.3	29.6	25.5	35.4	61.7	42.5	70.4	77.2	38.3	37.8	27.8	14.5	6.7	13.9	3.5	9.9	18.0	10.6	13.8	16.1	10.3	13.7	13.9	21.4	15.1	1.4	8.2	21.2	13.5	11.2	5.5	9.0	7.9	7.2	9.6	8.6	7.2	8.3	7.3	8.6	6.4
PACSIN2	SDPII	ENSG00000100266	"Protein kinase C and casein kinase substrate in neurons 2"	Q9UNF0	22	42835412-43015145	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049854, HPA056520"	Enhanced		Supported	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"			83000	"Nuclear speckles, Vesicles, Cytosol"	"Plasma membrane"	"HPA049854: AB_2680915, HPA056520: AB_2683163"	"unprognostic (5.62e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (4.48e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (1.09e-13)"	"unprognostic (2.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.95e-1)"	20.1	42.0	19.4	19.4	20.7	14.3	22.9	32.3	21.3	18.7	28.4	17.5	21.1	22.5	20.8	18.9	19.3	17.5	33.3	28.0	17.9	19.5	32.5	20.7	25.8	16.9	20.6	15.7	17.4	77.3	14.3	21.5	33.8	32.4	24.6	23.5	26.6	31.7	16.6	23.9	19.4	25.6	25.1	17.8	22.5	27.8	12.6	19.2	13.1	31.0	15.8	18.4	17.7	17.6	4.7	8.3	37.9	12.6	6.7	4.5	5.0	24.7	26.0	21.9	14.0	11.3	12.1	18.0	22.6	13.7	20.5	17.1	27.0	14.6	11.5	19.2	16.7	17.6	14.3	24.0	13.5	11.7	14.2	18.5	13.3	38.4	16.1	13.0	40.4	11.6	23.7	26.9	11.8	16.7	16.0	8.4	17.5	16.2	13.8	20.5	12.0	11.0	17.0	32.8	7.7	23.5	14.7	14.3	6.4	27.0	18.7	50.7	13.5	17.4	24.7	15.3	19.5	16.9	13.3	6.3	8.6	12.6	14.6	11.6	33.2	7.9	7.0	17.4	2.8	12.6	3.0	4.2	3.2	2.4	8.3	4.7	3.2	2.4	37.9	6.7	12.1	3.1	4.5	5.0	19.4	20.7	32.3	21.3	17.9	19.5	20.6	15.7	32.4	19.2
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177525-47186443	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	4.1	17.0	3.9	2.2	5.7	0.4	4.3	3.5	4.7	6.5	8.5	8.6	7.1	1.6	6.7	7.6	12.6	4.8	5.8	40.6	4.0	2.4	2.9	10.0	3.9	0.8	7.6	3.6	6.3	14.6	4.8	1.0	8.0	4.4	8.6	1.1	4.6	11.3	6.7	121.6	11.9	1.9	7.4	8.3	1.5	6.0	1.6	6.5	0.3	8.5	44.6	7.1	6.4	5.7	0.0	0.1	0.0	0.9	0.0	0.2	0.9	16.4	8.3	3.8	16.6	3.3	3.3	18.6	5.1	7.4	10.8	6.1	12.3	2.3	0.1	1.6	2.8	27.1	7.6	12.5	4.3	2.5	12.9	2.5	31.3	28.2	6.5	0.5	2.6	9.3	16.8	5.7	9.1	4.8	5.4	0.2	4.4	32.6	0.3	12.1	4.7	16.6	10.1	14.4	2.6	4.5	15.6	0.1	13.0	8.1	5.8	7.6	41.0	2.2	2.3	18.9	19.0	2.4	14.1	2.8	1.3	1.5	6.1	5.7	9.7	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.9	5.7	3.5	4.7	4.0	2.4	7.6	3.6	4.4	6.5
PAF1	"F23149_1, FLJ11123, PD2"	ENSG00000006712	"PAF1 homolog, Paf1/RNA polymerase II complex component"	Q8N7H5	19	39385852-39391195	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041875, HPA043637"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA041875: , HPA043637: "	"unprognostic (5.33e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-1)"	"unprognostic (8.37e-2)"	"prognostic favourable (8.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.73e-1)"	28.9	33.2	30.7	30.6	32.9	33.7	34.1	35.1	40.0	28.5	25.4	39.5	25.8	23.5	27.3	31.0	30.0	30.1	27.1	32.6	31.1	28.3	27.9	47.9	23.7	27.6	32.7	29.9	42.2	26.0	45.0	35.1	27.1	34.9	32.7	22.0	22.7	27.1	41.0	50.9	22.4	24.4	26.3	36.2	32.7	26.5	59.1	28.5	31.5	32.1	25.4	31.7	28.1	24.7	31.5	16.5	24.5	21.1	21.8	25.1	15.4	35.3	45.9	30.3	16.1	19.5	16.6	12.3	29.5	27.8	35.1	34.0	37.6	19.1	28.4	20.7	24.3	12.4	32.6	24.7	28.9	31.8	38.3	27.9	29.0	24.5	21.1	23.7	26.6	16.7	17.0	29.1	19.0	25.7	21.6	23.6	28.8	40.1	26.8	15.7	10.6	15.5	27.3	29.7	19.8	26.2	40.4	25.6	17.3	31.8	21.1	16.0	20.1	20.3	24.0	21.2	27.9	21.8	32.4	25.6	23.1	24.4	20.9	20.8	19.4	21.1	15.0	24.5	24.0	21.1	25.1	31.5	20.1	23.8	16.5	29.3	23.0	20.7	24.1	21.8	18.7	15.7	19.4	15.4	30.7	32.9	35.1	40.0	31.1	28.3	32.7	29.9	34.9	28.5
PAFAH1B1	"LIS1, MDCR, MDS, NudF, PAFAH"	ENSG00000007168	"Platelet activating factor acetylhydrolase 1b regulatory subunit 1"	P43034	17	2593210-2685615	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport"	"Developmental protein"	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004489, HPA020036"	Approved		Supported	Centrosome			1100000	Centrosome		"CAB004489: AB_627889, HPA020036: AB_1854925"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.17e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.80e-2)"	"prognostic favourable (3.16e-4)"	"unprognostic (3.31e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.58e-2)"	20.1	20.4	35.6	17.0	40.8	10.0	20.8	57.1	63.7	22.3	21.5	24.2	13.8	19.2	23.8	21.1	21.9	20.1	19.6	28.8	33.7	38.3	24.7	17.2	23.0	18.2	34.3	47.0	22.4	16.4	37.5	26.2	20.2	46.5	20.9	20.9	14.8	17.6	24.1	41.6	27.2	21.9	27.2	29.9	17.9	19.3	37.2	28.0	25.9	26.9	17.3	22.8	18.6	25.5	7.5	3.5	9.3	5.3	8.7	13.3	3.9	22.1	21.1	32.6	12.1	25.7	30.4	17.0	30.8	27.0	26.9	27.8	25.7	10.3	25.0	25.7	38.0	23.1	28.5	23.0	33.7	20.9	18.1	20.3	21.5	9.8	26.6	14.1	35.7	26.5	29.3	27.1	32.3	23.5	15.0	28.2	33.1	9.1	22.2	10.5	14.6	10.3	15.9	25.2	12.9	23.6	12.4	14.7	24.1	26.7	13.3	24.3	14.2	11.0	33.2	29.5	14.2	23.1	26.5	12.0	18.5	19.6	23.8	13.1	28.4	7.8	3.4	6.5	7.7	4.3	9.7	7.5	10.1	8.3	3.5	5.2	9.5	8.1	9.3	8.7	5.3	2.7	13.3	3.9	35.6	40.8	57.1	46.2	33.7	38.3	34.3	47.0	46.5	28.0
PAFAH1B2		ENSG00000168092	"Platelet activating factor acetylhydrolase 1b catalytic subunit 2"	P68402	11	117144267-117176894	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051836	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"			1600000	Cytosol	"Nucleoli, Plasma membrane"	"HPA051836: "	"unprognostic (1.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.21e-3)"	"prognostic unfavourable (9.44e-4)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.01e-1)"	"prognostic favourable (4.25e-4)"	"prognostic unfavourable (7.79e-5)"	"unprognostic (8.18e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	21.5	34.1	30.6	19.2	29.7	33.5	32.3	43.5	41.3	21.6	20.2	33.3	12.7	21.1	23.4	22.8	23.3	20.8	19.3	26.2	31.9	36.8	24.6	22.5	20.5	17.7	39.3	31.6	23.6	23.0	23.1	24.2	26.9	39.6	22.2	19.6	17.3	19.3	17.4	14.1	20.8	18.0	19.9	51.6	18.3	21.4	29.9	26.3	15.1	30.9	10.8	20.4	25.9	20.3	26.8	21.6	36.8	35.7	18.9	31.4	26.9	14.8	17.0	19.7	28.3	22.0	15.4	15.3	25.0	21.9	13.9	12.7	31.0	32.8	16.1	35.9	29.9	23.9	28.5	32.3	18.4	14.3	11.0	41.3	15.6	19.9	19.7	14.2	15.8	17.0	25.6	27.8	35.1	22.8	21.9	12.3	21.3	9.5	13.7	21.0	18.0	13.4	15.4	22.3	17.6	21.3	23.3	21.9	29.1	28.8	21.8	9.5	24.3	12.3	36.4	25.5	16.9	12.4	17.7	3.9	5.9	21.6	10.3	27.4	21.4	32.1	30.8	26.7	24.2	33.3	28.2	26.8	28.0	25.3	21.6	25.4	29.3	31.4	36.8	18.9	35.7	15.8	19.5	26.9	30.6	29.7	43.5	37.8	31.9	36.8	39.3	31.6	39.6	26.3
PAG1	"CBP, PAG"	ENSG00000076641	"Phosphoprotein membrane anchor with glycosphingolipid microdomains 1"	Q9NWQ8	8	80967810-81112068	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.1;HMC-1: 25.6;SK-MEL-30: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001632, HPA066527"	Enhanced		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA001632: AB_1079557, HPA066527: "	"unprognostic (8.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (1.24e-6)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (6.82e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.94e-3)"	5.5	3.8	5.3	20.2	6.1	12.2	4.1	22.3	7.6	2.7	12.3	5.4	2.3	8.6	3.5	2.8	2.9	3.2	12.1	5.5	6.4	4.3	3.2	6.4	20.3	21.2	7.5	4.2	2.6	16.6	0.8	4.2	17.7	7.7	3.9	10.1	10.6	5.0	4.4	3.8	6.2	14.9	3.5	9.9	12.1	5.1	1.4	7.4	15.2	3.4	0.4	15.3	6.2	4.4	2.2	4.1	10.9	13.3	1.6	6.8	2.4	0.0	0.0	2.7	0.1	5.1	4.9	0.1	1.1	8.6	0.5	1.1	0.1	0.0	19.1	0.1	0.3	0.8	0.0	1.0	0.5	0.5	2.5	11.2	0.2	0.0	5.2	1.8	25.6	2.3	0.6	5.0	4.7	0.0	0.1	0.1	8.2	0.1	6.7	0.1	0.2	0.7	5.1	1.3	0.0	0.9	4.1	0.5	1.0	0.0	0.2	19.9	0.6	1.9	0.1	0.6	0.3	0.0	0.6	3.2	0.8	6.8	5.5	6.4	4.7	10.9	1.4	1.9	2.6	6.3	6.5	2.2	6.6	4.6	1.8	1.4	5.4	4.0	2.3	1.6	13.3	4.1	6.8	2.4	5.3	6.1	22.3	7.6	6.4	4.3	7.5	4.2	7.7	7.4
PAIP2	PAIP2A	ENSG00000120727	"Poly(A) binding protein interacting protein 2"	Q9BPZ3	5	139341587-139369720	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035945, CAB037212, HPA056766"	Approved		Supported	Vesicles				Vesicles		"CAB037212: AB_1841072, HPA035945: AB_10672996, HPA056766: "	"unprognostic (1.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.80e-3)"	"unprognostic (7.70e-3)"	"unprognostic (8.91e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.92e-2)"	36.2	57.4	50.8	27.0	46.7	36.3	34.4	64.5	59.9	31.0	27.6	32.0	25.7	16.1	36.0	33.3	26.0	35.2	24.9	62.9	49.7	57.8	39.0	41.8	26.8	36.1	58.4	51.7	44.2	23.7	20.5	47.2	34.2	61.8	32.6	20.6	23.0	32.2	33.0	56.1	17.7	18.2	31.3	57.0	32.0	23.0	59.2	41.0	45.8	30.4	27.0	38.2	30.9	28.2	54.9	45.2	122.8	53.3	49.4	65.5	74.8	20.6	23.5	46.3	27.6	34.7	19.8	22.5	18.9	26.3	24.7	38.8	31.4	20.1	36.6	40.6	14.3	20.6	40.3	26.0	32.8	35.0	31.6	33.7	35.0	28.1	22.4	20.8	24.9	22.4	21.7	18.5	21.2	25.1	32.0	32.5	22.3	27.3	56.4	50.8	27.9	17.1	31.6	58.6	39.7	19.6	37.0	21.5	39.1	28.0	25.9	55.3	50.1	43.8	15.4	13.3	16.3	14.4	15.3	47.5	57.5	38.1	23.4	36.8	13.6	69.9	45.3	107.8	46.7	48.8	51.0	54.9	52.0	53.3	44.1	48.5	60.9	59.5	122.8	49.4	53.3	45.2	65.5	74.8	50.8	46.7	64.5	59.9	49.7	57.8	58.4	51.7	61.8	41.0
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77321707-77474635	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.0;brain: 71.4"	"Cell line enhanced"	"Detected in many"		"U-266/70: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"			200000	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	5.4	6.0	30.5	13.8	39.5	22.9	7.8	49.1	71.4	9.8	18.2	8.4	2.3	18.2	9.1	13.3	9.9	9.8	13.2	5.3	19.0	16.9	11.3	6.0	6.9	7.5	12.8	40.6	10.4	9.2	11.8	10.8	11.9	39.2	12.2	20.2	5.4	10.4	8.8	34.0	6.7	18.9	11.6	7.8	11.7	17.1	11.1	6.6	7.6	17.7	3.9	9.4	10.5	10.4	2.7	42.3	70.0	30.4	4.3	2.4	12.2	11.8	8.0	17.4	7.8	7.1	11.9	13.9	13.6	9.7	12.9	15.2	11.4	15.9	10.6	5.0	11.7	6.1	12.1	14.4	20.4	12.2	9.8	11.2	5.4	0.7	4.7	18.9	16.6	8.8	8.7	15.1	22.5	3.0	7.4	18.7	23.4	0.8	12.0	8.7	25.7	6.9	18.5	22.5	0.4	3.3	9.9	7.5	7.4	7.3	3.1	5.7	13.9	8.6	0.2	8.6	14.9	45.9	11.3	51.4	26.4	7.0	7.2	12.6	9.3	0.3	29.3	45.0	1.9	28.7	1.5	2.7	1.4	1.8	42.3	1.9	1.3	2.4	70.0	4.3	30.4	3.6	1.1	12.2	30.5	39.5	49.1	71.4	19.0	16.9	12.8	40.6	39.2	6.6
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694695-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 48.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli				Nucleoli		"HPA030111: , HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	12.8	9.9	12.0	12.2	9.7	11.5	15.9	9.1	15.7	12.7	8.7	5.8	7.7	5.9	10.5	9.9	15.7	8.7	7.2	8.6	9.2	9.8	12.3	17.5	7.2	16.3	10.9	9.2	13.8	10.6	6.8	9.1	9.1	11.3	48.8	9.8	4.2	10.3	10.4	20.6	7.8	6.8	10.5	10.1	10.9	7.4	6.3	9.9	8.4	9.3	18.5	11.7	8.2	9.1	8.4	11.5	2.4	10.3	8.1	12.3	5.8	14.1	5.6	7.3	12.5	9.1	8.3	10.5	9.3	7.7	14.1	13.9	12.3	6.4	14.4	23.4	7.9	7.6	14.9	12.0	20.4	8.4	10.0	7.9	5.2	14.1	13.3	21.8	10.4	7.7	10.5	13.7	23.4	9.4	23.8	4.2	11.7	8.4	10.9	20.1	15.8	10.0	11.3	9.5	22.3	10.2	8.5	11.0	9.5	6.9	17.9	19.9	7.9	8.0	8.1	11.5	8.3	12.3	23.0	9.9	27.0	15.8	4.7	14.7	21.5	1.1	7.1	2.4	8.4	10.3	8.6	8.4	7.6	8.4	10.0	6.4	10.2	12.3	0.3	8.1	8.0	11.5	4.8	5.8	12.0	9.7	9.1	15.7	9.2	9.8	10.9	9.2	11.3	9.9
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 44.6;MCF7: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavourable (9.85e-4)"	"prognostic favourable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	6.8	11.1	11.0	12.7	12.3	4.8	11.9	13.7	12.4	17.3	19.6	13.7	19.9	26.0	12.2	17.3	20.1	15.3	16.5	8.1	10.9	8.1	19.4	17.0	18.7	5.4	13.7	7.7	13.8	29.6	11.2	17.0	23.0	10.3	29.6	8.1	19.7	40.9	18.5	10.3	18.6	25.1	9.0	8.3	7.9	18.6	22.3	12.5	8.8	15.2	10.1	14.7	11.5	15.0	2.8	3.4	4.2	2.5	3.6	4.5	1.9	17.6	44.6	6.6	10.1	2.1	2.2	20.1	8.4	3.4	5.7	5.7	29.2	15.0	4.0	12.8	5.3	6.5	3.6	6.7	2.1	10.7	10.2	4.8	8.1	14.2	3.4	4.8	7.0	2.7	3.0	5.3	3.8	7.4	9.5	3.2	3.4	49.1	5.1	5.3	12.1	10.7	5.2	5.2	3.0	5.5	19.4	21.3	14.7	8.6	38.3	9.5	17.0	8.0	12.3	9.7	16.7	11.1	15.0	3.6	3.4	3.3	11.9	2.9	11.6	1.0	2.5	4.2	2.6	1.4	3.6	2.2	2.9	4.5	3.4	2.8	2.2	2.2	2.1	3.6	2.1	2.9	3.0	1.9	11.0	12.3	13.7	12.4	10.9	8.1	13.7	7.7	10.3	12.5
PALB2	"FANCN, FLJ21816"	ENSG00000083093	"Partner and localizer of BRCA2"	Q86YC2	16	23603160-23641310	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB014895, HPA057000"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB014895: , HPA057000: "	"unprognostic (1.11e-1)"	"unprognostic (5.67e-3)"	"prognostic favourable (2.83e-5)"	"unprognostic (1.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (2.35e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.21e-1)"	12.4	9.9	10.7	19.6	11.9	6.8	15.2	16.5	14.1	12.4	14.0	10.8	9.1	14.8	10.9	13.5	17.6	9.6	7.8	10.5	10.0	10.6	13.7	16.1	9.2	13.4	9.7	12.5	15.3	10.6	13.7	16.1	9.1	14.9	10.9	12.7	8.6	11.0	14.7	10.3	17.0	14.1	12.8	10.8	14.1	11.0	16.9	10.5	12.9	12.1	12.0	15.3	13.6	13.3	3.7	3.9	7.2	7.7	3.9	5.5	2.0	11.8	9.2	11.1	7.7	9.2	7.3	9.9	8.6	13.1	14.1	17.1	7.8	12.4	12.5	6.3	6.0	10.6	9.8	14.4	16.9	7.3	5.7	7.6	12.6	21.9	8.6	14.0	12.4	8.2	14.7	13.3	15.2	7.5	15.7	6.7	12.4	11.7	14.4	14.6	24.6	5.3	16.7	13.6	17.1	10.7	10.6	8.2	8.1	8.8	10.0	11.2	9.2	9.6	5.4	16.9	6.5	8.3	9.2	7.9	12.8	12.8	11.1	10.3	10.1	7.2	3.3	3.0	4.4	4.2	5.3	3.7	4.9	5.3	3.9	3.1	5.5	4.3	0.2	3.9	7.7	2.8	3.1	2.0	10.7	11.9	16.5	14.1	10.0	10.6	9.7	12.5	14.9	10.5
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497066-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 203.3"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Actin filaments"	Cytosol	"CAB070159: AB_1726016, HPA035905: "	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.28e-4)"	17.3	8.9	8.5	19.6	7.5	0.1	28.1	2.1	6.7	58.4	71.9	5.7	46.4	6.7	82.2	25.6	84.3	31.3	30.8	95.0	9.2	3.2	12.7	3.6	24.9	17.0	4.6	4.7	28.0	3.0	25.6	3.9	14.0	6.0	71.4	17.9	9.2	11.4	50.9	30.5	8.9	16.8	203.3	6.7	25.8	31.4	14.1	6.9	2.2	12.7	17.2	5.8	140.3	82.7	0.2	2.2	13.6	3.2	0.6	5.1	1.5	17.6	8.7	19.4	12.0	17.9	19.5	27.3	12.1	30.5	10.7	15.2	0.2	1.0	7.6	3.1	5.2	3.7	11.8	30.8	13.7	16.0	3.6	0.1	25.1	2.2	31.3	0.0	0.2	29.7	19.2	19.1	28.7	4.5	0.0	0.1	64.4	0.8	5.1	0.3	5.6	5.2	1.7	18.0	0.1	1.2	3.5	2.0	10.5	22.8	1.7	1.6	10.8	0.1	14.5	11.2	42.4	4.7	19.6	10.9	0.1	0.3	9.4	0.2	3.1	13.6	3.2	0.0	5.1	1.9	0.2	0.1	0.6	2.7	2.2	0.2	0.6	2.0	0.8	0.6	1.2	0.2	0.5	1.5	8.5	7.5	2.1	6.7	9.2	3.2	4.6	4.7	6.0	6.9
PALM	KIAA0270	ENSG00000099864	Paralemmin	O75781	19	708939-748329	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 47.6;brain: 56.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.2;EFO-21: 15.0;REH: 26.6;SH-SY5Y: 17.1;U-2197: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	35	"monocytes: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041713, HPA049578"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA041713: AB_10794305, HPA049578: AB_2680822"	"unprognostic (9.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-2)"	"prognostic favourable (9.81e-4)"	"unprognostic (2.74e-2)"	"prognostic favourable (5.44e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.00e-2)"	47.6	11.8	49.1	5.1	39.9	2.2	11.3	13.3	56.5	22.7	8.2	12.4	4.2	9.2	10.7	6.7	5.8	17.7	7.2	9.6	37.7	18.9	21.9	3.5	9.0	2.2	19.2	28.1	21.2	2.1	1.2	10.2	17.6	11.9	12.2	2.7	6.1	5.9	18.6	7.0	6.9	7.5	9.0	14.7	10.5	3.6	8.2	12.5	0.0	3.3	3.3	1.9	5.0	8.4	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	4.3	8.4	16.2	1.3	0.1	1.2	1.1	0.0	1.1	0.3	1.0	0.0	0.0	15.0	0.1	1.5	4.2	0.0	0.2	0.0	8.3	0.0	3.4	5.3	5.9	0.0	0.1	3.8	0.0	0.7	0.0	0.6	2.9	0.0	1.1	8.5	0.6	5.0	3.4	2.4	26.6	0.0	0.1	0.4	0.0	0.9	17.1	4.3	0.0	0.1	1.5	4.0	0.0	0.0	8.8	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	49.1	39.9	13.3	44.4	37.7	18.9	19.2	28.1	11.9	12.5
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99645943-99694541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.9;skeletal muscle: 106.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 42.5;LHCN-M2: 13.7;TIME: 59.6;U-87 MG: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"				"Actin filaments"	"Plasma membrane, Focal adhesion sites"	"HPA017959: AB_1854949, HPA030549: "	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favourable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favourable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	84.9	18.6	8.3	6.2	4.3	0.0	46.4	1.1	3.7	17.1	6.5	3.9	4.0	1.3	18.6	10.1	16.2	8.7	5.3	59.0	5.6	3.4	5.1	20.9	10.6	3.4	3.9	3.8	17.4	2.2	4.4	4.7	16.8	19.0	8.1	2.6	7.9	34.0	4.4	106.9	18.0	3.5	12.2	4.1	2.3	2.8	7.5	2.2	2.1	3.4	48.2	6.2	6.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.7	2.9	0.0	0.1	0.0	0.0	0.0	0.0	5.5	7.1	0.0	0.0	0.0	1.1	0.5	0.0	0.0	42.5	6.0	0.0	13.7	0.1	0.0	0.0	0.0	1.8	0.0	10.6	0.0	0.0	2.2	0.2	0.1	0.0	2.7	0.0	0.6	0.0	59.6	0.0	0.1	4.6	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	4.3	1.1	3.7	5.6	3.4	3.9	3.8	19.0	2.2
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929882	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol				Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	15.2	21.5	18.7	18.5	18.9	20.8	19.7	21.8	24.8	14.7	14.4	16.8	10.7	11.8	15.5	15.5	28.9	19.1	14.3	11.0	17.4	18.6	18.8	20.3	16.1	18.5	16.2	16.2	14.4	13.5	15.3	15.7	18.1	20.8	14.5	16.4	17.0	15.8	13.2	14.4	12.8	14.5	16.6	12.3	20.6	12.1	28.9	14.1	23.2	17.0	10.5	24.6	17.3	16.4	5.8	8.6	8.0	12.8	8.3	6.4	3.1	21.4	13.9	15.0	7.6	18.0	15.6	8.2	14.1	15.5	18.6	24.1	18.7	11.5	17.4	6.5	15.8	17.7	16.1	27.4	23.8	5.1	7.1	23.8	9.9	34.9	15.1	15.8	7.9	13.7	12.0	20.7	13.4	17.4	17.5	16.3	20.0	5.3	13.6	14.0	15.0	10.4	11.2	20.9	11.0	11.5	19.7	19.6	9.6	17.5	19.2	34.9	11.6	12.8	11.9	22.3	11.2	29.1	21.6	9.2	26.6	13.3	6.6	14.5	17.4	1.6	11.2	4.7	4.4	12.8	4.3	4.7	4.3	4.5	8.6	5.8	4.4	4.0	8.0	8.3	10.7	3.0	6.4	3.1	18.7	18.9	21.8	24.8	17.4	18.6	16.2	16.2	20.8	14.1
PANX1	"MRS1, PX1, UNQ2529"	ENSG00000110218	"Pannexin 1"	Q96RD7	11	94128928-94181972	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016930	Uncertain		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA016930: AB_1854954"	"unprognostic (1.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (7.09e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (1.49e-7)"	"unprognostic (1.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-3)"	13.5	9.4	7.9	13.5	14.3	3.8	18.0	7.8	14.8	10.1	11.8	5.6	4.3	6.1	10.8	6.6	9.4	8.7	13.7	13.4	5.6	10.2	8.7	19.4	14.7	6.7	7.4	9.2	9.0	8.5	10.1	7.8	11.0	8.7	9.4	8.6	3.9	9.7	8.6	29.8	11.5	7.4	14.7	5.0	9.6	10.7	12.3	7.4	12.7	10.2	13.9	8.7	13.6	14.1	2.6	5.0	3.6	7.4	4.2	5.1	6.1	11.6	5.0	13.2	7.9	12.3	16.8	8.6	14.6	31.2	12.6	15.6	12.7	18.5	3.7	13.7	14.9	24.9	10.3	24.2	12.8	16.0	5.4	17.4	5.2	6.5	11.9	8.9	15.6	13.2	17.1	16.4	14.8	10.5	11.2	13.7	14.0	3.7	14.7	2.1	10.4	9.0	17.6	17.5	4.6	8.2	11.7	5.5	16.0	10.2	5.9	7.0	12.5	4.6	7.5	25.1	13.0	8.2	14.5	2.2	8.5	6.2	10.4	9.2	15.9	3.6	7.4	0.5	4.3	4.2	5.0	2.6	3.5	4.4	5.0	2.4	3.2	3.6	0.5	4.2	2.6	0.8	5.1	6.1	7.9	14.3	7.8	14.8	5.6	10.2	7.4	9.2	8.7	7.4
PANX2	"hPANX2, PX2"	ENSG00000073150	"Pannexin 2"	Q96RD6	22	50170731-50180294	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 8.9;HDLM-2: 13.7;Hep G2: 16.0;MCF7: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 1.8;granulocytes: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004624, HPA039117"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA004624: , HPA039117: AB_10805354"	"unprognostic (1.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-9)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.08e-1)"	1.6	2.6	10.3	2.6	9.2	5.3	1.4	22.4	31.4	1.8	1.1	1.2	10.5	1.1	2.4	2.7	3.8	4.9	2.3	1.1	14.2	8.8	3.4	7.8	2.4	1.2	15.9	7.9	3.5	3.0	1.0	4.1	1.6	23.9	3.8	1.0	1.5	5.5	6.2	1.5	2.6	1.2	1.2	4.5	2.7	1.4	2.6	2.4	0.0	3.8	0.2	1.5	1.8	0.9	0.0	1.8	5.2	0.0	0.0	0.0	0.0	0.8	1.8	0.3	1.9	0.0	0.2	4.2	2.2	2.2	0.5	0.3	0.4	6.7	0.0	8.9	0.2	0.4	1.1	0.8	0.1	13.7	1.2	0.3	2.8	16.0	0.7	0.1	1.0	0.1	0.9	0.6	0.0	0.5	1.1	0.0	0.2	8.8	0.0	0.8	3.3	3.6	0.8	0.0	3.3	0.0	1.3	8.4	0.8	1.4	0.1	5.1	0.5	0.6	3.8	0.4	3.6	5.8	4.1	1.5	0.1	0.5	0.2	0.0	6.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.8	0.0	0.0	10.3	9.2	22.4	31.4	14.2	8.8	15.9	7.9	23.9	2.4
PAPD7	"LAK-1, POLK, POLS, TRF4, TRF4-1"	ENSG00000112941	"Poly(A) RNA polymerase D7, non-canonical"	Q5XG87	5	6713007-6757048	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045487, HPA046742"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"				Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA045487: AB_2679346, HPA046742: AB_2679781"	"unprognostic (1.45e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.62e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (7.99e-5)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.60e-2)"	"prognostic favourable (8.55e-4)"	13.5	7.9	9.6	13.9	11.1	25.8	16.3	22.7	12.3	15.1	16.6	10.6	14.8	9.5	13.2	8.0	12.2	11.3	11.4	8.6	10.7	7.3	9.7	19.9	13.2	14.1	14.8	5.8	18.5	13.3	13.2	12.2	10.0	9.0	11.6	8.3	10.2	17.0	10.6	10.4	16.7	13.1	13.9	7.9	14.8	10.1	11.1	11.7	25.4	11.3	11.3	11.6	12.5	34.9	1.9	3.8	0.7	0.7	0.5	2.3	0.8	16.3	11.1	13.7	16.8	9.9	8.9	19.7	11.1	14.0	13.9	15.8	11.5	9.1	12.0	8.6	13.7	12.2	11.1	8.6	12.8	13.4	7.1	6.1	35.1	6.2	6.2	9.2	9.3	6.0	7.5	15.5	10.0	8.1	8.2	15.9	11.3	9.0	12.5	12.0	7.4	8.7	11.3	11.6	3.0	5.5	9.4	13.6	10.4	26.6	12.9	7.6	7.8	5.1	7.1	16.7	17.5	14.6	15.5	15.2	6.3	10.6	10.8	8.6	10.3	0.0	0.7	0.7	2.1	0.4	2.3	1.9	1.7	1.6	1.2	1.5	1.9	1.7	0.4	0.5	0.6	3.8	1.8	0.8	9.6	11.1	22.7	12.3	10.7	7.3	14.8	5.8	9.0	11.7
PAPOLA	PAP	ENSG00000090060	"Poly(A) polymerase alpha"	P51003	14	96501433-96567111	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001788	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA001788: AB_1079564"	"unprognostic (3.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavourable (2.41e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.05e-1)"	35.8	43.4	49.1	45.7	51.6	54.5	39.7	61.2	60.5	41.0	45.1	25.2	45.6	34.9	43.8	48.3	42.0	38.7	35.6	71.8	46.3	39.6	40.0	50.2	37.1	44.7	48.1	39.7	58.2	52.9	50.2	68.7	54.5	45.6	45.1	45.8	24.0	39.2	45.5	46.4	35.5	45.5	38.9	41.9	50.9	40.4	53.0	55.7	53.0	54.8	34.8	49.6	44.9	119.5	26.4	23.0	39.0	23.5	25.2	23.4	19.8	32.0	31.0	39.9	40.0	28.9	32.7	90.8	29.4	31.8	35.0	33.7	35.8	33.2	43.5	33.9	34.4	27.8	13.0	40.5	62.8	35.9	21.1	35.1	23.5	35.1	29.9	45.9	35.6	29.8	35.5	39.1	35.0	39.1	32.9	39.9	33.7	46.7	35.9	23.3	27.2	35.3	38.4	48.6	25.2	34.9	51.2	41.0	27.2	39.2	30.8	28.6	43.7	40.4	31.1	24.7	19.7	27.8	35.8	31.5	47.1	38.4	40.0	35.2	41.4	39.0	19.7	32.7	15.5	23.5	20.4	23.8	19.6	22.6	23.0	26.4	23.4	21.8	27.4	25.2	22.6	15.2	18.7	19.8	49.1	51.6	61.2	60.5	46.3	39.6	48.1	39.7	45.6	55.7
PAPOLG	FLJ12972	ENSG00000115421	"Poly(A) polymerase gamma"	Q9BWT3	2	60756230-60802085	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017795, HPA035349, HPA035350"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB017795: , HPA035349: , HPA035350: "	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.72e-4)"	"unprognostic (2.49e-1)"	"unprognostic (6.97e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (4.21e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.62e-2)"	12.3	9.5	11.6	11.6	11.9	5.8	9.9	19.4	15.3	10.2	8.2	9.8	7.8	6.8	12.1	6.2	10.1	9.0	10.2	8.5	15.1	10.1	8.6	6.9	9.4	14.8	10.9	11.3	17.1	9.9	13.3	18.9	11.8	12.5	9.6	9.2	7.7	11.1	8.7	13.1	11.7	9.7	9.9	21.0	15.0	9.1	14.2	11.0	23.1	27.5	6.6	14.3	10.9	11.1	6.1	3.7	13.2	6.9	9.4	9.7	4.1	5.1	4.8	9.0	7.3	11.6	8.7	8.6	5.7	5.6	4.9	5.2	8.1	4.4	7.4	6.0	4.4	8.7	12.7	5.4	9.2	12.8	6.8	9.4	4.7	5.7	7.0	9.8	6.5	6.5	6.4	5.9	12.4	7.8	9.2	7.0	5.4	4.1	11.3	6.7	14.3	4.4	9.3	16.0	6.6	5.3	4.9	5.3	7.4	9.1	5.7	5.1	3.8	6.0	7.3	6.3	7.6	4.7	5.3	7.0	4.1	18.0	5.1	11.2	4.5	13.2	4.1	8.7	6.7	4.3	8.3	5.9	7.2	6.0	3.7	6.1	7.9	7.3	10.6	9.4	6.9	3.3	9.7	4.1	11.6	11.9	19.4	15.3	15.1	10.1	10.9	11.3	12.5	11.0
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Golgi apparatus"	"HPA064625: "	"prognostic favourable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favourable (6.40e-4)"	2.4	3.5	25.6	6.6	32.4	1.3	2.2	14.9	31.0	4.2	28.9	35.5	14.2	14.5	4.4	6.7	13.7	5.4	4.9	2.9	27.3	17.5	5.3	1.5	5.8	7.2	48.5	15.8	19.5	2.5	3.7	1.8	5.5	28.2	3.8	28.1	1.9	1.9	28.5	1.1	2.7	25.1	5.2	69.2	4.8	24.1	3.1	36.5	3.1	2.6	0.4	6.0	7.3	3.3	1.0	6.0	2.0	2.6	7.0	16.3	3.2	0.6	0.6	7.0	3.0	4.3	7.0	4.8	2.1	7.9	1.3	2.9	2.6	2.4	0.7	0.8	1.4	0.3	0.9	3.4	2.1	9.4	1.2	4.2	0.6	26.5	1.2	1.1	0.6	1.9	0.4	0.9	5.0	7.5	0.9	4.2	5.4	0.9	2.7	3.8	3.6	0.3	7.3	1.1	1.7	8.2	2.0	2.7	5.7	0.5	0.2	8.0	0.2	9.4	3.1	2.7	1.1	0.8	1.2	1.2	1.6	1.0	2.5	10.9	14.0	2.0	2.6	1.3	2.5	0.5	3.8	0.9	7.6	5.2	6.0	1.0	16.3	7.6	0.5	7.0	0.5	3.0	4.7	3.2	25.6	32.4	14.9	22.8	27.3	17.5	48.5	15.8	28.2	36.5
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Cell Junctions,Cytoplasmic bodies"				"Cell Junctions"	"Cytoplasmic bodies"	"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavourable (4.41e-4)"	16.4	12.9	13.8	7.0	15.8	0.3	16.8	4.4	8.3	24.8	20.3	7.4	19.7	7.1	21.4	13.6	34.5	14.7	13.2	17.1	10.7	6.3	18.0	15.9	15.2	3.0	7.8	4.3	28.4	26.2	19.0	15.8	14.4	8.8	20.5	15.3	11.7	15.5	17.3	28.3	34.4	14.9	21.1	8.7	3.3	14.2	9.1	9.2	12.8	15.6	14.6	13.4	20.7	29.5	0.0	0.0	9.0	0.1	0.0	0.0	2.1	18.9	46.1	15.7	10.6	11.8	10.1	22.4	8.6	10.4	15.3	17.3	16.8	16.1	0.1	12.5	18.0	13.8	13.3	22.3	19.9	0.1	9.9	0.0	5.8	17.2	15.0	2.0	0.0	12.2	21.4	20.0	15.2	9.6	12.8	6.0	18.4	13.2	21.3	1.4	6.6	16.4	17.0	15.9	8.3	31.8	14.6	8.1	8.1	10.2	14.7	15.9	8.2	2.5	11.0	7.7	22.4	14.3	9.0	4.9	6.0	0.0	8.3	0.0	8.4	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.1	13.8	15.8	4.4	8.3	10.7	6.3	7.8	4.3	8.8	9.2
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545793-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.9;BJ hTERT+: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	13.9	4.3	6.7	6.9	6.5	0.0	8.6	2.1	4.6	11.9	17.5	8.3	11.3	5.3	15.1	8.9	7.1	10.3	11.8	6.7	7.9	5.3	10.8	5.0	8.2	2.9	7.5	4.3	12.6	12.3	13.5	3.6	6.3	7.7	11.7	8.5	14.7	5.0	8.5	4.5	7.1	14.1	26.1	6.7	4.4	7.2	5.4	7.5	0.8	8.6	7.3	3.7	9.6	22.7	0.0	0.0	0.0	0.1	0.0	1.0	0.1	2.2	1.8	5.4	1.9	16.9	8.0	3.1	3.4	10.7	2.8	3.2	5.0	1.5	0.0	4.1	6.7	0.2	0.7	0.8	3.0	0.1	2.7	7.4	4.4	0.0	1.7	0.0	0.4	3.1	1.5	1.0	4.8	4.2	0.2	0.1	4.0	0.8	0.0	0.0	0.8	0.5	0.0	2.6	1.8	3.5	2.3	0.6	1.8	1.8	1.7	1.4	2.6	0.0	9.4	2.3	1.6	4.8	1.6	0.0	0.0	0.0	2.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.1	6.7	6.5	2.1	4.6	7.9	5.3	7.5	4.3	7.7	7.5
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662778	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.8;pancreas: 31.0"	"Cell line enhanced"	"Detected in many"		"REH: 17.6;RPMI-8226: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"				"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: "	"prognostic favourable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	2.7	6.1	11.7	3.5	12.4	2.1	2.8	26.8	16.1	2.0	3.0	2.2	3.7	2.0	2.4	3.6	2.7	2.5	3.1	2.3	13.8	7.2	5.5	3.1	3.5	4.0	7.9	5.7	3.3	31.0	5.3	13.9	1.5	7.4	2.7	2.0	1.4	3.8	4.6	7.0	1.5	2.5	2.7	3.7	3.7	3.2	16.9	3.4	2.5	2.3	1.4	3.4	2.9	3.1	11.4	5.3	3.7	1.0	1.2	8.5	2.1	5.6	6.1	1.7	14.9	1.2	0.2	3.1	0.1	0.7	2.2	2.1	3.0	2.4	9.5	2.9	0.1	4.5	3.4	0.7	0.5	4.4	3.2	3.8	2.8	3.5	1.6	1.6	9.0	0.1	0.3	2.1	0.8	1.1	0.3	2.2	0.4	5.5	9.7	2.0	2.0	4.0	17.6	1.1	15.3	5.9	3.3	14.5	7.8	0.9	2.1	2.3	13.1	0.6	0.9	0.2	0.5	1.4	2.9	2.3	7.4	8.4	1.7	3.4	0.6	2.1	1.0	0.4	4.5	0.5	8.5	11.4	6.4	5.9	1.2	7.4	3.2	2.4	3.7	1.2	0.1	5.3	6.1	2.1	11.7	12.4	26.8	16.1	13.8	7.2	7.9	5.7	7.4	3.4
PARD6B	PAR-6B	ENSG00000124171	"Par-6 family cell polarity regulator beta"	Q9BYG5	20	50731544-50756795	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 40.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.4;MCF7: 27.2;T-47d: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013376	Uncertain		Supported	Cytosol				Cytosol		"HPA013376: AB_1854972"	"unprognostic (1.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavourable (8.38e-4)"	"unprognostic (2.27e-1)"	"prognostic favourable (6.38e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.07e-2)"	3.7	2.3	1.6	3.1	2.3	2.6	7.9	3.5	2.0	2.7	13.9	1.4	11.3	4.5	2.2	12.1	5.8	5.7	6.6	2.1	2.0	1.9	40.0	8.0	15.4	1.9	1.5	1.3	3.4	9.9	7.3	3.7	24.1	2.7	4.0	3.0	12.2	3.6	17.2	4.3	3.8	17.5	1.0	1.6	2.4	8.3	6.4	0.5	2.9	14.4	1.0	5.8	3.5	5.5	3.6	3.1	3.4	1.5	3.8	6.1	1.1	2.8	3.3	0.9	2.0	0.6	0.2	4.4	0.2	0.3	0.5	0.4	15.4	6.8	1.3	3.0	0.0	2.3	1.4	2.1	0.8	0.6	0.8	0.7	1.0	6.1	0.6	0.4	0.7	0.0	1.0	0.3	0.9	0.0	1.6	0.9	0.0	27.2	1.3	1.2	1.6	1.3	0.7	0.9	1.1	7.0	3.2	0.6	0.9	2.2	5.2	1.5	26.6	0.7	0.1	0.3	1.8	0.3	0.5	1.1	0.7	1.0	0.7	0.5	0.6	2.9	0.7	3.4	3.6	0.9	4.0	2.9	3.7	3.6	0.8	3.6	6.1	3.8	2.8	3.8	1.5	3.1	2.3	1.1	1.6	2.3	3.5	2.0	2.0	1.9	1.5	1.3	2.7	0.5
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: "	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	4.0	5.6	4.3	4.2	5.4	1.4	5.3	7.8	6.3	4.8	5.1			6.7	4.9	3.0	6.2	4.3	3.6	6.6	4.6	5.9	9.2	5.2	3.5	5.8	4.5		4.7	3.5	8.1	4.7	5.8		4.9	6.1		4.7	5.1	8.1	6.7	5.1	4.7	4.0	5.9	4.7	5.8			4.9		6.9	4.4	4.8	6.9	7.0	12.5	7.7	8.3	9.4	5.5	12.7	10.6	18.7	13.7	9.0	11.2	13.7	12.7	14.0	14.8	14.2	8.5	11.9	9.6	8.3	10.8	14.5	15.7	8.0	16.0	14.7	14.6	9.8	8.7	9.3	10.2	14.1	8.2	7.2	15.5	12.4	20.5	9.0	16.6	8.5	11.1	7.1	15.6	12.7	18.4	24.3	18.6	21.2	11.1	12.0	8.2	12.9	16.3	10.3	16.4	13.3	18.9	7.9	9.1	9.3	11.3	9.6	14.2	9.4	14.1	20.5	15.9	15.0	6.7	12.5	6.2	3.0	5.2	5.5	7.9	6.9	7.1	6.7	7.0	6.9	9.4	9.1	3.0	8.3	7.7	5.4	5.5	5.5										
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol			69000000	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	44.6	67.9	69.3	38.1	64.9	33.7	45.4	57.2	62.7	34.0	36.4	33.4	43.2	27.3	35.8	56.6	40.9	39.0	41.6	71.7	56.9	57.2	60.5	77.1	28.6	46.1	61.6	57.2	45.9	60.4	66.6	48.4	44.6	41.2	44.7	39.5	38.6	46.5	39.4	128.7	19.8	27.5	48.1	52.5	37.5	37.2	38.2	32.2	38.8	71.6	43.3	46.5	41.3	43.4	49.5	141.8	38.8	61.0	52.8	87.2	90.6	68.2	61.5	61.3	70.4	66.0	63.5	30.1	63.6	59.6	62.6	50.6	56.0	74.8	84.7	71.9	68.2	49.0	66.1	85.0	81.4	75.3	71.4	91.0	91.9	83.1	57.0	86.8	56.1	59.8	36.3	63.8	76.7	65.6	88.3	63.1	86.8	63.9	60.4	110.3	50.0	63.5	46.5	82.3	116.1	98.2	35.1	71.7	60.2	63.6	98.3	99.2	54.8	64.7	62.1	57.8	46.1	53.3	69.7	61.3	98.3	120.5	76.2	132.9	81.8	22.7	61.0	38.8	52.6	55.4	49.7	49.5	52.7	62.2	73.9	38.6	45.6	52.4	21.0	52.8	44.1	141.8	87.2	90.6	69.3	64.9	57.2	62.7	56.9	57.2	61.6	57.2	41.2	32.2
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435701-14632728	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	19.4	25.9	14.9	23.5	19.1	12.5	19.8	16.8	23.5	21.3	21.0	22.7	23.3	14.4	24.6	29.0	19.0	19.4	22.5	18.4	15.4	19.0	17.9	18.9	26.7	31.6	22.2	17.9	21.8	22.7	37.4	26.0	21.9	21.0	21.4	21.8	21.0	18.9	31.0	19.2	21.0	18.8	28.7	18.3	20.1	19.6	25.4	19.6	29.4	27.8	14.0	26.8	25.6	19.3	16.1	15.6	13.3	14.8	15.0	17.8	11.0	11.8	13.9	7.3	9.2	12.2	14.0	8.5	10.0	14.1	12.5	12.0	7.7	11.0	21.0	25.5	11.5	12.8	16.8	11.3	17.4	17.8	9.9	14.4	9.6	17.1	12.8	17.1	14.4	12.7	14.2	11.2	16.1	8.4	12.3	11.9	12.2	14.6	17.2	11.1	9.9	8.3	22.8	16.5	21.2	8.5	8.2	9.2	6.6	20.5	11.1	13.8	11.8	9.9	7.7	12.2	6.4	6.6	10.2	12.1	12.9	25.7	13.4	12.6	13.4	11.9	11.1	13.3	13.5	14.8	13.9	16.1	13.1	15.5	15.6	13.9	17.8	17.8	7.2	15.0	14.3	10.8	14.7	11.0	14.9	19.1	16.8	23.5	15.4	19.0	22.2	17.9	21.0	19.6
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm			39000	Nucleoplasm		"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: , CAB075727: , HPA045168: "	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavourable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.5	15.3	42.6	30.1	11.2	9.2	24.3	18.9	16.9	25.8	21.2	24.3	14.0	83.2	28.3	11.5	21.5	58.5	18.6	22.7	34.9	81.7	32.2	20.4	15.9	6.7	53.4	15.6	9.1	7.4	20.7	14.7	20.0	51.2	42.5	13.3	13.6	17.1	19.3	78.4	30.4	51.8	73.0	76.9	12.1	20.4	42.9	37.6	24.6	27.6	15.5	23.2	33.5	15.2	13.7	22.7	18.5	35.4	17.3	29.0	71.5	11.4	18.1	30.7	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8
PARP10	FLJ14464	ENSG00000178685	"Poly(ADP-ribose) polymerase family member 10"	Q53GL7	8	143977153-144012772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.4"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA028122, HPA052427"	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA028122: AB_10601979, HPA052427: "	"unprognostic (9.80e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.63e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.30e-3)"	14.2	18.8	8.8	27.4	9.5	15.7	18.6	5.3	8.7	14.4	16.5	9.3	20.7	20.5	20.3	18.3	15.8	18.0	21.8	6.4	8.9	4.1	20.5	19.1	21.4	23.6	10.4	6.8	22.4	15.3	9.3	14.2	10.4	9.2	17.7	3.8	12.7	27.7	14.9	12.5	14.3	21.8	9.6	8.9	31.1	13.1	15.8	9.8	27.8	15.4	10.4	21.6	8.8	12.9	2.4	16.4	3.2	2.8	1.9	4.6	2.4	8.4	0.8	0.6	1.5	4.2	3.8	4.6	1.4	1.8	9.5	10.7	0.4	14.8	10.5	20.2	4.5	3.2	0.2	5.0	0.4	23.7	0.0	11.6	4.9	5.3	4.1	4.5	14.0	2.4	5.0	4.7	1.9	1.4	0.2	8.4	1.8	10.3	15.7	7.9	0.5	6.8	14.8	1.7	14.1	3.9	10.7	0.5	0.5	9.8	1.0	18.6	11.0	6.8	6.5	4.9	7.4	8.2	5.2	14.3	8.4	2.4	7.1	15.4	2.6	0.0	1.9	3.2	4.6	2.8	3.0	1.2	2.2	3.7	2.3	2.4	1.6	2.3	1.1	1.9	2.7	16.4	1.6	2.4	8.8	9.5	5.3	8.7	8.9	4.1	10.4	6.8	9.2	9.8
PARP11	C12orf6	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	7.1	14.5	11.2	8.6	9.2	3.7	8.3	11.0	9.1	6.4	5.4	5.6	4.8	4.9	10.2	7.5	5.0	6.3	5.6	5.1	6.1	5.7	5.7	5.7	6.3	12.8	5.0	5.7	13.1	6.6	10.0	10.4	4.1	7.6	12.0	5.7	7.2	6.6	6.0	4.1	3.9	6.5	7.2	6.1	9.2	4.2	12.8	5.6	16.9	12.3	2.7	12.1	8.3	5.8	10.7	10.2	18.3	10.2	8.2	12.5	7.1	2.5	2.1	13.6	2.1	4.3	6.9	3.8	3.0	5.1	5.3	5.3	7.8	2.0	7.4	1.9	6.6	2.1	4.5	4.5	8.6	14.9	4.5	10.6	0.0	5.7	4.9	7.1	4.0	5.5	3.5	4.2	11.8	3.9	2.8	6.0	7.4	3.5	3.8	2.7	5.0	0.3	7.6	9.3	1.7	2.5	5.7	0.9	3.1	2.9	2.6	3.9	0.5	6.5	7.7	4.6	4.5	7.0	4.0	2.9	6.3	10.5	4.4	4.0	1.2	18.3	10.2	10.2	9.2	8.5	12.5	10.7	10.2	6.7	10.2	10.1	11.7	9.4	10.2	8.2	6.4	8.9	4.3	7.1	11.2	9.2	11.0	9.1	6.1	5.7	5.0	5.7	7.6	5.6
PARP14	"KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680618-122730840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol				Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	21.6	10.3	5.6	15.8	7.2	11.7	9.3	2.3	6.0	11.6	13.3	5.9	6.4	11.4	10.6	12.7	11.7	7.2	10.0	6.5	5.2	4.8	13.7	21.5	26.0	16.7	7.3	5.2	10.0	6.7	7.2	6.8	17.5	6.3	12.3	6.7	7.5	8.5	5.5	5.2	5.7	22.3	11.9	6.8	29.7	7.6	4.6	4.9	18.7	20.4	6.4	18.9	12.8	12.4	15.9	4.2	20.8	10.5	7.4	7.0	2.8	5.9	4.9	3.1	3.3	4.4	10.6	0.0	2.3	15.5	29.2	45.1	2.6	11.7	0.0	9.7	5.1	4.6	4.6	4.7	6.0	9.0	0.5	5.4	2.3	4.0	10.8	2.4	2.7	6.4	2.4	5.1	2.0	12.6	2.5	8.8	1.0	3.0	9.1	1.6	0.4	4.2	12.7	3.2	1.6	7.1	6.1	0.2	0.0	5.9	1.3	6.6	2.2	4.3	8.6	1.5	3.9	0.9	2.1	3.4	0.6	1.0	4.7	5.7	2.7	8.3	8.2	4.0	6.9	10.5	6.0	10.2	3.8	4.5	4.2	15.9	3.2	3.4	20.8	7.4	9.3	0.6	7.0	2.8	5.6	7.2	2.3	6.0	5.2	4.8	7.3	5.2	6.3	4.9
PARP2	ADPRTL2	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343582-20357905	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA052003: "	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	11.5	16.6	23.6	8.9	28.5	20.9	15.2	36.7	31.3	12.0	11.7	16.8	9.3	11.2	18.8	16.8	10.7	14.7	8.9	14.0	19.2	17.8	14.0	15.0	12.0	11.8	16.6	30.8	20.2	11.8	11.6	14.6	11.3	22.1	11.3	12.9	10.8	10.5	12.9	25.9	15.1	10.8	14.6	13.9	11.4	11.6	20.4	17.4	6.0	11.7	13.9	15.2	9.3	10.4	6.7	5.6	1.8	5.0	6.9	12.3	4.9	20.2	14.8	22.8	17.1	7.6	7.2	16.6	22.5	12.3	28.6	35.5	13.9	19.4	15.0	10.2	7.1	19.0	30.3	10.3	33.9	12.0	14.8	13.7	17.9	23.3	6.8	28.3	7.9	5.0	8.8	17.8	19.7	14.7	14.5	20.5	19.6	12.5	14.5	12.2	12.5	23.1	18.2	31.0	9.7	11.4	10.6	15.8	10.9	25.1	14.0	6.6	12.9	9.6	10.0	17.5	26.5	12.0	18.2	19.2	24.5	19.9	7.3	12.6	19.3	1.8	5.0	0.5	9.5	4.5	12.3	6.7	8.9	8.3	5.4	4.6	9.6	9.3	0.1	6.9	2.5	5.6	5.2	4.9	23.6	28.5	36.7	31.3	19.2	17.8	16.6	30.8	22.1	17.4
PARP3	"ADPRT3, ADPRTL3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: "	"prognostic favourable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favourable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	15.2	29.2	11.2	14.6	17.1	2.8	13.6	5.7	18.8	7.5	17.3	10.6	14.3	26.9	10.3	14.1	10.8	12.1	16.2	12.4	11.6	12.3	17.3	22.3	13.3	9.7	12.0	14.2	8.2	3.9	34.2	9.8	6.2	12.2	12.1	10.7	13.2	14.0	18.1	14.6	6.1	26.3	18.9	8.7	12.8	15.8	4.5	10.2	2.9	17.0	9.6	10.3	15.1	8.9	9.0	2.9	1.7	4.1	6.6	4.9	2.3	6.0	3.3	1.0	9.0	8.7	16.5	2.5	9.8	15.9	12.2	13.7	1.9	15.9	8.2	2.6	16.2	0.9	2.5	8.9	5.9	20.0	0.6	4.2	6.7	6.3	9.5	2.5	5.8	13.1	5.5	7.7	5.2	6.1	1.7	7.7	9.3	1.5	2.2	6.3	1.3	9.6	3.5	1.5	7.0	7.4	6.6	1.0	3.4	9.9	2.8	5.3	3.4	2.8	13.7	24.5	5.1	3.6	5.9	11.8	14.3	3.5	15.8	7.4	7.6	0.0	2.6	1.7	3.6	4.1	3.4	9.0	4.2	2.8	2.9	4.3	4.9	4.9	0.1	6.6	2.0	1.2	4.3	2.3	11.2	17.1	5.7	18.8	11.6	12.3	12.0	14.2	12.2	10.2
PARP4	"ADPRTL1, p193, VAULT3, VPARP, VWA5C"	ENSG00000102699	"Poly(ADP-ribose) polymerase family member 4"	Q9UKK3	13	24420926-24512810	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Ribonucleoprotein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011739	Approved		Supported	Cytosol				Cytosol		"HPA011739: AB_1854986"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.97e-2)"	"prognostic favourable (1.21e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.84e-3)"	25.3	24.7	6.6	16.7	12.9	11.6	14.6	2.3	7.0	17.8	39.4	16.7	21.6	22.9	19.1	11.2	22.2	14.9	23.8	11.3	7.9	5.6	28.8	17.3	17.8	16.5	14.6	4.4	15.9	15.5	11.2	12.6	14.8	12.5	16.1	24.1	14.0	17.7	30.9	6.5	10.2	49.9	15.5	20.5	28.4	20.4	7.0	12.1	28.8	18.2	11.3	26.2	23.3	13.2	9.0	16.4	26.1	18.6	11.8	12.9	10.6	15.0	13.5	6.6	11.9	18.3	26.1	5.6	17.5	23.0	15.4	13.8	5.5	39.2	11.2	17.5	15.9	17.5	9.8	17.7	12.6	25.8	6.9	16.1	12.5	12.6	10.4	20.6	16.0	15.0	6.0	12.7	6.8	25.2	4.5	5.0	18.2	6.9	13.0	9.9	7.5	16.7	12.3	12.4	15.8	28.6	31.0	6.0	7.7	12.8	5.2	12.1	2.5	17.1	35.7	7.0	7.3	8.9	17.8	5.7	6.6	14.8	12.7	10.9	15.2	25.2	12.4	26.1	12.9	15.3	12.9	9.0	10.8	12.8	16.4	5.1	8.1	9.6	14.3	11.8	18.6	6.2	12.7	10.6	6.6	12.9	2.3	7.0	7.9	5.6	14.6	4.4	12.5	12.1
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.9;BJ hTERT+ SV40 Large T+ RasG12V: 41.8;SK-MEL-30: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: "	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favourable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.2	13.0	0.9	2.7	14.7	34.9	41.8	4.2	8.9	1.8	6.0	5.4	8.9	2.3	4.8	7.3	13.9	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.5	4.7	4.9	1.2	7.4	0.8	7.5	1.4	3.5	8.9	3.5	0.4	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.1	1.2	32.3	3.8	3.1	4.4	1.5	4.4	0.3	1.6	4.6	2.4	3.3	5.2	3.0	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3
PARPBP	"C12orf48, FLJ20641, PARI"	ENSG00000185480	"PARP1 binding protein"	Q9NWS1	12	102120185-102197520	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA039677	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA039677: AB_10673426"	"unprognostic (7.84e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.54e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.52e-3)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.83e-1)"	"unprognostic (5.61e-8)"	"unprognostic (3.50e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.16e-3)"	"unprognostic (6.14e-2)"	1.8	1.5	1.7	6.3	1.9	11.0	2.4	2.0	2.8	1.8	4.0	1.0	1.4	3.3	2.4	1.9	6.7	0.9	1.4	2.4	1.6	4.8	3.1	1.0	1.8	5.4	1.8	2.2	1.8	1.1	0.3	1.0	4.1	4.4	2.9	5.5	0.4	2.2	1.1	1.2	2.6	3.7	2.2	1.7	5.6	2.4	14.5	0.4	26.6	1.4	5.9	6.7	3.3	2.7	3.0	1.9	6.2	1.5	1.2	4.5	1.9	7.2	15.6	13.2	7.5	2.2	2.0	9.3	11.3	6.2	18.1	16.1	8.1	5.5	13.5	6.5	4.0	8.0	21.5	6.4	19.2	13.9	12.8	17.3	9.3	7.3	0.6	18.2	5.2	1.8	1.4	12.6	7.7	11.9	15.9	8.4	11.7	5.7	16.2	16.7	17.5	14.5	10.9	21.5	8.8	5.6	11.4	8.9	8.6	7.5	9.1	6.4	14.9	6.5	4.6	9.3	9.1	11.5	13.8	6.5	12.9	12.1	6.4	18.5	12.1	6.2	1.2	2.4	1.6	1.5	0.4	3.0	2.5	2.2	1.9	1.5	1.4	1.6	0.0	1.2	1.2	1.7	4.5	1.9	1.7	1.9	2.0	2.8	1.6	4.8	1.8	2.2	4.4	0.4
PARVA	"FLJ10793, FLJ12254, MXRA2"	ENSG00000197702	"Parvin alpha"		11	12377185-12530801	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 4.0;memory CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	40	"T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005964	Approved		Supported	"Actin filaments,Focal adhesion sites,Cytosol"				"Actin filaments, Focal adhesion sites"	Cytosol	"HPA005964: AB_1079569"	"unprognostic (3.87e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.30e-2)"	"prognostic favourable (1.76e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.38e-2)"	"unprognostic (6.78e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.82e-2)"	30.5	8.3	7.1	14.4	6.5	0.0	44.0	3.9	8.3	29.2	39.2	3.5	25.8	6.9	40.5	17.6	27.0	17.2	35.2	21.3	6.4	5.3	15.3	10.7	13.2	8.5	5.3	7.8	22.7	16.2	10.1	6.3	16.3	5.5	31.7	16.4	18.3	13.4	35.1	6.4	7.7	13.1	55.9	5.0	8.4	24.2	8.4	2.8	0.4	10.5	8.1	5.0	38.8	33.4	0.0	0.0	0.0	0.0	0.0	4.0	0.1	7.6	7.6	7.1	9.2	36.4	28.3	16.6	29.4	30.3	20.8	19.5	5.6	12.0	0.0	9.8	53.4	4.7	0.0	15.3	24.8	0.1	3.8	0.0	10.8	4.2	28.0	0.0	0.2	22.3	6.2	8.7	13.7	25.8	0.0	0.0	30.9	4.6	0.0	0.0	3.3	6.6	0.0	17.8	0.0	11.5	7.5	1.1	0.0	22.6	9.1	15.1	4.3	0.2	31.9	25.1	10.5	13.5	8.0	0.0	0.0	0.0	13.9	0.0	27.6	0.0	0.0	0.0	0.5	0.0	4.0	0.0	1.3	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	7.1	6.5	3.9	8.3	6.4	5.3	5.3	7.8	5.5	2.8
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563622-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	301	"testis: 30.0"	"Group enriched"	"Detected in some"	7	"BEWO: 19.5;HMC-1: 31.1;U-266/84: 14.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PASK	"KIAA0135, PASKIN, STK37"	ENSG00000115687	"PAS domain containing serine/threonine kinase"	Q96RG2	2	241106099-241150264	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 24.1;testis: 22.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 24.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA016450, HPA021079"	Uncertain		Supported	Cytosol				Cytosol		"HPA016450: AB_1854992, HPA021079: AB_1854993"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.99e-6)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.38e-3)"	1.5	1.1	2.4	10.3	24.1	8.9	3.1	6.3	5.2	2.2	2.1	2.2	2.1	3.8	2.9	6.7	3.1	7.2	3.3	1.1	2.9	2.7	3.7	1.3	3.0	14.5	1.3	1.6	1.9	3.3	4.4	4.9	1.1	3.6	12.1	2.8	4.7	2.7	1.8	2.0	4.9	3.9	1.4	1.6	4.4	3.4	22.0	7.2	9.0	4.8	1.9	9.9	2.7	1.9	7.1	1.1	4.8	1.0	2.7	6.0	3.0	4.9	6.7	9.1	11.5	0.7	1.4	12.1	4.8	1.5	4.4	6.2	5.4	5.0	2.6	1.0	1.1	12.5	10.3	4.1	3.2	10.4	9.7	7.1	12.4	9.6	0.5	9.7	11.2	0.6	3.3	4.6	1.3	3.1	9.2	3.5	3.1	5.6	11.5	10.2	10.1	4.1	18.3	9.2	3.2	1.7	11.2	16.1	4.9	2.8	5.5	2.1	4.6	7.0	4.1	6.1	5.5	7.7	6.4	4.8	4.8	12.2	3.8	7.3	5.6	4.8	1.0	0.7	1.7	0.6	1.5	7.1	5.9	5.3	1.1	6.6	3.7	3.9	1.3	2.7	1.0	0.7	6.0	3.0	2.4	24.1	6.3	5.2	2.9	2.7	1.3	1.6	3.6	7.2
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ, crumbs cell polarity complex component"	Q8NI35	1	61742406-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4"	"Cell line enhanced"	"Detected in many"		"A-431: 19.3;BEWO: 16.4;RPTEC TERT1: 16.9;RT4: 18.1;SK-BR-3: 16.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA066352, HPA066960, HPA069079"	Approved		Enhanced	"Cell Junctions,Centriolar satellite"				"Cell Junctions, Centriolar satellite"		"HPA066352: , HPA066960: , HPA069079: "	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favourable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	2.6	4.6	3.4	6.3	4.4	1.9	11.6	66.4	3.2	5.7	9.6	2.0	17.9	5.5	4.4	17.7	11.6	5.3	10.3	27.8	2.3	5.1	19.8	7.7	12.5	6.1	4.6	2.0	4.7	17.9	15.2	21.4	2.8	14.2	8.4	7.0	4.4	24.8	24.3	25.4	13.9	15.7	5.2	15.8	2.2	6.3	2.7	3.0	1.3	17.0	11.1	9.6	7.4	7.5	1.8	0.3	9.9	0.2	3.2	4.1	0.8	19.3	3.9	1.3	1.7	0.7	1.9	16.4	1.1	1.5	1.2	1.6	6.7	7.3	0.1	5.2	2.4	11.6	2.8	10.2	2.1	1.9	4.8	0.1	5.6	6.0	1.7	0.0	0.1	0.7	10.9	2.0	4.6	0.6	0.0	0.0	1.0	6.8	0.0	0.0	6.7	1.0	0.0	1.5	2.7	16.9	18.1	3.4	1.1	4.9	16.1	4.2	12.8	0.2	0.1	1.0	2.5	0.1	2.2	0.8	1.4	2.5	0.9	0.0	0.2	0.4	0.1	9.9	1.9	0.1	3.5	1.8	3.1	2.6	0.1	1.5	4.1	2.6	0.9	3.2	0.2	0.3	2.7	0.8	3.4	4.4	66.4	3.2	2.3	5.1	4.6	2.0	14.2	3.0
PATL1	"FLJ36874, Pat1b"	ENSG00000166889	"PAT1 homolog 1, processing body mRNA decay factor"	Q86TB9	11	59636716-59668980	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039030	Uncertain		Supported	"Cytoplasmic bodies"				"Cytoplasmic bodies"		"HPA039030: AB_10673232"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (4.56e-4)"	"unprognostic (3.93e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.37e-3)"	"unprognostic (6.74e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.34e-3)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (3.86e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.18e-1)"	17.8	17.7	12.8	23.2	17.3	41.3	17.5	18.3	16.2	16.2	19.6	15.1	10.8	18.5	17.6	15.3	18.8	12.7	14.7	16.3	11.8	8.9	17.7	27.6	20.5	15.7	16.9	9.1	20.2	11.4	14.1	14.7	27.1	14.1	12.2	17.9	14.0	16.5	17.2	37.3	18.2	19.3	15.8	15.4	17.8	13.9	11.1	16.5	19.2	15.0	17.2	19.7	18.9	27.5	4.8	5.3	8.2	6.7	3.8	6.8	3.1	22.7	17.8	13.2	12.9	13.0	14.7	11.4	15.1	26.1	27.5	27.7	11.5	20.1	22.4	14.8	16.2	17.1	19.1	18.2	29.5	19.5	8.7	12.9	8.7	11.3	46.8	16.9	28.8	16.5	14.1	23.5	32.4	13.1	15.8	18.3	15.5	10.5	16.2	15.4	13.3	11.8	13.3	22.0	9.5	17.0	21.3	9.5	9.1	21.3	16.1	26.1	22.8	12.5	12.6	18.0	16.5	31.2	13.3	18.8	20.8	19.3	21.7	14.2	14.7	3.9	5.5	7.6	6.8	6.7	5.7	4.8	5.3	6.0	5.3	4.0	5.4	5.1	8.2	3.8	6.5	3.5	4.3	3.1	12.8	17.3	18.3	16.2	11.8	8.9	16.9	9.1	14.1	16.5
PATZ1	"dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG"	ENSG00000100105	"POZ/BTB and AT hook containing zinc finger 1"	Q9HBE1	22	31325804-31346232	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047893, HPA048315"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA047893: , HPA048315: "	"unprognostic (3.25e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.06e-4)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-3)"	"prognostic favourable (8.71e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (8.54e-8)"	"unprognostic (9.22e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	"prognostic favourable (7.79e-6)"	9.6	11.2	13.0	12.7	12.9	12.9	12.1	16.8	16.0	14.2	13.0	21.7	21.8	9.4	19.6	14.4	7.3	22.2	14.1	10.4	14.0	11.8	11.4	11.0	17.4	30.3	15.3	13.4	27.7	16.6	25.4	11.0	8.9	13.6	14.0	6.8	17.5	17.5	17.8	9.1	7.5	11.9	15.6	12.5	14.3	10.5	13.0	15.5	38.5	18.9	8.2	13.8	17.4	14.2	4.7	7.1	4.8	1.8	3.5	5.7	2.0	8.3	10.5	21.5	12.6	5.7	5.3	11.3	2.5	6.5	10.4	9.6	7.3	8.1	17.8	9.3	4.7	6.5	14.5	7.8	5.4	10.4	13.3	7.5	7.3	14.9	9.3	25.1	10.1	8.2	9.4	6.6	7.4	8.2	3.1	7.2	6.6	25.4	16.0	17.3	14.4	12.4	27.2	9.1	5.9	7.0	17.7	28.1	22.5	6.4	7.8	14.0	15.5	16.1	5.8	7.0	13.3	4.3	8.6	9.3	6.1	16.2	2.9	3.3	11.9	0.0	1.8	4.8	3.4	1.1	3.5	4.7	2.6	4.4	2.5	3.8	5.7	4.1	0.8	3.5	0.6	7.1	3.7	2.0	13.0	12.9	16.8	16.0	14.0	11.8	15.3	13.4	13.6	15.5
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735603-100829941	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1"	"Group enriched"	"Detected in some"	9	"AN3-CA: 14.2;EFO-21: 19.8;RPTEC TERT1: 14.1"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 1.0;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebellum: 1.5;pons and medulla: 3.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 7.9;pons and medulla: 8.1"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"			Nucleoli	"Golgi apparatus"	"CAB013024: AB_2533990, HPA047704: , HPA070751: "	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	1.0	0.1	3.1	0.1	0.0	30.5	0.0	1.5	93.7	0.1	9.1	0.0	0.1	0.1	0.1	43.1	0.1	0.1	0.0	0.2	0.0	1.5	0.3	0.6	0.7	0.0	1.8	0.8	0.0	0.5	0.1	19.4	0.1	0.1	0.1	0.0	1.7	0.1	0.1	2.4	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	14.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.1	0.1	0.1	0.2	0.0	1.8	0.1
PAX3	"HUP2, WS1"	ENSG00000135903	"Paired box 3"	P23760	2	222199888-222298996	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Deafness, Disease mutation, Proto-oncogene, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.1;retina: 39.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.5;BJ hTERT+ SV40 Large T+ RasG12V: 8.9;HBF TERT88: 6.6;RH-30: 12.9;SK-MEL-30: 22.7"	"Cancer enriched"	"Detected in some"	24	"melanoma: 20.3"	"Group enriched"	"Detected in some"	6	"cerebellum: 19.1;pons and medulla: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.9;midbrain: 1.6;pons and medulla: 1.4"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.0;midbrain: 11.7;pons and medulla: 3.5"	"HPA063659, HPA069000"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA063659: , HPA069000: "	"unprognostic (2.57e-2)"				"unprognostic (1.48e-2)"	"unprognostic (1.27e-2)"		"unprognostic (1.65e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.70e-1)"		"unprognostic (6.18e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.26e-1)"		"unprognostic (9.70e-2)"	0.8	0.1	0.0	0.1	0.8	0.1	2.9	19.1	0.2	0.3	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.2	2.2	0.0	0.1	0.2	0.1	0.0	0.1	7.8	0.4	0.1	39.6	7.9	0.2	8.6	7.9	0.1	0.1	4.2	0.1	0.2	2.9	0.8	0.0	0.1	3.9	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	5.1	5.1	7.5	8.9	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	6.6	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.3	0.1	0.0	0.0	12.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.8	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.8	19.1	0.1	0.0	0.2	2.2	0.0	7.8	0.8
PAX6	"AN, AN2, D11S812E, WAGR"	ENSG00000007372	"Paired box 6"	P26367	11	31784779-31818062	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.3;retina: 29.4"	"Cell line enhanced"	"Detected in some"		"AF22: 11.6;AN3-CA: 15.0;HEK 293: 14.1;HeLa: 11.0;U-251 MG: 12.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 78.3"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"cerebellum: 61.0;olfactory region: 41.2"	"Low region specificity"	"Detected in all"			"HPA030775, CAB034143"	Enhanced	Supported	Enhanced	Nucleoplasm				Nucleoplasm		"CAB034143: AB_1127044, HPA030775: AB_10601243"	"unprognostic (2.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	0.8	2.0	12.6	0.8	10.4	1.1	1.0	78.3	23.5	0.8	1.1	9.3	0.0	3.5	0.8	1.8	0.8	0.8	0.8	0.8	16.0	3.7	0.9	0.9	0.7	0.9	3.9	9.1	0.8	15.8	0.8	4.6	0.8	10.8	0.8	1.4	29.4	0.8	0.9	1.9	1.6	2.0	0.8	16.1	0.8	19.4	2.8	9.8	0.0	0.8	0.0	1.0	1.1	0.3	0.2	0.2	1.6	0.4	0.4	0.5	0.1	0.0	0.2	11.6	15.0	3.7	5.0	4.5	0.0	0.0	0.1	0.0	0.9	2.7	0.1	4.8	1.6	0.3	1.3	0.0	0.2	0.0	14.1	6.6	11.0	6.2	0.0	0.3	0.0	0.0	0.5	0.1	0.3	0.0	5.3	0.0	0.2	0.0	2.7	0.4	0.2	7.6	0.0	5.5	0.1	0.6	0.4	0.5	0.0	0.3	0.1	0.0	3.4	0.0	0.0	3.9	0.3	0.0	12.3	0.0	0.1	0.0	6.2	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.2	0.2	0.3	1.0	0.4	0.4	0.2	0.1	0.1	12.6	10.4	78.3	12.2	16.0	3.7	3.9	9.1	10.8	9.8
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278950	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 69.3;thyroid gland: 120.5"	"Group enriched"	"Detected in some"	10	"EFO-21: 26.7;RPTEC TERT1: 63.0"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"pons and medulla: 5.8"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: "	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	0.9	1.4	1.1	0.5	0.4	0.0	0.6	0.2	0.8	3.8	0.4	0.2	11.7	0.1	2.2	15.2	0.6	9.6	0.8	0.6	0.5	0.5	69.3	0.4	0.5	0.7	0.4	0.3	3.8	0.6	0.1	0.7	0.8	1.5	1.1	0.1	0.5	0.5	10.0	0.3	0.5	0.6	0.4	0.8	0.3	0.4	1.9	0.2	0.4	120.5	0.0	0.2	0.8	1.9	4.4	2.8	1.5	3.4	1.9	2.5	1.1	2.9	0.2	0.1	0.0	0.1	0.0	1.0	0.8	2.6	0.2	0.4	1.8	0.5	0.5	26.7	0.2	0.0	0.5	0.8	0.2	1.2	0.0	0.4	0.2	1.0	0.3	0.0	0.0	0.7	0.1	0.2	0.6	0.0	0.4	2.0	0.8	0.6	0.3	1.2	0.1	1.8	0.0	0.2	0.6	63.0	4.6	0.5	0.0	3.3	0.0	1.8	0.0	1.1	0.9	4.6	0.1	0.8	2.3	0.4	1.3	0.1	4.0	0.6	0.0	1.5	3.4	0.0	0.6	1.8	1.5	4.4	1.5	1.1	2.8	1.9	2.5	1.5	0.5	1.9	1.3	1.1	0.8	1.1	1.1	0.4	0.2	0.8	0.5	0.5	0.4	0.3	1.5	0.2
PAXX	"C9orf142, XLS"	ENSG00000148362	"PAXX, non-homologous end joining factor"	Q9BUH6	9	136992418-136993984	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045268	Uncertain		Supported	Nucleoplasm			77000	Nucleoplasm		"HPA045268: AB_10963079"	"unprognostic (1.85e-1)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (6.71e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.66e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.97e-3)"	14.0	10.2	20.7	17.2	18.4	28.0	15.6	14.7	25.4	11.9	17.8	16.4	10.3	22.0	10.6	12.9	14.1	11.8	14.3	12.4	19.4	16.9	14.2	18.2	12.9	24.2	20.7	12.5	10.1	25.9	9.4	17.1	17.1	16.0	16.0	4.9	9.9	24.8	15.7	15.8	19.5	18.1	7.1	25.3	27.8	28.0	6.4	14.7	34.5	16.4	11.5	15.0	11.5	10.3	8.3	56.3	4.1	12.6	19.1	36.2	13.5	10.1	11.4	1.8	7.0	3.3	3.0	27.4	7.9	4.7	5.3	2.8	5.0	7.5	9.2	13.8	2.0	16.4	0.6	5.9	0.4	23.6	16.3	7.2	5.9	4.2	5.0	10.2	16.0	2.2	5.6	1.8	2.3	4.8	10.7	2.7	1.1	22.5	10.7	16.8	11.1	35.1	14.0	3.8	26.1	3.5	5.3	8.7	10.9	6.8	16.8	8.9	20.1	8.6	6.3	2.5	7.7	12.0	9.3	5.1	4.4	6.2	4.5	11.7	9.4	4.1	10.8	4.1	36.2	12.6	31.1	8.3	20.2	31.2	11.0	7.8	11.2	25.6	3.7	19.1	6.4	56.3	15.1	13.5	20.7	18.4	14.7	25.4	19.4	16.9	20.7	12.5	16.0	14.7
PBRM1	"BAF180, PB1"	ENSG00000163939	"Polybromo 1"	Q86U86	3	52545352-52685917	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015629, HPA059373"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA015629: AB_1855012, HPA059373: "	"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.06e-1)"	24.3	14.8	13.8	20.6	15.9	17.2	24.4	19.1	13.8	18.9	18.5	14.0	22.9	12.2	25.9	13.9	19.9	18.9	13.7	15.9	11.1	10.0	11.7	14.5	14.9	16.5	16.5	8.2	25.1	15.4	14.4	30.6	28.0	14.7	16.1	15.3	12.7	17.5	16.2	21.8	17.2	14.3	21.1	15.6	19.1	14.8	13.1	13.7	51.0	22.0	10.5	17.1	22.4	23.0	6.6	10.7	11.1	8.7	4.6	7.4	1.9	12.3	8.0	28.6	14.0	14.1	14.4	20.0	17.0	11.8	19.7	17.3	8.9	8.4	30.0	2.4	20.0	8.5	24.8	12.9	24.0	32.0	13.3	28.4	15.0	6.9	20.2	23.6	21.6	13.4	14.9	22.0	14.2	19.0	16.2	16.5	19.8	4.1	39.0	7.1	17.3	13.1	20.4	17.9	15.2	8.2	24.2	19.4	21.5	20.5	4.9	16.2	9.2	13.7	21.9	18.5	14.0	15.9	20.8	11.9	18.8	28.5	11.4	19.2	18.4	10.1	5.0	11.1	4.8	3.2	4.9	3.6	4.8	5.3	4.8	6.6	7.4	4.7	2.7	4.6	8.7	10.7	4.5	1.9	13.8	15.9	19.1	13.8	11.1	10.0	16.5	8.2	14.7	13.7
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 30.5;NTERA-2: 29.9;SK-BR-3: 61.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	13.2	17.3	14.9	8.3	15.0	1.4	16.4	14.1	17.4	73.4	26.3	11.2	15.9	13.6	67.2	15.3	20.8	35.1	25.8	12.6	10.9	9.7	15.4	4.2	10.4	2.3	11.6	14.6	35.2	29.4	21.3	12.4	9.6	8.1	27.6	9.3	10.2	19.6	25.1	16.8	6.0	14.6	56.8	8.0	5.1	13.9	9.7	8.7	2.7	17.4	8.5	6.6	32.2	24.7	0.0	0.1	2.9	0.0	0.3	0.2	2.5	1.1	22.3	22.1	5.9	14.9	7.2	1.3	9.3	6.1	2.5	1.8	4.3	4.0	0.0	1.9	12.7	7.8	8.6	2.4	1.0	1.1	9.3	30.5	17.9	0.0	9.8	0.0	7.8	7.1	0.0	1.6	0.7	0.1	0.0	0.0	0.6	14.7	0.0	0.1	29.9	1.1	0.0	7.3	8.9	1.8	13.3	0.8	13.1	10.8	61.6	0.0	23.4	0.0	0.1	1.3	3.1	8.7	2.7	2.8	21.1	0.0	0.1	0.0	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.1	0.0	2.5	14.9	15.0	14.1	17.4	10.9	9.7	11.6	14.6	8.1	8.7
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria			96000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	8.9	3.3	8.1	13.7	5.4	3.5	1.8	7.8	3.5	3.4	4.4	3.2	0.0	3.7	2.9	3.8	3.7	20.6	1.0	1.7	5.2	4.4	27.7	17.0	10.7	0.0	5.7	20.6	5.3	2.8	6.4	2.9	8.4	0.0	1.2	19.0	5.0	2.4	6.3	7.4	3.7	6.9	1.8	3.2	0.9	7.2	10.2	17.3	9.2	7.0	7.5	1.2	3.2	3.9	3.6	4.6	2.0	1.9	2.2	0.0	4.0	2.8	3.3	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888784	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 67.5;Hep G2: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Approved		Enhanced	Nucleoplasm,Cytosol			210000	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: "	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	18.3	25.5	18.1	9.6	15.6	4.3	19.7	13.2	14.8	13.9	18.4	7.8	24.3	12.6	13.9	21.4	26.5	25.6	22.9	32.5	10.8	23.7	38.7	99.0	14.0	7.8	16.7	12.3	18.5	73.0	15.8	15.5	11.7	16.4	26.9	20.3	16.3	16.2	20.7	23.1	5.8	17.2	18.1	14.5	10.2	19.2	7.0	8.7	4.3	36.8	16.2	12.3	22.4	31.8	11.8	20.9	3.5	19.4	8.0	16.9	7.5	20.4	48.5	2.9	30.1	11.0	10.3	3.9	6.6	11.0	10.3	8.2	67.5	36.2	4.2	19.2	7.2	13.6	18.3	10.6	7.0	10.9	33.1	3.7	7.7	66.3	11.6	3.6	13.6	10.0	11.6	10.2	4.8	27.6	7.2	0.3	7.1	34.1	0.4	12.2	4.1	45.4	2.0	4.0	13.4	43.2	21.1	12.7	21.5	5.5	37.6	14.3	10.9	7.1	11.4	1.7	14.4	2.5	16.2	0.1	0.8	0.1	9.4	11.9	2.6	0.0	10.7	3.5	8.8	19.4	6.9	11.8	11.6	12.6	20.9	4.1	3.8	7.9	0.6	8.0	13.3	15.3	16.9	7.5	18.1	15.6	13.2	14.8	10.8	23.7	16.7	12.3	16.4	8.7
PCBP1	"hnRNP-E1, hnRNP-X, HNRPE1, HNRPX"	ENSG00000169564	"Poly(rC) binding protein 1"	Q15365	2	70087454-70089203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037113, HPA043803, HPA068497"	Supported		Enhanced	"Nuclear speckles,Cytoplasmic bodies"			12000000	"Nuclear speckles"	"Cytoplasmic bodies"	"CAB037113: AB_1840915, HPA043803: , HPA068497: "	"unprognostic (1.63e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.08e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (1.71e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	52.7	57.6	34.4	49.7	36.7	79.5	149.6	33.3	39.9	38.8	47.2	32.4	45.7	41.1	54.1	39.3	55.6	39.3	45.4	55.1	34.0	31.2	41.6	69.5	46.3	77.8	43.5	29.8	42.3	88.3	42.8	30.5	52.7	37.5	36.3	31.2	29.6	47.9	42.0	149.0	41.5	39.6	59.7	39.1	52.0	43.2	31.6	42.1	91.0	43.8	59.9	48.4	49.6	148.0	15.1	29.2	49.6	32.1	31.6	30.3	28.9	61.4	63.5	54.9	42.8	59.3	45.4	88.5	46.1	42.7	45.8	38.6	73.5	41.4	84.6	23.8	52.3	55.1	64.4	67.2	47.0	60.3	49.7	67.6	38.9	112.2	66.9	55.9	65.1	39.5	43.9	37.7	52.7	58.1	69.1	62.7	57.4	76.4	72.0	84.1	55.4	42.0	58.3	60.1	84.8	62.2	63.7	52.2	42.0	37.9	77.8	54.5	46.2	50.9	53.3	43.1	54.1	36.4	58.1	83.6	85.8	85.9	45.6	77.7	52.9	12.6	30.8	45.5	30.3	32.1	27.8	15.1	23.7	26.0	29.2	14.4	24.2	26.9	49.6	31.6	26.7	21.0	27.7	28.9	34.4	36.7	33.3	39.9	34.0	31.2	43.5	29.8	37.5	42.1
PCBP2	"hnRNP-E2, HNRNPE2, HNRPE2"	ENSG00000197111	"Poly(rC) binding protein 2"	Q15366	12	53452102-53481162	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038356	Uncertain		Supported	Nucleoplasm,Cytosol			2000000	Nucleoplasm	Cytosol	"HPA038356: AB_10697248"	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (1.82e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.05e-2)"	"prognostic favourable (8.23e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.20e-2)"	105.3	106.7	110.8	85.7	93.4	158.1	180.8	136.5	131.5	84.1	67.2	50.5	75.7	69.2	101.7	84.5	75.3	89.5	71.0	112.1	105.0	53.1	112.6	108.3	83.8	118.8	94.5	88.9	124.5	148.2	98.1	88.7	62.4	93.2	61.7	71.0	65.0	88.3	61.2	96.5	94.4	71.3	90.8	115.4	73.0	86.2	98.7	104.2	106.8	91.2	57.1	93.5	76.8	132.5	20.9	31.5	17.2	18.5	12.4	28.8	13.7	57.4	89.5	87.5	70.4	127.5	98.7	67.1	61.2	84.0	100.5	72.0	104.1	86.6	103.1	59.9	91.7	56.5	96.4	83.4	96.2	63.8	69.5	103.6	69.9	102.1	128.6	101.1	68.4	113.5	70.0	84.9	136.7	96.3	88.4	185.2	89.7	156.3	94.9	113.9	111.8	62.9	76.4	79.5	120.8	79.4	90.0	86.4	75.9	83.8	75.5	59.8	105.7	88.1	70.2	52.1	71.5	47.5	62.1	103.1	71.0	95.3	61.2	64.9	56.6	8.3	18.1	13.1	15.9	18.5	26.1	20.9	24.5	20.5	22.5	20.9	28.8	23.6	17.2	12.4	17.0	31.5	27.4	13.7	110.8	93.4	136.5	131.5	105.0	53.1	94.5	88.9	93.2	104.2
PCBP4	"LIP4, MCG10"	ENSG00000090097	"Poly(rC) binding protein 4"	P57723	3	51957454-51974016	"Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.5"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 48.5;SK-MEL-30: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"B-cells: 4.6;granulocytes: 4.6;T-cells: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057754			Supported	Cytosol				Cytosol		"HPA057754: "	"unprognostic (7.17e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.94e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.72e-2)"	19.5	16.6	27.2	9.6	21.9	3.0	10.6	86.0	56.3	12.7	16.7	36.2	16.0	15.1	15.4	12.1	14.5	10.4	18.3	36.5	29.2	29.9	21.2	38.9	13.9	17.0	28.9	13.0	16.3	22.0	22.9	15.8	7.8	16.4	20.1	8.6	47.3	20.3	19.6	97.5	13.6	29.0	14.4	44.4	10.9	13.3	10.6	19.7	11.9	17.3	11.0	15.7	13.3	9.6	4.6	0.3	4.6	0.0	0.1	10.2	2.4	10.0	3.4	13.8	20.1	6.3	11.3	2.3	23.1	11.3	13.9	9.0	12.8	3.6	0.3	3.4	18.3	2.4	12.9	8.1	6.5	15.9	2.0	1.2	11.6	13.2	10.2	1.3	9.8	15.3	15.1	8.9	3.9	6.9	0.6	4.5	22.3	4.7	0.5	1.5	6.7	9.3	7.0	6.7	1.8	4.9	7.2	27.3	48.5	6.3	3.4	41.0	6.4	4.9	13.8	15.0	28.3	4.7	12.3	3.0	1.9	2.0	17.3	2.8	21.7	4.6	0.0	3.1	10.2	0.0	7.1	4.6	9.6	9.8	0.3	2.3	4.6	3.5	0.0	0.1	0.0	0.1	10.0	2.4	27.2	21.9	86.0	24.2	29.2	29.9	28.9	13.0	16.4	19.7
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase alpha subunit"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 106.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 53.2;SCLC-21H: 29.5;U-937: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria			120000	Mitochondria		"HPA041716: , HPA047792: "	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	15.6	26.2	9.7	11.3	11.1	3.2	12.0	24.0	10.7	12.0	17.5	12.0	14.3	6.7	16.4	106.7	8.8	8.4	7.6	12.4	9.5	7.5	51.3	44.3	8.1	4.0	11.2	8.2	9.7	12.7	5.5	12.4	10.5	12.6	13.1	13.7	11.7	12.2	10.4	10.7	7.7	7.8	17.0	12.0	8.2	16.1	4.7	10.9	4.2	11.9	5.0	6.9	10.8	8.8	3.7	13.0	1.6	10.8	7.3	6.1	4.7	3.2	5.8	9.6	3.1	9.2	8.0	5.4	3.2	4.8	3.0	2.8	7.2	4.4	0.2	4.9	3.2	3.7	2.8	4.5	5.0	5.3	3.2	7.5	4.1	15.4	5.1	0.3	3.7	7.4	4.8	2.8	4.7	6.2	3.0	4.3	5.5	3.5	0.8	16.9	5.9	2.6	6.6	4.1	5.2	53.2	6.4	29.5	3.5	2.2	12.3	5.4	8.9	13.4	4.5	3.1	2.6	2.1	2.2	4.2	3.8	0.1	6.0	41.0	2.2	1.5	8.5	1.6	4.6	10.3	6.1	3.7	3.0	4.3	13.0	2.6	4.1	5.1	1.3	7.3	10.8	1.1	6.0	4.7	9.7	11.1	24.0	10.7	9.5	7.5	11.2	8.2	12.6	10.9
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.4;RH-30: 46.0;RT4: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: "	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	2.0	3.2	11.9	4.9	11.5	0.4	3.0	1.2	25.3	23.2	18.4	1.7	34.3	3.1	15.3	22.9	13.0	8.9	7.4	16.7	13.4	11.9	2.2	1.2	2.8	1.4	8.0	11.0	4.5	1.1	0.5	0.8	0.5	11.7	9.9	7.3	6.2	1.6	32.2	0.9	10.1	5.3	23.7	5.3	15.3	14.2	1.2	4.4	0.0	3.9	1.3	1.4	20.1	7.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	5.5	7.6	11.5	11.2	0.0	1.4	0.0	0.7	0.3	0.7	9.9	0.0	0.0	0.0	5.7	0.4	14.4	1.3	0.0	16.4	0.0	10.4	0.0	11.9	0.2	0.0	6.7	3.4	0.3	4.1	2.8	0.0	0.0	3.4	0.0	0.0	0.0	3.3	1.5	0.0	46.0	0.0	0.3	24.2	0.3	0.1	0.1	0.4	0.5	0.7	2.5	0.0	9.3	2.4	2.5	0.0	0.0	0.0	0.0	7.2	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.5	1.2	24.9	13.4	11.9	8.0	11.0	11.7	4.4
PCDHA4	"CNR1, CNRN1, CRNR1, PCDH-ALPHA4"	ENSG00000204967	"Protocadherin alpha 4"	Q9UN74	5	140806929-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1"	"Cell line enhanced"	"Detected in some"		"A549: 8.9;AF22: 8.7;EFO-21: 7.6;T-47d: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043180, HPA073478"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"HPA043180: AB_10806381, HPA073478: "	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.90e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.00e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.94e-5)"	"unprognostic (5.01e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.29e-3)"	"unprognostic (4.79e-2)"	0.9	0.8	5.1	0.9	6.5	3.2	1.7	12.1	8.7	2.1	1.1	1.6	0.4	0.9	2.3	2.0	0.6	1.6	5.1	1.2	4.5	3.2	2.0	0.6	1.7	1.5	1.9	2.1	1.1	4.1	1.0	1.4	0.7	3.9	1.8	1.1	0.4	1.1	1.3	1.1	2.0	0.9	1.1	3.0	1.1	1.0	1.4	2.4	0.0	1.3	0.1	0.7	1.3	0.8	1.5	1.3	2.0	0.7	0.8	1.1	0.0	0.2	8.9	8.7	0.4	0.1	0.3	0.3	0.2	0.1	0.1	0.1	0.2	1.8	0.3	7.6	0.2	0.3	0.0	0.1	0.2	0.2	0.1	0.3	0.6	0.3	0.1	0.3	0.5	0.4	2.3	0.2	0.4	0.5	0.2	1.2	0.3	0.2	0.2	0.3	2.5	1.2	0.2	0.2	0.3	0.3	0.4	0.4	3.7	0.1	1.9	0.8	7.6	0.3	0.9	1.9	1.2	0.7	0.2	0.5	0.2	0.2	0.3	0.4	0.8	1.8	0.7	0.7	1.1	0.4	0.8	0.8	0.8	0.7	0.3	1.5	0.8	1.1	2.0	0.8	0.7	1.3	0.6	0.0	5.1	6.5	12.1	6.6	4.5	3.2	1.9	2.1	3.9	2.4
PCDHB3	PCDH-BETA3	ENSG00000113205	"Protocadherin beta 3"	Q9Y5E6	5	141100473-141103827	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.1;HAP1: 3.7;SH-SY5Y: 16.2;U-138 MG: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA050296	Uncertain		Supported	Vesicles				Vesicles		"HPA050296: "	"unprognostic (2.72e-2)"	"unprognostic (7.47e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-4)"	"unprognostic (9.34e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.52e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.18e-4)"	5.7	4.6	3.1	2.6	9.3	0.4	5.9	3.8	6.2	4.8	2.5	2.2	1.3	1.4	8.0	3.0	1.3	3.1	3.1	3.6	3.8	3.0	4.9	0.8	3.3	1.0	3.0	3.8	5.6	3.9	4.4	17.3	1.8	4.0	5.4	2.1	3.4	2.4	2.4	1.9	2.0	2.1	3.8	3.0	1.5	1.8	11.6	2.0	0.0	2.1	2.3	0.7	2.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.3	2.1	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.2	0.0	3.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.6	16.2	0.0	0.2	0.0	2.0	0.1	0.0	5.7	0.8	0.6	0.3	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.3	3.8	6.2	3.8	3.0	3.0	3.8	4.0	2.0
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: , HPA077526: "	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	4.9	3.6	11.3	2.2	9.7	0.9	3.7	8.7	12.2	7.2	2.4	11.6	0.3	1.2	9.2	3.2	3.2	5.6	6.2	4.6	9.3	7.0	2.7	2.7	5.4	1.4	7.0	8.6	9.0	2.6	7.5	3.0	3.9	7.3	4.4	2.8	3.1	2.4	4.4	1.9	2.9	2.1	5.0	7.0	2.2	2.0	1.8	7.8	0.1	2.6	1.3	1.4	2.8	3.3	0.9	0.9	0.5	0.0	0.0	0.7	0.0	0.1	0.3	2.1	0.2	14.4	10.5	0.1	2.2	3.0	0.6	3.4	0.0	0.3	3.8	1.0	1.7	0.5	0.5	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.6	0.2	0.2	2.7	0.5	0.2	0.1	1.7	0.2	1.2	8.5	0.4	2.9	0.6	0.1	0.9	7.8	2.7	0.2	0.2	0.3	1.6	1.7	0.2	0.4	0.4	3.1	0.2	6.0	3.0	0.7	4.6	3.9	0.2	2.2	0.7	3.3	1.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.9	0.0	0.0	11.3	9.7	8.7	10.6	9.3	7.0	7.0	8.6	7.3	7.8
PCF11	KIAA0824	ENSG00000165494	"PCF11 cleavage and polyadenylation factor subunit"	O94913	11	83156988-83187451	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040779			Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA040779: "	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.24e-3)"	"prognostic favourable (1.34e-4)"	"unprognostic (3.74e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (2.03e-5)"	17.6	15.2	21.8	33.5	23.3	32.1	21.1	29.7	21.3	22.1	19.7	13.6	30.8	14.0	25.6	36.8	21.9	23.4	20.8	14.0	21.7	10.0	15.7	14.5	24.0	25.8	26.6	15.4	28.9	16.1	22.4	32.5	18.9	19.2	25.6	17.9	13.8	22.5	28.5	27.0	32.5	21.2	21.4	20.6	27.2	17.7	20.1	27.4	29.4	23.4	22.5	25.1	24.8	29.3	11.4	6.8	17.5	7.2	13.0	10.5	5.3	11.0	7.9	12.9	11.0	15.5	15.2	10.4	10.6	7.9	10.3	7.9	13.5	11.1	25.0	8.1	7.7	11.2	18.8	7.3	9.9	17.7	6.4	14.6	10.3	9.5	8.7	17.1	16.3	10.8	14.2	7.8	11.4	10.3	16.9	12.2	9.6	11.8	16.0	19.1	13.5	8.9	15.3	16.3	14.9	8.9	16.5	10.8	12.0	13.0	10.4	10.4	10.4	11.9	10.6	14.7	7.6	10.8	7.0	11.0	18.4	53.1	6.4	11.4	11.3	12.0	7.2	14.2	10.5	6.9	9.1	11.4	7.4	7.6	6.7	10.4	8.6	8.5	17.5	13.0	5.1	6.8	5.1	5.3	21.8	23.3	29.7	21.3	21.7	10.0	26.6	15.4	19.2	27.4
PCGF1	"MGC10882, NSPC1, RNF68"	ENSG00000115289	"Polycomb group ring finger 1"	Q9BSM1	2	74505043-74508580	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA011356, HPA069156"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA011356: AB_1855063, HPA069156: "	"unprognostic (2.41e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (1.69e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.13e-1)"	3.8	3.1	2.5	2.5	6.1	4.8	4.5	5.6	7.4	4.2	4.6	4.1	2.5	4.0	5.2	2.5	3.0	4.4	2.5	2.9	2.5	2.3	3.4	3.3	3.5	4.0	2.5	6.2	5.4	4.1	4.4	4.2	3.1	5.4	3.1	3.4	2.5	3.6	2.5	2.5	4.3	3.2	3.0	5.7	3.1	3.4	5.1	2.5	2.5	5.1	2.5	4.1	2.6	3.4	7.5	8.5	2.9	7.7	4.1	8.1	3.9	4.0	2.8	2.3	3.5	2.2	3.5	4.3	4.4	4.8	4.2	2.5	7.4	2.0	6.0	2.0	4.3	2.2	4.3	5.7	2.8	5.1	8.3	2.5	3.5	5.4	3.7	7.7	4.1	6.3	4.2	2.5	12.8	2.4	7.1	4.3	2.6	6.1	5.7	8.0	3.9	2.8	4.3	6.1	2.8	5.2	5.4	3.2	10.6	3.6	4.4	6.4	1.7	7.2	3.1	4.7	4.3	7.7	4.1	3.5	3.1	5.0	4.2	3.8	5.3	1.7	7.7	2.9	5.4	5.5	6.0	7.2	7.0	6.8	8.5	7.5	5.7	5.6	2.7	4.1	6.1	4.8	8.1	3.9	2.5	6.1	5.6	7.4	2.5	2.3	2.5	6.2	5.4	2.5
PCGF2	"MEL-18, RNF110, ZNF144"	ENSG00000277258	"Polycomb group ring finger 2"	P35227	17	38733897-38749817	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047732, HPA063531"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA047732: , HPA063531: "	"unprognostic (1.56e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (4.55e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.10e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	5.7	7.2	6.6	2.9	6.7	0.0	12.2	11.6	7.7	9.0	3.6	1.1	8.7	2.6	8.9	9.5	4.4	8.8	7.8	7.0	6.9		10.7	1.8	7.9	2.2	2.4	4.4	11.4	4.7	10.1	12.0	8.3	3.9	6.7	3.8	11.4	7.8	7.6	3.3	4.1	4.2	5.9	2.9	5.3	5.2	2.7	3.7	0.0	7.7	3.9	1.6	6.3	18.6	0.8	0.3	0.3	0.4	0.0	0.5	0.1	8.0	18.9	14.0	25.2	7.8	6.3	5.9	6.4	10.0	10.3	9.5	11.6	9.2	0.6	7.1	8.1	13.0	7.1	6.1	7.3	4.9	10.3	3.8	9.7	28.3	8.4	0.5	4.9	6.1	5.4	7.6	7.5	13.2	7.1	10.7	6.9	21.4	0.8	0.1	11.4	7.6	6.4	8.0	1.6	8.4	11.8	8.2	15.8	6.2	4.5	13.4	17.8	0.8	14.1	13.0	14.1	12.6	11.3	6.4	1.9	2.0	10.1	1.0	12.1	0.0	0.4	0.0	0.5	0.0	0.5	0.8	0.3	0.0	0.3	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1										
PCGF3	"DONG1, FLJ36550, MGC40413, RNF3, RNF3A"	ENSG00000185619	"Polycomb group ring finger 3"	Q3KNV8	4	705748-770640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061879	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA061879: "	"unprognostic (1.24e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.66e-1)"	"prognostic favourable (3.73e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.47e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.25e-4)"	17.3	29.0	18.2	22.0	18.8	28.0	18.9	31.4	21.8	17.7	15.2	12.4	21.4	24.3	20.9	19.1	17.9	17.5	18.1	14.0	16.5	11.2	14.6	15.3	17.8	18.2	17.2	17.5	28.6	15.3	6.5	20.0	21.3	15.3	20.5	11.9	15.1	20.4	15.8	15.5	55.8	22.5	15.2	11.8	26.4	20.8	18.0	16.9	20.8	21.3	19.2	17.6	15.3	20.0	7.3	7.2	6.9	11.6	6.9	5.4	3.5	11.3	10.2	18.9	21.5	8.6	9.0	23.3	15.4	8.5	12.7	12.9	11.2	12.5	8.1	10.3	14.8	7.9	8.8	12.5	9.7	10.7	9.5	11.6	12.1	19.7	10.6	7.9	15.5	11.2	16.7	11.0	5.0	16.2	15.9	6.7	12.3	12.6	21.2	28.0	12.5	18.6	21.0	12.0	5.1	7.5	18.6	27.0	20.4	8.0	8.6	8.2	16.7	11.3	19.3	12.4	10.0	10.3	19.7	16.2	13.7	12.7	9.8	12.7	22.8	5.5	11.6	4.7	5.4	7.5	4.8	6.7	3.4	3.4	5.1	7.3	4.3	3.0	6.9	6.9	3.5	7.2	5.0	3.5	18.2	18.8	31.4	21.8	16.5	11.2	17.2	17.5	15.3	16.9
PCIF1	"bA465L10.1, C20orf67, PPP1R121"	ENSG00000100982	"PDX1 C-terminal inhibiting factor 1"	Q9H4Z3	20	45934628-45948023	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"				Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: "	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavourable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	18.5	15.7	12.7	18.4	17.8	26.2	19.2	33.7	27.9	26.0	19.4	26.7	15.9	14.7	29.8	17.0	19.4	28.8	16.9	23.7	12.9	12.4	16.3	13.2	18.9	23.9	17.7	13.6	37.5	23.5	21.5	18.9	18.7	14.4	20.0	10.8	23.9	20.6	20.8	27.1	24.2	17.1	19.6	16.1	22.8	16.3	17.6	16.2	36.0	24.8	15.3	22.2	18.7	20.4	31.8	28.1	42.4	26.4	38.3	32.7	31.9	11.4	15.8	12.3	15.2	8.6	10.6	13.7	4.6	14.0	14.1	13.7	26.9	15.4	12.3	15.6	12.3	13.0	8.8	16.0	6.1	7.6	6.3	15.8	12.7	18.0	16.3	14.1	15.9	14.6	16.8	8.6	13.9	11.7	11.0	17.3	10.0	23.9	27.8	26.5	4.4	13.9	17.4	11.4	15.1	11.4	12.0	16.9	16.9	17.5	16.5	8.8	17.3	16.6	10.0	17.3	13.9	15.3	9.1	20.1	11.5	11.3	21.8	13.1	10.1	37.2	26.4	42.4	32.7	25.7	25.6	30.2	28.3	29.5	28.1	31.8	29.8	25.9	42.3	38.3	24.8	22.6	29.1	31.9	12.7	17.8	33.7	27.9	12.9	12.4	17.7	13.6	14.4	16.2
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 34.9;hTCEpi: 33.9;SK-MEL-30: 32.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria			3300000	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.4	3.1	0.9	5.8	3.6	3.7	14.8	6.8	8.2	5.7	9.3	5.1	6.3	13.9	0.8	10.5	8.0	6.0	8.8	4.7	7.1	0.2	2.5	1.7	27.2	34.9	4.8	11.0	4.3	33.9	3.6	8.8	4.6	7.1	25.8	2.2	23.7	1.2	2.4	1.0	4.1	2.8	3.4	7.9	1.7	8.5	3.7	5.9	5.2	6.8	32.1	9.1	7.5	0.8	1.2	6.6	1.8	1.9	17.7	5.5	3.4	3.5	7.7	3.0	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3
PCLAF	"KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15"	ENSG00000166803	"PCNA clamp associated factor"	Q15004	15	64364311-64387687	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.1;lymphoid tissue: 78.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"T-reg: 24.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 24.2"									HPA047929			Supported	Centrosome				Centrosome		"HPA047929: "	"unprognostic (5.34e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (4.38e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (9.77e-15)"	"unprognostic (5.59e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.22e-1)"	2.1	1.8	0.7	24.5	0.8	42.1	2.6	0.4	0.8	1.8	7.7	0.6	1.0	4.6	1.6	2.8	18.8	0.6	4.0	2.2	0.8	1.0	2.5	3.0	4.0	21.8	1.4	0.4	0.9	1.4	0.1	0.6	5.1	0.7	1.6	10.1	0.5	3.1	0.4	0.9	2.8	8.1	1.6	1.9	10.9	4.9	3.0	0.5	78.3	1.2	18.0	20.7	4.3	5.7	2.2	3.2	2.0	0.4	5.2	24.2	2.7	30.4	35.2	30.0	19.1	3.1	11.3	21.9	23.5	20.9	45.3	65.8	39.5	29.0	58.5	8.4	11.9	22.9	74.7	18.2	51.3	37.1	26.8	57.3	37.1	34.0	0.3	37.7	21.2	3.8	1.9	35.8	7.2	34.4	35.2	21.5	52.1	35.1	45.6	84.6	11.1	15.3	59.6	56.8	38.4	21.5	31.5	2.9	15.4	18.6	14.8	10.8	20.9	52.4	4.8	22.5	47.2	27.2	62.7	11.7	40.6	36.6	9.3	83.2	15.1	2.0	0.2	1.2	1.6	0.1	0.2	2.2	4.8	4.5	3.2	0.5	0.4	0.8	1.6	5.2	0.4	0.2	24.2	2.7	0.7	0.8	0.4	0.8	0.8	1.0	1.4	0.4	0.7	0.5
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18029944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Enhanced	"Nuclear membrane,Centrosome,Cytosol"				Centrosome	"Nuclear membrane, Cytosol"	"CAB058695: , HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	19.6	19.0	26.2	26.7	40.4	25.1	25.1	29.2	29.0	25.0	21.1	21.6	22.8	12.4	23.3	27.3	16.4	26.4	17.8	23.0	22.9	18.4	18.8	22.0	19.1	21.1	24.5	24.9	29.1	27.0	42.0	35.8	19.8	26.4	20.2	16.3	16.2	19.4	25.3	63.1	17.6	18.3	26.7	27.2	20.8	17.9	80.0	28.0	40.2	28.2	19.1	20.4	27.0	22.6	11.5	14.9	19.9	7.5	11.2	13.0	4.3	20.3	21.7	33.4	44.2	18.9	19.7	17.3	17.2	21.2	18.4	20.8	14.7	12.2	26.7	11.9	17.1	14.8	21.3	15.8	31.4	8.8	8.2	45.8	15.4	29.8	21.1	20.0	11.8	17.1	16.9	21.3	23.7	21.1	30.9	20.8	22.4	10.2	42.9	33.2	27.5	6.3	25.9	29.9	9.5	15.2	28.3	25.6	19.3	18.4	10.1	26.4	15.9	29.3	18.8	16.8	13.7	20.5	14.5	8.9	19.6	23.9	14.2	22.1	17.1	19.9	6.0	14.4	11.5	3.8	12.0	11.1	10.4	13.0	5.9	11.5	11.6	11.6	6.4	11.2	7.5	14.9	10.3	4.3	26.2	40.4	29.2	29.0	22.9	18.4	24.5	24.9	26.4	28.0
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol			8200000	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavourable (4.02e-7)"	"prognostic unfavourable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.88e-4)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavourable (6.38e-4)"	19.1	18.4	35.7	13.0	43.0	28.5	19.3	33.5	58.3	20.2	16.9	19.2	12.4	14.7	16.0	22.2	17.9	15.8	11.0	43.9	35.0	38.8	21.3	29.5	15.1	14.6	35.1	46.0	16.2	14.6	16.4	15.5	17.2	57.4	22.1	18.1	11.6	17.2	21.4	69.5	14.7	13.6	19.6	28.6	12.0	12.7	29.1	19.2	18.1	19.3	15.9	17.9	14.4	13.7	31.6	53.0	51.2	58.0	30.0	37.4	51.6	21.4	17.0	17.4	21.8	37.5	31.0	19.4	35.3	20.2	28.1	35.5	49.3	16.4	27.2	30.0	29.8	26.8	29.9	35.2	40.6	18.9	43.3	41.5	32.0	48.2	25.1	49.4	51.1	15.4	26.1	32.0	34.6	26.5	59.3	26.7	33.5	63.9	24.0	37.7	14.2	19.1	19.9	22.6	19.5	27.3	15.8	33.2	12.8	26.8	42.8	22.9	25.9	35.2	19.7	16.6	21.0	31.4	38.3	16.9	26.2	27.8	26.1	33.0	32.8	40.0	58.0	51.2	30.2	53.6	30.1	31.6	30.6	32.7	53.0	24.2	28.5	32.5	30.8	30.0	52.2	23.9	37.4	51.6	35.7	43.0	33.5	58.3	35.0	38.8	35.1	46.0	57.4	19.2
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 115.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favourable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavourable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	13.9	21.4	11.1	31.8	15.8	87.2	13.7	17.2	14.6	13.7	23.1	15.6	13.7	18.9	15.7	13.7	36.0	12.7	17.5	13.6	11.6	9.8	21.7	14.9	17.8	41.6	18.8	10.8	14.4	14.3	14.0	13.9	24.0	14.3	10.8	26.1	18.7	17.7	15.6	11.0	16.5	20.5	12.8	16.1	24.5	15.7	40.5	17.4	115.8	18.1	40.7	38.7	17.3	17.2	16.9	16.0	8.7	11.6	19.6	24.4	16.9	73.2	57.7	58.6	25.2	13.9	13.0	41.1	48.3	28.5	45.5	64.7	45.0	58.6	74.5	15.7	17.2	55.1	34.6	58.2	41.7	22.1	38.2	52.3	22.2	104.8	5.9	71.6	23.5	9.4	13.8	38.7	9.2	25.9	46.5	63.0	44.3	26.5	136.8	79.2	43.8	32.0	75.6	51.5	60.1	20.6	42.8	50.3	34.2	33.8	52.3	33.1	36.9	36.5	17.3	32.9	37.8	46.2	55.1	32.0	91.3	126.2	14.8	68.2	42.1	2.4	11.6	8.7	19.2	10.9	23.8	16.9	24.4	19.3	16.0	13.6	22.4	20.1	3.8	19.6	11.4	14.7	23.3	16.9	11.1	15.8	17.2	14.6	11.6	9.8	18.8	10.8	14.3	17.4
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574095-101594437	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	27.9	30.4	40.0	25.8	48.5	30.7	34.0	48.6	40.2	33.8	32.2	25.0	25.0	24.1	34.1	34.4	30.5	28.3	25.5	35.6	35.1	36.9	32.0	29.7	29.0	32.2	41.1	35.7	45.9	25.2	34.6	32.9	30.7	39.8	36.9	28.6	26.8	25.4	32.8	37.2	24.1	22.8	48.6	32.3	24.3	24.8	17.8	38.0	25.1	38.7	22.4	34.6	40.1	44.3	19.8	15.8	31.0	22.1	23.6	22.9	25.6	38.6	21.3	30.3	24.2	28.5	41.1	34.0	26.7	35.6	27.3	31.0	25.4	21.3	41.1	19.8	28.5	21.0	40.6	34.0	57.5	29.7	23.1	44.1	26.4	30.3	21.2	40.5	21.5	24.2	33.4	23.0	30.9	37.7	41.2	24.1	33.6	16.3	34.8	34.3	49.1	34.2	20.4	28.5	31.2	36.1	22.9	40.8	32.2	24.8	24.4	35.6	22.4	30.7	24.2	25.1	34.9	13.1	28.2	18.3	28.3	50.4	25.1	43.2	30.9	31.0	15.1	24.7	15.6	17.7	20.3	19.8	20.5	18.9	15.8	16.0	21.1	19.4	13.7	23.6	22.1	12.5	22.9	25.6	40.0	48.5	48.6	40.2	35.1	36.9	41.1	35.7	39.8	38.0
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324122-46445769	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 82.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 10.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7"	"Low region specificity"	"Detected in all"							"HPA016820, HPA019887, HPA032101"	Enhanced		Enhanced	Centrosome				Centrosome		"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: "	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	4.7	4.7	16.6	6.9	20.4	12.6	3.6	8.3	16.5	3.2	4.0	4.4	3.8	3.7	3.7	4.1	5.1	3.4	5.0	8.2	12.0	4.2	3.2	4.4	4.3	6.4	7.0	9.7	4.9	3.3	5.9	8.0	3.4	5.6	4.0	4.1	2.0	4.1	4.1	82.3	10.4	4.0	4.2	4.3	5.5	4.6	14.5	9.7	9.1	4.4	2.2	4.8	4.7	5.1	0.4	5.3	4.9	1.2	0.5	10.7	2.3	9.2	7.3	11.3	6.9	5.7	5.8	7.1	7.2	5.0	7.2	6.4	8.8	6.0	9.3	4.6	8.2	6.7	9.1	6.2	5.0	27.0	12.8	24.6	13.6	6.8	1.9	12.4	10.2	3.1	4.7	9.6	4.8	5.5	12.4	14.0	9.8	15.4	12.2	12.8	11.2	5.0	15.2	4.6	8.1	5.6	10.0	13.9	6.2	15.5	9.7	4.7	9.2	9.7	7.5	12.9	6.5	7.3	11.4	12.1	10.1	10.0	8.0	12.2	6.9	4.9	0.8	1.3	2.0	0.6	5.9	0.4	0.9	5.9	2.3	0.2	0.7	10.7	0.5	0.5	1.2	5.3	0.9	2.3	16.6	20.4	8.3	16.5	12.0	4.2	7.0	9.7	5.6	9.7
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362339	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Pregnancy	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 157.6;intestine: 71.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.5;HaCaT: 21.8;RH-30: 14.4;RPTEC TERT1: 20.2;U-2 OS: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 157.6;neutrophil: 57.4"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 157.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavourable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	15.8	3.8	2.9	13.7	2.8	1.5	9.5	2.4	3.2	8.5	51.8	2.9	4.5	19.7	6.5	13.9	9.6	7.8	22.9	6.7	3.8	2.4	3.7	1.9	7.7	5.6	2.3	3.1	17.2	3.4	9.5	3.2	7.7	3.5	4.5	6.7	3.3	5.0	5.8	4.0	4.8	71.5	6.9	3.5	2.5	3.3	5.1	2.4	18.0	6.4	14.2	4.5	7.1	11.4	11.7	12.2	157.6	4.4	12.6	12.7	0.8	1.1	0.8	2.4	1.6	1.5	0.5	15.5	2.1	0.2	0.1	0.0	8.2	0.9	0.3	0.6	0.2	21.8	1.1	0.6	0.1	0.2	1.9	2.8	1.6	0.7	0.4	0.8	1.3	2.9	0.2	0.5	0.2	4.5	3.2	1.0	1.5	5.1	3.2	4.9	10.6	0.9	0.6	14.4	0.8	20.2	1.2	0.2	0.2	3.3	0.7	0.2	1.2	3.5	3.5	0.7	31.5	1.8	0.9	0.2	0.1	0.4	2.4	1.2	12.0	157.6	4.2	16.2	9.7	2.3	8.3	8.8	9.8	8.9	1.9	11.7	9.9	12.7	57.4	12.6	4.4	12.2	8.4	0.8	2.9	2.8	2.4	3.2	3.8	2.4	2.3	3.1	3.5	2.4
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900965-81911464	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Supported	"Intermediate filaments,Centrosome"			7000	Centrosome	"Intermediate filaments"	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favourable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	13.6	5.5	13.3	5.7	12.7	5.3	10.4	12.2	17.0	6.5	16.2	13.4	6.4	30.7	5.8	8.6	7.6	12.2	8.0	17.7	14.0	11.8	21.7	46.5	7.2	6.3	13.4	16.0	7.8	11.5	8.2	4.6	6.0	15.9	10.1	8.5	5.8	10.8	6.6	13.5	4.5	26.5	5.0	14.3	4.1	11.5	70.8	11.0	5.6	6.7	6.8	5.8	7.5	4.4	7.3	6.6	2.1	3.5	4.7	8.4	4.0	12.1	7.0	5.6	15.8	28.2	14.9	8.3	8.7	18.8	12.3	14.6	27.4	12.7	4.2	4.8	9.1	10.0	8.5	16.2	7.1	1.2	6.9	9.2	9.6	62.6	30.2	9.2	7.7	12.2	9.4	11.1	8.6	11.3	17.0	8.8	9.1	10.3	10.9	11.4	4.5	7.5	7.2	6.0	15.0	14.7	23.0	7.2	6.6	6.6	36.4	8.5	10.1	21.9	7.6	9.1	6.0	6.8	7.2	5.7	2.4	4.1	9.4	12.4	8.9	2.1	3.5	1.2	7.1	3.4	4.6	6.0	8.4	7.2	6.6	7.3	7.0	7.2	1.0	4.7	3.0	6.5	5.0	4.0	13.3	12.7	12.2	17.0	14.0	11.8	13.4	16.0	15.9	11.0
PDAP1	"HASPP28, PAP, PAP1"	ENSG00000106244	"PDGFA associated protein 1"	Q13442	7	99392048-99408829	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021103, HPA050294, HPA060836"	Approved		Enhanced	"Plasma membrane,Cytosol"			40000	Cytosol	"Plasma membrane"	"CAB021103: AB_10057973, HPA050294: , HPA060836: "	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavourable (6.67e-4)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.97e-2)"	26.7	25.7	25.5	25.0	23.9	23.0	22.4	23.4	28.5	22.8	25.9	18.3	21.6	21.1	25.8	21.6	32.2	20.5	23.4	30.2	23.4	20.4	25.2	31.8	20.5	20.2	23.2	23.5	23.4	28.2	23.3	18.0	28.8	24.2	23.0	22.0	19.0	27.8	26.4	103.5	24.8	19.6	26.9	22.2	20.5	22.6	19.7	24.3	20.1	22.4	37.2	25.2	24.1	28.2	11.3	15.8	24.2	11.9	20.4	14.2	4.6	30.7	26.9	18.2	23.2	14.1	14.7	11.8	25.6	14.8	20.7	17.5	27.2	15.4	13.6	22.7	24.1	16.7	21.9	25.6	20.2	19.3	24.3	13.7	26.0	23.6	20.7	25.7	13.6	15.4	19.3	22.7	37.3	20.6	32.3	24.8	20.2	64.2	35.7	35.1	23.3	29.2	16.5	18.2	23.5	20.9	23.7	18.7	37.4	19.1	30.5	13.0	13.4	13.5	18.6	27.9	30.9	33.0	39.9	23.9	27.3	30.1	22.4	23.1	29.1	7.6	9.4	8.6	12.4	11.9	11.1	11.3	11.5	8.9	7.4	11.1	8.3	10.3	24.2	20.4	10.6	15.8	14.2	4.6	25.5	23.9	23.4	28.5	23.4	20.4	23.2	23.5	24.2	24.3
PDCD11	"ALG-4, KIAA0185, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396648-103446292	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	11.3	11.8	11.6	13.9	12.5	9.6	13.8	12.6	12.0	11.0	10.4	10.6	8.9	8.5	17.3	10.6	17.3	14.3	9.9	10.3	10.5	7.0	11.0	14.0	11.3	14.7	9.9	8.6	16.5	17.2	17.7	14.4	10.9	10.5	12.1	12.0	9.2	11.3	13.0	42.8	22.3	11.1	13.6	9.5	14.7	10.8	22.8	12.4	20.7	10.9	13.8	17.0	11.2	16.8	5.6	5.4	1.4	4.4	3.4	9.1	3.5	10.1	15.1	10.5	29.6	9.2	8.3	11.8	11.2	7.9	11.3	9.3	20.5	10.0	28.0	8.0	8.0	18.2	27.0	14.1	12.8	12.9	18.2	16.3	9.6	16.4	11.0	32.4	11.2	8.6	13.0	17.4	39.8	12.1	26.1	12.6	10.9	11.5	16.2	18.5	21.6	14.6	16.4	15.1	12.7	7.1	10.0	7.1	13.3	7.5	8.9	12.4	8.8	9.2	13.1	8.4	10.6	11.2	20.9	16.1	22.4	26.6	7.4	31.4	6.2	0.1	4.4	1.4	5.7	4.3	9.1	5.6	5.4	4.6	4.7	4.1	4.8	5.6	0.6	3.4	3.6	5.4	3.8	3.5	11.6	12.5	12.6	12.0	10.5	7.0	9.9	8.6	10.5	12.4
PDCD6IP	"AIP1, Alix, Hp95"	ENSG00000170248	"Programmed cell death 6 interacting protein"	Q8WUM4	3	33798352-33869707	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011905, CAB016212, HPA051604"	Approved		Enhanced	Vesicles	"Intracellular and membrane"		6200000	Vesicles		"CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: "	"unprognostic (1.53e-1)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.88e-3)"	"unprognostic (4.49e-2)"	"prognostic favourable (3.90e-9)"	"unprognostic (9.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.11e-1)"	39.1	26.8	18.6	26.2	27.2	16.0	27.0	24.0	31.5	33.8	36.8	26.3	16.5	28.6	33.7	22.7	45.2	27.1	26.2	29.6	20.7	19.7	42.8	41.5	29.9	24.8	22.7	18.1	33.0	21.2	34.9	26.3	43.2	48.9	26.6	34.0	23.0	27.4	20.4	29.5	31.7	57.9	25.9	24.8	32.2	29.1	24.2	16.8	35.9	35.1	25.6	37.3	28.6	31.6	11.8	12.3	10.8	18.2	12.0	9.7	8.9	17.7	18.6	12.0	10.0	31.5	32.5	13.2	22.7	21.8	20.3	21.2	12.8	17.5	25.4	14.2	29.9	15.7	18.6	23.8	23.2	10.6	15.5	21.8	15.3	10.6	21.0	21.7	22.6	25.3	27.7	22.9	27.4	30.1	19.6	10.6	29.4	9.2	13.3	13.1	11.6	23.1	12.7	14.8	16.5	25.3	15.2	5.9	10.6	22.3	26.7	12.0	25.9	20.9	37.2	24.1	12.1	20.0	18.8	10.7	14.3	21.3	22.7	23.9	11.8	6.3	13.4	10.8	8.7	18.2	9.3	11.8	9.6	8.6	12.3	10.1	8.5	8.2	8.1	12.0	17.2	5.7	9.7	8.9	18.6	27.2	24.0	31.5	20.7	19.7	22.7	18.1	48.9	16.8
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562690-100576735	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favourable (4.23e-4)"	12.9	15.9	14.7	16.4	16.2	12.0	18.0	10.7	16.5	12.7	18.8	14.3	15.3	10.5	20.1	23.5	22.5	14.9	13.1	17.6	14.6	15.8	20.9	12.2	13.5	14.0	24.4	15.9	15.4	10.4	10.8	11.4	17.1	17.4	19.6	17.9	10.2	12.0	15.4	35.7	22.0	12.1	49.6	18.3	14.5	13.3	14.0	14.5	13.4	13.0	18.8	19.6	29.9	16.8	26.5	33.4	22.2	43.6	25.6	31.4	23.3	13.2	18.5	19.5	16.9	6.3	8.8	21.8	16.5	10.2	29.8	18.6	23.2	8.2	21.3	25.1	19.3	11.1	24.1	15.9	23.7	34.2	20.8	22.5	10.0	27.2	16.7	23.8	24.1	9.8	29.1	26.4	16.9	18.3	18.7	14.5	22.1	22.5	23.8	36.5	25.6	27.3	23.3	20.9	14.9	18.3	30.7	18.4	16.1	12.9	17.7	18.1	13.9	16.5	14.3	18.8	19.9	14.5	22.6	8.8	16.3	22.4	11.6	27.8	14.7	18.6	19.3	22.2	19.4	34.9	22.1	26.5	29.7	21.5	33.4	20.8	31.0	23.8	2.1	25.6	43.6	18.4	31.4	23.3	14.7	16.2	10.7	16.5	14.6	15.8	24.4	15.9	17.4	14.5
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0;lymphoid tissue: 65.4"	"Cell line enriched"	"Detected in some"	8	"HeLa: 105.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.7;T-cells: 9.6"					"Group enriched"	"Detected in many"	5	"amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol				Cytosol		"CAB009752: AB_2268159, HPA031192: "	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favourable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	27.8	18.4	30.4	3.0	34.2	2.5	25.4	1.0	48.0	8.9	7.7	3.8	1.9	3.5	9.4	4.9	10.2	11.6	12.0	11.3	18.0	6.1	7.0	10.4	5.1	3.8	3.8	27.0	3.4	2.4	4.4	3.4	6.6	6.7	4.8	5.2	3.0	2.3	6.3	6.6	4.8	4.2	10.3	2.1	65.4	4.2	2.9	7.4	0.1	7.0	3.9	2.2	8.3	11.2	3.7	1.2	0.2	1.0	0.1	9.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	105.0	0.1	0.2	0.0	1.6	0.0	0.2	0.5	4.3	2.3	0.1	0.1	0.0	0.0	0.0	0.0	1.5	2.9	0.0	0.0	0.2	0.0	0.0	9.4	0.5	0.0	0.0	0.4	0.0	0.0	13.4	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	9.6	1.0	5.6	3.7	5.7	5.6	1.2	2.5	3.7	3.0	0.2	0.1	0.5	0.0	2.3	1.9	30.4	34.2	1.0	48.0	18.0	6.1	3.8	27.0	6.7	7.4
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469631	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 31.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 21.6;NB-4: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"CAB017632: AB_1127109, HPA043310: , HPA076091: "	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	6.4	2.5	9.0	4.2	13.9	3.4	6.3	15.0	38.5	8.4	4.3	3.2	0.4	2.0	4.4	1.1	3.1	4.8	5.0	4.1	12.4	6.9	2.8	1.9	7.7	2.0	5.3	19.4	1.7	9.8	17.3	2.3	4.9	34.7	3.7	3.0	3.1	7.1	4.0	26.1	2.2	2.7	4.7	3.6	4.1	6.1	31.8	4.5	0.0	5.4	1.0	1.9	4.6	3.5	0.2	3.3	5.9	4.4	5.3	2.0	1.3	0.0	1.4	0.3	3.9	11.4	6.8	2.2	3.2	6.5	0.4	1.1	3.4	3.1	1.4	9.6	8.4	0.3	2.2	0.4	0.2	3.7	3.2	13.4	4.7	3.7	7.4	2.2	21.6	5.0	0.4	3.6	0.0	3.1	10.5	3.2	2.3	0.9	1.3	24.9	1.7	2.8	8.8	2.2	11.5	0.5	0.8	2.5	0.9	0.2	0.1	3.5	0.5	4.4	6.5	4.9	6.3	3.3	2.0	6.4	0.5	7.1	2.1	0.1	3.9	5.9	2.6	5.1	1.5	4.4	0.8	0.2	0.5	2.0	3.3	0.1	0.1	0.7	0.2	5.3	4.4	0.2	1.2	1.3	9.0	13.9	15.0	38.5	12.4	6.9	5.3	19.4	34.7	4.5
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell line enhanced"	"Detected in many"		"A549: 24.8;AN3-CA: 28.5;HeLa: 41.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 28.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favourable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.2	1.9	4.4	6.8	8.6	46.2	5.3	4.2	13.0	13.5	18.6	1.4	14.7	4.1	17.1	14.0	10.3	6.6	12.7	15.5	4.5	5.8	12.8	3.4	11.1	3.7	5.2	6.6	5.3	2.9	7.0	9.0	11.8	2.7	18.2	11.2	8.6	24.4	16.5	60.0	5.1	7.5	35.8	5.0	3.8	10.2	2.6	2.8	4.4	6.2	11.3	9.5	20.0	11.2	6.1	0.7	28.1	1.1	0.1	0.8	0.5	0.0	24.8	5.2	28.5	0.9	1.8	4.1	0.6	0.7	1.4	2.0	9.7	0.8	1.9	0.1	0.2	4.2	0.0	1.1	2.4	1.1	2.8	3.6	41.0	2.1	3.8	1.7	0.2	3.8	0.9	3.9	0.7	2.9	0.0	0.6	2.4	1.7	1.3	4.0	0.9	1.3	0.4	6.5	4.1	6.5	9.3	0.9	3.3	6.5	11.0	5.6	0.8	3.7	3.4	0.3	0.1	4.9	1.3	1.4	0.0	0.2	4.2	6.8	1.1	2.0	1.1	28.1	0.8	0.0	0.8	6.1	0.7	0.3	0.7	6.1	0.5	0.4	1.5	0.1	0.1	0.0	0.4	0.5	4.4	8.6	4.2	13.0	4.5	5.8	5.2	6.6	2.7	2.8
PDE4DIP	"CMYA2, KIAA0454, KIAA0477, MMGL"	ENSG00000178104	"Phosphodiesterase 4D interacting protein"	Q5VU43	1	148808181-149048286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"heart muscle: 106.0;skeletal muscle: 276.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 62.3;ASC TERT1: 50.7;K-562: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA012678			Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA012678: AB_1855123"	"unprognostic (2.14e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.31e-2)"	"unprognostic (6.73e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	4.8	2.9	9.2	4.3	8.3	2.3	9.0	12.1	15.1	4.8	6.2	8.3	5.6	3.8	3.1	11.8	6.1	3.3	5.0	106.0	9.7	7.8	6.6	9.3	5.5	3.8	15.6	8.1	2.3	3.4	13.6	7.7	10.2	9.3	4.6	4.1	7.2	5.4	4.5	276.2	4.1	7.7	3.1	18.5	2.9	4.4	1.7	11.2	1.5	3.1	18.1	3.8	3.6	6.1	12.0	6.7	7.4	5.9	4.7	13.2	4.3	7.8	1.5	2.2	2.4	62.3	50.7	13.0	9.2	8.7	9.0	11.8	7.2	5.0	4.0	2.8	13.2	4.0	5.3	6.5	15.3	2.9	7.6	2.0	3.2	2.8	16.5	1.7	2.1	36.0	13.0	38.2	20.8	3.5	50.9	9.4	15.9	13.3	1.3	1.0	7.8	3.3	2.9	5.6	1.5	5.4	8.1	10.7	0.9	9.0	26.3	7.2	7.8	2.3	4.6	10.4	2.3	26.1	20.4	4.1	5.8	5.9	42.6	1.6	6.4	7.4	5.3	4.1	5.4	5.9	5.5	12.0	10.9	7.2	6.7	11.7	8.4	4.6	1.2	4.7	1.9	2.9	13.2	4.3	9.2	8.3	12.1	10.2	9.7	7.8	15.6	8.1	9.3	11.2
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971394	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.4;fHDF/TERT166: 28.1;U-138 MG: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"			"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.35e-5)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (3.17e-4)"	11.5	9.1	3.2	6.5	3.4	0.7	7.9	1.3	3.5	21.8	6.1	1.9	8.4	2.2	21.3	9.4	6.1	9.0	12.7	3.6	2.4	2.0	9.7	10.3	6.9	4.3	2.2	3.8	10.4	9.8	28.0	2.2	4.9	1.9	17.7	2.4	5.5	26.6	9.3	6.5	4.1	5.4	11.9	2.0	4.1	5.6	4.3	1.7	2.2	10.4	4.4	1.5	8.3	4.7	0.0	0.2	0.0	2.1	0.0	0.0	0.7	1.0	1.6	18.4	12.1	3.4	6.7	0.4	9.6	10.2	5.8	7.8	1.0	4.3	0.0	1.7	28.1	1.1	5.1	6.3	8.0	0.0	2.3	11.2	1.7	1.0	9.0	1.7	0.1	6.9	3.2	14.7	10.6	2.8	0.0	0.0	14.3	0.0	0.0	0.0	0.2	0.7	0.0	3.8	0.0	11.0	0.4	0.0	0.0	0.0	0.0	0.1	1.4	0.5	12.4	20.0	0.2	5.0	7.8	0.0	0.0	0.0	7.6	0.0	0.7	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.7	3.2	3.4	1.3	3.5	2.4	2.0	2.2	3.8	1.9	1.7
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113837-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 169.0;ASC TERT1: 58.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	8	"monocytes: 4.1;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"			35000000	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (8.11e-4)"	61.8	10.4	8.3	11.0	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17.0	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5.0	19.6	9.2	21.5	6.7	1.4	21.4	16.0	7.3	23.6	35.1	0.4	0.1	0.0	4.1	0.0	2.9	0.6	0.0	0.0	1.0	0.0	169.0	58.5	0.3	5.9	24.5	4.1	7.0	0.6	0.0	0.0	0.7	16.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.4	24.0	0.0	0.0	26.3	0.0	5.7	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	2.2	2.8	0.3	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	2.9	0.6	0.0	0.4	0.1	0.8	0.1	0.1	0.0	1.3	0.0	0.0	4.1	0.0	0.0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 alpha 1 subunit"	P08559	X	19343893-19361705	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"		15000	Mitochondria		"HPA047487: , HPA047864: , HPA063053: "	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favourable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	22.5	16.1	14.7	11.7	24.3	20.4	14.7	18.6	25.0	12.3	28.6	13.0	27.7	22.7	13.0	21.6	17.2	12.4	11.8	89.3	15.5	12.2	36.6	26.6	10.5	8.9	14.8	19.9	12.2	28.7	25.0	11.6	14.9	19.0	10.8	28.2	12.7	41.8	18.3	107.3	12.7	21.1	21.2	12.7	11.5	24.9	6.3	12.0	11.3	15.0	44.9	14.9	13.1	12.4	39.4	45.1	34.8	46.1	35.5	36.6	31.9	25.7	32.1	23.3	24.5	22.6	17.3	28.6	17.8	15.9	37.0	28.6	45.7	16.6	44.1	13.2	21.4	33.7	71.4	30.9	39.0	14.6	39.8	21.9	55.3	40.2	24.0	34.9	17.9	22.3	28.8	34.1	33.8	22.4	19.2	18.7	25.8	34.1	29.1	35.9	23.7	56.2	30.1	39.0	54.0	63.6	26.4	12.9	13.7	28.4	36.0	32.2	38.0	24.5	13.9	19.1	17.2	52.0	22.5	15.9	16.4	29.2	18.0	24.5	16.5	34.8	35.0	24.2	30.3	46.1	36.6	39.4	29.4	32.8	45.1	29.3	29.0	30.6	6.1	35.5	39.1	29.8	31.1	31.9	14.7	24.3	18.6	25.0	15.5	12.2	14.8	19.9	19.0	12.0
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 alpha 2 subunit"	P29803	4	95840019-95841474	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	146	"testis: 60.5"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria				Mitochondria		"HPA047487: , HPA047864: , HPA063053: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 beta subunit"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria			6500000	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	21.8	34.3	22.5	19.5	28.4	8.6	17.1	15.1	26.2	18.0	21.6	18.4	19.2	16.2	17.2	18.2	22.8	15.0	16.5	64.2	24.1	20.8	38.7	41.8	13.9	18.2	23.7	23.3	11.0	17.2	26.0	20.0	21.6	26.4	19.5	23.9	16.1	17.6	22.1	92.2	14.3	17.3	24.5	22.8	23.2	21.4	21.8	17.5	20.9	16.1	33.8	20.6	17.9	14.4	37.0	50.1	33.6	39.8	43.4	38.6	38.3	19.0	26.7	27.7	20.8	28.2	34.7	33.2	24.1	30.2	35.6	36.7	48.1	18.5	40.7	13.6	30.4	11.1	33.7	22.1	27.3	23.5	24.7	36.3	50.4	36.3	28.5	29.4	20.4	30.2	20.4	28.7	16.9	30.6	18.7	18.4	38.6	18.2	27.8	31.0	38.1	30.3	13.3	21.6	39.2	56.2	26.1	19.2	21.2	22.3	32.1	23.9	47.5	31.6	22.4	19.1	25.4	20.0	27.2	25.7	36.5	28.7	29.3	35.0	18.0	16.4	35.4	33.6	31.5	39.8	33.2	37.0	31.2	30.0	50.1	33.3	35.1	31.4	7.0	43.4	35.9	33.7	38.6	38.3	22.5	28.4	15.1	26.2	24.1	20.8	23.7	23.3	26.4	17.5
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746392-43773279	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"		390000000	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: , HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	16.9	21.2	10.0	20.5	13.5	20.8	31.1	12.7	9.2	24.7	19.4	12.3	33.9	22.2	19.7	42.4	21.7	18.4	25.1	20.6	10.2	12.7	27.3	112.5	20.0	34.6	12.4	10.3	22.4	46.8	21.1	21.7	44.0	13.3	24.6	21.2	13.7	43.4	36.9	8.7	17.9	28.8	15.8	11.4	25.2	20.5	17.1	14.3	15.6	74.0	16.4	19.8	14.7	28.3	7.7	18.3	13.5	10.8	11.7	14.1	14.5	12.2	4.6	9.7	21.8	19.8	21.2	29.9	24.6	24.3	18.3	22.7	12.8	12.6	14.0	16.0	28.0	19.5	12.3	23.8	15.9	10.1	18.2	18.9	7.3	11.8	32.5	10.7	13.8	13.6	19.7	13.8	23.3	31.8	10.9	6.9	17.8	4.2	3.6	12.1	9.8	18.6	7.0	15.3	10.5	15.5	10.0	9.8	10.9	20.5	19.7	7.7	13.7	10.9	21.5	15.2	8.0	12.2	11.9	3.1	3.6	14.7	19.5	16.9	11.4	10.0	10.3	13.5	13.4	10.5	14.1	6.5	8.5	10.8	9.6	7.7	7.2	8.4	2.9	11.7	10.8	18.3	6.7	14.5	10.0	13.5	12.7	9.2	10.2	12.7	12.4	10.3	13.3	14.3
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028641	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 164.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		12000000	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavourable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	17.6	13.0	7.7	25.6	11.9	7.4	27.4	5.1	7.9	25.5	20.9	12.1	28.8	18.2	19.4	46.3	15.2	20.8	28.1	16.9	7.3	8.0	27.7	164.3	19.1	29.1	11.6	6.2	19.4	76.3	7.0	19.1	24.7	12.0	18.0	21.9	7.8	36.4	26.5	5.8	10.1	21.3	17.8	13.9	27.9	23.7	11.5	11.3	19.2	89.8	11.9	24.3	17.4	22.6	26.6	63.3	16.2	21.2	21.5	35.9	34.5	32.6	31.1	33.8	94.5	30.9	22.1	49.0	46.0	30.8	26.4	43.1	25.8	88.4	23.5	103.3	37.8	21.4	22.8	43.6	23.2	16.7	13.4	11.3	9.0	56.5	41.5	25.7	31.9	21.7	19.6	28.9	23.2	53.5	18.4	64.2	23.1	35.7	24.4	29.3	50.4	18.1	16.1	26.2	57.0	30.8	25.7	10.8	28.4	41.7	30.1	16.0	17.1	19.8	29.2	20.8	11.8	50.5	32.3	48.9	22.0	16.6	48.6	30.4	70.8	16.2	20.1	12.1	34.3	21.2	35.9	26.6	22.6	26.7	19.4	15.1	21.5	22.7	2.7	21.5	21.0	63.3	16.6	34.5	7.7	11.9	5.1	7.9	7.3	8.0	11.6	6.2	12.0	11.3
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067062-123225227	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"		2900000	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favourable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavourable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	11.6	17.1	2.6	11.2	3.1	6.3	9.3	1.0	4.0	10.0	11.0	2.4	10.9	5.6	12.2	17.1	6.7	9.1	22.2	7.2	2.5	1.2	11.0	66.0	14.4	7.1	2.2	1.8	11.4	18.3	5.2	12.1	29.1	1.9	14.3	10.8	12.7	10.8	7.6	8.1	6.1	8.2	9.5	2.3	8.6	17.6	18.0	2.5	3.2	18.2	5.5	7.9	7.8	6.9	3.2	12.8	0.3	9.0	0.5	2.4	2.3	8.1	5.0	6.3	7.6	28.9	26.2	33.6	15.5	26.0	8.7	24.0	16.0	7.5	0.0	20.3	24.0	4.3	2.7	9.4	9.2	0.2	3.1	3.6	1.5	19.1	12.0	8.9	0.5	22.5	14.2	5.9	12.4	29.4	4.5	21.3	5.9	9.9	2.4	10.5	4.6	5.2	2.3	4.5	22.5	7.3	4.8	6.8	4.1	7.5	8.5	13.3	7.4	11.0	16.3	2.2	7.1	10.5	4.2	6.3	1.6	3.6	7.2	7.1	7.5	0.0	9.0	0.3	1.4	2.2	2.4	3.2	1.0	0.9	5.4	0.8	0.6	0.6	0.2	0.5	0.4	12.8	0.0	2.3	2.6	3.1	1.0	4.0	2.5	1.2	2.2	1.8	1.9	2.5
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		53000000	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.20e-4)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	26.9	32.7	16.7	25.0	29.9	19.9	28.7	11.3	16.8	33.4	26.1	13.9	53.7	20.4	30.4	76.1	27.1	25.5	22.4	32.7	14.2	13.9	42.1	118.4	30.4	36.3	17.8	12.7	26.5	141.6	24.9	23.3	39.5	19.0	22.6	30.1	14.6	53.4	45.0	15.7	16.1	28.4	26.5	14.3	35.1	30.9	12.4	19.5	18.1	97.9	20.1	29.7	21.9	30.6	45.2	61.0	52.0	46.2	51.5	52.2	59.7	33.9	36.9	52.9	82.9	68.1	58.9	94.0	82.7	76.8	43.4	58.5	52.3	67.1	55.2	58.2	80.8	27.9	39.7	69.2	46.7	43.2	31.3	44.7	28.9	84.9	73.7	45.8	33.6	42.5	53.2	42.0	75.8	97.8	38.4	119.1	42.8	40.2	17.6	47.5	44.1	29.2	42.3	53.9	99.9	61.8	41.1	33.9	67.9	32.6	47.8	46.4	16.9	77.7	48.0	40.8	52.1	36.7	47.8	112.4	69.3	35.8	55.1	57.6	57.0	52.0	44.4	20.5	47.5	46.2	52.2	45.2	37.7	44.7	48.6	33.1	18.4	31.0	8.1	51.5	33.9	61.0	37.7	59.7	16.7	29.9	11.3	16.8	14.2	13.9	17.8	12.7	19.0	19.5
PDIK1L	CLIK1L	ENSG00000175087	"PDLIM1 interacting kinase 1 like"	Q8N165	1	26111165-26125543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064157			Supported	Nucleoplasm				Nucleoplasm		"HPA064157: "	"unprognostic (1.09e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.99e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.47e-1)"	"unprognostic (1.78e-2)"	7.0	6.0	8.6	6.2	12.3	19.9	11.5	17.8	15.9	8.6	8.9	7.1	7.6	9.5	7.8	6.4	11.4	7.5	5.8	4.8	8.5	10.6	8.5	11.3	6.7	8.0	9.3	9.9	10.2	15.3	10.7	9.9	5.6	11.5	6.8	10.6	6.1	10.2	8.9	7.7	9.4	9.7	6.5	8.3	8.3	10.2	7.8	9.3	19.1	22.2	6.7	8.8	8.8	8.0	6.7	9.3	11.0	6.1	5.6	10.4	5.2	5.5	2.1	5.8	7.3	2.2	3.0	1.9	1.4	2.0	3.7	2.4	1.4	7.9	11.6	4.2	2.1	4.1	7.8	2.9	3.6	4.1	5.2	10.3	3.3	1.5	3.4	10.8	6.2	1.6	4.2	3.3	6.7	3.3	12.2	11.6	1.2	3.1	15.7	4.8	2.6	3.1	8.4	5.3	13.9	2.5	4.3	9.3	7.9	5.6	7.1	7.2	4.0	3.7	3.1	4.1	3.6	5.2	4.5	17.3	17.1	8.8	4.3	13.4	3.8	11.0	5.0	4.2	6.7	4.6	6.2	6.7	9.4	7.4	9.3	5.6	10.0	8.0	0.5	5.6	6.1	3.5	10.4	5.2	8.6	12.3	17.8	15.9	8.5	10.6	9.3	9.9	11.5	9.3
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	20.6	26.1	17.2	5.2	27.5	3.2	10.8	53.7	34.4	10.1	16.1	16.1	10.1	15.5	13.1	69.8	12.5	14.4	11.5	51.7	18.2	13.0	33.7	27.8	9.0	5.7	14.6	20.9	27.7	24.1	16.9	7.5	8.6	14.2	12.7	12.4	19.5	14.0	16.5	101.0	10.6	16.5	15.1	9.9	7.8	13.6	7.2	11.4	6.2	15.6	31.4	7.4	13.8	9.4	11.3	20.1	8.9	12.9	16.5	17.4	12.2	6.4	9.4	11.3	10.1	11.9	9.0	1.2	7.1	10.5	10.6	10.3	0.9	7.1	8.2	11.9	19.8	3.1	7.5	2.8	10.5	16.5	10.4	7.3	9.2	6.9	6.4	0.0	8.0	18.9	11.0	6.9	0.5	9.2	2.9	8.2	6.0	8.3	6.1	0.0	2.4	9.1	9.2	25.2	11.1	5.8	5.5	7.5	11.4	10.0	3.2	4.7	18.5	7.3	4.7	12.5	10.3	8.5	5.1	16.2	15.3	4.4	18.3	2.6	8.0	8.9	12.9	6.8	14.0	9.8	11.1	11.1	12.5	14.8	14.2	11.3	14.6	15.0	2.2	16.5	10.5	20.1	17.4	12.2	17.2	27.5	53.7	34.4	18.2	13.0	14.6	20.9	14.2	11.4
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465221-24539837	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA046583: , HPA072492: "	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	9.6	5.6	5.7	9.8	17.3	16.3	12.8	3.3	23.6	8.0	14.7	5.5	5.6	13.6	7.3	15.7	9.5	13.2	7.0	16.9	12.5	6.8	13.7	11.1	11.2	13.4	6.2	13.7	11.0	7.3	12.8	14.1	7.7	14.9	8.3	10.1	9.9	19.3	5.2	3.9	14.2	15.6	8.6	6.1	17.9	12.7	23.1	4.8	12.5	6.2	4.1	14.9	10.3	9.2	4.5	7.2	36.4	10.9	7.1	11.0	6.7	9.0	4.6	3.9	6.5	0.1	0.0	4.1	2.7	2.4	3.7	6.5	0.4	11.0	9.1	1.8	0.7	2.0	11.3	6.9	9.9	7.8	5.4	4.9	5.3	2.6	1.3	4.1	4.8	0.7	3.0	0.9	0.9	5.5	0.9	13.9	0.5	16.9	7.8	5.4	7.0	5.4	4.0	7.0	13.4	3.2	17.6	2.5	3.2	14.7	6.0	4.5	8.2	1.6	0.1	2.6	3.8	4.8	3.2	8.9	6.8	11.0	7.1	6.4	5.3	9.4	8.9	21.3	7.6	10.9	11.0	4.5	6.2	6.2	7.2	4.1	4.9	5.7	36.4	7.1	10.4	2.3	5.1	6.7	5.7	17.3	3.3	23.6	12.5	6.8	6.2	13.7	14.9	4.8
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291024	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 95.1;HHSteC: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 39.1;memory B-cell: 49.1;naive B-cell: 44.9"	"Group enriched"	"Detected in many"	6	"B-cells: 49.1;granulocytes: 39.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"			210000000	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favourable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	60.9	6.4	2.9	32.3	3.7	2.7	69.9	3.6	3.7	30.6	78.8	3.0	24.3	27.8	30.0	35.6	48.3	28.0	38.4	107.5	3.0	2.4	19.8	49.0	78.8	91.6	6.3	2.2	23.3	20.5	11.7	6.7	53.0	16.5	34.7	34.7	12.8	34.5	27.4	150.1	26.4	96.3	27.2	8.6	52.9	28.3	14.3	3.6	23.4	76.9	54.9	41.9	65.0	38.9	49.1	6.8	39.1	0.5	1.7	3.2	9.2	33.9	21.9	1.5	0.0	8.1	5.5	35.3	10.4	32.4	27.1	44.5	46.2	52.7	0.0	2.9	28.1	95.1	11.1	60.2	27.5	0.0	17.2	33.8	6.5	74.9	92.7	0.0	1.7	15.8	31.7	13.8	50.0	48.4	7.3	8.6	6.4	6.0	0.1	0.5	3.1	17.7	28.5	1.2	11.9	13.9	32.3	6.1	2.5	11.2	10.3	0.1	8.4	14.9	42.6	10.6	2.5	0.0	0.0	4.1	0.0	11.1	11.6	0.0	5.0	0.0	0.5	39.1	2.8	0.1	0.0	49.1	0.5	3.2	6.8	44.9	0.1	2.0	1.7	1.7	0.3	0.7	0.4	9.2	2.9	3.7	3.6	3.7	3.0	2.4	6.3	2.2	16.5	3.6
PDLIM2		ENSG00000120913	"PDZ and LIM domain 2"	Q96JY6	8	22578279-22598025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 81.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003880	Approved		Supported	"Actin filaments,Focal adhesion sites"				"Actin filaments, Focal adhesion sites"		"HPA003880: AB_1855149"	"unprognostic (1.04e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-3)"	"unprognostic (9.33e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (1.37e-7)"	"unprognostic (6.14e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.08e-3)"	10.4	7.0	5.4	10.9	5.9	6.0	10.4	16.2	7.9	19.8	27.6	8.4	7.7	17.8	11.1	11.0	41.1	9.0	19.9	10.1	6.3	5.0	20.9	16.4	26.5	17.2	6.9	7.1	13.1	15.6	2.2	5.7	42.3	10.8	11.2	3.2	11.3	12.4	10.0	53.5	48.8	32.2	16.2	10.1	81.6	5.6	8.5	5.0	7.5	5.5	23.4	21.0	12.7	23.2	9.6	12.4	49.3	20.2	8.7	16.4	10.2	22.6	14.0	9.5	16.6	18.7	32.1	10.7	35.8	26.8	25.8	26.1	16.0	3.8	9.3	10.1	32.3	11.6	5.3	24.4	5.0	0.0	3.6	2.9	9.1	11.5	23.8	3.2	22.7	34.2	3.0	12.6	3.5	14.1	0.8	6.1	17.4	11.9	4.1	3.8	7.8	1.4	3.3	1.8	1.0	4.5	4.6	2.9	7.1	7.5	20.5	32.4	7.2	6.6	17.5	28.1	29.0	33.5	16.4	0.1	0.2	3.0	28.9	13.0	20.6	22.7	15.5	49.3	16.4	20.2	14.6	8.4	12.4	16.1	12.4	9.6	8.6	12.2	32.9	8.7	19.4	8.0	12.8	10.2	5.4	5.9	16.2	7.9	6.3	5.0	6.9	7.1	10.8	5.0
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535612	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 447.7"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 50.0;RH-30: 12.3;U-266/70: 40.2;U-266/84: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol			270000	Cytosol		"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.13e-6)"	"unprognostic (2.78e-3)"	7.8	1.2	1.6	5.2	1.9	0.1	3.7	2.2	1.0	6.6	16.5	1.4	7.9	2.3	22.2	17.0	27.2	9.3	9.9	29.5	1.5	1.6	0.8	0.8	5.6	1.4	1.6	1.0	11.1	2.1	0.1	1.9	2.2	1.6	15.2	3.6	4.8	5.3	18.7	447.7	1.0	6.1	49.5	1.4	3.4	10.2	3.9	0.7	0.1	6.2	87.3	9.1	28.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.4	1.9	5.5	0.0	0.0	3.9	0.0	1.2	0.0	4.1	0.0	0.0	50.0	0.0	0.0	0.0	0.9	0.3	0.0	12.3	0.1	0.0	0.0	7.4	5.6	0.0	0.0	2.9	0.2	0.0	2.7	0.0	3.0	0.0	2.5	40.2	11.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	2.2	1.0	1.5	1.6	1.6	1.0	1.6	0.7
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 129.6;skeletal muscle: 173.0"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 51.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"			2200000	"Nucleoplasm, Plasma membrane, Focal adhesion sites"		"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	11.6	4.8	6.2	4.2	6.1	8.7	9.8	3.4	5.8	12.7	11.0	3.7	7.1	5.6	37.5	12.9	14.0	10.2	11.0	129.6	5.3	5.2	12.9	13.9	5.6	5.3	5.4	4.5	10.3	8.1	3.4	6.8	18.9	10.2	15.3	5.4	12.6	15.3	12.5	173.0	5.6	15.8	22.1	4.9	7.0	5.6	5.5	3.7	1.0	5.3	52.9	9.5	17.7	7.1	3.2	5.6	51.1	12.2	2.7	3.9	3.8	8.6	25.7	10.0	3.9	22.1	15.2	3.9	21.2	17.6	12.2	9.8	23.7	19.3	3.4	21.7	21.2	9.0	13.6	19.8	20.4	6.1	5.7	12.7	16.8	8.9	31.9	4.1	11.4	20.4	17.5	29.1	22.7	27.3	5.4	3.8	25.8	8.5	4.2	1.4	3.4	10.8	2.0	7.4	3.1	13.6	27.8	5.0	6.7	11.5	26.5	5.9	3.1	1.3	34.2	31.8	5.0	13.7	12.8	2.6	3.4	3.5	17.3	3.0	7.4	51.1	6.8	5.9	3.8	11.8	3.1	3.2	3.7	3.9	5.6	2.5	2.5	3.2	6.8	2.7	12.2	1.9	3.4	3.8	6.2	6.1	3.4	3.9	5.3	5.2	5.4	4.5	10.2	3.7
PDLIM7	ENIGMA	ENSG00000196923	"PDZ and LIM domain 7"	Q9NR12	5	177483394-177497606	"Predicted intracellular proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 159.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 27.2;eosinophil: 20.5;neutrophil: 80.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 80.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018794, HPA048815"	Approved		Enhanced	"Actin filaments,Focal adhesion sites"			7600000	"Actin filaments, Focal adhesion sites"		"HPA018794: AB_1855155, HPA048815: AB_2680530"	"unprognostic (7.70e-3)"	"unprognostic (3.75e-2)"	"unprognostic (9.27e-3)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.18e-3)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (6.19e-10)"	"unprognostic (6.72e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.68e-2)"	12.4	5.6	3.7	21.1	9.3	12.5	8.3	0.5	5.9	54.6	76.0	3.2	42.6	9.0	85.0	35.8	33.9	35.5	52.3	11.1	3.8	5.0	8.3	2.4	11.6	8.9	3.5	5.8	28.2	3.1	2.1	10.3	11.5	5.6	42.0	7.6	17.6	9.1	61.7	159.6	5.3	16.5	129.5	3.1	12.7	27.0	11.7	2.4	3.7	5.4	24.9	6.5	67.8	19.6	1.8	4.8	80.6	8.4	0.4	1.4	3.9	24.8	4.9	23.7	18.7	6.4	11.8	24.1	47.6	26.0	27.1	19.5	9.6	22.5	4.5	49.2	29.1	12.0	3.9	32.3	6.3	6.2	5.7	14.6	16.3	9.0	17.6	7.8	49.3	25.7	5.4	21.7	10.4	16.2	10.8	3.2	19.6	19.2	1.4	17.2	16.4	21.4	29.0	21.2	2.8	18.1	5.1	3.6	7.8	18.6	3.5	9.1	5.1	7.0	58.3	32.7	35.5	12.4	43.4	0.8	0.9	5.3	15.5	8.4	7.4	27.2	8.4	20.5	0.9	3.9	1.1	1.8	0.6	1.4	4.8	1.0	0.6	0.7	80.6	0.4	4.9	0.3	1.2	3.9	3.7	9.3	0.5	5.9	3.8	5.0	3.5	5.8	5.6	2.4
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.2;TIME: 33.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavourable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favourable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	8.9	4.4	9.6	4.0	8.0	14.6	3.2	7.0	7.8	8.3	9.8	4.6	33.2	5.0	23.7	11.2	19.9	4.1	5.9	12.3	0.5	2.0	2.3	5.5	1.6	9.1	1.1	3.3	9.4	11.8	14.1	22.6	18.7	0.8	8.2	10.1	2.1	6.9	3.6	4.4	5.7	1.7	5.7	0.9	5.7	6.2	0.8	4.2	4.6	0.5	21.6	1.5	1.4	33.2	10.1	6.5	23.6	8.3	4.6	1.9	4.2	12.9	4.2	8.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Supported	Mitochondria				Mitochondria		"HPA019950: AB_1855156, HPA062059: "	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	10.7	7.2	7.4	3.7	10.5	3.2	8.7	11.5	16.5	4.9	7.5	10.1	5.7	10.4	7.9	7.2	8.9	7.2	6.0	4.8	7.4	7.1	18.1	16.5	8.6	5.0	9.0	9.4	14.9	13.8	12.0	7.0	7.7	16.0	7.8	8.4	8.5	7.1	6.9	6.3	4.7	6.2	4.6	6.3	4.0	6.7	8.6	8.9	4.6	18.0	4.0	5.9	6.3	5.5	3.3	1.3	1.8	0.4	6.1	6.3	2.0	7.2	8.8	5.5	10.7	14.7	7.6	6.9	3.7	14.7	8.8	13.2	17.9	5.1	10.0	5.4	5.3	9.1	15.8	8.5	8.5	2.3	8.0	5.0	4.4	11.6	8.0	6.4	8.9	5.7	6.4	12.4	12.9	3.7	9.6	7.2	7.8	4.7	12.5	4.6	6.4	11.2	12.3	7.6	15.8	4.6	7.7	11.0	6.2	12.1	5.0	4.5	6.6	3.1	3.5	5.4	7.3	3.2	5.5	12.8	11.8	10.0	7.4	5.1	5.3	1.3	0.4	1.8	6.3	0.3	5.2	1.8	3.1	5.1	1.3	3.3	4.5	5.0	1.3	6.1	0.2	0.8	0.9	2.0	7.4	10.5	11.5	16.5	7.4	7.1	9.0	9.4	16.0	8.9
PDS5A	"KIAA0648, PIG54, SCC-112"	ENSG00000121892	"PDS5 cohesin associated factor A"	Q29RF7	4	39822863-39977956	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036661, HPA036662"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA036661: AB_2675233, HPA036662: AB_10696783"	"unprognostic (4.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.81e-2)"	24.9	18.7	15.8	34.7	17.3	22.6	44.9	25.9	19.2	20.5	23.8	12.7	22.9	17.5	20.7	19.8	28.3	17.2	17.4	18.3	17.0	16.6	21.1	29.6	26.8	35.1	16.5	13.1	26.3	23.7	34.0	18.7	30.3	15.5	19.9	22.0	12.2	23.2	21.4	22.3	21.6	21.9	18.7	19.3	26.9	18.1	12.1	15.4	61.3	26.0	18.6	29.9	21.3	41.7	5.2	4.6	3.7	3.4	6.3	6.7	2.2	19.3	14.5	18.6	19.6	18.0	18.2	14.9	15.6	14.9	18.6	18.6	14.0	22.0	37.9	17.3	18.6	10.7	31.8	18.3	26.9	12.6	12.1	26.0	18.3	14.7	18.0	31.6	22.3	11.9	20.8	19.7	29.3	23.6	30.6	16.1	19.1	13.6	39.4	27.9	10.6	9.8	36.9	33.2	13.8	17.8	19.7	25.8	15.3	21.7	15.0	13.9	15.2	28.1	22.2	21.1	22.0	15.2	26.5	13.7	23.8	40.7	15.0	32.5	16.5	3.7	2.5	3.7	5.2	3.4	6.7	4.5	5.1	5.7	3.8	5.2	6.2	4.7	1.0	6.3	2.2	4.6	4.2	2.2	15.8	17.3	25.9	19.2	17.0	16.6	16.5	13.1	15.5	15.4
PDS5B	"APRIN, AS3, CG008, FLJ23236, KIAA0979"	ENSG00000083642	"PDS5 cohesin associated factor B"	Q9NTI5	13	32586427-32778019	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039513, HPA040015"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA039513: AB_10671999, HPA040015: AB_10671047"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.91e-2)"	14.8	11.2	18.9	11.8	20.5	25.8	17.0	21.2	27.5	21.8	16.2	8.0	10.2	8.1	25.4	18.3	9.8	16.1	10.6	9.8	17.2	16.0	13.6	12.6	14.1	15.9	12.6	22.9	22.0	9.9	15.4	17.8	14.2	14.7	17.7	11.3	8.6	11.3	13.9	14.0	13.6	13.6	16.5	12.5	16.6	12.7	15.3	14.3	29.1	14.0	7.7	13.7	16.9	24.2	9.2	7.7	8.3	6.5	5.6	8.3	3.3	6.1	3.7	16.9	9.0	8.1	5.9	4.7	10.4	7.0	8.9	9.0	5.1	10.3	22.5	3.8	5.1	8.2	12.2	6.5	10.6	17.9	4.6	20.3	6.7	7.0	4.8	18.5	12.5	4.5	3.3	7.4	6.7	6.7	7.0	15.2	8.1	7.9	22.1	13.9	12.5	4.5	22.7	23.4	7.7	5.7	5.1	4.4	10.7	12.0	11.9	4.4	11.4	12.4	13.2	8.6	8.3	6.1	6.2	4.7	5.2	19.2	3.6	12.6	12.3	5.8	6.0	8.3	7.2	4.9	8.3	7.8	8.3	7.4	7.7	9.2	8.2	7.9	7.5	5.6	6.5	5.3	5.9	3.3	18.9	20.5	21.2	27.5	17.2	16.0	12.6	22.9	14.7	14.3
PDSS2	"bA59I9.3, C6orf210"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152557-107459564	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Enhanced	Cytosol				Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favourable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favourable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	10.6	27.3	7.2	17.0	8.3	8.3	19.6	9.0	10.3	10.4	12.7	9.0	13.7	9.6	13.1	11.4	11.5	9.2	11.2	16.0	7.0	6.8	22.1	27.4	18.2	18.3	9.2	5.3	10.8	14.0	11.4	19.4	7.0	9.6	15.6	13.9	12.0	19.9	19.9	13.1	9.0	10.1	11.0	8.1	9.1	10.5	12.8	10.1	11.3	14.1	11.1	10.6	10.9	12.9	8.5	9.4	4.1	12.1	4.6	8.3	4.3	5.6	7.6	6.5	10.1	11.3	14.5	15.0	10.0	12.7	9.6	9.3	7.5	8.2	10.8	9.2	11.1	7.8	15.7	12.5	13.2	6.9	7.7	10.7	9.0	12.5	12.0	13.8	8.7	10.7	14.9	15.2	12.1	10.1	15.2	14.7	9.4	7.0	4.0	14.6	4.1	9.9	7.2	5.8	8.7	11.9	7.8	6.4	5.6	6.8	12.0	14.3	9.8	16.7	6.3	6.9	4.1	9.6	8.5	4.1	5.0	8.4	12.8	20.6	12.6	4.1	6.6	3.5	5.3	7.6	8.3	6.6	5.6	6.8	9.4	8.5	7.3	6.9	0.9	4.6	12.1	4.5	7.1	4.3	7.2	8.3	9.0	10.3	7.0	6.8	9.2	5.3	9.6	10.1
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920020-27926231	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 10.4;intestine: 33.0;pancreas: 24.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;CACO-2: 2.0;CAPAN-2: 2.4;HDLM-2: 6.8;HEK 293: 4.1;HeLa: 10.3"	"Group enriched"	"Detected in many"	11	"colorectal cancer: 8.4;liver cancer: 1.9;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB025873: , HPA059146: "		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	33.0	0.0	0.0	31.1	0.1	0.0	0.1	0.1	10.4	0.1	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.0	0.1	24.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	17.6	0.0	0.2	0.1	4.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.8	4.1	0.0	10.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PDXDC1	KIAA0251	ENSG00000179889	"Pyridoxal dependent decarboxylase domain containing 1"	Q6P996	16	14974591-15139339	"Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 91.1"	"Cell line enhanced"	"Detected in all"		"T-47d: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047369, HPA049121, HPA051484"	Approved		Enhanced	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA047369: , HPA049121: , HPA051484: "	"unprognostic (3.67e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.47e-3)"	"unprognostic (4.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (3.13e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	10.5	13.2	11.0	11.7	10.7	6.0	27.8	15.4	16.9	13.8	21.6	9.0	11.8	27.7	10.9	16.5	14.2	11.0	16.6	15.5	11.5	8.1	21.9	33.8	11.2	12.7	10.2	10.0	11.2	37.4	17.2	26.0	19.6	12.8	19.6	25.3	13.7	25.2	14.7	22.1	8.8	30.9	13.1	14.9	10.6	24.6	91.1	8.7	6.9	16.3	8.2	9.5	13.4	11.1	11.0	12.8	12.0	8.3	7.7	12.6	7.8	7.8	11.6	12.0	10.0	6.7	8.1	19.8	7.4	6.6	5.5	7.7	14.2	17.2	15.1	16.3	9.9	12.9	8.4	7.6	8.0	9.2	11.5	9.1	19.5	37.2	17.5	7.2	21.8	8.5	7.9	9.6	8.1	5.8	6.7	9.9	13.0	19.3	4.7	3.8	5.8	4.4	7.3	4.9	18.0	8.8	12.8	12.3	8.8	20.0	11.5	19.0	46.4	11.2	9.0	4.3	3.9	4.7	9.5	9.3	9.0	14.6	8.8	6.1	13.6	3.2	8.0	12.0	11.0	8.3	12.6	9.2	8.0	8.9	12.8	11.0	10.0	9.4	1.1	7.7	6.6	5.9	7.0	7.8	11.0	10.7	15.4	16.9	11.5	8.1	10.2	10.0	12.8	8.7
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 68.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm			870000	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.51e-3)"	28.1	13.2	37.4	8.7	36.6	13.3	13.3	21.9	38.5	9.7	13.8	11.0	15.7	16.7	9.0	13.2	11.0	12.9	8.8	11.4	26.1	30.4	22.8	17.4	20.4	9.5	24.1	22.7	16.4	17.6	25.7	20.7	12.6	20.3	10.6	11.8	7.8	18.3	13.9	5.8	14.3	22.1	8.8	10.1	7.8	15.2	68.9	10.7	3.9	13.6	7.0	11.0	9.7	8.6	2.7	2.5	1.3	7.7	1.9	3.3	2.4	17.2	21.2	3.4	6.4	8.3	11.8	4.1	6.2	9.8	6.1	5.1	17.2	27.1	5.8	6.7	8.9	13.1	6.5	17.8	4.0	6.5	5.6	5.9	23.2	12.7	16.4	5.5	8.7	16.7	17.0	6.4	7.1	2.8	10.3	13.5	5.7	11.7	0.8	10.1	9.2	8.1	6.6	2.0	16.2	26.3	21.2	3.3	3.9	25.9	24.0	9.2	7.9	7.8	5.1	4.4	8.7	5.9	5.8	8.2	3.8	3.4	18.3	16.1	4.3	1.3	4.8	0.2	1.7	4.4	3.3	1.4	1.7	1.9	2.5	2.7	2.0	1.4	1.3	1.9	7.7	1.2	1.5	2.4	37.4	36.6	21.9	38.5	26.1	30.4	24.1	22.7	20.3	10.7
PDZD7	"bA108L7.8, DFNB57, FLJ23209, PDZK7"	ENSG00000186862	"PDZ domain containing 7"	Q9H5P4	10	101007683-101032295	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7;intestine: 25.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 11.9;THP-1: 17.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA074542			Supported	Nucleoplasm				Nucleoplasm		"HPA074542: "	"unprognostic (1.46e-1)"	"unprognostic (2.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.54e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-1)"	2.4	2.3	7.0	1.7	10.7	2.4	0.9	15.9	11.6	0.8	3.4	2.4	0.0	17.4	2.5	1.9	1.0	1.1	3.0	1.2	6.3	7.8	2.2	0.7	1.9	1.6	12.5	8.3	1.4	1.7	3.8	6.2	1.8	17.7	1.5	0.7	1.1	2.1	1.2	1.4	3.8	25.3	2.0	9.1	2.6	1.9	2.1	4.8	0.0	2.2	0.0	0.6	1.3	1.0	1.3	0.7	6.9	2.1	2.3	1.5	0.6	7.3	1.0	0.5	0.8	0.9	0.2	2.5	1.3	0.7	0.0	0.4	1.7	1.9	3.6	3.5	0.3	2.3	0.2	0.7	0.0	1.0	2.4	0.2	3.5	2.3	0.6	0.6	3.3	0.4	0.3	0.2	0.2	0.3	0.6	0.9	0.1	1.8	0.5	1.4	0.6	2.6	1.6	1.0	0.4	1.8	0.8	11.9	5.5	0.8	0.4	1.2	2.5	17.4	0.5	1.2	2.6	1.4	1.1	1.5	0.1	0.3	6.5	1.3	0.7	2.9	2.1	1.5	1.0	1.3	1.0	1.1	0.9	1.3	0.4	1.3	1.5	0.8	6.9	2.3	0.8	0.7	0.6	0.6	7.0	10.7	15.9	11.6	6.3	7.8	12.5	8.3	17.7	4.8
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118135858-118145584	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 260.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA008819, CAB013493, HPA063904"	Enhanced		Supported	"Plasma membrane"			62000000	"Plasma membrane"		"CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: "	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favourable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	26.8	207.3	83.0	15.2	82.3	13.5	32.3	63.3	102.7	35.5	50.4	58.0	18.9	75.3	22.9	52.8	24.3	28.5	22.6	57.6	77.6	69.7	132.7	260.7	22.1	16.0	77.8	71.5	43.5	46.2	139.2	30.8	16.5	59.1	35.4	25.4	41.2	43.6	33.1	65.1	20.9	75.4	23.4	79.1	15.3	20.6	22.7	43.5	8.7	94.9	26.1	19.7	20.2	17.8	45.2	37.3	3.0	12.1	20.9	45.3	36.4	31.7	27.1	38.5	40.0	60.7	29.8	59.9	25.3	29.6	40.0	20.6	16.2	11.0	51.2	25.5	37.9	22.9	56.9	23.5	31.3	12.8	54.4	25.7	30.6	112.6	35.1	46.5	11.3	29.4	39.1	23.6	16.5	18.6	42.6	19.1	40.0	37.6	25.3	94.2	37.3	32.9	50.1	28.7	93.4	49.0	31.0	46.1	35.8	52.6	36.6	49.5	52.5	31.7	20.1	30.8	17.5	30.0	25.4	18.7	33.2	26.4	36.1	34.8	33.2	0.7	11.0	3.0	26.9	12.1	42.4	45.2	45.3	33.3	33.3	32.5	43.9	35.3	1.2	20.9	10.3	37.3	41.2	36.4	83.0	82.3	63.3	102.7	77.6	69.7	77.8	71.5	59.1	43.5
PECR	"HSA250303, SDR29C1, TERP"	ENSG00000115425	"Peroxisomal trans-2-enoyl-CoA reductase"	Q9BY49	2	215996329-216082955	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.2;RPTEC TERT1: 23.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 30.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021593, HPA022539"	Enhanced		Supported	Peroxisomes				Peroxisomes		"HPA021593: AB_1855177, HPA022539: AB_1855178"	"unprognostic (7.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-3)"	"unprognostic (5.61e-2)"	"prognostic favourable (1.36e-5)"	"unprognostic (6.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.64e-2)"	14.2	4.4	3.2	6.5	3.3	3.5	7.0	6.7	3.7	2.8	11.5	4.4	2.7	13.2	2.0	6.6	2.4	4.5	7.2	2.7	3.3	3.1	17.4	78.4	3.6	3.8	4.4	2.9	3.2	3.1	3.8	5.4	0.9	3.5	3.1	4.2	6.2	3.5	3.5	3.4	3.3	20.9	3.2	5.1	2.8	2.6	0.9	3.6	2.4	8.5	2.0	3.5	2.2	4.1	5.1	1.4	4.1	3.9	8.8	14.7	4.1	3.8	4.2	1.7	0.1	10.4	3.9	2.1	0.9	2.1	2.5	4.1	4.8	11.0	0.1	7.9	2.2	0.9	4.7	5.6	4.3	6.0	5.0	4.9	2.4	24.2	10.5	1.3	3.4	3.3	3.9	2.5	3.6	2.4	2.0	5.6	5.3	2.7	1.5	1.3	3.1	3.2	3.3	3.3	0.5	23.3	0.6	2.4	3.4	2.3	4.8	9.5	5.7	4.1	0.0	1.6	1.7	4.0	2.7	6.5	5.5	1.9	3.5	1.8	3.6	0.8	3.9	1.3	6.4	1.5	7.3	4.2	8.6	7.3	1.4	5.1	9.2	6.0	4.1	8.8	2.0	0.2	14.7	4.1	3.2	3.3	6.7	3.7	3.3	3.1	4.4	2.9	3.5	3.6
PEG3	"KIAA0287, ZKSCAN22, ZNF904, ZSCAN24"	ENSG00000198300	"Paternally expressed 3"	Q9GZU2	19	56810083-56840728	"Predicted intracellular proteins, Transcription factors"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.0;ovary: 106.4;placenta: 49.8"	"Group enriched"	"Detected in some"	5	"BEWO: 31.4;Hep G2: 63.9;RH-30: 21.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.3;plasmacytoid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.3"	"Low region specificity"	"Detected in all"							HPA026070	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA026070: AB_10603328"	"unprognostic (1.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.48e-5)"	"unprognostic (6.92e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (6.68e-3)"	2.0	29.8	10.1	1.0	51.0	0.5	4.5	9.8	22.4	4.1	2.4	5.9	0.0	0.7	9.1	2.6	1.7	5.8	1.2	2.3	9.7	9.6	1.8	2.1	1.7	0.7	3.5	16.0	106.4	1.9	7.3	24.6	49.8	21.3	1.8	1.2	0.4	2.3	2.5	1.7	1.8	1.7	4.1	4.8	1.6	2.0	12.3	7.3	0.0	2.7	0.0	2.7	2.6	2.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.9	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	21.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	10.1	51.0	9.8	22.4	9.7	9.6	3.5	16.0	21.3	7.3
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA053966: , HPA056028: , HPA060760: "	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favourable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.0	12.3	19.8	13.8	22.0	10.5	10.9	22.9	28.0	12.6	11.8	25.5	8.4	12.9	14.3	9.8	17.4	17.3	11.4	18.2	19.9	18.8	9.6	10.6	11.2	17.2	20.2	18.6	21.0	18.9	18.2	17.0	12.4	18.3	13.8	8.6	13.8	16.5	14.7	38.2	17.2	11.6	12.2	18.7	13.6	12.4	21.3	18.1	17.0	14.5	12.3	13.3	11.2	10.6	3.8	3.5	5.8	3.4	3.8	4.5	1.9	15.7	34.6	13.7	21.6	10.7	7.9	30.8	11.4	8.0	15.9	17.0	33.7	11.7	38.0	17.6	9.0	24.3	25.5	17.9	9.0	19.6	36.4	16.9	17.4	27.1	13.8	13.6	22.8	9.7	11.1	19.6	16.5	11.8	20.3	16.7	8.7	21.6	25.6	16.1	22.5	11.6	27.1	12.1	18.7	11.1	12.0	13.8	18.4	19.7	14.5	14.7	17.5	9.2	11.8	12.3	17.4	18.6	22.0	9.0	15.4	15.8	13.9	14.1	15.8	0.9	2.4	5.8	3.1	3.1	3.1	2.6	3.0	2.4	2.4	3.8	3.3	4.5	1.4	3.8	3.4	3.5	2.0	1.9	19.8	22.0	22.9	28.0	19.9	18.8	20.2	18.6	18.3	18.1
PER1	"PER, RIGUI"	ENSG00000179094	"Period circadian regulator 1"	O15534	17	8140472-8156506	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 23.2;hTCEpi: 27.1;hTERT-HME1: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047947, HPA067064"			Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA047947: , HPA067064: "	"unprognostic (7.64e-2)"	"prognostic favourable (3.89e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (2.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.21e-3)"	"unprognostic (6.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.09e-3)"	"prognostic unfavourable (1.94e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-2)"	39.4	33.4	13.2	21.6	15.0	27.3	31.3	19.5	23.9	27.8	24.6	20.9	27.8	6.9	19.5	17.2	31.6	25.2	36.9	24.0	13.3	6.3	14.2	18.6	25.8	10.8	15.6	11.3	50.1	61.8	19.3	29.8	12.7	20.1	23.1	8.1	36.6	23.3	43.5	70.3	47.9	16.9	29.3	17.5	16.7	23.6	13.8	17.1	4.6	28.5	33.1	12.1	30.2	25.0	1.6	4.9	3.3	3.6	0.5	2.1	1.2	1.0	3.8	4.4	6.3	14.5	10.7	2.5	1.5	2.7	1.9	2.3	3.8	2.5	7.1	1.2	2.2	3.1	4.4	23.2	1.3	2.2	5.5	3.7	8.3	1.1	20.0	1.5	5.7	16.0	27.1	3.3	26.5	4.2	4.7	9.9	3.5	3.5	4.3	2.9	3.8	2.5	6.0	2.5	3.7	4.6	0.8	1.9	4.7	3.2	3.7	3.0	2.7	1.1	7.2	2.2	4.3	0.8	1.3	5.8	2.2	2.5	3.0	1.8	1.6	0.0	3.6	1.7	1.9	2.5	2.1	1.0	1.7	1.2	4.9	1.6	1.6	1.1	3.3	0.5	1.2	0.7	1.1	1.2	13.2	15.0	19.5	23.9	13.3	6.3	15.6	11.3	20.1	17.1
PER3		ENSG00000049246	"Period circadian regulator 3"	P56645	1	7784320-7845177	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019530	Approved		Supported	Cytosol				Cytosol		"HPA019530: AB_1855201"	"unprognostic (5.11e-2)"	"prognostic favourable (7.14e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.34e-4)"	"unprognostic (3.87e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-2)"	"prognostic favourable (2.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.62e-1)"	10.2	9.1	10.9	6.0	15.6	0.5	10.4	42.4	17.5	13.5	14.5	22.5	11.2	5.0	16.2	8.9	13.9	10.8	13.5	17.2	10.1	9.4	10.4	20.5	9.6	3.3	11.2	10.7	15.7	13.3	16.0	15.2	2.1	13.4	13.0	5.5	23.2	18.8	17.7	20.4	11.1	7.4	18.5	16.2	6.7	14.0	8.7	10.9	0.9	19.0	15.6	7.1	13.2	9.5	1.3	1.8	1.1	3.3	0.9	5.1	1.6	4.2	1.2	3.7	1.1	0.6	0.3	1.1	1.8	3.3	3.4	4.7	5.0	16.6	1.9	1.0	7.3	1.9	13.3	0.8	5.1	0.1	0.7	13.3	4.9	0.7	4.2	0.4	4.6	1.8	1.4	3.7	3.7	1.2	10.7	3.5	1.4	3.3	7.3	5.9	2.0	3.5	6.4	1.3	0.1	1.9	0.8	4.8	5.2	15.6	0.0	6.7	4.0	0.5	2.5	9.2	13.4	2.8	2.4	0.5	0.3	1.6	6.4	21.2	12.7	0.9	1.6	1.1	4.2	2.0	5.1	1.3	2.0	3.8	1.8	0.8	1.7	2.1	0.2	0.9	3.3	1.4	3.1	1.6	10.9	15.6	42.4	17.5	10.1	9.4	11.2	10.7	13.4	10.9
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavourable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	24.4	28.1	26.0	26.1	30.1	28.2	29.6	19.0	31.8	19.7	21.9	27.2	18.1	20.4	28.0	21.3	31.2	28.0	22.7	18.1	26.3	18.5	24.2	34.9	19.8	30.0	27.2	26.6	30.5	49.0	31.3	17.0	20.2	23.6	24.2	19.2	18.6	22.2	22.1	34.1	32.3	19.8	22.9	24.3	26.4	25.2	34.5	27.2	21.2	25.3	23.1	24.9	21.8	22.6	14.4	17.8	3.9	19.4	12.4	16.2	16.3	34.2	39.2	14.4	30.7	16.7	16.4	22.3	22.8	18.8	39.0	30.5	45.4	14.8	46.6	20.4	25.9	23.9	44.5	40.8	28.8	19.9	42.8	22.5	22.5	39.0	41.6	54.4	23.8	23.1	25.7	40.5	40.9	25.1	37.1	19.0	23.6	43.2	26.4	55.2	28.1	28.7	33.7	25.2	45.5	21.4	23.8	25.0	26.0	22.5	25.8	30.2	18.1	28.0	19.8	45.9	34.8	23.2	38.1	24.2	20.6	47.6	32.1	25.0	29.3	3.9	15.8	3.9	13.3	19.4	16.2	14.4	12.4	12.7	17.8	13.8	14.2	12.7	0.6	12.4	13.9	15.4	9.5	16.3	26.0	30.1	19.0	31.8	26.3	18.5	27.2	26.6	23.6	27.2
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528531	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes				Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	11.3	13.8	8.9	13.1	19.1	5.8	14.0	14.3	14.7	12.7	13.2	15.8	19.0	10.2	12.2	18.7	13.0	9.5	10.6	13.4	9.5	9.3	22.4	20.3	8.4	9.9	15.4	9.3	14.3	17.5	23.3	22.5	8.0	18.5	12.9	15.4	13.7	13.6	20.6	16.1	15.0	12.7	12.2	15.0	10.2	12.9	10.2	13.6	15.2	13.8	14.6	11.1	11.5	11.6	5.5	2.1	3.1	3.6	7.9	6.2	1.9	5.6	6.3	10.3	17.4	6.5	5.6	9.3	3.8	5.0	4.5	6.5	3.8	6.1	8.5	8.6	4.3	5.8	7.8	6.8	7.2	8.7	6.9	4.0	6.7	4.7	4.5	7.2	4.6	6.1	6.2	6.8	9.2	7.0	14.9	12.1	7.1	10.7	14.4	7.1	7.1	5.9	10.2	11.5	10.5	6.4	8.4	7.6	12.3	8.8	24.4	7.5	5.0	3.1	5.8	4.4	5.9	16.5	3.9	13.6	10.7	11.7	4.1	4.3	6.9	1.1	2.0	3.1	4.7	3.2	4.6	5.5	4.9	5.1	2.1	4.7	5.7	6.2	1.6	7.9	3.6	1.3	4.6	1.9	8.9	19.1	14.3	14.7	9.5	9.3	15.4	9.3	18.5	13.6
PEX11B		ENSG00000131779	"Peroxisomal biogenesis factor 11 beta"	O96011	1	145911350-145918837	"Disease related genes, Predicted membrane proteins"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA017150, HPA050104"	Supported		Supported	Vesicles				Vesicles		"HPA017150: , HPA050104: "	"unprognostic (4.59e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (2.67e-4)"	"prognostic favourable (6.85e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.62e-3)"	"unprognostic (4.28e-1)"	12.0	17.3	25.9	13.3	29.5	8.5	24.4	25.1	39.6	19.9	18.2	17.3	21.3	18.4	16.2	27.2	21.6	20.1	14.7	17.9	25.8	28.1	25.4	19.8	14.9	18.4	24.0	20.3	19.7	23.2	20.4	16.4	17.3	26.9	18.2	21.7	15.7	19.0	20.9	23.7	20.6	17.2	16.1	14.7	18.7	18.4	18.0	14.8	21.4	20.3	17.2	25.3	16.7	13.9	42.5	42.8	32.0	29.6	29.5	37.0	34.1	11.2	10.3	9.2	9.0	21.5	16.9	9.5	11.4	15.1	14.9	11.6	4.7	13.2	10.6	12.4	16.1	13.7	8.0	17.0	10.5	11.7	6.0	6.4	6.8	12.1	30.3	19.4	12.0	22.1	21.2	10.1	10.0	19.0	11.7	17.5	23.5	17.8	14.8	18.5	3.3	12.7	13.8	13.8	23.1	25.6	8.0	6.4	10.5	8.6	16.6	10.3	22.9	30.2	16.8	10.1	8.1	13.1	8.2	19.0	21.9	14.9	17.0	11.0	6.9	32.0	29.6	20.6	28.7	26.3	31.2	42.5	32.9	31.0	32.0	37.2	37.0	33.5	14.7	29.5	25.8	42.8	34.8	34.1	25.9	29.5	25.1	39.6	25.8	28.1	24.0	20.3	26.9	14.8
PEX13		ENSG00000162928	"Peroxisomal biogenesis factor 13"	Q92968	2	61017225-61051990	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032141, HPA032142, CAB032689"	Enhanced		Supported	Vesicles				Vesicles		"CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676"	"unprognostic (2.44e-3)"	"unprognostic (4.10e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (8.07e-5)"	"unprognostic (5.42e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.63e-2)"	11.7	11.5	14.2	9.1	14.7	8.4	29.2	21.4	14.9	14.3	13.1	10.3	6.0	13.0	12.3	10.3	15.7	8.9	11.6	16.3	14.1	11.7	17.7	31.8	16.8	13.1	11.7	11.7	16.5	19.5	10.9	18.7	11.9	10.8	19.6	14.1	11.6	13.7	8.7	20.7	11.5	15.3	17.4	12.2	8.2	12.7	18.2	12.3	11.7	18.0	9.7	11.0	13.7	13.3	8.3	7.9	15.1	7.0	8.0	10.5	6.2	10.4	7.7	11.0	14.1	10.6	8.4	17.0	10.9	8.5	7.5	7.7	11.5	15.9	6.8	11.8	10.6	15.7	9.7	13.1	14.2	6.6	6.7	6.2	10.4	18.9	12.6	9.2	7.6	10.2	20.3	10.2	15.8	13.4	15.1	6.1	11.3	9.5	6.9	11.2	12.0	7.8	7.4	12.2	8.5	14.1	26.2	12.5	8.6	12.2	16.6	9.8	11.1	4.8	10.5	14.4	19.2	8.3	9.2	10.0	7.7	17.2	9.1	9.6	10.1	15.1	6.1	8.8	8.3	5.8	7.9	8.3	9.7	9.2	7.9	6.7	10.5	7.9	6.0	8.0	7.0	7.0	8.2	6.2	14.2	14.7	21.4	14.9	14.1	11.7	11.7	11.7	10.8	12.3
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"				Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: , HPA049231: "	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	14.9	11.6	14.3	12.2	22.3	8.3	13.1	15.7	35.0	11.8	14.8	18.6	8.3	18.0	14.4	10.4	22.6	14.8	12.2	17.8	14.4	16.2	13.3	25.9	13.6	11.6	13.0	16.1	15.7	15.3	13.6	14.2	17.7	22.4	21.9	10.5	14.8	20.0	31.0	22.1	14.6	20.9	10.7	11.1	11.2	12.8	18.7	11.4	11.4	13.5	11.6	17.3	38.7	13.6	4.2	5.0	7.3	3.8	4.2	8.4	3.6	15.4	14.6	12.5	13.7	9.2	8.7	8.1	17.9	15.1	20.0	19.1	15.4	28.9	11.3	18.0	13.7	18.6	13.0	17.3	9.6	15.8	21.2	13.9	15.9	21.1	13.9	15.6	20.0	10.5	14.0	15.1	14.0	12.8	21.7	11.7	9.0	12.8	14.9	20.6	12.8	17.2	16.2	10.4	16.2	15.8	10.3	14.9	17.0	17.3	14.5	16.1	13.3	11.2	12.3	14.7	15.5	14.1	15.2	16.8	13.6	22.1	16.1	21.7	15.6	1.9	3.8	7.3	8.4	2.8	5.3	4.2	4.4	6.2	4.7	3.9	5.8	5.2	0.6	4.2	2.5	5.0	5.2	3.6	14.3	22.3	15.7	35.0	14.4	16.2	13.0	16.1	22.4	11.4
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276812-160286348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044837, HPA051966"	Supported		Supported	Peroxisomes				Peroxisomes		"HPA044837: AB_10962496, HPA051966: "	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (2.92e-5)"	"unprognostic (3.46e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.24e-2)"	41.9	20.4	21.5	8.0	27.8	6.2	24.4	10.0	30.6	12.5	12.9	23.8	8.9	11.0	13.0	15.0	14.6	13.6	11.3	21.7	18.5	21.0	19.5	61.6	12.2	8.7	20.3	17.2	14.5	12.6	17.5	14.3	15.0	25.0	16.8	13.8	17.8	16.2	16.3	32.9	14.1	12.7	10.0	17.4	11.8	12.7	11.4	12.9	9.1	22.2	12.1	11.3	13.4	8.7	9.7	13.0	11.8	15.6	6.9	10.2	7.5	12.4	7.6	29.5	9.1	25.2	24.9	22.2	10.2	21.1	19.0	15.1	14.0	15.2	15.3	17.5	15.5	12.2	14.1	18.3	15.0	13.3	7.0	10.7	10.8	14.3	20.5	19.3	13.6	37.3	21.2	25.7	16.5	13.3	16.1	11.8	21.3	6.9	14.5	6.3	21.0	20.1	18.3	14.5	18.3	19.2	25.2	9.6	16.0	40.8	20.7	15.4	20.2	19.1	10.1	11.0	13.2	12.5	12.0	17.7	22.7	28.0	18.2	8.4	16.2	9.2	12.2	11.8	10.2	15.6	8.3	9.7	5.9	7.2	13.0	5.6	7.5	6.8	4.8	6.9	10.2	6.3	8.7	7.5	21.5	27.8	10.0	30.6	18.5	21.0	20.3	17.2	25.0	12.9
PEX2	"PAF-1, PMP35, PXMP3, RNF72, ZWS3"	ENSG00000164751	"Peroxisomal biogenesis factor 2"	P28328	8	76980258-77001044	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010983, HPA011410, HPA027729"	Approved		Supported	Vesicles				Vesicles		"HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416"	"unprognostic (6.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.09e-3)"	21.3	30.9	25.4	17.9	23.8	17.3	30.7	20.7	24.6	24.3	23.8	24.1	65.7	22.5	25.7	24.3	21.6	24.1	18.0	22.1	26.9	20.7	31.3	25.3	20.4	27.8	29.8	18.3	20.5	26.4	21.2	32.6	17.4	25.9	25.8	22.9	24.9	28.7	63.6	32.4	17.4	27.2	25.7	30.5	23.1	27.0	14.7	30.9	32.2	34.4	19.0	23.4	24.2	23.5	17.3	17.1	52.4	22.9	28.3	22.3	24.2	27.7	9.4	15.3	15.4	16.4	20.6	8.0	20.8	23.8	16.1	17.8	5.9	24.9	15.8	31.1	18.7	10.7	10.4	15.8	19.6	29.1	8.6	19.3	8.7	9.0	11.1	15.9	15.3	23.1	13.4	12.2	14.6	17.5	10.5	15.2	16.8	8.3	28.0	9.5	9.0	8.5	5.1	12.2	13.1	18.7	19.7	5.4	14.2	13.4	61.0	11.3	19.0	11.5	17.5	14.8	19.5	19.0	10.3	28.3	16.4	27.6	18.8	8.5	16.4	52.4	20.3	35.8	22.3	20.8	19.9	17.3	15.6	17.9	16.9	17.2	20.6	19.6	14.1	28.3	22.9	17.1	17.4	24.2	25.4	23.8	20.7	24.6	26.9	20.7	29.8	18.3	25.9	30.9
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450807-143490010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Supported	Nucleoplasm,Peroxisomes				"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favourable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	10.1	47.5	13.7	14.0	15.5	3.3	14.5	17.3	17.7	13.6	8.5	12.1	14.0	7.0	12.5	16.4	21.1	12.5	9.0	15.8	14.3	11.4	22.7	29.2	9.6	10.3	13.7	15.9	14.4	8.6	16.2	14.8	22.2	17.4	15.0	8.1	10.4	12.8	15.7	12.6	14.6	8.8	12.7	14.6	8.7	11.3	14.4	12.7	10.1	19.3	13.5	11.6	11.9	15.1	18.2	8.7	7.8	9.6	12.0	18.7	8.1	14.4	3.6	7.6	16.0	12.7	12.5	9.6	13.0	10.6	18.0	22.0	23.4	9.4	25.4	15.5	13.9	12.3	10.5	18.4	22.3	14.7	12.9	17.9	7.3	15.0	11.7	28.9	7.3	15.2	12.6	17.3	13.0	9.9	15.2	11.7	17.2	10.2	14.6	11.7	4.9	13.0	11.2	17.2	10.9	22.1	6.3	11.8	4.2	17.3	15.0	11.5	7.5	9.6	9.0	12.9	11.1	22.0	15.4	8.4	10.6	25.4	16.9	20.0	10.1	7.8	5.1	4.9	13.2	8.0	15.1	18.2	14.1	13.1	7.9	15.4	18.7	17.9	0.8	12.0	9.6	8.7	16.5	8.1	13.7	15.5	17.3	17.7	14.3	11.4	13.7	15.9	17.4	12.7
PEX5	"PTS1R, PXR1"	ENSG00000139197	"Peroxisomal biogenesis factor 5"	P50542	12	7188685-7218574	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039259, HPA039260"	Enhanced		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA039259: AB_10673419, HPA039260: AB_2676417"	"unprognostic (7.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.31e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.13e-1)"	24.8	20.7	24.5	13.4	27.3	7.8	16.9	23.4	28.8	14.4	12.2	20.8	13.2	12.3	15.1	12.6	13.7	17.3	20.2	15.6	25.5	22.2	22.5	27.0	14.4	17.6	28.3	21.0	25.2	26.7	22.0	26.5	10.6	17.4	13.3	12.5	13.1	16.5	15.4	41.4	17.3	12.4	16.6	26.3	9.7	11.4	31.4	15.1	22.3	15.7	13.5	19.4	12.3	18.4	4.5	9.2	4.6	7.3	5.2	7.8	4.2	6.6	13.5	5.8	15.2	13.8	9.1	11.5	6.8	8.7	8.4	8.5	16.9	10.4	67.5	3.5	8.1	9.0	10.7	9.5	8.2	10.1	10.0	6.3	8.8	11.6	7.3	8.9	6.2	11.4	15.7	6.0	16.7	6.8	12.3	2.5	6.5	8.6	22.4	8.5	18.6	7.1	10.6	12.3	9.8	6.3	9.5	5.2	11.1	9.4	20.8	8.6	4.9	5.3	6.3	8.6	14.8	6.9	7.7	4.2	4.8	24.0	8.4	9.4	5.6	0.1	3.3	4.6	6.5	2.9	7.8	4.5	4.8	5.7	5.3	3.7	6.5	5.8	2.9	5.2	7.3	9.2	1.9	4.2	24.5	27.3	23.4	28.8	25.5	22.2	28.3	21.0	17.4	15.1
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963870-42979220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 73.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	13.0	14.9	12.1	11.5	18.9	9.0	11.5	21.7	19.0	14.7	16.9	14.6	15.3	9.8	11.9	8.8	18.2	23.4	13.0	10.4	12.9	12.1	11.3	18.8	7.4	17.6	17.3	9.1	20.0	73.2	21.3	18.2	10.6	16.0	17.8	8.5	10.8	15.0	12.8	15.2	14.2	24.6	10.5	9.9	12.8	10.6	10.6	17.2	22.3	21.5	6.9	10.9	11.2	12.4	4.3	4.3	4.8	3.2	4.0	6.1	2.5	17.7	8.5	4.3	16.1	16.1	15.5	4.5	3.1	4.9	2.6	5.4	5.4	5.2	7.2	4.4	7.4	16.8	15.0	16.2	2.7	14.0	7.9	2.4	12.0	3.1	10.9	2.4	5.0	19.3	18.8	10.6	2.9	12.9	12.6	7.4	5.6	2.0	6.3	8.0	5.3	7.5	13.6	7.6	2.9	6.5	5.2	13.6	5.9	2.9	11.6	16.3	22.7	10.9	7.2	8.2	1.6	4.0	7.1	11.1	9.8	9.9	2.8	12.6	6.5	2.1	3.2	4.8	3.0	2.4	5.4	2.6	4.4	6.1	4.3	4.3	5.5	5.1	2.0	4.0	1.5	2.5	2.1	2.5	12.1	18.9	21.7	19.0	12.9	12.1	17.3	9.1	16.0	17.2
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913937	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA049202: "	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favourable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favourable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.5	17.8	8.1	7.0	8.9	4.0	13.5	7.0	10.7	8.7	8.5	7.9	14.0	6.1	5.5	18.9	9.1	8.9	17.0	14.5	7.2	6.7	16.3	10.0	9.2	4.7	8.9	9.5	6.1	43.6	15.5	10.2	6.7	6.9	11.7	9.2	13.6	15.4	18.9	11.7	12.0	6.6	7.5	9.6	4.7	14.5	19.4	5.4	5.9	11.5	7.5	6.8	6.9	7.0	4.6	5.4	4.3	5.3	2.9	6.9	1.8	4.7	4.6	4.6	6.5	6.0	8.9	2.5	6.6	8.3	7.1	7.5	5.7	5.6	1.7	12.6	7.1	6.1	3.3	12.3	8.8	4.9	8.0	6.4	4.6	0.8	14.4	8.0	3.7	8.5	13.0	5.1	10.2	5.3	11.9	5.1	9.7	11.3	3.5	9.9	4.7	7.9	4.7	4.7	4.9	15.4	6.4	8.7	12.6	6.1	8.7	8.5	5.7	10.1	4.0	4.6	2.2	7.2	5.1	7.2	4.7	0.0	3.7	7.3	5.6	0.2	3.0	4.3	2.6	2.5	2.0	4.6	3.4	4.2	5.3	2.9	6.9	4.1	0.5	2.9	5.3	5.4	6.4	1.8	8.1	8.9	7.0	10.7	7.2	6.7	8.9	9.5	6.9	5.4
PFDN2		ENSG00000143256	"Prefoldin subunit 2"	Q9UHV9	1	161100556-161118111	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028700, HPA058304"	Approved		Enhanced	Cytosol			60000	Cytosol		"HPA028700: AB_10603983, HPA058304: "	"unprognostic (2.56e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (9.10e-4)"	"unprognostic (9.59e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (4.39e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.66e-2)"	36.5	30.4	47.2	22.7	41.7	40.9	20.9	25.1	38.8	19.6	19.9	27.8	15.1	19.1	20.8	29.1	19.7	18.5	16.0	38.2	41.4	48.6	25.9	41.1	18.5	23.5	52.2	32.9	18.5	20.8	13.6	29.3	25.1	42.7	20.1	17.9	12.9	21.2	20.8	62.2	15.0	18.4	19.4	48.6	21.2	17.8	22.1	31.8	14.7	18.3	20.9	24.3	22.7	26.2	34.4	61.7	33.4	37.3	18.2	28.5	21.0	42.8	28.8	22.4	28.9	20.4	19.5	24.5	31.9	28.9	27.6	21.9	37.8	32.6	29.0	37.5	20.7	31.8	33.9	39.1	33.2	31.6	34.9	32.1	40.9	53.4	60.1	44.0	32.2	21.8	51.5	44.3	126.2	31.0	47.1	20.5	24.7	43.4	32.9	52.3	43.8	72.0	28.3	22.6	34.7	29.8	25.7	29.5	49.3	24.5	32.4	50.8	26.7	55.6	27.2	28.6	41.9	35.8	66.6	31.6	29.9	55.8	34.8	30.1	39.1	24.7	32.7	33.4	19.2	31.4	21.8	34.1	23.5	23.1	39.1	34.4	24.8	24.1	16.2	18.2	37.3	61.7	28.5	21.0	47.2	41.7	25.1	38.8	41.4	48.6	52.2	32.9	42.7	31.8
PFDN5	"MM-1, PFD5"	ENSG00000123349	"Prefoldin subunit 5"	Q99471	12	53295291-53299450	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008587	Approved		Supported	"Intermediate filaments,Cytosol"			110000	"Intermediate filaments, Cytosol"		"HPA008587: AB_1079597"	"unprognostic (3.56e-3)"	"unprognostic (2.31e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (5.45e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (5.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.01e-3)"	75.9	73.7	105.0	82.3	85.4	119.3	142.4	53.8	66.7	97.0	77.1	56.3	102.5	39.7	94.3	156.8	80.3	94.6	91.0	77.0	82.7	76.7	81.8	83.5	64.9	117.2	94.3	69.2	134.5	155.8	49.6	81.2	67.3	63.3	96.1	65.4	60.1	116.4	99.9	87.0	71.6	54.1	108.1	91.0	83.8	64.7	60.5	64.9	60.5	128.1	108.9	101.1	91.8	144.9	163.9	98.0	63.7	127.8	69.4	158.4	329.0	35.4	54.7	53.0	47.7	102.9	143.2	38.7	88.9	121.1	82.9	56.1	50.0	54.7	48.0	53.7	95.5	32.6	46.1	63.7	80.3	45.4	64.5	43.7	67.7	68.6	66.2	71.0	47.8	136.5	93.6	58.5	45.8	73.6	51.0	64.8	82.2	125.4	49.7	106.0	50.0	84.6	40.6	57.5	56.8	94.5	52.5	44.9	51.2	57.1	50.5	64.5	65.6	90.8	64.4	46.9	35.8	22.1	39.7	48.6	51.8	70.6	51.4	56.9	42.8	63.7	127.8	46.5	80.9	97.0	110.9	163.9	123.2	97.6	98.0	156.8	158.4	125.9	38.3	69.4	100.2	91.0	95.8	329.0	105.0	85.4	53.8	66.7	82.7	76.7	94.3	69.2	63.3	64.9
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 13.9;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 16.7;granulocytes: 13.9"					"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA049975: , HPA063575: "	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (8.63e-4)"	"unprognostic (1.86e-2)"	3.3	6.1	9.8	5.8	16.6	15.7	5.1	2.1	14.6	7.3	16.0	19.5	5.3	23.2	4.0	9.1	7.7	4.5	9.1	22.8	14.1	7.7	22.0	3.6	10.9	5.3	13.4	15.1	4.3	11.9	6.2	27.5	3.0	25.3	3.9	18.1	22.4	6.3	3.5	34.9	6.4	18.7	4.0	17.4	12.5	10.7	6.1	15.1	6.5	38.4	8.8	5.0	3.4	3.6	1.6	16.7	13.9	1.9	1.1	0.4	0.4	9.5	4.2	2.8	4.8	5.7	2.8	4.6	1.3	1.7	2.4	1.3	10.2	13.8	1.7	2.2	2.1	13.6	2.0	5.1	1.4	0.3	2.1	13.5	10.6	3.8	4.8	0.0	9.5	4.1	7.8	2.3	12.9	0.5	9.2	0.1	1.3	2.9	2.3	0.4	3.8	6.4	0.0	0.0	0.2	3.3	9.9	4.4	2.7	8.9	15.1	11.2	10.3	1.1	0.2	0.0	5.2	7.3	1.2	4.4	4.4	0.9	5.9	0.0	2.6	1.0	0.9	13.9	0.2	1.9	0.3	1.3	0.1	0.3	0.8	1.6	0.3	0.4	2.6	1.1	1.3	16.7	0.0	0.4	9.8	16.6	2.1	14.6	14.1	7.7	13.4	15.1	25.3	15.1
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.6;skeletal muscle: 135.7"	"Cell line enhanced"	"Detected in many"		"A549: 71.1;RPTEC TERT1: 44.9;T-47d: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: "	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	105.6	9.0	16.4	25.7	17.9	77.0	43.4	8.5	29.4	6.6	8.8	29.1	10.6	7.4	9.4	6.3	13.0	14.4	22.4	5.7	16.6	13.2	22.1	11.2	15.1	12.1	19.2	12.9	8.0	8.1	4.0	10.2	7.5	20.7	5.4	3.8	19.3	9.1	20.0	135.7	11.8	6.9	6.5	36.0	12.4	6.7	4.6	16.8	3.3	2.9	4.7	10.3	10.3	10.1	1.5	3.6	20.5	7.1	0.8	4.7	2.9	5.1	71.1	5.6	4.5	21.4	2.7	3.0	7.6	5.4	5.6	8.8	3.3	18.8	8.8	5.0	3.3	16.6	6.0	12.0	6.5	10.4	4.2	5.2	3.6	1.2	1.8	5.0	7.9	1.9	4.0	9.7	2.3	10.9	3.8	3.3	4.5	8.4	3.5	4.7	5.5	5.0	8.0	2.7	3.4	44.9	2.6	5.4	2.2	5.5	6.0	10.8	46.8	6.0	13.7	5.9	5.4	0.7	9.1	6.8	2.3	8.0	16.3	5.9	9.0	2.2	5.6	5.5	1.8	7.1	4.7	1.5	3.4	2.3	3.6	1.4	2.5	2.4	20.5	0.8	4.1	2.2	3.2	2.9	16.4	17.9	8.5	16.9	16.6	13.2	19.2	12.9	20.7	16.8
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137712	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol			4500000	Cytosol		"HPA018257: AB_10960391, HPA056484: "	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.55e-4)"	"prognostic unfavourable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	14.6	7.9	29.6	22.0	28.9	9.2	8.1	34.2	61.4	9.7	20.5	11.5	7.9	26.8	19.2	11.0	36.0	12.8	19.8	62.0	29.3	32.9	20.0	2.8	9.2	18.2	22.2	29.8	9.3	8.8	1.5	16.8	8.8	21.3	20.3	19.4	14.7	13.4	36.5	24.4	16.5	31.1	34.3	21.1	11.3	20.7	71.8	14.8	9.6	19.3	11.7	13.3	26.9	15.6	8.9	12.5	16.2	4.7	14.3	20.4	8.9	47.4	66.8	4.5	0.1	4.5	9.4	58.3	29.6	10.6	30.0	36.1	70.4	50.6	5.7	23.6	21.3	38.6	22.8	46.1	31.5	16.0	17.6	20.5	32.2	3.8	10.6	8.3	34.6	4.3	10.4	31.4	15.7	57.7	5.7	0.2	33.2	37.1	28.1	8.9	7.3	23.4	22.1	7.4	22.9	32.5	18.7	12.3	10.6	21.0	17.8	26.2	14.7	13.0	69.4	20.5	11.0	61.7	32.2	32.5	29.3	20.4	52.5	15.9	12.5	16.2	4.7	1.6	15.9	2.3	12.6	8.2	15.9	14.8	8.0	8.9	6.0	9.5	0.7	14.3	0.9	12.5	20.4	8.9	29.6	28.9	34.2	51.7	29.3	32.9	22.2	29.8	21.3	14.8
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 509.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB037134, CAB037140"	Enhanced		Supported	Cytosol			1100000000	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	65.2	48.2	24.0	125.4	36.7	118.0	61.3	15.6	25.9	63.8	102.3	33.1	46.7	66.4	97.4	52.9	96.6	67.5	87.8	40.7	22.0	19.6	80.5	137.3	70.5	159.4	37.4	17.3	53.7	37.2	18.3	27.5	82.8	28.5	62.0	68.2	39.3	46.0	52.6	51.6	51.2	96.4	119.4	33.3	138.7	70.4	27.2	30.5	199.3	46.6	65.3	116.3	97.9	54.4	154.4	263.4	356.5	322.9	223.0	288.9	509.4	138.1	166.6	62.6	50.2	32.3	40.3	93.9	118.1	77.6	102.6	77.8	64.5	48.8	100.4	102.7	99.8	87.3	55.8	120.4	82.7	174.6	109.7	102.8	85.3	83.7	88.7	64.8	244.6	47.8	52.9	79.5	79.3	92.0	56.7	73.3	122.9	68.7	123.4	139.7	97.3	102.3	123.7	84.0	64.6	99.4	73.9	25.7	76.3	79.3	49.8	72.3	46.6	55.0	112.5	89.7	83.3	67.3	171.6	52.3	53.0	80.9	77.4	77.8	136.3	168.7	216.8	356.5	286.3	278.7	190.1	154.4	236.8	270.9	263.4	135.2	154.8	221.1	255.4	223.0	322.9	212.4	288.9	509.4	24.0	36.7	15.6	25.9	22.0	19.6	37.4	17.3	28.5	30.5
PGAM5	"BXLBv68, MGC5352"	ENSG00000247077	"PGAM family member 5, mitochondrial serine/threonine protein phosphatase"	Q96HS1	12	132710819-132722734	"Enzymes, Predicted intracellular proteins"	Necrosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036978, HPA036979, CAB068215"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"CAB068215: , HPA036978: AB_10964347, HPA036979: AB_10960559"	"unprognostic (9.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.13e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.53e-2)"	12.2	16.5	11.7	14.3	14.0	12.5	18.6	14.6	22.1	8.4	13.9	8.3	9.9	13.6	10.4	9.9	22.0	11.5	13.4	22.6	14.2	12.1	13.9	26.3	8.5	17.6	9.9	11.8	11.9	30.2	8.1	9.6	10.3	10.4	10.1	10.4	8.5	16.0	11.4	27.4	15.2	12.0	10.2	7.5	13.0	11.7	13.6	5.1	17.6	16.3	17.4	14.5	11.6	12.9	4.0	6.7	7.7	3.1	3.3	3.7	1.4	19.1	36.9	7.9	22.2	5.6	4.5	18.5	9.9	6.1	16.7	9.4	46.0	11.1	24.8	18.3	8.5	16.8	37.0	18.6	6.8	12.2	29.1	29.7	17.3	23.9	12.7	28.1	17.4	5.5	13.7	19.4	20.9	12.1	37.2	10.3	6.5	34.7	38.1	28.1	29.9	26.2	29.2	8.8	19.8	10.8	26.6	29.0	16.3	17.1	24.1	10.6	30.4	15.6	10.4	8.5	18.5	17.0	24.0	21.5	31.5	35.6	11.0	23.1	14.2	7.7	2.4	0.7	2.5	2.5	3.7	3.6	2.9	2.8	2.0	4.0	2.9	3.6	2.0	3.3	3.1	6.7	2.0	1.4	11.7	14.0	14.6	22.1	14.2	12.1	9.9	11.8	10.4	5.1
PGBD2		ENSG00000185220	"PiggyBac transposable element derived 2"	Q6P3X8	1	248906196-248919946	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA029888, HPA029889, HPA029890"	Uncertain		Supported	Vesicles				Vesicles		"HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002"	"unprognostic (1.06e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (6.08e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (7.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.25e-1)"	"prognostic favourable (2.05e-4)"	5.8	7.0	5.0	11.1	6.8	5.7	9.5	10.5	7.7	7.6	7.7	11.9	10.2	8.9	8.6	8.2	11.1	6.8	8.6	4.5	5.1	4.6	7.2	11.8	5.7	10.4	7.4	5.4	10.2	14.7	8.3	5.6	12.7	7.8	9.9	9.9	6.0	10.0	12.8	2.9	12.3	11.9	8.4	5.6	17.3	7.9	13.9	8.6	5.5	12.5	3.9	12.2	7.5	18.2	12.7	8.0	13.9	9.1	7.8	10.9	5.7	4.6	6.3	10.0	5.8	8.8	5.8	12.1	4.5	3.9	7.7	7.4	4.7	6.3	12.1	5.7	4.3	7.5	5.9	5.6	9.0	7.1	2.8	11.6	9.8	7.0	5.1	5.9	11.4	5.2	5.9	9.2	5.2	4.4	18.4	10.6	5.6	8.3	3.3	7.0	9.2	7.4	14.3	3.1	3.9	4.6	6.0	3.7	6.5	6.4	9.3	7.2	4.1	11.7	5.4	5.3	5.2	4.6	4.9	10.1	10.1	5.5	5.6	13.3	4.8	13.9	8.8	13.2	9.8	6.2	9.4	12.7	8.6	9.1	8.0	12.6	8.7	10.9	6.5	7.8	9.1	3.8	5.8	5.7	5.0	6.8	10.5	7.7	5.1	4.6	7.4	5.4	7.8	8.6
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289135-296107	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"pancreas: 148.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA039383: AB_10796225, HPA058829: "	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.12e-4)"	5.6	1.8	6.0	16.7	9.3	6.3	10.5	2.9	7.7	12.7	5.6	3.3	10.4	21.1	6.9	14.9	5.6	8.4	8.3	4.4	6.3	1.7	14.8	17.0	15.7	24.6	7.6	2.5	3.5	148.7	2.6	3.6	3.4	8.0	8.5	3.0	7.1	8.9	21.8	5.6	2.4	23.2	5.2	10.1	24.2	4.7	2.3	7.5	6.3	18.0	6.4	15.4	7.3	8.7	2.3	2.5	4.9	4.2	6.9	8.5	2.7	3.4	3.7	7.0	7.7	2.8	2.5	5.3	2.7	2.2	1.6	1.4	3.2	9.8	0.0	3.5	3.3	2.1	0.6	1.2	0.2	8.3	2.6	1.6	2.4	4.2	3.6	0.2	15.1	9.4	1.0	0.6	0.4	5.3	6.5	10.5	0.8	4.9	14.3	7.6	5.4	0.6	13.5	1.4	4.8	3.7	1.2	0.0	1.6	1.0	5.1	4.7	3.7	1.9	4.9	3.3	4.7	1.0	0.3	22.8	0.6	3.6	0.5	2.7	3.8	1.5	0.9	1.2	8.5	4.2	7.2	2.1	1.3	4.7	0.6	2.3	3.1	6.1	4.9	6.9	3.2	2.5	0.2	2.7	6.0	9.3	2.9	7.7	6.3	1.7	7.6	2.5	8.0	7.5
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511629-17521288	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol			10000000	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	27.3	31.5	15.6	23.6	13.9	29.3	33.7	9.0	20.1	23.8	29.5	16.0	17.9	21.9	16.6	18.7	38.0	25.9	27.8	18.5	13.9	11.6	25.9	42.7	27.5	60.0	14.3	11.8	32.0	42.1	19.1	16.4	26.5	10.9	23.5	13.5	16.8	31.5	20.7	10.9	27.2	30.8	13.3	16.8	31.4	20.8	15.8	12.2	46.6	26.7	19.2	27.6	18.5	21.6	17.6	46.4	45.8	44.5	17.4	14.9	22.4	18.6	16.8	10.6	7.2	16.2	27.0	20.3	12.8	20.9	12.9	16.6	8.0	28.3	20.7	14.4	20.0	12.9	5.9	20.0	3.9	10.3	23.2	9.7	7.8	14.3	27.9	10.3	10.8	31.7	27.7	7.7	23.2	17.3	11.0	5.1	15.8	20.5	22.6	29.0	14.1	70.6	15.3	6.8	13.1	17.4	15.1	13.5	16.2	8.2	9.1	18.0	13.2	18.7	16.2	13.4	3.7	26.7	7.2	9.0	6.3	8.8	19.1	26.5	13.1	15.2	40.8	45.8	14.9	44.5	12.1	16.4	13.2	13.2	46.4	17.6	12.5	12.6	39.6	17.4	41.5	34.4	14.0	22.4	15.6	13.9	9.0	20.1	13.9	11.6	14.3	11.8	10.9	12.2
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.0;HDLM-2: 5.2;hTCEpi: 1.7;Karpas-707: 4.3"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB025879			Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"			"Vesicles, Plasma membrane"		"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	5.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 163.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Enhanced	"Nucleoli,Endoplasmic reticulum"			6000000	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	25.0	46.0	37.7	11.9	36.9	5.6	60.2	21.8	37.8	36.2	30.5	30.9	42.9	27.0	39.9	71.4	15.0	38.9	20.1	10.0	38.6	50.4	58.7	163.9	15.6	8.8	38.1	29.6	24.7	10.9	23.8	15.5	12.3	35.3	33.5	22.5	22.1	17.5	53.7	5.7	12.5	42.9	22.0	46.9	10.0	18.9	14.2	27.1	6.9	24.7	12.2	7.7	21.3	17.3	3.6	9.9	11.4	11.8	4.8	8.0	28.7	26.8	17.0	33.4	38.4	72.2	34.7	21.7	40.6	47.3	21.6	26.9	20.5	33.0	7.7	44.5	42.1	21.5	36.4	17.0	29.1	8.2	41.8	8.7	16.3	23.0	12.0	14.3	4.7	35.7	9.6	26.2	13.6	13.9	9.2	4.8	25.3	28.7	10.7	10.5	87.5	28.7	12.8	20.9	11.2	28.5	20.5	31.2	13.9	29.7	49.4	15.9	11.4	9.2	10.7	15.1	22.2	53.2	38.2	5.1	9.3	8.4	41.1	22.8	28.6	9.2	11.8	11.4	5.5	11.3	7.3	3.6	7.5	8.0	9.9	3.1	7.7	6.3	5.7	4.8	10.0	7.1	7.6	28.7	37.7	36.9	21.8	37.2	38.6	50.4	38.1	29.6	35.3	27.1
PHACTR3	"C20orf101, PPP1R123"	ENSG00000087495	"Phosphatase and actin regulator 3"	Q96KR7	20	59577509-59847711	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 56.1"	"Cell line enriched"	"Detected in some"	4	"THP-1: 51.8"	"Group enriched"	"Detected in some"	5	"glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051834, HPA054847"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA051834: , HPA054847: "	"unprognostic (7.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.43e-7)"	"unprognostic (1.99e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.83e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.32e-1)"	1.6	2.7	31.3	1.8	29.2	2.0	1.4	15.9	56.1	1.5	1.9	20.0	0.0	2.1	1.3	2.0	2.8	1.4	3.3	3.0	27.3	14.6	2.0	2.1	5.3	1.4	28.3	19.4	6.9	1.5	1.4	0.5	1.9	21.3	1.4	1.8	0.0	1.3	1.3	1.4	2.6	2.1	1.5	25.4	8.0	1.8	1.8	29.8	0.0	1.4	0.0	1.4	1.6	0.0	0.0	2.5	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.8	0.0	0.0	0.0	10.1	0.0	0.7	2.7	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	31.3	29.2	15.9	34.1	27.3	14.6	28.3	19.4	21.3	29.8
PHAX	"FLJ13193, RNUXA"	ENSG00000164902	"Phosphorylated adaptor for RNA export"	Q9H814	5	126600268-126627252	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059630, HPA070326"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA059630: , HPA070326: "	"unprognostic (1.06e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.91e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.07e-2)"	3.9	4.9	7.9	3.2	7.6	1.5	4.2	8.9	8.2	3.7	3.2			2.1	4.9	3.9	4.8	4.2	3.6	5.0	7.2	6.5	3.8	4.0	3.1	5.2	6.9		6.6	3.5	4.6	3.0	3.5		4.5	3.0		3.5	3.2	5.7	5.7	2.3	4.3	6.6	3.2	2.9	2.5			4.6		5.3	3.8	3.0	10.4	8.2	8.8	7.2	13.1	11.2	6.6	9.6	9.7	8.6	17.0	12.6	12.5	12.3	13.8	10.2	11.3	10.7	13.8	9.8	9.7	12.6	17.6	7.9	12.2	18.9	16.7	15.9	13.4	8.1	11.4	5.5	7.5	6.6	9.0	12.4	10.6	11.2	10.1	9.6	6.5	11.4	17.4	8.3	9.3	8.5	11.0	8.1	7.6	12.2	8.0	10.6	11.4	11.5	13.1	12.2	10.9	14.1	14.4	9.5	15.0	19.2	10.8	10.6	20.9	9.0	8.4	11.0	13.8	11.2	13.9	8.8	6.3	8.1	9.6	7.2	10.9	10.4	9.5	9.9	6.2	9.5	10.8	11.2	5.3	13.1	7.2	8.2	8.0	6.6										
PHB	PHB1	ENSG00000167085	Prohibitin	P35232	17	49404049-49414905	"Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 189.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003280	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"		3800000	Mitochondria	Vesicles	"HPA003280: AB_1855732"	"unprognostic (2.31e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.33e-2)"	"prognostic unfavourable (1.58e-4)"	"prognostic unfavourable (9.91e-4)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.36e-2)"	"prognostic favourable (3.77e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.09e-3)"	27.4	31.6	21.8	19.9	24.9	19.0	30.6	12.9	25.9	21.6	38.9	24.0	17.0	26.9	24.1	17.7	28.6	24.3	18.6	41.6	21.9	20.9	54.0	53.7	19.2	18.5	27.6	21.4	27.1	24.1	27.8	18.8	24.1	22.0	25.3	40.7	24.7	41.8	20.2	41.7	19.5	32.7	26.6	20.5	22.7	25.0	16.6	18.2	23.3	42.5	35.6	22.3	22.4	24.0	33.4	84.6	6.3	28.0	28.4	34.7	40.2	36.1	67.5	16.2	31.8	21.8	17.3	45.1	26.7	17.8	43.4	28.5	189.6	32.5	67.0	49.0	24.6	23.6	44.0	38.6	45.0	29.1	57.9	33.8	43.8	85.7	16.1	66.6	20.9	19.2	26.8	46.9	17.3	31.6	60.2	18.1	28.1	61.5	46.2	41.7	30.1	64.5	37.0	61.6	55.0	29.5	38.3	32.8	27.9	20.2	23.6	37.5	40.2	31.1	27.5	41.2	31.8	32.1	57.3	23.2	63.4	64.8	27.0	44.4	35.6	6.3	25.3	6.2	32.3	28.0	34.7	33.4	28.7	31.0	38.1	29.9	30.4	30.9	2.5	28.4	21.0	84.6	28.1	40.2	21.8	24.9	12.9	25.9	21.9	20.9	27.6	21.4	22.0	18.2
PHB2	"Bap37, BCAP37, p22, REA"	ENSG00000215021	"Prohibitin 2"	Q99623	12	6965327-6970825	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014889, CAB026335, HPA039874"	Supported		Enhanced	Mitochondria			780000	Mitochondria		"CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448"	"unprognostic (4.64e-3)"	"unprognostic (4.32e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (3.07e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.61e-2)"	36.2	46.2	20.0	41.5	21.3	33.5	37.1	21.6	29.7	42.7	48.6	19.8	42.8	40.0	46.3	36.2	55.6	37.7	29.1	44.3	17.9	17.2	36.0	72.8	24.0	64.9	18.8	18.8	68.9	92.3	28.0	22.1	27.4	17.2	48.6	39.5	25.8	62.7	29.1	72.9	39.5	46.3	56.0	17.5	36.6	37.5	20.5	19.0	57.2	50.4	77.4	45.7	46.4	39.9	36.4	47.6	20.9	35.9	38.1	41.6	34.4	36.5	35.3	29.6	40.1	24.0	42.0	66.2	25.9	33.4	45.9	36.4	55.7	38.5	76.1	11.4	25.0	29.9	54.1	45.7	37.2	42.2	45.2	40.0	22.9	52.3	40.4	64.4	29.4	43.3	31.2	29.0	63.4	45.0	35.6	17.5	32.3	36.3	59.1	58.9	113.3	31.5	41.5	47.6	47.3	36.7	41.1	15.3	53.0	20.9	59.7	66.9	9.4	51.6	27.1	19.8	32.4	15.6	54.6	17.6	21.3	78.3	26.7	33.6	28.1	20.9	30.0	14.6	30.8	35.9	37.3	36.4	35.3	35.8	47.6	34.8	32.0	31.8	12.4	38.1	30.4	44.4	41.6	34.4	20.0	21.3	21.6	29.7	17.9	17.2	18.8	18.8	17.2	19.0
PHC1	"EDR1, HPH1, RAE28"	ENSG00000111752	"Polyhomeotic homolog 1"	P78364	12	8913896-8941467	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, DNA-binding"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"BEWO: 31.7;NTERA-2: 113.9"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006973	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA006973: AB_1855278"	"unprognostic (4.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.63e-2)"	7.9	10.0	23.5	12.1	27.7	4.4	9.6	37.1	20.7	15.0	11.9	10.6	19.9	4.9	23.3	11.1	12.6	18.4	12.2	11.0	18.4	10.2	11.0	3.0	10.8	11.1	9.8	20.6	23.5	10.2	26.2	34.5	10.3	13.9	14.2	7.1	18.3	15.5	16.3	8.0	4.0	8.2	17.1	9.1	9.9	9.2	26.5	12.3	7.8	18.9	5.5	10.5	11.5	13.5	2.4	2.9	1.5	5.9	2.1	3.8	1.9	1.4	2.7	10.5	9.6	3.0	3.3	31.7	1.4	3.0	2.6	3.4	1.4	2.3	3.7	1.2	2.4	1.1	2.8	3.4	3.2	12.3	1.6	4.9	2.6	1.6	3.5	2.4	8.4	4.1	2.1	4.2	4.1	3.0	0.9	1.3	2.7	1.6	3.5	4.2	113.9	0.7	5.1	6.7	0.1	2.6	5.5	1.9	6.9	2.2	5.2	3.7	0.7	2.5	1.8	4.4	7.5	3.0	2.0	2.6	1.6	5.3	2.1	1.3	3.1	1.5	0.5	0.0	2.1	2.5	1.3	2.4	3.5	3.8	0.3	2.4	3.1	2.5	0.1	2.1	5.9	2.9	1.9	1.9	23.5	27.7	37.1	20.7	18.4	10.2	9.8	20.6	13.9	12.3
PHC2	"EDR2, HPH2"	ENSG00000134686	"Polyhomeotic homolog 2"	Q8IXK0	1	33323623-33431052	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"neutrophil: 37.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047403	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA047403: AB_10964220"	"unprognostic (8.58e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (2.28e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (2.35e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	58.8	32.6	16.9	32.5	30.5	27.9	38.7	22.8	25.6	28.4	31.0	32.4	20.0	16.6	31.5	19.4	27.9	27.9	32.1	49.8	19.3	16.7	46.5	52.6	46.3	45.5	36.6	13.5	32.4	32.9	18.4	24.0	29.5	28.0	25.4	18.5	37.9	23.7	31.1	90.9	21.8	20.0	39.4	28.1	47.9	30.7	25.9	31.9	24.3	43.6	12.3	17.8	45.3	25.6	0.6	1.5	37.3	2.9	0.7	1.1	0.8	11.0	7.2	31.8	12.1	33.4	38.4	9.4	11.0	24.0	15.3	16.9	4.5	24.8	9.9	9.3	17.3	5.9	6.3	18.8	14.9	4.7	5.7	6.6	3.5	11.4	51.5	8.0	6.4	62.6	11.7	27.6	21.9	20.3	5.8	7.6	39.9	4.5	17.4	8.2	7.2	21.2	19.9	13.2	5.5	28.1	8.4	19.4	17.8	8.6	8.7	43.4	4.3	10.4	20.0	15.4	7.8	13.0	20.6	5.3	3.6	7.4	36.6	8.6	42.1	3.1	2.6	1.2	0.8	2.5	0.7	0.6	0.9	0.7	1.3	0.5	1.1	0.6	37.3	0.7	2.9	1.5	0.6	0.8	16.9	30.5	22.8	25.6	19.3	16.7	36.6	13.5	28.0	31.9
PHC3	"EDR3, FLJ12729, FLJ12967, HPH3"	ENSG00000173889	"Polyhomeotic homolog 3"	Q8NDX5	3	170086732-170181749	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039162, HPA062031"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA039162: AB_10671038, HPA062031: "	"unprognostic (4.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.76e-2)"	17.9	11.7	12.0	13.1	19.2	50.9	17.4	28.2	16.7	14.9	16.1	18.8	13.8	12.8	19.1	10.1	14.6	14.4	15.0	14.2	14.8	7.6	12.0	11.2	18.7	19.2	15.4	11.7	19.0	13.5	23.3	26.3	11.5	14.7	15.4	13.3	19.1	18.4	16.0	17.3	15.9	17.0	20.4	16.5	15.0	16.0	14.6	17.7	16.4	19.2	8.6	17.1	20.9	15.4	15.7	19.7	18.6	8.7	8.9	14.5	5.3	16.7	15.9	3.5	5.8	9.9	10.1	6.5	7.2	8.0	7.4	9.3	10.5	8.4	8.0	17.6	10.0	8.4	7.6	6.9	13.3	18.4	7.0	13.6	14.3	4.8	5.8	16.9	7.4	7.2	4.1	11.1	15.8	5.5	3.2	22.4	6.9	15.5	7.7	3.5	3.6	5.9	5.7	14.8	11.5	3.8	18.9	3.8	2.3	23.8	15.0	5.0	17.3	13.1	11.0	10.3	6.2	8.5	12.3	21.6	17.4	23.6	6.5	6.4	6.2	6.6	5.5	18.6	12.7	8.7	10.7	13.1	12.3	11.1	5.9	15.7	12.7	11.2	7.5	8.9	5.4	19.7	14.5	5.3	12.0	19.2	28.2	16.7	14.8	7.6	15.4	11.7	14.7	17.7
PHF10	"BAF45a, FLJ10975, XAP135"	ENSG00000130024	"PHD finger protein 10"	Q8WUB8	6	169703905-169725566	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055649	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA055649: "	"unprognostic (1.74e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.76e-3)"	"prognostic unfavourable (3.42e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"prognostic favourable (1.12e-5)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (2.63e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.76e-2)"	19.2	34.3	19.9	21.2	39.0	18.7	19.8	18.3	22.4	17.1	20.8	23.1	26.1	12.9	16.7	17.0	26.5	17.9	21.6	20.1	23.2	10.5	18.6	27.9	20.3	23.3	35.3	13.1	33.5	23.6	25.8	22.1	17.7	28.5	22.1	14.6	21.6	22.2	19.8	30.0	23.1	20.3	23.8	29.0	27.0	21.7	23.3	28.3	26.9	23.0	13.6	24.4	22.7	33.5	4.8	3.0	6.3	3.3	2.4	6.2	1.8	8.6	8.7	35.0	36.6	12.2	7.4	14.4	11.9	10.8	14.7	16.2	25.3	9.1	25.9	7.2	8.3	11.1	26.8	12.9	21.4	20.6	23.9	25.7	15.4	33.0	12.5	37.5	1.6	5.5	13.7	9.4	8.7	23.1	28.5	16.8	10.5	15.0	7.1	32.3	11.0	5.5	34.0	24.8	20.7	18.2	9.3	16.7	22.4	16.2	5.4	11.6	10.6	45.1	15.5	8.3	14.0	10.6	15.0	15.0	12.6	32.2	10.9	25.2	13.2	3.0	3.0	6.3	3.4	3.2	3.3	4.8	6.0	4.8	3.0	4.2	5.9	6.2	0.5	2.4	3.3	2.8	3.7	1.8	19.9	39.0	18.3	22.4	23.2	10.5	35.3	13.1	28.5	28.3
PHF11	"BCAP, IGER, NY-REN-34"	ENSG00000136147	"PHD finger protein 11"	Q9UIL8	13	49495610-49528987	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016566, HPA016708"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA016566: , HPA016708: AB_1855286"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (7.98e-6)"	"unprognostic (3.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavourable (4.46e-7)"	"unprognostic (9.81e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (3.46e-4)"	25.2	32.3	16.8	37.8	23.7	23.3	27.6	6.1	18.8	18.9	20.6	18.0	13.7	17.8	22.0	21.5	19.4	17.2	22.9	19.5	15.2	17.9	22.4	17.1	20.7	38.0	23.3	12.5	19.2	23.1	10.1	13.6	20.8	18.0	21.4	16.2	12.7	27.1	20.5	11.3	19.2	23.1	32.1	22.9	31.3	20.0	9.7	22.2	37.1	25.7	17.8	28.1	25.8	20.3	21.4	20.7	26.2	27.0	14.4	39.3	21.7	5.4	2.2	0.8	0.0	11.3	21.6	6.9	13.1	15.0	18.9	20.0	0.0	13.1	13.1	3.6	14.7	3.7	4.8	4.5	11.2	26.5	4.0	6.4	4.4	5.7	14.0	4.7	10.1	13.0	7.2	7.6	4.2	12.0	1.3	5.8	14.1	4.4	14.8	11.1	2.6	1.5	14.4	0.0	3.9	17.0	10.0	0.4	0.1	3.4	7.4	0.2	4.3	10.7	10.6	4.6	1.8	6.5	3.7	4.2	2.1	8.1	9.5	6.7	6.9	13.9	22.3	15.2	23.7	27.0	27.4	21.4	30.3	27.9	20.7	19.3	25.0	27.4	26.2	14.4	24.4	18.0	39.3	21.7	16.8	23.7	6.1	18.8	15.2	17.9	23.3	12.5	18.0	22.2
PHF12	"KIAA1523, PF1"	ENSG00000109118	"PHD finger protein 12"	Q96QT6	17	28905250-28951771	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021410, HPA021452"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA021410: AB_1855287, HPA021452: "	"unprognostic (9.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (2.16e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-3)"	14.0	12.0	16.7	16.5	17.9	38.4	15.6	30.7	18.4	17.1	17.4	18.5	25.4	13.2	21.0	16.4	11.4	18.1	16.1	11.3	13.0	10.5	14.2	14.8	17.2	17.7	18.6	15.2	20.7	20.3	18.6	18.7	12.2	14.0	23.4	12.9	18.9	16.6	24.5	15.6	16.5	18.0	16.2	10.2	25.2	15.4	17.5	18.2	22.1	18.9	7.3	18.0	19.2	16.6	4.5	4.9	25.6	2.7	3.5	4.3	1.5	10.1	16.4	22.4	13.5	13.6	9.8	10.5	10.1	14.8	15.4	14.8	10.9	9.6	11.4	12.5	11.5	10.6	14.3	8.4	15.0	18.8	15.5	12.0	18.1	8.5	12.4	12.9	15.0	10.8	9.3	14.2	13.0	11.1	10.1	11.8	9.6	10.5	24.5	17.4	13.1	7.3	24.1	18.4	11.3	10.3	12.5	15.2	13.1	15.0	24.0	12.0	13.1	18.2	6.6	12.8	11.9	12.4	12.0	14.7	13.0	13.3	9.9	10.1	13.2	9.6	2.7	3.9	3.9	2.2	3.9	2.7	3.1	4.3	1.5	4.5	3.0	3.3	25.6	3.5	2.4	4.9	1.7	1.5	16.7	17.9	30.7	18.4	13.0	10.5	18.6	15.2	14.0	18.2
PHF2	"CENP-35, JHDM1E, KDM7C, KIAA0662"	ENSG00000197724	"PHD finger protein 2"	O75151	9	93576407-93679587	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010831	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA010831: AB_1855294"	"unprognostic (9.42e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (9.34e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.89e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.19e-2)"	16.8	14.6	17.4	17.7	22.2	16.7	23.2	33.1	19.0	19.8	18.1	27.8	18.6	11.3	22.0	15.9	14.5	18.4	16.7	19.1	15.3	14.5	10.8	9.3	17.8	20.7	23.1	15.6	27.1	18.5	22.6	21.7	17.6	16.6	18.6	10.6	16.9	19.0	21.9	27.8	21.4	13.3	24.9	18.5	21.4	15.9	9.6	18.2	19.8	18.8	12.0	12.1	16.4	32.5	2.5	3.8	5.0	2.6	1.0	4.0	2.2	9.2	7.7	16.2	13.3	10.4	8.1	8.4	7.3	9.8	10.6	7.6	3.6	5.4	6.6	5.4	9.4	18.0	10.2	7.0	5.6	17.7	6.7	5.4	8.8	5.6	9.3	10.4	18.4	8.1	12.2	5.0	8.4	8.4	7.7	11.3	7.3	20.4	20.0	11.7	4.2	6.7	22.5	12.5	2.6	6.7	11.6	21.3	10.5	7.6	12.6	6.6	8.4	18.5	9.7	10.0	8.7	11.0	10.4	9.2	1.5	4.9	5.5	6.5	11.2	1.1	2.6	2.5	3.3	1.4	3.1	1.8	3.3	2.1	2.7	2.5	3.6	4.0	5.0	1.0	2.0	3.8	1.9	2.2	17.4	22.2	33.1	19.0	15.3	14.5	23.1	15.6	16.6	18.2
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950381	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	19.1	11.6	14.0	16.8	19.0	14.1	17.2	25.1	19.2	15.9	15.9	16.1	8.1	8.1	19.1	11.6	16.5	14.2	14.8	15.2	14.1	13.8	11.2	11.1	16.5	17.3	14.9	13.0	18.9	9.4	17.9	20.0	15.6	15.0	14.7	11.7	14.7	15.3	15.7	46.6	12.9	12.3	17.2	18.9	20.8	12.7	17.4	15.2	19.4	14.2	14.5	20.8	18.7	21.8	12.0	8.2	23.6	11.9	13.0	12.4	6.5	9.6	7.7	13.5	19.9	9.8	11.3	12.6	11.0	10.5	11.1	9.7	22.4	7.3	16.1	10.0	14.6	6.0	12.4	15.3	13.6	7.2	5.3	30.0	14.7	8.3	9.9	14.3	11.7	8.8	21.6	11.7	18.1	12.1	12.2	10.4	12.7	5.7	14.5	8.4	6.7	9.6	10.6	20.0	9.5	8.8	6.7	12.3	10.0	19.6	22.8	10.1	18.0	10.7	16.9	24.6	5.6	12.7	11.2	9.6	11.4	11.8	18.2	10.5	12.6	11.9	8.6	23.6	10.6	9.0	11.3	12.0	10.5	11.9	8.2	9.8	12.0	12.4	20.5	13.0	11.9	7.7	5.5	6.5	14.0	19.0	25.1	19.0	14.1	13.8	14.9	13.0	15.0	15.2
PHF23	"FLJ16355, MGC2941"	ENSG00000040633	"PHD finger protein 23"	Q9BUL5	17	7235028-7239722	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052410	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA052410: "	"unprognostic (1.76e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.72e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	13.5	29.9	16.8	17.6	20.6	6.4	14.6	13.9	18.1	16.7	28.2	15.5	22.2	16.8	18.4	18.3	24.9	15.6	19.5	17.1	18.1	15.1	26.6	30.7	13.4	20.2	19.7	11.2	22.0	15.4	14.8	15.7	21.3	11.6	18.7	13.2	13.4	14.3	18.3	15.1	13.2	21.7	17.2	11.1	21.3	14.2	16.6	16.3	36.1	18.4	15.7	24.7	19.8	15.8	14.1	15.5	17.0	7.8	9.0	17.6	7.2	18.2	28.7	32.9	21.4	21.4	21.9	12.8	24.8	27.4	30.4	25.8	15.8	13.0	26.9	15.5	26.5	17.8	30.7	20.4	25.1	27.0	25.0	20.2	19.5	17.3	34.5	9.7	32.1	29.8	19.7	26.3	17.6	28.6	22.1	6.5	35.2	13.7	16.6	19.7	31.1	12.7	22.8	16.0	13.1	32.1	10.2	10.8	34.6	17.7	14.6	27.9	17.6	11.7	26.2	26.8	18.8	15.8	30.7	12.4	12.6	13.8	24.1	15.9	23.0	17.0	7.7	13.5	15.9	6.0	13.8	12.1	12.2	17.6	8.6	14.1	10.3	12.7	14.9	9.0	7.8	15.5	10.0	7.2	16.8	20.6	13.9	18.1	18.1	15.1	19.7	11.2	11.6	16.3
PHF5A	"bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7"	ENSG00000100410	"PHD finger protein 5A"	Q7RTV0	22	41459717-41468725	"Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028885	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028885: AB_10602079"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (3.02e-8)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.91e-2)"	24.5	20.8	21.4	21.4	24.9	47.6	27.8	21.3	27.3	20.7	24.0	27.6	18.2	22.0	24.4	26.8	28.8	22.2	21.9	18.3	22.0	20.8	26.1	28.9	20.0	30.9	32.4	23.8	21.9	25.9	18.1	24.5	29.7	23.0	20.1	29.0	21.5	22.4	20.0	32.4	25.3	26.9	22.3	29.5	27.1	24.8	27.3	28.8	38.0	23.4	30.4	38.4	21.3	22.8	33.8	34.2	39.5	33.5	30.4	35.0	40.0	22.9	16.7	28.6	18.8	21.1	16.0	19.8	23.6	19.2	30.8	26.2	22.6	13.7	33.3	13.8	17.4	17.9	38.6	27.9	35.0	20.5	40.2	20.7	25.2	26.2	22.1	54.0	16.5	15.4	21.8	24.3	30.5	21.8	27.5	21.4	22.1	30.7	43.6	36.0	28.6	24.6	33.2	25.4	23.3	20.3	18.3	14.1	11.8	25.8	17.1	25.4	13.7	28.2	14.8	16.5	28.9	13.2	28.2	17.7	31.0	56.0	15.9	23.7	17.5	21.4	33.5	38.9	27.0	30.8	35.0	33.8	31.2	33.6	34.2	30.4	30.9	30.1	39.5	30.4	28.4	28.8	32.5	40.0	21.4	24.9	21.3	27.3	22.0	20.8	32.4	23.8	23.0	28.8
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373253-134428791	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	7.4	19.3	10.2	14.1	12.2	6.5	9.7	18.2	13.5	8.7	8.0	11.6	20.3	7.8	9.0	30.1	11.5	7.3	6.1	7.2	11.0	11.1	9.9	7.5	8.4	20.4	12.5	9.3	30.7	10.4	24.1	18.1	8.2	13.3	8.6	9.5	5.4	11.3	16.8	6.2	7.4	10.2	8.1	17.1	17.8	8.1	8.3	14.4	30.2	11.8	6.0	25.0	8.9	9.8	18.4	11.0	5.3	7.4	9.6	9.9	5.0	11.3	9.4	41.3	16.9	7.7	9.9	7.8	11.4	9.1	12.2	15.2	5.6	11.8	18.2	26.2	6.9	10.2	28.8	12.9	20.6	14.8	13.4	17.6	16.1	6.4	8.3	17.5	9.8	6.5	9.8	13.3	16.6	17.0	12.9	9.0	14.9	7.4	28.2	8.7	12.6	12.7	27.9	15.1	13.8	13.0	13.7	14.3	16.9	8.7	8.1	11.9	7.5	9.7	12.9	11.4	8.2	14.3	17.4	4.6	10.7	24.6	7.5	20.9	14.2	5.3	6.1	3.7	7.9	6.0	8.5	18.4	8.2	7.1	8.8	12.8	9.9	8.2	2.5	9.6	7.4	11.0	8.3	5.0	10.2	12.2	18.2	13.5	11.0	11.1	12.5	9.3	13.3	14.4
PHF7	"HSPC226, NYD-SP6"	ENSG00000010318	"PHD finger protein 7"	Q9BWX1	3	52410657-52423641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 260.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.0;U-266/70: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036283, HPA070305"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA036283: AB_10795026, HPA070305: "	"prognostic favourable (7.38e-5)"	"unprognostic (4.57e-2)"	"unprognostic (6.97e-3)"	"prognostic favourable (9.44e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.61e-3)"	"unprognostic (7.44e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.05e-6)"	"unprognostic (2.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.34e-2)"	"unprognostic (6.79e-2)"	0.9	0.6	0.3	0.6	1.5	0.8	0.9	1.0	1.4	0.5	1.0	1.2	0.4	0.7	0.5	2.0	0.6	0.6	0.4	1.9	0.6	0.4	0.6	0.9	0.6	0.5	1.1	0.7	0.4	0.9	0.6	0.5	0.5	0.7	0.7	1.0	1.2	1.0	0.7	1.5	1.0	1.0	0.5	0.9	0.7	0.6	260.7	0.4	1.7	0.5	0.6	0.6	0.9	0.5	6.7	2.6	3.9	2.5	2.2	4.9	1.7	2.0	0.6	1.5	6.4	1.1	1.6	2.7	2.0	2.1	1.6	2.0	1.0	0.8	3.3	0.2	1.5	1.1	1.1	3.1	2.8	4.1	1.5	3.8	0.4	2.3	1.1	4.1	7.2	0.9	3.5	1.5	3.3	2.3	2.3	14.0	1.2	0.9	4.9	1.6	0.7	4.3	2.2	1.4	4.0	1.7	0.9	1.1	1.2	1.8	0.1	1.6	0.9	2.1	1.7	2.7	1.9	2.9	4.1	16.6	7.9	2.0	1.1	9.6	1.6	0.7	2.2	3.9	2.1	2.5	2.5	6.7	2.5	3.7	1.1	3.8	1.7	3.5	0.5	2.2	1.4	2.6	4.9	1.7	0.3	1.5	1.0	1.4	0.6	0.4	1.1	0.7	0.7	0.4
PHF8	"JHDM1F, KDM7B, KIAA1111, ZNF422"	ENSG00000172943	"PHD finger protein 8"	Q9UPP1	X	53936676-54048958	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038779, HPA062015"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA038779: AB_10675950, HPA062015: "	"unprognostic (6.35e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.85e-2)"	"prognostic favourable (3.74e-5)"	8.8	6.8	8.2	11.5	9.4	10.7	11.1	12.5	9.2	10.3	8.2	12.9	27.4	7.9	12.2	54.0	10.7	11.1	9.8	7.8	7.2	5.4	8.8	21.7	10.5	11.2	11.3	7.0	16.8	14.1	10.6	14.6	9.8	9.4	12.8	7.5	10.3	10.3	14.7	8.4	9.6	11.1	8.9	8.5	11.8	9.7	30.6	10.4	19.6	11.1	8.1	13.0	12.8	16.1	6.2	5.1	10.7	7.9	5.4	9.5	5.1	8.8	7.7	11.7	11.3	7.3	5.7	19.2	6.7	5.9	7.5	6.7	8.7	7.2	13.0	4.0	6.0	9.3	29.0	5.8	8.0	20.2	13.8	7.8	9.9	8.7	5.7	12.1	14.7	6.4	8.1	8.6	11.8	6.9	10.3	19.0	4.3	8.8	16.5	9.3	21.2	11.6	16.3	13.0	12.7	5.1	10.7	17.1	8.4	17.8	11.9	5.9	11.8	8.5	7.9	6.0	8.5	11.0	5.5	14.5	13.3	15.7	7.0	15.4	6.4	10.7	4.5	7.2	6.2	7.9	9.5	4.3	6.2	7.1	5.1	6.2	4.6	5.0	7.7	5.4	5.2	4.0	9.2	5.1	8.2	9.4	12.5	9.2	7.2	5.4	11.3	7.0	9.4	10.4
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744226	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 16.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			9000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: , HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (1.48e-4)"	"prognostic favourable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	18.8	1.9	33.3	4.4	32.1	4.4	13.8	7.8	27.2	11.9	5.8	49.7	9.4	4.2	6.1	41.0	16.7	24.5	3.9	5.3	26.7	20.5	14.0	53.2	4.3	5.7	42.0	20.7	17.3	58.2	67.5	5.7	6.4	23.3	24.5	4.7	8.7	62.9	16.4	1.7	35.9	3.0	8.1	28.3	1.9	9.0	8.6	38.1	9.9	15.8	7.3	7.3	7.9	14.1	6.7	3.2	2.9	0.7	1.2	16.5	3.2	13.5	5.5	14.5	34.9	8.3	11.0	27.1	12.3	22.2	17.6	29.2	28.7	2.4	0.0	5.3	32.9	18.3	26.9	25.6	12.4	0.1	24.5	4.3	19.5	19.8	17.3	27.4	0.1	15.8	42.8	16.8	20.0	12.6	7.8	32.5	7.7	53.3	18.3	8.4	36.3	42.3	16.1	25.2	2.3	1.1	16.2	15.7	14.3	9.0	6.0	98.9	12.2	46.8	0.1	2.9	15.3	17.9	13.7	26.8	6.7	27.4	35.6	38.3	22.6	2.9	0.7	0.2	2.9	0.2	0.2	6.7	1.8	4.9	3.2	2.7	9.1	16.5	2.0	1.2	0.2	1.8	2.4	3.2	33.3	32.1	7.8	27.2	26.7	20.5	42.0	20.7	23.3	38.1
PHIP	"BRWD2, DCAF14, FLJ20705, ndrp, WDR11"	ENSG00000146247	"Pleckstrin homology domain interacting protein"	Q8WWQ0	6	78935867-79078236	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019140, HPA019838"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA019140: , HPA019838: "	"unprognostic (1.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.71e-5)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-2)"	14.7	9.6	13.3	14.9	16.9	40.2	19.4	30.1	14.6	19.1	13.9	11.8	15.0	9.4	18.1	14.1	11.6	16.1	12.3	12.2	11.0	9.7	10.4	7.9	15.4	16.8	15.8	11.0	19.8	15.5	20.6	28.4	14.2	12.8	14.7	12.8	11.0	15.6	18.3	16.6	14.1	13.8	17.1	13.7	14.9	12.9	10.2	17.9	27.8	13.4	8.8	14.4	17.1	22.6	8.3	6.2	17.3	6.1	5.1	7.3	2.2	8.9	7.3	17.5	17.0	6.7	9.7	10.2	9.7	7.7	8.3	10.6	9.0	5.6	14.9	7.7	6.0	8.3	13.1	6.1	14.2	21.4	9.5	16.7	13.8	6.6	3.1	18.5	10.7	5.9	5.5	10.0	10.1	8.7	16.7	14.5	8.0	6.0	7.1	13.3	11.0	8.0	12.6	22.4	6.4	8.9	12.2	17.2	10.9	13.0	9.9	6.1	7.7	24.8	10.2	9.7	6.9	4.6	15.9	9.9	9.7	8.5	4.1	12.0	14.4	10.2	5.0	8.4	5.6	3.3	6.0	6.8	6.6	6.1	3.3	8.3	7.3	5.8	17.3	5.1	6.1	6.2	5.4	2.2	13.3	16.9	30.1	14.6	11.0	9.7	15.8	11.0	12.8	17.9
PHKG2		ENSG00000156873	"Phosphorylase kinase catalytic subunit gamma 2"	P15735	16	30748270-30761176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 44.5;testis: 95.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065618, HPA068751"			Supported	Cytosol				Cytosol		"HPA065618: AB_2685520, HPA068751: AB_2686025"	"unprognostic (7.63e-3)"	"prognostic favourable (7.90e-4)"	"prognostic unfavourable (9.92e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-2)"	"prognostic favourable (8.02e-4)"	"unprognostic (6.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	4.3	8.3	8.7	6.9	8.0	15.9	5.8	9.1	12.0	4.7	7.9	7.3	9.0	6.8	5.6	7.8	5.3	6.8	7.2	6.4	9.0	9.3	8.2	11.0	5.8	6.8	8.6	9.2	4.7	5.1	17.3	8.5	6.3	11.8	7.7	7.6	6.4	7.0	9.9	6.4	8.4	7.3	6.3	5.8	6.9	7.2	95.4	7.3	5.5	8.6	5.5	7.7	5.2	4.7	8.8	21.2	44.5	22.7	23.5	16.8	17.6	13.5	8.9	7.5	9.2	7.1	5.7	16.9	9.5	14.3	13.0	14.9	7.7	6.8	11.7	11.3	9.8	13.0	7.8	12.1	10.5	6.3	21.7	6.4	14.8	21.6	10.9	9.9	9.2	7.7	6.6	12.5	5.9	13.2	8.7	6.8	9.4	31.2	11.7	14.6	10.3	10.4	15.8	11.7	15.6	14.9	15.3	10.1	7.0	7.7	21.5	9.1	16.9	8.6	7.8	8.0	8.9	10.0	8.7	13.8	7.5	8.0	15.9	19.4	6.5	14.0	22.7	44.5	16.2	22.4	13.3	8.8	11.6	16.4	21.2	8.5	10.4	12.1	18.2	23.5	15.9	18.2	16.8	17.6	8.7	8.0	9.1	12.0	9.0	9.3	8.6	9.2	11.8	7.3
PHLDA1	"DT1P1B11, PHRIP, TDAG51"	ENSG00000139289	"Pleckstrin homology like domain family A member 1"	Q8WV24	12	76025447-76033932	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 142.4"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 43.3;RPTEC TERT1: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1"	"Group enriched"	"Detected in many"	7	"monocytes: 2.5;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016160, HPA019000, HPA063520"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: "	"unprognostic (9.09e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.55e-3)"	13.2	15.9	9.4	8.4	12.1	9.0	13.5	6.4	15.7	11.5	4.5	11.1	4.8	3.4	7.1	3.1	33.3	5.1	20.0	9.6	8.2	7.9	13.8	33.2	14.2	3.0	8.4	5.6	10.8	8.8	2.6	6.0	7.1	10.0	4.8	5.5	24.9	142.4	6.5	3.3	6.3	7.0	7.6	9.7	14.6	10.8	2.3	10.1	2.5	18.0	13.2	19.9	17.0	17.8	0.3	0.1	0.4	2.5	0.3	4.1	0.6	13.5	16.3	12.8	7.0	6.0	12.4	0.9	11.5	31.1	5.2	7.3	9.0	16.6	0.0	3.5	4.8	7.0	0.3	19.3	11.3	2.0	0.2	0.3	0.8	15.2	8.7	0.3	3.5	3.8	14.2	21.8	43.3	12.5	1.1	0.4	26.8	1.7	0.0	1.7	4.6	25.2	0.0	3.3	0.4	54.9	30.8	0.9	2.4	2.0	0.1	37.4	8.2	0.1	11.6	17.9	1.7	20.8	11.3	0.2	0.0	0.0	30.2	0.2	22.3	0.3	0.1	0.2	2.4	0.2	3.9	0.3	2.5	2.5	0.0	0.2	0.5	0.6	0.4	0.3	2.5	0.1	4.1	0.6	9.4	12.1	6.4	7.7	8.2	7.9	8.4	5.6	10.0	10.1
PHLDB2	"FLJ21791, LL5b, LL5beta"	ENSG00000144824	"Pleckstrin homology like domain family B member 2"	Q86SQ0	3	111732497-111976517	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 104.0"	"Cell line enhanced"	"Detected in many"		"A-431: 31.9;HaCaT: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035146, HPA035147"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035146: AB_10600927, HPA035147: "	"unprognostic (2.83e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.53e-1)"	"prognostic favourable (7.03e-8)"	"unprognostic (3.24e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.83e-1)"	15.5	3.8	1.3	13.2	1.9	0.4	9.9	1.6	2.9	13.9	22.8	1.4	8.4	2.8	17.4	10.1	10.7	10.7	9.1	21.7	1.3	1.2	36.6	24.6	14.4	2.2	2.1	1.9	8.5	6.4	0.9	5.3	104.0	7.1	16.7	4.4	6.9	7.0	14.3	6.0	5.8	6.5	49.3	2.4	7.9	11.4	4.3	0.4	1.7	5.9	6.8	2.3	33.8	17.8	1.0	1.0	0.4	0.1	1.7	5.6	1.3	31.9	3.5	20.1	0.0	6.5	10.8	8.2	18.5	9.1	12.3	14.6	10.0	2.3	0.0	19.5	7.1	33.3	0.3	11.9	22.5	0.4	0.4	0.0	8.6	3.3	7.1	0.0	0.1	12.6	7.1	8.4	15.8	19.7	0.0	0.1	3.7	0.0	1.3	0.0	8.1	6.2	2.8	25.9	0.0	7.3	7.7	0.5	1.5	18.3	0.3	1.9	0.6	0.1	17.2	3.3	28.2	8.8	4.5	1.7	0.0	0.0	3.4	0.0	6.3	0.2	0.0	0.0	5.2	0.0	3.7	0.4	3.6	5.6	0.1	1.0	0.0	2.3	0.4	1.7	0.1	1.0	0.8	1.3	1.3	1.9	1.6	2.9	1.3	1.2	2.1	1.9	7.1	0.4
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2a"	O14813	11	72239077-72245664	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7"	"Cell line enriched"	"Detected in single"	228	"SH-SY5Y: 112.7"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in single"	96	"pons and medulla: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"pons and medulla: 0.8"	"Low region specificity"	"Detected in some"			"HPA053810, HPA065621, HPA078004"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA053810: , HPA065621: , HPA078004: "			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.4	24.6	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.5	0.0	0.4	0.1	0.0	1.4	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	12.1	0.9	0.7	1.7	0.7	3.7	0.0	0.0	3.2	0.3	2.1	0.1	1.6	5.2	0.0	0.0	0.0	0.0	0.0	2.6	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	112.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0
PHOX2B	"NBPhox, Phox2b, PMX2B"	ENSG00000109132	"Paired like homeobox 2b"	Q99453	4	41744082-41748970	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.5;brain: 24.8"	"Cell line enriched"	"Detected in single"	91	"SH-SY5Y: 52.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	99	"pons and medulla: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"pons and medulla: 5.9"	"Region enriched"	"Detected in single"	38	"pons and medulla: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA074325: , HPA074941: "			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	14.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	24.8	0.2	1.4	0.8	0.0	0.0	0.0	0.0	3.2	0.5	0.4	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.8	0.0
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25233975-25279092	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 49.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA004099	Approved		Supported	Cytosol				Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favourable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	9.2	7.1	3.4	13.6	2.9	3.9	8.0	3.2	2.3	8.7	48.4	4.1	11.3	19.4	7.4	8.0	13.5	4.9	9.5	4.2	3.1	2.7	12.9	38.6	14.3	9.4	3.5	2.3	6.9	10.5	4.2	5.7	7.7	2.9	6.4	9.8	3.3	22.6	12.0	4.4	8.6	49.3	6.9	4.5	13.8	11.3	8.0	2.7	18.6	16.2	12.9	14.1	7.8	10.3	1.4	1.8	1.5	1.0	0.4	4.1	0.4	11.3	2.0	4.8	5.1	6.5	12.1	11.8	17.1	16.1	15.0	19.2	3.6	12.2	29.4	3.9	12.9	4.7	10.9	8.6	14.9	8.9	3.8	9.4	5.1	9.1	6.2	18.9	7.3	8.1	7.8	5.6	5.9	10.1	6.2	24.7	14.5	4.4	18.2	16.9	8.4	4.6	11.0	18.9	17.1	13.2	8.1	10.1	2.2	8.7	6.9	3.5	9.8	11.0	10.4	10.7	2.7	6.5	11.0	28.4	13.5	22.4	12.5	16.1	10.8	1.5	0.4	0.0	1.3	1.0	0.9	1.4	1.5	1.2	0.3	1.0	1.4	1.3	0.2	0.4	0.9	1.8	4.1	0.4	3.4	2.9	3.2	2.3	3.1	2.7	3.5	2.3	2.9	2.7
PI4KB	"PI4K-BETA, pi4K92, PIK4CB"	ENSG00000143393	"Phosphatidylinositol 4-kinase beta"	Q9UBF8	1	151291797-151327715	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006280, HPA006281, CAB022071"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.23e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (8.51e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (7.08e-2)"	25.5	22.2	29.8	21.6	32.3	41.6	27.3	42.6	47.2	30.8	27.1	44.8	26.6	21.8	38.6	35.8	25.6	33.0	25.1	23.8	26.3	22.5	25.6	19.3	27.2	26.2	38.7	28.8	38.6	22.6	41.8	35.5	24.2	29.6	32.2	28.1	28.8	27.1	29.9	36.2	36.9	25.3	39.8	22.7	34.7	23.7	33.1	34.0	26.2	41.2	24.6	28.7	27.1	30.1	17.1	19.7	27.9	20.4	14.7	20.3	17.1	19.3	16.2	14.1	22.1	39.2	29.0	12.0	20.6	36.0	27.0	22.5	20.7	17.6	18.3	23.8	31.5	18.3	23.4	21.2	20.9	24.9	20.8	13.1	19.2	10.6	27.5	15.0	25.3	30.3	25.9	29.9	21.4	26.0	22.3	27.9	22.9	36.0	16.0	12.2	11.3	24.7	14.3	11.9	21.5	18.7	24.6	17.1	14.7	14.3	29.2	18.5	24.6	28.7	20.2	19.4	15.3	15.4	21.9	29.7	19.3	35.8	22.1	15.8	33.5	25.2	17.5	27.9	15.6	20.4	17.4	17.1	16.1	20.3	19.7	15.1	13.6	12.5	17.2	14.7	19.6	11.4	15.9	17.1	29.8	32.3	42.6	47.2	26.3	22.5	38.7	28.8	29.6	34.0
PIAS2	"ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4"	ENSG00000078043	"Protein inhibitor of activated STAT 2"	O75928	18	46803224-46920160	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 61.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068792	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA068792: "	"unprognostic (9.59e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavourable (1.27e-4)"	"unprognostic (1.71e-1)"	5.6	6.7	9.8	4.7	12.7	7.0	6.1	16.7	13.5	4.7	5.6	8.1	8.0	3.7	6.0	8.8	4.7	5.3	5.5	7.5	8.4	8.1	7.4	6.6	4.9	6.5	7.9	8.5	5.8	5.0	19.3	10.4	4.8	12.1	7.7	8.1	8.2	5.9	7.9	15.6	8.5	4.8	5.7	7.6	6.5	5.3	61.6	9.1	7.5	9.2	4.1	5.8	5.3	4.6	6.8	5.1	2.9	4.4	4.8	6.7	2.1	11.8	4.9	5.6	7.9	5.6	7.0	2.6	6.3	5.0	5.5	5.1	5.7	4.5	12.0	3.5	4.7	4.0	11.1	6.6	7.8	5.9	4.1	7.4	4.7	6.7	5.5	12.3	5.3	7.2	4.1	4.8	5.1	4.9	5.4	3.1	10.8	6.4	7.2	7.2	6.0	3.1	13.1	11.9	0.1	5.0	9.2	10.6	8.2	5.7	3.7	4.1	5.5	5.5	6.2	11.8	5.1	4.0	4.6	9.3	4.6	15.3	8.8	13.3	11.5	1.5	4.4	2.8	5.4	3.4	3.8	4.1	4.8	6.1	5.0	6.8	6.7	5.7	2.9	4.8	3.0	5.1	4.2	2.1	9.8	12.7	16.7	13.5	8.4	8.1	7.9	8.5	12.1	9.1
PIAS3	"FLJ14651, ZMIZ5"	ENSG00000131788	"Protein inhibitor of activated STAT 3"	Q9Y6X2	1	145848522-145859836	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006389, HPA067383"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA006389: , HPA067383: "	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (6.12e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.06e-1)"	"prognostic unfavourable (1.21e-7)"	"unprognostic (5.14e-2)"	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-2)"	15.2	9.8	10.7	12.8	12.7	4.5	17.4	19.1	16.3	29.1	16.2	17.9	16.5	7.5	25.5	15.0	26.4	36.7	20.2	14.1	11.5	9.7	13.9	6.4	13.6	8.2	11.6	11.9	21.2	11.7	14.7	13.8	10.5	11.9	20.3	8.4	28.8	20.9	26.8	17.4	28.6	10.3	23.1	10.7	10.2	15.9	10.0	12.1	7.3	11.4	19.2	22.7	22.6	24.2	6.1	8.6	10.7	11.9	15.1	12.6	6.8	13.2	9.2	9.5	8.4	14.7	27.8	5.8	12.5	17.3	14.3	15.9	7.5	8.7	6.8	13.5	21.3	13.7	4.9	19.8	12.1	7.4	7.2	3.1	6.3	3.9	14.7	5.6	15.6	22.6	12.9	13.2	7.5	20.6	5.0	9.5	29.6	22.1	6.0	2.9	14.7	15.0	9.4	6.5	4.4	11.3	8.0	3.2	15.2	12.0	6.7	6.1	31.0	8.5	31.6	19.1	14.2	12.6	8.0	13.1	5.9	4.5	18.5	4.2	9.4	8.5	9.5	10.7	11.7	8.8	12.5	6.1	7.7	12.6	7.0	4.3	7.1	6.7	2.2	15.1	11.9	8.6	8.2	6.8	10.7	12.7	19.1	16.3	11.5	9.7	11.6	11.9	11.9	12.1
PIBF1	"C13orf24, CEP90"	ENSG00000083535	"Progesterone immunomodulatory binding factor 1"	Q8WXW3	13	72782059-73016461	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052269, HPA066120"	Approved		Supported	"Centriolar satellite"	"Secreted to blood"			"Centriolar satellite"		"HPA052269: , HPA066120: "	"unprognostic (1.54e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-1)"	14.3	12.1	8.6	17.5	11.3	11.6	15.9	17.3	12.7	20.0	15.3	6.7	14.1	8.9	15.0	14.6	13.2	14.3	10.8	12.7	8.5	8.2	14.5	12.0	13.4	11.5	9.0	8.9	19.0	9.8	10.1	43.9	16.6	11.6	17.4	11.4	6.6	13.7	16.7	12.1	10.8	13.8	13.1	14.8	19.2	10.8	17.2	11.9	30.8	22.7	10.6	10.3	18.6	14.9	7.9	6.5	8.2	4.7	11.0	12.3	3.4	8.5	2.7	11.5	6.6	10.1	17.7	4.4	7.8	10.6	8.1	9.8	3.7	14.6	7.7	9.4	8.9	7.5	6.0	7.9	13.0	7.8	5.8	5.4	7.4	4.4	13.0	19.9	5.1	11.4	6.5	8.6	21.4	10.4	7.5	4.0	10.8	2.4	9.7	12.2	6.0	2.6	7.8	8.3	8.0	16.5	4.6	6.5	10.5	6.1	4.2	10.5	7.1	14.6	7.7	4.1	4.3	6.4	4.7	6.6	4.7	3.9	12.4	11.4	8.8	8.2	4.5	7.5	8.3	4.7	8.9	7.6	8.9	8.7	3.9	7.9	12.3	10.0	4.4	11.0	4.4	6.5	6.7	3.4	8.6	11.3	17.3	12.7	8.5	8.2	9.0	8.9	11.6	11.9
PICALM	"CALM, CLTH"	ENSG00000073921	"Phosphatidylinositol binding clathrin assembly protein"	Q13492	11	85957684-86069882	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019053, HPA019061"	Enhanced		Enhanced	Vesicles			28000	Vesicles		"HPA019053: AB_1855361, HPA019061: AB_1855362"	"unprognostic (9.27e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.36e-3)"	"unprognostic (9.02e-3)"	"unprognostic (9.80e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavourable (6.61e-4)"	"unprognostic (4.31e-1)"	"prognostic favourable (2.02e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-1)"	72.9	24.2	35.6	43.1	51.4	37.1	51.3	30.2	39.7	38.7	35.9	60.0	27.7	39.6	41.6	26.0	41.3	31.5	48.1	41.4	43.7	34.2	63.9	53.8	45.1	35.2	52.0	33.5	38.2	29.7	70.6	23.8	76.7	50.7	29.9	32.0	26.7	31.8	37.0	35.5	35.0	45.3	49.9	70.7	49.5	30.7	22.9	55.1	31.0	30.8	28.5	34.8	44.0	49.2	2.1	7.1	25.8	8.5	3.9	5.3	3.1	28.9	13.8	21.9	15.3	33.6	35.3	41.4	37.3	48.5	29.5	26.1	54.4	39.5	22.6	38.5	59.8	24.0	22.9	27.2	42.7	6.7	8.2	64.2	18.8	17.3	34.3	15.0	28.9	30.6	29.5	55.3	46.1	32.0	41.1	18.7	55.5	17.0	17.6	13.8	12.0	7.9	12.2	33.2	16.0	57.3	24.5	13.3	10.8	45.8	15.5	12.3	21.0	12.2	34.6	54.6	19.0	64.4	29.7	6.7	17.5	20.7	12.9	11.9	36.8	3.6	8.5	4.2	3.9	7.2	3.3	2.1	2.9	5.3	7.1	1.4	3.0	2.7	25.8	3.9	7.2	2.5	3.8	3.1	35.6	51.4	30.2	39.7	43.7	34.2	52.0	33.5	50.7	55.1
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	1.8	1.1	0.6	12.9	0.6	6.0	0.6	0.6	1.2	1.2	5.2	0.6	0.6	3.3	2.0	1.3	4.6	0.8	1.4	0.9	0.6	1.8	0.7	0.6	1.9	7.5	0.9	0.6	0.6	0.6	0.0	0.6	1.4	1.0	2.5	1.8	0.9	0.8	1.2	0.6	1.6	3.7	2.1	0.6	7.0	2.7	3.3	0.6	14.3	0.6	5.1	6.0	1.8	1.9	0.7	0.3	0.0	0.0	0.0	3.2	0.4	5.1	6.0	14.7	5.9	2.6	3.1	5.4	5.1	2.7	5.1	4.0	9.5	8.6	6.2	2.1	2.5	14.3	15.1	4.3	1.9	9.9	5.5	7.2	16.9	6.8	1.3	2.9	5.9	1.7	0.0	2.2	1.8	5.2	4.7	12.5	4.8	4.5	3.0	12.0	12.0	4.2	6.4	4.9	8.7	2.8	2.9	6.1	3.9	3.9	4.3	2.3	4.8	3.1	3.5	3.1	16.1	4.9	9.3	10.1	9.3	5.9	2.9	12.7	4.4	0.0	0.0	0.0	1.5	0.0	0.5	0.7	0.1	1.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.3	3.2	0.4	0.6	0.6	0.6	1.2	0.6	1.8	0.9	0.6	1.0	0.6
PIGN	"MDC4, PIG-N"	ENSG00000197563	"Phosphatidylinositol glycan anchor biosynthesis class N"	O95427	18	61905255-62187118	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039922, HPA040374"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039922: AB_10805597, HPA040374: AB_10794738"	"unprognostic (1.93e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (6.51e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.71e-1)"	12.6	14.1	8.3	10.2	13.2	13.7	13.5	10.5	12.4	15.1	13.2	16.6	12.2	12.0	18.3	12.7	33.2	9.2	11.0	12.8	9.6	7.8	11.2	15.9	9.0	9.5	10.4	8.8	12.9	16.6	19.7	27.2	17.1	11.9	15.2	15.7	14.7	20.3	13.7	15.2	19.0	12.7	9.6	15.4	9.3	17.4	16.2	12.2	18.6	15.3	12.7	18.6	16.8	18.1	13.1	13.4	14.8	10.0	16.3	11.5	4.5	16.8	10.1	10.1	12.8	12.6	17.1	13.5	16.8	13.2	11.0	13.2	13.1	17.2	18.7	24.6	12.7	23.3	13.5	14.2	17.5	15.5	9.1	11.4	15.6	10.2	9.0	23.3	13.3	10.0	9.5	11.1	13.0	13.9	13.4	28.0	12.1	15.3	11.6	7.1	17.1	9.4	12.5	18.8	18.1	13.6	26.0	11.5	11.8	22.4	15.9	7.1	25.2	14.9	15.7	22.4	16.4	8.8	12.5	29.7	27.6	9.3	12.3	13.3	21.8	11.4	10.0	7.6	9.6	8.5	9.9	10.3	9.7	9.2	10.8	13.1	11.2	11.5	14.8	16.3	9.0	13.4	7.8	4.5	8.3	13.2	10.5	12.4	9.6	7.8	10.4	8.8	11.9	12.2
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favourable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.3	16.8	17.6	17.2	26.3	9.2	20.0	22.6	17.2	22.1	17.2	13.9	22.2	15.6	20.3	19.2	16.8	18.2	20.2	16.3	14.5	11.6	25.7	16.3	22.2	11.3	17.6	16.1	17.6	14.2	62.9	23.0	23.5	28.5	18.7	14.3	15.2	15.6	27.5	15.4	13.1	17.9	19.5	31.8	17.5	18.3	19.4	18.0	11.4	32.2	9.3	11.5	23.1	20.5	4.4	5.2	6.0	7.2	4.2	4.8	1.6	22.8	10.5	17.6	10.9	12.7	13.0	15.7	14.5	15.7	10.6	14.9	25.4	2.6	6.7	7.2	12.4	15.2	14.0	11.0	19.0	5.7	12.1	4.1	12.7	9.9	13.9	5.2	6.7	10.1	7.8	10.5	20.6	25.3	9.8	6.5	8.2	7.1	2.8	3.2	10.0	8.1	2.9	18.3	4.6	13.2	20.3	10.4	9.2	22.0	9.5	10.2	5.6	5.3	31.5	8.6	12.4	22.2	8.8	2.6	5.8	5.5	10.2	4.9	9.9	4.1	4.1	2.9	4.6	2.5	3.0	3.6	3.7	3.6	5.2	4.4	4.8	2.8	6.0	4.2	7.2	3.7	2.3	1.6	17.6	26.3	22.6	17.2	14.5	11.6	17.6	16.1	28.5	18.0
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 41.2;HMC-1: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody				Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: "	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	22.6	9.8	4.2	3.5	3.9	5.2	28.7	5.3	5.1	5.4	5.8	10.5	8.6	9.1	14.5	5.2	9.7	5.5	8.4	9.7	11.6	6.2	41.2	6.7	6.3	4.0	10.0	65.3	4.4	6.5	3.8	7.7	8.1	15.7	6.8	6.7	10.3	5.8	7.0	6.0	9.2	4.2	4.4	6.5	8.3	12.5	3.7	2.7	14.7	6.4	18.9	16.0	23.9	8.5	3.5	4.4	7.5	7.4	11.5	7.5	8.3	8.5	9.7	4.8	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106907145	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.2;HMC-1: 15.2;Karpas-707: 12.6;MOLT-4: 23.0;U-266/70: 30.9;U-937: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA069976: "	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	5.0	1.8	2.2	16.0	3.1	27.8	2.3	0.8	1.7	1.7	4.1	2.7	0.0	2.8	1.7	2.0	2.0	1.8	3.5	1.7	1.7	1.5	1.9	1.5	4.3	13.1	3.0	1.0	1.7	1.5	0.6	1.4	2.0	2.5	2.2	2.6	1.9	3.1	0.5	1.1	1.3	6.1	1.9	6.4	17.4	2.5	7.6	3.0	40.8	2.3	0.9	21.2	4.1	1.5	6.2	5.6	14.2	24.5	5.3	5.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	0.0	0.0	11.9	15.2	0.0	0.0	0.0	0.0	4.7	8.5	12.6	0.0	0.0	23.0	4.6	0.0	0.0	6.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	0.0	0.1	0.0	0.0	30.9	0.0	11.5	0.0	21.8	2.9	4.6	3.4	14.2	5.6	10.6	5.1	4.7	2.6	4.2	5.6	6.2	2.8	3.8	13.9	5.3	24.5	4.9	2.6	3.6	2.2	3.1	0.8	1.7	1.7	1.5	3.0	1.0	2.5	3.0
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 28.0;U-937: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA044505: , HPA052247: , HPA052412: "	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	13.8	4.1	2.0	13.0	3.4	51.0	7.2	0.6	1.8	2.1	5.6	3.6	0.0	2.5	1.9	3.1	3.1	3.8	5.7	3.1	3.4	1.6	2.7	2.4	16.4	22.9	5.0	0.6	2.5	1.8	0.7	1.3	2.3	3.0	2.7	2.1	2.4	3.1	1.0	1.0	1.8	10.4	2.9	5.3	23.8	2.6	4.0	2.5	17.6	2.2	1.9	12.4	4.5	2.8	3.6	8.0	23.8	12.1	5.7	13.6	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.3	1.0	0.0	0.0	0.0	0.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.8	0.4	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	4.9	10.6	3.7	13.6	10.0	8.8	3.2	7.5	11.4	8.0	3.6	5.8	8.9	23.8	5.7	12.1	6.4	9.2	9.5	2.0	3.4	0.6	1.8	3.4	1.6	5.0	0.6	3.0	2.5
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIKfyve, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266267-208358751	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042558, HPA042604"	Uncertain		Supported	Vesicles				Vesicles		"HPA042558: , HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favourable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	15.9	13.5	17.7	21.1	21.9	36.1	24.9	25.6	23.1	14.8	12.1	14.0	16.6	9.1	14.7	18.3	11.2	12.6	11.1	12.5	19.4	14.3	16.2	15.2	16.5	23.1	14.4	15.3	15.6	31.5	21.5	17.0	14.1	20.6	17.7	11.5	13.8	13.7	19.7	13.6	12.9	15.3	13.5	24.4	21.7	12.1	19.3	15.8	23.5	18.2	7.8	22.6	12.4	14.0	7.5	2.1	1.4	1.2	5.6	2.6	0.5	5.0	5.0	12.0	9.3	12.1	14.5	5.6	6.2	12.6	7.3	10.0	7.2	4.2	5.8	6.5	10.6	5.2	10.4	6.9	12.5	4.9	6.6	20.8	9.9	6.4	9.2	18.3	18.8	10.8	7.6	8.5	16.0	11.8	14.0	10.5	9.1	2.1	16.6	13.8	9.9	3.8	6.2	9.3	7.9	9.4	7.3	3.8	9.1	6.8	4.4	12.3	2.8	19.8	13.5	9.2	6.1	6.1	5.7	7.4	8.7	12.4	7.3	16.0	9.0	1.4	1.0	0.7	1.7	0.8	1.1	7.5	2.3	2.6	0.9	5.4	1.8	2.1	1.4	5.6	1.2	2.1	1.5	0.5	17.7	21.9	25.6	23.1	19.4	14.3	14.4	15.3	20.6	15.8
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170203-37175426	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 34.8;HMC-1: 64.9;U-698: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 64.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 64.6;T-cells: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	39.3	5.4	7.4	18.5	8.9	80.9	20.1	8.1	9.9	23.0	17.9	4.7	4.2	17.9	15.4	9.8	56.3	21.6	24.7	20.8	8.2	3.7	7.5	24.5	14.5	35.7	7.4	2.2	20.0	9.6	2.0	5.6	28.7	12.7	15.6	8.8	6.9	12.8	4.5	26.5	31.3	26.1	31.6	10.7	21.4	12.1	6.8	7.6	15.0	7.2	20.1	28.8	32.6	31.2	1.7	1.4	64.6	1.7	8.4	19.0	8.5	3.0	1.2	2.0	1.1	4.6	2.4	23.5	1.0	3.3	2.2	3.6	4.5	4.2	6.0	1.7	1.2	3.5	2.0	3.2	2.0	27.5	1.3	34.8	1.3	5.8	4.7	0.6	64.9	8.3	4.0	2.0	1.3	0.6	29.9	9.8	0.3	0.7	1.9	3.1	3.7	1.9	4.6	3.6	7.1	0.6	18.4	9.7	1.9	2.3	0.2	0.6	0.5	1.0	1.1	1.3	3.9	5.8	1.3	4.6	2.4	116.6	0.5	8.8	1.3	64.6	1.7	24.4	14.7	1.6	19.0	1.7	13.1	12.9	1.4	1.3	11.9	9.0	14.1	8.4	0.9	0.4	9.4	8.5	7.4	8.9	8.1	9.9	8.2	3.7	7.4	2.2	12.7	7.6
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960513-49964080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol				Cytosol		"HPA068758: "	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	32.5	15.5	6.8	19.9	16.7	62.4	50.5	7.6	11.9	16.4	22.6	11.3	20.9	15.9	14.4	17.6	25.0	15.9	37.8	23.6	7.5	7.9	29.1	25.7	38.3	29.4	21.1	4.9	13.9	36.4	4.8	14.9	31.4	15.1	28.4	7.6	9.7	27.6	22.7	39.9	31.3	20.9	12.2	10.1	25.4	33.6	13.0	13.5	9.7	19.1	19.9	19.0	25.6	18.3	6.1	5.7	16.9	4.0	1.2	4.5	1.9	7.2	4.8	3.2	6.1	2.5	1.9	18.5	4.6	7.4	5.4	3.9	8.0	6.2	12.9	5.8	1.2	6.2	6.2	3.4	1.9	9.7	25.7	5.3	11.5	9.6	12.0	11.5	10.3	3.6	11.5	3.3	5.7	17.6	7.3	45.7	1.6	16.2	5.8	20.6	6.8	7.7	27.2	5.4	15.3	2.9	5.5	11.6	8.1	8.9	40.6	28.4	5.3	15.3	4.6	3.4	14.8	5.6	7.4	23.5	14.9	11.0	8.6	6.5	9.2	0.0	3.1	0.1	1.9	3.2	2.3	3.4	4.4	3.8	2.5	6.1	4.1	1.7	16.9	1.2	4.0	5.7	4.5	1.9	6.8	16.7	7.6	11.9	7.5	7.9	21.1	4.9	15.1	13.5
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444415-6451469	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.3"	"Cell line enhanced"	"Detected in many"		"AF22: 49.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA043783: , HPA049934: "	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	1.9	4.5	1.2	1.6	1.1	3.1	2.2	1.0	0.8	1.3	4.7	0.6	0.4	4.3	1.6	1.7	6.0	0.3	2.5	1.6	0.5	0.5	0.8	0.9	2.1	1.7	0.6	0.4	1.6	0.4	0.0	1.0	0.9	1.2	0.8	6.2	0.4	1.3	0.4	0.4	3.7	4.5	2.7	1.0	9.5	1.8	1.0	0.4	27.3	0.4	3.9	3.6	2.3	2.0	0.4	0.0	0.8	0.4	3.3	1.5	1.2	12.4	16.8	49.8	22.3	0.4	1.4	3.9	14.6	9.0	24.0	16.2	9.9	5.4	0.0	5.8	11.8	9.1	25.1	6.5	12.9	19.2	10.0	0.0	10.0	12.0	0.0	0.5	15.2	0.7	0.4	9.9	3.9	7.5	2.9	7.1	15.0	8.9	2.7	0.1	21.8	11.0	22.3	20.0	8.7	3.9	1.9	11.3	15.9	12.6	13.2	12.3	6.1	1.2	3.5	18.8	15.3	11.0	23.8	2.5	9.0	0.0	7.3	6.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	0.0	0.4	0.2	0.7	0.8	3.3	0.4	0.0	1.3	1.2	1.2	1.1	1.0	0.7	0.5	0.5	0.6	0.4	1.2	0.4
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849682	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004528, CAB009326, HPA068650, HPA070887"	Approved		Enhanced	Nucleoplasm,Cytosol			30000	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: , HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favourable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favourable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	24.5	36.3	40.0	18.7	38.8	25.6	9.3	27.4	66.0	9.2	15.8	18.1	8.5	22.9	14.0	8.3	11.3	16.4	10.1	25.9	38.0	35.2	17.4	14.5	13.2	14.8	38.7	37.2	13.9	21.1	9.5	13.6	13.3	57.3	23.2	6.5	14.1	21.3	15.7	50.2	10.2	21.7	11.1	19.6	15.4	19.6	24.8	15.0	19.7	9.9	8.1	9.3	11.1	9.7	36.4	72.8	88.2	44.9	40.7	53.8	46.2	25.9	23.8	17.8	16.5	6.2	5.6	10.5	19.4	8.4	14.5	14.0	22.1	8.3	16.1	31.0	7.2	13.3	12.2	11.7	4.6	34.3	52.0	41.8	29.3	19.0	10.1	19.5	24.6	7.6	7.9	9.4	4.4	11.8	18.9	24.5	8.7	18.2	29.5	76.2	17.0	36.6	27.0	18.5	27.0	10.4	12.8	22.4	26.4	18.7	9.4	21.7	12.0	23.4	19.9	20.1	16.1	31.1	31.1	31.6	29.7	21.7	21.5	25.0	24.7	52.2	43.4	88.2	42.0	44.9	39.2	35.6	41.5	42.1	39.7	36.4	33.1	37.2	26.8	40.7	41.7	72.8	53.8	46.2	40.0	38.8	27.4	66.0	38.0	35.2	38.7	37.2	57.3	15.0
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA054483: , HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favourable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favourable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.1	17.8	18.6	12.7	12.8	10.7	9.9	10.4	11.9	12.8	13.1	9.0	11.3	4.6	30.4	10.7	10.8	16.5	18.3	15.8	11.5	37.1	7.8	21.2	23.4	7.1	12.3	6.6	7.2	10.1	13.9	4.8	12.9	13.1	20.2	9.5	18.3	10.7	20.7	13.3	16.1	10.7	14.8	13.4	16.2	10.6	11.9	21.3	12.2	5.7	10.7	8.8	11.2	13.0	5.8	8.9	15.9	7.5	6.9	7.5	7.6	16.7	12.3	6.3	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1"	ENSG00000254093	"PIN2/TERF1 interacting telomerase inhibitor 1"	Q96BK5	8	10764963-10839884	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023139, HPA023146"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA023139: AB_1855384, HPA023146: "	"unprognostic (4.01e-1)"	"prognostic favourable (2.45e-5)"	"unprognostic (7.80e-3)"	"unprognostic (3.35e-2)"	"unprognostic (4.10e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.40e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	14.3	14.4	9.9	16.0	13.9	14.8	13.8	14.5	16.5	12.6	14.2	12.6	7.1	11.5	15.7	8.9	19.3	10.7	9.3	11.7	10.6	10.1	13.1	19.4	11.2	19.2	13.2	10.9	16.1	17.2	7.6	10.7	13.3	17.6	11.4	12.0	15.6	14.9	8.5	21.2	19.0	11.3	15.9	11.1	14.8	11.7	24.0	9.7	18.7	12.4	17.8	19.6	11.5	14.3	9.8	8.8	4.4	8.4	8.9	16.0	8.4	6.5	8.8	9.6	9.0	8.1	6.6	11.0	10.0	4.5	11.1	7.5	9.3	5.8	17.7	3.5	5.4	13.3	24.2	18.6	14.4	7.2	7.2	7.4	6.2	10.0	9.1	7.9	4.6	5.5	11.8	8.7	16.4	15.3	23.5	11.0	10.8	7.8	25.9	9.9	21.9	9.9	21.2	11.7	16.1	8.2	8.1	7.9	8.3	6.7	8.0	22.1	8.5	9.9	9.3	6.7	14.5	8.5	12.9	4.9	12.9	32.2	6.9	15.0	15.1	1.5	6.8	4.4	12.5	8.4	16.0	9.7	10.9	13.1	8.8	9.8	15.0	11.6	0.4	8.9	7.3	6.8	12.3	8.4	9.9	13.9	14.5	16.5	10.6	10.1	13.2	10.9	17.6	9.7
PIP4K2B	"PIP5K2B, PIP5KIIB, PIP5KIIbeta"	ENSG00000276293	"Phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	P78356	17	38765689-38800126	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 23.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047875, HPA062220"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA047875: , HPA062220: "	"unprognostic (7.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (4.54e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.79e-1)"	"unprognostic (4.82e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (1.36e-4)"	"unprognostic (2.48e-1)"	5.1	6.5	12.4	3.3	12.9	1.1	5.0	8.8	17.4	6.8	2.7	7.0	4.2	2.2	7.2	5.9	3.5	7.4	3.6	7.1	9.6		4.1	2.2	5.0	4.2	5.4	13.3	13.3	3.0	5.1	2.7	5.4	7.5	5.1	3.2	4.1	3.8	6.5	23.6	5.8	2.3	7.3	4.7	5.1	2.5	2.8	6.5	2.0	4.7	2.2	4.5	3.7	5.9	3.3	3.1	2.4	2.4	3.4	5.0	3.7	5.9	13.1	21.8	22.7	19.1	15.2	4.5	11.1	12.4	14.1	11.5	8.8	5.9	15.2	7.0	19.0	12.8	14.4	9.2	13.6	10.5	9.3	13.2	8.5	13.0	8.7	15.1	8.1	13.3	11.3	11.0	8.1	11.6	11.5	7.2	15.1	4.5	13.8	11.0	12.2	6.1	15.0	21.6	8.3	10.3	7.4	12.2	17.7	11.2	4.6	11.3	14.4	14.3	12.3	11.9	7.9	10.2	9.6	9.5	11.9	6.9	14.1	11.9	10.7	1.6	2.4	0.8	4.8	2.2	5.0	3.1	4.1	4.6	3.1	3.3	4.7	4.2	2.4	3.4	1.8	3.0	3.9	3.7										
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	18.1	19.5	15.7	15.4	21.0	9.6	20.2	22.6	27.6	19.8	18.0	20.3	14.7	16.4	24.8	22.6	20.7	19.4	20.7	18.9	17.3	13.4	17.8	18.3	21.7	17.1	12.7	17.5	20.4	16.6	21.8	25.3	44.6	14.6	17.3	15.6	29.5	17.8	15.2	26.1	20.4	20.4	27.2	16.1	20.1	16.8	42.1	14.0	19.3	20.1	13.9	22.3	16.2	17.7	9.1	8.7	11.7	6.2	4.7	5.9	6.3	17.7	13.8	21.4	24.6	14.1	14.9	21.0	23.4	33.0	43.8	39.3	25.1	17.2	16.1	25.0	24.9	15.1	27.7	16.1	38.4	24.3	19.8	12.8	18.2	11.9	26.7	22.9	16.2	19.9	14.9	27.2	34.5	17.8	12.5	13.8	22.0	24.8	22.8	11.4	31.7	21.4	22.1	18.7	12.0	22.5	10.3	14.3	19.0	31.6	24.4	20.6	25.5	21.7	17.0	17.4	24.4	16.0	28.1	19.3	32.1	36.4	16.9	6.7	20.8	0.1	5.5	7.3	5.3	6.2	4.1	9.1	5.0	5.9	8.4	4.6	5.4	4.2	11.7	4.7	4.8	8.7	3.9	6.3	15.7	21.0	22.6	27.6	17.3	13.4	12.7	17.5	14.6	14.0
PIP5KL1	"bA203J24.5, MGC46424"	ENSG00000167103	"Phosphatidylinositol-4-phosphate 5-kinase like 1"	Q5T9C9	9	127920879-127930797	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Karpas-707: 28.9;RPMI-8226: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 1.2;MAIT T-cell: 1.0;memory B-cell: 1.0;myeloid DC: 1.0;naive B-cell: 2.4;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA056240	Uncertain		Supported	Cytosol				Cytosol		"HPA056240: "	"unprognostic (2.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.51e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.95e-8)"	"unprognostic (1.87e-1)"	"unprognostic (7.21e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.59e-1)"	0.6	0.7	3.1	0.6	1.0	1.4	2.5	2.4	5.3	2.1	0.6	1.9	0.6	0.5	1.3	0.6	3.7	1.8	1.2	0.6	2.1	2.9	1.3	0.6	2.9	0.6	1.4	2.6	0.7	1.3	6.5	4.8	1.6	8.3	3.3	0.2	1.0	8.7	4.1	0.6	4.7	0.6	1.0	1.5	0.6	2.4	2.5	1.2	0.6	2.9	0.6	0.6	1.2	4.0	2.4	1.3	0.0	1.2	0.0	1.0	0.3	0.0	0.4	0.4	0.5	0.5	1.3	2.7	0.6	0.5	0.1	0.1	0.2	3.5	0.3	1.1	2.3	1.1	0.0	2.6	0.1	0.3	1.7	0.0	0.8	0.0	0.8	0.0	0.1	1.4	1.7	0.3	0.0	0.0	0.0	28.9	0.0	2.4	0.0	1.0	0.2	0.4	0.2	0.0	18.9	0.0	0.0	0.9	1.7	0.1	0.7	0.0	1.0	1.3	0.3	0.3	1.0	0.6	0.1	2.6	1.7	0.6	5.2	0.4	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.0	0.1	0.0	1.0	2.4	0.2	0.1	0.0	0.0	0.1	1.3	0.0	0.3	3.1	1.0	2.4	5.3	2.1	2.9	1.4	2.6	8.3	1.2
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 117.9;SK-MEL-30: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol				Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favourable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	20.9	16.1	14.1	5.9	16.8	5.7	26.5	8.5	13.5	8.1	7.5	14.0	21.8	7.7	11.2	18.8	20.7	16.2	13.4	14.0	11.7	12.1	13.9	23.7	18.6	8.6	20.8	9.8	13.0	2.6	5.4	9.1	12.1	15.6	12.1	8.3	25.0	7.5	18.0	9.8	13.7	6.9	24.6	26.0	15.5	13.8	7.2	14.4	1.3	12.1	19.9	9.1	26.5	11.7	0.0	0.5	1.0	0.5	0.0	2.2	0.3	2.3	13.0	7.8	11.5	4.6	5.2	2.5	0.7	4.5	1.9	4.3	3.6	20.4	0.0	25.9	2.0	16.6	9.1	3.6	0.7	0.0	2.0	1.4	14.7	10.5	6.0	0.7	5.2	1.5	12.6	7.3	2.5	117.9	1.0	3.3	1.6	4.9	0.5	0.6	8.4	8.2	0.0	1.5	6.4	3.8	23.0	3.0	8.3	6.3	3.5	44.3	7.3	4.5	7.3	1.0	1.9	4.9	1.4	1.5	6.4	0.0	5.0	2.6	10.3	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.3	14.1	16.8	8.5	13.5	11.7	12.1	20.8	9.8	15.6	14.4
PITPNM1	"DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1"	ENSG00000110697	"Phosphatidylinositol transfer protein membrane associated 1"	O00562	11	67491768-67506263	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060227	Approved		Supported	"Cytosol,Cytoplasmic bodies"				"Cytosol, Cytoplasmic bodies"		"HPA060227: "	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.68e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.69e-2)"	6.5	14.3	20.1	19.6	17.6	20.4	3.5	23.2	30.7	6.0	12.1	6.4	11.0	16.0	7.0	7.2	10.0	20.5	8.0	10.6	16.6	21.6	14.7	7.3	8.6	21.9	17.8	14.2	3.0	6.4	9.3	15.0	6.9	18.6	5.6	6.7	15.6	5.2	9.9	4.6	3.5	17.7	5.2	6.3	15.2	13.6	4.9	8.0	9.3	11.1	4.5	14.6	12.1	4.7	1.6	2.1	2.9	6.8	0.2	2.5	2.0	5.6	14.3	8.8	6.4	9.7	5.8	14.3	5.6	9.9	6.9	3.9	12.8	10.4	5.6	13.5	7.9	14.8	6.7	12.3	2.3	40.6	2.7	7.6	24.7	4.8	7.7	8.5	16.6	7.2	7.9	10.4	6.9	8.3	5.8	5.1	5.7	8.5	14.6	20.3	8.9	6.2	10.6	2.8	7.6	11.6	11.4	8.5	5.4	12.4	17.5	13.6	3.4	7.6	8.1	12.5	9.6	7.9	3.9	7.5	3.5	5.0	17.6	10.3	4.9	0.0	2.6	1.8	2.5	6.8	2.2	1.6	1.7	2.2	2.1	1.2	0.7	1.7	2.9	0.2	5.3	0.8	1.5	2.0	20.1	17.6	23.2	30.7	16.6	21.6	17.8	14.2	18.6	8.0
PITPNM2	"NIR3, RDGB2, RDGBA2"	ENSG00000090975	"Phosphatidylinositol transfer protein membrane associated 2"	Q9BZ72	12	122983480-123150015	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"lymphoid tissue: 169.5"	"Cell line enhanced"	"Detected in many"		"HEL: 16.5;MOLT-4: 30.5;WM-115: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 4.7;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003414, HPA003978"	Approved		Supported	Vesicles				Vesicles		"HPA003414: AB_1855410, HPA003978: AB_1855411"	"unprognostic (2.43e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.99e-2)"	3.4	5.9	3.3	3.2	7.9	3.5	3.1	9.3	8.0	3.9	3.5	2.4	3.2	3.5	3.6	5.2	3.7	2.5	2.2	4.6	2.8	2.2	3.7	4.3	5.1	6.1	2.4	2.6	14.0	2.5	5.3	4.2	3.0	2.3	2.7	1.6	3.7	2.7	3.1	3.3	3.0	3.6	4.5	2.5	3.3	2.7	14.8	2.2	169.5	2.3	2.2	4.3	4.7	2.7	0.8	0.0	0.1	0.1	4.7	2.3	1.6	2.5	5.0	1.6	2.3	1.2	2.2	9.8	0.4	0.6	1.3	0.7	2.2	2.1	0.0	2.2	0.8	7.3	1.3	1.2	0.5	0.1	1.6	16.5	2.9	5.9	0.8	0.6	3.5	1.1	2.2	1.7	1.4	2.6	3.7	0.2	1.6	1.6	30.5	3.4	1.9	2.2	8.8	0.1	6.3	2.4	2.7	1.5	0.5	3.6	3.0	2.4	0.6	1.8	7.6	1.9	2.2	3.1	2.8	0.5	0.5	11.7	4.8	1.2	14.7	0.0	0.0	0.1	2.3	0.0	0.2	0.4	0.6	1.7	0.0	0.8	1.5	1.4	0.0	4.7	0.1	0.0	1.1	1.6	3.3	7.9	9.3	8.0	2.8	2.2	2.4	2.6	2.3	2.2
PITRM1	"hMP1, KIAA1104, MP1, PreP"	ENSG00000107959	"Pitrilysin metallopeptidase 1"	Q5JRX3	10	3137728-3172841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006753, HPA006754"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA006753: AB_1079624, HPA006754: AB_1079623"	"unprognostic (1.83e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.08e-2)"	26.7	39.4	22.7	20.4	34.4	31.0	21.5	29.7	47.8	21.6	23.4	29.8	19.1	19.1	27.6	27.2	25.0	21.3	23.7	41.0	22.1	19.3	28.8	47.1	23.6	21.2	22.9	25.6	35.3	25.7	31.2	26.0	17.8	38.8	27.2	22.4	29.2	25.1	23.8	62.0	28.0	25.3	26.3	19.1	18.9	21.6	41.6	20.4	48.6	28.7	33.0	26.8	26.0	22.4	11.5	13.7	6.0	13.9	12.4	13.9	9.1	25.4	20.6	8.2	11.1	23.3	25.3	9.4	37.8	17.6	30.2	16.5	18.6	15.6	12.8	13.2	23.6	19.7	13.1	29.2	22.8	22.1	18.7	18.1	16.9	13.9	13.3	7.0	21.6	20.8	21.7	33.0	18.9	31.4	18.3	16.9	39.9	22.0	17.6	7.3	5.6	25.1	8.7	11.4	18.2	24.0	19.5	10.5	6.4	28.6	21.0	15.9	24.4	8.4	38.5	23.9	6.7	58.4	18.1	13.6	14.2	13.3	36.5	12.9	11.7	6.0	9.4	4.9	13.1	12.0	12.9	11.5	11.3	12.2	13.7	6.8	12.1	13.9	1.4	12.4	13.9	7.6	13.8	9.1	22.7	34.4	29.7	47.8	22.1	19.3	22.9	25.6	38.8	20.4
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.4;retina: 53.5;skeletal muscle: 28.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 17.7;HEK 293: 7.8;LHCN-M2: 18.2;RH-30: 15.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"hypothalamus: 2.1;midbrain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 9.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 5.1"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA050074: , HPA062728: "	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.6	0.1	0.0	18.6	0.0	0.1	0.3	0.0	0.1	1.1	3.0	0.0	0.3	0.1	0.1	1.3	2.7	0.2	1.1	3.5	0.0	2.1	0.3	0.1	0.1	0.1	1.1	0.0	0.1	0.5	0.1	12.5	30.4	0.0	8.3	0.3	53.5	9.3	0.2	28.8	0.9	3.4	15.9	0.0	0.1	0.5	0.3	0.0	0.0	0.1	16.8	0.4	19.4	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	1.8	0.0	0.7	1.8	1.5	2.9	0.6	0.3	2.0	1.5	17.7	0.0	0.0	3.8	3.6	0.3	0.1	0.0	1.1	0.0	7.8	0.0	1.4	0.0	6.6	0.0	3.7	2.0	0.1	0.3	0.0	0.0	0.4	0.0	18.2	0.5	1.9	0.0	0.3	0.3	0.0	15.3	0.0	0.3	2.4	0.0	0.0	1.4	2.4	0.2	0.1	0.0	0.0	2.4	5.8	0.0	2.9	0.0	0.1	0.7	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334709-109409994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: "	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	21.6	27.0	40.1	15.9	49.9	29.0	22.1	41.6	63.0	29.0	23.8	19.7	16.8	12.5	29.2	25.0	20.7	20.3	18.6	24.4	44.3	46.2	24.1	29.2	19.4	14.3	36.8	44.0	35.4	14.8	42.8	30.3	21.8	53.2	31.7	20.6	12.5	17.3	37.7	17.1	13.6	15.9	39.2	37.6	19.5	15.8	17.0	27.4	16.7	35.9	9.7	16.3	35.5	21.4	10.3	11.7	29.9	15.5	10.7	12.2	10.6	11.8	8.2	33.1	25.4	32.9	36.1	18.0	19.4	29.4	15.4	25.3	7.6	16.1	15.2	27.0	37.3	6.9	19.3	24.0	28.3	12.9	7.3	17.5	16.8	10.2	23.3	13.1	26.2	24.8	20.1	20.6	29.6	24.5	12.0	28.7	24.8	7.2	15.7	12.1	6.6	5.5	10.2	29.1	25.3	24.0	10.6	6.3	16.3	20.0	7.3	23.4	16.5	19.4	28.2	21.9	10.7	20.2	9.1	19.4	16.5	18.0	23.2	18.3	14.4	17.3	11.6	17.3	9.5	12.2	9.4	10.3	9.4	8.7	11.7	7.4	12.1	8.9	29.9	10.7	15.5	4.9	12.2	10.6	40.1	49.9	41.6	63.0	44.3	46.2	36.8	44.0	53.2	27.4
PJVK	DFNB59	ENSG00000204311	Pejvakin	Q0ZLH3	2	178451346-178461409	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042621			Supported	Mitochondria				Mitochondria		"HPA042621: AB_10797503"	"unprognostic (4.01e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.06e-3)"	2.2	1.4	2.5	1.0	3.5	0.7	4.4	1.3	3.7	2.1	1.5	1.2	3.5	0.7	3.5	7.2	2.2	2.6	2.6	1.0	2.7	2.2	2.1	2.2	1.0	1.3	2.8	4.4	7.0	1.0	1.4	3.9	1.0	2.0	2.3	0.9	2.4	2.1	2.7	2.7	3.5	1.3	1.7	2.7	1.0	0.9	35.2	1.3	1.0	2.3	1.7	1.2	1.6	1.2	1.5	6.5	0.6	0.3	0.4	1.3	0.1	0.4	3.1	4.0	3.2	5.4	5.9	2.1	2.5	2.5	2.3	3.5	1.2	5.2	3.6	2.6	1.5	1.5	2.9	1.6	1.5	1.1	1.1	1.1	4.3	0.7	5.2	0.9	0.3	5.5	3.9	2.6	5.6	2.6	0.6	2.2	2.6	0.5	3.4	2.2	4.8	1.3	4.4	3.0	2.1	3.6	1.6	2.8	2.4	1.2	0.6	1.0	1.2	1.0	1.7	2.6	1.0	0.8	0.3	7.3	4.5	1.1	1.2	2.0	1.0	0.0	0.3	0.0	0.3	0.2	0.4	0.8	0.4	0.2	0.1	1.5	1.3	0.7	0.6	0.4	0.0	6.5	0.0	0.1	2.5	3.5	1.3	3.7	2.7	2.2	2.8	4.4	2.0	1.3
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007668-88077777	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 36.5;BJ hTERT+: 55.4;fHDF/TERT166: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB004544: AB_672377, HPA015794: AB_1855437"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	18.4	13.6	8.2	7.7	10.9	5.0	15.1	15.1	10.7	31.4	19.4	15.5	18.5	5.6	42.7	9.8	13.9	25.7	15.3	12.8	9.0	5.2	27.5	7.9	13.4	5.5	12.6	6.4	27.0	9.8	21.9	8.1	12.8	9.2	15.6	7.3	14.1	7.4	22.3	5.4	6.2	9.6	29.3	7.2	5.4	14.8	9.9	12.0	5.5	10.2	3.3	4.9	13.9	21.4	0.5	1.3	4.8	0.8	1.0	1.4	0.4	1.9	10.8	12.2	6.2	28.2	18.9	3.6	36.5	55.4	17.1	17.1	0.5	3.4	1.0	8.0	43.9	2.4	2.1	5.4	15.0	5.5	1.9	1.7	5.5	1.1	15.7	4.1	3.5	15.6	2.4	13.4	7.2	7.7	0.2	2.9	14.9	3.7	2.9	2.0	6.3	1.8	5.6	7.2	1.5	15.2	4.5	2.4	5.5	6.7	0.3	8.6	2.6	3.1	11.8	16.2	3.5	4.5	4.9	2.3	0.7	1.1	9.6	0.6	14.8	4.8	0.5	0.9	0.8	0.8	1.4	0.5	0.8	0.6	0.3	0.5	0.9	0.6	0.9	1.0	0.3	1.3	0.4	0.4	8.2	10.9	15.1	10.7	9.0	5.2	12.6	6.4	9.2	12.0
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 102.0;HSkMC: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 58.2;naive B-cell: 62.1"	"Lineage enriched"	"Detected in many"	10	"B-cells: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: "	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	21.1	25.1	39.2	22.7	31.9	7.5	18.4	12.9	37.7	28.0	44.0	13.5	15.4	12.5	31.8	19.3	31.7	31.4	29.3	107.1	23.0	17.2	22.9	14.4	39.0	17.9	16.7	25.9	17.2	13.3	13.8	19.5	32.6	14.3	30.2	13.3	26.2	18.8	32.5	25.6	8.0	17.9	52.8	11.9	13.2	24.1	41.5	11.4	3.2	25.8	18.6	18.2	42.2	20.3	62.1	6.2	0.4	0.3	0.7	1.6	3.1	5.1	5.3	8.7	5.6	13.1	26.8	1.2	12.5	102.0	14.2	10.7	12.2	2.4	20.1	10.3	10.9	2.0	1.7	2.7	4.6	10.1	3.2	3.1	0.8	8.6	12.2	0.4	0.2	41.4	5.5	6.9	1.5	31.6	2.4	0.5	1.3	6.6	3.1	5.1	4.6	7.7	0.5	0.2	0.4	7.8	1.0	3.5	11.5	3.2	1.5	8.4	4.0	2.5	20.4	19.5	8.7	8.6	6.0	2.7	7.5	14.1	9.7	0.3	8.3	0.4	0.3	0.1	0.2	0.2	0.2	58.2	0.3	0.3	1.5	62.1	1.0	1.6	0.4	0.7	0.2	6.2	0.1	3.1	39.2	31.9	12.9	37.7	23.0	17.2	16.7	25.9	14.3	11.4
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol			540000000	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (1.30e-4)"	"prognostic unfavourable (2.74e-6)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.5	209.8	42.3	50.0	50.9	57.2	35.0	88.5	206.7	142.1	143.9	59.0	100.5	62.1	89.6	165.6	118.9	133.7	180.0	111.4	109.0	63.2	38.0	105.5	48.8	35.5	49.3	82.0	51.9	83.9	109.5	45.0	83.6	9.5	49.8	224.1	50.7	18.4	21.2	52.3	80.1	54.7	135.4	118.3	188.7	105.0	44.0	48.0	115.4	71.2	90.5	49.9	35.9	65.1	161.9	88.6	158.2	160.5	64.0	90.4	54.7	199.3	81.6	158.6	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA068860: "	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (8.33e-4)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	0.9	0.7	0.7	9.4	0.6	19.5	1.3	2.6	0.8	1.3	2.9	0.3	0.5	1.9	0.8	1.5	7.2	0.2	1.5	1.4	0.7	0.7	0.8	1.0	1.3	6.2	0.8	0.2	0.3	1.3	0.0	0.7	4.3	0.4	0.6	0.8	0.3	1.3	0.2	1.6	3.4	3.2	0.6	1.0	4.4	2.7	61.4	0.2	42.8	0.3	9.2	12.7	0.7	2.0	0.8	0.4	0.3	0.5	0.4	4.4	1.0	24.6	17.3	6.8	9.7	0.1	0.3	18.3	19.2	4.6	12.2	11.7	13.4	14.7	15.4	8.6	2.1	31.7	4.7	6.1	2.2	19.8	15.6	7.8	15.6	11.7	0.0	8.7	22.3	0.2	0.5	7.2	1.9	2.5	22.4	27.4	3.9	37.0	24.4	24.2	11.1	9.2	26.6	15.1	29.8	2.3	5.4	12.9	13.6	9.3	24.2	7.2	13.8	17.4	2.3	16.4	20.8	23.9	20.0	20.8	15.4	26.5	6.2	11.7	19.0	0.0	0.4	0.3	0.3	0.3	0.0	0.8	0.5	0.5	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.1	4.4	1.0	0.7	0.6	2.6	0.8	0.7	0.7	0.8	0.2	0.4	0.2
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	"Protein kinase N1"	Q16512	19	14433053-14471867	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003982, CAB010278"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	"unprognostic (3.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.24e-2)"	28.8	19.5	19.1	27.6	26.7	39.6	25.3	21.9	19.2	19.2	26.0	20.9	16.5	10.0	25.4	19.7	16.6	22.2	22.5	38.3	17.1	17.6	17.9	16.3	27.9	42.2	19.5	16.3	21.7	32.3	15.8	18.7	22.7	19.2	22.6	6.9	21.5	22.6	22.7	43.2	7.6	16.9	22.5	19.4	39.7	24.2	21.5	18.9	39.2	17.8	13.8	24.0	22.1	30.5	11.5	17.0	24.1	30.6	13.5	20.7	15.2	37.2	22.2	8.3	17.2	13.4	15.8	13.7	13.4	16.1	14.2	13.6	8.6	21.4	35.6	34.8	23.0	8.6	13.2	6.0	5.5	28.8	17.1	42.6	14.2	18.4	44.5	16.7	26.8	11.4	4.3	8.6	13.5	32.9	18.8	24.7	10.4	15.3	25.2	15.5	15.0	25.4	33.9	11.3	25.6	7.0	6.1	30.2	42.8	8.3	10.6	21.7	9.6	29.2	49.2	28.3	12.1	34.1	20.3	32.5	29.6	19.4	18.5	33.6	22.1	15.4	17.3	24.1	20.7	24.2	15.7	10.7	14.0	14.2	17.0	11.5	13.1	14.3	21.3	13.5	30.6	11.1	15.9	15.2	19.1	26.7	21.9	17.3	17.1	17.6	19.5	16.3	19.2	18.9
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"				"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: , HPA057913: "	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.3	9.2	18.2	10.9	12.2	13.9	11.8	13.8	12.8	15.6	16.2	9.7	16.8	9.2	16.5	13.1	18.4	17.7	10.5	21.3	3.3	12.9	6.8	19.0	8.3	10.7	6.7	2.0	11.4	11.0	12.2	14.8	17.7	11.3	6.7	16.7	4.7	7.7	5.8	9.1	10.7	7.4	27.7	3.8	13.8	46.0	8.8	5.8	20.7	12.0	17.8	8.9	6.1	16.5	13.2	11.9	16.9	14.4	3.7	3.2	6.3	5.5	6.6	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2
PKNOX1	PREP1	ENSG00000160199	"PBX/knotted 1 homeobox 1"	P55347	21	42974510-43033931	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004285, HPA057215, HPA065017"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB004285: AB_2164128, HPA057215: , HPA065017: "	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (4.54e-8)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (3.67e-2)"	"prognostic favourable (6.71e-4)"	"unprognostic (9.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.31e-3)"	6.8	6.4	7.9	8.7	9.2	3.9	7.3	24.2	9.1	12.3	8.3	9.9	9.0	5.0	14.3	9.8	7.4	10.0	8.4	6.1	7.2	7.9	6.7	6.6	6.9	8.1	10.7	5.4	14.4	15.7	6.9	13.3	11.9	8.6	8.7	6.9	5.4	7.1	12.4	11.7	9.2	6.1	15.2	7.6	7.5	6.6	42.9	10.1	12.2	16.4	5.8	7.6	9.3	18.2	4.9	3.3	10.1	4.9	4.0	7.6	4.1	8.7	3.1	4.1	3.9	7.7	11.7	5.1	11.2	7.8	6.9	5.9	5.3	6.8	12.2	9.4	9.8	4.7	9.2	7.1	9.0	8.4	7.6	7.2	5.8	5.0	8.0	6.5	5.8	8.9	11.8	8.5	6.9	6.5	5.7	9.2	15.5	5.2	6.1	7.3	6.3	6.8	9.8	18.4	6.7	13.4	7.0	13.1	7.9	8.0	5.8	7.7	4.9	8.3	7.7	10.8	5.4	5.9	7.2	5.3	6.0	6.4	13.5	11.7	5.6	0.4	3.7	2.7	7.2	4.9	7.6	4.9	5.2	5.9	3.3	4.1	6.4	5.6	10.1	4.0	3.3	3.0	5.3	4.1	7.9	9.2	24.2	9.1	7.2	7.9	10.7	5.4	8.6	10.1
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 26.7;AN3-CA: 6.6;hTEC/SVTERT24-B: 5.3;LHCN-M2: 7.8;SK-MEL-30: 5.3;WM-115: 14.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: , HPA055368: , HPA066962: "	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	5.8	4.1	10.0	3.3	12.4	0.7	1.7	16.3	25.7	5.1	2.8	3.6	0.2	2.0	5.6	4.7	2.7	9.8	3.4	7.9	7.3	6.9	2.9	1.1	9.6	2.4	5.2	12.3	23.6	6.3	0.9	7.3	12.8	6.9	10.2	2.8	24.3	2.5	8.7	19.5	4.0	2.4	4.6	4.6	3.4	2.5	7.2	3.1	0.0	18.3	8.4	2.2	3.3	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	26.7	6.6	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	7.8	0.2	0.0	0.0	2.6	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.4	16.3	25.7	7.3	6.9	5.2	12.3	6.9	3.1
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790745-32896840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 134.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 60.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 22.1"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	3.1	0.7	1.4	7.9	5.2	1.1	3.3	2.2	1.8	6.1	14.2	1.4	6.9	6.5	1.2	2.0	3.3	21.6	4.4	134.7	3.9	0.9	3.6	13.6	1.1	3.4	0.7	2.0	9.5	5.4	9.6	14.7	24.1	3.8	3.5	13.3	12.6	24.6	5.0	3.4	1.9	13.3	1.3	1.3	2.4	4.8	3.4	0.4	2.7	0.6	2.3	4.3	2.0	2.1	0.6	3.9	10.4	2.1	1.5	1.0	0.6	16.9	3.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.7	15.3	0.0	10.4	0.0	15.1	2.1	13.4	0.0	0.0	4.8	0.1	0.7	15.9	9.5	0.9	0.2	0.0	12.7	0.0	14.7	0.5	3.0	4.8	1.4	4.4	0.0	0.1	9.3	2.9	0.0	7.4	5.0	4.5	8.0	1.9	1.6	0.7	3.5	0.0	7.7	0.2	0.1	0.0	6.8	0.0	4.1	4.0	0.0	0.1	0.0	0.0	0.8	5.1	1.4	10.4	0.4	1.6	1.0	0.2	0.6	0.4	3.9	0.6	0.9	0.5	1.2	1.5	2.1	0.8	0.6	0.6	1.4	5.2	2.2	1.8	3.9	0.9	0.7	2.0	3.8	0.4
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell line enhanced"	"Detected in many"		"A-431: 37.0;CAPAN-2: 26.0;HaCaT: 50.0;hTCEpi: 32.7;MCF7: 23.3;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: "	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.0	7.2	0.0	0.1	0.0	0.0	15.5	0.3	0.2	0.8	0.4	14.7	26.0	0.0	1.5	0.2	50.0	0.0	18.9	0.1	0.0	9.3	0.0	4.3	10.2	0.1	0.0	0.0	0.1	32.7	0.1	8.0	0.1	11.0	0.2	0.1	23.3	0.1	0.0	0.0	12.5	0.1	0.0	0.1	0.4	7.4	10.6	0.1	10.7	37.9	0.0	13.7	0.1	1.3	0.2	1.3	0.6	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456964-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 111.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"				"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: , HPA070648: "	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favourable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	7.3	3.9	42.7	3.7	42.1	4.2	15.5	14.5	26.6	19.8	7.1	49.9	6.9	7.1	8.3	8.9	10.7	11.8	8.9	12.1	47.7	31.2	34.2	9.7	7.3	3.0	66.9	14.7	8.3	8.7	12.2	6.6	3.4	28.4	7.8	8.1	10.4	19.3	13.1	4.0	9.4	6.4	8.5	111.7	3.2	7.7	5.6	31.6	3.3	18.2	2.4	5.5	9.1	6.9	0.1	0.7	1.0	5.3	0.0	2.1	0.5	16.5	9.2	12.7	14.4	5.9	6.4	12.1	13.8	7.4	20.8	18.1	30.9	15.7	10.6	10.3	16.0	13.4	16.4	13.8	34.9	15.9	8.4	10.0	10.4	25.2	9.9	15.8	2.2	2.8	13.3	14.3	21.9	10.5	13.6	16.9	15.8	18.3	6.9	6.8	13.5	7.0	9.2	19.0	9.1	30.8	12.0	22.2	3.9	9.6	14.4	11.3	17.1	14.5	4.8	12.5	14.0	9.2	17.3	9.7	8.1	7.8	7.3	8.7	12.1	0.0	1.0	0.0	0.4	0.3	0.7	0.0	1.5	0.6	0.4	0.1	1.2	0.4	1.0	0.0	5.3	0.7	2.1	0.5	42.7	42.1	14.5	26.6	47.7	31.2	66.9	14.7	28.4	31.6
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261062	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"		20000000	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	23.8	9.1	9.6	6.6	9.4	5.6	19.7	16.4	16.1	5.4	6.2	10.0	4.7	5.0	7.7	11.2	5.7	7.2	8.5	31.3	7.9	8.6	24.1	11.8	15.9	23.1	7.5	9.2	7.4	6.4	11.3	9.2	24.4	7.7	6.2	5.7	8.5	7.6	5.8	39.9	10.0	5.3	8.2	6.8	16.2	6.2	9.3	6.2	11.3	10.4	6.8	4.9	9.1	5.0	3.7	8.8	9.4	18.2	1.3	4.5	7.7	4.7	5.0	4.0	12.7	19.2	14.1	9.3	11.8	15.7	17.8	15.0	11.7	8.8	8.6	14.8	16.7	7.3	4.3	5.0	8.2	2.4	6.5	2.5	4.9	9.3	10.3	2.3	12.7	9.6	5.7	17.8	2.8	10.8	3.6	4.6	11.4	10.2	3.2	7.0	2.5	5.8	4.7	5.8	26.6	8.9	4.4	1.3	2.6	15.7	4.7	9.7	12.3	11.5	8.8	15.5	7.6	20.1	7.3	17.2	14.6	10.4	14.2	6.6	5.9	9.4	14.4	9.3	3.1	16.8	3.2	3.3	3.4	4.5	8.8	3.7	4.5	3.7	0.6	1.3	18.2	7.8	3.2	7.7	9.6	9.4	16.4	16.1	7.9	8.6	7.5	9.2	7.7	6.2
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828953-186988981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1"	"Cell line enhanced"	"Detected in many"		"A549: 16.7;HeLa: 24.3;RPMI-8226: 30.2;U-2197: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Cytosol			78000	Cytosol		"CAB010050: AB_631312, HPA050062: , HPA054206: "	"prognostic favourable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	6.0	8.6	3.4	3.5	5.3	2.2	3.8	1.5	4.7	8.5	10.9	2.9	52.6	5.4	7.7	7.4	7.0	12.3	4.2	6.6	3.3	2.5	6.7	1.1	4.9	5.2	6.5	1.4	5.1	3.8	63.5	2.7	2.9	5.6	10.9	4.2	2.9	5.8	56.1	0.6	6.1	10.3	14.6	7.5	4.2	5.1	2.7	5.3	0.4	2.7	5.9	2.3	19.4	9.4	0.0	7.8	7.7	8.4	1.1	0.2	1.5	0.0	16.7	0.0	0.0	10.5	4.2	0.0	0.6	6.4	0.8	1.4	0.1	6.6	0.0	0.0	0.0	1.2	10.4	3.1	0.3	5.1	0.2	3.1	24.3	0.0	6.5	4.5	1.6	2.3	2.2	8.4	1.7	7.0	6.8	2.5	0.0	0.0	0.0	0.0	0.9	2.2	0.0	0.0	30.2	0.0	2.3	0.1	0.0	2.5	0.8	2.9	0.3	6.2	1.4	6.2	0.8	28.5	1.3	1.0	0.0	0.0	2.3	13.6	8.8	0.1	7.1	7.7	0.0	8.4	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.6	1.1	3.9	3.2	0.0	1.5	3.4	5.3	1.5	4.7	3.3	2.5	6.5	1.4	5.6	5.3
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26904083-26947463	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			5300	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favourable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	13.6	20.1	9.4	12.4	13.1	29.6	11.9	12.9	18.0	13.4	12.3	11.1	13.5	10.5	15.6	12.8	16.2	10.8	13.6	26.2	10.1	10.2	15.0	19.6	14.4	16.4	9.6	10.9	12.3	12.9	15.0	10.0	17.4	13.4	12.1	13.1	9.5	13.4	11.6	52.6	13.5	12.3	16.1	10.0	16.1	12.0	15.7	7.9	27.0	13.0	18.2	14.6	14.9	12.7	13.2	12.2	19.2	17.9	13.5	16.5	8.6	27.2	16.2	20.5	20.7	13.9	17.8	15.4	25.7	14.7	19.7	19.3	5.7	13.1	24.7	21.5	19.6	11.0	20.3	20.3	21.8	32.5	8.6	15.3	26.6	10.9	14.2	12.3	20.9	15.8	12.2	24.0	17.6	19.6	9.3	25.1	21.1	11.4	23.7	12.0	29.7	14.1	16.9	12.9	14.6	15.3	16.4	13.2	22.5	13.8	16.3	8.0	11.3	9.5	23.7	0.0	24.4	12.7	20.7	8.3	17.9	25.7	13.9	17.6	10.2	19.2	11.9	18.7	11.2	16.8	12.5	13.2	11.6	11.3	12.2	11.5	10.7	12.2	11.2	13.5	17.9	6.3	16.5	8.6	9.4	13.1	12.9	18.0	10.1	10.2	9.6	10.9	13.4	7.9
PLAG1	ZNF912	ENSG00000181690	"PLAG1 zinc finger"	Q6DJT9	8	56160904-56211324	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.0;ASC TERT1: 17.2;HSkMC: 12.2;hTERT-HME1: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA072290			Supported	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"				"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA072290: "	"unprognostic (1.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.14e-2)"	1.9	3.6	2.4	3.5	2.9	2.1	2.5	11.0	2.7	7.6	3.8	4.1	9.0	3.4	3.4	9.8	2.0	7.5	2.1	6.8	1.9	1.8	3.7	1.2	4.6	6.7	4.8	2.1	11.6	2.2	2.1	17.8	8.0	4.6	5.1	1.6	7.9	7.5	9.2	1.4	3.4	5.5	2.5	6.3	6.2	3.0	5.2	4.5	11.7	3.5	1.5	5.2	4.8	7.0	3.5	0.2	1.1	0.5	0.7	4.6	1.0	1.5	0.0	9.5	0.1	13.0	17.2	3.0	4.2	5.5	2.0	0.9	0.6	4.9	0.2	4.1	2.3	0.3	2.6	5.6	2.0	0.1	5.8	6.0	0.5	1.4	2.7	1.9	1.8	12.2	3.1	1.1	12.6	3.7	2.5	0.1	4.2	0.0	0.5	3.6	2.7	1.4	4.7	0.7	3.7	2.6	0.5	0.1	0.0	0.1	0.0	0.3	0.1	1.8	5.6	2.9	3.8	4.7	1.0	1.5	1.1	2.2	3.3	0.7	0.8	1.1	0.1	1.1	0.3	0.1	0.2	3.5	1.0	0.6	0.1	2.0	4.6	4.3	1.0	0.7	0.5	0.2	0.2	1.0	2.4	2.9	11.0	2.7	1.9	1.8	4.8	2.1	4.6	4.5
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 95.0"	"Cell line enhanced"	"Detected in many"		"AF22: 35.0;RH-30: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"				"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: "	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (4.94e-6)"	"prognostic unfavourable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	14.6	28.5	2.3	14.8	4.3	7.7	12.3	2.0	7.6	12.9	8.9	4.6	10.0	3.9	19.5	16.3	12.4	7.7	13.0	9.0	5.1	1.5	6.8	1.5	12.1	8.2	2.6	2.2	16.0	11.2	5.2	45.6	95.0	3.6	12.6	8.6	19.3	11.7	7.3	4.5	23.1	7.9	16.8	3.8	6.8	10.9	6.8	2.0	3.9	5.6	24.2	12.0	14.2	18.4	4.1	10.3	16.4	8.1	1.7	1.4	2.3	0.0	1.5	35.0	0.0	13.9	28.6	0.1	12.0	7.7	6.0	12.5	0.1	1.9	0.8	5.9	10.4	0.0	0.2	4.2	11.8	0.9	1.6	14.9	17.5	0.2	4.6	13.3	3.0	21.5	1.5	5.2	4.6	11.8	1.4	0.2	7.1	2.0	5.5	6.2	5.8	1.1	6.7	35.6	0.0	11.2	0.3	3.1	3.4	17.3	0.0	0.0	0.0	16.5	6.8	0.0	12.8	27.7	12.9	3.1	3.0	0.1	9.2	5.5	0.6	3.4	8.1	16.4	1.0	6.2	1.0	2.7	0.9	1.4	10.3	4.1	0.7	1.2	14.8	1.7	1.9	4.6	1.3	2.3	2.3	4.3	2.0	7.6	5.1	1.5	2.6	2.2	3.6	2.0
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 118.0;bone marrow: 165.0"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 49.4;U-251 MG: 70.2;U-87 MG: 61.3;WM-115: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 118.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"		760000	"Plasma membrane"		"CAB073533: , HPA050843: "	"unprognostic (9.28e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.59e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"prognostic unfavourable (2.33e-5)"	"unprognostic (8.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (7.83e-9)"	"unprognostic (4.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.33e-2)"	25.2	3.6	3.0	23.6	4.8	165.0	6.3	2.2	6.1	10.7	7.5	4.4	1.8	3.3	9.5	6.0	8.6	10.6	23.0	11.5	4.5	3.2	5.1	6.1	39.4	8.1	6.0	1.1	11.9	4.3	2.5	4.4	12.2	6.9	6.1	6.0	4.6	11.0	3.7	7.9	3.5	7.3	7.2	7.1	12.6	12.0	6.3	6.3	2.5	4.4	7.7	7.0	22.7	14.9	0.2	21.3	118.0	50.5	0.6	0.9	21.0	14.0	4.9	4.5	0.3	4.0	14.4	2.7	29.6	30.1	18.7	23.5	0.4	16.6	0.5	7.5	18.3	6.0	1.2	7.3	20.9	0.9	0.9	2.6	7.4	0.6	5.1	3.1	34.3	14.8	1.4	49.4	7.4	20.6	2.7	0.6	17.9	1.0	3.4	8.4	1.4	10.6	3.9	3.0	1.0	5.8	0.7	0.2	3.9	13.2	3.0	3.9	0.6	9.8	21.1	41.3	21.2	18.9	70.2	0.6	1.4	0.1	61.3	5.8	59.7	7.2	48.9	72.4	0.7	41.5	0.8	0.2	0.9	0.6	21.3	0.1	0.3	0.4	118.0	0.6	50.5	6.8	0.3	21.0	3.0	4.8	2.2	6.1	4.5	3.2	6.0	1.1	6.9	6.3
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251523-64269150	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"intestine: 77.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Enhanced	Nucleoplasm			94000	Nucleoplasm		"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	5.8	9.7	6.1	7.0	5.4	3.7	10.9	6.3	5.8	8.6	40.6	3.1	8.8	59.3	9.1	5.9	16.8	7.7	11.8	4.8	5.4	2.6	5.5	3.2	9.1	4.8	3.5	2.2	11.0	4.0	7.6	2.9	11.1	4.8	6.4	7.0	5.0	6.5	6.3	3.8	10.7	77.5	7.0	4.5	7.2	8.0	4.6	5.4	4.2	5.0	8.2	9.3	6.3	8.8	0.3	4.4	0.9	1.4	0.3	0.8	0.4	17.6	9.9	9.8	14.6	10.3	8.0	9.8	14.1	10.7	12.1	7.4	8.7	13.5	1.2	8.5	17.7	30.5	11.0	13.2	4.2	8.5	6.1	13.8	20.5	6.5	7.1	3.3	9.1	6.7	8.8	13.1	9.8	17.6	6.8	1.5	15.3	21.3	4.2	7.0	15.9	10.9	9.2	22.1	5.2	7.4	18.7	2.6	10.8	20.9	26.3	10.0	13.8	6.4	30.5	11.2	13.4	25.6	9.1	1.9	0.9	1.4	18.5	7.9	10.3	0.0	1.4	0.2	0.7	1.4	0.8	0.1	0.8	0.7	1.3	0.3	0.4	0.4	0.9	0.3	1.4	4.4	0.2	0.4	6.1	5.4	6.3	5.8	5.4	2.6	3.5	2.2	4.8	5.4
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	94030812-94332823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.6"	"Cell line enhanced"	"Detected in many"		"RT4: 18.7;U-2 OS: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol				Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.2	2.4	4.1	9.1	5.5	0.0	2.2	1.8	7.9	9.2	13.8	3.1	1.6	5.0	11.4	4.6	4.5	4.2	3.8	12.8	4.1	2.6	6.3	0.7	7.2	0.4	2.4	6.8	3.2	12.8	0.1	5.2	3.1	6.4	3.3	12.6	44.6	2.1	7.7	4.3	0.7	4.6	5.8	2.4	5.8	8.7	1.7	2.3	0.0	15.1	7.3	1.1	7.9	5.4	3.2	1.2	0.8	0.9	1.1	2.3	0.5	6.0	8.3	1.8	1.0	1.0	5.9	2.3	3.7	1.0	0.8	1.2	5.4	1.5	0.7	1.9	3.0	2.6	4.2	1.0	1.3	0.4	2.1	0.4	4.6	0.5	0.1	0.8	0.3	2.4	0.0	2.2	0.0	0.0	0.4	0.3	7.2	0.2	0.7	0.8	0.6	8.7	0.1	5.7	0.2	0.2	18.7	0.8	1.5	4.4	6.0	0.5	5.1	0.5	0.6	3.9	11.2	2.3	4.9	0.5	0.2	0.3	3.1	1.0	3.5	0.4	0.5	0.1	1.5	0.9	1.3	2.6	1.6	1.1	0.6	3.2	2.3	1.8	0.8	1.1	0.8	1.2	0.6	0.5	4.1	5.5	1.8	7.9	4.1	2.6	2.4	6.8	6.4	2.3
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 4.0;T-cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol				Cytosol		"CAB004277: AB_628119, HPA036681: , HPA036682: "	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	20.2	15.1	25.1	20.9	22.1	8.3	34.9	52.6	26.8	19.9	13.9	23.4	12.5	16.5	27.6	13.9	13.5	17.0	18.7	20.9	25.4	13.6	15.3	6.8	19.3	30.7	18.5	20.5	28.7	9.1	16.9	14.2	22.2	18.7	18.4	13.2	20.0	13.2	20.6	13.4	22.3	17.1	22.2	15.4	20.1	12.4	19.9	23.9	48.1	28.5	11.9	21.9	17.1	21.1	0.7	0.0	0.0	0.0	4.0	8.0	3.3	5.3	6.8	32.9	24.1	13.2	9.3	10.5	8.8	11.4	17.8	15.2	16.4	1.8	12.0	10.9	9.6	10.0	14.3	15.8	10.4	3.4	7.6	0.8	11.4	19.3	10.0	4.7	3.3	11.8	8.9	13.1	10.3	19.9	8.9	7.9	16.1	40.1	28.9	3.7	12.2	12.6	23.1	24.0	5.9	9.8	9.9	11.7	22.4	15.8	7.4	15.9	8.6	5.5	21.4	42.7	13.9	13.6	10.7	8.9	3.9	10.0	10.2	5.1	17.7	0.0	0.0	0.0	5.9	0.0	8.0	0.3	5.2	4.9	0.0	0.7	5.7	5.4	0.0	4.0	0.0	0.0	4.4	3.3	25.1	22.1	52.6	26.8	25.4	13.6	18.5	20.5	18.7	23.9
PLCH1	"DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3"	ENSG00000114805	"Phospholipase C eta 1"	Q4KWH8	3	155375580-155745067	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7;testis: 15.8"	"Cell line enhanced"	"Detected in some"		"A549: 8.2;AF22: 26.6;NTERA-2: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036176, HPA057978"	Uncertain		Enhanced	Vesicles				Vesicles		"HPA036176: AB_10671837, HPA057978: "	"unprognostic (1.08e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.94e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-2)"	"prognostic favourable (3.03e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-2)"	0.3	0.3	3.9	0.7	14.1	0.5	3.9	7.4	14.7	2.1	3.9	5.7	4.1	3.9	1.4	12.9	0.5	12.4	2.4	2.5	4.5	3.6	2.1	0.4	6.1	0.3	3.4	7.3	0.5	2.5	0.8	3.2	0.8	6.5	0.8	3.9	5.6	2.3	3.4	0.6	0.5	3.9	0.5	1.9	0.3	5.8	15.8	2.9	0.0	8.9	0.0	0.4	1.3	0.4	0.1	0.3	0.7	0.0	0.0	1.2	0.9	0.0	8.2	26.6	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.5	6.6	0.0	0.5	0.0	0.0	4.7	0.0	0.0	0.0	2.4	6.6	0.0	0.9	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	1.5	6.1	14.1	1.1	0.6	0.0	0.0	1.6	0.1	2.5	0.6	0.0	6.4	0.0	2.8	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.9	3.9	14.1	7.4	14.7	4.5	3.6	3.4	7.3	6.5	2.9
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 149.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Supported	"Endoplasmic reticulum,Cytosol"			490000	"Endoplasmic reticulum, Cytosol"		"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favourable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	45.7	57.5	44.6	23.1	79.0	12.8	21.9	35.5	126.1	31.2	23.5	25.4	17.1	22.6	26.3	35.0	18.3	30.0	30.8	33.0	46.4	73.4	22.1	25.6	49.7	25.2	44.7	53.9	44.8	42.5	32.9	122.1	38.9	62.2	29.6	16.1	31.6	35.3	37.2	27.4	24.2	23.5	25.6	28.6	48.9	23.0	17.0	19.3	11.9	20.6	11.2	12.9	27.3	20.7	3.6	23.0	149.2	24.6	9.7	7.8	16.8	13.9	43.2	28.0	44.0	77.9	37.1	21.3	34.7	35.4	25.2	28.9	8.2	15.8	6.1	36.4	30.1	6.5	6.7	13.6	11.0	22.6	24.6	6.5	14.8	10.3	53.2	2.7	75.0	70.6	28.5	19.2	13.2	21.1	23.0	24.6	18.1	18.3	4.7	13.0	18.2	8.9	6.0	21.3	24.9	12.9	10.5	20.1	33.4	16.6	10.3	18.5	14.2	47.0	37.2	21.3	10.2	18.0	7.7	25.6	27.3	6.3	34.2	10.9	13.1	149.2	24.6	35.3	7.8	12.8	6.4	3.6	6.2	6.9	23.0	3.1	6.5	6.5	2.5	9.7	5.7	3.3	6.1	16.8	44.6	79.0	35.5	126.1	46.4	73.4	44.7	53.9	62.2	19.3
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915147-143976734	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease mutation, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 144.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Enhanced	"Intermediate filaments,Focal adhesion sites,Cytosol"			7100000	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	20.9	11.0	15.9	16.5	13.3	27.9	13.1	15.0	20.7	20.7	17.7	14.6	16.7	13.1	20.2	16.8	25.1	18.2	29.0	23.4	18.9	10.7	11.2	10.9	16.6	15.0	9.9	13.0	18.0	14.0	8.8	12.0	24.2	13.2	17.5	9.8	13.0	17.8	14.8	144.9	36.4	24.1	24.7	11.0	16.9	21.4	6.7	12.7	16.3	9.2	44.2	24.5	20.2	19.2	1.5	3.4	0.8	4.1	0.7	2.9	3.2	16.3	51.2	3.3	4.1	6.0	13.4	11.7	24.0	10.7	6.4	3.6	7.1	17.1	1.6	18.7	35.1	19.4	2.2	33.6	2.5	12.2	1.8	6.2	52.0	5.8	9.5	2.0	5.2	15.4	6.6	17.2	33.6	7.4	3.0	5.3	7.4	28.7	1.2	3.4	2.2	72.1	0.3	9.4	4.4	10.7	30.3	3.4	3.4	40.9	8.7	3.9	10.7	2.4	23.8	24.8	44.9	21.8	28.4	0.8	0.6	1.2	23.6	2.6	35.2	0.0	4.1	0.2	1.4	3.8	2.8	1.4	2.7	2.0	3.4	1.5	2.0	1.1	0.8	0.7	2.7	2.8	2.9	3.2	15.9	13.3	15.0	17.3	18.9	10.7	9.9	13.0	13.2	12.7
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 6.9;NK-cells: 11.6;T-cells: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: "	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	11.7	7.4	18.2	8.7	30.2	2.6	13.6	15.8	37.9	13.6	14.9	25.4	11.4	17.1	17.9	14.5	26.7	8.8	16.3	19.4	19.8	16.6	27.1	25.4	24.4	9.0	15.6	24.4	13.9	18.1	18.8	22.9	30.6	20.7	12.7	13.9	9.5	16.0	13.6	22.5	43.9	17.2	16.0	19.6	8.7	14.0	25.5	15.0	3.4	18.7	13.9	11.7	16.1	16.1	6.9	1.8	1.3	1.6	11.6	16.5	6.2	7.7	7.1	7.2	5.0	10.5	12.0	8.7	8.6	15.1	5.2	5.7	6.0	9.7	4.8	4.2	7.7	17.0	6.8	26.3	4.8	3.4	6.7	0.0	7.0	7.0	6.9	0.8	2.3	6.5	21.8	4.3	18.4	17.5	7.1	0.0	4.8	2.9	4.3	0.7	5.6	4.8	1.2	10.3	0.9	63.5	8.6	9.9	4.8	11.1	8.3	8.7	4.6	0.0	16.6	4.4	3.6	4.8	4.3	0.0	0.0	1.6	6.8	0.0	2.7	0.1	1.5	1.3	16.5	1.4	10.8	2.9	10.0	13.2	1.8	6.9	15.9	13.5	0.5	11.6	1.6	0.9	6.6	6.2	18.2	30.2	15.8	37.9	19.8	16.6	15.6	24.4	20.7	15.0
PLEKHA3	FAPP1	ENSG00000116095	"Pleckstrin homology domain containing A3"	Q9HB20	2	178480468-178516462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034496, HPA034497"	Approved		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA034496: AB_2674189, HPA034497: AB_10603126"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.93e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.02e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.52e-2)"	7.1	13.6	8.1	7.4	13.4	9.3	6.4	14.0	10.2	8.6	8.5	6.9	6.1	9.1	7.3	13.0	6.8	7.2	6.8	12.2	8.0	8.9	9.8	8.1	7.2	6.5	8.7	5.4	10.6	7.4	13.0	12.6	9.7	11.0	9.1	5.5	9.1	6.1	9.3	7.6	4.0	9.8	14.4	7.3	7.6	7.8	18.7	5.4	7.3	8.4	4.0	6.0	14.3	6.5	4.2	2.4	2.5	1.5	2.9	2.8	0.4	4.4	2.9	3.5	4.4	6.8	3.7	6.6	7.2	5.5	3.6	3.9	1.2	3.0	3.8	9.3	5.1	3.1	3.1	1.9	6.8	11.5	3.1	5.9	3.0	3.4	4.8	3.7	6.7	3.3	6.3	6.6	4.2	3.2	2.7	6.0	4.6	1.4	4.9	5.5	5.8	4.3	2.6	5.1	6.6	4.7	2.6	3.5	5.0	3.6	2.6	10.7	3.1	6.6	3.6	7.1	6.9	8.9	8.0	7.5	14.6	3.7	9.3	3.1	4.0	1.4	0.9	1.2	1.9	0.9	1.7	1.9	2.8	2.1	0.9	4.2	1.8	2.0	2.5	2.9	1.5	2.4	1.1	0.4	8.1	13.4	14.0	10.2	8.0	8.9	8.7	5.4	11.0	5.4
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777317-17014443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.4;HaCaT: 28.7;RT4: 39.3;SK-BR-3: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 6.8;MAIT T-cell: 4.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 6.8;T-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: "	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favourable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	6.8	1.2	5.3	6.6	8.0	0.1	10.7	2.9	4.9	7.7	18.1	10.9	10.0	17.7	4.7	6.0	30.6	6.0	15.1	13.6	7.5	4.2	18.1	9.0	6.4	1.2	7.2	4.6	8.1	18.9	19.1	3.2	18.7	14.5	6.0	11.5	18.2	15.0	16.3	2.7	8.9	32.0	2.7	8.1	1.7	15.2	7.4	7.9	1.4	7.2	1.9	5.5	10.7	12.4	0.5	0.9	6.8	0.3	0.2	4.5	0.3	5.1	4.6	4.9	2.2	0.2	0.0	8.1	0.0	0.1	1.7	3.2	7.9	43.4	0.0	2.0	0.6	28.7	6.5	0.0	1.2	1.5	6.3	13.3	3.7	5.4	0.1	0.0	0.1	0.2	2.5	0.0	0.1	0.0	0.5	0.1	0.7	3.3	3.0	0.1	2.7	4.5	4.1	0.0	1.0	4.2	39.3	3.1	0.3	5.9	16.9	0.2	4.3	1.5	1.1	0.0	1.6	1.2	1.0	2.9	0.9	5.8	0.0	0.2	0.0	0.2	0.3	6.8	0.6	0.1	4.5	0.5	0.8	0.6	0.3	0.2	0.2	0.4	0.6	0.2	0.1	0.9	0.1	0.3	5.3	8.0	2.9	4.9	7.5	4.2	7.2	4.6	14.5	7.9
PLEKHA8	"FAPP2, MGC3358"	ENSG00000106086	"Pleckstrin homology domain containing A8"	Q96JA3	7	30027404-30130483	"Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072314			Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA072314: "	"unprognostic (5.49e-3)"	"unprognostic (8.62e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.07e-2)"	7.3	5.6	9.7	7.2	11.6	3.2	7.5	16.3	13.0	8.5	7.8	8.3	4.8	8.3	8.6	10.0	9.2	5.4	7.7	6.0	8.2	7.5	14.0	6.1	7.1	8.7	9.9	5.8	9.3	9.0	10.5	8.8	21.0	9.9	7.6	8.4	9.1	8.5	9.0	4.8	7.9	9.0	8.7	7.8	5.2	6.9	8.1	9.6	6.9	6.6	1.7	10.2	8.7	8.6	1.2	0.5	2.8	0.9	1.0	1.7	0.3	6.5	4.5	20.7	21.9	5.9	4.7	14.4	4.8	3.8	3.8	5.0	8.5	2.9	15.4	6.6	4.8	4.8	10.8	5.7	5.5	2.9	7.2	8.9	7.6	7.9	5.1	3.9	3.1	2.3	4.4	5.2	7.4	8.2	8.1	5.6	5.5	4.4	7.7	2.8	13.8	5.1	0.0	5.9	10.3	4.3	5.3	2.7	15.8	5.3	17.3	6.9	6.0	4.0	7.0	3.4	14.5	3.5	5.5	11.6	20.2	9.0	6.7	2.5	8.1	2.8	0.6	2.5	1.7	0.6	0.9	1.2	1.0	1.1	0.5	0.8	1.2	1.6	0.1	1.0	0.9	0.1	1.0	0.3	9.7	11.6	16.3	13.0	8.2	7.5	9.9	5.8	9.9	9.6
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 18.1;Karpas-707: 16.1;U-698: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"memory B-cell: 14.7;naive B-cell: 15.9"	"Lineage enriched"	"Detected in single"	29	"B-cells: 15.9"	"Region enriched"	"Detected in many"	5	"thalamus: 56.1"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027128: , HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	27.5	2.2	7.3	10.6	7.3	2.3	10.0	2.4	7.1	8.3	5.8	10.1	4.8	4.8	7.8	14.1	9.6	8.9	8.1	5.9	7.7	6.7	4.5	5.1	12.1	13.5	10.5	3.0	4.7	2.8	8.2	5.1	13.9	11.1	4.1	6.2	3.4	3.5	5.4	6.4	8.9	6.0	5.7	19.6	28.9	4.5	7.3	7.7	39.7	6.0	5.8	13.3	7.4	8.5	15.9	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	12.2	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	6.8	3.0	4.8	4.7	0.0	1.7	18.1	1.6	0.0	7.6	2.0	0.3	0.9	0.0	0.0	0.0	1.3	0.8	4.6	0.0	0.1	7.5	0.0	16.1	0.0	0.2	1.5	0.0	0.9	0.5	0.8	0.0	0.0	3.6	8.0	0.3	0.1	0.0	2.1	1.5	0.0	0.0	7.6	0.0	1.7	0.0	3.3	0.0	0.0	11.2	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.5	14.7	0.3	0.4	0.0	15.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.4	7.3	7.3	2.4	7.1	7.7	6.7	10.5	3.0	11.1	7.7
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: , HPA065323: , HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favourable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	12.8	2.9	17.2	7.8	36.9	11.4	19.8	7.3	29.4	15.2	15.9	67.3	9.3	10.2	31.6	9.9	26.4	19.8	17.5	12.5	24.2	12.8	19.5	16.5	8.4	4.0	40.7	21.6	16.8	22.7	17.9	3.7	22.3	19.5	12.3	12.1	13.6	19.6	31.6	5.9	19.6	10.0	20.7	24.5	16.0	11.5	5.1	40.9	1.2	14.5	6.4	5.3	16.6	17.1	0.0	0.7	16.7	1.9	6.4	12.2	2.9	28.5	13.3	11.1	16.8	1.2	0.0	19.3	3.2	3.8	5.1	4.1	14.0	12.6	0.0	5.8	3.1	27.6	7.5	25.4	1.7	0.0	6.5	12.7	16.4	3.3	1.5	0.4	6.1	1.5	14.8	1.0	9.2	3.3	0.0	0.1	1.7	13.5	0.0	11.6	3.7	14.2	0.1	5.5	1.9	14.0	20.9	3.8	6.8	6.6	9.9	9.5	10.8	2.8	6.4	2.2	23.0	0.1	4.4	0.0	0.0	0.0	0.2	1.3	3.9	4.5	1.9	11.7	12.2	1.1	8.6	0.0	3.7	5.2	0.7	0.0	0.4	2.7	16.7	6.4	0.7	0.0	1.1	2.9	17.2	36.9	7.3	29.4	24.2	12.8	40.7	21.6	19.5	40.9
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.4;placenta: 39.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 55.6;CACO-2: 17.6;CAPAN-2: 9.7;RT4: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.9;granulocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"				"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: "	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	7.5	0.2	0.3	8.9	0.7	1.0	15.8	0.3	0.4	4.4	30.3	0.4	1.1	19.4	0.6	1.6	19.9	0.5	6.7	1.2	0.3	0.0	1.1	2.5	1.8	0.3	0.3	0.3	0.6	4.5	1.9	3.3	39.6	0.5	2.6	9.6	0.7	8.8	2.3	0.3	6.7	43.4	0.5	0.3	0.4	5.7	0.5	0.3	0.5	3.4	11.3	8.6	6.8	8.6	0.3	3.9	2.5	0.2	0.1	0.4	0.1	0.2	2.1	0.2	0.0	1.1	0.1	55.6	0.1	0.0	0.1	0.1	17.6	9.7	0.1	0.1	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.2	4.6	0.3	0.0	0.0	0.1	0.0	18.7	0.1	0.0	0.4	8.3	0.1	2.7	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.4	2.5	0.1	0.1	3.9	0.1	0.1	0.3	0.7	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
PLEKHM1	KIAA0356	ENSG00000225190	"Pleckstrin homology and RUN domain containing M1"	Q9Y4G2	17	45435900-45490749	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025018, HPA039473"	Approved		Supported	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA025018: AB_1855465, HPA039473: "	"unprognostic (1.52e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (1.28e-6)"	"unprognostic (8.71e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	8.0	3.6	2.5	3.6	4.5	10.9	5.3	7.6	5.6	6.1	4.1	2.6	0.9	2.2	2.9	2.0	17.2	3.7	3.8	3.9	4.2	1.7	1.7	3.1	4.5	7.3	10.5	2.9	2.5	4.2	3.5	3.6	2.8	4.7	2.6	3.0	3.4	7.6	2.7	6.3	5.8	3.4	2.5	5.3	4.5	3.0	2.4	3.4	6.7	3.8	6.5	10.4	5.2	6.7	2.4	1.3	9.8	1.4	1.3	1.4	0.9	5.8	8.5	1.5	2.8	6.0	2.9	5.3	1.7	3.9	3.0	3.1	2.6	3.2	3.0	5.1	5.6	1.5	3.5	2.1	0.9	11.8	4.1	0.0	3.1	3.5	6.3	0.0	4.4	11.3	6.7	4.8	7.9	9.0	2.9	3.5	4.7	3.6	5.8	1.1	0.9	6.0	2.6	3.1	2.7	4.4	9.0	2.6	2.4	3.0	2.3	3.2	5.2	2.5	10.3	7.3	2.7	5.5	3.0	3.6	3.8	1.2	4.1	1.5	3.0	3.8	1.4	1.3	1.4	1.0	0.8	2.4	1.0	1.1	1.3	1.0	0.7	0.6	9.8	1.3	1.3	1.0	1.2	0.9	2.5	4.5	7.6	5.6	4.2	1.7	10.5	2.9	4.7	3.4
PLEKHO1	"CKIP-1, OC120"	ENSG00000023902	"Pleckstrin homology domain containing O1"	Q53GL0	1	150149183-150164720	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 60.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061018			Supported	Mitochondria				Mitochondria		"HPA061018: "	"unprognostic (1.41e-2)"	"unprognostic (7.04e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (6.47e-11)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.52e-2)"	10.9	17.0	14.2	34.4	22.1	10.2	10.5	17.0	14.4	9.6	44.5	5.4	6.4	11.8	16.9	7.7	16.8	11.9	14.1	17.8	10.2	6.9	5.8	5.8	12.9	29.0	8.2	13.1	13.5	2.5	1.4	3.5	10.1	8.0	18.2	8.3	7.9	4.7	12.1	15.8	3.6	17.4	60.7	6.5	29.4	22.3	24.8	7.3	15.0	3.8	3.1	17.4	29.3	17.7	11.0	16.0	18.7	15.8	2.1	5.1	5.4	5.1	1.2	17.2	13.4	5.5	4.9	1.4	8.9	12.3	12.1	10.7	0.3	0.1	0.1	1.7	10.4	0.4	8.6	0.4	3.9	30.6	4.3	0.9	0.7	3.1	10.5	7.0	29.1	7.2	0.4	15.0	2.3	11.4	1.9	13.4	16.4	2.3	26.7	13.9	16.1	2.3	24.2	9.3	5.8	2.0	1.4	10.8	17.6	0.7	0.0	6.7	0.9	7.0	15.9	8.0	9.1	8.2	10.6	5.1	0.1	3.2	31.8	0.0	3.0	1.5	15.8	0.3	3.5	14.1	3.8	11.0	5.1	3.7	11.7	10.5	3.5	3.0	18.7	2.1	12.8	16.0	3.7	5.4	14.2	22.1	17.0	14.4	10.2	6.9	8.2	13.1	8.0	7.3
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 233.1;liver: 139.9"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.8;HHSteC: 171.3"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 83.5;eosinophil: 76.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 83.5;monocytes: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"				"Lipid droplets"		"CAB037331: , HPA016607: "	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.77e-1)"	233.1	17.4	1.8	6.5	2.8	14.9	98.9	1.1	3.2	11.2	47.4	2.0	5.4	28.4	7.7	7.8	6.2	6.1	10.9	37.0	1.7	1.6	36.0	139.9	18.3	9.6	2.2	1.2	37.5	4.5	2.0	4.7	46.4	3.0	17.1	3.5	5.9	8.5	4.5	75.7	13.5	61.6	6.8	3.1	9.8	5.5	16.5	2.4	4.4	8.8	4.0	4.6	63.2	102.9	3.2	8.6	83.5	21.1	2.0	11.5	11.8	0.0	2.8	3.2	2.3	197.8	27.0	35.9	9.1	7.1	5.5	6.3	4.3	0.6	0.0	0.1	18.6	0.3	3.1	0.0	9.6	11.5	0.0	15.1	0.4	16.1	171.3	1.8	27.8	28.5	3.2	13.6	0.0	6.8	2.7	3.3	21.6	0.7	4.1	6.2	4.3	5.6	10.0	1.5	0.1	0.0	10.6	0.2	5.3	4.2	1.0	9.0	2.2	4.0	10.7	0.0	1.7	8.6	0.0	2.0	2.0	6.1	0.0	3.1	0.8	83.5	14.9	76.1	11.5	19.7	10.0	3.2	10.1	8.2	8.6	2.9	9.9	8.4	0.9	2.0	21.1	1.0	9.6	11.8	1.8	2.8	1.1	3.2	1.7	1.6	2.2	1.2	3.0	2.4
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867768	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Enhanced	"Lipid droplets"			9300000	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: "	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favourable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.27e-5)"	"prognostic unfavourable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	13.2	28.9	7.4	16.9	16.3	25.5	12.7	2.8	10.8	17.8	17.5	37.9	4.2	29.1	9.3	12.6	46.9	9.5	14.8	12.4	9.2	7.0	10.4	19.6	9.9	13.6	32.4	8.3	23.4	8.1	3.1	3.9	28.3	17.8	11.0	8.9	6.7	18.1	9.7	40.0	31.8	38.6	11.1	26.7	13.1	11.1	13.6	25.1	20.0	13.1	35.8	29.1	14.1	19.7	12.5	28.9	45.9	37.5	9.4	8.4	19.0	27.7	16.4	11.5	10.4	12.7	41.4	5.0	40.5	37.8	32.7	30.3	10.7	25.4	14.4	9.2	50.9	12.7	5.2	22.8	19.3	16.4	7.5	15.6	9.3	19.6	9.1	11.1	23.8	32.3	9.5	23.2	5.0	17.0	23.7	6.4	39.6	11.4	15.8	15.0	8.6	26.7	27.2	15.5	8.1	27.8	6.4	0.5	5.4	12.6	11.5	9.9	14.6	25.2	25.3	17.4	17.2	69.6	20.8	9.0	11.5	9.9	52.4	15.8	20.0	28.3	37.5	16.1	3.8	26.2	3.8	12.5	6.7	4.3	28.9	9.3	5.4	3.4	45.9	9.4	18.0	21.4	8.4	19.0	7.4	16.3	2.8	10.8	9.2	7.0	32.4	8.3	17.8	25.1
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 75.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Supported	"Vesicles,Lipid droplets,Plasma membrane,Cytosol"			11000	"Lipid droplets, Plasma membrane"	"Vesicles, Cytosol"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (8.31e-4)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	75.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.4	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8
PLIN5	"LSDA5, LSDP5, MLDP, OXPAT"	ENSG00000214456	"Perilipin 5"	Q00G26	19	4522531-4535224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6;salivary gland: 40.3;skeletal muscle: 40.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;RT4: 5.0;SH-SY5Y: 4.7;T-47d: 10.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 14.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 14.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077050			Supported	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"		"HPA077050: "	"prognostic favourable (7.68e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavourable (8.56e-4)"	"unprognostic (1.24e-2)"	"unprognostic (6.06e-3)"	"prognostic favourable (2.81e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (1.97e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"prognostic favourable (2.16e-4)"	20.9	1.7	8.0	2.9	5.2	3.9	6.5	4.2	5.8	1.8	3.3	2.0	10.5	1.6	1.6	5.5	1.9	3.1	1.9	12.0	7.8	1.4	5.8	44.6	2.8	1.5	3.4	2.6	25.8	30.1	0.5	6.2	0.6	3.7	4.5	0.9	3.4	40.3	4.6	40.8	1.7	1.3	1.5	1.7	1.8	11.5	1.4	4.2	0.0	2.2	6.0	1.1	3.7	5.7	0.6	0.4	14.7	0.5	0.8	0.4	0.1	0.5	0.3	1.1	3.8	2.8	0.1	5.5	0.2	0.2	0.2	0.1	0.4	1.0	0.3	1.2	0.2	0.4	0.0	0.0	0.0	0.5	0.4	0.3	1.4	1.7	0.6	0.4	0.9	0.7	0.0	0.0	0.1	0.3	1.2	0.5	0.3	0.9	0.3	0.9	0.7	0.5	0.3	0.2	3.4	0.3	5.0	0.7	4.7	0.5	0.8	0.0	10.4	0.7	1.0	0.6	0.5	0.5	0.3	0.6	0.2	0.2	0.5	1.1	0.2	1.5	0.5	0.8	0.3	0.4	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.4	14.7	0.8	0.3	0.4	0.2	0.1	8.0	5.2	4.2	5.8	7.8	1.4	3.4	2.6	3.7	4.2
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA017327: , HPA035026: AB_10602080, HPA043198: "	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.6	5.5	20.7	10.6	0.7	2.0	9.4	11.4	8.1	15.2	15.8	7.7	12.0	15.7	4.2	6.3	7.7	14.6	9.1	23.5	12.2	6.0	14.2	8.8	7.2	0.2	20.0	16.9	0.6	0.9	13.9	6.4	11.7	16.5	21.0	12.8	8.1	30.8	9.0	9.6	6.3	16.1	14.5	5.4	5.0	7.4	11.5	9.4	7.2	6.6	3.5	5.3	8.7	5.0	12.0	11.6	8.1	14.2	10.9	11.9	22.4	6.1	15.3	13.2	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0
PLPBP	PROSC	ENSG00000147471	"Pyridoxal phosphate binding protein"	O94903	8	37762593-37779767	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017033, HPA023646, HPA023733"	Approved		Enhanced	Cytosol			20000	Cytosol		"CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742"	"unprognostic (1.55e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.85e-2)"	23.3	18.2	22.0	14.6	23.3	8.4	20.6	19.7	23.2	15.7	29.1	16.1	18.3	21.3	17.2	16.2	14.0	18.9	16.4	30.1	19.7	21.4	37.0	48.2	16.5	14.7	20.7	20.3	17.8	38.4	26.2	17.9	13.2	15.3	19.5	25.5	15.2	18.6	19.2	32.6	11.0	24.7	19.4	18.5	15.1	20.0	7.2	15.4	16.6	30.6	15.7	18.3	20.1	28.8	27.4	40.0	46.1	46.5	24.1	39.2	34.2	17.9	17.6	14.6	13.2	11.0	13.5	11.4	20.5	18.6	14.2	16.2	20.9	9.3	21.6	24.6	16.3	16.4	27.1	21.5	23.9	17.9	11.4	29.9	7.0	19.9	21.6	13.6	20.3	9.8	20.1	13.8	22.4	21.5	15.7	17.2	11.9	13.2	43.8	12.6	17.3	14.4	28.8	17.9	12.7	23.3	23.5	8.7	9.4	16.9	8.2	21.4	17.9	17.8	19.0	7.9	24.1	26.5	13.3	16.9	33.3	16.1	11.1	19.9	14.0	46.1	38.4	45.6	31.8	43.8	33.3	27.4	32.6	30.5	40.0	22.9	29.2	27.8	16.2	24.1	46.5	23.7	39.2	34.2	22.0	23.3	19.7	23.2	19.7	21.4	20.7	20.3	15.3	15.4
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55535050	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 91.2;fHDF/TERT166: 27.7;HMC-1: 47.8;HSkMC: 35.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: "	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	56.3	26.7	12.5	14.8	14.6	0.6	57.9	10.6	18.5	34.5	30.9	26.1	18.0	17.3	36.8	26.0	18.4	20.4	61.0	33.7	13.4	10.8	34.5	42.0	15.9	17.3	20.8	10.1	16.5	17.6	16.9	10.1	22.4	21.4	82.0	24.7	29.8	9.8	24.0	18.4	16.6	25.4	39.6	28.2	10.2	21.7	18.1	14.5	4.4	32.7	9.6	10.0	43.1	18.1	5.4	13.6	3.3	0.7	2.7	9.5	1.6	1.9	4.8	1.4	2.8	91.2	10.6	2.0	4.3	12.1	2.4	5.6	3.3	3.6	2.0	4.1	27.7	1.2	4.9	2.4	2.7	1.3	3.9	0.2	2.1	4.1	14.4	0.5	47.8	35.0	5.1	3.5	2.2	3.9	0.0	5.5	4.7	1.2	1.3	1.0	3.2	3.9	0.4	2.4	0.1	9.1	15.5	1.7	1.2	4.3	0.8	2.6	3.1	0.3	4.8	0.8	1.4	3.6	3.1	3.4	1.4	2.3	3.2	0.2	3.9	0.0	0.4	3.3	1.5	0.4	1.6	5.4	5.2	3.2	1.9	3.4	9.5	7.5	0.3	2.7	0.7	13.6	2.2	1.6	12.5	14.6	10.6	18.5	13.4	10.8	20.8	10.1	21.4	14.5
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494747-56645301	"Enzymes, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 102.8;ASC TERT1: 51.4;HSkMC: 63.5;U-2197: 93.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.4"									"HPA028892, HPA072751"	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA028892: AB_10602149, HPA072751: "	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favourable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	46.4	17.2	29.0	10.8	30.7	4.2	39.1	13.5	27.5	102.7	15.5	33.8	22.1	8.1	32.7	36.9	20.8	36.7	24.0	23.3	39.9	13.5	30.2	57.7	24.3	6.7	19.2	30.1	27.9	12.2	30.7	7.2	70.9	20.0	37.7	14.4	34.7	22.4	58.7	16.6	24.4	12.5	32.9	16.5	7.9	18.7	23.4	29.7	5.2	107.1	19.4	6.7	35.8	44.0	5.4	0.0	0.8	0.3	0.0	0.0	0.2	0.4	1.5	2.0	0.2	102.8	51.4	4.9	5.4	5.5	5.0	2.5	4.3	0.8	0.7	0.6	8.1	0.8	0.2	0.1	1.0	0.0	1.3	0.1	0.6	6.0	2.5	0.0	0.0	63.5	0.4	4.8	4.0	4.7	0.3	0.0	5.4	0.4	0.0	0.0	6.1	5.9	0.0	0.0	0.2	0.8	4.5	0.0	4.0	1.7	2.2	0.5	0.7	0.0	2.9	25.2	2.1	93.3	0.2	0.0	0.0	0.0	4.4	0.2	1.7	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	29.0	30.7	13.5	27.5	39.9	13.5	19.2	30.1	20.0	29.7
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028709-101325135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 38.5;kidney: 24.4"	"Group enriched"	"Detected in some"	4	"Hep G2: 5.6;SCLC-21H: 10.3"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA014760: , HPA014968: AB_1855702, HPA014979: "	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.8	0.9	12.6	0.7	38.5	0.7	1.4	1.7	24.4	1.0	0.9	7.6	0.0	0.8	0.8	5.2	0.8	1.0	0.9	0.8	12.7	7.0	24.4	5.0	2.8	0.7	7.5	5.5	0.7	1.1	0.7	0.1	0.8	5.3	1.0	1.0	0.1	1.1	0.8	0.8	0.8	0.8	0.8	10.2	0.7	0.9	1.5	9.3	0.0	0.7	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.9	10.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	38.5	1.7	6.4	12.7	7.0	7.5	5.5	5.3	9.3
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535006-154550435	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"				"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: "	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	20.2	18.1	23.3	14.9	30.9	17.5	25.2	29.3	28.6	22.7	19.5	24.7	16.7	15.6	24.4	19.3	24.4	22.8	16.0	16.2	22.9	22.2	26.0	34.9	17.1	20.4	28.9	24.3	23.9	14.2	28.2	21.9	17.8	29.4	18.4	22.7	13.3	19.4	23.3	23.0	16.5	22.1	29.2	32.5	19.1	16.8	13.3	25.9	22.0	24.8	22.3	31.5	18.3	16.5	25.2	25.2	23.2	30.9	34.0	28.8	23.7	23.4	19.2	24.9	26.5	29.4	25.6	21.0	30.2	37.0	41.3	33.8	22.6	20.8	25.6	15.5	35.8	17.3	32.4	40.4	45.9	25.8	16.2	30.7	15.3	21.9	30.2	30.6	25.8	27.5	37.5	48.8	38.4	35.3	31.3	32.9	35.9	16.8	23.5	14.6	18.8	20.9	23.3	12.9	15.5	28.6	15.1	14.5	16.4	18.4	19.9	28.8	19.1	21.5	22.7	24.7	28.0	21.7	26.8	17.2	22.3	32.2	23.2	14.8	32.8	23.2	19.4	15.2	23.7	22.5	28.2	25.2	24.8	25.6	25.2	19.2	26.6	24.8	5.2	34.0	30.9	24.8	28.8	23.7	23.3	30.9	29.3	28.6	22.9	22.2	28.9	24.3	29.4	25.9
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544864	"Predicted intracellular proteins, Transporters"	"Antiviral defense"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 54.7;BJ hTERT+ SV40 Large T+ RasG12V: 72.7;HHSteC: 50.1;SK-MEL-30: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Nucleoplasm, Golgi apparatus, Plasma membrane"		"CAB070421: AB_11153452, HPA068923: "	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.9	14.9	11.9	39.7	21.4	27.0	31.1	5.7	19.0	20.9	29.6	7.2	22.1	18.4	19.6	25.7	25.4	19.5	30.8	22.7	16.1	12.7	32.0	36.5	33.8	38.6	17.6	4.9	40.0	26.1	10.3	18.4	25.7	22.1	25.0	28.0	12.6	32.3	34.2	16.4	9.9	24.6	19.4	29.8	46.0	20.5	15.4	14.8	16.4	27.5	14.9	19.5	27.5	48.0	6.5	27.5	26.2	41.2	14.3	8.1	17.6	17.0	6.9	4.4	2.0	6.6	11.2	6.7	5.4	14.7	54.7	72.7	5.4	14.3	1.3	12.8	3.4	14.1	3.5	5.1	9.2	5.2	3.5	11.0	2.2	4.1	50.1	6.3	5.8	17.7	8.6	6.0	30.8	8.0	7.0	17.1	11.1	6.6	4.8	2.4	4.2	6.1	4.4	4.8	0.4	15.4	4.7	2.7	0.0	6.9	3.3	90.5	3.4	7.7	4.8	4.4	3.8	9.8	8.9	13.1	2.4	0.0	4.4	4.6	3.8	8.2	41.2	11.0	5.6	40.4	8.1	6.5	3.7	5.0	27.5	4.9	2.6	3.8	26.2	14.3	22.7	7.3	2.1	17.6	11.9	21.4	5.7	19.0	16.1	12.7	17.6	4.9	22.1	14.8
PLSCR3		ENSG00000187838	"Phospholipid scramblase 3"	Q9NRY6	17	7389727-7394843	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048387, HPA068609"	Supported		Supported	Mitochondria				Mitochondria		"HPA048387: , HPA068609: "	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.11e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.55e-2)"	21.9	11.5	6.2	17.8	6.1	5.2	31.0	4.4	7.9	24.0	12.7	7.4	16.3	5.6	29.2	22.0	21.6	15.6	17.7	25.3	5.6	5.7	15.3	12.9	25.0	67.2	5.8	7.6	19.9	10.0	10.1	9.0	17.3	8.4	15.4	6.3	10.2	12.5	17.8	16.1	17.8	10.5	21.4	13.1	29.0	11.6	8.6	6.4	12.1	12.2	26.0	21.0	21.5	20.1	12.9	9.5	1.9	13.3	6.6	30.8	12.1	14.2	3.2	2.7	8.4	10.3	18.1	3.6	13.0	11.9	11.1	10.4	4.9	3.3	3.6	10.6	18.6	19.5	3.4	21.2	5.6	9.8	1.9	3.4	4.3	3.4	13.9	1.2	4.5	13.1	14.4	11.1	16.7	17.1	2.0	2.8	14.4	7.3	3.8	1.0	2.5	9.2	7.8	2.3	3.8	10.4	9.2	2.4	8.1	6.6	4.8	3.0	8.2	0.6	27.8	7.6	7.8	8.7	5.4	3.2	3.6	1.4	11.9	4.3	8.8	1.9	10.0	1.1	16.8	13.3	17.1	12.9	30.5	17.1	9.5	12.0	25.2	15.0	1.0	6.6	10.9	1.1	30.8	12.1	6.2	6.1	4.4	7.9	5.6	5.7	5.8	7.6	8.4	6.4
PLXDC2	"FLJ14623, TEM7R"	ENSG00000120594	"Plexin domain containing 2"	Q6UX71	10	19816239-20289856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HHSteC: 12.4;U-2197: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 21.2;intermediate monocyte: 12.6;myeloid DC: 13.3;neutrophil: 31.4;non-classical monocyte: 12.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 13.3;granulocytes: 31.4;monocytes: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017268, HPA070793"	Approved		Supported	"Nuclear bodies"			560000000	"Nuclear bodies"		"HPA017268: AB_10965928, HPA070793: "	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.66e-2)"	31.7	13.1	15.9	8.2	20.6	5.5	25.5	3.8	12.4	14.5	9.1	17.9	11.5	4.9	14.2	9.2	11.1	11.5	20.4	14.5	16.8	8.3	12.9	3.9	21.9	5.4	26.1	9.6	11.3	4.2	17.0	5.6	5.5	16.7	10.3	5.7	8.7	9.8	9.7	6.1	21.1	8.0	18.0	27.7	10.5	6.0	7.8	22.7	0.4	10.5	12.3	3.6	11.9	17.7	0.0	13.3	31.4	21.2	1.5	1.1	5.4	0.0	0.0	3.3	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	1.3	1.1	0.0	0.0	0.5	1.7	5.3	0.2	12.4	0.0	0.0	4.2	0.3	0.0	1.5	0.0	0.1	1.1	0.6	0.7	0.3	0.1	2.2	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.1	1.4	0.2	0.0	0.5	0.6	0.0	4.9	2.6	29.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	3.0	21.2	4.1	0.5	12.6	1.1	0.0	0.0	0.1	13.3	0.0	0.0	0.0	31.4	1.5	12.7	0.6	0.0	5.4	15.9	20.6	3.8	12.4	16.8	8.3	26.1	9.6	16.7	22.7
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol			2600000	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavourable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	4.6	2.1	4.4	3.8	2.5	0.0	3.1	5.2	9.3	3.6	2.5	2.5	2.5	1.6	3.8	5.2	3.7	3.3	2.7	10.2	6.2	5.3	2.5	5.3	6.3	3.1	2.9	5.0	5.0	4.9	18.7	2.5	4.9	3.9	3.7	0.7	2.5	7.9	4.1	5.6	8.8	2.5	2.9	2.5	5.6	2.3	5.2	2.5	2.5	3.2	2.5	2.5	3.5	12.6	0.6	0.0	0.0	0.9	0.0	1.1	0.5	17.7	8.4	9.3	7.4	12.3	13.8	14.9	10.6	9.1	6.1	6.1	27.9	8.3	2.0	16.0	11.4	27.5	4.8	20.8	2.5	2.8	7.5	0.2	4.9	7.2	8.1	2.1	1.5	13.8	14.6	11.3	8.8	3.0	10.2	3.7	6.5	10.3	4.1	3.9	9.0	7.5	5.5	23.9	5.5	5.3	35.8	8.3	9.1	7.7	7.3	10.1	11.7	13.5	11.2	9.8	12.6	17.8	11.1	2.2	1.5	3.9	14.1	4.0	10.3	0.0	0.0	0.0	0.7	0.1	1.1	0.5	0.6	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.9	0.0	0.8	0.5	4.4	2.5	5.2	9.3	6.2	5.3	2.9	5.0	3.9	2.5
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146050-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA030325: , HPA030326: , HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	6.8	5.0	4.8	11.4	6.9	6.5	7.6	11.2	4.9	11.9	13.4	4.4	9.3	7.0	11.3	7.1	14.2	11.0	9.1	16.9	5.1	5.5	9.6	9.7	6.2	8.3	3.7	3.1	21.0	11.3	12.5	23.8	6.9	8.6	23.5	8.5	17.6	8.6	8.7	38.5	10.2	8.0	27.7	4.8	5.2	7.6	4.0	2.9	16.6	23.0	10.6	12.1	19.5	8.5	4.1	2.4	3.0	1.0	4.8	4.0	1.5	11.6	5.2	4.7	7.3	1.5	1.0	0.3	5.9	5.9	8.8	11.3	6.1	5.7	34.1	7.2	1.3	4.5	9.5	4.7	20.1	10.5	12.2	6.9	3.2	5.7	1.7	19.8	5.5	1.5	3.5	3.3	7.1	2.1	2.6	18.3	2.7	1.8	12.4	15.7	1.9	5.2	20.7	23.3	24.7	9.9	2.2	13.2	9.2	3.5	5.7	5.8	0.0	17.5	3.4	0.2	5.3	1.8	12.3	9.7	14.2	7.3	2.4	17.1	0.8	1.9	1.0	2.9	2.2	0.6	3.5	4.1	2.7	3.7	1.6	3.1	4.0	3.5	3.0	4.8	0.6	2.4	0.5	1.5	4.8	6.9	11.2	3.9	5.1	5.5	3.7	3.1	8.6	2.9
PMEL	"D12S53E, gp100, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 230.1"	"Cell line enriched"	"Detected in some"	66	"SK-MEL-30: 431.8"	"Cancer enriched"	"Detected in many"	500	"melanoma: 2481.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"		14000000	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA031649: "	"unprognostic (4.63e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.98e-1)"	"prognostic favourable (3.70e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.04e-1)"	0.9	0.1	0.4	0.4	0.5	0.4	3.4	0.4	0.5	38.2	1.0	0.4	0.5	0.4	11.8	0.4	0.4	0.2	0.6	0.5	0.4	0.0	0.6	1.8	0.7	1.9	0.4	0.4	1.6	0.6	0.9	0.4	0.9	0.4	0.5	0.2	230.1	1.1	0.4	0.6	46.8	0.6	1.3	0.8	0.4	0.2	1.5	0.4	0.4	0.4	0.6	0.6	0.5	0.8	1.3	2.3	2.1	1.4	0.2	1.9	0.6	0.7	0.0	0.2	0.0	4.4	0.0	6.5	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	431.8	0.2	0.4	0.0	0.0	0.3	0.0	0.4	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.4	0.7	0.3	0.0	1.9	1.3	0.5	0.4	0.0	0.9	1.1	0.1	2.1	0.2	0.4	2.3	0.4	0.6	0.4	0.5	0.4	0.5	0.4	0.0	0.4	0.4	0.4	0.4
PMEPA1	"STAG1, TMEPAI"	ENSG00000124225	"Prostate transmembrane protein, androgen induced 1"	Q969W9	20	57648392-57711536	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 60.4;prostate: 67.3"	"Cell line enhanced"	"Detected in many"		"SiHa: 39.5;U-2 OS: 25.8;U-251 MG: 90.8;WM-115: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.2;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	7	"B-cells: 5.2;dendritic cells: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072291			Supported	Vesicles	"Intracellular and membrane"			Vesicles		"HPA072291: "	"unprognostic (2.72e-3)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (4.73e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.83e-3)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (2.87e-7)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.87e-3)"	"prognostic unfavourable (7.60e-4)"	27.0	7.8	7.5	10.6	34.8	1.3	9.5	2.6	12.6	60.4	10.8	11.0	4.2	4.4	22.1	6.7	7.1	7.7	21.8	10.7	7.5	8.6	5.3	1.7	8.5	4.5	10.2	5.9	6.2	18.6	2.6	5.6	3.0	12.1	67.3	5.7	21.3	11.6	13.3	17.4	6.8	7.6	17.6	8.1	4.0	5.3	3.2	9.1	1.3	5.4	6.0	6.2	8.4	13.0	5.2	18.4	0.1	0.3	0.0	1.6	0.4	5.9	14.5	0.4	0.7	0.4	0.0	0.1	0.9	0.0	0.3	0.1	0.2	18.8	0.0	3.5	1.4	23.0	0.3	19.4	0.2	0.1	0.7	0.0	4.0	0.0	0.3	0.0	0.1	0.2	10.9	0.8	2.4	2.5	0.1	0.2	1.2	12.3	0.7	0.1	1.8	1.8	0.0	7.0	2.1	4.7	0.0	3.4	2.7	39.5	23.5	2.7	3.6	0.7	6.3	3.5	25.8	0.3	90.8	1.1	0.1	0.0	1.6	0.2	45.8	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.6	0.2	0.0	5.2	1.6	0.9	0.1	0.0	0.0	18.4	0.4	0.4	7.5	34.8	2.6	12.6	7.5	8.6	10.2	5.9	12.1	9.1
PML	"MYL, RNF71, TRIM19"	ENSG00000140464	"Promyelocytic leukemia"	P29590	15	73994673-74047812	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008312, CAB010194, CAB016304"	Supported		Enhanced	"Nuclear bodies"				"Nuclear bodies"		"CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643"	"prognostic favourable (3.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.30e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (3.29e-4)"	"unprognostic (2.67e-2)"	"prognostic unfavourable (6.27e-8)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.99e-2)"	46.2	15.4	13.5	29.9	13.0	30.0	50.0	11.4	17.2	24.7	21.9	8.3	22.1	16.9	29.4	22.1	19.3	23.0	25.6	17.6	10.7	7.5	20.5	12.9	37.2	27.3	11.9	12.4	21.2	11.0	9.6	15.0	22.4	16.1	21.2	8.7	14.6	38.0	27.7	18.7	24.2	19.6	20.1	14.3	25.9	21.4	8.7	13.1	25.3	25.9	23.3	23.0	20.7	35.6	11.8	12.9	19.1	18.2	12.7	13.2	7.8	13.8	5.2	4.6	4.4	13.2	18.7	15.9	7.2	12.8	22.3	25.8	5.5	25.0	6.2	25.4	12.9	25.5	6.3	14.4	3.2	21.7	9.7	13.4	8.2	6.0	15.3	12.7	12.3	35.1	10.4	15.1	7.9	15.5	11.3	11.1	13.1	6.5	10.4	19.9	5.0	9.6	8.1	5.5	11.6	24.9	23.1	4.0	4.4	11.5	6.3	17.1	4.9	10.7	25.8	22.6	6.2	11.2	14.3	11.6	7.3	3.0	15.6	16.2	7.2	5.4	12.7	19.1	12.4	18.0	9.6	11.8	9.9	13.2	12.9	9.8	8.1	8.2	11.0	12.7	18.2	8.3	12.9	7.8	13.5	13.0	11.4	17.2	10.7	7.5	11.9	12.4	16.1	13.1
PMM1	Sec53	ENSG00000100417	"Phosphomannomutase 1"	Q92871	22	41576894-41589890	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030712, HPA074950"	Uncertain		Supported	Cytosol				Cytosol		"HPA030712: AB_10669600, HPA074950: "	"unprognostic (2.66e-1)"	"prognostic favourable (5.92e-4)"	"unprognostic (3.25e-2)"	"prognostic favourable (6.09e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.78e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (6.56e-3)"	"unprognostic (5.76e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.70e-1)"	20.8	25.1	24.3	15.2	28.8	15.3	15.0	15.5	27.9	24.7	29.5	12.6	14.1	25.3	12.1	20.1	36.5	24.8	14.7	17.7	19.6	20.6	32.8	32.2	21.7	10.8	20.3	25.5	34.8	30.5	7.7	8.7	9.7	17.8	13.7	13.9	11.8	13.0	17.3	6.6	13.6	22.0	14.3	15.2	6.0	24.5	27.6	13.2	8.8	8.9	12.7	14.7	15.2	13.2	10.6	13.2	24.5	12.7	6.8	27.1	10.3	5.2	9.8	6.7	14.4	19.4	30.2	7.8	21.0	24.0	19.4	21.4	7.8	5.1	4.9	7.0	25.0	7.9	8.8	13.6	10.9	10.3	13.4	1.2	12.3	16.4	30.7	7.4	8.1	25.1	13.2	20.1	8.4	3.1	5.4	17.8	26.3	13.9	5.6	10.7	2.1	13.2	4.3	7.2	10.2	8.2	5.7	1.9	3.8	17.1	6.1	25.1	7.0	8.2	2.4	22.0	12.1	20.4	10.7	11.2	10.7	7.9	24.5	6.2	13.2	9.6	12.7	24.5	16.3	10.2	13.8	10.4	16.8	13.8	13.2	10.6	18.3	12.9	16.6	6.8	12.0	5.0	27.1	10.3	24.3	28.8	15.5	27.9	19.6	20.6	20.3	25.5	17.8	13.2
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria			6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favourable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favourable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.3	26.9	12.9	26.0	9.8	14.3	19.8	15.0	12.1	21.0	15.3	30.7	17.2	20.1	15.8	15.2	33.6	23.8	22.0	9.3	28.9	28.8	16.2	34.7	37.1	17.3	21.0	14.1	21.0	15.2	16.3	8.4	17.7	41.0	13.3	13.0	39.8	19.8	27.1	26.3	25.5	24.7	18.3	44.5	14.4	10.3	26.5	17.4	20.2	28.8	17.5	39.2	28.7	14.6	15.0	16.1	12.3	19.0	8.2	10.9	21.7	19.7	18.4	13.4	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing beta subunit"	O75439	7	103297422-103329511	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria			57000	Mitochondria		"HPA040674: AB_10961998, HPA074168: "	"prognostic favourable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favourable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	29.1	41.8	31.8	23.0	34.3	41.5	31.6	41.1	38.4	29.0	26.9	21.6	28.2	35.1	32.0	25.9	27.9	26.9	23.5	41.4	27.7	20.1	45.9	47.2	21.9	31.3	32.6	35.0	36.8	40.6	41.1	33.9	24.8	34.2	31.6	31.5	20.8	30.6	31.0	31.5	31.6	31.0	25.7	27.8	27.9	33.6	31.3	35.9	37.2	33.2	24.2	30.0	30.7	27.9	19.5	18.4	9.7	16.1	12.9	21.9	15.7	12.1	17.6	20.8	27.9	12.6	25.6	15.7	11.3	19.5	22.9	27.3	18.8	14.0	31.3	18.2	19.3	15.8	24.9	18.2	21.9	10.9	29.7	10.8	30.2	25.0	15.4	14.8	12.8	23.4	17.0	17.9	17.3	12.1	20.9	31.8	20.9	28.3	24.6	35.0	25.4	22.1	17.2	14.5	31.8	21.5	21.8	26.1	31.9	15.3	45.2	22.3	18.5	19.9	10.0	20.3	24.3	36.0	21.0	24.4	31.2	24.0	15.0	24.0	15.9	9.7	14.1	9.3	14.7	16.1	16.1	19.5	17.1	14.7	18.4	14.3	21.5	17.4	4.4	12.9	13.6	9.4	21.9	15.7	31.8	34.3	41.1	38.4	27.7	20.1	32.6	35.0	34.2	35.9
PMS1	"MLH2, PMSL1"	ENSG00000064933	"PMS1 homolog 1, mismatch repair system component"	P54277	2	189784085-189877629	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031013			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA031013: "	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (2.38e-6)"	"unprognostic (5.31e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (1.86e-6)"	"unprognostic (1.29e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.92e-2)"	"prognostic favourable (3.73e-4)"	9.8	8.2	9.6	9.8	12.4	9.9	10.1	14.6	13.2	10.6	7.5	6.9	17.3	6.6	11.8	14.5	7.3	11.4	7.5	7.1	9.7	8.0	6.3	8.6	7.1	11.1	10.1	9.9	12.2	9.8	7.6	18.2	7.6	14.2	8.9	8.2	6.7	8.4	15.0	8.4	9.9	8.5	9.6	10.7	11.1	11.5	38.8	10.9	9.6	9.6	7.3	9.2	8.2	8.4	14.0	8.1	2.9	5.5	9.0	13.2	3.7	7.9	7.2	18.4	14.5	10.1	15.3	16.2	15.2	7.5	12.9	15.7	11.8	10.9	23.7	8.7	6.3	11.8	17.9	11.2	18.4	17.7	10.4	23.6	13.1	17.6	14.0	13.6	10.7	9.8	11.4	12.0	24.6	13.4	19.6	12.9	15.9	5.5	16.1	19.1	18.2	16.6	18.7	12.6	22.7	12.4	11.7	17.2	12.0	11.3	7.1	10.8	8.1	11.2	10.4	14.1	9.7	8.8	13.4	10.3	12.6	20.5	8.2	12.1	8.9	2.2	5.5	2.9	12.0	3.3	11.2	11.7	8.8	13.2	5.0	14.0	8.9	11.4	2.8	9.0	4.1	8.1	8.2	3.7	9.6	12.4	14.6	13.2	9.7	8.0	10.1	9.9	14.2	10.9
PMS2	"H_DJ0042M02.9, HNPCC4, MLH4, PMSL2"	ENSG00000122512	"PMS1 homolog 2, mismatch repair system component"	P54278	7	5973239-6009125	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010235, HPA066490, HPA070310"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB010235: AB_2167281, HPA066490: , HPA070310: "	"unprognostic (5.13e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.38e-2)"	"prognostic favourable (1.23e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-2)"	6.3	7.4	8.7	6.0	19.8	3.6	8.1	15.5	21.2	6.2	6.0	11.5	6.9	6.4	6.4	6.3	7.5	7.5	5.0	5.3	9.0	10.3	14.2	5.8	5.5	9.1	8.4	9.5	7.5	7.1	16.6	7.1	5.9	16.2	7.0	6.2	8.0	7.1	7.8	5.7	14.8	6.8	7.1	7.5	6.9	6.1	4.8	5.8	7.5	12.4	5.7	10.7	7.7	6.5	6.2	5.8	7.2	7.9	4.0	9.3	6.3	9.5	10.5	8.4	20.9	6.6	9.8	7.2	5.2	3.9	5.0	4.1	9.1	6.9	18.1	6.2	7.4	13.2	12.6	3.3	5.5	7.1	5.1	7.9	8.5	6.5	11.3	9.7	5.4	10.3	9.6	4.0	15.0	9.2	14.7	8.8	8.3	8.8	2.9	6.9	8.5	6.4	9.9	10.1	9.2	10.6	7.2	7.7	16.6	10.1	14.7	11.0	18.2	6.8	7.8	6.4	14.3	9.4	9.3	11.8	19.7	18.2	4.5	9.5	14.6	7.2	5.4	3.1	8.4	7.9	9.3	6.2	6.6	7.2	5.8	5.6	8.8	6.2	2.4	4.0	3.2	5.3	6.4	6.3	8.7	19.8	15.5	21.2	9.0	10.3	8.4	9.5	16.2	5.8
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99398051-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favourable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favourable (1.09e-4)"	24.7	28.5	48.9	28.3	49.8	53.7	29.9	123.3	69.7	35.5	38.3	22.8	39.9	26.7	43.1	58.7	19.8	29.4	22.3	31.0	46.9	17.5	25.5	21.7	26.6	42.2	48.0	29.8	49.3	24.7	34.7	83.9	21.7	41.0	34.1	28.2	24.1	30.8	34.5	39.4	31.9	34.4	31.5	61.0	39.3	28.2	17.4	57.1	32.1	44.7	18.0	30.7	29.5	30.3	18.0	13.1	20.4	7.4	15.6	12.3	2.2	11.3	7.7	41.3	28.3	14.7	21.9	19.1	18.0	9.9	10.8	13.4	13.8	20.7	34.9	12.1	10.1	17.4	20.7	15.7	21.9	28.6	23.1	20.2	38.3	13.8	11.2	28.0	28.7	21.5	22.4	12.0	15.7	15.7	23.5	22.9	14.2	11.4	13.3	32.2	23.1	7.1	26.9	11.6	12.4	21.2	19.7	16.7	22.1	9.0	11.7	15.4	15.6	24.7	17.3	10.9	12.8	10.6	15.4	15.9	11.0	32.0	16.4	28.9	12.6	6.9	7.4	6.6	8.6	4.2	8.5	12.0	8.4	6.8	3.3	18.0	12.3	11.8	20.4	15.6	4.8	13.1	7.7	2.2	48.9	49.8	123.3	69.7	46.9	17.5	48.0	29.8	41.0	57.1
PNKD	"BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2"	ENSG00000127838	"Paroxysmal nonkinesigenic dyskinesia"	Q8N490	2	218270392-218346793	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010134, HPA017068"	Approved		Enhanced	Mitochondria			31000	Mitochondria		"HPA010134: AB_1079645, HPA017068: AB_1855495"	"unprognostic (3.15e-3)"	"unprognostic (1.80e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavourable (5.13e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-3)"	21.8	28.3	33.2	15.9	41.0	13.4	16.4	26.6	51.1	29.8	27.5	14.3	28.9	18.1	14.6	37.0	13.3	28.3	30.4	37.3	31.0	26.5	42.4	107.0	23.4	34.2	33.2	23.6	18.1	18.8	22.3	15.6	28.1	26.8	34.8	25.1	15.9	27.3	27.1	33.8	12.9	15.9	16.6	25.7	18.0	29.5	23.3	20.6	11.6	29.7	15.3	16.3	19.0	13.4	64.0	32.7	44.9	35.4	38.4	43.3	38.9	15.2	20.0	14.7	23.0	22.1	18.7	27.1	9.6	20.8	22.8	25.7	32.8	15.1	17.9	19.3	16.0	15.8	28.2	18.0	16.1	37.1	35.2	26.0	36.6	48.4	24.2	16.8	11.6	25.4	17.8	15.6	4.5	24.6	19.1	23.3	20.2	43.7	21.8	40.1	14.6	20.5	21.5	14.8	14.9	26.2	23.2	14.2	12.0	6.9	46.9	27.3	15.6	16.3	15.2	9.5	16.3	11.2	13.0	9.7	9.9	19.2	24.2	27.7	11.4	33.7	35.4	44.9	32.1	34.1	30.4	64.0	35.1	38.3	32.7	52.0	38.8	37.3	9.8	38.4	31.0	30.4	43.3	38.9	33.2	41.0	26.6	51.1	31.0	26.5	33.2	23.6	26.8	20.6
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favourable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	13.1	32.4	11.2	22.0	11.8	24.3	15.0	18.0	13.8	14.0	17.4	17.0	26.4	15.6	16.7	25.3	13.6	18.1	18.2	16.8	12.3	9.5	20.1	16.8	15.9	21.0	13.9	14.2	17.1	22.5	19.7	26.8	17.1	12.9	18.7	15.0	19.6	20.3	22.4	12.8	15.3	15.7	13.2	10.1	30.7	17.9	17.2	13.9	22.3	23.0	17.0	20.6	14.6	12.4	7.9	7.5	19.3	12.7	2.7	7.7	3.8	12.8	8.7	8.8	13.8	8.4	6.5	14.3	20.8	10.6	9.6	8.4	6.9	16.9	8.3	6.6	6.3	10.5	3.1	11.7	5.7	10.7	13.3	14.1	16.4	6.0	6.3	13.3	19.0	6.1	6.2	8.7	5.7	12.6	6.9	16.8	12.5	8.2	13.5	10.7	8.2	17.7	11.5	8.1	16.8	9.9	27.5	10.4	16.8	9.1	27.4	4.6	4.7	8.3	17.8	18.8	11.5	4.5	17.1	18.6	7.5	6.7	17.0	6.0	14.9	1.4	8.8	12.2	7.7	8.5	6.4	6.5	6.6	5.8	7.5	7.9	4.9	4.4	19.3	2.7	12.7	4.3	6.8	3.8	11.2	11.8	18.0	13.8	12.3	9.5	13.9	14.2	12.9	13.9
PNN	memA	ENSG00000100941	"Pinin, desmosome associated protein"	Q9H307	14	39175183-39183218	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001378	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA001378: AB_1079648"	"unprognostic (9.28e-3)"	"unprognostic (5.07e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.38e-3)"	"unprognostic (7.40e-2)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.30e-2)"	21.7	25.3	38.9	38.4	50.8	57.5	26.1	54.3	39.3	31.0	30.0	26.4	34.6	27.9	40.4	66.6	29.5	29.6	21.6	19.1	40.1	18.4	27.3	45.7	24.2	40.7	43.9	31.2	36.6	31.3	31.3	61.3	26.7	44.8	33.9	32.0	18.7	26.7	24.5	37.7	27.0	36.0	34.7	49.1	42.6	26.9	21.7	50.4	32.7	37.1	25.9	32.8	28.4	39.9	20.8	15.8	20.4	10.5	10.6	13.5	3.9	32.1	15.4	42.2	20.7	9.8	8.6	31.1	25.7	7.2	17.7	17.1	24.5	50.6	49.7	16.4	11.2	33.9	31.9	17.5	30.9	22.4	22.7	33.0	46.6	54.1	8.1	42.7	24.2	11.8	15.3	16.1	13.4	11.3	31.2	28.0	14.5	26.5	30.2	36.6	28.0	22.7	40.1	31.5	13.3	14.6	49.1	21.0	11.8	26.5	20.4	14.8	25.1	24.7	20.8	25.9	20.5	12.0	30.2	23.0	18.2	42.8	13.0	35.5	15.4	5.1	10.2	15.1	13.2	8.0	12.2	14.8	9.0	8.0	8.3	20.8	13.5	12.3	20.4	10.6	10.5	15.8	9.7	3.9	38.9	50.8	54.3	39.3	40.1	18.4	43.9	31.2	44.8	50.4
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157844-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056928			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavourable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	18.5	19.2	13.0	17.2	19.0	21.8	15.4	10.0	12.8	10.8	13.1	9.1	10.2	9.9	15.3	15.4	14.9	13.8	13.2	24.5	19.1	9.6	16.6	27.4	12.9	15.0	15.0	11.9	20.0	27.0	13.2	15.7	16.3	13.1	14.4	12.2	8.9	12.7	15.0	48.8	12.4	9.5	15.1	11.7	13.6	13.2	11.4	13.9	9.7	16.6	15.1	15.2	15.8	21.4	14.7	12.6	2.0	13.2	10.6	15.5	14.4	15.1	16.6	7.7	12.6	9.5	7.9	19.4	14.5	9.4	16.3	11.6	31.8	9.0	20.8	12.2	9.6	13.0	24.8	17.1	25.7	14.4	17.4	20.2	7.9	23.3	14.8	16.1	9.3	10.2	12.6	16.5	18.9	11.9	27.8	11.3	14.6	11.2	15.7	15.2	21.7	18.1	13.3	19.0	22.1	12.4	12.9	13.8	10.3	10.8	13.4	23.2	9.5	9.0	8.9	18.8	20.3	16.7	40.1	9.1	13.1	32.1	15.4	24.1	25.5	0.4	9.4	1.9	10.1	13.2	15.5	14.7	11.4	11.5	12.6	11.1	13.3	12.2	2.0	10.6	9.4	9.0	11.7	14.4	13.0	19.0	10.0	12.8	19.1	9.6	15.0	11.9	13.1	13.9
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477094	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 153.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 81.4;U-937: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol			100000000	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	24.7	7.6	9.5	15.0	14.0	69.4	15.7	13.9	11.8	9.5	19.1	6.2	25.2	29.4	5.9	153.1	34.0	7.8	15.7	12.1	11.5	8.4	49.7	24.2	18.3	13.2	13.5	3.4	3.6	11.0	8.7	8.4	45.3	17.7	6.0	16.1	3.8	9.2	7.9	3.3	10.6	32.0	9.8	16.3	18.0	17.0	4.5	12.5	7.0	7.1	21.7	19.1	7.5	14.7	13.1	20.7	4.1	12.4	15.7	33.7	12.1	13.2	17.9	3.8	8.6	4.3	3.5	11.7	13.6	6.4	11.1	11.0	10.3	12.2	35.4	15.8	7.2	14.3	20.1	25.6	14.8	11.4	17.7	29.6	15.3	17.0	4.0	81.4	15.4	2.3	9.3	33.5	14.8	47.3	14.5	22.1	13.9	12.3	23.9	48.0	10.8	29.9	20.2	5.7	13.7	39.4	12.6	16.6	3.7	26.0	33.2	2.1	12.2	14.5	37.9	7.6	10.1	17.1	23.0	10.2	17.0	40.1	6.5	92.8	0.7	4.0	12.4	4.1	18.1	11.5	33.7	11.2	20.3	20.0	20.7	13.1	12.9	16.3	1.6	15.7	10.6	11.7	6.9	12.1	9.5	14.0	13.9	11.8	11.5	8.4	13.5	3.4	17.7	12.5
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"				"Lipid droplets"	Nucleoplasm	"HPA055173: , HPA062602: , HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.4	8.2	1.7	4.4	64.1	5.7	11.0	11.1	9.0	7.0	6.2	6.9	10.5	6.2	6.6	8.3	9.4	2.5	4.6	2.1	7.9	22.7	8.5	3.6	11.1	21.0	5.8	10.8	11.2	6.0	4.7	5.4	5.7	7.2	6.3	6.2	6.1	7.8	12.9	4.9	17.6	7.6	3.7	13.8	6.8	2.4	6.3	8.4	20.6	17.6	6.4	7.5	6.8	10.2	6.3	4.9	4.1	5.0	24.3	15.0	5.2	15.8	8.4	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Enhanced	Nucleoplasm,Cytosol			150000	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	6.0	13.1	9.9	5.1	13.0	2.9	8.6	8.3	16.5	6.2	7.0	8.6	6.9	8.5	4.2	9.6	8.1	8.4	10.1	10.2	8.7	12.0	26.0	64.7	5.3	7.7	11.2	9.9	8.0	13.7	17.3	7.4	5.8	11.1	6.9	7.4	8.4	8.3	7.1	14.7	5.5	9.6	5.2	7.1	6.8	6.7	6.4	6.0	5.2	14.4	8.2	6.1	5.4	5.2	6.8	12.2	2.4	16.4	7.7	8.2	8.7	17.5	14.5	1.1	2.7	7.4	5.7	0.0	5.9	3.9	6.7	5.8	23.8	13.0	16.7	28.5	5.9	10.6	9.1	16.2	9.7	20.3	7.8	11.8	6.8	24.7	8.0	10.4	8.1	7.6	12.7	12.4	15.4	8.7	11.1	5.8	7.8	13.1	10.5	3.4	2.1	18.0	8.9	5.1	12.2	18.5	9.1	5.9	4.9	5.4	8.8	5.0	15.6	3.8	9.1	10.8	6.3	10.7	12.4	13.8	15.2	8.8	8.8	9.1	5.5	2.1	11.0	2.4	6.8	16.4	8.0	6.8	6.2	7.4	12.2	5.7	8.2	7.9	1.1	7.7	10.4	8.9	6.4	8.7	9.9	13.0	8.3	16.5	8.7	12.0	11.2	9.9	11.1	6.0
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634265-55693910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Enhanced	Mitochondria				Mitochondria		"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	11.1	11.7	13.3	6.5	21.7	11.7	10.8	13.3	18.8	5.7	8.2	12.8	5.4	5.7	8.3	8.8	9.5	7.9	5.8	11.0	12.4	10.9	9.8	11.4	9.1	7.1	24.1	7.4	6.9	9.1	7.4	14.3	5.1	15.2	7.7	10.1	4.2	9.0	6.3	23.5	10.1	7.0	7.9	17.6	10.4	7.6	13.5	22.5	9.6	10.0	7.8	5.9	5.3	7.4	9.8	7.4	6.1	6.5	3.8	8.6	4.7	6.7	3.6	5.0	2.3	3.6	6.3	6.7	10.0	6.1	15.9	10.7	10.5	3.2	14.1	4.2	4.7	5.4	6.4	7.8	7.4	5.0	14.2	8.1	4.6	5.3	9.5	18.3	5.5	7.0	5.4	6.6	5.7	4.9	8.5	3.2	6.3	3.8	11.2	12.8	12.1	6.1	11.1	8.4	12.4	6.7	4.2	12.2	7.3	3.6	11.1	12.2	3.0	8.1	5.1	3.8	3.2	3.3	10.2	14.3	1.1	3.0	7.2	16.0	6.4	4.2	6.5	6.1	8.1	5.7	4.8	5.4	3.7	8.6	2.8	9.8	6.9	7.9	6.1	3.8	5.1	7.4	2.4	4.7	13.3	21.7	13.3	18.8	12.4	10.9	24.1	7.4	15.2	22.5
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23959109-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favourable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favourable (4.05e-4)"	35.6	32.8	21.1	39.3	21.4	39.0	36.8	22.3	21.0	38.6	40.6	17.1	25.9	32.0	37.5	24.4	28.7	24.9	32.7	41.9	20.9	19.4	33.3	21.3	37.2	40.6	21.8	20.2	39.7	25.2	29.2	28.5	36.2	18.6	37.1	30.8	23.8	26.2	30.1	32.8	18.7	38.4	37.9	26.1	34.4	29.3	16.9	18.7	44.6	56.0	23.0	34.4	49.1	35.6	46.8	38.9	69.5	40.5	36.6	48.9	52.8	23.6	9.4	41.3	28.5	28.6	26.3	15.8	26.3	23.5	30.7	24.7	27.4	30.0	64.7	25.9	16.7	21.1	27.6	22.9	34.2	45.9	17.8	61.4	28.9	28.7	24.4	59.5	28.2	19.7	29.0	25.1	23.5	29.6	51.9	36.4	17.9	19.3	36.8	22.7	55.9	17.5	41.8	26.9	27.4	30.8	25.5	24.8	21.7	22.8	19.6	26.8	21.3	37.5	23.6	19.9	19.2	19.4	16.7	30.8	35.3	44.2	13.5	57.7	20.3	69.5	40.0	44.0	39.6	40.5	41.3	46.8	43.3	42.6	38.9	46.7	48.9	41.2	26.7	36.6	37.1	27.9	44.6	52.8	21.1	21.4	22.3	21.0	20.9	19.4	21.8	20.2	18.6	18.7
POC5	"C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444"	ENSG00000152359	"POC5 centriolar protein"	Q8NA72	5	75674124-75717481	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037509, HPA037510, HPA061521"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA037509: , HPA037510: AB_10672349, HPA061521: "	"unprognostic (1.33e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (1.60e-7)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.62e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (6.74e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (1.09e-4)"	8.3	8.9	9.3	9.2	17.0	12.4	13.5	12.7	11.5	9.8	7.1	10.1	6.4	6.2	10.9	12.0	6.1	12.8	6.2	5.4	8.6	8.3	9.8	6.6	8.2	14.1	13.8	8.7	16.2	7.8	8.6	6.5	10.5	16.2	9.8	9.1	10.2	6.7	7.7	5.6	8.9	8.6	10.4	13.6	15.1	7.6	25.5	11.1	27.2	8.3	5.3	14.6	8.5	8.4	15.6	15.2	20.4	9.9	14.9	18.5	7.6	9.2	7.1	12.1	12.0	5.2	4.2	8.9	8.8	5.2	15.4	11.6	10.5	8.3	12.2	17.0	4.6	8.5	10.7	8.5	11.6	12.7	7.0	7.9	5.4	5.7	7.1	9.1	15.8	4.7	8.4	11.5	19.6	6.1	7.6	22.4	7.1	10.6	14.9	11.6	5.2	6.2	9.4	10.0	14.5	7.0	4.5	9.6	10.6	8.1	4.5	9.2	8.5	10.4	2.6	5.2	11.5	9.0	17.5	14.1	29.1	17.7	7.8	11.9	12.4	7.1	9.3	20.4	13.7	9.9	12.0	13.4	14.0	14.8	13.6	15.6	14.7	14.0	8.8	14.9	7.6	15.2	18.5	7.6	9.3	17.0	12.7	11.5	8.6	8.3	13.8	8.7	16.2	11.1
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B, actin binding protein"	Q8WVV4	X	85277396-85379743	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.8;skin 1: 55.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.0;CAPAN-2: 11.3;HaCaT: 11.5;RT4: 38.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.0;naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"			430000	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.5	0.4	0.3	9.9	0.3	0.0	3.7	0.4	0.4	7.0	41.8	0.0	0.5	10.9	0.8	1.6	21.4	1.6	10.0	6.3	0.3	0.3	2.5	0.5	1.4	0.4	0.3	0.2	1.0	2.9	0.0	2.5	3.4	0.1	3.9	16.9	0.1	5.6	0.9	0.4	55.6	55.8	0.7	0.4	5.5	7.6	0.4	0.0	0.3	0.7	20.3	9.2	4.9	6.9	6.0	0.0	0.0	0.0	0.0	0.8	0.1	1.7	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	11.3	5.8	1.6	0.0	11.5	2.5	0.1	0.0	1.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	1.9	0.0	4.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	38.6	0.0	0.0	0.0	2.9	0.0	1.2	0.5	0.1	0.0	0.0	0.1	0.1	0.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.2	0.1	0.0
POGK	"BASS2, KIAA15131, KRBOX2, LST003"	ENSG00000143157	"Pogo transposable element derived with KRAB domain"	Q9P215	1	166839447-166856344	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007838, HPA031630"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA007838: AB_1079651, HPA031630: AB_10601490"	"unprognostic (3.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (5.93e-4)"	"unprognostic (4.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	12.1	10.3	24.3	15.1	27.3	10.4	24.2	18.4	23.6	17.6	13.1	27.6	8.4	10.2	17.6	12.6	16.1	13.5	12.4	11.1	24.4	18.4	15.7	12.0	20.9	13.5	27.7	17.7	19.9	14.8	30.0	10.0	15.1	21.1	12.0	15.4	12.2	12.9	15.2	6.6	20.2	12.1	16.8	30.5	14.5	14.9	6.8	25.6	9.2	13.0	5.2	17.7	16.9	24.2	9.4	10.0	6.3	10.8	9.9	7.3	5.6	15.6	13.3	14.6	17.9	15.5	12.9	8.3	10.9	11.1	14.0	10.6	10.1	13.4	17.6	16.4	11.2	15.7	18.1	14.4	12.8	21.4	12.4	6.9	12.1	7.1	13.2	24.7	19.6	9.7	22.9	15.7	22.5	12.4	23.8	12.0	13.4	7.5	15.3	6.2	23.8	15.3	17.5	8.0	15.5	14.6	38.3	19.1	23.0	15.5	21.5	20.1	20.4	23.1	11.5	14.9	14.8	11.7	19.6	16.9	21.8	23.1	8.3	12.4	14.0	2.8	7.7	6.3	6.7	9.9	7.3	9.4	6.5	7.1	10.0	5.8	6.1	6.3	1.1	9.9	10.8	5.0	5.6	5.6	24.3	27.3	18.4	23.6	24.4	18.4	27.7	17.7	21.1	25.6
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468938-119494708	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"			"Endoplasmic reticulum"	Cytosol	"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favourable (2.23e-4)"	11.9	12.1	7.6	10.7	12.0	3.9	10.9	13.9	10.6	10.1	9.5	9.8	27.4	5.9	13.7	11.7	9.3	10.1	6.9	8.3	7.3	8.9	8.3	10.3	9.1	14.3	15.0	5.6	10.5	29.2	12.1	14.5	11.5	10.9	9.4	10.9	8.7	7.8	25.7	5.1	14.0	12.1	15.2	14.0	14.9	8.2	4.7	8.9	11.7	8.6	4.1	15.6	10.6	10.2	9.9	14.3	9.4	11.5	19.8	16.0	10.3	7.4	5.0	8.7	9.6	22.0	12.6	6.2	11.9	12.2	9.7	13.3	8.1	4.9	11.5	16.2	15.0	8.8	11.6	11.8	15.4	9.9	7.5	13.5	7.9	8.8	14.3	14.8	15.9	12.9	7.7	9.6	13.5	11.0	7.3	14.1	9.8	7.5	8.4	14.3	8.9	9.2	8.4	8.8	16.9	8.4	9.6	9.5	14.6	5.7	3.6	9.2	9.5	12.4	13.9	9.5	5.9	2.8	6.1	19.4	16.8	15.7	8.3	15.0	13.4	1.9	11.5	9.4	12.0	10.8	13.8	9.9	13.6	12.5	14.3	7.0	16.0	15.2	0.9	19.8	7.0	8.0	14.7	10.3	7.6	12.0	13.9	10.6	7.3	8.9	15.0	5.6	10.9	8.9
POGZ	"KIAA0461, ZNF280E, ZNF635m"	ENSG00000143442	"Pogo transposable element derived with ZNF domain"	Q7Z3K3	1	151402724-151459465	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division"	DNA-binding	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006800, HPA008781"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006800: AB_1855516, HPA008781: AB_1855517"	"unprognostic (2.87e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavourable (8.67e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.00e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavourable (3.92e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (4.40e-4)"	11.6	15.2	18.3	15.6	20.1	23.5	18.2	40.6	24.8	16.1	17.8	22.2	21.9	10.0	24.2	39.0	11.0	23.9	17.7	12.4	15.4	13.5	16.9	14.4	13.9	12.7	18.7	20.7	37.4	13.2	33.0	26.8	10.4	17.3	17.8	14.5	17.1	15.4	17.6	15.4	24.1	13.0	19.3	20.3	16.7	13.1	21.2	21.8	20.3	21.6	7.4	13.9	15.0	17.6	5.2	4.0	7.8	2.6	2.9	5.6	1.8	9.8	13.0	32.6	18.4	14.6	14.2	11.2	8.7	8.0	10.0	10.5	14.5	10.4	20.9	15.2	11.0	8.7	18.8	9.3	13.1	17.7	10.5	12.7	17.7	8.3	10.8	17.6	13.1	12.5	7.7	11.0	13.3	15.9	11.9	20.2	9.8	25.4	19.4	11.5	23.1	7.8	19.0	15.6	10.7	10.8	16.3	17.8	18.2	14.7	12.5	14.5	16.3	23.1	13.2	12.1	14.6	10.0	12.6	14.7	12.6	40.5	8.7	9.4	10.2	7.8	2.5	5.5	4.2	2.1	3.6	5.0	4.2	5.6	2.2	5.2	4.3	4.2	4.8	2.9	2.6	4.0	2.9	1.8	18.3	20.1	40.6	24.8	15.4	13.5	18.7	20.7	17.3	21.8
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693919-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	10.5	5.5	8.0	15.0	10.2	14.3	10.9	12.0	9.6	10.1	9.7	11.8	5.8	5.7	11.2	7.7	10.2	8.9	5.5	9.3	7.8	6.6	6.1	4.9	7.2	12.7	10.3	4.5	12.9	7.3	8.5	8.5	10.7	8.7	7.3	11.0	7.5	7.9	9.3	22.4	9.3	7.5	9.7	13.1	9.0	7.9	5.7	10.0	30.1	7.0	8.5	14.7	9.9	10.6	4.6	2.5	1.2	4.6	2.7	3.8	1.7	14.0	10.5	13.9	11.2	2.6	3.1	3.1	10.5	5.8	11.3	13.0	8.7	7.4	18.0	3.6	4.5	11.6	26.4	8.5	15.3	9.3	11.2	13.4	20.5	6.5	1.1	17.5	7.2	2.0	1.8	14.1	4.1	5.8	12.3	9.2	7.8	9.8	19.0	5.9	13.5	8.8	17.1	36.5	13.6	4.1	9.3	12.6	7.8	12.4	5.9	5.6	11.6	5.8	4.6	10.0	6.9	19.1	10.0	5.5	7.9	14.5	5.8	8.3	11.1	0.0	2.0	1.2	3.0	4.6	2.9	4.6	3.4	3.8	2.5	3.2	2.4	2.4	0.6	2.7	1.3	1.6	3.6	1.7	8.0	10.2	12.0	9.6	7.8	6.6	10.3	4.5	8.7	10.0
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261762-65305589	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037570	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favourable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	7.5	6.6	4.9	11.9	8.8	9.8	7.5	14.1	8.8	12.0	9.6	9.8	6.4	6.7	10.1	5.5	10.4	9.3	5.9	6.1	5.2	4.5	7.9	7.0	7.5	14.7	10.3	5.5	10.3	7.9	8.0	4.8	9.3	6.5	7.1	9.6	6.7	8.9	7.5	6.5	8.0	9.2	10.7	10.2	13.6	8.8	15.0	8.4	35.7	7.9	10.3	19.7	8.6	7.3	6.0	13.3	8.0	10.1	4.9	7.3	7.7	14.2	13.1	21.6	10.0	3.2	3.9	7.4	9.7	15.5	31.4	23.2	5.2	12.5	17.1	11.2	8.5	8.9	17.6	14.6	26.9	9.2	6.6	12.8	19.8	5.9	1.9	11.9	10.6	2.6	2.0	27.2	5.7	11.6	12.4	11.5	21.2	19.6	25.5	5.3	16.1	8.3	13.8	12.6	16.4	9.4	9.8	14.1	8.4	9.3	10.2	3.2	12.8	6.1	4.3	11.6	9.4	15.3	7.0	5.4	6.4	17.6	8.3	7.6	15.5	8.0	10.1	3.9	6.5	9.5	7.3	6.0	6.9	7.1	13.3	5.6	5.6	5.1	5.0	4.9	7.6	10.4	7.1	7.7	4.9	8.8	14.1	8.8	5.2	4.5	10.3	5.5	6.5	8.4
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418016	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB004375: AB_675487, HPA046524: "	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	7.9	5.7	5.4	18.3	9.9	31.6	6.6	9.4	5.4	8.2	10.0	6.1	5.9	6.8	9.5	7.2	11.3	6.9	5.2	5.5	4.4	3.2	7.6	9.3	10.9	15.7	7.0	3.6	8.2	8.4	5.2	5.1	10.9	6.7	6.3	5.2	4.9	8.1	5.4	7.2	13.1	9.9	6.2	7.7	14.1	6.5	13.2	6.5	27.4	12.1	8.1	14.2	5.9	7.8	9.3	10.5	2.1	8.5	5.4	7.3	5.6	18.1	25.0	13.7	7.9	1.7	1.5	14.1	11.3	5.0	13.9	17.8	13.6	14.4	26.0	6.4	3.4	14.9	16.2	12.3	4.8	21.9	43.5	22.6	24.2	17.9	1.6	21.5	20.0	2.9	3.8	12.6	3.8	7.1	24.3	20.2	5.8	12.2	33.3	33.7	16.1	18.2	33.1	23.0	22.8	4.4	17.3	14.3	12.9	11.2	13.8	2.6	7.6	20.4	5.6	7.1	23.0	7.6	19.8	19.1	31.4	27.8	7.7	24.3	6.9	1.6	6.2	2.1	7.3	7.8	6.2	7.8	6.5	5.9	5.7	9.3	6.5	5.9	1.1	5.4	8.5	10.5	4.5	5.6	5.4	9.9	9.4	5.4	4.4	3.2	7.0	3.6	6.7	6.5
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114681-44124358	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	17.2	19.1	17.5	14.3	16.7	16.3	33.9	14.3	25.9	15.8	15.4	17.1	12.6	13.9	16.1	9.7	27.5	34.5	14.5	35.9	16.3	13.8	15.9	43.6	15.3	16.2	15.2	14.7	24.4	49.0	18.9	17.9	12.9	15.0	15.9	12.9	17.4	19.9	14.3	42.6	19.3	11.5	15.7	13.7	11.9	16.0	14.4	14.8	27.7	20.3	25.1	15.8	13.4	16.7	28.1	37.0	3.2	13.7	13.3	29.3	21.3	26.1	34.6	19.3	40.4	17.2	18.5	19.2	16.2	16.3	22.2	16.6	29.2	25.2	60.6	20.7	23.2	36.3	31.6	44.1	14.5	17.2	37.1	13.4	37.2	24.6	19.6	40.7	16.4	16.8	27.0	34.3	33.5	18.6	48.8	29.1	24.5	42.7	49.6	77.1	30.3	34.0	33.5	25.9	86.0	19.3	16.9	38.3	30.0	20.1	72.7	13.8	42.0	52.6	14.5	29.5	37.2	36.1	50.5	45.9	67.8	58.1	26.4	41.3	41.6	0.5	13.7	3.2	17.9	12.4	26.8	28.1	21.6	18.2	23.2	27.3	29.3	21.4	1.1	13.3	11.8	37.0	17.0	21.3	17.5	16.7	14.3	25.9	16.3	13.8	15.2	14.7	15.0	14.8
POLD3	"KIAA0039, P66, P68, PPP1R128"	ENSG00000077514	"DNA polymerase delta 3, accessory subunit"	Q15054	11	74493851-74669117	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058846	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA058846: "	"unprognostic (3.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavourable (9.17e-4)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (3.99e-3)"	"unprognostic (1.54e-3)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (7.90e-6)"	"unprognostic (7.92e-3)"	"unprognostic (2.65e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.23e-1)"	12.6	8.2	11.3	12.8	17.5	8.3	12.7	10.3	16.4	13.8	15.6	12.5	10.3	14.5	18.1	11.7	14.1	15.6	14.1	9.6	10.2	7.8	40.3	10.0	12.7	14.0	12.1	13.1	15.9	17.5	9.3	16.0	12.4	12.3	13.2	17.2	9.9	13.0	11.8	10.4	10.8	17.1	18.2	9.1	13.9	14.5	19.8	13.9	15.2	14.2	8.0	13.5	15.9	13.7	8.1	14.7	16.5	19.0	8.7	11.0	9.6	12.3	11.2	17.4	11.9	5.4	9.3	12.4	16.8	9.4	17.6	14.9	14.7	16.1	17.6	12.5	8.0	16.2	14.4	11.0	22.2	13.2	9.2	11.2	17.5	4.9	3.9	21.4	10.2	4.1	7.0	20.4	11.0	6.7	10.1	14.2	10.1	9.7	24.0	9.6	10.5	11.6	23.1	43.9	14.6	8.0	11.9	11.7	7.8	19.9	10.0	19.4	11.7	13.7	6.4	17.4	12.6	19.5	13.2	10.0	20.9	39.4	10.0	13.6	13.1	6.0	19.0	12.5	8.2	15.1	8.1	8.1	10.4	7.2	14.7	6.7	10.4	8.5	16.5	8.7	14.8	4.3	11.0	9.6	11.3	17.5	10.3	16.4	10.2	7.8	12.1	13.1	12.3	13.9
POLDIP3	"KIAA1649, PDIP3, PDIP46, SKAR"	ENSG00000100227	"DNA polymerase delta interacting protein 3"	Q9BY77	22	42583721-42614962	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018419, HPA048790"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA018419: AB_1856928, HPA048790: "	"unprognostic (2.00e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.05e-3)"	"prognostic favourable (7.79e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.96e-2)"	"prognostic favourable (3.36e-4)"	"unprognostic (3.73e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	17.7	24.5	25.8	22.9	31.6	43.8	25.3	30.9	33.2	28.4	23.2	36.2	23.4	19.2	31.3	27.8	28.1	41.4	28.8	20.6	25.9	19.2	24.4	19.7	25.1	24.4	38.0	24.9	71.5	24.1	27.7	24.4	30.8	27.4	27.5	22.5	24.0	28.1	27.0	23.8	28.5	21.2	27.2	24.5	26.9	28.0	28.2	38.3	37.9	33.5	17.4	33.2	21.2	27.0	22.2	33.0	22.7	28.5	20.9	26.8	27.0	17.1	17.6	39.7	18.4	17.9	20.7	25.5	19.8	16.8	30.5	22.8	20.5	11.9	29.1	12.8	23.4	20.0	41.3	22.6	23.9	14.0	30.4	23.1	20.7	21.2	16.7	35.9	23.7	14.3	25.8	22.4	23.4	21.4	24.7	19.4	24.0	19.1	29.9	26.0	22.0	16.6	38.0	36.1	19.7	25.4	11.1	13.1	11.2	24.0	21.0	21.1	19.3	26.4	19.4	19.4	23.5	13.1	19.8	18.9	23.0	27.0	15.8	22.3	27.3	18.1	28.5	22.7	25.7	26.5	26.8	22.2	23.0	21.8	33.0	22.2	25.6	22.5	16.6	20.9	22.7	16.9	23.7	27.0	25.8	31.6	30.9	33.2	25.9	19.2	38.0	24.9	27.4	38.3
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687365	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 34.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA058210: , HPA067385: "	"unprognostic (1.60e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (3.19e-8)"	"unprognostic (8.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	6.1	3.4	6.7	10.2	4.4	29.3	6.2	34.8	14.4	7.0	6.6	2.0	7.6	7.3	6.1	4.4	7.5	6.2	6.5	4.7	5.6	1.6	3.8	8.6	5.4	8.2	3.3	4.3	8.7	6.8	3.6	3.1	6.5	5.1	6.8	7.7	4.3	8.7	7.4	8.9	17.9	8.5	6.8	3.7	16.7	7.8	25.6	4.4	29.8	5.1	6.0	10.3	6.7	8.7	0.5	1.7	0.8	0.8	4.8	0.7	0.5	11.1	14.9	22.1	10.6	4.7	3.6	19.7	11.4	5.2	13.7	10.0	18.0	6.6	12.8	4.8	6.2	15.5	15.4	7.7	8.4	5.9	19.5	20.2	19.2	8.8	0.9	15.8	11.6	2.8	3.0	14.2	4.7	4.8	22.6	7.2	6.7	18.1	25.9	28.9	17.2	8.9	21.5	12.5	5.8	4.3	18.3	18.5	10.6	13.3	10.9	2.5	16.1	9.8	4.3	12.5	12.8	9.4	11.5	9.6	6.5	20.1	6.8	21.9	8.8	0.0	0.3	0.8	0.5	0.1	0.7	0.5	0.3	0.4	0.7	0.3	0.5	0.3	0.1	4.8	0.8	1.7	0.6	0.5	6.7	4.4	34.8	14.4	5.6	1.6	3.3	4.3	5.1	4.4
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.6;lymphoid tissue: 17.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	3.3	2.2	1.5	11.6	2.8	17.6	3.4	1.7	1.6	4.4	4.2	1.1	1.5	2.6	2.8	3.5	9.0	2.4	2.3	1.6	1.0	1.2	2.5	5.1	2.2	5.3	1.1	0.3	2.7	5.0	1.4	2.5	4.1	1.4	2.1	5.2	2.6	2.6	0.7	1.1	3.7	7.7	2.9	2.7	5.4	3.0	5.3	2.4	17.6	1.6	10.3	8.4	2.1	4.2	1.2	0.9	0.7	0.0	3.2	2.7	0.5	17.1	8.8	16.7	7.7	0.8	4.9	8.5	9.8	5.0	15.6	18.1	8.8	13.5	10.7	5.6	5.5	10.6	16.7	6.0	18.5	12.5	9.2	15.9	9.7	10.9	0.4	18.9	6.9	1.4	0.4	8.5	1.4	9.0	13.9	6.9	15.6	15.0	19.2	12.4	9.8	20.6	16.4	15.4	9.7	5.6	9.7	12.0	6.9	9.9	5.8	3.1	11.7	6.7	3.2	2.5	18.6	10.4	7.7	5.0	10.2	24.7	4.7	14.0	10.0	0.0	0.0	0.7	0.9	0.0	0.7	1.2	0.9	1.7	0.6	1.2	0.1	0.8	0.0	3.2	0.0	0.9	2.7	0.5	1.5	2.8	1.7	1.6	1.0	1.2	1.1	0.3	1.4	2.4
POLG	"POLG1, POLGA"	ENSG00000140521	"DNA polymerase gamma, catalytic subunit"	P54098	15	89305198-89334861	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056821, HPA078482"	Approved		Supported	Mitochondria				Mitochondria		"HPA056821: , HPA078482: "	"unprognostic (1.87e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.45e-1)"	17.8	15.2	19.8	19.0	19.2	16.8	24.6	23.2	20.9	14.1	16.0	14.6	13.6	20.0	17.6	9.0	20.7	14.3	14.0	17.4	16.7	8.8	14.9	19.5	17.8	21.8	17.3	15.3	16.6	17.9	17.7	12.9	16.2	16.0	15.4	13.2	10.5	15.9	12.0	35.9	19.8	18.5	14.1	12.7	22.9	16.2	12.4	17.3	29.0	15.4	12.1	19.2	16.5	18.9	6.0	9.0	9.0	6.5	9.2	10.9	6.7	6.8	13.0	9.0	11.7	14.7	9.4	11.5	13.7	7.3	14.1	11.1	19.0	17.2	10.8	21.2	10.8	14.9	24.0	11.6	4.7	23.3	20.6	16.4	13.7	6.8	12.5	15.2	27.1	8.5	17.0	9.7	8.3	16.8	14.4	12.2	11.4	12.1	17.3	15.5	8.1	5.8	17.7	11.0	15.3	8.0	16.8	20.0	7.3	19.5	14.3	15.9	11.9	17.1	12.5	19.1	13.2	28.0	13.1	13.1	7.6	15.0	12.2	17.5	15.2	4.9	6.3	9.0	9.2	6.5	8.0	3.3	7.6	10.9	9.0	6.0	6.6	6.9	2.3	9.2	5.2	6.0	4.3	6.7	19.8	19.2	23.2	20.9	16.7	8.8	17.3	15.3	16.0	17.3
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576150-43615660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	7.4	9.4	7.5	9.7	10.4	4.6	7.2	10.5	10.5	8.5	8.4	12.7	8.0	5.7	9.6	7.1	11.4	7.8	6.2	6.7	5.3	4.4	7.2	7.5	9.8	16.3	8.9	8.1	7.4	13.0	7.1	9.7	5.1	7.9	6.9	10.1	8.9	8.6	5.6	9.5	11.7	7.9	11.8	6.9	9.2	7.6	24.7	6.8	22.1	9.9	6.2	18.3	8.6	8.4	8.6	4.3	4.5	2.6	6.8	7.2	3.2	20.2	4.7	6.3	9.2	9.0	14.9	15.0	21.7	6.8	12.7	14.7	5.3	3.6	22.5	5.5	8.8	5.1	6.4	13.7	15.8	11.3	4.9	6.6	13.1	15.4	6.7	11.2	8.9	10.0	16.7	10.4	5.6	12.0	10.4	13.5	16.0	6.7	10.2	2.9	1.9	3.5	11.2	6.5	5.6	4.8	15.2	7.1	2.4	6.9	5.8	3.4	8.2	5.0	16.2	11.8	11.4	5.5	10.9	12.7	8.8	40.6	5.6	6.6	12.8	4.5	2.6	4.1	7.2	2.5	6.4	7.8	6.0	5.2	2.1	8.6	5.0	5.2	2.0	6.8	1.9	4.3	7.0	3.2	7.5	10.4	10.5	10.5	5.3	4.4	8.9	8.1	7.9	6.8
POLI	"RAD30B, RAD3OB"	ENSG00000101751	"DNA polymerase iota"	Q9UNA4	18	54269404-54321266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012000, HPA064696"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA012000: AB_1847786, HPA064696: "	"unprognostic (1.64e-1)"	"unprognostic (5.79e-3)"	"unprognostic (9.72e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.99e-2)"	16.5	11.1	10.2	9.5	14.0	5.2	15.8	9.6	14.7	12.9	9.9	13.4	13.7	6.6	13.2	13.1	6.6	10.3	8.3	9.1	8.7	7.6	12.9	6.4	9.0	7.4	10.9	9.0	16.4	11.8	17.6	21.3	17.4	15.3	12.7	7.7	9.6	11.3	14.7	7.2	8.2	7.6	10.9	12.0	8.2	9.0	30.5	10.9	17.3	27.3	1.5	7.0	12.7	10.5	9.9	10.3	10.9	10.7	7.9	12.7	7.1	7.7	2.8	21.3	12.9	7.2	14.1	6.9	6.4	13.8	7.4	12.4	2.1	7.4	3.7	2.1	9.3	6.4	5.0	7.3	8.3	8.8	2.5	4.6	3.2	5.4	11.8	7.3	3.8	15.2	11.2	6.4	13.4	15.6	3.1	10.5	12.3	6.1	5.2	6.4	7.3	3.1	3.3	4.3	9.1	8.4	10.3	10.0	10.2	4.6	4.1	6.8	14.8	3.3	7.5	13.9	3.8	2.1	5.3	8.5	1.9	5.2	9.9	6.6	10.1	5.4	10.7	10.9	8.3	5.7	7.7	8.6	8.8	8.6	10.3	9.9	12.7	7.6	6.7	7.9	5.8	8.1	9.8	7.1	10.2	14.0	9.6	14.7	8.7	7.6	10.9	9.0	15.3	10.9
POLK	"DINB1, DINP, POLQ"	ENSG00000122008	"DNA polymerase kappa"	Q9UBT6	5	75511756-75601144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012035, HPA057303, HPA068117, HPA069375"			Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA012035: , HPA057303: , HPA068117: , HPA069375: "	"unprognostic (9.66e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.02e-1)"	14.7	12.7	10.1	8.6	12.9	6.3	13.4	17.0	13.4	18.1	10.7	8.8	13.6	6.3	21.3	12.1	11.7	10.5	9.5	11.4	14.1	10.5	12.6	12.3	12.2	9.2	14.1	12.9	15.5	11.1	18.5	23.9	15.2	17.2	13.9	8.1	6.5	10.2	10.5	15.2	10.3	9.2	15.4	16.9	13.1	9.0	9.8	12.4	12.1	18.8	9.3	8.9	12.7	10.2	7.0	7.5	6.0	13.3	4.6	4.5	2.5	6.4	6.6	4.1	5.2	5.4	10.9	3.5	12.3	8.7	9.6	10.0	4.2	5.2	6.6	10.1	8.1	2.5	3.8	4.2	11.5	7.3	4.4	6.0	5.8	1.9	10.4	3.8	4.9	5.0	5.2	7.7	5.3	8.0	5.3	3.9	9.0	0.5	7.5	3.1	1.5	3.9	3.2	10.5	4.6	5.8	2.2	4.2	4.6	9.2	2.5	3.3	3.6	3.7	10.0	7.0	3.6	3.3	7.0	4.5	4.1	5.9	4.7	6.1	12.0	5.7	7.1	3.4	3.3	7.9	2.9	7.0	3.7	4.0	6.1	5.4	4.5	3.0	6.0	4.6	13.3	7.5	4.1	2.5	10.1	12.9	17.0	13.4	14.1	10.5	14.1	12.9	17.2	12.4
POLL		ENSG00000166169	"DNA polymerase lambda"	Q9UGP5	10	101578882-101588270	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066704			Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			"Nucleoplasm, Golgi apparatus"		"HPA066704: "	"unprognostic (3.71e-3)"	"unprognostic (6.93e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.64e-3)"	11.0	15.1	14.4	16.0	17.1	9.2	13.4	11.2	22.1	13.7	12.6	16.4	15.6	14.3	15.1	22.1	15.4	18.1	17.7	12.3	11.1	10.4	16.4	16.5	11.8	13.0	9.6	13.0	20.9	30.7	21.7	23.7	11.7	12.7	17.2	15.0	19.5	17.8	14.7	26.1	12.8	11.9	12.7	9.4	15.6	16.7	53.2	11.2	4.6	18.3	10.2	14.2	14.8	11.6	8.5	10.7	1.1	8.5	8.4	11.9	7.1	12.5	11.5	9.1	12.6	9.2	17.2	12.7	8.3	14.5	12.8	13.5	8.4	15.2	3.1	13.2	7.5	15.8	10.0	12.3	10.3	11.1	13.6	9.8	10.8	9.5	17.0	10.2	9.0	15.6	16.8	14.1	29.4	13.7	10.9	10.9	8.0	10.0	0.0	11.2	4.8	6.8	0.0	8.1	5.1	10.7	7.6	6.4	9.3	5.1	8.6	14.3	26.2	5.9	7.3	4.6	9.3	5.2	9.1	15.8	7.9	4.7	9.9	8.9	3.4	0.5	8.5	1.1	6.7	5.9	10.6	8.5	7.4	6.8	10.7	7.1	11.9	7.9	0.9	8.4	5.7	0.2	8.9	7.1	14.4	17.1	11.2	22.1	11.1	10.4	9.6	13.0	12.7	11.2
POLM	Tdt-N	ENSG00000122678	"DNA polymerase mu"	Q9NP87	7	44072247-44082540	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058900, HPA066007"			Supported	Nucleoplasm				Nucleoplasm		"HPA058900: , HPA066007: "	"unprognostic (2.44e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-3)"	10.7	8.7	7.0	18.0	7.1	7.6	12.2	11.9	8.8	13.8	11.2	11.1	11.7	12.2	10.1	12.0	11.7	11.8	11.8	10.8	6.8	4.4	13.0	12.5	10.1	20.9	9.9	7.0	13.8	12.3	10.0	9.0	8.1	8.2	11.8	7.1	12.4	13.5	14.3	11.2	12.0	12.6	8.9	9.0	18.7	12.0	6.8	8.1	30.1	15.4	8.3	17.6	12.4	10.7	5.9	4.8	31.6	2.1	3.5	4.2	1.3	1.0	1.5	1.5	3.4	2.2	2.5	4.9	3.5	3.9	2.7	1.6	1.9	2.6	11.1	3.5	2.9	3.3	1.6	37.7	1.5	3.9	3.5	1.3	1.6	0.7	3.1	3.4	5.0	4.0	3.6	2.2	2.8	4.8	1.6	5.4	2.3	2.5	7.0	3.0	3.3	8.1	5.6	0.9	4.4	3.0	1.8	1.6	2.9	1.7	7.2	3.6	4.6	6.0	3.3	1.9	2.8	1.9	5.1	8.9	4.4	8.7	3.5	3.1	4.6	8.6	1.8	5.1	3.3	2.1	3.3	4.0	2.9	3.0	1.6	5.9	4.2	3.4	31.6	3.5	1.6	4.8	2.7	1.3	7.0	7.1	11.9	8.8	6.8	4.4	9.9	7.0	8.2	8.1
POLN		ENSG00000130997	"DNA polymerase nu"	Q7Z5Q5	4	2071918-2242121	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035939, HPA035940"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA035939: , HPA035940: "	"unprognostic (8.52e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	13.6	3.9	6.1	2.5	5.7	1.8	5.2	11.1	5.5	2.8	2.9	3.5	2.9	2.7	4.0	5.8	2.6	3.6	3.3	2.8	4.4	2.9	3.6	3.4	3.0	2.7	4.3	4.0	2.8	3.1	2.4	7.6	2.3	3.8	4.6	1.8	1.7	4.7	3.5	2.7	2.7	2.4	3.3	5.6	3.5	2.9	12.3	5.2	8.5	2.4	0.9	2.6	2.5	2.6	0.2	0.1	2.4	0.0	0.0	0.9	0.1	0.3	2.7	0.5	1.9	5.7	2.2	0.0	1.9	1.0	1.1	1.6	0.1	0.2	1.2	0.5	1.7	0.4	2.2	0.8	1.6	0.3	2.9	0.1	1.9	0.0	0.7	0.2	2.5	3.0	0.8	1.6	1.4	0.6	0.2	2.3	3.1	0.3	0.2	0.2	0.2	0.5	0.0	3.8	0.9	0.8	0.5	2.5	0.0	0.2	0.0	0.2	0.0	0.7	0.3	0.1	1.9	1.1	0.6	0.6	0.7	0.0	0.6	1.8	1.1	0.0	0.0	2.4	0.2	0.0	0.9	0.2	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.1	6.1	5.7	11.1	5.5	4.4	2.9	4.3	4.0	3.8	5.2
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"				"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: , HPA049700: "	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (8.41e-4)"	"unprognostic (7.20e-2)"	14.3	12.9	10.1	12.4	16.5	9.7	10.3	12.2	20.3	11.1	11.0	17.4	8.3	9.4	19.5	7.4	13.5	12.3	11.7	12.7	9.0	9.2	11.5	15.1	9.4	9.6	9.0	9.4	12.6	14.3	18.2	15.9	11.4	13.8	10.7	11.8	13.9	11.2	12.5	22.5	12.3	8.6	16.0	8.0	11.2	10.4	14.9	10.9	14.0	10.3	11.4	14.2	10.9	9.6	2.6	2.6	1.8	2.5	2.0	3.8	1.2	9.3	21.3	9.5	18.3	9.3	7.5	13.8	8.6	5.7	12.4	7.7	26.7	7.4	21.5	9.2	8.8	10.9	24.5	12.7	11.1	8.9	12.6	18.5	9.1	17.9	6.6	17.5	10.0	5.7	8.0	18.4	14.4	9.6	24.5	5.4	8.5	8.3	12.9	7.5	17.3	14.1	15.6	20.9	10.0	5.5	15.4	14.8	7.7	9.5	12.6	6.8	7.4	6.1	15.2	15.1	11.9	12.8	17.3	7.7	7.4	18.8	7.8	15.1	13.3	1.8	1.5	0.2	3.0	2.5	3.8	2.0	1.5	2.5	1.8	2.6	1.4	1.8	0.7	2.0	1.9	2.6	0.7	1.2	10.1	16.5	12.2	20.3	9.0	9.2	9.0	9.4	13.8	10.9
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.4	9.9	6.3	13.0	6.8	6.6	11.8	7.1	5.4	12.0	10.5	22.2	5.6	22.7	10.6	4.7	13.3	26.4	14.5	13.9	10.2	13.3	13.1	9.9	16.7	7.2	20.9	9.1	6.2	10.5	12.5	19.3	9.3	23.7	8.2	6.3	8.3	9.4	13.6	30.6	19.7	14.2	10.4	24.1	8.3	9.0	15.9	14.8	6.5	16.5	9.0	7.6	7.4	8.4	7.4	10.9	6.8	10.4	11.1	18.3	19.6	5.6	13.4	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0
POLR1C	"RPA39, RPA40, RPA5, RPAC1"	ENSG00000171453	"RNA polymerase I subunit C"	O15160	6	43509702-43562419	"Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031010			Supported	Nucleoplasm				Nucleoplasm		"HPA031010: AB_10603131"	"unprognostic (2.84e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (1.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	16.2	20.8	11.8	15.6	18.6	7.4	22.1	11.8	19.2	19.1	19.1	16.4	14.1	14.0	22.5	18.0	24.0	23.3	14.5	12.7	11.7	13.3	26.9	26.6	12.4	13.5	12.4	10.3	22.9	30.7	14.2	20.5	18.5	13.4	19.3	17.4	19.1	24.1	15.4	17.5	21.9	12.8	16.2	9.9	21.3	16.1	20.9	11.4	17.4	35.2	18.3	27.9	16.3	16.8	23.0	18.6	2.1	13.4	17.5	26.2	14.7	24.7	20.7	9.1	24.6	14.0	15.2	14.4	15.2	11.3	17.1	14.6	27.4	8.4	28.2	16.6	14.7	15.1	21.9	19.3	19.9	14.8	22.9	19.2	20.9	37.9	17.6	29.3	13.5	13.5	18.8	23.3	29.6	13.3	44.1	8.3	14.9	34.9	15.2	21.2	16.8	17.9	10.4	14.3	18.9	20.5	34.8	16.8	11.3	13.3	11.6	20.1	12.5	25.9	15.9	12.3	16.5	13.1	23.9	12.0	26.5	47.0	8.3	20.1	13.5	2.1	13.4	1.9	16.0	10.3	21.7	21.6	19.0	15.8	18.6	23.0	26.2	23.5	1.3	17.5	8.3	16.9	13.6	14.7	11.8	18.6	11.8	19.2	11.7	13.3	12.4	10.3	13.4	11.4
POLR1E	"FLJ13390, FLJ13970, PAF53, PRAF1"	ENSG00000137054	"RNA polymerase I subunit E"	Q9GZS1	9	37485935-37503697	"Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022527, HPA052400"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA022527: AB_1854924, HPA052400: "	"prognostic favourable (2.27e-4)"	"unprognostic (2.09e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.24e-2)"	15.4	12.2	10.5	20.2	11.6	9.3	19.7	10.7	9.0	19.0	13.9	10.0	14.9	7.0	20.5	14.7	15.1	17.3	13.7	14.9	9.1	9.2	7.6	23.9	10.1	15.5	9.0	9.2	36.9	25.9	10.3	9.6	8.7	9.5	17.3	9.3	9.5	19.5	18.4	17.2	13.1	9.0	22.4	10.2	10.8	13.0	11.2	11.5	16.0	15.3	13.3	17.1	21.9	16.8	8.1	3.9	1.4	4.3	9.0	16.9	5.5	19.4	18.3	10.1	16.0	19.0	24.4	6.6	17.2	6.7	17.9	15.9	15.7	6.5	28.3	8.4	19.9	8.2	24.6	20.5	22.7	27.3	11.5	13.5	23.2	11.1	14.2	25.9	9.6	25.9	7.3	35.1	30.3	9.1	35.3	12.5	15.7	9.3	17.9	8.9	17.9	15.0	16.0	9.3	13.5	9.3	7.2	14.5	11.9	11.5	9.2	14.8	9.0	17.3	6.2	21.3	32.5	18.2	34.4	6.8	9.6	29.8	7.3	16.5	17.6	0.0	2.5	1.4	10.6	4.3	16.9	7.4	10.2	10.8	3.9	8.1	12.8	11.1	0.8	9.0	3.4	2.7	5.4	5.5	10.5	11.6	10.7	9.0	9.1	9.2	9.0	9.2	9.5	11.5
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031168	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	24.5	34.3	31.1	34.6	31.0	21.4	24.8	43.8	33.3	25.9	26.0	18.8	24.9	22.5	35.1	21.4	27.4	28.3	21.2	32.9	29.3	21.7	26.2	21.4	21.2	32.4	28.0	30.2	26.4	28.1	40.7	37.3	25.4	28.3	24.8	26.5	18.4	30.5	28.2	61.8	24.4	27.3	27.6	26.4	27.1	28.8	26.6	26.8	33.4	27.0	34.7	35.1	31.5	22.4	19.8	15.2	27.8	13.9	18.0	23.8	12.7	24.7	20.7	37.4	31.6	30.9	27.9	20.0	33.0	33.6	33.1	31.0	26.3	25.0	38.6	31.3	30.5	17.6	44.9	25.1	47.4	18.3	20.1	29.0	23.1	22.9	35.8	49.9	33.6	30.0	25.3	37.8	23.1	39.4	43.1	33.0	38.1	18.1	47.0	19.3	30.8	24.3	34.3	24.6	21.2	22.6	28.2	31.2	35.0	20.5	39.1	28.4	21.0	27.8	28.7	24.1	32.4	25.2	43.3	26.6	25.3	56.3	27.5	27.0	29.8	27.8	12.2	16.8	20.7	12.4	22.0	19.8	20.3	21.4	15.2	14.4	19.9	23.8	11.3	18.0	13.9	12.9	20.9	12.7	31.1	31.0	43.8	33.3	29.3	21.7	28.0	30.2	28.3	26.8
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462387-57472010	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favourable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	26.2	30.1	24.2	18.4	26.9	23.9	25.8	34.1	37.6	27.2	22.9	28.8	23.1	21.5	26.0	45.0	26.2	30.3	29.9	32.6	24.5	25.9	38.3	44.8	29.9	30.2	25.0	30.1	37.2	39.4	33.7	35.0	29.2	25.5	29.2	26.0	29.6	30.4	31.4	47.5	23.7	27.9	26.1	24.1	22.4	25.2	26.4	21.9	30.5	35.8	27.3	27.1	27.5	22.2	21.8	16.2	41.7	19.8	26.2	28.6	21.9	17.4	28.8	24.1	21.9	21.9	19.7	21.4	23.0	25.1	37.0	24.5	36.8	22.1	19.7	27.1	25.3	18.3	31.9	24.2	41.2	9.1	23.7	15.1	17.2	42.0	24.9	27.4	29.1	17.6	20.0	28.2	26.1	22.2	26.2	11.1	24.1	24.1	30.3	29.0	36.1	43.9	44.3	28.6	34.9	29.9	17.3	30.7	35.8	37.3	20.8	24.1	15.9	25.3	17.1	23.4	23.8	17.7	26.2	25.8	22.0	40.1	23.5	23.7	30.8	24.8	17.3	29.0	20.7	16.4	22.6	21.8	23.6	19.1	16.2	20.9	28.6	26.8	41.7	26.2	19.8	13.2	22.5	21.9	24.2	26.9	34.1	37.6	24.5	25.9	25.0	30.1	25.5	21.9
POLR2D	RBP4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843551-127858157	"Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA034694: , HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	8.2	9.4	8.1	8.9	9.1	17.9	7.9	9.3	12.6	6.9	7.7	12.3	6.9	6.3	7.5	6.2	9.8	7.7	7.6	7.3	7.8	6.3	6.3	13.5	7.2	11.8	9.9	7.5	10.3	17.4	7.4	9.4	10.2	8.7	7.2	9.9	7.3	7.6	6.5	21.9	8.9	7.8	9.8	8.8	11.1	7.8	46.4	9.9	16.7	6.3	9.1	16.8	8.0	7.2	16.7	20.6	11.4	22.1	16.7	21.0	14.3	18.2	11.9	22.2	15.5	8.3	9.1	17.8	17.5	8.3	21.1	18.9	26.9	15.1	28.4	15.1	11.7	9.7	31.8	15.1	32.8	16.6	17.3	28.0	11.9	24.7	9.7	30.0	15.6	6.4	11.4	28.2	16.2	13.7	39.0	25.5	12.0	14.5	29.8	13.7	31.1	13.8	28.7	23.5	25.5	7.0	12.5	13.8	18.5	11.8	14.6	14.7	16.3	20.8	13.8	18.3	25.8	10.3	20.1	30.1	48.7	51.0	15.9	15.0	18.0	5.7	15.8	11.4	19.4	21.5	18.1	16.7	15.6	16.9	20.6	15.1	21.0	17.8	5.0	16.7	22.1	13.5	13.9	14.3	8.1	9.1	9.3	12.6	7.8	6.3	9.9	7.5	8.7	9.9
POLR2E	"hRPB25, hsRPB5, RPABC1, RPB5, XAP4"	ENSG00000099817	"RNA polymerase II subunit E"	P19388	19	1086579-1095380	"Predicted intracellular proteins, RNA polymerase related proteins"	"Host-virus interaction, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063030, HPA068992"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA063030: AB_2684926, HPA068992: AB_2686065"	"unprognostic (2.52e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.03e-2)"	"prognostic favourable (3.21e-6)"	"unprognostic (3.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.77e-2)"	41.4	26.2	29.6	22.8	27.9	19.8	27.6	19.0	36.9	20.1	26.5	18.6	18.4	20.1	21.4	22.6	34.1	26.3	25.8	27.6	29.6	26.3	34.0	57.9	25.1	25.1	30.1	22.6	22.0	21.0	39.7	13.0	26.4	33.4	24.3	29.5	20.3	17.9	18.9	33.2	23.7	26.9	25.7	22.1	23.1	21.5	29.3	15.5	31.9	30.6	21.1	36.7	22.1	20.6	12.8	28.2	17.9	30.4	16.7	17.5	20.9	14.3	13.3	18.7	14.9	25.7	16.0	8.7	10.7	14.8	17.7	10.4	15.6	5.3	12.1	4.8	31.6	11.7	35.0	11.8	33.0	12.5	10.6	15.8	16.6	14.3	10.2	23.1	11.9	11.7	7.7	12.3	23.4	16.2	17.7	13.8	19.8	11.9	12.7	7.2	15.0	10.2	13.6	18.5	11.5	18.1	16.7	9.5	10.8	17.8	12.5	7.4	13.1	10.8	22.0	9.0	10.0	16.2	12.3	21.4	28.5	21.1	14.7	15.0	10.2	12.1	30.4	17.9	16.4	20.5	17.5	11.7	15.5	17.2	28.2	12.8	12.4	12.7	16.1	16.7	22.2	19.6	14.7	20.9	29.6	27.9	19.0	36.9	29.6	26.3	30.1	22.6	33.4	15.5
POLR2F	"HRBP14.4, RPB6"	ENSG00000100142	"RNA polymerase II subunit F"	P61218	22	37952607-38041915	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in single"		"melanoma: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000827, CAB009882"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"CAB009882: AB_2299942, HPA000827: AB_1079834"	"unprognostic (8.27e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.11e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.86e-2)"	31.7	31.4	37.5	23.4	43.8	23.0	28.2	32.6	54.5	25.2	27.8	57.3	20.4	26.3	24.2	18.7	24.6	23.2	20.3	37.8	33.5	31.2	25.1	58.5	17.9	19.8	44.8	44.1	30.2	26.1	43.5	28.8	21.2	38.4	21.4	21.0	21.0	38.0	29.6	67.9	19.0	25.7	20.8	39.6	16.8	26.9	21.9	48.3	13.1	28.5	23.4	18.0	19.0	26.8	36.1	49.5	52.4	36.7	40.1	38.5	29.3	34.0	40.3	28.5	30.4	34.3	20.1	25.4	31.9	18.7	32.8	30.9	46.7	12.1	26.3	23.1	27.6	24.6	39.2	30.9	16.2	32.1	66.3	24.5	41.4	63.4	29.9	47.8	15.8	26.6	23.5	44.2	17.1	28.0	46.8	22.2	23.7	48.4	37.2	57.7	41.0	30.7	37.1	26.2	30.7	18.1	21.2	42.8	16.0	29.4	21.1	46.1	14.7	33.2	25.6	28.9	41.1	35.7	36.1	25.1	38.8	54.9	29.4	24.4	32.5	34.5	36.7	52.4	34.3	33.3	32.1	36.1	30.0	33.2	33.4	28.9	27.3	27.2	46.2	40.1	28.1	49.5	38.5	29.3	37.5	43.8	32.6	42.7	33.5	31.2	44.8	44.1	38.4	48.3
POLR2G	"hRPB19, hsRPB7, RPB7"	ENSG00000168002	"RNA polymerase II subunit G"	P62487	11	62761544-62766710	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053000	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA053000: "	"unprognostic (7.58e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-2)"	"prognostic favourable (8.23e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (6.02e-5)"	"unprognostic (8.50e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.21e-1)"	27.9	34.6	39.4	28.7	37.7	29.4	37.2	18.6	33.5	28.0	25.4	39.9	25.0	17.3	27.0	44.0	27.4	32.3	25.2	25.0	35.0	27.7	30.6	32.1	29.8	47.5	41.4	27.6	28.1	29.0	29.6	20.4	29.0	30.7	28.3	32.9	31.4	22.3	27.2	18.9	27.5	19.5	32.6	45.4	30.7	22.6	18.7	33.6	47.7	28.2	26.3	49.2	25.4	23.2	48.9	61.3	51.5	54.1	46.4	47.4	64.6	25.0	44.7	48.3	30.2	25.3	24.6	12.0	17.8	22.6	43.0	34.2	27.0	29.2	36.4	41.4	27.0	24.5	21.9	33.6	38.3	69.4	27.5	24.0	35.6	31.6	35.5	31.9	22.0	24.0	34.0	19.9	40.6	33.5	30.0	24.0	30.4	78.7	46.2	42.0	29.9	45.8	38.1	44.2	47.8	31.7	21.4	20.2	34.3	30.4	23.2	44.4	66.7	27.5	13.2	21.6	23.3	42.0	20.6	19.0	35.0	39.7	22.0	20.5	28.6	46.9	49.0	51.5	45.2	51.7	43.5	48.5	39.0	43.9	57.6	48.9	37.1	45.7	21.6	46.4	54.1	61.3	47.4	64.6	39.4	37.7	18.6	33.5	35.0	27.7	41.4	27.6	30.7	33.6
POLR2H	RPB8	ENSG00000163882	"RNA polymerase II subunit H"	P52434	3	184361718-184368596	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037745, HPA055813"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA037745: AB_10672914, HPA055813: "	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.61e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (8.82e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.02e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavourable (1.65e-10)"	"unprognostic (1.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-3)"	18.1	32.6	19.6	19.2	17.5	14.8	24.5	24.2	24.6	28.8	29.9	13.8	19.8	32.0	19.9	23.5	26.7	23.1	26.7	16.3	17.8	16.3	34.1	41.0	17.8	21.7	16.4	17.0	21.8	46.4	15.8	20.7	27.2	17.0	19.2	33.6	19.7	26.0	17.0	19.9	20.7	38.8	20.0	13.2	21.5	25.6	20.6	12.5	28.1	29.7	23.1	26.3	18.5	16.2	17.4	18.2	7.7	15.3	14.6	26.6	11.5	50.1	17.7	19.1	28.2	21.3	15.2	23.7	19.0	19.9	26.0	33.5	45.2	24.1	28.4	47.6	14.8	20.4	34.0	34.1	23.3	27.8	45.0	27.3	20.8	28.2	19.2	28.7	16.0	19.5	19.5	17.0	30.7	26.9	21.0	18.9	20.6	59.6	28.3	38.4	20.7	36.9	16.6	17.5	38.5	31.0	22.8	28.9	20.5	16.0	49.8	27.6	62.2	23.1	14.0	12.4	19.6	16.5	50.5	38.0	39.4	53.2	19.7	30.7	16.5	3.4	9.6	7.7	15.2	15.3	18.4	17.4	18.0	16.2	18.0	16.4	26.6	19.7	0.7	14.6	9.6	18.2	18.7	11.5	19.6	17.5	24.2	24.6	17.8	16.3	16.4	17.0	17.0	12.5
POLR2I	"hRPB14.5, RPB9"	ENSG00000105258	"RNA polymerase II subunit I"	P36954	19	36113710-36115346	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035632, HPA045156"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035632: , HPA045156: AB_10964748"	"unprognostic (1.95e-2)"	"unprognostic (7.88e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	9.6	10.7	27.4	6.1	26.7	10.7	14.3	17.5	29.3	15.1	12.4	24.5	9.8	12.4	9.2	10.7	11.5	18.2	10.4	21.6	25.8	23.7	10.7	19.8	8.6	10.1	29.0	17.1	14.0	25.9	9.7	14.0	8.3	16.2	10.9	6.6	7.4	18.4	18.5	30.3	14.8	7.1	9.4	37.8	10.3	11.4	26.8	16.6	9.7	11.4	15.9	9.3	8.3	7.9	13.5	22.0	6.9	10.2	9.2	13.7	10.3	7.5	23.8	4.0	4.2	2.9	2.5	9.0	6.8	3.6	9.6	5.4	14.8	5.4	16.1	14.0	2.4	4.9	6.7	9.8	2.0	14.7	25.0	18.4	7.0	11.2	6.8	15.5	7.9	3.6	5.5	5.5	5.6	4.2	11.5	7.1	3.0	21.4	8.1	16.5	9.3	20.6	14.7	5.9	10.5	7.7	4.6	26.0	14.8	7.9	14.1	4.0	6.7	5.2	4.2	6.4	11.1	4.2	9.1	6.8	13.1	11.3	8.7	10.0	6.9	6.9	10.2	5.9	9.0	7.2	11.8	13.5	11.2	12.3	13.2	13.3	13.7	12.7	0.6	9.2	8.7	22.0	10.7	10.3	27.4	26.7	17.5	29.1	25.8	23.7	29.0	17.1	16.2	16.6
POLR3A	"hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029545	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	7.1	10.2	10.3	8.3	21.7	5.9	10.6	22.2	29.7	9.2	8.1	12.8	7.4	8.6	9.4	13.3	8.6	8.5	7.4	7.4	9.4	9.6	9.3	9.3	6.8	8.7	8.1	11.0	11.5	10.7	13.8	17.3	10.1	20.4	10.2	10.7	10.4	8.6	8.2	17.6	11.2	7.8	9.7	6.6	8.9	8.2	11.7	9.8	12.6	9.6	4.4	13.4	7.9	8.0	7.5	5.4	8.0	6.4	6.5	8.8	3.6	7.3	8.8	9.3	15.4	6.1	7.9	6.2	8.4	11.0	10.9	10.8	11.5	5.3	9.1	5.2	7.3	8.6	16.1	9.2	13.3	6.7	11.8	7.3	7.0	14.2	5.8	12.5	6.2	6.7	6.6	19.3	18.0	9.5	13.6	5.7	10.5	5.4	9.4	8.0	10.1	40.0	9.0	5.9	5.9	5.4	4.8	8.5	10.8	8.1	15.1	8.6	11.2	6.6	10.4	7.0	6.8	7.6	16.6	8.9	9.3	11.1	12.5	13.2	3.4	8.0	5.2	2.9	7.8	6.4	7.6	5.6	6.0	7.2	4.8	7.5	5.7	6.6	3.3	6.5	5.4	5.4	8.8	3.6	10.3	21.7	22.2	29.7	9.4	9.6	8.1	11.0	20.4	9.8
POLR3C	"RPC3, RPC62"	ENSG00000186141	"RNA polymerase III subunit C"	Q9BUI4	1	145824088-145842505	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027508, HPA027516"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027508: AB_10600091, HPA027516: AB_10600894"	"unprognostic (1.43e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavourable (1.85e-5)"	"unprognostic (2.34e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.38e-1)"	21.1	11.9	13.5	21.2	13.4	16.9	21.7	28.3	16.4	18.0	14.2	12.2	11.1	9.4	19.2	16.2	15.1	16.9	14.6	12.7	12.1	9.9	15.7	15.3	13.3	25.4	14.7	15.8	21.9	23.1	16.7	10.9	13.9	12.6	15.7	15.9	11.9	16.9	13.0	18.3	20.3	14.9	17.5	11.0	20.5	14.9	29.3	15.0	26.5	15.9	11.4	21.3	17.5	15.8	21.1	23.6	29.5	23.9	20.6	20.7	15.9	15.8	13.2	11.0	9.1	14.5	17.7	11.7	15.0	18.5	21.5	20.6	19.0	8.6	27.4	15.3	20.5	15.8	17.8	16.1	22.3	11.2	14.0	14.6	15.4	11.3	26.2	30.1	19.0	16.9	11.8	24.0	42.8	13.3	18.4	16.2	22.6	22.1	15.6	13.7	15.7	17.7	14.6	13.7	18.0	14.0	11.4	10.2	15.4	13.5	19.8	20.3	15.2	28.2	13.9	18.9	15.0	10.3	21.0	25.4	24.6	31.9	6.9	15.6	14.5	29.5	20.9	21.1	15.9	23.9	20.7	20.1	17.6	16.4	22.0	21.1	18.0	16.4	1.7	20.6	17.3	23.6	14.9	15.9	13.5	13.4	28.3	16.4	12.1	9.9	14.7	15.8	12.6	15.0
POLR3D	"BN51T, RPC4, TSBN51"	ENSG00000168495	"RNA polymerase III subunit D"	P05423	8	22245104-22254600	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061331, HPA067875, HPA068461, HPA069089"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA061331: , HPA067875: , HPA068461: , HPA069089: "	"unprognostic (2.33e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (9.15e-6)"	"unprognostic (1.15e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (2.12e-4)"	14.7	12.9	10.3	14.0	13.6	9.8	18.4	8.8	15.7	13.9	11.9	13.9	8.2	9.3	14.3	9.3	16.5	11.9	13.9	16.6	10.0	8.3	11.7	11.2	12.7	13.4	16.5	13.7	18.1	20.8	10.5	16.3	20.2	13.2	14.5	11.9	9.7	14.5	11.2	34.4	11.9	9.6	17.5	13.5	13.2	12.2	29.4	12.0	8.0	12.6	10.8	13.1	14.7	15.9	9.1	13.6	1.6	5.7	11.2	10.7	5.3	6.5	19.7	10.8	12.2	10.6	15.5	11.7	17.8	11.0	15.3	13.1	14.0	5.5	21.7	15.2	11.3	11.5	24.6	8.3	12.3	7.1	9.3	19.0	10.0	19.0	16.8	5.9	14.9	12.8	16.7	19.3	22.5	12.8	25.0	14.3	12.4	9.9	21.6	12.5	27.2	11.3	17.0	14.4	16.6	7.2	5.9	12.4	22.9	7.1	8.2	24.7	6.4	8.3	14.0	14.9	14.0	18.5	17.5	16.5	15.1	13.4	10.0	10.9	19.6	0.1	5.6	1.6	8.5	5.6	10.4	8.3	9.1	10.3	7.4	9.1	10.7	9.4	0.2	11.2	5.7	13.6	5.9	5.3	10.3	13.6	8.8	15.7	10.0	8.3	16.5	13.7	13.2	12.0
POLR3E	"FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335103	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	10.8	15.8	8.9	10.4	11.1	9.8	15.5	11.7	12.9	11.7	10.7	12.0	13.0	9.7	12.4	9.3	13.1	11.1	8.5	13.9	10.9	7.0	9.5	14.0	9.5	12.7	11.1	9.8	11.0	21.2	15.7	15.8	8.9	10.7	12.7	6.6	11.8	15.0	15.2	50.7	12.7	8.9	9.2	10.0	9.5	12.4	9.6	10.7	10.4	12.3	9.1	14.0	11.4	10.4	5.9	5.7	1.9	3.8	5.3	7.2	4.8	6.6	9.2	2.7	6.7	5.2	4.0	9.1	5.3	2.7	3.5	2.5	11.6	4.7	13.7	7.0	3.7	6.4	13.2	7.4	2.9	9.1	18.9	7.0	10.1	22.2	6.5	10.9	7.7	3.9	8.3	7.6	9.3	9.1	19.8	5.6	4.1	10.7	10.9	4.5	13.6	7.8	14.2	6.0	17.6	3.7	3.9	9.8	7.3	5.1	9.4	5.2	5.4	6.3	5.7	3.6	4.1	3.1	5.8	7.6	13.5	12.6	4.1	8.3	6.7	0.0	3.3	1.9	6.5	3.8	7.2	5.9	7.2	6.8	5.7	5.1	7.0	5.8	0.3	5.3	3.1	3.3	7.2	4.8	8.9	11.1	11.7	12.9	10.9	7.0	11.1	9.8	10.7	10.7
POLR3G	"RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514553	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.2"	"Cell line enhanced"	"Detected in all"		"WM-115: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010109, HPA052658"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB010109: AB_2165718, HPA052658: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	2.7	1.6	7.1	3.6	10.2	4.4	3.8	7.2	7.2	3.7	2.6	6.7	1.4	2.8	2.7	8.4	7.3	2.7	2.4	2.7	7.7	7.7	1.7	4.0	2.9	8.1	10.3	6.1	4.1	4.1	11.1	3.9	3.1	20.2	2.9	3.1	2.6	4.2	1.5	4.4	7.4	2.3	4.2	16.0	3.3	2.1	8.0	8.1	1.0	5.9	8.5	3.2	4.4	4.7	3.9	2.1	6.8	2.8	5.4	3.2	0.8	10.5	6.1	7.2	1.9	2.2	4.1	3.3	5.3	1.7	8.4	6.9	3.5	7.9	29.0	1.8	2.2	4.4	9.0	8.5	30.3	13.3	8.1	10.6	2.9	5.4	3.8	7.4	2.7	2.7	3.9	14.1	10.7	10.4	15.1	2.6	3.0	5.2	7.7	4.7	34.4	27.3	6.9	3.2	16.3	2.5	1.0	9.2	2.5	2.1	4.0	14.6	2.2	2.1	12.4	4.6	8.9	6.5	19.9	6.6	17.2	21.3	10.2	9.9	36.7	6.8	0.6	0.3	3.2	0.8	1.6	3.9	1.1	2.0	0.9	2.4	2.4	2.6	1.6	5.4	2.8	2.1	0.5	0.8	7.1	10.2	7.2	7.2	7.7	7.7	10.3	6.1	20.2	8.1
POLR3H	"KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525804-41544606	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome				Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favourable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.8	14.0	30.0	9.1	28.8	5.5	13.5	21.0	27.4	12.1	7.5	15.8	12.6	6.1	10.5	11.7	17.0	19.0	10.3	14.8	24.0	20.5	10.0	18.9	14.7	10.9	22.2	17.6	22.4	13.7	13.1	11.5	7.9	17.2	11.0	6.8	12.1	12.2	14.2	7.7	14.6	6.2	14.4	14.2	7.2	7.9	14.2	16.5	7.0	15.4	8.2	9.3	8.1	9.1	11.6	11.2	0.6	13.8	3.9	10.2	7.5	16.1	10.9	10.1	14.7	11.1	10.1	6.7	13.6	12.7	23.2	18.7	22.0	5.3	13.8	10.7	22.8	7.4	18.5	22.2	14.6	12.5	22.8	8.2	17.3	10.5	11.5	34.1	14.1	12.6	14.5	30.5	8.2	11.3	17.3	8.9	12.9	15.4	8.7	9.3	7.1	14.2	13.4	7.9	14.3	10.8	9.5	9.8	5.8	17.7	18.0	8.6	7.2	9.7	10.1	13.9	15.0	24.0	18.0	6.7	12.5	20.8	24.2	12.2	13.1	0.0	10.0	0.1	7.3	13.8	10.2	11.6	7.1	8.6	11.2	10.1	10.0	8.1	0.6	3.9	12.7	10.8	4.4	7.5	30.0	28.8	21.0	26.9	24.0	20.5	22.2	17.6	17.2	16.5
POLRMT	"APOLMT, h-mtRPOL, MTRNAP, MTRPOL"	ENSG00000099821	"RNA polymerase mitochondrial"	O00411	19	617224-633604	"Enzymes, Predicted intracellular proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006366	Uncertain		Supported	Mitochondria				Mitochondria		"HPA006366: AB_1079654"	"unprognostic (3.24e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.96e-2)"	"prognostic favourable (4.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.48e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	10.2	10.7	10.1	16.3	11.9	6.9	8.1	12.1	20.7	9.5	11.6	12.3	4.4	16.7	9.8	12.2	14.4	8.7	12.7	24.7	11.5	8.9	12.9	21.4	7.3	11.8	9.4	15.1	10.1	15.9	9.5	10.7	6.2	9.7	10.2	8.8	8.5	9.6	11.7	42.2	16.7	12.8	10.8	8.4	12.8	11.2	32.1	6.3	11.6	11.1	8.6	10.4	10.1	7.8	8.2	7.3	3.1	5.5	7.5	9.0	5.3	10.4	19.0	4.3	19.1	9.1	5.2	16.0	4.9	5.8	7.3	6.7	19.1	7.2	10.8	10.0	4.5	10.9	16.1	9.4	5.4	12.1	38.3	8.4	11.8	24.5	9.5	14.1	16.0	5.0	13.3	7.4	9.1	10.3	15.7	10.8	6.7	14.8	18.7	19.4	17.3	13.4	18.1	6.0	18.4	9.7	9.0	14.0	9.9	4.4	12.2	12.2	6.9	12.9	6.1	7.9	10.2	12.4	14.4	25.8	21.2	16.5	17.0	11.8	9.7	0.0	3.7	3.1	9.0	5.2	7.1	7.8	6.7	6.6	7.3	8.2	5.7	6.3	0.6	7.5	5.5	7.2	4.1	5.3	10.1	11.9	12.1	20.7	11.5	8.9	9.4	15.1	9.7	6.3
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: , HPA049817: "	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	19.4	15.2	14.5	16.0	17.7	35.0	14.4	25.9	22.0	13.1	16.6	16.0	14.2	19.5	17.9	14.8	15.8	15.8	14.9	11.8	11.7	10.0	14.0	16.6	13.3	18.7	10.8	12.7	18.6	23.3	14.9	20.6	15.4	13.4	18.6	11.4	20.2	17.4	11.7	18.4	17.0	19.1	12.1	12.7	19.0	16.3	17.3	13.5	24.5	19.5	15.2	22.3	15.8	14.5	3.7	4.3	3.7	3.6	4.5	5.2	2.6	16.9	12.4	15.5	34.9	8.4	6.9	12.9	12.2	10.3	12.1	10.6	21.9	10.8	23.5	4.0	10.5	13.0	15.4	11.8	13.6	20.3	30.7	17.4	12.5	14.5	8.6	36.2	22.3	9.1	8.4	16.1	14.8	9.0	47.8	17.5	11.9	13.0	21.6	23.1	16.3	15.1	19.7	12.1	19.7	6.2	14.9	22.2	19.6	10.7	20.5	10.9	17.1	19.1	12.7	21.8	13.5	17.1	24.3	21.1	19.6	34.0	12.7	23.2	21.6	0.1	2.3	3.7	5.2	1.4	3.0	3.0	3.3	3.8	2.6	3.7	3.0	4.3	2.6	4.5	3.6	4.3	1.7	2.6	14.5	17.7	25.9	22.0	11.7	10.0	10.8	12.7	13.4	13.5
POMP	"C13orf12, HSPC014, UMP1"	ENSG00000132963	"Proteasome maturation protein"	Q9Y244	13	28659104-28678925	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026995	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA026995: AB_1845546"	"unprognostic (2.00e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (2.05e-5)"	"unprognostic (2.71e-3)"	"unprognostic (2.50e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.83e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.81e-2)"	35.4	31.5	44.5	29.3	37.7	27.4	28.8	21.1	38.2	24.2	32.2	17.7	19.6	27.5	21.1	41.4	30.1	20.3	22.9	52.7	38.4	36.3	38.6	58.4	27.8	28.4	48.2	32.1	18.5	22.9	11.7	21.9	48.4	38.1	23.5	33.9	18.0	20.4	26.7	68.2	20.6	35.0	28.3	40.4	31.5	24.1	32.5	29.2	31.3	30.9	44.7	33.0	29.3	19.9	36.7	62.7	38.5	57.3	24.9	35.9	41.6	23.0	28.5	30.4	35.4	35.1	39.5	28.4	53.0	47.4	53.5	42.8	55.6	52.7	40.9	32.4	41.1	34.5	39.8	41.3	73.1	30.8	30.6	38.4	30.9	42.6	48.8	46.3	32.0	31.7	43.2	38.5	35.9	42.1	48.8	16.8	68.3	40.8	39.0	66.3	52.5	33.8	37.8	46.4	27.4	60.2	36.5	35.7	27.5	23.8	34.2	35.7	23.8	54.2	37.9	25.6	26.1	40.3	43.8	14.4	25.7	57.7	30.5	31.5	55.9	31.8	45.5	27.3	30.2	57.3	26.3	36.5	31.1	33.6	53.9	36.7	22.1	31.5	38.5	24.9	56.1	62.7	35.9	41.6	44.5	37.7	21.1	38.2	38.4	36.3	48.2	32.1	38.1	29.2
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117297-98159834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli				Nucleoli		"HPA066194: "	"prognostic unfavourable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (1.26e-6)"	"prognostic unfavourable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	6.1	5.5	7.8	9.0	9.7	3.7	5.8	14.3	10.2	4.3	5.4	5.2	2.7	4.3	6.0	4.2	9.1	6.6	3.9	5.0	5.7	4.7	10.5	6.4	5.2	9.1	4.1	7.6	8.4	5.8	7.6	11.1	3.5	7.4	5.0	13.8	6.2	5.1	4.2	5.7	8.2	5.1	5.2	4.0	8.8	5.7	11.8	6.2	8.8	5.0	5.6	11.3	4.3	5.0	10.5	7.7	10.9	7.4	4.1	9.8	2.5	12.6	7.6	8.3	7.7	2.9	2.1	5.5	10.9	9.2	11.4	8.5	7.8	8.2	8.9	15.7	7.9	8.5	24.2	10.8	12.3	6.4	10.2	17.8	6.1	5.3	1.3	9.4	11.2	1.7	2.0	12.6	5.0	8.8	9.7	8.1	10.6	10.1	13.6	4.8	6.3	10.6	11.3	4.9	6.4	8.3	6.8	20.0	4.7	5.0	8.5	3.8	11.6	3.5	12.0	10.0	7.2	12.6	21.5	8.1	7.6	19.2	7.8	10.2	8.7	10.9	6.7	4.6	9.8	7.4	7.8	6.2	7.1	6.5	6.2	10.5	9.3	8.6	0.9	4.1	3.4	7.7	5.9	2.5	7.8	9.7	14.3	10.2	5.7	4.7	4.1	7.6	7.4	6.2
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706053-100707495	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	12.3	16.6	20.5	15.1	21.0	25.3	16.1	25.1	33.2	11.3	14.7	8.7	14.0	17.5	13.9	12.5	20.4	13.4	13.9	19.6	18.3	18.1	13.1	31.4	11.7	18.2	16.8	22.0	13.2	21.2	6.6	11.5	18.1	13.3	16.0	8.1	10.0	24.2	15.8	46.4	22.6	17.6	12.3	12.9	12.3	15.5	7.0	9.4	11.0	11.6	20.5	11.8	11.5	12.5	32.1	30.4	46.4	35.6	42.1	37.0	32.0	24.3	24.2	9.8	17.3	5.2	5.0	19.2	13.8	6.5	15.3	15.2	35.4	15.8	19.8	23.3	6.0	15.5	14.3	16.2	7.6	17.9	43.2	8.9	15.8	34.0	8.8	13.6	10.9	5.8	6.1	15.7	15.5	8.5	31.5	17.7	8.0	69.0	34.1	46.7	30.1	33.5	25.8	10.4	33.5	9.1	13.4	19.7	20.0	11.1	34.4	16.3	11.3	13.8	8.3	21.3	25.6	41.8	27.1	7.5	20.4	35.4	13.4	23.5	23.1	46.4	35.6	38.2	32.4	34.1	29.4	32.1	32.5	31.6	30.4	26.4	29.9	31.1	21.9	42.1	35.3	27.9	37.0	32.0	20.5	21.0	25.1	33.2	18.3	18.1	16.8	22.0	13.3	9.4
POT1	"DKFZp586D211, hPot1"	ENSG00000128513	"Protection of telomeres 1"	Q9NUX5	7	124822386-124929983	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA068538			Supported	Nucleoplasm				Nucleoplasm		"HPA068538: "	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.42e-2)"	12.0	13.2	11.1	8.3	14.3	6.2	15.8	13.0	16.6	13.4	10.1	16.0	12.0	7.8	17.0	13.4	10.1	12.6	11.3	11.2	15.5	11.3	16.6	14.7	9.9	14.0	15.0	12.4	15.7	9.4	15.5	29.6	11.1	16.4	12.0	9.7	12.2	8.7	10.1	9.5	8.0	8.8	13.1	16.4	13.6	9.5	15.8	14.8	17.9	21.5	9.3	12.9	13.6	9.8	4.8	3.6	2.7	3.3	5.2	7.4	2.7	12.7	5.5	8.1	6.2	5.4	10.2	5.7	7.2	8.5	8.2	12.4	4.4	12.9	11.5	5.8	5.4	5.1	8.8	7.3	12.9	14.9	12.9	11.2	5.4	4.7	12.2	10.8	6.7	7.2	8.7	7.5	11.9	10.4	19.9	27.6	9.2	2.5	14.4	11.4	9.1	9.0	8.5	8.5	16.4	7.0	7.1	8.6	11.5	7.3	9.8	10.1	4.3	10.4	3.4	9.9	4.4	11.9	9.5	15.3	15.7	16.4	10.0	12.4	12.2	0.9	3.1	2.7	4.3	3.3	6.3	4.8	4.5	5.0	3.1	3.4	7.4	5.5	0.7	5.2	3.0	3.6	4.4	2.7	11.1	14.3	13.0	16.6	15.5	11.3	15.0	12.4	16.4	14.8
POU2F1	"OCT1, OTF1"	ENSG00000143190	"POU class 2 homeobox 1"	P14859	1	167220829-167427345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002608, HPA058559, HPA064323"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"				"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB002608: , HPA058559: , HPA064323: "	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-3)"	"unprognostic (4.26e-2)"	"unprognostic (5.67e-6)"	"unprognostic (4.47e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (2.98e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.17e-2)"	6.9	5.7	15.5	7.3	11.9	12.6	7.2	36.4	13.8	7.7	6.6	9.5	5.2	4.1	7.5	8.4	5.3	6.5	4.3	5.1	14.5	6.7	7.0	5.8	6.6	8.2	7.7	10.8	8.1	6.1	15.5	8.3	9.6	7.1	6.7	6.8	12.0	5.5	6.5	10.5	8.8	6.6	5.5	6.3	9.3	6.1	10.1	10.9	7.4	6.9	4.9	9.7	7.6	6.2	7.5	5.9	8.6	5.9	1.4	4.4	2.2	6.3	5.1	13.3	4.0	1.6	1.6	5.4	0.8	1.4	1.6	1.6	7.4	3.7	7.2	3.4	1.3	4.9	8.1	2.4	2.3	2.9	3.1	5.0	3.5	6.0	1.0	5.5	3.4	1.1	1.4	1.8	3.3	2.1	5.4	4.1	2.1	3.3	5.0	3.6	15.5	2.0	7.3	4.8	3.2	2.8	3.6	8.1	6.1	4.9	3.6	3.3	4.1	6.8	3.4	3.0	4.9	1.8	3.1	4.0	1.8	16.6	1.4	3.4	3.9	8.6	2.3	2.8	4.4	2.7	3.3	7.5	2.3	2.0	2.5	6.8	3.2	2.4	3.3	1.4	5.9	5.9	2.1	2.2	15.5	11.9	36.4	13.8	14.5	6.7	7.7	10.8	7.1	10.9
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.1;Daudi: 38.2;hTEC/SVTERT24-B: 15.0;U-266/70: 26.6;U-266/84: 25.7;U-698: 30.3;U-87 MG: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 33.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404"	Enhanced		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB002513: AB_442118, HPA049056: , HPA062096: , HPA064404: "	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavourable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"	1.9	2.0	5.6	43.1	7.4	4.8	1.2	12.0	5.7	0.9	3.2	2.5	0.0	2.1	0.9	1.7	1.4	1.5	2.3	4.8	5.7	5.9	1.6	1.4	3.1	31.4	6.8	1.5	0.7	1.6	0.4	2.1	2.5	6.6	2.5	2.1	1.4	2.1	2.3	0.7	1.2	10.8	1.9	6.5	22.7	3.1	6.0	6.2	1.9	1.3	0.6	30.0	4.3	1.0	13.9	8.0	1.7	33.1	0.6	2.7	4.5	0.3	0.5	0.6	0.0	0.0	1.0	0.1	2.8	18.1	1.8	3.5	0.1	0.5	38.2	1.0	1.0	0.3	0.2	2.9	8.2	0.1	0.1	0.9	0.1	0.0	0.2	0.3	0.7	0.8	0.5	15.0	1.0	1.1	0.4	8.8	0.4	0.2	0.1	2.0	0.1	0.2	0.4	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.2	0.0	4.8	1.4	7.8	0.8	0.0	0.3	26.6	25.7	30.3	14.6	0.9	1.0	1.0	10.7	0.1	1.2	19.3	1.1	11.0	1.8	1.6	8.0	13.9	0.9	1.3	1.7	0.6	33.1	1.3	2.7	4.5	5.6	7.4	12.0	5.7	5.7	5.9	6.8	1.5	6.6	6.2
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38044611-38046794	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 10.5;skin 1: 31.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.8;HDLM-2: 18.8;NTERA-2: 5.2;SCLC-21H: 3.7;SK-MEL-30: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7"	"HPA055980, HPA073824"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA055980: , HPA073824: "	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.8	2.1	4.0	0.9	10.5	0.7	0.8	1.2	6.8	0.6	0.7	1.1	0.0	0.6	0.7	0.8	3.4	0.7	0.7	0.7	7.7	0.9	0.7	0.6	0.6	1.7	3.9	2.9	0.7	0.8	0.6	0.0	0.6	1.4	3.6	0.6	1.6	0.6	0.7	1.3	31.0	0.7	2.5	0.6	0.7	0.7	1.5	2.6	0.0	0.7	1.3	1.7	1.5	0.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	10.8	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.1	0.0	0.7	3.7	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	10.5	1.2	6.8	7.7	0.9	3.9	2.9	1.4	2.6
POU3F2	"BRN2, OCT7, OTF7, POUF3"	ENSG00000184486	"POU class 3 homeobox 2"	P20265	6	98834592-98839470	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"brain: 28.0"	"Cell line enhanced"	"Detected in some"		"AF22: 51.0;SK-MEL-30: 7.0;U-251 MG: 15.6;WM-115: 13.5"	"Cancer enriched"	"Detected in some"	11	"glioma: 16.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047081, HPA056261"		Approved	Supported	Nucleoplasm				Nucleoplasm		"HPA047081: , HPA056261: "	"unprognostic (5.94e-4)"	"unprognostic (7.80e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.77e-1)"	"unprognostic (9.38e-11)"	"unprognostic (4.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.04e-1)"	0.9	1.0	9.0	0.9	10.8	0.9	0.9	3.4	28.0	0.9	0.9	10.3	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.9	9.8	7.1	0.9	0.9	0.9	0.9	10.7	6.8	0.9	0.9	0.9	0.0	0.9	9.7	0.9	0.9	0.0	0.9	0.9	0.9	1.0	0.9	0.9	8.4	0.9	0.9	1.2	9.0	0.0	0.9	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	51.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.2	2.2	1.6	0.4	0.0	0.0	0.0	2.8	1.4	0.0	0.0	7.0	0.4	0.0	0.0	0.3	0.0	0.1	15.6	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.0	10.8	3.4	12.5	9.8	7.1	10.7	6.8	9.7	9.0
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104855511-104858574	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1"	"Group enriched"	"Detected in some"	6	"AF22: 27.0;AN3-CA: 25.8;HEK 293: 10.0;RPTEC TERT1: 30.6;SH-SY5Y: 8.5"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA052792: , HPA056039: , HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavourable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			0.2	0.2	9.0	0.1	8.6	0.0	0.1	4.3	18.9	0.0	0.3			0.0	0.0	27.2	0.0	0.0	0.0	0.0	9.9	6.0	23.7	0.0	0.0	0.1	8.9		0.1	0.0	0.0	0.0	0.0		0.0	0.1		0.0	12.1	0.0	0.5	0.0	0.0	10.0	0.0	0.1	0.1			0.0		0.1	0.0	0.0	0.4	0.4	0.9	0.2	0.3	0.2	0.0	0.0	0.0	27.0	25.8	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	3.2	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.8	0.6	0.0	30.6	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.0										
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"	P49335	X	83508261-83512127	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"brain: 39.0"	"Cell line enriched"	"Detected in single"	145	"AF22: 14.7"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Region enriched"	"Detected in all"	6	"basal ganglia: 39.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062295			Supported	Nucleoplasm				Nucleoplasm		"HPA062295: "					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.5	0.5	3.3	0.5	39.0	0.6	0.5	5.0	15.2	0.5	0.7	2.4	0.0	0.5	0.5	0.5	0.5	0.5	1.3	0.5	2.8	1.6	2.5	0.5	0.5	0.5	2.4	3.7	1.1	0.5	0.5	0.1	0.5	2.4	0.5	0.6	0.0	0.5	0.5	0.5	0.5	0.5	0.6	1.7	0.5	0.5	0.5	6.6	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	39.0	5.0	4.2	2.8	1.6	2.4	3.7	2.4	6.6
POU4F3	"BRN3C, DFNA15, DFNA42, DFNA52"	ENSG00000091010	"POU class 4 homeobox 3"	Q15319	5	146338839-146341722	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.8"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.9"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Region enhanced"	"Detected in single"		"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038215	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA038215: AB_10697245"	"unprognostic (8.41e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.12e-1)"		"unprognostic (1.03e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (7.82e-2)"	0.6	0.1	0.4	0.4	0.6	1.0	0.4	2.8	0.9	0.3	0.2	0.2	0.2	0.1	0.6	0.7	0.2	0.4	0.3	0.2	0.7	0.4	0.3	0.2	0.3	0.2	0.7	0.2	0.6	0.2	0.0	0.2	1.8	0.2	0.2	0.2	0.2	1.1	0.4	0.2	0.8	0.2	0.8	2.4	0.6	0.2	0.4	0.2	1.5	0.5	0.2	0.2	0.6	0.2	0.7	0.4	0.0	0.0	0.0	0.4	0.0	0.2	1.0	0.2	0.4	0.2	0.3	0.0	0.0	0.0	0.2	0.4	0.9	0.2	0.3	0.2	0.3	0.5	0.3	0.0	0.9	0.4	0.5	0.0	0.1	0.0	0.1	0.1	0.8	0.4	1.6	0.4	0.1	0.3	0.2	0.5	0.1	0.1	0.4	1.9	0.1	0.3	0.8	0.0	0.1	0.4	0.5	1.8	1.6	0.6	0.5	0.1	0.4	0.1	0.0	0.0	1.9	0.0	0.6	0.6	0.8	0.7	0.0	0.6	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.8	0.2	0.7	0.4	0.7	0.2	0.2	0.2
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"HAP1: 52.5;NTERA-2: 139.7"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: "	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favourable (2.04e-5)"	1.2	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	2.3	2.3	1.2	1.2	4.9	3.1	5.7	1.2	5.2	4.3	1.2	1.2	0.0	11.1	5.0	2.0	1.2	1.2	1.2	1.2	8.8	0.0	1.2	1.2	1.2	4.7	1.0	1.2	1.2	3.0	1.2	1.8	5.9	1.2	1.2	1.2	6.3	2.2	1.2	1.2	1.2	1.2	1.2	11.2	1.2	3.0	1.8	1.8	1.0	1.1	0.9	0.3	0.6	0.2	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.7	52.5	0.6	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	139.7	0.0	0.1	0.1	0.1	1.0	1.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.1	1.4	1.0	0.5	0.8	0.7	0.5	1.0	0.4	0.4	0.2	3.0	0.9	0.6	1.8	1.1	0.5	1.8	0.3	0.3	1.2	1.2	1.2	1.2	1.2	0.0	1.2	1.2	1.2	1.2
POU5F1B	"OTF3C, OTF3P1, POU5F1P1"	ENSG00000212993	"POU class 5 homeobox 1B"	Q06416	8	127322183-127420066	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.4;EFO-21: 3.3;hTERT-HME1: 8.3;NTERA-2: 4.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA058267			Supported	Nucleoplasm				Nucleoplasm		"HPA058267: "	"unprognostic (1.74e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.85e-2)"	"unprognostic (9.31e-4)"	"unprognostic (2.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.56e-2)"	"unprognostic (5.11e-2)"	"unprognostic (5.60e-10)"	"unprognostic (1.21e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-3)"	1.0	0.2	0.2	0.2	0.2	0.6	2.0	0.0	0.4	1.0	0.9			0.0	2.6	1.7	0.9	1.5	0.5	0.3	0.4	0.3	2.8	0.7	0.6	0.7	0.1		0.5	1.2	2.5	0.9	0.6		2.5	1.4		5.1	0.9	0.0	1.6	0.5	0.2	0.0	1.1	0.7	0.4			1.7		0.4	0.8	1.2	0.5	0.1	3.0	0.2	0.0	1.4	0.1	0.5	0.1	0.1	1.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.4	1.2	0.0	3.3	0.0	0.4	0.4	0.2	0.1	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.7	0.4	0.0	8.3	0.1	0.0	0.2	0.0	0.3	0.1	0.1	4.1	0.1	0.0	0.0	0.0	0.3	0.3	1.2	0.1	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.3	1.0	0.1	1.4	0.1	0.3	0.4	0.0	0.5	0.7	0.9	2.6	0.0	0.2	0.1	1.4	0.1										
POU6F1	"BRN5, MPOU, TCFB1"	ENSG00000184271	"POU class 6 homeobox 1"		12	51186936-51217708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA047021, HPA050411"	Enhanced		Supported	"Nuclear bodies,Actin filaments"				"Nuclear bodies"	"Actin filaments"	"HPA047021: , HPA050411: "	"unprognostic (4.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.58e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.11e-3)"	"unprognostic (4.45e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (6.61e-4)"	"unprognostic (2.48e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.33e-1)"	8.2	6.9	8.4	5.1	11.6	2.8	5.7	17.6	21.8	8.5	5.6	6.4	2.4	3.7	7.1	2.3	3.9	5.9	5.6	3.5	8.2	4.6	5.2	2.8	5.5	4.1	10.0	8.3	12.4	6.1	3.1	6.2	3.3	8.1	6.9	2.2	5.0	8.4	6.9	13.6	5.6	5.7	6.6	6.6	6.3	3.8	2.4	10.1	0.0	7.5	1.2	3.0	4.7	6.2	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.6	1.3	1.8	2.4	0.6	2.1	1.0	0.8	1.0	1.1	1.3	0.3	0.9	3.1	0.3	0.7	0.0	2.2	0.1	0.0	4.8	3.1	0.8	1.6	0.0	1.7	0.8	4.3	1.2	0.9	1.8	0.3	3.5	1.1	8.5	0.5	0.0	0.4	1.1	3.0	0.0	0.9	1.0	0.0	0.6	0.0	2.3	3.9	2.0	0.0	4.3	0.9	2.8	2.7	1.9	1.6	0.6	2.2	5.5	4.4	0.4	1.7	0.7	0.7	0.0	0.0	0.0	1.0	0.0	0.1	0.8	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	11.6	17.6	21.8	8.2	4.6	10.0	8.3	8.1	10.1
PPA1	"IOPPP, PP, PP1, Ppase, SID6-8061"	ENSG00000180817	"Pyrophosphatase (inorganic) 1"	Q15181	10	70202830-70233911	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019878, HPA020096"	Supported		Supported	Vesicles			110000	Vesicles		"HPA019878: AB_1855601, HPA020096: AB_1855600"	"unprognostic (1.50e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.74e-1)"	46.6	55.5	41.3	36.8	56.0	24.2	88.7	66.8	62.2	34.8	45.7	25.2	43.7	33.2	30.4	59.6	48.6	38.1	31.5	30.0	46.7	54.2	40.7	59.0	39.1	54.6	74.3	47.5	17.9	72.6	23.3	29.5	34.6	60.7	24.4	53.4	26.1	36.8	42.1	37.0	24.6	41.0	32.8	72.7	22.4	32.5	25.1	47.2	20.4	52.0	35.8	44.4	32.7	40.2	21.5	48.9	1.0	17.7	15.5	35.6	25.3	58.1	24.1	21.6	63.6	58.8	51.9	20.2	21.8	41.0	34.2	36.1	73.4	30.9	84.3	19.9	21.7	47.1	63.2	42.5	35.0	79.2	60.1	23.0	24.4	41.9	37.1	56.6	14.6	34.0	50.9	27.4	73.1	41.3	53.6	45.4	32.2	34.1	54.7	53.2	22.5	66.9	33.5	24.7	49.3	71.3	36.6	64.9	21.8	24.0	94.1	18.6	23.5	25.5	18.7	9.5	36.2	31.2	41.3	15.0	32.8	61.7	14.7	79.5	8.3	0.0	17.7	0.4	13.3	13.8	35.6	21.5	30.8	23.1	48.9	13.8	34.2	28.9	1.0	15.5	14.5	11.3	30.1	25.3	41.3	56.0	66.8	62.2	46.7	54.2	74.3	47.5	60.7	47.2
PPARA	"hPPAR, NR1C1, PPAR"	ENSG00000186951	"Peroxisome proliferator activated receptor alpha"	Q07869	22	46150521-46243756	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 12.1;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;granulocytes: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058901, HPA067049, CAB075701"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB075701: , HPA058901: , HPA067049: "	"unprognostic (1.96e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (4.39e-9)"	"unprognostic (4.84e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.18e-2)"	5.7	6.6	5.8	6.0	6.2	4.2	6.9	2.6	4.5	3.8	11.8	5.9	9.9	13.9	4.8	6.6	6.3	3.9	9.1	19.6	5.1	4.1	17.8	30.9	3.8	3.4	6.1	4.9	9.1	13.4	6.6	3.5	3.1	7.8	6.2	7.1	13.5	8.1	8.2	17.1	5.8	19.7	5.0	4.7	3.5	5.7	2.7	7.1	1.3	5.4	10.4	4.8	7.3	12.3	1.5	3.8	12.1	1.4	0.9	1.5	0.3	6.8	1.7	2.1	7.6	12.1	7.8	4.8	5.9	11.9	6.4	6.6	3.3	3.3	2.4	3.0	13.8	3.1	6.4	7.8	5.8	7.0	8.1	7.6	4.3	7.0	7.6	5.1	13.0	6.1	6.3	4.7	10.9	1.3	2.7	5.7	5.9	1.7	5.8	1.9	0.3	1.7	6.9	7.8	3.2	4.4	4.0	2.1	6.4	2.3	2.1	7.5	2.4	4.0	2.3	6.7	7.2	6.0	2.6	5.7	3.3	1.0	10.5	5.8	2.0	1.7	1.0	12.1	1.4	1.4	1.2	1.0	0.7	0.7	0.7	1.5	0.8	0.6	0.8	0.9	0.8	3.8	1.5	0.3	5.8	6.2	2.6	4.5	5.1	4.1	6.1	4.9	7.8	7.1
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 97.6;breast: 102.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 47.4;ASC TERT1: 27.0;BEWO: 55.9;CAPAN-2: 25.0;HSkMC: 27.8;PC-3: 24.9;RT4: 34.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: , HPA063663: "	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavourable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favourable (5.52e-5)"	97.6	1.6	1.9	17.1	1.2	0.7	102.1	1.5	1.3	3.1	24.9	0.8	2.1	7.5	3.5	2.2	2.8	2.4	8.7	12.5	1.4	0.9	6.7	5.9	24.8	11.4	1.1	0.9	6.7	1.2	2.8	0.3	26.8	0.9	10.4	13.9	1.1	5.8	1.5	5.0	2.7	9.6	7.4	1.2	7.0	11.9	3.5	0.6	0.9	6.2	4.3	2.1	30.2	14.1	0.0	0.4	0.0	2.3	0.0	0.7	0.3	9.6	8.6	0.0	0.0	47.4	27.0	55.9	0.9	10.4	1.3	0.5	1.8	25.0	0.0	0.0	0.9	3.9	3.4	0.1	0.2	23.2	4.8	0.0	1.9	2.3	12.6	0.0	0.0	27.8	2.3	2.3	9.0	0.1	0.0	0.0	2.0	2.4	0.0	0.1	0.1	24.9	0.0	0.0	0.0	7.1	34.1	0.0	0.2	4.0	1.5	0.5	0.0	7.7	7.8	1.8	2.6	1.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	1.9	1.2	1.5	1.3	1.4	0.9	1.1	0.9	0.9	0.6
PPARGC1A	"PGC-1alpha, PGC1, PGC1A, PPARGC1"	ENSG00000109819	"PPARG coactivator 1 alpha"	Q9UBK2	4	23755041-23904089	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.5;liver: 49.7;skeletal muscle: 55.6"	"Cell line enriched"	"Detected in some"	7	"A-431: 42.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063136			Supported	Nucleoplasm				Nucleoplasm		"HPA063136: "	"unprognostic (1.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.28e-6)"	"unprognostic (5.00e-2)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.35e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.58e-2)"	"prognostic favourable (1.49e-14)"	"unprognostic (3.62e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (3.07e-3)"	5.7	2.4	3.1	2.4	4.2	0.3	1.3	4.7	5.5	2.6	9.4	4.2	1.8	5.7	0.9	4.8	3.0	1.2	2.2	24.6	3.3	3.1	49.5	49.7	2.5	0.4	3.1	1.8	1.3	2.8	14.6	7.6	0.3	7.8	2.6	6.6	14.0	30.4	3.0	55.6	5.5	14.2	1.6	3.2	0.8	3.1	3.4	3.4	0.3	17.4	18.2	1.5	1.7	1.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	42.9	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.1	4.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	6.2	0.0	2.0	0.1	1.4	0.0	1.7	0.2	0.7	0.0	0.4	0.3	0.0	0.8	3.8	0.0	0.0	0.8	0.7	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	4.2	4.7	5.5	3.3	3.1	3.1	1.8	7.8	3.4
PPARGC1B	"PERC, PGC1B"	ENSG00000155846	"PPARG coactivator 1 beta"	Q86YN6	5	149730298-149855022	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050543			Supported	Nucleoplasm				Nucleoplasm		"HPA050543: "	"unprognostic (2.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.51e-3)"	"unprognostic (6.55e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.01e-6)"	"unprognostic (8.45e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.77e-3)"	4.5	2.4	3.9	9.5	7.1	4.3	3.5	16.3	8.7	3.9	15.6	1.6	16.3	13.1	5.4	2.6	9.0	5.5	6.2	10.0	3.3	4.1	2.3	3.7	7.4	3.0	3.3	4.8	3.2	3.4	17.7	2.0	3.2	7.2	6.4	11.6	7.6	4.0	19.7	10.3	6.6	16.6	18.6	2.7	4.2	7.9	2.0	1.3	2.2	1.7	8.4	5.8	11.5	5.6	1.9	2.4	2.2	6.2	0.8	0.7	0.5	0.5	1.8	0.8	4.5	1.8	0.6	7.3	0.3	0.0	0.5	0.7	8.1	1.9	8.8	1.3	0.0	5.5	6.7	3.4	0.6	0.5	5.8	8.2	3.2	1.7	0.5	11.3	3.3	0.9	4.5	1.7	3.0	0.9	5.6	2.9	0.4	2.2	4.1	5.3	2.9	4.8	7.9	4.9	4.9	1.4	10.8	2.4	0.6	1.2	9.6	1.5	2.6	3.7	1.2	1.0	1.7	3.6	1.8	3.6	2.6	5.2	2.3	7.2	0.9	1.0	2.0	0.7	0.4	3.8	0.7	1.9	0.4	0.3	2.4	0.9	0.6	0.6	2.2	0.8	6.2	0.3	0.3	0.5	3.9	7.1	16.3	8.7	3.3	4.1	3.3	4.8	7.2	1.3
PPFIA1	"LIP.1, LIPRIN"	ENSG00000131626	"PTPRF interacting protein alpha 1"	Q13136	11	70270700-70385312	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 78.4;SK-MEL-30: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017032, HPA042271"	Uncertain		Supported	"Focal adhesion sites,Cytosol"				Cytosol	"Focal adhesion sites"	"CAB017032: , HPA042271: "	"unprognostic (1.89e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.58e-4)"	"unprognostic (7.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavourable (8.26e-4)"	"unprognostic (1.14e-1)"	"prognostic favourable (3.76e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.14e-2)"	28.9	18.6	20.9	17.5	20.8	20.8	40.5	22.8	24.1	15.9	18.3	27.7	18.5	15.5	26.2	20.4	19.4	16.9	23.9	19.3	19.7	12.0	18.1	15.5	25.4	15.9	18.9	17.8	21.0	17.7	21.2	34.1	24.9	20.7	13.8	16.3	21.9	19.0	18.5	38.7	24.2	17.8	18.4	30.0	14.7	15.6	29.8	22.5	17.0	25.2	10.0	13.6	18.7	18.6	2.6	2.8	10.0	4.8	1.1	2.2	1.0	78.4	10.6	9.7	6.6	9.1	5.7	10.3	9.2	7.5	11.5	7.6	20.0	7.0	7.3	12.0	7.4	11.4	8.2	7.9	9.9	4.9	5.7	5.9	11.1	6.4	9.3	7.7	7.2	7.2	12.7	14.7	12.1	7.4	9.9	6.0	9.9	10.7	5.3	4.6	5.8	9.1	6.1	24.5	6.4	5.6	10.8	9.5	6.4	13.7	17.3	45.1	11.6	8.2	10.1	11.5	9.0	15.9	9.7	7.3	4.6	10.3	9.5	5.4	13.4	0.0	3.6	1.7	1.3	1.9	2.2	2.6	2.2	1.9	2.8	2.3	1.7	1.0	10.0	1.1	4.8	2.8	2.1	1.0	20.9	20.8	22.8	21.4	19.7	12.0	18.9	17.8	20.7	22.5
PPHLN1		ENSG00000134283	"Periphilin 1"	Q8NEY8	12	42238447-42459715	"Predicted intracellular proteins"	"Keratinization, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA038902, HPA038903"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA038902: AB_10674844, HPA038903: AB_2676263"	"unprognostic (4.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.92e-2)"	"prognostic unfavourable (1.28e-7)"	"unprognostic (2.85e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (5.06e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.04e-2)"	25.6	32.4	29.0	37.2	34.2	37.6	27.8	43.0	32.2	24.3	23.7	18.9	27.7	19.2	35.3	27.7	27.0	25.3	24.5	29.0	25.6	28.7	25.2	25.2	23.0	44.3	23.8	35.0	30.6	21.3	20.7	39.9	24.2	26.3	22.6	27.1	21.6	31.1	24.9	32.0	26.1	26.9	28.3	24.6	30.5	23.1	48.4	24.9	51.4	23.1	28.6	47.2	28.1	25.3	25.0	24.1	23.1	14.5	23.7	33.2	12.2	14.6	13.7	16.3	13.5	14.7	16.4	14.4	17.3	19.7	18.2	15.1	22.1	18.6	25.0	22.0	18.4	13.7	16.7	18.1	22.5	21.5	17.4	39.2	14.1	19.9	15.5	46.1	22.6	19.5	18.6	14.4	13.9	22.7	19.1	19.4	19.9	11.2	25.8	27.8	14.1	13.6	22.1	18.6	22.9	28.4	13.0	11.6	17.0	15.2	12.4	14.8	18.8	23.2	15.6	10.6	19.0	10.2	14.8	22.4	31.1	40.4	18.0	85.3	7.0	21.0	12.8	23.1	19.3	14.5	23.2	25.0	24.7	25.9	24.1	21.1	22.7	22.6	8.3	23.7	13.4	22.9	33.2	12.2	29.0	34.2	43.0	32.2	25.6	28.7	23.8	35.0	26.3	24.9
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"		120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.3	49.5	44.7	101.6	156.7	91.0	39.3	94.0	123.5	74.4	88.5	71.2	73.1	37.6	76.4	145.5	64.2	81.7	63.1	38.4	23.8	30.8	53.0	54.7	93.1	164.3	52.9	48.0	83.8	68.1	43.4	105.8	89.8	37.0	131.0	56.4	62.8	16.1	81.1	39.0	31.8	30.9	47.5	191.8	77.2	61.4	25.3	39.9	43.0	74.0	68.4	44.2	161.8	55.2	74.4	61.7	41.6	63.4	71.2	68.9	39.5	69.5	85.2	74.2	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.3	14.3	14.4	19.7	21.4	16.1	21.8	15.2	8.3	14.0	10.6	18.5	10.5	16.2	6.8	14.1	11.8	43.6	17.4	17.1	53.7	15.2	29.0	12.9	25.5	16.6	18.2	21.8	10.1	14.2	12.0	17.9	15.2	36.2	29.0	15.5	14.7	26.0	16.5	19.8	19.1	11.8	7.1	13.9	15.4	7.7	24.4	16.3	11.4	23.7	21.6	10.9	17.4	14.7	14.0	15.8	15.4	20.0	16.7	34.6	20.7	17.8	19.7	14.0	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4
PPIE	"CyP-33, MGC111222, MGC3736"	ENSG00000084072	"Peptidylprolyl isomerase E"	Q9UNP9	1	39692182-39763914	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019357, HPA020131"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA019357: , HPA020131: AB_1847405"	"unprognostic (2.94e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavourable (5.05e-5)"	"unprognostic (5.86e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.00e-1)"	19.3	23.8	23.7	24.3	22.5	18.6	25.7	25.9	36.1	25.5	28.1	35.6	22.2	19.7	30.6	26.5	26.0	34.7	21.1	27.1	22.3	22.1	25.2	29.8	20.6	25.9	26.3	20.5	35.5	42.1	27.4	23.6	21.9	24.9	26.1	22.7	26.9	30.7	28.9	29.6	21.7	23.2	34.2	25.6	25.7	23.9	38.8	20.2	22.8	33.7	21.9	33.9	31.5	22.6	43.3	31.6	14.1	27.2	49.0	46.9	44.2	9.6	16.7	15.4	12.3	17.1	15.2	8.1	16.6	16.7	25.4	23.9	20.8	28.5	27.4	23.5	18.6	14.7	21.0	24.7	24.3	17.7	22.6	30.2	19.4	6.3	23.5	27.2	16.6	13.8	22.6	23.8	8.8	22.8	30.6	19.2	18.5	17.3	12.5	22.1	18.4	18.7	18.6	11.6	15.6	19.2	18.0	21.9	17.5	17.4	14.2	12.0	17.8	71.5	14.8	16.0	17.7	19.7	25.5	26.3	26.3	18.9	11.1	35.1	25.0	11.6	27.1	14.1	38.3	27.0	37.0	43.3	39.7	38.2	31.6	39.8	46.9	38.9	2.2	49.0	27.2	28.5	40.0	44.2	23.7	22.5	25.9	36.1	22.3	22.1	26.3	20.5	24.9	20.2
PPIF	"Cyp-D, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 32.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria			27000000	Mitochondria		"HPA077416: "	"unprognostic (2.21e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.45e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.88e-2)"	16.5	76.2	12.1	15.7	18.8	52.0	16.9	7.1	21.3	8.3	18.1	27.1	13.2	13.3	5.2	7.6	21.0	8.8	10.0	36.5	13.0	14.5	21.0	73.1	9.4	19.4	23.3	16.6	7.2	42.0	12.0	6.2	11.3	25.2	6.6	19.9	7.5	12.7	21.9	44.4	22.5	11.1	9.9	28.0	19.6	34.0	20.8	18.0	8.8	10.0	73.9	19.8	12.5	11.0	8.0	18.6	32.8	14.9	3.6	5.0	6.5	35.1	15.0	10.5	20.7	9.8	12.8	13.5	20.5	27.0	45.2	42.8	35.0	17.1	36.6	11.4	14.4	21.1	32.6	19.1	70.5	11.6	30.7	57.3	14.7	61.6	16.7	39.4	13.6	30.0	13.8	44.8	44.9	7.9	55.7	45.2	15.3	18.1	10.2	33.0	8.8	83.4	17.6	16.3	18.7	17.5	32.9	21.0	15.6	10.5	42.7	15.8	18.7	30.5	7.1	19.8	18.0	23.3	39.5	21.0	21.3	29.6	19.6	51.4	5.3	5.1	14.9	7.3	4.7	11.4	5.0	8.0	4.2	4.3	18.6	3.9	3.8	3.7	32.8	3.6	4.1	2.3	4.2	6.5	12.1	18.8	7.1	21.3	13.0	14.5	23.3	16.6	25.2	18.0
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584340-169641406	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: "	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.2	25.3	28.5	23.8	45.3	39.2	26.7	45.0	40.7	33.1	27.1	14.6	26.0	25.3	27.1	28.1	29.4	24.3	21.2	24.2	30.0	20.3	26.0	41.1	25.5	30.4	27.7	35.9	29.5	22.8	39.4	56.7	26.0	38.0	29.3	23.9	13.8	28.6	28.8	27.8	24.5	30.8	31.9	39.7	29.7	24.1	19.8	33.7	24.1	28.4	22.6	29.9	37.4	27.6	36.4	23.7	41.7	24.7	18.7	29.6	13.3	19.1	9.1	25.8	14.1	14.3	17.6	24.3	21.9	16.5	16.2	16.8	24.9	22.1	33.1	20.2	15.8	18.5	20.2	18.0	24.0	23.0	16.3	49.8	13.6	30.3	13.8	46.8	22.2	14.8	20.4	22.0	24.7	17.8	48.0	27.6	18.5	15.5	34.5	28.7	37.0	9.3	31.8	25.8	32.3	20.1	28.9	22.6	14.9	23.6	17.6	23.8	16.4	27.1	20.4	21.2	16.2	14.1	18.0	16.1	23.1	46.2	15.6	25.1	19.4	20.7	20.0	29.9	20.3	20.1	23.2	27.6	27.0	23.8	14.9	36.4	29.6	23.7	41.7	18.7	24.7	23.7	22.9	13.3	28.5	45.3	45.0	40.7	30.0	20.3	27.7	35.9	38.0	33.7
PPIL2	"CYC4, Cyp-60, UBOX7"	ENSG00000100023	"Peptidylprolyl isomerase like 2"	Q13356	22	21666009-21700015	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"K-562: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035344, HPA055637"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035344: AB_10672863, HPA055637: "	"unprognostic (1.97e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.77e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.46e-2)"	"unprognostic (5.39e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-3)"	15.0	21.5	19.4	20.9	24.6	16.6	13.5	24.1	30.9	17.7	17.4	25.3	19.1	18.6	21.8	17.0	22.3	15.7	16.5	20.0	17.2	17.1	21.2	20.3	14.6	23.7	15.6	20.9	16.6	31.4	23.6	30.2	31.4	19.0	19.5	17.6	23.6	22.0	16.5	25.5	17.5	19.1	15.2	15.0	21.3	19.5	18.4	17.6	32.8	27.0	13.6	33.5	17.4	16.2	8.7	11.7	4.8	17.3	12.8	13.2	9.1	6.5	6.8	8.0	8.4	8.1	7.0	7.2	8.6	6.1	10.5	9.0	6.9	4.3	11.2	5.2	9.5	9.6	10.6	7.3	6.3	6.9	10.8	10.5	6.8	8.1	5.9	16.5	9.9	7.5	6.6	7.5	5.7	9.0	69.7	8.1	7.5	10.2	7.4	4.5	7.6	4.2	9.6	11.8	2.3	5.3	6.6	12.4	6.8	7.8	12.4	2.8	8.9	5.5	10.9	6.6	10.7	7.7	5.4	9.4	6.8	8.5	7.5	6.3	7.9	1.0	8.6	4.7	9.5	13.9	11.4	7.0	11.1	12.0	11.7	8.7	9.8	8.9	4.8	12.8	17.3	11.1	13.2	9.1	19.4	24.6	24.1	30.9	17.2	17.1	15.6	20.9	19.0	17.6
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Supported	Nucleoplasm			35000	Nucleoplasm		"HPA040765: , HPA062187: "	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favourable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	12.4	17.9	18.1	15.5	19.2	24.2	21.1	20.1	20.2	19.4	16.4	18.4	21.1	12.7	17.2	24.3	25.4	19.1	15.9	17.6	17.5	21.8	15.9	19.4	15.9	23.7	20.0	11.8	31.4	16.7	11.9	17.4	15.5	23.0	19.5	16.6	16.3	13.8	15.8	13.4	14.7	15.7	16.8	23.2	20.2	15.7	18.2	13.0	26.3	23.7	19.4	25.5	28.6	13.6	23.4	21.7	18.7	14.1	20.6	20.6	10.7	7.9	7.1	22.0	9.5	17.3	37.1	7.2	12.8	13.8	14.7	14.9	5.2	15.2	7.6	13.5	13.7	10.5	7.6	15.5	13.2	16.2	18.5	32.4	19.9	35.0	8.9	31.0	16.5	13.4	15.3	12.0	19.1	9.8	25.6	18.8	18.8	12.7	23.8	24.7	13.4	11.4	9.0	12.3	12.1	19.4	12.4	9.1	8.5	12.9	12.2	20.5	10.2	14.1	13.3	21.3	12.0	12.6	10.5	20.6	19.5	36.1	16.2	13.9	13.4	18.7	12.7	12.7	12.7	10.8	18.5	23.4	15.6	13.7	21.7	18.9	19.1	20.6	3.0	20.6	14.1	17.9	20.1	10.7	18.1	19.2	20.1	20.2	17.5	21.8	20.0	11.8	23.0	13.0
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504733-149546038	"Enzymes, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	20.0	20.1	20.6	15.0	35.5	30.6	21.2	35.1	27.8	24.0	15.3	19.7	10.1	14.1	21.1	27.2	15.7	18.0	19.8	18.3	21.3	15.6	18.8	23.0	17.9	15.7	20.9	18.0	32.9	16.0	20.8	36.6	22.6	23.9	20.5	16.8	15.7	18.2	16.7	14.8	15.4	16.0	20.0	22.7	17.6	16.0	15.9	19.4	27.0	26.8	8.2	16.8	22.0	19.2	21.4	16.6	24.9	17.8	28.7	24.6	14.8	10.9	5.9	20.7	17.1	12.3	16.2	19.3	21.7	20.7	23.7	25.4	12.4	11.3	11.6	15.0	16.7	10.0	15.8	8.3	37.7	16.8	14.9	12.8	13.0	21.3	19.4	23.3	10.9	12.6	14.2	24.2	20.3	12.9	27.8	7.0	18.4	11.7	13.2	20.0	16.3	9.3	17.9	19.1	5.8	18.0	8.4	12.2	9.4	25.8	11.3	14.7	13.3	17.0	15.1	15.7	12.4	27.8	20.6	9.3	4.7	18.2	13.3	18.7	22.7	24.9	16.1	18.1	14.7	17.8	20.4	21.4	19.5	16.9	16.6	16.6	24.6	18.7	13.4	28.7	16.1	16.2	20.7	14.8	20.6	35.5	35.1	27.8	21.3	15.6	20.9	18.0	23.9	19.4
PPIP5K1	"HISPPD2A, IPS1, KIAA0377, VIP1"	ENSG00000168781	"Diphosphoinositol pentakisphosphate kinase 1"	Q6PFW1	15	43533462-43590253	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039380	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039380: AB_10673528"	"unprognostic (8.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.59e-3)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.85e-3)"	"prognostic favourable (7.14e-8)"	"unprognostic (2.67e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.95e-3)"	1.7	5.2	3.4	1.8	6.4	1.1	3.4	28.4	7.0	2.8	6.1			9.1	2.2	5.6	3.7	3.1	2.5	2.1	3.6	5.0	2.5	1.4	1.4	2.0	3.3		3.0	2.9	13.4	7.6	0.9		3.4	6.5		4.7	2.7	6.3	7.2	8.8	2.3	2.8	2.3	5.3	4.5			5.0		3.0	3.3	2.7	5.3	3.2	4.3	2.8	3.5	3.8	3.0	8.5	5.6	4.9	9.1	3.0	1.9	8.5	4.2	5.4	6.1	9.0	6.5	8.1	8.0	6.5	5.8	23.2	9.6	18.5	6.2	7.8	7.6	12.0	17.0	3.5	6.9	13.6	12.5	3.4	16.3	7.4	11.5	6.5	8.6	11.9	4.5	6.6	4.5	7.7	2.4	6.1	9.8	5.0	4.0	6.7	15.4	14.9	4.6	11.0	10.5	4.2	19.3	11.5	2.8	5.4	6.4	6.7	10.3	2.6	3.2	9.9	10.1	15.7	5.1	4.3	1.4	0.0	2.7	2.8	3.8	5.3	3.3	3.6	3.2	3.6	2.7	2.5	1.0	3.5	2.1	2.4	0.8	3.0										
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"			850000	Cytosol	"Plasma membrane"	"HPA029209: "	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	16.2	11.7	13.8	15.0	18.3	64.0	15.1	20.5	28.6	15.5	32.4	13.3	9.4	19.1	17.4	12.7	15.2	10.7	10.8	37.1	13.5	16.1	22.8	26.7	14.6	11.8	15.6	19.1	12.1	13.3	18.2	12.2	15.8	24.3	16.5	19.4	12.3	18.7	13.5	56.1	16.7	25.2	15.0	13.8	11.6	14.9	29.7	12.7	23.4	13.3	11.6	13.4	15.2	16.5	4.0	2.7	8.0	2.1	4.7	4.5	1.9	47.8	10.8	9.4	8.0	14.4	13.4	12.0	13.2	15.5	9.8	9.3	6.1	14.1	28.8	12.6	14.9	10.7	9.7	13.6	17.2	25.9	5.5	17.7	7.7	9.5	12.1	20.0	12.7	11.3	16.3	11.5	15.8	9.6	9.8	23.0	11.9	21.0	26.0	4.7	8.8	9.1	9.4	21.8	9.3	11.8	23.0	16.0	12.0	13.7	16.0	11.1	16.1	8.8	13.2	20.5	20.5	8.9	9.3	17.9	10.1	33.7	9.4	7.9	10.3	6.7	1.8	5.1	3.5	1.8	3.8	1.7	2.8	3.1	2.7	4.0	2.2	2.1	8.0	4.7	2.1	1.6	4.5	1.9	13.8	18.3	20.5	28.6	13.5	16.1	15.6	19.1	24.3	12.7
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381194-27409687	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavourable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favourable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	12.7	17.0	9.9	19.9	9.2	19.4	30.2	10.9	19.3	17.9	14.6	9.1	16.9	12.1	26.8	12.5	19.4	19.2	17.7	13.6	8.8	7.6	12.6	18.6	14.7	20.2	9.4	8.0	13.4	18.6	13.8	13.2	11.4	8.7	10.2	16.4	9.1	16.4	18.7	24.1	10.9	12.2	14.9	6.7	14.7	14.1	93.3	8.4	25.8	14.1	19.1	22.5	25.2	17.3	20.2	40.3	24.5	29.1	22.7	38.3	19.0	50.1	41.4	30.4	23.4	19.4	15.8	28.1	31.3	20.6	37.6	30.2	63.7	26.6	59.2	23.0	22.2	27.5	51.1	35.2	33.8	24.7	41.5	57.6	30.2	67.3	17.5	56.9	24.4	17.1	20.4	38.3	30.9	35.9	48.2	18.4	28.5	44.9	42.2	61.7	44.2	29.9	43.7	63.7	31.1	25.3	35.0	40.9	46.3	28.1	31.1	22.4	17.2	18.7	28.8	28.2	34.1	24.6	47.4	40.2	45.0	93.6	22.0	46.6	21.1	22.1	17.8	24.5	26.9	22.3	26.5	20.2	28.7	27.9	28.5	18.0	21.7	22.4	9.1	22.7	29.1	40.3	38.3	19.0	9.9	9.2	10.9	19.3	8.8	7.6	9.4	8.0	8.7	8.4
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643982-62935037	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.1;parathyroid gland: 36.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.1;HMC-1: 28.3;SK-BR-3: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.3;granulocytes: 5.3;monocytes: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB020694: , HPA044244: , HPA058777: "	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.6	2.1	10.6	1.6	12.4	3.1	5.7	37.1	16.3	8.5	2.8	14.0	12.4	3.6	6.9	7.7	1.1	7.5	9.1	2.2	13.0	12.2	11.7	3.9	3.2	1.5	14.3	9.0	9.4	4.9	36.6	13.3	7.1	8.5	15.0	3.6	7.7	10.2	11.6	1.5	1.2	2.1	2.2	8.9	1.3	6.2	1.4	15.0	0.5	3.8	0.1	2.1	3.4	1.2	0.0	2.3	5.3	1.7	0.2	0.0	0.3	0.5	5.4	1.0	0.0	0.2	0.0	11.9	1.3	1.3	0.8	0.2	35.1	2.5	0.0	1.2	0.6	0.7	3.8	0.1	0.5	0.1	1.9	6.6	1.0	7.9	0.0	2.0	28.3	0.0	0.1	0.0	0.3	0.1	1.7	0.0	0.6	4.0	0.6	0.9	7.1	2.6	0.9	2.5	9.8	8.1	12.4	3.1	0.0	2.2	16.0	5.2	8.7	1.1	0.1	0.2	0.7	0.1	0.4	1.4	9.0	1.8	0.1	0.0	0.5	5.3	1.7	3.0	0.0	1.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.2	1.4	0.0	0.0	0.3	10.6	12.4	37.1	16.3	13.0	12.2	14.3	9.0	8.5	15.0
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 59.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 27.1;Karpas-707: 23.6;U-698: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria				Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	3.6	6.1	19.2	8.8	17.2	5.9	9.3	21.1	26.8	12.9	3.8	12.5	2.5	3.0	21.8	5.5	7.6	14.1	6.0	59.1	23.1	14.6	11.8	5.1	6.5	14.5	21.6	15.9	22.0	7.3	10.4	8.4	6.4	17.0	11.1	4.3	4.7	7.1	5.3	8.3	1.9	6.7	18.2	15.0	10.9	5.4	12.3	19.4	7.3	5.4	1.9	15.8	6.5	8.1	31.8	38.8	5.5	3.4	7.9	16.1	7.1	2.1	0.7	2.8	4.9	4.2	5.5	1.1	3.4	6.3	11.6	13.7	5.6	0.5	27.1	3.8	2.2	0.2	8.2	2.6	4.6	20.9	3.4	4.8	2.1	5.0	3.3	6.6	2.6	3.6	1.3	7.1	6.2	1.9	7.2	23.6	3.3	3.1	8.7	3.6	1.7	1.1	5.0	4.6	10.3	4.0	0.9	2.2	1.9	2.1	0.2	2.5	11.2	1.8	0.3	4.0	2.1	1.3	2.0	7.4	6.8	22.7	4.4	5.4	6.7	5.5	2.9	2.3	12.4	3.4	16.1	30.4	11.8	12.4	5.5	31.8	11.7	14.1	0.9	7.9	0.9	38.8	13.3	7.1	19.2	17.2	21.1	26.8	23.1	14.6	21.6	15.9	17.0	19.4
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 43.7;skeletal muscle: 81.9"	"Cell line enhanced"	"Detected in many"		"RT4: 21.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"non-classical monocyte: 43.7"	"Lineage enriched"	"Detected in all"	10	"monocytes: 43.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043577			Supported	Vesicles				Vesicles		"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	1.7	0.9	5.4	1.2	4.5	1.3	1.9	0.7	4.1	1.3	1.7	0.1	0.7	0.6	1.5	1.0	2.2	0.8	1.0	0.9	3.3	2.3	1.2	1.5	1.5	1.6	2.6	2.2	0.8	0.5	1.3	1.4	2.4	2.7	2.3	1.0	10.6	1.5	1.4	81.9	2.4	1.4	2.6	3.4	15.7	1.7	2.9	3.5	2.5	0.9	0.0	2.4	4.0	1.9	1.9	4.3	2.3	43.7	1.1	2.9	1.9	1.9	5.1	0.9	3.9	4.5	6.1	11.2	1.4	2.3	0.4	1.7	1.3	12.0	8.1	2.4	1.3	5.7	2.3	1.7	0.7	7.9	3.3	6.4	2.0	1.5	1.1	0.5	13.7	2.5	2.6	2.3	1.3	0.7	7.3	7.3	0.8	1.4	2.2	3.5	3.1	1.1	1.4	1.1	2.3	2.5	21.8	4.4	5.2	0.7	8.4	6.3	2.8	1.9	1.1	6.4	3.9	3.1	1.0	1.2	3.2	1.6	4.7	1.7	5.5	1.7	1.6	1.0	2.2	7.2	2.0	1.9	1.4	2.2	4.3	1.3	1.6	2.9	2.3	1.1	43.7	0.8	1.5	1.9	5.4	4.5	0.7	4.1	3.3	2.3	2.6	2.2	2.7	3.5
PPME1	PME-1	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171099-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 69.0"	"Cell line enhanced"	"Detected in all"		"RH-30: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"			16000	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: , HPA064396: "	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavourable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	9.4	16.1	13.3	6.2	27.6	8.4	9.3	27.4	38.5	11.4	9.2	13.5	9.4	7.1	13.1	16.5	13.5	15.2	8.9	12.8	14.6	18.3	12.3	6.5	8.2	5.5	13.6	18.6	12.4	10.4	69.0	13.6	15.5	22.4	15.1	9.8	9.6	11.9	15.9	21.0	16.2	7.4	13.4	12.7	5.0	8.3	22.9	9.3	8.6	14.9	7.9	8.5	11.4	10.2	7.5	11.3	10.9	9.6	12.2	14.0	8.4	9.9	13.0	8.9	9.4	9.3	7.7	8.8	14.6	9.6	27.7	22.0	28.6	6.6	5.3	10.2	10.8	16.6	13.2	10.0	26.1	7.4	5.0	7.9	14.1	12.2	18.6	5.7	7.0	7.4	8.2	14.7	6.4	8.1	18.4	4.5	48.4	6.6	6.7	6.1	7.0	10.4	8.0	90.6	8.0	10.4	6.9	12.2	10.4	17.5	8.0	20.5	14.7	5.9	4.9	11.1	13.3	10.6	11.2	8.5	10.8	9.4	8.2	5.2	9.0	1.3	8.6	10.9	10.8	9.6	13.3	6.9	13.8	12.7	10.8	7.5	14.0	11.2	5.0	12.2	8.5	11.3	9.7	8.4	13.3	27.6	27.4	38.5	14.6	18.3	13.6	18.6	22.4	9.3
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166410-161178013	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030123, HPA054287"	Uncertain		Supported	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA030123: AB_10603987, HPA054287: "	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavourable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	7.3	14.8	11.6	9.1	12.1	31.7	10.2	23.5	16.5	11.0	9.9	13.2	8.5	6.0	11.7	13.5	7.5	33.2	9.5	9.5	11.5	12.5	12.0	9.1	10.2	11.2	14.2	16.1	13.0	13.1	10.5	12.3	10.1	12.1	11.0	6.7	14.4	11.3	14.6	8.5	15.9	7.1	10.0	10.6	12.0	8.2	6.9	13.7	9.2	11.0	6.1	8.7	8.7	8.2	9.8	11.5	6.9	7.7	12.3	16.7	8.9	7.0	6.5	9.8	6.4	7.4	7.9	3.3	4.9	5.7	6.0	8.1	7.7	6.8	5.5	11.8	3.4	4.9	7.5	7.9	5.5	3.8	14.9	6.7	14.7	17.5	7.9	2.2	3.7	6.3	7.9	5.9	8.3	11.4	19.7	8.6	4.4	6.6	8.9	7.0	7.0	14.0	10.8	6.8	13.1	11.4	3.1	7.8	12.5	5.9	8.7	9.8	15.6	10.4	4.0	5.6	6.2	4.8	6.2	15.4	11.2	8.5	5.7	4.9	4.3	6.9	7.7	5.5	12.7	7.7	8.4	9.8	9.8	8.8	11.5	8.6	8.6	8.8	1.6	12.3	5.3	7.2	16.7	8.9	11.6	12.1	23.5	16.5	11.5	12.5	14.2	16.1	12.1	13.7
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398183-67421183	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 177.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			8100000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: "	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favourable (1.17e-4)"	"unprognostic (7.60e-2)"	28.4	35.4	24.2	42.0	32.3	42.1	25.1	19.6	33.4	23.9	39.6	22.1	29.9	33.9	19.6	25.8	59.7	22.8	28.6	33.0	21.8	17.1	43.7	55.0	27.6	49.3	19.9	19.9	20.1	53.3	23.1	21.6	44.0	19.3	27.2	33.2	23.2	49.7	31.1	39.0	34.4	47.3	20.5	21.3	53.7	35.1	15.7	19.4	77.7	38.5	40.5	63.9	25.5	25.7	78.8	76.6	126.2	118.0	68.2	113.9	177.2	46.2	53.4	31.7	46.6	15.8	19.4	32.3	22.9	26.9	46.3	35.2	76.3	55.9	39.8	39.1	34.8	40.5	36.6	47.7	28.5	41.8	24.8	38.2	25.2	40.0	34.5	48.5	49.4	21.8	31.6	39.4	23.2	46.4	35.5	33.0	37.4	105.5	61.5	95.4	52.5	42.3	43.7	43.9	34.5	45.4	38.3	24.8	41.2	26.6	47.8	70.7	57.2	33.6	33.0	35.7	36.6	42.1	29.6	33.1	30.6	45.2	42.8	33.4	37.6	81.4	80.1	126.2	88.6	100.5	69.3	78.8	79.8	90.5	76.6	77.0	49.1	69.2	93.3	68.2	118.0	54.4	113.9	177.2	24.2	32.3	19.6	33.4	21.8	17.1	19.9	19.9	19.3	19.4
PPP1CB	"PP-1B, PP1B, PP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			7700000	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB022558: , CAB069426: , HPA065425: "	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	28.5	22.6	30.0	20.5	37.6	29.5	32.4	19.1	29.8	51.1	39.3	21.1	30.7	24.4	58.0	31.8	86.0	37.0	33.3	67.1	27.8	27.9	32.0	20.0	35.3	22.3	27.4	24.4	39.7	21.9	48.9	28.7	42.3	22.0	46.4	27.7	25.2	36.5	38.6	99.6	25.1	30.0	100.8	27.5	25.2	31.4	25.5	21.4	28.1	27.5	32.9	25.3	82.1	50.5	15.6	25.4	41.5	42.7	23.5	28.3	17.9	36.4	23.0	80.2	24.8	27.5	25.6	46.7	19.6	22.4	19.1	18.9	20.4	21.6	29.2	24.7	20.3	22.6	22.8	26.2	22.8	46.3	11.8	22.0	28.2	22.0	59.9	24.9	10.4	19.6	37.3	20.6	43.2	23.1	20.0	29.0	25.0	18.3	26.4	21.6	26.3	18.2	26.0	71.1	22.2	62.2	44.1	22.0	27.2	30.5	33.9	26.6	16.4	14.0	27.6	25.6	28.2	18.3	23.6	20.7	32.5	59.8	27.2	26.9	18.9	22.5	24.8	32.1	16.8	37.8	21.3	15.6	25.5	19.6	25.4	13.4	22.7	25.5	41.5	23.5	42.7	19.6	28.3	17.9	30.0	37.6	19.1	29.8	27.8	27.9	27.4	24.4	22.0	21.4
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600400-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favourable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favourable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	11.5	19.1	10.8	19.6	12.6	5.2	17.4	18.8	16.2	20.4	13.0	24.2	17.0	12.6	14.7	13.0	14.7	15.2	16.4	9.7	15.9	10.3	14.0	20.4	14.6	14.1	14.5	12.4	16.0	21.6	28.8	17.9	10.1	10.4	14.9	15.5	19.6	12.8	21.0	14.1	12.8	13.0	15.4	14.1	17.4	15.6	21.6	11.8	33.5	16.6	12.5	17.0	14.7	13.2	4.8	6.1	6.2	5.4	1.8	5.7	3.5	5.4	6.7	8.6	7.0	7.9	5.4	4.6	5.4	6.9	7.8	6.5	7.3	3.3	5.3	4.0	4.5	8.4	10.2	10.0	5.9	5.8	5.5	6.5	5.8	3.5	8.1	5.7	6.4	6.3	5.8	6.9	14.3	7.1	6.0	6.7	6.9	6.8	7.3	4.9	4.4	4.8	7.6	9.0	10.2	7.9	6.8	12.1	5.2	7.0	6.7	6.0	6.7	7.0	4.4	6.1	5.3	6.7	4.3	12.3	6.6	5.7	5.6	6.6	5.2	6.2	5.1	5.6	5.3	4.5	5.7	4.8	3.7	4.3	5.6	4.0	3.5	3.9	6.2	1.8	5.4	6.1	3.9	3.5	10.8	12.6	18.8	16.2	15.9	10.3	14.5	12.4	10.4	11.8
PPP1R12A	"M130, MBS, MYPT1"	ENSG00000058272	"Protein phosphatase 1 regulatory subunit 12A"	O14974	12	79773563-79935460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041296, HPA071956"	Approved		Supported	"Actin filaments,Cytosol"			300000	"Actin filaments, Cytosol"		"HPA041296: , HPA071956: "	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.19e-2)"	"prognostic unfavourable (1.72e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.38e-1)"	20.1	8.9	17.2	19.4	17.2	23.8	15.9	18.3	18.3	28.0	45.2	6.5	20.9	10.1	36.6	16.5	34.2	28.1	17.0	13.7	12.6	8.8	8.7	6.6	15.8	13.3	9.9	15.4	17.3	7.0	11.0	15.2	18.9	10.4	33.1	17.2	24.0	11.4	42.1	13.7	12.9	19.3	73.7	8.8	14.6	23.2	10.8	10.4	18.8	14.2	9.9	12.4	47.6	29.3	14.9	11.0	50.6	16.9	25.5	18.7	10.8	15.5	12.9	19.1	10.9	14.8	14.6	16.7	32.0	17.9	20.7	13.9	12.1	7.8	13.6	13.1	43.4	12.4	14.8	12.4	25.5	18.3	9.0	37.0	15.4	8.8	11.5	24.0	23.3	12.0	9.5	20.9	19.5	14.3	15.0	16.6	22.2	9.9	26.4	12.7	14.8	9.6	21.8	21.2	10.1	12.3	25.6	9.1	6.7	24.7	8.7	10.8	12.1	11.6	21.0	22.2	11.6	15.2	17.8	10.6	10.0	18.4	7.6	13.6	18.9	35.6	11.7	50.0	17.9	12.5	16.1	14.9	17.1	18.7	11.0	13.5	13.8	17.7	50.6	25.5	16.9	9.3	18.0	10.8	17.2	17.2	18.3	18.3	12.6	8.8	9.9	15.4	10.4	10.4
PPP1R13B	"ASPP1, KIAA0771, p53BP2-like, p85"	ENSG00000088808	"Protein phosphatase 1 regulatory subunit 13B"	Q96KQ4	14	103733752-103847590	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006394, CAB015454"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB015454: AB_2252775, HPA006394: AB_1079668"	"unprognostic (1.20e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (3.22e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.62e-3)"	"prognostic favourable (3.28e-11)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.23e-1)"	7.1	5.5	12.1	5.0	13.2	1.0	7.7	23.3	16.6	8.6	9.0	7.8	6.4	8.7	9.1	4.5	13.5	12.3	5.8	24.5	10.0	6.5	8.3	5.9	11.9	3.3	5.3	9.8	13.3	13.2	12.2	15.6	7.1	10.5	13.3	7.3	13.9	11.6	8.2	7.6	12.9	11.2	6.7	5.2	13.0	11.9	21.2	6.3	1.1	28.4	4.3	7.9	10.1	7.3	0.7	0.0	0.0	0.0	0.2	2.0	0.3	3.9	3.4	0.4	4.6	0.8	0.3	1.7	2.5	1.9	3.5	1.6	2.6	3.6	1.0	9.7	2.1	8.3	4.8	3.6	2.9	2.0	3.3	0.0	1.2	4.4	3.2	0.4	3.7	0.9	4.2	0.3	4.0	6.7	0.5	1.7	2.2	16.1	0.0	0.3	0.8	4.3	10.1	2.7	2.3	7.1	9.9	5.5	14.6	7.8	6.2	1.9	15.3	0.6	5.6	2.5	3.3	2.0	2.4	3.7	4.4	6.7	1.5	2.5	1.2	0.0	0.0	0.0	1.4	0.0	2.0	0.7	1.3	0.0	0.0	0.5	0.2	0.5	0.0	0.2	0.0	0.0	0.9	0.3	12.1	13.2	23.3	16.6	10.0	6.5	5.3	9.8	10.5	6.3
PPP1R13L	"IASPP, RAI"	ENSG00000104881	"Protein phosphatase 1 regulatory subunit 13 like"	Q8WUF5	19	45379634-45406349	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 78.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.1;hTCEpi: 51.3;hTERT-HME1: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB005016, HPA041231, HPA059883"	Approved		Enhanced	Cytosol				Cytosol		"CAB005016: AB_2168576, HPA041231: , HPA059883: "	"unprognostic (1.87e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-3)"	"prognostic unfavourable (3.39e-5)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (5.40e-4)"	"unprognostic (2.52e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.69e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	6.7	6.6	2.5	3.6	4.1	0.6	14.5	3.5	3.4	13.2	6.2	2.4	8.5	2.9	5.8	8.2	51.6	3.6	4.7	37.2	4.0	1.2	8.0	5.7	8.5	1.6	3.9	2.5	4.4	12.4	6.6	6.6	38.7	3.9	11.5	3.8	5.1	17.8	15.7	3.8	78.3	7.1	3.8	3.3	2.5	4.4	1.6	6.1	2.7	10.6	24.4	25.6	13.2	22.9	0.6	0.7	0.0	1.5	0.0	2.3	0.2	20.8	2.9	1.2	1.0	1.2	0.8	18.2	3.8	0.6	4.7	6.5	6.0	19.5	2.4	1.7	3.0	28.0	1.0	35.1	4.3	6.4	1.5	0.3	9.6	2.2	2.7	0.2	0.9	1.1	51.3	7.4	35.6	8.8	2.1	0.9	0.3	17.1	0.4	0.4	1.4	4.9	1.9	1.4	0.4	6.1	25.1	0.6	2.1	19.3	18.6	0.4	16.3	0.5	13.4	6.0	18.4	0.4	18.4	10.5	10.7	1.6	0.9	0.7	1.4	0.0	0.0	0.0	1.5	0.4	0.7	0.6	2.3	0.4	0.2	0.2	0.1	0.7	0.0	0.0	1.5	0.7	1.3	0.2	2.5	4.1	3.5	3.4	4.0	1.2	3.9	2.5	3.9	6.1
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256591	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"A549: 39.7;EFO-21: 34.2;K-562: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 46.4;naive B-cell: 42.7;plasmacytoid DC: 39.3"	"Group enriched"	"Detected in many"	29	"B-cells: 46.4;dendritic cells: 39.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: , HPA054534: "	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (1.25e-5)"	"prognostic unfavourable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	45.4	34.9	22.5	15.1	28.7	2.6	20.1	4.4	37.9	21.1	56.1	60.9	16.6	13.9	39.6	10.8	32.6	20.1	31.7	13.0	34.4	19.0	8.9	4.0	21.1	2.8	43.6	19.2	22.7	17.1	1.7	1.6	24.2	28.4	29.7	10.0	4.4	10.4	70.3	13.9	3.5	16.5	79.9	76.0	31.1	22.9	18.7	38.2	0.0	3.3	3.4	2.1	51.6	15.6	46.4	39.3	1.1	0.1	1.4	0.1	3.7	0.0	39.7	0.1	0.0	0.2	0.0	1.7	3.7	0.0	0.0	0.0	3.1	0.0	0.0	34.2	0.2	0.1	3.4	0.0	0.0	0.5	0.0	7.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	16.5	0.1	0.0	0.2	0.0	0.1	1.3	0.0	0.0	1.0	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.1	0.0	46.4	0.0	0.0	6.8	42.7	0.1	0.0	0.3	1.4	0.0	39.3	0.0	3.7	22.5	28.7	4.4	29.7	34.4	19.0	43.6	19.2	28.4	38.2
PPP1R16B	"ANKRD4, KIAA0823, TIMAP"	ENSG00000101445	"Protein phosphatase 1 regulatory subunit 16B"	Q96T49	20	38805705-38923024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.4;lymphoid tissue: 35.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 22.2;HMC-1: 24.0;HUVEC TERT2: 14.1;U-266/70: 39.0;U-266/84: 15.6;U-698: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049571			Supported	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Nuclear speckles"	"HPA049571: "	"unprognostic (2.62e-2)"	"prognostic favourable (2.11e-4)"	"unprognostic (2.67e-3)"	"unprognostic (3.35e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (7.87e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.90e-2)"	11.2	3.2	26.3	15.9	44.4	13.0	4.4	19.7	35.1	3.6	4.5	25.6	0.0	3.6	3.5	1.9	3.3	5.8	5.3	4.9	25.5	9.1	24.4	2.6	7.3	30.1	15.0	18.8	1.6	1.5	1.2	1.8	3.7	10.9	2.1	5.1	1.6	2.3	2.3	3.4	1.8	9.2	6.8	18.6	14.4	4.9	1.2	15.1	5.1	3.2	0.5	35.0	7.5	3.7	8.4	4.9	3.5	1.3	3.9	5.2	1.6	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.2	0.3	0.0	0.0	0.4	0.0	0.0	0.5	0.1	1.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	14.1	0.3	4.7	0.0	0.0	2.8	3.7	3.1	0.0	1.9	0.0	0.0	0.0	0.0	7.1	8.0	0.0	0.0	0.0	0.0	1.2	2.1	0.0	0.3	0.0	0.0	39.0	15.6	15.3	0.0	0.0	0.0	0.0	0.3	3.5	5.2	0.7	2.8	8.4	3.7	5.1	1.1	5.4	2.2	3.0	0.0	3.9	1.3	4.9	3.7	1.6	26.3	44.4	19.7	35.1	25.5	9.1	15.0	18.8	10.9	15.1
PPP1R26	KIAA0649	ENSG00000196422	"Protein phosphatase 1 regulatory subunit 26"	Q5T8A7	9	135479079-135488893	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044686, HPA063817"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA044686: AB_10795987, HPA063817: "	"unprognostic (1.79e-1)"	"unprognostic (8.80e-3)"	"prognostic unfavourable (3.98e-4)"	"prognostic favourable (9.91e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-1)"	"prognostic favourable (6.93e-4)"	"unprognostic (9.23e-2)"	"prognostic favourable (6.20e-13)"	"unprognostic (4.46e-3)"	"unprognostic (8.31e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.07e-3)"	5.2	6.2	13.8	3.0	10.1	1.0	8.4	3.0	18.2	6.0	6.4	6.9	12.4	7.9	5.0	6.4	5.1	9.0	8.1	11.3	13.2	10.2	8.1	6.6	8.9	2.1	8.3	9.6	7.5	12.5	22.9	11.9	5.4	9.1	7.4	4.4	8.9	13.3	10.8	6.9	4.0	8.0	8.1	5.7	4.7	11.4	6.1	7.3	1.1	8.2	2.8	4.5	7.4	3.7	0.6	1.7	3.0	1.3	2.6	0.6	0.4	6.7	10.2	5.5	5.6	2.3	2.0	0.0	3.7	5.1	5.1	3.4	9.9	11.8	0.0	7.1	3.6	25.3	5.0	4.8	1.7	0.3	5.6	0.1	15.4	7.3	5.5	3.3	12.6	1.4	9.1	2.5	6.3	3.2	6.8	0.0	2.9	15.5	0.1	1.0	8.0	14.1	0.0	9.6	11.2	4.9	9.1	8.4	12.4	6.6	9.3	6.9	7.2	3.0	3.8	1.9	8.7	9.1	4.2	5.2	12.3	0.2	4.0	0.6	4.8	0.0	1.3	3.0	0.4	0.4	0.0	0.6	0.2	0.0	1.7	0.4	0.0	0.0	0.3	2.6	0.6	0.3	0.6	0.4	13.8	10.1	3.0	18.2	13.2	10.2	8.3	9.6	9.1	7.3
PPP1R8	"ard-1, ARD1, NIPP-1, NIPP1, PRO2047"	ENSG00000117751	"Protein phosphatase 1 regulatory subunit 8"	Q12972	1	27830778-27851676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027406, HPA027417, HPA027452"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490"	"unprognostic (5.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.58e-2)"	18.0	14.5	28.6	15.5	37.0	23.2	19.4	23.1	29.7	18.9	16.0	18.2	12.0	13.3	24.0	15.6	19.6	19.4	14.6	16.2	23.4	17.7	13.9	14.8	17.6	28.6	24.6	25.7	24.6	18.5	14.2	18.9	17.4	24.4	15.3	18.0	11.7	15.1	19.5	17.8	17.8	15.1	21.8	24.6	16.9	14.3	21.4	25.6	20.7	17.9	9.4	24.6	18.6	16.0	11.9	9.7	17.0	11.4	14.0	16.5	14.9	20.9	14.9	32.5	21.1	20.5	21.5	18.7	22.6	23.9	38.9	31.5	16.7	24.2	30.1	16.0	25.7	19.0	38.2	21.2	28.3	25.2	23.2	39.3	20.3	24.5	20.7	36.1	28.0	18.7	23.2	35.2	31.5	23.0	33.2	20.6	23.1	13.7	39.4	21.3	40.2	17.4	32.3	26.9	28.6	20.9	19.4	22.8	20.7	27.8	21.8	26.9	19.1	22.7	18.9	19.2	17.5	30.0	21.0	19.1	29.1	38.0	18.7	47.1	24.4	17.0	10.0	9.1	14.0	10.0	16.5	11.6	11.6	15.8	9.7	11.9	12.8	12.1	5.9	14.0	11.4	7.3	11.4	14.9	28.6	37.0	23.1	29.7	23.4	17.7	24.6	25.7	24.4	25.6
PPP2CB	PP2Abeta	ENSG00000104695	"Protein phosphatase 2 catalytic subunit beta"	P62714	8	30774457-30814314	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018600, HPA043236"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB018600: AB_675841, HPA043236: "	"unprognostic (9.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.70e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.89e-2)"	"prognostic favourable (5.82e-7)"	"unprognostic (9.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.65e-3)"	26.7	21.0	61.3	11.9	54.9	2.6	28.7	32.0	46.2	28.8	24.1	30.7	19.4	21.7	34.5	37.5	29.7	28.2	23.1	27.2	57.3	43.7	41.0	35.7	27.7	8.4	52.6	39.8	48.0	22.9	33.7	14.8	27.4	47.7	23.7	24.5	12.5	19.5	29.1	27.4	18.0	31.2	39.0	49.7	15.0	18.9	18.8	48.2	6.3	44.5	14.0	14.0	17.7	34.3	5.8	7.9	5.1	6.5	7.3	4.8	1.7	22.0	19.2	33.7	12.9	33.7	30.7	18.8	29.5	27.6	30.7	32.1	20.2	16.2	10.7	29.0	39.3	13.3	20.0	33.9	41.3	6.7	10.6	14.4	13.1	20.3	38.7	6.4	8.2	27.1	38.8	25.9	29.0	36.6	22.1	11.4	51.6	10.8	17.4	8.2	24.6	11.1	12.2	13.6	8.0	41.0	17.8	32.4	13.4	13.6	14.5	28.4	7.9	11.0	38.5	26.5	19.9	8.7	24.3	5.9	7.6	12.7	22.6	5.9	33.8	4.8	5.0	3.3	4.2	6.5	4.8	5.8	3.8	4.2	3.5	2.7	3.8	4.6	5.1	7.3	3.0	7.9	2.8	1.7	61.3	54.9	32.0	46.2	57.3	43.7	52.6	39.8	47.7	48.2
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4"	"Cell line enhanced"	"Detected in some"		"A-431: 15.4;A549: 22.7;CAPAN-2: 15.2;MCF7: 18.7;PC-3: 21.5;SCLC-21H: 20.8;U-2 OS: 12.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Enhanced	Cytosol				Cytosol		"HPA042122: , HPA042770: , HPA060473: "	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	1.5	6.6	28.2	1.6	33.9	1.1	2.4	17.0	78.4	11.8	1.5	13.8	0.5	1.7	25.3	7.0	25.2	10.5	1.4	1.9	25.8	19.5	1.2	1.1	1.1	1.3	25.6	19.3	1.3	1.7	1.1	5.9	1.1	19.1	5.5	1.4	0.4	1.4	14.4	1.7	28.8	2.0	11.8	32.0	1.3	1.9	4.7	13.5	0.0	1.1	3.9	3.6	1.5	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.4	22.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	9.9	0.0	7.1	11.1	0.3	0.0	0.0	1.3	0.0	1.5	1.7	0.3	0.0	0.0	3.3	5.9	0.0	0.0	0.0	0.0	0.0	3.0	18.7	0.0	0.0	1.1	21.5	0.0	0.0	0.6	0.0	0.0	20.8	4.0	0.7	0.0	0.0	9.6	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	33.9	17.0	40.2	25.8	19.5	25.6	19.3	19.1	13.5
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333963-386955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 43.5"	"Cell line enhanced"	"Detected in many"		"PC-3: 15.2;U-698: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA026606			Supported	Nucleoplasm				Nucleoplasm		"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favourable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favourable (1.90e-5)"	1.8	1.3	8.8	1.1	11.7	3.8	4.8	9.1	8.7	7.6	1.2	0.0	0.0	1.4	6.6	0.7	2.4	2.3	1.4	17.7	12.2	2.9	4.1	1.1	1.5	1.7	15.4	6.2	6.9	2.9	1.5	11.0	8.9	13.0	2.4	0.7	0.0	1.6	1.2	43.5	3.9	1.3	1.6	8.3	1.8	1.8	4.1	15.0	0.0	1.0	0.0	0.9	2.9	2.6	0.1	0.6	2.3	0.1	0.0	1.3	0.1	0.5	5.2	0.7	2.2	0.1	0.2	7.0	5.8	1.5	5.2	6.2	5.2	0.0	0.0	3.2	4.4	0.0	0.2	0.0	1.3	3.7	4.2	1.2	1.8	0.2	0.0	1.9	2.2	0.1	0.1	0.0	3.2	0.1	1.0	0.3	1.2	2.6	8.8	7.7	2.3	15.2	4.0	3.4	0.3	1.4	1.5	0.0	9.0	0.0	0.9	4.1	0.0	2.3	0.3	3.1	2.9	0.0	1.9	0.0	0.0	23.8	0.1	2.6	3.9	0.0	0.0	2.3	0.1	0.1	1.3	0.1	0.1	0.0	0.6	0.1	0.3	0.3	0.1	0.0	0.1	0.5	0.0	0.1	8.8	11.7	9.1	8.7	12.2	2.9	15.4	6.2	13.0	15.0
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: "	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	14.5	12.5	19.1	15.5	23.8	26.4	12.2	17.9	22.1	12.9	13.8	11.4	9.5	14.1	10.9	11.0	8.9	10.0	12.5	14.8	17.9	11.4	10.1	10.5	12.1	18.9	28.4	17.2	12.6	9.5	11.3	30.8	12.7	20.6	11.8	14.7	6.8	10.2	9.7	20.0	6.5	15.3	14.5	22.8	21.5	13.1	46.8	24.1	18.9	8.7	7.5	16.4	14.7	10.4	12.2	12.7	32.1	19.2	13.9	14.7	11.4	15.5	8.5	14.8	13.2	9.8	19.7	11.1	12.6	10.7	14.8	18.2	6.7	11.3	16.7	5.0	12.0	6.7	6.7	4.8	22.1	18.3	7.8	9.3	4.6	24.8	14.3	17.3	18.4	15.1	4.5	11.1	6.9	20.1	9.8	17.0	21.3	11.3	18.2	16.2	13.5	9.9	18.1	11.4	13.7	5.2	9.1	16.0	13.9	15.4	11.1	20.2	7.4	20.7	17.0	16.2	6.9	13.6	14.4	15.2	20.0	34.0	8.2	16.6	18.4	20.0	15.0	32.1	10.7	19.2	11.7	12.2	10.8	13.8	12.7	11.0	9.6	11.7	28.1	13.9	16.4	8.1	14.7	11.4	19.1	23.8	17.9	22.1	17.9	11.4	28.4	17.2	20.6	24.1
PPP2R5A	"B56A, B56alpha, PR61A"	ENSG00000066027	"Protein phosphatase 2 regulatory subunit B'alpha"	Q15172	1	212285537-212361863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059288			Supported	Cytosol				Cytosol		"HPA059288: "	"unprognostic (3.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	40.9	8.4	21.9	23.2	24.1	46.6	26.5	13.7	17.6	19.5	23.9	19.6	18.9	15.9	21.2	13.4	36.7	12.9	25.7	31.9	17.5	16.6	22.4	34.0	37.9	17.1	25.6	14.2	11.8	27.5	17.0	14.4	21.5	16.4	30.6	23.2	16.5	22.2	20.0	24.3	20.0	27.6	28.5	21.1	28.6	26.4	10.0	24.4	35.2	27.6	29.2	18.3	28.8	38.8	2.1	1.6	14.5	3.0	3.1	4.9	1.4	17.3	7.2	3.7	7.5	40.7	24.9	30.0	7.6	14.6	8.5	8.1	21.5	17.4	12.1	5.8	11.9	12.3	7.0	10.6	8.9	10.5	9.2	7.8	8.0	7.8	13.2	16.0	12.1	10.3	14.5	7.8	11.4	20.4	11.2	12.8	4.7	7.4	6.3	10.9	6.2	15.7	8.2	5.8	15.1	15.2	7.9	5.3	3.6	10.3	32.6	24.6	20.3	14.5	4.3	6.0	6.2	9.4	8.2	20.4	15.6	15.7	7.2	12.5	4.4	14.5	2.0	9.4	4.6	2.2	3.1	1.4	3.6	4.1	1.3	2.1	2.1	4.2	9.9	3.1	3.0	1.6	4.9	1.4	21.9	24.1	13.7	16.1	17.5	16.6	25.6	14.2	16.4	24.4
PPP2R5E	"B56E, B56epsilon"	ENSG00000154001	"Protein phosphatase 2 regulatory subunit B'epsilon"	Q16537	14	63371357-63543374	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006034, CAB072342"	Approved		Supported	Cytosol				Cytosol		"CAB072342: , HPA006034: AB_1079670"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.62e-2)"	"prognostic favourable (4.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.22e-2)"	20.9	19.3	18.1	27.2	18.8	16.9	26.5	27.6	32.7	21.3	22.3	11.7	14.2	14.1	20.5	19.2	29.2	16.3	18.9	20.2	19.2	20.5	20.1	22.9	27.7	19.1	16.4	20.1	21.5	14.7	29.0	18.8	21.0	18.5	18.5	27.3	15.7	17.3	28.3	31.2	19.2	17.6	23.2	17.7	20.2	16.6	25.1	13.5	35.5	27.4	21.3	21.7	28.5	20.8	3.3	3.6	2.7	3.4	9.2	5.1	1.1	38.7	11.4	20.9	9.8	14.5	17.1	20.0	16.3	13.5	17.8	17.8	14.4	15.6	17.1	10.0	16.6	16.0	21.3	15.1	30.9	15.5	5.2	11.1	8.6	11.9	15.5	17.7	13.7	12.5	17.0	17.4	19.4	17.8	14.1	18.7	19.5	25.9	17.7	8.0	15.8	20.8	18.0	21.4	12.9	17.1	29.7	11.9	23.3	20.9	17.4	10.8	25.6	9.0	16.6	28.0	31.3	14.2	14.3	6.8	10.2	22.3	12.9	11.4	18.9	2.7	2.5	2.4	4.2	2.7	3.9	2.3	4.6	5.1	2.3	3.3	3.6	3.9	2.0	9.2	3.4	3.6	2.6	1.1	18.1	18.8	27.6	32.7	19.2	20.5	16.4	20.1	18.5	13.5
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol			35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.4	21.6	16.4	7.4	21.4	19.7	8.7	9.2	7.9	24.3	9.2	9.0	19.3	9.7	13.9	28.5	14.8	22.6	6.4	14.7	19.7	10.2	15.8	23.5	7.5	16.9	15.0	18.9	21.7	16.3	5.7	25.5	13.9	23.3	4.9	17.7	6.4	8.9	9.0	34.9	10.7	8.4	15.4	30.3	11.5	17.7	15.2	10.2	13.6	13.4	18.9	20.6	23.4	18.8	14.1	11.9	12.2	16.4	11.4	13.3	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085377	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: "	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	24.7	26.6	13.5	26.1	14.1	26.7	18.6	16.0	15.9	19.2	28.4	14.5	20.5	22.5	19.2	28.4	39.1	17.7	31.9	28.5	12.6	12.1	28.9	52.3	27.4	25.3	12.5	12.8	22.5	26.3	23.9	16.2	51.6	11.9	18.3	17.4	18.8	22.0	14.9	26.0	26.1	38.8	15.9	11.9	36.2	22.6	39.0	9.5	59.7	27.1	26.5	37.9	22.2	21.1	19.5	30.3	57.3	28.2	12.4	23.6	12.0	30.3	34.1	22.8	31.8	21.6	18.2	35.4	27.1	30.2	35.7	39.7	30.0	39.7	23.7	34.9	31.9	24.8	28.2	33.6	21.1	29.6	50.5	16.1	21.2	66.2	32.8	22.6	30.5	26.4	29.8	32.5	20.6	41.4	31.3	21.7	27.2	87.6	39.3	41.2	43.3	18.2	44.0	23.7	41.2	33.7	31.3	22.2	32.8	13.3	40.2	23.1	37.0	38.5	26.3	20.9	21.9	16.8	20.8	37.2	40.9	27.7	29.8	29.1	25.2	21.4	26.9	57.3	18.3	28.2	13.1	17.0	19.2	20.6	30.3	19.5	17.2	15.2	56.9	12.4	24.5	23.5	23.6	12.0	13.5	14.1	16.0	15.9	12.6	12.1	12.5	12.8	11.9	9.5
PPP4R2		ENSG00000163605	"Protein phosphatase 4 regulatory subunit 2"	Q9NY27	3	72996785-73069199	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034695, HPA039837, HPA073758"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA034695: AB_10671231, HPA039837: , HPA073758: "	"unprognostic (4.60e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.62e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.35e-1)"	16.7	19.6	18.3	17.2	25.9	57.7	17.7	18.0	23.4	19.7	17.5	15.7	10.7	16.1	18.0	13.2	15.9	18.7	15.6	24.5	18.6	14.2	15.8	34.0	17.6	15.8	30.8	14.8	24.0	15.1	21.0	20.2	28.5	20.5	14.3	16.2	13.4	16.1	12.0	27.2	12.1	18.1	15.9	20.8	17.1	14.0	17.0	25.8	28.4	17.1	9.8	16.5	14.4	18.8	7.1	14.3	17.7	4.7	8.5	13.6	3.2	12.3	14.5	31.1	18.9	16.6	14.7	18.9	24.8	17.5	22.7	23.7	21.1	14.9	23.2	14.5	14.9	8.8	24.2	13.8	29.4	35.4	9.0	26.3	16.4	24.9	18.2	38.2	27.5	15.7	20.6	27.3	22.4	16.1	23.3	26.8	18.6	18.0	31.8	17.1	28.5	12.1	29.9	17.6	21.6	19.0	33.1	7.4	18.5	28.9	19.1	22.9	17.5	21.8	17.6	20.4	24.5	23.4	21.1	16.7	34.3	45.9	14.3	29.6	22.7	5.4	4.7	10.7	10.6	2.6	11.7	5.5	10.9	10.9	4.0	7.1	9.6	8.7	17.7	8.5	4.1	14.3	13.6	3.2	18.3	25.9	18.0	23.4	18.6	14.2	30.8	14.8	20.5	25.8
PPP4R3A	"FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1"	ENSG00000100796	"Protein phosphatase 4 regulatory subunit 3A"	Q6IN85	14	91457611-91510554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002568, HPA063917"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA002568: AB_1079207, HPA063917: "	"unprognostic (5.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.34e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.53e-2)"	19.0	14.2	22.1	25.7	19.7	48.5	20.1	33.2	22.6	20.6	22.7	15.0	22.0	19.8	22.0	17.7	22.7	21.0	23.4	15.7	19.4	14.2	20.7	27.8	21.4	29.0	20.8	16.8	23.4	21.7	25.6	24.0	25.1	16.3	21.6	20.9	14.7	20.5	29.1	34.8	25.4	27.1	19.9	18.0	29.1	21.2	25.3	18.3	44.6	19.6	20.3	27.5	19.9	25.6	9.0	7.4	8.5	4.7	12.1	10.0	3.6	14.6	17.5	22.1	15.5	12.1	12.1	30.2	12.6	12.4	14.3	14.2	15.1	19.2	33.0	16.1	11.1	15.9	21.5	16.3	22.5	26.8	8.8	16.9	12.3	12.4	13.7	33.1	18.5	8.4	25.2	11.1	16.9	14.5	15.2	24.5	15.9	23.6	24.9	16.0	16.2	12.4	28.9	23.8	14.1	14.4	23.8	25.9	14.2	18.7	45.8	15.8	24.0	19.2	14.3	12.8	11.5	13.1	16.0	18.9	28.3	38.0	15.3	15.6	19.9	8.5	3.1	3.6	7.2	3.5	10.0	7.1	7.3	6.5	2.9	9.0	9.0	7.3	3.4	12.1	4.7	7.4	9.3	3.6	22.1	19.7	33.2	22.6	19.4	14.2	20.8	16.8	16.3	18.3
PPP4R3B	"FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2"	ENSG00000275052	"Protein phosphatase 4 regulatory subunit 3B"	Q5MIZ7	2	55547292-55618880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001233, CAB017185"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Centrosome"				"Nucleoplasm, Nuclear speckles"	Centrosome	"CAB017185: , HPA001233: AB_1080033"	"unprognostic (9.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	11.9	10.4	12.1	10.6	13.1	8.1	10.9	17.5	13.1	11.2	11.4	8.6	7.4	11.5	8.8	7.8	12.0	12.5	9.1	5.3	12.8		12.7	18.1	8.3	13.0	13.3	7.9	10.8	13.6	10.7	11.7	11.1	11.4	9.5	10.6	7.8	9.6	9.1	6.0	11.0	14.4	10.3	11.1	10.8	11.0	8.0	12.3	18.7	12.6	6.2	14.3	11.3	10.0	17.6	16.9	23.9	19.6	20.0	25.3	21.6	19.7	15.4	17.0	14.3	18.2	19.2	23.4	15.9	17.4	13.8	11.8	18.1	19.1	26.8	32.4	15.7	17.2	19.3	13.1	20.7	38.5	8.1	26.7	14.5	24.2	29.5	30.4	22.2	14.8	31.7	16.8	29.1	21.6	25.3	27.2	18.2	23.1	19.6	20.0	16.7	12.2	18.3	25.7	20.2	19.0	20.7	21.2	12.9	17.3	24.0	25.8	15.1	24.7	16.9	21.2	27.2	10.4	21.9	28.1	21.1	10.3	19.8	29.0	22.5	21.2	15.6	23.9	20.4	19.6	23.0	17.6	21.5	21.2	16.9	16.9	25.3	22.0	18.1	20.0	19.3	9.2	21.5	21.6										
PPP4R4	"CFAP14, KIAA1622, PP4R4"	ENSG00000119698	"Protein phosphatase 4 regulatory subunit 4"	Q6NUP7	14	94146128-94279735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3;testis: 14.0"	"Group enriched"	"Detected in some"	4	"RH-30: 16.3;T-47d: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041866, HPA050321"	Approved		Supported	Cytosol				Cytosol		"HPA041866: AB_10804120, HPA050321: "	"unprognostic (2.65e-3)"	"unprognostic (3.06e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.49e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.24e-2)"	1.0	1.7	15.2	1.3	15.5	1.1	3.5	4.9	21.3	6.9	1.0	1.9	0.1	1.0	2.1	4.0	1.4	4.0	1.5	1.1	11.1	6.9	1.3	3.0	3.1	1.2	4.7	9.8	11.5	1.6	1.1	7.1	1.7	8.0	1.4	1.1	2.3	1.2	1.8	1.0	2.0	1.0	1.3	5.2	1.0	2.1	14.0	4.1	0.0	1.3	0.0	1.8	1.2	1.3	0.3	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	1.7	0.9	0.4	0.0	0.5	0.2	1.5	1.0	0.4	0.1	0.5	0.9	0.0	0.0	0.0	4.0	4.1	0.4	0.2	0.4	0.0	0.0	1.0	0.2	0.0	0.3	0.0	0.4	0.0	3.8	0.0	0.0	0.1	0.4	0.5	0.0	0.1	1.0	0.9	0.1	16.3	0.0	0.2	0.9	0.2	0.1	0.0	0.0	0.1	17.3	0.0	0.0	3.1	1.7	0.1	0.1	0.8	0.1	0.3	1.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	15.2	15.5	4.9	13.2	11.1	6.9	4.7	9.8	8.0	4.1
PPP5C	"PP5, PPP5"	ENSG00000011485	"Protein phosphatase 5 catalytic subunit"	P53041	19	46346994-46392981	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022641, HPA029065, HPA056933"	Approved		Supported	Vesicles,Cytosol			47000	"Vesicles, Cytosol"		"CAB022641: , HPA029065: AB_10610284, HPA056933: "	"unprognostic (8.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (3.45e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	18.9	24.7	23.0	18.1	28.8	13.4	15.9	25.2	50.8	20.4	21.1	19.4	15.2	18.0	23.0	15.2	20.1	27.8	20.5	48.2	20.8	23.9	22.6	22.1	17.4	19.3	21.9	29.8	16.7	21.5	26.3	23.9	17.3	34.5	19.5	17.5	19.7	21.0	21.4	40.8	16.4	15.3	23.5	16.2	21.7	20.6	19.0	15.3	15.6	18.1	20.5	16.1	17.1	18.1	10.6	11.1	1.9	14.1	14.0	19.8	8.9	19.5	36.8	22.0	16.6	16.6	17.8	10.2	24.3	19.8	29.6	26.7	26.4	15.6	30.0	13.3	17.7	16.1	28.9	28.7	8.9	20.8	39.2	25.0	27.0	18.7	18.5	33.8	17.5	16.2	13.6	20.8	15.5	25.4	24.0	15.5	16.8	21.2	18.9	63.4	16.6	20.1	28.2	19.0	24.0	17.7	26.8	31.3	23.0	20.4	26.0	8.7	16.3	21.6	21.1	13.0	21.6	9.6	25.4	12.5	28.7	36.0	13.9	28.4	21.6	0.0	6.8	1.9	19.8	12.1	12.7	10.6	9.2	15.3	11.1	8.7	8.9	12.0	0.1	14.0	14.1	7.9	9.3	8.9	23.0	28.8	25.2	50.8	20.8	23.9	21.9	29.8	34.5	15.3
PPP6R1	"KIAA1115, SAP190, SAPS1"	ENSG00000105063	"Protein phosphatase 6 regulatory subunit 1"	Q9UPN7	19	55229780-55258995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043989, HPA063681"	Approved		Enhanced	Cytosol				Cytosol		"HPA043989: AB_10987309, HPA063681: "	"unprognostic (1.15e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (3.82e-6)"	"unprognostic (2.22e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.20e-1)"	13.2	18.4	27.8	30.8	26.2	49.7	9.8	12.5	28.0	11.2	20.7	14.0	9.0	22.9	13.5	11.3	17.5	16.8	17.7	12.8	27.3	12.4	12.5	25.1	14.6	45.2	13.0	14.0	11.9	12.5	13.9	15.3	15.8	9.8	11.7	7.8	11.5	13.7	14.4	18.4	13.3	22.9	11.3	9.2	31.6	25.1	39.9	13.4	57.3	14.0	13.4	31.0	17.7	12.6	2.6	21.2	4.4	3.0	6.1	9.2	4.2	20.1	29.4	6.0	9.6	7.2	6.6	15.3	12.9	11.4	13.6	11.7	19.3	14.0	52.8	7.1	11.5	9.9	2.1	13.5	5.3	19.6	50.1	40.0	14.1	14.2	12.4	59.0	39.5	9.7	7.8	13.5	9.2	8.7	20.8	23.4	8.8	12.9	43.1	21.2	8.2	24.2	26.5	11.8	43.6	9.6	25.8	17.2	9.5	12.0	14.5	12.7	7.9	44.5	11.3	21.5	10.6	8.2	19.4	11.7	21.1	37.4	19.6	48.7	16.3	0.0	2.0	4.4	9.2	3.0	5.3	2.6	3.8	7.2	3.0	2.3	4.0	5.9	2.3	6.1	2.4	21.2	2.7	4.2	27.8	26.2	12.5	28.0	27.3	12.4	13.0	14.0	9.8	13.4
PPP6R2	"dJ579N16.1, KIAA0685, SAP190, SAPS2"	ENSG00000100239	"Protein phosphatase 6 regulatory subunit 2"	O75170	22	50343304-50445090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030656, CAB034919"	Uncertain		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB034919: AB_2183817, HPA030656: AB_10602926"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.70e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (7.51e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.77e-3)"	16.8	22.1	21.3	19.6	20.7	17.9	32.2	39.0	52.7	13.0	15.8	18.5	20.6	23.1	17.2	13.3	18.6	16.2	17.3	25.6	19.8	18.3	18.7	40.6	19.0	32.8	19.8	22.4	16.8	23.7	19.7	26.7	14.9	19.4	19.8	11.7	20.2	26.3	18.2	47.3	25.8	20.0	21.2	20.4	21.2	22.5	37.8	17.3	21.1	21.1	11.7	18.5	15.6	13.6	9.8	12.3	16.0	10.3	6.4	14.3	8.5	16.1	9.5	14.9	18.9	11.0	11.8	13.4	16.2	17.3	17.3	17.6	8.0	10.0	19.5	8.0	16.0	13.2	9.1	12.0	6.5	10.0	16.9	10.4	18.3	19.7	14.4	24.3	28.6	17.5	13.1	10.4	5.6	15.1	10.6	17.1	12.5	26.1	16.6	17.7	6.1	11.9	23.4	11.4	12.7	12.7	19.2	9.4	12.6	16.6	25.9	13.1	9.3	18.6	17.3	16.2	14.7	13.4	10.6	18.4	4.4	17.2	16.9	12.0	22.2	4.0	9.6	6.3	10.8	10.3	12.7	9.5	7.6	11.5	9.8	9.8	7.4	9.5	16.0	6.4	7.4	12.3	14.3	8.5	21.3	20.7	39.0	52.7	19.8	18.3	19.8	22.4	19.4	17.3
PPP6R3	"C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3"	ENSG00000110075	"Protein phosphatase 6 regulatory subunit 3"	Q5H9R7	11	68460731-68615334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017183, HPA038467, HPA038468"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"CAB017183: , HPA038467: , HPA038468: "	"unprognostic (9.46e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.29e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (1.54e-2)"	"unprognostic (6.43e-2)"	33.0	29.8	16.7	25.7	24.1	36.5	26.8	35.7	25.8	33.2	29.6	27.9	24.9	21.5	43.8	24.3	29.9	26.6	24.6	27.5	17.3	16.5	28.8	28.2	27.9	26.8	25.0	18.5	36.4	23.8	49.0	48.1	40.0	23.7	28.3	27.5	28.2	28.2	29.2	46.4	25.8	31.5	35.5	24.3	31.1	27.7	28.2	24.0	45.5	39.2	34.8	31.8	34.3	26.9	14.8	15.0	16.9	16.7	11.7	17.7	7.1	24.9	29.6	30.6	21.4	16.4	16.7	23.8	21.9	21.3	25.5	23.5	51.2	25.4	28.8	21.6	20.4	23.6	33.7	24.8	33.8	27.8	14.1	33.3	30.0	17.3	15.7	31.5	29.7	16.5	16.7	26.2	28.4	23.2	28.0	21.5	18.2	33.4	31.6	24.3	15.3	17.6	29.7	41.8	28.0	17.0	36.3	17.4	20.7	31.1	24.7	45.2	36.6	16.9	23.0	25.2	23.9	26.7	18.6	17.0	23.7	37.8	18.2	14.0	26.7	14.6	11.5	14.4	14.7	15.2	14.0	14.1	15.6	14.4	7.4	14.8	17.7	16.1	16.9	11.7	16.7	15.0	15.0	7.1	16.7	24.1	35.7	25.8	17.3	16.5	25.0	18.5	23.7	24.0
PPRC1	"KIAA0595, MGC74642, PRC"	ENSG00000148840	"Peroxisome proliferator-activated receptor gamma, coactivator-related 1"	Q5VV67	10	102132994-102150331	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038511, HPA057571"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA038511: AB_10672521, HPA057571: "	"unprognostic (2.27e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.29e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (6.71e-7)"	"unprognostic (8.65e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.93e-2)"	18.9	12.0	10.0	20.2	12.3	18.1	14.2	13.1	12.2	13.4	15.6	9.5	9.7	9.1	17.4	10.1	18.4	16.2	14.2	14.4	9.3	6.1	10.3	18.0	18.9	14.2	15.0	7.8	25.4	35.6	13.5	13.1	15.3	10.4	14.2	9.8	10.0	12.6	9.7	32.8	19.6	11.3	17.0	9.7	14.7	14.8	11.5	11.4	13.2	12.2	15.9	19.3	14.2	15.4	4.0	4.6	0.3	2.4	7.6	4.6	2.2	13.1	19.8	12.2	24.4	10.9	11.2	15.6	11.9	16.0	17.1	14.2	22.2	15.2	28.9	10.0	17.8	25.0	24.7	23.5	15.1	11.8	19.3	27.4	14.2	21.3	14.7	21.5	12.0	14.8	21.2	20.0	38.1	10.6	20.4	17.1	13.5	22.6	17.2	30.2	20.9	11.7	24.1	17.3	12.3	14.7	13.2	8.4	12.3	10.1	11.3	14.1	18.2	11.4	11.6	13.7	17.3	13.9	26.6	14.4	10.1	26.0	15.4	27.1	6.8	0.0	2.1	0.3	3.6	2.4	4.6	3.1	2.8	4.4	4.6	4.0	3.3	4.1	0.1	7.6	2.3	1.9	1.7	2.2	10.0	12.3	13.1	12.2	9.3	6.1	15.0	7.8	10.4	11.4
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40071461-40097727	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 86.0;THP-1: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		130000	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	33.3	27.1	37.6	31.0	41.5	33.3	39.7	35.2	41.0	30.3	21.0	31.5	17.2	12.9	31.3	19.4	18.5	20.7	23.2	18.1	32.7	35.8	29.4	18.4	47.3	48.5	35.3	29.1	24.7	17.4	30.4	21.2	25.9	34.6	28.0	26.0	26.3	22.1	23.6	8.3	13.8	16.6	36.5	33.6	61.3	17.9	13.8	29.1	19.8	18.7	14.4	30.0	23.0	19.8	9.3	77.4	59.9	90.0	7.2	19.1	91.6	10.0	6.8	11.0	6.2	13.3	11.4	21.6	5.6	10.2	13.6	16.8	39.2	16.9	11.5	11.0	5.9	17.7	17.1	10.1	18.7	14.5	17.6	6.0	16.8	19.3	15.1	13.5	14.5	10.7	11.1	10.8	10.1	18.3	13.9	16.8	7.6	20.1	7.7	10.1	20.8	10.6	8.7	14.8	20.0	9.5	18.0	8.8	9.3	11.0	86.0	34.2	12.5	159.9	6.4	6.6	14.2	6.2	16.7	15.1	31.6	11.1	8.5	33.0	12.0	6.2	90.0	48.2	9.9	77.6	11.8	9.3	14.7	11.5	77.4	9.2	19.1	14.7	59.9	7.2	58.3	7.6	16.8	91.6	37.6	41.5	35.2	41.0	32.7	35.8	35.3	29.1	34.6	29.1
PPWD1	KIAA0073	ENSG00000113593	"Peptidylprolyl isomerase domain and WD repeat containing 1"	Q96BP3	5	65563236-65587549	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019353, HPA019360"	Enhanced		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA019353: AB_1855668, HPA019360: AB_1855669"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (6.72e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	17.5	15.8	24.3	23.5	26.1	26.0	18.9	28.3	29.7	21.3	16.5	17.9	16.8	15.0	22.0	20.9	17.3	20.4	17.1	14.9	20.0	12.6	14.2	17.3	16.3	28.7	20.9	18.3	26.0	18.6	22.7	26.9	20.9	20.9	18.7	21.5	13.1	16.6	17.7	18.0	23.7	21.2	16.9	19.3	28.9	17.8	19.1	21.1	32.4	19.5	15.2	26.7	16.7	23.7	15.6	13.5	18.1	12.3	15.4	23.3	14.5	19.7	13.1	19.6	18.9	17.3	21.4	20.9	19.2	13.7	20.7	26.0	19.7	19.6	22.4	15.3	13.8	17.6	21.2	19.7	28.1	18.7	18.5	13.9	20.5	17.2	15.0	12.9	14.6	17.0	8.1	19.9	14.2	17.8	18.9	15.8	16.4	19.9	19.8	16.3	13.8	7.7	18.5	26.2	18.9	12.1	16.7	10.0	7.9	18.9	8.2	17.1	12.0	17.0	13.5	11.4	16.0	12.3	28.1	9.0	13.4	23.5	12.5	19.0	12.1	18.1	10.1	16.7	17.2	11.1	20.7	15.6	18.9	18.7	13.5	12.3	23.3	20.4	8.2	15.4	12.3	7.8	20.7	14.5	24.3	26.1	28.3	29.7	20.0	12.6	20.9	18.3	20.9	21.1
PQBP1	"MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS"	ENSG00000102103	"Polyglutamine binding protein 1"	O60828	X	48897912-48903143	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001880	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA001880: AB_1079671"	"unprognostic (7.25e-2)"	"prognostic favourable (1.48e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.68e-7)"	"unprognostic (2.68e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-3)"	24.8	35.3	29.2	22.4	28.5	34.8	28.3	30.3	35.0	27.4	31.9	25.9	23.9	35.6	34.9	22.6	26.9	29.0	25.3	23.5	25.8	30.8	24.8	34.7	20.5	24.7	27.9	25.6	38.8	37.1	21.3	30.2	19.5	26.5	26.0	18.9	27.2	33.6	27.3	43.3	31.9	31.7	29.6	25.3	25.6	27.4	13.6	25.8	31.7	33.8	23.1	27.7	26.6	32.5	32.3	36.7	20.5	30.6	27.7	41.3	27.6	28.5	35.1	18.8	18.2	16.6	11.7	14.3	16.7	19.6	33.8	21.1	41.9	12.7	26.1	14.0	11.2	22.2	31.6	12.5	13.1	22.8	27.3	22.7	27.4	30.0	16.5	26.6	20.4	15.2	23.4	27.9	28.2	18.5	21.2	49.6	14.6	46.2	11.4	26.7	17.6	38.4	19.1	18.9	59.3	20.9	18.8	28.1	15.0	21.9	24.3	18.4	30.1	20.4	17.0	15.4	27.0	19.0	22.1	29.2	29.6	19.6	8.7	25.1	15.8	14.5	30.6	20.5	23.2	29.6	30.3	32.3	32.1	23.1	36.7	26.3	32.5	30.1	8.4	27.7	26.3	31.6	41.3	27.6	29.2	28.5	30.3	35.0	25.8	30.8	27.9	25.6	26.5	25.8
PQLC2	FLJ20320	ENSG00000040487	"PQ loop repeat containing 2"	Q6ZP29	1	19312326-19329300	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057810	Approved		Supported	Vesicles				Vesicles		"HPA057810: "	"unprognostic (7.84e-3)"	"unprognostic (6.56e-2)"	"unprognostic (6.54e-2)"	"prognostic favourable (3.50e-4)"	"unprognostic (3.77e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (2.64e-5)"	"unprognostic (2.61e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.46e-2)"	10.9	19.9	11.7	8.5	12.3	18.4	9.4	28.8	16.2	12.2	13.1	16.8	8.6	16.9	11.5	15.5	9.2	8.8	11.1	9.3	10.6	11.2	11.9	20.3	12.1	11.1	14.3	9.1	10.9	19.4	10.0	19.4	24.8	14.4	11.7	7.7	18.9	12.1	11.0	10.9	15.3	16.2	9.3	12.2	12.2	13.3	13.8	10.9	6.2	14.0	9.2	10.5	8.0	9.0	5.1	16.7	7.8	10.1	2.9	3.4	3.5	8.2	8.7	8.2	13.0	8.0	7.5	10.4	10.4	14.3	14.5	12.4	12.6	10.4	2.6	13.6	7.6	6.2	7.9	9.3	6.6	5.5	9.7	2.0	7.4	13.5	22.9	1.7	3.6	12.4	9.8	20.5	6.5	5.6	14.8	6.1	13.9	7.4	1.1	5.7	7.8	7.8	4.5	10.3	4.6	10.9	5.4	10.1	8.4	7.8	5.3	19.8	8.8	20.4	7.4	12.2	7.1	20.5	9.1	10.8	7.5	1.4	14.9	10.3	9.9	0.9	8.7	7.8	3.2	7.1	2.4	5.1	3.4	2.7	11.1	5.0	1.0	2.1	5.4	2.9	10.1	16.7	3.1	3.5	11.7	12.3	28.8	16.2	10.6	11.2	14.3	9.1	14.4	10.9
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722522	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 62.1;prostate: 40.3"	"Cell line enriched"	"Detected in some"	33	"PC-3: 90.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"											HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047871: "			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.6	2.0	30.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	40.3	62.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	9.9	5.1	0.8	0.0	2.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	90.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.5	0.0	0.2	0.5	0.0	0.4	0.0	0.8	0.1	0.1	2.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966038-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 18.9;T-reg: 5.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 18.9;T-cells: 5.8"	"Low region specificity"	"Detected in single"							"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"				"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	3.2	2.8	3.5	13.0	3.8	43.3	3.6	12.5	5.8	3.4	9.3	1.6	0.2	6.1	3.5	4.7	15.0	2.6	2.8	3.5	5.1	4.9	2.3	1.9	5.8	9.2	3.4	4.7	3.6	3.8	1.6	1.5	10.4	5.2	2.4	9.9	2.7	3.9	1.0	2.5	9.9	6.6	5.4	3.5	5.8	5.0	44.3	0.8	44.5	1.8	15.3	16.5	3.5	4.9	0.9	2.0	18.9	0.4	2.0	5.8	0.7	32.4	39.7	33.2	22.6	3.5	6.0	17.8	46.8	27.7	51.9	39.7	26.5	31.7	12.4	18.6	29.8	44.3	37.8	20.0	49.1	22.9	41.9	25.6	51.9	24.3	0.8	12.6	22.2	1.5	2.6	29.4	30.2	29.0	21.3	26.6	48.2	28.2	12.9	19.3	13.0	17.0	13.6	41.5	16.6	23.1	24.7	30.3	24.0	44.5	24.8	16.1	29.7	25.0	17.3	34.3	30.3	28.3	67.4	8.6	22.8	15.3	15.0	31.4	52.3	18.9	0.4	2.0	0.5	0.0	0.3	0.9	1.0	1.0	1.8	0.4	0.9	0.4	0.2	2.0	0.2	2.0	5.8	0.7	3.5	3.8	12.5	5.8	5.1	4.9	3.4	4.7	5.2	0.8
PRCC	RCCP1	ENSG00000143294	"Papillary renal cell carcinoma (translocation-associated)"	Q92733	1	156750610-156800817	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavourable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (1.02e-2)"	31.3	24.9	28.5	25.8	29.7	33.7	23.7	33.2	43.5	29.8	30.0	35.9	21.8	24.6	35.1	22.8	30.3	25.6	28.7	23.8	28.0	24.5	26.1	33.1	22.0	30.1	22.1	25.2	30.1	23.7	31.0	22.7	38.8	22.6	25.6	21.5	25.6	37.2	24.0	47.4	33.6	30.1	25.7	20.4	29.7	24.1	26.2	19.2	51.9	27.5	29.8	30.7	25.4	23.8	21.4	27.1	36.9	23.1	19.3	22.1	16.9	19.8	17.2	13.6	15.5	11.4	9.1	23.7	13.9	13.6	15.5	13.4	27.0	16.8	20.4	24.1	10.9	20.8	19.3	14.6	12.1	25.5	25.3	14.9	12.7	17.4	14.1	20.5	17.6	12.9	17.0	13.5	12.4	14.2	24.6	19.0	10.9	35.4	23.4	24.1	32.9	21.4	20.6	12.0	27.4	16.3	19.1	24.2	43.2	14.7	37.1	23.0	26.7	33.1	13.0	15.8	16.6	17.3	22.8	49.1	73.4	31.6	15.6	13.3	14.6	26.9	20.0	36.9	20.5	20.6	19.6	18.0	18.5	22.1	22.4	21.4	18.4	18.9	19.3	19.3	23.1	27.1	18.5	16.9	28.5	29.7	33.2	43.5	28.0	24.5	22.1	25.2	22.6	19.2
PRCP	"HUMPCP, PCP"	ENSG00000137509	Prolylcarboxypeptidase	P42785	11	82823502-82970584	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017065, HPA071115"	Approved		Supported	Vesicles	"Intracellular and membrane"		34000000	Vesicles		"HPA017065: AB_1855676, HPA071115: "	"unprognostic (3.24e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.88e-2)"	"prognostic favourable (2.65e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.07e-1)"	32.6	45.9	25.0	21.5	22.2	13.1	69.5	19.4	23.8	38.8	17.9	17.9	27.6	11.0	30.7	35.5	32.2	24.6	25.6	66.3	25.8	18.9	52.4	52.5	38.1	95.1	27.0	14.8	27.8	23.4	30.6	19.3	59.8	34.9	25.1	18.4	25.1	38.1	34.5	10.3	26.2	15.7	32.8	45.0	25.1	16.8	17.4	17.7	9.8	27.9	24.2	31.7	39.4	30.1	13.1	50.0	31.2	27.9	12.1	6.2	14.7	7.5	8.2	12.6	25.4	97.9	35.9	14.8	16.0	28.6	15.4	22.5	20.3	15.5	10.8	23.4	23.2	11.9	11.5	10.5	18.0	9.6	8.3	7.7	11.4	12.6	18.3	6.9	28.2	26.2	8.3	16.0	15.2	50.8	8.3	15.2	15.7	3.4	1.0	24.7	7.3	7.7	5.6	21.9	12.9	21.5	13.8	5.3	11.5	21.9	12.7	9.0	15.2	9.5	13.2	18.1	18.1	15.6	7.8	14.3	24.4	9.6	7.4	8.4	9.3	15.5	26.4	17.4	5.3	27.9	6.1	9.9	5.3	5.8	50.0	13.1	4.4	6.2	31.2	12.1	21.2	8.9	5.0	14.7	25.0	22.2	19.4	23.8	25.8	18.9	27.0	14.8	34.9	17.7
PRDM15	"C21orf83, ZNF298"	ENSG00000141956	"PR/SET domain 15"	P57071	21	41798225-41879482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 17.5;U-266/70: 16.1;U-698: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024268, HPA029255, HPA029256"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA024268: AB_1855688, HPA029255: , HPA029256: "	"unprognostic (8.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.85e-4)"	"unprognostic (4.22e-4)"	"unprognostic (6.50e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.86e-3)"	4.8	4.7	9.0	8.1	7.0	4.6	5.5	10.4	7.5	4.8	5.4	7.3	8.4	7.9	5.4	4.5	6.7	5.9	4.9	4.4	4.3	3.4	3.9	5.1	4.7	17.0	8.0	4.8	6.7	5.9	5.6	6.4	3.3	6.0	6.3	5.0	4.3	7.6	7.3	9.3	8.3	7.7	5.1	6.6	9.4	5.4	6.2	7.8	10.8	6.1	6.9	16.8	4.8	7.7	3.0	1.5	1.2	2.5	0.1	1.3	1.3	1.3	2.9	2.5	3.2	0.7	1.3	2.6	1.1	0.9	1.3	1.0	1.9	1.7	17.5	1.2	1.3	2.9	2.2	1.4	1.2	1.7	2.3	3.2	6.7	2.1	0.7	2.7	2.1	0.7	1.7	1.4	1.2	1.7	2.9	1.0	1.6	3.6	2.6	2.0	2.7	1.9	4.5	1.7	2.0	1.3	2.3	4.1	2.5	5.3	2.1	1.0	2.1	1.5	2.2	2.0	0.7	1.3	2.0	16.1	1.9	31.9	1.6	3.3	2.7	0.0	1.4	1.2	1.3	2.5	0.1	3.0	0.2	1.1	1.5	1.0	0.8	1.2	0.0	0.1	0.6	0.7	0.8	1.3	9.0	7.0	10.4	7.5	4.3	3.4	8.0	4.8	6.0	7.8
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;CACO-2: 3.4;HAP1: 3.2;HEK 293: 4.2;HHSteC: 4.9;MCF7: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.4"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.4"	"Region enriched"	"Detected in many"	5	"basal ganglia: 16.1"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm				Nucleoplasm		"HPA050343: , HPA060467: "	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (4.70e-5)"	"unprognostic (4.06e-2)"	2.7	0.7	5.3	1.4	5.6	0.5	1.6	0.5	4.7	2.1	6.2	3.3	12.8	14.1	1.5	4.5	1.1	2.0	11.7	5.1	5.2	1.9	7.0	0.6	4.2	1.4	2.9	3.1	3.6	12.7	1.2	1.1	0.6	3.3	1.1	0.9	16.1	1.3	15.0	1.2	0.9	8.0	1.5	2.5	4.2	14.8	1.4	4.8	0.0	10.7	0.0	0.9	1.1	1.5	0.3	0.1	0.0	0.0	5.4	0.4	0.0	0.0	0.0	1.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.4	0.7	0.0	0.6	0.0	0.0	3.2	0.0	0.0	0.4	4.2	0.0	0.0	0.7	4.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	5.4	0.0	0.0	0.0	0.0	5.3	5.6	0.5	4.7	5.2	1.9	2.9	3.1	3.3	4.8
PRDM4	PFM1	ENSG00000110851	"PR/SET domain 4"	Q9UKN5	12	107732866-107761272	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024322, HPA067437"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA024322: AB_1855691, HPA067437: "	"unprognostic (4.64e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (1.11e-3)"	"prognostic unfavourable (7.66e-4)"	"unprognostic (9.64e-2)"	"unprognostic (9.06e-3)"	"unprognostic (5.31e-2)"	"prognostic favourable (3.15e-7)"	"unprognostic (9.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.62e-3)"	13.5	9.6	14.6	10.4	18.0	13.5	12.3	21.2	20.6	12.1	15.2	12.7	13.3	12.1	15.4	13.1	16.3	11.4	10.6	9.1	11.5	11.3	19.5	6.8	11.9	10.5	13.3	15.4	14.6	11.4	53.6	9.5	12.8	15.8	11.3	15.5	12.4	12.9	12.1	12.9	13.1	14.8	13.1	9.3	12.1	11.6	10.3	14.6	10.4	13.2	7.4	13.5	12.8	28.1	5.1	4.5	2.6	7.5	2.1	4.2	1.4	11.2	12.6	13.8	14.3	14.9	15.4	10.5	15.4	20.2	15.7	12.0	8.8	4.9	14.6	6.6	16.3	8.1	14.3	11.3	17.1	10.6	14.6	11.6	9.2	9.3	19.3	16.4	11.9	18.8	21.8	17.7	30.6	20.3	13.9	17.7	18.6	11.9	9.2	14.6	7.2	17.2	7.5	13.8	14.3	16.2	17.4	17.1	16.0	11.6	8.3	13.9	10.0	8.4	20.5	12.1	8.8	16.1	12.8	12.6	12.4	10.4	8.8	7.8	8.9	2.2	1.7	2.6	4.0	5.8	2.8	5.1	2.1	3.6	4.5	4.5	3.5	4.2	0.7	2.1	7.5	2.4	4.0	1.4	14.6	18.0	21.2	20.6	11.5	11.3	13.3	15.4	15.8	14.6
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 15.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"eosinophil: 9.1;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: "	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	5.0	5.9	3.5	3.6	3.9	4.6	5.4	1.9	5.4	9.3	5.2	2.7	6.3	1.9	8.6	7.0	3.3	7.7	6.1	5.0	3.2	3.1	3.1	0.8	7.4	2.7	3.4	4.2	15.2	10.3	19.3	12.5	5.0	6.1	7.7	4.4	9.4	3.3	6.8	2.2	2.7	3.2	9.5	6.2	3.3	4.1	5.0	3.3	0.5	8.4	5.1	2.3	5.8	14.1	0.0	0.0	9.1	0.0	0.0	0.3	0.0	1.7	2.8	6.5	0.1	3.9	8.1	7.7	3.8	8.4	3.9	3.5	3.6	1.0	0.4	1.0	5.1	0.0	0.0	0.8	5.2	0.0	1.1	2.3	2.5	0.2	4.2	7.9	0.1	5.7	2.5	2.8	3.5	2.9	0.0	11.9	4.8	0.3	1.2	0.0	4.8	2.2	0.0	7.5	4.9	1.4	0.0	1.2	5.2	0.0	0.1	0.7	5.4	3.4	1.1	0.2	2.3	4.0	3.8	11.0	15.3	0.0	3.0	0.0	2.9	0.1	0.0	9.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	6.7	0.0	0.0	0.0	0.0	0.0	3.5	3.9	1.9	5.4	3.2	3.1	3.4	4.2	6.1	3.3
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45511036-45523047	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004682, HPA007730"	Approved		Supported	Mitochondria			110000000	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (2.89e-4)"	43.3	58.2	71.0	43.8	57.4	12.0	75.5	31.6	60.0	46.9	51.1	72.2	42.6	78.5	40.8	75.7	136.1	49.7	46.9	84.2	56.5	73.0	121.7	136.5	52.9	51.0	99.1	51.2	43.0	20.4	34.1	34.3	58.3	87.8	42.2	53.0	48.8	53.5	52.2	78.9	46.9	77.6	52.4	98.3	46.5	52.5	25.7	72.6	29.7	130.1	114.3	91.0	49.1	56.3	44.7	50.3	64.4	64.5	20.4	72.3	58.7	65.4	120.6	49.7	63.2	56.4	48.3	106.4	74.4	77.4	80.8	67.2	59.9	28.3	57.8	78.6	79.8	67.8	107.9	71.9	80.0	44.5	83.3	43.7	170.2	167.6	24.5	50.5	57.2	41.4	53.8	80.2	19.0	92.6	79.8	20.0	80.2	52.5	67.7	49.3	155.8	126.4	119.4	62.7	76.1	145.2	56.4	66.2	33.3	68.3	185.5	4.8	50.4	40.9	78.7	32.3	73.1	69.1	99.0	14.0	78.1	110.1	53.4	35.2	18.9	64.4	55.6	18.4	28.5	60.6	37.5	44.7	45.5	37.9	50.3	36.2	28.3	31.0	2.4	20.4	64.5	33.5	72.3	58.7	71.0	57.4	31.6	60.0	56.5	73.0	99.1	51.2	87.8	72.6
PRDX4	AOE37-2	ENSG00000123131	"Peroxiredoxin 4"	Q13162	X	23664262-23686399	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 127.6;pancreas: 320.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008659, CAB027389, CAB047362"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		11000000	"Endoplasmic reticulum, Cytosol"		"CAB008659: AB_1620984, CAB027389: , CAB047362: "	"unprognostic (3.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (7.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.10e-2)"	11.6	14.8	3.8	7.0	6.4	3.9	11.2	3.3	5.4	13.2	10.7	6.5	17.4	8.9	11.5	10.5	13.1	9.6	12.9	17.6	3.8	4.0	11.8	127.6	8.9	16.9	7.2	4.0	14.6	320.8	6.1	15.8	21.9	7.4	9.3	11.4	8.0	25.4	14.1	7.8	7.2	10.6	8.8	8.1	12.6	12.8	25.2	6.1	4.7	12.0	10.0	15.0	10.8	8.7	27.9	31.4	2.0	39.3	24.1	22.7	21.3	24.2	33.5	14.2	27.4	77.4	39.6	20.0	32.7	35.7	29.7	43.4	35.1	30.6	20.9	15.4	42.4	29.4	40.8	20.3	28.5	12.7	78.5	14.8	29.6	44.3	32.3	19.0	14.1	41.9	26.3	28.9	29.0	37.2	28.5	77.1	27.4	36.1	9.7	29.8	49.0	49.2	13.5	35.5	117.8	26.5	8.5	20.8	17.7	30.1	35.8	24.1	37.8	24.3	24.5	21.2	14.0	54.7	24.5	25.3	30.6	22.3	38.0	24.7	30.2	1.7	20.6	2.0	17.8	32.2	21.8	27.9	22.7	18.6	31.4	16.2	16.4	16.7	1.5	24.1	39.3	22.0	22.1	21.3	3.8	6.4	3.3	5.4	3.8	4.0	7.2	4.0	7.4	6.1
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318088-64321811	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Enhanced	Mitochondria			19000000	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (2.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (1.24e-5)"	"unprognostic (8.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.03e-2)"	28.7	69.7	70.3	38.6	60.3	57.0	35.5	69.3	73.9	47.2	79.3	31.9	49.0	49.5	26.6	54.8	69.6	94.9	44.8	102.4	56.7	74.2	57.3	54.2	50.3	25.0	68.6	70.2	42.2	72.0	36.0	53.7	49.1	71.4	30.7	71.2	33.9	77.5	62.6	104.7	27.0	51.2	30.9	44.1	27.3	64.5	35.0	29.3	25.1	82.0	64.8	33.5	34.4	50.4	55.2	69.2	115.0	66.9	48.4	40.5	75.3	26.0	53.2	32.3	53.3	34.8	52.3	37.3	32.7	52.4	24.0	30.0	38.7	53.6	38.3	57.2	52.2	59.7	30.1	69.4	15.3	53.1	23.7	38.6	83.8	44.1	71.4	14.6	32.9	53.0	90.7	40.3	40.9	36.5	21.7	91.0	33.8	66.2	25.5	63.5	48.9	68.2	24.6	33.1	135.2	90.0	51.8	27.4	52.0	27.3	60.7	93.2	44.4	33.3	35.1	34.4	32.0	39.7	14.4	46.6	55.4	45.0	41.6	29.5	26.8	79.8	66.9	85.4	37.7	59.6	32.7	53.8	35.0	30.8	52.4	55.2	34.8	35.0	115.0	48.4	52.5	69.2	40.5	75.3	70.3	60.3	69.3	73.9	56.7	74.2	68.6	70.2	71.4	29.3
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"			180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	51.2	15.8	26.2	29.0	101.5	49.6	22.1	104.7	35.7	43.7	31.1	29.7	34.5	33.4	33.5	85.8	29.9	34.2	33.7	35.6	29.3	31.6	22.1	27.0	33.5	57.3	23.1	7.3	41.1	34.2	24.0	33.7	42.8	49.2	6.9	49.6	10.5	15.7	30.5	57.5	97.9	18.8	30.3	34.0	65.5	11.7	12.2	22.6	36.1	42.5	24.0	35.9	32.7	28.8	17.1	19.5	25.8	28.4	10.5	15.4	27.4	20.4	20.1	15.5	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1
PRELID1	"CGI-106, PRELI, PX19"	ENSG00000169230	"PRELI domain containing 1"	Q9Y255	5	177303774-177306959	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005701	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA005701: AB_1079721"	"unprognostic (1.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (7.63e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavourable (2.89e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	18.9	25.0	21.9	33.9	20.3	30.3	21.6	12.0	31.1	16.9	44.6	14.8	15.4	43.5	18.3	15.5	35.6	17.4	20.6	16.8	19.3	18.6	46.1	62.3	18.9	43.0	20.2	14.7	20.3	91.6	12.3	17.7	29.4	21.0	19.8	35.0	18.9	40.1	16.4	11.9	26.2	70.6	19.0	14.8	43.5	24.6	12.9	13.5	25.2	29.3	27.2	33.7	18.0	18.9	27.1	77.4	111.7	94.2	30.4	26.4	49.2	31.8	30.0	18.3	48.7	16.4	17.8	60.8	22.8	15.9	33.3	32.2	67.1	36.6	27.1	26.9	21.4	18.1	32.5	60.9	22.8	116.1	45.0	23.4	31.1	44.6	17.3	36.8	33.0	16.0	21.9	26.3	22.5	41.2	25.8	39.3	32.4	82.8	23.6	53.9	37.2	49.6	7.6	36.9	48.7	21.7	26.7	29.2	36.7	21.3	42.5	39.6	27.4	45.3	22.7	30.5	26.7	25.0	54.5	22.0	37.7	39.4	26.3	49.7	31.7	31.5	75.7	111.7	26.4	94.2	25.8	27.1	21.9	26.2	77.4	21.1	19.3	21.1	55.2	30.4	90.3	28.3	23.3	49.2	21.9	20.3	12.0	31.1	19.3	18.6	20.2	14.7	21.0	13.5
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105277565-105403084	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol			1400000	Cytosol		"CAB025414: , HPA031388: , HPA031389: , HPA031390: "	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	13.0	14.2	10.1	22.2	10.1	10.4	36.2	10.9	24.9	11.9	27.2	5.2	11.2	20.2	13.2	10.9	16.4	10.5	15.0	19.0	8.8	7.1	8.9	14.6	23.9	31.4	8.3	15.4	13.6	18.8	16.1	11.1	15.4	9.7	9.4	33.0	8.9	14.9	11.5	58.0	24.2	19.0	15.3	8.5	11.9	14.0	20.1	8.8	17.4	10.2	18.5	13.3	18.2	21.0	8.3	15.3	7.1	18.7	16.6	16.3	11.2	10.8	13.3	14.2	15.9	33.6	19.9	14.0	14.6	13.7	19.3	20.5	16.9	6.9	13.9	14.4	17.1	16.9	20.9	42.8	22.0	21.0	20.4	18.7	11.2	19.2	13.0	18.8	13.7	18.5	26.1	13.9	35.8	18.0	31.8	24.9	23.3	17.6	12.5	19.1	13.7	13.3	19.4	24.5	9.1	14.4	25.9	18.6	26.5	12.8	21.5	10.2	9.2	30.2	18.1	8.9	12.3	11.1	17.9	7.3	4.8	18.2	15.7	20.5	27.6	4.8	13.6	7.1	16.0	15.4	15.6	8.3	13.7	16.3	15.3	6.8	12.9	15.2	0.7	16.6	18.7	6.5	12.0	11.2	10.1	10.1	10.9	24.9	8.8	7.1	8.3	15.4	9.7	8.8
PREX1	"KIAA1415, P-REX1"	ENSG00000124126	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1"	Q8TCU6	20	48624252-48827883	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.7;brain: 35.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 43.2;SK-BR-3: 45.3;T-47d: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001927	Supported		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA001927: AB_1079674"	"unprognostic (8.07e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.47e-2)"	"prognostic favourable (8.56e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.86e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-2)"	10.8	8.1	20.5	25.1	24.9	32.7	12.4	11.4	25.0	9.6	5.1	35.5	0.2	4.6	3.2	2.7	4.8	3.7	9.5	4.9	21.8	15.5	4.1	4.0	17.7	28.3	26.2	12.1	2.2	3.9	5.2	5.8	8.4	17.4	3.9	4.6	7.7	4.0	2.8	4.6	2.7	8.6	5.6	27.6	28.7	6.1	4.5	23.9	2.8	6.7	1.0	15.1	10.3	2.5	2.0	2.1	11.7	2.7	2.1	9.3	2.2	0.6	1.6	22.0	0.0	0.3	1.6	7.7	0.7	0.9	3.1	0.8	0.1	0.0	4.4	14.0	1.9	0.2	1.1	0.0	2.1	1.0	0.5	0.6	2.5	0.0	1.3	2.3	14.4	1.8	0.0	7.2	0.0	19.0	0.0	0.1	4.1	43.2	0.0	6.8	0.8	1.8	6.4	6.4	2.6	0.1	0.0	4.6	0.7	4.0	45.3	5.0	40.5	18.5	21.2	1.2	4.5	0.0	1.2	0.2	0.9	5.4	20.6	4.8	6.7	5.2	2.3	2.5	5.0	2.7	3.0	2.0	2.7	4.2	2.1	1.7	0.4	1.5	11.7	2.1	2.3	1.7	9.3	2.2	20.5	24.9	11.4	17.7	21.8	15.5	26.2	12.1	17.4	23.9
PRIM1		ENSG00000198056	"DNA primase subunit 1"	P49642	12	56731596-56752373	"Predicted intracellular proteins"	"DNA replication, Transcription"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040010	Uncertain		Supported	Vesicles				Vesicles		"HPA040010: AB_10805599"	"unprognostic (3.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavourable (2.40e-8)"	"unprognostic (4.68e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.53e-2)"	5.7	5.2	6.7	9.8	9.3	26.0	10.1	16.0	10.6	6.0	8.2	6.7	5.5	4.5	6.2	4.9	9.6	6.2	3.1	4.0	7.6	4.6	4.5	8.2	5.4	11.1	9.2	4.6	9.7	10.7	7.9	12.3	5.0	7.9	5.2	11.1	5.3	7.0	4.3	6.3	7.9	8.3	6.1	11.8	10.2	6.3	17.0	10.8	28.3	5.1	6.8	13.2	5.6	6.9	8.6	6.3	3.5	6.2	5.3	12.7	4.6	12.2	10.5	14.6	9.0	1.7	2.6	17.2	10.4	8.5	18.5	17.3	11.4	15.8	24.0	8.7	4.8	12.4	17.7	11.3	20.3	11.9	10.9	31.7	6.8	10.9	0.5	38.8	13.4	1.1	2.1	16.3	7.1	6.6	29.9	38.0	10.7	9.0	22.2	14.7	16.3	13.3	25.0	25.7	20.7	4.4	9.3	14.9	13.3	12.4	6.0	5.6	19.4	14.9	3.0	9.6	22.8	10.0	13.1	13.8	27.6	13.6	5.9	16.5	12.7	1.4	1.4	3.5	7.8	3.4	9.0	8.6	10.5	7.5	3.4	8.2	12.7	10.0	0.0	5.3	6.2	6.3	9.1	4.6	6.7	9.3	16.0	10.6	7.6	4.6	9.2	4.6	7.9	10.8
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646849	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.7;prostate: 22.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm				Nucleoplasm		"HPA046566: "	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavourable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (3.00e-5)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavourable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	5.4	1.6	1.7	9.0	2.3	7.8	4.1	6.5	3.3	5.3	3.9	2.5	2.4	3.0	9.7	3.7	5.6	3.7	2.7	3.1	2.8		3.5	2.7	2.7	7.1	3.6	1.5	4.3	2.2	2.4	5.4	5.9	1.7	22.6	5.0	3.5	7.3	3.4	1.1	3.4	3.7	5.8	3.6	6.7	2.4	5.3	3.1	21.7	4.6	4.5	8.7	4.7	2.7	5.0	7.3	2.5	5.4	5.6	7.9	2.7	15.1	6.2	12.4	14.3	7.1	12.5	10.3	18.7	18.3	20.9	28.1	9.8	7.3	13.9	10.4	23.3	10.3	11.1	10.7	25.9	15.1	9.0	16.4	8.5	16.4	2.9	15.8	10.4	4.7	4.0	23.0	8.1	9.4	15.5	36.9	17.4	9.6	16.5	12.5	7.8	6.1	12.6	17.1	11.0	7.6	7.9	9.2	6.9	12.1	5.8	7.6	12.4	13.7	6.5	21.3	21.0	39.0	15.8	5.0	9.6	16.1	9.7	16.7	11.4	0.3	2.4	2.5	5.5	5.1	6.2	5.0	5.0	7.5	4.1	4.9	3.6	7.9	1.0	5.6	5.4	7.3	5.9	2.7										
PRKAA1	AMPKa1	ENSG00000132356	"Protein kinase AMP-activated catalytic subunit alpha 1"	Q13131	5	40759379-40798374	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005050, HPA035409, HPA064946"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB005050: AB_562037, HPA035409: , HPA064946: "	"unprognostic (2.07e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-2)"	40.6	15.7	9.4	15.9	16.1	29.0	26.2	14.3	17.7	30.2	24.0	19.9	18.9	21.7	23.5	20.9	22.5	20.4	21.3	15.0	10.5	11.7	35.9	40.7	24.8	16.7	12.2	8.5	28.8	20.6	25.3	20.0	16.8	35.7	26.1	22.3	20.0	23.2	17.9	18.5	16.6	32.6	20.7	14.1	25.1	22.1	29.3	11.4	21.4	28.0	20.5	22.9	32.5	17.9	8.4	6.5	15.9	8.9	10.8	12.6	6.5	11.3	11.8	9.5	12.6	23.5	24.5	9.0	19.3	19.8	14.5	13.0	11.1	14.7	6.7	9.0	19.8	9.2	8.7	17.6	27.5	19.6	7.9	13.3	27.3	8.8	19.4	12.6	14.0	22.6	8.6	19.4	20.0	21.4	6.2	19.4	21.6	5.4	11.6	9.9	4.1	14.3	9.8	20.3	9.8	22.3	19.3	8.2	8.3	33.9	22.6	11.5	11.9	10.5	22.9	26.2	14.2	15.1	15.7	7.7	6.0	8.0	16.4	27.4	13.9	14.1	6.6	12.7	10.0	8.1	12.6	8.4	9.4	9.4	6.5	7.7	11.5	10.0	15.9	10.8	8.9	2.0	11.3	6.5	9.4	16.1	14.3	17.7	10.5	11.7	12.2	8.5	35.7	11.4
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 40.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5;RPTEC TERT1: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Golgi apparatus"	"HPA044540: "	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavourable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favourable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3.0	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2.0	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5.0	4.6	2.2	6.0	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0.0	4.0	12.3	0.8	4.4	2.1	0.2	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.7	2.0	0.0	0.7	0.5	2.3	1.8	1.4	2.5	4.3	3.8	4.7	0.0	0.6	0.6	0.0	7.8	0.0	7.1	0.0	8.5	0.0	6.9	5.2	0.0	0.0	0.1	0.6	0.0	3.5	0.3	0.8	0.0	0.0	1.0	0.1	0.0	0.0	5.5	5.4	0.0	0.0	0.0	14.0	1.2	2.0	5.4	5.7	0.1	0.0	3.2	0.0	0.0	1.5	2.3	2.7	6.3	0.0	0.0	0.0	4.5	0.0	1.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5.0	0.8
PRKCA	PKCA	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302636-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"			1900000	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	4.0	19.6	26.5	9.0	22.8	2.5	3.0	10.8	33.9	7.0	13.8	19.0	3.5	14.6	14.8	6.7	4.7	6.1	10.8	5.8	31.6	15.6	16.7	6.5	6.0	8.4	18.7	15.6	20.4	5.5	1.7	6.0	6.5	17.6	17.2	11.2	7.0	3.1	22.3	6.6	3.8	12.7	13.7	15.0	7.9	7.9	3.7	14.4	0.4	4.5	1.3	5.9	9.5	9.5	0.0	1.4	0.1	2.7	0.1	4.0	1.0	2.3	12.3	2.5	2.6	6.2	15.9	0.3	13.3	8.7	9.6	8.2	1.4	1.5	3.1	3.6	21.4	0.3	1.3	1.5	20.9	5.1	3.0	0.0	7.3	6.4	8.5	3.8	20.9	6.9	0.6	12.0	10.3	8.2	8.0	0.0	14.8	0.7	7.7	2.3	1.0	6.6	1.4	18.8	0.0	3.4	2.0	1.5	8.5	4.4	2.5	0.1	0.3	5.4	24.5	16.7	9.7	10.4	8.3	0.0	0.0	0.3	53.0	0.0	8.2	0.1	0.6	0.0	0.5	0.8	1.5	0.0	2.5	1.2	1.1	0.0	4.0	2.3	0.0	0.1	2.7	1.4	0.5	1.0	26.5	22.8	10.8	28.2	31.6	15.6	18.7	15.6	17.6	14.4
PRKCB	"PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835946-24220611	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.2;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in some"		"HEL: 40.8;HMC-1: 40.9;K-562: 58.1;THP-1: 18.4;U-937: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol			3400000	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: , HPA054203: "	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.0	1.9	13.9	20.8	55.6	20.4	1.8	14.1	57.2	4.1	4.7	4.4	0.6	4.9	3.5	1.2	3.2	2.6	3.9	1.5	23.4	7.8	1.8	3.7	5.4	31.0	11.0	20.4	1.2	1.4	0.9	1.4	2.5	8.3	6.2	4.4	3.5	1.9	8.4	1.2	4.6	9.1	5.8	7.3	31.2	3.8	6.4	6.4	24.1	3.9	0.0	27.7	7.6	1.7	23.6	18.5	21.8	14.6	20.1	19.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.8	40.8	1.9	0.0	0.0	5.9	40.9	0.0	0.1	0.0	0.0	0.0	58.1	0.1	0.0	0.0	12.9	12.9	0.3	0.0	12.3	0.1	2.3	0.1	3.6	7.1	0.0	0.0	0.0	0.6	0.0	18.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	16.4	0.0	17.5	7.6	14.4	14.5	10.7	6.7	23.6	9.5	17.2	6.2	22.1	7.8	19.0	21.8	20.1	14.6	18.5	6.7	7.5	13.9	55.6	14.1	57.2	23.4	7.8	11.0	20.4	8.3	6.4
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 63.3;THP-1: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in all"	7	"dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 124.2;thalamus: 366.1"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"			300000	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavourable (2.24e-4)"	"prognostic favourable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	27.8	33.4	9.4	29.7	11.5	30.3	17.6	5.7	10.7	10.3	27.8	10.1	43.7	21.4	5.5	21.3	18.3	16.1	33.7	11.9	8.3	3.7	16.5	4.5	29.2	24.5	10.2	5.6	8.1	13.4	6.1	5.1	7.5	7.1	17.9	16.1	10.3	14.1	40.7	3.9	17.1	42.9	17.4	10.2	32.1	24.8	9.6	8.0	10.5	26.9	13.4	26.3	22.9	12.7	3.1	17.6	20.7	22.9	2.4	1.5	6.4	7.7	3.0	1.2	2.0	9.0	5.2	11.2	4.7	5.9	5.8	5.7	7.3	7.6	20.0	2.1	10.2	3.5	7.9	11.5	4.7	17.4	6.0	11.1	4.1	7.8	5.7	14.6	25.1	4.1	8.4	5.9	5.5	5.0	2.2	2.9	8.3	19.1	1.6	24.9	3.1	5.5	1.7	3.0	4.7	6.3	16.7	2.0	1.4	3.6	63.3	9.7	5.3	45.2	7.2	2.8	3.6	3.7	4.4	4.4	6.8	10.2	6.7	25.2	5.4	17.7	22.9	17.0	1.5	22.2	1.0	3.1	1.1	1.2	17.6	2.9	0.8	0.7	20.7	2.4	15.3	8.5	1.1	6.4	9.4	11.5	5.7	10.7	8.3	3.7	10.2	5.6	7.1	8.0
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222365-170305981	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"				Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: "	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavourable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favourable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	10.3	7.5	11.4	5.9	15.5	2.1	9.5	14.8	16.6	12.5	11.1	7.0	6.0	10.4	13.1	8.4	20.6	15.1	10.5	10.1	9.5	7.7	13.0	6.7	14.8	3.9	5.6	9.4	15.2	7.7	12.4	14.7	9.8	11.0	16.3	12.2	7.3	25.8	12.6	12.7	11.0	11.6	12.5	6.8	6.1	30.2	15.0	5.3	12.6	23.1	8.4	9.9	16.3	13.0	1.9	1.8	1.0	1.3	5.8	4.8	1.4	35.9	9.1	9.2	9.8	8.2	11.4	14.9	9.2	13.7	12.3	13.3	13.3	17.6	11.0	30.5	13.0	16.9	17.3	18.1	21.1	8.0	10.7	10.2	11.6	7.4	13.0	9.2	4.6	10.2	12.7	10.4	16.5	9.5	11.2	9.1	12.3	12.4	13.3	3.6	19.3	10.2	9.6	14.2	18.2	19.3	11.0	14.6	11.9	20.0	26.3	9.0	28.9	6.3	10.1	12.8	9.9	11.9	15.2	15.7	15.1	15.7	9.2	7.2	5.0	0.1	1.3	1.0	2.6	1.2	4.0	1.8	3.6	4.8	1.8	1.9	3.9	2.2	0.7	5.8	1.1	1.8	2.3	1.4	11.4	15.5	14.8	16.6	9.5	7.7	5.6	9.4	11.0	5.3
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4"	"Cell line enhanced"	"Detected in some"		"HEL: 30.9;MOLT-4: 23.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 6.5;T-cells: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"			200000	"Centriolar satellite"		"HPA065279: , HPA073098: "	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (3.51e-2)"	0.9	0.7	3.6	9.4	4.3	3.1	0.8	0.9	5.2	1.3	1.1	7.4	0.1	1.2	1.8	5.4	1.6	2.6	1.3	0.5	4.4	4.0	4.6	0.9	3.3	6.6	4.0	2.2	1.1	7.7	0.3	1.0	0.4	2.7	1.4	1.3	5.4	2.8	1.0	63.4	0.6	2.5	0.8	3.6	3.4	1.4	0.9	4.5	32.1	9.1	7.5	6.8	1.9	0.8	0.0	0.1	1.1	0.2	6.5	19.7	5.2	0.0	2.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.2	1.8	0.2	0.0	0.0	0.0	1.8	3.3	0.0	0.0	2.1	30.9	0.0	0.2	0.4	1.5	0.3	0.1	2.0	0.1	0.1	0.3	6.7	0.0	0.0	0.0	23.2	4.3	3.2	0.0	4.5	0.7	0.0	6.5	1.6	0.2	1.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.1	0.1	0.1	12.7	0.2	9.8	0.0	13.5	13.2	0.1	0.0	10.7	10.0	0.8	6.5	0.0	0.0	19.7	5.2	3.6	4.3	0.9	5.2	4.4	4.0	4.0	2.2	2.7	4.5
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435288-11450968	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"		62000000	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: , HPA043560: "	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	46.9	37.4	26.9	32.5	28.5	50.9	45.0	37.8	39.4	46.8	42.6	36.3	50.1	43.6	50.1	48.4	41.2	50.2	50.2	31.5	27.7	27.3	41.2	85.6	39.9	53.2	29.6	32.1	72.6	77.7	52.9	40.3	72.7	27.0	48.8	38.4	43.9	58.8	53.1	31.3	43.8	41.8	40.1	38.6	42.5	37.9	42.8	29.8	51.6	60.1	32.7	41.9	44.6	44.9	26.2	44.1	32.8	29.8	19.5	28.5	19.4	48.6	34.2	38.0	63.6	65.1	84.4	39.5	52.4	71.6	61.5	58.1	49.9	54.8	31.3	85.0	72.1	48.5	39.1	57.1	49.8	33.6	25.1	27.2	42.9	43.2	48.7	42.4	40.0	77.0	42.7	57.7	45.6	42.1	31.4	71.0	53.1	71.8	33.0	49.0	79.9	44.2	35.3	34.7	79.7	42.8	42.6	24.1	47.5	45.8	47.7	42.9	49.0	47.0	42.4	74.7	35.3	70.8	61.4	87.4	103.9	21.8	57.1	44.6	50.9	15.9	29.8	23.8	24.9	22.2	28.5	23.9	21.0	23.8	22.6	26.2	20.3	21.3	32.8	19.5	24.4	44.1	22.0	19.4	26.9	28.5	37.8	39.4	27.7	27.3	29.6	32.1	27.0	29.8
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050470-2185395	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.6;placenta: 93.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 15.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favourable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.2	7.8	15.9	3.0	31.8	1.4	3.9	39.8	43.6	3.2	8.6	17.1	2.3	20.0	1.7	5.5	10.1	6.5	3.1	6.4	15.5	6.4	11.3	6.8	22.3	5.0	12.2	23.6	1.9	8.5	9.8	12.0	93.0	27.3	5.8	7.5	2.6	7.0	3.0	0.4	8.8	18.4	1.2	8.4	6.9	6.1	17.5	13.5	0.6	14.1	0.9	5.0	4.0	4.6	0.4	0.3	15.0	0.3	0.8	2.6	0.3	7.5	4.8	1.7	8.9	0.0	0.0	23.5	0.5	0.2	5.6	0.3	12.1	16.4	0.0	14.9	1.9	13.2	10.1	12.5	4.0	0.5	11.2	0.0	7.7	16.1	1.6	0.0	5.8	0.3	7.5	0.0	4.3	0.0	3.3	0.1	0.1	9.2	0.4	0.0	3.4	11.7	0.0	0.0	2.6	9.6	7.9	12.3	9.9	6.1	13.7	2.6	9.6	2.0	0.0	0.0	7.1	0.1	0.0	3.5	0.6	0.1	0.6	0.1	8.5	0.3	0.0	15.0	0.6	0.3	2.6	0.3	1.0	0.6	0.0	0.4	0.8	0.4	1.2	0.8	0.0	0.3	0.8	0.3	15.9	31.8	39.8	43.6	15.5	6.4	12.2	23.6	27.3	13.5
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;fHDF/TERT166: 19.0;HSkMC: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (3.89e-1)"	7.4	10.6	8.0	5.3	9.7	0.7	19.0	4.9	8.9	5.1	8.7	5.1	24.1	3.1	8.3	9.0	3.5	6.8	9.0	6.3	9.8	5.9	15.1	2.3	14.9	1.6	5.6	6.6	15.7	7.3	35.7	9.2	4.5	10.8	20.1	3.5	4.9	3.5	24.4	3.1	2.7	3.5	19.7	16.4	2.4	4.8	16.1	8.6	0.5	8.2	2.9	1.8	14.1	12.2	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	4.0	17.8	16.7	0.1	12.1	9.3	12.4	6.7	0.0	0.5	0.0	1.2	19.0	0.1	5.9	1.4	6.8	0.0	4.1	0.0	0.1	0.4	9.0	0.0	0.1	17.7	0.6	0.8	1.4	2.5	1.2	0.4	11.6	1.3	0.0	0.0	2.5	6.2	0.0	7.0	3.2	13.2	5.6	3.6	7.1	2.1	0.0	4.7	0.0	0.1	6.3	11.7	4.8	1.0	3.5	0.0	0.0	0.0	3.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	8.0	9.7	4.9	8.9	9.8	5.9	5.6	6.6	10.8	8.6
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favourable (9.15e-4)"	17.1	7.6	7.0	25.8	6.5	18.1	18.0	2.5	6.8	16.8	13.7	5.8	18.7	13.7	14.8	16.5	23.4	15.6	17.4	7.4	6.3	3.1	13.2	9.1	21.3	24.8	7.5	2.7	17.0	12.5	10.3	17.2	20.1	6.6	14.8	7.7	11.9	15.6	21.5	7.5	26.8	19.8	11.7	6.8	34.8	15.2	6.6	7.2	41.5	18.7	10.5	33.0	17.4	37.5	6.6	0.4	7.3	1.0	2.9	6.1	1.9	8.6	13.4	5.3	6.5	4.4	3.6	6.8	4.5	7.1	9.4	10.3	7.4	8.5	10.1	7.9	6.0	12.9	4.7	12.0	2.9	8.6	7.0	10.6	4.2	3.9	5.8	7.7	15.7	4.3	5.8	5.4	4.6	16.5	6.8	14.6	3.9	9.1	14.8	25.0	4.5	6.8	9.7	2.5	16.3	5.8	12.9	3.4	10.8	8.4	7.0	1.8	5.6	3.1	7.8	4.0	8.0	3.4	3.6	14.3	56.9	5.0	4.2	6.4	4.2	0.9	1.0	3.4	5.6	0.9	4.9	6.1	5.7	6.1	0.4	6.6	5.1	4.9	7.3	2.9	0.7	0.0	4.0	1.9	7.0	6.5	2.5	6.8	6.3	3.1	7.5	2.7	6.6	7.2
PRKD3	"EPK2, PRKCN"	ENSG00000115825	"Protein kinase D3"	O94806	2	37250502-37324808	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029529	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029529: AB_10602082"	"unprognostic (1.39e-1)"	"unprognostic (7.34e-2)"	"prognostic favourable (4.84e-4)"	"unprognostic (1.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-1)"	16.1	22.1	9.5	20.7	10.7	5.3	35.1	4.8	9.2	17.2	18.0	7.2	7.2	6.0	19.2	16.0	9.8	11.3	10.0	11.6	12.7	6.1	9.9	8.4	20.4	22.3	11.4	3.7	15.0	7.6	12.9	20.7	11.1	10.3	14.4	8.3	27.8	11.1	13.3	19.1	11.5	12.1	16.5	15.4	22.0	10.5	16.8	10.8	16.2	11.8	9.3	21.2	12.4	17.7	16.4	8.2	5.7	8.3	6.3	11.5	3.4	12.6	5.4	14.3	11.8	10.9	18.4	10.5	8.2	15.3	9.3	9.5	8.6	4.5	18.6	6.9	12.3	5.0	9.7	10.1	12.6	24.0	14.2	12.2	8.3	5.8	4.5	8.7	7.5	8.6	5.2	14.7	9.7	16.5	10.2	22.9	10.8	2.1	3.8	6.8	15.1	5.2	12.8	22.6	15.9	6.2	14.3	10.8	28.0	7.9	4.5	48.2	4.9	8.0	15.9	26.7	13.9	10.6	9.2	26.2	48.5	21.7	9.3	3.7	16.0	5.7	8.3	5.5	10.5	6.6	9.1	12.4	8.8	8.4	7.8	16.4	10.4	11.5	1.5	6.3	3.3	8.2	4.1	3.4	9.5	10.7	4.8	9.2	12.7	6.1	11.4	3.7	10.3	10.8
PRKDC	"DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic polypeptide"	P78527	8	47773108-47960183	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm			1100000	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: "	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	21.3	20.5	16.0	22.3	22.0	27.4	30.2	16.5	23.1	19.6	20.6	17.3	18.1	12.0	26.2	14.5	27.4	24.4	13.0	21.1	20.8	15.2	16.7	18.4	17.0	33.6	16.6	18.2	24.6	23.8	33.4	29.4	20.5	17.3	17.9	20.3	17.8	17.9	17.8	34.0	23.9	18.4	27.0	20.3	24.4	19.1	20.5	15.9	44.4	20.8	15.9	27.9	21.3	19.1	17.0	13.9	7.1	11.5	11.5	11.3	2.3	32.4	27.8	27.1	25.7	16.9	17.9	11.5	13.8	13.6	19.5	19.2	18.1	10.7	31.0	12.0	16.9	18.5	35.8	18.9	30.6	6.8	22.2	60.9	25.0	22.2	7.3	23.1	12.7	12.9	6.2	30.7	32.2	20.0	40.5	13.1	21.4	15.2	32.6	19.1	29.8	8.4	16.0	21.3	10.9	9.8	28.0	13.6	17.3	42.6	13.9	13.4	19.9	16.0	23.2	25.5	21.7	20.1	27.7	11.5	14.6	44.6	14.4	26.3	20.6	6.7	8.1	3.5	8.7	6.3	10.9	12.6	10.8	8.8	5.9	17.0	11.3	10.3	7.1	11.5	11.5	13.9	7.4	2.3	16.0	22.0	16.5	23.1	20.8	15.2	16.6	18.2	17.3	15.9
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347420-162727771	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;HEL: 9.0;Karpas-707: 5.7;RPMI-8226: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: "	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favourable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	6.8	7.1	7.9	2.3	12.2	1.5	4.2	7.2	13.4	5.3	4.3	6.3	4.6	2.8	7.8	4.4	6.1	3.4	4.3	17.7	9.2	6.2	17.4	3.6	2.6	3.0	5.8	5.2	6.4	3.0	5.6	8.6	2.0	5.5	4.0	2.4	8.3	3.5	4.8	41.8	4.0	3.3	6.6	5.9	2.7	3.5	10.3	6.8	0.6	3.8	4.7	2.7	4.9	2.1	4.6	1.2	4.2	0.8	1.8	4.6	1.3	0.0	0.3	1.2	3.6	0.9	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	9.0	0.2	0.0	0.8	0.2	0.1	3.1	0.1	0.0	0.5	0.0	0.4	5.7	0.9	0.5	0.1	0.1	0.2	0.8	0.0	0.0	5.7	0.6	0.1	0.9	2.5	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.3	0.1	0.3	0.8	0.1	0.0	0.1	0.1	2.2	2.8	0.8	4.2	2.1	0.5	3.5	1.5	2.0	2.2	1.2	4.6	4.4	4.6	1.5	1.8	0.4	0.3	0.2	1.3	7.9	12.2	7.2	11.7	9.2	6.2	5.8	5.2	5.5	6.8
PRKRA	"DYT16, HSD14, PACT, RAX"	ENSG00000180228	"Protein activator of interferon induced protein kinase EIF2AK2"	O75569	2	178431414-178451512	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	RNA-binding	"Disease mutation, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004648, HPA034996, HPA034997"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (8.33e-5)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.99e-2)"	"prognostic favourable (5.45e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.78e-2)"	15.7	14.5	18.3	11.3	20.3	13.0	31.2	17.1	30.9	15.7	18.7	16.9	10.8	11.0	18.0	19.4	16.6	13.9	13.1	22.2	17.4	17.5	18.0	14.5	13.7	12.1	18.3	17.2	14.9	19.8	17.4	21.5	8.7	18.8	17.4	14.8	13.2	13.8	18.1	55.3	18.2	10.9	33.1	20.2	9.4	15.2	23.5	15.7	13.8	16.7	14.8	14.1	18.5	17.7	19.4	29.2	13.5	13.9	13.5	20.1	16.4	10.8	8.3	24.6	12.0	22.7	26.0	19.3	16.8	16.3	21.1	23.1	23.1	15.6	22.2	19.0	19.1	10.2	19.2	13.2	23.6	19.8	12.5	13.6	10.0	22.0	26.4	10.7	7.6	15.0	30.4	19.8	22.2	20.0	12.5	19.0	28.5	11.3	21.0	27.5	22.3	16.8	18.5	41.2	22.4	23.7	12.4	15.4	19.3	10.9	10.6	21.7	14.8	14.0	11.6	17.7	20.1	16.1	13.9	26.2	16.3	27.0	20.5	16.4	10.4	3.1	13.9	13.5	11.0	13.5	15.9	19.4	17.2	13.4	19.9	15.3	19.5	15.9	3.7	13.5	13.2	29.2	20.1	16.4	18.3	20.3	17.1	30.9	17.4	17.5	18.3	17.2	18.8	15.7
PRKRIP1	"C114, FLJ13902, KRBOX3"	ENSG00000128563	"PRKR interacting protein 1"	Q9H875	7	102363872-102426676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051146	Uncertain		Supported	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA051146: "	"unprognostic (4.78e-3)"	"unprognostic (7.23e-3)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (8.25e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.79e-3)"	"prognostic unfavourable (4.39e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.88e-1)"	"prognostic favourable (1.94e-4)"	14.9	19.3	20.1	21.1	22.6	31.0	15.2	28.0	23.0	15.9	14.0	19.2	24.2	14.9	17.6	20.4	15.0	16.2	13.9	16.5	19.0	21.2	16.7	12.3	14.6	22.4	19.1	20.3	18.9	17.0	26.6	18.9	18.1	17.9	17.7	11.6	17.1	21.5	17.8	20.7	27.0	14.5	16.6	20.1	19.1	14.6	43.7	19.0	15.8	16.8	12.4	19.6	14.1	14.4	15.3	18.5	21.7	15.7	14.7	15.1	10.7	12.5	8.7	10.8	13.7	6.4	5.6	10.4	9.6	8.1	14.4	13.6	12.0	12.3	11.7	16.5	7.7	11.0	6.9	8.4	9.2	13.4	12.7	5.8	9.6	8.8	9.8	8.8	7.9	5.3	8.9	11.6	8.5	8.1	13.8	26.8	11.1	26.1	22.6	27.3	10.8	8.9	15.0	8.9	18.8	7.8	8.6	8.8	17.5	15.2	21.1	12.9	10.1	11.2	9.1	16.5	16.1	18.6	12.4	23.3	19.1	22.4	12.3	14.0	19.9	5.3	12.7	20.1	13.8	12.4	13.0	15.3	13.1	14.2	8.1	15.1	15.1	14.1	21.7	14.7	15.7	18.5	13.4	10.7	20.1	22.6	28.0	20.8	19.0	21.2	19.1	20.3	17.9	19.0
PRKX	PKX1	ENSG00000183943	"Protein kinase, X-linked"	P51817	X	3604370-3713608	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015324	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	4.3	1.3	12.3	7.5	15.8	5.4	11.2	4.4	12.3	6.9	5.2	5.4	11.5	4.1	7.3	8.4	13.6	16.5	3.9	4.0	14.0	7.4	14.2	2.0	8.4	9.5	27.9	5.6	4.8	4.1	3.2	2.3	6.6	22.7	3.7	5.2	3.1	6.5	5.3	1.6	9.9	6.0	3.0	17.6	10.0	3.1	6.1	22.7	6.1	28.8	3.2	8.0	3.7	11.2	2.5	2.8	12.2	4.1	3.3	3.8	1.7	4.5	4.2	11.6	8.6	2.2	3.0	10.6	2.7	1.0	1.3	1.8	6.2	3.1	0.4	2.7	2.1	3.1	10.8	8.1	2.3	5.0	7.5	5.0	3.2	0.1	2.3	6.4	38.9	2.0	8.7	1.4	5.4	13.1	5.8	6.5	4.4	3.9	7.3	5.8	7.7	4.8	13.7	11.1	8.5	10.7	3.8	7.8	5.0	2.8	1.8	2.7	1.4	5.1	7.1	1.2	2.0	1.9	1.8	0.1	0.3	5.8	0.7	5.8	3.0	12.2	3.1	1.8	3.5	3.3	3.8	2.5	3.7	3.3	2.3	2.4	3.1	3.3	0.8	3.3	4.1	2.8	2.5	1.7	12.3	15.8	4.4	12.3	14.0	7.4	27.9	5.6	22.7	22.7
PRMT1	"ANM1, HCP1, HRMT1L2"	ENSG00000126457	"Protein arginine methyltransferase 1"	Q99873	19	49675786-49689029	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022550, HPA069769, HPA072136"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB022550: , HPA069769: , HPA072136: "	"unprognostic (1.88e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (8.04e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.10e-2)"	21.3	31.5	27.4	28.1	29.7	21.8	22.0	29.4	35.9	31.8	25.5	26.9	27.8	21.4	36.0	22.5	28.9	45.4	24.5	56.4	25.2	28.6	23.4	20.8	22.0	34.9	32.0	23.8	43.4	35.0	20.0	31.7	27.9	25.6	33.3	18.4	34.1	20.9	31.5	83.8	21.9	19.8	38.3	20.9	33.3	20.3	24.9	28.0	25.0	32.9	31.3	32.0	29.8	23.8	51.9	41.2	9.2	23.6	38.7	35.5	31.8	37.9	86.9	60.3	72.7	16.4	18.6	31.8	24.4	42.7	70.6	60.8	64.8	30.3	62.5	18.2	28.6	28.1	50.8	51.6	30.9	48.5	87.2	45.6	23.9	70.3	40.1	54.8	32.8	26.0	25.7	39.5	56.9	41.7	47.9	44.4	27.4	57.4	70.7	67.8	63.6	56.6	50.3	48.7	57.0	39.7	80.2	67.3	52.4	28.1	29.2	14.9	22.1	32.3	25.9	41.6	40.4	19.0	58.1	42.8	64.4	61.7	25.5	39.7	43.5	5.8	20.2	9.2	28.6	23.6	35.5	51.9	26.6	30.5	34.2	41.9	29.9	29.1	3.9	38.7	17.1	41.2	24.2	31.8	27.4	29.7	29.4	35.9	25.2	28.6	32.0	23.8	25.6	28.0
PRMT2	"HRMT1L1, MGC111373"	ENSG00000160310	"Protein arginine methyltransferase 2"	P55345	21	46635167-46665124	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018976, HPA029591"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA018976: AB_1855719, HPA029591: AB_10601250"	"unprognostic (1.82e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.76e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.23e-1)"	19.9	14.7	37.1	21.8	43.6	18.7	28.4	21.4	37.2	25.5	25.2	35.4	12.0	14.7	24.5	15.9	30.7	27.1	23.4	29.4	37.4	53.1	19.9	8.5	21.7	28.7	44.8	32.2	48.5	15.1	19.9	20.1	26.2	44.9	22.0	17.1	20.6	21.0	28.0	9.5	28.1	20.0	28.5	69.6	25.6	17.4	10.1	40.3	13.8	20.1	7.4	28.3	23.1	26.0	18.9	27.6	64.2	26.1	50.8	60.2	41.6	22.7	19.5	39.5	14.7	28.8	28.2	9.7	21.5	24.2	24.4	22.3	27.4	18.6	13.4	27.3	38.3	6.7	18.4	27.1	14.2	33.4	17.7	34.7	16.5	20.4	13.9	10.3	16.5	17.4	27.0	29.6	21.2	35.2	22.0	25.2	37.3	25.4	14.8	19.4	21.6	23.0	19.1	10.0	8.8	19.0	19.5	28.6	17.8	22.7	10.4	41.0	14.0	10.7	31.8	23.9	16.4	12.6	14.1	6.7	6.1	8.5	21.9	28.1	34.4	44.2	19.6	64.2	60.2	26.0	43.6	18.9	40.5	51.0	27.6	16.7	49.9	56.9	26.3	50.8	26.1	23.8	29.0	41.6	37.1	43.6	21.4	37.2	37.4	53.1	44.8	32.2	44.9	40.3
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920511-22929585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: "	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavourable (1.82e-4)"	"prognostic unfavourable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (1.04e-4)"	17.0	21.6	18.3	17.8	22.8	12.0	21.2	18.4	24.9	20.3	25.0	18.1	24.9	16.1	24.9	19.6	33.1	28.0	16.6	22.3	15.3	13.2	25.7	22.2	15.8	15.6	17.2	15.2	30.2	30.9	30.8	17.4	24.3	15.9	21.1	22.6	16.9	19.0	21.7	42.0	21.7	14.5	22.2	13.4	17.9	19.5	22.1	17.3	22.7	30.9	19.6	22.1	20.8	22.0	17.6	23.8	4.3	17.6	9.8	15.6	15.5	40.0	38.7	28.0	27.7	13.3	15.2	30.5	27.6	20.5	42.9	36.4	35.4	37.3	39.1	22.6	20.3	32.0	55.4	46.4	49.6	25.1	26.8	24.3	26.1	54.4	25.6	51.0	21.2	15.0	24.8	33.2	60.6	20.3	34.4	21.4	22.1	36.2	36.4	22.8	25.0	49.0	43.1	34.0	28.4	20.8	27.5	30.2	19.8	30.1	32.4	14.1	21.8	19.3	19.0	18.2	26.0	25.9	35.1	29.4	62.6	52.0	11.5	24.8	28.4	1.7	16.8	0.2	8.2	17.6	13.4	17.6	11.3	13.5	23.8	15.5	15.6	12.5	4.3	9.8	13.2	14.1	9.4	15.5	18.3	22.8	18.4	24.9	15.3	13.2	17.2	15.2	15.9	17.3
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056679-107059294	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059424: "	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	6.6	16.1	14.4	10.5	13.4	4.6	10.8	12.6	13.9	8.9	10.3	11.5	10.4	8.1	9.7	11.3	10.9	12.2	9.8	5.0	11.8	16.2	16.7	16.3	5.9	11.5	12.2	14.1	12.3	16.8	15.0	13.8	9.6	13.2	11.8	9.7	12.6	8.3	11.4	2.1	7.6	9.3	8.0	13.6	11.5	9.5	9.4	10.6	18.2	9.5	3.4	11.1	10.1	7.3	9.7	14.7	1.8	10.1	14.6	10.9	7.6	3.5	0.0	7.1	3.1	4.7	5.2	1.9	4.8	3.6	4.7	4.8	4.6	2.5	8.8	6.7	4.4	5.1	6.5	7.1	3.7	0.0	6.9	5.3	10.0	6.6	4.7	10.9	3.3	4.9	3.9	4.2	4.3	4.0	7.1	1.3	4.2	81.7	6.4	3.8	3.0	6.7	8.1	15.5	3.3	11.3	7.3	13.3	16.2	6.5	9.5	3.1	6.6	8.2	4.6	3.5	7.1	7.2	7.1	1.5	1.0	1.5	5.1	5.1	2.8	1.8	8.9	1.6	7.5	10.1	8.4	6.9	7.6	6.8	11.9	9.7	10.9	10.9	0.5	14.6	9.2	14.7	7.8	7.6	14.4	13.4	12.6	13.9	11.8	16.2	12.2	14.1	13.2	10.6
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358563	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: "	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favourable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	14.8	14.4	15.6	12.7	22.0	11.1	12.9	29.4	20.5	11.4	11.7	20.2	13.9	7.0	18.9	11.9	12.7	18.1	9.3	23.1	14.4	13.1	9.5	12.2	9.7	17.0	11.2	18.7	21.9	14.8	12.0	14.0	11.4	13.3	12.8	7.6	20.8	17.3	16.2	34.0	16.9	9.9	18.5	11.6	12.4	9.9	17.0	13.1	24.4	11.1	12.0	14.9	13.3	10.4	10.8	26.2	9.9	8.5	18.6	18.1	11.5	10.1	16.5	7.8	19.7	7.5	7.1	26.3	10.2	5.5	12.9	10.7	41.6	10.2	21.6	17.1	8.6	13.2	11.1	10.3	7.1	7.7	16.7	6.4	18.5	18.8	5.5	11.8	10.0	7.8	4.4	10.6	10.0	7.7	15.1	1.2	7.0	17.0	14.5	18.2	12.9	11.2	19.5	11.5	14.6	6.0	9.3	10.8	8.4	34.0	8.6	6.9	14.3	11.7	9.2	9.2	8.1	10.9	9.0	6.6	12.3	22.1	11.6	12.6	9.4	9.9	7.0	5.9	15.8	8.5	18.1	10.1	10.6	13.9	10.2	10.8	16.1	14.1	0.8	18.6	7.7	26.2	11.7	11.5	15.6	22.0	29.4	20.5	14.4	13.1	11.2	18.7	13.3	13.1
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041502	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 72.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 15.7;RH-30: 8.3;SH-SY5Y: 40.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000842, HPA001030"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000842: , HPA001030: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	2.3	9.6	3.7	2.1	8.1	1.0	2.9	14.0	5.8	1.8	3.0	13.1	0.3	2.7	1.9	2.0	1.5	3.0	2.6	13.1	6.2	4.1	5.4	72.4	2.0	13.5	8.4	4.3	7.3	13.9	1.0	11.4	1.3	5.5	1.4	3.2	2.4	1.1	1.3	4.1	1.5	3.1	1.7	9.6	14.9	2.8	5.9	9.2	0.0	7.5	0.6	1.5	1.6	2.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.3	0.0	15.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.8	2.7	0.0	0.2	0.0	0.2	0.0	0.8	0.7	0.0	8.3	1.2	0.1	0.2	1.2	40.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	8.1	14.0	5.8	6.2	4.1	8.4	4.3	5.5	9.2
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890730-60906588	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	20.5	32.2	33.6	27.0	37.9	32.0	28.9	49.6	61.8	30.4	30.6	21.3	24.5	24.2	27.1	21.4	36.7	34.9	20.1	18.0	32.8	46.3	21.5	39.4	18.0	33.1	35.0	50.0	41.3	31.3	45.7	37.6	24.9	46.2	37.7	31.5	21.5	28.8	30.9	31.9	39.0	24.6	28.8	23.7	28.3	23.7	15.2	24.4	46.3	25.3	24.4	41.7	24.8	24.8	3.1	5.3	4.4	11.8	2.4	3.3	1.2	43.8	34.3	38.6	27.5	22.6	19.9	35.0	23.9	32.5	48.1	36.2	37.7	33.2	63.6	32.2	22.9	40.3	54.2	43.1	37.4	43.3	34.6	52.9	27.2	40.4	32.8	69.9	37.8	21.1	32.8	36.9	41.6	37.3	52.5	36.8	23.5	61.8	70.5	52.6	68.2	46.3	62.7	39.5	49.8	24.3	28.8	32.9	39.6	29.6	49.3	39.8	51.5	38.7	23.3	21.3	34.3	37.1	38.6	32.9	46.0	64.0	26.5	48.0	32.0	4.4	11.8	2.6	3.2	5.4	2.6	1.3	2.6	2.3	4.8	3.1	3.3	3.0	0.7	2.4	2.9	5.3	2.2	1.2	33.6	37.9	49.6	61.8	32.8	46.3	35.0	50.0	46.2	24.4
PRPF3	"hPrp3, Prp3, RP18, SNRNP90"	ENSG00000117360	"Pre-mRNA processing factor 3"	O43395	1	150321476-150353195	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027226, HPA067116"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027226: AB_1855770, HPA067116: "	"unprognostic (2.75e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.59e-5)"	"unprognostic (7.89e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.78e-3)"	21.9	18.6	22.1	28.6	24.0	38.4	23.3	37.8	27.5	21.2	20.0	25.6	27.8	16.7	35.7	27.9	18.6	21.5	17.4	17.3	18.9	12.3	17.6	19.7	20.9	26.2	19.6	19.5	32.7	17.4	22.5	41.9	23.5	17.0	22.0	20.3	27.7	18.9	23.2	19.2	21.6	20.1	22.5	23.6	26.8	16.2	18.9	24.0	27.6	27.7	18.1	27.3	20.7	20.9	13.2	9.3	12.4	19.1	9.9	15.6	7.7	16.5	17.9	18.2	11.6	12.3	13.3	24.8	17.3	12.1	26.8	18.6	13.7	15.5	21.9	11.6	14.1	19.6	32.9	12.1	24.2	10.9	15.2	18.9	26.0	13.0	12.2	23.2	12.2	9.7	16.9	22.8	19.8	16.2	22.4	13.3	19.0	24.6	19.0	20.2	26.1	16.2	27.7	14.8	14.4	11.0	10.0	15.7	13.9	14.5	17.0	13.1	20.3	55.9	12.9	16.9	13.0	14.2	28.4	12.8	22.8	24.6	11.2	21.0	17.5	6.9	8.6	12.4	15.6	11.4	15.0	13.2	11.3	10.1	9.3	10.2	11.7	12.1	5.2	9.9	19.1	7.5	8.5	7.7	22.1	24.0	37.8	27.5	18.9	12.3	19.6	19.5	17.0	24.0
PRPF31	"hPrp31, NY-BR-99, PRP31, RP11, SNRNP61"	ENSG00000105618	"Pre-mRNA processing factor 31"	Q8WWY3	19	54115410-54131719	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041939, HPA061873"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA041939: AB_10793938, HPA061873: "	"unprognostic (1.32e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (9.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.04e-2)"	22.8	24.5	23.8	26.3	25.8	24.2	22.1	29.0	33.2	22.2	24.4	24.1	29.5	24.0	33.1	23.3	25.1	26.9	25.9	23.3	23.3	20.3	22.5	27.2	21.0	30.1	24.8	31.6	27.3	21.1	34.2	22.2	24.1	22.0	23.4	18.6	22.9	39.9	27.1	50.0	24.7	21.8	25.9	23.3	26.2	22.9	26.0	22.7	25.8	25.8	25.4	25.4	24.5	26.8	16.2	18.6	10.1	18.2	17.9	21.2	15.9	18.7	30.9	12.7	18.6	8.4	8.1	11.6	16.2	11.7	16.5	15.4	15.5	13.3	20.7	12.1	10.6	9.4	17.4	16.5	12.6	18.4	50.0	16.8	23.6	18.1	9.2	31.6	13.7	10.5	7.9	13.3	11.4	16.9	20.9	9.5	10.5	14.6	21.0	8.8	11.4	34.4	18.7	18.7	15.9	11.0	24.6	14.4	16.2	22.6	17.1	8.6	10.9	13.1	19.0	21.3	17.1	10.3	24.3	12.6	22.1	23.3	16.4	17.3	13.1	7.4	15.2	10.1	18.0	18.2	18.9	16.2	17.3	18.9	18.6	16.0	15.3	15.3	3.3	17.9	15.8	15.7	21.2	15.9	23.8	25.8	29.0	33.2	23.3	20.3	24.8	31.6	22.0	22.7
PRPF38A	"FLJ14936, Prp38"	ENSG00000134748	"Pre-mRNA processing factor 38A"	Q8NAV1	1	52404564-52420839	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053099, HPA058407"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA053099: , HPA058407: "	"unprognostic (1.29e-1)"	"unprognostic (6.12e-2)"	"prognostic favourable (7.16e-4)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (3.83e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.69e-2)"	"prognostic unfavourable (7.41e-5)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.82e-1)"	13.5	13.2	21.5	16.9	19.2	25.4	20.6	30.5	18.5	17.3	17.2	20.7	12.9	12.9	22.1	16.0	15.0	18.0	11.3	11.5	19.1	16.8	15.4	12.1	15.1	22.1	20.3	14.0	28.1	12.6	19.2	19.9	15.9	16.6	17.6	19.1	17.2	13.4	15.1	10.0	17.4	16.2	14.5	19.3	17.8	12.9	18.8	22.1	36.4	19.3	13.7	22.1	14.1	20.1	9.1	9.7	12.5	8.8	13.3	15.3	6.6	8.1	4.0	14.4	6.9	5.7	5.7	8.6	5.6	3.8	9.3	9.0	7.3	4.1	17.0	5.9	3.8	6.1	20.4	6.1	12.2	9.2	15.6	22.7	15.1	7.6	7.1	25.3	8.4	4.3	5.4	10.2	9.8	7.8	20.8	4.4	5.5	4.6	19.5	15.2	17.7	9.5	19.2	21.8	14.2	8.2	4.9	9.6	11.7	11.4	9.4	11.0	6.5	20.5	6.1	5.3	8.0	7.9	11.0	8.5	12.1	17.1	7.8	22.1	6.7	12.5	7.5	10.5	9.8	8.8	13.3	9.1	11.0	11.8	9.7	8.5	15.3	11.6	6.0	13.3	8.6	5.4	10.7	6.6	21.5	19.2	30.5	18.5	19.1	16.8	20.3	14.0	16.6	22.1
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275343-113292905	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	16.4	20.9	13.8	23.8	17.4	18.4	21.7	19.4	23.2	15.2	15.7	14.4	20.0	13.4	18.9	28.6	22.9	17.8	17.6	16.8	15.3	13.9	21.5	24.3	15.2	19.6	12.4	19.2	24.3	22.7	19.1	19.6	17.2	19.0	20.6	17.6	13.9	16.8	19.7	26.1	21.8	14.7	21.1	14.4	18.7	15.9	16.6	12.6	21.8	16.5	18.2	23.1	18.0	24.6	16.5	19.9	18.1	21.7	17.0	17.9	13.7	12.8	22.1	14.7	16.2	10.4	10.8	15.0	20.2	10.1	22.3	16.4	21.5	12.0	26.8	11.9	10.9	29.7	30.8	17.7	25.2	19.0	11.6	13.6	19.3	15.7	9.5	23.9	12.5	7.8	12.2	23.2	22.5	10.6	23.3	14.9	19.0	20.0	22.3	17.1	23.4	24.3	20.8	35.3	18.4	9.7	10.5	19.4	13.1	29.5	16.0	9.3	25.0	12.5	10.4	18.2	13.8	23.4	25.6	19.2	51.9	26.3	14.0	15.4	23.3	18.1	15.8	15.1	15.2	19.3	17.9	16.5	15.2	13.8	19.9	16.4	15.5	15.3	5.3	17.0	21.7	13.1	13.6	13.7	13.8	17.4	19.4	23.2	15.3	13.9	12.4	19.2	19.0	12.6
PRPF40A	"FBP-11, FBP11, FLAF1, FLJ20585, FNBP3, HIP10, HYPA, NY-REN-6, Prp40"	ENSG00000196504	"Pre-mRNA processing factor 40 homolog A"	O75400	2	152651593-152717997	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038272, HPA038273"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA038272: , HPA038273: AB_10671526"	"unprognostic (1.81e-1)"	"unprognostic (2.91e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (1.58e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.05e-2)"	22.8	21.5	18.8	25.6	21.7	36.6	22.3	30.0	21.3	23.2	24.8	13.0	19.0	22.2	25.1	20.6	28.8	20.3	17.1	16.8	21.1	14.3	26.0	31.1	21.8	27.0	25.2	15.6	24.5	21.1	25.3	30.8	28.4	21.4	23.0	20.7	11.5	23.4	23.3	32.7	25.4	27.0	18.6	24.4	30.5	21.3	25.7	28.7	48.6	24.7	25.7	26.0	24.6	22.8	41.3	50.9	53.3	55.6	39.5	43.4	40.5	21.0	21.0	23.7	24.1	13.8	18.5	33.1	20.9	18.6	29.6	27.4	39.3	19.9	44.1	30.9	21.0	21.6	30.9	25.0	32.1	24.2	26.0	40.4	19.4	26.2	17.9	44.4	28.3	14.7	21.5	39.5	45.0	22.8	43.1	20.8	18.2	12.6	18.8	20.3	35.4	25.3	36.5	25.1	28.7	15.1	33.9	29.5	19.6	25.0	18.4	23.0	16.2	27.9	26.8	31.7	19.8	17.9	26.8	13.6	21.7	44.5	20.1	26.2	19.1	45.0	42.2	53.3	43.1	51.7	39.5	39.9	40.1	38.6	47.7	41.3	43.4	38.5	37.8	39.5	55.6	50.9	34.4	40.5	18.8	21.7	30.0	21.3	21.1	14.3	25.2	15.6	21.4	28.7
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favourable (6.82e-5)"	23.2	21.6	19.6	24.0	20.5	8.5	21.4	35.6	26.8	18.3	19.3	6.0	14.7	12.0	22.2	14.2	23.6	14.7	13.6	16.3	16.5	11.7	15.0	14.5	13.0	15.4	14.5	14.1	19.1	14.4	20.9	30.9	17.1	21.0	14.9	15.7	5.3	22.7	20.4	45.7	16.3	16.4	14.9	23.7	19.0	13.6	11.6	20.2	21.8	21.1	11.3	17.4	21.4	22.2	9.7	13.6	7.5	11.9	11.8	9.1	3.9	14.4	12.6	19.8	13.6	11.3	10.5	9.6	14.1	15.5	15.4	15.5	12.0	7.3	23.8	17.8	15.8	13.0	25.0	12.2	22.1	11.1	18.3	26.7	14.4	10.7	8.7	29.4	14.6	9.6	8.1	10.9	6.8	15.3	36.5	8.8	15.0	8.5	21.6	9.9	11.9	11.7	24.5	19.2	23.0	9.8	16.4	15.4	10.1	16.3	10.2	12.4	15.9	14.8	16.3	15.1	8.7	9.9	13.6	10.0	15.6	27.7	8.3	13.5	18.4	7.5	11.9	3.6	7.6	9.9	9.1	9.7	8.6	9.0	10.2	9.3	8.0	8.0	6.1	11.8	8.7	13.6	6.3	3.9	19.6	20.5	35.6	26.8	16.5	11.7	14.5	14.1	21.0	20.2
PRPF6	"ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K"	ENSG00000101161	"Pre-mRNA processing factor 6"	O94906	20	63981135-64033100	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047106	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA047106: AB_10963084"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.16e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.39e-3)"	31.5	26.3	28.3	25.0	35.2	25.0	31.4	66.3	46.7	30.1	26.9	43.7	20.8	25.9	37.0	28.9	29.3	44.6	30.3	28.8	26.8	27.6	25.7	25.8	27.9	31.6	28.7	31.0	46.5	33.7	40.5	30.8	29.8	30.1	29.5	23.3	32.3	33.0	34.5	49.3	49.1	27.7	34.2	31.4	32.7	27.6	41.5	30.5	43.8	31.2	28.4	34.4	31.6	27.1	30.1	25.0	31.9	30.4	51.7	44.3	33.8	20.0	24.5	18.0	19.0	20.6	14.5	23.7	15.9	18.0	48.9	21.9	65.5	24.6	25.3	38.9	21.0	31.3	29.0	33.0	26.1	12.1	16.8	21.4	32.7	59.1	22.8	28.9	29.8	16.4	23.6	22.5	26.1	18.1	20.8	22.1	16.2	24.7	29.1	36.2	16.0	30.6	32.2	15.4	24.3	18.6	20.3	18.0	21.1	30.8	31.7	20.2	31.1	37.8	25.5	28.2	16.2	22.4	29.2	18.5	18.0	26.8	20.6	17.5	21.8	31.9	25.3	30.1	30.1	26.7	42.1	30.1	37.3	32.4	25.0	26.3	44.3	36.9	21.5	51.7	30.4	23.2	32.7	33.8	28.3	35.2	66.3	46.7	26.8	27.6	28.7	31.0	30.1	30.5
PRPF8	"hPrp8, Prp8, PRPC8, RP13, SNRNP220"	ENSG00000174231	"Pre-mRNA processing factor 8"	Q6P2Q9	17	1650629-1684882	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009941, CAB015457"	Supported		Enhanced	Nucleoplasm			240000	Nucleoplasm		"CAB009941: AB_2171185, CAB015457: AB_831685"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	30.0	37.4	23.1	25.7	40.3	39.0	26.2	43.1	57.2	31.2	28.0	36.5	29.5	19.4	35.6	28.4	29.4	35.4	28.1	34.0	22.2	24.3	23.3	35.5	27.9	30.7	21.3	23.9	47.7	25.9	66.5	45.4	31.1	32.5	30.7	27.2	45.1	30.5	33.1	46.3	30.7	27.5	36.3	17.9	34.1	26.4	45.9	19.6	63.4	30.9	22.2	41.2	32.2	27.9	14.5	20.1	10.0	12.3	10.1	17.1	5.4	18.4	40.2	24.2	19.6	21.0	16.4	19.5	13.8	17.7	27.1	21.9	37.3	9.1	27.1	14.7	24.8	25.7	59.1	23.7	31.3	17.1	37.9	21.5	34.9	31.8	12.3	25.4	23.9	15.6	15.2	34.9	24.4	23.8	21.2	21.6	19.4	20.1	18.3	31.8	16.7	14.9	36.0	13.8	13.0	10.4	20.5	12.4	18.7	27.8	10.1	13.6	14.9	17.0	21.9	16.5	14.2	25.2	31.5	7.9	8.1	19.1	13.7	18.4	20.4	10.0	6.5	6.7	15.7	8.9	17.1	13.3	14.7	15.7	9.7	14.5	13.0	16.4	7.1	10.1	12.3	20.1	14.8	5.4	23.1	40.3	43.1	57.2	22.2	24.3	21.3	23.9	32.5	19.6
PRR13	"DKFZP564J157, FLJ23818"	ENSG00000205352	"Proline rich 13"	Q9NZ81	12	53441605-53446645	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 190.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA039396, HPA046219"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA039396: , HPA046219: AB_10963936"	"unprognostic (1.09e-1)"	"prognostic favourable (9.08e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"prognostic favourable (7.55e-4)"	31.9	48.0	29.7	38.3	36.4	64.0	29.3	19.5	38.3	23.8	81.1	27.0	26.6	117.5	24.2	34.4	31.2	35.0	40.1	31.1	30.9	30.1	88.2	51.4	35.5	49.3	34.3	39.2	30.2	29.3	16.1	26.5	32.5	31.3	30.0	70.6	27.1	26.1	44.9	33.3	22.9	110.7	24.5	32.5	53.6	51.9	15.7	28.7	41.6	34.3	21.6	45.6	35.8	25.3	79.6	60.1	190.5	86.5	50.8	72.9	117.1	24.8	50.2	12.4	13.8	21.4	27.4	27.3	20.8	30.5	26.7	26.2	90.8	58.6	39.1	71.1	30.2	22.5	25.3	32.9	32.9	37.8	18.8	57.0	27.7	42.6	52.8	85.0	78.6	36.2	33.3	50.0	34.5	28.5	49.0	39.3	42.0	67.4	47.5	83.5	20.5	34.0	42.2	10.6	41.6	59.5	43.2	11.2	8.3	30.9	44.3	37.2	62.4	66.0	29.4	18.1	17.9	32.4	20.4	29.3	35.5	57.4	24.4	51.5	34.1	63.6	75.8	142.7	50.7	84.6	49.4	79.6	56.9	53.8	60.1	70.8	53.5	57.5	190.5	50.8	86.5	49.7	72.9	117.1	29.7	36.4	19.5	38.3	30.9	30.1	34.3	39.2	31.3	28.7
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620720-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 25.9;HEK 293: 47.2;U-266/70: 24.3;U-266/84: 25.8;U-698: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: , HPA066501: "	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	10.9	18.4	20.7	28.9	22.1	5.0	12.2	25.2	29.1	15.0	24.6	18.4	11.9	4.8	19.7	51.5	47.2	32.3	13.8	24.2	18.4	13.2	16.0	10.2	41.7	14.9	14.3	20.4	29.3	12.2	4.8	18.5	8.6	15.9	30.9	7.1	15.0	12.3	15.9	35.1	28.8	23.0	12.8	11.5	43.5	34.6	46.3	16.7	27.1	16.8	10.4	14.4	16.0	13.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	11.7	11.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.4	13.1	0.0	0.0	25.9	0.0	0.0	47.2	0.1	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	24.3	25.8	24.6	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	22.1	25.2	29.1	18.4	13.2	14.3	20.4	15.9	16.7
PRRC2C	"BAT2D1, BAT2L2, KIAA1096, XTP2"	ENSG00000117523	"Proline rich coiled-coil 2C"	Q9Y520	1	171485551-171593511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025766, HPA028659"	Approved		Enhanced	Cytosol				Cytosol		"HPA025766: AB_1845277, HPA028659: AB_10600786"	"unprognostic (4.16e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.66e-3)"	"unprognostic (8.71e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (7.76e-6)"	"unprognostic (7.03e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.34e-2)"	33.1	21.2	32.9	40.1	35.7	61.2	32.6	44.3	37.0	35.1	26.0	19.8	41.4	21.2	32.9	38.8	37.3	28.5	26.3	23.5	27.4	25.4	25.5	30.2	35.2	39.8	33.8	30.2	37.3	29.6	47.2	43.7	35.9	30.6	28.7	32.4	18.2	31.4	53.9	24.5	38.5	33.2	32.9	36.7	37.3	27.6	27.3	36.9	45.3	29.5	30.3	41.1	35.3	33.8	4.8	4.4	7.5	2.9	5.8	3.0	1.0	26.5	20.6	29.0	19.0	20.5	24.0	21.5	15.4	22.0	18.1	16.6	31.5	19.1	39.2	24.3	22.5	23.9	31.3	24.5	27.9	22.0	16.7	29.8	15.9	21.9	21.4	48.2	24.4	23.1	18.9	30.5	45.8	26.2	39.3	21.7	20.5	12.7	28.8	20.5	38.2	36.0	21.8	21.6	19.2	25.6	29.9	18.7	19.3	23.4	28.0	17.8	19.0	34.0	32.6	20.6	19.0	19.9	31.9	18.3	19.5	57.7	13.1	23.9	18.4	3.4	2.9	1.5	2.9	2.7	3.0	3.7	2.8	2.8	1.2	4.8	2.6	3.0	7.5	5.8	2.8	4.4	2.1	1.0	32.9	35.7	44.3	37.0	27.4	25.4	33.8	30.2	30.6	36.9
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;REH: 15.2;U-138 MG: 13.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 7.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 7.3"									"HPA014447, HPA019203"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	3.7	7.2	27.2	2.8	40.5	0.8	2.1	86.7	53.6	10.1	6.0	6.0	3.1	6.2	20.7	8.3	4.4	10.2	10.3	5.3	18.9	13.0	2.1	0.9	5.7	3.5	5.5	33.2	35.7	2.4	8.6	17.6	7.1	18.0	16.2	2.6	5.2	4.6	14.4	4.3	3.1	6.8	10.3	7.4	1.8	7.3	9.9	10.2	0.0	2.8	0.3	1.6	5.1	10.7	0.2	0.0	0.5	0.2	7.3	0.6	0.3	0.3	1.2	19.9	7.4	1.0	3.8	0.5	2.4	4.0	0.8	0.9	1.1	2.3	0.2	0.5	3.3	2.0	2.7	0.4	0.3	5.3	1.6	1.3	8.9	0.8	0.2	0.0	0.3	3.4	0.1	1.4	0.1	1.0	0.2	1.6	0.6	3.3	0.5	0.6	5.7	1.0	15.2	1.1	0.4	0.1	0.7	4.3	4.5	0.2	2.9	0.4	7.4	0.1	1.1	13.7	4.8	0.8	1.3	3.4	0.4	0.1	5.4	0.1	0.5	0.5	0.0	0.1	0.2	0.1	0.3	0.1	0.6	0.4	0.0	0.2	0.4	0.2	0.2	7.3	0.2	0.0	0.1	0.3	27.2	40.5	86.7	53.6	18.9	13.0	5.5	33.2	18.0	10.2
PRRX1	"PHOX1, PMX1"	ENSG00000116132	"Paired related homeobox 1"	P54821	1	170662728-170739419	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 72.3;ASC TERT1: 57.7;BJ hTERT+: 40.4;HSkMC: 29.4;U-138 MG: 28.3;U-2197: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051084, HPA063566"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA051084: , HPA063566: "	"unprognostic (2.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavourable (6.60e-10)"	"unprognostic (4.23e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.69e-3)"	44.8	4.4	5.2	7.2	6.3	0.0	21.0	4.0	9.2	58.5	4.1	6.7	10.6	0.4	31.4	19.4	10.8	17.9	14.5	19.5	6.8	4.5	1.8	0.7	10.4	13.0	6.1	5.3	27.6	1.9	3.4	3.1	2.7	7.7	17.3	2.5	17.4	18.4	34.1	58.6	11.9	2.2	23.0	6.6	1.0	2.3	17.6	6.8	5.0	21.7	28.7	14.9	19.4	31.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	72.3	57.7	0.0	20.5	40.4	2.9	2.9	0.0	0.0	0.0	0.0	16.8	0.0	3.5	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	29.4	0.0	14.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	28.3	0.5	27.0	3.1	0.0	0.0	0.0	14.9	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.2	6.3	4.0	3.9	6.8	4.5	6.1	5.3	7.7	6.8
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol			210000	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	9.3	9.7	9.3	8.8	11.6	3.7	16.0	15.7	16.4	15.0	12.5	10.9	16.2	11.7	17.9	15.7	11.5	15.6	12.8	31.3	10.5	10.3	18.0	12.8	10.1	11.8	11.9	9.2	17.1	16.2	16.5	16.2	7.2	8.8	12.2	14.0	12.7	13.3	18.2	24.4	10.5	11.8	14.7	7.9	11.0	10.5	16.3	8.6	15.0	41.6	8.5	12.9	13.8	13.6	12.1	9.5	14.7	8.9	14.3	19.0	18.3	3.8	4.1	7.4	7.1	9.2	2.5	4.1	1.8	4.0	6.9	6.0	5.1	4.6	7.9	8.0	2.4	5.6	7.2	4.8	5.5	8.6	8.2	9.3	4.3	7.2	5.1	6.1	4.7	3.1	9.2	3.6	3.6	3.2	7.3	6.7	3.2	9.3	9.3	5.0	6.9	5.4	8.5	4.7	7.6	4.9	5.3	10.7	8.7	6.2	8.6	5.7	11.9	9.3	2.2	2.4	2.9	2.7	2.9	16.4	13.8	61.0	2.4	4.7	6.1	12.5	6.4	13.4	14.0	6.0	16.9	12.1	15.5	15.7	9.5	11.6	19.0	15.0	14.7	14.3	8.9	5.1	14.5	18.3	9.3	11.6	15.7	16.4	10.5	10.3	11.9	9.2	8.8	8.6
PSAP	"GLBA, SAP1"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851375	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 296.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2"	"Group enriched"	"Detected in all"	12	"dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"		86000000	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	151.5	178.6	106.6	95.1	137.9	79.7	93.3	93.2	143.4	136.7	74.4	134.2	89.5	53.7	116.0	118.2	71.7	88.1	129.7	164.0	99.5	93.7	108.5	119.6	125.5	136.8	135.4	128.0	137.1	93.7	134.8	76.0	165.5	106.7	94.1	73.4	118.2	88.1	117.0	151.6	67.6	63.3	133.5	109.3	159.8	87.4	60.5	126.1	84.4	103.1	54.1	61.4	102.8	76.3	13.4	97.2	80.8	322.1	9.5	12.5	306.2	24.6	46.6	30.3	63.2	296.6	170.6	107.0	44.8	133.4	35.3	42.1	43.0	62.9	13.4	92.5	73.1	54.1	11.4	36.4	25.0	26.1	21.5	15.7	21.1	24.3	114.3	10.2	90.3	108.5	84.1	35.2	67.6	62.6	22.3	65.0	43.7	15.7	44.9	15.3	13.9	22.7	9.4	17.3	37.3	41.1	42.4	33.6	29.7	41.9	127.1	168.9	25.8	23.4	81.3	49.9	35.4	33.3	36.5	72.6	55.1	23.8	79.2	20.4	36.6	19.4	252.0	30.1	12.5	322.1	10.3	13.4	10.3	10.8	97.2	11.8	11.3	10.6	80.8	9.5	263.2	48.5	11.3	306.2	106.6	137.9	93.2	143.4	99.5	93.7	135.4	128.0	106.7	126.1
PSAPL1		ENSG00000178597	"Prosaposin like 1 (gene/pseudogene)"	Q6NUJ1	4	7430294-7434973	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skin 1: 42.2;stomach 1: 23.9;testis: 19.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;HaCaT: 3.8;hTCEpi: 4.8;RPMI-8226: 20.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA038013: AB_10673652, HPA038482: "		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	1.4	0.6	0.0	1.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297143-78330093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 56.0;liver: 112.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 148.4;SK-MEL-30: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol			1700000	Cytosol		"CAB014882: , CAB040567: , HPA042924: "	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	3.1	25.0	44.6	3.8	33.4	1.7	3.0	8.5	50.5	2.4	3.3	44.8	0.9	3.2	2.7	28.4	9.3	16.0	1.6	1.4	33.9	22.3	56.0	112.2	1.6	4.5	42.2	24.6	3.7	54.6	4.8	2.1	2.2	21.9	5.3	3.3	8.1	26.2	2.8	1.1	24.7	2.8	2.3	29.8	2.4	7.0	5.1	35.0	2.2	13.7	4.9	5.9	4.2	2.6	3.0	0.2	0.2	0.1	0.0	13.3	3.1	26.8	18.1	15.2	27.0	4.5	5.3	36.0	22.8	16.3	11.6	21.8	4.6	5.2	17.4	10.1	51.3	26.7	26.0	25.2	17.4	17.0	9.2	5.9	8.3	35.5	41.8	33.2	10.7	16.9	148.4	15.4	41.3	10.6	6.4	45.0	9.6	10.0	11.3	5.3	34.9	19.8	5.6	9.9	20.5	15.8	6.2	6.9	16.1	6.3	11.0	90.8	5.2	41.9	2.4	2.9	9.5	10.8	18.5	30.6	28.2	0.1	34.3	26.3	13.9	0.0	0.0	0.0	4.9	0.0	5.7	3.0	4.8	6.5	0.2	1.0	7.9	7.3	0.2	0.0	0.1	0.0	13.3	3.1	44.6	33.4	8.5	24.9	33.9	22.3	42.2	24.6	21.9	35.0
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682724	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.5;HeLa: 22.2;RT4: 31.8;SK-BR-3: 8.1"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA030783: , HPA056418: "	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	0.4	0.2	0.0	0.2	0.0	0.2	0.3	0.0	0.2	7.0	2.4	0.7	0.1	0.6	0.3	0.2	72.6	1.1	21.2	0.1	0.0	0.0	2.6	0.1	3.0	0.2	0.0	0.0	0.1	0.3	0.1	0.5	17.2	0.0	30.1	0.7	0.1	11.7	0.6	0.1	0.8	1.5	18.9	0.0	0.2	230.2	0.2	0.0	0.0	0.1	9.3	35.1	112.0	54.5	0.0	0.8	0.0	0.3	0.0	0.0	0.0	5.3	0.3	0.0	0.0	1.1	3.7	5.5	2.5	0.5	1.1	0.9	0.0	11.5	0.0	0.2	0.2	1.1	0.0	0.2	0.6	0.3	0.0	0.0	22.2	0.0	0.0	0.0	0.7	3.2	4.1	2.4	0.0	0.0	0.0	0.0	0.8	2.9	0.8	0.3	0.6	0.6	0.3	0.0	0.4	0.5	31.8	0.1	0.2	2.6	8.1	1.7	0.1	0.1	0.5	0.8	0.9	1.5	0.0	1.0	0.0	0.0	1.5	0.4	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
PSEN2	"AD3L, AD4, PS2, STM2"	ENSG00000143801	"Presenilin 2"	P49810	1	226870184-226896105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013634, HPA038005"			Supported	Nucleoplasm				Nucleoplasm		"CAB013634: , HPA038005: "	"unprognostic (3.40e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.53e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	8.9	13.2	9.5	5.9	7.9	1.2	8.1	16.6	10.7	9.2	9.2	5.9	7.3	9.4	16.4	9.0	9.4	8.7	12.0	9.7	6.5	10.8	7.8	7.7	9.0	11.6	8.1	9.3	13.1	31.6	14.0	15.2	7.6	14.8	12.8	6.9	15.9	9.6	13.4	22.1	6.8	12.2	17.0	4.9	10.6	7.1	21.8	5.3	1.4	6.0	7.2	7.0	9.0	7.2	5.1	7.7	19.4	18.7	12.3	3.4	3.1	8.9	13.4	4.0	12.4	5.5	1.8	6.7	7.6	14.9	9.5	7.3	10.5	11.5	0.1	10.3	9.7	4.6	7.1	7.2	3.9	9.6	12.9	6.1	9.5	6.8	9.2	4.7	10.0	5.3	8.1	11.4	6.2	4.4	10.4	4.1	5.5	7.5	0.1	5.4	12.3	11.1	0.1	14.7	14.4	8.4	7.6	7.0	11.7	6.1	16.9	30.2	14.5	6.0	4.8	6.8	5.7	6.2	9.5	16.4	24.1	0.4	12.0	1.5	8.9	19.4	5.7	12.1	3.2	6.5	3.4	5.1	1.1	2.9	7.7	2.6	0.6	1.7	1.2	12.3	18.7	0.6	1.4	3.1	9.5	7.9	16.6	10.7	6.5	10.8	8.1	9.3	14.8	5.3
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15511019	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	15.1	20.3	42.7	20.8	48.8	24.9	12.2	65.3	49.4	22.6	16.1	19.0	11.5	10.8	27.9	18.2	12.9	20.0	14.9	16.0	38.7	42.7	16.1	10.5	15.6	35.4	34.1	30.2	43.6	8.1	18.8	24.9	18.7	32.4	18.3	15.3	12.3	9.0	21.1	16.3	12.3	14.2	21.3	37.7	24.6	12.5	37.2	29.3	70.4	18.1	6.5	31.9	17.0	16.1	11.4	2.6	8.5	4.3	8.0	16.4	1.9	17.6	11.7	40.0	29.2	8.6	10.5	8.9	21.3	15.2	19.2	22.8	4.9	9.2	37.6	4.9	11.2	4.9	24.8	11.5	27.8	24.7	15.0	130.0	30.7	9.1	10.5	15.1	14.4	8.8	3.4	16.0	11.8	16.7	21.4	20.9	12.4	6.4	31.3	37.7	62.0	18.2	29.3	21.8	7.6	10.7	6.2	25.4	28.0	19.0	8.4	9.9	8.5	20.4	11.8	14.0	14.1	10.4	20.1	9.0	12.6	33.9	11.1	15.3	8.0	8.5	2.1	4.2	5.5	1.6	6.7	8.4	11.0	7.6	2.4	11.4	16.4	10.1	7.2	8.0	4.3	2.6	9.8	1.9	42.7	48.8	65.3	46.6	38.7	42.7	34.1	30.2	32.4	29.3
PSMA1	"HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30"	ENSG00000129084	"Proteasome subunit alpha 1"	P25786	11	14504874-14643635	"Enzymes, Predicted intracellular proteins"	Immunity	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB033765, HPA037646, HPA043891"	Supported		Enhanced	Nucleoplasm			27000000	Nucleoplasm		"CAB033765: AB_2253026, HPA037646: AB_10670386, HPA043891: AB_2678718"	"unprognostic (1.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.66e-3)"	"prognostic unfavourable (3.79e-5)"	"unprognostic (3.28e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.27e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (4.03e-11)"	"unprognostic (1.93e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.23e-2)"	46.6	46.3	33.7	36.0	40.2	45.7	39.0	28.3	42.7	33.4	35.5	23.1	37.4	37.3	42.1	43.1	43.7	33.0	32.2	55.4	31.7	34.1	47.8	61.0	38.8	42.3	32.0	32.4	34.0	35.6	28.2	39.4	55.2	36.9	35.6	42.4	32.9	34.9	37.1	86.6	35.3	42.7	39.0	26.7	45.8	37.3	31.6	25.9	53.0	45.5	62.8	42.2	41.5	31.7	24.2	55.4	20.9	42.3	30.5	35.7	45.2	66.1	46.8	39.2	46.9	39.1	39.4	32.7	39.1	51.5	59.7	49.1	40.5	83.6	57.9	43.4	41.3	49.9	44.7	48.5	56.6	56.2	66.4	36.1	31.1	47.8	51.4	59.8	47.2	38.2	28.9	32.4	67.8	58.4	67.6	48.8	53.0	43.9	54.4	45.0	32.7	69.8	36.9	58.1	35.9	51.9	46.9	32.4	20.4	41.7	46.8	34.9	27.9	36.6	46.1	39.1	36.8	68.4	47.8	21.4	57.2	51.8	57.8	47.7	49.9	20.9	42.3	11.0	24.3	31.1	32.3	24.2	28.3	27.2	55.4	20.6	25.7	25.0	9.4	30.5	29.4	31.3	35.7	45.2	33.7	40.2	28.3	42.7	31.7	34.1	32.0	32.4	36.9	25.9
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome subunit alpha 4"	P25789	15	78540405-78552419	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol			12000000	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: , HPA060613: "	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	41.2	38.8	24.9	36.7	25.8	33.4	33.0	25.3	37.5	32.4	38.0	17.9	23.7	39.4	35.3	32.5	49.9	27.1	24.4	37.7	29.8	27.6	55.7	76.3	37.4	45.1	25.5	26.9	31.2	24.4	20.2	25.9	55.4	33.8	35.3	41.3	19.1	26.0	25.0	60.3	26.3	49.1	36.6	28.1	45.5	31.5	36.5	21.4	61.6	42.6	75.0	44.8	41.3	28.3	29.4	61.9	31.4	75.6	37.7	40.0	61.4	40.1	58.2	50.4	44.4	31.8	30.1	39.5	37.8	30.4	46.6	50.0	60.5	58.7	87.7	55.9	34.8	55.0	101.6	41.0	45.1	35.9	70.8	73.6	43.6	48.7	51.6	74.8	45.5	24.3	25.7	39.2	39.1	50.2	78.9	34.4	38.0	57.8	50.4	70.2	47.4	34.2	43.9	66.7	29.4	47.2	70.4	44.5	32.5	60.6	44.3	46.1	40.9	61.6	39.9	34.8	46.5	38.3	64.3	31.5	74.2	82.7	32.6	112.5	38.3	18.8	47.4	31.4	27.8	75.6	28.5	29.4	29.2	29.0	61.9	22.9	23.3	28.3	21.7	37.7	69.7	35.3	40.0	61.4	24.9	25.8	25.3	37.5	29.8	27.6	25.5	26.9	33.8	21.4
PSMA5	ZETA	ENSG00000143106	"Proteasome subunit alpha 5"	P28066	1	109399031-109426427	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028392, HPA028398, HPA028441"	Approved		Supported	Cytosol			22000000	Cytosol		"HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003"	"unprognostic (3.82e-2)"	"unprognostic (3.09e-3)"	"prognostic favourable (1.45e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.05e-1)"	12.1	23.7	13.2	17.3	15.0	7.7	16.2	8.2	40.5	13.3	16.1	9.8	16.7	15.1	15.8	23.0	21.5	17.6	16.7	20.8	13.8	13.5	27.5	41.9	17.1	24.2	13.4	14.9	13.6	21.4	12.6	11.5	20.9	12.8	12.3	14.9	10.2	16.8	14.2	31.6	15.8	21.8	14.4	12.9	18.5	15.2	16.3	10.3	31.5	27.9	23.4	19.8	14.0	11.7	2.1	1.2	7.3	2.2	2.8	7.1	1.6	1.2	1.0	1.6	1.2	3.8	4.1	1.4	0.9	9.1	6.0	3.5	1.2	1.1	5.2	1.2	4.0	1.6	2.3	3.1	3.7	1.1	1.5	2.2	0.9	1.5	2.9	2.9	1.2	1.9	3.0	1.8	3.0	2.2	1.8	1.4	2.5	1.5	30.5	1.2	1.4	1.5	0.8	3.1	0.8	4.8	1.6	1.4	1.1	1.6	5.4	1.9	1.2	2.6	1.4	1.0	0.7	2.1	1.2	0.8	1.8	6.6	6.6	6.6	1.0	7.3	1.0	0.7	4.0	2.2	4.8	1.8	5.8	4.9	1.2	2.1	7.1	6.5	0.3	2.8	2.0	0.8	5.3	1.6	13.2	15.0	8.2	17.5	13.8	13.5	13.4	14.9	12.8	10.3
PSMA6	"IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27"	ENSG00000100902	"Proteasome subunit alpha 6"	P60900	14	35278633-35317493	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003049	Approved		Supported	Nucleoplasm			19000000	Nucleoplasm		"HPA003049: AB_1079703"	"unprognostic (9.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (3.27e-4)"	"unprognostic (1.29e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.08e-2)"	33.8	42.7	26.7	31.4	38.8	37.1	38.7	24.2	35.0	28.0	35.8	19.4	24.5	32.2	31.0	30.2	37.9	24.7	20.3	54.2	30.5	27.6	47.3	49.0	37.3	36.4	30.1	36.8	31.1	36.7	14.2	35.8	61.2	31.8	22.5	38.6	18.1	27.3	25.5	94.6	31.8	39.5	27.3	25.2	35.7	28.9	67.5	26.5	86.2	26.0	37.2	38.1	28.8	24.5	37.9	68.5	41.4	65.1	49.9	54.8	104.8	58.9	43.6	32.7	33.2	27.0	28.8	65.4	30.9	37.8	46.8	42.6	40.6	42.8	39.5	59.5	30.0	42.3	38.1	35.3	56.1	39.7	20.8	31.0	31.8	121.4	30.6	64.5	29.0	21.9	29.4	32.7	41.7	39.6	33.1	27.7	37.8	62.6	98.6	55.1	31.2	49.7	147.1	33.2	31.6	40.0	75.8	34.8	29.4	34.5	50.8	32.5	60.8	42.7	32.9	30.2	29.8	30.7	34.2	29.5	64.6	72.2	24.5	40.9	34.0	32.8	65.1	41.4	46.3	59.4	46.2	37.9	44.8	47.1	66.8	29.9	35.9	43.0	23.5	49.9	56.6	68.5	54.8	104.8	26.7	38.8	24.2	35.0	30.5	27.6	30.1	36.8	31.8	26.5
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome subunit beta 1"	P20618	6	170535117-170553341	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm			14000000	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	60.8	59.3	38.5	40.4	53.7	53.2	55.0	31.4	46.4	40.5	48.6	37.9	49.9	45.1	56.8	90.6	51.7	49.8	43.1	71.9	40.9	40.1	56.4	93.2	46.9	66.7	40.8	41.1	43.7	67.3	35.4	48.4	80.6	48.4	40.6	52.7	43.8	43.6	50.0	109.3	56.1	46.0	59.7	44.9	51.4	46.9	47.1	38.1	47.1	47.9	75.2	60.4	50.1	42.0	71.0	98.1	51.9	81.9	71.6	79.3	104.1	42.5	40.0	57.1	73.6	51.1	40.2	60.8	40.8	60.0	68.0	69.6	87.5	36.8	62.3	53.2	54.5	43.1	63.3	64.8	71.0	63.4	71.2	53.2	40.6	109.7	60.0	62.4	47.5	45.8	39.9	65.6	42.6	58.0	105.0	53.5	62.0	114.6	46.7	87.1	52.1	55.1	45.2	45.3	79.0	70.5	25.6	57.1	46.6	39.2	60.9	31.2	41.7	90.4	44.1	27.7	44.5	67.3	75.3	45.8	60.6	77.4	64.7	70.7	59.4	40.1	81.9	51.9	53.2	75.8	62.1	71.0	62.2	57.7	98.1	53.4	59.2	57.2	47.5	71.6	67.6	55.8	79.3	104.1	38.5	53.7	31.4	46.4	40.9	40.1	40.8	41.1	48.4	38.1
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome subunit beta 10"	P40306	16	67934502-67937087	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 117.3"	"Cell line enhanced"	"Detected in many"		"REH: 36.0;U-266/70: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA030224, HPA030225, CAB034384"	Enhanced		Supported	Vesicles,Cytosol			1400000	Cytosol	Vesicles	"CAB034384: AB_2171876, HPA030224: , HPA030225: AB_10603231"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-2)"	"prognostic favourable (5.44e-4)"	11.5	13.0	9.1	24.9	11.8	23.9	11.4	4.0	7.8	8.0	21.6	5.6	8.5	42.4	9.3	9.5	10.6	12.4	16.6	12.0	6.9	4.9	16.9	17.2	19.5	38.3	9.5	5.6	8.7	61.5	0.9	6.9	11.2	8.5	13.5	6.3	5.8	27.9	11.6	6.9	7.0	35.6	7.7	6.5	49.7	23.8	2.5	7.8	39.2	13.1	10.4	20.5	13.2	8.4	50.8	75.2	100.0	98.1	69.1	68.8	117.3	5.9	5.3	0.4	0.8	0.4	3.5	21.0	2.0	8.5	6.9	9.8	2.7	29.1	21.6	3.7	2.7	8.7	0.1	1.9	0.5	9.6	0.5	7.7	1.8	3.0	12.0	14.3	23.6	5.3	1.2	3.0	0.0	4.0	0.7	8.3	1.9	7.4	28.1	14.7	0.3	2.0	36.0	2.2	29.5	4.7	10.4	0.3	0.4	6.7	11.8	2.6	2.4	31.0	6.7	4.4	1.2	1.9	2.3	40.3	7.2	14.4	10.9	18.7	9.5	57.1	89.4	67.1	68.8	98.1	50.2	50.8	54.0	57.3	74.6	49.1	45.3	50.1	100.0	69.1	71.4	75.2	60.8	117.3	9.1	11.8	4.0	7.8	6.9	4.9	9.5	5.6	8.5	7.8
PSMB2	HC7-I	ENSG00000126067	"Proteasome subunit beta 2"	P49721	1	35599544-35641844	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm			15000000	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavourable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.5	30.5	29.4	28.0	35.1	37.2	25.3	20.1	50.9	23.2	26.1	35.9	15.4	27.5	27.8	25.0	30.4	26.5	20.7	23.8	30.6	33.4	27.9	63.8	24.6	30.4	30.6	24.8	22.7	24.6	22.0	21.8	37.5	32.6	23.1	27.8	22.8	23.0	24.9	54.7	28.2	27.0	28.7	32.5	29.3	22.8	23.5	21.5	42.8	22.7	29.1	34.0	23.9	22.4	24.6	30.2	19.4	35.3	25.1	28.1	25.4	40.6	25.5	27.8	19.0	14.8	17.8	35.2	19.3	22.7	39.8	32.5	30.2	48.9	40.6	45.3	22.7	25.3	35.8	32.0	33.5	33.1	33.2	36.8	27.9	29.5	26.7	38.6	21.7	19.4	20.3	47.5	23.1	31.2	43.9	23.2	25.6	18.7	50.2	28.9	37.2	27.1	31.1	28.4	28.6	27.6	22.0	24.7	18.2	22.1	20.9	29.8	15.4	17.6	21.5	19.9	23.5	18.8	45.5	20.0	32.2	41.1	29.5	40.7	34.5	17.4	27.0	19.4	23.1	33.0	23.4	24.6	23.1	24.2	29.7	19.3	16.7	20.9	9.7	25.1	35.3	30.2	28.1	25.4	29.4	35.1	20.1	50.9	30.6	33.4	30.6	24.8	32.6	21.5
PSMB5	"MB1, X"	ENSG00000100804	"Proteasome subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome			8200000	"Nucleoplasm, Centrosome"		"HPA049518: , HPA061796: "	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (2.85e-4)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (4.73e-4)"	28.1	38.8	33.6	19.3	35.5	9.6	29.0	19.4	42.9	24.7	28.3	26.8	25.4	21.0	24.2	49.2	31.6	31.6	22.0	37.7	32.9	33.3	35.3	45.4	20.6	18.3	37.5	35.4	22.2	36.6	35.4	26.6	32.5	33.9	27.2	32.2	21.1	28.4	28.7	101.2	22.3	17.2	34.9	32.5	16.7	25.1	27.6	27.3	15.7	29.0	47.3	22.7	20.6	25.2	32.3	53.4	24.6	39.9	19.4	46.8	39.5	22.1	47.1	33.7	31.9	45.4	39.2	33.3	31.6	37.6	55.8	47.4	39.6	35.2	27.5	29.5	42.9	30.2	53.8	39.4	53.9	16.8	37.2	17.4	34.4	139.6	35.9	21.1	21.0	43.7	37.0	41.3	34.5	57.6	26.2	15.6	45.6	65.1	12.0	29.0	37.4	76.4	16.2	25.4	18.3	43.3	32.1	43.0	33.5	22.2	45.2	30.3	21.8	27.5	30.9	27.3	27.8	25.2	31.0	13.5	26.8	20.6	21.3	17.1	33.8	24.6	39.9	17.3	29.3	39.0	34.2	32.3	35.1	28.1	42.6	30.1	46.8	35.6	15.5	19.4	27.9	53.4	28.7	39.5	33.6	35.5	19.4	42.9	32.9	33.3	37.5	35.4	33.9	27.3
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome subunit beta 6"	P28072	17	4796144-4798503	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol			2800000	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: "	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavourable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	28.6	35.0	33.7	23.2	36.4	31.7	34.0	24.2	41.5	29.6	31.7	26.7	26.8	22.6	33.4	47.1	41.9	30.3	24.2	72.0	30.4	30.5	41.4	67.1	25.7	35.3	33.4	34.0	25.3	41.8	40.8	26.6	49.6	35.9	26.4	36.1	23.5	30.6	36.6	97.4	33.6	23.2	40.5	29.7	29.0	31.2	27.0	28.0	35.8	34.6	53.8	39.6	27.9	26.0	93.9	96.3	51.1	95.3	60.4	81.2	107.9	46.0	80.6	43.5	37.1	37.1	33.4	50.2	24.4	51.1	74.7	58.6	59.9	37.6	35.8	48.5	58.4	46.7	66.1	68.4	72.9	46.6	69.7	21.2	53.0	69.6	42.8	21.9	33.9	31.5	52.5	65.2	62.1	72.5	32.4	54.5	57.2	54.8	38.7	36.6	36.9	56.0	43.4	30.9	47.4	56.0	31.1	25.5	31.3	35.0	27.4	25.1	33.4	24.6	34.5	36.9	27.9	49.5	59.0	22.8	30.3	21.8	52.8	40.1	44.3	51.1	95.3	50.5	57.1	87.5	57.8	93.9	62.3	62.6	96.3	79.8	53.7	56.1	32.9	60.4	78.0	89.7	81.2	107.9	33.7	36.4	24.2	41.5	30.4	30.5	33.4	34.0	35.9	28.0
PSMB7		ENSG00000136930	"Proteasome subunit beta 7"	Q99436	9	124353466-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Supported	Nucleoplasm,Cytosol			2700000	Nucleoplasm	Cytosol	"HPA052408: , HPA054902: "	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	36.9	56.9	51.0	32.8	55.1	53.4	41.9	33.7	52.7	26.6	33.3	34.0	27.9	32.5	33.6	52.1	41.9	32.6	29.2	59.6	44.5	41.3	53.7	87.1	27.0	33.6	43.6	46.9	32.7	67.1	38.5	24.1	53.2	47.3	28.8	37.1	31.1	48.2	26.9	76.7	48.7	32.2	31.4	39.9	28.6	33.1	50.3	36.5	48.2	32.7	67.7	39.5	32.3	30.8	53.4	67.9	45.2	62.7	53.6	66.2	69.0	51.9	63.5	43.5	52.5	30.7	36.7	62.7	50.6	69.8	73.4	50.7	83.4	50.8	59.3	40.9	47.3	74.4	54.1	53.6	67.4	57.0	46.7	37.1	101.0	69.2	69.5	73.6	37.1	43.9	47.3	76.4	76.6	61.5	75.7	42.2	56.6	90.4	52.8	49.5	64.3	90.9	46.8	64.9	69.3	51.9	34.0	51.3	41.8	48.1	61.7	74.9	71.1	32.4	48.7	47.5	38.3	60.6	75.7	45.8	128.3	59.8	79.4	45.4	66.7	40.4	61.7	45.2	41.8	62.7	45.0	53.4	48.1	46.1	67.9	47.5	46.3	44.9	27.3	53.6	58.4	57.8	66.2	69.0	51.0	55.1	33.7	52.7	44.5	41.3	43.6	46.9	47.3	36.5
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome subunit beta 9"	P28065	6	32844136-32859585	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 69.1;lymphoid tissue: 54.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 29.1;REH: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol			420000	Cytosol		"CAB015180: AB_2172368, HPA042818: , HPA053280: "	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	13.3	9.7	5.0	30.0	7.9	10.7	11.6	1.6	5.3	7.6	16.5	6.0	3.4	15.7	8.8	7.1	10.8	7.4	10.8	8.9	5.1	4.7	12.2	12.2	17.7	32.7	7.3	3.7	9.2	5.4	1.2	4.5	5.5	6.3	12.5	5.8	7.7	9.0	3.5	6.2	7.6	36.1	5.7	9.8	54.9	11.2	3.0	6.7	35.4	14.4	9.3	35.2	15.9	8.8	31.8	17.2	69.1	30.5	23.4	31.1	45.7	0.0	1.4	0.0	0.1	1.1	2.9	2.0	0.2	3.2	4.2	9.7	0.0	9.1	29.1	0.4	2.6	5.9	0.4	6.2	0.5	16.4	0.0	17.7	0.5	1.1	15.7	3.1	1.3	1.3	0.2	2.6	0.4	1.5	0.7	5.4	1.4	0.4	13.4	4.1	0.0	0.9	21.5	0.0	6.9	2.8	0.5	0.0	0.0	2.7	1.7	1.9	2.3	6.5	1.5	4.5	0.4	8.5	2.5	10.1	15.3	9.3	4.6	11.8	3.8	21.9	22.4	39.3	28.7	30.5	23.8	31.8	23.3	27.5	17.2	23.4	17.5	22.9	69.1	23.4	29.4	12.7	31.1	45.7	5.0	7.9	1.6	5.3	5.1	4.7	7.3	3.7	6.3	6.7
PSMC1	"p56, S4"	ENSG00000100764	"Proteasome 26S subunit, ATPase 1"	P62191	14	90256495-90275429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 178.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000872	Approved		Enhanced	Nucleoplasm,Cytosol			46000	"Nucleoplasm, Cytosol"		"HPA000872: AB_1079705"	"unprognostic (4.10e-1)"	"unprognostic (9.70e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-2)"	23.7	21.6	28.2	16.7	26.6	26.9	24.6	17.1	39.1	18.4	21.0	11.8	14.3	12.7	23.7	27.9	23.4	18.0	13.7	34.5	37.8	19.1	22.8	29.7	17.9	16.2	19.8	29.3	16.1	20.4	21.8	15.9	25.3	37.2	19.0	23.0	12.1	18.9	22.8	178.0	22.9	17.2	23.2	31.3	19.3	20.0	42.1	15.6	14.4	18.0	29.2	25.4	23.3	17.2	21.4	37.7	57.0	38.1	28.7	36.4	37.8	31.8	30.2	34.8	36.3	30.6	28.2	36.6	30.9	43.3	68.3	51.6	27.9	36.0	27.2	47.2	37.3	33.1	42.5	36.0	80.0	32.4	18.6	21.3	20.3	23.9	26.4	32.2	28.6	25.2	28.6	44.4	32.7	41.1	30.0	16.4	46.9	60.4	24.0	42.0	30.7	37.5	28.8	45.1	22.2	38.4	33.2	36.6	24.5	25.2	65.6	25.8	41.2	28.5	31.1	26.3	23.6	28.2	44.6	28.4	44.7	40.3	38.1	29.4	40.1	30.9	37.6	57.0	26.6	34.1	26.2	21.4	27.5	27.2	37.7	20.7	25.3	24.8	41.7	28.7	38.1	26.4	36.4	37.8	28.2	26.6	17.1	39.1	37.8	19.1	19.8	29.3	37.2	15.6
PSMC2	"MSS1, Nbla10058, S7"	ENSG00000161057	"Proteasome 26S subunit, ATPase 2"	P35998	7	103344254-103369395	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019238, HPA049621"	Supported		Supported	"Cytosol,Cytoplasmic bodies"			39000	"Cytosol, Cytoplasmic bodies"		"HPA019238: AB_1855834, HPA049621: "	"unprognostic (4.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.41e-1)"	29.3	35.8	29.4	27.2	35.3	41.6	24.4	25.9	39.7	23.2	23.4	26.2	22.0	22.8	28.2	26.6	29.9	22.5	19.5	38.5	30.1	24.7	36.9	58.8	24.4	26.2	32.0	29.9	23.7	18.5	27.8	33.6	31.1	37.0	23.1	24.8	23.2	24.1	24.8	83.5	31.2	23.2	29.2	31.5	28.4	24.9	23.4	34.3	27.5	25.5	35.2	31.8	26.5	22.2	25.7	40.7	65.7	52.3	29.6	50.2	35.1	51.5	36.2	31.0	45.6	33.4	25.0	28.6	38.5	35.7	44.9	45.1	43.9	45.9	34.8	82.5	33.8	31.8	39.1	27.4	47.2	55.4	26.4	31.1	30.0	31.9	29.4	50.7	38.8	22.2	22.4	44.8	15.0	33.5	72.0	47.4	38.4	73.8	50.1	33.6	38.6	38.2	28.2	38.8	40.7	30.5	32.3	28.2	25.3	36.1	53.6	33.6	24.7	25.9	35.7	39.5	47.9	74.4	60.7	42.6	99.0	68.1	43.7	53.5	60.6	65.7	30.5	28.1	26.5	44.2	30.1	25.7	31.0	28.2	40.7	20.1	27.5	27.6	4.6	29.6	52.3	23.8	50.2	35.1	29.4	35.3	25.9	39.7	30.1	24.7	32.0	29.9	37.0	34.3
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Supported	Nucleoplasm,Cytosol			180000	"Nucleoplasm, Cytosol"		"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	27.9	25.9	37.3	24.1	49.3	31.8	26.2	25.6	39.7	25.1	28.2	24.9	21.1	20.3	27.2	26.0	29.4	25.0	21.8	45.7	32.8	28.0	30.7	60.2	21.5	22.8	36.1	27.3	21.0	25.2	31.0	16.8	39.8	28.2	22.6	24.0	21.3	32.1	29.8	134.7	34.8	20.9	30.8	24.3	25.7	24.9	24.0	22.9	33.5	27.1	38.3	28.8	25.5	25.3	39.2	45.1	32.6	54.7	45.0	51.1	61.3	39.0	44.5	42.8	31.5	20.6	22.2	41.7	32.6	48.5	82.1	58.3	39.6	22.9	31.7	20.3	41.0	39.3	37.5	42.7	37.1	47.2	48.4	30.5	54.5	38.2	26.6	35.5	32.6	24.7	23.1	33.3	37.6	46.0	43.1	30.0	50.0	87.1	44.7	45.2	41.9	53.8	47.3	84.2	27.8	38.2	29.5	31.3	27.1	26.7	37.7	20.5	46.5	37.1	32.5	47.1	59.6	66.6	83.5	32.5	37.5	36.7	48.6	35.6	58.8	24.4	43.5	32.6	47.9	53.1	43.7	39.2	40.4	43.8	45.1	32.8	35.6	36.2	9.8	45.0	54.7	45.1	51.1	61.3	37.3	49.3	25.6	39.7	32.8	28.0	36.1	27.3	28.2	22.9
PSMC3IP	"GT198, Hop2, HUMGT198A, TBPIP"	ENSG00000131470	"PSMC3 interacting protein"	Q9P2W1	17	42572315-42577831	"Disease related genes, Predicted intracellular proteins"	"DNA recombination, Meiosis"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044439	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA044439: AB_10964210"	"unprognostic (2.98e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-7)"	"unprognostic (6.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (9.41e-4)"	"unprognostic (6.03e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.82e-1)"	4.0	2.0	6.6	4.2	12.1	9.2	5.2	5.0	7.7	3.4	4.3	7.0	4.1	1.7	5.2	5.5	3.9	8.6	2.4	2.1	7.4	6.3	2.8	1.2	3.1	4.7	9.7	4.1	4.8	2.7	8.5	2.1	5.4	8.7	5.5	4.3	2.4	2.5	5.7	1.9	4.1	1.9	6.9	12.7	2.3	2.8	29.8	9.9	3.1	2.5	1.5	7.1	4.2	3.3	2.4	6.2	2.2	0.5	0.2	1.9	0.3	6.3	9.5	16.0	11.6	3.7	5.3	3.6	24.8	7.9	21.7	27.0	9.4	4.1	6.8	5.5	7.3	9.7	12.3	9.5	25.1	9.4	10.3	4.1	21.4	11.2	0.5	14.3	4.6	1.8	2.1	34.3	11.5	6.3	13.8	12.4	18.9	7.3	9.7	8.9	9.7	9.0	10.2	16.2	6.1	4.9	5.2	21.2	13.5	9.9	3.7	10.0	8.8	6.3	3.0	23.6	13.5	17.6	40.8	9.7	16.5	9.7	11.0	6.8	25.4	0.0	0.2	1.8	1.9	0.3	1.9	2.4	0.9	1.7	0.2	0.8	0.3	0.9	2.2	0.2	0.5	6.2	1.2	0.3	6.6	12.1	5.0	7.7	7.4	6.3	9.7	4.1	8.7	9.9
PSMC4	"MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7"	ENSG00000013275	"Proteasome 26S subunit, ATPase 4"	P43686	19	39971005-39981441	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002044, HPA005471"	Approved		Supported	Nucleoplasm,Cytosol			66000	"Nucleoplasm, Cytosol"		"HPA002044: AB_1079707, HPA005471: AB_1855838"	"unprognostic (1.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-1)"	24.0	31.3	23.4	26.1	26.9	15.0	20.3	23.9	37.1	22.8	25.0	26.1	24.9	26.4	29.8	34.0	29.9	25.1	22.2	35.9	24.1	25.4	40.4	65.6	20.1	21.3	25.6	27.4	22.7	19.6	33.1	22.1	29.7	32.3	22.5	24.6	21.8	21.1	28.1	57.3	25.8	24.8	27.1	26.0	25.2	24.1	29.7	25.5	27.9	30.2	28.0	28.5	28.9	20.1	18.1	34.4	16.0	43.1	19.8	28.1	25.8	22.4	72.9	14.8	19.3	12.7	10.6	17.0	13.3	16.3	29.6	23.0	42.1	16.3	11.2	26.0	15.7	12.1	19.8	18.0	22.5	19.8	20.8	16.5	13.7	34.2	18.7	17.1	19.8	11.1	14.6	24.1	16.5	19.3	21.1	17.1	18.1	33.9	20.3	9.9	26.7	22.2	17.8	17.8	16.1	19.7	33.8	19.2	24.7	15.1	24.0	12.0	16.6	15.1	12.8	19.4	19.4	17.7	32.3	20.7	35.9	17.2	24.6	18.2	21.4	14.8	20.5	16.0	23.6	32.2	20.0	18.1	21.1	23.9	34.4	16.9	17.1	17.6	11.1	19.8	43.1	17.1	28.1	25.8	23.4	26.9	23.9	37.1	24.1	25.4	25.6	27.4	32.3	25.5
PSMC5	"p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1"	ENSG00000087191	"Proteasome 26S subunit, ATPase 5"	P62195	17	63827152-63832026	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017871, HPA064293"	Enhanced		Supported	"Plasma membrane,Cytosol"			100000	"Plasma membrane, Cytosol"		"HPA017871: AB_1857638, HPA064293: AB_2685234"	"unprognostic (9.65e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (9.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	36.8	43.1	44.8	35.8	42.6	26.7	30.3	47.7	48.3	29.5	36.5	30.3	40.8	26.2	32.0	42.4	46.0	32.2	42.0	41.7	38.6	42.9	52.3	48.7	26.3	33.5	50.1	42.2	28.2	36.7	77.0	32.6	42.9	41.8	32.7	36.7	26.7	36.0	41.7	94.2	45.2	28.9	41.8	39.3	33.4	33.2	32.7	35.7	33.0	37.8	60.4	43.9	33.3	32.4	30.4	31.2	30.9	40.9	34.2	57.7	40.5	41.6	62.8	43.9	28.4	30.8	32.6	36.2	42.5	30.5	51.5	40.9	67.5	26.1	28.1	29.3	42.4	31.1	44.1	39.4	73.9	25.2	46.6	61.9	51.5	55.0	30.8	61.9	41.4	32.5	29.6	52.7	48.8	46.4	46.4	36.1	47.7	73.1	45.7	23.4	38.6	54.3	42.9	87.1	40.8	36.3	49.1	36.9	50.3	29.1	51.4	24.0	50.7	30.0	43.5	63.2	59.4	29.1	85.2	38.3	59.1	45.5	37.9	44.6	40.1	22.8	25.6	30.9	37.8	37.2	51.4	30.4	44.8	40.4	31.2	24.4	37.7	42.2	8.1	34.2	40.9	22.4	57.7	40.5	44.8	42.6	47.7	48.3	38.6	42.9	50.1	42.2	41.8	35.7
PSMD10	p28	ENSG00000101843	"Proteasome 26S subunit, non-ATPase 10"	O75832	X	108084207-108091618	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002920, CAB010434"	Approved		Supported	"Intermediate filaments,Cytosol"			82000	Cytosol	"Intermediate filaments"	"CAB010434: AB_640866, HPA002920: AB_1079708"	"unprognostic (1.59e-3)"	"unprognostic (4.12e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.95e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	15.8	23.6	35.5	14.3	32.1	14.2	20.9	27.4	31.1	21.7	19.0	30.3	13.4	14.8	22.4	29.8	21.6	27.1	15.1	14.7	32.0	50.2	20.5	19.0	16.5	18.0	38.9	29.6	19.9	11.1	20.3	20.9	26.1	39.0	19.4	19.8	17.1	14.6	19.0	13.3	15.3	17.4	21.6	38.9	14.8	15.7	15.6	23.8	21.2	24.3	12.2	21.8	22.0	16.1	28.1	30.7	40.2	38.8	32.2	32.4	35.1	31.0	31.6	21.7	19.5	33.0	24.9	19.7	25.6	21.3	23.2	20.3	18.8	20.0	26.5	39.3	24.4	16.9	34.1	24.7	35.8	28.7	29.4	15.5	30.7	23.6	16.8	24.0	17.4	18.9	27.0	21.5	26.1	57.2	29.9	36.0	28.9	40.7	22.6	21.0	39.4	43.1	22.9	31.1	28.0	24.9	20.2	14.0	13.4	39.2	16.3	25.7	17.6	20.8	41.0	18.5	10.7	31.1	18.9	28.8	39.5	28.1	25.6	33.5	21.7	38.3	26.9	40.2	28.2	33.0	30.2	28.1	28.6	30.1	30.4	27.2	28.8	32.2	13.2	32.2	38.8	30.7	32.4	35.1	35.5	32.1	27.4	31.1	32.0	50.2	38.9	29.6	39.0	23.8
PSMD14	"pad1, POH1, Rpn11"	ENSG00000115233	"Proteasome 26S subunit, non-ATPase 14"	O00487	2	161308038-161411717	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002114, HPA003828"	Approved		Supported	Nucleoplasm			9400	Nucleoplasm		"HPA002114: AB_1855850, HPA003828: "	"unprognostic (3.50e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.61e-3)"	"prognostic unfavourable (2.66e-8)"	"unprognostic (3.11e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.84e-3)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (3.10e-6)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.66e-1)"	18.2	26.3	24.8	19.9	25.0	16.8	19.8	21.0	36.9	14.7	17.9	13.5	11.0	15.0	15.6	16.3	23.7	14.4	12.2	22.3	24.8	26.1	23.5	33.7	16.2	24.9	26.2	16.1	11.8	15.0	18.6	24.3	21.5	27.9	16.8	21.9	13.0	15.1	16.7	60.8	16.7	14.3	20.6	26.0	20.2	13.6	19.0	15.3	22.1	18.2	21.6	25.6	15.2	13.1	22.9	27.2	13.1	24.6	23.6	29.6	24.7	35.2	30.7	34.6	30.3	25.2	21.5	42.3	37.2	35.8	53.2	43.4	45.1	30.1	41.9	56.7	27.0	27.2	37.6	39.3	53.3	43.6	28.3	41.8	24.9	50.6	31.0	40.5	24.9	16.4	29.8	60.1	56.2	39.5	45.3	30.2	44.2	33.7	29.8	30.6	48.0	46.6	25.8	33.6	40.9	46.8	30.3	30.1	22.1	25.2	28.5	34.3	19.4	26.1	31.2	35.7	33.6	24.2	40.5	18.1	48.8	39.4	38.3	27.0	39.2	13.1	17.9	8.8	25.3	24.6	26.5	22.9	27.4	27.0	27.2	19.1	22.2	26.5	1.9	23.6	19.1	26.7	29.6	24.7	24.8	25.0	21.0	36.9	24.8	26.1	26.2	16.1	27.9	15.3
PSMD3	"P58, Rpn3, S3, TSTA2"	ENSG00000108344	"Proteasome 26S subunit, non-ATPase 3"	O43242	17	39980797-39997960	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017038, HPA048972"	Approved		Supported	Nucleoplasm,Cytosol			380000	Nucleoplasm	Cytosol	"CAB017038: , HPA048972: "	"unprognostic (3.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.36e-3)"	"unprognostic (5.75e-3)"	"unprognostic (7.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavourable (4.47e-7)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.45e-2)"	25.1	27.7	20.0	25.0	26.1	22.0	21.3	30.0	40.3	22.5	28.1	22.4	16.8	23.2	26.8	21.2	27.7	22.7	23.7	36.1	20.6	21.4	23.8	54.4	20.8	22.3	19.2	23.7	24.0	23.6	28.1	20.8	33.8	24.5	23.2	25.4	21.4	22.5	21.9	93.2	33.2	23.5	24.7	17.6	26.9	21.1	19.9	17.5	35.7	24.3	39.2	26.3	20.7	21.2	15.6	24.3	14.4	17.0	13.1	17.7	12.0	32.1	40.2	22.1	31.7	18.0	11.7	26.3	23.8	24.7	42.9	33.3	33.2	27.8	38.8	59.8	25.4	50.5	39.1	31.0	29.1	38.9	43.6	22.4	20.6	32.8	16.4	30.1	25.2	15.5	26.5	45.3	19.9	24.2	45.6	24.2	19.8	23.4	46.6	20.8	30.6	23.9	34.4	30.7	36.3	21.4	21.8	29.2	22.1	22.7	139.3	19.5	31.3	26.1	21.5	18.6	32.9	27.4	42.4	26.4	33.5	43.2	28.4	22.8	29.9	6.6	16.8	14.4	15.1	17.0	15.1	14.4	14.6	17.7	24.3	15.6	13.7	16.5	5.5	13.1	14.3	16.7	12.6	12.0	20.0	26.1	30.0	40.3	20.6	21.4	19.2	23.7	24.5	17.5
PSMD4	"AF, AF-1, Rpn10, S5A"	ENSG00000159352	"Proteasome 26S subunit, non-ATPase 4"	P55036	1	151254703-151267479	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038807, HPA039252, CAB047300"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418"	"unprognostic (3.83e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (6.66e-10)"	"unprognostic (9.80e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.91e-1)"	27.5	28.0	44.3	24.4	46.4	25.5	29.9	25.7	50.4	21.9	28.6	28.3	16.5	22.7	25.1	41.5	26.7	31.4	21.8	38.7	37.5	36.8	25.3	44.7	20.2	28.2	47.5	44.8	26.7	27.7	27.4	19.3	30.0	43.2	23.0	28.1	24.3	25.6	31.2	86.7	28.0	20.5	39.3	29.6	26.3	25.8	35.9	29.1	23.1	23.7	25.7	36.2	28.0	19.8	62.7	65.1	111.6	76.0	54.2	74.2	88.2	41.8	50.5	37.3	30.5	40.7	30.2	40.7	28.5	34.9	45.5	36.3	66.0	48.0	34.1	69.9	40.1	43.9	47.9	43.0	38.9	55.5	41.8	33.2	43.0	68.0	45.0	39.0	38.8	32.7	35.8	51.9	48.0	39.6	51.7	43.3	38.1	123.6	35.9	47.5	70.9	51.1	30.5	36.3	61.5	44.6	36.0	29.3	50.0	31.6	46.4	37.6	48.5	77.2	34.8	22.7	35.7	27.8	48.5	51.9	64.5	72.7	37.6	36.8	41.3	59.6	71.5	111.6	43.0	76.0	48.4	62.7	50.5	47.3	65.1	61.1	46.4	46.0	95.8	54.2	75.5	39.2	74.2	88.2	44.3	46.4	25.7	50.4	37.5	36.8	47.5	44.8	43.2	29.1
PSMD6	"KIAA0107, p44S10, Rpn7, S10"	ENSG00000163636	"Proteasome 26S subunit, non-ATPase 6"	Q15008	3	64010549-64024010	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"MCF7: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036921, HPA036922"	Uncertain		Supported	"Golgi apparatus,Vesicles"			8600	Vesicles	"Golgi apparatus"	"HPA036921: , HPA036922: AB_10670850"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (8.65e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.95e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.22e-3)"	17.1	27.4	16.1	16.3	19.3	33.8	18.4	15.8	24.2	14.5	16.0	13.2	21.4	12.1	17.9	23.1	23.5	14.5	18.7	31.4	16.2	16.8	24.5	29.1	14.2	20.0	18.4	17.7	13.6	100.6	21.9	16.3	22.2	21.1	15.8	16.2	12.3	20.3	20.1	55.9	20.3	12.9	18.0	16.2	17.0	17.4	41.7	16.2	23.5	14.9	32.4	21.8	15.9	15.1	54.1	53.5	62.3	58.1	47.2	59.6	65.6	12.2	12.7	18.9	13.2	13.3	11.9	16.0	16.9	17.0	29.8	22.0	23.7	10.5	16.7	7.5	17.2	8.4	21.9	19.0	28.1	17.1	13.0	22.3	10.3	15.8	19.6	25.3	14.6	12.8	13.5	24.6	10.8	18.6	22.4	11.3	20.9	176.8	17.4	16.0	23.6	9.0	14.6	12.9	16.6	23.5	17.7	6.8	11.0	12.6	11.2	16.8	9.8	16.1	15.5	13.3	14.1	18.9	27.7	13.7	20.4	25.5	19.5	24.1	15.2	41.0	51.7	60.2	48.8	58.0	51.0	54.1	55.8	53.1	53.5	49.4	56.2	54.3	62.3	47.2	58.1	37.3	59.6	65.6	16.1	19.3	15.8	24.2	16.2	16.8	18.4	17.7	21.1	16.2
PSMD7	"MOV34, P40, Rpn8, S12"	ENSG00000103035	"Proteasome 26S subunit, non-ATPase 7"	P51665	16	74296775-74306288	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019379, HPA049824, HPA056069"	Enhanced		Enhanced	Nucleoplasm			340000	Nucleoplasm		"CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025"	"unprognostic (4.75e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.62e-2)"	"prognostic unfavourable (6.64e-5)"	"prognostic unfavourable (7.71e-6)"	"unprognostic (1.97e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-2)"	26.5	30.3	23.6	20.8	32.8	45.7	21.7	21.7	34.4	17.7	26.6	22.4	17.0	19.8	24.3	26.1	31.5	16.9	17.6	59.0	22.0	21.7	25.0	47.8	20.3	23.5	24.9	22.9	17.1	18.8	23.2	17.4	44.1	36.1	30.3	28.3	16.7	22.8	27.1	88.8	30.6	22.3	26.4	25.1	27.1	21.8	20.3	22.4	30.7	18.2	34.4	28.4	34.6	22.3	50.3	71.0	64.7	60.8	44.6	56.5	58.1	27.0	45.0	33.4	17.1	24.2	25.0	42.1	38.0	32.1	46.8	43.4	59.5	37.6	37.0	42.2	30.7	35.0	26.6	34.4	41.8	21.9	29.3	28.6	34.9	45.4	31.9	46.3	48.7	23.0	34.7	42.2	42.3	41.0	42.3	16.4	29.7	66.9	26.5	43.8	36.2	22.6	38.4	21.6	49.1	24.8	40.8	21.3	24.1	36.9	13.9	21.8	29.4	31.8	37.1	28.1	23.6	30.6	28.3	35.2	45.2	107.8	38.3	33.8	29.0	45.6	58.4	64.7	49.8	60.8	48.5	50.3	49.7	52.0	71.0	36.1	48.7	49.9	34.8	44.6	60.2	59.6	56.5	58.1	23.6	32.8	21.7	34.4	22.0	21.7	24.9	22.9	36.1	22.4
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888731-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"			330000	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	25.6	10.7	11.5	12.9	12.1	27.8	18.7	15.3	12.0	9.6	22.1	9.2	14.8	19.5	14.4	13.6	12.3	10.7	12.5	13.9	10.6	11.2	19.2	19.8	12.3	14.8	10.6	9.0	13.0	28.6	4.9	8.3	8.7	12.7	9.5	4.8	9.4	15.3	14.2	28.6	12.4	16.3	15.7	11.6	14.8	24.7	13.6	8.7	13.8	10.9	17.1	9.2	8.2	11.8	24.5	36.7	29.6	26.3	14.9	25.9	27.3	20.5	31.6	2.6	4.8	4.4	4.5	5.5	21.0	6.8	10.5	6.0	23.0	2.5	15.3	17.8	10.8	8.4	7.5	11.0	6.3	29.6	16.6	12.5	14.7	11.4	11.0	8.8	8.9	8.0	5.2	11.8	4.5	6.3	11.2	2.2	6.6	24.1	17.5	6.6	5.5	24.7	13.4	7.2	9.4	5.1	20.7	5.5	7.7	21.1	3.1	11.3	9.1	4.4	16.6	10.1	11.6	19.7	14.6	12.0	25.9	22.3	18.1	11.5	9.2	20.3	26.3	29.6	20.9	25.4	16.7	24.5	20.1	18.9	22.2	19.5	15.8	13.6	24.1	14.9	22.0	36.7	25.9	27.3	11.5	12.1	15.3	12.0	10.6	11.2	10.6	9.0	12.7	8.7
PSME3	"Ki, PA28-gamma, PA28G, REG-GAMMA"	ENSG00000131467	"Proteasome activator subunit 3"	P61289	17	42824385-42843758	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008388, HPA012510"	Supported		Enhanced	Nucleoplasm			260000	Nucleoplasm		"CAB008388: AB_592552, HPA012510: AB_1855752"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavourable (5.41e-5)"	"unprognostic (6.02e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	29.8	32.4	31.7	27.8	37.6	28.2	25.9	22.7	52.7	25.3	28.6	25.3	16.7	26.3	28.4	18.8	44.9	24.8	22.1	32.1	24.8	25.9	47.9	48.5	24.8	32.5	28.7	28.3	27.1	31.0	38.1	21.3	31.3	34.9	23.9	32.0	26.8	29.2	27.5	49.7	32.3	30.1	28.9	21.0	32.8	30.5	32.7	20.4	34.5	29.7	20.4	39.5	31.1	24.8	26.2	38.0	50.4	43.3	32.4	32.3	38.4	38.9	64.6	29.7	31.7	27.2	27.8	40.5	44.8	34.1	61.9	43.7	53.8	29.7	59.8	35.1	38.6	35.2	48.1	47.3	72.7	30.6	48.2	31.9	33.8	38.5	30.8	70.1	37.0	27.2	32.5	46.7	46.7	37.8	62.4	21.3	41.8	22.7	65.9	24.4	44.0	35.3	43.4	54.2	47.7	32.7	55.2	37.3	38.2	27.3	22.9	34.6	53.0	30.2	36.4	48.5	34.0	40.1	65.0	33.4	51.5	75.6	34.3	40.5	49.4	22.9	38.2	35.0	30.1	43.3	32.3	26.2	24.8	28.9	38.0	24.1	23.1	26.1	50.4	32.4	35.2	21.3	28.9	38.4	31.7	37.6	22.7	52.7	24.8	25.9	28.7	28.3	34.9	20.4
PSME4	"KIAA0077, PA200"	ENSG00000068878	"Proteasome activator subunit 4"	Q14997	2	53864067-53970840	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 49.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060922	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA060922: "	"unprognostic (2.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavourable (8.99e-4)"	"unprognostic (7.26e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (4.84e-4)"	"unprognostic (4.76e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-1)"	11.3	8.4	5.2	10.1	7.8	9.9	8.5	4.2	8.3	12.2	8.0	9.1	7.0	3.9	11.2	5.9	8.8	7.5	10.6	30.9	6.2	3.4	4.9	12.2	11.3	7.9	8.7	5.1	6.6	7.0	7.4	8.4	6.1	6.7	6.8	6.2	6.1	14.2	8.6	49.8	7.1	6.8	11.6	4.1	6.4	9.5	23.8	9.4	8.6	9.0	11.7	8.6	11.5	10.1	4.3	2.0	2.4	1.3	2.3	3.3	0.8	15.5	11.0	17.1	4.9	5.8	12.3	10.5	16.4	15.7	18.1	14.8	17.1	6.5	22.5	14.9	17.8	10.8	19.4	14.4	31.7	15.8	9.9	33.7	11.1	22.9	7.5	17.6	10.0	9.3	8.9	20.6	16.8	18.6	27.2	14.6	16.2	6.5	10.7	7.2	15.6	9.2	12.7	23.8	14.7	9.9	16.4	12.1	13.7	10.6	14.7	8.8	11.0	7.5	21.5	16.0	12.9	11.5	15.2	9.1	8.9	14.0	12.5	15.2	9.7	2.2	0.8	2.4	3.3	1.3	1.8	3.2	2.2	2.0	1.2	4.3	2.4	3.0	2.2	2.3	1.1	2.0	1.6	0.8	5.2	7.8	4.2	8.3	6.2	3.4	8.7	5.1	6.7	9.4
PSMF1	PI31	ENSG00000125818	"Proteasome inhibitor subunit 1"	Q92530	20	1113263-1189415	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041122, HPA041300"	Approved		Enhanced	Cytosol			270000	Cytosol		"HPA041122: AB_10805838, HPA041300: AB_10794370"	"unprognostic (1.79e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.03e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.32e-2)"	27.3	21.5	23.4	23.9	26.4	27.3	23.0	22.9	32.7	21.8	26.5	26.9	19.8	27.2	24.6	24.1	29.3	22.5	27.4	27.7	21.6	21.2	25.1	63.7	23.7	29.9	23.2	19.8	28.2	48.3	23.7	20.4	20.5	28.2	21.2	19.3	26.2	33.6	24.0	67.2	25.3	28.4	23.9	23.4	22.8	25.7	86.2	19.2	31.9	27.7	42.1	24.5	26.2	25.7	31.4	28.7	51.5	33.9	24.1	33.6	26.2	38.3	35.0	8.4	20.0	18.1	19.2	14.7	23.5	17.8	21.2	19.0	32.9	27.0	19.6	15.8	24.2	34.9	21.7	39.7	26.7	11.4	13.0	27.9	6.2	59.7	24.3	32.7	9.5	19.1	23.1	24.0	37.3	22.9	27.8	39.4	17.2	20.4	41.6	28.6	12.5	21.6	20.1	17.9	32.0	18.8	32.6	21.5	15.2	25.8	45.3	21.2	30.4	11.9	27.2	27.3	18.7	31.6	31.5	24.5	47.9	20.9	12.1	22.7	20.8	43.2	28.6	51.5	23.0	33.9	26.5	31.4	30.8	25.0	28.7	27.6	28.4	24.7	31.1	24.1	33.2	16.4	33.6	26.2	23.4	26.4	22.9	32.7	21.6	21.2	23.2	19.8	28.2	19.2
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favourable (1.46e-4)"	"unprognostic (7.72e-2)"	10.6	14.6	17.8	14.1	18.7	45.0	16.8	24.6	24.7	13.9	15.0	15.3	11.7	12.6	16.0	23.3	15.6	17.1	12.8	11.4	18.9	19.8	13.1	9.2	10.2	19.0	14.6	18.4	16.3	11.2	8.4	23.6	25.7	15.9	11.9	16.4	17.6	11.4	9.4	20.3	14.7	13.1	15.0	12.2	13.8	12.3	23.9	13.6	27.5	12.9	10.7	21.2	12.3	10.9	18.2	17.8	14.8	18.7	9.6	18.2	12.1	18.2	7.6	17.9	8.9	7.4	7.9	23.3	9.8	13.0	18.7	17.0	25.2	10.6	24.4	10.6	10.4	9.3	20.7	11.9	19.6	10.5	10.2	28.0	5.5	30.6	14.5	20.1	18.0	12.1	2.5	11.3	12.7	15.8	15.2	10.1	16.3	19.9	23.5	19.6	25.1	10.1	16.2	17.9	12.7	19.2	27.8	16.5	8.5	13.4	22.7	8.6	13.2	21.2	9.3	11.3	10.8	10.7	9.4	8.7	5.1	42.2	5.1	12.1	13.4	10.6	18.1	11.0	10.2	18.7	11.1	18.2	13.7	9.4	16.6	18.0	13.8	10.4	14.8	9.6	13.5	17.8	18.2	12.1	17.8	18.7	24.6	24.7	18.9	19.8	14.6	18.4	15.9	13.6
PTBP1	"HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4"	ENSG00000011304	"Polypyrimidine tract binding protein 1"	P26599	19	797075-812327	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB013507	Supported		Supported	Nucleoplasm			3100000	Nucleoplasm		"CAB013507: AB_2533082"	"unprognostic (2.82e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavourable (2.71e-4)"	"unprognostic (4.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.28e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.72e-2)"	38.7	31.3	13.2	37.5	16.9	43.5	38.4	13.5	16.2	36.4	35.9	19.1	32.5	34.9	42.9	32.7	49.7	31.8	39.0	24.0	13.9	9.5	45.3	68.8	37.7	56.2	20.2	9.6	47.5	47.5	37.5	31.8	65.0	15.9	35.3	24.7	35.5	51.9	31.0	15.9	43.6	41.0	26.2	13.8	49.2	31.2	34.1	18.2	94.9	49.4	43.7	62.7	31.5	36.2	19.2	26.3	14.6	27.7	22.8	24.7	23.4	78.9	69.5	40.5	34.6	13.8	17.5	61.2	48.3	24.4	40.2	32.1	67.3	38.2	66.7	31.1	33.0	47.1	55.6	45.9	38.3	69.6	61.5	54.6	66.0	67.6	26.0	73.5	58.5	17.5	32.2	50.1	27.8	38.2	83.5	34.8	64.9	69.5	88.3	35.9	70.2	37.3	99.9	30.5	39.6	24.9	77.3	45.4	51.9	60.4	33.6	27.5	35.7	43.2	58.0	43.9	45.9	48.2	84.1	38.5	70.1	89.8	25.1	53.7	52.7	8.2	21.6	14.6	24.0	27.7	24.7	18.6	19.5	22.2	26.3	19.2	19.6	19.2	9.5	22.8	24.6	15.0	21.1	23.4	13.2	16.9	13.5	16.2	13.9	9.5	20.2	9.6	15.9	18.2
PTCD3	"DKFZp666K071, FLJ20758"	ENSG00000132300	"Pentatricopeptide repeat domain 3"	Q96EY7	2	86106182-86142157	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041154, HPA041382"	Supported		Supported	Mitochondria				Mitochondria		"HPA041154: AB_10795488, HPA041382: AB_10795695"	"unprognostic (1.16e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.26e-1)"	"prognostic favourable (6.77e-4)"	"unprognostic (3.69e-1)"	"unprognostic (7.79e-2)"	"prognostic favourable (6.86e-4)"	13.9	18.6	18.5	12.2	23.2	18.0	14.5	24.5	22.7	13.0	17.5	19.7	11.3	14.3	15.2	15.5	12.7	13.6	9.6	35.0	17.7	16.6	18.0	21.9	11.7	15.4	20.2	19.0	20.2	13.8	17.9	22.7	13.2	21.4	13.0	19.7	11.4	11.1	12.9	45.4	14.2	14.2	13.4	17.9	15.8	14.8	22.8	20.5	20.4	14.9	13.1	15.3	12.4	13.0	13.4	9.4	6.3	11.1	11.9	14.7	7.5	7.6	18.5	11.0	9.2	8.2	8.6	13.2	17.0	6.8	9.0	9.1	34.4	7.4	19.3	6.0	8.9	14.2	22.2	8.7	11.6	8.6	19.5	15.3	11.5	28.4	8.6	12.4	11.6	10.2	6.4	6.8	12.3	7.8	15.9	7.3	7.9	7.1	10.2	14.8	10.0	11.9	13.8	15.5	14.6	12.3	15.5	12.0	7.4	7.4	12.4	14.5	6.6	7.6	5.5	7.2	7.7	7.3	9.3	17.4	22.3	15.6	7.0	14.2	5.5	3.4	8.6	6.3	11.6	5.9	13.6	13.4	10.5	12.2	9.4	13.4	14.7	10.7	0.3	11.9	11.1	9.4	11.8	7.5	18.5	23.2	24.5	22.7	17.7	16.6	20.2	19.0	21.4	20.5
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863113-87971930	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: "	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	42.4	24.1	17.7	20.9	17.7	13.5	32.8	39.9	19.7	43.1	26.7	9.9	19.0	15.1	29.8	22.8	26.8	30.3	21.0	19.1	16.0	17.4	19.6	32.4	27.2	30.4	15.7	19.5	29.1	21.3	16.4	23.6	36.4	14.2	35.3	17.7	21.6	16.8	20.8	16.8	20.4	25.4	26.0	11.7	40.9	17.8	18.7	12.5	49.7	25.2	13.3	18.6	29.6	30.9	4.3	5.1	29.6	11.0	4.3	4.7	2.0	10.4	4.9	5.7	5.1	13.1	9.0	5.1	5.6	12.5	6.6	9.3	5.0	12.9	12.3	3.8	9.2	6.3	7.5	6.4	10.5	6.2	2.1	4.1	12.8	6.1	14.0	13.8	7.1	6.1	17.9	8.3	10.8	9.3	3.1	33.6	6.0	8.0	7.7	25.1	2.1	0.0	12.0	3.0	9.1	10.3	6.0	2.0	9.2	7.5	3.5	9.4	9.9	20.0	8.1	21.9	5.1	8.5	4.5	11.1	14.3	14.1	6.8	13.1	1.3	8.3	7.9	12.2	3.6	11.0	3.9	4.3	4.0	3.5	5.1	3.7	4.7	4.5	29.6	4.3	7.2	4.2	3.5	2.0	17.7	17.7	39.9	19.7	16.0	17.4	15.7	19.5	14.2	12.5
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 31.0;BEWO: 32.9;HaCaT: 43.0;SK-BR-3: 31.6;U-2197: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	19.3	0.0	9.2	31.0	10.7	32.9	1.4	12.7	0.2	0.3	0.9	14.1	0.0	0.5	3.5	43.0	0.1	1.4	0.1	0.0	0.1	0.0	13.7	0.0	0.7	0.0	0.0	6.3	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	1.7	0.0	0.0	0.0	1.0	20.6	0.1	0.7	17.2	31.6	0.1	16.5	0.0	0.1	0.0	0.0	81.7	0.0	0.0	0.0	0.0	16.2	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 211.4;urinary bladder: 163.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.1;ASC TERT1: 22.3;BJ: 27.3;BJ hTERT+: 37.3;HEL: 17.1;HMC-1: 72.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		25000000	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (9.35e-4)"	4.5	1.1	1.8	9.1	3.1	2.6	2.5	0.5	2.7	2.6	35.3	4.6	3.0	3.9	2.5	1.6	25.7	16.7	9.4	4.9	1.9	1.6	3.9	1.8	4.0	1.4	3.5	0.7	3.6	1.0	0.7	2.4	0.8	2.5	60.9	9.3	1.5	1.9	2.3	0.7	55.9	6.5	211.4	4.9	3.6	7.8	1.0	3.1	0.4	1.5	5.3	4.2	163.9	19.5	2.5	13.0	14.4	8.5	1.9	0.1	13.7	0.0	0.1	0.1	0.0	28.1	22.3	0.0	27.3	37.3	0.2	0.2	0.0	0.0	0.9	1.3	4.6	1.7	0.0	2.5	0.2	0.0	0.0	17.1	0.1	0.0	8.1	1.1	72.7	11.4	0.2	1.4	0.0	10.1	0.0	0.0	0.5	0.0	0.0	1.5	0.3	0.1	0.0	0.3	2.0	3.5	0.0	0.1	0.1	0.1	2.3	0.0	0.0	1.9	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	7.4	0.0	12.0	7.6	14.4	0.0	8.5	0.0	1.7	0.0	0.0	13.0	2.5	0.0	0.0	3.5	1.9	6.1	0.9	0.1	13.7	1.8	3.1	0.5	2.7	1.9	1.6	3.5	0.7	2.5	3.1
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680427	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"ductus deferens: 324.6;seminal vesicle: 377.9"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 93.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 12.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 12.8"	"Region enhanced"	"Detected in many"		"hippocampal formation: 16.5"	"Low region specificity"	"Detected in many"			"CAB000113, HPA001335"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	5.7	2.1	1.2	3.7	1.1	32.6	1.5	0.8	1.9	21.1	11.4	1.1	324.6	0.4	2.3	1.8	1.7	4.0	9.5	9.1	1.1	1.0	3.3	2.7	22.1	2.3	1.3	0.8	1.6	0.4	3.1	2.2	2.5	1.9	9.2	2.7	3.9	0.9	377.9	1.0	1.1	2.4	7.7	4.7	0.9	11.4	1.0	0.9	0.6	1.5	3.4	1.3	17.3	1.9	0.0	0.5	12.8	0.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.5	0.5	0.0	21.3	93.1	0.1	0.8	3.3	3.9	0.0	0.0	0.1	2.8	0.0	1.7	0.3	0.0	0.0	0.1	0.5	0.0	3.1	0.0	0.1	0.2	0.6	2.6	6.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.2	0.0	0.1	0.3	4.5	0.1	3.1	0.1	0.0	0.0	0.0	6.5	0.1	0.5	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.8	1.9	1.1	1.0	1.3	0.8	1.9	0.9
PTHLH	"HHM, PLP, PTHR, PTHRP"	ENSG00000087494	"Parathyroid hormone like hormone"	P12272	12	27958084-27972705	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.6"	"Group enriched"	"Detected in some"	4	"HaCaT: 63.2;HBEC3-KT: 78.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"T-reg: 3.0"	"Lineage enriched"	"Detected in single"	30	"T-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035982	Approved	Approved	Supported	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted in other tissues"			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA035982: AB_10794631"	"unprognostic (1.67e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavourable (1.82e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.87e-3)"	2.9	1.0	6.5	3.5	5.3	0.0	20.2	1.4	8.7	11.0	2.3	1.4	2.1	2.4	11.2	2.0	17.0	1.2	45.6	4.0	4.3	3.5	0.4	0.2	1.3	1.1	1.4	4.3	2.6	1.7	0.7	2.3	3.6	3.1	5.5	1.8	2.4	5.3	2.6	0.7	1.5	1.6	13.4	0.8	3.6	1.9	1.3	1.0	0.1	1.4	15.8	3.4	8.0	12.3	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.3	2.1	0.0	0.0	0.6	0.6	0.0	0.0	0.2	0.1	0.2	0.0	1.7	0.0	0.1	0.5	63.2	0.2	78.1	0.0	1.5	0.3	0.1	0.4	0.0	0.1	0.0	0.1	0.0	4.3	2.0	7.7	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.3	0.1	7.6	0.0	0.0	0.0	3.5	0.0	0.4	0.1	0.0	1.2	0.3	1.9	1.1	16.6	1.0	0.0	2.5	1.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	6.5	5.3	1.4	6.2	4.3	3.5	1.4	4.3	3.1	1.0
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"			32000	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavourable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	22.6	20.4	36.0	14.4	42.3	3.1	19.3	20.5	40.8	24.9	17.9	55.7	23.5	14.5	20.2	29.9	14.6	18.7	18.4	20.0	43.5	23.9	22.3	17.0	21.5	13.0	41.4	31.4	19.4	18.2	33.1	13.0	42.1	30.0	19.2	20.7	11.0	21.9	25.5	17.9	13.5	16.3	21.9	38.0	12.2	17.5	21.2	46.1	2.8	22.5	10.2	14.0	22.2	17.8	8.6	7.2	1.8	3.9	5.2	5.7	4.1	14.6	23.4	32.5	11.7	13.7	14.7	21.0	14.5	20.2	13.6	13.4	10.2	12.2	8.9	33.0	18.6	17.4	19.1	33.3	20.6	0.1	8.9	19.7	12.9	14.0	18.7	0.0	9.4	10.0	16.4	17.0	24.0	40.1	19.8	0.2	18.2	25.5	0.2	0.2	12.6	26.2	13.1	17.8	0.4	28.7	33.5	12.9	16.1	22.7	7.3	14.7	17.2	0.3	24.2	13.4	25.3	15.8	16.3	0.0	0.1	0.9	17.4	0.1	18.1	1.8	3.9	0.0	0.3	1.6	0.0	6.8	0.8	0.1	5.3	8.6	5.7	2.0	1.7	5.2	0.9	7.2	0.2	4.1	36.0	42.3	20.5	40.8	43.5	23.9	41.4	31.4	30.0	46.1
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.7;brain: 65.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.0;REH: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5"	"Low region specificity"	"Detected in many"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"			84000	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favourable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (5.11e-4)"	"unprognostic (3.33e-3)"	7.2	4.7	20.4	24.3	30.0	46.7	4.9	65.2	48.3	5.4	14.5	7.8	5.0	16.6	4.3	4.7	7.9	6.8	6.4	4.7	30.5	7.0	6.8	5.0	11.5	35.6	4.3	25.4	2.4	5.4	5.2	5.3	4.1	3.9	10.1	11.9	8.3	12.6	6.7	2.2	15.1	18.4	5.5	4.8	32.0	10.8	4.3	3.7	37.8	5.6	2.9	35.4	13.0	6.0	26.9	18.7	24.0	25.8	14.7	19.0	21.5	10.9	3.0	0.8	0.9	23.5	1.7	6.4	0.8	0.5	0.6	0.8	2.9	6.3	37.0	1.2	1.7	10.1	0.3	9.2	0.3	2.5	0.2	7.6	2.9	0.5	4.8	8.2	13.8	12.7	13.8	0.8	5.3	0.3	8.9	25.7	0.6	1.1	14.0	16.5	0.6	0.8	41.0	0.2	25.3	2.6	8.6	5.8	1.0	3.9	2.7	1.4	3.3	21.2	5.2	0.4	0.8	0.7	0.3	20.7	8.9	20.0	1.6	17.8	0.7	22.3	23.7	18.0	19.0	22.4	12.5	25.5	9.6	13.3	18.7	26.9	12.1	14.2	24.0	14.7	25.8	6.2	9.5	21.5	20.4	30.0	65.2	48.3	30.5	7.0	4.3	25.4	3.9	3.7
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell line enhanced"	"Detected in some"		"A-431: 11.3;CAPAN-2: 21.8;HaCaT: 17.7;hTCEpi: 24.0;RT4: 13.8;T-47d: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	11.3	1.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	21.8	0.0	3.9	0.0	17.7	0.0	0.0	0.0	2.8	0.2	0.0	4.5	0.0	0.0	0.0	3.6	0.0	24.0	0.0	0.1	0.0	0.1	1.3	0.1	6.3	0.0	0.1	0.1	8.2	0.0	0.6	0.2	0.0	13.8	0.2	1.2	1.3	4.3	0.0	13.3	0.8	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.2	0.2	0.6	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713541	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047183	Approved		Supported	Nucleoplasm,Cytosol			610000	Nucleoplasm	Cytosol	"HPA047183: "	"unprognostic (1.49e-3)"	"prognostic favourable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	72.8	37.7	60.0	78.4	65.2	161.4	76.1	38.2	64.2	75.0	80.9	53.9	33.9	56.3	84.8	59.9	83.7	66.7	47.2	38.7	66.3	48.3	67.3	73.5	63.5	104.0	68.7	59.6	80.5	79.5	31.3	97.9	59.1	54.2	50.0	82.7	42.2	55.5	53.4	60.6	92.5	62.8	58.4	86.6	90.1	69.2	113.9	67.2	127.5	73.4	50.4	118.6	70.0	69.9	189.1	134.7	114.4	126.9	117.0	167.3	255.0	97.8	58.8	83.9	74.8	25.5	34.1	86.2	66.8	56.1	58.4	61.3	56.9	114.7	155.0	76.6	52.1	51.8	118.0	82.3	74.3	122.8	92.8	199.7	48.5	91.9	31.7	226.6	85.5	49.3	30.9	51.7	42.8	95.2	116.0	66.0	50.9	139.8	318.2	309.0	126.3	49.1	219.3	59.8	105.4	71.5	87.5	171.3	105.4	76.8	76.9	58.4	57.9	180.2	70.6	49.3	87.5	60.2	71.8	80.0	39.3	310.3	33.7	139.0	78.9	114.4	113.6	75.3	99.1	114.0	143.5	189.1	143.8	120.6	126.3	160.4	160.6	134.8	23.1	117.0	126.9	134.7	167.3	255.0	60.0	65.2	38.2	64.2	66.3	48.3	68.7	59.6	54.2	67.2
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343865	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 160.7"	"Cell line enriched"	"Detected in some"	12	"AF22: 186.3"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	166965	1800000	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favourable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	7.8	6.6	55.5	2.0	43.3	0.9	27.7	38.6	58.5	30.7	7.2	26.9	9.9	2.5	25.2	18.7	25.0	7.2	18.2	29.4	42.3	29.7	12.7	3.4	6.5	2.6	31.6	27.0	7.2	3.4	160.7	52.5	11.8	31.4	38.5	7.7	19.0	12.0	18.1	1.5	3.6	4.0	17.7	23.4	12.4	5.4	16.8	23.3	1.3	5.1	8.7	5.3	7.7	18.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	186.3	2.2	0.0	0.1	15.2	4.8	14.3	2.7	3.7	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	14.4	0.1	0.0	0.3	0.0	0.0	0.0	0.8	12.7	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.6	0.1	10.3	0.0	0.0	0.0	13.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	43.3	38.6	42.0	42.3	29.7	31.6	27.0	31.4	23.3
PTOV1		ENSG00000104960	"Prostate tumor overexpressed 1"	Q86YD1	19	49850735-49860744	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051812, HPA075125"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA051812: , HPA075125: "	"unprognostic (2.70e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.08e-2)"	"prognostic favourable (9.20e-4)"	"unprognostic (4.65e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.70e-2)"	24.1	49.1	31.6	23.7	33.6	26.8	27.3	37.8	47.1	23.7	20.9	32.5	28.4	25.0	29.9	28.1	16.3	24.9	24.6	23.5	31.1	34.1	24.9	29.3	19.1	22.5	32.2	30.3	34.3	39.3	26.9	40.1	24.5	28.5	32.6	7.3	19.5	44.6	27.4	70.2	23.6	28.8	14.3	29.0	28.9	27.3	27.4	27.9	24.8	33.0	18.6	11.4	18.9	30.4	7.9	9.9	9.5	3.5	6.0	5.1	1.5	11.7	24.3	24.7	26.5	3.5	5.7	15.2	14.5	12.9	13.6	14.3	13.2	20.3	12.7	13.9	7.2	13.1	9.1	11.2	3.3	33.1	61.1	8.2	18.9	20.5	9.0	6.7	16.8	10.9	7.2	5.7	2.3	11.2	19.2	15.4	6.2	14.5	30.2	30.6	15.9	22.3	36.8	10.0	17.8	11.7	20.7	32.1	35.1	12.4	14.5	6.1	14.2	7.5	16.2	16.2	26.9	9.6	11.8	16.3	9.7	16.6	16.7	9.6	20.5	7.9	3.5	5.0	3.6	3.0	4.7	7.9	4.0	3.1	2.4	7.8	5.1	4.7	9.5	6.0	1.7	9.9	1.6	1.5	31.6	33.6	37.8	47.1	31.1	34.1	32.2	30.3	28.5	27.9
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol			4800000	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	16.5	35.1	41.6	19.8	41.2	18.1	23.9	32.0	74.2	27.5	27.4	27.2	30.1	18.3	26.7	26.0	31.8	30.1	28.7	42.1	38.0	32.4	32.6	41.0	22.1	19.8	30.8	35.5	23.2	22.4	55.0	22.5	21.4	37.0	33.4	21.7	20.8	36.0	41.5	110.7	27.2	18.8	35.3	21.9	24.4	23.8	62.4	17.6	23.7	27.2	37.0	21.3	22.1	23.9	12.6	19.2	7.8	15.5	17.7	18.4	14.9	24.8	44.1	27.2	50.4	18.4	22.6	27.2	26.0	29.5	35.8	25.0	23.6	30.7	25.9	19.7	44.1	40.5	28.4	32.1	30.8	46.0	15.5	16.0	46.7	22.4	54.8	27.6	34.8	27.0	31.7	26.1	24.9	36.4	23.7	28.8	30.0	64.5	25.1	17.1	42.7	43.9	25.1	25.1	47.6	37.5	31.2	29.5	20.9	52.7	54.4	32.5	57.7	12.0	26.7	29.7	26.9	30.6	36.7	26.3	67.3	23.4	36.6	18.0	40.9	5.8	15.5	7.8	18.4	15.5	17.6	9.6	14.0	16.4	19.2	12.6	13.1	13.1	5.4	17.7	14.4	13.8	14.0	14.9	41.6	41.2	32.0	74.2	38.0	32.4	30.8	35.5	37.0	17.6
PTPDC1	"FLJ37312, PTP9Q22"	ENSG00000158079	"Protein tyrosine phosphatase domain containing 1"	A2A3K4	9	94030794-94109856	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.1;T-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016747, HPA026832"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA016747: AB_1855908, HPA026832: AB_10602917"	"unprognostic (3.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-2)"	7.0	12.0	7.6	4.4	32.3	1.5	6.4	4.7	16.4	4.7	4.9	25.3	1.4	3.1	6.2	4.9	4.4	4.4	4.7	10.0	12.1	6.9	5.1	2.4	6.8	3.7	13.9	8.9	6.3	12.2	6.8	8.9	3.7	19.9	5.6	5.9	4.1	4.3	4.4	7.0	6.2	3.6	8.3	20.5	3.0	7.1	15.0	13.0	1.6	5.1	1.3	3.9	4.9	3.6	1.1	0.3	0.0	0.2	0.0	2.0	0.1	6.2	2.7	4.9	6.3	6.1	8.5	6.6	4.5	3.2	4.7	3.9	2.6	5.2	5.2	3.1	3.5	4.9	5.0	2.9	4.6	7.0	1.4	1.2	7.2	2.8	8.0	1.4	4.0	8.4	10.5	7.0	9.8	4.9	3.0	0.0	8.7	3.3	5.2	2.2	3.5	5.1	5.7	9.8	0.0	2.6	1.5	4.3	5.5	6.2	5.9	9.7	3.2	2.5	6.9	6.2	3.8	9.5	5.5	7.7	8.4	0.7	4.6	2.6	8.6	0.0	0.2	0.0	0.1	0.0	0.1	0.4	1.1	0.0	0.3	1.1	2.0	0.7	0.0	0.0	0.2	0.2	0.0	0.1	7.6	32.3	4.7	16.4	12.1	6.9	13.9	8.9	19.9	13.0
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase, mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040348, HPA043932"	Approved		Supported	Mitochondria				Mitochondria		"HPA040348: , HPA043932: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	24.0	24.5	22.3	13.1	23.2	19.8	23.3	16.5	25.2	15.7	14.8	18.5	17.5	14.6	14.7	21.4	14.3	16.9	17.9	17.1	18.5	21.9	20.1	21.8	25.1	16.7	23.1	16.2	15.7	39.3	18.3	18.7	21.8	14.4	15.8	11.5	20.1	26.4	19.5	23.4	11.2	13.1	12.7	17.6	14.7	16.9	44.6	10.3	10.8	19.9	15.7	15.0	11.0	11.5	20.4	40.8	22.1	24.4	15.4	17.5	16.8	22.0	12.5	1.5	10.0	11.6	8.9	4.3	13.0	12.3	13.0	12.4	20.7	11.8	15.9	14.4	9.7	18.9	10.3	13.5	13.9	19.4	31.0	7.3	25.6	26.0	17.0	14.2	9.7	8.8	15.3	6.1	18.7	9.2	18.6	12.2	9.5	41.6	12.1	18.3	9.3	23.2	22.2	8.4	13.5	15.6	14.1	9.3	11.4	19.7	7.2	11.7	33.5	15.3	9.9	9.7	14.8	15.6	19.5	18.6	12.4	10.8	7.6	12.3	5.8	6.0	24.4	22.1	16.0	20.9	15.4	20.4	15.2	17.3	27.7	18.0	15.2	14.4	1.9	15.4	19.4	40.8	17.5	16.8	22.3	23.2	16.5	25.2	18.5	21.9	23.1	16.2	14.4	10.3
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase, non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"			11000	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	22.1	22.2	12.1	31.9	16.0	35.3	17.9	12.9	16.6	18.2	17.8	18.8	14.2	10.5	20.0	16.6	23.2	17.1	18.0	20.5	15.8	9.0	43.8	16.7	42.7	36.1	14.1	14.1	21.8	12.2	31.2	18.8	28.3	18.7	20.0	14.8	21.0	16.3	15.0	41.0	18.6	21.9	16.9	15.8	45.3	17.5	23.5	13.3	26.9	15.7	13.9	42.8	20.0	18.4	15.9	9.4	18.8	16.4	3.9	10.7	6.4	20.7	10.5	12.7	8.7	8.3	11.5	18.0	14.0	13.3	41.1	15.0	30.8	43.8	10.3	24.9	12.9	18.5	10.1	40.1	26.2	15.3	9.0	14.6	10.2	16.2	16.6	15.1	20.0	13.4	28.2	18.5	22.8	23.6	25.3	9.5	22.3	11.5	16.2	12.0	6.7	14.4	14.4	14.8	9.8	23.7	15.6	10.2	11.7	20.1	25.5	22.6	16.5	16.2	35.0	35.9	14.4	16.1	17.3	10.4	8.4	12.6	22.5	10.3	13.2	12.0	5.6	18.8	10.7	9.5	7.9	15.9	9.0	8.2	5.5	13.7	7.7	8.3	12.2	3.9	16.4	9.4	7.1	6.4	12.1	16.0	12.9	16.6	15.8	9.0	14.1	14.1	18.7	13.3
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase, non-receptor type 11"	Q06124	12	112418351-112509913	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"			160000	Nucleoli	"Nucleoplasm, Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	25.4	16.8	38.6	14.4	39.0	17.7	30.8	17.5	39.5	18.3	14.7	26.9	9.9	11.9	19.1	13.3	17.6	11.1	13.1	30.1	38.0	32.2	18.0	23.1	15.1	14.5	45.3	22.5	13.1	14.0	29.3	12.9	16.6	26.2	16.2	13.9	9.4	12.0	20.0	34.0	14.1	11.1	28.0	45.7	10.9	12.8	7.6	32.1	10.9	21.2	8.2	13.7	17.4	15.4	17.3	17.1	22.0	11.8	11.3	15.4	6.3	34.8	33.3	24.3	23.0	35.4	34.6	28.8	42.4	46.3	33.4	25.2	33.1	13.5	36.9	22.1	39.2	20.9	31.2	37.6	55.7	28.0	25.7	53.7	31.0	18.1	35.4	43.0	34.3	28.0	37.9	35.9	51.1	27.6	40.7	13.0	32.2	25.2	30.2	20.9	29.4	21.8	31.1	35.9	21.2	30.8	39.2	16.9	20.8	40.8	31.3	26.0	36.0	29.9	33.6	39.4	35.3	23.4	37.1	25.2	41.5	36.9	32.7	30.2	36.8	22.0	11.0	15.0	14.8	9.5	14.1	15.5	13.4	12.1	12.6	17.3	15.4	11.8	10.3	11.3	11.8	17.1	9.8	6.3	38.6	39.0	17.5	39.5	38.0	32.2	45.3	22.5	26.2	32.1
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase, non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 44.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	10.3	5.9	10.8	2.7	16.9	0.7	9.9	5.7	11.6	15.9	4.1	13.0	7.6	1.2	10.8	21.2	18.7	11.4	6.5	5.3	10.4	5.7	22.1	1.6	18.0	4.3	16.9	7.9	24.1	4.3	26.6	38.3	3.0	14.2	12.0	2.4	39.0	5.9	9.4	1.0	43.0	2.3	8.7	10.3	3.5	3.6	12.2	17.6	1.9	16.9	12.4	11.8	15.7	17.6	0.0	0.5	0.1	4.9	0.1	2.3	0.1	5.0	2.5	44.4	4.3	18.8	16.4	0.0	9.3	19.1	3.5	4.5	0.0	2.5	0.0	2.0	10.3	16.7	7.7	14.1	6.9	0.1	5.7	4.2	5.5	0.0	2.3	7.4	0.0	10.5	4.5	2.6	8.6	0.0	0.0	7.2	0.0	2.2	0.6	2.7	10.1	1.9	1.5	0.0	0.0	13.5	21.2	2.6	3.7	2.8	6.2	5.1	3.6	0.2	0.0	3.4	2.7	0.0	1.2	7.6	0.0	0.0	3.6	0.0	1.5	0.0	0.2	0.0	0.2	3.0	2.3	0.0	2.2	0.3	0.5	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.1	0.1	10.8	16.9	5.7	11.6	10.4	5.7	16.9	7.9	14.2	17.6
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase, non-receptor type 14"	Q15678	1	214348696-214552449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: "	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	13.6	10.0	3.0	6.5	2.4	0.2	15.0	0.8	3.7	13.6	8.5	2.6	11.0	1.0	15.4	8.0	8.6	9.2	9.7	7.0	3.5	1.9	11.2	2.0	12.2	6.6	2.4	1.3	11.8	5.0	6.3	4.0	13.2	4.9	10.6	2.9	7.2	9.2	23.4	21.6	18.8	3.5	9.4	4.3	5.3	5.7	8.3	2.4	1.4	8.1	6.9	3.7	12.4	17.7	1.0	0.5	1.9	0.4	1.0	0.6	0.1	8.7	3.9	3.2	4.6	5.6	9.5	9.4	9.9	9.3	7.6	6.4	7.9	4.6	0.0	11.1	23.1	7.8	4.3	11.1	13.1	0.1	3.3	0.8	11.1	1.4	10.1	0.1	0.4	7.1	11.6	13.2	21.3	14.7	0.0	0.1	18.4	0.9	0.1	0.1	7.0	4.2	0.1	16.0	0.0	13.7	4.4	0.0	0.7	12.3	8.1	5.0	8.0	0.3	26.2	17.9	7.0	6.4	14.1	0.5	0.0	0.0	9.6	0.1	14.9	1.3	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.4	0.1	1.0	0.5	0.6	1.9	1.0	0.4	0.5	0.6	0.1	3.0	2.4	0.8	3.7	3.5	1.9	2.4	1.3	4.9	2.4
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase, non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favourable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	16.7	12.5	12.6	27.0	14.3	33.7	19.9	32.6	19.2	14.7	15.0	7.8	17.8	12.9	12.2	14.9	17.0	13.7	15.7	12.8	13.1	6.8	13.6	20.5	21.6	30.3	15.3	10.3	22.1	28.2	10.4	27.2	13.3	13.8	14.4	17.1	7.9	26.3	16.0	13.1	16.0	15.3	11.8	24.7	24.2	13.1	9.4	15.9	61.3	14.7	11.7	28.9	16.5	15.8	29.1	32.8	19.9	28.0	31.7	29.2	19.6	13.0	7.9	9.3	3.1	10.6	19.2	9.0	8.7	19.4	18.7	16.8	17.2	18.9	20.5	14.7	9.0	7.8	15.1	23.9	24.7	7.9	9.1	14.5	6.9	17.9	14.7	33.9	13.8	16.1	22.7	17.0	33.8	9.5	14.0	27.9	15.0	14.9	33.8	28.0	11.1	9.3	11.4	14.6	23.2	15.7	20.9	16.7	8.7	17.7	10.4	15.1	8.7	19.5	7.2	23.8	23.0	17.7	18.8	8.9	8.9	29.6	11.2	18.7	9.9	11.5	28.0	19.9	21.0	24.6	28.2	29.1	24.8	23.1	32.8	20.3	18.3	20.0	10.2	31.7	22.8	28.0	29.2	19.6	12.6	14.3	32.6	19.2	13.1	6.8	15.3	10.3	13.8	15.9
PTPN20	"bA142I17.1, bA42B19.1, CT126, DKFZP566K0524, PTPN20A, PTPN20B"	ENSG00000204179	"Protein tyrosine phosphatase, non-receptor type 20"	Q4JDL3	10	46911396-47002488	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 13.2"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 32.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA043337, HPA046896, HPA048310, HPA069148"	Enhanced		Supported	"Centriolar satellite"				"Centriolar satellite"		"HPA043337: , HPA046896: , HPA048310: , HPA069148: "	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.34e-2)"	1.2	9.7	1.0	1.9	3.1	0.0	3.4	3.4	5.4	0.8	1.3	1.0	5.0	1.1	1.4	0.4	3.4	1.0	0.5	8.8	1.4	3.4	4.3	0.6	0.6	0.2	2.4	0.8	1.6	3.9	0.0	2.3	0.3	11.7	1.1	1.5	1.2	7.8	3.2	11.0	5.6	1.0	0.6	1.2	1.0	1.0	13.2	0.0	0.2	1.9	1.7	0.5	1.0	1.0	2.8	2.2	0.0	0.0	2.3	3.1	0.7	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	1.9	2.4	0.0	0.0	0.0	32.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.5	0.8	5.9	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	2.8	1.7	0.4	1.1	0.6	2.2	3.1	0.0	2.3	0.0	2.2	1.3	0.7	1.0	3.1	3.4	5.4	1.4	3.4	2.4	0.8	11.7	0.0
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase, non-receptor type 23"	Q9H3S7	3	47381011-47413441	"Enzymes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favourable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	15.9	18.5	23.1	17.4	22.3	19.2	21.6	22.8	25.0	18.1	12.5	21.4	14.6	20.7	20.0	15.1	17.2	17.2	12.8	13.2	17.9	11.7	16.4	13.0	16.8	17.8	24.6	23.7	23.4	19.4	53.4	29.9	17.1	20.5	16.9	10.4	15.2	20.8	19.0	25.7	25.9	16.0	16.0	20.3	19.2	17.9	17.8	22.7	9.7	24.8	9.7	11.1	17.7	18.1	1.4	1.1	3.7	1.2	0.9	1.5	0.8	13.1	18.7	10.4	13.5	13.6	10.5	10.0	11.9	11.9	11.2	9.5	15.8	13.0	9.4	11.0	13.5	11.8	9.0	13.0	5.4	8.6	9.6	12.8	13.7	14.6	15.0	7.5	17.5	14.0	13.3	14.5	14.9	13.7	9.6	12.9	11.9	18.3	7.1	6.3	11.1	13.1	4.4	5.1	11.2	8.4	25.3	5.6	13.1	10.5	22.5	8.7	12.8	7.3	13.8	17.2	14.5	23.8	16.9	18.4	12.1	5.4	18.6	7.1	12.1	3.7	1.2	0.0	0.8	0.5	0.6	1.4	0.6	1.3	0.4	0.7	0.6	0.8	1.4	0.9	0.5	1.1	1.5	0.8	23.1	22.3	22.8	25.0	17.9	11.7	24.6	23.7	20.5	22.7
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Cell line enhanced"	"Detected in many"		"HEL: 28.1;HL-60: 24.9;HMC-1: 110.1;THP-1: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli			7400000	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favourable (1.87e-4)"	"prognostic unfavourable (5.42e-4)"	"prognostic favourable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favourable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.8	5.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.9	6.4	2.0	1.5	0.0	3.3	0.0	3.8	0.0	1.2	1.1	28.1	0.6	2.4	0.0	24.9	110.1	0.0	2.8	0.0	1.2	0.0	0.0	0.2	0.0	6.0	9.0	14.6	1.5	0.9	8.2	0.0	14.2	3.0	5.4	0.5	0.0	0.9	4.5	0.0	1.4	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.9	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase, receptor type K"	Q15262	6	127968779-128520674	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 4.8;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"			13000000	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: , HPA054822: "	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favourable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	12.0	5.2	18.6	10.7	20.3	1.2	20.9	4.7	24.4	12.2	21.9	25.6	11.2	25.7	12.1	10.3	9.1	13.2	29.6	11.4	17.2	12.6	13.3	23.6	17.4	5.7	20.5	19.3	15.6	25.7	11.4	12.2	17.4	14.9	16.3	23.4	3.9	18.3	17.5	9.1	13.5	27.4	14.6	17.1	6.4	24.6	2.7	23.7	15.3	10.1	6.5	7.6	18.4	15.1	4.8	0.0	0.0	0.0	0.4	1.6	0.2	4.4	4.8	2.9	0.2	6.1	8.2	2.9	12.1	23.5	5.0	4.6	8.0	3.7	0.0	3.7	11.1	12.7	3.0	9.6	7.1	13.4	4.9	0.1	7.4	11.1	7.5	0.0	0.4	6.0	8.9	10.5	14.4	13.7	0.0	0.2	12.3	9.0	6.8	0.0	3.0	6.2	24.5	6.2	0.8	12.4	9.2	15.3	0.0	12.5	14.0	0.7	3.8	0.3	23.1	7.9	5.5	15.3	10.9	0.1	1.6	0.0	10.1	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	4.8	0.4	1.6	0.0	0.4	0.0	0.0	0.1	0.2	18.6	20.3	4.7	24.4	17.2	12.6	20.5	19.3	14.9	23.7
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 14.0;RT4: 26.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: "	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favourable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.5	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	26.7	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria				Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	15.9	22.9	17.1	12.4	17.1	9.9	20.7	12.5	22.1	15.6	17.2	11.8	16.3	11.6	14.3	36.7	16.4	13.8	13.1	12.6	19.3	17.8	14.8	34.7	12.1	12.5	16.7	15.2	14.2	19.9	10.3	18.3	13.6	21.0	15.9	20.7	8.1	13.7	18.7	23.3	11.4	11.0	16.8	17.1	15.5	14.3	15.7	18.1	9.0	11.8	13.5	16.9	13.0	10.5	15.6	21.6	12.6	29.3	13.1	15.5	13.0	19.8	37.9	12.2	11.1	23.2	20.0	13.1	19.1	16.9	16.4	24.0	24.4	15.6	14.4	29.0	16.0	19.8	26.2	24.6	23.9	27.7	35.7	25.7	19.7	44.8	35.8	22.7	14.6	22.5	32.1	25.4	29.6	27.2	28.6	16.1	24.3	47.9	19.4	18.5	10.5	30.0	10.6	20.5	21.0	27.3	28.6	15.8	20.5	9.9	10.8	23.4	25.2	16.2	17.9	21.4	21.7	12.8	20.7	20.9	23.2	21.4	14.1	14.2	16.3	1.9	25.8	1.1	9.2	24.4	12.4	15.6	10.8	10.4	18.5	13.1	15.5	11.1	12.6	13.1	29.3	21.6	12.3	13.0	17.1	17.1	12.5	22.1	19.3	17.8	16.7	15.2	21.0	18.1
PTTG1	"EAP1, HPTTG, PTTG, securin, TUTR1"	ENSG00000164611	"Pituitary tumor-transforming 1"	O95997	5	160421822-160428744	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.5;testis: 100.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.5"	"Lineage enriched"	"Detected in all"	7	"T-cells: 54.5"									"CAB008373, HPA008890, HPA045034"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: "	"unprognostic (6.48e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.46e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (7.50e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.35e-2)"	1.5	1.7	2.1	16.2	5.5	34.1	2.9	1.4	4.6	3.8	8.2	1.0	0.7	5.8	1.3	2.6	24.1	1.0	1.9	2.3	5.1	2.7	1.7	1.4	3.8	19.2	1.5	2.2	1.1	1.2	0.2	2.0	5.0	2.2	1.6	11.3	1.5	4.5	1.1	1.2	8.7	5.8	4.5	1.4	7.5	3.4	100.1	1.0	29.8	23.9	23.2	35.1	3.3	7.2	8.1	6.1	2.4	2.1	3.3	54.5	4.7	45.5	23.7	53.6	38.4	9.1	8.9	16.7	24.2	55.5	64.3	70.5	45.8	40.1	49.8	21.6	27.5	23.9	33.2	67.3	92.3	56.9	30.2	26.2	32.1	27.5	1.8	23.8	23.1	4.2	11.3	43.6	26.5	45.3	21.0	38.8	66.0	21.4	28.4	58.5	27.0	34.5	26.5	63.0	42.7	32.8	9.3	33.4	21.2	34.9	21.3	71.9	43.5	26.1	19.3	29.1	38.9	22.7	70.6	33.4	29.8	56.9	31.3	41.2	51.5	1.9	0.7	2.4	7.0	2.1	2.5	8.1	14.4	16.2	6.1	5.5	3.6	8.9	0.8	3.3	1.4	5.8	54.5	4.7	2.1	5.5	1.4	4.6	5.1	2.7	1.5	2.2	2.2	1.0
PTTG1IP	"C21orf1, C21orf3, PBF"	ENSG00000183255	"PTTG1 interacting protein"	P53801	21	44849585-44873903	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034146, HPA061827"	Uncertain		Supported	Nucleoplasm			380000	Nucleoplasm		"CAB034146: AB_1568894, HPA061827: "	"unprognostic (1.78e-2)"	"prognostic unfavourable (8.61e-4)"	"unprognostic (5.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (5.40e-4)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.90e-1)"	47.1	52.1	46.7	33.6	48.7	29.6	53.3	20.9	38.7	50.1	47.2	57.0	29.3	43.6	53.2	47.6	36.2	40.4	50.9	59.9	51.8	31.0	75.6	71.9	58.2	38.8	59.6	30.2	49.6	39.8	23.4	27.3	111.6	43.0	40.5	41.4	50.0	46.0	57.7	30.8	32.1	72.8	51.8	45.8	38.8	58.9	35.2	52.6	19.8	62.4	25.1	25.3	48.2	60.0	5.3	40.5	58.1	35.6	12.5	16.8	37.2	30.8	17.4	20.6	19.6	40.4	23.6	16.7	28.2	40.2	22.9	22.2	37.4	42.3	4.2	108.0	44.0	14.2	9.4	18.0	22.1	7.2	10.4	32.9	11.0	32.8	39.5	12.5	11.2	36.3	29.7	24.9	17.4	49.2	16.5	11.1	70.7	13.3	9.1	12.8	21.9	21.9	9.0	21.2	20.3	98.8	10.8	15.6	24.1	31.4	34.5	61.2	26.7	21.0	67.5	29.1	17.0	22.6	43.3	10.6	9.9	5.3	19.5	28.2	26.0	58.1	35.6	20.8	10.3	28.9	16.8	5.3	13.4	10.8	40.5	5.0	13.0	8.9	49.4	12.5	30.4	18.4	16.8	37.2	46.7	48.7	20.9	35.7	51.8	31.0	59.6	30.2	43.0	52.6
PUF60	"FIR, RoBPI, SIAHBP1"	ENSG00000179950	"Poly(U) binding splicing factor 60"	Q9UHX1	8	143816344-143829859	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045733, HPA052096, HPA059714"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110"	"unprognostic (3.49e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.42e-2)"	35.4	21.1	28.5	19.1	29.5	51.1	20.8	22.8	40.0	19.5	28.4	37.3	16.7	41.2	25.6	21.3	23.8	30.8	23.8	26.7	29.8	25.5	21.7	34.4	18.0	28.7	29.9	30.9	23.9	24.4	13.3	21.6	33.0	24.3	22.8	11.2	22.8	39.1	31.4	47.5	36.6	23.8	21.0	29.4	26.2	28.5	28.9	27.9	28.7	23.2	24.2	21.9	20.2	21.3	40.9	42.9	28.3	44.6	41.4	50.9	53.3	21.0	49.0	7.4	7.1	4.0	3.6	12.2	16.9	6.2	16.3	16.5	21.3	23.8	18.4	16.1	13.2	18.6	20.1	21.0	0.9	20.2	32.4	23.7	25.9	22.6	14.6	7.8	16.6	10.0	13.2	21.5	6.6	15.8	19.1	8.2	4.8	72.3	35.4	5.2	18.4	43.6	19.2	10.2	19.4	4.6	20.9	14.4	17.1	21.6	9.2	17.3	26.1	3.6	17.9	16.8	40.9	19.9	21.9	15.4	21.6	24.3	16.9	11.5	16.2	24.1	37.9	28.3	45.6	43.3	50.9	38.6	38.3	45.2	42.9	40.9	35.8	41.7	21.1	41.4	44.6	26.2	44.9	53.3	28.5	29.5	22.8	40.0	29.8	25.5	29.9	30.9	24.3	27.9
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favourable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	25.1	26.3	30.1	17.1	35.0	36.3	27.0	38.1	35.9	24.0	20.8	28.1	16.5	17.6	27.6	24.5	22.6	29.1	18.3	22.0	24.2	29.7	23.6	20.3	20.4	18.8	22.8	25.5	33.9	21.8	38.1	31.7	31.4	33.1	22.8	24.0	25.8	25.4	23.9	40.7	29.7	22.8	25.9	20.1	19.1	20.6	15.9	22.1	27.9	28.3	15.6	27.1	23.4	24.1	18.9	25.2	27.6	24.8	28.5	27.1	22.0	17.2	23.1	37.7	23.9	29.7	25.7	25.8	20.8	25.3	21.5	24.6	24.2	29.9	20.4	21.9	27.9	25.4	30.9	22.9	27.9	16.9	26.8	22.0	27.1	28.8	20.8	26.7	21.2	27.4	29.0	28.6	30.4	29.4	30.3	19.3	24.6	14.4	26.1	19.3	38.5	16.2	27.2	25.7	21.7	31.5	26.2	31.2	23.8	28.6	22.2	24.5	22.3	20.4	30.6	18.0	16.3	23.9	20.5	15.5	14.2	22.5	16.1	19.9	22.7	27.6	24.8	18.5	25.7	23.8	26.3	18.9	23.2	25.0	25.2	18.8	26.6	26.9	14.8	28.5	24.6	14.6	27.1	22.0	30.1	35.0	38.1	35.9	24.2	29.7	22.8	25.5	33.1	22.1
PUM2	"KIAA0235, PUMH2"	ENSG00000055917	"Pumilio RNA binding family member 2"	Q8TB72	2	20248691-20352234	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030316, HPA049670"	Approved		Enhanced	Cytosol				Cytosol		"HPA030316: AB_10610289, HPA049670: "	"unprognostic (2.41e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.87e-2)"	20.3	20.7	21.1	35.2	20.0	18.3	25.2	41.2	26.0	31.4	35.4	19.5	13.5	20.5	26.1	20.5	25.1	19.9	25.7	25.7	22.1	19.8	22.9	25.6	24.6	26.8	20.7	21.1	29.1	23.2	32.9	24.2	39.3	17.5	24.3	22.9	21.8	22.7	42.6	19.2	27.7	27.8	20.5	18.5	25.4	23.5	14.6	20.2	56.2	35.7	21.7	28.1	26.8	29.0	6.6	5.6	15.3	8.6	9.4	10.0	4.8	23.5	17.3	21.1	15.1	13.0	13.8	22.7	17.2	17.1	15.4	14.0	14.3	11.1	31.6	3.9	14.5	13.2	21.2	11.8	23.8	29.5	13.6	32.2	12.7	19.5	14.3	33.9	30.9	9.9	25.1	14.7	26.6	17.8	24.6	26.6	18.2	11.3	30.4	19.7	18.6	11.3	26.0	36.6	23.8	14.2	21.4	18.2	26.1	14.4	18.9	14.9	11.1	19.0	17.8	20.2	19.7	12.8	21.1	31.7	38.3	59.9	12.2	24.5	17.3	11.8	5.5	7.4	8.1	6.7	9.8	6.4	9.0	9.8	5.6	6.6	10.0	8.0	15.3	9.4	8.6	4.7	6.8	4.8	21.1	20.0	41.2	26.0	22.1	19.8	20.7	21.1	17.5	20.2
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844241	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 71.7;HEL: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli				Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.4	17.0	11.5	19.0	15.2	14.8	22.1	15.6	17.7	18.9	16.9	8.3	9.8	11.2	17.1	10.6	29.3	15.7	10.5	15.1	16.7	5.9	23.2	18.4	18.6	18.9	14.0	14.3	24.4	17.8	11.5	23.1	15.9	15.8	18.0	17.3	6.1	20.7	10.3	21.0	16.4	13.2	19.5	18.2	17.8	14.2	13.8	14.9	15.4	15.1	14.5	18.9	20.1	21.6	15.3	13.7	3.8	12.8	15.9	18.4	7.8	16.6	12.3	10.4	10.6	8.7	9.3	11.9	15.6	8.2	16.1	15.1	9.3	7.8	18.4	3.6	10.6	8.4	18.7	13.4	21.0	71.7	6.6	69.9	12.4	11.1	11.6	30.8	13.1	7.5	5.9	13.0	18.7	11.8	7.3	8.4	13.9	7.6	15.6	25.1	26.6	5.4	18.4	8.1	7.9	10.9	11.3	10.8	10.3	9.4	8.7	8.4	5.5	16.7	11.3	10.9	8.9	10.3	20.8	3.9	6.4	26.0	8.2	11.2	7.9	3.8	9.2	2.7	13.2	12.8	18.4	15.3	13.7	13.2	12.1	13.5	15.3	14.8	1.3	15.9	10.4	13.7	10.0	7.8	11.5	15.2	15.6	17.7	16.7	5.9	14.0	14.3	15.8	14.9
PURB	PURBETA	ENSG00000146676	"Purine rich element binding protein B"	Q96QR8	7	44876293-44885361	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048766			Supported	Nucleoplasm			13000	Nucleoplasm		"HPA048766: "	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.22e-2)"	12.1	9.6	19.1	12.0	20.3	13.5	14.2	30.8	22.0	13.7	14.2	11.1	6.6	8.7	13.1	9.4	13.9	11.6	11.6	9.1	18.5	9.2	11.3	10.0	12.4	11.1	15.6	13.4	12.5	10.1	17.4	10.4	15.4	12.9	12.8	9.0	11.0	11.3	11.6	14.3	16.7	10.7	18.5	12.4	10.8	10.8	7.8	15.0	12.3	13.9	7.8	11.9	11.7	11.8	1.5	1.6	3.3	1.2	1.5	2.0	0.6	8.8	5.0	9.0	16.9	8.4	13.4	6.0	12.3	9.7	9.3	9.0	7.5	7.0	13.4	10.8	14.2	16.5	8.4	10.9	18.5	10.8	6.8	6.7	12.3	4.2	8.4	10.5	10.7	11.0	14.0	17.7	13.0	9.8	11.7	12.6	19.4	12.3	8.7	13.2	14.0	8.8	7.2	27.3	8.7	7.7	15.4	8.9	12.7	12.3	25.7	7.6	17.2	12.0	16.5	16.3	17.9	10.6	20.7	22.1	19.3	4.3	12.2	12.3	21.6	1.6	1.2	1.7	1.9	1.1	2.0	0.9	1.6	1.5	0.6	1.5	1.5	1.7	3.3	1.5	0.9	1.6	1.2	0.6	19.1	20.3	30.8	22.0	18.5	9.2	15.6	13.4	12.9	15.0
PUS1		ENSG00000177192	"Pseudouridylate synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA051636: , HPA057593: "	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.7	15.8	18.8	19.5	23.3	26.2	11.2	8.8	16.9	8.7	11.9	9.4	11.0	12.4	13.6	18.7	16.5	12.9	25.1	8.6	15.6	8.3	10.7	22.8	11.0	21.4	11.7	15.8	10.1	19.8	7.2	9.5	8.3	11.7	11.7	10.5	7.6	11.4	15.7	13.5	15.4	13.9	9.7	6.2	17.4	13.6	11.9	16.4	11.6	10.3	11.6	15.8	10.8	12.8	5.9	4.6	1.9	2.0	9.1	4.0	1.3	15.2	20.0	4.7	8.4	4.6	7.9	29.2	11.8	5.0	9.0	5.8	22.1	10.0	18.3	13.7	6.4	19.4	15.6	11.2	5.9	8.1	31.6	18.4	9.7	19.3	12.4	31.4	16.9	7.9	9.1	10.3	8.8	8.8	22.8	5.6	5.2	26.6	20.6	28.2	25.1	30.5	19.7	6.8	18.9	7.3	21.3	13.3	7.4	9.9	13.6	10.9	14.9	34.0	7.7	7.2	15.4	15.3	17.1	15.5	11.6	21.7	7.4	25.2	9.9	1.2	2.0	0.4	3.2	1.4	2.2	5.9	2.7	3.3	1.6	5.5	4.0	2.1	1.9	9.1	1.3	4.6	2.4	1.3	18.8	23.3	8.8	16.9	15.6	8.3	11.7	15.8	11.7	16.4
PUS7L	DKFZP434G1415	ENSG00000129317	"Pseudouridylate synthase 7 like"	Q9H0K6	12	43718993-43758817	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056203, HPA058750"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA056203: , HPA058750: "	"unprognostic (3.41e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	8.0	7.0	14.9	9.1	18.5	6.1	10.6	20.3	16.6	9.2	7.3	3.7	8.3	7.3	7.3	7.9	9.7	6.1	7.7	6.9	14.2	9.0	9.3	7.9	5.4	10.4	8.3	12.6	10.2	9.5	12.7	21.7	7.7	11.5	8.3	9.1	2.7	8.4	9.4	6.1	7.2	7.6	6.3	12.1	9.2	7.6	5.6	11.3	13.0	11.6	6.1	11.3	8.6	8.3	6.6	5.2	8.6	4.3	5.1	6.9	3.4	6.4	4.8	4.3	2.4	3.0	10.7	7.6	5.6	4.8	7.5	5.8	17.2	4.6	14.7	7.2	6.9	5.8	6.2	5.7	13.0	4.5	3.8	10.8	5.4	6.4	3.7	17.2	7.0	4.4	4.3	7.8	8.2	5.4	18.7	6.5	17.5	2.6	8.8	4.4	7.8	5.2	8.4	10.1	8.8	3.3	4.9	7.2	2.3	6.9	7.6	3.0	8.9	4.9	3.9	7.7	5.1	8.9	8.8	5.7	9.8	14.9	7.1	28.4	2.5	8.6	4.3	4.8	5.0	3.8	6.2	4.4	5.4	5.3	4.4	6.6	4.8	6.9	3.1	5.1	3.1	5.2	2.1	3.4	14.9	18.5	20.3	16.6	14.2	9.0	8.3	12.6	11.5	11.3
PUSL1	FLJ90811	ENSG00000169972	"Pseudouridylate synthase-like 1"	Q8N0Z8	1	1308567-1311677	"Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032057, HPA039999"	Uncertain		Enhanced	Vesicles				Vesicles		"HPA032057: AB_10601251, HPA039999: "	"unprognostic (2.04e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (7.55e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavourable (1.62e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-1)"	7.6	11.7	8.0	8.8	6.8	8.8	9.1	9.4	9.2	13.6	9.2	9.8	15.4	9.9	11.2	14.4	17.1	9.1	10.3	9.2	7.9	6.0	9.5	16.2	7.1	7.8	12.2	6.8	11.4	19.5	6.2	13.2	8.0	6.6	12.4	5.0	9.5	23.3	13.7	11.0	17.0	9.6	7.5	6.5	8.8	11.4	8.3	7.7	9.0	10.6	16.7	11.9	10.9	9.8	9.0	11.3	5.8	16.6	8.1	13.4	7.8	10.0	4.5	4.6	7.8	2.2	3.6	6.3	9.1	5.0	9.0	6.1	15.6	6.6	6.1	7.4	4.4	8.2	5.1	8.3	1.6	6.8	33.4	8.5	8.2	9.3	8.5	10.1	8.2	3.5	4.3	4.9	3.8	4.0	10.8	2.8	4.1	8.2	9.5	13.1	6.2	20.0	8.8	3.5	14.5	6.9	3.8	21.3	7.7	7.1	21.3	7.2	5.9	6.7	4.7	5.8	6.0	9.4	8.6	11.2	3.5	26.1	7.2	9.1	3.4	3.6	12.3	5.8	10.6	16.6	10.6	8.9	11.6	8.7	11.3	9.0	7.7	7.7	4.9	8.1	14.0	7.1	13.4	7.8	8.0	6.8	9.4	9.2	7.9	6.0	12.2	6.8	6.6	7.7
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"Poliovirus receptor"	P15151	19	44643798-44663583	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 65.6"	"Cell line enhanced"	"Detected in many"		"TIME: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;monocytes: 8.1"									HPA012568	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"		940000000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248"	"unprognostic (2.90e-3)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavourable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavourable (2.75e-4)"	10.0	13.9	7.4	7.5	8.1	4.7	9.2	11.0	11.0	6.5	10.6	6.5	4.1	13.7	11.3	5.7	6.6	8.8	9.2	23.5	5.8	10.0	10.6	65.6	14.8	2.4	6.0	6.5	10.4	15.9	9.9	20.7	15.5	9.7	10.4	7.7	6.6	8.5	6.9	19.8	5.5	13.0	11.1	7.0	4.8	12.3	6.0	7.2	2.3	8.5	10.8	3.7	8.3	6.7	0.0	5.6	1.2	8.1	0.6	0.4	2.2	21.5	15.1	1.5	6.1	1.8	2.2	2.6	36.4	10.2	12.0	13.7	8.8	9.2	0.0	21.0	10.5	14.2	5.1	13.8	8.0	2.6	9.9	3.8	9.5	5.9	12.7	1.4	8.3	2.9	6.8	10.5	20.7	13.0	1.8	0.0	5.5	1.9	1.3	1.3	3.4	11.2	0.0	6.9	2.0	25.7	6.6	6.5	7.6	23.1	14.5	5.1	8.2	3.7	52.7	14.5	17.9	10.7	28.4	0.0	2.1	0.0	11.6	7.4	8.2	0.0	6.4	0.0	0.2	6.6	0.0	0.0	0.0	0.4	5.6	0.0	0.2	0.1	1.2	0.6	8.1	0.5	0.0	2.2	7.4	8.1	11.0	11.0	5.8	10.0	6.0	6.5	9.7	7.2
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2, small subunit processome component"	Q15269	21	44107290-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 30.5;Daudi: 26.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA024573	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	6.1	6.1	11.3	7.7	14.6	3.6	6.3	9.7	12.8	4.0	9.0	9.6	2.4	4.4	7.8	9.2	8.2	5.9	4.8	4.6	6.8	4.8	6.9	8.7	5.0	7.9	15.4	5.7	5.0	12.8	1.4	4.0	7.6	8.9	8.1	1.8	4.9	8.2	5.2	8.0	14.7	5.6	2.2	6.4	8.8	10.6	5.3	17.2	3.6	4.8	8.6	16.8	5.0	5.7	6.8	2.6	2.9	4.3	3.4	6.9	5.0	1.1	0.4	0.3	1.2	3.5	3.6	9.2	11.8	6.2	15.7	10.6	30.5	0.5	26.4	0.4	0.0	1.3	0.5	8.9	9.1	6.4	19.0	3.1	5.5	7.0	2.3	2.3	0.9	0.2	0.0	10.9	0.0	0.5	10.1	10.6	5.2	0.3	0.1	0.7	0.3	1.1	1.5	0.1	13.6	0.0	0.4	9.2	1.6	0.6	1.0	7.4	0.0	1.0	6.0	6.4	1.1	14.2	1.4	14.3	17.0	1.2	0.4	2.8	9.1	0.2	2.2	2.9	6.0	3.1	6.6	6.8	4.9	6.9	1.6	4.1	4.9	6.1	1.2	3.4	4.3	2.6	3.5	5.0	11.3	14.6	9.7	12.8	6.8	4.8	15.4	5.7	8.9	17.2
PWWP2A	KIAA1935	ENSG00000170234	"PWWP domain containing 2A"	Q96N64	5	160061801-160119423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046733, HPA058233"			Supported	"Nucleoplasm,Focal adhesion sites"				Nucleoplasm	"Focal adhesion sites"	"HPA046733: , HPA058233: "	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.24e-3)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (3.51e-4)"	8.4	9.3	9.5	12.7	22.3	11.9	9.1	52.7	16.0	14.4	13.6	19.9	5.3	9.6	10.8	7.2	8.7	9.5	8.1	7.4	15.9	8.8	10.3	8.6	9.8	12.0	25.2	8.9	10.5	10.5	10.6	15.1	11.2	17.0	11.9	14.7	10.3	8.8	8.4	7.0	14.7	10.6	9.3	13.8	12.5	11.8	6.3	21.3	18.6	9.8	5.8	11.4	10.7	10.1	6.0	2.9	6.0	4.4	1.1	4.9	0.9	10.6	5.1	13.4	11.4	14.9	11.7	18.9	8.5	7.0	7.6	7.8	16.6	20.8	17.2	13.1	6.5	7.7	11.6	13.3	12.6	17.8	12.9	12.3	9.5	8.5	11.4	12.4	9.4	8.3	6.7	15.3	11.7	12.2	9.4	11.2	12.9	8.9	10.6	12.1	15.7	6.7	16.7	11.9	11.0	9.3	7.6	15.8	11.0	14.4	14.5	15.4	11.2	13.8	16.2	13.3	9.2	9.9	16.5	12.8	11.5	15.3	8.8	12.6	13.1	6.0	4.4	2.4	2.8	2.0	2.2	6.0	3.0	3.3	2.9	3.7	4.9	2.7	5.0	1.1	2.6	2.7	2.5	0.9	9.5	22.3	52.7	16.0	15.9	8.8	25.2	8.9	17.0	21.3
PWWP2B	"bA432J24.1, FLJ46823, PWWP2"	ENSG00000171813	"PWWP domain containing 2B"	Q6NUJ5	10	132397168-132417863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.2;MCF7: 22.0;SK-BR-3: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038056, HPA038502, HPA078118"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA038056: AB_10697093, HPA038502: , HPA078118: "	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"prognostic favourable (5.75e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-2)"	7.3	14.1	5.1	4.2	14.7	3.0	6.6	1.8	13.4	5.1	10.0	2.0	9.0	6.4	4.3	3.3	8.9	5.1	8.4	3.8	6.4	4.3	4.1	2.3	5.5	3.7	4.1	6.9	4.7	23.4	8.9	6.3	12.6	4.3	5.5	3.3	5.1	14.0	5.9	19.5	6.2	5.7	5.4	1.1	14.9	14.7	6.5	7.1	2.1	5.7	4.8	6.9	5.8	4.5	4.9	2.1	3.7	7.2	7.2	2.0	1.0	10.7	6.5	0.8	4.2	0.6	0.5	29.2	1.3	1.3	0.8	0.7	2.9	6.3	0.0	4.5	0.8	11.5	1.2	1.5	0.1	8.0	3.2	1.2	5.7	2.8	3.1	3.5	4.8	0.4	4.1	0.4	1.2	0.6	2.1	0.9	0.5	22.0	0.1	13.3	1.3	4.8	2.6	0.0	2.4	0.3	8.2	5.4	6.7	0.8	17.0	3.3	5.2	8.7	2.1	0.4	2.3	2.0	0.9	0.2	0.1	2.2	2.6	3.2	0.8	0.0	2.4	3.7	2.0	5.0	1.6	1.5	1.1	1.3	2.1	4.9	0.9	0.8	0.4	7.2	7.2	1.3	0.0	1.0	5.1	14.7	1.8	13.4	6.4	4.3	4.1	6.9	4.3	7.1
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426126	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 81.1"	"Cell line enhanced"	"Detected in many"		"U-937: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Approved		Supported	"Plasma membrane,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favourable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	9.3	9.4	20.7	17.0	51.4	33.6	7.6	22.6	31.4	28.9	8.9	81.1	2.4	6.3	14.2	5.3	6.6	8.0	9.6	7.5	33.7	19.9	10.4	5.7	8.2	23.8	68.6	23.4	11.1	8.5	13.7	6.1	17.5	43.9	6.0	6.4	4.4	8.8	7.7	7.6	7.5	7.7	11.8	55.9	13.5	8.3	6.7	56.6	3.7	40.3	2.5	26.1	9.8	13.1	31.3	18.8	31.8	22.5	8.7	11.2	13.4	4.2	2.5	1.9	3.5	26.6	23.6	5.6	6.9	14.6	6.6	9.3	1.2	0.9	22.6	1.6	11.6	1.3	6.0	4.3	7.0	5.6	3.8	3.9	3.0	1.7	31.0	33.5	6.9	20.2	10.5	8.3	14.4	5.8	4.7	7.4	11.8	1.6	7.3	34.6	2.3	6.3	12.6	3.3	4.0	4.2	2.4	1.7	1.2	4.7	3.3	5.4	11.4	34.7	5.9	8.3	3.4	15.7	7.2	5.8	5.7	22.5	12.0	47.6	3.4	14.6	20.1	29.4	11.2	16.2	9.9	29.0	8.1	9.4	18.8	31.3	7.1	8.4	31.8	8.7	22.5	13.5	8.7	13.4	20.7	51.4	22.6	31.4	33.7	19.9	68.6	23.4	43.9	56.6
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 49.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"				"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: "	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavourable (1.09e-4)"	"prognostic unfavourable (3.72e-5)"	"prognostic unfavourable (7.12e-5)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	35.4	26.2	17.9	26.7	16.5	31.6	45.9	15.5	18.6	25.0	29.0	12.4	31.7	25.6	27.6	30.9	16.0	29.8	31.8	26.2	18.0	7.6	27.6	13.1	35.8	42.9	15.7	8.1	14.8	16.3	17.6	13.9	34.0	15.8	24.9	23.5	24.7	22.1	40.1	98.5	19.7	34.7	44.4	20.3	34.0	20.6	19.8	14.4	9.9	26.7	22.8	11.6	30.1	45.7	0.5	7.6	49.5	12.3	14.4	26.3	14.5	32.6	16.2	5.8	5.8	11.7	30.4	39.3	27.6	24.1	22.5	11.9	18.9	20.5	2.2	18.2	28.1	23.3	4.0	50.3	18.0	1.8	3.6	0.4	11.9	6.7	16.9	0.5	0.7	14.8	33.0	23.6	26.8	40.0	5.7	3.7	44.0	21.6	2.0	0.7	8.2	56.3	4.8	9.6	2.0	23.1	31.4	9.5	2.8	24.8	7.6	14.9	18.8	2.7	52.7	15.7	17.2	19.5	32.9	4.0	2.2	0.8	45.1	4.9	30.6	9.8	12.3	13.4	26.3	4.4	14.2	0.5	12.1	17.2	7.6	0.4	9.6	12.8	49.5	14.4	0.2	1.2	9.1	14.5	17.9	16.5	15.5	18.6	18.0	7.6	15.7	8.1	15.8	14.4
PYCARD	"ASC, CARD5, TMS-1"	ENSG00000103490	"PYD and CARD domain containing"	Q9ULZ3	16	31201485-31203450	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 130.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 33.9;NB-4: 53.4;THP-1: 39.4;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4"									"CAB006853, CAB015948, HPA049074, HPA054496"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol			1100000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506"	"unprognostic (1.00e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavourable (6.09e-7)"	"unprognostic (4.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.97e-2)"	11.6	4.4	3.6	16.7	4.6	22.4	8.6	3.6	3.3	8.2	26.8	6.8	4.1	38.7	5.4	7.9	20.7	6.8	8.5	6.6	2.4	2.6	5.6	6.8	15.0	32.8	6.4	1.8	6.6	6.1	1.3	3.2	6.6	4.0	9.7	4.4	4.7	9.6	5.6	3.5	31.2	29.9	3.5	6.4	34.1	13.3	3.7	3.3	20.6	5.5	22.3	26.3	7.9	11.8	17.1	66.8	130.8	90.4	16.0	16.0	53.1	5.6	13.3	0.1	0.0	1.3	3.0	0.1	2.8	3.9	1.8	1.2	0.0	7.1	2.3	0.0	2.7	15.7	0.6	10.5	0.0	17.0	0.0	2.2	1.6	4.3	4.6	19.8	15.7	3.9	5.5	0.8	0.1	3.8	9.7	3.6	0.5	33.9	0.0	53.4	3.6	0.0	17.2	0.0	7.4	0.1	5.5	0.1	0.0	2.4	0.0	2.7	3.3	39.4	2.5	0.1	0.2	2.3	0.0	0.1	0.0	0.0	1.3	24.4	0.0	37.8	90.4	71.4	15.1	87.5	9.5	17.1	12.7	15.5	66.8	15.2	8.9	12.3	130.8	16.0	85.0	61.0	16.0	53.1	3.6	4.6	3.6	3.3	2.4	2.6	6.4	1.8	4.0	3.3
PYGL		ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944736	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 56.1;HMC-1: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 36.0;neutrophil: 41.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"			17000000	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	47.6	9.9	4.9	9.7	6.8	40.0	28.1	1.3	3.9	17.2	10.1	3.0	23.7	1.7	10.9	7.3	24.8	7.8	5.5	15.0	3.9	3.4	6.8	58.8	19.6	25.6	6.5	1.6	15.4	4.1	12.5	3.7	23.3	5.3	11.4	10.3	17.8	11.8	55.2	7.1	15.3	3.5	11.2	8.7	38.8	4.5	6.8	5.4	2.4	7.1	9.1	7.3	18.4	24.3	0.0	7.3	41.4	13.8	0.1	0.0	5.5	28.3	8.0	2.1	13.2	9.8	11.8	23.0	5.7	4.8	15.7	24.0	21.1	3.6	0.0	11.1	33.8	56.1	21.4	28.8	27.3	0.1	9.0	5.4	12.8	16.4	17.6	20.6	62.0	25.1	11.8	21.3	9.0	13.9	2.2	0.1	11.1	28.3	0.0	28.4	7.9	29.7	0.5	7.3	1.1	21.8	19.0	0.9	0.9	25.8	9.0	0.3	4.2	40.4	0.6	6.1	10.2	11.4	18.3	0.2	0.0	0.0	5.6	21.3	3.2	11.3	13.8	36.0	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	41.4	0.1	3.9	0.3	0.0	5.5	4.9	6.8	1.3	3.9	3.9	3.4	6.5	1.6	5.3	5.4
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"				"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: , HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.34e-4)"	17.5	21.4	16.2	21.2	14.8	13.2	20.3	16.3	17.1	15.2	21.2	14.2	27.1	21.8	16.1	30.8	46.7	16.3	21.5	13.6	14.0	14.7	19.4	31.3	14.4	28.6	14.7	14.0	13.3	24.8	15.3	19.8	21.5	12.8	20.7	21.5	18.3	22.9	24.5	18.2	27.2	29.9	16.3	13.2	25.5	15.8	21.1	14.1	26.3	22.5	31.2	39.1	16.5	19.9	29.5	35.9	21.6	27.2	14.4	53.6	24.1	17.4	13.9	20.4	11.3	12.4	16.2	33.5	12.8	15.5	12.2	10.3	20.3	20.8	21.9	19.6	12.4	13.7	15.7	27.5	9.8	16.9	11.7	17.8	11.9	25.0	15.2	20.6	16.3	14.5	17.8	13.7	20.6	12.9	15.2	24.4	14.2	26.2	13.2	36.8	35.6	7.3	11.9	8.1	25.1	24.9	24.8	13.8	15.9	16.4	22.1	11.5	26.9	43.7	10.0	7.4	10.4	11.4	9.3	12.9	19.5	33.8	12.6	14.3	11.4	3.9	24.5	21.6	18.7	27.2	22.9	29.5	34.0	26.1	35.9	25.2	22.6	22.6	5.8	14.4	18.5	19.6	53.6	24.1	16.2	14.8	16.3	17.1	14.0	14.7	14.7	14.0	12.8	14.1
QARS		ENSG00000172053	"Glutaminyl-tRNA synthetase"	P47897	3	49095932-49105135	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol			21000	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favourable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favourable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	20.9	16.3	9.7	19.3	10.2	18.4	22.7	15.8	13.2	17.6	27.3	13.1	27.7	17.2	12.3	19.8	35.1	16.4	20.0	22.0	9.8	9.6	27.1	26.0	15.0	33.9	12.4	7.2	21.6	33.8	20.3	13.7	25.7	9.6	16.2	29.9	15.2	31.7	28.7	33.3	26.7	31.8	16.7	11.2	21.1	16.9	30.1	11.3	36.8	16.5	34.8	33.3	19.4	18.5	20.4	40.0	8.9	32.3	21.8	24.0	19.6	18.6	19.0	31.6	45.3	40.8	44.4	32.6	20.7	47.4	41.2	40.5	23.9	24.2	57.6	13.3	34.3	23.7	44.9	34.1	29.6	16.4	35.9	45.4	30.4	41.8	21.5	36.9	28.0	46.7	29.9	31.7	27.0	44.9	20.2	25.6	30.1	10.0	26.6	33.1	27.2	29.6	17.5	26.6	42.5	27.6	27.8	11.6	32.4	18.4	46.7	28.6	38.7	43.1	25.9	18.8	26.6	30.9	23.1	22.1	37.6	32.3	19.2	33.3	11.9	8.9	23.1	8.7	13.5	32.3	18.1	20.4	16.8	14.9	40.0	15.2	15.5	15.4	2.6	21.8	26.1	16.9	24.0	19.6	9.7	10.2	15.8	13.2	9.8	9.6	12.4	7.2	9.6	11.3
QKI	QK3	ENSG00000112531	"QKI, KH domain containing RNA binding"	Q96PU8	6	163414000-163578596	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport"	"Developmental protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 100.3"	"Cell line enhanced"	"Detected in all"		"AF22: 64.0"	"Cancer enriched"	"Detected in all"	6	"glioma: 42.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019123, CAB022602"	Enhanced	Supported	Supported	Nucleoplasm				Nucleoplasm		"CAB022602: , HPA019123: AB_1855980"	"unprognostic (2.42e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.27e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavourable (2.31e-5)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.09e-2)"	32.4	12.4	37.5	16.2	63.5	27.1	14.6	15.1	100.3	14.9	12.2	83.9	3.7	4.0	14.7	4.9	16.0	12.3	15.7	64.0	43.7	18.1	11.1	18.4	24.9	11.4	72.5	31.9	18.4	7.6	7.8	4.7	23.4	46.5	7.9	8.4	7.1	10.2	11.1	59.9	12.4	7.1	21.1	68.8	16.9	8.9	20.5	74.3	5.0	10.4	10.8	11.4	15.8	17.7	1.7	7.3	10.8	8.4	7.4	3.8	1.3	4.2	18.0	64.0	21.3	19.4	21.6	14.9	11.6	27.5	19.1	23.1	12.2	3.9	5.2	9.7	29.1	6.4	33.9	12.1	31.0	10.4	10.9	20.4	9.9	13.6	23.7	10.8	6.3	25.2	5.0	20.4	32.5	26.3	29.8	12.3	12.3	8.1	7.2	2.3	8.2	9.1	11.1	39.9	10.3	10.5	13.5	1.2	7.4	12.4	6.8	5.1	2.6	17.7	26.7	13.2	11.2	14.2	21.3	7.8	9.5	6.3	11.4	9.6	31.0	3.4	8.4	3.8	2.3	5.4	3.8	1.4	1.6	2.0	4.3	1.7	1.5	2.5	10.8	7.4	5.5	7.3	1.1	1.3	37.5	63.5	15.1	41.4	43.7	18.1	72.5	31.9	46.5	74.3
QPCTL	FLJ20084	ENSG00000011478	"Glutaminyl-peptide cyclotransferase like"	Q9NXS2	19	45692483-45703989	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040797	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA040797: AB_10794148"	"unprognostic (6.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.14e-2)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (2.15e-8)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.71e-2)"	6.3	10.2	8.2	9.6	10.2	13.3	7.8	10.3	13.5	9.6	11.6	6.3	9.6	11.2	7.6	10.2	11.4	8.6	15.9	5.0	8.9	10.8	7.9	18.2	11.8	10.7	7.3	8.0	11.2	10.7	9.5	10.8	9.6	10.8	10.8	9.5	7.7	13.5	10.8	3.2	12.4	7.9	6.1	6.4	12.9	9.5	5.9	5.0	9.7	17.1	7.5	13.2	11.9	6.4	3.1	3.6	5.1	2.1	4.1	4.3	1.2	10.1	6.9	5.5	22.6	5.5	2.6	4.2	6.6	9.5	9.4	15.5	7.3	7.6	12.4	7.2	7.2	6.4	6.8	7.3	5.8	3.5	8.7	4.6	8.9	14.5	9.3	4.6	8.0	4.8	8.9	7.8	11.4	8.3	6.1	21.8	5.8	8.0	4.3	5.5	3.9	3.9	5.1	4.0	9.9	10.7	4.8	5.2	3.2	6.7	5.5	11.2	4.2	7.2	5.3	4.8	8.0	5.0	6.3	20.4	12.1	11.7	16.6	10.6	3.8	3.1	2.0	0.9	4.3	2.1	3.0	3.1	2.1	1.4	2.4	2.8	2.1	2.8	5.1	4.1	1.3	3.6	1.4	1.2	8.2	10.2	10.3	13.5	8.9	10.8	7.3	8.0	10.8	5.0
QRICH1	FLJ20259	ENSG00000198218	"Glutamine rich 1"	Q2TAL8	3	49029707-49094363	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037677, HPA037678"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA037677: AB_10671883, HPA037678: "	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.82e-2)"	"prognostic favourable (7.46e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-1)"	28.9	27.6	20.4	23.6	26.8	43.1	27.8	38.9	35.0	26.2	23.3	27.0	21.2	21.0	30.7	22.0	28.4	26.7	23.7	21.5	20.9	16.7	20.3	22.1	26.0	30.3	17.8	22.1	30.5	23.3	30.7	27.3	32.1	23.6	22.6	21.4	28.4	26.4	26.0	32.3	34.1	30.0	24.6	15.9	35.2	25.8	53.9	21.8	40.3	25.9	20.2	37.1	28.1	23.6	15.5	16.0	15.9	26.0	15.8	20.1	11.1	18.3	17.6	35.1	16.1	23.1	22.2	21.9	20.8	27.2	34.9	31.8	19.2	23.4	29.5	13.4	27.1	14.7	32.1	29.1	30.3	25.2	19.3	28.8	24.5	15.8	20.8	25.2	33.3	25.1	22.1	34.9	22.4	27.0	19.5	27.0	23.7	13.6	36.5	17.3	28.6	22.1	18.3	18.3	24.3	21.7	28.6	13.4	27.0	23.6	22.0	17.2	19.7	28.5	23.5	22.9	26.0	20.2	29.7	24.4	28.3	35.7	20.9	24.2	26.1	14.0	13.2	15.9	16.8	16.5	19.9	15.4	16.2	18.6	16.0	15.5	17.5	20.1	9.9	15.8	26.0	11.4	16.6	11.1	20.4	26.8	38.9	35.0	20.9	16.7	17.8	22.1	23.6	21.8
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154834-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 172.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 194.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042127, HPA056243"	Uncertain		Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"		3200000000	"Golgi apparatus"	Vesicles	"HPA042127: , HPA056243: "	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavourable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	15.9	18.7	8.0	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9.0	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28.0	24.5	12.1	20.6	19.4	18.4	12.3	19.0	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8.0	7.1	11.4	41.5	5.9	1.4	17.7	18.1	37.5	70.5	44.2	44.7	37.8	26.7	0.6	13.4	0.6	27.5	35.3	9.0	1.7	11.9	18.5	2.4	2.7	1.3	3.5	1.8	194.6	4.5	12.8	20.0	5.4	40.3	48.4	55.6	1.8	6.5	24.9	7.2	0.9	8.4	4.8	17.0	1.8	3.2	1.0	6.2	11.9	5.1	5.2	12.9	17.6	8.5	3.2	21.5	65.4	47.4	18.6	31.7	37.3	4.8	7.8	1.1	18.0	14.6	14.2	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5.0	19.2	1.8	4.4	4.3	20.4	8.0	13.1	3.9	5.5	11.4	8.0	9.5	7.3	13.6	10.1	9.0	8.5	9.1	13.4	9.1
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245841	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"		5700000	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: "	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavourable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.2	8.0	8.4	15.9	14.1	16.0	7.3	30.3	10.6	5.8	5.8	9.4	8.9	6.0	8.1	13.2	5.6	8.1	5.5	7.0	7.6	7.1	7.0	9.2	6.5	19.1	11.0	6.7	9.4	21.7	12.1	29.2	5.8	9.6	6.1	6.7	7.9	6.5	4.9	5.1	12.4	10.3	8.1	7.1	14.6	7.6	11.7	10.1	8.3	12.1	6.0	16.7	5.4	6.4	3.4	0.8	1.6	0.3	0.4	0.8	0.2	7.2	17.7	14.7	19.5	8.3	10.1	18.6	9.3	10.4	18.1	16.7	13.2	15.8	11.2	15.3	12.4	23.6	17.4	13.4	14.7	16.5	8.7	6.0	29.3	14.5	11.8	17.8	9.2	8.0	13.6	17.9	21.8	13.2	14.4	30.3	9.6	12.3	6.6	11.9	17.4	11.3	12.2	19.1	18.3	6.2	6.6	15.8	11.9	14.6	11.6	7.8	8.3	10.4	7.5	22.0	16.0	18.0	21.1	10.7	14.3	24.7	14.7	9.4	20.5	1.6	0.3	0.7	0.5	0.0	0.8	1.9	0.6	0.2	0.1	3.4	0.2	0.4	0.1	0.4	0.0	0.8	0.3	0.2	8.4	14.1	30.3	10.6	7.6	7.1	11.0	6.7	9.6	10.1
R3HDM2	KIAA1002	ENSG00000179912	"R3H domain containing 2"	Q9Y2K5	12	57253762-57431005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038327, HPA038328"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA038327: AB_10674681, HPA038328: "	"unprognostic (9.46e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.49e-2)"	15.9	16.6	33.7	15.7	26.3	18.0	15.6	44.0	35.0	16.2	14.6	21.6	16.5	19.2	20.5	13.2	17.6	20.8	17.2	28.2	26.4	18.8	15.1	18.6	20.6	17.9	21.4	28.1	28.7	16.9	20.4	33.1	15.0	19.5	25.1	14.6	17.8	13.6	14.7	32.0	18.7	17.0	15.5	25.5	19.4	16.9	17.0	20.7	15.1	17.7	10.0	15.0	17.7	14.5	6.6	3.3	8.7	8.3	5.2	5.3	1.3	10.6	14.9	12.4	15.4	20.4	28.9	8.6	11.2	13.6	7.9	7.3	4.8	12.9	11.8	14.0	15.7	13.9	7.3	14.1	9.2	16.4	9.5	14.5	5.9	6.1	15.1	9.5	18.6	19.5	22.3	13.6	29.0	11.0	10.0	15.5	13.3	13.9	13.3	7.1	3.1	11.0	8.2	10.3	7.7	7.0	11.6	12.6	13.7	10.6	14.2	11.5	12.4	17.7	12.9	8.2	6.4	18.7	11.5	9.3	4.5	4.8	17.4	10.0	14.7	5.3	4.3	3.2	2.8	3.6	3.6	6.6	5.0	2.6	2.1	3.5	5.3	3.2	8.7	5.2	8.3	3.3	2.0	1.3	33.7	26.3	44.0	35.0	26.4	18.8	21.4	28.1	19.5	20.7
RAB11A	YL8	ENSG00000103769	"RAB11A, member RAS oncogene family"	P62491	15	65726054-65891991	"Predicted intracellular proteins"	"Cell cycle, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013097, HPA051697, HPA060686"	Approved		Enhanced	"Vesicles,Centriolar satellite"				"Vesicles, Centriolar satellite"		"CAB013097: AB_2533987, HPA051697: , HPA060686: "	"unprognostic (4.15e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.85e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.83e-2)"	"prognostic unfavourable (4.37e-4)"	"unprognostic (4.29e-2)"	"prognostic favourable (1.46e-5)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.21e-1)"	43.3	64.1	32.4	27.0	49.6	25.1	35.4	34.9	57.3	41.3	49.9	27.7	30.5	31.4	36.4	31.7	131.6	34.2	42.8	34.5	35.0	40.5	52.4	28.7	38.1	32.8	34.3	36.6	35.6	24.5	32.3	36.6	60.5	60.5	35.8	52.2	33.7	58.3	31.2	27.3	79.8	35.2	34.3	33.1	55.3	47.9	47.4	25.1	32.4	46.2	60.7	62.1	51.7	60.6	18.1	31.5	54.0	33.3	15.1	24.5	59.5	42.0	49.9	51.0	36.9	46.7	43.9	66.7	45.0	45.9	41.1	49.1	45.8	75.8	55.3	46.0	51.5	65.2	80.2	59.6	38.8	36.0	47.9	66.2	36.1	40.5	35.6	31.0	39.4	44.7	67.9	40.3	33.6	90.9	53.1	33.0	57.9	41.8	30.6	24.6	42.5	28.4	26.1	38.7	51.2	110.3	110.6	36.8	39.1	32.4	51.6	41.7	68.2	36.3	68.6	32.6	46.5	31.3	39.7	17.4	41.3	43.0	30.2	52.7	34.9	32.4	32.1	51.8	14.0	29.8	14.3	18.1	21.0	16.6	31.5	14.1	19.8	15.5	54.0	15.1	33.3	20.3	24.5	59.5	32.4	49.6	34.9	57.3	35.0	40.5	34.3	36.6	60.5	25.1
RAB11FIP1	"FLJ22524, FLJ22622, Rab11-FIP1, RCP"	ENSG00000156675	"RAB11 family interacting protein 1"	Q6WKZ4	8	37858618-37899467	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.6"	"Cell line enhanced"	"Detected in many"		"K-562: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 39.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 39.0"	"Low region specificity"	"Detected in single"							"CAB017037, HPA023904, HPA024010, HPA025960"	Enhanced		Enhanced	Vesicles				Vesicles		"CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992"	"unprognostic (1.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (6.61e-4)"	"unprognostic (4.32e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-2)"	"prognostic favourable (1.14e-6)"	"unprognostic (4.94e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.50e-1)"	6.9	3.2	1.3	16.8	1.0	17.8	7.4	1.8	1.3	8.9	37.1	1.9	17.8	13.8	2.9	8.8	30.9	5.6	31.5	5.9	1.1	1.3	8.4	4.1	64.5	8.4	1.1	0.6	4.7	31.5	3.9	12.9	26.0	6.9	7.0	16.4	9.9	20.9	21.3	3.4	13.8	90.6	5.3	1.3	10.9	15.2	5.4	0.9	16.4	8.5	14.9	34.1	9.6	9.6	2.3	6.9	39.0	7.7	4.1	4.0	3.3	17.2	7.6	0.8	3.4	0.2	0.0	23.5	1.8	2.8	3.3	4.2	17.0	9.9	7.0	5.5	2.1	13.4	6.2	3.9	4.9	18.2	5.8	1.3	4.0	4.9	9.3	3.0	15.7	2.2	5.3	1.2	3.4	0.0	29.7	3.5	1.7	4.1	5.0	4.4	5.1	2.3	1.6	4.2	5.4	17.0	17.7	3.2	3.7	4.5	22.5	5.5	15.2	5.8	0.2	0.1	10.2	0.2	0.3	7.1	8.3	1.9	0.1	4.1	2.4	6.9	7.7	13.7	1.8	3.7	4.0	2.3	1.3	1.2	6.9	1.7	0.8	0.9	39.0	4.1	6.9	4.2	2.9	3.3	1.3	1.0	1.8	1.3	1.1	1.3	1.1	0.6	6.9	0.9
RAB11FIP2	"KIAA0941, nRip11, Rab11-FIP2"	ENSG00000107560	"RAB11 family interacting protein 2"	Q7L804	10	118004916-118046603	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037726	Approved		Supported	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA037726: AB_10672390"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (9.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.17e-1)"	8.8	7.1	11.8	6.4	21.6	12.0	7.2	13.3	19.9	11.4	9.7	7.9	19.0	3.8	23.0	29.8	6.8	12.9	8.6	7.2	10.5	7.1	12.8	5.6	7.7	8.5	8.0	12.9	10.7	7.0	8.6	6.6	8.3	11.5	12.7	5.3	6.9	6.2	27.2	6.5	6.3	6.7	20.0	7.5	7.7	15.5	8.6	8.8	10.0	11.8	3.8	5.6	10.5	13.7	2.3	2.6	1.9	1.2	0.9	2.3	0.4	5.2	6.7	5.6	7.1	9.4	12.0	6.1	10.4	12.1	6.4	6.7	5.4	5.6	10.8	8.4	10.6	3.7	7.8	4.6	10.0	2.7	8.2	3.9	6.9	3.7	13.6	7.1	4.2	11.7	8.7	9.1	20.0	3.9	2.8	9.2	8.3	1.9	5.4	5.3	4.8	4.7	4.7	19.9	3.6	9.6	4.2	1.3	10.4	7.3	3.0	12.8	2.3	6.7	5.7	8.6	7.0	10.1	10.3	6.7	5.6	7.0	8.9	12.3	5.3	1.5	1.2	1.4	1.5	0.8	1.4	2.2	1.2	1.5	0.6	2.3	2.3	1.3	1.9	0.9	0.7	2.6	0.6	0.4	11.8	21.6	13.3	19.9	10.5	7.1	8.0	12.9	11.5	8.8
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425619-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Approved		Supported	"Vesicles,Cytokinetic bridge,Centriolar satellite"				"Vesicles, Cytokinetic bridge, Centriolar satellite"		"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favourable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favourable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	10.2	13.4	19.3	7.5	16.9	8.7	7.3	29.7	27.4	11.5	10.6	12.2	9.0	13.4	11.9	11.0	8.2	9.5	11.3	14.0	18.7	12.1	70.5	12.2	10.5	8.1	12.0	18.0	13.4	22.2	22.4	14.6	10.0	10.6	11.5	5.4	9.9	13.2	12.6	23.5	12.2	14.6	10.8	8.9	10.2	7.6	13.5	11.9	5.7	8.6	7.4	5.3	9.7	16.6	1.1	0.8	0.1	0.1	0.1	1.5	0.6	4.4	10.1	9.7	8.5	14.3	9.4	8.4	8.4	7.9	7.7	5.6	7.4	2.1	12.2	9.9	12.3	4.6	6.0	8.9	2.7	9.0	8.6	5.5	9.4	21.5	15.3	5.4	6.8	9.0	6.1	7.9	6.9	11.7	2.8	4.8	9.7	13.6	8.8	10.8	8.1	4.1	18.3	7.8	3.2	7.8	2.7	10.1	9.4	8.6	10.5	5.3	5.9	10.1	19.0	11.3	7.5	10.5	5.5	6.7	5.3	14.4	4.3	3.9	8.3	0.0	0.1	0.0	1.5	0.0	1.3	0.8	0.9	0.7	0.5	1.1	0.6	0.3	0.1	0.1	0.0	0.8	0.0	0.6	19.3	16.9	29.7	27.4	18.7	12.1	12.0	18.0	10.6	11.9
RAB11FIP5	"GAF1, KIAA0857, pp75, RIP11"	ENSG00000135631	"RAB11 family interacting protein 5"	Q9BXF6	2	73073382-73156721	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Cell line enhanced"	"Detected in many"		"TIME: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 2.6"					"Low region specificity"	"Detected in all"			"HPA036406, HPA036407"	Enhanced		Enhanced	"Vesicles,Centriolar satellite"				"Vesicles, Centriolar satellite"		"HPA036406: , HPA036407: AB_10669778"	"unprognostic (1.49e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (3.23e-3)"	"unprognostic (1.45e-1)"	"prognostic favourable (2.26e-5)"	"unprognostic (1.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.66e-3)"	8.4	5.4	5.3	3.8	9.3	1.5	6.3	9.5	16.7	5.2	4.2	2.8	4.6	3.5	7.9	7.3	5.3	5.6	8.2	7.2	4.9	6.3	14.9	2.3	4.8	2.1	5.6	6.5	6.7	8.4	22.3	4.3	11.4	16.0	5.3	2.1	5.1	9.5	5.9	9.0	5.8	2.6	5.2	2.9	18.9	4.9	46.4	2.5	0.0	3.9	4.7	2.7	5.3	7.4	0.1	0.0	0.0	0.0	0.0	2.6	0.5	12.0	5.4	0.4	3.8	4.0	4.8	7.0	18.2	10.0	6.2	4.8	3.9	3.0	0.0	9.6	9.2	4.9	2.3	5.6	2.8	20.9	6.7	4.4	2.3	2.5	4.9	0.0	0.8	5.8	5.3	7.6	5.0	8.5	3.4	2.4	4.4	0.3	0.0	0.1	2.9	8.6	4.1	4.9	10.2	5.4	1.5	1.8	1.9	6.0	2.5	2.7	1.4	0.2	25.0	15.1	8.8	11.2	9.5	7.9	2.3	0.0	11.8	4.7	1.4	0.0	0.0	0.0	2.6	0.0	0.5	0.0	1.2	1.9	0.0	0.1	0.2	1.5	0.0	0.0	0.0	0.0	0.8	0.5	5.3	9.3	9.5	16.7	4.9	6.3	5.6	6.5	16.0	2.5
RAB13		ENSG00000143545	"RAB13, member RAS oncogene family"	P51153	1	153981617-153986358	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 7.7;myeloid DC: 10.7;plasmacytoid DC: 12.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 12.0;monocytes: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003996	Approved		Supported	"Plasma membrane,Cytosol"			4600000	"Plasma membrane, Cytosol"		"HPA003996: AB_1079728"	"unprognostic (4.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.80e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (1.28e-2)"	49.0	40.4	18.1	28.7	30.2	29.7	52.1	13.6	23.5	33.1	33.6	13.7	46.6	17.8	28.5	47.1	43.2	25.0	46.7	36.9	21.9	17.0	61.3	51.5	40.8	36.7	22.9	11.1	39.2	65.6	28.4	11.1	29.0	29.1	41.5	24.5	21.6	47.4	44.4	26.8	25.0	28.7	35.3	31.3	44.8	34.5	24.0	24.7	5.9	54.8	35.0	24.9	41.0	78.4	1.0	12.0	0.9	7.7	0.0	0.7	2.4	17.1	21.1	19.2	20.1	64.4	115.1	6.2	20.9	49.5	18.9	19.3	21.3	14.6	0.0	31.5	24.9	11.8	11.3	19.0	26.3	11.0	8.8	14.3	13.3	11.9	27.0	0.0	10.1	83.7	16.5	32.6	14.5	32.9	3.0	0.0	32.1	35.6	0.0	7.3	30.8	20.2	4.1	24.9	0.0	42.6	18.1	1.2	15.8	27.3	23.7	42.1	38.9	11.4	60.9	34.4	20.4	21.3	22.6	0.1	0.0	0.2	53.6	2.4	52.2	0.0	7.7	0.1	0.0	1.4	0.1	0.8	0.1	0.1	10.7	1.0	0.1	0.7	0.9	0.0	0.2	12.0	0.0	2.4	18.1	30.2	13.6	23.5	21.9	17.0	22.9	11.1	29.1	24.7
RAB14	"FBP, RAB-14"	ENSG00000119396	"RAB14, member RAS oncogene family"	P61106	9	121178137-121223014	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026419, CAB037066"	Approved		Supported	Vesicles			9900000	Vesicles		"CAB037066: AB_1841128, HPA026419: AB_1855996"	"unprognostic (1.30e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-3)"	"prognostic favourable (1.79e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	28.4	29.2	35.7	29.7	37.3	41.4	37.2	36.5	50.2	29.9	30.3	31.4	38.2	28.5	27.9	26.1	50.1	25.6	25.5	24.3	33.3	34.1	37.0	58.7	57.5	38.0	44.5	34.8	27.5	22.7	38.6	25.2	30.7	35.0	29.5	31.5	20.0	29.2	55.5	28.2	42.4	27.4	24.7	43.0	28.1	31.3	23.5	41.4	23.9	32.4	25.8	34.3	27.7	32.3	19.0	23.3	24.0	30.9	19.2	21.5	15.7	21.8	22.3	28.4	23.7	33.1	36.2	22.4	31.1	25.0	24.1	19.2	17.6	23.9	21.0	18.2	29.8	41.8	20.2	23.2	27.3	18.0	13.3	22.7	30.9	17.9	22.9	24.2	27.3	23.0	42.0	24.7	27.3	34.1	17.1	19.3	36.0	20.6	23.4	19.5	16.8	25.2	18.6	30.8	24.5	26.5	31.4	25.1	14.7	37.0	32.9	21.2	34.6	19.2	31.5	25.9	18.9	31.9	21.7	17.4	32.7	21.4	24.3	21.3	33.8	23.4	21.9	24.0	18.0	30.9	17.9	19.0	16.9	19.5	23.3	17.0	20.4	20.2	23.7	19.2	30.2	14.3	21.5	15.7	35.7	37.3	36.5	50.2	33.3	34.1	44.5	34.8	35.0	41.4
RAB1A	"RAB1, YPT1"	ENSG00000138069	"RAB1A, member RAS oncogene family"	P62820	2	65070701-65130106	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005331, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Cytosol"			19000000	"Endoplasmic reticulum, Cytosol"		"CAB005331: AB_632290, HPA056141: "	"unprognostic (4.78e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (1.55e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.63e-2)"	53.0	57.6	54.6	34.8	58.4	80.8	54.0	47.7	63.2	49.2	50.3	24.8	53.8	52.7	46.7	75.8	58.8	40.7	40.9	49.9	48.1	52.8	77.8	75.4	48.2	40.7	44.0	55.3	37.1	53.5	38.5	59.7	108.6	47.3	40.5	52.2	34.0	68.7	57.1	43.8	35.5	51.6	47.6	49.6	34.5	53.2	30.9	42.4	21.5	56.9	53.1	34.9	52.2	45.1	19.1	33.2	45.0	37.1	24.4	25.1	22.2	39.2	29.1	35.8	20.8	86.6	51.0	56.4	58.4	39.7	25.9	27.5	50.2	26.0	15.9	33.6	57.6	25.2	32.5	51.9	41.0	19.6	19.5	20.1	23.2	73.6	55.0	20.8	18.3	45.0	53.0	33.9	30.3	50.8	28.6	18.5	50.8	35.1	12.2	25.1	28.2	26.2	12.5	33.9	25.3	50.0	44.0	25.8	23.0	26.8	43.9	49.2	27.3	19.6	48.7	33.4	42.6	35.2	32.6	28.9	17.8	38.3	44.4	32.2	32.3	35.3	37.1	32.2	19.5	36.8	21.5	19.1	21.1	21.0	33.2	13.9	20.5	20.4	45.0	24.4	31.6	27.6	25.1	22.2	54.6	58.4	47.7	63.2	48.1	52.8	44.0	55.3	47.3	42.4
RAB1B		ENSG00000174903	"RAB1B, member RAS oncogene family"	Q9H0U4	11	66268533-66277492	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010225, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"			26000000	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB010225: AB_2284660, HPA056141: "	"unprognostic (6.07e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.09e-5)"	"unprognostic (2.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.85e-2)"	47.5	47.7	36.2	32.5	42.4	33.1	47.8	35.6	60.6	42.0	45.6	38.0	35.7	46.5	42.0	37.2	61.2	45.8	48.4	50.2	34.5	31.5	47.3	67.8	43.0	51.8	34.8	38.6	44.4	52.9	55.0	42.5	63.6	34.6	49.5	38.4	45.3	62.2	48.6	82.8	50.6	58.0	49.2	38.7	47.3	45.6	36.5	30.9	49.2	54.7	50.4	55.9	40.1	41.2	26.3	36.4	84.7	44.2	36.3	47.3	59.7	39.0	45.4	22.9	31.1	39.3	29.4	21.3	32.5	40.0	44.2	31.2	25.8	41.6	16.3	43.0	47.8	37.9	26.1	46.7	24.3	32.6	23.5	25.9	29.5	22.4	26.2	22.0	47.8	30.7	40.3	37.3	19.4	41.6	26.6	29.8	42.0	78.8	38.1	35.5	24.2	43.1	23.6	18.9	42.6	44.4	37.0	23.0	25.3	24.4	59.9	23.7	91.3	25.5	41.9	42.3	28.6	49.8	28.8	16.3	12.9	21.3	48.0	18.8	38.6	27.2	38.8	61.2	47.3	40.8	35.7	22.7	28.5	38.4	31.6	26.3	25.0	29.7	84.7	36.3	44.2	36.4	30.7	59.7	36.2	42.4	35.6	60.6	34.5	31.5	34.8	38.6	34.6	30.9
RAB20	FLJ20429	ENSG00000139832	"RAB20, member RAS oncogene family"	Q9NX57	13	110523066-110561733	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.5;SK-BR-3: 35.9;T-47d: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003621, HPA052111, HPA068647"	Uncertain		Enhanced	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA003621: , HPA052111: , HPA068647: "	"unprognostic (5.59e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.65e-1)"	"prognostic favourable (8.57e-4)"	"unprognostic (6.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.28e-2)"	"prognostic favourable (4.48e-4)"	30.9	23.5	3.7	11.9	5.3	11.9	27.5	1.3	4.0	6.9	20.2	5.2	3.0	15.7	6.0	8.8	4.1	6.8	17.8	17.0	5.3	2.5	15.9	38.2	27.8	21.9	7.1	1.8	17.0	14.5	3.2	5.8	12.6	9.1	9.4	8.3	8.5	10.9	3.2	8.8	2.6	23.8	5.0	13.4	32.9	15.0	6.3	3.6	2.5	13.6	1.9	4.2	13.2	13.6	1.9	8.3	13.4	19.4	0.0	3.6	5.6	8.0	1.2	0.8	1.6	5.3	1.4	13.1	0.7	2.5	3.4	5.3	19.5	16.5	0.0	5.8	0.7	3.1	1.6	5.0	1.8	9.0	1.2	8.0	1.5	9.0	3.3	1.1	2.4	2.9	0.8	1.8	0.5	1.3	1.5	0.0	0.7	9.7	0.0	11.6	1.7	3.5	0.7	0.0	3.6	5.9	10.7	0.2	0.9	1.5	35.9	10.9	22.6	12.4	0.9	0.8	1.8	0.0	1.1	0.0	0.0	0.0	11.7	15.8	1.7	2.8	19.4	3.5	0.6	17.0	0.7	1.9	1.6	0.5	8.3	1.2	3.6	1.2	13.4	0.0	12.7	0.4	0.4	5.6	3.7	5.3	1.3	4.0	5.3	2.5	7.1	1.8	9.1	3.6
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222314	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Developmental protein"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 62.4;urinary bladder: 48.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.0;U-2197: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	6.0	3.0	6.7	5.7	5.1	0.2	4.0	7.3	4.8	23.1	32.9	5.1	9.6	3.0	34.1	8.0	9.7	8.1	12.4	7.0	7.4	4.5	3.3	1.8	4.9	1.7	6.4	5.4	8.2	1.6	2.9	3.5	12.3	6.7	24.9	7.5	3.6	2.8	26.9	4.7	3.1	7.0	62.4	6.6	1.1	8.7	4.3	7.2	1.4	15.1	3.9	1.7	48.9	11.2	0.3	1.5	1.3	0.6	0.9	2.0	0.3	4.7	1.9	6.8	4.8	10.5	32.0	6.3	14.0	24.3	12.3	12.8	4.1	2.3	0.9	4.4	22.4	1.7	7.1	5.1	14.7	3.5	3.3	3.4	3.1	3.2	6.5	1.8	0.5	11.9	5.9	15.3	14.4	6.4	5.2	2.9	13.6	4.0	1.5	1.9	2.5	2.6	1.7	10.1	1.4	8.5	3.3	3.5	2.4	7.0	3.3	3.6	3.0	2.0	8.5	19.2	6.0	56.4	8.1	2.5	2.8	2.3	10.8	3.8	9.4	0.3	0.4	1.3	0.3	0.4	0.0	0.3	1.1	0.5	0.3	0.3	2.0	0.8	0.0	0.9	0.6	1.5	0.0	0.3	6.7	5.1	7.3	4.8	7.4	4.5	6.4	5.4	6.7	7.2
RAB30		ENSG00000137502	"RAB30, member RAS oncogene family"	Q15771	11	82973133-83071923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 21.6;HDLM-2: 19.3;U-698: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 23.2;naive B-cell: 25.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054514, HPA060565"	Approved		Enhanced	Vesicles				Vesicles		"HPA054514: , HPA060565: "	"unprognostic (3.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.21e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.85e-1)"	12.2	17.3	15.8	14.5	21.6	12.7	13.8	19.9	22.5	10.3	12.6	30.6	2.2	16.7	10.3	6.7	7.0	7.2	6.5	9.9	17.2	12.2	4.5	8.5	7.4	21.1	27.9	15.0	15.5	4.9	6.0	10.0	10.0	22.8	8.6	14.3	10.9	8.8	6.7	19.8	11.8	20.0	11.6	29.3	10.9	11.2	4.2	29.2	3.3	7.2	5.0	29.0	11.0	8.3	25.1	2.6	0.5	0.4	0.9	5.4	2.7	1.4	1.9	2.0	1.3	4.6	6.6	2.4	3.3	3.4	6.5	3.2	3.5	0.6	21.6	4.1	5.0	1.8	3.0	2.2	4.2	19.3	0.6	5.3	6.2	1.7	1.1	0.6	0.9	4.2	1.5	3.2	2.2	5.3	0.6	5.4	3.9	2.7	0.7	0.1	2.7	3.6	1.5	5.6	8.1	3.8	1.3	2.6	1.7	9.4	2.0	1.0	4.5	0.0	6.5	3.1	6.9	3.1	1.0	8.5	4.5	58.4	1.2	0.5	2.2	0.5	0.3	0.5	2.3	0.1	1.6	23.2	2.2	2.2	0.8	25.1	5.4	4.6	0.5	0.9	0.4	2.6	4.1	2.7	15.8	21.6	19.9	22.5	17.2	12.2	27.9	15.0	22.8	29.2
RAB3GAP2	"DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69"	ENSG00000118873	"RAB3 GTPase activating non-catalytic protein subunit 2"	Q9H2M9	1	220148293-220272454	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cataract, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026273, HPA027299"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA026273: AB_1856007, HPA027299: AB_1856008"	"prognostic unfavourable (3.05e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.76e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	16.7	16.2	14.9	19.6	18.7	14.3	17.8	24.2	22.4	15.6	13.5	14.3	13.9	12.2	16.8	14.9	15.6	12.8	12.8	15.3	16.5	18.8	18.9	15.6	14.3	18.2	17.1	15.6	16.2	14.5	35.6	28.3	19.8	21.9	14.2	13.5	11.6	15.6	15.8	19.9	13.1	15.0	14.9	15.2	14.9	14.5	10.1	15.5	26.1	20.5	11.9	21.7	16.0	15.8	7.1	5.2	12.3	5.1	3.6	8.9	4.6	13.8	10.6	12.8	9.6	14.8	17.6	14.6	14.3	13.6	13.0	15.3	9.7	11.6	17.3	10.1	13.8	13.3	13.3	10.9	15.1	14.4	8.7	13.5	14.1	9.0	19.5	19.2	13.9	13.9	12.5	12.6	19.6	11.8	23.2	11.2	14.6	3.9	14.7	6.8	27.6	6.3	8.1	17.7	15.4	11.0	11.5	12.8	15.5	14.8	14.5	23.2	15.1	18.4	17.1	14.2	6.6	9.7	15.2	10.0	12.1	15.2	12.2	16.3	16.6	12.3	3.9	7.5	7.1	4.9	8.6	7.1	7.0	8.9	5.2	5.5	6.3	7.4	2.5	3.6	5.1	3.3	8.0	4.6	14.9	18.7	24.2	22.4	16.5	18.8	17.1	15.6	21.9	15.5
RAB43	"ISY1, RAB11B, RAB41"	ENSG00000172780	"RAB43, member RAS oncogene family"	Q86YS6	3	129087569-129122801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 73.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.3;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046840, HPA060085"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA046840: , HPA060085: "	"unprognostic (3.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	5.4	6.2	3.9	8.0	3.3	14.6	5.3	6.0	3.6	6.4	7.0	3.2	7.2	5.8	5.4	6.8	4.1	5.3	12.0	3.8	2.8	2.0	9.1	73.9	11.4	12.1	2.7	1.6	7.8	7.4	2.5	8.0	4.7	3.7	7.3	1.7	7.7	7.4	4.7	1.9	3.0	5.9	4.9	2.7	9.9	5.7	5.2	2.1	17.3	17.1	2.6	13.6	6.6	6.0	1.3	1.1	13.3	1.6	1.5	3.5	1.3	15.4	4.3	1.0	4.1	1.9	0.9	6.1	5.4	3.5	3.0	2.6	6.6	6.7	0.4	12.4	3.9	6.5	0.4	6.1	0.7	7.8	4.1	1.0	0.7	8.6	19.1	3.5	9.2	5.2	3.8	1.5	0.4	6.1	1.7	7.8	4.3	6.6	3.4	6.8	4.9	7.0	7.4	2.3	4.4	9.9	13.2	0.3	1.9	2.3	5.0	9.9	2.1	3.7	8.8	6.8	4.8	5.5	2.0	12.2	6.4	2.4	6.2	0.7	7.3	0.5	1.5	2.6	1.9	1.6	0.9	0.6	1.8	1.5	0.7	1.3	3.5	3.0	13.3	1.5	0.7	1.1	2.7	1.3	3.9	3.3	6.0	3.6	2.8	2.0	2.7	1.6	3.7	2.1
RAB5B		ENSG00000111540	"RAB5B, member RAS oncogene family"	P61020	12	55973913-55996683	"Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010224, HPA068337"	Approved		Supported	Vesicles			1000000	Vesicles		"CAB010224: AB_2175453, HPA068337: "	"prognostic unfavourable (2.24e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.09e-1)"	"unprognostic (8.42e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.31e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.49e-1)"	26.6	27.9	39.9	18.3	56.2	14.3	32.9	42.0	67.4	39.2	34.0	73.3	24.0	24.8	41.2	45.0	48.9	37.2	26.0	39.2	39.3	36.2	33.4	31.8	33.7	18.8	42.2	39.3	42.2	22.7	53.2	25.6	32.2	61.8	37.1	38.8	33.5	31.8	47.5	47.1	42.8	29.3	38.2	58.7	21.2	30.9	27.8	41.0	18.3	30.8	27.2	33.8	40.4	35.3	6.9	5.7	21.9	7.2	5.2	8.5	5.8	18.8	12.6	25.4	18.4	42.3	37.1	22.9	17.5	31.4	21.4	18.1	20.6	24.0	10.4	21.2	32.6	13.9	15.8	23.5	20.2	13.7	12.4	12.3	16.8	11.6	30.5	9.9	19.4	30.0	44.4	20.0	17.1	26.7	10.7	31.2	27.0	12.5	12.5	15.4	11.1	11.0	10.9	15.7	13.5	40.2	31.1	12.8	11.4	22.5	22.4	27.8	32.7	32.0	22.3	14.1	10.5	10.5	6.7	18.5	14.6	6.7	23.3	9.3	11.9	12.1	7.0	21.9	8.5	6.9	7.9	6.9	6.8	7.4	5.7	5.9	7.9	6.1	20.7	5.2	7.2	5.6	5.4	5.8	39.9	56.2	42.0	67.4	39.3	36.2	42.2	39.3	61.8	41.0
RAB5C	"RAB5CL, RABL"	ENSG00000108774	"RAB5C, member RAS oncogene family"	P51148	17	42124976-42155044	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003426, HPA004167"	Approved		Enhanced	Endosomes			3600000	Endosomes		"HPA003426: AB_1079735, HPA004167: "	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.56e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.06e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.12e-2)"	50.4	47.8	40.8	43.6	49.4	69.6	43.8	27.9	68.8	33.8	41.9	53.0	25.8	53.6	41.9	28.5	36.4	35.6	36.0	26.2	38.5	34.3	70.3	63.6	46.0	44.5	46.5	32.5	34.9	30.5	28.4	20.1	42.1	41.4	29.8	35.1	37.3	33.1	36.6	16.8	33.8	49.7	39.1	40.4	50.0	44.4	25.2	42.2	29.8	53.5	21.0	36.8	38.7	31.7	13.9	23.8	56.9	31.4	14.8	15.9	21.8	28.7	54.3	17.0	24.5	38.0	26.3	32.9	35.4	37.5	49.1	42.9	38.3	28.5	14.0	31.3	43.8	40.5	31.2	34.2	31.5	18.0	40.9	21.3	22.2	55.2	37.4	27.9	35.0	33.8	36.1	36.8	25.8	51.1	24.3	21.7	33.1	26.3	28.3	25.0	16.8	0.1	18.6	29.3	23.7	36.9	43.2	9.5	24.3	18.1	115.1	38.0	50.8	27.4	47.9	50.2	28.0	42.1	37.5	20.2	26.1	17.8	33.1	21.9	50.8	13.6	31.4	34.8	14.1	29.7	12.6	12.7	13.8	14.1	23.8	13.9	11.4	11.3	56.9	14.8	29.7	16.0	15.9	21.8	40.8	49.4	27.9	68.8	38.5	34.3	46.5	32.5	41.4	42.2
RAB7A	RAB7	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128726122-128814796	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"		"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes			9000000	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	61.5	57.0	64.6	43.8	59.9	41.7	49.5	44.8	67.1	43.5	55.4	69.5	29.4	45.1	49.8	60.7	63.2	44.2	43.1	73.5	62.9	60.2	58.4	69.6	51.7	42.7	66.9	53.6	51.3	34.1	44.0	52.7	64.2	66.2	39.2	50.8	60.9	47.0	41.6	146.3	54.2	45.9	48.9	69.0	52.3	40.7	26.3	61.9	37.7	52.0	51.0	50.7	42.8	47.7	27.7	60.7	102.8	58.7	31.7	33.8	52.9	72.8	24.8	32.2	18.6	73.0	41.2	34.8	70.4	51.3	39.5	41.7	43.5	42.0	33.6	46.2	46.3	38.4	35.7	48.1	44.8	43.3	25.2	73.6	24.1	42.7	60.2	72.7	46.4	48.6	51.4	36.8	43.2	35.1	33.6	32.7	51.6	53.8	45.2	54.9	31.2	34.0	33.4	36.8	35.7	44.1	70.6	24.2	33.6	45.0	41.1	73.9	42.1	49.3	62.3	44.2	27.3	82.9	32.4	46.5	51.0	56.7	66.2	49.3	55.8	38.2	54.1	59.1	27.5	58.7	26.1	27.7	28.5	27.3	60.7	25.1	27.2	26.5	102.8	31.7	54.6	23.6	33.8	52.9	64.6	59.9	44.8	60.8	62.9	60.2	66.9	53.6	66.2	61.9
RAB8A	"MEL, RAB8"	ENSG00000167461	"RAB8A, member RAS oncogene family"	P61006	19	16111629-16134234	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041945			Supported	"Nucleoplasm,Plasma membrane"			16000000	"Nucleoplasm, Plasma membrane"		"HPA041945: "	"unprognostic (1.10e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (6.56e-5)"	"unprognostic (6.60e-2)"	"unprognostic (7.25e-2)"	"prognostic favourable (1.71e-4)"	"unprognostic (9.99e-2)"	23.4	22.8	15.6	24.5	14.1	32.5	15.9	16.6	13.6	18.2	23.1	18.5	15.0	37.6	17.2	11.8	22.9	18.0	17.1	10.6	13.6	11.2	24.8	57.8	19.3	24.9	14.2	8.4	23.3	24.7	8.8	15.5	30.9	13.6	16.3	20.1	16.5	27.4	14.7	5.2	22.3	56.2	14.1	16.7	43.4	20.1	15.9	14.7	33.4	18.5	12.7	36.1	19.7	17.9	34.3	45.4	55.2	81.1	39.0	31.8	75.5	28.9	19.6	16.2	13.5	13.1	11.7	25.3	17.6	15.2	23.5	24.7	22.3	33.5	20.0	20.1	17.2	19.2	21.6	21.7	15.0	41.0	12.6	41.9	18.2	22.9	15.0	36.3	41.8	12.1	11.3	22.1	9.6	19.3	19.4	30.6	18.6	33.4	30.2	31.9	20.2	31.5	34.5	17.8	35.4	17.3	22.2	14.9	14.7	17.8	21.2	11.1	17.1	13.6	19.0	19.8	12.8	38.4	30.0	16.7	34.1	30.1	19.1	36.4	21.3	36.0	50.6	55.2	31.8	69.8	28.4	34.3	28.4	28.6	45.4	31.8	22.5	26.5	53.8	39.0	81.1	32.5	26.6	75.5	15.6	14.1	16.6	13.6	13.6	11.2	14.2	8.4	13.6	14.7
RAB8B		ENSG00000166128	"RAB8B, member RAS oncogene family"	Q92930	15	63189469-63267782	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074534			Supported	Nucleoplasm,Vesicles			5200000	Vesicles	Nucleoplasm	"HPA074534: "	"unprognostic (7.67e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.47e-2)"	21.8	12.1	15.2	20.9	12.9	50.8	22.6	10.1	12.2	15.8	17.7	11.8	7.6	13.6	14.2	8.6	10.9	12.7	18.4	17.5	19.2	14.4	13.7	11.4	27.7	30.8	15.3	12.9	25.2	5.7	6.6	11.7	22.0	16.9	14.3	9.0	9.8	9.3	11.3	7.5	8.2	21.1	14.3	19.5	33.7	9.8	11.8	11.5	38.8	16.4	4.7	27.8	24.4	23.7	10.7	10.4	30.8	14.5	13.1	19.2	14.3	4.7	4.0	15.4	6.3	29.4	24.3	4.6	4.7	10.7	8.5	16.7	4.3	3.9	12.9	4.3	10.1	2.4	13.2	6.4	14.4	19.4	2.6	16.2	3.6	2.8	27.4	6.1	10.3	14.6	3.3	16.1	9.4	21.6	6.3	12.5	15.6	3.1	9.9	3.3	9.6	3.9	8.5	20.5	1.8	6.8	22.4	1.3	3.3	7.1	0.9	13.1	3.4	6.2	24.3	15.9	10.3	8.4	6.3	8.1	8.1	12.3	10.2	17.3	43.2	27.1	14.5	11.9	15.8	13.1	14.4	10.7	12.8	15.0	10.4	10.6	10.0	12.2	30.8	13.1	11.6	1.3	19.2	14.3	15.2	12.9	10.1	12.0	19.2	14.4	15.3	12.9	16.9	11.5
RABEP1	"neurocrescin, RAB5EP, rabaptin-5, RABPT5"	ENSG00000029725	"Rabaptin, RAB GTPase binding effector protein 1"	Q15276	17	5282265-5385812	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004549, HPA019669, HPA024235, HPA024691"	Supported		Supported	Vesicles				Vesicles		"CAB004549: AB_628192, HPA019669: AB_1856019, HPA024235: AB_1856020, HPA024691: AB_1856021"	"unprognostic (3.22e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.73e-2)"	"prognostic favourable (6.43e-4)"	"unprognostic (1.14e-1)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.00e-3)"	19.2	16.7	29.6	18.8	31.1	10.3	31.8	24.1	32.7	16.3	14.2	19.0	12.5	10.9	18.1	18.3	12.7	12.9	15.0	27.4	29.7	25.9	16.6	21.8	13.1	21.1	36.2	24.4	15.5	12.1	38.4	16.3	20.2	31.3	22.2	14.2	10.0	14.8	16.0	41.2	11.6	13.4	20.8	35.6	17.7	15.7	11.8	29.0	21.4	17.6	13.5	25.5	14.5	13.0	37.6	14.2	12.6	19.3	9.1	11.2	6.4	17.9	22.2	23.3	13.0	24.5	24.6	12.8	23.4	17.4	24.5	23.4	19.6	7.5	37.8	19.5	23.5	14.1	34.1	19.3	34.6	24.9	31.2	23.2	27.4	14.9	23.2	15.1	15.3	19.0	13.3	23.5	30.6	21.1	19.7	18.7	21.2	12.4	25.0	12.4	10.7	10.7	23.7	28.0	12.6	12.3	16.4	10.1	15.8	20.6	20.6	19.6	37.4	7.0	18.6	21.0	9.8	21.1	27.2	11.0	12.0	20.3	16.3	24.8	14.3	4.9	9.0	8.7	11.2	9.2	9.8	30.2	8.7	10.6	9.2	37.6	11.1	9.7	12.6	9.1	19.3	14.2	8.0	6.4	29.6	31.1	24.1	32.5	29.7	25.9	36.2	24.4	31.3	29.0
RABEP2	"FLJ23282, FRA"	ENSG00000177548	"Rabaptin, RAB GTPase binding effector protein 2"	Q9H5N1	16	28904421-28936526	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047641	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA047641: "	"unprognostic (4.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (5.84e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.86e-2)"	"prognostic favourable (1.24e-6)"	"unprognostic (7.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.92e-3)"	4.7	13.7	5.4	19.8	10.0	8.5	6.0	4.4	8.6	5.6	7.8	9.9	17.3	14.3	5.9	7.3	11.6	5.3	14.1	8.7	6.5	5.8	10.8	6.6	6.7	35.5	11.9	6.0	5.5	11.3	10.3	11.2	9.1	8.1	17.3	4.1	11.2	16.7	13.9	5.1	17.8	17.5	7.1	6.9	31.5	9.3	8.8	8.4	8.3	9.2	7.5	23.0	10.2	7.6	14.9	3.6	2.4	3.0	5.1	3.5	2.7	8.2	14.0	3.5	6.4	1.9	3.0	6.3	10.1	6.1	7.2	7.0	9.6	7.5	16.0	15.9	3.8	10.5	1.3	5.9	1.2	6.1	5.8	6.2	10.0	13.6	4.3	4.3	19.6	5.0	5.1	8.5	1.4	9.9	3.0	5.8	5.2	19.4	5.6	10.0	4.6	6.5	19.7	3.2	10.8	4.8	11.0	5.5	7.0	4.5	21.6	4.4	17.5	9.7	16.3	11.3	5.4	7.5	9.8	9.0	2.8	12.1	11.8	11.4	8.0	0.5	2.5	2.4	3.5	2.8	2.6	12.2	2.5	3.3	3.6	14.9	2.3	2.1	0.7	5.1	3.0	2.1	2.1	2.7	5.4	10.0	4.4	8.6	6.5	5.8	11.9	6.0	8.1	8.4
RABGAP1	"GAPCenA, TBC1D11"	ENSG00000011454	"RAB GTPase activating protein 1"	Q9Y3P9	9	122940833-123104866	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041651, HPA064860, HPA072273"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA041651: AB_10794673, HPA064860: , HPA072273: "	"prognostic unfavourable (8.09e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.90e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (6.06e-6)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.05e-2)"	16.9	12.6	24.2	12.5	31.0	5.1	17.1	16.9	36.3	18.8	27.6	19.5	16.4	9.5	23.6	20.9	25.5	18.2	15.2	20.0	22.4	20.8	16.2	9.0	15.0	14.0	23.9	25.0	19.6	12.6	29.1	17.7	18.5	23.9	24.1	18.6	19.4	18.1	25.4	23.7	17.3	12.8	25.6	23.0	13.5	17.8	16.4	17.5	11.4	31.2	8.6	16.2	22.9	16.4	4.1	3.9	6.1	5.5	2.1	4.5	1.4	8.9	12.1	19.1	15.8	22.1	18.0	11.8	9.4	17.1	14.7	13.8	13.9	8.8	12.5	7.6	14.7	30.6	12.1	11.8	15.8	11.6	7.3	9.7	19.5	10.6	18.9	7.8	8.4	17.4	18.2	12.6	14.3	16.6	8.3	9.5	17.6	20.0	10.2	6.2	7.0	9.3	16.9	34.9	10.5	12.2	10.0	10.8	8.3	16.9	15.3	8.6	29.0	4.4	12.7	12.5	7.4	13.6	9.4	9.3	15.2	13.0	11.7	4.0	10.9	6.1	3.6	4.3	2.6	5.5	2.0	3.0	2.7	2.3	2.8	4.1	4.5	2.9	5.6	2.1	2.4	3.9	3.1	1.4	24.2	31.0	16.9	36.3	22.4	20.8	23.9	25.0	23.9	17.5
RABGEF1	"rabex-5, RABEX5"	ENSG00000154710	"RAB guanine nucleotide exchange factor 1"	Q9UJ41	7	66682164-66811464	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA001407			Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA001407: AB_1856024"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (4.06e-5)"	"unprognostic (3.77e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.64e-4)"	"unprognostic (6.45e-2)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.55e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	18.4	15.2	13.0	14.7	14.4	59.2	12.0	22.4	16.8	16.9	14.1	12.6	9.4	9.1	16.4	9.5	20.6	12.0	13.5	10.8	13.5	15.6	14.9	17.2	10.5	10.6	12.8	12.1	14.7	13.2	13.3	10.2	18.8	13.5	13.1	11.0	13.8	10.6	16.1	12.1	21.9	15.5	15.3	11.9	15.3	11.9	21.5	9.8	13.1	22.3	20.7	18.2	19.1	16.3	15.7	10.4	18.1	13.5	15.4	10.9	7.6	20.2	6.1	5.3	8.9	14.4	20.2	5.3	17.8	22.9	18.8	17.9	5.6	13.2	9.9	7.0	25.8	8.5	7.3	9.7	26.3	6.7	5.8	5.3	7.1	5.6	11.5	9.1	7.5	10.0	12.5	24.3	26.9	4.9	9.7	7.2	18.7	10.2	6.0	12.6	7.0	8.8	5.4	9.3	7.4	16.4	9.3	6.1	9.5	8.3	18.3	9.6	10.5	5.7	6.4	30.6	6.4	18.7	13.9	9.4	12.2	11.7	14.2	10.1	9.7	18.1	7.8	9.4	8.6	6.9	9.3	11.2	8.1	10.9	7.3	15.7	8.8	8.2	15.1	15.4	13.5	10.4	6.7	7.6	13.0	14.4	22.4	16.8	13.5	15.6	12.8	12.1	13.5	9.8
RABGGTA	PTAR3	ENSG00000100949	"Rab geranylgeranyltransferase alpha subunit"	Q92696	14	24265538-24271739	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043488	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA043488: AB_10794887"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (5.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (1.51e-4)"	"unprognostic (2.01e-1)"	6.9	9.9	8.6	7.1	9.4	8.7	7.5	9.4	16.2	8.2	9.8	8.4	13.6	7.2	6.4	11.6	37.2	12.3	8.1	10.9	6.9	8.0	12.5	15.0	10.6	10.7	7.7	8.5	8.0	16.4	15.7	10.2	14.1	10.6	8.0	8.0	7.2	12.8	9.2	11.1	13.3	12.1	6.9	6.1	11.5	9.4	11.3	7.0	7.3	9.4	20.3	18.2	8.4	11.4	6.5	12.7	6.7	16.8	6.9	6.3	6.3	3.5	5.9	2.3	3.2	3.7	6.8	12.5	5.3	5.1	8.6	7.5	6.0	5.2	5.4	3.9	6.5	6.9	2.8	12.2	3.5	6.8	7.2	3.1	5.0	20.6	7.0	6.6	11.9	7.3	14.0	4.2	5.7	7.1	2.7	4.2	6.6	15.3	3.5	4.9	1.4	8.6	3.1	2.1	3.8	7.8	6.8	6.1	3.6	4.0	8.3	4.3	4.1	4.7	5.2	4.1	3.0	1.8	2.8	5.7	4.3	3.4	2.8	4.2	6.3	3.1	10.0	6.7	5.9	16.8	5.1	6.5	5.7	5.1	12.7	4.2	5.0	4.4	2.6	6.9	12.4	4.0	6.3	6.3	8.6	9.4	9.4	16.2	6.9	8.0	7.7	8.5	10.6	7.0
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB025859: , HPA039427: , HPA043912: "	"prognostic unfavourable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavourable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	3.7	2.6	4.9	10.0	11.3	21.0	4.2	6.3	7.8	4.2	10.1	4.7	1.5	6.5	3.3	1.9	17.7	2.7	4.0	2.7	4.8	4.5	5.9	2.8	5.6	13.7	7.8	5.0	2.5	2.0	3.3	1.4	8.4	5.4	2.4	11.9	2.0	4.7	2.1	3.8	8.7	7.5	7.6	5.9	5.9	6.8	29.4	6.6	40.9	2.4	8.7	17.8	6.0	6.5	6.3	2.2	16.5	3.5	8.8	14.8	4.8	43.9	40.1	32.0	20.4	5.9	7.1	27.4	46.6	22.4	48.9	33.4	40.1	33.6	24.4	20.8	24.7	29.8	31.8	21.6	52.2	46.7	20.1	31.4	39.7	13.1	2.1	33.0	25.9	3.9	4.0	33.1	26.5	16.5	22.6	37.4	45.6	30.8	27.2	16.5	22.9	26.6	26.0	39.1	17.9	13.0	21.9	26.9	23.3	38.0	24.2	12.9	47.0	14.9	15.0	32.4	29.2	20.7	33.5	19.9	49.1	29.0	16.3	22.6	18.9	16.5	2.6	3.9	5.7	3.5	4.9	6.3	6.9	7.8	2.2	3.9	4.2	5.5	0.5	8.8	1.9	1.5	14.8	4.8	4.9	11.3	6.3	7.8	4.8	4.5	7.8	5.0	5.4	6.6
RACK1	"Gnb2-rs1, GNB2L1, H12.3"	ENSG00000204628	"Receptor for activated C kinase 1"	P63244	5	181236909-181248096	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004288, HPA021676"	Uncertain		Supported	Nucleoplasm,Vesicles			130000	"Nucleoplasm, Vesicles"		"CAB004288: AB_2247471, HPA021676: AB_1849868"	"unprognostic (4.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (2.98e-6)"	"unprognostic (4.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.62e-1)"	100.5	72.1	32.2	92.0	32.8	74.9	185.3	45.0	34.3	102.3	85.7	36.2	66.0	43.0	86.0	82.9	128.1	98.3	81.8	102.5	29.8	29.2	80.6	113.7	95.7	223.3	38.2	27.6	189.2	330.4	48.8	68.3	72.3	31.8	102.6	61.2	57.8	119.7	66.9	133.8	115.5	72.1	92.8	37.6	107.8	70.5	52.9	32.4	197.4	115.4	117.0	141.8	99.7	113.5	92.9	69.4	19.2	50.8	47.1	81.4	138.7	66.0	56.4	85.7	107.1	131.7	242.1	86.6	59.6	162.6	140.0	141.4	121.0	58.7	134.8	78.1	103.4	45.7	97.8	331.2	103.6	134.1	105.5	46.0	62.4	60.2	164.8	105.8	46.7	231.6	178.6	105.2	146.6	142.3	60.9	99.1	107.4	102.5	104.5	68.0	59.7	51.1	81.6	53.1	112.5	147.8	63.4	71.3	84.1	30.5	101.7	150.0	69.4	92.3	75.0	48.6	44.3	42.7	90.0	74.4	107.0	84.1	46.6	82.7	49.5	19.2	50.8	16.3	45.9	43.6	69.5	91.9	70.3	53.8	69.4	92.9	81.4	65.2	7.8	47.1	37.1	53.3	68.6	138.7	32.2	32.8	45.0	34.3	29.8	29.2	38.2	27.6	31.8	32.4
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905264-34918989	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA006692: "	"prognostic unfavourable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.1	6.5	3.4	3.2	4.9	4.8	4.4	5.2	4.7	5.4	3.2			2.9	4.6	3.8	3.7	3.5	3.3	6.6	3.5	4.4	3.7	3.5	5.6	6.1	2.9		4.0	3.3	3.0	3.4	6.0		5.3	3.1		4.3	3.7	7.4	4.5	3.6	3.3	2.6	3.1	3.7	5.8			5.2		4.7	3.8	4.7	9.4	7.6	7.2	3.1	4.8	9.3	2.6	5.8	6.8	7.2	14.0	5.1	5.9	10.4	9.2	9.0	9.7	8.0	6.4	8.0	15.2	3.3	8.2	5.4	7.9	5.6	10.9	6.8	6.8	8.1	20.7	4.3	8.7	11.1	7.5	5.3	4.8	10.5	7.0	4.6	14.4	9.0	8.2	7.2	11.3	7.9	9.4	10.3	10.4	15.2	5.3	4.7	6.2	7.5	7.9	19.0	13.0	8.5	8.0	9.3	4.2	12.7	9.6	6.5	9.6	5.0	9.1	13.4	6.6	16.8	8.8	7.2	3.0	6.8	5.9	3.1	7.7	8.7	6.5	8.0	2.9	9.4	9.3	8.0	2.3	4.8	2.9	7.6	5.3	2.6										
RAD17	"CCYC, RAD17Sp, Rad24"	ENSG00000152942	"RAD17 checkpoint clamp loader component"	O75943	5	69369293-69414801	"Predicted intracellular proteins"	"Cell cycle, DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004551, HPA005448"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004551: AB_628195, HPA005448: AB_1079738"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.74e-2)"	"prognostic favourable (5.79e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-2)"	11.8	12.6	10.6	15.3	15.3	9.3	16.5	13.9	14.2	11.0	10.9	12.3	13.7	7.0	12.9	12.2	10.0	9.9	7.8	11.5	11.1	12.8	18.6	16.1	13.2	24.6	11.6	10.7	11.7	18.3	15.1	32.0	12.9	14.7	12.2	13.3	10.0	12.8	18.8	15.7	9.6	11.9	10.5	13.4	14.5	11.6	37.7	11.6	17.0	15.1	10.0	17.0	10.5	13.6	10.5	4.4	4.9	3.6	7.6	7.5	3.1	7.7	3.4	10.8	12.7	0.0	0.1	13.3	7.7	9.7	10.5	14.9	8.2	8.5	34.0	8.4	4.4	3.6	10.7	4.4	16.4	0.0	5.8	8.2	8.3	8.2	13.0	0.2	10.9	7.7	7.5	7.8	7.7	9.1	7.9	10.4	13.2	0.0	15.1	5.6	6.7	4.3	13.2	9.9	7.5	12.6	7.0	11.3	7.9	7.0	2.2	0.3	10.5	10.2	2.7	0.0	9.6	4.9	4.9	13.5	20.7	11.6	10.8	16.2	7.0	1.4	3.0	4.9	6.0	3.6	5.7	10.5	5.4	6.4	4.4	7.2	7.5	6.3	1.2	7.6	1.7	2.2	7.2	3.1	10.6	15.3	13.9	14.2	11.1	12.8	11.6	10.7	14.7	11.6
RAD18	RNF73	ENSG00000070950	"RAD18, E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA006716: , HPA006724: , HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (3.73e-4)"	"prognostic unfavourable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	6.2	5.7	7.4	5.6	12.7	7.9	9.5	16.4	11.4	5.5	6.6	3.9	5.4	17.7	6.5	3.7	7.6	4.9	5.6	4.4	4.7	3.3	4.3	5.7	5.9	7.6	8.4	6.9	7.1	4.2	3.4	6.9	6.9	5.7	7.4	9.0	3.5	7.5	3.5	3.7	8.5	10.5	6.0	7.8	8.5	5.1	9.5	9.8	16.6	6.7	4.7	7.5	6.1	6.8	3.7	6.3	8.7	3.0	4.3	5.5	1.5	9.7	9.3	7.8	4.6	1.9	4.2	9.5	15.5	5.3	15.0	10.3	8.4	6.3	12.1	3.0	8.8	3.4	8.2	8.0	15.3	7.4	10.3	10.3	9.3	5.0	1.2	13.5	8.9	1.5	2.9	14.8	10.1	4.8	10.9	12.0	13.0	11.3	13.7	9.6	10.8	17.1	10.9	8.6	9.5	4.3	7.5	3.2	7.4	6.9	6.6	5.0	6.9	6.0	4.0	12.4	6.8	10.6	13.2	6.1	9.3	26.3	9.2	15.0	9.1	7.4	2.7	8.7	3.0	3.0	5.5	3.7	4.0	5.2	3.4	3.7	4.3	3.2	1.2	4.3	1.8	6.3	5.0	1.5	7.4	12.7	16.4	11.4	4.7	3.3	8.4	6.9	5.7	9.8
RAD21	"hHR21, KIAA0078, SCC1"	ENSG00000164754	"RAD21 cohesin complex component"	O60216	8	116845935-116874866	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020044, CAB022065"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB022065: , HPA020044: AB_1856035"	"unprognostic (7.85e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.43e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (1.86e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.58e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	31.6	40.9	48.2	30.5	52.2	78.5	37.7	58.8	55.3	24.2	36.3	37.5	21.5	24.8	30.5	25.3	32.1	23.1	22.0	37.8	45.6	44.1	30.5	27.9	29.6	49.2	54.3	35.4	33.5	18.2	29.1	30.0	38.9	45.5	26.5	37.3	19.0	25.3	31.0	37.8	24.0	26.0	33.4	49.7	31.2	31.5	37.6	56.2	58.3	41.9	20.9	50.4	37.1	36.0	8.7	5.4	17.9	7.1	8.0	25.4	6.2	42.6	21.0	41.1	23.1	20.7	17.9	18.4	29.7	28.2	33.0	30.5	17.2	40.3	63.1	16.4	21.1	23.8	35.0	19.1	38.7	83.7	22.5	64.3	25.8	21.9	13.0	20.6	37.9	15.2	15.7	19.3	23.4	25.8	25.8	88.4	28.4	25.7	94.3	12.1	24.1	26.5	34.6	29.9	31.7	19.6	25.1	52.0	26.8	31.1	84.0	20.0	35.2	25.5	18.8	23.3	34.2	24.4	31.1	46.8	53.8	56.8	19.9	29.7	27.9	17.2	4.5	15.5	11.0	5.3	11.2	8.7	12.9	13.0	5.4	8.3	13.5	13.0	17.9	8.0	7.1	4.5	25.4	6.2	48.2	52.2	58.8	55.3	45.6	44.1	54.3	35.4	45.5	56.2
RAD23A	"HHR23A, MGC111083"	ENSG00000179262	"RAD23 homolog A, nucleotide excision repair protein"	P54725	19	12945855-12953642	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 225.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026418, HPA053901, HPA057003, HPA065599"	Approved		Enhanced	Nucleoplasm,Cytosol			3100000	Nucleoplasm	Cytosol	"HPA026418: , HPA053901: , HPA057003: , HPA065599: "	"unprognostic (2.09e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.32e-3)"	"unprognostic (9.99e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.59e-3)"	19.6	15.2	19.1	13.4	17.7	19.9	16.0	15.1	25.3	12.9	18.0	14.6	10.7	13.6	15.3	14.3	19.9	17.7	13.6	34.3	16.6	16.0	13.2	24.5	14.2	14.1	15.4	15.6	17.1	21.1	14.0	12.3	17.3	15.5	15.1	10.7	12.6	18.6	15.8	225.3	19.8	11.9	16.5	15.4	15.7	14.9	19.1	12.5	14.6	17.2	37.7	13.8	20.7	17.0	29.5	30.0	22.7	35.6	26.5	32.1	22.5	31.4	11.6	13.5	13.9	22.5	25.8	22.6	15.4	31.0	36.6	33.3	13.0	22.7	26.8	35.5	23.1	24.4	18.4	32.0	13.9	37.8	23.4	10.8	15.0	12.5	43.8	23.3	31.7	26.3	48.0	26.4	50.6	25.1	27.7	24.7	32.9	30.7	29.0	28.9	18.5	28.8	15.3	14.0	43.5	28.5	12.6	25.0	19.7	17.0	31.1	34.0	24.2	40.5	19.7	52.7	14.0	62.5	47.0	35.8	29.9	19.5	43.4	44.1	43.2	10.4	27.9	22.7	29.7	35.6	32.1	29.2	25.3	25.1	23.4	29.5	24.6	27.8	3.9	26.5	34.9	30.0	27.0	22.5	19.1	17.7	15.1	25.3	16.6	16.0	15.4	15.6	15.5	12.5
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332194	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol			8200000	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	41.0	30.1	21.9	23.5	24.5	37.0	28.9	33.3	28.1	28.9	31.4	18.4	28.2	21.8	27.0	38.0	45.3	22.6	24.1	45.5	22.2	23.0	29.7	82.0	27.7	20.7	20.8	23.3	31.6	45.9	21.0	24.8	66.1	25.6	31.1	25.9	17.3	28.7	25.8	98.2	38.2	29.1	29.4	22.6	29.8	23.0	38.5	18.6	32.8	30.4	34.0	27.1	42.1	32.6	5.2	2.5	7.1	2.7	5.0	4.9	1.2	33.3	29.7	42.1	27.0	29.0	46.0	47.5	51.8	42.7	46.2	31.8	49.2	36.6	46.9	21.0	56.6	47.0	58.0	46.1	46.7	31.8	19.0	24.4	31.3	37.5	38.6	43.6	21.0	38.5	43.1	44.1	66.6	32.1	39.3	35.3	41.6	54.5	42.4	22.2	44.8	34.7	31.7	55.3	22.2	39.7	31.6	38.5	26.1	35.8	50.7	31.9	51.7	17.9	29.4	34.5	33.9	42.5	38.7	24.3	44.4	25.3	36.8	26.0	36.1	1.7	2.7	2.3	4.4	2.7	4.9	4.0	2.6	3.7	2.2	5.2	4.4	3.5	7.1	5.0	1.7	2.5	4.6	1.2	21.9	24.5	33.3	27.4	22.2	23.0	20.8	23.3	25.6	18.6
RAD50	"hRad50, RAD50-2"	ENSG00000113522	"RAD50 double strand break repair protein"	Q92878	5	132556019-132646344	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB022103, CAB024979, HPA052291"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB022103: , CAB024979: , HPA052291: "	"unprognostic (3.46e-3)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (7.50e-3)"	"unprognostic (4.22e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.62e-1)"	"prognostic favourable (1.95e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.40e-1)"	11.3	8.4	10.2	8.7	11.2	10.4	11.7	8.2	11.9	8.4	11.2	4.1	8.6	6.7	13.0	20.6	15.0	8.2	7.6	11.9	8.3	5.0	11.0	12.4	11.2	6.0	9.1	9.7	11.8	10.8	14.9	16.2	11.2	10.7	9.7	8.4	3.6	11.4	11.4	13.5	19.8	11.7	8.0	7.6	10.1	8.8	12.8	9.9	11.4	13.9	7.2	6.5	9.6	12.8	6.9	3.6	6.7	4.9	9.8	8.0	3.1	5.2	14.7	1.4	8.3	10.0	9.7	4.5	3.6	6.5	3.8	6.6	13.9	9.9	13.7	2.2	6.1	7.6	6.7	8.3	5.8	4.6	8.9	5.2	9.2	8.7	8.4	6.8	5.4	7.7	16.4	7.3	17.1	2.9	8.3	2.4	6.1	5.2	5.0	9.4	6.7	6.2	3.5	1.9	5.0	6.3	9.7	7.3	9.9	7.8	3.3	1.2	7.1	4.6	3.6	2.5	3.8	8.1	5.3	4.0	4.7	15.6	6.3	8.7	3.9	6.7	4.6	0.5	5.9	4.3	8.0	6.9	7.5	5.8	3.6	6.1	6.5	6.6	0.2	9.8	4.9	3.2	3.5	3.1	10.2	11.2	8.2	11.8	8.3	5.0	9.1	9.7	10.7	9.9
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.9;testis: 24.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB010381, HPA039310"	Enhanced		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"CAB010381: AB_2253533, HPA039310: "	"prognostic unfavourable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	1.0	0.9	0.4	6.6	0.9	5.3	1.0	0.7	0.9	1.1	5.7	0.4	0.3	1.7	0.8	2.0	4.9	0.5	1.7	1.8	0.5	0.5	1.0	1.0	1.9	7.4	0.5	0.3	0.9	0.7	0.0	0.4	6.2	0.7	0.8	7.6	0.4	1.4	0.3	1.3	2.1	2.6	1.2	1.1	5.0	1.5	24.0	0.5	27.9	0.6	3.7	9.7	1.0	1.9	3.1	1.7	2.7	2.2	2.2	8.8	1.7	12.5	5.6	13.4	5.0	1.4	3.6	12.1	22.3	6.1	19.8	19.9	13.1	8.6	7.1	11.0	7.9	26.7	25.2	10.4	19.3	14.8	8.6	17.8	10.9	10.0	0.1	14.4	12.2	0.5	1.8	13.3	5.9	10.7	23.3	20.0	17.1	11.0	20.5	13.3	15.3	7.0	23.5	18.9	11.9	7.2	17.0	6.0	11.2	9.8	17.3	3.5	10.5	12.0	4.5	14.3	9.1	20.0	11.4	5.0	24.9	23.7	6.2	30.1	12.5	2.0	0.9	2.7	4.1	2.0	0.8	3.1	4.3	5.5	1.7	1.6	1.2	2.1	1.3	2.2	2.2	1.2	8.8	1.7	0.4	0.9	0.7	0.9	0.5	0.5	0.5	0.3	0.7	0.5
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"				"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: "	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	11.1	22.7	22.1	10.1	20.8	19.4	15.4	20.8	31.0	12.3	13.7	16.0	11.1	7.3	14.3	23.1	13.2	11.8	10.9	24.9	20.2	17.4	13.7	13.9	8.9	19.6	17.2	21.4	13.4	11.2	20.0	18.3	15.1	28.9	18.3	15.0	13.2	10.6	12.7	15.5	10.3	9.6	14.4	14.0	14.4	13.2	18.9	12.7	23.8	12.6	11.7	18.6	12.6	11.8	14.4	13.0	18.8	11.3	11.2	21.7	9.2	15.4	18.0	11.1	12.2	6.1	5.3	25.4	8.5	3.9	11.4	14.5	7.6	10.0	9.1	12.6	5.8	5.9	14.9	12.0	21.3	22.2	30.7	12.8	20.2	28.9	6.0	16.5	11.5	3.1	10.8	12.7	10.3	12.7	19.9	12.5	9.7	77.6	23.3	23.0	3.0	16.7	15.1	17.6	17.2	6.9	9.7	13.8	12.8	6.8	3.3	12.8	10.1	17.5	4.0	9.6	25.6	8.7	10.3	11.8	43.8	26.7	9.8	16.3	11.0	18.8	7.5	9.8	13.7	11.3	13.3	14.1	15.0	14.9	13.0	14.4	16.4	15.4	4.6	11.2	9.8	11.7	21.7	9.2	22.1	20.8	20.8	31.0	20.2	17.4	17.2	21.4	28.9	12.7
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46247688-46278473	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 41.9;testis: 56.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028954: AB_2672840, HPA051537: "	"unprognostic (2.12e-2)"	"prognostic favourable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	1.9	0.6	1.5	12.9	4.7	9.4	1.3	3.0	1.9	1.1	4.8	0.7	0.5	2.8	1.2	2.1	5.2	0.3	1.2	1.5	1.8	1.5	1.4	0.5	1.5	6.0	1.9	0.7	0.8	1.4	0.6	0.5	4.2	0.9	1.1	5.8	0.6	1.4	1.0	1.4	3.0	3.6	1.8	3.2	4.1	1.7	56.6	0.6	41.9	1.7	3.8	9.6	1.0	1.7	0.5	0.3	0.0	0.1	0.9	4.1	0.7	9.0	6.7	20.4	12.5	1.5	1.0	19.0	10.7	4.7	18.0	18.5	14.4	5.9	17.7	8.1	4.5	9.4	18.8	6.0	15.9	9.6	19.0	21.7	18.1	14.3	0.0	21.6	12.7	0.6	0.4	17.9	5.3	5.6	15.5	18.1	9.8	8.5	26.9	24.1	18.2	11.2	21.6	11.4	7.7	4.4	7.7	9.7	7.0	7.8	10.7	2.6	3.8	15.8	2.4	19.4	11.6	10.0	17.9	7.6	4.4	19.1	5.2	14.4	7.8	0.0	0.1	0.0	1.2	0.1	0.2	0.5	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.9	0.1	0.0	4.1	0.7	1.5	4.7	3.0	1.9	1.8	1.5	1.9	0.7	0.9	0.6
RAD9A	RAD9	ENSG00000172613	"RAD9 checkpoint clamp component A"	Q99638	11	67317871-67398410	"Enzymes, Predicted intracellular proteins"	"DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006725, HPA048155"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006725: AB_1856041, HPA048155: "	"unprognostic (7.64e-2)"	"prognostic favourable (6.95e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavourable (2.82e-5)"	"unprognostic (6.16e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (7.52e-6)"	5.4	5.2	7.0	10.6	8.4	10.8	6.1	7.7	6.3	6.7	11.8	8.5	5.1	14.2	7.1	4.1	8.2	12.1	6.3	6.1	3.8	3.5	6.9	9.4	9.5	9.0	7.8	2.5	6.8	20.1	3.7	7.2	10.2	5.5	8.6	3.3	4.9	12.8	8.1	7.8	12.8	17.5	5.5	4.1	10.7	11.3	7.2	6.0	18.2	11.7	7.2	16.8	6.2	7.1	6.7	5.1	8.9	3.9	4.7	9.0	3.2	6.7	11.0	5.8	8.3	1.7	0.8	7.8	4.3	2.9	5.0	4.3	13.1	12.9	8.1	8.1	0.9	11.4	3.4	3.3	0.7	7.7	9.5	10.9	5.9	6.5	2.4	7.1	14.4	2.1	3.4	4.3	1.8	3.3	8.8	9.0	1.0	20.9	13.8	13.8	8.8	8.3	11.5	7.9	9.2	1.3	5.4	6.7	7.2	6.0	16.5	13.6	11.6	6.8	2.5	7.2	9.4	14.6	5.1	9.6	8.9	7.1	4.8	7.0	5.9	8.0	3.2	8.9	9.0	3.6	6.4	6.7	7.2	7.3	2.1	5.3	4.9	5.7	4.7	4.7	3.9	5.1	3.9	3.2	7.0	8.4	7.7	6.3	3.8	3.5	7.8	2.5	5.5	6.0
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.5;HeLa: 21.4;hTCEpi: 15.5;SiHa: 7.4;U-87 MG: 6.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"			"Focal adhesion sites"	Cytosol	"HPA054022: "	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	1.6	0.5	0.2	0.5	0.2	0.0	1.4	0.2	0.2	10.4	0.3	0.2	0.2	0.2	0.8	0.6	39.7	0.6	0.2	0.2	0.2	0.0	2.8	0.2	0.6	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.5	0.2	0.4	0.3	0.2	7.0	0.2	0.7	14.6	0.3	0.3	0.2	0.6	0.2	0.5	0.3	0.3	0.2	19.8	22.5	1.3	12.6	0.6	0.4	2.3	0.6	0.5	0.7	0.1	1.5	0.9	0.0	0.0	0.1	1.3	0.1	0.1	0.9	0.1	0.3	0.0	3.7	0.0	2.1	3.0	1.6	0.0	15.5	0.2	0.4	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.3	15.5	0.9	3.2	0.1	0.0	1.3	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.7	0.2	0.0	7.4	2.0	0.0	1.1	0.0	2.9	1.1	0.4	0.1	0.9	0.0	0.0	0.0	6.7	0.3	0.0	2.0	0.6	0.4	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.6	0.7	0.4	2.3	0.5	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.2;tongue: 18.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 22.9;hTCEpi: 18.3;SiHa: 9.0;U-87 MG: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062673			Supported	Vesicles	"Secreted - unknown location"			Vesicles		"HPA062673: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavourable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.5	10.0	0.3	0.6	0.3	0.0	2.5	0.2	1.0	5.6	0.6	0.5	1.4	0.2	0.8	4.3	21.2	0.5	1.2	0.9	0.4	0.2	2.3	0.2	1.3	0.1	0.3	0.1	1.9	0.1	0.1	1.2	0.1	0.5	2.9	0.1	0.8	3.9	2.2	0.4	4.3	0.5	1.8	0.9	0.2	0.6	0.5	0.2	0.2	0.7	18.4	10.7	2.8	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	1.0	0.0	1.3	1.9	1.7	0.0	0.6	2.4	1.0	1.5	0.0	1.2	0.0	0.4	1.3	2.0	0.7	4.0	0.8	0.2	1.2	0.4	22.9	0.0	0.5	0.0	0.0	2.6	18.3	2.8	1.3	0.4	0.2	0.1	0.4	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.8	2.4	0.3	0.2	9.0	0.3	0.0	0.3	0.2	1.3	0.5	0.4	1.1	0.6	0.0	0.0	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.0	0.4	0.2	0.3	0.1	0.5	0.2
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"lymphoid tissue: 462.4"	"Group enriched"	"Detected in some"	110	"MOLT-4: 65.8;REH: 62.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043939			Supported	Nucleoplasm				Nucleoplasm		"HPA043939: "	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.7	2.3	0.5	0.5	0.5	7.4	0.7	0.5	0.5	0.5	0.6	0.5	0.5	1.2	0.5	1.3	0.5	0.6	0.5	0.6	0.5	0.2	2.4	1.2	0.8	0.5	0.5	0.5	0.6	1.1	1.9	0.5	0.8	0.5	0.5	0.4	0.5	1.5	0.5	0.5	0.2	1.5	0.5	0.5	4.4	0.8	0.9	0.5	462.4	4.5	0.5	0.8	0.7	0.5	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	65.8	0.0	0.5	0.0	62.9	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5
RAI1	"DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS"	ENSG00000108557	"Retinoic acid induced 1"	Q7Z5J4	17	17681473-17811453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023898, HPA054906"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA023898: AB_10971089, HPA054906: "	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.28e-2)"	8.0	13.8	13.8	12.6	17.6	8.1	10.1	21.5	22.9	18.1	12.2	14.2	13.3	11.3	17.8	11.8	12.1	20.3	16.8	13.6	11.3	11.9	10.3	5.8	11.2	9.7	11.1	11.3	17.3	17.2	22.4	19.6	8.4	11.3	17.7	5.4	23.3	24.0	18.2	8.2	19.1	9.5	16.7	6.6	18.5	16.6	8.8	15.7	10.4	15.6	7.7	11.2	19.6	30.0	1.0	3.0	0.7	1.2	2.8	1.0	0.7	15.5	21.2	13.4	11.1	1.8	3.7	2.3	5.4	5.8	4.5	4.4	11.0	6.6	5.0	7.5	7.0	18.4	4.7	10.7	1.9	4.9	10.5	9.2	12.8	5.5	6.0	3.6	5.8	4.2	5.2	4.1	6.1	5.6	3.9	4.1	2.3	13.9	7.7	3.6	0.9	6.3	18.2	10.5	7.2	3.7	18.7	9.4	16.8	8.5	7.5	17.5	10.1	4.6	10.6	7.2	9.3	11.5	7.6	3.7	0.8	3.2	7.0	4.5	19.6	0.0	1.0	0.7	0.8	0.8	0.5	0.1	0.4	0.6	0.5	1.0	0.3	1.0	0.1	2.8	1.2	3.0	0.0	0.7	13.8	17.6	21.5	22.9	11.3	11.9	11.1	11.3	11.3	15.7
RAI14	"DKFZp564G013, KIAA1334, NORPEG, RAI13"	ENSG00000039560	"Retinoic acid induced 14"	Q9P0K7	5	34656237-34832627	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 64.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036949, HPA036950"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"				Nucleoplasm	"Actin filaments, Cytosol"	"HPA036949: AB_10670568, HPA036950: AB_10669721"	"unprognostic (7.63e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.75e-2)"	"unprognostic (5.49e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.58e-2)"	"prognostic unfavourable (9.75e-4)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.81e-2)"	"unprognostic (4.34e-2)"	5.6	4.5	3.9	8.3	5.9	0.5	5.1	4.4	3.2	23.3	9.1	5.5	14.1	2.5	29.2	8.2	8.8	6.8	8.8	3.6	4.4	3.5	7.7	11.2	10.4	5.1	6.9	1.5	9.5	4.8	6.4	2.7	64.4	5.6	10.4	4.0	8.2	8.4	10.8	2.0	7.6	3.6	34.7	17.0	21.2	6.0	26.6	5.7	2.1	6.7	2.7	3.8	22.5	14.9	0.8	0.6	2.5	0.8	2.5	3.3	0.3	2.7	10.8	12.4	8.3	6.6	23.4	15.9	32.5	26.2	18.8	18.9	8.1	3.5	0.6	13.0	15.9	1.8	14.1	24.0	40.8	0.0	6.7	4.4	10.1	4.9	20.7	0.1	0.4	21.8	7.5	33.7	26.9	59.5	6.2	0.2	24.4	2.1	0.4	0.1	9.7	10.4	3.9	19.0	0.1	21.8	15.5	3.3	1.8	19.2	2.8	8.7	3.3	0.5	38.3	30.6	16.4	7.5	14.1	0.7	0.0	0.0	25.9	0.0	11.9	2.5	0.8	0.3	3.3	0.3	0.4	0.5	1.0	0.2	0.2	0.8	0.3	0.6	1.6	2.5	0.1	0.6	0.1	0.3	3.9	5.9	4.4	3.2	4.4	3.5	6.9	1.5	5.6	5.7
RALA	RAL	ENSG00000006451	"RAS like proto-oncogene A"	P11233	7	39623483-39708124	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Exocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047037, HPA065232"	Approved		Supported	"Plasma membrane,Focal adhesion sites"				"Plasma membrane"	"Focal adhesion sites"	"HPA047037: , HPA065232: "	"unprognostic (1.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavourable (5.32e-5)"	"unprognostic (7.71e-2)"	"unprognostic (2.17e-1)"	"prognostic favourable (7.46e-4)"	"prognostic unfavourable (6.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.95e-2)"	19.2	25.2	24.7	14.3	24.6	4.8	24.4	16.1	22.0	18.4	22.3	17.2	8.0	23.5	15.7	15.5	44.9	15.0	20.0	13.8	24.7	20.2	15.9	15.4	30.3	14.8	27.6	18.9	17.4	11.6	12.8	14.2	23.7	20.3	12.9	23.6	9.1	18.5	12.7	16.8	19.5	25.5	15.7	36.0	16.0	24.4	12.2	21.9	19.9	13.8	31.0	28.9	15.2	20.8	13.3	16.3	21.5	11.2	15.7	20.4	11.5	19.7	4.5	11.2	9.7	21.4	17.8	7.7	17.3	25.1	15.8	17.6	11.3	9.7	10.1	6.5	13.4	20.5	15.8	11.3	27.3	9.7	7.5	7.9	7.4	8.3	34.7	13.7	11.3	14.0	13.8	28.1	40.1	76.6	15.8	6.8	16.0	6.4	9.7	16.3	31.4	9.0	12.1	10.1	8.8	16.1	9.2	20.1	19.5	10.7	17.2	11.8	16.0	15.1	24.5	9.3	8.3	11.7	12.3	12.1	9.3	12.4	10.5	14.3	16.9	21.5	9.8	11.0	9.7	11.2	12.0	11.5	15.7	12.4	16.3	13.3	20.4	17.9	4.5	15.7	8.6	10.6	19.7	11.5	24.7	24.6	16.1	20.8	24.7	20.2	27.6	18.9	20.3	21.9
RALGAPA2	"AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2"	ENSG00000188559	"Ral GTPase activating protein catalytic alpha subunit 2"	Q2PPJ7	20	20389552-20712488	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"RT4: 46.9;SCLC-21H: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042707, HPA043622"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042707: , HPA043622: "	"unprognostic (7.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"prognostic favourable (3.77e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.33e-2)"	26.5	7.0	7.3	9.9	8.1	19.4	16.9	11.4	8.7	10.6	12.7	9.6	14.9	10.5	15.2	9.6	8.9	10.7	13.0	7.8	8.3	4.2	11.0	26.4	26.5	13.0	10.8	4.4	8.0	18.5	14.1	20.9	18.5	7.4	13.2	13.5	8.2	22.6	12.8	26.0	15.3	10.0	9.6	8.4	8.2	18.1	8.6	9.3	8.2	23.2	6.0	10.2	13.9	15.7	1.7	2.0	7.0	2.1	2.6	2.4	0.6	3.4	2.2	4.6	2.4	2.3	1.8	5.2	0.9	0.9	1.1	1.5	1.8	4.8	1.5	3.1	1.4	3.6	4.8	4.0	2.2	7.0	2.3	5.3	1.1	3.3	0.9	6.8	3.2	1.6	3.0	1.8	0.8	6.6	1.1	3.0	1.8	2.3	2.5	9.0	1.9	2.1	3.8	3.1	2.1	4.1	46.9	26.2	2.3	3.5	2.6	3.0	1.8	6.5	1.7	1.8	1.8	1.4	1.2	1.7	1.2	0.7	1.6	4.5	2.6	5.9	2.1	6.0	1.7	0.7	2.4	1.4	1.1	1.6	1.0	1.7	2.1	1.5	7.0	2.6	1.6	2.0	1.4	0.6	7.3	8.1	11.4	8.7	8.3	4.2	10.8	4.4	7.4	9.3
RALY	"HNRPCL2, P542"	ENSG00000125970	"RALY heterogeneous nuclear ribonucleoprotein"	Q9UKM9	20	33993646-34108308	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040971, HPA043614"	Enhanced		Enhanced	Nucleoplasm,Vesicles			12000	Nucleoplasm	Vesicles	"HPA040971: AB_2677230, HPA043614: AB_2678581"	"unprognostic (2.06e-1)"	"unprognostic (9.54e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.80e-2)"	37.7	23.4	26.3	39.9	30.7	65.2	55.4	22.4	33.9	35.0	43.7	37.6	35.1	41.9	36.4	31.0	41.6	35.2	38.9	51.9	27.3	24.4	39.3	30.3	40.9	53.9	33.0	23.4	38.3	38.5	21.9	20.7	41.9	26.5	34.9	34.9	32.0	38.7	32.7	62.0	39.8	48.8	41.7	40.9	40.4	36.0	56.8	28.9	76.0	76.7	43.6	42.6	33.5	49.7	30.8	40.9	61.6	54.1	54.1	48.4	40.4	36.3	25.2	40.8	31.1	18.3	19.5	33.1	25.5	21.2	34.3	29.6	67.8	33.1	28.7	37.6	21.2	41.1	19.2	39.8	19.5	18.8	19.9	68.0	14.8	67.7	25.4	35.0	34.7	20.7	24.3	25.3	26.0	33.2	28.1	49.2	21.8	35.3	87.1	56.6	21.1	48.7	51.6	55.8	39.0	20.9	23.1	38.9	43.6	42.6	40.8	57.9	41.6	37.3	26.0	70.9	42.9	34.4	31.8	49.3	41.3	51.1	35.6	26.6	32.5	32.9	32.4	61.6	44.3	39.9	33.1	30.8	40.1	48.4	40.9	30.7	35.6	33.6	52.9	54.1	54.1	33.8	42.0	40.4	26.3	30.7	22.4	33.9	27.3	24.4	33.0	23.4	26.5	28.9
RANBP1	HTF9A	ENSG00000099901	"RAN binding protein 1"	P43487	22	20115938-20127357	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 213.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065868, HPA065931"	Supported		Enhanced	Cytosol			910000	Cytosol		"HPA065868: , HPA065931: "	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavourable (1.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (2.40e-2)"	"unprognostic (3.95e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.30e-2)"	26.4	28.6	27.9	34.7	28.0	57.1	26.0	32.4	46.0	23.3	33.3	25.7	17.2	30.5	29.6	15.7	38.7	26.4	23.1	18.2	25.1	28.3	22.5	41.1	21.8	50.4	28.4	34.9	26.8	37.0	16.0	22.0	26.8	28.4	20.5	25.7	18.1	24.1	21.9	22.8	23.0	27.8	30.7	24.4	30.4	24.9	58.3	26.7	58.2	22.0	27.6	40.7	22.2	25.9	37.6	37.7	24.2	33.7	29.7	37.1	31.4	38.5	19.8	44.7	24.2	7.5	9.0	37.7	35.5	15.6	46.4	33.6	36.2	13.9	60.2	15.9	14.3	35.9	41.4	31.1	25.4	25.8	98.6	50.4	20.3	38.0	11.5	80.9	27.5	9.9	14.8	36.7	13.1	20.9	213.8	24.2	20.8	30.1	58.5	55.3	50.8	35.1	59.6	63.0	15.4	15.9	21.2	44.8	33.2	32.6	18.2	20.3	12.7	33.9	16.0	32.2	62.7	24.1	39.3	24.4	33.0	95.5	17.5	36.6	26.9	6.6	32.8	24.2	25.8	33.7	28.3	37.6	37.0	32.7	37.7	33.8	37.1	28.3	3.3	29.7	29.6	35.0	36.9	31.4	27.9	28.0	32.4	46.0	25.1	28.3	28.4	34.9	28.4	26.7
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719481-108785811	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Enhanced	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: , HPA049497: , HPA051675: , HPA067564: "	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.5	24.3	14.4	17.0	18.6	35.5	24.4	23.1	22.2	19.8	17.1	12.8	25.5	13.3	19.9	21.5	17.0	19.1	14.8	20.2	12.9	12.5	18.9	19.5	17.7	19.2	15.1	17.0	32.4	24.1	48.5	37.5	18.8	16.5	21.8	15.8	14.3	20.0	31.6	37.5	17.3	17.4	23.2	17.8	16.3	20.9	20.6	15.9	26.6	28.7	18.0	17.5	20.5	19.7	5.6	5.1	8.3	6.3	4.2	8.7	2.3	18.2	11.2	16.1	14.6	18.8	16.9	15.6	16.5	13.1	13.6	12.0	27.8	8.8	28.8	12.8	17.1	15.4	27.5	17.1	19.9	17.5	13.3	30.0	13.9	19.6	11.0	35.0	10.1	14.1	13.1	21.3	16.6	20.8	32.1	16.0	18.0	10.1	15.5	14.3	20.3	13.4	14.6	24.8	13.9	12.1	22.9	23.5	10.8	14.6	12.6	16.0	8.0	16.1	24.8	14.3	18.9	10.0	18.4	13.3	19.6	26.2	11.1	15.8	11.0	8.3	5.3	5.1	7.6	3.4	8.7	5.5	6.3	6.9	4.2	5.6	6.2	6.7	8.3	4.2	6.3	5.1	5.1	2.3	14.4	18.6	23.1	22.2	12.9	12.5	15.1	17.0	16.5	15.9
RANBP3		ENSG00000031823	"RAN binding protein 3"	Q9H6Z4	19	5916139-5978142	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043375, HPA043389"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA043375: AB_10959889, HPA043389: AB_10963696"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.61e-1)"	"prognostic favourable (1.22e-5)"	"unprognostic (4.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (4.14e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.15e-2)"	"prognostic favourable (8.14e-4)"	"unprognostic (1.06e-2)"	19.5	30.2	24.8	25.2	31.5	20.9	18.6	38.2	40.9	21.2	29.8	31.6	18.3	24.7	28.2	16.5	23.4	23.9	20.3	30.8	25.0	26.5	19.3	24.6	21.9	26.7	24.3	21.2	29.2	33.1	22.4	26.1	22.3	28.8	25.6	14.2	30.1	27.9	28.0	33.9	21.2	25.1	27.9	25.0	24.9	24.9	36.7	28.0	33.5	21.9	14.7	27.7	28.0	20.9	20.7	21.3	25.0	21.4	14.9	28.7	20.1	30.3	21.4	18.2	20.3	13.7	14.0	13.0	19.4	18.4	22.8	24.7	26.9	10.8	28.7	21.9	15.0	18.9	16.2	18.9	14.0	29.3	26.4	15.4	16.7	32.0	14.9	22.4	22.6	13.6	13.1	14.2	16.3	16.6	27.8	27.2	12.8	12.7	37.3	10.9	33.3	27.1	27.7	17.5	26.1	14.8	23.5	20.1	22.6	17.3	18.3	17.1	14.0	17.1	17.1	19.3	14.1	33.6	28.5	28.2	28.4	24.7	24.4	28.3	23.6	13.2	20.8	25.0	22.7	21.4	23.3	17.0	22.0	22.7	21.3	20.7	19.6	25.1	24.0	14.9	20.6	20.2	28.7	20.1	24.8	31.5	38.2	40.9	25.0	26.5	24.3	21.2	28.8	28.0
RANBP6		ENSG00000137040	"RAN binding protein 6"	O60518	9	6011043-6015625	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043748, HPA052684"	Approved		Supported	Vesicles				Vesicles		"HPA043748: AB_10796796, HPA052684: "	"unprognostic (1.47e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.89e-2)"	"prognostic favourable (1.34e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.61e-1)"	10.6	14.6	11.8	12.6	18.1	27.0	11.7	23.7	27.1	8.6	7.2	8.1	8.6	7.5	9.3	7.5	9.8	8.2	7.8	13.6	12.8	15.8	14.2	15.3	8.4	15.8	19.7	17.3	10.4	10.9	16.1	16.2	15.6	32.0	10.4	7.4	5.4	10.1	9.3	15.1	10.0	11.6	10.5	16.0	14.3	10.9	6.1	15.0	22.3	12.6	9.2	16.0	9.3	7.6	4.2	5.2	7.2	11.1	4.8	8.1	4.4	10.7	5.9	12.2	10.3	10.7	8.5	6.6	13.8	9.6	11.9	9.7	3.2	3.3	14.6	3.8	10.6	6.2	10.7	12.3	13.4	34.4	6.2	38.0	22.3	6.6	6.3	14.4	8.1	9.2	6.8	7.5	7.4	13.8	2.9	12.3	11.4	3.6	10.2	23.3	5.4	5.0	11.0	7.6	6.9	12.6	7.6	6.0	8.9	6.5	4.9	3.7	7.8	9.8	16.3	11.3	6.8	5.5	12.8	7.3	11.7	14.0	6.4	8.6	4.1	7.2	7.2	6.4	4.6	11.1	4.5	4.2	6.7	4.7	4.5	3.7	7.9	7.5	2.3	4.8	7.7	5.2	8.1	4.4	11.8	18.1	23.7	27.1	12.8	15.8	19.7	17.3	32.0	15.0
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB033767: AB_2176959, HPA050007: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favourable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favourable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	12.4	12.7	15.1	14.0	13.6	30.1	24.8	13.1	24.0	14.5	14.4	9.8	9.8	8.3	13.2	14.3	40.8	9.7	15.5	12.2	15.0	16.0	11.8	16.0	17.9	10.5	18.0	14.3	12.4	11.9	14.7	10.6	15.7	13.7	13.9	11.4	8.3	14.4	11.4	31.8	16.9	9.1	14.7	12.4	9.5	11.0	60.1	12.6	20.9	10.7	20.0	18.0	14.4	21.0	2.0	2.3	3.8	2.0	2.7	8.1	1.2	16.4	7.2	17.5	17.6	23.8	22.1	18.5	20.2	22.8	21.2	22.4	11.0	9.8	14.6	33.0	23.5	9.0	13.4	11.7	29.3	24.5	12.5	14.7	14.3	20.3	32.9	22.9	11.0	22.3	15.2	25.1	20.8	17.2	31.0	11.7	23.5	16.6	26.1	19.1	7.7	10.2	21.0	13.7	20.7	16.8	19.1	22.1	15.5	16.3	30.3	29.9	16.1	19.5	16.9	19.4	13.7	15.8	20.7	28.2	34.3	19.8	8.9	14.6	35.7	0.8	1.3	3.8	1.9	1.8	3.8	2.0	4.0	2.0	1.4	1.7	3.8	2.6	1.8	2.7	2.0	2.3	8.1	1.2	15.1	13.6	13.1	24.0	15.0	16.0	18.0	14.3	13.7	12.6
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41245611-41286251	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"				"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favourable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	12.2	30.7	23.5	16.9	28.4	28.5	16.1	17.6	41.1	8.5	11.8	23.1	7.3	12.7	9.5	9.4	26.1	11.5	13.7	11.5	26.9	30.4	12.0	25.1	11.5	19.5	31.7	28.6	10.6	20.2	11.0	17.7	16.1	28.1	11.4	9.6	7.1	16.3	13.3	12.5	51.6	12.8	12.3	22.0	14.2	16.0	64.3	28.3	22.1	12.7	14.4	21.7	13.3	29.2	8.7	7.6	8.2	14.8	7.1	13.1	9.7	58.7	30.9	20.1	21.0	10.9	9.0	24.5	51.0	27.9	51.4	27.0	37.5	19.4	31.7	41.1	37.3	54.7	36.6	40.1	31.1	25.6	56.8	26.8	30.1	29.2	13.6	43.3	20.2	8.7	19.1	36.6	32.5	26.9	34.4	22.6	29.2	50.4	25.2	35.2	22.0	36.8	31.0	19.9	33.4	20.1	33.7	18.3	12.2	36.2	32.1	18.6	18.9	17.5	41.6	39.4	37.8	21.7	41.8	16.8	22.4	30.2	27.5	30.8	22.7	2.8	9.5	8.2	11.2	11.2	13.1	7.9	11.3	10.3	7.1	8.7	10.5	8.0	2.7	7.1	14.8	7.6	11.6	9.7	23.5	28.4	17.6	41.1	26.9	30.4	31.7	28.6	28.1	28.3
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288497-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA057280: , HPA057888: "	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	14.5	14.7	24.7	11.7	29.1	11.8	26.5	10.9	19.2	31.5	15.4	7.9	13.5	10.5	20.0	22.5	10.6	21.5	10.9	23.4	15.1	17.8	17.0	11.5	18.9	26.9	16.2	19.2	21.0	6.3	16.2	17.1	14.6	18.8	15.9	10.8	17.2	6.0	19.4	11.4	9.8	11.9	18.8	12.2	15.4	16.7	70.1	15.9	16.8	11.6	9.1	20.3	14.1	10.5	26.8	22.3	25.3	16.3	21.8	40.2	18.2	15.9	18.9	13.9	14.2	10.1	12.9	11.7	9.4	18.5	25.9	24.3	10.1	6.4	30.6	10.2	11.3	18.2	25.5	12.6	18.7	21.3	32.3	15.2	14.8	13.9	23.0	9.5	22.3	12.5	23.1	22.1	21.2	20.5	6.6	8.6	15.8	0.4	29.3	31.3	9.7	7.3	25.8	10.8	18.2	14.1	7.1	5.4	15.1	7.6	11.3	19.9	0.9	9.3	11.3	5.7	9.9	11.0	18.9	14.8	11.6	36.8	12.0	19.1	8.2	4.9	16.2	25.3	24.2	16.3	22.6	24.2	29.3	27.4	17.3	26.8	26.2	22.4	2.1	21.8	12.5	22.3	40.2	18.2	24.7	29.1	10.9	19.2	15.1	17.8	16.2	19.2	18.8	15.9
RAP1GAP2	"GARNL4, KIAA1039"	ENSG00000132359	"RAP1 GTPase activating protein 2"	Q684P5	17	2755705-3037739	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.5;pancreas: 26.0"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022148, HPA022896"	Approved		Supported	"Nuclear membrane,Cytosol"			110000	"Nuclear membrane, Cytosol"		"HPA022148: AB_1849474, HPA022896: AB_1849476"	"unprognostic (1.85e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.52e-5)"	"unprognostic (1.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.36e-6)"	"unprognostic (3.44e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.50e-2)"	1.2	4.6	6.7	2.9	13.5	16.8	3.1	27.5	22.9	2.7	5.3	2.2	0.0	5.9	3.7	1.0	2.5	5.8	2.7	9.9	6.5	6.3	3.9	0.7	3.4	3.4	4.3	16.4	3.3	26.0	4.5	8.0	3.3	15.8	2.6	5.6	2.6	9.0	3.5	0.8	2.7	5.5	2.3	4.3	3.2	15.4	2.3	3.1	1.6	2.1	0.3	3.0	1.6	2.2	0.5	3.0	7.2	6.3	2.9	5.2	2.0	4.4	5.6	1.1	4.6	0.0	0.0	9.2	6.0	2.8	0.8	0.7	12.3	2.0	1.6	1.7	0.7	6.2	3.6	11.3	0.2	0.0	3.9	2.0	7.8	5.5	1.1	0.4	2.2	0.2	9.8	3.2	8.1	0.1	11.6	0.8	0.0	5.0	1.6	1.1	6.7	5.4	7.4	4.0	4.3	3.4	2.3	12.5	30.3	8.7	9.1	3.9	4.5	1.3	1.3	5.3	8.4	0.9	5.0	0.0	0.0	0.6	0.3	3.8	8.6	1.5	2.3	3.3	5.2	4.7	2.0	0.5	1.7	3.7	1.8	0.4	0.3	1.9	7.2	2.9	6.3	3.0	1.6	2.0	6.7	13.5	27.5	22.9	6.5	6.3	4.3	16.4	15.8	3.1
RAP1GDS1	SmgGDS	ENSG00000138698	"Rap1 GTPase-GDP dissociation stimulator 1"	P52306	4	98261384-98443861	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019060	Approved		Supported	Cytosol			120000	Cytosol		"HPA019060: AB_1856068"	"unprognostic (8.12e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.44e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.60e-1)"	"prognostic favourable (2.00e-4)"	"unprognostic (7.11e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	11.3	9.7	25.8	12.9	28.2	9.0	13.1	28.0	43.6	9.3	12.0	20.0	9.0	7.3	8.9	8.7	13.7	6.1	8.6	6.8	29.7	28.0	12.3	15.2	10.1	15.3	36.9	20.5	7.9	13.8	8.4	15.3	9.6	30.1	8.0	14.0	8.0	8.6	11.9	3.6	10.5	9.0	16.3	37.0	12.5	8.2	15.5	26.2	16.2	13.0	4.8	17.0	12.5	7.6	13.9	31.9	16.0	14.7	19.5	22.7	8.4	17.7	10.3	13.2	11.3	17.1	20.5	5.3	30.2	16.8	18.0	14.2	7.7	23.0	21.1	9.8	22.5	10.1	16.3	27.6	24.4	21.5	6.7	13.0	13.3	10.0	33.9	21.6	9.1	23.8	16.9	15.9	24.7	23.6	8.6	18.1	44.6	9.3	35.7	10.7	4.8	7.5	14.9	7.9	7.1	18.3	13.9	19.6	11.9	12.6	28.4	16.7	6.4	14.1	23.2	18.7	13.5	8.6	17.9	6.2	10.8	17.7	15.5	16.2	24.3	16.0	10.6	5.7	14.2	14.6	14.3	13.9	14.5	13.6	16.7	11.0	7.8	11.9	1.6	19.5	14.7	31.9	22.7	8.4	25.8	28.2	28.0	30.5	29.7	28.0	36.9	20.5	30.1	26.2
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Approved		Supported	Vesicles				Vesicles		"HPA006426: AB_1856070, HPA075984: "	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	16.2	10.8	18.4	21.5	28.0	19.7	18.5	21.8	19.5	9.6	11.5	13.7	6.0	10.1	11.1	6.9	10.3	11.4	10.2	21.5	17.4	16.0	9.4	9.7	16.9	21.7	13.1	10.2	7.4	24.1	9.0	7.3	28.5	13.5	9.0	10.3	16.8	8.5	10.0	83.3	9.2	13.7	13.2	13.0	16.7	12.0	6.8	11.6	12.4	9.9	8.8	25.9	11.3	12.0	9.2	2.9	5.3	3.9	2.0	6.5	2.3	10.4	12.2	12.4	12.5	12.7	13.8	47.6	9.0	18.5	10.5	7.6	15.1	6.9	19.0	11.4	18.2	19.2	14.2	12.6	5.3	44.0	5.8	5.6	20.5	7.9	10.7	23.0	25.7	10.5	23.3	13.7	16.4	19.0	14.9	37.7	13.6	10.9	16.2	8.1	12.5	11.1	16.1	29.0	26.4	4.8	12.7	10.5	10.5	13.2	12.6	13.2	12.0	19.4	20.0	28.4	11.9	17.9	13.7	12.7	11.0	37.5	13.5	9.9	6.8	5.3	2.0	2.6	6.5	3.8	3.7	9.2	4.2	4.2	2.4	5.3	1.1	2.9	2.3	2.0	3.9	2.9	3.0	2.3	18.4	28.0	21.8	18.5	17.4	16.0	13.1	10.2	13.5	11.6
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.4;NK-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057169			Supported	Nucleoplasm,Vesicles,Centrosome				"Nucleoplasm, Vesicles, Centrosome"		"HPA057169: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	16.7	8.0	28.4	8.8	23.8	51.0	16.3	21.5	34.1	12.6	14.5	11.3	10.4	10.9	12.7	7.3	9.9	10.2	14.1	14.9	23.4	15.3	16.4	20.9	18.1	8.5	14.1	29.6	10.2	13.4	20.7	13.8	26.1	16.9	9.3	14.8	10.0	18.7	9.4	15.7	12.7	11.9	14.0	13.9	19.2	13.7	6.7	14.3	9.3	27.5	8.9	7.8	11.9	13.8	0.4	1.4	9.4	1.4	5.2	1.5	0.3	3.2	4.4	21.1	6.5	8.3	9.4	32.4	6.3	8.0	5.8	4.2	13.6	7.3	18.6	2.3	6.3	3.0	7.1	8.1	6.9	3.1	5.0	28.9	9.3	7.8	6.0	3.5	40.0	5.4	4.6	13.9	4.9	16.5	6.3	17.4	7.1	5.7	8.7	0.5	9.0	4.4	7.1	5.3	0.7	5.2	7.5	6.0	8.0	9.3	4.5	7.7	2.2	2.3	17.5	9.2	9.7	11.7	5.2	19.4	11.5	0.3	10.9	1.5	5.5	2.7	1.4	1.0	0.8	0.8	1.0	0.4	0.7	0.5	0.8	0.3	0.9	0.4	9.4	5.2	0.9	1.4	1.5	0.3	28.4	23.8	21.5	34.1	23.4	15.3	14.1	29.6	16.9	14.3
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118238-22357144	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 67.0;parathyroid gland: 258.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.6;HUVEC TERT2: 24.6;SCLC-21H: 19.0;TIME: 13.9;U-698: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			Nucleoplasm	"Nuclear bodies"	"HPA057821: , HPA076772: "	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favourable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	10.8	5.8	12.6	3.6	22.6	1.8	6.2	5.2	25.1	4.5	4.6	47.6	0.6	3.9	4.4	3.1	6.1	4.2	7.0	6.7	21.3	10.1	7.3	8.5	14.1	5.7	41.8	13.3	3.7	7.9	258.2	3.3	23.2	31.5	2.8	5.2	0.9	3.4	3.4	2.7	4.4	4.1	5.6	67.0	17.1	3.7	3.5	29.5	3.9	5.4	1.8	4.9	3.9	4.9	0.7	0.0	0.0	0.0	0.0	0.2	0.4	1.5	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	2.9	0.7	11.6	0.6	0.1	7.2	1.5	1.0	0.0	0.0	2.3	0.1	0.0	2.9	0.0	0.0	0.0	0.3	1.3	0.7	0.4	24.6	2.6	0.1	0.0	0.6	1.6	0.0	2.0	2.3	2.8	0.0	3.9	2.3	1.0	19.0	5.0	0.2	3.3	0.0	1.6	0.0	13.9	0.0	0.6	0.2	0.6	6.4	1.3	20.7	0.3	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.6	22.6	5.2	25.1	21.3	10.1	41.8	13.3	31.5	29.5
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309192-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 63.1;SK-BR-3: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 26.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058282			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA058282: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	27.6	13.5	5.0	18.6	7.6	32.3	23.7	11.5	15.2	30.2	29.6	5.0	16.8	18.0	23.8	23.9	17.3	23.3	30.2	24.3	5.9	6.1	14.6	24.0	32.0	23.4	4.6	7.8	50.0	9.3	7.4	18.1	16.6	6.5	22.9	8.5	26.8	12.1	32.7	43.1	14.3	31.6	18.6	3.7	31.1	14.3	21.8	2.9	9.7	16.3	15.4	20.2	31.5	20.3	1.0	6.1	26.6	9.3	2.5	2.6	1.9	5.0	11.9	3.6	6.0	7.0	10.8	3.6	4.2	6.3	6.2	4.0	8.2	4.4	2.7	6.6	9.4	14.9	4.1	9.9	3.5	20.2	6.1	7.7	6.0	8.0	11.3	2.7	24.4	15.1	2.9	6.5	8.3	9.1	4.8	5.9	6.9	63.1	1.7	9.4	3.1	3.8	3.6	21.1	10.2	3.6	4.0	1.5	12.2	8.9	40.1	12.2	37.8	11.1	10.6	7.7	13.2	13.5	4.5	14.2	4.7	2.3	12.9	5.5	22.8	8.7	4.2	15.7	1.6	6.9	2.6	1.0	1.7	1.7	6.1	0.9	0.8	1.3	26.6	2.5	9.3	1.8	1.4	1.9	5.0	7.6	11.5	15.2	5.9	6.1	4.6	7.8	6.5	2.9
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 39.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.9;HEK 293: 11.2;HUVEC TERT2: 9.3;WM-115: 25.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 22.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in many"	9	"basal ganglia: 97.9"	"Low region specificity"	"Detected in all"			"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favourable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	3.9	7.1	2.4	2.3	22.6	0.0	6.8	1.5	9.1	13.4	6.0	2.2	6.8	1.7	14.4	7.5	8.1	6.2	5.3	13.6	2.6	2.2	17.5	6.2	5.6	5.6	2.0	3.7	12.2	1.5	12.8	18.9	13.9	3.2	13.0	2.3	39.1	13.7	11.8	2.5	1.4	2.4	14.7	4.6	7.7	4.8	1.7	4.8	0.0	10.0	2.9	4.6	12.1	10.2	1.0	0.4	0.1	0.6	0.1	0.8	0.0	0.0	1.3	0.8	4.5	9.9	2.6	0.0	1.1	0.5	0.0	0.4	0.2	0.0	0.1	0.1	1.7	0.2	0.0	0.1	0.0	0.0	11.2	0.1	0.1	0.7	0.2	0.1	0.1	5.2	0.0	0.0	0.0	9.3	0.1	3.9	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.4	5.9	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.1	1.5	4.8	0.1	0.0	0.0	4.0	0.1	25.6	0.0	0.6	0.0	0.8	0.1	0.3	0.3	0.5	0.5	0.4	1.0	0.6	0.8	0.1	0.1	0.1	0.4	0.0	0.0	2.4	22.6	1.5	9.1	2.6	2.2	2.0	3.7	3.2	4.8
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 49.4;skin 1: 52.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.2;MCF7: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 5.6;T-cells: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053883	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavourable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	4.8	5.0	2.7	7.0	3.6	1.3	10.8	6.3	3.8	26.8	6.3	1.8	7.3	1.0	14.6	6.0	49.4	10.6	8.6	6.9	3.0	1.4	3.7	1.9	7.4	6.7	2.4	2.3	12.6	2.7	4.2	2.8	4.4	1.6	11.3	3.4	10.3	9.5	10.6	2.6	52.1	3.0	9.7	1.5	4.7	6.0	3.9	1.7	2.3	7.3	30.6	26.8	10.9	19.8	1.8	5.6	1.5	2.5	1.7	17.0	2.9	7.2	8.0	1.8	16.9	18.8	16.2	0.5	7.6	16.6	10.0	7.8	2.7	33.2	0.1	4.1	30.5	24.4	6.1	14.6	2.5	1.9	3.1	1.0	6.1	2.3	7.9	0.0	3.0	11.9	21.4	9.5	2.1	4.2	0.2	3.2	3.9	35.0	0.4	0.3	5.4	14.1	2.3	0.6	5.8	2.9	12.0	1.5	7.6	15.4	16.7	10.1	14.5	0.4	4.5	12.0	5.6	7.9	0.4	1.5	0.8	0.5	14.7	1.2	16.9	1.5	2.5	0.7	6.6	0.8	17.0	1.8	5.7	4.8	5.6	0.6	4.8	4.1	0.0	1.7	0.0	0.4	1.5	2.9	2.7	3.6	6.3	3.8	3.0	1.4	2.4	2.3	1.6	1.7
RARS	DALRD1	ENSG00000113643	"Arginyl-tRNA synthetase"	P54136	5	168486445-168519299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.59e-5)"	"prognostic unfavourable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	21.8	26.3	16.0	18.3	15.3	6.2	22.6	17.1	18.4	21.2	29.4	9.1	20.4	33.3	22.9	21.4	34.7	19.5	14.4	21.7	19.8	12.3	29.8	33.5	18.7	18.6	13.9	15.2	21.3	33.0	19.9	34.5	30.3	15.8	18.9	27.4	15.5	34.0	15.4	27.8	27.9	48.7	21.5	14.5	22.1	24.4	17.2	11.8	20.5	21.5	32.3	23.7	22.4	22.6	11.1	21.8	5.2	17.7	16.8	16.3	11.7	27.1	32.2	23.9	26.4	33.1	37.9	41.1	40.0	34.4	41.7	48.8	54.7	29.6	28.9	32.8	38.0	26.4	31.2	53.8	54.4	30.0	21.5	19.4	29.4	34.3	28.7	45.7	20.7	29.1	28.8	45.4	21.8	33.3	28.9	14.7	44.6	25.1	19.0	18.3	39.2	22.0	8.4	34.8	27.4	37.1	31.0	22.8	28.0	30.6	35.4	41.2	32.1	19.2	33.0	30.2	27.8	23.3	46.6	14.6	26.8	29.6	32.9	32.7	28.7	3.4	14.4	5.2	12.5	17.7	14.3	11.1	12.6	13.3	21.8	6.6	15.6	16.3	4.0	16.8	16.4	10.3	12.8	11.7	16.0	15.3	17.1	18.4	19.8	12.3	13.9	15.2	15.8	11.8
RASGRF1	"CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187"	ENSG00000058335	"Ras protein specific guanine nucleotide releasing factor 1"	Q13972	15	78959947-79090773	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 34.3;lung: 13.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.7;BEWO: 7.5;Karpas-707: 10.0;RPMI-8226: 12.0;U-2 OS: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010413, HPA041965"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB010413: AB_2238127, HPA041965: AB_10793939"	"unprognostic (2.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.14e-2)"	"prognostic favourable (6.14e-6)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.02e-6)"	"unprognostic (2.35e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.81e-2)"	"unprognostic (8.81e-2)"	1.0	1.1	7.6	2.3	12.2	0.8	1.1	34.3	33.0	1.9	1.1	11.5	0.0	1.1	1.6	1.1	1.0	1.5	1.0	0.9	12.8	8.6	1.3	0.9	13.0	2.8	8.9	12.0	2.3	4.5	0.9	0.8	1.2	19.2	1.7	1.2	0.4	0.9	1.2	0.8	0.9	1.2	1.0	16.9	1.8	1.1	1.2	5.8	0.0	0.8	0.0	3.1	1.7	0.3	1.9	0.2	0.0	0.0	0.0	0.6	0.1	7.7	0.1	0.1	0.0	0.0	0.0	7.5	0.0	0.4	0.4	1.1	0.0	1.4	0.4	0.2	0.0	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.1	0.1	0.0	0.0	10.0	1.0	0.0	0.0	1.3	0.0	0.0	0.0	1.8	12.0	0.0	0.3	0.8	0.0	0.0	0.1	1.5	0.0	1.6	0.0	0.0	14.7	0.0	0.2	0.0	3.4	2.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	7.6	12.2	34.3	33.0	12.8	8.6	8.9	12.0	19.2	5.8
RASGRF2	"GRF2, Ras-GRF2"	ENSG00000113319	"Ras protein specific guanine nucleotide releasing factor 2"	O14827	5	80960672-81230156	"Predicted intracellular proteins, RAS pathway related proteins"		"Calmodulin-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 23.8;ovary: 24.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 23.8;CACO-2: 14.4;EFO-21: 7.5;Hep G2: 19.1;HHSteC: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.8;MAIT T-cell: 7.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 2.2;naive CD4 T-cell: 6.4;naive CD8 T-cell: 4.3"	"Lineage enriched"	"Detected in single"	78	"T-cells: 7.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 41.1;cerebral cortex: 118.3;hippocampal formation: 72.9;olfactory region: 58.3"	HPA018679	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA018679: AB_1856089"	"unprognostic (1.32e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-1)"	13.3	1.6	11.6	4.3	14.0	1.5	5.4	1.5	23.8	3.8	2.7	18.7	1.5	2.7	3.9	1.6	2.1	2.6	7.1	4.3	11.1	6.6	6.6	1.0	3.8	4.5	8.5	5.5	24.6	1.4	6.8	3.4	13.2	8.9	5.3	2.3	17.1	1.9	2.4	3.1	1.5	2.9	3.8	15.2	3.0	2.3	2.9	5.6	0.0	4.3	1.1	3.9	4.1	2.4	0.0	0.0	0.0	0.0	0.0	7.7	1.5	0.0	1.3	0.3	0.1	0.0	0.0	23.8	0.4	5.7	0.2	0.3	14.4	0.0	0.2	7.5	0.0	0.4	0.0	0.0	0.8	0.3	2.4	0.1	0.1	19.1	13.2	0.0	0.0	0.6	0.0	5.5	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.1	2.8	0.0	0.1	2.8	0.0	0.9	0.0	0.2	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	2.8	0.0	7.7	0.0	3.8	2.2	0.0	0.0	6.4	4.3	0.0	0.0	0.0	0.0	0.8	1.5	11.6	14.0	1.5	23.8	11.1	6.6	8.5	5.5	8.9	5.6
RASGRP1	"CalDAG-GEFII, RASGRP"	ENSG00000172575	"RAS guanyl releasing protein 1"	O95267	15	38488103-38565575	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.1;lymphoid tissue: 55.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.8;MOLT-4: 27.2;REH: 7.6;U-698: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039389			Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039389: "	"unprognostic (3.44e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.30e-2)"	1.7	1.0	5.7	9.9	17.0	7.8	1.9	33.1	18.5	1.4	1.6	0.8	0.0	2.5	1.6	1.6	6.7	4.7	2.7	1.6	6.1	3.2	5.9	1.2	4.2	20.0	3.0	6.2	0.8	2.0	0.3	1.2	4.9	22.3	1.0	2.3	1.4	2.5	1.0	0.8	7.3	3.7	0.7	1.6	8.6	4.8	2.2	1.1	55.8	1.2	1.6	16.3	4.3	2.4	1.2	0.0	0.8	0.0	2.4	10.4	1.4	0.0	0.2	0.5	0.1	0.0	0.0	0.0	2.2	0.7	1.1	0.9	2.4	0.0	6.1	0.5	0.1	0.1	1.3	0.0	1.0	28.8	1.2	0.4	0.2	0.0	0.3	0.2	0.4	0.0	0.1	0.6	0.0	0.0	0.2	1.9	0.0	0.9	27.2	0.0	0.4	0.0	7.6	0.1	0.0	1.1	0.0	2.6	0.9	1.4	0.1	0.1	0.6	0.0	0.1	0.2	0.9	3.1	0.4	4.8	2.3	7.3	0.1	0.0	0.3	0.0	0.0	0.8	5.7	0.0	4.2	1.2	6.4	5.7	0.0	0.7	6.0	6.0	0.3	2.4	0.0	0.0	10.4	1.4	5.7	17.0	33.1	11.7	6.1	3.2	3.0	6.2	22.3	1.1
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1"	"Group enriched"	"Detected in some"	5	"HEL: 18.9;HMC-1: 18.9;U-937: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	4.5	1.8	2.4	8.0	3.3	23.3	5.4	0.7	1.8	1.8	1.7	2.8	0.1	1.4	1.6	2.9	1.6	2.6	3.4	6.2	2.0	1.3	1.5	1.8	11.8	23.1	3.4	0.2	1.1	1.6	0.5	0.9	3.0	1.8	1.7	1.2	1.7	1.6	0.8	1.5	1.4	2.4	2.7	4.2	19.2	1.9	0.8	2.4	0.5	1.0	0.2	1.0	2.6	3.1	0.1	5.2	22.4	9.5	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.9	0.0	0.0	0.0	0.1	18.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	6.0	7.1	10.6	0.0	8.5	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.0	22.4	0.0	9.5	0.4	0.7	2.1	2.4	3.3	0.7	1.8	2.0	1.3	3.4	0.2	1.8	2.4
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823645	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.2;BEWO: 20.1;Daudi: 20.5;HL-60: 24.1;NB-4: 31.2;U-937: 38.4"	"Cancer enhanced"	"Detected in all"		"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: "	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	8.3	5.1	26.5	21.5	26.9	38.6	3.6	10.2	45.8	14.9	4.1	59.5	0.1	2.7	13.0	11.6	5.2	9.8	7.8	2.4	33.2	22.4	2.0	3.0	10.1	26.2	54.7	8.7	3.5	1.7	0.7	2.6	4.5	39.7	3.9	5.0	19.8	2.0	4.8	1.2	2.2	5.7	18.6	106.1	14.9	3.3	9.9	27.3	4.7	2.5	0.6	34.2	10.7	2.7	7.9	14.1	42.1	17.9	2.4	4.7	10.6	0.0	4.8	11.9	19.2	0.1	0.0	20.1	1.1	3.3	0.2	0.0	1.1	0.0	20.5	1.9	1.0	0.0	1.7	0.0	0.3	7.3	0.7	13.4	0.0	0.2	0.0	24.1	13.7	0.0	0.0	0.4	0.0	7.8	0.0	8.1	0.0	0.0	3.5	31.2	2.6	0.3	5.5	1.3	7.8	0.0	9.5	0.1	0.9	0.0	0.3	0.6	0.0	15.4	0.2	0.5	2.6	0.2	1.5	0.1	1.9	12.6	0.1	38.4	0.1	21.1	17.9	29.5	2.4	15.4	4.7	7.9	3.9	3.3	14.1	5.3	2.6	2.1	42.1	2.4	16.8	9.4	3.4	10.6	26.5	26.9	10.2	19.3	33.2	22.4	54.7	8.7	39.7	27.3
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697567	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 44.4"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	22.4	13.8	4.2	24.0	4.5	5.9	48.4	2.5	4.5	15.3	64.1	6.5	21.6	8.3	18.5	12.5	27.0	9.4	30.1	37.4	4.6	4.4	5.8	6.4	19.4	22.2	7.4	2.9	13.6	10.0	1.0	4.3	16.0	7.6	26.5	17.8	14.1	18.9	21.2	16.0	5.0	18.0	80.1	10.8	25.7	25.6	6.9	5.5	7.6	5.3	6.3	14.5	57.4	30.9	5.5	3.2	44.4	6.6	4.1	7.9	0.9	9.7	11.0	3.5	6.7	3.8	5.5	21.4	4.3	22.3	5.8	6.8	7.9	10.4	15.4	9.1	3.0	4.3	10.6	4.4	7.0	12.6	4.1	10.0	4.9	8.9	10.5	10.6	7.1	3.7	3.9	13.2	9.9	24.5	5.3	7.6	6.7	9.3	6.9	6.9	7.8	6.7	11.2	11.3	6.5	7.5	11.9	7.9	8.3	7.2	1.4	50.9	6.3	6.7	35.4	4.7	5.8	4.9	4.6	7.1	7.5	10.0	5.7	9.3	13.6	5.9	6.6	4.2	5.1	6.3	4.2	5.5	7.6	5.6	3.2	3.7	7.7	7.9	44.4	4.1	5.9	3.0	7.7	0.9	4.2	4.5	2.5	4.5	4.6	4.4	7.4	2.9	7.6	5.5
RASSF7	"C11orf13, HRAS1, HRC1"	ENSG00000099849	"Ras association domain family member 7"	Q02833	11	560404-564021	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 31.8;HaCaT: 31.9;SK-BR-3: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA078015			Supported	"Centriolar satellite"				"Centriolar satellite"		"HPA078015: "	"unprognostic (1.11e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.58e-3)"	3.6	1.1	4.0	9.7	6.5	3.6	3.9	19.4	5.8	6.2	19.6	1.7	25.6	21.6	2.6	16.5	13.2	18.5	18.4	2.0	3.0	2.2	26.3	23.2	12.0	6.1	3.6	4.2	5.1	18.4	3.8	7.1	10.2	4.6	10.7	5.7	4.0	15.3	13.9	0.8	17.5	22.3	1.7	1.2	4.6	27.1	3.1	3.0	8.5	9.8	5.5	12.5	7.9	10.4	11.9	13.9	16.4	4.6	5.5	15.5	6.9	18.5	18.4	0.9	4.7	0.0	0.0	13.2	2.8	2.2	3.0	2.2	19.2	31.8	2.4	13.1	1.5	31.9	2.7	9.8	0.4	3.2	9.6	1.6	9.0	9.2	2.0	3.9	2.8	0.0	9.6	1.0	0.9	1.8	4.1	0.9	0.2	18.6	4.3	8.3	2.7	10.6	6.9	1.4	5.3	14.7	9.1	4.1	3.1	1.8	28.5	2.4	12.9	2.5	2.4	0.6	8.9	1.1	5.4	3.2	3.4	1.9	4.9	5.4	2.5	3.9	4.6	16.4	14.4	3.8	12.9	11.0	14.7	12.5	7.8	11.9	12.2	10.6	5.4	5.5	4.0	13.9	15.5	6.9	4.0	6.5	19.4	5.8	3.0	2.2	3.6	4.2	4.6	3.0
RAVER1	KIAA1978	ENSG00000161847	"Ribonucleoprotein, PTB binding 1"	Q8IY67	19	10316212-10333640	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043575, HPA049457"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA043575: , HPA049457: "	"unprognostic (2.04e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.97e-1)"	11.8	11.3	7.0	24.3	8.5	25.5	14.1	11.1	10.1	14.1	15.1	10.3	11.2	27.3	19.8	9.4	12.6	17.5	15.0	8.3	8.1	5.6	11.0	7.4	14.0	18.7	9.2	7.2	17.8	16.6	6.5	15.4	10.6	9.0	13.0	5.8	10.2	17.9	13.5	8.3	9.7	27.8	9.1	8.8	19.4	14.7	15.0	8.2	46.9	12.3	8.9	16.4	15.8	16.1	4.3	3.7	2.9	5.7	3.6	8.6	2.8	16.1	10.4	3.8	5.8	1.5	1.9	8.5	8.6	3.8	6.8	6.0	11.3	4.6	17.2	12.0	2.7	8.4	4.2	5.6	1.3	14.4	25.4	26.4	7.0	12.6	3.5	16.5	17.1	2.3	1.9	4.5	1.7	4.4	20.8	15.2	2.0	15.1	22.1	66.5	15.0	20.1	20.4	5.6	15.0	1.9	6.5	11.0	12.8	9.3	6.0	5.0	8.6	7.9	6.0	17.5	9.0	15.4	14.4	33.6	27.7	14.5	11.6	11.6	11.4	0.5	2.1	2.9	6.2	2.6	3.4	2.7	5.1	8.6	3.7	4.3	3.7	3.0	2.1	3.6	5.7	1.7	1.9	2.8	7.0	8.5	11.1	9.2	8.1	5.6	9.2	7.2	9.0	8.2
RB1	"OSRC, PPP1R130, RB"	ENSG00000139687	"RB transcriptional corepressor 1"	P06400	13	48303726-48599436	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000095, CAB016687, HPA050082"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000095: , CAB016687: AB_1622010, HPA050082: "	"unprognostic (4.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (6.92e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	19.6	21.5	14.9	23.2	18.4	14.7	28.1	25.6	19.4	18.0	13.2	11.5	19.0	12.3	16.8	19.5	27.9	12.7	15.3	19.5	15.4	15.3	18.1	12.1	25.4	30.1	17.0	11.8	15.2	11.6	12.8	17.2	21.5	16.0	15.5	15.3	11.6	20.0	17.4	27.9	20.3	14.3	16.8	23.6	29.4	13.7	14.4	15.3	39.1	19.9	15.8	25.3	17.4	23.6	20.5	10.3	13.2	12.2	3.6	4.6	4.0	9.0	4.9	13.4	14.4	6.6	7.7	6.1	17.9	14.9	18.9	16.1	4.2	16.1	11.7	4.1	11.9	12.6	17.4	14.4	28.9	16.4	6.6	21.6	10.1	7.1	7.1	18.5	20.5	4.3	8.9	12.2	15.7	13.0	7.1	9.7	21.6	4.3	57.9	9.3	6.5	5.4	24.9	13.4	13.5	19.6	8.8	0.6	13.7	17.7	8.9	14.6	9.7	24.2	10.1	11.7	7.7	14.3	16.1	4.3	1.2	0.1	6.2	11.6	15.8	11.0	9.7	5.0	4.6	12.2	3.7	17.4	3.8	4.6	9.3	20.5	3.2	3.8	13.2	3.6	12.1	10.3	4.5	4.0	14.9	18.4	25.6	19.4	15.4	15.3	17.0	11.8	16.0	15.3
RB1CC1	"ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131"	ENSG00000023287	"RB1 inducible coiled-coil 1"	Q8TDY2	8	52622456-52745843	"Predicted intracellular proteins"	"Autophagy, Cell cycle, Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024391, HPA053049"	Approved		Supported	"Nuclear membrane,Cytosol"				Cytosol	"Nuclear membrane"	"HPA024391: , HPA053049: "	"unprognostic (1.58e-2)"	"unprognostic (7.51e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (3.22e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.56e-3)"	"unprognostic (7.67e-2)"	"unprognostic (4.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.42e-1)"	16.2	13.7	36.6	9.8	19.8	38.0	15.0	21.8	36.8	14.5	13.3	7.9	11.9	11.0	15.5	11.9	15.0	11.0	12.2	22.7	31.1	17.0	15.2	18.3	13.5	10.5	16.5	22.5	18.4	14.6	21.5	15.2	13.3	17.0	14.2	10.1	7.6	12.9	11.4	35.9	13.2	13.2	13.4	12.2	11.7	12.0	28.2	17.0	21.6	15.7	10.3	10.9	16.4	14.1	7.1	7.6	25.5	9.7	8.5	8.4	6.6	13.7	12.3	15.2	13.2	16.9	19.3	8.7	10.5	21.5	11.1	13.9	8.5	15.6	10.1	17.7	15.4	18.4	18.7	9.8	21.1	7.6	16.4	17.2	12.8	11.8	20.9	6.1	9.7	18.0	20.3	11.0	30.3	15.0	20.4	16.5	13.5	9.0	15.5	9.1	15.0	6.3	8.0	7.3	10.2	10.2	10.8	14.7	15.3	10.9	12.6	23.2	14.3	11.2	17.6	10.7	15.0	16.8	9.2	16.4	14.1	10.1	16.9	10.7	11.9	22.3	8.0	14.7	7.8	7.6	7.8	7.1	6.5	7.9	7.6	6.2	8.0	7.4	25.5	8.5	9.7	3.9	8.4	6.6	36.6	19.8	21.8	36.8	31.1	17.0	16.5	22.5	17.0	17.0
RBAK	ZNF769	ENSG00000146587	"RB associated KRAB zinc finger"	Q9NYW8	7	5045821-5069488	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071231			Supported	Nucleoplasm				Nucleoplasm		"HPA071231: "	"unprognostic (2.82e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.04e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.12e-3)"	"unprognostic (5.75e-2)"	7.6	7.3	7.1	15.0	11.6	5.8	10.7	19.0	10.6	9.2	8.3	5.9	12.0	7.9	9.6	9.7	14.4	8.4	7.5	7.7	9.4	8.3	8.8	12.0	7.7	16.5	8.8	11.6	9.7	11.0	17.5	11.6	8.1	8.7	9.1	9.1	6.2	11.0	14.2	7.9	10.7	9.8	8.9	7.9	10.6	8.8	6.0	11.0	20.0	10.3	15.1	11.7	11.1	10.0	1.7	1.9	1.7	1.8	2.0	3.0	0.6	7.7	6.0	8.4	15.6	6.2	5.8	7.0	4.9	3.9	4.9	5.8	7.4	4.9	9.3	4.2	5.7	9.7	9.4	7.7	7.6	2.0	6.6	6.7	7.7	6.1	6.6	11.5	8.2	5.7	9.2	4.8	11.0	4.7	14.0	3.3	6.1	13.8	2.7	10.5	13.3	6.3	4.6	13.7	6.8	5.7	10.2	8.7	14.3	6.9	11.6	10.2	7.1	13.6	4.0	5.8	9.3	6.7	8.1	10.5	8.2	8.3	5.9	8.4	7.6	0.0	0.9	1.7	2.4	1.8	3.0	1.7	1.8	1.7	1.5	1.3	2.2	1.8	0.1	2.0	0.4	1.9	1.2	0.6	7.1	11.6	19.0	10.6	9.4	8.3	8.8	11.6	8.7	11.0
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm			27000	Nucleoplasm		"CAB006264: AB_425651, HPA060710: , HPA060724: "	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favourable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	23.8	33.6	28.2	34.3	27.8	23.4	29.1	30.5	35.1	32.2	24.1	32.0	42.3	20.5	36.0	29.2	26.0	35.4	21.3	24.0	27.9	24.8	25.2	25.4	23.0	43.9	30.6	29.0	37.6	31.3	27.0	32.9	26.2	26.9	24.2	35.5	31.2	30.1	43.1	31.8	24.9	26.8	32.6	26.9	27.6	28.8	53.4	31.4	73.3	35.8	20.5	65.2	32.5	26.6	33.7	45.4	26.7	39.4	33.1	32.4	48.4	15.4	13.6	38.9	28.3	12.0	11.4	15.7	11.8	10.3	24.1	23.5	19.4	31.9	47.0	13.1	13.9	10.0	42.5	12.3	26.1	18.3	20.4	43.8	27.4	25.4	17.4	41.3	19.0	12.5	15.7	18.2	11.8	17.8	30.8	33.7	20.6	10.8	53.0	13.0	43.2	15.9	51.5	40.9	40.8	16.9	33.2	37.2	22.1	28.0	10.0	19.1	17.1	19.2	14.8	14.7	15.0	18.5	15.8	26.8	28.1	52.8	17.5	33.4	22.5	26.4	38.8	26.7	31.1	39.4	32.4	33.7	29.7	31.4	45.4	26.6	26.7	28.8	10.2	33.1	35.3	38.3	30.3	48.4	28.2	27.8	30.5	35.1	27.9	24.8	30.6	29.0	26.9	31.4
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA049042: , HPA058085: "	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	12.9	17.0	13.7	10.9	23.1	13.5	13.0	20.9	23.3	13.7	11.2	16.4	6.7	11.3	16.4	12.8	11.9	12.6	9.9	10.4	13.2	12.9	20.6	17.3	10.5	16.5	13.5	12.5	16.2	16.8	15.9	21.5	10.3	15.0	11.8	13.2	12.7	14.6	12.0	18.8	14.9	12.7	11.6	10.5	14.0	10.7	9.5	13.7	22.5	17.4	8.9	19.8	11.7	16.7	8.6	6.1	19.1	7.7	7.7	9.6	3.3	10.5	11.2	10.8	12.8	15.1	8.7	11.8	10.0	8.6	12.9	12.9	11.8	12.8	16.5	7.7	7.3	12.2	18.0	6.7	15.4	14.0	9.7	13.8	11.4	9.5	9.8	17.2	11.3	7.0	8.7	12.0	10.3	10.3	26.5	17.0	10.7	9.7	16.6	7.3	17.6	18.7	14.9	23.1	20.6	9.0	7.7	17.0	13.7	14.2	15.0	12.8	16.2	9.8	7.8	10.7	11.5	15.7	13.2	8.3	11.5	20.3	9.5	10.8	16.4	19.1	5.2	7.5	8.6	6.3	9.2	8.6	8.1	8.8	5.4	7.1	8.0	9.6	11.9	7.7	7.7	6.1	8.1	3.3	13.7	23.1	20.9	23.3	13.2	12.9	13.5	12.5	15.0	13.7
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA replication, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: , HPA043544: "	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	15.1	17.6	17.2	14.0	16.4	81.4	17.9	33.0	15.7	17.8	18.8	16.3	19.8	10.2	23.2	18.7	15.3	21.2	17.6	14.7	15.0	13.2	13.1	15.8	15.7	18.1	18.7	12.2	27.2	14.4	20.7	23.1	73.9	15.4	18.2	14.4	18.4	13.7	14.7	19.2	19.2	16.4	18.4	19.2	18.6	16.4	25.1	18.7	24.3	18.6	11.8	15.5	17.9	17.9	3.8	6.9	8.5	3.7	6.5	4.2	1.0	17.6	9.2	21.8	22.6	16.7	17.4	23.6	14.3	13.2	13.1	14.2	10.2	14.3	24.5	10.8	12.1	17.0	23.3	12.5	21.7	13.4	18.1	21.1	26.5	29.0	13.0	28.0	12.6	15.1	17.4	17.0	20.1	18.7	26.5	22.4	15.1	18.1	22.6	25.3	25.0	8.8	31.1	22.1	21.6	12.6	15.8	17.5	15.3	20.1	18.1	25.3	14.1	24.9	16.2	16.3	12.0	14.0	15.3	20.0	19.8	30.9	13.1	18.6	13.4	8.5	2.3	3.7	4.0	3.7	4.2	3.8	4.1	2.8	1.6	3.8	3.5	4.0	5.0	6.5	2.1	6.9	3.1	1.0	17.2	16.4	33.0	15.7	15.0	13.2	18.7	12.2	15.4	18.7
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870414	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm			25000	Nucleoplasm		"CAB037084: AB_477448, HPA060710: , HPA060724: "	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.65e-2)"	16.0	81.2	16.6	21.1	26.7	20.3	15.5	13.3	16.2	34.6	22.8	15.3	103.2	13.1	32.3	77.3	20.9	24.5	19.7	36.2	15.1	13.1	17.3	18.5	14.3	19.7	13.7	15.5	41.6	19.0	47.8	16.0	28.7	12.2	26.2	18.1	16.5	19.0	87.6	78.2	16.4	17.9	25.9	15.9	16.0	23.5	31.6	13.6	30.8	18.1	18.2	24.5	24.3	18.5	36.6	29.4	23.7	41.2	32.8	37.7	27.3	53.2	39.7	30.2	39.8	19.0	22.5	19.2	26.5	26.7	39.1	44.4	23.2	35.3	59.0	40.8	25.7	28.3	53.8	39.5	52.0	33.3	73.9	24.9	48.3	27.6	16.1	37.6	30.2	17.4	14.6	45.1	33.1	39.2	24.9	31.5	30.9	35.8	42.0	34.8	33.9	36.9	36.9	55.6	69.6	28.4	35.9	28.1	20.9	50.1	24.1	23.5	80.0	22.8	18.1	18.9	19.4	49.8	29.4	22.0	31.5	77.4	24.3	25.4	22.9	16.6	18.3	23.7	36.4	31.3	34.8	36.6	30.4	37.7	25.4	31.0	32.2	35.9	7.4	32.8	41.2	29.4	27.9	27.3	16.6	26.7	13.3	16.2	15.1	13.1	13.7	15.5	12.2	13.6
RBBP8	"COM1, CtIP, RIM, SCKL2"	ENSG00000101773	"RB binding protein 8, endonuclease"	Q99708	18	22798261-23026488	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA039890, HPA052946"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA039890: AB_10794756, HPA052946: "	"unprognostic (1.55e-3)"	"unprognostic (4.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (7.21e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.04e-2)"	"prognostic favourable (1.71e-5)"	"unprognostic (3.91e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.48e-1)"	9.0	6.2	6.0	10.8	6.4	9.4	19.4	4.2	5.9	16.4	13.4	4.1	22.5	5.4	13.1	18.6	17.1	17.6	8.7	8.3	4.9	6.8	49.6	12.3	17.0	7.8	6.6	3.6	12.2	14.3	17.4	29.2	11.5	11.5	13.4	8.0	5.3	14.8	29.1	3.8	17.4	14.0	10.3	4.5	9.8	7.8	16.7	3.8	24.2	14.7	10.8	10.0	10.4	13.0	4.3	5.1	7.8	21.0	5.0	2.8	2.2	9.4	7.3	10.9	12.5	5.6	6.0	8.5	13.1	9.2	12.2	17.3	13.4	10.8	27.7	6.1	8.2	20.0	12.3	26.6	24.0	19.7	9.9	12.1	9.9	12.7	6.9	43.5	13.3	4.3	25.8	18.4	32.2	4.9	7.1	20.8	12.4	14.1	32.2	14.6	10.3	12.4	16.6	19.9	17.1	35.3	10.2	25.5	12.1	21.9	6.7	11.3	38.7	11.5	3.5	32.8	15.1	15.8	22.7	28.2	30.2	30.4	15.0	21.1	17.5	7.8	4.0	2.3	0.8	14.8	0.3	4.3	1.1	1.4	5.1	3.3	0.6	1.0	1.5	5.0	21.0	5.1	2.8	2.2	6.0	6.4	4.2	5.9	4.9	6.8	6.6	3.6	11.5	3.8
RBBP9	Bog	ENSG00000089050	"RB binding protein 9, serine hydrolase"	O75884	20	18486540-18497243	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015830, HPA049005"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA015830: AB_1845410, HPA049005: "	"unprognostic (1.17e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.21e-2)"	8.6	18.4	10.7	7.1	11.6	3.6	11.0	11.4	11.2	16.1	7.4	15.4	9.1	7.7	10.7	8.0	9.3	7.0	11.9	9.0	9.0	9.6	19.8	39.3	9.6	8.6	11.5	7.4	9.5	7.2	15.3	14.4	6.6	12.8	10.1	8.8	12.8	13.2	10.8	4.4	14.1	10.2	9.2	13.0	10.1	8.1	5.1	9.4	9.0	27.5	9.9	9.8	8.9	7.8	3.6	3.3	10.8	3.8	2.8	4.6	3.1	7.3	8.6	8.1	11.3	5.7	9.6	8.2	8.4	8.2	11.0	11.3	6.2	6.6	9.2	3.5	5.8	8.3	6.3	13.9	13.2	2.7	7.7	4.8	2.8	18.9	3.6	7.0	3.0	4.9	5.6	9.0	5.4	13.7	3.0	7.2	9.5	4.1	7.2	4.9	5.3	16.4	7.2	23.9	5.8	9.9	8.0	6.9	11.8	11.3	13.7	5.8	10.9	1.9	7.9	18.5	6.0	11.6	7.4	8.2	20.4	6.4	7.2	3.3	5.9	10.8	3.0	0.9	3.2	3.8	4.6	3.6	3.8	2.2	3.3	3.1	3.4	2.7	0.5	2.8	2.8	0.6	4.5	3.1	10.7	11.6	11.4	11.2	9.0	9.6	11.5	7.4	12.8	9.4
RBFA	"C18orf22, FLJ21172, HsT169"	ENSG00000101546	"Ribosome binding factor A"	Q8N0V3	18	80034358-80046397	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040485, HPA041479"	Approved		Supported	Mitochondria				Mitochondria		"HPA040485: AB_10795368, HPA041479: AB_10795697"	"unprognostic (5.31e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.00e-3)"	"prognostic unfavourable (2.06e-6)"	"unprognostic (2.98e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.82e-1)"	"unprognostic (5.00e-3)"	19.4	21.0	11.3	14.4	15.8	16.7	30.9	20.4	17.3	12.1	12.5	15.9	10.0	14.8	13.6	14.3	17.7	11.4	12.9	13.8	10.6	8.6	14.5	36.9	11.0	18.5	12.5	14.2	12.3	20.0	12.5	9.7	12.6	12.7	11.8	12.7	11.3	13.4	12.3	21.3	18.6	11.1	18.3	13.8	13.2	12.1	13.8	12.8	9.9	11.6	18.6	15.7	14.0	14.2	10.7	8.3	0.3	10.1	7.5	11.7	5.7	14.2	16.0	11.3	10.4	11.5	13.7	14.6	12.1	7.7	17.9	16.1	9.4	12.5	30.0	4.6	10.9	13.5	12.5	15.6	14.4	10.9	13.0	17.8	11.6	24.7	8.8	28.1	8.8	13.1	15.3	11.8	17.2	15.0	9.5	18.7	10.9	13.7	27.9	19.4	11.8	15.9	18.8	10.5	36.6	17.2	16.7	19.5	11.8	10.9	13.0	8.3	9.4	14.2	10.2	20.3	19.0	3.0	13.1	6.9	11.9	25.1	11.8	24.5	11.6	0.0	5.1	0.0	7.5	7.0	11.7	10.7	7.6	7.3	8.3	8.3	8.4	7.9	0.3	7.5	10.1	6.5	5.8	5.7	11.3	15.8	20.4	17.3	10.6	8.6	12.5	14.2	12.7	12.8
RBFOX2	"FOX-2, HNRBP2, HRNBP2, RBM9"	ENSG00000100320	"RNA binding fox-1 homolog 2"	O43251	22	35738736-36028425	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006240	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006240: AB_1079750"	"unprognostic (3.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.08e-2)"	14.0	11.6	25.7	7.6	30.5	0.4	12.7	58.4	37.2	26.4	23.2	7.4	11.2	7.9	38.5	13.8	22.9	20.4	16.7	20.8	19.6	15.9	10.2	10.6	12.7	3.7	12.0	26.3	43.3	9.3	20.5	20.6	21.3	22.8	18.3	13.6	9.7	10.3	20.5	40.7	12.6	10.6	32.6	9.7	5.4	13.3	10.4	10.1	1.8	18.7	5.7	5.3	18.1	15.9	0.0	0.7	0.0	0.0	0.1	3.1	0.1	14.8	9.7	31.8	18.6	20.0	33.7	13.1	28.0	37.5	20.9	23.0	18.7	6.4	9.6	13.5	31.7	14.5	11.6	12.8	26.7	7.6	13.3	5.3	8.7	6.9	6.0	1.5	4.0	24.4	16.6	19.9	22.7	25.4	4.0	1.2	22.8	5.8	1.4	0.8	12.4	13.5	2.2	28.3	2.2	14.4	16.7	9.8	37.4	31.9	5.0	9.9	5.9	1.8	31.3	29.9	17.6	17.7	12.9	1.0	3.1	11.8	14.0	2.2	16.8	0.0	0.0	0.0	1.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.1	25.7	30.5	58.4	37.2	19.6	15.9	12.0	26.3	22.8	10.1
RBFOX3	"FOX-3, HRNBP3, NeuN"	ENSG00000167281	"RNA binding fox-1 homolog 3"	A6NFN3	17	79089345-79516148	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.4;seminal vesicle: 21.5"	"Group enriched"	"Detected in some"	6	"A549: 12.9;NTERA-2: 11.7;SCLC-21H: 18.7;U-2 OS: 8.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 60.4"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030790, CAB078782"	Enhanced	Supported	Supported	Nucleoplasm				Nucleoplasm		"CAB078782: , HPA030790: AB_10602305"	"unprognostic (2.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.22e-15)"	"unprognostic (8.92e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-1)"	0.5	1.0	10.2	0.6	23.5	0.6	0.2	60.4	33.2	0.5	15.2	0.3	0.2	1.5	9.3	3.0	8.3	1.0	0.3	0.3	8.6	3.3	0.4	0.2	0.3	0.4	1.8	3.5	0.3	0.5	0.2	0.9	0.3	5.5	13.2	2.2	0.2	0.2	21.5	0.3	0.3	1.3	8.1	2.3	0.4	0.5	7.2	5.6	0.2	0.3	0.2	0.2	15.2	1.0	0.7	0.2	0.0	0.7	0.0	1.4	0.2	0.0	12.9	0.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	11.7	0.2	0.2	0.5	0.0	0.0	0.0	18.7	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.8	0.5	0.0	0.7	0.0	0.3	0.4	0.3	0.0	0.0	0.7	0.0	1.4	0.3	0.0	0.7	0.1	0.4	0.2	0.7	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.2	10.2	23.5	60.4	19.5	8.6	3.3	1.8	3.5	5.5	5.6
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095995	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	5.0	4.3	4.9	12.3	7.1	20.4	4.8	16.6	7.8	5.1	5.6	5.5	5.9	4.0	8.1	3.0	7.7	4.4	3.6	4.0	4.0	3.6	3.3	3.0	4.5	11.1	6.5	2.2	7.8	6.0	5.9	5.9	8.3	5.7	4.4	6.1	5.3	4.8	2.7	10.2	5.3	5.9	5.9	7.1	6.9	4.6	8.2	5.5	19.6	5.3	6.1	11.4	4.7	7.1	5.0	5.1	2.2	1.9	3.6	7.4	1.6	12.0	7.9	9.9	6.6	2.5	3.3	6.3	14.1	6.3	12.2	12.7	8.3	6.8	13.5	4.1	5.8	11.9	8.8	9.1	20.5	4.7	4.7	13.3	9.3	7.0	1.5	17.1	9.3	1.6	1.2	16.1	5.7	6.8	9.7	13.1	6.9	5.1	15.9	5.7	2.9	7.7	10.4	29.4	10.2	2.8	6.0	2.3	5.9	15.4	8.9	4.1	5.7	12.4	4.5	21.7	8.3	19.8	12.2	4.4	7.7	13.7	15.5	12.1	10.6	1.4	1.2	2.2	5.0	1.4	4.2	5.0	5.6	4.5	2.2	3.9	6.0	4.8	0.6	3.6	1.9	5.1	7.4	1.6	4.9	7.1	16.6	7.8	4.0	3.6	6.5	2.2	5.7	5.5
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491649	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favourable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	27.8	20.6	15.7	22.2	20.0	11.1	25.5	24.1	18.7	26.3	23.7	24.7	25.6	15.4	30.0	20.2	21.5	25.1	19.5	19.9	15.5	11.7	23.8	34.2	24.0	31.6	25.8	13.7	29.3	30.7	55.3	22.6	12.4	15.8	28.2	18.9	20.2	26.2	30.5	28.3	20.8	24.6	26.1	17.9	27.2	24.9	28.6	22.8	54.4	31.0	10.3	31.6	36.5	26.8	9.1	8.0	20.2	9.8	26.2	35.1	24.5	12.6	8.6	11.5	10.6	30.2	29.2	5.4	9.3	13.3	11.6	4.0	5.6	15.9	18.5	14.1	15.7	15.9	8.6	14.4	18.5	6.6	11.9	8.3	8.7	10.4	13.0	11.5	26.1	18.5	17.7	7.9	11.3	17.9	6.7	11.6	12.9	3.7	22.9	15.5	4.7	7.8	16.7	21.0	21.2	11.4	12.9	9.4	7.8	21.1	9.3	9.1	12.0	15.2	14.8	14.4	7.7	11.9	6.9	17.9	10.5	21.7	18.0	14.4	9.9	16.4	8.2	20.2	21.2	5.9	23.7	8.7	23.8	24.3	8.0	9.1	35.1	29.6	15.7	26.2	9.8	4.9	17.5	24.5	15.7	20.0	24.1	18.7	15.5	11.7	25.8	13.7	15.8	22.8
RBM10	"DXS8237E, GPATC9, GPATCH9, KIAA0122, ZRANB5"	ENSG00000182872	"RNA binding motif protein 10"	P98175	X	47144869-47186813	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034972, HPA057372"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA034972: AB_10602919, HPA057372: "	"unprognostic (9.07e-2)"	"prognostic favourable (6.71e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (2.86e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-3)"	18.1	22.2	19.8	38.0	21.9	34.0	17.1	41.2	22.9	19.9	20.5	25.7	22.7	21.8	22.1	17.3	23.7	26.2	29.1	21.7	19.8	18.3	18.4	21.6	17.1	27.2	20.1	19.2	36.4	27.4	20.1	28.3	24.9	17.9	23.5	14.2	18.5	25.1	28.8	20.6	23.8	23.7	18.9	17.2	24.7	20.5	8.7	21.4	32.9	26.8	18.0	22.7	17.6	20.9	15.9	14.6	14.4	19.2	12.3	18.3	11.5	20.7	22.5	21.6	25.5	11.6	9.5	25.1	15.8	9.3	16.4	16.0	19.6	17.1	25.4	9.7	10.9	20.3	28.1	19.9	9.0	25.7	25.5	19.0	27.4	20.5	16.9	19.1	22.9	12.5	9.6	27.0	22.0	17.5	15.8	20.4	9.9	31.7	35.0	32.4	35.6	25.3	31.0	18.0	26.2	12.1	18.4	25.6	19.5	23.9	17.9	15.2	22.0	19.1	15.3	19.3	24.5	20.8	16.6	21.5	17.4	20.9	17.1	13.8	26.9	14.0	10.8	14.4	18.3	14.5	17.0	15.9	14.7	15.3	12.3	15.6	14.8	14.1	10.1	12.3	19.2	14.6	16.6	11.5	19.8	21.9	41.2	21.9	19.8	18.3	20.1	19.2	17.9	21.4
RBM11		ENSG00000185272	"RNA binding motif protein 11"	P57052	21	14216130-14228372	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"brain: 20.6;epididymis: 55.3"	"Cell line enhanced"	"Detected in some"		"HEL: 3.7;NTERA-2: 2.9;REH: 2.8;SK-BR-3: 3.1;U-266/70: 2.9;WM-115: 2.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045885			Supported	Nucleoplasm				Nucleoplasm		"HPA045885: AB_10963937"	"unprognostic (1.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.44e-4)"	"unprognostic (2.18e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.92e-4)"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.24e-3)"	1.2	1.8	5.0	1.4	5.8	1.5	1.5	2.3	7.3	1.0	1.2	1.9	0.6	1.3	1.8	55.3	1.6	2.1	1.2	1.3	5.9	6.1	1.4	1.0	1.2	1.3	6.1	4.3	3.5	1.4	2.2	5.4	1.1	9.7	1.6	1.1	2.8	1.5	2.2	1.0	1.1	1.0	1.4	20.6	1.5	1.3	2.5	6.1	0.0	2.4	0.0	1.2	1.1	0.9	0.3	0.0	0.0	0.1	0.0	4.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.3	1.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	1.6	1.1	0.0	2.9	0.0	2.8	0.0	0.0	0.7	1.1	0.3	0.0	0.4	3.1	0.0	0.6	0.6	0.0	0.0	1.1	0.0	0.0	2.9	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.3	4.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	5.8	2.3	7.3	5.9	6.1	6.1	4.3	9.7	6.1
RBM12	"HRIHFB2091, KIAA0765, SWAN"	ENSG00000244462	"RNA binding motif protein 12"	Q9NTZ6	20	35648925-35664956	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043258, HPA043621"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA043258: AB_2678395, HPA043621: AB_2678584"	"unprognostic (8.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (7.96e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (4.44e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.87e-2)"	23.3	26.1	18.6	26.6	20.6	22.5	23.1	28.1	19.9	26.7	20.8	19.3	21.2	17.5	31.1	21.3	27.9	29.4	22.4	21.1	17.8	12.5	19.5	18.7	23.8	32.2	17.7	20.0	39.5	18.9	24.4	25.7	31.4	15.6	22.7	21.6	22.1	25.6	18.6	24.4	22.1	25.7	25.2	15.4	28.5	21.7	20.6	18.6	52.8	29.3	21.9	37.6	28.0	22.8	15.1	14.9	9.9	13.8	11.5	17.3	11.7	24.7	16.7	35.9	21.9	8.8	17.4	22.1	13.8	16.4	19.4	19.2	23.1	17.6	44.9	15.5	27.7	17.7	42.4	35.4	25.0	21.2	15.2	37.6	16.6	15.4	15.2	40.7	20.2	24.8	18.3	22.3	14.9	21.6	35.7	21.8	17.0	18.3	48.3	11.5	26.1	17.3	29.6	44.1	21.9	14.1	41.0	19.0	24.7	24.7	19.4	18.5	25.0	15.0	30.3	16.4	24.4	16.1	20.5	23.7	25.6	47.5	14.4	15.9	21.3	6.0	11.9	9.9	14.8	13.8	17.3	15.1	13.1	17.0	14.9	14.4	14.0	12.1	9.2	11.5	11.1	9.6	12.0	11.7	18.6	20.6	28.1	19.9	17.8	12.5	17.7	20.0	15.6	18.6
RBM14	"COAA, DKFZp779J0927, SIP, SYTIP1"	ENSG00000239306	"RNA binding motif protein 14"	Q96PK6	11	66616582-66627347	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006628	Supported		Supported	"Nuclear speckles"			13000	"Nuclear speckles"		"HPA006628: AB_1078546"	"unprognostic (6.96e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavourable (2.02e-7)"	"unprognostic (4.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (9.38e-3)"	"unprognostic (8.59e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	23.5	23.2	22.6	28.4	27.3	35.2	20.8	44.3	31.0	24.1	20.8	26.9	28.6	18.7	30.8	24.6	25.7	28.9	25.3	22.0	22.3	19.4	26.6	29.1	21.0	34.7	32.1	20.4	37.7	26.6	24.8	34.0	24.5	22.4	27.8	22.9	28.8	27.6	22.3	24.3	34.8	24.7	28.0	21.7	32.1	22.5	42.9	25.6	47.2	27.7	20.2	34.1	18.5	23.0	18.3	24.7	20.1	19.6	15.7	22.6	20.8	22.7	25.6	16.5	14.1	8.7	6.2	31.3	12.0	6.8	17.8	10.5	26.2	20.0	36.3	13.6	7.8	20.3	22.2	15.6	14.6	16.2	19.7	21.6	20.2	20.8	5.5	20.1	21.4	4.3	5.5	16.4	7.6	13.2	26.3	26.5	14.1	22.3	37.4	25.5	33.4	25.3	34.7	18.6	19.9	11.9	21.1	20.1	17.7	22.3	17.6	9.8	25.9	19.1	14.5	17.5	30.0	12.7	20.6	14.0	19.6	31.7	13.8	21.9	39.1	12.9	16.9	20.1	22.3	19.6	21.7	17.0	19.6	21.5	24.7	18.3	20.5	22.6	7.6	15.7	19.5	16.2	16.6	20.8	22.6	27.3	44.3	31.0	22.3	19.4	32.1	20.4	22.4	25.6
RBM15	"OTT, OTT1"	ENSG00000162775	"RNA binding motif protein 15"	Q96T37	1	110338506-110346681	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015201, HPA019824, HPA049642"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB015201: , HPA019824: AB_1856113, HPA049642: "	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.57e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (7.61e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (1.37e-4)"	"prognostic favourable (7.97e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	8.5	7.6	6.3	12.2	7.6	48.7	7.9	18.6	8.3	6.6	8.8	7.6	8.3	7.3	8.5	7.2	8.0	7.3	6.6	8.8	5.2	4.3	6.3	11.0	10.5	13.7	8.3	6.0	8.6	7.5	7.1	8.1	7.1	5.9	5.7	5.7	8.1	7.4	6.4	17.2	7.2	11.3	5.5	5.0	12.5	8.3	14.0	7.9	21.8	7.0	5.3	13.4	6.5	8.6	10.5	4.8	9.8	6.9	5.0	9.9	5.5	7.0	7.7	6.9	7.1	4.4	4.6	10.9	3.7	4.9	5.9	7.8	9.4	6.5	13.3	6.0	4.2	10.0	10.8	9.4	8.8	13.8	10.0	10.8	11.7	6.8	6.2	11.7	11.5	4.2	6.6	8.2	7.7	6.3	15.2	23.4	5.9	7.2	10.5	9.2	14.8	4.3	12.5	10.5	9.1	4.8	7.1	8.4	4.2	8.2	10.3	7.9	7.2	14.1	4.3	5.7	10.2	6.1	6.8	18.0	9.1	28.9	8.5	11.8	7.0	8.2	6.9	9.4	7.0	6.0	9.9	10.5	7.7	6.0	4.8	10.0	6.8	8.2	9.8	5.0	6.4	4.7	7.5	5.5	6.3	7.6	18.6	8.3	5.2	4.3	8.3	6.0	5.9	7.9
RBM15B	"HUMAGCGB, OTT3"	ENSG00000259956	"RNA binding motif protein 15B"	Q8NDT2	3	51391268-51397908	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036645, HPA058136"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA036645: AB_10671965, HPA058136: "	"unprognostic (2.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.01e-2)"	"prognostic favourable (1.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.84e-1)"	8.6	3.8	4.9	5.6	6.3	5.2	7.1	4.4	9.0	8.0	7.5	6.1	6.3	5.9	7.4	6.5	8.4	7.2	10.1	5.6	5.2		4.8	9.4	6.7	11.6	4.9	4.1	9.3	9.8	9.2	3.3	7.3	4.1	8.3	7.1	5.1	7.2	7.0	4.9	9.9	9.3	7.4	2.2	7.8	6.4	9.1	4.1	23.0	8.2	5.4	7.3	6.8	9.3	4.5	4.9	1.5	5.7	3.4	5.0	3.1	11.0	9.8	23.0	24.0	20.8	16.3	14.1	10.2	19.2	16.4	13.6	12.1	8.0	16.0	8.6	18.5	10.2	13.1	18.5	8.0	12.8	10.3	13.8	15.3	10.3	12.2	17.9	7.8	17.7	23.1	15.1	17.9	16.9	10.3	10.9	14.1	11.8	31.1	11.4	18.3	15.5	11.2	10.1	13.6	14.7	26.7	15.0	21.5	13.2	17.7	11.8	14.0	21.3	15.3	16.9	14.8	14.2	19.3	16.1	14.4	17.8	13.7	14.4	17.9	0.0	4.1	1.5	4.0	5.7	4.4	2.4	5.0	4.2	4.5	4.5	5.0	3.1	0.8	3.4	5.3	4.9	2.3	3.1										
RBM17	"MGC14439, SPF45"	ENSG00000134453	"RNA binding motif protein 17"	Q96I25	10	6088987-6117457	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037477, HPA037478"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA037477: AB_10671372, HPA037478: AB_2675494"	"unprognostic (8.55e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (4.57e-8)"	"unprognostic (3.78e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"prognostic unfavourable (4.31e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-2)"	36.5	28.0	36.2	40.7	43.1	67.9	52.5	37.2	35.8	31.4	31.9	38.2	25.2	36.4	40.0	29.9	31.3	32.7	30.5	28.9	35.5	24.6	28.5	25.8	44.9	46.0	37.0	29.2	34.1	37.1	30.2	23.4	42.6	35.1	25.2	38.5	24.7	30.2	28.7	50.5	25.9	40.3	37.4	39.2	47.6	30.2	35.7	41.0	49.3	38.2	20.5	46.8	29.9	53.3	47.9	33.6	41.4	34.0	31.4	41.2	22.8	41.3	24.4	31.7	27.4	17.2	15.8	39.0	27.9	12.4	28.4	31.0	39.9	33.4	49.4	19.8	20.2	41.3	28.0	30.0	30.9	48.7	27.8	42.5	24.5	33.8	21.4	23.1	21.0	16.1	22.9	29.2	16.1	34.5	44.7	25.0	18.2	47.6	41.0	14.4	19.8	17.0	44.5	17.5	25.6	20.7	26.0	13.2	17.5	26.5	24.6	20.6	32.3	23.6	20.9	17.4	34.6	37.2	29.3	24.8	28.3	83.1	16.1	30.1	11.1	28.2	34.0	41.4	33.4	33.4	34.1	43.7	33.0	33.0	29.4	47.9	33.7	31.5	17.5	31.4	24.6	33.6	41.2	22.8	36.2	43.1	37.2	35.8	35.5	24.6	37.0	29.2	35.1	41.0
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966371	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli				Nucleoli		"HPA038860: AB_10697400, HPA058732: "	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavourable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	15.4	18.4	19.9	23.5	26.1	23.8	17.1	25.0	26.7	13.7	15.4	27.5	16.0	14.7	17.7	15.1	15.7	15.1	13.0	14.3	19.4	12.6	16.5	15.7	15.2	22.1	22.4	16.2	25.5	21.3	22.0	16.6	16.9	19.4	19.0	15.8	16.0	16.1	16.2	20.0	16.3	16.5	19.6	14.5	19.1	16.7	17.3	26.3	16.8	26.7	14.4	21.5	17.1	21.7	8.1	6.7	1.4	11.9	7.9	9.1	4.8	7.0	14.2	8.5	16.6	8.6	6.9	13.0	12.8	10.1	14.5	10.7	19.0	10.0	12.7	8.0	10.8	10.1	20.0	12.3	11.5	22.9	11.7	27.2	14.0	18.2	6.5	20.5	13.0	8.5	8.2	17.7	6.5	10.5	29.2	5.2	8.9	10.6	11.5	15.5	18.6	12.2	15.4	8.2	11.0	9.9	13.8	10.2	8.2	11.4	16.7	7.8	18.3	5.9	11.9	9.6	11.8	8.2	7.8	9.5	7.1	12.7	12.9	14.7	12.1	0.0	4.9	1.4	9.1	8.8	6.9	8.1	6.4	7.4	6.7	7.0	5.2	7.1	0.3	7.9	11.9	4.6	5.5	4.8	19.9	26.1	25.0	26.7	19.4	12.6	22.4	16.2	19.4	26.3
RBM22	"Cwc2, FLJ10290, fSAP47, ZC3H16"	ENSG00000086589	"RNA binding motif protein 22"	Q9NW64	5	150690794-150701107	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001634	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA001634: AB_1079746"	"unprognostic (1.94e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-2)"	"prognostic unfavourable (5.50e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (7.29e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.87e-3)"	26.2	17.5	20.3	16.3	26.3	50.1	21.2	29.4	29.5	20.6	20.1	37.4	16.7	17.4	28.0	18.5	18.8	23.8	20.5	18.5	19.7	19.1	20.0	18.8	20.5	23.5	25.7	16.9	29.2	19.6	21.5	18.0	37.8	23.5	20.9	21.5	19.1	18.3	19.2	30.4	21.5	19.1	19.7	28.0	23.0	17.8	13.5	24.6	38.6	23.8	16.3	27.6	20.3	19.2	25.8	24.9	36.3	28.8	28.4	26.7	20.8	14.8	16.3	24.9	29.0	16.9	15.9	35.3	15.2	17.5	30.8	34.9	26.2	22.0	22.0	24.4	14.9	15.7	32.3	28.0	32.3	24.4	25.6	17.5	16.1	11.1	16.4	30.9	20.7	13.2	22.4	25.5	16.8	21.7	18.5	22.3	19.2	17.3	28.5	20.6	14.9	17.1	29.3	20.6	19.6	15.2	15.3	23.5	17.8	17.1	28.4	28.0	29.6	27.8	14.4	24.9	19.6	10.8	27.7	20.7	23.3	31.9	19.5	28.3	18.6	17.6	20.8	33.5	24.4	24.9	26.7	25.8	22.6	22.7	24.9	25.3	24.6	22.9	36.3	28.4	28.8	13.3	24.2	20.8	20.3	26.3	29.4	29.5	19.7	19.1	25.7	16.9	23.5	24.6
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281346-17293875	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 11.1;LHCN-M2: 28.6;RH-30: 29.5;T-47d: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA066927: , HPA067231: "	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7.0	2.7	0.1	3.0	0.5	9.7	7.3	3.4	7.8	1.7	41.0	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.7	4.5	5.9	0.0	0.0	0.0	0.0	9.0	3.3	6.1	6.5	0.0	0.5	0.0	2.8	6.4	0.0	5.6	0.2	11.1	0.0	0.2	0.0	0.5	3.0	0.2	0.0	0.5	3.2	0.0	1.2	0.2	0.7	0.0	0.0	28.6	1.3	0.0	0.0	2.0	0.7	0.0	29.5	0.0	0.0	0.0	3.9	0.4	0.0	0.0	0.1	13.8	0.2	0.0	2.1	4.9	0.0	7.7	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1
RBM25	"fSAP94, NET52, RNPC7, S164, Snu71"	ENSG00000119707	"RNA binding motif protein 25"	P49756	14	73058436-73123898	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003025, HPA070713"	Supported		Enhanced	"Nuclear speckles"			250000	"Nuclear speckles"		"HPA003025: AB_1079748, HPA070713: "	"unprognostic (1.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (4.22e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (8.09e-4)"	"prognostic unfavourable (4.26e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.73e-1)"	29.1	25.3	24.2	49.2	36.9	66.0	31.3	48.9	36.4	29.1	25.9	26.4	34.2	24.6	33.7	37.7	27.1	32.4	29.7	22.3	28.2	22.3	21.6	23.5	28.6	38.9	26.5	35.4	36.3	35.6	32.7	45.1	28.1	33.5	26.1	26.5	24.1	29.3	40.5	35.4	29.0	28.9	30.3	30.0	30.4	27.6	29.4	29.7	34.6	33.8	28.4	34.3	26.3	29.4	21.5	24.7	17.4	17.0	23.2	18.4	9.0	32.5	18.8	30.4	23.1	13.7	16.0	26.6	26.8	18.9	20.9	23.1	25.1	21.0	39.3	14.2	18.4	24.8	34.9	16.2	36.1	24.6	18.4	33.1	14.9	19.2	8.6	29.0	21.1	11.6	11.7	24.4	20.1	20.7	33.8	16.5	22.6	24.3	37.7	17.0	25.7	20.8	32.6	33.2	19.2	17.2	22.8	20.5	19.6	33.7	22.4	11.8	32.1	12.7	26.1	30.9	30.2	16.5	26.8	17.6	31.1	49.1	13.8	20.8	21.1	11.2	14.8	13.5	18.4	17.0	17.3	18.6	14.5	15.4	15.5	21.5	15.4	16.1	17.4	23.2	13.7	24.7	15.9	9.0	24.2	36.9	48.9	36.4	28.2	22.3	26.5	35.4	33.5	29.7
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli				Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: "	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	22.1	17.7	16.3	18.4	25.1	14.2	17.5	26.5	25.3	12.8	13.7	19.7	9.6	13.2	17.1	9.9	15.1	12.5	10.9	24.4	18.1	8.6	12.0	18.8	13.2	17.9	26.5	16.2	19.7	15.7	16.5	18.4	14.5	17.3	13.1	12.7	12.3	13.0	13.0	33.5	17.3	11.2	14.2	25.4	13.8	14.1	18.4	24.4	11.7	16.1	12.2	15.6	13.8	18.9	14.5	14.3	9.8	11.5	12.3	13.7	5.5	18.4	20.4	12.3	35.2	8.8	5.6	16.9	17.0	7.0	15.4	16.8	16.9	16.2	24.5	9.3	7.7	12.5	18.1	14.4	20.1	12.2	17.3	24.6	14.3	15.5	7.8	30.9	22.1	6.4	9.4	20.5	12.4	14.2	45.9	14.4	12.0	14.9	22.1	17.7	23.5	16.0	17.6	14.8	23.5	7.5	12.5	13.8	16.8	21.9	36.7	11.6	9.4	9.5	13.6	22.5	11.7	19.8	20.6	14.8	12.6	42.5	14.7	26.2	24.1	3.5	11.5	4.4	13.7	8.9	9.4	12.8	11.6	12.2	11.5	14.5	10.5	12.0	9.8	12.3	7.8	14.3	7.1	5.5	16.3	25.1	26.5	25.3	18.1	8.6	26.5	16.2	17.3	24.4
RBM3	IS1-RNPL	ENSG00000102317	"RNA binding motif protein 3"	P98179	X	48574449-48579066	"Predicted intracellular proteins"	"Stress response"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003624, CAB062559"	Enhanced		Enhanced	Nucleoplasm			24000	Nucleoplasm		"CAB062559: , HPA003624: AB_10602123"	"unprognostic (1.07e-2)"	"unprognostic (1.14e-3)"	"prognostic favourable (3.07e-7)"	"unprognostic (1.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	71.2	25.5	12.6	43.0	13.9	59.0	52.2	16.4	22.5	44.7	32.7	20.9	16.4	23.9	38.5	58.2	46.4	32.9	36.4	44.8	12.2	12.3	53.5	32.9	36.8	115.8	15.0	15.2	38.6	43.2	15.2	19.1	62.2	30.5	21.0	36.0	43.4	39.7	25.0	59.1	56.2	37.8	33.0	23.6	48.4	27.2	27.2	7.4	73.6	24.0	76.8	67.6	46.4	30.1	32.9	56.5	6.4	44.2	29.9	31.8	45.7	20.5	28.8	31.4	32.8	7.8	41.3	19.6	26.8	46.9	67.1	46.8	28.9	54.6	42.5	8.6	54.3	18.0	27.3	36.6	53.7	39.5	36.3	21.4	47.2	25.8	28.6	58.5	43.6	31.9	26.1	22.6	21.9	59.5	11.9	33.0	46.3	34.7	48.6	32.0	17.3	40.7	46.9	32.1	32.2	28.8	34.2	12.5	31.0	26.8	35.3	29.3	46.6	58.2	80.0	22.0	35.6	76.0	44.6	16.3	17.8	47.8	32.9	35.1	44.6	5.8	38.4	6.2	27.0	44.2	31.8	32.9	27.6	26.7	56.5	20.5	28.2	27.4	6.4	29.9	37.5	39.1	28.6	45.7	12.6	13.9	16.4	22.5	12.2	12.3	15.0	15.2	30.5	7.4
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161457	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	15.8	10.5	17.2	16.4	18.1	30.6	14.8	15.5	22.3	11.0	13.5	10.6	7.0	16.7	10.9	15.2	15.4	9.9	11.3	15.2	13.4	11.6	19.4	14.2	11.5	20.0	16.9	9.9	13.9	13.5	6.6	24.9	14.7	20.9	13.5	12.6	7.6	18.3	11.2	22.2	17.9	17.6	10.9	17.9	14.6	13.1	28.8	17.3	17.5	14.7	10.9	17.1	14.1	16.0	34.2	27.2	38.0	19.2	25.3	35.5	22.7	12.0	9.1	9.5	12.0	7.1	12.9	23.5	12.7	8.9	11.4	11.0	12.3	13.7	20.6	13.8	7.6	18.0	11.2	11.6	11.0	18.7	18.2	15.4	6.4	8.5	14.3	24.4	15.2	11.3	13.4	10.6	7.3	9.1	21.9	10.6	14.3	6.9	21.2	21.0	27.4	6.4	19.9	10.4	23.9	11.8	9.2	11.7	21.3	17.5	11.3	28.6	24.4	26.6	9.5	11.6	10.1	16.0	25.4	12.9	20.8	21.8	13.6	16.4	18.1	38.0	16.9	20.4	23.7	19.2	28.2	34.2	27.3	30.4	17.2	26.3	26.0	29.9	8.2	25.3	19.1	27.2	35.5	22.7	17.2	18.1	15.5	22.3	13.4	11.6	16.9	9.9	20.9	17.3
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391407-57409333	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.3;skeletal muscle: 107.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.8;U-698: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favourable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.83e-1)"	4.4	3.5	4.5	22.8	4.9	64.3	4.3	10.0	5.2	9.2	28.1	6.4	7.1	5.9	13.0	6.7	16.3	10.4	6.5	24.4	4.2	3.9	5.3	6.7	9.8	23.3	4.7	2.3	17.2	5.9	1.9	4.4	9.9	5.0	12.2	3.4	10.9	11.6	8.3	107.9	2.7	12.9	27.4	3.4	22.0	8.1	16.7	4.1	26.8	4.1	18.9	28.0	25.1	11.4	6.4	2.2	3.5	2.9	5.5	7.6	3.4	5.4	5.6	2.8	7.1	0.0	0.4	16.1	1.8	0.4	3.9	1.0	23.0	5.9	38.8	15.4	0.5	5.0	2.3	2.2	0.6	7.8	9.6	32.9	2.1	14.5	1.7	15.8	15.5	0.5	1.1	1.6	0.3	2.6	26.8	7.1	0.4	23.6	11.4	16.3	10.4	7.1	22.2	7.0	31.5	2.9	2.5	11.7	7.5	4.3	14.3	7.2	7.9	22.3	4.6	1.3	12.4	1.6	7.5	17.0	22.5	40.8	0.3	11.4	1.2	0.0	1.0	3.5	5.4	2.9	3.5	5.6	4.5	3.7	1.8	6.4	5.7	5.0	1.3	5.5	2.7	2.2	7.6	3.4	4.5	4.9	10.0	5.2	4.2	3.9	4.7	2.3	5.0	4.1
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"				"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	41.4	44.1	37.5	41.5	41.4	120.8	38.5	57.5	41.8	43.4	35.0	30.7	46.3	29.5	51.9	34.3	42.8	35.3	40.7	40.2	35.8	29.9	39.2	32.4	40.4	41.8	41.1	31.4	52.3	35.6	40.9	71.5	45.2	37.4	39.2	27.0	28.9	37.1	46.0	44.1	32.1	30.6	40.2	43.0	38.4	33.5	22.9	46.4	52.4	40.7	28.2	40.5	39.9	46.1	27.6	32.5	88.9	25.1	24.2	22.5	16.8	28.7	26.7	27.8	24.6	21.9	24.9	30.3	38.6	19.3	25.2	23.8	38.6	26.7	39.7	30.1	14.9	27.2	41.2	24.4	29.1	26.6	29.5	52.8	27.0	44.6	24.8	48.6	33.0	10.1	42.4	21.1	24.0	23.5	54.4	35.4	21.6	24.9	56.5	35.0	33.5	32.0	34.5	44.1	29.9	22.9	20.8	27.1	23.5	30.2	38.5	33.7	25.9	34.3	27.0	32.8	28.1	30.4	34.6	22.8	46.3	58.3	22.5	39.1	24.0	41.2	25.1	38.2	22.5	22.1	22.1	25.3	19.8	20.7	22.4	27.6	18.9	18.0	88.9	24.2	19.4	32.5	22.1	16.8	37.5	41.4	57.5	41.8	35.8	29.9	41.1	31.4	37.4	46.4
RBM45	"DRB1, FLJ44612"	ENSG00000155636	"RNA binding motif protein 45"	Q8IUH3	2	178112424-178139011	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020448	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA020448: AB_1856133"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (5.74e-9)"	"unprognostic (1.66e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavourable (5.34e-9)"	"unprognostic (3.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-1)"	9.5	13.7	15.7	12.4	18.1	7.3	17.3	15.3	15.4	12.2	16.2	10.4	19.7	11.8	13.9	19.3	12.3	14.7	10.3	10.5	14.8	13.1	13.4	15.6	11.0	14.4	15.2	16.2	12.2	16.1	16.2	24.0	6.9	14.6	12.1	19.1	11.1	17.0	14.1	11.2	16.1	13.2	12.0	11.9	16.5	12.4	13.4	16.3	21.6	14.0	7.0	18.7	11.1	10.2	10.8	8.1	4.4	9.5	11.8	11.5	5.6	8.9	9.6	15.2	6.3	13.7	15.4	9.1	11.8	13.7	12.2	13.6	10.0	7.4	14.9	8.2	14.0	8.0	12.6	16.0	15.6	11.7	10.7	11.6	6.9	14.5	14.0	13.9	11.1	12.2	13.6	12.9	10.8	13.2	10.5	12.4	16.3	14.2	14.0	9.4	10.8	12.0	10.9	10.9	14.8	18.1	20.6	9.4	10.0	8.8	8.7	11.2	12.4	13.0	11.3	9.2	8.6	10.5	11.6	11.7	13.1	18.5	8.9	11.0	12.4	4.4	5.6	1.8	6.9	8.5	8.4	10.8	7.5	7.5	7.5	8.4	6.7	8.2	1.2	11.8	9.5	8.1	11.5	5.6	15.7	18.1	15.3	15.4	14.8	13.1	15.2	16.2	14.6	16.3
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.6;BEWO: 49.6;CAPAN-2: 21.8;SK-BR-3: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 42.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 11.3;granulocytes: 42.4;monocytes: 14.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA006347	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	8.2	33.6	1.9	8.2	2.4	2.6	10.9	0.8	1.2	5.4	22.9	3.3	28.7	24.1	2.6	15.4	27.3	5.3	12.7	4.0	2.4	1.1	37.0	16.1	14.5	11.3	3.0	0.3	4.6	19.2	8.0	2.9	27.2	6.6	13.2	17.3	9.2	60.8	36.0	0.9	6.0	42.8	2.2	4.1	15.0	22.2	7.1	2.2	1.6	31.5	13.7	20.6	7.8	9.7	2.0	11.3	42.4	14.2	0.1	0.1	4.8	11.5	16.6	0.0	0.5	0.0	0.0	49.6	0.3	0.3	0.1	0.1	9.7	21.8	0.0	8.7	0.3	4.6	0.3	3.3	0.1	0.0	2.7	0.0	1.2	2.6	0.2	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.6	2.5	0.0	6.5	0.0	0.3	5.1	0.9	0.0	0.0	12.8	15.3	14.6	0.5	0.1	6.6	16.6	0.1	7.3	3.0	0.0	0.1	0.6	0.1	0.3	8.8	13.0	1.4	1.5	1.3	0.0	0.1	14.2	0.1	0.0	10.9	0.1	2.0	0.0	0.0	11.3	1.2	0.1	0.0	42.4	0.1	8.1	4.6	0.0	4.8	1.9	2.4	0.8	1.2	2.4	1.1	3.0	0.3	6.6	2.2
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92538005	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	11.1	13.0	23.9	10.8	36.0	24.6	14.1	28.3	34.2	11.7	9.0	18.4	7.1	10.3	12.0	12.4	9.9	10.9	8.9	12.1	22.8	15.2	12.4	10.5	9.9	17.1	42.4	15.1	17.0	10.6	11.1	18.3	10.6	20.7	11.5	11.0	9.0	13.0	8.9	16.5	10.8	10.7	9.7	28.0	14.5	9.8	12.5	36.9	13.6	14.5	6.6	13.9	10.2	10.1	20.1	10.6	37.5	12.1	18.1	25.8	14.0	7.4	5.5	9.5	14.9	11.8	12.2	7.5	9.0	9.3	11.9	11.3	6.4	10.3	10.6	16.2	7.6	7.7	9.8	7.2	13.3	12.0	12.0	8.4	12.0	7.3	10.0	14.7	10.0	9.4	14.2	11.7	12.5	11.9	16.6	18.9	11.0	8.8	18.9	15.0	8.5	9.2	8.8	8.4	14.4	9.5	7.2	11.4	15.9	8.9	17.3	12.5	5.4	14.5	6.1	16.9	9.2	13.3	12.8	11.3	14.9	18.2	7.9	12.9	15.4	37.5	10.1	21.0	18.5	12.1	20.2	20.1	20.3	18.9	9.7	18.5	25.8	22.1	13.4	18.1	9.9	10.6	18.3	14.0	23.9	36.0	28.3	34.2	22.8	15.2	42.4	15.1	20.7	36.9
RBM5	"H37, LUCA15"	ENSG00000003756	"RNA binding motif protein 5"	P52756	3	50088908-50119021	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017335, HPA018011"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA017335: AB_1856134, HPA018011: AB_1856135"	"unprognostic (4.11e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-3)"	"prognostic unfavourable (9.77e-4)"	"prognostic favourable (6.46e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (7.58e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.89e-3)"	33.8	25.9	34.1	43.7	37.8	37.7	37.0	51.2	38.9	38.5	33.1	47.7	41.3	25.1	53.2	45.9	28.9	40.5	27.6	28.5	31.1	25.0	30.4	26.9	30.3	41.2	38.1	38.4	63.5	36.3	37.7	58.6	40.3	30.3	41.5	33.5	40.4	35.7	37.9	45.9	54.5	34.7	37.9	41.1	47.0	30.9	36.4	39.5	41.4	42.0	28.5	45.5	31.8	36.6	14.3	12.2	29.6	14.4	14.0	20.1	10.3	9.7	12.1	44.0	19.1	18.4	26.7	10.4	29.9	18.0	22.3	15.7	12.1	11.3	23.0	10.4	19.5	8.6	29.6	14.5	24.0	21.4	10.9	29.0	41.3	10.8	22.7	26.5	23.5	23.8	16.5	24.2	23.9	23.5	19.7	15.6	20.8	8.7	26.9	17.9	15.7	13.8	14.7	19.2	11.9	16.1	49.2	6.3	14.7	24.6	10.8	14.9	9.9	25.5	26.6	14.8	15.6	20.5	17.2	21.6	31.5	24.5	11.0	16.3	17.1	29.6	14.0	18.5	17.5	14.4	16.6	13.7	15.8	18.1	12.2	14.3	20.1	15.8	26.1	14.0	14.0	9.3	18.4	10.3	34.1	37.8	51.2	38.9	31.1	25.0	38.1	38.4	30.3	39.5
RBM7		ENSG00000076053	"RNA binding motif protein 7"	Q9Y580	11	114400030-114414203	"Predicted intracellular proteins"	Meiosis	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA013993, HPA048003"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA013993: AB_1856137, HPA048003: "	"unprognostic (2.90e-3)"	"unprognostic (8.21e-3)"	"prognostic favourable (6.14e-4)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.38e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	21.6	13.0	11.4	12.9	14.9	39.9	20.2	15.1	13.0	19.9	17.2	11.9	8.4	11.0	20.2	13.9	19.2	18.2	15.4	13.9	12.1	7.3	14.7	28.6	18.2	18.7	15.5	8.7	26.3	14.9	14.4	17.7	23.8	11.9	20.9	16.8	8.4	18.1	12.1	17.2	13.9	17.7	18.7	15.8	20.0	16.6	16.7	16.1	22.0	21.5	12.5	15.8	24.3	20.5	13.4	15.4	36.2	16.5	17.5	18.6	12.7	12.6	8.5	11.1	10.6	14.6	19.9	12.2	20.9	28.3	24.5	28.4	18.5	28.8	15.4	29.2	19.4	11.6	13.5	15.2	32.2	14.1	7.4	18.3	9.7	15.3	24.8	12.0	12.7	19.6	20.3	20.4	28.8	21.8	17.8	2.9	18.9	3.7	13.9	12.3	14.0	14.1	11.0	20.3	14.6	20.5	14.1	9.0	8.7	18.1	8.6	9.5	8.3	8.2	19.5	7.5	17.5	9.4	21.9	7.5	7.7	13.6	5.2	21.2	12.5	36.2	16.2	18.2	13.0	16.5	18.6	13.4	14.0	12.3	15.4	11.9	17.5	15.0	15.6	17.5	16.0	14.8	14.9	12.7	11.4	14.9	15.1	13.0	12.1	7.3	15.5	8.7	11.9	16.1
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 120.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"			120000	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	6.2	6.5	9.1	9.5	9.8	18.7	6.1	6.3	9.8	8.3	6.2	9.6	9.8	6.2	7.4	5.0	15.1	5.7	5.0	6.4	7.3		6.4	6.5	5.5	11.2	7.0	7.1	7.6	5.1	6.9	5.5	7.9	13.5	5.7	5.0	5.7	6.2	6.3	24.6	7.2	6.0	6.8	13.2	6.5	5.8	8.5	9.5	6.8	6.3	4.8	11.7	7.1	3.5	101.9	120.1	118.0	85.5	85.3	89.3	115.9	51.2	42.0	38.4	30.5	13.8	13.6	47.2	31.4	21.3	45.2	33.3	55.4	39.0	47.1	49.7	21.6	35.3	40.8	34.3	37.2	41.7	38.9	36.3	31.8	40.9	19.6	60.5	31.9	14.9	25.9	40.4	43.4	33.5	54.5	44.7	34.7	141.6	60.8	48.0	65.9	73.3	54.0	33.5	46.8	28.9	49.5	39.4	48.3	46.8	24.1	42.6	45.1	73.7	34.5	36.5	46.6	35.8	85.8	50.5	79.6	69.1	32.7	36.5	31.4	89.7	77.6	118.0	86.5	85.5	82.1	101.9	82.5	87.8	76.5	90.1	77.7	86.3	89.3	85.3	79.9	120.1	89.3	115.9										
RBMS1	"C2orf12, DKFZp564H0764, HCC-4, MSSP-1, MSSP-2, MSSP-3, SCR2, YC1"	ENSG00000153250	"RNA binding motif single stranded interacting protein 1"	P29558	2	160272151-160493794	"Predicted intracellular proteins"	"DNA replication"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047943, HPA061791"			Enhanced	Cytosol				Cytosol		"HPA047943: , HPA061791: "	"unprognostic (2.81e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.81e-3)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (6.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.16e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (1.33e-7)"	"unprognostic (1.84e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.32e-1)"	29.4	8.7	4.0	15.6	9.4	11.6	23.0	2.6	7.1	25.9	19.1	2.9	11.4	4.4	29.1	13.5	15.8	17.0	17.5	30.1	4.1	4.1	16.2	8.1	22.8	25.3	4.0	2.9	22.9	4.4	24.3	12.7	74.2	7.2	18.6	5.9	11.2	11.7	16.0	10.5	14.1	9.7	21.7	5.3	23.3	11.5	7.1	5.6	15.7	12.3	11.7	7.8	23.9	23.9	1.2	7.3	24.2	11.0	6.6	16.8	5.7	13.6	5.0	18.1	2.3	26.1	45.6	21.9	17.4	24.9	12.1	12.5	13.9	10.3	0.1	21.8	29.4	8.3	8.7	12.7	19.9	11.0	6.5	5.1	12.6	11.1	23.9	8.3	0.3	54.5	10.1	20.9	9.4	18.9	0.3	6.4	28.9	10.6	7.7	8.4	11.1	11.2	5.8	15.8	6.8	18.4	16.8	2.3	6.1	10.8	6.5	16.0	3.3	13.1	22.6	21.6	13.6	19.7	15.6	3.4	0.1	5.8	17.4	12.6	13.7	2.1	11.0	13.5	5.0	6.3	16.8	0.5	8.7	7.6	7.3	1.2	14.2	6.4	24.2	6.6	3.5	4.1	1.3	5.7	4.0	9.4	2.6	7.1	4.1	4.1	4.0	2.9	7.2	5.6
RBPJ	"CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH"	ENSG00000168214	"Recombination signal binding protein for immunoglobulin kappa J region"	Q06330	4	26163455-26435131	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000251, HPA060647"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA000251: , HPA060647: "	"unprognostic (2.68e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.61e-1)"	"prognostic favourable (2.98e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.15e-3)"	37.7	16.2	23.9	25.7	37.0	35.9	26.3	28.0	34.1	27.5	30.4	37.2	19.4	16.3	37.0	20.9	24.0	22.7	21.7	18.5	27.3	22.4	18.3	13.3	29.6	19.9	33.4	23.5	30.6	21.8	25.3	21.2	44.3	28.3	24.8	23.1	14.1	20.4	20.1	21.5	26.1	21.6	32.3	36.5	22.1	21.0	24.3	38.9	21.9	21.3	15.8	20.6	35.7	36.1	11.8	43.7	70.6	29.8	23.1	21.0	18.0	18.8	5.9	18.1	11.3	27.4	37.3	13.4	16.3	13.7	15.1	18.0	5.0	10.6	15.8	11.0	10.7	3.4	16.1	8.4	29.7	9.0	8.8	12.4	8.1	8.6	13.1	22.9	11.1	17.6	8.0	29.9	10.9	7.9	12.7	6.2	27.9	6.4	15.4	22.5	47.9	8.6	14.7	34.5	7.3	8.1	7.2	26.2	11.0	7.3	6.2	7.1	6.4	15.9	9.7	15.3	8.2	24.5	15.3	12.0	13.7	17.0	36.0	25.6	13.4	6.4	29.8	35.8	10.5	24.1	13.5	11.8	16.4	11.4	43.7	11.2	14.2	12.1	70.6	23.1	21.7	10.0	21.0	18.0	23.9	37.0	28.0	34.1	27.3	22.4	33.4	23.5	28.3	38.9
RBPMS	HERMES	ENSG00000157110	"RNA binding protein, mRNA processing factor"	Q93062	8	30384479-30572261	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.5;RPTEC TERT1: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056999	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA056999: "	"unprognostic (1.65e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.47e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.16e-3)"	71.3	20.4	2.3	28.4	6.9	0.2	112.8	1.4	2.9	81.7	66.1	4.4	46.3	6.9	90.8	31.8	66.2	35.7	50.4	53.8	2.8	2.7	69.1	34.5	36.7	19.3	5.4	3.4	65.5	15.0	12.2	10.4	29.2	9.3	77.3	13.7	41.2	22.9	59.8	14.5	11.8	22.3	181.8	10.3	28.9	38.1	27.4	2.9	4.8	54.1	8.5	10.9	155.4	88.9	0.5	3.9	0.3	0.2	0.7	0.3	0.0	0.1	11.1	12.6	0.1	71.5	21.5	31.5	15.8	21.7	19.5	16.2	16.2	6.6	0.1	8.5	20.2	6.3	14.4	11.4	23.6	0.0	3.0	0.3	5.2	16.6	30.8	0.1	2.5	24.8	2.9	18.7	2.5	11.2	0.1	0.0	9.5	6.8	0.0	0.2	32.4	7.3	0.7	3.5	0.9	49.4	18.8	0.2	2.5	1.6	11.8	7.8	2.5	0.0	10.3	9.7	0.9	16.6	2.6	0.0	0.0	0.0	15.9	0.0	4.3	0.0	0.1	0.0	0.2	0.2	0.3	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.3	0.7	0.0	3.9	0.1	0.0	2.3	6.9	1.4	2.9	2.8	2.7	5.4	3.4	9.3	2.9
RBSN	ZFYVE20	ENSG00000131381	"Rabenosyn, RAB effector"	Q9H1K0	3	15070073-15099163	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044878	Approved		Supported	Vesicles				Vesicles		"HPA044878: AB_10967610"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.78e-1)"	11.6	8.7	18.0	8.7	19.8	21.4	10.7	19.6	26.1	9.9	10.6	21.9	9.4	6.4	12.9	10.2	12.3	11.2	7.7	12.9	16.6	13.7	7.4	9.3	11.3	8.2	16.6	15.3	18.2	7.1	13.3	7.1	10.6	17.0	10.6	7.5	10.9	7.6	13.1	15.7	13.7	7.7	14.5	16.2	9.2	8.6	11.6	16.7	3.6	15.5	7.6	8.1	9.9	9.6	7.9	4.3	13.6	7.3	3.2	9.5	2.9	8.2	12.1	9.9	12.8	11.0	8.2	26.3	9.1	8.9	11.0	10.0	7.3	5.0	5.8	5.3	12.0	5.3	12.6	11.0	9.7	7.3	11.2	6.6	14.4	6.0	7.5	6.6	7.4	8.8	12.5	14.0	9.4	8.8	9.9	6.8	8.2	10.9	3.6	3.3	8.5	9.7	4.8	11.3	6.4	5.7	9.5	2.6	9.3	11.1	6.8	8.1	17.5	4.9	10.7	10.0	10.5	9.6	12.8	6.1	9.1	6.9	9.5	7.5	9.3	9.0	5.4	12.3	5.3	7.3	4.7	5.2	7.2	6.5	4.3	7.9	9.5	6.4	13.6	3.2	6.2	4.1	4.7	2.9	18.0	19.8	19.6	25.3	16.6	13.7	16.6	15.3	17.0	16.7
RBX1	"BA554C12.1, RNF75, ROC1"	ENSG00000100387	"Ring-box 1"	P62877	22	40951347-40973309	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003038			Supported	Nucleoplasm				Nucleoplasm		"HPA003038: AB_1079827"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (5.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	24.1	27.9	41.6	22.2	35.3	37.6	32.9	28.0	35.7	23.0	22.7	27.4	15.8	18.4	19.4	43.7	27.6	21.2	16.6	39.2	38.3	37.4	34.2	28.3	23.6	28.1	40.4	22.3	18.5	15.6	12.3	19.5	54.1	32.4	20.3	23.9	22.1	21.3	20.8	46.5	21.8	23.0	23.2	45.2	26.4	21.4	16.4	24.8	31.7	31.1	37.4	34.4	19.5	19.4	33.4	60.7	32.2	41.5	23.9	38.5	62.6	33.1	19.0	35.9	17.8	25.5	30.5	20.2	26.7	24.6	40.3	35.7	30.7	16.0	29.1	18.1	26.2	19.0	34.0	30.6	42.7	33.8	54.2	18.0	27.8	37.4	21.9	43.9	23.4	25.2	24.8	29.1	21.1	34.1	21.2	29.6	35.5	40.6	26.4	50.7	19.7	20.0	34.7	24.9	36.6	46.0	21.5	16.9	11.0	23.5	23.6	23.9	20.3	30.3	22.6	24.6	25.4	20.6	25.4	25.2	23.1	43.1	30.8	22.4	27.3	32.2	37.2	29.9	24.7	37.0	23.1	33.4	30.9	26.0	37.6	29.4	27.0	29.2	12.6	23.9	41.5	60.7	38.5	62.6	41.6	35.3	28.0	35.7	38.3	37.4	40.4	22.3	32.4	24.8
RC3H1	"KIAA2025, RNF198, roquin, RP5-1198E17.5"	ENSG00000135870	"Ring finger and CCCH-type domains 1"	Q5TC82	1	173931214-174022297	"Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027428, HPA027434, HPA027448"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683"	"unprognostic (6.91e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.43e-3)"	"unprognostic (6.83e-3)"	10.4	7.8	11.8	8.0	10.3	32.6	10.6	26.7	14.0	9.9	10.3	12.3	8.3	6.9	10.9	8.4	11.8	9.4	8.1	9.0	11.9	7.4	8.1	11.2	11.3	8.8	10.4	7.1	10.8	9.8	10.2	14.6	9.1	12.4	8.7	8.6	13.3	9.0	7.6	19.1	14.0	10.6	8.4	9.3	13.6	9.1	9.7	9.0	15.2	9.9	7.7	13.6	8.4	9.8	2.8	1.6	10.4	3.9	2.3	2.7	1.1	7.3	10.2	5.7	8.8	10.8	8.4	7.8	5.0	7.1	5.8	5.1	9.3	8.2	10.4	9.0	8.1	7.1	8.5	7.0	8.2	7.2	2.1	9.0	7.6	7.8	6.6	11.6	10.5	8.0	5.5	8.4	5.7	8.9	10.2	6.4	7.0	5.5	7.0	10.6	9.7	1.1	7.7	10.2	7.6	10.3	14.2	6.8	6.1	9.5	12.2	4.8	8.2	11.8	12.8	7.6	7.6	6.4	6.4	8.0	8.0	13.4	5.1	5.3	7.5	4.5	3.2	4.0	2.0	3.2	2.1	2.1	1.9	2.3	1.6	2.8	2.7	2.3	10.4	2.3	3.9	1.3	1.5	1.1	11.8	10.3	26.7	14.0	11.9	7.4	10.4	7.1	12.4	9.0
RC3H2	"FLJ20301, FLJ20713, MNAB, RNF164"	ENSG00000056586	"Ring finger and CCCH-type domains 2"	Q9HBD1	9	122844556-122905341	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"Repressor, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042863, HPA062144"	Approved		Enhanced	Vesicles				Vesicles		"HPA042863: , HPA062144: "	"unprognostic (6.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (5.50e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	16.4	10.7	25.4	14.1	28.8	30.6	14.1	18.7	27.6	17.1	13.0	10.5	14.4	11.0	14.6	9.7	16.5	12.2	12.6	15.7	18.1	11.2	15.0	14.8	16.2	19.2	12.3	25.3	14.7	9.7	19.0	16.2	16.3	12.6	11.5	13.1	9.4	13.2	13.9	16.1	13.8	13.0	16.3	14.4	15.2	12.8	12.8	13.2	18.9	15.0	11.5	18.8	14.1	13.7	8.6	9.6	12.4	10.4	4.9	8.9	3.7	9.8	14.3	19.1	10.3	10.2	12.1	10.6	12.6	13.8	14.9	13.0	17.3	10.4	16.5	10.3	16.8	23.1	20.4	14.8	16.4	7.6	8.1	9.4	25.8	11.4	13.4	11.1	15.1	11.6	14.4	14.5	20.6	20.4	13.2	12.1	18.8	13.2	10.9	7.8	9.5	13.3	11.0	31.6	10.6	14.5	7.8	22.5	15.6	22.3	13.8	11.4	16.6	9.4	20.2	11.5	9.6	15.6	22.4	8.5	13.8	18.0	13.1	9.9	12.9	12.4	6.6	8.5	8.9	10.4	7.3	6.5	7.3	8.9	5.8	8.6	7.0	6.8	11.8	4.9	9.3	9.6	7.1	3.7	25.4	28.8	18.7	27.6	18.1	11.2	12.3	25.3	12.6	13.2
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	12.3	11.2	7.5	21.1	10.9	32.0	13.9	5.8	10.4	11.6	17.9	5.0	8.0	17.5	12.1	10.1	30.1	12.6	8.6	6.9	8.0	4.6	9.5	23.0	15.3	22.7	14.8	4.0	16.3	21.0	4.7	12.4	17.0	9.8	10.2	19.0	6.0	20.6	7.8	13.6	11.7	14.7	12.7	17.7	23.0	11.8	46.7	10.2	34.2	47.9	28.4	34.2	16.4	16.7	8.4	16.0	4.6	8.7	6.2	11.5	6.9	47.7	20.7	18.0	21.3	12.9	16.7	20.2	18.7	11.4	30.5	23.9	20.6	38.5	61.4	11.5	18.0	28.8	58.7	29.8	24.0	24.8	35.0	54.2	25.3	27.0	9.7	59.0	32.5	21.1	19.9	29.4	24.2	20.8	40.4	19.0	12.3	25.9	47.0	21.4	38.7	20.3	46.7	31.8	29.9	11.3	22.4	29.0	14.8	20.3	32.3	15.6	13.6	18.5	15.9	15.7	31.1	19.2	36.4	11.5	16.3	46.9	15.3	87.3	16.9	4.6	8.7	3.2	6.2	8.7	11.5	8.4	9.2	9.6	16.0	7.7	8.3	9.1	1.9	6.2	6.2	9.1	8.4	6.9	7.5	10.9	5.8	10.4	8.0	4.6	14.8	4.0	9.8	10.2
RCCD1	MGC14386	ENSG00000166965	"RCC1 domain containing 1"	A6NED2	15	90954870-90963125	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039683, HPA040776"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039683: AB_10794752, HPA040776: AB_10795478"	"unprognostic (1.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.63e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	5.2	9.9	6.1	12.5	8.1	6.1	17.3	14.3	7.0	5.3	9.2	3.3	5.8	8.0	6.4	5.9	9.2	6.2	8.7	6.2	5.5	6.7	8.5	11.3	6.6	5.7	8.4	1.5	8.2	12.1	9.3	3.2	9.4	6.0	5.6	7.4	3.1	8.2	6.2	5.2	11.8	9.7	8.6	5.6	10.1	6.5	18.9	7.2	21.9	11.0	8.3	14.5	6.4	5.7	3.1	2.3	0.1	2.0	1.7	2.9	0.8	4.8	7.2	1.7	3.6	4.2	5.1	12.8	5.6	1.0	1.6	1.7	3.4	9.3	17.1	9.1	3.4	10.5	5.5	1.5	2.8	14.3	11.3	12.3	12.2	4.9	3.5	5.9	4.9	3.7	5.0	1.7	2.3	2.7	9.3	11.3	4.9	1.6	7.0	6.1	6.5	3.0	8.4	8.6	18.2	7.6	2.2	5.6	6.4	9.7	6.3	6.6	7.2	11.4	4.2	1.0	7.2	4.1	0.2	20.3	8.3	10.2	1.9	13.0	4.8	0.1	0.7	0.1	0.8	2.0	2.1	3.1	1.7	2.7	1.6	2.1	2.9	1.0	0.1	1.7	1.1	2.3	2.1	0.8	6.1	8.1	14.3	7.0	5.5	6.7	8.4	1.5	6.0	7.2
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favourable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favourable (7.89e-5)"	8.8	12.1	15.7	9.9	20.1	15.6	17.8	20.7	16.8	10.2	12.7	9.8	8.7	9.0	11.0	7.5	8.4	12.9	7.2	17.6	14.1	16.2	17.1	12.5	10.4	12.2	15.9	15.7	16.2	10.6	14.9	13.0	10.5	17.1	12.0	14.2	7.7	12.3	11.3	29.7	5.9	9.2	12.4	16.7	12.2	10.3	13.4	15.4	14.9	20.3	8.0	12.7	9.7	12.1	4.4	7.4	18.9	8.8	4.6	7.4	4.3	6.0	3.1	9.4	8.7	9.9	8.7	5.4	4.1	9.6	8.5	10.0	8.6	7.5	10.1	7.8	5.9	3.6	23.8	7.2	13.0	8.2	7.8	13.1	5.9	11.0	8.5	17.6	7.2	8.0	9.1	9.7	9.2	17.1	12.0	10.3	19.8	9.8	16.1	7.1	15.6	5.5	8.7	22.1	8.5	13.2	10.4	14.5	8.0	6.7	15.8	17.4	8.9	8.0	6.7	5.6	5.6	5.0	6.8	10.9	7.8	14.3	6.8	12.5	8.8	18.9	8.8	8.5	4.3	5.2	7.4	4.4	5.3	5.0	7.4	2.2	3.9	5.5	3.7	4.6	4.7	3.8	5.2	4.3	15.7	20.1	20.7	16.8	14.1	16.2	15.9	15.7	17.1	15.4
RCN1	"FLJ37041, PIG20, Rcal, RCN"	ENSG00000049449	"Reticulocalbin 1"	Q15293	11	32090904-32105755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 123.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA038474, HPA062104"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		2300000	"Endoplasmic reticulum"		"HPA038474: AB_10672595, HPA062104: AB_2684683"	"unprognostic (1.65e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavourable (7.13e-6)"	"unprognostic (8.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavourable (2.70e-13)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.93e-3)"	25.0	19.8	9.6	14.3	38.8	1.6	38.2	7.6	11.4	22.3	13.6	5.8	17.0	10.8	23.3	123.1	12.2	18.2	15.3	19.4	9.2	9.8	12.4	33.7	17.9	20.2	7.0	5.9	35.2	16.4	17.9	34.9	32.6	9.7	22.6	12.6	11.4	37.0	24.2	12.8	9.1	10.5	19.2	10.9	11.5	11.8	11.4	6.9	5.4	16.8	10.0	6.9	25.3	32.3	4.3	11.0	0.5	11.8	7.5	12.4	6.5	13.2	14.3	33.1	22.0	81.4	62.1	38.1	45.6	55.7	32.2	58.1	12.5	17.0	0.0	31.6	74.3	16.3	11.9	13.6	48.4	6.4	26.0	2.9	10.3	4.5	60.2	2.1	4.4	86.5	16.9	20.4	23.0	70.4	1.7	2.4	36.8	11.0	6.0	4.0	14.2	16.2	4.7	41.5	3.9	27.4	30.9	8.9	4.6	12.1	2.8	34.9	17.5	8.4	36.7	41.7	23.7	36.1	38.5	0.1	0.0	0.1	57.9	2.7	23.6	0.2	10.0	0.3	12.4	11.8	9.7	4.3	5.7	9.9	11.0	3.5	4.2	8.0	0.5	7.5	7.2	6.4	2.0	6.5	9.6	38.8	7.6	11.4	9.2	9.8	7.0	5.9	9.7	6.9
RCN2	"E6BP, ERC-55, ERC55, TCBP49"	ENSG00000117906	"Reticulocalbin 2"	Q14257	15	76931619-76954392	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 147.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030694, HPA030695"	Enhanced	Supported	Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"		41000	"Endoplasmic reticulum"		"HPA030694: AB_2673573, HPA030695: AB_2673574"	"unprognostic (1.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.71e-2)"	"prognostic unfavourable (7.36e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.67e-2)"	13.8	14.7	29.9	12.1	32.6	9.9	16.8	25.1	37.5	16.8	15.0	17.3	28.1	10.4	20.6	147.5	14.9	25.0	15.3	17.3	29.5	41.5	22.6	9.3	13.5	12.5	27.2	29.5	18.8	11.0	28.4	17.8	27.7	24.6	19.6	17.2	15.5	12.0	21.9	22.7	10.6	11.0	18.2	18.5	12.4	13.8	48.2	14.8	14.8	22.1	17.0	14.3	17.8	13.3	15.9	12.0	9.8	7.2	14.1	19.0	11.5	20.4	14.5	64.8	30.5	28.0	32.0	40.5	24.4	33.3	31.8	26.6	17.9	17.6	12.8	35.4	26.5	31.3	49.0	21.0	40.7	9.8	38.2	6.3	21.2	29.6	33.5	22.8	9.8	28.9	29.1	15.6	20.2	33.5	15.9	12.8	33.1	13.1	22.5	15.7	49.3	16.2	23.8	42.7	8.1	20.9	27.5	37.1	37.0	39.9	22.4	46.4	21.8	25.3	17.9	37.6	30.4	23.9	50.1	18.4	56.6	15.2	21.4	19.2	34.0	4.5	4.8	9.8	14.8	4.4	17.2	14.8	15.7	19.0	10.2	15.9	17.8	17.2	2.6	14.1	7.2	12.0	10.9	11.5	29.9	32.6	25.1	37.5	29.5	41.5	27.2	29.5	24.6	14.8
RCOR1	"COREST, KIAA0071, RCOR"	ENSG00000089902	"REST corepressor 1"	Q9UKL0	14	102592661-102730576	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001956, HPA049327, HPA054241"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"CAB001956: , HPA049327: , HPA054241: "	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.05e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (3.72e-4)"	8.0	5.9	4.2	15.2	4.5	25.2	6.2	8.8	4.4	9.8	14.6	3.8	9.7	7.0	9.7	9.7	16.4	5.8	10.4	6.0	4.4	4.4	5.3	6.0	15.1	8.1	4.1	2.6	7.3	5.3	8.9	6.0	12.5	3.6	7.1	6.7	6.3	8.5	7.6	11.2	9.5	16.1	6.5	4.5	8.6	7.9	18.4	3.8	21.2	5.4	10.4	12.9	8.7	10.3	0.8	2.8	7.0	3.1	1.3	1.1	0.9	10.4	9.7	8.8	9.6	7.1	9.8	18.5	10.7	7.7	10.1	9.7	8.9	12.7	11.7	8.8	9.3	16.4	13.2	7.7	15.2	4.9	4.8	21.7	8.8	8.6	9.7	21.5	19.6	6.8	12.1	8.9	13.7	11.0	17.2	8.9	10.1	16.9	13.4	14.6	4.3	16.8	34.5	8.9	5.2	12.3	12.9	11.4	7.1	24.1	11.1	6.9	15.2	17.0	11.9	7.0	5.3	22.3	7.0	6.6	7.9	12.6	8.4	15.9	7.3	4.9	2.7	3.7	0.4	2.9	0.6	0.7	0.7	1.1	2.8	0.8	0.6	0.7	7.0	1.3	3.1	1.1	1.0	0.9	4.2	4.5	8.8	4.4	4.4	4.4	4.1	2.6	3.6	3.8
RDH10	SDR16C4	ENSG00000121039	"Retinol dehydrogenase 10"	Q8IZV5	8	73294612-73325281	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 134.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.6;BJ: 33.4;CACO-2: 29.8;HDLM-2: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.4;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049199			Supported	"Lipid droplets"				"Lipid droplets"		"HPA049199: "	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.23e-2)"	18.3	3.2	2.7	9.5	3.3	0.7	11.8	1.7	2.8	8.2	18.7	2.9	10.0	13.6	5.9	5.8	9.4	4.4	21.9	9.6	2.3	2.4	19.6	37.5	8.7	4.8	4.1	1.7	4.9	14.8	3.7	17.9	20.9	8.7	12.4	6.4	134.3	22.6	5.7	3.4	4.4	34.1	14.0	6.9	5.6	15.3	8.0	2.1	2.0	3.5	7.3	6.5	12.8	6.5	0.6	0.7	4.4	0.6	0.2	2.3	0.5	4.1	12.1	1.3	5.6	46.6	3.4	12.4	33.4	5.4	1.3	2.2	29.8	12.0	2.9	4.4	18.6	11.1	6.1	4.8	2.7	33.5	15.3	5.2	12.0	9.1	1.8	2.4	5.7	2.0	6.2	5.2	4.9	4.9	5.9	4.3	2.2	1.8	2.5	1.0	1.6	5.9	2.2	1.4	1.7	9.0	6.0	0.8	1.0	2.8	20.8	1.7	4.1	1.3	7.4	2.0	3.4	9.1	2.5	2.8	2.9	2.4	1.6	2.2	4.6	4.4	0.6	1.1	1.2	0.3	0.7	0.6	1.3	1.4	0.7	0.1	2.3	1.2	0.8	0.2	0.5	0.2	0.7	0.5	2.7	3.3	1.7	1.8	2.3	2.4	4.1	1.7	8.7	2.1
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"			"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favourable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.4	6.8	4.0	6.0	6.6	5.5	4.2	8.7	9.4	7.5	8.3	3.5	9.0	5.1	5.0	5.0	17.6	4.2	7.1	11.4	3.0	5.4	8.8	7.5	5.6	5.1	4.7	5.2	3.8	10.7	8.8	6.1	34.0	10.0	5.7	4.0	6.4	11.6	13.1	9.4	18.0	6.9	5.2	2.2	6.8	9.5	4.4	3.0	2.1	7.2	8.6	8.9	8.5	10.2	7.4	6.0	5.4	6.7	6.1	8.5	3.5	3.1	3.6	0.6	1.9	0.4	0.4	5.8	2.9	0.3	2.1	1.5	5.4	3.6	1.8	2.4	0.7	3.2	3.8	2.3	0.2	1.6	10.2	2.0	4.7	3.8	0.9	4.8	1.4	1.3	0.9	1.9	1.4	2.8	4.0	1.0	0.7	5.2	0.8	3.2	0.8	4.7	2.5	1.0	10.1	1.3	5.5	2.2	2.7	2.8	8.0	3.6	3.9	4.7	2.9	0.3	1.1	0.2	3.9	2.0	3.6	2.2	1.5	3.4	2.0	4.1	4.1	5.4	8.5	6.7	7.7	6.1	7.0	7.7	4.5	7.4	8.4	6.8	2.6	6.1	5.9	6.0	5.7	3.5	4.0	6.6	8.7	9.4	3.0	5.4	4.7	5.2	10.0	3.0
RDM1	"MGC33977, RAD52B"	ENSG00000278023	"RAD52 motif containing 1"	Q8NG50	17	35918066-35930773	"Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.7;lymphoid tissue: 6.2;testis: 24.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.6;T-47d: 17.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 5.7"	"Group enriched"	"Detected in many"	14	"NK-cells: 1.5;T-cells: 5.7"	"Low region specificity"	"Detected in all"							"HPA024794, HPA067546"	Enhanced		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA024794: AB_1856039, HPA067546: "	"unprognostic (9.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-8)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.53e-1)"	0.0	0.0	0.9	0.9	1.2	0.6	0.0	0.0	1.8	0.0	0.9	0.1	0.0	1.3	0.2	0.7	0.3	0.1	0.3	0.0	1.0		0.1	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	0.2	1.7	0.0	0.0	0.0	0.0	1.1	1.5	0.1	0.2	0.1	1.1	24.0	0.0	6.2	0.3	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	1.5	5.7	0.3	6.0	7.1	1.3	2.5	0.1	0.0	2.1	1.4	0.1	0.8	1.3	10.6	6.0	6.6	2.9	0.4	0.9	4.1	1.7	4.1	1.5	8.3	4.2	1.8	0.0	0.0	0.2	3.0	0.0	0.8	0.5	0.4	0.1	1.8	0.0	0.6	2.4	2.3	2.3	0.9	2.6	0.8	0.0	0.0	1.6	3.4	4.8	0.8	1.9	1.8	2.6	17.4	0.4	0.0	0.1	2.1	0.0	0.4	5.5	2.0	2.3	3.4	2.4	1.1	0.0	0.0	0.0	1.4	0.0	2.3	0.1	1.6	5.7	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	1.5	0.3										
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296722	"Disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 81.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			77000000	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	15.9	81.0	17.9	7.0	29.2	4.2	22.3	9.3	20.2	14.7	10.1	19.5	11.1	2.9	12.7	9.1	11.9	8.8	11.6	16.9	20.8	17.0	21.7	28.6	20.4	8.7	27.5	15.2	23.7	22.0	16.0	16.1	16.4	31.6	11.3	4.9	7.4	9.0	11.9	35.5	5.5	5.3	14.9	50.4	10.6	8.3	13.9	30.6	3.5	19.7	11.8	5.9	13.4	11.9	9.4	9.6	17.1	11.4	13.1	15.8	5.6	17.1	9.1	36.3	14.3	21.3	23.8	20.7	21.8	12.4	14.4	15.9	25.5	30.0	0.0	33.5	26.9	15.8	20.1	20.8	21.6	10.3	11.1	12.7	30.4	18.8	20.0	4.6	8.8	24.2	11.9	17.9	32.2	39.1	18.1	7.7	33.3	30.3	2.7	3.8	11.5	14.9	7.9	25.4	7.4	18.3	8.6	9.9	10.7	38.3	17.4	13.7	22.3	7.6	24.1	24.0	17.8	11.5	16.9	2.5	4.1	16.6	9.1	2.8	55.1	17.1	11.4	16.5	9.4	9.4	12.5	9.4	8.4	6.9	9.6	6.1	5.7	4.6	1.3	13.1	7.1	7.8	15.8	5.6	17.9	29.2	9.3	19.0	20.8	17.0	27.5	15.2	31.6	30.6
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036433-36124451	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 54.0;ASC TERT1: 43.3;BJ: 16.8;BJ hTERT+: 24.2;HSkMC: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"			37000000	"Plasma membrane"		"CAB025109: , HPA071729: "	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavourable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	15.9	8.9	6.9	6.3	8.2	1.5	31.7	9.1	7.8	18.9	10.2	8.5	6.2	4.3	18.4	7.5	13.7	12.0	15.6	11.3	8.4	4.9	6.9	6.7	16.7	6.1	8.3	4.9	17.2	3.9	3.7	7.8	12.7	8.3	12.3	7.6	10.5	7.8	8.9	5.7	8.7	7.7	17.3	7.9	8.1	9.8	7.9	8.5	8.4	10.5	9.8	6.2	17.8	16.8	3.5	3.7	1.2	5.5	3.6	8.9	3.1	0.3	0.6	2.1	1.1	54.0	43.3	0.0	16.8	24.2	1.2	2.9	0.0	0.0	0.6	1.6	14.8	0.1	0.4	0.3	1.7	1.0	0.9	0.6	0.7	0.0	4.3	0.0	2.9	19.3	0.4	1.8	0.7	3.8	0.0	0.5	3.1	0.0	1.6	0.2	0.7	0.5	1.7	1.6	0.0	0.8	0.0	0.2	1.1	0.3	0.2	0.6	0.0	2.2	11.4	2.3	0.8	1.5	0.9	0.7	0.8	0.7	1.4	2.2	1.5	1.2	3.3	0.9	5.4	3.5	6.1	1.7	7.1	5.7	3.7	3.5	8.9	6.4	0.5	3.6	5.5	2.1	3.2	3.1	6.9	8.2	9.1	7.8	8.4	4.9	8.3	4.9	8.3	8.5
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468911-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: "	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavourable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	32.7	15.8	10.0	22.0	12.7	10.8	18.2	10.9	11.2	18.0	16.3	9.4	11.0	7.5	19.8	14.4	18.7	14.6	14.1	17.9	11.2	7.2	19.6	18.0	19.5	25.7	15.3	7.6	16.0	11.9	8.0	14.8	17.1	12.0	14.0	12.7	6.7	13.1	12.4	15.0	12.4	15.5	20.5	19.5	34.0	12.9	10.8	13.0	27.4	17.4	14.3	25.0	22.6	13.0	19.3	15.2	11.3	20.7	23.1	28.0	13.8	17.5	17.8	13.5	10.0	27.4	34.5	15.7	34.0	28.7	21.9	25.6	19.5	14.7	21.1	13.1	23.1	12.9	14.4	16.9	31.3	35.3	9.6	25.7	19.8	8.2	10.6	17.8	19.5	19.2	8.7	31.1	22.9	24.6	9.0	10.3	28.8	8.5	19.5	20.8	22.5	12.1	16.1	54.9	16.3	8.4	12.1	3.6	10.8	25.3	6.8	17.8	17.3	11.4	33.1	30.9	20.1	27.0	31.5	4.2	12.4	46.3	26.1	10.5	22.7	9.3	11.8	11.3	21.9	20.7	21.3	19.3	20.5	21.0	15.2	16.0	13.6	18.8	5.5	23.1	18.8	11.6	28.0	13.8	10.0	12.7	10.9	11.2	11.2	7.2	15.3	7.6	12.0	13.0
RECQL4	RecQ4	ENSG00000160957	"RecQ like helicase 4"		8	144511288-144517845	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0;lymphoid tissue: 18.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"B-cells: 1.9;monocytes: 1.0;T-cells: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB017800, HPA025821"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB017800: , HPA025821: AB_1856168"	"unprognostic (5.92e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (1.91e-4)"	"unprognostic (1.12e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	2.0	1.6	2.6	12.3	5.6	21.0	2.8	11.5	3.7	1.8	4.3	1.5	1.6	5.6	2.5	4.9	9.4	1.5	1.9	1.9	2.3	1.7	1.6	1.9	1.6	5.9	1.5	2.2	1.9	3.5	0.3	2.4	2.7	2.2	7.7	1.5	1.4	5.4	0.9	2.1	9.4	4.8	1.1	1.7	4.7	3.0	18.1	1.8	18.9	2.5	5.3	8.0	1.6	1.8	1.9	0.1	0.0	1.0	0.0	1.6	0.2	10.3	18.5	8.7	18.2	0.5	0.8	15.2	10.5	1.9	7.8	6.6	18.2	15.3	7.1	7.0	1.7	12.6	5.7	4.5	2.1	12.4	21.8	25.5	31.7	13.5	0.1	6.4	21.2	1.1	0.6	8.7	1.7	2.1	25.3	9.2	2.6	32.0	23.5	17.5	6.0	22.2	24.6	6.8	11.8	2.1	11.2	17.1	10.3	14.2	11.9	3.7	14.5	14.2	2.9	12.6	38.3	15.1	19.3	5.1	5.4	11.9	7.3	20.0	12.6	0.0	0.1	0.0	1.1	1.0	0.0	1.9	0.5	1.1	0.1	0.0	0.9	1.6	0.0	0.0	0.0	0.1	0.0	0.2	2.6	5.6	11.5	3.7	2.3	1.7	1.5	2.2	2.2	1.8
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favourable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.4	12.9	12.6	11.7	16.0	10.0	9.8	11.4	17.7	9.4	10.6	24.4	17.4	22.9	10.5	13.2	20.4	11.8	12.4	6.7	12.9	8.6	14.9	15.8	8.4	16.8	14.5	11.0	14.3	10.8	17.6	21.9	32.3	14.3	12.2	9.8	13.2	15.6	14.0	6.8	21.1	23.2	9.6	13.2	16.6	23.8	21.0	17.0	12.1	21.4	6.2	16.0	12.1	12.8	5.2	16.4	6.0	3.9	3.8	4.2	3.2	11.0	20.5	8.3	11.7	11.6	7.8	19.1	8.2	6.9	10.7	9.5	9.0	11.8	13.1	8.9	7.2	10.5	8.6	9.8	10.2	7.0	16.1	23.9	24.8	13.0	11.6	7.7	11.9	11.0	12.1	10.6	12.8	13.9	12.0	11.7	7.9	9.8	15.8	10.5	5.4	15.9	12.8	19.4	13.2	9.0	13.2	10.0	9.7	8.9	16.1	11.0	28.9	6.2	7.0	13.8	15.9	7.5	8.4	16.7	9.5	12.6	11.3	7.7	9.9	6.0	3.1	4.4	4.2	3.9	2.7	3.6	2.7	3.1	3.8	5.2	4.1	2.9	2.1	3.8	1.9	16.4	2.2	3.2	12.6	16.0	11.4	17.7	12.9	8.6	14.5	11.0	14.3	17.0
REEP6	"C19orf32, DP1L1, FLJ25383, Yip2f"	ENSG00000115255	"Receptor accessory protein 6"	Q96HR9	19	1490747-1497927	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 90.8;liver: 119.0;testis: 71.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.8;Hep G2: 15.0;K-562: 41.8;T-47d: 34.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 114.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA003895, HPA048015"	Enhanced		Supported	"Endoplasmic reticulum"			26000	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA048015: "	"unprognostic (1.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.38e-2)"	2.4	20.1	4.1	0.7	5.9	0.6	3.9	3.1	6.0	1.4	41.7	2.8	4.4	60.2	1.0	5.7	2.7	1.4	7.6	0.9	4.5	1.9	6.1	119.0	0.6	0.7	2.6	2.1	1.7	10.1	0.5	2.2	0.7	2.1	4.9	0.7	27.4	5.6	11.8	0.7	1.7	90.8	1.1	1.6	0.6	1.3	71.2	1.1	0.3	1.6	1.1	2.1	3.2	1.2	1.0	4.2	0.1	4.8	5.8	7.1	2.3	2.0	2.5	0.8	10.3	1.6	0.5	11.5	0.5	0.1	0.5	0.5	15.8	6.4	1.1	3.6	0.3	2.1	2.7	0.1	0.2	0.5	1.1	6.0	0.3	15.0	1.2	0.4	2.0	1.3	1.1	0.0	0.3	0.3	41.8	1.5	0.1	7.9	0.5	1.3	3.8	5.6	1.5	0.3	2.6	3.0	0.9	0.2	5.6	2.8	4.0	1.7	34.9	1.6	0.9	0.8	1.6	2.4	0.4	5.0	1.4	0.1	3.5	2.6	2.3	0.0	1.5	0.0	7.1	1.7	3.8	0.1	2.1	1.5	2.5	1.0	2.8	3.2	0.1	5.8	4.8	4.2	2.0	2.3	4.1	5.9	3.1	6.0	4.5	1.9	2.6	2.1	2.1	1.1
RELA	"NFKB3, p65"	ENSG00000173039	"RELA proto-oncogene, NF-kB subunit"	Q04206	11	65653596-65663094	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004264, CAB005030, HPA063461"	Supported		Enhanced	Cytosol				Cytosol		"CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: "	"unprognostic (9.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (9.18e-4)"	"unprognostic (1.30e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (5.66e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.53e-1)"	36.2	23.1	21.4	27.6	32.0	50.2	37.8	21.5	28.2	35.6	32.3	22.9	23.6	23.6	36.9	26.8	36.4	32.8	33.6	28.9	21.1	12.9	28.4	38.5	37.7	30.8	35.6	13.3	51.9	29.0	27.3	19.3	27.1	22.6	31.1	19.7	23.9	32.8	39.2	46.5	35.2	26.7	33.5	29.5	38.1	31.8	20.6	30.1	34.3	26.3	30.6	36.4	54.7	38.8	15.2	13.2	18.3	14.4	21.3	23.3	12.4	26.1	26.9	12.0	16.7	19.2	18.7	12.2	20.1	24.4	23.2	18.8	12.2	26.6	19.8	33.8	28.2	23.4	13.8	24.4	16.4	23.3	19.9	21.8	20.1	17.7	21.2	16.1	30.9	21.5	24.1	25.8	30.6	28.1	21.8	23.1	18.6	34.9	29.2	13.6	7.8	23.7	24.4	11.8	29.6	19.4	23.7	9.9	22.8	17.2	27.0	26.8	31.4	10.6	38.3	25.1	21.5	38.3	19.1	35.0	32.2	21.1	28.4	11.1	23.9	10.5	11.3	15.1	20.5	14.4	23.3	15.2	18.2	20.4	13.2	13.7	17.3	18.2	18.3	21.3	12.5	13.1	17.8	12.4	21.4	32.0	21.5	28.2	21.1	12.9	35.6	13.3	22.6	30.1
RELL1		ENSG00000181826	"RELT like 1"	Q8IUW5	4	37590800-37686376	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013377	Approved		Supported	"Plasma membrane,Microtubules"				"Plasma membrane, Microtubules"		"HPA013377: AB_1844403"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.71e-2)"	21.1	3.0	5.5	6.2	9.7	28.8	19.3	6.4	6.5	8.4	10.4	6.5	2.8	7.2	8.3	7.8	9.8	7.3	9.7	12.1	5.1	5.0	4.9	5.5	10.4	14.6	9.1	2.1	8.9	4.0	2.6	3.2	20.7	17.9	6.2	7.5	8.1	5.3	5.0	10.1	11.5	8.6	11.1	28.2	10.9	14.7	4.1	5.3	6.0	18.1	9.6	6.6	15.6	13.3	0.1	3.2	16.1	4.0	0.9	1.7	1.3	2.8	3.7	9.0	6.4	6.2	5.2	7.1	5.1	5.3	4.5	5.7	11.4	3.5	0.6	3.9	4.7	2.7	2.9	5.4	7.1	0.0	1.5	1.1	3.1	9.8	3.7	4.2	2.9	7.0	4.4	5.5	5.5	18.0	2.2	2.9	3.3	2.4	4.4	2.2	1.8	1.1	1.6	32.6	1.5	4.4	4.2	2.0	5.6	4.7	3.5	4.5	12.1	1.4	21.4	9.1	5.3	6.9	5.7	1.5	1.6	4.8	8.3	6.7	6.9	0.0	4.0	2.5	1.3	0.8	1.2	0.1	1.2	1.1	1.6	0.0	1.1	1.7	16.1	0.9	0.5	3.2	1.1	1.3	5.5	9.7	6.4	6.5	5.1	5.0	9.1	2.1	17.9	5.3
RELT	"FLJ14993, TNFRSF19L"	ENSG00000054967	"RELT, TNF receptor"	Q969Z4	11	73376264-73397474	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 92.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062824, HPA071518"			Supported	Nucleoplasm				Nucleoplasm		"HPA062824: , HPA071518: "	"unprognostic (3.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.42e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavourable (4.07e-11)"	"unprognostic (1.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-1)"	3.5	2.2	3.5	11.7	8.8	92.2	2.8	3.5	5.7	1.4	2.1	7.4	0.0	2.7	1.9	2.5	3.2	1.6	4.1	5.3	4.0	5.2	2.0	2.0	8.4	18.2	8.3	3.9	1.5	1.6	1.8	3.1	4.1	13.9	1.7	2.0	2.3	4.6	1.3	22.1	2.5	5.6	2.8	14.3	18.1	2.5	3.0	4.6	4.8	1.8	3.9	9.0	3.3	2.1	4.7	6.8	12.1	19.2	0.3	1.1	3.1	5.6	5.7	4.4	4.4	0.5	0.6	5.1	6.3	3.9	7.3	4.4	5.4	2.5	10.4	20.8	4.1	8.4	2.8	3.1	2.6	6.3	5.4	9.9	7.1	2.0	1.2	9.8	17.4	0.7	1.3	7.7	2.0	2.6	7.4	13.9	2.0	5.4	7.0	10.1	4.0	7.1	13.9	7.8	9.1	1.4	2.4	5.9	5.6	5.4	4.9	6.6	2.7	8.4	3.6	9.2	6.5	15.2	11.2	4.9	3.8	11.5	5.6	9.6	9.7	0.4	7.0	12.1	0.5	14.3	1.1	4.7	0.6	1.0	6.8	3.7	0.8	0.4	11.6	0.3	19.2	6.8	0.2	3.1	3.5	8.8	3.5	5.7	4.0	5.2	8.3	3.9	13.9	4.6
REPIN1	"AP4, H_DJ0584D14.12, RIP60, Zfp464, ZNF464"	ENSG00000214022	"Replication initiator 1"	Q9BWE0	7	150368189-150374044	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036022	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA036022: AB_10610417"	"unprognostic (2.73e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.50e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.88e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.59e-2)"	"prognostic favourable (1.12e-4)"	"unprognostic (3.40e-2)"	"prognostic favourable (5.56e-4)"	"prognostic favourable (1.61e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-3)"	"prognostic favourable (6.41e-4)"	17.0	30.1	16.2	24.9	23.1	25.7	16.9	24.2	21.7	12.0	27.5	21.5	23.2	29.2	15.4	23.6	14.9	17.5	23.6	22.1	15.6	17.1	18.6	36.1	12.3	22.4	21.9	14.3	16.6	34.0	21.5	28.5	10.4	15.6	19.0	20.3	21.9	26.9	23.2	78.4	14.4	27.1	11.4	13.3	23.1	20.6	7.0	18.9	45.4	20.1	20.0	20.3	18.1	15.9	3.6	11.2	3.5	2.1	2.3	3.5	1.2	15.8	19.5	18.5	22.6	4.5	3.2	11.3	7.8	9.7	7.7	6.7	15.0	10.3	17.7	20.0	5.6	11.9	10.1	3.1	3.9	19.3	15.1	10.3	10.5	18.8	15.0	18.2	16.9	4.2	9.5	4.2	1.0	10.9	24.7	11.1	6.4	20.6	25.1	20.7	19.4	19.4	13.9	21.4	65.6	8.1	28.3	27.2	34.8	11.9	29.9	20.1	14.6	14.6	11.5	6.0	4.9	6.6	15.8	32.4	12.0	16.1	10.5	16.2	14.7	0.1	2.1	3.5	1.2	1.0	1.9	3.6	2.7	2.3	3.0	3.5	3.5	1.7	2.0	2.3	0.5	11.2	1.1	1.2	16.2	23.1	24.2	21.7	15.6	17.1	21.9	14.3	15.6	18.9
RER1		ENSG00000157916	"Retention in endoplasmic reticulum sorting receptor 1"	O15258	1	2391775-2405444	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037240, HPA051400"	Supported		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB037240: AB_2179604, HPA051400: "	"unprognostic (2.90e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (8.23e-8)"	"unprognostic (1.01e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.27e-2)"	31.2	59.8	21.6	26.6	24.8	21.2	40.5	22.6	31.1	30.6	40.2	34.6	34.6	34.1	34.0	39.4	63.0	27.0	44.2	31.3	21.0	18.0	44.9	125.8	28.3	39.6	26.8	24.8	31.3	55.8	29.8	31.8	44.8	23.5	30.0	47.5	29.7	57.7	36.9	36.7	35.5	51.5	32.3	24.6	38.6	34.3	35.7	25.3	26.9	36.6	38.5	41.7	28.3	37.3	40.6	62.3	86.1	63.0	36.3	57.3	65.4	38.1	21.8	26.2	29.3	48.3	57.6	19.5	56.9	52.1	51.6	51.9	30.7	59.5	27.0	48.2	58.5	41.4	30.3	35.0	65.9	33.8	27.8	30.1	46.0	29.4	52.3	33.3	37.7	46.5	35.7	53.5	47.6	47.0	35.9	46.7	59.9	27.2	23.6	24.4	17.1	52.9	27.7	25.6	34.9	46.0	18.5	21.6	24.9	31.8	75.7	44.8	29.9	24.8	32.3	40.3	22.8	71.0	41.8	44.4	49.5	48.7	42.5	49.0	20.3	46.5	58.5	66.4	50.3	63.0	46.1	40.6	44.7	53.7	53.9	35.1	33.9	41.6	86.1	36.3	61.8	62.3	57.3	65.4	21.6	24.8	22.6	31.1	21.0	18.0	26.8	24.8	23.5	25.3
REST	"NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966678	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB068222: , HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	14.4	11.4	6.0	15.6	8.9	21.5	39.7	2.1	6.3	13.7	11.0	5.6	13.0	6.5	14.2	13.7	14.5	11.2	13.8	22.1	6.1	4.5	13.9	12.0	18.2	35.6	8.2	3.0	13.9	15.9	22.4	4.5	14.4	11.8	17.3	7.6	7.2	14.0	27.6	13.8	11.6	12.0	16.3	15.2	18.7	10.4	15.3	8.2	43.4	13.4	8.3	14.0	15.6	19.5	16.7	10.7	9.0	8.4	16.7	15.3	4.2	7.0	9.0	12.5	12.4	9.4	11.9	15.8	10.5	9.4	11.3	10.3	8.9	10.9	16.9	16.9	11.4	6.5	9.2	11.1	17.8	8.9	5.5	15.4	7.1	7.9	11.5	19.4	9.2	11.7	10.0	10.8	11.2	13.9	9.8	18.2	13.0	11.2	22.3	13.2	10.6	5.9	19.8	10.7	5.2	12.8	12.8	0.2	5.7	12.7	12.4	9.4	13.2	12.7	19.6	14.4	12.8	8.0	9.4	7.3	5.4	10.2	9.2	11.0	7.4	9.0	3.6	7.7	10.6	5.3	8.9	12.0	10.5	10.4	8.1	16.7	15.3	9.3	3.7	16.7	8.4	10.7	10.3	4.2	6.0	8.9	2.1	6.3	6.1	4.5	8.2	3.0	11.8	8.2
RETREG1	"FAM134B, FLJ20152, JK1"	ENSG00000154153	"Reticulophagy regulator 1"	Q9H6L5	5	16473038-16617058	"Disease related genes, Predicted membrane proteins"	Autophagy		"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.0;skeletal muscle: 78.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.4;HSkMC: 18.1;MOLT-4: 11.9;RPTEC TERT1: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;T-cells: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012077			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA012077: "	"unprognostic (1.63e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (5.25e-10)"	"unprognostic (3.75e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.58e-1)"	9.8	2.0	8.5	3.7	11.2	1.1	8.7	9.6	19.6	7.4	12.4	14.9	0.3	6.5	2.3	5.4	2.0	4.1	7.1	45.0	11.2	9.4	30.3	21.8	4.9	3.1	13.2	11.4	1.7	19.0	17.7	8.0	6.7	18.5	5.9	16.9	1.5	3.9	3.0	78.5	5.6	12.8	1.5	16.8	1.6	6.1	5.7	15.4	14.1	3.6	12.5	2.3	2.0	4.4	0.9	0.1	4.0	0.4	0.1	4.4	0.6	0.8	0.3	0.1	2.1	16.4	2.0	9.6	0.1	2.1	1.9	2.6	1.4	0.1	0.2	1.5	0.0	2.4	4.8	0.5	0.6	2.4	2.2	0.0	7.2	0.0	0.1	3.1	0.0	18.1	7.4	0.3	2.0	0.0	0.0	0.1	0.7	0.6	11.9	0.0	0.5	0.3	1.9	0.0	0.7	16.6	0.5	10.9	1.3	0.6	0.7	7.8	3.6	1.4	0.0	1.5	0.2	4.0	1.8	0.4	0.0	0.0	9.3	10.8	3.9	4.0	0.4	0.1	0.6	0.0	1.6	0.0	1.5	0.8	0.1	0.9	4.4	2.7	2.3	0.1	0.1	0.0	1.9	0.6	8.5	11.2	9.6	14.4	11.2	9.4	13.2	11.4	18.5	15.4
REXO1	"EloA-BP1, KIAA1138, TCEB3BP1"	ENSG00000079313	"RNA exonuclease 1 homolog"	Q8N1G1	19	1815246-1848463	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042155, HPA042552"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA042155: AB_10806233, HPA042552: AB_10794280"	"unprognostic (1.36e-1)"	"unprognostic (3.86e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.70e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-2)"	10.9	17.6	15.6	11.9	19.5	19.3	11.5	13.0	25.4	6.2	9.3	10.3	3.4	12.1	9.5	5.5	8.3	7.7	7.8	7.7	14.0	5.9	8.3	10.3	9.0	14.2	8.6	10.3	9.7	16.1	5.1	6.6	13.7	8.9	7.8	5.6	7.6	11.1	7.1	13.8	14.2	11.7	9.4	5.7	20.0	10.4	31.7	11.6	9.6	7.8	6.2	9.7	7.8	9.0	1.4	1.2	2.0	0.8	0.7	1.4	1.0	11.9	7.7	7.1	11.0	2.8	3.7	14.4	8.7	4.7	6.4	5.7	10.0	6.7	10.3	5.9	6.0	10.6	5.3	9.7	2.8	16.3	8.3	10.8	8.4	5.8	6.5	9.5	17.8	6.5	5.6	8.4	5.6	5.8	16.2	17.9	3.3	7.5	15.7	10.7	16.0	7.6	14.1	5.9	9.7	4.2	6.8	10.5	11.5	5.4	9.2	11.2	8.0	14.1	10.0	10.1	8.8	16.8	14.5	29.2	14.0	8.9	8.1	11.5	13.0	1.3	0.8	0.5	1.0	0.7	0.8	0.6	0.8	0.6	0.6	1.4	1.1	1.4	2.0	0.7	0.8	1.2	0.3	1.0	15.6	19.5	13.0	25.4	14.0	5.9	8.6	10.3	8.9	11.6
REXO2	"CGI-114, DKFZP566E144, SFN"	ENSG00000076043	"RNA exonuclease 2"	Q9Y3B8	11	114439386-114450279	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038450, HPA038451"	Enhanced		Supported	"Nucleoli,Focal adhesion sites,Mitochondria"			390000	Mitochondria	"Nucleoli, Focal adhesion sites"	"HPA038450: AB_10672516, HPA038451: AB_10697391"	"unprognostic (3.26e-3)"	"unprognostic (2.36e-2)"	"prognostic favourable (6.51e-4)"	"unprognostic (6.84e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.69e-2)"	"prognostic unfavourable (6.70e-4)"	21.8	31.1	13.5	15.8	14.2	16.2	30.0	14.9	12.6	31.4	36.0	11.2	24.0	8.4	38.4	24.8	33.5	17.7	23.9	64.3	13.3	10.5	35.7	28.6	20.1	13.9	17.0	13.1	28.5	27.7	61.2	24.9	45.0	15.3	32.0	17.7	11.6	61.6	22.8	27.8	22.7	15.8	44.6	15.7	18.6	31.5	29.6	14.5	9.9	20.0	25.2	15.2	34.9	40.6	15.5	28.6	19.0	7.9	18.1	30.5	12.2	27.4	16.0	6.2	16.6	49.9	53.0	14.8	46.5	36.4	23.5	30.0	41.9	47.0	15.1	46.9	41.1	17.5	13.9	41.2	38.9	14.6	10.8	16.6	22.1	26.0	65.6	12.1	5.3	36.6	39.5	29.7	31.6	42.0	30.7	9.3	52.6	6.5	8.8	15.2	19.1	28.3	7.8	20.2	54.9	33.7	22.3	11.0	6.9	21.4	16.5	19.6	33.6	6.3	39.7	30.3	36.3	23.3	28.5	7.3	8.7	25.5	20.9	28.6	16.1	19.0	6.0	8.8	14.3	7.9	16.5	15.5	21.6	17.9	7.8	11.7	19.9	16.1	1.5	18.1	7.9	28.6	30.5	12.2	13.5	14.2	14.9	12.6	13.3	10.5	17.0	13.1	15.3	14.5
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA047006: "	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	9.9	13.7	16.9	15.1	18.4	10.9	14.5	21.6	18.3	12.7	11.9	11.9	13.2	13.8	14.5	10.7	15.5	13.5	11.2	14.6	13.8	11.8	12.0	19.3	9.7	18.3	18.0	13.2	22.2	21.4	13.3	14.6	14.1	15.4	13.7	10.1	8.8	14.9	13.1	36.4	15.1	13.5	11.9	16.1	16.9	13.0	18.7	18.4	15.0	15.2	9.1	16.3	12.5	21.3	5.5	3.6	3.3	2.5	7.2	5.2	1.8	5.7	13.5	6.3	9.3	6.6	6.9	11.3	10.0	5.7	10.6	7.0	16.0	7.5	18.9	6.8	5.4	15.8	13.2	10.5	6.1	12.2	12.3	10.2	14.3	12.5	8.3	23.3	10.0	6.4	8.9	11.1	15.3	7.7	22.4	8.3	6.7	16.7	16.3	14.0	12.8	19.5	11.6	10.4	18.8	6.7	5.5	18.2	9.9	10.6	12.4	11.4	15.2	9.4	6.7	19.4	10.1	9.2	12.2	5.5	6.7	13.0	7.2	13.5	11.5	0.7	2.5	3.3	3.9	2.5	4.3	4.7	4.0	4.0	2.0	5.5	5.1	5.2	0.1	7.2	2.0	3.6	3.4	1.8	16.9	18.4	21.6	18.3	13.8	11.8	18.0	13.2	15.4	18.4
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009520: AB_2178317, HPA046116: , HPA069306: "	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	18.7	24.0	20.2	22.5	24.9	26.8	21.2	19.9	22.7	23.8	17.8	17.1	20.3	12.5	20.7	19.0	19.4	15.8	11.9	15.4	17.9	14.6	23.4	24.9	17.2	26.3	29.0	22.7	26.2	34.1	41.3	30.7	17.6	23.5	20.1	14.5	10.5	17.4	18.9	13.5	17.8	16.0	21.0	32.7	21.6	17.1	12.4	28.9	33.6	22.3	14.6	27.3	25.3	17.4	15.3	13.0	6.4	8.1	10.8	13.5	4.7	15.5	7.1	20.1	16.4	9.7	12.4	10.3	18.1	16.5	18.5	22.1	13.7	15.9	38.5	12.2	12.1	7.6	18.4	15.7	29.9	6.9	12.6	17.2	13.5	12.5	11.8	24.0	11.5	9.4	12.7	18.7	21.0	14.4	16.9	8.2	14.0	6.3	35.2	15.5	12.3	9.0	28.1	36.7	12.1	8.0	10.9	14.1	13.7	10.6	4.2	13.7	11.1	13.6	10.9	15.3	18.9	14.1	22.8	11.6	15.8	36.6	12.6	25.2	15.2	6.4	8.1	3.2	13.2	6.2	9.6	12.4	11.4	11.2	6.2	15.3	13.5	11.9	3.7	10.8	7.4	13.0	9.9	4.7	20.2	24.9	19.9	22.7	17.9	14.6	29.0	22.7	23.5	28.9
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favourable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	11.0	9.5	16.1	15.8	15.4	23.0	15.3	13.9	16.6	10.1	12.8	10.0	5.0	8.6	10.0	9.4	17.9	10.1	9.0	9.1	12.1	9.1	10.1	23.0	10.6	20.4	12.3	14.0	11.7	15.1	10.9	8.6	17.5	15.1	11.0	15.0	8.9	12.2	8.1	16.5	18.8	10.0	12.7	14.8	14.2	12.2	13.5	14.0	22.1	10.4	14.7	28.5	9.9	11.6	22.4	18.7	27.5	24.2	24.8	13.6	15.8	23.1	18.0	21.0	20.8	4.3	5.1	9.6	13.6	15.0	27.7	33.4	19.9	21.6	21.8	3.8	9.6	15.9	17.1	22.7	28.8	15.6	29.7	13.3	25.1	14.7	3.4	20.0	8.3	5.2	5.1	26.0	18.0	14.8	27.6	13.5	21.3	27.3	19.8	38.8	23.9	15.2	29.6	23.4	27.3	14.8	18.7	17.1	21.7	16.1	30.5	11.1	22.1	18.4	5.7	27.4	18.2	21.1	30.3	8.3	10.7	37.9	13.9	30.9	28.5	19.5	22.0	15.6	11.4	24.2	11.7	19.0	9.9	10.4	18.7	22.4	12.6	9.5	27.5	24.8	22.4	10.0	13.6	15.8	16.1	15.4	13.9	16.6	12.1	9.1	12.3	14.0	15.1	14.0
RFC3	"MGC5276, RFC38"	ENSG00000133119	"Replication factor C subunit 3"	P40938	13	33818049-33966558	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 69.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030149	Approved		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA030149: AB_10602921"	"unprognostic (3.86e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.02e-3)"	"unprognostic (4.49e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.86e-1)"	8.0	17.7	5.7	19.1	7.2	14.4	10.9	19.9	10.2	7.9	7.5	5.6	5.9	6.9	11.6	8.9	10.3	7.0	6.5	6.2	5.2	5.5	5.4	6.2	6.6	19.1	4.7	5.6	9.6	7.6	3.7	5.9	14.2	8.6	5.7	10.3	7.0	7.8	4.6	6.1	7.5	7.0	6.6	5.6	11.8	6.3	17.8	3.7	34.7	6.1	9.7	19.2	5.2	7.0	8.2	7.9	8.5	7.5	3.3	8.3	4.1	11.4	11.5	22.0	17.7	1.7	2.7	11.9	16.0	7.4	21.5	18.7	15.1	17.8	43.1	6.7	6.2	17.7	27.7	11.3	29.1	16.5	16.6	24.9	13.4	16.3	1.9	30.1	12.0	2.5	1.5	18.5	12.8	7.1	17.3	10.9	12.9	13.4	25.4	14.4	25.8	10.0	9.5	25.6	9.9	6.4	10.3	11.4	20.1	12.0	16.2	8.4	13.0	16.7	3.7	11.4	12.7	14.4	17.0	6.1	8.3	69.1	8.2	17.9	21.7	1.6	5.7	8.5	4.5	7.5	4.9	8.2	5.5	4.7	7.9	7.8	7.4	6.3	1.3	3.3	6.5	3.3	8.3	4.1	5.7	7.2	19.9	10.2	5.2	5.5	4.7	5.6	8.6	3.7
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favourable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavourable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.1	6.9	11.5	14.1	16.0	26.8	10.5	28.0	13.9	8.8	11.6	5.3	5.8	8.2	11.8	7.3	13.0	10.2	7.6	8.0	8.6	6.2	8.2	9.3	6.6	22.1	14.5	9.8	12.7	11.9	6.5	9.0	11.0	12.5	7.3	16.1	5.9	8.1	5.8	8.1	8.7	11.8	13.6	8.4	15.6	9.8	20.3	12.8	28.6	6.4	11.0	25.2	8.3	8.5	11.2	7.7	7.4	10.3	7.0	16.5	6.2	34.5	11.9	28.2	18.0	4.1	4.4	22.3	16.8	10.6	26.8	29.7	17.8	16.6	25.0	39.0	8.0	18.3	24.8	16.4	33.0	37.6	21.9	25.6	18.2	18.0	3.2	27.0	17.3	3.8	5.9	18.3	14.4	8.9	20.0	35.6	18.2	16.5	34.0	25.4	24.9	16.2	26.9	24.3	34.2	9.6	12.9	27.7	13.7	20.9	23.1	18.9	39.2	25.9	4.1	16.2	20.5	27.2	50.0	19.9	44.0	83.1	14.3	29.8	21.3	0.0	2.2	7.4	9.8	3.3	9.4	10.6	9.7	10.1	3.9	11.2	9.8	8.9	0.4	7.0	10.3	7.7	16.5	6.2	11.5	16.0	28.0	13.9	8.6	6.2	14.5	9.8	12.5	12.8
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Supported	Nucleoplasm			450000	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: "	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	19.5	13.0	13.8	9.3	13.3	11.7	43.8	14.3	13.8	11.4	11.8	9.0	22.7	14.9	13.5	20.9	13.4	16.3	17.0	12.2	11.6	8.7	12.5	34.5	16.7	10.1	11.2	8.0	19.7	26.6	4.1	10.7	8.2	9.9	11.8	4.8	10.6	27.3	20.4	32.6	13.3	12.7	12.9	8.5	8.9	13.2	12.8	10.6	5.7	12.6	10.5	7.6	12.4	12.8	3.4	3.4	4.3	5.0	0.4	6.3	1.5	9.3	9.3	2.7	9.4	7.0	6.2	12.1	8.7	5.1	4.2	3.3	5.7	6.7	2.2	6.3	13.8	5.2	1.9	7.5	0.8	2.8	9.8	3.2	2.2	23.1	34.7	1.2	6.9	11.2	5.1	7.2	12.3	7.8	4.0	8.2	3.3	11.5	6.9	3.3	2.7	9.8	4.8	3.3	4.9	4.7	5.7	4.8	12.2	3.3	5.7	25.7	15.7	6.7	2.9	6.6	9.0	6.3	4.7	11.0	2.1	2.3	8.3	2.0	5.7	2.3	5.0	4.3	4.1	1.4	1.5	2.5	2.8	4.3	3.4	3.4	2.8	1.9	2.0	0.4	1.5	2.7	6.3	1.5	13.8	13.3	14.3	13.8	11.6	8.7	11.2	8.0	9.9	10.6
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621394-74666881	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA048258: , HPA075649: "	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	7.3	5.2	4.2	12.2	6.1	33.9	7.8	7.8	5.6	7.4	6.7	8.4	8.4	5.5	9.7	10.0	12.8	6.3	5.5	5.4	3.9	3.7	6.5	5.6	6.5	12.0	6.1	4.8	7.7	9.6	8.5	7.5	11.5	5.3	6.5	8.1	7.2	8.0	8.4	4.5	11.6	7.8	5.6	4.8	9.7	6.2	35.1	7.2	40.5	7.0	7.5	18.0	7.2	8.6	9.3	7.1	13.8	10.9	9.1	11.7	6.5	13.9	17.9	13.5	9.8	2.8	3.9	15.3	12.6	9.7	20.2	17.6	23.3	14.7	19.5	10.3	9.8	16.8	22.1	13.1	24.8	6.1	13.2	17.2	14.6	13.1	2.5	17.3	18.0	2.8	4.2	25.4	15.7	8.5	26.0	8.8	15.1	22.2	25.2	15.9	26.6	8.7	39.3	9.2	17.2	7.2	14.8	10.1	10.7	20.3	7.2	9.0	13.2	14.8	8.3	14.8	14.2	8.3	15.8	11.9	22.1	58.4	10.6	13.4	17.9	13.8	6.8	9.9	9.3	6.3	10.2	7.8	7.7	8.6	7.1	9.3	11.7	8.1	7.7	9.1	10.9	5.5	10.9	6.5	4.2	6.1	7.8	5.6	3.9	3.7	6.1	4.8	5.3	7.2
RFX1	EF-C	ENSG00000132005	"Regulatory factor X1"	P22670	19	13961538-14007039	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048722, HPA052966"	Approved		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA048722: , HPA052966: "	"unprognostic (6.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (5.45e-2)"	"prognostic favourable (2.42e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.61e-2)"	"prognostic favourable (4.92e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.56e-2)"	7.4	7.4	13.1	8.7	13.1	9.8	7.0	36.2	19.3	10.3	6.0	6.2	10.2	10.6	8.0	4.6	8.0	8.5	6.3	7.0	11.7	5.9	7.9	8.6	7.0	7.2	8.6	9.5	10.2	12.5	11.9	18.9	8.0	9.5	8.5	3.1	9.8	12.7	12.4	11.0	7.0	9.2	4.4	6.8	12.0	11.2	21.0	10.8	11.6	10.9	3.4	9.3	6.8	13.6	3.9	3.5	10.8	3.5	3.4	2.0	1.1	6.1	6.3	3.4	4.1	2.0	2.6	10.2	3.4	2.3	4.0	3.5	6.4	6.2	3.5	6.9	1.8	8.1	2.4	2.5	1.4	3.5	13.9	4.0	7.0	5.7	3.8	4.0	8.5	1.9	2.7	3.6	2.1	3.1	10.1	3.9	2.1	9.4	7.3	8.8	7.6	9.5	6.4	3.5	4.9	4.0	3.3	14.1	7.4	5.9	5.2	4.8	5.5	4.2	3.7	7.0	5.7	7.6	5.9	9.3	4.1	2.4	5.6	4.0	6.2	0.7	3.5	1.6	1.4	1.1	1.3	2.9	1.6	1.5	1.7	3.9	1.7	2.0	10.8	3.4	2.0	3.5	1.0	1.1	13.1	13.1	36.2	19.3	11.7	5.9	8.6	9.5	9.5	10.8
RFXANK	"ANKRA1, BLS, F14150_1, MGC138628, RFX-B"	ENSG00000064490	"Regulatory factor X associated ankyrin containing protein"	O14593	19	19192229-19201869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049157, HPA053330"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA049157: , HPA053330: "	"unprognostic (3.16e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.04e-3)"	16.2	11.0	15.8	19.5	17.8	28.4	15.6	7.6	15.3	19.5	20.1	14.9	17.4	16.9	16.6	20.3	21.8	25.3	12.8	17.7	14.3	12.7	19.0	11.3	14.3	22.5	16.0	10.1	18.8	17.9	12.2	14.0	21.9	13.6	17.7	9.0	16.1	27.0	22.4	32.0	18.7	15.3	11.9	13.0	26.5	16.7	8.5	9.3	49.6	36.6	21.8	23.4	15.1	13.8	25.1	31.7	28.4	18.2	18.3	23.3	15.7	18.4	11.6	8.3	16.5	2.9	8.1	20.7	9.2	9.7	15.9	15.8	9.6	38.8	18.2	23.7	9.5	13.8	7.0	18.2	7.1	12.5	11.0	14.5	11.8	14.0	30.3	20.6	30.8	15.5	10.8	13.9	10.2	15.8	28.8	20.8	8.6	37.1	26.8	27.4	9.9	26.4	22.8	8.4	31.7	13.1	13.0	6.8	14.3	9.6	12.3	22.6	17.8	42.2	15.4	8.7	9.2	20.5	14.8	24.1	26.0	27.0	12.6	25.7	16.5	20.5	17.7	28.4	15.1	18.2	12.6	23.6	16.9	16.3	20.0	25.1	17.1	16.5	7.6	18.3	13.3	31.7	23.3	15.7	15.8	17.8	7.6	15.3	14.3	12.7	16.0	10.1	13.6	9.3
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457559-41470882	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.9;lung: 120.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.0;BJ hTERT+: 78.9;Daudi: 25.7;U-698: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 46.2"	"Lineage enriched"	"Detected in many"	26	"T-cells: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"		390000	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: "	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	58.6	6.7	26.7	8.8	33.1	109.9	27.7	21.6	22.7	12.8	5.6	36.1	4.2	5.7	8.7	3.1	5.4	7.6	14.3	15.1	32.1	16.8	11.0	8.3	120.1	10.8	41.7	15.2	1.8	13.4	8.7	7.1	70.6	21.1	10.7	3.6	16.1	33.2	6.8	12.7	10.8	4.9	11.3	22.2	7.3	8.0	7.1	34.8	15.2	26.9	5.8	6.9	9.5	8.7	1.7	1.7	0.2	0.2	0.1	46.2	2.8	0.2	0.1	8.8	0.0	1.7	15.0	0.3	0.2	78.9	0.0	0.3	10.9	0.1	25.7	0.2	1.0	0.2	0.3	0.5	0.1	2.6	1.2	0.0	1.9	0.8	0.8	0.9	0.3	1.1	1.7	0.3	11.0	9.0	1.9	0.0	0.2	0.0	5.7	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	4.9	6.0	0.0	0.9	0.5	0.1	0.0	0.0	27.0	0.0	0.6	0.2	0.0	0.2	0.0	1.6	0.1	1.6	1.2	13.8	4.4	1.7	1.7	46.2	10.5	0.2	0.1	0.0	0.5	23.1	2.8	26.7	33.1	21.6	21.7	32.1	16.8	41.7	15.2	21.1	34.8
RGP1	KIAA0258	ENSG00000107185	"RGP1 homolog, RAB6A GEF complex partner 1"	Q92546	9	35749287-35758575	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020414, HPA021085"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA020414: AB_1852289, HPA021085: AB_1852291"	"unprognostic (2.10e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (2.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.81e-3)"	"unprognostic (9.77e-2)"	"prognostic favourable (8.55e-13)"	"unprognostic (2.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.18e-1)"	13.4	18.2	12.0	11.4	16.8	7.1	12.3	13.7	24.8	12.2	17.7	18.3	23.8	14.9	15.3	12.5	14.0	12.3	12.1	17.6	11.6	11.2	16.7	14.2	13.2	9.8	10.7	14.8	15.0	17.6	32.6	18.3	14.1	13.0	12.9	19.1	15.4	18.3	22.5	25.8	13.1	17.2	14.1	10.6	12.8	16.5	13.2	13.7	11.2	17.3	11.9	13.0	13.5	10.6	4.0	2.1	3.4	1.9	3.7	3.7	0.9	11.7	11.0	12.9	10.7	12.1	13.1	7.6	9.3	13.5	12.9	12.1	9.4	4.5	9.1	6.7	11.8	6.7	12.3	17.5	10.7	12.1	7.3	7.8	21.1	7.0	11.4	8.4	11.1	13.1	22.5	13.6	16.6	15.3	5.3	5.1	11.7	5.5	2.6	3.0	5.4	13.0	8.6	9.2	6.4	11.3	8.2	9.5	10.2	8.2	11.6	7.5	9.6	4.0	19.3	10.4	13.2	7.1	7.7	7.6	10.5	9.7	14.8	3.6	13.3	3.4	0.9	1.4	2.6	1.5	3.7	2.8	1.9	3.0	0.6	4.0	2.3	2.4	2.3	3.7	1.9	2.1	1.6	0.9	12.0	16.8	13.7	24.8	11.6	11.2	10.7	14.8	13.0	13.7
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499828-119542708	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.9;lymphoid tissue: 96.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"			1400000	"Nucleoplasm, Plasma membrane"		"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: "	"unprognostic (1.64e-2)"	"prognostic favourable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favourable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	9.6	7.7	11.9	28.2	12.1	23.6	15.4	2.8	12.4	25.8	44.0	17.0	5.3	12.5	15.3	13.1	21.9	10.8	18.8	11.7	12.0	10.5	8.3	3.9	13.5	47.6	17.4	6.7	10.3	3.9	0.8	6.6	16.9	10.5	17.8	18.9	6.4	18.1	8.2	13.2	9.3	23.1	19.1	28.5	18.7	12.8	3.7	11.1	96.9	14.7	11.1	34.3	17.9	20.0	6.9	40.2	20.5	26.3	7.6	77.9	63.0	29.6	5.5	0.4	52.1	7.5	48.1	4.9	13.8	21.0	8.4	13.5	1.7	7.1	12.7	7.4	10.7	6.6	7.7	8.4	22.2	6.2	8.9	34.0	1.6	4.0	12.0	6.9	92.5	18.7	11.2	16.2	15.1	15.9	8.7	10.3	9.6	13.4	40.2	24.0	2.4	15.0	7.8	0.0	4.7	4.3	6.9	2.1	1.7	2.6	34.0	48.7	6.5	12.3	20.9	4.8	4.1	6.8	11.8	0.5	7.9	4.6	1.4	30.2	2.1	20.5	21.5	0.2	15.0	26.3	15.7	6.9	32.5	25.8	40.2	3.6	77.9	58.5	9.9	7.6	21.6	23.9	35.0	63.0	11.9	12.1	2.8	12.4	12.0	10.5	17.4	6.7	10.5	11.1
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: , HPA067421: "	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favourable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	4.7	4.4	20.7	4.1	22.0	2.3	4.4	10.2	37.2	5.4	2.9	10.2	1.5	5.3	6.4	5.6	13.5	7.5	4.4	4.7	13.4	5.6	4.4	6.7	6.5	3.4	12.3	16.3	8.9	3.1	3.1	6.1	4.1	9.4	6.8	2.2	3.1	6.5	5.7	6.8	20.6	4.6	3.0	18.9	4.1	3.2	5.5	9.9	4.3	3.8	3.4	3.6	5.5	7.9	1.0	1.5	1.6	3.9	0.4	1.3	0.7	3.9	5.0	10.1	7.3	3.4	2.7	4.2	4.3	3.4	4.4	3.3	4.0	2.4	0.9	2.7	3.7	3.9	2.0	13.6	1.4	0.1	1.6	0.4	2.8	9.8	3.1	0.3	5.6	2.3	9.3	2.3	3.1	9.7	4.6	0.2	4.0	3.4	0.7	10.6	4.8	4.8	10.0	3.9	3.2	2.3	11.8	11.4	11.8	2.7	1.9	9.0	4.6	6.7	7.3	8.6	5.6	1.7	4.5	5.0	3.9	2.2	5.1	5.9	6.1	1.0	1.2	0.3	0.9	3.9	0.3	0.2	0.8	0.5	1.5	1.0	1.3	0.5	1.6	0.4	3.7	0.8	0.6	0.7	20.7	22.0	10.2	37.2	13.4	5.6	12.3	16.3	9.4	9.9
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	Autophagy	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 95.0;bone marrow: 36.7;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 48.8;NB-4: 38.4;THP-1: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"				"Cell Junctions"	"Nucleoli fibrillar center"	"HPA056384: , HPA069984: "	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	7.0	4.8	6.0	19.0	7.5	36.7	12.7	2.5	5.0	3.3	3.5	6.8	1.9	5.5	2.9	2.9	4.4	4.1	4.5	5.1	5.4	4.9	4.0	7.2	10.4	27.2	9.1	2.6	2.7	3.9	0.8	2.6	5.6	5.7	3.9	1.8	2.2	6.1	2.2	1.6	4.3	10.6	3.2	7.1	43.1	5.7	2.8	7.2	15.2	3.7	1.2	19.5	6.1	3.6	17.3	29.9	95.0	55.5	9.1	13.8	22.0	4.8	7.4	2.1	3.8	0.9	1.6	3.6	3.0	2.1	6.4	2.6	10.9	6.7	8.5	8.5	1.9	4.7	2.1	3.9	1.5	4.1	4.1	12.1	3.8	4.4	1.2	24.7	48.8	1.0	2.4	2.7	0.9	4.1	4.6	4.5	1.9	8.6	18.2	38.4	2.2	9.4	15.3	1.2	6.1	1.8	2.4	4.1	3.8	3.1	1.9	4.0	2.6	32.6	4.3	6.0	3.0	1.0	2.9	2.8	2.2	10.3	3.3	18.9	3.9	33.1	35.5	95.0	13.4	50.4	13.8	17.3	12.7	12.7	29.9	17.1	8.9	9.2	79.6	9.1	55.5	17.1	13.5	22.0	6.0	7.5	2.5	5.0	5.4	4.9	9.1	2.6	5.7	7.2
RGS2	G0S8	ENSG00000116741	"Regulator of G protein signaling 2"	P41220	1	192809039-192812283	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Translation regulation"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 39.1;hTERT-HME1: 27.0;Karpas-707: 25.6;PC-3: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 135.8;neutrophil: 234.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 234.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013385			Supported	Cytosol				Cytosol		"HPA013385: "	"prognostic favourable (2.43e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.49e-2)"	"prognostic unfavourable (2.90e-5)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	22.7	62.0	8.1	39.2	20.1	84.9	23.3	6.0	10.0	20.7	57.5	4.5	50.6	23.2	43.3	34.2	45.5	27.4	35.0	14.2	8.2	13.2	9.4	10.8	24.3	32.6	8.9	6.6	25.1	84.3	1.9	52.6	16.7	16.9	99.8	19.1	44.0	5.0	54.5	4.4	6.4	33.9	135.0	19.0	50.6	22.5	13.0	7.9	3.9	4.2	5.7	6.2	72.1	28.5	0.3	6.2	234.2	26.6	0.1	1.8	12.2	0.0	5.3	7.0	0.6	13.8	2.1	0.4	2.6	3.3	0.8	0.9	4.7	3.2	0.4	0.7	2.4	2.6	4.5	4.7	0.8	0.6	3.3	1.2	3.5	0.1	6.1	3.1	0.7	2.2	39.1	1.8	27.0	6.5	1.1	25.6	2.7	0.0	1.7	4.4	9.3	61.8	1.7	1.6	1.3	4.5	4.3	2.5	13.1	1.8	0.1	2.9	0.2	1.6	1.8	1.3	1.2	1.4	1.3	15.3	0.4	1.3	18.8	0.6	4.7	135.8	26.6	38.0	0.8	10.5	1.8	0.3	0.5	0.5	6.2	0.1	0.3	0.3	234.2	0.1	17.7	0.8	0.3	12.2	8.1	20.1	6.0	10.0	8.2	13.2	8.9	6.6	16.9	7.9
RGS3	"C2PA, FLJ20370, PDZ-RGS3"	ENSG00000138835	"Regulator of G protein signaling 3"	P49796	9	113444731-113597743	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 52.5;HDLM-2: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044234			Supported	"Plasma membrane"				"Plasma membrane"		"HPA044234: "	"prognostic unfavourable (9.93e-4)"	"unprognostic (4.04e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (6.62e-4)"	"unprognostic (6.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.90e-1)"	25.2	17.8	7.6	10.7	18.3	4.7	34.0	4.2	13.8	9.8	13.0	27.9	5.1	9.9	11.4	8.0	11.3	8.4	25.0	52.2	9.7	10.1	31.9	20.1	24.9	12.5	18.4	8.5	7.2	17.5	6.3	8.1	18.9	18.1	14.5	9.6	12.9	5.6	6.6	24.6	7.0	10.8	17.9	16.8	16.2	12.3	14.8	17.1	4.0	13.2	10.7	8.3	18.3	8.1	1.4	3.8	10.6	4.1	22.4	15.0	7.8	0.9	3.5	8.5	7.8	2.6	3.9	0.6	8.6	52.5	7.0	6.0	8.4	3.2	3.6	6.4	6.9	2.2	0.1	3.3	4.1	84.3	0.0	0.3	2.8	5.1	5.4	0.0	1.1	7.1	3.5	19.5	2.8	26.4	0.0	3.6	12.7	3.8	0.2	0.3	2.2	2.9	0.2	4.2	0.5	14.5	1.7	6.7	0.9	0.8	6.7	5.1	4.6	0.7	12.7	23.7	2.5	1.0	16.2	1.8	0.3	0.5	27.3	0.8	10.8	3.4	3.5	2.1	15.0	4.1	10.1	1.4	3.5	12.1	3.8	1.2	1.4	6.6	10.6	22.4	3.1	0.1	2.0	7.8	7.6	18.3	4.2	13.8	9.7	10.1	18.4	8.5	18.1	17.1
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775515-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.5;brain: 38.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.0;HaCaT: 6.8;hTERT-HME1: 8.3;RH-30: 7.3;SH-SY5Y: 6.4;U-2 OS: 7.3;U-251 MG: 7.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol				Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.7	11.5	9.1	0.8	18.3	0.7	0.9	27.6	38.1	0.9	0.8	1.6	1.7	1.0	1.0	0.8	0.9	0.7	1.3	0.7	11.5	8.3	4.2	0.8	0.9	1.1	3.6	8.9	1.3	1.4	0.7	2.8	0.7	4.7	0.8	0.9	1.3	0.7	1.4	0.7	0.9	0.9	0.7	1.4	1.0	4.6	7.8	1.8	0.0	0.7	0.0	1.0	0.7	0.1	0.7	3.6	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.9	0.0	2.7	5.2	7.0	0.5	0.0	0.0	0.0	0.4	3.6	6.8	0.0	0.1	3.5	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.3	0.5	0.0	0.0	2.2	0.0	0.0	0.0	3.8	0.2	0.0	7.3	0.0	0.0	0.0	5.9	6.4	0.4	0.3	0.3	0.0	0.0	2.8	0.0	7.3	0.4	7.9	0.0	4.2	0.0	1.1	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	9.1	18.3	27.6	20.7	11.5	8.3	3.6	8.9	4.7	1.8
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: "	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	12.7	14.8	10.8	16.7	16.0	11.0	13.6	8.3	13.0	13.8	14.3	21.2	9.4	11.0	20.6	16.3	13.6	15.4	12.4	14.5	11.4	9.0	13.6	16.9	12.6	17.7	17.6	11.0	18.8	20.4	18.6	17.1	10.5	13.0	15.7	12.4	13.1	14.3	15.5	13.9	13.0	17.5	15.6	16.5	17.3	13.2	25.6	14.7	56.6	17.3	8.8	18.9	18.7	15.4	19.9	16.6	9.8	15.5	8.8	12.5	8.5	5.1	4.4	4.7	7.2	14.3	14.2	0.0	12.2	9.8	6.0	6.9	3.8	8.9	4.8	10.2	12.3	6.0	0.0	12.7	11.6	12.3	4.9	7.0	2.9	3.4	15.4	7.5	4.1	13.3	18.6	11.5	25.1	4.6	18.9	12.6	6.3	9.8	12.7	3.8	0.0	4.7	5.5	0.0	7.0	4.9	6.2	4.6	3.5	6.7	2.4	9.0	6.8	8.6	6.1	2.8	6.2	10.5	3.5	14.1	6.6	34.7	8.9	9.1	8.0	8.1	11.1	9.8	6.1	15.5	9.7	17.3	9.6	7.5	13.7	19.9	10.8	8.9	2.5	8.8	10.3	16.6	12.5	8.5	10.8	16.0	8.3	13.0	11.4	9.0	17.6	11.0	13.0	14.7
RHBDD2	"NPD007, RHBDL7"	ENSG00000005486	"Rhomboid domain containing 2"	Q6NTF9	7	75842602-75888926	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045074, HPA051960"	Uncertain		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA045074: AB_10965705, HPA051960: AB_2681673"	"unprognostic (2.75e-1)"	"unprognostic (3.89e-2)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (9.79e-2)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-2)"	"prognostic favourable (8.68e-6)"	"unprognostic (3.73e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.03e-1)"	12.3	50.9	44.3	9.2	64.6	12.1	12.1	14.4	68.3	17.9	11.9	18.5	43.8	18.2	8.5	31.8	14.2	22.6	12.5	14.1	48.5	69.1	18.5	21.7	22.1	8.9	33.6	29.9	12.3	23.6	81.3	56.5	10.6	37.1	15.8	9.1	23.0	22.8	57.3	6.0	14.4	12.5	7.0	16.2	9.5	15.3	15.5	10.7	9.5	34.3	4.2	7.6	10.0	9.6	11.1	13.5	76.4	14.0	13.2	27.4	12.2	7.4	24.6	11.1	22.4	6.5	4.2	4.6	4.5	17.8	10.3	8.7	13.3	20.6	2.8	4.0	8.5	12.2	7.3	5.3	3.2	8.5	14.4	2.5	15.5	12.7	17.9	4.2	23.2	9.2	13.1	11.6	5.2	6.6	5.7	18.3	8.7	49.6	8.0	23.7	10.8	14.1	5.9	7.7	21.4	16.9	13.4	14.7	29.3	16.8	35.7	17.1	23.3	8.0	6.2	16.2	13.5	10.6	9.3	15.2	5.3	4.4	16.1	6.7	19.7	76.4	14.0	17.6	18.9	13.9	16.6	11.1	21.3	16.7	13.5	10.8	18.0	15.3	24.0	13.2	7.9	11.1	27.4	12.2	44.3	64.6	14.4	68.3	48.5	69.1	33.6	29.9	37.1	10.7
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206052723-206102459	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 117.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 185.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 42.8;ovarian cancer: 41.1"					"Cell type enriched"	"Detected in some"	51	"basophil: 117.7"	"Lineage enriched"	"Detected in many"	51	"granulocytes: 117.7"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"				"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.3	0.0	0.0	3.9	0.0	0.0	1.8	0.0	0.0	13.1	3.1	0.0	12.1	0.9	6.2	8.2	3.4	1.6	16.2	0.4	0.0		6.8	1.8	5.2	4.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	9.4	3.3	2.9	0.0	16.9	1.5	0.2	4.0	7.0	0.0	0.4	2.4	1.1	0.0	0.6	0.0	1.7	2.5	4.3	10.0	0.3	2.2	117.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.1	0.0	8.4	185.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	37.2	0.0	0.0	0.0	0.0	0.2	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	117.7	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2										
RHOA	"ARH12, ARHA, Rho12, RhoA, RHOH12"	ENSG00000067560	"Ras homolog family member A"	P61586	3	49359145-49412998	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Host-virus interaction"	Hydrolase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005052	Approved		Supported	"Plasma membrane,Cytosol"			65000000	"Plasma membrane, Cytosol"		"CAB005052: AB_562216"	"unprognostic (1.50e-1)"	"unprognostic (3.38e-1)"	"prognostic favourable (3.08e-4)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.15e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.44e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (3.21e-6)"	"unprognostic (5.14e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.52e-2)"	141.1	89.5	63.0	79.8	60.6	91.4	93.1	34.3	77.3	80.3	79.1	100.4	48.9	63.6	84.4	66.4	116.7	67.8	74.2	72.5	57.6	54.8	104.0	80.7	104.6	102.4	74.0	43.8	102.7	64.9	45.8	48.2	105.3	68.8	76.0	80.3	81.6	66.5	72.0	86.0	73.9	90.8	88.9	97.3	116.0	73.4	57.3	60.3	127.1	108.1	80.1	99.8	103.4	75.7	42.6	78.4	124.2	125.7	38.3	50.5	151.5	54.9	42.4	53.2	57.0	61.1	92.6	41.6	119.6	76.7	83.6	77.2	35.9	57.6	80.6	34.4	143.6	31.3	58.4	65.2	85.9	62.1	34.8	77.0	57.0	42.1	65.5	75.8	57.7	72.3	46.4	68.4	55.1	107.0	41.0	50.7	99.1	26.2	82.6	74.0	50.8	54.0	38.2	53.5	63.4	72.3	62.8	19.5	44.4	71.8	52.0	53.8	33.7	85.5	115.5	67.1	60.8	88.6	86.0	50.4	102.2	92.6	65.5	74.7	76.7	52.5	99.7	106.8	49.1	125.7	41.6	42.6	41.4	47.6	78.4	37.5	32.2	40.1	124.2	38.3	120.4	58.7	50.5	151.5	63.0	60.6	34.3	77.3	57.6	54.8	74.0	43.8	68.8	60.3
RHOT2	"ARHT2, C16orf39, MIRO-2"	ENSG00000140983	"Ras homolog family member T2"	Q8IXI1	16	668086-674174	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA012624, HPA012895"	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA012624: AB_1856272, HPA012895: AB_1856271"	"unprognostic (1.59e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (5.01e-4)"	"unprognostic (4.68e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.55e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.25e-1)"	"prognostic favourable (5.43e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-2)"	15.2	22.8	19.9	26.4	22.3	25.8	16.4	33.3	22.6	14.6	27.2	14.7	19.5	29.5	16.4	27.6	17.3	17.3	28.5	26.5	18.4	11.5	21.8	23.0	15.7	23.4	20.1	20.5	17.3	25.1	18.1	25.3	17.7	19.9	23.3	8.9	30.5	31.7	20.2	21.9	25.3	25.1	13.8	10.4	27.0	24.5	15.8	15.3	20.2	22.1	14.6	20.8	16.6	16.3	11.0	16.4	16.9	18.6	8.7	20.1	13.2	9.4	18.1	10.6	16.3	5.3	5.5	18.8	15.8	7.4	13.5	10.3	25.2	14.5	10.5	11.3	6.4	17.7	7.5	15.0	3.4	15.0	31.0	12.6	22.4	18.0	9.8	11.5	17.2	8.9	12.9	10.0	5.8	9.5	22.8	8.9	7.1	38.5	12.1	12.8	26.0	12.5	28.2	11.8	22.0	8.6	17.9	22.9	27.1	14.8	19.6	8.6	20.2	18.1	15.3	10.5	16.9	8.9	11.3	23.8	15.0	14.7	6.9	11.0	14.9	4.5	16.1	16.9	20.1	18.6	12.2	10.1	16.0	15.9	15.9	11.0	12.2	10.3	13.8	8.7	14.3	16.4	18.0	13.2	19.9	22.3	33.3	22.6	18.4	11.5	20.1	20.5	19.9	15.3
RIC8A	"synembryn, synembryn-A"	ENSG00000177963	"RIC8 guanine nucleotide exchange factor A"	Q9NPQ8	11	207511-215113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041491, CAB046012"	Approved		Supported	Cytosol				Cytosol		"CAB046012: AB_11129402, HPA041491: "	"unprognostic (3.93e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (8.60e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (1.11e-6)"	"unprognostic (2.13e-3)"	"unprognostic (8.70e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.63e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.60e-1)"	30.9	30.2	31.4	27.1	35.4	28.8	27.5	27.8	51.7	29.3	31.4	25.9	32.5	24.1	35.8	36.6	36.5	35.4	33.2	31.9	27.0	25.5	33.9	39.5	28.4	28.7	23.8	30.0	35.1	38.0	34.9	30.2	43.7	27.4	29.8	26.1	33.2	29.4	36.1	22.5	32.2	35.1	41.3	21.2	32.5	28.4	40.3	18.6	43.9	33.2	24.9	33.3	33.3	27.3	31.3	20.7	40.2	26.6	31.9	40.1	37.2	50.7	24.8	20.2	20.0	27.7	22.9	14.0	36.7	29.7	50.4	35.0	21.3	36.1	20.3	15.4	55.6	27.6	22.9	38.9	28.2	24.4	22.9	11.4	17.5	19.7	22.4	19.0	38.3	25.0	34.5	31.2	28.3	24.7	19.5	19.8	38.6	20.5	22.7	15.2	18.4	30.8	21.4	19.9	13.8	29.2	13.4	21.0	18.9	28.5	32.2	19.6	22.8	15.4	27.6	33.4	29.4	12.2	34.1	22.0	32.5	19.5	32.9	17.3	24.9	27.5	19.7	40.2	40.1	23.0	39.3	31.3	35.9	34.6	20.7	27.2	31.1	31.4	28.8	31.9	26.6	17.0	29.8	37.2	31.4	35.4	27.8	51.7	27.0	25.5	23.8	30.0	27.4	18.6
RILPL2	"FLJ30380, FLJ32372, MGC7036"	ENSG00000150977	"Rab interacting lysosomal protein like 2"	Q969X0	12	123410683-123436717	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 34.9;THP-1: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028958	Uncertain		Supported	Cytosol				Cytosol		"HPA028958: AB_10602124"	"unprognostic (1.94e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favourable (5.24e-7)"	"unprognostic (2.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.74e-2)"	14.8	5.6	5.8	13.2	7.1	42.9	13.6	3.8	5.7	25.1	7.7	5.3	12.8	4.1	17.8	10.6	10.2	14.2	13.4	7.4	6.3	5.1	12.8	7.8	21.6	15.3	6.3	4.7	12.2	5.0	6.0	7.0	7.7	7.2	18.2	3.8	8.2	21.4	15.6	4.4	6.5	9.8	9.6	7.6	29.9	7.6	7.8	5.8	8.6	25.7	7.4	14.3	14.0	22.0	8.5	13.6	26.2	19.0	3.1	9.0	7.8	2.5	2.4	1.2	4.5	5.1	4.1	2.8	3.0	6.3	2.4	2.0	2.7	1.4	1.6	2.5	4.2	2.0	1.8	2.0	2.4	5.0	2.0	16.2	2.5	3.8	5.3	12.3	9.5	3.3	1.6	2.5	1.9	2.4	2.2	1.9	2.1	1.7	4.4	34.9	1.1	2.5	3.6	2.6	2.8	2.5	4.2	0.6	1.6	3.5	0.8	2.7	3.5	22.3	3.0	2.5	2.8	4.2	1.8	2.2	1.7	3.1	2.5	8.7	1.1	12.5	19.0	21.5	3.8	14.4	3.5	8.5	7.8	6.5	13.6	5.7	3.4	3.7	26.2	3.1	15.7	6.9	9.0	7.8	5.8	7.1	3.8	5.7	6.3	5.1	6.3	4.7	7.2	5.8
RIOX1	"C14orf169, FLJ21802, JMJD9, MAPJD, NO66"	ENSG00000170468	"Ribosomal oxygenase 1"	Q9H6W3	14	73490964-73493392	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003730			Supported	Nucleoli				Nucleoli		"HPA003730: "	"unprognostic (4.70e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.35e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-3)"	"unprognostic (8.62e-2)"	3.9	2.4	4.3	5.2	5.6	8.0	4.0	7.6	8.0	5.3	4.1	6.7	3.6	4.1	4.5	5.7	3.9	4.7	3.3	5.3	3.4		4.1	5.1	4.1	8.4	5.8	4.9	4.5	6.1	5.2	3.2	2.8	4.6	4.0	4.1	4.7	5.0	5.0	2.8	4.0	3.4	4.8	2.1	5.0	3.9	10.5	5.2	17.3	4.5	3.6	7.5	3.7	4.4	3.5	5.2	5.1	3.8	4.9	7.4	1.3	10.3	9.4	6.1	9.4	7.9	4.5	11.7	7.1	5.2	7.3	6.6	8.1	5.3	17.7	5.2	6.1	12.3	11.6	7.0	6.1	11.2	12.8	11.1	5.6	5.3	4.4	0.0	14.9	4.8	6.5	7.0	3.2	6.6	8.0	6.6	6.5	16.3	19.3	12.6	6.7	15.9	15.4	9.5	5.3	7.2	7.8	12.7	9.2	11.8	21.2	7.5	21.1	11.1	9.4	0.0	12.2	6.3	0.0	9.1	9.7	6.2	3.2	9.2	7.2	0.2	2.2	5.1	6.4	3.8	7.4	3.5	6.5	5.1	3.0	2.7	6.0	4.4	0.9	4.9	2.3	5.2	2.8	1.3										
RIOX2	"FLJ14393, JMJD10, mdig, MINA, MINA53, NO52"	ENSG00000170854	"Ribosomal oxygenase 2"	Q8IUF8	3	97941818-97972457	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007603, HPA008080, CAB013458"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960"	"prognostic unfavourable (4.41e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.68e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.76e-1)"	13.9	9.6	12.7	13.6	16.7	2.2	14.1	8.1	11.1	9.8	11.0	12.2	14.5	8.1	10.7	11.3	20.4	11.3	12.1	8.2	10.9	12.6	13.1	14.2	9.1	13.1	13.9	11.9	14.2	22.5	13.8	15.0	27.1	14.1	11.2	13.9	10.2	20.3	11.3	27.1	14.9	8.3	11.2	14.7	12.1	10.5	6.6	11.2	6.3	48.4	12.8	15.6	14.7	12.5	13.1	21.8	1.6	11.1	8.2	13.6	9.1	20.2	12.2	4.3	9.4	10.3	15.7	11.5	9.9	7.6	11.7	9.6	8.2	10.7	27.1	11.4	11.2	11.8	13.8	14.1	18.4	51.3	6.4	8.5	5.3	9.8	16.6	17.4	4.0	12.0	19.1	8.9	21.9	11.8	11.8	12.1	11.8	5.9	13.8	5.7	9.4	16.2	0.0	14.7	27.0	11.8	11.9	23.3	8.4	10.6	14.6	16.5	13.0	7.3	9.5	11.7	12.9	6.3	20.4	17.9	9.2	27.2	13.7	17.4	12.5	1.6	10.9	0.6	8.7	9.4	13.3	13.1	13.6	10.6	13.4	10.3	13.2	10.8	0.7	8.2	11.1	21.8	12.0	9.1	12.7	16.7	8.1	11.1	10.9	12.6	13.9	11.9	14.1	11.2
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063991-3115187	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favourable (6.71e-4)"	24.5	12.0	6.9	15.7	12.4	10.5	28.0	11.9	11.0	16.4	18.9	9.6	22.9	14.5	16.8	17.7	17.1	13.5	17.9	12.3	7.5	6.8	18.5	36.7	16.7	19.8	11.8	6.6	13.2	19.9	14.4	17.9	24.4	10.2	17.8	16.6	10.9	21.1	18.7	11.4	18.9	24.8	21.3	6.9	19.4	15.8	9.0	9.4	18.6	18.5	15.2	19.2	15.0	20.4	4.1	3.2	6.6	3.9	6.6	7.6	2.1	9.5	6.9	10.4	10.7	22.2	14.2	5.7	15.1	20.5	16.0	18.4	9.3	6.6	9.0	14.6	21.6	11.0	12.9	12.4	17.5	18.6	7.0	11.5	4.5	6.7	12.5	10.0	14.8	19.2	11.1	14.8	10.7	13.8	13.0	5.2	15.4	12.4	6.9	10.9	6.5	8.6	8.4	7.7	10.1	14.3	19.2	9.0	8.8	9.9	6.3	16.7	11.4	7.1	16.7	17.5	9.4	6.6	11.1	8.0	10.3	9.6	7.3	5.5	19.4	1.1	3.0	6.4	6.1	3.7	4.9	2.0	4.9	7.6	3.2	4.1	4.1	5.4	6.6	6.6	3.9	2.9	5.7	2.1	6.9	12.4	11.9	11.0	7.5	6.8	11.8	6.6	10.2	9.4
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757747-89791063	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol				Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavourable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favourable (8.05e-4)"	12.0	5.5	9.3	11.2	7.9	13.6	10.0	3.0	9.3	9.7	7.9	10.6	5.2	3.5	10.9	7.8	8.3	7.0	17.3	11.6	9.2	8.6	7.7	10.4	18.7	10.9	11.8	5.8	8.9	13.2	14.7	7.3	20.8	9.1	10.7	5.6	4.6	10.2	5.8	3.1	10.4	6.9	10.4	16.5	14.2	8.3	5.6	11.5	5.1	8.5	4.9	11.8	15.0	7.6	7.5	6.9	19.4	11.2	3.8	5.5	4.3	10.1	3.5	1.8	2.6	4.4	6.1	3.3	11.3	19.3	6.0	7.8	3.1	5.3	7.9	17.6	6.3	2.4	4.8	3.7	11.1	5.6	4.9	6.6	1.7	3.1	12.4	2.4	3.2	4.9	3.0	8.5	27.7	6.3	3.2	2.6	5.5	2.1	0.0	5.0	1.0	8.4	1.7	2.5	3.8	14.0	4.6	0.3	2.0	2.7	7.1	5.3	6.8	3.0	5.6	3.7	3.5	6.2	5.2	5.2	2.3	4.7	9.0	0.2	2.4	8.8	5.7	19.4	3.6	10.6	4.1	7.5	5.5	4.7	6.9	4.3	5.2	5.5	4.5	3.8	11.2	2.3	1.2	4.3	9.3	7.9	3.0	7.4	9.2	8.6	11.8	5.8	9.1	11.5
RITA1	"C12orf52, FLJ14827, RITA"	ENSG00000139405	"RBPJ interacting and tubulin associated 1"	Q96K30	12	113185526-113192368	"Predicted intracellular proteins"	"Neurogenesis, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039094, HPA039095, HPA061531"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA039094: AB_10671037, HPA039095: , HPA061531: "	"unprognostic (7.10e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (9.79e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	6.7	20.7	14.4	7.9	17.6	7.4	7.7	16.6	29.7	8.4	10.7	7.8	3.4	14.7	7.2	8.2	11.3	16.4	8.3	12.3	13.4	12.9	14.1	24.1	7.5	11.5	11.8	15.0	10.5	9.6	7.3	10.6	5.9	13.2	9.2	7.1	10.5	14.8	10.5	31.4	9.3	15.3	5.6	5.7	8.7	8.0	6.6	7.3	13.0	12.3	12.0	11.1	7.6	6.4	7.8	14.2	24.6	8.9	12.8	10.2	8.0	12.2	16.0	4.1	10.9	5.5	4.2	7.5	8.0	16.5	11.9	9.5	18.8	6.1	23.5	12.6	6.7	9.4	9.4	10.4	7.0	14.2	13.6	8.0	7.9	11.9	9.2	10.6	6.7	6.6	9.5	11.7	6.6	9.7	15.4	4.4	7.0	17.5	11.8	28.9	13.9	20.2	10.6	4.4	19.8	9.6	17.5	13.9	8.0	10.2	21.4	17.2	17.9	16.2	6.3	7.5	10.7	8.7	11.3	15.3	12.8	25.3	11.3	8.9	10.6	24.6	8.9	5.7	10.1	4.2	10.2	7.3	9.0	9.1	10.2	7.8	9.0	9.7	0.2	12.8	4.9	14.2	9.5	8.0	14.4	17.6	16.6	29.7	13.4	12.9	11.8	15.0	13.2	7.3
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221751	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"retina: 164.1"	"Cell line enriched"	"Detected in single"	48	"SK-MEL-30: 21.4"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Group enriched"	"Detected in many"	4	"amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7"	"Group enriched"	"Detected in some"	7	"basophil: 3.3;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: , HPA044083: "	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1.0	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.0	3.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	6.9	10.6	0.6	7.0	3.7	1.3	1.6	0.6	0.4	0.1
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74585217-74614617	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (1.20e-1)"	11.8	14.3	17.5	10.6	25.6	37.4	12.4	12.6	20.5	12.2	7.4	8.3	5.6	6.4	10.6	8.0	10.2	9.5	10.7	10.5	17.1	16.6	11.6	9.7	13.8	9.2	12.4	13.7	12.4	9.7	19.5	18.5	10.5	28.6	11.9	7.6	5.2	8.9	8.7	11.2	10.2	7.1	10.1	13.9	9.8	8.4	6.9	12.4	9.7	13.0	6.2	10.1	10.5	9.3	3.5	4.8	16.3	7.4	5.2	4.6	3.0	13.5	13.8	13.4	11.2	13.5	14.3	13.2	13.1	15.2	11.7	14.5	10.7	14.2	7.3	15.3	16.4	11.8	26.9	15.7	18.0	6.6	14.2	12.8	24.3	6.5	12.0	19.3	22.9	13.8	9.9	16.7	28.7	13.6	11.1	13.3	15.4	10.3	14.3	10.9	20.6	13.3	13.7	28.4	12.3	10.9	16.2	9.9	11.5	24.5	11.9	15.2	6.7	15.2	18.0	14.2	13.8	14.5	11.4	7.1	13.6	11.7	15.5	19.6	13.8	16.3	5.9	5.6	3.2	7.4	3.3	3.0	4.1	4.0	4.8	3.5	4.5	4.1	11.4	5.2	5.4	2.6	4.6	3.0	17.5	25.6	12.6	20.5	17.1	16.6	12.4	13.7	28.6	12.4
RMDN1	"CGI-90, FAM82B, FLJ20665, RMD1"	ENSG00000176623	"Regulator of microtubule dynamics 1"	Q96DB5	8	86468257-86514357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026495	Approved		Supported	"Actin filaments,Centrosome"				Centrosome	"Actin filaments"	"HPA026495: AB_1848414"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.60e-1)"	"prognostic favourable (8.51e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.71e-3)"	"unprognostic (3.47e-1)"	20.4	20.1	19.0	19.5	18.4	12.2	16.9	10.8	13.3	13.8	22.5	13.9	7.7	16.3	11.6	13.3	21.1	12.4	14.2	44.3	17.6	16.7	35.0	32.5	21.0	23.6	22.2	10.7	11.6	13.0	14.5	15.6	12.7	19.1	12.6	17.2	13.6	12.2	18.9	45.2	18.5	29.0	17.7	23.1	19.2	16.9	14.4	15.3	25.6	29.3	27.1	18.0	14.3	11.2	17.8	22.1	38.6	27.9	15.5	18.0	12.6	21.3	9.3	10.9	6.2	21.5	35.3	13.3	15.7	14.2	12.5	12.3	11.0	13.7	25.6	13.4	13.0	20.9	13.9	15.7	15.0	21.7	10.9	13.4	11.0	27.5	11.5	6.0	0.3	19.1	14.9	16.7	25.9	28.1	14.1	14.1	19.8	19.3	21.3	2.8	5.5	23.4	12.2	15.3	26.3	14.8	13.5	5.1	11.5	13.0	51.9	22.1	29.2	11.3	15.2	14.0	22.7	17.7	9.4	18.3	15.1	19.9	18.3	9.7	18.9	5.6	17.1	38.6	12.3	21.6	14.3	17.8	12.8	14.4	19.5	12.3	10.6	13.7	6.8	15.5	27.9	22.1	18.0	12.6	19.0	18.4	10.8	12.5	17.6	16.7	22.2	10.7	19.1	15.3
RMDN2	"FAM82A, FAM82A1, FLJ32954, RMD2"	ENSG00000115841	"Regulator of microtubule dynamics 2"	Q96LZ7	2	37923187-38067142	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 38.4"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA034705, HPA034706"	Enhanced		Supported	"Golgi apparatus,Mitotic spindle,Cytosol"				"Mitotic spindle, Cytosol"	"Golgi apparatus"	"HPA034705: , HPA034706: AB_10696362"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.06e-2)"	"prognostic favourable (2.63e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.34e-1)"	4.6	38.4	6.1	8.7	6.8	1.9	8.9	6.2	8.2	6.3	9.7	1.8	5.9	6.8	7.0	9.2	3.7	4.3	5.5	4.6	5.9	3.5	6.6	24.0	8.2	3.3	3.2	5.1	3.2	4.2	3.2	8.6	3.1	4.6	8.1	8.7	5.2	5.7	10.2	5.0	2.9	14.7	7.7	4.8	14.1	4.6	15.6	4.0	2.1	4.7	3.6	2.1	4.3	9.0	7.5	6.0	4.8	8.0	6.3	6.1	2.3	3.3	3.9	2.6	1.7	11.9	12.2	1.5	7.1	9.2	3.6	3.7	1.0	11.2	2.3	3.1	10.6	3.9	0.9	4.8	4.5	4.6	2.6	4.0	1.5	3.4	6.2	0.0	4.1	17.4	3.8	4.9	0.7	2.0	4.7	2.0	6.4	1.3	0.7	4.0	5.1	3.9	0.0	0.6	0.4	9.3	3.0	2.0	7.8	5.6	0.6	6.3	1.2	5.4	2.8	5.0	5.3	2.6	2.8	3.9	6.7	4.7	5.9	0.9	5.0	0.0	4.9	1.0	4.0	8.0	6.1	7.5	1.9	2.5	3.3	5.0	2.0	4.3	4.8	6.3	6.1	6.0	0.2	2.3	6.1	6.8	6.2	8.2	5.9	3.5	3.2	5.1	4.6	4.0
RMDN3	"FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3"	ENSG00000137824	"Regulator of microtubule dynamics 3"	Q96TC7	15	40735884-40755851	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009975, HPA074840"	Supported		Enhanced	"Cytokinetic bridge,Mitochondria"				Mitochondria	"Cytokinetic bridge"	"HPA009975: AB_1078811, HPA074840: "	"unprognostic (2.54e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.94e-3)"	"prognostic favourable (6.70e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.04e-3)"	22.9	17.3	29.0	12.4	26.4	16.0	15.5	22.6	29.6	15.2	14.6	20.7	9.3	34.4	10.2	10.5	14.9	15.4	14.7	12.1	27.2	21.1	14.7	28.4	27.8	11.1	26.0	29.3	12.0	21.6	17.6	7.3	15.3	18.4	14.1	6.7	10.6	25.3	13.4	12.7	12.9	39.6	9.6	29.4	9.8	14.4	12.2	22.9	7.8	16.1	11.6	8.5	13.6	10.4	7.6	25.5	2.5	9.7	28.1	14.4	10.6	8.4	7.7	9.3	16.0	7.7	7.3	16.3	22.1	8.6	15.7	11.5	27.7	9.5	7.2	29.4	11.4	29.2	10.3	16.4	0.6	19.0	14.7	23.2	22.7	13.6	29.0	15.5	18.5	14.1	14.8	11.1	9.2	10.5	24.2	20.0	5.9	17.1	11.6	10.0	7.4	15.4	18.3	11.2	16.8	11.5	14.3	22.5	8.2	17.5	23.7	8.2	18.6	16.9	16.4	17.1	12.2	22.8	18.4	15.3	17.8	11.5	12.2	16.6	18.6	1.9	6.2	2.5	14.4	8.2	12.6	7.6	10.5	13.0	6.8	6.7	8.2	8.9	1.0	28.1	9.7	25.5	9.1	10.6	29.0	26.4	22.6	26.9	27.2	21.1	26.0	29.3	18.4	22.9
RMI1	"BLAP75, C9orf76, FLJ12888"	ENSG00000178966	"RecQ mediated genome instability 1"	Q9H9A7	9	83980711-84004074	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 35.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021661			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA021661: "	"unprognostic (9.59e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.24e-2)"	9.3	9.9	6.2	16.6	7.5	3.9	5.1	13.1	6.1	5.7	7.6	2.9	5.9	7.6	4.1	6.3	7.7	7.5	3.5	3.8	5.3	8.5	5.5	6.3	7.0	13.2	7.4	3.5	5.4	10.0	9.1	7.5	11.0	9.6	6.6	9.1	3.9	7.7	6.3	6.4	5.4	10.5	4.0	8.1	21.0	7.1	11.7	4.8	35.7	7.3	6.3	11.4	5.6	4.5	4.3	9.8	14.4	8.1	5.1	3.9	3.7	13.8	9.5	20.1	7.0	3.1	4.9	18.9	13.9	7.9	12.7	11.7	4.6	9.4	29.3	5.0	6.8	20.2	13.4	6.7	14.8	16.8	3.4	12.3	7.7	5.8	4.5	22.7	12.7	4.3	4.3	10.1	7.5	6.0	9.2	15.1	13.2	9.8	28.3	7.9	17.2	9.1	26.2	19.7	10.9	5.8	5.9	17.2	10.6	13.0	9.9	5.4	10.6	10.1	4.2	13.2	8.6	13.0	11.0	6.6	13.8	11.2	8.4	9.9	14.2	14.4	6.1	11.2	2.8	7.3	3.3	4.3	3.3	2.9	9.8	4.0	3.2	3.7	10.6	5.1	8.1	2.8	3.9	3.7	6.2	7.5	13.1	6.1	5.3	8.5	7.4	3.5	9.6	4.8
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11351762	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.7;testis: 29.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;T-cells: 3.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favourable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.0	1.8	4.2	18.0	5.1	4.8	2.8	0.7	4.1	2.8	7.3	1.0	0.4	4.3	2.5	3.2	11.8	1.0	2.6	1.9	2.5	1.5	3.1	2.3	2.9	17.9	1.6	5.6	3.6	1.6	0.7	1.1	13.2	1.2	2.6	9.0	0.8	2.9	1.7	1.1	8.7	5.6	1.1	1.4	4.2	4.0	29.6	1.2	31.7	1.4	2.8	20.4	3.6	4.5	6.5	0.6	0.9	0.0	0.3	3.0	0.3	19.0	12.8	25.1	10.7	1.1	5.5	10.5	11.1	8.8	10.5	17.6	4.9	22.7	26.5	9.6	5.2	11.2	10.7	10.6	17.1	5.2	10.0	14.5	7.6	32.4	0.4	5.6	6.5	1.2	2.0	4.5	4.4	5.7	20.0	21.1	5.5	22.0	19.2	26.0	21.1	5.1	23.3	27.1	28.3	6.2	12.4	14.5	11.5	9.4	15.8	8.2	26.7	8.4	1.8	8.5	7.9	16.2	1.6	5.8	9.5	31.4	7.9	18.4	15.5	0.0	0.0	0.9	0.6	0.0	0.0	6.5	0.2	0.0	0.4	2.5	1.8	0.7	0.2	0.3	0.0	0.6	3.0	0.3	4.2	5.1	0.7	4.1	2.5	1.5	1.6	5.6	1.2	1.2
RMND1	"bA351K16.3, C6orf96, FLJ20627, RMD1"	ENSG00000155906	"Required for meiotic nuclear division 1 homolog"	Q9NWS8	6	151404762-151452181	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031397, HPA031398, HPA031399"	Approved		Supported	Mitochondria				Mitochondria		"HPA031397: , HPA031398: , HPA031399: AB_10601156"	"unprognostic (1.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.04e-1)"	12.9	15.7	9.0	6.8	12.1	4.0	17.0	14.5	15.6	10.5	12.8	7.7	6.4	13.2	10.9	11.7	8.3	12.2	8.0	11.4	9.9	11.7	34.0	29.1	7.8	8.2	10.1	13.5	15.7	9.9	6.9	11.2	14.4	14.0	8.0	11.5	10.5	7.3	8.0	10.9	7.9	14.9	11.2	8.9	6.9	8.0	8.6	7.0	11.2	18.9	6.0	9.5	10.6	11.9	11.3	7.2	6.8	12.2	13.2	11.3	5.0	8.0	3.7	8.3	17.2	11.2	25.5	11.3	12.7	12.3	9.8	13.6	10.6	6.1	7.7	9.1	8.1	7.0	15.2	7.9	17.1	8.8	12.1	12.1	5.9	21.7	22.9	27.1	3.9	17.8	10.2	14.0	21.4	12.7	13.2	6.2	14.9	26.3	9.2	8.7	6.1	7.4	10.5	10.2	9.5	13.9	3.6	13.9	13.4	9.0	11.4	15.1	19.1	17.5	7.2	7.7	10.1	16.0	9.9	6.4	8.4	8.8	19.3	21.2	8.9	2.1	5.9	6.8	7.1	8.2	11.2	11.3	8.5	9.9	7.2	9.0	11.2	10.2	2.9	13.2	12.2	3.3	11.3	5.0	9.0	12.1	14.5	15.6	9.9	11.7	10.1	13.5	14.0	7.0
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806556-12815201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favourable (1.18e-4)"	"prognostic favourable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favourable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavourable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	6.5	5.5	6.4	11.4	10.6	21.9	6.6	11.0	7.5	6.8	6.6	9.2	1.6	8.6	6.8	4.4	14.1	6.0	5.7	5.1	6.7	4.8	8.7	5.9	5.5	9.2	10.6	5.8	7.3	7.0	6.2	4.1	11.8	6.1	5.3	5.7	5.5	8.8	4.3	7.1	13.4	7.1	4.4	7.8	12.0	7.4	14.1	8.4	44.8	8.6	13.4	17.4	6.0	8.0	11.3	7.8	7.1	6.8	12.9	8.6	5.0	14.8	11.2	6.8	6.8	1.0	1.9	8.4	6.9	2.9	10.4	12.1	8.8	5.7	15.9	10.5	1.6	8.9	5.5	6.8	5.7	8.6	15.0	7.6	11.9	6.8	0.7	7.0	7.1	1.0	1.7	8.8	3.2	4.0	10.5	4.7	4.9	25.5	12.8	6.9	6.7	19.6	13.8	9.8	11.4	2.6	5.9	14.1	8.2	7.5	2.7	3.1	7.4	4.3	3.8	12.4	6.2	17.6	11.4	11.5	12.7	12.6	7.3	11.2	10.0	7.1	6.8	6.4	8.6	6.6	7.0	9.8	7.0	6.1	4.2	11.3	6.6	6.5	6.8	12.9	5.9	7.8	5.5	5.0	6.4	10.6	11.0	7.5	6.7	4.8	10.6	5.8	6.1	8.4
RNASEH2B	"AGS2, DLEU8, FLJ11712"	ENSG00000136104	"Ribonuclease H2 subunit B"	Q5TBB1	13	50909678-51024120	"Disease related genes, Predicted intracellular proteins"			"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 120.1"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 68.7;NB-4: 51.0;REH: 57.5;THP-1: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040084, HPA041469"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA040084: AB_10697714, HPA041469: AB_2677496"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.50e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavourable (2.54e-8)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	11.9	10.5	11.3	20.2	14.1	28.3	10.9	11.3	10.9	14.0	15.2	9.4	12.9	8.9	20.0	12.6	11.6	15.8	11.6	14.7	10.0	8.8	9.1	7.9	14.3	25.7	11.8	9.9	14.0	18.0	6.3	12.0	10.6	8.5	15.4	12.4	9.6	12.7	12.9	15.8	8.5	13.9	15.5	10.0	18.5	11.5	16.4	11.3	120.1	15.8	11.0	20.4	15.1	12.2	34.2	31.3	5.5	13.9	12.0	34.5	16.9	8.0	6.6	3.6	7.3	4.8	9.5	8.6	5.8	6.6	8.3	7.0	8.6	12.5	22.9	3.7	5.9	7.7	11.3	5.3	10.0	8.4	9.3	20.5	4.7	5.1	6.6	37.5	13.6	3.8	6.8	7.3	6.5	7.4	11.3	10.9	11.3	3.8	68.7	51.0	11.7	5.2	57.5	10.7	15.4	6.4	4.7	8.0	11.8	6.9	2.5	7.4	3.9	51.2	5.2	7.5	6.3	8.8	12.8	14.7	9.7	27.1	1.9	28.1	8.7	0.9	12.6	5.5	11.1	13.9	12.7	34.2	22.1	18.2	18.2	29.0	19.9	18.5	2.1	12.0	11.9	31.3	34.5	16.9	11.3	14.1	11.3	10.9	10.0	8.8	11.8	9.9	8.5	11.3
RNASEL	"PRCA1, RNS4"	ENSG00000135828	"Ribonuclease L"	Q05823	1	182573634-182589256	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002633, CAB010906"	Approved		Supported	Cytosol				Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	"unprognostic (3.46e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.81e-1)"	8.1	10.8	7.4	9.5	10.9	3.7	8.3	5.7	7.7	12.5	9.3	6.7	8.5	8.0	12.4	11.9	10.0	8.8	8.0	5.8	7.0	5.3	9.9	3.9	8.4	10.1	7.7	3.3	14.0	5.3	13.5	18.0	8.5	10.1	10.5	10.8	13.3	10.5	10.3	4.1	6.3	12.2	9.6	7.4	10.5	8.8	3.5	6.7	13.3	13.3	2.8	11.0	13.9	11.0	5.0	7.2	26.9	13.5	5.0	9.2	4.9	2.3	3.3	1.4	0.5	7.6	13.3	2.6	4.5	5.6	4.6	4.3	1.9	5.1	5.1	7.9	5.1	4.3	3.3	4.6	1.8	4.0	2.8	5.9	1.2	0.2	3.9	11.0	11.7	9.4	10.6	2.4	0.7	2.0	2.1	3.9	4.0	3.3	3.2	4.6	1.1	0.9	4.8	1.1	2.6	4.9	3.1	0.7	0.2	4.0	4.9	3.8	5.0	12.3	2.5	2.4	1.9	2.5	2.4	3.5	1.2	0.6	3.8	6.8	3.5	16.8	7.2	24.6	4.9	7.6	6.4	5.0	5.8	5.2	6.0	3.8	9.2	6.7	26.9	5.0	13.5	7.2	4.6	4.9	7.4	10.9	5.7	7.7	7.0	5.3	7.7	3.3	10.1	6.7
RND1	"ARHS, Rho6, RHOS"	ENSG00000172602	"Rho family GTPase 1"	Q92730	12	48857145-48865898	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.8;liver: 50.6"	"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077800			Supported	"Vesicles,Plasma membrane,Actin filaments"				"Vesicles, Plasma membrane, Actin filaments"		"HPA077800: "	"unprognostic (5.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (8.38e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.35e-3)"	2.9	1.3	9.9	2.6	15.0	2.0	2.8	2.6	21.8	1.4	2.8	1.4	0.2	2.6	4.4	1.5	1.8	1.1	13.3	2.5	7.4	7.6	1.8	50.6	12.3	1.4	7.1	8.6	0.9	2.0	3.2	3.2	1.6	8.6	3.7	2.3	1.0	4.0	1.5	0.6	0.6	2.3	2.6	5.6	0.9	6.1	0.8	2.3	0.0	5.5	2.1	2.4	6.9	2.0	1.7	1.7	0.0	0.0	0.5	1.6	0.2	0.6	4.2	2.1	1.1	0.4	0.0	0.3	0.0	0.2	0.6	0.7	2.6	0.9	3.2	0.8	0.0	0.0	1.7	0.1	0.4	1.0	1.0	0.4	0.0	1.6	0.2	0.9	0.6	0.0	0.1	0.3	0.4	1.1	0.1	3.3	0.0	5.4	0.4	0.2	5.0	0.2	1.0	0.2	1.5	0.6	0.8	0.0	0.5	0.1	38.6	0.1	3.8	0.1	0.2	0.0	0.4	0.0	0.5	1.7	2.8	5.8	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.6	1.7	0.2	0.1	1.7	1.1	0.7	0.1	0.0	0.5	0.0	0.0	0.4	0.2	9.9	15.0	2.6	20.4	7.4	7.6	7.1	8.6	8.6	2.3
RNF111	"ARK, Arkadia, DKFZP761D081, FLJ38008"	ENSG00000157450	"Ring finger protein 111"	Q6ZNA4	15	58865175-59097419	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038576, HPA038577"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038576: AB_10964492, HPA038577: AB_10960052"	"unprognostic (7.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.74e-2)"	12.8	11.2	15.3	15.6	19.3	21.2	12.7	24.1	21.9	15.1	9.8	18.8	10.9	11.4	16.4	9.8	16.2	12.6	13.0	11.0	13.0	13.0	12.9	14.8	13.3	13.9	15.7	15.5	16.8	14.8	20.8	19.2	16.7	17.8	12.7	10.3	12.9	14.9	12.5	15.0	14.1	10.9	11.7	14.2	14.3	12.0	15.7	16.9	14.9	16.4	6.5	17.8	15.8	14.8	7.9	5.2	26.7	9.9	3.3	6.1	2.0	9.7	22.7	14.5	12.4	12.6	14.2	12.4	12.8	15.0	12.8	16.5	9.9	6.5	12.0	14.5	17.8	19.2	3.9	9.5	16.0	12.4	8.1	14.9	9.2	7.6	13.7	8.6	16.8	11.1	10.4	13.8	15.3	14.2	13.7	12.1	15.7	4.7	11.4	5.6	11.9	8.8	11.5	20.7	9.8	9.8	17.5	11.9	17.4	11.5	11.4	11.1	8.9	10.7	16.3	20.5	17.2	10.7	12.2	8.7	11.9	14.3	12.5	14.0	15.4	6.4	9.9	9.3	4.8	7.0	4.8	7.4	4.9	4.3	5.2	7.9	5.5	4.2	26.7	3.3	7.6	4.9	6.1	2.0	15.3	19.3	24.1	21.9	13.0	13.0	15.7	15.5	17.8	16.9
RNF113A	"Cwc24, RNF113, ZNF183"	ENSG00000125352	"Ring finger protein 113A"	O15541	X	119870475-119871827	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA000160, HPA076658"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA000160: AB_1079821, HPA076658: "	"unprognostic (2.85e-1)"	"unprognostic (4.38e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (7.93e-4)"	"unprognostic (7.99e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.91e-2)"	"prognostic favourable (6.23e-4)"	11.3	10.7	12.3	14.3	14.9	35.2	12.6	18.6	15.5	11.8	14.6	8.7	14.8	15.0	14.9	12.3	12.7	12.8	11.8	14.2	12.2	14.4	10.9	20.6	12.3	25.1	12.8	11.4	16.4	20.5	7.6	11.4	11.9	11.3	10.5	11.8	11.1	17.6	13.7	12.7	17.6	17.8	9.4	12.9	26.2	13.3	4.0	12.9	25.6	14.2	8.3	21.7	14.0	21.7	33.2	24.4	39.8	25.3	22.9	35.6	26.4	8.0	12.1	5.8	9.1	11.7	8.5	11.3	7.3	13.7	9.8	11.8	10.3	7.1	14.3	14.2	7.4	10.2	13.3	10.3	7.3	10.4	9.2	8.1	13.4	12.0	16.1	16.5	14.1	10.4	11.4	9.8	14.5	9.3	6.1	19.7	9.5	24.4	11.4	20.2	8.0	17.4	10.4	12.0	22.1	10.1	10.4	7.6	6.7	11.4	17.5	16.1	4.3	15.7	6.6	9.8	3.3	13.3	14.6	22.3	17.0	13.6	8.9	22.1	6.2	29.1	23.0	39.8	30.4	22.4	30.9	31.5	32.8	32.4	24.4	33.2	34.8	30.9	10.3	22.9	25.3	20.1	35.6	26.4	12.3	14.9	18.6	15.5	12.2	14.4	12.8	11.4	11.3	12.9
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953892	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (3.01e-4)"	"unprognostic (1.36e-2)"	23.2	21.3	24.4	18.3	25.7	31.2	20.6	26.7	23.1	24.0	29.7	32.6	21.1	29.5	20.3	23.4	20.2	23.6	20.1	21.9	23.0	25.3	30.3	31.6	24.4	24.0	28.3	19.4	28.4	36.8	16.1	21.6	40.6	23.7	24.5	21.3	27.1	27.8	24.1	43.8	15.2	33.9	17.6	29.3	36.3	24.2	101.9	24.1	28.3	37.9	20.0	24.1	22.6	25.0	28.5	32.5	43.4	44.6	23.7	29.4	34.9	15.6	15.4	7.9	8.3	16.3	11.3	23.3	14.0	15.9	29.0	12.3	45.7	12.9	7.6	28.0	7.4	12.6	11.8	14.1	10.0	13.7	8.6	9.6	10.3	32.1	14.3	17.4	11.6	9.8	13.0	11.1	7.6	6.9	18.0	8.9	8.5	52.6	14.6	18.1	8.2	22.1	16.0	8.3	13.7	15.3	12.8	12.1	8.7	17.1	108.1	21.6	28.8	16.2	9.1	26.3	12.2	13.8	16.1	18.3	19.1	14.4	14.9	11.4	14.5	38.5	42.5	35.7	22.0	39.2	24.6	28.2	24.6	22.4	32.5	28.5	29.4	23.7	43.4	23.7	44.6	26.7	28.8	34.9	24.4	25.7	26.7	23.1	23.0	25.3	28.3	19.4	23.7	24.1
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018372-32073213	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"				"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	21.9	2.3	4.1	9.1	5.7	18.2	20.4	1.2	6.6	5.0	8.9	12.2	3.3	12.3	7.2	5.5	3.9	4.3	6.0	5.4	6.1	4.1	2.1	14.1	10.3	13.5	7.7	3.1	2.4	4.2	2.5	1.3	4.4	7.0	3.1	7.8	1.6	5.0	1.9	4.4	6.0	26.0	4.1	12.0	7.4	4.2	3.3	8.3	14.8	3.2	2.9	7.2	4.5	6.2	2.1	3.4	9.0	3.8	11.7	12.5	5.1	0.7	0.1	0.1	0.2	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.5	0.9	0.7	0.1	3.9	1.6	0.2	0.2	0.2	0.1	5.1	31.8	1.0	1.5	0.0	1.7	0.3	0.1	1.1	0.0	1.1	1.3	4.8	2.6	0.9	5.4	0.3	0.1	0.3	0.3	0.5	0.2	0.1	0.1	7.8	0.8	2.5	0.1	0.1	0.5	0.1	0.0	3.7	0.1	0.1	0.4	6.8	4.2	9.0	3.8	3.3	12.5	2.0	8.2	2.0	10.1	10.5	3.4	2.1	8.2	10.6	1.5	11.7	1.9	3.4	10.0	5.1	4.1	5.7	1.2	6.6	6.1	4.1	7.7	3.1	7.0	8.3
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812708-149962139	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: "	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	24.0	21.3	30.6	19.0	39.4	9.8	28.5	19.9	30.4	19.0	17.7	39.9	16.2	14.3	16.8	33.7	16.8	15.9	20.4	16.4	40.5	29.7	35.8	39.2	31.7	19.6	60.9	26.8	18.1	19.6	23.5	14.9	32.4	40.7	25.5	20.3	19.5	36.1	20.9	18.0	18.4	16.3	20.4	102.2	25.5	17.0	12.5	51.2	13.3	32.1	18.8	15.9	21.4	16.5	8.8	15.7	72.4	31.5	7.8	8.5	14.6	19.4	12.1	8.2	9.3	32.3	19.8	13.7	10.8	27.8	10.4	15.5	10.6	28.0	8.1	15.8	13.2	18.5	11.0	13.8	14.7	9.9	8.0	9.7	5.6	10.3	21.5	10.4	13.9	20.9	26.3	8.8	23.9	11.5	3.0	16.5	9.3	10.9	7.5	6.9	5.5	9.5	5.4	8.8	34.3	20.2	9.1	4.3	12.5	8.9	13.4	34.7	25.5	11.1	12.0	14.2	5.7	15.0	6.9	28.0	18.4	16.7	11.9	9.8	7.6	12.9	20.3	16.6	6.8	25.2	8.5	8.8	7.6	7.6	15.7	8.3	7.3	7.5	72.4	7.8	31.5	11.2	8.3	14.6	30.6	39.4	19.9	29.2	40.5	29.7	60.9	26.8	40.7	51.2
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990291	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008716	Approved		Supported	Cytosol				Cytosol		"HPA008716: AB_1856337"	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.06e-2)"	21.2	29.5	23.7	11.2	33.9	7.8	22.0	22.5	40.2	18.4	18.7	26.2	16.0	15.3	21.0	21.5	15.6	14.3	15.4	32.9	23.6	24.7	31.3	31.3	13.8	13.3	28.9	17.3	15.9	17.1	26.3	28.8	23.6	47.7	21.6	19.8	20.9	18.1	20.1	27.7	11.9	20.9	20.5	26.3	13.8	15.7	33.7	15.0	16.2	26.3	13.3	14.9	16.7	14.0	12.3	17.1	32.6	18.8	16.8	17.0	12.2	12.5	21.0	14.8	29.0	26.6	27.9	9.9	25.8	14.4	18.2	20.2	17.4	14.7	22.2	30.3	26.5	6.9	18.8	25.4	16.3	16.7	16.2	14.1	11.0	7.9	29.3	15.5	12.6	20.9	22.4	24.1	30.4	22.5	17.1	31.1	37.2	15.0	15.0	4.9	6.2	24.0	9.9	16.4	24.1	25.0	21.8	16.3	13.3	22.6	41.5	43.9	28.9	12.1	23.2	24.2	7.8	11.4	24.4	19.6	22.8	20.4	20.7	19.0	29.8	32.6	13.4	13.0	17.0	15.8	16.5	12.3	15.0	16.9	16.2	10.6	11.5	16.7	3.3	16.8	18.8	17.1	16.7	12.2	23.7	33.9	22.5	40.2	23.6	24.7	28.9	17.3	47.7	15.0
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favourable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favourable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.7	24.8	9.7	18.9	30.2	10.1	14.5	9.1	8.4	10.0	13.4	15.4	7.1	7.9	8.8	14.8	11.5	6.9	12.7	8.4	12.7	24.5	7.5	9.0	21.6	18.7	11.4	22.8	17.7	13.6	9.8	22.2	10.6	7.3	13.6	9.7	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.1	7.3	10.4	11.6	7.1	26.0	20.8	17.8	5.9	18.4	13.3	14.2	8.8	6.6	13.6	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA046109: "	"unprognostic (6.15e-3)"	"prognostic favourable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	20.8	9.3	8.9	10.7	11.1	31.6	18.7	21.1	13.0	13.6	11.2	10.7	12.3	11.1	13.9	8.5	14.3	10.1	10.9	12.0	10.2	10.2	7.5	18.8	14.3	12.0	13.8	11.0	14.6	9.2	12.0	8.1	9.9	15.3	10.1	10.8	9.1	11.0	13.6	20.8	20.1	10.1	12.9	10.5	11.7	10.7	18.4	13.4	17.6	9.6	13.9	15.2	14.7	17.1	6.2	5.8	21.8	10.0	7.7	11.6	5.7	12.3	4.9	8.9	11.6	8.3	6.1	12.7	7.6	4.8	5.1	8.1	9.6	6.1	13.1	17.6	6.3	12.6	12.4	9.0	7.9	6.2	6.1	24.9	12.5	11.9	4.3	7.6	6.2	6.0	3.5	8.0	7.1	7.4	7.4	13.8	5.1	20.9	25.1	4.5	10.5	6.5	11.3	10.3	10.6	4.3	17.1	7.4	7.5	8.6	10.6	6.5	16.0	6.8	7.3	8.9	7.0	9.4	10.0	11.8	11.1	19.9	8.7	9.2	7.0	21.8	6.6	7.5	11.6	7.1	10.4	5.7	9.8	8.3	5.8	6.2	8.7	9.1	7.3	7.7	10.0	5.5	6.2	5.7	8.9	11.1	21.1	13.0	10.2	10.2	13.8	11.0	15.3	13.4
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748868-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA058368"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA038505: , HPA046138: , HPA058368: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	12.3	7.0	12.0	11.6	14.0	23.1	12.0	22.6	15.6	13.1	11.2	12.2	6.3	7.4	14.2	8.2	20.6	10.7	10.8	9.2	12.6	5.9	8.9	9.3	16.9	11.3	15.4	9.1	14.6	10.7	17.5	10.4	8.6	13.9	10.5	10.0	8.4	12.4	8.8	15.0	14.1	10.3	14.2	10.1	12.6	10.3	7.2	14.9	12.6	11.5	7.4	12.5	13.1	15.8	0.6	0.8	5.0	1.9	1.2	1.6	0.6	8.1	6.3	7.6	7.5	5.0	6.6	3.1	6.4	6.1	7.2	6.3	10.5	6.2	14.6	6.6	7.7	7.9	10.3	7.7	9.5	7.3	6.6	10.1	11.6	4.1	5.7	5.3	8.5	6.1	6.1	8.2	18.7	11.6	8.9	11.8	7.2	6.9	9.1	9.6	3.0	4.1	8.6	18.2	8.0	4.6	8.6	3.4	6.2	8.7	6.6	13.9	8.2	6.9	7.7	12.0	10.1	7.5	5.7	8.6	4.5	17.4	2.4	5.9	6.9	2.8	1.9	1.5	1.6	1.1	1.2	0.3	1.5	0.9	0.8	0.6	1.1	0.9	5.0	1.2	1.0	0.8	1.2	0.6	12.0	14.0	22.6	15.6	12.6	5.9	15.4	9.1	13.9	14.9
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487061-228495766	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030098	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	15.7	30.3	25.6	12.5	28.1	12.3	10.3	33.2	54.7	11.4	10.7	15.5	12.5	14.7	12.9	12.2	18.0	14.2	14.5	17.7	25.2	24.9	16.2	20.4	11.5	9.8	20.2	29.3	20.2	19.4	22.3	16.4	8.8	22.7	15.0	6.6	12.3	30.3	12.6	55.5	15.5	13.2	8.6	16.3	19.0	14.2	9.5	11.4	11.1	27.9	19.4	11.2	10.0	13.1	2.0	1.7	8.7	2.1	1.0	2.3	0.6	9.3	7.0	4.9	10.3	5.4	3.5	9.5	7.8	4.8	4.9	3.7	3.6	6.5	21.2	16.3	8.9	7.4	6.2	6.6	1.8	9.6	8.0	6.4	5.2	4.6	14.7	7.3	12.6	6.1	11.8	3.8	5.1	4.3	10.2	41.5	3.5	5.2	11.6	6.5	11.0	7.2	9.9	4.5	20.0	3.5	5.9	10.9	11.0	7.9	16.5	21.0	11.6	17.5	9.9	6.1	6.3	6.6	7.4	75.5	22.6	11.6	16.4	7.7	10.2	0.0	1.1	8.7	1.3	2.1	1.5	1.2	1.5	2.3	1.4	2.0	1.4	1.2	0.3	1.0	1.4	1.7	1.3	0.6	25.6	28.1	33.2	47.3	25.2	24.9	20.2	29.3	22.7	11.4
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045364-185102608	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	17.8	15.0	14.3	13.9	12.4	15.3	29.7	15.6	23.6	16.6	12.0	7.8	20.7	10.4	16.2	12.6	15.2	11.5	13.1	12.0	16.0	13.1	13.7	11.1	16.7	20.7	9.4	10.4	19.9	15.0	12.3	26.5	28.4	11.4	13.2	13.5	10.1	17.3	20.6	13.1	12.5	9.8	14.8	11.2	16.2	12.2	27.8	9.4	17.2	15.1	11.5	16.1	17.6	16.9	14.7	19.9	20.6	22.1	17.4	19.4	12.0	13.9	7.7	28.5	11.3	8.1	13.9	27.1	9.9	12.6	15.7	12.6	12.3	23.4	4.2	12.4	12.1	4.9	19.5	14.3	19.1	12.2	10.2	22.5	4.7	10.7	11.9	23.0	12.7	13.0	8.8	12.8	16.5	15.7	17.8	10.0	11.3	8.7	19.9	6.8	38.2	4.2	22.9	17.7	4.0	11.9	9.9	8.4	14.4	6.9	4.2	20.2	8.8	12.4	11.1	11.3	14.7	10.7	12.6	16.5	10.7	15.6	7.0	10.9	12.6	19.3	17.0	20.6	13.5	21.1	19.4	14.6	12.5	12.6	19.9	14.7	12.8	12.6	7.9	17.4	22.1	10.0	13.2	12.0	14.3	12.4	15.6	23.6	16.0	13.1	9.4	10.4	11.4	9.4
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533851-101563344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB012478: , HPA051773: "	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	16.4	17.1	24.6	17.0	24.9	12.1	17.7	24.4	26.3	18.6	16.4	27.7	15.9	10.1	18.3	18.7	20.4	19.1	13.2	24.1	22.3	22.1	20.5	14.4	14.9	15.5	25.2	20.7	21.1	19.5	31.5	23.1	15.1	30.0	21.6	16.1	16.8	16.2	17.7	32.0	16.3	12.5	23.6	28.8	17.0	13.9	28.2	25.8	21.2	22.0	15.3	18.6	21.1	19.0	13.0	12.5	21.0	23.5	13.8	18.6	10.4	9.5	24.4	14.1	15.4	17.4	13.8	12.0	16.8	13.5	16.8	14.8	14.8	10.2	21.2	9.0	12.9	24.4	16.3	14.2	17.3	22.2	7.5	11.4	22.3	14.8	12.8	19.5	13.7	13.5	15.3	14.8	19.3	9.8	10.8	12.6	18.2	12.5	15.1	5.2	31.1	12.4	14.6	48.8	10.5	6.9	9.2	15.1	19.0	23.7	12.7	13.8	11.4	9.2	13.9	15.6	15.7	11.1	14.0	13.6	42.0	11.7	13.8	7.4	18.9	21.0	12.7	19.1	18.6	17.5	14.0	13.0	15.4	13.9	12.5	11.2	16.2	14.9	13.9	13.8	23.5	7.9	11.9	10.4	24.6	24.9	24.4	26.3	22.3	22.1	25.2	20.7	30.0	25.8
RNF208	DKFZP761H1710	ENSG00000212864	"Ring finger protein 208"	Q9H0X6	9	137220247-137221581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 12.1;MCF7: 29.0;REH: 23.4;RPMI-8226: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021256, HPA021429"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA021256: AB_1844331, HPA021429: AB_2180654"	"unprognostic (2.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.12e-8)"	"unprognostic (3.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.40e-2)"	3.7	7.1	17.3	1.2	13.3	0.7	4.3	10.1	27.4	1.9	1.7	1.5	1.2	2.0	1.7	2.7	4.6	3.4	1.2	6.2	18.1	10.8	3.7	8.1	1.8	3.4	9.4	4.6	1.5	8.8	5.7	3.0	1.2	3.5	4.0	0.6	1.8	11.4	5.5	13.2	6.6	2.4	1.2	3.3	1.8	3.4	3.1	2.1	1.2	2.1	3.2	1.2	2.1	1.3	0.6	0.0	0.8	0.7	0.0	1.2	0.8	0.7	1.5	1.0	1.7	0.7	0.1	3.1	0.4	0.6	0.7	0.7	4.4	2.8	0.4	2.2	0.5	2.3	2.5	0.1	0.1	1.0	0.9	3.1	5.1	12.1	2.3	0.6	1.0	0.5	0.8	0.7	0.3	0.7	4.3	0.2	0.3	29.0	1.5	1.4	1.3	3.2	23.4	0.2	12.9	0.8	0.1	2.9	10.4	0.3	0.9	0.6	10.5	2.2	0.3	0.5	0.6	1.0	0.0	0.4	0.4	0.1	1.4	0.2	0.5	0.0	0.4	0.2	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.8	17.3	13.3	10.1	27.4	18.1	10.8	9.4	4.6	3.5	2.1
RNF213	"C17orf27, KIAA1554, KIAA1618, MYMY2, NET57"	ENSG00000173821	"Ring finger protein 213"	Q63HN8	17	80260866-80398786	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Ubl conjugation pathway"	"Hydrolase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003347, HPA026790"	Approved		Supported	Cytosol				Cytosol		"HPA003347: AB_1079204, HPA026790: AB_10602296"	"unprognostic (8.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.97e-3)"	"prognostic unfavourable (4.65e-5)"	"unprognostic (7.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-2)"	17.0	15.1	7.4	16.9	10.3	22.4	10.2	4.7	7.5	11.0	12.2	15.6	14.9	8.5	16.6	13.0	13.2	9.7	12.1	8.5	7.8	7.8	17.1	11.6	15.4	17.9	10.9	5.6	11.5	9.0	41.1	11.4	15.1	10.0	11.2	8.0	12.3	11.7	12.5	9.0	8.7	14.8	13.6	14.3	17.0	10.6	5.9	8.7	24.5	15.9	7.5	18.2	13.6	15.4	7.2	13.9	37.9	9.6	11.4	12.1	1.8	16.1	28.7	2.9	2.0	10.5	16.1	2.2	4.1	8.9	18.5	15.8	3.0	7.5	1.0	3.5	8.5	9.4	3.9	5.3	6.3	36.5	1.7	2.5	11.6	5.3	4.5	2.6	2.6	8.8	3.6	10.4	4.5	14.2	4.6	6.0	6.9	3.9	10.5	1.1	2.1	6.6	7.2	6.7	1.2	5.1	14.0	2.8	3.9	9.9	21.1	7.5	4.8	3.3	18.3	10.3	8.2	6.0	4.2	2.6	2.4	2.9	7.7	3.1	3.7	6.9	9.6	4.2	12.1	8.0	8.1	6.2	8.6	9.7	2.3	7.2	6.9	8.5	37.9	11.4	6.9	13.9	6.4	1.8	7.4	10.3	4.7	7.5	7.8	7.8	10.9	5.6	10.0	8.7
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.4	15.6	12.8	21.8	15.3	13.3	8.8	15.5	16.3	16.1	14.9	11.3	8.3	12.7	8.0	17.3	10.4	13.3	10.9	13.2	7.9	11.6	9.8	9.5	11.4	18.4	16.0	16.8	13.7	14.0	12.3	15.1	12.7	19.6	8.9	17.8	22.2	6.0	25.5	17.6	13.0	15.3	18.1	7.1	9.6	12.2	9.8	15.6	9.8	24.6	8.8	9.7	16.4	13.8	16.3	29.4	16.6	13.9	7.2	5.4	10.3	12.2	14.9	25.9	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3
RNF24	G1L	ENSG00000101236	"Ring finger protein 24"	Q9Y225	20	3927309-4015582	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 59.0;bone marrow: 59.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 59.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 59.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011900	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA011900: AB_10671089"	"unprognostic (6.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (2.65e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.42e-1)"	"prognostic unfavourable (2.67e-7)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.24e-1)"	9.1	9.3	13.1	11.6	13.0	59.4	14.8	12.3	16.2	9.2	6.6	8.4	17.0	4.7	9.1	20.6	8.1	8.0	9.3	7.4	13.0	10.5	9.5	3.2	14.5	14.1	10.5	9.9	9.3	5.9	5.3	8.2	5.6	9.4	9.9	5.8	5.4	9.8	14.9	3.2	11.4	5.3	9.0	12.8	14.8	7.6	6.3	7.6	6.3	8.8	4.5	6.0	9.4	15.5	1.1	4.6	59.0	5.8	1.7	1.8	2.4	8.0	3.7	5.4	4.8	20.7	35.3	1.9	6.7	14.4	6.8	9.8	2.4	7.9	1.7	1.5	13.6	5.4	2.1	7.5	11.5	1.2	1.7	14.9	6.5	1.9	18.2	29.7	5.9	11.8	2.4	18.1	15.5	6.3	18.8	4.1	11.0	2.2	4.9	7.3	8.2	5.2	5.6	4.7	1.4	3.8	4.4	5.2	4.2	18.9	11.5	5.0	4.0	10.7	9.7	17.0	5.6	11.5	8.0	3.5	3.6	0.7	8.8	10.4	5.3	20.7	5.8	11.8	0.9	2.1	0.9	0.3	1.8	1.4	4.6	1.1	1.2	1.4	59.0	1.7	2.8	0.2	0.8	2.4	13.1	13.0	12.3	13.5	13.0	10.5	10.5	9.9	9.4	7.6
RNF34	"FLJ21786, RIF, RIFF"	ENSG00000170633	"Ring finger protein 34"	Q969K3	12	121400041-121430623	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074151			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA074151: "	"unprognostic (3.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavourable (6.72e-8)"	"unprognostic (3.39e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.80e-2)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.55e-3)"	"prognostic favourable (3.02e-4)"	11.9	10.6	18.2	19.6	23.4	10.4	12.3	25.2	26.9	11.2	17.3	21.5	10.0	17.0	15.0	12.7	14.4	11.7	15.5	16.0	17.6	17.7	10.8	11.1	11.6	27.2	19.3	19.4	14.0	12.2	11.1	17.1	10.2	19.3	10.2	14.2	12.7	12.4	12.9	45.7	13.8	16.0	15.0	21.3	19.4	16.3	20.8	17.2	21.7	12.7	9.1	22.5	16.4	11.5	31.8	16.9	36.5	20.3	29.9	42.8	25.8	18.4	22.4	14.6	15.3	11.6	10.7	18.4	19.7	17.7	19.7	15.1	27.7	7.1	26.6	15.2	21.2	13.4	22.0	12.4	17.6	38.7	13.0	30.8	15.5	25.4	14.0	26.5	21.7	9.5	16.8	17.1	14.9	20.6	23.2	12.5	19.3	14.6	23.3	38.9	18.8	20.4	22.3	19.2	15.6	13.6	22.1	21.7	14.1	24.8	9.3	15.0	16.1	20.2	16.5	17.0	12.3	14.7	15.5	22.2	36.7	29.0	12.1	18.7	17.0	26.9	17.9	36.5	32.4	19.9	33.0	31.8	37.8	34.1	16.9	25.5	32.8	32.6	27.4	29.9	20.3	14.3	42.8	25.8	18.2	23.4	25.2	26.9	17.6	17.7	19.3	19.4	19.3	17.2
RNF38		ENSG00000137075	"Ring finger protein 38"	Q9H0F5	9	36336396-36487548	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015853	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA015853: AB_1856365"	"unprognostic (2.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.30e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"prognostic favourable (2.90e-6)"	"unprognostic (3.88e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.39e-2)"	11.9	8.0	13.1	7.7	14.5	20.3	11.1	18.8	17.0	13.6	14.1	12.2	8.1	6.4	16.3	12.9	10.1	11.7	9.6	9.5	10.0	11.1	12.3	6.8	11.7	14.5	9.2	12.3	24.4	12.8	12.2	5.7	21.2	14.0	15.3	10.1	14.4	10.3	12.8	9.6	8.9	10.2	16.9	8.5	11.4	8.7	46.3	10.0	13.1	14.4	4.3	11.1	16.5	13.5	6.2	4.1	12.2	4.3	8.4	8.7	4.2	9.3	5.3	20.6	12.2	9.5	8.8	20.2	5.8	7.4	7.2	9.5	9.0	5.2	14.1	6.2	11.3	3.7	13.1	6.9	11.2	12.5	5.6	17.0	7.5	8.8	7.4	12.5	15.6	9.0	7.4	9.1	8.8	18.3	3.5	13.6	11.6	3.2	12.8	6.6	13.8	3.8	11.8	9.3	7.8	12.3	10.8	8.6	9.3	6.6	6.7	6.6	6.4	12.8	18.0	6.9	10.5	4.0	6.9	9.0	18.7	10.0	6.3	10.6	8.8	12.2	4.3	7.2	7.2	4.1	6.0	5.8	6.5	7.6	4.1	6.2	7.0	7.0	8.0	8.4	4.1	3.3	8.7	4.2	13.1	14.5	18.8	17.0	10.0	11.1	9.2	12.3	14.0	10.0
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"				"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: "	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavourable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	28.6	29.1	25.4	32.2	39.4	36.4	28.6	35.9	50.3	28.2	25.1	34.8	28.4	27.0	32.2	28.0	30.3	27.8	27.1	24.6	22.7	22.8	32.3	25.6	27.4	41.9	23.5	23.4	32.1	31.0	31.2	30.0	29.4	36.7	28.5	26.7	29.2	36.1	28.5	26.0	28.5	29.3	31.8	23.1	41.9	28.9	36.8	23.7	50.4	29.3	19.1	51.5	27.7	26.3	36.9	35.3	41.8	39.9	39.7	43.7	45.8	19.8	18.9	19.8	13.8	17.2	18.0	22.1	24.3	27.4	25.9	23.5	21.4	18.8	25.2	14.5	24.5	13.0	20.9	19.0	24.7	11.8	12.6	30.5	19.5	20.4	25.9	21.4	26.7	20.8	23.1	24.0	20.1	23.9	16.1	34.9	26.4	13.6	34.3	29.9	30.4	23.7	25.0	18.8	13.0	17.6	25.4	18.4	17.4	17.0	13.3	16.9	21.0	16.2	19.9	22.6	11.1	21.3	37.2	45.2	60.1	27.9	22.0	23.4	23.4	14.6	29.6	41.8	43.7	39.3	43.7	36.9	37.5	43.0	35.3	27.2	36.2	36.3	32.9	39.7	39.9	23.6	39.9	45.8	25.4	39.4	35.9	50.3	22.7	22.8	23.5	23.4	36.7	23.7
RNF40	"BRE1B, KIAA0661, RBP95, STARING"	ENSG00000103549	"Ring finger protein 40"	O75150	16	30761745-30776307	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041330, HPA054227"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA041330: AB_10793872, HPA054227: "	"unprognostic (1.61e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (8.11e-8)"	"unprognostic (9.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.60e-3)"	21.0	25.2	26.4	21.3	26.5	40.8	20.9	36.8	28.2	25.8	21.0	22.0	18.0	20.1	28.4	17.0	25.6	24.4	21.3	22.8	22.2	17.1	20.0	21.2	20.2	21.9	20.9	18.9	30.5	24.4	44.0	21.6	25.3	19.6	21.4	15.1	20.0	27.3	21.1	20.0	25.5	20.3	18.3	18.6	20.0	19.6	43.1	22.8	23.5	26.8	15.4	20.6	22.5	21.4	7.6	12.0	15.0	14.9	9.9	13.3	12.9	20.3	31.9	19.4	18.4	14.8	15.5	21.2	20.8	16.1	24.1	18.8	25.7	19.0	16.2	30.6	17.8	22.1	35.3	18.5	18.9	23.2	41.4	15.8	35.0	26.7	19.8	27.4	18.6	14.4	15.5	30.2	17.1	20.2	34.8	15.5	14.6	34.0	26.1	25.7	20.2	19.3	51.9	21.4	31.2	10.6	18.1	32.4	23.8	16.3	20.9	15.0	32.0	31.2	21.8	27.1	13.8	19.1	23.7	23.1	28.5	32.2	22.5	24.4	27.6	6.2	11.5	14.7	12.9	13.4	13.3	7.6	7.2	9.9	12.0	6.5	5.4	8.3	15.0	9.9	14.9	6.2	6.2	12.9	26.4	26.5	36.8	28.2	22.2	17.1	20.9	18.9	19.6	22.8
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178354-32180793	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: "	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favourable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	9.8	20.6	19.3	9.0	20.6	10.3	14.0	13.6	16.8	11.3	25.7	17.4	14.7	18.1	12.3	14.6	15.9	16.9	13.9	19.2	16.9	12.0	32.7	38.1	14.7	11.6	16.3	14.2	19.0	19.3	7.2	5.8	23.4	12.3	13.1	19.1	12.2	25.3	15.3	24.5	13.4	36.7	13.7	19.7	10.2	14.2	9.6	9.6	10.8	18.0	14.2	12.5	13.2	9.9	6.7	26.9	7.2	6.4	7.5	7.0	6.5	5.2	6.8	4.6	17.8	5.1	3.5	3.6	2.1	2.7	4.6	5.3	9.1	4.4	6.8	7.7	5.1	4.3	8.6	4.8	4.9	4.2	11.7	5.4	7.7	18.7	6.0	0.0	11.1	3.5	6.5	7.8	5.9	9.3	13.9	7.4	6.7	7.4	6.6	15.6	0.0	2.9	4.5	5.3	9.5	13.1	3.3	4.8	10.0	4.1	4.5	4.6	9.3	19.1	4.2	5.2	5.0	0.0	8.1	4.0	6.1	8.0	3.6	12.1	3.0	5.1	4.6	7.2	7.0	6.4	6.1	6.7	5.7	6.2	6.6	6.0	6.4	6.3	2.4	7.5	4.5	26.9	5.7	6.5	19.3	20.6	13.6	16.8	16.9	12.0	16.3	14.2	12.3	9.6
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222493	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	16.4	19.8	22.3	15.9	27.5	25.1	24.2	26.6	28.9	13.1	16.4	8.1	20.3	15.5	13.0	13.0	20.9	13.4	12.5	17.9	20.4	17.3	16.9	17.5	14.5	18.4	15.8	22.6	10.9	14.2	17.9	26.3	23.3	16.8	15.2	17.2	8.1	16.1	13.5	24.8	15.5	21.0	14.3	16.7	16.6	15.1	28.7	14.5	23.6	16.1	14.4	20.7	14.1	19.5	13.5	12.5	24.6	15.0	13.3	13.2	9.2	12.6	11.1	4.2	6.2	14.7	11.6	9.5	21.7	17.8	14.1	10.0	13.9	16.3	22.7	10.9	20.6	17.0	11.8	17.6	23.5	21.7	7.4	24.7	9.4	11.9	23.1	25.8	26.1	10.9	34.4	15.8	33.9	14.1	9.5	0.0	21.8	11.3	14.4	15.1	3.4	7.8	11.5	16.4	8.9	17.4	16.7	7.7	4.7	11.6	21.3	20.6	8.1	25.4	18.4	12.2	7.4	16.3	15.5	5.8	5.4	13.6	11.1	14.8	15.9	24.6	10.1	23.7	11.9	13.1	12.8	13.5	13.0	13.2	12.5	9.4	13.2	11.2	7.1	13.3	15.0	6.5	13.1	9.2	22.3	27.5	26.6	28.9	20.4	17.3	15.8	22.6	16.8	14.5
RNF7	"CKBBP1, ROC2, SAG"	ENSG00000114125	"Ring finger protein 7"	Q9UBF6	3	141738204-141747560	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036995	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA036995: AB_10673627"	"unprognostic (5.68e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.17e-3)"	"unprognostic (8.58e-3)"	"prognostic unfavourable (1.54e-9)"	"unprognostic (4.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.36e-2)"	26.0	44.0	31.4	21.7	37.0	30.7	38.3	19.4	28.6	26.1	37.0	17.5	36.3	38.6	30.4	42.0	37.1	22.9	41.8	47.6	27.4	27.6	33.2	35.3	27.2	32.1	26.7	21.6	30.5	57.6	16.2	33.9	40.6	20.5	37.3	34.5	29.2	36.2	28.9	69.9	35.7	42.7	36.2	23.9	23.7	26.8	44.4	18.7	27.0	35.1	50.6	27.4	37.5	35.2	32.7	44.9	36.3	52.2	22.5	41.7	42.9	48.2	19.6	29.1	23.5	27.8	38.5	19.2	27.1	25.6	23.3	24.7	22.8	24.1	16.2	63.6	30.0	23.6	18.0	25.5	29.6	15.6	33.7	16.0	18.5	32.9	37.1	25.1	15.7	35.9	28.8	18.5	31.8	32.9	16.9	22.8	34.4	37.1	15.9	28.3	30.9	32.6	17.4	18.7	35.0	49.7	21.4	16.1	20.1	31.1	32.2	45.1	30.1	33.1	24.9	23.3	22.4	41.2	22.7	21.8	18.1	33.4	36.4	27.9	26.4	36.3	52.2	33.7	33.0	44.5	33.1	32.7	35.6	35.0	44.9	29.3	34.7	35.9	18.5	22.5	46.6	41.4	41.7	42.9	31.4	37.0	19.4	28.6	27.4	27.6	26.7	21.6	20.5	18.7
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353972-37394738	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA050731: , HPA064925: "	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	8.0	11.7	13.1	8.2	17.8	8.9	11.5	25.7	18.7	9.2	9.5	10.6	6.8	6.9	13.5	5.7	18.3	12.0	8.8	17.6	13.4	14.8	11.8	7.5	10.8	8.3	12.0	16.0	13.2	6.5	11.9	16.4	10.2	13.7	8.6	8.2	8.0	10.2	11.9	15.2	9.9	8.4	10.7	9.6	7.7	7.6	19.8	13.8	6.6	8.0	9.4	13.3	12.9	15.2	8.8	8.3	2.6	8.1	7.6	10.8	5.5	6.5	3.9	9.5	11.3	7.7	11.1	2.7	6.8	8.4	12.9	14.2	5.8	3.7	8.1	4.2	6.6	6.2	13.2	8.6	13.6	8.5	12.8	14.0	6.9	8.7	4.4	7.4	10.3	5.5	8.3	7.7	9.0	12.4	9.4	2.8	7.4	4.3	9.0	9.2	6.6	5.2	7.1	8.8	5.6	6.6	4.6	18.8	6.3	5.1	5.8	9.4	5.2	7.3	5.6	8.5	7.6	8.0	10.0	8.4	11.1	40.0	4.2	10.6	9.8	1.0	4.6	2.6	10.8	6.0	10.0	8.8	8.1	10.2	8.3	6.0	7.1	9.4	0.6	7.6	8.1	3.6	9.3	5.5	13.1	17.8	25.7	18.7	13.4	14.8	12.0	16.0	13.7	13.8
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol			27000000	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favourable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	39.8	35.7	18.5	27.6	25.7	40.8	57.9	14.7	33.1	34.9	27.8	43.0	25.9	27.3	36.6	34.2	51.4	30.5	32.8	49.5	20.4	16.5	32.6	46.2	36.1	36.6	37.1	25.3	36.2	32.4	25.7	21.1	35.1	24.3	30.7	8.7	25.6	37.5	33.2	41.6	60.7	26.0	37.7	31.7	29.8	25.3	37.9	29.6	17.1	41.4	41.9	25.8	35.5	38.6	12.9	47.8	10.3	53.3	9.8	12.1	35.3	21.1	30.1	3.3	11.2	18.3	26.1	12.4	19.9	13.8	18.1	15.7	16.8	25.9	11.7	15.4	37.8	19.9	5.7	19.9	2.8	14.9	27.4	7.9	8.3	15.4	61.8	10.4	25.4	22.2	29.6	10.5	13.1	12.3	10.3	19.9	10.3	21.1	8.0	19.7	5.5	30.7	10.2	7.3	15.0	11.1	7.7	9.6	6.6	11.9	17.3	19.8	12.4	32.8	22.0	31.1	9.1	11.2	13.3	12.7	13.5	8.6	33.9	23.6	20.4	5.7	44.4	10.3	10.4	53.3	12.1	12.9	11.2	10.4	47.8	9.5	10.5	9.3	3.2	9.8	48.7	13.9	10.7	35.3	18.5	25.7	14.7	33.1	20.4	16.5	37.1	25.3	24.3	29.6
RNMT	RG7MT1	ENSG00000101654	"RNA guanine-7 methyltransferase"	O43148	18	13726660-13764558	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039409	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA039409: AB_10795289"	"unprognostic (3.02e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.78e-1)"	18.9	10.1	13.3	12.7	20.4	40.1	16.6	19.7	27.3	14.0	11.5	10.3	12.1	9.1	15.4	13.1	12.6	12.2	9.9	21.2	14.9	18.2	12.9	12.0	12.4	14.6	14.5	21.8	19.6	13.3	16.6	21.2	16.1	28.5	14.7	11.6	10.8	12.8	12.2	29.1	14.3	11.3	15.1	16.1	12.3	11.4	17.1	12.6	12.2	19.2	15.8	15.8	26.5	11.4	20.1	20.8	21.6	13.1	9.4	15.7	4.1	11.4	6.8	13.2	9.9	9.8	12.5	9.2	9.4	11.7	9.8	13.3	8.0	5.5	12.8	11.6	9.6	4.6	15.5	13.5	16.6	7.1	8.3	9.6	7.0	7.5	10.8	25.0	8.2	9.5	14.7	10.3	29.1	7.5	14.4	12.9	11.1	7.1	15.9	9.0	10.1	5.3	10.4	13.9	17.4	9.0	9.0	10.2	15.3	10.6	7.8	18.1	6.8	10.5	7.7	19.7	27.7	16.0	10.0	26.0	28.3	26.6	14.5	9.6	9.8	21.6	13.1	8.5	12.5	10.3	10.1	16.2	11.9	10.3	8.1	20.1	15.7	12.2	7.1	9.4	11.4	20.8	12.8	4.1	13.3	20.4	19.7	27.3	14.9	18.2	14.5	21.8	28.5	12.6
RNPC3	"FLJ20008, KIAA1839, RBM40, SNRNP65"	ENSG00000185946	"RNA binding region (RNP1, RRM) containing 3"	Q96LT9	1	103525691-103555239	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052434			Supported	Nucleoplasm				Nucleoplasm		"HPA052434: "	"unprognostic (1.87e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.34e-5)"	"unprognostic (9.00e-2)"	"prognostic favourable (1.53e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"prognostic favourable (7.82e-4)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.19e-1)"	"prognostic favourable (5.25e-4)"	19.8	18.5	42.1	16.7	52.4	15.3	20.7	53.4	41.2	22.3	17.8	19.1	22.2	16.4	24.2	40.7	11.9	25.8	15.4	20.1	33.5	12.7	19.4	10.9	17.0	22.4	25.6	28.6	27.2	29.6	25.1	42.5	9.0	24.4	17.5	16.3	17.2	26.9	18.2	28.9	26.6	19.3	13.8	24.5	20.3	16.1	11.0	33.0	15.5	37.9	14.0	18.3	18.7	18.4	33.6	26.3	61.3	23.1	9.3	19.2	3.2	6.9	5.6	12.1	6.0	7.5	13.3	8.1	9.7	6.4	7.8	11.7	6.0	11.8	13.3	15.5	4.7	14.1	7.4	7.6	9.1	8.6	14.0	13.8	29.5	6.0	5.4	18.3	12.0	12.2	11.6	6.6	4.6	7.1	8.6	15.4	8.9	3.9	10.4	9.3	7.9	8.6	14.4	11.2	10.3	10.2	7.5	13.0	6.3	6.5	9.1	9.7	6.2	8.5	9.5	8.4	8.4	4.5	6.2	11.6	3.9	11.6	14.9	14.2	4.3	42.7	23.1	15.3	13.5	10.7	9.8	24.6	16.1	12.2	6.7	33.6	19.2	17.5	61.3	9.3	12.1	26.3	10.7	3.2	42.1	52.4	53.4	41.2	33.5	12.7	25.6	28.6	24.4	33.0
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036074, HPA036075, HPA061487"	Approved		Supported	"Nucleoplasm,Golgi apparatus"	"Secreted - unknown location"		6600000	"Golgi apparatus"	Nucleoplasm	"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: "	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	18.5	22.0	6.4	14.9	8.2	9.5	16.7	9.2	11.0	17.8	34.2	13.5	21.2	31.1	17.4	18.7	33.2	19.2	21.8	11.5	6.1	4.6	22.5	18.3	21.5	14.1	7.0	5.4	18.0	19.5	11.6	10.4	26.3	9.0	18.4	26.8	16.4	25.1	13.6	10.0	18.3	66.6	12.8	8.1	22.7	15.7	21.2	6.0	13.9	28.4	19.1	24.7	17.6	17.5	2.3	12.1	12.3	17.0	1.6	3.1	2.2	19.0	20.7	12.3	18.5	20.2	19.0	31.1	14.7	28.5	18.4	20.8	14.8	24.4	4.1	18.9	25.8	34.6	15.7	28.7	12.9	11.3	20.3	10.4	9.9	13.9	17.2	26.4	36.8	17.3	29.7	16.4	18.9	33.1	23.6	6.2	18.6	17.4	3.6	11.2	17.4	10.3	13.9	17.4	29.4	38.3	17.3	14.3	12.1	36.3	45.4	14.6	34.5	15.1	23.6	8.7	11.7	8.4	17.8	13.8	11.1	3.7	8.6	22.5	17.3	10.8	9.2	12.3	1.9	15.7	2.6	1.6	2.0	2.2	12.1	2.3	1.8	2.1	6.7	1.6	17.0	4.5	3.1	2.2	6.4	8.2	9.2	11.0	6.1	4.6	7.0	5.4	9.0	6.0
RNPS1		ENSG00000205937	"RNA binding protein with serine rich domain 1"	Q15287	16	2253116-2268412	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044014	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA044014: AB_10966286"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.27e-1)"	15.5	17.7	25.2	17.4	22.9	42.6	17.1	36.0	34.1	16.4	19.2	19.2	11.5	16.2	20.7	17.0	22.1	21.4	18.3	20.0	23.1	26.7	15.5	18.5	14.8	23.7	20.7	27.4	22.2	17.1	18.3	20.9	26.8	21.7	18.6	14.4	16.7	15.7	20.0	50.9	23.0	15.6	17.8	16.2	19.5	16.6	73.5	13.7	19.5	17.6	29.9	22.8	17.2	15.9	52.4	40.0	30.2	44.3	43.9	48.7	62.1	18.2	28.1	28.0	31.7	16.0	15.3	34.5	19.9	17.1	34.2	29.8	54.6	26.5	36.8	22.8	18.8	28.3	37.9	27.2	22.9	28.9	49.6	24.3	23.2	35.5	27.3	26.1	29.0	18.3	31.1	27.3	37.2	26.0	47.9	38.0	26.8	46.4	64.2	61.2	63.4	22.6	81.4	28.7	58.3	22.2	12.8	66.0	38.1	25.2	30.3	29.0	30.7	33.1	16.7	29.6	28.1	26.1	30.7	34.7	47.3	91.8	12.6	28.9	34.6	10.0	37.1	30.2	46.7	42.9	46.1	48.1	45.5	47.6	40.0	52.4	43.5	45.9	11.4	43.9	44.3	33.9	48.7	62.1	25.2	22.9	36.0	34.1	23.1	26.7	20.7	27.4	21.7	13.7
ROBO1	"DUTT1, FLJ21882, SAX3"	ENSG00000169855	"Roundabout guidance receptor 1"	Q9Y6N7	3	78597240-79767815	"Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013524, HPA052968, HPA074461"	Uncertain		Enhanced	"Plasma membrane"			6500000	"Plasma membrane"		"CAB013524: , HPA052968: , HPA074461: "	"unprognostic (2.89e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavourable (9.88e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.16e-2)"	12.5	10.1	15.5	10.7	30.2	0.4	7.3	12.5	22.0	15.9	9.4	14.7	1.6	3.5	10.5	8.2	13.7	5.6	8.6	9.0	12.3	12.4	3.7	4.0	8.3	9.3	14.7	8.9	18.4	2.3	2.1	29.6	8.4	12.2	14.5	6.9	8.5	5.5	13.8	4.5	21.8	5.4	11.4	8.1	9.2	5.0	10.8	15.7	14.0	5.5	8.8	18.8	13.2	14.1	1.0	0.7	0.0	0.4	0.1	3.1	0.1	0.0	10.9	10.4	16.6	14.5	9.6	0.5	8.3	11.2	6.6	5.6	0.2	4.6	0.0	0.0	10.3	4.3	12.6	8.6	8.3	0.1	16.0	6.3	21.6	17.0	3.5	0.1	1.6	15.9	11.8	25.0	11.9	6.6	0.8	19.7	6.8	5.1	0.0	0.0	13.2	3.9	0.3	10.9	0.1	0.0	3.5	8.1	5.5	17.9	4.1	6.6	12.7	0.1	0.1	22.1	9.7	13.1	14.0	0.7	0.0	0.0	20.1	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.7	0.3	0.0	3.1	0.0	0.1	0.4	0.0	0.0	0.1	15.5	30.2	12.5	13.6	12.3	12.4	14.7	8.9	12.2	15.7
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179761-11348330	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol			3700000	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	26.9	7.8	14.6	9.5	21.9	4.4	21.4	26.1	26.4	16.6	16.5	5.6	8.6	12.3	22.4	11.0	12.4	13.2	11.9	12.3	13.4	7.6	11.4	12.3	16.7	6.8	7.2	16.7	15.1	8.6	12.9	14.8	18.4	10.3	14.4	20.3	5.6	10.3	14.4	28.0	8.7	13.8	42.9	7.1	12.6	10.7	5.8	9.6	5.9	10.5	5.1	6.2	22.1	20.8	2.5	3.0	3.6	2.2	3.5	3.3	0.9	6.5	15.9	13.2	12.9	23.8	16.7	8.4	15.5	14.5	10.1	10.7	15.0	14.3	8.2	9.2	24.5	7.3	9.5	8.9	16.0	11.7	5.7	16.4	27.4	30.0	8.6	9.1	4.7	13.0	5.7	12.4	8.9	16.1	14.2	3.3	15.0	5.5	6.7	4.7	7.3	9.8	8.1	29.0	2.6	5.5	18.5	6.2	6.6	30.4	10.6	10.6	4.3	5.1	21.9	20.9	15.1	8.3	13.6	2.6	3.2	7.3	9.0	10.8	29.1	3.6	1.8	1.7	2.7	2.2	3.3	1.6	2.2	1.8	1.3	2.5	1.9	2.1	3.0	3.5	1.7	3.0	1.8	0.9	14.6	21.9	26.1	26.4	13.4	7.6	7.2	16.7	10.3	9.6
RORC	"NR1F3, RORG, RZRG, TOR"	ENSG00000143365	"RAR related orphan receptor C"	P51449	1	151806071-151831872	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.8;skeletal muscle: 63.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.1;Karpas-707: 11.0;MOLT-4: 5.6;RPMI-8226: 5.8;SK-BR-3: 5.0;T-47d: 8.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 7.0;pons and medulla: 2.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 28.3"	"Lineage enriched"	"Detected in single"	44	"T-cells: 28.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065620			Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA065620: "	"unprognostic (6.51e-2)"	"unprognostic (7.78e-2)"	"prognostic favourable (1.83e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-4)"	"unprognostic (6.29e-5)"	"unprognostic (1.13e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (2.94e-5)"	"unprognostic (2.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-2)"	1.3	1.6	0.4	3.4	0.9	0.0	3.3	7.0	0.3	2.7	10.0	0.7	19.8	4.2	1.2	6.7	3.4	8.7	3.5	4.8	0.4	0.5	13.3	30.8	8.7	0.7	0.9	0.3	1.3	30.3	8.5	9.4	0.2	2.4	7.0	4.0	2.8	27.8	33.4	63.8	9.8	10.3	0.8	0.3	0.7	7.7	6.4	1.1	69.8	15.6	11.1	4.0	2.4	1.7	0.0	0.1	0.0	0.0	0.6	28.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	2.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.8	0.3	0.0	0.0	0.2	0.1	5.0	0.0	8.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.9	0.0	28.3	0.0	4.4	4.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	3.0	0.6	0.4	0.9	7.0	0.3	0.4	0.5	0.9	0.3	2.4	1.1
RP9	PAP-1	ENSG00000164610	"RP9, pre-mRNA splicing factor"	Q8TA86	7	33094797-33109401	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: "	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"	10.1	13.8	11.7	9.4	16.0	20.7	14.9	17.1	16.0	10.9	12.2	13.0	7.0	10.3	14.6	18.8	8.1	10.0	10.7	19.2	11.1	10.1	11.4	11.5	9.7	19.4	17.4	8.6	14.2	16.9	10.4	14.2	11.7	11.0	14.0	11.8	12.8	15.0	14.4	34.7	10.7	12.5	15.7	11.8	17.2	10.5	15.2	12.6	13.6	15.6	9.0	18.2	13.4	16.0	34.1	11.7	8.1	5.0	5.9	8.4	3.3	9.7	14.0	14.8	16.9	9.4	8.9	7.0	12.4	10.6	14.5	11.6	12.4	7.2	12.4	8.2	10.3	9.8	17.9	10.7	18.6	5.6	11.1	9.1	11.1	11.6	16.6	12.1	6.3	8.9	10.1	16.4	32.5	11.8	16.2	11.4	14.4	20.2	12.9	33.2	12.4	10.1	13.0	12.9	8.2	10.4	9.4	14.3	19.7	8.7	19.6	21.2	10.3	16.8	9.4	14.3	20.1	12.7	20.2	18.6	16.8	24.7	10.1	17.2	27.6	6.4	5.0	8.1	6.6	3.6	6.1	22.0	7.0	7.4	5.3	34.1	8.4	7.8	0.9	5.9	4.6	11.7	5.9	3.3	11.7	16.0	17.1	16.0	11.1	10.1	17.4	8.6	11.0	12.6
RPA1	"HSSB, REPA1, RF-A, RP-A, RPA70"	ENSG00000132383	"Replication protein A1"	P27694	17	1829702-1900082	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004563, HPA006914, HPA046497"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: "	"unprognostic (1.84e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavourable (9.00e-9)"	"unprognostic (9.59e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.52e-2)"	19.8	18.9	17.5	22.2	18.6	15.7	19.6	21.0	19.2	20.1	21.2	17.0	26.7	15.9	23.7	20.1	23.8	23.2	20.6	27.6	15.0	15.6	13.3	15.2	19.2	27.6	19.6	19.8	28.8	17.8	18.8	15.7	15.2	15.0	20.2	16.5	20.9	22.9	23.3	46.1	23.6	18.6	21.7	15.0	18.7	17.0	13.9	17.5	36.7	21.1	24.4	33.1	23.6	19.1	24.6	14.5	23.9	19.7	34.2	27.1	25.2	27.4	28.2	25.7	23.6	13.0	13.1	28.7	22.6	14.2	30.1	31.5	39.9	12.7	38.7	21.3	14.4	25.6	31.8	19.4	34.0	25.3	37.4	23.5	35.0	16.6	8.6	17.2	20.9	10.7	12.8	29.6	13.0	21.7	22.1	22.3	21.0	15.8	37.0	11.0	19.6	16.5	51.6	13.8	21.0	13.4	19.0	11.1	17.2	32.1	11.3	20.0	23.2	13.6	16.8	20.5	17.9	23.7	34.2	6.2	16.2	22.3	14.7	27.2	25.4	16.7	11.3	23.9	25.9	16.2	26.3	24.6	27.1	25.7	13.8	15.4	26.8	24.3	5.5	34.2	19.7	14.5	25.0	25.2	17.5	18.6	21.0	19.2	15.0	15.6	19.6	19.8	15.0	17.5
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favourable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	18.6	17.1	33.6	24.3	38.8	20.5	26.6	23.6	30.5	20.0	15.4	17.2	17.6	9.9	19.5	26.3	18.7	28.8	19.2	22.5	31.4	22.1	19.5	18.4	19.3	37.1	22.0	26.7	32.6	15.3	16.4	27.0	17.2	25.4	17.2	19.0	18.0	16.2	19.8	45.0	22.6	16.8	18.6	22.1	28.4	15.3	34.6	27.7	25.4	30.7	17.2	37.9	20.3	17.1	46.2	31.5	48.4	18.1	49.3	55.9	65.9	13.0	12.5	21.0	15.7	14.3	13.2	12.7	24.3	16.5	31.1	27.1	17.7	16.2	33.3	15.6	9.6	12.2	29.6	13.7	30.4	24.6	27.5	38.7	16.9	15.2	7.2	51.3	27.3	5.7	7.7	30.0	15.5	13.4	40.4	29.0	18.0	13.3	36.5	22.5	41.1	26.7	24.4	31.1	15.5	11.1	14.2	17.9	17.3	26.8	10.8	21.2	11.2	15.2	8.5	7.7	16.7	41.5	15.9	23.6	52.5	28.9	19.0	45.5	13.9	42.8	18.1	48.4	51.6	14.0	55.9	46.2	48.8	47.3	20.4	39.0	55.8	53.9	18.1	49.3	18.1	31.5	42.5	65.9	33.6	38.8	23.6	30.5	31.4	22.1	22.0	26.7	25.4	27.7
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92298965-92402056	"Enzymes, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA046443: "	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	6.8	7.0	7.8	7.3	10.5	12.0	7.6	27.2	11.6	8.4	6.3	7.1	7.2	6.6	11.1	11.5	5.6	6.3	5.5	5.9	8.1	8.6	8.1	10.6	5.2	8.2	7.7	6.7	8.2	8.6	9.4	16.1	6.7	11.7	7.6	5.8	6.4	7.2	7.1	10.5	10.7	6.3	7.4	9.9	7.6	6.4	6.7	8.7	12.8	9.4	6.5	6.3	6.6	7.6	4.4	3.5	4.9	2.4	4.0	4.8	1.2	6.2	3.8	6.7	6.1	5.5	7.1	5.7	4.9	3.4	3.2	2.7	2.7	2.8	9.3	8.5	3.6	4.3	5.5	3.2	5.0	6.3	4.0	5.7	6.9	3.6	3.3	9.8	5.7	3.6	3.9	4.2	4.1	3.4	5.8	6.2	4.9	3.2	8.3	6.2	5.2	4.3	6.2	8.9	4.0	4.2	5.6	6.2	4.6	8.0	7.3	4.0	3.9	7.5	6.0	4.9	6.2	5.6	6.9	6.0	7.0	4.9	3.4	6.2	3.3	4.8	2.4	1.9	4.1	1.7	4.8	3.4	3.2	3.5	1.8	4.4	3.5	3.8	4.9	4.0	1.9	3.5	2.8	1.2	7.8	10.5	27.2	11.6	8.1	8.6	7.7	6.7	11.7	8.7
RPAP3	"FLJ21908, hSpagh, spag"	ENSG00000005175	"RNA polymerase II associated protein 3"	Q9H6T3	12	47661249-47706061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038311, HPA038312"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA038311: AB_10671527, HPA038312: AB_10672512"	"unprognostic (5.76e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.47e-1)"	"prognostic unfavourable (2.01e-5)"	"unprognostic (9.89e-2)"	"unprognostic (9.87e-3)"	"unprognostic (6.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.11e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-2)"	12.1	13.2	20.3	17.0	19.9	10.6	15.3	23.5	23.2	13.2	16.2	6.7	14.9	13.0	15.7	14.7	16.4	15.2	11.7	15.4	18.4	14.8	12.9	16.0	10.3	25.7	18.8	18.4	23.3	12.1	15.7	24.6	12.3	20.5	14.2	12.5	5.2	14.4	12.8	47.6	11.1	12.8	15.1	22.8	18.2	12.1	14.3	19.1	21.5	13.4	14.4	26.7	16.8	13.2	15.1	10.2	22.7	16.9	9.3	11.5	6.2	15.7	14.8	18.0	12.3	9.7	13.9	15.2	15.7	16.3	20.0	17.2	20.4	18.0	35.0	21.7	13.9	15.8	15.5	9.3	23.4	18.6	14.6	23.6	10.0	9.9	8.4	25.0	16.5	6.8	11.5	23.3	8.5	12.4	25.8	10.8	17.6	11.3	21.4	18.1	19.3	12.7	17.4	21.7	17.1	16.3	14.4	13.0	9.5	18.4	15.2	15.7	15.5	15.1	8.9	13.9	18.4	15.2	17.3	8.5	15.8	25.0	13.0	55.6	8.5	2.6	7.6	22.7	7.9	14.4	8.1	15.1	8.9	8.5	10.2	14.0	11.5	10.3	14.2	9.3	16.9	7.1	10.9	6.2	20.3	19.9	23.5	23.2	18.4	14.8	18.8	18.4	20.5	19.1
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84497790	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli				Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	20.9	20.4	21.3	25.1	36.2	42.7	26.3	14.8	24.7	21.3	24.8	12.8	18.8	18.8	25.5	27.4	26.0	20.8	18.2	39.8	17.9	16.5	33.1	33.8	21.3	27.2	16.7	15.1	23.9	21.3	16.8	25.7	19.8	16.0	23.7	24.0	14.1	20.8	26.2	56.8	22.1	22.7	20.8	16.6	33.9	22.8	31.0	20.3	31.8	29.3	27.9	30.2	30.0	23.1	36.9	23.1	29.2	26.0	31.8	33.9	26.1	19.0	13.4	17.0	14.2	13.3	17.7	19.2	19.6	17.4	25.7	22.9	10.1	8.2	14.7	22.2	15.5	14.5	25.5	20.2	28.4	21.1	26.8	36.9	15.1	17.5	18.5	35.5	12.1	14.1	30.1	26.8	19.1	20.5	35.6	18.9	22.4	9.9	33.3	23.9	42.4	30.0	21.5	27.3	11.8	24.4	22.4	21.4	20.0	11.4	24.5	46.8	13.8	24.3	14.0	19.4	19.3	30.5	40.5	13.1	15.4	32.4	9.1	32.0	17.3	29.2	21.3	19.6	26.6	24.6	29.3	36.9	30.4	26.9	22.5	31.0	33.8	33.9	8.9	31.8	26.0	23.1	31.3	26.1	21.3	36.2	14.8	24.7	17.9	16.5	16.7	15.1	16.0	20.3
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 81.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavourable (2.04e-4)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavourable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	21.1	17.1	13.9	14.1	19.2	15.4	20.7	16.7	17.3	14.5	13.8	9.0	10.3	10.3	15.4	12.1	19.2	15.8	14.4	19.6	16.5	11.0	18.8	30.7	12.2	15.3	16.8	11.3	20.9	25.9	13.7	21.6	15.5	19.3	15.5	14.1	9.5	14.0	11.5	46.3	16.7	10.6	19.8	17.4	16.3	14.2	18.1	18.7	10.0	20.4	29.3	15.8	22.1	15.1	10.3	9.3	0.8	7.7	11.1	12.4	6.1	7.9	3.8	4.3	17.0	7.6	11.9	11.3	11.4	6.8	10.1	10.1	15.4	5.7	18.6	10.9	5.7	9.1	14.3	10.8	22.9	7.9	13.1	12.2	4.8	8.9	9.1	18.4	5.9	7.2	8.7	14.0	28.7	8.0	32.3	10.3	12.6	7.7	13.6	19.4	12.5	6.9	13.1	8.2	13.3	9.7	7.9	7.3	9.5	5.0	6.7	18.7	6.1	15.7	5.2	8.3	7.4	81.5	30.4	4.4	6.8	23.2	11.1	23.3	16.7	0.3	6.9	0.8	5.9	7.7	12.4	10.3	8.4	7.7	8.1	7.8	11.1	10.5	0.2	11.1	4.9	9.3	7.3	6.1	13.9	19.2	16.7	17.3	16.5	11.0	16.8	11.3	19.3	18.7
RPGR	"COD1, CORDX1, CRD, RP15, RP3"	ENSG00000156313	"Retinitis pigmentosa GTPase regulator"	Q92834	X	38269163-38327564	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	"Guanine-nucleotide releasing factor"	"Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 55.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 15.3"									"HPA001593, HPA073455"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA001593: AB_1079835, HPA073455: "	"unprognostic (3.22e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-6)"	"unprognostic (1.93e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.61e-3)"	16.4	5.9	6.1	7.1	9.0	17.4	13.8	7.2	7.0	8.3	8.4	7.1	2.5	5.1	8.8	9.4	5.4	20.8	9.4	6.3	7.2	9.4	4.9	4.9	10.7	7.8	8.9	4.2	7.9	7.2	3.8	55.4	6.3	14.6	5.9	6.4	6.3	3.7	4.8	13.3	4.3	6.2	8.3	9.9	5.1	4.9	11.6	5.7	5.8	8.3	3.6	5.4	7.7	10.9	1.9	2.6	15.3	2.6	1.6	3.1	1.7	3.3	4.4	2.5	2.3	2.9	4.1	1.9	4.2	4.9	3.1	3.6	1.9	1.7	4.9	1.4	2.7	3.2	3.0	1.3	4.3	5.2	5.5	1.8	2.1	3.9	2.6	22.5	4.3	5.9	1.8	6.2	7.0	14.1	2.3	0.0	4.2	1.3	6.6	12.6	6.5	5.6	4.9	8.6	4.6	2.7	2.2	1.9	3.7	4.6	1.9	5.0	1.2	3.9	16.4	3.4	6.0	8.0	5.0	1.4	2.7	4.3	8.0	4.4	4.6	1.4	2.6	5.7	1.4	2.3	3.1	1.9	1.7	1.8	2.6	1.8	2.5	2.0	15.3	1.6	1.8	1.8	1.9	1.7	6.1	9.0	7.2	7.0	7.2	9.4	8.9	4.2	14.6	5.7
RPGRIP1L	"CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134"	ENSG00000103494	"RPGRIP1 like"	Q68CZ1	16	53598153-53703938	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039405, HPA040530"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039405: AB_10794636, HPA040530: "	"prognostic unfavourable (6.93e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.92e-4)"	"unprognostic (5.95e-2)"	3.0	6.5	8.0	3.8	13.8	2.7	6.1	5.3	12.7	6.3	3.3	2.4	6.8	2.4	7.3	7.8	3.9	11.7	4.9	3.3	9.1	9.9	5.5	2.2	3.5	3.1	5.9	13.2	6.5	3.2	18.5	25.8	3.8	9.0	5.2	3.5	1.7	3.4	5.3	2.3	3.6	2.0	6.3	3.5	1.9	3.5	20.9	4.7	3.1	7.6	2.3	3.1	4.4	3.6	4.9	2.0	1.8	1.0	2.1	5.6	1.3	8.9	11.2	10.1	9.2	12.1	11.8	4.4	10.0	6.6	9.4	2.7	6.1	7.3	6.0	7.2	10.3	10.5	8.4	9.6	16.7	3.6	5.9	2.2	9.4	6.1	5.0	5.4	4.1	7.4	5.9	10.5	6.5	7.0	5.5	3.5	13.8	3.4	8.9	3.8	6.4	5.3	15.1	13.8	7.2	12.1	2.4	17.5	6.6	12.4	5.2	4.6	7.9	4.3	6.3	10.2	7.3	8.4	8.9	4.6	5.2	10.7	15.5	3.3	6.0	1.7	0.9	1.1	3.6	1.0	3.5	3.2	2.6	3.3	0.8	4.9	2.6	5.6	1.8	2.1	1.0	2.0	2.1	1.3	8.0	13.8	5.3	12.7	9.1	9.9	5.9	13.2	9.0	4.7
RPL10	"DXS648, DXS648E, FLJ23544, L10, NOV, QM"	ENSG00000147403	"Ribosomal protein L10"	P27635	X	154389955-154409168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB010339, HPA011311"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"		"CAB010339: AB_2181277, HPA011311: AB_1856431"	"unprognostic (2.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (7.67e-6)"	"unprognostic (6.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.68e-2)"	103.6	65.3	41.4	108.0	48.5	103.7	152.6	82.4	70.7	118.2	80.6	44.6	107.8	51.3	100.4	75.5	105.2	122.3	52.6	82.5	38.2	31.9	112.1	155.0	97.6	190.2	48.2	37.4	223.5	242.3	35.0	51.9	87.4	53.1	83.6	77.1	66.7	109.9	101.5	125.9	121.8	108.9	78.7	51.4	93.9	90.5	33.9	47.2	158.9	198.9	137.9	134.4	86.9	119.3	252.9	168.6	64.4	124.1	149.1	304.9	445.3	187.8	87.1	87.3	66.8	198.2	375.4	77.2	72.2	167.6	139.1	177.0	77.2	84.5	372.4	175.0	120.5	73.0	170.8	173.0	119.6	81.8	135.4	50.2	62.4	84.6	233.1	107.9	74.4	283.3	274.0	83.6	261.3	218.2	70.7	119.0	135.8	94.3	117.5	105.0	68.7	150.6	140.9	82.7	206.9	151.8	67.1	70.0	117.0	17.4	153.8	213.5	56.0	150.9	105.0	48.7	92.6	109.6	159.9	283.6	204.8	370.4	74.0	155.8	60.8	64.4	124.1	18.1	149.9	107.7	256.2	252.9	251.6	186.2	151.2	243.2	304.9	231.1	13.0	149.1	94.9	168.6	178.0	445.3	41.4	48.5	82.4	70.7	38.2	31.9	48.2	37.4	53.1	47.2
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468408-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			360000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: "	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	55.0	41.7	35.5	80.8	28.0	79.0	96.9	25.3	37.6	71.5	76.4	22.8	62.3	35.0	91.2	62.5	88.7	91.0	72.6	45.2	28.1	23.1	45.4	71.1	44.8	94.0	28.5	38.0	155.3	141.2	18.6	35.6	56.6	25.6	86.5	55.2	34.7	104.5	66.1	98.5	92.9	47.2	56.8	27.3	51.4	55.5	33.2	20.1	70.6	62.0	121.6	76.5	77.4	86.4	165.3	104.4	8.5	62.8	101.1	186.5	235.1	65.8	68.0	77.4	72.7	116.0	211.6	87.7	68.3	140.6	96.3	76.8	98.4	63.8	197.7	63.0	92.5	58.5	104.2	155.8	80.1	68.5	91.8	75.9	63.0	137.4	171.8	110.6	63.3	245.9	182.7	70.6	237.0	141.0	89.4	97.8	109.2	116.4	116.7	134.5	81.2	60.1	92.4	74.6	153.0	121.7	109.0	54.6	80.0	42.0	96.6	192.8	104.5	201.8	81.3	31.5	56.9	41.8	85.9	61.8	100.6	130.6	39.5	129.1	56.3	8.5	62.8	5.9	82.7	61.2	146.9	165.3	137.8	106.1	104.4	146.8	186.5	145.8	6.1	101.1	52.4	98.5	104.4	235.1	35.5	28.0	25.3	37.6	28.1	23.1	28.5	38.0	25.6	20.1
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560657-89566828	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"			53000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: "	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	82.5	56.0	46.7	105.0	38.4	112.7	150.9	37.7	44.0	114.5	114.9	31.3	76.9	65.5	118.4	85.4	144.0	98.4	101.6	85.2	38.6	32.1	60.8	118.3	90.4	385.1	38.8	37.4	231.3	255.8	36.5	57.5	66.0	27.0	136.2	44.4	43.0	267.3	87.6	197.4	137.7	66.7	90.2	44.8	104.7	71.1	106.5	24.6	135.0	102.4	129.6	98.6	109.3	156.8	277.8	163.1	26.9	96.9	120.7	299.0	355.4	66.8	74.4	52.9	85.7	95.2	158.6	110.8	42.3	91.7	88.4	35.9	112.3	103.8	94.1	87.4	71.7	93.1	62.8	111.2	44.1	26.3	174.3	32.0	41.5	148.9	203.8	38.9	39.1	192.1	237.1	56.6	142.9	92.1	97.8	53.7	67.9	209.5	106.4	305.2	108.1	79.1	158.7	56.0	132.2	107.3	56.2	74.6	109.1	58.6	76.5	126.9	150.5	231.1	53.7	57.1	61.7	50.3	57.9	81.4	76.5	96.0	74.6	137.3	60.0	26.9	96.9	15.3	129.1	74.9	239.2	252.5	234.3	176.5	116.8	277.8	299.0	230.2	10.7	120.7	56.7	163.1	163.7	355.4	46.7	38.4	37.7	44.0	38.6	32.1	38.8	37.4	27.0	24.6
RPL14	"CTG-B33, hRL14, L14, RL14"	ENSG00000188846	"Ribosomal protein L14"	P50914	3	40457292-40468587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 92.6;hTCEpi: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004136	Approved		Supported	"Endoplasmic reticulum,Cytosol"			210000	"Endoplasmic reticulum, Cytosol"		"HPA004136: AB_1079839"	"unprognostic (1.36e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.15e-1)"	49.9	33.5	28.3	57.4	43.8	47.2	134.4	28.7	57.6	85.4	68.2	21.4	48.0	29.8	87.0	30.9	66.0	61.0	56.7	46.7	40.8	22.8	42.5	69.8	44.6	61.7	24.7	22.2	151.9	117.3	48.4	34.4	60.8	40.6	81.8	42.0	36.2	162.9	73.6	72.3	66.7	39.0	59.1	24.7	69.6	52.4	23.8	11.7	42.9	63.3	100.2	58.5	48.7	77.0	26.6	16.0	4.6	11.6	14.3	38.3	47.9	9.5	5.3	32.5	11.5	26.3	92.6	18.9	14.7	49.3	55.5	42.1	11.1	3.8	41.9	12.4	14.5	2.9	16.5	25.7	32.7	14.2	18.2	20.1	9.2	10.6	40.3	28.5	10.8	44.8	96.7	15.8	33.5	50.8	23.6	5.9	38.4	9.2	9.4	26.0	9.3	17.3	4.4	12.3	20.3	41.1	7.1	10.1	16.3	7.7	7.5	22.3	11.7	15.7	16.9	11.3	8.2	14.3	18.6	18.3	22.0	22.9	5.0	21.5	10.4	3.7	11.6	4.6	21.1	11.6	35.5	26.6	31.7	27.7	16.0	24.1	38.3	34.9	1.8	14.3	9.9	14.6	24.9	47.9	28.3	43.8	28.7	57.6	40.8	22.8	24.7	22.2	40.6	11.7
RPL17	"L17, rpL23"	ENSG00000265681	"Ribosomal protein L17"	P18621	18	49488453-49492523	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043724, HPA046385"	Supported		Supported	"Endoplasmic reticulum,Cytosol"			28000	"Endoplasmic reticulum, Cytosol"		"HPA043724: , HPA046385: "	"unprognostic (1.11e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavourable (3.60e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-3)"	59.6	60.0	40.5	57.8	58.1	101.1	127.2	41.7	42.9	66.7	64.4	26.3	67.8	40.9	64.1	65.5	84.9	76.7	79.7	49.5	32.2	31.1	99.4	184.2	48.0	106.0	42.9	32.3	177.4	203.2	21.7	72.5	77.1	43.6	60.7	53.1	39.8	83.3	83.8	67.6	76.3	69.7	43.7	38.1	78.5	66.8	92.7	32.9	66.6	81.7	146.2	75.2	58.2	70.4	140.6	102.8	22.2	59.2	95.1	158.9	142.2	98.1	62.5	91.1	107.5	150.7	308.0	86.8	110.5	128.7	104.8	79.5	84.0	47.9	170.4	76.3	109.2	117.9	123.5	198.2	112.3	70.6	127.7	89.9	74.3	114.4	131.4	291.6	72.3	293.3	224.7	109.1	258.9	143.1	87.9	125.1	130.0	79.8	105.2	187.3	92.7	51.4	104.6	118.7	219.3	141.9	117.7	69.8	84.2	40.8	85.1	170.8	80.5	191.1	113.6	77.8	66.2	38.1	115.9	112.9	105.2	157.8	74.4	177.7	74.0	22.2	59.2	15.2	82.8	53.2	158.9	140.6	134.5	109.0	93.7	117.9	150.4	127.9	12.7	95.1	43.8	102.8	104.8	142.2	40.5	58.1	41.7	42.9	32.2	31.1	42.9	32.3	43.6	32.9
RPL17-C18orf32		ENSG00000215472	"RPL17-C18orf32 readthrough"		18	49481681-49492479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043724, HPA046385"	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA043724: , HPA046385: "	"unprognostic (1.62e-1)"	"unprognostic (1.67e-2)"			"unprognostic (1.70e-3)"	"unprognostic (3.83e-4)"		"unprognostic (1.95e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"		"unprognostic (2.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"		"unprognostic (5.42e-2)"		7.8	34.4	16.3	17.1	12.5	7.2	8.5	23.6	28.6	9.7	10.7	3.5	11.5	22.8	10.4	9.9	14.8	5.9	13.8	13.7	11.8	14.8	17.6	34.0	8.9	18.9	14.8	4.6	10.5	37.7	3.4	13.7	13.3	6.8	9.6	5.3	6.1	12.6	14.6	11.4	5.6	15.2	5.8	14.1	13.5	10.4	16.3	4.7	11.2	14.2	26.7	12.9	9.1	7.0	6.7	10.6	9.7	9.3	5.8	9.7	10.2	6.6	3.2	13.3	15.7	15.2	9.7	0.3	6.8	5.7	2.6	7.8	2.1	13.7	3.9	3.6	7.2	7.6	10.6	2.2	9.3	8.3	3.5	7.3	2.1	2.8	3.4	7.4	17.2	16.1	5.7	4.1	9.5	3.6	1.5	17.6	15.9	3.2	11.2	5.8	5.9	0.3	6.3	6.1	12.1	22.7	0.7	12.7	23.9	3.1	11.8	15.9	14.8	17.2	1.5	7.6	3.5	8.0	3.8	6.7	8.7	6.5	11.1	4.7	9.7	3.5	9.3	4.9	7.1	6.4	9.2	6.7	9.2	9.4	10.6	6.2	6.3	9.7	9.7	5.8	6.1	7.1	8.4	10.2	16.3	12.5	23.6	11.7	11.8	14.8	14.8	4.6	6.8	4.7
RPL18	L18	ENSG00000063177	"Ribosomal protein L18"	Q07020	19	48615328-48619536	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"NB-4: 548.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046572	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			100000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA046572: "	"unprognostic (2.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.27e-2)"	56.2	57.3	50.3	79.1	40.8	122.4	84.9	35.2	51.1	89.8	76.6	44.8	60.8	66.1	100.6	56.1	129.6	78.2	99.2	43.4	38.3	33.1	56.4	101.9	62.1	194.1	40.3	27.0	206.5	260.5	19.8	57.1	74.8	26.8	100.5	39.6	54.6	136.7	62.3	78.8	108.6	60.5	69.1	39.7	88.7	64.0	45.8	28.6	114.9	115.8	116.5	122.2	91.2	90.5	137.1	84.5	19.0	57.5	71.1	144.1	148.6	57.1	89.2	32.9	57.0	33.5	66.1	48.0	26.3	43.8	54.5	45.9	80.4	53.2	83.7	27.6	25.1	47.4	29.8	59.7	20.8	35.6	103.8	30.3	41.7	76.8	67.8	42.1	47.3	77.9	87.7	29.2	39.4	53.6	42.7	73.7	34.2	72.6	66.2	548.2	52.3	44.5	69.4	26.4	75.8	44.1	70.7	46.7	60.9	23.7	83.6	79.3	47.1	82.1	30.5	40.5	45.0	25.0	60.2	61.3	71.4	49.9	25.4	65.1	47.6	19.0	57.5	12.2	65.7	47.6	115.3	130.3	116.4	88.1	79.2	137.1	144.1	113.9	8.6	71.1	37.3	84.5	89.6	148.6	50.3	40.8	35.2	51.1	38.3	33.1	40.3	27.0	26.8	28.6
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204727	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"SK-BR-3: 937.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol			100000	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: "	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	72.3	57.7	51.3	56.7	56.9	122.5	94.7	41.8	88.6	72.2	64.5	42.2	62.7	48.7	67.0	56.7	77.7	78.1	65.9	87.3	49.2	37.0	62.3	124.4	70.7	229.5	50.5	53.0	156.4	124.4	33.1	51.7	57.3	58.7	60.0	52.5	48.1	113.8	67.6	91.4	95.8	58.8	57.5	57.1	74.4	66.1	45.2	34.1	53.0	63.3	94.9	103.4	63.1	75.9	208.2	143.4	40.4	108.7	116.2	236.3	325.8	47.0	64.0	46.4	56.3	85.0	107.5	48.1	44.3	90.4	91.7	73.8	69.7	44.5	115.2	78.0	63.2	80.0	69.8	91.6	47.3	46.7	122.5	41.1	47.8	90.7	132.6	100.6	56.9	119.7	100.6	70.6	127.9	79.1	71.4	67.4	63.3	46.4	133.2	140.6	47.5	47.7	79.0	66.1	115.1	82.7	59.0	56.5	62.8	26.6	937.7	138.3	90.8	128.1	46.5	35.9	48.5	54.6	81.4	89.0	88.1	84.7	48.7	76.8	46.1	36.7	108.7	40.4	116.1	90.3	180.1	208.2	187.2	146.8	143.4	193.1	236.3	190.8	17.1	116.2	72.6	132.4	146.2	325.8	51.3	56.9	41.8	88.6	49.2	37.0	50.5	53.0	58.7	34.1
RPL21	"DKFZp686C06101, FLJ27458, L21, MGC104274, MGC104275, MGC71252"	ENSG00000122026	"Ribosomal protein L21"	P46778	13	27251309-27256691	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047252	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			22000	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA047252: "	"unprognostic (4.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.55e-2)"	"unprognostic (7.72e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-1)"	54.7	44.0	57.3	52.2	68.7	133.6	105.9	39.8	50.7	63.7	61.7	46.3	32.7	42.7	57.8	53.0	59.3	57.7	55.0	63.9	48.0	36.8	64.3	148.7	44.8	100.9	53.6	44.4	142.9	109.8	19.0	48.2	57.8	61.2	52.5	57.2	36.5	85.7	47.2	68.0	72.2	66.3	64.4	48.7	72.8	58.0	46.4	50.0	60.5	58.3	87.6	92.6	59.1	64.9	178.1	103.2	34.8	57.9	95.6	224.2	258.9	56.3	47.4	83.9	67.7	87.5	166.6	71.1	102.5	94.0	80.5	52.3	114.2	105.2	216.5	39.6	81.4	75.6	96.1	104.3	95.2	68.3	87.5	169.2	48.2	88.2	82.8	230.9	67.2	148.0	171.2	52.6	134.1	90.1	69.8	53.9	91.2	80.5	116.3	143.6	109.5	79.6	87.0	161.2	90.8	75.1	67.9	72.7	67.7	47.6	95.8	83.1	64.4	206.6	99.5	35.8	46.7	56.1	83.6	36.5	51.2	161.3	45.8	147.7	60.6	34.8	55.8	22.1	101.6	56.9	162.9	178.1	153.1	125.7	75.9	164.1	224.2	177.8	11.9	95.6	57.9	103.2	104.1	258.9	57.3	68.7	39.8	50.7	48.0	36.8	53.6	44.4	61.2	50.0
RPL23	"L23, rpL17"	ENSG00000125691	"Ribosomal protein L23"	P62829	17	38847865-38853843	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003373	Approved		Supported	Cytosol			76000	Cytosol		"HPA003373: AB_1856436"	"unprognostic (1.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (4.19e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.45e-1)"	103.1	79.0	47.1	86.5	56.3	125.2	175.1	35.2	54.6	117.2	86.6	26.4	106.1	48.7	93.4	115.8	132.6	92.1	119.4	163.9	58.9	39.5	79.6	107.5	112.3	239.3	52.1	51.0	240.1	329.6	33.8	55.3	68.4	73.2	99.9	76.1	52.5	114.5	101.3	150.0	119.8	69.5	192.7	72.8	95.5	80.1	49.2	42.6	89.3	95.2	117.3	132.0	152.4	207.2	160.0	168.4	29.0	94.3	87.5	176.7	163.2	90.9	91.6	121.0	102.4	216.4	284.5	84.9	91.4	138.5	115.3	86.8	132.0	81.4	202.8	91.1	100.4	161.1	104.8	177.3	141.6	70.1	156.6	74.5	120.1	187.8	162.6	205.1	78.4	266.6	221.1	100.0	209.9	122.0	117.8	102.9	148.0	81.6	179.8	219.7	88.3	55.8	122.6	177.5	199.0	161.0	116.0	82.4	122.5	49.1	84.9	184.0	140.4	258.1	85.2	53.2	81.8	83.1	151.5	66.7	102.4	158.8	81.5	123.3	68.4	29.0	94.3	19.6	82.3	76.6	101.9	160.0	130.7	100.1	134.8	149.7	176.7	145.4	15.2	87.5	65.5	168.4	95.4	163.2	47.1	56.3	35.2	54.6	58.9	39.5	52.1	51.0	73.2	42.6
RPL24	L24	ENSG00000114391	"Ribosomal protein L24"	P83731	3	101681091-101686782	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA051653	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			19000	"Endoplasmic reticulum, Cytosol"		"HPA051653: "	"unprognostic (7.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (2.72e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.08e-1)"	"prognostic favourable (8.25e-4)"	"unprognostic (5.37e-2)"	61.3	58.9	60.6	99.3	68.8	87.9	135.5	73.0	90.1	94.7	64.0	15.8	84.3	49.6	74.2	98.0	75.5	65.4	82.9	110.0	45.6	43.8	58.3	70.3	122.0	256.0	50.7	46.3	174.7	211.4	25.9	65.5	68.2	53.4	69.0	54.7	30.4	133.9	109.9	175.9	66.2	46.2	98.7	80.7	51.4	60.5	30.2	44.1	61.3	84.7	134.3	71.7	105.1	175.4	128.2	107.7	29.6	65.6	85.5	173.8	214.1	163.5	54.4	83.4	92.0	91.5	164.0	126.3	94.3	105.4	127.5	93.5	108.2	72.5	180.5	117.0	72.1	87.1	96.6	116.8	127.8	96.7	96.9	107.0	47.2	80.9	89.9	120.3	56.7	159.1	149.9	80.2	143.3	107.9	97.9	90.1	117.2	109.3	128.2	184.3	150.1	118.2	113.1	82.3	172.4	130.1	73.0	178.7	83.1	49.1	88.3	209.1	107.9	221.4	78.8	55.6	103.2	30.4	114.6	79.2	101.1	315.6	74.5	127.4	93.2	29.6	65.6	16.3	86.1	57.1	125.2	128.2	136.4	104.2	90.5	127.0	173.8	132.3	10.9	85.5	56.9	107.7	121.1	214.1	60.6	68.8	73.0	90.1	45.6	43.8	50.7	46.3	53.4	44.1
RPL26	L26	ENSG00000161970	"Ribosomal protein L26"	P61254	17	8377516-8383250	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 586.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030449, CAB037301"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"CAB037301: AB_796168, HPA030449: AB_10602125"	"unprognostic (2.02e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.38e-1)"	122.5	64.5	70.2	102.5	49.8	132.2	170.4	44.4	52.4	127.6	131.6	34.8	68.1	53.1	76.4	97.0	161.2	87.6	98.6	68.1	54.8	42.5	100.6	138.3	97.5	117.5	61.6	32.6	183.0	586.0	32.2	41.1	82.2	47.7	129.0	84.0	41.5	95.3	87.4	170.8	106.3	98.6	103.6	62.9	129.0	75.9	53.0	45.1	104.9	131.6	145.8	107.9	154.7	127.6	154.9	120.8	25.1	92.1	93.0	158.2	165.0	101.9	93.8	92.3	109.2	174.4	287.2	90.3	88.6	131.8	120.3	90.9	99.1	52.5	178.2	101.9	104.9	113.3	117.4	181.5	141.7	66.5	211.4	69.5	103.6	114.3	203.9	103.2	90.2	244.7	363.4	99.6	299.5	148.1	78.7	53.7	126.3	70.1	113.8	141.3	86.8	62.3	113.7	93.8	110.8	161.7	76.6	38.4	82.0	47.7	89.2	204.8	91.2	138.3	92.8	48.7	60.8	67.1	155.0	43.2	50.4	77.9	79.7	146.9	72.1	25.1	92.1	18.2	89.9	78.3	130.5	154.9	134.3	116.8	120.8	140.1	158.2	136.0	10.9	93.0	69.5	104.5	111.3	165.0	70.2	49.8	44.4	52.4	54.8	42.5	61.6	32.6	47.7	45.1
RPL26L1	RPL26P1	ENSG00000037241	"Ribosomal protein L26 like 1"	Q9UNX3	5	172958729-172969771	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030449	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA030449: AB_10602125"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (2.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-3)"	11.2	23.0	17.9	14.7	17.9	18.0	15.2	10.5	21.1	13.1	12.8	8.2	14.4	13.5	14.5	21.6	18.1	14.7	11.9	19.5	20.7	16.8	20.0	25.9	10.5	16.7	16.2	18.0	14.1	25.5	9.1	15.4	14.2	16.3	12.1	14.6	11.5	18.4	16.7	19.0	9.7	10.8	14.0	12.8	13.3	12.2	73.6	11.8	20.0	16.2	18.2	14.9	13.1	11.9	19.7	40.0	17.5	36.2	14.6	21.7	20.9	29.6	26.9	24.4	33.5	16.9	17.9	31.7	28.4	16.7	41.1	36.7	32.8	32.0	22.4	73.0	38.9	19.3	40.2	56.4	38.0	28.5	52.3	16.5	31.6	40.1	33.3	24.0	14.7	22.3	23.9	42.3	29.7	23.5	22.6	18.9	29.2	65.9	29.3	38.0	15.5	42.9	21.4	37.8	29.7	23.9	18.7	24.6	15.1	26.0	23.9	37.7	29.3	25.9	24.7	47.0	26.1	27.4	21.3	16.9	26.3	41.8	37.0	30.2	27.8	7.8	36.2	15.5	14.3	31.4	18.3	19.7	17.4	19.6	40.0	15.1	14.5	18.4	17.5	14.6	26.8	27.5	21.7	20.9	17.9	17.9	10.5	21.1	20.7	16.8	16.2	18.0	16.3	11.8
RPL27A	L27A	ENSG00000166441	"Ribosomal protein L27a"	P46776	11	8682411-8714759	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 555.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060776, HPA063379"	Supported		Enhanced	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA060776: , HPA063379: "	"prognostic favourable (7.84e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (2.83e-10)"	"unprognostic (2.28e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-2)"	65.9	58.8	49.6	116.1	81.5	146.4	149.4	47.8	80.5	69.7	69.9	25.1	64.2	60.1	73.2	74.9	98.4	76.4	88.5	103.5	59.9	33.9	57.0	71.3	111.1	316.9	44.5	49.3	132.2	278.5	10.4	54.6	64.8	64.0	70.1	75.7	42.1	115.8	70.1	124.6	97.9	69.2	109.2	47.1	92.0	72.4	56.8	28.5	74.6	89.3	127.5	120.5	71.0	128.7	341.9	188.5	71.3	122.3	161.9	351.8	555.6	168.0	117.0	74.8	89.7	103.0	197.1	113.1	109.3	138.1	125.4	96.4	147.9	157.1	238.4	86.4	95.6	123.0	98.6	152.4	94.5	87.0	212.0	105.0	114.3	182.4	171.0	190.1	123.6	215.3	272.6	19.7	209.3	124.2	108.0	75.3	105.9	126.6	141.6	286.6	121.5	122.6	124.0	78.6	144.9	117.8	168.5	85.6	153.9	40.5	155.7	169.7	68.8	217.9	112.7	40.8	110.2	105.0	138.0	85.8	187.9	195.0	93.9	130.3	74.1	71.3	122.3	37.8	208.1	119.1	266.8	341.9	295.7	244.4	188.5	301.2	351.8	290.3	29.7	161.9	108.1	180.0	198.2	555.6	49.6	81.5	47.8	80.5	59.9	33.9	44.5	49.3	64.0	28.5
RPL28	"FLJ43307, L28"	ENSG00000108107	"Ribosomal protein L28"	P46779	19	55385345-55403250	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA050459	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA050459: "	"unprognostic (4.70e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.53e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (6.61e-5)"	"unprognostic (4.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.93e-3)"	91.7	86.3	81.9	112.8	68.3	166.7	88.9	32.8	84.1	117.1	107.7	86.7	71.1	89.9	144.6	81.3	224.2	105.0	118.0	72.9	66.2	54.4	87.1	228.8	133.0	398.1	70.4	50.7	200.5	198.5	25.5	73.7	88.7	53.2	122.7	61.2	88.0	143.3	77.9	102.1	136.4	108.1	76.8	70.7	205.5	85.8	75.9	27.4	375.5	144.6	108.5	269.6	131.8	121.7	139.5	93.6	27.8	77.2	66.7	146.6	190.9	119.3	139.0	48.4	96.1	86.5	139.3	81.7	81.1	77.6	71.0	65.9	135.4	63.8	179.5	58.4	73.4	75.2	55.0	104.2	31.5	69.4	312.4	110.7	87.9	164.7	143.9	128.7	97.6	195.4	149.9	52.7	106.9	76.2	85.6	147.8	63.2	138.0	143.8	119.7	115.9	152.1	146.0	69.8	136.6	89.9	239.2	61.7	102.0	51.6	170.2	122.1	70.7	138.0	92.3	63.5	71.6	50.8	128.5	121.9	175.6	112.0	81.1	157.6	53.5	27.8	77.2	21.9	77.0	67.8	119.7	137.8	129.9	101.2	93.6	139.5	146.6	130.8	24.4	66.7	56.3	88.3	117.7	190.9	81.9	68.3	32.8	84.1	66.2	54.4	70.4	50.7	53.2	27.4
RPL29	"HIP, HUMRPL29, L29, RPL29P10"	ENSG00000162244	"Ribosomal protein L29"	P47914	3	51993600-51995942	"Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 434.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA069064	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA069064: "	"unprognostic (3.77e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	91.6	61.7	42.5	64.6	33.0	110.2	111.0	30.1	39.7	102.4	98.1	30.3	57.1	53.6	59.6	72.8	124.7	76.0	68.7	72.1	33.8	26.0	55.7	122.9	64.8	219.4	36.0	26.0	150.1	434.1	16.3	34.3	50.7	26.3	91.1	41.2	38.9	103.7	54.8	160.8	102.5	73.8	80.2	38.1	83.9	59.7	58.7	25.2	85.9	83.3	123.3	92.4	88.5	87.1	137.9	98.1	32.8	80.0	74.8	132.2	202.9	69.2	90.1	69.5	105.9	123.9	194.9	98.1	77.5	95.8	106.5	88.7	107.2	106.5	193.8	33.8	78.7	63.1	100.2	164.9	51.0	78.8	136.3	100.3	116.5	178.9	147.0	145.5	96.8	238.2	234.6	78.5	139.9	119.2	78.2	148.9	78.5	158.2	126.2	189.2	115.4	153.0	58.7	76.6	187.9	136.2	144.9	56.2	109.7	58.0	133.9	132.4	100.2	248.9	103.3	59.8	80.4	92.2	115.5	97.1	137.7	137.8	79.1	174.5	79.0	32.8	80.0	22.6	68.8	61.7	115.0	137.9	112.2	87.6	98.1	128.2	132.2	109.9	10.8	74.8	48.4	82.8	100.8	202.9	42.5	33.0	30.1	39.7	33.8	26.0	36.0	26.0	26.3	25.2
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol			120000	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: "	"unprognostic (9.79e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.32e-2)"	71.7	71.8	51.3	72.3	50.3	107.0	134.5	50.8	49.3	102.2	94.4	42.7	78.1	63.1	207.5	79.6	126.9	101.6	96.2	54.5	41.4	38.8	66.6	102.5	74.5	205.9	47.4	57.7	217.8	453.1	50.9	75.0	74.5	58.0	138.7	57.0	74.8	216.3	68.5	48.9	118.1	62.6	115.6	50.7	84.3	74.4	76.4	23.3	105.5	158.5	82.3	109.8	119.9	105.7	198.9	114.8	18.9	56.4	150.3	249.0	326.4	86.4	80.1	91.6	101.3	117.3	254.3	123.5	67.0	127.6	67.1	60.3	100.6	66.1	357.7	92.9	80.7	57.6	97.7	143.3	44.7	60.8	96.3	90.0	95.8	150.5	173.2	127.9	76.0	245.7	194.2	58.0	206.7	130.4	101.3	124.4	96.9	111.3	129.8	186.2	95.8	55.9	104.3	88.9	179.5	123.9	128.2	83.9	99.1	42.0	137.6	219.3	103.7	208.6	129.2	45.1	71.3	47.2	76.3	95.6	72.2	158.4	101.6	113.1	50.9	18.9	56.4	11.9	132.5	51.7	205.6	198.9	192.1	153.7	101.2	175.8	249.0	195.2	8.1	150.3	44.5	114.8	126.1	326.4	51.3	50.3	50.8	49.3	41.4	38.8	47.4	57.7	58.0	23.3
RPL34	L34	ENSG00000109475	"Ribosomal protein L34"	P49207	4	108620566-108630412	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 400.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035139	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA035139: AB_10602925"	"unprognostic (1.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-2)"	"prognostic favourable (2.76e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.72e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.96e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	68.5	52.6	65.9	77.6	63.7	118.0	165.2	43.7	52.9	82.0	70.1	25.5	57.5	47.3	106.0	111.1	76.4	75.2	61.9	59.2	53.7	41.4	60.2	98.4	56.1	110.1	54.6	49.7	157.4	305.1	17.8	68.3	63.8	59.0	74.3	61.0	35.2	129.9	60.2	87.1	77.6	57.6	87.5	57.5	70.8	60.3	43.2	32.2	63.3	82.2	109.5	95.4	67.6	102.3	300.5	153.8	56.2	116.4	134.2	331.0	400.6	58.6	42.9	77.9	110.7	169.1	267.7	76.7	90.7	115.2	74.8	62.7	108.6	104.4	178.5	54.6	88.1	41.9	83.7	141.4	98.3	65.8	134.1	74.5	90.1	166.2	142.4	186.8	83.5	238.0	202.1	61.1	139.0	134.5	130.5	102.5	123.2	114.0	114.4	228.2	89.3	86.8	105.2	83.7	108.1	156.2	99.0	83.6	107.1	37.0	216.2	127.0	71.9	170.9	99.3	51.3	69.6	53.6	80.1	76.6	99.9	143.9	69.9	116.8	62.7	56.2	116.4	35.6	122.0	86.8	207.8	300.5	247.8	165.5	121.2	257.1	331.0	244.9	24.9	134.2	74.9	153.8	176.2	400.6	65.9	63.7	43.7	52.9	53.7	41.4	54.6	49.7	59.0	32.2
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396154	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: , HPA077586: "	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavourable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	62.9	40.7	50.7	81.5	53.8	139.8	136.1	27.7	46.8	65.3	71.0	25.1	53.4	45.6	67.5	71.4	77.1	59.0	60.6	54.9	43.1	31.1	47.3	60.1	43.4	190.1	42.1	50.6	165.3	171.4	15.0	35.1	44.7	41.8	55.9	68.3	26.1	158.1	71.5	125.7	96.5	54.1	65.5	44.6	67.9	54.6	26.3	32.6	60.8	69.3	118.6	104.0	71.9	74.0	162.9	113.2	13.7	74.2	86.7	175.5	199.2	121.7	65.9	101.3	49.9	124.9	224.1	64.8	93.8	103.0	123.1	188.2	78.1	62.6	236.0	93.9	77.9	82.3	151.4	131.4	128.4	83.0	166.1	109.1	116.3	71.9	179.6	198.4	105.2	212.6	248.2	99.7	185.0	113.9	131.8	126.9	99.2	175.4	91.8	236.7	134.6	134.1	86.2	221.7	184.9	112.6	50.8	68.0	135.8	87.6	98.4	167.9	47.5	224.6	105.1	36.6	89.6	101.1	95.1	108.0	154.2	186.5	45.0	295.8	39.0	12.5	74.2	13.7	86.6	73.6	140.3	162.9	162.3	120.6	111.4	134.0	175.5	156.7	7.2	86.7	70.4	113.2	84.9	199.2	50.7	53.8	27.7	46.8	43.1	31.1	42.1	50.6	41.8	32.6
RPL38	L38	ENSG00000172809	"Ribosomal protein L38"	P63173	17	74203582-74210655	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052543	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA052543: "	"unprognostic (1.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (2.51e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.71e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (6.17e-8)"	"unprognostic (1.89e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-2)"	105.7	85.6	114.6	92.9	94.2	140.7	148.5	58.8	142.3	91.1	107.6	42.6	88.1	74.9	88.2	104.6	89.3	88.2	86.2	152.3	87.3	69.2	67.5	83.5	132.5	313.8	111.4	104.1	258.2	305.8	26.7	59.9	62.8	95.4	73.0	79.4	41.2	118.9	101.8	283.6	108.0	73.8	150.8	162.9	108.0	77.7	99.6	108.3	77.1	67.7	143.5	133.2	92.9	195.6	174.9	141.2	54.0	106.3	80.4	217.6	213.6	95.1	94.6	91.2	93.0	125.0	148.2	90.4	103.7	67.0	95.0	66.6	106.1	73.1	168.5	72.7	88.6	86.1	108.7	134.6	74.5	46.9	174.4	96.3	80.3	136.9	146.0	179.7	86.1	284.4	189.4	89.1	145.3	138.8	118.1	94.0	79.3	100.2	174.0	217.4	106.6	143.4	126.0	193.5	149.6	112.5	74.7	82.7	154.3	43.3	181.3	224.3	138.1	187.3	90.7	79.5	129.5	73.1	135.3	127.8	197.0	173.9	65.1	119.2	75.5	54.0	106.3	37.3	112.2	84.4	132.9	174.9	190.5	140.5	115.2	174.7	217.6	185.8	34.0	80.4	74.5	141.2	117.4	213.6	114.6	94.2	58.8	142.3	87.3	69.2	111.4	104.1	95.4	108.3
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034600	Uncertain		Supported	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"			830000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	63.6	33.4	37.0	59.0	40.4	70.6	88.2	34.5	42.2	73.6	60.5	33.5	42.3	18.8	67.3	49.8	81.3	65.7	39.4	38.8	31.7	26.4	53.2	84.5	46.1	103.9	35.1	26.3	139.1	159.9	33.1	42.0	52.0	34.1	67.6	50.9	35.9	66.2	51.0	87.2	77.1	36.4	67.3	47.9	60.3	46.3	42.8	20.0	81.3	66.1	91.7	102.8	74.2	55.9	72.5	58.7	5.9	40.9	45.0	97.0	135.7	44.2	89.4	37.8	63.7	170.4	309.9	66.8	54.1	111.7	83.8	65.1	98.8	77.7	175.4	61.7	128.8	80.6	270.2	209.1	92.7	48.4	162.0	107.5	80.1	82.0	240.2	112.6	53.9	304.0	272.6	91.0	363.9	133.9	98.4	69.0	125.2	73.0	75.0	50.1	82.7	64.0	84.1	86.3	170.2	115.1	87.9	67.3	70.4	33.3	94.9	133.6	70.1	162.8	78.4	43.8	66.2	40.7	85.9	67.9	105.2	117.3	53.9	151.6	49.3	3.5	40.9	5.9	38.2	36.2	71.1	72.5	74.6	53.7	58.7	60.5	97.0	75.7	2.7	45.0	33.5	37.4	57.0	135.7	37.0	40.4	34.5	42.2	31.7	26.4	35.1	26.3	34.1	20.0
RPL41	L41	ENSG00000229117	"Ribosomal protein L41"	P62945	12	56116586-56117943	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053169	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA053169: "	"unprognostic (7.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	98.5	110.3	143.6	75.9	178.6	148.9	195.6	79.5	215.4	106.8	115.5	35.9	97.1	80.0	92.1	140.7	139.3	117.6	74.2	113.4	104.3	59.9	95.5	109.2	84.1	125.0	91.5	167.3	235.3	238.3	38.1	116.4	78.5	108.2	110.5	115.8	46.3	129.7	105.6	182.5	161.0	92.4	84.6	103.4	112.0	115.2	60.6	80.2	73.6	103.5	133.3	157.2	93.8	118.0	381.7	228.0	112.6	145.3	178.3	351.7	503.4	199.0	253.6	231.7	158.9	252.9	395.7	149.6	181.6	237.8	232.2	187.9	246.0	237.6	378.1	236.5	230.1	165.5	287.4	292.3	200.7	153.9	282.6	165.3	195.7	249.7	286.1	296.0	143.9	439.2	396.9	210.7	462.2	268.3	163.1	362.3	225.3	364.8	268.7	442.1	277.4	241.1	201.4	220.0	302.2	296.8	285.0	138.4	240.4	170.1	256.9	357.3	306.7	360.1	167.7	100.1	184.6	124.6	180.4	165.9	288.5	305.5	155.0	240.1	106.1	112.6	145.3	79.4	203.4	128.5	283.3	381.7	331.0	262.1	187.5	334.4	351.7	298.2	59.8	178.3	119.0	228.0	245.5	503.4	143.6	178.6	79.5	215.4	104.3	59.9	91.5	167.3	108.2	80.2
RPL5	"L5, PPP1R135"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92831983-92841924	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043717: AB_10964719, HPA054444: "	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	119.4	80.3	50.0	70.0	50.1	113.8	140.5	46.9	46.8	158.6	111.4	45.0	75.1	61.7	135.2	114.6	159.4	100.5	73.1	73.0	43.5	43.1	99.7	114.9	89.9	148.2	54.5	36.2	296.8	306.5	40.8	90.3	90.2	44.3	175.4	78.8	64.3	121.5	73.2	109.1	97.8	95.3	153.4	61.9	130.1	90.0	68.8	45.7	156.6	210.0	97.7	118.9	191.2	146.6	104.5	85.2	12.8	45.9	72.4	143.0	142.1	116.8	50.2	89.5	75.5	116.4	235.3	143.6	69.9	93.6	87.1	62.4	133.0	51.1	220.5	112.3	78.5	74.7	102.6	131.0	111.3	69.8	140.4	114.4	83.6	122.4	139.7	175.1	48.2	192.4	206.7	77.3	170.2	120.2	141.6	116.3	99.7	66.3	139.4	198.6	138.2	94.9	128.1	173.4	142.4	105.6	97.3	76.3	91.3	45.5	127.1	203.3	70.0	240.9	73.0	44.0	80.4	83.1	126.0	72.0	68.3	149.2	29.8	151.0	29.8	12.8	45.9	7.2	60.9	44.8	122.1	104.5	111.5	91.6	85.2	88.4	143.0	123.9	4.4	72.4	38.3	71.1	83.2	142.1	50.0	50.1	46.9	46.8	43.5	43.1	54.5	36.2	44.3	45.7
RPL8	L8	ENSG00000161016	"Ribosomal protein L8"	P62917	8	144789765-144792587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045095, HPA050165"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			240000000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA045095: AB_2679213, HPA050165: AB_2681038"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.13e-2)"	65.9	45.5	32.1	53.7	34.7	120.1	115.2	31.0	61.9	63.9	78.4	26.4	51.1	95.2	106.4	57.1	76.0	51.2	68.9	78.7	27.2	23.6	48.2	62.6	54.5	169.4	29.0	28.8	125.7	349.6	11.8	45.2	38.4	28.8	61.3	15.7	45.6	174.7	57.3	202.1	89.0	82.8	84.9	29.2	79.7	96.4	48.9	17.0	61.2	73.2	103.2	72.8	64.7	100.0	174.8	117.5	31.1	82.7	77.9	136.8	251.3	120.4	142.3	10.2	44.2	11.4	26.0	97.8	87.3	16.5	26.7	19.0	124.2	65.2	162.1	126.4	10.3	73.0	13.3	30.4	4.9	70.4	161.9	96.2	109.6	87.5	28.6	63.0	52.5	28.0	34.7	12.0	20.6	19.6	129.5	37.6	11.3	322.1	89.9	85.4	95.0	161.3	88.2	58.9	152.4	14.2	91.4	62.3	104.0	83.8	45.7	119.9	105.8	61.0	78.4	35.5	135.2	74.1	104.9	68.8	58.7	140.2	70.7	104.8	48.6	24.1	80.3	31.1	70.5	82.7	117.9	166.8	119.3	86.9	117.5	174.8	136.8	105.0	9.8	77.9	78.5	64.5	113.8	251.3	32.1	34.7	31.0	61.9	27.2	23.6	29.0	28.8	28.8	17.0
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452521-39458949	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			24000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	52.6	35.2	42.2	73.9	44.4	179.1	202.3	35.7	51.6	63.0	59.8	34.5	42.2	69.8	50.4	226.8	49.9	48.1	69.7	58.2	42.3	27.6	47.4	73.2	35.8	48.7	34.7	51.7	158.5	126.2	37.4	44.7	38.7	42.5	47.8	59.1	31.7	93.7	71.4	66.3	62.9	38.8	49.5	34.0	45.2	46.5	56.9	25.9	36.0	63.2	70.1	59.0	46.0	56.6	118.3	72.5	26.2	41.4	63.0	145.0	148.9	3.2	2.8	122.4	2.8	6.6	9.0	4.7	57.6	87.0	71.9	54.6	8.0	65.4	142.9	6.6	57.9	65.1	5.4	6.2	78.7	52.0	115.0	4.5	24.1	7.8	8.5	9.3	37.8	11.9	180.9	4.4	82.7	5.4	109.2	66.7	5.0	4.3	77.5	9.8	109.2	3.8	71.6	122.7	4.9	89.4	3.7	4.6	48.8	1.9	47.3	7.3	104.4	6.7	4.1	3.0	4.6	83.7	7.9	102.5	143.9	124.1	83.1	86.9	3.3	26.2	41.4	12.3	52.1	40.1	101.2	118.3	102.2	71.4	57.2	103.8	145.0	111.7	6.9	63.0	31.2	72.5	77.0	148.9	42.2	44.4	35.7	51.6	42.3	27.6	34.7	51.7	42.5	25.9
RPLP0	"L10E, LP0, P0, PRLP0, RPP0"	ENSG00000089157	"Ribosomal protein lateral stalk subunit P0"	P05388	12	120196686-120201235	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 408.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003512, HPA073501"	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA003512: AB_1079844, HPA073501: "	"unprognostic (2.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (7.66e-12)"	"unprognostic (2.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.47e-1)"	67.3	59.5	20.6	76.6	31.6	100.5	119.8	26.8	26.0	58.4	76.8	22.0	61.8	50.5	95.9	66.0	128.3	74.8	88.6	49.8	28.9	16.2	47.1	121.7	55.4	59.7	21.9	26.6	117.5	408.6	13.5	36.6	70.1	41.5	72.4	60.8	32.8	138.5	54.6	101.0	113.9	57.3	63.8	23.4	60.0	69.0	73.0	18.7	89.6	90.8	162.5	82.8	64.2	116.6	135.9	143.3	10.7	63.4	82.7	172.4	193.3	126.0	109.1	92.8	158.8	189.6	312.3	132.4	97.1	168.7	152.0	99.1	120.6	77.6	276.3	98.2	169.9	100.2	164.3	201.7	96.3	106.7	125.2	131.8	72.4	103.0	204.5	177.0	99.7	281.5	345.4	106.5	316.4	179.5	161.4	80.1	144.5	136.4	178.2	119.7	176.8	146.2	130.0	130.6	216.4	152.0	145.6	99.1	120.7	70.0	104.8	190.8	187.1	214.1	120.6	71.7	109.4	90.8	120.4	181.1	190.6	137.9	128.8	127.4	60.3	10.7	63.4	5.3	71.5	58.3	172.4	135.9	131.9	97.1	137.0	123.2	131.4	104.4	5.0	82.7	35.1	143.3	83.4	193.3	20.6	31.6	26.8	26.0	28.9	16.2	21.9	26.6	41.5	18.7
RPLP1	LP1	ENSG00000137818	"Ribosomal protein lateral stalk subunit P1"	P05386	15	69452784-69456194	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1030.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003368			Supported	"Endoplasmic reticulum,Cytosol"			1000000	"Endoplasmic reticulum, Cytosol"		"HPA003368: AB_1079845"	"unprognostic (5.04e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (2.30e-9)"	"unprognostic (7.75e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.83e-2)"	59.6	57.2	47.5	76.8	42.9	171.7	451.2	68.8	103.3	70.1	79.0	20.8	57.9	87.5	73.5	76.3	100.7	65.7	80.6	341.6	35.5	29.7	55.8	69.9	290.9	1030.2	42.4	33.3	134.3	209.0	8.6	36.0	52.3	45.6	71.0	33.3	61.3	102.8	60.7	262.9	155.2	74.3	128.2	38.8	77.4	77.1	45.7	32.7	73.0	50.8	146.9	71.8	72.3	95.5	329.0	226.3	79.6	176.1	169.8	267.2	368.8	82.7	84.7	38.0	87.6	54.5	65.8	81.7	72.9	43.3	40.8	32.7	85.9	84.4	115.9	109.0	38.3	113.3	58.5	57.3	8.9	116.2	179.0	97.6	97.3	83.8	95.5	86.4	89.2	82.7	100.5	29.7	55.7	49.2	91.8	98.9	28.8	77.6	94.2	254.8	142.1	81.7	96.7	124.2	169.6	39.3	89.7	60.9	118.7	73.2	90.6	297.4	74.7	199.0	86.3	59.2	132.5	70.6	118.3	202.7	323.2	98.3	70.9	220.7	48.8	79.6	176.1	60.4	119.5	124.7	220.2	329.0	247.2	162.7	215.0	278.5	267.2	223.0	26.2	169.8	70.2	226.3	202.7	368.8	47.5	42.9	68.8	103.3	35.5	29.7	42.4	33.3	45.6	32.7
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619970-128681075	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum"			8200000	"Endoplasmic reticulum"		"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	52.3	37.5	22.2	26.6	23.8	24.4	48.2	20.9	31.4	45.8	40.8	31.9	58.8	28.5	38.3	110.2	32.2	38.3	38.8	47.1	23.0	28.0	55.4	174.0	47.4	50.6	26.4	18.3	37.8	62.9	43.5	36.9	58.3	24.3	31.4	41.1	28.6	54.1	55.5	34.4	24.0	37.0	33.5	31.8	48.0	33.7	26.9	23.3	34.3	69.1	27.3	36.5	32.7	39.7	26.7	53.1	64.4	43.5	23.4	45.1	53.3	60.8	33.2	27.7	51.0	75.1	50.3	62.8	52.5	69.0	69.8	81.3	68.7	57.3	38.1	49.5	75.7	61.3	44.7	46.7	68.3	27.3	28.7	67.2	24.7	56.4	82.8	54.4	35.4	41.7	54.7	45.9	67.9	54.4	27.6	51.1	45.7	55.6	30.2	59.8	35.1	30.4	33.0	37.3	91.6	48.3	36.6	42.7	24.6	43.1	44.7	53.1	47.8	56.4	35.4	36.1	28.2	52.7	38.9	55.2	43.4	40.7	59.2	40.6	52.0	38.8	43.5	35.7	37.3	40.0	45.1	26.7	30.7	33.8	43.5	18.3	19.1	29.2	64.4	23.4	40.2	53.1	30.5	53.3	22.2	23.8	20.9	31.4	23.0	28.0	26.4	18.3	24.3	23.3
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241623	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"			2800000	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (2.44e-4)"	29.2	47.6	16.6	24.2	19.6	30.1	34.8	13.2	21.4	34.3	30.5	23.3	52.6	24.0	38.3	70.3	35.1	29.5	34.8	36.3	14.2	14.1	52.9	105.7	38.7	53.0	19.1	14.7	33.3	72.2	38.2	28.7	110.3	19.8	33.3	34.7	43.1	64.6	49.1	32.9	26.0	43.2	30.2	15.6	47.5	35.7	43.5	14.5	27.9	56.8	26.4	42.3	27.8	27.7	48.1	96.3	55.8	70.1	60.8	72.3	92.9	36.5	33.1	34.7	46.2	48.2	36.2	68.9	48.5	57.7	62.2	52.9	105.0	64.3	28.7	59.4	62.5	53.5	35.9	57.7	56.7	13.3	22.2	32.8	38.7	70.0	46.6	51.7	55.0	34.1	57.7	49.3	51.3	59.6	50.3	93.6	43.5	33.1	29.8	52.8	28.0	47.1	27.1	64.4	94.1	42.6	34.9	28.7	30.7	58.8	142.0	56.4	70.1	87.1	38.5	70.7	43.1	36.8	42.1	56.3	67.2	30.2	69.3	35.1	57.0	55.8	70.1	45.1	62.8	66.6	72.3	48.1	59.2	62.8	78.7	37.4	53.8	55.5	13.0	60.8	53.7	96.3	52.9	92.9	16.6	19.6	13.2	21.4	14.2	14.1	19.1	14.7	19.8	14.5
RPP25	FLJ20374	ENSG00000178718	"Ribonuclease P and MRP subunit p25"	Q9BUL9	15	74954416-74957464	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.6;SCLC-21H: 17.1;SK-MEL-30: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.7;monocytes: 6.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046900	Approved		Supported	"Nucleoplasm,Centriolar satellite"				Nucleoplasm	"Centriolar satellite"	"HPA046900: AB_10962049"	"unprognostic (9.36e-2)"	"unprognostic (7.17e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (7.18e-2)"	"unprognostic (5.73e-3)"	"unprognostic (5.50e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.50e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.53e-1)"	3.9	7.3	3.0	1.9	4.6	0.0	2.2	3.2	14.0	3.4	6.7	3.7	1.2	6.0	1.7	1.3	3.3	1.8	3.7	2.5	2.5	6.8	2.6	1.9	5.1	2.7	8.0	5.1	12.0	4.9	9.0	2.8	6.1	10.6	2.1	4.1	3.2	2.4	1.3	1.9	2.1	4.6	2.0	7.9	6.2	5.6	1.9	1.8	3.1	4.9	2.6	2.5	4.1	2.4	2.3	16.7	0.3	6.4	0.3	2.7	1.4	8.9	6.8	1.7	0.0	0.6	0.4	2.9	1.7	2.0	0.5	0.4	9.2	8.2	0.0	7.8	1.7	2.7	5.3	0.3	0.1	3.3	0.2	0.0	7.9	0.2	18.6	0.0	5.3	2.4	0.2	3.4	0.0	7.9	6.0	0.0	1.7	3.4	1.4	2.3	8.2	2.7	0.0	0.0	6.0	1.6	0.1	17.1	12.8	12.8	11.3	25.5	2.2	7.1	1.8	0.0	0.7	1.6	0.0	0.1	0.0	0.0	0.9	13.9	10.0	0.0	3.3	0.0	1.5	6.4	0.9	2.3	1.1	1.3	3.3	1.9	2.7	2.1	0.3	0.3	4.8	16.7	0.4	1.4	3.0	4.6	3.2	14.0	2.5	6.8	8.0	5.1	10.6	1.8
RPP25L	"bA296L22.5, C9orf23, MGC29635"	ENSG00000164967	"Ribonuclease P/MRP subunit p25 like"	Q8N5L8	9	34610486-34612104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052187, HPA059698"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA052187: , HPA059698: "	"unprognostic (1.56e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-1)"	"prognostic favourable (3.01e-9)"	"unprognostic (4.63e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.40e-1)"	"prognostic favourable (8.21e-4)"	7.4	10.1	11.1	7.9	13.8	4.9	9.3	8.6	14.0	8.2	18.0	7.2	14.0	15.4	9.9	11.4	13.3	11.8	10.9	19.9	9.8	8.8	11.1	19.9	9.3	10.1	10.1	9.1	11.7	20.4	6.3	7.6	11.0	7.5	14.4	8.2	6.4	15.7	9.5	56.0	9.7	18.4	9.3	7.1	11.4	8.6	10.9	6.1	14.4	14.8	21.9	11.3	11.0	10.4	40.7	30.1	41.5	35.4	32.5	41.7	24.8	18.8	24.6	10.0	9.7	10.3	9.5	10.0	8.1	8.5	13.5	15.5	10.8	12.8	14.5	12.6	4.9	12.7	15.1	20.4	4.8	29.4	20.3	8.7	18.3	15.8	21.9	8.9	13.3	16.9	19.7	11.2	26.1	14.1	13.9	15.6	10.2	20.1	18.5	33.6	9.2	22.3	16.5	10.6	14.6	14.4	9.9	6.7	3.9	14.9	16.8	9.5	15.3	15.8	6.4	4.2	12.4	10.2	6.7	7.6	13.3	16.6	12.8	18.6	20.3	41.5	35.4	33.3	25.6	28.8	31.6	34.9	30.2	26.9	30.1	40.7	35.5	33.5	32.9	32.5	33.6	24.5	41.7	24.8	11.1	13.8	8.6	14.0	9.8	8.8	10.1	9.1	7.5	6.1
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli				Nucleoli		"HPA045128: , HPA050398: "	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favourable (2.89e-6)"	13.1	12.2	12.4	10.7	13.6	9.7	18.3	22.4	12.4	13.6	16.7	12.0	15.8	14.4	15.7	16.1	15.2	18.2	10.3	10.0	11.6	10.2	17.4	21.6	12.5	16.3	15.0	10.0	14.4	16.8	11.3	16.0	17.4	12.7	18.4	15.7	11.7	17.1	14.9	20.9	14.8	17.9	14.3	11.5	16.7	13.5	38.6	12.7	18.8	19.8	13.9	18.5	13.4	13.6	31.0	25.7	23.4	24.5	18.6	31.4	20.2	20.9	15.9	8.7	11.2	11.8	12.2	15.4	10.2	7.7	16.0	16.5	16.0	22.1	17.6	11.0	9.5	19.7	17.5	17.7	14.8	13.4	15.9	18.1	9.7	14.0	25.4	10.2	15.3	14.5	24.5	13.1	11.6	12.8	20.9	12.6	12.2	17.3	18.2	11.2	10.1	7.8	15.0	8.8	21.9	20.5	8.3	8.3	10.5	14.1	24.5	28.2	21.9	16.5	11.0	7.4	12.9	15.6	13.4	17.5	18.7	24.0	14.5	12.5	7.0	8.5	24.5	23.4	25.6	23.7	25.1	28.8	26.2	31.4	25.3	31.0	30.6	27.8	8.3	18.6	18.6	25.7	22.0	20.2	12.4	13.6	22.4	12.4	11.6	10.2	15.0	10.0	12.7	12.7
RPRD1A	"FLJ10656, HsT3101, P15RS"	ENSG00000141425	"Regulation of nuclear pre-mRNA domain containing 1A"	Q96P16	18	35984387-36067576	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 88.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040602	Supported		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA040602: AB_10673137"	"unprognostic (2.06e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.92e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.95e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.30e-1)"	16.8	27.0	32.1	12.0	32.0	7.8	19.0	28.5	36.9	16.9	18.1	22.8	26.3	14.4	20.0	88.6	18.4	19.7	14.4	21.3	30.2	27.6	20.8	16.5	14.5	13.8	27.5	31.3	19.3	17.6	20.2	24.0	13.7	30.2	23.3	16.1	13.2	20.2	23.4	36.1	15.3	13.5	21.2	27.8	16.0	14.9	20.3	23.5	10.2	24.4	11.1	14.3	20.6	20.1	8.6	10.7	5.0	8.4	9.3	7.6	4.3	12.0	13.4	22.8	24.2	12.5	14.8	14.2	22.0	21.6	12.7	18.0	3.6	13.5	17.0	23.1	15.8	20.2	25.3	22.1	18.1	15.0	14.5	18.0	20.1	14.2	22.1	30.0	9.8	11.3	29.6	12.1	34.6	18.2	16.2	18.6	16.3	15.0	15.9	12.8	18.3	9.7	13.3	7.3	27.2	19.5	26.1	39.9	33.7	18.2	10.2	18.7	14.0	21.6	22.1	13.4	8.4	7.1	17.8	21.1	29.1	17.6	13.6	24.9	13.4	0.9	6.3	3.0	4.4	8.4	6.5	7.5	5.8	5.0	10.7	8.6	7.6	5.8	5.0	9.3	5.5	7.4	3.1	4.3	32.1	32.0	28.5	36.9	30.2	27.6	27.5	31.3	30.2	23.5
RPRD1B	"C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60"	ENSG00000101413	"Regulation of nuclear pre-mRNA domain containing 1B"	Q9NQG5	20	38033546-38127780	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 113.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066290, HPA072645"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA066290: , HPA072645: "	"unprognostic (3.14e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.47e-1)"	8.8	9.4	7.5	14.5	8.3	20.9	9.6	9.8	10.0	9.0	10.2	12.5	11.4	7.3	12.9	10.7	10.7	11.5	10.4	16.4	7.6	6.5	10.2	113.9	8.9	13.4	7.9	7.6	10.5	16.2	13.7	8.6	9.4	8.3	10.7	8.6	11.0	9.1	15.5	24.3	9.6	10.2	9.6	7.5	10.7	9.1	10.2	7.2	11.4	10.4	8.4	19.3	12.7	9.0	5.5	8.3	7.3	10.7	5.6	8.9	6.3	15.5	7.0	13.4	6.8	8.7	12.1	13.8	11.2	9.0	12.6	11.3	35.9	14.7	13.0	16.4	7.4	18.7	11.9	18.2	15.1	6.1	6.8	21.9	9.2	17.9	10.5	16.6	7.5	9.4	18.1	13.0	15.2	7.9	19.1	10.5	9.5	11.0	24.6	11.9	7.7	14.9	15.8	27.3	13.1	6.8	13.0	14.7	10.1	19.4	29.1	13.6	15.5	15.1	9.1	25.5	15.0	9.5	12.3	13.1	12.3	23.9	15.1	9.7	8.3	0.7	8.3	7.3	7.0	9.4	8.9	5.5	6.8	6.3	8.3	5.1	8.7	7.8	6.7	5.6	10.7	4.4	4.0	6.3	7.5	8.3	9.8	10.0	7.6	6.5	7.9	7.6	8.3	7.2
RPS11	S11	ENSG00000142534	"Ribosomal protein S11"	P62280	19	49496365-49499689	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049719	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA049719: "	"unprognostic (1.49e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.50e-7)"	"unprognostic (5.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-3)"	103.0	76.8	80.6	187.8	68.7	161.8	165.7	50.4	75.3	138.6	134.1	43.2	105.8	67.0	149.4	132.4	142.8	132.3	133.0	135.9	63.2	53.5	84.3	105.7	101.9	354.2	71.5	64.2	242.4	490.0	41.7	89.7	72.2	63.4	116.6	103.4	72.7	193.2	104.0	223.4	140.8	88.1	198.4	69.9	132.6	96.3	67.2	48.3	137.3	119.0	190.7	169.5	145.6	230.6	232.4	173.3	45.1	96.7	91.3	161.6	231.8	110.2	171.9	130.6	201.7	188.9	286.0	87.5	93.8	185.4	133.7	128.2	119.0	92.1	270.6	58.6	127.7	74.3	154.0	185.9	131.9	115.3	267.3	163.6	113.1	171.0	176.5	289.0	121.6	283.7	303.3	89.3	230.0	192.9	161.5	144.3	144.2	123.2	134.8	217.7	120.6	177.3	130.1	165.4	143.9	191.9	260.5	139.6	186.3	63.9	215.3	139.5	70.0	300.6	110.4	106.2	95.5	51.5	123.4	144.4	219.6	192.4	44.2	199.1	90.6	45.1	96.7	29.9	95.6	82.8	127.6	232.4	137.5	110.9	144.1	221.1	161.6	135.7	25.9	91.3	70.6	173.3	109.8	231.8	80.6	68.7	50.4	75.3	63.2	53.5	71.5	64.2	63.4	48.3
RPS12	S12	ENSG00000112306	"Ribosomal protein S12"	P25398	6	132814441-132817564	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA006124, HPA006365"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"			280000	Cytosol	"Golgi apparatus, Vesicles"	"HPA006124: AB_1856460, HPA006365: "	"unprognostic (6.58e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.04e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.66e-2)"	95.6	65.1	66.4	169.3	53.2	199.6	187.3	49.6	66.9	98.4	83.8	42.5	93.7	73.1	106.1	99.2	129.4	88.0	113.7	152.2	56.1	44.6	78.0	108.8	182.0	515.8	67.8	42.0	222.2	403.5	23.2	46.3	87.7	44.5	94.4	82.1	56.5	220.6	71.5	100.5	153.8	79.5	162.6	71.8	122.9	85.4	62.6	52.5	139.6	116.7	155.1	130.9	109.7	196.8	159.2	101.3	17.4	54.3	70.9	211.8	222.0	66.7	50.8	78.9	122.4	152.4	193.7	93.8	85.2	114.9	90.6	87.7	104.4	64.1	148.0	118.2	108.9	65.2	85.6	142.6	83.2	96.9	110.2	100.9	66.6	147.4	170.8	283.6	78.8	207.4	233.9	78.3	277.5	119.0	165.2	98.5	110.0	136.2	119.4	165.2	97.3	83.0	135.2	63.1	93.7	120.4	69.5	67.2	54.8	28.7	184.7	227.9	78.3	288.7	103.5	38.7	111.1	129.7	157.1	148.0	120.5	110.4	127.9	161.1	55.2	17.4	54.3	7.8	95.6	50.7	147.0	159.2	168.0	123.1	73.4	139.3	211.8	174.2	5.7	70.9	40.7	101.3	90.8	222.0	66.4	53.2	49.6	66.9	56.1	44.6	67.8	42.0	44.5	52.5
RPS14	"EMTB, S14"	ENSG00000164587	"Ribosomal protein S14"	P62263	5	150442635-150449756	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 708.0;pancreas: 483.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018504	Approved		Supported	"Endoplasmic reticulum,Cytosol"			540000	"Endoplasmic reticulum, Cytosol"		"HPA018504: AB_1856463"	"unprognostic (5.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (1.47e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.14e-2)"	60.9	43.2	50.1	64.3	39.1	92.8	111.6	22.6	37.2	85.1	70.3	28.0	50.6	33.6	59.6	86.4	79.4	91.7	57.2	59.2	35.7	30.3	53.6	74.7	57.0	96.6	39.8	32.5	115.1	483.0	17.4	38.9	62.0	35.3	69.7	61.5	41.1	61.8	50.8	93.4	95.0	60.6	67.0	37.0	68.4	58.3	48.5	33.8	84.5	93.9	71.2	83.6	87.1	65.2	360.5	205.3	51.0	166.0	157.4	465.9	708.0	87.6	160.8	83.7	170.4	128.2	241.2	137.4	67.4	113.0	110.0	100.4	219.1	113.1	199.0	99.3	127.2	70.3	125.2	299.6	74.8	92.3	151.2	72.3	149.2	164.5	182.4	206.4	74.9	183.1	117.3	112.0	264.2	152.8	95.4	78.8	139.2	236.7	89.1	174.1	86.2	136.6	87.5	96.4	213.1	143.9	161.3	92.3	105.1	48.8	244.4	193.4	107.7	226.5	94.7	59.5	50.0	50.3	90.6	107.0	150.4	130.7	74.2	202.4	39.2	51.0	166.0	36.7	186.2	114.2	261.9	360.5	313.3	226.8	181.1	299.4	465.9	319.4	25.7	157.4	97.0	205.3	196.8	708.0	50.1	39.1	22.6	37.2	35.7	30.3	39.8	32.5	35.3	33.8
RPS16	S16	ENSG00000105193	"Ribosomal protein S16"	P62249	19	39433207-39435948	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA064222	Approved		Supported	"Endoplasmic reticulum,Cytosol"			36000	"Endoplasmic reticulum, Cytosol"		"HPA064222: "	"unprognostic (4.63e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.28e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.62e-2)"	89.8	60.8	49.0	123.2	46.1	127.3	126.9	39.8	46.8	124.8	120.7	48.6	80.0	67.2	97.9	80.8	150.1	108.1	105.9	118.7	41.7	35.7	81.5	147.6	103.7	243.2	49.2	29.9	248.1	457.6	19.9	48.8	97.0	35.5	129.5	52.8	73.8	130.5	87.6	205.5	113.4	110.9	126.3	52.2	136.7	92.1	57.4	37.7	153.9	125.1	183.6	151.0	143.8	159.8	153.7	106.4	17.6	71.8	71.7	179.1	225.5	138.3	296.6	79.7	90.4	120.1	148.1	74.0	63.8	74.7	83.4	76.9	188.7	76.9	117.3	82.9	79.6	46.3	93.2	155.3	52.8	137.0	220.6	92.6	101.0	194.9	122.6	135.1	62.9	172.7	242.1	73.5	117.4	106.9	118.2	132.7	86.9	213.9	184.6	136.3	98.4	108.6	123.8	82.4	141.9	91.5	156.3	81.1	116.8	47.9	215.8	164.1	61.9	262.6	64.2	69.6	91.3	73.7	138.8	185.0	191.5	148.7	72.0	129.3	67.1	17.6	71.8	11.0	84.5	57.9	120.9	153.7	140.8	105.6	91.9	143.2	179.1	143.0	13.2	71.7	48.2	106.4	94.7	225.5	49.0	46.1	39.8	46.8	41.7	35.7	49.2	29.9	35.5	37.7
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272010-33276510	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 484.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050159, HPA055007"	Approved		Supported	Cytosol			90000	Cytosol		"HPA050159: , HPA055007: "	"prognostic favourable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	67.0	49.1	43.4	126.4	32.2	109.6	132.5	20.9	37.7	99.8	105.5	17.8	48.6	44.6	83.1	109.2	120.3	66.7	92.9	71.5	31.2	26.1	48.1	69.1	69.1	263.7	34.5	35.4	154.5	484.7	8.9	33.0	56.3	26.6	95.9	65.2	37.0	168.4	53.7	107.6	140.4	56.9	99.6	35.8	89.9	56.8	40.2	32.3	94.1	94.3	155.9	90.6	101.6	114.8	98.8	55.7	7.8	30.3	49.6	92.4	130.1	51.4	29.8	39.6	103.9	67.9	134.5	63.8	51.6	75.2	67.9	51.4	75.1	30.1	169.7	55.6	54.7	37.9	62.1	81.7	53.4	53.2	97.6	63.3	35.6	98.8	132.5	109.3	33.8	145.3	161.9	51.8	154.9	64.4	84.0	53.3	59.9	86.2	55.1	121.7	54.5	43.1	65.9	64.0	113.6	62.4	66.7	45.5	67.1	20.1	103.4	162.3	70.9	190.5	53.2	32.0	37.4	33.9	67.5	64.0	129.8	130.0	17.9	119.2	38.9	7.8	30.3	3.9	42.7	27.4	72.8	98.8	83.0	60.9	55.7	80.2	92.4	78.5	3.1	49.6	20.2	50.6	61.4	130.1	43.4	32.2	20.9	37.7	31.2	26.1	34.5	35.4	26.6	32.3
RPS19	"DBA, S19"	ENSG00000105372	"Ribosomal protein S19"	P39019	19	41859918-41872926	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 546.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063217			Supported	Nucleoplasm			52000	Nucleoplasm		"HPA063217: "	"unprognostic (8.02e-3)"	"unprognostic (9.04e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.96e-2)"	"prognostic unfavourable (2.32e-8)"	"unprognostic (1.16e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	63.2	51.5	41.6	67.3	38.6	116.3	98.2	20.5	36.2	62.3	86.8	29.7	48.4	64.8	89.9	47.7	134.3	75.2	66.9	43.2	31.9	26.5	52.0	110.8	53.6	104.9	48.4	38.1	139.4	121.2	11.7	38.5	69.8	38.4	88.3	53.3	28.9	117.8	41.3	64.7	110.0	62.7	44.9	35.7	110.4	61.4	79.0	36.3	103.3	81.6	95.2	94.4	70.0	138.8	420.3	255.5	23.6	255.6	250.5	376.5	546.5	146.3	212.0	136.0	120.2	177.2	234.7	150.7	114.2	136.4	146.8	131.5	164.0	100.7	216.6	129.7	102.3	78.0	116.8	194.7	68.4	89.0	215.4	106.8	66.1	168.0	304.8	177.5	110.8	332.2	398.1	88.1	172.0	146.6	118.2	151.7	119.5	168.7	163.3	125.3	157.0	88.2	182.0	109.1	104.2	134.4	158.2	96.9	119.3	62.9	215.0	158.8	121.4	290.1	113.5	94.7	149.8	63.1	179.5	170.8	178.6	201.7	103.5	153.8	107.5	23.6	116.2	12.4	221.3	206.9	333.3	403.7	329.8	286.1	186.0	420.3	376.5	337.2	17.0	250.5	255.6	255.5	248.1	546.5	41.6	38.6	20.5	36.2	31.9	26.5	48.4	38.1	38.4	36.3
RPS20	S20	ENSG00000008988	"Ribosomal protein S20"	P60866	8	56067295-56074581	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003570	Approved		Supported	"Endoplasmic reticulum,Cytosol"			100000	"Endoplasmic reticulum, Cytosol"		"HPA003570: AB_1856466"	"unprognostic (2.57e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (1.21e-8)"	"unprognostic (3.64e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-2)"	164.6	74.7	74.1	177.3	61.8	191.2	193.8	30.4	57.8	148.1	118.9	49.5	104.1	58.3	100.6	108.4	161.3	91.2	108.3	140.0	57.3	47.0	88.0	136.5	124.0	280.9	67.7	41.8	267.4	218.0	28.5	69.2	77.9	48.1	136.7	60.5	70.2	165.9	104.1	161.5	132.2	86.1	152.5	75.9	157.1	98.5	79.6	47.5	168.0	141.7	143.6	140.8	179.7	157.7	214.3	142.6	64.0	77.1	78.0	248.9	267.6	142.9	128.2	126.5	122.9	181.6	209.9	107.4	96.4	143.2	114.7	105.5	132.8	139.0	211.1	119.3	101.4	90.4	78.8	152.1	97.1	91.3	109.5	175.0	118.1	165.6	174.5	97.6	115.2	205.0	159.3	75.0	216.9	138.8	139.9	126.5	112.9	176.5	266.9	195.4	169.6	55.4	146.7	46.6	109.0	137.7	155.4	42.3	131.5	41.6	113.3	188.5	164.3	203.1	90.8	86.7	149.1	114.2	152.2	138.0	118.7	154.1	131.6	171.2	77.2	64.0	77.1	31.3	101.6	64.5	144.7	214.3	189.1	135.6	100.5	180.9	248.9	181.3	14.6	78.0	59.0	142.6	125.7	267.6	74.1	61.8	30.4	57.8	57.3	47.0	67.7	41.8	48.1	47.5
RPS21	S21	ENSG00000171858	"Ribosomal protein S21"	P63220	20	62387116-62388520	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003371	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA003371: AB_1079846"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (8.46e-4)"	"unprognostic (6.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.60e-1)"	69.0	66.0	93.6	140.3	61.5	191.6	177.7	59.2	89.7	93.5	105.1	24.3	84.0	72.0	121.5	85.7	99.6	93.3	97.8	66.0	65.6	47.3	62.9	86.1	66.4	199.9	74.0	86.6	189.4	321.2	12.8	49.2	53.0	52.7	76.3	61.9	33.1	164.2	97.3	172.3	129.6	71.5	120.0	51.1	94.9	73.3	92.9	60.0	92.9	86.3	175.2	90.8	84.4	229.7	170.4	122.5	18.1	59.8	71.0	175.9	158.2	99.5	104.1	53.1	100.4	59.2	105.1	70.1	64.4	51.6	161.6	61.6	347.1	133.6	122.4	133.4	49.6	139.9	58.8	179.3	55.8	30.4	153.0	201.5	149.2	263.9	120.8	154.8	90.9	116.8	251.0	61.1	111.3	74.9	102.9	102.0	55.3	151.5	173.8	220.5	81.3	318.5	118.0	135.0	185.0	75.8	112.7	97.8	96.9	66.2	296.6	134.7	126.1	203.4	78.7	95.6	126.4	80.9	125.9	163.2	185.3	133.2	114.3	94.6	50.6	18.1	59.8	13.9	85.7	50.5	122.2	170.4	146.0	112.6	87.6	170.0	175.9	152.7	9.4	71.0	40.0	122.5	92.7	158.2	93.6	61.5	59.2	89.7	65.6	47.3	74.0	86.6	52.7	60.0
RPS23	S23	ENSG00000186468	"Ribosomal protein S23"	P62266	5	82273358-82278577	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054853	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"		"HPA054853: "	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (6.61e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (3.87e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-1)"	114.6	62.1	72.6	129.7	54.8	139.2	191.8	45.1	53.7	141.2	118.9	46.5	83.5	62.2	131.8	94.1	145.2	118.3	114.4	79.4	61.4	52.9	92.8	134.8	90.1	200.7	74.4	34.7	269.5	211.6	41.6	65.6	94.6	51.9	134.3	89.8	52.9	126.7	84.7	205.4	134.3	97.0	129.6	77.7	150.1	83.8	61.4	51.5	194.5	141.5	171.9	173.8	160.7	165.8	140.7	110.8	11.1	56.6	63.8	136.1	158.2	91.4	36.1	104.0	79.7	175.1	236.9	106.1	87.9	133.4	133.1	132.4	50.6	62.6	215.9	61.7	113.8	47.2	155.5	252.9	138.3	78.3	87.8	88.3	53.4	49.1	231.4	127.4	64.1	227.3	301.0	101.5	266.8	171.4	91.7	68.0	114.9	59.5	140.4	129.4	66.5	84.1	94.1	149.1	194.0	129.2	38.7	66.9	87.5	45.3	78.9	178.1	59.9	197.7	121.6	19.0	73.9	46.2	138.0	97.9	143.0	151.7	44.8	165.1	41.6	11.1	56.6	8.7	60.1	52.4	92.2	140.7	103.0	81.1	97.6	130.8	136.1	112.3	6.0	63.8	43.3	110.8	73.4	158.2	72.6	54.8	45.1	53.7	61.4	52.9	74.4	34.7	51.9	51.5
RPS26	S26	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044676	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: "	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	36.5	66.6	33.3	29.0	48.8	39.2	49.7	23.8	73.7	44.5	45.6	34.9	20.5	20.0	35.9	50.4	49.9	43.5	28.4	39.8	25.8	24.8	61.8	154.3	29.5	56.0	31.4	26.2	75.8	80.4	25.6	29.7	28.7	45.1	35.4	49.1	28.5	38.0	41.1	62.2	50.9	57.5	36.9	30.0	51.6	40.3	47.0	32.5	47.3	58.4	60.0	78.4	46.7	41.2	93.0	69.8	29.8	42.8	63.6	107.4	108.8	52.8	65.1	74.2	27.5	102.8	152.5	74.4	53.9	80.1	89.9	52.6	99.9	24.0	118.0	34.1	56.9	24.9	83.3	46.4	61.6	46.6	133.6	62.3	43.4	59.6	94.9	40.4	34.2	92.3	148.7	47.4	54.0	68.2	42.4	39.4	72.7	82.0	30.3	73.5	72.8	147.4	41.3	22.3	72.6	75.1	53.6	27.9	48.2	21.1	46.6	30.6	41.2	45.3	22.1	22.4	45.8	28.5	43.2	33.9	64.9	63.7	24.8	80.8	28.6	29.8	41.4	27.1	74.6	42.8	83.8	93.0	97.8	81.8	55.3	79.8	107.4	99.3	17.0	63.6	38.2	69.8	101.7	108.8	33.3	48.8	23.8	73.7	25.8	24.8	31.4	26.2	45.1	32.5
RPS27A	"S27A, Uba80, UBCEP80"	ENSG00000143947	"Ribosomal protein S27a"	P62979	2	55231903-55235853	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033319, HPA041344, HPA049132, HPA054087"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"CAB033319: AB_793618, HPA041344: , HPA049132: , HPA054087: "	"unprognostic (7.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.75e-2)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (2.60e-6)"	"unprognostic (1.09e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.60e-1)"	54.1	45.0	46.8	66.0	85.5	111.5	120.1	33.3	77.9	74.5	60.0	21.4	43.0	37.3	66.0	57.8	68.3	61.4	51.2	47.1	57.0	32.7	71.1	172.7	43.9	84.3	42.4	68.3	167.1	88.9	20.7	53.7	57.1	52.1	57.7	52.5	25.3	70.5	46.9	101.9	69.1	52.5	46.3	40.4	77.1	58.9	48.6	36.4	62.8	64.0	144.0	82.1	52.1	71.1	194.8	130.9	42.2	62.9	122.8	253.3	267.6	104.8	61.0	66.9	111.2	93.4	178.5	127.9	82.7	95.2	90.9	57.6	113.8	119.1	146.9	139.9	78.9	99.7	96.6	113.1	106.3	124.5	111.8	135.3	65.6	152.2	135.9	201.7	92.7	160.5	225.1	61.0	166.4	123.2	120.6	134.9	103.8	82.1	117.9	243.0	160.7	78.2	112.5	170.5	173.6	102.8	100.4	88.5	70.2	56.8	247.2	184.4	109.9	172.3	117.3	83.4	126.9	74.3	140.0	121.5	84.2	95.5	119.3	171.7	83.0	42.2	62.9	24.1	129.3	59.1	183.5	194.8	197.3	154.8	91.1	179.3	253.3	206.8	14.4	122.8	52.5	130.9	120.7	267.6	46.8	85.5	33.3	77.9	57.0	32.7	42.4	68.3	52.1	36.4
RPS27L		ENSG00000185088	"Ribosomal protein S27 like"	Q71UM5	15	63125872-63158021	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066851			Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: "	"unprognostic (4.62e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.38e-1)"	"prognostic favourable (9.08e-6)"	"unprognostic (1.75e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.10e-3)"	46.8	64.2	21.3	19.8	29.7	18.2	53.6	16.3	23.4	29.4	58.5	15.5	30.4	46.0	30.2	49.3	40.4	27.0	38.3	47.1	22.8	22.2	61.0	75.2	31.7	23.4	32.6	19.2	26.5	65.9	19.2	38.8	35.6	43.9	56.2	55.3	18.3	99.8	46.0	47.1	18.1	80.4	54.8	39.9	28.2	41.9	15.7	27.3	19.4	53.9	25.7	19.8	55.0	36.3	34.5	30.9	51.5	47.6	27.2	75.4	38.3	17.1	48.0	43.5	11.7	63.7	75.5	43.6	54.2	38.7	11.9	29.2	8.8	23.9	16.1	19.4	51.8	6.6	14.7	26.7	20.1	11.9	19.9	13.3	40.5	62.7	73.4	10.5	36.9	59.0	35.9	26.9	20.5	67.5	12.2	16.2	99.3	23.7	13.5	16.5	12.8	14.0	10.6	20.9	18.2	33.5	34.7	6.3	9.6	19.7	8.3	38.3	18.4	24.5	71.4	63.3	59.6	13.6	24.0	18.3	15.6	14.3	67.1	29.2	57.0	51.5	34.3	40.0	27.5	35.9	33.9	34.5	41.6	32.0	30.9	26.9	32.9	33.1	11.4	27.2	47.6	30.8	75.4	38.3	21.3	29.7	16.3	23.4	22.8	22.2	32.6	19.2	43.9	27.3
RPS29	S29	ENSG00000213741	"Ribosomal protein S29"	P62273	14	49570984-49599164	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 526.9;pancreas: 892.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004107	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA004107: AB_1079848"	"prognostic favourable (2.66e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.48e-3)"	"unprognostic (7.71e-2)"	59.9	53.6	54.5	108.8	58.9	140.0	155.5	34.4	88.2	68.6	89.6	17.9	67.6	71.4	54.9	67.9	75.3	56.1	63.5	108.2	43.1	33.8	54.5	75.3	74.3	232.1	64.3	56.2	128.3	892.4	8.5	41.6	44.5	53.1	50.6	58.9	29.2	86.0	67.9	177.4	102.6	70.9	76.3	74.6	98.1	63.3	94.0	60.6	53.2	45.6	136.9	101.6	47.1	83.8	303.1	164.3	62.9	102.0	123.1	363.7	526.9	147.8	98.1	102.7	91.9	118.1	201.4	135.9	101.5	86.7	92.8	76.1	98.9	137.2	135.0	116.3	85.2	129.7	117.9	144.4	103.3	88.0	213.0	105.7	89.0	172.2	144.7	269.6	91.9	208.2	236.5	60.9	177.8	132.0	117.8	177.5	89.8	196.7	184.0	168.0	125.2	277.2	154.7	127.9	154.5	111.8	132.6	77.8	89.8	72.0	133.3	235.1	173.8	235.9	121.7	71.1	190.8	66.0	89.6	205.0	227.5	182.7	50.1	111.4	68.4	62.9	102.0	46.1	175.8	81.1	219.7	303.1	322.1	227.3	122.6	281.3	363.7	295.6	24.4	123.1	73.4	164.3	181.8	526.9	54.5	58.9	34.4	88.2	43.1	33.8	64.3	56.2	53.1	60.6
RPS3	"FLJ26283, FLJ27450, MGC87870, S3"	ENSG00000149273	"Ribosomal protein S3"	P23396	11	75399486-75422280	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063339	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"			430000	"Endoplasmic reticulum, Cytosol"		"HPA063339: "	"unprognostic (3.62e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (6.92e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-1)"	72.2	52.7	36.6	108.4	41.2	122.2	136.6	32.1	33.8	105.1	102.0	32.5	65.2	65.8	102.4	84.7	136.5	92.2	107.7	58.5	29.7	26.5	52.9	78.1	71.0	218.6	47.6	30.6	224.7	288.7	13.8	51.3	75.9	35.0	105.7	65.7	47.6	151.0	61.8	86.9	117.6	78.0	110.6	42.1	121.4	75.4	54.1	36.5	126.5	119.4	134.7	130.1	110.3	118.9	104.5	69.7	22.6	44.5	64.6	144.2	213.9	85.5	53.1	75.5	83.1	95.5	170.4	97.7	82.1	105.8	109.0	71.1	153.1	102.5	299.4	100.6	73.7	124.1	97.4	152.7	100.5	79.2	76.1	122.6	53.0	67.6	142.6	197.9	80.4	199.9	208.7	74.5	207.1	142.9	122.1	85.3	97.9	94.0	118.7	95.2	94.8	63.0	112.8	264.9	218.1	107.0	71.6	65.0	92.2	60.5	143.9	83.5	146.9	151.7	114.4	52.7	87.8	71.8	74.1	78.3	96.5	331.7	31.6	111.1	53.2	22.6	44.5	14.7	94.2	31.6	129.1	104.5	123.0	99.4	69.7	95.6	144.2	111.8	11.2	64.6	30.1	60.8	78.2	213.9	36.6	41.2	32.1	33.8	29.7	26.5	47.6	30.6	35.0	36.5
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099573-151104652	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 440.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"			63000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	71.7	46.9	48.4	69.2	47.7	124.7	160.3	40.4	43.5	114.1	98.4	30.4	61.9	45.0	75.3	84.4	142.8	73.3	53.9	51.1	36.8	33.3	72.8	94.2	79.4	102.5	42.6	43.5	179.5	143.8	18.1	49.3	70.5	38.0	113.3	62.4	39.0	113.8	48.5	116.8	97.1	73.5	62.0	43.1	94.2	64.2	61.9	30.7	120.4	126.8	111.6	90.6	111.4	86.3	211.6	187.7	44.3	92.8	142.9	282.7	440.7	79.4	58.5	111.6	109.6	143.6	281.1	113.9	84.8	130.9	120.2	74.4	113.0	116.2	360.7	42.4	92.4	52.8	113.1	141.5	114.2	79.4	109.4	77.9	72.3	130.5	166.3	184.8	80.8	208.5	292.1	73.9	196.6	142.5	125.2	188.9	142.6	118.7	199.5	219.6	104.7	45.3	146.2	108.9	120.6	139.1	96.6	107.3	106.2	38.1	139.5	186.6	93.3	224.7	86.5	58.8	77.8	64.8	93.2	146.9	236.3	220.8	75.5	135.0	69.6	44.3	92.8	27.2	120.6	74.5	203.9	211.6	203.1	157.9	156.5	185.7	282.7	226.9	15.1	142.9	62.1	187.7	145.5	440.7	48.4	47.7	40.4	43.5	36.8	33.3	42.6	43.5	38.0	30.7
RPS5	S5	ENSG00000083845	"Ribosomal protein S5"	P46782	19	58386400-58394806	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 495.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055878, HPA061979"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"			860000	"Endoplasmic reticulum, Cytosol"		"HPA055878: AB_2682954, HPA061979: AB_2684650"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-1)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (2.79e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.01e-1)"	93.2	62.4	40.6	71.7	36.4	118.0	111.7	28.4	34.9	105.3	100.7	34.6	69.1	51.1	108.4	66.2	159.0	103.7	81.4	50.9	33.3	28.9	63.1	160.1	79.1	162.1	37.8	30.9	199.2	376.8	19.4	45.0	72.5	31.9	112.3	50.9	45.5	145.6	54.9	162.7	122.7	63.3	81.1	39.0	103.1	66.0	66.8	34.0	136.8	134.5	144.1	129.6	104.5	131.0	150.0	86.6	16.9	44.9	64.8	138.0	156.5	75.0	110.5	42.2	67.1	82.3	106.6	66.1	42.0	69.9	51.8	33.1	82.3	55.5	156.3	53.0	59.5	49.0	67.0	103.5	21.5	42.4	495.1	61.8	61.5	103.8	102.1	103.6	52.7	135.2	172.2	53.7	122.8	67.5	78.5	83.7	55.2	61.0	100.1	71.2	70.0	149.3	97.3	60.5	137.0	57.2	95.0	63.4	79.1	29.4	84.6	86.3	48.8	125.9	42.5	78.3	57.5	31.2	91.4	112.5	190.6	115.2	49.0	77.6	42.9	16.9	44.9	8.6	54.2	41.1	99.7	150.0	94.6	70.4	82.9	141.7	138.0	106.0	6.5	64.8	30.1	86.6	74.7	156.5	40.6	36.4	28.4	34.9	33.3	28.9	37.8	30.9	31.9	34.0
RPS6	S6	ENSG00000137154	"Ribosomal protein S6"	P62753	9	19375715-19380254	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 573.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004027, HPA031153"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			100000	"Endoplasmic reticulum, Cytosol"		"CAB004027: AB_2238583, HPA031153: AB_10602245"	"unprognostic (3.95e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.34e-2)"	"prognostic favourable (4.12e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.06e-3)"	90.0	65.3	64.1	110.2	70.2	166.3	152.8	37.0	50.4	125.4	149.9	38.8	57.4	73.0	91.6	97.7	166.8	87.7	81.5	70.0	51.5	44.4	88.5	91.3	104.0	243.5	66.0	36.2	206.6	441.2	26.1	64.0	67.9	64.7	152.5	83.9	53.3	109.1	72.1	129.5	139.9	96.3	157.8	84.5	137.8	87.5	67.2	53.2	127.9	147.0	119.7	125.8	207.4	143.4	237.2	135.7	30.1	75.5	129.7	274.9	399.9	106.2	69.9	71.1	83.2	120.6	186.1	85.4	71.9	93.8	86.4	72.3	58.1	49.3	244.4	71.2	68.6	52.3	79.6	110.6	93.9	127.3	76.2	161.1	90.5	105.3	147.3	85.3	80.5	154.3	202.4	57.5	169.7	103.8	67.6	99.8	93.2	64.0	180.6	573.5	133.3	47.6	141.4	71.9	116.2	119.6	91.5	71.1	95.6	27.2	115.8	148.5	75.4	311.8	76.1	49.8	53.3	51.5	112.3	47.2	91.4	165.9	33.7	128.3	29.0	30.1	75.5	23.3	111.6	67.1	193.2	237.2	205.0	150.5	135.7	196.8	274.9	215.8	12.8	129.7	60.6	126.1	152.7	399.9	64.1	70.2	37.0	50.4	51.5	44.4	66.0	36.2	64.7	53.2
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 29.6;U-937: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 60.4"	"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favourable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.84e-4)"	"prognostic favourable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favourable (8.33e-4)"	11.0	8.2	6.3	24.2	9.7	15.8	5.0	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6.0	8.0	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10.0	7.4	3.3	8.6	8.6	15.8	3.6	19.0	5.5	1.1	9.0	45.2	2.8	7.9	27.0	9.7	2.7	9.0	15.9	13.9	4.9	17.3	6.2	4.5	5.0	22.0	40.1	18.0	7.9	8.3	17.1	9.7	3.4	2.8	3.7	0.1	0.0	3.7	0.8	1.5	4.2	4.0	4.0	8.1	18.3	4.5	0.5	11.5	6.3	22.7	3.0	15.1	4.1	20.1	8.5	7.0	1.3	23.7	29.6	0.7	8.3	3.8	6.9	1.8	3.4	6.7	0.2	5.4	0.8	23.3	7.2	11.0	12.6	3.6	8.0	12.0	2.7	4.1	1.6	6.9	6.6	3.2	4.2	20.3	1.2	0.2	5.3	0.7	3.3	4.1	4.9	10.0	2.5	31.8	4.0	9.6	18.0	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22.0	5.0	3.9	5.5	34.5	7.9	17.3	8.6	6.0	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9.0
RPS6KA2	"HU-2, RSK, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.2;ASC TERT1: 39.0;HHSteC: 39.5;HSkMC: 35.1;hTERT-HME1: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: , HPA054237: "	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favourable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14.0	11.9	12.5	40.9	25.0	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18.0	12.1	22.7	10.6	7.4	11.1	9.0	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	2.1	0.0	4.3	6.2	53.2	39.0	0.0	4.6	8.9	2.5	3.6	0.0	1.3	0.2	1.5	16.1	1.9	2.2	9.9	2.3	0.9	0.5	0.0	9.4	0.1	39.5	0.1	1.7	35.1	7.1	13.7	42.4	13.9	0.0	0.0	10.4	0.4	0.2	0.4	1.1	2.5	0.7	2.2	6.2	2.7	2.3	2.4	16.8	1.6	4.3	5.8	0.1	3.3	5.1	9.1	0.9	25.1	1.3	1.2	1.8	0.6	6.0	0.2	8.6	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25.0	18.3	22.4	18.4	22.7	25.7
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavourable (8.17e-4)"	"prognostic unfavourable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	14.9	9.1	13.3	15.7	17.1	13.2	7.6	37.6	22.7	7.7	12.4	13.1	5.8	14.0	11.0	6.9	18.5	8.1	10.5	7.8	10.9	10.1	8.7	9.6	10.9	15.0	16.7	9.9	6.5	9.2	5.7	4.7	16.6	9.8	8.3	8.4	10.0	10.9	8.9	16.3	17.3	15.4	9.8	11.5	22.2	18.3	3.3	13.5	7.6	6.7	16.7	16.4	9.7	8.8	0.5	12.6	1.4	3.0	0.3	1.0	2.1	27.7	15.5	2.2	5.7	5.0	4.7	32.1	14.7	7.8	11.6	5.8	15.4	14.6	2.8	17.3	8.5	25.7	2.7	12.0	5.7	8.7	5.2	6.5	13.3	7.8	5.0	6.6	12.2	4.7	11.3	9.8	8.1	7.0	2.6	4.0	5.9	25.4	5.9	10.3	2.5	32.9	11.7	9.3	9.3	8.0	12.9	3.3	2.6	15.3	9.4	12.9	11.0	8.2	13.9	15.8	19.9	28.6	13.2	4.8	3.7	2.9	10.5	7.6	8.0	1.1	3.0	1.4	0.9	2.4	1.0	0.5	0.7	0.7	2.7	0.4	0.4	0.4	0.2	0.3	1.4	12.6	0.6	2.1	13.3	17.1	37.6	22.7	10.9	10.1	16.7	9.9	9.8	13.5
RPS6KA5	"MSK1, RLPK"	ENSG00000100784	"Ribosomal protein S6 kinase A5"	O75582	14	90847862-91060636	"Enzymes, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.5;SK-BR-3: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001274, HPA001780, CAB025458"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB025458: , HPA001274: AB_1079417, HPA001780: "	"unprognostic (3.05e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (4.20e-4)"	"unprognostic (3.70e-2)"	"unprognostic (5.80e-4)"	"unprognostic (6.70e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.38e-4)"	"unprognostic (5.73e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.75e-1)"	4.9	2.4	8.3	13.0	21.6	5.8	16.3	32.9	12.2	7.0	11.0	12.0	4.2	9.3	11.8	2.6	11.9	8.9	6.7	6.1	9.0	7.9	4.5	4.1	6.1	7.3	12.8	9.7	10.2	4.9	12.0	6.9	14.9	11.0	8.0	11.7	2.8	8.7	9.9	14.3	6.6	9.8	19.4	17.1	7.4	9.8	5.2	13.7	4.8	8.6	7.8	7.7	11.6	7.3	5.8	2.5	20.0	3.2	8.4	7.1	2.2	1.2	1.7	2.0	1.3	0.0	0.4	8.5	0.7	1.1	2.2	3.4	0.9	2.2	5.8	2.4	2.1	3.7	1.7	1.7	4.7	0.9	3.1	5.8	1.6	0.2	0.0	5.7	29.5	0.5	3.5	1.4	1.1	2.4	0.6	6.6	2.3	2.4	1.7	2.9	0.6	2.6	3.1	9.4	2.9	2.5	2.2	9.9	3.1	2.4	14.8	8.4	2.8	1.9	0.5	0.7	1.3	0.6	2.9	2.9	2.7	5.0	1.4	4.2	9.3	10.5	2.7	7.8	3.6	2.1	5.9	4.4	4.8	3.5	2.5	5.8	5.6	3.0	20.0	8.4	3.2	1.0	7.1	2.2	8.3	21.6	32.9	12.2	9.0	7.9	12.8	9.7	11.0	13.7
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84187907	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.7"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 10.8;PC-3: 11.7;RH-30: 14.4;SH-SY5Y: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.7	2.9	5.9	1.0	12.2	0.0	2.3	4.7	5.1	3.1	4.5	1.1	20.7	1.7	2.7	4.0	1.5	4.0	1.9	1.2	5.1	2.9	9.2	0.9	0.8	0.2	1.5	3.3	4.9	3.4	13.5	9.1	0.5	4.4	4.3	3.7	1.5	3.0	15.0	1.4	2.3	2.0	1.7	1.0	0.6	2.4	2.6	2.7	0.8	14.5	0.9	0.6	3.3	2.3	1.2	0.8	2.4	0.5	0.7	2.8	0.1	0.0	3.6	3.5	0.0	3.4	3.4	0.0	7.5	4.0	3.4	2.8	2.7	3.0	0.0	0.0	4.1	0.1	9.0	6.0	7.9	0.0	4.5	0.0	0.1	0.0	3.0	0.0	0.0	1.9	0.0	0.0	3.7	0.8	0.0	0.1	2.7	0.0	1.3	0.1	10.8	11.7	0.0	14.4	0.0	0.5	8.3	0.0	11.5	0.0	4.2	0.0	1.9	0.0	0.0	0.1	4.3	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	2.4	0.4	0.5	0.5	0.3	0.4	1.2	0.4	0.7	0.8	0.6	0.4	0.4	1.1	0.7	0.5	0.4	2.8	0.1	5.9	12.2	4.7	5.1	5.1	2.9	1.5	3.3	4.4	2.7
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K1, STK14A"	ENSG00000108443	"Ribosomal protein S6 kinase B1"	P23443	17	59893046-59950564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"MCF7: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: "	"unprognostic (2.25e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.35e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (5.09e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.52e-3)"	18.4	18.3	16.6	23.2	19.5	20.5	18.4	25.7	24.2	18.1	18.2	13.1	18.4	13.1	19.6	16.5	25.4	14.5	14.9	14.2	15.7	12.6	13.5	20.0	14.8	17.3	20.3	17.5	21.6	22.3	24.5	18.9	20.3	17.6	16.7	15.0	10.1	17.3	21.5	50.3	15.8	14.1	19.3	19.8	17.6	17.5	10.7	20.0	17.8	16.8	18.4	22.0	18.5	20.8	8.9	12.8	25.9	11.1	9.4	13.5	8.3	10.6	10.4	8.9	8.4	6.1	9.0	6.7	9.9	9.2	8.7	9.7	8.5	5.3	12.9	12.3	8.2	5.5	11.7	8.9	14.0	7.1	13.1	8.8	6.8	9.7	9.1	13.6	8.9	9.1	6.8	10.1	7.5	11.3	11.7	8.3	6.4	74.4	16.1	5.8	6.0	8.0	9.5	15.0	12.1	7.2	7.9	6.5	7.8	8.3	4.8	5.2	9.5	7.5	9.7	8.5	14.1	6.9	13.1	15.0	12.7	14.5	6.4	8.4	6.7	25.9	10.1	9.0	11.4	10.2	13.5	8.9	10.5	13.0	12.8	8.6	12.3	12.9	10.0	9.4	11.1	8.0	9.5	8.3	16.6	19.5	25.7	24.2	15.7	12.6	20.3	17.5	17.6	20.0
RPS6KB2	"KLS, P70-BETA, p70S6Kb, STK14B"	ENSG00000175634	"Ribosomal protein S6 kinase B2"	Q9UBS0	11	67428460-67435408	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010010, CAB019404"	Approved		Supported	Cytosol				Cytosol		"CAB019404: AB_331355, HPA010010: AB_1856469"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.01e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.03e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.66e-1)"	8.7	14.1	8.5	12.8	9.2	18.0	11.2	12.9	11.5	13.1	13.0	12.5	12.3	19.8	10.2	10.1	36.1	11.0	10.7	10.7	8.8	4.2	11.3	27.8	10.7	12.0	11.4	8.7	9.5	18.7	9.6	11.7	13.8	8.7	17.2	9.9	11.7	18.1	15.8	25.0	41.4	17.7	8.8	7.6	18.6	17.1	7.5	8.8	21.8	11.4	28.6	21.8	10.1	15.6	15.7	27.1	16.4	28.3	17.8	20.7	20.2	21.7	16.5	9.0	15.2	4.2	8.1	11.8	10.5	13.2	19.7	13.7	25.7	14.6	8.0	18.3	10.3	16.2	10.1	16.0	8.0	13.8	27.0	12.9	21.0	20.9	14.2	16.3	16.0	10.3	16.9	10.4	10.7	14.6	20.7	21.5	9.9	33.3	25.1	25.7	9.7	21.2	18.6	12.5	38.0	9.1	12.5	13.6	14.6	10.8	30.1	22.4	35.4	13.6	6.1	10.3	11.0	24.8	11.7	19.3	15.8	12.9	16.9	10.3	12.8	9.7	22.6	16.4	15.7	25.2	15.9	15.7	14.9	15.3	27.1	14.3	10.9	11.9	15.1	17.8	28.3	18.7	20.7	20.2	8.5	9.2	12.9	11.5	8.8	4.2	11.4	8.7	8.7	8.8
RPS6KC1	humS6PKh1	ENSG00000136643	"Ribosomal protein S6 kinase C1"	Q96S38	1	213051233-213274773	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026531, HPA031565"	Approved		Enhanced	Endosomes,Lysosomes				"Endosomes, Lysosomes"		"HPA026531: AB_10601497, HPA031565: "	"unprognostic (3.90e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (8.10e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.44e-2)"	12.0	14.1	15.6	10.0	19.4	6.4	17.1	13.5	19.4	14.1	13.1	12.6	8.8	9.2	15.9	8.4	10.3	11.8	11.6	9.4	17.3	15.6	9.8	10.8	13.6	7.5	17.8	16.8	14.4	13.5	19.9	16.7	12.3	15.3	17.6	10.1	7.3	8.9	17.7	14.1	6.7	8.7	18.5	22.3	11.0	12.5	26.5	13.2	6.8	10.4	6.1	7.8	14.6	16.0	2.5	8.7	13.7	6.8	4.0	3.3	2.2	7.4	6.4	10.6	11.4	10.6	15.7	9.3	9.8	14.4	15.2	17.5	5.2	8.3	4.7	6.6	14.7	6.1	12.8	8.0	11.6	9.9	4.7	12.7	7.6	7.2	9.8	8.0	15.1	10.3	6.9	13.3	7.3	12.6	16.3	7.3	15.5	4.0	3.3	2.6	15.3	7.3	4.0	10.0	4.6	7.0	7.5	6.2	16.1	10.6	8.4	14.0	12.0	3.4	11.7	10.4	9.6	11.9	6.4	4.3	8.3	3.6	4.4	3.1	10.6	13.7	4.6	3.3	2.8	6.8	2.3	2.5	2.3	2.4	8.7	1.9	1.5	3.3	0.5	4.0	6.3	1.0	1.6	2.2	15.6	19.4	13.5	19.0	17.3	15.6	17.8	16.8	15.3	13.2
RPS8	S8	ENSG00000142937	"Ribosomal protein S8"	P62241	1	44775251-44778779	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029266			Enhanced	"Endoplasmic reticulum,Cytosol"			52000	"Endoplasmic reticulum, Cytosol"		"HPA029266: AB_10601611"	"unprognostic (9.70e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (1.02e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (9.05e-9)"	"unprognostic (1.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.57e-2)"	55.7	60.7	44.8	44.4	46.3	100.1	82.0	50.1	65.5	69.6	47.8	33.8	37.0	40.7	61.9	48.4	78.0	66.7	43.9	36.8	34.6	23.7	41.6	74.1	36.5	77.7	34.8	34.6	195.0	98.3	13.1	37.2	45.4	36.8	53.5	42.5	32.3	61.0	72.7	53.7	91.2	45.6	39.4	35.6	57.0	47.4	71.9	29.0	64.8	40.9	97.3	72.0	52.7	71.2	146.1	98.0	15.3	50.2	61.2	128.4	168.5	100.6	50.4	81.1	106.7	141.0	221.9	132.7	74.1	117.5	104.8	84.4	86.5	110.3	191.0	81.7	89.7	69.1	103.9	129.0	77.6	69.1	181.5	71.2	71.8	114.9	200.4	141.4	69.8	176.5	214.1	69.8	187.5	125.1	105.7	134.3	97.4	79.7	155.4	151.4	177.1	87.3	125.3	99.3	213.1	117.5	86.6	86.8	100.2	40.0	224.7	293.7	78.5	284.6	85.3	52.1	91.4	79.9	125.8	106.0	103.9	144.4	63.7	169.9	62.4	10.3	50.2	15.3	55.1	49.1	94.1	146.1	101.4	76.7	79.2	124.5	128.4	106.7	5.0	61.2	38.1	98.0	84.2	168.5	44.8	46.3	50.1	65.5	34.6	23.7	34.8	34.6	36.8	29.0
RPSA	"37LRP, LAMR1, LRP, p40, SA"	ENSG00000168028	"Ribosomal protein SA"	P08865	3	39406689-39412542	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB009561	Approved		Supported	"Plasma membrane,Cytosol"			710000	"Plasma membrane, Cytosol"		"CAB009561: AB_2182543"	"unprognostic (3.67e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-1)"	47.5	42.9	48.8	88.4	56.9	107.0	76.7	26.3	56.2	50.9	63.6	29.1	65.6	48.4	73.5	50.1	93.4	82.4	52.2	67.3	43.2	33.7	44.1	63.8	67.5	300.2	41.7	37.7	145.1	264.7	35.7	42.2	45.0	43.5	58.9	71.5	31.4	148.1	50.2	60.4	70.5	53.0	73.9	48.1	76.8	58.4	60.2	26.8	83.5	72.8	105.2	112.4	53.8	80.4	92.4	64.0	6.9	24.8	61.5	101.2	114.8	92.6	84.9	73.9	121.8	65.0	148.4	116.2	66.2	107.5	151.0	88.5	92.9	80.8	209.9	40.7	130.3	37.1	159.7	152.9	130.2	75.7	83.6	95.0	80.7	90.1	126.0	133.4	89.6	164.7	254.9	116.1	186.3	155.4	98.6	101.8	109.0	64.8	154.9	99.8	247.1	146.1	73.2	105.9	154.0	105.6	42.9	53.5	109.2	36.1	279.0	114.8	81.4	185.7	61.2	46.4	85.6	77.1	161.0	78.7	119.6	125.2	74.4	130.0	61.3	6.9	20.6	4.8	53.8	24.8	93.5	92.4	89.8	71.4	58.1	89.5	101.2	88.4	3.0	61.5	20.4	64.0	66.1	114.8	48.8	56.9	26.3	56.2	43.2	33.7	41.7	37.7	43.5	26.8
RPTOR	"KIAA1303, KOG1, Mip1, raptor"	ENSG00000141564	"Regulatory associated protein of MTOR complex 1"	Q8N122	17	80544819-80966371	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013514, HPA064306"	Approved		Enhanced	Vesicles,Lysosomes				"Vesicles, Lysosomes"		"CAB013514: AB_2533523, HPA064306: "	"unprognostic (5.09e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.77e-2)"	13.6	12.3	10.5	11.1	14.5	10.2	9.3	17.5	21.0	12.6	13.1	19.0	9.6	12.2	15.0	9.3	14.2	12.5	8.0	15.5	10.8	10.5	8.3	12.9	11.0	9.0	12.2	9.9	12.8	9.8	14.3	14.1	9.7	12.7	12.0	7.4	15.2	10.4	13.9	23.7	12.3	11.0	13.6	9.5	11.6	11.1	10.3	12.7	16.7	10.2	11.1	11.9	14.3	10.5	2.1	1.9	3.1	2.4	1.7	3.8	1.2	9.6	19.3	4.6	8.2	6.6	5.7	8.6	7.3	6.7	11.6	8.7	15.1	8.6	8.1	5.8	8.9	5.9	7.4	9.8	6.6	2.9	12.0	12.5	10.7	13.6	6.7	11.2	8.9	8.4	6.7	11.9	6.9	11.5	15.5	3.3	6.5	5.3	10.7	4.7	4.9	15.5	5.1	8.4	6.6	3.4	11.0	9.1	9.2	8.9	14.3	8.1	9.3	8.2	5.2	24.5	10.4	7.7	9.3	5.2	1.9	8.0	14.9	5.9	14.9	3.1	0.9	0.0	3.8	2.4	2.5	2.1	1.6	1.8	1.9	1.1	2.3	2.2	0.0	1.7	1.3	1.1	3.6	1.2	10.5	14.5	17.5	21.0	10.8	10.5	12.2	9.9	12.7	12.7
RRAGC	"FLJ13311, GTR2"	ENSG00000116954	"Ras related GTP binding C"	Q9HB90	1	38838198-38859823	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018247, HPA055489"	Supported		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA018247: AB_1856475, HPA055489: "	"unprognostic (2.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (9.97e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-2)"	27.8	14.0	18.6	11.9	24.1	20.1	36.5	15.9	22.3	13.4	19.4	13.3	11.0	14.1	14.9	11.1	20.7	11.8	13.6	19.0	16.7	13.8	18.8	13.9	15.0	14.2	18.9	14.1	17.6	12.9	13.9	8.9	27.6	21.4	12.6	13.3	11.9	12.7	13.8	15.5	24.6	13.0	17.0	15.6	12.8	12.9	12.7	15.9	11.2	12.9	8.2	16.0	16.0	14.9	4.9	11.3	7.7	3.3	2.0	4.0	2.0	12.0	5.5	7.2	7.9	38.6	26.2	11.2	11.2	23.0	15.3	16.3	4.2	8.0	7.5	6.5	17.4	7.3	13.4	7.4	12.7	12.2	9.5	7.2	6.7	4.7	47.4	8.4	8.2	23.2	18.8	16.3	21.3	15.9	7.3	15.2	22.1	3.3	6.0	4.8	9.2	9.4	5.9	12.8	5.0	10.8	14.1	3.8	5.6	9.0	6.7	23.4	6.2	6.4	14.1	18.7	7.7	20.4	9.5	12.0	19.2	8.9	17.4	9.5	9.6	0.5	3.3	6.7	2.5	3.0	4.0	4.6	3.7	3.0	3.1	4.9	3.3	3.1	7.7	2.0	2.3	11.3	3.3	2.0	18.6	24.1	15.9	22.3	16.7	13.8	18.9	14.1	21.4	15.9
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 136.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.8;plasmacytoid DC: 23.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"			44000	"Endoplasmic reticulum"		"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (9.38e-4)"	19.9	18.3	6.7	16.1	11.2	5.9	13.8	4.9	7.4	22.1	23.6	17.8	49.5	18.5	16.3	24.4	17.1	12.3	37.3	15.8	7.8	6.3	27.1	88.9	20.5	10.6	13.0	5.6	23.4	136.1	24.7	18.4	51.4	10.4	19.4	16.7	14.8	84.2	56.0	7.7	11.0	32.2	13.0	13.3	20.4	30.0	12.1	12.2	5.0	32.8	11.6	19.2	18.7	18.9	0.9	23.5	18.8	4.7	5.7	2.5	1.5	31.0	22.2	6.7	14.9	30.8	33.3	35.1	48.8	41.1	20.7	28.1	49.3	29.4	12.0	16.5	46.0	31.4	7.1	39.6	16.9	5.6	5.5	13.9	6.4	50.9	44.2	5.1	17.5	44.0	11.9	33.4	19.8	20.3	5.8	11.7	30.9	14.1	2.0	11.7	7.8	21.5	3.6	17.7	41.3	17.4	10.6	3.4	2.5	27.7	65.9	20.0	11.5	7.8	36.4	44.2	16.5	22.9	16.0	21.6	16.3	3.9	16.7	5.6	22.4	5.4	4.7	18.8	2.5	2.9	1.7	0.5	0.8	1.4	2.4	0.9	0.8	0.9	4.2	5.7	4.0	23.5	0.7	1.5	6.7	11.2	4.9	7.4	7.8	6.3	13.0	5.6	10.4	12.2
RREB1	HNT	ENSG00000124782	"Ras responsive element binding protein 1"	Q92766	6	7107597-7251980	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001756, HPA034843"	Approved		Supported	"Nucleoli fibrillar center,Nuclear speckles"				"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA001756: AB_1856477, HPA034843: "	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.92e-1)"	17.4	13.3	3.4	17.9	3.6	24.1	15.9	1.4	3.3	15.8	16.8	3.6	13.5	9.7	18.5	16.3	26.6	9.4	19.1	8.5	3.8	2.1	12.7	18.5	14.4	15.9	4.2	1.8	12.5	26.4	14.6	11.2	15.9	4.6	13.7	8.3	15.2	23.6	18.5	30.5	16.5	20.3	14.5	5.2	20.0	9.6	10.6	4.4	12.8	15.9	17.1	24.9	12.5	17.5	3.0	7.8	8.6	3.6	5.2	2.3	2.0	6.8	6.6	5.5	6.4	5.2	3.3	22.7	2.7	3.8	3.1	4.2	10.2	5.4	3.2	5.8	5.1	5.0	7.9	8.5	3.4	4.6	6.4	12.9	4.6	12.8	7.1	7.1	9.8	5.7	7.0	4.9	7.5	4.1	22.6	0.0	3.5	8.3	4.2	19.8	2.5	5.8	6.7	6.8	5.2	5.2	13.2	1.5	1.3	6.0	8.8	5.7	6.6	16.6	6.4	6.1	3.9	4.3	3.5	2.2	2.4	5.0	1.7	5.9	4.9	6.0	3.6	8.6	2.2	3.1	1.7	3.0	1.3	1.4	2.4	1.6	2.3	2.1	2.8	5.2	3.2	7.8	0.8	2.0	3.4	3.6	1.4	3.3	3.8	2.1	4.2	1.8	4.6	4.4
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138876	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Enhanced	Cytosol			13000	Cytosol		"CAB022093: , HPA057265: , HPA064297: "	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	13.9	25.3	8.0	15.2	12.2	18.5	14.4	18.0	12.6	15.7	15.9	11.1	11.5	11.9	13.0	9.8	25.4	10.7	8.7	11.9	7.9	9.0	9.2	13.1	11.0	20.2	9.0	10.3	13.6	10.7	24.2	11.2	22.7	18.4	14.0	18.9	12.0	15.4	10.7	28.3	26.8	12.5	17.5	10.7	12.4	13.8	10.5	9.1	78.6	9.8	28.0	27.1	17.5	18.5	5.6	4.3	3.3	8.3	5.7	24.3	6.0	45.4	24.7	40.5	23.5	6.2	12.4	15.7	41.9	20.8	47.7	49.2	22.2	34.6	49.2	10.2	20.9	36.6	37.5	30.1	56.5	24.2	39.8	25.0	37.1	17.3	2.5	42.8	18.4	5.8	8.1	26.1	18.8	22.8	32.6	23.3	39.7	20.6	50.3	9.3	25.6	25.1	40.8	31.7	17.6	13.1	12.9	34.7	19.0	36.9	22.3	6.7	22.0	15.0	13.0	44.9	23.5	44.4	30.7	15.2	21.1	53.8	24.9	28.7	27.8	3.3	2.5	2.6	7.7	6.5	13.3	5.6	14.2	10.7	4.3	3.5	11.3	9.2	0.0	5.7	8.3	2.7	24.3	6.0	8.0	12.2	18.0	12.6	7.9	9.0	9.0	10.3	18.4	9.1
RRM2		ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10131419	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 120.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.4"									HPA056994	Enhanced		Supported	Cytosol				Cytosol		"HPA056994: "	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	4.7	2.2	0.4	32.6	0.4	29.0	4.2	0.4	0.9	3.5	9.3	0.4	0.4	5.2	2.1	1.7	21.6	0.7	5.0	3.3	0.4	0.5	2.0	3.9	5.7	16.4	0.6	0.1	0.9	2.9	0.0	0.7	5.4	0.3	1.0	10.6	0.1	2.9	0.0	0.5	2.8	11.3	3.2	0.8	19.8	5.4	8.0	0.0	120.9	0.8	22.3	33.1	3.8	5.2	1.4	0.3	0.6	0.2	1.8	10.4	2.6	29.1	17.7	25.0	17.1	2.2	4.1	24.8	47.7	23.6	34.1	37.1	29.5	14.0	26.8	6.6	14.9	14.3	40.5	24.6	41.8	60.0	15.6	51.6	17.0	26.0	0.1	38.2	24.8	1.4	0.5	41.7	3.5	27.5	21.6	79.5	42.4	22.0	42.2	20.5	20.2	20.7	31.8	54.6	18.4	16.7	22.2	24.8	20.4	39.2	27.9	4.8	15.0	6.9	9.6	26.1	38.0	19.5	66.8	51.6	40.5	54.7	18.5	32.4	37.5	0.3	0.1	0.1	3.7	0.0	0.0	1.4	2.6	2.9	0.2	0.4	0.2	1.2	0.6	1.8	0.2	0.3	10.4	2.6	0.4	0.4	0.4	0.9	0.4	0.5	0.6	0.1	0.3	0.0
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102239118	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, DNA replication"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB006854: , HPA028812: AB_10602246"	"unprognostic (7.76e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.17e-2)"	11.8	18.6	11.7	11.5	11.4	4.3	9.3	8.5	13.5	9.5	10.1	9.8	9.5	10.2	8.2	10.8	8.0	9.7	8.2	11.3	17.5	12.8	17.5	15.1	15.8	12.6	14.9	10.6	9.7	9.5	34.7	24.8	11.6	23.1	11.2	11.1	7.7	9.7	10.9	34.6	7.4	7.6	8.2	26.1	10.6	7.1	6.6	9.4	6.3	37.1	8.1	13.1	10.7	7.0	7.4	6.2	18.3	8.4	3.0	3.3	2.8	5.6	10.1	12.0	7.1	17.0	16.4	9.6	13.2	16.0	7.1	8.3	3.6	4.6	36.4	12.5	14.6	2.1	5.8	13.4	10.1	5.9	6.3	9.1	4.3	7.6	13.8	2.8	19.5	20.8	25.3	7.8	11.9	19.8	6.7	5.6	22.7	5.6	4.8	5.3	6.7	7.5	3.1	4.9	7.3	16.5	6.5	3.0	6.0	6.9	3.7	7.9	9.9	6.3	15.1	11.0	21.4	7.6	3.6	5.9	5.4	33.1	16.2	4.3	11.6	10.0	5.1	5.3	2.2	4.5	3.3	5.6	2.0	2.8	6.2	7.4	2.3	2.5	18.3	3.0	8.4	1.8	1.4	2.8	11.7	11.4	8.5	13.5	17.5	12.8	14.9	10.6	23.1	9.4
RRN3	"DKFZp566E104, TIF-IA"	ENSG00000085721	"RRN3 homolog, RNA polymerase I transcription factor"	Q9NYV6	16	15060022-15094317	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049837	Supported		Supported	Nucleoli				Nucleoli		"HPA049837: "	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	7.8	6.0	4.3	4.0	5.7	10.0	7.2	9.2	6.3	4.9	5.1			5.0	6.3	5.4	4.5	5.9	4.7	5.5	3.9	5.0	5.5	10.1	4.3	5.9	3.7		8.4	5.8	8.9	5.8	4.9		6.6	6.5		4.6	4.8	15.2	5.3	5.0	5.1	3.9	6.2	5.3	4.9			6.2		6.3	6.6	4.9	10.7	8.2	12.3	7.0	10.0	14.2	9.5	7.6	10.2	8.0	6.8	9.5	8.2	5.8	9.7	6.5	9.5	9.1	9.4	11.2	13.5	15.5	8.6	7.5	14.9	9.9	13.8	10.8	10.1	29.6	13.6	18.0	13.8	11.0	34.6	8.5	13.7	13.4	15.2	6.7	8.2	11.7	13.1	12.0	10.6	14.1	9.0	8.5	23.3	11.1	14.9	7.9	10.0	16.9	11.9	10.4	12.3	10.7	15.9	9.9	6.8	11.3	5.3	7.9	9.8	9.4	13.4	19.0	6.7	13.3	14.5	12.3	6.4	5.9	11.2	6.6	13.3	10.7	9.8	11.0	8.2	7.7	14.2	11.0	1.0	10.0	7.0	5.2	9.4	9.5										
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	12.0	10.6	12.1	12.8	15.6	9.7	9.4	11.4	20.0	8.6	8.9	18.0	6.0	10.6	10.0	9.1	19.8	10.9	9.3	8.5	14.3	11.3	8.3	16.6	7.3	15.1	16.3	14.4	14.8	16.6	9.4	7.6	10.3	14.9	9.4	6.7	9.9	14.7	9.8	15.6	20.1	9.7	7.4	11.5	11.1	11.9	13.8	15.6	10.5	9.6	11.4	14.7	8.9	9.8	10.9	8.8	1.5	4.3	10.4	12.3	6.0	16.2	8.8	6.0	10.1	3.3	3.7	11.7	8.3	4.9	11.6	8.2	22.9	9.7	15.7	6.9	4.5	8.3	11.2	8.1	5.3	7.8	21.9	22.4	8.1	14.0	6.8	14.1	8.1	5.0	7.6	11.6	9.2	6.1	29.2	11.8	5.4	19.2	12.2	19.4	20.2	13.1	22.7	4.8	28.9	5.9	9.0	14.3	8.6	8.7	9.3	10.9	9.8	9.7	7.0	7.8	8.8	8.2	14.4	14.8	12.7	16.3	11.8	23.7	10.1	0.1	4.3	1.5	9.7	4.0	12.3	9.6	10.1	9.9	8.8	10.9	11.2	7.4	0.9	10.4	1.9	7.5	5.8	6.0	12.1	15.6	11.4	20.0	14.3	11.3	16.3	14.4	14.9	15.6
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: , HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.8	21.1	5.6	12.1	4.3	5.1	12.4	10.0	6.0	10.4	8.1	22.9	14.7	17.4	13.0	6.3	20.4	15.4	11.6	7.0	9.4	18.5	13.4	7.9	17.8	7.2	20.9	17.7	5.3	16.4	25.6	23.7	5.8	19.2	11.7	5.9	20.5	14.1	13.5	24.2	14.3	15.6	7.7	17.2	7.2	8.8	7.6	16.2	8.0	7.7	10.0	18.6	10.9	7.6	7.0	12.0	15.6	31.5	23.9	20.8	20.5	10.0	26.9	7.4	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659548-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	12.7	10.3	10.7	20.0	13.7	7.6	14.5	13.9	12.5	13.1	11.1	11.5	9.4	9.5	16.1	9.2	15.7	14.0	12.2	8.4	9.5	8.6	7.5	17.7	10.4	22.8	13.1	7.5	20.0	20.6	11.8	11.4	8.4	10.3	11.3	10.9	15.0	13.9	12.8	21.6	14.1	11.1	12.9	9.9	16.9	11.8	32.5	12.6	25.6	9.6	12.6	20.5	13.5	14.1	6.0	3.2	2.1	2.7	5.8	9.8	5.3	16.6	9.9	10.6	15.9	6.9	7.4	8.7	8.8	6.3	9.8	8.1	22.4	7.3	32.7	5.8	6.9	7.5	26.0	15.2	11.7	11.0	20.7	19.3	11.4	14.0	9.5	30.1	7.7	7.6	9.7	11.7	13.6	10.9	30.2	9.6	8.6	8.7	23.9	9.1	36.0	11.0	31.5	10.7	22.9	7.1	8.0	21.0	11.2	16.5	12.2	12.2	8.0	9.4	9.6	3.0	9.6	7.9	16.0	13.1	16.7	39.1	9.6	32.5	9.9	2.1	2.6	0.7	7.2	2.7	8.5	6.0	9.1	8.6	3.2	5.3	8.6	9.8	0.1	5.8	2.3	2.6	7.0	5.3	10.7	13.7	13.9	12.5	9.5	8.6	13.1	7.5	10.3	12.6
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021645-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029904, HPA029905"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: "	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	25.0	29.7	21.0	24.9	27.2	23.3	57.7	18.0	42.1	21.3	22.4	16.0	24.9	19.4	23.8	24.7	31.9	20.6	20.1	31.3	22.7	21.4	25.2	32.7	24.1	46.5	21.1	28.0	17.3	37.4	37.0	28.8	23.4	27.3	24.6	23.8	19.5	23.5	36.4	61.9	28.4	21.4	28.3	28.5	29.4	25.7	23.9	15.8	25.0	22.6	30.9	31.8	23.7	28.2	6.5	9.7	4.0	4.6	3.1	7.7	1.2	42.6	24.1	24.0	35.0	25.9	24.3	20.2	33.8	30.7	43.4	42.7	43.7	18.6	19.8	27.6	35.1	22.9	40.0	41.0	48.1	25.0	40.7	31.7	26.7	46.6	30.1	26.3	24.7	24.5	25.1	51.8	22.2	35.2	38.3	21.6	40.1	45.0	31.6	28.8	26.6	25.0	29.9	23.7	22.8	26.5	40.3	30.7	26.9	24.9	22.9	38.6	31.5	32.5	28.2	40.1	30.6	26.4	53.0	20.3	30.5	52.8	17.5	33.3	37.2	3.9	3.6	3.1	5.9	4.6	4.7	6.5	4.2	7.0	3.7	2.6	3.9	7.7	4.0	3.1	3.6	9.7	2.1	1.2	21.0	27.2	18.0	42.1	22.7	21.4	21.1	28.0	27.3	15.8
RRP8	"KIAA0409, NML"	ENSG00000132275	"Ribosomal RNA processing 8"	O43159	11	6595075-6603620	"Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038487, HPA057562"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA038487: AB_10672518, HPA057562: "	"unprognostic (9.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (3.10e-7)"	"unprognostic (4.64e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.87e-2)"	13.8	11.9	13.9	15.8	14.8	32.1	17.9	18.1	15.3	15.9	24.9	16.1	10.5	14.0	15.5	21.3	13.8	11.9	15.4	16.2	16.0	10.3	13.3	24.7	14.3	16.0	18.4	13.6	12.4	12.7	12.0	12.3	12.8	14.2	19.8	14.4	11.8	10.9	19.7	18.6	15.5	12.8	19.5	11.0	17.7	15.1	12.3	18.6	11.8	14.2	9.7	16.6	20.2	13.9	13.3	14.4	20.3	12.0	14.4	13.8	10.2	10.2	10.2	4.1	5.3	8.6	7.5	5.8	5.3	6.6	12.3	11.6	10.5	12.0	14.4	5.2	5.0	10.4	11.7	9.3	13.1	6.9	16.8	6.8	12.3	11.8	9.8	12.3	9.5	6.4	12.2	5.8	10.7	12.6	13.4	8.4	9.7	12.7	11.9	18.4	10.1	9.3	10.7	3.3	3.2	11.5	8.2	6.3	7.4	7.6	15.5	8.6	8.4	10.8	6.5	11.7	5.4	11.3	10.2	9.4	8.5	13.7	9.9	12.4	7.5	20.3	11.0	10.7	13.7	11.8	13.2	10.9	13.5	12.6	14.4	13.3	13.3	13.8	4.4	14.4	12.0	11.0	12.6	10.2	13.9	14.8	18.1	15.3	16.0	10.3	18.4	13.6	14.2	18.6
RRP9	"RNU3IP2, U3-55K"	ENSG00000114767	"Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein"	O43818	3	51933430-51941941	"Predicted intracellular proteins"	"rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038798	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA038798: AB_10672653"	"unprognostic (5.57e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.92e-2)"	18.6	19.4	17.5	17.3	22.9	14.1	15.9	11.0	16.3	15.0	12.7	9.3	11.2	14.4	16.4	8.9	16.5	16.7	15.9	12.7	13.6	9.1	12.0	18.6	13.4	18.7	14.2	18.6	17.4	34.7	12.6	10.6	12.1	12.8	13.8	10.5	8.7	13.2	13.1	30.9	15.7	11.0	14.1	9.5	15.6	12.1	15.3	14.0	11.1	12.7	17.7	13.6	13.9	21.6	12.8	13.1	1.5	9.3	12.9	13.7	7.0	10.6	15.2	7.3	17.4	10.8	6.0	18.6	11.8	6.5	20.0	12.7	25.9	12.2	30.9	5.0	8.3	9.9	25.3	18.1	8.1	14.0	11.0	20.8	9.0	23.0	21.7	22.7	17.5	12.5	13.4	25.0	23.8	7.7	19.7	7.8	8.7	16.9	19.1	22.7	28.8	39.2	11.9	8.3	23.7	9.7	15.8	9.1	10.7	10.6	11.9	11.3	6.2	14.8	7.3	14.0	18.7	34.6	48.2	13.5	21.8	28.8	12.5	28.4	22.0	1.5	6.6	0.4	12.8	9.3	13.7	12.8	11.0	11.2	12.4	10.5	8.7	10.4	0.5	12.9	4.5	13.1	8.9	7.0	17.5	22.9	11.0	16.3	13.6	9.1	14.2	18.6	12.8	14.0
RRS1	KIAA0112	ENSG00000179041	"Ribosome biogenesis regulator homolog"	Q15050	8	66429028-66430733	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055549, HPA060937"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA055549: AB_2682846, HPA060937: AB_2684390"	"unprognostic (7.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.84e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.82e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.29e-2)"	"unprognostic (8.35e-3)"	12.0	11.2	8.7	14.1	12.4	7.0	9.9	8.5	9.8	8.5	9.6	7.1	7.2	10.3	13.4	6.6	12.2	11.2	9.8	9.6	8.5	7.5	9.5	18.0	6.7	14.6	11.5	7.9	19.0	41.4	8.3	5.8	7.6	11.1	9.0	7.1	6.4	9.8	9.7	31.7	10.2	7.7	14.0	7.8	9.5	12.0	4.9	9.9	8.6	7.5	19.2	11.5	13.7	13.1	6.8	15.2	0.6	11.8	11.2	17.8	6.8	22.7	28.8	5.9	12.4	6.4	5.2	9.6	14.4	6.4	11.2	8.3	12.8	15.2	31.0	5.0	7.6	21.4	14.5	16.4	12.4	17.0	24.4	24.6	8.7	22.8	9.5	14.6	13.1	6.8	13.3	12.3	16.4	7.2	21.5	13.2	8.1	26.4	29.0	26.6	38.5	33.9	6.2	7.6	12.9	15.6	18.8	8.1	17.9	7.0	11.7	16.0	20.1	13.0	12.4	20.8	18.6	17.4	33.1	23.7	21.2	23.9	9.7	23.1	14.0	0.0	8.9	0.6	10.0	11.8	17.8	6.8	12.7	11.7	15.2	6.7	11.9	13.6	0.3	11.2	7.2	7.1	9.1	6.8	8.7	12.4	8.5	9.8	8.5	7.5	11.5	7.9	11.1	9.9
RSAD2	"cig5, vig1, viperin"	ENSG00000134321	"Radical S-adenosyl methionine domain containing 2"	Q8WXG1	2	6865806-6898239	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"		Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 31.8"	"Group enriched"	"Detected in some"	5	"BJ hTERT+ SV40 Large T+: 30.4;BJ hTERT+ SV40 Large T+ RasG12V: 46.9;HMC-1: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 24.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA041160, HPA049409"	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA041160: AB_10795489, HPA049409: "	"unprognostic (8.91e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.89e-2)"	"prognostic unfavourable (4.60e-4)"	"unprognostic (3.27e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-3)"	"unprognostic (9.47e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.79e-1)"	31.8	3.1	4.8	10.1	8.7	12.5	4.1	1.1	7.8	7.2	5.6	4.7	2.1	3.4	4.8	7.8	2.9	5.5	6.2	5.3	5.3	5.8	6.1	3.6	15.3	7.7	4.8	5.6	3.5	2.1	1.2	6.2	10.1	12.5	3.7	3.1	7.5	20.2	2.5	5.5	1.0	4.9	5.2	6.1	10.8	7.2	2.3	2.0	11.5	10.2	3.5	2.8	4.0	2.0	0.4	2.7	24.3	5.1	1.6	3.2	2.2	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.4	30.4	46.9	0.0	0.9	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	21.9	0.0	0.0	2.0	0.0	0.0	0.5	0.4	0.0	0.0	2.8	0.6	0.1	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	0.1	14.6	3.6	24.3	1.8	5.1	2.2	0.2	1.9	1.7	2.7	0.4	3.2	2.4	14.4	1.6	4.5	0.2	0.9	2.2	4.8	8.7	1.1	7.8	5.3	5.8	4.8	5.6	12.5	2.0
RSBN1	"FLJ11220, ROSBIN"	ENSG00000081019	"Round spermatid basic protein 1"	Q5VWQ0	1	113761832-113812476	"Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042124, HPA049484"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA042124: AB_10794644, HPA049484: "	"unprognostic (3.26e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-3)"	10.4	8.4	8.6	9.4	14.6	35.8	10.3	23.9	12.0	17.0	14.4	6.9	8.1	7.7	13.4	8.6	9.7	10.9	8.4	8.1	8.9	9.1	10.4	7.9	11.5	11.8	8.1	7.3	18.3	13.3	17.6	15.1	8.2	8.4	11.5	10.9	9.6	10.1	10.7	17.1	10.7	10.9	11.5	7.2	12.8	8.8	12.4	10.0	22.6	11.8	5.7	12.7	16.6	10.7	20.7	16.4	25.7	9.2	14.3	20.8	7.3	11.8	3.4	11.7	6.9	7.0	8.1	5.6	4.2	9.1	8.6	9.1	4.0	3.6	10.4	6.8	5.2	5.2	8.3	5.2	14.2	10.1	6.0	7.9	3.7	4.5	5.3	14.7	8.5	6.1	5.7	7.4	7.0	6.8	11.8	6.6	6.3	12.2	11.8	8.8	9.9	5.9	21.5	11.4	5.4	5.2	5.1	11.9	9.4	8.1	8.0	7.2	3.8	10.0	8.1	7.8	8.5	11.5	6.8	8.8	6.5	13.2	8.0	9.0	13.0	25.7	9.2	14.6	18.6	6.9	18.8	18.3	20.1	17.1	7.6	20.7	20.8	16.9	17.9	14.3	7.5	16.4	17.4	7.3	8.6	14.6	23.9	12.0	8.9	9.1	8.1	7.3	8.4	10.0
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696443-77783022	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	12.9	10.6	15.0	22.1	14.6	9.5	15.5	28.7	17.0	22.8	23.5	8.9	12.1	11.1	17.2	13.6	15.0	14.2	13.4	10.6	12.4	10.3	12.0	14.9	15.7	18.2	11.1	11.0	19.2	14.9	19.5	16.2	12.2	11.8	18.8	15.1	13.9	14.0	15.4	13.6	11.7	14.9	18.0	11.0	20.7	14.3	29.8	13.8	34.5	21.1	6.7	18.0	23.6	28.2	7.2	7.0	31.5	4.0	3.0	5.2	1.2	8.8	6.8	11.4	20.0	8.0	10.3	5.6	6.6	7.1	9.4	10.8	8.4	15.9	18.2	2.6	6.8	7.7	15.5	8.5	13.5	9.8	8.3	14.5	10.8	8.3	6.8	17.8	13.7	7.3	6.2	8.6	9.5	7.7	19.6	19.2	9.7	10.2	15.2	17.9	8.1	6.1	15.9	11.4	19.1	5.9	11.7	13.5	14.1	10.0	18.2	7.2	11.1	9.5	7.4	14.1	13.0	8.4	10.0	8.6	9.1	29.3	6.7	16.5	9.2	9.1	4.0	6.4	5.2	2.9	3.9	5.4	4.5	3.8	2.2	7.2	4.3	4.7	31.5	3.0	3.2	7.0	4.5	1.2	15.0	14.6	28.7	17.0	12.4	10.3	11.1	11.0	11.8	13.8
RSC1A1	RS1	ENSG00000215695	"Regulator of solute carriers 1"	Q92681	1	15659869-15661722	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027813, HPA028676"	Approved		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA027813: AB_10600308, HPA028676: AB_10600895"																		3.0	0.9	0.3	1.7	0.4	2.8	2.6	0.1	0.6	2.2	0.6			0.0	1.2	0.0	3.5	1.2	1.1	2.9	0.3	0.5	4.0	7.7	2.7	2.0	0.4		4.6	0.2	2.1	1.3	2.3		3.9	1.3		0.1	0.8	0.6	2.1	0.6	3.0	0.8	0.1	0.6	4.7			1.7		3.2	1.1	2.2	1.1	2.8	0.5	3.5	1.7	2.3	1.5	3.3	3.8	4.7	3.1	5.9	4.1	6.3	2.8	4.6	7.7	7.3	6.3	5.4	7.3	2.7	6.2	2.2	12.3	3.9	9.6	4.8	3.1	6.8	7.6	6.7	1.3	10.0	3.5	3.2	0.0	13.3	7.4	4.8	18.6	6.9	5.6	3.3	5.2	0.0	5.1	2.2	4.5	6.6	3.0	1.8	6.1	3.8	1.5	5.2	2.3	4.5	3.3	0.9	4.7	4.0	7.3	3.5	2.0	2.1	3.9	12.7	1.5	2.7	2.8	0.0	1.2	0.5	0.4	3.5	1.4	1.1	0.5	2.3	2.8	0.2	0.6	0.5	0.0	1.7	0.1	0.7	2.3	1.5										
RSF1	"HBXAP, p325, RSF-1, XAP8"	ENSG00000048649	"Remodeling and spacing factor 1"	Q96T23	11	77659996-77821017	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022626, HPA046129, HPA057547, HPA064567"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"CAB022626: , HPA046129: , HPA057547: , HPA064567: "	"unprognostic (2.67e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.00e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (6.19e-2)"	"prognostic favourable (5.94e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	15.9	20.1	20.4	19.5	23.5	21.1	14.4	32.3	20.0	19.0	14.2	11.0	15.2	8.7	19.3	14.6	13.4	14.1	15.7	13.1	18.7	17.2	14.0	10.9	15.6	13.2	16.2	15.3	26.0	15.6	25.3	27.3	16.9	18.7	16.3	12.0	8.1	13.4	21.3	15.7	13.5	12.7	16.7	15.8	16.2	12.5	21.1	21.8	22.4	21.1	8.4	12.3	21.3	25.8	21.7	18.5	27.7	15.7	13.6	17.1	4.0	10.3	7.0	24.4	13.0	8.3	10.5	9.2	12.2	12.0	10.1	12.5	18.3	14.5	17.6	13.2	8.5	10.9	14.2	9.1	19.0	12.5	6.4	16.6	9.9	4.9	7.9	15.7	11.8	8.7	6.9	13.7	22.2	12.7	27.0	16.8	11.5	7.0	11.0	8.8	14.1	9.6	18.5	42.3	11.5	5.3	13.6	14.8	14.9	18.8	7.4	7.3	13.4	7.8	15.8	17.9	15.5	27.9	8.8	10.1	13.0	40.8	4.7	10.7	13.4	21.3	10.7	17.8	17.1	9.9	11.7	18.2	10.3	10.7	8.1	21.7	14.3	14.2	27.7	13.6	15.7	18.5	9.6	4.0	20.4	23.5	32.3	20.0	18.7	17.2	16.2	15.3	18.7	21.8
RSG1	"C1orf89, MGC10731"	ENSG00000132881	"REM2 and RAB like small GTPase 1"	Q9BU20	1	16231700-16237162	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028453, HPA041672"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028453: AB_10601692, HPA041672: "	"unprognostic (7.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"prognostic favourable (1.36e-10)"	"unprognostic (1.45e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	3.2	7.5	14.2	3.7	17.1	5.8	3.3	3.7	9.8	6.0	3.7	3.9	12.6	4.2	5.6	3.2	8.9	11.8	3.8	7.9	10.4	12.0	5.3	3.6	3.2	4.5	9.3	10.5	10.1	8.3	7.9	8.0	4.1	10.4	5.4	3.3	5.7	8.0	7.5	2.1	7.4	3.6	6.1	7.9	5.9	6.6	6.7	7.5	1.7	11.6	0.3	4.0	5.9	3.0	3.2	2.2	4.0	3.5	2.9	6.2	1.4	4.0	10.8	3.3	10.9	2.2	4.1	3.0	4.5	2.9	3.6	1.5	3.9	6.1	8.6	9.0	2.5	3.3	6.0	5.8	0.3	12.8	5.0	4.2	9.4	0.8	5.6	2.8	7.8	2.1	5.0	4.2	3.8	3.5	15.3	3.4	3.0	4.9	3.0	2.1	0.8	4.2	7.7	0.4	6.9	3.2	2.5	8.0	5.4	1.7	2.7	4.1	8.3	2.7	3.4	1.0	1.7	2.2	1.4	9.3	3.4	4.9	2.9	6.2	6.1	0.0	1.2	4.0	5.0	3.5	6.2	3.0	3.1	1.4	2.2	3.2	3.0	2.4	1.1	2.9	2.2	0.7	3.2	1.4	14.2	17.1	3.7	9.8	10.4	12.0	9.3	10.5	10.4	7.5
RSL1D1	"CSIG, DKFZP564M182, L12, PBK1, UTP30"	ENSG00000171490	"Ribosomal L1 domain containing 1"	O76021	16	11833850-11851585	"Predicted intracellular proteins, Ribosomal proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043483	Supported		Enhanced	Nucleoli				Nucleoli		"HPA043483: "	"unprognostic (4.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.88e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.95e-4)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (3.24e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.68e-2)"	31.5	16.8	11.6	15.8	15.0	18.6	36.1	16.3	16.2	26.6	21.5	11.5	12.6	14.9	20.6	14.0	28.6	21.8	14.2	17.3	11.2	11.4	17.9	24.0	15.9	29.4	14.2	11.7	58.1	32.7	14.9	20.7	22.0	15.0	30.2	18.1	14.7	18.1	17.0	66.9	21.2	23.2	25.6	15.7	25.2	17.8	19.9	12.6	25.2	27.8	19.8	28.7	37.8	20.8	32.2	31.0	3.0	30.2	28.5	49.0	53.4	21.0	20.1	16.9	21.1	22.2	40.1	20.1	19.7	22.1	25.6	26.2	19.4	20.0	53.1	32.7	16.3	15.0	45.2	29.9	41.7	20.7	24.3	26.1	19.8	44.2	41.5	37.0	17.5	29.2	42.5	26.4	61.5	24.8	45.8	24.7	31.3	23.4	28.9	21.5	43.2	20.9	30.2	31.1	56.2	22.9	18.6	23.7	19.4	37.1	28.3	26.3	24.4	28.8	15.1	17.1	19.1	16.1	28.3	19.9	28.5	61.9	18.5	39.0	22.7	3.0	30.2	2.9	18.2	28.6	33.2	32.2	33.6	23.4	31.0	27.0	49.0	35.0	1.6	28.5	26.1	19.1	23.4	53.4	11.6	15.0	16.3	16.2	11.2	11.4	14.2	11.7	15.0	12.6
RSL24D1	"C15orf15, HRP-L30-iso, L30, RPL24, RPL24L"	ENSG00000137876	"Ribosomal L24 domain containing 1"	Q9UHA3	15	55180806-55197067	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA062724, HPA063392"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA062724: AB_2684850, HPA063392: AB_2685002"	"unprognostic (3.40e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.19e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.41e-1)"	27.7	24.3	26.7	23.4	28.8	76.1	47.8	35.7	29.9	40.6	32.2	10.0	25.6	18.1	34.5	26.6	34.2	26.4	21.4	25.3	25.1	25.3	24.3	26.7	27.0	35.8	25.4	25.8	54.7	37.8	15.0	23.2	22.4	24.1	44.3	20.5	11.2	25.8	21.3	47.2	19.3	21.1	50.4	27.5	28.6	28.8	24.2	20.6	39.5	43.1	36.9	27.4	61.9	49.6	29.1	27.0	11.4	24.1	22.7	45.1	47.7	15.8	16.2	17.8	23.4	14.0	26.4	14.4	16.9	18.9	14.2	18.1	15.4	9.8	49.6	15.2	12.1	19.5	23.4	19.4	19.0	24.1	14.5	25.3	13.0	19.1	32.2	47.7	16.6	22.3	41.3	14.2	41.2	17.6	47.9	36.0	16.4	16.2	26.1	42.1	22.0	14.5	20.8	22.3	74.7	21.2	14.8	25.3	30.3	7.8	21.9	54.5	21.0	70.7	12.2	11.7	13.7	13.6	24.0	34.7	53.0	49.3	18.2	47.3	19.5	11.4	23.8	11.4	19.6	23.4	31.1	29.1	29.5	24.3	27.0	22.5	45.1	34.0	6.0	22.7	24.1	21.1	32.4	47.7	26.7	28.8	35.7	29.9	25.1	25.3	25.4	25.8	24.1	20.6
RSPH1	"CILD24, FLJ32753, RSP44, RSPH10A, TSGA2"	ENSG00000160188	"Radial spoke head 1 homolog"	Q8WYR4	21	42472486-42496354	"Disease related genes, Predicted intracellular proteins"	Meiosis		"Ciliopathy, Disease mutation, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.4;fallopian tube: 85.5"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;MCF7: 10.8;RPTEC TERT1: 16.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 6.7"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016816, HPA017382"	Enhanced		Supported	Centrosome				Centrosome		"HPA016816: AB_1858393, HPA017382: AB_1858392"	"unprognostic (1.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.22e-3)"	"unprognostic (1.99e-1)"	0.6	2.5	11.5	0.9	16.4	0.7	1.7	1.2	4.7	4.5	2.6	15.9	3.1	4.5	3.6	22.5	1.0	85.5	3.8	0.6	11.6	15.0	3.8	0.8	17.4	0.7	4.8	4.5	12.9	2.2	4.8	21.4	0.6	38.4	2.2	2.5	1.0	0.9	2.4	0.9	2.4	4.1	1.1	4.6	0.6	3.4	21.9	7.7	0.2	4.8	0.0	0.7	1.5	0.2	0.6	6.7	0.5	0.3	0.0	0.3	0.3	1.6	1.2	0.1	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	3.5	0.1	0.6	0.0	2.0	0.0	0.5	0.0	0.2	0.1	5.4	0.5	0.0	0.0	0.1	0.2	0.3	1.0	0.0	0.1	0.0	0.0	0.3	0.0	10.8	0.1	0.2	0.3	0.5	0.0	0.4	0.0	16.2	1.3	2.5	1.0	2.6	3.9	0.3	4.4	0.4	0.2	0.0	0.1	0.1	0.0	0.5	2.5	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.3	0.2	0.1	0.4	0.3	0.3	0.3	0.6	0.3	0.2	0.2	0.0	0.1	6.7	0.2	0.3	11.5	16.4	1.2	4.7	11.6	15.0	4.8	4.5	38.4	7.7
RTCA	"RPC, RTC1, RTCD1"	ENSG00000137996	"RNA 3'-terminal phosphate cyclase"	O00442	1	100266207-100292769	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027982, HPA027990, HPA028151, HPA028331"	Uncertain		Enhanced	Nucleoplasm			8700	Nucleoplasm		"HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: "	"unprognostic (4.79e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.12e-2)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (9.55e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.94e-2)"	20.9	25.0	19.4	17.8	24.9	25.5	20.0	22.6	31.7	14.7	22.9	20.3	19.9	31.7	14.2	26.0	27.0	13.4	19.9	25.5	20.0	21.0	31.7	23.0	16.1	21.8	21.5	20.7	13.3	27.7	21.1	17.2	21.2	33.1	20.9	22.2	14.1	18.5	17.4	35.4	14.6	37.8	15.4	20.5	24.2	21.8	12.2	12.4	25.0	18.3	20.2	20.8	18.7	17.5	9.6	8.0	8.2	19.6	11.0	20.1	7.7	21.5	11.2	11.0	14.8	14.0	22.8	30.2	25.6	12.5	16.7	14.4	18.2	10.9	22.1	19.5	16.2	11.0	13.5	12.1	20.2	22.1	11.3	14.6	12.8	22.9	21.6	26.5	23.1	18.5	19.1	21.9	29.2	20.7	25.0	33.7	25.2	7.1	13.6	20.6	16.9	21.7	9.8	19.8	9.7	20.5	17.7	8.9	11.1	16.5	24.0	35.0	5.2	34.0	18.0	15.8	11.1	24.7	30.7	19.6	19.6	17.7	33.3	23.0	9.4	8.2	9.1	7.5	10.8	11.3	13.8	9.6	10.0	12.8	8.0	7.1	9.3	10.5	4.4	11.0	19.6	7.6	20.1	7.7	19.4	24.9	22.6	31.7	20.0	21.0	21.5	20.7	33.1	12.4
RTCB	"C22orf28, FAAP, HSPC117"	ENSG00000100220	"RNA 2',3'-cyclic phosphate and 5'-OH ligase"	Q9Y3I0	22	32387582-32412255	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000535, HPA001103"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol			43000	Nucleoplasm	"Vesicles, Cytosol"	"HPA000535: , HPA001103: AB_1078351"	"unprognostic (1.84e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.07e-2)"	"prognostic favourable (4.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	26.4	30.1	20.1	20.4	29.7	15.1	29.2	22.9	34.5	25.7	35.6	35.2	32.7	51.6	29.7	25.8	30.8	26.9	22.9	26.4	19.6	24.6	42.4	55.1	23.1	22.7	29.1	26.2	29.0	29.4	38.4	29.9	33.7	36.7	27.0	42.3	27.1	29.9	28.6	40.9	46.6	61.7	31.8	24.4	29.3	29.7	30.8	25.5	32.0	32.7	30.1	46.6	26.5	24.2	44.6	51.5	29.0	47.7	37.0	40.5	44.0	31.7	28.6	35.9	26.9	31.4	23.5	28.6	27.9	33.7	44.7	42.5	37.1	13.0	7.9	18.7	32.5	21.7	41.0	40.5	57.9	39.8	41.2	22.5	24.3	33.7	21.6	52.5	20.6	23.0	26.9	44.1	43.0	40.1	26.6	22.5	32.5	26.5	22.3	18.2	20.5	26.2	34.7	38.8	40.6	30.7	27.7	37.1	20.5	30.2	19.6	35.4	21.5	20.5	30.1	24.7	36.4	21.4	26.7	15.7	12.5	28.5	25.5	23.8	32.1	29.0	43.5	27.4	31.7	47.7	35.5	44.6	33.3	33.0	51.5	43.6	39.9	34.6	4.3	37.0	35.5	28.9	40.5	44.0	20.1	29.7	22.9	34.5	19.6	24.6	29.1	26.2	36.7	25.5
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870966	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 144.6"	"Group enriched"	"Detected in some"	4	"HEL: 22.7;SCLC-21H: 28.1;SH-SY5Y: 45.0"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9"	"Group enriched"	"Detected in many"	15	"dendritic cells: 7.9;monocytes: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"			140000	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: , HPA044249: "	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favourable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	6.3	8.3	27.4	6.1	46.3	1.6	3.0	98.5	144.6	2.6	2.9	11.0	0.0	2.7	2.1	1.6	2.3	8.6	4.4	1.9	32.3	50.7	2.3	1.9	4.8	2.7	21.3	45.9	1.7	3.6	19.2	10.3	2.7	35.1	5.0	3.0	1.2	2.3	2.6	1.6	2.3	3.4	2.7	12.1	10.6	3.6	2.6	10.5	0.0	2.7	0.0	2.3	2.5	0.9	0.0	7.9	0.4	4.6	0.0	0.0	1.0	0.0	0.0	0.3	0.3	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	22.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	28.1	45.0	5.5	0.0	0.0	0.0	0.0	0.0	3.8	1.1	0.0	2.0	0.0	0.0	0.0	7.5	1.6	0.2	0.0	4.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	1.0	27.4	46.3	98.5	94.7	32.3	50.7	21.3	45.9	35.1	10.5
RTN3	"ASYIP, HAP, NSPL2, NSPLII, RTN3-A1"	ENSG00000133318	"Reticulon 3"	O95197	11	63681446-63759891	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 122.2;brain: 149.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 122.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 122.2;monocytes: 42.2"	"Low region specificity"	"Detected in all"							"HPA015649, HPA015650"	Enhanced		Supported	"Endoplasmic reticulum"			620000	"Endoplasmic reticulum"		"HPA015649: AB_1856498, HPA015650: AB_1856499"	"unprognostic (8.11e-3)"	"unprognostic (8.51e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (1.30e-6)"	"unprognostic (5.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (9.87e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-2)"	43.6	19.6	72.2	11.9	71.6	22.3	21.5	55.9	149.6	21.7	20.0	50.2	9.3	12.3	14.8	19.7	12.4	21.0	13.1	12.8	78.3	72.9	22.0	19.9	17.7	7.3	72.6	53.5	11.9	20.7	36.4	14.0	14.1	109.9	12.9	18.8	12.7	30.4	18.9	10.8	22.6	14.6	18.6	66.0	9.2	12.8	10.3	39.2	6.8	40.9	5.1	10.7	13.1	8.9	3.3	14.7	122.2	42.2	4.6	7.4	28.1	30.9	22.9	27.6	26.3	51.2	36.4	11.0	28.2	30.1	25.0	26.8	19.9	68.8	36.7	48.2	42.2	32.0	39.5	13.9	33.0	29.5	21.1	46.9	33.6	13.9	42.6	41.7	37.9	24.0	41.2	30.3	33.9	33.7	26.5	59.6	21.9	25.4	22.0	46.4	32.2	26.0	29.3	19.3	67.6	49.2	17.6	58.7	34.0	45.7	50.4	52.6	55.6	34.4	31.3	14.9	20.2	51.7	21.5	38.0	32.7	29.4	57.4	34.7	15.7	40.1	42.2	52.8	4.9	21.1	5.3	3.3	5.0	4.9	14.7	2.3	3.7	4.0	122.2	4.6	25.1	8.8	7.4	28.1	72.2	71.6	55.9	118.2	78.3	72.9	72.6	53.5	109.9	39.2
RTN4	"ASY, KIAA0886, NOGO, NSP-CL"	ENSG00000115310	"Reticulon 4"	Q9NQC3	2	54972187-55112621	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 157.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005388, HPA023977"	Supported		Enhanced	"Endoplasmic reticulum"			13000000	"Endoplasmic reticulum"		"CAB005388: AB_2285559, HPA023977: "	"unprognostic (1.31e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.24e-3)"	"prognostic unfavourable (1.00e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.91e-2)"	103.7	60.5	75.1	27.9	85.0	19.3	63.6	66.6	105.5	24.8	35.4	52.9	17.5	45.0	29.3	36.0	43.0	26.3	38.5	30.8	71.9	69.7	86.5	103.5	36.2	19.6	84.9	75.8	27.4	23.7	59.9	16.1	33.8	99.0	45.2	35.7	24.7	23.6	38.1	171.1	48.1	55.2	47.4	92.6	20.1	23.5	14.6	62.7	14.7	25.9	47.2	16.5	48.1	35.4	2.8	6.1	33.3	7.7	16.8	15.8	4.4	32.5	23.7	23.2	6.0	79.0	74.1	13.0	108.5	92.2	33.6	31.5	19.4	31.1	7.1	57.7	73.5	29.6	15.2	43.6	51.3	20.1	11.7	9.8	14.6	30.6	157.2	17.5	5.1	55.5	41.8	45.9	89.5	62.9	19.9	16.4	144.9	9.5	21.4	18.0	20.8	21.2	9.6	30.6	14.6	78.0	39.3	15.3	18.0	24.8	14.6	30.3	12.4	13.5	89.3	65.8	27.9	25.8	62.0	10.0	8.1	4.5	66.9	20.4	52.8	33.3	4.3	10.9	4.3	4.9	3.5	2.8	6.9	3.8	4.0	1.6	11.7	4.8	7.0	16.8	7.7	6.1	15.8	4.4	75.1	85.0	66.6	105.5	71.9	69.7	84.9	75.8	99.0	62.7
RTN4R	NOGOR	ENSG00000040608	"Reticulon 4 receptor"	Q9BZR6	22	20241415-20283246	"Disease related genes, Predicted membrane proteins"		Receptor	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.0;brain: 33.2"	"Cell line enhanced"	"Detected in many"		"NB-4: 20.0;REH: 28.2;SCLC-21H: 17.2;SK-MEL-30: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB012443			Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"			1300000	"Plasma membrane, Focal adhesion sites"	"Actin filaments"	"CAB012443: "	"unprognostic (1.28e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.07e-1)"	0.8	1.1	10.9	1.2	7.0	1.3	0.7	33.2	24.6	0.8	1.7	1.2	0.3	3.9	4.9	0.5	0.9	1.3	0.6	1.4	8.8	3.1	0.9	4.0	1.7	1.1	1.4	6.8	1.1	2.7	0.6	1.6	1.1	4.9	1.2	0.6	0.7	1.3	1.2	0.8	5.2	1.8	0.7	2.8	5.9	2.3	1.1	0.5	0.1	1.1	0.4	0.7	0.7	0.7	0.1	1.3	0.0	0.0	0.7	12.0	1.7	4.1	2.0	1.2	3.0	0.0	0.0	0.6	0.4	0.0	0.3	0.1	3.2	1.1	0.2	1.4	0.0	6.8	0.7	1.7	0.0	0.1	7.3	0.1	1.8	0.4	0.7	0.1	0.2	0.0	2.2	0.0	0.2	0.0	0.2	0.2	0.0	5.8	2.1	20.0	4.7	3.6	28.2	0.0	0.2	0.2	1.7	17.2	2.8	2.0	1.4	13.4	1.6	0.5	0.0	0.2	8.1	0.0	0.1	0.0	0.5	0.5	0.2	4.1	0.0	0.0	0.0	0.0	5.1	0.0	12.0	0.0	4.5	5.1	0.2	0.1	2.7	5.7	0.0	0.7	0.0	1.3	3.1	1.7	10.9	7.0	33.2	20.1	8.8	3.1	1.4	6.8	4.9	0.5
RTP4	"IFRG28, Z3CXXC4"	ENSG00000136514	"Receptor transporter protein 4"	Q96DX8	3	187368332-187372076	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.1;HDLM-2: 10.0;Karpas-707: 8.2;REH: 8.0;SK-MEL-30: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA064887, HPA071189"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA064887: , HPA071189: "	"unprognostic (1.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (6.83e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.95e-2)"	"prognostic favourable (4.35e-4)"	"prognostic favourable (1.45e-4)"	7.7	4.6	3.2	6.9	3.6	0.7	5.9	1.0	3.1	8.1	13.3	6.0	3.8	9.2	6.7	7.1	6.2	11.3	7.6	2.9	3.1	3.0	8.6	8.8	8.0	12.0	3.8	3.0	6.4	9.7	0.3	3.0	5.9	3.3	10.1	6.1	7.7	10.8	5.6	0.9	2.2	23.2	5.2	5.4	13.5	8.0	1.9	1.5	16.8	10.5	4.3	8.6	10.5	4.7	5.1	6.0	4.7	10.5	12.4	16.2	5.6	2.5	0.0	0.0	0.0	1.2	4.3	0.1	0.0	1.0	1.7	1.5	0.0	9.1	1.2	0.0	1.0	3.0	0.0	0.1	0.0	10.0	0.0	0.0	0.0	0.1	1.6	0.0	2.3	1.0	0.0	0.3	0.0	0.3	0.0	8.2	0.0	0.0	5.8	0.0	0.0	0.0	8.0	0.0	6.6	2.1	6.5	0.0	0.0	0.0	0.2	15.5	0.0	4.0	0.1	0.1	0.2	0.0	0.1	6.6	2.1	0.0	0.0	2.2	5.0	4.7	6.9	4.7	10.4	8.5	10.2	5.1	8.3	9.4	6.0	4.8	6.4	7.4	2.1	12.4	10.5	0.1	16.2	5.6	3.2	3.6	1.0	3.1	3.1	3.0	3.8	3.0	3.3	1.5
RTRAF	"C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1"	ENSG00000087302	"RNA transcription, translation and transport factor"	Q9Y224	14	51989475-52010691	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039824	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA039824: AB_10793922"	"unprognostic (2.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-1)"	41.8	46.1	28.7	43.9	38.7	51.9	78.8	21.0	52.1	28.8	40.2	18.8	44.3	26.9	36.3	45.8	38.7	29.7	41.3	110.7	31.2	25.8	34.5	37.8	44.8	80.0	30.8	31.5	45.4	72.2	25.1	33.7	29.9	39.2	32.1	40.6	21.4	39.5	49.6	95.6	36.5	30.6	58.9	39.1	30.6	46.9	94.7	26.3	54.7	38.6	55.1	44.5	38.6	47.6	37.5	40.3	19.2	35.9	32.0	47.9	37.7	44.5	30.3	52.2	50.5	35.1	46.9	50.0	35.7	39.5	39.6	44.8	32.5	39.5	61.1	38.3	29.5	35.8	48.6	32.6	51.7	32.9	27.2	23.7	63.2	43.1	56.4	50.4	27.4	35.3	33.9	29.8	49.2	44.6	24.4	29.3	38.2	49.6	63.7	63.8	40.6	51.4	58.2	49.7	28.8	38.0	52.2	37.0	37.7	45.1	81.7	55.8	54.7	40.1	31.0	43.4	47.7	36.4	44.5	11.0	15.4	62.1	21.4	39.8	49.2	14.3	32.0	19.2	26.9	34.8	33.5	37.5	37.7	32.2	40.3	31.3	35.2	35.1	6.7	32.0	35.9	36.9	47.9	37.7	28.7	38.7	21.0	52.1	31.2	25.8	30.8	31.5	39.2	26.3
RUBCN	"KIAA0226, rubicon, rundataxin"	ENSG00000145016	"RUN and cysteine rich domain containing beclin 1 interacting protein"	Q92622	3	197671393-197749727	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Endocytosis, Immunity, Phagocytosis"		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050908, HPA054497"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA050908: , HPA054497: "	"unprognostic (2.91e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (6.65e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (9.91e-5)"	"unprognostic (1.99e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.23e-1)"	10.7	8.4	19.3	15.5	24.0	10.7	6.8	30.0	24.6	7.9	9.8	12.4	6.4	10.7	9.1	6.5	14.5	7.7	10.4	10.3	18.1	18.8	7.8	5.7	12.4	19.8	14.6	19.4	14.0	11.0	13.3	16.6	8.5	18.3	7.4	8.8	8.3	7.1	11.2	9.7	11.7	12.0	11.4	15.1	22.3	11.3	22.0	15.8	7.9	7.4	7.0	22.3	9.6	8.0	7.8	14.7	12.8	4.1	1.5	4.4	1.2	14.8	3.5	4.2	8.5	7.4	4.2	4.3	6.9	4.5	8.2	7.0	6.2	4.1	17.1	13.5	7.4	8.1	7.8	3.8	6.7	4.4	6.9	10.4	6.0	2.3	4.3	5.9	8.7	3.5	4.9	7.2	8.6	5.1	5.7	42.7	5.5	12.0	7.0	3.7	3.6	11.5	7.0	4.3	10.6	4.8	6.5	17.0	4.1	5.0	9.8	5.5	14.5	3.9	6.8	5.0	4.8	13.6	9.1	20.2	16.2	13.0	6.6	10.9	4.3	0.6	2.4	12.8	3.6	3.5	2.3	6.6	3.0	4.4	1.4	7.8	2.2	3.0	2.7	1.5	4.1	14.7	3.6	1.2	19.3	24.0	30.0	24.6	18.1	18.8	14.6	19.4	18.3	15.8
RUBCNL	"C13orf18, FLJ21562, KIAA0226L"	ENSG00000102445	"RUN and cysteine rich domain containing beclin 1 interacting protein like"	Q9H714	13	46342000-46438190	"Predicted intracellular proteins"	"Autophagy, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.1;lymphoid tissue: 24.0"	"Group enriched"	"Detected in some"	5	"Daudi: 39.1;U-698: 64.6"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"memory B-cell: 29.9;naive B-cell: 31.1;neutrophil: 31.1;plasmacytoid DC: 22.5"	"Group enriched"	"Detected in many"	17	"B-cells: 31.1;dendritic cells: 22.5;granulocytes: 31.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Supported	Cytosol				Cytosol		"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favourable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"	3.7	1.6	4.5	21.2	4.3	15.0	5.7	2.9	3.6	5.5	8.1	2.9	1.3	1.5	3.0	3.2	1.0	2.0	3.8	1.5	3.4	3.7	1.5	1.7	5.5	20.2	4.5	2.7	0.9	1.2	0.1	2.7	3.3	5.2	2.2	11.2	3.0	6.5	1.8	0.8	2.7	14.9	2.8	8.8	24.0	1.6	15.9	3.7	10.1	2.2	0.2	21.7	2.9	2.0	31.1	22.5	31.1	1.6	0.3	0.0	1.2	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	1.5	0.0	39.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.4	11.2	0.0	1.6	0.0	0.0	0.8	0.0	0.1	0.0	0.6	0.0	9.0	0.0	0.0	0.3	0.0	0.1	0.2	9.0	64.6	0.4	0.1	0.0	0.0	1.0	0.0	0.0	1.6	0.0	29.9	0.0	0.0	1.0	31.1	0.0	0.0	31.1	0.3	0.9	22.5	0.0	1.2	4.5	4.3	2.9	3.6	3.4	3.7	4.5	2.7	5.2	3.7
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550558-179610026	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"			9600	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	20.9	27.9	19.7	24.7	22.4	21.1	36.9	22.4	18.9	18.2	20.2	16.9	27.9	16.9	22.5	16.9	25.9	18.8	20.7	14.8	19.7	14.8	23.9	17.5	20.8	23.1	18.8	17.1	19.4	19.8	22.6	21.5	17.3	19.7	20.9	15.5	16.4	21.2	18.3	26.7	24.2	18.8	17.5	14.7	27.9	18.6	12.2	20.5	20.1	27.3	14.1	20.1	20.7	34.3	3.2	3.4	7.9	4.5	1.2	2.9	21.5	7.1	11.8	6.3	8.3	12.2	10.1	7.2	12.7	9.1	7.5	8.8	11.4	16.7	11.6	7.2	15.4	6.6	11.5	16.6	8.9	36.6	8.7	20.2	9.0	8.2	12.5	11.2	11.1	10.2	9.2	5.1	14.6	8.2	8.2	11.1	6.7	21.6	11.9	7.8	6.7	5.5	10.7	4.5	10.7	12.6	11.7	6.3	9.0	18.6	12.0	6.6	9.6	13.8	9.8	10.0	3.3	5.3	9.9	6.9	10.6	20.8	9.2	20.3	9.1	7.4	3.4	7.9	1.7	3.6	1.0	2.7	2.0	1.7	3.0	3.2	1.4	1.8	5.9	1.2	4.5	3.4	2.9	21.5	19.7	22.4	22.4	18.9	19.7	14.8	18.8	17.1	19.7	20.5
RUFY3	"KIAA0871, RIPx, Singar1, ZFYVE30"	ENSG00000018189	"RUN and FYVE domain containing 3"	Q7L099	4	70704204-70807315	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022952, HPA022970"	Enhanced		Supported	Cytosol				Cytosol		"HPA022952: , HPA022970: AB_1856307"	"unprognostic (4.33e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"prognostic favourable (1.28e-4)"	"prognostic unfavourable (8.95e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.50e-2)"	"prognostic favourable (8.02e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.45e-3)"	"unprognostic (5.41e-1)"	10.9	24.5	39.1	11.8	53.4	6.9	12.5	36.4	66.3	12.3	8.7	24.1	6.7	8.1	20.6	16.3	15.3	9.3	12.7	8.9	64.5	34.4	15.5	13.6	14.8	13.6	37.0	51.3	25.5	9.8	8.5	61.4	12.0	54.2	13.8	11.4	12.8	10.1	11.5	15.4	29.9	9.9	15.1	80.2	16.0	12.8	25.3	32.5	7.1	31.6	5.9	11.5	9.3	12.3	3.5	6.0	0.0	3.1	2.2	2.8	1.0	3.7	2.6	31.0	7.3	15.0	17.5	12.4	12.1	4.6	3.9	4.5	4.4	9.2	14.9	5.0	10.0	3.8	4.7	5.3	6.3	8.1	6.0	3.2	3.6	4.9	8.5	3.7	1.9	12.3	8.4	5.3	6.2	8.4	8.8	15.4	8.7	4.6	23.0	3.9	7.4	3.3	5.7	9.7	6.8	7.7	3.6	29.0	14.3	4.4	7.8	7.3	5.3	1.8	7.1	13.5	9.4	4.0	2.8	17.2	7.8	15.9	14.0	2.7	2.7	0.0	3.1	0.0	2.2	3.0	2.8	3.5	1.5	2.0	6.0	3.1	1.5	1.6	0.0	2.2	2.8	4.8	1.0	1.0	39.1	53.4	36.4	66.3	64.5	34.4	37.0	51.3	54.2	32.5
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"Runt related transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 54.3;lymphoid tissue: 58.6"	"Cell line enhanced"	"Detected in many"		"HEL: 65.0;HMC-1: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA004176: AB_1078412, HPA037912: "	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	11.5	3.2	5.2	14.8	7.3	29.8	54.3	1.0	4.3	12.5	4.7	3.8	4.0	3.8	2.9	7.4	6.5	4.6	12.4	7.6	6.1	2.0	4.2	6.7	17.9	13.9	8.5	1.1	6.5	5.8	1.6	5.5	6.4	6.0	9.9	5.1	3.5	29.8	8.8	14.4	8.3	5.1	6.8	12.3	10.6	12.7	2.9	6.6	58.6	4.6	5.7	14.2	11.0	9.1	3.2	3.4	17.0	3.9	1.3	4.8	2.0	13.0	1.0	0.0	0.1	3.4	4.4	8.6	7.4	7.5	4.1	3.1	0.6	10.0	6.4	0.5	6.5	11.8	0.8	8.8	6.0	9.9	1.0	65.0	2.6	3.0	6.3	7.5	39.2	8.5	5.3	12.5	12.4	2.3	4.4	3.8	8.7	2.8	30.3	11.9	0.6	3.8	30.7	22.8	3.9	5.5	5.2	0.3	0.0	7.6	1.9	2.7	3.9	17.6	9.7	6.8	8.8	10.1	11.1	12.5	5.1	6.1	8.5	16.5	9.9	17.0	3.2	6.3	3.4	1.4	3.3	3.2	3.1	3.2	0.9	3.1	4.8	3.8	3.5	1.3	3.9	3.4	4.0	2.0	5.2	7.3	1.0	4.3	6.1	2.0	8.5	1.1	6.0	6.6
RUNX1T1	"AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2"	ENSG00000079102	"RUNX1 translocation partner 1"	Q06455	8	91954967-92103286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 57.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 12.9;fHDF/TERT166: 11.0;HEL: 23.7;HSkMC: 9.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 57.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049852, HPA070951"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA049852: , HPA070951: "	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-4)"	"unprognostic (2.29e-4)"	"unprognostic (5.56e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-4)"	"unprognostic (8.98e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.80e-3)"	9.6	4.6	7.7	4.5	11.5	0.4	6.9	57.8	13.0	14.0	7.8	1.1	2.0	2.0	11.8	5.9	4.1	7.7	7.8	12.3	5.8	4.0	2.5	1.3	6.0	2.0	3.6	9.6	7.7	1.8	1.7	8.6	8.7	4.2	4.2	4.0	5.3	4.7	4.1	5.5	3.6	3.6	10.3	3.0	2.9	4.2	5.6	3.7	0.0	5.2	3.3	1.8	5.7	5.9	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.3	3.5	5.1	0.0	5.1	7.8	3.4	5.3	0.0	0.0	12.9	0.0	11.0	0.0	2.7	0.3	2.3	0.0	2.1	23.7	0.0	0.0	1.4	0.0	0.0	9.5	0.0	5.7	0.2	7.3	0.1	0.0	0.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	4.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.6	0.0	2.6	0.0	4.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	7.7	11.5	57.8	13.0	5.8	4.0	3.6	9.6	4.2	3.7
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"Runt related transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.1;RH-30: 24.3;U-698: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 16.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB008374: AB_590789, CAB062561: , CAB068226: , HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavourable (3.97e-9)"	"prognostic unfavourable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavourable (6.66e-5)"	3.7	2.1	4.9	13.7	7.0	15.5	5.7	1.0	7.2	13.5	6.0	5.6	7.4	4.1	3.5	2.3	3.4	2.4	6.8	1.8	7.4	3.5	3.9	1.8	5.3	8.6	6.3	3.4	5.0	1.9	1.3	3.8	3.3	7.2	9.5	7.8	5.4	19.8	14.9	2.2	4.9	10.8	3.4	10.5	6.6	6.0	2.1	7.3	6.5	4.2	4.5	11.7	7.3	8.9	0.1	11.4	5.3	0.6	16.0	10.2	0.7	1.6	0.5	0.3	0.0	1.5	4.0	0.0	1.5	3.6	5.1	7.2	0.0	0.9	0.0	1.8	2.1	2.0	0.0	1.4	9.4	6.1	0.7	0.0	1.1	0.0	8.0	6.3	0.0	10.8	1.1	4.5	5.1	0.0	0.0	29.1	9.1	0.4	0.2	11.1	0.3	0.2	0.0	24.3	0.0	5.0	3.2	0.0	0.0	1.1	0.0	1.8	1.7	0.5	0.2	5.2	4.2	8.0	5.5	9.2	0.0	25.4	5.9	2.4	2.3	5.3	0.6	3.2	1.2	0.1	10.2	0.1	2.8	3.2	1.8	0.1	0.5	1.5	4.8	16.0	0.1	11.4	2.3	0.7	4.9	7.0	1.0	7.2	7.4	3.5	6.3	3.4	7.2	7.3
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"Runt related transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.5;lymphoid tissue: 47.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 38.7;Karpas-707: 52.1;SK-MEL-30: 28.9;U-266/70: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB025416: , HPA004195: , HPA059006: "	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavourable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.0	1.1	0.9	25.4	1.1	31.5	3.4	0.5	1.0	11.9	8.0	1.2	0.3	2.5	1.7	1.4	3.5	1.7	6.2	1.3	0.9	1.1	2.2	2.3	11.7	28.8	2.8	0.7	1.3	1.0	0.0	1.0	1.3	1.8	2.3	2.3	2.8	6.5	2.2	2.2	9.5	13.7	1.3	1.8	30.6	2.7	2.1	0.8	14.2	1.8	3.1	47.6	8.9	2.2	4.5	1.0	4.3	4.6	18.1	15.1	3.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	6.2	6.1	5.3	0.1	3.6	0.0	0.2	38.7	0.6	0.1	0.6	0.0	0.0	1.4	13.4	0.0	0.0	0.0	0.3	0.0	0.0	52.1	0.0	0.0	0.4	12.0	0.2	1.0	0.0	0.0	7.3	0.0	0.1	1.2	0.0	2.4	0.0	28.9	0.0	8.3	0.0	0.0	0.5	0.0	0.1	18.1	12.5	5.9	0.0	13.5	1.4	0.4	0.7	4.3	15.1	3.0	8.1	4.5	5.7	13.2	0.9	3.8	2.8	10.3	0.9	18.1	4.6	1.0	5.7	3.1	0.9	1.1	0.5	1.0	0.9	1.1	2.8	0.7	1.8	0.8
RUSC1	NESCA	ENSG00000160753	"RUN and SH3 domain containing 1"	Q9BVN2	1	155320896-155331114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028510, HPA029922, HPA029923"	Approved		Enhanced	Cytosol				Cytosol		"HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288"	"unprognostic (1.98e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (7.78e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavourable (2.65e-4)"	"prognostic unfavourable (9.24e-6)"	"unprognostic (7.59e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.40e-1)"	10.9	15.9	24.8	8.7	24.1	8.9	12.2	46.1	45.4	16.6	20.2	5.6	9.2	17.5	13.0	7.4	21.8	12.4	13.6	12.2	18.5	22.3	12.9	4.9	11.0	7.4	14.4	26.4	13.3	12.5	11.5	21.5	14.7	26.1	16.3	19.0	8.7	18.1	18.1	8.7	22.7	19.5	15.3	8.9	7.6	14.2	3.1	6.2	12.6	8.4	11.4	8.8	12.1	16.1	3.4	7.5	5.1	18.9	2.6	6.4	4.2	23.4	14.9	8.5	12.6	10.7	11.6	16.6	11.2	7.2	14.8	16.7	17.0	15.6	4.6	8.6	11.3	32.8	13.3	16.3	6.4	6.3	16.9	6.7	14.7	8.9	8.8	6.6	11.6	11.9	10.3	14.9	5.1	15.3	10.0	3.2	12.8	44.8	8.2	8.4	16.8	23.8	11.3	5.9	8.2	14.0	18.0	8.8	14.5	9.5	26.8	5.7	39.9	11.4	6.9	19.1	15.8	18.0	22.1	2.6	5.8	2.8	13.4	8.9	5.1	5.1	6.8	3.2	5.8	8.1	6.4	3.4	4.7	5.8	7.5	1.5	2.6	5.5	0.9	2.6	18.9	7.1	4.7	4.2	24.8	24.1	46.1	45.4	18.5	22.3	14.4	26.4	26.1	6.2
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol			47000	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	17.6	15.1	10.7	15.8	14.2	11.9	13.9	7.9	14.0	12.5	11.6	12.9	14.3	8.4	19.2	11.4	19.2	37.3	11.3	18.6	11.4	13.6	20.9	13.7	12.9	18.7	10.0	9.8	15.4	13.6	26.5	14.2	19.9	13.0	12.0	14.1	11.5	10.2	12.0	12.9	11.8	10.2	16.1	8.8	21.9	10.9	44.7	10.3	33.4	15.2	18.1	23.9	12.6	15.0	10.6	8.7	1.5	7.9	10.9	20.2	7.2	26.7	24.3	14.9	24.3	11.7	11.4	19.6	13.1	11.3	25.3	17.5	25.4	15.9	38.0	13.1	12.5	21.3	39.8	27.8	29.5	15.5	19.5	31.5	14.1	17.0	12.1	29.4	10.1	11.6	14.7	21.3	27.4	16.9	25.8	8.9	14.4	38.1	31.5	22.3	37.6	20.8	25.9	18.1	26.4	15.1	10.1	25.1	22.5	14.5	12.0	20.1	21.8	21.8	10.9	11.5	14.1	17.3	19.8	9.1	14.5	37.3	14.2	18.1	14.4	0.8	4.8	1.5	11.3	7.9	14.6	10.6	13.6	14.0	7.7	10.2	11.5	12.8	0.2	10.9	7.4	8.7	20.2	7.2	10.7	14.2	7.9	14.0	11.4	13.6	10.0	9.8	13.0	10.3
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993448-49015995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	6.9	5.3	6.7	7.5	7.1	13.4	4.8	8.2	10.4	4.8	9.9	7.6	6.3	11.2	8.3	5.5	16.1	5.5	7.2	9.1	6.9	6.0	7.6	10.3	5.5	8.2	7.7	8.1	6.5	8.7	1.6	6.4	5.5	6.7	6.0	3.2	6.5	10.0	6.6	27.8	7.7	10.0	3.7	7.1	6.9	10.7	59.0	5.8	14.6	8.8	9.4	8.1	6.4	12.9	12.6	16.4	5.6	14.3	11.0	12.5	15.2	28.8	29.7	3.5	20.0	1.5	2.7	9.4	15.6	6.8	17.9	11.8	15.4	12.5	27.1	12.1	3.1	15.3	2.1	10.2	2.1	16.4	12.2	17.7	8.9	7.8	5.0	34.7	12.4	3.1	2.0	4.0	2.1	6.6	30.6	11.5	1.6	5.9	30.6	4.1	10.7	4.4	25.4	16.0	17.4	3.2	11.1	14.2	20.5	15.7	13.1	5.6	11.6	13.3	9.7	11.4	16.7	7.5	38.6	23.4	26.7	28.0	8.4	17.0	16.3	5.6	14.3	4.2	11.1	11.1	11.2	10.9	11.1	9.1	16.4	12.6	12.2	8.0	1.0	11.0	10.8	12.5	12.5	15.2	6.7	7.1	8.2	10.4	6.9	6.0	7.7	8.1	6.7	5.8
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.9;non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.9;monocytes: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favourable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavourable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	18.5	10.1	9.9	10.4	6.7	19.6	36.8	4.6	9.8	11.0	9.3	4.9	8.1	14.0	10.1	6.1	24.2	9.3	12.9	14.2	9.0	3.7	11.7	49.3	12.8	10.4	6.0	7.0	11.7	20.6	8.0	10.7	9.6	9.4	9.7	2.0	9.5	9.3	9.7	45.8	19.0	15.2	10.6	9.5	11.5	8.8	5.9	8.1	1.5	13.6	18.3	5.9	16.0	23.7	0.1	1.7	14.9	12.3	1.3	1.1	1.8	5.5	15.6	2.0	5.0	3.5	3.3	24.0	3.0	3.5	4.3	2.5	8.6	8.7	0.0	8.2	4.3	27.0	0.7	10.6	0.2	7.9	2.0	0.0	19.0	13.1	4.5	6.5	2.4	5.3	4.5	5.4	2.5	3.7	10.7	0.5	1.0	14.9	0.5	1.4	3.8	5.4	2.8	7.4	10.8	0.2	24.1	4.4	2.0	9.5	9.1	2.4	12.6	8.9	4.8	5.3	6.4	5.7	2.6	0.7	0.0	0.1	4.0	6.6	3.4	1.1	5.2	2.8	1.1	9.3	0.0	0.1	0.7	0.7	1.7	0.0	0.2	0.9	14.9	1.3	12.3	0.1	0.9	1.8	9.9	6.7	4.6	9.8	9.0	3.7	6.0	7.0	9.4	8.1
RXRB	"H-2RIIBP, NR2B2, RCoR-1"	ENSG00000204231	"Retinoid X receptor beta"	P28702	6	33193588-33200688	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;RH-30: 8.7;RT4: 8.2;T-47d: 8.5;U-698: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002003, HPA063653"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB002003: , HPA063653: "	"unprognostic (3.51e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-3)"	"unprognostic (8.13e-3)"	"unprognostic (9.53e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.53e-3)"	24.9	18.9	13.0	14.0	16.1	9.8	16.0	24.7	23.2	22.8	17.1	17.7	17.3	19.0	17.4	56.6	13.7	18.5	17.1	27.7	13.5	12.3	14.1	17.4	16.5	9.8	16.4	15.6	19.1	16.2	3.6	17.5	19.2	15.5	20.1	8.4	16.0	16.2	22.0	19.7	25.5	14.1	28.4	10.4	19.8	13.9	10.4	18.2	18.5	22.0	10.9	24.5	14.0	14.5	1.9	1.4	5.2	1.2	1.9	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	7.0	0.0	5.3	4.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	5.8	0.0	0.0	0.0	0.0	0.0	5.2	0.0	5.2	0.0	0.0	0.2	3.1	0.0	0.0	8.7	0.0	5.3	8.2	0.0	4.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	3.8	0.0	0.0	6.8	5.8	8.4	0.0	0.0	0.0	5.2	0.8	2.9	2.5	0.9	1.8	1.9	2.5	2.4	1.3	0.8	2.4	1.5	1.9	1.9	1.2	1.4	2.5	0.7	13.0	16.1	24.7	23.2	13.5	12.3	16.4	15.6	15.5	18.2
RYBP	"AAP1, DEDAF, YEAF1"	ENSG00000163602	"RING1 and YY1 binding protein"	Q8N488	3	72371825-72446621	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053357	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA053357: "	"unprognostic (6.80e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.12e-2)"	"prognostic favourable (2.50e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.22e-1)"	7.7	6.3	9.5	10.5	12.1	8.2	8.6	6.1	13.3	9.7	7.6	23.1	7.7	5.8	13.3	6.8	7.0	7.1	8.2	5.8	10.9	8.6	7.4	10.2	11.3	6.3	20.4	4.2	10.4	6.3	6.4	11.5	15.8	15.8	10.9	7.6	9.0	5.8	8.0	3.4	6.7	9.4	8.8	12.6	9.0	6.0	9.3	26.1	3.8	6.0	5.2	7.1	7.9	6.8	1.6	4.2	8.5	3.0	1.9	1.8	0.8	5.6	3.5	7.3	6.1	8.3	11.7	5.4	5.7	8.5	7.3	8.6	5.3	6.5	4.6	4.9	6.4	2.4	7.6	5.8	9.5	32.9	4.0	17.7	4.2	5.3	8.9	4.4	6.0	13.0	12.1	9.5	16.1	4.3	5.7	15.0	7.7	7.3	5.4	5.1	18.5	4.8	5.7	5.6	3.4	7.1	8.1	6.4	17.3	10.5	9.8	10.2	4.5	6.3	4.6	11.0	9.2	7.3	4.8	15.2	13.4	5.1	4.4	9.5	11.9	3.3	1.4	4.7	1.4	2.8	1.4	1.3	1.6	1.2	1.5	1.6	1.8	1.3	8.5	1.9	3.0	4.2	1.8	0.8	9.5	12.1	6.1	13.3	10.9	8.6	20.4	4.2	15.8	26.1
S100A3	S100E	ENSG00000188015	"S100 calcium binding protein A3"	P33764	1	153547329-153549372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.7"	"Cell line enhanced"	"Detected in many"		"A549: 33.4;HBEC3-KT: 17.8;HeLa: 21.7;U-2197: 19.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 26.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 3.6;non-classical monocyte: 6.9;plasmacytoid DC: 8.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 8.9;monocytes: 6.9"					"Low region specificity"	"Detected in many"			"HPA042674, HPA056140"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"			390000	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA042674: AB_10796581, HPA056140: "	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.34e-3)"	"unprognostic (3.97e-3)"	"prognostic unfavourable (1.61e-6)"	"unprognostic (8.13e-2)"	"unprognostic (3.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (8.10e-2)"	4.7	0.6	0.6	3.3	3.1	1.5	2.2	0.6	1.7	3.7	1.2	1.3	0.1	0.4	2.4	1.6	7.4	1.6	1.6	7.9	0.5	0.7	10.2	0.1	14.2	4.6	1.7	0.1	1.2	5.3	0.0	0.3	5.6	3.5	3.6	1.0	0.3	2.0	1.6	2.5	44.7	1.0	1.8	1.5	2.1	0.7	1.4	0.4	0.5	1.7	2.1	4.9	3.7	4.0	0.7	8.9	0.0	6.9	0.0	0.3	0.4	2.8	33.4	0.0	0.0	3.2	2.1	0.0	2.3	12.2	2.9	4.9	0.9	1.0	0.0	7.5	5.8	8.8	0.0	17.8	1.6	0.1	0.0	0.1	21.7	6.0	0.8	0.0	0.1	1.5	9.1	7.1	8.0	0.6	0.0	0.0	15.7	0.2	0.0	0.0	0.2	4.1	0.0	2.4	1.8	9.7	7.2	0.5	0.0	2.1	2.5	0.7	0.1	0.2	3.0	1.2	1.9	19.5	2.4	0.5	0.6	0.0	15.6	0.2	7.4	0.0	0.2	0.0	0.0	3.6	0.3	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.9	8.9	0.1	0.4	0.6	3.1	0.6	1.7	0.5	0.7	1.7	0.1	3.5	0.4
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 419.2"	"Cell line enhanced"	"Detected in many"		"A549: 112.8;ASC diff: 146.4;BJ hTERT+: 281.6;fHDF/TERT166: 201.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Enhanced	"Plasma membrane"			13000000	"Plasma membrane"		"CAB002618: , CAB027387: , CAB058698: , CAB068227: , CAB068228: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favourable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	125.9	10.1	2.6	29.2	8.3	75.2	171.6	2.2	4.6	52.1	33.9	2.7	25.8	7.3	26.8	52.2	58.6	27.9	34.7	59.9	3.0	1.7	27.8	6.1	80.7	53.2	10.8	3.1	12.7	6.7	0.0	3.0	46.9	6.6	49.5	28.0	19.3	29.8	13.4	25.4	44.5	25.5	38.5	8.9	55.9	17.2	18.2	6.2	8.5	23.7	57.5	26.4	34.9	58.2	18.6	213.1	281.6	293.3	17.3	162.7	419.2	0.5	112.8	0.5	3.3	146.4	100.9	0.1	71.5	281.6	1.4	6.3	0.8	7.9	0.0	13.1	201.4	2.8	0.4	1.0	1.1	16.1	0.0	48.2	25.1	2.5	0.1	4.2	81.6	15.7	1.1	2.8	0.6	0.1	0.4	0.1	102.5	0.4	0.1	50.0	0.3	43.3	2.5	0.1	106.3	4.4	3.0	4.3	0.5	1.2	54.5	0.4	3.3	60.4	0.1	0.3	0.6	96.1	0.4	3.5	24.0	0.5	0.2	53.7	5.5	49.5	293.3	30.8	141.2	201.4	147.2	18.6	127.2	112.3	213.1	6.2	22.4	66.5	281.6	17.3	253.9	37.4	162.7	419.2	2.6	8.3	2.2	4.6	3.0	1.7	10.8	3.1	6.6	6.2
S100A6	"2A9, CABP, CACY, PRA"	ENSG00000197956	"S100 calcium binding protein A6"	P06703	1	153534599-153536244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 375.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002601, HPA007575, CAB040549, CAB047354"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			5100000	"Plasma membrane, Cytosol"		"CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859"	"unprognostic (8.80e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-2)"	"prognostic favourable (7.56e-4)"	126.4	32.6	14.8	104.9	29.9	73.8	223.6	13.3	14.6	95.4	176.8	10.1	51.2	70.2	65.0	135.5	126.5	42.2	264.5	112.3	13.0	22.5	103.4	6.0	151.9	61.5	45.6	7.9	38.1	13.5	0.5	17.7	100.1	27.3	85.1	85.5	28.5	58.7	55.2	59.1	45.1	98.1	88.9	35.5	27.5	69.9	29.6	17.8	4.9	76.9	183.0	36.2	150.9	145.0	30.7	130.1	303.7	180.7	9.1	69.2	201.7	77.6	86.9	0.0	7.2	146.3	189.8	0.2	95.2	237.8	48.3	63.4	6.0	162.4	0.1	30.2	141.3	33.7	1.5	136.7	22.8	31.9	0.0	16.2	58.1	5.3	55.4	0.7	11.2	88.5	113.7	51.7	89.5	107.1	0.0	0.1	120.3	11.7	0.2	6.6	0.1	143.0	0.0	10.8	28.1	375.0	72.1	22.4	3.9	129.5	131.9	97.9	18.1	25.2	156.4	46.7	12.2	95.3	154.5	0.2	0.2	0.2	181.3	17.4	99.6	139.8	180.7	74.1	62.0	96.8	67.3	30.7	58.5	60.3	130.1	17.2	37.3	49.5	303.7	9.1	86.9	68.3	69.2	201.7	14.8	29.9	13.3	14.6	13.0	22.5	45.6	7.9	27.3	17.8
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391188	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1"	"Group enriched"	"Detected in some"	28	"hTCEpi: 27.5;SK-BR-3: 100.9;THP-1: 53.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.7;neutrophil: 720.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 720.9;monocytes: 320.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	10876880	530000000	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	14.0	0.8	0.8	30.5	2.6	718.8	1.1	0.5	1.6	123.0	2.8	0.7	0.4	0.4	12.0	1.2	532.3	5.5	2.1	36.7	1.5	0.5	1.4	4.3	26.2	37.3	3.3	0.4	2.1	2.7	0.1	0.9	4.7	3.3	1.4	0.4	1.3	92.4	0.3	2.5	6.2	1.0	9.0	1.8	72.4	2.0	1.9	0.9	2.6	4.6	597.1	257.6	5.0	224.1	0.6	63.7	720.9	320.7	0.3	0.6	244.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.6	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	27.5	0.0	0.9	0.0	1.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	100.9	0.0	0.6	53.6	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.6	0.0	8.2	320.7	38.9	0.4	26.5	0.6	0.6	0.3	0.2	63.7	0.3	0.3	0.3	720.9	0.3	6.4	2.5	0.4	244.7	0.8	2.6	0.5	1.6	1.5	0.5	3.3	0.4	3.3	0.9
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 227.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 381.5;neutrophil: 638.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 638.3;monocytes: 381.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	10597950	1400000000	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavourable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4.0	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169.0	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2.0	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228.0	24.3	237.0	0.5	87.5	638.3	381.5	0.3	1.0	323.2	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	35.7	0.0	2.1	0.0	14.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	12.4	0.0	0.8	0.0	0.6	0.3	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.4	7.5	0.0	9.2	0.1	0.0	0.3	227.6	0.1	3.6	28.9	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	6.5	0.0	5.3	381.5	46.4	0.5	31.6	1.0	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15.0	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598962-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 342.0"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 81.0;WM-115: 159.2"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 78.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 78.0"	"Low region specificity"	"Detected in all"							"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol			120000	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: , HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	67.7	14.0	60.9	5.6	51.0	2.0	13.2	39.4	151.2	5.2	9.1	101.0	3.0	4.7	1.5	7.6	8.6	2.1	8.3	6.6	74.6	65.4	1.5	1.6	2.9	9.8	152.0	36.5	2.4	3.0	1.1	3.1	1.4	90.3	3.0	8.3	7.4	10.1	15.3	1.3	5.7	7.5	4.3	342.0	5.7	4.3	1.5	46.4	0.0	1.3	1.8	10.8	8.2	1.6	0.1	3.4	0.7	1.9	11.0	78.0	10.6	0.1	0.0	17.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	81.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	1.0	159.2	0.0	0.1	0.0	78.0	1.8	22.4	0.0	0.2	14.5	3.4	0.1	0.6	33.3	0.7	11.0	1.9	0.8	0.0	10.6	60.9	51.0	39.4	37.6	74.6	65.4	152.0	36.5	90.3	46.4
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693069-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 37.2;Hep G2: 39.1;hTCEpi: 43.6;RT4: 80.0;SK-BR-3: 44.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"					"Group enriched"	"Detected in some"	41	"basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9"	"Lineage enriched"	"Detected in many"	68	"granulocytes: 89.9"									HPA019502	Enhanced		Supported	"Nuclear bodies"			1200000	"Nuclear bodies"		"HPA019502: AB_1856530"	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.0	1.1	0.0	42.8	0.0	0.0	0.0	0.3	5.2			0.1	0.0	0.0	23.3	0.3	1.0	0.0	0.0	0.0	0.0	1.9	2.4	0.0	0.0		0.0	0.0	0.0	0.0	16.4		4.8	5.4		1.1	0.0	0.0	3.9	0.5	0.1	0.0	4.4	70.0	0.0			0.0		2.5	47.6	5.1	0.0	0.0	89.9	1.3	0.0	0.0	0.4	5.0	3.2	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.0	6.2	0.0	0.0	0.0	2.4	0.0	0.1	3.6	39.1	0.0	2.3	0.1	0.0	43.6	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.0	4.5	0.0	5.7	0.0	0.0	0.0	0.0	80.0	0.0	0.0	7.3	44.8	0.0	1.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	47.8	1.3	24.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.0	0.0	0.4										
S100PBP	"FLJ12903, S100PBPR"	ENSG00000116497	"S100P binding protein"	Q96BU1	1	32816767-32858879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027242, HPA027328"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA027242: , HPA027328: "	"unprognostic (4.29e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.44e-2)"	"prognostic favourable (5.22e-5)"	"prognostic unfavourable (1.26e-6)"	"unprognostic (1.61e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.71e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	8.5	11.0	9.6	13.2	15.9	13.9	10.5	18.1	12.4	13.0	9.0	18.9	12.2	6.8	19.8	11.9	8.5	11.1	11.4	6.5	9.0	12.0	7.2	7.5	8.7	15.6	14.9	8.7	20.1	6.5	8.7	13.4	12.1	12.0	12.6	8.9	11.0	8.6	10.3	6.3	9.2	10.0	13.7	11.0	14.6	7.7	35.2	16.1	14.2	11.3	6.5	15.9	10.2	12.1	7.7	10.3	5.7	3.5	16.9	8.3	3.4	6.2	7.6	18.3	9.0	8.6	12.3	9.1	12.4	8.7	11.9	13.0	4.8	9.9	18.8	9.6	8.2	9.9	18.3	7.6	14.4	10.4	4.7	25.1	14.4	6.4	10.3	10.9	9.9	8.7	7.2	11.5	13.9	12.3	14.1	14.6	14.1	2.9	17.4	9.5	20.1	5.9	14.3	18.9	16.7	5.2	4.0	7.4	7.2	12.2	3.5	13.6	7.0	6.9	6.0	14.8	10.9	13.3	7.6	22.7	20.3	19.3	7.4	12.2	7.5	5.4	3.5	5.7	6.3	1.9	8.3	7.7	5.3	6.9	3.7	4.9	3.6	5.1	3.9	16.9	1.6	10.3	5.1	3.4	9.6	15.9	18.1	12.4	9.0	12.0	14.9	8.7	12.0	16.1
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236888-101241518	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.9"	"Cell line enhanced"	"Detected in many"		"BJ: 19.0;HUVEC TERT2: 53.7;TIME: 29.9;U-251 MG: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles				Vesicles		"CAB010104: AB_2238920, HPA075568: "	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (8.78e-4)"	72.3	8.4	24.7	16.6	26.2	9.7	46.3	21.6	21.8	13.3	10.5	9.5	2.5	5.7	12.1	5.0	14.7	11.5	17.6	43.5	22.9	15.4	8.9	20.5	35.7	24.5	23.2	14.0	7.9	11.0	13.4	4.7	29.6	21.2	8.9	7.0	9.3	7.5	5.6	21.7	8.2	9.8	19.0	11.0	35.2	8.0	5.8	13.9	4.4	17.0	8.7	15.7	15.2	18.5	27.4	0.2	88.9	0.2	33.4	49.8	30.8	3.5	0.0	3.8	0.0	0.4	9.1	0.0	19.0	3.4	11.5	4.1	0.0	0.1	0.0	4.7	6.6	0.0	0.5	0.2	7.7	1.3	0.3	1.3	0.1	0.0	1.8	0.0	0.8	12.2	0.0	0.0	0.9	53.7	0.0	3.9	3.6	0.0	4.5	0.0	1.0	1.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.9	1.9	0.7	0.4	36.8	0.3	0.0	0.2	0.1	0.0	0.1	88.9	0.1	4.9	49.8	0.1	40.2	25.1	45.3	44.1	0.2	27.4	35.7	36.2	1.4	33.4	0.2	0.2	26.8	30.8	24.7	26.2	21.6	16.8	22.9	15.4	23.2	14.0	21.2	13.9
S1PR4	EDG6	ENSG00000125910	"Sphingosine-1-phosphate receptor 4"	O95977	19	3172346-3180332	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.8;HL-60: 14.4;NB-4: 14.2;REH: 40.1;U-937: 13.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA060601, HPA067232"			Supported	Mitochondria				Mitochondria		"HPA060601: , HPA067232: "	"prognostic favourable (3.13e-4)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.58e-2)"	"prognostic favourable (2.22e-4)"	"unprognostic (2.98e-2)"	"prognostic favourable (1.45e-6)"	"unprognostic (1.27e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (6.64e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.15e-3)"	2.0	0.5	0.7	8.3	0.3	14.9	1.3	0.6	0.7	0.5	0.9	0.4	0.2	0.8	0.7	0.7	1.2	1.4	0.7	2.1	0.3	0.2	1.2	1.4	6.4	35.9	0.3	0.4	0.7	0.3	0.0	0.2	1.7	0.6	0.7	0.0	1.0	1.3	0.2	1.1	0.4	7.1	0.2	0.5	34.2	3.9	0.3	0.3	10.2	1.5	0.2	10.7	1.9	0.6	14.1	7.3	44.2	15.3	5.4	23.1	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.0	0.1	0.0	0.0	0.0	10.8	0.0	4.6	0.1	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	40.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	13.7	0.0	16.4	10.4	27.4	11.8	11.6	10.5	11.3	14.7	11.4	7.3	14.1	12.4	11.9	44.2	5.4	15.3	6.6	23.1	7.2	0.7	0.3	0.6	0.7	0.3	0.2	0.3	0.4	0.6	0.3
SAAL1	FLJ41463	ENSG00000166788	"Serum amyloid A like 1"	Q96ER3	11	18069935-18106091	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039003, HPA039004"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA039003: AB_2676303, HPA039004: AB_10673602"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.78e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.87e-1)"	10.1	10.1	12.5	23.6	11.4	22.5	14.0	17.3	12.5	10.7	13.0	12.9	9.2	11.0	13.2	11.6	11.8	9.9	10.2	10.2	10.0	8.8	10.1	11.3	7.6	18.2	11.7	8.2	12.7	14.4	5.8	16.8	9.6	10.3	9.6	16.9	10.8	10.1	8.7	9.5	9.7	11.2	13.5	9.4	15.1	11.5	17.8	12.9	22.1	8.7	11.5	20.5	11.6	10.5	14.5	17.8	7.4	12.0	8.1	16.2	8.5	11.0	17.3	12.5	17.1	8.5	9.6	10.5	12.5	8.6	19.1	22.8	24.0	4.2	30.0	6.7	7.0	14.6	23.9	20.2	27.0	13.2	25.0	13.7	10.7	15.1	6.9	23.1	12.2	6.6	9.5	12.3	18.5	16.2	20.3	10.1	15.6	15.1	26.7	22.1	16.3	17.3	26.8	22.1	10.5	10.8	13.2	15.6	14.7	11.2	12.0	14.7	7.7	10.6	6.5	22.0	15.3	12.5	17.7	5.0	15.0	33.2	9.1	18.5	20.0	7.4	10.5	3.3	11.8	12.0	11.6	14.5	14.0	10.8	17.8	10.2	11.5	11.9	0.5	8.1	11.5	9.0	16.2	8.5	12.5	11.4	17.3	12.5	10.0	8.8	11.7	8.2	10.3	12.9
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favourable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favourable (1.70e-4)"	28.7	27.6	26.4	34.8	32.5	50.7	26.2	50.8	36.0	28.9	29.7	34.3	18.6	31.0	32.1	17.3	26.6	25.8	22.6	26.9	28.2	25.8	23.8	29.0	27.1	38.0	31.5	26.2	35.0	29.2	31.2	35.0	35.5	28.1	27.5	20.5	21.4	31.1	28.8	53.6	35.5	31.0	27.8	31.4	39.1	28.4	30.3	32.1	61.4	26.3	19.5	31.3	30.7	45.6	32.8	31.6	48.4	42.3	31.2	37.5	30.5	27.3	24.2	29.5	18.9	13.1	11.8	33.7	20.5	13.3	17.5	14.8	36.2	15.7	44.3	16.3	10.2	25.7	28.3	16.8	18.5	29.9	27.8	32.5	22.3	33.8	12.4	40.1	28.8	10.5	15.6	15.7	16.7	13.8	45.2	22.8	13.4	24.2	42.1	31.7	39.2	24.1	42.4	32.3	30.7	13.6	23.0	27.2	23.3	23.1	18.7	21.0	17.2	21.7	21.3	17.9	22.0	21.9	31.5	37.0	31.6	40.6	17.2	33.3	23.6	35.0	28.4	48.4	36.2	28.4	36.7	32.8	36.0	35.2	31.6	32.2	37.5	36.0	30.6	31.2	42.3	26.6	34.5	30.5	26.4	32.5	50.8	36.0	28.2	25.8	31.5	26.2	28.1	32.1
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: "	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favourable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favourable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favourable (2.12e-4)"	25.7	29.6	31.0	29.6	33.7	35.4	17.4	50.8	46.2	27.4	21.6	28.4	23.1	25.8	30.2	27.4	15.7	26.8	19.4	21.0	30.3	24.6	32.2	20.0	18.2	26.8	30.5	26.5	42.8	24.2	31.0	38.4	17.3	28.6	28.4	20.9	21.3	23.6	34.8	38.1	18.9	25.7	24.8	43.4	29.4	20.1	23.4	34.3	23.5	26.9	11.1	25.2	24.1	32.7	11.4	9.3	24.3	9.5	6.4	13.3	5.6	17.8	23.3	17.0	12.5	16.6	10.7	19.8	17.0	9.2	10.6	10.1	29.6	12.9	34.1	15.5	8.5	16.4	20.6	10.6	17.6	23.7	22.1	25.9	23.7	22.9	9.7	21.6	24.5	10.6	11.3	15.6	12.1	10.4	24.8	17.3	12.5	19.9	25.8	20.7	29.0	24.7	32.8	14.7	19.0	12.0	30.5	16.0	14.9	22.5	10.3	13.7	15.3	13.3	16.4	13.2	13.8	16.5	23.1	23.0	20.4	24.8	13.5	18.8	21.5	24.3	9.5	15.8	11.9	8.2	13.3	10.3	10.5	9.2	8.3	11.4	11.7	9.1	18.3	6.4	8.5	9.3	9.5	5.6	31.0	33.7	50.8	46.2	30.3	24.6	30.5	26.5	28.6	34.3
SAGE1	"CT14, SAGE"	ENSG00000181433	"Sarcoma antigen 1"	Q9NXZ1	X	135889205-135913061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 10.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 14.7;K-562: 10.6;Karpas-707: 18.4;U-2 OS: 5.2;U-266/70: 6.4;U-266/84: 16.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA003033, HPA003208"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA003033: AB_1079865, HPA003208: AB_1079863"				"unprognostic (1.11e-1)"	"unprognostic (5.26e-2)"			"unprognostic (1.15e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.37e-1)"		"unprognostic (7.12e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	6.4	16.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802520	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6"	"Cell line enhanced"	"Detected in some"		"AF22: 13.6;AN3-CA: 9.5;BEWO: 18.2;NTERA-2: 32.7;SiHa: 8.3"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"NK-cell: 6.3"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.3	0.4	0.3	0.3	0.9	1.2	0.3	0.8	0.9	0.4	0.7	0.3	2.2	0.1	0.3	0.8	0.3	0.2	0.3	0.3	0.3	0.1	0.5	1.9	0.3	0.3	0.3	0.3	0.3	4.6	8.8	0.6	0.3	0.9	3.1	0.2	4.5	2.2	0.4	0.3	0.3	0.7	0.3	0.3	0.8	0.3	11.7	0.3	0.3	8.6	0.3	0.3	0.9	0.3	0.1	0.1	0.6	0.1	6.3	0.2	0.0	0.0	0.9	13.6	9.5	0.0	0.1	18.2	0.0	0.1	0.0	0.1	4.7	0.1	0.0	0.1	0.1	2.3	0.1	0.0	0.2	0.2	0.0	0.0	3.2	0.2	0.1	0.0	1.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	32.7	0.2	1.2	0.0	0.0	0.0	0.3	3.1	1.7	8.3	0.0	0.8	0.0	0.5	0.0	0.5	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.6	6.3	0.1	0.1	0.0	0.0	0.3	0.9	0.8	0.9	0.3	0.1	0.3	0.3	0.9	0.3
SAMD4B	"FLJ10211, hSmaug2, MGC99832, SMGB"	ENSG00000179134	"Sterile alpha motif domain containing 4B"	Q5PRF9	19	39342396-39385710	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016800, HPA059385"	Approved		Enhanced	Cytosol				Cytosol		"HPA016800: AB_1856552, HPA059385: "	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavourable (2.17e-6)"	"unprognostic (3.41e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.24e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.91e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-2)"	24.9	24.6	34.8	19.5	43.9	15.0	19.5	24.9	34.3	26.3	19.5	40.0	18.8	15.9	24.5	15.2	32.7	27.9	22.5	18.8	29.2	19.5	16.5	14.1	20.4	11.8	37.3	24.0	35.2	22.5	37.5	23.5	21.9	32.6	21.1	13.7	20.9	19.9	30.4	18.1	25.1	18.4	23.7	28.7	19.0	18.9	23.0	37.7	13.6	21.2	12.3	15.2	21.8	24.2	3.0	2.5	6.8	2.8	2.1	3.7	1.2	30.9	42.6	21.8	16.5	21.3	25.7	18.0	17.9	19.7	14.4	12.0	37.2	17.4	10.3	23.5	28.6	15.0	21.5	16.4	9.9	20.8	35.0	10.4	17.5	15.4	22.1	11.2	10.9	25.2	19.4	23.5	17.6	13.5	30.6	11.4	17.5	21.2	12.1	5.5	17.3	17.3	14.7	14.0	9.0	12.0	25.2	22.4	21.8	23.5	16.2	12.8	13.1	12.1	17.7	23.6	17.2	50.9	31.3	21.4	19.2	11.6	31.4	8.8	23.0	2.9	2.8	3.9	3.0	1.1	2.2	3.0	2.2	2.4	2.0	2.0	3.7	2.6	6.8	2.1	0.9	2.5	0.9	1.2	34.8	43.9	24.9	34.3	29.2	19.5	37.3	24.0	32.6	37.7
SAMD5	dJ875H10.1	ENSG00000203727	"Sterile alpha motif domain containing 5"	Q5TGI4	6	147508927-147737547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;Hep G2: 32.6;K-562: 21.9;RH-30: 15.4;WM-115: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067811	Uncertain		Supported	Vesicles				Vesicles		"HPA067811: "	"unprognostic (4.16e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.09e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.50e-1)"	1.6	2.2	1.6	3.4	5.7	0.2	4.9	1.4	4.7	3.9	7.1	0.7	1.9	3.6	10.9	2.2	15.9	1.7	6.6	2.4	2.7	3.4	26.5	12.8	8.0	0.5	1.9	2.2	1.4	2.4	17.3	13.9	14.6	14.1	3.0	10.1	9.8	4.9	3.3	0.8	3.6	5.4	4.0	1.3	1.7	5.5	10.9	2.6	0.0	3.0	6.3	6.5	2.6	3.9	0.7	0.5	1.8	0.4	0.6	0.5	0.1	5.5	0.7	0.7	1.1	0.0	0.0	0.0	1.8	0.7	0.1	0.1	8.5	0.0	0.3	1.9	0.0	0.0	0.1	1.3	0.2	0.0	1.0	0.4	0.7	32.6	0.1	0.0	0.7	0.0	0.0	0.1	0.0	3.6	21.9	0.3	2.5	0.0	0.0	0.0	0.1	1.5	0.0	15.4	3.3	0.0	1.2	0.3	0.0	0.5	0.1	1.4	0.0	0.0	2.5	0.2	0.8	0.2	0.6	0.0	0.5	0.0	0.0	0.0	10.8	1.8	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.1	0.7	0.5	0.4	1.1	0.6	0.4	0.5	0.2	0.1	1.6	5.7	1.4	4.7	2.7	3.4	1.9	2.2	14.1	2.6
SAMD8	"FLJ25082, SMSr"	ENSG00000156671	"Sterile alpha motif domain containing 8"	Q96LT4	10	75099586-75182123	"Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 18.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044402			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA044402: "	"unprognostic (4.32e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (3.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.26e-3)"	17.6	14.6	18.8	9.3	18.9	20.7	11.9	12.4	34.8	15.6	7.9	20.1	10.2	8.2	15.0	10.1	17.9	9.4	12.5	14.3	18.6	15.9	10.1	10.1	10.7	8.7	22.7	13.8	18.7	7.6	13.0	17.1	14.8	17.4	11.5	7.0	10.9	8.9	11.5	28.3	7.6	9.3	13.7	37.8	10.0	7.7	19.9	15.5	5.5	10.7	7.3	8.6	10.9	18.1	5.7	3.6	18.3	5.9	3.8	3.3	1.5	5.5	5.3	8.1	6.4	17.8	16.4	10.3	10.0	19.1	6.6	9.0	7.8	7.9	4.5	6.6	9.3	10.0	4.5	6.8	11.9	4.9	6.7	1.8	5.3	5.3	9.8	2.0	4.6	15.8	6.9	12.3	17.8	9.1	3.7	7.8	12.7	4.3	3.2	2.5	3.5	20.7	3.0	7.4	1.6	6.3	4.8	1.2	5.8	9.1	10.9	8.8	4.6	1.9	15.6	6.6	12.3	7.9	6.5	5.5	4.1	4.2	10.2	4.4	4.1	2.4	3.7	2.2	2.9	4.5	1.9	4.8	3.1	3.3	3.2	5.7	2.7	3.1	18.3	3.8	5.9	3.6	2.8	1.5	18.8	18.9	12.4	21.3	18.6	15.9	22.7	13.8	17.4	15.5
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.6;lymphoid tissue: 35.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	9.6	4.0	2.3	9.2	2.4	5.2	2.6	1.0	1.6	9.3	6.8	0.6	0.9	4.3	2.8	3.0	34.6	2.7	4.3	2.5	1.3	1.5	6.3	3.5	7.8	10.8	2.5	1.1	6.3	2.3	0.1	6.4	11.3	3.1	5.3	7.0	0.7	5.7	1.6	2.4	1.5	12.7	2.2	2.5	21.7	6.3	2.5	1.7	35.4	3.3	9.9	9.5	4.8	9.7	5.5	3.0	15.6	9.8	7.4	7.6	2.6	12.2	1.6	0.4	0.1	5.5	7.0	0.1	4.8	20.1	23.0	30.5	0.1	13.6	5.1	7.6	11.8	14.5	0.0	4.4	7.8	17.4	0.6	7.4	8.2	0.0	2.5	8.3	10.4	3.1	6.4	7.6	2.1	3.4	0.5	12.8	4.8	0.0	12.3	6.8	0.0	3.5	4.1	4.1	5.8	0.1	1.5	2.0	0.2	3.7	1.4	3.9	0.4	4.1	14.8	5.4	1.9	16.1	2.6	7.6	1.4	4.7	5.6	4.9	5.3	15.6	3.6	12.7	7.6	7.0	7.3	5.0	5.9	6.5	3.0	5.5	6.3	5.7	15.5	7.4	9.8	2.1	7.2	2.6	2.3	2.4	1.0	1.6	1.3	1.5	2.5	1.1	3.1	1.7
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36889773-36951901	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.2;BJ hTERT+ SV40 Large T+: 24.3;BJ hTERT+ SV40 Large T+ RasG12V: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 46.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			100000	Nucleoplasm	"Plasma membrane"	"HPA047072: "	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	54.3	18.6	8.7	31.8	13.0	9.9	35.9	4.9	9.7	14.5	21.2	9.0	8.7	15.8	13.5	20.2	24.1	33.4	15.3	25.4	8.7	6.0	12.5	12.4	25.7	48.3	14.5	4.9	22.1	18.1	4.9	22.4	13.7	10.2	14.0	13.2	11.6	14.7	9.7	9.2	11.4	20.6	21.3	13.7	40.7	19.2	15.1	15.0	9.7	14.9	10.7	18.5	23.2	50.2	0.4	46.7	2.8	23.4	6.0	10.9	19.1	3.8	1.5	0.7	1.5	57.2	10.9	0.7	2.3	4.2	24.3	26.0	4.8	1.3	8.2	3.3	1.5	3.0	6.0	2.8	5.1	2.4	2.0	0.4	2.1	2.5	5.0	4.7	1.4	13.3	0.1	8.5	0.2	3.1	1.5	1.9	0.5	1.2	0.0	1.7	0.7	3.2	0.2	3.9	3.1	0.9	0.6	2.9	0.4	3.0	1.1	2.9	1.4	7.5	0.8	1.9	2.1	2.0	3.4	1.1	3.0	3.4	1.6	0.4	0.6	0.2	19.4	0.6	6.1	23.4	5.6	0.4	6.9	6.4	46.7	0.4	8.5	6.3	2.8	6.0	20.4	11.0	10.9	19.1	8.7	13.0	4.9	9.7	8.7	6.0	14.5	4.9	10.2	15.0
SAMM50	"CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W"	ENSG00000100347	"SAMM50 sorting and assembly machinery component"	Q9Y512	22	43955421-44010531	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034537	Enhanced		Supported	Mitochondria			3700000	Mitochondria		"HPA034537: AB_10602794"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-3)"	"prognostic favourable (2.63e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.52e-1)"	"prognostic favourable (4.43e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.60e-1)"	21.7	25.1	12.4	13.9	13.6	10.2	16.0	10.5	20.1	17.4	15.6	11.2	17.2	18.9	12.6	13.5	14.6	16.3	18.2	34.3	11.3	11.9	18.5	18.8	8.9	18.6	12.7	14.7	16.0	16.7	60.6	12.2	7.6	16.4	10.4	13.7	14.3	19.3	13.6	79.5	15.8	21.2	14.2	12.3	12.2	18.5	11.5	8.6	17.4	10.8	34.6	15.1	11.5	11.0	27.7	34.0	22.4	19.6	18.2	29.3	18.5	21.9	20.9	20.4	24.6	26.4	28.0	28.5	21.6	23.2	32.0	27.6	29.8	16.2	36.5	15.9	24.6	26.6	30.1	28.9	28.8	10.0	37.2	19.7	27.5	35.1	18.5	62.5	29.8	32.3	23.2	27.5	12.8	32.8	16.8	12.1	28.6	31.3	24.4	24.5	19.9	25.1	28.7	22.1	29.5	26.6	28.2	12.2	19.9	23.9	25.6	35.3	24.0	20.6	20.1	20.7	25.0	19.1	17.6	18.0	24.7	28.1	26.0	22.8	20.7	19.2	19.6	22.4	21.2	19.2	29.3	27.7	19.8	21.5	34.0	24.5	20.8	19.5	3.2	18.2	14.7	13.4	22.7	18.5	12.4	13.6	10.5	20.1	11.3	11.9	12.7	14.7	16.4	8.6
SAP130	FLJ12761	ENSG00000136715	"Sin3A associated protein 130"	Q9H0E3	2	127941217-128028120	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034664			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA034664: AB_10603238"	"unprognostic (2.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (7.89e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	9.3	8.7	8.9	10.4	11.3	18.0	7.8	12.2	14.1	9.7	9.3	13.8	6.6	8.2	11.7	9.5	9.9	9.4	8.2	8.0	9.6	8.5	6.8	7.8	7.9	9.1	9.7	9.0	11.6	8.4	16.3	13.8	10.4	9.6	9.1	9.8	8.8	11.3	8.5	10.5	11.6	8.9	10.3	8.9	8.3	9.0	50.3	9.9	17.1	8.8	6.9	11.9	9.9	9.5	5.8	6.8	15.6	8.5	3.5	6.2	3.5	20.3	11.3	21.2	17.1	14.1	9.8	23.3	13.0	12.8	20.2	16.0	26.7	8.5	17.0	11.8	14.7	14.3	23.4	13.4	21.1	9.4	15.0	16.9	10.1	20.7	17.0	14.6	13.4	9.1	10.1	26.7	16.8	16.1	20.4	12.7	16.8	22.7	20.3	11.5	21.9	12.6	14.0	17.5	11.4	10.8	18.1	11.2	13.5	13.7	13.0	8.1	9.8	10.1	13.7	19.6	21.3	18.1	13.7	17.8	17.5	20.4	16.1	9.9	12.5	2.4	4.2	4.8	6.2	3.0	4.8	2.4	4.4	4.0	3.7	5.8	3.2	3.5	15.6	3.5	8.5	6.8	3.0	3.5	8.9	11.3	12.2	14.1	9.6	8.5	9.7	9.0	9.6	9.9
SAP18	"2HOR0202, MGC27131, SAP18p"	ENSG00000150459	"Sin3A associated protein 18"	O00422	13	21140514-21149084	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011352, CAB012273"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB012273: , HPA011352: AB_1856563"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.78e-2)"	35.3	67.0	55.2	45.3	57.4	81.0	38.0	35.2	49.1	30.0	44.8	43.9	37.6	53.1	37.5	40.3	59.5	32.4	33.0	66.3	68.4	61.3	63.2	47.5	34.8	41.7	64.9	50.2	37.3	52.3	16.2	38.8	43.1	54.9	34.4	23.8	26.4	50.1	34.5	121.6	31.4	48.6	48.1	73.5	31.6	41.6	79.2	49.3	34.0	34.9	51.0	24.4	37.3	48.6	90.1	107.4	97.9	96.4	70.0	94.1	143.8	30.0	17.0	27.5	29.7	29.9	25.1	42.7	38.5	28.6	35.7	26.4	30.6	58.3	31.2	47.6	31.8	31.6	33.8	24.1	40.4	47.6	17.1	44.4	22.4	50.6	34.0	60.3	36.0	25.2	27.6	27.2	32.7	26.8	21.0	17.8	32.2	38.4	68.0	99.1	34.6	18.7	43.2	43.5	31.0	50.0	27.0	32.1	28.0	24.7	36.8	47.6	35.6	88.5	32.5	22.0	24.5	39.8	44.8	27.7	38.5	85.9	21.4	35.9	40.3	69.6	82.9	97.9	70.0	89.0	70.6	90.1	86.2	82.4	81.2	77.6	84.2	83.2	83.4	70.0	96.4	107.4	94.1	143.8	55.2	57.4	35.2	49.1	68.4	61.3	64.9	50.2	54.9	49.3
SAP30		ENSG00000164105	"Sin3A associated protein 30"	O75446	4	173369969-173377532	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022627, HPA059012"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"CAB022627: , HPA059012: "	"unprognostic (1.53e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.83e-2)"	"unprognostic (8.71e-2)"	"prognostic unfavourable (1.24e-6)"	"unprognostic (4.95e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (1.54e-7)"	"unprognostic (3.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	16.9	19.8	15.6	19.2	18.3	29.6	13.7	19.4	21.6	13.5	21.9	22.5	11.1	14.3	13.6	15.2	13.0	15.4	13.4	20.1	18.0	14.7	7.6	10.3	13.5	10.5	23.4	13.9	17.3	10.5	6.6	9.2	10.7	15.8	16.3	11.2	15.3	11.8	15.7	10.0	8.0	13.8	19.0	24.2	15.7	28.6	26.8	23.3	10.7	12.1	7.2	9.7	24.9	17.6	0.7	2.9	1.9	4.1	0.0	1.9	0.8	15.2	5.2	15.1	14.6	9.7	6.0	3.3	7.2	6.2	8.1	10.0	2.2	6.2	13.8	3.4	8.3	3.8	12.2	6.1	6.2	15.5	11.6	18.4	12.5	6.2	9.2	10.5	11.7	10.0	3.0	6.9	7.0	9.5	9.5	59.0	10.4	6.5	14.9	11.8	6.7	10.1	12.2	5.4	9.8	4.8	2.5	12.3	26.0	10.2	10.3	4.6	4.4	6.3	9.2	5.8	7.8	13.5	16.6	33.3	11.9	13.1	18.8	25.8	16.5	1.3	4.1	0.0	1.9	2.4	0.7	0.4	1.0	1.2	2.9	0.7	0.2	0.6	1.9	0.0	1.3	0.1	1.4	0.8	15.6	18.3	19.4	21.6	18.0	14.7	23.4	13.9	15.8	23.3
SAP30BP	"HCNGP, HTRG, HTRP"	ENSG00000161526	"SAP30 binding protein"	Q9UHR5	17	75667116-75708062	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042382, HPA052943"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA042382: AB_10793881, HPA052943: AB_2681995"	"unprognostic (6.92e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (4.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.31e-3)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.06e-2)"	"unprognostic (6.58e-2)"	19.2	18.4	28.7	21.7	27.6	28.6	22.1	25.2	31.2	25.3	22.6	39.0	15.4	17.2	25.7	26.5	22.0	22.8	22.0	22.3	29.5	24.9	19.3	23.1	19.6	24.3	29.6	23.9	23.9	21.0	29.2	21.1	25.4	24.7	22.3	22.4	22.6	31.8	26.6	31.2	19.3	19.2	24.5	31.7	24.3	20.1	21.6	25.0	26.1	20.4	15.6	31.0	25.4	21.0	21.3	29.9	21.6	21.4	22.6	25.8	20.1	12.9	15.6	13.1	12.2	13.0	13.7	14.5	13.8	15.3	25.9	27.1	14.3	11.0	14.1	7.4	13.2	10.1	15.6	15.5	26.8	5.0	17.8	11.1	11.3	15.3	12.8	11.7	9.7	12.9	14.2	19.8	21.2	35.7	13.1	11.2	20.4	13.6	18.9	9.7	10.9	18.5	12.3	19.5	10.7	22.0	11.1	8.8	15.1	12.7	12.6	14.4	20.3	9.9	13.3	22.7	13.9	9.9	18.3	8.2	3.1	16.7	15.3	8.6	18.0	13.6	21.4	21.2	23.7	17.5	25.8	20.9	21.9	24.2	18.1	21.3	21.7	22.5	21.6	22.6	20.0	29.9	23.0	20.1	28.7	27.6	25.2	31.2	29.5	24.9	29.6	23.9	24.7	25.0
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062124-137070588	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavourable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	1.0	0.4	11.5	10.5	7.0	3.3	2.6	1.4	14.4	2.5	6.2	10.1	0.0	7.6	1.0	0.4	7.8	0.8	5.4	0.4	9.6	7.5	1.2	0.4	2.7	4.7	8.0	3.8	0.3	0.8	0.3	0.4	1.8	5.4	5.4	3.5	0.0	7.3	0.4	0.4	5.4	7.7	1.0	7.0	2.7	4.6	1.5	2.7	9.2	0.6	3.5	10.0	1.0	1.9	0.5	0.8	0.5	1.7	0.0	0.4	0.4	16.4	8.9	3.5	10.5	0.1	0.2	19.0	2.7	1.8	2.9	1.3	16.9	7.6	17.2	8.9	1.3	23.5	11.1	3.1	0.6	11.9	12.8	7.5	9.9	18.9	0.0	8.5	13.1	0.0	0.5	1.0	1.9	4.7	10.4	7.8	0.8	38.9	2.4	23.1	6.6	20.4	26.4	13.5	19.2	3.6	4.8	18.5	10.9	10.5	29.4	4.0	23.7	16.3	3.0	2.6	9.1	8.0	13.4	2.7	7.8	8.3	6.2	10.2	8.4	0.2	1.7	0.0	0.0	0.5	0.4	0.5	0.3	0.0	0.8	0.2	0.1	0.0	0.5	0.0	0.8	0.2	0.3	0.4	11.5	7.0	1.4	6.1	9.6	7.5	8.0	3.8	5.4	2.7
SAR1A	"SAR1, Sara, SARA1"	ENSG00000079332	"Secretion associated Ras related GTPase 1A"	Q9NR31	10	70147289-70170523	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, CAB022545, HPA048368"	Supported		Supported	"Endoplasmic reticulum"			10000000	"Endoplasmic reticulum"		"CAB022545: , HPA006923: AB_1856577, HPA048368: "	"unprognostic (3.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.13e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavourable (7.00e-5)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.13e-2)"	52.7	40.0	26.7	24.5	31.9	91.1	37.8	27.8	35.7	32.6	26.9	28.6	38.3	17.3	35.7	34.6	30.8	28.2	30.4	34.6	25.6	27.0	31.7	48.8	38.2	27.0	26.6	27.8	36.5	29.8	30.0	37.0	51.6	30.3	28.5	25.3	29.5	39.6	40.5	35.9	27.5	25.1	36.0	28.3	31.8	28.6	18.4	23.5	24.9	34.8	28.9	25.5	36.4	28.8	18.7	22.9	27.7	30.4	40.2	40.1	32.6	21.7	14.5	20.7	35.7	71.1	43.1	15.2	34.7	43.4	33.2	40.1	42.6	19.5	19.5	17.2	42.2	23.8	26.7	19.9	32.7	25.3	12.7	14.3	17.0	20.7	32.8	22.3	14.7	44.4	19.5	21.1	36.9	17.4	18.8	26.6	30.5	14.8	18.7	18.5	17.6	40.8	18.3	23.1	11.3	24.8	16.8	11.7	19.9	26.2	37.1	18.5	17.6	15.2	24.2	17.1	23.9	23.7	23.7	17.7	30.5	27.1	22.8	29.8	13.0	25.4	24.7	27.7	36.3	30.4	40.1	18.7	29.3	36.1	22.9	15.0	29.0	38.1	27.4	40.2	26.6	17.8	20.0	32.6	26.7	31.9	27.8	35.7	25.6	27.0	26.6	27.8	30.3	23.5
SARAF	"MGC8721, TMEM66"	ENSG00000133872	"Store-operated calcium entry associated regulatory factor"	Q96BY9	8	30063012-30083208	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040400			Supported	"Endoplasmic reticulum,Rods & Rings"			17000	"Endoplasmic reticulum"	"Rods & Rings"	"HPA040400: "	"unprognostic (1.11e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.86e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (5.28e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.03e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-1)"	30.7	80.7	58.1	37.3	69.0	57.8	62.1	45.8	89.0	40.9	32.8	35.8	49.3	26.9	35.0	65.9	20.2	42.9	39.5	34.3	57.5	80.9	38.7	67.0	39.1	77.7	59.1	49.8	60.6	67.8	44.6	48.9	61.6	53.4	45.6	28.1	26.1	69.4	45.5	29.7	18.4	30.7	30.4	62.4	36.4	38.7	21.3	35.4	50.3	50.0	16.0	36.0	35.4	37.3	36.9	30.2	96.2	36.9	29.0	99.7	91.0	21.7	15.5	19.7	13.0	33.8	23.5	15.0	26.9	38.7	23.4	30.3	8.3	24.4	14.7	39.6	29.2	19.3	19.8	22.3	19.3	7.8	14.4	20.2	11.0	10.7	34.0	6.4	24.1	36.6	41.9	26.3	21.7	32.5	23.6	31.6	17.7	8.2	23.6	10.6	17.4	16.8	19.0	13.0	20.2	32.5	8.9	8.5	30.3	23.5	23.4	30.1	20.2	13.6	23.1	15.7	45.0	7.1	8.8	22.3	20.3	13.4	38.9	17.5	25.4	96.2	30.1	50.8	41.3	28.9	45.2	27.0	59.4	47.5	30.2	36.9	99.7	67.4	58.4	29.0	36.9	25.1	53.5	91.0	58.1	69.0	45.8	89.0	57.5	80.9	59.1	49.8	53.4	35.4
SARNP	"CIP29, Hcc-1, THO1"	ENSG00000205323	"SAP domain containing ribonucleoprotein"	P82979	12	55752463-55817756	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030902, HPA030903"	Supported		Supported	"Nuclear speckles"			120000	"Nuclear speckles"		"HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.31e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.19e-1)"	24.3	31.5	32.3	22.8	32.6	40.2	30.8	34.8	29.6	28.8	29.2	22.3	19.9	16.0	26.0	30.8	30.4	22.7	18.2	39.5	27.1	33.5	30.9	25.1	26.3	31.3	35.9	23.6	28.0	31.1	19.4	27.4	28.4	29.4	26.0	28.9	19.8	20.5	26.6	44.4	20.3	25.7	27.9	31.3	30.6	22.1	26.4	28.9	34.6	25.8	20.8	41.8	31.4	23.4	39.7	50.1	68.1	50.2	40.6	53.1	43.7	26.9	23.6	59.7	25.1	27.6	39.9	28.3	38.7	29.3	46.5	39.1	33.1	29.9	43.9	26.0	30.2	15.3	52.3	36.4	50.3	34.4	30.1	44.2	39.0	28.2	39.5	36.9	33.2	29.4	27.0	30.5	22.9	49.0	31.6	32.4	46.4	21.6	45.8	58.1	52.0	21.0	42.2	31.1	35.9	62.4	29.8	25.4	20.8	32.1	20.6	32.1	31.3	49.2	33.9	18.8	18.8	24.1	29.3	20.6	27.5	60.1	22.6	37.7	23.5	63.7	46.2	68.1	38.2	50.2	34.7	39.7	40.7	40.7	50.1	34.6	32.6	36.5	35.7	40.6	42.3	48.0	53.1	43.7	32.3	32.6	34.8	29.6	27.1	33.5	35.9	23.6	29.4	28.9
SARS	SERS	ENSG00000031698	"Seryl-tRNA synthetase"	P49591	1	109213918-109238169	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Uncertain		Enhanced	Cytosol			100000	Cytosol		"HPA016939: AB_1856585, HPA064668: "	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favourable (9.47e-4)"	"prognostic unfavourable (5.75e-4)"	"prognostic unfavourable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	35.8	42.6	46.1	28.2	45.9	16.3	38.3	42.6	60.6	40.1	37.6	31.2	30.9	33.5	39.4	36.0	42.0	39.6	28.7	43.9	55.9	47.3	37.6	58.6	44.5	28.8	46.4	56.0	44.4	68.7	55.3	40.1	44.9	64.1	34.3	41.0	22.0	54.2	42.3	72.3	46.1	31.1	42.9	41.0	29.4	46.0	20.9	35.0	25.3	75.0	32.9	38.7	41.8	60.4	54.3	45.9	48.6	48.3	41.0	66.1	88.9	32.7	12.9	24.8	37.3	37.3	33.9	42.7	34.5	35.8	30.0	37.5	24.9	10.1	35.4	17.9	48.7	18.0	38.6	48.8	35.0	25.0	23.5	13.7	16.0	18.0	75.0	17.2	15.4	41.6	85.5	35.4	77.0	35.7	31.3	44.4	29.2	31.4	19.1	8.8	10.3	30.5	15.8	31.7	15.8	22.8	17.5	34.5	18.3	16.5	26.7	93.6	15.1	20.6	28.1	17.9	22.6	25.4	24.1	33.9	13.7	29.0	56.5	18.9	60.8	35.6	44.5	48.6	56.0	48.2	58.4	54.3	59.3	55.4	45.9	52.5	61.8	57.7	21.3	41.0	48.3	29.6	66.1	88.9	46.1	45.9	42.6	60.6	55.9	47.3	46.4	56.0	64.1	35.0
SART1	"Ara1, HAF, SNRNP110, Snu66"	ENSG00000175467	"SART1, U4/U6.U5 tri-snRNP-associated protein 1"	O43290	11	65961689-65979828	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Allergen, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031188, HPA031189, HPA031190"	Supported		Enhanced	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Golgi apparatus"	"HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.15e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	22.3	17.5	26.4	25.0	27.8	50.7	21.7	28.5	27.2	21.4	19.6	17.7	20.9	22.7	26.3	17.4	19.0	20.3	20.7	19.5	23.8	16.8	15.8	18.2	19.0	26.2	23.0	25.7	26.8	28.4	22.5	19.2	22.4	25.2	18.1	12.0	15.9	27.1	27.2	34.6	26.2	19.9	27.9	29.2	29.2	20.3	20.4	25.6	24.0	20.5	19.1	19.0	20.6	41.3	5.9	5.8	12.1	5.3	4.1	8.1	2.7	22.5	27.3	12.5	16.8	12.3	9.8	19.2	17.5	12.4	20.3	13.3	19.7	15.7	25.7	20.2	15.2	22.2	15.7	16.0	10.3	20.6	15.6	29.7	19.4	18.2	18.5	25.6	25.0	12.3	12.3	18.8	16.9	12.6	18.7	18.3	11.6	40.7	32.9	36.9	21.3	26.1	36.2	18.2	27.0	8.4	15.1	14.2	20.1	16.6	17.1	20.3	19.1	20.9	18.7	25.4	25.1	24.9	24.5	28.0	21.8	22.5	21.1	13.0	21.5	2.0	4.5	12.1	7.1	5.3	6.0	5.9	8.0	7.4	5.8	5.4	5.9	6.6	6.3	4.1	3.1	4.9	8.1	2.7	26.4	27.8	28.5	27.2	23.8	16.8	23.0	25.7	25.2	25.6
SART3	"KIAA0156, p110, RP11-13G14, TIP110"	ENSG00000075856	"Squamous cell carcinoma antigen recognized by T cells 3"	Q15020	12	108522580-108561400	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028840, HPA044322"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA028840: , HPA044322: "	"unprognostic (1.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (6.32e-6)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.36e-2)"	18.0	19.0	29.3	30.0	27.6	25.9	19.6	35.7	27.9	22.8	19.1	19.1	19.4	14.7	24.7	19.5	23.7	22.5	19.1	16.2	21.5	19.3	16.1	19.8	18.6	28.7	16.3	26.1	30.2	17.2	28.9	25.8	20.2	19.6	21.6	21.0	19.0	18.6	28.7	43.9	23.3	19.6	20.2	15.7	25.9	18.7	20.5	20.1	36.2	25.5	15.5	30.5	20.9	20.5	11.7	13.0	14.3	10.4	11.4	15.0	9.2	12.3	23.4	20.7	21.5	12.2	9.8	16.5	12.1	16.5	22.9	17.9	20.6	8.6	21.1	7.1	12.1	11.9	33.7	16.5	21.3	22.5	18.1	28.9	15.6	20.3	18.9	27.6	15.6	13.7	14.9	16.0	23.8	14.2	30.9	13.0	13.7	16.3	24.4	23.8	31.6	24.8	23.8	17.4	18.8	12.1	23.5	21.5	14.9	16.9	6.6	10.9	18.0	20.6	9.2	13.6	8.6	10.4	10.8	16.5	22.8	28.9	13.9	16.7	17.7	14.3	9.3	10.4	13.5	7.8	15.0	11.7	9.1	12.0	13.0	11.3	14.0	11.2	3.1	11.4	10.4	8.8	13.6	9.2	29.3	27.6	35.7	27.9	21.5	19.3	16.3	26.1	19.6	20.1
SASS6	"DKFZp761A078, FLJ22097, SAS-6, SAS6"	ENSG00000156876	"SAS-6 centriolar assembly protein"	Q6UVJ0	1	100083563-100132955	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028187	Uncertain		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite"	Cytosol	"HPA028187: AB_10602220"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.76e-8)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.54e-1)"	6.2	3.8	3.8	6.1	5.4	10.9	5.9	17.8	6.9	6.4	6.1	5.0	8.3	6.4	4.8	5.5	6.2	4.3	2.5	3.2	5.4	3.5	3.3	3.5	3.3	8.5	5.5	3.3	5.3	4.2	10.2	12.0	5.9	5.8	6.9	6.4	3.1	5.1	4.8	3.8	4.5	7.0	4.9	6.2	7.3	4.6	15.0	6.9	17.1	4.6	5.0	7.7	4.5	4.8	5.1	1.4	8.1	2.3	2.3	3.6	1.4	11.2	3.8	9.3	8.9	1.1	2.0	13.5	7.1	3.5	9.4	11.3	5.9	6.1	12.1	6.2	2.9	10.5	12.5	4.3	12.7	6.7	12.6	10.3	8.2	7.6	0.6	17.4	10.4	1.0	2.0	7.8	6.9	4.9	16.6	12.0	4.3	3.3	15.5	8.4	12.0	7.7	11.1	18.1	6.3	4.5	5.2	6.6	9.9	7.1	11.6	6.0	5.7	10.5	2.4	6.5	8.3	7.6	10.0	6.0	12.2	17.0	5.4	11.5	3.6	8.1	1.2	4.8	3.5	2.3	3.6	5.1	3.4	2.9	1.4	3.9	3.1	3.0	3.5	2.3	1.7	1.4	3.1	1.4	3.8	5.4	17.8	6.9	5.4	3.5	5.5	3.3	5.8	6.9
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345387-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"lymphoid tissue: 331.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 92.0;MOLT-4: 21.5;REH: 25.7;T-47d: 20.6;THP-1: 39.3;U-937: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 37.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 18.6;T-cells: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favourable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	6.7	5.3	11.8	11.7	11.0	16.4	5.9	10.1	22.7	5.6	15.1	3.6	16.1	6.8	5.9	11.1	5.3	8.0	7.7	10.9	10.8	8.1	5.4	7.2	7.6	25.9	10.0	15.6	6.2	14.8	22.4	12.9	1.8	6.6	10.1	8.2	5.9	17.9	26.2	35.7	9.2	11.3	12.1	8.1	11.5	10.4	2.9	4.5	331.6	11.3	4.6	11.8	18.7	11.0	4.7	1.2	4.7	0.6	18.6	37.9	7.9	0.4	0.0	2.6	0.0	3.7	3.6	0.3	0.7	2.5	0.6	2.1	0.1	4.7	0.9	0.0	0.8	0.0	9.6	1.1	1.2	92.0	5.8	0.0	0.2	0.0	0.5	5.3	0.8	1.6	0.8	0.0	0.1	0.6	0.1	5.1	0.4	0.0	21.5	6.8	3.9	0.3	25.7	1.3	0.9	1.0	3.2	1.2	7.3	0.0	0.8	0.0	20.6	39.3	0.3	2.7	1.7	1.2	0.7	0.2	0.0	2.0	2.2	20.7	1.2	4.7	0.5	1.3	14.3	0.6	25.8	0.5	9.7	7.4	1.0	4.7	37.9	22.6	1.2	18.6	0.3	1.2	1.7	7.9	11.8	11.0	10.1	22.7	10.8	8.1	10.0	15.6	6.6	4.5
SATB2	"FLJ21474, KIAA1034"	ENSG00000119042	"SATB homeobox 2"	Q9UPW6	2	199269500-199471266	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.1;intestine: 33.2;lymphoid tissue: 11.0"	"Cell line enhanced"	"Detected in many"		"HEL: 19.4;K-562: 21.2;THP-1: 28.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"amygdala: 7.9;cerebral cortex: 29.7;hippocampal formation: 19.7"	"Group enriched"	"Detected in many"	10	"cerebral cortex: 52.6;hippocampal formation: 45.2"	"HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB023669: AB_1129287, CAB062562: , CAB067751: , CAB068229: , CAB068230: , CAB068231: , HPA001042: AB_10601711, HPA029543: AB_10959737"	"unprognostic (1.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.53e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.54e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.37e-8)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.95e-6)"	"unprognostic (1.08e-3)"	2.4	5.0	4.5	11.0	10.0	0.5	2.0	0.5	26.1	2.3	27.9	0.4	0.4	1.4	1.7	1.1	0.9	1.1	1.4	0.7	5.6	1.6	3.6	2.8	0.8	0.6	2.3	15.5	1.9	3.4	3.1	1.1	0.8	4.6	1.9	33.2	0.1	1.5	2.6	2.1	1.7	5.0	2.9	4.9	0.7	1.0	2.4	0.0	0.0	1.6	2.4	1.0	1.6	3.1	0.2	0.0	0.0	0.7	0.0	0.5	0.1	1.2	0.8	8.7	4.0	4.2	5.1	0.6	3.0	4.4	2.2	2.9	0.1	2.8	0.4	0.1	6.5	0.2	6.9	1.8	3.5	4.4	6.0	19.4	1.6	2.3	0.9	8.8	8.6	2.4	3.2	4.3	2.8	0.2	21.2	0.0	6.3	0.4	0.4	11.0	1.6	1.4	0.8	3.0	0.1	3.3	0.3	1.9	0.0	1.5	0.0	4.5	1.8	28.9	3.0	15.9	3.0	5.0	8.0	1.3	4.1	12.7	11.0	7.1	12.5	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	4.5	10.0	0.5	26.1	5.6	1.6	2.3	15.5	4.6	0.0
SAV1	"salvador, WW45, WWP4"	ENSG00000151748	"Salvador family WW domain containing protein 1"	Q9H4B6	14	50632058-50668331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001808	Approved		Supported	Cytosol				Cytosol		"HPA001808: "	"prognostic favourable (2.92e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.20e-2)"	"prognostic favourable (3.83e-6)"	"unprognostic (2.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.90e-3)"	28.5	13.5	13.9	10.8	16.2	5.0	30.3	11.9	13.9	23.3	18.9	19.9	13.8	11.7	19.3	15.5	13.9	17.1	20.7	23.1	15.6	12.5	18.4	13.5	22.1	10.9	17.3	11.1	30.8	31.3	24.5	11.2	17.0	15.6	29.2	10.1	18.6	34.0	19.8	25.6	15.9	18.3	16.0	20.1	16.6	16.5	22.5	17.7	5.5	32.1	12.1	11.0	23.5	36.7	7.1	2.3	1.1	0.7	0.9	1.9	0.9	36.3	4.2	7.1	4.9	17.6	16.3	8.9	10.3	34.1	13.5	17.4	6.1	18.7	5.7	25.5	10.1	16.7	10.0	11.2	25.2	17.3	7.8	6.2	6.7	4.4	8.7	6.7	5.7	10.1	14.5	6.0	13.5	9.6	10.2	2.9	16.7	6.8	5.7	4.2	13.3	6.5	6.5	19.7	2.4	8.5	5.2	8.9	6.9	18.3	10.9	15.3	8.0	6.9	6.9	6.5	22.2	8.8	6.2	4.4	5.7	3.5	4.5	2.7	8.6	1.1	0.7	0.1	1.7	0.6	1.9	6.2	1.4	1.2	0.7	7.1	1.1	1.4	1.1	0.9	0.7	2.3	1.6	0.9	13.9	16.2	11.9	13.9	15.6	12.5	17.3	11.1	15.6	17.7
SAYSD1	"C6orf64, FLJ11101"	ENSG00000112167	"SAYSVFN motif domain containing 1"	Q9NPB0	6	39104064-39115189	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 52.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007959		Approved	Supported	Vesicles				Vesicles		"HPA007959: AB_1078359"	"unprognostic (2.65e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-3)"	8.2	7.2	7.2	5.7	8.7	5.9	11.2	7.1	9.0	7.9	7.3	8.1	6.9	8.8	7.9	10.5	6.5	8.1	9.3	6.7	7.3	6.9	8.1	8.3	6.3	8.2	9.3	6.5	8.4	9.5	4.9	6.1	6.1	7.0	8.5	7.2	6.4	11.1	8.0	5.6	6.6	8.6	6.3	7.0	6.8	6.9	52.7	7.3	18.2	8.4	5.1	9.0	6.2	7.7	14.8	9.3	19.4	12.2	11.7	19.1	9.5	11.4	7.4	6.7	7.9	11.1	14.7	6.9	5.3	5.8	6.4	6.8	10.6	8.2	10.4	7.7	6.9	7.9	5.8	5.0	6.8	6.5	10.5	6.8	4.5	9.2	9.0	7.7	10.3	10.1	12.4	2.5	6.4	5.9	11.5	6.4	7.2	15.7	12.2	12.8	5.8	3.8	1.7	8.2	4.1	13.4	8.1	18.9	7.6	9.2	8.0	8.1	13.1	10.2	7.6	8.5	6.2	2.6	6.8	0.1	3.2	12.8	4.9	11.2	6.2	7.6	9.0	19.4	12.2	12.2	14.2	13.1	13.3	11.0	9.3	14.8	19.1	15.8	4.3	11.7	11.9	7.4	17.3	9.5	7.2	8.7	7.1	9.0	7.3	6.9	9.3	6.5	7.0	7.3
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS, ribosome maturation factor"	Q9Y3A5	7	66987677-66995601	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol			55000	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavourable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	40.9	34.5	37.7	18.7	44.0	41.7	44.5	23.6	43.2	30.7	37.5	35.3	20.2	39.1	35.6	27.3	40.8	27.7	34.0	70.0	39.2	40.9	36.9	38.4	32.1	16.7	50.6	36.6	31.9	27.5	50.4	26.9	38.6	44.6	35.1	35.7	20.1	23.5	40.5	130.7	26.1	34.4	52.0	63.2	16.7	32.8	15.9	48.2	7.2	33.9	38.7	15.6	54.0	38.0	21.6	15.5	20.8	12.6	16.6	39.1	19.4	31.0	13.2	11.7	10.6	42.7	31.9	13.1	52.9	43.6	40.5	31.2	27.1	16.0	11.5	40.2	48.3	15.1	19.7	31.4	43.6	11.0	26.0	5.7	24.6	16.2	38.0	14.4	7.9	28.8	42.3	30.8	53.6	24.9	41.7	12.6	62.9	18.6	7.6	21.0	13.0	31.4	5.8	25.2	24.2	42.7	13.9	18.0	12.4	26.5	45.9	35.1	34.2	12.2	33.1	54.8	18.7	27.7	38.5	7.8	9.2	26.4	18.8	23.7	30.3	20.8	11.1	20.2	23.4	12.6	29.6	21.6	30.6	27.2	11.3	18.7	39.1	31.5	4.7	16.6	11.2	15.5	25.9	19.4	37.7	44.0	23.6	43.2	39.2	40.9	50.6	36.6	44.6	48.2
SBF1	"DENND7A, MTMR5"	ENSG00000100241	"SET binding factor 1"	O95248	22	50445000-50475024	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074004			Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA074004: "	"unprognostic (4.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.11e-2)"	"prognostic favourable (3.46e-5)"	"unprognostic (2.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.05e-1)"	13.4	12.7	32.6	18.6	22.9	16.3	7.0	26.2	39.6	7.3	10.0	30.3	6.8	13.4	10.1	3.6	16.8	8.8	9.8	12.0	35.1	17.5	8.7	7.6	9.4	23.5	29.5	26.1	12.4	22.7	6.9	8.6	8.2	21.1	9.9	4.9	8.5	15.4	11.7	30.3	22.1	15.8	8.2	22.3	16.8	13.9	38.5	23.8	22.0	23.5	5.3	13.1	10.2	7.7	4.6	9.1	3.2	3.8	2.9	7.6	3.2	13.8	11.7	10.2	13.8	10.5	8.1	28.1	9.8	8.5	9.2	7.6	16.0	9.9	32.0	7.1	11.5	13.1	8.4	11.9	2.3	11.6	31.9	7.2	23.6	20.5	18.2	22.1	11.1	10.9	19.0	11.9	9.0	6.2	11.5	8.7	6.3	17.3	21.9	21.3	4.2	13.3	28.9	19.4	19.6	5.4	11.3	8.1	19.6	15.2	15.0	19.3	8.7	10.3	10.4	14.6	21.4	10.3	12.1	16.2	5.2	15.5	16.6	9.1	13.7	0.8	2.1	3.2	7.6	2.2	4.3	4.6	5.3	6.1	2.6	3.2	4.0	6.2	3.2	2.9	3.8	9.1	4.4	3.2	32.6	22.9	26.2	39.6	35.1	17.5	29.5	26.1	21.1	23.8
SCAF11	"CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP"	ENSG00000139218	"SR-related CTD associated factor 11"	Q99590	12	45919131-45992120	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038862, HPA045456, HPA046345"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA038862: AB_10672830, HPA045456: , HPA046345: "	"unprognostic (2.83e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.13e-2)"	34.4	17.0	17.5	34.1	19.5	46.1	25.8	19.1	17.9	29.0	24.5	12.4	29.0	17.0	25.1	25.9	25.8	21.0	21.1	33.6	15.8	16.6	27.9	32.2	27.8	29.9	19.2	12.5	31.7	21.3	32.7	26.8	23.0	20.6	26.5	21.4	15.3	24.3	31.0	35.4	24.1	30.7	25.5	21.7	38.1	17.4	22.7	20.6	42.3	27.8	21.9	28.6	29.1	33.9	18.4	19.2	32.8	13.6	12.9	15.3	7.9	15.0	13.7	17.0	14.1	11.7	16.1	15.8	17.8	14.5	15.4	11.2	49.0	16.5	31.5	20.1	18.8	14.9	17.4	14.3	17.5	17.3	11.8	29.4	18.2	12.8	9.2	30.8	19.8	13.3	15.4	13.2	20.0	15.8	22.4	17.4	19.4	14.2	23.0	17.2	13.2	18.7	18.8	22.8	15.9	14.6	19.2	9.8	10.1	19.7	16.9	9.5	15.6	33.3	19.5	15.9	13.1	11.9	9.4	12.6	9.3	51.6	13.3	66.3	6.0	20.9	13.0	17.3	14.7	12.5	13.3	17.7	13.9	14.1	9.8	18.4	15.3	13.7	32.8	12.9	13.6	19.2	12.4	7.9	17.5	19.5	19.1	17.9	15.8	16.6	19.2	12.5	20.6	20.6
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671033-31732075	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	18.8	14.9	15.1	32.7	16.3	19.0	18.4	24.0	21.4	19.9	23.2	20.3	12.9	19.4	21.6	17.6	22.3	16.8	22.3	15.4	13.2	11.5	14.0	22.5	19.0	27.1	15.3	11.9	23.9	18.5	23.7	18.1	20.3	14.3	17.6	16.8	17.1	18.4	19.3	23.3	24.2	21.9	16.1	13.3	23.7	17.9	25.6	14.6	44.2	16.5	12.8	26.4	18.9	20.4	14.1	12.0	12.7	13.2	9.6	12.8	8.4	13.8	9.2	18.6	13.4	10.1	7.7	12.7	10.4	10.9	10.9	10.3	17.6	10.1	28.4	6.2	10.0	8.6	20.1	10.0	12.1	12.7	12.0	22.6	7.1	14.6	11.6	24.1	9.5	8.6	11.4	14.6	12.6	9.6	29.8	14.9	9.0	18.6	25.5	17.6	23.8	8.0	25.3	20.7	9.3	7.6	10.9	12.8	13.8	15.8	12.3	8.9	9.4	16.2	11.0	11.4	11.0	10.9	10.4	9.6	8.9	32.8	8.2	19.4	10.6	8.2	9.4	12.7	12.8	13.2	12.8	14.1	7.5	12.1	12.0	14.0	8.8	9.5	5.0	9.6	11.4	8.4	6.6	8.4	15.1	16.3	24.0	21.4	13.2	11.5	15.3	11.9	14.3	14.6
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733325-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	27.9	19.1	17.4	32.0	19.1	36.1	27.5	28.1	22.2	30.0	23.4	18.2	20.8	14.2	28.3	21.6	18.5	25.1	21.9	19.3	16.9	13.4	19.8	17.6	19.6	23.5	16.2	15.1	32.6	20.0	33.6	24.1	23.8	14.8	24.4	20.7	17.9	21.9	30.1	28.5	26.9	21.2	23.8	14.3	21.7	19.9	25.4	20.2	42.6	24.7	20.1	22.8	26.1	32.9	5.4	3.3	3.8	6.7	6.1	7.5	2.6	8.4	8.2	24.4	14.7	16.5	17.0	15.0	13.8	19.5	18.3	18.7	12.9	8.6	26.4	11.3	15.9	11.5	21.5	18.2	24.7	11.5	10.8	23.7	8.9	15.7	19.2	21.8	15.9	18.2	19.4	16.0	25.1	15.6	27.4	16.1	16.8	15.3	23.3	14.8	17.0	6.2	22.4	13.3	14.3	15.5	15.5	15.1	17.7	14.4	19.0	10.5	12.4	25.4	14.2	10.5	12.8	13.5	13.9	15.1	11.1	29.3	13.1	13.6	16.2	1.2	2.8	3.5	6.0	3.9	5.8	4.8	6.2	5.9	3.3	5.4	6.3	5.6	3.8	6.1	6.7	3.2	7.5	2.6	17.4	19.1	28.1	22.2	16.9	13.4	16.2	15.1	14.8	20.2
SCAI	"C9orf126, FLJ36664, NET40"	ENSG00000173611	"Suppressor of cancer cell invasion"	Q8N9R8	9	124942608-125143506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 34.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020632	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA020632: AB_1845804"	"unprognostic (1.93e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-3)"	4.5	6.5	9.5	6.4	14.3	6.8	5.4	9.5	19.1	5.0	4.5	3.5	3.1	3.3	5.9	4.6	4.1	6.1	3.7	3.7	7.1	7.9	4.4	3.8	8.5	7.2	4.6	12.0	7.6	4.6	5.7	4.6	2.7	4.8	5.5	5.0	12.4	3.7	3.3	4.2	6.6	4.0	4.0	4.0	5.0	4.4	5.2	5.1	34.4	5.3	2.1	6.2	4.2	4.5	2.9	3.1	1.5	1.7	2.5	2.6	1.3	3.8	3.0	4.0	3.8	2.2	5.4	6.7	2.4	5.1	2.6	3.7	3.8	3.7	6.9	1.8	2.4	6.5	5.1	2.6	5.3	4.9	1.9	4.5	5.5	3.3	3.1	4.8	3.5	2.1	2.3	4.0	2.7	3.7	6.4	8.1	3.9	4.2	15.3	3.3	3.9	3.3	9.7	6.4	5.9	1.8	5.3	4.1	2.6	5.7	3.1	3.0	7.8	2.1	3.8	2.4	4.4	4.0	4.2	4.5	8.5	6.6	2.9	4.0	3.5	0.8	1.2	0.2	1.1	1.7	1.2	2.0	1.9	1.3	0.8	2.9	2.6	1.8	1.5	2.5	0.6	3.1	2.6	1.3	9.5	14.3	9.5	17.0	7.1	7.9	4.6	12.0	4.8	5.1
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"			110000	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favourable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	28.8	27.9	15.7	32.2	21.9	22.6	38.7	7.6	16.5	20.9	37.8	27.6	24.6	37.7	22.5	27.9	54.7	24.7	27.0	18.8	14.8	10.1	34.2	37.8	28.8	42.1	24.2	11.6	20.5	32.1	42.7	17.6	47.8	17.4	20.3	37.1	17.5	56.4	31.9	18.5	36.1	47.5	17.1	20.1	39.4	33.2	29.2	20.1	25.8	29.2	28.3	38.4	21.4	25.8	37.8	59.5	46.9	51.3	36.6	47.0	47.4	12.6	16.7	7.2	11.1	21.9	11.4	21.5	13.1	16.7	14.0	15.1	23.9	30.1	10.5	17.3	19.7	46.3	21.3	16.3	5.8	41.4	20.9	26.6	9.7	16.4	16.6	13.6	51.2	14.6	29.1	13.2	9.6	13.5	8.8	19.9	9.8	19.4	6.9	15.7	7.1	10.8	12.1	6.6	36.1	16.1	18.3	7.4	7.5	10.7	19.0	12.0	26.1	21.9	12.6	12.1	7.2	13.0	15.2	13.8	20.2	10.7	11.3	32.2	8.8	46.9	51.3	39.4	46.6	48.3	37.6	37.8	42.7	46.9	37.8	32.5	35.6	38.2	34.6	36.6	50.3	59.5	47.0	47.4	15.7	21.9	7.6	16.5	14.8	10.1	24.2	11.6	17.4	20.1
SCAMP3	C1orf3	ENSG00000116521	"Secretory carrier membrane protein 3"	O14828	1	155255979-155262430	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071167			Supported	Vesicles				Vesicles		"HPA071167: "	"unprognostic (4.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.18e-2)"	23.6	41.8	21.0	20.8	25.6	16.8	28.8	22.5	35.5	21.9	19.0	36.1	26.8	24.1	20.7	17.8	27.1	21.9	21.5	37.8	19.8	20.2	33.3	40.8	23.4	25.5	27.1	26.3	22.6	41.5	41.5	20.0	37.0	26.2	23.0	17.3	26.0	33.0	28.1	45.3	30.0	20.9	18.9	30.4	27.0	24.4	14.5	26.4	21.6	27.3	23.6	27.3	23.9	20.8	32.2	32.5	25.6	35.0	29.9	28.7	30.0	13.8	29.7	9.0	17.9	21.9	17.3	9.2	16.6	19.7	18.8	17.7	16.2	19.7	12.8	24.8	19.3	21.6	12.9	12.6	6.9	17.5	23.7	9.0	19.4	13.2	21.9	17.0	15.4	15.1	16.1	23.5	10.8	15.7	16.0	31.1	20.3	27.6	15.6	15.7	17.3	32.6	13.5	7.3	39.4	11.1	12.4	11.7	23.6	11.6	27.2	19.2	29.3	26.5	12.8	21.1	11.9	21.8	24.6	41.3	38.4	15.9	20.8	18.2	24.3	25.6	29.0	23.2	28.7	31.1	25.6	32.2	26.6	26.8	31.6	30.5	24.6	26.3	2.6	29.9	35.0	32.5	26.6	30.0	21.0	25.6	22.5	35.5	19.8	20.2	27.1	26.3	26.2	26.4
SCAND1	"RAZ1, SDP1"	ENSG00000171222	"SCAN domain containing 1"	P57086	20	35953617-35959472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047138			Supported	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Actin filaments"	Cytosol	"HPA047138: "	"unprognostic (3.88e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.15e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.48e-2)"	38.7	31.8	23.5	25.4	22.0	50.3	21.6	13.7	37.7	18.1	30.3	12.3	22.4	45.3	19.3	32.8	21.0	17.0	27.1	19.8	21.6	22.7	30.7	39.6	18.0	26.5	21.0	18.4	19.8	30.7	8.8	21.2	16.9	14.5	26.8	7.2	19.1	36.2	27.8	50.7	19.5	35.4	15.4	16.5	31.9	40.6	23.8	13.4	34.8	26.8	26.2	15.9	14.8	17.3	42.0	60.9	70.6	61.6	30.4	47.2	43.2	13.0	9.7	3.8	7.3	2.0	2.4	24.4	9.1	3.6	4.0	4.7	8.9	9.7	10.1	23.6	1.5	12.2	0.8	4.3	0.4	3.6	21.7	24.9	5.3	19.0	7.0	7.8	10.3	4.2	3.4	3.3	0.7	6.4	10.8	8.1	2.4	13.1	21.8	55.4	12.8	38.3	16.6	11.8	16.5	3.8	5.2	18.8	27.8	15.0	24.0	20.2	16.3	14.8	12.8	13.4	12.0	12.9	8.9	24.3	11.9	14.2	15.6	8.4	10.4	70.6	61.6	57.3	35.1	40.9	27.7	36.6	35.0	30.9	45.8	42.0	29.7	29.0	53.3	30.4	39.6	60.9	47.2	43.2	23.5	22.0	13.7	37.7	21.6	22.7	21.0	18.4	14.5	13.4
SCAPER	"Zfp291, ZNF291"	ENSG00000140386	"S-phase cyclin A associated protein in the ER"	Q9BY12	15	76347904-76905444	"Predicted intracellular proteins"			"Disease mutation, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046253, HPA061180"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046253: , HPA061180: "	"unprognostic (3.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.02e-1)"	"prognostic favourable (2.69e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.89e-3)"	9.0	10.9	17.0	9.3	15.6	8.8	9.4	26.0	20.7	10.3	8.3	10.7	9.8	8.9	10.0	10.8	12.1	9.0	7.5	17.8	15.9	17.2	12.6	9.9	8.4	7.1	17.3	13.2	16.8	10.9	24.1	36.3	24.6	15.6	9.9	6.3	7.7	9.7	9.5	17.9	9.8	8.3	10.4	20.6	7.5	7.9	25.7	14.7	12.6	16.3	8.7	7.7	9.4	9.5	13.2	6.6	20.4	4.6	12.0	14.3	2.8	5.0	4.7	6.6	3.7	3.3	6.1	5.4	6.9	4.9	3.2	4.5	4.9	4.1	5.0	6.1	2.3	5.5	15.3	2.8	4.8	11.7	7.5	2.7	5.7	2.4	4.2	7.1	6.3	5.0	5.1	3.8	6.1	4.2	3.8	14.5	5.4	2.1	6.9	2.2	1.9	2.7	6.3	10.4	1.7	2.9	5.1	15.5	7.5	9.1	3.2	7.4	4.7	5.9	5.1	7.3	6.9	3.4	6.0	8.8	18.4	7.5	4.3	9.0	4.8	20.4	4.6	11.5	8.6	2.5	9.8	11.0	8.7	7.6	2.5	13.2	14.3	9.1	7.7	12.0	2.9	6.6	6.6	2.8	17.0	15.6	26.0	17.1	15.9	17.2	17.3	13.2	15.6	14.7
SCARA3	"APC7, CSR, CSR1, MSLR1, MSRL1"	ENSG00000168077	"Scavenger receptor class A member 3"	Q6AZY7	8	27633868-27676776	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 52.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 49.6;HeLa: 54.6;HUVEC TERT2: 37.8;U-2 OS: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029861, HPA047386"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA029861: , HPA047386: "	"unprognostic (2.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (6.03e-3)"	7.5	4.6	16.4	9.0	27.3	0.4	10.6	10.3	26.8	19.9	11.2	7.7	14.2	3.4	33.8	9.4	14.5	52.2	18.4	4.8	16.2	13.0	3.8	2.7	7.8	7.4	16.4	10.3	13.1	2.8	2.2	3.6	11.8	21.2	12.4	5.4	8.6	13.7	42.6	1.1	6.0	5.1	40.5	21.8	2.0	5.9	3.9	12.1	3.2	19.2	4.7	13.2	11.3	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.1	2.5	0.0	13.5	49.6	11.3	6.5	10.2	7.0	5.2	5.9	4.2	0.0	15.3	13.0	12.1	0.0	12.0	3.3	0.0	1.4	4.7	54.6	0.2	1.4	0.0	0.0	20.8	0.7	10.8	0.5	37.8	0.0	0.0	3.9	2.9	0.0	0.0	3.4	6.2	0.0	0.0	0.0	2.2	7.2	0.0	1.6	1.5	8.6	0.0	8.4	0.1	13.4	5.8	35.0	21.4	3.4	0.0	0.0	0.0	9.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	27.3	10.3	22.5	16.2	13.0	16.4	10.3	21.2	12.1
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;CAPAN-2: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: "	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	30.4	28.0	59.8	40.9	199.5	115.1	12.2	3.2	72.1	7.8	41.8	24.1	138.2	12.8	2.6	7.6	54.4	32.9	116.8	6.9	4.3	13.6	7.2	17.8	48.2	38.6	10.0	7.8	62.6	35.4	30.4	53.6	14.8	20.0	39.2	3.1	47.6	11.3	12.0	20.7	8.1	5.3	22.1	40.2	34.2	34.1	3.7	14.4	6.4	30.5	62.7	34.2	21.6	5.9	0.7	9.3	0.7	6.7	11.0	5.8	19.8	14.3	31.3	5.0	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 145.6;skin 1: 70.8;tongue: 62.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.9;HaCaT: 24.3;HBEC3-KT: 11.6;RPTEC TERT1: 47.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favourable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (1.73e-5)"	0.4	0.0	0.1	0.2	0.4	0.0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0.0	0.8	0.2	145.6	0.0	0.3	0.1	0.1	0.0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0.0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0.0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.8	0.0	24.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	47.3	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681353-51721031	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 118.3"	"Group enriched"	"Detected in some"	7	"NTERA-2: 20.0;SCLC-21H: 47.9;SH-SY5Y: 22.6"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"		4800000	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: "	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	1.7	12.9	29.6	2.1	25.4	1.7	1.7	33.4	118.3	1.5	2.4	6.5	0.0	2.9	1.5	1.6	1.6	1.6	1.6	1.5	22.6	23.5	1.5	1.5	1.8	1.7	13.6	37.7	1.5	11.5	1.4	23.7	1.5	27.1	1.6	2.8	1.3	1.5	1.4	1.5	1.8	2.6	1.7	13.2	1.5	8.7	2.9	7.3	0.0	2.1	0.0	1.5	1.6	0.1	0.9	1.2	1.9	0.5	0.3	0.8	0.2	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	20.0	0.0	0.1	0.0	0.1	0.0	0.2	47.9	22.6	0.1	0.1	0.0	0.0	1.4	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.1	4.3	0.4	0.4	0.6	0.8	0.2	0.5	0.9	0.6	0.4	0.4	0.7	0.5	0.6	1.9	0.3	0.5	1.2	0.2	0.2	29.6	25.4	33.4	40.6	22.6	23.5	13.6	37.7	27.1	7.3
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"			Cytosol		"CAB004005: , CAB044060: , CAB062563: , CAB068232: , HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660179	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0"	"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 37.7;SK-BR-3: 40.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA020518, HPA024264"	Enhanced		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	4.1	1.0	14.5	2.3	30.3	1.0	0.9	1.5	13.3	1.2	11.2	7.5	1.0	16.2	1.2	0.7	14.5	3.6	2.0	0.5	11.1	4.2	30.3	0.6	3.4	0.6	22.8	2.3	0.8	0.9	1.1	3.1	46.0	20.0	2.3	10.2	0.6	9.0	1.0	0.6	2.5	31.7	1.0	27.9	0.6	12.2	4.3	23.4	0.0	1.0	2.7	8.2	5.5	1.1	4.5	1.5	3.5	1.5	2.1	1.9	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.1	8.3	0.2	0.2	0.1	0.6	0.1	1.3	0.1	0.2	0.0	37.7	1.4	1.7	0.0	0.4	40.9	0.0	4.3	0.3	0.0	0.1	0.3	0.8	0.0	1.4	0.1	0.1	0.0	0.1	0.1	3.5	1.5	1.0	1.7	1.3	1.5	4.5	1.5	1.4	1.0	2.5	1.6	1.9	2.5	2.1	1.4	1.5	1.0	0.8	14.5	30.3	1.5	13.3	11.1	4.2	22.8	2.3	20.0	23.4
SCMH1	Scml3	ENSG00000010803	"Scm polycomb group protein homolog 1"	Q96GD3	1	41027200-41242154	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048898, HPA053292"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA048898: , HPA053292: "	"unprognostic (6.02e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.08e-2)"	"prognostic favourable (5.80e-4)"	12.5	13.1	14.7	18.2	15.3	11.2	21.3	15.9	13.9	15.8	27.9	6.7	23.4	9.0	21.4	16.7	11.1	16.5	17.2	27.2	12.6	8.8	14.8	9.5	11.4	10.5	7.6	12.5	24.8	30.2	26.5	23.0	7.8	10.7	22.7	12.6	16.8	19.2	23.8	28.4	8.4	12.7	36.9	7.4	8.7	18.5	26.6	6.7	11.3	14.3	11.1	8.3	22.7	25.7	4.3	7.6	2.2	2.2	2.9	4.2	1.7	8.9	6.0	14.3	13.1	6.6	12.6	0.0	7.2	12.6	12.1	12.6	5.7	11.6	16.4	5.5	13.1	2.2	11.0	9.7	10.5	11.3	8.4	7.6	8.1	14.3	28.7	16.3	12.6	13.6	9.9	8.0	19.5	12.1	7.1	12.8	11.8	4.8	16.3	14.1	13.2	6.4	18.1	15.0	9.7	9.7	11.2	10.1	10.8	12.5	10.0	10.4	8.9	42.0	8.9	12.8	10.0	7.8	13.1	13.1	7.3	17.9	8.0	14.7	11.6	1.3	1.2	2.2	3.3	2.2	4.2	4.3	3.9	3.1	3.7	2.1	2.9	2.4	0.0	2.9	0.5	7.6	2.7	1.7	14.7	15.3	15.9	13.9	12.6	8.8	7.6	12.5	10.7	6.7
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107704104-107824317	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.3;lymphoid tissue: 24.6"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 36.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"gdT-cell: 19.5;MAIT T-cell: 18.0;memory CD4 T-cell: 27.3;memory CD8 T-cell: 24.3;naive CD4 T-cell: 26.9;naive CD8 T-cell: 23.9;NK-cell: 17.6"	"Group enriched"	"Detected in many"	5	"NK-cells: 17.6;T-cells: 27.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063326, HPA065958"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA063326: , HPA065958: "	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	1.3	0.6	0.5	13.9	0.6	2.7	1.4	0.3	0.5	1.2	5.4	0.3	0.3	10.1	0.9	4.9	1.3	1.2	2.4	0.6	1.7	0.9	1.7	2.7	3.2	24.6	0.4	0.0	0.7	1.4	0.0	3.9	0.3	0.5	1.2	2.1	1.6	5.7	0.0	0.3	0.9	12.4	0.4	0.9	11.5	2.4	10.4	0.2	23.9	1.5	1.3	24.5	2.3	1.3	4.5	0.3	3.6	0.1	17.6	27.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	2.1	19.5	0.0	18.0	4.5	27.3	24.3	0.0	3.5	26.9	23.9	3.6	17.6	0.1	0.3	2.6	9.4	0.5	0.6	0.3	0.5	1.7	0.9	0.4	0.0	0.5	0.2
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 33.9"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 11.3;Hep G2: 6.0"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: "	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	1.1	1.3	5.2	1.1	13.6	1.0	1.1	10.3	26.6	1.1	1.1	2.3	0.0	1.0	1.1	1.1	1.0	6.8	1.0	1.1	6.9	8.3	1.1	1.1	5.6	1.0	5.7	9.7	1.0	1.0	1.1	2.9	1.2	33.9	1.1	1.1	0.3	1.0	1.0	1.2	1.1	1.1	1.1	3.6	1.1	1.1	1.4	4.2	0.0	1.1	0.0	1.0	1.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	11.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.2	13.6	10.3	26.6	6.9	8.3	5.7	9.7	33.9	4.2
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Group enriched"	"Detected in some"	4	"LHCN-M2: 21.5;RH-30: 17.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.3	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.8	2.7	0.0	0.3	0.0	1.1	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	3.5	0.0	0.0	21.5	1.0	0.0	0.0	2.0	0.0	0.0	17.9	0.0	0.0	2.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0
SCNN1D	"dNaCh, ENaCdelta"	ENSG00000162572	"Sodium channel epithelial 1 delta subunit"	P51172	1	1280436-1292029	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA026884	Enhanced		Supported	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA026884: AB_10601501"	"unprognostic (2.08e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.60e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (5.27e-2)"	"prognostic unfavourable (6.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.06e-2)"	3.2	3.8	4.0	1.9	5.1	3.6	1.2	12.8	6.3	1.7	2.0			7.0	3.2	1.1	1.1	3.9	1.5	1.5	4.1	3.3	1.4	3.2	1.5	2.5	3.1		4.6	3.0	0.8	5.9	1.3		2.3	0.2		8.6	2.4	3.9	4.6	5.1	1.0	3.2	3.8	2.4	10.2			1.3		0.7	0.7	1.8	0.5	0.9	0.0	0.2	0.0	0.8	0.2	0.6	5.0	1.9	5.2	1.4	0.8	0.9	3.3	1.0	1.7	1.9	0.9	2.8	3.5	1.8	1.5	0.8	0.9	0.8	0.3	6.6	3.0	0.4	5.9	1.3	1.4	0.1	3.6	2.3	1.1	2.6	0.0	0.5	2.4	8.4	0.4	1.8	1.4	2.4	1.0	3.7	9.3	0.4	0.8	0.7	0.2	2.7	3.8	1.4	1.5	2.2	6.6	1.8	1.4	3.1	2.6	4.9	1.1	11.3	0.7	2.9	2.8	6.1	3.5	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.2										
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 gamma subunit"	P51170	16	23182715-23216883	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.9;salivary gland: 26.8"	"Group enriched"	"Detected in some"	7	"hTCEpi: 30.7;RT4: 13.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.8"	"Low region specificity"	"Detected in all"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA071194: "	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	1.1	0.3	0.6	0.2	0.0	0.4	2.5	9.7	0.4	14.0	5.5	0.0	4.8	0.2	3.2	1.7	10.3	0.5	0.2	0.2	1.5	0.0	42.9	0.2	15.6	0.2	0.0	0.3	0.2	3.8	0.2	6.5	0.7	0.7	10.2	1.1	0.0	26.8	12.8	2.2	6.6	0.2	0.3	0.3	0.2	6.9	0.3	0.0	1.5	25.5	3.3	3.9	1.7	11.3	0.3	0.3	1.8	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	13.8	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	1.8	0.2	0.1	0.3	0.1	0.0	0.6	0.0	9.7	0.4	1.5	0.0	0.0	0.3	0.7	0.0
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927229-53051703	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Peroxisomes			370000	Peroxisomes		"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favourable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favourable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	29.1	26.2	21.8	19.9	21.2	14.0	30.3	12.0	19.7	24.4	51.9	15.9	28.1	49.2	19.0	28.8	32.2	18.1	32.1	29.3	20.0	20.0	54.2	168.3	21.8	14.0	25.6	17.8	22.8	24.6	16.7	24.1	17.1	21.9	25.5	40.5	18.9	21.8	23.3	22.0	18.8	80.1	20.6	27.1	20.9	33.9	16.7	19.4	23.0	28.2	28.6	17.6	22.3	20.5	36.4	57.1	67.8	50.7	40.8	49.2	61.2	25.9	14.3	19.3	35.3	63.3	54.1	20.9	31.0	46.6	20.4	29.6	12.8	28.2	24.7	33.6	45.4	18.3	13.2	29.0	31.2	36.0	19.2	26.6	20.5	26.3	42.2	38.3	44.9	43.9	39.6	24.2	12.1	57.7	23.6	12.9	41.2	15.0	42.5	33.3	21.1	28.1	22.4	33.9	33.8	56.5	44.2	16.0	19.2	27.1	55.0	25.9	28.1	43.8	44.6	27.8	14.4	48.4	24.7	21.6	27.4	28.9	36.0	38.1	25.7	55.4	48.7	67.8	49.2	50.7	39.9	36.4	39.2	48.6	57.1	29.8	33.2	47.1	7.5	40.8	46.8	37.1	47.1	61.2	21.8	21.2	12.0	19.7	20.0	20.0	25.6	17.8	21.9	19.4
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribbled planar cell polarity protein"	Q14160	8	143790920-143815379	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"				"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: , HPA064312: "	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	13.0	6.1	15.1	10.8	12.2	9.4	15.9	10.1	13.9	15.1	18.4	17.5	9.8	14.8	9.4	5.9	36.6	11.6	11.9	8.0	12.2	7.7	10.2	13.6	11.5	12.9	13.5	12.8	10.9	17.2	11.2	9.6	9.5	11.8	10.9	7.6	7.5	22.9	11.2	36.8	33.3	16.3	11.2	9.7	11.2	17.0	10.1	16.4	14.0	9.1	11.9	9.6	11.6	17.8	0.6	0.5	0.2	0.4	0.2	1.5	0.6	18.5	15.0	6.9	8.7	2.5	3.2	11.6	10.4	3.0	4.8	4.0	6.6	12.1	7.3	12.7	3.0	19.4	3.7	14.0	0.9	8.1	20.6	10.2	12.9	11.5	5.7	4.2	5.8	2.7	13.6	4.7	4.0	5.3	12.9	2.6	3.7	36.9	11.0	9.1	5.2	19.0	13.3	6.4	8.2	2.5	18.7	15.0	11.0	11.8	13.0	11.0	16.4	10.2	10.1	5.3	22.2	9.4	14.6	9.2	9.0	7.5	5.5	4.3	8.3	0.1	0.1	0.1	0.6	0.4	1.5	0.6	0.4	1.2	0.5	0.4	0.4	0.4	0.2	0.2	0.1	0.2	0.4	0.6	15.1	12.2	10.1	13.9	12.2	7.7	13.5	12.8	11.8	16.4
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841333	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"			350000	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (5.83e-4)"	43.4	10.3	8.3	14.2	14.1	6.7	20.8	17.7	13.1	10.6	17.3	11.2	23.6	25.1	11.4	18.1	8.9	15.4	13.3	17.9	8.6	8.9	29.3	17.4	8.3	8.7	8.1	9.6	11.8	25.3	11.4	14.5	7.8	10.5	13.6	6.1	14.8	20.1	19.2	20.0	10.9	20.1	9.7	7.3	15.0	9.8	4.0	10.9	8.5	18.1	9.0	11.0	10.7	10.0	16.9	19.2	25.9	13.4	16.5	22.1	10.8	11.9	19.0	5.3	5.1	15.5	12.0	16.1	6.0	12.3	9.3	9.5	14.2	14.3	6.6	12.2	3.1	6.5	1.7	10.6	3.2	15.8	13.1	6.7	13.9	12.3	5.5	3.1	5.4	11.5	8.0	5.7	4.4	10.4	2.2	7.5	12.7	10.8	10.6	5.5	2.6	7.6	14.2	4.0	26.7	7.4	5.4	4.1	17.1	3.4	7.3	8.0	16.4	6.3	4.8	8.5	9.1	2.3	2.8	31.2	4.0	3.1	23.1	5.6	1.9	12.3	12.8	25.9	16.9	13.4	16.3	16.9	14.0	16.4	16.3	15.6	22.1	12.2	3.2	16.5	6.5	19.2	13.9	10.8	8.3	14.1	17.7	13.1	8.6	8.9	8.1	9.6	10.5	10.9
SCRT1	"DKFZp547F072, ZNF898"	ENSG00000261678	"Scratch family transcriptional repressor 1"	Q9BWW7	8	144330565-144336281	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 20.3"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 10.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045265	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA045265: AB_10959521"	"unprognostic (7.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-4)"	"unprognostic (5.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-1)"	0.3	2.3	2.1	0.3	6.6	0.3	0.3	5.7	20.3	0.3	0.3	0.0	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.3	2.2		0.3	0.3	0.3	0.3	0.0	3.8	0.4	0.7	0.3	0.0	0.3	4.2	0.3	0.3	0.0	0.3	0.3	0.5	0.3	0.3	0.3	0.4	0.3	0.3	1.2	2.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SCYL1	"GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP"	ENSG00000142186	"SCY1 like pseudokinase 1"	Q96KG9	11	65525077-65538704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015015	Uncertain		Supported	Cytosol				Cytosol		"HPA015015: AB_1856643"	"unprognostic (5.56e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (6.49e-3)"	"unprognostic (4.27e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.29e-3)"	24.1	35.5	24.1	20.2	24.4	22.8	49.4	24.6	47.3	25.0	21.6	19.0	27.8	22.5	26.9	30.0	24.1	26.7	21.4	35.8	25.1	21.1	24.1	61.4	22.4	22.9	21.7	23.9	34.1	40.7	27.0	24.3	30.7	19.6	24.7	14.3	24.9	34.0	30.3	51.2	23.6	19.8	23.0	17.1	24.7	24.4	31.4	20.6	18.0	27.3	20.2	20.2	24.9	24.1	10.7	15.5	27.9	13.7	11.1	14.7	12.1	19.8	17.1	13.8	19.1	25.3	22.1	18.9	24.7	33.6	29.5	23.1	24.6	12.0	14.3	25.1	32.0	18.2	14.5	18.5	10.3	16.8	18.6	16.8	18.8	28.2	36.0	11.0	24.3	30.6	18.4	25.3	18.9	19.3	17.5	20.3	18.3	43.2	14.7	25.4	13.3	23.9	15.0	10.7	26.2	18.1	17.8	12.8	13.6	15.2	33.7	26.8	33.4	14.0	19.0	23.5	15.8	38.0	14.5	28.1	19.5	14.9	27.2	9.2	16.4	1.9	13.7	17.6	14.7	13.2	11.8	10.0	13.8	14.6	15.5	10.7	11.2	10.5	27.9	11.1	8.5	11.3	9.5	12.1	24.1	24.4	24.6	47.3	25.1	21.1	21.7	23.9	19.6	20.6
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favourable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	17.0	17.9	19.6	16.5	30.2	7.3	21.5	17.6	26.7	19.9	17.9	9.6	14.0	14.0	26.2	23.2	19.5	18.9	10.6	16.4	18.2	15.4	21.9	23.9	14.6	22.8	16.4	19.1	22.7	26.9	20.4	30.6	17.5	22.6	18.5	18.6	9.4	18.3	20.8	32.3	19.6	16.1	24.9	16.2	23.5	18.1	24.1	19.9	21.5	25.8	17.1	22.9	21.3	17.5	13.2	10.3	5.6	16.8	15.4	17.8	10.5	14.4	5.9	14.5	19.3	17.2	15.6	15.2	20.6	17.9	17.3	15.0	18.0	20.8	22.8	15.5	18.9	15.0	22.0	19.9	21.7	20.0	11.6	19.5	12.9	14.9	16.3	32.9	22.2	13.5	22.6	18.2	20.1	15.0	34.7	18.8	17.6	16.0	33.4	11.6	23.5	9.0	20.3	27.2	19.1	16.5	16.2	21.9	18.2	14.1	28.8	23.3	13.2	19.4	14.2	18.6	18.8	22.2	17.1	17.3	18.0	31.1	20.9	14.9	22.9	5.6	9.9	2.7	14.2	12.7	17.7	12.1	17.4	16.1	10.3	13.2	17.8	14.9	1.6	15.4	16.8	9.0	14.7	10.5	19.6	30.2	17.6	26.7	18.2	15.4	16.4	19.1	22.6	19.9
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 60.9;hTCEpi: 56.3;U-251 MG: 58.0;U-266/70: 60.1;U-266/84: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Supported	"Focal adhesion sites"	"Secreted to blood"	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavourable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	30.8	17.3	5.5	13.8	1.5	0.2	17.3	8.6	8.3	8.1	6.8	3.6	18.8	0.0	3.2	6.1	30.4	2.4	60.9	5.4	0.1	1.6	0.0	1.6	18.5	1.3	1.3	0.1	0.8	56.3	7.2	17.3	0.8	0.7	12.1	4.3	18.4	0.0	0.3	4.9	33.5	0.6	2.0	23.3	10.3	46.3	1.6	12.8	6.5	43.9	1.9	4.3	0.3	1.3	32.1	10.3	1.1	58.0	60.1	126.7	0.1	9.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582860	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 99.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 166.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 166.5;monocytes: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"		1500000	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	106.2	32.0	28.5	37.6	45.2	51.5	67.4	20.9	29.0	42.7	28.4	18.8	22.2	19.7	38.4	28.2	37.8	28.0	47.9	36.9	32.1	25.8	41.4	41.7	73.1	49.7	33.4	16.9	35.5	20.1	36.4	16.4	68.5	47.6	35.5	33.6	53.0	41.5	20.7	22.5	24.7	34.3	37.9	39.0	70.1	31.0	25.4	22.2	34.3	44.4	23.4	21.4	50.0	44.2	5.9	21.7	166.5	44.8	3.4	9.8	29.7	14.4	22.4	23.9	12.4	89.4	77.1	10.5	14.9	53.2	21.6	28.5	8.9	30.3	0.0	24.0	19.9	6.0	12.9	17.1	26.8	2.6	11.0	21.7	19.9	7.1	99.4	5.5	35.4	52.6	23.2	21.7	65.3	51.8	10.7	12.7	49.0	3.8	12.2	6.5	14.9	6.4	5.9	7.3	2.8	34.4	15.2	10.4	18.9	15.9	6.8	73.0	6.2	15.2	44.5	20.9	9.0	24.6	9.5	3.8	5.1	8.7	53.2	0.0	18.7	52.9	44.8	43.7	5.7	30.0	7.1	5.9	7.6	6.0	21.7	5.4	9.8	7.4	166.5	3.4	26.4	6.0	8.5	29.7	28.5	45.2	20.9	29.0	32.1	25.8	33.4	16.9	47.6	22.2
SDCCAG8	"BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7"	ENSG00000054282	"Serologically defined colon cancer antigen 8"	Q86SQ7	1	243256034-243500092	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025737, HPA044477, HPA072495"	Approved		Enhanced	Centrosome				Centrosome		"HPA025737: , HPA044477: , HPA072495: "	"unprognostic (4.12e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.68e-3)"	"unprognostic (4.69e-2)"	13.5	12.6	17.2	10.0	17.7	7.9	13.0	12.3	17.6	11.4	10.5	22.5	10.4	7.5	13.3	17.7	11.6	17.9	17.6	12.8	16.8	13.5	15.2	7.9	14.8	10.4	17.4	12.0	19.9	17.3	18.0	32.4	11.4	14.2	15.5	8.3	10.7	16.8	13.1	15.1	10.2	9.3	11.3	18.9	15.0	11.0	8.0	20.9	17.4	32.7	7.2	10.4	11.8	10.7	9.8	9.9	9.3	10.7	12.5	8.6	5.2	5.4	4.6	0.7	3.4	5.1	2.9	5.6	3.4	2.9	0.6	1.3	4.5	9.8	2.1	5.7	2.9	1.9	0.6	4.1	1.4	3.5	5.5	1.8	3.4	1.9	3.3	1.7	4.6	6.0	3.9	3.0	6.5	4.2	2.6	3.2	2.5	1.5	0.7	4.3	0.6	7.8	2.8	0.8	1.8	6.1	3.5	4.8	4.8	4.1	2.1	7.8	3.6	2.8	4.2	5.9	1.3	1.8	1.9	4.4	2.2	1.0	2.8	3.8	25.9	9.3	10.7	9.0	6.0	10.5	3.8	7.5	6.4	7.8	9.9	9.8	8.6	6.5	6.9	12.5	5.7	7.9	5.0	5.2	17.2	17.7	12.3	17.6	16.8	13.5	17.4	12.0	14.2	20.9
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999331	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"				"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	25.6	11.2	10.7	13.3	12.8	33.6	21.6	10.8	11.5	12.3	10.6	17.9	9.0	11.0	15.1	11.5	14.3	12.8	13.4	12.2	10.8	11.0	11.9	17.9	16.2	13.9	14.1	9.8	16.2	14.2	15.6	13.9	14.5	12.5	12.9	11.6	11.1	12.0	11.2	20.9	18.0	12.9	12.7	13.5	14.4	11.5	14.1	14.4	33.9	15.8	11.0	14.1	15.6	16.9	8.2	7.8	17.9	7.2	12.5	11.2	6.3	8.4	6.2	10.1	10.7	7.0	7.9	12.5	9.1	8.6	12.5	9.6	8.9	9.8	12.5	14.2	7.6	11.0	12.6	7.9	15.2	9.5	10.2	13.7	5.3	8.2	12.9	13.5	16.7	8.6	11.5	13.2	16.8	8.5	25.0	15.2	9.2	2.5	18.7	10.7	14.0	6.6	15.8	13.0	16.1	7.5	6.0	9.0	15.0	10.3	11.3	17.1	11.2	16.6	8.3	10.6	7.5	13.7	19.8	9.1	6.5	15.4	11.0	8.4	21.0	16.3	6.0	5.5	8.2	6.2	11.2	8.2	8.3	7.9	6.7	7.1	8.6	8.0	17.9	12.5	7.2	7.8	6.4	6.3	10.7	12.8	10.8	11.5	10.8	11.0	14.1	9.8	12.5	14.4
SDF4	Cab45	ENSG00000078808	"Stromal cell derived factor 4"	Q9BRK5	1	1216908-1232031	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011249, HPA011895, CAB015227"	Supported	Supported	Supported	"Golgi apparatus"	"Intracellular and membrane"		720000	"Golgi apparatus"		"CAB015227: , HPA011249: , HPA011895: "	"unprognostic (1.98e-1)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.04e-2)"	34.7	36.0	17.9	37.3	22.7	19.7	56.3	20.6	33.2	30.3	49.9	21.3	46.6	48.5	35.5	53.4	26.2	26.9	57.5	50.8	18.7	18.5	36.3	73.8	55.8	46.2	19.7	21.3	33.1	56.4	25.9	31.1	47.9	18.2	30.3	25.6	26.5	46.7	52.1	30.7	25.5	56.2	27.6	18.0	33.8	32.9	30.0	18.1	20.5	35.1	28.5	19.6	28.5	44.8	11.5	16.0	20.6	15.9	19.6	22.0	7.0	28.3	25.8	14.3	45.2	69.9	35.3	17.1	55.7	51.1	41.0	34.4	30.4	49.6	18.0	43.2	53.6	29.2	16.3	24.4	12.6	30.1	27.6	31.5	39.8	42.4	32.2	31.7	42.7	43.4	12.6	30.8	17.5	32.7	25.9	47.8	20.1	20.5	15.6	32.0	13.0	34.7	17.5	18.5	47.6	27.2	13.8	51.9	18.4	37.0	44.1	36.6	22.9	36.4	41.5	42.4	23.0	31.8	31.6	29.5	27.8	29.5	48.1	59.8	18.3	10.4	14.9	20.6	15.0	9.9	11.6	9.4	21.5	22.0	16.0	11.5	12.4	10.7	12.7	19.6	15.9	10.0	16.5	7.0	17.9	22.7	20.6	33.2	18.7	18.5	19.7	21.3	18.2	18.1
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria			780000	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavourable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.4	29.9	12.3	20.1	21.2	15.9	33.4	14.2	18.1	24.5	25.0	32.4	25.1	22.8	45.0	16.2	23.9	21.7	29.0	14.5	48.6	19.9	11.6	82.6	42.0	13.1	14.4	15.1	15.8	18.7	18.3	9.7	26.5	18.6	19.0	11.5	28.2	19.1	39.0	4.2	37.9	24.7	17.9	44.2	52.2	24.5	13.6	7.8	67.0	43.3	17.6	26.3	18.3	19.2	18.2	17.9	10.8	11.7	20.2	8.6	16.8	17.6	20.9	11.5	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054170	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"			Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: , CAB068234: , CAB068235: , HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favourable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	17.8	25.6	19.8	16.6	21.7	17.0	26.4	18.0	29.1	13.9	30.8	12.3	15.1	34.0	14.2	15.7	19.8	13.6	15.1	86.9	18.2	16.4	51.0	75.1	16.8	24.6	20.1	18.9	10.5	30.7	20.0	11.3	15.6	16.7	13.0	31.5	11.7	15.9	19.5	96.2	13.2	31.4	21.3	16.5	17.2	21.7	18.7	15.7	14.2	15.5	52.2	18.0	15.4	17.1	22.2	45.9	48.5	48.7	18.9	26.7	25.0	25.5	25.4	14.5	18.5	28.2	28.1	16.5	22.4	28.8	51.4	46.5	35.7	30.8	35.1	28.0	30.2	30.2	57.7	44.7	58.0	20.6	47.3	31.6	26.4	27.4	34.6	49.4	23.6	28.8	29.5	44.4	75.3	36.3	26.4	40.7	35.7	21.1	32.8	28.2	12.0	51.1	23.6	27.9	43.5	47.3	14.5	27.3	15.0	30.4	38.1	63.9	22.3	27.9	18.0	19.8	22.3	36.3	29.5	17.0	20.9	35.9	30.3	75.3	21.8	16.6	38.4	37.4	18.3	48.7	18.3	22.2	21.2	19.5	45.9	18.3	19.3	19.5	48.5	18.9	42.2	21.5	26.7	25.0	19.8	21.7	18.0	29.1	18.2	16.4	20.1	18.9	16.7	15.7
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321178	"Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles			15000	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: "	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	25.2	30.7	19.0	24.2	24.7	20.6	25.5	16.2	24.9	37.9	47.0	22.6	38.1	47.7	29.6	30.8	30.1	24.7	41.6	30.6	19.5	20.7	33.2	58.3	27.0	19.9	24.7	17.5	24.7	66.8	22.3	48.1	44.1	20.2	23.2	27.9	22.3	63.5	33.4	42.6	25.5	57.1	32.0	21.9	25.9	27.2	26.4	20.5	29.0	38.2	32.8	28.6	25.8	24.2	26.9	60.8	29.1	44.6	23.2	27.7	41.2	20.8	31.7	25.5	9.8	41.5	46.1	84.7	42.7	52.2	49.9	57.7	26.1	17.1	19.1	19.6	67.6	8.5	32.7	38.0	25.6	16.6	34.0	23.3	25.7	63.1	56.9	26.5	20.6	40.8	30.7	52.2	32.6	59.2	24.9	28.3	38.5	43.0	25.9	29.2	28.9	38.4	25.2	18.3	33.9	30.4	15.7	14.3	17.8	18.7	17.4	16.6	22.5	25.9	44.2	20.6	23.5	30.6	36.6	23.5	32.7	44.2	38.9	37.3	33.9	28.0	44.6	28.1	24.5	38.4	27.2	26.9	24.6	23.7	60.8	22.2	20.3	21.2	29.1	23.2	29.5	54.2	27.7	41.2	19.0	24.7	16.2	24.9	19.5	20.7	24.7	17.5	20.2	20.5
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77086716-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 90.8;TIME: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 71.8"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021463: , HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	40.8	34.0	25.4	25.3	39.1	33.4	40.6	42.3	33.2	27.7	11.1	21.9	12.2	13.3	15.8	18.9	18.8	15.9	21.2	18.2	27.0	19.5	25.1	15.8	38.4	25.8	31.6	20.6	12.6	18.3	17.3	18.6	49.3	22.5	10.8	10.5	24.2	21.4	12.9	51.0	11.9	12.2	16.2	25.8	33.9	18.4	35.4	24.4	10.0	24.0	14.4	26.0	15.7	14.7	2.4	2.3	71.8	6.2	1.5	2.0	1.9	11.7	8.6	15.2	23.3	6.4	7.9	5.4	10.7	9.2	12.6	10.9	11.4	7.7	31.4	21.5	14.7	4.5	6.7	10.4	16.4	5.8	6.1	16.4	6.6	14.8	10.8	3.3	7.7	11.1	4.2	10.5	11.0	90.8	10.0	26.5	17.7	5.9	5.7	4.4	5.5	7.8	4.4	24.4	23.3	21.4	4.7	11.7	9.1	11.8	6.2	6.6	5.2	3.6	56.7	14.3	13.5	7.8	7.6	15.2	11.9	16.5	6.2	3.4	4.2	4.2	3.2	9.2	0.7	5.5	0.6	2.4	0.7	0.5	2.3	1.2	0.8	0.5	71.8	1.5	6.2	0.8	2.0	1.9	25.4	39.1	42.3	33.2	27.0	19.5	31.6	20.6	22.5	24.4
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396857-30425317	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 43.0;liver: 112.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.3;hTCEpi: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.1"									HPA064466	Approved		Supported	Nucleoplasm,Cytosol			190000	Nucleoplasm	Cytosol	"HPA064466: "	"prognostic favourable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	1.9	1.2	13.6	1.9	14.2	2.4	22.7	7.3	15.0	2.2	5.7	12.6	7.3	10.1	2.4	43.0	8.0	2.3	4.3	1.1	10.8	10.4	3.6	112.3	1.8	2.1	16.1	10.4	1.3	1.9	3.7	5.0	1.5	10.6	25.7	1.4	24.2	4.0	7.8	1.0	2.9	13.5	2.4	8.9	1.0	3.4	1.2	10.4	1.1	4.3	0.6	2.7	1.8	2.9	0.8	0.9	0.5	0.2	0.1	7.1	1.5	9.9	2.4	2.0	2.7	3.0	7.5	0.1	8.1	6.5	4.8	5.0	0.6	6.7	0.2	2.4	9.8	7.7	1.2	38.3	5.3	0.9	1.9	0.2	2.4	3.6	4.1	0.0	2.6	5.2	20.9	4.4	7.9	12.0	0.0	0.2	9.6	1.7	1.0	0.2	0.0	3.4	0.4	3.5	0.2	8.5	3.3	1.2	1.4	5.0	1.1	4.5	6.5	0.1	18.2	6.7	4.3	2.7	4.9	0.1	0.0	0.3	14.7	0.0	5.3	0.1	0.2	0.4	0.9	0.2	0.4	0.8	2.6	0.6	0.1	0.6	7.1	4.7	0.5	0.1	0.1	0.9	1.1	1.5	13.6	14.2	7.3	13.4	10.8	10.4	16.1	10.4	10.6	10.4
SEC16A	"KIAA0310, p250, Sec16L"	ENSG00000148396	"SEC16 homolog A, endoplasmic reticulum export factor"	O15027	9	136440096-136483759	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005684	Supported		Supported	"Endoplasmic reticulum,Golgi apparatus"				"Golgi apparatus"	"Endoplasmic reticulum"	"HPA005684: AB_1079189"	"unprognostic (1.24e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.30e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-1)"	"prognostic favourable (4.47e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.41e-1)"	9.7	11.2	13.4	10.6	16.4	21.5	10.1	36.8	21.0	11.4	9.4	9.2	10.7	10.0	11.7	8.9	10.9	10.4	9.0	8.7	13.3	5.4	10.0	23.8	11.6	10.5	12.3	11.5	10.7	20.2	11.9	26.3	7.6	13.2	13.2	7.2	10.4	16.3	9.7	14.3	13.4	11.3	7.3	6.7	13.4	19.1	46.7	12.9	19.6	15.8	5.7	8.1	10.0	8.4	5.9	6.1	4.7	7.2	3.3	7.1	4.5	10.9	24.3	12.3	20.2	13.1	13.5	14.5	13.6	11.9	10.2	7.8	17.5	9.4	11.0	9.6	16.5	30.2	13.6	19.5	5.5	23.2	8.8	11.2	22.7	13.9	12.7	19.0	19.9	14.5	14.1	14.1	16.7	13.8	13.9	15.3	10.7	47.3	12.7	10.2	10.8	17.3	18.3	15.2	18.6	10.4	14.7	17.4	11.5	17.6	26.7	8.3	27.3	15.0	19.8	16.4	12.4	13.2	10.4	7.3	11.1	14.2	12.8	8.6	16.3	3.9	5.9	2.8	6.3	7.1	6.5	5.9	6.4	7.1	3.6	3.8	4.2	6.7	4.7	3.3	7.2	6.1	4.5	4.5	13.4	16.4	36.8	21.0	13.3	5.4	12.3	11.5	13.2	12.9
SEC23B	"CDA-II, CDAII, CDAN2, HEMPAS"	ENSG00000101310	"Sec23 homolog B, coat complex II component"	Q15437	20	18507482-18561415	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008216, HPA069974"	Uncertain		Supported	Vesicles				Vesicles		"HPA008216: AB_1079895, HPA069974: "	"unprognostic (4.47e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.52e-1)"	"prognostic favourable (8.25e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.21e-2)"	11.8	32.9	16.5	16.5	19.0	17.2	21.3	13.5	20.0	21.8	16.9	28.8	40.9	12.8	11.2	29.2	24.0	17.4	14.3	8.2	16.2	14.8	27.1	32.8	17.4	15.3	22.3	12.3	13.2	43.1	32.8	31.8	13.1	18.0	19.4	18.9	15.6	69.5	46.3	4.4	14.9	14.9	10.8	22.0	19.7	20.5	23.4	18.3	19.2	34.3	12.7	20.8	12.8	12.5	27.5	44.1	50.8	38.4	32.9	34.1	36.6	24.7	27.9	15.8	14.6	10.7	12.0	35.5	21.0	14.4	26.4	22.7	24.2	22.9	11.5	13.9	16.1	26.7	27.7	38.5	28.5	13.8	12.6	18.7	11.1	36.2	21.8	26.0	23.8	9.0	22.9	38.2	49.0	16.2	21.6	25.4	17.9	25.6	17.8	13.8	14.6	30.1	18.5	24.1	35.9	24.4	25.1	25.1	17.9	24.6	56.6	23.0	24.8	27.6	13.3	16.5	9.0	18.5	25.7	32.1	44.2	17.6	14.1	14.0	23.0	50.8	38.4	42.1	24.7	38.4	34.1	27.5	25.3	26.4	44.1	22.2	23.0	24.1	19.6	32.9	35.9	33.4	29.1	36.6	16.5	19.0	13.5	20.0	16.2	14.8	22.3	12.3	18.0	18.3
SEC23IP	p125	ENSG00000107651	"SEC23 interacting protein"	Q9Y6Y8	10	119892711-119944658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038403, HPA043305"	Approved		Enhanced	Vesicles				Vesicles		"HPA038403: AB_10675796, HPA043305: AB_2678416"	"unprognostic (4.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.81e-3)"	"unprognostic (3.43e-2)"	21.6	22.4	11.7	26.3	15.9	21.3	22.0	18.2	16.1	21.3	19.4	19.2	22.8	15.5	25.7	25.7	21.1	20.4	22.0	18.2	18.7	11.4	19.0	32.9	20.0	25.5	10.4	13.0	23.2	21.6	19.3	23.2	21.2	16.8	21.0	21.9	19.1	23.3	27.0	24.3	20.9	20.4	26.0	12.4	20.2	27.5	30.9	11.1	23.3	22.2	15.2	25.4	21.6	18.7	14.3	14.3	15.1	20.6	14.6	17.6	11.1	19.3	23.7	16.2	23.2	16.0	21.0	13.9	19.4	32.2	20.4	24.2	22.8	18.8	21.6	9.0	27.8	16.7	23.6	22.0	30.3	16.9	20.9	17.7	12.5	18.1	21.9	19.9	21.6	24.1	12.0	26.2	24.5	26.2	14.5	16.2	19.8	12.3	18.6	14.0	19.2	17.1	16.7	32.4	11.9	15.1	19.2	7.5	17.4	18.1	12.8	15.4	14.1	12.7	23.2	12.6	12.2	18.6	22.4	21.3	19.1	25.9	20.5	23.9	10.9	15.1	12.3	12.2	14.0	19.3	17.6	14.3	13.9	15.7	14.3	12.1	14.8	13.9	5.0	14.6	20.6	9.0	14.4	11.1	11.7	15.9	18.2	16.1	18.7	11.4	10.4	13.0	16.8	11.1
SEC24C	KIAA0079	ENSG00000176986	"SEC24 homolog C, COPII coat complex component"	P53992	10	73744384-73772161	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040196, HPA040213"	Supported		Supported	Vesicles				Vesicles		"HPA040196: AB_10796449, HPA040213: AB_10796451"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.46e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.34e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.77e-2)"	20.6	34.2	17.8	24.8	24.7	10.8	21.2	30.2	33.5	28.7	23.4	29.4	22.6	22.3	29.1	30.7	49.6	25.5	25.8	23.5	18.3	16.2	25.1	44.9	23.1	23.3	25.8	18.9	28.3	27.6	46.6	35.3	39.1	21.7	29.2	23.6	27.1	35.9	39.7	33.6	25.2	25.1	27.2	18.2	28.9	25.7	29.8	23.6	30.1	31.2	28.4	38.3	24.4	28.3	9.3	12.5	15.4	15.0	14.9	26.3	13.4	20.7	21.0	16.6	29.7	18.1	14.9	13.7	15.7	26.8	21.2	20.0	19.4	14.2	16.5	13.1	21.0	18.1	23.2	20.8	18.4	21.9	16.5	15.3	15.3	20.5	14.4	23.0	21.5	12.7	23.1	18.6	23.2	21.8	18.1	24.1	20.7	18.5	17.1	15.8	10.4	77.1	18.7	13.4	13.5	14.0	11.9	6.0	15.5	12.3	43.2	17.2	31.7	20.4	21.2	9.0	16.3	17.3	18.1	24.6	23.8	24.6	25.5	23.5	10.3	15.4	10.5	9.0	20.4	15.0	26.3	9.3	12.2	15.8	12.5	7.3	9.0	11.8	8.0	14.9	12.4	10.4	7.5	13.4	17.8	24.7	30.2	33.5	18.3	16.2	25.8	18.9	21.7	23.6
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818661-82901166	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol			22000	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (2.69e-4)"	41.3	40.6	22.5	28.0	29.2	30.6	34.5	27.4	30.6	46.4	36.0	26.4	39.2	35.7	53.6	50.2	37.7	34.8	36.1	42.8	23.7	23.8	47.3	57.8	33.9	26.6	25.3	25.3	67.1	79.1	42.7	62.7	54.1	36.0	37.2	38.1	32.6	47.8	46.0	38.7	34.1	51.4	46.2	24.5	28.4	35.9	23.3	23.3	35.7	50.0	31.0	39.5	47.1	37.6	29.4	34.6	34.8	36.0	40.5	40.0	30.5	24.8	11.3	32.7	23.1	58.3	72.7	23.8	46.4	52.0	26.1	32.4	19.5	32.0	32.3	20.4	92.5	11.9	32.2	30.7	36.2	32.9	12.8	19.7	19.4	51.1	58.0	21.0	25.1	69.5	39.0	39.9	45.9	42.3	29.9	32.1	46.4	21.8	27.7	17.0	22.4	10.3	20.7	17.7	23.9	42.1	14.4	21.1	23.5	18.4	32.1	29.9	25.0	23.8	43.2	34.4	17.9	30.1	29.0	24.1	10.3	44.4	34.4	25.4	39.5	34.8	31.1	23.3	32.6	34.8	40.0	29.4	29.2	31.8	34.6	24.4	29.3	28.0	9.5	40.5	36.0	28.9	24.0	30.5	22.5	29.2	27.4	30.6	23.7	23.8	25.3	25.3	36.0	23.3
SEC31B	"DKFZP434M183, SEC31B-1, SEC31L2"	ENSG00000075826	"SEC31 homolog B, COPII coat complex component"	Q9NQW1	10	100486642-100519864	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035882, HPA040819, HPA060052"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles, Cytosol"		"HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: "	"unprognostic (1.23e-1)"	"unprognostic (3.13e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.10e-4)"	"unprognostic (8.23e-3)"	"prognostic unfavourable (6.41e-7)"	"unprognostic (2.31e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-4)"	2.8	2.4	3.3	3.2	5.0	6.4	2.6	12.1	11.8	2.7	2.8	5.4	4.3	1.9	3.0	3.5	1.4	2.9	2.6	5.6	3.1	3.6	2.7	3.4	2.4	4.3	3.3	5.6	3.9	0.8	3.9	5.0	2.4	6.3	2.9	2.7	6.1	2.8	2.5	13.6	2.4	2.9	3.2	3.4	4.9	1.9	16.2	3.4	0.0	2.6	5.2	3.6	2.3	1.9	0.9	0.0	0.1	0.2	0.0	2.1	0.1	0.4	0.4	4.5	1.5	1.4	2.5	0.4	0.9	2.0	0.4	1.4	0.4	0.7	1.0	1.3	0.0	0.5	2.4	0.6	1.2	5.5	1.3	2.2	2.9	0.5	1.9	1.6	1.9	3.8	2.3	0.3	2.7	0.8	0.6	2.7	0.1	0.0	2.8	4.9	0.0	0.9	4.3	0.1	1.8	1.4	0.0	0.3	1.5	0.5	0.1	0.9	1.2	0.6	0.0	0.6	0.7	0.4	0.3	2.1	1.0	1.2	0.1	5.3	0.7	0.0	0.1	0.0	0.5	0.2	2.1	0.0	0.0	0.4	0.0	0.9	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	3.3	5.0	12.1	11.8	3.1	3.6	3.3	5.6	6.3	3.4
SEC61A1		ENSG00000058262	"Sec61 translocon alpha 1 subunit"	P61619	3	128051641-128071683	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favourable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	28.6	38.2	15.2	23.2	16.2	18.5	38.4	12.8	16.2	45.0	24.2	15.9	77.9	22.1	32.6	52.8	31.1	28.3	34.4	27.6	14.3	13.5	37.6	132.2	33.2	44.9	17.4	10.3	28.5	178.4	31.5	36.5	51.6	15.2	26.2	26.0	19.0	87.1	81.7	22.7	22.7	32.5	31.3	15.4	28.8	33.8	21.2	15.4	22.9	35.5	28.8	36.6	24.2	26.4	13.8	35.6	40.0	25.1	18.7	39.3	29.0	39.5	20.8	20.9	37.2	59.4	51.3	38.5	63.9	74.1	55.7	60.1	39.5	28.8	26.4	38.6	82.4	35.2	32.7	45.1	54.0	23.8	17.9	30.1	23.2	41.5	87.6	38.1	34.3	56.3	54.6	52.5	67.8	48.9	19.7	64.7	64.5	36.1	19.6	12.6	28.2	29.2	20.7	18.8	51.8	29.0	34.7	23.8	23.4	31.5	30.1	40.2	28.0	32.6	48.0	43.9	24.9	51.0	29.8	59.3	28.2	38.0	71.9	24.8	56.7	40.0	25.1	19.1	28.3	23.0	39.3	13.8	20.5	24.8	24.7	8.5	13.0	15.0	6.6	18.7	22.4	35.6	13.1	29.0	15.2	16.2	12.8	16.2	14.3	13.5	17.4	10.3	15.2	15.4
SEC61B		ENSG00000106803	"Sec61 translocon beta subunit"	P60468	9	99222064-99230615	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049407	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA049407: "	"unprognostic (1.11e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.46e-1)"	"prognostic favourable (1.26e-5)"	"unprognostic (1.96e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"	26.2	39.8	20.3	27.1	20.7	41.1	37.2	12.6	20.2	36.5	26.2	15.8	47.9	28.5	32.1	52.7	29.3	26.8	26.4	19.8	19.3	17.7	42.0	153.0	31.9	49.3	19.9	14.8	31.6	175.5	13.6	38.5	36.3	17.7	28.9	19.8	21.3	116.6	50.8	16.9	20.5	31.2	21.0	20.1	41.4	29.7	19.9	16.8	43.8	49.3	29.2	35.9	24.5	24.0	36.9	173.3	71.5	48.5	31.0	52.5	47.1	37.9	37.3	43.0	42.7	42.7	54.7	52.1	56.6	59.5	53.7	46.9	53.2	30.0	52.1	43.4	51.7	47.0	30.1	45.2	25.9	54.8	41.9	27.2	36.3	75.0	93.0	46.6	35.1	48.8	69.9	42.2	37.8	65.4	42.6	102.0	50.5	69.8	42.3	68.4	34.4	87.6	41.2	36.6	67.2	58.0	27.4	44.9	31.8	31.7	73.9	72.5	28.6	64.6	45.7	38.5	45.9	64.1	47.0	55.0	37.0	33.3	64.1	30.2	25.3	71.5	48.5	44.5	39.1	38.4	52.5	36.9	43.3	39.3	49.4	25.0	27.5	30.1	40.6	31.0	33.2	173.3	38.3	47.1	20.3	20.7	12.6	20.2	19.3	17.7	19.9	14.8	17.7	16.8
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA053295: , HPA060535: "	"prognostic unfavourable (3.32e-4)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	19.9	26.0	22.2	14.4	20.0	20.2	17.4	17.3	19.2	22.8	17.6	13.9	21.9	11.5	22.4	21.5	16.3	18.6	15.4	19.5	18.4	14.5	14.2	35.2	17.6	10.6	19.2	17.9	30.5	45.8	24.9	32.3	27.9	16.8	20.0	13.3	14.0	46.6	27.2	15.3	14.6	12.6	20.2	20.0	13.7	18.5	21.6	21.5	16.7	36.2	9.3	11.7	24.2	21.4	6.1	9.6	6.3	12.0	9.2	11.1	4.9	11.2	6.8	18.9	23.5	19.8	23.5	17.0	23.9	26.5	11.5	16.3	12.2	14.0	20.9	20.5	21.5	16.5	13.1	15.4	17.7	25.1	14.5	22.6	10.8	12.5	31.0	25.7	13.4	18.3	25.5	18.3	40.6	15.9	18.8	33.8	23.4	8.9	8.0	11.6	14.9	7.4	25.7	22.4	17.0	13.9	14.8	16.7	18.9	13.2	20.0	23.9	14.2	38.1	17.1	17.3	10.8	17.3	18.5	12.9	9.5	20.8	19.1	22.6	19.8	6.3	7.3	6.3	7.0	6.3	11.1	6.1	5.9	5.7	7.4	6.1	6.6	5.1	2.5	9.2	12.0	9.6	3.1	4.9	22.2	20.0	17.3	19.2	18.4	14.5	19.2	17.9	16.8	21.5
SECISBP2	SBP2	ENSG00000187742	"SECIS binding protein 2"	Q96T21	9	89318506-89359662	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044314, HPA054905"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA044314: AB_10964885, HPA054905: "	"unprognostic (1.07e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (8.98e-9)"	"unprognostic (5.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.55e-3)"	17.3	24.8	19.5	23.1	26.6	26.4	30.0	28.3	28.9	22.1	22.5	21.7	19.8	20.5	28.1	26.0	16.7	23.3	17.7	13.4	22.5	15.9	26.8	25.4	30.0	25.6	20.6	16.2	36.7	34.3	26.9	33.9	29.9	21.0	21.0	24.9	21.3	26.8	21.3	32.6	25.8	23.6	21.3	24.7	29.7	23.2	58.2	22.8	26.6	31.5	11.8	23.4	19.9	26.3	14.1	11.7	21.5	9.5	9.1	16.1	5.9	14.1	9.7	26.6	15.3	12.6	13.6	19.3	8.2	10.3	9.9	9.8	5.4	12.0	21.3	7.3	7.7	18.0	17.9	8.3	9.2	14.0	10.6	10.4	7.6	13.7	10.9	20.8	15.7	8.5	15.8	8.3	10.0	12.3	13.3	25.3	9.4	13.2	28.5	10.7	27.6	9.6	13.8	13.0	13.9	11.1	11.0	19.5	19.1	7.4	16.7	21.6	14.7	18.1	11.3	9.6	11.2	12.9	12.6	30.8	19.6	8.8	16.8	13.6	13.8	12.2	7.6	12.7	10.4	7.9	10.1	12.9	10.7	10.2	6.7	14.1	16.1	13.5	21.5	9.1	9.5	11.7	12.5	5.9	19.5	26.6	28.3	28.9	22.5	15.9	20.6	16.2	21.0	22.8
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747427-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 48.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 68.0;U-698: 44.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 45.9"	"Group enriched"	"Detected in many"	5	"memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9"	"Group enriched"	"Detected in many"	4	"B-cells: 20.8;dendritic cells: 17.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 191.0"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA040045: AB_10796116, HPA058792: "	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (4.33e-4)"	5.4	3.3	4.0	36.3	5.6	2.3	3.8	45.9	6.4	13.7	19.3	1.5	1.5	19.3	2.2	18.1	6.2	3.6	22.0	2.4	3.3	2.8	6.9	3.6	14.3	27.7	2.1	1.7	3.1	48.0	10.9	2.9	13.7	3.0	4.2	16.7	12.9	23.1	1.0	1.3	1.7	30.3	3.4	2.1	33.5	24.6	2.2	1.1	2.8	12.5	3.8	46.7	14.8	2.2	20.8	17.9	0.4	0.1	3.7	4.3	1.4	5.0	5.5	4.1	1.3	0.6	0.8	0.6	2.5	6.8	1.9	6.2	3.4	23.4	68.0	12.0	17.1	3.2	3.0	10.8	2.6	3.6	1.7	0.7	9.0	4.6	17.6	9.3	0.4	1.4	8.7	6.8	2.6	25.5	4.4	0.0	1.3	3.8	0.0	0.6	11.7	4.9	0.3	22.3	9.4	15.0	16.9	10.1	1.9	16.6	0.2	1.7	0.8	11.5	11.1	0.1	8.1	0.1	7.1	0.4	0.1	44.4	30.9	3.9	4.6	0.4	0.1	0.0	2.8	0.0	3.4	20.8	3.5	3.1	0.7	20.8	1.5	2.4	0.3	3.7	0.1	17.9	4.3	1.4	4.0	5.6	45.9	6.4	3.3	2.8	2.1	1.7	3.0	1.1
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364302-151372733	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 112.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.1;HEL: 28.3;HSkMC: 19.6;SK-BR-3: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 4.8"					"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli			57000000	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	27.9	5.1	17.2	28.9	16.4	17.6	18.4	6.5	11.9	15.1	105.1	10.4	15.8	17.2	13.5	23.1	11.0	32.4	28.8	11.7	18.5	5.1	20.8	56.3	64.9	5.6	10.9	14.9	13.2	7.2	1.4	4.1	5.6	11.3	19.1	112.3	27.9	14.5	15.4	15.9	6.4	29.1	22.9	6.5	13.0	29.1	4.1	13.0	0.0	52.9	18.3	6.0	15.8	8.1	0.0	4.8	0.0	1.1	0.0	0.0	5.5	0.0	4.2	7.9	0.4	38.1	15.2	2.0	1.5	0.7	0.8	1.6	4.3	1.3	0.0	7.3	2.6	0.0	0.0	0.1	0.6	0.0	3.6	28.3	14.2	6.8	8.0	0.0	0.0	19.6	0.2	1.3	0.0	4.8	2.8	0.0	2.0	3.1	0.0	0.0	6.3	8.0	0.0	0.4	0.1	1.7	0.0	0.1	0.1	0.0	68.0	0.0	11.7	0.4	0.4	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	17.2	16.4	6.5	11.9	18.5	5.1	10.9	14.9	11.3	13.0
SELENON	"MDRS1, RSMD1, RSS, SELN, SEPN1"	ENSG00000162430	"Selenoprotein N"	Q9NZV5	1	25800176-25818224	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Desmin-related myopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058076	Approved		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA058076: "	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-1)"	"prognostic favourable (2.23e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (3.40e-5)"	"unprognostic (1.94e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.56e-3)"	"unprognostic (5.89e-2)"	41.4	27.2	26.3	26.4	24.8	12.4	53.6	22.0	29.7	32.2	21.9	26.5	26.3	14.3	30.7	20.4	25.4	34.3	27.4	29.3	26.3	16.3	33.0	15.1	35.2	47.8	19.2	18.2	35.3	39.9	23.0	23.7	31.6	22.0	37.5	17.8	30.0	29.1	35.0	30.0	18.0	16.5	45.8	21.0	29.1	24.4	11.6	19.1	10.7	31.4	17.6	16.8	26.1	28.0	1.7	2.1	5.9	3.3	0.7	2.6	1.0	11.9	11.5	38.4	32.8	25.0	44.0	13.0	14.5	22.0	16.2	13.0	2.9	12.7	0.0	9.7	21.9	11.7	10.0	15.4	12.4	12.7	7.7	11.7	4.4	3.6	18.1	2.4	27.9	46.8	10.4	16.9	8.5	50.5	4.1	1.7	15.2	6.1	0.5	3.5	14.4	7.9	10.3	16.7	1.4	6.6	3.4	8.0	13.6	9.2	8.4	12.2	8.4	8.3	42.0	16.5	11.3	30.1	8.5	1.4	0.0	0.3	22.8	3.7	19.8	5.9	3.3	3.8	1.8	2.6	1.1	1.7	1.7	1.3	2.1	1.1	2.6	1.6	0.5	0.7	2.5	0.3	1.7	1.0	26.3	24.8	22.0	29.7	26.3	16.3	19.2	18.2	22.0	19.1
SELENOS	"AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP"	ENSG00000131871	"Selenoprotein S"	Q9BQE4	15	101270817-101277500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"plasmacytoid DC: 96.1"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 96.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010025	Approved		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA010025: AB_1079900"	"unprognostic (1.90e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.83e-2)"	"prognostic favourable (5.19e-4)"	"unprognostic (2.42e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.66e-2)"	25.1	34.7	16.3	19.6	17.1	18.0	38.3	11.4	15.6	22.8	33.7	20.7	51.6	33.2	21.6	33.7	24.8	20.5	21.9	35.0	15.6	14.6	30.9	58.2	27.0	24.5	24.6	13.4	19.3	80.9	14.6	27.5	38.2	21.2	23.5	37.8	16.5	58.0	42.1	28.3	20.6	41.5	21.8	26.8	27.5	26.8	44.4	18.7	9.7	34.0	22.5	26.4	21.0	30.9	10.0	96.1	17.5	14.8	14.3	17.2	9.6	9.3	14.9	13.4	11.9	29.5	20.9	11.2	28.6	21.9	20.0	20.2	17.7	22.8	7.1	10.6	25.3	26.7	14.5	12.9	13.1	12.9	19.4	12.0	13.4	18.3	46.8	9.0	13.9	18.2	36.9	13.3	39.8	14.9	12.0	81.0	21.3	15.1	6.5	14.0	10.2	9.7	8.4	11.0	15.5	20.1	22.5	7.6	19.1	19.9	18.8	39.8	14.0	20.5	15.7	18.9	12.4	25.3	21.7	58.8	49.1	10.3	20.6	10.8	22.7	17.5	10.8	12.3	16.0	12.9	15.4	10.0	12.4	17.2	9.3	7.0	9.4	14.0	3.7	14.3	14.8	96.1	10.9	9.6	16.3	17.1	11.4	15.6	15.6	14.6	24.6	13.4	21.2	18.7
SEMA4D	"C9orf164, CD100, coll-4, FLJ39737, SEMAJ"	ENSG00000187764	"Semaphorin 4D"	Q92854	9	89360787-89498130	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.1;skeletal muscle: 43.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.9;HMC-1: 33.1;MOLT-4: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015662, HPA023277"	Approved		Supported	"Endoplasmic reticulum,Vesicles"			4100000	Vesicles	"Endoplasmic reticulum"	"HPA015662: AB_1856671, HPA023277: AB_1856672"	"unprognostic (2.94e-2)"	"prognostic favourable (4.17e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (4.06e-5)"	3.9	5.6	18.0	18.6	20.7	14.3	3.6	7.7	20.9	4.0	5.9	54.0	3.1	6.1	3.9	7.4	9.3	6.6	7.2	4.9	28.2	18.8	8.4	2.0	6.7	32.0	42.6	15.0	4.1	4.6	4.9	5.3	3.2	27.5	4.9	5.8	2.9	6.7	4.2	43.3	8.8	9.6	3.3	107.1	19.2	9.4	6.1	23.3	25.3	4.9	3.1	27.6	8.3	5.3	2.6	4.6	21.2	4.1	4.7	14.0	7.8	4.0	3.0	2.8	4.1	0.1	0.2	6.5	0.4	0.2	0.8	0.6	2.0	4.6	15.5	1.7	0.0	2.1	2.5	1.2	0.3	42.9	2.5	6.5	1.0	0.2	0.5	8.6	33.1	0.1	0.9	0.2	0.1	1.6	1.5	10.6	0.0	6.7	38.9	10.8	6.9	0.1	12.4	0.9	4.3	5.5	4.2	6.7	4.4	1.1	3.6	0.1	3.4	4.7	1.0	0.0	2.6	0.3	2.0	11.9	5.1	2.2	2.0	10.5	2.5	7.3	4.1	20.4	13.3	3.8	8.0	2.6	10.6	11.1	1.5	1.6	12.2	14.0	21.2	4.7	4.1	4.6	9.5	7.8	18.0	20.7	7.7	20.9	28.2	18.8	42.6	15.0	27.5	23.3
SEMA5B	"FLJ10372, KIAA1445, SEMAG, SemG"	ENSG00000082684	"Semaphorin 5B"	Q9P283	3	122909193-123028605	"Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;heart muscle: 11.7"	"Cell line enhanced"	"Detected in some"		"AF22: 41.4;NTERA-2: 8.0;SH-SY5Y: 11.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066548	Enhanced		Supported	Cytosol				Cytosol		"HPA066548: "	"unprognostic (7.34e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.92e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (1.31e-3)"	"unprognostic (5.96e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-1)"	1.5	1.2	12.0	0.7	12.3	0.3	1.1	0.8	13.6	2.1	1.5	4.3	0.4	1.9	2.8	5.5	1.5	3.0	4.7	11.7	13.0	3.3	6.1	1.4	2.2	1.1	2.5	3.3	1.3	3.1	1.1	2.5	5.0	2.0	1.8	1.8	6.0	0.9	3.1	1.6	1.2	1.3	3.8	1.7	0.5	0.7	1.1	5.7	0.1	2.2	2.5	1.3	3.3	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	41.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	11.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.0	12.3	0.8	13.2	13.0	3.3	2.5	3.3	2.0	5.7
SENP1		ENSG00000079387	"SUMO1/sentrin specific peptidase 1"	Q9P0U3	12	48042898-48106308	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011765, HPA046491"			Supported	"Nucleoplasm,Focal adhesion sites"				Nucleoplasm	"Focal adhesion sites"	"HPA011765: AB_1079907, HPA046491: "	"unprognostic (2.66e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (7.72e-5)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.20e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (8.37e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-1)"	5.7	3.3	3.0	9.0	4.0	8.4	5.2	5.3	3.2	5.5	4.9	3.8	3.5	3.4	6.2	4.3	5.7	5.2	3.8	3.6	2.7	3.3	3.8	3.9	4.3	7.3	3.0	2.3	6.2	4.4	6.1	11.4	8.1	3.0	4.4	4.7	5.1	20.0	4.7	6.8	6.6	4.5	5.8	4.3	6.4	4.5	60.2	3.6	15.0	5.2	4.8	8.3	5.7	6.3	5.3	3.8	7.1	2.6	3.8	5.5	2.3	7.0	9.1	11.3	8.5	3.4	5.0	8.4	7.6	8.5	13.1	10.6	11.1	11.4	19.2	6.6	6.9	6.9	14.0	6.7	13.3	17.4	6.3	16.8	8.8	5.3	5.6	15.6	11.4	4.1	5.5	11.7	10.5	6.8	14.7	9.1	6.8	5.6	19.5	5.0	10.3	6.9	18.4	12.0	9.4	3.6	8.6	11.9	8.2	11.0	6.7	4.5	10.6	7.5	6.2	11.1	9.9	6.5	8.0	9.5	15.3	18.7	6.8	36.3	5.0	2.0	1.8	7.1	4.3	2.6	5.5	2.4	4.2	3.9	3.3	5.3	3.6	4.1	3.8	3.8	2.0	3.8	5.0	2.3	3.0	4.0	5.3	3.2	2.7	3.3	3.0	2.3	3.0	3.6
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO1/sentrin/SMT3 specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol				Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavourable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	10.3	10.1	16.0	7.6	19.8	13.8	11.6	18.8	20.2	8.7	8.8	13.8	7.8	9.2	9.5	15.4	9.3	9.7	7.0	10.9	15.2	15.1	11.3	14.2	9.5	8.6	14.6	12.0	16.0	9.1	15.6	16.7	13.4	13.9	9.7	9.6	9.1	11.0	10.3	24.6	13.9	8.5	9.2	12.9	9.2	9.4	34.9	17.1	11.0	11.2	7.3	8.9	8.5	9.3	4.2	4.4	7.8	3.2	5.1	3.8	1.9	15.2	3.1	7.6	8.6	13.7	9.3	9.9	7.2	8.1	9.0	9.6	11.6	4.9	8.2	13.5	6.4	8.1	15.8	5.8	13.3	6.1	7.5	5.6	6.4	6.9	7.3	8.2	3.7	5.7	8.7	5.1	6.2	6.2	6.6	11.8	7.7	7.6	6.9	9.1	28.1	5.3	8.2	10.4	13.7	4.9	5.1	7.9	8.8	5.9	13.2	11.0	18.1	11.0	3.9	6.0	6.5	10.9	11.2	13.6	16.2	15.2	9.8	8.8	8.1	7.2	3.0	5.4	3.7	2.8	3.8	3.0	3.1	3.0	2.2	4.2	3.7	3.6	7.8	5.1	3.2	4.4	2.7	1.9	16.0	19.8	18.8	20.2	15.2	15.1	14.6	12.0	13.9	17.1
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO1/sentrin/SMT3 specific peptidase 3"	Q9H4L4	17	7561875-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA060290: "	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favourable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	16.3	16.0	22.3	20.9	23.4	16.6	18.0	29.2	38.4	15.9	22.5	18.4	16.8	16.2	18.6	22.7	18.6	19.9	17.0	26.1	21.0	19.2	17.5	15.1	18.7	18.8	20.0	23.3	19.6	17.8	29.5	17.3	23.6	17.2	16.0	20.5	17.3	18.6	21.9	22.0	20.8	17.6	23.1	15.3	18.9	17.2	28.8	16.4	18.9	19.0	14.2	23.4	16.8	32.8	0.8	0.7	1.1	0.7	1.1	1.7	0.3	26.2	31.8	18.9	29.2	21.4	15.7	19.7	19.3	19.8	33.6	31.6	19.0	11.5	31.4	19.1	25.3	25.3	40.6	30.1	28.3	22.1	37.1	16.3	27.0	19.4	29.0	15.0	20.8	20.1	30.8	38.3	37.6	26.9	20.8	8.8	25.9	17.6	36.3	11.4	23.4	19.4	33.3	17.7	18.1	22.4	15.4	18.9	24.4	19.3	18.7	20.5	15.7	9.8	14.1	19.3	16.8	18.3	41.3	13.0	13.5	19.9	19.5	15.9	28.5	0.1	0.7	0.2	0.4	0.4	0.1	0.4	0.2	1.3	0.1	0.8	1.7	0.5	1.1	1.1	0.1	0.7	0.3	0.3	22.3	23.4	29.2	38.4	21.0	19.2	20.0	23.3	17.2	16.4
SENP5	MGC27076	ENSG00000119231	"SUMO1/sentrin specific peptidase 5"	Q96HI0	3	196867856-196934714	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006684			Supported	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA006684: "	"unprognostic (4.07e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.63e-2)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.57e-3)"	"prognostic unfavourable (2.14e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.71e-2)"	13.8	13.5	20.0	15.3	20.0	25.7	16.1	28.3	23.8	15.0	15.1	16.1	14.5	11.3	14.6	16.2	16.3	12.9	14.4	15.9	18.9	21.7	13.6	19.5	15.2	15.9	19.4	18.4	17.5	15.7	19.8	21.5	17.8	23.5	15.1	14.0	12.0	13.2	15.9	17.8	16.4	13.0	16.8	18.2	17.1	14.0	36.6	16.4	19.3	14.1	9.2	21.1	14.9	20.1	8.9	7.8	15.8	8.7	7.6	8.9	4.2	13.1	6.0	9.6	8.6	8.1	9.8	7.6	8.4	9.0	9.1	14.7	10.4	5.2	12.3	23.4	9.2	9.1	9.9	4.5	14.9	6.6	6.5	16.7	8.9	7.3	9.5	13.7	7.9	8.4	12.1	9.3	9.9	8.9	11.0	19.1	10.6	11.3	12.9	8.1	7.4	11.9	8.3	7.7	8.3	4.5	7.5	6.0	8.0	9.4	10.6	10.3	17.8	10.5	10.0	8.9	9.2	12.2	17.1	20.4	35.7	26.5	12.0	11.1	10.1	15.8	7.6	7.1	8.9	8.1	8.1	8.9	8.6	8.8	5.0	8.5	8.0	8.6	14.9	7.6	8.7	7.8	6.9	4.2	20.0	20.0	28.3	23.8	18.9	21.7	19.4	18.4	23.5	16.4
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO1/sentrin specific peptidase 6"	Q9GZR1	6	75601509-75718278	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (2.83e-5)"	"unprognostic (1.72e-1)"	25.9	20.0	24.3	21.8	24.5	27.1	25.9	35.0	24.3	32.5	27.7	23.5	24.9	16.8	37.7	21.2	21.0	27.4	21.5	20.0	22.8	19.8	24.1	22.5	22.5	21.1	29.6	20.3	38.7	21.8	40.1	44.2	26.8	27.0	27.7	21.8	23.0	20.4	25.7	27.8	22.0	24.1	43.0	27.2	24.7	21.3	26.1	28.6	28.5	34.8	15.8	23.9	27.1	34.0	9.9	10.9	19.4	13.1	9.8	11.2	5.5	10.7	11.3	25.7	18.4	20.0	26.7	19.1	19.4	21.7	16.4	20.6	15.5	10.4	18.3	18.4	22.4	13.8	24.1	12.9	25.5	26.8	20.8	27.7	13.6	14.4	27.8	24.0	20.4	20.6	21.6	15.4	34.4	27.1	33.4	20.3	20.1	13.1	9.5	13.0	15.6	9.6	18.0	13.6	26.6	17.6	16.1	22.5	23.2	16.6	14.7	16.8	13.2	23.0	22.6	14.7	16.1	7.5	20.0	23.3	23.1	14.6	7.4	23.0	15.5	5.2	7.4	19.4	7.7	7.9	11.2	9.3	7.8	10.2	8.7	9.9	11.2	9.9	14.7	9.8	13.1	10.9	6.5	5.5	24.3	24.5	35.0	24.3	22.8	19.8	29.6	20.3	27.0	28.6
SEPT10	FLJ11619	ENSG00000186522	"Septin 10"	Q9P0V9	2	109542982-109614206	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047860, HPA056304, HPA060310"	Enhanced		Supported	"Actin filaments"				"Actin filaments"		"HPA047860: , HPA056304: , HPA060310: "	"unprognostic (1.84e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.18e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.12e-2)"	27.5	12.3	9.2	13.8	15.6	0.0	27.8	2.5	12.1	25.4	27.3	25.0	20.0	8.8	21.6	21.0	37.5	15.0	18.7	25.7	11.8	8.2	18.5	27.0	24.9	15.5	20.0	8.7	23.3	11.0	17.1	9.3	20.7	24.8	24.9	16.8	13.7	19.7	26.0	15.3	30.2	13.8	42.5	39.0	15.1	15.6	33.7	15.3	4.7	18.2	24.3	12.5	32.9	24.2	1.6	1.2	0.2	4.5	0.0	6.7	1.6	21.7	5.9	21.7	13.9	17.5	33.0	13.3	35.5	62.9	25.2	29.4	11.0	12.7	0.0	17.9	27.7	10.2	9.2	22.5	33.5	41.2	6.6	0.0	8.8	15.7	13.2	0.0	2.9	20.5	10.3	22.6	29.9	33.4	0.5	0.1	30.6	2.0	0.0	2.1	16.2	11.5	0.0	17.6	3.6	21.1	29.0	6.4	13.4	20.8	0.4	16.4	5.7	0.2	33.8	26.5	18.8	10.2	14.6	13.3	7.3	0.1	23.5	0.4	31.9	0.0	4.5	0.0	0.2	2.9	0.2	1.6	2.8	0.8	1.2	0.7	1.5	0.5	0.2	0.0	1.8	0.0	6.7	1.6	9.2	15.6	2.5	12.1	11.8	8.2	20.0	8.7	24.8	15.3
SEPT2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"			8800000	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favourable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	64.2	46.4	76.5	42.9	69.9	29.1	58.7	34.9	61.8	69.3	48.4	85.2	57.4	37.8	59.5	59.8	46.8	48.2	54.0	56.2	65.8	55.4	64.6	31.4	51.2	51.3	76.5	52.7	63.4	73.0	56.6	56.3	58.9	60.7	53.7	53.3	48.8	43.6	64.7	39.5	32.0	42.2	81.8	100.8	51.5	45.6	67.7	57.2	36.2	64.2	39.0	47.5	56.5	42.6	25.5	51.2	38.5	50.5	51.3	36.9	59.4	31.9	28.8	78.5	51.3	73.1	79.8	40.6	70.8	69.8	45.5	58.0	16.1	34.8	13.0	16.9	80.9	28.5	51.2	47.9	74.9	32.8	36.4	52.2	28.8	59.4	44.8	49.7	31.9	71.0	31.4	37.9	36.6	79.2	46.5	19.1	66.9	23.0	29.4	30.4	57.1	21.1	29.1	98.7	27.5	67.5	48.9	56.3	37.9	49.0	33.9	46.7	20.3	44.9	74.8	55.8	23.7	53.8	41.8	37.7	32.8	45.8	48.0	30.4	77.0	38.5	46.0	26.3	30.3	50.5	36.9	25.5	29.6	31.2	51.2	21.6	26.2	27.4	16.3	51.3	37.2	38.6	29.5	59.4	76.5	69.9	34.9	52.3	65.8	55.4	76.5	52.7	60.7	57.2
SEPT4	"ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2"	ENSG00000108387	"Septin 4"	O43236	17	58520250-58540818	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 77.8;brain: 94.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.7;HHSteC: 11.4;HSkMC: 5.8;SK-MEL-30: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006855, HPA021587, HPA022905"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687"	"unprognostic (1.12e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (3.28e-7)"	"unprognostic (6.40e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.75e-3)"	14.8	77.8	70.5	2.6	80.0	0.9	7.2	44.3	82.7	4.0	3.3	92.4	0.0	2.7	3.5	3.9	3.2	2.7	8.3	14.3	84.8	49.9	8.5	25.0	9.5	5.9	94.8	32.3	5.4	3.9	4.8	2.4	9.9	49.7	2.5	3.1	10.0	4.4	3.8	4.2	3.9	2.9	6.0	84.0	18.0	2.8	7.3	56.5	0.0	4.5	0.5	3.8	5.1	1.3	1.7	5.5	2.9	5.5	1.4	7.6	5.6	0.0	0.5	0.9	2.7	1.1	0.1	0.5	0.1	0.3	1.7	1.9	0.1	0.1	0.0	4.0	0.6	0.2	1.4	1.1	0.4	0.1	0.7	1.0	0.2	5.7	11.4	0.1	0.5	5.8	2.3	0.4	2.1	0.5	0.0	2.7	0.1	0.0	0.0	0.1	0.5	0.7	0.2	0.0	1.2	0.0	0.0	2.9	1.7	0.0	0.1	25.0	0.4	0.3	0.0	0.1	1.3	0.0	1.1	0.8	0.4	0.0	0.9	0.0	0.3	0.0	5.5	1.1	7.6	0.7	2.4	1.7	1.6	2.0	5.5	0.6	2.9	2.3	2.9	1.4	0.0	0.3	1.0	5.6	70.5	80.0	44.3	50.5	84.8	49.9	94.8	32.3	49.7	56.5
SEPT7	"CDC10, CDC3, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Enhanced	"Nucleoli,Actin filaments,Midbody,Cytosol"			16000000	"Actin filaments"	"Nucleoli, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	35.5	28.5	89.0	26.8	77.8	31.9	29.5	41.9	81.5	35.1	28.7	54.3	11.5	15.7	37.8	36.2	31.7	25.4	34.2	47.5	86.4	58.1	24.3	21.5	28.3	38.8	79.6	66.2	42.8	11.2	22.9	31.9	41.0	72.0	28.4	28.2	9.6	14.9	29.9	21.7	29.1	20.1	42.6	76.8	29.5	18.1	19.3	98.2	33.0	22.6	17.3	41.4	36.9	24.0	40.4	24.0	47.3	24.8	69.1	56.8	48.6	36.6	17.7	45.1	29.6	50.8	52.6	23.1	47.3	43.7	40.4	34.8	27.4	28.5	34.7	32.2	48.1	27.9	31.8	31.5	57.7	23.7	16.7	27.9	24.7	14.8	29.7	33.6	30.9	34.1	24.7	31.7	31.3	42.1	21.9	27.5	65.5	17.1	33.9	56.5	48.3	25.0	35.1	42.9	19.9	39.1	27.4	24.2	42.5	33.0	42.6	28.3	31.4	37.3	35.5	40.8	48.4	25.0	52.0	32.4	29.5	87.6	26.1	56.3	86.1	47.3	20.7	34.9	55.4	24.0	56.8	40.4	39.6	50.5	24.0	37.4	35.6	44.9	39.3	69.1	24.8	17.2	34.2	48.6	89.0	77.8	41.9	81.5	86.4	58.1	79.6	66.2	72.0	98.2
SEPT9	"AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SeptD1"	ENSG00000184640	"Septin 9"	Q9UHD8	17	77280569-77500596	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042564, HPA050627"	Approved		Enhanced	"Actin filaments"			120000	"Actin filaments"		"HPA042564: AB_2678054, HPA050627: "	"unprognostic (7.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (1.61e-5)"	"unprognostic (4.23e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.80e-1)"	25.5	33.3	23.2	53.3	16.4	28.2	38.6	42.9	28.3	39.4	45.7	19.8	29.0	34.4	50.7	29.3	36.3	35.0	61.3	18.7	20.2	19.8	27.1	40.8	29.6	75.1	19.3	23.9	36.4	14.9	32.3	24.3	30.8	21.0	35.8	20.8	31.7	28.7	41.5	24.5	27.7	49.9	56.2	26.2	54.6	38.0	35.8	15.0	137.8	19.7	27.4	61.9	47.0	37.9	10.2	20.4	13.9	27.1	8.4	17.1	10.2	36.3	49.6	35.3	29.0	40.4	66.6	18.6	27.6	33.1	18.2	13.6	39.0	36.1	49.1	24.2	57.4	21.8	14.4	53.4	13.9	1.2	9.1	18.6	25.5	72.5	32.3	12.2	33.3	34.6	19.9	24.6	20.8	24.6	20.5	6.7	16.9	38.0	89.4	11.0	31.4	40.8	41.3	29.0	16.4	30.0	60.1	25.7	49.1	30.9	57.0	34.8	38.8	10.8	35.9	27.0	22.3	31.5	19.7	1.6	2.8	82.1	37.3	10.8	54.7	2.2	9.1	13.9	12.4	24.0	10.7	8.8	16.1	14.5	8.8	10.2	17.1	14.4	3.4	8.4	27.1	20.4	16.2	10.2	23.2	16.4	42.9	28.3	20.2	19.8	19.3	23.9	21.0	15.0
SERBP1	"CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1"	ENSG00000142864	"SERPINE1 mRNA binding protein 1"	Q8NC51	1	67407810-67430415	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020559, CAB026297"	Supported		Enhanced	Cytosol			430000	Cytosol		"CAB026297: AB_425924, HPA020559: AB_1856701"	"unprognostic (1.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.59e-1)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.76e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.34e-3)"	38.3	30.4	22.5	35.7	30.0	33.8	36.9	25.4	27.7	35.4	32.8	25.5	28.6	30.9	36.4	35.2	68.4	25.9	39.4	32.6	22.3	19.1	30.6	48.4	27.5	47.9	29.7	18.6	33.5	56.1	52.2	21.8	28.7	25.0	34.8	27.1	23.2	41.8	28.5	87.5	50.5	29.9	42.0	26.8	31.9	31.5	35.8	28.7	48.9	42.6	54.1	41.3	36.0	40.7	34.3	35.4	16.8	30.2	46.7	44.4	33.9	58.5	35.8	38.5	38.2	34.3	31.5	57.0	61.8	24.3	43.0	36.5	69.0	26.2	113.4	46.4	33.4	45.2	60.3	57.9	46.7	50.6	72.5	104.4	67.2	61.1	30.0	84.5	40.1	32.1	39.1	55.2	50.4	46.6	116.3	40.0	34.3	40.8	63.6	51.3	133.8	47.3	73.5	84.5	56.7	33.3	48.9	65.0	45.6	48.0	52.3	56.0	28.6	51.7	48.5	39.5	48.1	56.9	83.1	37.3	47.7	101.8	32.5	80.3	44.1	9.8	27.4	16.8	35.0	30.2	44.4	34.3	35.2	35.3	35.4	33.4	41.4	37.4	9.0	46.7	27.4	32.3	41.7	33.9	22.5	30.0	25.4	27.7	22.3	19.1	29.7	18.6	25.0	28.7
SERGEF	"DelGEF, Gnefr"	ENSG00000129158	"Secretion regulating guanine nucleotide exchange factor"	Q9UGK8	11	17788048-18013162	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037811, HPA037812, HPA074086"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037811: AB_10672726, HPA037812: , HPA074086: "	"unprognostic (2.67e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.82e-2)"	8.2	14.2	30.1	7.5	22.3	4.7	15.2	24.4	31.4	13.1	10.7	9.5	4.3	6.1	11.8	17.7	9.6	13.9	10.3	9.9	28.6	24.1	15.6	12.3	10.0	8.0	27.9	18.1	26.1	17.4	17.7	19.3	4.8	23.0	13.6	11.5	10.1	12.3	17.1	11.8	11.1	6.2	14.4	10.4	7.6	10.1	3.9	10.7	7.8	25.3	8.8	11.8	9.5	15.6	15.4	14.4	8.9	11.8	11.3	22.0	14.1	6.6	7.7	7.3	13.7	12.7	13.1	4.4	5.3	12.0	6.2	8.2	5.5	2.2	6.0	7.0	6.7	8.7	25.9	17.0	5.4	13.1	21.1	9.2	7.0	22.7	14.2	8.1	10.6	11.7	18.7	3.0	13.4	6.7	5.5	11.6	9.5	10.3	7.8	17.7	5.6	9.2	11.3	8.0	6.6	15.1	10.0	17.1	4.0	9.9	9.9	10.0	4.7	7.6	3.4	6.5	7.6	8.4	6.3	8.0	9.6	7.7	10.0	9.4	6.2	7.2	11.8	8.9	21.1	9.3	17.4	15.4	21.3	16.0	14.4	11.1	21.7	19.2	1.2	11.3	9.4	5.9	22.0	14.1	30.1	22.3	24.4	31.4	28.6	24.1	27.9	18.1	23.0	10.7
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256079	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.6;RT4: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: "	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	6.9	21.1	9.0	7.8	11.2	3.0	6.7	5.3	15.6	10.2	16.3	28.8	11.2	5.1	6.9	12.9	9.7	9.6	8.4	4.1	9.5	7.3	5.3	26.3	8.0	9.3	13.4	7.0	9.8	7.8	4.2	5.3	24.7	12.1	20.3	17.5	3.6	9.8	8.4	3.1	10.9	9.5	4.4	9.7	8.3	9.7	18.9	15.0	7.8	5.2	6.7	12.3	9.3	7.7	0.8	4.0	6.2	6.9	0.4	17.5	4.7	5.1	9.2	3.1	2.0	4.3	4.6	9.3	4.2	2.8	1.8	1.9	18.5	26.6	0.8	4.3	5.4	14.9	4.2	11.1	2.7	0.7	2.2	0.6	1.1	9.9	1.6	0.6	1.9	5.2	6.2	4.8	12.6	3.4	1.6	4.4	4.9	8.8	10.3	2.5	4.3	3.2	12.3	2.7	1.4	5.5	25.4	0.2	3.0	3.7	8.7	16.3	3.8	3.2	3.7	5.4	1.5	5.4	5.2	5.7	1.6	13.3	10.2	1.8	22.0	6.2	6.9	4.4	1.6	3.4	1.2	0.5	13.9	4.2	4.0	0.8	17.5	10.5	3.6	0.4	1.0	0.9	4.5	4.7	9.0	11.2	5.3	10.9	9.5	7.3	13.4	7.0	12.1	15.0
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 3314.2"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 318.5"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 139.3;monocytes: 203.0"					"Region enriched"	"Detected in many"	6	"cerebellum: 334.2"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	1663100000000	210000000000	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favourable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favourable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	0.9	0.4	0.7	4.9	1.4	3.0	2.4	0.2	0.7	2.6	7.5	0.5	3.1	6.3	0.8	8.6	0.4	0.7	14.2	1.0	0.4	0.5	74.1	3314.2	13.6	5.3	1.0	0.2	0.6	7.4	0.0	0.4	0.8	0.8	0.6	4.1	0.6	0.9	3.6	0.2	0.3	36.2	1.4	1.3	8.9	7.0	0.8	0.8	0.5	0.8	0.2	0.9	0.5	0.6	0.3	33.5	139.3	203.0	0.2	0.3	100.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	12.6	40.1	0.1	1.1	0.0	0.1	0.0	0.8	0.0	4.9	0.0	0.2	0.1	318.5	0.0	1.1	0.1	0.2	0.4	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.5	0.1	1.1	0.1	21.5	0.2	0.0	0.0	0.4	0.1	0.1	18.9	0.1	0.1	0.1	5.0	0.1	0.6	0.2	0.1	0.4	0.3	2.8	0.0	0.4	110.2	29.1	0.2	165.9	0.3	0.3	0.1	0.2	33.5	0.1	0.2	0.1	139.3	0.2	203.0	0.7	0.2	100.0	0.7	1.4	0.2	0.7	0.4	0.5	1.0	0.2	0.8	0.8
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2842006	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 119.2;lymphoid tissue: 108.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;U-937: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"			49000000	"Cytoplasmic bodies"		"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	11.4	15.1	3.5	13.4	7.0	75.8	6.4	2.9	3.3	25.1	23.6	5.7	5.3	26.0	6.6	8.6	119.2	7.6	18.1	8.3	3.5	3.9	11.4	36.9	32.6	37.4	7.5	1.8	7.8	66.7	8.3	10.4	11.9	6.2	6.5	16.7	6.7	23.5	3.6	21.8	4.4	49.2	5.6	6.8	34.8	18.0	3.9	5.3	9.4	14.0	98.9	108.0	7.2	20.8	12.8	38.3	48.5	49.6	21.7	16.7	38.7	12.9	15.1	0.8	0.1	3.3	7.0	13.1	3.8	10.9	4.5	8.2	14.2	37.5	0.1	27.5	8.0	8.2	1.5	3.4	3.4	18.5	2.7	22.8	5.1	10.9	12.0	4.0	14.7	8.7	5.9	2.3	1.0	14.8	8.1	3.1	4.0	6.0	0.5	10.5	1.5	7.2	1.2	0.1	13.2	15.5	2.8	2.9	1.6	8.7	3.4	18.9	1.7	12.9	9.1	1.5	3.6	3.2	1.1	0.0	0.6	0.1	5.5	42.6	0.7	27.1	49.6	28.5	16.1	25.7	14.5	12.8	15.6	14.8	38.3	9.6	16.1	16.1	48.5	21.7	19.5	14.8	16.7	38.7	3.5	7.0	2.9	3.3	3.5	3.9	7.5	1.8	6.2	5.3
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 43.9;tongue: 15.3"	"Cell line enriched"	"Detected in some"	7	"U-937: 47.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2"					"Low region specificity"	"Detected in all"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol			42000	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: "	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	1.3	0.1	0.0	2.3	0.2	43.9	0.1	0.3	0.1	1.1	0.7	0.0	0.0	0.1	0.2	0.3	3.1	0.1	0.1	5.5	0.0	0.0	0.0	0.2	3.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	4.8	0.2	0.1	0.1	0.0	1.0	0.1	1.3	2.5	0.1	0.1	0.0	2.8	0.1	0.1	0.1	4.0	0.9	15.3	1.5	0.1	1.3	0.3	2.1	3.3	4.2	0.3	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.2	4.2	3.3	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.3	0.1	0.1	1.8	0.3	0.0	2.1	0.1	0.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.1
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476761-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 99.3;skin 1: 60.7;tongue: 118.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 143.8;HBEC3-KT: 47.4;hTCEpi: 99.9;hTERT-HME1: 25.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		660000	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavourable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavourable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.2	0.1	0.1	0.9	0.1	0.0	9.7	0.1	0.1	23.6	2.7	0.1	0.7	3.9	2.1	0.5	99.3	0.1	4.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	4.1	1.0	0.1	11.1	0.3	0.1	60.7	6.8	0.9	0.1	0.1	2.2	0.4	0.1	5.1	0.1	118.8	41.2	7.1	19.7	0.6	0.5	1.2	0.4	1.0	0.5	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.4	0.0	143.8	0.0	47.4	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	99.9	0.0	25.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	10.5	0.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.2	0.6	0.5	0.3	1.2	1.0	0.2	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SERPINH1	"CBP1, CBP2, colligen, HSP47, SERPINH2"	ENSG00000149257	"Serpin family H member 1"	P50454	11	75562056-75572783	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 165.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 117.6;HHSteC: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004441, HPA029198"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		730000	"Endoplasmic reticulum"		"CAB004441: AB_627757, HPA029198: AB_10601712"	"unprognostic (3.80e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.35e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.22e-15)"	"unprognostic (2.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	38.2	20.1	10.5	29.3	10.9	1.0	54.1	5.7	8.4	39.4	16.9	6.0	10.3	6.4	32.7	16.8	17.8	23.6	21.4	29.6	11.8	7.0	18.5	11.5	35.7	13.5	17.1	2.7	48.3	13.9	5.9	11.0	69.9	23.2	26.2	11.0	13.8	7.7	16.7	9.5	12.3	9.4	57.8	12.9	14.3	14.2	12.5	13.0	7.4	36.1	8.7	8.2	38.7	165.4	1.3	5.5	5.0	1.6	7.1	7.4	2.4	5.4	18.3	34.5	71.0	53.5	49.4	15.7	50.4	34.3	38.0	48.5	97.4	28.5	0.0	45.7	117.6	32.7	23.6	15.7	18.5	2.2	4.5	3.9	18.1	19.5	104.4	0.1	0.7	58.8	16.2	36.3	12.2	51.9	8.3	1.7	17.7	42.7	0.1	6.9	30.6	4.9	2.7	19.1	4.4	9.2	10.4	0.8	11.4	31.5	5.9	9.5	14.0	6.7	27.3	39.2	32.7	26.7	12.2	2.2	2.2	0.5	16.9	0.0	52.5	5.0	1.6	0.1	7.4	1.5	6.7	1.2	5.1	5.3	5.5	1.3	5.7	4.6	0.3	7.1	0.2	4.7	4.2	2.4	10.5	10.9	5.7	8.4	11.8	7.0	17.1	2.7	23.2	13.0
SERTAD2	"KIAA0127, Sei-2, TRIP-Br2"	ENSG00000179833	"SERTA domain containing 2"	Q14140	2	64631621-64751005	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019021, HPA020904"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA019021: AB_1856740, HPA020904: AB_1856741"	"unprognostic (1.40e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (4.03e-4)"	"unprognostic (2.15e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.55e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.21e-3)"	"unprognostic (6.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.84e-1)"	14.3	5.5	4.3	11.3	5.5	52.1	10.4	6.4	5.9	12.4	8.6	9.1	5.6	4.6	9.6	7.6	24.7	7.8	8.4	10.9	4.7	3.5	6.7	11.0	11.8	12.5	7.2	4.4	12.1	5.8	8.4	6.2	17.4	6.0	8.6	6.5	10.2	18.4	7.5	10.8	18.8	9.9	9.5	6.7	24.5	7.2	7.4	8.4	53.8	7.6	16.7	25.7	22.0	16.7	5.4	8.8	3.8	3.1	2.6	4.2	1.4	14.3	4.2	8.0	8.0	6.9	17.6	9.2	11.5	11.1	6.8	6.5	10.8	11.0	12.2	6.4	18.8	5.7	5.2	7.0	14.6	1.1	7.9	8.0	4.0	7.8	1.5	7.0	4.1	11.9	9.3	15.7	10.2	4.1	5.0	6.8	15.9	3.4	7.5	7.7	4.4	11.3	6.6	13.7	4.7	9.3	13.2	9.3	3.6	8.1	5.7	14.4	3.8	5.7	12.4	37.2	19.2	21.7	9.3	11.7	4.4	14.1	13.8	13.0	14.5	2.3	2.7	3.8	1.8	2.8	1.1	4.7	1.8	2.0	2.8	5.4	4.2	3.1	3.8	2.6	3.1	8.8	0.9	1.4	4.3	5.5	6.4	5.8	4.7	3.5	7.2	4.4	6.0	8.4
SERTAD4	DJ667H12.2	ENSG00000082497	"SERTA domain containing 4"	Q9NUC0	1	210232799-210246631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 36.3"	"Cell line enhanced"	"Detected in many"		"A-431: 7.3;BEWO: 7.6;SCLC-21H: 7.6;SK-BR-3: 8.7;T-47d: 10.7;U-2 OS: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027344, HPA028514"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA027344: AB_10601770, HPA028514: AB_10611391"	"unprognostic (1.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.85e-2)"	"unprognostic (6.55e-2)"	"unprognostic (4.24e-1)"	1.5	1.0	2.3	0.7	7.7	0.1	12.3	2.6	4.3	6.2	6.2	1.5	4.6	1.1	6.2	3.2	15.7	3.2	2.9	4.2	1.8	2.1	2.5	0.2	3.4	0.4	2.8	0.4	2.5	0.2	1.5	1.4	11.7	3.0	3.6	3.3	1.0	36.3	11.1	0.5	5.3	1.1	6.0	2.7	0.3	2.3	0.7	2.1	1.9	3.2	14.6	7.7	1.7	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	1.6	0.0	0.8	0.8	7.6	1.8	1.8	1.4	2.5	0.3	0.9	0.0	0.2	0.4	3.6	0.3	0.6	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.3	1.7	0.0	0.0	5.3	0.3	0.0	2.5	0.0	1.2	1.3	7.6	6.6	1.2	8.7	0.1	10.7	0.0	2.3	2.1	9.1	0.1	5.5	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.7	2.6	4.3	1.8	2.1	2.8	0.4	3.0	2.1
SERTM1	C13orf36	ENSG00000180440	"Serine rich and transmembrane domain containing 1"	A2A2V5	13	36673912-36697839	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3"	"Group enriched"	"Detected in some"	5	"HAP1: 2.6;HEK 293: 3.1;NTERA-2: 7.9;SH-SY5Y: 4.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.7"	"Group enriched"	"Detected in many"	7	"amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054814, HPA070485"	Uncertain		Enhanced	Vesicles				Vesicles		"HPA054814: , HPA070485: "	"unprognostic (8.71e-2)"	"unprognostic (2.11e-1)"		"unprognostic (5.58e-3)"	"unprognostic (4.66e-3)"			"unprognostic (4.05e-3)"		"unprognostic (5.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.00e-8)"	"unprognostic (2.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.44e-2)"		5.0	1.8	13.9	0.5	10.1	0.5	1.2	0.3	30.2	16.4	0.7	1.3	1.8	0.6	30.9	13.5	0.5	25.3	0.5	0.6	26.5	2.0	0.6	0.5	5.6	0.5	1.5	11.6	14.5	0.8	1.0	11.2	0.5	2.4	0.9	0.5	8.2	0.5	1.2	0.5	0.6	0.6	17.4	0.9	0.5	0.9	1.5	0.0	0.0	9.3	0.0	0.5	1.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	10.1	0.3	21.6	26.5	2.0	1.5	11.6	2.4	0.0
SESN1	"PA26, SEST1"	ENSG00000080546	"Sestrin 1"	Q9Y6P5	6	108986437-109094819	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"B-cells: 21.0;NK-cells: 21.8;T-cells: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073659			Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA073659: "	"unprognostic (2.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (6.47e-5)"	"unprognostic (2.68e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-3)"	"prognostic favourable (2.07e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.95e-2)"	23.5	14.2	14.5	11.0	23.7	22.7	39.3	21.2	18.9	13.2	16.9	10.2	17.3	10.3	17.1	14.4	11.9	15.2	10.0	32.4	13.0	11.3	8.8	14.1	17.5	54.1	12.2	14.6	33.0	16.1	18.1	25.6	26.8	13.0	15.2	12.8	9.5	10.0	17.2	69.2	19.7	18.6	17.9	13.7	19.3	14.9	20.8	13.6	9.6	18.2	15.4	16.4	16.1	15.3	21.0	2.1	3.9	3.0	21.8	30.6	7.8	1.5	2.5	11.6	5.4	14.8	18.9	36.4	6.1	7.0	2.1	4.1	4.7	1.6	12.7	5.1	4.5	1.8	3.1	12.2	2.6	1.1	15.5	5.6	3.2	17.7	9.1	2.2	5.8	20.4	19.5	3.8	6.2	10.9	4.1	9.2	10.4	3.0	4.8	7.0	4.7	1.6	3.9	3.3	5.8	4.5	7.6	2.8	5.8	3.3	2.1	2.4	2.0	14.6	6.7	1.6	3.2	1.5	1.9	9.3	5.3	5.2	3.6	5.6	3.5	3.9	1.0	1.2	14.2	2.3	30.6	4.4	13.3	11.1	1.0	21.0	16.6	8.8	3.9	21.8	3.0	2.1	5.6	7.8	14.5	23.7	21.2	18.9	13.0	11.3	12.2	14.6	13.0	13.6
SESTD1	"DKFZp434O0515, Solo"	ENSG00000187231	"SEC14 and spectrin domain containing 1"	Q86VW0	2	179101692-179264790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.3"	"Group enriched"	"Detected in many"	4	"B-cells: 4.3;dendritic cells: 1.1;monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058236, HPA077408"	Approved		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"HPA058236: , HPA077408: "	"unprognostic (2.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (9.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"unprognostic (9.21e-2)"	"prognostic favourable (2.78e-11)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-2)"	23.6	5.0	11.2	6.5	11.3	8.1	32.1	10.3	17.0	12.7	10.0	15.8	9.1	4.3	11.1	7.9	8.8	6.4	12.0	9.6	13.5	9.9	12.7	6.5	16.9	6.2	14.4	9.4	9.0	6.2	8.9	7.2	12.5	12.7	9.4	7.6	7.6	16.6	9.2	5.7	7.0	8.7	22.5	21.0	6.5	9.1	15.9	11.5	3.7	6.1	6.2	9.1	19.9	23.7	4.3	1.1	0.2	3.7	0.6	0.1	0.6	0.0	1.2	15.3	2.7	27.8	12.2	8.1	5.3	2.1	2.2	3.8	2.7	3.5	2.6	7.1	5.1	2.5	6.5	3.0	4.1	1.9	1.7	3.2	6.9	7.1	2.2	1.7	1.4	9.0	1.3	3.4	8.6	9.0	0.5	1.3	3.8	1.8	4.1	0.2	3.9	1.5	5.9	10.1	1.7	6.1	13.6	3.4	5.8	4.7	2.0	1.5	0.3	2.0	15.6	7.5	3.8	3.7	2.7	0.8	0.0	6.3	3.7	0.7	2.2	0.0	2.1	0.0	0.0	1.8	0.0	2.7	0.1	0.0	1.1	4.3	0.1	0.0	0.2	0.6	3.7	0.0	0.1	0.6	11.2	11.3	10.3	16.1	13.5	9.9	14.4	9.4	12.7	11.5
SET	"2PP2A, IPP2A2, PHAPII"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"			880000	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: "	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavourable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	47.2	49.7	66.5	59.3	65.8	71.8	56.5	64.2	61.2	54.4	51.3	55.3	45.6	40.1	64.8	33.1	71.6	51.6	48.9	81.6	63.6	57.3	51.7	57.8	51.2	91.1	65.4	56.1	76.5	61.3	55.0	38.7	65.4	47.3	59.2	56.4	36.3	52.1	46.9	76.3	53.6	45.7	59.0	73.5	62.8	46.8	34.8	58.6	152.9	69.1	46.2	92.7	74.4	84.1	72.2	66.4	43.2	56.5	78.8	77.9	69.7	50.4	57.6	82.9	65.6	24.8	38.9	76.5	41.7	46.2	60.3	41.6	79.2	62.0	130.6	35.3	42.9	94.7	122.5	62.7	69.0	59.5	52.2	75.1	89.7	64.4	55.4	137.0	49.2	32.3	49.1	51.3	103.0	56.3	145.7	53.0	49.3	85.2	114.7	50.6	138.4	61.4	105.0	103.1	105.7	46.5	57.0	84.5	53.1	91.8	61.7	49.8	76.9	42.7	53.9	71.3	53.5	43.9	68.9	41.7	119.8	155.4	33.9	73.0	67.9	34.5	53.9	43.2	58.9	56.5	72.1	72.2	67.9	62.8	52.7	66.3	65.8	77.9	35.4	78.8	45.6	66.4	52.3	69.7	66.5	65.8	64.2	61.2	63.6	57.3	65.4	56.1	47.3	58.6
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"AF22: 9.3;Karpas-707: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.9;naive B-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: , HPA057259: "	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favourable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	10.6	2.9	3.8	13.2	8.7	2.1	9.8	16.0	12.6	16.9	14.6	4.2	19.9	2.5	14.0	17.5	6.6	11.0	7.9	6.8	3.6	3.5	15.0	7.2	9.8	7.0	2.9	7.4	12.8	8.2	9.1	5.1	10.2	3.2	12.2	5.3	14.0	6.9	21.3	14.5	6.6	6.9	19.9	3.7	5.9	9.1	5.5	1.2	3.4	8.4	8.7	8.8	11.9	13.3	7.5	4.3	0.2	1.6	0.0	0.6	0.2	0.0	1.6	9.3	0.0	2.7	0.7	0.6	0.7	1.7	0.9	0.7	0.1	0.0	0.5	0.3	1.0	2.7	1.0	2.9	0.6	0.8	0.4	0.0	1.0	0.6	0.0	0.0	0.0	2.2	1.1	0.0	1.8	0.3	0.0	37.1	0.2	0.5	0.0	0.0	1.3	0.6	3.0	0.0	3.2	3.1	2.1	4.7	2.5	0.0	0.0	0.5	1.3	0.0	0.0	5.5	2.1	0.0	4.3	4.9	0.3	0.0	3.3	0.1	3.1	0.2	0.0	0.0	0.6	1.1	0.0	4.9	0.1	0.5	0.1	7.5	0.0	0.2	0.0	0.0	1.6	4.3	0.0	0.2	3.8	8.7	16.0	12.6	3.6	3.5	2.9	7.4	3.2	1.2
SETD1A	"KIAA0339, KMT2F, Set1"	ENSG00000099381	"SET domain containing 1A"	O15047	16	30957294-30984664	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020646, HPA058376"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA020646: AB_1856752, HPA058376: AB_2683695"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.18e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.94e-1)"	11.0	10.5	10.0	12.4	10.2	25.6	10.3	23.0	14.5	11.1	12.1	14.1	7.6	10.2	15.3	6.7	9.4	11.2	9.7	7.6	8.8	6.7	9.3	10.5	9.0	12.6	9.3	9.8	15.3	14.8	15.6	12.9	11.3	9.5	10.9	5.7	13.5	12.7	10.5	15.2	12.3	11.4	11.7	8.0	14.5	10.3	22.3	10.0	15.5	12.7	5.4	14.1	10.6	9.9	2.0	2.6	2.5	1.4	1.3	1.6	0.9	6.4	12.5	8.6	10.0	4.9	3.5	9.3	7.3	5.5	6.3	5.3	10.6	6.6	17.3	8.1	6.7	8.5	7.7	7.4	5.2	9.2	30.0	8.0	21.6	11.8	4.7	13.6	13.8	5.9	5.9	8.8	5.6	4.8	16.1	9.8	3.4	13.5	16.1	13.8	12.2	8.3	24.5	8.5	10.9	3.9	7.1	9.3	9.5	9.8	8.1	5.4	8.4	11.0	6.5	9.5	9.2	6.0	7.6	14.9	18.0	16.9	7.6	11.8	7.2	0.0	0.8	2.5	1.2	1.4	1.6	0.2	1.0	0.8	0.6	2.0	0.7	1.5	0.5	1.3	0.4	2.6	0.4	0.9	10.0	10.2	23.0	14.5	8.8	6.7	9.3	9.8	9.5	10.0
SETD1B	"KIAA1076, KMT2G, Set1B"	ENSG00000139718	"SET domain containing 1B"	Q9UPS6	12	121804180-121832584	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021667, HPA059412"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA021667: AB_1856753, HPA059412: "	"unprognostic (1.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	13.8	9.6	9.3	16.8	9.4	22.7	18.1	22.0	11.1	19.6	25.0	7.4	16.0	13.0	27.2	14.8	15.8	21.1	18.2	10.0	8.9	4.6	10.1	10.9	10.9	11.9	5.4	7.4	17.4	14.3	12.1	11.9	12.2	7.1	16.5	6.8	14.4	15.9	31.1	12.9	11.8	15.3	14.7	5.4	14.4	17.8	9.1	7.3	31.1	14.7	8.9	14.7	22.8	14.4	1.3	2.1	3.9	2.0	1.0	2.1	0.8	6.0	12.0	6.3	10.5	5.9	4.1	9.6	5.6	4.6	4.5	2.6	6.8	3.7	4.5	5.2	6.3	9.4	7.3	4.6	2.5	7.9	9.0	13.8	14.9	5.8	5.1	12.5	11.8	4.9	5.4	6.1	4.8	4.7	14.0	3.2	3.1	14.2	17.9	16.6	8.9	7.3	14.0	4.2	6.4	4.0	12.6	7.8	6.0	12.9	8.6	4.7	10.7	10.8	7.9	6.5	8.1	9.1	6.3	6.2	3.1	2.7	5.3	7.8	7.3	3.9	0.9	2.0	1.9	2.0	1.3	1.2	1.3	1.8	0.7	1.3	2.1	1.3	3.8	1.0	0.8	2.1	1.3	0.8	9.3	9.4	22.0	11.1	8.9	4.6	5.4	7.4	7.1	7.3
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017093: , HPA035574: "	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	18.9	21.9	33.1	18.2	29.1	13.2	40.9	58.0	38.9	21.7	20.7	15.4	22.1	14.0	24.0	27.0	20.7	22.0	18.4	18.3	29.6	13.8	15.4	22.1	26.5	29.8	23.0	30.1	29.7	22.7	25.6	31.4	23.0	25.1	20.6	20.4	16.7	22.3	22.7	16.6	29.0	19.8	24.1	22.8	22.5	18.7	21.3	26.6	21.0	25.9	14.8	24.2	20.4	37.5	3.7	4.0	4.7	2.0	4.3	4.1	1.0	9.8	11.8	24.4	11.0	14.4	15.0	58.1	9.7	13.1	14.1	16.2	11.7	12.2	21.4	5.8	14.1	8.2	22.7	12.8	15.6	15.0	11.3	20.9	19.9	10.9	14.6	15.9	13.9	14.5	20.9	21.3	25.3	14.9	20.4	14.1	12.0	14.4	14.0	13.3	18.4	9.6	16.4	19.2	9.5	11.0	15.8	9.7	15.2	14.1	11.7	8.7	15.6	11.7	17.6	14.8	17.0	8.0	11.5	10.2	12.8	35.7	10.6	11.5	13.9	2.3	2.0	1.7	3.8	1.2	2.5	3.4	2.5	4.1	1.3	3.7	2.4	2.2	4.7	4.3	1.4	4.0	1.0	1.0	33.1	29.1	58.0	38.9	29.6	13.8	23.0	30.1	25.1	26.6
SETD6	FLJ21148	ENSG00000103037	"SET domain containing 6"	Q8TBK2	16	58515479-58521181	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041481, HPA053546"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041481: AB_10804004, HPA053546: "	"unprognostic (1.32e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (3.74e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.73e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.55e-1)"	7.8	11.3	7.7	7.4	8.8	4.3	12.6	18.6	11.8	8.4	7.1	6.6	17.0	7.0	10.2	14.0	11.5	10.3	9.6	8.6	8.8	7.0	11.7	12.1	7.9	7.9	8.9	9.0	9.0	20.0	22.1	17.1	7.0	8.3	12.2	8.2	7.2	15.5	19.7	14.7	14.4	7.8	9.2	7.7	9.2	9.6	10.2	9.7	5.5	13.6	9.5	8.8	7.4	10.3	3.2	3.9	3.8	3.0	8.6	4.9	2.7	1.8	3.7	0.8	7.2	2.8	2.0	13.5	3.1	3.4	4.4	2.5	6.4	3.7	13.5	4.9	3.1	5.7	5.7	4.1	3.2	1.7	20.3	0.6	6.2	11.5	2.9	9.8	6.1	2.5	8.2	3.7	5.6	3.1	10.7	1.7	0.9	6.6	0.2	11.8	15.3	8.3	0.2	1.7	18.3	4.6	0.2	13.5	9.4	13.4	10.2	5.0	6.6	1.2	2.7	1.7	4.8	2.0	5.1	9.3	5.6	10.0	3.4	4.8	3.3	3.8	2.4	0.2	4.6	3.0	3.3	3.2	3.9	4.9	3.9	3.1	4.8	4.8	0.1	8.6	2.9	3.8	3.2	2.7	7.7	8.8	18.6	11.8	8.8	7.0	8.9	9.0	8.3	9.7
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing lysine methyltransferase 7"	Q8WTS6	4	139495941-139606699	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	Nucleoli				Nucleoli		"HPA058111: "	"prognostic unfavourable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	26.1	13.2	12.0	9.6	12.3	5.7	26.3	10.2	16.2	27.9	17.7	17.9	11.0	4.8	23.8	12.0	18.3	13.8	16.9	25.2	13.0	10.0	7.2	30.7	12.1	6.9	18.0	10.1	13.3	13.8	26.8	9.3	12.0	15.4	22.8	10.2	12.4	13.7	13.9	56.4	14.2	9.9	33.3	19.0	11.8	17.7	10.6	16.5	2.9	10.3	15.2	9.9	24.2	30.1	2.3	6.8	1.8	5.6	0.5	5.6	1.6	8.9	11.5	4.4	2.6	26.1	22.5	9.7	21.2	22.0	10.8	9.2	6.8	12.2	20.8	8.4	35.6	4.5	14.6	16.7	17.7	10.2	10.3	2.9	15.0	0.2	12.9	9.9	4.4	19.5	19.6	17.2	18.4	13.7	1.7	32.3	13.8	14.9	6.5	1.5	2.1	7.6	6.1	15.3	11.9	10.5	8.2	17.2	5.7	14.1	20.9	5.0	8.3	9.1	22.2	19.2	13.6	22.9	17.5	28.0	26.8	13.2	22.1	10.0	9.2	1.0	5.6	0.5	0.6	3.2	4.1	1.8	1.8	1.8	6.8	2.3	0.8	0.5	1.8	0.5	4.8	3.5	5.6	1.6	12.0	12.3	10.2	16.2	13.0	10.0	18.0	10.1	15.4	16.5
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"U-698: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: "	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavourable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavourable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	16.9	15.4	9.5	21.2	15.9	16.9	17.7	21.6	18.2	18.6	15.4	25.2	18.6	13.0	22.8	18.9	15.6	16.8	14.0	10.9	9.6	8.5	13.3	12.7	15.6	20.7	15.3	13.2	23.9	17.6	21.0	15.4	18.4	13.7	14.9	16.8	20.6	16.1	18.5	20.0	18.0	17.1	17.9	13.7	21.9	15.0	33.5	14.2	24.5	18.6	12.0	20.7	18.6	16.3	11.2	12.8	6.9	14.9	7.6	9.1	5.3	5.7	6.7	9.8	6.4	4.7	6.3	16.3	4.8	5.5	6.9	5.9	4.5	8.0	11.4	6.6	5.3	7.3	9.1	5.1	5.5	5.5	11.3	6.4	6.9	5.2	6.7	11.3	6.1	8.2	5.8	5.7	9.2	8.1	10.8	9.3	4.9	11.1	7.8	6.6	13.4	5.4	9.1	6.3	8.4	5.3	6.6	7.1	13.0	7.3	8.6	5.8	9.3	15.4	5.4	4.0	4.2	4.4	6.7	9.7	10.4	88.6	4.2	4.0	3.9	6.8	10.7	6.9	8.3	14.9	8.7	8.7	7.4	9.1	12.8	11.2	8.3	8.3	6.5	7.6	10.6	8.6	4.7	5.3	9.5	15.9	21.6	18.2	9.6	8.5	15.3	13.2	13.7	14.2
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA057999			Supported	Nucleoli				Nucleoli		"HPA057999: "	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favourable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	14.1	6.2	7.3	7.2	9.2	3.7	14.2	6.9	8.5	12.5	6.5	6.2	5.2	4.3	19.4	7.6	7.2	12.5	8.2	6.3	6.6	4.3	10.1	5.3	5.1	6.5	9.1	8.7	19.4	9.8	5.7	7.4	5.6	6.5	13.9	6.9	5.7	11.9	10.0	7.7	7.3	5.7	16.8	7.2	5.0	6.0	7.3	10.8	13.1	11.5	8.3	4.4	11.3	13.3	3.8	1.6	1.9	3.3	0.5	5.3	1.5	2.9	2.7	8.1	1.7	19.4	6.5	8.2	3.3	1.0	3.2	3.1	2.8	2.3	7.9	3.5	1.8	2.6	7.1	5.0	3.6	5.3	6.1	9.8	4.8	4.5	2.2	4.6	4.2	7.6	3.8	2.4	0.8	4.7	6.5	3.0	5.0	4.1	6.9	2.9	7.9	4.6	8.1	8.0	3.2	3.0	4.1	6.4	9.5	4.0	5.0	4.2	4.7	2.7	3.1	4.9	6.8	4.1	4.3	3.9	9.4	19.5	1.7	5.3	4.0	1.9	1.1	1.3	2.3	3.3	2.0	2.9	2.7	2.9	1.0	3.8	4.5	5.3	0.2	0.5	1.9	1.6	1.7	1.5	7.3	9.2	6.9	8.5	6.6	4.3	9.1	8.7	6.5	10.8
SETSIP	SETP18	ENSG00000230667	"SET-like protein"	P0DME0	1	92074533-92075441	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.8"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.3"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA063683	Approved		Supported	"Nucleoplasm,Lipid droplets"				Nucleoplasm	"Lipid droplets"	"HPA063683: "	"unprognostic (2.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (7.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.88e-8)"	"unprognostic (3.43e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.35e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	0.0	0.0		0.1		0.3	0.0		0.8	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.1			0.2	0.0	0.2	0.0			0.2	0.0	0.0		0.3		0.0	0.0		0.3	0.0	0.7	0.0	0.0	0.0		0.0	0.0	1.8			0.0		0.0	0.0		0.3	0.2	0.6	0.3	0.1	0.2	0.1	0.6	0.7	0.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	1.3	0.5	0.4	0.0	1.2	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	1.2	0.0	0.0	2.3	0.0	1.6	0.5	1.2	1.0	1.4	0.0	0.6	1.5	0.6	1.3	0.9	0.5	0.7	0.2	0.0	0.7	0.4	0.2	0.2	0.7	0.6	1.2	0.0	0.1	1.8	0.0	0.0	0.6	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1										
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354985	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"HPA024105: , HPA057269: "	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	20.3	12.3	13.0	23.5	15.0	14.0	16.1	16.7	14.8	14.7	16.0	11.2	14.5	9.9	18.3	15.2	13.2	17.5	12.3	13.8	13.0	8.3	12.5	15.8	18.5	23.5	19.8	12.6	15.8	11.0	24.0	24.6	13.4	16.9	13.8	12.6	8.6	16.2	16.1	18.4	15.2	19.4	16.9	20.6	25.7	13.2	34.5	18.1	26.3	31.6	10.8	24.0	18.8	16.3	8.0	5.5	16.9	5.0	5.3	6.5	2.3	9.2	12.3	14.3	15.4	18.5	22.4	8.6	12.3	13.8	10.0	9.4	13.0	10.5	15.7	6.0	22.8	18.9	14.3	10.6	11.0	14.9	6.2	16.4	13.9	11.2	17.3	25.2	20.0	15.7	16.8	17.0	15.2	16.0	19.0	12.7	11.5	13.3	15.5	9.6	15.3	9.7	14.8	20.8	10.4	11.1	12.1	8.9	13.7	20.2	9.0	11.2	12.4	13.0	18.2	21.0	9.1	14.0	11.7	7.8	13.1	24.4	9.6	10.1	11.2	7.7	4.9	4.8	6.1	4.5	6.5	6.2	4.6	4.6	3.6	8.0	5.0	4.3	16.9	5.3	5.0	5.5	3.4	2.3	13.0	15.0	16.7	14.8	13.0	8.3	19.8	12.6	16.9	18.1
SF1	"ZCCHC25, ZFM1, ZNF162"	ENSG00000168066	"Splicing factor 1"	Q15637	11	64764606-64778786	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018883	Supported		Supported	Nucleoplasm			52000	Nucleoplasm		"HPA018883: AB_1856763"	"unprognostic (1.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavourable (4.85e-5)"	"unprognostic (3.72e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.78e-1)"	43.4	36.1	35.7	50.0	37.7	124.4	43.7	61.9	49.0	45.3	41.8	51.8	40.6	38.9	48.2	42.9	39.1	49.2	44.3	39.7	34.3	26.9	38.5	39.3	38.8	54.2	37.8	32.9	66.9	47.2	40.7	43.6	33.7	33.3	47.1	28.1	46.5	47.2	56.4	60.9	47.0	44.8	43.7	28.6	59.6	41.5	65.2	44.6	75.0	45.4	30.9	52.5	39.8	56.1	11.1	12.2	15.9	11.7	9.7	15.5	8.9	35.3	43.1	39.6	34.3	22.2	17.7	46.8	25.4	21.7	34.4	26.6	36.7	40.2	56.8	31.9	28.5	42.3	44.9	44.2	29.5	42.4	30.4	36.4	27.8	27.1	35.4	38.8	37.8	23.2	22.9	43.7	46.0	30.8	53.7	37.1	26.1	37.7	74.7	54.2	53.6	31.5	63.9	27.4	44.4	23.0	39.5	31.3	41.5	35.6	31.5	34.8	47.4	41.4	26.8	38.7	35.1	35.4	40.3	43.3	34.1	52.2	34.2	33.4	46.8	3.7	10.5	11.1	15.5	11.7	15.4	11.1	11.6	14.9	10.7	9.4	13.9	14.1	15.9	9.7	10.1	12.2	11.4	8.9	35.7	37.7	61.9	49.0	34.3	26.9	37.8	32.9	33.3	44.6
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356947	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nuclear speckles"			19000	"Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	32.6	30.2	23.3	37.3	25.6	44.6	35.0	33.6	37.3	29.2	26.4	24.8	27.7	26.1	36.3	23.0	32.2	29.4	30.7	26.2	21.5	16.6	24.9	29.7	28.5	48.2	23.5	26.1	45.7	31.4	44.4	27.2	25.9	19.6	27.2	24.5	29.7	31.8	33.1	45.5	36.3	29.5	27.6	18.7	34.6	29.1	78.4	25.7	50.9	32.9	26.6	34.9	32.7	42.6	13.2	10.6	16.2	13.7	12.1	16.6	8.3	26.1	18.4	25.4	24.6	15.1	13.5	30.3	20.8	13.3	22.6	16.9	24.4	17.5	32.7	14.3	14.7	25.3	32.0	22.1	24.9	29.7	28.1	30.6	22.8	19.9	13.6	61.3	34.1	13.5	15.7	28.6	23.4	16.2	33.8	34.3	16.5	15.0	29.8	13.9	41.9	15.4	42.6	31.8	26.6	12.9	29.1	26.3	24.1	26.4	16.1	24.0	19.7	20.2	22.7	29.1	25.9	20.7	38.3	26.6	32.1	33.1	22.4	22.8	29.9	7.6	9.8	15.0	13.5	11.3	13.7	12.8	13.5	14.4	10.6	13.2	15.3	13.7	16.2	12.1	13.7	6.4	16.6	8.3	23.3	25.6	33.6	37.3	21.5	16.6	23.5	26.1	19.6	25.7
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990921	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: "	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavourable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	7.0	6.4	5.3	6.3	5.9	13.6	7.6	7.4	5.5	6.3	6.5			4.3	9.4	8.7	6.8	7.7	4.1	4.3	4.8	4.9	5.9	6.2	6.1	8.4	5.3		8.7	6.7	6.4	5.7	5.6		6.1	7.2		5.9	7.2	15.3	7.7	5.9	7.7	4.3	7.9	6.2	5.8			6.3		10.3	6.2	6.1	23.6	19.0	10.6	20.6	18.7	27.8	20.6	15.7	12.0	21.7	18.5	13.6	12.6	26.3	15.4	14.1	27.0	21.9	19.7	16.7	29.9	13.5	14.9	13.6	27.6	22.4	33.2	13.6	26.9	38.0	19.2	17.0	12.5	46.2	18.4	11.9	15.7	28.0	18.5	18.7	33.4	11.8	19.5	10.5	24.3	26.7	53.6	18.7	29.1	37.3	21.5	12.4	16.4	19.0	14.1	19.7	9.2	16.2	10.9	18.3	16.8	14.2	15.6	13.0	30.5	11.4	16.1	30.5	13.6	42.6	17.6	10.6	15.3	9.8	21.8	18.9	21.2	20.4	25.8	22.0	19.0	23.6	27.8	23.6	2.0	18.7	20.6	11.8	26.3	20.6										
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197389784-197435091	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"			840000	"Nuclear speckles"		"HPA050275: "	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	53.9	49.9	36.5	54.5	44.9	88.0	57.9	60.8	47.3	72.3	54.2	44.3	45.6	36.8	64.6	72.0	50.5	53.3	43.1	39.6	34.7	26.0	49.7	50.7	53.1	65.3	56.5	27.7	73.6	60.5	66.2	81.4	64.6	46.7	50.0	51.0	37.0	54.4	45.4	49.3	48.5	67.8	41.2	50.2	88.1	48.8	33.3	53.5	113.0	53.3	38.0	65.7	62.4	56.0	32.7	41.9	41.1	37.8	39.6	45.9	29.4	30.7	28.2	63.6	34.7	49.3	50.4	53.4	43.0	44.0	37.6	46.1	53.8	33.2	58.7	29.0	43.7	29.8	63.5	34.9	58.8	44.9	39.5	62.1	69.0	63.2	37.2	65.9	45.3	52.6	34.1	39.1	48.2	43.7	44.4	40.5	41.6	27.0	60.6	63.5	50.0	44.6	53.4	54.4	39.0	52.2	78.2	35.7	44.3	41.1	25.2	29.4	24.9	50.5	44.0	29.5	25.4	29.8	30.5	37.0	60.1	84.3	28.3	39.9	32.6	27.7	33.1	39.1	37.5	37.8	40.6	32.7	32.5	35.3	41.9	30.8	33.9	33.9	41.1	39.6	36.1	23.8	45.9	29.4	36.5	44.9	60.8	47.3	34.7	26.0	56.5	27.7	46.7	53.5
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"			57000	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavourable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	52.4	42.9	50.1	45.8	61.7	75.7	47.3	57.0	75.7	50.6	46.0	61.7	33.0	42.6	53.0	61.8	45.4	65.0	43.5	47.3	51.2	45.5	51.2	56.8	45.2	55.5	54.8	42.4	74.1	60.5	75.2	63.5	58.9	50.5	50.1	49.1	48.8	42.4	51.4	48.8	50.0	46.8	51.9	44.6	56.7	44.2	86.0	52.9	85.9	60.6	34.5	67.7	47.7	47.1	43.8	39.7	63.3	57.8	43.2	57.9	51.5	52.6	42.5	46.0	43.1	47.8	44.0	38.1	40.1	54.6	62.6	47.2	34.8	45.9	50.4	45.5	47.1	48.9	66.4	46.1	52.6	40.2	34.3	54.3	40.0	56.7	48.4	53.8	41.4	37.5	45.0	63.3	73.3	44.9	50.7	83.7	47.7	71.5	60.7	79.3	47.7	39.7	55.2	39.5	71.5	47.3	43.6	36.7	53.6	40.2	42.4	59.5	53.4	34.1	37.2	51.5	43.9	57.2	45.1	64.4	75.3	64.0	57.0	35.5	46.5	56.9	39.4	63.3	57.9	46.0	55.7	43.1	51.3	54.0	39.7	43.8	50.3	49.6	52.0	43.2	57.8	30.9	50.0	51.5	50.1	61.7	57.0	75.7	51.2	45.5	54.8	42.4	50.5	52.9
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523788-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041134: , HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	23.8	21.1	11.8	22.1	23.2	24.7	22.4	24.9	26.9	23.4	20.6	20.9	15.6	17.1	27.5	13.9	31.8	22.1	15.6	20.1	14.0	12.8	17.0	19.0	18.4	28.5	16.9	15.0	33.3	22.5	34.0	26.8	19.9	16.5	18.4	16.4	20.2	22.6	17.3	30.9	28.9	18.8	20.1	15.4	21.0	17.9	15.5	15.9	47.7	25.1	17.2	31.9	23.7	25.0	23.2	21.4	16.4	18.8	21.0	25.9	19.7	18.4	19.4	25.2	17.6	12.5	11.6	19.0	17.5	15.0	22.9	18.6	19.8	14.8	24.8	14.2	13.7	21.8	26.5	15.0	37.0	8.0	18.6	19.3	15.9	20.9	8.5	27.1	22.8	11.0	10.9	25.5	18.9	13.7	26.3	8.9	18.2	22.8	23.8	13.4	23.1	11.2	42.1	19.6	27.8	7.4	25.5	21.9	16.2	57.1	9.1	8.8	19.6	13.5	14.0	17.0	18.6	13.1	18.4	10.0	21.9	66.5	11.3	17.4	15.8	11.5	15.8	16.4	23.1	18.8	25.4	18.6	21.8	24.2	21.4	23.2	25.9	22.0	5.4	21.0	17.9	12.0	24.0	19.7	11.8	23.2	24.9	26.9	14.0	12.8	16.9	15.0	16.5	15.9
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094881-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054408	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA054408: "	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	31.0	52.5	32.9	34.0	37.2	76.6	41.7	18.6	35.8	36.9	42.6	23.8	45.3	33.1	34.5	42.6	46.9	47.1	39.8	47.7	32.0	31.1	54.4	84.8	30.3	62.4	32.5	26.0	40.9	100.7	22.3	48.4	31.3	28.0	32.1	40.6	26.5	43.1	60.4	47.4	39.8	40.3	33.2	30.6	38.7	33.9	47.3	24.7	56.7	47.7	63.7	43.4	35.3	30.2	42.7	76.4	38.4	80.7	38.6	48.6	68.5	22.4	30.6	35.1	64.8	41.2	47.0	20.9	23.4	39.5	48.2	55.2	32.3	20.6	37.6	42.1	38.0	26.8	40.3	53.8	34.1	38.7	56.8	41.0	27.3	71.0	39.7	79.7	26.4	47.9	72.7	52.9	52.9	58.3	52.4	54.9	43.1	79.8	51.4	72.0	22.5	37.0	32.2	46.0	38.0	52.3	20.3	48.3	30.5	32.7	40.0	43.5	29.1	49.1	31.4	24.8	33.9	44.4	50.5	41.3	49.8	35.3	40.2	67.1	30.5	30.6	80.7	38.4	38.4	56.1	47.2	42.7	43.6	45.2	68.8	39.1	43.5	43.3	21.6	38.6	49.8	76.4	48.6	68.5	32.9	37.2	18.6	35.8	32.0	31.1	32.5	26.0	28.0	24.7
SF3B6	"CGI-110, Ht006, P14, SAP14a, SF3B14a"	ENSG00000115128	"Splicing factor 3b subunit 6"	Q9Y3B4	2	24067584-24076443	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034829, HPA034830"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA034829: AB_10673104, HPA034830: AB_10669680"	"unprognostic (6.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.35e-3)"	"prognostic unfavourable (5.57e-5)"	"unprognostic (1.74e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (2.80e-2)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-1)"	39.4	43.5	39.5	31.0	35.9	72.5	57.1	24.2	35.5	43.7	49.7	30.8	34.6	39.5	41.3	58.6	62.9	36.5	35.4	38.8	35.5	31.5	60.3	64.5	33.1	37.1	35.3	29.2	41.5	43.1	26.4	41.4	49.3	30.8	41.8	45.5	27.1	46.4	36.3	40.8	33.4	62.1	46.0	40.4	42.5	35.8	42.2	34.7	56.9	57.1	63.3	47.3	49.6	42.2	54.1	49.9	71.1	45.6	44.0	62.4	47.4	49.1	23.8	38.3	31.8	30.4	47.5	23.6	37.4	40.0	45.2	46.7	50.8	31.2	36.8	21.2	34.4	29.3	39.2	47.0	54.9	36.1	47.1	38.9	30.6	44.1	54.8	48.0	24.3	43.9	56.4	45.9	52.8	45.3	44.0	28.0	47.1	37.1	36.1	72.6	30.8	47.1	26.6	52.6	36.5	53.6	27.7	34.3	51.6	20.9	41.4	82.3	20.2	49.7	27.0	25.0	34.6	26.1	61.2	28.1	36.1	99.6	34.1	80.3	34.3	56.6	43.9	64.9	36.8	45.6	40.5	54.1	46.9	43.9	49.9	40.7	46.4	49.1	71.1	44.0	40.2	45.6	62.4	47.4	39.5	35.9	24.2	35.5	35.5	31.5	35.3	29.2	30.8	34.7
SFMBT1	"DKFZp434L243, RU1, SFMBT"	ENSG00000163935	"Scm like with four mbt domains 1"	Q9UHJ3	3	52903572-53046750	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 30.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036152, HPA064564"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA036152: , HPA064564: "	"unprognostic (2.78e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.39e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.57e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.55e-2)"	3.1	2.4	5.1	7.0	3.7	5.5	6.8	10.5	5.8	3.2	4.9	3.1	2.7	3.1	2.8	5.2	4.9	3.7	3.8	4.8	4.1	2.4	4.5	6.3	7.3	6.3	2.6	4.3	2.4	11.8	15.1	12.0	3.1	3.1	4.6	5.4	2.9	4.6	2.1	17.7	4.8	4.4	4.1	4.1	5.9	4.2	30.2	2.4	3.9	5.1	2.7	5.6	3.2	12.9	8.2	0.9	10.9	2.1	3.6	5.3	2.4	15.3	4.2	6.8	12.3	1.5	1.1	13.9	3.3	3.2	10.2	12.7	8.6	13.2	7.9	4.0	2.0	1.3	6.8	4.3	12.4	14.2	4.3	6.6	8.8	3.8	2.4	10.3	6.9	1.0	6.3	7.0	4.7	1.8	2.2	11.8	3.3	4.8	6.5	4.1	3.5	4.5	5.8	6.3	4.4	1.4	16.5	8.0	5.1	14.4	6.0	7.3	3.9	9.6	1.1	4.6	10.3	7.8	10.3	5.7	19.8	16.8	4.2	4.3	7.6	2.0	2.1	10.9	3.4	1.1	4.5	8.2	5.2	3.1	0.9	6.9	4.8	5.3	3.8	3.6	1.1	0.9	2.5	2.4	5.1	3.7	10.5	5.8	4.1	2.4	2.6	4.3	3.1	2.4
SFMBT2	KIAA1617	ENSG00000198879	"Scm like with four mbt domains 2"	Q5VUG0	10	7158624-7411486	"Predicted intracellular proteins"		Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.2;REH: 14.5;RPMI-8226: 13.5;THP-1: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035447, HPA035448, HPA070388"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA035447: , HPA035448: AB_10669904, HPA070388: "	"unprognostic (4.36e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.17e-3)"	"unprognostic (5.37e-3)"	"unprognostic (7.29e-2)"	3.0	4.2	9.6	5.9	11.7	6.1	6.2	6.6	13.7	2.5	2.8	26.7	1.1	2.0	4.3	3.7	2.3	3.7	3.6	3.9	12.6	6.9	2.7	1.1	4.1	7.2	14.6	7.4	11.2	3.8	10.1	6.6	3.7	10.8	6.5	3.4	3.9	4.6	3.6	3.9	1.2	3.5	3.4	10.6	9.0	2.9	1.5	9.7	2.0	7.8	1.1	6.2	3.7	4.1	0.1	5.4	1.7	7.4	1.3	1.8	0.4	0.0	3.4	0.2	0.0	0.0	0.2	3.1	0.1	0.0	0.0	0.0	0.0	0.8	5.3	0.0	0.1	1.5	5.9	0.0	0.0	0.3	5.3	0.0	8.8	0.0	0.4	5.7	0.7	0.8	0.2	0.0	0.1	0.0	8.9	16.2	0.0	2.3	4.5	9.0	1.0	0.0	14.5	1.7	13.5	0.0	0.4	1.3	11.1	0.0	0.0	0.0	0.8	17.4	0.0	0.0	1.8	0.2	0.1	6.9	9.9	0.0	0.7	10.9	0.1	0.1	0.4	1.7	1.4	3.8	0.8	0.1	0.5	0.9	0.7	0.1	1.8	1.1	0.2	1.3	7.4	5.4	0.0	0.4	9.6	11.7	6.6	13.7	12.6	6.9	14.6	7.4	10.8	9.7
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Cell line enhanced"	"Detected in many"		"A-431: 68.6;HaCaT: 108.3;HBEC3-KT: 166.7;hTCEpi: 111.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	Nucleoli,Cytosol	"Secreted in other tissues"		54000000	Cytosol	Nucleoli	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	68.6	11.6	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	36.2	0.6	3.0	0.0	108.3	0.0	166.7	0.0	16.4	0.5	0.0	11.6	12.2	0.0	0.0	0.1	0.0	111.9	0.0	29.3	0.0	0.1	0.4	0.0	14.6	0.0	0.0	0.2	19.3	0.0	0.0	3.8	25.9	15.8	0.0	0.0	16.6	2.9	0.1	7.7	0.1	0.0	0.0	31.7	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193148	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm			280000	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favourable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	40.5	35.7	31.5	39.4	31.4	122.5	48.3	53.0	38.5	39.0	31.4	37.8	32.9	30.0	45.3	36.5	45.5	43.0	28.1	34.0	29.1	24.6	36.4	34.2	47.6	48.8	26.3	32.6	59.9	40.2	45.8	46.3	35.5	31.9	35.5	38.0	35.7	39.6	38.0	44.9	42.9	34.1	36.5	32.8	42.4	35.5	37.5	32.9	95.2	35.3	24.1	60.6	35.9	38.6	6.9	11.2	4.4	8.8	4.9	8.9	3.3	36.1	30.2	52.8	29.8	13.0	19.6	49.6	19.8	20.2	33.9	24.8	32.9	26.2	66.1	27.6	22.9	33.1	57.4	38.8	46.3	35.2	38.1	49.7	32.6	39.0	17.6	51.6	29.6	15.6	15.1	29.4	14.3	29.5	56.1	31.6	32.9	31.5	60.4	44.3	62.9	29.3	61.4	35.9	43.0	32.7	44.0	38.1	42.4	28.6	22.3	28.7	26.1	36.8	31.3	27.2	40.0	17.8	42.4	36.2	30.7	67.3	19.4	34.2	38.6	2.6	6.5	4.4	7.7	8.8	8.9	6.2	7.6	6.1	5.8	6.9	7.2	7.9	3.4	4.9	6.4	11.2	8.2	3.3	31.5	31.4	53.0	38.5	29.1	24.6	26.3	32.6	31.9	32.9
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 34.2;T-cells: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Uncertain		Enhanced	Mitochondria				Mitochondria		"HPA019543: AB_1856789, HPA063745: "	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	5.6	14.0	15.2	12.0	20.9	12.9	8.1	20.7	24.5	6.5	18.8	7.9	5.3	13.2	6.5	6.0	12.6	6.6	7.1	9.4	14.5	18.3	28.3	66.8	5.3	17.0	15.3	17.0	13.6	9.7	7.4	11.8	10.4	15.1	7.6	12.5	5.7	7.7	8.0	11.7	6.3	13.4	8.1	15.0	8.2	10.1	5.0	11.0	13.9	7.7	7.3	17.8	11.3	9.1	4.5	3.0	34.2	2.6	4.8	16.0	5.6	10.0	32.0	16.4	17.7	5.6	12.2	26.4	25.8	10.9	21.8	21.2	40.1	20.4	21.1	20.1	13.5	13.0	31.4	45.0	23.7	51.6	26.3	15.5	28.9	17.5	8.3	30.2	19.6	9.9	8.8	24.1	10.6	16.7	22.2	16.8	15.8	35.3	35.3	2.4	12.9	10.6	29.7	16.8	22.6	8.2	39.7	28.0	17.9	24.9	23.6	12.6	11.4	10.0	16.2	17.3	27.4	12.6	33.6	21.4	25.2	48.2	28.3	27.3	17.9	34.2	2.1	10.4	11.3	2.6	9.4	4.5	16.0	12.6	3.0	3.8	12.7	12.9	0.6	4.8	1.7	1.4	12.7	5.6	15.2	20.9	20.7	24.5	14.5	18.3	15.3	17.0	15.1	11.0
SFXN3	"SFX3, SLC56A3"	ENSG00000107819	"Sideroflexin 3"	Q9BWM7	10	101031234-101041244	"Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008028, HPA048105"	Approved		Enhanced	Mitochondria			81000	Mitochondria		"HPA008028: AB_1079938, HPA048105: "	"unprognostic (2.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavourable (3.79e-4)"	"unprognostic (3.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (3.56e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	14.4	8.1	11.5	8.7	13.9	4.1	10.7	40.2	22.9	14.5	19.0	15.5	13.6	24.4	13.8	17.7	6.5	14.9	12.9	11.3	12.5	9.8	9.2	3.4	16.4	5.4	18.3	13.7	10.6	7.0	17.1	6.9	16.2	18.4	8.8	8.4	9.1	8.4	13.8	2.7	15.7	44.8	19.9	13.7	8.3	8.2	5.6	16.9	4.3	7.5	5.1	5.5	10.7	11.2	2.2	15.7	8.9	14.8	4.3	9.8	8.3	15.4	6.0	0.6	1.8	16.3	17.3	1.6	9.4	33.5	12.1	9.8	9.9	17.1	0.6	9.1	22.1	11.4	2.8	20.6	5.3	4.3	3.6	1.8	10.0	7.1	11.2	1.4	15.1	11.9	3.0	10.6	10.0	26.5	0.1	0.5	19.6	2.5	0.6	2.2	0.7	14.6	1.5	11.9	4.2	17.8	2.4	3.3	16.2	5.1	0.6	14.0	5.0	11.0	21.7	10.7	8.4	9.4	4.6	2.4	0.9	0.0	26.1	8.4	8.5	8.9	14.8	7.1	9.8	11.1	7.5	2.2	6.7	6.6	15.7	1.0	4.1	5.1	2.8	4.3	6.1	2.5	7.0	8.3	11.5	13.9	40.2	22.9	12.5	9.8	18.3	13.7	18.4	16.9
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 141.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 50.1;RPTEC TERT1: 76.9;SK-MEL-30: 49.8;TIME: 59.8;U-266/84: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 45.9;monocytes: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: "	"unprognostic (2.05e-2)"	"prognostic favourable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	45.6	35.5	16.8	12.8	43.2	15.8	22.9	10.6	25.0	18.4	62.3	51.7	10.8	14.2	14.9	11.2	30.0	16.1	47.8	12.5	22.9	9.6	37.5	51.1	31.2	8.4	48.8	16.6	47.2	47.8	141.3	4.7	19.2	28.3	18.3	11.3	45.8	26.2	18.4	12.4	25.8	131.8	13.6	40.3	7.6	31.1	12.2	50.1	6.2	22.3	24.8	20.4	26.1	31.7	0.6	4.0	45.9	11.7	0.9	0.7	3.1	0.6	1.1	0.7	0.0	8.6	2.1	0.9	12.3	25.7	16.1	13.2	1.9	1.7	2.0	1.8	12.7	0.4	1.1	1.9	11.9	0.0	0.5	0.1	30.7	1.4	50.1	0.1	1.1	12.9	12.4	15.8	20.6	27.0	3.9	31.4	5.7	0.1	0.1	0.4	0.7	1.3	0.3	1.4	0.2	76.9	0.2	0.3	3.0	38.7	0.1	49.8	0.0	0.3	59.8	4.7	2.0	28.9	2.7	5.9	54.8	6.3	4.4	1.9	6.3	0.6	11.7	45.9	0.2	6.8	0.5	0.6	0.4	0.2	4.0	0.4	0.5	0.6	26.2	0.9	3.7	0.2	0.7	3.1	16.8	43.2	10.6	25.0	22.9	9.6	48.8	16.6	28.3	50.1
SGK2		ENSG00000101049	"SGK2, serine/threonine kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.1;kidney: 39.1;liver: 32.9"	"Group enriched"	"Detected in some"	5	"A549: 13.5;CAPAN-2: 10.6;EFO-21: 5.4;Hep G2: 13.7;RPTEC TERT1: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA008859: , HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favourable (5.65e-4)"	11.4	0.7	2.8	4.3	9.9	0.2	3.1	1.0	10.2	1.4	21.3	33.1	0.9	17.8	1.0	19.7	0.7	1.6	7.9	0.7	4.3	2.5	39.1	32.9	0.6	0.5	6.9	5.1	3.2	14.1	0.5	1.7	0.5	13.7	1.4	23.4	0.0	0.9	1.8	0.4	3.2	20.7	1.0	14.2	0.7	11.9	1.0	6.0	0.0	1.0	0.2	0.2	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.6	10.6	0.0	5.4	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	13.7	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	19.4	2.2	0.1	0.5	0.0	0.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	9.9	1.0	10.2	4.3	2.5	6.9	5.1	13.7	6.0
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66667596-66862022	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006699, HPA027146"	Supported		Supported	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favourable (5.52e-6)"	"prognostic favourable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favourable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	6.5	5.9	13.9	8.7	20.9	7.7	23.9	9.8	14.8	12.0	10.0	24.0	8.7	8.6	8.0	10.3	7.6	7.8	7.8	5.4	16.1	10.2	14.9	13.6	9.9	8.5	28.8	9.3	9.8	15.6	29.2	14.8	5.9	14.6	7.8	10.7	17.2	7.0	7.7	6.1	12.4	10.8	6.0	32.8	8.2	7.2	8.9	21.9	8.3	17.3	4.3	6.8	6.1	8.0	5.8	13.8	21.4	15.7	6.9	13.3	8.0	11.4	2.9	0.5	1.8	3.5	6.8	6.5	7.3	6.9	4.0	4.2	5.2	7.7	8.6	1.8	8.0	3.7	6.0	4.3	5.0	4.8	10.2	7.8	2.1	5.1	3.5	7.0	9.3	3.3	3.8	1.9	6.7	6.4	1.5	4.2	7.6	1.8	5.5	4.3	1.6	4.0	9.7	4.3	5.8	5.4	2.6	2.5	1.9	3.3	4.9	11.0	23.1	14.0	7.6	3.8	3.4	3.3	2.7	5.2	9.9	9.9	4.4	11.8	3.9	21.4	15.7	6.2	8.1	9.3	13.3	3.7	8.4	8.5	13.8	5.8	9.0	6.9	2.5	6.9	4.4	7.7	5.3	8.0	13.9	20.9	9.8	14.8	16.1	10.2	28.8	9.3	14.6	21.9
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186292	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 40.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035501: , HPA069302: , HPA069857: "	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.6	0.6	0.4	9.1	0.4	8.9	1.0	0.4	1.5	0.9	3.4	0.3	0.6	2.7	0.8	0.5	4.0	0.3	1.7	0.4	0.3	0.4	0.8	1.0	0.9	6.9	0.4	0.1	0.5	0.5	0.0	0.4	3.7	0.2	0.6	3.5	0.1	1.0	0.1	0.3	1.1	3.4	0.8	0.4	4.9	1.5	8.6	0.2	40.1	0.5	2.4	7.4	1.2	1.5	9.0	4.5	8.3	0.2	0.3	2.7	0.6	9.4	10.8	14.7	9.0	0.7	1.3	10.0	10.2	5.2	14.9	16.3	7.6	11.7	14.5	5.1	4.2	5.5	13.9	5.6	18.8	18.4	9.2	16.4	7.4	6.1	0.1	14.9	14.2	0.1	0.4	16.3	6.9	8.8	14.0	25.9	12.3	9.3	23.4	8.4	15.7	8.2	15.0	18.9	8.4	3.7	6.9	7.3	7.7	11.2	13.9	6.7	9.0	10.5	2.4	11.3	13.5	10.0	20.3	11.1	25.9	16.8	6.2	15.1	16.9	8.3	0.1	1.5	0.3	0.2	0.1	8.6	0.7	0.8	0.4	9.0	0.2	0.4	1.6	0.3	0.2	4.5	2.7	0.6	0.4	0.4	0.4	1.5	0.3	0.4	0.4	0.1	0.2	0.2
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200583782	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.6;lymphoid tissue: 25.7;testis: 27.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: "	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	5.3	1.7	1.5	8.6	2.3	5.3	3.5	4.0	3.1	1.6	2.7	0.7	0.3	2.1	1.6	1.0	3.7	1.6	1.3	1.4	1.9	1.5	1.8	1.0	1.9	6.5	2.7	3.7	2.2	1.2	1.1	0.9	2.2	3.2	1.4	2.9	0.1	1.7	1.5	1.0	2.0	2.8	1.7	3.5	3.9	1.7	27.9	2.3	25.7	1.5	4.1	7.0	2.0	1.8	3.8	2.1	12.6	1.9	2.4	4.2	1.4	15.5	7.3	17.6	7.9	2.4	3.9	10.9	17.9	7.5	15.4	15.5	11.2	10.5	10.1	8.3	8.5	11.6	15.5	9.3	26.4	20.3	7.7	19.1	10.5	8.0	0.7	19.9	15.5	1.5	1.1	15.5	8.0	13.6	14.7	15.0	29.1	6.9	16.0	8.2	12.5	18.2	12.7	23.3	9.3	6.4	6.1	10.3	7.1	13.1	6.4	7.8	6.8	11.7	8.2	16.2	16.1	14.8	15.6	6.8	14.2	22.1	10.2	13.4	23.1	12.6	1.8	5.1	2.8	1.7	1.9	3.0	3.2	2.8	1.0	3.8	2.4	3.0	1.3	2.4	1.9	2.1	4.2	1.4	1.5	2.3	4.0	3.1	1.9	1.5	2.7	3.7	3.2	2.3
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815961-70881173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	9.6	11.2	12.0	20.2	11.4	4.9	24.4	10.8	10.6	16.2	17.1	16.0	21.9	13.3	15.5	16.8	26.7	13.5	13.4	8.3	11.3	9.8	18.2	27.1	10.4	20.1	11.9	9.5	10.0	34.6	15.4	10.2	11.3	10.4	16.1	15.6	7.6	15.0	19.5	7.6	28.6	32.5	12.1	15.7	22.9	10.3	15.3	11.0	14.7	17.6	12.8	18.0	21.4	26.8	5.6	9.7	8.9	24.8	10.9	11.5	6.6	10.5	14.1	13.6	15.5	3.7	4.9	9.0	6.2	6.7	6.8	8.9	15.3	23.4	9.5	7.4	6.3	17.8	11.7	12.5	9.7	15.2	6.2	0.9	7.2	18.2	14.2	4.1	8.6	9.2	21.2	9.1	24.0	4.2	2.8	8.3	9.6	11.7	5.0	2.8	6.1	7.8	6.5	10.4	3.5	10.8	44.8	9.3	11.3	12.4	19.1	11.3	9.9	3.0	8.1	6.1	16.2	4.7	11.9	3.4	4.7	4.4	6.1	7.7	4.3	0.6	11.5	7.9	11.5	20.3	10.4	4.7	7.5	9.4	9.7	5.6	5.7	9.0	8.9	10.9	24.8	5.4	6.8	6.6	12.0	11.4	10.8	10.4	11.3	9.8	11.9	9.5	10.4	11.0
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684214-63728039	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.4;U-698: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA053149: , HPA064908: "	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	10.5	12.1	12.1	15.7	11.6	4.3	7.6	14.3	12.9	9.2	9.6	15.1	3.9	6.2	8.4	10.3	5.7	5.9	8.9	5.5	13.1	12.6	24.7	29.4	10.3	18.5	13.0	7.0	7.4	14.1	15.5	6.4	49.4	11.1	9.0	8.7	6.7	5.7	7.0	4.4	4.8	8.9	7.9	19.6	16.5	5.8	8.2	9.8	15.4	7.8	3.7	19.1	8.6	7.3	3.2	0.5	8.8	3.3	0.5	2.0	0.5	10.3	3.3	1.6	4.7	6.0	5.6	19.9	8.5	5.9	5.3	6.0	1.4	5.9	23.4	2.5	4.3	11.0	2.6	5.0	8.6	9.1	3.1	2.1	2.0	2.3	7.4	3.8	6.7	4.1	8.1	4.6	7.3	2.5	1.2	0.6	7.7	3.8	4.4	0.0	1.1	7.2	1.1	4.6	1.8	8.4	5.2	1.0	2.7	5.9	5.6	4.4	7.3	1.4	2.8	7.4	5.1	5.2	4.2	5.6	3.4	30.5	5.4	0.0	3.1	8.8	0.3	2.8	1.0	2.3	1.0	3.2	1.0	0.7	0.5	0.8	1.5	1.1	0.4	0.5	3.3	0.3	2.0	0.5	12.1	11.6	14.3	12.9	13.1	12.6	13.0	7.0	11.1	9.8
SGSM3	"DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3"	ENSG00000100359	"Small G protein signaling modulator 3"	Q96HU1	22	40370591-40410289	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048980	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA048980: "	"unprognostic (4.63e-2)"	"unprognostic (7.51e-3)"	"unprognostic (3.02e-2)"	"prognostic favourable (4.47e-5)"	"unprognostic (1.81e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.98e-3)"	10.5	17.2	18.2	15.9	19.4	11.4	12.0	27.2	29.9	18.7	21.5	13.7	27.2	21.5	13.6	14.9	19.7	17.0	34.5	14.1	17.7	17.3	14.6	14.4	13.3	20.0	16.1	26.3	13.2	51.6	16.4	22.3	14.5	18.5	24.2	16.4	14.4	43.9	22.9	20.5	17.7	20.6	11.7	11.9	19.8	51.5	20.6	14.2	13.3	19.8	11.1	20.9	15.3	13.9	15.7	21.0	10.2	10.1	20.9	13.0	9.9	16.8	9.6	14.3	15.7	15.8	8.8	20.3	16.1	10.5	12.1	15.9	5.4	14.2	10.5	11.2	17.2	13.7	13.4	19.5	4.8	26.0	31.9	7.1	23.9	5.0	15.2	10.2	15.6	14.4	13.8	13.6	8.2	21.2	8.7	14.6	8.9	27.0	14.2	10.5	9.5	6.5	26.5	9.0	22.8	12.4	15.0	8.8	11.4	17.7	25.7	12.1	21.4	17.5	18.4	4.2	15.3	10.9	9.2	22.1	10.1	13.7	17.6	8.6	10.5	0.7	9.4	10.2	13.0	10.1	10.9	12.1	8.1	10.4	12.3	15.7	10.0	8.0	2.2	20.9	7.2	21.0	7.5	9.9	18.2	19.4	27.2	29.9	17.7	17.3	16.1	26.3	18.5	14.2
SH2D4A	"FLJ20967, PPP1R38, SH2A"	ENSG00000104611	"SH2 domain containing 4A"	Q9H788	8	19313617-19396218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 50.6;U-2197: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.4;neutrophil: 5.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.4;granulocytes: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001871, HPA001919"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA001871: AB_1079949, HPA001919: AB_1079947"	"unprognostic (9.08e-2)"	"unprognostic (8.40e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.70e-2)"	"unprognostic (8.84e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (6.02e-8)"	"unprognostic (1.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	4.1	8.5	2.1	6.8	1.8	0.0	3.3	0.7	3.2	7.4	8.9	1.7	15.2	6.3	2.5	3.7	17.5	4.6	12.8	2.9	3.7	1.3	10.0	20.0	8.8	2.2	1.8	2.0	20.5	12.8	6.1	3.6	13.5	2.2	7.6	5.5	5.1	16.3	20.1	2.6	5.9	10.6	6.5	1.4	1.8	15.6	3.2	2.4	0.6	20.7	14.6	9.9	11.9	14.1	0.7	1.4	5.3	0.0	0.4	0.6	0.1	16.5	18.8	0.0	0.0	1.9	2.3	12.9	20.7	10.3	20.3	19.8	15.4	15.0	0.0	5.0	50.6	8.6	0.7	5.6	21.3	0.0	0.2	0.0	11.7	2.3	11.2	0.4	0.0	2.2	7.0	13.8	2.5	0.1	0.0	0.0	3.3	7.4	0.0	0.1	4.5	7.2	0.0	0.0	5.3	5.5	17.4	1.1	0.0	18.6	20.1	0.0	3.8	1.4	0.3	6.6	0.0	37.4	6.2	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	1.4	0.7	0.6	0.0	5.3	0.4	0.0	0.1	0.4	0.1	2.1	1.8	0.7	3.2	3.7	1.3	1.8	2.0	2.2	2.4
SH2D5		ENSG00000189410	"SH2 domain containing 5"	Q6ZV89	1	20719732-20732837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 19.5;placenta: 14.8;testis: 9.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.9;hTERT-HME1: 31.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030182			Supported	Cytosol				Cytosol		"HPA030182: AB_10670431"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.80e-6)"	"unprognostic (1.11e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-2)"	0.4	0.9	4.5	1.3	19.5	0.4	0.3	0.5	19.2	0.6	0.5	0.3	0.0	1.2	1.4	0.3	0.5	0.5	0.6	0.3	3.9	4.1	0.4	0.3	0.4	0.3	1.5	7.3	1.7	0.3	0.6	0.1	14.8	2.1	0.5	0.3	0.0	0.4	1.8	0.3	0.6	0.5	1.2	0.3	0.4	0.6	9.4	0.7	0.0	2.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.6	3.8	0.8	0.0	0.0	0.0	0.1	4.6	6.5	4.5	3.0	1.6	1.5	0.0	1.2	1.3	0.4	3.3	24.9	1.8	0.0	1.7	0.0	0.5	1.2	3.7	0.0	0.0	0.2	5.2	8.4	31.9	0.0	0.0	0.0	1.9	0.9	0.5	0.0	1.5	5.0	0.1	0.1	0.2	4.7	0.6	1.4	0.2	0.3	0.1	1.5	0.0	0.0	0.0	5.5	9.7	8.2	2.2	0.0	0.0	0.4	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	19.5	0.5	12.3	3.9	4.1	1.5	7.3	2.1	0.7
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631283-79703659	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 104.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 37.8;HEL: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 7.4;neutrophil: 2.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm			4700000	Nucleoplasm		"HPA047486: "	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favourable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	21.0	3.9	11.6	6.5	10.7	1.1	29.3	9.7	18.3	14.6	24.7	2.6	7.9	17.3	9.1	13.0	29.8	9.3	14.2	7.4	12.3	13.8	8.2	27.6	8.0	4.1	14.6	7.8	3.5	11.6	17.9	12.6	14.4	22.4	13.8	24.1	9.6	104.4	6.4	8.3	7.1	17.3	8.2	13.9	3.8	34.1	3.7	2.4	0.4	38.3	11.1	15.0	8.7	12.6	0.0	0.2	7.4	0.3	0.0	1.2	10.8	3.9	0.7	3.6	0.7	3.2	2.8	8.6	0.2	2.6	0.9	1.9	37.8	7.7	0.0	5.5	0.2	1.8	3.3	4.3	3.2	0.0	4.8	19.2	0.8	7.2	1.4	0.7	0.5	1.5	3.5	2.7	1.6	11.2	7.6	0.0	0.3	0.6	0.0	0.0	3.1	1.3	0.0	1.0	0.1	0.9	12.7	9.8	10.7	0.2	1.1	0.2	0.2	1.6	6.3	2.5	1.6	0.0	2.2	5.7	2.7	0.0	0.4	0.0	0.8	7.4	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.2	2.7	0.0	0.0	0.2	0.0	10.8	11.6	10.7	9.7	18.3	12.3	13.8	14.6	7.8	22.4	2.4
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254853-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: "	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	38.6	72.5	12.7	20.0	13.4	29.9	35.7	34.8	22.3	30.5	12.7	20.7	42.0	7.5	33.9	20.4	11.9	32.2	29.0	9.6	17.2	11.2	19.6	9.9	38.8	25.1	13.0	18.9	49.6	7.1	30.0	14.7	19.5	15.1	13.5	4.9	12.4	22.4	45.1	61.7	10.1	10.3	21.0	19.0	14.8	7.2	17.0	10.8	9.3	20.8	7.7	18.9	25.3	44.3	13.3	4.8	8.0	3.9	13.0	28.9	9.5	7.2	3.6	1.7	3.4	15.7	13.3	92.0	4.0	2.7	2.2	2.7	2.3	3.3	6.1	1.7	10.5	0.9	0.8	3.4	1.9	4.7	3.4	4.1	16.5	0.4	6.0	1.1	2.1	10.6	2.5	10.0	2.1	30.7	4.5	2.0	3.0	26.0	14.4	6.8	3.6	5.5	0.2	8.2	27.5	2.6	12.2	4.1	2.2	5.5	5.0	5.8	4.5	3.0	23.6	5.9	8.2	5.6	3.1	0.8	1.7	4.2	11.2	4.0	7.9	3.5	3.9	4.5	28.9	1.3	9.1	10.9	13.7	19.9	4.8	13.3	7.5	9.8	8.0	13.0	2.1	2.2	5.7	9.5	12.7	13.4	34.8	19.2	17.2	11.2	13.0	18.9	15.1	10.8
SH3D19	"DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19"	ENSG00000109686	"SH3 domain containing 19"	Q5HYK7	4	151102751-151325632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 54.3;ASC TERT1: 46.4;HSkMC: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016424, HPA058562"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA016424: AB_1856814, HPA058562: "	"unprognostic (1.09e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.86e-1)"	"prognostic favourable (1.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.64e-2)"	56.0	9.5	6.8	11.2	14.2	0.0	24.2	4.4	9.2	19.2	28.5	20.1	10.7	20.3	22.8	13.9	23.6	17.3	29.6	31.7	7.8	5.1	12.8	23.1	26.1	3.7	13.6	5.5	27.2	7.8	15.4	6.0	16.8	12.7	18.8	23.0	12.4	14.1	19.8	12.8	17.4	35.9	26.6	7.7	3.1	14.6	12.3	15.1	0.3	15.6	12.8	6.7	27.7	23.8	0.0	2.3	0.0	0.0	0.0	0.2	0.0	7.0	5.2	3.3	2.6	54.3	46.4	7.2	8.7	9.3	3.9	4.0	6.7	8.7	0.0	3.5	8.1	5.2	3.5	10.0	3.8	0.0	2.8	0.0	6.3	7.1	13.1	0.0	0.0	36.8	7.7	5.8	9.0	22.5	0.0	0.0	10.1	2.9	0.0	0.1	6.7	7.6	0.0	0.2	0.1	4.8	4.9	0.2	4.6	6.2	6.4	5.1	2.0	0.0	16.3	12.3	4.4	5.4	3.4	0.0	0.0	0.0	6.3	0.0	15.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	6.8	14.2	4.4	9.2	7.8	5.1	13.6	5.5	12.7	15.1
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306387-36324886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 26.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.1;SK-BR-3: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"											"HPA042212, HPA042456, HPA066168"	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: "	"prognostic favourable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavourable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.6	1.1	11.6	3.4	9.5	1.9	10.1	12.2	11.3	4.4	5.3	1.1	1.4	16.6	2.8	2.7	7.1	1.9	3.0	2.2	5.2	2.2	8.6	1.4	4.5	2.8	1.9	7.0	4.0	1.0	1.3	2.2	19.4	7.4	7.0	6.0	12.4	12.7	2.6	1.0	16.2	24.3	2.0	2.4	1.6	2.3	6.6	1.9	0.0	26.2	4.1	4.5	3.7	6.7	0.1	0.3	2.0	0.5	2.7	0.6	0.0	9.9	0.3	1.9	2.2	0.6	1.2	10.8	4.8	1.0	3.6	1.6	5.6	4.0	1.8	5.3	2.0	16.1	1.7	3.6	3.0	0.5	0.7	1.6	3.4	4.4	1.6	0.9	2.4	0.6	3.0	2.4	1.8	1.3	0.2	3.1	1.7	5.9	1.6	0.9	1.2	1.9	2.4	0.1	1.2	4.1	1.2	4.0	2.0	1.1	12.1	3.8	0.4	0.4	2.8	1.5	0.8	4.8	0.5	3.5	1.1	2.1	4.1	0.9	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.0	11.6	9.5	12.2	11.3	5.2	2.2	1.9	7.0	7.4	1.9
SH3GL1	"CNSA1, EEN, MGC111371, SH3D2B, SH3P8"	ENSG00000141985	"SH3 domain containing GRB2 like 1, endophilin A2"	Q99961	19	4360370-4400547	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021485	Approved		Enhanced	Cytosol				Cytosol		"HPA021485: AB_1856816"	"unprognostic (1.32e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (6.85e-2)"	"prognostic favourable (1.86e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (9.36e-8)"	"unprognostic (5.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	20.5	22.4	12.8	17.7	14.5	28.9	17.5	19.1	25.9	21.6	18.7	13.3	11.9	25.4	16.9	12.1	66.0	15.0	16.1	13.2	13.0	8.0	13.8	19.7	14.8	13.0	11.4	13.0	23.5	20.5	5.6	17.3	33.9	9.4	17.1	6.2	14.9	22.1	16.8	8.6	40.4	29.8	18.8	9.0	19.5	16.4	13.7	11.3	10.1	14.2	19.1	33.0	22.2	30.0	6.1	6.5	9.7	5.1	3.8	7.4	3.4	31.7	14.4	15.0	19.8	17.6	27.5	27.7	27.7	23.9	24.7	24.6	22.4	16.8	7.2	11.7	27.4	26.3	10.6	30.4	6.6	9.5	17.7	8.6	19.8	29.3	25.4	7.7	9.8	23.0	21.2	20.8	12.8	29.0	22.3	16.4	19.8	26.6	7.5	8.1	37.6	16.1	5.9	20.9	12.5	19.5	28.1	14.8	22.8	24.4	24.4	17.3	16.8	12.3	43.7	23.8	17.4	49.8	28.0	10.5	6.4	7.6	34.3	20.1	32.6	1.0	3.8	4.8	5.0	1.9	4.8	6.1	7.4	6.9	5.0	4.5	4.2	4.5	9.7	3.8	5.1	6.5	6.6	3.4	12.8	14.5	19.1	25.9	13.0	8.0	11.4	13.0	9.4	11.3
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol			18000	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavourable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	42.3	19.9	15.0	22.1	18.8	23.7	50.5	13.7	16.9	20.1	24.1	17.8	25.7	20.0	19.9	25.6	42.4	15.2	20.0	48.1	15.4	12.6	22.4	24.0	27.6	40.2	18.2	14.8	18.0	28.5	18.2	18.4	23.7	20.3	19.7	24.8	11.7	30.2	24.5	89.7	19.4	24.4	26.6	24.5	33.6	16.1	45.4	16.2	19.0	20.0	29.7	20.8	28.5	35.6	8.9	10.4	69.7	16.3	13.9	14.5	10.0	19.1	7.0	11.3	10.3	47.4	41.2	18.6	29.0	29.1	27.6	29.3	20.3	16.0	9.8	18.7	35.9	11.2	10.0	18.9	26.3	21.1	7.1	23.4	10.8	21.5	28.7	12.5	23.9	29.4	22.0	30.4	33.5	43.5	8.7	27.7	36.9	5.7	11.3	8.0	11.0	12.1	13.0	47.5	7.2	23.7	33.1	12.4	9.0	16.3	21.1	34.5	8.3	12.8	38.0	26.6	16.1	33.2	23.9	14.6	13.5	14.5	13.2	12.9	16.1	29.4	13.7	14.7	10.6	14.5	10.4	8.9	9.9	10.6	10.4	8.1	4.8	8.5	69.7	13.9	16.3	10.2	14.5	10.0	15.0	18.8	13.7	16.9	15.4	12.6	18.2	14.8	20.3	16.2
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favourable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favourable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favourable (4.28e-4)"	9.3	18.8	36.9	11.7	27.0	30.4	16.6	31.3	47.2	15.8	16.4	33.0	43.7	25.7	14.4	14.2	29.5	21.0	13.6	14.8	34.2	24.4	15.8	6.6	14.9	13.6	28.8	37.9	20.0	35.9	29.1	26.8	45.2	26.3	21.3	10.1	13.4	30.0	33.8	19.4	46.6	20.4	16.6	30.9	14.9	25.8	7.8	24.1	16.9	16.4	15.0	15.8	27.8	18.1	7.7	7.6	6.6	4.6	5.0	4.9	2.8	13.2	11.2	5.5	7.5	3.3	4.2	16.5	4.6	10.5	9.2	8.5	7.0	22.9	14.0	3.7	8.2	32.7	1.7	10.0	2.6	8.9	7.5	3.5	18.0	6.1	7.0	3.1	8.6	3.0	11.5	4.7	4.2	7.7	4.7	18.7	4.6	32.6	18.0	8.4	4.9	7.9	36.6	10.4	62.6	10.3	16.1	17.4	14.1	6.7	17.5	7.2	25.1	4.7	7.0	4.3	7.4	10.9	10.1	18.2	8.9	8.9	10.0	3.9	2.3	4.4	3.3	6.6	4.1	1.6	4.9	7.7	4.7	3.8	2.7	3.8	3.4	3.0	2.7	5.0	4.6	7.6	3.9	2.8	36.9	27.0	31.3	47.2	34.2	24.4	28.8	37.9	26.3	24.1
SH3KBP1	CIN85	ENSG00000147010	"SH3 domain containing kinase binding protein 1"	Q96B97	X	19533975-19887601	"Predicted intracellular proteins"	"Apoptosis, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003351, HPA003355, CAB021892"	Enhanced		Supported	Cytosol				Cytosol		"CAB021892: , HPA003351: AB_1079956, HPA003355: AB_1079954"	"unprognostic (1.17e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.96e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (2.10e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.92e-2)"	25.0	6.6	17.2	31.0	23.7	32.2	25.3	3.3	18.1	10.6	19.3	23.6	2.6	7.1	6.3	6.6	4.6	6.6	11.3	14.4	17.2	20.1	7.9	8.2	16.6	32.9	30.2	11.4	5.7	3.6	13.1	10.2	17.0	22.6	5.1	19.1	6.8	12.5	4.1	6.1	14.7	12.2	7.9	28.8	22.0	9.6	3.0	27.0	19.5	11.5	5.5	34.9	10.7	17.1	13.6	35.8	51.3	24.5	17.8	51.2	39.4	12.4	13.1	2.1	4.7	10.6	20.5	11.0	11.3	16.5	5.8	9.3	8.9	25.8	23.3	11.9	16.3	1.4	4.8	4.5	9.4	7.6	3.3	5.0	3.4	7.1	6.9	31.6	40.0	12.0	4.5	12.0	35.7	8.7	1.8	28.2	14.7	5.6	18.8	32.1	3.6	17.5	11.7	20.4	2.1	6.7	2.5	1.5	1.5	10.5	1.4	16.0	1.3	37.2	27.6	10.2	8.8	12.9	12.4	41.3	27.3	20.7	21.7	26.3	45.0	10.4	24.5	39.6	46.1	18.7	36.0	13.6	45.1	47.7	31.9	12.2	37.6	37.3	51.3	17.8	21.5	35.8	51.2	39.4	17.2	23.7	3.3	18.1	17.2	20.1	30.2	11.4	22.6	27.0
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094256-169271105	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;monocytes: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"				Vesicles	"Intermediate filaments"	"HPA074783: "	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favourable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	15.2	4.8	13.8	7.2	11.8	3.7	11.1	2.5	12.7	7.5	17.2	15.9	10.8	15.7	6.8	7.2	7.1	6.9	19.7	7.8	17.8	9.3	14.6	9.6	11.3	3.7	13.0	10.9	11.9	12.0	5.2	7.8	8.6	10.3	17.2	16.0	10.7	20.9	10.7	16.2	6.8	17.2	8.8	11.7	4.5	27.6	7.0	11.3	0.9	23.1	7.6	5.5	9.4	6.3	0.4	3.4	0.0	8.5	0.3	0.0	0.7	7.3	6.2	5.6	16.2	6.1	7.6	7.3	20.6	10.0	15.4	7.1	6.1	8.9	0.0	1.0	21.4	4.9	4.5	8.1	17.0	0.0	2.6	4.3	14.1	3.2	13.8	1.5	0.1	4.5	4.5	13.1	10.4	9.4	0.0	0.0	14.2	3.0	1.5	1.4	2.8	5.3	2.3	1.8	0.3	7.0	5.8	4.2	5.1	5.2	8.0	2.0	2.6	0.6	8.5	7.3	5.7	12.1	7.2	0.5	0.0	0.0	8.2	1.5	8.7	0.0	1.4	0.0	0.0	5.9	0.0	0.4	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.3	8.5	0.2	0.0	0.7	13.8	11.8	2.5	12.7	17.8	9.3	13.0	10.9	10.3	11.3
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936579-146081791	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.8"	"Cell line enhanced"	"Detected in some"		"A-431: 10.5;CACO-2: 35.8;HBEC3-KT: 11.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basal ganglia: 11.5;cerebral cortex: 2.9"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.4;T-cells: 1.6"	"Region enriched"	"Detected in single"	14	"basal ganglia: 23.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 14.5"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035903: AB_10696515, HPA058119: "	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	2.6	0.6	1.2	6.2	11.5	0.0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0.0	0.3	1.1	1.0	14.3	0.0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1.0	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10.0	0.0	1.4	0.3	0.1	0.0	1.6	0.3	10.5	2.9	0.1	0.6	0.0	0.0	0.0	0.1	0.8	2.2	0.9	35.8	9.9	0.0	5.6	0.4	9.8	0.0	11.5	2.1	0.1	0.1	0.0	4.2	4.8	0.6	0.0	0.0	0.1	6.2	3.3	7.9	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.8	0.0	0.1	0.0	4.6	1.0	0.0	0.0	0.6	0.2	0.2	3.4	0.0	5.0	0.4	9.2	0.8	3.4	0.0	0.0	0.0	5.6	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.6	0.7	1.4	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129348-109504632	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 13.8;RPMI-8226: 13.2;TIME: 15.3;U-266/84: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA044822: , HPA048444: "	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	17.4	5.6	2.7	3.4	4.4	0.6	18.3	1.7	5.4	5.3	3.6	3.3	2.5	1.0	5.5	2.2	3.4	4.8	5.6	6.4	3.0	2.1	2.5	0.8	6.0	2.9	4.3	1.5	3.0	1.8	0.6	2.6	6.5	3.8	3.4	1.6	4.6	2.4	5.9	6.4	2.9	2.3	4.6	2.8	2.0	2.7	4.3	2.9	1.5	3.4	3.6	4.0	4.6	3.4	0.4	0.4	1.8	0.2	0.0	0.6	0.3	0.0	0.0	0.1	1.4	6.3	4.8	0.0	2.8	8.2	2.1	0.8	0.7	0.0	0.0	2.1	2.0	0.0	0.1	1.2	0.9	0.0	2.8	0.0	0.1	0.0	13.8	0.0	0.0	8.3	1.9	9.6	4.3	7.6	0.0	7.9	4.8	0.0	0.0	4.2	0.7	7.9	1.7	0.0	13.2	0.0	0.0	0.4	1.7	0.0	0.0	0.3	0.1	0.0	15.3	2.7	8.2	7.8	3.6	2.7	17.8	0.0	0.0	4.1	3.7	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	0.6	1.8	0.0	0.0	0.4	0.0	0.3	2.7	4.4	1.7	3.3	3.0	2.1	4.3	1.5	3.8	2.9
SHANK1	"SPANK-1, SSTRIP, synamon"	ENSG00000161681	"SH3 and multiple ankyrin repeat domains 1"	Q9Y566	19	50661827-50719450	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 35.7"	"Cell line enhanced"	"Detected in some"		"REH: 7.3;SH-SY5Y: 3.5;U-138 MG: 4.1;U-2 OS: 10.4;U-87 MG: 3.9;U-937: 4.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA032129, HPA032130"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA032129: AB_10602796, HPA032130: "	"unprognostic (1.62e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.29e-3)"	0.9	2.6	27.9	0.9	10.0	1.2	0.9	13.6	35.7	1.3	0.9	1.1	0.0	0.9	1.3	1.0	0.9	2.2	1.1	0.9	25.6	12.3	0.9	0.8	0.8	0.9	6.0	11.1	0.9	0.9	2.1	2.8	1.0	4.1	1.0	0.8	0.2	0.9	1.0	1.0	1.2	0.9	1.1	2.2	0.9	0.8	1.4	3.5	0.4	0.9	0.0	0.9	0.9	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.5	0.0	1.2	1.2	0.1	0.1	0.0	0.0	0.0	1.9	0.7	0.0	0.2	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.1	0.6	0.0	0.0	0.7	0.1	0.1	0.8	1.2	0.1	7.3	0.0	0.7	0.0	0.0	0.0	3.5	0.0	0.0	1.1	0.0	3.1	2.2	4.1	10.4	0.0	0.0	0.0	0.0	0.0	3.9	4.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	27.9	10.0	13.6	23.0	25.6	12.3	6.0	11.1	4.1	3.5
SHARPIN	"DKFZP434N1923, SIPL1"	ENSG00000179526	"SHANK associated RH domain interactor"	Q9H0F6	8	144098633-144108124	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 99.4"	"Cell line enhanced"	"Detected in all"		"PC-3: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044453	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044453: AB_10962490"	"unprognostic (4.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.00e-1)"	12.0	14.5	15.8	7.9	11.7	13.2	10.9	9.0	15.3	11.3	12.3	13.7	17.3	11.5	11.4	14.7	11.4	12.9	10.3	14.7	14.0	8.9	14.1	25.7	10.0	9.3	14.6	11.3	11.9	14.0	11.7	10.2	9.6	13.3	12.2	7.2	10.5	16.8	11.8	25.5	13.5	10.7	9.4	9.2	12.5	12.0	99.4	12.3	6.1	10.9	10.8	7.1	10.1	9.5	12.7	22.4	26.1	21.2	17.3	22.1	11.0	8.5	12.6	7.1	5.6	11.5	11.9	8.1	8.0	9.5	10.7	10.6	8.9	13.9	3.7	14.7	9.7	9.8	3.5	12.1	3.0	11.2	9.5	9.3	14.5	10.5	20.4	3.2	8.7	13.3	20.0	8.9	10.2	11.4	6.2	8.8	9.7	14.1	11.0	9.2	2.9	46.0	7.7	5.4	12.4	11.3	9.8	7.2	11.1	13.7	20.7	13.2	21.7	12.0	9.6	8.4	13.3	12.0	10.7	10.8	8.2	5.0	12.2	8.0	6.6	12.5	18.1	26.1	16.7	21.2	18.6	12.7	16.6	22.1	16.6	12.3	13.8	15.0	9.3	17.3	18.4	22.4	16.5	11.0	15.8	11.7	9.0	15.3	14.0	8.9	14.6	11.3	13.3	12.3
SHB		ENSG00000107338	"SH2 domain containing adaptor protein B"	Q15464	9	37919134-38069211	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	71	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.1"									"CAB010161, HPA049911, HPA052108"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				Cytosol	"Nucleoplasm, Cytoplasmic bodies"	"CAB010161: AB_2187742, HPA049911: , HPA052108: "	"unprognostic (4.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.96e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-1)"	8.6	5.6	7.5	5.3	15.9	7.2	8.0	1.4	12.5	8.2	8.4	16.1	3.2	10.1	6.1	5.6	19.6	5.9	29.4	20.2	8.9	5.0	13.6	34.2	11.6	3.1	17.9	5.3	5.6	17.8	13.7	13.1	7.7	12.6	12.9	7.0	7.6	18.9	11.3	6.4	13.0	9.5	11.9	7.6	6.7	14.1	3.5	16.3	2.7	7.7	10.3	11.1	10.7	11.9	0.0	0.0	8.1	0.0	0.0	0.1	0.0	9.2	14.7	1.5	0.2	1.7	4.1	2.6	10.2	12.5	7.1	5.5	3.5	6.4	0.0	12.4	8.8	8.9	5.8	15.0	5.1	7.8	11.7	0.0	5.1	10.8	11.3	0.4	0.5	3.6	4.8	11.2	8.6	7.3	3.7	3.1	8.3	6.2	1.1	0.4	3.8	14.0	0.5	4.3	0.5	14.8	3.3	15.7	12.6	1.3	11.2	2.5	7.0	0.5	9.0	3.3	12.0	1.7	16.2	0.9	0.3	0.1	19.7	0.9	3.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	15.9	1.4	12.5	8.9	5.0	17.9	5.3	12.6	16.3
SHC1	"p66, SHC, ShcA"	ENSG00000160691	"SHC adaptor protein 1"	P29353	1	154962298-154974395	"Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001844, CAB005374, CAB016305"	Supported		Enhanced	Cytosol				Cytosol		"CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826"	"unprognostic (4.12e-2)"	"prognostic unfavourable (6.74e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.94e-3)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (7.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-1)"	45.1	36.4	14.6	27.8	15.9	20.4	43.6	11.8	12.6	33.9	30.5	11.1	32.9	23.1	34.8	28.1	31.4	32.5	30.5	23.4	11.7	8.5	30.1	54.7	37.5	36.5	13.9	8.7	36.1	21.5	23.0	44.7	47.3	18.9	31.9	23.7	31.5	22.4	24.9	22.1	20.3	39.5	35.4	16.0	38.6	25.8	16.2	11.1	19.9	37.7	21.1	29.8	40.4	31.2	13.9	21.8	31.9	27.0	12.7	23.7	19.8	13.9	29.0	22.3	35.9	24.5	49.2	11.7	51.1	46.6	29.7	22.6	10.3	33.8	7.5	41.9	61.4	12.0	5.9	50.6	26.8	9.2	3.2	19.3	23.9	18.2	64.1	6.2	22.0	73.0	60.1	37.0	46.2	65.1	8.5	60.9	62.1	11.5	7.1	3.8	19.5	12.3	6.4	7.4	15.5	14.3	10.6	2.8	77.8	30.6	17.1	16.7	25.0	13.1	77.1	47.0	29.4	9.9	26.7	27.5	17.6	12.8	45.8	8.4	60.7	17.0	20.8	31.9	23.7	27.0	23.5	13.9	19.0	20.9	21.8	13.3	15.6	14.1	17.0	12.7	25.7	10.0	14.1	19.8	14.6	15.9	11.8	12.6	11.7	8.5	13.9	8.7	18.9	11.1
SHC3	"N-Shc, NSHC, SHCC"	ENSG00000148082	"SHC adaptor protein 3"	Q92529	9	89005771-89178767	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1"	"Cell line enhanced"	"Detected in some"		"AF22: 19.0;RT4: 7.0;SH-SY5Y: 7.0;U-87 MG: 10.6"	"Cancer enhanced"	"Detected in some"		"glioma: 5.1"	"Group enriched"	"Detected in many"	4	"amygdala: 15.7;basal ganglia: 20.8;cerebral cortex: 31.5;hippocampal formation: 14.2;olfactory region: 24.7"	"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031427, HPA046656, HPA072448"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA031427: , HPA046656: , HPA072448: "	"unprognostic (6.22e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.07e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.53e-7)"	"unprognostic (8.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.84e-4)"	1.6	10.8	15.7	0.8	20.8	0.5	1.8	0.8	35.1	7.3	1.2	2.3	0.0	1.1	1.5	1.7	1.5	2.2	2.7	1.0	14.2	4.7	1.4	0.6	6.0	0.8	3.1	24.7	0.7	4.4	10.4	1.0	0.8	5.2	1.5	1.4	0.0	6.4	1.4	0.9	1.8	0.9	1.8	1.5	0.6	0.8	1.0	1.3	0.0	1.3	0.0	0.8	1.7	3.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	19.0	0.0	4.2	1.3	0.0	1.4	3.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.4	0.4	0.2	0.0	2.9	0.0	1.9	0.0	5.0	0.0	0.0	0.0	0.1	0.0	1.1	2.4	0.2	0.2	0.0	3.9	4.1	7.0	2.5	7.0	0.5	0.0	0.0	0.0	0.3	2.9	0.7	0.1	1.1	0.1	0.0	0.0	0.0	10.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	20.8	0.8	31.5	14.2	4.7	3.1	24.7	5.2	1.3
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 57.8;liver: 108.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA023314	Enhanced		Supported	Nucleoplasm,Cytosol			240000	"Nucleoplasm, Cytosol"		"HPA023314: AB_1856830"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favourable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	10.9	3.2	2.2	4.9	4.1	2.1	10.4	6.5	3.0	4.6	15.2	5.3	7.3	12.3	2.8	7.4	16.3	3.9	4.0	2.0	2.6	1.8	57.8	108.3	4.3	3.8	3.5	1.9	4.1	3.5	30.1	1.6	2.8	3.6	3.4	3.5	7.2	9.8	8.0	5.7	6.2	15.1	2.3	2.9	8.6	3.9	6.3	3.8	11.1	10.9	10.8	8.7	4.3	6.3	8.6	6.7	6.2	10.6	13.0	18.7	7.9	23.7	24.1	7.6	12.0	19.5	12.2	28.3	5.0	6.2	16.9	18.7	23.9	10.6	18.5	15.0	4.3	23.5	16.0	20.2	9.6	11.0	23.3	8.3	18.9	18.0	4.9	5.5	9.0	10.1	8.0	13.1	5.9	11.6	7.0	4.2	6.0	17.5	27.4	7.6	9.6	7.9	22.5	30.3	15.7	26.9	16.2	10.5	5.5	34.2	6.5	8.6	26.6	7.8	2.7	3.3	9.8	29.9	15.8	8.6	8.2	7.4	6.4	13.0	7.8	6.0	8.2	6.2	10.1	10.6	17.1	8.6	12.3	12.8	6.7	6.9	12.3	13.0	0.1	13.0	7.5	3.1	18.7	7.9	2.2	4.1	6.5	3.0	2.6	1.8	3.5	1.9	3.6	3.8
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229327-57234935	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.1"	"Cell line enhanced"	"Detected in all"		"RH-30: 208.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Enhanced	Microtubules,Mitochondria			160000	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavourable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	13.0	13.5	5.9	15.0	7.1	12.6	9.5	9.6	9.5	10.5	11.5	6.1	5.0	13.4	10.2	8.5	22.1	8.6	10.3	11.0	6.5	5.4	15.5	103.1	11.8	18.7	8.7	4.6	17.9	38.9	4.5	8.1	16.8	6.5	10.3	9.4	7.1	44.6	5.7	16.5	13.7	11.5	9.9	7.6	23.5	13.4	5.4	6.3	26.1	13.2	19.0	25.6	11.2	13.8	33.6	14.5	6.5	11.7	9.7	48.7	12.3	24.6	11.4	11.6	30.6	9.1	14.0	23.0	13.4	21.8	17.9	16.5	16.4	11.9	45.7	22.2	16.5	15.8	20.9	21.7	9.7	25.5	18.6	18.8	7.0	11.6	67.4	31.1	16.7	17.9	31.6	14.4	48.2	17.8	19.7	43.5	13.6	16.2	24.7	17.0	9.9	18.6	16.7	208.3	42.3	9.0	11.4	24.9	11.9	7.0	16.5	48.4	22.4	38.3	11.2	7.3	14.8	9.4	18.1	58.3	31.9	38.8	15.7	29.0	13.0	6.5	9.8	5.9	6.9	11.7	8.0	33.6	12.1	7.4	14.5	32.4	5.3	5.4	0.5	9.7	7.5	4.8	48.7	12.3	5.9	7.1	9.6	9.5	6.5	5.4	8.7	4.6	6.5	6.3
SHOX	"GCFX, PHOG, SHOXY, SS"	ENSG00000185960	"Short stature homeobox"	O15266	X	624344-659411	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;breast: 13.9"	"Group enriched"	"Detected in some"	4	"BJ: 19.1;BJ hTERT+: 8.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA035141, HPA060931"			Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA035141: , HPA060931: "	"unprognostic (7.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.82e-2)"			"unprognostic (2.45e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.67e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.38e-1)"	3.8	1.0	0.3	0.7	0.3	3.0	13.9	1.8	0.8	0.3	0.4	0.2	0.2	1.4	0.3	0.6	0.3	0.4	0.4	0.4	0.7	0.3	0.3	0.3	0.3	0.6	0.3	1.4	0.3	0.9	0.0	0.3	4.8	6.3	0.8	0.3	0.2	1.4	0.2	2.8	1.4	1.0	0.2	0.4	1.6	0.4	0.4	0.2	0.2	0.5	0.2	0.2	0.3	0.3	2.2	1.9	5.5	1.8	2.5	1.5	0.8	0.1	0.2	0.1	0.2	0.2	0.1	3.2	19.1	8.8	2.9	3.1	0.3	0.3	0.3	0.1	0.4	0.3	0.2	0.0	0.9	0.2	0.1	0.1	1.3	0.1	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.3	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.5	0.0	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.2	0.1	0.2	0.1	5.5	1.8	1.8	1.4	1.1	1.5	1.6	1.1	1.2	0.5	2.2	1.5	1.5	5.2	2.5	1.5	1.9	1.0	0.8	0.3	0.3	1.8	0.4	0.7	0.3	0.3	1.4	6.3	0.2
SHQ1	"FLJ10539, Shq1p"	ENSG00000144736	"SHQ1, H/ACA ribonucleoprotein assembly factor"	Q6PI26	3	72749277-72861914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042792	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA042792: AB_10959736"	"unprognostic (1.10e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (2.83e-4)"	"prognostic favourable (6.49e-4)"	"unprognostic (2.05e-1)"	"unprognostic (4.54e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.30e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	10.5	15.6	6.8	17.2	9.2	11.4	14.8	8.7	9.0	10.1	12.1	9.6	11.9	9.1	15.6	16.7	13.3	15.5	9.7	14.8	8.0	8.0	10.7	10.7	14.8	15.5	15.1	5.9	12.3	17.5	12.2	12.8	7.2	10.4	9.7	12.3	11.0	13.1	13.6	17.5	11.3	10.3	11.4	7.5	12.0	10.7	17.3	7.5	29.8	12.5	10.4	13.4	11.2	17.0	10.1	12.9	3.1	9.7	17.0	14.9	10.4	5.9	8.1	5.5	9.0	7.2	9.1	5.6	10.0	7.2	10.4	11.4	6.2	4.7	9.9	4.9	6.8	4.9	11.2	9.2	12.7	8.7	9.0	10.2	6.7	7.5	7.5	17.3	8.6	9.2	7.0	15.3	6.3	9.6	8.2	6.2	8.3	8.7	48.7	6.0	15.3	10.3	11.8	8.7	7.4	9.0	7.8	3.4	14.0	9.1	6.5	4.6	6.6	6.6	6.7	8.3	8.2	13.7	8.5	11.4	22.9	14.7	7.5	14.0	8.2	0.6	8.6	3.1	11.2	9.7	14.9	10.1	12.6	12.0	9.1	9.3	14.3	12.4	0.4	17.0	8.4	12.9	10.2	10.4	6.8	9.2	8.7	9.0	8.0	8.0	15.1	5.9	10.4	7.5
SIGLEC10	"MGC126774, PRO940, SIGLEC-10, SLG2"	ENSG00000142512	"Sialic acid binding Ig like lectin 10"	Q96LC7	19	51410021-51417803	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 99.9;lymphoid tissue: 74.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.8;HEL: 10.6;HMC-1: 8.5;NB-4: 6.5;U-698: 15.3;U-937: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 99.9;monocytes: 66.7"									"CAB025807, HPA027093"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane, Actin filaments"	"CAB025807: , HPA027093: AB_1856858"	"unprognostic (7.18e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.95e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.05e-2)"	2.6	6.2	4.5	24.6	9.8	9.1	1.4	0.7	4.9	2.7	3.7	5.7	0.0	5.3	1.3	0.7	2.2	2.7	2.7	1.6	3.3	3.0	2.6	7.2	7.7	74.6	6.6	1.8	1.2	2.4	0.2	2.5	1.1	7.7	2.6	3.3	0.7	2.3	0.7	0.6	0.9	9.6	3.2	7.4	37.0	3.1	0.9	4.8	2.0	1.2	0.2	13.2	4.8	1.3	5.8	5.1	99.9	66.7	0.0	0.1	4.4	0.1	0.0	0.4	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	20.8	0.6	0.0	0.4	0.0	0.1	0.0	6.4	1.5	10.6	0.2	0.1	0.0	4.8	8.5	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.0	0.4	0.1	6.5	0.6	0.3	1.3	0.1	0.4	0.0	0.2	0.3	0.3	0.3	0.1	0.2	0.1	3.9	0.5	0.5	1.0	0.4	0.2	1.0	0.2	15.3	0.4	8.8	0.3	1.5	5.6	99.9	0.1	33.9	0.0	5.8	0.0	0.0	5.1	3.6	0.0	0.0	11.5	0.0	66.7	0.2	0.1	4.4	4.5	9.8	0.7	4.9	3.3	3.0	6.6	1.8	7.7	4.8
SIGLEC15	"CD33L3, HsT1361"	ENSG00000197046	"Sialic acid binding Ig like lectin 15"	Q6ZMC9	18	45825512-45844080	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 5.9"	"Group enriched"	"Detected in some"	7	"PC-3: 8.5;U-87 MG: 25.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 5.9;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	40	"dendritic cells: 2.1;monocytes: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053509			Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA053509: "	"unprognostic (3.89e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.40e-2)"	"prognostic favourable (9.14e-5)"	1.1	0.3	0.1	4.3	0.1	0.0	3.0	0.2	0.1	2.1	0.2	0.0	0.0	1.6	0.3	0.0	0.3	0.3	3.4	1.9	0.1	0.1	0.5	1.4	2.0	0.9	0.1	0.0	0.5	0.2	0.0	0.1	1.1	0.0	1.1	0.1	0.1	0.2	0.2	0.7	0.3	2.5	3.2	0.1	3.7	0.9	0.3	0.0	1.2	0.2	0.0	2.6	4.2	0.2	0.0	2.1	0.0	5.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.5	0.8	0.1	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.3	0.0	0.0	0.0	25.7	0.6	0.0	0.0	5.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SIK3	"FLJ12240, KIAA0999, L19, QSK"	ENSG00000160584	"SIK family kinase 3"		11	116843402-117098437	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045245, HPA048161"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA045245: , HPA048161: "	"unprognostic (3.19e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.12e-5)"	"unprognostic (1.82e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	13.0	12.2	24.7	13.8	36.9	14.3	13.5	24.0	34.4	13.5	16.6	40.5	10.4	10.9	18.6	9.9	13.7	16.6	12.8	16.0	23.7	16.2	13.9	17.6	13.7	11.9	25.8	24.4	22.4	19.5	29.4	18.4	16.3	23.9	11.4	11.7	10.6	11.7	15.6	16.9	11.3	14.0	18.4	17.2	14.2	14.5	26.0	38.0	10.4	22.1	6.9	12.9	14.5	12.9	2.4	1.7	3.9	3.7	1.6	1.8	0.7	7.7	6.0	9.6	10.1	8.3	8.9	15.3	5.9	10.7	4.7	5.3	14.6	9.0	9.2	9.7	10.9	12.2	7.9	8.6	6.6	25.3	5.0	20.7	6.6	9.0	7.7	7.4	8.2	9.8	5.0	10.0	16.2	6.2	9.9	6.9	6.4	2.6	6.6	8.0	5.3	4.5	8.5	5.5	7.3	6.5	1.5	9.3	7.5	16.0	7.0	3.2	4.6	7.8	7.1	5.8	7.4	9.6	5.9	4.9	3.5	11.8	5.4	12.2	7.8	3.9	1.1	0.0	1.0	1.5	1.8	0.4	0.9	0.4	1.7	2.4	0.3	0.1	2.6	1.6	3.7	0.1	0.1	0.7	24.7	36.9	24.0	32.2	23.7	16.2	25.8	24.4	23.9	38.0
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"Single-minded family bHLH transcription factor 2"	Q14190	21	36699133-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"PC-3: 22.9;RPTEC TERT1: 28.8;RT4: 17.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.5"	"Group enriched"	"Detected in some"	4	"hypothalamus: 2.1;midbrain: 0.8"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (2.88e-4)"	0.5	0.3	0.8	0.1	2.3	0.0	0.1	2.4	2.3	2.8	0.2	0.2	0.0	0.1	0.3	1.5	31.3	0.3	0.2	0.1	2.5	1.1	16.1	0.1	0.1	0.1	1.4	0.7	0.1	0.1	1.2	1.7	0.1	0.3	6.8	0.0	0.2	0.4	0.0	15.7	0.3	0.1	0.0	0.4	0.1	5.5	0.2	1.3	0.0	0.2	11.0	28.7	1.5	0.4	0.3	0.7	0.0	0.0	0.0	0.8	0.0	3.2	5.0	0.2	0.2	0.0	0.0	5.0	0.1	0.0	0.4	0.0	2.6	7.6	0.1	4.6	0.1	1.7	2.5	0.0	0.2	3.9	7.9	0.1	7.2	0.2	0.0	0.0	0.0	0.8	0.7	0.0	1.4	0.0	0.1	0.0	8.3	1.9	0.0	0.0	0.2	22.9	0.0	0.1	0.1	28.8	17.3	0.2	0.3	8.2	0.0	0.7	2.1	0.2	0.3	0.0	1.4	0.5	0.2	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	2.3	2.4	2.3	2.5	1.1	1.4	0.7	0.3	1.3
SIMC1	"C5orf25, FLJ44216, OOMA1, PLEIAD"	ENSG00000170085	"SUMO interacting motifs containing 1"	Q8NDZ2	5	176238367-176345991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 29.3;testis: 41.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037889, HPA037890"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA037889: , HPA037890: "	"unprognostic (1.15e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.81e-3)"	"prognostic unfavourable (2.32e-6)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.20e-2)"	3.1	15.1	5.4	5.0	3.9	2.0	3.3	10.2	5.4	7.5	4.5	2.0	2.9	3.9	8.0	6.8	3.1	9.3	5.3	2.0	6.2	4.4	1.8	5.1	3.1	3.5	2.5	3.0	29.3	3.4	4.2	7.6	3.3	3.4	6.1	4.9	4.0	3.8	4.7	5.5	2.3	5.1	6.2	3.0	5.5	5.1	41.5	3.7	4.5	2.1	2.7	3.4	4.4	5.4	7.1	8.1	10.5	5.3	10.8	6.3	3.5	1.8	5.0	16.2	12.9	8.5	8.3	8.2	6.9	6.8	7.2	8.9	17.4	5.4	0.0	8.6	8.0	1.7	17.5	12.3	9.0	3.1	13.1	8.7	3.3	2.2	19.0	9.6	6.8	5.6	5.1	4.8	8.6	6.6	21.9	8.4	8.5	8.5	9.3	7.6	5.9	5.5	13.9	10.8	12.0	4.7	3.7	10.6	11.6	7.5	1.1	6.6	4.4	18.3	4.7	8.8	4.7	7.9	5.9	2.1	2.3	13.7	3.5	6.4	5.0	7.0	5.3	10.5	5.2	5.2	6.3	7.1	6.3	4.0	8.1	6.9	5.3	4.1	0.7	10.8	4.0	3.9	4.1	3.5	5.4	3.9	10.2	5.4	6.2	4.4	2.5	3.0	3.4	3.7
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	21.0	15.4	14.0	19.4	18.5	31.6	20.4	26.3	15.5	26.3	20.2	19.9	15.3	11.8	26.6	16.8	17.7	22.1	15.9	13.4	14.2	11.8	13.6	13.9	17.4	20.7	13.0	14.2	27.6	19.8	23.4	16.8	17.2	13.0	22.9	14.3	23.0	17.6	20.5	18.2	23.5	17.9	24.5	12.8	20.3	16.8	28.5	15.1	48.7	24.0	12.8	26.9	26.0	19.0	9.8	6.5	9.3	8.3	9.7	12.7	6.3	12.7	26.4	23.6	15.5	11.8	12.5	13.7	9.6	14.9	14.1	15.2	14.6	17.3	27.8	10.0	14.1	22.8	34.2	14.4	15.5	22.4	17.7	26.2	20.1	11.4	8.9	24.8	22.4	15.1	11.1	16.4	17.2	12.6	20.6	31.0	11.4	14.8	24.3	15.9	23.0	11.1	24.6	31.3	17.1	10.1	23.4	18.7	18.7	23.6	10.6	13.2	16.1	19.7	11.0	17.5	23.7	11.5	14.1	21.3	33.4	29.5	10.4	25.4	9.7	3.3	4.8	6.9	8.5	4.8	12.7	9.3	10.8	10.7	6.5	9.8	11.1	9.5	9.3	9.7	8.3	4.4	9.5	6.3	14.0	18.5	26.3	15.5	14.2	11.8	13.0	14.2	13.0	15.1
SIPA1L3	KIAA0545	ENSG00000105738	"Signal induced proliferation associated 1 like 3"	O60292	19	37907228-38208372	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042072, HPA045480, HPA074988"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA042072: , HPA045480: , HPA074988: "	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.96e-2)"	6.2	6.2	10.8	15.3	11.9	5.4	10.0	18.1	13.2	9.8	18.3	13.0	13.9	31.1	6.7	6.4	9.0	9.3	7.6	11.1	15.8	7.7	12.4	6.9	10.5	11.4	10.5	7.8	6.0	17.1	7.4	7.8	3.4	8.5	9.7	12.8	11.2	14.1	9.1	11.4	19.0	29.7	6.2	8.7	12.2	16.4	8.1	12.4	11.7	18.2	6.7	20.2	10.0	11.8	4.6	0.9	1.1	3.5	0.9	1.4	0.3	16.6	29.5	3.7	4.6	2.2	2.2	2.5	7.2	6.1	4.7	4.5	10.1	9.7	9.5	6.2	6.1	3.8	3.3	13.5	5.3	3.2	1.6	2.6	2.8	3.1	4.3	1.8	2.8	1.7	7.1	8.9	19.1	5.4	1.8	2.0	8.3	5.1	2.3	2.4	3.0	7.9	5.2	3.0	1.4	10.5	14.3	8.8	4.7	7.9	13.6	1.1	9.0	1.7	11.5	8.0	2.8	24.5	11.0	2.7	4.6	3.2	10.3	2.4	10.3	0.2	0.4	1.1	0.5	0.7	0.2	3.0	0.4	0.5	0.2	4.6	0.4	1.4	0.3	0.9	3.5	0.9	0.3	0.3	10.8	11.9	18.1	13.2	15.8	7.7	10.5	7.8	8.5	12.4
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884669-67918390	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: "	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	17.2	32.3	12.6	21.1	17.8	17.0	18.1	22.6	14.5	24.2	20.5	15.7	14.0	9.2	19.0	12.7	12.7	15.1	15.2	14.7	14.1	10.4	13.9	17.3	12.6	16.1	17.0	10.1	26.6	14.4	16.4	13.3	14.7	12.1	21.7	12.5	12.1	12.3	16.1	19.9	12.9	15.0	21.0	17.7	13.5	13.2	25.4	16.3	28.1	15.2	9.3	14.7	21.6	37.5	4.9	3.9	3.8	3.5	3.6	7.1	1.8	8.2	9.4	15.0	16.7	14.3	11.1	9.4	11.5	11.9	15.8	14.1	10.4	7.1	17.4	6.2	7.6	6.6	18.6	3.8	17.0	9.3	10.8	9.2	7.1	8.1	13.1	9.9	7.1	10.2	9.3	9.5	16.4	6.3	11.7	9.5	11.5	6.6	9.2	13.7	18.6	15.2	16.7	11.8	6.8	7.4	5.1	9.7	13.3	21.0	13.9	14.5	10.1	9.2	5.3	12.3	11.5	10.9	11.1	8.0	9.5	34.5	6.3	15.1	5.0	3.8	2.4	3.2	3.4	3.0	4.9	4.9	3.7	4.7	3.9	3.3	7.1	4.2	3.1	3.6	3.5	3.5	2.9	1.8	12.6	17.8	22.6	14.5	14.1	10.4	17.0	10.1	12.1	16.3
SIRT5		ENSG00000124523	"Sirtuin 5"	Q9NXA8	6	13574529-13615158	"FDA approved drug targets, Predicted intracellular proteins"		Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021798, HPA022002, HPA022992"	Approved		Supported	Mitochondria				Mitochondria		"HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915"	"unprognostic (8.53e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (8.76e-10)"	"unprognostic (2.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.36e-3)"	5.9	6.2	8.8	6.8	10.4	5.9	9.2	11.1	13.5	4.9	7.2	6.4	12.5	8.1	6.8	6.7	5.7	8.0	6.6	22.9	8.5	8.3	9.9	29.9	9.8	6.9	9.5	6.9	8.8	10.5	12.9	7.6	5.3	8.3	6.5	8.3	6.2	8.6	8.7	25.8	8.8	8.5	6.2	6.9	9.5	7.6	6.6	6.1	7.5	8.5	7.0	6.5	6.8	6.0	9.2	4.6	10.9	9.3	7.3	10.0	5.6	6.0	4.7	6.0	7.8	3.8	5.0	4.6	3.1	3.3	3.4	5.1	7.6	7.2	8.7	18.9	2.4	9.8	4.2	6.1	5.2	4.0	7.0	5.5	4.4	12.2	6.3	4.4	4.8	5.4	12.4	3.0	10.8	6.1	7.8	3.3	4.0	7.3	4.8	8.8	5.1	7.5	8.7	3.9	15.8	7.0	6.6	10.0	3.6	3.5	6.1	13.8	7.0	2.9	5.4	5.2	3.0	3.2	3.4	8.1	9.1	5.9	2.9	4.4	5.0	0.5	4.5	10.9	8.1	6.1	8.2	9.2	10.0	7.9	4.6	9.1	9.5	8.5	1.5	7.3	9.3	4.6	7.2	5.6	8.8	10.4	11.1	13.5	8.5	8.3	9.5	6.9	8.3	6.1
SIRT6		ENSG00000077463	"Sirtuin 6"	Q8N6T7	19	4174109-4182604	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049729, HPA071776"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA049729: , HPA071776: "	"unprognostic (4.58e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.36e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.13e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.84e-2)"	"prognostic favourable (9.13e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favourable (2.58e-4)"	9.5	11.7	9.4	14.6	11.5	17.8	8.0	15.2	16.3	9.0	26.3	11.0	14.8	19.3	10.6	11.9	11.1	8.9	9.9	11.4	9.5	9.0	12.1	14.2	8.7	12.7	10.8	8.5	8.1	17.3	9.4	13.4	12.1	8.2	12.0	15.3	10.9	12.1	11.9	10.2	13.0	18.4	8.0	7.9	15.1	15.3	6.6	7.0	14.4	10.7	10.0	11.9	8.1	8.9	10.7	14.1	12.4	16.2	5.1	12.0	8.0	13.9	9.4	4.8	6.0	3.8	3.5	7.5	6.8	5.1	5.9	5.2	6.3	5.3	9.1	7.5	4.6	9.0	2.7	7.5	0.9	17.1	5.4	3.7	5.1	5.7	8.5	9.6	14.7	4.8	5.9	6.1	3.8	5.1	8.3	20.9	3.1	10.5	13.2	10.1	8.2	8.8	10.4	4.4	10.3	5.5	6.3	6.4	10.4	6.2	5.9	13.2	5.8	12.7	7.8	5.9	6.0	20.8	10.0	26.4	13.9	9.8	11.9	15.4	7.1	5.2	13.4	11.3	11.6	16.2	6.5	10.5	7.8	9.3	14.1	10.7	6.9	6.5	12.4	5.1	12.5	11.9	12.0	8.0	9.4	11.5	15.2	16.3	9.5	9.0	10.8	8.5	8.2	7.0
SIRT7		ENSG00000187531	"Sirtuin 7"	Q9NRC8	17	81911939-81921323	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 17.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037261, HPA053669"	Approved		Supported	"Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center"	Vesicles	"CAB037261: AB_1079989, HPA053669: "	"unprognostic (8.15e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavourable (1.97e-5)"	"unprognostic (3.03e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavourable (1.69e-7)"	"unprognostic (4.34e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.16e-2)"	6.2	5.9	6.7	10.1	12.8	22.6	6.4	17.0	11.4	8.2	12.9	7.0	9.0	14.3	5.5	4.6	28.8	7.2	10.6	3.9	6.7	2.6	7.9	9.8	7.9	11.3	11.0	6.6	4.8	18.7	4.9	7.8	8.8	7.6	7.1	6.7	3.7	12.7	7.0	5.3	15.7	15.3	5.1	5.7	14.1	18.4	8.9	8.8	8.3	6.7	7.3	16.4	8.3	12.3	3.9	1.8	17.4	3.4	1.3	2.6	1.2	16.0	13.4	1.6	5.8	4.4	4.2	10.8	8.1	6.8	9.6	9.0	11.5	12.8	7.1	6.3	4.5	11.6	6.6	5.0	3.1	6.1	14.2	6.3	6.5	18.0	13.3	8.1	12.9	4.2	15.9	9.1	7.6	7.1	6.7	3.5	4.5	12.6	8.6	11.6	4.2	13.9	5.8	3.5	6.7	9.3	10.5	7.0	9.2	9.3	22.6	10.4	9.4	19.5	5.6	4.2	9.5	8.0	14.7	5.9	1.8	5.2	10.5	11.1	7.0	3.0	2.3	17.4	2.6	3.4	0.9	3.3	2.0	2.1	1.2	3.9	1.8	0.6	3.8	1.3	2.6	1.8	1.0	1.2	6.7	12.8	17.0	11.4	6.7	2.6	11.0	6.6	7.6	8.8
SIVA1	"CD27BP, SIVA, Siva-1, Siva-2"	ENSG00000184990	"SIVA1 apoptosis inducing factor"	O15304	14	104753100-104768494	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA065398, HPA066693"			Supported	Nucleoplasm				Nucleoplasm		"HPA065398: , HPA066693: "	"unprognostic (1.86e-1)"	"prognostic favourable (5.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.19e-3)"	"unprognostic (5.85e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.43e-2)"	20.4	17.6	16.1	25.2	15.2	53.5	18.2	16.6	16.8	19.2	24.1	11.1	21.7	24.4	19.8	32.2	19.3	19.5	25.5	25.9	13.0	12.5	18.4	34.4	15.5	22.5	16.3	12.9	23.7	50.0	5.8	23.7	17.7	14.1	20.6	5.1	20.3	32.7	28.3	66.5	15.0	25.0	19.8	10.3	21.5	21.6	32.2	14.0	51.6	30.0	29.5	18.0	20.6	32.6	38.4	95.6	46.4	33.4	17.9	38.4	35.6	26.4	40.0	11.0	18.1	3.8	4.8	28.9	14.4	8.0	18.0	15.7	30.5	23.3	25.3	21.7	5.2	26.3	4.1	14.6	1.4	19.8	40.2	10.0	24.1	36.4	9.6	16.9	17.1	5.9	6.6	8.2	2.5	10.1	9.9	14.4	4.0	85.2	58.0	38.5	16.6	55.5	34.1	22.7	20.0	3.9	22.9	28.6	14.5	20.2	12.2	18.8	23.4	19.4	11.0	14.3	17.9	34.3	23.4	11.8	12.6	30.6	16.8	19.8	16.2	32.9	27.6	46.4	28.6	31.2	32.1	38.4	34.5	31.1	20.6	36.9	38.4	32.5	26.2	17.9	33.4	95.6	35.7	35.6	16.1	15.2	16.6	16.8	13.0	12.5	16.3	12.9	14.1	14.0
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 52.7;RH-30: 28.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB058690: , HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavourable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.9	0.2	11.7	6.8	8.0	0.1	2.0	4.5	2.3	2.0	0.0	3.7	0.0	1.1	0.4	2.7	3.9	3.6	0.8	0.0	9.4	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.7	1.6	0.3	0.1	2.6	0.0	52.7	1.3	0.0	0.2	0.0	4.7	0.0	28.8	0.0	2.2	6.4	1.1	0.1	2.3	0.1	2.4	1.3	0.2	6.7	3.1	3.2	3.6	2.9	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0
SIX2		ENSG00000170577	"SIX homeobox 2"	Q9NPC8	2	45005161-45009430	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 23.3;skeletal muscle: 21.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.4;LHCN-M2: 21.5;RH-30: 14.8;SCLC-21H: 25.3;U-2197: 16.4;U-698: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056958			Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA056958: "	"unprognostic (1.14e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.09e-6)"	"unprognostic (1.28e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.53e-9)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.05e-1)"	5.8	0.2	0.2	0.2	0.4	0.1	3.4	0.5	0.4	13.3	0.4	0.2	0.0	0.1	1.1	0.8	0.8	0.1	0.1	0.8	0.1	0.0	0.4	0.1	0.3	0.2	0.9	1.8	0.3	4.6	5.7	13.5	0.3	1.4	5.2	0.1	9.3	23.3	1.3	21.0	0.3	0.1	0.4	0.8	0.1	7.4	1.1	0.0	3.9	0.7	4.0	0.8	1.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	6.2	23.4	0.0	0.1	1.0	0.4	0.0	0.1	0.0	0.0	1.0	0.0	0.0	2.1	3.9	0.2	0.0	1.1	0.0	7.5	0.0	0.0	0.0	2.1	1.1	0.0	4.8	0.0	0.7	0.0	0.0	21.5	0.7	0.0	1.2	0.2	4.7	0.0	14.8	0.0	0.0	1.2	25.3	0.2	3.2	0.1	0.0	0.1	1.8	0.3	0.4	1.2	16.4	0.0	0.5	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.1	0.0	0.9	1.8	1.4	0.0
SKA1	"C18orf24, MGC10200"	ENSG00000154839	"Spindle and kinetochore associated complex subunit 1"	Q96BD8	18	50374995-50394173	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.5;testis: 28.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA045495	Approved		Supported	Microtubules				Microtubules		"HPA045495: AB_10960405"	"unprognostic (2.18e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.66e-3)"	"unprognostic (5.93e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (9.60e-8)"	"unprognostic (1.03e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.91e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.50e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	1.3	1.5	0.3	6.3	0.3	12.1	1.5	2.2	0.5	1.2	1.9	0.1	0.0	1.7	0.5	0.8	6.1	0.3	1.1	0.4	0.5	0.4	0.6	0.8	1.3	5.2	0.5	0.4	0.4	2.8	0.1	0.3	3.3	0.4	0.4	2.8	0.2	1.2	0.0	0.6	1.5	2.0	1.4	1.0	4.4	1.5	28.0	0.0	27.5	0.4	5.9	8.7	0.9	1.6	2.1	0.6	2.5	0.9	1.7	1.9	1.1	9.8	3.9	6.3	6.1	0.5	0.9	3.8	10.9	4.6	12.8	12.7	6.4	3.5	8.8	2.9	3.4	8.8	9.0	4.5	12.1	12.4	3.0	10.6	3.1	6.7	1.1	16.8	10.6	0.5	0.4	11.0	6.5	7.2	13.4	30.8	10.5	3.5	11.8	3.8	4.7	3.1	5.8	8.1	8.6	2.5	1.1	5.4	3.4	6.6	3.5	5.1	5.0	5.8	3.9	12.8	7.1	4.4	11.7	13.3	21.4	15.0	5.6	13.7	10.9	1.9	0.9	0.5	0.9	0.4	0.6	1.7	1.2	1.9	0.5	2.1	0.7	0.8	2.5	1.7	0.5	0.6	1.5	1.1	0.3	0.3	2.2	0.5	0.5	0.4	0.5	0.4	0.4	0.0
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176602	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 41.6;testis: 12.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Enhanced	"Microtubules,Mitotic spindle,Centrosome,Cytosol"				Microtubules	"Mitotic spindle, Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.8	0.6	0.6	6.4	0.6	6.2	0.9	0.4	1.6	0.8	2.8	0.3	0.0	1.1	1.0	0.8	5.1	0.2	0.3	0.4	0.8	0.5	0.8	0.5	1.0	6.1	0.6	0.3	0.5	0.4	0.0	0.6	2.6	0.8	0.4	4.0	0.2	0.9	0.0	0.5	2.4	3.1	1.1	0.5	2.6	1.4	12.6	0.3	41.6	0.3	5.7	6.4	0.5	1.4	0.4	0.2	0.3	0.3	1.9	2.3	0.6	11.2	5.9	10.7	9.1	0.0	2.3	8.4	15.2	6.4	19.2	13.1	9.8	12.1	15.4	4.5	8.4	10.6	14.3	6.2	21.0	13.1	7.3	20.5	3.9	5.5	0.0	15.8	7.9	0.4	0.4	15.4	5.1	9.4	10.6	6.6	12.7	8.7	24.0	14.2	12.4	11.1	15.8	23.0	7.1	4.3	4.4	13.7	5.0	5.0	7.9	3.2	7.1	12.2	3.7	7.6	11.0	7.1	18.2	4.0	8.4	15.4	1.8	12.4	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.8	1.4	0.2	0.0	0.8	0.3	0.0	1.9	0.3	0.0	2.3	0.6	0.6	0.6	0.4	1.6	0.8	0.5	0.6	0.3	0.8	0.3
SKAP2	"RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R"	ENSG00000005020	"Src kinase associated phosphoprotein 2"	O75563	7	26667062-26995239	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005560, HPA024045"	Enhanced		Supported	Nucleoplasm,Cytosol			3200000	Nucleoplasm	Cytosol	"HPA005560: AB_2667360, HPA024045: AB_2671416"	"unprognostic (8.52e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.51e-2)"	20.8	22.5	11.5	29.4	12.9	12.8	28.5	6.0	12.8	7.7	15.3	7.6	11.0	10.5	5.2	15.4	14.0	9.4	9.6	12.6	9.5	12.1	20.4	7.8	31.6	36.4	12.0	8.9	13.3	6.1	25.1	10.9	5.3	15.5	10.2	15.0	2.5	5.8	9.8	8.3	8.6	16.5	21.1	42.6	31.8	11.7	10.1	11.5	6.4	6.1	1.9	19.3	19.3	28.1	9.9	12.3	37.3	18.0	8.3	5.1	6.7	11.5	6.1	0.6	15.3	2.9	2.4	3.8	4.7	7.1	2.3	5.9	4.9	46.9	9.0	20.9	8.9	6.3	8.4	4.8	5.0	5.1	13.5	9.9	1.8	6.4	3.9	18.2	35.0	10.5	4.5	6.9	9.4	14.3	5.2	4.7	9.3	2.1	0.0	9.2	0.5	6.0	11.8	1.5	0.7	29.0	9.1	7.6	0.2	8.6	4.7	6.2	6.4	9.6	20.8	3.9	0.1	13.1	4.9	7.4	9.4	15.8	9.4	23.7	15.1	8.2	12.6	19.4	3.7	15.0	5.1	9.9	2.1	3.0	9.6	8.0	0.5	2.9	37.3	8.3	18.0	12.3	3.5	6.7	11.5	12.9	6.0	12.8	9.5	12.1	12.0	8.9	15.5	11.5
SKI		ENSG00000157933	"SKI proto-oncogene"	P12755	1	2228695-2310119	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Craniosynostosis, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010449, HPA066567"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB010449: AB_2187342, HPA066567: "	"unprognostic (3.99e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.69e-2)"	"unprognostic (5.24e-3)"	12.5	4.7	11.8	7.1	22.5	4.8	8.1	34.5	21.2	9.8	8.2	5.5	3.1	4.6	11.9	4.4	5.9	9.1	8.0	9.0	11.0	4.1	4.4	6.1	11.1	6.9	6.2	10.1	10.4	9.6	4.2	6.2	7.4	8.5	8.4	3.5	4.0	12.0	11.9	6.8	11.7	5.9	9.3	5.3	9.3	6.0	7.2	5.3	3.6	6.9	8.1	5.1	7.6	7.8	0.8	0.3	3.0	0.6	1.3	0.6	0.4	10.3	6.0	14.6	14.2	24.4	14.7	9.6	15.6	8.7	9.7	7.2	9.1	8.1	6.6	11.7	20.0	12.3	8.1	12.6	9.0	7.2	17.7	16.6	9.1	12.8	16.3	9.3	17.8	15.7	7.0	14.6	11.0	11.9	9.3	5.1	11.9	6.6	1.1	10.3	14.7	11.7	5.1	9.2	5.4	8.3	4.1	21.0	13.7	15.2	13.6	15.1	4.6	12.0	21.5	16.8	10.5	23.6	12.1	4.0	2.8	6.1	8.9	16.2	6.8	0.6	0.5	0.3	0.5	0.6	0.5	0.3	0.4	0.5	0.3	0.8	0.6	0.5	3.0	1.3	0.3	0.1	0.4	0.4	11.8	22.5	34.5	21.2	11.0	4.1	6.2	10.1	8.5	5.3
SKP1	"EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L"	ENSG00000113558	"S-phase kinase associated protein 1"	P63208	5	134148935-134177038	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB012982, HPA053745, HPA058134"	Approved		Supported	Nucleoplasm,Cytosol			600000	Nucleoplasm	Cytosol	"CAB012982: AB_2533076, HPA053745: , HPA058134: "	"prognostic unfavourable (7.53e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (5.72e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (5.20e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.40e-1)"	63.7	90.2	101.8	35.1	113.6	59.2	110.3	109.3	152.1	94.0	70.5	78.8	55.7	43.6	73.9	99.3	72.9	84.5	64.4	116.0	112.7	100.7	113.8	83.5	52.8	52.3	109.9	121.7	98.4	44.6	116.8	81.4	83.1	114.2	84.8	69.1	68.5	54.7	113.4	141.7	59.9	55.2	82.3	106.3	47.0	58.8	69.3	79.7	57.5	108.0	82.1	60.9	71.8	58.2	113.5	78.4	136.3	90.7	96.4	157.1	209.1	67.4	52.7	78.6	105.7	121.8	99.5	56.1	78.7	100.1	92.5	95.8	80.9	65.8	50.0	118.2	106.1	37.8	78.5	118.9	107.8	45.7	55.5	39.4	82.8	57.5	57.5	30.2	49.0	85.1	95.9	81.0	64.2	98.8	47.5	44.2	138.2	53.3	65.1	32.5	45.6	56.8	36.0	84.1	61.2	103.3	76.0	64.4	50.5	106.7	27.3	71.8	79.1	47.4	74.2	59.8	37.1	62.4	79.7	27.5	45.8	74.3	83.2	58.0	64.7	132.3	83.2	136.3	91.3	78.3	102.0	113.5	131.3	111.8	78.4	99.8	157.1	123.5	78.0	96.4	90.7	69.6	130.2	209.1	101.8	113.6	109.3	152.1	112.7	100.7	109.9	121.7	114.2	79.7
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36184319	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.1"	"Cell line enhanced"	"Detected in all"		"BEWO: 73.6;RH-30: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.72e-7)"	"prognostic favourable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	6.5	6.9	7.8	8.0	7.5	12.9	6.5	11.5	9.0	7.5	7.7	10.3	3.7	10.2	9.9	6.3	13.5	8.1	4.9	4.1	7.3	5.1	4.2	14.0	5.8	9.4	8.8	7.4	7.7	6.1	3.9	12.5	49.1	6.5	7.2	9.5	6.1	6.3	5.4	3.4	7.6	7.7	6.4	7.4	9.4	5.3	3.9	7.4	19.5	5.0	7.5	11.7	7.9	8.4	6.5	16.0	14.7	7.9	7.7	8.5	5.0	7.4	3.7	15.8	17.6	3.9	6.2	73.6	9.7	7.3	24.8	18.8	20.6	5.9	10.8	2.6	7.8	7.8	17.7	12.3	26.7	4.8	10.1	6.3	13.8	9.7	1.9	13.9	2.9	5.7	3.2	4.5	3.1	6.8	10.8	2.5	8.9	3.6	16.1	8.0	14.4	5.7	16.0	92.3	6.9	1.8	7.9	13.6	16.3	30.4	6.6	4.3	6.7	7.9	3.1	9.3	10.8	3.5	6.7	3.1	3.0	13.4	4.2	17.1	6.7	10.3	7.9	14.7	5.4	7.2	8.5	5.6	5.7	5.8	16.0	6.5	7.9	6.0	1.5	7.7	4.1	4.3	5.3	5.0	7.8	7.5	11.5	9.0	7.3	5.1	8.8	7.4	6.5	7.4
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341322-48426212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol			13000	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: "	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (5.77e-4)"	"prognostic favourable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	14.8	9.3	6.8	11.7	8.6	7.0	12.6	9.2	10.7	18.4	20.7	6.1	11.7	6.9	18.1	12.2	24.0	14.3	12.3	21.3	7.3	5.6	12.8	16.1	14.0	10.6	7.6	7.2	16.4	10.4	17.2	9.4	29.7	8.0	19.0	13.1	14.1	15.2	17.3	49.2	20.1	15.5	30.6	6.2	11.4	13.2	23.6	5.8	23.8	12.1	22.2	16.9	24.9	23.7	7.7	8.5	10.9	8.6	10.7	13.5	4.2	12.6	5.0	9.1	8.9	14.1	17.4	6.4	19.5	25.0	17.6	18.3	4.9	10.7	7.6	12.1	22.4	8.4	37.0	18.4	31.0	6.3	3.8	13.4	7.4	5.6	15.1	12.2	13.7	14.7	27.2	20.3	23.7	10.3	8.5	8.6	17.6	6.4	14.0	10.1	3.8	7.2	8.0	17.7	4.8	15.4	14.0	6.0	7.7	7.9	6.0	8.3	7.5	8.7	13.0	19.3	18.3	12.2	19.9	11.7	12.1	6.5	15.1	14.0	13.8	10.9	8.0	9.6	8.8	5.8	9.9	6.1	11.0	13.5	8.5	7.7	9.1	9.8	7.5	10.7	8.6	2.9	7.1	4.2	6.8	8.6	9.2	10.7	7.3	5.6	7.6	7.2	8.0	5.8
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692800-1712555	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	19.8	18.1	26.9	30.4	28.0	60.7	27.5	23.8	30.0	19.3	19.3	14.2	20.7	16.3	20.4	21.9	25.0	19.0	15.8	17.9	25.1	26.5	23.7	21.2	18.7	43.9	19.9	24.0	23.1	17.8	13.0	19.5	27.7	16.0	20.0	21.3	17.9	24.7	21.2	15.1	24.7	17.0	20.5	17.1	26.1	18.2	50.6	12.4	52.4	24.9	17.7	42.8	23.7	26.6	24.4	24.1	45.3	29.8	19.8	36.1	30.4	28.8	11.9	17.1	18.0	15.2	17.4	17.8	25.4	21.7	30.9	31.3	24.5	33.7	38.2	15.2	21.0	17.7	34.4	23.0	36.2	15.6	18.6	47.8	14.8	24.6	18.8	44.2	23.4	12.0	18.5	23.5	15.6	17.5	34.2	37.7	37.8	10.4	68.0	40.3	21.3	21.1	51.3	28.0	24.1	29.7	22.0	19.5	15.0	21.5	14.0	15.0	23.2	29.2	14.8	25.9	14.9	27.3	39.5	22.0	39.9	91.2	24.3	37.9	25.5	9.3	29.8	21.8	23.6	22.3	21.4	24.4	30.8	33.2	24.1	18.0	26.5	25.1	45.3	19.8	19.8	19.1	36.1	30.4	26.9	28.0	23.8	30.0	25.1	26.5	19.9	24.0	16.0	12.4
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favourable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	11.3	15.1	12.8	9.6	26.2	9.6	20.8	14.7	22.1	20.8	11.3	38.2	8.4	35.3	12.3	12.7	17.3	15.4	12.1	12.9	14.5	14.2	16.1	18.0	18.6	7.9	40.0	15.4	10.4	20.6	29.8	21.7	16.4	29.7	18.0	11.8	18.7	26.9	14.8	17.6	15.6	11.6	11.0	33.1	9.5	12.5	8.7	31.0	15.8	29.9	8.7	16.5	12.9	13.9	4.1	9.8	3.0	9.5	8.3	7.1	4.6	7.5	9.8	13.1	12.0	14.5	12.3	43.7	8.3	30.1	7.9	9.3	12.4	14.4	4.7	16.4	9.2	10.6	11.8	7.8	9.3	6.8	7.1	11.2	12.0	14.1	15.4	7.6	22.7	13.5	9.8	14.7	15.0	9.4	9.7	2.4	9.2	8.8	9.0	5.1	19.3	6.8	5.8	11.9	8.3	9.6	11.4	9.0	8.0	6.3	19.2	8.4	21.6	5.1	11.3	8.1	6.8	9.0	4.3	5.9	8.0	1.9	22.8	4.1	3.4	0.7	6.6	2.4	6.4	9.5	5.8	3.6	5.0	6.3	9.8	4.1	7.1	6.6	3.0	8.3	6.0	4.1	3.8	4.6	12.8	26.2	14.7	22.1	14.5	14.2	40.0	15.4	29.7	31.0
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;thyroid gland: 20.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.9;HHSteC: 18.4;U-2197: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031123	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.1	1.1	11.1	0.7	19.4	0.0	2.0	0.8	7.0	1.2	3.0	1.7	0.4	4.9	0.4	2.9	3.5	1.7	8.1	0.5	3.8	1.2	2.1	5.7	1.9	0.4	1.0	3.6	0.5	9.0	8.2	1.9	2.2	8.6	2.5	4.1	6.2	10.0	0.4	1.8	1.0	3.4	0.4	1.3	0.4	3.8	4.6	2.0	0.4	20.5	0.4	0.7	1.9	1.7	0.2	0.2	1.8	0.5	0.0	0.2	0.0	8.3	0.0	1.4	0.0	1.8	2.5	4.1	0.4	1.0	0.5	0.9	10.9	4.0	0.0	1.0	3.7	5.1	0.0	0.0	0.2	0.0	0.0	0.0	3.7	0.0	18.4	0.0	0.6	4.7	5.0	1.4	0.6	0.0	0.0	0.3	0.7	2.2	0.0	0.0	5.7	0.4	0.0	0.1	0.0	4.2	0.6	2.4	0.0	4.9	5.1	0.1	9.2	0.2	0.1	0.1	0.7	35.7	0.0	0.1	1.0	2.8	1.7	0.0	0.7	1.8	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	19.4	0.8	7.0	3.8	1.2	1.0	3.6	8.6	2.0
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 128.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.8;EFO-21: 11.2;Hep G2: 31.9;HHSteC: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA014333: , HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	0.7	0.9	2.6	0.5	6.2	0.4	0.9	2.5	3.6	0.9	0.5	15.1	0.0	0.4	0.9	0.7	0.6	1.1	0.9	0.6	3.4	3.1	128.6	7.0	0.8	0.5	9.3	2.1	1.8	3.0	0.4	0.6	12.9	6.5	2.3	0.5	8.1	1.7	0.6	0.6	1.0	0.4	0.9	7.8	0.5	1.7	2.7	5.6	0.0	0.8	0.0	0.6	1.0	0.4	0.6	2.4	2.7	0.4	0.7	0.9	0.0	0.0	0.0	0.9	3.3	5.0	4.7	9.8	2.0	1.2	1.1	0.8	0.0	0.0	0.1	11.2	0.1	1.2	0.0	1.5	2.6	0.0	0.3	3.8	0.2	31.9	11.2	0.0	2.8	6.3	4.4	6.4	3.2	0.0	8.5	0.2	0.0	0.3	0.0	0.4	6.0	0.0	0.1	0.0	0.0	0.7	0.2	0.4	0.1	0.0	2.3	0.5	1.7	0.1	0.1	0.1	2.4	5.1	0.0	0.3	0.6	0.0	0.3	0.0	0.2	2.7	0.4	0.3	0.9	0.2	0.2	0.4	0.3	0.3	0.1	0.6	0.6	0.6	1.3	0.7	0.3	2.4	0.3	0.0	2.6	6.2	2.5	3.6	3.4	3.1	9.3	2.1	6.5	5.6
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684713-6713567	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	65	"liver: 150.4;salivary gland: 153.9"	"Cell line enriched"	"Detected in single"	61	"Hep G2: 35.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	0.8	1.0	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0.0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0.0
SLC14A1	"HsT1341, JK, RACH1, RACH2"	ENSG00000141469	"Solute carrier family 14 member 1 (Kidd blood group)"	Q13336	18	45687025-45752520	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 44.5;prostate: 64.7;urinary bladder: 29.6"	"Cell line enriched"	"Detected in some"	14	"RT4: 49.9"	"Group enriched"	"Detected in many"	5	"glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059570, HPA077233"	Supported		Supported	"Plasma membrane"				"Plasma membrane"		"HPA059570: , HPA077233: "	"unprognostic (2.04e-1)"	"unprognostic (2.56e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.93e-2)"	2.2	2.1	15.6	1.5	21.5	10.3	2.4	4.6	24.2	2.9	1.6	33.7	0.0	1.9	1.1	1.4	1.1	1.0	8.7	8.2	33.7	11.7	10.1	1.5	4.1	2.4	28.0	23.4	1.0	1.5	1.2	0.4	2.0	44.5	64.7	1.8	0.0	2.6	3.2	3.4	1.7	2.1	3.9	34.9	2.6	2.0	1.0	44.0	0.0	3.6	0.0	2.6	29.6	3.0	0.7	0.3	2.4	0.1	1.8	7.2	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	1.3	49.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.4	0.0	1.9	0.0	0.0	1.1	0.5	0.5	0.1	0.1	2.4	2.0	0.0	0.1	0.6	2.0	2.4	0.0	0.7	0.5	3.4	0.4	1.8	0.0	0.3	7.2	1.1	15.6	21.5	4.6	24.2	33.7	11.7	28.0	23.4	44.5	44.0
SLC15A3	"hPTR3, PHT2"	ENSG00000110446	"Solute carrier family 15 member 3"	Q8IY34	11	60937084-60952530	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.3;HHSteC: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047880, HPA057642"	Approved		Supported	Vesicles				Vesicles		"HPA047880: AB_10959455, HPA057642: "	"unprognostic (5.61e-2)"	"prognostic favourable (4.07e-5)"	"unprognostic (8.79e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.78e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	27.2	7.5	7.7	23.5	8.3	36.8	9.3	2.0	7.0	11.0	16.3	10.6	8.1	9.0	10.3	7.4	12.0	8.6	15.4	11.1	8.2	5.4	8.9	9.1	30.1	24.2	12.2	5.9	16.1	6.6	1.9	5.0	26.6	9.8	10.2	6.7	13.2	5.8	5.5	4.0	4.2	14.0	9.7	12.6	40.0	9.8	5.0	8.3	8.6	5.6	6.5	19.3	11.4	9.3	5.0	10.8	15.0	12.5	0.1	1.4	2.2	3.4	0.1	1.3	0.0	7.6	5.4	13.1	0.8	13.3	35.8	43.3	0.0	1.7	5.5	0.1	5.8	1.1	0.0	0.4	1.3	5.5	0.0	0.0	0.0	0.2	21.0	0.2	0.5	3.8	0.1	9.6	0.0	2.1	0.0	1.0	2.2	0.2	0.0	0.8	6.3	0.2	2.4	0.1	1.7	0.0	0.8	0.0	0.0	1.6	6.7	0.5	2.8	4.3	0.0	0.2	1.1	0.7	0.1	0.0	0.0	3.4	2.3	0.1	9.5	0.0	9.5	0.9	0.1	12.5	0.1	5.0	0.0	0.0	6.0	2.4	1.3	1.4	15.0	0.1	6.4	10.8	0.0	2.2	7.7	8.3	2.0	7.0	8.2	5.4	12.2	5.9	9.8	8.3
SLC15A4	"PHT1, PTR4"	ENSG00000139370	"Solute carrier family 15 member 4"	Q8N697	12	128793191-128823983	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016713	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA016713: AB_1856978"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (8.45e-4)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (5.14e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavourable (7.56e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.57e-1)"	12.7	7.0	6.6	11.4	7.3	17.6	10.7	8.7	10.2	11.6	8.8	16.0	4.2	5.4	17.2	5.7	9.1	12.3	10.0	9.8	8.4	5.0	8.1	20.4	10.9	14.8	13.8	6.6	10.4	8.2	8.4	6.2	8.8	9.7	7.4	5.4	16.1	8.4	8.8	35.1	9.7	8.2	12.2	10.2	12.2	7.9	27.8	10.1	29.7	9.1	7.3	17.8	11.9	10.5	2.0	20.1	12.1	2.4	4.2	5.0	1.7	6.3	10.5	2.7	5.8	23.7	15.4	9.8	11.1	9.4	8.0	9.1	4.7	9.2	23.1	5.7	9.6	7.2	7.3	6.8	8.7	11.3	6.7	3.1	6.3	8.3	24.7	10.6	3.3	9.9	12.6	6.6	17.4	5.5	5.1	14.6	16.2	4.3	5.5	2.8	9.4	6.1	4.7	5.8	8.9	15.4	8.1	4.8	3.9	4.5	8.6	11.8	11.5	2.9	8.2	8.9	5.0	4.4	6.7	4.9	10.8	10.7	11.9	7.5	0.1	0.0	1.8	4.4	5.0	2.4	2.5	1.9	0.9	2.9	1.1	2.0	1.0	2.5	12.1	4.2	1.0	20.1	0.4	1.7	6.6	7.3	8.7	10.2	8.4	5.0	13.8	6.6	9.7	10.1
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: "	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavourable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavourable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	19.9	4.7	14.4	12.3	10.0	8.5	47.4	10.8	8.2	8.5	13.7	15.8	11.6	21.9	15.1	9.7	19.1	20.1	20.1	16.1	13.7	20.4	18.0	12.8	18.3	17.7	22.9	1.9	11.9	24.6	12.6	24.7	20.5	22.7	14.6	9.5	3.9	13.5	11.5	46.6	15.0	12.0	22.8	15.1	10.5	0.3	16.0	8.4	20.9	0.6	16.0	0.9	8.7	13.8	8.2	14.5	16.1	15.9	7.7	6.7	22.1	23.8	14.5	10.1	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.1;skeletal muscle: 33.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 28.8;HEK 293: 12.4;RPMI-8226: 23.8"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Low region specificity"	"Detected in many"							HPA016860	Approved		Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	7.6	4.9	1.8	2.4	5.4	0.4	1.1	9.5	2.0	0.8	4.8	1.7	1.7	7.6	0.7	1.6	0.7	1.1	1.0	2.8	1.8	1.0	8.1	9.8	6.1	1.8	0.8	0.5	1.2	25.1	8.9	1.5	17.4	5.6	1.2	1.3	3.6	3.5	6.0	33.4	12.1	6.0	0.8	1.0	2.7	3.9	3.5	0.8	19.6	2.2	1.5	0.9	4.4	1.4	0.5	0.3	0.8	0.2	0.3	4.7	0.3	0.6	0.6	0.2	1.3	0.0	0.0	2.3	0.0	0.1	0.5	0.7	5.0	0.2	4.0	0.9	0.1	0.0	28.8	0.0	0.5	0.0	12.4	4.7	0.3	4.7	0.0	4.9	4.8	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	2.0	6.1	0.6	8.9	1.8	3.5	4.3	23.8	0.0	0.4	6.7	2.1	0.1	0.6	1.1	1.1	0.7	0.0	0.1	1.1	0.3	1.6	1.9	0.0	1.0	0.2	3.7	0.5	0.8	0.2	0.1	0.2	0.2	0.2	0.2	1.1	0.3	0.0	0.5	4.7	4.0	0.8	0.3	0.1	0.3	4.0	0.3	1.8	5.4	9.5	2.0	1.8	1.0	0.8	0.5	5.6	0.8
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036075-7040121	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 55.9"	"Cell line enhanced"	"Detected in many"		"A549: 17.9;HaCaT: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA065245: "	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	2.5	1.3	1.4	3.5	0.8	0.2	1.6	1.5	1.0	1.8	4.9	0.7	1.2	8.0	1.1	1.4	5.0	1.5	3.2	1.3	1.2	0.7	12.0	55.9	2.9	7.6	0.8	0.5	1.7	2.8	2.7	1.0	3.3	0.7	1.5	1.3	1.8	3.5	1.5	0.5	4.5	10.2	0.7	0.6	4.8	1.6	0.7	0.3	3.6	3.0	2.4	5.8	1.8	2.4	6.8	2.8	2.4	2.2	2.7	3.9	1.3	10.0	17.9	4.2	2.6	2.6	1.5	1.8	1.0	2.6	2.3	5.3	5.8	11.3	6.4	1.7	1.6	15.9	3.3	5.5	0.9	7.9	2.2	2.6	1.4	13.8	3.0	0.9	6.2	1.7	6.3	3.4	2.8	9.5	3.0	1.8	2.4	5.0	3.8	1.6	1.7	1.4	1.8	1.4	1.1	2.2	2.8	0.2	1.1	3.1	1.8	1.4	4.8	1.4	3.5	1.5	3.5	2.4	1.5	3.2	6.6	0.4	4.4	2.3	0.7	0.0	2.0	2.2	3.2	1.9	2.3	2.3	2.9	3.9	2.1	6.8	3.1	2.9	2.4	2.7	2.2	2.8	3.0	1.3	1.4	0.8	1.5	1.0	1.2	0.7	0.8	0.5	0.7	0.3
SLC16A3	"MCT3, MCT4"	ENSG00000141526	"Solute carrier family 16 member 3"	O15427	17	82228397-82261129	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"CAB017490, HPA021451"	Approved		Supported	"Nuclear membrane,Plasma membrane"				"Plasma membrane"	"Nuclear membrane"	"CAB017490: AB_2189333, HPA021451: AB_1853663"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.07e-4)"	"unprognostic (4.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-3)"	"unprognostic (4.26e-3)"	"prognostic unfavourable (1.19e-7)"	"prognostic unfavourable (2.02e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.71e-7)"	"unprognostic (2.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.36e-2)"	10.4	4.8	3.9	16.9	5.2	11.2	8.8	1.0	5.2	8.0	10.5	3.8	1.7	8.0	4.8	4.7	12.4	5.0	10.4	7.4	4.1	3.8	10.9	3.7	19.0	14.2	9.6	0.6	8.3	3.9	1.4	3.6	36.7	8.4	6.9	4.3	42.9	8.1	4.8	81.2	2.1	8.0	4.5	8.0	17.3	13.9	12.7	6.9	3.9	8.7	7.3	11.0	13.0	7.4	3.7	10.3	40.4	12.4	9.9	6.2	5.4	11.4	5.7	0.1	0.1	2.5	8.3	11.4	47.9	29.5	34.0	38.7	2.7	30.0	0.1	37.7	33.7	4.1	4.1	69.4	14.3	20.6	0.2	21.8	42.6	50.0	43.9	32.0	27.0	17.0	10.2	22.9	10.5	18.5	0.1	6.8	29.5	3.1	0.3	31.6	0.4	46.6	0.1	0.5	7.5	18.0	0.5	0.7	0.3	46.0	41.0	0.5	5.9	27.0	31.9	67.9	1.1	1.0	49.9	22.0	0.3	1.0	33.3	20.3	0.5	17.5	12.4	34.6	4.1	11.7	6.2	3.7	3.5	4.6	10.3	2.8	1.8	2.2	40.4	9.9	11.8	6.1	3.0	5.4	3.9	5.2	1.0	5.2	4.1	3.8	9.6	0.6	8.4	6.9
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73654155	"Disease related genes, Predicted membrane proteins"	"Amino-acid transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 155.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.9;ASC TERT1: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.09e-1)"	7.2	5.8	6.4	2.9	6.8	2.9	9.6	6.3	6.8	4.9	7.8	4.7	12.5	6.5	5.1	17.2	5.0	3.4	6.2	6.2	4.5	6.7	24.3	13.2	7.6	4.9	5.0	4.5	3.4	8.7	155.6	9.3	12.6	6.7	6.9	8.6	6.6	15.5	8.6	3.5	4.8	12.9	4.6	5.9	4.3	6.0	4.1	4.7	3.0	30.5	2.6	7.1	5.9	4.3	5.2	9.9	12.4	10.6	12.0	9.4	6.0	2.7	3.8	3.8	6.1	40.9	30.5	5.1	9.2	23.1	2.5	8.7	2.5	6.8	2.5	4.4	12.8	4.9	5.3	2.3	4.4	1.8	6.1	1.1	2.0	5.8	8.2	2.1	4.3	13.9	3.4	5.6	3.9	6.3	2.7	2.8	8.6	1.8	0.8	1.2	2.8	2.2	1.8	4.7	10.9	6.4	7.7	1.5	2.7	1.8	5.5	5.3	2.5	13.0	9.2	1.2	1.1	4.9	2.1	8.0	11.2	0.7	4.1	4.5	3.6	12.4	10.6	4.2	8.5	9.7	8.3	5.2	9.4	8.1	9.9	3.7	7.8	8.6	7.4	12.0	6.0	7.4	8.2	6.0	6.4	6.8	6.3	6.8	4.5	6.7	5.0	4.5	6.7	4.7
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241073-117279430	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.3;brain: 28.3;cervix, uterine: 31.2"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 89.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	10	"hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5"	"Cell type enriched"	"Detected in some"	13	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 26.3"	"Region enhanced"	"Detected in many"		"midbrain: 75.4"	"Group enriched"	"Detected in all"	5	"midbrain: 143.8;pons and medulla: 34.7"	HPA073224	Enhanced		Supported	Vesicles,Centrosome				Vesicles	Centrosome	"HPA073224: "	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.7	13.9	1.7	3.1	2.0	2.0	2.0	1.7	1.6	31.2	2.3	0.5	2.2	1.5	11.2	4.9	3.0	1.1	15.9	1.0	1.9	9.0	1.1	3.3	7.6	1.5	28.3	0.2	9.7	3.7	0.5	1.6	2.1	26.5	10.8	3.4	3.1	1.0	4.0	1.1	5.8	2.5	5.4	2.9	0.5	3.5	1.5	0.3	14.1	0.6	3.4	2.9	3.1	5.4	0.0	2.0	26.3	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.2	89.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.0	26.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.0	0.0	1.1	1.7	2.0	1.7	1.6	1.9	9.0	28.3	0.2	26.5	0.3
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132798553	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 23.4;RPTEC TERT1: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029747, HPA049659"	Approved		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA029747: AB_10600797, HPA049659: "	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favourable (3.55e-4)"	"prognostic unfavourable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.3	7.3	26.2	6.0	21.9	4.5	11.0	13.1	20.6	9.4	9.5	18.8	3.1	14.4	7.0	7.8	10.7	10.1	11.5	4.2	21.6	15.8	11.8	6.0	5.7	7.2	19.5	10.8	7.4	7.8	13.0	6.9	15.5	17.0	5.0	11.4	7.4	11.7	4.9	4.8	10.5	10.4	5.8	21.7	7.0	14.9	2.3	16.3	8.3	10.1	5.9	8.6	10.6	5.5	7.5	15.6	0.6	11.3	2.8	9.4	6.5	3.9	3.7	6.4	0.0	0.8	2.4	3.9	1.4	4.5	2.9	9.2	8.3	8.2	0.1	5.8	0.8	11.1	8.7	9.7	2.3	5.8	16.3	2.1	6.9	10.0	4.9	1.9	0.2	6.5	9.4	4.5	9.8	9.2	23.4	1.5	2.4	5.6	6.0	0.2	8.5	5.3	9.7	7.0	6.5	23.7	7.0	12.9	0.0	7.7	15.3	12.2	5.3	0.0	4.2	1.3	3.4	1.3	3.8	5.1	0.4	0.2	7.0	0.2	1.0	0.0	11.3	0.5	3.7	2.5	6.7	5.5	5.7	5.2	15.6	7.5	8.2	5.6	0.6	2.8	0.2	12.1	9.4	6.5	26.2	21.9	13.1	20.6	21.6	15.8	19.5	10.8	17.0	16.3
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.3;U-266/70: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome				Centrosome		"HPA034963: , HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favourable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	6.0	20.3	31.4	7.6	34.4	10.3	12.7	8.8	43.1	13.5	8.3	8.1	6.1	5.6	11.7	7.8	6.5	4.7	3.8	5.1	20.6	23.5	1.9	11.1	4.5	8.7	17.1	21.2	12.2	28.4	6.1	10.3	6.0	15.4	9.1	7.8	12.1	5.7	6.9	29.6	15.9	5.1	11.3	5.8	6.3	7.0	7.8	8.5	15.7	5.3	11.5	15.8	5.4	7.8	1.1	8.4	2.0	10.1	5.5	3.9	1.4	3.6	2.8	1.6	8.6	3.7	2.4	2.3	7.0	3.4	2.9	5.0	0.7	0.5	12.0	1.6	10.9	10.6	3.3	0.8	3.0	4.8	1.3	6.2	3.4	7.3	7.9	10.4	5.8	1.1	18.4	3.9	6.1	1.8	4.8	30.3	2.0	3.2	8.8	6.9	1.1	3.4	3.2	0.4	29.7	1.2	1.8	7.3	3.5	4.3	4.0	71.3	4.7	11.5	0.4	4.0	4.8	7.8	4.2	33.3	16.4	29.1	5.9	20.9	21.2	0.0	2.3	2.0	1.0	5.3	1.4	1.1	1.1	1.8	4.4	0.3	0.0	1.0	0.0	5.5	10.1	8.4	3.9	1.4	31.4	34.4	8.8	25.9	20.6	23.5	17.1	21.2	15.4	8.5
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 34.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 34.6;monocytes: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA035239, HPA035240"	Enhanced		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (8.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.66e-8)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.82e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.57e-3)"	"prognostic unfavourable (1.18e-7)"	"unprognostic (1.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.83e-2)"	39.3	5.7	3.4	16.0	5.4	16.2	45.0	0.9	3.0	20.7	15.8	5.0	50.4	4.9	14.3	33.7	33.9	18.1	31.2	10.0	4.5	2.2	23.7	4.1	23.4	17.7	8.2	0.9	33.3	24.6	0.2	9.1	25.8	4.9	35.2	13.8	5.2	99.0	55.7	6.9	18.6	12.1	23.1	5.3	19.8	17.9	21.7	6.1	14.9	6.5	28.4	25.9	48.3	44.9	7.0	34.6	0.9	22.4	6.9	5.6	7.4	24.2	44.9	10.8	16.3	28.2	24.0	25.6	34.7	39.7	26.1	37.9	40.7	27.5	26.6	17.0	86.1	39.2	31.5	41.2	19.5	17.6	28.5	44.2	17.2	38.1	73.0	30.7	26.1	39.0	103.2	30.6	77.6	13.8	46.6	70.6	13.9	41.3	14.0	82.7	18.9	19.8	16.0	12.2	37.9	14.6	53.1	16.7	12.2	17.1	46.8	37.2	26.9	40.6	10.3	15.7	25.1	12.2	28.2	43.8	42.3	22.2	29.5	38.4	38.4	0.0	11.5	0.9	5.3	19.9	4.4	7.0	3.1	3.7	17.8	2.5	0.7	2.3	0.3	6.9	22.4	34.6	5.6	7.4	3.4	5.4	0.9	3.0	4.5	2.2	8.2	0.9	4.9	6.1
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.1;testis: 23.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.4;NTERA-2: 5.3;U-698: 24.1"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 52.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 152.9"	"Low region specificity"	"Detected in all"			"HPA041505, HPA044066"	Enhanced		Supported	"Plasma membrane,Intermediate filaments"				"Plasma membrane"	"Intermediate filaments"	"HPA041505: , HPA044066: "	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavourable (6.88e-6)"	0.4	0.5	3.2	0.5	9.6	1.2	0.8	52.1	12.8	0.4	0.5	0.6	0.0	0.6	0.8	4.2	0.4	0.5	0.5	0.4	4.8	4.0	0.4	0.5	0.5	0.5	1.6	3.4	0.6	0.9	0.6	0.0	4.3	3.0	0.9	0.6	0.1	0.7	0.9	0.5	9.2	0.5	0.5	1.4	0.7	0.5	23.3	0.9	0.0	0.6	0.0	0.6	0.4	0.0	2.0	0.7	2.2	0.7	0.5	0.6	0.1	0.1	0.0	0.3	0.3	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	1.2	6.4	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.5	0.0	0.3	5.3	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.2	2.5	0.0	0.3	0.1	0.0	0.3	1.0	0.2	0.1	0.4	0.1	24.1	0.1	0.3	0.1	1.6	0.7	0.5	0.6	0.4	0.4	1.0	0.5	0.3	0.3	2.0	0.6	0.6	2.2	0.5	0.4	0.7	0.3	0.1	3.2	9.6	52.1	6.5	4.8	4.0	1.6	3.4	3.0	0.9
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887780-2903740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.1;kidney: 13.4;liver: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;CAPAN-2: 6.9;MCF7: 13.0;SK-MEL-30: 24.1;WM-115: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 9.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1"									HPA068288	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA068288: "	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	1.4	0.3	0.2	6.0	0.7	0.0	0.6	0.2	2.2	0.5	13.7	0.6	0.2	12.8	0.8	1.2	1.1	0.4	4.9	0.3	0.2	0.3	13.4	13.6	0.6	0.2	1.3	1.5	0.4	0.2	0.0	0.3	2.0	1.6	0.7	9.8	0.2	4.2	0.2	0.4	1.0	20.1	0.6	1.6	0.8	1.4	0.6	0.4	0.2	0.3	1.6	0.3	0.5	0.9	0.0	4.9	5.2	9.1	0.5	0.6	2.7	0.8	7.0	0.1	0.3	0.0	0.0	0.6	0.4	0.3	0.0	0.2	1.6	6.9	0.0	0.6	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.0	0.6	4.0	0.5	0.0	0.1	0.1	0.2	0.0	0.4	0.2	0.0	0.6	0.0	13.0	0.0	0.3	0.1	0.3	0.2	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.3	24.1	0.0	0.6	1.4	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.2	1.9	10.8	5.2	9.1	1.6	0.3	5.1	0.1	0.0	0.1	0.3	4.9	0.0	0.0	0.1	2.2	0.5	3.5	0.0	0.6	2.7	0.2	0.7	0.2	2.2	0.2	0.3	1.3	1.5	1.6	0.4
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 49.6;SK-BR-3: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"											HPA023048	Supported		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favourable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favourable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (1.31e-4)"	10.2	4.9	2.7	5.9	3.2	5.2	6.3	3.3	5.2	4.2	9.5	3.9	7.5	13.9	1.3	3.8	12.2	5.4	8.2	4.3	2.1	2.5	21.0	51.8	3.3	4.6	3.7	4.6	2.4	17.4	10.7	2.1	2.1	3.5	5.6	4.4	4.7	16.8	6.6	2.0	5.9	11.2	1.8	4.7	1.6	7.4	21.8	2.5	7.8	3.3	7.7	8.7	4.3	3.4	0.9	0.7	0.0	1.2	3.6	1.9	0.7	14.0	26.0	2.5	12.4	0.9	0.7	5.0	6.0	1.9	7.7	5.8	15.7	6.0	6.3	4.7	1.4	9.0	3.5	6.2	1.4	4.6	20.1	5.1	15.8	49.6	1.1	11.5	6.3	0.5	3.2	5.4	1.0	4.4	8.6	7.9	2.6	26.4	16.8	12.2	2.5	19.6	12.8	5.3	19.9	6.8	12.7	16.4	11.1	5.6	38.2	1.3	16.3	6.4	1.9	5.9	19.5	8.6	10.8	4.9	2.5	3.6	2.6	12.2	5.1	0.0	0.9	0.0	0.8	1.2	1.5	0.1	0.5	1.9	0.7	0.9	0.5	0.4	0.0	3.6	0.2	0.4	1.0	0.7	2.7	3.2	3.3	5.2	2.1	2.5	3.7	4.6	3.5	2.5
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 79.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018997	Approved		Supported	Mitochondria				Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favourable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	7.7	10.3	4.2	4.9	11.8	4.1	6.7	3.0	7.5	5.4	12.5	21.1	15.6	8.9	5.1	8.0	6.9	5.9	6.7	4.5	5.6	5.3	17.7	79.1	5.5	4.9	14.5	4.8	5.9	7.3	8.2	8.8	8.9	12.4	5.9	10.2	12.6	5.7	17.3	4.6	8.2	9.7	5.0	13.1	7.2	7.9	4.3	12.6	1.8	7.9	3.0	4.8	5.0	5.3	3.7	8.9	3.1	6.7	2.8	2.4	2.1	16.4	14.6	16.8	5.8	2.9	2.3	23.6	4.2	3.2	10.1	10.3	26.1	15.5	7.4	19.9	2.6	9.8	18.8	6.0	12.0	2.9	12.4	8.4	13.7	20.3	6.8	10.7	6.7	6.2	6.4	8.7	7.8	11.6	23.7	2.8	4.9	18.1	0.0	10.0	29.6	9.0	4.2	10.0	17.1	24.3	15.6	8.1	26.5	14.5	30.7	24.8	9.1	8.2	6.8	7.6	16.9	17.8	12.7	5.8	14.5	4.7	9.3	10.3	12.4	0.6	4.6	3.1	2.2	6.3	2.4	3.7	1.8	2.0	8.9	2.0	1.2	1.5	0.8	2.8	6.7	4.7	1.8	2.1	4.2	11.8	3.0	7.5	5.6	5.3	14.5	4.8	12.4	12.6
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes				Peroxisomes		"HPA052708: , HPA060972: "	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	9.7	15.0	10.2	10.2	10.9	3.3	16.8	12.9	14.1	11.8	7.2	12.2	7.5	6.4	22.4	22.6	8.7	13.7	7.4	5.5	10.4	13.4	18.6	19.7	9.0	11.8	10.3	7.7	26.5	12.4	14.3	13.0	14.9	11.9	12.6	8.7	9.5	11.4	10.3	4.6	10.9	7.1	12.1	11.4	8.8	8.9	12.1	9.5	12.6	14.7	10.4	11.2	7.1	8.7	10.2	6.8	5.9	4.9	10.3	11.7	6.4	13.2	7.3	12.4	10.8	7.9	9.5	10.1	12.1	13.2	19.2	21.2	10.6	5.0	15.7	7.4	11.8	10.6	18.0	9.9	19.7	16.1	24.2	17.6	11.4	11.0	11.1	20.2	9.4	9.5	13.3	17.0	10.9	11.7	25.3	7.5	15.6	11.4	12.2	13.1	10.5	12.1	13.3	19.3	22.8	15.8	11.3	8.6	7.8	24.8	15.3	14.7	12.7	6.0	6.8	10.8	14.8	9.6	10.9	8.3	16.1	14.9	11.8	10.2	11.8	5.9	4.4	5.1	7.0	4.9	9.2	10.2	8.1	7.5	5.7	9.5	11.7	9.3	1.8	10.3	3.9	6.8	10.8	6.4	10.2	10.9	12.9	14.1	10.4	13.4	10.3	7.7	11.9	9.5
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856931-48898993	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.8;liver: 58.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.6;RPMI-8226: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Supported	Mitochondria,Cytosol			13000	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	11.9	13.7	6.7	5.6	7.3	3.4	10.2	3.0	5.6	3.3	19.7	4.7	5.2	25.0	4.7	3.1	3.3	5.0	9.9	37.1	7.3	4.6	16.8	58.3	6.6	4.9	8.5	5.1	2.7	16.8	5.9	5.1	3.3	5.8	5.0	9.1	5.4	7.4	3.7	27.4	4.0	32.2	5.7	5.5	8.8	7.5	4.4	6.6	9.1	5.5	5.5	5.9	4.5	9.8	9.4	33.3	57.8	29.0	17.3	28.4	24.7	1.4	4.4	3.5	4.9	11.3	4.3	0.7	7.8	4.2	5.5	5.7	5.5	6.8	6.5	5.5	12.3	1.4	8.7	3.5	4.1	16.4	4.1	9.0	6.9	6.9	5.1	9.4	17.4	5.5	4.0	7.4	1.2	7.0	8.0	34.6	7.2	3.7	10.3	4.7	1.8	9.9	3.7	2.1	47.7	5.9	3.4	1.4	5.0	7.2	0.0	4.0	11.0	4.4	5.7	6.2	1.1	9.1	5.7	12.9	8.9	7.5	9.0	6.7	8.2	13.8	29.0	57.8	28.4	21.0	18.1	9.4	16.1	20.8	27.0	7.8	12.7	21.3	13.5	17.3	21.4	33.3	16.1	24.7	6.7	7.3	3.0	5.6	7.3	4.6	8.5	5.1	5.8	6.6
SLC25A23	"APC2, FLJ30339, MGC2615"	ENSG00000125648	"Solute carrier family 25 member 23"	Q9BV35	19	6436079-6465203	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009675, HPA050883"	Approved		Supported	Mitochondria				Mitochondria		"HPA009675: , HPA050883: "	"unprognostic (3.51e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.25e-1)"	"prognostic favourable (1.10e-12)"	"unprognostic (8.95e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.22e-1)"	12.1	13.0	68.2	5.2	97.6	0.4	6.3	21.5	51.7	12.5	22.3	17.6	10.3	18.2	13.0	11.9	31.2	16.1	10.1	36.2	66.2	25.1	17.9	13.0	11.3	4.0	25.6	33.1	15.8	10.0	24.5	5.5	2.2	28.0	14.3	23.5	12.2	32.1	20.3	37.0	11.9	18.6	30.7	16.9	4.3	9.9	3.7	25.9	1.2	29.2	9.7	14.1	16.8	9.3	2.5	0.9	0.8	0.0	0.7	4.5	0.9	19.8	8.0	11.7	36.7	15.7	6.9	5.3	5.7	9.5	11.3	13.6	20.2	13.3	11.1	14.2	14.6	16.9	23.8	13.8	9.0	0.0	20.0	8.0	17.0	16.1	14.6	0.5	19.0	19.8	12.2	10.0	4.4	11.7	23.1	14.2	2.2	14.5	7.0	11.4	8.4	24.7	3.4	3.1	17.1	30.2	3.6	0.8	11.5	4.1	25.6	10.5	13.3	17.6	4.0	3.5	15.3	0.9	3.8	2.6	3.5	9.8	1.6	18.9	5.6	0.8	0.0	0.0	4.5	0.0	1.1	2.5	2.7	2.3	0.4	1.0	4.0	3.4	0.0	0.7	0.0	0.9	2.6	0.9	68.2	97.6	21.5	51.7	66.2	25.1	25.6	33.1	28.0	25.9
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134036-108200849	"Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria			8900	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favourable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	19.8	10.8	3.0	13.1	3.3	3.8	25.2	2.3	4.5	15.9	26.6	3.9	9.6	13.6	12.4	11.8	11.4	9.0	16.1	12.4	2.8	3.3	15.3	2.9	17.8	10.8	3.0	2.7	13.5	7.2	13.2	7.7	10.4	5.3	12.4	18.2	9.8	11.2	9.7	7.4	6.9	42.4	9.7	4.0	17.0	9.0	5.1	1.5	10.3	13.7	10.8	9.4	10.8	18.2	2.9	4.8	4.4	7.1	1.7	4.3	2.1	23.9	5.3	16.4	5.1	11.3	14.9	8.2	8.4	9.9	15.0	16.5	6.5	8.0	0.0	7.7	15.4	9.4	4.8	13.5	20.3	5.9	2.5	1.5	8.0	3.1	9.3	3.9	3.2	11.1	9.6	8.7	11.2	11.4	4.0	8.1	18.8	15.7	2.2	0.8	9.7	6.2	4.0	21.5	7.2	10.1	12.4	3.1	5.4	11.8	8.5	11.1	8.2	6.8	7.7	8.5	4.3	15.1	9.0	2.2	1.3	0.0	2.9	7.0	5.0	2.8	4.9	4.4	2.3	5.7	2.9	2.9	2.7	2.3	4.8	2.3	1.3	2.3	0.6	1.7	7.1	1.4	4.3	2.1	3.0	3.3	2.3	4.5	2.8	3.3	3.0	2.7	5.3	1.5
SLC25A25	"KIAA1896, MCSC, PCSCL"	ENSG00000148339	"Solute carrier family 25 member 25"	Q6KCM7	9	128068201-128109245	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020381	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"			"Vesicles, Mitochondria"		"HPA020381: AB_1857037"	"unprognostic (4.62e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (1.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.70e-2)"	"prognostic favourable (4.65e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.42e-2)"	29.2	15.8	7.3	8.1	12.8	5.5	10.6	8.8	20.0	14.4	7.2	6.3	20.0	7.9	14.6	8.2	22.7	17.5	31.6	5.6	7.6	9.0	9.5	48.4	12.4	6.7	7.5	8.0	13.6	52.6	12.1	19.0	7.6	15.0	8.5	5.5	13.6	7.6	63.5	31.3	9.5	10.0	17.3	8.7	7.8	10.5	7.3	5.3	5.4	10.8	20.2	9.7	8.6	9.6	2.9	4.6	3.8	8.4	1.5	7.6	3.9	5.8	6.1	8.7	12.6	6.6	5.7	5.8	12.1	11.3	10.2	6.8	11.0	6.1	7.6	3.7	5.6	10.4	6.8	4.0	3.9	8.8	5.6	4.4	12.4	6.5	10.5	5.0	10.1	7.2	3.8	10.0	7.4	6.9	15.8	16.4	6.4	14.1	8.9	5.1	8.8	9.6	8.8	7.5	15.9	3.9	6.1	21.7	9.3	12.7	8.2	16.9	9.0	2.9	4.4	11.6	6.9	8.7	11.9	14.4	25.1	8.1	7.8	2.7	9.5	3.8	2.3	1.2	4.8	7.3	2.4	1.7	5.3	4.8	4.6	2.9	4.5	7.6	0.4	1.5	8.4	1.5	3.9	3.9	7.3	12.8	8.8	20.0	7.6	9.0	7.5	8.0	15.0	5.3
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria				Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favourable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	11.8	12.9	20.2	8.5	14.8	13.3	16.5	7.9	27.2	10.3	12.6	15.8	9.2	9.7	11.1	12.9	14.3	13.1	10.1	19.5	16.9	12.8	15.7	22.7	10.0	15.2	17.6	11.8	20.0	21.2	16.2	11.6	11.9	14.6	10.8	13.4	12.6	16.1	12.6	29.8	16.5	11.0	16.8	14.3	11.4	12.7	18.3	12.6	12.0	19.0	14.2	12.9	13.4	10.8	12.0	12.2	3.6	7.1	10.5	14.4	9.1	6.3	6.1	3.8	7.7	8.4	8.7	8.0	5.3	10.1	7.2	6.8	8.1	8.5	6.5	3.2	9.7	4.7	4.4	9.9	7.4	6.7	10.3	9.8	4.9	11.7	10.2	13.8	8.4	11.9	19.6	5.7	13.7	5.3	4.3	8.7	8.6	7.9	5.7	15.8	11.1	3.6	6.0	6.9	11.0	5.9	4.7	2.9	8.9	7.7	6.7	12.6	5.6	10.9	6.0	7.6	7.2	9.5	9.3	12.9	16.7	8.4	10.4	13.2	8.2	1.3	6.8	3.6	10.9	7.1	9.9	12.0	12.1	11.1	12.2	10.2	14.4	12.3	0.4	10.5	4.1	11.6	11.1	9.1	20.2	14.8	7.9	27.2	16.9	12.8	17.6	11.8	14.6	12.6
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678193	"Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 25.8;hTCEpi: 14.6;U-698: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria				Mitochondria		"HPA069732: "	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favourable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	13.3	15.0	18.5	6.6	28.8	1.5	18.7	63.8	30.2	11.8	13.2	20.2	11.3	5.0	28.4	50.9	7.6	13.9	14.2	11.9	17.6	10.5	12.6	12.2	10.1	4.2	24.7	28.9	39.4	9.7	25.8	37.8	2.6	19.6	31.0	11.5	23.6	14.3	17.9	11.2	28.1	6.8	17.0	18.0	6.3	9.1	12.6	26.9	0.4	21.7	7.7	3.8	11.4	17.6	0.0	0.4	0.3	0.0	0.0	0.3	0.0	2.0	1.3	2.3	7.8	8.9	6.2	0.1	1.1	3.6	1.1	0.2	0.0	2.8	0.8	5.4	1.9	4.0	1.1	3.4	0.7	0.0	11.6	0.0	25.8	2.8	4.7	0.1	0.3	9.6	14.6	0.0	9.2	0.2	0.1	0.0	0.9	0.8	0.0	0.1	1.2	3.0	0.0	3.0	0.1	5.9	7.3	7.1	0.7	5.4	0.3	2.9	5.8	0.0	0.8	4.9	3.3	0.5	0.9	3.1	0.0	15.9	0.7	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	18.5	28.8	63.8	30.2	17.6	10.5	24.7	28.9	19.6	26.9
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 233.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria			5500000	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favourable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	35.7	71.2	23.6	38.3	27.2	24.6	48.9	25.1	50.2	29.8	69.6	22.4	33.8	53.9	38.5	35.9	54.6	30.1	55.1	233.5	22.9	25.3	60.2	72.6	47.0	75.5	27.8	26.0	39.6	59.7	55.5	29.1	34.2	31.6	33.8	53.3	30.9	53.5	33.5	190.6	33.8	76.0	46.7	19.6	35.6	51.4	16.9	15.1	42.0	41.5	125.8	44.4	38.5	31.9	46.8	82.3	33.4	78.5	43.3	56.6	76.3	75.6	59.1	78.4	64.9	71.4	118.8	101.1	66.4	88.5	86.1	72.0	106.1	39.8	103.4	39.5	80.4	65.2	79.5	89.7	90.8	38.9	63.4	61.6	43.6	70.3	88.0	72.1	49.0	112.3	80.3	62.5	90.0	121.5	66.4	30.7	102.6	56.4	66.9	80.5	72.6	97.1	76.5	81.7	114.7	111.3	76.0	40.3	54.0	79.5	71.5	109.6	96.6	78.9	81.6	48.0	45.3	52.6	66.4	52.0	61.1	72.3	37.8	42.6	61.7	24.4	59.5	33.4	40.1	77.2	47.4	46.8	45.7	44.3	82.3	33.3	47.9	45.3	26.4	43.3	78.5	50.3	56.6	76.3	23.6	27.2	25.1	50.2	22.9	25.3	27.8	26.0	31.6	15.1
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730378-127774299	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	687	"testis: 68.6"	"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria				Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: , HPA071684: "					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024763, HPA047402"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA024763: , HPA047402: "	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	24.1	14.9	11.1	19.6	17.0	21.6	21.6	22.1	21.9	16.3	14.7	15.4	8.8	11.0	19.4	13.0	13.1	18.8	19.6	16.4	12.6	16.5	15.2	29.6	16.1	23.9	16.4	11.6	21.0	13.4	17.3	30.1	16.5	24.2	14.9	14.2	15.7	13.0	13.1	17.8	13.9	14.1	18.5	14.1	25.1	14.4	15.3	13.6	17.2	14.9	11.7	19.8	18.3	14.2	8.9	5.0	1.8	4.6	5.7	9.3	6.5	14.9	5.4	7.3	8.9	10.1	11.7	4.9	12.7	18.0	14.3	14.9	6.5	9.2	32.5	12.1	13.7	9.6	10.5	10.7	22.2	19.8	7.5	24.0	4.6	8.3	17.5	11.7	10.9	11.5	8.9	16.1	24.0	14.8	14.8	12.8	14.2	6.0	19.9	9.6	8.8	10.8	15.0	7.8	22.4	9.7	6.9	20.5	9.0	6.2	10.2	21.3	9.1	8.4	10.2	17.8	11.8	20.4	16.3	9.1	8.6	33.9	15.1	17.2	13.1	0.7	3.9	1.8	7.7	4.4	9.3	8.9	8.3	8.8	5.0	6.5	8.6	8.7	1.1	5.7	4.6	4.3	6.5	6.5	11.1	17.0	22.1	21.9	12.6	16.5	16.4	11.6	24.2	13.6
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143241-185150382	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"		"Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria				Mitochondria		"HPA046835: , HPA071684: "	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	3.0	4.2	6.9	2.0	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3.0	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3.0	2.0	6.3	6.1	3.6	3.0	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0.0	4.6	62.4	3.4	4.4	2.1	3.5	3.0	0.4	0.0	0.7	4.1	1.5	0.7	3.2	2.7	5.4	2.9	0.3	4.9	2.7	0.9	3.3	3.3	7.0	1.8	2.3	1.9	3.2	2.6	10.3	2.8	2.1	4.0	8.8	1.6	4.9	8.2	6.0	1.4	1.6	2.2	7.0	5.0	1.4	2.4	3.8	1.8	2.0	5.1	1.6	3.1	4.3	7.0	2.6	1.4	3.3	7.4	5.0	8.7	6.6	3.2	1.4	12.4	2.5	1.2	1.8	0.2	1.5	1.6	3.4	7.8	3.5	3.0	2.4	0.3	3.0	0.0	0.0	0.0	4.1	0.0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3.0	0.4	0.7	0.0	3.0	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063999-19112888	"Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 42.3"	"Cell line enhanced"	"Detected in many"		"K-562: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9"	"Group enriched"	"Detected in many"	6	"B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1"	"Low region specificity"	"Detected in all"							HPA049449	Approved		Supported	Mitochondria				Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favourable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favourable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	4.8	5.7	13.8	4.5	12.2	7.5	4.9	22.5	15.4	7.0	4.8	5.9	4.5	5.7	6.8	4.4	4.5	7.4	4.7	8.9	9.7	7.8	26.7	42.3	5.4	8.5	5.9	7.8	13.8	7.4	6.5	9.6	3.2	7.9	7.6	3.0	12.2	11.0	6.3	26.7	5.2	5.6	5.7	6.1	7.3	4.6	4.5	8.1	6.6	17.1	7.3	12.2	5.5	5.4	6.2	0.7	0.2	0.6	2.8	5.1	1.5	6.3	0.8	1.6	2.9	6.3	5.2	2.6	3.1	4.7	4.8	5.5	1.2	12.8	4.6	7.3	2.9	1.2	3.3	2.6	2.8	1.1	6.3	1.6	1.7	10.2	5.0	0.7	3.2	5.2	1.8	3.6	2.2	2.1	17.8	8.3	2.5	5.7	7.6	7.3	0.9	6.6	5.9	2.9	8.8	1.9	1.2	1.8	1.3	3.3	0.1	1.4	5.8	3.6	1.9	3.6	2.0	7.4	3.0	9.6	5.2	3.6	3.8	9.8	1.8	0.0	0.2	0.2	5.1	0.5	2.8	6.2	2.9	4.3	0.3	5.1	1.9	2.8	0.0	2.8	0.6	0.7	2.9	1.5	13.8	12.2	22.5	15.4	9.7	7.8	5.9	7.8	7.9	8.1
SLC25A46		ENSG00000164209	"Solute carrier family 25 member 46"	Q96AG3	5	110738136-110765161	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039601, HPA071582"	Approved		Supported	Mitochondria				Mitochondria		"HPA039601: , HPA071582: "	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"prognostic favourable (8.41e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (1.98e-1)"	16.9	15.6	11.9	12.7	19.3	11.3	13.6	17.6	25.7	12.5	14.0	12.2	8.5	15.7	13.4	9.5	16.4	9.5	10.0	20.8	10.4	10.0	18.7	22.0	11.4	13.7	14.5	14.8	10.2	12.4	12.7	20.2	11.5	27.7	10.2	14.7	8.3	14.2	10.7	55.6	13.0	15.4	13.9	15.0	12.1	12.9	15.8	12.3	20.4	12.5	14.3	17.5	13.1	10.9	14.6	15.1	20.2	17.3	17.7	16.3	14.9	12.4	9.6	9.1	7.4	21.2	20.0	3.7	15.6	20.3	17.9	22.4	13.2	10.6	33.6	16.0	18.2	10.3	14.4	25.8	20.3	21.5	8.3	14.4	14.0	9.5	18.9	12.6	14.5	16.9	7.6	21.1	14.9	11.1	10.9	21.1	18.5	10.0	18.3	5.3	6.8	9.7	9.0	20.4	25.0	11.4	14.6	16.1	11.9	13.5	10.4	16.4	11.4	10.4	14.6	15.8	8.0	14.3	18.7	40.6	25.4	25.2	16.4	14.7	8.4	20.2	14.7	11.5	12.3	17.3	12.4	14.1	13.7	12.6	15.1	14.6	14.8	14.8	6.2	17.7	15.2	10.6	16.3	14.9	11.9	19.3	17.6	25.7	10.4	10.0	14.5	14.8	27.7	12.3
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468400-119471319	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria			7800000	Mitochondria		"HPA046835: , HPA071684: "	"unprognostic (1.25e-2)"	"prognostic favourable (7.35e-4)"	"prognostic favourable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favourable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	26.0	28.9	26.8	32.2	29.5	36.5	36.6	21.8	39.0	23.0	74.1	16.3	26.0	120.7	22.5	18.3	64.1	17.5	39.5	31.4	22.5	18.8	80.7	71.0	38.3	53.8	27.2	23.8	18.1	128.2	22.5	14.6	30.7	24.2	18.9	84.9	20.1	58.3	21.5	16.6	42.1	157.5	33.6	20.5	34.3	68.2	16.8	17.1	87.0	31.1	59.9	47.0	30.8	33.8	51.6	97.8	18.5	113.2	33.4	48.0	84.9	81.9	78.8	30.9	53.1	19.8	29.2	57.4	30.6	33.4	64.7	58.0	65.5	52.0	104.1	41.3	29.4	57.7	75.7	64.0	59.2	27.5	73.0	35.1	47.6	46.6	25.1	95.2	58.0	31.7	72.0	66.6	42.5	67.1	28.1	43.1	35.3	182.5	84.2	96.7	65.0	127.1	46.3	39.1	80.8	49.3	66.0	37.4	35.4	52.7	80.2	62.1	33.1	48.2	27.9	30.6	44.3	68.2	109.9	50.6	62.9	83.3	33.9	97.4	49.5	10.1	68.1	18.5	20.7	113.2	23.9	51.6	30.1	26.9	97.8	39.7	30.1	28.3	11.3	33.4	84.9	53.9	48.0	84.9	26.8	29.5	21.8	39.0	22.5	18.8	27.2	23.8	24.2	17.1
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392724	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA046835, HPA071684"	Approved		Supported	Mitochondria			7200000	Mitochondria		"HPA046835: , HPA071684: "	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	18.5	19.7	12.1	12.2	14.0	23.7	14.4	8.2	12.2	9.8	16.5			28.9	14.3	4.8	16.4	10.4	7.0	9.4	10.3	8.2	18.4	5.4	11.1	14.4	9.4		25.6	38.7	10.1	14.0	8.6		12.4	8.8		45.0	12.5	6.1	14.9	23.3	7.7	5.8	15.4	19.2	2.4			16.3		9.5	14.2	11.2	62.2	85.7	3.7	69.0	30.1	43.6	71.2	22.0	48.3	34.3	35.0	23.8	46.4	37.1	33.8	32.4	24.9	24.8	63.8	27.0	81.9	27.3	22.2	14.3	23.0	40.3	7.9	20.5	73.1	44.8	33.1	72.8	55.8	32.2	54.7	76.5	74.3	19.5	28.7	37.0	31.2	19.3	24.4	46.9	59.6	61.7	43.5	65.0	30.1	28.4	63.5	30.4	55.4	56.0	88.0	22.8	69.4	96.1	38.5	66.4	42.2	25.5	14.3	49.7	33.6	50.1	8.0	55.3	3.8	31.1	13.8	2.4	58.1	3.7	29.4	69.0	43.6	62.2	40.4	34.8	85.7	47.5	38.1	37.2	3.0	30.1	67.9	41.0	38.7	71.2										
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavourable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	9.9	30.9	10.2	10.2	19.3	16.3	8.4	9.1	18.0	11.6	8.2	12.6	14.1	8.7	11.6	14.6	6.9	9.2	10.0	5.1	9.4	30.5	12.4	6.9	12.8	14.3	10.5	17.4	18.3	7.9	14.9	25.6	21.1	17.2	11.8	5.1	15.6	12.2	14.8	6.5	13.1	11.9	11.6	9.3	17.3	7.3	4.8	7.3	1.8	18.1	4.9	6.7	9.8	14.1	0.4	1.3	0.1	2.3	0.1	4.9	1.9	0.5	8.3	9.8	7.6	4.9	3.7	11.4	4.7	5.9	10.7	6.7	9.5	1.7	0.1	9.7	4.9	3.2	5.4	3.5	4.2	11.3	9.8	0.0	10.5	8.8	13.1	0.0	1.5	6.7	5.8	5.1	2.4	9.0	4.1	12.1	6.3	7.8	0.4	0.2	4.4	8.1	0.4	1.1	4.4	9.7	9.1	3.9	12.0	4.8	11.9	12.3	14.3	0.2	6.7	8.6	5.1	7.3	0.5	13.6	5.1	1.3	4.5	0.0	6.9	0.0	2.3	0.0	1.8	0.9	2.6	0.4	3.2	2.6	1.3	0.2	4.9	2.0	0.1	0.1	0.3	0.0	4.0	1.9	10.2	19.3	9.1	18.0	9.4	30.5	10.5	17.4	17.2	7.3
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;MCF7: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: "	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favourable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	20.7	3.7	4.9	6.4	4.3	3.7	15.0	7.5	6.6	11.1	11.6	3.6	7.9	3.5	10.1	39.1	9.4	9.5	9.2	7.0	3.5	2.4	12.2	19.5	21.1	7.0	3.5	4.7	13.6	5.7	4.5	6.7	9.7	3.3	11.6	6.1	4.6	7.7	9.7	3.6	11.0	6.8	10.5	1.8	6.9	14.4	15.4	3.4	3.5	8.6	10.3	5.5	9.7	9.4	0.6	5.9	13.7	8.7	2.2	2.2	2.5	3.9	0.2	1.7	0.8	35.0	6.8	3.0	1.5	3.0	0.6	0.8	2.3	1.8	0.5	4.1	1.6	12.2	1.6	1.4	0.4	0.3	2.3	0.8	2.1	0.9	4.2	1.4	2.8	4.5	4.6	0.2	0.8	4.7	0.3	0.7	0.2	18.5	0.1	4.0	4.0	1.9	7.0	0.3	0.4	0.9	0.4	3.4	3.8	0.8	8.1	1.5	2.1	4.0	1.1	0.8	1.7	4.3	0.0	1.3	1.1	0.1	2.0	4.7	0.6	7.2	8.7	13.7	2.1	7.3	1.5	0.5	1.0	2.2	5.9	0.6	0.5	1.1	1.7	2.2	7.2	1.0	0.3	2.5	4.9	4.3	7.5	6.6	3.5	2.4	3.5	4.7	3.3	3.4
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340646-128361470	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 56.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Supported	Vesicles				Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favourable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	7.7	7.1	9.9	7.0	13.6	2.5	4.9	9.4	26.5	6.5	25.7	15.8	5.2	54.0	6.6	5.6	26.1	4.4	9.8	7.7	11.6	15.9	17.7	20.8	5.8	5.0	14.8	9.6	5.6	11.3	9.8	5.4	5.8	21.9	5.7	8.3	6.7	7.5	7.3	6.7	24.3	56.1	8.1	11.6	5.1	8.6	13.2	7.9	6.8	12.7	15.2	14.9	8.5	9.5	3.7	7.2	2.6	6.2	1.9	8.1	3.3	10.2	20.1	10.3	13.2	15.7	4.8	11.8	8.7	5.5	10.0	7.3	14.4	10.0	9.6	7.0	9.3	35.2	12.4	10.0	3.1	9.6	19.0	5.7	17.7	12.4	8.4	10.5	9.2	6.3	13.7	10.4	8.3	11.4	13.5	6.7	9.2	25.2	12.4	10.0	4.6	32.0	15.2	10.1	17.8	17.2	15.4	17.9	9.8	14.5	26.7	9.5	13.3	4.0	16.7	12.1	11.8	13.1	10.7	6.0	8.5	3.1	12.3	6.3	13.6	0.0	4.1	2.6	8.1	5.6	6.1	3.7	5.2	6.4	7.2	1.7	4.1	4.3	1.6	1.9	6.2	6.4	3.6	3.3	9.9	13.6	9.4	26.5	11.6	15.9	14.8	9.6	21.9	7.9
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319258-71381423	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.5;Hep G2: 21.7;RT4: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA046085: , HPA054976: , HPA057905: "	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavourable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (3.43e-3)"	11.3	4.0	6.4	6.6	8.3	1.9	6.8	3.2	12.6	8.3	6.1	11.3	2.4	4.1	12.1	4.6	3.5	9.4	7.4	3.6	8.0	5.5	3.9	12.5	11.1	10.5	9.8	6.5	15.8	7.4	7.1	2.8	24.6	6.7	8.3	6.0	4.6	7.5	5.4	2.1	3.7	4.9	8.9	8.0	9.4	8.9	4.9	7.7	9.3	6.7	1.3	6.2	18.4	10.0	3.6	19.3	2.8	12.9	5.7	4.0	5.6	1.2	7.3	1.0	4.6	4.2	3.3	19.5	1.3	1.4	0.4	0.2	8.0	5.2	4.2	3.9	2.7	11.6	3.3	1.8	0.0	3.3	3.3	1.2	0.6	21.7	2.0	1.0	2.7	3.2	8.0	0.1	0.3	1.9	3.9	4.1	0.5	11.3	2.7	2.1	2.5	2.6	3.3	0.4	3.4	1.6	17.3	5.5	5.8	3.9	12.7	1.0	1.9	2.3	3.0	0.1	2.4	1.3	0.0	1.1	1.8	2.3	5.1	14.3	0.8	2.8	12.9	1.4	4.0	10.1	3.4	3.6	3.2	3.6	19.3	1.5	2.6	3.6	1.0	5.7	6.3	13.6	3.4	5.6	6.4	8.3	3.2	12.6	8.0	5.5	9.8	6.5	6.7	7.7
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925375-42959176	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 194.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.2;CACO-2: 71.8;Hep G2: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"			36000000	"Plasma membrane"		"CAB002759: , HPA031345: , HPA058494: "	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (3.65e-8)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (4.05e-4)"	4.2	3.7	12.4	3.9	16.9	45.2	4.1	6.7	15.5	15.2	4.8	15.1	4.3	2.4	7.6	3.4	28.8	8.5	8.6	5.0	15.4	13.7	7.6	2.1	2.4	5.3	18.2	5.0	3.4	3.7	7.3	2.9	194.0	15.5	5.2	3.3	44.2	8.4	7.9	1.8	42.1	2.9	2.5	17.8	3.4	5.5	2.5	12.5	1.8	4.0	11.5	12.0	22.2	24.5	8.4	14.7	1.3	0.2	3.0	7.5	2.7	10.6	15.3	12.7	3.2	1.5	0.5	44.2	7.0	15.2	8.6	12.8	71.8	29.7	4.0	21.0	2.1	9.9	2.8	16.3	3.8	2.4	2.6	6.6	8.9	49.0	4.4	3.6	1.9	1.8	12.6	5.4	5.9	1.4	14.8	0.9	3.9	18.9	1.6	2.5	8.1	3.9	1.6	4.1	5.6	7.9	5.2	6.7	4.7	8.2	26.0	3.0	1.1	4.6	3.2	7.9	5.7	1.4	15.8	0.7	1.5	2.4	15.6	2.5	6.4	0.3	0.2	1.3	7.5	0.2	6.9	8.4	4.1	5.1	2.9	7.3	3.2	4.7	1.0	3.0	0.1	14.7	4.7	2.7	12.4	16.9	6.7	15.5	15.4	13.7	18.2	5.0	15.5	12.5
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.6;CAPAN-2: 10.4;HaCaT: 7.9;HEK 293: 6.5;U-2 OS: 11.3"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: "	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	3.0	1.0	2.6	0.0	2.0	1.1	0.2	1.8	7.6	1.0	4.2	0.0	10.4	0.4	1.6	0.1	7.9	0.0	0.8	1.5	0.0	6.5	0.0	0.9	0.1	0.3	0.0	0.0	1.5	0.7	0.8	0.2	0.6	0.6	0.9	0.2	0.9	0.1	0.1	2.3	0.7	0.0	1.3	2.8	2.3	1.0	0.3	0.8	0.1	2.4	0.0	0.1	0.0	0.1	0.2	11.3	0.2	1.0	3.9	3.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996348-171026750	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 77.4;liver: 172.8"	"Group enriched"	"Detected in some"	68	"CACO-2: 7.1;Hep G2: 23.7"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB010444: AB_641068, HPA028997: "			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favourable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	27.9	0.0	0.0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	77.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211578742	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 53.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA015275: AB_1857083, HPA049000: "	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	11.4	16.6	9.3	7.5	11.4	15.5	17.3	5.2	13.6	13.0	15.3	6.9	4.9	17.2	7.1	7.6	9.0	9.2	12.9	6.1	9.7	7.9	13.4	53.3	12.0	3.5	9.5	8.0	9.5	8.9	8.8	4.8	9.3	8.7	7.3	8.9	7.7	5.9	9.2	3.6	13.9	28.1	7.5	8.3	10.7	6.4	12.5	5.5	3.1	11.0	5.2	4.4	7.7	8.4	0.5	2.5	3.9	4.2	1.3	1.7	1.0	4.6	6.8	3.7	4.8	16.3	7.6	33.1	12.8	9.4	6.8	6.7	2.9	22.2	2.6	11.2	11.7	8.0	5.6	7.4	8.2	6.6	4.2	2.1	13.8	6.8	9.2	7.3	4.7	11.3	18.7	8.7	14.2	4.2	8.2	12.3	8.4	4.2	1.4	4.6	11.5	5.4	4.4	1.8	9.5	21.2	12.5	3.8	6.6	12.5	6.5	28.6	3.3	9.5	6.7	5.1	11.9	17.0	10.1	5.4	8.2	2.1	4.8	7.4	4.4	3.9	3.9	1.3	1.2	4.2	1.7	0.5	0.9	0.8	2.5	0.3	0.9	1.2	0.4	1.3	3.2	1.7	0.8	1.0	9.3	11.4	5.2	13.6	9.7	7.9	9.5	8.0	8.7	5.5
SLC30A5	"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1"	ENSG00000145740	"Solute carrier family 30 member 5"	Q8TAD4	5	69093646-69131069	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035373	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA035373: AB_10794630"	"unprognostic (9.81e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	19.4	22.1	14.4	19.4	15.7	13.3	29.7	14.9	18.5	25.0	20.9	13.2	33.7	19.7	24.3	32.4	20.5	20.3	23.5	25.4	14.5	15.4	28.6	39.2	24.3	23.7	15.5	13.1	25.4	50.5	29.6	38.1	34.3	13.9	24.5	19.8	17.6	36.8	35.3	17.1	21.2	25.0	18.1	13.2	20.1	20.3	18.1	12.7	22.1	33.5	18.8	19.6	18.2	28.9	8.3	13.2	12.4	6.9	5.6	9.1	3.3	15.6	12.2	11.3	19.9	29.9	23.1	36.0	24.9	22.6	15.7	24.1	11.2	19.8	20.8	31.7	16.9	17.0	15.7	18.9	26.7	24.8	18.1	23.2	15.4	18.2	24.1	14.5	25.8	15.6	25.0	16.2	19.3	15.2	13.9	24.9	20.0	19.8	19.1	30.3	12.9	13.9	15.4	14.4	37.5	23.5	14.7	20.3	16.1	19.7	19.8	33.7	19.1	32.4	13.8	10.3	13.3	25.6	24.6	22.6	27.7	16.2	20.2	26.5	25.2	12.4	6.7	10.7	6.1	6.8	6.5	8.3	9.1	8.9	8.4	6.3	8.4	7.1	5.9	5.6	6.9	13.2	6.1	3.3	14.4	15.7	14.9	18.5	14.5	15.4	15.5	13.1	13.9	12.7
SLC30A6	"FLJ31101, ZNT6"	ENSG00000152683	"Solute carrier family 30 member 6"	Q6NXT4	2	32165841-32224379	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055032, HPA057328"	Uncertain		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA055032: , HPA057328: "	"unprognostic (5.61e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-3)"	"prognostic unfavourable (6.55e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (9.58e-6)"	"unprognostic (2.98e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.30e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	15.9	17.9	10.3	11.9	13.1	5.4	15.3	21.1	13.7	16.6	14.4	14.2	10.6	12.6	22.5	12.1	16.8	13.8	13.5	13.5	10.6	8.7	17.9	18.4	14.3	17.9	17.3	8.1	17.8	23.7	15.7	19.8	18.1	13.2	13.7	15.3	14.8	17.2	12.4	18.8	15.2	14.3	14.1	20.1	16.2	14.9	12.8	15.9	21.3	17.8	9.9	18.8	15.0	14.2	4.3	3.9	12.5	3.1	9.2	6.1	2.6	18.4	13.8	14.2	12.4	18.1	16.3	15.8	17.3	17.2	14.2	13.0	10.7	17.5	8.8	11.5	13.8	11.6	16.9	11.9	18.2	17.7	9.4	19.2	7.9	13.7	11.7	20.0	11.9	12.1	18.7	19.1	15.4	11.4	16.1	11.8	16.2	6.8	10.5	9.2	21.5	7.3	9.5	17.2	12.9	15.7	16.2	10.7	16.3	13.6	14.7	13.6	8.1	9.2	9.7	18.3	10.1	12.0	20.3	16.1	28.0	13.1	16.2	15.7	18.3	12.5	3.1	2.6	3.6	2.7	4.9	4.3	3.3	4.0	3.9	3.8	5.0	4.6	3.5	9.2	3.0	3.2	6.1	2.6	10.3	13.1	21.1	13.7	10.6	8.7	17.3	8.1	13.2	15.9
SLC30A7	"ZNT7, ZnTL2"	ENSG00000162695	"Solute carrier family 30 member 7"	Q8NEW0	1	100896076-100981753	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018034	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA018034: AB_1857089"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.37e-1)"	15.6	14.2	5.0	13.1	6.4	10.3	12.7	7.4	7.6	13.3	10.8	6.2	17.2	10.8	13.3	13.7	10.8	9.4	13.2	9.3	5.9	5.6	13.0	43.1	18.1	25.6	7.7	4.6	10.5	19.1	17.1	17.7	25.2	9.2	11.9	14.7	10.8	17.5	18.1	5.7	12.6	15.8	9.0	8.1	16.2	13.3	7.5	6.4	24.7	13.2	10.9	17.4	10.5	11.1	5.5	8.2	13.9	14.9	8.4	10.7	5.9	10.7	5.7	6.1	13.5	13.1	13.4	15.5	7.1	19.0	8.7	11.4	5.8	7.8	4.3	15.5	14.5	10.7	7.1	10.6	13.3	6.8	4.4	8.5	9.6	10.3	14.7	11.2	9.1	15.2	6.8	14.6	17.9	14.0	5.1	19.0	11.8	4.9	8.2	5.6	6.6	7.0	4.1	11.0	5.6	7.7	12.7	3.4	6.6	12.8	14.3	9.2	7.1	6.2	15.1	20.6	7.9	19.0	11.4	13.0	6.8	4.8	21.0	9.2	5.4	13.9	10.7	7.4	10.7	10.4	9.2	5.3	9.9	8.4	8.2	5.5	8.9	9.6	5.3	8.4	14.9	7.7	7.2	5.9	5.0	6.4	7.4	7.6	5.9	5.6	7.7	4.6	9.2	6.4
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in some"	81	"BEWO: 12.3;EFO-21: 46.6;RPTEC TERT1: 33.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037989	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus"	"HPA037989: AB_10670536"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0
SLC35A2	"UGALT, UGAT, UGT, UGT1, UGT2, UGTL"	ENSG00000102100	"Solute carrier family 35 member A2"	P78381	X	48903180-48911958	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036087	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA036087: AB_10604093"	"prognostic unfavourable (3.16e-4)"	"unprognostic (3.34e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.25e-3)"	"prognostic unfavourable (9.64e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.16e-2)"	"prognostic favourable (8.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	11.4	17.2	10.5	9.7	12.2	10.9	21.9	5.9	18.4	16.2	22.7	20.5	13.4	13.5	11.5	24.2	17.2	23.1	14.3	12.8	10.3	10.9	18.8	43.6	14.5	18.9	12.0	9.7	10.6	30.6	18.8	16.2	29.8	12.7	14.1	23.1	10.3	16.9	14.7	12.9	15.9	13.0	9.0	13.8	12.1	19.8	8.8	10.3	8.8	13.3	12.5	13.0	11.3	11.4	7.5	18.5	24.2	15.7	7.8	10.9	6.9	20.4	23.7	8.0	11.5	17.3	14.1	11.9	21.1	20.6	21.2	25.6	25.5	36.2	7.7	10.0	23.2	29.5	21.7	16.3	17.6	10.1	14.7	8.5	14.9	19.9	20.2	16.1	18.4	15.0	27.5	18.6	17.7	12.4	16.1	12.8	15.6	19.5	7.9	13.3	16.8	28.8	8.5	14.4	23.5	19.2	16.8	9.4	15.2	22.0	23.9	12.0	35.2	12.7	8.9	12.8	13.1	23.0	11.9	19.9	13.5	8.4	15.5	13.3	15.7	11.4	14.4	24.2	10.2	15.7	10.9	7.5	9.2	9.6	17.5	7.3	5.8	10.6	15.9	7.8	10.6	18.5	8.8	6.9	10.5	12.2	5.9	18.4	10.3	10.9	12.0	9.7	12.7	10.3
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813015	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA064001: "	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.64e-4)"	"unprognostic (2.30e-2)"	14.9	4.8	5.1	7.2	4.5	1.5	14.3	4.4	7.3	7.0	13.8	4.4	4.9	17.4	7.1	3.2	22.5	6.1	8.8	5.3	5.4	3.9	6.0	74.7	7.1	7.1	3.9	3.6	4.9	11.4	4.9	7.8	10.5	5.6	6.0	9.8	3.6	15.5	7.0	8.5	3.4	17.4	6.8	5.0	6.5	13.4	7.4	4.8	5.6	5.2	7.0	10.9	9.4	8.6	4.7	8.3	9.9	10.5	4.3	16.7	8.6	5.3	13.8	3.1	8.0	10.2	10.4	10.6	11.6	10.1	6.8	7.5	6.2	8.7	5.0	5.5	13.2	14.1	6.6	6.8	3.2	13.0	7.9	2.8	11.0	11.2	22.5	5.5	8.8	12.3	8.3	5.2	5.6	8.8	6.4	7.5	7.1	11.5	2.8	4.3	14.0	19.5	3.8	5.3	11.8	7.6	13.3	3.1	4.5	8.6	8.3	4.8	7.4	2.9	13.4	14.2	8.3	24.9	8.3	5.5	12.9	2.5	10.2	7.3	7.7	5.0	10.2	9.9	10.2	10.5	11.1	4.7	16.7	13.4	8.3	3.6	8.5	7.4	1.6	4.3	6.9	7.2	10.8	8.6	5.1	4.5	4.4	7.3	5.4	3.9	3.9	3.6	5.6	4.8
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA027011: "	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	16.8	25.9	19.4	26.7	24.0	25.6	17.5	30.3	25.0	19.1	19.3	22.8	21.3	22.0	19.2	20.9	23.4	24.3	20.2	13.5	19.0	12.9	20.7	26.7	17.4	22.9	19.9	13.6	21.0	30.5	18.0	23.7	29.8	17.7	23.6	12.2	28.9	30.9	17.3	13.4	25.6	20.7	15.8	19.3	26.1	21.6	19.6	23.3	19.7	23.0	13.5	23.4	19.1	19.3	17.4	42.9	26.8	21.9	18.3	28.3	23.5	14.1	17.1	8.0	6.4	11.2	10.7	14.8	7.7	14.7	8.7	10.3	24.0	22.6	9.5	26.5	9.1	20.1	4.5	17.5	3.2	7.6	13.5	8.3	10.5	19.1	21.2	10.9	9.9	15.4	22.3	12.3	14.4	7.2	13.1	17.5	6.4	34.3	7.6	16.3	10.3	16.7	7.2	8.6	18.3	11.0	14.0	11.8	16.4	7.2	37.6	24.1	22.2	19.1	6.9	22.4	14.3	11.3	12.3	23.4	19.2	9.8	25.3	12.4	9.9	19.0	21.9	26.8	23.8	21.5	22.2	17.4	24.4	24.0	23.9	16.9	28.3	25.5	19.5	18.3	16.7	42.9	22.1	23.5	19.4	24.0	30.3	25.0	19.0	12.9	19.9	13.6	17.7	23.3
SLC35D2	"SQV7L, UGTrel8"	ENSG00000130958	"Solute carrier family 35 member D2"	Q76EJ3	9	96320706-96383710	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA064047	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA064047: "	"unprognostic (3.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.44e-1)"	8.7	6.1	5.9	7.8	13.6	4.6	8.8	1.6	10.8	7.9	23.8	21.2	4.2	30.7	8.3	8.7	8.7	7.8	16.2	7.3	7.8	5.2	20.1	27.9	13.2	17.6	13.7	4.7	10.5	26.0	8.0	5.1	10.5	9.2	8.0	22.6	13.1	8.5	5.3	2.8	5.7	39.6	11.2	14.3	6.5	18.7	5.1	9.8	2.7	14.3	5.0	7.5	10.0	8.0	1.5	2.4	1.6	1.4	1.9	5.3	1.0	11.4	9.0	5.6	11.6	7.2	14.9	10.8	5.2	10.9	8.0	6.7	18.4	38.0	0.2	8.6	4.6	16.7	7.8	8.1	7.1	5.4	6.4	4.1	3.8	31.6	10.7	0.0	0.0	12.2	9.7	6.1	17.6	17.5	7.7	0.1	8.8	7.8	0.0	0.0	5.0	10.4	0.0	0.0	0.0	19.0	7.0	2.1	13.2	4.5	9.0	22.9	5.7	8.3	15.5	5.6	6.0	8.0	5.0	0.0	0.3	0.0	11.5	0.0	7.6	1.6	1.4	1.0	1.8	1.0	2.4	1.5	2.2	3.5	2.4	0.3	0.7	1.7	0.1	1.9	0.8	0.1	5.3	1.0	5.9	13.6	1.6	10.8	7.8	5.2	13.7	4.7	9.2	9.8
SLC35E1	FLJ14251	ENSG00000127526	"Solute carrier family 35 member E1"	Q96K37	19	16549831-16572382	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016570, HPA062214"	Approved		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA016570: AB_2190214, HPA062214: "	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.75e-2)"	15.2	12.7	11.9	9.3	12.3	10.3	13.5	11.7	19.2	15.1	12.4	8.7	22.4	9.7	11.3	10.3	14.2	11.2	13.7	12.6	9.3	9.7	11.6	20.1	13.5	9.5	8.3	7.9	11.9	34.5	25.8	14.4	23.9	10.7	17.9	9.4	11.4	23.7	21.4	23.1	14.3	13.4	10.0	5.9	9.7	17.0	6.4	7.2	14.0	13.8	12.3	13.9	15.2	14.1	5.9	3.2	7.9	5.0	4.5	5.2	2.9	17.7	7.0	5.1	11.2	18.8	14.6	11.9	12.9	13.8	10.6	12.6	8.2	12.7	9.3	20.8	20.1	11.9	13.7	14.5	12.1	10.6	19.7	8.4	8.1	9.6	15.1	13.9	10.1	11.6	17.1	11.7	17.6	10.2	12.9	12.6	14.0	16.9	10.1	6.4	5.9	23.8	9.8	7.7	10.9	10.9	11.5	8.5	8.4	8.9	14.3	7.9	10.0	6.8	11.1	14.2	7.0	19.0	14.8	16.3	17.4	10.5	20.9	14.8	8.7	5.0	3.9	7.9	4.1	2.5	5.2	5.9	4.3	3.6	2.7	2.8	3.2	2.5	4.8	4.5	5.0	3.2	4.8	2.9	11.9	12.3	11.7	19.2	9.3	9.7	8.3	7.9	10.7	7.2
SLC35G2	"DKFZp564K2464, MGC3295, TMEM22"	ENSG00000168917	"Solute carrier family 35 member G2"	Q8TBE7	3	136818647-136855892	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 1.6;memory CD8 T-cell: 3.5;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052054, HPA064728"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA052054: , HPA064728: "	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.91e-4)"	"unprognostic (2.56e-4)"	"unprognostic (5.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavourable (1.16e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.30e-2)"	20.2	24.6	10.6	3.7	12.0	1.3	18.3	16.6	17.4	8.1	3.6	6.4	6.6	2.2	6.7	8.1	4.1	5.0	8.7	7.6	11.6	15.2	4.3	7.1	6.0	3.3	10.9	10.5	5.3	13.3	6.7	15.9	11.7	11.3	4.8	3.8	3.2	2.7	4.8	2.8	3.0	2.4	8.5	12.4	3.1	3.1	17.2	4.9	0.9	8.8	2.1	2.5	8.2	9.3	0.2	0.0	0.0	0.1	0.0	3.5	0.3	1.7	4.9	5.0	2.2	10.1	8.2	0.0	7.8	34.1	11.7	17.7	4.6	2.7	0.0	6.0	8.0	0.6	5.9	0.3	10.9	0.0	1.6	1.4	6.0	2.8	12.9	0.0	0.0	11.7	0.9	10.2	2.8	8.8	0.8	0.0	15.0	0.0	2.1	1.5	1.1	3.7	1.8	3.3	0.0	10.0	0.4	8.3	5.5	6.3	0.0	10.7	0.0	0.8	5.9	8.7	2.2	3.8	8.4	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.5	0.0	0.1	3.5	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.3	10.6	12.0	16.6	17.0	11.6	15.2	10.9	10.5	11.3	4.9
SLC38A10	"MGC15523, PP1744"	ENSG00000157637	"Solute carrier family 38 member 10"	Q9HBR0	17	81245000-81295547	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021374, HPA023161, HPA024631"	Enhanced		Enhanced	"Golgi apparatus"			44000000	"Golgi apparatus"		"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860"	"unprognostic (2.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"prognostic favourable (2.92e-4)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (5.34e-7)"	"unprognostic (6.55e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	22.8	18.6	8.1	17.0	11.3	18.5	43.0	9.9	10.2	15.8	23.8	13.8	22.0	21.8	17.4	30.7	13.2	15.2	28.4	17.3	7.4	9.2	18.0	59.2	24.6	23.7	11.6	6.7	23.7	55.1	6.8	30.2	23.2	10.0	16.0	6.5	15.1	33.3	26.1	8.7	11.2	26.2	10.9	10.4	21.0	19.1	25.0	12.3	20.2	25.9	10.3	15.8	18.4	13.0	6.6	10.0	17.2	15.4	4.6	9.8	7.9	17.1	30.1	5.3	27.7	20.3	9.6	31.5	21.1	19.1	13.0	15.3	14.0	28.8	13.2	24.2	14.5	20.7	5.3	10.6	4.8	13.1	15.8	13.2	10.7	23.5	18.2	13.0	31.6	16.6	7.9	11.6	7.6	24.7	9.8	20.3	9.6	21.8	7.8	22.2	5.2	14.9	12.8	11.1	13.3	9.1	16.2	10.1	26.4	17.0	10.7	23.0	15.2	27.2	24.3	21.0	12.3	15.6	11.3	17.9	7.8	7.5	12.5	20.2	21.5	11.0	10.2	17.2	8.1	12.0	9.8	6.6	7.8	9.8	6.3	6.6	5.4	5.8	8.2	4.6	15.4	10.0	5.5	7.9	8.1	11.3	9.9	10.2	7.4	9.2	11.6	6.7	10.0	12.3
SLC38A9	FLJ90709	ENSG00000177058	"Solute carrier family 38 member 9"	Q8NBW4	5	55625845-55773194	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.2"	"Cell line enhanced"	"Detected in all"		"BEWO: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043785, HPA061702"	Uncertain		Supported	Vesicles				Vesicles		"HPA043785: AB_10961859, HPA061702: "	"unprognostic (4.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavourable (7.24e-5)"	"unprognostic (2.49e-1)"	"unprognostic (8.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.87e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.12e-1)"	7.2	6.3	8.2	6.9	8.0	5.2	6.8	9.9	9.7	6.4	7.5	9.2	6.7	6.6	7.5	5.9	9.0	5.8	7.1	3.9	6.2	6.4	6.7	13.5	6.4	8.4	9.4	6.4	6.9	18.2	10.1	11.8	44.2	8.6	5.9	8.5	6.7	7.6	5.3	5.2	6.2	7.1	7.2	8.8	8.9	7.7	15.8	8.5	13.3	7.1	5.7	11.4	8.7	6.9	10.8	10.8	7.4	11.8	8.9	10.0	6.4	7.9	8.1	6.8	9.1	9.5	9.8	49.1	6.7	9.5	8.1	13.5	13.1	11.0	13.1	11.4	5.5	9.9	9.1	7.9	10.7	7.0	8.6	4.1	8.7	8.7	15.1	7.4	5.0	11.8	9.5	9.0	10.6	9.1	9.0	8.7	7.6	6.8	9.3	7.1	12.6	7.4	7.1	11.4	13.2	11.0	6.4	3.8	6.0	6.9	4.3	11.4	9.3	15.0	12.4	1.7	5.5	12.0	7.0	9.4	19.3	7.9	4.2	7.6	4.7	4.8	11.8	7.4	7.8	10.2	10.0	10.8	6.3	9.0	10.8	6.2	9.2	7.7	2.9	8.9	7.5	10.8	8.1	6.4	8.2	8.0	9.9	9.7	6.2	6.4	9.4	6.4	8.6	8.5
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA053999: "	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	14.7	25.1	9.0	12.1	9.5	6.1	15.8	11.9	11.9	24.7	19.8	12.2	43.3	17.3	20.1	24.6	14.4	13.6	25.6	20.7	8.7	8.9	24.6	55.1	20.2	11.6	12.6	9.6	14.4	49.2	37.1	24.2	43.8	18.8	22.8	22.9	16.8	48.0	41.7	10.4	11.3	18.8	20.1	10.6	15.2	21.1	9.5	10.7	9.9	28.2	14.4	17.0	16.6	13.9	2.6	3.4	6.2	2.8	4.2	5.1	2.1	8.4	9.8	15.0	13.9	22.6	15.5	13.1	22.6	29.7	17.6	20.7	16.0	8.2	6.3	11.1	25.1	9.5	11.3	13.3	15.7	8.0	10.0	10.8	11.4	20.5	16.3	10.7	13.1	14.6	11.3	15.5	16.8	14.0	11.7	10.4	12.1	9.6	5.9	6.2	6.4	9.0	6.3	8.8	10.5	11.8	10.6	9.8	7.9	9.2	21.7	12.3	21.0	9.9	13.8	16.2	9.9	12.1	15.0	16.3	14.3	5.6	9.8	10.2	17.9	6.2	2.4	2.3	5.1	2.8	4.8	1.8	3.2	3.9	2.3	2.6	2.9	3.3	2.4	4.2	1.6	3.4	3.0	2.1	9.0	9.5	11.9	11.9	8.7	8.9	12.6	9.6	18.8	10.7
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856102-62888875	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 129.8;SiHa: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			210000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB010455: AB_638288, HPA017980: "	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favourable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (1.48e-4)"	28.5	30.8	34.6	23.0	36.8	62.4	30.8	18.7	34.8	26.0	26.8	25.3	30.4	34.3	29.2	41.2	31.2	23.8	19.9	14.7	31.3	27.1	71.4	31.8	33.5	17.8	37.8	24.1	29.9	39.2	138.6	19.3	75.5	32.9	28.3	13.9	52.5	39.0	27.5	32.5	32.1	33.8	19.6	38.0	21.9	28.2	33.4	30.8	13.6	33.7	33.4	22.2	20.6	56.6	16.6	73.9	11.6	36.2	20.3	39.8	37.3	16.1	68.1	6.9	21.6	8.4	6.8	64.4	28.1	10.8	14.8	13.0	65.1	30.6	17.8	31.2	16.5	56.0	12.7	55.1	7.9	32.3	12.0	12.7	49.6	28.7	78.4	14.9	18.6	14.8	129.8	18.0	55.0	8.6	24.6	39.4	9.0	77.8	15.3	19.0	11.6	23.0	15.9	10.5	34.7	10.3	9.0	11.9	5.7	132.3	49.6	95.4	17.8	19.6	15.7	15.0	22.4	22.0	19.8	49.0	54.3	56.4	14.7	23.5	42.8	8.5	36.2	11.6	30.1	34.8	39.8	14.4	27.7	30.8	22.1	16.6	23.5	25.2	7.5	20.3	27.6	73.9	26.2	37.3	34.6	36.8	18.7	34.7	31.3	27.1	37.8	24.1	32.9	30.8
SLC41A3	FLJ20473	ENSG00000114544	"Solute carrier family 41 member 3"	Q96GZ6	3	126006355-126101561	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045847	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA045847: "	"unprognostic (1.77e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (1.49e-7)"	"unprognostic (1.36e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.57e-1)"	"prognostic favourable (6.04e-7)"	"unprognostic (1.26e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.54e-2)"	11.2	20.2	21.3	10.7	20.7	5.3	22.2	29.8	43.4	18.6	10.6	12.6	12.1	10.1	21.1	32.9	10.8	24.0	16.3	17.1	17.9	20.6	14.0	8.5	9.5	14.3	17.1	16.5	31.2	17.6	19.7	16.9	10.9	21.4	12.5	10.9	18.6	16.7	14.5	25.5	10.7	8.9	17.1	11.7	8.8	10.7	30.5	6.0	27.7	18.0	11.5	10.4	12.3	11.9	9.0	8.6	9.3	8.2	13.0	18.8	5.6	17.5	7.3	12.0	10.1	34.2	20.1	18.1	10.0	17.5	14.0	16.6	9.6	16.0	12.9	19.1	19.8	13.8	4.4	17.5	12.3	12.4	13.8	7.0	13.6	13.8	28.3	12.7	7.8	19.4	21.5	8.4	17.4	19.3	5.8	10.8	18.4	9.4	14.0	10.4	9.1	11.3	7.4	12.4	17.4	16.7	13.0	9.3	10.1	15.5	5.0	42.6	5.1	17.1	13.2	13.1	10.1	19.8	11.3	8.2	6.7	6.3	11.9	5.7	11.9	9.3	5.7	3.9	11.2	8.2	9.1	9.0	10.6	11.5	8.6	8.4	9.2	8.7	1.2	13.0	5.1	8.4	18.8	5.6	21.3	20.7	29.8	43.4	17.9	20.6	17.1	16.5	21.4	6.0
SLC44A1	"CD92, CDw92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 111.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 71.8;ASC TERT1: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064714			Supported	Nucleoplasm,Mitochondria			270000	Mitochondria	Nucleoplasm	"HPA064714: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favourable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	8.7	7.4	40.0	6.4	48.8	5.3	14.6	7.2	37.0	9.9	26.7	69.5	10.2	12.0	8.8	18.4	10.1	8.5	11.0	6.9	50.0	29.6	12.0	20.3	9.8	4.6	64.3	21.3	8.0	8.0	20.5	3.9	12.3	38.2	6.6	26.9	4.6	6.0	14.8	4.8	11.4	14.0	9.5	111.6	4.8	18.9	2.3	59.4	2.3	24.0	5.1	7.9	12.4	7.9	2.4	3.7	2.5	5.4	8.7	1.8	1.6	6.7	5.7	1.5	1.9	71.8	56.8	4.9	5.7	14.9	3.7	5.0	6.0	18.0	9.0	2.9	21.5	13.5	4.6	8.2	6.4	7.8	3.8	11.2	4.0	7.5	4.8	2.2	5.8	31.5	6.8	7.1	6.5	11.7	0.3	18.8	4.2	9.6	8.9	2.5	8.7	5.5	1.8	6.0	6.8	5.1	15.9	7.5	2.9	8.0	8.9	8.0	8.8	6.8	10.0	3.7	3.4	4.0	4.1	14.5	9.5	6.8	7.2	4.9	4.9	2.5	5.4	1.1	1.1	2.1	0.8	2.0	1.2	0.8	3.7	2.4	1.8	0.6	1.0	8.7	1.2	1.3	1.1	1.6	40.0	48.8	7.2	29.8	50.0	29.6	64.3	21.3	38.2	59.4
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394756-28407197	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.7"	"Cell line enriched"	"Detected in many"	5	"CACO-2: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	3.1	17.8	4.6	2.5	7.0	1.3	5.1	13.2	5.2	2.9	43.8	5.2	9.4	45.4	2.2	4.5	1.8	6.7	3.0	2.2	4.4	6.0	3.8	17.9	3.2	4.9	4.0	4.0	4.4	5.0	8.1	7.8	5.0	5.0	3.7	2.7	6.1	5.7	5.8	2.0	2.0	52.7	2.6	4.6	4.9	2.3	2.2	4.2	2.2	4.0	0.4	1.2	2.4	2.4	2.7	2.6	7.1	5.9	2.9	1.7	0.8	1.7	7.3	2.4	4.0	2.0	0.4	7.6	2.0	1.5	1.7	1.9	66.1	2.1	0.2	1.2	1.1	5.6	2.7	4.6	1.4	4.2	6.4	0.0	4.5	5.6	0.7	0.0	3.3	0.9	8.5	1.8	5.3	0.1	2.8	0.4	0.3	2.3	0.0	0.2	1.4	0.9	0.1	2.0	0.8	1.3	3.8	6.5	3.4	14.2	6.6	0.9	5.1	1.1	0.2	0.2	2.9	0.4	2.1	3.0	3.4	0.1	0.4	0.4	1.5	7.1	1.6	1.1	0.8	5.9	1.4	2.7	0.9	0.7	2.6	1.7	1.0	1.7	2.3	2.9	4.3	1.1	1.6	0.8	4.6	7.0	13.2	5.2	4.4	6.0	4.0	4.0	5.0	4.2
SLC48A1	"FLJ20489, hHRG-1, HRG1"	ENSG00000211584	"Solute carrier family 48 member 1"	Q6P1K1	12	47753916-47782753	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065396, HPA073994"	Approved		Supported	Vesicles				Vesicles		"HPA065396: , HPA073994: "	"unprognostic (9.60e-2)"	"prognostic favourable (4.27e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (9.39e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.63e-3)"	"prognostic favourable (1.34e-6)"	"unprognostic (1.45e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-2)"	16.2	13.5	27.8	5.0	33.5	7.7	10.7	12.5	39.5	13.1	8.3	90.7	6.7	5.6	11.9	12.7	13.9	21.9	11.5	12.8	32.7	20.8	18.5	6.3	11.7	4.9	44.1	27.9	35.6	10.6	24.3	6.4	13.2	38.6	9.3	8.2	7.4	13.2	18.1	16.7	14.7	5.3	12.7	44.5	11.3	7.7	5.1	39.7	4.9	35.6	6.1	6.0	9.9	7.6	7.1	8.5	23.7	11.9	1.2	5.4	4.0	4.5	14.0	2.2	16.7	14.7	6.3	4.9	3.2	7.1	3.1	3.2	4.4	12.2	2.7	42.0	8.9	17.9	2.8	3.7	2.4	22.7	2.8	19.0	11.7	6.0	8.4	5.0	11.3	3.7	7.6	4.4	5.4	8.6	4.9	11.1	1.9	9.3	2.4	5.2	1.5	6.9	2.3	0.6	14.8	12.4	12.0	2.9	1.3	4.3	5.4	3.0	18.0	4.7	4.7	4.4	5.9	8.3	2.3	9.0	5.5	0.8	5.7	24.1	2.6	0.0	11.9	7.8	3.6	8.5	3.2	7.1	4.4	3.7	8.5	6.3	5.4	4.4	23.7	1.2	4.8	1.6	3.4	4.0	27.8	33.5	12.5	39.5	32.7	20.8	44.1	27.9	38.6	39.7
SLC4A1AP	"HLC3, kanadaptin"	ENSG00000163798	"Solute carrier family 4 member 1 adaptor protein"	Q9BWU0	2	27663471-27694976	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036679	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA036679: "	"unprognostic (5.63e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (2.21e-1)"	"unprognostic (7.89e-3)"	"prognostic unfavourable (3.76e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (1.79e-4)"	12.3	16.1	18.8	14.2	27.0	12.7	13.9	27.4	29.0	11.5	11.3	15.8	8.7	11.6	12.8	12.2	14.2	12.3	9.8	18.6	17.9	19.6	15.3	15.0	12.8	14.6	17.0	20.5	15.2	13.3	23.8	16.0	14.5	29.1	12.6	12.3	9.0	12.4	12.1	26.0	15.1	12.0	12.5	15.4	13.1	12.5	29.9	16.8	16.1	14.6	14.9	15.1	11.1	11.0	16.7	13.3	40.8	17.9	22.5	19.5	14.1	21.6	12.6	12.8	11.9	13.2	12.2	18.8	18.0	12.5	19.0	15.6	18.4	15.9	13.7	16.8	14.4	15.5	20.4	14.0	17.1	19.1	16.7	15.8	13.3	20.2	16.1	22.5	15.1	10.9	17.8	18.9	18.0	19.3	22.8	15.0	17.5	13.2	15.1	22.1	12.9	12.5	12.6	28.0	15.8	19.6	10.1	13.9	13.7	14.0	19.2	17.3	11.6	14.8	19.5	17.8	16.1	12.3	21.0	24.8	35.1	44.0	19.3	18.2	14.1	40.8	17.7	24.2	17.6	16.9	17.4	13.5	16.1	15.3	13.3	16.7	19.5	16.5	16.5	22.5	17.9	10.7	17.1	14.1	18.8	27.0	27.4	29.0	17.9	19.6	17.0	20.5	29.1	16.8
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 48.5"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"				"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	14.5	5.0	3.2	10.5	4.6	3.3	17.0	4.0	4.8	10.8	38.2	5.0	8.8	48.5	8.1	12.6	8.4	6.5	12.5	9.3	5.0	3.8	15.3	3.7	9.3	10.3	4.8	1.9	9.0	3.3	2.4	4.4	5.6	4.5	10.3	6.9	20.0	8.3	8.4	5.6	5.6	43.4	18.2	5.8	9.7	7.8	6.1	5.5	6.8	6.3	14.7	15.5	15.0	14.9	1.8	2.0	0.1	0.9	2.4	3.9	0.7	5.8	10.9	9.9	4.6	4.6	8.3	7.1	20.0	9.3	7.7	6.0	3.0	3.0	13.4	1.7	7.7	2.5	9.4	9.7	12.3	11.3	3.1	6.1	7.5	3.2	8.0	13.8	5.4	6.6	4.2	11.7	37.8	12.6	4.0	4.7	15.8	2.1	13.8	3.2	6.5	10.9	9.4	7.9	2.6	18.1	4.2	2.5	6.2	9.1	6.8	3.1	15.4	5.4	8.8	18.2	5.1	12.5	15.4	1.8	1.9	7.7	15.9	9.8	8.3	0.0	0.5	0.0	3.0	0.6	2.0	1.2	3.8	3.9	1.4	1.8	1.5	2.7	0.1	2.4	0.9	2.0	3.2	0.7	3.2	4.6	4.0	4.8	5.0	3.8	4.8	1.9	4.5	5.5
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.1"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: , HPA052726: "	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	10.1	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1
SLC6A16	NTT5	ENSG00000063127	"Solute carrier family 6 member 16"	Q9GZN6	19	49289638-49325225	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"testis: 102.2"	"Cell line enhanced"	"Detected in many"		"AF22: 17.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA076812			Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA076812: "	"unprognostic (1.98e-1)"	"unprognostic (7.15e-3)"	"unprognostic (6.39e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.18e-2)"	1.5	0.4	0.8	1.1	0.9	1.9	1.0	0.8	0.8	1.3	1.1	0.8	0.8	0.3	1.5	1.0	0.8	2.0	1.0	0.8	0.8	0.3	2.0	3.6	1.6	3.1	0.8	0.8	2.9	2.6	0.7	0.8	1.3	0.8	1.8	0.3	0.9	0.8	1.2	0.8	0.7	1.2	0.8	0.8	1.7	1.0	102.2	0.8	0.8	1.1	0.8	2.4	0.8	1.2	7.8	2.1	4.8	3.7	3.8	3.1	2.2	0.0	6.9	17.5	6.3	0.3	2.8	3.2	0.9	1.4	0.6	1.9	0.4	0.6	8.1	1.1	0.7	0.3	1.9	0.3	2.1	1.3	2.0	0.7	0.7	1.5	1.3	0.5	2.9	2.8	1.1	1.3	1.0	1.5	1.5	1.1	2.2	1.5	0.4	0.5	6.2	0.9	0.3	4.2	1.5	0.9	0.0	0.2	0.4	2.7	0.1	0.6	2.8	0.2	8.7	1.4	6.6	4.1	0.0	3.9	4.1	7.3	0.1	1.9	0.4	0.4	0.8	4.8	3.1	2.2	3.0	7.8	1.1	3.1	0.8	4.5	2.7	1.8	4.0	3.8	3.7	2.1	1.7	2.2	0.8	0.9	0.8	0.8	0.8	0.3	0.8	0.8	0.8	0.8
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.0;lung: 50.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 5.4;Hep G2: 14.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enriched"	"Detected in single"	36	"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	5	"midbrain: 69.9"	"Low region specificity"	"Detected in all"			"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: "	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.1	6.3	0.1	0.3	1.6	0.9	0.1	0.7	0.1	0.1	0.3	0.1	50.5	0.1	0.1	0.1	0.1	0.6	0.0	0.1	11.3	11.2	0.1	0.0	0.2	0.7	0.1	0.1	0.4	25.0	0.4	0.1	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.0	0.1	1.0	0.2	0.4	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	14.4	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.0	0.4	0.2	0.1	0.0	2.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	11.2	0.1
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 66.3;RT4: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA009277: "	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (2.65e-7)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	10.6	3.8	8.6	1.4	3.4	0.1	18.0	2.5	8.3	11.5	2.5	2.4	2.9	0.8	6.4	11.8	3.7	13.6	5.1	9.7	6.8	0.9	3.8	68.1	3.3	2.8	4.4	3.5	35.1	32.2	78.2	3.0	29.0	9.1	4.9	1.5	13.0	2.4	3.3	57.8	3.3	2.0	4.3	10.9	1.8	3.3	7.7	3.5	0.0	14.3	10.4	1.2	3.4	6.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	10.1	0.0	0.1	11.1	0.0	6.8	0.5	0.6	3.3	0.0	0.0	2.3	0.0	0.0	7.3	1.7	2.3	0.0	3.8	0.0	8.0	7.0	66.3	3.0	0.0	8.9	1.4	8.6	8.2	3.1	0.0	0.0	7.7	10.7	0.3	3.5	3.7	0.9	0.0	5.1	5.3	0.8	17.0	0.1	1.3	0.5	0.2	3.1	0.0	0.3	7.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.6	3.4	2.5	8.3	6.8	0.9	4.4	3.5	9.1	3.5
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869488	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 71.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 106.7;hTCEpi: 183.4;MCF7: 99.4;SiHa: 150.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 15.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"HPA052673: , HPA056077: "	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	8.2	3.2	18.3	14.7	24.5	71.2	4.3	15.9	45.8	7.9	4.6	16.7	8.9	6.2	5.3	30.4	38.7	3.3	6.4	8.2	19.8	22.1	3.6	9.7	3.8	11.1	23.9	9.6	5.1	12.1	1.5	9.0	28.4	23.4	4.3	3.4	34.9	11.5	15.4	11.2	10.7	5.7	4.8	17.7	6.4	12.7	34.9	19.8	3.7	4.2	16.7	15.0	11.5	7.7	0.5	15.9	0.6	0.0	0.2	1.4	0.4	14.6	55.6	1.0	15.6	0.4	0.9	40.1	11.8	4.3	7.2	4.6	36.2	21.0	13.4	10.5	15.0	66.2	11.5	106.7	5.0	14.1	5.8	11.0	52.2	25.9	16.8	10.2	20.3	3.0	183.4	8.8	65.7	1.4	16.4	15.1	5.7	99.4	12.3	15.1	5.1	13.5	11.9	4.3	20.6	8.0	1.2	9.0	3.5	150.7	30.1	32.3	13.8	13.6	1.1	2.5	16.8	10.4	9.1	19.6	16.0	58.1	9.9	25.5	24.0	0.6	0.0	0.0	1.0	0.0	1.2	0.5	0.5	0.8	0.3	0.0	0.1	0.4	0.1	0.2	0.0	15.9	1.4	0.4	18.3	24.5	15.9	28.1	19.8	22.1	23.9	9.6	23.4	19.8
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 67.7"	"Cell line enhanced"	"Detected in many"		"BJ: 15.1;fHDF/TERT166: 36.6;hTERT-HME1: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"			"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: "	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	3.9	2.9	7.7	4.4	14.3	1.4	2.0	3.5	15.3	5.5	7.3	1.8	7.1	3.3	12.2	3.9	4.0	3.9	5.3	67.7	7.7	6.6	11.0	2.2	3.7	2.5	5.2	8.2	2.1	1.5	1.1	1.9	6.8	7.6	12.2	3.4	1.0	1.5	17.2	1.5	2.1	3.6	20.5	2.8	4.4	2.5	1.4	2.5	0.1	1.6	0.0	1.3	9.8	2.8	0.0	2.4	25.2	6.0	0.0	0.0	0.5	1.5	1.1	1.1	0.1	1.7	3.5	0.0	15.1	5.8	5.0	3.3	0.0	2.5	0.0	1.2	36.6	0.6	0.2	2.5	5.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	5.7	10.7	0.4	0.0	0.2	6.4	0.0	0.4	0.0	0.7	2.1	4.0	7.9	0.0	1.7	0.2	1.7	0.3	0.0	0.0	0.0	0.0	0.3	5.1	4.8	0.1	0.0	1.6	0.8	0.0	0.0	0.8	0.9	0.7	0.0	4.9	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	25.2	0.0	6.0	0.1	0.0	0.5	7.7	14.3	3.5	15.3	7.7	6.6	5.2	8.2	7.6	2.5
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098815-27166981	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 60.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavourable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	7.1	11.3	7.5	9.9	10.1	7.3	8.4	11.7	18.9	8.7	14.0	5.0	26.9	20.7	10.6	6.8	10.3	7.1	24.4	13.4	4.6	5.3	7.3	2.4	11.2	5.8	5.0	6.7	6.9	6.4	13.4	8.0	42.5	14.8	8.5	10.2	10.1	60.7	55.4	3.8	9.2	24.7	8.1	3.9	10.5	45.6	8.3	4.9	6.0	8.0	6.5	9.0	18.8	8.4	0.9	0.6	5.5	1.5	0.4	4.2	1.8	13.5	4.7	4.4	4.5	10.1	7.3	27.3	11.1	17.1	9.8	10.7	5.6	8.8	6.1	9.6	14.6	17.0	4.3	27.7	6.1	7.3	4.0	9.3	3.0	2.4	30.7	5.5	7.1	9.1	13.4	16.5	23.0	16.2	2.6	6.0	14.4	8.1	2.8	2.9	6.2	9.7	5.0	3.9	2.8	5.1	20.5	5.1	1.6	9.4	12.8	5.6	5.9	3.4	17.4	10.4	4.2	9.7	6.1	5.4	3.4	1.8	11.2	6.1	6.0	0.1	1.5	1.5	1.9	0.9	4.2	0.2	2.2	2.0	0.6	0.9	1.4	1.7	5.5	0.4	1.5	0.1	0.8	1.8	7.5	10.1	11.7	18.9	4.6	5.3	5.0	6.7	14.8	4.9
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619707-102711318	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8"	"Cell line enhanced"	"Detected in some"		"A-431: 8.1;CACO-2: 5.6;MCF7: 6.3;RT4: 14.2;SK-BR-3: 12.6;T-47d: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: "	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.2	0.4	0.9	10.8	1.4	0.0	1.0	0.5	1.9	1.0	15.0	0.6	8.4	4.6	0.2	5.8	0.5	0.2	16.8	0.2	1.5	1.0	4.6	0.2	0.2	0.0	0.9	0.7	0.2	0.2	0.1	1.7	0.0	1.8	4.5	16.1	0.9	3.7	11.7	4.4	1.3	9.5	0.4	1.3	0.2	19.8	5.3	0.6	1.0	0.6	1.8	3.1	2.8	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	8.1	5.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.2	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	2.5	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.3	0.0	0.1	0.2	4.3	0.0	0.0	0.0	1.0	14.2	0.0	0.0	0.0	12.6	0.0	15.8	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.9	1.4	0.5	1.9	1.5	1.0	0.9	0.7	1.8	0.6
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470458-524332	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.8;intestine: 85.1;kidney: 43.6"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 27.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"cerebellum: 4.6"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavourable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	0.6	0.6	0.5	16.2	1.0	0.0	0.6	4.2	0.9	0.9	27.5	0.7	1.1	12.7	0.9	3.4	2.4	0.8	65.8	0.6	0.6	0.6	43.6	0.5	0.5	0.9	0.9	0.7	0.8	1.1	0.6	0.9	0.5	1.2	1.4	2.3	1.2	2.1	0.8	0.7	4.2	85.1	1.1	0.6	0.5	22.7	1.1	0.5	0.6	0.7	2.4	2.7	0.8	2.0	1.9	2.0	0.2	1.2	3.5	6.8	2.9	4.2	3.8	6.9	7.3	1.6	1.9	5.5	4.2	2.4	5.1	3.2	9.2	4.8	10.1	5.5	1.8	6.9	3.8	2.5	2.5	27.9	7.2	4.6	16.3	3.3	2.6	3.4	5.9	2.7	5.2	2.2	3.5	1.5	6.0	5.3	1.8	6.5	3.7	16.5	2.6	6.2	5.5	6.5	5.3	1.7	3.6	7.8	3.3	12.5	3.5	2.6	7.9	2.6	1.9	5.9	5.3	4.0	2.6	8.9	3.6	5.7	3.7	15.1	3.7	0.0	1.2	0.1	4.3	0.5	3.8	1.6	5.6	4.1	1.4	1.9	6.8	5.2	0.2	3.5	0.4	2.0	4.2	2.9	0.5	1.0	4.2	0.9	0.6	0.6	0.9	0.7	1.2	0.5
SLC9A3R2	"E3KARP, NHERF-2, SIP-1, TKA-1"	ENSG00000065054	"SLC9A3 regulator 2"	Q15599	16	2025356-2039026	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 59.5;PC-3: 56.1;WM-115: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.6;intermediate monocyte: 2.7;myeloid DC: 6.8;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.8;monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001672, HPA066520"	Enhanced		Supported	"Plasma membrane"			120000	"Plasma membrane"		"HPA001672: AB_1080017, HPA066520: "	"unprognostic (6.99e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"prognostic favourable (1.03e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.20e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.80e-2)"	51.5	19.4	20.0	10.0	25.4	1.1	41.0	15.5	26.6	29.7	13.1	15.2	13.5	13.5	28.7	10.3	16.1	20.9	30.4	65.1	18.4	15.7	40.7	80.9	51.2	11.1	21.0	15.9	18.3	14.0	5.3	17.4	25.1	17.8	25.5	6.5	37.5	76.3	22.9	60.9	7.1	15.7	9.9	12.2	39.0	35.0	8.8	13.5	2.5	32.7	21.5	12.3	13.3	25.0	0.1	6.8	0.0	3.6	0.1	0.9	1.0	6.2	37.3	1.0	7.7	1.2	1.7	1.1	27.2	16.5	13.8	4.5	4.9	8.3	0.0	12.9	11.6	6.1	2.9	2.7	1.4	0.0	8.9	0.6	16.1	11.8	9.2	0.1	2.8	1.9	2.7	4.0	1.2	13.7	4.5	0.5	0.9	59.5	0.1	6.9	1.5	56.1	5.3	1.6	9.8	3.0	0.5	7.1	6.7	1.9	37.8	2.4	30.6	3.2	34.8	4.3	6.3	0.3	37.6	1.0	0.8	0.1	0.5	0.7	40.3	0.0	3.6	0.0	0.9	2.7	0.3	0.0	0.2	0.2	6.8	0.1	0.9	0.9	0.0	0.1	0.9	5.0	0.2	1.0	20.0	25.4	15.5	26.6	18.4	15.7	21.0	15.9	17.8	13.5
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles				Vesicles		"HPA059445: , HPA059590: "	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	4.3	5.7	16.4	4.7	27.6	4.0	3.1	15.3	35.1	5.2	5.2	7.8	1.6	7.5	5.7	3.2	5.6	5.2	4.8	7.2	19.1	24.3	6.2	3.9	5.7	4.7	15.0	15.6	7.4	3.3	9.3	8.6	4.0	22.3	3.6	5.5	4.6	3.3	4.6	5.5	4.1	6.5	6.5	9.5	4.8	5.2	5.1	4.0	3.6	5.9	1.7	5.8	4.7	3.2	5.3	6.8	3.2	8.4	5.9	13.9	6.0	13.0	6.9	7.3	2.7	10.4	10.1	13.1	10.5	11.3	9.1	19.3	6.0	10.5	9.7	24.1	12.1	7.8	9.4	9.4	13.2	7.6	8.6	2.6	11.0	3.5	5.5	7.6	9.2	5.6	8.4	15.0	7.5	7.7	4.8	14.0	10.0	5.8	10.0	2.2	4.1	9.4	6.8	10.9	9.9	6.5	6.6	6.5	4.9	7.6	0.8	6.1	3.2	5.9	10.9	11.3	8.1	16.8	13.6	6.7	14.9	8.6	6.9	13.0	6.3	2.2	6.0	3.2	8.1	8.4	13.9	5.3	9.5	7.9	6.8	4.0	10.6	7.9	2.6	5.9	6.6	4.3	8.0	6.0	16.4	27.6	15.3	25.9	19.1	24.3	15.0	15.6	22.3	4.0
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599252-46759172	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 42.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles				Vesicles		"HPA048938: , HPA075385: "	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (8.58e-4)"	"prognostic unfavourable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	1.7	7.2	4.4	3.8	42.0	4.4	7.9	7.0	12.4	1.8	1.2	1.8	1.2	1.7	1.2	3.8	3.2	2.5	2.2	2.3	3.3	7.1	3.3	4.1	1.8	7.8	3.6	4.3	6.3	4.6	11.5	13.6	1.4	12.7	6.5	1.3	2.3	7.3	2.9	10.0	2.9	2.7	1.0	2.7	4.7	8.2	1.3	8.2	2.8	6.9	1.7	8.2	2.3	2.2	4.3	6.0	2.1	0.6	1.4	0.7	0.5	7.3	5.6	0.8	2.4	0.9	5.6	3.2	7.0	8.7	4.2	3.4	5.7	7.9	16.1	2.2	11.1	3.4	5.4	7.9	7.7	8.4	2.9	1.6	2.2	2.3	3.5	0.8	13.3	3.5	1.0	11.9	7.9	5.9	0.1	0.3	5.7	11.0	1.8	0.9	3.9	6.7	7.1	0.3	0.2	3.2	8.2	6.1	0.7	3.6	5.4	1.5	7.1	0.3	0.3	9.0	3.0	1.4	4.1	1.7	0.4	8.1	12.8	0.1	2.9	1.0	0.6	0.3	0.6	0.6	0.4	3.4	0.7	0.3	2.4	4.3	0.4	0.5	2.1	1.4	0.6	6.0	0.7	0.5	4.4	42.0	7.0	8.3	3.3	7.1	3.6	4.3	12.7	8.2
SLC9B1	"NHA1, NHEDC1"	ENSG00000164037	"Solute carrier family 9 member B1"	Q4ZJI4	4	102885048-103019739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Fertilization, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 43.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9"	"Not detected"	"Not detected"							"HPA058971, HPA065520"			Supported	"Centriolar satellite,Mitochondria"				Mitochondria	"Centriolar satellite"	"HPA058971: , HPA065520: "	"unprognostic (4.87e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.06e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-5)"	"unprognostic (5.78e-2)"	1.1	1.1	1.1	1.1	3.1	0.9	0.9	1.4	2.0	0.9	0.8	3.7	0.0	0.8	2.6	2.3	0.7	0.9	1.6	0.9	1.6	1.0	0.8	0.7	1.1	2.4	2.4	1.1	1.5	1.3	1.2	2.4	0.9	3.1	1.1	0.8	2.8	0.7	0.9	0.7	1.9	0.8	0.7	4.4	1.0	0.8	43.1	2.3	4.2	1.1	0.0	1.7	1.2	0.9	2.0	1.9	0.6	0.6	0.4	4.9	0.6	0.4	0.0	2.2	3.3	4.5	3.3	0.7	0.8	1.1	0.0	0.2	0.0	0.2	1.7	0.6	1.7	0.0	1.7	0.9	1.5	3.2	2.3	2.5	2.0	0.0	0.0	0.7	0.5	0.5	1.0	0.0	1.8	1.3	1.2	1.7	1.7	1.3	1.0	2.2	0.8	0.0	2.7	1.8	0.5	0.9	0.5	2.1	5.0	0.6	0.8	2.5	0.4	1.7	0.7	0.9	0.3	1.0	1.1	5.5	4.0	1.4	1.2	1.0	2.4	0.6	0.6	0.1	1.5	0.4	1.7	1.8	1.2	1.8	0.7	2.0	4.9	2.8	0.3	0.4	0.3	1.9	1.7	0.6	1.1	3.1	1.4	2.0	1.6	1.0	2.4	1.1	3.1	2.3
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"				"Plasma membrane"		"HPA071152: "	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.1	0.5	0.8	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.0	1.7	0.1	2.1	0.1	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.5	1.1	0.0	0.3	0.2	0.0	1.4	0.1	0.1	0.1	3.5	1.4	0.0	2.1	0.3	0.1	13.7	0.1	0.1	0.2	9.5	0.0	2.1	1.9	2.3	0.0	0.2	0.2	2.7	0.7	0.0	0.0	1.4	0.7	0.3	20.5	8.2	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 88.1"	"Cell line enhanced"	"Detected in some"		"A-431: 35.2;A549: 9.7;CAPAN-2: 7.0;HeLa: 8.0;PC-3: 9.7;U-2 OS: 8.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: "		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	88.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642445-62685785	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 55.5;RPTEC TERT1: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;dendritic cells: 2.6;T-cells: 4.3"	"Region enriched"	"Detected in single"	5	"cerebellum: 7.5"	"Low region specificity"	"Detected in many"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"				"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavourable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	25.0	5.2	16.4	5.3	22.4	3.9	27.2	11.3	23.8	5.0	6.4	1.6	4.3	4.2	5.5	2.3	24.1	5.2	5.6	18.1	19.0	9.2	16.6	3.1	29.4	5.7	18.1	2.3	3.1	5.4	13.8	1.2	11.9	24.8	2.8	5.5	7.1	20.1	4.1	19.2	16.5	4.4	3.6	9.8	4.5	14.9	3.3	16.5	0.5	4.5	4.0	8.7	7.4	18.5	2.3	2.6	0.0	0.5	0.0	4.3	0.7	4.0	5.2	0.2	3.0	0.7	0.6	7.5	1.3	4.6	4.0	1.4	8.8	4.2	4.8	12.7	0.1	6.1	4.6	0.3	1.5	0.5	2.6	5.8	6.0	6.4	0.0	4.4	1.8	0.0	1.8	0.0	1.7	0.7	4.5	1.3	0.0	4.0	4.5	17.4	1.4	55.5	8.3	0.3	7.1	53.2	3.9	5.0	7.1	1.1	1.2	4.4	0.2	2.1	0.8	0.1	3.0	2.0	7.5	2.6	4.1	3.0	11.0	6.4	0.7	0.0	0.0	0.0	0.2	0.5	0.0	2.3	0.5	0.1	2.6	2.0	0.7	0.3	0.0	0.0	0.1	0.0	4.3	0.7	16.4	22.4	11.3	23.8	19.0	9.2	18.1	2.3	24.8	16.5
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667047-69835064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;NTERA-2: 5.9;RPMI-8226: 5.5;SCLC-21H: 6.4;U-266/70: 3.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory region: 8.2"					HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.7	0.2	0.5	1.5	0.7	1.5	0.2	0.1	0.8	0.3	0.4	0.1	0.0	0.4	0.5	1.5	1.0	0.5	0.4	21.4	0.7	0.7	0.2	0.4	0.3	4.1	0.3	0.3	0.2	0.7	0.0	4.7	0.0	0.5	4.2	0.7	0.6	0.9	0.0	13.9	0.3	0.7	0.2	0.2	0.8	0.3	0.4	0.0	9.5	0.5	16.2	1.7	0.9	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	2.3	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	5.9	0.9	1.0	0.9	5.5	0.1	0.0	6.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.1	1.2	3.4	0.5	0.0	0.3	0.0	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.0	1.7	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.7	0.1	0.7	0.7	0.7	0.3	0.3	0.5	0.0
SLF2	"C10orf6, FAM178A, FLJ10512, FLJ25012"	ENSG00000119906	"SMC5-SMC6 complex localization factor 2"	Q8IX21	10	100912569-100965136	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 58.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038499, HPA057568"	Approved		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA038499: AB_10672520, HPA057568: "	"unprognostic (9.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	9.8	20.2	19.5	17.1	26.6	12.1	11.3	21.4	21.4	12.2	10.7	22.0	13.0	9.4	20.9	56.1	9.4	17.3	9.6	11.6	17.8	14.2	10.9	10.2	11.6	15.6	29.4	17.3	29.4	12.3	11.6	26.8	17.4	18.3	14.5	12.1	7.8	10.3	16.0	17.9	15.1	11.5	12.9	22.7	22.0	9.9	26.7	31.3	14.7	11.3	10.5	13.2	10.8	19.9	13.8	9.5	8.6	8.9	10.9	14.0	5.6	9.7	8.0	11.8	12.2	6.2	8.5	4.5	10.3	7.3	9.7	11.8	5.8	6.8	9.0	6.4	4.3	9.9	8.1	3.4	11.8	10.2	6.5	8.4	5.3	11.4	4.6	10.7	9.9	3.9	5.0	7.4	8.0	6.2	5.8	9.0	14.1	6.5	7.2	5.9	5.3	6.0	7.1	58.3	3.1	3.8	5.0	2.5	5.1	6.5	1.7	11.8	10.3	3.9	8.0	11.4	9.5	7.0	11.7	7.2	10.7	7.5	7.8	12.4	5.9	6.8	8.9	8.6	14.0	8.8	12.2	11.1	10.8	11.5	6.5	13.8	12.0	10.6	4.6	10.9	8.8	9.5	9.8	5.6	19.5	26.6	21.4	21.4	17.8	14.2	29.4	17.3	18.3	31.3
SLFN11	FLJ34922	ENSG00000172716	"Schlafen family member 11"	Q7Z7L1	17	35350305-35373701	"Predicted intracellular proteins"	"Antiviral defense, DNA damage, Immunity"	"Helicase, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA023030, HPA062062"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA023030: AB_1856613, HPA062062: "	"unprognostic (1.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (9.93e-10)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (6.33e-2)"	"unprognostic (8.81e-3)"	20.9	5.3	5.4	10.3	10.0	6.0	24.1	3.2	5.2	15.5	7.3	4.8	10.3	3.0	12.2	24.6	8.1	15.0	9.9	12.6	6.6	2.8	5.5	3.5	20.4	10.4	6.9	2.2	21.3	4.4	2.1	5.0	5.4	8.9	7.8	6.1	8.9	8.3	9.6	6.0	4.1	10.1	10.3	6.7	17.5	6.1	4.2	7.3	18.3	19.0	4.6	12.9	10.9	17.7	3.1	13.0	1.4	18.3	2.0	6.0	5.2	8.0	7.2	0.0	0.0	7.4	21.4	0.1	9.9	7.2	17.3	30.3	0.0	0.0	0.0	0.1	13.0	3.9	22.4	0.0	21.0	4.5	26.8	17.4	0.0	0.0	9.7	22.5	0.0	8.7	0.2	19.2	0.0	28.2	0.0	0.0	2.9	0.0	32.0	18.2	0.1	0.0	27.2	21.1	0.0	0.2	3.8	0.0	0.0	0.0	3.7	0.0	5.9	16.2	14.6	4.7	0.1	17.8	14.9	0.7	0.2	0.0	3.5	19.6	10.2	0.4	11.8	1.4	4.3	18.3	6.0	3.1	2.7	3.9	9.2	1.3	2.1	2.9	1.3	2.0	11.4	13.0	3.9	5.2	5.4	10.0	3.2	5.2	6.6	2.8	6.9	2.2	8.9	7.3
SLIRP	"C14orf156, DC50"	ENSG00000119705	"SRA stem-loop interacting RNA binding protein"	Q9GZT3	14	77708071-77761104	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020291	Approved		Supported	Mitochondria			38000	Mitochondria		"HPA020291: AB_1845563"	"unprognostic (9.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.37e-1)"	31.9	36.0	65.2	25.0	55.1	33.6	49.9	24.3	54.7	29.2	49.8	30.6	23.2	37.2	23.7	65.1	38.1	24.4	26.5	63.6	47.5	50.5	57.5	69.8	19.1	24.3	53.7	40.6	26.1	49.3	19.3	34.8	30.0	44.9	25.2	46.7	27.8	36.9	30.6	105.7	20.5	42.1	31.9	46.3	26.3	32.0	31.7	34.4	16.5	27.4	72.9	34.6	27.9	23.5	35.2	52.2	20.9	59.6	18.3	33.0	40.5	41.2	82.0	33.7	32.8	22.2	22.4	45.4	23.4	22.1	46.6	40.7	110.9	37.9	30.0	24.8	26.6	40.9	61.4	47.8	61.9	16.4	68.9	30.3	77.6	110.2	34.1	20.0	21.8	23.9	31.5	37.3	41.6	38.3	29.6	17.2	40.5	133.5	30.6	54.9	52.2	116.0	28.2	28.2	33.5	47.8	78.7	43.1	28.2	24.8	52.8	33.8	55.3	35.6	22.2	23.8	42.8	25.7	40.8	18.6	33.8	56.1	32.7	39.4	30.5	17.4	59.6	20.9	23.8	56.5	25.0	35.2	31.7	23.3	50.8	31.2	33.0	27.3	19.1	18.3	56.9	52.2	31.7	40.5	65.2	55.1	24.3	54.7	47.5	50.5	53.7	40.6	44.9	34.4
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301129	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 79.7;fHDF/TERT166: 28.3;RT4: 24.7;SH-SY5Y: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"NK-cell: 4.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"			"Cell Junctions"		"HPA051630: "	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	38.5	12.5	6.7	6.3	7.9	0.2	31.8	20.3	10.8	28.0	13.2	1.8	13.0	3.2	21.6	22.4	18.2	14.8	32.5	28.3	6.2	4.6	12.0	1.5	24.9	6.7	2.2	7.1	29.4	4.6	37.6	3.8	12.4	10.7	28.5	5.9	7.7	10.7	9.8	4.9	17.5	7.1	44.4	2.0	7.7	8.2	6.3	0.3	11.8	16.6	10.8	6.2	36.8	32.1	0.1	0.0	0.5	0.1	4.1	0.0	0.0	0.0	2.6	0.0	0.0	79.7	1.4	0.0	4.4	0.7	1.0	2.1	0.0	0.0	0.0	1.0	28.3	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.7	0.2	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	6.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	6.7	7.9	20.3	10.8	6.2	4.6	2.2	7.1	10.7	0.3
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4"	"Cell line enhanced"	"Detected in some"		"AF22: 11.2;HeLa: 5.5;U-138 MG: 3.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013843	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA013843: AB_1857233"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.3	3.3	0.1	6.8	0.1	0.2	3.1	9.2	0.4	0.2			0.0	0.1	1.0	0.2	6.7	0.1	0.1	4.8	4.2	0.0	0.0	0.2	0.1	2.6		0.6	0.8	0.0	0.0	0.0		1.8	0.3		7.4	3.1	0.2	0.2	0.0	0.0	1.0	0.1	0.5	0.2			2.0		0.3	0.0	0.4	0.7	1.4	1.6	0.3	1.4	0.4	0.1	0.0	1.2	11.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	2.0	1.3	5.5	0.0	0.8	0.0	0.0	2.5	0.2	0.0	1.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	2.8	1.4	1.0	0.3	0.2	0.4	0.0	1.7	0.3	0.0	0.3	0.0	0.8	2.6	0.0	3.9	0.0	0.0	0.6	1.7	0.0	0.0	3.5	0.1	1.1	1.1	0.3	0.4	0.4	0.2	0.4	0.4	0.4	0.3	0.1	0.7	0.4	0.3	1.6	1.4	0.3	1.4	0.2	0.1										
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792787-85806683	"Disease related genes, Predicted membrane proteins"	"Hearing, Sensory transduction, Vision"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 13.3;RT4: 45.6;WM-115: 10.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.1;cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 24.7"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"			9500	"Plasma membrane"		"HPA014491: AB_10601603, HPA014513: "	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.4	0.3	0.3	2.7	11.1	0.0	2.9	4.9	0.3	1.0	4.5	0.0	0.2	2.8	0.7	3.4	3.6	0.3	1.1	1.9	0.3	1.3	0.3	1.1	3.1	0.0	0.6	0.0	0.3	0.4	0.0	0.4	4.1	0.8	24.2	5.8	1.7	22.8	1.8	0.3	4.5	7.2	22.4	0.4	0.2	1.2	0.5	1.8	0.0	0.6	3.4	0.7	27.8	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	13.3	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	45.6	0.4	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	4.9	0.3	0.3	1.3	0.6	0.0	0.8	1.8
SLTM	"FLJ13213, Met"	ENSG00000137776	"SAFB like transcription modulator"	Q9NWH9	15	58879045-58933653	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040256, HPA040381"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA040256: AB_10674990, HPA040381: "	"unprognostic (2.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.24e-3)"	32.1	20.2	26.1	37.1	27.6	46.9	35.9	38.0	28.8	32.6	28.2	25.9	27.6	27.4	27.4	25.2	35.3	25.0	25.6	24.6	27.2	24.2	29.5	32.1	25.9	35.9	34.1	29.3	29.0	22.4	40.0	40.9	38.2	32.4	26.6	30.5	20.6	38.1	45.6	39.4	32.0	29.2	29.0	34.3	38.2	34.9	24.4	34.6	50.5	32.9	30.5	38.8	31.3	32.8	31.2	32.4	32.6	21.1	27.2	29.8	12.5	27.3	30.1	26.6	13.5	18.1	13.8	22.4	19.9	23.3	18.4	18.0	20.8	16.7	51.7	18.7	18.2	24.6	26.3	22.7	25.7	33.1	17.1	37.5	31.6	15.7	15.9	29.4	29.0	12.8	22.7	19.4	16.4	17.0	33.2	30.1	21.3	19.7	29.2	22.8	29.7	14.8	22.6	24.2	24.9	22.4	35.8	21.9	18.9	20.7	20.3	20.2	16.2	32.2	17.6	22.6	33.0	24.6	26.5	21.3	41.9	37.5	17.9	36.4	22.4	32.6	18.9	25.6	29.2	18.0	29.8	31.2	23.4	24.8	18.6	27.6	25.7	23.0	26.9	27.2	21.1	32.4	20.9	12.5	26.1	27.6	38.0	28.8	27.2	24.2	34.1	29.3	32.4	34.6
SLX4	"BTBD12, FANCP, KIAA1784, KIAA1987"	ENSG00000188827	"SLX4 structure-specific endonuclease subunit"	Q8IY92	16	3581181-3611598	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 19.9;testis: 25.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049421, HPA066238"	Approved		Supported	"Nucleoplasm,Cell Junctions,Cytosol"				Nucleoplasm	"Cell Junctions, Cytosol"	"HPA049421: , HPA066238: "	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.28e-5)"	"unprognostic (6.52e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.74e-2)"	2.9	3.1	5.3	6.1	8.5	6.0	2.4	19.9	11.8	2.5	2.9	9.8	2.5	4.9	6.5	3.3	3.4	3.0	2.8	2.2	7.4	4.3	2.9	2.7	3.0	8.6	3.8	8.1	2.7	3.1	3.7	8.6	2.6	7.4	3.3	2.2	5.4	3.0	2.6	5.5	4.2	4.0	3.1	3.3	4.8	3.7	25.0	3.2	5.8	2.6	1.0	6.5	3.1	2.7	0.6	0.2	3.0	1.1	0.6	0.6	0.7	2.9	9.2	6.0	7.5	2.3	2.4	6.3	4.8	2.4	5.6	6.1	4.6	3.7	10.9	4.8	2.4	6.7	4.1	3.3	3.3	9.1	5.1	7.4	6.7	2.9	2.0	7.2	10.5	1.8	2.5	5.2	2.9	4.0	7.1	5.9	4.4	5.1	4.4	6.3	5.0	3.5	8.9	10.0	3.0	2.2	2.1	5.1	4.6	4.1	3.0	1.5	7.3	5.6	4.7	6.4	9.0	5.5	5.6	5.4	4.2	12.7	2.1	7.3	6.3	3.0	0.4	0.0	0.6	0.5	0.4	0.3	0.3	0.3	0.2	0.6	0.3	0.5	0.5	0.6	1.1	0.2	0.3	0.7	5.3	8.5	19.9	11.8	7.4	4.3	3.8	8.1	7.4	3.2
SMAD1	"JV4-1, MADH1, MADR1"	ENSG00000170365	"SMAD family member 1"	Q15797	4	145481194-145558079	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 22.2;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.2;monocytes: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005389	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005389: AB_656608"	"unprognostic (8.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.15e-2)"	20.4	7.8	19.9	7.9	21.3	3.8	21.1	17.9	17.8	18.5	15.5	14.3	13.6	11.9	33.2	22.7	16.2	20.3	13.7	10.3	13.5	10.3	12.7	37.4	11.0	11.9	9.3	10.0	12.3	13.1	33.7	14.7	8.7	12.2	13.6	16.9	7.8	17.5	16.0	22.6	20.2	15.3	24.6	12.6	10.1	11.4	10.5	14.3	15.3	15.2	14.9	10.3	16.5	21.9	0.0	4.0	22.2	11.9	1.2	0.7	0.8	3.8	5.0	9.5	11.4	3.7	5.4	4.7	5.5	13.3	9.0	6.9	2.4	14.2	3.3	3.3	12.6	5.6	10.7	12.3	5.4	0.0	5.4	0.0	4.2	5.0	9.9	6.4	1.0	7.4	14.6	4.8	9.5	45.6	4.3	0.1	11.4	3.7	9.6	0.1	8.8	6.2	18.5	8.8	11.5	9.8	6.8	14.8	7.1	7.8	17.1	3.4	5.8	0.0	13.7	4.4	6.1	4.5	3.4	12.6	0.0	22.3	7.0	0.1	4.5	22.2	2.1	0.8	0.0	5.3	0.0	0.0	0.4	0.0	4.0	0.0	0.2	0.0	0.0	1.2	11.9	0.0	0.7	0.8	19.9	21.3	17.9	14.9	13.5	10.3	9.3	10.0	12.2	14.3
SMAD2	"JV18-1, MADH2, MADR2"	ENSG00000175387	"SMAD family member 2"	Q15796	18	47808957-47931146	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025507, HPA067203, CAB073546"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"CAB025507: , CAB073546: , HPA067203: "	"unprognostic (1.55e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.82e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (9.44e-5)"	"unprognostic (1.91e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.28e-2)"	38.5	39.2	29.0	26.2	25.9	19.6	31.4	19.5	28.9	28.8	34.2	29.4	28.9	21.5	26.6	26.3	33.5	28.8	25.7	31.1	26.1	27.1	26.4	20.9	28.3	23.8	30.9	24.3	36.6	28.1	25.7	24.4	34.8	28.6	27.8	29.8	31.7	29.7	28.7	33.9	28.0	26.4	34.6	35.4	34.1	26.3	29.2	26.2	60.7	46.1	23.6	31.5	35.1	35.7	12.0	21.8	28.9	24.7	24.5	25.9	19.7	22.4	32.2	19.7	19.0	31.5	38.5	22.5	24.5	29.4	25.6	29.9	12.3	21.5	34.9	17.6	31.0	24.8	22.1	27.3	34.3	37.9	11.3	29.6	48.7	19.9	36.7	41.1	30.3	28.4	35.3	21.9	50.7	28.2	13.7	29.3	31.4	14.6	28.2	19.8	9.6	7.7	20.6	28.7	23.8	57.4	38.7	18.2	21.4	29.5	20.2	24.0	15.3	27.4	31.5	38.0	21.9	10.3	17.8	28.7	27.5	30.4	26.3	28.1	27.7	28.9	22.6	25.0	16.9	24.7	21.2	12.0	23.1	20.9	21.8	9.4	25.8	19.8	22.7	24.5	20.8	15.5	25.9	19.7	29.0	25.9	19.5	28.9	26.1	27.1	30.9	24.3	28.6	26.2
SMAD3	"HsT17436, JV15-2, MADH3"	ENSG00000166949	"SMAD family member 3"	P84022	15	67063763-67195195	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008094, HPA046386, HPA067203, CAB069409"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: , HPA067203: "	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (2.93e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-2)"	25.3	4.6	12.2	18.5	12.4	12.4	21.6	5.0	12.7	20.9	17.9	7.6	9.5	12.7	19.9	16.6	35.3	14.3	27.7	19.7	7.5	4.8	15.6	13.6	13.9	14.0	6.0	7.5	23.0	12.6	7.0	10.8	11.5	8.2	20.5	9.2	30.8	12.5	10.8	37.3	19.6	19.0	23.2	5.5	11.2	15.8	7.0	7.7	10.5	21.8	23.4	29.7	31.4	24.6	4.8	2.5	3.2	1.9	0.4	6.3	1.8	12.5	42.1	7.9	3.8	13.9	32.1	6.2	7.3	30.0	10.1	8.2	8.7	33.7	4.2	9.8	20.7	29.8	8.2	30.7	10.1	3.3	3.1	0.4	11.9	6.5	10.5	1.6	0.7	29.0	7.2	8.9	7.6	34.1	10.1	11.7	12.6	6.5	0.3	6.3	4.7	13.2	0.4	2.3	1.5	6.8	40.4	0.2	2.7	9.6	5.3	8.3	1.4	7.8	28.7	13.7	12.8	9.8	8.2	4.5	1.2	5.2	12.4	1.8	12.2	0.0	1.9	3.2	5.5	1.5	5.7	2.1	6.2	6.3	1.8	4.8	2.8	2.4	0.1	0.4	1.5	2.5	3.1	1.8	12.2	12.4	5.0	12.7	7.5	4.8	6.0	7.5	8.2	7.7
SMAD4	"DPC4, MADH4"	ENSG00000141646	"SMAD family member 4"	Q13485	18	51028394-51085045	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019154	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA019154: AB_1853480"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.00e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (4.40e-2)"	"prognostic favourable (1.92e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	25.6	17.5	16.0	14.0	16.7	11.4	24.9	29.7	16.0	27.9	22.6	17.9	21.3	15.1	28.2	18.8	21.7	20.5	17.5	19.6	15.3	11.5	21.0	22.0	20.1	16.0	17.2	13.3	30.5	25.0	30.0	28.9	30.6	14.2	27.8	17.4	18.4	23.1	22.8	39.7	18.2	23.4	27.6	13.9	21.7	19.3	17.6	18.4	38.8	35.0	13.9	18.1	29.0	24.1	3.6	3.6	3.4	1.8	2.9	4.7	1.3	8.5	11.3	30.7	8.8	12.7	19.6	17.3	15.0	16.5	20.2	25.4	6.9	2.0	14.2	4.5	13.0	14.1	17.2	6.7	21.5	12.3	9.7	9.8	11.3	7.9	12.6	17.1	7.7	8.9	11.4	9.9	14.6	14.6	11.0	13.1	11.9	4.5	10.1	4.9	16.0	7.1	13.2	15.6	13.9	9.7	3.7	19.0	11.3	14.0	2.6	9.3	7.0	10.0	11.0	17.1	7.9	4.3	9.9	19.7	13.7	12.3	11.1	6.7	11.3	0.8	1.8	1.8	3.2	1.1	3.7	2.2	3.3	2.6	3.6	3.6	4.0	4.7	3.4	2.9	1.3	2.9	4.3	1.3	16.0	16.7	29.7	16.0	15.3	11.5	17.2	13.3	14.2	18.4
SMAD5	"Dwfc, JV5-1, MADH5"	ENSG00000113658	"SMAD family member 5"	Q99717	5	136132845-136188747	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 33.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058931	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA058931: "	"unprognostic (6.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.99e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.15e-1)"	22.6	14.2	13.7	10.2	14.6	8.6	18.2	27.5	15.7	27.9	16.7	19.8	15.9	12.4	33.5	15.8	20.8	17.3	14.0	15.9	14.9	12.4	15.7	20.2	16.7	10.4	18.0	12.2	33.5	15.3	25.2	23.0	24.1	16.4	23.0	16.9	22.0	16.9	18.8	19.3	27.5	12.7	25.7	16.7	16.3	14.4	11.5	19.0	8.4	19.2	15.2	15.7	25.6	27.9	7.3	7.4	33.1	6.1	9.3	7.2	2.4	13.8	11.7	14.4	12.7	15.7	24.1	15.2	19.3	13.6	12.9	20.0	51.4	10.1	15.3	16.2	14.9	12.8	16.8	22.0	21.1	6.6	10.4	10.2	12.7	9.6	13.1	6.2	10.9	17.3	13.4	20.3	14.1	16.0	9.7	10.6	14.2	5.6	5.0	6.3	8.6	5.9	10.6	27.9	9.0	7.8	14.3	13.0	13.6	16.8	4.4	16.8	9.8	7.6	18.4	19.6	12.5	14.4	19.1	12.0	14.3	19.4	12.6	8.0	14.8	33.1	6.1	13.0	7.2	3.9	5.5	6.5	4.2	4.6	6.1	7.3	1.4	4.3	1.0	9.3	4.4	7.4	1.1	2.4	13.7	14.6	27.5	15.7	14.9	12.4	18.0	12.2	16.4	19.0
SMAD6	"HsT17432, MADH6, MADH7"	ENSG00000137834	"SMAD family member 6"	O43541	15	66702228-66782848	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 20.8;HaCaT: 12.3;HeLa: 17.1;U-2197: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061917			Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"				Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA061917: "	"unprognostic (1.20e-1)"	"unprognostic (7.43e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.59e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.55e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.33e-1)"	"prognostic favourable (5.45e-5)"	9.8	1.9	2.5	3.1	4.6	0.6	5.1	0.8	2.8	6.3	4.7	2.6	2.1	3.8	5.2	1.9	3.1	4.4	11.6	21.6	3.0	2.0	6.1	6.2	37.1	1.2	3.6	2.3	5.1	3.1	2.3	2.8	13.8	4.5	9.7	2.5	18.5	1.6	22.1	1.8	1.6	3.8	3.1	2.9	3.2	8.0	1.7	2.0	0.0	16.7	0.6	0.8	6.8	7.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.8	6.9	1.1	2.4	4.3	1.1	6.5	4.9	0.1	0.8	0.0	1.3	3.1	0.5	20.8	4.1	12.3	1.5	0.0	0.1	1.5	5.7	10.7	17.1	1.1	0.5	0.0	0.8	1.4	0.0	0.0	0.0	0.9	0.9	0.7	0.3	1.3	0.1	2.9	2.1	2.6	0.0	1.2	1.4	2.3	5.4	2.5	1.1	2.6	2.9	0.5	1.0	1.9	4.2	3.0	3.9	12.1	0.9	0.3	1.2	0.2	2.1	3.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.5	4.6	0.8	2.8	3.0	2.0	3.6	2.3	4.5	2.0
SMAD7	"MADH7, MADH8"	ENSG00000101665	"SMAD family member 7"	O15105	18	48919853-48950711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026212, HPA028897"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB026212: , HPA028897: AB_10600811"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (8.15e-2)"	"unprognostic (5.35e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-1)"	9.5	3.3	3.1	7.4	4.3	8.6	11.6	8.0	7.7	11.4	11.5	4.2	5.1	5.5	6.5	3.0	2.8	4.2	5.7	27.0	5.8	3.1	7.4	6.5	13.7	2.8	6.1	4.4	4.5	5.6	14.6	3.9	11.2	6.0	9.3	7.0	7.1	5.3	11.5	4.9	4.4	15.0	5.0	6.3	2.9	7.2	3.2	2.8	3.6	10.0	5.7	3.4	6.8	19.4	0.1	0.3	8.3	0.8	2.6	1.9	0.4	2.3	1.9	1.6	5.4	9.5	4.0	13.7	10.9	4.6	4.3	1.9	0.6	3.3	0.2	20.6	7.9	12.4	3.9	3.6	2.3	23.6	6.2	0.1	5.8	5.1	1.7	4.7	11.8	3.4	3.3	4.8	5.2	0.8	3.9	15.5	6.4	0.8	0.0	1.4	11.4	0.8	1.4	1.7	5.2	6.6	2.5	3.0	6.5	4.9	2.3	4.7	1.9	3.7	10.4	11.5	6.3	3.2	10.6	8.4	4.1	1.3	5.0	3.0	1.7	5.8	0.2	8.3	1.4	0.8	1.2	0.1	1.4	1.3	0.3	0.0	0.4	0.9	0.0	2.6	0.2	0.0	1.9	0.4	3.1	4.3	8.0	7.7	5.8	3.1	6.1	4.4	6.0	2.8
SMAD9	"MADH6, MADH9, SMAD8, SMAD8/9"	ENSG00000120693	"SMAD family member 9"	O15198	13	36844831-36920765	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8.6;SH-SY5Y: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009119, HPA031162"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009119: AB_2286517, HPA031162: "	"unprognostic (2.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.68e-3)"	"unprognostic (3.50e-3)"	"prognostic favourable (5.99e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.71e-3)"	"unprognostic (4.23e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.07e-3)"	"unprognostic (3.74e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (2.47e-2)"	4.4	3.1	7.0	3.2	6.2	0.6	4.1	10.7	11.8	6.3	8.2	14.3	4.1	2.6	10.0	11.3	5.8	5.1	7.4	6.9	15.0	6.2	5.0	1.4	5.3	2.6	10.7	8.9	10.1	1.3	3.0	6.2	6.7	10.2	14.9	6.0	11.9	17.7	12.4	13.8	2.1	4.0	8.4	15.5	1.5	5.9	2.7	11.0	0.0	38.9	1.9	3.4	7.7	12.6	1.7	1.7	1.1	0.8	0.7	1.4	0.2	0.0	0.1	0.5	5.8	1.7	0.8	0.2	6.6	0.7	1.8	1.1	0.0	0.1	0.2	4.2	8.6	0.3	5.8	0.1	2.0	0.2	8.2	0.0	3.0	4.6	1.8	0.5	0.1	3.0	0.5	0.0	0.0	3.5	0.0	0.0	4.2	0.3	0.1	0.5	0.8	0.6	0.1	6.2	0.0	0.0	0.9	5.1	27.6	1.3	0.2	0.3	0.4	0.2	6.3	2.7	2.2	1.5	1.6	0.1	0.0	0.0	1.9	0.2	0.4	1.1	0.4	0.3	1.2	0.8	0.8	1.0	1.2	1.3	0.2	1.7	1.2	1.4	0.9	0.7	0.5	1.7	0.4	0.2	7.0	6.2	10.7	7.8	15.0	6.2	10.7	8.9	10.2	11.0
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270890	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favourable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	7.5	6.9	0.9	11.3	1.7	0.9	26.3	1.1	1.3	13.1	22.6	0.9	5.3	6.9	8.0	13.6	53.4	3.2	21.8	6.0	1.0	1.0	10.9	4.3	17.6	14.2	1.5	0.4	5.2	14.9	4.6	1.9	50.0	3.0	4.8	24.3	2.6	10.2	6.9	3.6	12.6	8.5	3.4	4.3	11.5	14.1	4.8	0.7	1.2	4.2	28.7	33.1	7.9	24.6	22.5	2.6	8.6	3.7	12.3	9.5	3.5	24.7	7.6	0.9	0.8	3.4	13.5	41.9	19.1	19.3	9.8	6.1	15.1	26.1	0.3	3.4	11.8	8.8	5.4	7.4	13.7	1.2	4.4	3.3	0.9	5.0	9.4	0.8	3.2	8.7	5.7	21.2	19.2	23.5	2.6	1.4	15.7	21.8	4.0	3.0	3.9	29.6	0.2	0.3	0.9	14.2	5.7	1.0	1.2	4.1	16.8	3.0	14.5	1.2	8.1	10.9	10.4	0.5	11.6	0.5	0.7	0.5	16.1	8.2	5.9	1.9	3.7	6.4	9.5	2.4	6.1	22.5	4.2	6.9	2.6	17.6	3.9	7.0	8.6	12.3	2.6	1.5	2.7	3.5	0.9	1.7	1.1	1.3	1.0	1.0	1.5	0.4	3.0	0.7
SMARCA1	"hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI"	ENSG00000102038	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1"	P28370	X	129446501-129523500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003335, HPA064712"	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA003335: AB_1080024, HPA064712: "	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (3.03e-4)"	"unprognostic (9.26e-2)"	"prognostic favourable (5.09e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.33e-2)"	10.4	44.6	14.5	5.0	15.2	0.4	11.8	12.0	12.0	17.1	11.4	7.7	25.5	3.9	15.8	31.4	9.6	12.0	12.3	19.3	13.9	17.9	13.9	34.1	9.2	2.5	13.1	8.4	42.2	9.0	34.8	29.9	21.0	14.6	23.8	4.3	9.7	9.8	42.9	8.7	4.6	4.8	17.7	14.0	6.9	10.0	33.0	13.1	2.0	26.0	6.8	2.6	16.8	15.3	0.3	0.8	0.0	0.0	1.6	4.3	0.5	6.7	15.1	31.3	20.4	22.8	20.7	10.8	13.8	40.0	20.6	23.4	5.2	24.1	0.0	21.5	25.9	6.4	19.4	8.1	23.3	0.0	3.6	0.0	13.7	28.4	10.0	0.0	0.0	25.9	2.3	14.7	2.8	15.0	3.5	1.7	22.2	0.0	0.1	0.0	12.5	8.7	0.0	16.9	0.0	20.3	8.3	7.5	20.6	1.9	0.2	3.4	14.0	0.1	10.4	13.8	7.1	9.0	7.5	0.0	0.0	0.0	12.2	0.0	8.5	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.0	0.0	0.3	4.3	1.3	0.0	1.6	0.0	0.8	0.0	0.5	14.5	15.2	12.0	12.0	13.9	17.9	13.1	8.4	14.6	13.1
SMARCA4	"BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2"	ENSG00000127616	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"	P51532	19	10960825-11079426	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004208	Supported		Supported	Nucleoplasm			260000	Nucleoplasm		"CAB004208: AB_626762"	"unprognostic (2.68e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (7.19e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.80e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	10.3	12.4	15.5	18.0	21.3	20.5	10.9	29.1	28.0	13.2	12.8	16.6	9.7	14.3	16.6	9.4	24.7	15.7	12.8	11.6	14.4	17.7	13.0	9.9	13.0	18.1	17.1	16.8	13.6	13.4	18.1	11.5	14.6	16.1	13.3	9.4	17.3	18.2	12.5	21.9	20.4	12.0	10.6	16.1	13.2	14.5	22.2	12.4	58.2	15.5	10.1	21.5	15.2	12.6	9.8	11.2	8.6	13.5	11.4	13.7	5.9	20.5	1.1	36.7	34.7	7.2	6.1	16.1	14.3	8.6	17.5	13.0	28.7	0.9	48.3	22.2	12.5	15.1	28.6	17.7	9.7	19.8	21.5	38.5	18.2	33.3	10.9	27.9	19.2	10.3	8.6	14.7	15.2	15.6	34.4	18.2	13.7	42.0	46.2	23.9	37.3	31.1	49.3	23.2	25.0	11.2	26.1	41.8	37.9	15.2	19.6	16.3	16.6	20.9	20.7	26.1	13.6	23.8	23.6	37.7	41.8	48.0	14.8	26.8	22.2	8.1	8.3	8.6	13.7	9.5	12.2	7.4	10.4	11.6	8.5	9.8	11.4	11.2	5.2	11.4	13.5	11.2	8.8	5.9	15.5	21.3	29.1	28.0	14.4	17.7	17.1	16.8	16.1	12.4
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513463-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"CAB005227: AB_2191863, HPA008751: AB_1857268"	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	21.0	39.5	24.7	24.8	32.6	34.5	21.9	26.9	29.2	24.0	23.8	27.7	24.6	17.9	27.3	26.3	19.8	23.0	23.8	29.8	25.0	25.1	21.1	21.0	33.3	29.5	30.2	26.5	29.4	24.6	33.1	33.3	27.7	29.6	23.1	22.5	16.3	22.0	25.7	24.6	14.7	22.6	22.9	34.6	28.6	22.8	37.8	32.8	44.3	28.5	15.1	29.7	25.6	23.7	11.7	13.2	15.4	19.4	15.6	16.3	10.6	11.8	9.3	34.2	21.5	20.1	14.6	20.5	15.0	17.9	21.9	18.6	15.8	16.7	32.1	10.4	12.8	9.4	31.3	14.0	21.3	21.2	11.1	24.0	13.7	13.0	14.9	29.6	14.1	12.8	10.2	15.5	13.4	17.0	21.6	20.3	14.3	10.6	34.5	10.3	27.9	13.4	38.4	21.9	10.4	17.2	14.5	27.5	23.2	19.6	13.9	17.3	10.0	13.9	18.0	14.5	11.2	15.1	14.7	22.3	26.8	39.0	11.4	24.9	14.7	5.0	10.7	15.4	13.9	12.7	16.3	11.7	14.2	15.0	13.2	11.5	14.9	14.7	9.7	15.6	19.4	10.1	16.1	10.6	24.7	32.6	26.9	29.2	25.0	25.1	30.2	26.5	29.6	32.8
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	12.8	15.4	15.4	22.2	14.6	8.6	20.1	26.7	25.1	15.4	13.6	9.4	14.4	12.6	19.6	17.5	17.2	16.5	13.9	12.9	13.6	14.7	16.6	14.9	21.6	22.8	17.6	11.1	20.8	15.0	17.2	33.0	18.3	14.9	15.4	16.5	10.2	14.9	20.9	11.8	26.5	13.9	15.6	17.9	17.6	13.9	15.3	16.2	42.0	20.2	11.4	17.8	16.0	15.9	5.5	4.3	3.5	3.0	7.5	6.2	2.7	7.3	9.6	29.7	19.4	8.6	14.1	15.4	13.1	12.3	11.0	10.5	8.5	12.0	18.9	9.1	11.2	6.4	20.9	11.1	15.9	14.4	9.5	13.6	10.3	13.1	12.4	19.8	14.6	14.4	9.1	13.6	17.6	17.0	22.4	7.9	16.6	5.8	33.6	10.5	20.6	4.7	19.6	17.0	9.6	12.8	9.0	17.5	25.8	10.1	17.0	14.4	8.7	13.4	16.1	14.3	15.3	8.7	10.0	11.1	16.7	22.7	13.4	10.6	17.6	3.5	2.5	0.3	4.6	3.0	4.8	5.5	5.1	4.9	4.3	4.2	5.5	6.2	0.0	7.5	2.9	3.7	4.1	2.7	15.4	14.6	26.7	25.1	13.6	14.7	17.6	11.1	14.9	16.2
SMARCB1	"BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5L1, Snr1"	ENSG00000099956	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	Q12824	22	23786931-23838008	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009196, HPA018248, HPA019127"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165"	"unprognostic (2.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.63e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (6.52e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.43e-3)"	"prognostic favourable (1.14e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.04e-2)"	11.0	15.2	14.6	33.2	15.4	16.9	12.1	30.4	21.9	13.4	25.1	16.4	11.4	41.1	17.2	11.0	15.6	12.3	15.0	12.6	13.2	14.2	14.6	11.7	14.0	32.8	13.0	13.8	21.3	16.1	7.9	15.7	20.8	12.8	11.0	9.4	16.7	40.9	13.1	28.1	14.7	27.4	10.6	12.8	19.8	24.1	37.7	12.9	29.4	15.7	12.0	16.0	21.1	12.2	19.5	9.9	4.8	11.6	7.0	7.5	5.9	1.5	1.0	19.0	1.7	1.8	0.5	3.8	6.0	1.8	1.8	2.9	2.2	1.8	15.5	5.2	0.8	2.9	4.5	2.9	3.0	2.5	6.6	12.9	1.7	1.3	2.0	13.6	3.8	1.1	2.2	2.1	4.7	0.9	3.5	8.6	1.1	3.8	11.1	3.1	5.7	3.8	7.0	15.3	7.0	1.5	3.0	9.0	6.8	1.4	0.4	10.2	1.4	2.1	1.6	1.6	6.6	2.6	1.7	9.5	8.7	10.3	1.3	7.5	4.6	4.0	10.0	4.8	3.8	10.2	5.2	19.5	4.6	4.6	9.3	6.4	3.8	2.5	0.8	7.0	11.6	9.9	7.5	5.9	14.6	15.4	30.4	21.9	13.2	14.2	13.0	13.8	12.8	12.9
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585272-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	16.5	9.3	14.5	22.6	18.9	16.7	21.8	16.5	17.2	19.3	22.4	19.6	13.1	13.3	20.0	15.2	21.8	12.5	16.4	10.3	13.9	11.3	18.7	15.6	13.6	18.6	18.1	11.3	18.7	25.6	16.4	15.1	28.0	11.7	22.1	20.8	14.5	18.9	16.9	19.8	24.3	17.8	32.6	16.1	18.7	16.6	18.7	18.3	45.0	21.1	12.8	27.7	24.9	27.0	8.2	4.7	4.3	5.4	4.0	8.1	3.9	14.3	7.6	32.0	24.8	7.2	12.3	21.6	11.5	10.8	14.9	15.3	13.6	15.3	33.6	9.3	14.4	12.4	30.1	17.8	21.9	16.0	17.9	32.9	13.1	18.5	10.8	30.1	15.2	10.3	15.8	16.8	18.7	17.4	27.6	11.4	16.0	10.7	39.1	15.7	42.2	11.7	17.6	18.6	29.5	16.0	18.9	14.3	28.8	17.8	17.5	12.7	15.2	28.1	13.9	10.0	14.2	11.3	18.7	14.0	17.8	40.1	7.3	28.5	14.0	4.0	3.5	3.4	6.2	5.4	5.6	8.2	6.7	8.1	4.4	6.3	6.4	7.5	4.3	4.0	3.8	4.7	6.3	3.9	14.5	18.9	16.5	17.2	13.9	11.3	18.1	11.3	11.7	18.3
SMARCC2	"BAF170, CRACC2, Rsc8"	ENSG00000139613	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2"	Q8TAQ2	12	56162983-56189567	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004321, HPA021213, HPA061788"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: "	"unprognostic (7.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	25.0	22.2	34.5	17.4	36.5	15.7	22.5	43.7	40.7	24.9	20.4	29.9	17.1	21.5	29.1	16.6	18.2	25.5	18.6	19.0	35.0	22.7	19.8	14.1	21.6	20.9	29.2	24.2	38.4	21.8	36.1	21.1	19.9	27.5	24.6	19.0	26.7	26.1	28.2	32.3	26.8	21.7	27.2	22.6	23.4	20.6	17.7	32.1	21.3	30.2	13.2	23.2	27.5	22.7	8.8	7.0	19.0	12.2	6.2	12.7	9.6	19.7	30.6	32.6	23.5	20.4	21.3	13.6	17.7	19.0	21.4	20.8	17.6	24.8	28.8	17.1	20.6	23.0	21.0	17.9	19.4	21.9	19.6	45.7	20.7	11.1	10.9	21.5	34.0	19.8	13.5	20.2	10.2	27.1	26.0	24.1	19.7	20.7	36.2	19.3	11.0	20.9	21.5	26.2	22.5	16.0	25.9	24.2	25.0	30.1	21.1	8.1	35.5	19.1	23.1	18.3	22.4	16.3	13.0	22.9	16.7	20.1	19.0	14.4	19.4	13.7	7.6	19.0	11.9	10.0	12.7	8.6	8.4	8.4	7.0	8.8	6.2	7.8	6.6	6.2	12.2	5.0	8.2	9.6	34.5	36.5	43.7	40.7	35.0	22.7	29.2	24.2	27.5	32.1
SMARCD1	"BAF60A, CRACD1, Rsc6p"	ENSG00000066117	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1"	Q96GM5	12	50084972-50100712	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004101	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA004101: AB_1080026"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavourable (2.53e-8)"	"unprognostic (3.62e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	21.3	24.5	16.4	22.6	22.7	29.9	21.3	27.8	28.2	19.8	19.9	29.5	17.6	18.8	23.6	23.4	23.3	19.9	18.2	15.6	16.3	13.8	25.1	18.3	19.4	26.1	15.7	20.4	24.7	19.6	44.3	17.8	24.7	18.8	20.4	22.4	20.3	21.4	25.9	16.6	19.7	24.0	23.8	18.5	28.1	17.4	34.4	14.9	64.3	24.3	17.9	36.7	19.3	18.2	6.0	6.7	4.4	3.4	3.1	6.9	2.3	8.0	13.6	40.3	23.3	12.6	11.9	20.0	10.1	17.9	29.7	17.4	37.4	12.7	31.6	15.2	19.2	10.4	34.0	26.4	25.7	24.4	25.1	31.1	13.8	21.6	15.0	27.5	12.5	12.0	17.8	17.5	31.8	34.9	26.3	19.6	15.0	19.0	39.9	14.8	50.4	22.4	47.9	10.5	27.6	16.8	19.0	21.8	36.3	21.2	10.8	42.1	24.3	23.1	20.9	15.3	17.1	9.6	20.5	27.7	24.3	28.1	12.4	11.2	17.3	4.4	2.3	4.1	6.1	2.1	5.8	6.0	3.3	3.9	3.6	5.6	2.1	6.9	1.1	3.1	3.4	6.7	5.0	2.3	16.4	22.7	27.8	28.2	16.3	13.8	15.7	20.4	18.8	14.9
SMARCD2	"BAF60B, CRACD2, PRO2451, Rsc6p"	ENSG00000108604	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2"	Q92925	17	63832081-63843065	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA059934, HPA061348"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA059934: , HPA061348: "	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.79e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (4.75e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (9.94e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.80e-2)"	22.0	25.0	6.9	23.1	11.5	21.2	25.6	29.0	12.5	21.7	24.6	14.3	36.5	17.8	17.2	25.8	30.7	22.7	25.9	13.4	8.6	5.3	16.0	21.3	20.1	26.5	15.8	8.9	18.0	42.5	17.3	16.1	33.2	10.1	24.2	18.0	15.0	42.9	30.2	11.1	36.3	25.6	22.1	8.9	26.1	26.4	17.7	13.6	40.6	23.3	23.7	28.0	23.7	22.5	11.0	14.5	13.0	11.6	9.1	13.6	6.7	26.1	17.1	4.6	20.8	29.0	47.4	25.9	9.8	14.7	21.6	14.1	20.0	15.2	30.3	5.7	17.6	17.9	14.8	22.5	13.7	8.0	35.5	20.6	7.0	29.4	23.8	24.2	23.0	36.8	28.2	11.6	10.2	17.8	16.2	18.4	12.8	63.3	38.3	26.0	10.6	19.7	39.3	16.0	35.0	15.6	19.9	17.3	30.7	12.3	50.7	21.1	46.8	24.2	11.7	13.8	8.3	12.5	16.8	21.6	16.0	20.5	10.7	24.1	10.0	5.4	11.6	10.6	11.5	10.0	7.6	8.8	12.9	12.3	14.5	11.0	8.6	11.6	13.0	9.1	11.5	12.9	13.6	6.7	6.9	11.5	29.0	12.5	8.6	5.3	15.8	8.9	10.1	13.6
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 3.1;monocytes: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA063955: , HPA065517: "	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	9.7	16.0	34.2	4.0	40.3	4.9	9.8	25.4	36.8	12.9	5.6	7.8	7.9	2.9	8.6	11.4	6.7	14.5	10.7	38.5	22.2	24.7	4.9	2.0	8.3	4.0	18.7	18.8	19.2	7.5	6.8	14.7	4.6	13.3	10.8	3.6	7.6	6.6	18.1	75.2	5.7	3.4	10.0	14.1	4.3	4.8	9.0	11.6	0.0	7.4	9.5	2.5	10.1	4.8	0.2	2.6	3.1	8.8	0.0	0.8	2.1	0.3	2.8	9.4	33.2	14.9	6.7	0.7	6.1	6.2	3.6	2.1	2.1	1.9	3.6	2.2	9.6	0.6	7.5	0.6	1.4	1.1	4.6	0.0	1.9	0.6	12.9	0.1	6.0	15.9	0.8	1.2	0.1	0.7	7.1	1.2	18.9	3.8	0.6	4.7	2.9	1.2	0.2	14.7	0.1	3.2	0.0	5.4	10.9	5.7	1.0	4.4	0.8	9.2	1.1	2.3	3.7	7.1	2.0	7.8	0.0	2.9	6.6	8.2	10.3	0.6	8.8	0.0	0.2	1.9	0.1	0.2	0.8	0.0	2.6	0.0	0.5	0.8	3.1	0.0	0.4	0.0	0.7	2.1	34.2	40.3	25.4	27.9	22.2	24.7	18.7	18.8	13.3	11.6
SMARCE1	BAF57	ENSG00000073584	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1"	Q969G3	17	40624962-40648864	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	Neurogenesis	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003916, CAB037318"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB037318: AB_476780, HPA003916: AB_1857279"	"unprognostic (7.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-2)"	25.1	20.2	14.4	17.2	18.8	18.4	20.2	17.0	16.7	37.6	25.1	18.0	12.6	18.4	42.8	19.5	31.0	21.1	20.6	19.6	13.3	12.0	23.0	22.6	20.1	22.3	16.5	14.3	39.5	16.9	13.3	20.4	34.8	15.2	32.4	19.2	17.9	20.6	21.9	32.0	21.3	22.6	33.4	15.8	30.3	19.1	22.0	17.5	53.9	23.8	18.9	25.1	31.2	21.0	40.3	32.0	34.0	30.3	47.2	44.0	39.2	20.5	34.3	42.1	31.3	22.3	32.1	20.7	25.9	35.8	30.5	23.0	22.4	17.9	32.7	37.5	35.0	28.1	26.0	27.4	36.7	30.6	33.8	23.4	18.5	39.4	22.5	42.6	23.8	27.8	21.7	24.3	35.5	32.8	34.0	13.0	29.1	23.1	78.0	8.8	23.5	17.0	43.8	47.4	24.8	36.8	35.3	33.7	32.6	23.0	66.9	21.5	40.1	26.8	26.8	24.8	27.4	22.4	31.9	24.4	28.4	48.9	25.3	19.6	38.2	31.8	26.0	34.0	39.1	26.8	40.5	38.4	35.8	40.9	31.3	40.3	30.2	34.9	11.0	47.2	30.3	32.0	44.0	39.2	14.4	18.8	17.0	16.7	13.3	12.0	16.5	14.3	15.2	17.5
SMC1A	"DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb"	ENSG00000072501	"Structural maintenance of chromosomes 1A"	Q14683	X	53374149-53422728	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005499, CAB025404"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB025404: , HPA005499: AB_1080028"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.80e-3)"	"unprognostic (9.49e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.18e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.39e-2)"	20.6	14.1	14.6	24.2	28.2	24.6	16.2	33.6	21.7	19.9	18.2	22.0	10.5	16.2	27.5	10.0	22.4	21.7	12.5	16.2	16.8	10.8	19.2	23.5	15.4	30.2	25.2	13.0	21.8	17.2	31.0	18.4	19.5	18.0	13.4	17.3	12.5	16.8	12.9	24.3	16.2	19.7	21.7	21.3	20.1	17.5	10.4	25.8	38.3	16.8	11.1	25.7	22.0	21.3	14.3	15.5	13.7	18.7	15.6	17.8	10.6	28.2	31.7	25.2	21.5	9.3	10.3	14.1	17.1	11.3	21.7	17.6	18.8	16.5	27.6	14.7	11.4	21.6	44.9	24.7	24.3	23.6	52.3	24.1	36.8	13.1	3.8	34.0	34.6	5.8	6.4	24.3	14.8	18.7	35.4	17.8	16.9	17.1	30.6	10.3	37.4	16.9	32.9	43.5	25.5	9.2	18.6	26.8	22.6	44.7	22.1	9.4	23.7	13.9	10.5	18.5	19.6	18.3	16.6	11.7	19.7	25.6	10.6	38.7	18.1	6.1	13.8	13.7	17.8	18.7	17.0	12.2	12.0	15.6	15.5	14.3	14.2	10.9	9.4	15.6	17.4	12.9	8.8	10.6	14.6	28.2	33.6	21.7	16.8	10.8	25.2	13.0	18.0	25.8
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 35.4"	"Cell line enhanced"	"Detected in some"		"A-431: 9.0;EFO-21: 4.3;SiHa: 18.7;U-266/70: 4.2"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.2	0.0	0.5	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.0	18.7	0.1	0.0	0.1	1.6	0.1	0.0	0.0	0.5	0.0	4.2	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.7	0.4	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.3	0.6	0.0	0.0	0.0	0.2	0.0
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141417	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA071309: "	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	7.4	6.1	6.6	10.1	10.5	15.2	6.1	8.1	9.1	7.9	7.5	4.0	5.1	7.0	6.1	5.2	11.4	5.1	3.6	7.1	6.5	6.8	8.6	5.7	5.5	14.2	8.2	5.2	6.0	4.1	5.2	6.5	7.5	10.7	5.2	8.5	3.0	5.9	4.7	4.2	6.8	6.9	5.4	8.6	13.7	5.9	12.3	8.7	56.1	7.2	12.9	14.7	6.1	6.3	8.9	5.1	12.0	8.3	8.0	7.4	2.8	18.1	14.0	15.8	14.6	3.3	4.9	14.8	16.8	8.0	15.1	12.8	12.1	14.1	34.7	8.2	8.6	30.8	22.9	10.9	20.5	22.0	9.6	20.9	22.5	7.8	0.9	12.6	21.1	3.2	2.2	20.4	8.3	10.6	16.8	28.6	13.6	8.8	32.9	6.5	13.7	11.0	22.1	45.3	13.0	6.5	6.6	15.0	11.6	20.0	9.4	4.9	18.9	8.6	8.4	18.4	19.4	25.4	21.0	10.5	35.2	20.4	11.9	18.6	22.2	12.0	2.8	2.8	6.2	7.1	7.0	8.5	5.7	6.2	3.0	8.9	6.7	7.4	0.4	8.0	8.3	5.1	6.9	2.8	6.6	10.5	8.1	9.1	6.5	6.8	8.2	5.2	10.7	8.7
SMC3	"BAM, bamacan, CSPG6, HCAP, SMC3L1"	ENSG00000108055	"Structural maintenance of chromosomes 3"	Q9UQE7	10	110567691-110604636	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037411, HPA043206"	Uncertain		Supported	Nucleoplasm			10000000	Nucleoplasm		"HPA037411: AB_10671753, HPA043206: "	"unprognostic (3.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.89e-3)"	"unprognostic (9.74e-3)"	"unprognostic (8.06e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.73e-3)"	"unprognostic (7.22e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	17.1	13.4	16.8	15.4	22.9	32.7	21.3	37.8	18.0	19.2	15.1	9.9	10.7	13.3	20.1	14.3	19.7	15.6	9.9	11.9	16.7	11.2	16.6	17.2	12.6	23.7	18.6	15.4	26.5	18.4	22.2	36.6	22.9	17.7	14.6	15.1	8.8	15.3	14.3	18.4	18.4	18.8	19.6	22.2	18.1	13.5	32.0	23.2	47.4	19.4	11.4	20.8	20.7	19.7	13.2	11.0	19.1	10.5	15.1	17.7	7.4	26.8	16.8	36.6	26.0	12.2	10.5	15.8	21.8	21.8	20.2	19.9	21.2	22.7	35.1	9.6	14.6	21.5	26.2	13.2	30.9	28.6	22.5	28.3	21.2	19.0	12.2	40.2	21.9	8.3	10.8	22.3	35.2	14.8	22.5	27.2	17.4	14.1	30.9	21.4	25.2	13.5	26.3	66.3	19.0	12.5	12.0	20.9	23.9	23.5	6.8	17.9	10.9	19.7	15.2	16.3	25.8	18.3	31.4	15.8	14.1	38.0	14.5	38.8	13.3	19.1	7.7	18.6	13.0	10.5	16.1	13.2	15.1	14.0	8.4	13.1	15.5	15.1	8.4	15.1	8.9	11.0	17.7	7.4	16.8	22.9	37.8	18.0	16.7	11.2	18.6	15.4	17.7	23.2
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434962	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (4.20e-5)"	"prognostic unfavourable (9.00e-4)"	"prognostic unfavourable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	4.8	5.5	3.0	25.4	4.4	15.1	4.0	3.1	3.2	5.3	10.1	1.7	5.3	6.5	5.2	4.9	19.3	4.6	7.0	5.7	2.4	1.7	4.4	6.3	7.9	16.5	3.1	1.3	4.7	4.2	1.7	10.8	7.4	2.6	4.4	6.9	2.7	5.7	6.9	5.9	4.6	7.0	6.2	3.1	13.1	5.7	20.7	3.2	70.2	5.1	7.6	14.3	7.8	6.3	8.8	6.1	30.5	7.6	7.8	15.8	4.8	62.1	11.5	26.2	12.1	5.0	5.1	12.1	31.0	14.7	35.9	31.2	14.5	35.8	39.4	18.1	12.7	36.0	29.8	15.0	57.8	52.2	20.8	38.1	19.7	4.7	2.8	25.2	31.2	2.6	2.2	19.0	15.5	15.2	21.9	45.8	21.4	11.2	30.9	6.2	15.4	27.1	31.4	41.2	28.6	6.7	7.7	15.8	16.4	23.7	21.9	10.8	26.3	18.9	14.4	23.0	19.2	20.9	56.5	30.6	31.3	71.9	16.4	25.9	25.5	30.5	3.2	12.1	6.7	4.7	6.5	8.8	10.5	8.0	3.5	7.2	6.7	6.0	5.7	7.8	7.6	6.1	15.8	4.8	3.0	4.4	3.1	3.2	2.4	1.7	3.1	1.3	2.6	3.2
SMC5	"KIAA0594, SMC5L1"	ENSG00000198887	"Structural maintenance of chromosomes 5"	Q8IY18	9	70258962-70354888	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054900	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA054900: "	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	12.8	9.0	11.5	21.6	13.7	20.8	15.3	34.2	14.7	15.3	14.2	6.9	16.7	12.2	14.4	12.8	14.3	15.5	12.9	13.1	10.7	7.3	10.1	13.3	14.3	15.6	15.0	9.5	33.2	19.9	10.7	30.0	15.9	12.2	15.6	15.9	5.5	17.5	24.3	36.9	11.3	16.9	18.8	13.3	13.9	13.1	11.7	14.6	20.2	13.5	11.1	14.2	14.9	22.9	11.5	11.3	14.7	9.4	9.8	11.9	5.2	22.4	5.6	14.2	8.6	8.3	15.6	11.2	15.6	13.6	8.6	9.4	2.1	12.3	22.6	5.1	11.7	20.7	15.3	10.4	17.2	10.1	5.5	13.1	9.3	6.7	10.6	21.3	13.6	10.9	7.3	11.5	13.3	8.9	9.6	9.1	15.8	3.4	28.0	7.5	10.9	7.9	16.6	23.4	7.0	8.7	11.1	10.2	7.6	15.5	10.0	4.3	6.0	9.1	9.7	11.6	12.2	15.6	21.3	11.3	15.0	15.7	9.7	11.2	13.7	14.7	7.7	12.8	11.9	8.4	11.1	10.1	10.2	11.0	5.9	11.5	11.5	10.4	5.1	9.8	9.4	11.3	10.5	5.2	11.5	13.7	34.2	14.7	10.7	7.3	15.0	9.5	12.2	14.6
SMC6	"FLJ22116, SMC6L1"	ENSG00000163029	"Structural maintenance of chromosomes 6"	Q96SB8	2	17663812-17800242	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035057, CAB037186, HPA042733"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB037186: AB_1080031, HPA035057: , HPA042733: "	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.94e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (3.15e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.25e-2)"	9.5	5.2	6.9	16.3	10.9	10.0	13.2	10.3	9.5	10.3	10.0	5.6	7.6	7.6	9.2	15.8	16.4	7.8	8.1	9.7	7.1	7.5	10.5	16.8	8.2	17.9	8.9	5.0	9.7	6.8	7.0	29.6	12.2	11.4	8.1	11.8	22.8	14.0	13.5	10.4	12.5	12.5	7.6	9.3	19.4	8.4	28.8	11.3	16.0	8.2	13.8	18.7	8.4	12.6	18.4	17.3	5.0	3.9	4.4	8.8	2.4	21.0	10.5	13.9	11.5	15.0	14.5	14.1	11.3	8.0	7.3	7.2	11.7	8.3	18.4	7.3	10.3	14.8	16.6	13.2	11.3	21.8	10.8	25.3	6.6	17.7	14.0	17.5	13.7	10.8	9.4	11.8	15.5	16.7	27.7	15.4	13.8	8.6	13.5	9.1	18.8	8.5	16.2	39.3	12.5	7.1	11.8	12.3	13.1	16.4	8.6	12.6	5.5	7.9	18.2	18.2	7.3	14.1	19.9	10.9	17.6	37.4	9.2	19.3	12.9	1.2	2.4	5.0	5.3	2.6	4.4	15.5	4.1	4.7	3.2	18.4	2.9	4.0	2.0	4.4	3.9	17.3	8.8	2.4	6.9	10.9	10.3	9.5	7.1	7.5	8.9	5.0	11.4	11.3
SMCR8	FLJ34716	ENSG00000176994	"Smith-Magenis syndrome chromosome region, candidate 8"	Q8TEV9	17	18315310-18328055	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021557, HPA024646"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA021557: AB_1857283, HPA024646: AB_1857284"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.11e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.09e-3)"	"unprognostic (7.11e-2)"	"prognostic favourable (1.35e-4)"	"unprognostic (9.41e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.27e-2)"	10.4	10.0	6.1	11.1	11.4	25.0	10.5	13.9	15.8	8.7	8.5	11.2	10.6	8.0	12.2	6.9	10.4	9.1	7.8	7.3	7.2	6.3	9.6	7.9	10.7	12.4	6.7	5.7	10.8	9.6	14.0	17.1	11.6	9.3	9.7	9.3	12.0	13.6	7.9	13.3	10.4	13.0	7.9	7.1	16.1	10.9	8.8	8.8	15.8	9.5	4.7	15.8	12.5	10.9	1.1	1.2	5.2	2.2	1.1	1.2	0.9	6.4	9.1	4.6	5.3	6.4	4.3	8.3	4.7	6.3	8.2	8.0	13.8	2.8	3.8	3.5	5.7	8.6	9.0	5.5	7.7	7.8	7.6	7.1	9.0	3.9	6.9	2.8	17.6	5.5	7.1	9.5	6.0	5.9	5.9	3.7	4.9	3.9	4.7	4.1	4.3	3.8	5.2	11.7	6.0	3.8	7.4	2.4	5.6	5.3	6.8	10.0	13.8	5.7	5.7	4.7	5.7	12.3	6.2	5.6	6.3	2.0	6.6	4.5	4.8	5.2	1.7	1.5	1.0	1.2	0.9	1.1	0.8	1.1	1.2	0.8	1.2	1.1	2.1	1.1	2.2	1.0	0.7	0.9	6.1	11.4	13.9	15.8	7.2	6.3	6.7	5.7	9.3	8.8
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: "	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favourable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favourable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	8.7	12.3	20.3	14.6	18.0	15.3	19.9	19.5	17.9	15.2	12.9	10.2	14.7	11.0	13.0	20.2	16.4	15.7	10.7	21.3	15.8	16.2	14.1	18.4	10.1	14.4	16.3	12.4	23.2	21.6	11.3	12.9	9.8	9.9	16.4	12.1	15.5	37.0	15.9	26.4	10.4	18.0	9.8	13.3	10.6	12.9	10.9	7.9	15.2	23.4	18.7	16.1	14.9	16.9	5.4	5.0	2.3	3.5	2.9	5.9	3.0	2.2	1.5	3.0	3.7	5.7	4.1	2.4	0.8	4.1	5.1	4.4	2.9	2.2	5.8	1.0	4.3	2.5	4.0	4.3	3.3	1.5	6.6	1.9	3.2	4.1	7.1	3.5	2.5	3.2	7.3	2.0	4.2	5.0	3.1	5.1	3.5	5.8	4.9	5.3	1.1	3.3	4.3	2.7	8.4	6.4	2.6	3.8	2.5	2.0	4.6	5.0	3.9	3.8	2.0	2.2	2.4	1.9	1.5	3.5	3.8	6.9	3.3	3.4	1.6	2.3	3.5	1.6	2.7	1.7	3.7	3.7	5.4	2.8	5.0	5.4	5.9	3.9	0.3	2.9	2.5	3.8	3.0	3.0	20.3	18.0	19.5	17.9	15.8	16.2	16.3	12.4	9.9	7.9
SMG1	"ATX, KIAA0421, LIP"	ENSG00000157106	"SMG1, nonsense mediated mRNA decay associated PI3K related kinase"	Q96Q15	16	18804853-18926454	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Nonsense-mediated mRNA decay"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006870, HPA031623, HPA073972"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA006870: AB_1079725, HPA031623: , HPA073972: "	"unprognostic (6.34e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.32e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	4.7	3.0	2.1	4.5	3.5	11.7	6.2	13.2	3.0	4.4	4.5			3.1	5.4	5.1	5.5	4.0	3.0	4.5	2.3	2.2	4.6	5.4	4.1	6.2	2.3		6.3	4.5	7.2	3.9	3.1		4.2	5.0		4.7	3.3	21.1	14.4	5.0	3.9	3.4	4.5	4.3	4.0			6.0		5.8	5.2	4.9	7.1	4.6	19.1	5.6	2.3	6.1	1.0	23.2	15.6	14.7	10.4	16.9	17.9	10.9	10.9	10.7	11.9	13.3	13.7	8.6	32.1	15.7	15.1	13.3	16.9	9.5	19.0	20.6	10.6	14.6	13.7	17.5	13.7	19.6	11.6	10.5	16.1	24.5	29.6	16.6	22.4	17.9	13.1	12.4	13.5	11.8	15.7	9.0	15.7	19.8	11.0	10.2	18.3	13.4	10.2	16.9	11.5	11.9	9.2	12.5	21.0	17.9	12.0	11.0	16.1	9.2	11.9	21.2	11.9	15.3	10.6	19.1	2.5	3.4	6.1	2.8	2.9	3.7	4.0	4.3	2.5	7.1	5.4	4.7	7.6	2.3	5.6	4.6	3.7	1.0										
SMG6	"C17orf31, EST1A, KIAA0732, SMG-6"	ENSG00000070366	"SMG6, nonsense mediated mRNA decay factor"	Q86US8	17	2059839-2303771	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042932	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA042932: AB_10964261"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.30e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.30e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.08e-2)"	12.7	16.6	18.1	18.9	17.6	11.9	10.9	19.1	18.4	15.0	10.6	15.1	13.2	9.0	26.2	11.9	16.1	22.2	16.7	16.4	12.8	15.9	11.5	7.3	11.5	10.7	13.4	16.1	38.7	9.3	16.2	17.2	10.1	14.5	14.5	9.5	18.6	10.4	13.3	14.0	15.3	10.3	18.9	12.8	9.0	9.7	39.2	11.5	22.3	11.6	8.4	16.8	12.7	12.4	2.0	3.3	4.8	3.6	4.6	4.3	1.5	8.4	13.0	18.8	12.1	20.3	16.5	9.7	13.7	15.1	15.6	13.3	15.8	4.3	8.9	4.9	20.1	12.4	13.7	11.7	16.4	8.9	8.6	8.7	6.9	7.7	11.6	4.6	6.3	23.3	8.6	12.6	11.2	14.2	7.1	10.9	11.6	6.7	11.6	3.7	6.0	6.8	12.1	12.0	3.5	9.0	7.8	3.2	9.6	14.3	4.2	5.9	6.5	3.4	18.6	14.4	7.9	15.2	14.3	9.5	5.7	4.2	11.5	5.2	8.3	4.8	1.8	2.0	3.7	0.8	3.7	1.2	3.1	3.5	1.0	2.0	4.3	2.9	1.4	4.6	3.6	3.3	1.8	1.5	18.1	17.6	19.1	18.4	12.8	15.9	13.4	16.1	14.5	11.5
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7, nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	14.6	14.3	20.7	17.1	25.3	30.9	17.6	35.8	29.3	17.6	18.1	19.9	6.6	16.8	16.6	13.6	19.1	22.1	12.9	20.0	17.8	14.8	18.2	18.7	15.6	19.7	16.0	23.1	22.7	18.7	25.9	20.2	18.7	15.9	15.1	20.4	15.9	17.2	14.5	19.2	20.5	17.8	15.2	14.4	18.9	18.3	52.1	15.1	31.6	19.9	12.7	23.9	14.5	22.3	9.3	11.7	11.2	9.6	9.5	10.3	8.0	21.5	13.2	19.0	14.9	13.0	12.4	31.8	13.3	24.5	14.9	11.4	19.5	16.9	30.5	15.3	16.4	23.5	25.6	19.7	17.7	13.5	11.2	24.6	14.3	15.8	13.2	32.2	15.8	11.2	18.1	20.3	47.2	16.2	30.5	21.6	15.4	21.9	22.6	14.2	33.0	7.6	14.3	21.3	23.8	11.4	20.2	25.7	20.1	20.5	29.2	15.9	29.1	13.2	15.4	16.9	17.5	16.7	18.8	23.6	27.7	25.3	13.7	18.3	18.0	3.1	9.3	9.5	9.7	9.6	8.9	9.3	8.8	9.5	10.7	8.5	9.9	10.3	11.2	9.5	5.0	11.7	7.8	8.0	20.7	25.3	35.8	29.3	17.8	14.8	16.0	23.1	15.9	15.1
SMN1	"BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A"	ENSG00000172062	"Survival of motor neuron 1, telomeric"	Q16637	5	70925030-70953942	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.3;MOLT-4: 37.1;T-47d: 28.7;WM-115: 38.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB016324, HPA045271, CAB069888, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: , HPA073601: "	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavourable (6.62e-13)"	"unprognostic (2.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.14e-2)"	4.3	3.3	5.1	4.7	4.4	23.9	5.1	6.0	4.3	6.1	4.0			2.8	5.2	7.4	4.7	5.7	8.0	3.5	5.2	5.0	6.8	7.0	3.7	16.4	4.6		8.0	5.3	6.4	5.2	4.7		4.6	6.0		3.8	3.5	5.8	5.9	3.1	9.2	5.2	5.2	6.1	6.9			4.9		2.5	10.7	5.1	15.8	14.7	5.2	11.3	9.0	16.1	7.1	2.8	0.6	1.1	1.3	3.0	4.5	15.1	1.1	1.7	1.7	1.3	1.3	1.3	1.4	23.3	2.2	1.5	1.7	1.2	1.5	0.3	1.7	21.0	1.7	1.9	0.4	2.4	1.9	0.5	3.7	0.6	0.6	0.9	0.9	2.1	0.9	1.0	37.1	15.5	1.4	0.6	1.9	4.6	11.0	0.9	1.6	1.7	3.6	1.5	4.1	19.5	28.7	3.9	10.5	10.9	1.2	1.0	2.3	1.3	0.9	13.9	1.6	1.5	38.2	5.2	9.1	3.4	10.1	11.3	16.1	15.8	10.3	9.4	13.4	12.5	14.2	13.4	3.1	9.0	10.5	14.7	12.5	7.1										
SMN2	"BCD541, GEMIN1, SMNC, TDRD16B"	ENSG00000205571	"Survival of motor neuron 2, centromeric"	Q16637	5	70049612-70078522	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 37.7;MOLT-4: 33.8;NB-4: 31.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009344, HPA045271, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"CAB009344: AB_2193083, HPA045271: , HPA073601: "	"unprognostic (2.07e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.98e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.19e-1)"	3.9	2.7	5.4	3.7	4.8	10.4	4.2	5.6	9.8	3.9	4.0			0.2	4.9	19.1	10.0	2.9	11.5	3.2	5.2	5.1	6.6	5.4	6.2	8.6	4.1		7.0	7.9	11.4	5.0	3.8		4.7	6.9		8.5	5.4	5.2	3.3	2.6	12.1	5.5	4.0	5.4	9.8			5.1		0.0	10.9	4.8	15.0	14.0	4.7	14.9	9.2	15.6	6.2	16.6	0.1	0.1	0.0	6.6	7.9	37.7	8.9	5.7	11.5	11.4	0.1	0.1	0.3	25.7	9.1	7.5	0.2	0.0	7.7	0.2	0.3	18.1	0.0	0.6	0.0	0.3	0.0	0.0	14.8	0.0	0.3	0.2	0.0	0.1	0.0	0.1	33.8	31.7	0.1	0.1	0.0	13.0	19.3	7.5	0.0	9.4	20.7	16.9	3.7	23.7	12.0	7.5	15.8	7.8	0.3	0.1	0.2	0.1	0.3	21.3	0.1	0.0	21.5	3.9	6.1	4.7	8.1	14.9	15.0	13.7	13.1	9.3	13.1	15.0	15.6	13.1	1.2	9.2	10.1	14.0	13.1	6.2										
SMNDC1	"SMNR, SPF30, TDRD16C"	ENSG00000119953	"Survival motor neuron domain containing 1"	O75940	10	110290730-110304951	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061214, HPA070666"			Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA061214: , HPA070666: "	"unprognostic (4.65e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavourable (8.08e-6)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (7.20e-4)"	"unprognostic (2.68e-3)"	"unprognostic (6.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-1)"	21.3	18.0	16.7	20.0	17.5	38.3	26.6	24.0	20.1	19.0	18.1	17.5	13.5	13.9	23.6	13.1	24.1	18.4	16.7	19.4	15.0	15.4	19.3	20.8	23.5	32.7	15.0	14.4	23.4	15.3	18.0	24.3	25.2	16.5	18.0	16.1	19.6	18.0	17.4	34.3	19.0	16.6	21.3	22.7	21.8	17.0	19.8	16.9	30.0	18.9	14.9	24.7	25.4	22.4	6.2	9.2	17.4	9.7	6.3	8.7	4.5	15.3	11.7	17.2	19.7	13.4	16.0	12.8	17.8	18.6	23.7	24.4	15.0	19.0	21.8	11.6	11.1	16.7	25.2	12.3	26.8	12.3	13.5	21.7	10.0	17.5	16.0	23.8	21.0	12.4	13.2	18.8	31.8	13.1	19.5	20.4	18.3	7.2	25.4	23.2	19.1	8.1	22.0	34.5	11.4	13.2	11.1	8.6	11.6	11.5	9.8	20.4	12.1	13.7	14.3	13.9	15.9	12.7	22.6	16.9	17.5	33.1	14.0	33.5	10.7	5.7	9.6	14.7	6.1	9.7	7.5	6.2	7.9	7.6	9.2	5.5	7.1	6.8	17.4	6.3	9.7	5.5	8.7	4.5	16.7	17.5	24.0	20.1	15.0	15.4	15.0	14.4	16.5	16.9
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 34.7;Karpas-707: 59.3;RPTEC TERT1: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1;neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nuclear membrane"	"Nucleoplasm, Vesicles"	"HPA047117: , HPA060198: "	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (3.33e-6)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	3.5	3.1	26.0	4.1	22.7	24.2	3.4	10.1	29.0	9.6	6.7	23.5	17.6	9.5	10.2	6.9	6.1	4.7	14.0	2.9	28.8	16.2	3.8	4.4	2.1	4.0	25.1	16.5	9.2	28.9	8.7	6.0	5.7	20.7	8.1	1.4	6.5	10.6	10.2	2.5	7.8	7.1	3.9	25.9	2.9	7.4	3.9	24.1	0.3	3.9	3.4	2.6	5.3	5.2	0.1	2.1	3.5	0.9	0.2	0.2	15.3	3.1	34.7	2.4	1.8	1.7	2.5	4.4	4.5	8.7	3.3	2.2	14.2	8.7	0.0	1.5	4.1	6.3	2.0	2.1	1.4	0.0	1.0	6.1	1.1	14.4	10.7	1.1	2.5	9.6	3.9	6.9	2.9	5.8	1.3	59.3	1.9	0.9	2.3	3.4	3.0	4.7	2.0	3.0	8.2	27.3	2.4	0.4	2.1	8.4	0.9	15.6	0.1	1.5	6.9	3.8	3.6	0.6	3.5	2.7	0.4	0.0	3.2	1.5	2.9	0.0	0.9	0.1	0.0	0.4	0.0	0.1	0.2	0.2	2.1	0.0	0.0	0.0	3.5	0.2	0.1	1.0	0.0	15.3	26.0	22.7	10.1	17.6	28.8	16.2	25.1	16.5	20.7	24.1
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358325-68448688	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Lipid metabolism, Sphingolipid metabolism"	"Developmental protein, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.4;MOLT-4: 13.4;RPMI-8226: 11.1;SCLC-21H: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 44.5"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 44.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.1"	"Low region specificity"	"Detected in all"			"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favourable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	3.5	2.3	6.0	3.1	18.3	1.8	1.6	9.4	15.4	1.0	9.6	2.5	0.0	46.4	1.7	0.7	1.8	2.7	17.2	1.2	8.7	3.6	0.9	3.8	2.1	3.5	2.5	5.0	2.7	1.9	0.7	10.7	0.8	3.9	2.2	5.8	4.3	2.2	0.9	1.8	8.1	42.7	1.2	1.4	3.0	18.6	4.2	4.4	73.0	1.3	1.3	4.3	1.6	1.2	0.6	44.5	6.1	0.0	0.0	0.7	0.3	0.3	0.7	0.3	0.1	0.0	0.0	5.2	0.4	0.0	0.4	0.1	2.9	0.9	0.4	0.5	0.2	1.1	0.0	0.0	0.1	0.3	0.7	0.1	2.1	0.3	0.0	0.0	9.4	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.3	0.2	13.4	2.5	0.6	0.1	0.6	0.2	11.1	0.0	0.1	12.9	2.5	0.4	1.5	0.6	1.0	0.8	0.0	0.4	0.8	1.4	0.1	2.1	1.1	0.2	0.2	0.8	0.2	1.0	0.0	6.1	0.7	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	44.5	0.5	0.3	6.0	18.3	9.4	15.4	8.7	3.6	2.5	5.0	3.9	4.4
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 99.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"			11000	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: , HPA058590: "	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavourable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	17.4	3.3	5.0	8.3	3.8	1.5	13.2	12.7	4.7	34.3	99.3	2.0	7.5	10.3	72.4	12.5	26.4	23.5	32.5	27.6	4.3	1.3	7.0	4.7	9.1	1.7	3.6	2.2	18.2	6.8	1.3	2.0	6.0	5.3	34.5	10.6	14.9	4.6	66.7	28.8	6.4	20.3	91.7	1.7	16.9	36.7	6.2	4.0	1.8	5.1	16.8	2.2	61.3	21.4	4.1	1.3	0.3	2.8	0.3	3.1	1.9	19.6	5.9	2.0	7.5	3.1	5.0	16.4	29.5	13.8	24.3	16.7	8.2	6.3	8.8	2.6	16.2	2.9	2.0	17.4	11.5	2.9	16.2	9.3	4.7	9.7	2.8	13.8	16.3	4.1	1.6	32.1	5.3	20.9	9.9	7.3	16.6	17.6	1.5	3.0	2.2	25.1	5.5	5.8	9.3	9.7	6.4	3.2	3.5	9.2	4.4	4.3	5.2	2.2	32.9	17.9	16.9	16.7	21.8	7.0	8.4	5.2	25.9	5.4	55.8	0.0	2.8	0.0	0.5	0.7	0.2	4.1	0.5	1.2	1.3	0.2	3.1	1.7	0.3	0.3	0.7	0.7	0.1	1.9	5.0	3.8	12.7	4.7	4.3	1.3	3.6	2.2	5.3	4.0
SMUG1	"FDG, HMUDG, UNG3"	ENSG00000123415	"Single-strand-selective monofunctional uracil-DNA glycosylase 1"	Q53HV7	12	54121277-54189008	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026804, HPA065892"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA026804: , HPA065892: "	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.58e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (6.12e-2)"	"prognostic favourable (1.31e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.73e-1)"	9.5	15.2	17.3	7.0	16.4	4.9	15.5	13.2	16.1	9.8	11.1	11.7	13.5	9.2	9.5	24.1	19.2	14.2	9.2	10.7	15.0	7.8	13.8	23.5	7.8	17.0	11.5	15.0	10.3	23.6	8.3	11.5	14.9	14.4	11.9	10.5	14.2	16.2	10.9	13.6	16.4	16.2	9.2	10.4	11.2	15.2	12.1	14.1	12.6	12.4	6.1	13.1	10.0	9.8	24.2	23.8	38.0	25.0	13.0	20.8	17.0	12.9	23.9	9.4	9.7	17.5	13.7	16.0	10.0	13.1	15.8	14.5	23.9	29.0	7.7	25.8	14.4	17.0	6.5	26.4	10.2	8.1	13.9	11.6	19.1	17.0	20.9	7.7	14.5	15.6	41.2	18.6	18.5	12.7	19.3	17.0	17.3	24.9	9.7	15.2	11.7	21.6	7.1	9.6	13.9	19.6	19.0	14.0	16.7	11.5	19.9	17.5	31.0	14.6	6.1	10.7	11.8	9.5	11.4	15.9	12.5	5.2	15.4	6.1	16.0	38.0	25.0	28.7	15.8	19.7	15.7	24.2	15.6	17.0	21.1	18.8	14.1	14.1	24.5	13.0	15.8	23.8	20.8	17.0	17.3	16.4	13.2	16.1	15.0	7.8	11.5	15.0	14.4	14.1
SMURF2		ENSG00000108854	"SMAD specific E3 ubiquitin protein ligase 2"	Q9HAU4	17	64542295-64662068	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 54.0;HBF TERT88: 41.5;LHCN-M2: 41.5;TIME: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071508	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA071508: "	"unprognostic (1.21e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	12.3	9.2	10.5	9.0	15.0	11.5	10.2	16.7	10.0	9.2	9.1	11.5	8.1	9.3	7.9	6.9	7.6	7.8	10.5	8.2	12.6	4.6	9.4	5.7	19.0	8.6	9.5	4.8	8.5	9.0	8.2	10.7	15.3	10.1	10.6	8.2	9.6	9.9	7.6	7.5	11.0	13.7	8.9	6.6	9.9	9.8	21.6	10.6	8.9	11.4	4.1	9.6	9.4	11.7	3.0	3.0	4.8	2.2	7.3	3.5	1.7	15.6	4.3	3.7	2.8	2.6	10.0	1.8	54.0	24.6	21.1	18.4	2.4	12.0	2.1	3.4	9.2	3.5	3.5	9.3	41.5	1.1	2.3	2.2	2.6	2.9	2.3	2.9	1.4	2.7	3.6	29.3	11.2	24.3	3.2	2.1	41.5	3.4	6.7	1.3	2.2	5.7	1.5	9.0	1.3	5.8	2.8	3.5	3.1	3.3	1.7	2.5	2.8	2.3	47.8	24.0	13.0	9.2	35.8	2.4	2.8	3.8	5.9	1.7	7.2	2.8	2.2	4.8	3.3	2.0	2.8	2.0	2.4	3.5	3.0	3.0	2.3	2.6	4.4	7.3	1.0	2.6	1.1	1.7	10.5	15.0	16.7	10.0	12.6	4.6	9.5	4.8	10.1	10.6
SNAI1	"SLUGH2, SNA, SNAH, SNAIL, SNAIL1"	ENSG00000124216	"Snail family transcriptional repressor 1"	O95863	20	49982999-49988886	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 17.6;TIME: 24.5;WM-115: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB005883, HPA056831, HPA069985, CAB078687"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB005883: AB_443967, CAB078687: , HPA056831: , HPA069985: "	"unprognostic (4.60e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (4.76e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.61e-5)"	"unprognostic (3.34e-3)"	"unprognostic (9.85e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (2.63e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (8.82e-7)"	"unprognostic (1.88e-2)"	18.3	8.0	1.8	5.9	3.8	5.5	11.1	2.9	2.7	5.9	3.4	5.8	2.6	1.6	5.4	4.2	4.0	8.2	22.2	11.8	3.1	1.2	5.2	7.2	14.3	5.9	3.1	1.3	6.8	7.0	3.6	4.9	15.9	2.9	6.1	1.3	11.0	3.4	3.8	3.6	3.2	2.3	4.3	6.3	8.1	4.5	4.5	3.6	0.7	18.7	4.1	2.0	10.8	13.9	0.0	4.1	0.0	0.6	0.0	0.0	0.1	0.7	0.6	3.4	0.5	1.1	0.6	6.9	2.9	3.7	0.6	0.4	5.5	0.8	0.4	8.1	5.2	0.1	1.0	0.0	0.3	0.0	0.7	0.4	1.2	3.3	8.9	0.9	2.8	2.0	0.2	1.3	0.0	8.8	4.2	0.1	0.0	1.2	0.1	1.0	4.6	2.4	1.5	0.9	0.4	4.1	0.0	1.5	3.5	17.6	4.5	0.7	0.9	4.0	24.5	0.0	4.4	0.0	0.0	0.1	0.1	4.5	1.4	1.3	15.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	1.8	3.8	2.9	2.7	3.1	1.2	3.1	1.3	2.9	3.6
SNAP23	"HsT17016, SNAP23A, SNAP23B"	ENSG00000092531	"Synaptosome associated protein 23"	O00161	15	42491233-42545356	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 102.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001214, CAB037083, CAB037317"	Approved		Supported	"Plasma membrane"			12000000	"Plasma membrane"		"CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.76e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	29.9	24.0	15.2	28.4	20.5	14.3	28.6	11.1	17.5	20.8	30.8	21.6	27.7	23.0	38.9	18.6	20.3	21.3	18.7	24.6	16.6	11.7	22.8	23.0	28.0	35.4	27.3	10.5	24.6	19.8	10.4	17.7	81.6	18.9	24.1	24.5	16.3	37.0	25.8	32.8	15.3	40.8	22.8	23.4	41.6	22.1	25.1	21.3	20.1	20.3	18.1	35.1	25.5	53.7	17.2	22.9	102.0	36.3	10.3	11.5	23.0	17.1	7.7	14.7	14.3	24.1	19.1	22.6	21.7	16.4	12.8	15.6	25.2	6.8	8.4	28.6	13.3	14.7	16.3	12.7	18.3	14.1	9.4	39.8	8.4	23.6	17.5	15.9	38.3	15.2	10.0	11.5	19.6	49.1	29.8	8.7	17.4	5.9	19.0	16.5	12.4	6.0	35.0	8.7	13.7	18.0	15.5	2.3	9.4	15.6	14.3	13.7	20.5	23.0	38.6	13.0	17.7	15.6	21.3	18.7	33.1	44.6	15.7	32.5	16.7	30.2	24.7	102.0	8.4	36.3	9.8	17.2	8.9	8.2	22.9	15.4	11.5	8.8	56.2	10.3	34.4	9.5	9.8	23.0	15.2	20.5	11.1	17.5	16.6	11.7	27.3	10.5	18.9	21.3
SNAP29	"CEDNIK, SNAP-29"	ENSG00000099940	"Synaptosome associated protein 29"	O95721	22	20858983-20891218	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		"Ichthyosis, Neuropathy, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031823, CAB037092, HPA056492"	Supported		Supported	Nucleoplasm,Cytosol			34000	Cytosol	Nucleoplasm	"CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: "	"unprognostic (1.76e-1)"	"prognostic favourable (6.99e-4)"	"unprognostic (3.72e-3)"	"unprognostic (3.26e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.51e-3)"	"unprognostic (6.08e-2)"	19.4	18.8	15.9	15.5	15.3	15.7	15.5	13.4	19.7	16.0	18.8	15.3	17.1	16.5	15.2	11.6	21.7	12.3	19.9	23.1	13.8	13.0	17.7	36.1	13.4	20.1	15.1	12.3	15.7	16.6	13.1	11.5	26.4	13.7	13.6	17.7	19.0	17.7	17.1	27.6	17.6	16.8	17.6	15.9	24.1	17.4	47.0	14.9	18.3	15.1	15.9	18.2	15.3	16.3	10.8	20.0	23.0	33.2	26.1	14.9	14.0	15.5	6.4	9.1	7.5	10.3	15.1	11.8	14.8	13.4	16.7	16.9	8.8	5.5	9.7	9.5	13.9	9.2	11.9	10.0	18.1	14.0	9.1	16.2	7.2	9.4	14.8	14.3	13.2	11.9	14.2	17.5	12.7	11.7	70.2	14.0	15.4	10.7	13.0	13.8	3.0	6.7	12.5	20.4	3.9	9.8	8.4	7.4	8.9	15.9	10.0	16.7	15.7	11.5	10.1	17.1	15.6	11.7	11.5	14.3	23.2	17.9	12.8	9.7	12.2	19.5	20.0	23.0	10.6	27.4	11.0	10.8	10.5	11.4	17.4	9.2	9.7	9.8	22.6	26.1	33.2	20.0	14.9	14.0	15.9	15.3	13.4	19.7	13.8	13.0	15.1	12.3	13.7	14.9
SNAPC1	"PTFgamma, SNAP43"	ENSG00000023608	"Small nuclear RNA activating complex polypeptide 1"	Q16533	14	61762357-61796428	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 42.5;U-2 OS: 56.4;U-251 MG: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA067076, HPA072276"			Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA067076: , HPA072276: "	"unprognostic (7.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.26e-1)"	9.9	12.3	7.5	8.6	10.3	7.0	8.4	12.1	8.0	14.4	6.8	5.6	11.6	4.9	10.3	15.8	9.2	8.7	10.4	11.2	7.8	7.6	8.7	7.0	10.5	9.7	11.8	5.4	12.1	5.0	8.8	27.2	11.3	14.2	10.3	4.2	5.7	7.2	19.8	5.6	8.7	5.2	6.9	14.5	9.5	5.4	24.9	9.4	9.1	9.8	8.2	8.9	17.4	14.3	12.0	9.3	7.5	7.0	9.6	13.1	5.1	14.9	2.9	2.9	6.1	3.2	3.8	3.4	12.7	8.4	14.6	8.7	1.0	3.1	3.1	16.9	5.4	4.7	2.8	3.8	24.1	3.4	2.0	1.8	1.5	2.1	8.6	1.9	4.1	3.6	2.6	12.3	42.5	5.5	2.0	2.9	13.9	1.9	4.7	3.1	2.8	9.7	3.6	7.7	1.1	11.9	2.3	2.1	5.0	8.3	1.5	10.0	3.0	3.1	8.5	16.1	56.4	10.4	38.8	1.9	2.0	2.7	10.9	2.5	9.5	7.5	7.0	5.8	6.4	5.9	8.3	12.0	8.1	5.5	7.0	12.0	13.1	8.5	7.1	9.6	4.9	9.3	8.7	5.1	7.5	10.3	12.1	8.0	7.8	7.6	11.8	5.4	14.2	9.4
SNAPC2	"PTFdelta, SNAP45"	ENSG00000104976	"Small nuclear RNA activating complex polypeptide 2"	Q13487	19	7920316-7923250	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049843, HPA077597"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049843: , HPA077597: "	"unprognostic (4.56e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (4.89e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.78e-2)"	12.5	15.1	11.0	14.2	17.1	20.3	12.0	19.3	19.8	30.8	20.0	13.2	11.9	14.2	32.4	11.8	20.3	21.8	12.1	12.1	11.7	11.6	15.6	11.1	12.3	12.4	10.6	13.6	24.2	15.1	12.0	16.5	13.6	12.2	24.8	6.0	10.8	18.0	27.0	8.1	16.4	11.3	22.8	9.1	14.8	11.9	28.7	12.3	18.3	17.5	10.4	11.4	29.9	16.1	11.5	20.1	14.7	20.9	17.7	15.5	10.4	9.0	10.5	5.0	19.4	7.0	14.9	4.6	9.6	10.4	9.6	8.7	4.8	7.9	7.8	12.0	11.3	11.2	3.5	7.2	2.8	10.0	8.9	10.9	4.6	6.8	12.7	6.8	18.1	12.1	11.2	11.3	7.0	10.8	10.7	13.2	5.8	8.1	8.7	19.3	6.4	23.6	10.3	4.9	7.7	8.8	3.2	5.9	13.2	5.0	5.4	21.6	8.8	7.4	14.0	32.5	11.5	30.2	12.0	12.6	20.6	4.7	20.3	14.1	10.2	4.5	16.4	14.7	13.7	20.9	13.7	11.5	11.7	11.8	20.1	11.0	12.2	12.2	2.4	17.7	20.7	13.3	15.5	10.4	11.0	17.1	19.3	19.8	11.7	11.6	10.6	13.6	12.2	12.3
SNAPC3	"MGC132011, MGC33124, PTFbeta, SNAP50"	ENSG00000164975	"Small nuclear RNA activating complex polypeptide 3"	Q92966	9	15422704-15465953	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053145, HPA066031"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA053145: , HPA066031: "	"unprognostic (2.62e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.93e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.09e-2)"	9.8	18.5	18.7	10.3	21.1	4.6	10.4	26.3	21.2	17.9	13.2	10.4	10.3	11.6	16.5	15.5	12.6	10.8	10.8	17.5	18.0	14.0	12.3	8.6	10.0	11.2	15.2	16.3	17.4	11.1	12.8	18.4	16.7	21.8	13.3	14.6	9.6	10.5	11.3	19.3	13.7	14.2	12.8	15.2	12.8	10.5	14.7	15.9	11.9	11.3	6.8	10.8	12.9	15.1	12.2	7.7	5.0	21.2	5.0	8.2	5.5	4.1	5.3	11.2	4.2	9.0	9.4	6.5	6.5	2.8	3.8	4.5	2.5	1.8	2.9	2.5	4.0	2.5	5.9	3.0	4.7	13.5	6.9	10.4	11.1	3.4	4.5	2.3	8.1	6.1	6.1	2.7	3.1	7.0	2.9	4.8	8.7	1.3	2.8	7.4	3.6	13.9	5.7	1.3	1.6	6.6	2.5	11.9	8.5	2.2	2.0	1.5	4.8	4.8	5.8	6.4	2.5	2.7	8.1	6.3	7.5	3.6	4.1	3.1	2.9	3.4	10.1	5.0	5.7	16.7	5.5	9.9	5.7	5.1	7.7	12.2	8.2	7.9	1.2	5.0	21.2	6.3	7.9	5.5	18.7	21.1	26.3	21.2	18.0	14.0	15.2	16.3	21.8	15.9
SNAPC5	SNAP19	ENSG00000174446	"Small nuclear RNA activating complex polypeptide 5"	O75971	15	66490135-66497813	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024379	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA024379: "	"unprognostic (4.43e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.56e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.69e-2)"	16.6	20.7	30.9	17.0	29.8	7.5	16.7	29.1	30.5	13.9	18.7	15.2	15.5	12.6	17.2	33.0	13.4	17.6	13.5	32.2	21.8	26.6	22.2	27.4	15.3	16.3	22.8	25.0	16.8	14.1	28.8	21.6	12.6	20.0	18.7	15.6	15.8	16.0	24.5	34.1	9.4	14.5	19.1	15.6	16.1	14.3	25.2	17.2	14.0	22.1	17.3	17.4	15.7	12.4	26.4	25.2	23.9	28.9	26.9	35.5	19.8	7.0	26.3	9.8	12.0	14.0	13.0	10.6	8.1	11.9	11.1	8.4	15.3	17.2	8.5	24.0	10.3	15.1	27.4	11.8	11.9	14.5	16.3	11.6	26.0	20.0	16.3	29.1	12.7	11.0	14.4	9.2	23.5	9.3	37.2	16.1	7.9	16.7	12.4	10.4	10.6	11.7	13.5	10.3	31.1	14.4	9.9	12.3	9.2	9.2	18.0	35.9	17.3	21.3	6.5	9.3	19.0	10.2	15.6	13.4	20.3	14.4	9.7	36.3	19.8	23.9	16.1	23.6	22.5	26.7	30.2	26.4	27.2	30.0	14.3	19.9	35.5	31.5	8.3	26.9	28.9	25.2	30.0	19.8	30.9	29.8	29.1	30.5	21.8	26.6	22.8	25.0	20.0	17.2
SNCAIP	SYPH1	ENSG00000064692	"Synuclein alpha interacting protein"	Q9Y6H5	5	122311354-122464219	"Disease related genes, Predicted intracellular proteins"			"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 22.6;ovary: 32.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;BJ hTERT+: 7.4;HBF TERT88: 4.8;RPMI-8226: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 9.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064687	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Cytoplasmic bodies"	Nucleoplasm	"HPA064687: "	"unprognostic (7.28e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-1)"	3.9	1.2	2.2	2.1	5.8	0.7	4.1	15.4	6.4	16.0	1.6	3.7	4.0	1.6	22.6	4.3	0.9	4.5	2.4	1.5	3.4	2.2	1.6	0.4	1.4	4.5	1.6	2.4	32.3	0.7	0.3	1.6	2.1	3.2	2.6	1.1	2.3	0.8	2.7	0.7	1.9	1.1	10.6	1.5	6.1	1.2	11.6	2.1	0.5	1.2	3.3	1.4	4.6	4.1	0.4	0.4	9.9	0.3	0.1	0.4	0.0	0.0	0.1	7.7	0.2	0.0	0.5	0.5	3.5	7.4	1.3	0.4	0.5	0.6	0.1	0.3	3.4	0.2	3.0	0.5	4.8	2.8	1.0	0.0	0.6	0.4	0.1	0.0	0.4	0.6	0.1	0.6	0.4	2.3	0.0	2.0	0.0	0.0	0.2	0.1	3.7	0.6	0.2	0.0	7.9	0.3	1.0	1.5	0.3	0.0	0.7	0.0	0.6	0.2	0.8	0.4	1.0	0.5	0.8	0.2	0.2	0.3	0.4	0.0	0.5	9.9	0.3	0.0	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.4	0.2	0.4	1.7	0.1	0.1	0.4	0.1	0.0	2.2	5.8	15.4	4.3	3.4	2.2	1.6	2.4	3.2	2.1
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958618-86963260	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 93.7;RT4: 77.2"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 292.8"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581"	Enhanced	Supported	Supported	"Nuclear bodies,Centrosome"				Centrosome	"Nuclear bodies"	"CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (2.29e-8)"	"prognostic unfavourable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	74.1	78.3	82.3	5.3	20.8	1.0	28.9	12.3	44.5	9.5	5.8	4.6	6.4	4.8	6.1	12.0	11.0	26.5	6.2	9.0	40.0	92.9	4.1	1.9	4.6	4.9	72.9	35.1	15.0	3.5	1.6	1.7	4.9	100.1	11.9	2.7	10.8	10.9	44.4	6.6	8.5	5.4	5.8	35.2	20.2	2.6	2.9	5.3	0.2	3.4	3.3	9.6	76.6	18.3	0.0	0.7	0.0	2.4	0.0	1.8	0.6	0.2	1.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	93.7	0.0	1.9	0.1	7.8	0.0	0.3	0.0	0.0	0.0	0.5	18.2	0.3	0.1	0.0	0.1	0.4	7.3	0.0	0.0	6.6	0.6	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	77.2	0.0	0.0	0.6	1.0	0.1	20.3	0.0	17.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.6	82.3	20.8	12.3	44.5	40.0	92.9	72.9	35.1	100.1	5.3
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652180-128092609	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol			1200000	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favourable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	21.5	29.8	25.3	25.3	19.8	22.5	45.4	28.1	28.1	33.3	20.0	13.0	57.7	21.3	36.1	38.4	24.8	26.7	25.3	28.3	20.9	16.6	17.3	39.6	38.8	64.2	20.2	19.0	39.7	130.3	22.2	30.3	33.7	27.6	24.5	20.2	13.9	37.5	66.7	20.5	21.5	19.2	41.0	40.1	24.9	30.8	37.0	18.0	22.3	26.6	13.5	24.9	26.5	24.2	28.1	34.9	16.1	30.0	21.0	30.9	28.5	27.9	25.4	19.5	35.3	29.5	30.9	26.7	33.0	39.0	30.2	34.0	32.8	24.3	37.2	16.7	40.4	23.5	27.4	35.8	29.6	20.3	23.2	20.5	30.4	31.4	53.8	31.7	20.2	45.5	39.9	25.8	43.3	37.5	22.7	37.4	30.1	20.9	34.5	23.8	21.8	31.7	24.1	17.4	83.2	23.7	19.8	24.5	26.5	23.9	111.1	38.2	13.9	22.6	37.2	24.6	16.1	44.6	25.6	46.1	17.3	39.1	49.4	27.4	44.5	16.1	30.0	5.9	26.1	28.1	30.9	28.1	19.8	21.0	32.3	16.2	14.3	15.8	2.2	21.0	22.8	34.9	15.8	28.5	25.3	19.8	28.1	28.1	20.9	16.6	20.2	19.0	27.6	18.0
SNF8	"Dot3, EAP30, VPS22"	ENSG00000159210	"SNF8, ESCRT-II complex subunit"	Q96H20	17	48929316-48945117	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059320	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA059320: "	"unprognostic (7.85e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (7.64e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (2.81e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.38e-1)"	22.5	27.8	24.9	20.6	26.2	25.2	32.4	12.9	22.6	17.9	23.5	16.6	29.7	22.1	18.9	28.7	23.0	17.7	24.9	31.5	20.1	19.2	30.8	39.0	18.2	27.3	23.9	21.5	22.3	26.7	17.9	17.4	21.7	19.0	17.6	26.8	18.3	25.2	23.1	40.7	19.2	24.0	25.7	18.2	20.7	24.7	19.8	16.0	28.3	24.0	30.9	26.2	20.5	33.8	5.2	8.3	11.2	6.7	1.7	5.7	1.5	16.1	32.4	20.2	25.8	21.1	12.3	32.0	13.6	18.9	26.7	24.1	79.6	16.9	14.9	24.0	25.7	10.8	18.8	19.2	29.9	21.2	30.4	16.4	41.1	33.5	18.5	22.2	18.7	15.2	19.3	25.5	19.7	25.0	16.2	15.1	27.2	32.3	23.8	19.0	9.9	27.7	15.7	36.9	17.5	16.0	18.1	13.4	26.8	16.4	7.7	19.4	19.5	27.5	20.8	29.0	23.1	18.0	25.5	22.2	25.3	17.7	25.5	12.1	22.4	2.3	5.7	11.2	3.2	6.2	1.8	5.2	4.8	3.7	6.4	5.2	3.2	2.7	2.3	1.7	6.7	8.3	5.7	1.5	24.9	26.2	12.9	22.6	20.1	19.2	23.9	21.5	19.0	16.0
SNIP1	PML1	ENSG00000163877	"Smad nuclear interacting protein 1"	Q8TAD8	1	37534449-37554344	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, RNA-mediated gene silencing"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036896	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036896: AB_10670244"	"unprognostic (1.37e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.24e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.34e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	10.6	13.4	10.6	13.3	12.4	15.9	15.0	18.4	14.4	12.8	10.8	10.0	14.2	8.5	14.2	11.9	13.5	11.9	10.0	8.5	11.1	9.0	9.9	20.6	10.2	11.7	10.8	10.5	12.7	15.3	9.8	13.1	13.2	9.9	13.3	9.0	12.3	11.7	11.5	13.5	13.2	12.3	11.6	7.9	14.9	11.8	21.7	11.6	16.9	10.5	11.1	14.0	11.7	17.0	3.7	4.3	4.6	3.5	3.1	5.5	1.8	6.1	3.5	6.9	6.8	8.3	7.9	4.7	7.9	9.0	7.6	6.7	3.4	5.6	8.5	6.2	8.4	6.5	6.4	7.2	6.3	7.6	9.3	13.1	6.1	6.9	9.5	12.0	7.4	7.6	8.5	7.5	9.6	7.3	9.2	7.9	5.3	4.6	7.1	9.4	11.2	8.1	7.5	11.6	7.1	5.5	5.9	5.6	11.2	8.4	5.5	10.3	4.9	6.6	12.1	6.0	6.7	7.5	7.8	9.4	10.9	7.0	7.1	8.6	5.4	4.1	3.1	3.9	5.5	2.8	5.4	3.7	3.7	5.3	2.6	3.6	5.1	4.5	4.6	3.1	3.5	4.3	4.2	1.8	10.6	12.4	18.4	14.4	11.1	9.0	10.8	10.5	9.9	11.6
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274336-96305515	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm			6600	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.6	25.2	18.4	28.4	21.9	32.0	26.1	37.2	25.8	24.4	23.6	23.7	20.6	18.4	34.7	22.6	23.4	26.5	22.0	22.0	19.7	12.3	19.0	25.8	22.7	25.1	16.6	18.9	39.3	22.7	49.4	25.2	33.7	18.9	21.3	22.0	25.5	28.3	23.0	39.7	25.3	27.6	28.3	15.8	25.2	23.4	34.3	19.5	57.3	25.3	21.3	31.2	33.7	24.0	8.5	7.7	15.3	7.5	9.1	12.6	6.0	23.1	26.3	35.3	26.5	16.5	14.6	33.2	16.0	19.6	29.3	28.1	47.8	17.0	40.3	25.4	20.4	18.4	64.8	21.8	30.4	21.8	34.2	51.6	41.9	25.9	10.7	39.5	22.7	15.1	13.6	33.3	28.4	23.8	45.1	27.2	16.9	20.2	37.0	11.8	46.0	25.5	43.7	34.3	25.3	11.4	34.2	39.2	37.4	26.0	22.3	16.6	21.2	24.7	20.6	24.5	29.7	24.8	23.0	25.3	29.8	50.3	16.5	26.4	26.1	15.3	5.6	7.5	10.1	7.0	12.2	7.8	7.8	12.6	7.3	8.5	7.6	9.3	6.2	9.1	7.5	7.7	8.5	6.0	18.4	21.9	37.2	25.8	19.7	12.3	16.6	18.9	18.9	19.5
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53010-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.9;skeletal muscle: 63.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: , HPA044248: "	"unprognostic (7.87e-2)"	"prognostic favourable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	7.1	10.1	31.4	11.5	25.4	15.6	7.4	15.7	31.2	7.1	9.7	6.8	5.4	7.2	6.6	9.6	8.8	8.8	6.3	28.7	25.0	22.6	11.7	16.4	5.4	16.4	28.1	20.3	10.9	10.8	7.7	10.8	4.9	24.7	9.8	10.1	7.5	12.6	8.4	63.7	4.3	6.4	8.6	13.5	6.6	10.2	6.4	7.7	9.4	9.4	11.0	16.4	6.8	4.8	18.0	56.9	23.2	9.9	5.2	6.5	5.7	11.4	26.1	14.5	16.8	5.2	6.1	7.1	9.7	6.3	21.8	18.5	35.0	11.2	36.4	11.6	7.9	11.8	26.5	17.9	16.8	13.1	20.6	21.1	36.4	35.0	5.5	38.4	25.0	7.8	6.4	19.4	5.4	11.7	31.4	8.7	12.4	54.3	20.1	16.0	17.3	12.7	32.6	15.5	43.4	11.5	8.1	15.9	10.3	22.0	28.5	4.7	18.4	18.7	9.2	9.7	12.1	12.4	15.5	9.0	21.4	56.4	5.1	20.6	14.7	2.8	6.6	23.2	4.0	9.9	5.0	17.5	4.2	4.9	12.8	18.0	4.5	4.5	4.5	5.2	8.5	56.9	6.5	5.7	31.4	25.4	15.7	31.2	25.0	22.6	28.1	20.3	24.7	7.7
SNRNP40	"HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57"	ENSG00000060688	"Small nuclear ribonucleoprotein U5 subunit 40"	Q96DI7	1	31259568-31296782	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026527, HPA027345"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA026527: AB_1858814, HPA027345: AB_2239703"	"unprognostic (2.31e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.28e-2)"	"prognostic unfavourable (4.73e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.24e-2)"	20.2	23.1	13.2	19.6	20.2	25.2	21.2	24.1	21.8	20.9	20.1	30.0	20.9	16.2	25.6	23.0	23.4	23.0	15.4	17.8	14.3	15.4	18.8	19.1	17.4	31.6	31.5	14.0	26.7	15.8	15.0	20.2	21.9	23.5	20.8	22.8	20.2	17.9	22.4	22.6	20.8	19.9	22.0	22.3	27.3	18.7	31.3	21.3	44.0	24.4	17.0	38.2	20.0	19.4	33.7	32.8	27.5	33.8	36.7	44.3	47.8	20.6	15.6	29.2	24.0	14.7	12.1	20.0	17.4	17.3	31.9	31.7	22.4	21.1	27.0	17.2	13.7	19.9	44.0	20.8	33.1	28.7	32.4	39.8	22.5	24.4	18.1	43.6	18.2	11.3	16.7	31.1	23.5	25.8	37.0	16.1	18.4	14.8	32.1	25.7	52.3	22.6	25.6	41.2	20.8	13.6	17.1	20.0	19.5	27.7	14.5	32.8	14.4	28.0	17.8	18.0	26.3	24.8	33.0	13.1	16.1	37.3	14.6	41.0	29.2	26.0	26.7	27.5	37.2	33.8	42.6	33.7	36.4	36.6	32.8	30.9	39.2	44.3	5.9	36.7	30.3	27.9	37.4	47.8	13.2	20.2	24.1	21.8	14.3	15.4	31.5	14.0	23.5	21.3
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590199-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029234	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavourable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	9.5	7.1	12.3	11.7	14.9	15.6	12.6	28.9	13.3	10.5	10.3	7.0	13.6	9.9	11.7	8.6	9.4	9.2	7.1	12.2	11.9	7.5	10.7	12.7	8.6	11.7	14.1	8.1	14.4	10.5	7.3	11.0	9.2	11.4	10.5	10.1	5.9	10.1	13.0	15.8	11.0	11.5	10.5	17.8	11.2	9.6	5.3	14.3	15.3	10.4	7.1	10.0	9.9	30.2	3.3	2.7	6.0	2.0	2.7	3.7	1.7	5.7	4.6	9.6	17.9	5.2	7.7	6.5	6.6	6.1	7.1	7.9	9.7	4.7	13.5	7.1	5.4	7.4	11.9	7.0	11.0	10.4	11.6	9.7	14.6	18.7	5.5	11.6	6.5	5.4	10.9	8.0	6.2	6.1	13.6	2.1	9.9	3.2	18.9	16.8	13.0	5.2	20.4	8.3	18.1	6.5	5.1	14.9	4.1	12.7	3.3	11.2	6.4	4.1	6.8	9.5	4.3	5.6	11.2	3.5	19.3	8.3	3.2	9.3	17.0	0.4	2.0	1.0	2.0	1.4	3.4	1.7	2.4	2.6	2.4	3.3	2.1	3.7	6.0	2.7	0.8	2.7	1.7	1.7	12.3	14.9	28.9	13.3	11.9	7.5	14.1	8.1	11.4	14.3
SNRNP70	"RNPU1Z, RPU1, Snp1, SNRP70, U1-70K"	ENSG00000104852	"Small nuclear ribonucleoprotein U1 subunit 70"	P08621	19	49085419-49108605	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001718, HPA042050, HPA043516"	Supported		Enhanced	Nucleoplasm			30000	Nucleoplasm		"CAB001718: , HPA042050: , HPA043516: "	"unprognostic (2.22e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (4.59e-5)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (6.12e-5)"	"unprognostic (5.18e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"prognostic favourable (5.35e-5)"	46.9	46.5	50.1	65.8	57.0	51.9	29.8	89.6	73.1	36.7	36.2	40.5	46.5	45.8	44.0	38.8	38.9	34.0	35.4	33.3	46.5	34.6	30.6	35.0	29.3	47.6	53.8	49.0	43.3	36.1	37.8	41.8	34.3	43.4	43.0	27.3	26.6	42.7	52.7	73.5	48.1	44.6	28.5	41.5	45.6	45.2	30.5	58.1	34.9	39.8	25.6	37.3	26.9	35.0	5.3	3.2	3.2	3.7	7.9	3.9	1.2	33.9	39.4	27.7	19.8	11.3	7.0	33.9	26.4	16.3	27.6	23.8	23.9	20.1	41.7	25.5	17.0	30.4	34.3	24.9	20.4	27.3	91.4	38.0	19.8	27.2	5.9	41.1	25.6	9.7	6.9	19.7	13.3	20.5	38.9	12.8	16.4	29.4	42.3	65.6	35.0	34.1	49.3	27.5	24.4	16.9	21.3	23.8	28.3	33.1	18.7	17.5	19.6	24.7	30.6	20.2	38.1	17.7	42.2	34.4	29.0	50.7	17.2	26.8	19.0	1.5	3.7	3.2	3.6	2.5	2.1	5.3	2.3	1.5	3.2	3.5	3.9	2.3	1.7	7.9	1.9	2.8	2.4	1.2	50.1	57.0	89.6	73.1	46.5	34.6	53.8	49.0	43.4	58.1
SNRPA	"Mud1, U1-A, U1A"	ENSG00000077312	"Small nuclear ribonucleoprotein polypeptide A"	P09012	19	40750637-40765389	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB004652, HPA046440, HPA054834"	Supported		Supported	Nucleoplasm			23000	Nucleoplasm		"CAB004652: AB_425687, HPA046440: , HPA054834: "	"unprognostic (3.53e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.03e-1)"	"unprognostic (8.04e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (2.96e-9)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.01e-3)"	27.6	25.0	28.1	35.8	30.8	44.0	39.2	28.8	32.6	31.9	31.8	16.7	33.8	31.2	35.2	35.5	32.8	31.3	27.0	23.6	23.4	19.2	26.9	26.6	28.2	56.3	26.9	19.7	44.7	34.8	16.1	30.6	23.4	25.1	32.3	29.0	19.5	29.7	37.4	43.1	26.6	36.2	41.8	36.4	40.4	27.2	30.9	29.8	49.8	35.1	34.0	37.9	33.2	47.4	14.8	29.9	3.8	17.2	14.2	18.2	11.9	34.5	30.7	35.1	28.2	9.4	11.7	30.0	12.0	16.7	32.2	35.0	25.2	28.7	42.3	17.9	15.9	26.3	34.7	31.1	29.6	23.2	37.8	30.9	25.3	31.6	14.5	35.2	20.4	11.1	7.5	20.6	34.6	28.2	34.4	23.3	21.4	28.4	66.3	56.0	37.6	26.0	58.0	24.4	33.3	21.5	18.5	27.5	28.0	23.4	25.2	19.5	25.1	32.5	15.4	17.1	30.7	18.0	30.0	25.9	28.7	62.3	17.4	39.0	21.8	1.6	15.1	3.8	16.1	17.2	16.8	14.8	16.5	18.2	29.9	13.9	16.9	15.9	1.4	14.2	8.1	18.3	16.2	11.9	28.1	30.8	28.8	32.6	23.4	19.2	26.9	19.7	25.1	29.8
SNRPA1	Lea1	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"				Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: , HPA048499: "	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favourable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	11.9	13.3	12.4	26.1	19.6	35.2	17.7	9.7	17.2	9.9	18.0	10.2	10.4	14.6	14.3	21.1	24.6	12.4	11.8	17.3	17.9	9.8	16.1	19.7	14.1	29.2	11.2	12.2	10.8	16.3	9.1	10.7	29.3	14.1	10.3	19.3	11.3	17.2	9.1	13.4	12.1	22.5	11.7	9.4	26.4	15.9	24.3	7.0	33.4	11.6	18.1	30.0	12.3	12.2	21.7	23.5	8.4	18.2	18.3	26.9	15.3	31.2	21.9	21.1	10.7	6.0	4.9	20.8	29.1	13.5	26.2	20.0	46.7	28.0	34.8	16.7	19.7	18.7	31.5	20.8	28.1	17.6	48.7	27.3	35.6	24.6	4.6	31.2	19.6	4.0	15.6	16.7	21.1	16.8	37.9	32.8	16.0	34.6	31.4	33.2	27.0	18.6	31.4	22.8	35.0	19.1	82.2	16.5	17.3	17.7	20.3	21.9	19.6	24.7	12.1	14.0	26.6	16.3	29.0	27.1	80.2	67.6	11.3	29.5	16.5	1.4	15.0	8.4	24.6	18.2	24.1	21.7	25.4	24.2	23.5	19.1	21.2	26.3	2.9	18.3	16.6	22.3	26.9	15.3	12.4	19.6	9.7	17.2	17.9	9.8	11.2	12.2	14.1	7.0
SNRPB	"COD, Sm-B/B', SmB/SmB', snRNP-B, SNRPB1"	ENSG00000125835	"Small nuclear ribonucleoprotein polypeptides B and B1"	P14678	20	2461634-2470853	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003482, CAB009610, HPA067842"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB009610: AB_2193859, HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (1.07e-5)"	"unprognostic (5.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (9.47e-2)"	26.6	28.5	14.8	41.1	16.4	78.9	29.0	20.8	17.7	26.3	33.6	10.6	26.8	27.1	34.4	30.2	46.7	26.8	29.6	29.2	10.9	9.9	26.2	36.4	29.3	39.5	18.3	16.5	29.5	34.4	14.7	20.7	35.7	16.6	23.9	23.4	16.0	29.6	21.2	43.8	37.9	27.9	23.4	12.3	39.5	26.9	30.3	15.6	60.1	29.3	51.0	39.6	24.7	28.1	57.9	65.0	36.8	56.9	41.7	63.8	63.7	79.2	108.7	39.2	36.0	8.8	15.8	44.5	35.0	26.7	72.2	58.8	125.9	57.7	59.7	22.4	20.4	58.7	37.8	64.5	36.6	24.5	67.4	40.9	21.9	117.1	31.0	56.6	25.2	18.1	25.0	58.9	26.0	40.1	56.3	43.3	29.4	54.8	88.9	90.7	86.9	52.8	54.1	40.3	72.1	27.0	42.1	42.5	46.6	42.8	58.2	49.9	54.1	62.5	27.7	43.1	36.3	37.8	78.1	36.2	90.8	89.3	14.5	62.9	43.6	36.8	47.1	35.3	59.4	56.9	49.9	57.6	53.0	52.4	62.4	57.9	43.5	50.5	24.4	41.7	56.4	65.0	63.8	63.7	14.8	16.4	20.8	17.7	10.9	9.9	18.3	16.5	16.6	15.6
SNRPB2	"Msl1, U2B''"	ENSG00000125870	"Small nuclear ribonucleoprotein polypeptide B2"	P08579	20	16729961-16742563	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050814, HPA076104"	Supported		Enhanced	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA050814: , HPA076104: "	"unprognostic (4.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (8.45e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavourable (6.03e-7)"	"unprognostic (4.23e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.06e-1)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.77e-1)"	27.1	29.4	30.8	29.9	31.5	46.6	32.4	23.2	33.3	25.1	28.6	18.3	19.5	24.7	33.5	37.9	25.4	28.2	22.8	30.9	31.0	29.7	45.4	30.2	24.7	39.9	28.7	33.0	33.4	21.5	19.7	41.9	35.2	25.5	25.9	28.1	16.9	23.0	25.5	34.7	18.4	30.1	31.8	30.8	36.0	27.0	24.3	28.3	40.8	33.1	31.1	35.7	34.1	22.7	21.2	29.8	29.0	24.5	19.8	30.6	18.1	17.8	17.6	23.2	14.4	11.6	14.7	25.9	17.7	14.8	19.3	19.0	20.2	20.3	28.7	13.9	15.1	16.8	18.2	20.6	27.7	9.4	15.3	26.5	5.8	37.1	13.6	30.9	18.3	14.5	13.8	17.6	13.8	18.1	21.8	13.1	19.6	18.6	35.4	37.5	20.6	23.7	20.3	27.9	20.1	18.7	12.2	12.3	35.3	13.1	36.2	87.1	22.9	25.3	15.3	17.7	17.6	15.8	29.1	11.6	23.7	32.1	8.4	18.4	38.2	26.5	19.5	29.0	19.3	24.3	24.8	21.2	24.5	21.8	20.5	19.6	21.5	23.5	8.4	19.8	24.5	29.8	30.6	18.1	30.8	31.5	23.2	33.3	31.0	29.7	28.7	33.0	25.5	28.3
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757406-34773794	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB034338: AB_2295245, HPA042419: , HPA055490: "	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	20.9	24.6	28.3	25.5	29.5	56.2	23.5	19.0	26.7	20.3	28.2	19.0	26.9	26.6	28.5	33.7	28.1	32.1	31.6	56.8	24.4	22.4	26.7	34.9	25.3	36.3	27.4	28.3	26.3	62.5	18.5	19.5	27.1	23.8	22.9	24.3	19.7	30.6	26.5	54.9	20.7	27.3	25.0	29.3	28.6	25.5	66.6	26.3	39.8	36.9	47.2	33.7	24.1	21.0	58.6	53.4	32.6	56.7	38.4	58.3	55.5	47.2	29.2	38.5	50.2	20.9	20.4	29.7	27.1	29.8	54.3	46.0	50.4	18.7	53.1	36.3	33.7	22.8	58.0	40.5	44.3	35.4	61.1	41.0	24.9	69.3	36.3	52.1	26.1	25.2	39.6	55.1	39.3	34.4	65.8	31.0	39.1	39.6	62.3	86.2	41.9	35.7	43.2	32.5	51.1	35.0	20.2	47.7	34.3	24.3	25.1	59.4	38.5	78.9	22.8	33.4	39.2	27.1	65.9	34.5	89.6	74.8	15.1	91.2	56.6	26.8	43.8	32.6	35.3	50.1	40.4	58.6	43.5	40.4	50.3	51.0	47.4	43.0	7.9	38.4	56.7	53.4	58.3	55.5	28.3	29.5	19.0	26.7	24.4	22.4	27.4	28.3	23.8	26.3
SNRPD2	"Sm-D2, SNRPD1"	ENSG00000125743	"Small nuclear ribonucleoprotein D2 polypeptide"	P62316	19	45687454-45692569	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041437	Supported		Supported	Cytosol				Cytosol		"HPA041437: AB_10795119"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (8.58e-5)"	"unprognostic (1.95e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.12e-2)"	37.2	45.7	57.1	66.4	63.2	75.8	73.2	26.0	66.6	51.9	47.1	17.7	54.3	33.3	43.4	60.2	51.2	55.7	48.8	47.5	49.7	43.6	43.2	36.3	33.9	76.7	45.2	66.7	85.3	68.6	19.9	43.8	38.6	55.1	42.8	46.2	26.6	38.6	40.9	55.7	48.5	33.4	61.5	51.1	44.7	39.7	45.0	47.1	62.3	45.6	56.5	67.7	40.4	89.0	104.7	74.4	22.0	44.8	68.8	113.4	127.2	75.8	108.2	71.7	76.0	68.6	62.0	38.5	50.2	57.0	70.2	74.6	59.4	49.4	85.9	40.6	59.8	45.9	90.0	90.9	67.5	55.0	119.0	82.9	65.4	86.4	47.2	99.7	55.5	71.1	65.3	63.1	60.6	70.9	74.1	61.3	57.7	102.3	101.4	91.5	68.3	64.8	69.0	73.5	69.7	61.9	97.2	64.0	71.9	65.7	73.1	63.7	43.1	109.2	48.7	38.9	60.7	33.7	94.5	62.1	141.7	145.9	53.8	80.9	59.3	20.1	44.8	22.0	72.7	40.3	92.0	104.7	97.5	85.6	65.9	88.7	113.4	97.5	5.4	68.8	30.9	74.4	91.3	127.2	57.1	63.2	26.0	66.6	49.7	43.6	45.2	66.7	55.1	47.1
SNRPD3	"Sm-D3, SMD3"	ENSG00000100028	"Small nuclear ribonucleoprotein D3 polypeptide"	P62318	22	24555503-24609980	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001170	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			360000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA001170: AB_1080042"	"unprognostic (3.30e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.28e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	23.7	31.8	23.8	28.9	23.3	29.7	29.5	27.1	27.4	29.3	38.3	24.7	29.8	27.9	31.6	30.6	41.8	30.8	27.1	31.6	21.8	24.2	38.5	61.6	26.5	36.4	24.3	26.8	33.9	34.0	27.8	31.8	33.3	22.6	27.8	33.1	27.9	42.9	27.3	59.0	26.7	35.5	29.6	25.5	32.3	27.8	22.4	23.1	46.8	39.2	61.0	42.7	27.1	30.2	42.5	39.0	38.1	34.9	36.6	33.2	29.8	40.7	14.0	44.0	15.9	16.5	14.2	16.6	39.8	18.3	39.7	37.0	19.9	15.8	36.4	18.8	24.9	30.8	55.8	48.8	40.5	27.7	57.0	39.1	28.2	30.0	18.0	96.4	24.6	16.3	22.7	43.0	22.6	28.9	26.8	18.5	16.2	20.8	41.0	24.0	24.3	20.2	39.5	46.0	18.9	35.4	31.7	20.6	22.9	25.5	16.7	21.2	25.1	26.2	30.4	33.1	33.3	16.6	29.4	19.1	36.9	66.9	16.3	33.2	22.3	12.2	31.4	38.1	28.2	34.9	31.3	42.5	30.7	30.6	39.0	36.3	29.4	33.2	15.7	36.6	34.7	37.1	28.9	29.8	23.8	23.3	27.1	27.4	21.8	24.2	24.3	26.8	22.6	23.1
SNUPN	"RNUT1, SNURPORTIN-1, Snurportin1"	ENSG00000169371	"Snurportin 1"	O95149	15	75598083-75626469	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005004	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"		"CAB005004: AB_425829"	"unprognostic (2.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-3)"	"unprognostic (9.07e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.14e-2)"	17.3	17.5	18.7	13.9	21.7	11.8	22.8	16.1	26.8	20.6	17.0	16.0	21.1	13.6	25.6	20.5	14.2	23.2	19.6	17.2	18.2	17.8	19.4	20.6	15.2	17.1	18.3	21.1	26.2	15.2	17.2	14.2	14.8	19.6	16.9	16.9	17.6	18.3	26.8	29.8	15.8	15.9	23.5	14.0	18.5	15.7	31.1	13.6	25.4	23.3	17.0	19.2	16.0	21.0	17.2	20.6	5.0	17.4	14.2	29.4	17.0	11.0	15.0	13.7	9.5	19.1	21.4	10.4	11.6	16.8	19.6	21.4	11.0	27.4	20.6	16.0	14.6	13.0	26.7	15.9	15.5	11.8	24.1	24.4	13.8	7.0	18.4	16.7	17.1	19.8	16.3	14.6	18.3	18.5	15.5	13.4	19.8	3.8	16.0	16.4	17.9	8.5	20.7	10.6	20.0	17.4	5.9	12.6	8.7	5.1	17.0	28.5	14.3	30.7	12.4	16.0	14.7	8.7	10.0	9.7	17.9	30.3	17.3	25.5	20.9	3.8	17.4	5.0	21.9	16.0	26.1	15.4	22.7	20.7	20.6	17.2	29.4	24.9	3.3	14.2	16.1	20.3	17.4	17.0	18.7	21.7	16.1	26.8	18.2	17.8	18.3	21.1	19.6	13.6
SNURF		ENSG00000273173	"SNRPN upstream reading frame"	Q9Y675	15	24954986-24977850	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 140.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 58.0;U-698: 30.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA065733			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA065733: "	"unprognostic (2.08e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.59e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-2)"	11.9	20.8	47.6	10.9	50.2	16.7	9.7	59.3	140.9	8.1	19.1	16.7	13.7	5.5	13.2	72.6	9.9	8.1	20.4	32.1	47.7	47.8	23.6	20.1	15.5	14.8	45.6	40.9	15.4	19.4	23.9	40.9	6.4	44.4	21.8	6.3	16.0	12.3	13.9	69.6	7.6	10.8	7.9	28.4	23.9	17.8	7.3	18.9	9.5	40.4	6.5	11.3	9.7	6.7	13.4	11.8	6.1	1.4	10.1	22.0	9.5	0.0	3.6	19.3	13.2	0.9	1.2	0.0	11.1	1.0	1.2	0.8	1.9	10.5	0.1	6.1	0.7	4.2	0.0	2.4	1.0	3.8	0.0	20.0	14.5	0.5	3.4	21.0	7.4	3.0	0.6	2.2	0.0	1.4	2.0	0.0	2.1	0.0	15.1	0.1	58.0	0.5	15.3	23.9	0.2	0.8	24.1	11.3	8.7	0.0	1.0	5.5	11.4	2.0	20.6	8.4	8.9	0.2	2.4	16.9	20.7	30.7	12.7	9.3	7.0	6.1	0.8	3.0	8.3	0.4	16.2	11.1	17.3	14.9	1.5	13.4	22.0	20.0	0.9	10.1	1.4	11.8	17.1	9.5	47.6	50.2	59.3	65.9	47.7	47.8	45.6	40.9	44.4	18.9
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	30.5	23.4	20.3	24.0	24.8	59.5	28.3	32.1	26.2	26.1	27.6	29.6	21.5	24.6	32.5	24.3	29.1	25.4	20.5	26.3	20.6	18.3	23.5	25.3	24.8	31.5	23.9	26.7	32.1	26.5	19.8	31.6	32.3	26.8	29.8	24.9	22.3	23.4	17.6	41.8	33.3	30.7	30.8	23.7	32.3	24.2	36.3	24.3	37.5	34.1	24.2	30.4	33.0	25.0	32.5	38.2	47.8	44.1	47.6	47.1	35.5	39.4	29.2	30.0	31.8	24.8	27.9	34.9	27.1	23.9	29.9	27.6	29.0	36.2	38.5	24.9	20.2	38.9	36.0	25.8	40.7	30.6	28.5	31.1	26.4	29.0	35.6	21.7	36.9	21.4	34.5	27.1	37.4	29.0	44.5	29.0	22.8	40.4	38.7	37.0	33.6	39.4	41.9	38.8	26.4	27.7	36.6	32.3	35.0	37.4	33.1	37.3	47.4	41.8	30.6	32.8	37.6	29.5	32.4	28.7	40.6	42.9	29.8	35.1	36.2	42.0	38.0	47.8	32.1	40.6	36.0	30.9	36.2	36.3	38.2	32.5	38.3	36.0	36.1	47.6	44.1	22.7	47.1	35.5	20.3	24.8	32.1	26.2	20.6	18.3	23.9	26.7	26.8	24.3
SNX1	"HsT17379, MGC8664, SNX1A, Vps5"	ENSG00000028528	"Sorting nexin 1"	Q13596	15	64094123-64146090	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047373, HPA052761"	Approved		Enhanced	Endosomes,Lysosomes				"Endosomes, Lysosomes"		"HPA047373: AB_2680018, HPA052761: AB_2681939"	"unprognostic (3.99e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.26e-1)"	"prognostic favourable (9.88e-6)"	"unprognostic (2.27e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.95e-1)"	30.6	47.3	22.4	27.4	31.2	16.8	36.3	17.7	25.3	32.4	30.3	46.9	44.7	26.0	30.8	39.2	38.7	21.2	23.5	30.9	24.8	20.1	30.6	38.6	33.7	31.3	40.1	23.5	25.0	31.2	43.0	22.2	31.1	30.3	31.0	27.1	22.5	30.8	48.4	40.9	29.1	26.3	30.4	54.1	37.5	30.2	17.7	35.9	32.9	80.8	18.5	35.9	32.3	31.7	34.5	42.3	51.9	50.6	30.7	30.6	43.9	19.0	25.4	22.0	18.7	39.0	29.2	7.1	26.3	31.1	28.1	33.2	17.2	34.7	22.9	27.1	27.6	29.9	34.8	31.5	23.5	37.0	15.4	26.3	29.9	24.7	21.3	26.5	30.1	32.9	20.3	21.9	17.1	28.9	20.8	9.0	29.0	28.4	28.2	22.5	14.9	15.0	25.6	20.3	32.2	43.3	45.9	17.8	17.0	23.4	18.0	22.8	25.8	24.6	28.7	24.5	33.1	15.6	15.1	23.9	60.4	32.4	19.6	36.4	25.3	41.5	50.6	51.9	29.7	47.2	25.0	32.0	25.4	28.9	42.3	34.5	24.7	24.0	38.1	30.7	43.5	28.4	30.6	43.9	22.4	31.2	17.7	25.3	24.8	20.1	40.1	23.5	30.3	35.9
SNX10		ENSG00000086300	"Sorting nexin 10"	Q9Y5X0	7	26291895-26374329	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;brain: 39.0;liver: 37.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 26.6;U-937: 21.8;WM-115: 75.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 67.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015605, HPA064782"	Approved		Supported	Nucleoplasm,Nucleoli,Microtubules				"Nucleoplasm, Microtubules"	Nucleoli	"HPA015605: AB_1857342, HPA064782: "	"unprognostic (6.42e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.87e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (8.06e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.50e-1)"	17.7	8.7	20.2	18.6	17.9	20.9	6.7	13.2	39.0	2.9	3.3	2.1	0.1	2.5	5.4	0.8	1.8	1.9	5.2	1.3	22.2	32.7	21.3	37.4	22.4	18.0	27.8	20.8	1.0	5.0	0.6	3.0	8.9	36.2	2.2	3.9	1.8	1.4	1.5	0.9	1.0	3.6	5.4	15.4	22.1	2.3	3.0	2.1	3.8	1.9	0.1	13.6	6.3	1.8	16.3	20.1	67.6	30.9	9.0	5.6	11.6	13.6	1.2	0.0	2.6	0.0	0.0	14.9	0.0	1.0	0.0	0.0	0.1	4.6	6.0	10.7	0.0	0.4	3.4	0.9	0.0	8.2	3.2	0.6	0.1	9.0	0.0	12.7	2.3	0.1	1.4	0.0	1.1	0.2	0.3	0.0	0.0	2.4	5.3	13.4	3.9	1.3	0.0	0.0	0.3	26.6	2.9	5.8	1.8	2.9	2.2	15.5	3.9	18.2	0.0	0.0	3.2	0.0	3.4	4.6	3.7	4.0	0.1	21.8	75.8	8.2	29.2	0.7	4.0	30.9	3.8	16.3	2.8	3.4	20.1	14.5	1.5	2.6	67.6	9.0	30.1	7.4	5.6	11.6	20.2	17.9	13.2	39.0	22.2	32.7	27.8	20.8	36.2	2.1
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Cytosol				Cytosol		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	23.4	25.9	19.9	16.0	21.9	16.6	26.7	25.2	30.1	20.1	23.3	16.1	17.8	17.7	23.8	37.0	17.1	17.8	17.4	17.4	19.5	24.2	33.2	41.0	23.8	17.7	21.6	18.0	17.9	27.7	27.2	35.5	29.6	30.8	21.1	22.2	19.9	17.7	20.2	9.6	17.1	31.0	15.8	20.7	24.6	26.8	49.1	17.1	16.1	26.1	11.2	18.2	22.6	15.1	8.9	16.4	20.0	24.1	13.4	13.3	8.9	14.9	9.1	15.0	22.0	34.4	25.2	15.8	19.2	26.5	15.1	23.4	16.5	25.3	19.7	23.8	24.7	20.3	10.3	19.8	23.9	17.4	6.0	21.5	12.7	24.7	28.4	20.1	22.4	22.0	15.0	17.6	17.9	26.8	21.7	17.1	32.8	17.4	1.2	38.5	6.0	10.3	8.1	30.6	9.4	36.8	27.8	6.6	15.1	11.7	26.0	17.8	16.1	36.1	23.9	12.0	7.5	14.9	19.9	17.2	27.3	7.3	24.6	23.8	24.1	18.1	13.6	20.0	13.3	20.3	10.0	8.9	9.0	11.9	16.4	8.8	8.2	10.3	6.3	13.4	24.1	4.8	10.2	8.9	19.9	21.9	25.2	30.1	19.5	24.2	21.6	18.0	30.8	17.1
SNX15		ENSG00000110025	"Sorting nexin 15"	Q9NRS6	11	65027408-65040572	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038955	Approved		Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Nucleoli, Cytosol"	"Vesicles, Plasma membrane"	"HPA038955: AB_10672834"	"unprognostic (2.00e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.93e-1)"	"unprognostic (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.06e-3)"	"unprognostic (4.45e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.79e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-4)"	17.9	13.6	17.1	12.7	18.3	11.6	23.5	25.7	21.9	13.2	22.7	16.7	9.5	19.7	14.2	8.9	15.9	11.4	13.9	15.1	16.2	14.3	15.7	9.8	14.1	14.7	16.3	14.5	18.3	17.7	13.7	8.4	9.5	13.4	15.1	11.6	11.2	15.6	15.4	25.2	17.2	20.4	15.0	17.6	11.3	13.5	7.6	15.8	12.4	14.4	10.1	11.5	14.9	12.5	7.7	8.0	10.9	18.3	3.2	7.1	5.7	17.4	12.9	8.4	8.2	10.1	7.5	4.7	1.7	7.9	13.8	12.7	10.1	13.7	17.8	9.9	9.9	9.8	9.8	8.7	3.8	26.7	8.1	8.9	10.6	16.9	11.0	4.6	14.4	6.3	13.0	14.6	8.4	8.2	15.0	11.4	7.2	10.5	16.3	20.7	9.0	12.8	13.5	5.0	19.1	10.2	3.8	15.2	11.4	14.9	13.5	12.9	13.6	10.7	16.1	14.0	13.4	14.1	7.4	12.3	21.0	17.0	13.7	7.3	4.8	7.8	11.3	10.9	6.9	13.6	5.6	7.7	7.1	6.1	8.0	6.1	5.2	4.7	1.6	3.2	18.3	5.5	6.7	5.7	17.1	18.3	25.7	21.9	16.2	14.3	16.3	14.5	13.4	15.8
SNX16		ENSG00000104497	"Sorting nexin 16"	P57768	8	81799581-81842866	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024730, HPA024731, HPA024817"	Approved		Supported	Vesicles				Vesicles		"HPA024730: AB_10600220, HPA024731: AB_1857346, HPA024817: AB_10602313"	"unprognostic (5.50e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.41e-3)"	"unprognostic (3.21e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.73e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-1)"	11.7	5.9	6.6	5.8	10.0	9.5	16.2	13.1	14.8	13.7	9.8	3.0	4.2	6.9	10.7	8.1	18.8	7.2	11.9	8.3	7.3	9.6	14.8	7.6	12.1	6.2	11.2	11.4	10.8	4.9	7.9	12.1	5.7	10.2	13.2	7.3	3.8	8.8	8.6	6.6	11.7	11.8	11.7	11.4	17.1	9.4	15.6	8.7	15.3	18.7	7.5	6.5	10.0	15.9	4.5	5.0	11.6	6.1	3.2	6.5	2.6	8.1	2.8	4.2	4.0	14.3	9.2	5.0	10.4	13.2	9.1	13.7	2.0	6.7	1.3	6.0	7.3	7.1	3.7	4.6	14.9	10.8	2.1	4.3	3.6	4.1	11.0	1.8	7.8	7.0	7.9	4.1	8.3	7.5	2.7	16.2	22.6	4.8	9.2	3.3	1.6	4.2	3.9	6.0	1.5	9.2	4.1	6.8	5.5	1.9	2.8	5.4	7.3	3.7	4.2	12.8	9.5	9.2	4.7	9.9	7.4	3.4	5.5	5.6	10.2	11.6	6.1	7.1	2.9	3.8	2.7	2.3	3.7	2.4	5.0	4.5	4.3	3.8	8.3	3.2	3.1	4.0	6.5	2.6	6.6	10.0	13.1	14.8	7.3	9.6	11.2	11.4	10.2	8.7
SNX17	KIAA0064	ENSG00000115234	"Sorting nexin 17"	Q15036	2	27370496-27377533	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043867	Supported		Supported	Vesicles				Vesicles		"HPA043867: AB_10961129"	"unprognostic (2.57e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.32e-3)"	37.7	45.8	27.2	30.5	29.8	22.6	33.4	28.5	51.1	34.1	33.8	34.9	28.7	23.7	39.0	38.5	35.3	41.2	37.7	37.6	26.2	25.8	33.6	61.6	36.7	68.1	29.1	27.0	40.4	37.0	31.5	37.0	32.6	30.3	33.7	29.5	34.0	34.9	37.5	26.4	31.6	29.2	38.1	32.8	48.8	30.5	36.8	21.7	52.3	39.5	28.2	41.3	32.0	29.1	34.3	58.4	38.1	61.1	27.3	35.1	86.6	27.8	46.7	23.0	36.6	40.5	34.2	19.4	30.4	43.7	34.8	27.3	25.2	24.4	21.9	39.8	49.5	17.1	19.6	32.0	27.0	28.1	31.5	22.6	17.2	34.3	42.2	27.6	29.0	34.9	31.0	23.1	31.2	38.1	19.6	23.5	41.5	27.4	32.9	26.0	21.1	30.1	14.8	43.9	43.2	32.4	20.9	27.9	31.7	19.1	27.8	11.4	22.2	17.8	30.3	41.3	22.2	23.2	29.6	42.9	31.1	27.5	38.1	29.3	44.2	33.0	59.1	38.1	30.8	61.1	29.6	33.4	30.0	31.8	58.4	34.3	28.4	30.3	13.9	27.3	60.5	33.0	35.1	86.6	27.2	29.8	28.5	51.1	26.2	25.8	29.1	27.0	30.3	21.7
SNX19	"CHET8, KIAA0254"	ENSG00000120451	"Sorting nexin 19"	Q92543	11	130875436-130916509	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013447	Uncertain		Supported	Mitochondria				Mitochondria		"HPA013447: AB_1857347"	"unprognostic (8.79e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.97e-2)"	"prognostic favourable (3.56e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	22.3	23.1	24.0	16.9	30.6	10.0	17.2	18.0	38.0	17.1	23.8	35.6	25.3	17.1	22.9	32.5	17.9	19.8	20.4	22.6	22.8	22.2	24.1	25.6	17.5	15.3	31.0	15.3	20.6	26.6	32.9	28.5	18.5	28.0	21.7	22.2	23.7	23.1	27.2	26.4	19.0	17.8	26.0	30.8	18.5	22.3	36.2	28.2	24.6	31.1	12.1	18.1	23.0	16.4	5.9	5.4	11.3	6.6	3.6	6.2	5.2	6.7	7.4	9.6	13.4	28.9	20.4	6.3	18.0	21.4	9.1	9.5	8.4	13.0	6.4	12.6	19.8	12.3	1.4	12.9	11.7	10.3	5.8	11.6	7.4	0.0	21.0	0.0	9.1	23.2	16.0	9.3	10.2	11.1	10.2	0.0	19.4	4.9	9.4	7.7	2.9	9.5	7.2	9.1	3.7	9.9	12.2	9.4	8.7	7.7	12.4	6.1	22.0	7.3	14.7	12.8	9.5	10.4	10.5	2.2	0.0	0.0	5.3	7.7	14.6	11.3	6.0	4.4	4.8	6.4	6.2	5.9	4.7	5.7	5.3	4.4	5.6	4.4	3.6	3.6	6.6	5.4	4.1	5.2	24.0	30.6	18.0	38.0	22.8	22.2	31.0	15.3	28.0	28.2
SNX2		ENSG00000205302	"Sorting nexin 2"	O60749	5	122774996-122830108	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037400	Approved		Supported	Endosomes,Lysosomes			39000000	"Endosomes, Lysosomes"		"HPA037400: AB_10670381"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (7.90e-6)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (8.76e-7)"	"unprognostic (8.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.59e-2)"	32.1	28.0	27.7	36.0	27.7	22.1	52.1	30.4	24.7	22.0	24.1	14.1	34.0	20.4	24.7	36.6	25.3	24.9	22.0	33.3	27.2	17.4	38.5	30.1	39.5	58.9	27.2	23.2	33.1	26.2	24.7	29.8	34.7	26.0	23.3	24.5	12.4	27.7	29.7	20.9	23.4	27.4	35.8	27.7	45.8	27.0	14.5	28.1	16.0	40.4	21.2	34.6	30.3	30.4	84.6	34.5	30.5	43.5	9.6	16.5	32.1	16.3	13.1	17.3	13.5	39.2	23.9	73.4	13.3	20.7	15.6	22.8	22.9	23.8	21.1	32.9	15.2	5.6	36.3	24.2	23.2	20.8	21.7	21.4	13.0	15.6	26.4	9.3	16.0	22.4	18.6	16.3	23.5	17.1	10.9	15.6	16.7	14.8	7.7	12.5	10.8	15.5	33.3	17.3	23.7	23.3	26.7	13.9	10.5	15.5	18.0	21.5	22.7	22.5	19.3	13.9	12.5	19.9	15.1	11.7	14.5	23.0	18.4	34.3	16.6	30.5	43.3	26.7	8.7	43.5	10.0	84.6	11.9	10.4	34.5	84.4	11.8	9.9	15.2	9.6	42.7	10.2	16.5	32.1	27.7	27.7	30.4	24.7	27.2	17.4	27.2	23.2	26.0	28.1
SNX25	SBBI31	ENSG00000109762	"Sorting nexin 25"	Q9H3E2	4	185204237-185370185	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6"	"Group enriched"	"Detected in many"	4	"B-cells: 3.6;T-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036928			Supported	Vesicles				Vesicles		"HPA036928: AB_10669720"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.89e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.55e-3)"	3.0	3.7	2.6	2.9	5.3	0.1	4.6	11.9	4.2	2.7	5.6			1.1	3.3	2.8	3.1	4.7	3.9	4.4	3.3	5.6	5.6	4.1	15.1	4.9	4.6		3.4	4.6	7.2	5.7	5.6		7.9	3.0		2.8	4.3	4.8	2.5	3.5	3.1	2.1	4.2	2.6	5.9			8.5		6.0	3.8	2.2	3.6	0.2	0.0	0.2	0.6	1.5	0.2	5.8	3.1	3.9	5.6	10.6	7.9	5.9	18.0	8.6	9.1	7.6	2.6	4.1	16.8	2.0	12.8	2.3	4.5	3.9	10.3	27.8	7.5	2.8	3.8	6.1	6.2	1.9	4.1	5.4	4.3	7.9	4.4	7.9	5.9	16.9	12.0	1.7	0.7	3.3	3.2	3.0	2.4	4.5	4.2	22.1	2.2	8.5	6.2	3.7	1.0	14.7	2.1	2.4	15.2	5.2	3.4	5.0	7.8	15.3	6.2	3.6	8.6	1.4	6.5	0.0	0.0	0.0	0.6	0.2	1.0	2.5	1.3	1.5	0.0	3.6	0.4	0.9	0.0	0.6	0.0	0.2	0.8	0.2										
SNX5		ENSG00000089006	"Sorting nexin 5"	Q9Y5X3	20	17941597-17968980	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020679, HPA051187, HPA076450"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB020679: , HPA051187: , HPA076450: "	"unprognostic (6.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavourable (2.30e-10)"	"unprognostic (1.67e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.99e-1)"	23.0	30.7	19.0	29.1	19.7	26.5	20.6	12.8	17.8	17.4	21.1	16.4	16.3	27.3	17.9	40.9	18.5	17.0	17.3	20.0	17.2	14.0	35.9	30.3	18.7	43.8	20.4	14.8	29.4	18.7	17.7	15.4	24.4	15.6	17.6	22.9	17.8	18.1	14.8	34.9	14.5	23.6	14.0	21.8	46.4	18.2	9.8	17.8	25.6	64.4	19.6	27.3	20.5	19.0	32.8	28.8	33.4	34.5	15.2	26.7	19.5	18.4	20.2	8.6	9.4	6.1	10.6	51.6	14.8	8.3	9.5	10.9	19.5	26.2	30.6	9.2	9.3	20.8	12.0	23.2	13.0	7.7	10.7	27.2	8.3	115.7	9.5	19.0	32.8	10.0	10.3	10.3	18.8	13.7	13.1	20.7	11.4	14.4	16.7	16.8	9.2	10.1	19.9	21.9	22.8	11.7	21.5	8.6	4.9	14.1	21.7	19.0	11.8	12.4	10.8	15.1	18.7	9.3	18.5	14.7	22.3	24.8	7.4	6.9	13.1	23.5	23.5	33.4	23.8	32.0	21.6	32.8	21.8	23.2	28.8	30.5	13.2	19.2	1.9	15.2	34.5	14.8	26.7	19.5	19.0	19.7	12.8	17.8	17.2	14.0	20.4	14.8	15.6	17.8
SNX6		ENSG00000129515	"Sorting nexin 6"	Q9UNH7	14	34561094-34630183	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049374	Approved		Supported	Endosomes,Lysosomes				"Endosomes, Lysosomes"		"HPA049374: "	"unprognostic (1.89e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.68e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	35.7	27.0	26.7	23.0	23.2	16.3	29.4	19.0	21.5	20.8	28.1	30.7	17.7	37.0	37.9	18.0	24.9	16.3	21.6	19.0	28.3	22.0	30.4	18.6	17.6	33.5	33.7	18.1	20.7	15.5	61.1	19.1	46.2	26.7	22.3	24.3	14.7	20.1	18.6	20.3	18.3	38.4	23.2	50.9	33.6	20.8	23.1	23.3	28.5	21.5	19.6	21.9	28.5	22.5	30.5	29.4	56.0	43.1	29.8	43.9	45.2	31.7	18.0	21.0	13.6	32.7	67.4	29.5	31.4	34.8	32.4	28.4	17.3	39.7	20.6	26.3	41.2	22.5	22.2	23.2	56.7	25.2	8.9	12.4	11.0	31.6	28.1	21.8	15.5	43.3	25.6	22.1	32.2	44.0	13.3	17.1	43.3	18.3	19.6	10.7	11.4	21.6	21.0	24.3	20.8	41.3	24.3	16.5	17.8	25.3	22.0	26.3	28.4	14.2	43.2	23.3	16.6	22.5	20.1	15.8	25.7	23.4	12.7	12.0	25.9	26.7	32.8	39.5	32.3	43.1	41.7	30.5	43.9	37.4	29.4	27.0	33.6	36.0	56.0	29.8	39.7	19.3	42.7	45.2	26.7	23.2	19.0	21.5	28.3	22.0	33.7	18.1	26.7	23.3
SNX8	Mvp1	ENSG00000106266	"Sorting nexin 8"	Q9Y5X2	7	2251770-2354318	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057296, HPA060194"	Approved		Supported	Vesicles				Vesicles		"HPA057296: , HPA060194: "	"unprognostic (2.22e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.32e-2)"	"prognostic unfavourable (8.47e-6)"	"unprognostic (5.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.35e-1)"	14.3	7.3	11.7	13.9	12.8	10.1	15.6	11.1	14.2	6.8	8.4	11.4	4.8	11.7	7.3	9.9	11.3	7.7	11.0	14.0	12.0	9.6	8.2	9.1	10.7	24.1	12.7	9.6	9.1	10.8	4.7	7.9	15.4	10.9	4.7	7.8	12.9	8.5	3.9	9.9	9.9	9.6	6.5	17.0	33.1	7.7	20.5	12.5	4.9	9.5	6.9	18.9	9.5	8.5	18.2	13.1	4.5	10.2	1.2	2.0	4.8	17.2	16.9	7.0	9.7	9.7	9.5	16.5	8.4	12.6	14.3	17.8	11.9	13.5	10.1	3.5	9.9	4.6	6.0	4.6	7.3	2.5	5.6	5.6	6.9	9.8	24.8	5.4	9.4	19.0	5.4	17.5	6.8	5.4	11.0	12.0	11.6	11.3	1.8	5.8	12.6	8.4	8.9	14.4	4.6	3.3	8.2	3.4	8.9	7.7	21.3	12.0	15.8	11.8	8.1	12.1	32.2	19.7	10.9	7.8	9.6	9.3	11.9	7.3	32.5	4.5	9.4	3.0	1.8	10.2	1.4	15.5	1.4	1.9	13.1	18.2	1.4	1.6	1.6	1.2	9.6	3.4	2.0	4.8	11.7	12.8	11.1	14.2	12.0	9.6	12.7	9.6	10.9	12.5
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA031410: AB_10603339, HPA057203: "	"unprognostic (1.63e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	44.7	18.9	13.0	16.5	14.7	17.2	35.4	6.7	16.2	27.4	24.6	19.8	43.5	18.1	32.1	19.5	31.4	17.2	26.4	20.4	12.2	10.8	17.8	25.4	14.6	22.5	19.7	11.4	19.8	22.5	17.7	10.8	45.0	13.3	25.0	17.7	11.1	25.2	41.7	16.5	21.2	28.0	44.6	16.4	19.8	21.5	10.9	18.4	5.0	18.4	17.9	20.3	34.0	40.2	4.1	11.2	1.3	7.3	0.5	6.7	1.0	7.8	5.1	5.5	6.4	27.4	24.4	11.6	15.7	44.3	10.7	14.4	4.5	8.0	0.0	7.8	24.3	5.2	6.4	10.5	9.0	6.4	7.5	4.9	7.9	6.8	13.7	2.6	10.0	14.4	9.4	11.0	10.8	14.8	24.9	0.0	5.2	4.4	0.0	3.9	4.3	6.7	0.0	5.5	8.9	17.3	4.6	3.5	6.4	10.0	4.6	24.0	2.2	5.6	12.0	11.9	5.4	38.0	8.3	0.0	0.0	0.0	23.8	2.0	6.9	0.0	1.0	1.3	0.6	3.2	2.4	4.1	1.7	1.3	2.0	3.4	6.7	2.1	0.1	0.5	7.3	11.2	2.8	1.0	13.0	14.7	6.7	16.2	12.2	10.8	19.7	11.4	13.3	18.4
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 87.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: "	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	23.9	87.4	4.1	8.3	5.7	7.0	9.6	2.9	4.0	6.8	7.2	5.6	7.8	5.5	8.2	6.0	3.4	8.3	9.8	5.7	5.5	4.1	12.1	8.8	18.6	13.0	6.2	2.3	10.8	15.5	8.1	14.6	11.6	4.9	13.1	6.9	9.6	51.1	8.9	4.1	5.8	7.0	7.5	10.5	13.6	8.1	6.8	4.9	4.0	6.2	2.9	7.2	9.4	8.7	6.6	24.3	19.8	26.8	18.5	16.0	14.8	20.2	9.5	7.8	11.6	30.5	16.7	42.0	9.8	17.3	21.7	25.5	9.7	23.2	11.5	15.5	17.8	7.5	24.9	5.8	23.5	13.1	5.1	5.3	8.0	10.1	12.5	9.1	2.1	13.2	3.8	25.4	21.8	9.3	11.4	5.9	33.8	4.3	9.6	2.9	3.8	3.1	12.1	10.1	6.7	19.2	12.7	2.4	6.1	15.1	6.4	5.6	6.7	6.3	8.8	25.9	12.4	28.3	21.5	8.4	30.6	9.8	10.3	4.9	48.0	19.6	26.8	0.7	14.0	17.0	13.5	6.6	13.1	13.1	24.3	5.5	12.7	12.6	19.8	18.5	11.1	4.4	16.0	14.8	4.1	5.7	2.9	4.0	5.5	4.1	6.2	2.3	4.9	4.9
SOCS1	"Cish1, JAB, SOCS-1, SSI-1, TIP3"	ENSG00000185338	"Suppressor of cytokine signaling 1"	O15524	16	11254405-11256200	"Cancer-related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.3;lymphoid tissue: 58.3"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 47.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 15.2"	"Cell type enhanced"	"Detected in many"		"basophil: 12.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010355, HPA074108"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	"Cytoplasmic bodies"	"CAB010355: AB_2193144, HPA074108: "	"unprognostic (4.50e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-2)"	"prognostic favourable (1.10e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.31e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (1.08e-6)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.67e-1)"	10.9	2.8	0.7	19.2	1.5	13.9	37.9	15.2	1.1	15.8	6.3	0.3	2.2	3.3	4.9	7.6	5.6	4.2	11.0	3.6	0.6	1.0	11.1	42.3	9.6	25.8	0.8	0.0	9.3	3.8	0.7	16.8	9.3	2.4	5.3	1.8	3.2	3.7	3.9	2.3	6.0	11.0	6.5	1.1	14.7	6.6	7.1	0.4	58.3	5.1	4.8	14.7	5.4	8.3	4.4	1.3	12.9	0.1	5.5	2.7	0.4	1.2	0.2	0.5	0.1	1.6	0.2	1.8	1.0	7.3	0.4	0.6	0.3	0.2	2.8	2.2	0.4	0.5	0.2	0.1	0.1	47.2	0.3	0.7	0.0	3.8	0.6	0.0	8.7	0.6	0.1	1.0	0.0	0.1	6.3	0.8	0.0	1.1	3.1	1.8	5.3	0.8	0.3	0.3	0.3	0.5	0.2	0.7	0.1	0.2	1.7	0.5	0.0	0.4	0.0	0.6	3.1	0.4	0.6	0.2	0.2	4.4	1.2	0.3	0.6	12.9	0.1	8.8	2.2	0.0	2.0	1.4	2.5	2.7	0.0	4.4	2.7	2.5	0.3	5.5	0.0	1.3	2.6	0.4	0.7	1.5	15.2	0.6	0.6	1.0	0.8	0.0	2.4	0.4
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659622-31668931	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 282.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			91000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	39.2	86.5	71.1	29.1	74.3	24.6	108.6	35.6	74.9	26.8	37.7	19.1	35.4	62.5	24.6	42.2	25.8	36.0	46.8	96.5	77.8	73.1	84.0	282.6	23.0	26.8	80.2	67.0	53.9	27.2	27.1	30.4	29.7	96.1	35.1	32.6	19.3	19.7	39.3	83.9	20.5	45.5	45.2	88.2	19.2	25.8	22.2	43.8	12.3	30.1	34.7	25.6	25.4	124.0	57.6	32.3	24.9	57.2	29.6	95.6	55.6	55.6	48.7	34.2	34.2	45.8	31.9	28.4	47.0	28.1	32.0	24.2	63.1	35.4	66.7	49.5	43.3	20.2	49.0	34.6	26.4	49.2	60.9	107.6	63.9	90.2	30.3	47.5	40.3	33.1	26.4	44.8	24.9	35.9	74.2	85.3	38.5	90.4	51.0	47.9	51.4	52.0	43.9	69.0	103.7	62.5	34.2	37.4	31.4	87.1	46.1	45.2	53.0	42.0	42.0	24.9	55.1	33.6	34.6	65.2	141.0	79.0	50.8	69.3	33.0	22.1	21.9	24.9	45.0	30.2	51.6	57.6	73.1	56.9	28.6	40.9	76.2	59.3	5.1	29.6	57.2	32.3	95.6	55.6	71.1	74.3	35.6	74.9	77.8	73.1	80.2	67.0	96.1	43.8
SOD2		ENSG00000112096	"Superoxide dismutase 2"		6	159669057-159745186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 254.9;skeletal muscle: 475.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 181.9;HSkMC: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"neutrophil: 254.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 254.9"									"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria				Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavourable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	77.8	28.6	6.2	82.8	13.8	147.9	32.5	3.6	12.5	13.1	25.6	5.7	3.6	9.1	13.3	16.6	20.3	12.6	19.9	42.4	5.8	6.4	157.4	197.5	33.9	52.7	14.3	2.6	31.8	24.9	6.9	7.0	10.0	16.1	27.1	6.1	6.4	39.9	7.4	475.1	9.0	8.1	27.9	25.5	18.4	13.8	13.6	7.3	3.0	36.8	20.8	11.8	43.4	52.8	2.3	5.8	254.9	22.7	0.9	4.5	15.0	3.6	4.6	4.1	9.4	26.6	44.5	2.1	5.3	181.9	6.5	15.1	9.5	2.1	7.5	16.0	5.9	6.3	4.3	4.6	4.9	7.3	8.9	7.9	7.8	16.2	19.7	7.5	3.4	80.3	7.7	20.6	15.4	3.3	10.8	9.0	6.2	3.9	6.2	4.8	6.9	5.8	8.4	5.6	6.9	12.1	6.0	7.8	3.0	11.2	5.7	2.3	3.5	3.5	3.1	19.1	6.9	10.1	9.2	3.8	9.8	9.0	21.1	5.8	2.4	6.2	19.2	9.4	2.2	14.9	2.4	2.3	3.1	2.2	5.8	1.8	2.6	2.1	254.9	0.9	22.7	0.8	4.5	15.0	6.2	13.8	3.6	12.5	5.8	6.4	14.3	2.6	16.1	7.3
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA binding protein"	P18583	21	33542618-33577481	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: "	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	40.0	41.1	33.3	32.7	42.8	87.7	40.8	46.2	42.3	38.7	36.1	41.3	34.1	27.8	51.9	41.6	39.3	44.8	27.7	37.5	32.9	25.6	32.0	38.0	41.3	44.8	40.0	32.6	52.9	40.4	92.1	70.3	42.4	41.2	41.3	37.6	37.6	40.7	36.3	64.1	39.2	41.6	34.6	47.6	47.0	41.2	29.6	41.4	59.0	42.1	27.3	46.4	43.0	47.3	20.1	27.1	26.8	15.5	15.2	17.2	9.0	27.2	13.7	35.6	20.1	31.5	28.5	25.6	19.1	25.6	20.3	19.2	22.8	19.8	44.3	11.2	31.8	20.3	41.3	31.9	32.3	18.3	20.2	57.4	18.8	30.2	23.4	54.1	26.4	30.2	37.2	23.9	36.8	30.8	43.2	44.7	29.1	27.5	28.9	30.5	38.8	16.0	28.4	38.0	32.7	31.3	24.4	20.5	20.2	32.0	27.4	22.1	25.0	31.8	30.5	21.7	20.2	16.3	20.7	42.0	34.4	52.9	23.3	46.4	21.1	18.6	14.4	18.7	15.4	12.6	15.3	19.9	17.1	16.0	10.9	20.1	17.2	16.7	26.8	15.2	15.5	27.1	14.5	9.0	33.3	42.8	46.2	42.3	32.9	25.6	40.0	32.6	41.2	41.4
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 126.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;HMC-1: 26.0;SK-MEL-30: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 7.6;eosinophil: 2.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, HPA043084"	Enhanced		Supported	"Focal adhesion sites,Centrosome"				"Focal adhesion sites"	Centrosome	"HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favourable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"	95.0	6.4	23.0	16.4	21.6	1.8	23.5	16.8	22.5	14.9	70.2	18.7	22.1	8.1	41.8	12.5	45.0	25.1	28.9	83.7	20.9	8.3	5.9	14.7	8.7	1.4	13.4	14.1	9.8	7.3	17.5	3.5	9.9	19.2	42.0	20.0	6.4	7.2	65.7	46.4	6.3	15.5	126.5	20.6	2.9	40.0	5.5	19.3	0.0	4.0	12.7	1.2	63.9	31.4	0.1	0.0	7.6	1.2	0.6	1.0	0.2	0.7	0.6	6.3	1.6	2.3	0.1	0.9	0.2	0.0	0.2	0.0	14.9	5.6	0.0	1.2	0.1	0.3	1.1	0.2	0.1	1.7	2.3	3.6	0.2	8.9	0.8	0.0	26.0	0.4	0.2	0.3	0.1	2.6	5.9	1.2	0.6	0.4	0.0	0.3	2.9	1.4	0.5	2.1	0.2	7.0	9.8	2.7	2.0	0.9	0.3	22.3	1.2	0.2	0.2	0.0	2.2	0.1	1.2	0.8	0.2	0.1	2.7	0.2	6.3	7.6	0.2	2.2	0.7	1.2	1.0	0.1	0.3	0.4	0.0	0.1	0.3	0.1	0.2	0.6	0.2	0.0	0.5	0.2	23.0	21.6	16.8	20.7	20.9	8.3	13.4	14.1	19.2	19.3
SOX10	"DOM, WS2E, WS4"	ENSG00000100146	"SRY-box 10"	P56693	22	37970686-37987422	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Deafness, Disease mutation, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.4;salivary gland: 98.4"	"Group enriched"	"Detected in some"	705	"SK-MEL-30: 61.4;WM-115: 88.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003171, HPA068898"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB003171: AB_2195374, HPA068898: "																		3.3	4.0	21.0	3.7	33.1	1.6	18.7	3.2	32.8	3.2	8.1	64.4	0.5	2.9	1.8	2.8	2.8	1.9	3.4	3.9	26.9	15.2	1.7	1.7	1.6	1.6	41.3	13.7	2.4	2.2	1.7	0.7	1.6	24.7	2.3	3.9	22.8	98.4	7.1	1.8	15.8	3.8	3.2	46.6	1.8	2.4	3.1	42.5	0.0	1.7	0.0	1.6	2.5	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	88.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	33.1	3.2	24.6	26.9	15.2	41.3	13.7	24.7	42.5
SOX11		ENSG00000176887	"SRY-box 11"	P35716	2	5692667-5701385	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 3.1;brain: 12.3;heart muscle: 5.3;intestine: 3.3;testis: 3.7"	"Cell line enhanced"	"Detected in some"		"AF22: 25.9;NTERA-2: 12.7;REH: 9.2;RH-30: 9.9;SCLC-21H: 15.9;SH-SY5Y: 24.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 2.0;glioma: 8.5;ovarian cancer: 1.8;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000448, HPA000536, CAB056152, CAB056153"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB056152: , CAB056153: , HPA000448: , HPA000536: AB_1080060"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.35e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.04e-8)"	"unprognostic (2.79e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.45e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.47e-2)"	0.5	0.5	4.2	0.5	7.1	0.6	0.6	0.3	12.3	0.4	3.3	5.8	0.0	0.6	0.7	0.6	0.5	0.5	0.6	5.3	4.4	5.1	0.5	0.5	0.6	0.5	3.3	5.0	0.5	0.4	0.5	0.7	0.5	4.5	0.5	0.8	0.0	0.9	0.4	1.0	0.6	0.7	1.3	6.3	1.0	0.6	3.7	3.6	0.0	0.6	0.0	0.6	0.5	0.1	1.1	0.8	3.1	1.5	1.6	1.1	0.5	0.0	0.0	25.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	12.7	0.0	9.2	9.9	0.3	0.0	0.0	15.9	24.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.8	0.3	0.6	0.0	0.0	6.0	3.1	0.5	1.0	0.5	0.8	1.1	1.1	0.6	0.7	0.6	0.7	0.9	0.9	1.6	1.6	1.5	0.8	0.9	0.5	4.2	7.1	0.3	6.4	4.4	5.1	3.3	5.0	4.5	3.6
SOX12	SOX22	ENSG00000177732	"SRY-box 12"	O15370	20	325595-330224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"B-cells: 1.8;dendritic cells: 1.5;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055052, HPA061627"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA055052: , HPA061627: "	"unprognostic (1.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-3)"	"unprognostic (8.80e-2)"	"prognostic unfavourable (6.64e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.12e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.20e-2)"	5.2	7.4	11.0	4.9	10.2	5.4	10.3	27.5	14.1	8.2	7.8	10.1	11.0	4.1	10.9	11.3	5.8	10.2	5.2	6.8	10.9	8.8	8.3	4.7	5.3	5.1	11.3	5.7	14.6	12.6	7.7	7.0	5.0	8.4	8.7	3.0	7.8	8.8	13.8	2.3	9.0	4.8	8.5	6.9	7.6	5.0	8.2	10.9	12.1	8.2	2.0	3.8	7.8	9.0	1.8	1.5	0.3	0.2	0.2	1.3	0.2	3.6	12.9	12.7	8.6	6.1	4.5	3.8	5.1	4.5	4.7	4.6	2.6	3.8	8.3	3.9	5.8	4.4	9.2	1.6	2.6	4.1	6.4	5.3	5.0	25.8	7.9	7.3	1.4	6.2	5.3	3.9	1.6	6.1	12.4	4.3	3.0	9.0	2.5	18.0	20.7	17.1	13.0	3.2	6.6	6.6	0.4	15.6	18.2	3.4	15.1	18.8	14.3	10.2	6.8	18.1	18.0	0.4	4.5	12.5	13.2	8.5	3.3	7.2	3.5	0.3	0.2	0.3	0.5	0.1	0.2	1.7	0.6	0.8	0.2	1.8	1.3	1.1	0.1	0.2	0.0	1.5	0.8	0.2	11.0	10.2	27.5	10.7	10.9	8.8	11.3	5.7	8.4	10.9
SOX13	"ICA12, MGC117216, Sox-13"	ENSG00000143842	"SRY-box 13"	Q9UN79	1	204073115-204127743	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.6;SK-BR-3: 49.4;T-47d: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 4.1;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051790, HPA054843"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA051790: , HPA054843: "	"unprognostic (4.88e-3)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (4.74e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	22.2	10.7	11.0	6.9	8.6	0.8	18.4	9.2	9.9	37.0	17.2	14.4	16.1	13.5	30.3	12.4	10.9	22.3	16.4	9.7	11.0	6.9	19.0	12.3	20.5	4.3	13.7	7.0	13.5	12.8	34.2	5.6	27.3	14.3	23.5	8.3	13.7	13.1	18.7	14.2	9.9	16.8	18.2	12.1	8.4	8.2	8.7	13.3	0.1	10.4	7.5	7.0	19.5	19.2	0.0	0.0	0.5	0.0	4.1	2.6	0.3	8.4	5.4	11.7	0.8	11.2	3.4	23.6	3.3	1.9	5.2	3.2	4.5	6.3	0.0	10.8	2.1	13.7	4.4	4.3	2.5	3.9	2.2	0.0	3.7	5.0	2.5	0.0	4.9	3.5	2.1	3.3	2.9	7.5	0.0	0.0	1.0	10.3	0.0	0.0	15.5	6.6	0.1	4.0	5.1	3.9	19.5	1.8	0.9	3.3	49.4	14.7	22.0	1.0	4.3	1.1	3.1	5.0	2.3	0.0	0.0	0.0	1.8	0.1	3.1	0.2	0.0	0.5	2.5	0.0	2.6	0.0	1.2	1.4	0.0	0.0	0.0	1.0	0.3	4.1	0.0	0.0	0.0	0.3	11.0	8.6	9.2	9.9	11.0	6.9	13.7	7.0	14.3	13.3
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Group enriched"	"Detected in some"	7	"A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"				Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: , HPA074049: "	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	40.8	1.0	0.6	0.3	0.0	0.1	3.2	0.4	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	45.9	0.0	18.3	0.1	1.1	1.2	0.1	0.5	0.1	0.0	0.0	0.9	0.0	18.2	0.2	4.1	0.0	0.9	0.3	0.0	0.3	0.2	0.5	1.2	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.4	0.5	1.5	0.5	1.0	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0
SOX2		ENSG00000181449	"SRY-box 2"	P48431	3	181711924-181714436	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 80.1"	"Cell line enhanced"	"Detected in some"		"AF22: 67.5;HAP1: 28.7;NTERA-2: 55.0;U-251 MG: 12.6"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm				Nucleoplasm		"CAB079745: , HPA045725: , HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"	1.8	2.5	30.3	2.0	25.8	1.5	1.6	13.9	80.1	1.8	2.3	24.3	0.0	2.0	1.5	1.8	15.9	5.0	1.8	1.7	36.0	19.2	1.5	1.5	3.4	1.5	19.4	18.5	1.7	1.6	1.5	5.8	1.5	18.6	3.9	2.0	1.0	6.3	1.9	1.6	1.8	2.3	1.7	18.4	1.6	9.7	3.0	22.4	0.0	1.5	2.1	6.9	2.3	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	28.7	0.7	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	55.0	0.1	0.0	0.1	0.0	7.4	0.1	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	25.8	13.9	20.0	36.0	19.2	19.4	18.5	18.6	22.4
SOX3	PHP	ENSG00000134595	"SRY-box 3"	P41225	X	140502985-140505116	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 18.2;testis: 12.4"	"Group enriched"	"Detected in some"	10	"AF22: 7.6;HEK 293: 8.2;NTERA-2: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA054720, HPA075003"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA054720: , HPA075003: "					"unprognostic (6.04e-2)"					"unprognostic (3.75e-1)"			"unprognostic (8.62e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.27e-3)"		0.3	0.5	2.6	0.3	2.7	0.3	0.3	0.6	2.6	1.5	0.3	5.0	0.0	0.3	0.6	0.3	0.3	18.2	0.3	0.3	2.2	5.0	0.3	0.3	0.3	0.3	2.0	1.8	4.7	0.3	0.4	3.2	0.3	3.6	0.3	0.3	0.5	0.3	0.3	0.4	0.3	0.3	0.3	2.3	0.3	0.3	12.4	0.6	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	0.6	2.6	2.2	5.0	2.0	1.8	3.6	0.6
SOX4		ENSG00000124766	"SRY-box 4"	Q06945	6	21592768-21598619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0"	"Region enriched"	"Detected in many"	4	"olfactory region: 66.5"	"Low region specificity"	"Detected in all"			HPA029901	Approved		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	4.2	0.7	2.0	1.9	0.9	6.0	6.3	3.0	6.3	6.7	2.8			3.0	18.0	4.1	2.3	4.2	5.5	2.0	1.1	1.8	4.3	1.3	5.1	0.8	0.6		18.1	5.3	0.0	1.8	1.0		4.1	3.7		9.6	1.4	0.3	4.1	2.7	4.9	0.3	1.0	4.4	2.5			3.4		1.4	6.2	3.6	3.1	21.8	12.8	10.0	3.3	1.1	2.0	1.8	5.2	13.3	55.4	4.9	1.2	21.7	0.8	1.7	1.0	0.9	3.5	3.5	0.6	22.2	1.3	5.4	6.9	3.8	0.7	7.6	14.5	0.5	2.4	2.3	0.8	1.8	0.4	2.1	3.9	0.4	1.6	15.6	0.1	0.0	1.1	4.3	47.6	4.5	9.9	5.0	21.0	1.1	0.0	9.6	16.7	17.4	31.2	7.7	9.0	2.9	4.4	6.5	11.9	1.5	5.2	0.3	3.9	0.3	0.0	15.4	0.5	6.5	6.1	12.8	9.8	0.9	0.2	5.5	0.0	2.8	0.1	0.1	4.1	3.1	1.1	0.8	0.4	3.3	10.0	21.8	0.9	2.0										
SOX5	"L-SOX5, MGC35153"	ENSG00000134532	"SRY-box 5"	P35711	12	23529500-24562544	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 52.0"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;Daudi: 11.7;HDLM-2: 24.7;K-562: 10.7;WM-115: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.3;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	6	"B-cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060499			Supported	Nucleoplasm				Nucleoplasm		"HPA060499: "	"unprognostic (9.11e-4)"	"unprognostic (4.64e-3)"	"unprognostic (3.23e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.70e-4)"	"unprognostic (6.95e-2)"	"unprognostic (4.53e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.75e-2)"	8.5	2.4	9.2	3.1	5.4	0.7	4.4	3.8	10.5	10.6	2.9	3.0	2.7	1.1	8.7	1.8	2.6	4.5	3.8	3.6	10.0	2.8	2.9	12.9	3.3	4.2	4.1	6.4	9.1	2.5	0.7	6.9	9.9	7.2	2.8	1.8	5.2	4.0	4.9	2.7	7.1	2.7	4.3	5.1	2.5	2.9	52.0	5.5	0.0	3.3	1.6	3.7	2.9	5.4	4.3	0.7	0.1	0.0	0.7	0.1	0.2	0.1	0.1	11.8	0.0	6.7	3.5	0.0	0.1	0.0	0.1	0.4	2.1	0.1	11.7	0.6	0.0	0.1	6.7	0.0	0.1	24.7	1.7	2.5	0.0	5.5	4.5	0.0	0.1	1.8	0.0	0.6	0.0	0.0	10.7	0.5	0.3	0.0	4.5	0.0	3.5	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.5	0.0	0.0	4.8	0.2	2.4	0.0	0.2	1.5	0.0	1.1	0.3	0.0	0.7	2.7	0.0	9.9	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	3.7	0.0	0.1	0.1	0.7	0.0	0.7	0.0	0.2	9.2	5.4	3.8	10.5	10.0	2.8	4.1	6.4	7.2	5.5
SOX6		ENSG00000110693	"SRY-box 6"	P35712	11	15966449-16739591	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.1;kidney: 28.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.8;HAP1: 4.8;hTCEpi: 5.5;SK-MEL-30: 4.9;WM-115: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001923, HPA003908"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA001923: AB_1080065, HPA003908: AB_1080063"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.89e-4)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-3)"	"prognostic favourable (6.47e-12)"	"unprognostic (9.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.04e-2)"	1.4	0.9	3.9	0.8	3.5	17.7	0.8	0.8	5.7	1.4	30.5	0.8	2.3	5.0	0.8	4.9	1.6	3.3	6.3	2.5	2.6	2.5	28.4	3.8	2.0	0.8	3.0	0.8	1.7	14.5	0.0	2.9	1.9	0.9	0.8	0.8	1.1	0.8	0.8	8.1	4.5	70.1	0.8	1.4	1.1	0.6	10.3	1.0	0.8	2.8	1.4	0.8	0.8	0.8	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.6	4.3	4.1	0.0	0.0	0.0	0.3	1.3	0.1	0.1	5.8	0.0	0.0	3.7	0.0	0.1	4.8	1.3	0.0	0.0	0.5	0.0	0.0	0.2	0.7	0.0	0.0	0.0	5.5	0.0	0.1	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	2.1	0.0	0.0	0.0	0.4	0.0	4.9	0.0	0.0	0.0	2.8	2.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	3.9	3.5	0.8	2.5	2.6	2.5	3.0	0.8	0.9	1.0
SOX8		ENSG00000005513	"SRY-box 8"	P57073	16	981808-986979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 64.9"	"Cell line enriched"	"Detected in some"	5	"RH-30: 50.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041640, HPA058665"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA041640: AB_10964357, HPA058665: "	"unprognostic (1.40e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (6.05e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.47e-1)"	"unprognostic (9.09e-2)"	1.6	1.5	18.4	1.8	25.1	1.0	2.5	3.2	64.9	1.2	1.4	20.9	0.0	1.1	1.1	1.1	1.2	1.1	1.5	1.8	22.6	14.5	1.0	1.0	1.0	2.7	26.5	5.4	1.0	1.5	1.0	0.1	1.4	12.0	1.3	1.5	0.9	8.6	1.4	1.3	1.3	1.2	1.2	27.1	1.8	1.7	1.9	30.4	0.0	1.1	0.0	3.1	1.1	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.2	1.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.1	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	50.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.2	18.4	25.1	3.2	11.8	22.6	14.5	26.5	5.4	12.0	30.4
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box 9"	P48436	17	72121020-72126420	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 63.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.5;Hep G2: 35.3;U-251 MG: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB022456: , CAB068240: , HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.6	32.2	4.3	31.6	1.1	23.4	20.3	32.4	7.4	14.6	28.4	8.1	16.6	3.5	1.9	7.7	7.4	11.7	9.5	35.5	15.7	11.7	3.9	3.4	1.9	14.6	13.7	1.2	31.9	1.2	7.0	1.4	21.3	21.7	15.7	12.9	63.4	14.4	3.0	13.1	12.9	2.1	15.6	1.3	35.2	25.2	20.2	0.0	17.8	5.3	5.0	1.9	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	7.1	14.8	29.5	1.5	0.4	0.0	1.8	1.5	3.1	1.7	9.9	15.3	0.0	1.1	0.4	11.6	0.0	6.9	2.9	0.0	0.9	0.0	1.5	35.3	0.1	0.0	0.0	0.2	0.6	3.6	3.4	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.5	11.0	0.0	11.9	0.1	13.3	0.7	0.7	0.7	1.5	1.7	0.0	6.3	0.1	0.0	6.1	16.5	3.2	24.3	0.0	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	31.6	20.3	26.7	35.5	15.7	14.6	13.7	21.3	20.2
SP1		ENSG00000185591	"Sp1 transcription factor"	P08047	12	53380176-53416446	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000330, HPA001853, HPA012292"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394"	"unprognostic (1.12e-1)"	"unprognostic (8.52e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (1.43e-4)"	"unprognostic (6.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.12e-2)"	20.7	18.1	8.8	13.9	14.2	17.0	20.1	30.0	14.7	20.9	21.9	17.5	19.3	19.6	25.4	21.2	35.0	20.4	18.7	12.1	14.1	6.8	31.3	14.1	17.6	14.2	18.3	9.7	22.5	17.9	19.0	11.3	19.5	14.4	16.2	20.1	21.5	25.8	19.5	22.0	25.8	30.0	18.4	21.0	19.0	18.8	22.4	15.2	25.8	16.6	17.3	26.6	25.1	21.6	2.7	3.0	11.2	4.2	1.7	2.8	1.4	17.7	19.5	22.3	16.3	18.0	20.8	17.8	12.8	16.6	15.8	14.6	16.2	35.6	24.1	17.0	14.7	25.7	25.6	17.4	17.7	18.4	14.9	21.2	24.7	8.8	12.6	19.3	17.9	21.9	18.1	16.2	31.5	16.2	20.3	34.9	11.6	25.4	28.8	14.8	12.3	14.7	20.5	21.5	14.2	12.4	32.1	11.8	15.7	26.0	21.9	13.2	27.5	20.7	15.6	18.6	17.4	13.8	13.6	12.0	13.8	24.1	14.2	16.1	14.8	4.5	4.2	2.5	2.2	2.7	2.8	2.3	2.2	2.1	2.4	2.7	2.4	2.6	11.2	1.7	3.1	3.0	1.6	1.4	8.8	14.2	30.0	14.7	14.1	6.8	18.3	9.7	14.4	15.2
SP100		ENSG00000067066	"SP100 nuclear antigen"	P23497	2	230415942-230544090	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA016707, HPA017384"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA016707: AB_1857398, HPA017384: AB_1857399"	"unprognostic (8.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.25e-2)"	39.7	27.7	7.0	44.0	12.9	56.8	33.4	3.4	9.4	25.6	28.3	5.5	19.1	15.3	18.9	20.5	22.5	16.1	20.3	32.3	7.1	5.3	21.7	24.8	36.0	48.5	13.0	4.0	23.8	19.9	1.8	13.7	25.1	10.9	24.0	12.4	13.9	23.4	17.6	14.6	17.3	35.4	20.2	15.6	52.2	18.6	9.8	10.6	25.9	31.6	17.8	37.4	27.0	34.7	44.1	17.4	75.6	25.2	30.8	33.2	26.1	13.3	4.0	0.2	1.8	20.8	33.8	3.2	17.4	39.1	40.5	65.4	2.4	15.8	6.2	14.1	18.8	6.6	0.2	16.6	29.7	14.8	0.5	10.6	6.9	5.3	30.1	12.5	14.6	27.7	9.8	19.4	17.6	30.5	5.4	10.2	15.4	3.6	7.8	13.3	0.6	6.4	5.9	9.5	4.3	11.5	11.4	0.1	0.2	6.9	2.2	29.9	2.1	13.0	36.7	19.6	5.2	11.9	10.0	12.8	4.1	13.9	18.7	13.7	9.4	31.8	22.5	28.6	33.2	19.2	26.3	38.9	32.3	28.5	16.8	44.1	31.0	27.3	75.6	30.8	25.2	17.4	29.1	26.1	7.0	12.9	3.4	9.4	7.1	5.3	13.0	4.0	10.9	10.6
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230167293-230225729	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 65.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 28.4;BJ hTERT+ SV40 Large T+ RasG12V: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA047036, HPA058554"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA047036: AB_10963065, HPA058554: "	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	21.4	8.9	6.5	29.9	12.1	17.6	12.3	3.1	7.5	10.2	8.9	11.6	3.2	7.6	13.5	8.0	11.1	8.1	11.7	8.6	6.0	5.7	10.0	10.4	14.6	43.4	10.7	4.6	12.7	10.0	8.9	13.0	11.2	8.9	12.2	9.4	9.3	10.3	5.4	8.0	7.9	18.6	9.5	12.7	45.2	9.2	4.0	10.3	32.7	8.4	5.7	35.1	14.3	13.2	36.0	21.3	65.9	31.7	13.2	16.5	10.4	3.1	1.7	1.0	1.8	5.7	9.5	3.4	6.0	12.1	28.4	40.7	0.0	5.0	13.6	5.6	6.1	2.0	3.8	9.2	10.7	12.2	2.3	5.7	2.6	3.4	5.9	8.3	6.9	13.4	4.6	8.3	11.9	9.8	2.0	4.9	8.0	1.9	12.4	16.2	3.5	2.0	7.8	10.1	5.1	22.8	4.3	0.2	2.3	2.2	4.9	12.1	3.7	7.1	7.2	5.2	3.2	1.2	2.9	5.3	1.8	6.8	5.7	7.9	4.2	18.6	12.0	29.1	14.7	20.4	12.6	36.0	14.1	12.9	10.6	34.5	14.6	15.2	65.9	13.2	31.7	21.3	16.5	10.4	6.5	12.1	3.1	7.5	6.0	5.7	10.7	4.6	8.9	10.3
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favourable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	18.8	15.0	16.9	21.9	20.5	19.1	21.0	28.5	23.4	17.3	16.3	26.9	12.5	16.9	20.5	16.2	19.9	18.3	14.9	20.2	13.8	11.8	17.2	13.3	17.4	22.3	14.1	13.0	20.5	19.7	31.0	14.5	21.4	18.5	16.2	15.8	26.9	18.7	18.2	30.2	19.2	20.8	16.6	17.6	22.2	16.5	23.2	16.3	31.9	21.7	16.0	28.3	18.9	18.0	8.3	6.3	14.3	9.3	12.7	11.5	7.8	16.3	18.9	13.0	11.0	6.4	6.0	12.4	9.6	7.1	10.0	9.1	20.6	8.3	14.2	8.7	12.6	12.6	9.0	8.4	10.6	20.6	12.7	14.4	12.7	10.6	6.0	12.8	17.1	8.7	9.9	11.8	11.1	9.5	15.5	24.2	9.6	22.2	31.6	8.1	5.9	12.6	14.4	17.8	8.9	7.0	26.5	13.0	15.6	8.4	8.9	9.5	12.9	12.2	15.5	17.6	9.4	12.3	14.8	21.6	23.8	12.7	9.6	8.7	14.2	14.3	8.0	12.1	11.5	9.3	10.1	7.0	8.8	10.7	6.3	8.3	10.2	10.3	14.3	12.7	8.1	6.1	8.8	7.8	16.9	20.5	28.5	23.4	13.8	11.8	14.1	13.0	18.5	16.3
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428034-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: "	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	5.8	4.7	7.9	8.9	11.0	10.2	6.3	25.9	9.5	8.6	4.4	6.4	3.8	3.1	9.2	5.8	4.1	7.8	4.6	6.5	8.3	6.1	5.4	3.4	6.0	11.7	8.6	6.9	19.8	5.2	17.1	11.8	3.7	6.7	7.3	4.3	6.0	5.0	5.7	10.5	5.0	5.6	5.3	6.8	9.1	4.9	6.0	10.0	27.0	13.1	4.8	11.2	6.8	6.3	5.4	1.5	7.2	1.8	3.5	8.3	3.1	2.2	1.7	5.0	7.9	1.5	0.9	1.4	2.3	1.6	2.6	3.6	3.4	2.6	9.0	1.4	1.5	2.8	7.4	2.1	5.3	2.6	2.8	4.8	3.2	1.4	1.1	3.9	5.6	1.1	1.9	2.8	3.3	5.3	5.9	6.9	2.2	1.0	9.1	2.9	12.0	2.1	20.5	8.5	3.2	0.9	1.6	6.5	8.1	5.2	2.4	1.8	2.6	2.9	2.3	4.3	5.4	2.7	4.1	9.1	7.1	14.2	2.5	6.3	6.0	4.3	0.8	7.2	6.8	0.9	8.3	3.7	6.4	6.6	0.9	5.4	7.6	7.1	1.9	3.5	1.8	1.5	7.6	3.1	7.9	11.0	25.9	9.5	8.3	6.1	8.6	6.9	6.7	10.0
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Cell line enriched"	"Detected in some"	5	"BEWO: 44.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"				Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favourable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.4	0.0	0.0	0.0	0.0	44.6	0.2	0.2	0.9	0.2	9.4	0.9	0.0	0.3	0.0	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	5.6	1.4	0.0	0.0	5.7	0.0	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0
SPAG1	"CILD28, CT140, FLJ32920, HSD-3.8, SP75, TPIS"	ENSG00000104450	"Sperm associated antigen 1"	Q07617	8	100157906-100259278	"Disease related genes, Predicted intracellular proteins"	Fertilization	Hydrolase	"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023748, HPA053682"	Enhanced		Supported	Cytosol				Cytosol		"HPA023748: , HPA053682: "	"unprognostic (9.95e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (9.11e-3)"	"unprognostic (8.83e-3)"	"unprognostic (1.54e-1)"	"prognostic favourable (2.62e-4)"	2.0	1.5	3.9	3.5	6.8	9.1	3.6	6.4	5.9	6.0	12.8	7.8	13.5	3.0	3.0	8.5	8.1	10.4	4.4	5.4	5.6	6.1	7.5	10.8	10.0	2.6	4.1	2.6	4.5	3.3	13.0	21.2	1.9	26.2	4.8	19.3	2.8	6.1	14.4	0.7	8.0	3.4	2.0	5.7	2.7	6.5	18.2	5.4	1.3	4.5	0.5	4.3	5.6	3.9	2.9	0.8	2.5	0.6	3.2	0.6	0.2	20.2	5.5	0.3	1.2	1.3	1.1	3.1	3.8	2.3	4.6	4.9	5.4	9.0	0.8	13.7	1.2	10.8	4.0	7.3	4.3	11.8	4.1	3.4	6.2	2.0	1.7	0.9	3.0	0.9	3.9	5.7	4.5	3.9	0.1	11.0	0.7	7.2	1.9	0.9	0.3	6.1	0.3	0.8	3.1	17.7	9.8	3.2	2.4	5.2	4.3	4.5	6.2	3.8	3.5	4.6	6.7	2.4	9.7	7.4	5.7	0.5	4.4	3.2	2.3	0.0	0.4	1.8	0.5	0.0	0.3	2.9	0.4	0.5	0.4	1.2	0.1	0.6	2.5	3.2	0.6	0.8	0.0	0.2	3.9	6.8	6.4	5.9	5.6	6.1	4.1	2.6	26.2	5.4
SPAG7	"ACRP, FSA-1, MGC20134"	ENSG00000091640	"Sperm associated antigen 7"	O75391	17	4959226-4967872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024032, HPA052394"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA024032: AB_1857410, HPA052394: "	"unprognostic (7.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.79e-5)"	"unprognostic (4.66e-3)"	"unprognostic (5.51e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.72e-2)"	18.1	19.8	23.5	15.7	24.4	15.5	16.1	14.4	30.9	15.9	19.4	10.5	20.0	14.7	23.2	22.9	18.5	27.6	17.0	53.7	20.5	19.4	25.2	24.4	17.9	15.6	19.8	21.8	14.8	19.4	19.4	13.2	24.8	22.6	17.7	15.5	16.6	18.9	20.1	106.4	14.3	17.6	20.1	21.8	17.4	17.7	15.0	12.8	13.9	22.5	47.9	16.0	15.7	15.4	38.0	42.8	30.8	35.5	24.3	41.9	33.2	12.2	27.0	35.8	19.8	24.8	36.3	20.7	24.4	27.6	23.8	18.4	15.8	16.1	15.6	36.0	29.8	17.6	17.8	37.0	10.8	22.8	15.9	16.9	22.2	21.9	34.8	9.3	25.4	39.8	26.7	20.3	38.1	29.9	11.2	16.2	28.9	19.4	17.0	20.8	20.3	8.7	18.0	22.7	11.1	40.7	15.4	10.1	19.9	20.7	8.3	20.0	17.9	14.8	28.8	16.2	10.6	7.9	19.8	14.3	11.3	9.5	32.0	13.4	20.9	28.1	35.5	30.8	35.4	29.2	38.4	38.0	33.4	33.0	41.7	31.4	41.9	36.6	9.4	24.3	27.8	42.8	37.2	33.2	23.5	24.4	14.4	30.9	20.5	19.4	19.8	21.8	22.6	12.8
SPAG9	"CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1"	ENSG00000008294	"Sperm associated antigen 9"	O60271	17	50962174-51120865	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 6.3;neutrophil: 13.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040446, HPA061458"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA040446: AB_10671691, HPA061458: "	"unprognostic (1.36e-1)"	"unprognostic (6.61e-2)"	"unprognostic (6.04e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.27e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.67e-2)"	"prognostic unfavourable (8.10e-4)"	21.6	16.4	32.1	12.5	42.6	15.8	13.8	32.7	46.6	15.9	15.6	44.8	7.6	14.0	19.6	9.1	20.7	12.3	18.8	15.1	33.1	25.5	23.6	22.8	20.5	8.7	55.7	25.9	22.2	21.0	25.8	14.6	21.8	37.1	13.2	14.1	12.2	9.9	14.4	39.6	14.2	14.2	19.1	50.2	12.1	10.5	33.3	55.2	8.5	28.2	9.5	10.6	15.0	13.6	1.0	1.3	13.4	1.3	0.5	1.8	0.4	17.5	19.7	25.4	12.3	24.1	21.4	22.4	14.5	14.2	16.3	20.3	17.7	12.1	9.5	10.1	23.7	15.2	16.6	12.1	30.3	14.4	19.7	7.9	15.6	13.1	18.1	11.4	9.3	15.4	14.2	21.9	39.4	13.3	17.5	10.6	22.9	8.8	7.2	4.8	6.7	25.7	8.2	28.3	8.4	14.9	33.5	19.7	27.5	12.7	11.9	13.1	9.7	13.7	18.5	45.4	10.7	34.9	21.1	15.1	21.7	15.6	15.5	6.8	15.7	6.3	1.3	0.8	1.4	0.8	1.0	1.0	1.2	1.3	1.3	1.0	0.7	0.9	13.4	0.5	0.5	1.1	1.8	0.4	32.1	42.6	32.7	34.9	33.1	25.5	55.7	25.9	37.1	55.2
SPANXA1	"CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX"	ENSG00000198021	"Sperm protein associated with the nucleus, X-linked, family member A1"	Q9NS26	X	141583674-141585011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	28	"testis: 14.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA046423: , HPA073647: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1			0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPANXA2	SPANX	ENSG00000203926	"SPANX family member A2"	Q9NS26	X	141589435-141590772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 15.5"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA046423: , HPA073647: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXC	"CT11.3, CTp11"	ENSG00000198573	"SPANX family member C"	Q9NY87	X	141241463-141242496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	24	"testis: 27.3"	"Group enriched"	"Detected in some"	5	"A-431: 13.0;U-2 OS: 6.3"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA046423: , HPA073647: "															"unprognostic (3.56e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	13.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	6.3	0.0	0.5	0.0	0.0	0.2	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPART	"KIAA0610, SPG20, TAHCCP1"	ENSG00000133104	Spartin	Q8N0X7	13	36301638-36370180	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 45.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039053, HPA039054"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039053: AB_10672769, HPA039054: "	"unprognostic (3.73e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.18e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.79e-2)"	28.7	34.7	23.2	12.1	28.0	14.5	44.9	21.3	26.7	37.1	22.5	23.1	26.2	9.1	29.9	48.4	17.7	26.1	26.2	17.5	24.7	22.3	33.7	13.7	18.4	12.9	31.8	19.4	46.1	10.3	13.2	29.8	32.2	28.9	26.6	10.0	17.2	11.9	27.0	20.6	12.4	9.7	37.0	35.7	20.2	14.4	18.3	32.5	7.0	25.1	8.7	7.8	31.4	58.7	3.2	6.0	45.8	6.8	4.1	8.3	5.3	0.0	6.0	16.3	0.0	36.0	30.3	11.7	14.6	22.0	14.8	14.7	0.0	0.0	0.0	9.1	17.6	8.4	22.1	10.1	16.0	1.1	12.8	18.2	7.9	3.8	36.2	18.9	36.9	29.9	16.4	12.2	17.2	21.6	7.9	3.2	26.5	1.3	5.6	31.8	8.2	2.1	0.0	27.4	0.6	17.2	7.5	1.7	4.0	12.4	5.0	15.4	2.9	22.4	17.8	11.1	5.6	15.3	8.5	3.9	0.0	0.0	12.3	16.5	19.3	45.8	6.7	8.7	4.4	6.7	4.3	3.2	6.2	1.8	4.8	3.2	8.3	4.4	10.6	4.1	6.8	6.0	1.5	5.3	23.2	28.0	21.3	26.7	24.7	22.3	31.8	19.4	28.9	32.5
SPATA13	"ARHGEF29, FLJ31208"	ENSG00000182957	"Spermatogenesis associated 13"	Q96N96	13	23979805-24307074	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 19.4;HDLM-2: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA040185, HPA041208"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040185: AB_10795521, HPA041208: AB_10794193"	"unprognostic (8.80e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.21e-1)"	"prognostic favourable (1.16e-4)"	5.5	11.8	14.7	13.9	23.7	21.4	11.8	5.5	15.2	9.2	8.8	33.7	10.9	9.4	7.8	11.9	3.2	8.2	9.8	6.4	15.3	10.5	13.1	17.8	15.3	16.8	27.9	7.4	12.1	29.7	6.1	8.3	13.7	17.7	12.1	10.2	7.5	6.8	9.8	2.4	6.3	11.5	6.2	25.7	47.8	13.8	5.2	27.2	11.9	10.7	3.1	12.8	6.5	4.5	1.2	2.5	19.3	4.7	9.6	17.7	5.8	1.7	2.9	15.2	1.9	0.5	1.3	0.6	4.4	19.4	2.3	1.9	3.7	7.7	11.6	2.4	4.0	3.3	4.3	1.3	5.8	26.2	5.2	2.8	2.2	4.2	0.7	4.4	2.2	1.7	0.2	2.5	1.4	3.8	0.0	9.8	2.4	6.4	8.1	1.5	4.9	3.7	7.1	5.8	6.1	10.3	5.7	5.5	4.2	0.9	9.6	8.6	1.3	2.6	4.4	3.0	2.4	0.2	3.1	2.2	0.0	0.0	2.6	4.3	14.2	2.4	3.1	0.0	17.3	4.0	13.5	1.2	14.7	17.7	2.2	1.0	15.6	16.0	19.3	9.6	4.7	2.5	13.8	5.8	14.7	23.7	5.5	15.2	15.3	10.5	27.9	7.4	17.7	27.2
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051331-52097292	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 41.7;testis: 65.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 19.7;BEWO: 14.8;BJ hTERT+: 9.5;HSkMC: 18.2;hTCEpi: 17.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.5"	"Cell type enriched"	"Detected in single"	23	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favourable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	4.2	2.6	1.2	3.3	0.0	3.7	0.1	1.1	6.8	2.3	3.6	5.3	1.2	2.5	9.9	4.9	41.7	11.5	1.5	3.1	2.8	3.7	4.4	12.0	0.3	0.6	0.6	7.6	1.6	4.2	6.1	1.8	12.5	3.5	3.5	1.4	13.2	6.0	1.1	4.3	2.8	1.8	0.8	0.5	2.9	65.7	0.8	1.3	1.6	4.1	3.1	2.3	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.1	0.0	7.9	19.7	14.8	5.5	9.5	0.3	0.4	0.0	0.9	0.0	0.0	7.2	0.1	0.0	4.2	0.2	0.0	0.6	0.0	0.0	4.6	7.0	0.0	0.0	18.2	17.5	0.6	2.7	4.1	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	1.1	1.2	0.6	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.3	0.1	1.1	3.1	2.8	0.6	0.6	12.5	0.8
SPATA24	"CCDC161, T6441"	ENSG00000170469	"Spermatogenesis associated 24"	Q86W54	5	139396563-139404088	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044000	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044000: AB_10959668"	"unprognostic (2.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	1.0	2.8	3.6	1.0	3.2	0.3	1.4	1.5	2.7	1.3	1.6	2.7	1.8	2.5	1.6	9.4	1.4	6.4	2.9	8.5	3.4	2.6	6.2	1.9	1.9	2.5	2.4	2.1	1.6	2.2	6.1	7.0	1.0	3.2	2.2	0.9	1.7	3.2	1.5	8.7	0.9	2.6	1.9	2.7	1.9	1.5	52.2	2.1	1.8	2.9	3.4	1.9	1.8	3.5	5.7	3.6	2.0	3.1	2.4	7.7	2.5	6.4	4.1	5.8	3.1	1.7	3.2	4.7	1.6	3.1	3.4	6.0	9.3	8.6	10.3	4.8	3.1	3.6	4.4	7.2	3.8	41.2	5.1	3.1	7.7	7.0	6.4	0.7	5.7	2.8	3.6	5.1	6.2	4.1	3.1	18.2	4.6	3.7	6.5	4.9	4.2	3.5	15.2	3.8	13.9	8.1	3.3	4.5	4.1	6.3	12.2	2.9	3.5	7.1	7.6	2.0	2.8	3.9	4.6	4.4	4.2	9.5	4.0	5.4	1.7	0.0	3.1	2.0	4.6	2.3	6.5	5.7	4.9	5.5	3.6	3.3	5.5	7.7	0.2	2.4	0.9	2.1	2.4	2.5	3.6	3.2	1.5	2.7	3.4	2.6	2.4	2.1	3.2	2.1
SPATS2	"FLJ13117, SCR59, SPATA10"	ENSG00000123352	"Spermatogenesis associated serine rich 2"	Q86XZ4	12	49366584-49527424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038642, HPA038643, HPA076823"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA038642: , HPA038643: AB_10672523, HPA076823: "	"unprognostic (2.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (9.57e-8)"	"unprognostic (4.55e-2)"	"unprognostic (6.32e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (5.20e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.81e-1)"	7.7	8.2	10.6	19.9	12.4	5.6	9.4	25.7	18.0	13.5	12.1	4.0	7.7	11.2	19.0	8.3	9.1	6.7	11.0	7.5	11.7	8.9	9.1	5.1	8.0	14.2	9.0	11.0	9.0	12.1	30.6	24.8	8.6	15.6	10.1	11.5	9.8	19.2	9.2	9.7	15.8	10.5	11.6	6.1	11.1	12.2	24.2	4.5	8.8	13.6	5.4	19.1	13.7	13.8	7.8	10.2	1.9	1.8	1.6	2.3	1.5	7.5	17.0	14.7	17.2	8.6	13.5	4.8	8.9	12.6	15.3	12.4	15.7	17.3	18.8	20.8	7.9	9.1	12.6	16.9	19.8	14.2	7.3	16.9	13.0	12.3	15.6	4.5	10.2	11.5	8.4	24.0	22.7	35.7	9.0	17.4	15.7	13.2	9.1	6.8	15.3	17.3	14.0	24.6	22.5	14.2	9.7	16.5	14.9	18.8	12.6	21.4	21.8	5.2	32.2	6.7	16.5	6.0	5.6	23.1	26.1	15.4	8.8	7.8	9.7	1.9	1.8	0.6	2.3	0.5	2.3	7.8	1.9	1.5	5.0	4.9	1.7	1.5	1.3	1.6	0.3	10.2	1.4	1.5	10.6	12.4	25.7	18.0	11.7	8.9	9.0	11.0	15.6	4.5
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482263	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA055427: , HPA066310: "	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	25.0	13.5	22.4	14.3	20.1	4.2	46.1	15.7	25.7	33.1	34.5	14.5	27.2	34.3	20.4	20.7	28.0	34.8	46.9	46.4	18.4	18.8	37.7	44.9	22.4	14.7	21.9	20.9	30.0	24.3	17.1	24.7	26.9	20.3	27.3	34.6	14.9	63.4	28.8	26.5	15.6	44.6	20.6	23.4	22.1	42.2	11.5	16.7	14.3	21.6	17.5	12.3	25.4	46.5	2.2	9.8	22.9	3.3	4.2	17.0	1.6	27.1	15.7	18.5	2.3	12.4	15.9	6.9	48.7	16.3	31.7	23.8	42.4	29.9	0.1	11.3	30.9	27.0	5.6	28.4	20.9	16.3	7.8	0.2	14.3	50.8	22.3	4.6	2.0	19.5	28.3	21.2	20.3	12.3	6.3	19.6	42.1	8.3	0.7	1.3	4.5	36.2	0.1	65.9	1.9	76.5	22.2	0.5	5.2	12.7	7.1	19.8	3.8	6.5	20.4	21.1	21.3	6.5	27.7	5.8	5.6	0.3	18.0	2.2	29.6	22.9	3.1	4.2	3.6	3.3	8.3	1.6	3.9	3.6	9.8	2.2	1.7	2.0	3.1	4.2	2.5	7.6	17.0	1.6	22.4	20.1	15.7	25.7	18.4	18.8	21.9	20.9	20.3	16.7
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24, NDC80 kinetochore complex component"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA051234: "	"unprognostic (1.57e-1)"	"prognostic favourable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	2.8	3.2	1.1	9.0	1.0	19.4	3.8	0.4	1.9	2.8	4.0	0.8	0.9	3.5	2.2	2.8	8.4	1.4	2.4	8.2	1.0	0.4	1.8	2.6	4.2	4.9	0.6	1.0	1.1	1.0	0.1	1.0	5.9	0.6	1.4	3.5	0.8	2.4	1.5	2.7	3.2	4.4	6.7	0.7	5.5	4.0	13.3	0.7	58.0	0.9	12.8	12.2	2.3	3.2	1.9	1.3	7.2	1.4	4.2	3.7	0.7	26.0	9.8	13.6	11.1	1.9	3.6	6.2	15.3	5.7	14.5	16.5	10.3	8.9	20.7	17.5	6.8	14.2	10.6	10.9	10.8	10.9	9.1	27.8	22.9	15.3	0.4	19.4	12.5	0.7	0.4	10.3	4.8	12.8	14.8	43.7	10.1	17.2	26.6	11.8	9.6	15.9	21.3	20.9	6.7	4.3	8.6	14.3	10.3	13.4	8.4	3.5	8.2	7.1	12.0	13.8	14.6	18.4	18.3	26.7	13.7	19.9	10.1	19.3	11.1	4.1	1.4	1.5	1.4	1.2	1.2	1.9	2.3	3.4	0.5	1.9	2.7	1.7	7.2	4.2	1.3	1.3	3.7	0.7	1.1	1.0	0.4	1.9	1.0	0.4	0.6	1.0	0.6	0.7
SPC25	"AD024, MGC22228, SPBC25"	ENSG00000152253	"SPC25, NDC80 kinetochore complex component"	Q9HBM1	2	168834132-168913371	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 38.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.1;T-cells: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047144, HPA050544"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA047144: , HPA050544: "	"unprognostic (3.52e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (8.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (4.74e-6)"	"prognostic unfavourable (9.44e-5)"	"unprognostic (1.84e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.11e-16)"	"unprognostic (9.91e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.57e-1)"	0.9	1.6	3.6	7.2	2.2	6.7	2.1	0.4	3.5	1.3	4.0	0.9	0.0	6.8	1.3	1.5	8.5	0.6	1.0	1.1	2.7	1.6	1.5	1.6	1.9	7.5	1.2	2.5	1.2	2.6	0.7	0.2	3.3	1.1	0.8	3.1	1.3	2.1	0.0	0.7	2.1	3.8	1.8	0.7	4.1	3.0	5.9	1.1	38.0	0.6	5.6	8.0	1.5	2.7	1.1	0.0	0.4	0.1	0.0	2.5	0.4	1.0	8.4	19.5	10.9	0.9	0.9	7.0	11.2	4.3	11.3	9.1	4.3	7.8	6.9	4.9	1.8	10.4	7.5	0.0	10.1	4.7	11.5	13.9	5.3	1.9	0.0	10.3	4.2	0.0	0.5	7.2	0.1	5.7	1.1	7.9	3.2	5.1	7.5	12.5	0.6	11.2	13.5	19.4	3.1	4.5	6.6	14.6	0.9	10.0	6.8	1.8	0.5	7.3	1.6	1.7	20.6	6.6	9.4	15.2	26.5	6.9	2.2	1.6	6.6	0.0	0.1	0.2	0.0	0.1	0.0	0.9	0.4	0.0	0.0	1.1	0.2	0.5	0.4	0.0	0.0	0.0	2.5	0.4	3.6	2.2	0.4	3.5	2.7	1.6	1.2	2.5	1.1	1.1
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 55.8;salivary gland: 98.0"	"Group enriched"	"Detected in some"	5	"MCF7: 68.4;SK-BR-3: 47.3;T-47d: 37.8"	"Group enriched"	"Detected in many"	10	"breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"midbrain: 2.1"	HPA055707			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA055707: "	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.4	2.4	0.2	0.0	28.5	0.3	0.7	12.0	6.5	0.2	0.3	4.4	4.0	0.3	0.9	2.4	16.1	0.1	0.4	0.3	0.1	0.1	5.5	0.1	0.3	0.1	0.6	1.3	0.0	0.1	0.2	0.1	55.8	4.0	0.2	98.0	4.5	0.1	3.0	7.8	0.1	0.1	0.1	10.8	0.1	0.1	0.2	0.1	7.8	22.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	47.3	0.0	37.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.4	0.3	0.3	0.1	0.1	0.1
SPDYA	"Ringo3, SPDY1, SPY1"	ENSG00000163806	"Speedy/RINGO cell cycle regulator family member A"	Q5MJ70	2	28782517-28850611	"Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	50	"testis: 93.4"	"Cell line enhanced"	"Detected in many"		"NB-4: 5.9;THP-1: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035162, HPA066214"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA035162: , HPA066214: "	"unprognostic (3.41e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.10e-4)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.66e-13)"	"unprognostic (8.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.55e-5)"	0.4	0.7	0.7	0.4	0.8	0.7	0.4	1.8	0.6	0.7	0.4	0.5	0.4	0.6	0.4	0.8	0.4	0.3	0.7	0.4	0.8	0.6	0.5	0.6	0.4	0.7	0.6	0.4	0.9	0.6	0.1	0.8	0.4	0.4	1.0	0.2	0.4	0.6	0.4	0.5	1.8	0.5	0.5	0.5	1.1	0.3	93.4	0.4	0.8	0.7	0.4	0.4	0.6	0.4	0.6	1.4	0.0	0.3	0.6	1.0	0.0	1.0	0.5	1.6	3.7	0.0	0.0	2.0	0.9	0.1	0.3	0.1	1.0	0.8	0.9	1.1	0.0	2.4	0.4	0.0	0.4	0.5	1.0	0.8	2.1	3.0	0.1	1.0	1.7	0.3	0.2	0.2	0.5	0.0	0.4	1.5	0.7	0.4	0.4	5.9	0.5	0.4	0.8	2.9	0.9	1.1	0.6	1.3	0.8	1.9	2.4	0.7	0.7	5.6	0.2	2.9	2.3	1.6	1.3	0.8	1.5	1.5	0.8	0.8	0.6	0.0	0.3	0.0	1.0	0.3	0.2	0.5	0.5	0.5	0.1	0.6	0.7	0.8	0.0	0.6	0.2	1.4	0.1	0.0	0.7	0.8	1.8	0.6	0.8	0.6	0.6	0.4	0.4	0.4
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20009344-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9"	"Cell line enhanced"	"Detected in many"		"SiHa: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	10.7	8.3	21.3	7.2	38.0	29.9	8.1	16.0	30.8	7.0	14.9	49.9	0.7	9.5	15.4	6.1	11.4	7.3	20.0	4.1	23.1	15.4	4.3	2.0	5.6	5.7	35.8	21.2	17.0	8.3	3.0	6.8	4.8	29.3	7.3	15.5	3.0	5.9	4.9	4.3	4.8	11.4	11.5	28.2	17.3	9.8	25.8	41.5	0.2	6.7	1.4	6.0	7.0	4.2	2.9	14.7	18.9	9.4	8.5	3.4	3.0	17.2	18.0	9.8	3.2	7.4	3.8	21.1	7.0	5.8	7.1	8.8	29.3	15.4	1.0	22.9	6.0	12.9	7.4	16.7	3.5	5.2	7.9	7.1	19.7	3.2	2.7	0.7	4.2	4.0	17.0	10.0	11.3	0.1	0.8	8.7	5.5	14.7	0.2	3.9	7.8	4.3	4.2	19.7	9.9	17.3	8.7	3.2	3.2	36.8	17.7	7.8	15.6	4.6	0.5	0.9	10.8	1.0	19.0	3.4	4.3	1.4	10.4	5.9	4.1	18.9	9.4	17.8	3.1	5.3	2.9	2.4	1.9	3.4	14.7	2.9	1.8	2.4	8.1	8.5	4.6	4.4	0.9	3.0	21.3	38.0	16.0	30.8	23.1	15.4	35.8	21.2	29.3	41.5
SPECC1L	"CYTSA, KIAA0376"	ENSG00000100014	"Sperm antigen with calponin homology and coiled-coil domains 1 like"	Q69YQ0	22	24270817-24417740	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA070614	Uncertain		Supported	"Actin filaments"				"Actin filaments"		"HPA070614: "	"unprognostic (3.54e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-3)"	"prognostic favourable (7.92e-4)"	"unprognostic (3.15e-3)"	"unprognostic (6.20e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.41e-1)"	15.0	15.5	21.6	16.9	19.5	12.7	22.1	46.5	24.4	20.1	17.1	12.3	19.0	8.6	20.7	16.6	19.7	18.2	15.7	20.2	19.5	16.0	15.7	16.9	19.1	12.6	15.8	12.1	25.8	15.0	22.6	23.1	20.4	20.5	23.4	19.0	12.2	16.8	22.2	17.0	11.0	13.7	24.1	17.8	13.9	14.3	33.8	19.2	17.1	27.3	8.9	14.6	17.5	32.5	6.5	7.0	8.6	6.9	2.4	6.7	3.3	13.7	10.7	20.0	11.1	19.8	19.4	6.8	19.5	16.2	17.6	17.6	11.6	3.8	20.1	4.7	18.3	12.5	18.4	11.3	21.0	11.7	10.1	13.0	6.1	10.8	13.1	22.9	12.6	16.2	9.3	15.7	16.6	20.3	10.9	8.7	18.7	8.0	11.8	8.5	9.9	8.2	10.8	20.7	7.1	9.0	10.9	17.5	18.2	17.1	13.1	11.4	8.4	6.5	21.3	37.6	21.2	9.1	13.4	10.3	9.7	8.9	10.8	8.7	13.5	6.7	4.5	8.6	6.7	6.9	5.2	5.3	4.5	3.1	4.4	6.5	5.7	5.6	6.1	2.4	2.9	7.0	3.1	3.3	21.6	19.5	46.5	24.4	19.5	16.0	15.8	12.1	20.5	19.2
SPEN	"KIAA0929, MINT, RBM15C, SHARP"	ENSG00000065526	"Spen family transcriptional repressor"	Q96T58	1	15847864-15940460	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015825, HPA050257"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA015825: AB_1856823, HPA050257: "	"unprognostic (3.91e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.83e-1)"	18.2	11.2	18.2	18.2	22.2	27.2	17.3	38.2	25.9	18.5	13.4	20.7	17.7	11.9	19.0	12.7	16.7	19.4	11.8	13.5	17.6	11.5	14.4	13.2	17.8	16.6	23.4	17.5	31.2	23.9	35.1	17.5	16.2	19.0	14.9	13.3	11.6	16.2	16.2	24.0	22.8	16.0	15.1	22.0	16.5	13.7	13.6	23.3	18.3	20.1	8.7	18.0	17.1	41.9	5.0	2.7	7.7	2.4	1.3	1.7	0.6	12.5	10.7	13.4	10.0	13.4	8.2	7.2	6.5	8.6	7.1	6.0	9.6	9.8	17.8	7.8	12.8	18.2	12.5	11.6	11.5	15.9	34.7	22.3	9.4	6.1	6.1	18.3	10.7	6.0	8.4	10.6	15.4	8.0	23.1	18.3	5.7	7.0	15.1	7.2	6.0	8.2	14.6	13.0	11.0	4.0	11.3	10.3	10.4	18.3	9.0	7.8	3.2	9.0	14.5	6.5	8.1	12.6	9.3	11.1	7.2	20.3	6.4	14.7	9.1	7.7	1.5	0.9	1.6	2.4	1.3	1.8	1.7	1.4	0.7	5.0	0.9	1.3	4.2	1.3	1.2	2.7	1.1	0.6	18.2	22.2	38.2	25.9	17.6	11.5	23.4	17.5	19.0	23.3
SPG11	"FLJ21439, KIAA1840"	ENSG00000104133	"SPG11, spatacsin vesicle trafficking associated"	Q96JI7	15	44562696-44663678	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040412, HPA040947"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA040412: AB_10795418, HPA040947: AB_10796232"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.99e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.19e-2)"	"prognostic favourable (6.28e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.06e-2)"	23.8	24.6	16.6	26.4	22.2	25.8	23.4	21.2	21.2	20.8	26.0	31.7	25.8	17.9	18.6	28.1	22.9	19.0	20.2	19.3	16.1	15.2	22.0	25.1	22.6	26.9	26.3	15.6	20.5	25.5	33.4	25.9	15.7	22.1	22.3	21.6	18.7	22.7	26.6	19.0	31.8	26.2	21.5	22.1	39.2	22.8	22.1	23.1	35.8	30.9	12.6	26.0	23.0	19.4	12.8	7.1	13.6	13.0	6.7	8.3	3.8	8.1	5.5	14.2	13.8	22.2	21.9	10.2	8.6	11.1	8.4	10.8	6.7	7.9	6.0	10.8	11.4	18.7	9.8	13.2	8.3	18.0	6.0	13.8	13.1	10.1	15.7	13.7	12.7	16.7	15.1	6.9	19.9	11.9	17.5	15.5	11.9	7.1	6.1	12.7	7.5	7.6	8.1	11.9	6.5	17.9	21.4	9.3	10.9	9.4	15.0	8.0	14.2	18.8	12.9	11.2	5.6	13.9	10.3	15.5	13.7	12.0	11.5	18.2	11.4	6.0	8.8	12.3	7.8	10.2	8.3	10.9	6.5	5.8	6.9	12.8	5.4	6.4	13.6	6.7	13.0	7.1	6.6	3.8	16.6	22.2	21.2	21.2	16.1	15.2	26.3	15.6	22.1	23.1
SPG21	"ACP33, BM-019, GL010, MAST"	ENSG00000090487	"SPG21, maspardin"	Q9NZD8	15	64963021-64990310	"Disease related genes, Predicted intracellular proteins"			"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 47.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040407, HPA040436"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA040407: , HPA040436: AB_10796454"	"unprognostic (7.47e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.40e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.19e-1)"	34.2	34.0	22.4	27.6	24.3	28.2	48.6	12.6	23.7	31.1	28.7	25.1	38.7	23.8	31.6	73.3	29.4	34.9	30.6	25.3	23.4	22.9	39.2	66.3	33.3	40.4	25.7	17.8	35.6	25.3	26.3	28.4	48.2	18.8	30.0	28.3	33.7	31.9	47.0	35.4	28.9	37.8	30.4	29.3	31.7	31.1	26.8	19.3	33.5	50.1	28.9	26.1	31.4	24.7	9.4	20.4	47.7	35.8	3.9	5.5	11.5	22.3	33.5	16.9	32.0	43.8	43.4	21.2	14.0	47.8	28.0	32.7	15.0	34.9	25.8	21.9	32.8	30.0	48.5	32.9	26.7	10.6	15.6	22.3	22.7	27.0	55.6	21.0	19.8	29.5	37.7	22.2	42.1	33.4	18.5	21.0	34.1	31.9	19.3	18.5	18.7	17.6	20.1	18.1	45.1	28.7	27.2	20.8	18.6	16.6	35.3	31.8	24.1	35.9	16.3	23.8	24.8	33.8	20.9	15.1	25.6	15.1	30.8	56.0	20.0	2.1	35.8	3.8	4.0	21.3	3.7	9.4	3.8	4.1	20.4	8.1	5.5	3.1	47.7	3.9	17.2	6.6	4.3	11.5	22.4	24.3	12.6	23.7	23.4	22.9	25.7	17.8	18.8	19.3
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 33.7;U-251 MG: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 11.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	9.3	2.2	4.7	10.5	3.5	15.0	20.4	0.4	3.2	5.5	5.0	4.0	0.4	1.9	6.3	8.3	13.8	5.3	12.7	10.5	5.3	2.1	4.1	2.4	12.9	10.1	4.4	1.5	5.5	15.1	3.1	2.7	7.4	4.7	4.3	1.1	11.0	11.5	1.7	6.8	8.7	6.3	5.2	4.0	2.7	3.8	3.7	6.3	3.0	9.4	16.2	12.1	5.6	7.0	0.2	8.0	2.4	3.4	0.1	1.4	1.3	9.6	1.0	4.2	0.2	2.1	2.0	4.4	22.3	14.8	18.8	11.4	5.2	1.0	0.4	2.0	16.4	2.0	3.2	28.6	4.6	0.4	1.7	0.1	7.1	33.7	4.7	0.3	0.8	3.8	0.5	29.3	11.6	18.1	4.5	0.0	3.7	12.3	0.9	0.1	0.2	8.1	0.6	1.1	0.7	1.0	0.1	0.5	1.0	2.2	0.2	19.3	0.8	1.3	29.4	29.6	5.7	22.7	37.7	0.4	0.1	0.4	22.5	1.7	4.4	2.4	3.4	0.0	1.4	1.7	0.4	0.0	0.2	0.4	1.0	0.2	0.0	0.3	0.4	0.1	0.3	8.0	0.0	1.3	4.7	3.5	0.4	3.2	5.3	2.1	4.4	1.5	4.7	6.3
SPHK2		ENSG00000063176	"Sphingosine kinase 2"	Q9NRA0	19	48619291-48630717	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065508			Supported	Vesicles				Vesicles		"HPA065508: "	"unprognostic (5.33e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavourable (5.19e-4)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (4.45e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.80e-1)"	"prognostic favourable (9.30e-4)"	"unprognostic (1.25e-1)"	"prognostic favourable (2.59e-5)"	"unprognostic (1.18e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.06e-2)"	9.3	8.9	12.6	9.9	13.0	5.2	5.1	13.6	22.0	7.2	12.9	13.4	4.9	33.2	7.4	4.2	4.9	7.3	7.8	4.7	22.5	14.8	19.3	15.2	6.1	8.7	26.3	14.9	9.1	7.2	15.0	9.5	4.1	22.3	8.7	6.2	7.2	7.5	8.0	6.1	4.3	22.2	4.9	14.1	8.4	11.3	17.2	13.7	4.0	9.1	3.1	5.3	6.2	12.4	10.4	7.4	12.5	9.4	7.2	7.0	4.2	4.0	11.7	4.4	8.0	4.8	2.0	8.3	4.4	3.7	5.2	6.2	20.0	5.4	7.6	3.0	2.8	3.0	4.1	3.6	0.7	8.6	9.6	8.4	5.1	7.0	7.6	5.4	9.3	3.7	1.9	3.6	2.5	2.8	5.5	6.8	2.5	4.2	12.6	33.3	5.8	5.7	11.7	3.5	4.9	2.4	2.7	15.9	12.6	4.2	6.7	4.2	3.6	3.6	4.5	7.4	4.1	5.8	8.8	13.1	15.1	8.4	4.3	6.2	6.7	12.5	8.3	3.6	6.0	9.4	5.9	6.5	4.8	5.8	7.4	10.4	6.6	7.0	3.3	7.2	7.4	6.6	4.6	4.2	12.6	13.0	13.6	22.0	22.5	14.8	26.3	14.9	22.3	13.7
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378576	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 100.3;lymphoid tissue: 70.2"	"Cell line enhanced"	"Detected in some"		"HEL: 18.7;HL-60: 32.9;HMC-1: 61.4;NB-4: 55.5;THP-1: 43.2;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 45.4;neutrophil: 24.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 45.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB004079: AB_10692379, HPA044653: "	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	24.4	8.1	6.7	35.7	15.2	100.3	9.0	1.5	6.6	3.6	5.2	8.6	0.0	7.6	3.2	6.2	4.0	8.5	7.7	15.7	5.6	5.1	5.8	11.9	37.2	51.1	12.6	1.6	6.1	3.5	0.9	3.6	10.1	9.6	4.5	3.9	3.9	6.4	2.6	3.3	5.0	10.5	7.6	12.1	70.2	5.8	5.4	10.5	9.6	3.7	2.7	16.8	9.1	5.7	1.0	4.6	45.4	9.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	32.9	61.4	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	55.5	0.0	0.0	10.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	43.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	17.5	0.0	24.4	0.0	3.6	5.4	45.4	0.0	7.8	0.0	1.0	0.0	0.0	4.6	0.8	0.0	0.0	24.8	0.0	9.1	0.2	0.0	1.5	6.7	15.2	1.5	6.6	5.6	5.1	12.6	1.6	9.6	10.5
SPICE1	"CCDC52, SPICE"	ENSG00000163611	"Spindle and centriole associated protein 1"	Q8N0Z3	3	113442718-113515187	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064843	Approved		Supported	Centrosome				Centrosome		"HPA064843: AB_2685367"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.89e-2)"	"unprognostic (4.75e-3)"	"unprognostic (6.53e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.95e-2)"	8.1	6.3	9.3	13.4	8.6	6.1	11.7	17.8	8.4	14.0	9.6	8.1	20.6	6.4	16.3	9.8	10.2	13.5	11.1	8.3	8.9	4.9	7.8	7.7	11.5	6.6	7.1	7.6	15.3	11.2	12.5	40.4	7.7	8.6	11.6	10.9	7.8	15.0	19.6	5.1	10.2	8.9	11.3	9.9	6.8	10.5	10.5	8.9	17.1	12.9	4.7	10.7	13.2	14.4	8.5	12.0	4.5	5.4	3.2	9.3	2.5	16.0	10.6	13.2	11.3	8.1	9.9	9.3	8.4	5.8	10.2	12.9	8.9	9.5	10.1	10.7	6.9	15.6	6.8	7.9	14.3	6.2	3.6	9.4	10.7	6.2	4.1	17.1	7.1	6.9	7.8	10.6	4.8	7.5	5.7	8.7	4.3	16.7	14.6	8.1	12.9	12.7	11.2	9.8	8.0	4.5	11.3	7.2	12.2	9.0	9.2	5.5	10.4	8.2	7.3	7.4	9.9	5.0	7.1	8.6	5.6	14.4	11.3	10.2	8.3	4.5	5.4	1.9	4.5	3.7	6.9	7.3	6.7	5.2	3.7	8.5	9.3	6.9	2.8	3.2	3.4	12.0	3.2	2.5	9.3	8.6	17.8	8.4	8.9	4.9	7.1	7.6	8.6	8.9
SPIDR	KIAA0146	ENSG00000164808	"Scaffolding protein involved in DNA repair"	Q14159	8	47260575-47736306	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA027201, HPA041582"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA027201: AB_10603774, HPA041582: "	"unprognostic (5.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.72e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.93e-2)"	"prognostic unfavourable (8.91e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (2.04e-6)"	"unprognostic (5.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.35e-2)"	21.1	21.6	24.0	22.4	20.7	15.6	23.8	47.5	32.1	18.2	18.9	15.5	17.1	12.8	29.7	18.9	28.6	19.5	25.1	14.4	20.1	17.5	15.3	16.3	21.4	18.0	15.9	18.7	28.4	20.5	19.4	39.8	21.4	22.4	20.8	18.5	19.9	20.6	15.8	15.7	24.0	15.1	21.4	18.6	23.3	20.2	16.7	15.3	12.7	23.2	10.5	25.2	21.0	24.8	7.9	9.6	5.2	11.1	8.6	11.4	5.5	8.3	14.1	8.9	14.1	10.3	12.7	7.3	10.7	7.9	8.5	12.3	7.6	19.7	16.8	12.9	9.4	4.6	9.3	8.1	12.8	5.0	8.8	11.7	12.4	14.3	11.1	8.7	7.3	6.9	7.9	6.8	10.2	6.2	8.5	6.0	8.4	20.5	16.3	21.7	11.0	3.5	8.1	5.2	0.9	11.6	31.5	4.5	10.6	15.8	13.2	5.9	12.7	16.3	10.9	6.8	9.8	8.3	7.2	7.2	12.8	11.8	7.1	12.0	6.5	4.8	11.1	3.5	11.4	7.2	11.3	7.9	5.1	6.9	9.6	7.4	5.7	5.1	5.2	8.6	8.2	1.6	10.0	5.5	24.0	20.7	47.5	32.1	20.1	17.5	15.9	18.7	22.4	15.3
SPIN1	"SPIN, TDRD24"	ENSG00000106723	"Spindlin 1"	Q9Y657	9	88388419-88478694	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Meiosis, Wnt signaling pathway"	"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000162, HPA068784"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA000162: AB_1080079, HPA068784: "	"unprognostic (1.53e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (8.78e-2)"	"unprognostic (8.32e-2)"	"prognostic favourable (8.69e-6)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-1)"	12.2	15.0	28.3	9.4	34.2	7.0	19.7	22.6	38.0	34.9	14.4	23.7	10.2	10.4	34.4	44.0	15.5	28.6	17.5	15.6	27.1	28.7	24.9	11.3	14.1	8.3	21.7	27.2	32.2	12.2	28.4	19.6	26.9	26.3	21.6	14.1	16.8	12.9	24.6	3.5	13.4	12.1	25.7	22.0	9.9	11.6	18.5	15.9	12.7	22.9	6.8	9.1	15.4	21.3	4.5	8.1	8.1	4.2	4.2	7.8	4.9	23.2	11.6	19.2	16.2	13.1	15.4	22.5	23.4	21.7	26.8	19.7	8.5	13.6	12.9	13.9	28.6	35.8	14.2	21.2	30.8	13.5	8.7	6.2	24.5	9.0	12.1	14.1	6.8	12.8	22.2	18.1	25.6	15.2	7.9	0.0	30.0	16.0	23.8	6.4	31.6	10.9	32.0	20.9	4.2	24.2	16.4	27.2	20.5	27.8	17.6	10.2	13.5	11.2	14.4	17.8	19.0	26.4	16.5	5.4	8.0	11.3	21.5	13.1	16.6	8.1	4.2	6.4	6.7	3.8	7.1	4.5	5.0	6.9	8.1	3.4	7.1	7.8	0.6	4.2	3.3	3.8	4.5	4.9	28.3	34.2	22.6	38.0	27.1	28.7	21.7	27.2	26.3	15.9
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor, Kazal type 5"	Q9NQ38	5	148025683-148137289	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 12.1;HeLa: 17.9;Karpas-707: 15.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"		28000000	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	0.1	0.0	0.2	0.1	0.1	0.0	2.8	0.1	0.2	101.6	0.7	0.2	0.1	0.0	3.2	0.2	313.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.2	1.7	0.2	18.1	0.1	0.2	48.6	0.1	0.1	0.1	0.1	0.7	0.2	0.1	3.6	0.3	97.4	65.3	0.3	64.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	1.5	0.0	12.1	0.0	1.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.2	0.7	15.8	0.0	1.7	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	4.6	2.4	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	4.1	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 121.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.3;HaCaT: 58.6;hTCEpi: 41.7;RT4: 47.5;SK-BR-3: 88.0;T-47d: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		3400000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: "	"prognostic unfavourable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.2	0.5	0.9	11.6	1.2	0.0	12.6	2.9	0.8	12.9	64.4	1.2	38.6	31.9	3.6	25.5	71.1	6.4	30.7	0.8	0.8	0.7	27.9	1.5	18.5	3.7	0.9	0.6	3.4	25.0	28.8	9.7	85.5	1.3	17.5	17.9	3.2	50.8	24.0	0.6	39.1	121.0	2.3	1.0	3.1	17.6	1.9	0.7	4.8	15.4	26.9	44.3	12.8	21.5	5.1	19.0	15.3	10.9	3.6	1.8	3.8	18.8	0.1	0.0	0.1	0.0	0.0	51.3	0.3	0.4	0.6	0.3	30.0	31.5	0.0	22.5	0.0	58.6	4.8	28.2	0.4	0.1	1.6	0.8	0.5	1.6	0.3	3.3	14.9	0.0	41.7	0.6	2.6	2.3	0.4	0.1	0.0	14.6	0.1	2.5	5.8	2.7	1.9	0.0	3.7	28.4	47.5	12.6	0.6	1.4	88.0	2.3	42.0	2.4	0.0	0.0	0.3	0.1	0.0	0.1	3.5	0.1	0.1	2.4	0.1	0.0	10.9	7.9	0.3	9.3	0.5	5.1	1.8	0.8	19.0	3.9	0.7	0.2	15.3	3.6	9.6	2.3	0.2	3.8	0.9	1.2	2.9	0.8	0.8	0.7	0.9	0.6	1.3	0.7
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 303.9;kidney: 700.7;placenta: 331.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 213.7;Hep G2: 105.2;RPTEC TERT1: 466.7"	"Cancer enhanced"	"Detected in all"		"glioma: 1690.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Region enhanced"	"Detected in all"		"pons and medulla: 331.4"	"Low region specificity"	"Detected in all"			"CAB002212, HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	180200000	54000000	"Golgi apparatus"		"CAB002212: AB_564074, HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavourable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61.0	4.7	2.7	27.3	0.0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2.0	97.0	9.1	3.1	23.6	1.3	1.5	331.0	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2.0	2.4	58.9	0.0	1.7	0.0	1.6	5.3	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	6.1	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	213.7	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	105.2	0.0	0.2	0.2	0.0	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	9.9	0.0	0.1	0.0	50.1	466.7	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.2	0.0	0.5	1.1	0.0	1.1	0.0	0.3	0.4	19.5	0.0	19.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	25.5	42.7	4.3	28.8	37.2	26.4	97.0	9.1	52.3	58.9
SPPL2A	"IMP3, PSL2"	ENSG00000138600	"Signal peptide peptidase like 2A"	Q8TCT8	15	50702266-50765808	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036062, HPA067304"	Enhanced		Supported	Vesicles				Vesicles		"HPA036062: AB_10611670, HPA067304: "	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.66e-1)"	20.5	23.5	6.9	18.0	8.6	15.0	23.3	6.2	8.1	16.4	29.3	10.8	15.3	24.9	14.5	17.9	18.7	13.0	14.9	37.6	7.8	5.3	23.3	44.8	19.2	23.9	8.3	6.1	13.2	32.7	61.0	11.8	32.2	14.4	14.7	26.9	14.9	21.7	15.5	63.1	15.8	39.2	20.5	8.5	21.2	18.3	10.2	7.4	21.6	15.6	17.4	17.7	19.7	13.9	9.8	19.4	24.0	27.3	11.9	15.4	22.4	15.2	26.5	10.3	13.7	40.9	24.4	16.3	24.6	41.3	22.6	32.3	30.7	17.7	9.5	18.4	48.1	23.0	12.4	14.9	25.3	19.4	7.6	18.0	18.2	15.9	33.8	11.1	29.4	21.2	27.5	18.7	30.3	22.2	13.5	37.4	29.8	35.2	5.2	4.3	4.5	6.0	6.5	16.1	20.8	31.1	35.5	8.3	9.4	14.8	28.6	16.6	20.3	22.1	27.0	36.6	14.7	23.4	28.9	15.2	26.0	10.5	16.5	18.8	24.9	21.2	26.9	24.0	15.4	24.6	9.7	9.8	12.6	13.9	19.4	9.3	7.2	11.5	19.4	11.9	27.3	17.1	15.4	22.4	6.9	8.6	6.2	8.1	7.8	5.3	8.3	6.1	14.4	7.4
SPPL3	"DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4"	ENSG00000157837	"Signal peptide peptidase like 3"	Q8TCT6	12	120762510-120904371	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004194, HPA059958"	Uncertain		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA004194: , HPA059958: "	"unprognostic (3.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.96e-3)"	"prognostic unfavourable (1.29e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.40e-2)"	17.8	15.3	18.9	12.8	23.1	13.9	19.4	21.8	31.4	25.2	20.4	25.6	18.4	14.0	23.1	13.3	39.5	23.3	18.2	13.9	17.4	18.3	18.3	14.9	20.8	21.5	19.2	20.6	25.9	19.6	42.4	14.3	21.9	16.5	16.9	21.7	19.1	19.2	22.7	13.8	48.3	18.5	23.5	17.1	19.0	14.2	34.7	20.8	25.2	24.7	22.2	20.6	19.8	29.3	4.1	6.3	7.3	2.9	2.8	4.4	1.5	12.3	12.3	18.7	11.7	24.8	16.8	13.2	9.5	28.4	20.5	16.5	12.8	12.7	11.4	0.1	16.5	15.2	19.1	20.5	21.3	9.0	11.7	9.8	7.4	9.7	26.2	11.2	12.7	16.8	32.9	17.6	16.5	20.1	10.7	5.7	17.6	10.9	14.9	9.0	12.5	8.8	8.9	15.8	8.1	16.1	35.2	12.8	13.8	18.1	8.4	14.3	25.2	7.8	14.9	9.5	13.0	5.8	7.1	13.4	24.0	11.1	14.2	9.4	15.7	7.3	2.9	2.6	3.2	2.8	4.4	3.2	4.0	4.0	4.9	4.1	3.9	4.3	5.5	2.8	2.4	6.3	3.1	1.5	18.9	23.1	21.8	31.4	17.4	18.3	19.2	20.6	16.5	20.8
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887360-72892158	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 61.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 9.9;monocytes: 9.3"	"Low region specificity"	"Detected in all"							HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol			52000	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	13.3	22.6	6.3	6.1	8.2	0.0	36.2	2.0	6.4	6.0	17.1	3.1	8.9	11.4	5.7	19.1	13.4	13.2	11.4	16.1	6.4	6.0	20.3	43.5	7.2	5.3	7.9	5.0	8.7	61.7	16.7	5.5	3.9	7.9	17.3	16.2	4.5	20.9	8.8	16.0	3.3	15.1	9.5	4.9	4.7	15.4	4.9	7.2	1.0	31.7	6.2	3.6	9.5	41.4	0.0	9.9	0.7	9.3	0.0	0.4	2.5	13.9	39.2	0.2	6.1	16.1	5.8	9.8	6.6	9.6	4.9	4.6	24.9	14.5	10.2	7.9	7.8	13.2	17.5	10.5	4.1	2.9	13.6	15.3	9.7	25.5	6.0	2.4	4.2	5.2	11.8	5.4	6.1	12.9	15.7	2.0	6.4	29.4	0.9	9.1	3.3	37.5	0.0	25.5	6.0	26.0	21.9	2.4	4.6	12.1	27.3	8.9	12.3	2.9	15.8	5.4	13.2	9.4	11.5	2.2	4.9	0.7	7.7	5.2	9.3	0.0	9.3	0.7	0.4	2.6	0.4	0.0	0.2	0.1	9.9	0.0	0.2	0.4	0.0	0.0	1.0	0.9	0.0	2.5	6.3	8.2	2.0	6.4	6.4	6.0	7.9	5.0	7.9	7.2
SPRED1	"FLJ33903, PPP1R147"	ENSG00000166068	"Sprouty related EVH1 domain containing 1"	Q7Z699	15	38252326-38357249	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.3;non-classical monocyte: 4.0"	"Lineage enriched"	"Detected in many"	4	"monocytes: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042193, HPA061805"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA042193: AB_10794079, HPA061805: "	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"prognostic favourable (7.08e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.21e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.27e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavourable (7.37e-5)"	"prognostic unfavourable (8.29e-5)"	"unprognostic (6.04e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.01e-1)"	17.6	9.5	21.2	9.5	24.2	1.1	12.4	8.6	24.6	13.9	12.3	14.7	2.9	9.1	12.5	7.2	7.1	8.1	15.3	8.0	18.2	14.0	10.4	6.3	18.9	7.5	16.1	12.9	10.0	5.3	11.7	6.2	15.3	13.8	10.2	12.3	10.2	8.0	10.3	4.1	6.9	9.4	10.6	16.5	9.8	11.5	9.0	13.7	2.3	33.7	5.4	5.5	9.2	11.8	0.0	1.0	0.2	4.0	0.2	0.3	0.1	5.0	4.0	28.8	5.2	10.1	18.5	2.3	12.1	11.8	6.2	7.8	3.5	4.0	0.0	4.5	9.6	4.1	2.9	7.8	12.2	0.7	0.9	5.8	2.6	3.3	12.4	3.1	16.7	12.0	3.9	11.7	10.9	4.8	5.3	5.7	14.6	1.3	1.2	2.3	5.7	10.4	0.0	6.1	3.2	9.7	8.0	1.3	6.3	3.3	1.6	12.2	1.3	0.7	8.6	15.1	7.7	9.1	7.1	5.0	3.2	7.6	10.7	1.3	24.1	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.2	4.0	0.0	0.0	0.1	21.2	24.2	8.6	20.3	18.2	14.0	16.1	12.9	13.8	13.7
SPRTN	"C1orf124, DKFZP547N043, DVC1, Spartan"	ENSG00000010072	"SprT-like N-terminal domain"	Q9H040	1	231337104-231355023	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025073	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA025073: AB_1847695"	"unprognostic (2.63e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.35e-2)"	8.0	8.3	7.5	7.7	9.4	16.2	9.0	7.3	10.0	8.4	7.1	12.4	8.2	6.4	8.5	7.2	11.2	7.3	7.3	8.4	7.7	7.1	8.1	9.6	6.1	9.4	9.9	7.1	7.2	6.3	9.0	12.7	12.5	10.9	6.6	6.3	7.1	8.7	7.2	18.5	9.3	7.0	8.1	10.1	9.2	7.3	23.3	9.3	16.1	8.3	10.9	9.6	7.8	7.6	6.7	6.5	13.8	9.1	8.6	10.1	5.0	11.4	10.1	9.2	10.0	8.5	6.1	11.1	10.5	9.2	12.2	10.5	11.4	10.2	10.4	11.3	8.6	17.2	12.9	10.4	13.1	8.7	22.5	6.5	9.8	7.8	9.2	10.8	9.6	8.3	11.2	13.0	10.7	12.1	15.8	10.3	12.0	6.2	11.5	6.4	9.0	8.6	10.2	12.2	12.4	10.4	8.6	11.6	11.1	11.1	8.7	11.9	15.8	16.6	8.9	10.5	10.7	14.9	16.7	7.9	8.3	14.2	8.2	9.6	17.7	9.3	6.6	13.0	7.7	9.1	8.7	6.7	7.8	9.1	6.5	5.2	9.3	10.1	13.8	8.6	6.5	6.1	8.1	5.0	7.5	9.4	7.3	10.0	7.7	7.1	9.9	7.1	10.9	9.3
SPRY2	hSPRY2	ENSG00000136158	"Sprouty RTK signaling antagonist 2"	O43597	13	80335976-80340951	"Disease related genes, Plasma proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 68.8;SK-MEL-30: 37.4;WM-115: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037205, HPA042198"	Approved		Supported	"Actin filaments,Microtubules"				"Actin filaments, Microtubules"		"CAB037205: AB_261923, HPA042198: "	"unprognostic (9.37e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.80e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.86e-2)"	44.5	20.4	23.2	9.8	21.9	20.8	45.0	41.2	29.3	26.5	22.7	18.6	10.5	14.3	17.1	15.5	16.9	23.8	25.4	28.2	22.7	15.0	15.0	22.3	21.8	9.2	20.8	22.7	14.4	22.1	7.1	10.2	11.5	33.9	16.2	23.0	19.0	28.0	16.8	25.4	14.4	18.1	19.7	30.4	23.6	14.5	6.0	20.2	3.7	15.6	13.1	5.3	16.7	20.5	0.6	1.8	3.9	0.0	7.5	1.7	0.4	0.4	1.9	21.8	68.8	28.9	19.0	1.5	17.5	8.0	4.0	4.8	8.7	2.6	0.0	3.0	7.2	1.6	1.2	3.5	4.5	0.0	3.9	3.0	1.1	2.2	6.6	15.6	1.2	8.4	3.8	6.8	16.7	7.7	1.0	0.0	9.0	0.3	2.1	7.1	8.6	5.0	6.3	29.0	0.0	7.5	2.9	0.2	12.1	1.4	0.8	37.4	1.6	14.0	11.2	3.7	1.4	7.8	3.3	0.0	0.0	0.0	25.6	6.0	35.0	0.0	0.0	3.9	0.8	0.0	0.3	0.6	0.0	1.7	1.8	0.0	0.1	0.3	0.1	7.5	0.0	0.3	0.0	0.4	23.2	21.9	41.2	29.3	22.7	15.0	20.8	22.7	33.9	20.2
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66685248-66729226	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7;skin 1: 36.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 19.9;NTERA-2: 23.1;SCLC-21H: 23.5;T-47d: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Cell Junctions,Cytosol"			4800000	"Cell Junctions, Cytosol"		"CAB009844: AB_2194521, HPA039293: , HPA043529: "	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	0.8	4.9	26.2	1.0	38.3	1.7	4.5	29.6	46.7	9.6	0.9	2.0	0.0	1.0	1.1	1.2	12.7	2.6	1.2	0.7	19.7	8.2	12.7	7.1	0.9	0.5	6.5	24.7	0.8	8.3	12.2	3.9	0.7	14.4	6.8	0.7	1.7	13.4	3.1	0.7	36.9	0.9	1.2	1.9	0.9	1.2	18.9	6.2	0.0	0.5	0.1	3.3	1.1	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.4	3.3	1.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.1	8.0	0.0	1.7	0.0	7.7	11.7	1.1	0.0	0.0	4.6	0.0	19.9	1.1	0.3	3.3	0.3	0.1	5.4	0.0	3.5	2.9	3.2	0.0	0.0	12.5	2.6	1.5	23.1	10.3	10.7	1.3	6.6	4.4	1.1	23.5	13.8	6.5	16.4	1.5	18.7	0.9	0.6	0.0	4.1	0.6	5.1	0.3	1.2	6.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.2	38.3	29.6	46.7	19.7	8.2	6.5	24.7	14.4	6.2
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: "	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	16.4	17.7	13.3	11.4	17.1	9.9	16.8	19.9	17.6	20.3	17.2	20.9	18.1	14.0	17.3	15.1	30.5	19.2	15.5	11.4	13.9	15.3	19.0	13.5	14.8	10.6	18.0	12.2	35.3	15.8	23.6	23.1	28.3	20.5	14.5	18.8	12.0	18.5	13.3	9.4	20.1	17.8	15.1	20.8	10.7	16.0	19.8	14.1	9.7	26.2	16.0	16.5	17.4	20.9	9.3	21.0	21.1	22.1	10.2	15.2	16.0	18.1	16.4	11.4	9.5	27.9	21.7	19.7	19.1	24.4	16.5	17.9	10.3	37.9	10.0	12.2	24.1	47.6	12.3	16.2	19.2	11.5	7.1	9.2	9.3	10.0	21.0	15.2	12.5	19.6	19.6	17.0	18.6	15.0	21.5	12.5	18.7	19.5	9.5	3.8	15.3	12.0	10.6	13.8	7.6	16.4	11.1	9.3	8.6	25.7	19.7	11.6	10.1	9.0	19.0	16.1	12.4	18.5	13.3	9.0	12.3	5.6	19.2	7.5	19.3	14.6	22.1	11.9	11.5	21.6	11.0	8.9	11.6	11.6	21.0	9.3	14.2	10.7	21.1	10.2	19.2	10.8	15.2	16.0	13.3	17.1	19.9	17.6	13.9	15.3	18.0	12.2	20.5	14.1
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606401-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA039372: , HPA040177: , HPA047957: "	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	14.0	12.7	6.2	9.7	9.2	33.6	11.9	10.9	10.9	13.7	10.9	6.9	9.9	8.3	11.9	8.6	15.5	12.5	12.2	9.9	5.8	6.5	14.9	25.1	9.7	8.7	6.0	6.8	16.7	16.9	13.6	14.0	15.3	8.5	12.5	9.7	7.9	13.3	13.9	16.3	12.5	13.7	9.3	7.6	15.0	11.0	7.1	5.5	17.7	12.8	8.0	13.3	12.5	11.8	2.7	3.4	7.8	5.7	7.3	8.7	3.3	8.1	8.1	6.4	9.0	10.8	11.3	9.9	12.1	13.3	10.1	12.2	7.2	3.6	18.3	6.8	11.3	8.5	10.6	9.5	14.5	9.6	10.0	7.3	4.9	6.6	10.4	15.5	14.6	9.3	9.9	6.4	13.1	11.0	10.2	29.1	11.2	8.8	10.3	6.2	5.8	9.0	9.5	17.9	7.8	10.5	11.7	6.2	8.8	10.8	12.5	8.4	7.8	6.6	9.7	9.9	8.4	19.2	7.4	10.2	12.6	14.3	11.8	8.6	8.3	7.8	4.1	5.8	5.7	5.7	8.7	2.6	5.6	5.7	3.4	2.7	5.2	5.6	6.0	7.3	5.4	2.9	6.0	3.3	6.2	9.2	10.9	10.9	5.8	6.5	6.0	6.8	8.5	5.5
SQOR	"CGI-44, SQR, SQRDL"	ENSG00000137767	"Sulfide quinone oxidoreductase"	Q9Y6N5	15	45631148-45691294	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 64.4;RPTEC TERT1: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA017079, HPA041589"	Enhanced		Supported	Mitochondria			30000	Mitochondria		"HPA017079: AB_1857467, HPA041589: "	"unprognostic (6.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.15e-1)"	"prognostic favourable (2.57e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"prognostic unfavourable (8.80e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.44e-2)"	"unprognostic (4.38e-1)"	23.6	8.6	4.4	33.5	5.7	12.0	16.7	1.6	3.8	11.9	54.7	3.0	12.1	14.2	11.7	11.4	38.7	8.4	15.2	12.2	2.8	2.3	16.9	34.2	27.1	22.4	6.8	2.3	8.7	27.7	7.4	7.5	7.0	4.8	18.0	48.5	11.2	21.5	15.2	66.9	14.3	31.5	21.5	4.9	21.4	19.7	4.6	3.1	11.7	19.0	36.6	30.3	24.6	20.7	11.0	27.8	62.3	43.5	10.0	29.2	29.2	7.6	13.8	0.0	0.8	28.5	34.3	0.0	8.3	28.3	5.1	7.7	0.5	12.1	7.2	8.2	6.4	6.9	0.4	64.4	3.1	24.2	0.2	0.5	3.0	9.6	8.3	3.9	1.1	10.0	19.1	11.9	27.1	14.1	0.0	8.9	5.4	6.1	2.4	9.1	0.0	8.3	0.3	1.4	9.6	40.8	11.3	0.2	0.2	2.0	5.6	2.7	11.9	12.5	15.6	2.0	0.5	30.0	1.8	11.3	11.7	0.4	20.6	21.2	2.2	18.4	43.5	16.2	16.3	32.9	22.8	11.0	21.6	18.3	27.8	9.5	11.3	12.2	62.3	10.0	29.0	8.1	29.2	29.2	4.4	5.7	1.6	3.8	2.8	2.3	6.8	2.3	4.8	3.1
SQSTM1	"A170, OSIL, p60, p62, p62B, PDB3"	ENSG00000161011	"Sequestosome 1"	Q13501	5	179806398-179838078	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Differentiation, Immunity"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 196.4;HHSteC: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004587, HPA064165, HPA068843"	Supported		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB004587: AB_628279, HPA064165: , HPA068843: "	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (2.31e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.01e-1)"	47.8	74.5	12.4	21.6	16.0	19.5	60.4	26.2	23.4	25.2	31.7	20.9	39.8	22.9	29.4	27.7	30.8	23.1	45.2	51.9	13.9	12.8	38.6	88.3	33.3	33.4	23.2	16.3	32.3	51.8	22.7	33.6	72.7	15.6	36.2	15.2	28.9	39.0	36.2	102.8	15.3	22.0	36.3	15.5	25.6	40.0	18.9	17.9	18.8	60.4	45.3	17.5	47.9	64.0	27.8	34.2	100.4	58.3	28.2	38.7	52.4	13.9	79.8	3.8	11.4	56.5	39.0	57.4	20.4	61.0	16.2	20.8	15.6	57.7	2.2	56.7	31.2	17.3	7.5	17.2	7.6	196.4	11.7	6.6	28.9	24.4	135.4	6.7	36.3	32.7	21.9	30.3	46.9	16.6	7.0	46.9	34.6	11.0	2.6	6.5	9.4	24.9	5.2	8.4	21.8	24.0	61.1	8.4	7.4	30.2	29.5	72.8	14.7	11.6	36.9	28.4	12.6	26.9	26.1	70.2	73.5	7.3	64.7	11.4	31.5	90.0	58.3	59.9	32.7	39.6	38.7	27.8	28.9	29.2	34.2	27.1	24.0	24.0	100.4	28.2	36.6	14.8	38.7	52.4	12.4	16.0	26.2	23.4	13.9	12.8	23.2	16.3	15.6	17.9
SRA1	"SRA, STRAA1"	ENSG00000213523	"Steroid receptor RNA activator 1"	Q9HD15	5	140537340-140558252	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Receptor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 26.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044598, HPA050153"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA044598: , HPA050153: "	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.69e-2)"	"prognostic favourable (8.01e-6)"	"unprognostic (9.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-1)"	4.8	9.9	2.5	4.8	3.0	5.6	2.7	13.3	3.5	2.5	3.3			3.1	3.0	4.1	2.5	2.6	3.5	4.3	2.7	3.0	3.5	14.4	4.4	3.5	2.2		4.9	2.7	4.5	7.7	3.7		3.7	3.0		5.5	4.4	4.4	3.9	3.4	3.4	2.1	5.7	4.6	6.8			4.1		3.1	2.3	2.3	9.0	15.6	26.9	16.4	7.5	11.3	14.2	6.1	14.8	7.9	8.2	3.8	5.3	11.0	10.6	6.1	6.9	7.3	27.1	3.9	5.3	7.8	4.0	4.2	1.4	7.8	2.8	8.1	9.2	4.6	16.1	10.2	8.2	8.3	6.3	10.1	4.1	3.7	1.9	3.1	4.7	8.1	4.5	18.8	6.8	13.1	2.4	11.9	7.5	6.7	5.0	3.6	7.4	5.6	6.6	6.1	5.6	7.1	7.0	9.5	4.9	6.6	3.4	5.7	8.5	10.2	6.7	5.5	8.1	10.9	4.3	8.1	16.4	12.0	7.0	14.3	6.5	9.0	6.8	6.7	15.6	7.4	5.6	6.4	26.9	7.5	13.3	9.3	11.3	14.2										
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.5;HBEC3-KT: 33.0;PC-3: 32.1;RT4: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.3;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.0;monocytes: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Plasma membrane,Cell Junctions,Cytosol"			20000000	"Plasma membrane, Cell Junctions"	Cytosol	"CAB004023: AB_2106059, HPA030875: "	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (1.63e-4)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (5.22e-5)"	6.9	17.5	12.8	11.1	12.0	5.4	9.9	6.4	16.0	16.0	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7.0	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4.0	6.6	10.5	10.4	26.4	20.0	0.3	3.0	0.1	5.3	0.6	0.1	1.6	7.6	35.5	8.1	7.3	3.1	4.9	17.0	7.1	6.1	8.6	5.5	13.3	6.9	0.2	4.4	12.8	14.0	4.9	33.0	3.4	0.0	4.4	1.9	1.2	20.7	7.4	0.1	3.0	5.3	11.2	5.6	7.5	7.8	0.2	0.0	1.4	5.2	1.8	0.2	3.8	32.1	8.3	2.1	0.2	3.6	34.0	7.6	27.5	8.0	11.3	8.8	10.1	2.8	11.5	10.4	7.0	3.8	6.3	0.1	0.2	0.1	7.3	0.0	7.7	0.0	2.6	0.0	0.0	5.3	0.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.1	0.6	4.4	3.0	0.1	1.6	12.8	12.0	6.4	16.0	11.3	6.6	3.3	9.9	5.1	4.8
SRCAP	"DOMO1, EAF1, KIAA0309, SWR1"	ENSG00000080603	"Snf2 related CREBBP activator protein"	Q6ZRS2	16	30698209-30741409	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA028929	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA028929: AB_10601265"	"unprognostic (1.26e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.11e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.07e-1)"	13.5	15.5	15.4	17.1	15.6	23.6	13.6	24.8	18.1	14.8	16.3	20.4	14.0	14.1	23.6	12.0	13.0	15.1	16.0	11.9	11.5	9.3	10.5	9.3	11.6	13.9	18.2	10.8	17.2	17.8	31.2	18.2	16.3	13.0	14.1	10.3	17.5	17.2	13.4	23.5	14.8	18.0	13.4	12.6	16.0	15.9	22.4	14.0	20.5	17.4	10.1	15.1	21.4	12.7	3.2	2.3	6.2	3.2	1.7	2.4	1.5	13.9	27.6	16.6	16.9	13.1	9.3	18.0	10.6	9.8	12.2	9.7	13.1	10.3	29.0	14.6	13.4	14.0	17.2	13.2	10.0	18.7	39.6	18.5	24.2	11.2	5.9	21.4	22.3	9.7	6.6	18.3	15.0	12.4	28.3	16.5	8.8	17.2	18.3	8.5	17.3	12.4	25.5	13.1	16.6	3.8	16.1	16.1	16.7	11.8	15.4	4.5	17.4	12.1	20.0	17.3	12.7	9.7	14.1	18.7	15.8	21.4	13.9	11.2	13.2	0.7	1.8	6.2	2.4	3.2	1.9	1.8	1.3	2.4	1.3	3.2	1.3	1.1	5.4	1.7	0.8	2.3	2.1	1.5	15.4	15.6	24.8	18.1	11.5	9.3	18.2	10.8	13.0	14.0
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837002	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.7;SK-BR-3: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"CAB005406: AB_2194226, HPA043343: , HPA043878: "	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favourable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	34.0	78.2	16.4	9.3	17.9	14.8	15.5	5.8	22.3	15.7	13.8	31.9	30.4	28.9	8.6	23.4	20.5	15.7	17.6	10.2	13.5	10.3	9.0	49.9	11.9	14.4	20.3	16.7	20.5	7.7	9.6	12.5	16.0	11.8	18.0	6.4	15.1	72.7	33.0	16.8	14.5	27.4	7.1	13.1	7.3	13.6	16.8	16.2	15.2	9.5	13.6	13.8	11.9	15.0	0.6	0.4	4.7	0.8	0.4	2.2	0.5	13.7	32.5	4.0	25.0	8.2	15.2	7.0	5.1	16.2	4.4	10.8	6.6	26.9	8.6	4.8	4.0	39.3	4.6	13.6	1.1	5.3	2.0	4.7	27.0	6.9	10.3	0.6	9.1	11.8	5.8	6.2	3.8	5.0	9.1	31.1	1.0	34.0	11.4	7.9	5.4	6.5	8.1	2.9	49.7	3.6	7.2	4.8	19.9	6.0	48.2	14.3	16.3	9.1	5.7	2.4	12.0	5.7	3.2	9.1	0.8	3.9	14.0	6.8	12.4	0.0	0.8	0.4	1.8	0.5	0.4	0.6	0.8	0.3	0.4	0.4	1.6	2.2	4.7	0.4	0.6	0.3	0.2	0.5	16.4	17.9	5.8	22.3	13.5	10.3	20.3	16.7	11.8	16.2
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907308	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"				"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: "	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favourable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"	13.9	45.2	42.9	19.6	41.7	18.2	16.3	51.9	66.5	16.5	27.7	32.7	22.3	26.1	19.4	41.5	42.4	18.9	28.7	33.9	37.3	33.6	18.9	20.4	27.9	21.1	21.7	38.4	22.7	29.7	34.2	17.4	15.8	34.2	22.8	20.9	25.4	29.0	20.0	17.2	32.9	22.3	19.8	24.7	16.0	30.2	13.5	21.0	15.6	14.3	20.5	26.1	17.1	19.0	9.6	8.4	2.0	5.5	1.8	6.4	4.9	18.0	12.9	34.5	32.0	20.2	27.1	19.3	6.0	20.4	7.2	14.8	15.2	24.0	32.3	8.6	14.8	31.1	19.6	40.1	5.1	9.1	21.4	16.1	22.8	15.1	33.8	23.5	11.0	25.4	22.8	18.8	23.6	14.1	16.5	39.0	7.5	23.0	17.0	17.8	21.8	10.0	19.7	19.7	51.8	29.9	19.0	14.0	10.5	13.9	25.6	25.7	16.1	42.0	15.0	9.7	18.2	4.5	7.1	28.5	14.5	25.7	9.5	17.9	14.8	0.0	5.5	2.0	6.4	4.9	4.4	9.6	3.5	4.6	6.6	7.3	3.2	3.6	1.0	1.8	4.0	8.4	2.1	4.9	42.9	41.7	51.9	66.5	37.3	33.6	21.7	38.4	34.2	21.0
SREK1	"DKFZp564B176, SFRS12, SRrp508, SRrp86"	ENSG00000153914	"Splicing regulatory glutamic acid and lysine rich protein 1"	Q8WXA9	5	66139971-66183615	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037673, HPA037674, HPA059332"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA037673: , HPA037674: AB_10671376, HPA059332: AB_2683983"	"unprognostic (1.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.40e-2)"	"prognostic favourable (2.54e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.69e-2)"	11.1	13.4	12.8	15.6	14.5	38.0	16.3	24.2	14.7	12.9	10.1	8.9	17.3	10.9	18.5	15.9	9.6	13.6	10.6	8.2	12.4	13.3	10.6	10.5	12.5	12.7	11.1	12.0	12.2	14.3	23.4	30.3	12.2	11.4	12.2	10.7	11.9	12.4	16.5	11.9	20.2	12.6	13.7	11.3	14.9	11.0	11.0	11.4	19.5	14.3	9.8	9.5	10.6	10.5	6.5	6.0	8.5	5.6	7.7	6.0	2.8	5.0	6.2	8.8	5.2	4.2	7.9	8.7	6.0	3.4	3.2	3.5	9.3	6.0	7.6	7.6	4.6	6.9	4.5	6.0	5.7	5.3	10.1	7.3	16.0	6.7	3.7	6.6	8.5	4.5	5.9	4.0	4.5	5.2	6.5	5.6	3.4	4.9	6.8	15.3	4.7	3.2	9.2	4.0	5.4	5.6	9.2	10.4	7.0	5.7	2.7	4.8	6.7	8.5	5.4	5.2	3.2	7.1	6.1	5.9	4.1	8.6	5.1	10.6	5.7	8.5	5.6	5.2	5.0	3.9	5.4	6.2	4.7	6.0	4.2	6.5	5.6	5.6	4.1	7.7	3.7	6.0	4.4	2.8	12.8	14.5	24.2	13.8	12.4	13.3	11.1	12.0	11.4	11.4
SRF	MCM1	ENSG00000112658	"Serum response factor"	P11831	6	43171299-43181507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001819, CAB005416"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB005416: AB_2255249, HPA001819: AB_1079928"	"unprognostic (1.44e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.01e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.97e-2)"	17.7	8.1	10.7	15.6	12.3	14.1	12.9	11.6	14.5	24.9	38.1	10.6	17.9	8.1	35.3	14.9	28.2	24.8	23.7	30.6	9.4	6.5	10.5	11.3	13.9	11.8	7.8	6.2	25.6	13.1	13.8	10.1	14.1	7.5	26.9	9.4	15.4	8.7	29.9	29.7	10.2	16.8	47.9	5.4	18.2	20.8	10.0	8.1	16.1	14.9	14.6	13.2	36.0	17.7	1.9	3.7	4.7	2.9	1.1	3.1	1.0	17.2	6.9	16.1	10.6	9.5	7.9	23.7	15.8	13.1	13.7	8.5	18.4	5.1	21.9	14.5	16.8	14.0	16.3	13.9	12.2	24.1	16.0	19.8	13.6	18.1	18.2	18.5	24.1	13.4	15.3	21.1	15.6	11.4	14.0	17.2	10.3	18.6	22.7	16.2	11.2	8.5	17.5	16.4	7.8	10.0	11.2	9.5	8.6	12.9	9.9	15.6	10.1	34.4	13.8	16.3	12.5	15.7	27.0	12.0	9.9	36.7	10.2	13.3	10.9	1.7	1.7	2.9	3.1	2.9	2.5	1.9	1.8	2.3	1.8	1.9	1.4	2.4	4.7	1.1	2.3	3.7	2.1	1.0	10.7	12.3	11.6	14.5	9.4	6.5	7.8	6.2	7.5	8.1
SRFBP1	"BUD22, FLJ25286, p49, Rlb1, STRAP"	ENSG00000151304	"Serum response factor binding protein 1"	Q8NEF9	5	121961961-122075570	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042737, HPA058150"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles				"Nucleoplasm, Nucleoli"	Vesicles	"HPA042737: AB_10796583, HPA058150: "	"unprognostic (8.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.03e-1)"	"unprognostic (8.96e-3)"	"unprognostic (6.31e-3)"	"prognostic unfavourable (5.31e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.45e-2)"	21.8	9.4	11.6	11.1	15.2	10.1	17.2	15.0	14.8	12.7	10.2	6.1	8.5	9.1	13.0	12.1	14.2	11.1	9.6	10.7	11.8	8.0	14.3	12.6	11.2	12.5	13.1	11.9	17.1	10.6	15.5	20.2	11.5	14.2	12.8	10.9	5.1	13.0	9.5	19.7	10.7	9.5	11.3	16.0	15.4	10.1	9.3	14.9	12.5	15.6	13.8	11.6	14.4	17.5	10.3	9.6	2.6	12.8	7.4	11.5	4.3	10.8	8.0	7.4	11.6	8.5	7.9	12.3	10.4	7.6	11.5	13.5	6.5	10.8	13.7	12.2	6.5	8.0	12.0	14.2	21.5	19.4	6.8	13.1	5.8	6.6	9.1	15.1	11.0	9.5	11.0	14.4	14.3	12.4	12.0	11.2	12.0	4.9	10.4	4.8	10.8	5.3	10.8	17.4	14.3	12.6	11.2	7.6	7.1	9.6	9.5	17.9	9.7	9.1	9.0	17.8	10.9	12.6	15.1	6.0	11.2	15.8	10.2	12.3	15.6	0.6	7.3	2.6	6.6	12.8	8.4	10.3	7.3	7.2	9.6	8.9	8.6	11.5	1.2	7.4	10.1	9.1	6.7	4.3	11.6	15.2	15.0	14.8	11.8	8.0	13.1	11.9	14.2	14.9
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088106-69104811	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 259.2;bone marrow: 657.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 229.4;NB-4: 133.3;THP-1: 229.8;TIME: 138.6;U-937: 185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 259.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 259.2"					"Low region specificity"	"Detected in many"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Intracellular and membrane"		50000000	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavourable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	51.3	12.3	11.0	74.4	18.7	657.4	27.0	5.7	11.8	11.6	13.8	9.7	3.4	8.1	11.6	10.5	13.3	19.6	31.6	31.9	21.0	14.0	29.1	23.2	107.8	87.1	18.4	3.0	11.9	7.4	6.5	13.2	33.0	32.9	12.7	12.6	15.7	8.4	6.8	15.1	3.7	16.8	21.1	42.4	129.8	11.7	10.7	12.6	28.2	15.2	6.5	31.1	46.1	16.2	3.3	28.4	259.2	46.1	40.8	22.7	53.1	0.2	2.1	0.0	0.0	42.8	41.9	0.0	5.0	3.3	12.6	15.4	0.0	0.9	0.4	6.3	0.2	0.0	0.0	1.0	43.7	27.2	0.0	4.4	1.8	0.0	17.5	229.4	50.2	17.0	0.0	34.9	2.1	65.3	4.0	22.6	66.3	0.0	0.9	133.3	0.0	4.3	0.1	0.1	23.0	0.0	0.3	0.0	0.0	0.1	0.0	0.8	0.1	229.8	138.6	10.4	0.6	0.2	1.0	26.5	25.5	2.9	6.2	185.8	0.0	82.5	46.1	116.7	22.7	34.3	14.8	3.3	11.0	16.9	26.1	1.6	6.2	13.2	259.2	40.8	29.7	28.4	17.1	53.1	11.0	18.7	5.7	11.8	21.0	14.0	18.4	3.0	32.9	12.6
SRI		ENSG00000075142	Sorcin	P30626	7	88205118-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 140.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Supported	Nucleoplasm,Cytosol			1400000	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favourable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	20.6	22.0	47.7	24.6	53.5	18.7	22.4	18.9	43.6	24.1	140.7	32.5	7.0	45.3	18.1	33.1	15.6	39.4	14.2	19.4	35.9	40.2	21.7	14.6	21.9	16.6	45.0	44.8	23.3	18.4	12.1	18.3	21.2	36.9	19.5	115.0	11.1	17.7	18.4	8.7	11.1	62.8	25.2	41.9	14.6	16.2	10.0	28.0	9.2	19.7	9.4	19.4	27.0	18.7	29.7	34.5	95.4	42.1	36.3	36.4	32.7	34.1	13.1	35.5	36.5	57.6	48.6	17.8	20.5	33.3	23.2	27.6	12.2	77.6	38.0	21.7	31.1	34.6	44.6	46.5	30.4	30.6	20.0	19.7	36.2	0.0	34.9	26.2	21.1	49.7	42.6	24.5	35.7	69.5	17.4	33.0	31.8	21.6	38.2	18.0	31.2	26.5	15.9	50.3	21.0	43.2	34.2	25.7	30.5	62.6	36.0	28.6	17.0	11.7	43.4	43.5	36.5	39.9	36.5	30.9	14.3	40.7	42.7	25.1	73.7	86.5	26.1	95.4	31.0	36.5	36.4	29.7	34.5	35.2	34.5	24.9	25.8	29.8	16.3	36.3	42.1	27.5	34.7	32.7	47.7	53.5	18.9	43.6	35.9	40.2	45.0	44.8	36.9	28.0
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029567	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA048977: , HPA062044: "	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	18.4	27.5	18.6	21.3	21.0	13.6	22.5	18.2	26.0	24.6	19.2	23.2	31.2	19.3	24.1	25.5	22.6	18.0	17.1	21.8	18.7	22.5	34.4	67.8	19.4	24.0	23.7	17.1	21.1	43.2	30.1	47.1	26.4	29.4	23.2	21.7	19.2	48.1	31.2	28.4	19.6	24.4	20.0	22.3	23.5	22.3	30.8	19.4	32.3	23.6	22.5	27.9	23.9	17.6	20.5	23.4	26.3	30.1	29.5	33.4	19.7	20.3	22.0	21.1	19.8	21.8	22.5	25.4	29.2	26.6	30.2	38.8	26.5	22.9	29.7	29.8	27.8	21.5	28.9	23.0	43.9	29.5	14.5	24.0	21.0	62.1	33.9	25.6	24.3	18.8	22.7	22.2	39.6	30.4	21.2	32.5	31.4	33.8	27.4	14.4	16.2	21.4	21.9	25.8	23.7	36.0	31.1	20.1	21.6	20.9	27.2	26.6	36.1	17.8	23.0	18.4	19.8	21.9	20.1	28.2	37.8	37.2	13.1	16.5	21.9	15.9	19.8	26.3	23.6	24.0	29.3	20.5	23.6	26.0	23.4	18.6	22.3	21.7	19.3	29.5	30.1	16.0	33.4	19.7	18.6	21.0	18.2	26.0	18.7	22.5	23.7	17.1	29.4	19.4
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072653	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol				Cytosol		"HPA023303: AB_1857477, HPA055617: "	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (2.18e-4)"	"prognostic unfavourable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (4.02e-3)"	23.2	23.8	39.8	20.3	41.1	17.5	22.9	35.4	44.1	25.4	28.1	16.6	26.3	18.4	25.7	34.4	37.6	26.0	16.4	25.5	32.4	24.9	24.9	28.9	21.8	22.1	23.8	32.2	32.3	43.1	33.4	29.1	32.0	34.5	24.4	25.0	16.6	27.6	25.8	71.7	35.4	19.7	30.8	30.3	22.6	25.2	18.4	32.4	20.6	32.0	20.4	34.5	25.6	27.3	17.5	20.4	20.2	16.4	26.3	24.5	10.5	38.1	33.8	20.9	21.8	29.8	24.1	37.8	27.9	20.5	33.4	26.2	28.5	21.3	30.2	14.4	28.3	26.0	39.3	29.6	50.0	12.6	43.7	28.1	27.3	41.8	35.3	33.0	21.9	21.2	33.1	29.3	25.8	38.8	40.0	28.5	28.0	23.3	31.8	20.5	19.3	35.7	27.0	55.9	30.9	27.9	33.7	25.7	25.2	25.6	41.5	30.7	37.0	30.1	24.8	36.5	27.9	16.8	37.2	28.2	12.8	34.1	26.4	24.6	27.1	3.7	16.4	20.2	15.2	15.0	16.5	17.5	21.5	23.3	20.4	14.6	24.5	18.2	2.6	26.3	14.8	15.8	18.8	10.5	39.8	41.1	35.4	44.1	32.4	24.9	23.8	32.2	34.5	32.4
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavourable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	13.5	7.1	8.1	15.4	11.7	32.1	11.7	22.5	17.8	12.8	23.8	7.8	10.8	20.3	15.2	7.9	24.9	8.9	10.8	8.7	8.9	7.8	17.8	18.9	14.9	14.6	8.0	8.3	9.5	26.0	11.7	17.7	27.9	9.6	10.5	28.7	12.4	17.6	9.4	19.9	26.2	25.7	11.3	7.9	19.0	13.9	32.7	7.6	21.0	8.5	17.0	19.8	15.2	15.7	4.3	2.8	24.6	3.4	5.0	6.7	2.9	29.3	11.1	16.4	24.5	9.2	12.0	20.8	18.0	17.4	16.9	18.0	31.3	9.9	39.2	15.3	11.1	15.1	32.0	21.5	30.3	26.7	23.1	20.6	13.1	27.1	8.2	30.4	10.1	7.7	11.7	19.4	25.4	21.1	43.6	16.6	14.1	10.4	31.3	23.7	13.4	12.2	22.1	19.7	24.2	16.9	49.3	35.1	12.9	18.5	17.6	12.5	9.9	20.3	15.2	15.9	12.4	10.7	22.6	9.8	21.6	36.8	6.3	35.4	14.1	24.5	2.1	13.7	4.3	2.5	6.1	4.3	5.7	5.7	2.8	3.3	4.8	5.2	24.6	5.0	3.4	1.6	6.7	2.9	8.1	11.7	22.5	17.8	8.9	7.8	8.0	8.3	9.6	7.6
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	9.9	12.1	24.8	10.1	27.6	7.1	13.3	28.4	47.1	12.7	9.4	21.0	7.8	8.2	13.2	11.9	11.9	10.9	11.6	10.4	26.4	28.6	10.3	10.1	9.2	11.5	27.2	30.2	13.0	10.5	11.9	15.3	12.0	27.3	14.0	10.9	7.9	10.1	11.1	7.9	16.9	8.2	13.3	23.1	12.0	11.3	69.3	32.3	22.1	11.3	4.7	14.0	13.6	9.7	12.2	7.3	58.2	8.1	10.0	11.9	6.0	13.1	8.7	13.9	27.6	14.9	16.9	7.8	12.8	15.1	12.9	15.1	6.8	11.2	8.3	16.4	16.6	7.9	14.1	13.6	16.5	14.4	12.5	11.8	8.2	5.9	17.3	11.2	17.7	11.7	25.3	10.9	20.6	22.1	11.6	34.2	14.2	24.8	41.5	8.5	11.5	9.6	13.5	15.4	18.2	18.6	20.4	20.5	14.2	14.6	22.0	13.5	8.2	7.8	14.5	23.8	17.4	22.6	12.0	37.6	37.0	20.5	9.3	11.6	17.7	11.2	8.1	26.0	11.9	5.5	7.1	12.2	9.0	8.9	7.3	11.6	8.5	9.7	58.2	10.0	6.2	6.4	10.1	6.0	24.8	27.6	28.4	38.7	26.4	28.6	27.2	30.2	27.3	32.3
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673267	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"			12000	"Nuclear speckles"		"HPA049941: , HPA058612: "	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	25.0	22.4	16.6	21.8	29.5	44.5	26.9	38.0	30.0	37.1	27.9	39.7	26.3	20.7	35.6	65.6	21.7	31.7	18.6	23.9	19.5	16.6	24.1	27.7	22.8	27.3	27.2	21.1	49.8	20.3	26.7	35.5	35.2	32.6	33.3	20.8	31.8	24.2	25.5	34.4	30.5	28.6	24.2	32.4	29.8	21.5	23.4	29.8	43.4	24.2	20.3	36.4	28.5	29.8	20.3	19.1	23.9	23.7	27.9	26.2	14.8	16.9	13.7	27.2	24.3	15.3	15.8	26.7	19.9	13.2	19.9	22.9	15.0	28.5	38.0	12.6	16.8	21.3	27.0	19.5	26.2	13.0	18.7	29.1	26.5	17.8	10.7	33.5	19.3	10.8	12.3	16.1	23.8	17.2	28.2	20.9	20.4	14.7	30.3	22.5	44.7	9.3	27.2	21.7	18.5	17.4	17.7	16.5	14.9	21.4	17.4	14.8	15.6	16.4	19.0	17.5	18.2	23.7	19.9	18.7	14.3	46.9	18.9	39.5	19.3	23.9	17.8	19.2	21.8	21.7	26.2	20.3	20.7	21.2	19.1	19.7	19.2	21.8	23.6	27.9	23.7	16.6	15.4	14.8	16.6	29.5	38.0	30.0	19.5	16.6	27.2	21.1	32.6	29.8
SRRM2	"Cwc21, KIAA0324, SRL300, SRm300"	ENSG00000167978	"Serine/arginine repetitive matrix 2"	Q9UQ35	16	2752329-2772538	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 36.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041411, HPA066181"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA041411: AB_10796671, HPA066181: "	"unprognostic (8.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.23e-2)"	"prognostic favourable (6.77e-4)"	"prognostic unfavourable (5.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.50e-3)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.84e-2)"	41.4	50.2	50.1	73.1	69.8	105.5	48.0	85.3	77.1	53.1	51.7	61.5	57.9	56.1	60.4	44.5	53.1	56.8	60.7	43.7	51.0	28.2	47.2	56.0	48.7	53.3	70.3	38.2	70.8	74.8	88.1	49.1	43.8	48.8	52.5	48.2	45.6	80.8	63.0	91.7	67.4	63.4	46.7	52.9	63.2	61.7	37.8	69.8	48.7	58.9	38.3	46.2	52.0	69.5	9.0	11.6	36.4	8.9	23.9	4.7	0.9	22.9	29.4	46.8	32.3	33.0	32.3	27.7	26.1	14.7	23.4	20.9	24.3	26.7	40.9	20.0	28.8	33.0	37.3	33.1	24.8	29.7	38.7	35.1	54.7	41.9	15.0	36.7	50.9	32.9	32.1	34.2	40.7	24.0	39.3	40.3	21.4	40.8	34.6	59.1	43.9	16.3	60.8	19.0	31.8	30.1	24.6	30.8	27.3	34.6	35.5	20.3	32.2	30.2	34.1	33.2	34.0	21.6	32.6	35.8	27.3	89.1	11.5	26.6	22.2	36.4	8.9	4.3	3.2	3.9	3.0	5.2	4.0	3.0	2.0	9.0	3.5	4.7	18.3	23.9	3.5	11.6	2.0	0.9	50.1	69.8	85.3	77.1	51.0	28.2	70.3	38.2	48.8	69.8
SRRT	"ARS2, Asr2, serrate"	ENSG00000087087	"Serrate, RNA effector molecule"	Q9BXP5	7	100875111-100888664	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042858, HPA058379"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA042858: , HPA058379: "	"unprognostic (5.83e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (1.90e-5)"	"unprognostic (4.36e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (1.01e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-3)"	18.8	25.2	23.0	32.4	26.7	62.8	22.0	43.4	28.2	25.5	20.7	27.6	37.6	24.3	25.9	27.9	26.5	23.0	22.3	19.3	26.0	15.5	24.2	29.6	20.2	36.5	26.7	20.0	31.6	25.7	26.4	32.6	25.2	24.1	30.8	17.2	23.5	32.4	39.1	23.8	44.2	24.3	18.8	17.4	31.8	22.4	67.6	28.9	39.9	27.9	24.3	32.6	18.9	26.2	10.4	9.9	13.2	14.9	6.1	26.1	12.3	24.6	29.7	31.0	29.9	13.3	9.5	28.6	27.5	14.1	28.5	24.6	38.7	28.1	41.3	19.0	20.1	23.6	37.2	24.7	14.3	36.5	30.5	39.2	34.2	31.8	11.9	50.6	67.2	14.2	9.7	25.3	7.2	15.4	34.2	33.7	19.6	42.9	46.6	55.8	31.7	26.1	43.8	23.7	24.8	18.2	27.4	24.4	23.6	27.2	34.0	17.8	21.3	31.1	23.2	32.3	30.9	27.2	37.1	21.3	30.3	43.9	17.9	33.8	30.2	4.6	9.2	13.2	19.7	14.9	12.3	8.4	12.9	26.1	9.9	10.4	11.3	15.9	6.8	6.1	10.4	9.0	6.2	12.3	23.0	26.7	43.4	28.2	26.0	15.5	26.7	20.0	24.1	28.9
SRSF10	"FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2"	ENSG00000188529	"Serine and arginine rich splicing factor 10"	O75494	1	23964804-23980927	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053805, HPA053831"	Uncertain		Supported	Nucleoplasm			28000	Nucleoplasm		"HPA053805: , HPA053831: "	"unprognostic (2.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (1.18e-6)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.74e-4)"	"prognostic unfavourable (1.01e-5)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.40e-2)"	34.1	41.8	23.7	34.3	27.1	69.0	34.5	35.5	28.7	35.0	29.2	24.6	35.0	26.8	44.1	34.4	30.6	36.2	24.8	27.1	25.3	21.7	33.0	41.0	32.0	41.6	24.0	22.3	42.8	33.6	29.5	47.9	33.7	24.9	32.5	34.3	23.1	31.1	32.9	30.0	27.1	32.5	30.7	29.8	40.0	31.2	32.4	29.2	73.8	42.9	22.0	41.2	31.4	33.1	51.9	44.1	53.3	50.1	47.7	47.1	41.6	31.7	25.5	43.8	27.7	24.8	20.9	27.5	37.1	16.0	34.4	30.5	25.9	31.8	69.3	24.1	17.8	27.7	49.8	26.2	44.2	37.7	35.6	41.7	44.0	33.6	18.9	45.6	30.1	13.1	20.3	22.4	22.2	26.9	53.2	26.5	28.9	22.5	49.8	33.2	56.0	25.3	45.7	32.1	34.8	28.8	25.7	31.9	25.0	28.3	25.0	27.2	27.0	36.8	25.8	28.6	27.9	26.2	35.8	26.7	36.5	55.9	24.7	51.1	31.5	53.3	43.0	44.3	36.4	50.1	45.8	51.9	41.9	42.3	36.4	42.9	47.1	41.6	27.4	47.7	48.9	44.1	46.9	41.6	23.7	27.1	35.5	28.7	25.3	21.7	24.0	22.3	24.9	29.2
SRSF11	"NET2, p54, SFRS11"	ENSG00000116754	"Serine and arginine rich splicing factor 11"	Q05519	1	70205682-70253052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008762	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA008762: AB_1856782"	"unprognostic (7.82e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.30e-3)"	"prognostic unfavourable (3.91e-4)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-3)"	"prognostic unfavourable (6.53e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	36.1	42.7	38.3	36.9	41.3	80.1	42.2	68.2	43.6	38.6	32.6	34.8	38.4	30.7	41.4	51.2	31.2	39.0	31.6	25.9	33.4	26.6	30.7	42.5	33.9	47.6	47.7	34.4	51.1	42.5	39.0	53.4	38.4	39.9	37.1	32.4	32.3	34.4	41.8	31.3	51.8	40.6	36.8	37.8	45.9	34.5	35.1	41.7	46.6	44.6	25.5	43.3	32.8	36.7	34.7	42.1	45.4	29.7	36.0	36.4	22.2	24.6	12.5	33.0	21.0	17.0	22.9	45.4	30.5	15.8	24.9	22.7	22.0	18.6	42.0	20.9	15.3	21.1	41.6	16.7	34.1	28.1	32.5	42.5	28.2	26.3	20.3	58.4	17.7	18.3	21.2	23.0	23.5	22.1	41.8	26.6	24.5	9.6	34.9	43.4	53.0	21.2	41.6	36.5	26.6	29.0	17.8	27.8	23.0	25.8	28.0	36.4	22.4	26.3	26.1	27.6	19.8	19.8	27.4	30.8	24.6	46.2	19.8	43.5	24.1	39.6	29.7	45.4	32.6	23.1	36.4	34.7	32.9	31.4	30.1	34.1	36.1	33.4	15.0	36.0	27.1	42.1	35.5	22.2	38.3	41.3	68.2	43.6	33.4	26.6	47.7	34.4	39.9	41.7
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm			1600000	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: "	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favourable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavourable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (1.95e-4)"	"prognostic favourable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	45.3	27.4	37.4	42.1	38.3	69.5	43.5	42.6	39.1	36.4	41.7	32.9	34.0	25.5	37.2	31.8	42.9	40.8	27.4	37.5	33.0	28.1	34.3	36.9	32.3	51.8	35.8	27.0	53.9	31.3	22.4	47.2	37.4	38.1	40.1	46.6	30.1	30.2	33.0	29.2	36.2	35.8	43.1	31.9	36.4	35.2	27.2	36.7	67.5	35.9	46.7	67.0	49.6	38.6	28.0	73.9	12.9	38.0	37.6	37.6	53.9	51.7	34.6	61.1	46.6	23.6	18.5	37.7	37.1	31.1	62.5	48.2	40.6	37.2	87.1	26.7	40.5	41.1	80.1	59.0	66.8	40.6	49.3	52.2	27.5	45.7	28.9	70.1	44.2	16.4	20.1	40.7	45.5	47.4	62.9	36.9	45.3	40.4	86.1	66.4	64.3	36.4	76.8	58.5	52.1	44.2	43.1	47.2	44.7	41.2	40.4	56.0	41.0	75.4	30.9	32.0	46.7	32.0	55.6	36.5	53.9	119.3	27.4	65.2	44.3	12.9	38.0	11.5	32.9	36.2	37.1	28.0	31.1	34.5	73.9	24.0	31.4	32.3	3.7	37.6	24.4	43.7	37.6	53.9	37.4	38.3	42.6	39.1	33.0	28.1	35.8	27.0	38.1	36.7
SRSF4	"SFRS4, SRP75"	ENSG00000116350	"Serine and arginine rich splicing factor 4"	Q08170	1	29147743-29181987	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050975	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA050975: "	"unprognostic (3.26e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (4.26e-4)"	"prognostic unfavourable (4.30e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.60e-2)"	42.5	26.5	26.8	31.7	34.6	46.6	38.7	37.5	28.3	33.9	35.8	27.9	30.7	35.1	39.0	29.1	35.9	30.7	26.3	28.7	26.0	22.3	27.8	40.7	36.7	37.1	35.0	24.1	43.0	30.4	28.5	27.0	40.7	27.9	35.2	26.2	27.8	33.6	34.8	47.0	38.0	34.0	52.6	30.7	38.7	29.9	23.4	33.8	46.9	35.1	23.6	30.0	55.6	70.2	23.8	25.6	44.8	26.1	20.0	35.0	20.7	31.0	18.6	34.9	12.7	25.5	19.4	21.8	26.2	19.3	31.0	26.6	17.0	19.1	35.7	24.6	21.6	29.2	29.4	23.8	31.5	43.3	35.2	54.5	27.4	26.5	26.7	36.4	34.6	15.6	30.3	26.2	33.7	25.5	44.1	28.4	21.0	15.4	46.5	31.5	37.6	17.7	43.4	38.4	24.0	21.0	31.9	21.4	24.6	32.3	18.3	29.9	12.1	22.0	24.8	25.1	20.2	27.3	42.6	26.8	20.1	39.5	24.1	46.9	27.2	26.2	20.8	44.8	31.8	24.7	30.9	23.4	29.3	34.0	25.6	23.8	25.6	27.1	41.2	20.0	26.1	19.7	35.0	20.7	26.8	34.6	37.5	28.3	26.0	22.3	35.0	24.1	27.9	33.8
SRSF5	"HRS, SFRS5, SRP40"	ENSG00000100650	"Serine and arginine rich splicing factor 5"	Q13243	14	69726900-69772005	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043484, HPA056523"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA043484: AB_10797143, HPA056523: "	"unprognostic (2.08e-3)"	"prognostic favourable (7.91e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.07e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	66.6	60.1	67.1	60.9	74.4	131.5	70.3	111.7	88.8	54.3	63.3	67.8	77.1	42.6	71.3	74.6	66.3	79.3	50.1	48.5	66.2	43.0	40.5	60.8	69.4	63.3	86.4	62.1	76.6	41.0	56.4	124.8	59.2	74.0	59.0	54.7	69.2	68.5	75.6	76.0	78.1	74.1	59.7	68.6	66.5	62.0	35.3	75.6	47.8	70.8	52.3	69.1	69.6	55.8	41.2	37.4	60.8	45.1	30.8	38.2	24.4	69.2	20.2	49.6	22.3	30.7	26.5	27.5	33.4	36.0	27.3	29.0	25.4	44.5	71.8	17.7	45.3	33.1	37.5	47.7	32.3	61.3	20.6	54.1	54.3	27.8	35.7	50.4	41.0	55.1	30.4	31.5	33.8	37.8	37.5	42.8	16.9	56.2	57.9	34.2	29.1	18.7	49.7	23.6	27.6	34.7	85.3	25.9	37.0	56.7	34.4	43.1	37.4	42.5	46.6	16.0	42.9	17.4	31.2	41.7	27.2	116.1	37.7	43.0	22.0	39.0	24.1	37.2	37.3	43.4	38.2	41.2	33.2	33.4	26.2	40.6	33.2	31.5	60.8	30.8	45.1	37.4	27.4	24.4	67.1	74.4	111.7	88.8	66.2	43.0	86.4	62.1	74.0	75.6
SRSF6	"B52, SFRS6, SRP55"	ENSG00000124193	"Serine and arginine rich splicing factor 6"	Q13247	20	43457928-43464247	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029005, CAB034889"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB034889: AB_785899, HPA029005: AB_10610424"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (3.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-3)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (2.82e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.18e-2)"	24.9	35.9	21.7	29.3	31.5	57.0	34.7	30.6	23.0	26.7	21.4	29.5	44.4	20.3	32.1	36.9	23.3	35.6	26.7	18.3	21.4	18.5	30.3	41.4	25.5	26.3	33.9	17.0	41.4	48.3	30.4	47.8	29.0	24.2	30.3	26.7	26.3	32.0	30.2	25.6	27.9	30.0	24.5	17.8	38.8	29.3	27.0	30.5	49.4	36.7	38.6	34.4	21.3	20.7	12.3	17.3	14.7	24.2	15.3	22.1	14.6	15.1	10.9	31.4	20.4	18.1	25.0	23.5	21.3	13.5	19.3	16.3	22.7	19.2	30.0	16.0	25.2	21.3	32.4	40.6	26.0	8.8	17.8	25.2	21.6	25.8	22.4	29.7	19.5	42.3	21.8	17.2	15.8	18.0	18.2	19.0	18.3	18.1	38.2	35.4	18.4	16.2	22.2	19.6	24.2	22.6	25.4	24.2	31.4	26.7	38.9	34.8	21.9	34.9	18.8	19.5	14.4	16.7	22.0	24.7	15.1	39.8	24.5	22.5	13.6	14.7	14.5	6.7	15.8	24.2	17.5	12.3	16.6	15.0	17.3	12.2	22.1	20.7	7.2	15.3	19.0	14.8	13.2	14.6	21.7	31.5	30.6	23.0	21.4	18.5	33.9	17.0	24.2	30.5
SRSF7	"9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2"	ENSG00000115875	"Serine and arginine rich splicing factor 7"	Q16629	2	38743599-38751494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043850, HPA056926"	Supported		Enhanced	Nucleoplasm			1400000	Nucleoplasm		"HPA043850: AB_10964495, HPA056926: AB_2683277"	"unprognostic (2.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.44e-3)"	"prognostic unfavourable (3.18e-8)"	"unprognostic (1.02e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-3)"	42.2	32.2	32.8	51.1	37.3	76.7	39.2	34.7	38.9	26.8	37.2	21.4	34.8	20.4	34.1	27.3	50.2	36.9	25.9	29.8	26.9	24.6	25.1	34.9	34.3	45.5	37.5	23.8	31.7	38.2	20.4	50.4	34.3	32.8	27.4	37.2	25.0	32.8	32.4	31.7	26.2	37.7	36.6	33.4	34.8	38.8	35.9	33.0	44.1	26.1	38.6	59.2	28.2	40.7	20.9	47.6	8.8	33.4	20.8	22.9	22.3	43.8	38.2	51.3	33.0	15.8	12.5	36.3	37.6	16.2	37.9	30.5	45.0	33.8	71.7	25.8	24.4	24.8	64.5	46.0	45.7	44.6	40.3	43.2	27.4	45.9	13.4	53.0	31.5	7.4	15.7	26.0	50.4	31.4	62.4	28.7	32.0	48.8	67.1	47.0	56.0	35.0	59.6	43.1	40.6	28.1	42.7	35.3	34.2	35.9	31.8	25.2	29.0	48.5	27.1	23.0	36.0	19.7	52.3	31.7	47.4	107.2	27.3	55.6	31.6	6.4	23.1	8.8	21.3	33.4	22.9	20.9	16.4	21.0	47.6	14.1	18.6	21.1	2.3	20.8	19.6	28.6	17.4	22.3	32.8	37.3	34.7	38.9	26.9	24.6	37.5	23.8	32.8	33.0
SRSF8	"SFRS2B, SRP46"	ENSG00000263465	"Serine and arginine rich splicing factor 8"	Q9BRL6	11	95067197-95071224	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA049905	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA049905: "	"unprognostic (2.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (9.99e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.75e-3)"	5.5	6.4	6.1	4.9	9.6	5.3	9.6	6.0	14.3	8.7	6.9	8.0	9.2	7.1	8.0	8.0	6.8	7.4	6.8	6.4	6.5		9.5	6.8	6.1	8.7	6.1	9.5	10.7	10.4	9.7	8.2	6.5	7.2	9.4	7.5	10.1	11.4	8.6	5.4	6.6	7.8	7.1	4.8	9.0	7.1	3.0	5.0	3.7	11.6	5.3	6.5	6.1	5.5	7.9	3.8	7.0	2.0	5.6	12.4	3.7	4.3	4.6	11.6	0.0	15.5	9.8	13.1	6.6	7.4	3.1	3.4	10.8	14.4	23.4	19.7	10.1	9.6	9.7	14.4	3.6	14.1	10.5	19.8	5.4	9.7	11.4	19.8	10.8	12.6	15.4	3.3	15.6	9.7	14.9	13.0	6.1	6.0	10.2	17.7	6.1	12.8	12.8	3.5	18.7	12.3	14.7	14.7	15.1	8.2	14.6	9.5	5.8	11.0	8.9	6.1	8.2	8.2	6.7	7.0	10.7	12.6	3.1	13.3	13.3	7.0	2.0	0.6	5.7	1.1	8.2	7.9	9.6	8.2	3.8	6.9	12.4	9.5	0.6	5.6	1.0	3.5	9.9	3.7										
SRSF9	"SFRS9, SRp30c"	ENSG00000111786	"Serine and arginine rich splicing factor 9"	Q13242	12	120461668-120469793	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049849	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA049849: "	"unprognostic (3.80e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.50e-3)"	"prognostic unfavourable (9.85e-7)"	"unprognostic (9.65e-3)"	"prognostic unfavourable (7.80e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	25.8	50.7	29.5	37.9	28.5	33.8	31.2	24.9	30.6	31.5	36.4	21.7	35.5	29.8	26.7	37.4	53.6	32.6	42.3	20.7	26.7	27.9	37.2	42.5	27.2	41.4	31.6	25.3	37.1	68.5	34.9	36.5	49.3	27.9	33.1	35.8	29.3	33.9	30.4	17.0	32.4	31.0	25.1	23.8	39.6	33.0	52.5	25.0	53.1	43.7	36.8	51.0	26.5	35.7	22.1	18.7	28.8	15.4	15.7	14.8	5.1	54.8	38.4	59.0	38.0	27.0	27.1	63.2	37.8	34.0	48.5	41.8	46.1	25.9	53.6	44.2	31.6	32.9	53.1	53.7	53.6	40.1	54.5	45.7	25.8	45.0	34.9	56.2	41.8	28.7	34.7	42.1	36.8	44.1	57.3	16.2	41.7	76.9	55.4	109.9	73.9	33.6	62.0	24.8	51.7	42.0	70.2	52.4	37.4	44.3	23.6	43.6	71.0	49.7	38.4	36.1	42.8	27.1	40.8	50.0	37.4	67.0	38.0	42.5	37.6	12.3	10.7	28.8	14.8	11.7	11.2	22.1	11.7	13.0	13.9	17.7	11.5	12.8	12.2	15.7	15.4	18.7	11.9	5.1	29.5	28.5	24.9	30.6	26.7	27.9	31.6	25.3	27.9	25.0
SS18L1	"CREST, KIAA0693"	ENSG00000184402	"SS18L1, nBAF chromatin remodeling complex subunit"	O75177	20	62143795-62182484	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011827, HPA059046"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB011827: AB_778216, HPA059046: "	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.57e-2)"	"prognostic favourable (8.00e-5)"	"unprognostic (1.39e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-3)"	6.6	8.9	11.9	7.7	12.7	7.7	8.6	35.9	15.8	7.0	7.0	9.9	12.2	9.5	9.7	10.9	9.3	6.9	7.2	6.4	11.5	10.9	11.5	33.3	8.2	7.4	11.2	14.5	10.0	10.4	8.4	10.7	8.8	13.1	8.7	7.8	7.4	8.6	11.8	19.2	23.7	9.0	7.7	9.9	9.2	8.8	10.7	10.9	6.0	8.3	6.7	7.1	6.8	8.6	3.6	1.3	2.5	2.7	1.6	2.8	0.5	6.4	7.7	10.7	9.7	4.8	5.6	7.8	6.1	2.4	10.2	5.1	26.3	6.0	3.9	8.1	3.4	16.7	6.6	5.8	9.3	2.7	4.3	17.5	16.1	13.6	3.6	6.3	15.6	3.4	12.8	5.2	4.4	4.6	11.7	7.6	5.7	7.6	9.6	9.9	4.3	8.8	10.7	13.9	4.4	7.6	8.2	20.4	11.3	10.9	13.3	9.1	12.5	10.2	5.4	19.5	11.8	7.2	8.5	8.5	7.6	3.5	9.7	6.3	6.4	0.3	1.6	0.6	1.7	1.1	1.1	0.7	0.9	1.4	1.3	3.6	2.8	0.9	2.5	1.6	2.7	0.8	0.8	0.5	11.9	12.7	35.9	15.8	11.5	10.9	11.2	14.5	13.1	10.9
SSBP1	"mtSSB, SSBP"	ENSG00000106028	"Single stranded DNA binding protein 1"	Q04837	7	141738321-141787922	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002866	Supported		Supported	Mitochondria			250000	Mitochondria		"HPA002866: AB_1080092"	"unprognostic (2.95e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavourable (4.42e-4)"	"unprognostic (3.68e-2)"	"unprognostic (6.03e-2)"	"prognostic favourable (3.40e-4)"	"unprognostic (9.23e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.58e-2)"	41.1	52.5	45.4	40.9	52.6	41.7	51.6	26.8	44.3	41.7	42.4	33.9	38.7	36.9	45.2	58.9	61.0	37.1	36.8	57.8	38.6	38.6	55.2	83.4	31.0	56.0	42.7	41.0	45.2	49.6	40.7	44.4	47.2	44.4	38.8	44.8	34.1	41.2	39.0	62.9	42.4	40.8	45.5	36.7	50.7	44.6	38.3	33.3	62.9	45.6	67.4	54.7	42.8	38.6	42.6	41.2	31.3	35.9	36.3	48.7	40.8	39.1	45.4	40.6	51.1	18.1	29.4	37.3	28.3	27.2	36.2	40.7	47.9	44.9	61.2	40.1	23.7	29.5	47.0	49.4	51.4	29.4	49.0	30.0	34.2	42.3	35.8	88.0	23.9	27.7	33.7	37.8	53.3	44.0	75.6	25.9	49.4	57.5	62.3	114.9	89.5	56.8	36.1	36.9	79.7	47.3	38.6	36.6	50.2	33.0	43.9	43.9	29.7	38.8	31.7	25.7	24.9	39.7	75.0	46.8	61.9	109.6	52.8	79.3	56.1	31.3	29.1	26.6	30.1	35.5	44.0	42.6	48.7	40.2	36.8	37.0	45.1	48.1	7.5	36.3	35.9	41.2	46.4	40.8	45.4	52.6	26.8	44.3	38.6	38.6	42.7	41.0	44.4	33.3
SSBP2	HSPC116	ENSG00000145687	"Single stranded DNA binding protein 2"	P81877	5	81413021-81751797	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 89.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 36.2;REH: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020834, HPA068605"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB020834: , HPA068605: "	"unprognostic (4.62e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.04e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.39e-3)"	18.9	11.5	16.3	11.1	24.3	11.0	20.0	49.8	21.3	26.5	18.8	13.6	11.1	5.2	27.0	27.2	21.3	26.4	14.2	26.3	16.1	22.8	10.3	3.2	11.3	15.4	19.9	16.2	33.1	8.7	42.4	31.0	11.7	20.9	16.1	11.7	20.0	14.6	19.5	16.3	19.6	10.3	26.1	20.6	8.9	13.6	6.9	21.5	89.9	12.8	11.7	19.9	19.0	18.5	16.2	8.1	26.2	12.2	25.6	15.2	7.9	1.0	1.9	24.7	14.0	14.2	21.7	1.5	5.1	4.7	4.8	4.9	0.0	2.0	17.0	0.3	6.0	0.1	6.7	2.7	4.6	7.2	2.9	3.5	4.1	0.0	8.0	1.7	9.5	22.2	23.9	0.8	4.6	2.0	2.3	8.4	5.1	2.4	36.2	2.9	3.4	1.0	54.5	5.6	13.0	2.5	0.9	12.8	11.6	5.4	6.1	1.8	8.9	5.0	1.3	1.9	3.1	3.5	1.3	8.8	6.8	28.5	6.4	3.1	1.2	20.7	8.6	26.2	2.4	7.6	3.8	9.9	7.7	4.3	8.1	16.2	15.2	5.3	12.5	25.6	12.2	2.6	3.4	7.9	16.3	24.3	49.8	21.3	16.1	22.8	19.9	16.2	20.9	21.5
SSFA2	"CS-1, KIAA1927, KRAP, SPAG13"	ENSG00000138434	"Sperm specific antigen 2"	P28290	2	181891833-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 85.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: , HPA039989: "	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favourable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (5.79e-5)"	14.2	10.1	23.3	11.8	27.0	16.1	21.6	25.8	22.5	17.7	24.4	26.2	9.4	17.5	13.0	8.9	12.0	10.7	18.7	13.6	23.7	19.1	22.8	36.0	23.0	11.2	31.3	17.7	7.2	85.5	10.5	10.2	40.9	24.8	18.1	24.1	22.3	29.2	10.0	16.6	50.6	19.5	14.2	27.8	14.7	26.0	16.7	23.8	9.3	19.6	12.2	7.9	14.3	23.5	1.2	3.8	8.1	6.4	1.0	1.4	1.8	16.1	8.1	23.6	4.0	20.6	17.1	6.7	28.7	27.9	10.1	13.4	8.3	18.7	0.3	9.3	20.2	14.0	5.7	13.8	19.6	7.4	6.4	16.3	34.7	6.7	15.2	8.3	15.3	10.1	20.3	17.4	23.7	52.8	7.3	9.0	28.1	8.1	7.3	11.7	1.6	19.1	5.5	9.5	5.6	28.6	4.9	4.1	3.6	16.8	6.0	25.7	4.3	18.3	21.0	24.0	11.6	8.6	14.9	6.2	2.7	6.5	11.2	5.0	17.8	8.1	3.9	5.7	1.4	3.9	0.9	0.6	1.0	0.9	3.8	1.2	1.3	1.1	6.6	1.0	6.4	3.1	0.6	1.8	23.3	27.0	25.8	22.5	23.7	19.1	31.3	17.7	24.8	23.8
SSR1	TRAPA	ENSG00000124783	"Signal sequence receptor subunit 1"	P43307	6	7268306-7347446	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011276, HPA017062"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA011276: AB_1857503, HPA017062: AB_1857505"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.79e-6)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.19e-2)"	37.8	38.5	22.5	35.8	25.7	37.3	29.9	30.8	24.1	41.6	26.9	28.6	35.7	27.4	33.2	34.2	38.7	25.7	27.7	27.8	21.6	29.8	41.4	99.0	30.0	41.7	25.1	18.8	36.5	53.6	21.7	40.3	37.1	24.7	26.0	33.3	25.9	55.8	39.9	24.2	21.8	31.5	32.6	31.4	40.1	28.2	18.6	24.6	32.0	36.8	28.2	34.6	34.3	26.0	22.8	60.3	33.8	50.3	24.9	33.9	54.1	19.8	20.2	15.7	29.0	42.6	30.4	24.5	45.8	37.8	31.3	37.8	27.6	16.5	26.8	81.1	46.7	17.9	18.8	26.1	43.4	27.9	15.9	28.5	23.8	57.3	44.3	52.6	32.4	26.8	28.8	35.8	73.9	34.4	31.9	32.3	34.4	23.8	14.3	13.9	13.2	23.0	19.5	19.7	100.1	27.3	28.3	21.2	9.9	27.8	15.4	42.5	25.0	23.3	30.4	33.8	25.8	26.1	39.1	33.4	49.5	21.6	16.4	29.8	61.7	33.8	50.3	33.2	26.9	36.8	33.9	22.8	30.1	30.1	60.3	17.7	28.8	28.8	28.4	24.9	31.1	42.0	31.8	54.1	22.5	25.7	30.8	24.1	21.6	29.8	25.1	18.8	24.7	24.6
SSTR1		ENSG00000139874	"Somatostatin receptor 1"	P30872	14	38207999-38213067	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;intestine: 14.3;stomach 1: 22.8"	"Cell line enhanced"	"Detected in some"		"BJ: 46.8;BJ hTERT+: 13.0;BJ hTERT+ SV40 Large T+: 8.6;fHDF/TERT166: 27.6;HeLa: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003207, HPA031506"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA003207: , HPA031506: "	"unprognostic (1.40e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.34e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.19e-2)"	"prognostic favourable (4.28e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.28e-2)"	0.7	0.4	6.8	0.6	6.9	0.0	0.6	0.5	15.0	0.9	3.7	0.6	0.1	14.3	1.0	0.6	0.4	0.7	0.5	0.8	4.3	10.4	2.2	6.7	5.5	0.1	6.8	4.0	0.6	3.8	0.1	1.4	2.8	2.8	1.2	2.5	0.2	0.2	0.5	0.7	0.4	8.2	0.6	1.3	0.7	22.8	0.1	0.7	0.1	0.3	0.1	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	46.8	13.0	8.6	0.7	0.4	0.0	0.0	0.0	27.6	0.1	0.0	0.0	6.3	0.0	0.0	0.0	10.6	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	6.9	0.5	15.0	4.3	10.4	6.8	4.0	2.8	0.7
SSTR2		ENSG00000180616	"Somatostatin receptor 2"	P30874	17	73165012-73176633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.6"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007264	Uncertain		Supported	Cytosol				Cytosol		"HPA007264: AB_1080053"	"unprognostic (2.13e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.55e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (9.04e-7)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.95e-2)"	4.5	7.4	6.1	2.3	15.8	2.5	4.2	23.1	26.6	1.4	2.2	0.5	0.6	3.3	1.9	4.1	1.5	2.3	1.8	2.2	9.3	5.3	13.6	3.3	1.4	2.7	2.6	13.1	1.5	2.0	1.4	5.7	1.0	4.9	2.8	2.7	1.1	1.8	3.6	1.7	1.9	2.5	2.2	3.3	8.3	7.2	1.4	1.9	0.3	2.3	0.0	2.9	2.0	1.9	1.4	1.0	4.7	0.9	0.9	1.0	0.3	0.3	0.5	0.6	1.1	0.2	0.2	0.7	0.2	0.3	0.5	0.5	0.5	0.5	0.7	0.3	0.1	0.5	0.1	0.1	0.2	0.6	0.9	0.6	1.0	0.5	0.1	0.4	2.2	0.2	0.1	0.2	0.0	0.0	0.7	1.2	0.2	0.6	0.4	1.3	1.5	0.6	0.7	0.8	0.4	0.4	0.6	16.8	1.4	0.3	0.3	0.2	2.1	0.3	0.3	0.4	2.2	0.6	0.3	0.8	0.4	1.6	0.3	1.7	0.4	3.8	0.9	1.2	1.0	0.7	0.8	0.8	0.8	0.8	0.3	1.4	0.8	0.9	4.7	0.9	0.8	1.0	0.5	0.3	6.1	15.8	23.1	22.1	9.3	5.3	2.6	13.1	4.9	1.9
SSTR5		ENSG00000162009	"Somatostatin receptor 5"	P35346	16	1078781-1080142	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 8.2;lymphoid tissue: 5.2;pituitary gland: 9.0"	"Group enriched"	"Detected in some"	15	"Hep G2: 9.2;PC-3: 34.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 4.2;hypothalamus: 2.7"	"Low region specificity"	"Detected in many"			HPA066503			Supported	"Plasma membrane"				"Plasma membrane"		"HPA066503: "		"unprognostic (2.16e-2)"	"unprognostic (7.31e-2)"		"unprognostic (3.69e-2)"	"unprognostic (2.39e-2)"		"unprognostic (2.14e-1)"			"unprognostic (9.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"		"unprognostic (4.09e-2)"	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.4	0.0	0.7	0.6	0.9	0.5	0.0	8.2	2.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	9.0	0.0	0.0	1.1	0.0	0.0	1.1	0.9	0.1	0.1	0.8	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	5.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	1.3	0.3	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
ST13	"FAM10A1, HIP, HSPABP1, P48, SNC6"	ENSG00000100380	"ST13, Hsp70 interacting protein"	P50502	22	40824535-40857022	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043233, HPA046412, HPA047114, HPA047116"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.74e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.54e-2)"	"prognostic favourable (3.10e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.40e-2)"	43.0	46.0	36.8	26.2	32.0	20.9	39.9	32.2	35.3	45.0	36.4	41.3	33.0	23.9	57.1	37.9	32.9	46.5	32.7	44.0	33.8	33.6	63.2	72.0	23.7	25.0	40.8	28.8	141.6	31.8	38.6	38.1	35.9	36.6	45.1	27.6	30.4	34.8	37.8	75.3	28.3	25.9	42.4	52.0	25.6	31.9	29.3	40.5	38.7	50.3	38.5	30.2	49.4	76.7	41.3	29.4	23.3	36.6	28.2	62.1	39.0	45.4	36.7	55.5	48.3	51.6	80.2	50.5	43.1	55.2	53.6	46.9	65.9	27.2	65.6	37.4	43.1	33.3	72.9	42.3	63.7	41.8	46.6	47.1	73.6	74.6	47.1	68.0	38.1	71.2	44.8	48.2	32.8	55.1	56.2	28.7	51.0	34.1	59.5	32.4	31.5	24.2	68.7	47.3	51.6	54.3	69.0	18.5	18.7	49.8	40.1	61.6	38.9	43.0	41.4	44.8	43.7	37.5	34.9	33.2	65.3	61.5	61.3	31.9	43.1	23.3	21.4	22.5	24.9	29.3	37.8	41.3	39.1	29.6	29.4	36.6	62.1	46.7	7.4	28.2	36.6	20.7	32.7	39.0	36.8	32.0	32.2	33.8	33.8	33.6	40.8	28.8	36.6	40.5
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074719-76634601	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 18.2;HUVEC TERT2: 23.1;SK-MEL-30: 31.5;TIME: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA054566: , HPA055399: "	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	20.7	2.9	7.0	3.6	13.0	5.3	13.9	3.8	9.7	4.3	4.0	13.4	2.0	1.8	10.7	2.1	3.8	4.2	4.7	7.8	8.8	6.0	14.9	3.9	7.5	5.1	16.3	3.6	4.7	2.2	12.6	4.3	5.7	12.9	2.5	4.7	2.8	2.3	3.5	3.3	1.9	2.7	8.3	19.0	3.0	3.0	1.2	12.5	0.0	23.2	1.5	1.7	5.5	5.2	5.9	3.0	5.2	8.3	0.4	1.9	2.6	0.1	0.0	18.2	0.0	0.3	0.0	0.0	0.0	2.1	0.3	0.2	5.8	0.0	0.3	1.2	0.1	0.0	0.0	0.2	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.8	0.8	0.0	0.0	0.0	1.4	4.5	0.0	0.0	31.5	0.0	0.1	10.2	0.1	1.4	0.0	1.6	0.0	0.0	0.0	0.0	4.1	2.7	0.0	8.3	3.7	0.0	2.9	0.0	3.3	0.5	0.8	3.0	5.9	1.9	1.9	5.2	0.4	5.3	0.0	0.0	2.6	7.0	13.0	3.8	9.7	8.8	6.0	16.3	3.6	12.9	12.5
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230103	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 101.1"	"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favourable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	11.1	20.0	12.9	5.0	18.0	12.0	12.3	63.0	25.7	16.7	10.7	9.2	21.6	9.8	12.3	31.2	8.5	15.8	10.0	19.8	10.9	12.3	23.1	31.5	20.0	5.4	11.1	18.7	15.9	30.8	17.6	30.1	21.8	14.9	11.7	10.1	11.0	24.9	19.3	10.1	9.7	9.7	11.3	8.1	9.1	13.5	15.9	8.2	2.9	23.8	7.6	7.0	10.0	9.8	2.6	6.2	1.6	3.3	7.6	10.6	3.2	13.0	7.5	12.3	10.7	14.3	9.8	5.7	10.3	13.0	10.6	15.8	10.0	15.5	3.4	11.3	9.0	10.7	10.5	11.0	14.4	4.6	15.1	10.2	12.6	8.9	9.9	11.5	17.5	7.5	11.2	13.7	9.6	11.1	15.0	24.6	10.0	7.5	0.1	8.8	11.8	9.0	2.9	8.3	14.3	11.3	7.0	18.4	15.1	11.7	51.5	13.6	4.4	9.5	8.4	12.4	4.9	13.4	10.1	15.5	11.8	12.8	10.1	10.3	12.4	1.6	3.3	0.4	8.3	1.2	5.9	2.6	5.1	7.3	6.2	0.9	3.5	3.6	0.1	7.6	1.2	6.2	10.6	3.2	12.9	18.0	63.0	25.7	10.9	12.3	11.1	18.7	14.9	8.2
ST8SIA3	SIAT8C	ENSG00000177511	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3"	O43173	18	57350813-57371731	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 24.0"	"Group enriched"	"Detected in some"	42	"NTERA-2: 5.9;SCLC-21H: 10.1;SH-SY5Y: 11.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.9;pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063398, HPA066783"	Enhanced		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA063398: , HPA066783: "					"unprognostic (1.75e-1)"		"unprognostic (7.85e-2)"			"unprognostic (1.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.11e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.82e-1)"			0.1	4.5	3.4	0.1	12.0	0.0	0.0	7.9	24.0	0.0	0.2			0.9	0.0	0.0	0.0	0.0	1.1	0.0	3.8	4.8	0.1	0.2	0.1	0.0	1.2		0.0	4.2	0.0	3.5	0.0		0.1	0.2		0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.3	0.9			0.1		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	10.1	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766727	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 71.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.7;HaCaT: 4.3;RH-30: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA026871	Enhanced		Supported	Cytosol			210000	Cytosol		"HPA026871: AB_1857536"	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.6	0.2	0.1	0.5	0.1	0.4	0.5	0.1	0.1	0.7	1.4	0.1	0.1	0.1	1.1	1.1	2.5	0.9	0.6	0.4	0.1	0.1	0.1	11.7	0.5	19.9	0.1	0.1	0.4	0.2	0.0	0.2	0.4	0.2	0.5	0.2	0.1	2.1	0.3	0.1	0.2	0.3	0.2	0.1	71.3	0.3	1.5	0.1	0.2	0.7	0.5	0.4	0.3	0.4	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.7	0.2	0.0	0.0	15.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	4.3	0.0	0.0	0.0	0.0	1.1	0.4	0.7	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.1	2.5	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.1	0.3	0.1	0.6	0.8	0.4	0.0	1.1	0.2	0.2	0.0	0.3	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251193	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"skeletal muscle: 222.7;tongue: 107.8"	"Cell line enriched"	"Detected in some"	23	"RH-30: 224.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 8.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 8.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039285: , HPA039527: AB_10673424"	"unprognostic (6.16e-2)"	"prognostic favourable (2.01e-4)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	3.7	0.2	0.1	0.6	0.1	1.6	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	10.3	3.2	0.2	0.1	0.1	0.1	0.1	0.2	0.4	0.6	0.7	0.2	0.0	0.1	0.1	0.4	0.2	0.2	0.0	2.3	0.2	0.1	5.4	0.0	222.7	0.2	0.3	0.1	0.3	1.1	0.1	1.2	0.0	0.1	1.2	107.8	3.8	0.1	0.1	1.1	4.9	0.5	8.0	0.0	0.3	1.8	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	2.6	0.0	0.0	0.0	1.6	9.6	1.0	0.1	0.0	0.0	0.0	0.2	0.2	0.7	0.5	0.1	3.4	0.0	0.1	1.2	224.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.9	0.1	3.1	0.0	0.0	6.1	0.5	0.0	8.0	0.1	1.1	0.0	0.3	4.9	0.5	0.0	0.1	0.3	0.0	4.0	1.4	0.3	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336233-136752403	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA035015: AB_10603117, HPA058653: "	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	26.0	10.9	13.3	12.9	15.6	12.9	17.9	46.5	14.3	24.8	14.9	11.2	12.0	9.1	21.3	10.8	12.8	16.8	10.5	12.3	12.9	7.4	12.0	10.2	13.3	12.9	14.0	7.2	22.6	13.8	17.3	20.4	20.5	14.3	16.3	14.3	13.0	14.5	14.0	20.8	17.2	12.7	16.8	9.5	14.5	12.2	9.5	18.9	29.7	15.6	11.7	18.6	17.0	29.0	8.9	6.7	13.2	4.8	8.0	7.4	2.9	17.3	9.0	15.3	13.1	11.5	20.0	8.2	19.5	25.1	18.4	17.5	15.3	7.7	13.6	12.4	20.2	12.1	16.4	8.9	25.2	16.6	7.7	14.5	13.1	8.4	8.8	25.2	14.6	12.6	10.1	13.5	15.2	14.2	9.2	27.5	11.6	14.8	16.6	8.2	9.9	7.2	14.9	16.6	18.1	10.1	12.5	7.5	12.0	20.9	8.4	8.8	11.9	10.7	11.9	21.3	15.5	18.9	17.2	20.6	14.1	30.9	13.1	8.6	13.5	4.8	4.4	6.5	7.0	4.6	7.4	8.9	5.9	6.3	4.1	7.3	6.7	5.2	13.2	8.0	4.8	6.7	6.9	2.9	13.3	15.6	46.5	14.3	12.9	7.4	14.0	7.2	14.3	18.9
STAM	STAM1	ENSG00000136738	"Signal transducing adaptor molecule"	Q92783	10	17644125-17715914	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"T-reg: 33.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034399, HPA043882"	Supported		Supported	Vesicles				Vesicles		"CAB034399: AB_2197486, HPA043882: "	"unprognostic (1.09e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (3.44e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.02e-1)"	13.5	16.7	16.8	9.3	21.8	58.5	10.8	23.2	25.4	12.9	9.4	22.7	6.3	11.4	15.0	8.9	14.5	9.6	12.2	23.7	18.4	18.4	14.3	9.5	14.6	10.3	18.6	16.1	15.5	17.2	14.4	13.4	11.7	24.5	12.8	11.0	16.1	12.7	9.4	26.0	11.5	9.7	12.3	20.7	8.8	13.3	10.8	15.0	25.1	15.2	12.5	13.0	13.7	10.6	2.4	4.3	17.2	3.6	7.2	33.4	2.9	14.9	9.6	13.5	6.8	16.6	12.3	5.4	20.9	10.0	21.3	17.2	12.7	15.1	4.1	3.1	17.5	8.4	13.4	11.1	17.4	4.8	6.8	39.3	8.6	22.8	18.2	2.9	21.1	11.4	14.7	17.4	15.0	10.8	13.6	5.6	23.4	5.6	15.8	2.9	7.3	4.9	8.4	12.5	5.5	9.8	6.1	6.2	10.5	11.9	9.0	18.8	13.4	4.8	12.2	12.0	11.8	19.9	9.3	3.6	4.9	7.0	13.7	4.8	7.6	17.2	3.5	5.4	2.9	3.6	2.7	2.4	6.2	3.0	4.3	1.7	4.5	3.6	2.9	7.2	3.2	2.6	33.4	2.9	16.8	21.8	23.2	25.4	18.4	18.4	18.6	16.1	24.5	15.0
STAM2	Hbp	ENSG00000115145	"Signal transducing adaptor molecule 2"	O75886	2	152116801-152175992	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035528, HPA035529"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA035528: AB_10601606, HPA035529: AB_10672868"	"unprognostic (1.53e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	17.8	19.1	17.2	12.4	19.9	4.9	21.3	16.1	19.5	19.6	16.7	17.6	17.2	15.1	18.5	16.0	17.8	21.6	15.6	16.1	15.3	15.4	24.6	17.8	17.6	13.0	19.9	14.4	20.6	20.5	23.1	34.0	16.7	20.4	22.1	18.4	14.5	19.5	19.3	14.3	17.6	19.6	19.8	20.0	14.0	18.8	24.3	21.2	16.0	23.8	13.2	14.7	19.5	16.6	2.3	3.3	14.0	6.5	2.5	2.2	1.7	5.4	5.2	4.9	5.9	12.9	15.4	5.3	11.3	13.0	7.3	9.3	5.2	5.2	7.1	9.0	16.0	5.5	5.4	10.4	11.8	8.7	4.3	5.1	3.7	7.8	14.8	7.4	10.0	11.8	10.0	13.6	18.4	7.8	3.3	5.0	14.9	5.3	3.9	5.8	3.0	7.6	3.2	6.0	3.8	11.4	9.3	2.6	4.0	6.2	5.6	9.3	7.5	6.9	10.2	16.3	5.3	12.8	6.8	4.2	4.3	4.6	12.4	6.0	8.9	14.0	3.5	4.4	1.9	4.7	1.8	1.7	2.0	2.0	2.7	2.3	1.7	2.1	8.8	2.5	6.5	3.3	2.2	1.7	17.2	19.9	16.1	19.5	15.3	15.4	19.9	14.4	20.4	21.2
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 158.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			11000	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: "	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	12.9	12.8	22.1	13.9	23.0	10.5	17.8	20.1	21.8	18.1	18.4	35.0	13.6	17.8	23.1	15.4	22.7	16.5	14.7	19.0	23.3	21.2	19.6	16.9	13.4	15.3	33.0	14.3	16.3	15.1	20.9	17.8	20.6	26.3	20.2	20.7	14.6	18.3	15.7	30.1	14.4	25.2	19.0	54.7	13.8	15.6	13.3	22.3	18.4	20.1	15.9	19.0	16.8	16.4	17.6	16.9	27.8	17.8	16.7	20.7	12.3	5.3	6.2	4.9	4.5	4.6	5.5	5.6	3.3	4.5	6.0	5.8	10.3	5.1	4.4	5.2	2.7	4.2	5.2	11.5	6.9	7.8	5.9	6.0	4.3	8.0	6.4	4.9	7.2	4.4	8.3	7.1	10.3	3.5	6.5	6.8	158.8	6.5	7.6	4.4	7.8	3.3	5.3	12.9	6.3	6.5	6.0	9.0	6.6	4.0	4.9	6.9	4.6	2.9	3.1	5.4	6.5	3.3	5.8	6.5	6.2	3.4	6.7	5.3	6.3	22.6	16.2	27.8	14.4	17.8	15.4	17.6	16.7	14.0	16.9	16.2	17.5	13.2	24.1	16.7	15.7	16.4	20.7	12.3	22.1	23.0	20.1	21.2	23.3	21.2	33.0	14.3	26.3	22.3
STARD10	"CGI-52, NY-CO-28, PCTP2, SDCCAG28"	ENSG00000214530	"StAR related lipid transfer domain containing 10"	Q9Y365	11	72754729-72794168	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 130.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 34.5;Hep G2: 35.2;MCF7: 100.1;SK-BR-3: 71.7;T-47d: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026661	Uncertain		Supported	Cytosol				Cytosol		"HPA026661: AB_1857538"	"prognostic favourable (6.92e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.04e-1)"	4.5	34.0	11.3	6.8	16.0	2.0	16.0	17.6	15.9	18.6	42.8	5.5	16.6	11.5	6.5	26.2	10.9	6.2	28.7	15.5	10.3	6.8	11.1	130.6	10.0	3.1	10.6	5.4	8.2	47.3	16.4	9.5	22.6	10.1	17.6	46.0	9.1	21.7	12.1	15.0	12.7	15.0	6.7	4.4	4.6	47.4	40.0	14.8	3.3	21.3	12.0	9.3	7.8	10.2	2.9	2.0	15.8	1.8	5.6	1.3	0.6	8.2	2.5	1.3	4.8	1.6	1.6	16.6	0.9	4.3	2.9	2.9	34.5	6.1	0.7	2.8	3.1	5.2	3.9	7.7	3.4	4.5	1.5	0.9	1.8	35.2	6.1	0.2	1.5	1.1	21.5	3.2	4.5	2.9	1.9	3.6	0.6	100.1	0.7	1.8	0.5	3.4	0.7	2.2	0.5	3.9	10.1	2.2	1.6	1.4	71.7	10.2	39.5	1.0	2.1	2.9	1.9	1.0	1.6	3.6	3.0	1.2	0.7	0.9	0.9	7.9	1.8	11.4	1.2	0.9	1.0	2.9	1.1	1.3	0.8	2.3	1.1	1.3	15.8	5.6	0.4	2.0	1.2	0.6	11.3	16.0	17.6	15.9	10.3	6.8	10.6	5.4	10.1	14.8
STARD3NL	"MENTHO, MGC3251"	ENSG00000010270	"STARD3 N-terminal like"	O95772	7	38178222-38230671	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019204	Enhanced		Supported	Vesicles				Vesicles		"HPA019204: AB_2197800"	"unprognostic (1.55e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.37e-2)"	"prognostic unfavourable (2.20e-4)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (9.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.37e-2)"	"prognostic favourable (8.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	18.3	15.6	28.9	15.3	26.5	23.4	20.3	16.1	37.7	23.2	14.6	22.5	11.8	12.7	23.3	19.8	9.6	19.4	15.5	18.2	27.9	36.7	23.8	11.8	22.4	15.8	34.6	19.4	17.8	11.1	9.5	19.7	33.7	29.8	29.3	16.7	16.4	10.0	16.1	10.6	4.5	13.7	22.9	33.1	17.6	11.8	21.7	15.3	13.4	23.2	5.9	10.2	17.3	16.0	14.4	21.0	27.0	23.4	34.2	27.8	20.8	12.6	13.5	30.0	19.3	20.7	20.7	10.5	20.7	21.4	20.5	27.0	10.7	20.1	10.0	20.9	18.8	13.7	16.4	15.6	31.1	8.9	14.3	20.1	7.6	14.6	18.3	22.1	23.6	19.4	7.8	21.7	17.3	37.1	22.9	17.4	31.4	7.8	12.4	35.6	21.2	10.8	15.4	27.8	4.6	28.6	11.8	12.0	28.2	7.1	18.8	19.5	13.1	29.2	25.2	14.1	20.1	21.9	29.1	18.6	18.7	3.7	28.5	39.4	45.6	14.4	23.4	27.0	27.8	20.0	12.7	14.4	11.7	20.5	21.0	14.1	9.9	19.4	26.3	34.2	21.5	14.9	11.6	20.8	28.9	26.5	16.1	37.7	27.9	36.7	34.6	19.4	29.8	15.3
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190964358-191020960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 88.9;BJ hTERT+ SV40 Large T+ RasG12V: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol			22000	"Nucleoplasm, Cytosol"		"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favourable (1.75e-4)"	"prognostic unfavourable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	27.9	27.2	17.4	47.8	17.8	19.5	20.4	15.0	21.7	21.0	19.8	14.9	17.5	22.7	17.1	27.4	23.3	14.5	29.0	25.5	15.6	22.2	34.9	35.7	29.4	57.9	16.9	18.8	24.3	18.7	20.0	24.0	24.3	23.6	23.6	20.3	17.9	47.5	18.0	20.1	17.4	24.6	24.8	21.8	49.0	24.2	13.5	10.4	58.7	36.2	18.5	30.2	29.3	16.5	10.8	16.2	55.0	47.1	22.7	54.1	44.6	8.8	9.4	4.4	7.4	19.5	26.4	14.4	13.4	41.1	88.9	100.1	14.9	10.2	3.6	8.5	28.7	7.5	5.0	10.7	17.6	30.1	4.1	16.3	7.4	8.7	13.6	8.4	10.2	17.5	6.8	16.4	5.8	10.7	8.9	21.6	16.3	7.2	6.3	10.6	6.2	15.5	5.3	12.1	4.4	11.7	11.0	6.2	6.0	15.8	6.0	41.2	6.3	10.4	9.4	17.7	10.4	15.3	8.6	36.8	53.8	3.4	13.5	7.2	8.1	13.0	36.9	27.0	14.7	47.1	19.9	10.8	35.1	21.0	16.2	8.6	35.8	26.0	55.0	22.7	27.6	7.4	54.1	44.6	17.4	17.8	15.0	21.7	15.6	22.2	16.9	18.8	23.6	10.4
STAT2	STAT113	ENSG00000170581	"Signal transducer and activator of transcription 2"	P52630	12	56341597-56360155	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003858, HPA018888"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB003858: AB_562227, HPA018888: AB_1857550"	"unprognostic (3.03e-1)"	"unprognostic (8.59e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavourable (4.78e-13)"	"unprognostic (1.88e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.46e-3)"	30.8	14.7	10.4	24.2	20.8	11.9	18.4	21.3	18.6	21.4	13.8	39.8	12.2	15.1	24.0	12.6	13.9	16.7	23.0	11.6	10.9	9.2	12.8	25.7	22.1	19.9	27.3	13.3	22.9	13.1	18.3	28.0	18.7	29.1	15.8	15.1	24.5	18.7	12.4	10.6	15.2	17.3	22.9	29.2	29.4	13.9	7.0	22.1	19.9	20.3	7.6	23.1	24.2	16.7	6.6	8.5	8.2	16.9	3.5	6.8	8.1	4.7	2.5	5.9	4.7	30.5	21.1	9.6	8.6	30.4	34.0	33.6	3.5	6.3	6.2	8.0	13.8	6.5	6.9	5.0	6.7	5.2	2.1	9.4	4.7	3.5	20.9	2.1	9.1	31.5	4.5	7.7	7.7	7.9	5.1	17.4	10.9	2.8	3.2	2.6	1.8	3.3	3.0	7.0	4.9	6.9	6.9	1.7	3.5	12.2	6.7	12.7	6.3	5.3	5.2	11.8	4.2	4.0	1.5	13.8	10.0	3.2	10.9	2.7	4.0	8.2	11.2	7.6	5.8	16.9	5.8	3.7	5.7	5.9	8.5	6.6	4.4	3.7	5.7	3.5	12.6	7.6	6.8	8.1	10.4	20.8	21.3	18.6	10.9	9.2	27.3	13.3	29.1	22.1
STAT3	APRF	ENSG00000168610	"Signal transducer and activator of transcription 3"	P40763	17	42313324-42388568	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001671, CAB003859, HPA058603, CAB068241, CAB068242"	Supported		Supported	Nucleoplasm,Cytosol			220000	"Nucleoplasm, Cytosol"		"CAB003859: AB_347629, CAB068241: , CAB068242: , HPA001671: AB_1080102, HPA058603: "	"unprognostic (1.83e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	44.6	30.7	23.2	34.4	27.5	35.3	49.3	15.7	23.5	25.1	31.5	18.4	21.7	20.5	33.2	27.4	36.4	32.7	34.0	82.9	20.1	14.7	34.5	90.0	45.7	45.5	26.0	11.1	40.6	32.1	18.6	27.9	24.6	27.6	28.9	21.8	24.3	29.3	22.9	53.4	28.4	28.6	49.7	25.1	41.4	29.4	15.4	25.7	16.8	38.0	31.2	28.8	40.4	53.1	10.8	13.7	69.7	20.2	13.9	21.7	26.7	16.6	31.7	14.0	13.8	30.0	28.6	10.2	19.6	24.9	17.0	16.6	8.3	16.2	5.2	19.4	19.4	25.5	12.7	20.0	13.9	43.0	8.7	36.2	19.3	17.1	22.2	8.8	23.6	44.6	19.7	13.5	19.6	23.0	22.2	16.6	11.2	11.8	32.6	8.8	8.1	0.0	7.2	37.4	7.7	26.9	21.7	12.9	8.4	22.6	53.6	8.1	28.1	13.3	19.4	26.3	13.5	15.6	16.0	25.7	20.0	4.4	16.3	9.4	11.6	26.2	19.4	24.9	21.7	20.2	17.3	10.8	16.0	16.8	13.7	10.4	16.6	15.8	69.7	13.9	18.7	7.5	12.0	26.7	23.2	27.5	15.7	23.5	20.1	14.7	26.0	11.1	27.6	25.7
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.3;HEL: 38.3;HMC-1: 22.3;K-562: 63.7;MOLT-4: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Approved		Enhanced	Nucleoplasm,Cytosol			140000	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: , HPA049883: , HPA051156: "	"prognostic favourable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	44.0	21.5	3.6	16.5	8.1	30.0	24.1	3.4	4.0	12.6	12.8	6.3	10.5	5.1	11.0	11.4	11.6	9.6	15.3	9.8	3.9	4.7	8.9	5.5	12.8	26.7	9.1	3.2	15.6	8.3	1.9	7.0	11.3	6.1	13.9	5.8	11.9	11.9	11.7	18.3	9.7	11.6	13.6	7.4	17.3	7.9	8.5	6.1	21.9	8.6	9.1	17.0	19.9	20.2	7.2	15.0	15.2	18.5	14.3	16.2	8.8	1.0	1.2	0.1	0.0	9.1	4.4	0.0	0.5	2.0	1.0	0.6	0.1	1.0	0.0	2.3	2.0	0.0	0.2	0.0	0.2	25.3	0.0	38.3	2.9	0.3	3.7	3.2	22.3	10.2	0.7	0.3	0.5	3.0	63.7	0.0	0.5	0.1	46.2	18.2	0.3	0.0	1.1	0.3	3.3	0.3	0.7	0.1	0.0	2.3	1.1	4.2	0.7	4.1	1.7	2.3	0.6	1.1	0.0	0.0	0.0	0.0	0.2	6.2	0.5	6.8	11.8	5.9	9.1	15.1	12.8	7.2	15.8	13.2	15.0	6.7	16.2	13.0	15.2	14.3	18.5	5.7	11.2	8.8	3.6	8.1	3.4	4.0	3.9	4.7	9.1	3.2	6.1	6.1
STAT6	"D12S1644, IL-4-STAT"	ENSG00000166888	"Signal transducer and activator of transcription 6"	P42226	12	57095408-57132139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001861	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA001861: AB_1080106"	"unprognostic (3.43e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.37e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.55e-1)"	"prognostic favourable (7.76e-4)"	"prognostic favourable (1.14e-4)"	33.6	34.9	10.4	35.9	12.8	12.8	27.9	4.6	11.6	37.8	47.3	6.2	28.4	23.9	44.5	26.6	40.8	31.8	33.8	20.9	10.2	3.9	35.0	31.0	34.9	25.2	13.3	12.0	41.9	21.2	18.1	9.2	22.0	9.8	42.3	26.2	23.3	30.1	26.5	11.4	39.1	59.4	43.8	12.2	48.4	32.1	13.3	7.9	29.3	31.1	24.4	42.8	43.1	34.0	6.2	9.6	27.6	13.0	4.7	5.9	14.0	16.8	16.8	4.1	6.8	41.0	39.8	11.9	13.4	29.5	14.9	10.9	7.6	22.9	40.4	21.0	29.7	23.5	5.1	26.0	11.0	18.1	1.9	9.3	17.9	9.4	24.5	10.7	30.5	55.4	21.5	18.1	16.1	26.3	6.5	5.7	19.2	5.7	11.7	12.0	6.3	3.4	13.6	0.3	13.7	25.8	28.1	0.1	0.4	12.5	10.5	12.6	15.6	24.7	21.8	0.3	8.8	15.5	0.2	0.1	0.4	10.1	13.5	10.5	17.9	9.8	12.5	6.8	5.9	13.0	5.2	6.2	4.8	4.8	9.6	6.2	4.7	4.3	27.6	4.7	11.0	4.6	4.9	14.0	10.4	12.8	4.6	11.6	10.2	3.9	13.3	12.0	9.8	7.9
STAU1	"PPP1R150, STAU"	ENSG00000124214	"Staufen double-stranded RNA binding protein 1"	O95793	20	49113339-49188367	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020839, HPA049892"	Approved		Supported	Cytosol				Cytosol		"CAB020839: , HPA049892: "	"unprognostic (7.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.17e-3)"	"prognostic unfavourable (4.41e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-2)"	30.8	34.2	33.3	32.6	30.8	34.9	59.4	28.7	38.3	28.7	35.7	31.4	24.3	34.3	34.1	25.2	31.1	43.2	31.2	37.4	30.0	27.1	55.7	77.1	30.9	26.9	33.9	28.8	31.2	44.4	58.1	20.9	31.1	39.7	30.9	30.7	26.0	31.3	31.5	51.0	30.1	38.8	34.8	45.4	25.3	33.1	28.6	28.8	39.1	48.6	20.6	28.6	45.6	36.7	14.0	13.1	29.9	15.0	11.1	17.4	9.9	25.8	19.8	21.6	9.5	22.0	27.4	24.1	19.7	23.7	59.1	26.9	67.5	28.6	17.7	34.1	24.6	28.5	28.8	35.2	49.8	6.9	16.6	14.5	15.4	53.6	18.6	11.7	14.3	21.9	30.3	24.0	28.2	28.9	25.2	11.1	22.3	16.5	20.4	19.5	17.7	27.8	15.7	28.5	17.1	24.2	22.8	25.1	22.3	49.0	47.3	28.5	30.1	16.9	26.3	35.8	31.1	22.0	23.3	10.0	11.5	20.2	26.2	12.6	20.6	19.6	15.0	14.6	14.9	12.5	16.7	14.0	16.0	15.8	13.1	13.0	14.8	13.9	29.9	11.1	14.5	12.5	17.4	9.9	33.3	30.8	28.7	38.3	30.0	27.1	33.9	28.8	39.7	28.8
STAU2	39K2	ENSG00000040341	"Staufen double-stranded RNA binding protein 2"	Q9NUL3	8	73420369-73747708	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019155, CAB020836"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB020836: , HPA019155: AB_1857565"	"unprognostic (5.75e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.62e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.25e-2)"	17.8	15.0	25.5	10.3	24.4	14.0	11.7	27.2	46.1	10.8	12.1	13.2	8.4	9.3	11.9	12.8	22.6	11.0	15.7	42.7	24.3	23.0	18.9	15.9	11.4	11.0	27.9	15.4	12.2	10.2	17.8	19.9	11.1	27.3	13.9	12.0	10.0	13.0	14.0	60.3	9.5	15.4	14.9	18.1	13.3	10.1	10.3	16.3	18.6	14.7	21.3	13.4	14.8	10.4	11.9	15.9	26.1	13.3	27.6	19.2	7.9	12.4	14.8	23.7	13.0	13.9	10.1	7.3	11.4	10.5	10.3	13.8	5.9	13.5	19.8	11.8	8.9	10.2	16.1	10.7	15.4	20.2	8.1	26.9	7.9	9.4	7.4	10.1	9.8	7.0	8.4	8.8	5.8	20.3	18.1	9.4	13.9	8.5	56.0	8.1	11.9	9.8	16.1	11.3	17.3	22.2	13.9	9.1	15.1	6.0	16.7	10.1	19.2	12.1	15.7	10.4	17.8	10.1	8.4	14.8	14.1	19.0	11.5	15.6	8.1	13.9	11.7	26.1	19.2	11.4	14.6	10.1	13.1	16.4	11.6	11.9	11.7	15.1	19.8	27.6	13.3	15.9	15.9	7.9	25.5	24.4	27.2	46.1	24.3	23.0	27.9	15.4	27.3	16.3
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.7;Karpas-707: 30.9;U-266/70: 19.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Supported	Cytosol				Cytosol		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.7	1.8	0.2	2.4	5.2	1.4	3.3	4.1	2.5	1.6	1.9	1.7	4.4	0.0	3.3	2.7	2.3	0.7	0.9	0.6	14.7	1.0	0.2	2.2	2.2	0.7	2.1	2.7	0.8	2.6	1.3	0.6	0.0	0.1	30.9	2.8	2.4	0.2	1.7	0.4	2.0	0.0	0.8	2.5	0.9	1.8	0.8	4.3	3.2	4.1	0.0	1.1	0.7	0.7	3.1	2.0	7.3	2.3	19.9	3.6	0.0	4.3	1.3	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4										
STEAP2	"IPCA-1, PCANAP1, STAMP1, STMP"	ENSG00000157214	"STEAP2 metalloreductase"	Q8NFT2	7	90167590-90238137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"prostate: 100.2"	"Cell line enhanced"	"Detected in many"		"A549: 13.2;CAPAN-2: 28.4;U-138 MG: 16.5"	"Cancer enriched"	"Detected in many"	12	"prostate cancer: 88.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029115, HPA055603"	Uncertain		Supported	Vesicles				Vesicles		"HPA029115: AB_10603894, HPA055603: "	"unprognostic (6.26e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (9.86e-5)"	"unprognostic (3.69e-2)"	10.7	4.1	6.2	9.7	14.5	1.3	13.6	8.7	18.2	7.0	8.3	2.3	2.2	5.7	5.4	3.6	9.1	7.5	8.8	9.4	5.1	5.2	6.5	3.6	10.8	1.6	3.2	11.1	19.5	6.4	10.3	17.6	1.4	6.0	100.2	7.0	3.8	6.8	6.7	2.3	3.5	5.9	9.0	2.9	3.0	9.2	2.3	1.6	1.6	5.8	1.2	2.5	10.4	19.9	1.1	0.4	1.3	0.4	0.3	0.2	0.0	1.8	13.2	0.3	3.7	7.1	6.9	0.2	1.6	3.4	0.2	0.5	2.4	28.4	0.0	0.2	4.4	1.1	2.9	2.0	0.5	0.0	2.8	0.0	0.0	0.6	0.6	0.0	0.0	5.0	0.4	6.9	1.4	3.6	0.0	0.2	3.9	0.0	0.0	0.4	5.4	1.4	0.0	0.0	0.1	6.2	3.9	0.3	1.3	2.0	0.0	0.0	10.0	0.0	3.0	16.5	3.7	2.3	1.4	0.0	0.0	0.0	7.1	0.0	0.6	1.3	0.4	0.5	0.2	0.2	0.1	1.1	0.1	0.1	0.0	0.4	0.2	0.2	1.2	0.3	0.2	0.4	0.0	0.0	6.2	14.5	8.7	18.2	5.1	5.2	3.2	11.1	6.0	1.6
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"			4900000	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	20.8	9.9	15.5	28.9	19.9	23.1	53.1	14.1	16.8	20.5	21.2	8.5	16.5	9.2	20.6	20.3	35.1	19.8	35.6	14.3	10.3	10.5	13.2	29.0	21.6	34.0	7.7	10.3	21.7	21.2	27.7	9.4	18.1	9.0	18.2	13.7	23.5	46.9	17.0	49.4	22.1	16.0	22.5	8.7	23.2	15.6	20.1	6.0	39.7	34.2	26.6	23.4	19.5	21.7	11.1	8.5	17.1	20.6	17.6	18.2	13.3	14.7	19.2	6.0	10.4	28.5	24.8	8.3	13.3	13.5	9.5	11.7	8.6	4.9	15.7	13.8	18.3	27.0	7.6	7.8	7.9	12.8	11.4	25.2	7.3	12.9	23.3	20.3	14.6	28.2	19.4	13.8	33.9	12.3	15.2	29.9	9.7	3.4	19.1	7.4	2.4	6.8	4.8	8.5	14.7	15.0	8.7	1.2	5.5	18.9	12.1	7.1	4.5	11.5	12.6	17.4	5.8	17.0	9.1	32.3	24.3	8.0	14.5	8.5	9.9	12.4	9.5	17.1	17.3	13.0	13.9	7.3	12.6	18.2	8.5	11.1	14.3	12.8	15.2	17.6	20.6	7.5	12.8	13.3	15.5	19.9	14.1	16.7	10.3	10.5	7.7	10.3	9.0	6.0
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 168.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			3700000	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.23e-4)"	"prognostic unfavourable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	27.3	49.7	32.2	32.0	40.5	25.8	41.5	45.3	41.9	28.3	25.5	29.2	20.6	19.2	30.1	25.2	31.5	36.2	21.6	34.4	32.2	42.8	24.7	27.8	25.4	31.9	47.7	22.5	34.1	24.1	39.1	38.3	37.0	40.7	30.1	28.5	20.3	22.6	29.5	51.9	27.6	20.7	33.2	39.7	26.5	24.4	56.4	49.0	29.8	46.1	23.4	41.2	26.0	168.2	32.2	26.8	20.9	39.6	39.5	35.9	39.5	49.0	76.6	48.4	40.3	27.0	18.0	43.6	44.6	24.0	64.8	37.8	56.1	42.1	58.7	52.5	35.3	52.1	121.3	44.7	71.3	46.1	49.5	82.7	51.5	51.5	23.5	43.6	52.3	18.2	28.1	53.6	40.5	45.6	81.6	33.8	37.2	71.8	65.6	59.5	58.3	64.8	64.5	46.1	59.5	45.2	43.5	39.5	35.1	50.9	53.9	41.4	57.2	30.2	40.9	41.2	51.0	53.8	60.0	30.8	66.5	62.0	53.4	43.9	59.3	19.0	25.3	20.9	35.9	36.2	35.7	32.2	27.2	32.0	26.8	26.0	30.5	33.8	7.7	39.5	39.6	22.2	24.0	39.5	32.2	40.5	45.3	41.9	32.2	42.8	47.7	22.5	40.7	49.0
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228435	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: "	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favourable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favourable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	13.4	13.7	13.5	11.8	12.4	19.3	16.7	17.8	16.0	12.2	16.1	8.3	19.8	18.1	10.8	8.7	15.1	10.0	11.8	15.3	12.6	9.8	10.7	22.1	9.4	12.5	9.7	10.4	11.0	16.8	10.7	11.6	12.2	9.9	12.2	5.3	11.9	16.0	12.2	49.2	16.8	18.0	7.7	7.6	16.9	15.5	59.8	7.5	11.8	12.4	14.5	19.0	11.4	9.8	2.7	1.9	11.7	6.3	1.9	1.8	0.5	21.1	10.2	7.8	14.7	7.4	6.7	16.5	10.3	10.8	9.7	10.4	8.3	14.8	13.9	11.5	10.8	13.7	7.6	15.9	3.0	25.9	18.7	14.2	0.6	10.5	15.9	14.2	23.8	12.2	11.6	7.5	11.1	9.7	26.5	19.1	5.5	15.8	13.7	14.4	14.9	12.6	21.7	8.3	15.5	8.8	15.5	18.1	13.0	0.0	7.7	11.1	12.1	23.4	13.1	10.1	11.4	19.7	16.4	37.6	15.8	10.4	10.0	19.0	10.3	2.0	4.2	4.5	0.6	6.0	0.4	2.7	1.0	1.8	1.9	1.0	1.0	0.9	11.7	1.9	6.3	1.0	0.7	0.5	13.5	12.4	17.8	16.0	12.6	9.8	9.7	10.4	9.9	7.5
STK11IP	"KIAA1898, LIP1, LKB1IP, STK11IP1"	ENSG00000144589	"Serine/threonine kinase 11 interacting protein"		2	219597860-219616451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036837, HPA036838, HPA053192"	Approved		Enhanced	Vesicles				Vesicles		"HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: "	"unprognostic (3.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.22e-3)"	"unprognostic (8.36e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.87e-2)"	"prognostic favourable (1.63e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	5.7	8.4	10.1	11.9	10.7	15.2	6.4	15.0	9.5	5.8	8.2	6.7	6.7	8.1	9.2	14.3	8.2	9.1	9.5	6.2	7.0	6.5	7.2	5.6	7.4	11.4	5.1	7.5	17.0	9.9	7.0	21.2	12.1	7.0	8.2	7.2	6.2	5.8	6.3	5.1	16.3	7.9	7.5	5.9	10.6	6.4	27.7	6.4	26.5	8.9	7.1	9.6	5.9	6.3	1.7	14.8	5.0	6.1	3.4	2.7	2.1	6.9	10.8	11.6	7.8	4.1	7.4	11.9	6.2	5.4	10.1	8.6	9.9	11.8	4.0	6.3	5.9	17.3	5.5	13.2	7.5	5.9	8.3	10.4	11.0	8.0	5.4	10.8	27.7	7.1	11.9	8.4	4.3	6.1	7.8	6.1	5.6	13.6	6.3	13.5	11.6	6.0	12.0	4.2	3.1	10.0	11.0	7.6	12.1	4.0	9.9	8.1	6.3	10.6	4.6	11.0	9.3	10.4	6.0	6.8	3.0	7.2	8.3	6.0	6.8	1.5	3.9	5.0	2.7	5.7	2.4	1.7	1.3	2.2	7.6	1.5	1.1	1.1	1.3	3.4	6.1	14.8	2.1	2.1	10.1	10.7	15.0	9.5	7.0	6.5	5.1	7.5	7.0	6.4
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.8;REH: 4.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031510, HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA031510: AB_10603119, HPA031511: AB_2673915, HPA068559: "	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	6.4	8.2	3.8	4.3	6.5	2.9	4.0	9.9	6.3	5.7	6.6	5.5	4.2	2.2	6.0	5.5	5.3	3.5	5.3	3.6	5.0	3.5	3.9	6.6	4.1	2.5	4.3	7.5	5.7	12.4	4.7	4.6	6.3	4.0	6.2	2.7	5.6	2.9	6.7	6.1	6.8	2.6	5.9	3.7	7.0	6.3	7.9	4.2	2.6	4.7	4.1	3.8	4.4	4.2	2.1	2.7	0.4	3.8	0.9	1.1	0.5	0.0	0.3	0.0	1.1	2.9	1.7	0.0	2.3	0.3	0.5	1.1	0.0	1.9	1.5	0.6	1.2	2.0	0.0	0.6	0.9	4.8	0.9	3.6	0.9	0.2	1.4	3.7	0.0	1.5	0.1	0.8	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.0	4.4	2.4	1.1	0.0	0.0	1.0	0.9	0.3	0.6	0.2	1.7	0.0	0.0	0.0	1.1	1.1	0.0	0.1	2.3	0.1	1.9	0.6	0.1	0.0	3.8	0.1	0.6	1.4	0.7	2.1	0.9	0.1	2.7	1.0	1.1	0.5	0.4	0.9	1.4	1.5	0.1	0.5	3.8	6.5	9.9	6.3	5.0	3.5	4.3	7.5	4.0	4.2
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol			2800000	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavourable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favourable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	28.6	14.2	15.0	29.7	16.9	19.1	34.8	12.2	21.0	36.3	37.4	12.1	23.0	31.9	24.6	26.5	68.4	20.4	41.3	30.0	14.7	12.8	30.5	14.2	23.9	31.2	10.6	10.1	20.0	20.6	12.4	13.9	38.4	14.7	28.3	28.8	36.8	30.8	21.6	18.8	60.6	67.9	34.8	9.2	31.7	30.2	22.1	7.6	38.2	28.2	41.6	48.5	39.2	45.4	8.1	11.2	11.4	13.4	1.5	13.7	6.7	36.0	11.2	20.0	18.5	30.8	18.4	28.4	16.9	23.8	23.7	23.2	32.9	49.0	25.7	8.6	21.1	32.7	18.5	37.2	22.7	64.0	9.5	27.4	14.4	18.8	43.5	27.6	19.5	11.9	59.5	18.6	54.8	20.3	9.9	17.8	15.5	15.7	20.6	11.4	17.9	8.5	26.1	12.3	13.9	22.8	32.6	11.7	16.8	10.7	17.2	22.8	20.8	26.9	27.4	15.1	11.0	12.3	19.4	17.4	9.1	9.6	23.5	16.7	24.8	5.8	13.4	6.1	6.1	10.6	7.2	6.6	11.4	8.7	11.2	8.1	7.8	6.1	11.4	1.5	12.7	7.5	13.7	6.7	15.0	16.9	12.2	21.0	14.7	12.8	10.6	10.1	14.7	7.6
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	"Serine/threonine kinase 35"	Q8TDR2	20	2101611-2177038	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 27.8;testis: 37.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026452, HPA051673"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA026452: , HPA051673: "	"unprognostic (2.25e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (9.46e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.99e-2)"	5.3	6.0	10.3	3.6	14.3	4.3	5.1	6.1	13.7	3.7	4.3	3.1	2.5	4.2	4.5	3.5	8.0	5.1	4.3	5.2	5.9	4.8	4.4	5.7	4.2	3.3	4.4	7.6	3.9	5.9	5.3	6.5	3.5	4.0	3.8	5.2	27.8	6.1	4.0	3.5	6.3	4.6	4.9	4.5	4.1	4.1	37.6	4.4	1.7	5.4	6.1	4.5	4.1	3.7	1.8	2.0	3.2	1.4	0.8	2.7	1.2	14.8	12.6	9.9	16.9	4.5	6.2	12.0	6.1	7.5	8.2	8.5	16.6	11.6	10.2	5.0	7.6	22.5	11.6	14.0	9.4	4.0	5.5	9.7	4.4	17.9	5.8	8.7	4.5	5.4	12.3	13.0	11.3	7.7	9.4	8.5	5.3	6.6	10.9	12.4	18.3	8.6	9.5	8.8	6.4	7.4	14.9	16.3	7.9	10.8	19.5	9.7	9.6	8.7	6.5	14.0	9.6	7.0	9.6	7.5	9.6	7.1	7.5	9.5	6.1	0.0	1.2	0.7	1.9	1.0	2.5	1.7	2.7	1.3	2.0	1.8	2.6	2.2	3.2	0.8	1.4	1.7	1.3	1.2	10.3	14.3	6.1	13.7	5.9	4.8	4.4	7.6	4.0	4.4
STK36	"FU, KIAA1278"	ENSG00000163482	"Serine/threonine kinase 36"	Q9NRP7	2	218672026-218702716	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027409, HPA027453, HPA030058"	Approved		Supported	Cytosol				Cytosol		"HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225"	"unprognostic (8.11e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (5.20e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.83e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-3)"	4.8	10.0	7.5	4.7	11.4	2.0	6.4	7.9	11.1	9.1	7.4	7.0	11.9	4.1	14.4	13.3	5.0	13.9	9.8	3.3	6.3	3.5	10.1	4.4	6.9	3.9	2.3	6.6	13.6	9.7	12.3	23.2	3.9	7.6	9.5	6.3	9.3	7.3	8.3	3.3	4.6	5.8	7.8	5.5	4.9	7.9	63.2	4.2	3.5	11.4	3.7	5.0	9.3	7.1	1.8	1.6	3.2	1.9	2.2	1.6	1.7	2.7	6.4	14.0	11.9	15.2	11.9	8.5	7.6	6.1	9.7	9.2	8.3	4.6	3.7	10.6	7.9	5.6	9.5	7.9	8.6	1.6	7.9	3.6	19.1	11.4	7.4	5.0	6.1	12.8	5.9	9.5	6.8	7.2	8.3	4.7	8.0	6.4	3.0	6.3	8.4	4.1	5.6	6.0	3.7	11.9	14.0	11.4	9.7	5.9	9.6	3.9	9.8	4.1	6.9	13.5	5.0	5.1	5.2	6.0	4.6	1.9	8.4	2.4	5.6	0.0	1.9	3.2	1.5	1.2	0.9	1.8	1.1	1.3	1.6	0.6	1.1	1.6	0.2	2.2	1.4	1.3	1.0	1.7	7.5	11.4	7.9	11.1	6.3	3.5	2.3	6.6	7.6	4.2
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168248141	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: , HPA062802: "	"prognostic favourable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	6.2	2.1	8.4	4.6	11.0	1.3	3.5	9.3	14.1	4.3	9.1	8.3	1.7	10.5	2.3	4.7	14.1	1.9	5.9	7.6	9.8	7.4	2.9	0.8	2.4	7.3	12.3	9.7	3.2	9.9	5.0	8.2	1.2	14.2	9.9	11.7	7.1	22.8	3.8	2.2	3.4	6.1	4.3	19.0	2.5	11.2	35.5	5.5	7.2	2.2	1.8	8.0	5.6	5.3	0.7	1.0	0.0	0.7	1.9	3.4	0.5	6.6	4.0	15.2	4.8	9.4	13.8	1.5	16.7	12.3	11.2	10.4	0.0	21.6	18.3	4.6	10.8	17.3	9.7	12.2	14.1	5.8	6.0	7.6	4.4	13.5	17.4	10.2	0.8	9.5	17.3	13.3	13.9	7.6	0.1	0.0	23.4	3.8	17.7	3.6	10.5	8.5	25.4	6.0	1.5	8.4	16.5	22.5	9.5	5.8	0.8	6.8	3.0	7.5	7.1	13.6	4.2	9.6	10.9	0.0	0.0	14.7	10.3	9.1	9.1	0.0	0.7	0.0	2.5	0.4	1.3	0.7	1.9	3.4	1.0	0.7	0.4	2.0	0.0	1.9	0.3	0.3	3.3	0.5	8.4	11.0	9.3	14.1	9.8	7.4	12.3	9.7	14.2	5.5
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966474-45079959	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	9.5	8.8	10.4	24.5	11.5	39.5	8.1	7.5	13.4	7.8	8.6	10.3	5.4	8.1	9.3	6.5	8.9	7.3	9.4	6.1	9.3	8.8	6.3	7.4	18.8	30.6	10.5	9.1	8.3	6.4	5.9	9.3	8.2	7.7	7.5	10.6	7.4	9.3	8.7	4.2	11.4	16.1	8.2	12.0	29.1	9.6	7.4	9.6	32.3	8.0	4.9	36.6	11.5	8.7	10.8	6.9	40.6	13.3	10.3	14.5	7.9	11.6	7.9	10.1	7.2	6.2	7.8	7.0	10.3	15.8	17.5	15.9	22.4	6.4	28.6	9.0	7.3	12.4	10.7	13.8	22.5	12.8	5.7	20.8	11.6	15.7	10.9	26.7	29.6	6.3	11.4	16.4	17.9	6.4	9.6	16.5	8.8	9.2	19.9	18.1	6.2	5.4	12.9	11.2	13.3	6.4	8.0	4.8	5.9	15.3	8.9	11.7	8.1	16.9	8.2	13.2	12.9	15.2	11.9	21.6	16.9	31.8	12.9	12.8	9.7	24.4	7.6	20.5	14.5	7.7	14.4	10.3	13.8	13.3	6.9	10.8	14.3	11.9	40.6	10.3	13.3	3.9	13.3	7.9	10.4	11.5	7.5	13.4	9.3	8.8	10.5	9.1	7.7	9.6
STK40	"MGC4796, SgK495"	ENSG00000196182	"Serine/threonine kinase 40"	Q8N2I9	1	36339624-36385896	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 19.2;monocytes: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008026	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA008026: AB_1857603"	"unprognostic (3.32e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.69e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.96e-2)"	"prognostic favourable (5.59e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	22.9	7.2	9.8	15.3	9.4	9.2	26.5	8.9	11.1	10.2	19.1	7.4	16.7	9.4	11.8	12.2	22.3	11.3	18.2	25.6	10.0	7.1	14.3	23.5	16.6	15.4	13.1	7.4	22.2	34.4	9.2	14.7	19.2	12.1	15.7	9.1	9.0	25.1	17.7	53.9	17.2	10.8	26.0	10.3	17.2	17.0	32.0	8.9	9.2	14.6	20.7	16.6	19.5	26.6	2.4	2.7	19.2	8.5	1.6	2.9	2.4	7.0	3.1	15.6	16.2	11.1	6.4	8.8	7.2	9.8	8.7	9.4	17.1	10.2	30.0	5.9	6.7	7.1	14.2	3.1	6.4	13.0	11.1	19.6	2.9	21.8	11.0	11.4	26.2	5.8	11.8	6.7	3.5	5.4	24.0	10.9	5.4	11.1	11.8	15.1	10.0	4.3	13.6	10.6	19.9	5.4	8.0	19.1	9.7	5.5	8.7	23.9	5.9	13.5	9.0	5.5	11.5	16.1	15.8	11.4	6.4	25.3	28.6	10.0	18.0	1.0	3.0	4.9	2.6	6.7	2.9	2.3	1.7	1.7	2.7	2.4	1.0	1.5	19.2	1.6	8.5	2.6	1.0	2.4	9.8	9.4	8.9	11.1	10.0	7.1	13.1	7.4	12.1	8.9
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 143.4;lymphoid tissue: 117.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 79.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 79.3;T-cells: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010107	Enhanced		Supported	Cytosol			210000	Cytosol		"CAB010107: AB_628297"	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavourable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	7.3	13.2	91.7	17.5	47.4	40.7	10.9	54.1	124.8	6.2	16.7	47.0	2.5	12.7	24.7	7.8	13.0	7.3	9.4	9.5	67.9	88.4	13.2	6.4	11.0	42.8	86.5	58.0	33.6	3.5	4.6	12.1	21.7	43.4	5.2	20.7	7.7	5.3	6.3	3.8	9.5	15.9	18.8	143.4	10.9	9.7	58.2	27.1	117.1	6.1	7.2	43.1	13.0	8.1	8.6	79.3	4.0	1.5	10.1	26.2	9.3	67.5	15.2	151.7	60.6	9.1	8.8	15.4	52.7	41.9	75.3	72.9	10.4	69.5	83.1	29.6	38.4	20.7	42.0	30.5	113.3	25.1	20.8	51.5	26.9	36.3	3.6	64.8	36.8	5.4	4.5	30.3	34.6	56.6	69.5	82.9	97.5	17.6	213.2	95.3	93.0	20.5	126.2	118.3	49.3	36.4	6.1	102.8	89.2	47.9	24.0	42.0	34.4	82.6	27.2	50.6	60.1	43.8	43.9	48.9	77.6	103.2	24.9	126.8	54.5	2.0	0.7	4.0	10.4	1.5	6.3	6.4	9.3	13.1	4.2	8.6	15.3	13.7	0.3	10.1	0.7	79.3	26.2	9.3	91.7	47.4	54.1	124.8	67.9	88.4	86.5	58.0	43.4	27.1
STN1	"bA541N10.2, FLJ22559, OBFC1"	ENSG00000107960	"STN1, CST complex subunit"	Q9H668	10	103882542-103918205	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037924, HPA037925"			Supported	Nucleoplasm				Nucleoplasm		"HPA037924: AB_10671636, HPA037925: AB_10672469"	"unprognostic (1.50e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.58e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.76e-1)"	"prognostic favourable (1.12e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.83e-2)"	13.6	21.0	7.4	10.4	12.6	8.8	13.2	10.7	12.7	13.2	10.9	14.4	10.1	9.1	12.9	10.7	35.6	9.9	18.5	25.4	7.9	9.2	18.6	9.6	21.3	15.6	11.6	6.8	17.6	30.1	23.3	15.3	12.9	17.0	13.0	12.8	13.1	17.2	10.8	19.0	11.8	11.0	14.0	11.9	13.4	16.3	26.8	9.1	19.7	13.9	18.2	24.2	18.0	15.9	9.2	14.4	38.5	12.0	23.5	38.4	16.8	13.2	10.5	11.7	9.7	9.7	29.4	4.1	6.8	17.7	8.2	7.5	6.2	21.1	8.5	12.2	7.9	12.3	4.3	15.5	7.7	12.3	6.6	7.9	3.5	11.6	13.4	6.0	6.4	19.3	25.9	8.0	23.0	15.8	4.3	17.3	13.6	10.4	14.2	10.6	2.6	15.1	11.2	8.4	8.9	20.2	15.5	6.9	8.3	4.7	7.3	12.2	6.2	5.3	22.4	10.3	7.5	7.2	9.4	24.9	6.9	8.6	15.2	12.8	4.3	10.8	12.0	38.5	24.6	7.7	38.4	9.1	27.3	22.3	14.4	9.2	20.2	23.9	17.6	23.5	7.8	13.2	34.2	16.8	7.4	12.6	10.7	12.7	7.9	9.2	11.6	6.8	17.0	9.1
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338988-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 104.0;hTCEpi: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"			140000000	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	96.0	27.5	29.3	29.7	41.6	89.2	78.6	15.0	19.4	28.7	46.4	23.2	14.6	14.4	35.7	26.7	34.9	28.2	45.2	46.4	27.2	18.5	35.4	114.4	66.0	40.2	24.2	15.1	31.5	11.8	21.0	11.3	77.0	28.1	36.8	16.7	27.7	23.0	28.3	50.6	25.4	25.0	50.4	37.8	48.3	34.5	17.4	23.3	4.4	29.6	25.1	16.1	56.6	51.8	1.4	8.6	5.2	13.2	33.2	43.4	25.8	1.4	9.7	0.8	4.4	104.0	29.9	0.0	25.9	25.7	7.3	11.5	1.2	1.9	11.8	6.4	32.2	2.5	5.4	24.0	13.0	7.2	2.2	27.4	21.3	3.7	56.4	10.1	5.8	49.5	85.0	11.4	15.2	26.0	5.9	15.8	15.8	7.7	0.3	7.7	11.8	3.0	1.4	0.0	25.6	5.7	0.2	1.0	0.1	21.6	19.2	11.1	6.5	8.4	33.0	16.9	5.3	16.8	2.4	6.7	7.3	0.7	6.5	10.2	9.0	3.4	8.5	0.9	43.4	13.2	42.8	1.4	22.0	38.9	8.6	1.1	4.1	22.0	5.2	33.2	9.0	1.5	2.0	25.8	29.3	41.6	15.0	19.4	27.2	18.5	24.2	15.1	28.1	23.3
STOML2	"HSPC108, SLP-2"	ENSG00000165283	"Stomatin like 2"	Q9UJZ1	9	35099776-35103195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015944, HPA062016"	Supported		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"		98000	"Plasma membrane, Cytosol"		"CAB015944: , HPA062016: "	"unprognostic (2.49e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (4.77e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (3.00e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.26e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.47e-2)"	23.2	38.6	20.5	24.8	20.7	26.9	25.3	20.9	30.3	22.1	30.8	19.9	17.4	26.6	26.6	25.5	32.9	28.2	35.4	49.6	18.6	19.1	38.6	67.1	17.1	31.7	18.8	18.8	30.9	48.3	20.4	17.4	28.5	20.7	25.6	33.6	25.0	32.1	25.5	59.2	26.3	39.0	26.7	13.8	23.1	28.7	23.2	14.3	32.4	34.8	46.3	33.8	24.8	21.1	34.7	44.4	20.5	27.1	33.8	40.3	37.7	46.5	54.0	29.0	43.3	21.4	25.7	31.1	23.0	34.0	65.8	48.2	60.8	21.9	39.4	16.3	29.4	20.0	44.3	51.7	44.0	33.6	40.5	24.1	45.8	57.5	62.5	45.6	27.7	32.5	40.5	53.3	64.2	42.9	39.1	24.2	32.1	37.6	40.5	80.9	45.4	34.2	35.5	24.6	42.1	35.6	28.1	27.0	32.8	13.0	35.0	29.8	24.3	29.4	23.1	22.5	31.8	18.6	40.6	17.0	29.0	37.1	29.9	29.0	30.2	20.5	27.1	14.8	25.5	23.1	30.0	34.7	28.8	28.7	35.8	30.2	27.8	25.3	4.7	33.8	16.6	44.4	40.3	37.7	20.5	20.7	20.9	30.3	18.6	19.1	18.8	18.8	20.7	14.3
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38991066	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2"	"Cell line enriched"	"Detected in single"	39	"AF22: 18.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"olfactory region: 29.0"	"Low region specificity"	"Detected in all"			"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA012892: AB_1857610, HPA071011: "		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favourable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.1	0.1	2.9	0.1	3.8	0.1	0.2	0.0	0.2	1.7	0.2	6.6	0.0	0.2	1.1	8.1	0.1	31.7	0.1	0.1	4.4	4.1	0.1	0.1	9.2	0.1	0.0	0.0	7.6	0.1	0.1	0.0	0.3	9.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.6	2.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.8	0.0	0.2	4.4	4.1	0.0	0.0	9.7	2.1
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 42.8;HMC-1: 24.3;Karpas-707: 22.0;RT4: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 3.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003086	Enhanced		Supported	Nucleoli,Cytosol			9800	Cytosol	Nucleoli	"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	6.1	1.2	26.8	1.5	23.5	5.6	11.5	2.0	22.4	4.3	5.3	18.1	1.6	4.7	1.8	6.7	11.3	13.6	7.1	4.0	26.1	11.6	17.5	3.7	5.0	1.3	10.3	11.5	3.7	1.3	0.6	7.9	4.3	9.6	2.6	6.1	7.9	4.6	3.8	9.5	9.2	4.9	2.2	4.5	18.7	6.8	4.0	15.9	0.3	13.1	4.9	3.4	6.8	6.6	0.0	0.5	0.8	3.6	0.0	0.1	3.2	1.7	1.3	4.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	4.2	1.5	0.0	2.2	0.0	11.8	6.5	14.7	0.0	0.2	2.3	42.8	7.9	1.6	0.0	0.0	24.3	0.6	13.0	0.0	4.4	0.0	15.7	22.0	0.4	2.6	2.1	0.0	4.7	1.1	0.0	6.9	1.3	3.1	17.7	11.5	0.7	5.2	0.2	0.0	0.6	0.1	0.1	0.9	3.6	3.9	1.0	2.5	4.5	0.0	3.2	0.1	1.1	0.0	2.4	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	3.2	26.8	23.5	2.0	17.5	26.1	11.6	10.3	11.5	9.6	15.9
STOX1	"C10orf24, FLJ25162"	ENSG00000165730	"Storkhead box 1"	Q6ZVD7	10	68827541-68895432	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;fallopian tube: 19.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.9;HAP1: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;T-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037844, HPA037845"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Intracellular and membrane"			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA037844: , HPA037845: AB_10671369"	"prognostic favourable (3.37e-5)"	"unprognostic (5.53e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"prognostic favourable (2.08e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.33e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.46e-2)"	8.7	6.4	17.8	1.7	13.4	0.6	4.8	1.8	13.4	2.0	2.6	6.8	1.3	2.0	2.8	11.9	2.5	19.1	1.7	0.9	16.1	9.3	4.5	0.9	2.2	1.8	11.5	10.2	1.9	1.6	6.1	8.8	1.5	5.6	2.3	2.8	5.0	2.6	2.1	1.9	1.4	2.8	2.5	2.4	0.9	2.2	3.8	7.3	3.3	8.7	0.0	1.7	1.6	0.9	0.7	3.5	0.0	0.0	0.2	3.0	0.2	2.2	2.4	5.4	10.9	2.3	0.0	3.2	0.2	0.1	1.6	1.7	2.3	3.3	2.1	3.1	0.0	0.6	10.1	0.0	0.8	2.5	4.2	0.2	0.5	3.1	0.3	2.7	3.9	0.2	0.2	0.3	0.0	0.1	0.5	0.3	0.2	2.2	4.6	3.4	1.8	1.5	3.4	0.1	0.0	3.2	5.7	1.7	4.9	3.9	1.0	0.7	2.4	2.2	0.0	0.0	0.2	0.0	1.5	1.0	1.9	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.4	0.8	0.6	0.0	0.7	3.0	1.4	0.0	0.2	0.0	3.5	0.3	0.2	17.8	13.4	1.8	12.5	16.1	9.3	11.5	10.2	5.6	7.3
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20-related kinase adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favourable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavourable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favourable (6.43e-4)"	13.3	17.7	19.4	14.6	23.7	17.5	13.0	25.0	28.4	15.2	13.2	27.1	8.7	9.5	16.1	20.6	14.3	20.9	14.5	15.1	18.9	20.2	14.7	13.0	13.9	19.6	20.9	21.7	18.5	12.5	21.9	17.5	14.4	26.0	13.8	13.1	22.2	12.6	16.7	10.3	20.1	12.0	19.1	19.4	20.7	12.6	55.4	21.4	16.2	13.3	8.9	21.3	12.9	12.8	11.2	16.2	18.6	10.0	15.6	11.7	7.5	7.2	21.7	18.9	19.0	18.6	13.9	7.4	13.8	12.7	19.9	17.8	5.6	8.4	11.0	8.6	11.7	6.0	12.5	13.3	19.8	12.2	12.1	21.8	15.2	13.4	13.2	20.6	15.7	14.5	11.5	22.6	13.0	22.0	13.9	11.8	18.8	13.4	24.2	14.1	9.4	12.3	15.8	30.1	13.5	17.8	14.3	20.7	23.2	9.4	15.5	15.1	11.4	15.0	17.6	19.0	13.5	15.3	11.4	11.8	12.5	13.9	14.1	12.5	14.9	18.6	9.5	8.6	10.5	7.1	9.7	11.2	9.7	11.7	16.2	9.0	9.6	8.5	11.4	15.6	10.0	13.7	7.2	7.5	19.4	23.7	25.0	28.4	18.9	20.2	20.9	21.7	26.0	21.4
STRADB	"ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK"	ENSG00000082146	"STE20-related kinase adaptor beta"	Q9C0K7	2	201387858-201480846	"Enzymes, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026549, HPA028520"	Approved		Supported	Aggresome,Cytosol				Cytosol	Aggresome	"HPA026549: AB_1844779, HPA028520: AB_10604100"	"unprognostic (6.34e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.65e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.83e-2)"	"prognostic favourable (4.45e-4)"	"unprognostic (4.93e-2)"	13.8	28.6	13.8	7.9	11.7	32.7	9.2	8.8	13.5	6.4	13.7	16.9	4.9	18.8	10.3	9.5	8.9	5.7	7.9	15.2	15.3	11.5	35.2	50.5	7.2	10.1	15.8	11.0	7.8	9.1	3.9	14.1	11.6	12.7	7.1	15.9	10.1	7.1	7.7	48.3	4.4	21.3	7.4	21.0	7.3	4.7	7.8	9.4	8.3	9.7	7.8	7.7	6.2	6.2	24.1	10.4	9.7	8.6	16.3	10.4	9.6	3.9	6.8	11.8	15.1	19.3	24.5	8.3	8.0	13.9	11.1	16.8	8.9	3.8	0.0	5.2	12.6	4.0	11.4	7.5	20.2	4.6	9.3	4.7	3.2	19.7	14.6	5.6	5.4	20.7	6.9	14.2	12.8	8.3	10.1	1.7	59.9	2.1	5.1	9.8	15.9	7.0	7.0	4.6	2.9	9.4	3.2	1.9	9.7	5.5	4.2	23.4	2.2	10.7	8.0	6.8	5.2	8.6	6.1	6.6	11.7	1.8	11.5	2.5	6.4	3.4	8.0	9.7	6.0	8.6	5.4	16.7	8.0	8.6	10.4	24.1	10.4	10.3	1.6	16.3	7.5	4.6	9.5	9.6	13.8	11.7	8.8	13.5	15.3	11.5	15.8	11.0	12.7	9.4
STRAP	"MAWD, pt-wd, UNRIP"	ENSG00000023734	"Serine/threonine kinase receptor associated protein"	Q9Y3F4	12	15882391-15903478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027320, HPA055557, HPA073876"	Approved		Enhanced	Cytosol			290000	Cytosol		"HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639"	"unprognostic (4.64e-3)"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (6.83e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (9.07e-4)"	"prognostic unfavourable (5.10e-4)"	36.7	39.8	43.5	28.1	43.2	24.1	46.4	38.1	55.3	30.5	29.4	19.3	29.2	24.7	31.8	29.1	33.7	24.7	25.8	54.0	55.7	44.9	46.4	42.9	27.7	30.4	35.8	48.3	25.5	38.7	40.4	36.7	34.4	47.1	27.8	29.5	20.5	26.0	32.2	109.2	25.3	23.6	37.4	51.5	20.7	28.9	32.9	27.5	27.9	42.6	36.6	29.4	28.6	29.8	36.9	44.6	30.8	41.8	29.2	43.4	38.5	32.6	38.5	36.8	31.3	32.6	32.6	49.1	39.2	27.3	35.4	33.1	55.0	28.8	36.4	19.5	39.8	23.8	43.9	43.0	52.3	48.6	35.6	36.8	30.6	24.1	53.5	42.6	17.9	31.3	36.7	39.0	44.0	41.1	28.2	11.1	46.0	22.8	35.4	20.4	129.7	25.2	27.3	50.6	21.0	41.0	33.7	23.7	40.4	31.6	21.9	42.7	40.8	22.9	34.4	26.5	31.5	28.0	48.0	12.8	17.3	59.8	32.6	23.7	33.4	26.8	36.7	30.8	34.6	41.8	38.9	36.9	36.0	33.3	44.6	30.8	35.4	37.3	17.0	29.2	35.9	27.4	43.4	38.5	43.5	43.2	38.1	55.3	55.7	44.9	35.8	48.3	47.1	27.5
STRIP1	"FAM40A, FAR11A, FLJ14743, KIAA1761"	ENSG00000143093	"Striatin interacting protein 1"	Q5VSL9	1	110031577-110074641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060302, HPA060498"	Approved		Supported	Cytosol				Cytosol		"HPA060302: , HPA060498: "	"unprognostic (2.75e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.23e-2)"	14.7	15.8	25.6	11.8	20.2	21.7	14.1	30.3	30.7	16.6	14.6	19.7	10.1	14.0	21.0	17.8	15.6	17.7	13.0	13.5	22.3	19.0	12.3	10.0	13.7	15.1	17.7	18.1	24.7	15.7	24.8	16.7	21.2	24.5	13.5	15.0	15.3	14.6	16.2	13.6	18.0	19.8	20.1	11.1	23.8	13.8	21.9	16.4	18.6	14.5	10.9	17.3	16.2	15.2	13.0	13.5	15.9	15.7	17.3	18.4	13.1	12.1	8.1	22.1	15.0	19.4	12.9	16.0	19.2	16.8	20.1	17.5	8.4	7.1	9.9	10.5	17.0	11.6	11.7	13.6	14.2	21.1	14.2	16.5	14.3	11.0	10.8	14.9	16.6	13.7	16.4	16.9	18.7	16.0	14.6	12.8	19.3	14.4	17.0	15.7	17.9	11.0	16.7	28.5	8.8	14.0	17.9	28.6	16.5	16.4	20.9	12.3	10.4	13.6	16.3	15.2	14.6	17.5	12.7	13.1	7.2	10.1	17.3	16.1	21.8	12.2	11.5	15.9	17.7	12.7	15.5	12.8	15.1	18.4	13.5	13.0	17.5	15.5	10.7	17.3	15.7	6.2	13.3	13.1	25.6	20.2	30.3	30.7	22.3	19.0	17.7	18.1	24.5	16.4
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"			15000	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favourable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.5	14.3	15.9	12.1	16.2	10.9	13.5	23.4	17.7	15.8	17.4	11.5	16.5	8.8	14.7	14.8	16.5	10.8	14.0	21.5	14.4	12.1	15.2	22.7	11.6	7.2	12.9	10.1	12.6	13.1	18.0	20.2	14.1	13.9	16.2	14.0	11.4	12.6	17.2	52.0	12.6	11.3	22.0	11.8	11.9	12.9	22.4	14.6	9.3	14.9	13.5	9.7	25.1	20.5	7.0	10.5	8.5	7.9	7.4	10.0	2.4	17.7	15.3	17.1	12.3	14.6	11.1	14.2	16.9	12.5	14.2	14.4	20.4	12.0	10.3	12.4	12.3	9.8	19.0	10.8	21.1	8.9	6.4	10.2	10.5	39.4	15.8	8.7	11.4	11.7	11.4	11.3	13.8	11.4	12.3	9.8	13.7	12.1	11.3	8.5	8.4	14.2	8.3	20.1	2.7	21.3	25.5	10.8	8.9	18.8	13.8	9.2	15.8	7.5	13.7	14.0	12.5	8.8	6.7	9.3	10.7	10.2	6.9	6.4	11.1	6.3	7.1	8.3	6.8	7.9	8.9	7.0	8.5	7.7	5.8	6.9	8.6	10.0	8.5	7.4	6.2	10.5	6.4	2.4	15.9	16.2	23.4	17.7	14.4	12.1	12.9	10.1	13.9	14.6
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3B, catalytic subunit of the oligosaccharyltransferase complex"	Q8TCJ2	3	31532638-31637622	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"			9300	"Endoplasmic reticulum"		"HPA036448: , HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	23.0	30.3	16.0	27.5	16.7	21.7	27.4	15.4	19.4	28.4	25.0	16.9	37.0	18.6	28.4	37.9	28.8	22.4	29.0	27.5	15.1	15.6	28.2	64.1	30.1	36.9	16.5	15.5	62.3	39.4	36.2	20.3	85.9	16.5	26.3	25.1	22.3	25.2	26.3	31.2	19.2	29.2	23.2	19.7	29.4	22.9	36.7	13.6	60.2	44.3	23.4	30.3	27.5	27.7	3.6	7.7	8.4	5.3	8.4	8.5	3.0	16.3	27.5	25.3	26.5	31.9	32.3	55.4	30.7	27.0	23.0	26.7	25.0	35.6	28.5	15.1	27.8	13.9	23.4	26.6	30.2	80.2	15.4	24.4	28.0	26.6	24.6	52.5	29.1	24.7	28.6	32.7	41.4	23.2	13.1	45.7	31.3	9.2	51.4	32.5	20.4	15.5	53.8	13.7	41.3	26.8	23.7	10.8	13.2	30.4	45.2	17.8	20.4	28.1	45.1	31.1	19.9	30.7	27.0	28.8	34.5	23.9	28.2	36.2	25.5	2.3	4.6	8.4	4.7	5.3	7.5	3.4	8.5	6.5	4.0	3.6	8.2	6.5	1.7	8.4	3.7	7.7	4.1	3.0	16.0	16.7	15.4	19.4	15.1	15.6	16.5	15.5	16.5	13.6
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favourable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	29.4	43.7	52.2	20.1	43.2	19.3	40.5	39.1	53.3	25.1	24.8	18.1	27.6	24.1	19.7	34.9	35.2	31.1	25.5	45.2	43.2	38.6	24.0	25.9	23.6	28.1	42.0	42.5	29.4	43.4	39.8	27.2	12.1	35.0	23.4	17.7	18.6	37.7	29.7	92.5	33.7	20.9	24.5	34.5	19.7	22.8	13.8	25.4	13.1	29.1	30.2	19.4	22.3	35.9	18.0	21.0	19.4	14.5	10.3	16.9	6.9	17.8	24.2	16.4	27.7	37.5	34.4	9.4	24.4	28.7	29.0	25.8	30.1	22.8	18.1	17.3	40.8	15.3	20.2	36.7	12.1	19.9	66.8	11.2	35.0	25.1	54.1	18.9	22.4	40.8	39.4	33.9	21.5	29.3	18.1	30.3	44.8	70.7	20.5	18.6	18.3	26.5	31.7	10.7	44.5	38.7	17.9	28.6	23.2	19.5	43.0	30.6	27.4	36.3	23.2	26.6	23.3	22.0	29.3	30.0	31.0	29.2	21.0	17.2	30.0	11.9	14.5	19.4	16.9	11.9	15.4	18.0	14.6	14.7	11.7	17.3	13.6	12.9	14.0	10.3	12.4	21.0	12.2	6.9	52.2	43.2	39.1	53.3	43.2	38.6	42.0	42.5	35.0	25.4
STX12	"STX13, STX14"	ENSG00000117758	"Syntaxin 12"	Q86Y82	1	27773183-27824452	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041038, HPA055300"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA041038: AB_10794261, HPA055300: "	"unprognostic (3.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.24e-1)"	38.5	20.2	32.2	16.3	29.6	6.3	22.9	25.8	35.9	20.3	19.4	27.3	23.5	22.9	20.4	42.1	25.7	15.0	25.9	15.3	31.2	31.9	23.2	18.5	31.2	16.3	35.5	29.0	15.2	19.5	16.7	19.6	21.1	32.3	20.8	21.4	11.6	17.7	22.2	14.2	17.1	20.9	23.1	36.9	20.0	38.7	9.0	19.9	6.3	67.0	11.0	13.9	19.4	14.8	7.6	14.2	10.1	21.7	5.2	6.4	8.3	8.6	4.2	11.3	7.3	21.5	26.2	5.8	18.3	27.1	16.9	19.2	5.1	11.3	9.5	19.8	24.5	7.3	7.4	9.1	17.0	8.3	8.8	5.4	4.6	5.1	16.9	5.9	11.3	24.5	11.2	23.7	13.6	27.1	7.0	9.5	18.4	3.1	5.1	4.5	4.7	5.9	3.2	9.0	5.7	14.9	14.3	12.7	6.9	8.6	7.4	13.2	5.1	5.3	29.1	8.6	4.9	19.5	6.3	5.7	4.1	5.4	14.0	9.1	12.0	10.1	19.6	7.5	3.7	21.7	6.4	7.6	4.4	5.7	14.2	6.5	4.9	4.1	9.3	5.2	21.0	7.0	4.4	8.3	32.2	29.6	25.8	31.8	31.2	31.9	35.5	29.0	32.3	19.9
STX16	"hsyn16, SYN16"	ENSG00000124222	"Syntaxin 16"	O14662	20	58651253-58679526	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041019, HPA042033"	Uncertain		Enhanced	Vesicles				Vesicles		"HPA041019: AB_10964273, HPA042033: AB_10963935"	"unprognostic (7.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (7.32e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.41e-2)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (3.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.89e-2)"	22.1	24.5	41.9	25.3	46.7	36.7	22.3	54.5	43.2	21.9	23.3	35.0	35.9	20.3	30.3	36.9	18.8	26.7	23.4	17.3	36.8	22.4	18.6	20.0	20.5	32.8	43.0	32.8	29.2	23.1	18.5	33.0	20.5	34.0	24.6	21.1	20.9	27.9	28.5	25.9	41.5	23.6	29.4	33.0	31.0	21.7	22.2	42.9	16.6	23.7	15.7	24.7	24.2	24.3	4.7	4.3	14.1	6.2	5.6	6.1	4.0	14.4	8.5	11.2	10.9	20.7	22.1	15.6	18.0	12.2	18.5	11.5	16.5	21.2	16.7	25.2	12.8	21.5	10.2	21.4	15.4	7.8	10.8	10.4	22.3	19.9	20.6	14.8	23.6	24.5	32.9	12.4	18.9	18.6	12.0	14.9	14.9	33.8	11.4	17.9	4.5	14.5	10.6	10.5	11.4	14.1	10.8	7.4	11.3	19.0	33.6	32.3	13.4	19.7	19.7	30.6	14.8	11.6	19.7	30.9	14.3	9.3	22.5	11.5	12.7	14.1	6.2	5.2	5.0	5.6	5.6	2.6	4.5	3.5	4.1	4.7	6.1	5.5	14.0	5.6	4.1	4.3	4.8	4.0	41.9	46.7	54.5	43.2	36.8	22.4	43.0	32.8	34.0	42.9
STX4	"p35-2, STX4A"	ENSG00000103496	"Syntaxin 4"	Q12846	16	31032889-31042975	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001330	Approved		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA001330: AB_1080167"	"unprognostic (2.31e-3)"	"prognostic favourable (3.65e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"unprognostic (5.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (2.88e-9)"	"unprognostic (6.90e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.26e-2)"	26.5	28.2	28.6	23.8	29.6	14.1	23.5	24.2	28.0	21.4	24.0	24.4	16.9	28.3	24.1	19.8	26.4	19.6	23.7	24.6	26.7	18.0	21.7	25.2	25.8	22.5	38.1	22.3	22.7	19.3	33.6	14.9	27.0	32.4	19.8	22.0	14.0	21.3	21.8	30.3	32.7	26.7	27.7	26.1	31.4	22.7	10.7	31.5	19.2	21.3	17.3	26.7	25.4	29.4	11.9	14.8	20.6	18.2	18.2	14.9	8.6	18.2	26.2	5.9	13.2	20.0	20.4	12.7	16.9	29.9	18.1	18.7	8.0	19.9	12.4	22.0	29.9	13.3	5.5	19.7	17.4	22.2	16.8	8.9	18.3	21.8	22.7	10.3	30.1	19.4	13.8	31.3	23.4	24.0	10.4	14.5	32.1	28.7	9.7	15.9	12.3	14.1	8.3	17.8	16.1	18.0	13.6	4.9	9.3	14.9	15.4	6.2	12.3	13.7	25.7	18.4	8.2	20.6	9.4	15.6	12.6	5.4	27.7	16.7	11.1	14.6	17.7	20.6	14.9	18.2	12.9	9.7	12.5	14.5	14.8	11.9	9.5	12.2	18.5	18.2	15.8	8.6	6.8	8.6	28.6	29.6	24.2	28.0	26.7	18.0	38.1	22.3	32.4	31.5
STX5	"SED5, STX5A"	ENSG00000162236	"Syntaxin 5"	Q13190	11	62806897-62832088	"Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001358	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA001358: AB_1080119"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.22e-3)"	21.3	20.0	17.5	16.2	17.0	28.3	22.6	33.0	24.2	26.9	19.6	17.6	40.9	17.2	21.6	36.4	22.3	23.7	20.1	17.7	17.6	15.7	22.3	42.6	21.0	17.7	18.6	16.7	29.3	33.7	22.8	20.2	37.4	17.4	27.9	18.2	20.6	47.3	32.2	17.1	26.4	23.0	19.2	16.0	24.0	22.1	16.1	19.7	29.1	33.7	16.4	29.0	22.5	22.3	9.4	10.0	24.9	10.4	9.5	9.7	4.7	17.3	11.1	14.9	13.2	20.5	22.7	13.8	17.1	24.1	28.9	23.4	8.3	17.2	11.1	16.0	24.3	18.2	12.9	16.2	21.4	25.8	12.3	9.6	14.9	16.9	24.8	11.4	14.8	18.7	18.5	25.7	31.2	14.0	8.7	30.9	15.3	20.9	15.4	18.5	5.0	16.4	15.9	14.4	29.5	13.0	9.2	11.2	9.5	13.8	21.9	26.1	24.2	15.4	15.0	21.1	11.1	24.2	10.9	28.3	15.9	11.7	16.9	8.0	12.8	8.2	8.8	24.9	8.5	10.4	7.4	8.7	6.7	8.2	8.1	9.4	6.4	6.2	14.0	9.5	9.1	10.0	9.7	4.7	17.5	17.0	33.0	24.2	17.6	15.7	18.6	16.7	17.4	19.7
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	12.2	10.4	17.6	14.1	18.9	2.9	12.4	21.7	25.5	13.4	10.4	15.5	7.2	9.8	11.3	10.7	22.2	10.3	9.6	8.1	18.6	13.2	11.6	6.5	15.3	12.7	18.5	13.1	11.5	5.5	9.2	6.8	15.0	16.1	10.1	11.1	6.4	10.7	9.6	5.7	16.5	9.9	11.8	15.0	11.6	10.5	7.3	20.0	14.1	15.3	7.3	17.8	16.3	15.6	1.7	5.1	5.9	3.6	0.4	3.2	1.4	9.8	11.1	11.0	14.6	11.6	13.7	18.6	12.7	16.4	10.0	8.6	10.3	9.9	10.0	17.6	13.9	17.7	9.9	22.4	11.8	7.2	7.3	6.7	8.4	10.0	11.5	9.5	8.7	12.4	20.6	16.9	17.5	20.2	12.3	7.1	13.3	14.2	9.1	9.0	17.1	5.6	8.0	13.4	14.4	11.9	24.8	15.6	16.6	13.3	25.7	13.9	15.6	8.7	16.6	13.9	7.3	12.9	10.2	12.1	6.7	7.3	6.8	9.4	8.1	5.9	3.6	4.5	1.8	2.9	1.9	1.7	2.6	2.7	5.1	1.7	3.2	2.4	3.4	0.4	2.5	1.7	3.2	1.4	17.6	18.9	21.7	19.1	18.6	13.2	18.5	13.1	16.1	20.0
STX7		ENSG00000079950	"Syntaxin 7"	O15400	6	132445867-132513198	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 13.0;classical monocyte: 16.5;eosinophil: 15.0;intermediate monocyte: 18.0;memory B-cell: 26.9;myeloid DC: 19.5;naive B-cell: 35.1;neutrophil: 26.4;non-classical monocyte: 18.2;plasmacytoid DC: 23.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001467, CAB062564"	Enhanced		Supported	Lysosomes			850000	Lysosomes		"CAB062564: , HPA001467: AB_1857623"	"unprognostic (1.91e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.42e-2)"	28.9	14.3	27.8	26.4	24.3	13.0	21.1	27.2	29.4	17.3	21.8	25.0	11.8	25.1	22.2	14.1	23.8	16.0	23.2	23.8	24.9	23.6	35.0	12.6	22.6	47.8	28.3	22.2	22.7	13.0	12.5	13.4	31.9	31.2	18.6	20.5	16.3	20.2	19.3	16.3	17.8	26.7	20.6	42.1	29.0	19.2	8.2	27.7	9.0	21.9	15.2	46.5	21.2	19.9	35.1	23.5	26.4	18.2	2.9	3.9	8.5	7.1	7.2	12.3	8.7	24.7	22.1	9.6	14.2	14.7	14.8	21.4	12.6	12.0	35.7	14.0	17.2	9.4	10.8	13.1	20.0	12.3	12.8	13.6	6.4	13.3	19.8	9.1	10.3	12.6	12.4	15.1	13.8	16.1	14.5	12.9	16.8	10.0	4.2	7.5	4.7	8.5	10.0	9.5	10.2	24.7	8.4	10.1	3.1	6.4	10.6	38.2	7.2	8.8	27.7	8.6	8.8	18.7	15.0	12.4	7.2	15.4	12.1	7.4	9.6	13.0	16.5	15.0	3.7	18.0	1.5	26.9	2.7	2.5	19.5	35.1	2.0	2.4	26.4	2.9	18.2	23.5	3.9	8.5	27.8	24.3	27.2	29.4	24.9	23.6	28.3	22.2	31.2	27.7
STXBP2	"Hunc18b, UNC18B"	ENSG00000076944	"Syntaxin binding protein 2"	Q15833	19	7636881-7647873	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.5;lymphoid tissue: 101.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 55.2;U-937: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 25.5;classical monocyte: 58.1;eosinophil: 35.5;intermediate monocyte: 73.1;myeloid DC: 30.2;neutrophil: 45.6;non-classical monocyte: 101.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 30.2;granulocytes: 45.6;monocytes: 101.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015564, HPA063868"	Approved		Enhanced	Cytosol			53000000	Cytosol		"HPA015564: AB_1857626, HPA063868: "	"unprognostic (1.20e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (4.65e-4)"	"unprognostic (4.22e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (7.68e-4)"	"prognostic favourable (5.13e-6)"	7.2	7.9	5.5	17.9	9.9	49.5	9.9	2.0	5.8	6.5	17.7	5.4	15.9	19.0	3.0	10.4	23.4	9.6	14.3	18.4	5.2	2.0	20.2	19.0	46.4	61.5	12.2	1.3	4.6	28.0	10.9	9.8	24.9	5.8	16.4	10.5	8.7	24.6	9.7	1.5	15.3	32.0	3.7	16.9	101.5	20.6	22.5	8.0	73.4	19.5	5.4	17.8	11.4	18.0	6.7	30.2	45.6	101.5	9.0	9.9	31.9	24.0	8.5	0.2	0.1	0.0	0.2	16.9	3.1	0.3	0.6	1.6	20.1	15.3	6.4	12.4	2.4	16.6	0.9	14.7	0.6	26.5	10.3	27.5	10.2	11.8	14.7	17.7	55.2	1.0	15.1	3.0	8.6	12.9	17.1	21.9	0.0	15.2	8.6	41.1	6.3	15.1	8.9	0.0	24.4	12.3	27.9	2.6	0.1	7.4	11.0	0.5	13.7	45.8	13.5	0.1	5.0	0.3	0.1	24.4	12.0	8.2	0.2	48.4	0.6	25.5	58.1	35.5	9.6	73.1	7.7	6.3	7.3	8.6	30.2	6.7	5.2	6.2	45.6	9.0	101.5	11.5	9.9	31.9	5.5	9.9	2.0	5.8	5.2	2.0	12.2	1.3	5.8	8.0
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 82.7"	"Cell line enhanced"	"Detected in many"		"HEL: 55.4;HMC-1: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol			11000	Cytosol		"CAB079016: , HPA039991: AB_10673368, HPA049727: "	"prognostic unfavourable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavourable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	4.4	9.1	4.3	6.6	5.9	14.0	9.0	7.8	9.0	6.7	17.6	2.0	22.1	3.9	4.6	6.5	10.2	3.8	9.2	3.5	3.6	4.3	2.0	2.4	3.8	3.5	3.3	4.7	3.0	10.9	82.7	15.5	3.1	4.3	5.7	7.8	6.5	5.7	21.0	7.0	10.9	35.1	5.3	2.7	4.7	4.0	9.6	2.3	2.2	4.2	5.6	4.6	5.3	9.1	0.9	0.5	11.2	0.6	0.5	1.7	0.3	2.8	2.5	1.3	4.5	6.5	13.8	1.5	6.5	9.8	4.9	5.5	2.1	1.9	2.0	1.5	13.0	3.4	3.8	5.8	6.0	4.4	3.0	55.4	7.3	2.3	7.5	18.9	60.6	10.0	4.1	9.7	20.0	6.2	14.9	2.6	9.6	4.1	3.0	4.9	1.0	5.8	0.4	6.9	0.7	2.6	4.9	2.9	2.1	5.1	3.6	2.2	1.0	7.4	7.2	7.0	2.5	3.4	5.9	2.1	0.0	2.4	3.9	6.9	5.0	4.7	0.3	11.2	1.2	0.5	1.3	0.5	0.7	1.4	0.5	0.9	1.2	1.7	4.0	0.5	0.6	0.4	0.3	0.3	4.3	5.9	7.8	9.0	3.6	4.3	3.3	4.7	4.3	2.3
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 homolog, transcriptional regulator"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	54.4	40.8	64.1	50.9	69.8	87.6	52.3	28.2	82.4	48.9	44.4	21.5	23.2	36.2	36.8	36.3	52.7	27.4	31.3	46.9	79.3	53.5	54.7	60.7	36.3	58.4	45.8	57.5	30.7	26.9	26.5	49.0	47.0	51.6	34.5	46.0	17.4	32.3	29.1	39.6	26.8	47.5	33.2	39.6	67.2	38.7	28.1	29.8	72.4	42.2	54.2	54.6	39.8	29.7	61.1	69.4	92.0	24.6	25.9	59.5	49.2	21.6	18.0	35.8	33.4	21.8	38.7	22.5	38.0	27.7	34.4	31.8	26.0	34.4	11.0	26.5	26.2	14.8	30.0	31.1	46.4	45.9	27.5	37.0	43.9	49.2	30.9	64.3	50.7	27.1	26.9	36.5	26.1	25.7	42.9	162.4	30.3	19.3	60.7	102.8	23.5	36.8	27.0	46.7	70.3	34.2	19.7	19.4	16.1	58.8	27.7	26.9	30.7	59.9	26.5	37.3	40.5	31.4	28.5	63.5	109.5	19.2	34.3	69.9	22.7	92.0	23.9	54.9	31.5	24.6	28.4	61.1	41.4	41.2	46.8	35.1	32.9	37.6	29.2	25.9	21.9	69.4	59.5	49.2	64.1	69.8	28.2	82.4	79.3	53.5	45.8	57.5	51.6	29.8
SUCLA2		ENSG00000136143	"Succinate-CoA ligase ADP-forming beta subunit"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria			6600	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (1.22e-4)"	21.6	18.5	19.2	8.6	22.1	5.2	17.5	29.7	32.4	15.3	15.7	11.7	15.6	24.5	12.7	12.1	14.6	11.3	9.4	42.1	20.0	21.6	34.0	12.9	7.9	11.4	22.6	19.1	14.4	10.8	19.8	14.9	12.2	28.7	16.2	16.5	8.9	13.9	14.8	89.0	10.0	22.7	14.7	18.3	9.7	12.3	8.0	15.4	15.6	16.9	25.6	10.2	11.0	12.6	17.1	29.5	12.4	25.0	23.4	25.2	17.2	17.2	20.0	25.4	15.2	29.1	22.0	15.3	26.4	29.6	27.5	18.7	35.5	19.6	24.2	20.2	25.8	24.0	33.5	25.1	34.9	23.1	28.7	27.2	19.0	23.0	20.3	27.5	15.9	20.7	29.6	18.7	22.1	20.2	18.3	8.8	27.3	11.9	28.3	31.5	26.3	25.6	24.1	23.2	18.7	39.7	16.7	14.1	16.8	22.0	20.4	15.5	18.1	24.4	15.4	15.3	9.9	21.7	18.3	9.1	14.2	28.2	9.5	20.1	22.4	5.7	24.5	12.4	17.6	25.0	21.2	17.1	19.7	21.6	29.5	16.3	25.2	24.9	4.5	23.4	20.0	24.3	21.6	17.2	19.2	22.1	29.7	32.4	20.0	21.6	22.6	19.1	28.7	15.4
SUCLG1		ENSG00000163541	"Succinate-CoA ligase alpha subunit"	P53597	2	84423523-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Supported	"Plasma membrane,Mitochondria"	"Intracellular and membrane"		330000	Mitochondria	"Plasma membrane"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favourable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	26.1	23.3	18.0	15.0	18.9	10.6	23.8	18.9	19.5	14.1	50.1	17.7	23.2	53.9	13.9	19.6	25.0	13.5	14.0	57.7	17.4	17.3	125.6	44.1	12.8	13.3	19.2	17.0	12.7	33.9	36.2	16.3	13.8	17.3	17.1	39.4	16.9	39.3	24.9	57.6	15.6	71.6	26.5	17.1	12.1	21.9	13.3	16.0	16.9	28.8	42.8	15.2	24.3	16.3	26.6	43.5	31.6	40.3	35.2	39.1	46.8	23.5	25.9	20.5	25.0	38.6	26.0	35.5	26.9	23.0	34.6	25.3	59.3	19.5	32.4	18.6	32.1	34.4	42.1	31.6	41.2	31.3	38.3	28.1	22.4	33.7	32.6	28.6	23.0	30.9	26.0	29.1	39.8	30.8	28.5	26.7	31.5	36.0	40.6	26.2	10.7	46.4	25.8	47.5	35.5	46.4	28.6	24.9	13.9	21.4	44.5	42.7	27.1	22.6	24.8	27.2	26.3	33.3	32.9	23.5	33.3	28.0	31.7	39.7	23.9	31.6	34.4	28.7	31.4	40.3	34.6	26.6	29.2	35.1	43.5	20.2	32.4	34.2	18.5	35.2	40.0	23.7	39.1	46.8	18.0	18.9	18.9	19.5	17.4	17.3	19.2	17.0	17.3	16.0
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming beta subunit"	Q96I99	3	67360460-67654614	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 90.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Supported	"Plasma membrane,Mitochondria"			290000	"Plasma membrane, Mitochondria"		"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favourable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	17.0	19.3	8.8	26.5	10.0	3.4	12.4	2.4	7.2	15.3	38.9	9.5	16.4	31.4	11.5	18.3	18.6	9.9	27.9	23.6	6.6	6.2	38.3	90.9	14.6	21.1	9.8	6.5	16.5	20.9	5.9	8.5	8.5	7.6	14.0	34.5	9.6	21.0	17.3	57.0	9.3	42.4	23.5	8.6	24.7	25.4	6.5	8.1	9.6	16.4	27.0	16.7	19.9	13.2	19.2	10.2	5.8	18.2	27.1	31.1	18.9	13.8	12.1	12.0	14.6	20.2	35.1	14.7	16.6	24.4	19.6	21.9	13.4	31.0	17.7	5.4	23.4	7.1	9.3	23.0	25.5	7.5	6.4	16.1	11.0	20.8	26.1	21.1	11.3	26.2	20.0	15.3	35.3	20.8	12.2	16.3	42.6	9.7	7.9	6.7	11.2	7.5	5.5	18.6	26.5	33.2	21.6	2.3	8.2	26.4	30.6	22.0	23.5	13.6	18.1	19.5	12.8	21.4	19.7	11.1	16.2	12.5	28.6	16.5	22.9	5.8	15.3	5.2	13.8	18.2	16.7	19.2	20.0	17.4	10.2	16.7	31.1	23.7	0.7	27.1	14.8	4.0	18.5	18.9	8.8	10.0	2.4	7.2	6.6	6.2	9.8	6.5	7.6	8.1
SUDS3	"FLJ00052, SAP45, SDS3"	ENSG00000111707	"SDS3 homolog, SIN3A corepressor complex component"	Q9H7L9	12	118376380-118418031	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040402, HPA041972"	Approved		Supported	"Nuclear bodies,Cytosol"	"Intracellular and membrane"			"Nuclear bodies, Cytosol"		"HPA040402: , HPA041972: "	"unprognostic (1.49e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-1)"	12.4	15.6	20.6	10.2	19.1	13.3	17.6	13.3	22.0	17.1	17.2	10.7	10.5	12.9	20.4	15.6	24.7	17.3	12.1	12.9	15.8	11.0	15.3	12.7	13.9	12.2	8.9	18.7	18.6	34.2	22.9	12.2	15.1	14.5	15.7	17.3	13.1	20.4	15.6	15.1	18.7	14.6	20.9	13.4	12.1	14.7	21.6	13.2	13.6	20.5	8.3	17.3	19.9	18.2	9.7	7.7	14.4	4.9	4.6	7.9	4.1	16.4	12.5	17.2	17.0	9.6	12.7	18.4	12.9	13.3	15.1	12.0	13.6	10.7	22.4	13.8	12.4	19.7	20.4	13.6	17.9	19.7	12.1	15.5	10.1	12.1	11.1	17.1	12.0	8.7	14.6	7.5	13.4	12.8	16.9	8.1	13.8	11.2	20.2	22.5	17.7	9.8	18.4	15.4	15.8	13.8	24.2	13.4	13.3	18.2	10.9	11.2	35.5	14.0	10.6	10.3	9.8	11.5	8.7	15.4	17.2	16.6	11.5	10.9	12.3	2.0	4.9	6.2	5.9	3.1	7.3	9.7	6.4	6.8	5.2	9.3	7.9	5.3	14.4	4.6	3.0	7.7	5.9	4.1	20.6	19.1	13.3	22.0	15.8	11.0	8.9	18.7	14.5	13.2
SUFU	"PRO1280, SUFUH, SUFUXL"	ENSG00000107882	"SUFU negative regulator of hedgehog signaling"	Q9UMX1	10	102503987-102633535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ciliopathy, Disease mutation, Joubert syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008700	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA008700: AB_1080125"	"unprognostic (1.55e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.15e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.82e-3)"	10.7	12.8	15.0	15.2	12.8	3.9	18.3	23.0	15.3	13.4	10.4	11.3	12.1	7.7	14.4	13.3	14.7	14.2	16.2	11.0	11.8	7.8	10.8	10.0	21.4	20.5	11.9	11.0	18.0	8.9	20.0	7.8	13.9	10.0	15.4	8.8	11.9	12.6	16.7	14.1	23.1	9.4	14.3	10.7	13.1	7.9	21.1	13.1	19.9	6.2	12.7	15.0	15.2	15.0	2.3	4.5	6.2	5.5	2.8	3.1	2.8	6.4	6.8	11.1	15.9	11.5	9.7	5.4	6.7	13.0	9.7	8.8	6.3	4.8	6.6	19.1	7.4	4.6	13.6	7.4	6.4	4.0	10.5	15.7	3.9	5.9	5.5	5.7	11.3	11.0	5.9	7.2	5.9	12.5	3.5	6.1	5.9	5.4	10.8	8.6	3.2	5.1	11.7	12.0	3.4	6.4	9.7	3.8	6.0	5.3	5.0	6.0	10.9	3.8	13.7	4.3	6.2	4.6	7.3	5.0	3.2	4.8	5.4	11.2	2.9	4.2	4.5	6.2	2.5	5.5	2.0	2.3	3.1	2.8	4.5	2.1	2.2	2.5	1.1	2.8	5.5	2.5	1.9	2.8	15.0	12.8	23.0	15.3	11.8	7.8	11.9	11.0	10.0	13.1
SUGP1	"DKFZp434E2216, F23858, RBP, SF4"	ENSG00000105705	"SURP and G-patch domain containing 1"	Q8IWZ8	19	19276018-19320844	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004890	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA004890: AB_1079935"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"unprognostic (5.21e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.25e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.42e-3)"	6.8	8.2	14.8	9.2	13.4	5.6	7.0	16.4	17.0	7.3	8.6	9.1	7.8	9.7	9.0	6.9	9.2	8.3	7.1	11.2	12.1	8.7	8.6	8.6	8.3	7.9	11.0	9.1	7.1	10.5	9.0	8.1	6.4	10.3	8.4	6.6	8.2	11.2	8.7	19.7	7.4	8.5	8.5	10.8	8.1	8.7	20.2	10.9	9.8	6.5	6.8	8.8	8.6	6.2	12.9	14.1	14.1	21.9	15.8	17.0	14.4	11.8	2.4	5.8	7.2	5.8	5.6	15.2	8.5	11.2	12.1	8.8	5.5	8.9	11.6	11.7	11.2	8.1	6.5	9.9	5.9	8.1	5.4	9.6	3.0	3.9	6.8	6.7	10.4	10.8	4.7	10.5	4.5	8.7	12.4	6.2	10.0	9.4	16.8	10.3	12.4	7.7	14.1	8.6	13.3	8.9	5.1	10.0	12.9	8.3	7.0	13.9	8.0	12.4	13.9	8.6	9.0	11.1	10.4	11.1	10.9	13.5	10.9	9.0	10.8	7.8	14.1	14.1	16.2	16.8	12.6	12.9	12.7	17.0	14.1	11.9	11.9	12.6	12.8	15.8	21.9	13.0	12.4	14.4	14.8	13.4	16.4	17.0	12.1	8.7	11.0	9.1	10.3	10.9
SUGP2	"KIAA0365, SFRS14"	ENSG00000064607	"SURP and G-patch domain containing 2"	Q8IX01	19	18990888-19034023	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041557, HPA061111"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA041557: AB_10794301, HPA061111: AB_2684432"	"unprognostic (1.35e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-3)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (1.94e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.60e-2)"	7.8	13.9	27.2	11.8	27.0	24.5	9.9	36.0	34.4	9.0	10.1	15.4	10.8	11.8	14.8	15.0	7.8	13.5	9.0	18.2	23.0	17.0	9.9	7.4	9.4	15.0	16.8	24.2	13.8	9.1	13.3	22.8	9.8	16.0	16.1	11.7	14.5	14.1	11.9	19.5	12.2	10.6	11.2	15.1	13.9	11.4	56.5	16.9	11.0	19.0	6.7	13.6	10.7	9.7	4.3	4.1	5.3	3.2	9.0	4.7	1.7	12.9	12.3	31.7	22.7	14.9	14.8	15.9	16.3	12.2	19.0	16.4	8.0	11.5	25.6	13.5	12.9	9.6	25.7	9.9	17.5	9.0	23.2	16.2	18.2	10.4	10.7	13.6	16.4	15.2	10.5	11.6	9.5	9.9	24.3	18.5	20.6	11.0	15.8	25.6	16.3	18.2	16.0	16.3	14.3	9.8	13.2	35.2	14.5	14.3	10.1	7.1	10.5	12.7	10.8	18.9	11.4	21.8	19.1	23.7	17.9	19.0	19.0	21.5	19.8	5.3	3.1	2.4	4.7	3.2	2.5	2.5	2.9	2.7	3.1	4.3	2.7	3.2	2.8	9.0	2.8	4.1	2.7	1.7	27.2	27.0	36.0	34.4	23.0	17.0	16.8	24.2	16.0	16.9
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870466-47886397	"Enzymes, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 211.7"	"Group enriched"	"Detected in some"	34	"Hep G2: 26.0;RT4: 17.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 5.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol			210000	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	46.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.4	1.1	1.1	8.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	211.7	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.6	0.0	0.1	0.1	3.9	0.1	0.0	42.7	0.1	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.1	0.1	0.6	0.2	1.3	1.0	5.3	0.8	2.3	1.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	26.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.2	0.0	17.7	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	5.3	0.8	0.7	0.9	0.4	0.6	0.7	1.0	0.6	0.3	1.3	1.3	1.0	3.1	2.3	0.4	1.0	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;CAPAN-2: 34.1;MCF7: 20.9;T-47d: 17.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB033013, HPA041724, HPA043539"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB033013: AB_661450, HPA041724: AB_2677638, HPA043539: AB_2678540"	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	5.6	7.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	34.1	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.0	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	20.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	2.9	0.1	17.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin-like modifier 1"	P63165	2	202206180-202238608	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: "	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favourable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	27.1	37.8	44.4	21.6	37.9	41.8	31.6	47.7	49.2	26.9	29.7	19.9	27.2	26.2	24.7	33.4	26.9	24.7	26.6	28.3	38.0	39.6	43.5	62.6	24.6	28.7	34.6	40.6	23.4	29.8	26.6	28.7	30.4	32.3	28.8	31.2	21.6	35.6	24.5	42.4	21.6	33.2	27.6	29.6	25.1	26.4	28.7	27.1	32.2	38.4	28.1	33.6	26.9	23.1	74.8	63.0	77.0	63.7	65.8	89.0	94.0	33.6	17.1	62.3	33.1	34.7	37.1	27.8	35.9	45.3	44.8	59.4	36.8	42.9	23.0	33.3	41.3	24.7	51.0	49.8	70.4	21.5	39.1	42.6	33.6	43.1	25.1	48.0	40.6	28.5	48.2	35.0	26.7	41.6	39.2	37.6	47.8	28.6	60.4	79.9	74.9	36.3	39.2	34.9	40.6	54.2	28.0	43.4	47.3	29.3	28.4	47.9	25.5	46.0	29.1	33.1	33.3	30.2	31.6	32.8	64.5	58.5	36.8	34.2	28.9	56.6	63.7	77.0	51.1	62.6	53.5	74.8	63.7	59.8	63.0	58.4	60.2	62.8	73.6	65.8	62.8	52.9	89.0	94.0	44.4	37.9	47.7	49.2	38.0	39.6	34.6	40.6	32.3	27.1
SUMO3	"SMT3A, SMT3H1"	ENSG00000184900	"Small ubiquitin-like modifier 3"	P55854	21	44805617-44818779	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012180, HPA042123, HPA048064"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB012180: AB_304041, HPA042123: , HPA048064: "	"unprognostic (2.77e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavourable (7.88e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.81e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-2)"	32.2	23.8	37.4	17.7	43.8	50.0	25.0	31.6	43.4	26.9	28.0	17.5	19.4	24.0	21.7	23.9	23.4	22.1	21.9	36.6	27.6	38.7	24.4	29.2	26.2	32.0	30.8	29.0	26.3	26.2	14.6	15.6	21.7	26.6	21.8	15.5	30.6	28.3	30.2	62.4	18.9	28.9	17.4	19.7	28.2	27.7	17.3	17.3	23.9	26.1	18.4	20.8	22.5	20.3	23.8	46.0	14.0	35.7	18.5	27.6	38.4	45.5	18.4	17.3	7.1	20.2	23.3	18.2	31.8	34.9	45.1	36.2	27.4	18.2	16.1	50.4	29.6	9.0	14.9	24.7	11.1	22.4	22.5	66.1	13.2	21.7	22.0	37.3	32.7	26.3	23.5	26.3	15.0	18.2	37.8	26.9	18.0	58.6	31.7	25.9	41.3	36.9	37.0	1.5	36.0	11.8	17.7	17.0	32.7	28.5	20.9	22.0	28.2	26.8	35.9	13.5	29.6	28.7	32.7	33.3	46.6	40.8	12.1	51.1	18.6	0.6	34.6	14.0	23.5	35.7	23.9	23.8	22.8	22.8	37.5	21.5	27.6	24.8	4.1	18.5	32.0	46.0	24.7	38.4	37.4	43.8	31.6	43.4	27.6	38.7	30.8	29.0	26.6	17.3
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	29.8	14.5	18.2	17.2	23.6	4.0	26.0	49.6	28.9	31.1	22.5	23.6	18.9	18.1	47.1	22.6	24.2	28.5	20.0	40.8	16.6	14.9	19.4	13.4	19.6	11.6	15.9	21.3	39.6	22.4	37.5	26.8	25.3	18.0	18.8	16.8	27.6	19.5	19.7	56.7	46.1	17.9	33.6	15.3	17.6	23.9	36.4	15.4	11.8	20.1	31.0	17.8	20.3	25.3	8.0	8.1	7.6	10.2	6.7	13.2	6.5	38.9	10.5	12.8	20.7	14.1	20.2	12.4	9.9	16.6	18.4	18.9	9.0	44.0	9.3	10.3	13.5	49.2	10.4	17.5	18.0	4.0	10.4	3.0	15.5	8.4	18.1	4.6	7.7	10.0	20.9	14.7	24.5	13.4	12.5	7.0	18.4	13.5	3.0	7.6	17.7	12.2	6.6	7.0	8.7	18.8	12.6	24.6	16.0	12.5	25.7	9.5	20.3	4.7	10.1	17.0	15.5	17.6	16.2	6.5	7.5	5.8	11.6	3.9	23.3	7.6	10.2	2.6	4.7	8.8	5.0	8.0	9.2	5.3	8.1	6.8	13.2	8.2	0.6	6.7	6.3	1.6	7.7	6.5	18.2	23.6	49.6	28.9	16.6	14.9	15.9	21.3	18.0	15.4
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	59.3	22.9	28.7	41.7	58.7	84.6	66.9	17.6	43.8	33.7	33.6	57.5	24.2	29.0	47.3	23.3	41.4	42.5	25.3	32.3	37.8	19.3	24.4	47.1	37.7	56.8	73.6	25.4	44.8	44.1	10.5	14.8	22.7	42.5	31.2	16.3	14.9	39.1	35.0	48.6	31.0	31.6	35.3	37.1	46.3	35.2	30.2	68.0	42.6	26.9	20.1	36.0	47.0	35.9	6.4	6.0	14.0	13.9	13.3	25.5	11.8	24.6	11.5	11.5	12.8	35.0	8.7	15.0	17.0	19.9	20.2	17.2	10.3	28.0	7.8	20.8	24.1	18.5	3.8	12.6	8.3	27.0	15.5	5.1	12.4	9.3	21.3	17.1	53.3	7.3	10.7	9.7	9.1	16.0	6.3	44.2	10.9	7.9	9.5	14.8	1.1	7.4	15.8	16.1	23.4	5.0	12.1	10.2	3.8	18.9	21.1	10.0	14.1	32.1	26.8	14.7	12.9	12.9	22.0	32.7	10.2	8.2	27.3	20.6	24.6	14.0	7.4	9.7	25.5	8.8	16.5	6.3	16.2	20.6	6.0	6.4	17.1	20.1	8.0	13.3	13.9	3.7	11.0	11.8	28.7	58.7	17.6	43.8	37.8	19.3	73.6	25.4	42.5	68.0
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351472-21384266	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: "	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	21.6	18.3	16.3	21.6	26.2	21.5	21.3	39.1	27.9	22.8	21.3	14.4	20.7	13.5	31.5	18.5	20.9	23.7	14.5	15.9	17.9	16.2	17.7	14.1	17.1	28.0	18.8	22.8	29.0	15.7	40.3	24.0	18.9	28.6	18.8	21.5	11.3	19.3	20.5	21.4	22.1	19.9	27.4	18.9	22.6	19.1	24.9	19.0	32.7	20.3	17.0	29.5	24.6	20.7	23.3	17.1	21.1	20.4	23.2	26.8	16.7	29.9	28.3	39.3	28.8	17.8	17.8	28.0	27.1	21.7	33.2	31.3	27.4	27.1	63.7	10.4	19.7	32.1	49.7	24.5	50.3	20.2	21.2	38.6	25.9	38.4	18.2	54.5	28.8	15.6	15.1	27.6	31.3	22.4	31.7	27.4	27.4	19.4	50.9	16.6	43.8	28.1	55.1	44.9	34.4	13.3	33.2	39.4	33.6	43.9	26.4	16.5	14.6	25.9	18.9	29.1	24.3	18.0	29.3	27.4	45.7	64.2	10.7	32.2	22.0	21.1	13.1	19.6	22.8	17.3	26.8	23.3	21.8	25.3	17.1	21.3	25.0	25.1	11.0	23.2	20.4	16.1	20.3	16.7	16.3	26.2	39.1	27.9	17.9	16.2	18.8	22.8	28.6	19.0
SUPT3H	"SPT3, SPT3L"	ENSG00000196284	"SPT3 homolog, SAGA and STAGA complex component"	O75486	6	44809317-45377953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024371	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA024371: AB_1857660"	"unprognostic (5.72e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.34e-1)"	"prognostic favourable (3.55e-4)"	"unprognostic (1.07e-2)"	"unprognostic (6.15e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.75e-1)"	"prognostic favourable (1.72e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-2)"	6.0	11.2	7.4	6.7	7.1	2.8	6.1	20.3	9.2	9.4	9.6	7.9	11.5	5.1	10.0	11.4	4.7	11.7	6.6	4.4	6.1	4.6	8.5	4.2	6.9	3.9	6.3	7.7	11.7	10.2	11.4	15.4	7.1	8.3	10.4	5.4	7.7	7.6	8.1	3.0	3.8	4.3	7.1	10.1	3.7	5.3	14.8	8.8	6.0	9.5	2.6	4.7	6.6	6.5	1.2	3.3	0.3	0.4	5.0	17.1	5.4	3.9	3.8	12.4	3.3	2.3	8.9	2.2	1.8	2.9	9.1	8.0	5.3	2.3	2.3	2.9	1.9	0.6	9.8	8.5	10.0	2.3	4.4	1.7	2.3	13.8	5.8	2.3	1.1	6.2	7.6	7.1	10.5	3.8	3.8	3.4	6.5	2.0	4.5	7.2	4.6	1.9	5.7	2.8	1.2	12.6	4.8	4.6	2.9	0.6	0.3	5.6	2.5	3.2	1.8	2.6	0.1	2.8	5.1	4.5	1.2	10.1	4.5	6.6	2.1	0.3	0.4	0.0	8.5	0.4	13.9	1.1	12.4	10.9	1.3	1.2	17.1	13.4	0.3	5.0	0.4	3.3	5.4	5.4	7.4	7.1	20.3	9.2	6.1	4.6	6.3	7.7	8.3	8.8
SUPT5H	"FLJ34157, SPT5, SPT5H"	ENSG00000196235	"SPT5 homolog, DSIF elongation factor subunit"	O00267	19	39436156-39476670	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029273, CAB034370"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB034370: AB_2196394, HPA029273: AB_10603896"	"unprognostic (3.96e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (7.00e-5)"	"unprognostic (7.30e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.38e-1)"	27.7	26.2	39.4	28.9	41.0	64.2	23.5	46.8	50.7	26.2	29.2	34.2	21.0	27.7	33.0	22.3	24.2	26.9	26.7	27.8	34.9	28.6	22.6	28.4	25.5	32.9	28.7	42.3	39.8	34.2	39.3	42.9	26.3	31.3	27.8	21.7	25.7	37.6	27.5	55.9	27.7	29.7	24.4	34.4	30.1	27.9	77.8	37.2	22.2	30.1	17.5	27.9	30.3	31.1	10.8	23.4	25.9	12.2	8.2	8.0	6.9	33.1	53.7	19.9	19.9	18.9	13.3	16.9	28.9	18.4	17.5	19.5	35.0	20.7	40.4	27.4	26.8	13.0	26.6	19.0	13.7	39.5	26.1	45.2	25.7	21.3	17.3	36.7	30.9	21.3	14.4	22.2	22.9	16.6	33.9	20.9	17.1	33.7	26.9	11.2	24.8	13.6	27.4	29.3	20.5	18.1	55.2	18.9	25.7	34.1	27.3	18.5	16.6	20.1	35.3	17.8	20.7	22.2	36.8	34.6	56.2	49.8	21.9	21.3	21.9	18.5	12.2	9.6	8.0	6.5	8.0	10.8	5.6	6.5	5.8	8.7	6.4	5.1	25.9	8.2	8.2	23.4	6.0	6.9	39.4	41.0	46.8	50.7	34.9	28.6	28.7	42.3	31.3	37.2
SUPV3L1	SUV3	ENSG00000156502	"Suv3 like RNA helicase"	Q8IYB8	10	69180232-69209099	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038380, HPA038405"	Supported		Supported	Mitochondria				Mitochondria		"HPA038380: AB_2675983, HPA038405: AB_10675797"	"unprognostic (4.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.48e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.33e-1)"	12.8	17.0	11.1	12.6	17.3	26.1	17.7	21.9	19.9	10.8	14.4	12.6	7.8	11.2	13.5	12.4	13.2	11.9	12.6	19.2	12.0	11.3	16.4	22.2	9.6	15.2	9.9	13.1	15.8	18.2	15.4	14.7	10.9	16.1	11.4	16.7	12.4	11.8	13.9	31.1	15.6	12.5	13.9	9.9	15.5	13.0	26.6	9.9	12.7	14.1	13.4	14.8	12.4	11.6	10.1	7.3	5.6	7.7	7.4	13.7	6.2	11.3	7.9	7.1	21.8	8.0	6.8	9.4	7.0	10.9	14.3	13.5	20.3	9.6	20.4	5.8	7.1	13.0	17.1	11.0	13.8	8.5	13.4	8.9	6.2	10.7	20.3	21.1	6.8	8.6	13.9	13.1	30.2	8.2	23.2	10.6	7.8	7.3	12.8	13.1	8.5	43.4	11.8	10.1	8.9	6.5	5.5	10.2	7.7	9.7	20.4	18.5	6.3	9.3	5.1	5.7	10.3	8.6	13.6	8.4	9.8	19.0	9.4	22.4	3.6	5.6	5.2	4.3	12.3	7.7	13.7	10.1	8.9	10.5	7.3	8.3	9.9	10.6	0.9	7.4	5.2	4.0	8.7	6.2	11.1	17.3	21.9	19.9	12.0	11.3	9.9	13.1	16.1	9.9
SURF2		ENSG00000148291	"Surfeit 2"	Q15527	9	133356552-133361169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.1"	"Cell line enhanced"	"Detected in all"		"MCF7: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044340, HPA052213"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA044340: , HPA052213: "	"unprognostic (1.53e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	8.3	9.2	15.8	9.0	13.2	8.2	10.7	13.1	14.5	5.7	8.8	7.4	10.8	13.2	6.4	12.0	11.0	10.7	11.2	8.9	13.4	11.0	14.3	12.0	6.5	12.1	13.1	8.7	9.0	17.5	7.1	11.3	5.9	10.3	7.7	5.7	7.7	14.2	8.8	11.5	14.8	11.4	6.9	9.4	8.6	9.3	50.1	6.6	10.6	10.1	14.9	9.8	6.5	8.3	17.5	15.6	13.1	16.2	13.2	26.9	14.1	7.1	12.4	5.2	6.5	3.8	3.0	11.0	3.6	3.2	5.9	3.0	17.0	6.0	7.2	5.3	2.4	19.7	8.3	9.0	2.7	6.9	11.4	5.6	14.2	6.3	7.7	9.3	4.3	3.6	10.6	8.3	12.3	2.7	8.9	4.9	4.0	43.2	9.5	6.2	16.4	24.0	10.7	7.8	16.8	5.0	8.2	19.5	9.9	8.2	13.6	10.9	14.5	4.4	5.1	8.9	9.0	9.1	13.0	6.2	12.2	7.7	5.7	5.5	8.9	13.1	16.2	12.0	17.8	16.2	23.1	15.6	21.9	20.2	13.8	17.5	20.8	19.7	7.1	13.2	11.6	15.6	26.9	14.1	15.8	13.2	13.1	14.5	13.4	11.0	13.1	8.7	10.3	6.6
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328774-133336398	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA023608: AB_1857671, HPA074622: "	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favourable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	14.8	16.8	19.9	15.0	22.7	16.2	15.7	16.4	25.8	13.9	16.2	14.0	11.9	21.7	18.6	10.9	17.4	18.5	15.9	13.9	19.1	17.9	14.5	16.2	12.6	17.6	19.6	22.9	27.4	23.1	16.5	11.8	12.5	24.6	15.8	13.1	11.6	18.3	19.5	47.3	17.8	22.3	18.0	23.6	18.8	13.6	16.5	19.8	8.6	14.4	11.1	13.5	15.3	19.1	7.7	8.9	3.9	4.7	4.6	8.5	3.6	4.1	6.6	5.1	7.6	3.2	2.9	8.4	6.7	3.9	6.0	3.7	10.3	7.2	12.2	5.2	3.7	12.7	6.5	7.0	2.2	8.1	7.4	8.4	7.5	6.1	5.8	14.1	7.3	4.2	6.3	6.3	5.8	3.1	18.2	6.6	5.3	10.9	11.4	11.6	14.8	11.9	12.1	7.1	12.3	5.2	4.0	10.7	9.1	6.5	10.8	5.8	9.4	8.0	6.3	13.7	7.2	6.9	9.0	4.9	6.9	15.8	5.1	9.7	8.0	3.9	4.7	1.9	6.8	4.4	7.0	7.1	6.2	6.1	4.9	7.7	8.5	7.0	1.3	4.6	3.7	8.9	5.0	3.6	19.9	22.7	16.4	25.8	19.1	17.9	19.6	22.9	24.6	19.8
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937018-32001045	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nucleoli, Nuclear bodies"		"HPA057436: "	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	10.1	10.8	13.4	15.4	10.4	25.5	33.5	16.0	13.8	11.2	11.4	7.5	13.6	10.1	12.5	8.1	12.3	9.8	7.7	9.7	9.1	7.6	10.9	11.5	10.6	19.9	9.3	9.9	10.0	10.1	15.5	10.4	15.3	9.5	10.7	10.9	6.9	10.1	9.6	8.7	9.9	12.2	9.6	7.7	15.2	10.7	17.1	12.5	31.8	12.0	6.5	18.9	10.8	19.5	5.5	4.6	4.1	2.6	4.4	5.5	1.2	14.0	12.5	11.8	13.5	6.8	8.8	12.1	13.7	12.1	16.9	20.5	9.4	7.9	30.8	10.6	8.5	12.5	17.5	7.9	27.5	10.8	17.0	21.3	10.6	6.8	8.0	33.5	21.9	6.1	8.9	16.8	12.9	10.3	20.5	42.8	14.5	4.9	39.8	19.5	6.7	7.6	23.8	30.2	24.9	9.9	13.8	15.1	11.8	22.1	7.2	13.2	20.8	28.0	7.6	13.4	12.2	16.1	21.1	23.4	29.1	38.1	9.8	20.7	12.1	1.4	1.9	3.8	3.8	2.6	3.0	5.5	4.1	4.0	1.4	4.4	3.9	5.5	4.1	4.4	1.8	4.6	4.2	1.2	13.4	10.4	16.0	13.8	9.1	7.6	9.3	9.9	9.5	12.5
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083172-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 52.2"	"Group enriched"	"Detected in some"	5	"Karpas-707: 11.9;SCLC-21H: 4.9;SH-SY5Y: 11.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 52.2;pons and medulla: 26.6"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.2"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.5	5.5	0.8	1.3	52.2	0.7	1.2	1.2	9.5	0.7	0.8	0.5	0.0	1.0	0.7	0.9	0.6	1.8	0.6	0.8	0.6	8.3	0.4	0.4	0.4	0.5	5.6	1.9	2.6	0.8	0.9	0.8	0.4	26.6	1.0	1.1	1.1	1.7	1.2	0.3	0.7	1.3	1.0	5.8	0.6	1.6	1.0	6.7	0.0	0.5	0.0	0.4	0.6	0.4	0.1	0.1	4.2	0.2	0.1	0.2	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.3	4.9	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.8	52.2	1.2	9.5	0.6	8.3	5.6	1.9	26.6	6.7
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736781	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 235.1;tongue: 93.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 40.1;U-2197: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.2;monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (5.70e-5)"	11.9	2.1	0.7	10.5	1.1	3.7	4.5	0.6	0.9	18.7	42.3	0.6	10.7	1.7	34.3	13.3	18.2	8.9	15.5	25.5	0.5	0.6	2.8	2.0	3.8	2.3	0.8	0.7	13.9	2.4	5.1	4.1	2.9	1.7	12.6	5.3	10.0	10.6	15.3	235.1	4.7	9.1	36.4	1.3	1.5	14.2	5.5	0.5	4.6	6.9	93.5	11.6	28.6	9.9	0.1	0.7	15.2	4.2	1.2	1.7	0.6	17.3	7.5	3.4	1.2	9.9	26.6	5.5	2.8	6.7	1.1	1.1	8.8	17.2	0.0	12.3	1.1	40.1	1.9	6.6	1.1	0.2	3.7	0.0	9.5	5.7	6.0	1.5	0.3	24.4	6.5	12.4	4.5	19.9	0.0	0.1	1.7	5.4	1.4	0.8	1.7	2.7	3.2	10.1	0.1	11.8	5.8	4.1	3.4	2.5	0.3	8.8	3.1	1.8	12.8	5.7	5.9	28.1	8.4	0.1	0.0	0.0	22.0	3.4	19.5	2.9	1.1	5.2	1.2	1.9	1.5	0.0	1.1	0.6	0.7	0.1	1.7	1.1	15.2	1.2	4.2	0.2	0.1	0.6	0.7	1.1	0.6	0.9	0.5	0.6	0.8	0.7	1.7	0.5
SWAP70	"KIAA0640, SWAP-70"	ENSG00000133789	"Switching B cell complex subunit SWAP70"	Q9UH65	11	9664077-9752991	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 29.5;naive B-cell: 29.6"	"Group enriched"	"Detected in all"	6	"B-cells: 29.6;granulocytes: 16.4;monocytes: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA006810, HPA006929"	Supported		Supported	"Plasma membrane,Actin filaments"			7100	"Plasma membrane"	"Actin filaments"	"HPA006810: AB_1857683, HPA006929: "	"unprognostic (4.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	30.8	7.3	10.6	24.0	12.0	10.6	25.8	4.2	13.7	14.5	12.9	10.5	10.4	9.0	19.0	10.8	14.5	11.5	13.2	12.5	12.7	8.2	11.4	5.8	20.6	36.0	12.3	7.9	9.2	8.8	17.5	8.4	25.4	11.9	15.9	7.8	13.1	15.8	11.3	9.7	21.2	16.2	14.0	14.7	32.6	9.9	5.2	12.0	7.5	16.4	10.2	42.2	20.6	26.5	29.6	2.9	16.4	9.7	2.8	1.4	1.7	11.4	6.4	9.1	0.0	19.0	16.6	16.0	12.5	15.3	11.9	13.2	7.0	9.1	45.8	12.4	24.0	13.8	11.0	7.0	15.4	4.1	4.4	12.1	7.7	3.4	10.6	9.3	22.6	11.6	8.8	8.7	15.6	36.2	1.1	0.1	12.4	1.8	2.7	4.5	8.3	3.3	6.6	8.5	1.3	9.9	30.5	0.4	4.6	11.9	15.4	10.0	6.1	7.1	41.4	21.0	7.5	17.5	11.7	1.2	3.4	32.3	8.3	10.5	8.5	5.7	2.0	16.4	0.4	4.8	0.2	29.5	0.5	0.4	2.9	29.6	0.4	0.5	0.4	2.8	9.7	0.8	1.4	1.7	10.6	12.0	4.2	13.7	12.7	8.2	12.3	7.9	11.9	12.0
SWI5	"bA395P17.9, C9orf119, SAE3"	ENSG00000175854	"SWI5 homologous recombination repair protein"	Q1ZZU3	9	128275379-128288990	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA052032, HPA055472"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA052032: , HPA055472: "	"unprognostic (1.27e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.15e-1)"	"prognostic favourable (9.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.38e-2)"	10.2	11.7	14.7	11.8	15.9	6.0	17.9	18.0	13.2	18.2	9.0	12.3	48.0	9.9	13.0	44.8	13.5	20.4	12.7	14.8	12.5	13.2	14.2	18.0	12.5	8.7	16.7	11.0	19.6	13.2	26.5	23.8	10.7	13.6	14.6	8.1	14.1	15.2	50.7	14.1	10.3	9.5	12.8	13.7	7.7	9.2	57.1	16.2	8.9	27.8	12.5	10.5	12.4	17.1	12.6	14.2	28.1	9.6	13.4	15.3	10.0	9.5	17.1	10.1	11.7	27.5	25.1	11.4	16.8	22.4	21.8	14.8	21.8	11.3	9.1	22.4	27.3	16.0	16.1	22.4	14.9	13.6	12.0	6.9	32.6	17.0	35.4	4.4	6.5	21.1	10.8	36.5	19.7	20.9	16.2	14.7	22.2	38.8	9.5	6.3	6.8	35.5	9.0	14.0	14.4	14.6	5.0	11.7	6.5	20.9	13.4	19.9	22.3	4.7	12.9	15.9	13.2	30.8	14.1	15.6	23.4	12.1	21.7	6.9	17.1	28.1	9.6	16.4	10.2	5.7	12.0	12.6	10.1	10.2	9.8	12.5	12.2	15.3	6.4	13.4	5.6	14.2	10.0	10.0	14.7	15.9	18.0	13.2	12.5	13.2	16.7	11.0	13.6	16.2
SYAP1	"FLJ14495, PRO3113"	ENSG00000169895	"Synapse associated protein 1"	Q96A49	X	16719632-16765336	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000175, HPA000882, HPA048047"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA000175: AB_1080142, HPA000882: , HPA048047: "	"unprognostic (4.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-3)"	17.6	31.3	13.1	12.9	12.3	26.2	16.5	10.2	14.0	17.1	23.8	12.2	16.1	20.6	17.0	13.7	18.5	14.4	20.7	25.7	13.5	13.7	28.7	51.4	17.6	11.4	15.8	11.0	19.9	14.3	22.8	15.9	18.9	18.4	16.2	16.1	10.7	15.9	21.3	22.5	12.6	33.0	12.3	17.3	13.7	16.9	10.1	11.2	15.3	16.2	13.3	15.1	17.9	13.5	12.6	11.1	17.8	15.0	13.8	15.2	9.1	16.0	13.6	9.8	18.3	13.4	15.2	4.5	12.8	9.2	10.8	10.8	12.7	13.4	12.6	18.9	12.5	9.6	11.9	16.8	14.4	8.2	23.9	5.0	14.6	12.1	9.6	8.5	7.8	10.4	8.0	18.6	15.8	14.8	10.8	7.1	14.5	18.9	4.6	9.2	11.4	15.0	5.0	12.4	12.6	15.9	10.6	10.1	12.4	23.9	17.1	12.7	22.6	7.7	11.6	13.9	7.3	28.1	10.4	7.8	6.6	14.6	13.6	4.3	11.3	9.2	10.5	12.7	15.2	11.3	12.3	12.6	13.0	13.9	11.1	10.8	13.1	13.6	17.8	13.8	15.0	9.2	14.4	9.1	13.1	12.3	10.2	14.0	13.5	13.7	15.8	11.0	18.4	11.2
SYBU	"FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL"	ENSG00000147642	Syntabulin	Q9NX95	8	109573978-109691791	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 82.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.2;PC-3: 14.9;SK-BR-3: 30.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"memory B-cell: 9.4;naive B-cell: 4.4"	"Lineage enriched"	"Detected in single"	29	"B-cells: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053057	Uncertain		Supported	Vesicles				Vesicles		"HPA053057: "	"unprognostic (4.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-1)"	"prognostic favourable (7.74e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.89e-2)"	"unprognostic (4.27e-2)"	17.6	19.7	18.2	2.5	25.5	0.8	13.3	36.8	31.3	7.7	8.7	4.0	11.5	7.1	3.4	7.9	4.1	12.8	6.9	2.6	15.2	23.0	3.3	26.6	5.2	3.1	13.5	17.9	5.5	82.7	1.6	12.4	2.1	14.7	5.1	12.5	3.5	12.6	10.0	2.5	5.3	7.4	5.1	7.2	1.2	8.7	1.7	5.1	0.3	7.6	1.1	5.1	2.9	3.8	9.4	0.1	0.0	0.0	0.0	0.3	0.1	5.1	2.6	2.1	0.0	0.3	0.3	1.4	1.8	0.0	0.0	0.0	4.6	3.1	0.4	0.3	1.4	13.2	0.4	3.5	0.0	0.0	7.1	0.0	7.8	4.6	3.4	0.0	0.0	1.2	4.5	0.0	4.3	1.9	0.2	0.9	2.0	0.1	0.1	0.0	0.4	14.9	0.0	0.0	0.0	5.7	1.2	10.0	1.1	4.7	30.4	1.0	3.8	0.2	2.7	0.1	1.1	0.0	0.8	0.8	0.0	0.3	6.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	18.2	25.5	36.8	31.3	15.2	23.0	13.5	17.9	14.7	5.1
SYCE1L	MRP2	ENSG00000205078	"Synaptonemal complex central element protein 1 like"	A8MT33	16	77199397-77213215	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 12.7;U-698: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062464, HPA066691"			Enhanced	"Intermediate filaments"				"Intermediate filaments"		"HPA062464: , HPA066691: "	"unprognostic (5.54e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (6.65e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.48e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (2.11e-5)"	"unprognostic (9.27e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.73e-2)"	3.5	3.4	2.8	4.1	2.7	2.9	3.7	5.2	2.4	8.7	5.0	0.4	11.5	2.1	7.8	7.6	4.4	2.8	1.8	7.0	2.8	3.0	4.3	1.4	1.9	4.5	2.1	1.4	8.5	2.7	2.3	2.3	1.6	1.5	6.6	1.6	5.4	11.1	8.7	1.7	4.3	4.6	2.0	2.5	4.2	2.3	22.4	0.4	6.4	8.0	2.0	2.4	2.3	4.4	3.5	12.2	12.0	2.2	2.7	10.5	3.4	2.8	1.1	2.7	1.3	0.3	0.0	0.5	0.8	0.3	0.5	0.9	0.6	5.6	1.8	3.7	0.6	4.0	0.2	0.0	0.3	1.7	12.7	0.4	1.0	0.0	1.8	0.9	1.2	0.1	0.4	0.1	0.3	1.9	0.7	0.2	0.3	4.1	0.7	1.2	1.8	4.4	6.5	0.7	0.6	2.5	0.7	2.8	3.4	0.4	0.3	0.0	0.1	1.1	6.3	0.4	6.4	0.9	0.2	5.4	2.0	9.9	2.8	0.7	0.1	4.0	1.3	12.0	6.1	2.2	7.3	3.5	7.9	8.4	1.6	2.6	8.7	8.0	1.3	2.7	1.6	12.2	10.5	3.4	2.8	2.7	5.2	2.2	2.8	3.0	2.1	1.4	1.5	0.4
SYCE2	CESC1	ENSG00000161860	"Synaptonemal complex central element protein 2"	Q6PIF2	19	12898786-12919276	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 41.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 11.8;MOLT-4: 10.6;SiHa: 11.6;U-266/70: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	4	"NK-cell: 6.3"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA042080, HPA062919"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA042080: AB_10794411, HPA062919: "	"unprognostic (3.00e-1)"	"prognostic favourable (3.85e-5)"	"unprognostic (9.99e-3)"	"prognostic unfavourable (9.91e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (8.39e-4)"	"unprognostic (1.79e-10)"	"unprognostic (7.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-5)"	0.4	0.4	0.3	0.3	0.4	2.9	0.3	2.0	1.6	0.5	0.4	0.3	0.3	0.2	0.3	0.6	0.3	0.4	0.3	0.3	0.5	0.2	0.3	1.1	0.5	1.0	0.3	0.3	0.8	0.4	0.0	0.4	0.8	0.4	0.6	0.1	0.3	0.6	0.3	0.3	1.1	0.3	0.3	0.4	0.5	0.3	41.2	0.3	2.6	0.4	0.3	0.7	0.5	0.4	0.1	0.2	1.4	0.1	6.3	0.6	0.1	5.7	1.1	3.0	1.8	0.3	0.8	3.2	1.4	0.6	0.8	1.0	0.2	0.8	4.4	11.8	0.8	1.2	1.0	0.3	0.9	1.6	0.7	1.2	2.5	0.5	0.1	2.8	4.0	0.8	0.2	0.3	0.6	0.2	1.1	1.3	0.6	2.4	10.6	1.9	1.9	3.3	3.2	1.4	1.1	0.6	0.9	2.1	1.4	11.6	0.6	0.7	2.3	3.1	0.8	0.8	1.6	4.3	0.4	12.3	1.5	4.9	1.0	3.9	5.5	0.0	0.1	1.4	0.2	0.0	0.1	0.0	0.6	0.0	0.2	0.1	0.2	0.4	0.0	6.3	0.0	0.0	0.5	0.1	0.3	0.4	2.0	0.6	0.5	0.2	0.3	0.3	0.4	0.3
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863563-59933655	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 11.1;testis: 41.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.2;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: , HPA065613: "	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	2.2	0.5	1.3	0.9	2.3	1.4	11.1	2.5	5.7	1.3	1.2	1.0	0.8	1.1	1.1	0.9	0.8	0.8	2.0	2.1	1.2	1.2	3.3	0.8	1.6	3.1	1.8	2.7	0.4	4.9	1.3	3.0	2.9	3.9	2.9	0.8	0.6	3.0	0.7	0.8	2.0	1.7	0.6	1.6	2.3	4.5	41.7	0.8	3.0	1.9	0.2	1.5	1.3	1.0	0.9	0.1	2.6	0.3	0.0	2.7	0.5	0.1	0.5	0.1	0.5	0.2	0.3	0.6	1.6	0.4	0.7	0.1	10.2	1.0	0.0	1.6	0.7	0.2	0.2	0.0	0.4	3.2	0.2	0.1	2.0	0.1	0.0	0.1	7.6	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	4.9	21.1	1.1	0.2	0.1	0.0	0.0	0.1	0.9	2.4	0.1	1.8	37.2	5.4	1.1	33.6	1.9	0.2	0.0	1.1	4.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	2.5	0.3	2.3	2.6	0.0	2.7	0.7	1.5	1.7	0.1	0.9	0.9	1.5	2.6	0.0	0.1	0.1	1.0	0.5	1.3	2.3	2.5	5.7	1.2	1.2	1.8	2.7	3.9	0.8
SYCP2L	"C6orf177, dJ62D2.1, NO145"	ENSG00000153157	"Synaptonemal complex protein 2 like"	Q5T4T6	6	10886831-10979320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 54.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.9;HMC-1: 27.9;K-562: 7.0;NB-4: 9.6;THP-1: 7.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"basophil: 2.9;eosinophil: 5.5;plasmacytoid DC: 7.6"	"Group enriched"	"Detected in many"	17	"dendritic cells: 7.6;granulocytes: 5.5"									HPA034679			Supported	Nucleoplasm				Nucleoplasm		"HPA034679: AB_10669729"	"unprognostic (3.25e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.57e-3)"	"unprognostic (4.23e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-2)"	0.9	0.4	0.9	0.8	1.0	0.7	0.7	2.6	1.5	0.5	1.1	0.8	3.7	0.4	1.1	8.9	0.6	0.5	0.7	3.0	0.8	0.7	1.6	0.4	10.1	0.5	1.0	0.5	1.5	5.5	54.0	0.7	4.0	0.6	0.8	0.4	2.9	1.2	0.5	1.9	0.6	0.3	0.5	0.9	0.6	0.4	5.1	0.6	0.7	2.5	0.0	2.2	0.5	0.3	0.0	7.6	5.5	0.3	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.0	3.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.1	4.3	0.0	0.0	0.0	0.0	8.9	27.9	0.0	0.6	0.0	0.0	0.0	7.0	0.0	0.0	0.0	2.2	9.6	0.5	0.0	0.1	0.3	0.0	0.2	0.0	0.4	2.5	0.0	2.4	0.0	0.1	7.2	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	2.9	0.1	5.5	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.9	1.0	2.6	1.5	0.8	0.7	1.0	0.5	0.6	0.6
SYF2	"CBPIN, DKFZp564O2082, fSAP29, NTC31, p29"	ENSG00000117614	"SYF2 pre-mRNA splicing factor"	O95926	1	25222679-25232502	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018265, HPA070710"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA018265: AB_10962002, HPA070710: "	"unprognostic (4.19e-3)"	"unprognostic (1.58e-2)"	"unprognostic (9.98e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-3)"	"prognostic favourable (5.72e-4)"	37.5	30.4	31.6	30.8	35.4	67.3	34.4	34.7	30.1	38.2	36.0	15.1	29.3	28.7	34.1	37.8	36.3	28.5	24.5	28.6	30.1	22.0	35.5	24.7	27.7	30.1	30.7	25.3	57.8	32.2	29.5	29.8	37.7	32.9	36.6	31.1	16.3	28.2	31.1	69.8	29.9	40.7	46.8	41.0	34.3	31.3	20.7	32.4	37.2	39.3	28.2	37.1	54.5	50.6	31.5	16.9	85.5	26.5	25.8	29.5	20.1	18.9	8.2	19.7	15.7	31.9	38.9	15.3	20.8	31.5	18.4	17.7	5.4	25.4	17.8	27.5	22.9	17.0	16.9	15.5	26.3	28.4	17.4	21.4	19.6	13.6	31.4	27.1	19.6	29.0	40.8	20.0	26.4	26.5	16.1	25.5	25.5	7.7	26.8	35.1	26.7	13.2	17.5	17.7	27.5	29.9	9.5	16.9	24.7	19.2	15.7	51.0	13.8	31.3	24.5	16.3	14.5	30.9	16.1	30.8	29.3	17.1	24.3	28.3	15.7	39.4	21.0	51.4	20.9	22.5	24.3	31.5	26.4	25.5	16.9	28.1	28.7	26.3	85.5	25.8	26.5	16.7	29.5	20.1	31.6	35.4	34.7	30.1	30.1	22.0	30.7	25.3	32.9	32.4
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863290	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: "	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	14.7	15.9	15.3	23.7	24.2	20.7	15.2	25.1	32.2	17.1	18.2	25.3	20.3	18.6	22.6	18.9	17.4	19.3	17.6	14.6	17.3	18.0	15.0	21.6	15.6	27.2	19.3	16.8	21.6	16.3	20.5	24.0	34.8	19.9	17.4	12.2	16.1	21.5	17.5	33.4	21.1	18.0	13.9	18.7	23.0	19.4	38.0	22.0	28.5	20.5	11.6	23.4	16.8	16.7	7.9	9.2	6.5	7.1	4.2	5.2	2.7	19.2	34.1	14.0	10.6	13.7	17.6	23.6	15.5	10.8	15.8	18.0	15.1	17.7	34.1	10.6	17.3	15.9	18.8	16.8	14.2	26.4	21.1	19.7	23.4	15.9	15.8	21.6	23.2	12.8	10.3	16.9	19.4	16.3	25.9	22.3	13.7	18.1	19.9	22.8	11.9	7.9	21.5	16.3	21.1	11.3	35.0	16.0	20.3	18.9	12.3	12.4	16.9	29.9	18.0	13.1	21.1	10.1	22.5	29.6	55.9	27.6	15.0	14.5	21.5	2.1	5.1	2.2	3.4	3.8	3.2	4.7	3.0	5.2	4.2	7.9	2.6	2.4	6.5	4.2	7.1	9.2	2.3	2.7	15.3	24.2	25.1	32.2	17.3	18.0	19.3	16.8	19.9	22.0
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607785-85643792	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275"	Supported		Supported	Nucleoplasm,Cytosol			77000	Nucleoplasm	Cytosol	"CAB010895: AB_261964, HPA041275: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavourable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favourable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	29.1	28.3	27.9	31.3	36.2	30.4	28.4	35.6	37.9	32.9	29.4	19.2	31.8	20.4	32.7	18.9	48.8	24.5	21.9	31.3	29.3	19.0	25.2	31.3	25.7	35.0	31.9	23.1	26.2	34.9	37.5	27.9	31.3	28.2	23.1	29.6	17.3	31.4	32.8	41.4	27.2	23.7	53.5	28.1	24.7	25.4	19.8	30.1	38.1	42.0	29.8	41.7	31.2	39.4	13.2	20.9	4.6	20.0	18.1	18.6	12.6	31.9	24.0	40.0	23.3	26.3	31.4	25.4	47.4	39.1	43.0	42.7	39.2	21.0	75.5	34.6	45.6	31.0	58.5	47.1	75.5	25.9	26.8	67.3	28.9	26.9	22.2	82.1	29.0	25.7	27.1	49.2	50.7	45.3	67.4	35.6	49.7	35.2	38.4	35.0	38.3	25.5	57.7	64.0	32.0	35.2	51.2	37.7	30.6	33.0	27.9	19.4	24.2	51.2	41.5	29.2	23.9	30.5	56.6	22.3	43.9	49.8	26.8	49.7	40.6	1.0	13.0	4.6	17.7	18.6	18.6	13.2	16.8	15.9	20.9	11.9	15.3	16.6	1.6	18.1	20.0	15.5	16.7	12.6	27.9	36.2	35.6	37.9	29.3	19.0	31.9	23.1	28.2	30.1
SYNDIG1	"C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B"	ENSG00000101463	"Synapse differentiation inducing 1"	Q9H7V2	20	24469199-24666616	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3;heart muscle: 28.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.0;RH-30: 22.8;RPMI-8226: 21.6;SCLC-21H: 5.3;U-87 MG: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044271, HPA059267"			Enhanced	Vesicles				Vesicles		"HPA044271: , HPA059267: "	"unprognostic (9.33e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (6.16e-6)"	"unprognostic (1.40e-3)"	2.6	1.7	12.5	2.1	12.0	0.7	0.8	21.3	22.7	4.5	1.5	23.3	0.3	1.9	2.6	1.5	0.9	5.1	10.0	28.2	12.8	8.8	6.2	0.7	1.1	2.5	14.5	12.9	1.3	1.4	0.9	0.6	0.9	11.5	3.2	1.6	0.5	0.8	14.8	0.6	0.8	2.8	3.1	22.4	1.4	2.2	1.3	16.6	0.1	5.1	0.0	3.1	2.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	22.8	21.6	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	12.0	21.3	19.7	12.8	8.8	14.5	12.9	11.5	16.6
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease mutation, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 33.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.8"									HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	12.7	11.5	18.2	9.1	30.2	41.7	9.0	62.0	25.0	16.8	7.3	9.8	12.4	2.7	15.2	18.4	6.2	12.9	7.9	22.7	21.0	17.5	18.4	11.2	16.1	13.7	13.2	15.1	27.7	10.6	37.3	37.0	4.7	19.7	10.1	6.3	10.5	3.6	12.5	22.0	16.9	5.3	19.1	9.7	15.5	9.0	8.3	11.6	9.0	20.6	9.5	12.1	10.0	12.3	3.2	0.8	33.8	1.5	4.7	6.4	1.4	0.1	3.9	2.8	3.2	3.9	8.6	1.0	8.8	4.6	2.3	4.2	0.8	0.1	8.3	0.5	4.8	0.2	1.0	2.3	2.4	10.0	2.7	3.5	2.6	2.7	9.0	0.6	1.6	5.5	0.5	5.0	10.3	4.4	0.0	9.5	6.2	0.4	1.4	0.1	0.6	1.5	1.9	5.5	2.3	8.9	0.1	1.7	2.6	1.4	0.5	6.1	0.5	0.3	5.9	10.7	14.5	3.7	4.8	18.9	8.0	13.3	5.9	1.9	3.1	3.0	1.1	33.8	6.4	0.7	4.1	2.9	4.2	6.1	0.8	3.2	4.0	5.1	1.1	4.7	1.5	0.7	5.1	1.4	18.2	30.2	62.0	25.0	21.0	17.5	13.2	15.1	19.7	11.6
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63852983-64226433	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 111.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 43.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 15.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in many"		"eosinophil: 30.3"	"Group enriched"	"Detected in many"	10	"granulocytes: 30.3;T-cells: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Supported	"Nuclear membrane,Intermediate filaments"				"Nuclear membrane, Intermediate filaments"		"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favourable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.8	4.5	2.3	18.0	2.8	5.5	29.7	15.8	3.3	16.1	13.4	1.9	7.7	3.6	18.8	13.6	17.2	7.1	8.6	27.3	2.3	2.4	35.6	13.0	15.2	11.0	2.7	2.1	22.8	22.4	60.1	17.6	14.1	16.3	13.7	4.8	13.0	9.8	9.2	111.4	24.1	10.6	10.2	2.3	16.0	6.9	14.3	1.9	16.9	30.9	29.7	15.8	11.1	26.4	2.3	1.1	30.3	0.1	1.5	16.3	1.3	17.3	5.9	8.7	2.8	8.7	2.6	11.5	1.2	1.2	2.0	3.5	1.9	3.6	43.5	1.8	1.1	8.4	5.7	2.2	2.5	6.6	2.2	0.2	4.3	0.5	1.7	0.7	0.2	3.7	8.2	2.5	2.3	4.5	0.2	3.5	1.4	9.7	4.6	0.2	3.9	1.8	5.4	8.2	1.4	13.2	8.3	8.1	6.0	13.8	3.3	3.7	3.8	0.1	3.9	3.2	5.2	1.0	3.6	4.8	2.1	16.5	0.9	0.0	4.6	0.2	0.0	30.3	16.3	0.1	11.0	2.1	10.0	10.8	0.0	2.3	4.9	7.4	13.3	1.5	0.1	1.1	11.1	1.3	2.3	2.8	15.8	2.6	2.3	2.4	2.7	2.1	16.3	1.9
SYNE3	"C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53"	ENSG00000176438	"Spectrin repeat containing nuclear envelope family member 3"	Q6ZMZ3	14	95407266-95475836	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.2;bone marrow: 10.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.8;ASC TERT1: 19.4;Karpas-707: 21.9;REH: 17.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055227, HPA077140"	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA055227: , HPA077140: "	"unprognostic (4.63e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.41e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.19e-2)"	12.2	2.4	1.2	2.7	1.3	10.0	6.5	0.3	1.2	2.1	1.0			0.6	1.2	0.6	1.1	2.0	1.2	2.8	1.6	1.1	0.4	1.0	2.7	4.0	1.6		3.0	0.1	0.0	0.5	2.1		0.6	1.6		1.9	0.4	1.1	2.8	1.5	1.2	2.6	2.7	0.9	1.6			1.7		4.3	1.6	2.8	3.4	2.6	5.4	5.1	0.9	3.7	2.2	0.6	0.0	0.3	0.5	24.8	19.4	7.4	2.7	4.8	2.6	2.1	3.9	0.6	3.1	0.4	1.3	0.1	0.6	2.0	1.2	10.4	0.4	2.1	0.5	1.0	3.2	3.3	5.5	5.4	0.7	3.3	1.9	4.6	0.1	21.9	2.0	0.7	1.9	3.6	0.1	1.3	17.3	12.1	6.7	0.3	0.3	0.5	2.7	0.1	0.0	1.3	1.0	4.8	4.2	1.9	1.2	2.6	0.3	2.6	5.3	3.0	3.9	7.4	14.5	5.4	5.1	0.4	2.2	4.0	2.8	3.4	2.9	2.3	2.1	3.3	3.7	3.0	2.4	0.9	4.1	2.6	2.3	2.2										
SYNGR1		ENSG00000100321	"Synaptogyrin 1"	O43759	22	39349925-39385588	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 21.0;monocytes: 18.9;T-cells: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029673, CAB034277"	Enhanced		Supported	Cytosol				Cytosol		"CAB034277: AB_2255766, HPA029673: AB_10670430"	"unprognostic (2.68e-3)"	"unprognostic (1.84e-3)"	"unprognostic (5.90e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-2)"	"prognostic favourable (2.41e-4)"	"unprognostic (1.16e-1)"	"prognostic favourable (4.98e-7)"	"unprognostic (1.32e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.04e-1)"	4.4	11.4	19.4	2.7	31.4	39.9	8.0	66.9	62.0	15.6	6.3	8.5	1.0	3.3	9.2	6.5	17.3	9.8	6.1	21.6	31.6	22.3	5.5	2.0	3.3	3.8	17.4	35.1	38.8	14.5	10.3	4.1	3.7	23.5	10.9	2.6	19.5	23.5	10.4	13.4	26.2	3.0	7.2	7.0	4.1	4.8	7.2	5.4	0.7	4.6	4.6	5.2	7.8	9.0	2.4	21.0	0.8	18.9	2.6	15.2	7.8	2.6	4.7	8.6	15.4	0.8	2.2	3.8	11.4	20.1	14.5	13.4	1.0	0.3	0.1	2.6	3.0	3.7	5.8	0.2	4.4	0.0	18.0	0.2	0.3	0.5	2.5	0.7	5.3	3.3	0.9	4.0	0.0	0.7	5.1	0.3	2.2	6.0	2.3	2.1	1.7	9.2	6.7	0.0	0.7	0.4	7.3	13.6	2.8	2.9	12.4	11.8	18.3	13.4	0.2	0.0	10.1	0.1	0.0	3.1	0.1	7.2	0.4	14.5	15.5	0.2	18.9	0.3	15.2	5.5	0.9	2.4	0.6	4.4	21.0	2.2	0.7	8.2	0.8	2.6	0.2	15.3	0.1	7.8	19.4	31.4	66.9	62.0	31.6	22.3	17.4	35.1	23.5	5.4
SYNM	"DMN, KIAA0353, SYN"	ENSG00000182253	Synemin	O15061	15	99098217-99135593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 111.2;smooth muscle: 147.5;urinary bladder: 85.2"	"Cell line enhanced"	"Detected in many"		"A549: 14.6;HeLa: 21.9;WM-115: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	8	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017192, HPA040066, HPA044200, HPA077856"	Enhanced		Supported	"Intermediate filaments"				"Intermediate filaments"		"CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: "	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (5.92e-3)"	"unprognostic (3.26e-3)"	6.9	4.2	4.5	5.0	5.4	0.0	11.9	2.5	5.5	2.9	38.4	9.0	27.6	5.4	4.9	7.2	42.1	3.1	9.6	24.8	6.0	5.7	0.8	0.8	2.0	0.7	11.8	4.2	2.9	0.9	1.8	2.0	2.7	8.5	30.1	11.1	10.9	3.2	62.6	111.2	1.5	11.9	147.5	18.2	0.6	16.7	1.5	3.7	0.0	1.4	14.5	1.7	85.2	21.6	0.2	0.1	0.1	0.0	0.2	1.8	0.4	2.5	14.6	3.2	8.7	6.6	0.3	0.2	1.4	2.1	0.8	0.5	2.1	1.9	0.0	2.1	2.1	1.6	2.2	0.0	0.6	0.2	3.6	0.0	21.9	2.1	3.7	0.0	0.4	0.4	0.1	1.4	0.3	1.7	0.0	2.9	2.2	1.4	0.2	0.3	2.9	4.6	0.0	3.0	2.1	0.8	1.4	1.4	1.7	8.6	1.3	5.2	0.0	1.4	1.9	1.6	0.2	1.1	3.4	0.0	0.4	0.0	0.1	0.0	49.6	0.1	0.0	0.0	1.7	0.0	1.4	0.2	1.8	1.1	0.1	0.0	1.6	0.6	0.0	0.2	0.0	0.0	0.0	0.4	4.5	5.4	2.5	4.4	6.0	5.7	11.8	4.2	8.5	3.7
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 185.8"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 25.8;LHCN-M2: 9.2;SH-SY5Y: 39.3"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 64.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"				"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: , HPA068563: "	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (3.91e-4)"	11.4	2.3	1.8	9.6	3.9	0.0	7.3	1.0	5.6	26.5	56.0	4.4	20.5	6.5	37.5	23.9	37.0	14.2	19.4	29.0	2.6	1.5	2.4	1.7	3.7	5.7	1.9	5.2	27.9	1.4	0.9	2.6	3.8	3.8	35.9	11.1	21.2	4.1	58.8	185.8	3.7	14.5	88.7	4.0	6.1	29.5	9.6	3.1	3.0	3.7	12.8	2.1	50.7	15.5	1.8	0.2	2.0	0.4	1.2	2.3	0.4	0.1	1.8	0.1	0.0	5.5	1.8	0.3	5.7	6.3	0.2	0.2	0.0	0.3	0.6	0.0	25.8	0.1	0.1	0.1	0.3	2.4	0.0	0.3	0.4	0.0	1.3	0.0	0.1	6.6	0.1	1.8	0.1	0.0	0.0	0.3	9.2	0.1	0.3	3.5	0.6	0.0	0.2	0.6	0.1	0.1	0.1	0.2	39.3	0.2	0.1	0.0	0.0	3.3	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.0	1.9	0.3	2.0	1.2	0.1	1.9	1.3	2.0	1.2	0.1	1.8	2.1	1.3	0.9	1.2	0.4	0.2	2.3	0.4	1.8	3.9	1.0	5.6	2.6	1.5	1.9	5.2	3.8	3.1
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"				"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: , HPA057142: "	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.2	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.5	0.7	0.3	0.5	0.9	0.1	0.1	0.0	0.4	0.1	0.2	0.3	0.6	0.4	0.6	0.2	0.2	6.0	0.1	1.2	0.1	0.0	0.3	0.3	0.3	0.3	0.2	1.8	0.2	0.7	0.2	5.8	0.2	0.0	0.6	0.3	0.4	0.1	6.1	0.1	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
SYT13	KIAA1427	ENSG00000019505	"Synaptotagmin 13"	Q7L8C5	11	45240301-45286319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.1;gallbladder: 18.8"	"Cell line enhanced"	"Detected in some"		"A549: 11.2;NTERA-2: 5.2;RPTEC TERT1: 34.3;SCLC-21H: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046224, HPA056602"	Uncertain		Supported	Vesicles				Vesicles		"HPA046224: AB_10961288, HPA056602: "	"unprognostic (4.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavourable (7.79e-5)"	"unprognostic (1.00e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.13e-2)"	0.4	4.5	15.8	1.5	15.1	0.4	0.5	19.0	38.1	0.3	10.6	1.2	0.0	10.9	0.6	0.3	0.4	0.5	18.8	4.5	11.8	19.5	8.0	0.6	0.8	0.4	10.6	15.1	0.4	6.4	0.4	9.4	0.4	27.9	2.0	11.2	0.9	1.4	0.4	0.5	0.5	11.1	1.1	2.2	0.5	9.2	1.8	0.3	0.0	1.8	0.0	0.3	0.4	0.2	0.2	0.0	1.4	0.0	0.2	0.2	0.0	0.0	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.2	0.1	0.0	0.0	0.0	34.3	0.0	9.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.9	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.0	15.8	15.1	19.0	31.1	11.8	19.5	10.6	15.1	27.9	0.3
SYT14	"FLJ34198, sytXIV"	ENSG00000143469	"Synaptotagmin 14"	Q8NB59	1	209938174-210171389	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.1;SCLC-21H: 6.8;TIME: 10.9;U-138 MG: 8.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036963			Supported	Vesicles				Vesicles		"HPA036963: AB_10670378"	"unprognostic (1.38e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.90e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-5)"		"unprognostic (1.92e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.81e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.30e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-3)"	0.7	3.2	5.9	0.8	7.4	0.8	0.6	17.4	10.2	0.6	0.7	3.8	0.0	0.7	1.4	0.8	0.6	0.6	0.6	0.6	4.5	2.6	0.9	0.6	0.7	0.7	3.3	5.9	0.8	1.2	0.6	31.1	0.6	5.0	0.8	0.8	1.1	0.6	0.6	0.7	0.7	0.7	0.7	2.4	0.7	0.9	9.5	3.0	0.0	15.9	0.0	0.6	0.6	0.4	2.0	0.8	2.1	0.5	1.1	0.8	0.1	3.3	0.1	0.0	0.0	0.3	0.0	0.0	2.7	13.1	2.8	1.5	0.0	0.2	0.0	0.1	0.3	4.2	0.0	0.0	3.3	0.6	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	1.9	5.8	0.5	0.0	0.0	5.0	0.0	0.0	0.0	4.5	1.8	0.0	0.1	0.1	0.2	3.0	6.8	3.1	0.0	0.0	5.6	0.0	0.1	10.9	8.3	4.0	0.7	1.4	0.1	0.1	0.0	0.7	0.0	1.9	2.1	0.4	0.6	0.8	0.2	0.4	0.6	0.5	0.4	0.3	2.0	0.4	0.6	1.8	1.1	0.5	0.8	0.4	0.1	5.9	7.4	17.4	10.2	4.5	2.6	3.3	5.9	5.0	3.0
SYT4	"HsT1192, KIAA1342"	ENSG00000132872	"Synaptotagmin 4"	Q9H2B2	18	43267878-43277650	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.8;pituitary gland: 31.5"	"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 72.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010574	Approved		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA010574: AB_2668309"			"unprognostic (2.91e-3)"		"unprognostic (2.03e-1)"			"unprognostic (2.37e-2)"		"unprognostic (2.87e-1)"	"unprognostic (7.67e-3)"	"unprognostic (5.30e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.80e-2)"		1.4	17.5	5.7	2.2	24.1	1.0	0.9	60.8	54.6	0.9	1.7	0.9	0.0	1.7	0.9	0.9	1.0	0.9	1.0	1.4	12.9	19.9	1.0	0.9	1.8	1.0	5.9	16.0	1.3	4.7	0.9	31.5	1.0	22.3	1.5	1.7	0.4	1.0	9.8	0.9	1.0	1.7	1.5	5.0	0.9	4.6	2.4	1.4	0.0	1.3	0.0	0.9	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	24.1	60.8	35.7	12.9	19.9	5.9	16.0	22.3	1.4
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134533	"Enzymes, Predicted membrane proteins"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"				Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	13.8	20.8	11.0	33.0	15.3	13.8	14.9	13.3	19.3	15.1	14.2	21.0	20.2	13.2	16.0	21.1	14.4	16.1	15.3	12.9	11.3	10.0	16.4	78.0	14.2	28.9	18.2	8.7	17.1	68.1	24.4	21.0	20.9	14.4	15.0	15.4	13.3	48.9	22.6	16.7	14.4	19.6	13.6	12.8	27.1	18.3	14.4	14.9	10.3	23.5	8.0	42.2	13.3	12.6	17.5	13.0	11.6	5.4	2.2	5.5	3.8	8.5	10.9	6.6	8.9	16.8	9.6	6.5	8.8	9.1	11.3	8.0	5.9	14.9	48.0	12.1	11.3	13.2	7.1	8.9	9.4	7.4	5.4	7.5	12.7	13.2	20.4	11.3	13.7	12.2	16.2	9.9	22.5	7.3	9.4	24.6	6.6	12.6	4.9	8.2	7.1	7.6	8.4	5.5	19.3	7.1	8.4	4.3	8.8	8.2	20.3	14.2	15.1	7.4	6.9	7.9	5.2	14.0	5.9	49.2	34.0	55.5	10.6	5.8	8.8	11.6	5.4	9.3	5.5	3.3	5.0	15.4	3.9	5.1	3.1	17.5	2.9	3.0	5.2	2.2	3.2	13.0	3.6	3.8	11.0	15.3	13.3	19.3	11.3	10.0	18.2	8.7	14.4	14.9
TAB1	MAP3K7IP1	ENSG00000100324	"TGF-beta activated kinase 1 (MAP3K7) binding protein 1"	Q15750	22	39399741-39437060	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032328, HPA039988, HPA057104"	Approved		Enhanced	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB032328: AB_2281637, HPA039988: , HPA057104: "	"unprognostic (1.76e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.73e-3)"	"unprognostic (9.23e-3)"	"unprognostic (4.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	12.2	14.9	18.3	13.6	20.8	13.6	12.5	24.7	28.1	16.9	16.2	32.0	10.9	16.9	18.8	10.7	13.6	17.9	19.2	18.9	17.9	15.7	12.4	14.8	13.7	15.8	22.7	18.8	26.7	19.5	16.3	12.5	13.8	15.9	16.9	9.1	19.6	21.6	19.1	27.8	17.3	15.7	14.3	17.2	17.2	14.4	11.9	20.6	13.0	13.3	10.9	13.0	16.8	14.3	5.9	8.2	6.1	8.7	5.2	7.6	6.3	12.0	12.5	12.8	14.6	13.6	11.5	11.3	10.1	12.6	15.6	14.8	11.5	8.7	18.3	8.0	9.8	14.8	12.9	14.8	6.2	14.1	20.7	8.0	15.4	11.3	11.9	15.0	15.4	11.6	13.2	11.7	12.8	11.3	14.6	12.6	7.7	7.8	11.5	12.5	8.9	12.8	20.9	18.2	18.2	12.0	12.9	11.4	8.4	14.4	17.9	12.6	14.6	16.6	9.7	10.9	17.3	8.3	8.2	19.9	12.8	13.3	12.8	10.7	10.6	1.4	8.7	6.1	7.6	7.2	6.2	5.9	4.6	6.1	8.2	5.9	7.5	6.7	1.3	5.2	6.7	3.8	4.6	6.3	18.3	20.8	24.7	28.1	17.9	15.7	22.7	18.8	15.9	20.6
TACC2	AZU-1	ENSG00000138162	"Transforming acidic coiled-coil containing protein 2"	O95359	10	121989174-122254545	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 109.4"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA031020, HPA031021, HPA061394"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			110000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA031020: AB_10669988, HPA031021: , HPA061394: "	"unprognostic (3.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-2)"	"prognostic favourable (2.50e-10)"	"unprognostic (7.02e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (8.45e-4)"	"unprognostic (1.61e-1)"	8.2	5.8	9.6	2.4	11.7	0.6	7.8	17.7	16.6	6.9	17.2	2.6	4.0	6.3	8.4	4.3	13.4	9.6	7.7	43.3	8.0	4.8	19.3	3.8	54.1	0.8	3.1	9.0	4.7	6.3	11.9	41.0	45.4	6.8	12.0	8.6	4.8	18.5	6.0	109.4	28.9	8.2	8.9	3.2	1.3	10.2	2.2	3.9	0.1	19.6	4.4	2.5	15.1	8.8	0.1	0.1	0.3	0.0	0.1	0.2	0.0	7.0	22.4	11.0	6.2	3.1	3.2	13.3	3.1	8.5	4.4	3.1	9.1	11.8	0.0	2.9	4.9	23.8	3.5	8.5	4.6	1.1	1.8	0.0	2.8	17.4	4.9	0.0	0.1	1.4	35.9	2.3	15.4	9.1	1.7	0.2	4.2	9.3	0.0	3.9	6.5	10.2	0.1	6.3	3.3	11.8	10.9	7.3	6.0	5.1	21.5	11.4	4.2	0.1	8.4	2.0	1.4	4.9	5.8	1.0	4.4	0.1	3.7	0.0	5.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	9.6	11.7	17.7	16.6	8.0	4.8	3.1	9.0	6.8	3.9
TACC3	ERIC1	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1721490-1745176	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.8"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: , HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	3.8	2.7	1.1	39.1	1.1	26.0	3.4	2.1	1.4	1.9	4.4	1.1	0.8	4.5	1.8	2.7	8.8	1.6	3.5	2.0	1.4	1.3	2.5	2.4	4.3	20.1	1.3	0.7	1.6	1.0	0.5	1.8	5.7	1.1	1.6	4.9	1.6	3.0	1.2	2.0	2.6	7.7	2.5	1.8	15.6	3.4	58.1	0.9	64.3	1.6	7.3	27.9	3.2	3.0	4.0	10.4	54.8	19.9	3.8	17.9	16.1	25.2	21.0	32.2	18.5	1.7	3.6	18.2	28.6	15.3	32.9	21.8	23.2	30.5	32.2	12.2	15.6	17.1	34.0	20.8	33.5	14.1	18.4	27.3	17.4	21.4	1.6	36.9	23.2	1.5	1.4	20.7	12.0	24.9	24.6	25.5	31.2	20.6	48.6	52.8	34.8	27.6	34.4	22.8	12.9	18.7	38.2	25.1	15.8	17.2	10.9	8.0	21.4	21.4	14.6	19.2	23.0	17.3	43.1	17.9	23.6	51.6	11.1	35.7	27.1	24.7	19.9	17.9	5.5	9.0	6.0	4.0	12.3	7.6	10.4	3.8	17.9	9.8	54.8	3.8	5.5	3.1	17.5	16.1	1.1	1.1	2.1	1.4	1.4	1.3	1.3	0.7	1.1	0.9
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600872-63608365	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favourable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	8.3	11.3	8.7	6.3	11.1	4.9	6.9	6.4	14.2	5.9	12.1	7.6	6.2	13.0	7.6	7.2	7.5	6.7	10.1	21.2	7.6	8.6	20.7	42.5	7.0	7.3	9.3	7.2	6.0	10.7	8.3	5.7	7.5	9.3	6.4	11.4	8.1	11.4	6.9	37.5	6.1	15.7	6.9	6.5	7.3	8.0	8.1	6.2	8.7	8.7	15.9	8.1	6.3	5.1	8.9	9.9	7.9	8.1	16.6	13.6	7.9	17.0	27.0	8.7	8.9	7.6	10.9	11.6	12.6	11.9	25.4	20.2	17.7	10.2	14.1	9.7	14.4	15.8	19.1	18.4	23.9	7.5	26.5	13.9	13.8	30.9	21.0	16.4	9.8	13.3	12.8	21.9	23.2	13.1	18.8	10.7	11.8	30.9	19.1	12.4	7.5	28.1	12.1	21.4	17.6	14.8	12.0	13.4	14.6	8.6	28.6	23.8	23.8	12.8	11.6	18.1	13.7	12.3	22.1	11.7	11.5	16.8	13.8	11.3	13.1	2.1	8.1	7.9	9.5	7.5	10.6	7.1	13.6	9.5	9.9	8.9	12.8	10.3	1.4	16.6	6.6	6.4	9.0	7.9	8.7	11.1	6.4	14.2	7.6	8.6	9.3	7.2	9.3	6.2
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575423-58577773	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Tumor antigen"	"Amyloidosis, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;salivary gland: 56.4"	"Cell line enhanced"	"Detected in some"		"A-431: 74.1;CAPAN-2: 100.5;HaCaT: 100.7;RT4: 34.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 12.4"	"Group enriched"	"Detected in many"	65	"dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"				"Plasma membrane"	"Nucleoli, Vesicles"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favourable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.7	17.1	0.0	0.0	23.1	0.0			0.0	1.7	2.6	103.9	2.7	0.9	0.0	0.0	0.0	10.4	0.0	8.0	0.0	0.0		0.0	9.0	0.0	0.0	1.5		15.7	0.0		56.4	12.6	0.0	42.1	0.0	0.0	0.0	0.0	7.3	0.0			0.1		20.6	17.7	36.1	0.0	3.7	12.4	3.2	0.0	0.0	1.8	74.1	0.0	0.0	0.1	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	100.5	0.0	9.7	6.3	100.7	0.0	18.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	1.1	4.2	0.0	0.1	0.0	15.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	13.5	34.8	0.0	0.0	3.2	26.8	0.1	17.5	0.1	4.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	12.4	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.8										
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876327	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"				Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	6.5	10.6	13.8	7.1	18.5	17.8	10.2	18.2	20.0	11.3	9.1	17.0	3.4	8.3	10.5	8.6	10.1	9.8	6.6	9.2	13.2	14.6	12.9	28.9	6.7	10.1	11.1	14.3	12.7	7.5	11.3	13.7	12.5	15.0	9.2	10.2	13.4	8.7	8.4	10.7	8.5	9.0	8.5	10.8	7.3	8.0	12.0	10.3	16.7	11.5	7.1	10.9	8.6	7.8	13.4	13.0	8.1	8.2	16.2	19.5	15.1	8.1	7.8	14.8	8.7	4.5	5.7	8.8	4.3	5.2	7.2	6.2	7.1	6.6	15.5	8.4	5.0	6.3	11.9	7.6	5.8	9.8	11.3	5.1	6.7	11.6	6.6	14.4	9.5	4.3	8.8	4.3	10.8	5.9	18.3	9.4	5.6	5.6	17.7	11.5	22.4	8.8	15.0	6.5	19.6	9.6	10.9	9.5	16.6	7.7	10.0	9.0	13.6	15.2	4.3	5.9	6.8	6.4	9.0	13.5	18.3	29.0	4.1	6.6	5.5	1.8	8.1	8.1	14.0	8.2	15.5	13.1	15.2	15.8	13.0	13.4	19.5	15.3	1.3	16.2	6.2	8.5	14.3	15.1	13.8	18.5	18.2	20.0	13.2	14.6	11.1	14.3	15.0	10.3
TADA3	"ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L"	ENSG00000171148	"Transcriptional adaptor 3"	O75528	3	9779860-9793011	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042250	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA042250: AB_10794043"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.83e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.56e-2)"	"prognostic favourable (5.47e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-3)"	21.9	39.3	37.3	28.1	35.2	22.0	44.2	16.8	43.4	29.7	25.8	23.4	30.6	23.1	29.6	25.5	25.1	35.8	34.2	34.1	33.6	30.3	26.1	34.2	32.1	40.8	29.7	26.2	46.8	21.0	25.8	30.3	18.9	27.5	34.2	21.5	23.0	25.9	34.6	39.0	20.0	24.7	26.1	25.3	25.6	24.9	48.0	21.6	32.7	33.9	22.5	28.5	29.6	27.1	13.3	18.3	46.4	31.2	18.7	23.8	18.1	13.5	14.0	22.9	13.0	20.9	19.2	49.1	13.5	25.2	19.6	24.7	14.5	16.2	14.8	17.0	31.9	8.1	13.2	19.4	9.0	17.7	14.6	32.1	17.8	15.6	29.8	11.3	54.6	19.5	25.4	27.8	20.3	13.0	21.4	18.6	24.1	38.7	11.4	11.1	21.0	13.5	5.6	11.4	18.8	20.0	13.2	8.7	25.7	11.9	6.4	23.2	24.0	29.7	17.8	26.2	21.5	13.6	19.3	14.9	16.6	25.1	37.9	21.2	20.7	20.6	15.8	46.4	23.8	24.9	12.1	13.3	17.0	19.4	18.3	12.5	15.2	16.4	20.3	18.7	31.2	11.3	20.7	18.1	37.3	35.2	16.8	43.4	33.6	30.3	29.7	26.2	27.5	21.6
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366239-71532374	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	20.1	16.2	15.0	17.1	19.8	16.3	17.7	20.7	18.0	20.7	15.5	23.8	17.1	10.0	25.4	17.1	14.4	19.1	16.1	12.9	15.4	12.0	11.9	12.9	13.8	17.8	18.5	16.5	23.9	17.5	25.5	19.3	15.4	17.3	16.9	15.4	20.8	14.5	16.1	19.6	16.8	17.1	18.3	17.2	21.3	15.8	12.2	21.3	19.4	20.1	12.0	18.7	18.4	15.8	5.0	4.7	5.2	4.8	4.2	4.9	1.8	11.2	9.8	11.2	7.5	9.0	15.6	7.0	8.4	7.8	8.9	7.4	7.3	6.8	10.5	7.2	9.4	10.7	15.6	6.7	11.4	6.9	13.7	12.5	12.9	7.2	6.5	23.7	12.1	9.1	6.8	9.5	18.0	9.2	17.0	25.5	9.0	7.9	13.1	10.5	12.9	12.9	12.1	22.8	12.8	6.0	14.6	5.9	9.2	23.4	8.2	10.4	6.0	12.6	11.6	10.5	8.8	8.4	5.8	10.9	10.1	13.6	5.8	19.1	7.8	4.4	4.1	1.1	4.4	2.8	3.8	3.0	4.6	4.5	4.7	5.0	4.4	4.9	5.2	4.2	4.8	3.5	3.1	1.8	15.0	19.8	20.7	18.0	15.4	12.0	18.5	16.5	17.3	21.3
TAF10	"TAF2A, TAF2H, TAFII30"	ENSG00000166337	"TATA-box binding protein associated factor 10"	Q12962	11	6606296-6612667	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004148, CAB022405"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB022405: , HPA004148: AB_1857736"	"unprognostic (1.69e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.10e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.24e-3)"	"unprognostic (9.03e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.38e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.80e-3)"	23.4	33.7	30.7	25.4	25.6	40.1	28.4	8.8	30.9	21.5	28.8	26.9	28.5	21.9	23.8	53.4	32.6	20.8	32.4	26.9	28.4	22.5	35.6	63.1	28.4	47.2	26.4	15.4	25.7	46.4	26.5	30.5	31.3	17.5	24.3	28.5	18.2	43.6	30.5	46.0	15.7	30.1	20.2	26.0	44.1	24.7	44.2	14.8	55.7	37.6	29.5	37.5	21.8	19.0	9.0	18.5	21.8	11.7	6.1	8.7	3.1	21.9	38.3	24.0	21.1	40.4	39.5	19.3	17.1	37.7	27.9	28.0	28.0	39.9	12.1	22.8	30.4	18.5	17.4	27.4	27.7	25.3	26.6	17.3	26.2	33.3	65.8	22.8	27.7	45.5	35.0	21.8	46.1	30.8	17.8	22.0	44.0	43.4	32.5	21.1	17.4	30.1	19.1	13.0	21.3	44.9	29.6	17.4	23.8	23.1	26.6	28.7	18.7	27.2	17.4	18.6	22.4	26.6	23.9	26.9	17.7	19.4	30.8	11.5	30.0	7.9	7.6	8.1	7.6	11.7	7.1	7.8	7.6	8.7	8.2	9.0	7.1	6.1	21.8	6.1	11.5	18.5	8.3	3.1	30.7	25.6	8.8	30.9	28.4	22.5	26.4	15.4	17.5	14.8
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877778-34888089	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA029326: , HPA049127: "	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favourable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	20.6	25.5	22.2	26.8	28.1	43.1	27.2	30.1	29.8	23.0	23.2	17.5	26.7	21.1	23.6	24.2	23.5	22.7	22.0	33.3	21.5	17.9	20.7	28.7	23.2	28.6	24.8	22.1	27.9	25.4	16.7	18.8	30.6	26.7	23.8	25.3	20.4	20.3	31.0	39.3	31.2	24.2	26.8	23.4	31.1	22.6	32.7	29.0	29.4	23.3	24.6	28.7	22.8	22.6	14.9	20.1	26.5	23.6	13.2	16.7	12.8	14.6	6.5	21.2	37.3	13.3	14.2	18.7	11.8	10.0	20.4	19.7	14.8	9.5	20.2	15.8	11.2	9.4	26.0	10.9	16.6	12.2	20.9	22.6	13.4	24.8	18.7	28.6	15.9	15.8	17.9	13.7	11.3	24.8	35.6	15.6	9.7	26.8	18.2	23.9	18.9	11.0	19.9	18.8	15.8	15.0	9.6	25.6	23.1	14.0	15.4	26.7	24.8	35.9	14.2	14.1	18.6	8.1	14.3	14.2	34.8	29.0	5.3	34.2	20.4	26.5	23.6	19.3	12.6	21.0	12.1	11.6	13.4	13.5	20.1	14.9	15.7	14.0	14.6	13.2	16.8	17.7	16.7	12.8	22.2	28.1	30.1	29.8	21.5	17.9	24.8	22.1	26.7	29.0
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076002	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	23.5	13.4	24.6	14.3	23.4	27.7	14.7	14.0	33.7	18.0	16.6	19.5	15.3	10.0	13.9	14.7	22.1	9.9	18.0	19.2	25.3	26.9	22.3	21.0	11.5	8.6	32.2	22.6	6.6	15.9	14.6	21.2	21.0	35.8	16.9	18.2	7.7	14.5	11.7	40.9	13.0	12.8	22.2	36.1	7.7	14.0	10.3	20.7	4.1	18.2	16.6	14.8	16.4	11.0	1.3	3.0	7.9	4.6	0.5	2.3	0.8	20.2	5.3	8.2	11.9	23.6	22.1	13.6	48.3	20.4	19.7	19.9	8.5	4.6	7.7	18.5	32.1	8.6	14.3	17.4	29.7	13.2	3.2	7.8	12.9	8.7	18.7	13.7	11.9	19.7	20.9	33.0	18.0	16.8	14.9	7.6	26.6	11.7	7.1	3.7	16.3	11.1	5.6	14.7	3.1	23.2	17.7	8.5	10.7	23.7	15.4	17.4	5.2	9.8	21.9	32.6	12.4	23.0	26.4	9.2	23.3	10.4	34.6	7.2	48.3	2.6	4.6	3.7	1.7	3.3	1.5	1.2	1.1	1.7	1.5	1.3	1.1	1.6	7.9	0.5	2.8	3.0	2.3	0.8	24.6	23.4	14.0	33.7	25.3	26.9	32.2	22.6	35.8	20.7
TAF15	"hTAFII68, Npl3, RBP56, TAF2N"	ENSG00000270647	"TATA-box binding protein associated factor 15"	Q92804	17	35713791-35864615	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052059, HPA063647"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA052059: , HPA063647: "	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.99e-1)"	14.0	12.9	12.7	15.3	16.2	13.9	11.0	13.7	14.1	10.5	11.7	15.0	13.2	12.7	10.2	11.0	12.6	8.0	11.5	13.1	11.8		9.8	15.0	8.9	19.4	14.7	8.3	10.7	11.3	14.6	18.1	11.1	11.1	11.4	10.1	9.2	9.8	15.3	26.9	14.7	13.4	17.5	15.9	12.7	11.0	11.3	15.5	21.1	9.4	12.8	15.8	12.0	9.8	3.7	3.2	3.8	3.6	4.7	7.2	2.2	28.7	47.3	25.3	24.5	20.3	11.5	16.6	32.9	11.2	15.0	14.7	31.6	20.8	57.2	23.7	21.3	30.6	33.6	33.1	21.7	16.1	43.9	32.9	34.4	33.1	20.0	53.1	22.1	18.3	17.4	22.7	35.7	20.2	30.8	23.7	16.9	34.3	57.9	12.9	15.6	13.6	34.6	37.6	21.4	19.0	51.7	19.2	18.9	41.0	12.4	13.0	29.0	18.3	27.3	11.6	25.3	16.7	39.5	22.4	27.3	41.7	22.9	26.2	19.0	3.8	3.5	3.5	4.9	3.4	7.2	3.0	3.5	3.8	2.5	3.7	3.3	3.7	2.0	4.7	3.6	3.2	3.9	2.2										
TAF1A	"SL1, TAFI48"	ENSG00000143498	"TATA-box binding protein associated factor, RNA polymerase I subunit A"	Q15573	1	222557902-222589933	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054334	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA054334: "	"unprognostic (3.01e-1)"	"prognostic unfavourable (9.26e-6)"	"unprognostic (7.98e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.98e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.06e-2)"	7.3	6.9	5.5	8.6	8.2	4.8	6.4	7.6	8.1	7.3	4.7	8.2	5.0	4.8	8.0	6.1	5.9	6.4	5.5	5.6	4.3	6.7	4.2	6.3	5.5	11.5	7.3	3.8	13.7	5.3	5.3	16.9	8.4	8.0	6.6	5.2	6.4	5.5	5.6	2.8	4.1	6.1	6.5	8.9	8.3	6.5	11.7	8.0	6.4	10.0	3.3	10.2	7.4	7.0	10.5	7.1	2.7	3.3	4.0	6.7	2.4	8.2	4.5	12.1	4.2	4.2	3.7	10.8	5.6	4.3	6.7	8.3	4.7	9.1	7.6	11.0	2.0	8.4	8.1	3.4	9.6	4.9	6.0	4.5	3.6	4.5	4.8	10.9	2.0	1.9	3.7	7.6	9.7	2.8	13.8	3.5	9.2	3.0	12.6	7.7	24.5	13.0	7.8	24.3	7.2	2.8	4.4	6.9	14.5	8.6	5.0	5.9	2.8	5.5	3.7	6.9	6.9	12.1	13.9	4.2	3.8	9.9	6.1	7.0	9.1	1.5	2.1	2.7	4.6	3.3	6.7	7.3	4.1	4.2	2.0	10.5	4.9	6.0	0.4	4.0	3.2	7.1	3.4	2.4	5.5	8.2	7.6	8.1	4.3	6.7	7.3	3.8	8.0	8.0
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843354-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favourable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	13.4	11.7	10.2	10.7	11.1	7.8	12.1	14.0	12.7	12.3	7.4	8.4	15.9	7.1	19.2	14.5	16.5	13.6	9.7	8.5	9.3	11.7	17.9	9.9	11.5	13.9	9.2	9.5	12.7	8.9	22.6	19.5	20.2	10.7	12.6	8.1	11.6	10.1	20.1	7.2	11.3	7.5	11.1	8.5	13.9	8.4	17.1	9.2	23.3	14.9	10.9	15.8	9.9	14.4	9.8	11.3	4.9	13.1	8.5	12.9	4.6	12.0	12.0	16.7	5.1	8.4	12.9	26.9	13.2	13.2	14.4	12.5	11.1	9.8	14.2	7.0	10.7	6.9	14.5	16.3	16.1	13.8	15.8	15.3	5.1	14.9	10.9	12.0	17.1	10.1	9.6	10.6	15.7	21.6	10.2	15.1	14.5	8.0	9.0	10.2	20.1	8.8	5.4	14.1	4.4	14.7	10.8	7.1	18.2	11.4	15.3	11.6	5.3	9.6	10.0	17.4	20.5	17.0	18.2	7.4	8.8	20.2	10.5	13.9	14.9	2.6	8.4	4.9	11.5	13.1	10.9	9.5	9.5	12.9	11.3	9.8	6.3	9.4	0.4	8.5	10.0	9.4	9.4	4.6	10.2	11.1	14.0	12.7	9.3	11.7	9.2	9.5	10.7	9.2
TAF1C	"MGC:39976, SL1, TAFI110, TAFI95"	ENSG00000103168	"TATA-box binding protein associated factor, RNA polymerase I subunit C"	Q15572	16	84177847-84187070	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072229			Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA072229: "	"unprognostic (9.39e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.53e-1)"	"prognostic favourable (1.76e-4)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (8.08e-6)"	"unprognostic (5.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"prognostic favourable (3.22e-4)"	19.0	11.6	19.0	16.7	18.5	22.8	18.9	21.8	17.8	17.3	12.3	16.4	14.3	15.5	20.4	14.9	16.7	16.9	19.5	15.5	16.2	9.1	15.8	9.7	13.1	19.8	18.2	13.0	30.4	19.1	13.0	16.9	12.4	15.5	17.5	6.3	17.2	22.7	17.8	13.6	21.3	14.2	12.1	12.0	25.1	14.9	13.0	17.0	12.7	15.2	10.3	15.6	14.3	16.3	3.1	4.0	1.0	3.4	3.5	4.7	2.2	5.9	6.5	3.7	13.1	3.2	3.4	19.0	7.2	2.8	5.9	2.1	7.1	4.6	6.6	9.6	2.7	11.7	2.3	2.8	1.4	5.8	9.9	3.8	9.9	4.8	2.4	4.0	12.1	5.1	3.8	5.0	1.9	11.5	9.2	2.3	2.9	13.1	6.2	13.3	15.1	6.8	15.8	3.1	5.3	2.5	5.3	19.1	9.2	14.5	4.1	24.0	16.1	4.2	4.5	10.9	9.3	10.7	6.4	11.0	8.5	13.8	5.6	4.9	6.9	0.0	3.2	1.0	4.1	3.4	4.7	2.3	1.6	2.6	4.0	3.1	1.9	3.4	0.2	3.5	1.4	1.5	2.3	2.2	19.0	18.5	21.8	17.8	16.2	9.1	18.2	13.0	15.5	17.0
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"				Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: , HPA060385: "	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	13.9	10.6	12.5	19.9	18.4	14.2	12.9	17.3	20.1	15.1	14.7	4.3	17.3	16.8	15.2	9.7	16.0	11.5	18.1	11.1	12.0	7.6	13.6	18.7	15.8	19.0	14.4	13.6	20.9	30.5	9.3	24.3	18.5	13.6	16.4	13.4	3.9	12.3	11.4	31.5	14.5	17.8	18.1	22.1	18.4	13.0	8.0	13.6	13.1	13.2	12.9	12.2	28.1	17.1	24.1	14.3	22.3	9.2	9.0	16.3	2.7	3.8	3.0	4.1	4.1	4.1	16.0	7.5	4.4	3.2	5.6	4.0	10.5	10.6	9.4	8.4	4.2	11.6	4.8	6.9	6.2	2.5	2.0	9.6	17.3	6.2	4.0	8.7	5.2	4.4	7.4	4.5	7.3	7.0	6.5	18.6	7.7	1.2	7.3	16.8	3.2	2.4	3.5	4.7	8.0	6.5	6.2	2.9	6.2	2.6	9.5	3.0	11.8	2.2	6.8	8.4	5.6	12.7	6.4	8.3	9.4	7.9	3.1	9.3	2.8	17.4	9.2	14.8	10.0	6.5	10.0	19.5	13.8	10.9	6.2	24.1	16.3	13.6	22.3	9.0	5.2	14.3	9.4	2.7	12.5	18.4	17.3	20.1	12.0	7.6	14.4	13.6	13.6	13.6
TAF3	"TAF140, TAFII140"	ENSG00000165632	"TATA-box binding protein associated factor 3"	Q5VWG9	10	7818504-8016627	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066184			Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA066184: "	"unprognostic (3.82e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavourable (2.14e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.30e-3)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (8.59e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	11.2	11.2	10.6	13.5	13.9	13.1	9.5	24.5	13.0	10.7	10.0	11.1	12.7	6.4	11.7	6.0	7.9	8.3	8.2	11.5	11.5	12.1	9.3	8.2	8.6	12.0	12.8	8.4	16.1	9.5	16.1	15.9	9.9	11.6	9.6	8.1	9.6	7.6	13.3	20.8	10.6	9.6	9.5	12.4	11.4	8.1	15.8	14.2	17.4	9.7	7.3	9.9	10.0	14.4	8.8	4.7	7.7	8.6	8.3	10.8	5.0	7.1	6.6	7.5	4.0	8.6	6.0	10.5	8.5	3.3	6.4	7.4	14.2	5.4	12.2	6.6	4.9	7.8	8.3	7.3	8.1	9.8	9.1	10.4	4.7	9.0	7.5	7.0	9.5	4.0	7.4	9.0	4.4	6.0	11.6	12.7	7.2	13.4	15.7	4.9	5.7	3.9	12.8	7.2	8.1	3.7	4.5	4.0	5.8	9.2	6.7	8.3	12.2	7.4	7.5	5.8	10.2	15.3	8.3	7.6	9.0	13.4	5.6	8.0	5.2	7.3	5.6	7.7	9.3	5.0	10.8	7.6	8.4	9.0	4.7	8.8	10.5	9.0	2.2	8.3	8.6	4.6	6.9	5.0	10.6	13.9	24.5	13.0	11.5	12.1	12.8	8.4	11.6	14.2
TAF4	"TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135"	ENSG00000130699	"TATA-box binding protein associated factor 4"	O00268	20	61953469-62065810	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008599, CAB031484"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB031484: AB_671207, HPA008599: AB_1080183"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.67e-2)"	"prognostic unfavourable (3.31e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.99e-2)"	7.7	11.4	8.5	7.8	9.5	9.8	6.2	16.5	9.6	8.9	9.8	8.5	4.2	10.1	8.5	3.8	7.6	7.0	7.0	4.9	7.7	4.5	6.6	8.9	6.2	7.1	9.6	6.0	16.7	12.4	4.3	6.4	6.8	6.4	6.8	4.6	6.4	6.6	7.6	13.2	7.7	10.4	6.8	5.8	9.7	10.9	17.9	8.7	16.5	6.8	4.3	5.8	7.7	9.9	0.1	0.2	2.7	0.6	0.0	1.4	0.2	5.5	5.2	3.1	3.6	1.5	1.1	6.3	2.8	1.2	4.6	2.4	17.4	4.6	4.5	7.1	1.5	7.2	2.8	3.3	2.0	3.8	4.0	10.4	5.8	8.0	1.5	4.9	9.4	0.8	2.9	2.1	2.1	1.8	8.3	4.0	0.8	6.0	13.8	6.0	4.6	7.4	12.8	7.2	4.7	1.5	5.1	5.3	4.6	8.4	8.9	2.9	5.4	6.0	2.2	5.9	8.6	5.9	5.0	5.6	5.2	7.1	3.5	3.0	4.1	0.0	0.6	0.7	0.1	0.2	0.0	0.0	0.3	0.4	0.2	0.1	0.3	0.5	2.7	0.0	0.1	0.1	1.4	0.2	8.5	9.5	16.5	9.6	7.7	4.5	9.6	6.0	6.4	8.7
TAF4B	"TAF2C2, TAFII105"	ENSG00000141384	"TATA-box binding protein associated factor 4b"	Q92750	18	26225936-26391685	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.7;U-266/70: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028937	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA028937: AB_10603034"	"unprognostic (2.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (7.38e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (1.72e-4)"	5.0	5.0	1.9	7.8	7.0	5.7	5.8	4.9	7.1	3.5	3.6	1.7	0.6	1.5	4.8	1.7	5.1	4.2	3.4	2.6	2.0	3.1	3.5	0.9	2.6	11.8	2.3	3.4	8.1	5.2	2.3	2.7	11.5	5.8	2.8	3.3	2.6	4.1	2.1	6.4	5.6	3.9	2.8	1.9	12.8	4.7	9.9	1.4	6.5	3.8	2.4	9.1	4.6	3.5	4.4	1.8	0.0	1.0	0.8	4.0	1.0	1.8	0.2	0.1	0.3	0.5	0.8	0.9	0.5	0.4	0.3	0.5	0.3	0.8	24.7	2.2	0.1	1.8	1.3	1.2	1.2	7.5	5.0	2.7	0.6	0.3	0.6	6.8	1.6	1.3	0.5	0.2	3.8	0.5	4.4	3.2	0.1	1.2	3.8	1.2	1.3	2.9	0.0	2.9	6.7	0.2	0.1	2.6	1.2	1.2	1.8	0.9	0.8	1.2	0.2	1.0	0.8	1.2	1.9	11.8	7.8	9.1	0.4	4.2	0.9	0.0	0.6	0.0	0.2	1.0	1.9	3.9	1.2	1.8	1.8	4.4	4.0	2.2	0.0	0.8	0.4	0.8	0.2	1.0	1.9	7.0	4.9	7.1	2.0	3.1	2.3	3.4	5.8	1.4
TAF5	"TAF2D, TAFII100"	ENSG00000148835	"TATA-box binding protein associated factor 5"	Q15542	10	103367967-103389065	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006195, HPA006474"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA006195: AB_1080188, HPA006474: AB_1080185"	"unprognostic (3.09e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (1.36e-9)"	"prognostic favourable (7.39e-5)"	"unprognostic (2.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	5.3	3.6	4.0	5.8	5.9	7.9	6.3	13.8	7.7	5.3	5.8	3.8	3.7	5.5	5.2	3.5	5.0	4.1	3.2	3.4	5.2	3.5	3.5	5.0	3.9	7.6	3.8	3.9	6.1	7.9	3.4	7.5	6.6	6.3	4.2	6.1	2.1	4.4	4.5	5.5	4.7	4.7	4.4	5.4	6.2	4.3	25.5	5.6	14.0	4.4	2.5	7.9	4.1	7.3	3.2	1.3	2.5	1.8	1.1	3.4	0.6	6.5	3.1	7.6	13.6	4.3	3.6	8.9	4.7	5.4	6.9	8.7	6.0	3.5	15.8	2.7	2.5	6.7	12.7	2.5	8.8	5.8	11.0	7.2	3.5	5.9	2.0	14.0	7.9	1.6	1.9	4.0	4.4	5.1	10.3	7.9	4.6	4.3	11.3	18.3	9.2	4.0	9.7	9.2	4.8	1.9	1.9	5.3	5.9	3.0	2.2	2.7	2.6	5.8	3.0	4.0	5.1	4.5	8.3	4.5	5.4	9.7	2.2	16.7	2.5	0.6	1.8	2.5	1.5	0.6	1.3	0.4	1.4	2.8	1.0	3.2	3.4	2.0	0.3	1.1	1.1	1.3	3.4	0.6	4.0	5.9	13.8	7.7	5.2	3.5	3.8	3.9	6.3	5.6
TAF5L	PAF65B	ENSG00000135801	"TATA-box binding protein associated factor 5 like"	O75529	1	229593111-229626047	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067941			Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA067941: "	"unprognostic (3.41e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.17e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	19.5	8.3	13.0	14.4	12.8	23.0	25.6	13.5	14.7	12.1	15.3	14.7	9.9	12.7	15.8	10.6	15.0	14.1	16.3	12.9	10.5	9.0	9.5	18.6	13.6	15.7	12.1	8.0	12.2	10.4	12.7	11.6	25.0	12.9	15.7	15.8	9.2	13.3	12.3	24.9	10.1	17.0	16.5	12.8	15.6	13.8	8.5	10.5	15.9	13.5	11.9	15.3	17.1	13.2	1.1	1.6	0.2	1.3	2.1	2.6	0.8	16.7	9.7	14.0	11.6	9.7	10.2	36.3	11.4	13.7	14.3	13.4	13.0	13.8	18.9	12.2	12.3	14.4	15.4	14.0	13.8	14.1	22.1	14.8	9.9	8.3	10.9	19.6	17.2	11.2	13.6	14.1	12.1	13.9	19.7	17.6	13.4	8.1	22.1	10.6	19.8	7.7	19.7	15.7	19.5	10.0	15.6	14.1	17.2	9.8	13.5	15.7	16.0	20.5	12.0	11.9	14.6	15.8	24.0	9.4	7.1	21.7	9.1	11.9	18.7	0.0	1.1	0.2	2.1	1.2	2.6	1.1	2.2	1.7	1.6	1.0	2.2	1.9	0.2	2.1	1.3	0.7	1.9	0.8	13.0	12.8	13.5	14.7	10.5	9.0	12.1	8.0	12.9	10.5
TAF6	"MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85"	ENSG00000106290	"TATA-box binding protein associated factor 6"	P49848	7	100107070-100119841	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006566	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006566: AB_1080194"	"unprognostic (5.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavourable (6.06e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.37e-1)"	14.1	19.8	21.5	15.4	23.6	13.9	12.0	23.5	35.8	19.4	17.5	12.7	12.6	12.1	24.1	17.6	16.8	23.6	16.8	17.2	20.5	16.3	16.1	10.2	12.9	14.3	13.1	15.9	26.2	16.6	22.6	21.7	19.5	19.3	15.8	13.7	15.6	17.9	23.3	23.1	17.9	13.2	23.7	13.1	14.6	14.0	27.3	14.7	21.7	21.3	11.5	17.0	19.6	14.9	15.3	14.3	13.2	25.7	14.0	18.7	13.1	17.1	32.2	20.8	34.2	27.5	14.6	29.2	18.9	21.2	24.3	22.6	23.9	20.9	15.7	21.6	28.9	14.5	28.6	22.5	26.2	25.6	18.6	15.1	31.2	15.7	27.3	14.5	14.3	14.8	14.1	35.7	39.5	19.7	26.1	29.0	21.9	60.9	30.9	23.7	30.8	25.9	22.9	25.6	23.2	17.3	14.0	19.0	27.6	23.8	37.1	15.8	13.5	14.5	19.5	37.0	38.0	47.8	24.4	17.9	31.0	26.4	25.1	20.5	31.8	12.7	11.0	13.2	15.6	11.4	18.7	10.2	15.0	15.7	14.3	15.3	15.3	14.3	6.4	14.0	25.7	8.5	13.9	13.1	21.5	23.6	23.5	35.8	20.5	16.3	13.1	15.9	19.3	14.7
TAF6L	PAF65A	ENSG00000162227	"TATA-box binding protein associated factor 6 like"	Q9Y6J9	11	62771303-62787342	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067239	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA067239: "	"unprognostic (5.41e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"prognostic favourable (8.98e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.45e-3)"	"unprognostic (9.65e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.61e-3)"	10.7	11.0	9.3	10.0	13.1	8.8	14.0	8.7	14.5	10.4	11.2	13.2	7.0	11.6	12.6	11.8	8.7	9.8	9.0	7.8	8.7	9.1	11.9	19.5	7.2	8.5	12.1	13.1	11.7	13.5	12.4	14.1	12.1	9.6	9.9	6.0	13.8	10.0	9.8	20.6	18.4	8.5	8.8	7.6	12.4	8.6	5.9	10.5	9.8	13.8	8.4	8.1	9.7	7.4	3.1	3.4	3.3	2.7	3.4	3.5	0.8	8.4	7.9	11.2	8.9	5.0	4.2	9.4	6.6	4.9	8.2	6.4	4.7	9.6	11.2	14.8	5.1	11.1	7.7	7.3	2.5	15.2	16.6	6.0	9.3	7.7	7.1	7.4	10.9	5.6	5.4	6.5	4.3	6.7	12.4	8.5	5.1	16.4	10.9	21.4	11.7	11.4	13.7	7.6	14.5	5.5	5.8	12.0	11.6	6.9	7.3	10.8	12.9	5.5	6.5	8.2	10.5	13.2	7.8	9.1	15.1	12.8	7.3	5.7	7.6	2.7	2.7	3.3	2.2	2.7	2.5	3.1	1.7	1.7	3.2	2.9	3.5	2.3	0.7	3.4	1.1	3.4	1.3	0.8	9.3	13.1	8.7	14.5	8.7	9.1	12.1	13.1	9.6	10.5
TAF7	"TAF2F, TAFII55"	ENSG00000178913	"TATA-box binding protein associated factor 7"	Q15545	5	141260225-141320821	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006429	Approved		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA006429: AB_1080196"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.78e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-2)"	33.2	29.9	29.2	28.8	32.2	31.6	38.7	39.6	33.6	28.6	24.1	26.0	21.0	20.2	34.6	39.8	24.9	35.0	22.2	46.4	30.3	30.8	28.6	29.7	25.3	32.9	32.0	26.1	50.7	24.8	20.1	47.1	38.8	28.9	34.8	26.5	21.3	26.8	28.0	69.5	26.9	30.0	31.8	32.9	37.0	23.9	33.5	28.9	65.5	45.7	33.9	39.1	32.3	53.6	18.8	17.8	49.6	16.5	27.1	29.8	19.8	19.8	16.6	37.9	27.7	33.9	31.5	23.7	25.9	23.2	36.9	36.1	23.2	22.4	53.6	52.1	26.3	17.0	23.8	24.1	37.3	23.3	26.6	9.6	20.5	19.3	30.9	13.2	20.3	28.7	35.9	14.3	25.5	26.5	20.4	42.0	35.4	24.9	29.6	32.1	13.7	6.1	37.9	50.7	39.1	27.1	26.8	30.4	34.8	21.2	30.6	28.9	43.6	43.5	24.3	5.2	18.0	17.0	31.4	11.4	46.1	48.5	22.8	30.9	20.8	44.7	11.4	49.6	18.3	13.9	23.7	18.8	21.5	20.3	16.1	18.7	29.8	24.6	34.6	27.1	16.5	17.8	17.9	19.8	29.2	32.2	39.6	33.6	30.3	30.8	32.0	26.1	28.9	28.9
TAF8	"FLJ32821, TAF(II)43, TBN"	ENSG00000137413	"TATA-box binding protein associated factor 8"	Q7Z7C8	6	42050513-42087461	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031730, HPA031731, HPA031734"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994"	"unprognostic (7.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.46e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.26e-2)"	24.7	17.4	11.9	17.1	13.2	25.5	17.4	9.6	15.1	15.6	19.0	15.2	21.4	14.9	16.1	17.6	15.6	11.4	12.1	22.8	11.5	9.9	18.7	14.1	16.2	19.9	15.0	13.2	13.8	14.0	22.3	12.3	19.1	12.4	15.6	13.3	16.4	16.4	19.6	25.5	12.8	14.1	14.7	12.2	20.6	17.2	18.9	12.2	36.0	24.3	11.2	20.1	16.7	15.6	15.4	19.8	19.7	24.6	8.4	13.2	7.3	9.8	10.8	8.9	10.0	10.1	9.3	8.2	4.6	8.1	12.2	12.7	18.5	5.9	15.1	10.0	6.7	7.4	14.5	9.8	9.5	13.1	14.0	19.1	13.0	9.0	12.4	11.0	14.0	12.7	7.8	8.7	11.1	13.6	23.5	16.0	6.8	13.1	10.1	16.7	5.5	5.1	20.8	10.6	11.6	10.8	8.1	9.3	8.2	8.4	6.6	9.4	9.9	13.6	12.6	11.0	11.6	5.1	9.4	13.9	13.5	32.0	5.0	12.3	6.2	13.4	12.1	19.7	13.2	12.8	9.3	14.1	12.0	10.3	13.0	15.4	12.5	12.1	15.2	8.4	24.6	19.8	10.1	7.3	11.9	13.2	9.6	15.1	11.5	9.9	15.0	13.2	12.4	12.2
TAF9	"AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32"	ENSG00000273841	"TATA-box binding protein associated factor 9"	Q16594	5	69364743-69370013	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028930, HPA053429, HPA058961, HPA072658"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028930: , HPA053429: , HPA058961: , HPA072658: "	"unprognostic (1.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.38e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (9.20e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.79e-1)"	11.3	7.2	6.8	5.5	8.4	16.6	8.8	6.5	9.5	6.7	8.0	4.0	6.3	6.3	5.9	10.0	10.9	5.1	5.7	9.2	5.6		11.5	18.0	6.5	8.2	6.8	6.2	7.3	7.4	4.4	10.8	8.6	9.4	7.1	9.1	4.4	5.2	5.2	11.0	5.3	9.7	6.9	5.7	8.7	6.1	30.1	6.8	10.2	9.8	9.8	9.8	7.8	5.0	24.9	21.8	29.8	28.8	14.9	25.0	31.2	17.7	18.7	11.9	20.0	19.1	25.1	31.3	17.7	26.7	29.8	39.9	19.8	21.9	24.1	13.3	25.4	13.2	15.9	35.7	39.2	11.0	19.7	19.8	31.2	25.0	46.8	19.4	28.7	29.7	23.6	20.6	46.2	24.1	19.8	19.3	28.1	24.5	22.0	30.5	14.2	14.7	14.2	19.9	27.3	25.3	19.6	19.9	14.1	16.8	10.3	30.7	16.3	28.7	16.8	11.6	17.7	12.2	29.2	17.9	21.5	30.4	16.9	23.6	13.3	28.4	28.8	29.8	14.9	26.1	22.4	24.9	22.2	18.3	21.8	19.7	25.0	21.4	4.5	14.9	20.6	13.5	23.2	31.2										
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.1"	"Cell line enhanced"	"Detected in some"		"HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;K-562: 16.5;MOLT-4: 8.8;TIME: 12.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.2"	"Region enriched"	"Detected in some"	5	"midbrain: 17.1"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB017805: , HPA047866: , HPA073983: "	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	9.1	2.7	7.0	1.8	5.7	33.1	7.1	1.6	6.9	3.3	2.4	12.0	2.3	1.6	3.7	3.3	2.5	4.1	4.2	3.9	8.8	3.5	4.5	2.4	14.6	2.2	11.1	4.4	1.5	1.3	2.2	2.1	9.8	7.3	2.4	2.4	2.1	1.4	3.0	3.1	2.0	3.3	4.4	9.4	8.5	2.1	1.8	9.2	0.0	6.7	4.1	1.5	2.5	5.5	0.3	0.1	3.2	0.3	0.4	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	11.0	16.5	0.0	0.0	0.0	8.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	1.2	0.4	0.1	0.1	0.1	2.2	7.0	5.7	1.6	6.9	8.8	3.5	11.1	4.4	7.3	9.2
TANK	"I-TRAF, TRAF2"	ENSG00000136560	"TRAF family member associated NFKB activator"	Q92844	2	161136908-161236221	"Predicted intracellular proteins"	"DNA damage, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010345, HPA037675, HPA037676"	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB010345: AB_2199871, HPA037675: , HPA037676: "	"unprognostic (1.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (2.78e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.30e-2)"	35.9	23.6	17.2	32.0	21.1	43.0	34.2	17.7	16.8	19.6	22.3	11.7	18.0	15.8	20.6	21.8	23.2	20.9	25.1	18.4	16.2	17.2	22.7	37.2	35.4	28.8	20.1	12.7	19.7	15.4	17.0	33.3	41.7	18.2	26.0	21.5	15.7	21.9	15.5	49.5	21.4	22.6	32.2	21.3	42.1	18.2	13.5	19.1	29.2	29.0	25.1	29.0	37.3	38.6	22.4	20.7	54.0	27.9	13.3	28.1	14.7	11.9	7.6	10.1	11.5	29.4	38.8	14.5	17.1	27.1	12.5	18.9	9.3	15.7	17.0	12.5	20.3	8.6	6.2	13.4	19.0	39.3	6.5	9.2	7.4	23.8	24.0	15.1	10.3	31.1	21.6	18.9	14.8	32.1	9.1	22.4	24.0	9.0	9.1	15.3	5.8	6.9	5.3	14.8	11.0	28.4	19.5	8.6	10.0	11.1	13.2	18.5	5.5	18.6	33.7	15.8	9.7	8.0	10.2	15.2	13.9	25.7	21.0	12.0	12.0	28.1	21.6	26.4	12.1	25.1	18.5	22.1	19.5	17.5	20.7	22.4	12.9	13.2	54.0	13.3	27.9	12.1	28.1	14.7	17.2	21.1	17.7	16.8	16.2	17.2	20.1	12.7	18.2	19.1
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973641-29992261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.51e-4)"	"prognostic favourable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favourable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	27.8	24.1	26.2	15.1	26.7	12.3	17.7	29.2	30.6	13.5	13.6	21.5	11.8	18.5	16.8	13.0	12.4	14.1	15.1	17.6	25.0	18.2	13.9	10.4	23.0	14.4	22.1	22.7	15.8	16.3	26.2	18.7	22.5	20.7	13.6	9.6	15.0	17.1	15.9	22.8	20.0	19.3	14.8	14.9	26.3	16.0	21.2	20.2	14.0	15.9	9.8	11.5	12.8	18.0	2.6	3.3	4.8	2.8	2.0	3.2	2.0	11.2	21.5	11.8	18.5	13.8	9.3	18.1	20.6	11.0	14.0	13.1	17.2	15.0	12.2	17.5	14.8	17.5	10.7	10.4	7.5	18.9	22.7	13.1	21.7	17.2	10.1	12.8	25.2	10.9	9.0	14.8	6.0	23.3	11.7	12.4	13.3	20.7	14.9	18.3	11.4	14.5	27.7	17.1	11.3	8.8	10.6	13.9	11.1	11.8	15.8	6.1	19.8	14.6	32.5	24.1	11.2	17.1	11.9	18.1	11.6	11.5	14.8	14.8	17.5	1.3	2.8	1.5	2.9	2.7	3.1	2.0	2.9	2.6	1.8	2.6	1.6	1.4	4.8	2.0	1.4	3.3	3.2	2.0	26.2	26.7	29.2	30.6	25.0	18.2	22.1	22.7	20.7	20.2
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853978	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Supported	"Endoplasmic reticulum,Centriolar satellite"			110000	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: "	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favourable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	10.7	7.9	3.8	20.4	5.2	6.1	8.7	3.1	4.9	6.5	12.6	4.5	1.9	9.1	8.2	3.9	10.5	6.4	9.6	6.5	3.5	3.3	6.5	6.4	17.6	26.9	6.4	3.6	5.0	4.4	3.0	3.6	8.7	6.0	9.0	5.4	6.6	9.4	4.4	7.5	15.3	19.5	5.7	5.2	24.2	12.6	5.8	4.9	20.8	13.1	8.9	20.3	6.6	7.6	22.7	8.8	45.3	10.9	14.4	25.3	21.0	2.8	1.8	0.0	1.7	0.9	1.2	16.6	1.5	3.4	6.9	9.4	0.1	3.0	5.9	3.9	1.1	5.5	1.1	2.4	0.4	10.1	1.5	6.6	1.3	2.3	4.3	0.0	2.4	1.3	2.1	1.9	1.2	1.7	0.4	5.6	0.8	1.7	1.1	13.1	0.0	1.9	5.9	1.2	3.9	8.9	0.5	0.0	0.3	1.6	4.2	5.7	3.8	11.8	0.9	2.6	1.0	6.3	0.0	7.5	10.4	1.7	1.7	4.0	1.8	27.7	10.6	44.2	15.5	10.9	16.3	22.7	17.5	16.4	8.8	20.9	25.3	19.4	45.3	14.4	10.5	7.2	21.7	21.0	3.8	5.2	3.1	4.9	3.5	3.3	6.4	3.6	6.0	4.9
TARBP2	Trbp	ENSG00000139546	"TARBP2, RISC loading complex RNA binding subunit"	Q15633	12	53500921-53506431	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051181, HPA061454, CAB069406"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB069406: AB_1622301, HPA051181: , HPA061454: "	"unprognostic (1.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.61e-3)"	"prognostic unfavourable (3.09e-4)"	"unprognostic (2.04e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavourable (4.75e-6)"	"unprognostic (8.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.31e-1)"	7.3	12.0	7.5	11.5	8.0	6.1	18.6	24.0	9.5	10.7	11.6	11.0	11.0	10.9	8.3	15.7	11.8	14.7	15.8	8.0	7.0	6.1	14.8	27.3	10.3	15.7	9.5	6.3	9.8	17.0	8.6	8.2	23.5	6.6	10.2	7.1	10.3	13.4	11.1	10.9	12.2	10.3	7.6	6.9	13.9	10.3	18.3	6.9	14.8	15.5	8.6	12.9	10.2	12.8	11.1	12.7	5.5	9.8	9.5	12.7	10.7	9.9	29.0	10.4	11.5	6.8	9.2	15.1	8.6	8.3	14.7	8.8	23.5	13.8	9.1	18.7	10.0	8.0	14.2	13.4	8.8	11.8	22.4	10.7	11.4	17.3	14.2	18.1	12.6	10.0	9.1	14.6	7.4	17.5	14.2	15.9	10.7	41.3	12.6	25.5	21.3	15.0	9.5	6.2	12.9	9.5	10.9	14.1	9.9	4.6	11.8	23.9	16.2	26.8	8.5	12.7	11.6	4.7	10.8	7.3	14.6	9.7	14.9	9.7	14.6	1.7	9.8	5.5	12.6	9.7	12.1	10.5	12.0	10.9	12.7	11.1	12.7	11.4	0.4	9.5	5.9	11.3	9.9	10.7	7.5	8.0	24.0	9.5	7.0	6.1	9.5	6.3	6.6	6.9
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11026420	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm			13000	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favourable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	36.1	38.1	52.3	43.3	62.9	31.7	42.8	86.2	61.8	38.7	39.8	47.6	37.5	39.8	45.8	47.2	47.8	37.9	32.4	40.8	49.5	36.7	39.3	48.3	40.2	52.8	59.0	45.2	53.0	39.1	60.2	68.1	44.2	46.5	43.3	52.9	38.4	41.7	45.3	57.1	43.0	43.4	50.5	44.7	46.1	38.1	34.5	62.6	52.2	46.7	38.0	63.5	38.1	47.9	29.4	31.7	16.5	24.8	33.6	31.1	17.0	52.0	35.7	61.3	31.4	33.3	28.0	36.2	35.8	31.6	58.9	44.1	42.2	38.5	69.4	26.3	39.7	37.3	74.4	41.6	77.6	37.2	35.9	52.5	59.4	56.1	27.3	63.0	35.0	22.8	47.3	41.3	33.9	41.7	67.5	39.1	49.8	42.0	46.0	51.1	48.9	32.0	54.6	49.2	44.1	42.4	38.6	41.9	34.6	48.7	38.6	27.6	38.7	44.5	38.0	39.6	46.4	32.5	51.4	29.2	36.1	73.4	25.9	63.3	41.9	16.3	19.6	16.5	25.4	24.8	31.1	29.4	26.0	24.6	31.7	21.2	25.9	27.7	7.9	33.6	23.6	22.2	26.8	17.0	52.3	62.9	86.2	61.8	49.5	36.7	59.0	45.2	46.5	62.6
TARS		ENSG00000113407	"Threonyl-tRNA synthetase"	P26639	5	33440696-33469539	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Supported	"Actin filaments,Cytosol"			170000	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavourable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavourable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavourable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	17.4	25.6	10.2	16.0	13.1	19.2	17.7	14.4	17.2	12.7	22.1	12.3	18.7	11.6	18.3	19.7	31.0	12.2	11.9	19.1	10.3	10.9	19.2	57.0	17.2	12.7	17.5	7.8	21.3	27.6	21.3	27.0	18.5	16.8	13.9	24.7	10.8	42.1	15.8	25.1	11.7	21.7	21.2	19.5	18.3	21.2	9.6	15.4	17.6	22.8	27.3	21.2	21.8	21.9	13.1	16.0	14.2	12.6	24.0	15.0	9.7	29.4	24.7	20.7	29.2	13.7	25.9	30.1	33.1	28.1	25.1	28.4	30.1	18.4	11.7	12.1	27.3	21.0	44.1	32.7	51.7	17.3	16.0	17.0	63.3	17.2	42.6	27.3	18.2	24.7	52.7	34.5	44.7	26.8	33.3	31.6	32.0	16.3	21.3	9.4	22.0	18.3	18.1	36.7	17.2	28.5	23.6	12.1	13.8	30.7	22.5	21.9	11.8	24.4	14.1	19.7	29.4	15.5	23.2	18.6	36.6	18.3	22.0	36.1	21.3	14.2	11.6	10.5	15.0	12.6	14.1	13.1	12.7	15.0	16.0	11.5	11.6	14.7	1.5	24.0	10.1	8.8	12.1	9.7	10.2	13.1	14.4	17.2	10.3	10.9	17.5	7.8	16.8	15.4
TATDN1	CDA11	ENSG00000147687	"TatD DNase domain containing 1"	Q6P1N9	8	124488485-124539458	"Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023634, HPA053045"	Uncertain		Supported	Nucleoplasm			2000000	Nucleoplasm		"HPA023634: AB_1857779, HPA053045: "	"unprognostic (2.19e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (2.53e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.12e-2)"	16.6	14.1	16.1	13.0	18.6	9.9	27.4	22.7	18.8	14.9	14.4	11.7	9.9	12.3	16.7	15.3	15.5	16.8	10.1	16.4	14.9	14.4	19.4	17.1	16.3	14.7	22.7	17.0	28.9	34.7	13.2	18.4	10.5	19.4	13.8	16.0	8.1	18.6	11.1	40.4	14.0	11.9	16.9	21.2	8.2	16.3	8.3	18.3	15.1	26.2	14.5	13.3	15.2	13.3	10.5	10.0	13.7	7.2	11.1	18.1	8.9	20.2	14.3	13.8	9.6	12.4	23.5	10.4	11.1	12.3	14.2	13.2	14.0	22.2	15.4	25.2	12.2	16.7	16.6	16.6	23.6	19.7	11.0	14.3	11.9	12.1	23.6	10.8	5.3	17.6	26.4	20.7	43.8	11.3	11.6	10.1	18.9	61.5	16.1	6.7	13.7	18.6	10.8	10.2	17.2	20.0	14.3	11.5	16.2	12.5	25.3	26.1	17.0	11.7	8.8	10.1	26.9	18.4	30.2	13.0	19.8	19.4	18.9	19.3	8.7	13.7	7.2	2.8	8.2	6.0	12.7	10.5	12.5	10.1	10.0	10.4	18.1	16.6	1.5	11.1	4.5	7.5	12.9	8.9	16.1	18.6	22.7	18.8	14.9	14.4	22.7	17.0	19.4	18.3
TBC1D10A	"AC004997.C22.2, EPI64, TBC1D10"	ENSG00000099992	"TBC1 domain family member 10A"	Q9BXI6	22	30291990-30327046	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA007725, HPA008142, HPA076041"	Approved		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA007725: , HPA008142: AB_1080209, HPA076041: "	"unprognostic (3.37e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.52e-2)"	13.5	10.7	8.4	14.5	13.4	7.8	14.8	10.5	13.6	16.5	12.0	4.6	17.6	9.3	9.7	16.0	31.5	11.6	13.8	6.4	8.4	6.6	16.0	10.8	14.3	15.6	6.0	6.5	16.2	12.7	8.9	13.0	35.7	8.1	13.6	6.1	17.3	15.0	19.4	4.3	27.1	10.4	10.5	7.0	15.8	10.6	17.5	6.1	19.8	14.6	10.2	22.7	12.7	23.2	13.3	22.3	21.0	23.9	12.9	26.1	17.1	11.5	4.6	1.9	6.1	5.8	7.3	15.1	6.8	10.1	8.0	12.9	5.3	4.6	5.8	6.6	11.9	11.5	2.9	6.4	4.3	4.4	7.8	1.6	4.0	3.8	14.9	2.3	8.3	9.7	10.6	15.9	2.7	3.6	3.0	5.7	6.0	14.1	16.7	5.0	1.2	6.0	7.5	8.2	5.3	8.0	11.6	3.2	2.5	6.9	10.7	15.8	9.1	1.5	6.6	15.2	6.8	8.3	3.6	5.6	2.4	5.3	10.6	3.5	8.6	17.0	8.9	21.0	16.5	17.1	18.2	8.4	19.3	16.9	12.8	13.3	26.1	21.3	6.0	12.9	23.9	22.3	16.2	17.1	8.4	13.4	10.5	10.5	8.4	6.6	6.0	6.5	8.1	6.1
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: "	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favourable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	20.0	31.2	31.9	24.4	33.8	10.6	22.0	18.1	32.8	16.0	20.2	22.5	17.0	17.3	16.2	21.9	24.3	18.8	15.0	22.9	28.6	27.5	32.1	21.6	20.7	48.4	28.8	20.5	23.3	19.3	23.6	20.7	18.0	29.0	19.6	20.7	26.1	23.2	16.7	35.1	37.3	20.0	17.8	37.3	26.2	35.8	22.4	29.3	24.0	14.9	17.9	19.9	16.7	15.4	5.3	7.5	26.4	8.2	5.5	8.9	6.0	10.3	11.3	12.7	14.2	10.6	8.9	7.7	8.3	9.1	7.8	6.7	11.7	21.7	16.7	4.9	9.9	7.5	21.3	19.1	9.6	4.6	6.9	27.9	7.4	12.2	7.3	12.6	62.9	6.8	27.1	7.4	12.2	7.3	26.4	6.0	9.4	6.7	19.3	12.8	17.2	12.7	24.3	16.8	18.0	11.6	7.3	19.5	13.9	6.9	7.5	25.6	10.4	12.0	7.3	8.6	6.5	7.5	12.2	11.6	26.8	17.1	8.1	16.2	8.3	1.7	8.2	3.5	5.9	5.3	8.9	5.2	6.4	6.3	6.9	5.3	4.9	4.5	26.4	5.5	2.4	7.5	7.5	6.0	31.9	33.8	18.1	28.0	28.6	27.5	28.8	20.5	29.0	29.3
TBC1D15	"DKFZp761D0223, FLJ12085"	ENSG00000121749	"TBC1 domain family member 15"	Q8TC07	12	71839707-71927248	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013388, HPA015592"	Supported		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA013388: AB_2199233, HPA015592: AB_1857789"	"unprognostic (3.87e-2)"	"prognostic favourable (7.06e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (5.34e-4)"	"unprognostic (5.73e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	37.4	27.4	20.2	14.3	22.5	35.2	26.4	19.6	23.7	21.8	20.2	17.0	19.8	15.1	22.9	15.4	20.2	15.1	20.4	15.4	16.9	16.4	22.3	32.9	24.5	19.0	28.9	18.7	22.7	26.3	19.1	38.0	25.4	23.8	18.0	14.8	12.0	20.6	14.4	44.0	19.2	20.8	19.5	26.3	21.4	17.8	19.4	27.5	22.2	25.9	14.5	18.6	27.5	16.3	5.9	6.3	13.9	8.8	7.2	13.5	6.7	13.8	13.8	11.6	11.9	23.4	23.4	17.7	15.0	34.0	18.7	23.7	9.7	11.7	17.6	10.1	13.7	8.7	14.3	10.4	20.5	15.5	12.1	16.7	13.3	9.9	19.7	21.2	12.2	22.7	13.3	14.3	27.1	15.5	16.1	9.9	15.9	10.2	14.1	13.2	24.1	12.0	11.2	13.4	19.6	14.1	13.4	12.8	11.0	19.8	17.5	16.7	17.9	15.5	15.7	16.1	7.3	18.3	8.9	25.4	23.4	22.5	9.7	14.1	14.5	2.0	6.8	8.6	8.1	7.0	9.3	5.7	10.1	7.9	6.3	5.9	12.9	11.1	13.9	7.2	8.8	3.8	13.5	6.7	20.2	22.5	19.6	23.7	16.9	16.4	28.9	18.7	23.8	27.5
TBC1D23	FLJ11046	ENSG00000036054	"TBC1 domain family member 23"	Q9NUY8	3	100261000-100325251	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038151, HPA038152"	Approved		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA038151: AB_10672405, HPA038152: AB_10672620"	"unprognostic (9.23e-3)"	"unprognostic (6.01e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.87e-3)"	"unprognostic (6.16e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.32e-1)"	26.2	28.3	13.4	13.2	14.3	20.4	17.8	28.2	18.9	18.0	17.9	13.6	18.2	18.3	19.1	14.3	20.5	13.3	14.4	16.2	12.8	10.6	20.8	23.2	15.8	11.6	17.6	13.8	19.6	18.5	18.3	25.6	33.5	16.8	16.5	16.0	12.2	20.6	10.6	30.9	20.5	29.6	15.5	19.3	18.2	15.2	17.0	18.1	19.1	16.8	15.7	15.1	21.0	16.9	11.5	17.5	22.5	20.1	20.8	15.5	14.8	33.0	6.8	8.0	4.3	15.5	21.0	7.8	20.1	20.2	21.0	25.2	13.5	5.7	7.9	9.8	20.9	11.2	28.5	12.6	32.8	4.7	7.3	21.7	8.3	8.8	15.7	9.6	17.6	16.9	10.6	11.5	16.9	11.1	17.8	11.8	13.3	6.8	7.7	4.7	9.1	13.1	6.5	17.4	9.3	12.4	7.2	11.4	6.5	10.5	8.0	13.4	8.7	9.5	11.0	14.8	14.6	7.0	12.8	11.5	12.2	14.3	20.0	9.4	12.6	22.5	16.6	20.6	12.0	19.3	12.6	11.5	11.8	11.1	17.5	10.8	10.9	11.6	11.2	20.8	20.1	7.5	15.5	14.8	13.4	14.3	28.2	18.9	12.8	10.6	17.6	13.8	16.8	18.1
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Deafness, Disease mutation, Epilepsy, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 33.4"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA044712: AB_10795619, HPA068080: "	"prognostic unfavourable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	6.0	5.8	11.0	2.9	9.6	3.7	4.9	15.8	17.7	4.2	3.5	2.8	6.7	3.8	3.3	5.0	2.2	4.3	3.5	4.9	9.0	5.4	7.6	6.6	6.4	3.0	3.8	12.2	2.1	16.6	5.2	5.6	3.6	7.5	4.5	1.9	5.4	33.4	6.4	6.1	3.5	2.8	3.1	3.7	3.4	3.8	2.4	4.5	0.8	5.5	1.0	2.3	4.0	2.9	0.2	1.3	0.0	0.9	0.2	2.2	1.0	2.6	5.0	3.3	6.8	4.0	4.0	2.9	4.7	2.4	3.1	2.6	4.7	2.2	6.5	4.3	3.6	4.7	5.2	1.4	2.2	7.1	6.2	5.9	6.5	4.0	2.4	4.2	2.5	1.5	2.1	2.7	1.1	3.8	7.1	3.6	2.8	4.6	2.9	8.5	3.0	3.3	15.1	6.4	4.5	2.2	1.7	26.5	6.4	3.1	11.6	1.9	3.7	3.8	4.0	6.1	6.6	5.9	4.6	2.4	2.1	8.1	2.6	6.2	5.4	0.0	0.7	0.0	2.2	0.8	0.7	0.2	0.5	0.7	1.3	0.1	0.5	0.3	0.0	0.2	0.9	0.6	0.0	1.0	11.0	9.6	15.8	12.4	9.0	5.4	3.8	12.2	7.5	4.5
TBC1D2B	KIAA1055	ENSG00000167202	"TBC1 domain family member 2B"	Q9UPU7	15	77984036-78077724	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041833, HPA048174, HPA052663"	Approved		Enhanced	Cytosol				Cytosol		"HPA041833: , HPA048174: , HPA052663: "	"unprognostic (3.13e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-3)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.19e-2)"	26.0	14.1	9.3	12.0	10.0	11.9	21.4	8.4	8.4	22.8	16.7	8.4	7.3	7.6	20.2	13.0	9.3	18.2	20.0	7.8	7.7	4.3	8.2	18.3	22.7	12.5	8.3	5.6	31.2	16.6	17.7	7.1	28.9	7.2	13.6	10.8	20.7	8.6	14.0	5.0	10.5	14.3	15.5	9.7	19.9	12.6	11.0	7.3	20.4	10.4	5.8	14.4	17.1	18.4	0.4	3.2	3.7	2.1	3.8	4.2	1.3	5.0	4.0	4.8	4.5	33.9	27.1	8.4	11.5	17.4	10.8	12.0	5.0	2.0	7.7	4.6	9.7	7.3	10.4	12.7	8.3	14.6	8.1	4.9	3.8	3.4	16.1	12.4	7.5	26.3	8.9	7.2	4.8	12.3	2.5	5.4	14.0	5.5	4.6	8.1	3.8	3.9	7.0	22.1	1.7	5.6	19.1	2.5	7.0	10.7	7.3	13.6	2.4	13.0	15.0	11.9	7.8	3.7	6.1	9.1	9.6	4.2	4.1	16.8	6.2	0.0	2.1	0.9	3.9	1.8	2.2	0.2	2.6	4.2	1.4	0.4	1.9	1.5	3.7	3.8	0.5	3.2	1.5	1.3	9.3	10.0	8.4	8.4	7.7	4.3	8.3	5.6	7.2	7.3
TBC1D30	KIAA0984	ENSG00000111490	"TBC1 domain family member 30"	Q9Y2I9	12	64781193-64881032	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 23.0;RPMI-8226: 13.6;RT4: 17.7;SCLC-21H: 16.6;SK-BR-3: 17.0;T-47d: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039772, HPA040043"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA039772: AB_10795409, HPA040043: AB_10795411"	"unprognostic (1.85e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (3.61e-5)"	"unprognostic (9.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.65e-5)"	"prognostic favourable (5.08e-4)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.67e-3)"	"unprognostic (7.80e-3)"	1.8	1.6	4.7	2.3	11.4	0.5	5.3	13.4	15.8	7.6	3.3	1.5	12.4	5.0	3.1	2.5	1.2	2.1	4.8	1.1	7.1	5.5	3.9	1.7	3.9	0.9	4.7	7.0	1.5	19.8	8.9	6.5	1.4	16.5	3.7	3.5	2.0	14.4	11.6	0.9	1.3	3.5	2.4	3.0	2.5	6.9	3.2	2.8	0.0	3.3	0.2	0.7	4.9	1.9	0.0	0.0	2.4	1.1	0.0	1.3	0.3	6.9	1.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.1	6.5	2.2	0.3	1.1	0.0	0.1	6.8	0.1	0.0	0.0	6.7	0.3	1.2	0.3	0.1	2.3	1.4	0.4	0.0	0.0	0.2	5.7	0.0	2.4	0.2	23.0	0.0	0.4	0.9	6.8	0.1	0.1	13.6	0.8	17.7	16.6	1.3	1.4	17.0	0.2	12.4	1.1	5.4	0.0	1.0	0.5	3.4	0.0	0.0	0.2	0.1	0.7	0.3	0.0	1.1	0.0	0.4	1.1	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.3	4.7	11.4	13.4	15.8	7.1	5.5	4.7	7.0	16.5	2.8
TBC1D4	"AS160, DKFZp779C0666, KIAA0603"	ENSG00000136111	"TBC1 domain family member 4"	O60343	13	75284665-75482114	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"GTPase activation"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;HUVEC TERT2: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 17.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.2;T-cells: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040145, HPA059885"	Approved		Supported	Cytosol				Cytosol		"HPA040145: , HPA059885: "	"unprognostic (5.44e-3)"	"unprognostic (5.23e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (1.07e-11)"	"unprognostic (6.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.88e-2)"	"unprognostic (3.45e-1)"	12.0	43.9	6.7	6.7	7.0	1.2	17.5	9.3	10.7	6.9	5.7	4.6	4.2	1.9	5.4	10.1	6.1	5.9	8.5	25.5	8.0	4.1	15.6	5.3	8.5	14.9	5.4	7.0	22.5	8.5	9.5	4.2	9.5	11.1	7.4	4.9	2.0	20.8	2.4	40.1	10.8	6.3	4.7	4.8	9.6	6.1	3.3	4.4	1.1	17.7	17.3	14.8	4.7	8.7	0.5	7.2	2.6	0.3	0.3	17.4	1.8	5.5	6.5	4.1	0.2	9.7	10.5	5.3	4.8	2.5	3.9	4.3	36.9	6.8	1.1	1.1	6.8	5.2	10.4	4.8	4.1	18.3	10.5	18.0	8.8	11.1	2.4	8.5	0.2	11.4	8.9	4.3	10.2	27.3	5.0	0.6	4.4	2.6	12.4	1.5	5.8	3.9	11.2	3.9	6.5	3.8	4.0	7.6	2.3	2.1	6.5	3.5	2.2	0.2	11.4	4.4	5.5	2.3	5.6	0.3	0.0	0.1	7.9	8.0	6.5	2.6	0.3	0.0	0.5	0.1	0.0	0.5	8.6	1.8	0.4	0.4	8.0	3.7	0.3	0.3	0.1	7.2	17.4	1.8	6.7	7.0	9.3	10.7	8.0	4.1	5.4	7.0	11.1	4.4
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	22.2	20.9	24.8	21.3	24.7	21.1	17.7	25.5	25.1	21.0	13.3	25.7	14.5	10.3	17.4	15.9	16.4	22.4	18.5	16.2	24.4	20.0	19.9	13.9	16.9	20.4	25.9	14.9	28.3	17.2	35.3	27.8	16.5	21.4	14.2	13.7	16.6	13.9	17.0	10.3	15.2	13.8	17.7	31.3	24.3	12.9	17.3	24.7	10.0	29.1	9.7	21.2	17.8	20.7	13.5	9.7	12.3	8.6	4.2	8.7	4.6	11.5	13.0	10.7	10.0	21.2	31.2	11.7	12.5	18.3	8.2	7.1	6.3	10.5	21.5	13.6	25.3	3.6	9.4	15.2	17.1	19.0	3.6	20.6	5.3	7.3	13.6	20.0	18.1	20.1	18.2	17.8	10.8	18.6	12.9	20.0	19.9	7.8	9.8	4.6	8.8	13.7	21.6	13.8	15.3	12.3	9.0	4.0	19.1	23.9	5.6	8.5	15.9	16.8	20.1	22.7	10.2	11.7	13.6	11.6	15.7	21.0	17.5	19.1	21.2	10.2	8.6	12.3	6.7	7.1	8.7	11.7	5.1	4.8	9.7	13.5	3.9	4.4	11.5	4.2	6.4	6.3	5.5	4.6	24.8	24.7	25.5	24.6	24.4	20.0	25.9	14.9	21.4	24.7
TBC1D8	"AD3, GRAMD8, HBLP1, VRP"	ENSG00000204634	"TBC1 domain family member 8"	O95759	2	101007617-101252866	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 76.0;skeletal muscle: 66.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.5;ASC TERT1: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 16.6;non-classical monocyte: 20.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015211, HPA037496"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB015211: , HPA037496: "	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (4.25e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.73e-2)"	"unprognostic (7.98e-3)"	14.4	4.0	3.0	5.5	4.2	7.3	14.1	10.1	5.1	7.6	19.6	2.2	52.8	4.3	7.8	12.2	8.4	13.2	12.0	24.1	4.8	2.7	8.9	12.8	11.8	6.8	3.0	3.8	5.1	27.5	3.9	8.5	4.4	6.1	25.7	3.8	6.7	15.1	76.0	66.3	15.2	22.7	7.7	5.0	11.3	13.3	11.3	2.8	3.3	5.3	8.3	8.0	8.7	8.6	0.6	4.0	0.2	20.6	0.0	0.3	1.8	2.0	12.8	1.0	3.7	36.5	26.0	10.5	1.2	22.3	0.9	1.1	4.5	3.3	0.9	11.5	0.9	6.4	2.1	9.8	0.6	0.6	1.9	0.6	4.2	15.5	2.5	0.0	11.0	12.0	9.4	1.2	9.3	13.0	0.2	1.1	1.1	5.6	1.1	6.4	2.8	13.7	2.5	3.2	0.2	7.4	13.6	8.0	3.9	1.7	3.1	4.4	0.9	9.4	10.7	0.5	1.9	1.9	0.8	2.1	0.1	0.0	4.7	3.2	3.3	0.0	5.1	0.2	0.1	16.6	0.2	0.2	0.1	0.1	2.8	0.6	0.3	0.2	0.2	0.0	20.6	4.0	0.1	1.8	3.0	4.2	10.1	5.1	4.8	2.7	3.0	3.8	6.1	2.8
TBCA		ENSG00000171530	"Tubulin folding cofactor A"	O75347	5	77691166-77868780	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036487	Approved		Supported	Nucleoli,Microtubules			1000000	Microtubules	Nucleoli	"HPA036487: AB_10669794"	"unprognostic (2.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	40.5	77.3	50.0	32.5	66.7	41.2	108.9	46.8	86.9	33.0	35.7	22.1	34.1	31.8	37.5	78.5	44.4	43.0	27.1	76.7	69.2	56.5	57.7	85.1	59.8	69.6	51.0	50.8	62.3	80.7	24.0	57.9	36.7	77.9	39.1	33.2	30.6	37.3	36.8	43.4	24.6	31.0	62.4	117.9	30.3	38.9	31.2	29.0	26.7	39.8	35.2	40.7	33.3	35.4	53.6	63.1	20.9	39.2	30.9	57.8	34.8	60.8	42.4	77.9	76.8	34.7	49.4	42.6	51.8	44.6	56.5	65.0	58.0	67.2	94.1	94.9	29.0	37.9	48.2	66.1	55.9	43.8	77.1	44.7	45.6	63.8	50.9	38.7	37.3	49.6	52.2	40.2	62.2	48.2	46.6	59.0	50.7	54.0	81.2	92.9	47.8	38.9	55.0	65.1	100.6	54.6	54.5	75.2	49.0	49.7	35.2	93.0	50.0	98.0	44.9	29.1	32.3	51.0	81.2	48.8	47.1	82.2	66.2	66.8	57.6	13.9	34.9	18.2	35.9	36.7	40.4	53.6	43.0	42.4	42.4	49.0	41.3	52.0	20.9	30.9	39.2	63.1	57.8	34.8	50.0	66.7	46.8	86.9	69.2	56.5	51.0	50.8	77.9	29.0
TBCB	"CG22, CKAP1, CKAPI"	ENSG00000105254	"Tubulin folding cofactor B"	Q99426	19	36114289-36125947	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041428, HPA041722"	Approved		Supported	Cytosol			340000	Cytosol		"HPA041428: AB_10794517, HPA041722: AB_10804007"	"unprognostic (3.88e-3)"	"unprognostic (3.05e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.25e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.15e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (3.11e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.02e-1)"	23.0	30.2	59.1	26.0	48.8	23.2	20.0	30.9	67.6	22.1	22.3	64.3	14.3	16.8	20.7	20.9	18.0	27.7	14.9	29.2	55.8	56.7	21.0	14.1	19.9	20.7	63.5	43.8	33.9	11.2	15.1	23.1	19.0	49.7	20.0	17.4	14.7	12.2	22.7	34.5	12.8	17.6	29.8	85.5	21.0	16.3	24.1	44.4	15.0	12.2	13.7	23.9	16.2	15.0	64.6	73.4	79.4	101.2	59.7	96.3	80.6	31.7	93.6	36.2	24.2	25.7	27.3	12.7	24.8	19.1	43.1	30.0	41.1	17.2	23.4	46.6	40.9	15.1	30.1	26.4	26.1	54.8	29.2	21.0	26.1	62.6	28.0	24.5	47.2	25.7	20.0	34.5	24.3	24.9	9.1	39.9	38.3	48.1	37.6	27.2	21.7	30.7	34.9	18.6	22.6	40.3	30.9	36.4	37.7	22.3	31.8	28.2	16.7	32.9	27.4	44.7	46.9	26.3	51.0	18.1	46.1	27.6	39.1	23.7	23.7	66.4	65.0	79.4	78.8	85.2	53.0	64.6	73.6	69.1	70.9	54.8	44.0	55.2	27.6	59.7	101.2	73.4	96.3	80.6	59.1	48.8	30.9	61.4	55.8	56.7	63.5	43.8	49.7	44.4
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744481-42746096	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035073, HPA035074"	Approved		Supported	Cytosol				Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	5.8	6.1	8.6	9.4	8.0	19.0	6.2	10.9	15.7	7.6	7.6	7.9	6.9	7.4	8.7	7.1	6.4	8.5	8.5	8.0	6.6	7.1	7.0	5.6	5.9	14.1	7.7	8.4	8.0	7.8	3.0	7.3	7.2	10.9	6.9	5.0	6.0	7.4	6.8	13.5	8.7	7.9	5.5	6.6	8.5	7.4	8.4	6.6	9.4	7.8	4.1	10.0	7.7	6.6	31.6	46.3	54.8	30.2	52.1	48.8	49.5	17.1	5.7	8.8	16.3	12.7	8.6	11.6	11.9	13.4	13.2	14.5	8.8	6.8	15.6	9.6	11.5	15.1	11.8	11.8	7.4	8.4	12.9	8.1	8.4	14.8	14.5	8.8	13.3	14.0	14.4	10.2	8.5	10.4	18.5	14.2	11.7	21.1	7.2	17.0	8.2	15.7	7.3	10.6	10.1	12.5	9.4	33.9	14.7	7.7	13.4	20.3	14.6	30.1	11.1	12.7	11.4	10.2	16.2	18.9	21.1	26.2	6.2	12.1	12.1	37.6	30.2	54.8	37.2	25.3	37.7	31.6	39.4	40.3	27.3	30.7	46.1	42.6	53.4	52.1	22.6	46.3	48.8	49.5	8.6	8.0	10.9	15.7	6.6	7.1	7.7	8.4	10.9	6.6
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64451880-64502108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA045797: , HPA060211: "	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	19.1	23.3	13.7	16.8	17.1	32.3	19.1	17.8	20.5	14.9	18.3	10.0	14.1	18.0	17.0	15.1	15.3	13.8	15.6	11.7	14.7	15.6	15.4	20.8	17.8	18.3	20.2	13.6	15.6	11.1	13.1	27.2	40.6	21.1	16.3	12.9	10.1	15.0	18.3	24.8	12.1	21.4	17.2	18.8	24.6	14.5	27.9	16.9	3.4	13.3	12.6	16.7	18.4	19.6	9.7	8.2	22.5	11.9	16.3	11.8	5.9	13.4	15.5	8.8	12.9	15.8	16.0	19.5	14.8	21.5	13.9	13.3	8.7	8.2	18.9	12.9	16.0	12.7	11.4	12.4	16.5	17.3	10.8	20.2	11.2	12.0	17.4	20.6	25.3	12.0	11.4	13.9	13.4	18.5	15.5	27.5	17.9	16.5	0.6	16.2	17.7	9.1	9.6	9.8	18.2	15.2	24.5	7.4	10.7	19.5	20.0	14.3	20.5	15.0	17.1	12.6	12.2	10.1	14.4	17.4	30.3	18.4	15.9	11.4	16.2	22.5	7.3	16.6	11.0	11.9	11.8	9.7	8.0	11.0	8.2	7.6	2.8	7.1	15.1	16.3	10.6	1.9	9.5	5.9	13.7	17.1	17.8	20.5	14.7	15.6	20.2	13.6	21.1	16.9
TBL2	"DKFZP43N024, WBSCR13, WS-betaTRP"	ENSG00000106638	"Transducin beta like 2"	Q9Y4P3	7	73568932-73578791	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007477, HPA051533"			Supported	Cytosol	"Secreted in male reproductive system"			Cytosol		"HPA007477: AB_1080214, HPA051533: "	"unprognostic (9.04e-2)"	"unprognostic (6.61e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (4.93e-4)"	"unprognostic (2.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.88e-5)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	8.9	12.1	3.7	5.4	3.3	1.8	5.9	2.7	5.3	8.7	6.6	3.4	11.6	6.1	6.5	10.9	7.3	5.5	6.3	5.4	2.5	2.5	6.1	14.2	6.5	4.7	3.5	2.1	10.7	27.0	8.5	7.0	13.0	3.4	6.5	6.9	5.1	16.3	8.0	4.9	6.9	6.3	5.4	3.0	5.4	8.2	70.5	3.7	6.2	11.8	4.2	5.2	8.5	6.2	4.2	14.4	13.2	11.4	8.3	6.7	7.6	12.0	13.9	4.8	7.1	13.1	12.6	6.0	14.6	10.9	5.5	10.0	21.2	13.1	9.9	3.2	12.8	9.3	10.1	5.8	11.0	3.9	6.9	3.6	7.3	13.8	18.8	7.2	13.2	7.9	10.1	17.0	13.6	6.3	14.5	7.8	8.5	11.7	7.0	7.1	4.9	11.4	4.6	8.6	21.9	7.1	8.5	5.0	8.1	14.5	39.6	9.1	10.4	5.5	10.7	10.5	5.1	9.7	14.6	15.8	9.8	11.1	13.4	8.9	12.2	13.2	11.4	5.2	6.6	7.9	6.5	3.4	5.6	6.0	14.4	4.2	6.7	4.2	1.0	8.3	7.0	10.8	6.5	7.6	3.7	3.3	2.7	5.3	2.5	2.5	3.5	2.1	3.4	3.7
TBL3	"SAZD, UTP13"	ENSG00000183751	"Transducin beta like 3"	Q12788	16	1972037-1982933	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042562, HPA055695"	Enhanced	Supported	Enhanced	Nucleoli				Nucleoli		"HPA042562: AB_10964911, HPA055695: "	"unprognostic (1.96e-1)"	"unprognostic (5.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.67e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.32e-2)"	"prognostic favourable (7.33e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.77e-1)"	8.9	7.9	6.0	9.5	8.3	6.0	5.8	16.3	9.6	6.2	6.8	8.8	6.8	7.7	7.1	6.3	9.4	5.4	6.0	7.5	6.6	6.1	7.2	8.7	6.9	7.2	7.0	7.3	7.7	8.9	10.5	5.5	7.3	5.7	5.7	3.6	5.6	10.5	6.0	18.2	9.5	7.8	5.9	4.8	6.7	9.5	20.5	6.5	9.5	7.2	11.5	9.3	5.1	5.4	8.5	11.2	5.8	12.0	14.8	12.1	8.5	5.5	10.7	3.0	5.8	2.9	2.3	9.7	5.1	3.3	4.4	3.6	13.7	10.7	7.3	12.1	3.9	15.0	4.8	6.0	2.3	5.4	6.8	4.6	5.4	5.2	3.3	8.0	4.4	2.4	4.5	5.5	3.3	5.5	9.3	5.5	2.6	8.9	10.2	4.5	7.0	4.4	17.8	5.5	12.3	2.2	2.1	6.9	5.4	4.6	11.9	4.4	9.0	5.4	8.6	6.1	7.3	5.4	9.9	9.9	4.3	11.6	3.6	5.1	7.0	4.8	10.2	5.8	12.1	12.0	10.7	7.5	8.9	11.8	11.2	8.5	11.4	8.6	2.5	14.8	11.7	5.7	9.6	8.5	6.0	8.3	16.3	9.6	6.6	6.1	7.0	7.3	5.7	6.5
TBP	"GTF2D1, SCA17, TFIID"	ENSG00000112592	"TATA-box binding protein"	P20226	6	170554302-170572870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009442, HPA049805"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009442: AB_632480, HPA049805: "	"unprognostic (2.86e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.55e-3)"	"unprognostic (7.10e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (1.51e-7)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	11.9	12.3	10.2	14.9	15.8	18.4	13.1	18.1	19.3	13.9	12.7	17.5	15.2	11.4	16.1	12.1	13.3	14.0	11.7	11.5	10.3	10.5	12.3	12.4	11.8	16.8	11.5	13.8	17.3	14.0	10.1	13.2	20.0	18.0	13.1	12.1	14.4	13.7	15.5	14.5	14.5	14.7	13.9	11.7	17.7	13.2	51.4	9.9	15.7	13.7	11.7	15.9	13.1	13.1	32.0	26.3	30.8	25.6	19.6	31.9	12.4	7.4	8.3	14.7	18.3	7.8	8.7	13.7	12.2	9.0	11.7	12.3	16.5	7.5	15.4	9.7	9.5	11.1	18.7	9.9	13.1	17.8	12.9	16.1	9.5	14.3	10.6	18.2	13.9	8.7	11.2	13.8	15.5	8.9	27.5	9.7	10.4	11.7	18.6	18.4	15.0	6.3	16.3	11.9	13.5	8.8	3.9	6.0	14.2	14.2	10.6	9.5	7.5	23.3	10.3	8.2	11.9	13.5	18.3	14.6	19.6	24.8	11.2	15.7	13.1	30.8	19.9	23.5	25.0	19.4	28.9	30.9	24.3	25.1	18.5	32.0	31.9	26.6	28.6	19.6	25.6	26.3	22.0	12.4	10.2	15.8	18.1	19.3	10.3	10.5	11.5	13.8	18.0	9.9
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA071810: , HPA071813: "	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favourable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavourable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	7.1	7.7	10.8	8.9	11.7	19.3	12.2	16.4	16.6	7.3	7.3	5.2	7.8	8.1	7.9	5.6	7.1	8.5	7.4	7.9	15.9	14.2	5.7	8.5	6.6	12.0	10.0	11.8	8.3	6.0	4.7	8.2	9.2	11.1	8.0	9.3	4.6	5.7	9.2	4.4	5.9	7.7	7.2	8.5	7.6	7.2	71.2	8.0	11.7	10.7	5.0	10.2	9.2	12.0	27.8	14.7	43.1	14.9	21.1	30.8	25.3	6.2	7.6	17.6	11.4	13.5	13.9	9.9	11.8	12.6	15.9	20.9	9.0	5.0	19.4	8.2	9.4	8.2	11.2	12.8	19.2	14.8	13.9	34.1	4.6	9.8	13.7	17.8	13.3	8.6	13.1	17.7	19.3	15.0	49.2	13.4	11.3	14.2	14.9	10.7	19.6	10.0	10.4	10.6	7.4	9.3	5.6	22.9	22.8	7.0	9.2	14.6	4.2	7.2	13.5	9.1	13.3	20.1	13.0	10.8	11.7	12.6	15.3	11.7	10.9	43.1	13.7	32.7	28.5	13.8	30.8	27.8	24.1	29.9	12.4	25.0	23.4	27.3	31.4	21.1	14.9	14.7	24.6	25.3	10.8	11.7	16.4	16.6	15.9	14.2	10.0	11.8	11.1	8.0
TBRG1	"FLJ14621, NIAM, TB-5"	ENSG00000154144	"Transforming growth factor beta regulator 1"	Q3YBR2	11	124622836-124635398	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055645, HPA068022"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA055645: , HPA068022: "	"unprognostic (1.64e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.13e-3)"	13.3	16.0	13.8	15.9	24.8	7.9	9.8	10.3	33.1	9.2	10.9	13.6	8.0	18.7	10.2	14.4	11.0	8.8	11.8	8.7	12.8	9.3	12.9	17.5	14.0	17.1	15.3	18.0	9.4	17.2	11.4	12.7	12.2	15.8	12.9	15.3	8.3	12.1	10.7	18.9	16.0	17.3	9.5	12.2	19.0	15.2	7.4	16.5	7.6	13.4	6.6	16.3	10.8	9.3	24.2	17.7	25.5	19.5	11.1	22.6	9.3	4.9	4.1	4.6	4.2	8.5	6.3	4.3	9.4	5.8	3.1	3.4	6.9	4.1	6.1	5.9	6.5	8.4	5.4	7.0	5.4	4.2	5.0	23.8	2.1	5.5	7.6	11.3	22.8	6.4	12.5	4.4	6.3	5.2	9.1	6.1	7.7	2.5	4.9	9.4	5.7	6.3	3.2	5.6	3.5	5.5	5.2	3.1	4.9	4.2	5.9	5.6	9.0	6.7	9.9	8.3	2.6	5.2	5.6	4.7	5.3	6.8	4.4	10.8	5.4	20.5	19.5	25.5	20.4	17.6	15.6	22.5	20.9	17.3	11.5	24.2	22.6	18.0	24.9	11.1	15.5	17.7	19.5	9.3	13.8	24.8	10.3	33.1	12.8	9.3	15.3	18.0	15.8	16.5
TBRG4	"Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948"	ENSG00000136270	"Transforming growth factor beta regulator 4"	Q969Z0	7	45100100-45112047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020582, HPA050430"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA020582: AB_1857804, HPA050430: "	"unprognostic (2.22e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-3)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.53e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.66e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.52e-1)"	13.7	16.8	10.8	16.0	15.6	14.9	13.0	12.9	22.1	10.5	20.8	15.6	14.1	21.8	14.2	8.2	20.1	12.8	12.4	26.2	9.8	10.0	20.9	27.7	10.5	17.0	10.6	8.9	15.6	16.9	11.3	10.1	16.2	14.7	13.6	14.1	10.8	14.2	12.4	42.6	16.9	17.8	13.9	9.9	16.2	14.0	22.5	9.5	15.0	13.8	23.7	20.3	14.5	13.3	15.8	20.1	10.9	24.2	9.7	21.0	17.5	12.9	30.1	9.6	21.1	8.7	8.1	19.4	10.5	9.7	20.4	16.9	32.5	18.3	24.7	16.2	10.7	33.9	22.3	23.9	10.4	12.8	20.9	17.0	19.7	22.2	14.6	19.3	17.5	10.7	22.2	19.4	14.0	12.5	46.9	12.5	12.4	21.8	19.6	44.2	30.5	24.0	17.4	12.4	36.0	11.9	13.3	19.1	18.1	10.7	59.6	20.7	26.6	32.1	9.7	15.2	18.4	9.2	17.0	22.4	22.4	36.2	14.0	27.8	34.1	7.4	13.3	10.9	18.4	24.2	17.6	15.8	15.4	17.8	20.1	12.3	21.0	19.9	1.0	9.7	20.4	7.5	14.6	17.5	10.8	15.6	12.9	22.1	9.8	10.0	10.6	8.9	14.7	9.5
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box 3"	O15119	12	114670254-114684164	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 117.7"	"Cell line enhanced"	"Detected in many"		"BJ: 33.8;BJ hTERT+: 32.2;RT4: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favourable (3.28e-4)"	4.3	60.5	0.9	3.3	1.9	0.0	19.9	0.7	2.3	18.2	12.2	1.7	69.6	14.2	13.1	18.7	1.9	7.5	5.0	6.2	1.2	1.5	4.1	15.1	12.6	0.8	1.2	0.5	15.6	1.1	0.3	5.3	67.8	1.6	32.3	1.5	2.6	7.3	117.7	4.2	4.8	19.4	9.7	1.4	2.6	2.2	3.5	1.2	0.5	36.3	7.3	3.5	24.6	25.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	5.9	0.0	0.0	8.9	12.3	13.4	33.8	32.2	13.1	13.0	5.3	1.4	0.0	0.5	5.8	1.5	2.8	1.2	16.2	0.0	4.0	0.0	1.5	15.4	2.9	0.0	0.0	5.4	0.8	4.4	9.1	0.1	1.2	0.0	1.1	0.5	0.0	0.1	0.0	1.8	0.0	0.0	0.8	0.0	42.2	2.2	6.5	4.8	2.2	1.1	1.6	0.0	0.0	4.0	2.6	2.2	10.9	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.7	2.3	1.2	1.5	1.2	0.5	1.6	1.2
TBXA2R		ENSG00000006638	"Thromboxane A2 receptor"	P21731	19	3594506-3606840	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 11.7;U-2197: 8.4;U-937: 7.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 12.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA077366			Supported	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Nuclear speckles"	"HPA077366: "	"unprognostic (1.59e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.17e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.25e-2)"	"prognostic favourable (7.17e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (4.32e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.02e-1)"	8.7	11.8	1.4	3.9	1.6	2.1	3.9	0.5	1.6	13.5	3.8	1.7	3.9	2.6	7.4	4.8	8.0	4.7	6.0	6.8	2.4	1.5	10.1	18.4	6.7	7.3	1.4	1.9	8.3	2.2	2.5	1.7	10.6	2.7	3.6	1.4	5.0	1.7	4.2	3.1	1.8	4.4	6.5	2.1	14.9	3.7	3.4	1.9	2.2	3.9	3.2	1.8	6.8	9.6	12.6	0.3	3.2	0.4	3.1	9.6	3.9	0.1	0.2	0.2	4.1	0.9	2.2	0.7	2.9	0.7	2.3	1.8	0.1	0.3	0.1	4.3	1.2	0.1	0.8	0.0	0.8	0.2	1.0	2.8	11.7	0.3	1.2	0.0	5.2	1.1	0.0	3.0	0.0	0.9	4.4	0.4	0.4	0.2	0.2	1.5	0.1	2.5	0.1	0.0	0.2	0.0	0.1	0.2	1.7	0.2	0.4	0.1	1.8	5.0	2.5	4.7	1.0	8.4	2.8	0.2	0.3	0.2	3.9	7.2	1.1	2.9	0.4	0.2	2.6	0.2	0.3	1.8	0.8	2.3	0.0	12.6	4.6	9.6	3.2	3.1	0.2	0.3	0.2	3.9	1.4	1.6	0.5	1.6	2.4	1.5	1.4	1.9	2.7	1.9
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.2;pituitary gland: 5.0"	"Cell line enriched"	"Detected in some"	4	"HeLa: 18.1"	"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.0"	"Group enriched"	"Detected in some"	24	"naive B-cell: 2.3;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"B-cells: 2.3;NK-cells: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.3	0.0	0.1	2.0	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.2	5.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.4	0.0	1.9	0.0	0.0	1.2	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.9	0.1	0.0	0.0	3.0	0.0
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.0;HUVEC TERT2: 9.6;TIME: 15.2;U-87 MG: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavourable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	3.1	2.7	1.5	5.8	2.7	5.8	8.4	2.0	4.0	5.2	1.8	0.6	2.0	1.8	6.1	2.1	13.1	2.2	3.5	3.5	2.3	1.9	3.1	6.4	7.1	12.4	1.6	1.2	4.2	3.2	2.1	3.8	8.1	2.8	5.5	1.6	1.7	5.7	9.2	2.1	6.7	3.5	5.0	4.7	4.0	3.1	2.2	2.0	7.3	2.3	7.6	7.0	8.0	12.1	2.6	1.0	7.0	0.4	3.5	6.5	1.3	4.7	0.3	0.3	0.3	0.9	0.9	1.9	1.5	2.6	0.6	1.9	0.2	0.5	0.3	2.0	1.2	0.9	0.1	2.4	2.1	9.0	0.5	0.8	0.7	0.2	1.1	0.3	0.6	2.5	1.1	0.3	0.9	9.6	2.6	4.7	4.1	0.8	0.6	0.9	0.3	2.4	0.4	2.0	2.2	0.0	1.9	0.3	0.2	0.5	3.4	0.3	1.8	0.3	15.2	1.4	1.0	5.2	0.4	7.5	2.4	0.2	13.2	0.5	2.7	7.0	0.4	0.4	4.0	0.4	4.2	2.6	6.5	4.1	0.3	2.5	5.8	4.6	1.6	3.5	0.3	1.0	6.2	1.3	1.5	2.7	2.0	4.0	2.3	1.9	1.6	1.2	2.8	2.0
TCAF2C		ENSG00000283528	"TRPM8 channel associated factor 2C"		7	143639230-143647646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	4	"blood: 2.2;parathyroid gland: 1.9;placenta: 1.3"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;U-266/70: 3.9;U-266/84: 1.8"									"Cell type enhanced"	"Detected in some"		"basophil: 2.2;T-reg: 1.8"	"Low lineage specificity"	"Detected in many"											"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"																		0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.9		1.3		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.1	0.0			0.0		0.0	0.0		0.6	0.0	2.2	0.0	0.0	1.8	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.1										
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	26.7	25.3	30.7	40.5	31.5	29.6	31.1	26.1	27.4	26.0	28.3	21.9	26.6	20.3	27.3	20.9	27.5	23.6	24.7	21.4	27.8	24.2	26.5	56.8	22.3	39.2	29.7	17.6	28.5	38.4	32.2	28.7	21.1	27.1	31.3	22.5	20.6	25.4	25.4	21.8	22.8	22.4	38.9	36.8	30.0	26.1	17.3	31.3	39.9	54.6	18.6	46.9	39.6	37.3	60.0	31.9	20.5	17.8	25.2	40.1	17.8	26.8	27.2	24.3	25.0	17.3	21.5	17.4	21.3	25.0	25.2	28.2	15.5	22.5	65.9	24.3	24.4	20.7	30.7	19.5	36.8	37.7	15.4	49.8	13.3	22.9	54.3	19.5	21.5	15.4	52.8	23.7	104.8	21.5	31.6	57.3	22.9	12.7	40.4	13.7	39.6	8.1	31.3	8.5	11.8	34.8	18.3	22.8	16.6	17.6	15.5	57.2	22.4	21.9	19.0	18.6	17.1	20.8	19.1	35.4	22.1	44.7	32.7	22.4	26.1	18.1	17.8	20.5	30.1	16.8	28.6	60.0	31.4	27.7	22.1	44.4	28.0	29.1	6.4	25.2	15.6	31.9	40.1	17.8	30.7	31.5	26.1	27.4	27.8	24.2	29.7	17.6	27.1	31.3
TCEA2	TFIIS	ENSG00000171703	"Transcription elongation factor A2"	Q15560	20	64049836-64072347	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043836	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA043836: "	"unprognostic (6.51e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.79e-1)"	14.8	19.5	31.4	7.9	32.8	6.6	9.3	34.7	40.4	18.3	11.7	17.7	11.0	5.6	18.8	10.9	8.4	24.5	13.5	19.1	27.7	30.0	14.8	27.5	10.9	9.2	27.2	32.8	30.3	16.1	18.6	17.9	14.7	26.5	16.9	3.2	14.5	17.9	22.3	30.7	10.4	7.8	11.7	18.3	16.2	10.5	32.0	18.9	8.7	15.0	6.1	5.2	10.9	15.4	9.7	3.0	4.4	2.6	3.6	5.5	1.6	7.5	8.2	13.1	22.2	11.7	7.3	5.3	7.9	8.8	14.0	6.7	4.8	13.4	8.6	17.8	9.1	20.2	5.2	6.7	2.7	5.3	10.3	3.2	14.3	12.6	17.4	3.6	4.6	11.3	6.0	3.6	4.6	9.5	5.6	16.2	4.2	16.5	14.7	17.5	8.4	19.8	14.3	9.9	22.2	7.0	5.0	12.9	21.8	8.0	5.5	19.8	15.0	9.0	13.5	25.2	13.3	14.2	4.8	18.9	12.4	4.6	22.4	4.2	5.0	2.4	1.7	4.4	3.6	1.6	1.6	9.7	3.2	2.6	2.1	5.0	5.5	3.4	0.8	3.6	2.6	3.0	5.4	1.6	31.4	32.8	34.7	37.6	27.7	30.0	27.2	32.8	26.5	18.9
TCEAL1	"p21, pp21, SIIR, WEX9"	ENSG00000172465	"Transcription elongation factor A like 1"	Q15170	X	103628704-103630953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057345, HPA060384"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA057345: , HPA060384: "	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.54e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.76e-2)"	10.5	24.7	23.8	9.1	20.8	4.2	19.5	19.9	45.1	29.6	17.1	5.5	29.7	7.3	45.8	20.2	18.4	32.1	17.6	13.5	27.0	18.6	10.6	7.5	10.1	7.8	12.2	25.3	59.1	9.0	13.5	11.2	8.5	19.9	25.4	8.4	6.1	6.4	40.3	22.4	8.1	8.7	49.2	23.5	9.3	13.3	9.3	13.2	3.1	15.5	10.5	4.7	33.9	24.7	18.3	16.6	11.3	8.4	13.4	14.7	8.2	9.6	9.3	5.3	7.2	22.9	15.9	7.0	13.7	13.9	13.5	14.7	4.1	9.6	4.5	14.2	17.7	9.7	8.8	7.2	10.0	0.0	10.9	6.0	13.0	7.9	10.3	0.0	9.2	19.4	14.1	10.4	5.7	13.8	2.2	2.5	26.9	10.6	5.3	0.1	1.7	15.1	5.5	17.0	0.0	18.5	9.6	7.3	6.1	14.0	6.6	15.1	6.2	5.7	10.9	9.8	3.6	22.8	7.0	2.5	8.0	0.1	12.8	0.0	9.7	11.3	8.4	0.5	10.4	5.7	14.7	18.3	9.4	8.6	16.6	16.1	12.5	14.3	0.9	13.4	2.3	13.0	8.0	8.2	23.8	20.8	19.9	45.1	27.0	18.6	12.2	25.3	19.9	13.2
TCEAL7	"MGC23947, WEX5"	ENSG00000182916	"Transcription elongation factor A like 7"	Q9BRU2	X	103330196-103332326	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 70.4"	"Cell line enhanced"	"Detected in some"		"AF22: 23.2;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;hTEC/SVTERT24-B: 23.2;LHCN-M2: 19.6;SCLC-21H: 58.6;U-87 MG: 21.8"	"Cancer enriched"	"Detected in many"	10	"glioma: 39.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051507, HPA065080"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA051507: , HPA065080: "	"unprognostic (1.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (4.31e-4)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.35e-3)"	4.9	22.1	31.7	3.8	33.4	1.0	7.8	33.0	70.4	16.8	6.4	20.1	1.8	3.9	36.4	14.7	5.1	5.4	9.7	9.5	31.1	44.2	4.6	2.6	3.8	2.5	34.4	27.4	23.2	1.3	1.3	14.0	2.5	51.8	10.3	6.9	2.0	2.9	11.3	2.9	1.5	4.9	23.3	45.1	5.0	2.6	3.2	19.4	0.0	3.0	2.2	1.9	7.5	5.7	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	23.2	0.0	10.2	15.8	4.1	3.3	17.0	7.3	20.9	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.4	12.6	0.0	0.2	0.1	0.0	0.0	5.1	0.0	0.0	13.2	0.0	23.2	0.0	7.5	0.1	0.0	19.6	0.0	0.0	0.0	0.1	0.0	0.0	14.7	0.0	0.0	0.0	58.6	15.7	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.4	0.1	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	31.7	33.4	33.0	46.7	31.1	44.2	34.4	27.4	51.8	19.4
TCERG1	"CA150, TAF2S, Urn1"	ENSG00000113649	"Transcription elongation regulator 1"	O14776	5	146447311-146511961	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064854, HPA069752, HPA069808"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA064854: , HPA069752: , HPA069808: "	"unprognostic (2.73e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavourable (5.34e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavourable (4.70e-11)"	"unprognostic (1.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.24e-3)"	15.7	12.1	16.8	20.9	28.1	34.2	16.7	36.3	22.7	14.2	15.3	13.7	10.1	15.3	19.6	13.9	18.6	17.5	14.8	14.5	16.3	12.7	10.7	10.0	14.7	23.8	12.4	19.1	20.5	12.6	14.4	18.5	17.8	17.2	15.0	16.4	13.0	16.1	19.0	34.9	19.0	15.2	17.5	12.7	16.6	16.8	19.5	14.9	21.9	14.7	14.9	23.9	18.7	16.5	6.5	10.5	2.6	11.6	10.5	8.3	5.8	19.4	14.4	22.4	15.3	6.2	9.8	28.3	14.8	12.0	16.5	19.5	23.3	20.7	33.6	11.1	12.0	17.4	27.1	18.5	25.3	19.8	21.7	22.2	16.3	14.1	6.6	32.6	17.4	6.8	11.0	15.8	17.4	14.5	25.8	12.4	12.6	13.9	28.4	18.4	22.2	16.4	27.9	26.4	22.3	10.3	15.3	14.6	18.0	16.4	17.5	10.7	18.6	16.5	16.1	14.4	16.9	12.2	22.8	12.9	14.2	45.2	13.5	28.0	16.1	1.0	6.4	2.6	6.7	9.6	7.9	6.5	7.8	8.3	10.5	6.0	8.2	8.1	0.5	10.5	11.6	5.4	6.9	5.8	16.8	28.1	36.3	22.7	16.3	12.7	12.4	19.1	17.2	14.9
TCF12	"bHLHb20, HEB, HsT17266, HTF4"	ENSG00000140262	"Transcription factor 12"	Q99081	15	56918623-57299281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 89.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004432, HPA065827"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"CAB004432: AB_671267, HPA065827: "	"unprognostic (1.19e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (7.26e-3)"	"unprognostic (5.57e-3)"	"prognostic unfavourable (5.24e-5)"	"unprognostic (2.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.41e-1)"	20.9	14.3	24.9	12.6	37.5	10.9	18.4	32.7	41.8	48.2	16.5	33.6	14.0	16.0	28.1	15.0	14.8	28.2	21.4	15.7	28.4	16.4	17.0	14.4	17.3	13.7	33.9	15.3	26.2	12.5	29.2	15.7	19.1	27.9	26.3	17.9	14.7	20.1	17.5	18.1	16.0	15.8	25.8	25.3	13.6	17.3	14.7	41.3	89.4	17.0	9.6	15.8	23.3	21.2	11.8	15.9	16.0	19.3	12.2	17.6	10.2	6.5	12.3	54.2	17.5	24.7	21.7	9.5	13.5	23.8	12.0	16.0	8.0	5.3	9.0	11.1	20.4	7.9	21.2	9.7	15.4	11.8	7.9	18.1	13.4	9.5	17.1	11.3	9.5	19.1	17.6	11.0	29.2	21.4	20.2	11.4	16.3	2.2	26.7	6.3	14.6	5.3	36.6	63.0	8.4	16.5	12.2	11.1	32.1	14.6	5.3	13.1	8.2	22.3	16.5	19.4	14.8	8.2	19.7	6.5	11.6	15.0	10.8	22.1	23.1	16.0	11.2	8.7	15.0	14.3	12.4	10.8	12.2	13.6	15.9	11.8	14.1	12.7	1.3	12.2	19.3	6.6	17.6	10.2	24.9	37.5	32.7	26.9	28.4	16.4	33.9	15.3	27.9	41.3
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0"	"Cell line enhanced"	"Detected in some"		"HEL: 10.7;HMC-1: 17.6;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA050998: , HPA060221: "	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	8.4	0.3	0.9	0.4	1.0	0.2	11.4	0.1	1.1	0.6	1.3	0.1	0.0	0.4	0.8	0.3	1.7	0.4	0.7	19.4	1.2	0.7	0.5	0.3	0.9	0.3	1.0	0.0	0.2	0.1	0.4	0.3	8.2	0.7	1.0	0.3	0.3	0.8	0.3	18.0	0.2	0.4	1.3	1.1	0.2	0.4	1.6	0.6	0.2	1.3	6.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.5	0.0	0.0	0.0	3.0	10.7	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.0	1.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	1.1	1.2	0.7	1.0	0.0	0.7	0.6
TCF20	"AR1, SPBP"	ENSG00000100207	"Transcription factor 20"	Q9UGU0	22	42160013-42343616	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB017849, HPA036786"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB017849: , HPA036786: "	"unprognostic (2.17e-1)"	"unprognostic (2.12e-2)"	"prognostic favourable (1.88e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (4.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.07e-3)"	"unprognostic (4.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	4.1	4.3	10.2	5.5	16.4	5.4	4.6	6.6	17.1	5.4	5.6	22.6	4.4	5.7	6.1	4.3	10.9	5.6	4.2	2.7	7.3	5.4	4.9	4.6	4.7	6.5	14.7	14.6	5.7	6.7	6.9	10.2	4.3	10.5	4.4	6.1	9.9	6.5	4.2	3.1	8.5	6.4	4.6	5.8	5.5	6.0	9.3	12.2	3.5	9.2	2.3	7.5	5.5	6.8	0.3	0.3	0.9	0.3	0.0	0.5	0.0	6.3	3.6	5.5	4.9	2.9	2.6	5.6	2.9	3.5	3.4	4.5	5.3	2.6	10.7	2.7	2.5	6.4	5.3	5.9	4.3	7.6	4.2	3.0	3.9	3.6	3.1	7.0	4.1	2.3	5.9	3.8	7.6	2.6	4.5	5.6	1.9	5.7	7.1	3.8	4.0	3.0	4.0	3.1	5.6	3.4	5.9	5.4	2.2	5.0	4.8	4.9	2.6	4.3	3.2	4.3	7.0	2.6	3.3	4.6	5.6	5.4	2.7	4.4	2.9	0.0	0.1	0.0	0.4	0.0	0.4	0.2	0.5	0.1	0.0	0.3	0.5	0.4	0.9	0.0	0.3	0.3	0.3	0.0	10.2	16.4	6.6	17.1	7.3	5.4	14.7	14.6	10.5	12.2
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652605	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 95.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB018351: AB_675504, HPA049808: , HPA062476: "	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	13.0	8.8	12.8	31.6	9.8	33.2	17.4	8.3	11.9	15.5	16.2	11.9	9.4	18.1	16.6	11.3	16.7	12.1	19.0	9.4	11.2	6.2	11.9	8.9	13.2	42.0	10.7	6.0	18.2	13.5	6.3	13.9	10.8	11.0	17.1	9.7	12.4	13.6	6.9	11.2	16.7	23.0	8.8	10.4	33.1	14.9	36.0	11.2	63.2	15.9	11.6	38.0	15.2	13.9	11.3	12.1	2.9	2.8	2.3	4.2	1.6	15.7	8.1	22.3	19.9	3.2	8.5	9.9	9.8	7.7	11.2	10.0	15.9	12.4	75.4	11.1	8.0	16.3	13.6	10.6	6.6	45.6	9.0	7.1	10.2	17.4	7.3	17.3	10.0	5.4	12.3	8.8	6.8	13.5	29.1	26.1	7.1	27.7	47.8	16.9	30.9	8.5	75.0	10.2	17.0	7.5	13.8	21.2	29.8	9.2	9.2	11.3	11.6	30.9	16.2	14.8	17.5	18.2	16.6	63.8	31.1	95.0	9.6	22.1	13.2	2.9	1.3	0.9	3.5	1.4	3.7	10.8	2.2	3.2	2.7	11.3	3.2	4.2	0.4	2.3	2.8	12.1	2.1	1.6	12.8	9.8	8.3	11.9	11.2	6.2	10.7	6.0	11.0	11.2
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222331-55664787	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease mutation, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.5;SH-SY5Y: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"memory B-cell: 29.7;naive B-cell: 22.0;plasmacytoid DC: 85.8"	"Group enriched"	"Detected in many"	36	"B-cells: 29.7;dendritic cells: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavourable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavourable (9.95e-4)"	34.6	16.0	20.3	14.4	17.0	10.7	23.5	48.7	32.4	35.4	13.5	14.9	12.0	6.6	27.4	9.6	12.5	16.9	20.4	19.9	23.5	11.9	6.0	6.2	21.9	16.8	16.7	20.3	31.8	7.2	16.2	15.7	32.8	16.1	9.5	10.1	9.2	9.4	13.2	12.1	12.2	10.7	28.4	15.0	14.6	7.4	17.0	17.5	6.4	16.4	12.7	17.0	18.3	14.5	29.7	85.8	0.3	1.2	1.5	0.1	1.7	0.0	1.1	11.7	3.6	2.8	4.9	0.0	5.9	13.1	4.2	5.6	7.3	1.1	9.0	0.0	13.0	1.5	5.4	5.2	2.9	41.5	4.1	3.5	0.0	0.0	1.3	1.5	0.9	6.4	1.6	5.9	0.2	15.3	5.8	6.8	3.6	0.0	2.2	0.0	3.5	0.7	13.2	4.9	20.1	0.0	0.2	4.2	52.7	0.0	0.5	0.0	0.5	0.4	15.4	16.0	5.6	0.6	4.6	5.1	9.6	8.0	3.5	1.6	4.6	0.1	1.1	0.1	0.1	1.2	0.1	29.7	0.0	0.0	3.3	22.0	0.0	0.0	0.3	1.5	1.1	85.8	0.1	1.7	20.3	17.0	48.7	26.9	23.5	11.9	16.7	20.3	16.1	17.5
TCF7	TCF-1	ENSG00000081059	"Transcription factor 7"	P36402	5	134114711-134151865	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 326.1"	"Cell line enriched"	"Detected in many"	15	"MOLT-4: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2"	"Group enriched"	"Detected in many"	19	"NK-cells: 14.2;T-cells: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019403, HPA058863, HPA070505"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB019403: AB_2199302, HPA058863: , HPA070505: "	"unprognostic (3.63e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.10e-2)"	1.8	3.6	1.3	21.8	1.5	5.2	3.1	0.9	1.2	2.1	3.3	2.5	2.2	5.6	1.4	16.3	2.7	16.1	2.6	1.6	1.5	1.2	2.7	3.7	4.0	41.8	1.3	1.0	2.5	7.2	0.2	6.1	1.4	4.7	2.9	2.3	3.6	7.9	1.8	0.9	2.9	15.1	0.9	3.3	14.4	3.7	2.4	1.1	326.1	4.4	2.2	32.5	3.3	1.5	1.2	0.1	1.0	0.1	14.2	35.8	6.9	0.0	1.0	1.1	3.8	0.5	2.1	1.5	0.3	0.5	0.1	0.1	7.9	2.5	0.0	1.9	1.7	0.1	1.7	0.4	0.0	0.3	1.6	0.0	1.0	5.9	0.0	0.0	0.2	0.1	0.0	1.6	0.0	0.2	1.0	0.0	0.1	0.0	166.9	0.1	1.2	1.4	0.2	0.0	0.1	0.4	0.1	0.4	3.3	0.8	0.2	0.2	0.2	0.9	0.2	10.8	0.0	4.9	0.3	0.1	0.0	0.0	5.7	0.0	0.5	0.7	0.1	1.0	4.4	0.0	10.3	1.2	17.8	10.4	0.0	0.4	35.8	21.8	0.7	14.2	0.0	0.1	2.1	6.9	1.3	1.5	0.9	1.2	1.5	1.2	1.3	1.0	4.7	1.1
TCF7L1	TCF3	ENSG00000152284	"Transcription factor 7 like 1"	Q9HCS4	2	85133410-85310388	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 17.9;NTERA-2: 41.8;RH-30: 19.0;T-47d: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071298			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA071298: "	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (6.16e-5)"	"unprognostic (1.79e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (2.06e-4)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (5.38e-4)"	21.0	3.9	3.3	6.5	6.4	4.2	28.7	5.1	5.3	28.2	14.7	7.5	14.5	4.1	21.2	11.8	13.8	10.4	9.1	11.6	6.0	3.0	9.3	7.6	11.1	5.5	4.5	3.8	20.3	3.2	11.6	5.7	4.8	6.3	14.0	4.3	16.8	8.8	19.6	13.4	8.3	6.9	17.8	5.9	7.9	6.8	7.3	5.5	2.2	18.6	8.7	6.1	18.0	20.4	3.7	2.0	8.4	1.2	1.8	2.2	0.4	0.9	0.7	14.2	10.8	5.4	1.1	8.7	1.0	3.5	2.4	2.3	2.1	0.9	0.4	1.7	2.3	2.2	10.8	17.9	1.7	0.8	1.7	0.3	0.8	0.9	0.5	0.8	2.1	0.9	3.3	0.2	0.6	4.7	0.3	0.8	2.8	0.6	0.0	0.8	41.8	0.3	0.3	19.0	0.2	1.1	1.6	0.4	4.4	1.6	7.2	0.5	18.6	0.3	5.1	2.8	4.1	0.2	1.3	0.5	0.2	0.3	0.1	0.5	2.2	8.4	1.2	2.2	1.2	1.0	1.5	2.1	1.4	1.6	0.4	3.7	1.7	2.2	3.4	1.8	1.0	2.0	1.1	0.4	3.3	6.4	5.1	4.0	6.0	3.0	4.5	3.8	6.3	5.5
TCFL5	"bHLHe82, CHA, E2BP-1, Figlb"	ENSG00000101190	"Transcription factor like 5"	Q9UL49	20	62841115-62861763	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.9;testis: 55.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055223	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA055223: AB_2682745"	"unprognostic (4.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (3.24e-4)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.01e-2)"	5.4	3.9	18.6	4.0	18.9	3.7	6.4	4.6	14.8	6.5	4.1	22.5	6.1	3.2	5.7	6.6	6.0	5.9	5.0	5.5	20.0	15.5	5.0	4.6	3.6	4.7	25.4	10.7	8.3	4.8	7.5	3.0	4.8	17.0	4.9	3.8	6.3	4.9	6.3	4.5	10.9	3.5	5.5	32.9	4.1	3.7	55.7	12.0	8.3	14.9	2.1	5.0	4.6	3.2	1.4	1.9	2.9	1.6	1.2	3.2	0.7	12.7	3.8	8.5	9.7	18.2	18.5	7.5	8.2	11.4	16.1	9.0	9.4	7.8	6.4	9.5	7.2	14.0	8.4	9.3	14.1	4.5	7.0	5.3	11.0	13.7	7.2	7.7	6.4	6.8	13.9	4.5	9.5	7.3	5.9	2.4	7.4	15.4	34.0	9.8	5.5	12.1	18.8	14.8	9.0	4.3	3.7	12.2	6.6	14.6	5.9	22.2	10.1	14.5	7.7	12.9	8.4	11.1	9.6	6.3	4.2	5.4	7.7	9.7	7.0	0.5	1.6	2.9	3.2	1.5	1.9	1.3	2.3	2.1	1.2	1.4	2.5	1.7	2.8	1.2	1.5	1.9	2.3	0.7	18.6	18.9	4.6	14.8	20.0	15.5	25.4	10.7	17.0	12.0
TCHP	"MGC10854, TpMs"	ENSG00000139437	"Trichoplein keratin filament binding"	Q9BT92	12	109900264-109983841	"Predicted intracellular proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038638, HPA061543"	Supported		Supported	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA038638: AB_10670785, HPA061543: "	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.52e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	8.6	10.4	16.0	11.3	29.3	8.3	9.3	22.9	25.0	10.2	11.2	19.0	7.5	9.9	13.0	10.9	18.3	8.7	8.3	10.3	15.9	11.0	8.5	7.0	10.0	14.5	23.8	13.9	11.3	12.7	12.1	12.1	10.4	18.6	10.7	9.6	11.0	13.4	11.6	10.8	36.1	10.2	15.0	15.9	15.0	10.2	12.5	24.2	10.9	12.0	7.7	15.1	11.4	15.4	3.2	3.3	4.5	5.2	9.2	7.4	4.4	16.3	14.6	7.9	9.5	7.0	7.6	10.7	15.5	8.3	13.6	7.6	9.2	5.8	23.0	4.6	9.1	13.8	8.6	9.8	12.3	12.3	8.5	16.6	9.1	8.9	8.5	22.5	12.8	6.2	12.0	14.3	10.8	12.1	17.9	4.7	11.2	11.2	20.5	22.9	9.5	14.9	18.9	15.6	19.4	6.2	14.7	11.8	12.4	11.4	12.3	11.0	11.1	16.4	13.4	14.0	9.7	8.9	19.8	13.4	17.0	16.5	14.9	18.7	14.5	0.0	4.2	3.4	6.2	2.7	4.3	3.2	5.4	7.4	3.3	2.3	5.4	4.2	4.5	9.2	5.2	2.4	7.2	4.4	16.0	29.3	22.9	25.0	15.9	11.0	23.8	13.9	18.6	24.2
TCL1A	TCL1	ENSG00000100721	"T cell leukemia/lymphoma 1A"	P56279	14	95709967-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"blood: 179.4;lymphoid tissue: 63.7"	"Group enriched"	"Detected in some"	157	"Daudi: 69.4;REH: 90.3;U-698: 92.2"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	381	"memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8"	"Group enriched"	"Detected in many"	487	"B-cells: 179.4;dendritic cells: 79.8"					"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	0.4	0.2	0.2	53.4	0.2	4.8	0.3	0.2	0.2	0.2	0.9	0.0	0.2	0.0	0.3	0.0	0.8	0.3	0.6	0.3	0.2	0.2	1.1	0.4	3.2	63.7	0.2	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.4	0.2	0.1	2.9	0.0	0.2	0.2	10.4	0.1	0.2	33.5	0.5	5.3	0.0	4.7	0.8	1.2	53.6	3.6	0.3	179.4	79.8	0.2	0.1	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.5	92.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	45.6	0.0	0.0	0.1	179.4	0.1	0.0	0.2	0.0	0.1	79.8	0.0	6.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TCOF1	"TCS, treacle"	ENSG00000070814	"Treacle ribosome biogenesis factor 1"	Q13428	5	150357639-150400308	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033199, HPA038237, HPA038238"	Enhanced		Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"CAB033199: AB_1130042, HPA038237: AB_10670660, HPA038238: AB_10671524"	"unprognostic (7.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.18e-3)"	"unprognostic (9.40e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (2.62e-5)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-1)"	15.9	11.7	15.0	21.2	17.5	17.8	13.1	16.6	23.6	12.6	18.1	12.5	10.3	10.7	18.3	13.6	16.8	14.4	12.9	18.0	14.3	12.0	11.7	9.6	12.4	24.2	20.3	17.7	16.7	14.5	16.4	13.9	15.0	17.0	15.2	13.3	10.2	15.0	17.0	19.1	18.6	14.4	17.4	12.6	19.4	14.0	14.7	18.1	25.8	13.6	12.0	23.1	18.0	15.5	5.9	3.0	1.9	2.8	11.5	7.0	3.7	21.4	24.0	12.3	23.2	4.8	6.4	33.4	16.9	6.8	23.0	23.4	59.3	17.0	31.5	15.5	6.2	25.2	26.8	30.3	16.9	16.5	28.9	15.4	15.9	22.4	5.1	25.3	11.9	5.3	7.1	27.3	21.0	10.2	22.0	9.5	7.9	19.6	27.5	18.7	37.3	23.1	25.0	19.5	18.3	5.6	15.3	16.9	17.4	19.6	32.0	15.4	14.3	10.1	9.9	17.4	21.6	20.8	31.7	11.8	14.7	34.6	13.7	21.9	15.5	1.8	2.8	1.4	5.6	2.7	7.0	5.8	5.1	5.3	2.7	5.9	4.3	4.6	1.9	11.5	2.7	3.0	3.3	3.7	15.0	17.5	16.6	23.6	14.3	12.0	20.3	17.7	17.0	18.1
TCP11L2	MGC40368	ENSG00000166046	"T-complex 11 like 2"	Q8N4U5	12	106301929-106347015	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 32.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039483, HPA042188"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA039483: AB_10795291, HPA042188: AB_10794415"	"unprognostic (1.41e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.97e-1)"	"prognostic favourable (9.52e-4)"	"unprognostic (3.87e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.05e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.67e-1)"	9.1	12.0	8.1	6.2	18.2	22.3	9.0	10.4	13.0	9.7	8.6	31.5	3.3	6.2	10.3	7.1	20.1	11.6	8.1	18.9	8.3	5.8	6.1	5.6	14.4	12.9	22.2	9.4	9.7	8.6	11.1	7.2	12.3	16.2	7.5	7.9	9.5	15.9	5.9	18.0	14.0	10.3	10.2	14.6	10.2	10.2	8.7	18.4	16.4	12.2	6.3	14.0	11.3	11.8	6.2	0.8	32.1	3.2	1.9	6.3	1.7	2.6	6.6	1.0	1.9	9.2	10.7	4.2	1.7	8.6	1.1	2.8	1.0	3.6	0.9	2.7	6.7	12.6	0.8	3.7	2.0	1.4	2.8	0.5	2.5	4.0	9.0	0.3	1.8	13.4	8.7	1.3	6.5	6.2	1.6	1.3	1.5	1.9	1.6	1.4	1.2	4.2	0.8	0.2	3.0	8.7	12.5	4.2	3.1	4.5	1.4	5.2	3.9	0.3	4.7	1.6	1.4	2.4	0.4	8.4	0.6	3.2	4.6	0.2	0.8	10.8	3.2	4.9	2.4	1.4	1.8	6.2	4.9	2.7	0.8	5.7	6.3	4.1	32.1	1.9	2.2	0.6	5.6	1.7	8.1	18.2	10.4	13.0	8.3	5.8	22.2	9.4	16.2	18.4
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965804-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA052263: "	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavourable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	12.3	16.6	7.0	17.9	11.1	15.9	12.8	10.7	13.4	17.7	14.7	10.0	11.3	11.0	15.8	17.8	23.8	12.4	12.8	12.0	7.7	6.9	13.4	17.4	13.7	19.7	8.7	7.9	14.4	13.2	11.0	21.0	27.9	10.8	13.0	16.8	10.9	13.2	11.3	11.1	16.3	18.7	17.8	8.8	19.8	13.1	5.8	8.1	33.4	12.4	15.3	19.6	13.3	14.7	18.9	41.4	18.8	24.3	14.2	13.6	7.2	13.2	6.7	21.2	12.3	5.3	4.7	21.4	10.0	4.1	14.0	7.9	11.4	6.0	31.2	6.1	8.3	8.8	25.3	11.8	11.1	12.7	20.5	24.5	10.1	5.1	4.9	30.4	18.6	5.5	15.7	10.4	8.4	13.7	27.3	5.2	6.8	13.8	33.9	17.1	25.7	10.8	35.0	10.9	11.1	15.4	19.6	28.0	19.4	12.2	14.3	8.9	22.9	16.4	8.3	4.4	7.2	4.6	11.8	11.4	15.1	26.8	4.8	16.4	8.4	18.5	24.3	18.8	13.6	16.3	10.3	17.7	13.0	11.2	14.9	18.9	13.5	12.1	16.0	14.2	15.9	41.4	12.6	7.2	7.0	11.1	10.7	13.4	7.7	6.9	8.7	7.9	10.8	8.1
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044768	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA071317: "	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavourable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	6.3	6.9	10.8	10.4	11.4	8.3	11.0	10.8	6.6	7.1	7.3	8.4	5.9	9.1	5.6	11.1	8.8	6.2	3.5	5.5	6.3	6.8	5.9	5.5	16.1	6.2	8.1	6.8	7.0	5.5	11.0	7.5	6.3	5.7	9.6	6.1	8.1	4.2	3.1	7.7	7.9	5.8	5.7	11.7	7.0	23.3	3.7	29.8	4.5	4.4	21.0	7.6	7.0	16.4	11.2	15.5	10.6	16.3	23.2	10.7	13.7	7.8	17.5	15.9	4.4	6.1	13.9	13.3	10.9	16.4	15.0	5.6	14.9	17.6	10.0	9.0	14.2	7.7	12.3	24.0	17.8	8.3	17.8	7.2	6.9	3.8	29.7	10.3	4.4	5.5	11.5	10.8	20.7	12.2	18.5	19.4	14.5	22.7	16.0	4.2	18.5	17.3	33.1	13.9	10.5	11.3	13.1	9.0	11.3	33.0	4.2	13.1	12.7	16.5	7.2	6.8	9.8	11.8	13.6	23.7	21.5	15.3	13.4	10.3	15.5	6.6	10.7	14.5	10.6	14.3	16.4	15.7	16.3	10.4	13.5	17.7	18.2	4.5	16.3	9.7	11.2	23.2	10.7	6.9	10.4	11.0	10.8	5.5	6.3	6.2	8.1	6.3	3.7
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649977-24667033	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.3;intestine: 55.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.6;neutrophil: 57.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: "	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favourable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.47e-5)"	6.8	4.8	8.2	15.4	9.2	3.7	5.6	10.8	7.5	6.1	36.0	3.7	4.9	25.8	4.9	5.2	4.9	4.5	6.2	8.1	6.8	6.9	16.4	10.4	6.5	7.1	7.7	6.3	5.7	5.9	4.4	9.4	5.7	6.5	12.3	27.9	3.6	4.9	4.8	5.0	4.8	55.7	6.1	5.8	6.3	5.1	21.1	5.7	8.2	5.3	4.1	7.3	9.6	7.0	5.3	3.3	57.3	3.9	6.9	8.3	5.7	17.7	14.1	16.1	18.6	25.0	25.6	12.6	15.8	20.3	15.1	20.4	19.3	10.1	21.4	27.8	16.5	13.1	19.6	18.0	20.7	27.3	20.5	20.0	15.0	31.5	15.9	30.6	19.3	17.1	17.0	15.8	14.3	24.4	17.8	9.2	22.7	12.6	23.8	19.6	14.4	12.2	20.7	17.0	22.9	26.0	25.2	20.4	11.7	12.9	32.7	25.8	15.0	17.8	18.2	14.8	12.3	11.0	23.0	13.3	39.1	29.2	10.2	40.4	23.6	15.6	3.5	7.1	6.9	3.7	8.3	5.3	8.0	7.5	3.3	3.5	6.6	7.2	57.3	6.9	3.9	3.1	7.9	5.7	8.2	9.2	10.8	7.5	6.8	6.9	7.7	6.3	6.5	5.7
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: "	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favourable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	13.7	12.0	13.0	10.3	14.7	6.9	16.9	13.8	14.2	16.7	17.2	11.7	14.2	12.9	15.2	14.2	16.5	14.4	12.7	16.7	12.9	10.6	16.2	13.5	16.9	11.3	13.5	14.8	20.6	21.3	15.3	15.4	12.4	17.7	15.5	15.5	11.1	12.5	14.8	42.4	15.2	16.7	19.0	16.8	12.9	14.8	15.9	15.0	18.7	16.9	18.6	12.1	19.0	15.4	3.8	7.2	2.3	3.5	3.0	6.9	2.1	4.4	4.9	10.9	25.4	4.4	9.5	6.4	5.1	5.8	6.0	3.9	3.2	7.4	10.9	2.1	7.5	6.3	8.9	7.5	6.5	8.1	6.8	20.2	9.4	6.2	8.5	14.2	10.6	6.4	10.7	3.5	10.6	8.1	4.5	6.6	6.4	4.8	12.6	7.4	8.3	3.8	6.7	5.2	7.2	8.1	5.9	9.6	11.6	7.3	9.0	18.4	4.6	6.2	6.8	3.8	3.9	4.3	5.6	13.3	11.5	9.4	3.6	7.4	11.6	0.5	2.3	2.3	5.5	3.5	3.8	3.8	6.2	6.2	3.3	2.7	5.2	6.4	0.1	3.0	2.5	7.2	6.9	2.1	13.0	14.7	13.8	14.2	12.9	10.6	13.5	14.8	17.7	15.0
TDRD7	PCTAIRE2BP	ENSG00000196116	"Tudor domain containing 7"	Q8NHU6	9	97411950-97496125	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.0;THP-1: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB020800, HPA022250, HPA024529"	Enhanced		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Cytoplasmic bodies"	Nucleoplasm	"CAB020800: , HPA022250: , HPA024529: AB_1857869"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavourable (5.91e-4)"	"unprognostic (2.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"prognostic favourable (4.76e-5)"	"unprognostic (4.03e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.67e-1)"	9.5	7.1	10.6	9.1	11.5	8.9	7.7	7.1	10.2	8.8	12.8	8.9	3.7	14.0	9.8	6.0	10.5	8.2	9.2	5.7	8.6	6.6	6.4	7.3	9.8	7.0	10.2	8.8	8.3	9.7	12.5	9.3	7.9	11.6	7.1	12.7	19.0	8.8	7.0	5.1	6.1	16.5	9.6	12.6	8.8	7.6	31.1	9.8	9.3	7.3	4.7	7.3	12.1	8.6	4.3	4.6	9.8	6.1	1.6	2.9	1.8	8.0	5.6	0.0	1.9	4.3	5.7	4.8	5.1	12.9	17.6	19.8	7.2	6.8	0.5	2.5	7.2	6.2	4.7	2.6	4.7	26.0	4.0	3.6	2.8	5.2	4.0	8.2	8.9	1.9	5.2	5.8	0.6	7.6	2.0	0.4	4.6	4.8	4.0	4.0	0.8	3.0	1.8	2.9	0.1	4.3	5.4	0.9	2.3	7.1	3.2	19.4	1.9	25.8	7.7	2.2	2.2	5.6	3.9	2.7	3.1	0.5	5.2	4.5	5.7	2.4	3.1	9.8	1.7	6.1	2.4	4.3	2.4	1.8	4.6	3.4	1.8	2.9	5.7	1.6	5.8	0.9	1.6	1.8	10.6	11.5	7.1	10.2	8.6	6.6	10.2	8.8	11.6	9.8
TDRP	"C8orf42, INM01, TDRP1, TDRP2"	ENSG00000180190	"Testis development related protein"	Q86YL5	8	489792-545781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 41.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;HBEC3-KT: 14.2;hTCEpi: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA008462	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA008462: AB_1845777"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (9.37e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.46e-4)"	"unprognostic (2.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-1)"	5.7	9.0	7.7	6.1	13.1	0.5	11.0	10.4	9.2	8.5	4.9	3.6	8.4	2.3	9.4	9.8	5.7	12.9	9.9	3.7	7.4	10.3	14.3	9.4	9.6	3.9	6.3	3.6	13.0	13.7	15.2	11.1	41.9	8.4	12.5	2.8	17.7	6.2	12.3	2.3	3.3	2.8	5.0	4.6	2.6	3.6	8.1	3.2	3.0	22.7	3.2	6.3	9.9	12.8	0.4	0.0	0.0	0.1	0.0	0.2	1.1	4.9	5.0	8.8	0.0	0.0	0.0	29.5	2.9	1.8	2.7	2.5	0.0	0.0	0.0	1.2	0.9	1.1	0.0	14.2	3.5	0.0	0.4	0.0	0.0	7.4	3.4	0.0	2.1	3.4	11.3	0.0	5.3	0.4	0.6	0.0	2.9	0.0	0.0	0.0	10.4	1.0	0.0	0.0	0.0	9.1	7.4	2.6	4.2	0.0	8.9	2.1	2.9	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	7.7	13.1	10.4	7.5	7.4	10.3	6.3	3.6	8.4	3.2
TEAD1	"AA, TCF13, TEF-1"	ENSG00000187079	"TEA domain transcription factor 1"	P28347	11	12674591-12944483	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057339, HPA062471"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA057339: , HPA062471: "	"unprognostic (1.00e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.40e-3)"	"unprognostic (8.39e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.18e-2)"	16.3	6.6	8.2	6.7	6.6	0.0	23.5	7.8	7.7	13.6	12.6	7.3	9.5	4.1	14.1	7.9	16.4	11.4	10.9	16.5	10.6	4.2	13.1	8.4	8.2	1.9	8.0	4.9	12.1	8.6	25.2	18.5	17.5	7.9	13.9	6.7	11.9	8.8	10.4	41.4	7.5	7.3	21.4	7.2	4.1	9.1	5.9	8.2	0.2	9.6	12.8	5.0	22.2	20.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	21.8	21.6	16.5	19.2	18.2	19.0	28.4	30.1	23.1	23.3	21.7	20.2	19.2	0.1	8.2	35.6	12.5	19.0	11.3	36.5	0.0	7.4	0.0	36.5	6.2	17.1	0.0	1.7	16.3	5.7	16.9	21.2	4.6	9.6	0.0	32.7	4.2	0.0	0.1	6.1	8.6	0.1	22.4	10.7	15.2	14.0	9.1	10.8	31.7	14.8	18.5	7.2	1.4	10.3	33.8	27.0	27.7	20.4	3.1	6.5	4.0	13.3	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.6	7.8	7.7	10.6	4.2	8.0	4.9	7.9	8.2
TEAD2	"ETF, TEF-4, TEF4"	ENSG00000074219	"TEA domain transcription factor 2"	Q15562	19	49340595-49362457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 42.2;AN3-CA: 45.6;HUVEC TERT2: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 4.1;naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	27	"B-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066292, HPA069963"			Supported	Nucleoplasm				Nucleoplasm		"HPA066292: , HPA069963: "	"unprognostic (2.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavourable (8.66e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.78e-2)"	17.6	8.1	4.5	9.3	4.3	0.0	19.5	2.1	3.4	21.7	21.6	3.9	11.6	3.9	20.2	12.4	12.8	14.4	12.8	25.6	4.1	1.5	11.3	18.3	19.9	8.7	5.6	1.8	25.2	18.1	4.9	4.5	10.5	5.2	19.0	6.3	19.0	10.0	13.6	6.1	4.8	8.1	21.8	7.5	11.8	14.7	10.9	3.2	1.8	9.5	8.9	5.1	16.3	26.4	5.2	0.0	0.0	0.1	0.0	0.1	0.1	3.7	8.7	42.2	45.6	4.5	6.7	7.5	6.9	7.4	8.0	9.4	0.7	2.1	0.3	9.3	11.7	4.2	11.6	2.3	4.4	0.0	5.3	0.0	8.3	5.7	7.9	0.0	0.1	7.9	5.5	5.4	2.6	28.4	6.4	0.0	11.2	4.6	0.0	0.0	14.2	11.1	0.0	12.7	0.0	7.3	0.0	0.0	25.7	11.6	1.7	3.0	12.5	1.0	16.7	14.5	9.0	3.0	0.5	0.0	0.0	1.4	0.5	0.1	5.6	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	4.3	2.1	3.4	4.1	1.5	5.6	1.8	5.2	3.2
TEAD4	"EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1"	ENSG00000197905	"TEA domain transcription factor 4"	Q15561	12	2959330-3040673	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 60.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 84.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 78.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.5"	"Low region specificity"	"Detected in all"			HPA056896	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA056896: "	"unprognostic (3.68e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.21e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (9.78e-9)"	"unprognostic (5.05e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-3)"	7.6	1.9	1.2	4.5	1.8	0.5	11.1	2.0	2.5	3.6	3.1	0.7	7.4	3.2	4.4	5.1	4.2	3.1	4.3	9.7	1.4	1.1	9.2	5.5	10.3	5.3	2.4	0.4	4.4	27.5	1.1	1.5	6.8	3.2	3.8	2.9	3.9	3.5	7.1	60.1	6.2	5.2	5.7	1.9	7.2	3.6	2.2	1.4	0.5	16.4	13.3	2.5	3.1	10.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.4	11.9	3.0	8.5	0.9	2.1	32.8	6.8	3.6	11.8	6.6	22.8	9.1	0.0	5.3	5.1	12.2	11.9	84.7	11.0	0.0	9.6	13.4	9.9	19.7	4.6	2.8	2.5	2.9	3.5	10.2	15.8	10.0	8.6	0.1	4.0	12.0	0.1	0.0	23.4	7.1	6.2	17.4	6.5	5.5	3.5	1.7	3.1	8.4	21.2	6.2	14.4	5.0	11.4	6.8	24.0	4.7	3.5	0.0	0.0	0.0	5.5	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	2.0	2.5	1.4	1.1	2.4	0.4	3.2	1.4
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269864	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 10.4;HMC-1: 16.4;U-266/70: 16.3;U-266/84: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 13.3;eosinophil: 11.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: "	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favourable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	3.9	4.5	0.8	7.2	1.1	9.8	5.1	0.6	2.0	3.4	4.8	0.5	8.4	2.8	3.0	21.6	9.5	3.6	2.1	3.3	0.9	0.9	4.0	5.7	6.4	7.0	1.5	0.3	2.9	2.9	2.6	6.4	2.0	3.2	2.0	2.5	3.0	6.8	4.7	2.1	8.1	6.5	3.0	1.2	6.7	2.2	5.5	0.6	4.4	4.4	5.8	11.1	3.2	6.5	0.9	1.3	13.3	0.6	2.9	0.4	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.4	1.8	1.0	2.2	0.0	1.7	1.5	1.6	0.0	0.5	0.9	0.0	1.5	0.1	0.7	10.4	0.7	0.1	0.0	1.7	16.4	0.0	0.2	1.4	0.0	0.0	5.7	0.4	3.2	0.7	1.0	3.7	0.3	0.7	2.4	2.2	0.0	2.8	0.7	0.0	0.2	0.5	0.2	0.4	0.6	3.3	0.0	0.0	0.0	2.2	0.0	16.3	11.6	2.1	0.0	2.3	0.1	13.3	0.5	11.0	0.1	0.6	0.3	0.9	0.1	0.4	1.3	0.6	0.4	0.4	0.4	2.9	0.1	0.1	0.0	0.3	0.8	1.1	0.6	2.0	0.9	0.9	1.5	0.3	3.2	0.6
TECPR1	"DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358"	ENSG00000205356	"Tectonin beta-propeller repeat containing 1"	Q7Z6L1	7	98214624-98252251	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 63.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021061	Approved		Supported	Vesicles				Vesicles		"HPA021061: AB_1847687"	"unprognostic (8.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"prognostic favourable (8.12e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.12e-2)"	6.5	4.7	11.5	8.9	10.6	5.2	6.3	9.0	15.8	4.1	5.9	6.2	5.1	8.4	4.5	5.5	5.8	4.8	7.6	5.9	10.4	9.0	4.6	5.4	9.0	11.0	6.8	12.8	4.0	63.9	4.2	10.2	7.7	9.8	6.9	4.9	8.0	29.5	5.0	6.9	5.4	8.1	4.6	8.5	11.2	9.3	3.3	7.0	6.4	5.9	5.9	6.4	5.1	5.4	3.4	4.1	6.1	7.4	1.6	8.7	3.1	2.9	4.1	5.8	12.5	5.1	3.0	4.3	6.2	3.4	4.9	6.0	3.9	3.7	2.4	10.0	7.1	1.9	3.9	2.9	2.1	5.8	5.6	3.5	5.8	4.2	6.0	4.2	6.9	5.3	2.3	4.7	3.7	17.2	2.3	13.8	3.7	4.8	6.1	4.5	2.3	4.0	5.1	5.9	17.3	3.7	3.2	10.5	11.7	3.6	11.0	5.7	3.3	6.1	17.6	4.7	8.1	12.0	5.1	17.6	6.3	1.2	9.8	3.7	8.7	2.6	4.7	1.4	3.9	5.2	2.4	3.4	5.1	3.1	2.9	3.2	8.7	7.2	6.1	1.6	7.4	4.1	5.1	3.1	11.5	10.6	9.0	15.8	10.4	9.0	6.8	12.8	9.8	7.0
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (2.60e-4)"	32.8	43.2	45.0	15.0	43.7	23.0	26.2	51.7	70.8	34.9	26.1	64.5	40.1	37.8	16.5	38.2	89.6	32.4	19.0	22.3	42.9	38.3	29.0	45.9	20.7	17.8	45.6	34.7	25.0	37.0	95.0	20.9	68.5	50.4	23.9	21.7	34.5	69.8	42.0	121.4	89.5	34.8	13.8	53.3	20.0	24.5	59.6	40.2	29.8	33.5	40.7	49.5	18.3	43.8	21.7	30.2	10.7	22.8	34.3	60.6	32.7	38.8	29.0	27.7	31.2	40.5	18.5	29.3	11.3	32.2	36.6	45.6	38.5	45.0	20.9	23.9	23.8	60.6	29.2	46.2	14.8	34.2	25.1	35.5	43.5	42.4	24.4	25.1	27.1	27.4	37.0	32.2	17.7	17.2	22.7	72.1	18.7	48.9	29.5	43.8	29.0	31.4	27.5	18.1	92.4	49.7	21.0	34.6	21.2	19.0	51.2	24.3	27.5	49.8	10.0	29.4	12.7	25.5	38.2	22.1	21.1	21.5	30.2	37.9	29.3	9.2	16.0	10.7	32.0	22.8	34.7	21.7	42.0	36.6	27.3	21.0	49.2	38.8	7.2	34.3	17.1	30.2	60.6	32.7	45.0	43.7	51.7	70.8	42.9	38.3	45.6	34.7	50.4	40.2
TEFM	"C17orf42, FLJ22729"	ENSG00000172171	"Transcription elongation factor, mitochondrial"	Q96QE5	17	30897336-30906820	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023788, HPA053044"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA023788: AB_1848818, HPA053044: "	"unprognostic (1.22e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (9.20e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.37e-3)"	7.0	9.6	11.8	10.2	13.7	4.0	11.1	23.3	16.6	7.5	8.1	7.4	7.2	10.6	8.6	9.6	9.7	7.6	6.8	12.7	10.1	6.9	13.0	12.3	6.9	10.0	15.4	8.5	10.5	7.3	10.8	16.8	10.4	10.6	10.6	10.3	8.6	7.9	10.4	7.7	8.5	9.1	9.6	11.0	13.7	7.4	5.7	13.3	8.6	10.7	6.7	9.8	7.9	11.8	6.7	6.4	4.9	10.0	4.3	6.7	4.8	6.0	9.7	5.8	7.3	4.5	5.8	5.0	5.9	5.0	13.4	11.2	6.4	2.9	7.7	5.9	4.4	8.6	10.7	4.3	11.7	2.4	13.4	3.7	9.7	6.4	4.8	6.7	4.8	4.4	5.1	7.7	3.0	5.7	8.3	7.0	8.8	4.3	5.8	9.9	4.4	5.0	3.0	10.2	6.1	10.0	5.7	9.9	3.0	5.4	4.3	5.1	9.7	4.6	3.9	5.2	6.1	5.9	5.7	3.4	5.6	5.4	4.2	5.6	5.1	3.5	6.6	4.9	4.6	10.0	5.8	6.7	5.6	4.2	6.4	6.4	6.7	6.6	1.9	4.3	7.3	5.8	5.7	4.8	11.8	13.7	23.3	16.6	10.1	6.9	15.4	8.5	10.6	13.3
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 35.8;NTERA-2: 17.8;TIME: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	7750000	8300000	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: "	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favourable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favourable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13.0	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4.0	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3.0	5.3	10.6	5.3	23.4	4.0	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.0	0.0	0.6	0.0	0.0	0.7	0.0	0.8	0.3	35.8	0.0	0.0	0.3	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5
TEKT5	"CT149, FLJ32871"	ENSG00000153060	"Tektin 5"	Q96M29	16	10627501-10694945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"testis: 30.4"	"Cell line enriched"	"Detected in some"	13	"BEWO: 16.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043578			Supported	"Actin filaments"				"Actin filaments"		"HPA043578: AB_10795772"	"unprognostic (5.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.24e-7)"	"unprognostic (3.80e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.12e-5)"	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.9	30.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.9	0.2	0.4	0.1	0.2	1.3	0.3	0.0	0.2	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.1	0.1	0.1
TELO2	"hCLK2, KIAA0683, TEL2"	ENSG00000100726	"Telomere maintenance 2"	Q9Y4R8	16	1493344-1510457	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041348, HPA041473"	Approved		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA041348: AB_10794514, HPA041473: AB_10795593"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.15e-3)"	13.8	11.7	9.2	14.2	9.0	19.3	14.3	21.9	14.9	11.1	11.3	15.7	11.4	17.3	11.7	14.8	12.9	11.8	13.4	9.6	9.9	9.1	9.6	11.1	8.8	14.4	10.2	15.9	12.1	18.5	8.6	10.3	12.1	10.9	12.3	3.6	11.1	18.6	11.0	18.9	23.5	16.2	10.4	8.3	20.7	14.0	9.0	10.4	17.3	10.6	11.2	14.8	10.6	10.5	8.3	8.2	3.2	11.4	3.8	5.1	5.0	8.1	12.2	3.8	7.2	1.5	1.6	14.7	13.0	2.5	6.3	4.6	15.6	7.8	12.0	11.3	2.0	8.6	2.7	4.9	1.2	7.0	23.6	6.9	14.1	9.0	2.5	8.7	10.4	3.1	1.9	5.8	1.2	3.7	17.7	4.3	2.5	27.5	10.2	23.3	12.2	10.3	30.6	5.3	12.2	2.3	7.7	16.0	9.0	11.2	10.7	4.0	9.9	10.5	5.8	13.7	9.6	13.2	10.7	7.9	5.0	21.9	4.3	12.3	11.4	0.0	6.8	3.2	5.1	8.6	5.1	5.4	3.6	4.3	8.2	8.3	4.2	3.2	0.5	3.8	11.4	5.0	3.3	5.0	9.2	9.0	21.9	14.9	9.9	9.1	10.2	15.9	10.9	10.4
TEN1	"C17orf106, FLJ39785"	ENSG00000257949	"TEN1, CST complex subunit"	Q86WV5	17	75979220-76000586	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA065069			Supported	Nucleoplasm				Nucleoplasm		"HPA065069: "	"unprognostic (1.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.85e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.85e-4)"	8.8	12.1	7.3	11.9	9.1	17.2	11.4	9.6	8.6	8.8	11.7	7.7	19.3	14.7	7.2	9.4	17.4	9.9	12.8	6.4	7.1	6.2	11.8	18.5	10.6	17.2	9.4	8.1	8.2	15.6	4.6	11.2	13.0	8.5	13.1	5.5	8.6	20.3	17.5	5.2	21.1	15.8	5.4	6.5	13.0	10.8	7.3	9.7	4.6	10.1	13.6	12.3	15.3	13.5	30.2	28.8	35.5	30.0	22.3	22.6	19.8	9.2	9.2	6.6	8.3	8.2	10.7	19.3	6.5	8.6	10.5	10.8	9.2	15.7	11.8	10.3	7.1	9.7	4.2	9.1	3.0	6.5	14.7	14.6	11.5	9.8	9.7	8.9	23.1	9.7	12.5	5.9	5.9	13.8	6.5	11.8	6.0	16.0	11.1	21.9	6.5	13.5	11.1	6.3	11.0	12.9	16.3	12.2	22.5	4.7	39.9	7.6	22.2	14.6	8.2	22.0	13.1	9.8	13.2	14.0	5.2	7.1	11.1	6.8	6.7	35.5	30.0	17.0	22.6	26.6	18.6	30.2	18.3	19.2	26.3	25.8	14.2	16.7	18.1	22.3	14.7	28.8	19.3	19.8	7.3	9.1	9.6	8.6	7.1	6.2	9.4	8.1	8.5	9.7
TEP1	"p240, TLP1, TP1, TROVE1, VAULT2"	ENSG00000129566	"Telomerase associated protein 1"	Q99973	14	20365667-20413429	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029206			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA029206: AB_10601271"	"unprognostic (4.53e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"prognostic favourable (9.58e-4)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.00e-1)"	14.7	10.4	5.4	22.0	8.7	4.5	11.4	5.8	6.6	8.9	24.1	11.2	7.7	27.7	12.9	11.3	9.4	7.9	15.7	9.3	6.3	3.5	9.4	9.2	14.1	15.0	7.7	3.0	9.2	8.7	28.2	11.7	7.0	7.3	10.8	18.1	8.1	11.4	8.3	13.4	10.0	38.3	10.9	12.2	19.5	11.1	3.6	8.7	14.2	11.2	6.6	20.8	9.7	10.9	4.2	8.3	7.8	4.4	0.9	1.8	0.5	7.3	2.9	3.4	3.6	20.7	8.6	5.8	4.9	4.6	3.0	4.2	6.3	7.7	5.7	3.4	14.0	7.2	2.7	9.9	5.3	7.2	2.8	6.9	6.4	4.2	6.2	5.7	12.6	12.0	9.4	6.2	4.8	14.0	2.4	4.6	11.0	4.4	4.3	4.0	1.3	2.7	9.5	8.1	2.0	10.2	10.5	1.0	1.4	3.9	10.1	3.2	5.5	3.9	14.3	12.0	8.5	4.4	1.4	10.3	5.9	3.7	2.8	5.4	4.4	4.1	4.0	0.2	1.8	4.4	1.7	2.9	0.8	1.6	1.3	4.2	0.9	1.1	7.8	0.9	4.4	8.3	1.3	0.5	5.4	8.7	5.8	6.6	6.3	3.5	7.7	3.0	7.3	8.7
TEPSIN	"C17orf56, ENTHD2, FLJ31528"	ENSG00000167302	"TEPSIN, adaptor related protein complex 4 accessory protein"	Q96N21	17	81228277-81239091	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063410			Supported	"Nuclear membrane,Nuclear speckles,Golgi apparatus"				"Nuclear membrane, Nuclear speckles, Golgi apparatus"		"HPA063410: "	"unprognostic (6.90e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (1.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.29e-1)"	"prognostic favourable (6.95e-4)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (7.31e-8)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.16e-3)"	8.5	6.7	8.0	11.9	8.5	17.3	21.3	11.9	9.8	6.0	9.9	9.0	7.3	14.9	7.9	8.6	8.8	8.0	6.6	4.9	8.8	4.7	9.8	13.3	12.5	13.5	12.5	6.3	6.8	11.1	5.3	9.2	7.7	9.8	10.1	6.5	4.8	9.1	9.3	12.4	15.8	12.4	9.8	8.5	17.0	9.7	9.1	9.8	12.2	12.6	7.5	9.0	7.2	7.0	3.0	2.7	7.6	2.9	0.7	1.8	1.2	8.7	12.9	5.0	8.1	3.5	5.8	10.0	7.8	4.4	7.8	7.2	8.3	6.2	6.3	4.4	5.2	11.4	5.2	6.6	3.8	3.8	17.1	5.2	7.2	11.9	5.2	5.6	10.9	3.0	8.6	3.6	4.1	12.4	6.4	6.2	5.0	7.6	10.5	13.0	5.5	11.1	6.6	6.6	6.9	3.0	5.6	6.7	7.8	9.3	10.2	10.7	6.9	10.1	7.9	10.6	6.1	8.1	7.4	8.4	5.8	4.7	7.8	4.8	5.2	4.2	2.4	7.6	1.8	2.9	1.1	2.5	1.2	1.4	2.7	3.0	0.8	0.8	4.3	0.7	1.9	2.7	1.6	1.2	8.0	8.5	11.9	9.8	8.8	4.7	12.5	6.3	9.8	9.8
TERF2	"TRBF2, TRF2"	ENSG00000132604	"Telomeric repeat binding factor 2"	Q15554	16	69355561-69408571	"Predicted intracellular proteins"	"Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001907, HPA002735, CAB010451"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898"	"unprognostic (2.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	15.6	14.9	22.1	18.2	24.4	16.1	14.1	32.2	30.0	16.2	15.2	20.0	13.3	13.4	19.2	16.4	15.3	16.1	14.0	14.7	21.2	22.1	13.2	14.9	12.6	32.6	19.6	21.6	20.5	22.2	26.9	13.4	15.8	17.1	15.5	15.0	14.5	12.0	15.3	28.9	15.3	13.6	19.6	17.3	14.9	12.6	15.8	16.5	23.0	16.9	9.6	42.2	17.2	21.5	15.2	5.4	11.2	4.1	4.9	7.5	2.9	8.0	13.2	11.9	12.0	11.4	8.5	10.2	8.3	10.4	19.7	15.3	12.0	11.1	37.2	11.3	10.2	13.1	14.5	10.1	18.5	6.9	11.5	10.7	7.0	10.9	9.7	10.6	9.1	8.6	10.3	15.7	19.3	13.5	20.2	5.4	12.7	11.0	21.0	13.6	13.8	6.4	29.5	7.9	21.4	8.5	6.0	13.6	10.6	27.5	6.3	7.4	11.9	12.4	8.2	12.4	10.9	8.5	9.8	14.5	15.2	47.0	10.7	9.6	11.9	11.2	4.1	4.5	6.8	3.4	5.1	15.2	6.8	5.9	4.1	8.7	7.5	7.5	4.7	4.9	3.5	5.4	5.2	2.9	22.1	24.4	32.2	30.0	21.2	22.1	19.6	21.6	17.1	16.5
TERF2IP	RAP1	ENSG00000166848	"TERF2 interacting protein"	Q9NYB0	16	75647786-75761872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006719, CAB018660, CAB018749"	Supported		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267"	"unprognostic (3.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (6.14e-5)"	"prognostic favourable (1.46e-4)"	"unprognostic (1.81e-1)"	"prognostic favourable (2.15e-5)"	"unprognostic (6.26e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.99e-1)"	22.5	45.0	51.0	17.9	71.8	35.3	18.2	70.1	64.9	20.9	12.6	30.5	12.5	12.5	21.7	28.3	13.6	17.4	17.2	30.0	44.2	68.4	21.5	19.6	17.2	28.4	47.5	53.5	30.9	16.7	37.6	41.8	12.6	48.3	23.4	13.0	18.9	15.5	22.3	18.5	15.1	12.7	18.5	39.4	22.3	14.0	24.3	32.5	20.5	26.2	10.5	27.6	16.2	15.6	20.4	8.9	40.5	12.4	17.1	23.9	7.2	6.4	6.1	13.8	10.6	15.7	16.5	4.3	19.7	17.0	16.8	12.5	6.7	7.1	33.1	26.4	13.2	9.4	13.6	5.6	14.3	12.4	19.8	16.8	9.5	15.3	20.6	22.6	24.1	14.0	16.0	13.4	20.9	11.2	19.6	14.0	19.2	19.0	27.3	29.0	6.9	14.2	31.0	8.9	27.2	12.5	6.0	33.6	20.3	25.6	6.0	15.6	13.8	22.3	12.3	16.1	8.5	13.9	15.0	58.6	51.0	46.5	16.9	15.5	15.2	20.2	9.1	40.5	13.1	8.0	16.3	16.9	20.1	21.6	8.9	20.4	23.9	15.4	14.6	17.1	12.4	8.7	18.6	7.2	51.0	71.8	70.1	58.6	44.2	68.4	47.5	53.5	48.3	32.5
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295069	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 61.2;fHDF/TERT166: 58.1;HBEC3-KT: 118.1;hTEC/SVTERT24-B: 74.6;LHCN-M2: 33.7;TIME: 96.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: , HPA065897: "	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	7.1	0.9	3.4	0.0	0.0	0.2	0.1	1.1	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	1.0	0.4	5.0	0.0	12.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	30.6	61.2	0.5	0.0	23.3	4.2	7.9	0.1	0.1	0.7	0.0	58.1	0.0	0.2	118.1	5.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.0	3.0	74.6	0.8	0.2	0.6	0.1	33.7	0.0	0.2	1.6	0.4	0.2	0.8	0.0	0.8	3.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	96.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 50.9;hTCEpi: 57.6;SK-BR-3: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in some"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"				"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favourable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.2	5.1	5.8	0.0	2.6	6.6	13.7	12.7	6.2	2.3	2.3	12.8	27.0	0.0	50.9	8.8	24.9	3.1	18.6	5.8	12.0	10.0	2.4	12.0	6.3	15.6	11.0	0.0	14.8	57.6	8.2	20.9	6.6	2.4	8.6	0.6	5.0	0.0	0.1	3.8	14.7	0.0	0.0	9.5	24.0	9.3	2.7	25.2	18.5	57.8	14.0	0.0	4.5	11.2	0.1	0.3	18.7	0.1	20.3	9.8	0.2	1.6	5.6	19.2	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7
TESC	"CHP3, FLJ20607, TSC"	ENSG00000088992	Tescalcin	Q96BS2	12	117038923-117099479	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.8;salivary gland: 92.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.5;NB-4: 103.7;U-937: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 55.8"	"Lineage enriched"	"Detected in all"	5	"monocytes: 55.8"					"Low region specificity"	"Detected in all"			HPA053200	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053200: "	"unprognostic (4.53e-3)"	"unprognostic (5.98e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.67e-3)"	1.8	8.4	5.0	2.4	12.1	25.5	2.3	1.2	6.8	1.8	1.2	1.8	19.4	1.8	1.3	32.9	1.3	1.3	45.8	13.2	6.2	2.2	4.6	1.9	2.9	1.8	2.4	3.3	1.5	40.5	0.7	4.0	2.5	2.2	2.5	0.7	0.3	92.6	24.4	1.3	1.8	1.7	1.4	1.6	2.7	34.4	5.0	2.2	1.2	2.1	1.2	2.5	6.5	2.3	1.9	8.5	11.3	55.8	2.5	2.3	3.9	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	2.3	0.7	0.0	0.1	1.2	0.0	0.0	6.3	4.1	17.7	1.4	12.1	0.0	7.5	64.5	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.3	14.6	103.7	1.4	0.0	0.0	0.0	8.3	8.9	2.3	2.7	0.9	0.0	0.0	0.5	0.0	8.1	0.0	0.0	0.2	0.0	0.0	2.7	6.1	0.0	0.0	34.4	0.0	0.0	11.9	11.3	1.8	14.9	0.1	1.3	0.6	2.3	8.5	1.9	0.0	1.0	3.0	2.5	55.8	0.6	0.7	3.9	5.0	12.1	1.2	6.8	6.2	2.2	2.4	3.3	2.2	2.2
TESK2		ENSG00000070759	"Testis-specific kinase 2"	Q96S53	1	45343883-45491166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.0;RT4: 12.7;SK-MEL-30: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027257: AB_10602477, HPA063869: "	"unprognostic (2.95e-1)"	"prognostic favourable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	5.5	3.3	6.1	5.9	17.4	12.6	9.6	7.8	12.6	7.7	8.4	25.7	4.0	11.9	4.7	5.7	9.1	4.1	3.9	5.8	9.6	5.1	3.5	9.7	5.5	6.0	19.2	4.7	14.4	4.6	6.7	4.1	8.3	13.2	22.1	10.1	7.6	11.2	5.7	10.1	17.1	14.8	4.4	18.7	6.3	5.6	11.7	14.8	4.2	5.1	3.2	7.2	8.2	9.7	7.5	2.0	15.9	5.9	1.1	3.7	2.6	1.6	0.0	0.8	0.0	3.2	1.7	13.0	0.6	4.3	1.9	3.2	3.6	1.5	5.2	0.6	1.5	2.0	3.4	2.7	1.5	3.7	4.3	3.5	1.8	2.7	1.7	1.2	9.8	1.8	2.9	2.1	3.0	1.5	0.6	10.9	1.2	0.6	3.0	2.4	3.4	1.5	4.4	0.1	1.4	1.7	12.7	0.3	1.4	3.3	6.4	12.1	9.9	1.5	0.0	0.2	2.0	1.6	1.1	7.1	4.2	1.0	1.0	0.0	0.8	9.4	3.8	10.6	2.4	2.8	1.7	7.5	2.2	1.6	2.0	5.7	3.7	2.1	15.9	1.1	5.9	1.1	1.5	2.6	6.1	17.4	7.8	12.6	9.6	5.1	19.2	4.7	13.2	14.8
TESMIN	"CXCDC2, MTL5"	ENSG00000132749	"Testis expressed metallothionein like protein"	Q9Y4I5	11	68707440-68751564	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"testis: 81.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 10.5;T-47d: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA018539			Supported	Nucleoplasm				Nucleoplasm		"HPA018539: "	"unprognostic (1.99e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (3.22e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-1)"	0.3	0.5	0.3	1.6	1.4	4.8	3.3	0.1	0.6	0.6	1.9	0.0	3.8	1.0	0.5	1.2	1.3	1.3	1.0	0.4	0.2	0.9	3.2	0.3	0.4	0.9	0.6	0.4	0.8	2.6	2.6	1.9	0.4	1.8	1.7	2.2	0.6	2.5	5.2	0.1	0.5	1.2	0.3	0.7	1.2	0.6	81.0	0.1	5.5	1.5	0.9	2.0	0.5	0.7	0.4	0.1	2.8	1.1	0.0	1.1	0.4	6.0	2.7	1.1	0.0	0.0	0.0	3.1	1.4	0.6	1.9	0.9	0.8	6.1	2.4	1.4	0.2	2.9	0.9	1.2	1.5	2.5	2.1	1.7	0.9	0.0	0.0	1.3	10.5	0.0	3.3	0.1	2.0	0.6	3.8	4.7	0.3	4.0	0.6	3.5	6.4	2.7	1.6	0.3	0.7	2.2	0.1	3.9	4.2	0.0	1.3	0.0	20.7	8.5	2.3	0.2	0.4	0.1	0.1	1.9	1.6	2.4	0.1	3.6	1.6	0.0	1.0	1.0	0.3	0.4	0.6	0.0	1.1	0.2	0.1	0.4	0.4	0.3	2.8	0.0	1.1	0.1	0.8	0.4	0.3	1.4	0.1	0.6	0.2	0.9	0.6	0.4	1.8	0.1
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560656-68694482	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.1;HAP1: 17.2;K-562: 9.6;NTERA-2: 10.1"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: "	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	4.4	1.6	3.3	4.3	2.6	1.6	3.1	4.4	4.3	5.1	2.4	5.8	3.2	1.2	6.0	3.4	2.4	2.9	3.5	2.4	3.5	2.3	1.8	1.5	1.6	1.7	2.5	2.6	6.1	1.6	7.4	2.2	5.8	2.9	3.2	2.0	8.1	15.9	4.8	4.0	2.2	1.8	6.5	3.6	1.7	2.2	1.4	5.9	1.2	3.2	3.2	1.8	5.1	5.4	1.3	1.1	1.0	0.0	0.9	2.3	0.2	0.6	0.7	6.8	7.7	0.7	0.6	15.1	0.3	0.8	0.6	1.1	4.6	0.2	0.0	0.2	0.7	0.0	17.2	0.0	0.7	0.2	2.7	1.8	0.0	4.0	1.0	1.5	0.9	0.9	0.1	0.4	0.0	0.1	9.6	1.2	0.6	0.5	2.7	1.2	10.1	0.9	2.6	2.2	0.2	0.3	0.7	1.9	3.0	0.3	0.4	1.4	0.9	1.2	0.2	0.6	1.4	0.0	0.5	0.5	0.5	2.7	0.1	0.0	0.1	0.0	0.0	1.0	1.5	0.0	2.0	1.3	0.8	1.3	0.2	0.5	1.4	1.1	0.0	0.9	0.0	1.1	2.3	0.2	3.3	2.6	4.4	2.6	3.5	2.3	2.5	2.6	2.9	5.9
TFAM	"TCF6, TCF6L2"	ENSG00000108064	"Transcription factor A, mitochondrial"	Q00059	10	58385022-58399221	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040648, HPA063684"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA040648: AB_10795635, HPA063684: AB_2685089"	"unprognostic (5.30e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.34e-3)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.24e-2)"	"prognostic favourable (2.74e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.39e-2)"	"prognostic favourable (2.22e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.76e-2)"	19.3	21.2	11.1	21.0	12.1	28.5	15.3	15.4	13.9	16.8	21.0	7.7	12.5	17.6	20.7	12.1	17.4	15.3	11.0	15.9	10.2	11.2	22.4	31.4	11.5	21.5	12.5	10.7	18.4	14.3	12.3	23.9	22.2	12.9	17.2	14.7	9.2	16.3	10.6	21.7	10.2	18.7	16.1	10.8	21.0	14.5	40.2	11.6	35.4	22.2	14.8	18.4	16.6	11.8	13.1	14.1	7.2	9.5	14.3	13.1	6.8	21.3	12.2	13.7	14.2	4.1	5.1	15.7	9.7	9.7	12.2	13.6	42.8	22.9	42.5	14.3	4.4	16.7	25.1	13.6	19.4	18.1	22.3	16.1	9.3	15.9	6.3	40.8	13.3	5.0	6.3	14.8	13.6	10.5	38.0	19.6	8.5	11.6	32.2	16.0	26.0	12.7	25.7	29.6	19.1	7.5	14.4	18.4	12.6	19.4	27.0	23.8	29.4	12.2	8.1	9.1	29.1	10.3	26.0	19.9	30.4	53.6	11.6	31.5	6.8	1.0	9.5	3.7	8.5	9.0	11.0	12.2	10.3	8.9	11.5	13.1	13.1	10.4	7.2	14.3	7.2	14.1	8.5	6.8	11.1	12.1	15.4	13.9	10.2	11.2	12.5	10.7	12.9	11.6
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 130.5;retina: 48.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.3;HDLM-2: 31.6;hTCEpi: 30.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Region enhanced"	"Detected in single"		"cerebellum: 4.3"	"Region enhanced"	"Detected in single"		"cerebellum: 8.6"	"CAB000326, HPA028850, HPA056871"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000326: AB_667767, HPA028850: AB_10600730, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.4	0.3	0.3	0.0	0.3	0.0	19.0	2.2	0.5	4.4	0.8	0.0	18.7	0.2	0.5	17.8	18.3	0.4	1.7	0.7	0.3	0.2	6.4	0.2	0.5	0.1	0.2	0.2	0.3	0.3	0.0	0.4	130.5	0.6	5.8	0.2	48.1	19.4	26.7	0.2	36.0	0.4	0.1	0.4	0.2	0.7	1.6	0.0	0.1	0.4	16.6	9.9	2.4	9.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	16.5	6.4	0.0	28.3	0.1	0.0	6.1	12.2	9.4	10.0	9.9	0.6	6.2	0.9	1.6	3.5	17.6	1.5	20.9	9.6	31.6	15.9	0.1	14.9	0.0	0.0	0.4	0.4	0.0	30.5	0.0	22.2	0.0	0.9	0.0	0.1	3.6	0.0	5.1	0.1	7.9	1.8	1.5	0.6	5.7	6.7	4.1	0.1	15.0	26.4	24.0	17.5	0.5	0.0	3.1	0.8	2.1	7.7	0.0	1.5	0.2	1.6	0.5	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.3	0.3	0.2	0.2	0.2	0.6	0.0
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629302-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 53.9;skin 1: 32.5"	"Group enriched"	"Detected in many"	4	"BEWO: 44.7;MCF7: 37.9;SK-BR-3: 72.1;T-47d: 20.1;WM-115: 26.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory region: 2.9"	"Low region specificity"	"Detected in single"			"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2686902, HPA057076: "	"unprognostic (1.74e-2)"	"prognostic favourable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.1	0.3	0.7	0.2	0.4	0.0	16.1	0.4	0.9	17.3	2.4	0.2	7.7	0.0	3.7	3.4	19.6	1.6	2.0	0.4	1.4	0.2	0.7	0.1	2.8	0.0	0.2	0.5	0.3	1.6	0.0	0.6	53.9	0.4	5.7	0.7	1.9	19.7	7.9	1.0	32.5	0.3	0.6	0.4	0.1	0.3	0.7	0.2	0.3	4.2	21.0	10.1	2.1	11.1	0.1	0.2	0.8	0.1	0.2	0.2	0.0	2.8	3.6	0.0	0.0	0.0	0.0	44.7	4.6	8.4	5.8	1.0	0.7	0.0	0.0	0.3	3.0	9.8	6.3	1.2	4.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	5.0	1.7	1.7	0.0	0.0	0.7	0.0	37.9	4.6	0.2	2.2	4.8	0.0	0.0	1.5	0.0	2.3	1.2	0.0	3.1	72.1	4.7	20.1	1.0	0.0	3.8	0.1	2.0	3.4	0.0	0.0	0.0	0.9	0.0	26.5	0.4	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.1	0.0	0.7	0.4	0.4	0.9	1.4	0.2	0.2	0.5	0.4	0.2
TFAP4	"AP-4, bHLHc41"	ENSG00000090447	"Transcription factor AP-4"	Q01664	16	4257186-4273075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001912	Supported		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA001912: AB_1080251"	"unprognostic (1.61e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.97e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavourable (4.31e-6)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.30e-1)"	8.2	7.0	9.6	11.8	9.6	3.4	7.3	31.6	15.6	10.0	6.8	6.6	5.7	11.1	10.1	3.7	9.9	12.5	7.0	4.8	8.0	6.3	4.4	6.3	5.5	11.1	11.1	7.1	18.7	22.2	6.3	6.7	6.9	8.8	9.0	3.9	6.1	13.2	7.0	8.6	12.2	10.1	5.5	12.8	10.2	8.3	3.1	14.9	13.0	8.4	4.5	7.3	7.4	11.0	1.7	0.5	0.9	0.1	0.1	1.2	1.0	7.0	7.4	6.4	9.3	2.7	7.2	10.6	2.7	7.2	4.8	5.2	3.7	11.1	24.1	7.2	2.6	10.4	11.7	9.4	1.5	14.1	8.3	7.4	6.9	9.9	3.8	12.9	4.3	6.7	6.1	5.2	14.6	3.1	13.6	6.4	1.8	11.0	18.2	21.4	14.6	9.8	16.0	14.3	25.0	1.8	5.3	13.2	10.0	9.2	9.7	9.0	4.8	10.2	2.0	6.5	5.1	22.8	7.1	10.6	8.7	20.3	4.4	12.9	4.5	0.0	0.0	0.9	0.4	0.0	1.2	1.7	0.2	0.0	0.3	0.4	0.3	0.7	0.0	0.1	0.1	0.5	0.2	1.0	9.6	9.6	31.6	15.6	8.0	6.3	11.1	7.1	8.8	14.9
TFB2M	"FLJ22661, FLJ23182, Hkp1"	ENSG00000162851	"Transcription factor B2, mitochondrial"	Q9H5Q4	1	246540560-246566324	"Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028482, HPA028554, HPA030265"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA028482: , HPA028554: , HPA030265: AB_10696209"	"unprognostic (4.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.79e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.44e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.53e-2)"	10.6	23.1	4.2	7.2	8.4	15.5	9.0	8.4	9.9	7.0	8.9	6.5	9.4	8.2	9.5	7.2	9.5	6.9	8.5	11.3	4.3	5.5	15.5	42.3	5.9	8.7	4.8	5.7	6.5	19.7	5.6	7.8	10.5	7.6	8.9	9.6	5.9	13.6	8.9	21.4	8.7	10.3	6.8	6.5	9.0	9.6	8.7	5.7	13.0	15.6	7.3	12.0	9.1	6.5	10.6	11.0	1.2	7.5	12.6	10.4	4.5	12.6	12.2	4.7	8.4	5.9	8.5	16.6	9.3	9.6	10.6	9.7	14.8	12.2	22.6	14.6	9.4	11.0	11.3	9.9	14.6	8.7	4.4	11.4	7.5	12.9	9.7	20.1	10.4	8.4	11.8	9.1	10.2	8.2	33.0	7.7	9.1	5.8	10.1	9.0	21.0	12.4	10.2	9.4	27.4	9.6	14.0	10.5	21.2	9.0	16.3	30.7	11.9	19.4	5.9	7.4	9.0	10.4	24.2	22.5	37.5	17.8	9.1	19.9	9.2	0.2	4.7	1.2	8.4	4.8	10.4	10.6	7.5	8.8	11.0	10.4	9.6	8.2	1.0	12.6	7.5	9.5	10.3	4.5	4.2	8.4	8.4	9.9	4.3	5.5	4.8	5.7	7.6	5.7
TFCP2	"CP2, LBP-1C, LSF, TFCP2C"	ENSG00000135457	"Transcription factor CP2"	Q12800	12	51093663-51173134	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070247			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA070247: "	"unprognostic (6.27e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.31e-2)"	17.4	16.7	21.1	29.3	21.6	9.6	17.7	22.7	21.6	20.2	19.0	20.5	20.8	15.7	19.3	18.9	16.7	21.1	20.7	17.7	20.0	18.7	17.2	12.5	14.1	20.4	19.4	24.9	20.8	14.6	29.2	23.2	22.4	15.4	20.3	21.7	16.4	17.8	19.0	26.6	15.4	15.9	23.8	21.3	18.4	16.1	11.2	18.6	32.1	17.9	12.9	25.9	19.0	18.1	4.5	8.2	9.1	9.4	9.4	6.1	5.0	7.4	12.8	19.2	17.2	11.0	13.9	28.2	14.5	7.8	12.7	7.5	24.4	16.0	0.6	12.7	12.6	14.3	24.5	15.5	12.7	16.0	14.2	22.5	12.3	10.2	9.2	25.5	21.9	9.5	14.1	13.1	20.9	11.8	22.8	0.0	13.4	0.0	23.0	16.9	27.8	23.3	17.8	10.6	0.1	16.6	17.9	18.3	16.0	17.9	14.7	11.7	5.5	21.3	11.9	11.7	12.7	12.1	12.5	13.9	23.5	0.0	11.1	15.9	8.4	9.1	9.2	9.0	3.9	7.7	6.1	4.5	4.1	4.2	8.2	3.4	4.9	4.0	3.5	9.4	9.4	3.5	5.4	5.0	21.1	21.6	22.7	19.4	20.0	18.7	19.4	24.9	15.4	18.6
TFDP1	"DILC, Dp-1, DP1, DRTF1"	ENSG00000198176	"Transcription factor Dp-1"	Q14186	13	113584721-113641470	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.4"	"Low lineage specificity"	"Detected in all"											"CAB033605, HPA044754, HPA068909"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB033605: AB_783105, HPA044754: , HPA068909: "	"unprognostic (4.28e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (5.50e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (7.57e-4)"	"prognostic favourable (6.17e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	16.0	13.3	20.1	28.0	21.1	71.6	16.4	24.4	22.4	19.3	19.6	16.3	28.6	16.0	16.8	20.5	36.2	18.0	27.0	26.3	19.0	16.8	17.9	20.9	16.5	32.5	18.0	12.7	14.4	26.7	9.9	16.3	21.8	15.2	16.0	23.0	20.2	18.9	24.2	26.9	22.3	21.3	18.4	23.5	25.6	16.4	37.5	10.3	38.8	21.7	32.7	34.4	18.5	20.8	3.6	4.7	20.4	4.0	1.6	5.4	2.0	62.0	15.3	19.8	16.8	26.9	24.0	22.5	35.0	31.8	45.5	42.1	31.8	29.2	57.9	11.7	33.5	29.9	34.3	31.1	44.7	39.4	39.9	33.6	25.0	19.9	16.9	84.3	29.7	19.8	28.0	28.8	16.8	30.5	27.6	15.6	40.4	21.3	37.0	32.8	18.2	19.7	25.3	17.6	33.1	17.3	23.8	51.2	15.1	15.7	43.2	10.5	29.7	68.0	21.2	14.8	23.6	31.3	38.5	13.3	16.3	59.7	33.0	52.3	25.0	20.4	2.3	3.6	2.6	3.0	2.9	3.6	3.5	3.1	4.7	2.6	5.4	2.7	3.1	1.6	4.0	2.4	4.2	2.0	20.1	21.1	24.4	22.4	19.0	16.8	18.0	12.7	15.2	10.3
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 140.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 80.4;REH: 42.8;U-698: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"				Nucleoplasm	"Vesicles, Mitotic spindle"	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favourable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	8.4	8.4	6.1	6.3	8.7	20.7	9.3	9.9	8.6	8.9	11.1	6.5	6.5	10.4	9.9	8.6	8.3	7.2	11.6	12.0	7.5	4.9	14.3	9.5	6.8	5.3	6.0	5.0	11.6	8.8	10.4	19.4	13.5	8.0	9.9	6.6	8.8	7.9	6.9	14.5	8.0	14.6	11.8	8.5	5.3	8.6	51.9	5.4	140.3	10.6	4.8	6.4	9.7	8.0	9.3	16.5	24.6	4.5	18.0	14.7	5.7	6.3	2.9	12.3	9.8	4.1	4.5	27.1	3.2	3.7	5.1	8.3	3.7	6.3	22.5	15.0	3.6	3.8	3.1	6.1	7.2	9.0	5.6	27.1	4.4	4.9	4.0	8.1	9.6	4.2	4.3	5.6	5.4	3.5	10.1	1.2	8.8	4.8	80.4	3.1	9.9	4.0	42.8	8.5	5.2	5.9	3.3	5.4	5.0	10.8	4.0	5.5	9.3	4.2	2.3	4.9	4.5	3.9	4.0	4.2	3.8	70.5	3.9	2.2	2.3	24.6	2.1	22.3	14.7	3.4	5.7	6.6	6.7	7.6	4.8	9.3	10.1	11.8	2.4	18.0	4.5	16.5	6.1	5.7	6.1	8.7	9.9	8.6	7.5	4.9	6.0	5.0	8.0	5.4
TFE3	"bHLHe33, TFEA"	ENSG00000068323	"Transcription factor binding to IGHM enhancer 3"	P19532	X	49028726-49043486	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023881	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023881: AB_1857931"	"unprognostic (2.68e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (6.03e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (2.19e-8)"	"unprognostic (1.93e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.25e-1)"	31.3	20.9	12.6	18.2	14.4	22.6	53.1	16.5	18.1	22.6	17.7	16.6	30.0	9.9	22.8	21.9	20.5	18.8	16.4	15.1	11.3	11.8	21.6	14.1	22.8	10.3	13.2	9.4	24.4	15.9	16.5	16.3	22.0	15.9	21.2	10.4	15.7	12.6	30.6	13.6	14.1	13.5	21.2	14.8	23.0	14.7	10.4	15.2	4.2	21.7	10.8	10.5	28.6	20.5	1.2	1.9	10.5	4.4	0.4	1.4	1.6	11.9	15.3	5.1	14.8	16.7	15.1	5.1	15.7	18.2	16.1	13.8	9.4	9.5	4.5	6.7	23.1	9.8	9.7	14.2	13.0	9.8	5.2	4.1	11.4	8.7	22.5	4.3	10.2	13.1	9.2	26.3	18.9	7.7	7.9	19.7	13.7	7.0	2.8	4.0	13.9	13.8	4.3	8.9	10.2	10.2	5.5	4.9	4.9	16.8	7.2	5.5	10.3	3.9	16.3	17.6	18.9	17.6	8.6	12.1	11.4	3.7	21.0	5.3	12.0	0.0	3.5	1.6	0.5	4.3	0.9	0.6	0.9	0.5	1.9	1.2	0.6	0.4	10.5	0.4	4.4	0.4	1.4	1.6	12.6	14.4	16.5	14.9	11.3	11.8	13.2	9.4	15.9	15.2
TFEB	"bHLHe35, TCFEB"	ENSG00000112561	"Transcription factor EB"	P19484	6	41683978-41736259	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;Daudi: 19.6;HDLM-2: 17.9;U-698: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049532			Supported	Nucleoplasm				Nucleoplasm		"HPA049532: "	"unprognostic (3.63e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.13e-2)"	"prognostic favourable (4.77e-4)"	"unprognostic (2.12e-2)"	"prognostic favourable (1.06e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-2)"	8.6	6.4	10.2	16.8	20.7	8.9	6.8	8.6	15.0	6.4	10.5	34.4	8.2	6.8	7.1	4.3	9.3	7.2	9.1	19.3	14.6	8.2	12.2	5.0	8.3	24.1	30.0	6.8	6.7	11.4	26.1	14.9	18.5	16.2	10.7	5.3	6.9	18.0	8.6	45.2	7.9	15.5	8.4	27.4	27.3	7.9	2.5	24.0	2.8	11.1	10.9	18.3	10.8	11.1	22.2	8.5	29.0	9.6	0.8	2.6	4.4	1.7	1.8	0.4	7.2	2.4	1.4	30.9	2.8	5.6	2.5	1.9	4.1	2.1	19.6	3.8	2.9	5.0	1.1	2.8	0.6	17.9	2.0	0.0	7.1	7.5	4.8	0.5	2.6	0.5	5.5	2.9	1.9	1.9	2.3	4.8	0.9	1.3	1.1	1.5	0.1	0.9	12.9	0.2	2.7	4.4	1.4	8.1	2.3	2.4	5.0	0.6	1.4	9.8	3.8	0.9	2.0	0.1	2.0	12.6	2.0	28.9	1.5	8.3	1.0	0.1	9.6	8.8	2.6	9.3	0.4	22.2	0.7	1.0	8.5	15.1	0.2	0.9	29.0	0.8	6.5	1.7	0.4	4.4	10.2	20.7	8.6	15.0	14.6	8.2	30.0	6.8	16.2	24.0
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 22.6"	"Cell line enhanced"	"Detected in some"		"HEL: 12.0;HUVEC TERT2: 8.4;THP-1: 15.9;TIME: 9.3;U-937: 18.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.7;myeloid DC: 7.7"	"Group enriched"	"Detected in many"	32	"B-cells: 4.9;dendritic cells: 7.7;monocytes: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB032260: AB_2202845, HPA063577: "	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	11.2	3.5	5.8	15.4	9.2	12.3	7.6	0.8	4.6	1.8	3.7	1.4	0.6	3.4	1.6	6.1	2.4	2.6	4.2	2.5	6.0	2.1	22.6	2.8	15.7	17.0	13.0	2.2	1.6	1.8	0.4	1.8	3.9	8.8	1.9	3.6	0.8	3.1	0.7	1.2	1.3	11.6	2.6	15.2	16.4	2.3	1.7	9.4	1.6	2.1	1.1	10.0	3.8	1.7	4.9	7.7	0.2	8.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	9.3	1.6	0.1	0.9	0.0	4.2	0.0	0.0	0.0	18.1	0.8	0.0	8.7	0.0	0.0	3.7	0.0	4.9	0.0	0.0	7.7	2.1	0.0	0.0	0.2	0.0	0.5	3.9	0.0	1.7	5.8	9.2	0.8	4.6	6.0	2.1	13.0	2.2	8.8	9.4
TFG	"FLJ36137, SPG57, TF6"	ENSG00000114354	"TRK-fused gene"	Q92734	3	100709331-100748966	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019473, HPA052206"	Approved		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA019473: AB_1857936, HPA052206: "	"unprognostic (1.14e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (3.31e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.45e-2)"	36.4	40.3	27.2	21.9	33.8	29.7	31.0	28.1	40.5	31.2	34.7	33.3	44.2	52.5	31.2	45.8	46.7	29.0	40.8	46.2	28.1	30.7	44.6	68.6	29.9	25.4	28.2	21.5	33.5	49.2	52.3	45.1	63.3	33.7	27.5	40.7	31.9	39.6	45.8	38.6	31.0	67.1	37.5	31.7	28.3	28.9	33.5	23.0	27.6	43.6	42.9	41.2	29.5	30.1	25.8	27.8	43.2	28.4	27.7	26.8	21.8	48.4	26.4	32.9	20.9	41.6	47.2	40.7	35.1	47.3	45.9	54.8	33.3	24.2	6.5	25.8	43.6	36.4	35.4	40.1	54.7	29.8	20.8	24.4	20.3	30.9	46.5	18.0	14.6	38.6	54.1	27.5	48.5	40.6	17.5	18.1	47.4	33.9	15.8	14.3	31.3	39.8	14.0	19.3	21.1	55.7	32.7	26.0	23.8	23.1	30.1	40.9	35.4	24.4	27.1	27.8	33.6	12.8	25.4	15.4	15.5	23.3	44.4	19.7	32.6	43.2	28.3	27.0	21.8	28.4	26.4	25.8	22.6	24.4	27.8	22.9	21.6	21.6	18.7	27.7	26.4	19.4	26.8	21.8	27.2	33.8	28.1	40.5	28.1	30.7	28.2	21.5	33.7	23.0
TFPT	"amida, FB1, INO80F"	ENSG00000105619	"TCF3 fusion partner"	P0C1Z6	19	54107013-54115675	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034958, HPA058534"	Approved		Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA034958: AB_10603036, HPA058534: "	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (6.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (3.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.71e-1)"	"prognostic favourable (3.13e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.66e-2)"	5.9	6.5	33.4	8.9	17.0	7.9	5.1	9.6	22.9	7.9	5.3	8.7	4.3	10.1	5.9	5.3	4.1	5.1	7.1	7.7	24.4	15.5	4.3	3.6	7.9	11.6	18.3	16.1	4.2	4.0	3.3	4.2	6.4	10.8	15.9	2.9	4.8	12.9	5.2	10.8	6.8	10.7	4.7	9.7	14.1	14.5	4.6	12.8	9.6	5.2	3.2	4.8	5.3	3.9	4.4	24.7	5.0	3.9	10.4	13.3	5.5	2.5	2.2	2.2	4.3	0.4	0.8	2.1	2.4	1.7	2.2	2.6	2.6	8.1	2.5	6.0	2.3	2.7	0.8	1.3	0.7	6.5	11.7	3.0	4.0	3.3	6.2	4.0	6.5	1.7	0.8	1.5	1.1	3.4	2.7	3.6	3.4	9.3	7.1	12.5	2.4	4.9	5.9	1.5	3.4	1.6	11.8	5.9	5.0	0.8	9.5	12.9	2.5	14.1	7.8	16.2	3.3	1.2	3.3	6.3	6.7	1.9	6.9	11.0	13.7	5.0	3.7	3.6	8.1	3.9	7.7	4.4	11.6	10.7	9.5	4.2	9.0	9.5	2.4	10.4	1.2	24.7	13.3	5.5	33.4	17.0	9.6	22.9	24.4	15.5	18.3	16.1	10.8	12.8
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	21.9	20.0	9.2	18.6	20.4	11.8	57.5	31.4	23.9	22.1	36.7	48.7	20.2	22.5	59.6	11.6	33.9	31.5	10.4	27.1	107.6	10.7	85.3	17.0	22.6	16.1	69.9	17.3	13.3	10.3	19.0	17.2	7.3	35.5	21.6	17.2	20.3	22.9	14.8	28.0	41.0	12.2	13.7	27.0	19.8	55.6	21.0	8.7	30.3	79.7	7.1	77.4	14.6	9.4	26.3	21.4	23.0	47.0	6.1	47.5	35.2	30.8	19.0	15.9	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"			13000000	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (7.73e-5)"	16.8	4.1	1.0	14.4	1.4	0.3	18.5	1.2	1.6	42.9	51.1	1.8	22.1	5.8	80.7	22.7	34.1	28.9	36.2	11.8	0.9	0.7	8.6	2.8	11.2	10.6	1.1	1.3	40.3	2.2	5.1	1.8	11.5	2.3	37.7	10.4	11.1	7.1	34.7	5.7	5.9	12.8	71.9	1.8	11.5	19.6	10.9	0.9	0.7	5.8	7.8	3.6	69.9	23.5	1.3	0.5	8.8	0.0	0.0	2.5	2.3	4.3	5.4	9.0	0.0	8.9	16.3	0.1	23.5	22.0	14.7	10.0	2.3	1.5	0.0	22.1	20.1	6.5	1.8	4.3	19.4	0.0	0.0	5.2	10.1	1.2	22.6	0.0	6.7	10.5	6.4	9.1	5.4	9.7	0.5	0.0	17.9	0.0	0.0	0.6	0.4	5.6	0.0	10.7	0.0	4.1	2.2	0.0	6.4	9.1	0.0	4.5	0.0	0.5	26.1	26.5	6.5	7.4	10.2	0.0	0.0	0.0	11.7	0.2	16.3	8.8	0.0	0.1	0.3	0.0	0.5	1.3	1.4	0.2	0.1	0.5	0.2	1.0	0.2	0.0	0.0	0.5	2.5	2.3	1.0	1.4	1.2	1.6	0.9	0.7	1.1	1.3	2.3	0.9
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: "	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	11.1	6.9	10.3	11.5	14.6	20.0	15.4	12.6	11.3	14.4	20.0	11.0	5.5	7.4	18.8	8.0	13.2	10.9	14.9	9.7	7.8	7.5	16.0	9.8	19.2	18.9	15.8	4.3	13.3	8.8	6.5	13.5	50.9	14.1	12.3	9.2	10.4	10.2	12.2	8.4	6.6	11.0	28.6	17.9	13.9	25.5	11.4	12.4	10.8	7.7	8.1	11.5	13.0	10.2	1.6	2.0	13.1	2.4	4.0	8.3	1.9	3.3	5.0	30.8	9.5	7.2	5.3	4.6	11.5	12.6	10.7	12.1	5.1	2.4	7.5	3.6	9.0	8.0	10.4	8.9	14.6	19.5	3.2	11.2	5.6	4.5	11.9	6.9	27.3	11.0	9.6	16.8	7.9	1.9	15.5	3.2	14.7	5.2	1.0	7.8	6.5	3.0	2.8	67.2	3.2	2.6	0.8	8.3	9.7	8.9	39.9	11.9	7.4	9.4	3.5	8.0	6.9	34.3	7.0	3.2	3.2	5.1	16.8	11.9	6.9	13.1	2.4	9.1	8.3	1.6	7.2	1.6	3.6	6.1	2.0	1.3	3.5	6.7	4.9	4.0	1.9	1.4	2.2	1.9	10.3	14.6	12.6	11.3	7.8	7.5	15.8	4.3	14.1	12.4
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606502-30694142	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.4;ASC TERT1: 80.5;HSkMC: 69.5;LHCN-M2: 65.8;TIME: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"			560000	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	91.8	24.6	6.7	24.6	10.3	7.3	88.3	3.6	7.3	36.5	42.6	9.8	18.6	13.2	42.6	23.3	36.2	28.4	42.6	73.5	6.9	5.2	32.6	21.9	52.6	75.7	12.6	3.7	22.2	26.0	17.4	10.3	24.2	9.9	35.2	17.5	27.9	22.5	19.5	34.9	17.0	31.3	37.2	12.0	68.7	26.8	15.4	8.2	19.3	40.9	16.8	26.9	48.0	82.0	5.3	6.8	20.0	6.6	1.4	19.7	3.9	2.4	14.4	0.9	0.0	53.4	80.5	2.4	12.5	17.6	4.3	4.3	3.2	13.3	0.3	45.3	16.8	5.0	0.6	18.3	7.2	1.0	1.3	1.4	1.6	16.2	22.8	2.2	11.8	69.5	16.3	18.6	18.0	46.7	0.2	0.0	65.8	0.2	2.3	1.6	0.4	5.8	2.0	5.8	0.3	23.2	5.8	0.0	0.9	3.7	1.0	3.5	0.0	2.4	60.3	21.2	5.2	9.6	4.7	0.4	0.0	2.0	12.7	2.5	8.5	6.9	2.9	20.0	3.5	3.0	3.2	4.0	5.4	4.2	2.6	5.3	19.7	9.1	12.6	1.4	6.6	6.8	1.2	3.9	6.7	10.3	3.6	7.3	6.9	5.2	12.6	3.7	9.9	8.2
TGIF1	"HPE4, TGIF"	ENSG00000177426	"TGFB induced factor homeobox 1"	Q15583	18	3411608-3459978	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062160			Supported	Nucleoplasm				Nucleoplasm		"HPA062160: "	"unprognostic (1.11e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.60e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.48e-3)"	31.9	16.6	6.9	17.2	9.3	11.2	22.0	2.7	6.2	26.8	23.8	15.5	48.4	9.6	32.7	47.3	27.1	24.8	31.4	12.9	6.5	7.2	24.7	33.6	27.9	10.6	8.1	5.9	23.0	20.2	5.3	10.2	49.6	9.9	33.2	22.4	15.3	25.1	29.8	21.2	22.9	16.6	18.5	8.6	23.1	19.8	23.1	9.2	18.1	60.2	11.2	21.0	40.5	29.0	18.2	14.0	20.4	17.3	7.4	27.5	12.7	6.1	28.3	18.6	5.9	19.0	25.7	45.5	11.9	45.7	9.8	12.5	11.2	28.4	0.3	4.0	9.7	6.4	7.1	13.4	12.9	2.5	2.9	0.8	13.5	21.1	35.7	8.9	7.4	17.8	57.5	17.7	47.2	20.8	6.4	0.1	19.1	12.1	5.8	11.0	47.4	6.2	6.1	8.3	2.0	40.1	30.5	5.2	5.2	31.5	24.7	17.4	5.7	8.0	8.9	15.3	13.3	18.0	7.4	1.0	0.1	2.8	15.7	3.4	19.2	20.4	17.3	2.9	25.9	6.5	27.5	18.2	21.6	25.2	14.0	12.8	15.5	18.0	7.8	7.4	6.1	1.4	11.4	12.7	6.9	9.3	2.7	6.2	6.5	7.2	8.1	5.9	9.9	9.2
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA053786: , HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	14.0	6.1	2.8	20.0	3.1	4.1	7.8	1.3	3.5	13.7	8.8	4.0	3.5	3.2	23.7	7.9	6.8	18.0	10.2	7.6	2.7	2.5	9.2	13.2	13.7	16.6	4.4	1.6	17.9	33.3	10.5	3.4	9.1	3.9	9.3	3.7	12.1	14.9	5.7	4.1	5.6	8.1	13.7	3.2	20.3	7.0	16.9	2.8	26.7	12.9	6.9	22.1	10.0	7.2	8.2	7.7	14.7	5.4	4.2	7.6	3.8	6.9	1.7	20.0	22.6	2.9	2.7	7.3	4.0	4.6	9.6	7.2	10.2	8.9	18.7	10.6	3.9	7.2	16.2	10.4	9.4	8.8	5.9	23.4	4.0	13.5	4.6	9.9	5.7	4.2	6.9	2.0	7.4	9.4	11.2	11.5	4.6	9.9	16.8	18.9	16.7	5.0	14.4	23.9	10.2	6.3	4.6	6.0	17.8	1.2	10.6	10.0	12.7	22.1	6.8	1.5	6.3	0.1	7.5	13.2	4.9	17.6	0.1	11.9	7.5	14.7	5.4	1.7	4.8	4.9	5.2	8.2	4.4	4.9	7.4	6.5	7.6	6.3	2.2	4.2	3.4	7.7	4.2	3.8	2.8	3.1	1.3	3.5	2.7	2.5	4.4	1.6	3.9	2.8
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328425	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"			9800000	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	40.0	40.7	34.3	38.4	38.0	55.6	36.5	51.7	43.1	33.3	50.0	38.7	31.5	53.2	41.2	31.1	23.9	33.3	44.9	43.2	31.9	34.4	59.6	66.2	44.1	37.4	35.4	36.7	36.1	34.4	39.5	21.8	50.4	35.8	34.0	50.1	26.9	38.9	36.5	23.7	23.7	63.1	36.0	40.3	47.1	36.8	22.3	33.2	31.8	44.8	17.0	37.7	39.9	32.9	9.4	14.9	34.2	34.1	8.6	12.3	22.7	11.2	29.1	12.4	16.3	29.9	31.4	28.9	34.2	39.9	23.3	18.7	24.3	34.1	14.1	27.1	47.3	18.4	8.9	16.7	38.7	23.1	8.9	20.2	10.3	26.0	16.3	39.1	46.9	23.2	10.7	30.1	18.2	33.6	11.6	23.2	34.3	10.2	12.6	19.9	10.9	11.8	13.3	45.5	10.4	25.0	17.7	11.7	9.7	29.9	22.5	19.8	12.6	17.6	35.6	50.0	18.6	37.7	40.9	15.2	19.5	13.8	37.0	30.4	32.5	17.6	27.5	23.5	12.3	26.9	9.6	9.4	9.2	8.3	14.9	9.1	9.6	9.1	34.2	8.6	34.1	5.6	7.2	22.7	34.3	38.0	51.7	43.1	31.9	34.4	35.4	36.7	35.8	33.2
TGS1	"NCOA6IP, PIMT"	ENSG00000137574	"Trimethylguanosine synthase 1"	Q96RS0	8	55773142-55825448	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025024, HPA029824"	Supported		Supported	Cytosol				Cytosol		"HPA025024: AB_1854330, HPA029824: "	"unprognostic (4.13e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.94e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.85e-2)"	12.1	10.0	7.2	18.2	9.1	13.3	12.6	18.1	10.2	11.6	14.1	7.2	18.2	7.6	14.3	16.0	13.5	14.1	9.4	8.5	8.8	6.7	12.6	8.8	10.7	18.8	5.3	6.9	14.8	9.6	12.3	13.8	10.2	7.4	11.9	10.1	7.1	11.6	20.0	19.6	14.1	16.8	11.5	6.3	17.7	10.5	10.8	8.0	29.7	11.6	13.2	18.3	14.5	14.5	10.4	10.1	10.0	7.6	6.3	13.1	4.8	9.1	6.9	8.2	9.1	7.2	7.2	8.6	8.6	8.8	9.2	9.4	6.4	8.9	20.8	6.0	5.7	8.8	17.3	11.0	11.7	11.6	6.6	22.2	7.7	3.6	10.2	12.4	7.7	7.1	7.5	8.8	18.1	7.0	18.1	8.2	7.5	7.0	27.9	8.1	30.0	2.8	19.9	5.9	6.6	8.4	9.2	8.4	11.5	11.0	6.7	9.9	9.2	7.6	6.9	6.8	8.6	8.1	7.8	7.2	4.7	26.3	6.7	9.7	8.6	10.0	5.5	8.8	11.6	6.3	13.1	9.8	11.6	11.2	5.5	10.4	11.9	12.4	6.3	6.3	7.6	10.1	9.2	4.8	7.2	9.1	18.1	10.2	8.8	6.7	5.3	6.9	7.4	8.0
THAP1	"4833431A01Rik, DYT6, FLJ10477"	ENSG00000131931	"THAP domain containing 1"	Q9NVV9	8	42836674-42843325	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071310			Supported	Nucleoplasm				Nucleoplasm		"HPA071310: "	"unprognostic (8.99e-3)"	"unprognostic (3.97e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.16e-2)"	12.7	12.8	12.0	11.5	12.6	12.8	19.7	16.7	12.5	14.3	14.2	9.2	9.8	10.5	13.3	11.7	13.2	13.6	9.3	15.9	12.3	11.6	14.3	15.9	9.7	15.2	12.4	9.4	15.5	11.9	11.6	16.3	12.3	13.4	15.7	10.0	6.8	10.4	11.7	21.8	7.1	15.3	12.8	13.7	16.1	10.7	16.2	14.1	26.4	17.7	8.9	14.5	13.9	30.1	16.1	15.6	23.3	14.9	14.7	24.7	13.8	9.2	8.4	7.8	7.5	12.0	13.7	9.5	12.8	9.8	11.9	10.9	7.1	12.1	11.4	10.6	9.4	9.7	12.8	10.9	15.1	11.0	9.4	11.1	7.7	8.4	14.8	9.1	11.8	10.7	16.4	13.1	17.0	15.1	12.3	13.5	13.8	5.7	21.9	10.7	15.5	6.7	9.9	14.0	9.0	12.8	7.0	6.4	7.5	14.1	8.9	17.7	12.4	10.3	9.0	10.5	7.8	13.9	12.7	11.1	11.9	10.9	10.5	12.2	11.3	17.2	14.9	23.3	16.6	12.9	18.1	16.1	19.7	18.4	15.6	13.3	23.4	18.3	17.7	14.7	13.3	7.7	24.7	13.8	12.0	12.6	16.7	12.5	12.3	11.6	12.4	9.4	13.4	14.1
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842082-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	15.2	12.1	13.4	13.5	14.5	8.5	31.4	15.0	17.2	23.8	19.1	16.7	13.0	12.0	19.9	13.3	18.9	18.0	16.7	29.5	12.4	12.4	13.9	13.5	14.9	22.2	11.8	9.7	22.6	23.1	17.2	13.3	14.2	12.7	20.4	11.0	17.2	14.8	20.6	40.7	17.7	16.0	19.8	10.4	21.0	15.8	11.8	9.8	30.2	29.0	17.3	18.0	21.7	27.1	10.3	8.7	8.5	10.8	11.5	19.9	10.6	12.3	16.2	11.3	10.6	15.8	10.9	11.9	6.4	11.0	15.3	13.3	20.7	9.6	27.1	13.2	6.4	14.6	19.8	11.7	8.8	10.0	22.6	10.8	9.4	25.1	14.5	13.7	12.3	9.9	11.6	10.6	9.3	11.3	15.4	6.4	9.3	19.3	14.8	24.7	22.8	14.2	29.2	13.5	24.4	7.7	8.0	15.8	17.9	18.5	6.7	13.3	16.5	14.1	9.0	9.9	12.0	8.8	7.8	25.4	25.2	26.7	7.6	15.2	10.6	3.5	8.4	8.5	16.8	10.8	13.4	8.9	15.4	15.4	8.7	10.3	19.9	15.8	2.5	11.5	9.7	7.0	18.4	10.6	13.4	14.5	15.0	17.2	12.4	12.4	11.8	9.7	12.7	9.8
THAP8	FLJ32891	ENSG00000161277	"THAP domain containing 8"	Q8NA92	19	36034985-36054762	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA064056, HPA070139"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA064056: , HPA070139: "	"unprognostic (1.33e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (9.01e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (3.19e-4)"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.48e-1)"	4.6	5.3	9.1	3.9	10.3	1.3	3.3	6.0	8.7	5.7	11.2	10.1	3.9	4.9	6.4	6.3	5.2	6.8	6.5	4.8	6.5	6.6	5.4	5.6	4.6	4.3	8.5	8.1	6.3	3.4	5.6	6.1	6.4	9.9	5.6	4.1	3.6	5.7	7.5	12.7	8.5	5.0	7.5	9.0	5.0	4.8	15.8	13.3	10.1	5.2	2.6	3.5	7.8	5.0	5.9	6.2	10.4	9.3	7.0	8.4	5.3	2.4	7.9	3.9	3.3	10.4	6.5	2.8	2.3	4.1	4.6	7.5	3.5	2.0	3.8	8.0	3.6	1.3	2.3	2.9	1.7	2.9	1.9	2.4	2.0	3.9	11.9	1.1	2.3	5.4	4.5	3.0	1.8	2.3	2.1	4.7	4.7	4.9	3.1	3.0	3.6	2.8	3.0	1.2	3.6	3.9	2.4	6.9	5.2	3.9	3.3	2.4	3.5	1.7	1.5	6.4	4.2	3.3	1.8	3.8	3.2	2.6	6.9	2.2	3.8	10.4	8.6	9.5	7.2	9.3	8.1	5.9	7.5	7.2	6.2	4.9	6.1	8.4	4.0	7.0	8.0	6.2	7.0	5.3	9.1	10.3	6.0	8.7	6.5	6.6	8.5	8.1	9.9	13.3
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favourable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favourable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favourable (9.62e-4)"	11.9	9.1	11.8	12.5	14.5	10.7	7.7	19.0	12.5	10.5	10.7	12.3	10.9	10.4	15.5	8.1	13.4	8.2	7.7	8.5	10.9	9.9	11.6	16.5	7.1	17.6	18.1	7.6	9.9	8.1	11.1	23.3	9.6	11.5	8.4	8.7	8.9	10.4	7.6	12.1	9.1	9.4	10.8	14.2	12.8	9.6	26.3	17.7	16.2	9.2	7.8	17.8	14.6	7.8	11.7	11.0	9.1	9.7	9.7	14.2	6.4	12.8	6.9	16.2	13.5	10.3	7.4	20.0	7.0	7.1	15.3	16.0	14.2	8.3	18.3	6.0	9.8	8.4	20.8	11.7	18.9	5.8	9.0	11.0	9.1	9.6	8.1	25.0	10.2	4.9	7.2	16.3	10.6	16.3	24.9	8.7	13.2	9.6	18.2	14.2	16.0	10.2	25.6	15.5	16.6	8.5	12.6	10.9	8.2	19.7	10.2	11.7	7.0	17.8	8.3	13.7	14.8	10.9	23.2	7.1	12.3	26.7	11.6	17.3	11.7	9.1	6.7	5.7	9.5	9.7	14.2	11.7	11.6	12.0	11.0	9.5	13.6	13.3	0.7	9.7	7.8	6.5	11.4	6.4	11.8	14.5	19.0	12.5	10.9	9.9	18.1	7.6	11.5	17.7
THOC5	"C22orf19, Fmip, fSAP79, KIAA0983, PK1.3"	ENSG00000100296	"THO complex 5"	Q13769	22	29505879-29555216	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048402			Supported	Nucleoplasm				Nucleoplasm		"HPA048402: "	"unprognostic (1.16e-1)"	"unprognostic (3.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (3.76e-6)"	"unprognostic (6.34e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.81e-2)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (9.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.97e-1)"	16.8	11.3	10.2	12.2	16.4	14.7	15.1	14.7	26.8	16.5	29.7	20.0	11.6	10.2	30.3	12.9	17.1	19.9	15.6	20.4	10.8	7.2	12.9	12.1	13.3	12.5	12.5	12.1	20.4	13.6	12.4	14.8	10.7	18.9	16.6	12.9	16.8	15.4	19.8	35.7	12.2	15.1	26.7	10.9	14.1	18.7	21.1	14.9	18.8	10.7	9.4	15.9	25.7	16.4	7.5	10.0	25.0	13.1	5.6	10.5	7.2	15.6	10.7	9.8	29.5	18.7	15.3	12.5	29.7	17.6	26.4	26.3	17.2	7.1	9.7	11.6	23.6	14.2	14.0	15.9	26.0	11.1	14.5	16.0	15.1	19.4	12.7	36.4	13.7	15.9	15.0	26.0	20.1	19.3	18.1	10.0	16.4	17.5	11.2	11.3	20.5	8.4	16.5	23.7	12.0	9.7	12.0	20.2	32.5	16.5	13.3	18.0	7.5	12.9	13.2	46.7	27.3	11.0	19.3	16.0	15.2	23.8	15.6	15.2	19.8	3.8	9.0	22.0	8.8	11.3	8.8	7.5	7.3	6.4	10.0	6.1	7.8	7.1	25.0	5.6	13.1	2.4	10.5	7.2	10.2	16.4	14.7	26.8	10.8	7.2	12.5	12.1	18.9	14.9
THOC6	"fSAP35, MGC2655, WDR58"	ENSG00000131652	"THO complex 6"	Q86W42	16	3024027-3027755	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Developmental protein, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052953	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA052953: "	"unprognostic (2.07e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (4.40e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.43e-2)"	10.5	12.0	7.8	14.6	8.2	16.7	12.8	7.0	9.8	10.0	13.7	9.1	11.9	15.5	15.7	8.6	13.7	10.4	19.3	9.5	7.0	5.6	12.9	17.5	12.4	15.5	11.0	4.8	13.2	20.7	11.8	13.2	28.0	9.0	15.1	8.6	7.2	16.6	11.0	17.0	20.6	17.6	10.5	6.5	16.9	10.5	9.0	6.8	27.3	12.7	19.4	17.9	10.0	11.6	17.8	34.5	5.0	24.4	14.3	16.4	16.3	12.6	20.7	15.1	15.8	7.7	8.9	26.6	3.9	9.1	9.2	13.7	13.7	15.0	24.1	12.9	6.5	17.5	16.4	12.5	5.1	21.2	21.0	13.0	19.1	19.9	13.2	19.0	28.7	8.9	15.1	11.2	28.0	8.5	18.9	13.0	4.5	29.7	10.7	35.3	27.0	8.9	29.0	11.3	28.1	9.6	6.4	31.0	14.7	11.1	17.7	7.2	12.7	20.8	7.0	9.6	22.3	10.8	14.1	9.4	8.0	29.1	2.5	13.1	9.6	0.8	24.4	5.0	14.8	23.7	14.9	15.3	13.7	14.3	34.5	17.8	16.0	16.4	1.8	14.3	13.1	29.1	14.2	16.3	7.8	8.2	7.0	9.8	7.0	5.6	11.0	4.8	9.0	6.8
THOC7	"FLJ23445, fSAP24, NIF3L1BP1"	ENSG00000163634	"THO complex 7"	Q6I9Y2	3	63833870-63863903	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044143	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA044143: AB_10794892"	"unprognostic (4.33e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.31e-1)"	24.3	28.5	41.1	19.7	34.7	29.0	33.3	20.6	37.6	24.6	29.6	14.8	24.1	27.7	22.2	24.6	43.6	18.7	27.2	36.1	38.5	28.3	30.5	32.5	17.2	25.9	33.9	35.2	21.1	35.6	18.0	23.8	42.0	33.7	24.6	30.4	14.8	30.4	22.8	52.9	27.0	34.9	31.1	27.2	20.4	21.5	24.6	15.5	34.4	21.3	43.0	27.6	28.4	22.8	25.4	31.4	32.2	24.8	27.6	32.1	17.7	19.5	12.0	13.8	3.4	18.5	25.4	13.2	17.3	17.9	20.3	20.4	14.4	21.7	23.4	7.3	22.2	11.5	15.5	27.2	28.4	23.9	11.3	20.9	15.7	16.6	19.5	29.1	10.3	18.3	22.9	17.4	30.8	22.2	16.0	22.8	24.6	144.9	25.5	26.4	17.5	9.7	18.6	13.0	31.9	35.1	18.7	6.9	16.0	15.0	21.1	23.4	13.5	40.5	16.0	14.8	15.8	18.3	30.5	15.0	22.0	28.4	18.4	37.3	19.2	32.2	21.9	17.1	22.2	24.8	30.7	25.4	27.6	30.0	31.4	17.4	23.8	24.8	13.1	27.6	20.7	28.9	32.1	17.7	41.1	34.7	20.6	37.6	38.5	28.3	33.9	35.2	33.7	15.5
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785460-2815807	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol			1400000	Cytosol		"CAB025497: , HPA035262: "	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	8.2	9.4	19.1	12.3	19.8	18.4	6.2	21.7	26.1	5.2	11.8	14.1	5.8	24.6	7.5	8.4	11.0	8.4	6.7	11.6	18.5	15.4	7.1	30.4	6.2	11.9	14.1	15.2	11.1	7.8	7.0	12.7	22.3	13.1	18.1	8.2	11.9	13.7	6.8	29.1	11.9	20.0	7.1	10.7	9.8	7.8	27.3	10.9	17.0	7.5	11.5	11.3	5.8	6.8	7.5	9.8	8.0	7.5	3.9	9.5	3.2	29.2	21.8	8.5	18.2	4.4	4.3	30.4	18.3	6.8	18.2	14.8	25.6	9.4	26.4	9.0	7.1	23.8	12.6	15.0	7.7	0.1	26.5	9.3	24.0	30.2	4.7	18.0	14.6	4.8	5.4	15.1	6.8	10.3	21.7	12.9	7.7	22.7	20.0	33.8	25.1	30.1	16.7	11.3	25.0	7.6	17.0	23.1	18.5	16.0	14.4	8.9	14.0	17.5	11.7	14.0	12.1	29.8	30.9	22.7	19.0	17.8	15.6	30.3	16.6	8.0	3.5	1.6	5.5	3.9	4.5	5.6	4.0	7.4	4.9	7.5	5.1	4.3	1.7	3.9	7.5	9.8	9.5	3.2	19.1	19.8	21.7	26.1	18.5	15.4	14.1	15.2	13.1	10.9
THRA	"AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3"	ENSG00000126351	"Thyroid hormone receptor, alpha"	P10827	17	40058290-40093867	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009654, CAB023349"	Approved		Supported	Cytosol				Cytosol		"CAB023349: AB_619577, HPA009654: AB_1854603"	"unprognostic (2.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.41e-3)"	"prognostic favourable (1.84e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-2)"	"prognostic favourable (6.05e-8)"	"unprognostic (3.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.88e-3)"	17.1	20.7	58.6	5.7	90.7	9.9	12.9	37.4	73.1	19.8	12.6	24.1	8.2	15.1	19.3	11.5	9.7	29.3	12.7	30.1	43.8	38.1	12.1	2.7	11.6	4.5	34.3	45.5	46.5	12.3	13.0	10.7	8.5	29.6	12.4	9.6	10.4	13.7	18.8	38.5	10.0	16.7	17.4	29.4	6.1	11.9	7.8	43.6	1.8	12.5	7.9	3.3	10.0	18.6	1.0	1.5	3.7	0.7	5.1	4.7	1.4	2.1	17.2	5.4	13.4	37.1	13.6	1.9	8.8	10.6	9.2	8.6	14.3	12.5	2.5	14.7	17.2	5.2	10.5	5.4	5.0	0.9	9.9	4.6	20.5	6.1	12.5	7.5	5.2	21.6	4.4	8.6	3.3	12.3	9.3	2.4	7.6	3.2	10.0	12.4	4.9	5.4	14.4	10.6	12.4	3.1	1.5	9.1	8.3	6.8	10.9	15.4	12.7	8.9	8.5	9.2	9.2	8.2	2.6	5.6	3.9	1.5	5.7	8.7	4.9	0.3	0.6	3.7	4.7	0.3	2.0	0.6	1.9	2.8	0.8	1.0	3.4	4.1	2.5	5.1	0.7	1.5	2.2	1.4	58.6	90.7	37.4	41.8	43.8	38.1	34.3	45.5	29.6	43.6
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224416-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"			22000	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: "	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favourable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	33.9	30.5	19.8	27.2	28.5	26.8	27.0	30.7	33.7	25.5	26.6	28.4	24.8	20.2	30.2	23.6	29.7	25.1	21.5	28.1	19.7	20.2	25.2	37.1	24.6	32.4	21.2	20.1	29.6	24.8	38.6	32.6	35.6	28.5	32.1	24.1	26.3	27.4	23.7	79.1	27.0	29.3	27.6	20.7	32.6	26.5	23.8	22.2	57.4	29.0	28.6	38.8	27.4	26.1	36.2	23.1	49.3	24.0	25.2	29.8	22.2	30.9	20.1	34.7	29.5	27.7	22.5	29.0	33.4	33.8	33.7	34.8	23.5	28.6	57.9	12.6	34.4	28.8	38.6	32.5	42.2	29.8	21.7	48.0	31.0	24.8	30.2	48.6	32.3	34.6	20.5	34.2	29.1	37.0	39.7	30.1	24.1	17.6	52.4	27.0	41.0	15.8	50.1	41.1	30.8	24.2	44.0	22.0	26.2	38.2	24.8	27.7	22.8	20.9	39.0	28.1	32.6	26.1	35.0	18.0	31.7	52.6	26.4	33.3	29.2	36.6	20.1	36.7	29.8	24.0	25.2	32.2	25.3	26.0	22.7	36.2	26.8	23.3	49.3	25.2	23.8	23.1	21.3	22.2	19.8	28.5	30.7	33.7	19.7	20.2	21.2	20.1	28.5	22.2
THRB	"ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2"	ENSG00000151090	"Thyroid hormone receptor beta"	P10828	3	24117153-24495756	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 26.0;RT4: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.2;naive B-cell: 4.3"	"Group enriched"	"Detected in many"	11	"B-cells: 4.3;granulocytes: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002008, CAB002009, HPA061035"	Approved		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB002008: , CAB002009: , HPA061035: "	"unprognostic (1.82e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-6)"	"unprognostic (3.37e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (9.46e-8)"	"unprognostic (1.32e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.34e-2)"	10.7	5.5	12.5	3.2	14.8	1.1	12.0	2.6	27.0	3.6	11.2	1.9	5.5	2.7	7.5	2.2	7.0	4.3	2.5	7.9	9.2	5.7	12.9	20.8	5.4	1.6	4.3	20.1	2.9	9.6	6.8	20.3	4.7	3.5	8.2	9.0	3.2	6.1	10.4	21.9	7.1	4.0	11.1	3.0	5.7	8.1	1.0	4.0	0.0	4.9	4.7	1.6	9.8	14.6	4.3	0.5	7.2	0.1	0.0	0.0	3.5	5.9	1.8	0.4	0.0	10.7	5.6	4.0	0.2	1.3	1.0	1.9	3.9	5.9	0.0	1.5	4.2	9.0	6.4	2.5	0.7	0.0	3.9	0.0	1.6	5.1	0.3	0.0	0.0	9.9	4.4	0.1	0.7	0.0	26.0	0.0	0.9	0.3	0.0	0.0	3.9	2.2	0.0	0.0	0.0	6.1	19.3	1.1	0.4	9.8	5.3	0.1	5.8	0.0	0.5	2.4	1.9	0.0	1.1	0.1	0.3	0.0	1.7	0.0	0.2	7.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	4.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.5	12.5	14.8	2.6	27.0	9.2	5.7	4.3	20.1	3.5	4.0
THSD1	TMTSP	ENSG00000136114	"Thrombospondin type 1 domain containing 1"	Q9NS62	13	52377167-52406494	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 12.0;HBEC3-KT: 12.1;hTCEpi: 12.0;hTERT-HME1: 12.3;HUVEC TERT2: 25.1;LHCN-M2: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012611, CAB020796"	Uncertain		Supported	Cytosol	"Intracellular and membrane"		810000	Cytosol		"CAB020796: , HPA012611: AB_1857990"	"unprognostic (1.21e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.90e-2)"	9.7	1.8	8.3	1.8	7.2	0.4	11.1	2.9	6.4	7.6	2.6	1.9	3.6	1.2	6.8	4.9	4.4	5.7	4.9	9.0	8.1	2.2	2.0	2.1	19.8	4.7	2.2	4.6	2.3	1.2	2.5	3.4	16.8	2.1	8.5	2.3	5.5	3.9	3.2	9.7	6.0	2.3	7.4	2.2	6.6	1.9	2.7	1.1	0.7	5.2	5.2	2.5	5.9	4.5	0.3	0.0	0.0	0.0	0.4	0.7	0.0	0.5	2.4	0.2	2.1	2.0	6.5	0.5	5.1	2.5	2.0	3.2	0.0	0.3	0.2	0.6	12.0	2.7	0.0	12.1	3.1	5.6	1.7	0.3	0.0	0.0	1.2	1.2	0.3	2.6	12.0	9.7	12.3	25.1	0.0	0.1	11.5	0.0	0.4	0.2	0.1	0.5	0.3	2.7	0.0	2.7	0.1	0.0	0.4	0.1	0.0	0.4	0.2	0.2	5.8	0.6	1.1	0.0	3.8	0.3	0.0	0.0	1.1	0.3	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.5	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.3	7.2	2.9	6.4	8.1	2.2	2.2	4.6	2.1	1.1
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362842-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: "	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favourable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	17.4	17.2	13.3	12.9	14.8	22.2	14.2	13.4	19.6	15.2	14.4	13.8	12.5	12.8	14.0	15.8	16.5	12.3	10.9	19.3	12.3	13.9	20.7	23.9	11.1	13.5	18.3	11.0	14.3	14.8	22.2	27.8	14.4	23.2	15.9	15.1	14.0	16.1	14.9	29.4	13.4	14.9	12.3	15.8	14.5	12.5	42.8	14.8	22.3	18.2	17.5	13.2	16.2	11.7	13.9	15.4	12.5	19.3	11.7	22.3	10.1	12.5	17.2	12.0	6.2	15.9	15.3	48.4	15.4	12.7	15.7	12.0	12.9	13.4	12.9	12.1	13.9	8.3	21.9	15.8	16.0	14.4	12.7	16.3	17.4	11.2	15.5	20.7	11.7	12.2	17.8	18.6	19.4	10.3	25.4	18.9	20.7	17.9	24.3	8.9	23.1	16.7	15.5	20.6	18.5	10.4	19.1	5.0	16.2	12.8	9.2	13.7	14.9	13.4	7.3	15.1	13.1	18.2	16.9	24.1	56.2	41.7	18.3	19.4	21.7	10.6	13.2	12.5	16.2	17.4	21.1	12.3	14.1	16.8	15.0	13.9	22.3	16.8	2.7	11.7	19.3	15.4	13.2	10.1	13.3	14.8	13.4	19.6	12.3	13.9	18.3	11.0	23.2	14.8
THYN1	THY28	ENSG00000151500	"Thymocyte nuclear protein 1"	Q9P016	11	134248279-134253370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038732, HPA038733"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA038732: AB_10697397, HPA038733: "	"unprognostic (5.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.48e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.01e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.61e-2)"	20.1	22.4	36.7	13.3	39.3	21.4	26.1	29.6	43.6	22.8	22.7	16.0	20.8	16.8	22.8	45.2	16.0	27.9	17.3	27.8	30.2	30.4	22.4	31.6	15.8	20.4	24.9	38.1	37.6	15.6	13.6	25.2	12.3	24.5	29.7	26.0	17.5	14.3	32.7	14.3	15.5	16.7	24.5	23.2	17.7	18.7	24.3	23.1	35.0	29.9	15.6	23.9	22.6	15.7	27.8	30.6	74.0	24.4	29.7	50.7	34.4	8.1	5.0	18.5	14.8	18.0	20.6	10.9	7.0	15.6	16.6	15.7	27.6	20.1	15.2	23.8	9.8	12.7	28.0	21.4	16.3	15.6	7.8	42.4	7.1	24.8	25.8	33.6	14.0	15.5	11.5	19.7	13.0	26.0	19.5	7.4	14.9	4.5	39.0	62.0	21.5	18.5	18.5	13.7	12.9	22.7	14.4	17.7	14.3	14.6	3.6	8.3	20.7	17.1	13.7	7.2	11.1	6.5	10.6	8.3	8.6	32.4	10.6	43.9	8.2	37.6	21.7	74.0	36.0	24.4	43.1	27.8	38.3	36.2	23.1	21.8	44.3	50.7	11.3	29.7	22.5	30.6	44.7	34.4	36.7	39.3	29.6	43.6	30.2	30.4	24.9	38.1	24.5	23.1
TIA1		ENSG00000116001	"TIA1 cytotoxic granule associated RNA binding protein"	P31483	2	70209444-70248660	"Disease related genes, Predicted intracellular proteins"	Apoptosis	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056961			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA056961: "	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.51e-3)"	"unprognostic (3.37e-3)"	"prognostic favourable (6.79e-5)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (8.05e-7)"	"unprognostic (4.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"prognostic favourable (1.02e-5)"	15.6	20.4	15.9	29.3	20.5	14.8	28.2	36.3	22.0	30.2	23.6	25.3	24.6	20.6	42.1	43.5	15.9	28.4	21.6	16.0	17.2	14.7	20.7	18.0	19.1	26.4	21.9	16.5	46.9	24.3	26.0	48.7	21.2	19.0	26.2	24.1	27.1	27.8	24.2	13.2	23.4	25.9	24.9	21.0	30.8	20.8	13.4	25.2	65.3	29.3	15.1	21.2	23.1	23.5	9.7	11.6	12.4	7.9	10.9	9.8	5.6	7.2	8.1	42.3	23.6	12.0	20.5	20.4	12.9	9.2	12.6	12.5	10.8	11.2	16.5	11.2	9.6	11.9	20.5	7.0	17.9	15.3	9.0	16.9	14.0	25.8	9.7	16.9	9.6	15.2	10.5	7.1	8.0	23.2	13.1	15.1	17.6	6.2	31.2	26.9	34.4	9.7	38.2	23.0	16.8	19.2	14.3	25.7	22.0	15.3	18.2	12.4	10.8	12.6	18.9	15.5	16.3	7.2	12.7	12.6	12.6	30.4	9.1	21.6	20.5	12.4	7.9	10.8	8.3	6.5	7.8	9.7	8.0	8.2	11.6	8.0	7.3	7.9	3.0	10.9	3.8	6.0	9.8	5.6	15.9	20.5	36.3	22.0	17.2	14.7	21.9	16.5	19.0	25.2
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.9;HEL: 18.3;HMC-1: 16.0;RT4: 19.0;SCLC-21H: 17.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	11.9	0.7	0.2	2.8	18.9	0.0	0.0	1.4	0.5	0.1	2.1	4.0	0.8	0.3	2.8	1.4	2.4	2.4	0.3	6.5	18.3	0.3	0.1	0.3	0.0	16.0	1.2	0.8	8.1	3.2	0.0	0.0	6.0	6.0	7.7	2.8	0.1	3.8	5.1	3.6	3.7	0.0	1.8	19.0	17.9	4.4	0.8	6.2	0.7	2.5	0.0	0.1	1.7	6.9	0.0	0.8	6.7	5.0	3.6	4.0	1.4	13.1	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1
TIAM2	STEF	ENSG00000146426	"T cell lymphoma invasion and metastasis 2"	Q8IVF5	6	154832697-155257723	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8"	"Cell line enhanced"	"Detected in many"		"AF22: 34.4;HDLM-2: 14.7;RH-30: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3"	"Group enriched"	"Detected in many"	5	"amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6"	"Low region specificity"	"Detected in many"			"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.6	2.1	5.3	1.7	9.4	0.7	1.5	7.9	21.1	1.5	11.6	0.7	0.1	11.0	1.2	0.8	1.0	1.2	4.0	3.5	4.7	2.0	0.7	0.7	0.9	2.0	1.7	9.5	0.9	1.8	0.2	1.8	0.8	0.6	3.0	1.1	1.3	2.4	3.6	3.0	1.0	27.4	1.4	0.9	1.2	4.0	15.6	1.9	0.0	7.8	0.0	2.5	2.3	1.2	3.3	0.9	8.3	11.3	0.8	1.8	0.4	4.3	0.8	34.4	4.0	1.5	4.2	0.4	1.8	1.1	1.7	2.9	0.5	2.5	1.0	1.8	3.1	0.6	1.2	0.0	1.2	14.7	1.9	0.2	0.6	2.0	0.9	0.3	1.0	2.8	0.1	0.6	0.1	2.4	0.5	0.1	3.8	0.4	0.4	0.9	2.5	0.9	4.4	22.4	0.4	0.1	0.2	0.9	7.9	0.1	0.4	0.2	0.3	0.5	0.8	0.3	8.7	0.3	0.9	0.2	1.7	0.2	0.1	0.5	2.2	0.4	0.2	3.1	0.2	3.2	0.3	3.3	0.5	0.3	0.9	1.0	0.6	0.4	8.3	0.8	11.3	0.3	1.8	0.4	5.3	9.4	7.9	21.1	4.7	2.0	1.7	9.5	0.6	1.9
TICRR	"C15orf42, FLJ41618, MGC45866, SLD3, Treslin"	ENSG00000140534	"TOPBP1 interacting checkpoint and replication regulator"	Q7Z2Z1	15	89575482-89631056	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.0;lymphoid tissue: 21.7;tongue: 9.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046746, HPA049454"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA046746: , HPA049454: "	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-5)"	"unprognostic (7.73e-3)"	"prognostic unfavourable (2.87e-6)"	"unprognostic (1.64e-1)"	"unprognostic (1.31e-4)"	"unprognostic (5.87e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.54e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.59e-2)"	0.9	0.4	0.3	3.5	0.4	6.9	0.6	0.1	0.4	1.0	2.5	0.1	0.1	2.2	1.0	0.1	9.0	0.7	0.5	0.3	0.2	0.3	0.3	0.2	0.7	2.9	0.4	0.1	0.9	0.1	0.0	0.3	3.9	0.1	0.5	2.6	0.2	1.2	0.1	0.1	1.0	3.2	0.4	0.2	2.9	0.9	7.7	0.1	21.7	0.4	9.5	12.2	0.8	2.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	7.0	9.7	12.6	7.2	0.5	1.0	7.1	5.2	2.4	7.3	7.7	10.5	5.5	9.4	2.8	1.7	14.1	17.3	4.6	6.7	4.7	16.6	14.0	9.4	5.5	0.0	9.9	5.1	0.3	0.3	6.0	4.4	3.6	13.3	11.0	4.2	6.6	8.7	8.4	8.4	5.0	12.5	11.4	7.5	1.7	10.0	5.4	5.3	12.3	7.0	2.1	5.2	6.7	2.1	8.0	10.0	16.2	10.5	2.6	4.9	8.1	2.7	8.5	4.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.4	0.1	0.3	0.2	0.3	0.4	0.1	0.1	0.1
TIGAR	C12orf5	ENSG00000078237	"TP53 induced glycolysis regulatory phosphatase"	Q9NQ88	12	4307763-4354593	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Autophagy"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034010, HPA040354, HPA044111"	Approved		Supported	Cytosol				Cytosol		"CAB034010: AB_1128227, HPA040354: , HPA044111: "	"unprognostic (1.76e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (3.18e-4)"	"unprognostic (5.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.05e-1)"	14.3	14.3	8.3	12.3	10.8	10.5	7.1	3.7	17.8	6.3	10.4	10.1	6.4	6.7	7.5	7.3	10.3	5.7	8.5	9.8	9.5	7.9	7.7	11.0	10.4	12.3	13.5	7.9	6.0	5.2	9.0	14.4	14.6	12.2	7.5	13.5	8.4	8.2	9.5	13.6	6.2	8.7	12.5	12.3	14.9	8.5	8.4	8.3	8.9	6.0	6.6	12.6	13.9	8.9	3.7	14.0	4.7	15.5	3.2	5.7	3.6	5.7	9.2	7.5	8.6	7.0	6.9	39.3	9.9	8.4	7.6	10.3	11.1	5.9	6.3	1.4	6.8	7.2	7.9	16.9	9.5	8.3	5.8	0.2	6.1	9.1	15.0	3.5	1.3	12.3	20.4	8.8	16.0	15.3	0.7	4.8	15.2	8.4	3.1	1.8	16.0	2.8	4.5	12.1	2.3	7.4	11.6	0.3	4.5	9.3	4.7	12.2	1.5	3.1	13.2	10.2	13.2	8.0	5.5	4.1	4.0	10.9	7.2	2.4	8.1	0.5	8.2	0.7	3.6	14.4	3.4	3.7	2.8	3.9	14.0	2.9	1.9	3.2	4.7	3.2	15.5	5.5	5.7	3.6	8.3	10.8	3.7	17.8	9.5	7.9	13.5	7.9	12.2	8.3
TIGD7	Sancho	ENSG00000140993	"Tigger transposable element derived 7"	Q6NT04	16	3298832-3305729	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041357, HPA041474"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041357: AB_10794992, HPA041474: AB_10795696"	"unprognostic (7.69e-2)"	"unprognostic (3.04e-4)"	"unprognostic (6.56e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.04e-1)"	"unprognostic (5.90e-3)"	"unprognostic (3.12e-2)"	3.7	5.6	7.7	8.2	7.6	1.3	11.7	8.6	6.8	8.5	5.9	5.3	5.8	3.1	9.3	8.2	5.2	8.8	4.7	7.7	7.1	8.3	6.8	3.9	4.6	4.8	7.1	3.7	17.4	4.4	16.9	17.6	5.3	7.5	8.4	3.6	3.8	4.1	8.9	5.5	3.5	4.0	6.9	6.7	6.5	3.7	12.5	7.3	8.5	11.0	2.8	5.0	11.0	6.1	4.9	1.1	6.3	2.8	3.8	5.7	1.5	0.8	2.0	5.5	2.9	2.9	4.2	4.5	2.9	1.7	4.4	4.1	0.3	1.7	2.0	4.6	2.1	0.5	1.9	0.8	5.6	0.1	2.8	5.7	1.7	0.1	3.3	0.9	7.6	4.4	1.4	4.1	1.3	3.3	2.8	3.6	3.7	1.2	1.8	8.7	6.2	4.9	10.1	1.3	8.3	2.4	0.5	7.5	2.8	6.7	0.9	2.5	3.2	3.3	1.1	2.6	6.4	2.7	1.6	7.6	7.7	6.3	1.6	3.3	3.0	1.0	1.4	6.3	3.3	1.0	5.7	1.6	2.8	4.8	1.0	4.9	5.5	3.6	3.5	3.8	2.8	1.1	2.9	1.5	7.7	7.6	8.6	6.8	7.1	8.3	7.1	3.7	7.5	7.3
TIMELESS	"hTIM, TIM, TIM1"	ENSG00000111602	"Timeless circadian regulator"	Q9UNS1	12	56416373-56449403	"Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA060655	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA060655: "	"unprognostic (3.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (1.43e-3)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (7.03e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (2.61e-5)"	"unprognostic (9.47e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.01e-2)"	4.5	6.1	3.3	13.4	9.9	19.2	13.9	4.8	8.7	5.5	6.6	5.3	6.7	5.9	5.9	4.9	10.9	4.1	3.9	3.1	4.4	3.0	5.8	14.0	6.0	14.3	9.2	2.6	3.4	7.8	7.3	9.8	10.7	6.7	4.8	8.8	7.8	6.3	3.7	5.2	5.4	7.9	5.6	7.0	10.8	5.9	7.8	6.6	30.4	6.5	4.8	17.3	5.9	5.8	9.1	2.0	0.6	2.5	2.4	3.0	1.7	12.5	29.1	37.1	17.1	3.3	3.4	21.1	13.7	8.3	19.6	15.5	14.7	18.5	36.5	14.0	7.9	10.8	27.0	10.7	18.1	17.3	15.2	28.0	15.6	10.8	1.7	21.0	20.8	2.3	3.4	14.0	8.5	10.3	26.0	33.0	16.4	24.6	29.7	16.4	26.3	12.3	29.9	18.9	17.8	7.6	16.1	28.6	19.8	25.5	14.5	4.0	25.6	16.6	6.1	15.3	15.4	13.9	11.2	12.5	15.9	20.4	7.1	12.9	18.2	0.1	1.0	0.6	3.0	2.5	0.6	5.7	1.9	2.1	1.6	9.1	1.5	0.6	0.3	2.4	1.7	2.0	2.6	1.7	3.3	9.9	4.8	8.7	4.4	3.0	9.2	2.6	6.7	6.6
TIMM10	"TIM10, TIM10A, TIMM10A"	ENSG00000134809	"Translocase of inner mitochondrial membrane 10"	P62072	11	57528463-57530803	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039946	Supported		Enhanced	Mitochondria				Mitochondria		"HPA039946: AB_10673023"	"unprognostic (9.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.40e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.15e-2)"	22.2	19.5	29.1	16.7	28.5	18.3	27.4	14.8	34.3	16.6	21.6	17.1	25.9	16.8	13.7	29.1	20.2	16.0	15.4	25.2	25.1	22.7	26.7	41.3	13.1	25.1	27.2	24.6	13.0	25.8	18.3	14.3	13.8	19.9	14.4	23.1	15.8	23.8	20.2	32.3	15.3	12.4	17.2	21.0	20.1	15.9	20.5	16.1	18.4	18.5	25.9	29.8	13.6	12.1	45.1	38.8	5.9	22.6	16.5	33.4	32.4	26.9	41.2	19.4	18.5	16.8	14.4	24.5	23.1	18.6	37.0	21.1	30.3	23.7	51.4	26.6	20.5	20.7	27.5	26.8	33.5	17.4	20.3	32.6	15.8	38.9	17.8	42.6	36.8	13.5	21.8	35.8	25.0	22.8	36.0	23.5	27.1	57.4	22.9	57.1	20.4	44.4	38.6	40.8	44.8	18.7	18.7	15.7	20.2	24.4	48.7	29.5	36.3	16.3	14.3	21.4	39.9	36.6	44.3	32.9	43.0	41.3	19.7	21.5	35.5	5.9	22.6	5.0	19.9	21.4	22.8	45.1	24.5	21.9	38.7	41.9	33.4	29.1	1.3	16.5	19.8	38.8	21.3	32.4	29.1	28.5	14.8	34.3	25.1	22.7	27.2	24.6	19.9	16.1
TIMM13	"Tim13, TIMM13B"	ENSG00000099800	"Translocase of inner mitochondrial membrane 13"	Q9Y5L4	19	2425624-2427894	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048985	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"				Mitochondria	"Nucleoli fibrillar center"	"HPA048985: "	"unprognostic (5.47e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.15e-2)"	"prognostic favourable (4.68e-5)"	"unprognostic (8.67e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (9.77e-4)"	"unprognostic (4.91e-2)"	"prognostic favourable (3.88e-5)"	"unprognostic (4.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.47e-2)"	18.5	38.2	21.7	21.3	19.9	25.0	15.7	15.9	28.6	14.6	26.4	18.5	19.8	43.0	14.2	20.4	32.5	17.1	22.9	28.1	20.6	19.1	29.4	49.8	13.6	20.7	23.1	19.3	22.5	57.0	9.7	16.9	21.5	21.1	20.6	14.7	16.7	32.7	26.1	56.6	22.3	34.5	13.7	17.3	21.7	25.6	33.3	17.4	23.6	20.0	44.6	18.5	15.7	17.4	21.1	72.7	10.5	36.1	19.6	21.0	24.5	28.7	30.2	11.0	21.7	6.2	6.3	15.1	16.8	5.9	12.4	9.1	43.5	14.6	17.3	6.0	5.5	21.3	17.0	22.8	3.4	15.9	59.9	14.4	29.4	33.1	17.8	28.0	15.8	14.6	12.4	13.6	9.3	14.8	29.3	26.1	4.9	12.0	32.9	38.4	30.8	44.4	24.9	8.8	46.7	12.0	24.7	41.0	37.7	7.6	31.1	19.4	20.7	31.1	13.8	14.7	16.2	27.4	33.5	41.2	21.1	18.1	15.0	38.3	22.2	6.3	36.1	10.5	14.5	33.2	17.8	21.1	16.6	15.2	32.6	19.9	21.0	17.9	2.3	19.6	19.5	72.7	16.3	24.5	21.7	19.9	15.9	28.6	20.6	19.1	23.1	19.3	21.1	17.4
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955491-201970661	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA010083	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavourable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	16.6	27.6	22.7	18.7	23.2	16.9	16.8	16.3	29.3	16.5	19.3	9.9	19.2	17.2	15.0	24.1	17.9	11.8	10.7	39.0	32.3	19.6	25.1	53.7	13.5	15.3	20.6	27.0	11.2	18.7	21.5	14.8	17.4	25.0	14.5	21.8	11.7	24.8	17.1	42.1	11.5	13.0	19.6	13.4	14.4	16.3	13.7	14.2	11.3	21.6	30.4	18.9	15.9	12.7	17.6	28.9	16.0	24.9	15.9	20.6	17.8	25.9	26.5	24.1	28.8	20.3	21.4	40.7	41.6	29.8	34.1	30.7	31.1	27.1	36.1	15.3	35.5	20.8	44.1	24.8	36.9	26.4	27.6	19.9	35.3	29.3	21.0	42.3	21.4	24.6	27.7	34.9	29.2	35.6	50.1	20.3	40.0	16.6	22.7	22.9	30.5	14.3	22.4	28.0	45.1	41.9	24.8	36.4	25.7	25.4	65.2	38.4	36.0	28.8	28.5	22.8	24.2	26.5	43.1	30.7	33.1	30.3	24.3	32.3	25.4	8.9	19.0	16.0	13.6	24.9	17.5	17.6	14.9	17.2	28.9	12.7	14.2	16.7	4.4	15.9	24.7	19.3	20.6	17.8	22.7	23.2	16.3	29.3	32.3	19.6	20.6	27.0	25.0	14.2
TIMM23	TIM23	ENSG00000265354	"Translocase of inner mitochondrial membrane 23"	O14925	10	45972449-46003734	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA031408	Approved		Supported	Mitochondria				Mitochondria		"HPA031408: AB_10600828"	"unprognostic (4.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"prognostic favourable (6.79e-4)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.21e-1)"	5.7	4.6	1.2	6.8	3.8	6.0	13.6	4.1	8.6	2.6	4.2	1.5	5.8	6.1	2.9	7.3	4.2	2.4	3.2	11.5	5.3		6.6	8.3	4.8	9.9	1.6	2.5	2.2	2.8	3.0	3.4	8.1	5.5	3.4	4.1	2.6	7.5	5.2	16.2	2.4	3.5	3.6	2.2	2.5	2.8	17.2	1.4	4.5	4.5	4.0	4.4	3.3	1.7	29.5	39.7	18.5	45.3	26.7	29.8	39.6	40.4	42.7	28.4	28.6	23.6	22.2	27.7	33.5	40.3	40.8	43.4	53.8	32.3	36.3	27.8	35.2	35.0	43.3	35.8	40.5	26.9	42.7	23.1	32.1	57.8	38.1	42.9	25.9	26.5	31.9	34.9	49.7	37.7	40.9	20.5	35.8	40.6	38.3	59.7	34.3	13.3	29.7	27.4	26.6	45.8	28.4	33.4	30.7	18.6	41.4	33.4	43.8	25.7	27.6	19.8	34.5	25.2	47.5	21.9	36.1	50.9	36.8	62.2	16.4	15.7	35.6	18.5	28.0	45.3	28.7	29.5	27.1	29.8	39.7	27.9	24.6	27.2	8.2	26.7	39.3	32.8	29.6	39.6										
TIMM29	C19orf52	ENSG00000142444	"Translocase of inner mitochondrial membrane 29"	Q9BSF4	19	10928733-10933535	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041858	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA041858: AB_10963429"	"unprognostic (8.45e-2)"	"prognostic favourable (9.93e-5)"	"unprognostic (8.99e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-3)"	"prognostic favourable (7.03e-7)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.26e-3)"	13.4	11.4	13.8	11.0	18.0	18.4	8.0	19.9	16.4	8.5	9.9	10.3	7.6	17.5	11.3	7.1	13.8	8.6	9.4	12.5	15.1	8.9	10.5	13.5	8.1	11.6	13.5	9.3	8.3	17.1	7.0	10.8	12.2	11.9	9.9	5.1	11.3	16.8	9.5	30.9	12.1	12.4	10.3	8.3	11.7	15.0	11.3	13.2	12.0	9.2	8.9	9.7	10.1	10.6	13.6	10.3	8.7	8.7	10.9	12.0	3.2	10.7	3.9	3.0	5.2	2.6	2.6	8.8	7.4	3.7	5.3	4.9	7.0	3.5	9.0	13.2	3.3	10.0	1.6	4.4	0.9	10.8	13.0	10.5	4.0	4.7	4.2	7.4	8.0	2.2	4.2	3.7	1.5	3.2	11.3	7.6	2.0	8.7	8.5	14.5	11.2	17.2	11.6	4.4	11.0	2.2	4.1	8.0	8.3	8.6	4.5	8.7	6.5	8.1	5.4	8.6	5.2	11.0	11.3	26.5	25.8	9.7	5.4	9.5	7.1	3.5	7.9	8.7	5.6	8.7	8.8	13.6	10.8	12.0	5.6	10.6	10.1	8.5	1.7	10.9	6.7	10.3	11.0	3.2	13.8	18.0	19.9	16.4	15.1	8.9	13.5	9.3	11.9	13.2
TIMM44	TIM44	ENSG00000104980	"Translocase of inner mitochondrial membrane 44"	O43615	19	7926718-7943920	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043052	Supported		Enhanced	Mitochondria				Mitochondria		"HPA043052: AB_10795713"	"unprognostic (1.75e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.18e-2)"	12.8	15.3	11.8	13.0	12.4	7.5	12.7	16.2	17.2	10.8	15.3	8.5	14.1	16.1	12.1	11.8	19.4	10.8	12.6	39.2	12.9	10.3	13.5	19.7	9.0	9.2	11.7	7.7	13.8	20.2	7.4	10.3	8.9	12.3	10.8	6.3	8.5	17.3	21.4	48.8	12.6	10.5	17.7	9.0	12.2	12.2	9.4	11.6	5.8	12.5	26.6	8.8	13.0	9.4	9.0	16.2	10.1	12.2	9.6	12.1	8.4	18.2	10.7	5.7	10.0	10.0	9.3	8.4	11.0	9.0	15.3	13.9	23.6	3.9	26.8	12.8	9.2	12.8	23.5	12.4	3.9	12.5	35.8	13.5	9.1	19.8	24.5	16.1	5.6	10.8	15.9	13.0	16.2	9.7	24.7	9.6	6.6	18.6	14.0	10.6	16.6	45.4	14.8	8.2	12.6	6.7	11.8	13.7	7.1	9.8	13.4	31.3	8.2	15.7	5.1	7.3	11.5	18.5	20.8	18.8	23.7	26.1	5.2	23.5	12.3	10.1	11.7	3.7	12.1	12.2	10.7	8.7	11.1	11.2	16.2	9.0	10.7	10.4	0.6	9.6	7.2	13.2	9.4	8.4	11.8	12.4	16.2	17.2	12.9	10.3	11.7	7.7	12.3	11.6
TIMM50	TIM50L	ENSG00000105197	"Translocase of inner mitochondrial membrane 50"	Q3ZCQ8	19	39480412-39493785	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"	RNA-binding	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048843, HPA056448"	Enhanced		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA048843: , HPA056448: "	"unprognostic (1.49e-1)"	"unprognostic (6.97e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.04e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.04e-2)"	21.3	20.2	17.9	17.0	25.8	23.0	15.7	14.3	38.2	13.4	18.4	18.0	14.4	18.0	19.0	11.7	22.6	15.8	12.5	42.2	17.6	17.4	23.9	28.0	14.2	16.6	17.8	20.2	16.4	19.8	16.4	13.4	20.0	22.0	15.3	12.0	18.1	18.3	14.6	58.1	14.0	16.1	16.5	12.7	15.1	16.9	40.4	14.7	18.5	24.0	25.5	16.9	16.9	18.2	19.3	27.4	10.3	25.3	17.0	19.9	27.8	26.6	64.0	11.9	29.7	10.5	9.6	21.7	21.1	10.8	25.0	20.5	45.9	18.9	30.2	22.4	14.2	15.3	23.8	21.8	13.4	26.3	34.7	28.0	18.7	31.6	16.0	54.5	19.4	12.2	15.5	18.7	17.2	16.2	44.7	18.1	15.7	35.3	33.3	20.9	20.7	24.5	34.0	23.8	23.2	17.2	36.8	31.6	17.7	25.3	37.0	43.3	17.3	29.6	16.3	31.1	29.0	25.6	49.0	17.1	31.5	45.5	23.3	27.4	34.5	10.3	25.3	6.1	16.9	24.0	17.3	19.3	16.2	18.5	27.4	18.1	18.4	17.0	2.1	17.0	22.4	20.6	19.9	27.8	17.9	25.8	14.3	38.2	17.6	17.4	17.8	20.2	22.0	14.7
TIMM8A	"DDP, DFN1, MTS"	ENSG00000126953	"Translocase of inner mitochondrial membrane 8A"	O60220	X	101345659-101349196	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	"Deafness, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003628	Supported		Supported	Mitochondria				Mitochondria		"HPA003628: AB_1080284"	"prognostic unfavourable (7.89e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (8.87e-5)"	"unprognostic (2.06e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.86e-3)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-3)"	"prognostic favourable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.86e-2)"	6.8	6.9	7.6	7.5	12.2	7.0	8.0	5.2	13.3	5.6	7.8	6.1	3.1	6.9	6.5	5.7	10.4	6.2	4.1	11.8	7.6	7.2	12.1	27.7	4.9	8.4	8.6	8.2	7.2	17.0	5.5	4.5	6.9	11.9	7.5	8.6	5.7	6.7	4.2	10.1	8.1	7.4	5.4	6.1	6.3	5.6	4.0	6.5	6.5	7.1	16.4	9.4	4.9	6.5	14.1	11.6	1.9	5.3	5.8	11.1	4.8	10.6	9.3	5.3	9.9	4.2	4.5	6.9	7.4	3.6	6.7	13.3	8.3	6.7	11.0	10.1	5.7	8.3	14.0	8.2	9.8	5.1	9.4	21.4	12.3	13.8	3.9	12.1	74.9	4.3	6.6	9.5	5.9	6.7	15.3	12.6	8.5	15.8	5.8	12.0	17.9	15.6	9.5	9.7	15.5	5.8	7.2	7.0	6.2	9.3	7.1	6.7	6.0	6.1	5.0	8.7	10.7	12.1	8.3	6.1	13.9	14.6	4.7	16.3	6.6	1.9	4.4	0.2	6.7	5.3	7.8	12.2	7.3	7.7	5.1	14.1	11.1	9.3	0.6	5.8	3.0	11.6	3.8	4.8	7.6	12.2	5.2	13.3	7.6	7.2	8.6	8.2	11.9	6.5
TIMM9	TIM9A	ENSG00000100575	"Translocase of inner mitochondrial membrane 9"	Q9Y5J7	14	58408494-58427614	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002932	Approved		Supported	Mitochondria				Mitochondria		"HPA002932: AB_1080287"	"prognostic favourable (8.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (9.89e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (6.39e-5)"	"unprognostic (3.41e-1)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.77e-2)"	22.2	20.8	23.0	14.6	33.9	14.6	25.0	18.7	25.2	18.2	22.5	16.4	19.5	19.7	20.3	29.7	23.3	18.8	19.7	18.7	20.8	19.1	23.7	21.4	14.5	25.9	20.2	20.6	31.8	42.8	11.9	18.9	17.5	22.1	19.5	15.0	15.4	29.1	20.3	33.5	17.8	13.9	25.9	20.9	18.5	20.2	21.4	22.3	20.1	25.2	24.8	19.3	26.6	17.9	17.6	14.3	4.0	10.6	16.5	19.2	7.6	25.1	21.5	17.1	16.5	19.7	35.9	23.3	24.5	13.0	18.5	16.4	21.8	27.2	33.6	26.4	14.2	17.6	22.6	23.7	27.0	22.5	12.9	17.5	14.6	24.7	49.5	28.1	16.8	28.4	30.2	18.0	36.7	19.0	28.1	20.9	18.6	42.6	26.0	35.0	14.6	37.9	22.1	25.9	21.2	24.6	22.4	21.9	13.1	15.6	40.3	42.6	28.6	16.5	18.9	23.5	32.2	15.5	26.5	14.4	14.2	30.9	18.4	27.3	27.5	4.0	9.0	2.2	9.4	10.1	17.4	17.6	15.0	13.9	13.1	14.4	19.2	17.7	0.9	16.5	10.6	14.3	15.1	7.6	23.0	33.9	18.7	25.2	20.8	19.1	20.2	20.6	22.1	22.3
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498532-119525090	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA053214: , HPA055846: "	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	13.6	17.2	18.1	10.4	16.7	5.9	13.8	8.6	16.2	16.4	12.2	20.4	21.5	9.2	13.3	19.4	18.5	13.6	14.9	43.9	15.9	15.4	22.8	20.5	13.0	15.9	20.9	11.9	11.8	12.5	20.4	17.4	21.4	16.4	15.2	14.5	14.0	14.3	21.6	37.2	16.0	15.3	12.7	21.9	14.3	12.3	13.3	15.6	9.9	19.9	20.3	14.5	16.7	11.1	12.4	13.8	16.3	15.5	8.5	15.8	15.5	14.0	13.2	6.6	5.6	25.7	17.3	14.9	4.1	13.8	12.0	13.8	8.9	8.7	10.3	7.1	14.5	6.6	16.5	13.4	19.6	8.6	5.9	7.6	6.2	10.0	13.5	5.9	5.0	15.1	20.7	9.6	12.5	16.9	10.3	9.9	22.0	17.5	6.1	12.5	8.8	16.5	5.2	4.6	13.5	18.0	7.0	8.8	16.3	4.2	6.4	15.8	10.6	16.2	8.4	6.8	5.1	6.1	7.1	6.4	6.0	14.0	11.5	15.0	10.6	6.8	13.8	16.3	8.4	13.0	10.1	12.2	8.3	10.3	13.8	12.4	10.4	9.0	3.4	8.5	15.5	11.9	15.8	15.5	18.1	16.7	8.6	16.2	15.9	15.4	20.9	11.9	16.4	15.6
TINF2	TIN2	ENSG00000092330	"TERF1 interacting nuclear factor 2"	Q9BSI4	14	24239643-24242674	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"parathyroid gland: 268.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059061, HPA069807"			Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nuclear bodies"	Nucleoplasm	"HPA059061: , HPA069807: "	"prognostic favourable (4.96e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.78e-2)"	"unprognostic (7.44e-2)"	15.8	27.8	10.4	17.0	11.3	13.3	18.2	10.1	16.7	14.5	13.1	17.9	12.9	9.5	16.8	16.1	22.4	12.6	13.7	12.4	9.3	8.9	14.8	11.4	18.8	27.0	13.7	9.8	15.4	17.1	268.9	11.9	15.3	10.9	13.5	12.5	11.3	14.8	15.5	14.9	13.9	12.9	15.1	11.7	21.0	14.5	7.7	12.4	26.1	16.6	12.6	19.5	14.9	14.2	27.3	17.7	46.9	21.4	25.4	27.4	28.8	11.6	10.7	15.5	8.1	17.1	12.8	7.9	12.0	15.2	17.6	16.5	4.6	13.1	17.1	6.9	16.9	11.5	8.7	10.7	11.2	21.7	4.4	10.7	9.8	18.3	14.8	11.3	15.5	14.0	17.3	14.1	13.5	19.0	4.2	21.9	14.2	12.8	17.0	5.6	3.6	13.3	14.0	9.9	12.4	15.7	16.8	9.5	8.8	12.5	11.9	10.7	8.5	7.3	15.2	8.3	10.1	14.0	9.3	16.9	12.0	9.7	9.9	6.4	12.2	41.6	20.6	46.9	27.4	21.4	21.8	25.7	21.6	25.5	17.7	27.3	22.8	22.8	26.0	25.4	19.6	15.0	25.2	28.8	10.4	11.3	10.1	16.7	9.3	8.9	13.7	9.8	10.9	12.4
TIPRL	"dJ69E11.3, MGC3794, TIP41, TIPRL1"	ENSG00000143155	"TOR signaling pathway regulator"	O75663	1	168178933-168202114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027995, HPA054282"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA027995: AB_10602900, HPA054282: "	"unprognostic (3.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-3)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (1.45e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.61e-2)"	19.6	22.3	17.0	18.6	29.6	29.7	21.4	18.4	29.1	19.4	21.9	11.2	12.9	18.9	25.9	17.7	28.5	17.5	17.1	23.1	17.4	20.5	22.9	38.3	16.2	20.2	18.0	19.3	21.6	22.2	23.8	31.9	19.8	23.1	19.9	22.7	11.4	17.9	18.6	32.0	16.2	23.2	23.5	16.0	19.0	16.1	22.8	12.4	35.2	17.8	21.1	21.2	23.3	18.5	17.7	21.5	36.2	21.4	19.3	23.9	17.7	26.4	11.5	18.2	16.5	14.9	21.6	10.8	19.8	20.9	21.7	19.5	17.9	19.7	18.5	27.4	18.9	32.0	13.5	19.3	21.0	17.8	13.8	17.9	12.0	8.6	26.2	35.6	24.8	17.4	24.8	18.9	25.3	22.8	25.8	26.4	18.7	9.2	31.8	18.5	14.6	20.7	15.6	18.6	25.3	19.5	13.0	11.8	26.3	15.3	21.7	38.8	23.7	36.7	20.7	18.4	21.1	17.2	26.7	28.9	29.9	41.3	12.0	23.6	21.0	36.2	18.7	24.2	16.2	21.4	16.2	17.7	19.0	17.2	21.5	17.7	17.1	16.9	24.2	19.3	21.4	16.1	23.9	17.7	17.0	29.6	18.4	29.1	17.4	20.5	18.0	19.3	23.1	12.4
TJAP1	"PILT, TJP4"	ENSG00000137221	"Tight junction associated protein 1"	Q5JTD0	6	43477523-43506556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030164, HPA030165, HPA030166"	Supported		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858"	"unprognostic (5.05e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.03e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavourable (9.02e-6)"	"unprognostic (4.27e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.61e-3)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-3)"	"unprognostic (7.51e-3)"	15.9	21.1	24.1	17.9	42.4	18.0	16.6	17.4	32.4	17.4	18.4	59.9	14.1	22.3	23.1	12.4	13.2	18.7	14.9	18.5	22.4	11.2	14.8	16.3	15.9	20.8	45.2	18.3	31.4	22.6	17.4	17.0	16.4	25.2	21.2	10.6	17.6	21.1	19.9	28.4	15.5	19.3	17.2	25.3	22.2	17.0	18.7	46.7	14.4	21.2	9.0	16.0	18.0	15.8	10.2	7.6	15.2	10.7	6.6	12.9	8.7	22.4	8.9	15.7	23.4	12.8	12.0	17.4	14.3	15.4	15.3	16.7	13.4	9.9	12.5	10.9	13.1	20.0	13.1	17.0	9.8	21.5	20.2	15.9	15.6	14.6	15.3	16.1	23.1	13.6	23.1	18.9	16.8	10.0	13.6	23.8	13.4	12.5	15.7	26.8	13.6	13.7	19.0	10.3	13.4	9.3	12.5	10.3	14.4	12.2	7.5	18.7	13.4	31.8	8.7	20.5	15.9	17.0	21.1	17.4	14.4	22.4	8.9	18.5	17.3	15.2	9.6	7.2	10.4	10.7	12.9	9.1	8.4	8.8	7.2	10.2	9.6	10.3	5.3	6.6	9.1	7.6	4.8	8.7	24.1	42.4	17.4	32.4	22.4	11.2	45.2	18.3	25.2	46.7
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968865	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"				"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favourable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	22.1	11.7	27.5	9.2	32.8	2.2	18.0	12.0	36.3	24.8	16.9	37.5	10.7	10.9	29.5	27.6	45.7	22.9	18.2	26.0	28.3	19.1	20.4	20.8	31.1	7.8	29.3	21.3	23.6	19.4	30.1	17.7	38.3	23.4	17.8	15.5	15.2	18.5	15.4	16.4	17.8	14.4	29.4	31.7	10.1	16.7	25.9	32.6	1.2	23.1	17.9	13.2	18.5	27.3	0.7	0.2	0.3	0.4	1.0	0.2	0.1	26.0	19.2	10.6	8.6	9.4	13.1	12.0	8.1	7.2	6.8	7.7	26.5	10.5	0.1	11.0	10.8	19.6	6.5	9.1	8.7	0.2	7.2	0.1	10.3	11.2	25.2	0.0	0.3	7.2	6.5	8.3	16.2	15.0	9.7	5.4	5.2	14.4	0.1	0.2	9.7	6.1	0.0	14.9	0.0	13.6	16.0	5.2	7.4	16.7	7.3	6.9	5.0	0.3	23.6	7.0	10.6	4.8	11.1	1.9	1.8	0.1	7.9	0.1	3.9	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.2	0.3	1.0	0.4	0.2	0.2	0.1	27.5	32.8	12.0	26.1	28.3	19.1	29.3	21.3	23.4	32.6
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69255208	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.0"									"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"			790000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: "	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favourable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	25.2	9.5	23.7	8.0	29.7	5.7	20.7	35.6	24.9	9.0	20.0	50.3	20.6	27.2	11.9	7.3	28.9	12.6	13.2	19.8	35.1	12.7	23.3	34.5	23.9	5.8	39.7	20.5	20.9	13.2	43.2	3.6	18.0	32.0	13.5	16.7	19.1	18.0	23.1	8.3	18.6	25.7	15.3	39.7	3.5	30.4	17.8	41.1	11.1	22.5	9.0	10.8	26.5	26.6	0.0	0.2	0.4	4.0	0.0	0.5	0.5	53.2	1.7	4.2	4.7	20.1	19.7	23.2	8.1	5.9	12.9	7.0	6.4	19.4	7.6	8.1	4.5	32.7	6.9	17.0	14.7	27.2	5.0	7.4	4.6	32.8	5.6	3.0	14.0	15.3	12.3	10.1	6.0	27.1	4.4	5.2	6.7	7.4	1.1	0.4	10.4	11.6	3.9	6.1	0.8	33.3	35.5	1.9	3.3	2.9	20.7	0.6	6.7	1.6	38.8	9.7	10.5	7.5	8.2	5.3	1.1	0.1	11.1	4.3	3.5	0.0	0.7	0.0	0.0	1.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.4	0.0	4.0	0.1	0.5	0.5	23.7	29.7	35.6	17.5	35.1	12.7	39.7	20.5	32.0	41.1
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708109-3750813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 22.3;CAPAN-2: 22.4;MCF7: 9.9;SK-BR-3: 13.0;T-47d: 27.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB013244: AB_2533257, HPA046863: , HPA053337: "	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favourable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favourable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.3	8.4	0.4	0.0	3.6	0.2	0.3	3.3	34.9	0.7	15.0	23.0	0.7	5.0	16.0	7.9	22.8	0.6	0.5	0.1	4.4	8.0	10.1	0.6	0.2	0.2	2.2	5.9	2.0	1.6	2.7	1.1	2.6	7.7	1.6	26.1	20.5	0.4	4.3	47.0	0.6	0.2	0.4	15.2	1.4	0.2	0.6	5.5	2.6	8.3	4.5	3.4	1.0	0.0	0.0	0.0	0.0	6.2	1.7	0.1	3.3	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	6.6	22.4	4.0	0.6	0.0	5.2	0.3	0.0	0.0	0.2	0.1	0.0	0.5	1.6	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.0	0.1	0.4	0.1	0.0	0.0	2.9	0.7	3.5	0.1	0.1	0.8	13.0	0.0	27.5	0.1	0.0	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	6.2	0.7	4.8	3.8	0.0	1.0	5.3	1.9	0.0	0.0	0.0	0.0	5.5	1.7	0.3	0.4	0.2	0.3	0.5	0.1	0.2	0.2	1.1	0.2
TKT		ENSG00000163931	Transketolase	P29401	3	53224707-53256052	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 216.3"	"Cell line enhanced"	"Detected in all"		"A549: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm			190000000	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	53.6	37.0	21.2	24.1	26.0	216.3	70.1	18.1	24.3	19.0	24.3	21.1	9.9	31.8	16.9	9.5	60.4	21.8	36.5	15.3	19.4	23.0	51.9	27.4	50.1	45.6	33.4	16.0	35.2	69.9	22.5	16.9	29.8	28.7	25.2	19.6	17.5	21.0	21.6	5.2	16.8	22.5	34.5	28.2	45.6	24.5	10.8	23.3	44.8	67.7	37.9	25.1	58.2	57.3	6.8	32.5	60.1	63.0	4.7	5.7	37.6	31.8	161.2	23.1	25.6	51.5	63.0	47.1	21.6	37.5	37.4	35.8	44.5	82.0	40.1	10.4	31.5	46.2	40.0	81.3	11.1	13.3	22.2	26.7	112.8	66.8	63.0	32.6	18.1	45.5	46.8	44.8	23.1	47.1	19.0	17.5	15.2	38.9	34.0	36.5	78.3	38.9	20.6	10.5	74.5	58.5	54.2	15.0	11.1	40.2	64.4	38.8	20.0	45.2	35.2	11.6	17.9	34.1	41.2	10.1	18.9	24.0	25.3	33.0	21.5	7.0	63.0	41.5	3.0	31.0	3.8	6.8	4.4	3.4	32.5	3.5	4.6	3.4	60.1	4.7	35.5	5.5	5.7	37.6	21.2	26.0	18.1	24.3	19.4	23.0	33.4	16.0	28.7	23.3
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295671-154330350	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"blood: 28.6;testis: 103.6"	"Cell line enriched"	"Detected in single"	157	"THP-1: 100.4"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 28.6;gdT-cell: 12.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 28.6;T-cells: 12.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA000505, CAB032191"	Enhanced		Supported	Cytosol				Cytosol		"CAB032191: , HPA000505: AB_1858022"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.1	3.3	12.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	100.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.0	28.6	12.0	0.1	1.8	0.0	1.4	1.1	0.0	0.0	3.1	2.7	0.4	3.3	0.1	0.1	1.5	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0
TLDC1	KIAA1609	ENSG00000140950	"TBC/LysM-associated domain containing 1"	Q6P9B6	16	84476421-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	5.5	4.9	7.6	7.1	10.7	1.8	7.3	8.1	11.5	8.1	7.1	6.3	5.2	6.0	14.0	8.8	24.4	6.9	6.5	4.7	6.3	4.5	7.6	5.1	6.4	6.1	5.0	9.4	8.7	5.2	11.3	4.4	15.8	10.7	7.8	7.8	12.9	7.7	6.1	4.5	11.0	9.3	10.7	4.0	5.4	6.8	8.1	3.4	8.3	7.6	6.5	10.0	10.4	12.1	3.3	2.7	13.6	3.5	3.1	8.7	2.6	14.4	10.2	9.0	4.8	4.1	7.2	4.2	10.7	9.6	11.0	3.2	5.8	17.5	2.0	5.8	20.6	16.1	2.5	28.7	14.6	1.0	2.1	1.6	5.0	5.0	5.1	1.2	5.0	5.0	12.5	10.3	13.6	4.6	2.6	2.5	7.4	3.4	1.1	1.2	2.7	3.5	4.5	2.3	0.6	9.8	8.1	2.9	2.1	9.7	6.9	4.8	10.0	1.9	11.2	7.8	3.5	4.1	4.4	2.0	3.4	5.3	4.6	0.6	2.6	13.6	3.1	4.4	3.8	2.7	3.7	3.3	6.8	5.5	2.7	2.7	7.6	4.7	3.1	3.1	3.5	0.8	8.7	2.6	7.6	10.7	8.1	11.5	6.3	4.5	5.0	9.4	10.7	3.4
TLE1	"ESG, ESG1, GRG1"	ENSG00000196781	"Transducin like enhancer of split 1"	Q04724	9	81583683-81689305	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011482, HPA071396"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB011482: AB_443210, HPA071396: "	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.59e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.65e-1)"	"prognostic favourable (8.07e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (7.60e-4)"	"unprognostic (4.09e-1)"	26.4	20.1	27.5	12.2	23.1	24.3	23.0	20.3	22.0	25.7	15.2	9.7	13.8	4.0	22.8	19.2	12.7	18.6	19.3	8.1	31.8	9.3	8.6	33.9	9.1	18.8	14.0	20.0	18.1	37.2	5.6	7.9	12.1	14.2	14.6	12.5	13.3	29.0	18.1	54.1	11.8	11.9	20.1	10.5	22.6	15.4	15.0	20.5	2.1	11.0	15.3	8.3	12.9	24.7	6.9	2.0	8.7	0.1	4.9	3.5	0.6	22.6	15.5	14.9	0.0	16.0	8.9	33.3	1.3	4.1	2.5	3.7	2.4	8.5	0.0	15.1	9.5	12.6	0.2	7.4	2.7	0.0	14.3	0.0	3.2	23.8	9.1	0.0	0.4	4.3	16.4	8.6	17.3	10.7	0.0	7.6	8.7	24.3	2.6	0.1	29.3	9.3	21.1	12.5	1.7	15.9	11.3	8.6	10.8	1.2	12.3	7.4	9.3	10.6	9.1	6.7	7.4	3.6	10.6	0.2	0.0	0.5	9.5	0.0	12.4	8.7	0.0	5.0	2.5	0.0	3.5	6.9	0.2	1.0	0.6	6.6	0.0	0.2	0.0	4.9	0.1	2.0	0.0	0.6	27.5	23.1	20.3	22.0	31.8	9.3	14.0	20.0	14.2	20.5
TLE2	"ESG, ESG2, FLJ41188, GRG2"	ENSG00000065717	"Transducin like enhancer of split 2"	Q04725	19	2997638-3047635	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.7;RT4: 19.6;T-47d: 14.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 85.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 3.1;T-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049103	Enhanced		Supported	"Nuclear bodies,Focal adhesion sites"				"Nuclear bodies"	"Focal adhesion sites"	"HPA049103: "	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-1)"	"prognostic favourable (2.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.87e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"prognostic favourable (2.39e-6)"	"unprognostic (2.12e-1)"	"prognostic favourable (9.49e-6)"	"unprognostic (2.66e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.60e-1)"	"prognostic favourable (8.88e-4)"	13.4	9.6	9.2	4.6	5.7	1.3	38.3	85.3	16.5	10.9	11.4	4.9	28.6	8.1	15.7	6.6	5.5	13.3	8.5	19.9	5.5	7.6	11.9	3.5	12.5	5.4	8.3	5.3	12.4	16.5	13.8	6.4	7.3	9.7	12.9	4.6	20.6	55.5	27.1	38.5	6.4	5.3	26.2	13.3	10.9	7.4	6.3	4.8	1.1	17.5	5.7	3.2	19.2	27.6	3.1	0.0	0.3	0.0	0.0	3.4	0.7	0.3	1.6	0.1	24.7	3.9	0.6	5.4	0.2	0.0	1.2	0.6	7.6	2.7	0.1	3.5	1.7	4.3	4.1	1.5	0.3	0.7	1.2	0.0	1.8	0.3	5.0	0.0	0.2	5.5	0.7	2.8	0.0	9.9	8.9	0.1	0.1	8.3	0.2	0.1	0.1	1.6	1.9	1.2	2.2	3.2	19.6	1.2	6.4	1.6	12.3	0.6	14.3	0.0	6.5	8.1	8.5	0.4	0.2	0.3	0.2	1.6	0.2	1.8	1.5	0.0	0.0	0.3	3.2	0.0	2.3	3.1	2.0	1.0	0.0	0.5	3.4	2.1	0.0	0.0	0.0	0.0	0.7	0.7	9.2	5.7	85.3	16.5	5.5	7.6	8.3	5.3	9.7	4.8
TLE3	"ESG, ESG3, GRG3, HsT18976, KIAA1547"	ENSG00000140332	"Transducin like enhancer of split 3"	Q04726	15	70047790-70098176	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 27.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054116	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA054116: "	"unprognostic (5.57e-2)"	"prognostic favourable (2.09e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.74e-1)"	18.7	5.5	10.1	28.8	6.3	62.9	13.1	6.1	11.2	16.0	16.5	10.4	14.2	16.5	9.9	9.2	24.1	8.6	11.3	8.6	8.6	6.9	10.9	13.8	16.8	15.4	7.6	5.7	12.3	14.7	5.2	9.2	34.4	9.5	19.4	7.2	11.3	15.7	18.1	7.6	21.6	27.4	7.5	12.5	20.9	14.1	18.4	6.5	30.7	14.8	12.8	28.0	10.2	15.8	6.0	4.8	27.1	2.7	1.5	2.0	0.8	2.9	9.3	5.7	8.2	4.6	4.4	30.2	1.0	2.1	1.3	0.9	12.9	8.4	7.6	12.7	1.0	5.3	14.3	5.2	1.4	10.8	17.6	12.5	19.0	2.2	4.4	4.2	19.6	7.5	2.1	4.7	3.8	6.8	9.4	35.0	2.2	8.0	14.1	10.7	5.2	9.6	13.2	5.0	8.8	2.4	17.4	7.3	10.7	23.2	10.6	10.4	11.7	9.1	4.3	3.9	7.6	11.4	6.5	33.4	21.1	13.2	5.6	12.8	9.3	1.3	2.7	1.3	1.1	2.6	1.0	6.0	1.5	1.4	1.6	2.9	1.6	2.0	27.1	1.5	2.7	4.8	0.9	0.8	10.1	6.3	6.1	8.7	8.6	6.9	7.6	5.7	9.5	6.5
TLE4	"E(spI), ESG, GRG4"	ENSG00000106829	"Transducin like enhancer of split 4"	Q04727	9	79571773-79726882	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 66.2"	"Cell line enhanced"	"Detected in many"		"BJ: 32.2;BJ hTERT+: 32.1;BJ hTERT+ SV40 Large T+: 30.3;fHDF/TERT166: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065357			Supported	Nucleoplasm				Nucleoplasm		"HPA065357: "	"unprognostic (6.68e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.94e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (6.94e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	6.1	11.6	11.6	11.6	25.3	40.0	6.9	22.5	21.2	7.4	7.3	28.8	3.6	6.0	11.4	5.5	12.8	10.3	13.0	6.2	14.7	11.3	5.6	4.4	8.9	10.8	28.9	15.0	26.1	5.3	14.0	45.2	14.6	20.4	4.9	8.6	8.6	7.5	7.1	23.8	13.5	8.0	11.2	31.2	12.4	10.5	66.2	30.3	18.8	8.1	5.1	14.2	12.2	9.3	1.2	2.2	17.3	4.7	2.3	4.8	2.0	0.0	5.8	23.5	0.1	4.3	3.6	7.2	32.2	32.1	30.3	12.1	0.8	3.3	2.6	0.0	50.4	6.8	1.6	5.7	14.7	11.6	10.0	0.0	2.8	0.1	4.6	6.8	4.2	4.1	4.2	8.7	1.6	7.8	0.5	7.0	10.0	0.2	8.9	2.9	7.4	1.4	8.1	12.4	2.3	1.9	0.8	9.7	14.4	4.5	0.6	0.0	0.0	7.9	11.3	11.7	0.0	0.2	1.6	4.6	7.4	3.4	4.2	6.0	5.4	17.3	3.4	12.9	3.9	4.7	4.8	1.1	2.1	2.9	2.2	1.2	1.2	2.1	9.2	2.3	3.6	0.8	0.5	2.0	11.6	25.3	22.5	21.2	14.7	11.3	28.9	15.0	20.4	30.3
TLK1	"KIAA0137, PKU-BETA"	ENSG00000198586	"Tousled like kinase 1"	Q9UKI8	2	170990823-171231314	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016043	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA016043: AB_1858027"	"unprognostic (2.13e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.36e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.53e-1)"	13.8	20.1	22.0	32.9	21.0	14.4	26.2	18.3	23.2	19.6	20.2	8.4	22.3	13.7	16.1	16.1	14.1	14.4	16.2	12.7	20.6	19.3	19.5	21.4	22.1	33.7	21.7	20.8	21.5	19.8	37.8	21.0	36.0	18.3	18.0	18.2	10.8	16.4	30.3	18.6	15.4	18.9	20.5	18.7	26.0	19.9	24.2	12.2	28.0	25.7	11.1	21.7	21.9	19.1	10.5	5.3	11.3	5.5	9.5	12.3	6.6	8.5	8.3	12.1	9.4	8.6	8.7	13.4	11.8	17.3	12.0	10.1	11.5	13.9	17.7	9.7	17.8	7.3	15.3	13.2	13.2	21.0	7.7	20.5	10.4	14.9	9.3	25.9	10.4	9.4	13.5	23.8	15.7	13.1	21.0	15.1	7.2	10.6	21.7	8.3	11.1	4.7	16.4	14.7	18.2	9.9	16.5	13.8	10.7	12.9	9.2	8.8	7.5	9.1	17.8	10.7	13.1	7.0	9.2	12.7	21.3	32.1	13.3	10.7	10.8	11.3	3.9	6.5	6.6	3.0	9.1	10.5	10.7	7.2	3.5	10.5	12.3	8.1	5.0	9.5	5.5	5.3	10.0	6.6	22.0	21.0	18.3	23.2	20.6	19.3	21.7	20.8	18.3	12.2
TLN1	"ILWEQ, TLN"	ENSG00000137076	"Talin 1"	Q9Y490	9	35696948-35732395	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002006, HPA004748"	Supported		Supported	"Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol"			3600000000	"Focal adhesion sites, Cytosol"	"Plasma membrane, Centriolar satellite"	"CAB002006: , HPA004748: AB_1857760"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (7.21e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.83e-2)"	"unprognostic (8.83e-3)"	47.4	23.7	10.9	29.3	16.6	25.1	38.1	9.6	11.8	34.7	64.0	18.8	22.8	13.0	57.4	20.6	41.2	38.3	48.4	30.3	11.1	7.1	30.5	36.1	33.0	26.0	17.9	7.3	39.0	12.8	19.6	14.6	30.4	14.4	39.5	15.5	22.8	14.9	43.6	24.5	16.5	27.6	87.0	12.4	54.1	38.2	17.3	14.1	33.4	20.7	12.5	20.7	72.5	49.6	3.3	6.8	12.7	9.2	4.8	7.1	7.1	11.3	19.0	11.8	16.2	40.6	30.9	13.5	31.7	34.9	30.8	27.9	15.7	5.1	13.8	10.5	58.5	6.2	13.8	19.7	22.6	31.1	8.9	31.3	24.7	13.9	25.2	18.9	52.4	37.3	9.4	45.3	21.5	47.2	10.7	14.2	40.6	5.0	12.7	4.9	9.6	14.7	17.1	6.9	8.0	15.4	9.1	2.6	11.3	15.4	8.6	10.1	7.3	13.1	56.9	49.2	19.1	15.0	25.5	4.9	4.8	9.6	38.1	10.2	44.3	6.7	7.0	8.4	7.1	7.8	5.9	3.3	4.2	5.4	5.3	3.2	2.0	4.2	12.7	4.8	9.2	6.8	2.8	7.1	10.9	16.6	9.6	11.8	11.1	7.1	17.9	7.3	14.4	14.1
TLN2	"ILWEQ, KIAA0320"	ENSG00000171914	"Talin 2"	Q9Y4G6	15	62390526-62844631	"Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.4;hTERT-HME1: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017194, HPA051828, HPA054787"	Enhanced		Supported	"Focal adhesion sites,Cytosol"			81000000	"Focal adhesion sites, Cytosol"		"CAB017194: , HPA051828: , HPA054787: "	"prognostic favourable (6.53e-4)"	"unprognostic (2.61e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.81e-6)"	"prognostic favourable (7.74e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.30e-1)"	12.5	3.1	7.0	12.1	7.0	2.3	5.3	5.4	18.9	5.6	24.3	4.0	1.7	3.3	6.5	4.2	3.4	3.2	6.3	8.5	6.8	6.0	36.9	1.8	1.9	1.3	6.2	4.2	7.0	3.3	2.3	3.0	2.4	4.5	3.1	5.4	5.5	5.4	1.6	16.9	1.6	16.6	6.9	9.6	0.8	4.1	3.5	1.3	0.9	29.0	4.5	1.3	4.3	7.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.8	2.6	3.9	4.5	29.4	2.8	4.3	6.5	5.1	6.0	6.0	7.1	0.9	2.2	3.0	11.3	1.1	4.9	1.0	5.3	7.0	0.5	0.2	10.7	4.7	1.0	0.7	0.2	5.1	2.7	8.0	23.9	0.2	0.2	0.1	10.0	3.4	0.3	0.3	6.8	1.9	2.7	9.8	2.7	3.1	5.4	0.9	4.5	5.0	0.5	1.7	1.4	1.7	1.8	10.9	14.8	17.5	16.5	0.1	0.4	1.4	4.9	1.6	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	7.0	7.0	5.4	12.9	6.8	6.0	6.2	4.2	4.5	1.3
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153705702	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 7.4;hTCEpi: 7.4;RPTEC TERT1: 7.6;RT4: 9.3;THP-1: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4"	"Group enriched"	"Detected in many"	46	"dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	16.3	6.9	6.9	30.0	11.1	34.6	7.3	1.4	5.3	4.7	4.7	3.0	9.3	2.2	3.1	8.0	3.2	7.2	10.0	7.2	6.7	3.3	9.8	7.3	31.1	37.8	12.4	1.4	4.2	5.1	1.1	4.4	6.4	9.9	5.5	1.9	3.3	15.0	9.9	2.5	3.1	4.0	6.6	21.9	29.3	3.9	4.8	9.5	0.9	3.3	1.0	8.5	7.3	3.5	0.2	19.1	72.9	29.5	0.8	0.2	9.3	3.9	0.0	0.1	0.0	0.5	1.6	0.0	0.0	0.3	0.3	0.5	1.9	0.2	0.0	0.4	0.0	3.5	0.4	0.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	6.8	0.5	7.4	7.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.4	1.5	0.1	0.0	0.0	7.6	9.3	0.0	0.2	0.4	0.0	1.8	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	0.9	6.2	29.5	0.2	0.0	28.1	0.0	0.0	0.1	0.0	19.1	0.2	0.2	0.0	72.9	0.8	18.4	0.1	0.0	9.3	6.9	11.1	1.4	5.3	6.7	3.3	12.4	1.4	9.9	9.5
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724730	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.1;TIME: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 30.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: "	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favourable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavourable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	29.2	12.1	15.5	23.5	12.5	17.8	21.9	9.4	10.3	6.9	6.8	10.6	3.0	4.4	5.8	7.7	5.0	6.8	10.6	10.9	19.9	7.5	9.0	16.5	16.0	30.9	12.4	11.4	6.7	3.0	2.9	3.8	22.8	10.5	5.7	7.4	7.2	9.0	3.6	7.4	5.2	6.6	10.4	11.1	41.4	4.5	2.4	13.0	1.1	8.3	5.6	7.5	12.1	16.1	0.6	7.5	30.1	21.4	0.0	0.0	6.9	0.0	0.0	12.5	0.0	5.8	11.8	0.1	5.0	8.7	1.2	0.7	0.0	1.2	1.7	0.2	12.8	0.0	0.0	1.1	1.8	0.0	0.0	2.6	2.6	0.1	4.4	9.0	0.0	7.3	0.0	2.7	0.3	15.2	0.0	29.1	15.2	0.0	0.0	1.8	1.5	0.6	0.0	14.1	9.1	0.5	14.6	0.0	0.0	3.1	0.0	0.5	0.0	4.9	21.1	0.6	9.5	0.0	2.3	0.0	0.0	0.0	0.4	9.5	7.4	17.6	21.4	7.2	0.0	19.6	0.0	0.6	0.0	0.0	7.5	0.2	0.0	0.0	30.1	0.0	20.2	0.3	0.0	6.9	15.5	12.5	9.4	10.3	19.9	7.5	12.4	11.4	10.5	13.0
TLX1	"HOX11, TCL3"	ENSG00000107807	"T cell leukemia homeobox 1"	P31314	10	101130505-101137789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"lymphoid tissue: 59.5;salivary gland: 19.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;HEK 293: 3.0;K-562: 15.0;SCLC-21H: 2.5;SH-SY5Y: 3.7;SiHa: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"pons and medulla: 0.5"	"Region enriched"	"Detected in single"	20	"pons and medulla: 0.5"	HPA053185			Supported	Nucleoplasm				Nucleoplasm		"HPA053185: "	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (7.32e-4)"	"unprognostic (1.06e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.06e-1)"	"unprognostic (7.35e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	19.5	0.0	0.1	0.0	0.6	0.0	0.0	59.5	0.0	0.1	0.1	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	3.7	2.5	0.0	0.0	0.1	0.4	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309284-171312134	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"brain: 46.6"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 24.0"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Region enriched"	"Detected in some"	22	"cerebellum: 46.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 2.5"	"Region enriched"	"Detected in some"	11	"cerebellum: 48.1"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA030504: , HPA060957: , HPA069359: "		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.4	0.5	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	24.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0
TM2D1	BBP	ENSG00000162604	"TM2 domain containing 1"	Q9BX74	1	61681046-61725423	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046058, HPA055621"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA046058: , HPA055621: "	"unprognostic (1.80e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.79e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (2.02e-7)"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	24.2	30.7	32.5	20.0	42.8	16.2	30.1	24.7	50.1	26.2	22.1	25.3	21.2	16.6	26.3	38.9	19.3	25.1	23.7	36.5	27.9	28.3	32.3	23.5	35.9	27.0	32.7	22.2	31.4	27.6	25.9	24.0	28.8	33.6	28.3	23.9	24.4	23.1	25.6	29.6	16.0	20.1	24.2	45.6	20.3	23.4	27.0	22.3	20.2	33.7	16.6	16.0	21.9	20.5	15.3	22.6	27.2	15.7	14.7	15.2	12.5	11.6	5.7	8.9	7.0	27.2	26.7	11.4	20.8	21.3	10.3	13.8	3.6	15.0	9.5	27.9	17.4	13.3	11.3	15.2	16.0	15.4	13.3	10.5	9.4	8.1	26.7	15.2	18.8	29.6	26.2	11.9	15.0	19.5	12.0	18.5	25.0	3.7	7.6	11.9	9.7	8.2	6.6	16.8	11.7	30.5	9.2	9.9	12.1	12.4	24.9	37.5	13.6	16.4	17.2	14.0	7.0	7.7	15.7	15.7	14.3	11.6	24.2	14.8	12.2	26.6	12.6	27.2	11.2	14.6	11.1	15.3	13.0	13.5	11.8	13.0	12.3	14.1	7.6	14.7	15.7	22.6	15.2	12.5	32.5	42.8	24.7	50.1	27.9	28.3	32.7	22.2	33.6	22.3
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362156-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	86	"intestine: 147.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;RPMI-8226: 4.4"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA051838: , HPA063184: , HPA065531: "	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	46.5	0.0	0.0	73.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.1	0.1	147.8	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	1.2	1.1	0.5	1.7	0.7	0.0	0.1	7.1	0.2	0.1	0.0	0.0	1.3	0.8	0.1	0.0	0.0	1.3	0.5	0.2	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.2	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.1	1.6	0.3	0.1	0.4	0.1	4.4	0.1	0.3	0.6	1.7	1.0	0.1	0.0	0.3	0.1	0.3	0.6	0.3	1.9	0.2	0.5	0.3	0.4	0.2	0.2	0.2	0.8	0.5	0.1	0.7	0.3	0.3	0.7	0.4	0.4	0.0	1.1	0.7	0.5	1.1	1.7	0.1	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 21.6;RPTEC TERT1: 24.9;T-47d: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: "	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	27.7	78.1	6.9	2.2	12.5	2.0	10.0	5.6	21.7	4.7	3.1	22.4	5.1	4.8	1.5	11.0	11.5	6.4	8.5	28.2	7.4	6.6	8.3	38.6	5.1	1.7	10.3	9.6	13.5	22.6	11.8	6.2	2.2	13.2	19.8	2.3	5.4	28.5	3.3	3.3	17.9	2.8	1.3	7.3	1.9	8.8	5.3	8.8	1.9	7.4	13.6	10.4	2.6	6.1	7.4	22.6	1.8	1.0	7.3	7.6	3.0	2.6	3.5	8.3	12.0	3.3	0.2	5.3	0.6	1.3	1.0	1.1	8.6	12.2	5.3	9.4	0.4	4.3	3.7	5.8	0.7	5.0	1.8	3.3	1.0	17.3	6.8	1.3	3.6	1.5	1.8	4.8	0.6	0.9	1.9	4.1	0.3	21.6	2.2	5.7	4.5	4.0	7.1	0.4	12.4	24.9	3.8	9.5	10.6	0.4	9.1	2.1	48.4	3.5	0.6	0.1	1.2	1.2	0.8	9.4	5.9	3.0	0.8	2.0	0.3	0.5	1.0	1.8	5.5	0.8	4.3	7.1	3.5	4.5	0.9	7.4	7.6	5.5	0.7	7.3	0.5	22.6	3.1	3.0	6.9	12.5	5.6	21.7	7.4	6.6	10.3	9.6	13.2	8.8
TM7SF3		ENSG00000064115	"Transmembrane 7 superfamily member 3"	Q9NS93	12	26973195-27014434	"Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057640			Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA057640: "	"unprognostic (4.24e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-3)"	"unprognostic (8.80e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	12.0	27.6	12.1	8.1	17.4	18.5	15.9	7.9	18.9	12.4	17.2	18.1	13.1	10.7	10.9	16.6	27.8	12.7	16.4	10.6	11.7	11.6	69.8	39.9	15.9	15.0	13.0	11.6	12.1	52.6	15.4	33.2	11.0	10.7	14.5	19.7	20.5	21.9	14.2	5.8	15.4	12.8	13.2	13.9	12.0	14.9	11.0	10.6	31.2	14.1	12.3	17.1	15.3	16.5	10.5	10.6	16.0	6.9	11.8	11.4	3.9	8.5	20.5	12.2	14.7	18.5	12.3	64.1	10.6	17.3	8.8	15.1	11.2	36.7	11.5	13.7	10.0	9.4	12.7	72.0	12.2	11.3	7.6	17.3	25.7	21.3	12.3	62.3	12.2	7.5	61.4	18.8	16.9	23.1	7.4	7.9	13.3	17.6	30.4	36.2	24.8	12.2	28.5	19.2	20.4	15.2	39.3	2.0	10.8	13.1	7.1	18.7	19.4	13.2	8.7	7.7	12.6	21.1	13.1	4.8	12.3	21.6	14.8	21.2	11.6	8.6	6.9	16.0	6.0	6.9	5.7	7.3	7.6	7.8	10.2	10.5	10.9	7.2	7.8	11.8	3.5	10.6	11.4	3.9	12.1	17.4	7.9	18.9	11.7	11.6	13.0	11.6	10.7	10.6
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: "	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavourable (2.70e-5)"	"prognostic unfavourable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.1	13.1	7.1	25.3	9.6	10.2	16.0	8.9	11.5	17.5	11.5	8.9	11.8	9.4	18.5	17.7	16.1	12.8	13.5	12.0	8.7	7.4	13.5	16.8	10.2	22.1	7.6	8.8	16.0	19.3	7.2	12.4	12.6	9.9	11.6	11.0	8.8	16.9	12.2	17.2	15.1	9.8	13.1	11.1	21.1	13.0	30.0	8.5	28.2	10.6	15.0	18.3	15.6	13.5	21.4	28.2	3.3	21.9	13.5	14.0	7.4	15.5	8.2	13.2	12.0	5.5	9.5	13.6	18.2	9.1	9.9	8.4	7.9	21.3	34.5	7.6	9.6	7.9	15.4	13.0	12.6	17.8	13.2	48.1	7.8	12.5	12.3	38.0	14.9	6.1	11.8	8.4	10.5	10.9	16.8	25.4	10.9	14.0	22.8	19.7	14.7	12.0	21.8	12.5	21.7	7.9	7.6	7.7	11.3	11.5	15.4	13.7	9.3	14.8	19.1	8.0	15.1	7.5	19.2	18.4	23.6	40.2	15.7	20.3	23.8	3.3	14.5	1.3	7.7	21.9	11.4	21.4	14.0	9.9	16.5	19.9	13.2	11.1	0.5	13.5	17.7	28.2	11.5	7.4	7.1	9.6	8.9	11.5	8.7	7.4	7.6	8.8	9.9	8.5
TMBIM1	"LFG3, PP1201, RECS1"	ENSG00000135926	"Transmembrane BAX inhibitor motif containing 1"	Q969X1	2	218274192-218292586	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012093, HPA070824"	Approved		Supported	Vesicles				Vesicles		"HPA012093: AB_1858056, HPA070824: "	"unprognostic (4.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.81e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.76e-3)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (1.69e-1)"	"prognostic favourable (3.38e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.50e-1)"	64.3	34.6	26.5	22.1	45.0	23.0	84.3	11.0	38.3	35.7	42.2	43.1	33.7	41.8	35.0	30.0	86.8	25.1	50.3	34.6	21.0	17.2	50.7	69.3	46.7	34.3	37.5	13.7	27.9	87.6	31.3	15.0	92.7	40.9	31.6	40.1	23.9	40.1	43.7	53.2	49.5	70.6	41.2	50.3	22.7	57.8	13.2	32.5	9.4	66.4	42.1	36.3	57.7	54.5	17.0	19.6	60.3	43.5	13.0	24.0	33.6	26.8	9.7	0.5	7.1	62.9	26.6	29.0	26.4	32.6	15.6	18.0	24.8	66.7	6.1	19.3	38.8	46.0	9.0	59.2	15.4	22.1	3.7	38.9	6.7	29.7	28.5	0.5	38.5	25.1	55.7	32.0	40.9	16.6	24.2	11.5	27.3	1.1	0.4	6.7	0.4	8.7	0.9	4.3	4.8	21.0	84.8	0.5	0.5	8.7	32.4	18.3	8.7	5.9	25.1	28.2	7.8	13.0	9.5	5.6	6.5	2.7	27.7	6.1	15.9	60.3	27.7	59.9	24.0	36.2	20.5	17.0	22.0	19.5	19.6	14.0	14.7	15.8	35.5	13.0	43.5	5.3	23.5	33.6	26.5	45.0	11.0	38.3	21.0	17.2	37.5	13.7	40.9	32.5
TMBIM4	"CGI-119, GAAP, LFG4, S1R, ZPRO"	ENSG00000155957	"Transmembrane BAX inhibitor motif containing 4"	Q9HC24	12	66135846-66170072	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA077642			Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA077642: "	"unprognostic (5.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-3)"	47.2	57.3	18.4	31.2	23.8	22.2	40.1	9.2	21.0	34.8	36.5	30.8	39.8	24.1	42.5	40.3	32.2	33.7	31.7	37.2	18.9	19.9	56.2	66.7	46.8	48.6	27.3	14.4	41.6	63.5	30.6	48.2	42.5	27.2	34.5	29.5	44.8	56.4	39.7	29.1	24.9	45.8	37.0	34.2	55.7	39.1	66.7	22.5	39.6	54.3	32.0	38.1	36.8	31.6	30.6	38.9	100.3	60.9	18.8	26.1	61.1	12.9	17.0	10.9	20.0	37.2	35.1	11.5	20.2	35.3	15.7	12.8	8.7	21.6	12.2	24.1	28.3	21.6	5.5	17.8	10.3	19.6	7.3	23.5	8.7	10.1	18.9	28.4	30.5	24.6	25.9	7.7	8.7	23.9	17.2	44.2	25.8	21.2	10.7	9.8	13.1	17.3	5.7	7.3	13.5	35.1	21.6	5.5	13.3	22.9	42.8	26.8	40.2	39.3	28.8	19.5	7.2	14.0	11.8	22.9	12.4	8.6	26.7	27.8	23.0	51.4	56.7	53.9	21.9	55.6	21.9	30.6	22.9	22.4	38.9	28.8	26.1	23.0	100.3	18.8	60.9	25.9	23.2	61.1	18.4	23.8	9.2	21.0	18.9	19.9	27.3	14.4	27.2	22.5
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331217-81374213	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	15	"parathyroid gland: 66.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 4.6"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 1.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol				Cytosol		"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.0	0.1	0.0	1.7	0.0	0.3	0.2	0.4	1.4	1.5	1.5	0.0	0.0	0.2	0.8	4.6	0.7	0.8	0.2	0.2	0.0	0.1	0.1	1.3	0.0	0.1	0.0	0.0	0.2	0.2	66.9	1.5	0.7	1.6	1.0	0.1	0.4	0.2	2.9	0.0	0.2	0.5	1.7	1.9	0.1	0.8	3.0	0.0	0.0	1.5	0.0	0.0	1.3	3.6	1.6	0.7	0.2	0.2	0.2	1.8	0.7	0.9	1.0	0.5	2.7	0.4	0.2	1.9	0.8	0.3	0.2	0.3	0.7	1.9	2.3	0.1	0.0	0.7	0.3	0.2	0.1	1.7	1.4	1.9	1.1	0.9	0.3	1.5	1.1	0.5	0.1	0.4	0.3	0.0	0.6	2.8	0.2	0.8	1.0	1.4	1.5	0.9	0.7	1.0	4.3	0.2	0.6	1.1	2.0	0.9	1.0	2.0	2.3	1.1	0.4	1.5	1.8	1.3	0.5	4.6	1.8	1.4	1.1	2.5	0.9	0.1	0.0	0.2	0.7	0.1	0.6	1.2	0.8	0.4	0.1	1.6	1.8	1.3	0.2	0.2	0.2	0.7	0.9	0.7	0.0	0.0	0.4	1.4	0.0	0.1	0.0	0.0	1.6	0.0
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054768			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA054768: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavourable (5.17e-7)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	28.8	48.5	28.1	18.7	29.8	17.2	34.1	21.5	28.7	30.2	47.4	26.9	37.6	43.0	28.4	43.3	34.3	24.9	30.6	25.9	23.8	26.8	62.6	89.8	24.9	23.6	27.2	21.0	30.6	37.3	32.6	50.1	47.0	31.1	30.7	48.8	29.9	43.5	38.5	20.2	20.9	70.9	23.7	31.4	29.4	29.9	34.4	22.4	36.3	53.7	24.1	31.1	29.4	25.2	46.0	76.6	52.5	57.6	45.1	61.7	78.0	29.6	33.6	25.7	15.5	47.4	22.5	25.1	51.0	36.2	30.1	31.4	47.9	45.0	18.9	53.1	36.9	42.3	33.4	26.8	32.8	48.1	30.9	23.9	39.0	29.5	38.3	40.7	31.5	30.6	31.2	34.9	28.2	21.8	62.0	37.2	42.1	23.0	32.1	30.9	32.8	38.1	23.7	28.8	47.8	36.5	39.2	26.5	46.4	39.1	41.6	31.0	54.5	51.7	23.9	27.7	23.1	24.3	47.2	71.2	96.2	66.6	22.2	26.6	36.7	52.5	55.6	51.2	53.0	50.8	55.6	46.0	56.5	56.5	41.8	39.8	46.0	53.2	43.1	45.1	57.6	76.6	61.7	78.0	28.1	29.8	21.5	28.7	23.8	26.8	27.2	21.0	31.1	22.4
TMED10	"p23, P24(DELTA), p24d1, p24delta1, TMP21"	ENSG00000170348	"Transmembrane p24 trafficking protein 10"	P49755	14	75131470-75176631	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034442, CAB037251, HPA047139, HPA050539"	Enhanced		Supported	"Golgi apparatus"			6000000	"Golgi apparatus"		"CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.51e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.17e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (8.67e-4)"	"unprognostic (2.06e-2)"	34.2	31.5	24.5	19.3	24.6	5.6	35.2	14.0	23.0	55.8	28.2	34.7	47.3	22.9	39.1	52.3	31.3	38.8	30.5	39.5	25.1	25.0	37.4	70.3	28.1	42.1	26.9	15.6	42.5	125.6	28.1	33.8	54.9	23.0	35.6	31.4	33.8	119.7	48.9	35.7	26.0	31.0	30.0	31.8	28.3	28.7	29.0	21.3	34.4	55.5	27.8	39.1	29.6	30.5	15.6	27.3	31.9	17.8	37.5	37.9	30.9	21.5	12.4	20.5	33.9	48.4	45.5	26.9	22.8	38.0	24.1	27.1	12.0	38.2	19.1	19.6	39.2	21.6	19.0	33.2	38.9	10.2	8.6	11.6	8.2	18.2	41.2	23.1	12.2	33.2	53.4	18.6	53.4	41.8	10.1	42.6	34.5	24.3	16.1	18.4	12.4	13.3	16.2	13.2	26.7	28.8	22.1	20.0	21.1	21.0	35.2	39.7	33.2	37.8	28.7	23.6	15.6	15.8	11.8	24.1	22.7	21.6	43.1	20.5	22.7	31.9	17.8	10.7	24.7	14.9	37.9	15.6	24.3	23.9	23.9	11.9	21.9	23.2	7.9	37.5	14.7	27.3	14.2	30.9	24.5	24.6	14.0	23.0	25.1	25.0	26.9	15.6	23.0	21.3
TMED2	"P24A, p24b1, p24beta1, RNP24"	ENSG00000086598	"Transmembrane p24 trafficking protein 2"	Q15363	12	123584531-123598577	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014060	Approved		Supported	Vesicles				Vesicles		"HPA014060: AB_1856389"	"unprognostic (6.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (3.36e-6)"	"unprognostic (3.57e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (2.35e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.87e-2)"	31.3	31.9	15.7	21.8	21.2	23.5	32.0	13.2	21.5	38.5	31.6	20.4	41.1	27.6	33.4	49.0	41.3	27.4	28.9	41.7	15.7	17.1	32.6	120.1	28.1	29.4	18.2	16.7	37.4	135.4	18.1	36.3	40.0	18.9	33.3	32.8	23.8	90.2	38.0	46.3	27.4	34.2	30.5	22.5	25.6	32.4	17.8	15.0	24.0	49.2	23.8	30.0	34.0	27.8	32.4	69.3	58.9	40.9	39.5	61.2	36.2	41.8	37.3	24.8	42.9	56.6	50.2	59.1	72.8	58.8	46.4	36.8	37.2	36.5	35.9	39.1	72.5	41.9	33.5	39.2	48.8	26.9	28.9	38.7	22.7	48.0	107.6	52.7	33.4	42.2	65.5	39.8	54.1	43.3	39.0	24.6	47.3	31.1	27.9	43.3	35.8	33.6	29.1	40.5	41.7	56.6	63.5	30.9	26.8	48.7	49.0	48.2	83.1	42.8	41.0	39.6	25.0	38.2	40.7	54.5	50.5	30.5	46.7	34.9	46.7	58.9	39.8	39.6	46.8	40.9	61.2	32.4	42.4	44.1	44.2	27.2	34.6	40.3	31.5	39.5	37.8	69.3	38.3	36.2	15.7	21.2	13.2	21.5	15.7	17.1	18.2	16.7	18.9	15.0
TMED3	"C15orf22, p24B, p24g4, p24gamma4"	ENSG00000166557	"Transmembrane p24 trafficking protein 3"	Q9Y3Q3	15	79311062-79427432	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 182.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049314, HPA076949"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA049314: , HPA076949: "	"prognostic unfavourable (7.71e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.85e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.09e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.52e-1)"	6.1	7.0	5.0	6.1	5.8	7.5	16.8	9.6	8.9	15.0	12.0	6.9	32.2	6.0	10.0	34.9	31.2	9.9	18.0	11.4	6.1	10.0	11.0	4.6	7.7	12.2	5.7	7.5	8.1	68.0	6.5	23.5	24.2	8.2	15.0	13.9	7.1	182.4	34.0	2.0	25.0	6.0	9.4	7.1	9.4	16.0	13.9	4.2	7.0	18.8	20.9	23.4	11.2	17.4	28.3	40.9	34.0	33.0	21.7	29.3	32.2	14.3	37.4	7.2	13.7	50.8	39.1	15.6	34.2	46.5	23.3	28.9	31.1	26.4	6.7	26.1	52.2	27.1	21.4	21.8	12.2	13.3	33.0	22.6	33.7	22.9	29.6	24.0	45.0	28.9	32.2	13.3	19.6	27.1	10.0	0.1	22.7	30.1	6.7	21.9	10.0	21.0	8.3	10.5	33.7	21.2	10.9	22.1	10.9	18.1	34.8	32.3	30.4	17.0	22.1	18.9	17.1	0.4	23.7	14.2	16.3	9.4	24.2	38.4	22.0	21.7	26.5	34.0	23.3	31.3	24.8	28.3	23.1	25.2	40.1	23.4	29.3	28.1	2.3	21.7	33.0	40.9	26.2	32.2	5.0	5.8	9.6	8.9	6.1	10.0	5.7	7.5	8.2	4.2
TMEM106B	"FLJ11273, MGC33727"	ENSG00000106460	"Transmembrane protein 106B"	Q9NUM4	7	12211241-12243367	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Amyotrophic lateral sclerosis, Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058342	Approved		Supported	Endosomes,Lysosomes				"Endosomes, Lysosomes"		"HPA058342: "	"unprognostic (5.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-1)"	17.1	48.3	16.2	11.4	23.7	6.2	17.0	18.5	29.0	26.0	20.3	19.4	13.5	16.1	24.9	19.7	18.5	19.9	18.0	20.8	15.7	16.2	30.9	33.0	12.9	11.7	20.5	21.2	22.1	18.3	17.5	31.3	35.3	26.8	27.2	22.6	15.2	23.2	24.3	23.9	15.5	18.1	24.8	24.8	13.5	15.5	12.0	21.3	14.7	30.7	14.9	12.4	21.4	17.9	7.6	2.8	8.8	6.3	14.1	19.4	7.3	9.8	23.4	9.5	25.3	22.2	21.6	10.1	14.6	33.4	10.3	13.3	5.7	38.9	3.9	16.5	19.4	11.4	8.2	9.6	14.1	5.7	7.5	4.8	10.9	6.7	17.9	12.7	6.9	17.3	12.4	7.6	18.0	15.8	11.5	11.8	15.4	4.2	2.8	7.2	15.3	9.5	7.1	8.2	7.7	25.5	9.9	12.2	17.3	15.6	14.2	13.4	12.9	9.1	15.6	14.9	18.0	12.8	12.5	10.9	19.7	4.6	18.6	5.2	34.1	8.8	4.2	4.8	9.4	4.9	13.5	6.3	11.6	11.1	2.8	7.6	19.4	13.5	2.5	14.1	6.3	0.9	9.7	7.3	16.2	23.7	18.5	29.0	15.7	16.2	20.5	21.2	26.8	21.3
TMEM11	"C17orf35, PM1, PMI"	ENSG00000178307	"Transmembrane protein 11"	P17152	17	21197280-21214624	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051795, HPA062854"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA051795: , HPA062854: "	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.61e-2)"	9.7	6.5	5.5	6.2	5.8	13.2	9.7	6.2	8.7	6.1	6.1	6.3	4.3	5.4	6.8	7.6	8.5	5.1	5.2	8.3	5.1	5.1	8.0	9.0	5.9	5.0	5.6	4.5	6.2	10.7	4.5	5.1	10.6	6.5	7.4	4.1	6.4	11.0	6.2	30.2	8.2	7.2	6.3	5.3	6.0	6.5	8.4	4.5	7.3	8.8	12.8	7.9	5.9	5.7	8.0	7.0	11.7	12.2	5.5	6.5	7.6	4.4	3.2	4.6	3.2	6.7	3.7	5.7	9.1	2.5	8.0	5.6	10.5	2.0	4.3	5.0	7.0	5.8	6.5	6.6	1.8	4.5	6.5	3.0	3.0	1.8	7.5	3.5	4.3	5.1	5.3	9.1	4.2	3.9	3.8	1.6	3.7	2.7	5.7	5.4	5.0	2.7	4.0	8.7	2.6	3.6	1.3	2.7	4.6	3.6	4.3	4.4	2.7	3.1	3.2	4.5	6.8	6.4	8.5	2.2	2.1	10.2	3.6	4.6	2.6	4.7	12.2	11.7	5.4	8.7	4.9	6.1	5.5	4.9	7.0	8.0	6.5	4.9	9.8	5.5	10.9	6.1	4.9	7.6	5.5	5.8	6.2	8.7	5.1	5.1	5.6	4.5	6.5	4.5
TMEM115	PL6	ENSG00000126062	"Transmembrane protein 115"	Q12893	3	50354749-50359610	"Plasma proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006319, HPA015497"	Supported		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB006319: AB_425880, HPA015497: AB_1858076"	"unprognostic (1.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (3.73e-5)"	"unprognostic (7.00e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.65e-2)"	"prognostic favourable (1.04e-7)"	"unprognostic (4.88e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	20.8	23.8	15.1	11.3	15.2	10.1	19.7	19.4	24.3	20.2	23.5	18.7	21.5	23.1	24.5	21.3	20.6	21.3	23.9	19.8	12.5	12.8	22.4	24.1	18.5	15.7	13.6	13.3	24.9	24.0	25.7	14.8	37.3	16.2	22.4	13.0	22.4	26.3	22.5	18.2	28.1	25.5	17.3	10.6	17.6	20.7	18.6	11.8	20.4	42.2	16.9	15.9	19.0	17.3	13.2	17.2	28.4	18.4	17.2	18.3	14.5	11.0	13.5	8.8	14.4	25.2	20.2	11.4	17.1	25.4	21.8	16.8	10.0	13.0	5.4	14.5	22.3	11.8	10.6	13.9	6.2	9.9	18.4	8.1	12.1	13.6	35.5	8.8	11.8	30.3	18.0	18.0	13.1	16.5	8.7	9.3	16.2	10.1	6.0	14.0	15.7	21.4	3.0	7.1	11.8	16.5	10.4	9.9	21.2	10.4	11.6	14.1	9.6	9.4	17.1	19.9	10.1	20.8	17.9	13.9	8.0	3.0	18.2	9.7	13.0	28.4	18.4	25.6	18.3	16.5	12.1	12.6	12.3	14.8	15.3	13.2	13.6	13.0	25.3	17.2	14.8	17.2	15.3	14.5	15.1	15.2	19.4	24.3	12.5	12.8	13.6	13.3	16.2	11.8
TMEM123	"KCT3, PORIMIN"	ENSG00000152558	"Transmembrane protein 123"	Q8N131	11	102396332-102470384	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 140.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026001, HPA062862"			Supported	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026001: , HPA062862: "	"unprognostic (2.64e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.36e-4)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.65e-2)"	21.3	23.1	18.8	30.1	23.3	39.8	38.6	7.4	18.8	35.2	38.2	19.1	15.1	12.4	65.3	20.8	31.9	21.6	20.8	36.8	20.7	14.0	27.0	95.4	39.5	55.5	22.6	13.7	27.8	24.7	14.5	8.5	23.9	21.1	34.9	19.9	13.9	53.3	22.2	13.2	29.7	17.6	29.7	22.4	39.9	23.7	22.9	24.6	71.9	66.0	20.1	27.1	43.7	39.8	23.3	30.3	48.3	29.2	52.4	55.5	51.3	28.8	25.9	26.8	24.9	34.3	28.1	18.2	22.5	48.8	46.1	51.3	32.8	140.1	48.7	58.1	52.1	31.3	29.1	37.1	51.0	29.3	10.6	25.3	10.2	48.7	30.3	53.7	19.0	31.3	42.3	32.9	49.3	51.5	16.9	0.1	38.0	9.3	46.6	16.8	16.0	23.7	28.7	74.1	46.7	43.9	28.6	12.7	15.0	27.3	37.4	14.8	23.1	21.0	60.3	31.0	34.8	26.8	16.9	18.9	10.5	49.5	9.0	59.9	20.4	30.1	26.8	48.3	26.3	29.2	40.0	16.7	41.3	31.8	30.3	23.3	55.5	46.9	17.6	52.4	24.2	8.1	42.9	51.3	18.8	23.3	7.4	18.8	20.7	14.0	22.6	13.7	21.1	24.6
TMEM126B	HT007	ENSG00000171204	"Transmembrane protein 126B"	Q8IUX1	11	85628573-85636539	"Predicted membrane proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA014480, HPA019186"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA014480: AB_1858083, HPA019186: AB_1858084"	"unprognostic (1.11e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.70e-3)"	"unprognostic (4.42e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.66e-2)"	15.5	17.0	28.9	13.5	28.0	6.4	22.1	26.7	33.2	19.7	21.2	12.2	15.5	21.7	21.9	35.4	16.5	15.9	19.1	26.2	27.2	31.7	27.5	19.9	16.5	18.9	28.7	25.7	15.9	15.3	13.9	28.0	14.6	28.8	19.8	20.0	14.2	16.8	16.6	15.7	15.1	20.8	24.2	24.9	19.3	18.9	11.7	27.0	15.1	22.6	17.5	18.8	20.8	14.3	14.0	14.9	12.5	13.2	15.8	19.6	11.5	14.5	12.0	13.6	6.4	25.7	20.6	4.3	12.9	14.1	10.3	15.7	33.3	14.8	15.5	28.6	11.0	17.7	21.7	13.3	9.8	21.4	19.7	11.7	21.2	14.6	14.6	28.6	14.5	15.0	17.0	15.7	19.1	15.7	27.8	12.8	25.5	18.7	11.4	35.5	14.7	19.8	9.9	10.2	13.0	20.2	16.3	12.4	7.7	12.2	10.0	12.6	20.2	17.7	8.2	15.8	11.1	39.7	13.5	6.0	33.5	18.7	8.0	23.4	8.3	12.5	11.7	5.7	15.4	13.2	19.6	14.0	19.1	18.4	14.9	12.9	19.1	18.9	4.5	15.8	9.6	13.4	18.3	11.5	28.9	28.0	26.7	33.2	27.2	31.7	28.7	25.7	28.8	27.0
TMEM130	"DKFZp761L1417, FLJ42643"	ENSG00000166448	"Transmembrane protein 130"	Q8N3G9	7	98846488-98870771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4"	"Cell line enhanced"	"Detected in some"		"BJ: 3.9;BJ hTERT+: 8.8;EFO-21: 8.6;NTERA-2: 5.1;SH-SY5Y: 10.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012928	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA012928: AB_1858085"	"unprognostic (1.36e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.97e-1)"	"prognostic favourable (7.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-1)"	1.3	28.2	27.3	2.0	53.8	1.4	1.8	14.1	82.2	3.5	1.8	2.8	0.0	1.6	1.8	8.0	2.2	1.7	2.2	1.4	29.3	47.0	2.8	1.1	5.4	2.4	13.4	35.1	1.7	1.6	1.5	24.0	1.3	25.8	2.7	1.9	1.0	1.3	6.2	2.1	1.3	2.1	1.6	9.2	1.4	1.4	26.4	3.9	0.1	1.4	0.0	1.2	1.7	1.2	1.0	0.6	4.8	0.9	1.0	0.7	0.3	0.0	0.7	0.0	0.0	0.3	0.0	0.2	3.9	8.8	0.7	0.6	0.1	0.1	0.1	8.6	2.2	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.3	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.2	0.7	0.4	0.7	0.2	0.2	5.1	0.0	0.2	0.0	0.8	0.1	0.0	0.6	10.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.4	0.3	0.1	0.4	0.5	0.2	2.2	0.9	0.6	0.5	0.4	0.4	0.7	0.5	0.4	0.2	1.0	0.7	0.6	4.8	1.0	0.6	0.6	0.4	0.3	27.3	53.8	14.1	44.2	29.3	47.0	13.4	35.1	25.8	3.9
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.5"	"Group enriched"	"Detected in some"	6	"AF22: 5.9;ASC diff: 8.5;Daudi: 9.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"gdT-cell: 5.4"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Supported	Centrosome,Cytosol			110000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	37.5	4.2	9.6	1.1	7.0	0.8	23.3	5.0	6.6	22.0	2.5	4.2	8.9	1.2	5.9	5.7	4.7	13.4	5.1	3.5	5.0	3.8	1.3	0.8	1.6	2.0	4.9	3.1	7.9	4.1	0.9	0.6	5.1	4.6	3.7	1.3	5.3	2.9	9.1	1.9	2.2	1.4	2.1	3.9	1.1	1.5	2.1	5.4	0.0	1.1	0.9	1.3	3.8	10.5	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	5.9	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.6	7.0	5.0	6.6	5.0	3.8	4.9	3.1	4.6	5.4
TMEM134	FLJ21749	ENSG00000172663	"Transmembrane protein 134"	Q9H6X4	11	67461710-67469272	"Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA043744	Approved		Supported	Cytosol				Cytosol		"HPA043744: AB_10794773"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.43e-3)"	7.1	15.3	11.2	11.9	14.9	4.8	7.8	6.5	12.7	10.1	11.2	13.4	16.1	8.8	7.2	16.4	30.2	10.3	14.1	22.7	9.7	7.9	13.1	23.7	8.1	10.9	12.9	7.9	6.9	42.1	6.9	4.7	10.7	10.1	15.6	5.1	7.1	16.9	14.0	46.2	31.8	10.2	6.9	12.5	12.3	14.0	12.0	9.7	11.1	8.3	20.7	21.6	10.4	13.2	51.9	23.9	25.9	44.5	22.7	32.2	19.2	7.0	2.7	3.8	8.3	2.6	4.5	4.3	1.5	2.7	1.7	0.7	3.3	8.4	6.7	16.3	3.6	5.9	1.7	6.2	1.1	6.4	2.9	1.2	2.4	3.4	4.0	1.3	2.0	4.4	8.0	1.3	4.6	1.8	1.6	3.9	3.8	16.7	7.4	4.9	6.5	9.5	3.7	2.3	21.7	6.6	7.2	3.7	8.0	5.3	8.4	15.4	20.4	1.3	3.4	6.3	5.5	7.4	1.9	16.6	10.5	4.4	9.3	1.7	5.0	12.5	15.4	25.9	20.9	34.7	22.9	51.9	25.0	23.3	18.2	50.3	25.5	23.9	7.2	22.7	44.5	23.9	32.2	19.2	11.2	14.9	6.5	12.7	9.7	7.9	12.9	7.9	10.1	9.7
TMEM135	FLJ22104	ENSG00000166575	"Transmembrane protein 135"	Q86UB9	11	87037844-87323758	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056685, HPA069473"	Uncertain		Supported	Vesicles				Vesicles		"HPA056685: , HPA069473: "	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.80e-1)"	31.6	28.9	10.5	9.5	12.0	5.9	23.3	11.4	14.8	8.3	14.3	12.8	18.9	21.8	15.1	7.8	7.4	8.4	12.6	12.6	9.9	11.3	16.5	31.2	11.7	9.8	13.8	10.2	14.1	9.2	14.7	24.4	13.5	12.9	15.4	12.1	12.8	16.9	17.8	14.9	7.5	20.1	11.1	11.2	8.3	10.1	15.7	11.4	14.1	15.0	6.4	7.0	10.7	9.9	5.9	7.0	2.2	6.0	8.4	10.4	4.5	4.2	6.9	4.8	6.6	15.7	15.1	6.2	3.2	8.5	3.9	8.4	12.1	19.2	12.0	8.4	4.2	4.1	6.6	7.9	4.2	10.5	4.1	9.6	7.3	42.2	8.8	5.2	4.9	17.3	4.8	5.2	3.6	9.8	8.8	16.4	4.2	3.4	12.7	6.1	5.8	5.9	6.7	3.9	9.5	8.8	13.1	2.5	6.3	5.1	14.6	7.0	20.8	5.8	5.2	4.3	5.3	14.7	2.5	6.9	12.4	13.0	3.0	5.9	7.8	0.9	5.8	1.7	9.7	6.0	8.5	5.9	6.3	10.4	6.6	5.2	7.1	6.8	2.2	8.4	2.7	7.0	6.5	4.5	10.5	12.0	11.4	14.8	9.9	11.3	13.8	10.2	12.9	11.4
TMEM141	MGC14141	ENSG00000244187	"Transmembrane protein 141"	Q96I45	9	136791355-136793257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014615, HPA050244"	Approved		Supported	"Cell Junctions,Mitochondria"				Mitochondria	"Cell Junctions"	"HPA014615: AB_2204756, HPA050244: "	"unprognostic (2.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	10.0	15.5	15.7	23.4	15.3	15.5	22.9	11.6	28.3	17.2	54.4	21.0	22.4	21.9	9.4	31.1	35.5	22.6	27.9	22.8	15.2	12.2	38.5	43.4	14.4	23.0	19.9	19.3	13.8	46.3	20.6	23.1	31.7	22.0	49.0	51.4	12.5	32.5	27.5	13.5	22.0	25.6	10.5	19.1	14.1	23.3	16.5	13.8	16.3	28.6	26.0	15.2	16.4	16.3	11.1	42.7	9.0	19.4	12.4	11.3	12.2	16.0	11.6	10.4	6.5	13.1	10.6	22.5	9.1	14.2	11.2	9.0	15.3	14.6	15.4	14.2	9.8	23.9	4.4	26.5	3.6	11.2	8.0	8.6	6.5	17.1	19.2	8.9	10.8	10.1	45.5	8.6	24.4	16.7	8.5	8.3	14.7	32.7	12.2	6.9	5.0	13.1	10.2	11.0	45.3	25.5	9.0	17.5	7.9	9.8	37.2	10.2	66.4	8.7	11.4	8.0	6.4	14.6	5.9	5.4	8.4	8.2	12.1	12.9	11.5	6.5	13.8	9.0	11.3	19.4	10.2	8.7	7.9	8.1	11.2	11.1	10.9	10.0	3.3	12.4	16.0	42.7	7.5	12.2	15.7	15.3	11.6	28.3	15.2	12.2	19.9	19.3	22.0	13.8
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: "	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavourable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	28.5	37.6	19.4	25.6	49.0	6.0	27.3	11.3	26.1	31.1	20.0	54.4	17.6	19.8	22.4	20.7	33.0	19.1	29.4	23.9	29.1	20.0	26.7	11.9	30.4	22.3	65.8	16.2	14.0	23.6	22.9	14.9	37.6	33.1	24.9	21.6	15.7	25.5	20.8	9.9	16.2	16.0	25.0	50.5	22.6	23.8	8.4	49.4	14.4	24.3	16.5	25.5	34.0	23.2	11.3	22.8	17.6	24.8	11.3	11.8	17.8	18.5	7.8	12.4	13.0	38.5	28.4	13.1	35.6	55.0	25.8	28.3	8.7	27.9	19.4	25.9	21.9	13.8	12.9	14.6	26.2	10.9	12.0	16.5	13.9	16.7	23.9	22.8	19.7	29.2	19.1	14.6	9.9	29.2	27.8	12.4	30.2	13.6	17.9	19.1	13.4	18.3	13.0	9.2	10.5	38.7	17.9	12.7	17.0	17.9	67.9	21.2	10.7	16.5	25.1	22.0	13.1	9.6	25.8	11.6	9.4	11.9	26.1	19.5	17.5	12.7	24.8	15.5	9.9	20.9	11.3	11.3	9.6	11.8	22.8	7.8	8.2	9.8	17.6	11.3	20.5	17.5	10.8	17.8	19.4	49.0	11.3	26.1	29.1	20.0	65.8	16.2	33.1	49.4
TMEM173	"ERIS, FLJ38577, MITA, MPYS, NET23, STING"	ENSG00000184584	"Transmembrane protein 173"	Q86WV6	5	139475534-139482935	"Disease related genes, Predicted membrane proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.8;EFO-21: 37.4;HDLM-2: 79.4;Karpas-707: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038116, HPA038534"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA038116: AB_2675841, HPA038534: AB_2676067"	"unprognostic (1.45e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (3.59e-8)"	"unprognostic (9.18e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.34e-1)"	22.9	6.5	6.3	17.4	6.7	18.1	15.9	1.2	4.5	22.5	9.4	6.0	13.3	6.4	16.7	18.1	16.0	24.4	13.5	26.3	3.8	3.1	12.5	8.1	32.0	41.3	7.9	2.3	30.7	3.9	1.9	8.1	13.9	6.8	20.3	8.8	14.7	16.6	14.6	10.3	9.6	10.9	16.2	7.1	35.8	8.0	11.1	6.3	15.8	13.0	16.5	29.7	17.7	17.9	0.3	26.9	5.8	29.1	39.8	28.9	26.1	1.1	0.5	0.0	0.0	1.2	4.0	0.1	6.4	24.8	3.2	10.3	0.0	8.9	0.0	37.4	19.3	4.7	0.1	9.5	1.2	79.4	0.9	5.4	2.5	0.3	2.2	1.6	0.1	5.7	0.4	2.1	2.6	11.0	1.6	24.9	11.5	0.0	0.8	8.3	0.0	1.8	0.3	2.3	7.4	2.8	2.4	2.5	0.0	2.2	2.3	6.2	0.3	21.5	8.0	0.8	0.4	2.5	1.9	0.0	7.5	0.0	0.1	23.2	2.8	5.8	29.1	0.0	28.8	19.4	14.2	0.3	28.2	23.2	26.9	0.2	19.4	17.5	2.4	39.8	7.8	9.2	28.9	26.1	6.3	6.7	1.2	4.5	3.8	3.1	7.9	2.3	6.8	6.3
TMEM179B		ENSG00000185475	"Transmembrane protein 179B"	Q7Z7N9	11	62787415-62790405	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016585, HPA062068"			Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA016585: AB_1844357, HPA062068: "	"unprognostic (1.18e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.76e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.60e-2)"	26.1	34.6	13.2	19.5	15.7	13.4	36.0	6.3	15.4	24.9	31.3	23.7	37.7	24.5	27.8	53.6	24.9	28.9	35.0	21.8	12.9	11.1	43.1	55.4	39.0	43.2	17.1	9.8	27.4	47.1	15.5	17.5	39.8	20.9	28.8	29.3	28.0	55.1	54.2	16.7	29.7	44.2	20.4	19.9	30.4	26.5	29.4	14.8	25.5	44.9	21.2	28.2	24.1	24.0	35.5	80.6	70.4	67.6	28.3	35.4	53.5	12.4	25.4	6.3	12.5	49.6	12.6	7.8	13.6	16.8	10.8	12.4	14.5	28.9	5.7	19.6	27.0	22.8	11.6	12.3	8.3	16.9	16.6	8.3	11.5	13.2	33.5	10.4	11.6	24.2	20.0	20.3	25.1	10.8	11.4	16.3	12.2	28.3	13.4	20.3	9.4	28.1	9.1	10.1	29.7	20.2	15.4	8.6	9.5	17.6	22.8	23.3	26.7	12.9	13.9	14.2	10.7	26.0	11.2	18.7	11.0	7.4	20.4	6.4	16.4	52.6	67.6	70.4	35.4	64.9	34.8	35.5	32.5	33.9	43.2	31.5	28.9	28.5	49.9	28.3	61.8	80.6	31.3	53.5	13.2	15.7	6.3	15.4	12.9	11.1	17.1	9.8	20.9	14.8
TMEM189	Kua	ENSG00000240849	"Transmembrane protein 189"	A5PLL7	20	50118254-50153734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059549	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA059549: "	"unprognostic (3.11e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.79e-2)"	"prognostic unfavourable (5.79e-11)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.42e-2)"	15.1	13.9	12.0	11.0	23.8	7.7	13.6	7.9	18.1	13.0	14.5	33.7	20.5	13.2	16.3	17.3	27.0	10.0	12.3	15.5	15.0	10.7	9.1	21.0	14.3	8.3	33.1	9.0	6.5	8.9	19.8	6.5	26.1	20.7	13.3	11.5	7.9	14.6	22.0	17.1	24.3	13.2	32.2	32.1	10.4	14.5	11.3	24.9	10.0	8.5	11.7	14.8	16.0	15.4	2.0	6.2	6.3	13.9	4.1	5.8	3.9	8.7	8.0	9.6	7.5	14.7	11.1	16.1	6.1	5.8	13.0	7.3	21.7	14.0	3.2	9.9	5.8	24.3	4.8	12.5	4.7	1.7	3.7	4.1	11.7	18.5	8.3	6.7	11.3	9.3	29.2	7.3	7.7	15.4	4.3	4.8	4.3	7.7	5.3	16.9	4.7	8.4	4.3	7.4	3.5	24.4	12.9	5.0	3.3	7.0	24.2	13.8	3.8	9.5	12.2	11.0	5.7	7.0	6.0	3.5	5.8	1.3	9.4	5.0	8.8	5.3	5.7	6.3	3.7	10.8	2.9	2.0	4.1	3.1	6.2	1.9	3.5	4.1	2.3	4.1	13.9	3.9	5.8	3.9	12.0	23.8	7.9	18.1	15.0	10.7	33.1	9.0	20.7	24.9
TMEM189-UBE2V1	"CROC-1B, Kua-UEV"	ENSG00000124208	"TMEM189-UBE2V1 readthrough"		20	50081124-50153637	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA052535, HPA053186"			Supported	Nucleoplasm				Nucleoplasm		"HPA052535: , HPA053186: "	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.41e-3)"	"unprognostic (2.71e-2)"		"unprognostic (1.52e-1)"	"unprognostic (6.05e-3)"					"unprognostic (2.40e-1)"			"unprognostic (8.19e-2)"	9.2	4.4	4.6	7.5	9.7	1.2	5.1	6.1	7.1	4.3	3.9	14.2	6.8	2.0	4.7	3.0	5.9	2.9	3.1	3.9	4.4	4.5	3.4	8.4	5.0	3.6	14.0	3.0	4.3	9.1	5.5	4.3	15.0	8.3	3.8	1.6	2.0	3.7	4.6	8.4	4.0	4.4	4.8	7.9	4.6	7.6	12.2	10.2	3.5	3.2	4.0	5.6	4.5	3.5	6.1	9.1	11.3	15.3	8.0	8.7	9.9	3.4	5.8	2.1	5.4	8.9	6.1	6.4	5.9	3.9	8.1	4.6	12.4	7.3	1.7	8.2	3.2	14.9	3.2	6.6	1.4	0.8	1.1	2.5	10.2	7.5	4.0	4.3	4.6	6.1	12.2	6.0	2.2	8.0	4.1	5.2	3.6	4.2	3.2	0.4	1.5	1.4	3.1	1.7	2.9	2.3	9.4	3.3	1.5	2.8	12.3	2.6	2.6	4.0	12.4	9.5	3.6	2.6	3.8	1.3	1.7	0.6	4.2	1.1	6.2	7.5	9.4	11.3	8.7	13.5	7.6	4.1	7.9	8.6	9.1	6.1	7.4	7.8	1.3	8.0	15.3	5.5	8.2	9.9	4.6	9.7	6.1	7.1	4.4	4.5	14.0	3.0	8.3	10.2
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes				"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavourable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favourable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.6	14.4	11.3	7.4	13.6	5.3	12.1	12.0	11.9	11.6	9.7	10.5	6.2	8.3	9.7	10.0	7.8	10.1	8.9	10.4	9.9	9.4	40.7	37.7	9.1	8.5	13.0	10.6	21.8	21.3	20.3	14.2	9.3	13.1	19.4	11.7	24.7	11.3	7.8	19.0	7.4	8.2	8.6	13.3	10.8	10.5	8.6	11.3	3.1	22.9	5.2	6.6	12.1	7.3	18.2	12.0	3.4	12.5	13.4	12.8	7.7	6.2	9.5	3.4	8.7	9.0	3.2	8.0	9.5	14.1	10.0	11.2	5.5	10.3	13.8	5.7	6.1	5.6	12.8	9.8	11.6	8.9	6.6	7.6	7.1	6.2	23.0	18.8	10.3	11.6	20.9	8.9	18.3	8.1	13.0	23.2	12.2	13.6	3.2	5.6	7.1	8.1	7.4	3.0	12.5	8.1	9.2	7.3	7.7	14.9	23.7	15.1	11.5	8.7	6.1	4.4	5.4	13.8	10.8	22.8	30.2	19.2	10.6	10.4	17.5	2.0	12.5	3.4	9.7	10.9	12.8	18.2	7.5	9.9	11.6	15.2	8.3	10.0	1.4	13.4	5.8	12.0	6.0	7.7	11.3	13.6	12.0	11.9	9.9	9.4	13.0	10.6	13.1	11.3
TMEM2		ENSG00000135048	"Transmembrane protein 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 67.6"	"Cell line enhanced"	"Detected in many"		"AF22: 37.7;BEWO: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044889	Approved		Supported	"Vesicles,Plasma membrane"			130000	"Plasma membrane"	Vesicles	"HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	23.3	3.9	6.0	10.5	4.4	12.4	13.6	8.9	6.0	3.0	18.6	1.9	10.1	12.2	4.5	5.2	4.4	4.9	19.2	9.5	8.6	3.6	9.3	24.9	35.7	14.0	4.0	4.1	3.1	9.2	24.0	9.5	67.6	4.3	5.5	13.1	7.9	9.5	10.2	5.5	6.4	20.0	5.5	5.1	15.6	14.5	3.7	2.4	6.4	8.0	4.6	8.8	11.4	6.8	6.3	0.9	5.5	2.1	0.5	4.1	1.4	5.9	28.8	37.7	1.7	3.9	7.1	35.0	20.3	13.0	14.1	10.4	8.1	8.2	0.1	6.1	5.2	9.0	12.2	2.8	19.2	0.7	3.7	10.3	6.1	21.4	6.1	0.0	2.8	7.3	3.1	10.9	2.4	18.5	1.4	3.0	7.6	5.0	1.2	0.1	7.8	2.8	0.9	11.2	0.8	8.9	19.4	1.9	0.2	5.3	3.7	5.4	2.6	0.4	8.1	9.6	10.8	5.3	10.1	0.6	8.7	0.3	1.8	0.9	12.1	0.2	2.1	5.5	2.7	1.9	0.8	0.7	2.9	2.6	0.9	6.3	4.1	2.0	4.5	0.5	1.8	0.2	3.9	1.4	6.0	4.4	8.9	6.0	8.6	3.6	4.0	4.1	4.3	2.4
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588922-9614873	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 37.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favourable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	6.2	7.3	9.6	5.7	9.4	10.3	4.0	8.7	11.9	4.4	3.9	10.5	4.4	5.4	6.9	5.1	5.9	5.8	4.0	13.2	9.3	7.9	5.7	2.7	4.5	5.0	9.4	8.3	9.0	9.2	5.5	12.6	4.5	7.9	4.9	2.8	12.6	6.7	5.6	37.0	7.1	3.9	4.9	6.7	5.3	4.0	8.2	7.1	6.9	4.5	13.9	5.4	3.8	4.3	1.4	4.3	0.0	0.8	0.4	1.9	1.0	7.7	10.4	6.6	15.5	2.8	1.8	5.9	9.1	2.8	10.8	7.7	19.2	7.0	13.5	11.6	3.1	16.2	7.3	7.2	3.6	8.8	18.3	9.5	10.0	9.7	5.1	11.5	9.9	3.4	3.3	14.5	2.4	4.3	12.1	3.9	4.3	9.1	9.9	8.4	6.7	9.7	21.1	11.3	11.0	3.8	4.2	15.8	11.9	7.2	17.6	7.8	5.4	7.3	3.9	13.0	11.3	14.2	17.0	6.6	5.4	12.1	9.0	19.0	11.4	0.0	0.8	0.0	1.1	0.6	0.6	1.4	1.4	1.9	1.1	1.1	1.0	0.7	0.0	0.4	0.4	4.3	1.8	1.0	9.6	9.4	8.7	11.9	9.3	7.9	9.4	8.3	7.9	7.1
TMEM214	FLJ20254	ENSG00000119777	"Transmembrane protein 214"	Q6NUQ4	2	27032910-27041695	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034551			Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Golgi apparatus, Cytosol"		"HPA034551: AB_10602481"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (2.39e-10)"	"unprognostic (1.54e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.92e-2)"	21.8	20.8	9.9	16.3	13.2	9.4	21.0	10.4	13.6	23.2	19.8	11.6	34.5	13.7	23.0	33.4	15.8	18.2	22.6	22.3	8.7	9.7	22.1	47.5	18.9	10.5	10.8	9.4	24.0	57.7	29.1	31.8	30.8	12.7	19.1	20.4	16.9	56.0	36.8	16.9	18.0	20.2	21.7	8.5	19.4	19.4	13.5	11.7	11.4	23.3	10.8	21.1	22.5	16.9	4.1	7.6	8.7	5.7	8.7	8.1	3.1	24.5	16.4	9.9	21.0	32.4	33.4	21.7	32.4	44.0	23.7	26.8	15.6	20.5	11.3	16.4	47.5	17.7	12.0	22.9	19.3	10.7	13.6	14.9	13.0	32.2	40.9	13.6	25.3	28.9	16.4	20.6	35.2	25.6	13.4	23.2	26.5	17.6	6.9	10.1	7.1	13.2	9.3	18.3	27.1	17.8	17.2	8.6	10.0	15.1	25.8	11.6	14.1	8.2	21.9	17.2	16.9	17.4	18.1	31.3	21.1	17.8	22.3	17.0	23.9	8.7	5.1	3.9	6.3	5.7	8.1	4.1	4.9	4.4	4.3	3.8	2.4	3.6	0.9	8.7	3.2	7.6	3.6	3.1	9.9	13.2	10.4	13.6	8.7	9.7	10.8	9.4	12.7	11.7
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783499-32787399	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.0;retina: 6.5;testis: 17.9"	"Group enriched"	"Detected in some"	6	"NTERA-2: 6.4;SH-SY5Y: 1.9"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"				Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA052804: , HPA063207: "	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.1	0.0	1.8	0.4	1.5	0.0	0.1	0.1	0.9	1.9	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.1	0.0	0.9	0.9	1.5	0.0	0.0	0.1	0.0	1.7	0.2	0.7	0.0	0.0	0.1	0.0	0.6	0.1	0.0	6.5	0.1	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	17.9	0.0	0.0	3.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.1	0.8	0.9	1.5	1.7	0.2	0.6	0.0
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212180-37258155	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 20.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 3.6;HEL: 4.7;hTEC/SVTERT24-B: 3.3;HUVEC TERT2: 4.9;TIME: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA045432, HPA071187"			Supported	Nucleoli				Nucleoli		"HPA045432: , HPA071187: "	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.3	2.7	0.4	0.4	1.4	1.3	0.3	0.4	1.1	0.3	0.3	1.6	0.0	0.4	0.2	1.1	1.4	0.4	0.7	0.4	0.3	0.4	0.9	0.5	0.5	0.1	0.9	1.0	1.1	3.1	0.6	2.3	0.2	1.0	0.4	0.3	1.1	1.5	0.1	1.0	0.5	0.4	0.5	1.6	0.2	0.2	20.1	0.9	0.0	0.5	0.0	0.3	0.4	0.3	0.1	0.4	0.2	0.0	0.0	0.6	0.1	0.1	0.0	0.3	0.0	0.2	1.2	0.0	0.3	2.7	1.0	3.6	0.7	0.5	0.1	0.2	0.0	0.5	0.3	0.3	1.0	0.1	0.2	4.7	0.0	0.1	0.3	0.0	2.7	0.5	0.7	3.3	0.2	4.9	1.3	0.0	0.5	0.0	0.1	0.4	0.2	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.2	0.0	0.1	12.8	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.1	0.4	1.4	0.4	1.1	0.3	0.4	0.9	1.0	1.0	0.9
TMEM230	"C20orf30, HSPC274"	ENSG00000089063	"Transmembrane protein 230"	Q96A57	20	5068232-5113103	"Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA009078, HPA061421"	Uncertain		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA009078: AB_1078345, HPA061421: "	"unprognostic (1.39e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.55e-2)"	40.0	40.4	34.3	17.1	27.9	15.6	80.9	20.2	44.8	35.7	29.9	23.2	33.3	18.7	30.2	39.0	26.0	27.4	31.4	49.7	32.7	36.1	44.6	81.0	32.9	49.2	41.1	23.1	31.5	53.5	22.4	31.5	21.8	25.8	33.8	27.9	27.4	26.8	31.0	32.4	10.6	29.4	28.1	44.3	20.6	25.8	24.0	16.4	18.8	42.5	24.9	22.2	31.5	18.9	45.6	44.7	30.5	49.2	39.1	48.2	78.3	33.4	23.6	31.0	23.3	70.2	62.7	23.6	27.1	41.0	26.9	29.8	18.6	33.5	16.1	22.4	39.2	27.9	23.0	40.5	39.1	17.8	26.4	28.4	7.4	56.9	45.0	32.8	11.8	43.3	45.3	20.6	41.4	35.3	26.5	44.5	44.0	9.5	33.0	30.7	23.6	33.7	21.4	20.8	34.4	40.3	17.2	26.2	31.8	16.3	34.4	56.5	27.5	31.4	29.6	35.0	20.4	33.5	29.0	29.8	59.0	31.3	14.1	28.4	36.6	28.4	48.1	30.5	39.3	49.2	48.2	45.6	43.1	41.9	44.7	37.9	45.0	44.3	15.6	39.1	46.1	43.8	38.6	78.3	34.3	27.9	20.2	44.8	32.7	36.1	41.1	23.1	25.8	16.4
TMEM250	"bA83N9.1, C9orf69"	ENSG00000238227	"Transmembrane protein 250"	H0YL14	9	136114581-136118863	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA066070	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA066070: "	"unprognostic (2.79e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"prognostic favourable (1.09e-4)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.64e-1)"	16.4	11.4	16.1	15.0	19.4	5.5	25.3	13.8	28.4	12.4	19.3	9.2	8.2	22.5	12.2	10.9	22.2	14.2	13.8	10.7	17.1	9.5	13.0	17.6	15.2	15.2	9.4	14.2	15.9	12.7	9.4	10.1	15.2	9.8	13.4	11.4	7.4	18.3	13.0	33.9	26.8	18.9	14.1	7.7	14.0	17.3	12.8	10.0	15.4	11.2	12.9	12.0	13.2	11.8	3.0	4.6	5.3	6.3	4.7	9.9	3.0	10.9	20.7	8.1	12.1	11.6	10.6	25.4	13.2	9.5	8.0	5.7	11.7	16.1	8.1	15.5	14.1	28.0	5.7	9.3	2.5	34.9	11.0	6.8	21.7	8.2	16.1	12.4	8.9	9.5	17.9	8.7	9.1	12.7	15.3	8.6	6.9	25.2	15.0	9.9	18.0	22.7	6.2	11.3	13.4	8.7	8.0	14.1	10.7	14.2	9.8	11.3	9.0	18.7	14.2	14.0	6.2	18.3	14.6	5.1	4.8	4.8	14.1	8.9	13.1	4.9	4.6	2.7	9.9	6.2	7.4	3.0	7.6	8.3	4.6	2.4	3.7	6.9	5.3	4.7	6.3	3.0	3.8	3.0	16.1	19.4	13.8	28.4	17.1	9.5	9.4	14.2	9.8	10.0
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059837-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 50.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.9;HEK 293: 3.6;NTERA-2: 3.6;U-937: 3.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	12	"cerebellum: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	6	"cerebellum: 65.8"	"Region enriched"	"Detected in all"	6	"cerebellum: 66.4"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: "	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.1	1.9	1.1	0.2	1.9	0.2	0.4	50.7	4.2	0.2	0.2	0.6	0.0	0.3	0.2	0.1	0.3	0.3	0.1	0.1	0.9	1.3	0.9	0.1	1.1	0.3	0.7	0.3	0.1	2.4	0.2	5.1	2.4	1.9	0.4	0.2	1.1	0.2	0.1	10.6	1.5	0.1	0.1	0.4	0.6	0.3	1.4	0.0	0.0	0.2	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.8	0.8	0.0	1.9	3.6	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	50.7	4.2	0.9	1.3	0.7	0.3	1.9	0.0
TMEM30A	"C6orf67, CDC50A, FLJ10856"	ENSG00000112697	"Transmembrane protein 30A"	Q9NV96	6	75252924-75284968	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014561	Approved		Supported	Mitochondria				Mitochondria		"HPA014561: AB_10601823"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.00e-1)"	29.9	29.6	42.7	28.3	63.3	23.8	27.2	40.3	55.1	33.4	31.3	36.8	22.3	21.2	31.9	25.7	30.1	24.6	30.6	22.9	45.6	48.2	39.6	48.1	45.0	23.9	43.8	41.0	25.2	41.0	57.0	45.5	29.4	50.5	33.6	36.8	20.5	31.9	31.7	18.6	19.4	22.5	39.8	45.3	28.9	28.0	14.1	40.3	21.1	43.1	17.0	29.3	32.8	22.8	9.1	24.3	42.7	26.8	13.1	16.3	16.7	10.4	10.1	18.7	15.6	47.1	44.3	15.4	42.6	33.5	16.6	25.4	10.8	24.4	12.2	29.5	37.4	12.3	8.3	23.7	44.4	15.6	12.3	11.7	11.0	11.1	26.9	14.1	20.6	41.0	23.5	23.0	12.9	52.7	11.4	21.6	32.3	6.9	4.9	10.2	6.6	8.7	8.2	13.2	15.3	64.3	25.7	13.1	12.8	21.6	10.7	14.3	11.8	44.1	45.7	21.0	23.5	13.1	30.0	17.8	24.2	5.2	16.6	27.2	32.9	12.3	26.8	17.7	12.7	26.6	15.3	9.1	13.0	12.2	24.3	7.5	12.5	12.6	42.7	13.1	25.6	10.6	16.3	16.7	42.7	63.3	40.3	52.7	45.6	48.2	43.8	41.0	50.5	40.3
TMEM35A	"FLJ14084, TMEM35"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078720-101096364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;seminal vesicle: 46.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.3;HUVEC TERT2: 31.7;SH-SY5Y: 8.1"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced		Supported	"Vesicles,Focal adhesion sites,Cytosol"				Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: "	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.6	6.7	12.8	1.7	28.2	0.7	1.3	21.2	28.6	3.3	17.3	2.5	6.8	3.5	7.4	3.9	10.4	4.3	3.6	1.1	14.4	33.8	1.1	0.7	2.6	0.8	12.2	10.0	7.7	0.9	6.1	1.5	0.8	30.0	20.5	9.1	2.9	1.0	46.4	1.3	0.9	4.1	11.8	3.9	1.3	3.4	1.8	2.3	0.0	1.3	0.0	0.9	13.3	2.7	0.2	0.0	0.2	0.1	0.6	0.8	0.4	0.0	0.0	3.3	0.0	2.4	6.3	0.0	0.6	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.0	2.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.1	0.0	1.1	0.0	31.7	0.0	0.0	4.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	1.4	8.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.4	0.2	0.6	0.1	0.0	0.8	0.4	12.8	28.2	21.2	28.6	14.4	33.8	12.2	10.0	30.0	2.3
TMEM63A	KIAA0792	ENSG00000196187	"Transmembrane protein 63A"	O94886	1	225845536-225882369	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.4"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 37.7;SK-BR-3: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066504, HPA066936, HPA068918"			Enhanced	"Vesicles,Centriolar satellite"			96000	"Vesicles, Centriolar satellite"		"HPA066504: , HPA066936: , HPA068918: "	"unprognostic (5.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-2)"	"prognostic favourable (8.79e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.92e-2)"	10.5	7.4	14.7	11.6	38.8	18.6	12.2	4.1	23.2	14.3	14.0	91.4	17.3	12.2	12.2	11.2	6.6	13.9	12.9	8.5	30.2	15.1	14.3	15.1	12.6	15.4	59.3	16.4	13.1	22.4	11.6	5.3	11.3	34.9	22.3	17.8	5.7	55.8	19.1	6.9	9.9	13.3	8.8	71.0	14.0	22.9	3.0	49.6	11.2	8.0	4.5	12.4	13.3	9.6	5.4	10.0	5.5	4.1	8.7	16.6	5.7	9.3	2.8	2.4	7.1	19.6	6.8	16.9	7.1	7.7	8.0	8.1	10.2	6.9	2.6	13.2	8.7	14.4	2.6	4.3	3.7	8.7	4.7	11.3	6.5	6.1	4.5	4.2	29.9	7.1	2.7	4.7	2.9	5.1	9.4	2.2	6.3	5.9	3.7	4.3	13.3	4.6	3.7	7.5	37.7	12.2	24.7	0.2	1.3	5.2	42.0	5.1	9.7	4.0	6.1	4.6	3.2	4.2	6.4	0.9	3.4	0.6	4.2	2.4	8.4	5.5	3.2	3.0	9.4	2.7	10.6	5.2	12.1	8.9	2.5	5.4	10.9	6.3	5.1	8.7	4.1	10.0	16.6	5.7	14.7	38.8	4.1	23.0	30.2	15.1	59.3	16.4	34.9	49.6
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA029249: , HPA029250: , HPA029251: "	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	9.7	13.2	24.4	8.7	21.4	14.0	9.4	33.2	34.3	9.1	19.7	14.8	7.5	17.1	8.2	11.7	21.1	8.6	13.2	16.6	21.6	15.2	10.7	28.6	35.0	5.2	13.1	18.2	8.0	10.6	19.6	10.2	12.8	22.8	12.9	18.4	18.6	13.9	8.8	29.4	29.6	17.0	9.7	13.8	6.3	24.5	22.7	16.0	4.7	11.4	14.8	8.9	14.4	13.4	1.3	1.3	1.7	2.1	0.3	2.6	1.2	18.9	10.0	9.5	16.1	15.1	8.9	16.2	7.8	10.5	9.5	9.0	7.1	7.0	3.2	12.8	11.6	18.7	11.1	28.9	5.5	8.8	9.7	9.3	7.3	20.9	10.7	1.9	9.8	12.2	25.2	12.2	7.7	8.6	30.1	5.6	9.6	18.8	2.0	4.5	4.9	5.1	2.4	5.9	6.0	23.4	18.0	10.4	8.5	7.2	16.7	17.3	19.6	5.0	10.3	11.4	13.6	8.7	9.4	6.7	4.9	3.6	17.7	3.2	14.1	1.1	2.1	1.3	1.4	1.1	2.5	1.3	0.7	0.7	0.9	0.8	1.0	1.1	1.7	0.3	1.4	1.3	2.6	1.2	24.4	21.4	33.2	34.3	21.6	15.2	13.1	18.2	22.8	16.0
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Uncertain		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: "	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	9.5	12.3	7.6	7.4	8.0	7.0	9.4	7.1	12.8	6.0	7.4	3.6	3.9	4.8	6.1	9.0	6.2	9.1	7.4	13.3	9.3	7.9	9.7	38.8	6.2	9.6	6.8	7.3	7.3	17.0	5.1	6.3	8.1	10.0	6.3	8.0	3.8	7.1	5.3	81.1	4.8	6.9	7.7	6.3	9.9	10.6	10.9	5.1	8.5	6.5	13.4	7.9	6.7	5.9	18.4	12.3	7.5	11.0	6.2	12.7	12.7	11.0	8.8	7.1	7.4	8.4	7.2	7.3	9.4	8.6	10.6	8.6	8.3	6.4	15.0	8.2	6.4	10.1	13.6	9.1	12.0	9.7	9.3	15.0	5.8	11.0	8.4	8.1	8.0	6.7	8.4	6.7	3.6	8.9	11.2	7.4	11.2	8.2	18.5	15.4	6.6	11.0	13.1	7.0	12.7	11.2	10.5	16.2	7.2	5.8	42.5	11.9	8.8	7.5	5.6	6.2	7.5	11.2	8.9	11.0	9.4	14.7	9.0	6.4	6.8	6.3	10.8	7.0	9.5	11.0	10.9	18.4	10.9	10.8	10.5	10.8	12.7	11.8	7.5	6.2	8.1	12.3	8.6	12.7	7.6	8.0	7.1	12.8	9.3	7.9	6.8	7.3	10.0	5.1
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 65.7;lymphoid tissue: 31.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.0;HDLM-2: 32.3;Karpas-707: 6.9;U-937: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 65.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 65.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria				Mitochondria		"HPA058401: , HPA070655: "	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	4.2	1.1	1.4	8.2	1.5	20.8	5.4	0.7	1.2	2.5	9.9	0.8	0.4	1.2	1.0	2.0	4.8	1.9	4.1	25.5	1.8	1.2	1.9	2.3	8.3	20.9	2.2	0.8	1.9	2.9	0.0	1.4	1.0	1.7	2.2	2.2	5.8	5.8	1.3	1.3	1.3	7.2	2.2	4.2	18.2	2.9	0.9	1.4	31.3	2.2	2.5	10.6	7.0	2.8	1.4	8.2	65.7	13.5	2.9	14.8	8.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.7	8.0	0.3	0.5	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.2	0.9	32.3	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	1.2	0.6	0.0	6.9	1.4	0.0	1.6	1.2	0.7	0.2	0.1	1.1	0.4	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.5	0.7	3.3	0.0	1.6	0.0	5.7	19.1	2.4	12.5	13.5	23.9	8.0	3.9	14.8	1.4	5.9	5.6	8.2	1.3	9.0	6.5	65.7	2.9	3.2	0.2	0.7	8.4	1.4	1.5	0.7	1.2	1.8	1.2	2.2	0.8	1.7	1.4
TMEM87A	DKFZP564G2022	ENSG00000103978	"Transmembrane protein 87A"	Q8NBN3	15	42210452-42273663	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018104, HPA018189"	Enhanced		Supported	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"HPA018104: AB_1858135, HPA018189: AB_2205198"	"unprognostic (7.07e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.63e-1)"	22.0	18.2	15.6	15.6	24.9	38.9	49.1	15.9	19.6	23.2	28.0	35.8	30.6	13.2	26.0	25.8	34.5	23.3	16.4	14.8	17.4	15.2	16.9	16.2	36.3	16.8	38.9	17.9	20.5	25.0	29.3	20.8	35.3	24.9	41.5	31.2	20.8	45.1	27.4	18.9	30.8	19.5	23.7	37.2	14.7	21.1	20.9	32.5	16.0	38.7	24.3	21.2	24.8	25.2	19.2	15.8	29.3	21.0	25.3	26.6	15.8	13.3	6.7	10.3	9.1	20.4	17.4	16.3	18.5	27.4	18.1	18.2	9.8	29.5	5.7	18.4	19.6	34.8	9.2	17.0	14.6	15.0	8.3	11.6	17.7	10.9	22.0	21.1	16.6	18.1	38.3	13.2	22.3	13.9	12.5	22.9	17.2	8.5	6.9	12.5	8.7	9.7	11.1	16.1	11.9	11.7	42.7	11.4	14.3	17.7	23.7	16.3	9.2	20.4	13.7	36.1	8.8	23.5	27.2	16.0	30.0	12.3	14.0	15.8	22.4	29.3	17.6	19.8	20.1	20.7	22.9	19.2	24.8	23.3	15.8	15.4	23.8	23.5	10.3	25.3	21.0	14.3	26.6	15.8	15.6	24.9	15.9	19.6	17.4	15.2	38.9	17.9	24.9	32.5
TMEM8A	"M83, PGAP6, TMEM6, TMEM8"	ENSG00000129925	"Transmembrane protein 8A"	Q9HCN3	16	370773-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"HPA051281: , HPA064673: "	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favourable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	8.4	9.3	6.9	9.5	7.8	15.2	13.5	7.7	7.9	6.8	16.6	7.3	24.1	17.7	7.3	29.6	11.8	6.5	15.2	10.0	5.6	4.3	28.7	33.5	13.0	10.7	7.1	3.2	8.3	44.2	11.5	10.7	45.5	6.7	11.4	6.0	8.8	22.5	8.8	12.8	3.7	25.0	5.0	4.7	13.2	17.5	26.3	6.0	12.6	12.3	5.2	14.6	9.3	8.8	2.0	2.9	24.3	5.5	0.9	7.6	3.3	4.4	11.7	6.7	12.3	9.2	8.3	13.4	12.7	13.3	6.5	9.3	45.8	20.8	4.7	17.3	12.2	6.3	3.0	14.0	1.8	13.4	11.2	7.8	7.9	26.1	21.3	5.9	14.8	9.6	4.2	10.0	2.9	15.0	12.5	7.3	8.1	27.4	8.2	11.5	10.6	4.6	17.9	7.7	10.8	10.5	11.4	8.0	9.2	7.1	7.2	37.4	12.9	11.8	21.8	18.5	20.0	12.8	6.7	14.7	7.3	9.3	9.4	6.3	11.7	4.6	5.0	6.3	7.4	5.5	5.9	1.8	5.8	5.8	2.5	2.0	7.6	5.5	24.3	0.9	3.8	2.9	4.3	3.3	6.9	7.8	7.7	7.9	5.6	4.3	7.1	3.2	6.7	6.0
TMEM92	FLJ33318	ENSG00000167105	"Transmembrane protein 92"	Q6UXU6	17	50271406-50281485	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 74.7"	"Group enriched"	"Detected in some"	4	"A549: 9.7;CACO-2: 16.5;CAPAN-2: 15.9;EFO-21: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 5.5"					"Low region specificity"	"Detected in all"			"HPA063009, HPA069820"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA063009: , HPA069820: "	"unprognostic (3.54e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (4.37e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (1.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.81e-2)"	0.2	0.1	0.3	1.9	0.3	0.4	0.3	0.3	0.3	3.3	27.9	0.3	0.1	23.3	1.2	0.3	1.0	0.7	11.7	0.1	0.8	0.3	0.4	10.2	6.1	0.1	0.3	0.2	2.4	1.2	0.0	0.1	0.3	0.9	1.2	1.8	1.1	4.3	1.2	0.1	0.2	74.7	0.4	0.4	0.3	17.9	0.5	0.3	0.1	0.1	0.4	1.6	2.2	3.7	0.1	0.2	5.5	0.1	0.0	0.0	0.0	1.0	9.7	0.2	0.0	0.0	0.4	2.1	0.2	0.3	0.0	0.0	16.5	15.9	0.0	33.0	0.7	0.1	0.2	1.8	0.1	2.6	0.1	0.0	1.0	1.6	0.1	0.1	0.1	0.1	1.9	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.0	0.2	3.6	4.3	0.2	0.0	4.1	3.6	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.5	0.0	0.1	2.3	0.0	0.0	0.0	0.2	0.1	0.2	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.2	0.9	0.3
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500090	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: "	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favourable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	14.6	25.6	26.6	11.2	32.0	13.9	9.8	24.4	32.7	11.7	16.7	30.3	8.2	15.4	13.0	8.5	14.5	27.4	13.7	21.1	21.7	13.3	14.0	9.6	17.0	10.6	24.0	23.0	17.1	13.9	17.2	18.6	18.6	21.9	12.5	11.5	25.4	11.8	12.5	40.4	16.2	15.2	9.4	15.9	14.3	14.8	16.5	23.4	10.7	18.4	9.6	9.2	13.7	7.1	4.6	6.2	5.5	4.6	4.3	7.1	4.5	7.5	19.7	16.3	25.6	8.2	9.3	23.4	4.5	10.0	7.7	7.9	6.6	11.8	10.6	15.1	7.9	9.9	7.8	12.5	4.3	9.5	11.1	10.8	8.8	9.9	11.1	12.0	23.5	16.1	7.0	7.7	6.7	14.0	11.2	12.4	10.1	8.8	24.8	7.5	6.8	7.7	17.6	19.3	9.8	7.6	19.9	14.5	15.4	5.4	23.5	13.5	14.5	14.3	8.1	7.7	9.8	8.0	6.4	27.0	7.7	5.8	9.1	11.1	10.5	0.2	4.6	5.5	7.1	2.9	5.4	2.0	3.3	4.7	4.6	4.6	2.8	4.4	1.2	4.3	2.7	6.2	4.1	4.5	26.6	32.0	24.4	32.7	21.7	13.3	24.0	23.0	21.9	23.4
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319095-28328685	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 228.7"	"Cell line enhanced"	"Detected in all"		"CACO-2: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"	2.0	11.5	3.1	2.8	3.3	1.7	3.4	2.9	4.9	2.6	4.2	2.2	1.2	4.7	2.9	1.9	3.1	4.0	8.1	1.6	2.4	3.0	2.2	33.7	12.5	3.4	2.4	2.7	8.2	228.7	1.7	0.6	2.0	7.7	6.9	3.8	3.2	1.5	2.8	5.7	3.6	3.2	3.4	4.0	1.7	13.2	31.5	1.3	4.6	1.3	3.9	2.5	12.5	6.0	9.0	13.8	1.7	2.3	8.2	10.0	4.6	9.9	25.1	48.1	23.7	6.4	9.2	15.8	9.6	6.2	15.3	20.5	71.0	7.6	27.3	10.6	3.7	10.7	30.5	16.4	12.1	12.8	21.4	10.2	13.1	30.2	5.8	16.2	8.2	18.7	2.1	15.0	6.2	4.6	21.4	20.6	5.1	16.8	25.3	15.3	21.2	6.5	20.4	52.9	24.6	18.8	45.4	34.7	15.2	15.4	12.3	7.8	21.6	7.5	3.0	16.5	13.1	14.1	17.6	16.6	32.7	24.9	3.3	11.7	9.7	0.4	2.0	1.7	7.3	2.3	8.5	9.0	6.2	8.8	13.8	5.1	10.0	9.3	0.9	8.2	0.8	8.0	5.8	4.6	3.1	3.3	2.9	4.2	2.4	3.0	2.4	2.7	7.7	1.3
TMEM98	DKFZP564K1964	ENSG00000006042	"Transmembrane protein 98"	Q9Y2Y6	17	32927910-32945106	"Disease related genes, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 96.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 7.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040473, HPA053385"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA040473: AB_10794876, HPA053385: "	"unprognostic (1.55e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.36e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (8.14e-4)"	"prognostic favourable (7.10e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.18e-3)"	"prognostic favourable (3.85e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	15.5	15.9	11.8	7.1	36.8	0.9	13.3	6.5	28.3	21.6	26.1	55.5	5.6	29.7	30.5	23.0	8.2	29.6	27.7	13.5	17.0	9.4	10.8	7.7	17.0	3.1	50.4	18.5	60.2	25.7	6.3	7.4	8.0	40.8	24.7	28.7	96.8	14.8	7.4	2.6	7.1	34.0	19.0	37.1	5.7	29.7	9.7	37.7	0.6	14.2	7.4	3.5	15.6	13.3	0.5	7.9	0.6	0.1	0.2	0.6	0.1	1.5	5.7	24.7	0.0	34.0	30.6	0.2	23.9	32.5	12.7	27.5	57.7	1.7	0.3	0.3	30.0	0.2	15.7	6.3	7.5	5.0	19.3	0.9	0.0	25.6	15.7	0.0	0.3	25.5	6.3	16.0	2.6	32.8	15.7	0.0	34.5	0.0	0.0	0.1	16.4	8.9	0.0	23.2	0.1	2.9	10.2	2.1	34.1	0.5	0.0	18.7	7.7	0.0	26.8	18.2	17.1	0.2	0.0	2.0	0.7	0.0	9.2	0.0	9.7	0.5	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.6	0.0	0.5	0.1	0.2	0.6	0.2	0.1	7.9	0.1	0.1	11.8	36.8	6.5	28.3	17.0	9.4	50.4	18.5	40.8	37.7
TMF1	"ARA160, TMF"	ENSG00000144747	"TATA element modulatory factor 1"	P82094	3	69019827-69052339	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008729	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA008729: AB_1080310"	"unprognostic (2.71e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.02e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-1)"	17.4	14.2	12.8	15.2	14.2	26.2	20.8	20.8	15.6	18.8	21.1	9.5	26.6	14.8	18.3	24.2	14.9	17.7	16.8	16.7	11.9	12.1	17.5	17.2	19.0	16.8	13.5	11.1	20.2	23.0	22.3	36.1	28.9	17.2	19.0	16.9	9.5	24.3	28.9	21.3	13.3	22.9	13.8	13.6	16.3	15.9	20.9	16.0	20.3	24.7	11.1	16.4	23.2	18.6	6.6	4.6	10.0	5.9	5.0	6.4	3.1	12.5	5.5	5.3	5.3	14.3	18.5	11.9	16.3	15.8	11.0	13.3	7.8	9.4	4.8	2.6	16.5	7.0	6.8	7.2	18.1	9.2	5.2	9.4	7.3	9.2	13.0	10.5	13.4	10.8	11.6	14.5	13.2	11.7	5.6	7.9	14.2	7.2	6.0	9.1	4.6	2.9	5.0	6.7	6.9	14.2	10.2	3.7	5.6	13.4	9.5	10.1	7.2	12.7	15.2	10.8	4.6	18.9	9.7	8.9	8.5	4.7	16.5	10.9	8.5	7.6	4.5	9.1	6.4	3.7	4.3	5.2	5.7	5.4	4.0	6.6	5.9	5.4	10.0	5.0	5.9	4.6	5.8	3.1	12.8	14.2	20.8	15.6	11.9	12.1	13.5	11.1	17.2	16.0
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155490115-155669944	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria				Mitochondria		"HPA034589: AB_10670571, HPA040331: "	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favourable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	10.1	15.0	8.5	6.7	10.5	6.7	10.4	17.1	13.5	11.3	10.5	10.0	9.1	10.7	10.9	10.1	9.5	9.5	7.4	22.3	10.3	7.5	15.8	16.9	6.9	14.6	12.5	7.4	12.4	10.7	18.4	17.5	7.6	11.5	7.7	11.6	10.6	16.2	9.6	28.1	7.8	10.0	13.8	13.7	9.2	9.8	3.1	11.2	12.2	10.5	5.3	8.7	10.2	9.1	9.1	10.3	14.7	15.7	4.3	5.6	4.5	15.2	7.5	6.2	18.1	7.7	11.9	0.0	6.2	9.1	7.8	20.4	5.3	8.6	0.0	25.0	10.8	8.3	13.2	6.0	8.9	6.2	9.1	6.8	12.2	6.2	10.8	6.4	4.9	12.6	12.7	8.7	13.2	12.3	9.5	5.6	12.9	5.7	7.7	7.2	1.9	0.1	7.7	9.9	5.8	9.4	5.2	5.9	8.9	5.8	0.3	6.7	6.7	7.3	10.3	6.6	6.3	13.0	7.6	7.0	7.5	5.9	8.0	10.0	6.0	1.9	10.1	11.3	3.9	11.4	2.9	6.2	4.3	3.3	10.3	9.1	5.6	4.9	14.7	4.3	15.7	4.7	4.2	4.5	8.5	10.5	17.1	13.5	10.3	7.5	12.5	7.4	11.5	11.2
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515512-98550379	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 130.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235"	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavourable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	10.8	9.5	8.1	25.0	9.5	36.8	12.7	19.1	11.0	16.9	22.9	10.7	8.7	15.9	18.4	17.1	23.0	15.4	10.3	9.6	8.5	8.3	15.8	20.5	13.8	34.0	9.0	11.2	34.7	21.6	9.9	9.9	13.6	7.6	15.6	17.6	12.5	14.0	9.7	9.4	11.7	22.6	10.7	9.4	29.1	16.8	11.4	10.3	130.9	13.2	12.2	35.4	13.0	17.9	14.1	10.9	18.1	33.1	9.7	15.6	13.3	30.3	20.0	49.4	25.1	4.1	5.5	29.3	25.0	13.2	33.9	24.6	21.8	15.2	53.0	15.4	14.5	19.5	41.4	18.8	31.1	37.0	25.7	45.4	18.3	14.4	3.7	52.4	30.3	3.1	6.2	20.0	10.8	19.3	38.2	20.6	21.0	19.1	85.4	41.3	29.7	18.8	71.7	32.8	36.7	12.0	28.4	39.1	23.4	42.7	26.9	13.4	30.3	25.2	10.3	19.7	17.2	13.4	25.5	22.4	38.2	59.3	5.6	30.4	26.1	18.1	14.4	6.1	9.5	25.0	10.2	10.9	11.1	10.8	10.9	14.1	15.6	11.7	1.1	9.7	33.1	6.1	13.3	13.3	8.1	9.5	19.1	11.0	8.5	8.3	9.0	11.2	7.6	10.3
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464551-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 75.6;pancreas: 64.5;prostate: 68.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.6;MCF7: 6.3;RT4: 35.2;SK-BR-3: 7.2;T-47d: 5.4"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA034493, HPA035787"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"			"Cell Junctions"	Nucleoplasm	"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favourable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.2	0.1	0.2	15.5	0.4	0.0	6.1	0.2	0.5	1.3	38.7	0.4	24.4	17.5	0.5	0.9	10.7	2.2	17.3	0.2	0.3	0.1	19.4	18.4	20.7	0.2	0.2	0.2	0.7	64.5	0.0	1.3	1.0	0.4	68.2	18.5	0.3	52.3	35.7	0.2	2.1	75.6	0.9	0.2	0.3	36.7	0.8	0.3	0.5	19.9	3.9	10.2	5.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.6	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.5	1.3	0.0	0.0	0.0	1.4	0.6	35.2	0.0	0.4	0.0	7.2	0.1	5.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.2	0.5	0.3	0.1	0.2	0.2	0.4	0.3
TMUB1	"C7orf21, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081080-151083546	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	10.6	15.2	10.3	16.1	11.0	13.7	17.8	9.1	16.0	9.7	27.5	9.0	17.0	31.8	10.4	15.4	21.6	9.6	18.0	17.3	10.6	9.6	25.5	35.5	12.9	15.6	10.2	10.0	13.1	51.5	9.5	21.1	18.9	8.3	16.1	6.0	12.7	29.6	12.9	33.8	15.1	39.2	12.8	8.7	16.1	24.0	11.5	8.5	23.9	23.6	12.9	19.1	18.7	11.8	8.0	4.2	18.2	3.6	3.1	9.5	1.8	24.1	21.8	5.1	26.5	3.4	4.2	19.3	9.9	8.3	8.8	9.9	18.8	29.5	16.2	21.3	4.8	16.5	5.7	8.7	1.9	29.6	20.2	6.9	20.2	28.4	8.6	8.5	24.5	6.4	7.3	7.4	2.0	6.5	43.0	22.1	3.9	39.0	28.3	36.7	22.0	13.2	17.7	6.5	29.9	9.1	18.8	18.9	21.0	8.0	12.4	12.9	9.7	11.9	7.9	11.3	8.2	14.1	16.3	34.9	19.1	11.1	26.0	16.0	14.2	3.5	2.7	18.2	5.4	3.6	4.7	4.4	8.0	5.8	2.8	8.0	7.8	4.5	4.7	3.1	2.2	4.2	9.5	1.8	10.3	11.0	9.1	16.0	10.6	9.6	10.2	10.0	8.3	8.5
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257546	"Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"			740000	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	21.8	24.2	13.6	18.5	18.3	15.5	19.7	14.1	12.3	14.4	20.7	17.2	27.0	17.7	17.5	19.2	25.0	13.3	15.0	11.3	13.5	11.9	24.9	29.2	20.0	25.3	22.6	9.2	15.5	23.9	18.4	19.0	21.9	16.3	14.2	21.2	13.3	21.0	27.9	12.5	16.7	23.4	17.0	24.9	29.1	18.1	12.9	17.9	37.5	23.5	17.6	17.4	20.2	19.9	9.4	17.0	9.6	17.5	12.6	12.5	13.3	13.6	12.6	17.5	9.4	14.0	11.0	18.8	17.2	13.9	17.4	22.3	12.7	25.2	19.5	16.2	11.5	13.5	30.9	11.3	31.7	19.6	10.6	14.2	11.0	12.5	12.2	32.6	14.4	13.1	10.4	11.7	8.6	15.4	11.7	13.5	16.5	16.8	14.5	17.6	19.9	15.8	15.4	31.6	11.7	16.8	17.8	11.1	8.2	13.7	9.2	12.3	13.5	14.6	9.9	18.4	17.1	13.0	15.6	11.8	11.9	16.0	8.1	18.6	17.2	9.6	15.4	7.2	10.2	17.5	12.5	9.4	10.9	10.5	16.2	7.4	10.8	12.0	5.7	12.6	12.6	17.0	12.1	13.3	13.6	18.3	14.1	12.3	13.5	11.9	22.6	9.2	16.3	17.9
TMX4	"DJ971N18.2, KIAA1162, PDIA14, TXNDC13"	ENSG00000125827	"Thioredoxin related transmembrane protein 4"	Q9H1E5	20	7977348-8019829	"Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000399, HPA015752"	Enhanced		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA000399: AB_1858471, HPA015752: AB_1858470"	"unprognostic (3.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.14e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.96e-1)"	"unprognostic (5.80e-3)"	"unprognostic (3.16e-1)"	"prognostic favourable (2.60e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.06e-2)"	11.2	24.6	15.4	10.6	20.8	15.7	12.2	19.9	30.5	27.5	17.6	11.7	34.2	8.0	18.0	21.6	10.0	18.6	13.3	35.0	15.5	30.9	18.5	17.3	11.6	14.7	15.6	16.2	23.0	11.0	23.9	40.9	7.6	21.8	16.7	8.2	14.7	24.2	31.4	21.7	6.5	10.2	19.2	10.7	9.9	13.7	48.2	7.2	8.5	16.3	8.8	8.7	14.8	11.2	10.1	9.9	51.2	8.0	11.5	17.8	13.5	4.2	6.3	6.3	7.1	14.1	15.7	1.9	10.9	15.2	7.0	5.0	4.2	10.6	11.4	8.7	10.9	3.8	4.5	6.7	7.3	5.7	5.0	5.6	2.8	6.9	13.3	20.7	8.4	9.5	8.6	6.0	14.1	8.0	6.9	29.2	7.7	2.8	0.6	13.0	5.0	7.0	6.5	22.6	11.8	9.9	2.4	12.6	15.4	18.2	0.8	10.7	7.7	10.2	10.5	18.9	5.2	7.0	10.6	29.5	8.2	22.7	9.1	10.3	13.1	22.6	8.0	23.3	12.2	4.7	12.0	10.1	12.5	17.8	9.9	8.1	7.6	10.2	51.2	11.5	5.0	3.3	15.9	13.5	15.4	20.8	19.9	30.5	15.5	30.9	15.6	16.2	21.8	7.2
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867188-137883312	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 48.4;REH: 42.0;U-266/84: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002116, HPA067479"	Approved		Supported	Vesicles				Vesicles		"HPA002116: AB_1858162, HPA067479: "	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	27.4	6.0	1.5	58.6	1.8	112.4	17.2	0.4	1.5	7.7	15.7	3.2	2.6	5.1	9.7	7.3	12.7	12.1	17.0	11.7	2.1	1.3	6.8	8.1	45.1	38.8	2.1	2.6	37.5	7.2	2.1	3.7	14.5	4.6	13.8	6.3	7.2	8.2	3.5	10.7	20.5	17.2	8.2	3.8	25.9	8.0	9.3	2.1	38.6	5.7	9.2	31.4	23.3	9.5	7.1	18.6	10.0	9.7	7.5	20.5	9.0	8.9	1.5	0.5	0.8	3.0	5.1	2.1	5.1	20.0	1.4	1.8	9.9	3.0	2.0	13.2	5.9	6.8	0.3	14.8	2.6	14.6	0.5	2.0	5.2	5.8	3.3	2.7	3.7	4.7	2.1	16.9	16.1	0.8	4.1	48.4	2.4	0.5	14.7	11.5	0.3	0.4	42.0	10.4	1.4	4.4	4.3	0.2	0.0	1.0	1.5	4.4	1.0	3.4	4.0	14.5	1.7	12.9	2.9	15.6	36.1	4.1	5.3	3.5	1.8	5.6	9.7	5.5	14.8	7.1	20.5	6.2	15.1	13.3	10.3	7.1	10.0	7.4	10.0	7.5	3.7	18.6	14.7	9.0	1.5	1.8	0.4	1.5	2.1	1.3	2.1	2.6	4.6	2.1
TNFAIP8	"GG2-1, MDC-3.13, SCC-S2"	ENSG00000145779	"TNF alpha induced protein 8"	O95379	5	119268692-119399688	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 73.4;lymphoid tissue: 83.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054434, HPA057089"	Uncertain		Enhanced	Nucleoplasm			270000	Nucleoplasm		"HPA054434: , HPA057089: "	"prognostic favourable (2.45e-4)"	"unprognostic (6.06e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-2)"	21.1	2.1	1.6	49.9	3.0	17.8	18.9	1.5	1.7	11.3	8.0	1.6	4.7	4.3	9.7	9.2	15.0	4.6	9.7	8.5	1.8	1.7	8.7	8.4	22.0	71.3	2.9	1.8	4.2	12.5	5.2	1.7	36.1	12.2	11.8	5.5	4.2	13.7	5.8	2.2	14.4	21.4	6.9	3.6	37.5	13.1	4.7	2.2	83.1	9.3	8.6	41.1	12.7	12.8	50.3	25.2	73.4	19.7	19.7	54.4	36.5	7.5	5.3	2.8	4.6	6.0	5.0	25.8	4.1	11.3	3.1	6.6	2.9	8.8	14.1	1.3	4.7	10.7	2.3	12.7	4.5	15.4	4.9	22.3	11.8	4.8	2.9	26.9	24.8	5.6	12.0	9.5	4.6	4.3	8.6	44.1	4.3	2.9	22.8	35.1	4.3	2.5	7.0	12.5	20.4	12.7	15.1	1.4	2.2	15.7	3.0	1.5	2.7	30.7	2.1	5.7	2.2	4.0	4.9	21.7	23.8	28.3	6.7	28.8	3.4	73.4	18.6	55.3	22.6	19.7	43.9	50.3	45.5	33.2	25.2	44.2	54.4	34.9	10.6	19.7	14.8	12.1	34.8	36.5	1.6	3.0	1.5	1.7	1.8	1.7	2.9	1.8	12.2	2.2
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.0;smooth muscle: 47.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 12.6;ASC TERT1: 32.2;HUVEC TERT2: 27.5;LHCN-M2: 25.8;TIME: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA077484: "	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (3.51e-4)"	4.6	2.4	11.8	4.1	3.8	0.8	10.5	0.6	5.8	9.8	4.1	1.8	2.8	1.2	47.0	9.9	11.5	20.9	3.7	5.5	11.4	3.1	1.9	1.5	6.6	5.4	1.9	5.6	17.5	1.6	0.6	1.8	1.4	3.3	6.6	5.0	0.6	1.9	3.5	2.1	10.7	3.2	47.0	1.5	14.7	2.9	3.4	1.1	0.0	2.5	4.7	2.4	12.3	18.8	1.4	1.0	3.7	1.5	1.7	0.8	0.3	0.0	0.1	0.0	0.0	12.6	32.2	0.1	0.1	0.0	0.3	0.5	0.0	0.3	0.0	0.6	1.7	0.0	0.4	0.3	0.1	0.0	0.3	0.0	0.9	2.0	3.3	0.1	0.7	11.8	2.5	2.4	9.3	27.5	0.0	0.0	25.8	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	36.8	2.9	0.2	9.4	0.7	0.1	0.0	0.0	6.0	0.0	0.0	2.8	1.5	0.7	0.5	0.7	0.6	0.8	0.6	0.5	0.3	1.4	0.6	0.8	3.7	1.7	1.0	1.0	0.4	0.3	11.8	3.8	0.6	5.8	11.4	3.1	1.9	5.6	3.3	1.1
TNFRSF10A	"Apo2, CD261, DR4, TRAILR-1, TRAILR1"	ENSG00000104689	"TNF receptor superfamily member 10a"	O00220	8	23190452-23225126	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA050958, HPA054475"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA050958: , HPA054475: "	"unprognostic (3.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (1.00e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-1)"	11.9	4.0	2.1	13.0	3.4	8.4	9.7	2.0	2.8	6.0	10.9	1.4	4.5	5.9	5.3	5.6	13.6	4.1	12.7	6.3	2.2	2.0	10.9	10.6	11.0	12.4	3.0	0.7	2.7	12.9	3.6	1.8	6.9	4.0	5.1	7.2	2.1	8.2	4.3	3.8	7.1	10.2	3.8	2.9	13.2	6.1	2.6	3.0	9.5	5.8	14.9	25.4	6.7	8.7	13.2	4.5	3.8	4.3	3.9	13.9	4.2	7.9	14.4	0.7	0.0	0.5	2.9	0.0	1.6	1.0	0.8	2.3	11.0	14.0	18.4	18.8	1.0	15.2	12.9	20.6	1.4	4.5	0.1	9.7	8.7	6.2	7.4	5.2	9.3	5.0	17.0	18.3	15.8	9.7	15.0	6.6	3.9	6.2	0.2	3.3	10.0	8.8	0.1	0.0	13.2	11.0	17.2	0.4	0.5	4.0	10.2	0.0	5.4	4.0	13.6	0.0	0.1	0.8	0.0	7.8	11.0	14.3	0.1	1.7	0.2	2.0	4.3	3.8	3.8	1.9	10.3	10.4	12.3	7.7	4.5	13.2	12.1	7.0	0.5	3.9	1.7	0.0	13.9	4.2	2.1	3.4	2.0	2.8	2.2	2.0	3.0	0.7	4.0	3.0
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391292	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 51.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: "	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	6.5	1.7	1.7	4.8	1.2	0.2	4.3	0.4	2.3	1.5	18.4	0.8	7.6	23.1	0.9	1.9	3.8	1.3	28.7	1.1	1.3	0.7	0.9	0.8	2.3	7.4	1.0	1.0	0.7	2.9	0.1	10.1	2.8	0.7	2.1	13.9	1.3	34.3	12.9	0.6	3.3	23.9	1.3	2.9	1.2	4.3	1.2	0.8	0.7	2.0	1.8	2.3	2.3	2.3	0.0	0.6	0.2	0.0	8.9	1.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.0	1.5	0.1	0.9	3.5	0.3	0.1	51.3	2.3	0.0	0.5	0.7	0.0	0.2	0.5	0.1	0.1	0.3	1.3	1.3	0.0	0.0	0.0	0.4	0.0	0.0	2.5	8.1	0.1	0.0	0.2	0.6	0.6	8.7	0.3	0.2	1.3	0.0	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	8.9	0.0	0.6	1.0	0.0	1.7	1.2	0.4	2.3	1.3	0.7	1.0	1.0	0.7	0.8
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.4"	"Cell line enhanced"	"Detected in many"		"RT4: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	35	"plasmacytoid DC: 31.6"	"Lineage enriched"	"Detected in single"	309	"dendritic cells: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"			1300000	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favourable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	25.9	3.7	9.7	8.7	13.6	5.9	7.8	7.4	20.8	9.6	19.3	26.9	1.0	6.4	9.1	3.0	21.8	9.9	18.7	4.1	13.8	16.0	26.2	4.6	9.5	11.5	26.8	7.9	5.0	17.9	35.6	4.4	17.0	29.5	10.2	18.5	3.0	15.2	2.4	3.5	2.7	10.2	8.2	63.4	11.6	30.4	5.8	10.1	11.5	2.9	19.2	16.5	41.2	11.6	0.0	31.6	0.1	0.0	0.0	0.0	0.2	29.9	9.7	9.5	3.0	26.1	7.7	10.8	3.5	6.9	1.1	0.4	16.8	21.2	2.2	14.2	2.5	18.1	1.4	12.9	0.6	0.0	2.9	0.0	1.2	16.9	15.3	0.4	0.1	13.7	15.5	0.6	11.8	5.1	0.7	0.0	0.3	5.9	2.6	0.2	7.4	10.1	5.6	2.9	3.2	18.1	102.3	6.8	1.5	3.0	2.8	2.4	2.2	2.1	1.0	2.8	2.6	0.1	3.2	0.0	0.0	3.1	4.7	2.1	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.2	9.7	13.6	7.4	20.8	13.8	16.0	26.8	7.9	29.5	10.1
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063377-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.3"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 109.9"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enriched"	"Detected in single"	14	"basal ganglia: 13.1"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 21.7;non-classical monocyte: 33.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 33.3"					"Low region specificity"	"Detected in many"			"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: , HPA032082: "	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	10.7	0.2	0.1	7.2	13.1	1.4	5.8	0.2	0.4	1.1	0.8	0.0	1.5	0.2	1.7	1.3	0.9	2.1	1.4	3.8	0.1	0.2	0.9	0.2	3.9	2.9	0.5	0.5	1.2	0.4	0.0	0.1	6.2	0.5	1.0	0.5	0.0	0.7	0.3	3.1	1.6	1.3	1.3	1.4	2.9	6.4	2.5	0.9	3.0	0.7	2.7	5.3	2.6	3.8	0.0	3.2	6.8	33.3	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	109.9	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.3	0.0	0.0	0.2	0.0	4.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.3	0.0	21.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	6.8	0.0	33.3	0.8	0.3	2.7	0.1	13.1	0.2	0.4	0.1	0.2	0.5	0.5	0.5	0.9
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171061339-171460408	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9"	"Cell line enhanced"	"Detected in many"		"AF22: 19.6;HEL: 26.6;HMC-1: 30.3;HUVEC TERT2: 19.5;WM-115: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3"	"Group enriched"	"Detected in many"	29	"granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol			9100	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	2.2	5.4	29.0	7.4	30.9	4.9	3.6	21.1	26.1	1.9	10.9	12.2	4.1	25.8	4.3	2.1	5.6	4.3	7.1	11.2	30.9	14.8	5.6	4.6	11.3	7.9	11.4	18.3	2.6	5.2	0.7	9.0	3.1	13.6	5.6	9.5	3.5	2.9	7.3	23.2	1.6	25.6	6.0	14.5	5.8	9.2	10.7	21.1	3.7	7.1	2.2	6.9	6.4	2.6	0.2	0.0	10.5	0.1	2.7	6.7	1.1	0.3	0.5	19.6	2.0	0.3	0.0	4.6	4.1	1.1	3.2	2.2	17.5	7.3	0.0	1.4	3.7	6.0	2.8	1.1	3.5	0.1	4.3	26.6	1.5	0.0	9.4	5.2	30.3	2.8	2.9	1.9	0.4	19.5	9.6	0.0	0.5	0.4	1.6	6.7	8.0	7.6	0.0	5.0	7.0	6.3	0.0	0.9	1.0	2.5	0.2	4.3	8.8	1.3	0.2	0.0	3.4	8.9	3.0	0.0	0.0	0.0	0.9	5.9	22.7	4.4	0.1	10.5	4.2	0.0	5.2	0.0	5.0	3.7	0.0	0.2	6.7	3.8	0.1	2.7	0.1	0.0	5.3	1.1	29.0	30.9	21.1	22.2	30.9	14.8	11.4	18.3	13.6	21.1
TNIP1	"ABIN-1, KIAA0113, NAF1, VAN"	ENSG00000145901	"TNFAIP3 interacting protein 1"	Q15025	5	151029945-151093577	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037893, HPA037894, HPA071950"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: "	"prognostic favourable (5.69e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-1)"	"prognostic favourable (6.86e-5)"	"unprognostic (7.45e-3)"	"unprognostic (2.94e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.84e-2)"	49.8	16.8	8.9	32.2	10.7	35.8	68.8	10.1	11.4	16.5	38.8	10.2	22.9	23.8	13.6	21.2	28.9	11.2	33.2	30.1	8.9	8.7	27.8	34.3	29.0	35.1	11.2	7.2	14.6	42.2	16.4	9.5	15.7	10.6	18.5	17.4	13.9	18.2	27.6	61.7	19.5	37.2	21.0	10.7	39.5	20.6	9.9	10.9	21.0	19.6	27.7	41.9	20.6	35.0	10.9	7.7	26.0	7.4	7.0	12.5	5.3	23.7	17.0	3.2	11.7	12.6	12.9	8.6	11.5	36.9	10.4	19.6	16.1	32.6	19.9	39.0	15.4	14.5	5.3	84.8	12.7	34.0	7.4	7.9	9.5	10.4	24.4	8.9	36.3	18.4	15.7	17.2	35.7	14.7	4.9	19.8	25.7	8.8	9.7	12.3	2.9	9.4	8.0	25.1	26.4	32.3	17.5	4.6	10.8	8.9	27.9	11.8	14.3	11.2	22.6	35.1	11.6	6.1	16.3	39.9	20.5	8.9	38.0	13.2	8.4	9.7	7.4	20.4	7.8	6.8	9.1	8.4	9.0	7.7	5.6	10.9	4.7	5.1	26.0	7.0	6.1	7.7	12.5	5.3	8.9	10.7	10.1	11.4	8.9	8.7	11.2	7.2	10.6	10.9
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756376	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB020818: , HPA049886: , HPA063197: "	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favourable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	16.7	10.3	7.8	14.5	14.0	18.9	32.5	3.4	12.4	9.8	26.4	7.3	7.1	16.4	11.9	10.1	14.5	9.6	13.7	26.6	7.4	6.5	23.4	16.6	16.0	17.9	11.2	4.7	12.3	24.2	3.5	11.4	15.3	12.4	13.6	10.1	9.7	10.7	13.5	21.9	10.5	37.2	23.9	12.2	17.8	15.3	11.7	11.1	8.1	14.2	12.3	18.2	15.1	33.7	9.8	7.3	20.9	11.8	4.4	11.2	4.7	12.3	17.0	5.4	8.1	17.3	11.9	23.4	13.6	12.2	12.7	12.4	19.4	20.2	11.4	15.5	14.8	8.2	9.6	15.6	7.5	8.9	12.1	13.6	10.0	21.4	21.6	11.1	17.3	15.3	14.2	14.0	12.7	18.0	13.8	16.1	8.8	25.8	14.6	27.5	14.1	29.1	9.6	8.2	5.9	13.6	14.0	8.1	9.1	10.6	11.1	14.9	12.1	16.4	20.9	9.8	10.9	15.4	20.8	16.8	11.3	8.2	18.0	20.1	10.6	6.4	7.2	20.9	6.7	11.2	7.2	7.8	10.2	11.2	7.3	9.8	8.4	7.0	7.1	4.4	11.8	3.4	10.2	4.7	7.8	14.0	3.4	12.4	7.4	6.5	11.2	4.7	12.4	11.1
TNPO1	"IPO2, KPNB2, MIP, MIP1, TRN"	ENSG00000083312	"Transportin 1"	Q92973	5	72816312-72916733	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016325	Approved		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"			47000	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"CAB016325: AB_675691"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavourable (6.55e-5)"	"unprognostic (8.93e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.49e-2)"	23.9	29.3	20.1	26.2	24.5	20.7	52.3	18.5	21.9	18.5	21.6	15.7	32.3	16.4	25.4	25.4	26.5	17.9	22.8	21.9	22.5	16.5	26.2	20.8	24.2	22.4	22.9	16.4	22.5	28.9	54.1	36.5	34.9	27.0	21.2	24.4	19.4	26.1	35.3	38.0	15.9	19.9	32.0	31.2	21.7	25.3	30.9	20.8	25.2	32.6	18.0	23.6	27.5	30.8	11.1	10.7	8.9	13.3	14.1	18.3	10.6	21.6	28.6	41.6	24.9	31.0	38.5	24.6	25.7	35.0	25.6	26.4	24.3	18.6	25.3	17.6	40.3	15.8	28.3	22.9	37.1	14.7	15.7	15.6	38.0	12.3	21.0	17.2	11.5	27.8	16.6	34.2	48.8	62.1	23.3	13.5	72.7	10.3	15.7	6.6	22.3	21.9	19.0	37.5	15.9	15.8	29.0	21.6	22.3	41.3	13.2	30.3	16.3	14.2	58.8	21.7	25.6	32.7	28.7	12.4	19.4	33.8	17.3	17.7	39.8	7.3	8.3	6.9	13.4	11.5	18.3	11.1	12.2	10.0	10.7	11.0	13.4	13.4	8.9	14.1	13.3	5.0	8.1	10.6	20.1	24.5	18.5	21.9	22.5	16.5	22.9	16.4	27.0	20.8
TNPO3	"IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2"	ENSG00000064419	"Transportin 3"	Q9Y5L0	7	128954180-129055173	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039555, HPA041537"	Approved		Enhanced	Vesicles				Vesicles		"HPA039555: AB_10672000, HPA041537: "	"unprognostic (5.76e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (3.29e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-2)"	17.8	24.0	22.6	23.8	20.5	28.9	16.2	29.6	21.4	15.2	18.4	15.8	30.1	15.5	19.7	17.9	26.3	16.1	12.9	16.1	16.6	17.7	19.1	21.6	15.4	20.5	17.7	15.5	20.7	19.8	21.7	19.2	13.9	18.4	16.7	19.7	15.6	19.0	20.4	41.4	19.2	17.8	18.9	16.2	17.2	21.9	36.3	15.1	29.5	22.3	15.9	26.4	22.6	18.1	16.6	15.9	20.9	21.7	14.4	17.4	10.5	20.1	22.8	17.8	30.0	17.3	15.0	15.2	18.1	15.9	17.0	20.1	18.6	18.6	25.3	8.5	19.4	14.9	35.9	17.5	24.5	20.9	15.9	18.6	19.0	14.5	16.5	33.9	15.9	14.0	17.8	20.7	18.6	21.1	42.1	18.2	21.7	14.9	29.3	25.1	50.8	21.1	20.9	16.6	20.6	17.2	19.0	22.1	17.5	19.3	9.1	20.4	10.3	21.2	15.8	21.6	10.7	25.4	24.7	23.5	18.2	35.0	31.3	34.9	37.5	20.6	13.6	20.9	17.4	17.2	15.5	16.6	14.2	15.4	15.9	15.5	14.1	16.1	15.9	14.4	21.7	7.7	14.5	10.5	22.6	20.5	29.6	21.4	16.6	17.7	17.7	15.5	18.4	15.1
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.6"					"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"				"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: , HPA024251: "	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	17.9	11.8	18.1	17.9	17.2	29.4	20.6	35.1	23.6	35.0	29.9	16.7	17.9	16.4	36.0	19.5	19.6	27.5	29.2	13.6	14.2	9.6	15.6	11.8	19.2	12.9	15.5	16.7	30.3	18.4	36.9	14.7	19.7	13.2	25.4	15.1	25.2	17.0	24.4	13.6	18.9	16.9	40.1	12.6	15.3	21.4	14.0	16.6	7.2	20.6	12.8	9.4	27.0	21.4	2.0	4.3	17.6	3.2	2.6	1.5	0.1	21.3	19.1	15.9	13.3	13.4	16.0	41.1	15.2	14.4	8.4	9.0	7.8	18.8	14.6	15.0	22.2	23.9	9.1	18.2	7.1	6.4	5.8	9.3	16.3	12.7	11.7	30.5	34.3	16.1	21.5	16.8	19.6	9.5	13.1	8.3	10.7	35.5	7.1	37.3	1.4	14.6	8.0	7.9	10.8	6.9	27.3	6.9	16.6	11.8	31.3	11.3	32.7	31.6	23.6	24.5	34.5	14.5	10.9	11.9	12.3	13.8	13.7	21.7	28.5	9.4	3.2	2.7	1.4	1.2	1.0	1.6	1.0	0.8	1.1	2.0	0.7	1.5	17.6	2.6	1.5	4.3	1.4	0.1	18.1	17.2	35.1	23.6	14.2	9.6	15.5	16.7	13.2	16.6
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218010421	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 153.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.3;ASC TERT1: 25.2;fHDF/TERT166: 21.9;REH: 24.1;TIME: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"				"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavourable (5.19e-4)"	77.6	15.6	5.2	21.1	13.7	9.2	33.5	2.9	8.9	50.0	68.9	17.2	45.6	6.0	61.1	29.8	52.0	31.1	46.7	41.0	6.8	4.8	24.0	9.2	28.9	6.1	15.8	4.1	32.3	14.1	6.0	3.8	14.0	14.3	55.1	11.4	27.6	12.8	63.4	40.8	10.1	17.2	153.0	13.7	17.0	30.0	22.6	12.2	1.5	18.3	9.8	4.0	124.6	53.6	0.2	1.0	0.9	1.7	0.0	0.0	2.9	0.0	0.1	3.0	0.0	46.3	25.2	0.3	7.8	2.6	0.4	0.3	3.4	0.0	0.0	4.5	21.9	0.5	0.3	0.4	0.2	3.1	0.2	6.6	1.9	0.9	3.4	0.0	0.8	12.0	0.0	8.3	0.0	10.9	0.2	0.7	6.5	0.9	0.0	0.4	0.3	0.1	24.1	5.8	0.3	1.6	0.0	0.7	3.5	1.3	3.3	0.8	1.1	2.4	21.4	5.7	10.3	5.7	1.7	0.4	0.0	0.0	3.3	0.9	0.4	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.7	1.0	0.0	2.9	5.2	13.7	2.9	8.9	6.8	4.8	15.8	4.1	14.3	12.2
TNS3	"FLJ13732, H_NH0549I23.2, TEM6, TENS1"	ENSG00000136205	"Tensin 3"	Q68CZ2	7	47275154-47582558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 66.6;LHCN-M2: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 5.8;intermediate monocyte: 4.7;memory B-cell: 3.7;myeloid DC: 4.0;naive B-cell: 2.9;non-classical monocyte: 4.4;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	6	"B-cells: 3.7;dendritic cells: 5.6;monocytes: 5.8"	"Low region specificity"	"Detected in all"							"HPA055338, HPA056015"	Approved		Enhanced	"Focal adhesion sites"				"Focal adhesion sites"		"HPA055338: , HPA056015: "	"unprognostic (1.46e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.70e-1)"	"unprognostic (6.60e-2)"	"prognostic favourable (5.21e-4)"	"unprognostic (3.13e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.09e-3)"	46.9	18.5	16.4	19.3	12.7	2.8	29.8	8.1	11.7	18.2	15.7	11.4	9.1	9.9	27.4	13.9	7.7	12.3	29.6	13.5	12.1	13.2	27.3	24.9	25.1	37.7	16.0	3.6	22.4	35.5	16.4	5.5	44.9	9.6	15.0	9.3	40.3	36.4	11.7	14.9	6.7	20.7	14.7	11.6	42.7	13.9	9.6	7.8	3.8	23.8	9.6	19.9	12.5	19.3	3.7	5.6	0.8	5.8	0.1	0.2	1.8	6.4	66.6	4.0	7.0	9.3	7.6	12.9	5.9	33.8	5.8	8.9	14.9	8.7	3.3	10.5	21.4	12.4	6.5	9.6	5.3	0.0	0.4	9.1	9.6	7.9	9.6	0.0	0.1	7.5	4.2	3.3	5.3	4.5	0.0	20.5	42.9	4.0	0.0	0.2	3.9	7.9	2.9	9.9	10.8	20.0	13.2	0.4	8.2	11.7	2.4	6.5	8.9	6.8	18.1	9.0	7.2	0.1	9.0	13.2	17.1	7.7	2.2	6.4	32.6	0.2	5.8	0.0	0.1	4.7	0.2	3.7	0.0	0.0	4.0	2.9	0.0	0.0	0.8	0.1	4.4	5.6	0.0	1.8	16.4	12.7	8.1	11.7	12.1	13.2	16.0	3.6	9.6	7.8
TOE1	hCaf1z	ENSG00000132773	"Target of EGR1, exonuclease"	Q96GM8	1	45339670-45343975	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053775, HPA069119"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA053775: , HPA069119: "	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.33e-1)"	"prognostic favourable (9.05e-4)"	"prognostic unfavourable (6.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (2.71e-4)"	"prognostic favourable (9.98e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.08e-1)"	7.4	9.2	8.9	8.0	10.6	9.7	8.1	11.6	9.4	7.4	8.9	8.7	11.2	9.8	10.8	11.0	8.3	8.9	8.7	7.5	6.4	5.6	7.1	7.9	9.4	8.7	5.1	7.4	9.4	7.4	10.8	7.8	8.2	7.7	8.8	9.2	10.0	9.9	7.7	4.3	6.9	9.4	10.0	9.4	11.0	9.4	18.7	5.0	14.6	10.3	6.1	8.8	9.1	7.3	8.7	6.0	13.8	6.8	3.2	9.6	4.7	8.2	4.5	6.3	7.5	3.8	3.1	11.4	6.6	6.0	12.3	11.7	5.5	4.4	14.3	6.7	7.9	7.4	9.9	11.5	8.6	9.1	8.1	15.2	8.7	6.1	3.2	9.1	8.3	4.5	2.0	12.4	7.9	9.8	11.8	7.9	8.4	6.4	16.2	7.7	14.0	6.1	11.7	11.2	6.3	4.9	10.9	6.7	6.9	6.8	17.3	12.8	4.3	14.6	6.7	5.2	11.1	9.5	11.8	5.6	7.5	9.1	7.8	12.0	6.7	13.8	5.7	5.7	7.9	6.8	9.6	6.2	7.7	8.4	5.5	8.7	6.9	8.3	0.8	3.2	5.9	6.0	8.5	4.7	8.9	10.6	11.6	9.4	6.4	5.6	5.1	7.4	7.7	5.0
TOM1L2		ENSG00000175662	"Target of myb1 like 2 membrane trafficking protein"	Q6ZVM7	17	17843511-17972422	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 81.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022541, HPA023304"	Enhanced		Supported	"Golgi apparatus,Intermediate filaments"			66000	"Intermediate filaments"	"Golgi apparatus"	"HPA022541: AB_1858182, HPA023304: AB_1858183"	"unprognostic (2.32e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.24e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"prognostic unfavourable (2.58e-4)"	"prognostic favourable (1.92e-4)"	"unprognostic (3.19e-2)"	"prognostic favourable (6.21e-9)"	"unprognostic (7.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.51e-2)"	11.8	14.8	24.7	7.3	27.4	3.5	10.4	23.2	38.2	10.5	12.8	32.3	8.7	8.8	12.8	8.2	35.9	12.7	8.8	81.5	25.9	21.8	13.1	4.4	14.4	4.8	24.4	23.8	15.7	12.2	28.7	14.4	6.3	42.3	21.1	9.7	19.5	9.7	19.3	32.0	29.0	10.5	16.0	16.4	7.7	10.9	14.7	20.9	4.3	24.8	13.7	10.5	12.0	11.0	2.7	2.2	14.6	3.9	1.4	5.3	1.8	11.1	13.4	3.6	2.8	8.9	9.0	5.7	19.3	9.1	10.9	9.1	12.3	8.1	2.0	25.3	18.9	46.8	2.9	11.3	6.5	3.1	5.2	3.4	12.1	2.3	5.5	0.7	2.3	10.6	7.8	9.9	7.4	10.9	1.2	3.0	13.8	11.7	1.4	1.8	0.6	8.2	1.9	8.7	5.0	14.2	21.9	4.1	3.8	8.6	11.2	6.9	5.7	1.5	13.9	10.1	2.7	20.3	7.0	2.6	2.1	0.8	11.7	1.0	24.2	7.1	3.9	5.1	3.5	1.2	2.5	2.0	3.2	2.8	1.8	2.7	5.3	3.9	14.6	1.4	3.4	2.2	1.5	1.8	24.7	27.4	23.2	38.2	25.9	21.8	24.4	23.8	42.3	20.9
TOMM20	"KIAA0016, MAS20, MOM19, TOM20"	ENSG00000173726	"Translocase of outer mitochondrial membrane 20"	Q15388	1	235109336-235128936	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005585, HPA011562"	Supported		Enhanced	Mitochondria				Mitochondria		"CAB005585: AB_628381, HPA011562: AB_1080326"	"unprognostic (1.30e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.97e-1)"	27.2	35.0	46.3	15.3	60.2	32.7	52.8	40.0	66.2	36.1	25.5	28.4	29.0	24.4	34.5	39.0	28.0	40.0	27.9	33.9	47.1	48.7	41.2	35.2	24.2	33.6	42.5	40.5	50.9	63.6	38.6	25.4	27.1	48.2	34.0	28.2	23.5	47.8	30.7	33.4	33.0	21.3	33.8	54.5	19.0	27.2	16.3	23.0	18.0	58.7	28.4	21.9	36.2	28.9	15.9	20.9	16.4	13.8	9.8	22.6	14.2	35.9	19.0	25.0	21.0	19.7	39.8	38.8	25.9	22.4	24.4	17.8	24.5	25.4	43.8	34.5	22.4	28.8	27.7	25.1	32.2	10.5	59.2	26.7	25.4	46.3	33.0	59.8	16.1	35.5	34.5	24.4	33.7	26.4	56.0	16.2	26.7	10.5	25.4	27.1	56.2	10.3	31.1	19.1	56.7	27.4	25.9	32.9	77.1	20.1	28.2	55.1	43.6	65.8	23.3	21.5	13.0	27.1	54.9	38.4	36.1	32.1	25.2	28.7	36.2	16.4	12.4	4.1	13.9	12.9	17.1	15.9	18.1	17.3	15.1	12.7	22.6	17.6	3.9	9.8	13.8	20.9	15.5	14.2	46.3	60.2	40.0	66.2	47.1	48.7	42.5	40.5	48.2	23.0
TOMM22	TOM22	ENSG00000100216	"Translocase of outer mitochondrial membrane 22"	Q9NS69	22	38681948-38685421	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003037	Supported		Enhanced	Mitochondria				Mitochondria		"HPA003037: AB_1080329"	"unprognostic (5.54e-2)"	"unprognostic (5.04e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (1.01e-1)"	"unprognostic (4.28e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	27.6	26.2	25.6	30.1	24.3	29.5	29.4	17.6	28.2	22.2	26.8	14.7	22.4	28.0	20.1	25.6	34.1	24.4	23.8	31.6	23.2	21.0	29.4	46.0	18.1	32.1	24.0	19.8	27.8	47.5	10.9	12.6	27.6	18.5	21.0	32.8	15.8	31.4	26.7	38.2	24.6	29.7	22.8	20.0	27.7	23.3	24.7	11.3	44.2	27.4	40.4	33.5	24.1	30.2	22.5	29.7	6.9	22.9	18.0	21.3	28.6	19.6	11.6	17.9	18.9	13.2	12.3	19.3	16.3	11.4	23.9	18.0	21.1	11.8	20.0	13.5	15.9	16.4	27.1	24.7	19.3	17.2	29.8	26.9	9.1	20.2	17.3	71.1	19.1	16.8	17.6	21.5	14.1	17.5	20.3	16.0	15.9	15.3	21.3	33.1	27.3	23.7	23.7	23.2	18.9	15.9	14.5	21.0	13.9	19.1	24.2	18.5	16.8	23.6	17.8	14.7	27.6	13.4	24.6	22.2	26.8	31.0	18.4	24.7	20.0	4.7	22.9	6.9	16.9	22.0	21.3	22.5	18.3	17.8	29.7	18.0	18.7	20.0	2.2	18.0	18.1	25.8	21.1	28.6	25.6	24.3	17.6	28.2	23.2	21.0	24.0	19.8	18.5	11.3
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA036231: , HPA036232: "	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	16.0	25.3	13.6	16.9	15.6	19.7	20.6	17.7	27.0	10.2	20.5	10.9	10.1	20.0	11.8	10.5	22.9	13.5	11.4	21.5	15.3	14.9	16.5	36.9	15.1	22.3	15.6	13.3	18.2	19.2	16.2	11.9	15.3	20.2	11.2	16.7	11.5	11.5	13.5	32.3	14.7	15.1	11.6	11.9	12.7	12.6	12.3	8.8	14.2	11.6	18.6	15.6	10.9	12.5	7.3	7.0	5.1	6.8	4.7	8.7	2.0	30.8	52.3	19.1	26.3	7.1	6.4	24.3	22.2	12.3	42.1	30.2	56.8	21.4	45.6	23.9	14.6	33.4	49.5	31.9	19.2	17.6	44.9	30.6	20.5	44.7	15.2	39.0	27.5	10.1	18.1	32.6	20.7	14.5	48.2	15.9	16.4	38.5	42.3	28.7	33.4	32.6	43.3	21.7	26.5	19.3	42.9	29.8	19.1	23.6	49.8	15.8	16.7	39.6	11.9	29.2	29.6	20.3	57.9	17.2	35.6	44.7	21.7	41.5	30.7	0.7	5.5	5.1	4.7	6.8	5.2	7.3	4.5	6.5	7.0	4.2	7.9	8.7	1.1	4.7	5.9	6.9	4.8	2.0	13.6	15.6	17.7	27.0	15.3	14.9	15.6	13.3	20.2	8.8
TOMM5	"bA613M10.3, C9orf105, Tom5"	ENSG00000175768	"Translocase of outer mitochondrial membrane 5"	Q8N4H5	9	37582646-37592642	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA048712	Approved		Supported	Mitochondria				Mitochondria		"HPA048712: "	"unprognostic (1.81e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (9.89e-3)"	"prognostic unfavourable (5.49e-4)"	"prognostic favourable (2.37e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.09e-2)"	33.2	37.8	34.5	31.2	39.7	28.3	44.1	24.3	38.5	26.7	34.7	13.1	28.3	37.5	28.7	32.7	36.9	25.4	31.1	39.6	30.9	34.7	44.3	45.3	24.4	37.4	37.6	26.3	27.4	83.8	12.7	28.8	19.6	32.3	25.2	31.2	17.3	49.6	36.2	51.5	24.1	34.8	34.1	23.9	38.9	31.2	33.0	27.2	24.5	36.3	46.1	37.8	26.7	35.3	59.1	43.1	14.0	33.9	40.2	54.9	50.5	54.3	63.5	37.7	33.7	43.3	42.5	20.8	41.5	26.6	40.5	43.4	67.5	22.6	37.3	34.1	39.3	18.9	33.4	49.5	42.3	52.3	52.9	32.8	88.3	96.7	35.6	53.6	21.7	36.7	27.2	44.6	44.2	46.1	79.7	41.9	41.1	43.6	45.1	47.2	65.5	40.3	38.4	31.4	54.8	46.3	34.1	32.6	30.0	21.3	29.0	30.3	20.3	62.9	31.2	28.1	60.1	44.1	64.0	15.9	46.2	62.2	34.4	46.4	43.2	12.3	32.2	14.0	43.0	33.9	52.7	59.1	53.1	47.7	39.0	49.1	54.9	50.5	3.7	40.2	28.5	43.1	42.1	50.5	34.5	39.7	24.3	38.5	30.9	34.7	37.6	26.3	32.3	27.2
TOMM6	"OBTP, Tom6"	ENSG00000214736	"Translocase of outer mitochondrial membrane 6"	Q96B49	6	41787662-41789898	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004801	Approved		Supported	Mitochondria				Mitochondria		"HPA004801: AB_1859553"																		44.1	68.7	54.2	47.4	51.9	55.4	66.4	26.0	52.6	44.0	44.7	43.6	37.1	29.1	38.9	83.4	62.1	49.0	32.1	64.6	45.3	43.8	80.9	92.6	37.7	60.4	45.1	36.3	56.9	84.5	31.6	39.7	49.9	42.3	47.1	53.1	48.4	83.1	43.8	80.2	47.2	48.7	39.4	41.5	58.7	42.0	53.1	37.2	56.7	65.9	78.3	71.9	44.7	38.7	66.2	75.2	39.0	70.5	33.8	56.9	89.2	64.0	32.1	38.8	39.2	36.5	44.1	41.3	32.2	34.1	41.6	40.3	55.5	30.0	29.4	39.5	38.4	20.5	61.8	53.4	53.8	41.2	65.2	52.7	41.0	90.3	28.9	70.2	34.3	39.5	56.1	45.7	39.3	50.0	131.3	36.1	51.1	75.8	50.4	111.4	34.1	32.6	37.0	24.3	86.5	56.0	33.0	34.4	48.0	22.0	38.0	53.6	46.4	142.7	35.0	28.6	35.5	28.4	48.0	33.4	71.3	129.4	16.2	59.7	36.8	15.1	69.1	39.0	49.1	68.7	47.7	66.2	50.2	48.7	72.0	61.8	56.9	55.4	9.0	33.8	70.5	75.2	46.5	89.2	54.2	51.9	26.0	52.6	45.3	43.8	45.1	36.3	42.3	37.2
TOMM70	"KIAA0719, Tom70, TOMM70A"	ENSG00000154174	"Translocase of outer mitochondrial membrane 70"	O94826	3	100363431-100401398	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014589, CAB017156, HPA048020"	Enhanced		Enhanced	Mitochondria			120000	Mitochondria		"CAB017156: , HPA014589: AB_1858185, HPA048020: "	"unprognostic (2.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.01e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.98e-3)"	21.7	16.1	16.2	12.4	52.4	9.6	21.3	23.6	26.5	16.9	18.2	12.5	13.8	19.4	17.4	15.0	20.8	14.2	12.2	25.2	16.5	19.8	24.9	40.7	10.5	13.5	16.1	20.6	21.7	18.0	20.1	17.1	15.5	29.0	19.0	20.6	13.3	14.5	19.4	42.8	13.3	17.8	22.3	14.0	12.1	14.8	14.7	15.6	18.7	20.5	19.9	16.6	22.3	22.5	4.3	3.0	2.5	2.5	5.6	5.4	1.8	23.6	16.6	14.2	20.3	20.0	21.8	18.4	20.3	17.3	18.5	19.2	23.5	13.6	28.3	17.9	17.1	23.5	25.5	18.5	27.4	10.7	11.8	32.5	11.0	22.8	12.5	39.5	15.0	19.4	17.2	16.5	27.0	13.5	23.1	23.1	22.1	17.5	26.7	16.0	19.5	35.4	24.6	28.7	30.1	15.0	17.9	25.7	21.4	14.7	23.7	26.4	30.7	22.5	12.2	16.4	21.8	9.1	15.1	25.2	35.9	48.1	15.8	23.9	12.4	2.2	2.2	2.5	4.1	2.2	5.1	4.3	5.1	4.5	2.9	3.1	5.3	5.4	0.6	5.6	2.5	3.0	2.0	1.8	16.2	52.4	23.6	26.5	16.5	19.8	16.1	20.6	29.0	15.6
TONSL	"IKBR, NFKBIL2"	ENSG00000160949	"Tonsoku like, DNA repair protein"	Q96HA7	8	144428775-144444444	"Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024679, HPA046494"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA024679: AB_1854441, HPA046494: "	"unprognostic (6.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (1.04e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (2.62e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.11e-3)"	"unprognostic (7.96e-2)"	1.4	2.8	1.4	11.0	1.8	11.7	1.9	6.1	2.7	1.9	5.5	1.4	3.2	5.5	2.2	1.8	5.6	1.7	1.3	1.6	1.2	1.1	2.0	2.3	2.6	3.7	1.9	1.2	2.4	2.3	1.1	1.1	2.6	2.9	2.1	1.7	0.8	3.1	2.2	1.0	4.0	6.8	1.4	1.9	5.6	3.5	4.8	2.1	10.3	3.3	3.6	5.3	3.9	5.1	0.6	0.1	0.0	0.2	1.9	0.6	0.1	6.9	6.2	4.7	7.3	0.3	0.5	11.3	5.9	1.1	3.5	2.8	5.0	6.0	6.4	6.0	0.9	4.7	4.5	3.6	0.8	6.6	9.0	15.2	7.9	5.1	0.2	4.6	9.6	0.6	0.5	3.7	0.7	1.7	17.1	4.8	1.4	14.2	11.5	7.9	6.6	9.1	14.0	3.0	6.7	2.0	7.5	7.8	4.4	6.1	4.1	2.6	6.0	4.3	1.9	4.4	18.2	4.9	7.1	1.7	3.1	3.9	4.2	9.9	5.1	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.2	0.6	0.1	0.6	0.5	0.4	0.0	1.9	0.0	0.0	0.2	0.1	1.4	1.8	6.1	2.7	1.2	1.1	1.9	1.2	2.9	2.1
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028818-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	26.6	31.0	24.6	46.3	25.3	55.3	37.4	39.6	31.1	21.3	30.0	11.1	26.7	29.7	22.9	22.5	36.0	20.5	29.2	21.0	23.0	18.3	31.8	32.7	37.9	38.6	21.9	20.9	25.5	22.5	22.2	39.9	43.9	25.2	23.3	27.2	13.6	25.3	34.3	26.2	24.6	48.4	23.1	27.4	36.9	26.7	14.2	24.2	54.2	31.5	25.1	40.6	25.2	41.7	9.0	17.2	18.4	11.1	5.8	8.2	4.6	21.5	15.1	28.3	23.1	11.5	13.7	28.0	19.5	17.2	22.7	20.7	39.6	27.2	61.5	20.9	10.1	21.0	33.9	31.2	33.3	13.3	17.3	78.4	12.1	28.1	29.9	33.8	27.0	15.5	16.7	22.1	36.4	23.7	34.0	21.4	25.6	47.9	47.7	21.4	22.8	28.1	40.8	26.6	32.7	24.2	20.1	23.5	16.3	30.6	19.0	19.8	21.1	30.3	23.2	18.4	15.6	17.0	20.9	13.6	15.2	71.7	24.7	19.0	17.4	9.1	9.2	14.3	6.5	9.2	8.2	9.0	7.2	6.8	8.6	8.7	7.7	6.9	18.4	5.8	11.1	17.2	7.9	4.6	24.6	25.3	39.6	31.1	23.0	18.3	21.9	20.9	25.2	24.2
TOP1MT		ENSG00000184428	"DNA topoisomerase I mitochondrial"	Q969P6	8	143304384-143359979	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001915, HPA021542"	Approved		Supported	Mitochondria				Mitochondria		"HPA001915: AB_1080331, HPA021542: AB_1858186"	"unprognostic (5.02e-3)"	"unprognostic (3.79e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavourable (1.52e-7)"	"unprognostic (3.66e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.55e-3)"	"unprognostic (5.66e-3)"	11.7	13.5	8.1	13.7	9.8	33.0	22.1	2.2	10.3	14.7	10.7	4.5	3.9	6.0	10.0	7.4	14.9	11.3	11.0	5.9	8.8	5.6	9.6	22.5	8.5	11.4	6.9	8.1	27.0	15.9	5.9	8.6	5.9	7.3	14.7	8.0	5.9	11.0	10.8	5.7	15.4	8.3	8.8	6.8	11.4	9.3	18.1	6.4	25.1	19.2	9.6	11.4	14.0	30.9	16.7	18.8	11.7	5.5	0.2	14.3	4.7	7.5	11.6	4.9	18.2	7.0	7.8	8.7	3.5	4.5	6.4	6.6	14.5	10.9	22.2	13.2	4.9	8.1	10.4	6.5	5.5	8.7	15.9	19.5	6.5	14.6	7.9	13.0	21.2	7.9	6.9	5.3	7.8	7.6	23.3	8.7	5.6	31.5	57.7	25.9	8.5	19.9	7.3	6.4	33.2	4.7	12.2	8.7	10.6	10.0	9.0	18.1	5.9	21.7	5.0	4.4	18.1	5.0	9.0	4.7	4.9	11.3	7.5	19.5	5.3	11.7	5.5	0.2	3.5	3.2	3.6	16.7	6.4	4.8	18.8	8.0	14.3	10.4	0.4	0.2	0.6	16.4	1.7	4.7	8.1	9.8	2.2	10.3	8.8	5.6	6.9	8.1	7.3	6.4
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.92e-6)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	33.7	44.9	57.2	26.1	2.8	5.8	12.7	46.4	25.0	42.7	37.9	21.0	25.9	54.5	23.6	15.7	53.8	43.9	18.5	57.4	29.1	29.3	36.0	28.7	35.1	0.2	50.4	38.3	1.2	1.5	30.0	30.6	22.4	38.9	37.4	46.1	11.7	58.4	33.9	23.7	17.9	49.6	88.8	22.6	10.3	21.6	33.8	24.3	37.4	46.7	14.7	39.2	23.2	14.7	28.2	39.7	32.5	44.5	21.5	24.3	47.6	15.9	34.8	46.9	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	19.3	18.8	23.4	23.1	29.7	26.5	21.1	48.4	33.5	24.1	22.4	21.1	18.9	17.1	29.6	25.6	21.1	20.6	20.7	22.7	22.0	19.9	20.3	18.4	17.7	28.2	21.0	28.5	26.8	17.2	43.0	21.6	22.3	26.4	24.7	20.8	17.6	21.3	22.3	31.3	20.9	19.3	24.4	23.4	24.6	20.1	11.3	22.7	60.2	28.3	20.7	27.3	34.8	21.5	5.5	5.6	5.3	4.6	7.8	7.2	2.2	10.5	10.9	24.1	29.5	8.0	10.2	9.6	10.2	13.1	9.5	10.4	5.5	8.4	32.6	7.1	14.7	9.0	20.0	11.3	16.0	15.6	10.7	49.5	13.6	9.3	5.6	38.7	26.5	7.3	5.7	10.6	9.3	15.4	16.6	16.1	12.2	11.7	25.0	9.6	18.3	8.3	104.7	13.6	15.1	8.5	37.2	12.2	21.1	15.2	10.9	9.3	11.3	34.6	14.7	13.2	10.3	10.5	10.9	24.9	14.1	34.7	8.7	29.0	8.8	4.2	2.9	5.3	6.3	3.3	6.9	4.3	6.1	6.4	4.3	5.5	7.2	6.4	2.0	7.8	4.6	5.6	4.4	2.2	23.4	29.7	48.4	33.5	22.0	19.9	21.0	28.5	26.4	22.7
TOPBP1	"KIAA0259, TOP2BP1"	ENSG00000163781	"DNA topoisomerase II binding protein 1"	Q92547	3	133598175-133662380	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022451, HPA036738, HPA036739"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB022451: , HPA036738: , HPA036739: "	"unprognostic (7.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavourable (5.76e-5)"	"unprognostic (2.05e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavourable (4.66e-5)"	"unprognostic (8.03e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (2.74e-3)"	"unprognostic (8.65e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.60e-1)"	13.0	8.2	9.7	16.1	11.7	32.9	17.2	14.4	13.8	9.6	10.8	5.4	8.2	9.7	11.5	10.3	15.0	9.7	8.8	12.1	9.2	7.8	7.4	8.6	10.2	21.3	8.8	9.2	11.0	12.6	10.0	9.8	14.0	10.7	9.5	14.0	5.1	12.0	7.2	10.8	13.6	13.0	11.0	13.1	18.9	10.9	24.6	8.8	38.0	10.3	11.5	20.9	11.0	11.1	2.8	3.1	6.1	2.7	3.0	4.4	1.2	15.7	9.9	16.0	13.0	3.0	4.0	12.0	12.3	9.8	15.3	19.7	13.7	10.1	28.6	10.9	8.9	18.4	23.0	8.2	23.6	17.3	10.2	26.8	14.2	8.4	2.9	28.6	21.2	4.7	5.1	14.9	9.0	10.4	16.6	20.6	12.0	10.8	28.0	15.3	13.2	8.4	18.9	19.9	20.9	5.4	10.9	15.2	16.9	15.2	8.3	12.7	13.9	26.7	7.2	16.2	14.7	16.3	13.5	12.4	18.6	55.2	9.5	15.4	14.1	4.6	2.0	6.1	2.2	2.7	3.3	2.8	2.3	2.2	2.0	1.9	2.2	2.3	2.4	3.0	1.5	3.1	4.4	1.2	9.7	11.7	14.4	13.8	9.2	7.8	8.8	9.2	10.7	8.8
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein"	Q9NS56	9	32540544-32552553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA060640: , HPA065661: "	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favourable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	16.0	12.5	12.7	8.5	16.0	22.9	13.7	18.6	15.1	14.0	12.2	9.6	9.5	8.8	12.9	11.4	13.1	10.5	11.7	9.3	15.9	9.6	14.6	17.4	10.6	10.0	20.1	5.2	17.5	13.2	19.6	19.5	17.9	14.8	13.1	10.3	9.2	11.0	10.8	10.9	10.2	16.8	12.3	17.8	12.4	10.7	18.9	15.0	15.5	15.6	9.8	10.5	16.3	16.0	5.2	4.9	33.4	5.9	7.1	7.4	3.4	8.0	7.5	10.3	9.0	12.6	11.4	6.5	10.3	9.7	8.6	10.0	4.6	4.1	13.1	5.9	10.2	5.4	12.1	11.7	12.1	10.9	6.6	44.2	13.0	5.8	7.8	12.5	12.2	9.2	13.1	12.4	8.8	10.4	7.6	6.8	13.9	4.3	11.2	23.1	13.7	7.6	11.6	9.2	5.9	11.4	8.5	5.1	8.2	10.3	5.6	6.7	5.7	7.2	10.9	9.4	9.6	4.9	7.6	4.8	7.7	14.2	8.7	7.2	4.2	14.6	4.9	10.0	5.0	4.6	5.4	4.6	5.4	5.8	4.9	5.2	7.4	7.2	33.4	7.1	5.9	4.0	6.3	3.4	12.7	16.0	18.6	15.1	15.9	9.6	20.1	5.2	14.8	15.0
TOR1A	"DQ2, DYT1"	ENSG00000136827	"Torsin family 1 member A"	O14656	9	129812944-129824134	"Disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012473, HPA051195"	Approved		Supported	"Nuclear membrane,Vesicles"	"Intracellular and membrane"			"Nuclear membrane, Vesicles"		"CAB012473: AB_2240792, HPA051195: "	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-1)"	19.8	26.8	17.8	21.9	19.3	28.0	37.5	19.9	28.4	18.8	19.0	15.5	17.8	15.2	22.5	19.6	15.0	17.4	22.7	18.0	18.4	19.7	20.9	47.1	19.3	34.4	16.1	14.3	20.4	18.8	15.2	15.9	28.9	15.6	20.8	21.3	14.9	18.9	24.7	15.8	17.8	21.0	24.0	15.9	23.1	18.1	11.7	11.3	32.8	22.6	11.9	18.2	21.0	16.1	17.3	24.1	53.3	28.8	24.9	24.0	27.2	13.1	19.8	14.6	16.8	22.3	21.7	19.5	30.8	38.2	27.6	23.7	12.8	19.4	16.2	18.2	39.8	31.1	14.0	20.4	22.7	25.7	13.4	14.5	20.8	12.7	28.1	31.9	27.0	29.3	20.7	26.0	18.9	29.5	25.7	13.1	30.3	32.9	22.7	31.0	21.9	22.6	11.9	23.1	16.4	22.5	16.9	11.1	19.6	31.9	12.5	16.9	25.0	25.1	26.1	27.4	15.6	20.3	23.5	15.0	33.3	14.9	20.3	18.5	21.9	30.0	28.8	53.3	24.0	26.4	20.1	17.3	20.6	21.6	24.1	12.9	17.7	18.3	28.2	24.9	21.3	22.1	22.4	27.2	17.8	19.3	19.9	28.4	18.4	19.7	16.1	14.3	15.6	11.3
TOR1AIP1	"FLJ13142, LAP1B"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179925000	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546"	Enhanced		Enhanced	"Nuclear membrane"			17000	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	29.3	26.4	27.1	25.1	28.1	52.2	25.4	28.6	30.5	33.2	40.0	24.6	38.2	11.6	33.6	33.0	30.1	27.6	27.2	29.3	28.3	20.8	27.2	27.1	25.5	28.2	31.7	23.6	42.5	24.6	31.1	30.5	20.3	27.3	33.6	17.0	27.0	21.9	42.9	44.7	17.8	21.6	46.9	26.1	27.8	30.9	23.5	32.2	24.9	34.5	28.8	21.8	40.7	30.5	19.0	27.9	61.0	35.9	21.4	29.4	29.9	12.9	13.0	9.0	11.5	40.9	27.5	17.4	17.6	21.0	16.5	17.0	10.2	24.6	3.4	19.5	17.9	22.8	8.4	14.1	19.4	22.0	8.5	9.3	12.4	9.9	18.8	31.4	28.8	22.2	11.0	20.1	19.0	14.7	13.4	17.2	17.2	11.5	12.8	9.8	13.0	5.1	7.9	14.2	8.9	16.0	25.3	7.7	10.7	21.7	20.9	29.3	16.4	32.4	15.1	23.3	9.8	15.2	20.6	19.5	25.6	6.9	8.8	17.4	35.1	45.8	26.4	61.0	24.9	29.1	29.4	17.7	23.0	24.9	27.9	19.0	23.8	24.4	41.0	21.4	35.9	20.2	24.2	29.9	27.1	28.1	28.6	30.5	28.3	20.8	31.7	23.6	27.3	32.2
TOR1AIP2	"IFRG15, LULL1, NET9"	ENSG00000169905	"Torsin 1A interacting protein 2"	"Q8NFQ8, Q9H496"	1	179839967-179877803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051849, HPA058348, HPA070542"	Uncertain		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA051849: AB_2681637, HPA058348: , HPA070542: "	"unprognostic (1.22e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.64e-3)"	"unprognostic (3.06e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (9.99e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.36e-1)"	13.3	16.4	11.2	7.3	13.1	30.4	17.5	12.1	11.6	9.1	19.8	10.0	26.9	15.2	11.4	18.7	15.9	8.5	10.1	11.2	11.1	10.0	11.7	37.9	13.2	9.5	9.7	10.4	13.5	16.4	17.4	19.3	41.3	11.0	9.3	8.3	10.0	9.9	16.9	23.0	12.0	30.7	11.6	12.0	9.0	12.2	8.8	11.2	6.7	17.4	10.5	9.5	10.4	13.4	6.9	9.2	17.7	8.7	4.9	7.4	2.5	12.7	12.8	10.2	21.0	25.2	14.1	40.2	16.9	20.8	13.8	14.1	18.9	22.3	10.4	21.6	18.4	19.3	17.6	17.5	18.7	11.6	9.5	12.7	20.9	15.7	18.5	13.3	14.6	22.2	13.7	18.6	20.2	19.4	24.3	11.1	16.6	7.4	9.6	9.2	24.2	3.2	10.6	14.3	14.7	10.6	22.2	8.5	21.6	19.1	21.4	16.5	21.3	9.7	24.9	20.1	18.5	11.1	13.3	17.7	25.1	20.7	11.1	9.7	18.9	17.7	6.6	7.7	7.1	8.7	6.8	6.9	6.8	6.1	4.4	6.9	7.4	7.2	13.4	4.9	7.9	9.2	5.7	2.5	11.2	13.1	12.1	11.2	11.1	10.0	9.7	10.4	11.0	11.2
TOX2	"C20orf100, dJ1108D11.2, GCX-1"	ENSG00000124191	"TOX high mobility group box family member 2"	Q96NM4	20	43914864-44069616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 77.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 45.3;PC-3: 20.3;U-266/70: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 9.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049900, HPA058396"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA049900: , HPA058396: "	"unprognostic (2.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.97e-3)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (7.45e-8)"	"unprognostic (1.60e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.60e-2)"	"unprognostic (3.12e-1)"	7.0	4.4	8.0	9.9	5.2	2.4	4.8	0.8	14.5	6.7	4.8	2.6	3.5	2.3	3.6	3.5	12.2	3.0	4.7	2.0	7.8	20.6	2.4	4.1	20.1	19.2	13.7	7.0	1.8	2.7	17.3	14.9	4.6	7.3	9.9	4.2	3.0	2.4	5.3	0.8	2.9	5.3	12.0	4.5	7.1	5.7	17.6	2.0	77.2	4.8	2.4	11.8	9.7	6.5	0.1	3.7	9.7	0.3	1.9	2.0	0.2	4.4	5.7	1.8	0.3	2.0	5.8	0.0	5.6	2.4	3.6	4.5	0.0	1.8	0.0	8.2	6.4	2.2	1.4	0.1	3.2	7.2	1.5	0.0	0.4	0.0	45.3	0.0	8.6	15.5	6.7	12.6	0.6	4.4	0.0	5.4	2.2	4.7	1.7	1.6	1.4	20.3	0.0	4.4	7.4	0.0	0.5	2.0	15.4	1.0	0.0	7.2	0.0	3.8	5.4	0.0	3.5	0.1	0.0	29.3	6.3	3.8	7.5	0.0	12.0	0.0	0.3	9.7	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.1	0.2	0.1	1.0	1.9	0.0	3.7	2.0	0.2	8.0	5.2	0.8	14.5	7.8	20.6	13.7	7.0	7.3	2.0
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52438005-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 18.7"	"Cell line enhanced"	"Detected in some"		"AF22: 19.7;HAP1: 9.6;Hep G2: 8.6;RT4: 37.5;SCLC-21H: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favourable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favourable (3.95e-4)"	0.7	3.1	7.1	5.0	4.7	0.0	3.9	0.6	6.0	7.0	13.5	6.0	0.2	9.4	1.3	9.2	0.9	3.0	14.8	0.2	3.2	5.3	9.5	5.8	2.7	0.1	5.4	3.6	1.0	7.8	0.0	5.8	0.3	5.1	1.8	15.1	2.7	11.0	0.7	0.3	1.1	13.5	0.9	7.0	0.2	18.7	0.7	4.7	0.0	0.2	0.3	2.1	7.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.7	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	3.4	0.1	4.6	37.5	13.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	4.7	0.6	4.3	3.2	5.3	5.4	3.6	5.1	4.7
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687550	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 102.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: , HPA051244: , HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favourable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	18.5	11.1	6.0	28.6	6.8	9.0	17.5	2.5	7.3	18.5	14.6	6.8	8.3	9.7	20.3	15.0	25.3	16.7	22.6	8.1	5.0	3.8	10.6	20.8	11.2	26.0	6.6	3.1	33.8	13.8	4.9	6.0	22.8	6.9	16.5	14.5	9.9	15.3	16.1	12.5	24.6	14.0	12.8	6.2	24.2	12.0	14.1	6.9	102.6	13.2	23.5	31.2	16.9	15.0	15.2	19.6	2.2	14.1	11.0	11.3	8.2	19.2	35.6	19.4	14.0	9.1	10.8	20.6	6.9	15.6	19.2	24.3	1.0	9.9	45.3	31.5	13.6	42.5	28.2	19.1	18.0	10.1	18.9	18.3	20.0	16.9	27.4	0.4	9.5	13.7	22.2	9.3	25.7	18.8	0.9	1.7	9.8	34.2	30.7	22.4	19.6	0.7	59.7	13.7	15.7	14.3	21.3	11.6	20.0	22.8	15.4	5.9	26.7	1.7	24.3	23.0	7.6	0.3	11.6	11.9	8.7	19.5	6.0	2.3	19.4	0.8	13.3	2.2	9.1	14.1	11.1	15.2	9.4	10.2	19.6	14.5	9.9	10.8	1.7	11.0	11.9	17.9	11.3	8.2	6.0	6.8	2.5	6.4	5.0	3.8	6.6	3.1	6.9	6.9
TP53BP1	"53BP1, p202, TDRD30"	ENSG00000067369	"Tumor protein p53 binding protein 1"	Q12888	15	43403061-43510728	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004083, HPA008788, HPA022133"	Supported		Enhanced	"Nuclear bodies"				"Nuclear bodies"		"CAB004083: AB_10694558, HPA008788: AB_1078070, HPA022133: AB_1844382"	"unprognostic (2.12e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.07e-1)"	"unprognostic (8.06e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.38e-2)"	7.2	12.9	13.4	9.0	20.7	8.9	9.6	21.9	22.9	17.2	10.0	12.5	10.1	5.7	14.6	15.1	7.0	13.8	9.8	10.7	13.9	12.9	8.6	4.1	8.0	7.2	7.1	14.8	15.9	7.4	30.0	34.8	10.7	17.9	11.4	9.5	7.9	9.8	12.3	7.9	8.2	7.2	15.0	7.9	7.2	7.7	18.3	9.3	15.2	16.2	4.9	10.8	11.5	11.1	5.4	3.5	3.7	1.9	2.1	4.8	1.8	6.2	10.7	31.3	19.5	13.0	16.2	7.6	10.8	16.4	15.4	19.6	9.2	7.6	6.7	9.6	18.4	15.6	22.5	13.2	18.4	18.3	7.7	12.8	18.7	5.5	8.5	14.1	18.5	12.5	9.4	20.7	15.5	18.2	12.5	6.0	17.8	4.4	11.0	6.6	20.1	6.6	11.8	11.7	4.4	11.4	14.8	28.4	13.2	15.6	7.0	4.2	14.4	8.0	12.9	16.5	11.2	13.0	9.6	4.8	10.4	15.8	13.7	7.0	8.4	3.7	1.2	2.5	4.1	1.9	3.5	5.4	4.4	4.1	2.9	4.9	4.8	4.4	1.4	2.1	1.2	3.5	3.4	1.8	13.4	20.7	21.9	22.9	13.9	12.9	7.1	14.8	17.9	9.3
TP53BP2	"53BP2, ASPP2, PPP1R13A"	ENSG00000143514	"Tumor protein p53 binding protein 2"	Q13625	1	223779899-223845972	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021603, HPA050429"	Supported		Enhanced	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA021603: AB_1844384, HPA050429: "	"unprognostic (1.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-1)"	10.0	8.3	26.5	17.2	28.7	38.8	20.8	9.3	17.9	10.9	12.0	12.6	8.1	7.9	11.9	9.8	15.9	9.4	17.4	10.9	17.3	14.7	10.1	13.9	21.4	18.6	18.7	8.6	15.5	13.0	16.4	8.3	8.2	12.9	9.6	9.5	17.7	10.2	8.1	12.0	9.9	9.5	12.2	13.0	10.6	9.7	10.2	14.9	17.3	22.1	7.4	11.7	11.8	14.8	2.2	2.9	6.7	2.7	7.2	4.0	2.0	15.3	7.7	21.0	13.2	7.5	7.3	13.4	9.9	14.1	14.5	12.5	15.9	9.3	0.0	8.7	8.2	10.5	16.3	5.9	19.5	29.6	16.1	20.3	7.5	5.4	15.2	16.7	14.3	8.7	6.5	13.3	13.7	8.5	25.7	15.4	12.0	4.4	12.7	10.3	18.1	7.5	16.9	21.9	1.7	13.0	9.7	18.2	23.5	10.9	13.6	14.3	7.7	23.0	9.9	14.9	10.5	16.0	18.5	7.6	7.9	12.7	9.0	11.3	16.9	6.7	2.7	1.6	2.3	2.6	2.8	2.2	2.6	4.0	2.9	1.9	2.7	1.9	3.2	7.2	2.0	1.7	1.6	2.0	26.5	28.7	9.3	17.9	17.3	14.7	18.7	8.6	12.9	14.9
TP53I11	PIG11	ENSG00000175274	"Tumor protein p53 inducible protein 11"	O14683	11	44885903-44951306	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 83.1;T-47d: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 23.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059727, HPA061276"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"				"Endoplasmic reticulum, Golgi apparatus"		"HPA059727: , HPA061276: "	"prognostic unfavourable (7.33e-5)"	"unprognostic (1.87e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (6.12e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (4.65e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	33.3	8.0	20.0	13.3	10.7	19.0	27.6	36.0	26.2	14.7	21.1	8.6	17.6	13.6	16.8	10.4	15.6	21.5	28.5	33.1	8.4	12.3	12.5	7.8	21.4	12.8	5.8	8.6	18.2	18.5	3.0	9.5	16.6	14.1	20.6	19.4	17.6	18.9	11.9	12.6	14.5	21.1	23.5	7.4	28.2	18.4	9.9	5.5	6.7	18.9	12.7	14.9	15.1	19.1	5.2	14.1	23.7	11.1	4.6	4.4	2.1	0.0	17.3	5.9	8.4	6.3	0.4	0.1	5.6	10.9	1.9	2.5	1.0	0.1	3.0	4.8	1.5	3.3	3.4	0.1	0.7	6.4	3.4	0.2	0.1	0.0	11.7	0.1	23.4	27.1	0.4	2.7	1.2	6.5	0.4	0.0	2.4	14.8	0.3	27.2	10.8	5.8	13.2	3.6	1.4	0.0	1.0	83.1	3.0	9.7	21.1	0.0	46.8	1.6	1.5	13.0	9.2	19.9	0.0	0.1	0.0	0.0	0.0	1.7	3.6	0.0	3.1	0.0	3.1	3.2	4.4	4.9	0.6	3.2	2.6	5.2	0.0	1.1	23.7	4.6	11.1	14.1	0.5	2.1	20.0	10.7	36.0	26.2	8.4	12.3	5.8	8.6	14.1	5.5
TP53I3	PIG3	ENSG00000115129	"Tumor protein p53 inducible protein 3"	Q53FA7	2	24077433-24085861	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 55.0"	"Cell line enriched"	"Detected in many"	6	"T-47d: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB017479, HPA022012, HPA028742"	Enhanced		Supported	Vesicles			200000	Vesicles		"CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456"	"unprognostic (3.66e-2)"	"unprognostic (1.41e-3)"	"unprognostic (5.55e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.10e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.57e-3)"	10.3	9.5	2.7	11.7	2.7	6.3	6.3	2.5	3.6	12.0	42.1	3.6	10.5	18.4	8.5	7.0	43.2	6.1	17.8	5.0	1.6	3.2	28.2	11.5	15.7	5.3	2.1	2.0	4.7	20.3	4.0	4.6	13.0	3.3	6.6	15.5	6.7	11.3	6.9	4.9	2.8	55.0	6.1	2.3	5.6	9.0	41.3	1.9	8.6	9.0	10.6	9.0	8.2	21.8	3.6	11.1	11.4	13.4	0.2	0.4	4.0	4.9	16.2	9.5	3.9	7.5	16.8	6.9	4.9	6.1	4.3	6.0	4.1	8.9	0.6	2.8	8.1	1.5	2.4	8.7	2.6	3.7	0.3	1.4	5.7	10.6	4.9	0.6	2.9	18.1	13.9	11.5	2.8	19.3	1.2	4.2	18.1	3.3	0.8	0.1	7.2	6.6	1.7	8.4	0.1	7.2	7.7	1.3	6.1	6.5	1.4	1.0	113.2	1.0	14.2	4.9	12.0	3.3	2.4	1.9	1.2	0.5	1.7	0.0	1.2	7.3	13.4	11.4	0.2	8.5	0.1	3.6	0.2	0.4	11.1	2.6	0.0	0.3	2.8	0.2	3.8	4.8	0.3	4.0	2.7	2.7	2.5	3.6	1.6	3.2	2.1	2.0	3.3	1.9
TP53INP1	"DKFZp434M1317, FLJ22139, P53DINP1, SIP, Teap, TP53INP1A, TP53INP1B"	ENSG00000164938	"Tumor protein p53 inducible nuclear protein 1"	Q96A56	8	94925972-94949411	"Predicted intracellular proteins"	"Apoptosis, Autophagy, Transcription, Transcription regulation"	"Activator, Antioxidant"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.5;U-266/70: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 25.7"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;granulocytes: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005856	Uncertain		Supported	Cytosol				Cytosol		"HPA005856: AB_10600832"	"unprognostic (1.39e-2)"	"unprognostic (4.47e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.31e-2)"	"prognostic favourable (1.11e-4)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.18e-2)"	"prognostic favourable (5.45e-5)"	8.2	8.3	5.1	21.0	7.6	17.9	14.3	5.9	5.9	8.3	11.1	7.4	11.5	8.4	10.2	11.6	10.6	8.4	11.2	8.6	5.5	3.1	7.8	50.0	21.0	51.9	6.9	3.5	7.4	42.7	6.7	6.9	12.4	5.7	14.9	10.4	8.4	13.3	15.3	17.9	9.1	24.8	9.9	5.3	28.9	12.3	22.3	7.4	39.8	7.9	4.6	31.4	15.5	6.6	6.8	0.8	25.7	2.1	2.9	3.6	1.3	0.2	1.0	9.8	3.8	12.3	11.6	10.2	2.3	5.4	1.0	2.5	0.8	0.2	2.1	5.1	4.4	1.7	0.0	3.8	2.4	0.1	1.2	1.3	2.0	5.8	8.2	0.0	6.9	19.0	9.1	2.8	1.1	16.0	0.7	32.5	5.0	0.6	1.5	0.5	0.9	0.2	1.3	0.7	11.3	2.6	10.5	1.3	8.0	1.4	0.8	2.0	4.8	1.3	11.0	2.0	2.4	0.0	0.3	35.1	7.2	0.9	3.4	0.0	0.0	25.7	2.1	6.1	0.8	2.0	0.8	6.8	2.4	1.6	0.7	5.9	0.5	0.4	9.6	2.9	1.2	0.8	3.6	1.3	5.1	7.6	5.9	5.9	5.5	3.1	6.9	3.5	5.7	7.4
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631416-189897279	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 83.2;skin 1: 54.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 23.3;HBEC3-KT: 44.6;hTCEpi: 33.8;hTERT-HME1: 32.3;RT4: 49.0"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favourable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	2.9	0.1	0.2	0.7	0.1	0.0	7.2	0.1	0.2	9.5	0.1	0.1	5.7	0.0	0.3	8.0	33.7	0.3	0.0	0.2	0.1	0.1	0.4	0.1	1.2	0.2	0.1	0.2	0.1	0.1	0.0	0.3	7.8	0.8	9.6	0.0	0.3	9.0	7.8	83.2	54.2	0.1	2.7	0.6	0.1	0.1	1.2	0.0	9.0	0.4	36.7	26.1	9.6	19.2	3.7	1.3	3.0	0.9	1.2	1.2	0.2	0.6	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	23.3	0.0	44.6	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.0	33.8	0.0	32.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.1	0.3	0.1	0.0	0.2	2.0	0.4	1.1	0.9	0.5	0.7	3.7	1.2	1.0	0.4	1.7	0.8	0.7	3.0	1.2	0.9	1.3	0.8	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.8	0.0
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652520-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 11.2;SCLC-21H: 14.3;U-698: 14.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 25.7"	"Cell type enhanced"	"Detected in some"		"eosinophil: 1.2;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: , HPA044516: "	"unprognostic (5.71e-3)"	"prognostic favourable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favourable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.5	0.3	1.1	3.4	2.3	1.0	1.1	25.7	0.4	1.5	0.7	2.4	1.3	0.3	0.4	6.2	4.8	12.8	1.4	0.3	1.9	1.2	0.2	2.1	3.8	2.0	0.5	0.0	2.6	1.5	0.3	0.7	1.7	3.2	3.6	0.4	0.4	5.5	1.4	0.4	11.9	0.5	0.3	0.9	4.2	0.8	9.8	0.3	2.5	0.4	0.8	7.1	0.6	3.9	1.4	0.1	1.2	0.1	0.0	0.6	0.1	1.9	0.1	0.2	6.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.4	3.2	2.0	1.6	0.0	3.3	2.1	0.7	0.0	0.6	6.8	0.1	3.2	1.9	0.0	0.0	2.3	0.0	1.4	0.0	0.1	0.0	4.2	0.0	0.6	1.5	11.2	1.5	0.4	0.1	0.0	9.2	0.1	0.2	2.9	14.3	6.7	0.3	0.0	0.6	8.6	7.0	0.0	2.3	6.1	0.0	4.5	2.7	0.5	14.4	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	1.4	0.4	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.1	2.3	25.7	0.3	1.9	1.2	0.5	0.0	3.2	0.3
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102597003-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"			410000	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: "	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	19.9	12.4	10.8	21.4	14.5	24.7	18.1	23.1	18.4	16.8	14.7	12.2	50.3	13.1	20.0	21.8	14.4	16.7	13.5	17.0	11.7	9.7	12.9	22.8	18.4	32.8	11.7	13.8	21.6	16.3	15.7	15.7	19.2	15.3	13.9	21.0	12.9	15.6	34.5	35.7	14.1	17.4	19.2	13.4	20.7	15.4	34.5	14.0	23.8	21.9	16.0	19.7	17.0	16.0	6.0	5.8	9.2	6.9	10.9	12.1	4.7	15.9	6.4	18.5	15.7	12.5	17.3	13.2	16.3	11.9	10.5	13.2	13.5	21.5	17.5	5.6	13.1	15.7	14.3	11.5	19.0	12.2	12.7	33.3	16.8	10.8	10.6	37.6	20.3	13.4	5.2	11.8	15.8	15.0	19.8	19.6	14.8	5.0	17.3	28.2	15.0	8.9	19.2	14.0	15.8	13.6	13.2	17.2	14.1	10.2	17.1	7.3	9.8	42.2	12.0	10.0	7.3	6.4	13.5	19.3	23.3	15.3	16.7	27.2	12.9	9.2	6.0	4.0	9.1	6.9	10.7	6.0	10.3	10.1	5.8	5.5	12.1	11.5	1.3	10.9	5.7	4.6	10.9	4.7	10.8	14.5	23.1	18.4	11.7	9.7	11.7	13.8	15.3	14.0
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693395	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 77.5"	"Cell line enhanced"	"Detected in some"		"A549: 8.4;AN3-CA: 6.2;SCLC-21H: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.5;NK-cell: 1.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favourable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.5	5.8	27.0	1.3	29.6	1.0	2.7	17.0	77.5	2.1	3.2	69.0	0.1	4.6	2.3	1.3	9.0	8.6	2.1	6.0	33.9	23.9	3.2	2.3	8.3	1.0	25.8	25.0	1.8	5.2	2.4	4.4	2.4	30.1	2.4	2.2	0.2	4.8	3.7	6.2	5.6	7.5	3.5	24.7	2.7	3.8	1.6	4.3	0.0	6.0	1.9	1.8	3.4	0.6	0.0	0.2	1.5	0.0	1.0	0.5	0.1	0.3	8.4	0.4	6.2	0.9	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.9	0.2	0.6	0.0	3.3	3.4	0.0	0.0	1.7	2.9	0.2	3.6	0.2	0.9	0.3	0.4	0.0	0.8	0.0	0.2	0.1	0.1	3.1	0.0	0.3	0.2	0.5	0.2	0.8	0.3	0.1	1.2	0.3	1.1	15.5	1.9	0.9	0.4	4.1	0.8	0.2	0.1	0.2	3.3	0.1	0.2	1.2	0.3	0.0	0.6	0.7	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.2	0.1	0.1	27.0	29.6	17.0	40.8	33.9	23.9	25.8	25.0	30.1	4.3
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favourable (4.71e-4)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	21.5	17.3	14.3	26.7	21.3	21.6	19.0	24.4	17.1	21.7	24.2	7.3	27.1	12.9	20.8	23.5	18.5	16.9	16.8	28.3	13.8	10.5	18.7	20.6	17.9	20.4	14.1	16.6	24.7	17.8	44.2	29.1	29.7	15.1	22.2	17.7	9.1	20.2	30.1	33.1	20.5	21.1	21.2	16.4	26.1	18.8	35.0	17.8	39.5	21.7	19.7	21.4	25.1	19.1	19.1	19.8	50.3	15.2	10.7	16.9	5.2	22.0	19.1	28.7	16.6	23.0	20.6	30.2	25.4	17.0	18.0	16.8	28.7	18.9	25.9	19.7	17.2	29.0	21.6	17.4	22.2	19.4	23.6	34.5	30.9	20.1	12.4	36.8	22.6	15.7	10.6	27.1	21.1	21.2	41.5	23.4	19.1	19.1	18.2	9.8	31.6	6.7	21.7	22.5	22.4	14.7	26.6	15.6	24.8	29.6	19.7	15.9	21.9	23.5	29.7	18.0	17.1	19.8	30.7	25.7	30.0	23.7	11.5	18.8	16.1	29.5	12.0	21.9	15.8	10.0	13.3	15.2	13.8	12.7	6.8	19.1	16.9	11.7	50.3	10.7	15.2	19.8	15.3	5.2	14.3	21.3	24.4	17.1	13.8	10.5	14.1	16.6	15.1	17.8
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.3;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.5;HDLM-2: 12.2;Karpas-707: 6.2;T-47d: 5.5;U-266/70: 5.9;U-266/84: 4.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 7.0"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA044751: , HPA060187: "	"prognostic favourable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	16.1	1.0	0.3	0.9	0.8	0.0	14.4	1.7	0.8	19.7	1.2	0.1	1.0	0.0	5.0	1.6	43.3	5.2	1.6	2.4	0.2	0.2	0.6	5.1	2.7	0.3	0.3	0.5	1.9	0.3	0.0	0.8	1.0	0.5	2.5	0.0	0.8	3.7	0.7	5.0	14.5	0.5	1.9	0.3	0.7	0.4	2.6	0.3	7.9	0.8	25.5	32.9	2.3	17.8	0.2	0.7	1.3	2.3	0.0	6.3	1.3	1.2	0.2	0.5	0.1	2.8	2.3	0.0	0.0	0.0	0.1	0.1	1.4	2.9	1.8	4.5	0.2	0.3	0.0	0.1	0.0	12.2	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	0.0	6.2	0.2	0.5	0.0	0.0	0.9	0.4	0.0	0.0	2.2	0.1	2.4	0.0	0.0	0.3	0.7	0.0	5.5	0.8	0.1	0.2	0.4	0.0	0.4	5.9	4.6	0.5	0.1	0.1	0.1	0.0	2.3	0.0	6.0	1.8	0.9	0.2	4.9	6.3	0.7	0.0	1.0	2.5	1.3	0.0	1.6	0.1	5.4	1.3	0.3	0.8	1.7	0.8	0.2	0.2	0.3	0.5	0.5	0.3
TPRKB	"CGI-121, CGI121"	ENSG00000144034	"TP53RK binding protein"	Q9Y3C4	2	73729104-73737400	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035712	Approved		Supported	Cytosol				Cytosol		"HPA035712: AB_10669674"	"unprognostic (1.11e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.21e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.16e-3)"	"unprognostic (3.01e-3)"	"unprognostic (5.10e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.68e-3)"	"unprognostic (5.66e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.03e-2)"	15.5	13.9	13.5	9.9	16.2	30.2	23.3	24.1	17.0	18.0	16.7	11.1	21.1	19.9	16.5	19.9	22.4	29.3	10.7	24.5	15.6	12.0	24.3	23.6	14.4	17.5	17.6	12.6	22.2	19.2	8.4	21.3	14.8	18.2	16.6	18.0	8.7	20.3	13.0	36.8	13.3	24.1	20.6	16.6	15.5	15.9	25.1	15.9	21.9	14.7	30.6	16.6	14.3	17.5	20.6	22.0	24.3	21.9	19.4	22.3	14.6	23.8	19.0	18.7	20.7	6.9	9.8	14.6	14.7	9.3	18.8	13.7	28.9	15.5	15.3	12.1	8.0	15.3	14.4	17.8	29.7	9.8	20.6	31.2	12.1	21.9	6.9	38.0	18.0	6.9	11.7	18.3	20.1	19.5	28.6	24.2	19.2	15.2	33.1	33.1	24.5	25.2	19.9	51.4	22.8	17.4	22.6	16.2	20.5	12.4	20.4	26.6	14.4	20.0	9.0	14.9	24.2	29.1	43.2	17.1	22.7	40.6	14.4	29.9	18.0	14.3	17.1	24.3	14.9	21.9	19.8	20.6	20.1	18.0	19.4	17.6	22.3	21.2	13.8	19.4	17.1	22.0	18.6	14.6	13.5	16.2	24.1	17.0	15.6	12.0	17.6	12.6	18.2	15.9
TPST1	TANGO13A	ENSG00000169902	"Tyrosylprotein sulfotransferase 1"	O60507	7	66205199-66420543	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3;neutrophil: 17.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047415, HPA061837"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"HPA047415: AB_10964056, HPA061837: "	"unprognostic (7.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.59e-1)"	"unprognostic (9.25e-3)"	"unprognostic (4.12e-2)"	"unprognostic (4.98e-1)"	"prognostic unfavourable (8.16e-6)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (3.73e-5)"	15.4	12.8	16.7	9.8	28.2	5.6	11.2	12.2	19.2	34.0	7.7	8.8	3.4	3.4	20.2	13.8	10.8	10.9	34.2	6.6	26.1	22.2	13.4	38.9	9.0	5.9	15.3	12.2	11.5	7.1	8.1	19.6	23.2	28.1	15.5	7.9	9.7	5.4	15.8	2.9	6.2	5.9	35.7	27.5	9.0	10.0	19.6	11.4	0.3	10.7	3.2	5.2	27.2	19.9	6.3	0.1	21.3	1.1	3.9	2.0	0.8	4.2	2.6	6.7	8.6	20.6	16.5	2.1	8.2	18.9	10.1	14.3	8.2	2.5	0.5	6.6	16.7	3.3	6.3	9.3	13.4	1.2	3.6	0.9	6.4	6.3	24.4	0.6	0.7	23.3	7.3	19.3	8.5	12.2	0.4	3.8	15.4	2.3	0.0	1.1	6.1	3.5	2.9	5.4	4.3	10.4	4.6	3.9	16.7	10.3	0.8	22.0	3.3	1.7	23.2	12.9	8.2	9.2	14.8	3.5	4.8	1.7	11.4	2.5	18.2	21.3	1.1	10.7	0.4	0.0	0.3	2.4	0.2	0.3	0.1	6.3	1.1	2.0	17.3	3.9	0.0	0.0	0.0	0.8	16.7	28.2	12.2	19.2	26.1	22.2	15.3	12.2	28.1	11.4
TPT1	"fortilin, TCTP"	ENSG00000133112	"Tumor protein, translationally-controlled 1"	P13693	13	45333471-45341370	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB008364, HPA039437"	Approved		Supported	Cytosol			3000000	Cytosol		"CAB008364: AB_591904, HPA039437: "	"prognostic favourable (5.90e-5)"	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (2.35e-4)"	"unprognostic (3.25e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.56e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (1.47e-1)"	"unprognostic (8.48e-2)"	"prognostic favourable (4.31e-5)"	"unprognostic (6.51e-2)"	197.3	108.4	81.7	126.7	74.3	156.7	185.4	35.2	41.3	173.3	229.7	66.5	131.7	101.9	197.9	162.6	234.4	97.1	168.2	292.9	74.4	58.0	141.0	317.4	179.5	286.0	85.1	27.1	273.2	671.6	32.3	97.4	188.3	46.3	203.4	91.6	77.5	460.5	124.6	772.2	98.5	178.1	169.1	101.1	180.2	107.7	95.9	52.1	211.5	306.1	322.2	178.4	211.5	356.3	106.0	111.8	76.0	91.7	110.6	165.2	205.6	58.1	52.8	89.4	58.4	264.1	368.4	106.3	124.0	193.3	79.2	83.2	118.5	151.5	124.1	104.7	128.7	101.5	72.1	182.0	109.8	57.3	63.1	99.4	48.0	131.5	266.9	135.2	155.8	302.0	370.5	50.4	305.1	163.5	73.6	34.3	161.5	106.2	163.7	323.1	101.9	56.3	103.3	84.8	92.7	203.0	122.3	38.1	102.1	41.1	131.8	189.2	75.6	394.4	106.5	36.6	52.1	59.3	76.0	84.7	85.6	117.3	97.6	108.1	28.4	76.0	91.7	44.6	82.3	71.6	149.6	106.0	154.6	111.3	87.2	84.4	165.2	133.5	42.2	110.6	65.9	111.8	134.7	205.6	81.7	74.3	35.2	41.3	74.4	58.0	85.1	27.1	46.3	52.1
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2, microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 92.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"				Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (8.07e-7)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.8	1.7	1.0	13.4	2.0	21.7	1.2	2.2	1.7	2.2	5.7	0.5	0.3	4.6	1.2	2.3	13.3	0.5	1.9	1.5	0.8	0.7	1.2	2.7	2.6	12.9	0.7	1.1	0.8	0.5	0.0	0.7	6.6	0.9	0.7	7.4	0.5	2.3	0.5	2.2	5.9	4.7	3.2	0.9	5.9	3.2	22.0	0.6	92.7	0.7	11.0	16.2	2.2	3.8	1.0	1.4	4.0	0.1	4.8	10.4	1.3	69.6	23.4	28.3	22.1	2.2	4.2	27.3	29.3	16.6	42.6	32.2	49.6	30.1	32.8	17.3	16.3	36.8	32.3	26.6	48.6	14.1	12.5	64.3	22.4	33.8	0.7	24.6	16.6	1.4	1.4	26.7	19.5	22.9	47.5	30.0	33.3	28.6	41.2	19.2	31.5	25.3	23.4	76.4	19.8	11.4	11.4	20.6	13.8	44.8	17.0	13.2	29.5	15.0	15.4	47.8	29.4	21.9	44.9	12.0	20.7	29.4	14.9	87.9	31.0	4.0	0.0	0.5	0.6	0.0	0.3	1.0	1.9	2.3	0.6	0.4	0.4	0.7	0.4	4.8	0.1	1.4	10.4	1.3	1.0	2.0	2.2	1.7	0.8	0.7	0.7	1.1	0.9	0.6
TRA2A	"AWMS1, htra-2-alpha, tra2a"	ENSG00000164548	"Transformer 2 alpha homolog"	Q13595	7	23504780-23532041	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054018	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles				Nucleoli	"Nucleoplasm, Vesicles"	"HPA054018: "	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.77e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (2.07e-5)"	"unprognostic (1.28e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.36e-3)"	23.4	29.4	27.8	29.5	34.1	70.6	27.4	38.1	27.5	30.3	22.9	29.0	31.6	19.8	32.7	34.5	29.4	25.9	17.6	18.7	28.6	29.3	21.3	21.8	28.6	32.2	35.8	18.5	36.8	27.4	14.9	46.6	24.4	28.2	26.4	30.1	23.7	21.9	26.7	15.7	31.6	22.6	35.2	30.4	33.8	21.1	25.9	37.3	35.6	24.7	20.5	38.0	25.0	31.8	15.5	23.9	20.4	23.0	14.7	21.7	8.2	19.0	21.1	32.7	51.2	17.6	11.1	21.2	24.2	11.5	24.3	20.1	17.3	26.2	35.9	14.0	17.9	31.6	39.2	22.6	30.7	21.6	22.9	22.0	23.3	27.3	18.4	25.6	20.7	13.1	15.7	18.4	23.1	27.7	42.7	17.6	27.6	18.6	31.0	43.1	29.3	21.8	35.4	25.8	21.5	28.2	27.5	28.4	23.1	22.7	26.3	16.2	20.6	28.9	24.9	19.5	27.9	17.8	28.1	19.8	24.7	29.5	16.7	35.0	25.9	11.5	14.9	18.5	21.7	23.0	18.7	15.5	20.3	19.8	16.8	14.4	17.7	20.9	20.4	14.7	20.4	23.9	20.0	8.2	27.8	34.1	38.1	27.5	28.6	29.3	35.8	18.5	28.2	37.3
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185915906-185938136	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol			40000	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: , HPA064972: "	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favourable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	36.2	38.0	34.9	52.5	32.4	34.5	34.1	29.8	29.1	30.5	39.5	20.3	31.7	22.4	37.8	32.3	36.5	27.1	31.0	26.4	29.9	30.1	33.0	37.1	27.1	36.9	29.8	21.9	28.9	31.0	28.6	31.3	38.0	20.9	31.6	27.5	26.1	26.6	32.3	50.8	22.7	24.9	35.7	27.1	31.9	28.7	38.4	25.1	57.2	29.6	47.3	42.8	34.0	50.3	34.5	37.0	30.7	21.0	20.6	25.0	10.7	31.3	13.0	32.6	16.6	9.5	7.5	17.9	25.5	16.4	28.2	22.3	20.8	16.6	30.4	30.7	13.0	20.5	35.6	24.8	33.1	25.5	22.6	28.4	11.7	27.6	12.7	30.1	23.0	7.2	12.3	16.6	16.1	21.5	27.1	19.4	21.5	16.5	74.5	43.7	48.5	20.2	45.2	26.3	35.5	27.3	13.7	24.2	24.1	16.8	23.7	30.0	23.9	33.4	12.2	19.1	25.0	15.9	38.2	35.8	87.2	56.7	19.6	35.0	30.0	30.7	21.0	16.1	20.2	17.1	18.1	31.7	19.8	18.7	18.3	34.5	25.0	22.7	22.1	20.6	18.6	37.0	18.5	10.7	34.9	32.4	29.8	29.1	29.9	30.1	29.8	21.9	20.9	25.1
TRAF2	"RNF117, TRAP3"	ENSG00000127191	"TNF receptor associated factor 2"	Q12933	9	136881912-136926607	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004603, HPA009972, HPA010634"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347"	"unprognostic (7.77e-2)"	"unprognostic (4.54e-3)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (4.91e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	7.3	6.6	8.7	20.3	10.4	15.9	8.6	16.0	10.0	7.3	8.7	7.4	7.3	11.1	12.3	6.9	12.3	9.0	8.3	8.3	7.5	6.5	8.5	12.3	11.5	19.7	11.2	8.3	6.8	13.9	5.9	8.8	12.1	8.1	10.2	6.2	7.5	13.0	10.1	6.4	13.0	10.4	10.6	8.2	13.8	10.7	13.7	6.4	16.4	14.7	5.2	15.9	8.4	37.5	12.6	11.5	6.7	8.3	10.1	17.4	6.2	10.6	32.9	8.9	7.9	2.5	4.0	17.4	8.8	4.9	12.9	8.8	20.3	19.3	13.3	11.5	5.5	28.1	12.2	14.4	5.3	20.2	9.9	10.0	29.7	12.6	3.7	9.8	10.4	3.0	4.4	10.5	6.0	6.0	16.8	15.2	5.7	15.5	15.9	14.1	14.5	14.8	15.1	13.7	18.1	7.9	8.4	14.6	6.8	11.0	25.8	10.0	18.5	11.6	6.8	16.9	10.9	11.0	14.7	6.3	10.3	13.2	6.0	8.1	12.4	1.3	3.7	6.7	10.4	4.2	14.6	12.6	11.1	13.0	4.9	10.0	9.1	10.9	3.3	10.1	8.3	11.5	17.4	6.2	8.7	10.4	16.0	10.0	7.5	6.5	11.2	8.3	8.1	6.4
TRAF6	RNF85	ENSG00000175104	"TNF receptor associated factor 6"	Q9Y4K3	11	36487027-36510272	"Enzymes, Predicted intracellular proteins"	"DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004605, HPA019805, HPA020599"	Approved		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.22e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.07e-1)"	13.0	11.0	12.9	8.5	17.0	31.8	11.9	18.1	15.0	10.6	10.7	13.6	8.2	9.5	12.9	9.8	12.4	11.5	9.4	13.9	9.8	7.1	11.2	12.3	15.2	9.2	14.8	10.6	14.6	11.3	11.0	11.9	10.3	12.7	9.6	10.5	10.5	11.0	9.3	13.9	12.7	12.5	12.1	10.1	13.0	10.3	15.0	12.8	18.5	15.6	6.7	10.8	11.3	13.0	10.6	7.7	27.7	11.4	9.6	13.1	8.5	5.1	6.5	12.6	7.1	11.9	8.7	5.5	7.8	8.4	7.2	9.5	5.7	3.5	6.8	4.8	8.2	9.7	10.0	7.9	12.0	11.1	11.7	6.5	5.1	5.1	7.7	7.2	8.0	8.1	11.1	3.9	11.8	10.1	9.7	7.4	9.0	6.3	11.5	3.9	6.8	6.0	7.6	17.1	3.8	8.7	10.7	2.1	11.1	7.8	7.6	5.5	8.7	7.0	8.0	10.3	9.1	9.4	9.4	8.7	7.3	7.3	5.8	5.2	7.7	27.7	8.0	20.9	11.9	11.4	11.7	10.6	10.3	11.6	7.7	8.1	10.0	13.1	11.1	9.6	8.2	4.5	8.0	8.5	12.9	17.0	18.1	15.0	9.8	7.1	14.8	10.6	12.7	12.8
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	16.0	18.2	18.3	22.3	20.6	28.5	39.1	28.7	25.6	22.1	29.4	9.1	21.1	37.3	20.4	18.3	32.9	21.9	36.9	21.0	18.3	14.8	21.3	47.3	18.3	40.9	13.4	14.7	19.3	41.6	17.7	20.3	19.5	12.8	16.2	16.9	13.0	24.4	23.1	25.5	32.2	37.8	28.8	14.1	21.4	25.1	13.2	10.6	26.1	20.3	30.9	21.9	21.9	28.9	6.7	12.3	7.7	13.9	3.0	7.1	5.2	20.8	26.7	15.3	27.3	15.8	30.0	18.0	16.1	20.3	19.0	17.1	32.4	27.0	13.4	19.1	20.5	24.5	14.3	28.6	7.2	21.1	18.3	19.1	35.6	24.8	21.0	20.3	27.7	29.6	23.9	18.3	24.0	36.7	20.3	18.1	18.0	47.7	20.8	23.6	30.0	13.1	38.9	25.4	26.8	15.3	11.2	30.8	25.6	13.5	25.9	17.6	29.4	25.0	27.6	23.1	32.5	21.5	17.5	26.2	19.4	17.7	13.2	13.2	17.9	3.7	10.0	7.7	5.4	13.9	5.0	6.7	5.3	5.7	12.3	4.9	3.8	4.5	6.9	3.0	9.4	6.0	7.1	5.2	18.3	20.6	28.7	25.6	18.3	14.8	13.4	14.7	12.8	10.6
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828599-49856574	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavourable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	4.8	1.6	3.4	6.0	10.7	9.5	3.0	7.4	3.0	3.5	3.7	2.0	3.2	2.3	3.8	2.4	4.5	3.0	2.9	1.5	2.7	2.7	1.6	1.2	1.3	8.1	2.0	2.8	3.4	1.6	1.6	2.0	2.5	3.0	2.9	4.8	2.7	3.1	1.7	2.8	6.7	3.4	3.4	5.1	3.7	1.9	25.0	3.4	11.5	2.2	3.1	6.8	1.9	3.0	5.1	1.6	0.6	3.0	2.7	4.9	1.6	6.4	7.9	11.3	11.3	1.0	1.6	9.3	7.8	3.7	16.5	15.8	9.5	7.4	15.9	5.5	4.5	8.5	11.8	8.9	12.4	9.1	7.8	11.9	9.6	8.5	0.4	9.7	10.0	1.1	1.3	13.2	7.0	4.3	8.6	11.5	7.3	9.3	16.1	12.4	9.0	13.0	8.9	7.6	9.2	3.0	9.0	5.5	9.4	8.6	7.3	5.5	6.6	13.9	3.3	10.6	12.6	14.5	15.2	8.5	20.2	17.0	5.3	13.2	9.4	0.0	1.5	0.6	2.3	0.8	2.0	5.1	1.3	4.9	1.3	3.8	1.7	2.6	0.3	2.7	3.0	1.6	0.8	1.6	3.4	10.7	7.4	3.0	2.7	2.7	2.0	2.8	3.0	3.4
TRAP1	"HSP75, HSP90L"	ENSG00000126602	"TNF receptor associated protein 1"	Q12931	16	3651639-3717597	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041082, HPA044227"	Enhanced		Enhanced	Mitochondria			1100000	Mitochondria		"HPA041082: AB_2677291, HPA044227: AB_2678864"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.80e-4)"	"unprognostic (7.10e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.82e-2)"	19.1	20.3	19.1	15.9	29.7	14.2	17.5	21.1	38.5	16.8	23.0	18.1	13.1	18.6	17.1	14.2	34.4	28.5	20.8	40.0	22.1	20.4	24.6	62.6	12.3	20.6	17.1	30.7	23.5	54.7	18.3	13.6	15.5	23.2	15.4	17.8	16.4	19.7	13.7	80.3	31.2	14.1	20.9	12.3	15.2	19.7	20.0	15.1	16.4	16.0	39.8	21.2	17.2	18.2	20.0	24.6	1.3	17.0	12.7	22.3	13.8	18.9	47.7	9.9	26.2	11.0	11.3	29.4	11.5	10.5	26.8	16.9	59.2	27.1	61.1	21.9	11.1	35.7	38.6	28.8	11.8	23.4	42.2	17.8	40.9	41.4	18.9	31.9	12.3	13.3	20.1	21.2	33.3	18.3	55.9	22.3	8.7	62.0	22.9	23.7	18.4	24.3	52.7	20.8	84.3	19.8	14.1	47.3	18.0	12.0	44.4	23.1	32.1	23.2	10.3	11.3	20.2	19.7	16.8	23.8	26.2	48.1	7.0	25.8	15.3	0.0	10.8	0.3	11.7	17.0	22.3	20.0	17.1	14.8	24.6	13.9	20.3	17.1	1.3	12.7	12.3	3.6	14.2	13.8	19.1	29.7	21.1	38.5	22.1	20.4	17.1	30.7	23.2	15.1
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favourable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favourable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	18.2	17.3	15.2	19.7	19.7	14.6	12.8	18.3	25.3	20.3	16.4	21.1	15.2	15.8	19.7	14.4	16.7	14.8	17.9	26.8	16.0	15.6	16.1	29.2	16.8	22.0	15.4	15.6	19.3	16.4	16.5	20.4	12.8	20.6	18.5	8.3	16.3	24.4	16.9	40.7	41.3	17.6	16.4	13.1	19.9	17.1	50.8	12.2	23.2	16.8	17.3	18.6	16.9	14.1	1.0	7.5	6.0	5.5	1.4	3.9	1.2	8.4	14.7	4.8	5.5	10.9	13.6	12.8	13.9	3.4	4.1	2.2	9.1	7.1	9.6	15.4	4.7	10.8	5.6	6.2	1.6	11.6	20.9	8.3	4.2	31.1	4.9	10.4	14.9	9.9	4.8	4.5	11.5	3.5	12.8	5.3	7.1	11.7	10.4	17.8	11.8	20.8	7.9	6.6	7.7	4.4	7.0	12.4	20.2	5.5	6.3	9.1	7.3	8.4	8.9	10.1	5.7	10.0	12.2	15.2	11.2	7.6	11.7	8.2	5.5	1.2	1.8	6.0	1.4	4.1	3.6	0.9	2.3	3.8	2.4	1.0	1.6	1.9	1.7	1.4	5.5	7.5	3.9	1.2	15.2	19.7	18.3	25.3	16.0	15.6	15.4	15.6	20.6	12.2
TRAPPC2L	HSPC176	ENSG00000167515	"Trafficking protein particle complex 2 like"	Q9UL33	16	88856220-88862686	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041714	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA041714: AB_10793930"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (3.75e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.94e-2)"	22.7	46.1	29.5	18.6	29.2	19.8	22.4	15.9	37.4	18.5	21.8	25.5	16.0	16.2	15.8	40.4	17.4	19.0	25.0	26.0	22.9	24.4	20.2	21.9	13.9	24.3	24.9	22.5	21.5	25.6	8.7	16.0	13.7	22.1	15.8	15.7	20.0	17.3	17.3	53.8	19.0	14.7	14.1	27.3	18.3	21.5	33.9	18.1	11.5	19.2	25.1	16.6	16.1	16.4	41.2	45.6	10.8	39.0	24.6	47.7	40.9	15.8	11.1	18.9	14.3	14.2	18.2	19.5	14.3	16.4	22.2	8.5	30.9	21.0	12.2	25.4	18.2	17.0	25.7	20.6	16.1	10.6	15.4	8.1	11.2	39.0	21.0	22.9	6.5	17.6	13.0	29.9	15.2	17.8	24.2	9.8	15.1	49.5	30.5	70.9	19.0	20.8	29.4	15.7	12.6	17.0	18.4	20.5	10.1	48.6	15.0	13.1	38.5	24.4	14.0	14.7	16.1	19.3	16.2	13.8	23.3	56.7	17.6	34.2	17.5	10.0	39.0	10.8	34.0	31.2	34.2	41.2	39.2	36.6	37.7	35.2	36.9	31.4	6.8	24.6	29.7	45.6	47.7	40.9	29.5	29.2	15.9	37.4	22.9	24.4	24.9	22.5	22.1	18.1
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 53.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: , HPA051273: , HPA059943: "	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	4.9	8.7	9.3	7.7	8.7	16.7	4.0	18.1	10.8	12.0	5.1	2.9	9.7	4.2	10.0	4.0	12.6	7.2	6.9	2.8	4.5	3.9	5.2	1.4	4.0	9.2	2.5	4.7	10.2	2.5	7.5	9.3	3.4	3.5	8.8	4.7	7.3	3.7	5.2	1.3	8.4	6.6	8.6	4.9	9.0	5.6	11.2	4.8	23.4	3.3	3.6	12.7	13.3	11.0	0.4	1.4	8.1	1.1	2.7	3.0	1.1	5.1	3.5	4.0	5.1	1.8	4.2	5.7	3.9	6.2	4.5	3.7	0.0	2.7	4.7	0.8	5.8	6.2	5.1	4.8	3.6	53.8	0.4	5.1	2.9	0.0	1.3	9.4	16.5	1.7	6.8	4.0	1.6	0.0	0.0	1.6	1.9	1.1	2.4	16.0	4.4	3.7	4.4	0.3	1.7	2.6	6.3	3.2	1.7	2.3	0.0	0.4	2.3	12.8	1.7	2.5	3.0	4.1	1.1	0.6	3.4	5.2	1.7	8.6	0.0	2.1	1.1	8.1	3.0	0.4	2.9	0.4	2.2	2.7	1.4	0.0	1.9	2.0	3.8	2.7	0.2	1.2	2.1	1.1	9.3	8.7	18.1	10.8	4.5	3.9	2.5	4.7	3.5	4.8
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol				Cytosol		"HPA035437: AB_10672092, HPA046721: "																		14.2	14.3	16.7	14.6	10.6	20.7	17.2	13.0	16.9	13.4	11.0	12.8	17.5	10.3	8.1	14.9	16.6	14.5	12.3	9.8	14.4	14.2	11.6	12.7	12.5	26.2	14.6	17.4	7.3	13.0	6.8	31.2	11.6	11.2	15.4	9.3	10.8	32.2	19.3	10.8	22.9	10.9	8.2	12.6	25.5	12.4	4.6	10.1	18.5	7.4	18.3	21.7	13.3	10.6	24.9	35.5	23.3	41.8	8.6	13.1	20.1	8.0	7.4	6.2	4.4	7.7	7.9	0.0	2.6	13.1	22.0	31.0	0.1	9.6	9.5	5.4	11.1	9.4	0.4	11.8	3.1	8.0	0.7	5.5	26.6	0.4	9.7	5.0	3.9	6.9	1.1	11.1	4.4	9.3	0.0	14.6	9.3	0.1	7.0	3.6	0.0	4.6	5.8	1.6	18.6	5.8	1.6	0.0	3.7	9.6	13.0	6.3	0.4	8.4	9.8	4.1	3.9	8.7	6.1	11.8	6.8	4.0	9.1	10.7	3.3	2.1	41.8	3.0	9.8	32.5	5.6	24.6	13.1	9.4	35.5	24.9	12.4	10.3	23.3	8.6	24.3	28.0	11.6	20.1	16.7	10.6	13.0	16.9	14.4	14.2	14.6	17.4	11.2	10.1
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	"Tribbles pseudokinase 3"	Q96RU7	20	362835-397559	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 39.0;salivary gland: 47.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 87.0;hTCEpi: 53.9;hTERT-HME1: 62.7;SK-MEL-30: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA015272: AB_1858269, HPA055442: "	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (1.70e-4)"	"prognostic unfavourable (6.75e-5)"	"unprognostic (1.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.07e-13)"	"unprognostic (7.62e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.05e-3)"	4.8	8.7	1.6	2.8	1.5	9.7	6.0	3.8	4.2	2.5	1.8	1.2	3.6	1.0	2.1	3.1	9.8	1.1	2.7	3.0	1.4	2.0	3.3	39.0	8.2	7.3	1.0	2.4	4.4	13.8	2.0	10.5	6.2	1.6	3.9	1.6	3.7	47.5	5.3	1.5	6.5	2.5	1.3	0.7	7.9	4.4	2.7	0.6	6.7	27.2	4.1	7.0	2.7	5.3	15.5	4.7	3.3	4.4	6.6	11.4	5.1	10.9	5.5	0.7	1.6	1.9	2.5	4.7	3.2	8.7	3.1	6.5	11.5	5.4	4.7	3.2	2.9	8.8	3.0	14.6	2.9	1.7	2.1	3.6	1.2	18.7	87.0	9.2	1.8	10.1	53.9	5.8	62.7	6.0	12.6	21.3	0.3	10.1	0.5	11.2	1.6	18.1	2.1	0.9	10.1	3.6	4.4	2.0	3.2	0.7	26.5	79.1	7.7	24.5	3.4	1.7	2.9	0.0	5.0	7.4	9.5	8.4	1.4	8.1	6.0	2.5	4.4	1.0	10.0	3.4	7.1	15.5	9.3	11.4	4.7	10.2	10.7	7.6	3.3	6.6	1.7	2.1	6.4	5.1	1.6	1.5	3.8	4.2	1.4	2.0	1.0	2.4	1.6	0.6
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: "	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	8.8	9.2	8.9	13.8	16.5	33.2	23.8	45.2	11.5	8.7	11.2	6.4	15.1	10.1	8.7	10.6	13.3	9.4	13.9	6.9	9.2	8.5	7.7	7.1	27.5	18.6	9.0	8.0	9.0	11.9	8.5	7.2	9.4	7.1	10.5	9.7	6.0	14.4	18.2	5.0	12.5	11.8	8.6	6.0	16.5	12.6	9.5	7.8	20.0	9.0	9.7	13.1	9.5	24.3	6.4	6.9	10.0	11.4	9.4	11.8	5.4	13.8	13.2	7.1	9.7	5.3	4.4	33.5	9.1	6.1	10.6	8.5	16.0	12.1	10.4	10.2	6.1	22.6	8.5	8.7	4.5	11.6	20.5	8.6	12.2	8.6	14.5	10.9	13.2	5.9	14.0	10.9	5.5	5.2	19.7	13.5	5.4	9.0	13.1	17.2	18.1	11.7	12.9	6.4	12.6	6.9	17.0	11.8	21.7	7.6	21.6	12.0	15.2	18.2	5.8	6.7	9.5	15.7	18.8	13.9	9.2	9.2	8.4	8.7	10.6	6.1	6.9	8.3	9.6	8.2	10.2	5.8	10.7	11.8	6.9	6.4	6.3	8.4	10.0	9.4	11.4	5.5	9.8	5.4	8.9	16.5	45.2	11.5	9.2	8.5	9.0	8.0	7.1	7.8
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 52.9"	"Cell line enhanced"	"Detected in many"		"A549: 64.1;HaCaT: 51.8;HeLa: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"T-reg: 25.1"	"Lineage enriched"	"Detected in many"	11	"T-cells: 25.1"									"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: "	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (6.71e-4)"	6.1	13.5	7.4	4.8	12.8	7.0	6.7	7.4	11.7	16.0	5.0	7.8	6.6	10.2	7.0	2.8	52.9	4.0	7.5	6.5	8.0	4.4	5.7	2.2	6.2	10.9	11.3	5.6	3.7	6.2	1.9	5.7	15.8	9.8	4.1	5.2	5.0	14.7	5.7	11.4	15.6	5.5	5.4	5.9	4.6	14.4	5.5	7.8	4.7	7.4	5.3	16.3	11.7	23.3	0.4	1.5	0.6	2.3	0.5	25.1	1.3	20.1	64.1	2.0	4.4	9.5	11.0	2.1	3.3	11.8	4.1	5.8	3.8	26.3	2.1	12.7	14.5	51.8	5.8	14.9	2.8	26.6	3.7	1.0	46.7	2.0	15.9	1.1	2.2	6.0	9.4	9.0	5.2	8.8	1.2	10.5	11.2	7.1	4.4	2.6	3.0	3.9	1.9	16.6	1.5	21.3	26.1	1.4	4.1	14.6	16.6	5.0	2.5	2.8	13.7	5.2	6.2	2.5	11.4	2.5	2.7	0.2	8.1	2.8	13.2	0.1	2.3	0.6	0.8	0.6	0.5	0.3	3.0	0.9	1.5	0.4	0.8	1.6	0.5	0.5	0.3	0.3	25.1	1.3	7.4	12.8	7.4	11.7	8.0	4.4	11.3	5.6	9.8	7.8
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689689-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.3;BJ hTERT+ SV40 Large T+ RasG12V: 47.9;HSkMC: 42.0;TIME: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"	34.3	6.9	8.8	32.8	13.3	22.2	17.3	3.2	10.3	14.4	12.2	10.6	15.1	6.5	20.0	18.9	17.6	17.2	20.2	12.4	10.3	6.6	13.9	19.3	29.8	62.2	15.5	6.5	21.9	5.6	2.1	8.1	9.4	13.3	20.4	13.7	15.0	17.2	14.6	7.1	7.8	28.7	13.5	22.9	65.4	11.2	6.3	12.0	35.6	15.5	13.4	40.6	19.8	13.5	49.0	55.2	33.0	50.3	18.0	58.1	47.3	0.8	0.2	3.4	0.6	18.5	37.3	1.0	10.9	19.1	20.8	47.9	0.3	2.2	23.0	3.3	15.4	2.3	7.6	11.4	2.0	0.5	0.0	1.3	1.2	0.4	24.3	3.5	2.2	42.0	10.8	4.1	1.9	25.6	0.5	1.2	22.6	0.4	12.0	3.6	9.8	1.2	14.9	0.8	0.5	10.9	3.5	0.4	0.8	1.0	1.0	0.4	1.2	3.9	33.4	12.9	7.0	0.6	0.6	1.3	1.1	2.5	16.2	6.4	1.7	27.4	35.7	23.8	35.8	43.5	47.0	46.5	39.0	37.8	42.8	49.0	35.2	33.7	33.0	18.0	50.3	55.2	58.1	47.3	8.8	13.3	3.2	10.3	10.3	6.6	15.5	6.5	13.3	12.0
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460334-138589993	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 42.7;HMC-1: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (9.94e-4)"	"prognostic favourable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	10.3	31.4	10.4	11.2	10.6	8.8	8.8	8.5	10.7	9.4	9.2	14.6	5.7	9.4	9.0	8.5	11.3	7.0	10.3	9.7	8.4	8.5	9.6	21.5	10.7	8.5	10.5	8.0	29.9	11.6	20.7	7.3	13.5	8.4	13.6	9.1	7.5	10.1	7.1	16.0	9.8	14.1	9.4	8.0	8.5	10.8	24.1	11.3	34.8	8.8	9.2	8.9	11.3	11.2	1.3	1.9	3.7	2.5	2.2	2.7	0.8	4.1	5.1	42.7	12.3	2.9	2.6	3.3	3.9	4.1	3.0	3.0	8.1	3.9	8.0	3.9	3.7	2.2	20.7	3.2	4.5	6.1	5.1	17.7	3.8	24.9	3.9	13.7	57.8	2.3	3.4	2.5	4.1	7.2	20.0	4.9	3.6	8.1	23.4	12.5	16.3	4.6	18.6	5.0	6.8	6.8	12.5	8.9	20.2	7.3	6.5	2.1	4.5	9.1	3.0	3.5	2.9	6.2	5.3	4.6	4.9	13.7	5.9	9.1	5.2	1.1	2.3	3.6	2.2	2.5	0.4	0.9	1.9	1.2	1.9	1.3	1.8	2.0	3.7	2.2	1.1	1.4	2.7	0.8	10.4	10.6	8.5	9.7	8.4	8.5	10.5	8.0	8.4	11.3
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044975: , HPA050456: "	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favourable (3.25e-5)"	11.9	12.6	10.6	20.0	12.2	13.8	13.2	17.6	14.9	10.7	16.1	15.9	14.5	18.5	12.9	18.4	21.5	21.1	18.6	8.4	10.8	11.3	19.5	19.2	12.2	21.3	13.1	8.1	10.9	15.3	16.3	11.5	10.8	12.3	13.4	9.8	17.7	18.4	20.6	9.9	21.5	21.9	14.2	13.1	17.6	15.2	10.9	14.0	13.7	15.8	10.7	21.7	14.7	24.6	3.6	3.8	1.7	4.2	2.1	4.1	3.6	10.2	2.2	0.0	14.5	4.8	2.8	4.7	2.8	3.3	7.2	7.2	0.0	0.4	22.9	8.2	7.1	11.7	0.0	10.0	2.3	0.0	6.7	3.5	1.6	8.3	4.5	4.5	2.9	3.0	3.5	7.3	4.6	4.5	1.6	0.0	0.0	0.0	7.5	11.1	0.0	3.9	9.9	6.9	3.3	6.0	9.6	0.4	6.2	10.5	4.6	2.9	3.6	1.5	7.5	5.6	3.9	0.0	0.1	9.2	16.4	12.1	0.0	13.0	8.9	1.7	3.1	0.5	3.9	4.2	3.2	3.2	2.9	3.8	3.8	3.6	1.8	2.7	1.7	2.1	2.6	1.9	4.1	3.6	10.6	12.2	17.6	14.9	10.8	11.3	13.1	8.1	12.3	14.0
TRIM28	"KAP1, PPP1R157, RNF96, TF1B, TIF1B"	ENSG00000130726	"Tripartite motif containing 28"	Q13263	19	58544091-58550722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 217.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010066, HPA064033"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"		140000	Nucleoplasm		"CAB010066: AB_2209905, HPA064033: "	"unprognostic (2.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (1.85e-6)"	"unprognostic (1.20e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.28e-2)"	24.2	26.4	17.9	40.1	20.6	52.2	30.6	34.5	26.3	46.7	36.5	26.2	26.2	26.8	43.3	30.0	34.1	34.5	38.5	28.4	18.5	16.4	27.3	42.3	29.5	38.1	29.2	22.7	69.3	47.0	30.7	25.7	45.6	22.8	37.6	18.5	21.5	31.8	32.4	56.5	41.2	27.5	38.4	17.9	34.9	32.9	48.1	23.1	119.9	50.6	33.5	33.5	34.0	46.4	13.7	14.6	5.0	7.6	16.0	16.9	6.3	35.8	77.2	41.5	30.6	18.1	13.9	46.3	23.6	21.4	23.0	17.6	53.8	30.2	39.5	15.6	20.3	24.6	46.9	33.9	15.1	20.2	217.0	67.9	35.0	42.7	19.3	43.0	43.7	18.8	18.9	29.4	23.1	21.5	33.0	22.3	21.2	53.1	60.1	53.1	29.1	49.8	57.1	25.1	42.4	20.6	59.6	41.6	32.6	24.6	32.0	13.1	22.0	41.9	19.8	54.2	21.5	11.8	42.2	28.7	46.8	44.1	24.5	32.2	34.3	1.3	7.1	5.0	8.9	7.6	11.6	11.5	12.8	12.3	9.0	13.7	16.9	15.1	3.8	16.0	4.9	14.6	8.2	6.3	17.9	20.6	34.5	26.3	18.5	16.4	29.2	22.7	22.8	23.1
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111275-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 53.0;hTCEpi: 70.5;RT4: 27.9;SiHa: 39.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Region enriched"	"Detected in single"	8	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020053	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"				"Nucleoplasm, Intermediate filaments"		"HPA020053: AB_1858280"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favourable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	0.3	0.2	0.1	0.0	0.1	0.1	7.3	0.0	0.1	30.4	0.6	0.2	1.6	0.3	3.1	2.9	176.3	3.7	0.8	0.1	0.1	0.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.2	0.0	2.2	24.4	1.1	11.1	0.5	0.0	25.5	4.8	0.9	90.1	0.2	1.6	0.3	0.0	0.2	0.7	0.0	7.5	0.1	113.6	93.6	9.6	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.3	0.0	0.8	0.0	53.0	0.0	12.1	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	70.5	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.2	0.9	39.6	5.6	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0
TRIM39	RNF23	ENSG00000204599	"Tripartite motif containing 39"	Q9HCM9	6	30326479-30343729	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051120, HPA059496"	Uncertain		Supported	Cytosol				Cytosol		"HPA051120: , HPA059496: "	"unprognostic (2.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.38e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.39e-3)"	8.6	7.6	5.2	14.3	6.4	11.8	7.4	8.6	7.6	10.2	11.2	7.3	9.7	7.1	10.0	15.2	11.9	8.5	13.6	6.1	5.4	5.5	7.6	9.6	11.1	6.7	7.7	6.3	10.3	9.1	8.9	11.4	11.6	7.1	7.9	7.1	11.4	8.2	15.5	9.9	6.5	10.9	8.8	6.0	13.1	8.0	14.1	7.2	7.8	8.9	8.3	10.1	9.1	12.3	3.4	1.6	8.4	2.5	4.4	5.2	2.1	4.4	0.2	3.8	6.8	1.8	1.8	3.9	2.0	2.5	3.0	2.7	5.3	0.6	5.6	4.1	3.8	1.4	4.4	3.1	3.1	4.4	4.8	4.5	0.7	1.9	3.9	6.6	5.0	2.1	2.6	3.8	4.2	1.9	6.6	4.5	3.9	4.0	1.4	1.4	5.1	3.2	3.1	0.8	4.2	3.3	4.3	8.3	4.1	1.6	3.3	3.9	4.4	1.7	1.7	3.3	2.7	4.0	6.8	8.2	10.0	5.8	2.0	2.4	5.1	1.4	1.7	6.8	5.2	2.5	4.6	3.4	3.7	3.8	1.6	3.3	4.4	4.1	8.4	4.4	2.4	1.2	2.9	2.1	5.2	6.4	8.6	7.6	5.4	5.5	7.7	6.3	7.1	7.2
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919600	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	19.1	22.6	13.5	22.1	15.9	6.7	22.1	20.1	15.5	19.5	17.3	12.4	22.5	13.9	21.9	18.8	16.4	19.0	19.8	11.1	13.3	9.3	16.6	17.9	21.1	22.4	15.3	8.8	35.0	23.2	18.9	27.4	16.1	12.2	21.9	15.7	18.4	19.4	33.8	9.4	20.7	18.3	18.1	11.9	18.2	17.4	16.2	14.5	18.4	20.5	11.9	18.8	20.0	28.9	18.6	17.0	20.0	19.2	13.9	30.3	17.4	9.5	11.5	6.9	5.7	18.1	17.0	3.1	16.1	19.7	13.5	15.7	6.1	9.5	14.0	0.1	13.7	11.4	9.1	9.9	13.8	14.2	0.7	11.4	6.1	9.6	25.6	16.4	16.3	18.1	21.2	10.5	26.6	11.8	16.6	21.6	11.2	11.9	12.1	14.8	5.2	9.9	6.9	9.8	15.9	14.9	12.4	8.1	5.7	12.3	18.9	19.2	8.7	9.5	14.3	15.0	13.4	28.6	15.5	18.2	19.9	11.3	9.8	18.5	19.8	20.0	19.2	15.3	20.6	19.2	23.8	18.6	21.6	23.5	17.0	18.6	30.3	22.2	8.2	13.9	16.6	12.7	21.5	17.4	13.5	15.9	20.1	15.5	13.3	9.3	15.3	8.8	12.2	14.5
TRIM41	"MGC1127, RINCK"	ENSG00000146063	"Tripartite motif containing 41"	Q8WV44	5	181222499-181235809	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024204	Approved		Supported	"Nucleoli,Nuclear bodies"				"Nucleoli, Nuclear bodies"		"HPA024204: AB_1858299"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.56e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (2.68e-2)"	10.0	8.3	25.5	9.4	24.3	9.3	5.4	7.3	17.0	6.9	6.5	19.8	8.8	11.2	6.1	8.3	7.3	8.4	7.0	9.8	26.9	20.4	10.7	7.6	6.9	6.0	37.3	12.5	5.9	12.3	18.8	7.6	7.3	17.0	7.0	4.0	7.8	8.3	8.4	30.0	9.0	9.0	5.3	43.7	7.5	9.5	19.1	18.3	10.6	11.3	7.2	7.2	5.8	5.2	2.2	2.4	3.9	2.3	1.9	4.3	1.4	4.6	12.1	4.5	7.5	5.4	5.4	10.6	6.8	3.7	5.0	4.7	10.2	7.0	7.8	11.1	4.6	8.8	4.7	16.3	2.7	38.5	14.9	8.9	11.9	5.8	5.2	6.5	6.1	4.7	8.4	6.2	2.2	2.8	11.1	9.7	2.8	16.6	9.8	7.3	4.2	5.8	9.3	6.9	10.2	2.9	7.4	7.0	6.6	6.3	7.4	9.5	14.8	7.4	5.9	6.9	4.7	4.1	5.1	21.4	13.5	11.1	7.2	7.7	5.8	0.9	1.4	2.2	2.4	1.1	3.6	1.9	2.5	4.3	1.6	2.2	2.6	3.1	3.9	1.9	2.3	2.4	3.2	1.4	25.5	24.3	7.3	17.0	26.9	20.4	37.3	12.5	17.0	18.3
TRIM45	"FLJ13181, RNF99"	ENSG00000134253	"Tripartite motif containing 45"	Q9H8W5	1	117111060-117122587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030266, HPA054308"	Uncertain		Supported	"Cytokinetic bridge,Cytosol"				Cytosol	"Cytokinetic bridge"	"HPA030266: AB_10795476, HPA054308: "	"prognostic favourable (1.58e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (1.27e-2)"	2.3	5.4	6.3	1.4	3.6	1.9	4.9	2.4	7.2	3.4	4.5	5.8	8.0	3.8	9.0	8.0	3.3	9.4	9.3	12.4	3.9	2.6	3.8	1.1	2.6	0.9	2.6	7.5	8.5	8.9	7.3	8.8	9.4	4.5	8.3	2.3	6.0	3.4	7.4	26.6	5.9	3.1	13.3	3.4	2.4	6.1	5.4	4.1	0.7	9.9	9.0	2.1	6.3	4.5	0.4	0.7	0.6	0.4	2.8	2.2	0.0	3.2	2.9	12.1	5.7	1.0	2.8	9.2	3.6	1.5	2.5	2.5	1.3	2.9	0.1	2.7	1.7	2.9	2.8	2.9	3.4	1.8	2.9	1.9	8.9	1.5	1.8	1.7	2.8	3.6	2.9	4.2	3.0	3.1	2.3	2.4	2.3	13.9	1.0	2.1	6.5	2.6	4.6	23.9	0.7	3.4	2.9	9.2	2.3	2.9	2.7	2.2	4.7	2.3	1.0	3.5	5.1	2.1	3.1	6.7	2.5	0.2	4.6	1.6	8.9	0.6	0.4	0.2	0.3	0.2	0.2	0.3	0.3	0.1	0.7	0.4	0.2	0.2	0.5	2.8	0.1	0.3	2.2	0.0	6.3	3.6	2.4	7.2	3.9	2.6	2.6	7.5	4.5	4.1
TRIM47	"GOA, RNF100"	ENSG00000132481	"Tripartite motif containing 47"	Q96LD4	17	75874161-75878575	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 23.3;RPTEC TERT1: 17.6;U-266/70: 20.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014933	Uncertain		Supported	Cytosol				Cytosol		"HPA014933: AB_10603219"	"prognostic favourable (6.54e-4)"	"unprognostic (8.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (5.59e-5)"	"unprognostic (2.08e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (9.69e-5)"	"unprognostic (3.94e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.98e-2)"	18.8	5.2	11.2	11.6	14.3	1.3	51.5	5.9	26.9	12.5	14.9	10.4	2.6	16.0	16.1	9.5	15.3	9.0	15.9	11.3	11.3	8.5	17.6	8.8	11.2	15.4	14.9	9.4	11.6	18.4	14.5	4.6	5.3	12.4	11.0	9.0	6.2	13.4	9.8	9.3	16.3	9.4	19.9	11.3	15.6	19.7	7.5	13.2	2.6	6.5	13.3	8.1	20.7	13.5	3.5	1.7	1.8	0.0	2.9	7.2	0.7	10.0	7.5	0.0	0.0	1.7	1.8	0.2	0.4	0.8	0.6	0.5	1.4	5.2	0.0	6.6	0.3	11.5	1.8	2.8	0.0	6.5	4.7	0.0	5.1	13.7	2.8	0.0	0.0	1.4	0.8	1.2	1.0	5.2	1.0	15.5	0.3	1.7	0.9	0.1	0.8	14.7	0.7	0.8	23.3	17.6	0.3	3.0	0.2	3.0	14.8	3.9	1.7	0.3	7.8	9.3	5.8	0.9	3.5	20.1	5.7	1.1	4.1	0.0	0.8	0.0	0.0	1.8	2.6	0.0	6.8	3.5	6.0	3.3	0.2	2.0	4.0	2.5	0.0	2.9	0.0	1.7	7.2	0.7	11.2	14.3	5.9	12.8	11.3	8.5	14.9	9.4	12.4	13.2
TRIM5	"RNF88, TRIM5alpha"	ENSG00000132256	"Tripartite motif containing 5"	Q9C035	11	5663557-5938619	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"CAB013497, HPA023420, HPA023422"	Approved		Supported	Cytosol				Cytosol		"CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379"	"unprognostic (2.60e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.48e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.12e-2)"	12.5	15.0	3.7	11.6	6.7	3.0	10.7	2.4	5.1	14.2	8.5	4.8	20.1	8.4	16.1	19.9	12.0	11.9	9.9	7.8	5.6	2.9	15.1	16.2	15.2	9.2	6.5	2.9	15.3	24.8	6.1	9.2	12.2	8.8	11.8	8.3	11.8	22.0	12.4	3.0	6.5	13.2	12.0	9.0	19.8	9.5	7.7	6.5	24.9	20.5	7.9	13.3	14.8	12.3	3.9	11.7	13.8	9.8	5.9	5.4	4.6	4.6	7.2	12.3	8.6	13.7	12.6	3.6	9.9	18.6	20.3	27.5	7.3	9.3	3.0	7.8	9.7	7.6	10.0	14.5	9.2	6.4	2.7	9.0	5.0	5.8	12.2	6.6	9.7	9.5	13.0	6.7	17.8	31.3	9.4	6.1	17.0	2.1	5.4	3.0	5.6	5.1	8.4	2.6	0.8	14.1	8.9	0.3	0.7	7.0	10.1	4.4	5.2	3.8	23.6	9.6	12.7	1.8	2.4	5.5	3.8	1.2	8.9	4.4	9.8	10.2	9.8	12.9	5.4	9.8	5.3	3.9	4.1	4.3	11.7	3.9	3.4	4.9	13.8	5.9	9.2	9.7	3.3	4.6	3.7	6.7	2.4	5.1	5.6	2.9	6.5	2.9	8.8	6.5
TRIM65		ENSG00000141569	"Tripartite motif containing 65"	Q6PJ69	17	75880335-75897003	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021575, HPA021578, HPA064820"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: "	"unprognostic (1.82e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (4.74e-6)"	"unprognostic (5.36e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.00e-3)"	"prognostic unfavourable (1.82e-5)"	"unprognostic (2.86e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-3)"	"unprognostic (7.50e-3)"	15.5	8.2	12.8	12.1	20.0	10.8	13.6	26.7	16.6	15.7	12.7	17.6	11.9	13.9	15.7	9.3	14.0	14.4	12.9	11.0	16.5	12.3	11.3	8.2	13.3	14.6	22.4	8.1	17.7	15.7	14.9	12.7	8.1	16.1	12.4	12.0	15.8	14.7	15.2	16.5	21.6	12.8	13.0	11.4	17.2	12.7	5.4	21.3	11.7	13.1	11.0	14.8	12.7	15.4	5.3	3.4	4.4	3.0	5.2	5.9	1.6	13.4	14.7	5.3	14.8	9.7	13.5	2.6	5.5	7.2	9.2	6.8	5.2	11.6	14.6	4.0	5.8	9.4	11.0	12.2	4.0	6.5	19.7	11.7	13.4	7.8	10.3	12.3	12.6	9.7	9.8	6.2	9.9	20.3	18.0	14.6	5.6	14.5	22.3	19.9	12.1	12.2	20.9	7.1	22.9	6.8	5.1	11.8	11.3	8.7	13.2	14.5	15.7	15.0	10.9	19.4	8.9	8.6	10.1	12.3	4.5	3.8	12.3	20.0	8.2	2.8	3.0	4.4	5.2	2.7	5.9	4.1	3.9	5.3	2.7	5.3	4.3	4.2	3.1	5.2	1.5	3.4	3.5	1.6	12.8	20.0	26.7	16.6	16.5	12.3	22.4	8.1	16.1	21.3
TRIM66	"C11orf29, KIAA0298, TIF1D"	ENSG00000166436	"Tripartite motif containing 66"	O15016	11	8612037-8682694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027420	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA027420: AB_1858316"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.79e-2)"	"prognostic favourable (8.89e-4)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (3.96e-4)"	"unprognostic (1.67e-1)"	"unprognostic (4.26e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.31e-1)"	5.6	8.0	4.1	7.0	12.1	4.5	8.3	10.5	11.3	4.9	6.0	12.5	13.2	6.1	9.9	19.4	6.7	5.7	6.1	3.2	4.4	5.2	5.6	12.9	4.8	8.6	3.5	5.8	5.5	11.3	7.8	17.3	4.1	8.3	5.6	8.3	9.3	5.7	11.3	5.7	19.9	6.9	6.3	5.3	7.7	6.4	19.8	3.7	8.8	9.2	4.5	12.3	5.9	5.3	2.5	3.8	0.9	3.5	1.9	3.3	0.7	6.1	5.7	3.4	12.3	7.5	5.7	4.3	3.8	4.3	2.7	3.5	7.2	11.8	6.1	2.6	3.3	8.2	3.7	3.3	3.3	7.0	2.9	5.7	9.0	4.0	3.1	4.7	4.8	8.9	3.4	2.3	7.9	3.5	3.1	6.4	3.5	6.8	2.5	4.0	1.8	5.2	3.5	2.6	2.5	3.9	7.5	2.5	2.4	5.5	3.9	2.6	5.1	1.1	2.8	5.2	4.8	2.9	3.3	2.8	4.1	7.7	3.5	5.5	2.9	0.1	1.4	0.9	1.9	0.4	1.2	1.5	2.1	2.5	2.0	2.5	1.9	3.3	0.7	1.9	3.5	3.8	1.4	0.7	4.1	12.1	10.5	11.3	4.4	5.2	3.5	5.8	8.3	3.7
TRIM68	"FLJ10369, RNF137, SS-56"	ENSG00000167333	"Tripartite motif containing 68"	Q6AZZ1	11	4598672-4608259	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023455	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023455: AB_1858319"	"unprognostic (4.77e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.78e-2)"	"prognostic favourable (4.14e-6)"	"unprognostic (4.23e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"	7.7	11.3	11.1	8.0	11.1	3.1	10.6	15.2	12.8	16.3	10.9	12.6	18.2	10.3	10.6	12.2	8.0	12.6	10.3	9.4	9.6	7.9	14.9	12.7	11.7	7.6	13.1	10.5	17.3	9.9	12.6	10.5	9.8	10.0	16.8	10.1	9.9	12.0	17.5	8.7	7.6	9.8	9.8	11.9	10.7	12.4	13.2	9.5	10.0	17.8	6.7	8.9	11.7	8.4	9.1	5.9	8.9	5.2	5.5	12.8	7.6	8.3	9.3	3.9	6.3	6.3	10.3	0.0	9.2	6.7	8.3	7.6	1.2	8.6	5.7	5.6	4.6	9.8	3.8	6.4	7.2	14.1	7.4	6.9	2.4	0.0	7.3	11.1	9.8	7.9	9.4	4.9	7.4	10.5	6.4	3.0	7.4	2.0	9.1	3.0	4.5	7.7	7.3	5.5	0.2	5.4	3.7	2.0	3.7	0.0	9.3	5.8	4.0	5.6	8.4	11.2	7.7	11.2	4.0	11.7	12.6	8.3	7.7	4.9	10.5	6.4	2.7	8.9	9.0	5.1	10.1	9.1	9.9	10.0	5.9	7.9	12.8	10.1	0.3	5.5	5.2	4.0	8.7	7.6	11.1	11.1	15.2	12.8	9.6	7.9	13.1	10.5	10.0	9.5
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102642310-102660680	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	31.7	18.4	26.1	23.9	25.2	17.0	18.0	26.1	31.6	31.8	19.5	22.9	15.4	15.8	18.0	14.3	17.8	21.6	19.8	25.0	23.2	18.0	27.2	21.9	23.0	25.4	20.1	20.0	19.3	35.9	24.7	14.7	17.5	16.3	17.4	8.1	19.4	28.5	18.5	34.8	14.6	23.7	13.6	15.7	22.5	21.2	11.7	21.9	48.3	26.6	14.5	30.3	21.4	15.9	9.0	11.9	17.8	5.3	5.5	7.2	3.9	27.6	6.5	6.4	10.5	7.1	14.4	6.0	9.9	20.2	10.8	8.7	11.7	33.4	8.9	26.7	22.0	10.2	4.3	13.3	8.9	9.0	8.4	22.5	5.4	26.7	18.1	5.0	9.0	16.5	7.4	23.7	14.0	14.3	4.2	13.4	8.4	18.0	9.5	16.9	3.5	13.2	4.8	14.4	4.4	12.8	19.5	3.9	7.6	5.5	6.8	13.1	19.2	10.0	26.6	14.5	6.5	8.1	22.2	12.3	8.0	5.2	22.1	12.6	3.6	10.7	4.8	2.6	6.8	4.4	6.7	9.0	7.2	5.3	4.1	7.0	6.4	5.5	17.8	5.5	5.3	11.9	6.9	3.9	26.1	25.2	26.1	31.6	23.2	18.0	20.1	20.0	16.3	21.9
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751526	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 19.4"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles			15000	Vesicles	Nucleoplasm	"HPA041934: , HPA072625: , HPA073886: "	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favourable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	19.7	10.7	6.0	9.2	7.2	2.3	16.8	3.7	5.4	25.6	19.1	4.5	20.6	9.7	17.8	16.7	44.8	12.0	17.6	18.1	6.5	1.9	14.0	4.5	19.5	5.4	6.7	3.5	22.4	12.9	7.0	4.8	25.4	7.0	19.2	6.6	20.2	16.1	18.3	103.7	10.4	10.1	20.9	6.7	7.1	11.3	8.7	5.4	2.8	31.7	21.6	21.7	24.3	26.5	1.5	19.4	0.1	0.7	1.6	0.9	0.4	26.6	16.2	5.7	8.6	22.4	23.5	20.5	17.2	19.9	19.7	17.3	21.9	15.4	0.5	23.4	14.5	19.9	12.8	25.1	11.8	16.8	5.1	8.7	15.3	16.7	18.4	0.4	2.7	27.1	17.1	17.5	13.5	20.2	12.7	7.3	14.4	9.0	2.3	6.0	12.1	13.8	3.9	11.7	7.8	16.6	13.3	0.0	6.6	22.7	10.2	6.4	10.7	4.7	39.4	13.3	23.9	34.7	18.1	7.7	4.2	2.6	21.5	2.5	8.7	0.0	0.7	0.0	0.5	0.1	0.7	1.2	0.2	0.9	3.8	1.5	0.3	0.2	0.1	1.6	0.1	19.4	0.0	0.4	6.0	7.2	3.7	5.4	6.5	1.9	6.7	3.5	7.0	5.4
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: "	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	13.0	15.0	10.5	10.8	12.5	7.7	12.1	18.5	14.1	17.4	13.0	8.8	15.2	11.1	13.3	12.7	14.7	11.4	11.2	12.9	9.2	6.7	15.5	16.1	10.6	9.4	12.2	11.1	16.0	27.1	27.1	34.9	24.4	15.2	14.5	11.0	9.4	15.1	15.3	24.0	12.4	15.9	11.2	10.7	15.2	16.2	14.0	13.5	16.4	18.4	11.1	11.9	15.8	12.5	20.0	12.7	17.0	13.0	12.1	14.1	3.9	12.4	12.6	8.2	8.6	14.5	22.5	12.5	19.8	15.2	9.8	11.3	7.6	20.3	8.7	14.6	17.4	16.4	10.8	9.6	21.5	13.2	3.3	9.8	11.4	7.2	11.1	11.5	9.8	8.6	11.8	17.3	14.9	15.6	6.4	10.1	15.3	17.4	6.5	2.8	3.7	9.0	8.1	15.7	4.3	8.8	20.4	6.0	5.4	16.0	9.4	6.1	20.5	5.8	20.6	11.4	8.1	11.9	8.9	9.0	13.8	7.8	13.4	6.5	14.3	8.2	8.8	17.0	13.3	8.0	12.8	11.8	14.1	12.1	6.9	20.0	13.5	14.1	8.7	12.1	13.0	12.7	12.2	3.9	10.5	12.5	18.5	14.1	9.2	6.7	12.2	11.1	15.2	13.5
TRIP4	"HsT17391, ZC2HC5"	ENSG00000103671	"Thyroid hormone receptor interactor 4"	Q15650	15	64387748-64455303	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016605, HPA050666"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA016605: AB_1858339, HPA050666: "	"unprognostic (1.56e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-2)"	"prognostic favourable (6.34e-6)"	"unprognostic (2.41e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.25e-1)"	17.1	14.7	14.2	18.8	15.1	13.7	18.3	15.9	19.6	14.3	20.8	16.6	23.5	17.5	17.1	14.6	22.6	15.3	15.6	15.5	12.4	11.2	28.5	15.8	15.3	15.0	17.1	14.6	15.9	19.9	22.9	19.6	19.3	15.3	15.7	20.4	12.7	16.5	13.6	14.6	20.6	26.2	17.3	15.7	20.0	17.4	15.0	14.4	28.0	27.1	17.4	18.6	16.8	17.5	8.6	10.4	30.9	19.7	9.7	11.5	8.3	10.8	16.2	14.3	10.1	11.8	15.6	13.4	11.6	15.0	20.1	19.6	13.5	24.5	7.8	3.9	17.6	15.5	23.1	13.2	19.2	15.8	6.5	11.4	11.6	14.1	21.1	12.3	21.7	19.4	17.4	15.9	16.7	17.5	13.1	9.9	18.4	12.5	7.7	12.8	8.3	8.7	11.9	10.8	13.0	19.7	20.9	7.7	12.2	10.4	12.6	20.9	15.9	18.5	15.4	14.4	9.8	9.5	16.3	8.3	14.8	7.8	11.9	12.7	17.9	30.9	11.4	26.6	11.3	14.6	9.6	8.4	10.8	11.4	10.4	8.6	9.2	9.7	16.1	9.7	19.7	8.2	11.5	8.3	14.2	15.1	15.9	19.6	12.4	11.2	17.1	14.6	15.3	14.4
TRIP6	"MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1"	ENSG00000087077	"Thyroid hormone receptor interactor 6"	Q15654	7	100867138-100873454	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046454, CAB046460, HPA052813"	Approved		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"			12000	"Plasma membrane, Focal adhesion sites, Cytosol"		"CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: "	"unprognostic (7.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	15.5	14.7	10.9	16.2	11.2	6.0	18.1	4.2	7.3	36.7	14.6	9.4	22.5	4.4	28.2	30.8	27.2	18.5	43.5	14.5	8.7	7.7	21.6	24.1	18.4	5.8	11.7	9.4	22.0	19.2	28.0	6.5	13.6	9.7	22.1	3.9	22.7	23.0	38.2	8.3	23.9	6.5	25.5	9.7	7.9	9.9	17.5	7.8	7.3	26.6	30.6	12.6	25.0	23.6	3.1	7.7	0.2	4.7	0.0	1.7	0.5	26.6	11.0	5.7	27.3	8.6	10.1	28.7	16.6	17.8	22.8	21.4	10.4	30.7	1.1	17.6	18.7	19.9	8.4	32.1	5.9	3.8	11.4	0.1	18.3	0.1	22.8	12.8	1.5	18.2	21.1	15.2	23.9	11.7	16.7	0.2	19.7	46.8	0.2	20.2	19.7	9.8	10.0	5.7	2.7	14.1	6.6	2.1	0.3	13.9	42.1	16.5	4.5	16.4	17.9	33.6	31.7	36.4	38.8	0.2	0.4	0.1	20.9	1.6	50.5	0.0	1.9	0.2	0.2	3.0	0.6	3.1	1.5	1.3	3.1	2.5	1.7	0.7	0.2	0.0	4.7	7.7	1.3	0.5	10.9	11.2	4.2	7.3	8.7	7.7	11.7	9.4	9.7	7.8
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"				"Nucleoli, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA047601: , HPA058241: "	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.6	4.7	9.2	4.7	5.5	7.7	6.7	8.1	3.1	5.7	4.3	3.9	8.3	9.2	3.1	4.8	3.9	10.7	5.1	8.8	11.7	4.7	6.3	4.1	6.4	5.2	16.0	6.8	4.9	13.2	5.7	12.5	5.8	14.6	8.3	4.8	7.7	13.5	3.3	5.5	4.6	7.8	8.8	5.9	7.7	5.5	5.8	5.0	4.4	24.6	8.1	8.0	6.9	4.2	5.8	6.0	4.7	9.2	5.8	9.7	8.4	4.4	9.4	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561862-101566446	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavourable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	18.0	21.2	13.1	13.6	14.1	14.4	19.7	16.4	19.1	16.1	15.3	5.5	12.9	11.6	14.6	13.1	20.9	15.0	10.7	20.4	13.0	13.4	26.6	34.6	10.0	19.3	12.5	16.7	18.8	12.1	9.9	19.9	18.2	18.5	16.2	14.2	5.5	14.5	13.0	35.2	15.2	16.5	15.3	14.3	19.6	15.6	14.7	10.6	23.0	16.6	30.5	18.5	15.6	11.3	21.6	15.4	27.4	14.8	12.2	23.1	11.8	20.8	10.2	13.6	13.7	12.5	10.7	12.7	12.4	12.2	16.3	18.2	15.5	14.1	43.4	16.3	7.7	21.1	26.2	19.0	22.4	15.5	12.9	29.1	8.1	11.2	9.6	25.5	12.4	12.5	19.8	14.2	13.3	15.8	24.6	9.7	17.5	14.3	20.4	18.7	25.2	22.1	15.2	11.1	19.4	20.8	17.7	33.9	19.4	9.7	20.7	27.4	27.3	28.2	10.4	8.9	16.8	5.9	13.1	11.3	20.6	41.6	15.0	18.4	13.3	27.4	11.2	7.3	13.6	14.4	18.8	21.6	16.8	15.8	13.5	20.4	23.1	21.1	4.9	12.2	14.8	15.4	15.0	11.8	13.1	14.1	16.4	19.1	13.0	13.4	12.5	16.7	18.5	10.6
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937235-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA047032: , HPA050408: "	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	10.5	12.9	10.5	11.3	12.1	20.6	8.5	15.0	10.5	7.3	7.4	5.7	47.8	5.1	9.1	7.9	11.9	7.9	5.6	13.2	8.4	9.5	10.2	10.1	7.2	13.2	8.3	11.8	9.6	9.6	9.8	13.9	9.4	13.6	7.2	8.2	5.1	8.2	33.9	24.4	9.9	8.6	8.0	8.2	12.2	7.5	15.5	7.9	10.3	8.7	10.6	12.7	8.8	7.9	9.2	17.8	5.9	8.7	13.9	11.6	7.1	25.2	12.5	8.4	12.9	4.8	6.2	11.7	12.2	6.2	11.9	10.0	16.4	11.2	30.1	6.4	6.7	19.4	16.8	19.3	20.0	6.2	11.7	24.8	5.8	14.7	9.3	22.7	6.5	6.1	10.2	21.2	16.0	5.0	14.9	9.4	13.7	7.0	23.6	12.4	19.0	15.7	15.7	16.7	16.5	8.1	16.1	16.4	25.4	14.8	19.2	19.5	10.2	11.1	4.9	14.2	13.2	13.0	24.4	15.3	29.5	35.3	6.2	18.8	13.8	2.0	7.9	5.9	9.6	8.7	11.0	9.2	10.8	11.6	17.8	8.2	11.2	11.6	0.8	13.9	7.6	8.1	11.3	7.1	10.5	12.1	15.0	10.5	8.4	9.5	8.3	11.8	13.6	7.9
TRMU	"FLJ10140, MTO2, TRMT"	ENSG00000100416	"TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA000824: , HPA035273: AB_10602901, HPA043300: "	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favourable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavourable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	8.5	16.1	11.5	9.9	16.0	6.4	7.5	17.8	16.0	9.7	8.7	11.5	10.2	10.9	12.1	18.0	10.9	6.2	7.3	16.8	11.3	11.9	20.5	18.8	7.1	10.2	15.7	11.8	8.0	22.7	20.0	13.6	9.7	11.2	8.7	10.2	9.0	12.5	15.5	17.8	9.8	7.6	9.4	11.4	8.7	9.2	8.3	13.9	6.5	9.6	8.3	9.8	7.1	9.1	6.2	7.6	3.9	9.6	7.5	11.3	6.3	10.8	9.9	4.3	9.6	8.0	5.7	10.7	11.3	8.0	16.1	12.5	14.0	2.7	7.1	8.0	10.1	9.7	18.1	10.1	13.8	4.6	24.4	8.4	15.2	16.5	6.9	16.1	5.8	5.4	11.4	16.6	5.3	10.3	11.7	1.7	9.7	11.4	6.2	13.2	16.1	17.5	7.4	9.2	13.1	8.0	7.5	10.2	12.3	10.0	11.8	18.9	6.7	6.7	7.5	7.2	12.8	10.1	12.6	4.2	4.5	7.6	10.1	11.7	14.4	0.0	6.8	3.9	11.1	9.4	9.4	5.7	9.4	10.0	7.6	6.2	8.6	8.0	1.4	7.5	9.6	6.0	11.3	6.3	11.5	16.0	17.8	16.0	11.3	11.9	15.7	11.8	11.2	13.9
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126916-3150879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria				Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	15.2	16.9	17.5	17.8	20.7	8.7	18.2	14.5	22.7	12.9	13.2	13.2	17.4	11.1	18.4	14.7	15.9	12.2	15.6	13.9	17.1	16.0	21.1	16.1	13.7	19.0	17.5	15.6	14.6	13.9	14.3	31.0	19.0	21.3	23.9	16.4	10.1	13.2	13.1	14.8	15.3	12.5	15.3	19.3	20.5	15.5	13.5	15.1	22.1	20.9	10.6	19.8	17.8	13.0	15.1	10.5	29.0	12.0	15.1	16.6	7.4	11.9	17.3	13.4	7.6	16.0	13.7	14.3	13.7	11.4	13.7	14.2	16.0	14.7	21.8	9.1	13.2	8.6	17.7	12.4	17.5	16.2	8.5	20.3	18.4	16.0	21.4	21.4	16.5	12.8	17.5	14.1	4.8	13.5	15.7	9.2	23.6	22.3	13.8	19.4	10.6	12.6	13.2	18.1	21.2	18.3	17.8	7.7	11.0	19.8	14.4	11.4	13.3	12.2	11.0	15.5	13.5	16.0	17.5	9.4	18.8	27.5	11.6	19.3	17.2	29.0	8.8	22.5	12.1	11.8	11.9	15.1	15.0	12.7	10.5	9.5	16.6	14.3	11.7	15.1	12.0	9.6	11.1	7.4	17.5	20.7	14.5	22.7	17.1	16.0	17.5	15.6	21.3	15.1
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 32.5;SK-BR-3: 21.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			6500	"Nucleoplasm, Plasma membrane"		"HPA041169: "	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favourable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favourable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	6.7	3.8	3.5	13.7	3.7	4.3	8.5	3.0	6.8	8.2	25.2	4.5	8.6	20.6	7.9	9.1	7.7	5.4	24.8	9.3	2.7	2.2	14.2	23.6	9.4	3.5	2.6	5.7	2.7	17.4	3.4	3.3	5.0	6.9	20.2	11.4	10.6	16.2	13.2	16.4	16.1	26.8	9.4	2.5	3.4	18.3	4.2	2.2	0.4	10.1	11.5	6.8	9.9	8.6	1.1	5.4	4.9	6.8	1.0	0.7	2.1	6.0	4.5	1.1	5.1	3.8	3.6	3.6	5.1	3.0	1.4	1.9	3.3	9.5	0.2	1.3	3.4	8.0	0.7	1.5	0.6	0.1	1.6	1.0	1.9	2.0	3.4	0.1	6.6	4.3	7.0	2.6	1.2	2.4	2.4	1.2	3.5	9.1	0.4	0.5	0.6	6.9	2.2	1.0	0.3	2.4	32.5	0.4	1.1	2.1	21.4	1.1	11.6	2.0	6.1	7.6	4.3	4.2	0.1	2.2	2.2	0.2	4.3	4.0	2.8	2.7	6.8	1.1	0.6	4.0	0.5	0.8	0.5	0.4	5.4	1.1	0.6	0.7	4.9	1.0	1.5	4.9	0.3	2.1	3.5	3.7	3.0	6.8	2.7	2.2	2.6	5.7	6.9	2.2
TRPS1	"GC79, LGCR"	ENSG00000104447	"Transcriptional repressor GATA binding 1"	Q9UHF7	8	115408496-115809673	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 13.4;SK-BR-3: 22.8;T-47d: 71.6"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 49.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060380, HPA071767"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA060380: , HPA071767: "	"unprognostic (4.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-1)"	"prognostic favourable (9.42e-4)"	"unprognostic (2.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (3.16e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.07e-3)"	6.7	4.5	11.4	6.8	12.0	8.2	65.9	7.0	8.9	16.8	7.7	7.5	9.2	2.0	11.7	6.8	16.3	7.2	11.7	5.9	14.0	4.3	9.8	3.3	6.5	5.9	8.7	8.1	6.8	2.4	9.1	9.7	4.0	10.8	11.7	4.1	4.1	16.0	10.6	4.1	13.5	3.6	12.6	20.6	5.2	4.7	13.2	8.6	1.8	7.2	14.8	9.2	9.6	17.6	1.8	3.1	1.6	8.5	1.8	2.1	1.3	0.8	0.1	1.7	0.0	1.6	6.0	0.1	1.4	3.3	0.9	1.5	0.1	1.4	0.7	0.0	3.6	0.0	6.7	1.2	1.0	0.0	2.0	0.0	2.8	0.0	2.1	0.0	0.0	2.8	1.2	2.5	4.7	0.8	0.3	11.0	1.7	13.4	0.0	0.0	0.3	1.4	0.0	0.0	8.4	1.4	0.0	1.5	1.1	0.7	22.8	0.9	71.6	0.6	0.0	4.0	2.1	1.1	2.7	3.0	0.0	1.2	4.3	0.0	2.6	0.0	8.5	0.0	1.7	3.5	2.0	1.0	2.1	2.0	3.1	1.8	1.9	1.8	1.6	1.8	2.5	1.1	0.8	1.3	11.4	12.0	7.0	8.9	14.0	4.3	8.7	8.1	10.8	8.6
TRPV2	"VRL, VRL-1, VRL1"	ENSG00000187688	"Transient receptor potential cation channel subfamily V member 2"	Q9Y5S1	17	16415542-16437003	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.6;fHDF/TERT166: 34.8;HMC-1: 29.3;SK-MEL-30: 30.2;TIME: 27.2"	"Cancer enriched"	"Detected in all"	8	"melanoma: 59.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044993	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA044993: AB_10960889"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.16e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.19e-6)"	"unprognostic (7.94e-2)"	"prognostic unfavourable (5.53e-4)"	"unprognostic (8.07e-2)"	"unprognostic (1.23e-1)"	25.4	17.6	5.9	14.3	4.9	15.6	11.3	1.9	7.6	6.7	6.0	4.2	0.5	5.4	8.2	6.1	5.7	6.8	6.7	8.9	5.0	8.1	4.4	4.5	25.8	24.9	6.0	4.2	8.9	8.4	7.7	1.8	15.6	8.1	6.3	5.0	4.9	4.4	2.1	3.8	5.0	8.8	9.2	4.1	23.4	5.3	2.8	2.5	23.4	5.7	4.2	18.0	8.1	6.7	9.0	25.9	20.4	22.3	26.5	29.8	17.4	0.0	0.5	0.0	0.0	8.5	26.6	1.6	2.6	3.0	3.0	2.9	0.1	0.0	3.0	0.7	34.8	0.0	0.0	0.0	1.7	13.5	0.2	3.3	0.0	8.2	10.2	4.6	29.3	11.8	0.0	17.9	0.2	1.2	11.4	8.5	14.1	0.1	5.9	6.4	0.0	0.0	3.5	0.1	1.3	13.2	0.3	0.4	0.0	0.0	0.0	30.2	0.0	4.0	27.2	0.0	0.1	0.1	0.3	0.0	0.1	1.5	2.7	6.8	4.1	20.4	12.2	15.2	29.8	22.3	25.9	9.0	21.9	27.6	25.9	8.7	12.5	21.7	3.0	26.5	19.8	22.7	21.2	17.4	5.9	4.9	1.9	7.6	5.0	8.1	6.0	4.2	8.1	2.5
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA054376: "	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	9.6	14.2	10.7	18.4	13.4	18.8	14.9	22.8	14.4	14.1	11.3	15.4	10.0	10.6	15.1	10.1	11.3	17.1	11.4	11.4	10.7	9.5	10.8	11.0	13.1	17.1	12.4	9.4	22.4	16.2	26.7	29.9	12.2	9.6	11.8	10.2	13.7	11.8	16.7	11.7	16.9	13.3	16.9	14.2	14.5	11.5	19.3	12.1	37.1	16.6	7.7	19.3	12.8	11.5	2.7	3.1	5.7	0.9	1.3	2.7	0.3	12.1	14.3	14.8	12.5	7.3	7.6	7.4	5.4	7.2	8.5	8.2	11.1	5.4	17.0	8.6	10.0	6.4	15.3	7.4	9.4	9.8	15.0	10.4	10.4	6.4	5.4	18.6	7.7	7.0	4.4	13.9	11.9	10.9	17.7	32.3	7.9	23.5	22.7	7.4	11.3	8.8	16.8	8.5	13.0	4.4	13.6	11.7	14.6	13.7	9.0	4.6	4.5	8.4	11.4	11.4	16.7	15.1	12.5	13.3	15.1	25.2	8.1	9.6	11.3	5.7	0.9	0.6	1.5	0.6	2.7	2.0	2.7	1.3	0.9	2.7	1.9	1.8	2.9	1.3	0.9	3.1	2.0	0.3	10.7	13.4	22.8	14.4	10.7	9.5	12.4	9.4	9.6	12.1
TRUB1	PUS4	ENSG00000165832	"TruB pseudouridine synthase family member 1"	Q8WWH5	10	114938193-114977676	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037914, HPA057552"	Approved		Supported	"Vesicles,Actin filaments"				"Vesicles, Actin filaments"		"HPA037914: AB_10672399, HPA057552: "	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.20e-3)"	"unprognostic (9.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-1)"	7.2	29.0	14.7	7.7	19.5	3.3	10.9	11.5	22.0	10.0	8.9	9.2	7.8	8.4	12.6	9.4	9.9	9.6	8.1	20.2	14.7	15.8	15.4	13.0	6.2	8.7	11.0	10.9	16.8	8.3	13.1	9.6	7.0	18.1	11.7	10.2	7.7	9.5	11.3	8.2	6.6	7.6	10.8	10.2	9.6	7.9	17.9	8.0	12.7	11.9	9.2	9.2	8.7	8.3	9.2	6.0	4.0	8.2	10.2	8.5	6.0	13.6	10.7	10.5	26.1	7.6	10.2	14.2	11.8	13.4	16.0	18.2	8.7	14.1	16.9	13.7	9.2	11.7	14.1	14.6	23.8	12.8	15.2	7.8	5.3	15.5	13.1	14.5	11.7	10.4	20.2	11.3	22.5	9.0	8.0	6.9	18.9	6.6	13.5	11.6	9.9	10.6	13.6	26.6	10.3	21.1	6.9	9.8	10.9	9.9	14.7	25.7	11.7	9.0	8.0	7.4	7.4	11.7	14.3	13.3	10.7	14.2	10.4	18.6	6.6	4.0	3.3	1.1	6.0	5.1	8.5	9.2	6.4	6.3	6.0	7.1	8.5	7.8	0.3	10.2	8.2	5.4	7.6	6.0	14.7	19.5	11.5	22.0	14.7	15.8	11.0	10.9	18.1	8.0
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol				Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: "	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavourable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favourable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favourable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	10.4	13.6	15.8	8.8	26.8	13.6	11.4	32.1	28.3	12.7	10.8	22.6	7.9	9.1	14.6	12.3	10.9	12.4	9.7	17.6	13.0	12.1	13.1	9.4	11.6	10.2	12.5	15.1	21.2	12.1	15.9	19.5	15.8	21.1	11.8	12.6	13.1	11.6	10.4	20.0	13.8	11.2	14.2	12.4	13.7	10.6	36.2	14.9	10.5	16.2	8.6	14.2	10.9	11.1	2.8	3.1	4.8	7.0	4.9	7.1	2.6	6.1	7.3	10.0	8.2	10.3	9.8	18.8	8.3	13.4	8.7	8.6	12.4	7.2	14.4	3.6	15.8	16.0	11.7	8.4	8.9	6.9	6.2	4.6	14.5	10.1	12.3	6.7	6.2	10.5	6.4	11.1	13.6	10.0	8.0	7.9	9.9	11.4	6.0	5.8	13.7	6.1	7.3	18.9	8.1	3.9	8.1	5.0	7.7	9.7	6.1	4.8	11.0	4.0	10.3	14.3	8.6	8.5	5.6	4.4	9.8	14.0	8.1	4.0	6.3	4.1	4.4	4.8	6.5	7.0	7.1	1.9	3.6	5.7	3.1	2.8	5.9	5.3	1.7	4.9	3.2	1.8	5.7	2.6	15.8	26.8	32.1	28.3	13.0	12.1	12.5	15.1	21.1	14.9
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047465-2089487	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol				Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: "	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favourable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	13.9	11.9	16.9	12.4	20.0	10.9	13.2	35.1	26.9	20.5	17.0	19.4	17.9	14.0	20.1	12.2	13.0	18.6	15.0	14.0	13.3	8.8	11.8	9.8	12.7	10.1	13.8	14.7	21.1	16.1	20.0	18.1	10.6	14.6	13.8	10.8	16.7	22.9	19.6	31.7	14.5	13.2	13.5	11.4	12.9	16.6	21.4	12.9	14.1	20.1	11.3	10.9	18.0	14.0	4.7	5.6	7.7	4.9	3.6	7.0	3.7	7.2	11.6	16.1	18.2	19.2	16.2	13.6	17.4	11.9	13.1	11.2	13.9	13.8	10.9	15.5	14.3	12.0	9.6	12.6	9.8	8.3	15.8	10.3	22.5	5.7	13.2	12.8	12.5	19.1	8.0	10.6	7.9	12.3	10.0	9.8	11.6	14.4	15.2	3.8	16.7	11.4	24.2	17.6	13.9	5.3	6.5	12.2	23.1	24.8	16.4	8.8	15.0	9.5	19.4	13.8	9.4	12.3	8.8	21.9	21.8	21.8	5.7	5.2	16.3	6.2	4.9	5.4	7.0	4.7	6.7	4.4	4.4	4.1	5.6	4.7	3.1	4.8	7.7	3.6	3.7	1.5	3.2	3.7	16.9	20.0	35.1	26.9	13.3	8.8	13.8	14.7	14.6	12.9
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484432-12539623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favourable (3.49e-4)"	8.8	10.6	9.7	8.8	19.1	6.7	10.9	16.5	14.0	10.4	9.8	12.7	8.4	5.8	14.0	9.9	7.9	12.8	10.3	14.3	10.5	12.3	9.8	7.3	7.3	10.9	11.5	7.6	18.0	11.9	14.3	15.3	4.9	10.2	10.5	10.9	13.5	7.2	13.1	16.7	15.3	6.1	12.3	12.3	6.1	8.5	11.3	9.1	9.9	12.5	9.6	8.1	8.6	8.3	8.5	7.1	2.6	4.2	5.0	13.7	5.6	8.0	14.0	7.5	9.9	12.8	13.6	17.4	7.6	6.7	8.1	5.9	7.9	8.6	9.7	5.3	6.2	7.5	12.5	13.0	9.3	7.6	15.6	10.6	18.8	8.1	9.9	16.6	4.1	11.7	15.1	14.8	18.2	6.5	15.6	5.3	9.4	15.1	12.6	7.6	10.6	16.9	9.6	5.2	19.3	12.2	8.2	4.9	8.6	7.0	6.3	5.9	11.4	11.6	5.8	5.2	5.1	7.1	11.7	5.0	12.7	12.0	7.0	16.7	6.5	2.4	4.2	0.3	6.4	4.2	10.9	8.5	9.8	7.4	5.9	8.3	13.7	11.7	2.6	5.0	3.6	7.1	3.5	5.6	9.7	19.1	16.5	14.0	10.5	12.3	11.5	7.6	10.2	9.1
TSEN34	"LENG5, SEN34, SEN34L"	ENSG00000170892	"TRNA splicing endonuclease subunit 34"	Q9BSV6	19	54189938-54194536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Disease mutation, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 24.8;monocytes: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041111, HPA048208"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA041111: AB_10794263, HPA048208: "	"unprognostic (3.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavourable (1.44e-7)"	"unprognostic (2.38e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.12e-1)"	12.3	28.0	10.4	10.8	10.2	8.2	15.4	4.0	12.8	19.8	19.5	9.4	19.2	3.0	17.3	23.4	20.2	25.3	18.1	20.0	8.8	9.8	15.4	20.0	13.4	18.2	8.7	8.9	31.8	27.3	19.2	14.3	22.0	8.7	23.2	12.3	15.7	17.8	29.5	15.7	14.7	9.8	18.6	7.8	18.0	13.0	27.3	7.7	12.9	28.5	19.6	14.9	19.8	15.5	1.4	2.6	24.8	8.1	0.8	2.4	1.5	28.9	4.2	11.8	16.8	7.0	14.3	12.8	3.6	7.3	8.8	8.2	2.1	4.2	2.2	1.0	5.6	20.4	16.0	21.3	6.4	7.5	24.4	2.6	0.8	2.3	6.7	0.7	3.6	22.9	9.8	6.0	7.1	17.9	5.8	1.3	18.6	3.5	1.5	0.0	2.7	3.1	7.3	8.0	1.0	25.2	2.5	0.6	6.8	0.8	21.6	8.0	17.1	2.1	1.2	0.0	12.2	12.6	22.2	8.2	7.9	2.0	21.1	1.3	13.4	4.1	8.1	17.8	0.9	3.3	1.8	1.0	1.3	2.4	2.3	1.4	2.3	0.9	24.8	0.8	5.2	2.6	0.7	1.5	10.4	10.2	4.0	12.8	8.8	9.8	8.7	8.9	8.7	7.7
TSFM	"EF-TS, EF-Tsmt"	ENSG00000123297	"Ts translation elongation factor, mitochondrial"	P43897	12	57782589-57808071	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 153.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006204			Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA006204: AB_1080405"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.93e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.49e-3)"	"prognostic favourable (8.82e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	14.5	46.2	16.6	14.7	21.5	15.3	18.5	18.2	24.3	12.7	18.8	13.3	17.6	17.8	11.6	13.7	16.1	12.4	10.3	27.7	14.6	15.6	27.0	30.2	10.1	14.6	15.4	20.8	10.3	19.6	17.0	13.1	11.6	17.8	11.7	18.3	11.1	13.5	14.1	33.5	14.7	13.4	17.7	11.6	12.5	14.0	23.2	13.6	11.3	15.4	26.9	13.4	14.4	13.0	18.5	18.7	9.0	16.8	20.0	23.5	16.0	8.2	9.6	5.8	8.6	5.4	5.4	8.4	6.9	6.2	11.3	7.9	11.2	10.9	20.7	13.3	6.1	9.8	9.7	10.0	8.6	8.4	11.8	12.6	8.1	9.8	8.2	16.0	7.6	6.2	10.2	8.6	4.9	7.0	16.2	11.2	8.5	9.5	9.5	17.4	8.8	12.8	11.6	153.6	18.5	10.7	9.4	12.5	7.7	7.4	13.1	12.6	22.7	11.7	5.1	6.2	8.7	9.0	7.4	8.3	17.0	16.1	8.7	9.7	7.3	3.7	14.8	9.0	18.6	13.8	23.5	18.5	20.9	18.4	18.7	16.4	21.2	21.7	4.2	20.0	16.8	14.7	18.1	16.0	16.6	21.5	18.2	24.3	14.6	15.6	15.4	20.8	17.8	13.6
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18527232	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"			14000	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favourable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	24.7	30.5	18.4	14.2	25.5	23.5	27.6	22.7	25.9	22.5	23.1	23.7	21.6	20.5	25.8	27.7	34.3	23.9	18.4	31.8	17.7	20.6	33.4	29.0	20.1	23.4	21.6	21.4	23.2	39.5	33.2	23.5	38.5	24.6	21.9	28.4	19.4	25.4	22.4	44.5	27.3	25.7	23.1	21.7	20.5	23.0	33.7	20.2	27.5	32.3	37.1	25.5	24.2	25.5	20.5	18.2	42.3	29.2	14.3	22.0	22.2	14.3	23.7	21.0	14.6	24.9	26.0	19.5	22.3	30.1	27.3	27.0	16.2	7.6	19.4	13.7	24.8	22.0	20.9	20.2	30.4	27.2	25.5	12.0	12.5	23.8	32.0	18.0	20.8	22.4	41.1	14.2	38.8	22.4	19.5	16.5	33.0	25.9	11.4	19.6	12.9	24.0	10.3	21.2	16.1	18.3	20.5	15.0	26.9	21.4	18.0	28.5	17.9	18.1	12.0	18.3	11.2	38.2	16.5	10.6	20.4	15.4	18.9	10.0	23.4	42.3	19.5	40.7	14.9	21.7	15.0	20.5	14.4	15.9	18.2	18.0	15.4	16.4	34.5	14.3	29.2	15.4	22.0	22.2	18.4	25.5	22.7	25.9	17.7	20.6	21.6	21.4	24.6	20.2
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31274945-31349547	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.7;RH-30: 26.1;U-138 MG: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.9"	"Group enriched"	"Detected in many"	35	"granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 20.4;hippocampal formation: 16.8"	"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	5.7	3.3	4.4	4.0	6.6	1.0	5.2	1.1	17.3	13.0	11.6	0.7	2.4	2.5	19.4	8.5	5.6	9.5	11.5	4.6	3.3	2.0	2.8	1.3	4.9	1.2	1.6	8.0	28.0	1.5	1.1	7.2	4.8	2.8	9.5	3.7	4.9	2.8	8.9	1.6	2.5	4.3	16.4	3.3	4.5	6.1	3.3	1.2	0.0	8.5	1.7	0.7	11.1	11.4	0.0	0.0	4.9	2.2	0.0	3.2	0.7	0.0	1.1	0.4	0.0	5.8	12.7	0.0	3.3	4.8	2.1	3.7	0.0	0.7	0.0	0.0	8.2	0.5	1.5	3.1	4.6	0.0	1.3	0.0	0.0	0.0	11.2	2.8	5.2	7.5	2.8	7.6	3.9	0.0	0.0	0.0	9.6	0.5	0.0	0.0	0.5	0.0	3.2	26.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	2.5	0.0	1.9	0.0	18.5	5.9	2.1	4.7	0.0	0.0	0.0	12.0	4.8	0.5	0.0	2.2	0.0	3.2	0.8	0.1	0.0	0.9	1.0	0.0	0.0	0.3	0.8	4.9	0.0	0.4	0.0	0.7	0.7	4.4	6.6	1.1	17.3	3.3	2.0	1.6	8.0	2.8	1.2
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"			320000	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: "	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	14.9	18.7	23.1	13.0	24.6	43.0	25.6	17.8	27.7	18.6	23.1	23.7	11.8	17.2	17.9	19.1	18.2	15.2	16.3	18.7	20.6	23.0	24.7	22.0	15.0	22.6	22.8	20.1	17.5	20.7	19.3	17.9	13.8	23.3	15.0	18.9	16.5	16.3	18.2	29.4	18.9	16.4	14.3	22.0	17.5	15.4	33.9	17.6	28.3	17.2	18.7	17.4	13.9	14.2	22.1	22.7	22.0	24.4	19.6	23.1	20.7	21.4	9.7	14.4	12.1	13.3	10.6	8.0	18.4	16.7	19.3	19.1	27.1	11.8	29.9	21.7	16.5	10.0	21.0	16.9	26.8	16.6	17.2	17.6	14.0	24.2	14.9	24.6	12.6	9.0	18.7	21.9	14.5	15.8	26.6	14.3	17.4	11.0	14.9	27.6	17.5	18.5	25.2	16.1	22.0	23.3	14.2	18.9	11.8	12.0	17.3	20.6	11.5	18.4	11.8	13.9	23.7	9.2	17.3	13.3	37.7	33.5	16.1	16.7	16.8	17.2	24.4	22.0	19.6	22.2	22.7	22.1	20.4	17.0	22.7	18.0	23.1	20.1	7.9	19.6	19.0	16.5	20.2	20.7	23.1	24.6	17.8	27.7	20.6	23.0	22.8	20.1	23.3	17.6
TSNAX	TRAX	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528653-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"			100000	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	27.4	29.9	23.9	17.1	26.7	12.0	23.4	28.0	33.1	19.7	16.2	21.9	17.2	15.8	20.0	24.6	18.0	16.4	16.7	22.7	25.1	23.9	29.1	23.0	18.4	22.6	22.1	22.1	18.6	14.6	32.3	36.0	18.3	28.5	21.3	18.0	19.6	17.5	19.9	52.5	20.6	14.8	18.9	28.2	24.0	15.5	17.5	24.4	24.5	26.7	25.4	22.0	19.1	17.3	10.0	11.7	54.6	17.5	18.7	13.5	11.0	11.0	9.1	13.9	11.4	10.3	12.7	15.8	12.6	19.1	16.2	14.0	7.8	15.6	15.6	21.3	13.7	12.1	11.0	11.4	21.1	13.9	19.2	15.0	9.4	10.3	14.2	24.8	31.9	15.5	12.6	15.7	12.1	11.8	24.3	11.1	21.9	4.5	15.9	12.1	20.5	11.1	15.8	15.3	21.1	18.1	12.8	13.3	25.6	13.2	16.7	42.4	24.3	42.0	10.9	11.2	10.2	22.4	22.6	18.9	24.9	17.4	18.3	19.6	30.6	54.6	11.2	29.2	11.4	13.5	10.8	10.0	12.3	11.2	11.7	9.9	13.2	12.7	11.4	18.7	17.5	6.8	13.5	11.0	23.9	26.7	28.0	33.1	25.1	23.9	22.1	22.1	28.5	24.4
TSPAN14	"DC-TM4F2, MGC11352, TM4SF14"	ENSG00000108219	"Tetraspanin 14"	Q8NG11	10	80454166-80533123	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014773, HPA057174"	Uncertain		Supported	Vesicles			170000	Vesicles		"HPA014773: AB_2208670, HPA057174: "	"unprognostic (7.52e-2)"	"prognostic favourable (3.56e-4)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.12e-3)"	"prognostic favourable (4.20e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.57e-3)"	56.8	10.3	15.4	17.2	14.1	22.0	45.1	5.2	16.8	30.0	14.1	15.1	28.1	13.3	18.9	22.4	44.6	22.2	15.1	15.2	13.4	7.7	22.9	16.0	32.9	47.4	18.8	10.8	21.7	14.4	12.3	7.4	39.0	13.0	20.0	12.3	22.7	24.8	16.5	11.3	33.3	17.3	15.3	16.5	28.2	12.6	12.9	14.5	16.0	26.2	19.1	26.7	30.5	28.4	4.4	10.1	16.2	47.7	26.1	29.0	21.3	21.5	31.9	29.6	10.2	45.7	14.6	13.9	11.1	21.3	12.1	8.9	30.7	12.6	7.0	21.4	6.0	22.5	8.3	20.1	9.9	12.3	3.2	19.7	3.8	26.3	15.3	7.3	4.8	14.0	17.9	12.2	22.3	45.0	10.9	5.1	3.4	18.5	10.6	5.2	6.7	0.0	36.8	3.4	1.1	47.4	31.0	6.4	9.7	4.4	30.9	34.2	12.5	17.7	63.6	3.0	12.7	2.9	7.7	2.5	9.1	2.5	10.1	14.9	13.3	3.8	14.8	16.0	29.0	30.4	13.2	4.4	22.7	25.7	10.1	4.2	27.1	25.2	16.2	26.1	47.7	4.0	17.9	21.3	15.4	14.1	5.2	16.8	13.4	7.7	18.8	10.8	13.0	14.5
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 44.6"	"Cell line enhanced"	"Detected in many"		"A-431: 8.4;EFO-21: 34.7;U-937: 15.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 11.9"	"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 35.0;NK-cells: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	3.7	0.6	1.1	4.7	2.5	9.6	3.2	0.9	2.0	20.1	31.0	1.5	8.9	2.5	30.6	6.9	12.3	14.2	10.6	6.1	1.1	2.6	4.0	0.6	3.0	1.5	1.9	1.9	6.5	2.0	6.4	2.0	1.5	11.9	15.2	6.2	1.9	2.2	15.7	2.0	1.6	7.0	44.6	1.6	2.2	10.0	4.4	0.8	2.6	4.0	4.9	0.9	25.4	7.0	0.2	1.2	35.0	2.9	25.9	7.4	3.8	8.4	0.1	0.7	0.0	0.0	0.1	0.0	1.4	0.5	1.3	2.2	1.6	5.2	0.0	34.7	1.9	1.2	1.1	0.0	1.5	1.7	0.6	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.4	4.5	0.7	7.9	0.9	0.0	0.5	0.0	0.2	3.1	1.8	2.8	2.1	0.9	0.1	0.1	0.3	0.1	0.1	3.4	0.2	8.0	7.2	0.2	0.0	0.0	15.2	3.8	27.8	2.9	16.6	5.9	0.0	1.9	0.2	7.0	7.4	1.2	0.1	1.2	6.0	35.0	25.9	0.0	1.2	0.9	3.8	1.1	2.5	0.9	2.0	1.1	2.6	1.9	1.9	11.9	0.8
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116276578-116279903	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031970, HPA031971"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092, HPA031971: AB_10602484"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favourable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favourable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	14.0	34.1	38.3	9.8	67.2	18.5	14.4	49.1	64.5	15.2	12.8	9.8	20.1	14.7	13.9	21.4	15.4	20.3	12.9	21.4	34.6	36.6	31.5	23.5	12.9	11.8	21.8	49.8	22.9	17.6	41.3	17.2	9.7	31.1	27.1	11.3	13.3	17.2	22.6	61.6	11.2	12.9	17.1	11.5	15.6	15.3	12.9	12.2	9.8	25.0	15.5	15.2	14.6	12.9	30.7	24.6	52.9	29.4	17.4	36.2	17.0	13.0	12.8	16.5	30.1	29.3	19.4	13.9	20.9	20.9	19.2	22.1	16.5	9.5	27.9	26.3	24.1	23.1	13.0	35.7	20.6	11.3	33.8	11.2	18.9	29.9	18.6	18.3	6.8	22.6	28.0	19.8	19.3	18.2	19.7	21.7	26.7	28.6	12.2	10.8	8.2	12.0	11.3	14.3	15.2	33.2	25.4	14.5	14.3	17.4	23.4	10.0	30.7	22.9	22.0	12.9	11.6	10.4	22.6	11.9	12.9	15.3	21.5	11.9	8.4	52.9	17.8	27.2	24.2	27.7	36.2	25.9	31.7	26.7	14.3	30.7	31.3	30.4	13.5	17.4	29.4	24.6	23.7	17.0	38.3	67.2	49.1	64.5	34.6	36.6	21.8	49.8	31.1	12.2
TSR1	FLJ10534	ENSG00000167721	"TSR1, ribosome maturation factor"	Q2NL82	17	2322503-2337507	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024434, HPA053087"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA024434: AB_1858413, HPA053087: "	"unprognostic (1.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.95e-3)"	"unprognostic (9.80e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.46e-3)"	15.6	11.8	11.2	14.0	14.1	11.8	14.7	12.5	15.9	10.3	12.8	12.1	11.7	7.9	15.9	10.8	20.0	12.5	10.5	14.8	11.5	9.3	10.6	18.5	9.8	13.3	13.3	12.7	14.5	23.8	14.2	9.6	13.7	11.1	12.6	12.9	10.5	12.8	15.7	42.2	16.2	9.8	20.1	10.6	11.6	12.7	18.3	11.4	14.4	10.7	25.0	15.4	14.2	12.3	8.3	11.4	1.4	10.7	5.6	11.8	5.7	26.4	27.3	12.7	25.6	10.3	12.1	26.8	20.9	11.5	12.7	9.8	43.5	11.0	26.9	19.3	16.3	22.8	27.4	24.2	16.4	12.7	32.4	19.8	22.0	20.0	14.4	18.3	14.5	12.3	15.2	24.4	28.1	12.3	26.0	15.1	15.6	15.2	18.1	8.9	31.3	16.4	19.6	17.5	18.8	15.6	16.7	9.2	20.6	18.2	14.2	14.3	13.3	8.0	13.7	17.9	15.1	21.8	39.8	11.3	14.8	16.5	17.6	20.9	22.2	1.4	6.7	1.4	8.9	10.7	11.8	7.5	7.2	7.6	11.4	8.3	7.6	9.0	1.1	5.6	10.3	4.3	8.7	5.7	11.2	14.1	12.5	15.9	11.5	9.3	13.3	12.7	11.1	11.4
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 16.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria			2800000	Mitochondria		"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.04e-4)"	8.5	29.7	6.0	13.5	7.6	5.7	6.1	5.0	10.5	9.5	38.4	12.9	10.9	37.4	5.9	4.0	16.6	6.8	38.4	14.1	5.1	4.9	19.7	102.1	6.2	3.2	8.2	7.0	7.2	23.9	1.8	2.3	5.0	5.9	8.1	21.6	6.2	13.6	6.9	8.3	5.4	39.5	3.8	4.7	3.5	22.8	3.3	6.7	1.8	8.5	12.8	10.5	7.2	9.2	1.6	16.0	14.3	11.5	2.2	1.2	5.2	15.1	33.7	4.3	14.4	10.4	4.1	8.0	8.4	7.2	4.9	7.4	9.8	10.0	4.0	7.1	6.6	13.1	3.1	8.4	1.1	11.7	18.9	4.2	6.4	19.0	26.1	5.8	10.0	8.0	9.6	3.6	3.1	12.0	5.0	7.0	2.3	34.7	0.2	18.8	7.3	14.8	13.6	4.6	7.0	13.8	14.2	2.5	6.5	8.9	16.0	11.4	16.5	14.8	9.0	5.6	10.5	9.3	2.6	5.3	5.3	1.2	2.0	16.9	3.3	5.3	11.5	4.9	0.6	3.0	1.1	1.6	0.5	0.4	16.0	0.8	0.3	0.2	14.3	2.2	0.8	1.1	1.2	5.2	6.0	7.6	5.0	10.5	5.1	4.9	8.2	7.0	5.9	6.7
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243680-43288259	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 20.8;SH-SY5Y: 7.9"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA031735: , HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	1.1	3.9	12.4	1.3	12.9	0.9	1.0	14.9	28.9	1.0	1.4	8.2	0.0	4.6	1.0	1.0	1.0	1.1	1.4	1.3	10.3	7.5	1.7	3.5	1.1	1.2	7.1	12.5	1.0	1.4	1.6	7.7	1.0	9.0	1.3	1.3	0.7	1.0	1.2	1.0	1.0	6.8	1.1	6.2	1.2	1.3	2.3	8.3	0.0	1.0	0.0	1.3	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	20.8	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.4	12.9	14.9	21.7	10.3	7.5	7.1	12.5	9.0	8.3
TTC1	TPR1	ENSG00000113312	"Tetratricopeptide repeat domain 1"	Q99614	5	160009113-160065543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036557, HPA057502"	Approved		Enhanced	Cytosol				Cytosol		"HPA036557: AB_10670112, HPA057502: "	"unprognostic (4.34e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.16e-2)"	25.3	28.0	44.4	21.0	36.0	14.3	25.4	31.4	44.9	21.7	25.2	25.4	16.8	16.9	21.3	38.4	24.8	21.0	16.6	33.9	41.7	42.9	31.3	27.7	20.5	26.9	48.9	33.9	23.7	16.0	25.7	23.9	22.0	56.7	22.0	29.4	15.9	23.7	25.1	50.5	21.6	20.6	26.7	37.4	25.2	19.7	20.3	26.6	27.4	26.8	20.0	33.5	25.9	18.0	46.0	38.4	54.2	41.3	43.2	45.3	52.8	24.5	25.7	19.2	32.1	22.9	16.5	21.8	27.6	24.6	30.4	36.2	36.0	28.7	25.3	54.1	23.6	19.5	25.5	37.8	49.1	46.7	27.1	22.6	20.3	25.8	32.4	37.4	19.0	15.4	25.1	26.8	22.5	36.4	21.5	25.2	34.6	19.2	27.1	29.5	21.8	26.3	26.3	27.0	27.8	38.4	23.1	15.9	17.9	19.1	22.9	50.9	36.2	36.4	25.5	20.3	17.5	18.0	42.4	18.2	33.1	24.5	28.1	42.8	26.2	47.0	39.1	52.4	32.4	41.3	40.4	46.0	38.4	37.6	38.4	40.6	35.6	39.4	54.2	43.2	39.0	34.1	45.3	52.8	44.4	36.0	31.4	44.9	41.7	42.9	48.9	33.9	56.7	26.6
TTC14	"FLJ00166, KIAA1980"	ENSG00000163728	"Tetratricopeptide repeat domain 14"	Q96N46	3	180602130-180617828	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009295	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA009295: AB_1858425"	"unprognostic (2.72e-1)"	"unprognostic (4.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.33e-3)"	17.2	20.3	30.0	30.4	32.0	23.1	20.5	18.2	32.4	22.8	20.8	15.8	25.6	19.3	29.0	37.9	12.7	25.2	16.9	16.8	25.6	15.4	22.3	14.1	18.6	30.7	22.8	28.7	41.9	24.3	33.7	49.0	18.0	22.1	26.4	19.0	15.9	15.5	28.7	11.9	17.8	20.7	17.5	23.8	25.7	19.8	16.6	24.3	41.1	35.2	11.1	23.0	20.3	23.4	14.2	18.2	17.1	13.7	14.3	15.0	5.9	8.6	6.9	10.9	6.3	14.9	12.8	10.4	12.6	10.2	9.2	15.2	9.5	11.6	13.1	13.6	9.0	12.6	10.2	6.6	12.4	24.2	10.3	12.3	16.1	22.0	11.0	13.1	11.4	16.4	12.9	9.1	4.6	7.2	5.2	2.6	10.3	2.5	9.9	1.0	7.8	14.1	11.7	6.8	13.9	5.3	6.6	9.3	9.2	12.0	6.1	11.9	22.4	12.8	11.4	18.6	9.6	8.4	23.1	19.6	29.8	29.4	8.9	16.6	8.1	17.1	9.8	10.4	11.6	10.7	14.1	14.2	12.2	11.4	7.4	12.5	15.0	11.9	7.8	14.3	13.7	18.2	10.4	5.9	30.0	32.0	18.2	32.4	25.6	15.4	22.8	28.7	22.1	24.3
TTC17	FLJ10890	ENSG00000052841	"Tetratricopeptide repeat domain 17"	Q96AE7	11	43358932-43494933	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038508	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA038508: AB_10671744"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.01e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (4.75e-6)"	"unprognostic (1.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.54e-2)"	12.7	13.6	16.3	15.8	18.4	6.8	21.2	21.1	17.0	12.7	10.7	9.1	21.1	10.9	15.0	13.9	11.5	17.7	11.5	10.5	12.8	7.4	12.0	19.9	20.4	19.8	21.7	11.3	26.6	47.7	20.5	20.8	15.0	15.4	13.8	12.0	10.6	20.7	11.7	12.1	10.9	14.0	17.7	12.9	11.9	16.4	12.3	17.3	11.1	19.5	9.1	11.1	12.8	12.5	22.4	23.3	24.5	29.0	20.4	23.1	21.1	5.7	12.0	12.6	19.8	31.8	26.5	8.9	14.1	18.9	11.8	14.3	8.3	8.6	12.3	14.2	14.1	12.3	8.8	9.2	14.3	9.4	11.6	9.4	7.7	8.1	39.4	14.0	12.1	24.5	28.6	8.6	27.9	11.7	13.5	10.5	11.9	7.0	10.3	8.1	18.8	10.4	9.7	13.4	14.2	15.0	8.6	6.7	16.1	10.9	29.3	17.6	27.5	16.0	15.6	17.0	7.5	19.0	20.2	20.7	16.6	11.8	10.9	8.5	18.0	22.3	28.3	23.8	21.0	29.0	21.9	22.4	22.6	19.7	21.9	20.7	23.1	21.0	24.5	20.4	24.7	23.3	20.3	21.1	16.3	18.4	21.1	17.0	12.8	7.4	21.7	11.3	15.4	17.3
TTC19	"FLJ20343, MGC19520"	ENSG00000011295	"Tetratricopeptide repeat domain 19"	Q6DKK2	17	15999380-16045015	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023010, HPA052380"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA023010: AB_1858429, HPA052380: "	"unprognostic (1.04e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.14e-2)"	"prognostic favourable (5.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	8.5	13.6	10.3	10.1	16.6	16.4	11.2	16.5	22.6	10.1	13.8	10.3	10.5	18.7	11.1	8.9	9.3	9.9	11.8	13.4	17.0	10.4	15.4	13.2	10.8	7.9	9.2	15.3	12.7	24.8	11.5	15.5	10.1	15.7	12.0	9.6	13.1	14.0	12.7	8.6	13.9	16.1	7.2	8.9	8.3	13.3	6.3	6.8	6.0	18.7	8.0	8.4	10.0	10.9	3.5	2.8	9.0	2.0	1.7	3.3	1.0	7.2	6.1	6.2	10.5	5.3	5.2	4.7	6.1	4.3	2.9	3.2	6.0	12.9	10.2	13.5	3.4	9.2	8.5	7.0	3.6	16.7	14.4	8.4	7.5	5.1	8.1	8.4	13.0	5.3	5.8	2.4	10.1	6.1	4.9	7.3	6.0	6.9	9.0	5.2	10.3	4.2	13.6	7.0	7.3	9.2	8.6	6.5	4.9	7.8	8.4	15.5	7.2	3.7	11.3	4.0	1.7	5.6	7.7	6.0	2.6	4.8	9.5	9.4	9.0	9.0	2.0	3.8	2.0	2.0	3.3	2.8	2.5	3.3	2.5	3.5	2.8	3.1	1.7	1.7	1.6	2.8	2.6	1.0	10.3	16.6	16.5	22.6	17.0	10.4	9.2	15.3	15.7	6.8
TTC21A	"IFT139A, STI2"	ENSG00000168026	"Tetratricopeptide repeat domain 21A"	Q8NDW8	3	39107704-39138903	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 51.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;naive B-cell: 2.7"	"Group enriched"	"Detected in many"	6	"B-cells: 2.7;monocytes: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035510, HPA035511"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA035510: , HPA035511: AB_10671514"	"unprognostic (1.85e-3)"	"unprognostic (6.95e-3)"	"unprognostic (7.74e-3)"	"prognostic favourable (1.79e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.58e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.91e-4)"	0.9	0.8	2.5	2.2	4.1	0.7	0.8	1.0	2.9	0.9	0.9	2.2	1.9	0.9	1.8	3.0	0.9	2.0	0.7	0.9	2.4	0.8	0.9	0.9	1.0	1.0	0.9	3.6	1.0	2.1	0.9	7.0	0.7	2.9	0.9	0.7	1.4	1.0	0.8	1.0	0.9	0.8	0.6	0.9	0.8	0.9	51.9	1.9	0.0	0.9	0.0	1.6	0.8	0.9	2.7	0.3	0.3	1.7	0.0	0.0	0.1	0.6	1.1	0.3	0.7	0.0	0.7	0.9	1.2	0.9	0.8	0.5	0.0	0.6	2.5	0.0	0.4	0.5	0.4	1.6	0.2	1.1	0.5	0.1	1.1	0.0	1.3	1.0	0.7	0.9	0.9	0.0	1.3	0.0	0.0	3.8	0.0	1.2	0.1	0.4	0.1	0.0	0.2	0.2	0.4	0.0	1.1	1.3	0.5	1.2	3.0	1.3	2.8	0.1	0.6	0.3	0.5	2.4	0.5	2.6	0.3	0.2	1.0	0.0	0.6	0.0	0.5	0.0	0.0	1.7	0.0	2.0	0.0	0.0	0.3	2.7	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	2.5	4.1	1.0	2.9	2.4	0.8	0.9	3.6	2.9	1.9
TTC21B	"FLJ11457, IFT139B, JBTS11, NPHP12, THM1"	ENSG00000123607	"Tetratricopeptide repeat domain 21B"	Q7Z4L5	2	165857475-165953843	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035494, HPA035495, HPA073293"	Supported		Supported	Mitochondria				Mitochondria		"HPA035494: , HPA035495: AB_10672866, HPA073293: "	"unprognostic (1.63e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.84e-2)"	10.4	9.0	11.3	7.0	18.3	8.6	11.7	39.6	19.8	12.3	9.2	7.1	5.3	6.5	13.8	10.0	6.7	15.3	7.5	10.4	10.1	8.1	12.5	8.9	9.4	8.9	12.3	11.9	17.5	10.1	10.4	17.6	9.8	15.7	14.9	8.9	6.3	9.1	10.2	16.4	10.7	8.2	9.7	12.2	8.4	8.5	9.7	13.8	16.2	9.4	7.1	8.0	9.8	11.8	3.8	3.1	8.7	2.7	3.7	4.7	1.8	4.9	3.8	17.4	7.1	11.8	11.4	4.6	9.9	8.1	8.0	7.9	5.4	3.3	11.5	6.0	7.0	5.2	11.7	6.2	9.5	8.0	5.8	9.4	6.7	13.1	6.9	8.8	0.0	6.2	4.0	9.2	6.7	8.6	12.4	8.7	10.1	2.7	10.8	7.0	7.2	9.4	12.0	14.0	3.9	6.2	10.6	12.5	7.3	7.8	1.9	8.7	2.9	6.3	6.3	14.1	6.3	7.8	7.3	5.0	7.0	10.6	5.9	5.5	8.8	8.7	1.9	3.3	2.9	2.3	4.2	3.8	3.4	2.9	3.1	3.2	4.4	4.7	0.8	3.7	2.7	1.6	4.2	1.8	11.3	18.3	39.6	19.8	10.1	8.1	12.3	11.9	15.7	13.8
TTC37	"KIAA0372, THES"	ENSG00000198677	"Tetratricopeptide repeat domain 37"	Q6PGP7	5	95463895-95555007	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037905	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037905: AB_10673034"	"unprognostic (5.99e-2)"	"unprognostic (7.65e-3)"	"prognostic favourable (2.62e-4)"	"unprognostic (8.48e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.30e-3)"	"unprognostic (6.88e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.98e-2)"	"unprognostic (7.90e-3)"	29.6	21.8	18.9	16.1	19.4	6.9	19.2	35.7	37.9	21.1	19.7	8.2	20.7	15.6	17.3	15.5	27.5	14.8	13.7	17.5	20.2	14.1	28.2	25.2	17.1	13.8	21.5	21.5	21.3	22.2	40.2	42.1	20.7	26.5	21.1	16.8	6.6	16.8	17.4	33.1	23.9	22.7	21.5	29.8	16.0	18.8	9.1	25.0	25.2	19.7	23.5	15.3	28.1	16.1	10.3	14.8	3.5	7.4	8.2	12.0	3.7	12.4	13.3	16.9	5.8	28.3	38.6	15.1	23.7	19.3	15.5	23.4	14.1	9.1	22.0	15.7	22.6	12.3	21.3	28.7	26.1	12.8	17.4	14.7	27.0	9.3	24.3	9.5	10.7	25.6	14.8	19.7	27.7	24.5	11.5	14.5	29.2	7.1	12.4	7.7	9.5	11.3	10.6	23.6	23.1	17.2	9.8	21.2	16.6	19.6	9.7	21.7	15.1	8.2	33.6	21.2	12.2	16.7	18.2	14.0	17.6	20.5	21.5	14.1	27.2	3.5	6.0	2.1	9.9	7.4	12.0	9.6	9.7	8.0	7.2	10.3	10.0	10.4	0.2	8.2	6.7	14.8	8.8	3.7	18.9	19.4	35.7	37.9	20.2	14.1	21.5	21.5	26.5	25.0
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715822-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"				"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	10.9	10.6	14.5	13.4	17.6	3.5	17.1	13.7	14.0	18.2	10.9	12.8	12.7	9.1	14.9	14.1	11.9	15.7	8.0	13.4	14.6	14.0	13.2	16.4	8.9	13.0	13.5	9.3	18.5	16.6	15.6	14.6	12.5	12.9	13.5	10.8	9.2	13.1	14.7	33.3	14.7	8.5	12.8	20.4	10.3	11.2	13.3	12.0	11.7	11.5	15.1	14.0	11.4	13.6	11.5	11.3	8.6	11.7	15.0	14.9	10.5	9.8	7.5	8.8	4.5	14.3	7.3	7.8	13.6	6.8	17.7	10.7	9.3	2.8	18.3	7.3	9.1	5.7	19.8	13.4	17.9	15.5	15.6	17.6	3.4	5.3	12.6	13.3	4.3	6.5	13.7	25.8	15.8	7.2	18.8	2.3	9.6	4.7	11.8	8.0	18.6	14.3	10.9	18.8	8.3	8.7	2.8	5.8	4.1	11.6	6.1	11.4	5.6	7.3	7.0	8.7	9.6	8.7	18.3	6.6	11.6	14.5	11.1	15.2	8.8	5.9	10.3	8.6	12.5	11.7	13.3	11.5	10.3	11.8	11.3	11.0	14.9	13.2	0.2	15.0	11.3	9.6	9.3	10.5	14.5	17.6	13.7	14.0	14.6	14.0	13.5	9.3	12.9	12.0
TTC5	Strap	ENSG00000136319	"Tetratricopeptide repeat domain 5"	Q8N0Z6	14	20256558-20305994	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045008, HPA054198"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA045008: AB_10960209, HPA054198: "	"unprognostic (2.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (8.54e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.07e-2)"	5.6	7.2	11.2	4.6	13.1	5.7	8.7	9.6	11.7	7.6	4.9	7.3	3.1	4.9	8.7	7.6	5.5	13.0	5.0	4.2	10.5	10.0	8.2	3.3	5.8	6.5	6.9	7.2	7.9	7.6	15.3	12.3	5.5	9.2	8.9	5.5	5.2	6.9	7.3	2.8	7.6	4.8	6.7	6.0	5.2	5.5	5.7	9.0	6.5	11.1	2.5	7.6	5.6	6.0	7.1	5.2	6.7	6.0	6.5	6.8	4.9	3.9	6.4	7.9	0.8	5.9	8.6	4.3	5.1	6.0	7.8	8.1	3.0	9.1	8.4	3.3	5.4	3.3	7.7	3.6	12.1	7.3	3.0	7.0	2.8	5.0	5.9	12.6	4.3	5.2	8.0	6.8	8.9	7.6	4.9	4.2	7.7	5.4	7.4	5.3	6.6	6.1	3.9	5.8	6.1	6.9	4.2	2.8	5.3	5.8	6.2	3.5	4.9	6.2	7.8	3.0	5.1	4.1	2.8	6.1	5.4	10.6	2.5	5.4	7.1	2.5	4.7	6.7	6.8	4.8	5.8	6.5	5.0	5.5	5.2	7.1	5.3	6.4	2.0	6.5	6.0	3.7	5.8	4.9	11.2	13.1	9.6	11.7	10.5	10.0	6.9	7.2	9.2	9.0
TTC7B	TTC7L1	ENSG00000165914	"Tetratricopeptide repeat domain 7B"	Q86TV6	14	90524564-90816479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.0;eosinophil: 9.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058363, HPA059577"	Enhanced		Supported	"Plasma membrane"			11000	"Plasma membrane"		"HPA058363: , HPA059577: "	"unprognostic (9.37e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.87e-2)"	"prognostic favourable (3.20e-6)"	"unprognostic (2.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.07e-2)"	16.2	9.0	29.1	6.6	20.1	6.7	7.1	40.6	33.7	10.0	7.9	10.9	5.6	3.8	11.0	5.0	11.8	5.7	7.0	23.8	26.0	15.9	7.7	6.7	8.9	2.8	14.7	18.3	9.9	17.2	6.7	7.0	19.2	20.3	10.1	3.6	8.8	8.6	11.1	37.4	3.2	4.2	13.1	8.8	10.6	6.1	2.7	8.1	0.3	5.9	2.5	2.1	8.1	4.8	0.4	0.7	9.7	0.6	0.5	1.2	0.7	8.3	7.6	9.0	6.6	8.4	10.0	29.7	6.8	5.9	9.2	9.9	2.0	2.2	0.1	10.8	7.7	0.1	5.8	4.8	8.9	15.3	6.3	18.9	3.9	1.8	8.5	0.4	33.2	7.4	3.2	4.9	6.1	13.1	10.5	15.7	8.8	9.0	0.2	7.4	5.1	6.6	16.4	14.9	2.8	2.9	6.3	13.8	9.5	6.8	2.8	14.5	4.0	5.8	14.9	9.4	7.5	6.8	11.1	5.4	2.6	0.1	13.6	1.8	9.2	7.0	0.3	9.7	0.2	0.6	0.3	0.3	0.3	0.2	0.4	0.4	0.3	0.2	1.4	0.5	0.2	0.7	1.2	0.7	29.1	20.1	40.6	27.8	26.0	15.9	14.7	18.3	20.3	8.1
TTF1		ENSG00000125482	"Transcription termination factor 1"	Q15361	9	132375548-132406851	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"DNA replication inhibitor, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA054837	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA054837: "	"unprognostic (7.07e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.71e-2)"	10.3	6.6	9.9	12.6	14.6	18.0	12.5	15.0	13.4	10.3	12.1	8.5	13.8	6.2	11.9	12.1	8.5	9.6	6.8	16.6	9.8	8.5	8.3	6.2	8.9	12.2	10.4	11.3	11.8	8.7	8.7	15.4	8.3	14.1	13.4	8.8	6.8	9.0	10.1	18.0	9.3	8.6	9.5	13.5	9.7	8.7	11.6	12.7	15.1	16.9	7.0	12.3	13.4	11.5	12.3	10.2	19.4	6.3	7.3	9.1	3.0	7.4	7.1	10.1	9.2	5.6	7.3	9.2	8.4	6.5	9.8	7.1	7.2	8.2	12.2	7.1	6.2	17.9	11.1	6.5	10.6	7.9	7.7	5.6	10.6	5.5	5.6	14.9	9.2	4.4	7.7	8.5	6.3	8.4	11.2	10.8	7.6	11.1	34.4	9.1	18.5	10.9	22.0	13.9	14.5	7.8	6.1	8.9	15.4	11.7	8.9	5.9	11.0	7.9	7.9	16.0	9.8	13.5	9.8	5.1	14.4	14.9	9.0	12.2	15.3	11.3	5.4	10.3	6.5	5.2	8.3	11.2	8.2	7.4	3.3	12.3	9.1	6.9	19.4	7.3	6.3	10.2	8.4	3.0	9.9	14.6	15.0	13.4	9.8	8.5	10.4	11.3	14.1	12.7
TTF2	"HuF2, ZGRF6"	ENSG00000116830	"Transcription termination factor 2"	Q9UNY4	1	117060303-117107453	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005776, HPA070762"	Approved		Supported	Cytosol				Cytosol		"HPA005776: AB_1080416, HPA070762: "	"unprognostic (1.82e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.01e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.41e-3)"	"unprognostic (5.27e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.34e-3)"	"unprognostic (1.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.65e-2)"	5.7	9.4	5.4	8.5	8.4	6.6	6.0	0.9	5.2	5.9	7.0	8.4	2.6	6.0	5.9	2.3	9.8	4.5	3.9	5.8	4.6	3.8	3.9	3.1	4.7	11.5	12.0	2.1	5.5	5.5	6.7	10.7	4.9	7.2	5.0	8.1	4.2	6.5	3.6	8.4	6.9	5.7	6.8	7.7	6.8	5.4	6.3	8.0	25.1	5.2	7.8	17.8	6.4	6.5	3.7	5.9	3.2	6.3	5.3	6.1	2.5	12.5	4.6	9.4	13.2	3.7	3.3	11.7	6.7	3.2	9.9	8.8	6.5	2.2	15.3	10.5	4.4	13.1	16.5	8.7	15.4	11.7	11.7	13.0	9.0	8.2	2.7	19.0	15.0	3.7	3.3	7.3	13.7	6.7	10.0	14.0	7.5	19.2	12.6	11.8	14.6	9.4	18.2	34.6	6.7	6.0	5.7	8.0	3.3	10.1	10.1	3.8	5.5	7.8	6.8	6.3	13.4	14.7	14.6	6.4	5.5	18.8	4.2	14.4	25.2	1.8	5.2	3.2	3.0	6.3	2.9	3.7	3.5	4.7	5.9	3.5	3.6	4.1	0.9	5.3	3.6	3.3	6.1	2.5	5.4	8.4	0.9	5.2	4.6	3.8	12.0	2.1	7.2	8.0
TTI2	"C8orf41, FLJ23263"	ENSG00000129696	"TELO2 interacting protein 2"	Q6NXR4	8	33473386-33513601	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023523, HPA029823"	Approved		Enhanced	Centrosome				Centrosome		"HPA023523: AB_1845776, HPA029823: AB_10602337"	"unprognostic (6.30e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.35e-2)"	10.7	13.1	8.0	9.7	12.2	12.0	10.7	11.1	13.5	11.0	9.3	11.2	6.4	8.7	11.8	10.9	11.4	10.5	7.3	12.7	9.4	7.5	10.7	14.0	9.3	14.9	10.1	10.5	10.9	9.9	11.7	16.5	9.2	9.6	9.8	9.5	11.4	12.1	8.7	14.8	11.0	10.5	9.8	10.7	14.3	9.7	25.7	9.0	22.9	13.2	7.6	17.1	10.3	10.2	22.1	36.7	19.3	14.6	17.2	19.3	24.0	5.2	9.8	12.8	12.8	9.4	6.8	5.4	7.9	9.0	13.3	13.3	7.5	4.4	15.0	12.0	5.8	9.3	20.5	9.2	11.9	6.7	6.2	8.9	5.8	8.0	10.6	8.2	9.0	5.5	11.8	9.9	9.0	11.5	13.5	11.9	9.2	10.5	24.6	8.6	17.1	6.5	16.8	10.4	7.1	7.3	5.6	15.7	8.3	7.8	7.2	9.6	7.3	6.7	7.5	8.2	7.3	8.5	7.6	6.5	6.3	22.3	8.2	8.3	8.8	10.4	14.1	19.3	15.7	14.0	16.1	19.2	16.0	15.6	11.9	22.1	19.3	18.1	13.0	17.2	14.6	36.7	15.2	24.0	8.0	12.2	11.1	13.5	9.4	7.5	10.1	10.5	9.6	9.0
TTLL5	KIAA0998	ENSG00000119685	"Tubulin tyrosine ligase like 5"	Q6EMB2	14	75633625-75955078	"Disease related genes, Predicted intracellular proteins"	Transcription	Ligase	"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032128	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA032128: AB_10600835"	"unprognostic (7.35e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.21e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.15e-2)"	5.9	6.5	7.6	5.9	11.1	10.1	7.4	12.0	10.4	8.0	6.5	18.0	6.4	4.9	11.8	7.7	8.1	11.8	6.7	6.8	7.9	7.1	6.6	4.4	6.6	5.0	10.1	6.9	8.1	5.8	13.2	9.5	7.6	13.9	7.4	7.6	8.2	7.7	7.5	5.2	7.2	4.8	8.9	15.8	4.2	6.0	51.1	10.5	10.1	8.1	5.5	7.3	7.1	7.1	3.8	5.7	12.4	3.8	3.4	5.1	2.3	14.0	10.3	9.1	9.4	7.1	11.2	8.4	8.3	10.1	10.0	12.9	6.3	13.2	4.0	4.6	8.7	13.4	7.8	13.7	19.0	4.7	4.7	7.8	10.8	6.9	6.1	5.6	7.5	8.5	6.8	12.5	14.0	21.4	4.4	6.7	9.9	19.6	9.5	7.7	6.4	10.6	5.9	12.7	5.4	9.6	13.9	12.0	7.6	17.6	12.8	4.4	17.6	6.2	24.2	13.4	11.9	11.8	7.7	5.7	8.1	9.2	13.5	6.5	8.8	12.4	3.5	2.7	4.6	3.3	4.0	3.8	4.2	4.5	5.1	3.5	5.1	4.7	3.8	3.4	3.8	5.7	3.4	2.3	7.6	11.1	12.0	10.4	7.9	7.1	10.1	6.9	13.9	10.5
TUBA1A	"B-ALPHA-1, FLJ25113, TUBA3"	ENSG00000167552	"Tubulin alpha 1a"	Q71U36	12	49184796-49189324	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 270.7;smooth muscle: 166.4"	"Cell line enhanced"	"Detected in many"		"AF22: 222.1;SCLC-21H: 149.7"	"Cancer enriched"	"Detected in all"	9	"glioma: 942.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 151.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008686, HPA039247, HPA043684, HPA063394"	Enhanced		Enhanced	Microtubules				Microtubules		"CAB008686: AB_1624202, HPA039247: , HPA043684: , HPA063394: "	"unprognostic (3.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (9.79e-2)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-3)"	27.8	25.5	82.1	29.4	81.3	24.7	35.4	63.2	163.0	40.6	48.8	210.9	6.9	9.9	71.7	34.8	27.7	65.3	37.9	26.3	99.3	118.3	10.3	4.2	39.8	13.4	131.0	50.2	35.7	9.9	16.0	20.6	23.1	165.2	35.1	26.7	16.7	13.6	53.4	5.9	20.0	14.5	166.4	270.7	11.6	18.3	15.7	50.4	19.4	7.4	7.3	10.6	35.1	14.5	14.8	28.9	151.2	69.2	7.5	15.7	38.4	0.2	10.0	222.1	31.6	20.2	48.9	0.8	18.7	24.0	12.3	28.7	0.6	4.0	7.9	23.3	60.5	0.4	26.3	6.8	9.6	6.6	9.0	2.6	2.0	2.2	3.9	4.7	0.2	27.5	2.6	24.2	2.5	72.9	3.1	9.0	65.9	4.4	20.1	3.8	23.4	7.4	16.2	15.9	1.0	55.0	0.9	149.7	81.9	5.2	0.3	7.1	15.7	6.4	62.0	13.2	8.3	1.5	5.4	3.1	8.7	15.9	7.2	7.7	13.1	38.8	23.0	73.1	15.7	48.9	11.5	14.8	13.9	14.3	28.9	14.6	13.6	12.5	151.2	7.5	69.2	9.3	15.2	38.4	82.1	81.3	63.2	126.2	99.3	118.3	131.0	50.2	165.2	50.4
TUBA1B	K-ALPHA-1	ENSG00000123416	"Tubulin alpha 1b"	P68363	12	49127782-49131397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011513, HPA039247, HPA043684, HPA063394"	Enhanced		Supported	Microtubules				Microtubules		"CAB011513: AB_2210057, HPA039247: , HPA043684: , HPA063394: "	"prognostic unfavourable (5.49e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.10e-2)"	"prognostic unfavourable (1.68e-7)"	"unprognostic (2.98e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavourable (2.85e-12)"	"unprognostic (1.60e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.55e-3)"	78.4	41.5	152.9	86.2	126.0	171.1	64.0	83.7	233.1	47.4	82.7	82.8	13.9	38.7	58.2	59.6	66.2	53.3	43.5	60.6	132.2	162.1	48.3	52.4	66.3	95.4	139.6	107.1	48.7	25.1	33.3	41.0	81.1	210.6	31.9	95.9	52.2	37.8	59.1	28.0	55.8	47.6	138.9	171.2	71.1	45.0	43.9	42.4	177.1	32.9	32.6	117.8	62.3	39.7	31.5	70.8	43.9	116.1	24.2	32.4	63.0	148.6	168.6	183.3	103.8	47.5	69.6	99.1	131.9	133.5	257.1	208.5	212.3	158.2	168.5	95.4	185.3	93.5	201.1	180.4	237.2	94.5	105.9	119.9	100.2	108.1	13.1	179.4	95.5	41.4	27.5	200.7	67.0	219.2	134.0	110.7	208.9	164.2	239.5	143.3	127.1	199.2	194.5	154.4	105.9	120.4	99.7	115.5	98.8	110.6	86.0	39.3	121.7	178.5	116.0	123.6	142.8	122.3	169.7	61.3	88.9	182.2	86.0	144.2	116.0	17.0	24.6	43.9	28.7	111.4	31.7	31.5	27.7	26.6	70.8	28.1	29.6	23.1	31.0	24.2	116.1	70.4	32.4	63.0	152.9	126.0	83.7	233.1	132.2	162.1	139.6	107.1	210.6	42.4
TUBA1C	"bcm948, MGC10851, MGC14580, TUBA6"	ENSG00000167553	"Tubulin alpha 1c"	Q9BQE3	12	49188736-49274603	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 35.4"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039247, HPA043684, HPA063394"	Supported		Supported	Microtubules				Microtubules		"HPA039247: , HPA043684: , HPA063394: "	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.15e-2)"	"prognostic favourable (7.37e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (8.48e-8)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (5.64e-6)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (6.26e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.45e-3)"	40.4	17.0	4.6	22.2	6.7	25.4	22.5	3.5	5.2	39.1	40.8	7.3	20.0	22.2	21.9	27.9	125.5	15.0	40.3	17.6	5.4	4.4	73.2	74.8	24.9	38.9	8.4	1.2	25.2	19.4	5.1	9.4	62.1	22.8	15.1	34.2	28.6	40.9	26.3	18.6	37.5	77.1	27.1	9.3	24.6	25.7	16.7	5.2	52.6	32.7	129.7	82.9	26.7	41.9	4.6	12.1	35.4	7.7	5.4	8.8	7.9	100.2	78.3	17.1	29.3	18.4	31.0	66.6	80.6	90.7	142.3	76.4	76.1	75.9	45.3	86.2	94.6	46.3	100.0	112.7	94.9	43.8	35.8	55.0	34.1	73.3	13.7	42.4	40.7	22.4	54.0	120.9	51.0	91.5	78.7	24.8	122.4	63.2	23.2	41.5	51.6	155.7	26.7	33.6	25.1	62.5	47.7	13.7	0.7	69.9	46.4	30.3	45.2	33.4	66.5	67.5	74.8	66.7	133.9	8.2	23.0	44.0	35.5	42.0	58.2	35.4	6.1	13.2	5.8	7.7	8.8	4.6	6.1	5.3	12.1	3.2	3.0	3.4	5.6	5.4	5.7	9.4	7.6	7.9	4.6	6.7	3.5	5.2	5.4	4.4	8.4	1.2	22.8	5.2
TUBA3C	"bA408E5.3, TUBA2"	ENSG00000198033	"Tubulin alpha 3c"	Q13748	13	19173770-19181852	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	415	"testis: 161.0"	"Group enriched"	"Detected in some"	50	"HDLM-2: 27.4;U-2 OS: 69.7;U-266/70: 22.6;U-266/84: 27.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules				Microtubules		"HPA039247: , HPA043684: , HPA063394: "	"unprognostic (3.76e-3)"				"unprognostic (1.33e-1)"							"unprognostic (3.00e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.26e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	161.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	69.7	0.0	0.0	22.6	27.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUBA3D	H2-ALPHA	ENSG00000075886	"Tubulin alpha 3d"	Q13748	2	131476093-131482934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	5	"testis: 104.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"CAB004972, HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules				Microtubules		"CAB004972: AB_425727, HPA039247: , HPA043684: , HPA063394: "	"prognostic favourable (4.65e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (4.75e-9)"	"unprognostic (4.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.96e-4)"	"unprognostic (2.28e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0.0	1.2	2.9	0.2	1.6	0.2	20.4	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	2.9	0.0	0.2	0.6	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	104.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	1.1	0.0	0.0	0.3	0.0	0.8	0.4	1.6	0.8	0.6	3.0	0.0	0.0	2.0	0.6	0.0	0.0	0.0	2.6	1.2	1.1	0.3	0.0	2.0	0.0	0.0	0.0	1.4	2.3	0.4	0.9	1.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.9	0.1	1.8	1.4	3.2	2.4	1.2	1.1	0.1	0.7	0.0	0.7	1.9	0.3	0.5	0.3	0.0	0.4	0.0	0.9	1.0	1.6	1.5	1.1	0.6	0.6	0.7	0.8	1.1	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.8	0.6	0.4	0.0	1.1	0.7	0.8	0.0	0.0	0.3	0.0	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TUBA3E		ENSG00000152086	"Tubulin alpha 3e"	Q6PEY2	2	130191743-130198461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"heart muscle: 14.2;testis: 51.0"	"Group enriched"	"Detected in some"	12	"BEWO: 8.8;U-2 OS: 5.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules				Microtubules		"HPA039247: , HPA043684: , HPA063394: "	"unprognostic (1.02e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.65e-7)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.02e-3)"	"unprognostic (8.94e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	1.1	0.4	0.1	0.7	0.1	14.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	51.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.0	0.5	0.1	0.9	0.1	0.1	0.0	0.0	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.4	0.4	0.0	0.9	0.5	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249711-219278170	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	Microtubules			500000000	Microtubules		"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: , HPA043684: , HPA063394: "	"unprognostic (8.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (4.54e-6)"	"unprognostic (1.52e-3)"	"unprognostic (4.47e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.32e-2)"	5.0	9.4	22.4	13.4	30.5	37.7	7.5	23.2	63.3	7.4	13.8	4.5	5.2	8.1	3.4	5.2	27.1	6.1	6.1	23.5	24.9	23.6	13.2	10.5	7.2	20.9	20.4	21.9	6.1	8.0	18.1	6.5	2.9	43.1	7.9	12.4	5.7	15.6	10.7	124.1	63.5	9.5	6.2	6.2	15.7	10.1	8.2	3.3	6.2	3.7	34.8	25.0	9.1	13.9	25.8	4.2	66.8	13.0	14.8	32.0	49.2	19.0	15.9	0.0	0.0	1.7	1.3	0.0	2.9	9.2	0.5	0.3	3.5	20.0	25.1	32.7	2.0	48.3	8.9	78.8	0.7	14.6	0.1	31.5	29.7	2.6	1.4	10.5	11.3	1.2	29.2	4.3	9.3	3.2	3.5	17.2	18.9	0.7	0.0	18.9	6.1	19.0	1.1	25.9	15.3	24.3	1.3	16.1	0.2	37.5	3.3	0.1	1.4	8.9	2.2	9.5	5.1	11.0	10.2	7.0	8.5	30.2	34.8	20.0	0.4	22.1	12.5	32.4	22.5	8.6	23.2	25.8	32.0	30.2	4.2	17.7	30.4	29.5	66.8	14.8	13.0	0.7	27.5	49.2	22.4	30.5	23.2	63.3	24.9	23.6	20.4	21.9	43.1	3.3
TUBA8	TUBAL2	ENSG00000183785	"Tubulin alpha 8"	Q9NY65	22	18110331-18146554	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 50.3;skeletal muscle: 125.4"	"Group enriched"	"Detected in many"	6	"NB-4: 20.4;SCLC-21H: 10.1;TIME: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2;NK-cell: 5.8"	"Group enriched"	"Detected in many"	14	"granulocytes: 4.2;NK-cells: 5.8"	"Group enriched"	"Detected in many"	4	"cerebellum: 61.3;olfactory region: 66.2"	"Low region specificity"	"Detected in all"			"HPA043684, CAB046031, HPA063394"	Approved		Supported	Microtubules			260000000	Microtubules		"CAB046031: AB_11124541, HPA043684: , HPA063394: "	"unprognostic (1.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.90e-5)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.61e-4)"	3.2	1.2	5.3	1.2	10.5	2.4	2.5	20.5	23.4	1.4	1.2	1.5	0.2	1.5	1.2	4.3	2.6	1.6	1.3	50.3	7.5	5.6	1.2	2.0	1.2	2.2	3.9	9.2	1.3	2.2	1.8	4.3	1.0	2.5	1.7	1.1	0.4	2.1	1.2	125.4	1.4	1.4	1.2	1.1	1.6	1.7	19.2	1.0	0.0	3.5	13.3	1.3	1.1	0.3	0.0	0.2	4.2	0.1	5.8	0.3	15.7	0.4	0.9	0.7	0.8	1.3	0.8	0.3	0.7	0.7	1.2	1.1	0.3	0.9	0.6	3.3	0.6	0.3	2.1	0.1	0.3	1.9	1.9	2.3	0.4	0.3	0.7	1.4	1.2	0.7	0.6	0.8	0.1	1.8	0.9	0.7	0.4	2.6	1.7	20.4	0.9	1.0	1.6	0.0	0.2	0.4	0.3	10.1	1.1	0.4	0.5	1.2	0.5	3.3	25.4	0.1	0.2	0.7	0.5	2.3	1.1	0.7	0.8	0.9	0.2	1.2	0.1	2.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	4.2	5.8	0.1	0.2	0.0	15.7	5.3	10.5	20.5	23.4	7.5	5.6	3.9	9.2	2.5	1.0
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30720201-30725426	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	Microtubules			510000000	Microtubules		"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: , HPA046280: "	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	51.6	27.7	30.0	31.8	33.2	78.8	30.0	30.9	57.2	43.3	37.0	24.3	18.7	10.8	58.5	39.7	39.9	41.0	29.6	33.1	23.7	48.2	31.4	74.1	32.7	62.1	27.8	24.0	81.5	27.0	15.3	16.3	41.1	39.9	32.2	34.2	30.6	27.9	24.3	29.6	37.6	24.3	37.6	27.4	47.7	29.1	19.7	14.4	198.7	26.9	36.8	91.5	39.7	34.3	15.4	17.5	8.6	15.4	12.3	18.2	19.8	41.9	15.5	60.6	26.3	17.1	29.7	0.5	0.0	0.0	0.0	0.0	29.6	16.1	21.0	26.0	19.4	14.5	48.9	44.0	0.0	11.8	30.9	0.5	0.0	16.9	8.2	57.2	28.2	22.0	10.3	0.0	0.5	21.3	16.5	0.0	26.6	30.3	41.3	0.2	0.0	18.3	0.0	0.6	12.3	35.4	23.9	10.5	35.4	22.8	10.1	0.4	26.4	5.2	13.1	63.8	28.4	0.0	0.2	19.6	37.6	48.6	12.6	56.9	80.6	4.9	7.7	8.6	15.5	12.2	18.2	15.4	12.1	17.6	6.2	10.0	12.3	12.2	4.3	12.3	15.4	17.5	14.2	19.8	30.0	33.2	30.9	57.2	23.7	48.2	27.8	24.0	39.9	14.4
TUBB2A	"dJ40E16.7, TUBB, TUBB2"	ENSG00000137267	"Tubulin beta 2A class IIa"	Q13885	6	3153669-3157526	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 158.3"	"Cell line enhanced"	"Detected in many"		"AF22: 53.3;CACO-2: 53.8;WM-115: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 6.0;monocytes: 2.6;T-cells: 5.5"	"Low region specificity"	"Detected in all"							"CAB015339, HPA043640, HPA046280"	Supported		Supported	Microtubules				Microtubules		"CAB015339: AB_2210539, HPA043640: , HPA046280: "	"unprognostic (2.57e-1)"	"unprognostic (9.86e-3)"	"unprognostic (5.90e-3)"	"unprognostic (7.98e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.42e-2)"	"prognostic favourable (4.65e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (1.61e-4)"	19.6	9.1	59.4	8.7	46.9	26.8	7.9	46.5	158.3	5.4	8.7	9.1	1.2	11.1	6.7	13.5	17.2	4.8	10.9	6.1	56.5	76.0	7.7	16.9	4.1	5.4	58.4	43.3	2.6	14.3	1.6	6.9	11.0	78.6	6.1	4.5	4.6	5.8	8.0	7.3	24.7	13.8	17.7	24.3	2.3	17.6	2.9	5.4	0.1	1.9	10.4	4.7	5.4	5.8	6.0	0.9	0.7	2.6	0.6	5.5	1.8	11.4	9.7	53.3	12.0	6.7	7.5	3.1	25.5	9.5	17.5	25.4	53.8	3.9	5.7	15.8	24.1	5.5	18.8	5.8	6.1	27.6	12.5	1.9	2.8	16.2	7.0	0.3	1.9	7.8	6.8	18.3	1.2	8.0	6.8	2.0	15.6	5.1	3.0	0.6	45.6	12.5	2.6	5.0	4.3	5.9	5.9	13.3	12.2	6.4	1.9	36.5	4.1	0.4	16.0	11.8	12.9	25.5	13.7	0.8	0.9	3.8	4.3	1.5	59.5	0.0	1.9	0.0	4.0	2.6	4.4	6.0	3.9	5.5	0.9	1.2	2.1	3.7	0.7	0.6	2.0	0.3	5.3	1.8	59.4	46.9	46.5	89.2	56.5	76.0	58.4	43.3	78.6	5.4
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 62.6;brain: 197.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 35.5;HAP1: 20.4;HEL: 29.8;PC-3: 14.8;REH: 14.7"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"B-cells: 5.3;T-cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	Microtubules			360000000	Microtubules		"CAB010768: AB_261775, HPA043640: , HPA046280: "	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	2.3	62.6	41.3	2.9	52.4	2.2	2.3	115.3	197.8	2.2	2.9	115.2	0.0	2.7	2.3	2.3	2.5	2.3	2.4	2.3	56.8	36.9	2.8	2.2	2.3	2.6	73.7	34.5	2.6	2.8	2.1	0.2	2.5	72.0	2.2	2.5	2.7	2.7	2.3	3.9	4.6	3.2	2.5	73.2	4.8	2.2	31.3	43.0	0.0	2.1	0.0	2.4	2.3	0.1	5.3	0.1	0.2	0.0	0.4	6.5	1.6	0.0	10.5	0.0	35.5	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.0	10.4	0.0	0.3	20.4	0.0	0.2	0.0	3.4	29.8	0.7	0.3	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	2.8	0.2	0.0	1.0	5.9	1.3	2.6	14.8	14.7	0.0	7.0	3.8	0.0	0.1	11.8	0.1	0.1	10.4	0.3	0.7	0.0	0.0	4.4	0.0	0.1	0.8	0.5	4.0	0.4	0.0	0.2	0.0	0.0	0.0	6.3	0.0	4.6	5.3	1.0	6.5	0.0	1.6	2.2	4.7	0.2	0.4	0.0	0.1	0.0	1.6	41.3	52.4	115.3	79.7	56.8	36.9	73.7	34.5	72.0	43.0
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241213-137243707	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 207.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	Microtubules				Microtubules		"CAB010880: AB_609915, HPA043640: , HPA046280: "	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavourable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favourable (6.36e-6)"	"unprognostic (1.69e-1)"	31.1	22.1	33.0	22.1	32.7	87.5	24.4	22.3	67.2	23.0	44.0	35.9	25.2	33.4	22.7	52.7	65.7	122.5	32.1	66.4	35.2	55.5	46.6	49.7	28.4	21.0	33.8	46.6	33.7	33.0	13.4	25.3	31.9	48.4	29.8	27.3	40.9	41.8	31.8	37.1	55.9	38.9	28.4	21.5	21.0	30.5	207.7	12.2	61.1	40.1	56.7	40.1	21.8	25.7	17.2	18.3	37.0	14.6	11.2	21.7	14.4	59.3	89.1	38.1	27.5	19.2	20.3	53.2	55.8	47.0	77.3	53.4	94.1	73.2	36.5	42.8	54.2	113.2	47.1	89.9	29.5	25.9	39.9	26.4	71.0	73.9	12.2	31.1	29.4	13.0	25.5	59.0	16.2	55.1	36.8	21.0	63.6	163.4	28.1	42.3	40.2	155.5	35.9	72.8	33.7	58.0	55.6	26.7	28.7	74.0	42.6	14.8	61.3	33.9	42.8	55.2	61.6	62.5	73.4	8.2	22.5	40.2	45.0	24.3	47.9	37.0	14.1	20.5	21.4	14.6	20.6	17.2	16.7	18.2	17.5	14.1	10.7	14.3	28.6	11.2	14.6	18.3	21.7	14.4	33.0	32.7	22.3	67.2	35.2	55.5	33.8	46.6	48.4	12.2
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859482-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (1.92e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (2.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (1.00e-5)"	"unprognostic (2.86e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (6.06e-4)"	"unprognostic (4.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.83e-2)"	8.7	8.0	9.3	8.1	13.8	6.8	12.4	19.9	12.2	12.3	11.2	13.5	16.6	6.7	13.6	16.4	18.2	10.0	8.3	8.4	8.9	7.2	8.5	9.3	8.8	10.2	16.1	8.5	16.3	13.2	10.4	18.7	7.2	12.3	12.3	8.2	11.7	11.4	12.2	9.9	11.6	7.5	9.3	13.4	9.3	9.6	9.2	16.4	16.2	15.5	10.3	13.8	14.1	13.0	10.1	8.8	14.1	7.6	8.1	17.6	6.9	5.9	8.1	6.4	6.7	3.6	2.6	5.4	4.6	2.7	6.1	5.1	8.8	3.9	5.4	7.9	1.0	5.0	8.9	2.8	5.9	3.1	10.9	6.3	6.9	10.4	1.9	3.7	3.4	1.4	4.4	5.3	2.0	4.8	13.5	3.8	2.1	41.9	7.6	4.3	5.6	3.6	8.2	9.4	8.4	2.4	2.7	6.0	3.6	3.3	2.6	3.2	6.3	3.6	1.5	4.4	9.8	3.1	5.0	4.4	6.6	8.2	2.1	4.3	3.9	5.6	7.6	14.1	10.9	5.0	12.4	10.1	13.5	11.5	5.2	8.6	17.6	14.2	8.2	8.1	5.3	8.8	14.1	6.9	9.3	13.8	19.9	12.2	8.9	7.2	16.1	8.5	12.3	16.4
TUBG2		ENSG00000037042	"Tubulin gamma 2"	Q9NRH3	17	42659305-42667006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011495	Approved		Supported	"Centriolar satellite"				"Centriolar satellite"		"CAB011495: AB_443396"	"unprognostic (2.60e-1)"	"unprognostic (5.85e-3)"	"unprognostic (6.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (4.68e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (2.31e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.61e-3)"	15.4	17.7	32.9	5.8	34.5	2.8	10.3	21.7	55.7	13.3	9.6	24.2	5.5	5.8	13.9	14.2	9.9	14.4	10.2	17.2	34.5	24.3	12.6	5.2	10.9	6.6	25.7	29.2	20.7	29.9	17.6	14.2	8.7	30.4	13.5	5.4	11.7	15.7	22.5	6.6	11.2	5.3	13.5	19.4	9.1	9.5	8.3	20.8	1.0	13.0	3.1	5.2	12.2	9.7	2.1	7.1	0.5	1.4	1.4	5.9	2.7	5.0	10.5	5.1	7.7	20.2	11.2	3.3	9.0	10.1	7.3	7.2	5.8	3.7	2.5	5.4	12.9	18.9	0.1	8.2	5.9	4.9	6.0	1.8	13.3	11.5	8.8	0.2	6.8	12.3	8.7	8.4	9.0	5.2	0.5	5.6	13.8	10.5	4.8	4.3	1.8	2.7	3.7	3.2	5.6	7.6	5.2	5.9	4.1	5.7	9.2	5.9	17.6	2.4	5.8	23.2	1.6	5.8	5.1	29.4	5.2	0.8	8.1	0.2	13.5	0.0	1.4	0.3	5.0	0.9	2.3	2.1	5.4	1.9	1.5	0.9	5.9	3.9	0.5	1.4	0.3	7.1	2.4	2.7	32.9	34.5	21.7	55.7	34.5	24.3	25.7	29.2	30.4	20.8
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278630-133312337	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.3	26.7	16.7	17.3	25.6	29.4	21.4	28.6	33.4	20.3	19.3	22.5	25.2	19.2	23.2	18.9	19.8	35.1	21.7	18.6	21.9	17.2	24.4	22.2	22.8	27.7	16.3	26.5	28.3	30.9	31.9	23.0	17.0	22.3	20.8	16.0	19.0	26.8	22.3	30.4	24.1	19.7	17.6	16.7	25.6	20.1	33.5	15.4	25.6	23.0	18.3	19.5	19.3	18.2	6.1	14.3	17.3	11.9	12.1	10.4	8.7	18.2	25.4	9.4	9.5	10.0	10.9	12.0	14.3	23.3	17.7	17.9	26.4	12.8	13.8	8.1	16.3	12.3	12.5	11.7	7.8	12.9	24.0	8.8	12.5	14.5	12.6	18.8	16.3	11.3	10.3	16.4	20.4	11.6	10.7	11.2	14.2	25.0	10.3	20.9	8.2	20.2	8.2	10.9	6.0	11.6	9.5	6.4	12.7	10.2	11.5	11.5	8.3	9.7	14.0	8.6	7.8	11.3	12.7	11.2	7.6	16.1	34.7	8.5	5.5	5.0	11.9	11.9	7.6	11.2	8.5	6.0	7.6	8.0	14.3	6.1	8.7	9.0	17.3	12.1	11.8	6.5	10.4	8.7	16.7	25.6	28.6	33.4	21.9	17.2	16.3	26.5	22.3	15.4
TUBGCP4	"76P, FLJ14797"	ENSG00000137822	"Tubulin gamma complex associated protein 4"	Q9UGJ1	15	43369221-43409771	"Disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043212	Approved		Supported	Centrosome				Centrosome		"HPA043212: AB_10796690"	"unprognostic (1.34e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-1)"	8.2	9.6	10.9	10.4	16.2	9.6	11.6	23.6	19.4	11.6	9.9	9.4	4.3	10.7	11.6	8.4	10.9	10.9	6.8	10.8	9.8	13.1	9.4	12.8	7.9	9.6	11.4	9.2	12.6	15.2	19.4	14.1	8.5	13.3	10.6	12.2	11.8	11.5	9.1	14.6	10.5	9.8	11.4	8.6	8.4	9.1	10.9	11.6	12.6	10.7	8.8	12.1	10.0	9.1	3.9	5.8	14.5	3.3	5.4	4.2	2.5	11.2	3.5	8.6	8.8	8.5	9.2	6.6	6.5	4.7	9.1	9.1	11.3	7.0	7.1	9.9	5.5	18.8	18.0	11.5	10.6	11.7	17.2	18.2	20.1	9.8	7.1	12.5	11.5	5.0	11.6	9.3	13.0	7.3	17.3	6.1	6.6	3.9	10.0	9.7	4.0	14.2	13.6	11.3	10.4	5.9	10.8	23.0	7.9	7.9	15.4	2.7	9.0	9.8	6.0	8.6	8.9	11.8	14.2	6.6	7.5	12.4	8.0	18.2	9.6	0.1	2.7	14.5	4.2	3.3	3.1	3.9	3.2	3.0	5.8	3.6	2.4	3.5	0.3	5.4	1.6	3.1	3.5	2.5	10.9	16.2	23.6	19.4	9.8	13.1	11.4	9.2	13.3	11.6
TUBGCP5	"GCP5, KIAA1899"	ENSG00000275835	"Tubulin gamma complex associated protein 5"	Q96RT8	15	22983192-23039673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039366, HPA040366"	Supported		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA039366: AB_10673243, HPA040366: "	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.53e-3)"	5.1	5.7	5.7	5.1	8.4	5.5	7.3	4.0	10.4	7.9	4.6	6.0	4.6	4.2	7.4	8.7	5.9	4.9	4.7	6.6	7.7		6.3	6.8	5.6	5.5	6.0	11.0	5.0	10.0	10.2	6.3	4.8	12.9	7.5	5.3	5.3	4.0	7.4	14.5	7.3	3.0	9.3	10.0	4.8	5.3	12.9	5.9	5.4	8.6	7.0	6.1	4.6	0.8	5.3	4.0	1.5	3.3	5.4	7.6	2.5	12.1	12.9	15.3	9.0	11.8	7.7	8.8	15.2	16.8	16.8	14.6	9.8	5.8	9.2	6.5	13.9	12.3	10.0	11.8	14.1	14.2	4.0	16.6	13.0	5.2	3.9	16.9	7.4	12.6	4.5	11.2	10.4	10.0	11.7	15.0	10.6	8.0	11.3	7.3	9.0	11.8	14.0	16.8	1.8	9.7	19.0	5.2	8.9	12.4	8.7	7.9	14.1	7.9	8.6	11.6	7.6	8.9	22.5	11.8	11.8	24.9	15.2	11.2	10.8	0.2	2.3	0.9	4.5	3.3	4.6	3.7	6.7	7.2	3.6	5.3	6.0	7.6	1.5	5.4	3.3	4.0	5.4	2.5										
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria			2800000	Mitochondria		"CAB075730: , CAB075731: , CAB075732: , HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	27.3	47.8	28.8	32.3	31.3	27.2	40.4	22.3	41.4	25.3	41.7	27.1	34.4	44.0	26.6	22.3	40.0	32.7	37.6	69.2	25.6	25.8	45.6	68.4	28.6	46.2	33.1	24.4	25.9	75.0	48.3	22.7	23.0	27.3	23.4	37.6	25.4	40.9	33.1	77.3	28.1	36.1	26.2	25.8	28.4	36.9	47.0	21.5	32.5	37.0	55.4	33.9	26.8	23.3	30.6	57.3	21.7	44.2	25.5	38.8	45.4	29.1	55.4	17.8	37.1	25.8	23.7	36.5	21.4	24.9	34.1	32.4	59.7	32.3	65.6	39.5	21.4	57.2	42.1	41.4	20.5	26.1	64.4	25.0	44.8	72.2	30.7	44.8	23.3	30.2	32.8	36.9	36.7	40.6	56.1	25.9	24.8	59.4	42.9	43.8	39.8	34.4	59.5	32.3	95.4	29.5	28.6	31.2	38.1	18.7	66.7	29.2	39.7	36.5	25.8	20.4	23.8	25.3	32.6	39.6	40.9	28.5	26.1	56.3	26.7	21.7	44.2	19.5	31.3	42.3	34.8	30.6	29.7	32.7	57.3	27.5	28.5	29.5	9.1	25.5	31.6	34.9	38.8	45.4	28.8	31.3	22.3	41.4	25.6	25.8	33.1	24.4	27.3	21.5
TULP3	TUBL3	ENSG00000078246	"Tubby like protein 3"	O75386	12	2877223-2941140	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015285, HPA018496"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"	"Secreted - unknown location"			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA015285: AB_1858460, HPA018496: "	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.80e-2)"	"prognostic favourable (2.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (7.18e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"	14.0	12.0	8.1	6.9	12.9	2.4	13.0	21.2	11.1	22.7	13.6	19.6	12.6	5.3	27.7	11.7	14.1	20.9	11.5	12.7	12.1	5.3	12.1	6.5	9.5	7.2	11.0	7.7	37.1	6.8	13.5	15.4	12.7	10.9	12.5	8.1	17.2	9.8	14.0	9.9	19.8	7.0	17.5	9.7	7.3	11.7	13.2	13.8	4.4	13.3	6.3	9.2	11.6	28.4	3.5	2.8	0.6	1.5	4.8	6.3	1.7	9.2	7.9	15.0	12.5	15.2	22.7	14.2	14.6	24.5	15.8	17.5	10.0	8.6	6.9	2.2	21.5	7.8	8.9	9.4	18.3	8.9	6.6	4.1	9.8	6.4	19.6	4.4	4.8	13.3	11.1	23.8	32.7	12.1	3.9	6.5	13.2	8.3	6.5	3.9	20.3	5.8	6.9	14.7	2.5	9.9	7.8	3.8	10.1	12.7	7.6	8.3	9.5	4.3	9.7	11.6	14.1	23.6	14.1	2.0	2.4	6.0	11.7	2.4	17.7	0.0	1.5	0.5	4.0	1.5	6.3	2.9	3.1	4.0	1.3	3.5	3.8	5.2	0.6	4.8	0.8	2.8	5.5	1.7	8.1	12.9	21.2	11.1	12.1	5.3	11.0	7.7	10.9	13.8
TUT1	"FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase"	ENSG00000149016	"Terminal uridylyl transferase 1, U6 snRNA-specific"	Q9H6E5	11	62575045-62592177	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA069055, HPA071838"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA069055: , HPA071838: "	"unprognostic (3.81e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavourable (9.51e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-3)"	10.9	12.1	10.7	9.9	13.6	7.8	12.9	13.5	13.3	10.5	8.7	15.9	13.0	12.9	11.5	10.8	10.0	16.9	13.7	10.7	13.6	8.3	12.2	22.7	9.6	18.1	15.5	9.5	14.5	26.2	15.5	16.2	12.3	13.0	13.9	6.2	11.9	16.4	11.9	20.5	13.9	11.7	10.2	11.4	14.6	12.5	18.6	13.2	17.1	14.0	8.8	13.6	11.5	9.8	13.1	9.4	6.6	7.3	9.8	16.0	7.2	7.2	9.1	6.3	8.8	7.7	4.4	8.2	7.8	4.8	6.6	5.8	8.2	14.2	11.6	18.1	3.8	13.7	11.6	9.1	3.4	8.9	6.1	11.9	9.3	7.7	8.6	8.4	5.4	6.2	9.8	8.3	12.6	6.3	17.8	12.0	5.6	15.9	11.9	17.9	7.2	11.2	13.4	10.1	28.1	6.1	4.2	10.5	14.7	6.0	11.3	9.7	15.8	8.2	5.7	7.5	6.8	8.7	5.9	20.9	18.3	14.2	8.8	6.7	6.2	5.9	5.9	6.6	10.5	7.3	14.6	9.8	9.9	8.4	7.8	13.1	16.0	12.5	3.6	9.8	5.3	9.4	8.9	7.2	10.7	13.6	13.5	13.3	13.6	8.3	15.5	9.5	13.0	13.2
TVP23C	"FAM18B2, MGC8763"	ENSG00000175106	"Trans-golgi network vesicle protein 23 homolog C"	Q96ET8	17	15502264-15563595	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA019585, HPA065603"	Uncertain		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA019585: AB_1848385, HPA065603: "	"unprognostic (2.87e-3)"	"unprognostic (5.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.33e-3)"	"unprognostic (3.00e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.09e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.45e-2)"	5.2	5.8	4.4	4.7	6.1	15.8	6.6	15.0	9.1	5.5	3.6	4.7	12.0	2.9	6.8	7.3	6.1	5.0	5.2	4.2	4.2	4.2	4.3	3.8	4.6	4.2	4.2	6.6	10.0	6.2	5.4	19.0	6.2	10.2	6.7	3.2	8.2	6.8	7.4	3.7	5.6	3.8	3.5	5.6	5.3	3.8	8.8	3.1	1.6	9.0	1.3	4.6	5.4	6.0	8.2	4.3	12.1	5.4	6.1	8.0	4.8	7.9	6.9	2.9	3.4	3.2	1.6	3.7	6.1	10.3	10.8	12.9	9.6	3.0	0.0	3.5	5.1	3.5	7.8	5.4	7.9	4.9	4.8	4.7	6.8	12.2	3.3	2.0	5.6	2.8	1.6	10.7	6.2	9.8	5.8	3.8	5.0	2.8	3.0	5.3	3.5	2.6	0.5	0.3	0.4	3.0	4.4	0.9	2.3	7.9	1.2	1.6	4.7	1.0	6.7	1.8	2.8	2.8	2.6	1.9	1.7	0.0	2.2	0.0	1.6	12.1	2.5	11.1	5.1	5.4	6.4	8.2	6.5	7.2	4.1	5.1	8.0	7.2	4.0	6.1	3.8	4.3	6.0	4.8	4.4	6.1	15.0	9.1	4.2	4.2	4.2	6.6	10.2	3.1
TWF1	"A6, PTK9"	ENSG00000151239	"Twinfilin actin binding protein 1"	Q12792	12	43793723-43806375	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018116	Approved		Supported	Cytosol				Cytosol		"HPA018116: AB_1855899"	"unprognostic (3.06e-1)"	"unprognostic (1.95e-2)"	"prognostic favourable (8.29e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.51e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.62e-1)"	14.2	15.8	15.1	11.0	15.8	11.8	20.4	7.8	13.5	17.9	19.7	8.5	33.1	20.5	13.3	15.4	39.5	13.8	14.8	6.7	14.9	11.9	17.6	31.3	12.6	13.7	16.1	9.6	15.7	21.0	8.8	23.5	14.0	14.6	14.6	20.5	4.6	14.8	32.1	3.5	10.7	24.1	16.0	15.7	10.0	16.9	9.7	12.7	7.1	25.0	19.1	9.6	18.3	19.4	7.8	5.4	10.1	5.2	14.7	8.7	4.1	26.6	19.9	10.4	12.6	27.1	31.4	25.4	37.6	30.9	30.5	23.1	31.9	37.5	7.2	35.0	35.8	18.2	14.2	26.7	43.4	2.5	16.6	6.7	16.9	15.0	22.2	7.6	8.7	21.4	21.8	31.6	35.4	26.5	7.2	8.2	47.2	14.2	3.6	5.3	6.3	32.8	3.1	11.7	8.1	40.3	33.5	7.7	11.5	31.2	28.4	27.0	26.5	7.6	25.4	37.7	25.1	30.1	31.0	7.2	7.0	9.9	34.6	19.8	14.2	10.1	3.3	6.7	6.7	4.9	7.6	7.8	8.1	8.3	5.4	3.9	8.1	8.7	5.4	14.7	5.2	3.4	8.0	4.1	15.1	15.8	7.8	13.5	14.9	11.9	16.1	9.6	14.6	12.7
TWF2	"A6r, A6RP, PTK9L"	ENSG00000247596	"Twinfilin actin binding protein 2"	Q6IBS0	3	52228610-52239260	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053874	Uncertain		Supported	"Plasma membrane"			14000000	"Plasma membrane"		"HPA053874: "	"unprognostic (4.24e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.07e-2)"	25.0	13.0	10.4	21.0	10.9	17.0	22.3	17.5	21.1	13.8	15.2	7.7	10.4	12.1	14.3	13.1	17.2	11.4	18.7	38.8	13.2	9.4	13.9	11.7	16.5	39.4	9.2	13.2	14.4	10.9	5.4	7.5	11.0	9.1	13.4	7.1	10.4	18.2	13.5	81.7	11.9	13.5	13.5	8.4	23.3	13.4	7.9	7.3	34.5	9.4	15.4	19.5	18.7	14.3	32.3	46.8	72.5	50.1	26.9	40.9	38.7	6.5	16.9	5.9	10.3	19.3	23.6	10.5	15.5	25.1	18.6	16.7	8.8	18.1	23.6	10.3	18.2	11.6	7.4	21.7	4.2	14.9	9.7	24.2	12.7	21.2	16.7	14.6	40.8	21.9	10.4	22.0	7.5	28.2	5.6	12.3	13.9	5.7	20.1	33.6	9.2	47.9	7.8	6.1	24.7	14.6	10.6	4.6	17.7	5.5	23.4	30.7	5.3	15.9	29.0	18.2	19.9	14.1	13.3	11.1	9.8	11.5	35.9	41.4	21.9	26.8	50.1	39.6	33.7	48.9	30.6	32.3	35.9	35.8	46.8	25.4	28.9	35.6	72.5	26.9	49.5	42.3	40.9	38.7	10.4	10.9	17.5	21.1	13.2	9.4	9.2	13.2	9.1	7.3
TWIST2	"bHLHa39, Dermo-1, DERMO1"	ENSG00000233608	"Twist family bHLH transcription factor 2"	Q8WVJ9	2	238848032-238910543	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 34.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.8;ASC TERT1: 20.9;BJ: 26.6;BJ hTERT+: 83.9;fHDF/TERT166: 38.0;U-2197: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 11.2"	"Lineage enriched"	"Detected in single"	52	"granulocytes: 11.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062870			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA062870: "	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-9)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.48e-2)"	25.8	1.3	0.2	4.7	0.6	0.6	21.7	0.1	0.4	34.6	8.4	0.4	4.3	0.6	14.3	6.2	9.1	7.4	5.8	4.3	0.6	0.2	0.7	0.3	4.2	0.9	1.1	0.0	15.6	0.7	0.0	2.1	9.1	0.4	13.1	1.9	3.9	2.2	7.1	4.3	9.7	2.3	12.4	1.7	1.2	3.3	4.6	0.5	0.0	4.0	6.4	3.4	15.9	18.6	0.2	0.0	11.2	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	32.8	20.9	0.0	26.6	83.9	12.4	18.7	0.0	0.0	0.0	0.8	38.0	0.2	0.3	2.1	9.1	0.0	2.8	0.0	1.6	0.1	5.6	0.0	0.6	4.8	1.1	6.0	5.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	4.6	0.5	0.9	32.5	0.3	0.0	0.0	0.0	0.1	0.8	1.7	0.0	0.1	11.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.3	0.6	0.2	1.1	0.0	0.4	0.5
TWISTNB		ENSG00000105849	"TWIST neighbor"	Q3B726	7	19695462-19709087	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	16.4	13.9	11.5	13.6	17.6	21.5	15.8	13.2	20.8	16.1	14.0	9.9	12.3	8.5	20.4	9.4	14.8	14.3	9.7	14.6	13.5	12.5	13.3	15.9	9.9	16.6	13.1	11.7	17.5	12.6	15.4	12.0	16.4	13.5	15.3	11.0	6.4	11.4	14.5	25.5	13.8	11.4	22.7	13.4	17.7	12.4	10.8	11.3	20.8	13.6	14.1	18.8	20.2	14.4	10.8	7.7	3.5	5.0	14.6	11.6	5.0	11.5	8.8	6.5	9.7	7.6	9.4	5.1	6.6	5.0	7.8	9.1	7.2	10.2	12.9	19.5	8.3	10.5	13.2	12.4	14.6	4.1	10.2	12.0	7.1	5.5	11.7	24.4	8.7	8.5	8.8	8.6	10.3	12.7	18.4	11.7	11.2	4.2	13.4	22.9	17.0	10.0	10.9	11.3	13.6	12.9	6.0	4.7	7.2	6.0	16.6	8.3	6.6	22.0	10.6	16.3	8.7	15.0	16.1	15.0	9.2	33.0	10.9	36.8	23.8	3.5	3.9	1.1	7.2	5.0	10.8	10.8	8.6	9.5	6.0	10.4	10.0	11.6	0.3	14.6	4.7	7.7	7.8	5.0	11.5	17.6	13.2	20.8	13.5	12.5	13.1	11.7	13.5	11.3
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"		6600000	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	13.0	8.9	8.3	6.9	8.5	2.9	17.3	5.0	6.2	21.9	17.4	9.3	56.2	4.7	33.0	21.5	19.0	14.4	16.4	9.2	8.4	7.1	19.8	4.8	12.6	6.6	11.0	6.1	20.4	4.4	12.7	11.4	10.7	9.1	26.5	10.2	10.6	9.4	34.8	6.1	7.6	8.6	36.0	12.3	9.4	12.0	13.0	8.1	4.3	20.5	8.7	6.8	26.0	17.9	3.3	7.8	7.5	4.1	4.1	7.5	3.1	14.8	5.4	15.6	7.7	30.8	27.9	7.2	28.4	35.4	15.6	22.5	5.7	19.6	2.1	14.4	37.5	5.2	15.2	11.2	28.9	5.8	4.3	3.8	4.6	2.8	27.4	2.7	8.0	28.2	9.2	13.1	6.3	24.2	5.8	3.9	40.0	4.5	3.0	3.4	5.1	4.4	5.3	16.0	1.3	17.7	19.9	2.0	5.4	22.3	6.2	6.0	7.0	6.5	20.0	28.7	14.4	26.9	17.7	5.8	5.1	4.0	17.6	3.9	10.1	7.5	4.1	5.8	6.7	2.2	4.4	3.3	3.2	6.8	7.8	2.8	3.8	7.5	2.0	4.1	0.7	7.8	1.4	3.1	8.3	8.5	5.0	6.2	8.4	7.1	11.0	6.1	9.1	8.1
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243811-110256640	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 447.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 127.1;granulocytes: 104.5"	"Low region specificity"	"Detected in all"							"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"		25000000	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favourable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	23.6	16.7	26.6	18.2	16.9	35.8	25.9	10.8	19.7	30.8	57.9	7.7	17.5	40.7	15.5	20.4	162.3	27.5	22.2	11.7	20.9	19.0	65.8	69.4	39.0	19.4	21.3	14.1	18.2	22.0	5.3	8.0	41.2	28.7	15.5	50.6	8.0	50.2	16.3	16.0	26.3	58.9	21.9	17.6	19.8	26.3	9.2	7.0	40.0	18.9	447.3	82.0	31.3	27.1	12.8	127.1	104.5	25.1	14.2	26.0	18.8	61.9	85.2	23.1	25.5	58.3	76.0	34.0	75.5	70.5	52.6	40.1	55.3	74.8	55.3	32.5	69.7	140.2	32.9	100.6	51.7	81.9	73.0	27.7	79.9	95.6	66.7	68.7	84.6	53.9	66.4	77.0	58.3	46.2	46.5	53.3	71.9	50.2	57.2	103.1	49.1	104.0	24.0	78.3	64.4	67.3	44.0	50.3	18.0	81.4	66.2	51.2	63.5	47.6	55.4	54.3	35.1	101.8	93.5	27.0	76.2	47.0	78.8	60.0	75.3	32.2	25.1	104.5	14.5	15.1	13.9	12.8	20.5	17.4	37.1	5.6	7.7	11.5	99.7	14.2	9.6	127.1	26.0	18.8	26.6	16.9	10.8	19.7	20.9	19.0	21.3	14.1	28.7	7.0
TXN2	MT-TRX	ENSG00000100348	"Thioredoxin 2"	Q99757	22	36467036-36482030	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Transport"		"Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000994, CAB008681"	Approved		Enhanced	Mitochondria				Mitochondria		"CAB008681: AB_1623682, HPA000994: AB_1080267"	"unprognostic (5.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic favourable (2.04e-4)"	"prognostic favourable (1.17e-6)"	"unprognostic (1.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	22.1	69.9	33.4	24.7	33.2	23.5	41.9	23.2	51.1	23.0	25.9	20.8	24.5	36.9	19.8	22.7	28.7	26.9	27.6	60.1	28.0	28.6	33.4	51.7	27.9	35.5	30.3	31.7	35.0	51.1	30.8	17.3	19.6	30.4	21.6	26.2	24.6	25.0	27.5	72.3	21.0	28.1	26.3	35.6	25.2	26.7	19.1	21.2	16.2	29.2	37.3	23.0	23.0	19.8	31.7	51.3	14.4	43.3	32.0	30.0	45.1	14.5	19.9	21.8	37.3	32.8	35.7	25.1	20.0	31.4	33.8	38.4	24.1	15.4	36.8	18.6	31.2	22.2	41.7	34.3	19.7	25.2	36.3	42.0	27.2	35.5	27.7	50.4	40.1	47.7	27.3	28.2	22.1	30.6	43.9	30.5	30.2	21.5	22.9	39.1	17.7	26.3	21.0	23.0	25.5	34.2	23.7	30.4	30.7	20.2	44.3	36.1	31.2	49.0	24.0	37.7	29.4	20.7	19.6	24.8	17.6	35.8	34.0	31.5	21.4	5.2	40.8	7.1	25.7	43.3	26.8	31.7	25.6	27.0	51.3	29.0	30.0	27.9	14.4	32.0	35.2	39.1	24.8	45.1	33.4	33.2	23.2	51.1	28.0	28.6	30.3	31.7	30.4	21.2
TXNDC11	EFP1	ENSG00000153066	"Thioredoxin domain containing 11"	Q6PKC3	16	11679080-11742878	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041174, HPA041390"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041174: AB_10794191, HPA041390: AB_10796670"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.82e-3)"	"prognostic favourable (2.12e-5)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.34e-2)"	12.5	12.5	6.1	10.9	8.1	24.1	12.3	12.8	9.9	12.7	20.8	8.3	13.2	19.2	12.9	16.0	12.6	12.7	17.5	11.4	7.3	4.4	21.2	47.2	22.4	21.3	7.4	4.4	13.9	22.9	28.6	11.4	15.0	7.1	13.2	15.4	18.6	24.1	14.3	23.2	9.9	27.4	7.8	5.0	23.6	17.6	5.6	6.7	15.9	28.6	11.6	33.2	15.0	10.2	5.7	3.6	9.6	3.3	7.8	9.2	3.5	8.7	6.1	2.8	3.9	7.7	6.5	5.0	8.7	11.9	8.0	10.3	3.0	14.0	22.1	14.7	10.9	7.9	3.5	7.3	6.6	9.8	4.6	4.7	7.0	14.7	11.4	6.8	9.5	4.9	8.3	8.9	14.2	10.0	7.1	28.5	7.0	7.9	5.3	2.6	3.7	3.1	6.9	5.8	47.3	9.1	4.7	4.0	3.8	17.0	13.3	9.2	8.1	9.5	10.3	3.7	4.3	17.4	5.0	38.9	21.2	13.3	7.9	8.7	6.2	4.9	3.3	9.6	2.7	2.5	6.6	5.7	4.9	6.0	3.6	4.9	4.8	3.1	1.0	7.8	2.8	2.8	9.2	3.5	6.1	8.1	12.8	9.9	7.3	4.4	7.4	4.4	7.1	6.7
TXNDC9	APACD	ENSG00000115514	"Thioredoxin domain containing 9"	O14530	2	99318982-99340702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031844, HPA031845, HPA031846"	Approved		Enhanced	Cytosol				Cytosol		"HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916"	"unprognostic (3.63e-3)"	"unprognostic (4.26e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (4.31e-4)"	"prognostic unfavourable (9.63e-7)"	"unprognostic (2.06e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	29.2	20.7	16.8	17.8	19.4	13.0	25.9	20.1	25.3	23.4	21.1	13.8	14.9	15.2	19.0	23.9	28.8	15.8	15.7	23.9	18.1	20.8	42.9	33.3	17.0	22.3	19.0	13.9	20.4	15.1	13.3	27.6	33.9	27.3	19.5	23.3	9.3	19.4	15.3	22.8	16.2	21.6	21.4	22.1	32.3	16.7	14.9	17.5	39.6	21.2	28.1	27.8	20.4	18.3	32.6	28.9	45.2	36.7	35.2	41.8	40.2	25.4	8.2	21.1	10.3	20.4	20.7	22.8	29.3	27.1	31.0	30.3	22.6	19.7	19.2	23.6	25.7	18.5	19.1	30.4	36.8	14.0	16.3	20.8	11.7	25.8	19.7	24.9	15.5	18.9	27.4	26.1	19.4	35.4	23.8	18.0	36.3	12.9	14.6	21.8	15.4	22.6	10.9	19.2	18.5	43.9	19.7	13.1	10.7	14.0	19.7	31.0	22.6	20.1	24.3	22.9	22.3	14.1	20.6	7.5	11.4	23.2	18.7	25.9	20.7	45.2	27.6	28.2	29.1	28.5	36.3	32.6	34.7	32.9	28.9	26.0	32.9	32.8	26.8	35.2	36.7	28.8	41.8	40.2	16.8	19.4	20.1	25.3	18.1	20.8	19.0	13.9	27.3	17.5
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597208-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol			1500000	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favourable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	20.5	31.9	27.9	17.8	30.0	34.0	24.4	20.6	34.5	22.5	20.1	21.5	17.3	20.1	22.1	33.8	29.6	18.0	19.8	37.2	27.7	28.5	28.0	38.5	16.4	21.7	27.7	22.8	26.1	34.3	21.5	23.3	26.8	32.1	23.1	21.6	17.6	22.4	20.9	64.4	17.6	21.1	26.5	23.4	20.4	24.0	19.3	21.1	22.3	96.0	27.7	23.3	27.7	18.9	22.2	29.9	39.0	35.3	23.4	23.0	30.9	24.8	24.5	33.3	34.2	28.9	42.4	23.6	29.7	30.5	38.3	32.5	21.8	24.5	27.0	26.5	32.2	31.0	31.4	26.8	39.7	27.5	14.4	37.0	20.5	40.7	33.9	53.8	24.2	32.1	27.8	36.0	33.1	30.8	27.0	45.4	38.7	23.8	31.1	35.2	24.1	26.4	25.5	22.4	46.9	44.7	38.8	27.6	25.2	16.8	23.7	28.0	25.8	28.9	24.4	40.3	21.3	14.0	28.8	44.1	47.2	42.2	26.3	41.3	29.4	39.0	35.3	25.3	15.9	29.6	21.7	22.2	19.7	20.8	29.9	19.3	19.4	19.6	26.5	23.4	27.9	25.5	23.0	30.9	27.9	30.0	20.6	34.5	27.7	28.5	27.7	22.8	32.1	21.1
TXNL4B	"Dim2, DLP, FLJ20511"	ENSG00000140830	"Thioredoxin like 4B"	Q9NX01	16	72044289-72094431	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065865			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA065865: "	"unprognostic (1.45e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	11.1	10.0	14.1	11.5	16.3	15.6	12.3	18.6	17.0	11.0	11.7	18.5	10.4	12.8	10.2	10.3	12.2	13.3	11.2	9.3	13.2	12.2	9.8	20.8	8.8	13.0	20.9	13.6	27.8	12.6	11.0	19.9	9.4	13.7	9.8	10.8	9.8	10.7	10.3	11.3	10.1	10.4	8.7	17.2	10.0	10.0	18.9	15.3	14.0	10.9	6.0	11.9	8.6	13.7	10.8	9.4	18.3	14.2	5.0	13.7	9.9	6.8	10.3	5.7	7.7	4.2	5.0	12.7	9.0	7.4	15.9	12.0	10.5	6.4	10.1	6.6	4.6	9.3	10.1	5.3	12.4	5.0	9.5	9.3	7.9	15.8	9.0	11.0	8.1	5.2	3.7	14.0	13.2	6.7	22.3	6.1	7.5	13.1	13.2	9.6	10.3	9.6	13.6	7.2	13.5	5.8	5.2	13.0	11.3	8.5	4.0	11.7	9.2	7.0	6.4	7.6	11.1	6.3	8.4	12.1	19.5	41.9	8.5	7.4	7.5	18.3	9.8	12.9	9.2	10.9	13.7	10.8	9.5	7.8	8.5	9.0	13.1	12.7	13.9	5.0	14.2	9.4	10.5	9.9	14.1	16.3	18.6	17.0	13.2	12.2	20.9	13.6	13.7	15.3
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350305	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm			5900000	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: "	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	19.1	79.2	14.1	15.6	16.9	22.6	18.5	11.1	13.7	13.0	21.8	9.7	19.7	23.5	23.5	14.7	16.7	19.0	23.2	32.4	11.0	11.7	25.3	19.6	29.3	18.1	12.0	10.9	16.4	7.9	10.5	16.2	30.8	16.4	25.3	19.1	18.1	10.6	26.5	30.0	5.7	17.0	99.6	10.9	14.9	24.2	14.8	8.9	15.6	16.5	16.9	13.2	73.2	72.0	8.1	14.2	37.6	16.2	8.3	10.2	8.7	22.0	102.6	11.9	11.2	57.5	32.2	41.6	41.0	26.0	18.5	19.2	10.8	32.9	16.5	19.1	143.4	7.7	23.5	15.7	22.0	8.0	10.2	13.9	80.6	45.6	92.3	21.7	15.2	18.3	16.2	40.9	13.1	63.4	19.1	7.8	27.7	10.6	22.2	9.9	11.5	105.8	22.0	8.3	14.3	21.5	12.1	18.6	11.2	33.1	52.4	32.7	12.4	12.8	84.7	9.1	18.9	20.3	33.5	8.6	16.8	24.8	19.1	12.0	53.9	33.0	10.6	24.7	9.1	14.0	10.2	8.1	8.4	9.0	14.2	5.2	7.6	6.6	37.6	8.3	16.2	9.2	7.1	8.7	14.1	16.9	11.1	11.2	11.0	11.7	12.0	10.9	16.4	8.9
TXNRD2	"TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941992	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Supported	Mitochondria,Cytosol			410000	Mitochondria	Cytosol	"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favourable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	9.8	30.2	8.5	8.3	10.1	11.6	7.4	19.0	15.0	8.3	10.3	9.0	7.6	9.2	11.9	12.3	8.8	8.4	13.0	22.6	8.3	7.5	13.9	40.9	10.8	8.4	7.8	9.7	11.9	13.0	9.9	9.9	14.0	7.1	17.9	4.5	10.0	15.2	8.8	16.5	6.0	10.2	5.4	5.6	11.2	14.6	10.5	6.8	4.9	12.6	9.2	10.5	7.5	7.9	4.8	9.1	5.8	12.1	4.8	4.9	4.9	6.3	13.2	1.2	5.1	2.4	3.4	3.0	6.1	7.2	11.1	8.2	12.2	6.6	3.5	14.9	6.4	11.3	6.1	8.4	4.2	6.7	15.1	5.9	10.5	7.2	4.6	6.6	2.9	3.3	6.4	5.7	4.8	31.4	32.8	6.0	8.6	15.4	2.2	9.9	6.1	9.4	3.4	29.3	3.2	6.7	6.9	6.5	5.7	10.5	13.8	7.0	11.2	9.0	17.4	8.1	48.8	6.7	12.8	6.0	4.4	2.2	7.8	5.1	10.2	3.2	12.1	5.8	4.3	9.2	3.3	4.8	3.8	3.9	9.1	3.6	4.9	4.0	1.3	4.8	8.7	3.4	2.4	4.9	8.5	10.1	19.0	15.0	8.3	7.5	7.8	9.7	7.1	6.8
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB020802: , HPA036109: "	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favourable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	13.7	3.5	4.5	7.1	8.4	12.7	2.3	6.1	5.5	5.0	7.1	6.3	7.8	0.0	7.8	8.4	5.5	5.6	6.3	6.3	0.0	4.1	1.6	3.3	4.8	7.2	5.5	0.5	11.6	5.5	1.7	11.6	3.6	3.3	0.0	8.0	9.9	1.1	3.0	6.4	2.7	0.4	3.9	2.2	5.3	6.9	7.8	4.8	17.4	5.1	8.8	7.0	2.1	6.0	6.1	1.5	8.3	2.8	3.6	1.5	0.0	3.3	1.9	5.2	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177452-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase, Tumor antigen"	"Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	70	"retina: 82.0;skin 1: 25.2"	"Cell line enriched"	"Detected in single"	844	"SK-MEL-30: 84.3"	"Cancer enriched"	"Detected in single"	1755	"melanoma: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles				Vesicles		"CAB000079: AB_564045, HPA043241: , HPA050889: , HPA064583: "	"unprognostic (1.16e-1)"								"unprognostic (1.01e-1)"		"unprognostic (1.85e-3)"		"unprognostic (9.75e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	82.0	0.7	0.0	0.0	25.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710290	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 277.3"	"Cell line enriched"	"Detected in some"	52	"SK-MEL-30: 173.5"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Region enriched"	"Detected in some"	5	"pons and medulla: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"olfactory region: 5.6;thalamus: 2.0"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Supported	Vesicles			16000	Vesicles		"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.2	0.0	0.2	0.2	0.3	0.0	1.7	0.2	1.0	0.2	0.5	1.3	0.2	1.6	0.2	0.3	3.6	0.2	1.4	21.5	0.9	0.1	5.7	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	5.0	0.2	1.8	277.3	1.1	0.2	1.3	51.1	1.4	0.4	1.1	0.2	0.6	0.5	0.2	0.2	0.2	0.9	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	173.5	2.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	1.0	0.9	0.1	0.2	0.3	5.0	0.2
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107587	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA044833: AB_10960990, HPA052083: "	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	20.0	15.1	20.8	19.2	21.1	48.5	61.0	25.6	20.8	16.1	21.5	9.7	12.3	17.6	28.8	26.5	19.3	27.6	17.1	19.5	19.7	15.8	14.6	17.1	35.2	33.5	25.7	2.9	22.1	48.3	15.3	27.8	21.2	20.8	23.9	13.7	9.6	44.5	19.8	33.0	16.6	20.4	38.7	23.9	21.0	17.5	33.9	22.7	20.6	27.3	26.5	20.0	22.9	31.7	58.4	82.8	81.2	54.1	33.1	55.5	53.8	25.0	27.5	15.0	11.3	8.8	6.3	35.1	21.8	15.1	17.8	15.9	63.9	9.2	42.9	11.9	14.1	12.3	31.3	23.1	9.2	33.6	70.7	69.4	14.1	24.0	21.5	29.8	17.1	8.7	14.3	28.8	18.4	14.7	38.0	19.4	12.4	47.1	24.7	33.1	31.8	31.7	40.8	14.4	21.6	11.8	10.6	22.8	17.4	23.4	14.1	11.5	17.2	17.4	18.3	14.8	20.2	13.4	22.7	26.0	30.6	35.5	14.2	55.0	22.8	48.4	52.6	50.9	42.2	52.5	41.4	55.9	46.4	42.1	54.1	58.4	46.4	44.8	81.2	33.1	54.1	82.8	55.5	53.8	20.8	21.1	25.6	20.8	19.7	15.8	25.7	2.9	20.8	22.7
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674715	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: , HPA043562: "	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	32.1	39.3	40.0	51.9	40.0	68.2	34.1	53.4	44.1	39.6	43.7	41.2	37.0	46.2	45.0	32.5	47.9	43.6	35.4	33.8	35.0	29.4	36.5	39.1	35.6	59.6	41.1	33.7	51.4	38.3	37.7	48.1	42.9	31.5	36.8	29.7	35.9	36.4	39.5	33.3	42.7	43.0	34.7	32.4	58.1	37.4	104.4	41.4	68.4	42.0	34.0	50.4	36.3	42.9	3.0	4.1	5.5	4.0	1.4	3.0	1.7	43.9	72.1	44.1	36.2	20.9	21.3	47.7	35.7	33.5	61.3	59.7	41.9	41.8	53.2	29.0	30.1	36.1	54.8	49.6	27.3	40.0	91.6	44.5	32.3	38.4	34.0	50.6	51.1	28.9	30.1	45.8	30.3	35.2	53.1	34.3	31.0	41.3	70.2	44.5	48.6	57.4	76.7	28.5	42.5	33.6	51.5	52.5	40.8	39.1	37.0	22.5	36.1	53.6	30.1	54.0	39.2	24.8	75.3	31.3	42.3	63.1	24.0	50.2	45.9	0.2	2.6	2.2	3.0	4.0	2.6	2.1	2.7	2.4	2.4	3.0	2.2	2.0	5.5	1.4	2.6	4.1	2.9	1.7	40.0	40.0	53.4	44.1	35.0	29.4	41.1	33.7	31.5	41.4
U2SURP	"fSAPa, SR140"	ENSG00000163714	"U2 snRNP associated SURP domain containing"	O15042	3	142964497-143060546	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037545, HPA037546, HPA061407"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506"	"unprognostic (2.01e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.09e-2)"	"prognostic unfavourable (8.44e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (2.85e-3)"	"prognostic unfavourable (8.86e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.12e-1)"	"prognostic favourable (6.78e-4)"	21.2	17.7	21.3	17.6	30.8	48.2	24.0	29.7	27.9	26.3	20.3	18.8	18.0	12.9	24.3	22.2	22.3	19.2	12.7	16.6	18.4	16.4	17.8	22.1	17.9	26.8	24.5	24.8	28.4	22.8	22.3	39.6	21.7	25.8	21.2	20.7	19.2	18.6	15.8	26.4	21.9	22.1	26.0	26.6	23.5	18.3	19.2	27.3	32.3	21.2	16.5	24.5	23.2	19.0	33.8	31.2	19.9	25.7	18.4	26.6	11.3	37.7	12.7	14.2	9.6	7.6	7.0	24.7	17.1	11.0	19.8	14.8	16.9	11.6	43.7	18.3	11.0	13.7	29.2	15.2	22.7	11.9	20.5	47.3	11.7	13.4	7.8	45.9	17.9	8.5	7.7	15.3	19.6	10.6	29.1	14.0	9.2	10.7	22.7	20.1	22.9	11.9	23.3	27.9	18.3	9.9	23.9	18.3	10.7	34.3	11.4	20.1	20.2	19.8	11.6	10.7	12.6	8.3	27.4	16.8	21.4	74.9	8.5	16.6	14.7	18.9	19.7	18.3	25.2	18.6	22.0	31.7	23.1	22.3	15.4	33.8	26.6	22.8	19.9	18.4	25.7	31.2	22.1	11.3	21.3	30.8	29.7	27.9	18.4	16.4	24.5	24.8	25.8	27.3
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.0"	"Cell line enhanced"	"Detected in many"		"BJ: 61.3;BJ hTERT+: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 2.2;intermediate monocyte: 4.3;memory B-cell: 1.2;myeloid DC: 2.0;naive B-cell: 3.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	11	"B-cells: 3.4;dendritic cells: 2.0;monocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041412: AB_10966708, HPA043503: "	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (1.03e-4)"	21.7	8.9	4.7	8.6	8.1	0.4	25.9	2.9	5.8	15.4	14.1	8.4	22.8	10.6	17.2	22.3	15.6	10.5	15.7	18.0	6.1	4.2	16.4	8.2	23.7	7.5	9.0	4.6	17.5	8.6	8.2	6.5	13.7	9.6	15.5	7.6	26.7	18.8	26.9	68.0	10.1	16.9	11.4	14.9	15.7	8.4	10.1	7.1	1.0	18.6	32.4	5.3	9.9	13.5	3.4	2.0	0.2	4.3	0.1	0.3	0.7	10.4	8.6	3.8	5.1	7.8	33.8	0.0	61.3	37.5	16.1	13.9	14.4	15.5	7.2	16.9	15.2	12.1	8.7	4.8	20.3	0.0	3.8	4.0	6.7	3.0	10.2	0.1	1.5	15.9	2.7	9.5	7.2	17.0	1.0	0.0	19.9	3.4	0.0	0.6	3.2	4.5	0.0	28.0	0.0	7.8	3.5	1.0	1.9	11.6	1.8	12.3	3.4	1.2	32.6	0.9	6.5	5.2	9.7	0.6	2.1	0.0	8.1	1.1	6.9	0.2	2.2	0.0	0.0	4.3	0.0	1.2	0.1	0.0	2.0	3.4	0.3	0.1	0.2	0.1	2.9	0.1	0.0	0.7	4.7	8.1	2.9	5.8	6.1	4.2	9.0	4.6	9.6	7.1
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 105.7;U-251 MG: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			19000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	38.4	18.5	7.0	17.4	9.8	17.2	24.8	9.0	13.4	16.1	26.9	5.7	45.7	17.2	10.9	19.4	23.6	15.7	18.3	22.5	7.7	7.8	11.0	67.1	16.0	7.4	6.6	8.9	20.4	31.4	5.1	16.0	21.5	9.1	13.9	26.9	7.8	43.9	62.5	19.4	12.4	33.4	28.8	7.1	8.1	23.0	37.7	3.7	5.6	12.4	13.5	15.3	24.4	16.7	8.3	5.6	8.1	1.6	6.2	16.1	4.8	29.9	2.1	6.0	4.8	29.2	23.4	4.1	44.1	16.2	34.0	27.8	5.7	14.1	1.1	9.9	33.8	5.2	6.7	12.8	56.1	4.7	10.1	5.3	6.9	11.1	13.7	9.0	3.6	10.8	6.1	37.3	105.7	20.8	29.9	12.4	45.4	5.5	5.2	5.8	4.4	9.8	4.7	11.7	14.6	5.3	3.5	6.4	6.7	19.2	12.0	10.2	5.9	10.3	35.3	17.2	15.8	43.2	68.8	20.8	7.3	9.9	9.8	4.2	10.8	1.0	1.6	8.1	13.0	1.6	16.1	8.3	7.9	13.3	3.4	6.5	7.6	9.5	1.6	6.2	0.8	5.6	3.9	4.8	7.0	9.8	9.0	13.4	7.7	7.8	6.6	8.9	9.1	3.7
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Enhanced	Nucleoplasm			16000000	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.21e-2)"	45.6	63.0	56.0	47.2	50.6	42.0	38.3	58.1	75.7	48.0	39.3	55.9	44.9	36.3	52.9	34.1	59.4	56.0	39.9	48.7	49.5	39.9	51.1	60.0	42.0	48.2	47.7	62.3	57.6	34.9	78.8	55.5	39.1	47.6	40.2	35.5	41.0	47.5	45.7	77.7	56.1	37.9	59.4	35.5	53.4	38.7	36.0	48.6	52.7	65.0	43.9	54.0	39.2	52.7	28.9	30.6	32.6	36.0	25.6	29.0	24.1	45.8	47.6	54.5	82.8	37.3	34.0	24.1	30.5	32.5	43.9	35.8	37.8	35.0	34.2	20.3	61.0	44.3	68.3	64.9	32.3	28.3	69.4	21.4	52.8	30.3	26.3	36.0	46.2	31.9	34.0	63.8	49.8	57.5	23.2	30.8	43.5	58.1	33.9	31.9	58.0	74.4	39.5	38.0	58.2	35.1	49.4	35.3	26.5	90.9	44.2	20.2	61.5	22.5	42.0	33.0	38.3	47.5	28.4	21.1	21.9	48.8	33.9	25.8	39.4	17.4	27.0	27.4	29.0	36.0	25.4	28.9	24.0	25.9	30.6	22.0	19.1	23.4	32.6	25.6	32.8	20.8	28.2	24.1	56.0	50.6	58.1	75.7	49.5	39.9	47.7	62.3	47.6	48.6
UBA2	"ARX, FLJ13058, HRIHFB2115, SAE2"	ENSG00000126261	"Ubiquitin like modifier activating enzyme 2"	Q9UBT2	19	34428352-34471251	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041436	Supported		Supported	Nucleoplasm			9400000	Nucleoplasm		"HPA041436: "	"unprognostic (2.37e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.39e-3)"	"unprognostic (8.72e-3)"	"prognostic unfavourable (3.76e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-1)"	49.2	23.5	25.1	29.5	28.4	30.6	70.9	44.3	30.4	26.5	25.4	20.7	24.0	17.8	32.3	24.2	27.4	25.1	23.7	31.0	25.6	27.7	22.8	25.5	24.5	37.8	26.9	23.2	30.3	29.4	28.8	26.8	39.1	25.1	25.1	23.9	20.7	20.9	31.5	56.3	29.2	20.4	28.8	27.4	28.6	20.9	56.7	19.9	55.9	25.9	27.1	34.4	29.2	38.9	8.6	10.8	7.7	6.2	8.5	13.0	3.6	28.6	42.0	43.1	17.8	23.4	19.2	17.6	22.4	19.3	29.0	32.5	35.9	17.5	53.7	34.7	18.2	11.7	45.6	17.5	41.0	38.4	30.8	57.0	21.5	35.9	30.2	45.2	24.8	13.8	22.3	20.5	36.2	22.7	56.4	30.5	25.4	28.7	34.8	25.1	32.3	14.6	27.7	29.7	23.9	20.4	30.1	36.7	36.0	20.4	18.8	30.1	13.5	55.5	14.6	32.7	22.8	20.9	40.1	32.2	45.7	52.0	20.7	34.6	28.7	5.9	4.8	7.7	8.4	5.0	11.2	8.5	10.5	12.1	6.0	8.6	13.0	10.4	0.6	8.5	6.2	10.8	8.0	3.6	25.1	28.4	44.3	30.4	25.6	27.7	26.9	23.2	25.1	19.9
UBA5	"FLJ23251, UBE1DC1"	ENSG00000081307	"Ubiquitin like modifier activating enzyme 5"	Q9GZZ9	3	132654446-132678097	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017235	Uncertain		Enhanced	Vesicles,Cytosol				Cytosol	Vesicles	"HPA017235: AB_1858507"	"unprognostic (4.34e-3)"	"unprognostic (6.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	14.8	30.3	17.8	12.3	19.8	13.2	17.4	17.9	26.2	14.5	15.0	10.5	27.8	16.2	13.4	24.2	15.1	13.3	12.7	21.2	15.3	16.3	22.7	29.8	13.7	14.8	16.0	25.0	15.1	41.4	29.3	32.7	18.1	21.2	18.8	16.7	11.7	37.8	33.5	32.5	15.7	17.9	14.6	13.6	18.9	18.5	15.3	12.7	17.9	23.5	17.5	17.4	15.1	12.5	11.1	14.1	5.0	6.6	18.9	15.0	7.9	27.0	10.1	17.8	14.6	12.6	14.4	18.7	23.4	24.2	14.7	17.1	18.3	10.1	21.6	17.2	16.9	16.5	17.6	18.4	21.9	20.5	7.5	26.2	16.3	20.5	12.5	32.1	15.4	12.5	10.9	14.0	21.1	16.5	16.3	32.0	16.4	24.0	17.7	12.1	16.2	9.7	15.5	15.6	40.9	13.5	21.0	17.2	15.5	13.7	13.8	19.8	16.6	16.3	14.8	15.6	15.3	7.5	12.2	30.3	20.3	40.0	17.8	11.7	13.9	4.1	5.1	5.0	9.6	5.8	11.6	11.1	10.8	15.0	11.8	6.9	12.9	12.8	1.1	18.9	6.6	14.1	10.7	7.9	17.8	19.8	17.9	26.2	15.3	16.3	16.0	25.0	21.2	12.7
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	16.8	12.6	14.1	14.1	16.6	22.7	13.0	18.0	16.0	17.0	10.5	14.6	7.0	12.2	16.7	10.0	20.5	9.9	12.4	9.5	12.0	12.0	10.2	16.4	14.5	17.3	18.7	11.2	14.3	10.9	17.4	44.8	18.5	17.7	12.7	13.2	7.5	13.7	10.4	10.1	12.6	15.3	13.4	20.7	16.9	13.9	14.6	18.6	27.1	12.3	13.3	19.9	15.7	19.5	5.6	5.1	9.3	4.0	9.7	5.8	1.9	14.8	8.3	13.8	10.8	6.8	8.1	9.3	30.8	12.1	14.1	16.5	8.7	20.1	18.8	11.0	12.6	8.8	14.2	15.3	21.3	21.6	4.0	12.0	14.7	8.1	5.8	21.1	9.2	5.7	4.9	18.2	11.1	12.4	28.6	11.2	16.6	5.6	21.9	4.8	8.1	10.1	13.0	28.3	6.9	11.5	16.9	6.7	8.5	17.4	12.4	5.8	8.2	5.7	17.9	13.1	14.7	10.6	13.4	8.1	6.3	19.0	23.3	5.9	12.5	9.3	3.0	4.6	4.4	3.9	4.8	5.6	5.1	5.8	3.7	5.2	3.9	4.5	2.2	9.7	4.0	5.1	4.2	1.9	14.1	16.6	18.0	16.0	12.0	12.0	18.7	11.2	17.7	18.6
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961380	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 113.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 59.3;K-562: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"			54000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favourable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	7.6	5.7	12.4	5.8	13.4	27.1	6.2	10.9	12.7	6.1	11.0	8.0	6.8	9.9	6.2	10.3	10.0	9.4	5.1	22.2	11.0	8.6	8.8	7.6	6.4	5.8	11.6	7.4	7.8	6.7	6.9	6.6	9.3	8.7	7.4	7.8	7.7	9.2	9.2	113.2	15.7	9.6	9.3	10.1	5.7	6.1	10.9	7.8	3.9	6.1	21.9	9.0	7.6	8.3	3.2	9.7	5.1	18.8	2.2	3.6	4.0	8.9	10.5	7.5	10.8	5.6	6.6	14.0	7.9	6.7	9.8	7.9	14.5	11.5	10.8	7.6	6.4	30.7	10.4	9.1	4.4	59.3	9.8	9.0	18.9	8.1	5.9	11.7	8.7	6.2	12.0	6.2	6.0	8.1	75.2	8.8	7.7	18.5	9.6	12.1	17.7	17.9	10.8	14.1	14.3	7.0	5.8	11.6	12.8	11.4	10.3	8.0	8.7	12.7	6.6	5.6	8.4	6.6	9.7	5.1	9.6	12.9	10.3	10.7	7.6	3.4	11.3	5.1	3.1	17.2	3.3	3.2	3.6	2.1	9.7	2.0	1.9	2.2	2.5	2.2	18.8	1.0	2.7	4.0	12.4	13.4	10.9	12.7	11.0	8.6	11.6	7.4	8.7	7.8
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favourable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	26.4	34.6	25.7	17.5	25.0	81.9	28.6	29.1	29.5	24.2	26.0	26.5	14.5	16.6	25.3	20.0	40.5	20.4	22.9	34.4	24.0	23.6	25.6	38.6	27.7	17.3	27.0	20.0	26.8	20.7	26.7	19.2	26.8	25.5	20.4	19.0	21.5	19.4	24.3	62.3	22.6	24.6	26.4	26.3	21.4	20.9	33.5	26.0	17.2	23.6	22.1	25.4	29.2	29.5	10.5	17.8	45.9	19.6	17.4	26.5	19.2	20.7	11.6	13.5	14.7	25.0	15.5	11.4	16.6	23.4	18.7	25.5	12.7	8.7	14.5	7.5	24.9	10.7	18.7	26.1	18.0	20.9	8.4	13.0	26.2	13.1	22.8	14.4	17.3	19.1	43.4	22.1	29.1	20.6	9.9	14.6	17.4	8.7	13.2	20.1	14.6	17.5	12.0	9.6	8.4	40.0	13.8	7.7	10.8	18.5	19.3	8.5	9.4	14.3	14.7	9.6	14.9	14.3	15.4	7.2	9.0	15.3	19.3	11.7	28.2	9.0	19.6	24.1	15.4	17.1	26.5	10.5	15.5	16.1	17.8	8.8	15.1	12.3	45.9	17.4	14.5	9.9	19.1	19.2	25.7	25.0	29.1	29.5	24.0	23.6	27.0	20.0	25.5	26.0
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 17.6;lymphoid tissue: 62.3"	"Group enriched"	"Detected in some"	6	"HEL: 14.6;MOLT-4: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"gdT-cell: 6.9;MAIT T-cell: 12.1;memory CD4 T-cell: 15.1;memory CD8 T-cell: 13.1;naive CD4 T-cell: 17.6;naive CD8 T-cell: 12.8;T-reg: 13.6"	"Lineage enriched"	"Detected in many"	15	"T-cells: 17.6"	"Region enriched"	"Detected in single"	13	"hippocampal formation: 0.5"	"Low region specificity"	"Detected in all"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA035367: "	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	1.1	0.7	0.3	19.7	0.3	2.6	0.8	0.3	0.3	0.9	2.8	0.1	0.0	1.9	0.8	0.8	1.2	1.3	3.2	1.1	0.3	0.4	1.4	1.1	6.0	23.1	0.4	0.0	0.7	0.6	0.0	0.6	0.4	0.3	1.2	1.0	1.1	5.0	0.2	0.3	0.5	5.9	0.6	0.7	10.8	2.2	0.4	0.0	62.3	1.4	1.1	14.1	2.6	1.1	0.0	0.0	0.3	0.0	1.1	17.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	14.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	12.1	0.0	15.1	13.1	0.0	0.0	17.6	12.8	0.3	1.1	0.0	0.0	13.6	5.1	0.3	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.0
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559925	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.2"	"Cell line enriched"	"Detected in some"	13	"RT4: 13.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favourable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	3.4	0.4	0.0	53.2	0.0	0.4	1.8	0.0	0.4	0.7	1.8	0.0	0.0	1.5	0.6	1.6	4.2	1.2	2.9	1.8	0.0	0.0	13.4	16.3	5.1	26.3	0.0	0.0	0.5	14.6	0.4	0.7	0.4	1.0	5.6	3.0	1.0	11.3	0.7	3.1	0.6	15.5	0.7	0.2	18.6	3.5	0.4	0.0	26.3	2.7	4.5	50.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (2.27e-3)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	32.5	27.5	17.3	14.6	30.3	37.4	16.2	33.8	30.2	40.3	38.3	14.2	22.4	25.8	34.4	37.2	23.5	24.7	17.9	38.9	35.8	14.6	11.4	22.0	12.7	27.8	28.5	19.6	25.5	25.6	38.6	16.8	27.9	14.0	23.1	45.6	34.5	43.9	26.9	28.8	31.1	22.4	18.4	24.0	32.5	21.4	13.3	13.7	45.0	20.7	24.6	18.0	24.9	27.2	25.9	11.6	51.1	38.1	22.4	36.4	25.3	27.5	36.1	20.2	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	36.2	9.6	20.0	19.0	17.5	18.9	32.3	27.3	14.4	17.6	21.0	28.9	24.4	19.8	33.0	17.4	14.5	15.1	20.2	19.2	31.4	16.3	10.9	26.5	31.0	20.5	12.9	22.4	16.2	27.5	15.9	13.5	15.0	19.9	36.0	15.8	21.2	20.4	34.1	8.6	9.1	20.6	22.0	27.6	15.7	28.1	27.0	21.1	21.4	10.1	47.4	21.8	35.6	29.7	20.5	14.3	27.5	29.8	30.1	41.2	27.9	23.1	24.4	20.3	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 130.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: , HPA054975: "	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	3.1	2.3	0.4	24.0	0.9	25.1	4.3	0.4	0.7	3.8	9.5	0.4	0.8	7.8	2.0	2.6	25.6	0.6	3.2	2.8	0.5	0.4	2.1	2.1	4.6	15.6	0.6	0.5	1.2	1.3	0.0	0.6	12.6	0.9	1.3	11.7	0.7	3.7	0.6	1.0	8.3	10.0	3.5	1.2	11.6	7.0	15.3	0.5	130.8	0.8	17.6	26.3	2.8	7.8	1.2	0.9	2.7	0.6	2.4	10.0	4.2	39.2	28.8	52.0	24.9	1.4	3.2	29.9	31.2	15.8	51.4	36.9	94.6	45.4	41.6	30.6	14.8	38.8	0.2	33.4	52.5	17.7	27.4	12.8	22.1	24.8	0.4	18.3	32.2	1.0	3.6	34.8	34.1	25.0	0.2	35.4	42.3	64.6	30.2	5.2	31.2	69.0	32.1	47.1	0.2	17.3	13.6	30.0	25.0	49.1	36.0	19.7	36.3	27.0	9.1	46.1	40.3	31.3	60.3	11.2	0.3	46.4	28.0	13.1	43.7	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.2	2.3	0.9	0.2	0.2	0.1	2.7	2.4	0.6	0.5	10.0	4.2	0.4	0.9	0.4	0.7	0.5	0.4	0.6	0.5	0.9	0.5
UBE2H	"GID3, UBC8, UBCH"	ENSG00000186591	"Ubiquitin conjugating enzyme E2 H"	P62256	7	129830732-129952949	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003302	Approved		Supported	Mitochondria				Mitochondria		"HPA003302: AB_1858526"	"unprognostic (1.15e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavourable (2.33e-5)"	"unprognostic (1.13e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.23e-1)"	29.0	49.9	31.1	16.6	31.0	22.5	24.5	36.1	30.2	31.1	27.3	33.2	26.6	15.2	35.5	25.3	32.1	29.4	26.6	61.0	26.4	25.4	27.6	28.1	26.3	17.5	28.1	23.4	27.6	52.3	41.8	29.5	37.9	33.3	24.1	16.8	22.9	28.5	28.8	46.3	21.3	16.5	31.5	26.2	19.1	22.7	24.7	29.5	24.7	37.7	23.6	29.5	25.5	34.3	6.1	3.7	7.8	2.2	1.3	6.5	1.9	22.7	12.3	14.6	14.8	36.4	31.3	25.3	21.1	27.2	12.9	14.4	6.6	24.4	9.4	26.4	20.7	17.3	12.5	22.4	16.9	11.6	6.6	3.2	18.1	7.9	28.6	6.5	10.4	42.0	29.8	17.4	28.0	25.1	7.7	27.4	19.9	8.1	8.6	7.1	23.0	14.7	6.7	7.5	20.1	27.0	29.9	5.6	16.9	19.3	43.2	11.3	4.5	6.4	25.5	14.1	7.1	19.8	20.9	25.0	18.0	15.6	28.0	7.8	13.7	3.5	2.2	5.1	4.7	1.7	6.4	3.8	4.7	4.2	2.0	6.1	6.0	6.4	7.8	1.3	2.1	3.7	6.5	1.9	31.1	31.0	36.1	30.2	26.4	25.4	28.1	23.4	33.3	29.5
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698044-39782792	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Supported	"Intermediate filaments,Actin filaments,Cytosol"			150000	Cytosol	"Intermediate filaments, Actin filaments"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	27.2	21.8	27.0	21.2	27.6	17.3	21.6	38.6	40.7	17.0	33.2	11.8	14.1	29.1	19.9	18.5	29.9	14.9	18.5	28.1	27.7	26.8	26.6	44.5	17.1	17.9	24.1	26.4	16.9	15.8	18.9	26.9	29.8	25.2	19.7	24.0	13.4	18.4	17.3	31.8	22.0	24.6	18.8	19.2	16.9	29.3	16.0	15.9	21.3	23.6	19.7	18.8	22.8	20.4	17.6	23.7	20.6	19.9	10.9	14.1	8.9	23.8	24.5	13.2	12.5	8.3	7.8	22.5	32.9	7.0	8.8	9.3	37.0	24.6	29.8	29.0	9.2	10.1	25.4	14.3	14.2	20.0	18.2	38.6	24.8	32.0	10.4	41.4	21.9	7.3	16.2	12.4	13.4	11.5	39.2	10.7	9.1	23.1	28.9	23.0	17.6	18.7	17.1	39.7	11.2	12.3	33.3	27.4	12.1	24.6	9.3	14.7	12.0	13.9	31.5	13.8	29.3	16.4	30.2	15.2	44.3	32.8	7.2	26.6	16.1	13.9	16.6	20.6	13.5	14.3	12.7	17.6	14.1	12.6	16.6	12.5	10.7	12.0	13.3	10.9	19.9	23.7	13.7	8.9	27.0	27.6	38.6	37.7	27.7	26.8	24.1	26.4	25.2	15.9
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93442262	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"			4600000	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: "	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	24.7	25.0	29.0	28.7	39.1	29.0	21.2	29.2	44.3	18.4	26.6	15.6	15.1	20.7	23.2	20.0	30.4	19.7	17.0	27.7	31.0	33.7	25.4	22.3	19.3	36.1	27.6	34.5	17.4	17.6	13.9	18.2	24.2	34.9	23.4	22.6	13.7	18.0	18.5	35.7	19.1	20.4	21.3	24.6	21.5	19.3	83.7	17.4	32.2	15.5	16.8	35.1	22.7	18.8	53.8	35.5	29.9	39.2	29.5	57.3	51.9	35.8	26.0	43.9	28.1	17.0	16.9	30.6	50.2	26.8	40.3	33.8	46.2	15.6	73.0	11.4	29.3	28.6	48.4	36.8	38.4	60.7	25.1	49.1	14.3	40.7	21.7	58.6	32.8	17.7	15.2	24.0	30.0	31.0	54.5	11.4	41.8	29.5	57.8	54.5	57.1	36.4	45.0	35.6	35.7	33.5	54.3	42.9	39.1	26.5	31.2	24.5	40.8	36.1	32.0	27.3	22.8	24.6	36.1	19.7	53.3	62.0	10.7	31.3	33.3	29.9	27.1	28.9	31.7	35.4	36.9	53.8	40.2	39.2	35.5	38.6	36.0	34.4	8.2	29.5	39.2	26.7	57.3	51.9	29.0	39.1	29.2	44.3	31.0	33.7	27.6	34.5	34.9	17.4
UBE2O	E2-230K	ENSG00000175931	"Ubiquitin conjugating enzyme E2 O"	Q9C0C9	17	76389451-76453206	"Enzymes, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023605	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"			1600000	Nucleoplasm	"Nuclear bodies"	"HPA023605: "	"unprognostic (8.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (6.84e-8)"	"unprognostic (3.54e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (4.34e-9)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	8.5	8.5	13.8	10.2	22.6	19.2	7.3	25.2	38.1	9.4	7.2	12.2	7.4	9.9	9.9	8.2	11.7	10.8	7.1	15.4	12.7	15.2	6.5	7.6	6.6	12.8	11.7	14.6	13.9	14.4	16.4	14.3	9.8	30.6	9.4	6.0	10.5	13.4	10.4	23.0	15.2	8.2	8.0	8.0	10.8	10.8	18.1	12.2	10.9	15.8	6.9	9.2	8.6	9.1	4.9	4.1	2.7	1.7	1.5	4.0	1.9	12.9	14.9	15.2	18.7	9.6	6.1	13.2	6.1	6.6	9.9	9.7	12.9	6.6	18.4	4.3	7.5	13.1	17.7	10.5	7.1	5.2	21.8	18.6	9.7	21.6	7.9	11.2	11.3	6.2	8.6	9.5	8.2	13.4	15.5	16.4	5.0	10.7	22.2	13.0	14.1	20.0	22.0	19.6	20.2	4.4	11.1	22.6	20.3	8.9	23.2	12.2	13.3	8.1	7.9	11.7	11.0	9.9	10.0	13.6	4.4	15.5	12.8	9.4	7.6	0.0	1.7	2.7	4.0	0.8	2.2	2.6	2.6	2.0	1.0	4.9	2.1	3.0	0.4	1.5	1.0	4.1	2.3	1.9	13.8	22.6	25.2	38.1	12.7	15.2	11.7	14.6	30.6	12.2
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448623-6494909	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.8;PC-3: 14.9;SCLC-21H: 13.9;U-266/70: 33.3;U-266/84: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favourable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	0.6	2.3	8.6	0.8	4.2	0.3	0.9	20.7	28.1	1.0	1.8	1.0	0.5	0.7	1.4	1.8	1.0	0.5	0.8	11.3	12.6	8.2	2.6	1.1	0.4	0.7	5.2	4.6	3.6	0.8	0.3	1.3	0.3	8.7	3.1	0.8	8.2	1.0	8.6	21.3	2.4	1.0	1.3	1.4	0.4	2.2	0.9	0.0	0.0	1.9	2.0	0.5	0.5	0.9	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	3.0	0.0	0.0	0.2	14.9	0.1	0.0	6.6	0.0	0.0	13.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	33.3	29.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	4.2	20.7	19.4	12.6	8.2	5.2	4.6	8.7	0.0
UBE2V1	"CROC-1, CROC1, UBE2V, UEV-1, UEV1A"	ENSG00000244687	"Ubiquitin conjugating enzyme E2 V1"	Q13404	20	50081124-50115959	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA052535, HPA053186"			Enhanced	Nucleoplasm			4000000	Nucleoplasm		"HPA052535: , HPA053186: "	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (4.58e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	35.2	35.3	44.9	31.7	52.4	25.6	29.7	36.9	61.7	27.4	37.7	33.8	19.3	34.2	29.1	32.7	43.6	27.4	28.7	38.1	37.5	39.3	39.2	61.8	34.1	36.8	36.4	33.3	37.2	60.8	36.7	23.2	45.9	44.7	30.3	37.3	38.7	38.6	35.0	46.0	37.8	40.1	43.7	29.0	40.2	33.3	23.2	23.2	35.0	30.2	32.0	50.7	49.0	31.7	37.4	40.1	33.9	39.1	54.2	57.4	70.2	29.2	18.3	34.6	20.6	28.4	49.0	19.2	33.3	32.9	71.0	34.2	91.3	22.1	28.5	30.9	43.1	25.9	25.3	45.7	61.9	19.9	15.9	27.9	13.7	40.4	25.6	33.9	22.6	39.0	27.6	34.9	23.3	47.8	34.7	17.4	39.6	19.7	30.5	26.9	24.1	32.4	16.9	39.5	26.0	49.0	21.1	20.3	24.5	33.9	59.3	25.1	22.7	30.8	41.5	39.4	36.5	33.3	26.8	17.3	22.2	23.1	42.9	17.7	27.2	25.5	39.1	33.9	56.6	38.5	57.4	37.4	47.0	53.9	40.1	31.0	48.3	52.4	13.8	54.2	33.0	31.6	44.4	70.2	44.9	52.4	36.9	61.7	37.5	39.3	36.4	33.3	44.7	23.2
UBE2V2	"DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2"	ENSG00000169139	"Ubiquitin conjugating enzyme E2 V2"	Q15819	8	48008400-48064708	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052535, HPA053186"			Supported	Nucleoplasm			1500000	Nucleoplasm		"HPA052535: , HPA053186: "	"unprognostic (3.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (4.96e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.62e-2)"	22.4	28.3	38.8	19.3	34.5	12.5	23.1	28.3	51.1	17.9	22.8	13.8	12.9	22.0	21.7	17.8	31.8	15.3	17.7	14.6	40.5	41.7	22.7	37.8	14.6	22.5	40.1	43.4	16.5	12.3	19.2	36.4	21.4	48.5	22.5	23.7	13.0	13.8	21.0	29.3	15.9	20.4	24.6	26.7	14.3	19.0	20.5	20.6	20.8	24.0	18.5	24.1	25.0	17.2	37.9	42.2	34.6	40.1	51.7	49.4	42.8	31.2	18.2	40.7	22.5	22.4	25.2	14.4	32.8	23.1	33.2	29.2	22.9	24.5	38.5	19.3	31.3	18.9	36.9	30.7	44.8	13.1	25.9	34.6	22.3	19.1	28.1	18.8	10.4	23.7	32.1	26.7	42.8	28.0	42.2	24.0	41.9	23.9	59.9	36.6	37.7	12.1	30.1	18.0	18.9	35.4	25.4	44.7	29.2	27.6	24.6	28.9	41.3	25.2	15.4	28.2	25.8	25.2	30.4	24.0	40.7	48.3	36.6	33.3	29.9	30.6	35.9	34.6	31.0	40.1	37.0	37.9	38.8	37.8	42.2	32.8	39.1	43.8	22.3	51.7	38.2	35.1	49.4	42.8	38.8	34.5	28.3	51.1	40.5	41.7	40.1	43.4	48.5	20.6
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908369-48929056	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favourable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	27.1	40.6	29.2	27.7	37.0	22.2	28.8	34.4	50.2	33.7	28.9	59.9	45.1	26.6	36.2	49.5	37.2	36.0	28.0	28.7	30.5	29.2	32.1	25.6	29.2	30.9	46.6	28.0	32.5	29.5	36.6	28.0	35.0	39.7	32.9	32.5	28.4	33.3	43.2	24.1	35.9	30.5	39.1	32.7	36.6	29.4	22.4	43.4	29.4	39.8	22.2	44.2	28.8	32.2	12.8	10.1	11.0	14.5	7.4	13.1	8.6	24.8	30.9	11.6	11.0	29.5	28.7	15.9	27.3	33.5	32.7	31.6	38.5	21.6	20.3	39.2	33.4	16.2	14.5	25.5	41.8	67.1	15.8	18.3	20.4	23.9	34.2	13.0	19.8	24.4	28.3	26.6	34.6	23.9	13.4	26.5	35.1	39.8	14.0	12.9	10.8	27.0	11.3	29.6	11.5	25.6	24.5	12.0	18.2	18.5	10.0	18.6	27.6	10.3	28.1	49.0	23.7	16.0	22.2	20.2	19.2	12.0	24.0	9.5	21.2	6.5	11.0	8.1	13.1	14.5	10.7	9.4	11.4	13.0	8.0	12.8	11.1	12.0	11.0	7.4	13.0	10.1	11.5	8.6	29.2	37.0	34.4	50.2	30.5	29.2	46.6	28.0	39.7	43.4
UBE4A	"E4, KIAA0126, UBOX2, UFD2"	ENSG00000110344	"Ubiquitination factor E4A"	Q14139	11	118359585-118399211	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055035, HPA064010"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA055035: , HPA064010: "	"unprognostic (1.32e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.86e-2)"	19.3	18.5	17.7	20.5	30.1	16.6	19.7	49.4	36.6	19.0	18.5	33.0	16.1	20.3	23.2	21.2	21.2	19.8	17.0	20.3	17.7	18.8	20.3	29.5	18.4	22.2	25.7	25.7	24.2	26.7	31.1	24.2	18.6	35.5	21.5	23.1	21.2	20.3	17.2	32.5	25.6	23.7	19.9	25.5	24.0	25.5	21.8	27.5	22.1	22.1	15.1	22.6	21.6	20.4	5.7	11.0	14.6	13.2	7.1	9.0	5.2	9.1	8.9	11.4	11.4	19.8	18.4	11.4	13.6	14.2	10.1	12.4	24.5	22.6	19.3	26.3	17.0	20.3	16.1	12.8	16.8	10.8	7.5	31.6	8.0	12.6	17.1	17.8	24.3	18.5	9.3	20.6	20.3	16.8	17.9	18.2	14.5	17.3	15.2	17.8	10.6	11.4	9.7	16.6	19.7	11.1	21.4	10.4	10.8	19.6	17.0	6.0	22.7	8.2	17.2	15.0	9.9	12.8	11.2	5.4	6.5	18.4	8.3	20.7	15.3	14.6	10.9	10.5	9.0	12.0	6.9	5.7	6.9	6.4	11.0	4.3	7.4	6.6	11.0	7.1	13.2	6.5	7.7	5.2	17.7	30.1	49.4	36.6	17.7	18.8	25.7	25.7	35.5	27.5
UBL4A	"DXS254E, GDX, GET5, MDY2, TMA24, UBL4"	ENSG00000102178	"Ubiquitin like 4A"	P11441	X	154483717-154486670	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003617	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA003617: AB_1080450"	"unprognostic (2.75e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.50e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-2)"	11.5	15.3	14.1	7.3	16.0	6.6	12.4	11.9	28.2	11.7	12.2	8.7	11.0	12.2	10.2	13.8	14.0	10.9	10.5	26.5	14.1	11.0	10.6	13.7	10.9	12.1	11.2	16.9	11.2	25.4	11.3	8.3	9.4	13.6	15.4	9.0	8.0	18.8	15.7	59.2	13.3	9.3	14.8	8.6	9.8	10.9	4.3	6.1	8.2	12.2	20.6	11.7	14.9	10.4	10.1	9.9	32.9	10.0	14.3	22.9	17.9	28.8	18.2	5.5	14.9	11.6	11.5	18.3	12.9	9.3	13.3	14.3	18.1	11.5	22.3	38.9	11.7	11.2	27.2	14.1	7.4	14.6	17.3	15.9	17.4	10.6	14.3	18.8	17.3	9.0	16.9	8.9	15.4	9.5	17.5	11.1	10.8	23.9	17.0	18.8	6.3	30.5	15.2	16.3	23.5	11.3	12.5	10.5	15.9	7.2	23.8	20.6	11.0	14.3	9.5	13.6	15.4	21.8	26.8	22.5	21.7	39.6	14.3	32.6	15.7	32.9	10.0	9.6	16.5	8.5	22.9	10.1	15.4	17.3	9.9	8.3	13.3	14.9	3.4	14.3	7.1	5.8	15.0	17.9	14.1	16.0	11.9	28.2	14.1	11.0	11.2	16.9	13.6	6.1
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263081-159286040	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	17.1	16.0	16.7	18.4	19.7	16.7	16.3	20.2	33.0	18.5	12.5	12.2	11.4	9.8	22.5	13.1	22.2	14.7	14.5	13.1	20.9	19.1	17.5	14.4	17.8	24.1	19.7	22.7	16.8	12.6	18.0	23.9	19.6	36.7	14.7	14.7	10.9	15.4	17.6	15.3	14.2	13.8	19.5	20.4	22.2	13.3	24.2	15.4	26.8	14.4	16.1	30.1	18.8	16.8	11.9	10.8	21.9	13.9	25.5	19.2	8.2	14.5	10.6	22.0	23.8	22.9	21.2	13.0	15.9	24.2	16.3	21.8	8.6	10.1	13.0	17.6	19.8	11.1	13.6	30.5	28.5	25.9	13.3	10.0	9.3	7.8	28.9	22.6	15.8	18.7	28.7	14.8	29.6	15.5	13.7	17.6	22.7	4.7	12.2	6.9	15.2	6.4	15.5	21.5	15.2	16.1	11.2	11.7	15.5	16.0	10.7	37.4	11.3	15.1	16.5	16.8	14.1	8.7	20.0	14.1	14.2	19.8	17.8	15.6	24.9	21.9	6.5	16.1	16.6	13.5	18.6	11.9	15.8	17.3	8.5	10.9	18.5	19.2	19.4	25.5	13.9	10.8	16.9	8.2	16.7	19.7	20.2	33.0	20.9	19.1	19.7	22.7	36.7	15.4
UBN1		ENSG00000118900	"Ubinuclein 1"	Q9NPG3	16	4846665-4882360	"Predicted intracellular proteins"	"Host-virus interaction"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 15.1"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061029, HPA069045"	Supported		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA061029: , HPA069045: "	"unprognostic (8.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.89e-2)"	14.1	12.4	10.5	16.6	11.5	38.2	19.8	20.2	15.4	12.6	12.4	11.0	18.1	13.4	13.1	11.8	24.5	11.7	16.6	15.5	11.2	6.5	10.4	15.3	19.1	16.5	9.4	10.8	14.4	12.9	17.6	12.3	10.4	9.1	11.7	13.4	15.9	15.9	14.5	20.9	15.1	15.2	12.8	6.6	21.2	12.5	36.7	10.1	27.1	12.0	13.8	13.7	11.6	15.8	1.2	1.7	15.1	1.2	0.9	1.6	0.9	9.1	11.3	13.1	13.0	11.6	10.8	10.8	11.5	10.7	13.2	12.7	9.4	10.9	17.0	10.7	10.9	12.3	16.7	10.2	11.2	16.7	8.8	13.8	15.1	7.3	11.2	16.7	15.3	7.3	13.7	15.3	16.5	17.2	22.9	14.4	9.7	13.1	18.3	7.8	11.3	8.8	29.5	16.4	16.0	7.0	10.4	18.0	9.9	19.6	16.1	9.9	15.9	15.0	17.5	14.1	13.6	45.7	14.1	14.1	14.6	33.9	8.3	10.7	23.7	1.4	1.2	0.9	1.6	1.2	1.1	0.9	1.2	1.4	0.8	1.2	1.3	0.8	15.1	0.9	0.9	1.7	0.8	0.9	10.5	11.5	20.2	15.4	11.2	6.5	9.4	10.8	9.1	10.1
UBN2	"FLJ25778, KIAA2030"	ENSG00000157741	"Ubinuclein 2"	Q6ZU65	7	139230356-139308236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 9.0;NK-cell: 3.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.0;NK-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019743, HPA020122, HPA020124"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-1)"	"prognostic favourable (4.49e-4)"	"unprognostic (1.24e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.05e-2)"	5.4	7.8	11.9	5.3	13.0	10.4	9.7	20.8	13.7	7.6	5.9	8.7	12.6	5.0	10.0	14.1	7.0	7.3	5.7	5.8	11.5	6.9	6.3	7.0	6.0	5.1	10.2	7.6	11.5	10.7	10.5	16.9	6.2	8.6	8.2	6.9	8.1	8.1	12.7	11.1	18.6	5.9	7.9	8.4	6.3	6.3	25.5	9.7	6.9	10.4	3.1	5.2	6.4	13.6	1.2	1.2	9.0	1.0	3.4	0.8	0.1	3.8	3.7	6.0	7.4	4.8	4.5	4.6	2.2	3.3	2.0	2.5	4.4	3.8	6.5	4.2	2.7	3.7	7.7	1.8	3.6	3.3	4.4	4.9	6.5	4.8	2.7	9.5	3.8	3.0	5.4	2.7	4.3	3.9	11.3	5.0	2.6	5.9	6.8	11.1	8.5	2.6	4.0	5.6	4.6	2.8	2.8	9.9	7.2	6.8	4.8	3.2	3.1	6.4	4.4	2.5	2.9	3.8	2.9	5.9	6.5	11.5	4.1	5.8	3.7	9.0	1.0	0.1	0.5	0.5	0.4	1.0	0.5	0.6	0.3	1.2	0.8	0.5	1.0	3.4	0.4	1.2	0.3	0.1	11.9	13.0	20.8	13.7	11.5	6.9	10.2	7.6	8.6	9.7
UBP1	LBP-1a	ENSG00000153560	"Upstream binding protein 1"	Q9NZI7	3	33388336-33441371	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003967			Supported	Nucleoplasm				Nucleoplasm		"HPA003967: AB_10601829"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (1.81e-4)"	"unprognostic (4.64e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavourable (9.45e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.88e-2)"	19.3	18.7	22.6	25.0	30.7	14.8	19.9	39.1	28.8	21.0	26.4	14.8	20.0	21.1	26.1	20.3	24.6	19.7	22.5	21.9	16.5	17.0	15.9	23.1	21.7	29.2	13.6	22.1	22.2	23.6	20.1	26.0	15.7	15.4	21.5	25.5	20.4	18.1	30.3	14.6	18.7	23.4	36.3	15.0	25.1	22.6	13.8	17.8	36.0	20.9	16.6	30.3	28.0	30.9	2.8	5.7	6.5	5.2	4.9	6.3	3.6	17.4	21.3	16.5	27.2	25.1	18.5	8.1	21.1	23.5	25.3	25.9	20.6	15.6	32.8	12.5	30.7	12.2	49.1	24.6	31.3	17.9	15.0	35.2	20.8	24.6	17.6	25.5	15.2	15.1	20.4	24.5	24.9	30.2	32.0	18.1	24.3	16.5	20.2	15.2	39.1	22.1	21.3	12.1	30.4	17.9	26.4	11.4	13.6	16.7	29.1	18.3	22.0	31.2	25.1	22.4	17.3	25.2	29.3	14.5	26.1	33.7	19.3	29.7	16.5	6.5	3.9	3.7	5.3	4.0	5.0	2.8	5.3	5.2	5.7	2.1	6.3	5.1	1.0	4.9	5.2	4.8	3.3	3.6	22.6	30.7	39.1	28.8	16.5	17.0	13.6	22.1	15.4	17.8
UBQLN1	"DA41, DSK2, PLIC-1, XDRP1"	ENSG00000135018	"Ubiquilin 1"	Q9UMX0	9	83659963-83708203	"Plasma proteins, Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037256, HPA054143"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB037256: AB_1858556, HPA054143: "	"unprognostic (4.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.07e-5)"	"unprognostic (3.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.29e-2)"	26.8	33.9	27.2	26.2	38.7	41.1	38.1	35.0	42.2	24.9	24.4	21.2	27.8	21.9	29.1	22.2	30.5	21.4	21.0	34.5	28.9	32.1	31.6	40.8	23.3	25.8	30.0	27.8	21.5	28.1	36.0	29.5	30.4	37.2	26.5	23.7	15.2	23.8	28.9	79.1	27.8	27.6	26.9	33.9	28.6	23.1	22.9	23.3	59.8	25.7	16.2	34.8	24.8	27.3	16.0	19.2	23.4	25.0	24.7	18.8	14.9	43.5	40.3	29.6	22.9	24.7	26.3	49.1	40.7	36.1	43.3	32.9	16.5	31.1	43.3	26.3	34.0	50.1	41.0	28.9	45.1	22.8	19.1	26.5	31.0	25.6	32.6	32.1	29.2	21.8	36.4	36.5	50.8	32.3	28.6	31.0	35.3	25.8	44.9	17.8	38.8	37.0	33.4	33.2	22.6	28.2	19.0	26.8	29.9	37.6	37.9	29.1	18.9	23.4	32.0	27.7	25.9	45.8	40.7	43.5	61.4	21.2	41.2	23.7	33.5	23.4	17.1	17.6	16.6	25.0	16.2	16.0	14.5	15.2	19.2	15.5	14.7	16.0	18.5	24.7	23.1	8.2	18.8	14.9	27.2	38.7	35.0	38.7	28.9	32.1	30.0	27.8	37.2	23.3
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563639-56567868	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"			200000	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.4	20.8	27.0	13.9	40.7	9.4	16.2	34.9	35.3	17.3	13.6	17.8	15.0	11.1	17.0	16.7	18.1	18.2	14.5	20.8	26.2	28.6	13.9	18.9	14.0	16.4	21.2	26.6	27.0	10.6	25.5	18.3	15.6	20.8	21.1	12.5	13.3	13.7	21.5	24.6	13.5	11.6	18.7	18.8	13.9	12.9	5.4	16.7	18.0	20.9	10.9	17.7	16.4	14.1	5.5	10.9	25.0	19.4	12.1	20.4	10.9	18.8	14.1	14.1	16.5	32.5	20.8	8.9	15.3	18.2	11.5	12.8	7.8	8.9	14.5	16.7	18.0	11.1	26.9	17.0	13.9	22.3	16.2	5.8	19.4	8.3	17.1	11.4	12.9	19.3	21.7	15.4	13.6	10.0	6.8	16.0	18.1	8.8	14.6	10.0	11.7	16.8	13.2	18.3	13.6	23.2	14.8	17.5	16.4	22.0	9.8	8.9	16.4	8.5	11.2	12.2	12.5	17.6	9.2	6.1	7.4	10.0	13.7	12.1	10.3	25.0	14.1	14.1	9.9	19.3	11.1	5.1	15.1	11.5	10.9	5.5	20.4	12.2	12.4	12.1	19.4	3.9	14.1	10.9	27.0	40.7	34.9	35.3	26.2	28.6	21.2	26.6	20.8	16.7
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035301-156053794	"Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA061797: "	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	7.1	6.7	13.8	7.4	19.9	3.9	12.4	23.1	25.2	9.9	7.8	6.5	4.2	7.2	11.9	8.9	11.6	10.2	6.2	9.3	17.7	9.7	7.9	10.2	8.5	7.3	15.0	18.7	15.1	14.1	10.6	3.6	8.4	12.4	8.9	8.8	6.4	12.4	11.8	24.3	11.6	7.4	13.1	8.7	6.8	9.4	6.9	13.7	7.9	6.8	6.6	8.9	8.2	8.4	1.9	2.0	9.7	1.2	1.7	3.2	1.1	16.7	20.2	19.4	19.1	13.4	8.3	19.2	14.2	7.8	14.3	10.8	18.1	15.3	28.7	13.1	12.9	18.9	19.6	15.3	13.7	24.1	20.8	15.7	11.6	17.5	8.6	16.9	29.8	6.2	19.8	19.7	16.1	16.9	29.4	16.0	12.9	20.7	18.5	17.0	26.6	18.9	23.8	14.3	28.3	11.6	17.1	14.3	41.6	14.2	35.5	14.6	34.2	18.6	16.3	13.3	17.5	13.4	15.2	35.7	28.3	31.2	8.1	17.0	18.5	9.7	1.1	0.6	2.5	1.2	3.2	1.9	2.0	2.7	0.9	1.5	1.5	2.1	0.0	1.7	0.2	2.0	1.6	1.1	13.8	19.9	23.1	25.2	17.7	9.7	15.0	18.7	12.4	13.7
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074506-19210276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	24.4	25.4	22.4	29.0	25.4	58.3	23.7	28.5	32.5	22.4	28.5	26.3	31.5	18.2	34.0	32.5	22.7	20.3	27.3	20.5	23.3	15.9	25.5	29.7	31.2	20.3	21.0	20.9	35.5	21.0	40.9	31.4	28.4	25.0	30.7	20.5	30.6	24.7	27.1	55.9	69.0	25.5	39.3	20.2	26.5	30.2	41.1	21.6	37.7	26.1	17.3	25.9	43.4	29.0	4.6	9.1	18.3	18.5	2.7	3.4	4.6	22.9	23.2	21.0	15.5	39.3	20.3	18.2	17.9	18.9	19.5	17.8	37.0	19.8	13.9	16.8	23.6	15.7	16.4	17.8	18.3	11.5	14.5	31.7	22.4	24.1	27.7	19.4	21.1	18.1	22.9	39.7	38.3	21.3	21.6	12.9	18.5	16.4	9.1	23.7	17.0	13.1	12.8	16.4	11.6	17.6	13.5	14.9	14.8	21.2	12.2	15.2	8.4	15.3	33.0	22.9	14.3	27.1	20.0	15.3	9.2	16.1	15.7	30.0	19.4	18.3	18.5	2.9	3.4	3.8	2.9	4.6	3.0	1.9	9.1	2.9	2.7	2.5	9.8	2.7	1.3	4.3	2.1	4.6	22.4	25.4	28.5	32.5	23.3	15.9	21.0	20.9	25.0	21.6
UBR5	"DD5, EDD, EDD1, HYD, KIAA0896"	ENSG00000104517	"Ubiquitin protein ligase E3 component n-recognin 5"	O95071	8	102253012-102412841	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053688			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053688: "	"unprognostic (3.79e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.54e-3)"	"unprognostic (8.29e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.45e-1)"	27.0	16.7	27.1	29.5	31.7	30.3	29.2	40.8	32.8	24.9	25.0	19.1	21.1	14.4	26.8	24.0	23.8	22.0	17.6	22.7	25.5	15.3	17.9	17.0	24.2	29.6	21.9	20.6	29.7	22.2	32.4	25.5	25.0	23.6	20.2	17.1	19.7	22.9	21.8	39.9	29.7	22.4	29.3	17.5	21.9	21.1	39.7	28.3	37.9	20.3	15.9	27.0	27.5	28.6	5.0	4.0	6.3	5.5	2.4	7.1	2.1	23.2	10.4	20.2	10.3	19.9	20.3	18.6	17.6	15.6	13.8	12.1	10.4	15.7	46.4	15.2	16.5	14.2	17.2	15.3	19.4	20.0	8.4	38.7	14.2	18.7	17.7	12.0	21.4	23.2	15.3	14.2	24.8	16.5	18.6	26.4	13.5	21.0	30.5	14.4	15.2	11.8	17.8	11.9	22.0	12.6	22.9	14.9	12.4	12.3	12.0	12.2	19.2	12.8	16.5	14.7	17.2	13.2	12.2	14.1	13.6	47.7	14.6	18.8	11.9	3.1	3.4	5.0	5.6	3.4	5.6	5.0	6.0	5.9	4.0	3.9	4.8	7.1	6.3	2.4	5.5	3.6	7.1	2.1	27.1	31.7	40.8	32.8	25.5	15.3	21.9	20.6	23.6	28.3
UBTF	"NOR-90, UBF, UBF1, UBF2"	ENSG00000108312	"Upstream binding transcription factor, RNA polymerase I"	P17480	17	44205033-44221626	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004611, HPA006385"	Supported	Supported	Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"CAB004611: AB_671403, HPA006385: AB_1080447"	"unprognostic (1.37e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.96e-3)"	"unprognostic (5.44e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	21.9	25.4	27.8	33.0	29.4	32.8	25.1	43.6	37.1	28.0	29.2	31.7	34.8	22.8	35.3	29.4	27.2	28.2	30.5	25.3	24.4	21.0	22.9	22.9	22.2	42.7	23.3	28.5	30.9	32.3	35.9	24.8	20.5	18.8	27.9	20.0	26.5	25.5	46.2	37.9	32.9	26.8	26.6	23.3	34.0	22.4	13.7	26.0	69.6	33.0	21.1	36.4	27.3	27.7	14.0	11.9	9.2	9.6	13.4	16.4	9.4	17.8	28.0	21.0	25.5	13.9	16.1	19.3	18.5	12.6	19.3	14.4	13.5	14.8	65.7	18.5	17.5	16.9	26.9	15.9	16.0	38.2	29.1	26.2	19.6	21.9	9.3	49.6	23.2	16.2	14.7	12.2	18.2	16.1	30.1	20.7	16.1	30.6	48.6	19.8	19.9	22.1	48.3	28.5	29.6	11.3	14.5	32.9	25.1	18.5	16.9	14.8	24.6	32.3	19.6	30.3	36.8	17.7	24.8	18.1	15.6	40.4	18.1	22.9	27.0	7.5	5.2	5.3	15.1	5.8	16.4	11.1	10.7	15.8	6.1	14.0	12.5	13.0	9.2	13.4	9.6	11.9	8.7	9.4	27.8	29.4	43.6	37.1	24.4	21.0	23.3	28.5	18.8	26.0
UBXN4	"KIAA0242, UBXD2, UBXDC1"	ENSG00000144224	"UBX domain protein 4"	Q92575	2	135741619-135785055	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036325	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA036325: AB_10669788"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.14e-3)"	32.5	37.8	24.3	27.0	28.4	24.5	29.5	28.6	27.6	35.5	29.2	26.6	35.0	31.7	32.7	33.2	29.4	26.5	27.7	25.5	25.7	21.2	34.3	64.7	27.8	24.1	30.0	28.8	34.7	38.8	42.1	39.7	33.5	33.0	30.5	27.6	23.0	38.0	38.2	52.0	29.7	33.8	26.2	38.3	25.4	29.7	32.1	29.8	47.3	39.9	25.0	25.1	35.5	36.3	24.8	27.3	33.6	23.4	27.2	24.8	16.7	40.5	11.9	24.2	19.7	32.1	35.4	27.1	35.0	35.2	30.2	27.1	19.8	30.3	26.2	45.6	30.8	29.1	14.8	20.8	32.0	32.6	18.1	23.5	17.5	26.3	29.4	26.1	23.0	26.9	17.7	28.4	26.4	35.5	22.3	37.5	27.2	20.2	31.0	13.9	18.8	20.6	26.1	33.0	43.9	29.0	30.3	23.7	14.4	31.4	19.6	18.8	22.2	21.5	33.1	26.3	12.7	26.3	17.5	32.9	19.7	22.4	33.0	17.5	24.5	26.0	18.5	27.1	23.7	20.3	22.8	24.8	22.6	22.9	17.7	22.2	23.2	22.1	33.6	27.2	23.4	27.3	24.8	16.7	24.3	28.4	28.6	27.6	25.7	21.2	30.0	28.8	33.0	29.8
UBXN7	"KIAA0794, UBXD7"	ENSG00000163960	"UBX domain protein 7"	O94888	3	196347662-196432474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048441, HPA049442"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA048441: , HPA049442: "	"unprognostic (8.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	13.8	12.7	14.0	11.2	17.6	29.9	13.3	30.4	16.3	14.5	13.1	19.2	13.5	9.0	17.3	14.3	13.4	14.4	9.9	9.6	15.6	12.1	11.4	10.4	13.3	13.3	16.3	12.9	21.4	12.9	23.1	23.4	14.9	16.2	12.4	11.5	11.4	12.8	13.3	10.3	17.5	12.9	13.4	14.0	13.5	10.8	17.9	19.0	24.7	13.2	6.7	13.6	13.9	17.2	9.6	6.3	10.4	6.5	7.6	9.5	2.8	14.9	4.3	18.7	9.8	9.7	17.2	7.8	12.5	8.3	7.2	6.6	12.2	6.5	13.9	25.7	8.4	12.1	13.9	7.4	13.4	5.7	8.6	22.4	10.1	6.6	7.5	11.1	7.2	10.3	8.5	10.1	12.7	11.5	10.5	9.7	8.3	6.5	11.5	6.0	10.8	6.0	13.4	14.0	9.5	6.0	6.4	12.7	9.6	19.4	5.6	9.9	15.1	9.5	14.5	8.4	7.4	7.4	13.3	13.3	18.2	20.4	7.6	13.1	6.0	10.2	5.9	8.9	6.1	4.9	5.8	9.6	5.4	4.0	6.3	7.5	9.5	8.3	10.4	7.6	6.5	2.9	8.7	2.8	14.0	17.6	30.4	16.3	15.6	12.1	16.3	12.9	16.2	19.0
UBXN8	"D8S2298E, REP8, UBXD6"	ENSG00000104691	"UBX domain protein 8"	O00124	8	30732247-30767006	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 30.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017725, HPA077538"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Nucleoplasm, Nucleoli"	"HPA017725: AB_1847462, HPA077538: "	"unprognostic (3.00e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (6.13e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (5.25e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-2)"	5.0	5.3	3.9	1.4	4.8	1.4	4.3	1.5	9.2	3.0	3.5	4.0	6.7	3.1	3.8	14.3	4.1	3.6	3.8	2.8	5.7		8.2	21.5	2.1	3.9	7.6	4.0	30.6	10.3	6.2	3.5	6.2	6.2	4.8	4.7	1.6	1.8	6.1	1.7	4.1	2.9	2.9	7.1	5.7	3.3	11.5	6.1	0.9	9.1	2.8	2.3	2.9	3.7	6.0	8.2	1.0	6.1	3.3	8.4	3.4	7.6	7.7	5.6	5.8	9.1	12.2	6.2	13.7	8.0	7.5	9.2	12.2	2.7	12.2	11.3	11.1	6.8	1.1	7.6	11.6	6.4	12.5	34.3	6.3	14.9	13.6	7.8	19.4	9.5	7.9	12.0	5.9	6.5	33.4	9.2	16.5	7.2	7.9	6.0	10.8	5.8	9.5	5.4	8.5	12.8	10.0	3.2	8.1	3.8	11.3	24.7	8.4	13.6	8.3	8.5	3.7	3.8	12.7	4.0	12.5	9.2	7.6	12.6	12.1	0.0	6.0	0.7	8.4	6.1	7.3	6.0	4.5	8.0	6.7	2.9	4.4	7.4	1.0	3.3	3.0	8.2	4.3	3.4										
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 225.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 97.1;SCLC-21H: 96.9;U-251 MG: 88.7;U-266/84: 85.5;U-87 MG: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.6"	"Lineage enriched"	"Detected in single"	37	"B-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol			440000	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (1.93e-4)"	8.2	40.2	52.4	8.9	65.1	2.0	3.1	17.5	225.8	4.5	6.3	11.5	0.0	5.5	6.0	1.8	2.7	5.7	6.5	5.4	53.4	97.4	14.0	2.0	2.7	6.5	62.0	57.1	15.4	6.3	1.8	30.5	2.7	100.6	5.3	4.7	6.0	3.0	4.4	7.5	2.7	8.6	5.2	38.6	2.3	2.8	8.0	8.3	0.0	3.9	0.0	4.5	5.6	2.8	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	55.0	11.4	0.0	1.5	1.9	0.0	57.6	29.7	20.4	20.6	11.1	0.0	0.0	97.1	29.3	0.1	21.0	0.0	8.3	0.1	8.6	0.0	0.3	0.0	44.0	0.0	0.0	10.6	0.2	16.3	0.0	0.1	0.0	0.2	10.8	0.0	0.0	0.9	32.9	62.2	0.0	24.4	0.0	30.8	0.0	96.9	60.9	0.3	0.2	0.1	0.0	0.4	0.3	1.3	0.4	0.0	88.7	45.5	85.5	0.2	94.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	52.4	65.1	17.5	92.6	53.4	97.4	62.0	57.1	100.6	8.3
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol			490000	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavourable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	13.7	39.1	23.6	11.9	37.6	17.4	21.4	17.5	18.7	10.6	21.2	11.4	12.8	12.8	9.0	40.5	37.7	8.1	12.4	15.5	20.6	12.6	20.7	36.8	10.3	12.2	18.2	13.5	7.7	20.8	9.5	28.9	26.3	14.7	12.4	25.0	6.1	24.0	14.9	31.7	28.8	15.0	16.9	13.3	15.3	14.5	24.6	18.6	18.9	28.1	29.8	20.2	16.0	16.2	17.4	46.0	15.8	43.5	20.5	23.4	17.3	53.2	8.9	7.8	5.4	14.6	17.4	22.5	20.2	20.0	26.3	29.5	49.3	25.9	27.6	14.6	21.2	29.4	18.2	49.0	40.0	14.7	15.9	17.4	14.8	31.5	21.1	41.5	13.1	15.5	34.1	20.5	33.1	25.6	19.0	7.9	39.5	19.2	16.8	27.2	11.6	26.9	13.5	12.6	18.1	30.9	21.7	23.5	6.9	11.5	22.4	9.3	12.9	11.8	19.8	11.5	13.7	12.2	26.9	11.1	12.3	32.1	23.2	45.0	8.2	15.6	24.1	15.8	10.9	43.5	14.2	17.4	19.9	15.5	33.6	16.0	19.8	18.3	5.4	20.5	36.2	46.0	23.4	17.3	23.6	37.6	17.5	18.7	20.6	12.6	18.2	13.5	14.7	18.6
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA075383"	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA005908: AB_1858585, HPA075383: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (7.10e-5)"	"unprognostic (4.33e-2)"	15.7	18.3	20.1	16.1	26.2	16.0	18.2	30.1	34.8	10.9	17.7	11.5	12.6	19.0	12.5	14.7	26.1	10.7	11.9	22.0	21.6	20.6	21.6	28.3	12.4	19.9	21.3	29.4	13.4	24.8	15.6	16.2	17.8	33.3	17.8	18.8	10.3	19.3	12.9	29.1	16.7	18.0	13.9	20.1	17.3	14.0	9.9	17.5	20.0	15.1	19.1	23.0	14.8	14.8	22.5	20.8	23.8	21.1	35.6	30.9	20.9	33.2	18.5	16.0	16.4	9.3	9.5	19.1	19.6	10.0	18.8	16.3	17.4	22.6	26.1	18.9	10.8	20.7	21.3	25.3	24.9	26.9	15.3	30.9	23.9	23.1	15.0	48.5	17.4	8.7	11.3	26.9	23.9	18.5	67.7	21.3	15.9	26.8	35.7	18.0	14.8	11.7	20.7	18.0	50.7	17.5	19.5	16.3	20.1	17.6	25.5	27.2	20.7	24.5	12.0	17.6	5.4	17.8	31.1	16.6	25.6	29.4	10.5	30.3	29.9	23.8	16.5	19.0	28.3	19.5	30.9	22.5	25.9	26.9	19.4	18.0	28.2	30.5	10.0	35.6	21.1	20.8	24.8	20.9	20.1	26.2	30.1	34.8	21.6	20.6	21.3	29.4	33.3	17.5
UCP2	"BMIQ4, SLC25A8"	ENSG00000175567	"Uncoupling protein 2"	P55851	11	73974667-73983307	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 219.1;lymphoid tissue: 144.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 66.9;SK-BR-3: 86.1;U-698: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025583, HPA075202"	Approved		Supported	Mitochondria				Mitochondria		"CAB025583: , HPA075202: "	"unprognostic (1.13e-1)"	"prognostic favourable (4.65e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (7.80e-6)"	"unprognostic (3.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.88e-3)"	19.8	9.8	5.3	40.4	9.5	24.5	15.9	1.1	4.9	8.1	7.7	10.2	20.3	11.4	4.2	12.0	4.5	37.9	13.1	11.5	4.4	5.5	12.8	10.6	20.2	85.6	7.8	2.4	7.2	4.7	1.2	6.2	8.7	6.5	6.5	8.9	14.2	17.4	17.2	45.3	4.3	24.7	6.4	9.0	91.1	12.3	5.5	5.9	144.8	17.9	19.3	55.7	19.4	2.9	141.6	219.1	101.8	135.3	119.8	180.2	172.1	0.1	14.1	3.2	9.6	1.8	0.0	2.4	2.3	1.6	9.7	2.8	24.7	12.0	66.9	33.5	3.6	0.6	2.3	0.0	4.5	16.9	0.8	39.0	5.9	5.1	5.8	20.5	16.4	2.1	0.0	9.1	0.0	1.2	17.9	27.3	1.9	24.1	21.2	11.1	2.6	2.8	19.6	22.3	37.9	27.0	39.9	4.9	6.0	12.6	86.1	4.8	25.4	18.3	1.8	0.0	12.4	2.8	4.6	9.4	4.4	55.7	1.7	8.1	0.1	45.7	81.5	101.8	112.6	135.3	69.9	141.6	92.3	95.0	88.4	134.2	86.9	91.1	11.4	119.8	111.3	219.1	180.2	172.1	5.3	9.5	1.1	4.9	4.4	5.5	7.8	2.4	6.5	5.9
UFL1	"KIAA0776, Maxer, NLBP, RCAD"	ENSG00000014123	"UFM1 specific ligase 1"	O94874	6	96521595-96555276	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030558, HPA030559, HPA030560"	Enhanced		Supported	"Endoplasmic reticulum"			6900	"Endoplasmic reticulum"		"HPA030558: AB_10600663, HPA030559: AB_10600537, HPA030560: AB_10602000"	"unprognostic (5.40e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.46e-1)"	20.2	26.3	19.8	21.9	24.0	14.6	20.9	16.4	23.6	22.1	17.9	19.4	32.1	21.5	20.5	28.5	23.6	18.6	20.2	22.1	21.6	17.8	21.6	32.7	15.8	21.5	31.1	20.0	24.8	35.7	28.8	32.4	25.6	28.0	24.6	19.2	14.2	23.9	30.7	33.0	19.3	28.4	18.5	33.0	18.8	20.6	13.4	27.3	29.2	27.6	23.1	20.1	24.0	18.8	11.2	12.6	10.1	11.7	14.7	14.7	7.9	8.7	4.7	9.9	16.6	14.4	22.1	14.8	12.4	12.7	8.0	7.5	5.8	10.3	21.4	15.9	12.4	17.2	8.1	11.7	11.7	11.4	7.3	9.3	7.4	10.6	19.2	17.5	14.0	15.7	11.0	9.5	26.4	13.0	12.4	23.7	15.0	8.5	6.4	10.9	3.6	5.3	8.1	11.7	16.8	14.4	16.1	7.0	6.8	10.2	12.1	11.5	29.4	15.1	12.7	11.2	6.1	11.3	13.0	14.0	7.2	16.4	17.2	11.8	10.2	7.8	9.2	10.1	10.9	11.7	12.5	11.2	11.5	11.6	11.8	11.0	14.7	11.5	2.0	14.7	11.2	12.6	12.7	7.9	19.8	24.0	16.4	23.6	21.6	17.8	31.1	20.0	28.0	27.3
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 125.8"	"Cell line enhanced"	"Detected in all"		"A549: 84.2;Hep G2: 97.5;U-2197: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm			42000	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavourable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	25.9	11.3	4.4	24.7	3.2	0.2	12.7	4.0	3.1	13.0	29.3	3.8	10.2	13.7	11.5	9.7	22.9	9.9	12.9	10.1	3.6	3.5	28.2	125.8	13.5	4.7	4.0	2.2	20.6	24.9	5.1	4.7	26.8	5.3	13.2	23.3	7.5	8.2	7.3	7.5	5.5	24.2	17.7	3.7	3.3	14.1	5.0	3.8	1.7	16.7	12.7	7.1	30.2	24.1	12.0	12.3	17.1	12.0	21.8	22.4	10.2	4.8	84.2	9.3	12.1	30.4	33.8	7.8	16.0	19.1	15.9	14.6	11.8	18.2	3.1	10.1	22.2	5.0	9.6	4.5	16.7	3.9	1.7	3.4	10.9	97.5	12.0	4.2	3.5	11.3	2.5	27.1	8.5	10.1	4.5	2.6	10.9	14.3	4.1	4.6	7.5	6.2	7.1	14.4	3.1	8.7	19.3	4.7	6.9	9.9	5.8	6.7	3.2	3.5	11.8	16.3	7.6	60.6	7.6	5.9	4.3	3.1	13.7	3.6	8.5	17.1	12.0	10.9	14.3	10.6	22.4	10.9	11.4	14.8	10.7	12.0	9.8	12.0	2.3	21.8	6.1	12.3	7.3	10.2	4.4	3.2	4.0	3.0	3.6	3.5	4.0	2.2	5.3	3.8
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 62.6;REH: 142.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.6	11.3	17.2	12.2	0.5	2.0	2.7	12.7	6.1	13.3	12.9	13.5	7.9	8.9	3.1	5.6	7.8	11.8	6.9	9.4	14.4	13.4	7.7	10.6	14.4	0.2	18.9	11.7	0.9	0.5	7.2	1.8	3.9	11.0	10.3	7.9	12.2	62.6	11.6	7.7	12.3	142.1	38.3	6.5	3.6	11.5	12.7	10.1	10.0	5.5	1.7	9.9	18.1	4.9	14.1	11.5	18.2	15.3	4.4	4.5	26.2	8.1	18.4	17.9	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9										
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA026633: AB_1858610, HPA026697: AB_1858611"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	14.1	12.9	10.6	25.4	12.2	49.1	19.0	24.8	11.8	18.6	15.6	12.7	17.6	7.9	17.5	15.1	13.3	12.0	11.9	11.3	10.2	10.6	10.1	9.8	13.5	19.3	12.3	10.5	18.9	14.5	12.7	12.7	14.6	11.4	19.3	12.0	10.7	13.0	16.4	15.7	11.0	12.0	17.1	12.2	14.1	11.6	10.6	14.8	40.3	15.2	10.2	19.8	18.7	18.2	5.1	2.5	7.5	1.4	1.2	3.6	1.2	6.6	7.5	10.9	4.6	9.0	12.9	8.0	15.3	9.4	9.6	16.9	4.8	4.8	10.2	3.3	7.6	4.3	10.0	8.9	14.8	18.3	4.7	17.7	14.7	7.6	7.4	8.2	6.0	5.8	5.8	7.5	18.4	37.5	1.7	9.9	22.7	2.3	13.8	32.1	4.2	5.6	15.8	5.0	3.6	7.2	4.6	9.9	3.8	6.6	4.4	9.6	5.5	16.6	31.7	10.3	3.8	4.3	12.8	2.6	7.9	11.9	5.0	7.2	4.1	7.5	1.1	4.3	2.3	0.9	1.7	3.5	3.6	1.8	0.7	5.1	2.3	3.0	1.3	1.2	1.4	2.5	3.5	1.2	10.6	12.2	24.8	11.8	10.2	10.6	12.3	10.5	11.4	14.8
UIMC1	RAP80	ENSG00000087206	"Ubiquitin interaction motif containing 1"	Q96RL1	5	176905005-177022633	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 32.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037503, HPA037504"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA037503: AB_10671373, HPA037504: AB_10671760"	"unprognostic (2.96e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.88e-3)"	"prognostic unfavourable (7.67e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.51e-2)"	"unprognostic (5.52e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.44e-1)"	12.7	11.1	11.8	17.3	13.7	35.3	12.6	27.8	12.7	12.2	13.8	7.8	12.0	6.4	14.9	11.7	8.9	10.7	8.8	16.0	9.5	6.6	8.7	8.1	12.1	36.7	11.2	8.9	18.2	12.7	7.0	10.6	8.7	10.4	10.5	9.0	8.8	8.5	10.8	22.9	10.9	10.9	13.7	7.8	15.0	10.4	47.5	11.5	22.1	11.8	7.3	29.5	13.6	28.2	8.5	4.9	32.5	6.3	7.4	7.8	3.3	10.9	10.9	11.4	14.5	10.8	10.1	16.6	11.8	12.9	14.7	15.6	12.8	12.9	45.0	14.1	9.3	8.8	11.6	25.4	17.6	37.6	10.4	14.3	12.1	10.9	11.9	17.8	9.6	7.1	12.2	11.2	30.5	17.1	12.7	10.9	12.1	10.4	19.0	11.7	8.1	6.7	18.6	16.3	19.1	15.4	7.3	12.4	9.8	24.8	8.4	12.2	7.4	10.8	13.6	8.6	9.3	7.5	15.4	19.4	20.2	24.2	8.3	19.3	9.2	7.0	6.3	16.8	5.0	4.0	5.5	6.4	5.8	4.8	3.8	8.5	5.6	4.6	32.5	7.4	2.8	4.9	7.8	3.3	11.8	13.7	27.8	12.7	9.5	6.6	11.2	8.9	10.4	11.5
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149964007-149973710	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.9;lung: 9.7;testis: 10.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 23.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: "	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.7	0.6	2.0	0.4	0.6	0.5	0.5	13.9	1.5	0.4	0.7	0.2	0.0	0.4	0.5	0.5	0.8	0.9	0.5	1.2	1.5	0.3	1.2	0.9	9.7	0.2	0.3	0.0	1.2	0.4	0.6	0.6	1.3	1.0	0.8	0.4	0.5	1.0	0.2	1.6	0.6	0.3	0.3	1.2	0.3	0.9	10.5	0.2	0.2	3.8	0.6	0.5	0.7	4.9	0.7	0.1	0.9	1.8	0.3	3.5	0.3	2.7	1.3	2.7	1.4	2.7	7.9	2.8	3.7	1.1	1.7	2.9	1.8	3.2	2.8	2.9	12.8	2.7	23.7	4.6	4.4	12.4	3.9	0.2	0.9	0.0	14.0	0.1	1.0	8.6	5.8	11.7	3.1	2.4	2.3	0.0	4.1	3.3	2.9	0.0	1.0	4.3	1.2	2.4	0.4	5.0	2.1	0.9	0.3	5.4	3.4	0.8	2.7	5.5	1.9	1.3	2.3	5.2	3.2	0.4	0.4	2.5	8.2	4.1	3.4	0.1	0.2	0.1	2.4	1.3	3.5	0.7	1.2	2.8	0.1	0.2	0.7	1.2	0.9	0.3	1.8	0.0	1.9	0.3	2.0	0.6	13.9	1.5	1.5	0.3	0.3	0.0	1.0	0.2
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942000-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 31.7;U-2197: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.5"									CAB018974	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"			"Vesicles, Plasma membrane"		"CAB018974: "	"unprognostic (2.09e-5)"	"prognostic unfavourable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	3.3	1.7	4.5	1.9	2.3	4.3	5.9	5.3	6.5	1.6	0.6	0.0	0.0	0.9	0.6	0.5	10.8	0.5	1.6	4.1	4.4	1.0	1.9	1.7	6.2	1.1	1.0	2.1	0.2	1.6	0.3	1.1	4.4	3.9	0.6	0.7	0.3	1.5	0.4	0.6	1.0	0.4	2.0	0.6	0.5	0.7	3.6	0.1	0.5	3.5	4.6	2.4	4.1	5.2	0.0	0.0	0.0	0.0	0.8	5.5	0.9	9.2	0.8	0.2	2.9	0.5	2.8	1.6	9.5	5.6	10.0	8.2	3.5	5.2	0.0	14.6	10.8	6.6	3.6	8.7	5.8	4.2	1.8	0.5	1.4	0.0	3.5	0.0	0.7	1.3	6.7	8.9	3.9	5.7	1.1	0.0	7.4	6.4	0.8	0.0	0.0	4.9	1.4	2.2	0.0	14.2	2.7	0.3	0.0	31.7	0.6	0.9	0.9	3.9	8.9	6.6	8.2	22.9	11.0	0.0	0.0	0.4	9.4	5.0	4.7	0.0	0.0	0.0	5.5	0.0	0.6	0.0	1.8	3.2	0.0	0.0	0.6	3.9	0.0	0.8	0.0	0.0	3.0	0.9	4.5	2.3	5.3	6.5	4.4	1.0	1.0	2.1	3.9	0.1
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730366-124749273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Supported	Cytosol				Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	8.4	12.2	4.9	6.8	6.8	4.8	8.0	9.3	7.6	5.9	9.1	8.5	5.2	8.4	6.8	6.7	13.2	8.2	6.6	3.6	4.0	3.9	9.6	20.7	5.2	10.1	7.3	3.6	8.9	19.0	9.5	9.3	11.6	4.7	6.4	7.1	6.4	8.9	4.0	10.9	9.5	8.5	5.5	5.9	9.8	8.3	6.8	6.2	10.6	7.4	12.0	9.3	7.8	6.4	16.6	13.1	4.6	9.8	10.2	13.0	7.9	1.4	4.3	5.0	2.0	3.0	3.4	5.2	7.4	2.3	3.1	2.6	3.7	2.0	3.8	8.2	2.9	8.3	7.0	2.4	5.0	4.3	4.0	7.7	2.8	2.6	2.6	8.0	5.9	3.8	2.3	1.9	3.9	1.4	3.5	1.8	2.3	3.3	9.9	1.5	10.9	2.8	6.5	5.9	3.1	2.5	2.4	4.0	2.6	11.1	4.0	4.1	4.0	3.0	14.2	2.5	5.0	6.8	2.9	7.4	10.1	10.3	2.8	3.3	2.5	4.5	9.0	4.6	12.5	9.8	12.1	13.7	8.9	11.3	13.1	16.6	13.0	10.4	0.6	10.2	8.0	9.7	10.3	7.9	4.9	6.8	9.3	5.7	4.0	3.9	7.3	3.6	4.7	6.2
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.1"	"Cell line enhanced"	"Detected in many"		"HEL: 55.1;HMC-1: 57.1;SK-BR-3: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"	"Low region specificity"	"Detected in many"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol			14000000	Cytosol	Vesicles	"HPA067117: , HPA073525: "	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	4.5	3.3	2.9	17.1	5.2	31.3	4.5	4.1	3.1	5.2	5.2	2.8	1.4	4.5	3.8	1.8	11.5	5.2	8.7	13.0	1.8	1.6	2.6	4.9	30.1	24.9	4.5	1.6	8.7	5.5	0.3	5.3	67.1	3.2	3.1	2.6	2.6	8.0	3.9	3.2	3.0	7.6	2.8	3.7	33.8	7.2	2.2	3.3	23.6	2.4	9.3	24.7	7.0	8.2	4.0	6.9	24.8	13.6	8.2	11.5	7.9	8.3	3.2	0.0	0.0	0.1	0.2	10.4	0.0	0.0	0.0	0.0	8.0	18.8	0.7	10.0	0.0	2.9	0.0	0.5	0.0	0.1	0.1	55.1	24.4	5.1	0.9	20.9	57.1	0.1	0.4	0.1	0.5	3.7	19.0	0.2	0.0	14.2	22.1	10.5	0.2	0.4	7.1	0.2	0.3	0.3	3.3	0.0	15.3	3.6	39.1	0.2	10.5	11.9	10.4	0.1	14.8	0.1	0.0	0.3	1.3	0.8	0.1	6.7	0.0	24.8	8.0	16.4	11.5	9.4	10.4	4.0	6.7	8.1	6.9	2.2	5.3	6.9	22.4	8.2	13.6	4.0	6.0	7.9	2.9	5.2	4.1	3.1	1.8	1.6	4.5	1.6	3.2	3.3
UNC45A	"GC-UNC45, SMAP-1"	ENSG00000140553	"Unc-45 myosin chaperone A"	Q9H3U1	15	90930180-90954093	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039228	Approved		Supported	"Nuclear speckles,Cytosol"			21000000	"Nuclear speckles"	Cytosol	"HPA039228: "	"unprognostic (1.46e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-3)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.85e-2)"	"prognostic favourable (7.46e-7)"	"unprognostic (9.30e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-2)"	19.1	21.0	10.1	14.4	10.1	11.9	20.6	21.8	14.6	20.3	27.6	10.7	23.2	13.0	29.7	15.5	24.9	20.4	24.8	12.8	9.5	7.3	16.2	15.9	15.2	13.2	11.9	12.3	22.1	19.4	25.8	14.1	22.8	11.5	23.8	10.9	15.3	20.2	29.6	6.9	26.6	16.9	35.8	9.7	15.7	22.4	18.4	10.8	18.0	20.8	12.6	16.9	33.2	30.4	10.1	12.0	12.1	11.9	10.8	14.5	9.8	15.1	30.9	12.8	11.1	35.1	16.3	11.4	17.2	14.9	23.5	18.9	24.6	20.1	17.9	23.2	21.7	33.7	21.7	22.2	11.1	19.8	31.6	34.5	32.3	17.6	19.9	8.5	23.5	20.1	27.2	23.0	16.9	31.8	15.2	14.7	17.6	24.4	10.9	7.3	17.3	15.7	21.8	19.5	19.0	16.0	36.1	18.1	16.4	23.2	23.2	21.5	21.0	17.7	31.3	20.1	14.5	16.9	18.0	14.1	19.5	8.4	19.7	20.0	20.4	12.1	9.0	5.4	14.5	8.3	14.0	10.1	11.9	11.2	12.0	8.3	10.0	9.1	1.8	10.8	11.9	10.7	10.5	9.8	10.1	10.1	21.8	14.6	9.5	7.3	11.9	12.3	11.5	10.8
UNC45B	"CMYA4, UNC45"	ENSG00000141161	"Unc-45 myosin chaperone B"	Q8IWX7	17	35147817-35189345	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2"	"Group enriched"	"Detected in some"	11	"BEWO: 4.6;HSkMC: 6.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.9;testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017861			Supported	Cytosol				Cytosol		"HPA017861: AB_1847012"	"unprognostic (7.17e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.49e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.13e-6)"	"unprognostic (6.77e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	0.3	48.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.2	62.5	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.2	23.2	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	0.2	2.9	0.0	0.7	1.8	0.0	0.0	0.4	2.0	0.2	0.3	0.3	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNK	"KIAA1753, ZC3H5, ZC3HDC5"	ENSG00000132478	"Unkempt family zinc finger"	Q9C0B0	17	75784771-75825799	"Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023636, HPA027962"	Uncertain		Supported	"Cytosol,Cytoplasmic bodies"				"Cytosol, Cytoplasmic bodies"		"HPA023636: AB_10601774, HPA027962: AB_10611522"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.04e-3)"	"unprognostic (9.51e-2)"	"prognostic favourable (2.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.73e-2)"	"unprognostic (9.78e-2)"	"prognostic favourable (6.58e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-2)"	11.6	11.7	13.0	17.8	14.6	13.9	15.5	19.5	14.5	17.8	11.2	15.0	17.6	12.5	18.7	16.1	13.5	17.0	15.4	10.6	13.0	8.7	12.3	11.8	18.4	17.6	14.5	14.3	24.5	18.2	18.5	20.7	13.4	11.2	15.6	6.8	22.2	19.6	16.3	15.0	25.1	13.7	14.3	9.7	21.2	12.9	22.1	16.4	15.6	17.5	8.2	16.1	13.8	15.2	2.8	1.9	0.4	1.1	1.3	2.3	1.5	6.3	10.2	11.4	9.6	3.6	3.4	9.3	4.3	4.6	4.8	5.9	3.7	7.4	13.7	3.7	4.6	5.9	5.7	5.1	2.2	7.0	18.8	8.5	8.2	7.9	4.9	6.5	10.9	6.7	3.1	4.1	4.5	6.3	4.4	6.8	3.8	12.7	14.5	9.0	4.9	6.8	15.4	11.4	6.9	4.5	6.9	10.6	20.7	5.6	7.8	15.0	9.5	10.1	4.5	11.5	6.3	5.0	5.5	11.8	3.4	7.5	8.3	4.2	7.0	0.3	1.1	0.4	2.3	0.7	2.3	1.1	1.3	1.4	0.7	2.8	2.1	2.0	0.4	1.3	0.9	1.9	1.3	1.5	13.0	14.6	19.5	14.5	13.0	8.7	14.5	14.3	11.2	16.4
UNKL	"C16orf28, FLJ23360, ZC3H5L, ZC3HDC5L"	ENSG00000059145	"Unkempt family like zinc finger"	Q9H9P5	16	1363205-1414751	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA055801, HPA073949"	Uncertain		Supported	Cytosol				Cytosol		"HPA055801: , HPA073949: "	"unprognostic (5.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-3)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.55e-1)"	9.6	10.0	14.0	10.4	12.9	12.1	10.1	27.9	16.3	10.5	7.3	9.3	10.2	11.0	15.2	7.9	6.0	11.0	5.0	5.7	12.2	4.5	6.3	4.8	9.1	11.7	9.2	8.3	18.9	10.1	6.5	7.2	9.0	10.1	10.5	4.4	9.3	12.3	12.7	14.4	10.5	10.6	7.2	5.6	14.3	9.9	8.4	11.7	11.0	11.7	7.0	7.6	10.8	9.3	1.9	3.2	7.6	2.1	2.4	3.7	1.3	3.4	9.0	2.0	5.1	1.8	2.0	16.0	8.5	2.6	2.5	2.0	6.6	7.3	1.3	18.2	3.0	6.2	2.6	0.8	1.7	15.6	7.7	2.3	9.2	5.9	1.2	1.2	5.5	2.5	1.2	3.7	1.6	4.3	7.1	4.8	1.1	5.2	3.8	4.1	5.7	10.1	10.1	1.9	9.2	1.4	0.7	6.9	4.1	4.4	3.2	0.6	5.0	2.1	3.8	5.3	7.7	4.4	3.6	10.2	5.6	6.0	4.3	2.9	5.9	5.7	2.1	4.5	3.7	0.7	2.1	1.5	1.5	0.9	0.7	1.9	2.8	1.4	7.6	2.4	0.7	3.2	1.6	1.3	14.0	12.9	27.9	16.3	12.2	4.5	9.2	8.3	10.1	11.7
UPF1	"HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2"	ENSG00000005007	"UPF1, RNA helicase and ATPase"	Q92900	19	18831938-18868236	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Nonsense-mediated mRNA decay"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019587, HPA020857"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA019587: AB_1856174, HPA020857: AB_1856175"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.98e-2)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (2.94e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.71e-3)"	"prognostic favourable (2.97e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-2)"	22.5	22.4	18.0	22.4	19.9	23.2	20.4	40.9	25.4	21.5	20.0	24.5	27.8	21.9	24.9	16.7	23.4	19.6	27.0	19.2	14.6	13.5	17.3	20.8	20.5	23.4	20.3	19.3	23.6	42.7	38.1	21.1	28.7	17.7	22.4	11.4	17.9	36.3	25.3	27.9	26.4	20.3	20.1	15.9	23.7	23.7	46.9	20.8	24.9	25.9	13.0	22.9	25.4	24.4	0.9	1.3	4.7	2.3	2.6	1.1	0.8	23.6	15.8	11.1	13.2	17.3	11.4	36.6	20.2	12.5	19.6	15.4	30.3	21.6	21.4	26.8	12.6	23.9	15.6	22.0	7.5	11.3	30.8	23.4	14.3	19.4	14.9	26.0	14.2	12.6	16.0	15.2	16.6	12.4	29.4	20.8	10.3	25.9	30.1	16.3	18.5	38.7	24.2	18.0	20.0	8.6	21.5	23.6	18.2	18.5	21.1	10.9	12.7	16.7	17.4	17.5	12.2	21.4	22.5	13.5	10.4	33.0	12.4	25.1	19.3	0.0	1.7	3.0	0.8	0.9	0.7	0.4	1.1	0.2	1.3	0.9	0.7	0.5	4.7	2.6	2.3	0.6	0.5	0.8	18.0	19.9	40.9	25.4	14.6	13.5	20.3	19.3	17.7	20.8
UPF2	"DKFZP434D222, KIAA1408, RENT2, smg-3"	ENSG00000151461	"UPF2, regulator of nonsense mediated mRNA decay"	Q9HAU5	10	11920022-12043170	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067008			Supported	"Cytosol,Cytoplasmic bodies"				Cytosol	"Cytoplasmic bodies"	"HPA067008: "	"unprognostic (1.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.48e-2)"	15.8	8.7	12.9	18.9	18.1	19.2	13.4	19.7	14.2	22.5	25.5	8.1	14.6	10.2	15.8	14.2	17.2	11.7	9.2	12.7	13.8	11.9	14.5	20.2	12.8	17.8	13.6	10.0	17.8	14.1	20.1	22.3	18.1	13.4	24.5	13.8	7.4	12.2	20.0	33.5	14.5	19.2	19.8	19.3	20.1	12.0	19.4	17.5	28.8	23.0	16.0	17.7	25.5	13.5	7.9	8.4	21.8	3.2	3.7	4.2	1.2	19.0	12.1	10.4	12.9	7.9	10.2	11.8	14.9	6.9	10.7	12.9	11.3	15.6	27.4	5.1	12.4	16.0	14.9	13.5	15.4	17.2	8.6	32.8	9.9	10.3	9.0	14.7	22.2	7.6	10.6	13.5	9.2	13.0	19.4	14.1	12.2	9.3	18.2	8.7	9.9	6.5	16.1	12.5	13.5	10.2	7.7	6.8	7.3	11.8	12.7	12.8	15.4	19.9	13.8	8.4	17.7	17.2	11.3	13.0	10.2	22.7	13.5	14.4	6.6	8.3	3.2	7.1	3.3	3.0	3.2	7.3	3.8	3.4	2.1	7.9	4.2	3.4	21.8	3.7	2.0	8.4	2.7	1.2	12.9	18.1	19.7	14.2	13.8	11.9	13.6	10.0	13.4	17.5
UPF3B	"HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B, regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: , HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavourable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavourable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.7	10.3	19.4	11.5	21.9	14.5	10.8	34.1	24.0	10.2	13.0	9.3	12.8	14.2	14.6	13.5	13.0	8.8	8.4	7.8	16.9	17.5	10.0	12.4	9.0	17.2	16.5	21.7	14.8	8.7	14.3	26.7	10.5	17.2	12.4	13.2	9.1	9.7	14.4	14.5	18.6	11.1	14.2	21.7	12.9	9.9	15.0	21.0	9.9	12.5	11.5	18.3	12.6	12.9	17.5	10.0	7.1	5.9	7.9	8.1	2.7	11.6	7.1	14.8	12.0	6.7	4.4	9.5	11.3	6.3	8.8	7.8	13.3	8.4	21.1	9.6	4.7	11.2	19.1	6.7	11.3	12.0	14.0	19.5	23.5	6.9	7.7	21.1	9.7	3.8	5.1	15.1	18.5	8.2	18.8	17.6	7.3	14.2	14.8	26.5	28.5	19.4	14.5	16.9	15.4	7.2	5.9	19.7	13.6	23.0	9.3	16.8	4.9	12.3	7.1	9.2	7.1	14.7	23.8	9.7	10.8	28.5	7.4	31.0	10.7	7.1	5.3	6.8	7.5	5.1	5.7	13.8	7.0	5.9	3.8	17.5	7.6	8.1	5.9	7.9	5.9	10.0	7.8	2.7	19.4	21.9	34.1	24.0	16.9	17.5	16.5	21.7	17.2	21.0
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108733	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"hTERT-HME1: 102.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA054040: , HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.7	8.4	2.8	12.6	4.2	17.6	7.1	5.7	3.8	10.3	8.0	1.7	2.1	7.5	2.8	4.2	37.7	3.3	8.5	7.0	2.3	3.3	12.4	9.1	18.3	17.4	5.8	1.4	2.9	5.8	2.4	5.0	28.9	5.5	3.0	7.6	2.9	7.5	2.1	5.1	2.0	9.7	5.2	3.9	13.9	2.5	1.8	4.8	1.2	6.2	34.0	19.4	7.9	19.6	0.6	8.2	15.7	22.0	5.7	19.7	16.0	6.5	7.8	0.8	1.6	2.6	1.2	8.0	3.2	4.4	4.1	5.1	3.2	3.1	0.0	1.1	2.6	4.5	1.5	13.0	2.6	1.3	1.4	0.2	1.8	1.3	2.4	0.2	0.5	1.6	6.3	1.8	102.5	2.6	0.4	3.8	2.1	0.7	0.0	1.1	3.1	6.8	0.0	1.7	1.7	9.4	3.3	0.7	0.7	3.3	0.9	23.7	0.8	0.2	3.7	9.6	8.2	2.6	8.1	7.4	9.9	1.1	9.7	0.9	23.2	15.7	22.0	15.1	19.7	16.7	12.5	0.2	12.6	13.5	8.2	0.6	13.0	12.0	9.1	5.7	15.9	0.7	11.2	16.0	2.8	4.2	5.7	3.8	2.3	3.3	5.8	1.4	5.5	4.8
UPRT	"DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3"	ENSG00000094841	"Uracil phosphoribosyltransferase homolog"	Q96BW1	X	75274085-75304600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000805	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA000805: AB_1080482"	"unprognostic (3.12e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"prognostic favourable (4.14e-4)"	"unprognostic (6.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.53e-3)"	8.8	15.3	14.6	7.9	15.8	14.9	10.7	20.3	18.7	11.5	9.9	10.8	10.8	14.2	10.0	12.5	13.0	10.2	8.4	12.0	13.1	17.7	15.5	11.3	10.0	10.7	14.9	9.6	8.7	14.1	18.7	19.5	7.6	13.2	12.8	11.0	9.1	13.1	8.6	13.3	7.4	10.5	14.0	10.9	11.0	13.9	3.0	12.4	10.6	13.9	6.5	11.9	9.1	7.9	8.3	11.1	8.9	16.4	14.7	13.3	7.4	7.7	5.5	6.1	5.7	6.6	7.1	5.8	5.4	6.4	5.9	6.6	4.8	5.2	10.8	4.7	5.6	3.4	14.0	4.9	9.5	9.8	5.6	6.8	5.8	6.1	6.4	13.3	14.1	5.4	3.4	8.1	4.2	10.2	7.9	10.9	15.3	3.3	15.0	8.1	12.4	9.0	7.1	16.1	5.2	15.0	4.5	0.4	6.4	7.6	7.9	7.4	3.6	8.5	8.5	7.4	4.5	13.6	4.6	7.4	24.1	10.5	7.9	14.6	4.7	5.1	7.4	8.9	8.3	10.7	9.5	8.3	8.3	8.5	11.1	7.2	10.5	9.3	1.3	14.7	16.4	5.0	13.3	7.4	14.6	15.8	20.3	18.7	13.1	17.7	14.9	9.6	13.2	12.4
UQCC2	"bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1"	ENSG00000137288	"Ubiquinol-cytochrome c reductase complex assembly factor 2"	Q9BRT2	6	33694293-33711727	"Disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039111	Uncertain		Supported	"Nuclear bodies,Mitochondria"				Mitochondria	"Nuclear bodies"	"HPA039111: "	"unprognostic (3.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.43e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.07e-1)"	13.4	22.9	26.1	13.3	31.4	14.6	17.7	15.0	22.9	12.4	15.8	12.0	12.3	12.8	17.4	23.4	15.2	10.9	9.2	71.0	19.2	23.0	18.3	23.4	8.9	12.3	22.8	22.6	11.5	25.3	7.9	24.5	14.4	20.6	15.7	17.2	18.9	19.6	14.3	76.4	12.2	10.4	20.0	20.0	12.9	15.9	30.9	18.3	12.3	19.0	22.0	14.9	10.9	11.0	39.7	38.9	7.2	39.6	21.9	31.5	34.8	42.4	30.6	34.3	29.7	28.5	28.8	27.0	24.3	24.4	33.8	33.5	49.1	18.0	17.1	39.2	29.2	22.9	23.3	33.9	30.1	21.8	38.3	33.5	20.3	67.8	46.8	31.2	27.5	29.3	54.6	27.1	43.9	25.1	35.6	35.5	39.7	45.7	30.2	64.9	20.8	34.9	21.9	28.1	58.0	23.9	40.4	59.0	20.9	26.8	41.0	33.5	36.0	79.5	23.2	38.9	33.0	25.0	49.9	27.4	38.0	28.9	11.7	47.3	44.8	7.2	27.0	5.2	24.0	39.6	29.1	39.7	30.3	27.4	31.9	32.8	31.5	28.4	2.6	21.9	32.7	38.9	31.1	34.8	26.1	31.4	15.0	22.9	19.2	23.0	22.8	22.6	20.6	18.3
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.7"	"Cell line enhanced"	"Detected in all"		"PC-3: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria,Cytosol			1300000	Mitochondria	Cytosol	"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favourable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	18.1	13.7	11.1	9.8	12.5	9.4	11.8	12.5	20.5	11.0	33.7	6.9	10.4	20.0	9.1	9.7	15.8	12.4	10.8	66.7	10.8	11.2	23.0	30.5	7.7	9.3	13.3	13.5	6.3	14.4	20.4	7.8	11.5	13.3	12.5	12.3	7.8	19.5	21.9	172.7	14.0	20.9	12.0	8.7	8.4	23.0	18.4	7.4	9.4	9.1	39.9	9.8	10.3	9.1	23.3	52.7	28.1	57.8	15.1	22.0	74.3	10.0	16.2	5.9	3.6	8.7	8.0	26.7	18.5	15.0	15.4	14.0	25.2	3.0	25.9	11.7	8.3	9.7	7.4	21.5	2.8	15.4	35.5	26.6	14.1	27.4	17.3	16.7	11.5	11.0	24.4	10.5	17.2	15.2	14.3	1.7	9.3	17.4	12.0	19.1	14.8	64.6	8.2	15.7	21.2	15.9	11.0	6.3	11.2	25.1	3.0	14.8	6.4	2.6	15.3	4.3	16.3	13.4	19.1	15.8	13.9	15.0	9.4	19.3	13.7	17.6	57.8	28.1	18.9	56.9	17.9	23.3	18.9	19.0	52.7	18.6	17.1	16.4	14.1	15.1	48.5	21.0	22.0	74.3	11.1	12.5	12.5	20.5	10.8	11.2	13.3	13.5	13.3	7.4
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21952660-21983660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria			4000000	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	22.7	26.8	20.6	17.1	32.7	20.5	21.3	29.2	33.7	17.7	38.4	17.4	19.5	45.0	20.8	18.6	28.7	20.0	19.1	94.9	19.8	19.3	35.1	35.8	15.9	23.6	20.9	28.5	21.9	20.8	36.6	20.2	17.8	29.6	17.7	40.5	18.5	22.1	20.2	103.9	22.2	42.0	30.4	16.5	16.5	29.3	10.3	19.2	25.2	21.4	70.0	22.9	27.9	20.0	20.0	30.6	14.3	29.3	18.7	25.7	27.4	18.9	20.9	12.9	8.6	14.4	20.2	18.3	18.4	15.0	16.9	17.2	33.7	18.8	37.7	16.6	15.8	34.7	20.9	18.5	19.5	17.2	19.4	21.3	18.4	47.6	15.3	27.1	54.0	23.6	23.2	13.2	18.2	22.1	23.0	19.7	18.3	25.2	28.1	17.6	14.1	16.1	32.9	29.9	41.2	25.3	22.4	17.8	13.0	26.1	33.0	19.8	37.8	28.8	19.5	12.0	11.3	11.7	16.4	14.3	10.3	33.4	19.6	28.8	13.7	14.3	24.7	12.8	16.9	29.3	21.9	20.0	20.5	18.6	30.6	15.8	22.8	20.8	9.1	18.7	27.6	13.2	25.7	27.4	20.6	32.7	29.2	33.7	19.8	19.3	20.9	28.5	29.6	19.2
UQCRQ	"QCR8, QP-C, UQCR7"	ENSG00000164405	"Ubiquinol-cytochrome c reductase complex III subunit VII"	O14949	5	132866560-132868031	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 174.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046693, HPA053323"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA046693: AB_10968453, HPA053323: "	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.92e-2)"	"prognostic favourable (4.23e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.37e-2)"	26.4	38.4	43.2	24.5	34.2	20.9	30.9	18.0	37.5	22.5	49.7	13.8	44.0	42.5	15.4	41.8	32.1	15.3	42.7	111.1	33.2	31.7	48.8	112.5	18.8	21.5	42.0	30.4	12.3	64.6	14.0	23.1	17.0	30.5	32.0	44.8	19.7	44.6	39.6	174.9	16.4	40.5	21.2	25.4	15.2	37.4	16.1	20.8	14.3	24.6	71.5	16.8	22.6	20.5	56.6	95.8	67.9	99.9	53.8	56.7	106.3	45.6	63.9	37.7	91.2	56.6	46.0	32.7	33.1	46.9	53.1	66.3	89.9	53.4	18.8	70.1	43.4	46.3	34.3	80.8	45.7	34.3	72.2	24.9	100.7	70.6	49.1	28.2	42.9	49.0	56.4	37.9	52.3	41.4	31.8	60.6	55.6	86.5	64.8	65.1	26.7	57.7	42.5	41.8	80.7	68.7	89.2	63.3	52.7	41.0	46.3	70.8	69.0	65.0	25.7	48.7	61.5	39.9	67.0	67.0	88.9	33.6	64.8	52.6	48.4	67.9	99.9	61.1	47.0	76.6	48.3	56.6	54.9	53.5	87.4	46.0	53.6	51.5	47.4	53.8	70.2	95.8	56.7	106.3	43.2	34.2	18.0	37.5	33.2	31.7	42.0	30.4	30.5	20.8
URB1	"C21orf108, KIAA0539, NPA1"	ENSG00000142207	"URB1 ribosome biogenesis 1 homolog (S. cerevisiae)"	O60287	21	32311018-32393026	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018334	Supported		Supported	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA018334: AB_1856088"	"unprognostic (1.58e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavourable (4.93e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.57e-1)"	"unprognostic (4.65e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.78e-2)"	10.7	14.7	8.5	9.5	13.0	7.4	11.3	10.4	16.2	13.1	8.4	12.6	20.1	6.1	22.2	11.0	13.3	16.5	8.7	10.7	9.2	8.8	8.7	14.9	7.7	9.5	11.7	8.7	17.6	14.1	13.0	15.3	8.6	17.4	19.4	7.5	6.4	15.7	24.9	16.0	16.6	6.7	13.9	10.0	8.7	8.6	14.9	10.9	9.6	10.6	10.2	13.8	16.1	12.4	2.5	1.3	2.5	1.2	3.2	3.5	1.1	7.8	10.0	4.5	9.3	9.3	7.4	7.3	8.1	4.1	6.2	4.8	13.8	4.5	7.9	4.5	7.9	4.9	12.6	19.2	6.4	6.0	7.6	26.9	9.1	7.3	6.7	14.9	6.0	12.0	6.7	14.0	15.4	6.6	24.0	7.8	9.0	7.9	9.6	5.3	14.9	9.3	11.5	10.6	9.5	4.2	7.5	10.2	9.1	9.5	8.0	8.8	7.0	5.8	7.6	15.3	9.2	6.3	9.1	11.0	10.6	12.6	7.0	13.7	7.8	2.5	1.2	0.1	1.8	1.1	3.5	2.5	2.0	2.3	1.3	2.1	2.7	2.5	1.4	3.2	0.7	1.2	2.0	1.1	8.5	13.0	10.4	16.2	9.2	8.8	11.7	8.7	17.4	10.9
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis 2 homolog (S. cerevisiae)"	Q14146	1	229626234-229660199	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli				Nucleoli		"HPA008902: AB_2213805, HPA046788: "	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	9.8	6.2	7.0	7.2	7.8	7.6	6.5	5.8	11.0	4.7	5.0	9.5	2.9	4.3	7.4	3.8	8.0	6.9	5.2	4.9	5.3	3.7	4.3	10.4	4.9	12.0	8.2	7.7	7.2	13.7	6.5	9.9	6.5	8.0	5.0	4.9	6.4	5.8	3.8	14.0	5.8	5.3	6.6	5.8	8.4	5.8	15.6	7.2	10.3	4.6	6.2	9.0	5.5	4.8	2.7	2.7	0.5	3.9	1.9	5.6	2.9	7.3	11.0	7.2	9.6	4.5	3.8	22.0	5.8	3.6	9.1	6.9	10.9	5.8	15.2	6.8	4.1	10.1	17.8	7.1	8.3	7.4	16.9	9.4	9.3	6.4	4.3	13.8	8.2	3.7	5.2	9.0	7.0	4.3	20.0	7.1	5.6	5.8	15.3	6.8	24.1	7.3	17.2	10.2	15.2	4.0	9.3	10.8	13.2	6.9	7.2	5.8	8.1	7.9	4.7	7.5	9.4	9.4	16.6	7.9	7.6	22.8	4.0	10.4	13.5	0.2	1.9	0.5	3.0	3.9	5.6	2.0	2.8	3.6	2.7	2.7	4.3	3.3	0.2	1.9	1.3	1.6	3.1	2.9	7.0	7.8	5.8	11.0	5.3	3.7	8.2	7.7	8.0	7.2
URGCP	"DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4"	ENSG00000106608	"Upregulator of cell proliferation"	Q8TCY9	7	43875894-43926411	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019879, HPA020134, HPA029468"	Approved		Supported	Cytosol				Cytosol		"HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.23e-3)"	"unprognostic (3.71e-1)"	"prognostic favourable (1.90e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.69e-3)"	13.7	27.1	18.5	13.4	21.4	8.6	13.4	28.3	29.5	15.8	18.2	18.6	14.8	22.2	18.3	15.1	13.8	15.6	11.6	19.3	18.3	15.9	20.4	21.3	12.1	9.5	13.8	19.5	21.6	18.4	22.5	22.1	14.4	17.9	17.7	19.6	19.8	18.4	17.1	26.8	17.4	21.0	19.1	10.9	13.8	12.8	7.0	17.2	8.3	14.6	7.9	12.5	15.0	12.3	6.1	9.8	5.8	7.5	2.6	11.9	6.1	13.8	13.0	5.2	16.8	14.3	13.2	5.1	15.4	30.6	18.8	19.2	10.8	11.4	8.3	8.8	16.5	22.5	14.8	12.4	18.5	15.6	8.5	5.6	12.9	9.3	15.2	8.7	10.8	10.1	15.3	14.8	14.4	9.3	14.1	6.5	12.5	10.6	9.0	7.4	9.9	12.3	12.7	7.2	11.4	17.9	14.2	13.8	23.3	17.4	26.0	8.1	13.2	10.5	8.6	10.6	4.7	11.8	12.8	17.9	25.9	10.4	12.3	13.7	20.1	2.6	4.5	5.8	9.0	7.3	9.9	6.1	9.6	11.9	9.8	5.6	10.6	9.3	0.5	2.6	7.5	1.5	9.6	6.1	18.5	21.4	28.3	29.5	18.3	15.9	13.8	19.5	17.9	17.2
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1, prefoldin like chaperone"	O94763	19	29923644-30016608	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA071709: "	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	16.4	21.2	19.7	15.9	21.5	17.8	21.0	21.7	19.8	18.4	18.0	18.9	16.6	12.9	19.7	19.4	20.5	17.7	14.2	17.5	19.2	16.5	16.6	22.9	13.0	20.7	22.7	15.4	26.3	21.8	21.8	28.8	15.0	21.1	22.6	18.8	12.7	16.7	18.5	45.0	25.3	17.7	15.7	28.3	18.7	14.0	69.2	22.8	21.0	32.1	14.5	20.3	18.6	17.2	6.6	3.1	3.8	2.5	3.7	6.2	1.4	22.6	30.9	14.5	22.5	10.3	15.1	24.5	14.8	12.6	10.9	12.5	16.2	15.0	35.3	29.5	17.2	16.1	30.7	19.0	24.8	24.5	17.5	32.1	15.3	20.9	15.0	30.8	13.8	13.2	26.1	9.4	35.7	8.0	38.0	9.9	13.6	19.4	20.1	13.0	13.5	9.5	19.9	26.9	14.2	7.2	26.9	23.4	18.4	17.0	20.6	21.7	8.5	19.5	10.5	26.9	23.9	13.1	22.4	27.5	29.6	23.9	13.2	27.2	16.1	3.8	2.4	3.2	5.7	2.5	4.8	3.5	5.1	5.8	2.0	6.6	6.2	6.1	0.3	3.7	2.3	3.1	3.8	1.4	19.7	21.5	21.7	19.8	19.2	16.5	22.7	15.4	21.1	22.8
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45012147-45015575	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol			5200000	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: "	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	20.7	50.2	23.1	12.2	26.2	67.5	20.7	14.2	28.6	17.7	24.2	16.5	25.9	11.2	27.8	22.6	17.8	20.8	17.4	34.0	21.1	20.3	29.6	58.1	14.3	14.8	21.6	22.9	27.4	18.4	35.9	17.6	25.8	16.2	19.2	12.3	24.3	45.6	19.2	28.8	12.1	13.2	22.9	18.9	16.6	15.0	16.3	11.5	17.2	26.3	23.6	16.0	15.0	13.0	25.7	48.6	20.6	36.3	26.0	27.4	35.6	12.5	8.2	13.2	17.3	22.8	21.5	6.4	15.3	39.6	32.3	24.9	11.8	6.6	8.9	16.2	23.2	6.5	25.1	29.9	22.5	7.9	26.4	46.0	19.0	39.1	26.6	14.0	8.6	22.3	19.0	30.8	25.0	41.4	79.8	9.8	30.8	10.5	9.5	12.1	20.5	29.1	14.4	19.6	12.9	28.1	10.6	14.1	11.1	16.8	12.6	25.9	9.9	14.7	26.8	18.4	14.4	6.3	24.7	10.2	10.9	7.5	28.8	21.3	9.2	17.6	36.3	20.6	19.7	25.8	20.0	25.7	23.8	19.2	48.6	23.7	22.3	20.3	6.6	26.0	15.5	32.4	27.4	35.6	23.1	26.2	14.2	28.6	21.1	20.3	21.6	22.9	16.2	11.5
USB1	"C16orf57, FLJ13154, HVSL1, Mpn1"	ENSG00000103005	"U6 snRNA biogenesis phosphodiesterase 1"	Q9BQ65	16	57999546-58021618	"Disease related genes, Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041791, HPA059854"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA041791: AB_10793933, HPA059854: "	"unprognostic (2.79e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.23e-3)"	"prognostic unfavourable (6.69e-7)"	"unprognostic (4.30e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.04e-2)"	23.7	26.3	19.5	28.7	20.3	29.0	16.1	8.2	30.5	17.4	19.1	16.8	10.3	15.2	19.1	18.6	16.6	14.7	16.1	22.4	19.9	21.4	18.0	47.5	19.6	20.6	19.0	16.5	18.4	16.6	18.5	13.7	18.8	26.1	16.5	20.8	13.4	14.3	21.3	13.5	16.1	16.8	26.7	14.2	27.6	18.5	18.1	15.5	18.5	21.8	14.3	21.7	25.4	19.3	6.2	16.7	50.0	26.5	12.8	18.5	9.0	17.6	37.2	12.7	24.1	16.5	11.7	20.1	14.9	20.1	24.0	17.1	24.1	10.7	10.9	19.9	22.2	13.3	20.1	32.1	34.6	10.4	11.2	13.6	15.4	34.7	18.9	18.0	40.1	16.6	19.2	30.5	17.9	26.2	18.2	5.4	20.1	18.7	16.4	20.8	21.0	30.4	16.5	11.5	18.2	17.0	21.8	6.2	14.5	39.2	10.3	9.4	5.1	18.4	28.2	14.2	20.9	15.1	20.4	8.2	12.0	20.1	17.1	17.2	17.3	25.2	18.0	25.0	18.5	20.3	12.1	6.2	10.9	14.1	16.7	4.3	6.8	12.1	50.0	12.8	26.5	7.3	13.1	9.0	19.5	20.3	8.2	30.5	19.9	21.4	19.0	16.5	26.1	15.5
USF1	"bHLHb11, MLTFI, UEF"	ENSG00000158773	"Upstream transcription factor 1"	P22415	1	161039251-161045977	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001480, HPA036233, HPA036535"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB001480: AB_2213986, HPA036233: , HPA036535: "	"unprognostic (3.66e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (9.40e-2)"	"prognostic favourable (8.70e-4)"	"unprognostic (1.59e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (6.01e-12)"	"unprognostic (1.24e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.08e-1)"	"prognostic favourable (1.95e-5)"	15.4	17.0	21.6	16.9	24.4	14.3	13.8	31.0	27.6	15.2	17.6	15.6	15.6	17.7	15.1	15.5	12.6	17.1	16.2	17.4	21.6	22.1	15.2	19.1	16.7	23.8	19.7	19.4	17.2	9.8	19.0	12.3	17.3	17.1	14.4	18.0	14.7	13.8	19.0	27.4	14.6	17.8	18.0	18.3	26.7	13.7	8.5	18.7	21.9	16.1	13.5	30.3	18.5	13.8	3.9	5.7	8.6	4.7	2.0	4.0	2.0	8.2	12.5	15.0	17.4	20.3	11.6	20.2	6.9	15.0	21.6	16.9	8.7	10.4	10.7	14.7	11.5	10.3	17.6	11.0	12.2	9.9	10.4	9.1	10.5	9.1	11.9	12.7	12.9	9.4	11.0	15.6	12.8	20.2	15.0	11.5	13.5	9.6	19.6	13.9	30.9	16.4	17.1	11.7	12.9	10.7	13.2	8.5	16.3	12.6	16.4	8.7	13.7	41.5	11.8	10.9	6.9	6.6	11.1	9.7	12.3	16.9	9.3	12.5	8.2	4.7	4.7	2.7	4.0	4.5	2.4	3.4	2.5	2.9	5.4	3.9	2.7	2.6	8.6	2.0	4.2	5.7	2.7	2.0	21.6	24.4	31.0	27.6	21.6	22.1	19.7	19.4	17.1	18.7
USF2	"bHLHb12, FIP"	ENSG00000105698	"Upstream transcription factor 2, c-fos interacting"	Q15853	19	35268978-35279821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029764, HPA046567"			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA029764: , HPA046567: "	"unprognostic (6.10e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.07e-2)"	"prognostic favourable (5.12e-5)"	"unprognostic (7.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-2)"	"prognostic favourable (3.28e-4)"	40.6	48.6	50.9	42.7	56.8	52.8	53.0	52.5	60.5	23.4	26.2	41.2	25.9	36.5	26.3	23.4	25.8	23.6	23.1	52.6	50.8	35.5	22.1	47.9	29.1	48.8	48.6	43.6	54.1	41.8	34.9	36.4	22.1	40.2	22.5	19.7	31.7	34.0	21.6	108.9	35.1	35.8	24.4	48.5	42.9	30.6	13.0	51.2	22.7	29.9	24.9	32.5	26.8	35.6	7.1	27.3	17.8	5.8	5.8	7.2	3.7	38.0	38.3	20.0	18.8	34.6	17.7	18.8	20.6	24.5	18.8	14.2	17.8	19.7	36.5	33.1	17.6	11.6	18.5	16.1	9.8	61.3	28.5	21.7	22.9	28.4	21.0	36.2	37.4	15.3	22.8	12.3	19.1	12.8	26.0	54.7	14.7	43.6	39.6	14.4	16.6	13.0	38.9	25.4	34.4	15.6	24.3	33.7	25.6	38.4	41.8	69.3	16.8	29.2	21.5	31.9	21.5	20.9	27.6	55.2	55.1	39.6	29.5	23.2	41.5	17.8	4.7	5.7	3.9	5.8	4.8	5.6	4.0	5.1	7.1	7.1	3.6	3.5	4.2	5.8	3.5	27.3	7.2	3.7	50.9	56.8	52.5	60.5	50.8	35.5	48.6	43.6	40.2	51.2
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.0;intestine: 57.0;kidney: 22.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 35.2;HeLa: 12.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favourable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.1	0.1	1.6	4.3	7.1	0.0	0.0	0.8	3.3	0.1	23.8	6.2	0.0	40.5	0.0	6.3	0.0	1.3	26.0	0.3	5.0	2.3	22.1	0.4	0.0	0.0	4.8	1.9	0.3	2.1	0.0	5.2	0.0	3.5	0.1	20.7	1.8	0.0	0.1	0.0	0.0	57.0	0.9	10.2	0.0	11.5	0.2	3.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	35.2	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	7.1	0.8	2.3	5.0	2.3	4.8	1.9	3.5	3.6
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724593-75814286	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 94.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"			43000	"Golgi apparatus"	"Nucleoli fibrillar center"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	18.1	22.1	9.9	14.9	11.5	4.1	14.6	13.8	13.2	18.1	16.5	9.1	24.9	13.0	18.6	25.3	20.1	15.8	12.1	35.4	10.9	10.4	18.7	38.8	13.6	10.8	11.5	11.7	23.2	23.6	16.8	32.1	23.1	16.1	19.4	14.0	11.4	20.8	22.2	94.4	13.2	17.3	19.1	14.7	13.5	14.8	15.3	10.6	15.0	20.7	27.0	14.1	23.8	18.8	10.1	14.6	16.8	21.2	19.1	20.7	11.2	14.2	11.3	15.9	21.3	39.0	51.8	14.6	33.5	41.1	18.5	22.6	11.2	22.1	18.8	20.7	30.7	16.6	23.8	20.8	27.9	20.6	9.2	12.9	10.1	23.5	30.7	17.0	14.9	29.4	25.7	19.2	37.8	27.6	22.3	21.7	27.3	9.3	16.8	9.0	21.7	6.7	11.2	15.2	15.0	27.6	16.6	12.7	12.4	12.3	26.1	21.1	19.1	14.0	21.2	17.0	10.5	30.7	12.6	20.5	11.0	9.1	25.3	10.3	20.0	16.8	11.4	10.1	15.2	16.5	20.7	9.3	12.9	14.5	14.6	10.1	13.6	13.1	7.0	19.1	21.2	11.8	12.9	11.2	9.9	11.5	13.8	13.2	10.9	10.4	11.5	11.7	16.1	10.6
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA028387: , HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	11.6	9.0	11.3	17.2	10.7	29.3	15.9	20.6	14.2	19.2	13.3	7.8	8.0	10.8	15.1	12.0	15.6	13.8	8.9	9.0	11.5	9.6	11.8	9.3	11.7	19.2	14.2	9.6	26.7	12.7	14.8	18.4	13.6	10.9	14.8	13.9	7.6	12.7	13.5	11.7	12.3	13.3	15.8	15.5	18.1	11.6	31.6	11.8	70.6	15.0	13.3	20.1	16.5	16.5	14.7	11.8	23.4	12.4	15.5	16.3	9.2	22.0	6.5	27.4	14.8	6.2	7.4	15.2	21.2	14.5	26.4	29.0	11.0	10.8	39.9	15.4	11.9	12.8	22.5	14.6	37.0	19.9	16.2	32.7	22.6	11.5	6.7	35.0	16.5	3.9	9.6	23.9	18.0	12.4	23.7	34.9	18.6	9.8	35.9	13.5	24.1	13.5	34.1	46.5	24.7	9.9	16.5	28.4	15.9	24.0	19.6	23.2	11.2	21.4	8.6	20.4	22.2	29.8	29.7	13.9	19.3	45.8	13.8	28.0	18.2	17.4	9.5	23.4	12.6	9.6	16.3	14.7	15.0	12.7	11.4	10.7	14.3	11.9	16.9	15.5	12.4	11.8	13.6	9.2	11.3	10.7	20.6	14.2	11.5	9.6	14.2	9.6	10.9	11.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699978-84779922	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 105.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favourable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	13.9	18.8	16.0	24.2	19.0	13.4	14.4	24.4	20.4	15.9	18.1	15.6	8.4	16.1	20.2	10.4	19.7	18.2	12.0	16.4	19.3	15.1	16.4	20.7	13.7	18.8	19.7	17.4	18.5	17.1	35.8	15.0	23.5	16.2	15.0	15.6	17.9	15.3	17.8	47.0	17.0	17.5	20.2	16.3	16.0	15.0	15.5	16.2	20.4	17.6	15.7	20.9	19.7	15.8	7.2	10.4	105.5	8.6	7.7	17.3	10.0	13.6	18.9	18.4	22.8	6.8	11.6	24.9	13.5	14.3	22.9	12.6	26.6	11.9	23.7	15.7	14.1	15.7	25.5	21.5	30.5	9.6	13.4	13.6	8.9	17.6	9.0	20.2	8.3	7.3	16.6	23.9	27.7	17.5	37.1	5.2	15.8	28.6	20.9	9.8	22.1	12.8	27.2	10.1	11.2	14.4	11.1	17.2	10.1	32.3	10.5	9.1	24.1	12.9	12.8	15.9	12.7	8.0	12.8	8.7	12.1	60.1	10.3	13.0	16.3	2.5	8.6	1.6	5.7	7.0	6.8	7.2	17.3	6.3	10.4	6.7	9.9	6.0	105.5	7.7	6.3	3.5	6.1	10.0	16.0	19.0	24.4	20.4	19.3	15.1	19.7	17.4	16.2	16.2
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232690-47248328	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 74.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favourable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	11.5	17.3	32.9	11.5	55.0	4.9	9.4	35.7	74.0	17.5	9.1	19.9	5.8	6.0	22.6	12.7	9.7	26.6	12.8	20.6	27.0	44.0	13.6	6.7	12.5	13.8	23.1	47.4	38.2	13.8	28.4	32.3	12.6	27.8	15.7	7.6	17.9	9.3	21.3	13.7	7.8	7.3	19.1	17.0	13.5	9.1	19.2	14.6	19.0	27.2	4.3	14.3	11.0	9.8	21.0	20.6	22.8	8.7	19.8	31.7	16.4	14.3	22.6	38.9	26.5	14.7	9.9	10.8	11.0	17.3	21.9	24.5	21.5	11.8	9.5	8.7	19.8	17.1	31.5	7.7	19.5	14.7	23.9	11.1	17.9	19.1	17.1	12.4	23.2	14.2	3.2	23.1	9.9	8.7	8.3	1.3	17.0	21.8	24.1	13.3	28.9	20.2	27.2	38.1	7.9	10.7	19.8	22.0	37.8	20.1	4.1	11.9	8.5	7.2	9.1	18.5	19.5	26.0	12.5	17.7	11.1	16.6	11.4	15.5	16.4	22.8	3.5	7.4	22.6	7.4	19.9	20.1	10.2	22.1	4.6	21.0	15.4	31.7	2.2	19.8	8.7	20.6	12.7	16.4	32.9	55.0	35.7	74.0	27.0	44.0	23.1	47.4	27.8	14.6
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	Cytosol			1400000	Cytosol		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (7.81e-5)"	"prognostic unfavourable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favourable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	24.8	24.2	25.9	20.7	32.1	19.4	21.7	21.7	28.4	16.5	17.1	17.9	19.1	13.4	19.4	24.3	25.3	14.7	14.4	23.3	22.1	27.6	23.2	24.4	15.8	21.9	22.6	28.8	16.2	16.2	22.3	18.0	25.1	29.2	29.9	19.4	14.5	16.7	20.5	53.3	15.7	12.9	23.9	22.1	15.4	15.6	17.2	16.5	19.5	20.1	25.4	28.6	17.8	17.8	13.1	15.2	7.7	15.2	23.0	21.2	11.0	26.8	22.1	18.8	19.1	18.7	18.7	33.7	35.3	19.4	36.0	33.6	28.7	14.4	39.9	27.0	28.9	15.1	37.1	27.0	41.1	11.3	18.3	22.5	14.8	22.5	18.7	55.2	21.6	14.9	20.9	36.7	21.1	27.6	31.0	29.7	35.4	21.8	30.8	15.1	18.4	26.0	25.7	24.7	29.1	26.6	23.3	22.0	18.5	36.6	17.7	15.0	17.3	14.9	31.2	42.3	32.0	38.8	50.0	19.6	35.6	39.7	24.4	23.0	26.3	5.0	10.7	7.7	17.8	15.2	21.2	13.1	17.7	18.4	15.2	10.1	17.5	16.9	0.8	23.0	11.4	11.1	16.7	11.0	25.9	32.1	21.7	27.1	22.1	27.6	22.6	28.8	29.2	16.5
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 68.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Enhanced	Cytosol			280000	Cytosol		"HPA006237: AB_1080502, HPA006428: , HPA071014: "	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavourable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	23.1	16.8	11.5	22.5	11.9	88.9	17.8	21.1	15.7	14.5	14.5	5.2	11.9	11.4	12.7	12.4	16.1	14.1	11.2	15.2	9.6	6.2	13.8	20.4	23.8	26.2	11.6	9.4	22.5	15.8	18.9	22.5	31.0	14.9	12.4	13.8	7.6	16.2	10.7	28.5	23.0	19.7	16.3	16.2	35.6	14.3	20.0	11.0	33.1	14.1	15.4	18.9	18.4	17.9	5.7	6.0	68.5	14.2	3.3	12.1	4.8	9.3	8.8	8.8	7.6	13.9	16.3	15.7	15.2	13.5	13.5	12.1	8.8	9.4	10.0	8.7	13.0	10.2	11.7	13.2	15.8	11.0	7.2	13.7	7.5	6.7	13.5	21.7	33.4	11.8	13.8	15.9	14.2	15.9	44.4	19.4	12.4	10.4	12.9	11.0	12.9	13.0	8.3	9.3	16.1	12.5	10.8	11.1	5.3	17.6	11.2	8.6	14.7	13.0	19.0	10.5	10.5	16.3	9.4	9.2	10.2	11.4	12.0	17.7	11.8	27.2	14.2	13.8	3.4	7.3	3.5	5.7	4.6	3.2	4.9	4.7	5.9	3.5	68.5	3.3	5.8	6.0	12.1	4.8	11.5	11.9	21.1	15.7	9.6	6.2	11.6	9.4	14.9	11.0
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381726	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 79.9"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favourable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	3.1	4.8	6.9	1.4	12.2	1.5	1.6	12.6	16.1	2.5	5.9	10.0	0.0	7.9	2.6	6.4	5.9	7.0	2.2	26.8	5.7	3.1	29.7	10.6	2.2	0.7	5.7	6.2	2.9	10.1	18.4	7.6	1.3	6.7	2.3	3.9	19.1	3.2	2.4	79.9	4.6	11.7	4.2	3.8	0.8	2.7	36.1	8.8	0.0	2.2	25.2	1.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	3.4	0.3	0.5	1.9	0.1	0.1	0.7	0.4	0.2	0.0	0.3	3.6	0.5	5.9	1.1	0.6	0.6	4.7	1.7	0.1	4.2	0.6	1.7	2.5	7.3	1.6	0.0	1.6	0.6	0.3	0.4	1.2	0.3	8.2	0.5	1.0	2.4	0.0	0.4	0.9	0.7	0.0	1.3	0.8	2.7	0.2	7.2	2.2	2.0	1.6	0.4	5.3	3.6	0.0	0.0	0.9	0.5	0.5	34.4	7.6	0.1	0.0	1.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.3	0.3	6.9	12.2	12.6	16.1	5.7	3.1	5.7	6.2	6.7	8.8
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favourable (3.35e-5)"	11.8	16.4	22.1	12.8	21.2	15.3	19.1	23.6	24.8	18.1	16.1	25.5	14.0	15.5	19.7	14.6	18.3	33.3	14.1	13.7	20.9	12.1	15.4	10.6	14.0	16.7	26.4	14.1	28.3	19.0	24.4	17.2	15.2	20.5	18.1	13.1	17.1	19.0	25.3	19.4	23.5	15.4	15.1	17.0	18.7	16.0	17.0	22.9	16.0	24.5	9.6	15.6	17.9	19.2	14.1	12.0	18.3	11.1	13.4	17.2	10.7	7.4	12.8	16.9	16.3	13.5	11.3	10.4	5.5	9.0	15.2	11.9	11.8	14.7	9.7	9.5	6.8	12.9	10.9	10.7	8.4	18.5	18.3	11.6	18.5	9.2	9.7	10.3	8.7	9.5	14.4	10.4	15.0	10.7	17.1	13.6	9.6	13.7	18.2	16.2	15.8	16.3	17.3	5.6	16.3	8.9	8.9	15.4	19.8	10.3	10.8	8.3	23.8	16.6	6.2	10.9	9.7	7.6	9.4	27.5	21.3	14.4	10.0	8.9	9.8	13.0	11.1	18.3	14.9	7.1	17.2	12.8	13.8	15.4	12.0	14.1	16.0	14.6	9.6	13.4	7.7	12.0	13.3	10.7	22.1	21.2	23.6	24.8	20.9	12.1	26.4	14.1	20.5	22.9
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215113	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 46.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: "	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavourable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	12.3	7.6	7.5	12.1	8.8	30.1	10.6	20.1	8.5	7.8	10.2	6.8	10.6	5.0	10.1	7.0	7.7	6.9	7.0	14.7	7.9	6.4	10.4	9.3	7.6	12.7	8.0	5.6	10.9	7.3	15.5	16.9	5.8	6.9	7.6	8.5	5.1	9.7	10.7	46.0	8.9	8.7	7.3	6.2	10.9	7.8	4.9	8.7	16.4	7.4	11.5	12.7	9.7	13.7	6.0	10.5	5.9	2.2	3.8	4.5	1.1	17.8	9.8	12.3	6.7	16.1	14.1	14.2	7.9	10.0	11.4	11.9	14.0	6.3	14.3	8.8	14.6	14.5	16.3	13.3	17.9	15.0	9.9	28.7	21.5	16.3	9.6	19.7	22.3	12.3	11.9	17.3	19.7	10.3	26.4	6.0	15.2	4.2	11.9	10.5	18.1	11.9	12.3	15.7	6.2	19.8	12.1	10.9	7.6	13.5	9.7	11.8	6.7	9.8	13.9	10.4	10.1	12.5	12.6	7.6	5.7	18.8	9.9	16.5	9.3	5.9	2.0	2.5	4.5	1.8	2.8	4.8	3.5	3.5	1.8	6.0	3.2	4.2	2.3	3.8	2.2	10.5	1.9	1.1	7.5	8.8	20.1	8.5	7.9	6.4	8.0	5.6	6.9	8.7
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol				Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	14.9	8.5	11.0	14.2	15.5	12.4	28.7	11.3	11.1	17.5	11.8	6.6	17.8	6.5	20.7	14.5	12.6	10.6	10.1	17.8	9.9	5.8	12.9	10.4	22.1	14.8	7.6	7.1	14.5	8.2	8.1	8.4	17.7	7.7	12.9	8.6	7.8	11.4	13.6	56.3	8.3	12.3	19.2	7.3	11.6	9.0	26.1	7.5	16.5	10.5	14.6	9.6	13.8	18.1	3.1	2.8	5.8	2.9	2.3	7.2	1.6	13.0	9.9	9.4	1.4	17.3	25.9	11.0	9.4	9.4	7.0	8.9	8.6	7.5	14.1	13.9	14.8	7.0	7.2	12.4	9.7	14.0	8.2	11.5	10.5	6.6	28.8	15.2	5.3	16.8	15.2	11.3	32.7	24.5	14.8	26.6	12.6	5.4	17.3	2.9	11.5	8.8	13.2	8.7	10.7	19.0	3.5	2.0	5.6	13.4	11.4	8.7	6.1	8.9	23.3	10.9	7.1	11.4	5.2	7.8	4.7	11.2	7.1	6.8	8.0	0.0	2.9	3.6	4.0	2.8	4.4	3.1	3.4	7.2	2.5	2.2	3.2	4.8	5.8	2.3	2.5	2.8	4.4	1.6	11.0	15.5	11.3	11.1	9.9	5.8	7.6	7.1	7.7	7.5
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 40.1;skeletal muscle: 50.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	3.9	3.4	4.8	8.6	5.7	2.4	5.7	26.4	8.6	11.6	5.1	4.9	14.0	4.7	6.0	6.0	5.7	5.0	4.0	40.1	5.0	4.8	5.1	5.6	5.1	7.2	6.8	4.5	7.5	4.1	10.6	9.7	3.9	4.8	8.9	6.0	5.7	5.7	12.2	50.2	3.5	5.1	11.6	6.4	6.9	4.4	5.5	3.8	3.6	5.1	10.1	7.7	7.1	4.6	10.3	4.1	2.1	3.7	17.9	16.2	6.0	10.3	11.6	15.7	20.7	12.8	12.7	11.1	7.6	10.5	10.3	17.7	17.1	14.9	13.7	17.4	10.3	20.3	22.1	14.3	14.4	15.3	10.0	7.3	8.1	9.2	7.9	9.4	7.3	7.6	10.9	11.9	14.2	18.6	12.6	8.9	10.8	5.2	7.1	15.3	18.8	8.4	17.6	21.8	16.6	11.4	10.2	6.9	7.4	18.1	6.2	5.9	15.1	3.3	9.8	11.5	17.2	10.4	7.8	6.1	8.7	11.6	1.1	18.3	7.4	0.1	3.2	2.1	16.2	2.4	8.4	10.3	4.1	11.4	4.1	8.4	2.7	9.4	0.9	17.9	3.7	1.2	5.6	6.0	4.8	5.7	26.4	8.6	5.0	4.8	6.8	4.5	4.8	3.8
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 33.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA053275: , HPA060513: , HPA077975: "	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favourable (1.38e-4)"	16.0	9.0	5.9	20.4	6.5	38.6	21.3	33.4	6.6	12.7	19.1	6.0	16.8	16.2	18.1	13.3	13.6	10.4	14.2	7.6	6.6	4.4	12.9	10.8	17.5	28.2	8.1	3.9	19.5	27.1	7.1	8.2	10.2	7.9	12.4	11.5	8.2	18.5	14.8	12.4	15.9	19.0	16.1	8.0	23.6	14.7	10.3	7.8	22.7	12.5	11.4	22.5	21.3	17.9	11.4	20.6	52.6	28.1	7.2	12.9	13.4	9.2	30.1	15.6	9.7	7.7	12.6	13.7	7.9	9.9	7.7	9.4	11.8	17.3	9.3	12.6	7.8	11.7	14.5	12.3	7.5	15.3	7.8	10.6	10.7	12.7	6.5	6.2	12.8	9.0	16.2	9.3	16.2	16.6	14.0	11.9	4.9	14.3	13.0	10.2	19.7	13.0	19.1	9.4	16.5	9.2	31.6	13.7	10.6	4.9	16.1	9.7	9.7	12.2	15.8	8.9	18.5	5.2	10.5	10.8	19.9	20.8	8.5	17.4	7.3	28.8	28.1	3.5	8.4	22.6	9.3	10.3	11.9	8.6	20.6	11.4	12.9	9.3	52.6	7.2	18.7	4.1	9.1	13.4	5.9	6.5	33.4	6.6	6.6	4.4	8.1	3.9	7.9	7.8
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	30.8	27.1	28.1	18.8	32.1	24.6	28.6	55.3	37.5	21.6	20.4	20.6	18.5	20.2	23.3	23.0	17.8	19.2	21.7	17.0	30.7	30.6	26.0	20.3	21.0	20.7	26.0	25.4	25.3	17.0	28.8	23.4	34.6	38.7	24.6	21.0	21.4	19.5	19.8	16.3	19.4	23.8	19.8	21.4	22.3	19.5	19.9	21.6	27.8	25.1	12.9	20.3	21.0	20.0	15.7	12.2	33.2	18.4	12.3	17.8	10.6	16.3	7.5	25.9	17.9	37.3	32.6	22.3	17.9	17.1	21.9	24.6	9.9	14.1	12.2	17.0	17.4	12.9	18.8	12.3	26.8	11.2	14.7	43.1	18.3	8.6	23.2	14.7	10.9	24.0	9.7	21.1	15.5	19.4	16.8	10.7	16.4	6.3	13.2	14.7	25.0	14.8	12.8	27.3	8.6	20.6	16.8	21.8	16.8	12.5	16.7	25.0	9.3	16.0	16.2	20.2	14.4	20.3	16.9	8.7	11.1	11.9	15.3	17.4	10.2	33.2	15.4	20.0	15.1	15.0	15.3	13.4	14.7	15.2	11.5	15.7	17.8	15.6	20.9	12.3	18.4	12.2	13.2	10.6	28.1	32.1	55.3	37.5	30.7	30.6	26.0	25.4	38.7	21.6
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nuclear speckles"				Nucleoli	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: "	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	26.3	23.4	12.9	21.3	16.0	36.5	28.1	28.3	17.4	17.2	16.4	25.4	19.2	12.3	25.1	22.2	14.6	18.0	21.9	17.4	10.4	11.2	15.9	16.4	20.0	17.2	17.5	16.0	41.3	33.6	19.6	30.0	23.4	14.6	21.0	15.1	20.4	21.8	45.5	19.5	29.3	15.1	25.2	14.5	18.2	17.3	20.8	13.7	12.8	19.3	11.2	22.2	24.6	18.1	6.7	12.4	8.9	5.3	5.6	8.8	2.5	15.7	19.1	5.6	10.4	12.1	13.5	10.8	13.0	13.2	12.5	8.4	18.5	8.0	20.2	6.6	11.5	11.6	13.2	9.6	22.4	4.8	20.0	18.4	27.8	19.2	12.4	20.1	10.1	11.7	16.0	17.8	39.9	10.8	14.6	21.3	10.3	12.1	18.3	20.4	8.7	15.3	14.1	12.3	13.5	7.9	16.6	16.6	10.1	9.3	43.5	23.6	11.2	12.8	9.2	29.5	13.7	17.1	22.9	15.8	6.2	24.8	11.6	15.8	9.2	8.9	3.9	3.1	7.6	5.3	8.8	6.4	7.2	6.4	2.3	6.7	8.0	7.7	5.7	5.6	3.3	12.4	4.8	2.5	12.9	16.0	28.3	17.4	10.4	11.2	17.5	16.0	14.6	13.7
USP39	"CGI-21, SAD1, SNRNP65"	ENSG00000168883	"Ubiquitin specific peptidase 39"	Q53GS9	2	85602856-85649282	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034823, HPA077350"	Supported	Supported	Supported	Nucleoplasm				Nucleoplasm		"HPA034823: AB_10602488, HPA077350: "	"unprognostic (1.10e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (8.46e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavourable (2.84e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (4.05e-7)"	"unprognostic (3.95e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-1)"	19.0	15.1	14.5	23.5	16.8	30.4	18.3	14.9	20.8	20.2	24.1	18.7	11.8	14.7	22.1	24.1	20.7	16.8	20.6	25.5	13.7	13.7	17.8	20.8	18.5	20.8	15.2	14.5	19.2	15.0	17.7	13.7	28.0	15.8	21.6	20.5	18.0	17.2	20.0	44.2	20.2	17.8	19.0	15.0	21.0	18.1	17.2	13.0	56.5	24.7	23.9	27.0	23.0	26.0	25.3	28.8	29.8	29.7	26.4	37.3	28.2	21.7	22.2	22.7	24.9	16.5	13.0	25.5	18.4	17.4	27.4	24.5	35.4	15.8	25.8	17.4	17.3	15.7	43.4	19.8	34.9	25.9	27.6	32.0	13.3	31.2	16.3	38.8	21.9	9.1	15.9	21.1	19.0	21.8	39.2	15.2	20.1	25.3	38.2	29.2	30.0	20.6	35.3	48.7	19.5	14.7	17.0	20.9	17.0	11.5	18.9	15.8	12.7	19.0	13.9	17.0	21.2	20.2	30.4	13.5	24.9	27.6	14.5	41.0	20.3	28.0	25.5	29.8	30.3	29.7	35.2	24.3	31.8	31.2	28.8	25.3	31.4	28.5	16.4	26.4	26.9	22.5	37.3	28.2	14.5	16.8	14.9	20.8	13.7	13.7	15.2	14.5	15.8	13.0
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277831-49340712	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favourable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favourable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	22.1	18.4	21.4	22.4	29.3	41.4	23.1	30.3	32.5	20.7	20.1	26.8	16.9	16.1	23.6	20.9	23.5	19.3	17.5	22.8	22.2	18.0	20.2	18.5	25.7	25.5	20.2	17.5	23.6	17.1	23.6	19.7	22.1	24.3	20.9	21.9	23.6	19.1	21.3	25.7	27.6	19.4	25.9	20.4	30.6	17.7	25.0	19.7	36.8	21.2	14.1	42.4	22.1	22.0	17.0	24.1	59.4	27.3	21.5	18.6	22.2	6.2	7.2	10.1	13.4	18.7	20.1	6.8	17.2	15.3	22.3	20.1	7.7	15.9	12.2	6.8	25.0	8.5	13.4	24.4	20.8	18.8	4.0	27.0	14.4	8.5	27.4	14.2	15.6	20.6	10.7	24.4	20.1	25.7	9.4	19.4	20.6	10.7	16.8	24.2	8.5	12.7	6.9	6.3	10.6	17.5	13.1	8.4	11.2	12.5	8.8	6.3	6.1	22.9	22.8	15.0	8.2	18.7	10.0	15.5	7.5	17.8	13.5	22.6	17.2	18.0	27.3	30.0	16.9	22.1	18.6	17.0	17.6	16.9	24.1	14.1	17.1	15.0	59.4	21.5	24.4	9.6	18.6	22.2	21.4	29.3	30.3	32.5	22.2	18.0	20.2	17.5	24.3	19.7
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavourable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	20.1	38.8	18.6	28.9	30.9	30.9	22.1	48.2	27.5	19.9	18.4	25.6	15.4	17.6	21.3	17.6	19.0	17.4	20.5	17.8	16.9	15.8	15.5	18.3	18.3	26.2	26.6	22.5	27.0	19.8	24.6	35.4	23.1	26.8	21.6	22.0	22.1	24.5	16.3	17.0	23.9	22.2	22.2	19.7	29.1	26.2	15.8	23.6	25.8	23.9	14.0	29.0	19.8	21.0	13.7	10.5	33.7	9.6	5.6	11.2	5.6	14.6	7.0	16.5	11.9	14.3	17.7	16.3	18.5	12.6	12.4	16.5	6.4	15.0	16.5	12.5	16.7	13.6	20.3	14.9	18.9	16.0	13.9	35.3	26.1	11.6	12.8	17.7	18.9	14.3	12.9	12.6	14.1	36.6	27.7	46.8	15.2	7.3	14.6	23.0	10.4	12.6	20.6	16.6	19.3	14.3	12.4	20.1	12.5	17.4	16.0	41.8	8.2	21.4	25.9	13.4	11.1	16.4	10.7	37.5	26.6	16.4	12.9	22.0	19.7	33.7	9.6	16.7	6.4	4.6	7.6	13.7	9.5	9.5	10.5	12.8	11.2	7.0	8.9	5.6	5.0	7.7	10.1	5.6	18.6	30.9	48.2	27.5	16.9	15.8	26.6	22.5	26.8	23.6
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514419	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA050215: "	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favourable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	19.4	21.9	21.0	20.6	20.6	21.6	18.1	27.3	21.6	21.4	23.9	13.8	19.5	20.2	22.1	17.4	22.3	17.4	15.5	17.4	19.7	18.2	28.2	26.4	17.0	25.4	21.8	15.2	21.9	16.7	42.6	43.2	29.1	29.7	16.7	18.9	10.7	19.9	17.9	24.3	17.8	32.1	19.2	29.3	30.3	17.7	27.5	26.1	28.9	24.1	12.7	20.9	22.3	18.4	16.7	10.6	38.1	15.1	9.5	11.9	6.9	11.0	15.9	8.9	15.7	16.3	18.3	12.4	15.9	18.9	15.5	18.4	10.6	7.3	11.7	12.3	18.2	21.5	12.2	11.9	18.4	10.2	8.1	21.6	14.8	10.9	16.8	14.4	14.6	14.2	14.3	13.7	23.3	15.0	12.3	14.2	14.5	22.7	9.2	5.7	10.2	7.3	8.4	16.6	17.5	14.7	26.1	11.4	10.4	16.8	25.1	20.8	13.7	17.7	17.0	16.1	9.1	49.6	21.0	11.1	23.1	12.9	12.9	29.2	15.5	38.1	13.3	22.4	11.1	12.4	10.7	16.5	11.4	11.1	10.6	16.7	11.9	10.7	22.7	9.5	15.1	9.9	8.5	6.9	21.0	20.6	27.3	21.6	19.7	18.2	21.8	15.2	29.7	26.1
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A, small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA047217: , HPA054023: "	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavourable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	15.1	11.4	8.2	13.3	11.2	10.2	15.8	12.7	13.8	13.3	13.4	8.4	8.5	8.5	17.6	13.9	16.9	13.9	9.0	10.0	7.1	7.2	13.2	14.9	10.7	14.8	7.6	9.8	17.4	22.7	13.1	13.8	12.5	10.6	13.5	14.7	8.6	13.2	10.6	19.6	11.8	11.0	15.3	7.7	16.1	13.3	4.3	7.7	20.7	12.4	16.3	19.5	16.0	13.5	11.1	11.8	16.2	14.3	15.5	14.6	7.7	14.2	15.9	8.6	22.5	14.4	14.7	14.4	15.8	12.1	15.9	12.7	16.2	14.1	33.8	31.9	11.4	18.3	34.2	17.2	19.6	11.2	17.0	19.3	13.6	12.3	16.3	27.2	14.8	18.0	15.2	21.6	22.9	12.5	19.1	10.6	13.7	23.4	19.6	20.8	17.8	17.9	15.4	12.9	23.1	11.0	10.9	9.0	23.6	9.0	16.6	18.6	8.9	15.9	10.8	7.0	9.2	19.6	30.3	13.3	15.4	30.1	10.6	33.8	15.8	16.2	8.0	4.0	12.7	14.3	14.6	11.1	10.7	11.8	11.8	10.9	13.5	12.4	1.0	15.5	12.0	9.4	14.4	7.7	8.2	11.2	12.7	13.8	7.1	7.2	7.6	9.8	10.6	7.7
UTP15	"FLJ12787, FLJ23637, NET21"	ENSG00000164338	"UTP15, small subunit processome component"	Q8TED0	5	73565443-73583377	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044697			Supported	"Nucleoli,Endoplasmic reticulum"				"Nucleoli, Endoplasmic reticulum"		"HPA044697: "	"unprognostic (8.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.22e-1)"	17.1	11.8	6.5	9.4	11.7	38.6	13.2	8.7	12.5	7.5	8.6	10.4	9.3	7.0	11.3	8.7	13.6	10.4	6.7	8.8	12.9	5.6	9.3	12.9	10.2	12.1	11.0	8.0	11.0	9.7	11.8	16.4	8.8	12.5	10.1	10.9	7.5	10.9	6.6	14.5	18.3	10.7	9.9	10.3	11.4	11.9	10.1	10.0	11.4	10.3	13.2	12.8	9.5	9.4	8.3	9.0	4.6	8.0	8.8	10.8	5.4	10.7	11.7	7.9	23.9	6.9	8.2	15.0	12.8	7.5	14.6	16.2	13.0	14.4	24.3	13.0	8.7	9.1	13.5	23.9	22.6	11.9	9.8	11.2	12.4	10.6	8.5	10.1	9.2	8.3	10.8	16.5	18.5	10.0	17.0	13.4	12.3	13.6	15.4	7.2	10.7	6.7	12.3	12.2	23.5	8.7	14.7	8.2	8.8	11.6	9.5	13.5	12.2	7.5	8.1	8.7	12.0	10.1	25.0	9.9	13.1	31.4	13.7	17.5	12.6	2.5	7.0	4.6	9.7	8.0	9.7	8.3	9.8	10.6	9.0	7.2	10.5	10.8	3.8	8.8	7.3	6.5	7.9	5.4	6.5	11.7	8.7	12.5	12.9	5.6	11.0	8.0	12.5	10.0
UTP18	"CGI-48, WDR50"	ENSG00000011260	"UTP18, small subunit processome component"	Q9Y5J1	17	51260528-51297936	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052378	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoli	"Nucleoplasm, Nuclear membrane"	"HPA052378: "	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (3.33e-4)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (2.47e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.93e-2)"	15.6	16.1	14.4	18.0	20.5	26.9	20.2	23.3	20.9	15.0	13.6	14.5	12.4	13.6	13.0	13.4	17.7	14.0	11.1	8.9	14.2	13.9	17.1	16.9	14.0	22.9	17.0	20.5	19.4	18.1	17.3	19.4	28.3	16.1	13.1	15.0	12.8	14.9	11.9	19.1	25.7	13.0	10.2	14.4	22.0	13.5	42.5	16.9	21.6	19.1	15.6	25.3	15.2	17.9	26.1	26.4	12.4	22.9	17.4	28.1	24.9	26.3	26.2	16.7	15.3	11.0	16.6	43.7	14.6	12.1	25.6	24.7	16.4	14.8	33.5	20.9	10.9	14.4	27.1	15.6	38.2	21.8	35.3	35.1	15.9	28.5	15.1	37.1	17.3	10.6	12.1	21.7	17.7	15.3	28.5	15.4	19.2	16.3	33.3	25.3	23.9	27.8	30.3	38.1	26.2	18.7	17.6	18.6	23.7	17.0	20.3	33.1	25.0	19.0	13.3	26.5	22.2	21.7	30.3	29.9	55.1	38.8	16.4	25.9	18.8	6.8	22.9	12.4	20.5	21.6	24.9	26.1	25.8	24.7	26.4	24.4	28.1	26.2	4.0	17.4	21.1	16.6	25.7	24.9	14.4	20.5	23.3	20.9	14.2	13.9	17.0	20.5	16.1	16.9
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20, small subunit processome component"	O75691	12	101280109-101386616	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA049341: "	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favourable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	14.7	11.9	8.4	10.7	9.7	8.3	15.3	8.4	9.6	14.1	8.0	11.8	7.0	5.0	12.5	8.4	10.9	10.3	5.8	8.3	6.7	5.8	8.0	12.0	12.0	17.8	9.0	6.3	16.3	14.2	17.9	9.5	9.7	8.2	8.8	10.1	9.9	13.8	8.5	13.1	10.8	8.0	9.4	7.1	11.3	8.6	12.6	9.7	11.9	9.8	11.0	12.9	9.4	13.8	3.1	2.8	0.1	1.1	2.0	2.8	0.6	4.4	11.2	8.5	3.9	7.6	8.9	10.4	7.7	6.1	12.4	6.9	12.8	3.2	11.9	4.1	8.6	9.3	18.7	8.0	16.1	5.3	7.6	12.6	6.0	9.5	4.3	20.9	5.8	5.8	4.2	17.2	5.9	8.5	19.8	2.4	9.0	5.8	9.0	5.9	22.2	11.7	10.3	13.9	9.3	5.2	13.6	9.8	6.6	14.5	9.2	8.7	9.7	4.7	9.6	14.7	7.2	10.2	15.0	4.5	6.7	20.0	8.0	9.6	22.4	0.1	0.8	0.1	1.9	1.1	1.9	3.1	2.1	2.4	1.4	2.4	2.3	2.8	0.1	2.0	0.7	2.8	1.8	0.6	8.4	9.7	8.4	9.6	6.7	5.8	9.0	6.3	8.2	9.7
UTP3	"CRLZ1, DKFZp761F222, FLJ23256, SAS10"	ENSG00000132467	"UTP3, small subunit processome component"	Q9NQZ2	4	70688479-70690551	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035655, HPA041453"	Approved		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA035655: AB_10601832, HPA041453: "	"unprognostic (2.44e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.44e-3)"	"prognostic favourable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.24e-2)"	19.9	23.4	17.6	21.3	17.9	14.5	17.1	20.1	20.3	15.7	16.1	12.1	12.1	14.3	19.4	14.2	23.5	19.4	13.3	18.9	17.0	12.1	24.5	27.5	16.4	26.7	15.5	16.2	17.2	17.0	16.4	21.2	22.9	18.4	14.5	15.2	9.9	16.0	16.7	18.1	20.1	22.8	18.2	14.7	38.7	19.5	11.5	20.3	33.3	16.5	21.6	27.2	15.5	17.6	7.3	13.6	6.3	12.7	6.5	8.6	5.2	12.0	11.8	15.9	13.2	22.7	17.2	13.7	25.2	16.3	14.5	14.1	15.4	16.2	53.4	15.9	21.5	10.2	23.3	34.5	21.1	16.5	13.3	20.3	15.9	16.5	24.7	30.6	18.1	23.2	20.8	17.7	17.5	19.4	23.1	18.0	23.4	25.1	28.3	17.2	11.1	17.3	12.2	21.9	21.8	26.1	19.6	13.4	18.3	10.7	24.5	15.6	13.5	12.4	21.5	14.8	25.1	14.0	16.1	26.4	19.4	38.8	18.0	15.1	12.9	6.3	11.1	5.5	7.0	12.7	7.3	7.3	5.8	7.8	13.5	6.8	8.6	7.2	0.9	6.5	10.8	13.6	7.0	5.2	17.6	17.9	20.1	20.3	17.0	12.1	15.5	16.2	18.4	20.3
UTP4	"CIRH1A, CIRHIN, FLJ14728, KIAA1988, NAIC, TEX292"	ENSG00000141076	"UTP4, small subunit processome component"	Q969X6	16	69131291-69231130	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 87.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041139, HPA043542"	Approved		Supported	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA041139: AB_10961278, HPA043542: "	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.16e-3)"	"prognostic unfavourable (9.05e-5)"	"prognostic unfavourable (8.18e-7)"	"unprognostic (1.31e-1)"	"unprognostic (4.76e-2)"	"prognostic favourable (2.88e-5)"	"unprognostic (2.12e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.32e-3)"	"unprognostic (9.57e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.20e-2)"	20.0	11.8	11.8	13.0	21.9	19.5	16.0	10.9	24.3	11.0	13.3	11.9	6.2	8.2	18.5	11.0	16.4	15.9	10.1	12.9	12.3	11.3	21.0	17.9	11.4	14.4	10.4	12.1	18.3	23.8	15.0	10.1	11.8	15.0	14.3	14.5	14.0	18.0	12.3	40.1	13.6	9.2	17.7	11.8	13.8	13.1	30.4	10.6	14.0	20.9	11.7	17.8	17.7	11.3	16.3	13.1	1.8	12.7	16.8	20.9	15.4	16.0	19.9	11.7	16.9	10.0	8.9	19.0	18.4	12.2	32.4	23.9	38.4	13.7	35.6	15.2	11.4	21.1	25.2	20.5	35.3	7.2	15.6	16.9	12.9	19.2	12.4	20.3	10.9	8.7	10.8	28.8	26.8	14.3	35.6	4.3	17.9	19.4	21.8	9.8	28.3	14.0	35.3	18.3	32.1	12.9	16.8	20.5	14.4	38.3	9.0	9.6	16.2	10.5	9.8	16.8	17.0	15.4	24.7	12.6	25.0	87.0	11.8	15.5	17.9	1.5	9.5	1.8	14.6	12.7	20.9	16.3	16.7	14.7	13.1	11.0	19.6	17.7	0.8	16.8	9.1	11.1	15.8	15.4	11.8	21.9	10.9	24.3	12.3	11.3	10.4	12.1	15.0	10.6
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6, small subunit processome component"	Q9NYH9	17	31860899-31901765	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	Nucleoli				Nucleoli		"HPA025936: AB_1845588, HPA055806: "	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	19.3	17.9	18.7	16.9	19.3	19.0	26.4	28.7	19.3	17.7	19.5	18.0	12.5	10.8	23.4	30.4	15.7	13.3	10.7	13.0	19.5	17.0	16.7	20.7	15.4	23.3	16.2	16.1	19.5	17.0	14.1	26.0	21.4	16.2	19.9	15.9	15.0	15.9	15.0	17.0	25.3	15.2	17.0	18.8	23.1	16.4	18.5	19.1	23.2	17.1	18.5	28.1	16.0	15.5	15.4	19.7	13.1	10.9	5.7	8.0	7.0	8.3	5.5	7.7	4.4	8.0	5.3	9.4	7.2	4.1	11.0	8.5	19.6	4.4	12.6	9.1	6.6	11.0	10.9	9.0	10.2	3.2	16.4	7.8	12.3	17.8	8.8	12.0	8.1	8.1	9.0	10.8	7.9	7.0	13.8	7.2	8.7	6.8	11.2	32.0	10.2	8.6	11.7	11.0	12.3	11.3	7.7	5.1	7.7	7.6	5.4	12.1	13.3	22.5	7.3	16.6	12.5	8.7	14.5	8.1	14.5	18.3	11.4	8.4	8.9	10.6	10.8	6.7	7.6	10.9	7.3	12.7	8.0	8.0	13.6	15.4	7.1	8.0	13.1	5.7	9.7	19.7	7.7	7.0	18.7	19.3	28.7	19.3	19.5	17.0	16.2	16.1	16.2	19.1
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 57.2;TIME: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			6000000	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favourable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	34.5	14.1	11.6	34.5	23.5	22.9	25.4	3.1	11.3	32.6	15.3	6.8	21.9	7.7	28.8	21.5	17.7	21.4	15.8	13.8	9.2	12.8	15.5	11.8	35.2	30.9	12.7	8.8	22.7	23.8	53.1	13.0	21.1	16.0	23.4	15.2	17.3	18.4	24.8	11.7	16.7	14.8	19.8	16.6	45.8	13.3	45.0	8.5	27.4	32.4	20.0	25.7	20.7	23.4	11.7	15.0	10.6	48.0	10.3	12.6	3.7	6.8	5.8	10.3	13.3	17.9	16.5	6.2	10.1	9.8	8.2	12.1	22.1	2.5	2.1	8.9	22.7	4.0	57.2	8.5	11.9	22.8	6.6	8.1	6.3	13.1	7.1	9.0	0.1	9.5	1.8	12.2	6.4	40.8	0.5	6.0	11.5	4.5	7.1	3.9	4.1	6.2	6.5	18.6	0.1	9.5	0.1	13.1	0.2	15.7	2.2	6.2	8.7	12.3	52.5	7.9	9.9	4.0	9.6	4.6	6.2	0.3	4.8	5.5	12.9	9.8	12.3	6.6	12.6	36.3	9.0	7.4	8.0	10.2	5.1	11.7	7.0	7.3	10.6	10.3	48.0	15.0	6.4	3.7	11.6	23.5	3.1	11.3	9.2	12.8	12.7	8.8	16.0	8.5
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651798-47659161	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"				"Centriolar satellite"	Nucleoplasm	"HPA050499: , HPA058400: "	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	30.9	37.4	21.7	33.7	23.6	54.4	38.9	20.0	27.3	26.7	31.9	24.8	33.5	23.2	26.8	39.8	30.1	32.4	31.3	47.3	20.9	16.5	34.7	66.8	24.9	46.1	23.6	24.9	50.5	54.1	21.4	29.6	39.0	26.0	30.0	31.1	19.5	46.5	30.5	42.1	36.2	29.1	21.1	27.6	37.1	31.9	24.7	22.6	50.4	37.0	33.2	41.6	24.5	32.5	58.2	60.2	26.2	35.8	36.0	73.5	52.0	44.8	49.8	21.2	28.2	48.6	58.7	37.3	29.1	42.6	50.0	47.5	42.7	42.8	51.5	21.2	41.5	36.4	30.1	39.8	35.7	33.6	59.8	25.9	56.7	42.2	56.7	57.1	51.0	41.2	51.1	42.1	45.3	40.2	28.2	49.8	42.3	49.4	38.9	79.5	30.5	56.9	34.7	43.1	70.7	40.2	33.1	20.2	26.4	32.3	35.3	45.0	41.4	52.9	29.3	35.0	38.2	48.1	31.9	39.4	34.7	46.2	44.6	63.5	35.3	18.7	35.8	26.2	40.2	35.5	54.1	58.2	57.7	43.2	47.4	56.7	73.5	60.2	23.0	36.0	32.4	60.2	52.9	52.0	21.7	23.6	20.0	27.3	20.9	16.5	23.6	24.9	26.0	22.6
VAC14	"ArPIKfyve, FLJ10305, TAX1BP2"	ENSG00000103043	"Vac14, PIKFYVE complex component"	Q08AM6	16	70687439-70801161	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027766, HPA075382"	Approved		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA027766: AB_1848651, HPA075382: "	"unprognostic (9.25e-2)"	"prognostic favourable (8.33e-5)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.26e-1)"	"prognostic favourable (1.56e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-1)"	26.3	26.6	22.9	22.8	21.8	16.3	17.4	15.6	34.9	17.9	18.4	27.0	18.5	19.8	18.8	15.8	21.0	20.9	17.0	22.2	22.9	23.5	25.7	27.1	20.1	34.9	22.3	20.8	19.2	27.8	33.7	21.4	20.1	25.8	17.9	14.1	22.9	24.3	19.4	23.3	24.6	21.6	19.2	22.2	29.0	20.0	21.7	20.6	31.2	26.0	16.3	22.9	21.0	16.3	5.5	9.7	6.6	5.9	3.7	5.5	1.9	11.2	11.2	9.5	10.6	13.8	10.1	14.5	8.2	13.0	15.7	7.3	13.8	18.3	14.5	10.7	9.8	14.3	12.4	13.3	7.4	4.4	13.0	7.3	8.5	17.0	35.7	12.5	15.4	16.7	14.0	23.2	21.2	14.9	12.8	6.6	13.7	16.3	11.6	20.9	16.7	10.6	14.0	6.9	21.4	7.5	7.8	11.3	12.3	27.2	8.3	18.7	12.3	11.8	11.8	20.9	12.0	13.3	8.8	9.5	11.6	27.8	34.9	11.2	9.5	1.3	4.8	6.6	2.9	5.9	2.5	4.0	3.7	5.5	9.7	5.5	3.5	3.1	1.6	3.7	5.4	5.1	2.3	1.9	22.9	21.8	15.6	34.9	22.9	23.5	22.3	20.8	25.8	20.6
VAMP7	"SYBL1, TI-VAMP, VAMP-7"	ENSG00000124333	"Vesicle associated membrane protein 7"	P51809	X	155881293-155943769	"Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036733	Approved		Supported	Vesicles			14000	Vesicles		"HPA036733: AB_10672228"	"unprognostic (7.54e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (2.83e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.97e-1)"	11.9	12.7	43.9	9.5	51.2	13.4	51.9	21.2	41.1	38.4	9.3	2.5	2.5	9.6	36.5	6.6	10.4	8.5	9.3	26.9	46.8	12.5	61.4	20.5	10.3	9.8	50.6	44.8	34.5	7.9	12.8	35.0	68.7	58.5	9.4	10.5	2.5	8.3	9.0	12.0	9.3	11.3	12.0	63.0	8.4	8.4	5.6	47.6	2.5	10.4	2.5	11.6	10.2	26.1	6.6	13.5	34.8	13.8	11.2	11.0	10.6	21.9	9.6	6.6	13.7	18.4	17.7	17.8	17.1	15.3	15.5	31.5	10.3	14.4	30.6	31.9	20.5	7.9	14.8	12.0	20.6	12.7	13.0	12.7	14.3	7.3	20.6	26.0	19.9	16.4	12.0	17.3	15.9	17.2	27.1	17.0	17.5	11.0	10.1	14.8	4.7	14.1	7.7	13.0	22.7	20.6	11.1	5.0	14.6	10.1	10.2	15.0	10.0	21.9	18.1	14.3	14.9	20.5	24.2	39.2	49.5	42.9	12.5	31.9	15.9	34.8	12.9	19.7	8.3	13.8	10.5	6.5	9.9	10.2	13.5	6.6	9.2	9.8	11.2	11.2	12.8	7.7	11.0	10.6	43.9	51.2	21.2	41.1	46.8	12.5	50.6	44.8	58.5	47.6
VAMP8	EDB	ENSG00000118640	"Vesicle associated membrane protein 8"	Q9BV40	2	85561562-85582031	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 172.5"	"Cell line enhanced"	"Detected in many"		"HL-60: 80.6;NB-4: 125.9;U-937: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006882, HPA007215, CAB037132, CAB037147"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"			210000	"Nucleoplasm, Golgi apparatus"		"CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: "	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-1)"	"prognostic favourable (8.07e-9)"	"prognostic favourable (1.59e-6)"	16.5	8.2	7.1	20.7	11.2	27.6	24.2	1.9	6.2	16.3	49.4	5.7	43.5	24.1	6.0	25.5	65.4	17.1	28.8	13.0	4.7	3.8	67.7	46.5	53.1	48.0	10.5	3.2	7.1	58.0	15.4	8.3	108.1	11.9	22.1	31.9	7.7	90.7	40.4	9.0	43.3	87.1	6.8	10.4	53.5	28.7	5.5	8.4	24.5	47.5	35.4	34.9	20.6	30.4	39.2	172.5	37.7	69.7	41.4	51.3	100.9	23.4	3.0	0.2	0.2	0.2	0.1	23.5	0.0	0.0	0.0	0.0	17.5	21.6	5.2	17.1	0.1	16.7	0.2	42.1	0.0	21.4	16.3	27.1	10.4	19.8	0.3	80.6	28.1	0.2	29.9	0.0	7.0	5.4	19.3	1.1	9.6	33.0	0.0	125.9	0.3	2.5	0.5	0.8	35.4	48.8	35.4	0.8	0.3	11.5	61.0	1.8	22.3	62.6	10.8	0.0	1.5	0.3	0.2	0.3	13.2	30.8	0.3	83.6	0.1	37.7	69.7	25.2	40.4	57.7	38.8	39.2	46.8	39.5	63.5	37.8	37.3	39.1	4.5	41.4	34.3	172.5	51.3	100.9	7.1	11.2	1.9	6.2	4.7	3.8	10.5	3.2	11.9	8.4
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914002-9960021	"Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"			5300000	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favourable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	27.5	64.8	28.8	21.0	35.5	73.5	27.4	32.9	39.4	24.9	34.3	30.7	19.3	27.8	30.8	23.8	42.3	27.9	29.4	39.9	28.0	30.2	32.7	33.2	35.1	24.6	33.4	28.8	40.6	36.5	25.0	19.4	35.2	48.1	25.2	32.7	18.0	27.9	21.8	55.4	27.6	32.3	28.5	39.1	27.7	34.0	25.2	28.8	36.3	36.4	28.3	22.9	36.0	30.2	24.5	30.6	62.5	37.3	22.2	24.6	39.7	18.5	11.3	13.7	8.9	16.1	17.5	19.1	23.1	19.2	21.0	23.1	15.1	18.5	18.3	21.6	20.1	13.0	13.2	22.0	24.1	11.3	16.6	29.9	12.1	23.3	38.3	40.3	57.3	16.4	22.3	19.9	23.7	21.2	30.0	19.2	18.4	10.0	30.9	23.4	8.8	18.0	16.2	18.6	24.8	20.5	18.8	19.3	10.5	26.7	16.3	16.6	15.2	20.9	22.6	34.3	25.5	35.5	28.0	34.4	27.9	21.9	19.4	17.4	23.5	26.1	37.3	62.5	19.3	32.4	22.7	24.5	20.3	20.7	30.6	22.7	22.2	20.4	59.2	22.2	26.4	21.8	24.6	39.7	28.8	35.5	32.9	39.4	28.0	30.2	33.4	28.8	48.1	28.8
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389122-58451101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"			220000	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favourable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	17.4	31.1	21.8	12.6	24.3	4.8	13.2	16.5	31.8	11.7	16.1	17.0	13.3	22.5	13.0	13.1	14.8	13.7	12.7	24.5	21.4	22.1	21.8	23.5	13.6	10.4	23.2	25.1	17.7	15.5	28.5	16.3	11.1	31.6	15.0	12.1	11.4	17.9	15.7	46.8	15.3	20.6	15.2	24.9	11.4	14.7	9.4	15.8	6.7	26.7	18.8	9.4	11.6	18.5	5.6	4.3	6.8	5.2	6.6	9.5	4.6	10.7	10.8	12.2	6.5	11.3	4.7	10.8	9.7	4.0	15.0	7.4	43.6	10.4	9.5	13.9	6.5	20.6	9.7	13.9	9.0	4.4	7.3	5.7	12.0	13.7	11.3	5.4	7.3	10.7	16.2	8.3	6.9	7.4	13.5	5.4	7.2	33.9	8.4	10.7	6.4	14.4	8.4	11.4	6.2	11.4	14.5	17.2	11.9	16.0	42.6	16.6	17.4	8.1	10.2	24.3	11.8	12.1	12.9	7.3	7.8	11.0	20.5	5.9	12.2	3.9	4.4	5.2	7.8	4.4	9.1	5.6	9.0	6.2	4.3	4.7	6.7	9.5	6.8	6.6	5.2	4.3	5.0	4.6	21.8	24.3	16.5	31.8	21.4	22.1	23.2	25.1	31.6	15.8
VARS	VARS2	ENSG00000204394	"Valyl-tRNA synthetase"	P26640	6	31777518-31795953	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 24.8;U-266/84: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol			23000	Cytosol		"HPA046710: "	"unprognostic (1.86e-2)"	"prognostic unfavourable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (1.86e-4)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	11.7	11.4	8.9	12.0	9.5	9.1	18.3	7.6	14.0	8.1	11.3	7.3	5.0	12.8	13.5	6.7	14.2	10.2	8.1	9.5	6.4	6.8	9.5	22.7	11.5	24.2	8.3	9.7	9.6	19.2	15.6	15.0	8.5	8.6	7.7	9.4	6.1	9.1	5.9	30.6	14.3	10.3	13.2	8.7	14.4	15.2	40.6	7.5	10.9	8.2	13.2	11.8	9.7	8.5	1.6	1.5	0.6	1.2	2.4	1.0	0.9	2.2	2.0	3.1	6.3	3.5	2.8	8.5	8.6	2.6	6.5	3.9	2.6	1.4	7.6	10.7	5.4	2.4	10.0	6.6	3.9	5.5	14.2	3.7	5.1	6.0	4.6	15.0	12.4	4.2	2.4	2.6	6.0	3.2	10.4	10.3	4.2	3.4	6.8	0.7	6.0	4.2	8.8	1.6	24.8	5.0	2.8	3.9	1.4	0.7	8.5	3.7	5.2	6.0	1.1	4.5	4.2	6.0	14.2	14.8	25.4	6.2	3.3	3.0	5.0	0.0	0.6	0.6	1.0	1.2	1.0	1.6	0.6	0.4	1.1	1.1	0.8	0.8	0.0	2.4	1.0	1.5	0.6	0.9	8.9	9.5	7.6	14.0	6.4	6.8	8.3	9.7	8.6	7.5
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 23.6"	"Group enriched"	"Detected in all"	6	"granulocytes: 23.6;monocytes: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"			110000000	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavourable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	29.1	10.3	4.9	33.3	5.9	40.3	19.0	3.9	4.7	22.6	38.2	5.3	15.4	28.8	37.5	13.3	34.3	23.8	32.2	21.1	5.2	4.3	17.9	21.1	30.5	44.5	7.7	2.2	22.5	10.5	2.9	7.5	31.5	6.2	26.8	9.8	8.9	12.9	20.3	10.4	13.0	43.7	36.7	4.8	69.2	33.4	14.4	6.6	28.3	11.7	12.8	33.2	39.2	17.5	1.8	2.6	23.6	10.4	2.0	2.1	2.2	15.3	16.1	4.7	8.1	2.4	4.1	12.1	15.8	12.2	10.9	9.5	7.3	32.2	7.1	13.4	12.6	14.3	1.4	15.6	3.7	20.8	3.7	40.7	8.0	12.3	13.4	14.9	63.9	6.3	8.8	10.2	6.6	16.3	24.3	15.5	6.7	12.8	6.8	12.8	8.3	11.1	5.1	2.9	2.6	9.3	49.1	5.6	3.9	18.8	9.6	11.1	10.4	25.5	24.1	17.5	17.7	5.6	24.9	8.3	9.9	12.1	12.2	18.1	21.0	5.6	4.0	23.6	2.1	6.5	1.5	1.8	1.7	2.0	2.6	1.7	1.1	1.3	17.1	2.0	10.4	1.0	1.2	2.2	4.9	5.9	3.9	4.7	5.2	4.3	7.7	2.2	6.2	6.6
VBP1	"PFD3, PFDN3"	ENSG00000155959	"VHL binding protein 1"	P61758	X	155197007-155239817	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006260, HPA023230"	Approved		Supported	Vesicles,Cytosol				Cytosol	Vesicles	"CAB006260: AB_425740, HPA023230: AB_1858727"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.80e-1)"	17.3	19.2	37.8	15.5	28.0	24.5	18.4	26.1	32.5	14.9	16.9	20.6	12.5	12.8	14.9	16.3	17.8	13.8	13.3	35.9	35.4	36.8	22.9	17.4	13.0	21.0	40.9	25.6	15.3	11.8	18.3	22.0	16.9	33.9	18.2	19.2	10.1	11.1	15.6	50.5	10.9	14.3	16.4	46.0	13.9	12.5	8.7	22.9	21.0	18.4	25.6	22.0	16.9	12.8	15.0	18.4	37.0	12.6	13.8	21.6	15.7	35.1	12.7	27.7	18.4	11.5	15.9	8.0	17.5	13.6	23.1	36.2	15.1	18.1	45.3	37.5	14.7	13.9	40.1	16.4	30.0	23.8	28.1	19.0	20.1	11.8	13.7	30.6	15.0	11.8	19.6	19.2	24.3	21.2	37.1	27.0	25.9	14.6	28.8	27.4	16.0	27.4	24.8	22.0	26.5	20.0	16.1	30.1	18.3	12.0	14.2	19.3	12.1	23.7	12.3	18.5	22.9	31.3	43.1	30.5	44.2	79.2	16.4	38.0	22.6	8.5	11.6	37.0	14.4	12.6	16.5	15.0	16.9	17.2	18.4	11.8	19.6	20.7	13.6	13.8	10.4	15.1	21.6	15.7	37.8	28.0	26.1	31.9	35.4	36.8	40.9	25.6	33.9	22.9
VCAN	"CSPG2, PG-M"	ENSG00000038427	Versican	P13611	5	83471465-83582303	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 58.1;HSkMC: 39.6;RPTEC TERT1: 73.9;U-2197: 32.6;U-251 MG: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 55.5;myeloid DC: 21.3"	"Group enriched"	"Detected in many"	31	"dendritic cells: 21.3;monocytes: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004726, CAB008979"	Supported		Supported	Vesicles	"Secreted to blood"		5200000	Vesicles		"CAB008979: , HPA004726: AB_1080561"	"unprognostic (7.90e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.09e-2)"	"unprognostic (6.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (7.59e-4)"	"unprognostic (4.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (5.17e-4)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.30e-3)"	33.3	18.3	14.8	53.2	10.3	20.1	12.3	4.8	16.2	25.2	8.4	17.9	1.7	3.6	14.5	23.5	9.0	7.6	23.2	35.7	19.8	8.9	8.5	3.1	25.8	21.2	13.9	9.8	5.3	3.2	3.7	2.0	52.0	14.4	8.9	8.9	3.3	6.5	4.1	9.0	9.3	4.7	33.9	18.2	18.4	6.2	8.7	19.4	1.1	5.7	6.5	2.3	24.4	9.8	0.0	21.3	1.2	55.5	0.1	0.1	17.7	0.0	1.0	58.1	0.0	23.7	16.3	0.0	0.4	1.1	0.4	0.3	0.5	0.0	0.0	9.0	21.0	0.0	0.0	0.0	0.3	0.0	1.8	0.4	0.0	0.4	1.1	0.0	0.0	39.6	0.0	24.7	0.2	0.0	0.0	0.0	12.3	0.0	0.1	0.0	9.8	1.9	0.0	12.2	0.0	73.9	0.0	0.7	3.0	0.0	0.0	0.0	0.0	0.1	22.4	17.7	0.1	32.6	33.4	0.0	0.0	0.0	8.1	0.0	3.1	1.2	55.5	0.1	0.1	7.7	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.9	0.1	0.8	0.4	0.0	17.7	14.8	10.3	4.8	9.8	19.8	8.9	13.9	9.8	14.4	19.4
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"			1800000000	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	31.9	7.3	4.3	19.0	6.0	8.6	24.4	5.4	5.3	37.9	41.2	6.7	24.4	8.0	72.1	29.2	36.1	27.6	44.8	35.0	4.7	3.9	20.8	6.9	25.9	9.3	3.8	5.5	29.2	12.8	18.1	7.6	22.6	9.6	43.3	18.0	20.2	14.9	38.8	59.1	14.4	20.2	113.1	3.8	23.6	23.6	29.5	3.3	3.0	15.3	20.5	11.7	73.9	26.1	3.7	12.9	21.6	11.3	2.8	9.9	15.6	23.6	16.2	29.4	20.7	36.8	42.9	16.2	31.2	94.8	21.4	24.3	14.5	20.6	1.0	26.1	54.4	30.3	19.3	15.7	22.6	2.0	8.2	11.2	15.8	6.0	20.2	2.2	17.2	35.4	4.2	28.9	26.4	28.5	8.1	2.4	35.5	4.0	0.3	2.6	13.9	57.3	3.9	15.3	3.0	30.6	30.6	1.1	4.4	17.3	19.7	8.9	9.1	3.4	38.1	23.4	9.8	11.3	29.2	0.4	0.9	4.6	27.3	6.4	6.6	8.5	7.6	21.6	9.9	10.8	7.0	3.7	4.7	5.1	12.9	1.6	1.8	3.6	7.0	2.8	11.3	5.0	1.2	15.6	4.3	6.0	5.4	5.3	4.7	3.9	3.8	5.5	9.6	3.3
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol			110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favourable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favourable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	17.4	42.3	40.1	43.6	30.7	24.5	19.9	38.9	37.6	26.6	22.3	26.6	27.6	27.0	43.5	19.5	54.3	20.6	20.8	40.1	25.4	21.8	53.7	37.0	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	18.5	15.9	44.4	20.2	26.1	17.9	29.4	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2
VCPKMT	"C14orf138, METTL21D, VCP-KMT"	ENSG00000100483	"Valosin containing protein lysine methyltransferase"	Q9H867	14	50108632-50116600	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001146, HPA076561"	Uncertain		Supported	Cytosol				Cytosol		"HPA001146: AB_1845558, HPA076561: "	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.97e-2)"	"prognostic favourable (2.40e-4)"	"unprognostic (8.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.90e-2)"	"prognostic unfavourable (4.75e-4)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.27e-2)"	5.2	7.6	7.6	9.5	16.9	12.6	6.0	15.3	14.0	6.3	5.8	6.3	3.7	5.4	9.8	8.3	10.5	5.8	7.1	4.6	9.9	7.1	6.2	6.9	5.7	10.9	7.1	6.3	5.1	6.3	6.2	8.6	4.8	12.0	5.0	5.4	4.5	5.1	5.4	4.8	8.1	5.9	8.6	5.7	9.2	7.0	11.0	7.4	10.6	7.4	5.2	12.5	7.9	6.1	17.1	3.8	6.1	3.1	8.0	8.4	3.4	4.1	4.8	4.1	5.6	3.0	3.6	5.0	4.3	4.7	4.9	3.7	2.7	5.2	13.7	3.0	3.1	8.8	5.4	7.6	5.0	6.7	3.5	2.5	2.1	3.2	4.5	7.0	3.8	2.5	4.4	5.2	5.6	5.9	3.2	6.0	3.7	5.8	14.1	7.0	4.3	7.8	9.8	8.3	3.6	6.2	6.5	7.5	9.0	6.5	1.9	7.4	4.7	6.4	1.7	8.0	6.3	2.8	4.6	5.7	11.5	5.3	2.8	6.2	3.9	6.1	2.0	0.0	6.5	3.1	7.6	17.1	6.3	7.8	2.5	14.5	7.5	8.4	0.6	8.0	1.4	3.8	5.2	3.4	7.6	16.9	15.3	14.0	9.9	7.1	7.1	6.3	12.0	7.4
VDAC2		ENSG00000165637	"Voltage dependent anion channel 2"	P45880	10	75210154-75231448	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043475	Enhanced		Supported	Mitochondria			4000000	Mitochondria		"HPA043475: AB_10795615"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.00e-3)"	"unprognostic (5.74e-2)"	"prognostic unfavourable (4.51e-4)"	"prognostic unfavourable (4.55e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.34e-2)"	26.2	31.9	27.8	18.7	40.5	25.1	59.7	34.2	55.4	29.0	39.1	24.2	19.9	31.8	25.5	20.3	63.7	25.0	18.5	141.7	28.1	24.1	38.2	24.4	23.2	23.0	27.6	37.7	29.6	38.9	37.6	18.4	24.1	36.5	24.2	40.3	23.0	30.5	30.6	99.7	30.7	30.5	43.7	27.9	17.8	31.1	30.4	16.9	15.6	27.5	31.9	30.0	33.7	39.1	44.8	63.2	39.0	62.9	36.0	49.6	54.6	41.6	34.5	41.8	52.9	37.2	50.8	43.8	54.3	61.2	59.6	56.3	52.0	39.9	49.7	30.6	45.3	56.2	76.5	53.8	58.6	26.9	44.5	28.9	29.2	58.6	37.3	54.9	32.2	44.9	63.8	50.8	108.7	44.0	48.8	40.6	62.5	30.8	35.3	44.7	35.9	133.5	42.4	33.1	31.5	58.6	26.2	26.5	31.3	29.9	100.4	63.5	58.5	24.7	33.9	29.8	40.8	43.9	58.1	32.7	44.5	51.3	43.1	54.4	25.2	39.0	51.5	38.0	32.5	54.0	39.6	44.8	44.7	36.4	63.2	36.0	45.5	41.7	17.7	36.0	62.9	30.8	49.6	54.6	27.8	40.5	34.2	55.4	28.1	24.1	27.6	37.7	36.5	16.9
VDAC3	HD-VDAC3	ENSG00000078668	"Voltage dependent anion channel 3"	Q9Y277	8	42391624-42405897	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 187.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026864	Uncertain		Supported	Mitochondria			9300000	Mitochondria		"HPA026864: AB_1858733"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.94e-3)"	19.9	18.8	26.0	13.7	29.8	18.6	17.3	38.3	39.1	16.0	23.7	14.5	12.3	19.1	19.1	17.7	26.8	21.5	13.9	85.8	28.2	35.3	27.9	22.1	12.5	14.6	32.5	24.6	18.1	15.0	17.5	16.5	15.4	44.3	17.6	26.2	16.0	22.2	20.8	187.5	13.0	22.7	22.1	19.6	17.3	16.6	27.4	13.0	20.5	21.6	39.7	18.4	23.1	13.3	34.4	59.4	47.5	44.4	31.4	52.4	81.9	48.2	48.6	38.3	40.7	32.3	28.1	19.0	38.6	33.0	49.7	45.5	37.5	41.3	49.6	37.1	32.7	30.9	51.6	41.4	54.8	25.1	42.6	75.4	32.5	53.3	23.1	36.3	42.1	21.8	31.5	37.6	17.6	60.3	59.1	34.6	50.6	26.7	77.4	41.7	45.4	31.7	41.0	70.5	35.1	53.4	43.0	33.8	29.0	24.4	29.0	24.3	61.3	27.7	32.2	19.4	33.8	48.2	37.4	32.2	53.7	56.5	26.0	51.3	32.6	31.1	44.4	47.5	42.1	43.8	42.4	34.4	45.1	41.7	59.4	24.2	45.1	43.3	22.0	31.4	38.5	43.8	52.4	81.9	26.0	29.8	38.3	39.1	28.2	35.3	32.5	24.6	44.3	13.0
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.1;parathyroid gland: 45.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 22.7;HDLM-2: 32.0;U-937: 31.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0"	"Region enhanced"	"Detected in single"		"olfactory region: 2.5"	"Low region specificity"	"Detected in some"			"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"				Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: , HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favourable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.0	9.2	0.2	10.0	0.3	2.5	7.8	0.3	0.6	3.5	40.9	0.4	4.1	21.2	1.2	7.7	10.2	1.1	10.7	1.5	0.5	0.3	13.0	0.6	8.3	3.8	0.5	0.1	1.3	6.5	45.8	11.7	4.4	0.6	2.1	12.6	0.4	4.9	2.8	5.3	15.2	57.1	1.2	1.5	3.1	2.6	1.5	0.2	2.0	1.9	9.4	8.2	4.0	5.2	0.7	5.7	7.5	7.0	0.2	0.8	1.2	5.4	0.9	0.0	0.0	4.7	6.9	0.1	6.7	3.4	5.7	5.0	4.0	4.6	1.4	7.3	4.6	10.2	0.2	22.7	2.7	32.0	1.6	2.4	1.3	0.3	3.5	4.8	7.7	9.3	10.6	6.3	10.4	0.4	0.7	1.5	2.6	3.7	0.1	2.3	0.0	7.4	0.1	0.0	3.5	5.2	5.5	2.6	0.1	5.7	16.5	2.0	18.6	2.7	0.4	11.0	2.9	3.2	3.8	0.9	0.0	1.2	3.4	31.4	2.7	0.2	3.7	2.1	0.0	7.0	0.1	0.7	0.3	0.0	5.7	0.1	0.1	0.0	7.5	0.2	6.9	0.6	0.8	1.2	0.2	0.3	0.3	0.6	0.5	0.3	0.5	0.1	0.6	0.2
VEZF1	"DB1, ZNF161"	ENSG00000136451	"Vascular endothelial zinc finger 1"	Q14119	17	57971547-57988259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027520, HPA048315"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027520: AB_10602680, HPA048315: "	"unprognostic (7.24e-2)"	"unprognostic (3.18e-1)"	"prognostic favourable (6.14e-5)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.03e-2)"	18.3	26.6	21.2	18.6	29.2	38.6	27.9	24.0	24.2	27.4	31.2	32.4	21.4	15.9	34.0	16.9	21.1	32.4	20.3	24.1	23.6	14.5	23.8	13.4	23.6	21.2	32.2	16.4	28.7	22.6	19.8	26.1	21.2	24.6	26.2	19.2	22.6	23.5	26.1	51.7	13.5	21.2	29.7	21.6	20.6	22.4	16.5	37.2	39.8	31.3	19.6	15.6	29.7	36.4	13.9	17.5	26.2	26.0	25.3	18.2	11.9	19.0	21.6	41.6	14.5	10.7	15.3	14.4	15.8	23.0	20.0	18.2	10.3	20.3	9.8	27.0	17.6	11.0	16.6	18.1	27.3	27.5	13.0	18.2	17.1	12.2	13.6	15.9	16.4	10.8	22.7	12.9	24.6	19.3	13.5	13.7	20.2	7.3	25.8	8.7	14.3	25.4	19.8	32.6	7.6	12.3	18.2	17.3	32.5	15.5	7.0	23.2	40.6	16.4	18.9	28.3	28.9	17.5	25.7	14.4	11.3	15.1	19.7	14.2	36.0	21.6	13.8	26.2	17.0	17.1	17.5	12.0	14.0	18.2	16.5	13.9	17.8	15.8	24.1	25.3	26.0	17.5	13.1	11.9	21.2	29.2	24.0	24.2	23.6	14.5	32.2	16.4	24.6	37.2
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302790	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavourable (1.93e-5)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	12.3	21.4	15.4	14.3	17.2	5.1	14.6	28.3	27.2	12.9	14.4	9.1	19.0	9.5	17.1	15.9	15.6	11.5	12.1	14.7	11.8	9.5	12.1	10.4	13.8	9.6	11.0	14.0	13.3	12.6	15.7	20.4	19.6	11.4	15.8	10.6	10.3	10.9	13.9	42.7	16.1	11.0	16.2	12.5	7.2	10.7	7.2	12.2	13.6	29.8	14.5	10.0	15.7	12.2	5.2	4.4	1.1	3.5	2.4	5.0	1.2	10.4	9.7	13.4	7.2	10.3	7.3	5.2	7.7	9.6	6.1	9.8	3.5	4.9	13.5	5.0	6.6	5.4	9.5	6.7	11.4	9.1	5.3	5.2	2.5	3.7	5.6	10.2	3.0	9.3	11.7	5.8	16.6	12.8	3.0	5.3	5.5	2.8	8.8	4.8	6.8	9.8	8.0	6.3	4.4	17.8	7.6	9.1	7.9	7.4	11.1	3.5	13.8	1.7	10.3	5.6	2.1	2.4	4.2	5.2	7.8	11.5	2.1	3.7	2.8	0.5	3.1	1.1	3.6	3.5	4.7	5.2	5.0	2.1	4.4	3.6	2.4	2.0	0.3	2.4	0.9	1.8	3.5	1.2	15.4	17.2	28.3	18.8	11.8	9.5	11.0	14.0	11.4	12.2
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165593	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 59.4;pituitary gland: 30.4"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 35.9;SK-MEL-30: 96.8;U-2 OS: 17.6;WM-115: 29.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	1273770	2800000	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavourable (4.25e-4)"	"prognostic unfavourable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	3.8	3.1	10.9	2.3	25.2	1.3	1.1	1.3	59.4	1.1	1.5	1.3	0.0	1.3	2.2	1.1	1.1	1.1	1.2	1.2	12.2	51.0	1.4	1.1	1.1	1.1	3.9	22.8	1.1	6.2	1.1	30.4	1.2	41.2	1.2	1.2	0.5	1.1	1.1	1.1	1.4	1.3	1.5	6.6	1.2	3.6	1.4	0.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	1.9	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.0	4.6	0.0	0.4	3.6	0.4	0.1	0.0	0.0	0.0	0.0	2.9	35.9	0.0	0.1	96.8	0.0	0.0	0.0	0.0	17.6	0.0	0.4	0.0	0.1	0.9	2.8	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	25.2	1.3	59.4	12.2	51.0	3.9	22.8	41.2	0.5
VGLL1	"TDU, TONDU"	ENSG00000102243	"Vestigial like family member 1"	Q99990	X	136532152-136556807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 124.6"	"Cell line enhanced"	"Detected in some"		"A-431: 24.7;BEWO: 38.1;CAPAN-2: 13.9;RT4: 65.4;SK-BR-3: 64.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 47.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA042403, HPA064616"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA042403: , HPA064616: "	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (4.54e-4)"		"unprognostic (5.16e-2)"		"unprognostic (1.80e-1)"	"unprognostic (4.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.37e-2)"		"unprognostic (5.53e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.7	1.4	0.4	0.3	0.1	0.1	0.0	3.7	0.1	0.9	0.1	0.1	0.1	0.2	0.6	0.0	1.3	124.6	0.1	2.8	0.0	0.1	5.0	2.3	0.1	0.1	0.1	0.6	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.7	19.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	3.7	13.9	0.0	0.0	0.0	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.0	64.3	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141008-10152220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005430, HPA031631, HPA031632"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005430: AB_2241850, HPA031631: , HPA031632: "	"prognostic unfavourable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	13.8	17.4	18.1	29.2	18.4	24.3	15.4	25.8	21.4	13.3	19.8	19.3	14.5	15.9	15.1	13.6	16.4	14.3	18.9	10.5	17.1	18.5	13.7	16.3	14.6	27.9	13.5	12.3	15.2	22.5	13.8	14.6	18.8	12.8	15.1	16.6	12.5	21.8	13.7	14.8	14.0	22.3	13.4	17.0	22.6	16.2	17.9	11.2	39.2	16.9	11.5	29.3	15.4	19.1	5.4	3.9	8.0	4.1	4.4	4.3	1.7	6.7	6.5	14.3	8.8	13.3	10.3	53.6	5.9	8.5	7.6	9.0	7.6	8.4	23.8	8.1	8.0	5.8	13.2	8.3	9.4	11.4	12.0	18.5	10.5	10.5	12.6	16.3	14.8	10.3	9.5	10.1	12.8	8.7	16.4	18.1	7.5	12.2	15.5	12.0	9.6	8.3	19.7	12.6	11.9	9.3	17.4	5.4	17.9	12.5	6.7	7.2	13.2	20.7	7.5	7.6	10.1	7.0	9.3	12.9	26.4	38.0	8.4	19.5	6.9	2.6	4.1	3.3	3.8	2.5	3.6	4.1	2.9	4.3	3.9	5.4	2.5	2.7	8.0	4.4	3.2	2.4	3.1	1.7	18.1	18.4	25.8	21.4	17.1	18.5	13.5	12.3	12.8	11.2
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419092-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Actin capping, Actin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 129.3"	"Group enriched"	"Detected in some"	106	"CACO-2: 122.1;Hep G2: 57.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"			41000000	"Plasma membrane"		"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.3	0.2	0.6	5.7	0.8	0.0	0.3	0.7	0.4	0.3	36.6	0.3	0.3	68.9	0.3	1.2	0.3	0.2	22.6	0.3	0.5	0.5	4.6	6.1	0.3	0.3	0.5	0.3	0.3	7.2	0.0	0.4	0.3	0.3	0.3	32.6	0.3	0.5	0.3	0.3	0.3	129.3	1.2	0.5	0.4	0.9	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.4	2.5	0.1	0.1	0.1	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	122.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.5	0.1	0.0	0.4	0.0	7.8	0.6	0.8	0.7	0.4	0.5	0.5	0.5	0.3	0.3	0.3
VIM		ENSG00000026025	Vimentin	P08670	10	17228259-17237593	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 558.9;fHDF/TERT166: 290.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000080, HPA001762, CAB058687"	Enhanced		Supported	"Intermediate filaments"			19000000	"Intermediate filaments"		"CAB000080: AB_2304493, CAB058687: , HPA001762: AB_1080568"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.87e-2)"	"prognostic favourable (9.75e-6)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (8.69e-8)"	"unprognostic (1.87e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.47e-3)"	254.1	29.2	29.3	51.3	36.2	93.6	285.0	7.5	21.1	137.6	58.0	29.9	46.0	15.8	92.6	100.0	78.4	80.7	71.3	94.8	30.5	14.5	38.7	15.5	100.5	171.0	37.6	26.1	302.9	27.1	32.1	46.2	95.0	38.3	90.5	30.6	161.6	42.6	43.4	52.3	76.2	43.1	101.6	50.7	93.0	38.3	69.8	20.1	56.8	142.0	74.6	73.1	99.2	139.1	24.3	112.1	68.9	90.4	12.2	60.8	61.0	0.5	32.3	58.5	93.3	194.1	558.9	0.0	152.0	101.2	114.7	102.5	0.2	2.0	0.0	8.1	290.4	0.2	8.2	4.2	112.0	100.8	11.3	16.0	16.5	0.0	59.8	8.4	6.6	204.4	0.1	169.2	96.2	186.0	24.8	46.3	203.0	0.1	20.5	25.7	18.6	40.8	16.0	81.2	2.6	114.9	0.0	0.2	28.1	0.0	0.2	152.7	0.2	9.7	157.8	114.4	49.5	95.8	180.1	52.1	26.3	3.7	172.8	0.8	108.7	68.9	90.4	26.5	30.0	59.5	38.6	24.3	49.6	39.1	112.1	14.9	30.8	30.0	53.5	12.2	55.9	44.9	60.8	61.0	29.3	36.2	7.5	20.7	30.5	14.5	37.6	26.1	38.3	20.1
VIRMA	"DKFZP434I116, fSAP121, KIAA1429"	ENSG00000164944	"Vir like m6A methyltransferase associated"	Q69YN4	8	94487693-94553529	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031530	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA031530: AB_10600818"	"unprognostic (2.51e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (7.90e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.87e-2)"	25.0	16.5	14.6	19.1	16.9	30.9	23.4	20.9	16.9	21.5	16.0	16.6	17.4	10.7	20.4	13.7	16.5	18.9	12.6	13.9	12.9	11.7	15.0	16.3	14.1	17.6	13.8	14.3	23.3	21.7	25.2	23.8	19.0	15.5	15.4	16.0	12.2	15.2	15.6	16.2	14.5	15.4	23.3	17.8	16.7	19.1	21.2	14.7	30.8	18.0	18.5	19.3	22.2	15.2	8.2	6.0	12.3	14.3	10.5	13.3	6.3	20.6	13.2	14.3	7.9	17.7	23.5	9.2	14.4	14.8	15.8	16.2	9.2	17.6	22.5	13.8	18.9	13.6	19.1	17.6	23.3	19.9	10.5	26.9	11.0	9.0	13.0	13.2	9.6	18.0	7.2	18.9	18.3	19.8	27.4	14.2	15.9	12.2	25.6	7.4	9.3	10.1	15.4	13.1	12.5	10.3	14.5	11.3	15.6	11.4	2.9	12.5	16.6	10.7	19.6	14.6	8.7	12.4	13.3	11.2	13.9	27.0	14.3	17.6	13.9	12.3	5.6	9.8	8.4	7.4	13.3	8.2	9.3	11.2	6.0	6.7	11.5	9.8	7.1	10.5	14.3	3.8	7.8	6.3	14.6	16.9	20.9	16.9	12.9	11.7	13.8	14.3	15.5	14.7
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 173.3"	"Cell line enhanced"	"Detected in all"		"ASC diff: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (5.99e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.09e-10)"	"unprognostic (1.11e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.66e-2)"	21.3	23.0	9.3	11.5	11.0	12.9	28.1	9.4	14.5	24.3	19.3	17.1	16.5	12.6	24.0	27.4	18.5	17.8	22.6	20.1	9.8	10.2	29.9	173.3	16.4	17.5	13.7	9.1	25.5	55.5	14.0	25.0	22.5	13.3	22.3	12.6	20.8	34.8	21.4	11.4	15.9	26.8	27.7	12.5	15.4	17.5	18.2	10.6	15.8	25.6	13.8	14.6	28.4	18.7	32.3	49.9	59.6	40.6	24.7	43.7	33.6	10.4	26.9	8.9	25.3	98.2	58.5	9.9	38.9	33.8	19.1	32.6	11.2	12.1	8.2	21.0	48.6	9.7	12.2	15.2	21.8	11.6	29.7	7.5	37.3	53.6	15.5	14.5	11.3	33.8	8.2	26.4	22.7	20.7	9.8	19.6	37.4	37.9	10.6	29.8	16.0	25.9	19.3	23.5	40.9	18.9	9.2	18.1	21.9	17.0	12.4	18.8	20.4	17.7	18.0	25.7	9.2	23.6	14.6	11.9	11.0	7.2	66.9	25.1	13.2	21.5	40.6	59.6	40.3	28.1	39.7	29.9	40.5	40.7	39.6	32.3	36.4	35.4	34.2	24.7	28.3	49.9	43.7	33.6	9.3	11.0	9.4	14.5	9.8	10.2	13.7	9.1	13.3	10.6
VKORC1L1		ENSG00000196715	"Vitamin K epoxide reductase complex subunit 1 like 1"	Q8N0U8	7	65873267-65959563	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA053954	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA053954: "	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (4.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.30e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.12e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.30e-1)"	"unprognostic (5.06e-2)"	38.2	9.2	10.5	8.3	16.7	3.0	23.7	9.0	19.7	10.4	11.1	14.2	9.2	8.6	10.1	8.8	10.0	8.8	8.0	9.3	10.3	11.4	8.2	17.8	14.3	6.2	12.0	12.1	14.4	11.7	28.5	8.0	9.7	14.1	9.9	10.0	8.0	9.0	10.5	14.9	11.4	9.7	9.3	13.2	5.7	9.9	9.4	7.6	9.1	11.1	4.5	6.6	9.7	9.3	2.8	7.5	5.6	4.2	6.5	3.4	1.8	22.1	14.4	11.6	14.5	37.0	14.7	21.1	24.2	15.7	14.5	14.7	13.8	22.0	19.4	19.6	17.3	15.3	16.5	9.8	24.2	12.1	16.3	13.2	13.1	11.8	18.1	18.3	10.2	11.8	12.6	14.7	20.5	14.3	27.7	14.9	17.2	8.7	14.9	21.3	27.8	10.8	16.5	16.9	24.1	13.9	9.0	14.0	19.9	18.7	33.9	10.6	17.1	14.2	16.2	23.5	16.1	14.7	24.5	13.4	21.9	22.3	14.4	20.8	20.4	3.8	2.7	5.6	2.9	2.5	2.4	2.8	3.4	3.2	2.8	2.5	2.3	2.3	3.1	6.5	4.2	7.5	3.1	1.8	10.5	16.7	9.0	19.7	10.3	11.4	12.0	12.1	14.1	7.6
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69172861	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes			19000	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: , HPA057498: "	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavourable (1.72e-4)"	"prognostic unfavourable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavourable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	30.7	25.8	31.8	18.8	37.1	25.2	29.6	42.6	37.2	23.3	27.5	14.5	15.1	21.4	24.5	20.7	37.1	20.7	20.9	40.7	33.3	21.1	34.3	26.5	23.9	17.7	26.5	25.4	24.1	19.3	31.4	24.5	36.4	29.9	23.9	28.8	15.3	25.7	20.3	29.3	33.8	28.0	22.9	35.4	24.7	22.7	34.2	29.1	21.8	27.8	23.6	22.8	30.8	27.3	16.9	28.1	28.2	29.4	34.7	28.1	25.3	33.1	12.7	15.6	28.0	27.6	25.1	13.8	20.3	33.0	24.9	28.4	29.8	32.6	10.3	16.5	22.2	23.0	23.4	20.3	34.6	9.3	12.7	15.5	11.8	16.6	35.7	23.4	12.5	22.7	31.9	24.8	55.3	26.1	29.7	14.7	39.5	10.5	10.5	26.5	10.5	32.3	13.1	25.9	12.4	29.0	19.7	9.6	14.3	27.6	38.1	36.9	15.0	20.1	29.9	16.9	21.7	27.4	26.4	8.8	21.3	16.9	23.2	38.2	8.8	28.2	25.4	22.9	27.9	29.4	25.3	16.9	21.6	28.1	28.1	13.7	19.2	26.6	23.0	34.7	24.2	11.5	24.1	25.3	31.8	37.1	42.6	37.2	33.3	21.1	26.5	25.4	29.9	29.1
VPS29	"DC15, DC7, PEP11"	ENSG00000111237	"VPS29, retromer complex component"	Q9UBQ0	12	110491097-110502117	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039748	Uncertain		Supported	Vesicles,Cytosol			140000	"Vesicles, Cytosol"		"HPA039748: AB_10674426"	"unprognostic (9.46e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (2.79e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-2)"	"prognostic favourable (7.70e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (4.29e-3)"	39.2	34.9	35.6	28.5	38.5	44.4	32.6	23.0	46.6	30.3	38.0	24.4	29.5	33.6	31.5	50.4	51.2	29.0	27.5	35.9	31.5	30.9	62.2	51.2	31.3	33.1	32.8	27.8	27.6	31.4	18.3	31.4	34.5	46.6	41.6	43.5	27.3	34.1	40.6	64.0	25.2	36.2	47.3	28.9	43.1	34.9	17.0	23.8	29.8	38.3	32.9	38.0	51.5	27.4	40.5	67.4	52.7	79.9	41.7	46.0	72.1	31.2	30.7	29.2	20.8	32.9	32.7	23.1	29.7	31.1	30.0	27.2	30.7	27.4	29.0	31.3	29.4	29.9	38.6	27.5	31.5	34.3	30.9	35.4	38.7	25.2	28.7	42.2	31.1	21.5	23.5	25.4	28.1	52.4	33.8	27.2	53.7	15.7	33.0	60.0	16.7	39.5	22.1	29.9	40.7	49.9	46.6	31.5	16.7	33.7	30.0	37.2	40.7	32.7	29.4	26.1	17.2	36.0	34.6	18.6	25.9	34.1	30.4	40.4	27.7	43.9	57.6	52.7	31.9	73.2	35.1	40.5	40.7	37.3	67.4	31.4	37.4	36.8	38.5	41.7	79.9	45.3	46.0	72.1	35.6	38.5	23.0	46.6	31.5	30.9	32.8	27.8	46.6	23.8
VPS35	"FLJ10752, MEM3, PARK17"	ENSG00000069329	"VPS35, retromer complex component"	Q96QK1	16	46656132-46689518	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"		"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040802	Supported		Supported	Endosomes,Lysosomes			320000	"Endosomes, Lysosomes"		"HPA040802: "	"unprognostic (1.11e-2)"	"unprognostic (8.70e-2)"	"prognostic favourable (7.74e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"prognostic unfavourable (2.10e-6)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.49e-1)"	"prognostic favourable (9.75e-5)"	"unprognostic (3.68e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.89e-3)"	14.1	12.6	15.1	11.8	21.1	18.3	15.7	13.1	23.6	14.3	15.2	11.9	10.0	11.7	13.0	19.3	16.4	14.8	11.2	14.0	15.1	18.6	13.4	9.2	14.4	11.6	20.4	17.0	16.2	11.7	22.8	18.0	15.3	31.7	14.5	12.2	8.4	12.3	12.7	11.9	19.5	21.9	12.7	16.5	14.0	12.3	12.1	10.9	14.0	12.2	11.8	13.0	17.1	11.6	2.4	2.9	3.1	9.2	1.7	3.2	2.0	8.5	8.7	10.0	6.3	12.1	16.6	5.4	8.2	10.2	11.7	6.2	8.5	6.0	9.1	8.7	10.0	8.4	10.2	12.3	13.5	2.5	11.6	6.7	4.9	6.5	11.3	9.5	6.7	11.0	13.8	10.1	5.9	11.6	6.4	2.5	12.4	6.1	10.9	9.1	3.0	11.4	11.3	14.3	16.6	11.3	7.2	7.2	8.3	8.1	9.1	7.4	3.8	8.8	11.6	8.9	2.9	9.2	9.7	5.5	5.6	9.3	15.4	12.3	4.9	2.2	2.7	2.6	1.6	4.5	1.7	2.4	1.9	2.1	2.9	2.4	3.2	2.4	3.1	1.7	9.2	1.7	2.7	2.0	15.1	21.1	13.1	23.6	15.1	18.6	20.4	17.0	31.7	10.9
VPS36	"C13orf9, CGI-145, Eap45"	ENSG00000136100	"Vacuolar protein sorting 36 homolog"	Q86VN1	13	52412602-52450628	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039734, HPA043947"	Approved		Supported	"Vesicles,Lysosomes,Plasma membrane,Cell Junctions"				"Vesicles, Lysosomes"	"Plasma membrane, Cell Junctions"	"HPA039734: , HPA043947: "	"unprognostic (2.43e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.57e-2)"	"prognostic favourable (9.91e-6)"	"unprognostic (6.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.83e-2)"	16.4	14.5	16.5	15.9	22.3	7.0	23.5	36.8	27.7	17.1	21.1	13.6	12.8	23.8	22.4	12.9	24.6	16.6	18.0	20.3	15.4	13.0	22.6	20.2	17.5	15.6	16.2	18.5	20.0	19.0	14.4	20.1	21.7	25.9	20.1	24.7	18.2	21.6	18.3	23.4	44.6	27.9	23.7	13.8	22.3	15.7	4.2	13.8	18.1	20.0	16.8	18.1	20.3	21.7	14.4	14.9	13.9	19.2	19.4	19.3	11.8	3.7	6.3	11.2	7.3	11.6	16.3	9.6	8.7	6.7	8.9	5.4	7.4	12.6	13.3	4.6	12.5	10.7	8.8	10.5	9.9	9.9	8.5	15.6	10.0	6.6	13.9	21.0	17.0	11.4	20.6	6.0	9.9	8.9	11.5	11.8	17.0	4.9	15.3	21.1	10.6	3.3	16.0	6.3	8.1	15.6	9.9	5.7	12.0	6.2	14.8	13.2	8.6	35.0	13.8	5.7	6.9	5.6	9.8	8.8	11.0	14.1	5.9	14.9	13.2	13.9	13.5	10.9	12.1	14.8	19.3	14.4	13.3	15.1	14.3	12.3	12.4	13.2	3.7	19.4	19.2	14.9	14.3	11.8	16.5	22.3	36.8	27.7	15.4	13.0	16.2	18.5	25.9	13.8
VPS4A	"FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1"	ENSG00000132612	"Vacuolar protein sorting 4 homolog A"	Q9UN37	16	69311356-69326939	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB018751, CAB034411, HPA060092"	Approved		Supported	Midbody				Midbody		"CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: "	"unprognostic (2.60e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (1.76e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.79e-2)"	20.2	19.6	24.8	14.4	26.5	13.0	24.2	28.7	35.6	12.9	17.8	19.3	14.5	22.0	16.6	14.5	26.3	16.0	16.1	34.3	24.4	22.8	23.2	13.7	15.8	17.5	25.4	29.3	21.0	31.4	29.7	9.6	16.6	33.6	17.5	13.2	15.6	30.4	15.5	81.6	24.3	20.5	18.4	34.3	15.0	18.9	15.5	17.4	8.9	27.5	21.1	13.0	15.6	21.2	11.1	11.6	15.7	13.1	9.3	18.1	14.4	10.9	18.8	13.1	17.1	11.8	10.5	11.4	15.0	13.6	19.9	13.4	17.7	10.3	18.6	14.9	14.8	16.5	12.9	15.1	12.0	7.8	16.7	11.7	11.3	14.3	18.3	14.5	10.9	12.1	19.8	17.2	15.8	14.7	19.3	5.6	14.6	24.5	18.8	11.0	14.7	13.3	25.5	10.5	21.8	10.0	9.0	21.7	13.9	31.9	10.0	11.4	17.4	11.0	17.5	18.4	11.6	16.7	11.6	20.3	16.0	33.8	16.9	9.9	20.2	10.0	11.6	15.7	14.6	10.2	13.3	11.1	12.3	18.1	11.6	10.1	14.3	13.0	9.5	9.3	13.1	6.8	13.8	14.4	24.8	26.5	28.7	35.6	24.4	22.8	25.4	29.3	33.6	17.4
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54, GARP complex subunit"	Q9P1Q0	2	63892146-64019072	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA055894: , HPA067981: , HPA070582: "	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavourable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favourable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	15.5	14.2	10.1	11.1	13.2	12.6	14.3	22.1	12.9	18.6	17.1	11.4	17.3	12.9	16.3	14.4	13.3	14.4	13.7	12.5	11.3	8.5	15.8	15.5	15.2	9.6	14.3	10.6	18.0	21.0	34.2	32.1	13.0	12.1	17.3	13.5	14.3	31.9	19.4	12.2	13.1	16.9	17.5	10.4	13.3	13.7	12.2	12.5	18.3	17.5	11.3	11.3	13.5	26.2	3.1	2.8	4.1	3.2	3.0	4.3	1.0	16.5	9.2	16.9	13.1	12.4	13.1	12.3	10.8	16.2	11.5	11.4	16.7	10.8	11.6	8.1	14.2	7.7	16.6	9.7	20.3	16.4	11.0	11.0	7.1	28.2	11.6	7.5	4.7	12.1	14.7	8.1	17.7	17.2	12.0	9.8	14.4	7.3	7.6	7.3	10.1	6.6	7.7	16.5	6.5	12.6	9.7	9.7	14.5	9.3	12.0	12.3	8.6	14.6	12.3	14.8	11.8	8.9	17.5	22.5	6.2	14.8	10.8	14.9	12.4	4.1	3.2	1.3	2.1	3.2	2.6	2.4	2.1	2.5	1.8	3.1	2.8	2.2	3.0	3.0	2.5	2.8	4.3	1.0	10.1	13.2	22.1	12.9	11.3	8.5	14.3	10.6	12.1	12.5
VRK1		ENSG00000100749	"Vaccinia related kinase 1"	Q99986	14	96797304-96931722	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	6.0	4.4	7.1	9.8	17.1	39.0	8.7	8.6	10.2	6.1	7.8	4.4	4.1	5.2	5.9	5.7	9.4	6.9	3.3	6.0	7.4	6.5	6.2	4.3	4.5	18.3	6.9	6.1	5.9	3.7	3.8	5.1	7.1	6.7	5.3	9.1	4.1	4.8	4.1	4.3	6.4	6.9	5.4	6.1	15.7	6.7	33.3	6.9	33.0	4.9	6.1	18.4	5.9	5.7	20.8	13.5	20.1	9.5	28.5	22.3	12.5	15.7	9.1	22.5	10.0	2.7	5.0	14.0	11.9	9.3	19.1	19.0	10.8	15.6	40.1	8.1	7.0	17.5	21.0	15.5	26.3	22.8	11.3	25.0	6.0	11.1	2.9	48.0	15.7	2.7	2.8	14.4	10.6	13.2	21.2	25.4	16.4	18.0	38.1	20.7	14.4	17.3	35.7	39.4	13.6	8.7	16.2	15.9	9.0	10.5	10.8	8.0	12.3	19.0	7.1	8.7	7.8	15.0	11.9	13.3	15.7	38.8	13.6	21.0	10.3	20.1	7.6	14.5	15.1	9.3	18.4	20.3	17.6	18.5	9.9	20.8	19.1	19.3	4.5	28.5	9.5	13.5	22.3	12.5	7.1	17.1	8.6	10.2	7.4	6.5	6.9	6.1	6.7	6.9
VRK2		ENSG00000028116	"Vaccinia related kinase 2"	Q86Y07	2	57907651-58159920	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: "	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	18.7	17.7	10.9	21.9	28.3	14.9	16.1	2.4	15.1	15.6	13.5	27.3	16.3	9.9	18.4	16.7	26.8	13.2	10.9	21.6	14.4	8.9	12.4	15.2	15.6	19.5	29.2	13.5	14.2	20.0	16.1	18.7	16.1	18.7	15.7	15.6	9.3	20.5	17.6	21.5	12.8	12.9	20.1	19.0	20.1	13.5	12.5	31.2	13.6	17.4	16.7	23.0	18.1	19.4	19.7	17.0	21.6	21.3	11.3	12.2	9.2	14.1	9.5	1.1	6.3	7.1	13.1	19.6	13.1	13.2	9.1	9.3	19.3	15.1	17.3	17.3	11.5	10.8	13.7	14.3	13.7	31.1	9.2	19.5	7.6	13.8	11.3	16.5	11.6	7.2	17.1	14.6	21.0	26.1	19.1	11.1	15.1	8.1	0.1	12.7	12.0	4.8	18.9	4.8	11.8	15.1	11.7	3.8	0.1	20.8	12.4	10.5	8.7	10.2	14.5	0.2	30.2	8.1	0.2	16.4	12.9	9.3	7.3	20.5	15.0	13.7	16.8	21.6	10.1	21.3	12.2	19.7	9.8	11.8	16.6	19.0	7.4	9.5	6.0	11.3	20.6	17.0	11.5	9.2	10.9	28.3	2.4	15.1	14.4	8.9	29.2	13.5	18.7	31.2
VRK3		ENSG00000105053	"Vaccinia related kinase 3"	Q8IV63	19	49976467-50025946	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 77.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA056489: "	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.66e-4)"	9.7	11.9	9.2	9.4	12.7	10.7	8.3	12.0	14.1	8.9	13.4	11.9	9.3	13.4	15.7	10.8	8.4	18.0	12.2	7.4	9.3	11.1	16.7	16.2	8.5	13.4	10.4	9.9	11.2	11.5	7.1	11.8	10.7	9.8	9.4	11.7	14.2	14.3	8.5	11.8	7.7	17.3	7.5	11.0	12.8	10.9	77.2	9.1	24.7	14.1	6.0	12.9	9.9	8.0	24.5	19.7	47.3	20.9	33.5	30.1	18.1	16.3	16.9	12.4	13.4	16.5	15.3	12.9	11.8	14.1	17.5	19.3	9.0	18.3	19.7	8.4	11.4	12.2	11.5	10.0	14.2	17.2	23.7	15.3	10.2	15.6	12.4	19.1	27.0	13.7	15.1	10.1	10.7	14.4	18.6	29.4	12.6	6.9	25.8	12.9	6.7	14.6	20.8	13.1	25.1	15.0	17.3	14.0	6.8	11.5	14.2	12.8	13.1	20.4	10.9	18.0	10.5	7.2	9.1	19.1	24.3	10.3	14.4	11.8	12.3	37.0	17.8	32.4	23.8	18.8	19.1	24.5	21.7	22.7	19.7	21.9	22.1	20.4	47.3	33.5	20.9	18.8	30.1	18.1	9.2	12.7	12.0	14.1	9.3	11.1	10.4	9.9	9.8	9.1
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224689	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol			22000	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavourable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavourable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	18.8	19.5	20.5	15.5	28.2	17.2	20.6	25.0	39.3	17.2	22.0	18.5	9.6	24.2	16.0	17.1	31.4	17.9	14.9	21.2	19.8	20.3	24.9	29.9	13.5	19.3	20.1	20.7	15.3	15.6	16.3	21.7	30.5	30.7	16.8	26.3	11.2	19.4	13.5	48.6	20.9	32.7	17.0	24.0	20.8	14.6	12.9	18.2	33.6	18.0	24.3	24.0	18.4	19.7	29.0	30.9	58.6	38.1	30.9	30.1	36.1	18.1	15.6	25.5	39.0	22.5	24.8	17.6	41.1	24.6	37.7	36.1	26.3	14.2	29.6	27.9	36.8	23.2	27.1	28.1	52.3	20.0	23.8	32.1	16.7	31.4	16.6	49.7	18.6	20.4	32.9	37.6	24.4	24.1	29.7	14.9	31.5	26.4	32.2	25.9	19.1	17.9	29.7	20.4	18.0	29.0	20.1	26.7	20.8	23.1	17.8	20.6	19.3	33.9	17.4	17.0	23.7	28.4	29.5	14.7	25.4	33.7	11.1	27.8	25.8	58.6	31.0	49.5	23.5	38.1	30.1	29.0	26.8	27.4	30.9	26.6	29.8	29.9	19.1	30.9	37.4	19.0	25.7	36.1	20.5	28.2	25.0	39.3	19.8	20.3	20.1	20.7	30.7	18.2
VTI1A	"MVti1, Vti1-rp2, Vti1a"	ENSG00000151532	"Vesicle transport through interaction with t-SNAREs 1A"	Q96AJ9	10	112446998-112818744	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054108	Supported		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA054108: "	"unprognostic (9.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (6.50e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic favourable (7.27e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-1)"	16.8	12.8	14.5	17.9	17.9	25.2	14.6	16.7	18.6	10.0	13.8	14.3	14.4	15.2	11.8	11.6	21.1	9.5	10.3	13.1	13.4	11.1	15.4	11.8	15.7	15.4	12.8	12.2	10.5	12.8	17.4	13.7	11.0	14.6	11.4	17.0	11.2	14.3	13.6	18.4	17.1	16.5	12.8	12.7	16.0	12.3	9.8	13.0	18.8	14.2	9.7	19.6	13.1	15.6	7.3	6.8	14.8	11.7	7.3	8.8	5.5	10.8	9.1	8.7	11.7	13.4	11.9	5.2	11.6	14.8	9.5	10.7	10.2	11.3	11.3	4.5	13.3	13.0	7.4	9.3	13.0	14.1	6.5	9.8	6.6	10.7	9.5	13.5	14.3	9.0	12.1	10.7	22.4	10.1	8.9	14.2	12.5	7.4	10.7	10.4	3.6	5.3	11.3	12.4	5.0	10.0	9.7	3.9	7.6	8.3	7.3	7.6	6.5	7.6	14.0	7.4	6.4	9.0	12.9	6.2	8.7	13.3	12.2	12.5	7.2	8.9	8.9	11.9	7.5	11.7	7.0	7.3	6.3	6.0	6.8	6.7	6.2	6.4	14.8	7.3	10.4	6.4	8.8	5.5	14.5	17.9	16.7	18.6	13.4	11.1	12.8	12.2	14.6	13.0
VTI1B	VTI2	ENSG00000100568	"Vesicle transport through interaction with t-SNAREs 1B"	Q9UEU0	14	67647075-67674831	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044121, HPA048150, HPA060118"	Approved		Enhanced	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA044121: , HPA048150: , HPA060118: "	"unprognostic (2.26e-1)"	"unprognostic (4.83e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.11e-2)"	"prognostic favourable (3.53e-12)"	"unprognostic (8.35e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.02e-3)"	37.5	21.4	49.3	14.9	39.3	14.3	32.1	12.6	32.9	11.3	22.8	16.8	16.1	21.3	12.5	42.5	34.1	14.6	22.0	49.6	36.9	30.4	39.0	30.5	14.8	16.3	38.1	20.5	12.7	27.9	20.3	11.3	21.0	24.2	16.2	27.4	15.4	25.7	18.8	31.0	21.8	20.2	22.9	37.1	15.6	20.7	15.4	20.2	8.2	25.9	18.8	19.5	19.4	24.2	18.7	22.4	52.1	29.6	20.1	21.7	18.9	38.3	19.4	11.3	6.5	22.6	13.5	16.4	17.0	10.6	8.2	8.5	9.6	13.8	11.5	14.5	18.9	10.9	12.9	12.9	13.4	11.8	8.2	11.6	11.7	12.3	9.7	7.2	8.4	13.1	14.0	9.1	9.4	9.5	7.6	9.0	12.0	45.5	9.0	26.7	7.3	31.3	10.9	12.8	4.2	12.2	23.1	6.3	13.1	12.0	16.3	24.1	15.2	20.3	13.6	22.9	34.2	18.4	15.7	8.5	9.1	17.7	19.3	13.5	10.5	28.6	23.4	52.1	19.8	29.6	16.9	18.7	17.5	20.2	22.4	16.4	16.7	20.4	10.6	20.1	24.7	14.7	21.7	18.9	49.3	39.3	12.6	32.9	36.9	30.4	38.1	20.5	24.2	20.2
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367276-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"liver: 321.7"	"Cell line enriched"	"Detected in some"	11	"CACO-2: 164.9"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"					"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	224300000000	32000000000	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favourable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.6	2.2	0.0	0.0	0.0	321.7	0.0	0.0	0.0		0.0	0.6	0.0	0.0	2.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4			0.0		0.0	0.0	0.0	0.3	0.2	0.6	0.2	0.7	2.1	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	164.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	15.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.9	0.0	0.9	0.9	0.1	0.3	0.6	2.1	0.6	0.7	0.0	0.2	0.0	0.1										
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 24.4;testis: 51.9"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA036700: , HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.0	0.2	1.7	0.0	0.0	0.0	0.2	1.1	0.2	2.0	0.0	0.0	0.5	4.3	0.0	24.4	0.5	0.4	1.7	1.6	0.0	0.0	4.0	0.0	0.1	0.1	2.3	0.0	0.0	1.1	0.1	3.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	51.9	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.1	1.7	1.6	0.1	0.1	3.2	0.3
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115362-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.7;HEL: 20.0;HHSteC: 15.5;HUVEC TERT2: 18.4;RPTEC TERT1: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 25.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: "	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	14.8	20.2	13.8	7.5	13.4	1.6	16.0	2.3	9.3	15.5	23.9	7.5	10.0	16.7	16.6	17.0	12.6	9.9	19.9	6.5	14.1	24.6	16.0	4.3	19.4	6.8	12.5	6.6	9.6	15.3	5.5	34.2	25.9	15.2	22.5	28.4	10.3	31.2	13.2	3.0	17.9	24.0	13.6	15.0	6.0	17.8	6.3	7.6	3.9	13.7	7.1	9.8	14.9	11.8	4.5	4.8	25.6	5.3	4.3	7.5	3.6	0.0	0.2	3.6	0.2	3.8	3.5	1.3	0.5	0.2	0.3	0.1	0.2	27.7	0.0	3.4	0.5	0.1	0.7	6.3	0.0	9.4	0.0	20.0	5.0	0.6	15.5	0.2	9.4	10.5	0.7	0.6	2.1	18.4	1.0	3.4	1.1	0.0	0.4	0.3	5.6	0.7	0.0	12.3	0.1	20.2	0.2	3.1	0.3	0.5	0.2	1.0	2.5	0.9	0.4	0.1	2.6	0.1	0.0	1.2	1.1	0.0	11.5	0.4	0.2	25.6	4.8	0.5	2.9	3.3	0.7	4.5	3.2	1.7	4.8	2.3	4.1	2.6	0.3	4.3	5.3	2.6	7.5	3.6	13.8	13.4	2.3	9.3	14.1	24.6	12.5	6.6	15.2	7.6
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295424	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.8;ovary: 10.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6;Hep G2: 18.9;HSkMC: 11.1;REH: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"		1300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: , HPA043921: "	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.9	1.1	0.9	0.6	1.3	2.3	3.1	0.7	1.3	2.8	1.0	1.4	3.4	0.5	1.4	2.9	1.5	5.7	1.4	1.0	1.3	1.2	0.6	19.8	0.8	0.3	0.4	1.1	10.7	0.1	0.5	0.5	9.1	0.3	1.8	0.6	1.3	1.7	1.0	1.9	0.9	1.1	1.2	0.2	0.9	0.3	1.8	0.5	6.5	0.8	1.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.2	1.1	0.4	0.2	1.7	0.0	0.2	5.6	0.0	0.3	0.0	0.4	0.0	2.0	0.0	0.1	0.4	0.0	0.5	0.0	18.9	1.0	0.0	0.1	11.1	0.5	0.5	0.0	1.7	0.2	0.3	0.3	0.0	4.1	0.0	1.6	0.0	10.6	0.1	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.5	0.7	0.0	0.4	0.2	0.3	0.5	0.1	0.2	0.4	0.9	0.8	0.2	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.7	1.3	1.3	1.2	0.4	1.1	0.3	0.5
WAC	"BM-016, FLJ31290, MGC10753, PRO1741, Wwp4"	ENSG00000095787	"WW domain containing adaptor with coiled-coil"	Q9BTA9	10	28532493-28623112	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036528, HPA042609, HPA074604"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA036528: AB_10670839, HPA042609: , HPA074604: "	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavourable (9.27e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.36e-1)"	30.6	25.2	36.5	29.8	40.9	59.3	30.4	83.3	46.0	30.4	36.5	27.8	26.9	24.9	33.3	30.6	29.0	28.3	25.9	40.8	37.4	31.6	32.2	28.7	29.4	32.9	36.4	35.5	39.6	33.8	41.8	44.2	34.8	35.4	32.3	28.8	21.2	27.0	31.7	31.8	28.9	27.5	36.4	38.1	33.5	27.3	28.1	41.0	30.1	36.5	18.3	36.6	40.3	78.9	15.0	14.9	19.9	20.6	23.0	17.6	9.7	30.6	19.7	40.5	24.7	33.4	32.2	28.5	29.9	23.8	35.1	40.3	28.0	34.4	41.0	21.6	27.5	30.0	32.9	22.5	38.8	42.1	27.2	43.5	22.1	21.9	39.1	21.1	34.1	27.7	43.4	38.5	34.0	30.8	38.3	38.3	29.2	23.8	46.8	18.5	23.4	10.2	33.9	55.9	27.4	25.1	17.9	40.7	30.6	24.8	32.9	45.0	25.0	33.8	25.6	22.3	27.8	24.1	26.4	20.6	18.4	44.5	23.6	40.2	19.6	14.6	12.1	12.4	14.6	20.6	17.6	15.0	13.2	16.8	14.9	13.6	15.0	13.6	19.9	23.0	15.9	11.3	14.2	9.7	36.5	40.9	83.3	46.0	37.4	31.6	36.4	35.5	35.4	41.0
WARS	"IFI53, IFP53"	ENSG00000140105	"Tryptophanyl-tRNA synthetase"	P23381	14	100333788-100376805	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.8;thyroid gland: 157.0"	"Cell line enhanced"	"Detected in all"		"HHSteC: 116.6;SK-MEL-30: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 131.2;non-classical monocyte: 142.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol			53000000	Cytosol		"HPA005573: , HPA018944: "	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favourable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	42.5	23.3	14.5	53.9	20.1	17.0	20.6	10.7	25.4	11.1	19.1	13.3	7.1	12.7	16.5	20.5	17.8	14.5	13.7	32.0	17.8	18.7	24.6	17.9	68.5	35.3	16.9	14.8	12.1	15.6	9.4	23.5	89.6	28.2	16.4	21.0	23.5	15.7	11.7	22.3	9.3	19.8	21.0	15.7	51.6	19.8	23.7	9.4	20.9	157.0	19.2	22.7	24.0	13.8	5.6	27.7	51.8	142.8	3.3	3.4	46.4	10.9	10.4	6.8	39.9	9.9	14.1	11.0	14.1	27.3	30.5	38.4	6.8	9.8	11.9	13.2	33.7	18.6	19.9	16.1	19.6	18.8	5.7	7.6	7.9	8.3	116.6	21.8	12.6	16.0	23.2	17.7	36.8	27.2	24.0	31.5	13.0	20.9	7.5	10.2	6.9	18.9	6.2	10.8	7.6	14.8	9.6	18.4	10.7	8.4	7.3	140.8	18.8	27.6	18.0	3.3	7.3	33.3	7.4	61.5	31.2	22.1	36.7	16.9	29.7	6.1	39.5	51.8	3.4	131.2	3.1	5.6	2.8	3.1	27.7	4.1	2.0	2.4	14.1	3.3	142.8	4.2	3.3	46.4	14.5	20.1	10.7	25.4	17.8	18.7	16.9	14.8	28.2	9.4
WARS2	TrpRS	ENSG00000116874	"Tryptophanyl tRNA synthetase 2, mitochondrial"	Q9UGM6	1	119031216-119140671	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069692	Enhanced		Supported	"Plasma membrane,Mitochondria"				Mitochondria	"Plasma membrane"	"HPA069692: "	"unprognostic (1.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.76e-3)"	"prognostic favourable (1.45e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-3)"	"unprognostic (4.71e-2)"	17.3	16.7	6.8	11.7	8.3	2.8	14.6	7.5	8.7	12.9	11.2	7.7	7.6	12.3	13.5	10.4	13.4	14.9	8.8	12.1	6.2	6.1	15.3	14.9	9.2	12.4	6.4	6.1	14.7	17.8	15.1	12.3	14.9	8.3	14.1	12.7	11.3	10.5	10.4	12.2	10.0	13.1	9.0	5.4	9.9	11.2	6.9	6.1	11.6	12.8	13.2	14.2	14.3	10.4	7.2	9.0	0.5	6.9	5.3	7.4	4.9	10.2	4.5	6.0	6.3	7.7	17.4	6.5	5.8	8.2	6.1	7.3	11.2	4.7	15.1	9.4	9.2	6.9	10.8	9.8	9.3	8.1	14.1	7.1	12.0	10.7	15.7	11.5	4.1	13.3	7.6	8.8	16.1	9.0	11.1	11.0	11.2	11.9	6.8	6.7	8.1	9.2	5.0	20.0	7.6	16.5	14.3	8.9	5.4	9.0	12.6	13.0	5.6	9.0	6.9	6.6	8.0	12.4	10.9	5.3	3.6	6.7	8.1	9.7	12.2	0.0	6.9	0.5	5.1	4.9	7.4	6.6	5.4	6.7	9.0	7.2	6.5	6.2	0.3	5.3	3.0	4.5	6.0	4.9	6.8	8.3	7.5	8.7	6.2	6.1	6.4	6.1	8.3	6.1
WASHC1	"FAM39E, FLJ00038, WASH1"	ENSG00000181404	"WASH complex subunit 1"	A8K0Z3	9	14521-73865	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA002689	Uncertain		Supported	Vesicles				Vesicles		"HPA002689: AB_1078803"	"unprognostic (9.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (5.00e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.37e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.02e-1)"	1.7	1.5		0.8		2.4	0.4		0.5	0.4	1.1			1.9	4.1	5.4	3.3	3.3	1.2	2.5			1.5	0.0	1.4	2.1			2.5	0.8	0.0		0.6		3.2	0.0		1.2	5.0	4.2	3.7	1.3	3.8		2.1	1.3	0.3			0.3		0.3	0.2		3.5	5.7	4.9	8.7	5.0	5.0	3.4	11.5	7.0	4.3	9.0	7.5	5.1	10.7	10.8	9.7	5.9	5.0	6.7	7.1	4.8	5.8	4.1	14.3	6.3	4.9	2.3	4.9	11.7	4.7	5.1	7.0	4.2	9.3	8.5	3.8	3.7	3.0	4.1	1.8	10.3	18.2	1.8	3.4	9.6	7.7	7.9	14.8	6.5	5.8	6.0	4.4	8.2	4.9	13.2	5.8	13.2	7.0	7.4	9.0	7.1	8.0	8.3	3.5	9.2	8.3	6.4	3.7	7.5	10.1	7.4	2.4	5.9	4.9	5.0	6.2	3.9	3.5	4.0	4.1	5.7	3.3	4.2	3.4	3.6	5.0	8.7	5.1	4.2	3.4										
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoli, Cytosol"	"HPA047844: , HPA060975: , HPA061022: "	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavourable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	24.0	21.0	15.8	31.4	19.3	24.7	27.1	22.5	18.3	19.1	21.2	16.2	12.6	19.4	22.8	15.3	15.7	15.5	14.4	42.9	17.6	13.9	26.1	12.1	20.7	20.2	15.3	15.8	22.5	14.0	21.2	27.0	17.7	22.0	16.7	23.0	13.1	17.5	16.5	15.5	19.2	21.3	16.8	14.6	27.4	16.2	9.4	14.8	27.0	21.4	9.8	20.2	18.4	27.4	6.6	9.0	11.7	13.9	9.0	12.5	8.8	10.9	5.3	9.1	10.6	37.1	20.8	7.4	12.9	27.4	19.2	20.6	12.4	16.5	9.7	8.1	19.2	12.0	13.1	10.9	19.0	9.2	9.5	6.9	10.7	12.4	25.9	11.7	12.0	21.3	13.7	21.0	13.3	14.5	11.2	9.8	23.1	7.8	6.4	19.2	7.4	25.2	9.8	13.2	5.7	13.2	12.7	3.1	9.8	12.0	11.2	17.2	13.8	8.1	21.3	9.8	8.3	27.8	10.6	10.1	20.1	8.3	21.6	21.6	3.9	1.2	10.7	11.7	12.0	13.9	12.5	6.6	10.2	11.0	9.0	6.5	10.2	7.4	5.1	9.0	8.2	5.3	10.4	8.8	15.8	19.3	22.5	18.3	17.6	13.9	15.3	15.8	22.0	14.8
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792961	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoli, Cytosol"	"HPA047844: , HPA060975: , HPA061022: "	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavourable (1.35e-5)"	"prognostic favourable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	17.2	15.8	10.0	33.6	15.7	30.1	27.2	24.9	17.1	16.7	15.8	10.7	15.9	12.2	18.3	17.0	12.3	13.2	13.6	23.2	14.2	10.2	20.6	12.8	17.3	14.8	16.0	8.4	20.2	10.1	22.7	16.5	13.4	16.2	13.4	18.5	13.0	15.3	24.0	17.1	14.8	17.0	15.8	14.0	15.5	12.5	10.1	15.3	19.4	14.9	13.2	14.6	19.3	14.8	10.7	11.4	17.2	20.3	12.2	13.4	11.6	11.1	12.0	9.8	11.1	25.5	22.6	5.9	13.1	21.6	15.5	14.9	7.3	10.9	9.2	8.9	19.3	10.1	10.9	6.0	15.6	8.5	9.1	9.5	14.9	5.6	27.1	9.5	11.8	21.3	14.6	16.8	12.6	15.9	15.1	7.3	19.0	5.8	6.3	16.4	7.1	1.8	7.9	14.4	4.7	11.5	17.5	4.8	10.8	15.2	7.7	18.4	10.4	9.6	26.7	8.1	8.7	21.3	8.7	10.3	15.9	9.1	11.4	22.9	4.3	12.5	16.9	11.0	13.0	18.2	12.5	10.7	10.8	13.4	11.4	9.6	10.8	9.7	17.2	12.2	20.3	8.4	10.1	11.6	10.0	15.7	24.9	17.1	14.2	10.2	16.0	8.4	16.2	15.3
WASHC4	"KIAA1033, SWIP"	ENSG00000136051	"WASH complex subunit 4"	Q2M389	12	105107324-105169134	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045666, HPA046737"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA045666: , HPA046737: "	"unprognostic (2.68e-2)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	26.2	22.1	14.4	22.8	18.1	16.0	20.2	14.8	16.8	20.8	16.2	16.4	21.1	11.5	22.3	18.0	15.9	15.3	18.2	13.3	14.3	11.9	25.6	28.5	19.4	31.5	18.7	11.9	21.7	19.6	20.7	30.1	23.8	24.0	18.5	14.8	14.6	17.5	18.0	18.0	24.3	21.9	18.2	22.1	36.5	14.3	9.9	17.4	21.3	17.9	12.2	29.8	16.7	18.9	11.4	7.9	11.0	20.9	5.3	3.6	4.3	9.9	12.0	10.7	7.8	25.2	25.2	12.8	15.4	17.8	18.1	16.8	8.5	5.8	22.3	8.6	25.8	9.2	9.1	9.5	14.6	8.1	6.9	4.6	11.1	7.0	17.0	12.7	8.9	20.1	11.1	16.4	13.3	29.3	9.1	8.0	19.6	5.0	7.1	13.3	12.9	10.0	13.5	14.6	7.0	24.1	11.6	6.9	8.7	16.0	11.4	15.8	8.4	13.7	35.6	22.0	6.0	13.9	10.0	10.5	9.9	18.1	15.5	11.3	22.0	9.9	10.2	5.9	2.1	12.4	3.1	11.4	3.4	2.8	7.9	9.0	3.6	3.4	11.0	5.3	20.9	4.0	2.3	4.3	14.4	18.1	14.8	16.8	14.3	11.9	18.7	11.9	24.0	17.4
WASHC5	"KIAA0196, SPG8"	ENSG00000164961	"WASH complex subunit 5"	Q12768	8	125024260-125091840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034216, CAB034219, HPA064649, HPA070916"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: , HPA070916: "	"unprognostic (1.98e-3)"	"unprognostic (3.75e-2)"	"unprognostic (8.40e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (6.74e-5)"	"unprognostic (2.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	21.7	28.1	16.7	17.3	25.1	18.5	20.1	17.1	23.7	18.7	18.2	38.0	13.0	17.9	22.2	16.5	19.6	15.8	18.0	17.1	16.9	15.2	23.2	18.2	16.8	23.0	22.8	16.4	16.5	17.1	25.9	26.4	22.0	28.7	18.3	20.7	17.9	22.6	17.3	23.1	18.6	16.8	20.7	24.5	19.6	18.3	9.3	22.5	25.0	23.9	17.8	20.6	20.4	16.0	8.4	16.0	9.7	21.5	13.5	13.5	9.6	15.5	18.4	10.1	12.4	23.1	24.8	6.7	16.8	25.9	17.9	19.0	6.8	16.9	14.0	12.0	21.8	12.2	16.5	15.3	23.5	18.4	9.2	18.8	11.4	8.9	22.5	5.7	19.1	24.6	10.2	14.7	12.8	20.4	10.8	14.5	21.6	34.1	17.1	4.6	9.7	18.8	11.6	9.1	14.3	13.6	19.6	5.3	10.7	19.6	44.4	15.5	19.1	10.0	17.7	9.7	21.6	16.1	14.9	13.0	11.9	12.6	25.8	10.9	13.5	7.7	13.7	9.7	11.8	16.8	12.5	8.4	11.3	11.9	16.0	8.1	9.1	12.5	4.8	13.5	21.5	5.8	13.5	9.6	16.7	25.1	17.1	23.7	16.9	15.2	22.8	16.4	28.7	22.5
WBP11	"NPWBP, PPP1R165, SIPP1"	ENSG00000084463	"WW domain binding protein 11"	Q9Y2W2	12	14784579-14803540	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039710, HPA040037, HPA046403, HPA049126"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA039710: , HPA040037: AB_10796115, HPA046403: , HPA049126: "	"unprognostic (4.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavourable (9.40e-4)"	"unprognostic (5.67e-3)"	"unprognostic (3.30e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	27.0	30.8	32.7	22.8	40.7	59.5	25.9	25.6	34.2	21.4	21.9	28.8	10.7	17.5	27.5	20.5	23.4	27.3	19.3	32.9	28.1	25.3	23.5	25.1	25.4	27.3	24.0	29.7	29.4	23.1	29.7	21.8	28.2	29.3	25.1	24.9	23.0	23.2	21.6	46.7	28.7	23.1	24.6	29.1	31.1	23.6	39.2	25.8	25.7	26.5	20.4	30.6	26.4	20.9	15.4	11.4	10.5	16.7	15.9	19.8	11.3	16.4	14.8	17.6	33.4	11.7	11.3	31.6	13.6	11.5	20.8	21.0	26.8	20.5	20.6	8.9	12.3	13.7	27.0	18.0	25.7	36.4	18.1	30.0	16.4	16.2	11.8	28.0	16.5	10.9	14.3	23.2	17.5	16.5	19.1	11.0	16.4	15.9	26.1	15.1	56.5	9.4	22.3	27.8	12.9	14.9	22.8	9.4	19.0	18.2	15.2	14.4	8.1	18.6	12.2	14.5	22.3	12.8	23.2	9.6	13.4	37.9	15.2	14.0	19.3	9.5	12.1	10.5	17.2	16.7	18.9	15.4	16.6	17.3	11.4	13.8	19.8	17.9	7.4	15.9	16.5	8.2	17.2	11.3	32.7	40.7	25.6	34.2	28.1	25.3	24.0	29.7	29.3	25.8
WBP4	"FBP21, MGC117310"	ENSG00000120688	"WW domain binding protein 4"	O75554	13	41061274-41084006	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038965, HPA058738"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"HPA038965: AB_10672836, HPA058738: "	"unprognostic (2.56e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.65e-3)"	"prognostic favourable (2.89e-4)"	"unprognostic (2.52e-1)"	14.0	14.2	17.2	7.9	22.1	11.4	11.5	15.8	17.2	12.0	10.7	8.6	8.9	9.6	16.6	14.1	10.9	10.1	8.0	18.8	14.7	15.8	10.5	13.4	8.7	9.0	14.7	19.0	11.8	7.5	8.8	11.3	15.9	15.9	12.5	8.0	4.8	7.2	13.2	76.2	9.4	9.6	14.7	15.0	7.9	8.1	10.0	12.8	12.7	9.6	12.6	9.3	13.3	11.1	10.9	15.2	22.7	16.2	9.7	12.9	5.0	8.8	5.9	16.5	10.6	10.8	16.5	10.1	20.2	14.3	15.9	12.3	9.3	9.5	12.7	8.1	14.1	12.6	6.2	10.0	20.5	13.1	8.7	17.9	5.7	9.4	16.6	11.1	11.7	13.5	15.4	11.6	16.5	13.4	9.5	5.6	16.6	7.5	16.0	12.2	10.0	4.9	15.0	10.2	5.0	14.5	8.8	3.8	9.1	6.4	7.0	9.5	5.7	17.5	11.7	10.0	9.2	13.7	11.6	3.7	4.1	8.9	12.3	8.2	13.6	13.0	11.0	9.7	9.3	9.6	8.5	10.9	11.8	9.9	8.9	10.6	12.9	12.6	22.7	9.7	16.2	15.2	11.3	5.0	17.2	22.1	15.8	17.2	14.7	15.8	14.7	19.0	15.9	12.8
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938950-55027105	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.1"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavourable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	5.0	2.8	6.3	6.6	7.5	10.8	3.8	7.2	4.6	3.7	4.9	2.7	0.6	3.2	4.2	2.9	7.0	4.0	2.3	2.3	3.2	2.3	2.8	2.1	2.9	8.9	3.3	2.5	4.1	2.0	3.0	1.9	6.0	4.4	2.1	7.3	2.6	3.0	2.2	2.0	4.5	3.6	4.6	2.8	4.6	2.8	8.8	3.5	21.1	2.1	6.4	11.2	3.6	4.3	4.8	1.8	4.3	0.9	4.3	4.6	1.6	15.8	10.2	20.2	8.9	2.0	4.8	11.8	15.4	6.6	12.4	15.3	6.7	10.6	18.1	7.9	4.4	13.5	30.1	8.8	26.2	12.1	5.2	11.9	10.0	6.5	0.8	22.5	9.1	2.5	1.6	15.3	6.0	8.0	14.9	9.1	11.9	8.7	21.1	4.4	16.0	10.7	19.8	29.2	6.9	3.5	10.6	11.8	8.3	16.3	4.1	5.3	11.1	4.5	5.2	15.8	18.8	11.5	13.0	2.7	5.6	24.2	7.2	11.1	12.4	4.3	0.8	1.4	2.3	0.6	3.2	3.0	2.7	3.3	1.4	4.8	3.3	4.6	1.2	4.3	0.9	1.8	3.9	1.6	6.3	7.5	7.2	4.6	3.2	2.3	3.3	2.5	4.4	3.5
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"			280000000	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: , HPA070293: "	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favourable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	40.2	23.7	19.0	49.4	18.1	33.5	35.0	8.1	22.6	53.5	53.3	25.8	38.4	39.2	80.9	54.2	59.6	54.9	57.6	49.5	19.6	20.5	55.4	41.3	41.7	57.4	22.1	17.1	51.5	22.2	19.5	18.6	40.4	26.8	47.1	38.3	37.6	38.5	49.1	32.1	31.6	54.5	88.0	19.5	46.9	41.1	38.0	16.0	74.5	49.9	36.4	50.2	69.6	41.5	22.9	40.2	54.2	61.2	32.5	55.6	64.1	30.2	30.3	27.2	22.8	20.6	34.3	43.0	76.4	70.5	69.1	54.3	36.2	38.2	21.0	24.9	91.2	19.8	29.5	55.9	73.9	32.8	10.1	60.0	31.1	25.7	48.4	19.0	69.6	32.9	28.7	70.1	35.1	74.2	17.9	35.0	66.9	17.3	83.8	26.8	32.2	30.5	39.6	24.9	17.8	43.1	48.2	9.2	10.0	32.6	18.1	31.4	15.2	20.7	111.6	53.3	22.4	44.1	66.9	22.1	35.4	27.6	56.4	28.9	66.1	37.1	29.0	54.2	48.3	51.7	37.4	22.9	40.6	48.2	37.8	16.9	41.7	44.4	54.1	32.5	61.2	40.2	55.6	64.1	19.0	18.1	8.1	22.6	19.6	20.5	22.1	17.1	26.8	16.0
WDR13		ENSG00000101940	"WD repeat domain 13"	Q9H1Z4	X	48590042-48608867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000913	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"				Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA000913: AB_1858795"	"unprognostic (5.03e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.65e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.54e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.32e-2)"	24.5	30.4	39.9	13.9	36.9	15.7	19.1	14.4	33.9	18.6	25.5	17.6	41.5	23.0	26.0	41.2	23.1	30.8	21.1	49.8	30.2	18.9	24.2	50.2	19.3	11.1	20.0	35.8	35.0	74.7	21.8	24.4	23.9	17.0	19.6	14.4	16.5	30.4	35.8	48.5	21.7	22.0	20.2	17.5	17.4	22.7	11.0	20.5	8.6	21.9	21.1	10.5	17.9	19.7	16.8	21.1	29.2	28.2	17.3	13.8	15.9	14.9	22.0	11.0	34.0	15.2	22.4	8.4	10.4	19.0	12.1	11.1	13.0	24.1	10.4	10.0	21.2	12.9	5.5	22.7	4.3	12.3	9.7	7.1	25.9	23.6	34.6	6.1	19.4	21.1	32.5	17.1	31.5	16.5	7.0	13.3	16.7	21.5	8.4	10.7	7.9	17.3	8.1	11.7	18.8	21.3	11.9	12.8	15.9	11.7	24.5	24.0	15.6	11.9	27.3	12.6	18.7	19.8	9.9	15.5	5.7	3.8	18.6	9.2	17.3	29.2	23.1	12.7	11.9	24.7	9.5	16.8	12.6	11.3	21.1	13.4	10.0	11.4	16.0	17.3	28.2	13.3	13.8	15.9	39.9	36.9	14.4	33.9	30.2	18.9	20.0	35.8	17.0	20.5
WDR18	Ipi3	ENSG00000065268	"WD repeat domain 18"	Q9BV38	19	984271-998438	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050193, HPA050200"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA050193: AB_2681047, HPA050200: AB_2681049"	"unprognostic (7.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	13.1	16.5	13.4	16.7	14.5	14.0	11.1	24.0	20.5	10.9	14.3	14.4	12.2	16.9	11.4	17.4	18.8	11.5	11.7	14.9	12.0	11.6	17.9	23.4	11.0	18.7	12.4	8.2	16.1	32.2	10.5	14.6	15.1	10.3	14.4	6.8	14.3	19.5	15.1	28.7	16.9	15.5	10.6	9.8	14.0	17.0	15.2	9.2	22.7	13.1	20.9	16.8	11.0	10.8	22.9	40.7	6.2	28.1	18.4	21.3	22.3	18.9	18.6	5.9	9.9	5.7	5.2	23.0	8.5	5.1	10.9	8.2	20.6	6.7	22.4	10.1	13.0	15.6	16.1	18.6	4.3	11.7	24.9	10.8	11.2	25.6	13.3	23.3	10.3	6.8	9.9	6.5	15.3	9.8	23.9	8.9	4.0	20.0	17.3	32.8	33.0	11.8	32.6	13.4	35.0	6.9	12.1	21.9	20.4	8.1	7.0	8.3	16.4	14.1	9.5	12.0	14.4	23.4	13.4	28.1	23.9	10.9	10.4	14.6	12.7	4.0	27.4	6.2	19.7	28.1	19.2	19.9	19.9	21.1	40.7	22.9	20.0	18.2	1.2	18.4	22.1	25.5	21.3	22.3	13.4	14.5	24.0	20.5	12.0	11.6	12.4	8.2	10.3	9.2
WDR24	"C16orf21, DKFZp434F054, JFP7"	ENSG00000127580	"WD repeat domain 24"	Q96S15	16	684622-690444	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039506	Approved		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA039506: AB_10795148"	"unprognostic (9.07e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.15e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.05e-1)"	"prognostic favourable (3.75e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	8.8	11.6	10.9	9.8	11.3	9.3	9.2	18.9	17.6	7.6	7.8	8.2	6.5	12.1	10.2	10.2	9.4	9.3	8.5	9.9	9.5	7.8	9.0	15.7	15.3	17.7	8.7	11.1	12.8	14.5	17.0	11.9	9.2	8.8	10.3	3.6	8.8	16.2	8.8	16.9	13.5	10.2	10.0	10.6	13.3	10.5	17.6	9.5	17.9	11.8	7.9	6.5	9.2	7.8	7.1	7.7	6.5	10.3	4.3	10.7	7.1	4.4	10.3	4.8	6.6	4.6	3.3	8.4	5.6	5.0	7.0	6.1	11.2	6.6	6.9	9.8	2.5	7.0	4.6	5.5	1.5	11.6	14.6	4.7	13.8	4.3	7.3	5.7	7.4	5.7	3.7	5.0	4.2	3.8	9.2	7.8	2.6	16.3	10.0	4.2	7.3	8.1	14.9	3.9	12.7	2.3	3.1	11.9	5.4	6.3	11.0	6.2	10.0	5.8	5.6	5.2	5.4	5.6	5.4	16.8	15.2	11.3	3.3	5.7	7.1	6.5	7.5	4.0	10.7	4.5	8.7	7.1	6.9	7.8	7.7	6.4	8.2	7.7	1.8	4.3	10.3	6.2	8.9	7.1	10.9	11.3	18.9	17.6	9.5	7.8	8.7	11.1	8.8	9.5
WDR25	"C14orf67, MGC4645"	ENSG00000176473	"WD repeat domain 25"	Q64LD2	14	100376418-100530303	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003113	Uncertain		Supported	Nucleoplasm	"Secreted to blood"			Nucleoplasm		"HPA003113: AB_2215263"	"unprognostic (5.31e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (7.36e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.62e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (3.89e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.51e-2)"	6.9	10.9	10.8	5.0	13.5	7.9	9.5	14.4	14.8	15.2	8.3	11.2	5.4	6.8	11.1	9.4	7.6	14.0	7.2	7.6	10.8	9.4	7.6	9.0	7.5	6.8	8.6	13.3	11.0	16.2	7.7	13.4	7.2	9.4	9.2	5.7	10.9	11.9	9.7	11.4	6.1	5.8	7.3	7.5	6.8	8.4	15.0	11.3	6.4	17.3	4.4	6.6	7.4	6.6	9.9	11.9	19.5	13.9	4.2	10.8	10.0	3.2	5.8	4.1	14.9	6.6	6.2	3.4	6.1	9.8	7.1	7.2	2.7	6.2	4.7	7.7	5.1	5.9	3.8	7.4	3.8	4.6	2.8	3.2	6.6	4.5	12.1	3.7	3.7	9.2	8.9	5.1	7.8	5.1	3.8	7.0	4.6	12.5	5.5	4.1	3.1	10.3	3.9	5.7	3.3	5.4	2.6	9.5	10.1	4.9	1.8	8.2	6.9	1.3	8.7	2.7	3.2	10.4	3.4	4.8	2.4	2.4	9.5	2.8	5.1	19.5	13.9	19.5	7.5	11.8	7.8	9.9	10.0	8.0	11.9	7.2	10.8	7.9	7.3	4.2	12.4	9.2	9.7	10.0	10.8	13.5	14.4	14.8	10.8	9.4	8.6	13.3	9.4	11.3
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385143-224437033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028539: AB_10669752, HPA061094: "	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavourable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	8.2	7.2	6.7	6.7	6.7	18.5	7.2	8.2	7.3	7.8	7.0	6.7	6.7	4.0	6.8	9.3	13.0	5.9	7.0	7.5	6.7	5.0	6.7	9.3	9.0	7.2	6.7	6.7	7.0	6.9	9.2	6.7	8.7	6.7	7.0	6.7	6.7	7.2	6.7	15.2	9.9	6.7	7.1	6.7	10.2	6.3	63.9	6.7	6.7	7.0	6.7	7.4	6.7	8.3	1.5	2.1	8.3	3.9	2.7	2.7	1.3	11.9	6.2	19.3	8.9	25.8	29.4	13.9	17.6	28.8	16.1	15.2	9.8	13.6	14.2	17.7	28.3	10.9	11.3	15.1	26.5	11.1	12.9	9.8	8.1	9.2	28.1	10.2	17.2	27.3	21.9	17.0	16.1	26.8	12.9	14.7	21.1	6.6	10.5	9.9	18.6	7.2	9.7	20.2	11.2	19.6	12.1	7.0	17.9	20.0	27.1	21.5	31.1	16.8	28.1	13.8	6.3	12.9	21.1	15.7	7.5	9.7	15.7	7.3	17.0	4.1	1.9	3.3	2.7	2.4	1.5	1.5	1.9	2.1	1.8	1.4	1.4	2.1	8.3	2.7	3.9	2.1	1.6	1.3	6.7	6.7	8.2	6.7	6.7	5.0	6.7	6.7	6.7	6.7
WDR27	MGC43690	ENSG00000184465	"WD repeat domain 27"	A2RRH5	6	169457212-169702048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037497, HPA037498"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA037497: AB_10671503, HPA037498: "	"unprognostic (2.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"prognostic unfavourable (1.78e-5)"	"unprognostic (3.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	6.7	8.0	8.6	11.8	9.2	7.0	9.3	10.1	10.9	9.9	7.9	10.3	7.1	8.1	17.2	10.2	8.9	13.4	8.1	5.0	6.1	4.1	7.2	6.3	6.6	8.2	5.9	5.1	18.2	8.5	8.4	9.9	5.9	7.2	9.2	6.3	8.4	11.2	5.9	5.9	7.5	8.6	9.1	4.7	7.8	7.7	21.5	8.6	7.6	12.7	4.2	9.0	10.2	10.8	4.7	2.1	1.5	1.1	0.7	6.0	1.2	4.4	6.1	15.5	8.7	4.6	6.1	7.8	6.0	1.5	2.8	4.4	8.2	6.4	4.4	4.6	1.8	8.9	4.9	4.3	4.5	5.9	8.8	8.4	11.1	5.3	3.3	4.6	1.2	5.9	3.7	3.8	4.5	5.7	19.4	9.1	4.7	6.6	2.9	11.4	7.3	5.4	7.7	5.4	6.5	3.6	3.9	8.8	10.6	4.9	3.6	3.7	4.4	7.8	5.5	4.2	5.3	6.2	6.9	8.7	3.4	9.8	5.2	9.1	7.3	0.2	1.1	1.5	1.9	0.7	3.2	2.1	2.0	2.5	1.1	4.7	6.0	1.7	0.5	0.7	0.5	2.1	1.2	1.2	8.6	9.2	10.1	10.9	6.1	4.1	5.9	5.1	7.2	8.6
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: , HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	12.5	13.5	7.7	10.6	10.7	3.3	12.2	8.4	9.7	10.5	7.7	6.8	9.7	7.3	12.6	6.5	13.3	10.5	4.6	8.7	7.1	6.4	8.5	14.8	7.3	15.5	6.9	6.2	12.1	21.4	16.3	14.8	8.4	8.3	8.4	10.8	6.6	9.8	8.1	25.4	10.5	6.8	11.7	6.2	8.5	9.3	14.9	6.9	15.2	11.1	9.5	15.2	10.2	9.1	8.7	11.9	0.5	6.6	7.9	12.4	6.3	15.0	9.6	9.6	14.5	10.4	8.6	11.1	10.5	6.9	12.3	10.8	10.0	5.0	17.8	14.5	7.8	10.1	23.7	12.1	19.6	14.6	12.3	16.7	10.2	8.1	8.6	31.3	8.9	8.4	8.7	15.5	23.6	11.7	20.3	8.8	10.7	8.7	14.9	7.2	34.4	15.3	14.2	33.2	13.5	6.1	10.0	14.8	13.5	12.0	14.9	17.0	5.9	13.1	10.3	9.2	14.7	16.8	23.5	12.9	15.1	27.9	13.5	20.2	23.8	0.1	6.0	0.5	8.8	6.1	11.4	8.7	8.0	10.3	11.9	7.9	12.4	11.3	0.5	7.9	6.6	6.6	10.7	6.3	7.7	10.7	8.4	9.7	7.1	6.4	6.9	6.2	8.3	6.9
WDR33	"FLJ11294, NET14, WDC146"	ENSG00000136709	"WD repeat domain 33"	Q9C0J8	2	127701022-127811187	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026897, HPA046527"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA026897: AB_1858803, HPA046527: "	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.32e-2)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-2)"	19.8	19.2	18.1	22.5	22.5	18.8	21.7	51.4	24.3	20.9	19.8	22.0	22.8	18.2	32.2	19.0	20.6	18.6	17.9	16.8	17.7	16.5	22.3	32.3	18.5	25.0	19.4	14.5	29.2	21.8	26.4	41.8	20.9	22.0	21.9	19.5	24.4	25.3	17.4	22.0	27.8	21.3	21.0	22.2	28.1	18.0	24.5	20.8	39.5	25.2	16.6	30.5	21.5	22.4	24.4	21.6	26.7	18.3	25.9	26.3	14.4	18.2	10.3	18.1	14.6	10.8	11.2	18.7	16.8	13.4	17.7	16.8	24.0	14.1	23.2	18.6	11.0	14.9	20.4	14.1	23.3	21.2	12.1	22.3	13.1	25.6	12.1	26.8	16.7	10.9	15.0	16.9	14.5	15.0	18.5	20.8	12.4	11.5	27.8	19.7	21.9	11.8	19.5	18.3	18.3	10.1	23.8	16.9	13.2	15.0	13.9	11.8	10.7	15.7	14.0	14.0	20.5	15.6	14.3	20.4	31.0	44.2	11.4	10.8	12.9	21.2	16.7	26.7	21.5	18.3	21.9	24.4	21.9	20.6	21.6	23.0	23.3	22.1	11.4	25.9	18.2	15.8	26.3	14.4	18.1	22.5	51.4	24.3	17.7	16.5	19.4	14.5	22.0	20.8
WDR36	"GLC1G, TA-WDRP, UTP21"	ENSG00000134987	"WD repeat domain 36"	Q8NI36	5	111091716-111130502	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Sensory transduction, Vision"		"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037796, HPA037797"	Supported		Supported	Nucleoli				Nucleoli		"HPA037796: , HPA037797: AB_10672725"	"unprognostic (2.14e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (4.91e-2)"	30.6	12.3	8.2	15.4	12.2	17.5	15.2	14.5	14.6	15.9	12.2	9.3	10.2	9.6	19.0	11.8	18.4	13.9	11.5	11.7	8.2	9.7	14.8	24.6	12.4	18.7	8.8	11.1	20.6	15.0	14.8	19.1	15.3	13.5	15.0	12.8	9.3	13.6	11.0	17.0	15.2	13.7	14.5	8.9	21.7	12.2	11.3	9.4	24.3	16.7	12.9	18.4	13.8	14.7	6.7	9.9	2.5	10.1	6.0	9.4	6.4	10.0	11.3	8.0	20.8	12.6	17.6	13.3	8.4	8.7	12.7	18.8	13.1	12.0	30.2	11.0	6.8	11.1	16.4	19.8	22.3	10.8	9.1	16.6	11.2	10.1	13.2	15.1	30.5	10.0	10.9	22.3	22.3	14.8	19.8	15.4	13.6	8.4	19.8	11.5	10.3	10.0	16.3	18.5	23.4	8.8	13.2	14.2	10.7	11.3	8.2	12.4	9.4	10.2	10.3	16.6	10.9	12.2	17.5	12.5	11.7	32.6	12.8	20.2	13.3	0.2	6.4	2.5	7.8	8.6	9.2	6.7	6.7	8.7	9.9	5.9	9.4	7.8	0.4	6.0	10.1	4.3	9.0	6.4	8.2	12.2	14.5	14.6	8.2	9.7	8.8	11.1	13.5	9.4
WDR4	"TRM82, TRMT82"	ENSG00000160193	"WD repeat domain 4"	P57081	21	42843094-42879568	"Predicted intracellular proteins"	"DNA damage, tRNA processing"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017381	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA017381: AB_1858807"	"unprognostic (3.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (5.48e-7)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.46e-2)"	9.1	9.3	8.4	14.2	8.4	12.1	7.5	9.3	11.1	7.6	7.2	6.7	6.5	10.7	12.5	5.1	17.4	8.2	8.1	6.1	8.3	4.9	7.3	12.2	7.8	18.2	8.9	8.4	9.7	22.0	6.9	8.4	8.9	8.5	7.0	7.0	6.8	11.8	8.4	13.1	10.2	7.5	7.4	6.6	11.7	7.3	10.9	9.6	10.1	9.3	11.3	17.0	8.5	11.1	7.5	9.1	0.2	8.8	4.4	5.5	4.4	14.4	20.4	5.5	7.8	3.3	3.6	13.2	8.4	3.0	7.1	4.6	20.4	7.5	24.2	4.9	6.0	8.1	18.9	10.7	5.1	7.8	18.0	24.3	21.3	17.2	5.8	14.9	6.1	2.0	4.7	9.7	7.1	9.3	29.3	9.0	6.2	12.1	15.4	8.5	13.7	20.0	16.9	3.3	23.9	5.4	8.9	12.9	8.4	8.8	13.1	4.2	8.6	11.6	6.8	11.1	7.4	5.1	16.8	12.4	8.6	19.6	5.4	23.8	13.0	0.0	5.4	0.2	3.5	8.8	4.7	7.5	4.7	4.3	9.1	7.2	4.8	4.9	0.0	4.4	5.0	4.4	5.5	4.4	8.4	8.4	9.3	11.1	8.3	4.9	8.9	8.4	8.5	9.6
WDR44	"DKFZp686L20145, RAB11BP, RPH11, SYM-4"	ENSG00000131725	"WD repeat domain 44"	Q5JSH3	X	118346073-118449961	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038084, HPA046719"	Approved		Supported	"Golgi apparatus"			1500000	"Golgi apparatus"		"HPA038084: AB_10675626, HPA046719: "	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.52e-2)"	14.3	14.9	17.7	13.3	25.0	9.2	12.6	19.9	19.5	15.2	13.5	20.4	13.1	14.0	16.0	12.2	19.8	12.9	20.4	13.9	16.3	15.0	10.8	21.5	13.4	15.4	21.8	16.6	15.2	11.6	25.9	19.9	12.4	17.0	13.6	11.0	9.9	12.8	19.3	17.1	9.8	14.2	22.5	18.0	13.2	15.1	16.3	22.7	17.6	12.3	9.9	15.2	15.9	14.8	5.9	7.7	10.7	7.7	10.7	10.6	5.9	11.0	6.5	7.1	4.0	12.1	10.0	3.9	17.5	12.3	12.8	18.1	4.4	12.8	3.2	10.3	12.5	8.7	13.8	8.3	14.7	12.5	6.1	12.6	17.1	2.8	8.4	7.8	8.8	5.8	9.0	12.1	8.1	11.3	9.9	11.1	12.1	5.4	6.1	4.7	12.8	10.6	4.9	6.1	4.8	10.4	7.1	3.0	4.8	16.6	5.9	5.4	5.2	5.7	14.2	9.5	3.7	12.8	9.8	4.2	6.6	4.5	8.0	9.4	6.3	9.5	4.9	10.7	8.8	7.4	8.9	5.9	7.3	8.7	7.7	5.2	8.5	9.2	3.0	10.7	7.7	5.6	10.6	5.9	17.7	25.0	19.9	19.5	16.3	15.0	21.8	16.6	17.0	22.7
WDR48	"KIAA1449, P80, SPG60"	ENSG00000114742	"WD repeat domain 48"	Q8TAF3	3	39051998-39096671	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038421, HPA058015"	Approved		Supported	Vesicles				Vesicles		"HPA038421: AB_10670780, HPA058015: AB_2683580"	"unprognostic (1.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.14e-3)"	"unprognostic (9.87e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-2)"	"prognostic favourable (1.63e-7)"	"unprognostic (2.41e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.69e-2)"	16.0	15.0	16.3	9.2	22.0	22.3	13.9	22.3	24.2	15.4	14.0	15.4	19.0	10.1	19.9	9.1	11.9	14.1	10.5	11.8	16.4	14.0	16.5	11.9	10.5	12.1	17.3	16.3	17.0	12.1	21.1	20.2	16.0	20.4	14.5	12.4	9.4	14.0	17.4	14.7	11.3	12.0	14.4	17.4	10.9	11.9	36.8	18.0	21.9	20.4	7.0	15.2	22.6	11.9	12.2	10.1	16.7	12.8	14.9	13.2	9.7	4.8	7.9	16.9	9.8	11.2	13.2	6.4	7.5	10.4	9.8	12.2	5.5	5.3	14.5	4.5	10.0	5.8	15.1	9.6	10.4	35.1	17.4	13.0	11.9	7.3	4.5	9.6	5.8	8.7	8.8	11.0	11.6	10.5	14.7	12.5	7.0	4.4	9.9	3.6	15.6	9.8	4.1	8.6	9.9	8.4	11.2	11.7	13.3	6.4	11.9	9.2	6.8	9.6	9.0	7.4	5.3	7.2	7.1	12.7	21.9	10.5	8.0	7.2	6.5	16.7	6.6	7.2	11.2	9.6	10.5	10.9	11.5	12.4	10.1	12.2	12.4	10.7	9.3	14.9	12.8	6.7	13.2	9.7	16.3	22.0	22.3	24.2	16.4	14.0	17.3	16.3	20.4	18.0
WDR5	"CFAP89, SWD3"	ENSG00000196363	"WD repeat domain 5"	P61964	9	134135365-134159968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047182			Supported	Nucleoplasm				Nucleoplasm		"HPA047182: "	"unprognostic (9.28e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.26e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.88e-2)"	14.0	14.3	18.5	18.5	18.1	17.2	27.8	23.1	19.4	14.8	14.3	11.5	13.2	17.5	18.5	12.4	21.0	15.6	13.6	12.4	12.3	10.8	11.8	20.8	13.0	16.0	14.4	15.4	19.1	21.4	16.2	17.6	14.7	12.7	13.3	14.3	10.2	16.9	19.6	32.9	20.5	16.9	13.9	10.0	13.7	15.4	41.6	14.2	19.6	14.3	18.5	17.4	15.2	22.9	7.1	11.3	1.8	10.5	5.3	8.5	7.0	15.4	19.0	18.2	20.7	9.9	11.0	28.9	15.7	10.4	21.5	14.7	22.1	12.8	24.7	10.0	12.7	38.7	24.6	16.1	17.6	16.5	16.8	14.2	29.7	17.8	10.6	31.8	15.0	10.6	15.3	16.0	19.8	14.2	26.4	13.9	14.9	41.3	27.1	26.1	23.1	24.0	29.7	36.9	23.3	10.5	15.2	30.5	15.9	23.6	18.6	10.4	25.5	28.1	12.3	22.1	20.3	20.2	25.2	7.3	13.8	26.8	12.8	21.7	17.7	1.0	10.5	1.8	8.1	6.6	8.0	5.4	8.1	8.2	11.3	7.1	8.5	6.4	0.9	5.3	5.4	9.4	7.1	7.0	18.5	18.1	23.1	19.4	12.3	10.8	14.4	15.4	12.7	14.2
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: , HPA075133: "	"prognostic unfavourable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	17.9	12.4	7.6	17.8	8.8	18.1	12.9	13.0	12.7	9.5	16.6	11.4	16.9	14.9	12.0	11.0	18.8	10.9	20.2	9.6	7.7	9.1	15.3	29.9	12.7	15.0	12.6	8.5	12.0	16.2	11.4	13.2	13.9	10.6	12.8	17.5	8.9	16.7	14.8	18.2	15.8	20.8	11.1	8.9	18.8	14.9	8.0	8.5	12.5	12.0	14.0	21.4	13.5	11.0	10.4	11.3	10.4	18.9	11.3	14.3	10.2	7.8	10.8	5.3	21.0	8.2	6.6	14.7	7.8	9.6	8.4	9.6	18.5	10.8	7.4	10.5	10.2	9.8	7.1	13.7	6.5	6.8	5.8	8.4	8.8	7.5	7.9	8.8	15.9	7.8	8.0	11.5	6.1	8.9	5.8	5.8	9.2	11.2	8.1	7.9	5.5	9.5	6.9	7.6	6.9	9.9	11.9	5.2	6.9	10.7	31.5	11.9	22.3	9.4	7.9	11.0	5.7	12.5	10.6	9.7	7.5	5.8	14.2	11.7	6.4	6.9	11.7	8.6	13.9	18.9	14.3	10.4	12.9	11.8	11.3	8.8	10.5	10.7	10.4	11.3	15.4	8.4	14.1	10.2	7.6	8.8	13.0	12.7	7.7	9.1	12.6	8.5	10.6	8.5
WDR6		ENSG00000178252	"WD repeat domain 6"	Q9NNW5	3	49007062-49015953	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042622	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA042622: AB_10966784"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.97e-6)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.94e-2)"	"prognostic favourable (4.52e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	15.8	36.7	21.5	26.1	23.5	14.9	19.7	29.9	29.9	32.7	31.0	30.8	56.4	27.5	39.0	37.0	18.7	33.1	32.6	20.4	20.1	20.4	26.0	22.0	21.1	28.2	22.8	26.9	60.9	46.0	56.7	55.8	24.3	22.1	39.0	22.1	34.3	33.4	54.4	23.9	26.6	28.3	40.8	17.5	29.1	24.7	23.7	22.1	26.9	50.7	20.3	25.1	31.2	24.6	12.3	14.4	10.3	12.9	11.7	18.9	12.0	17.4	24.1	39.9	33.8	26.8	21.9	27.0	26.1	21.6	29.5	24.0	21.4	25.3	28.1	16.7	41.6	20.0	31.8	36.5	21.1	22.3	21.1	26.6	59.1	28.1	27.2	27.4	12.0	39.3	26.3	27.2	20.6	21.5	15.1	30.1	26.7	34.7	31.8	31.3	35.4	22.4	18.7	17.1	17.7	35.0	51.9	19.4	36.4	19.6	16.1	11.3	28.0	22.0	28.7	22.0	35.4	21.3	34.6	53.2	22.7	24.4	29.8	35.2	15.7	3.7	9.1	10.3	16.9	12.9	18.9	12.0	12.5	12.9	11.3	12.3	14.7	10.9	3.4	11.7	6.5	14.4	10.5	12.0	21.5	23.5	29.9	29.9	20.1	20.4	22.8	26.9	22.1	22.1
WDR61	REC14	ENSG00000140395	"WD repeat domain 61"	Q9GZS3	15	78277835-78299794	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039932, HPA040065"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039932: AB_10796336, HPA040065: AB_10793926"	"unprognostic (1.08e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.74e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.72e-2)"	"prognostic favourable (2.03e-10)"	"unprognostic (1.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.09e-2)"	23.8	34.3	23.5	17.2	31.2	29.6	34.5	25.2	32.1	24.3	22.0	27.6	22.7	20.3	24.2	69.4	25.9	27.4	19.6	23.1	23.7	28.2	34.2	28.2	22.4	18.7	26.8	23.1	20.7	30.7	22.4	37.7	27.7	30.8	27.4	25.7	24.9	28.1	23.1	26.3	29.9	18.5	23.6	27.8	18.6	20.9	38.5	20.9	26.9	32.5	30.1	24.6	19.1	20.3	21.9	45.2	11.1	32.4	22.7	25.2	28.7	9.2	23.6	18.6	19.2	18.4	17.0	14.1	14.1	15.9	18.0	17.7	22.5	16.9	17.8	17.7	16.1	19.7	39.5	17.1	14.9	11.5	31.0	14.3	21.8	21.7	16.1	22.1	16.1	13.1	13.2	7.0	6.0	20.3	26.2	20.0	23.5	28.9	19.3	21.5	13.7	19.0	17.9	14.1	21.7	20.9	28.8	26.0	14.2	19.3	21.8	77.1	14.0	30.5	12.1	14.1	16.7	10.1	24.3	17.2	25.9	25.2	20.5	35.9	28.1	11.1	31.6	10.5	21.5	32.4	23.2	21.9	21.6	22.3	45.2	16.9	23.0	25.2	2.6	22.7	26.3	24.2	23.5	28.7	23.5	31.2	25.2	32.1	23.7	28.2	26.8	23.1	30.8	20.9
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054881-36105106	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 25.6;testis: 88.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	9	"monocytes: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA043255: , HPA043639: "	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.5	0.2	0.2	3.3	0.4	4.3	0.6	0.4	0.5	0.4	0.5	0.4	0.4	0.4	0.4	0.8	1.0	0.2	0.5	5.5	0.5	0.2	0.5	0.3	0.5	1.4	0.2	0.2	0.4	0.2	0.0	0.3	0.7	0.4	0.3	0.3	0.3	0.6	0.2	25.6	1.4	0.7	0.4	0.5	1.1	0.3	88.4	0.3	10.3	0.2	1.3	3.0	0.3	0.7	0.1	0.1	0.0	3.7	0.0	0.3	0.2	10.7	21.5	8.4	7.7	0.5	0.7	4.2	9.3	4.4	13.0	11.7	11.2	4.2	14.0	6.4	4.9	3.7	7.8	3.0	7.7	8.8	5.5	9.5	12.2	7.2	0.1	10.3	14.3	0.2	0.2	9.8	3.9	3.2	12.2	19.2	6.5	13.4	18.0	6.2	4.6	4.5	15.1	7.8	5.6	1.9	4.9	9.4	4.8	7.6	8.7	1.5	5.9	7.5	2.6	13.0	12.8	9.8	15.4	9.3	11.6	16.6	5.2	9.9	14.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.3	0.2	0.2	0.4	0.4	0.5	0.5	0.2	0.2	0.2	0.4	0.3
WDR74	FLJ10439	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	14.2	13.2	12.6	19.7	13.8	77.4	14.2	14.6	21.5	12.5	12.5	10.9	8.7	10.8	14.1	10.2	16.1	15.1	12.8	12.6	12.2	11.9	15.5	19.7	10.0	18.1	15.4	16.5	17.4	20.6	9.4	8.0	11.9	13.6	12.5	11.2	8.0	16.5	9.8	42.1	19.8	10.6	11.5	9.5	18.0	13.4	23.5	16.6	16.0	20.0	19.1	16.0	12.4	14.0	39.1	44.8	15.9	34.8	26.8	16.7	11.9	16.2	19.5	7.7	12.7	6.3	8.7	23.7	9.1	9.9	19.9	13.3	28.6	19.9	28.6	26.0	7.5	21.7	23.5	18.2	15.6	18.2	17.3	14.4	21.6	24.7	18.6	28.6	9.5	8.4	20.5	12.6	42.2	9.7	31.4	8.5	9.0	31.2	27.3	45.5	31.2	26.1	27.9	13.1	49.8	14.1	9.3	17.1	19.2	10.5	21.8	29.4	15.3	22.1	6.9	11.6	14.0	26.1	22.9	21.2	29.4	34.7	12.9	17.5	15.1	8.7	34.8	3.2	11.7	16.9	14.7	18.6	12.1	11.0	29.2	39.1	16.7	14.8	15.9	26.8	11.3	44.8	13.7	11.9	12.6	13.8	14.6	21.5	12.2	11.9	15.4	16.5	13.6	16.6
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 68.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favourable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	11.2	16.5	10.0	17.3	16.2	5.9	9.7	8.5	18.1	9.8	10.9	14.3	5.7	9.5	13.9	15.7	19.0	68.6	15.7	16.6	9.9	10.8	13.6	19.2	9.9	16.8	12.1	9.6	14.6	14.0	15.1	11.7	12.1	15.8	12.6	16.6	10.3	16.4	13.4	27.2	8.9	11.1	13.0	7.9	16.5	14.5	12.9	9.3	19.3	9.9	23.2	22.7	19.1	11.0	24.9	25.7	6.2	17.7	26.7	16.1	11.9	20.4	18.0	17.2	14.1	10.4	6.1	23.9	15.5	8.3	23.8	15.7	26.4	7.7	35.0	15.2	13.2	14.9	31.0	29.8	28.8	13.9	24.3	20.8	21.0	37.9	11.7	21.3	35.6	7.4	21.3	23.3	15.0	15.8	27.8	9.3	23.0	25.9	27.3	11.2	33.8	30.2	27.4	27.1	13.4	21.1	36.4	14.2	10.3	13.6	17.2	12.3	13.8	14.7	11.5	13.2	26.6	25.6	32.9	7.7	9.6	31.5	16.7	24.0	38.7	6.2	11.6	2.9	13.9	17.7	15.5	24.9	15.1	15.5	25.7	21.6	16.1	15.0	1.7	26.7	15.5	16.1	12.5	11.9	10.0	16.2	8.5	18.1	9.9	10.8	12.1	9.6	15.8	9.3
WDR82	"MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A"	ENSG00000164091	"WD repeat domain 82"	Q6UXN9	3	52254421-52288020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040427			Supported	Nucleoli				Nucleoli		"HPA040427: "	"unprognostic (7.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.26e-1)"	27.5	28.4	33.8	31.5	38.4	33.1	27.9	58.7	42.9	36.8	29.0	24.1	23.4	23.3	40.3	23.5	34.1	32.0	30.3	34.5	32.0	36.6	21.3	22.5	24.8	39.3	26.9	35.8	40.6	19.5	29.1	19.9	29.8	27.9	30.2	28.1	28.2	26.0	36.6	49.8	29.2	24.9	37.1	26.4	34.1	22.8	25.4	25.2	63.5	28.7	29.7	40.7	31.7	37.0	7.9	5.6	12.5	9.6	7.4	17.0	7.9	14.3	17.4	32.8	24.5	31.3	26.1	16.5	24.6	20.5	24.3	20.2	20.2	14.4	38.2	9.6	26.2	13.1	44.9	26.3	28.5	27.7	17.2	49.0	22.1	20.7	21.8	46.0	25.9	26.1	26.1	28.5	26.2	25.5	21.8	27.6	23.4	14.5	35.6	18.2	29.7	33.7	18.4	21.9	28.4	25.3	26.5	7.8	33.0	26.3	8.0	15.1	15.0	18.6	26.1	22.9	26.1	23.8	28.2	27.0	39.4	38.8	19.5	35.1	24.9	6.8	6.4	8.2	14.1	6.4	17.0	7.9	12.9	13.7	5.6	6.1	15.1	15.2	12.5	7.4	9.6	5.4	10.8	7.9	33.8	38.4	58.7	42.9	32.0	36.6	26.9	35.8	27.9	25.2
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234516-27308633	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favourable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	14.7	17.5	20.2	11.1	22.0	13.2	12.1	21.8	28.4	15.0	15.3	20.7	14.1	13.3	14.5	9.1	12.4	21.1	11.0	29.1	18.0	15.0	13.6	13.0	14.3	13.3	15.8	16.1	15.8	22.3	49.3	12.3	10.9	19.7	14.3	10.1	29.6	20.6	16.5	51.1	20.9	14.2	12.8	15.1	13.2	15.2	28.3	16.5	21.0	19.4	12.1	14.0	15.0	12.3	1.3	1.5	5.6	0.8	0.8	3.3	1.2	13.0	5.7	9.3	0.9	13.3	11.1	3.9	8.1	13.6	8.7	10.6	1.9	13.1	11.0	9.8	16.0	6.8	8.7	12.3	7.5	15.3	14.9	11.5	6.5	5.2	12.0	5.9	15.6	10.5	20.1	10.8	9.9	11.8	11.7	11.9	9.1	7.2	9.6	14.4	4.4	12.4	4.8	6.9	12.3	10.2	2.9	13.7	11.8	10.5	4.5	9.5	6.7	10.4	10.0	7.1	4.4	10.0	3.9	17.2	9.2	5.4	14.6	11.4	8.5	0.3	0.5	5.6	3.3	0.8	1.3	1.3	0.8	1.4	1.5	0.8	0.6	1.5	4.8	0.8	0.6	1.0	0.9	1.2	20.2	22.0	21.8	28.4	18.0	15.0	15.8	16.1	19.7	16.5
WDYHV1	"C8orf32, FLJ10204"	ENSG00000156795	"WDYHV motif containing 1"	Q96HA8	8	123416725-123467230	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: "	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	10.5	15.5	13.2	7.9	13.6	6.3	17.2	14.3	16.8	14.5	9.9	13.9	10.7	5.8	11.2	12.0	10.2	9.8	8.8	24.8	12.8	19.8	13.6	9.1	8.6	11.4	17.0	10.8	20.4	21.3	9.0	12.8	8.2	16.2	13.5	9.5	9.7	8.3	12.5	19.2	9.8	5.4	13.0	17.0	7.9	10.0	17.5	15.6	5.3	14.4	9.1	11.3	10.1	9.1	5.9	7.2	8.7	7.5	13.1	9.2	5.5	9.1	10.8	12.7	6.7	5.5	12.6	5.7	7.6	6.7	7.2	9.2	6.4	6.1	7.3	6.9	5.3	5.3	8.1	8.8	9.7	17.2	7.1	7.9	5.2	8.7	7.8	3.0	3.4	8.5	5.4	9.6	11.8	7.2	5.9	10.1	10.6	28.6	8.8	6.2	5.1	7.4	5.1	8.0	5.8	9.7	8.1	6.5	14.1	7.8	39.8	12.1	6.6	3.3	3.9	9.6	15.1	7.1	9.2	7.6	15.4	9.0	7.8	4.6	6.0	8.7	6.3	2.5	7.8	7.5	8.4	5.2	8.4	7.3	7.2	5.9	6.5	7.4	1.8	13.1	4.0	4.6	9.2	5.5	13.2	13.6	14.3	16.8	12.8	19.8	17.0	10.8	16.2	15.6
WEE2	FLJ16107	ENSG00000214102	"WEE1 homolog 2"	P0C1S8	7	141708353-141731271	"Enzymes, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 8.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.6	0.1	0.5	0.3	1.0	0.0	0.4	0.8	0.6	0.6	0.1			0.0	0.7	0.0	1.3	0.7	1.6	1.3	0.5	0.6	1.3	0.1	0.3	1.6	0.6		1.2	1.1	0.0	1.0	0.0		0.3	0.0		0.9	0.0	0.7	2.8	0.4	0.0	0.8	0.4	0.8	1.3			2.0		0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.0	0.3	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.5	1.6	1.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.2	0.1	1.7	1.1	0.5	0.0	0.3	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.4	0.6	0.0	0.1	0.1	0.6	0.0	0.5	0.0	0.0	0.2	0.0										
WHAMM	"KIAA1971, WHAMM1, WHDC1"	ENSG00000156232	"WAS protein homolog associated with actin, golgi membranes and microtubules"	Q8TF30	15	82809628-82836108	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039690, HPA040231"	Supported		Supported	Cytosol				Cytosol		"HPA039690: AB_10795405, HPA040231: AB_10795361"	"unprognostic (7.98e-2)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.20e-2)"	10.6	6.6	7.9	9.8	11.7	44.5	10.1	14.0	9.5	8.7	8.8	11.2	7.7	8.8	8.5	6.7	10.2	7.3	6.6	7.4	10.1	5.3	9.5	11.4	10.7	9.6	10.7	8.0	10.9	9.3	16.7	7.9	8.9	13.9	10.1	8.2	7.6	9.3	7.5	23.3	12.0	10.6	12.0	12.3	11.9	8.3	5.5	14.3	8.3	9.6	6.6	11.0	11.1	13.1	3.2	2.4	5.0	1.6	5.8	3.2	0.9	4.0	4.1	2.6	3.9	8.4	5.9	4.4	5.7	5.7	6.2	6.2	2.7	7.4	8.8	7.1	5.2	9.0	7.9	4.5	4.1	2.9	4.5	5.0	4.7	4.0	8.6	3.6	6.0	5.8	6.2	3.0	6.2	4.4	4.5	11.6	6.2	3.1	3.0	5.2	1.1	2.5	4.4	5.6	2.4	10.8	16.4	2.5	2.0	8.7	5.8	5.8	3.9	7.7	7.0	8.3	2.9	5.5	6.4	12.6	7.1	4.3	5.9	5.0	5.2	5.0	1.6	1.3	3.2	1.1	2.9	2.6	3.1	2.4	1.0	3.2	2.9	2.9	3.6	5.8	1.1	2.4	2.4	0.9	7.9	11.7	14.0	9.5	10.1	5.3	10.7	8.0	13.9	14.3
WIPF2	"WICH, WIRE"	ENSG00000171475	"WAS/WASL interacting protein family member 2"	Q8TF74	17	40219304-40284136	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024000, HPA024001, HPA024467"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA024000: AB_1858840, HPA024001: AB_1858841, HPA024467: AB_1858842"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (9.23e-2)"	13.0	9.4	21.0	11.5	21.6	18.8	10.7	23.0	27.4	12.8	17.3	15.8	11.1	14.8	13.2	11.7	18.9	11.9	12.4	7.9	22.3	16.8	15.6	9.4	15.4	9.5	16.7	18.5	10.3	13.7	19.3	10.6	14.5	16.1	11.0	17.1	9.4	12.2	13.4	7.6	18.8	16.2	15.0	13.8	14.1	15.8	9.5	17.7	8.3	11.2	8.1	13.3	12.4	20.4	4.3	4.1	11.4	3.2	3.8	5.3	1.5	11.0	16.8	7.3	6.8	7.7	8.1	7.3	9.8	6.8	8.9	9.5	8.2	9.5	6.3	11.1	11.6	18.8	6.2	7.4	12.1	11.3	7.5	6.8	8.3	9.8	7.8	8.9	7.8	6.4	9.5	9.4	10.5	8.6	6.5	5.9	8.5	6.3	8.8	4.5	4.4	5.2	5.7	8.8	6.3	9.5	17.3	9.0	6.3	17.5	47.6	6.4	16.1	5.6	12.4	6.1	9.2	11.5	11.0	6.7	10.2	6.6	13.4	4.8	9.0	6.8	3.2	3.5	5.3	2.9	4.6	4.3	3.2	3.4	2.4	3.7	3.7	3.3	11.4	3.8	3.2	4.1	3.8	1.5	21.0	21.6	23.0	27.4	22.3	16.8	16.7	18.5	16.1	17.7
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.5;ASC TERT1: 39.4;HHSteC: 49.6;HSkMC: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 25.0;eosinophil: 53.0"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favourable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	18.4	11.0	6.0	6.5	10.0	10.5	19.6	7.6	9.6	16.1	15.9	7.8	39.7	5.7	9.0	12.9	8.1	6.7	10.7	34.8	5.3	3.7	20.2	11.5	14.4	12.2	8.5	5.3	6.9	23.9	10.0	10.2	33.5	9.4	8.4	17.9	11.5	30.2	19.3	49.3	11.8	7.7	10.0	7.5	8.9	14.5	4.6	6.5	1.6	10.0	25.2	9.8	10.3	10.3	1.1	2.2	53.0	5.7	2.5	3.1	3.3	1.0	2.1	1.9	2.8	51.5	39.4	10.4	7.5	36.1	3.0	9.8	1.6	1.6	0.5	3.4	16.1	0.8	0.7	4.8	5.4	0.9	0.9	7.4	0.7	9.2	49.6	0.5	10.8	41.4	8.9	12.0	16.5	13.6	0.4	18.8	9.1	6.4	0.1	1.4	0.3	3.2	0.1	6.6	7.3	4.6	3.7	0.5	2.5	1.7	23.6	38.3	12.2	2.1	12.9	15.0	2.2	6.9	1.8	16.5	18.6	2.2	22.6	3.6	6.6	25.0	4.6	53.0	3.1	5.5	1.4	1.1	0.8	3.0	2.2	0.4	0.0	1.5	9.7	2.5	5.7	1.5	0.6	3.3	6.0	10.0	7.6	9.6	5.3	3.7	8.5	5.3	9.4	6.5
WIZ	ZNF803	ENSG00000011451	"Widely interspaced zinc finger motifs"	O95785	19	15419980-15449951	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: "	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	28.0	17.5	27.6	18.3	21.6	13.6	20.9	15.8	24.4	17.5	17.3	12.8	18.0	18.2	25.2	12.0	16.3	16.3	15.3	17.3	23.0	11.4	13.8	18.4	13.5	17.5	14.1	19.0	21.6	26.9	14.3	10.9	13.7	13.7	17.4	7.7	12.4	21.9	23.1	24.4	21.5	16.8	16.5	11.9	18.0	15.6	40.9	15.8	18.6	13.3	14.6	12.1	19.3	21.4	2.0	1.5	0.7	3.6	2.5	1.2	0.5	13.5	9.2	13.3	16.9	19.2	7.9	10.8	14.2	6.9	11.8	8.2	8.1	25.3	11.2	23.3	12.8	11.5	7.3	9.9	2.9	8.7	12.5	8.2	7.2	6.4	12.2	9.4	12.2	13.9	13.1	8.5	9.3	10.6	12.7	9.7	8.0	27.4	17.0	8.7	18.0	22.1	15.9	6.1	11.3	7.7	10.5	18.2	23.1	12.4	11.3	9.1	12.4	8.9	17.1	27.1	10.8	21.3	18.0	14.3	8.5	12.1	11.3	11.3	18.2	0.0	1.4	0.0	1.2	1.2	1.0	0.5	0.8	1.2	1.0	2.0	1.0	1.0	0.7	2.5	3.6	1.5	0.8	0.5	27.6	21.6	15.8	24.4	23.0	11.4	14.1	19.0	13.7	15.8
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls"	ENSG00000116729	"Wntless Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 71.8;ASC TERT1: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 10.0;neutrophil: 29.1"	"Group enriched"	"Detected in many"	46	"granulocytes: 29.1;monocytes: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA069520: "	"prognostic favourable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favourable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favourable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (3.51e-4)"	13.7	17.2	33.5	14.3	39.0	1.5	14.5	6.8	26.6	20.0	28.3	25.8	51.6	9.1	19.5	55.1	26.7	19.9	37.1	24.1	23.1	25.4	36.8	8.9	20.3	6.9	27.0	18.6	31.4	34.7	12.1	9.8	29.2	44.5	29.0	22.8	37.8	14.5	47.4	5.3	19.3	14.1	46.2	30.5	10.8	24.4	12.2	22.3	1.9	8.9	13.5	8.2	29.6	17.0	0.0	0.4	29.1	10.0	0.0	0.0	1.9	2.0	3.0	71.8	0.0	39.8	55.6	41.6	9.9	24.5	13.9	19.3	4.3	4.7	0.0	10.0	2.8	20.8	16.1	16.3	11.8	0.1	12.0	0.0	8.6	0.0	34.8	0.0	0.1	39.7	11.0	34.0	11.2	32.5	0.0	0.1	20.4	0.3	0.0	0.2	3.2	4.8	0.0	15.1	0.0	2.4	10.7	4.0	8.4	9.1	0.4	11.9	1.9	0.3	37.7	13.3	10.7	21.3	13.4	4.8	0.1	0.0	30.7	0.3	24.3	0.0	10.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.1	0.0	0.3	0.1	0.0	1.9	33.5	39.0	6.8	23.8	23.1	25.4	27.0	18.6	44.5	22.3
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752593-911452	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046541, HPA059157"	Enhanced		Supported	Cytosol				Cytosol		"HPA046541: , HPA059157: "	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	30.0	12.4	49.3	19.1	47.5	28.9	45.4	22.5	36.7	21.2	12.6	42.6	10.6	8.5	15.9	19.4	45.5	16.9	16.5	38.5	53.7	36.4	45.6	18.0	33.0	34.3	62.3	27.1	18.5	11.3	29.1	12.7	20.3	41.4	17.1	14.3	12.0	15.4	20.3	43.4	31.3	10.3	22.3	82.8	16.9	15.7	23.8	38.8	23.9	16.7	17.4	24.5	18.9	26.5	3.7	2.6	10.9	7.1	2.1	5.2	1.9	14.2	27.0	35.7	3.3	25.8	24.8	13.6	14.2	17.1	15.4	14.4	15.2	16.3	20.1	5.0	30.5	10.8	24.1	16.4	21.7	34.8	14.4	44.9	35.9	13.1	18.9	24.2	19.6	19.2	25.0	25.5	45.8	20.8	20.4	48.6	23.3	13.1	43.5	4.1	29.1	6.5	20.8	39.6	5.4	22.2	30.9	10.4	12.2	33.2	21.5	9.6	23.7	24.9	23.0	19.1	22.2	26.8	20.9	7.4	12.3	30.5	18.2	12.8	15.5	0.9	2.7	2.6	3.8	4.0	5.2	3.0	4.3	3.6	2.6	3.7	2.3	4.1	10.9	2.1	7.1	1.7	4.9	1.9	49.3	47.5	22.5	36.7	53.7	36.4	62.3	27.1	41.4	38.8
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: "	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	6.9	6.9	8.1	10.3	8.0	13.3	6.8	11.8	10.7	7.4	7.2	10.6	6.8	6.8	8.4	8.4	7.9	25.6	7.7	6.8	7.5	6.6	9.4	6.6	8.7	12.7	7.9	5.8	7.8	12.0	6.1	7.6	8.1	7.8	5.3	7.3	7.8	6.6	6.6	9.8	8.1	7.7	7.8	5.4	12.5	7.2	11.4	8.3	22.8	7.6	6.6	12.8	7.5	6.2	4.7	6.6	20.0	5.8	4.2	8.5	3.5	11.0	20.8	15.0	15.0	4.5	4.2	8.8	7.2	7.7	23.6	22.1	12.1	6.9	13.4	7.6	6.4	12.4	17.2	12.7	18.3	8.0	22.3	6.1	13.8	10.1	4.1	4.7	8.0	3.3	5.0	20.8	4.8	15.3	5.8	4.4	9.4	10.1	13.7	11.5	8.0	10.4	18.1	9.9	7.8	8.7	4.0	6.9	10.5	11.4	6.1	6.0	8.3	5.0	5.3	9.4	10.0	0.0	18.6	3.5	8.8	7.0	8.5	8.1	11.4	20.0	5.2	4.6	5.4	5.8	6.3	3.3	4.2	6.0	4.7	4.7	3.8	4.4	2.7	4.2	2.3	6.6	8.5	3.5	8.1	8.0	11.8	10.7	7.5	6.6	7.9	5.8	7.8	8.3
WRN	"RECQ3, RECQL2"	ENSG00000165392	"Werner syndrome RecQ like helicase"	Q14191	8	31033801-31173769	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	10.1	9.2	5.6	8.5	6.6	15.6	11.1	10.7	7.3	14.2	8.0	7.7	7.7	5.5	24.4	8.8	7.6	9.7	6.9	7.0	5.9	4.0	5.1	7.7	7.2	6.7	8.2	5.3	12.0	9.9	7.8	28.1	8.5	7.0	8.6	7.8	8.3	10.8	7.8	7.7	10.2	7.0	12.1	14.9	8.9	8.3	10.4	7.3	11.8	7.9	6.3	9.3	10.8	8.7	3.9	2.7	1.3	1.9	2.9	6.2	1.6	6.4	6.3	13.1	8.3	7.8	12.5	8.3	7.3	7.1	8.9	9.3	4.0	3.9	15.1	6.7	7.3	3.3	8.1	5.2	13.4	4.2	6.9	15.4	6.0	3.3	9.8	9.1	5.7	9.1	5.8	8.5	10.2	8.6	24.3	9.6	8.2	4.1	18.9	4.4	11.2	4.6	10.9	9.9	6.0	3.7	7.0	2.8	7.5	8.8	5.0	6.9	3.5	4.5	13.7	9.7	6.0	5.0	6.1	2.5	2.7	19.0	7.2	7.2	6.6	1.2	1.9	1.3	3.3	1.9	6.2	3.9	3.8	3.3	2.7	3.5	2.5	3.2	0.5	2.9	0.8	2.0	2.8	1.6	5.6	6.6	10.7	7.3	5.9	4.0	8.2	5.3	7.0	7.3
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"Wilms tumor 1"	P19544	11	32387775-32435630	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 69.0;fallopian tube: 34.5;ovary: 53.4"	"Cell line enhanced"	"Detected in some"		"HEL: 13.2;HMC-1: 17.0;K-562: 11.9;NB-4: 31.9;THP-1: 15.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 0.5"	"Low region specificity"	"Detected in single"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000327: AB_2304486, HPA035717: , HPA053848: "	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	10.3	0.0	0.2	1.8	0.6	0.0	0.2	0.2	0.5	20.3	1.5	0.2	3.7	0.0	69.0	9.3	0.4	34.5	0.8	2.1	0.9	0.0	5.3	0.2	0.8	0.5	0.2	0.2	53.4	0.2	0.0	0.2	6.9	0.3	0.9	0.0	0.2	0.2	4.2	0.2	0.0	0.4	23.7	0.2	14.6	0.0	24.5	0.2	0.2	0.3	0.2	0.2	1.3	4.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.0	6.1	0.0	0.0	0.0	4.6	13.2	0.0	1.1	3.7	8.8	17.0	0.0	0.0	2.7	0.0	0.0	11.9	0.1	2.7	0.0	7.7	31.9	0.7	3.7	1.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	15.3	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.2	0.5	0.9	0.0	0.2	0.2	0.3	0.2
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavourable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	37.6	31.0	21.5	38.7	24.7	106.0	37.5	30.1	22.3	29.7	28.2	19.4	25.1	19.1	33.8	34.6	30.3	28.8	27.3	28.9	22.0	22.1	28.5	28.8	29.7	36.1	20.9	21.2	37.1	30.1	23.1	31.2	35.0	22.1	33.0	28.7	23.7	30.3	27.2	81.2	29.3	28.6	30.9	22.6	36.5	27.1	20.4	21.6	53.2	36.3	26.2	39.3	33.4	34.6	26.6	22.3	33.4	27.1	23.9	30.5	14.7	14.0	13.5	30.4	27.8	35.7	39.6	19.9	22.0	74.7	28.2	37.7	26.0	13.4	34.9	13.2	24.1	19.2	29.5	25.8	36.7	18.2	19.8	34.8	14.7	36.7	29.9	31.4	21.1	47.0	25.0	31.5	41.7	21.4	37.4	32.8	29.7	14.1	43.3	42.3	25.7	11.3	28.9	19.7	24.9	30.3	17.3	29.1	21.2	41.4	23.5	10.9	10.8	39.0	19.1	19.9	21.7	28.9	31.9	23.7	26.4	53.8	18.3	31.5	19.9	27.2	19.2	22.6	23.4	24.3	26.4	26.6	28.3	27.8	22.3	23.8	25.6	25.8	33.4	23.9	27.1	18.9	30.5	14.7	21.5	24.7	30.1	22.3	22.0	22.1	20.9	21.2	22.1	21.6
WWOX	"FOR, SDR41C1, WOX1"	ENSG00000186153	"WW domain containing oxidoreductase"	Q9NZC7	16	78099413-79212667	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	Oxidoreductase	"Disease mutation, Epilepsy, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050992	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA050992: "	"prognostic unfavourable (9.07e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.50e-2)"	"prognostic favourable (4.49e-5)"	"unprognostic (3.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.77e-1)"	13.2	7.4	19.2	10.5	17.9	5.3	11.9	21.5	14.6	8.9	5.9	20.5	14.8	8.9	12.6	17.1	11.6	13.4	10.0	6.1	17.0	17.7	19.2	17.8	7.1	6.5	19.7	12.5	9.4	10.5	22.3	11.5	7.6	16.1	10.9	5.3	11.4	10.6	15.4	4.9	9.6	7.2	11.9	20.9	5.4	7.6	15.8	17.9	10.3	29.4	4.9	8.9	8.7	8.6	8.5	13.8	5.4	8.8	7.8	12.3	5.4	5.0	4.4	4.9	3.1	5.2	2.3	5.3	0.7	1.5	1.7	1.5	3.4	4.3	9.3	3.8	0.7	4.3	2.4	0.6	1.2	4.9	12.7	3.0	0.8	7.1	3.9	7.7	1.5	2.8	1.8	1.1	1.0	2.1	4.1	1.9	1.2	39.5	13.2	10.5	4.3	2.6	14.1	1.9	9.4	2.4	1.7	8.0	5.2	3.1	5.7	1.7	5.7	5.4	0.5	1.3	4.5	1.0	2.9	0.0	8.7	19.1	5.0	3.9	2.1	5.4	8.8	1.9	10.5	7.2	12.3	8.5	8.5	9.2	6.8	6.4	8.4	8.9	0.8	7.8	5.0	13.8	12.3	5.4	19.2	17.9	21.5	14.2	17.0	17.7	19.7	12.5	16.1	17.9
WWTR1	"DKFZp586I1419, TAZ"	ENSG00000018408	"WW domain containing transcription regulator 1"	Q9GZV5	3	149517235-149736714	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 59.8;SK-MEL-30: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6;memory CD8 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007415, CAB017483, CAB068248"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB017483: AB_2216639, CAB068248: , HPA007415: AB_1080602"	"unprognostic (1.85e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.01e-3)"	25.1	9.9	9.3	16.0	18.6	0.2	20.4	7.7	10.5	27.2	38.5	18.4	15.0	5.6	27.2	17.6	41.2	16.4	25.8	20.6	14.7	9.0	31.0	13.1	29.8	6.2	15.2	5.6	30.9	21.7	10.4	8.5	29.0	20.7	34.6	9.1	29.4	15.8	22.4	12.1	13.4	11.7	81.5	25.8	13.8	20.8	12.0	16.4	0.7	18.2	13.2	7.1	68.4	31.0	0.2	0.1	0.6	0.1	0.1	2.8	0.4	16.5	19.7	10.5	13.9	12.5	22.4	11.0	9.6	14.1	4.4	4.6	11.0	14.0	0.0	59.8	10.8	9.8	6.8	7.0	4.3	4.6	5.2	0.0	5.1	9.1	7.1	0.0	0.0	11.8	1.8	15.2	6.6	33.9	0.0	0.0	15.1	2.2	0.0	0.0	2.4	24.9	0.0	14.0	0.1	37.2	2.4	0.0	0.1	6.3	4.5	41.3	7.6	0.3	27.6	8.6	4.1	6.9	18.8	0.1	0.1	0.2	18.4	0.0	21.8	0.4	0.1	0.1	2.6	0.0	0.0	0.0	0.3	2.8	0.0	0.2	0.1	1.3	0.6	0.1	0.0	0.1	1.9	0.4	9.3	18.6	7.7	10.5	14.7	9.0	15.2	5.6	20.7	16.4
XAB2	"HCNP, HCRN, NTC90, SYF1"	ENSG00000076924	"XPA binding protein 2"	Q9HCS7	19	7619525-7629565	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048751			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA048751: "	"unprognostic (1.13e-1)"	"prognostic favourable (4.04e-4)"	"unprognostic (1.99e-3)"	"prognostic favourable (4.96e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (7.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.80e-3)"	13.5	18.4	12.2	13.3	17.8	35.7	17.8	22.9	22.6	16.3	12.1	19.2	12.1	16.3	15.5	12.1	17.8	18.9	12.7	17.5	11.9	10.3	20.1	24.6	13.0	17.0	16.8	11.4	29.6	34.3	11.9	12.2	14.6	13.3	15.2	5.3	13.6	28.7	18.1	18.0	19.5	13.8	13.7	13.4	18.8	22.8	30.2	15.8	24.8	21.4	13.2	15.9	18.6	15.6	15.2	9.0	9.9	14.1	8.9	16.7	13.8	15.4	14.2	8.6	11.2	9.1	6.8	16.8	9.1	10.7	16.2	16.5	18.3	10.2	10.5	18.1	8.4	13.6	12.2	13.2	4.1	18.3	15.7	13.9	12.0	16.0	11.8	18.4	12.6	12.0	11.0	11.4	8.3	9.8	12.4	27.9	5.0	17.1	17.2	28.7	19.6	28.1	19.2	10.9	18.3	6.4	12.2	12.3	14.1	10.3	10.2	8.9	12.9	16.3	9.6	7.4	12.2	16.8	15.3	48.2	28.4	15.2	12.7	15.7	11.0	8.3	12.2	9.9	14.8	11.6	13.6	12.3	13.8	11.0	9.0	15.2	16.7	12.6	7.3	8.9	14.1	7.8	15.8	13.8	12.2	17.8	22.9	22.6	11.9	10.3	16.8	11.4	13.3	15.8
XAF1	"BIRC4BP, HSXIAPAF1, XIAPAF1"	ENSG00000132530	"XIAP associated factor 1"	Q6GPH4	17	6755447-6775647	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 32.7;BJ hTERT+ SV40 Large T+ RasG12V: 33.8;HHSteC: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA057302	Approved		Supported	"Nucleoplasm,Mitochondria,Rods & Rings"				Mitochondria	"Nucleoplasm, Rods & Rings"	"HPA057302: "	"unprognostic (6.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.09e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.08e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.73e-7)"	"unprognostic (2.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.15e-3)"	32.8	7.5	12.2	27.0	13.2	17.5	14.4	4.3	14.0	12.8	10.5	8.9	11.4	15.3	15.6	22.4	11.8	12.0	20.1	13.1	10.7	7.9	19.1	37.9	25.1	15.8	11.0	9.6	34.6	2.7	2.2	8.6	15.2	16.4	13.2	10.1	9.9	26.4	9.0	9.1	10.7	14.4	14.7	10.8	35.0	14.0	5.4	11.0	17.3	10.5	9.2	11.3	12.0	13.4	4.3	7.7	13.1	11.6	7.7	8.5	5.3	1.9	0.1	0.2	0.5	2.7	6.2	0.2	2.5	10.3	32.7	33.8	0.2	2.9	0.5	0.8	3.8	1.2	0.0	0.5	3.7	4.4	0.1	0.7	0.3	0.4	15.0	0.4	3.1	2.8	0.0	4.3	0.1	2.7	0.2	10.6	1.0	0.1	2.2	8.7	0.2	0.8	4.2	0.1	0.2	0.0	1.8	0.2	0.2	1.2	0.2	5.5	0.3	12.0	0.3	0.4	0.3	0.9	0.1	1.5	0.5	0.2	0.9	7.2	0.8	13.1	8.8	4.2	7.5	11.6	5.7	3.3	5.9	5.2	7.7	4.3	4.0	4.1	10.6	7.7	10.7	0.8	8.5	5.3	12.2	13.2	4.3	14.0	10.7	7.9	11.0	9.6	16.4	11.0
XIAP	"API3, BIRC4, hILP"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913979	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: "	"prognostic unfavourable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	17.4	14.4	20.0	18.1	20.2	12.0	15.9	21.3	18.9	17.2	19.4	14.5	22.9	16.1	17.4	17.0	18.9	12.6	14.7	15.7	18.9	22.1	19.8	19.4	16.5	15.5	18.8	14.6	13.9	19.7	36.6	26.1	18.2	15.9	15.6	16.8	16.9	14.6	22.9	21.5	14.2	23.4	17.0	19.0	15.8	16.2	7.0	12.3	13.9	24.3	11.4	14.0	15.4	20.5	5.7	4.3	11.1	3.9	3.3	5.5	1.9	11.5	9.9	7.8	6.7	9.2	11.9	10.2	12.6	9.4	6.9	5.9	4.4	13.6	10.8	18.7	10.7	4.3	11.5	7.9	12.7	11.2	6.3	7.3	8.3	6.7	11.7	13.2	15.2	8.2	12.3	11.4	14.7	9.5	11.5	12.5	13.3	12.0	7.3	6.4	6.4	7.8	7.9	9.1	11.4	10.4	16.8	5.3	7.7	17.2	10.0	10.1	6.1	6.5	11.7	0.3	4.7	20.6	14.0	10.5	10.5	12.0	14.2	9.4	8.7	11.1	2.6	3.5	5.0	2.3	4.7	4.6	3.8	5.5	1.4	5.7	4.4	3.0	8.2	3.3	3.9	4.3	2.5	1.9	20.0	20.2	21.3	18.9	18.9	22.1	18.8	14.6	15.9	12.3
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178783	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: , HPA069673: "	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favourable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favourable (2.46e-4)"	20.2	17.1	14.2	24.0	30.2	8.4	21.4	16.1	19.3	22.3	18.9	20.8	27.5	18.0	24.6	18.3	16.9	24.9	25.1	12.4	16.2	14.4	24.6	23.4	19.9	21.1	33.4	15.2	35.0	20.9	35.4	26.7	28.0	22.1	20.9	15.9	16.7	17.6	30.3	22.4	30.5	23.6	17.7	22.6	23.3	15.9	12.9	30.6	18.5	25.7	12.4	20.8	22.4	22.3	10.9	7.0	34.6	8.8	8.8	12.2	6.1	4.4	11.5	13.0	8.3	19.5	13.5	44.0	11.1	32.0	10.8	8.4	4.2	5.4	15.0	4.9	13.5	5.6	8.5	17.8	8.9	6.0	7.3	7.9	12.2	7.7	17.3	5.9	15.1	19.1	21.1	14.3	28.8	12.8	10.9	8.1	12.0	9.4	4.9	5.7	7.7	7.8	6.2	5.9	12.0	13.6	13.4	2.8	10.1	12.1	10.1	8.0	10.6	4.8	20.0	4.2	11.4	6.3	5.1	18.7	13.6	8.9	10.0	7.0	15.1	12.0	8.2	9.4	9.8	6.3	9.6	10.7	11.2	9.6	7.0	10.9	12.2	8.7	34.6	8.8	8.8	6.7	9.2	6.1	14.2	30.2	16.1	19.3	16.2	14.4	33.4	15.2	22.1	30.6
XPNPEP1	"XPNPEP, XPNPEPL, XPNPEPL1"	ENSG00000108039	"X-prolyl aminopeptidase 1"	Q9NQW7	10	109864766-109923553	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025196, HPA030419, HPA030420, HPA030422"	Supported		Enhanced	Cytosol			760000	Cytosol		"CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783"	"unprognostic (3.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (8.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.18e-2)"	16.6	14.7	13.4	16.1	18.9	12.8	13.6	14.8	22.2	15.7	20.6	19.5	14.1	33.2	17.5	16.1	17.8	15.8	20.3	17.8	13.7	11.4	18.3	21.0	14.8	14.9	13.8	14.0	17.8	46.0	14.9	15.9	19.0	17.2	16.0	26.9	15.6	19.6	11.3	18.5	20.4	38.6	18.6	11.9	18.0	16.8	15.1	12.0	9.9	15.7	15.2	24.2	14.1	13.8	5.5	24.0	10.0	21.0	14.7	10.6	13.4	25.3	11.2	17.9	24.4	29.2	27.5	13.7	14.2	28.9	21.3	23.1	21.7	21.9	36.3	12.3	21.8	13.5	14.2	17.5	20.9	10.7	13.6	24.2	7.3	9.0	20.4	18.8	20.2	27.0	10.9	23.4	20.8	34.9	7.8	11.6	27.0	8.6	13.4	11.7	7.0	12.1	15.1	36.1	6.5	27.0	8.0	5.4	20.8	12.3	7.8	23.6	9.5	17.6	17.9	8.7	11.4	13.7	12.4	19.8	9.6	31.0	20.5	26.4	6.8	10.0	13.7	5.6	10.6	21.0	7.3	5.5	7.0	9.5	24.0	4.8	5.0	6.6	1.1	14.7	17.5	18.8	7.5	13.4	13.4	18.9	14.8	22.2	13.7	11.4	13.8	14.0	17.2	12.0
XPO1	"CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61477849-61538626	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"			170000	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: "	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavourable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	20.7	27.9	36.1	28.1	39.6	21.6	35.1	41.5	36.3	28.2	23.2	19.5	26.0	16.5	35.7	35.3	26.1	36.0	20.3	20.1	33.0	19.2	19.5	22.2	22.0	34.5	42.0	19.5	45.0	34.6	33.4	27.6	30.8	33.6	25.8	24.5	18.0	20.2	29.9	34.9	29.8	25.0	28.4	32.1	24.5	21.9	32.1	39.3	51.1	28.2	16.4	35.7	26.0	57.8	6.1	5.4	12.6	5.1	6.2	5.1	2.5	38.8	34.7	47.1	35.3	21.4	28.7	34.7	43.0	27.7	45.2	38.8	46.1	29.2	57.0	30.1	29.4	33.0	71.8	29.8	66.7	34.8	26.4	56.1	35.8	28.8	15.5	56.5	38.4	16.2	22.3	35.7	39.0	36.9	64.7	33.3	41.6	20.4	47.0	24.8	54.8	26.6	42.1	53.8	34.6	20.6	29.5	37.7	20.0	41.8	35.4	20.9	28.9	27.9	24.6	42.5	48.3	34.6	42.2	27.0	44.6	82.7	26.4	48.5	38.3	12.6	5.1	5.8	5.1	5.0	4.7	4.3	3.6	4.5	3.9	6.1	4.3	3.7	12.4	6.2	3.2	5.4	3.2	2.5	36.1	39.6	41.5	36.3	33.0	19.2	42.0	19.5	33.6	39.3
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA053768: "	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	8.9	6.6	4.9	6.9	9.6	10.9	7.9	13.6	11.1	7.5	6.7	11.6	7.9	5.0	11.4	5.9	7.5	7.3	4.9	12.8	6.1	5.3	6.9	6.1	7.7	8.6	8.0	5.3	9.0	7.8	8.1	12.9	6.8	10.2	7.3	7.6	10.7	7.4	7.4	47.3	8.2	7.2	8.2	8.3	8.6	6.7	7.9	8.0	14.3	8.4	6.3	12.3	7.8	7.3	3.1	2.7	3.1	6.0	3.1	4.0	1.2	6.6	5.0	8.3	7.9	4.0	7.1	8.6	7.6	5.6	9.0	7.5	10.2	8.4	14.7	4.1	7.3	11.0	19.1	10.3	16.8	10.0	5.5	23.3	6.3	6.9	6.1	20.4	7.6	6.9	6.5	9.1	17.3	10.8	11.0	4.9	8.5	5.5	9.7	9.0	9.4	4.7	10.8	13.7	6.1	6.3	8.1	9.5	6.6	6.5	9.5	7.8	5.6	11.2	8.9	6.4	5.0	7.8	10.8	3.2	4.8	12.2	3.1	13.1	9.5	3.1	2.0	2.1	3.4	2.3	4.0	3.1	2.9	2.9	2.7	2.6	3.6	3.5	0.0	3.1	6.0	2.0	2.7	1.2	4.9	9.6	13.6	11.1	6.1	5.3	8.0	5.3	10.2	8.0
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522330-43576075	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	11.5	12.2	9.5	10.8	14.0	9.0	10.8	14.6	15.4	9.6	8.8	11.5	8.3	7.8	12.0	12.0	16.7	9.8	7.5	8.9	8.0	7.3	10.0	13.1	9.4	10.0	9.5	8.0	11.9	19.7	17.7	16.1	9.5	9.4	10.5	11.5	9.7	12.9	10.6	14.9	15.3	8.6	12.3	8.0	9.9	11.2	42.3	9.7	18.3	16.7	8.5	13.7	10.5	10.4	3.7	5.9	3.6	11.7	8.4	6.8	4.4	16.0	9.6	16.2	32.5	8.4	7.1	15.0	8.4	5.9	16.6	12.1	26.5	5.6	21.9	11.0	8.0	13.9	26.8	12.3	18.8	15.9	21.2	21.2	11.6	19.2	12.1	23.3	11.3	5.1	12.8	17.5	27.4	11.8	45.3	17.3	11.2	19.7	17.6	11.6	17.3	9.8	19.2	17.2	16.4	9.6	12.7	33.4	13.8	11.7	10.8	15.0	12.5	18.8	9.9	12.3	14.7	11.7	17.7	11.0	12.0	43.0	4.4	20.4	13.1	0.0	5.0	3.6	6.3	6.4	5.8	3.7	5.6	6.8	5.9	3.4	4.5	5.9	0.5	8.4	11.7	1.8	5.5	4.4	9.5	14.0	14.6	15.4	8.0	7.3	9.5	8.0	9.4	9.7
XPOT	XPO3	ENSG00000184575	"Exportin for tRNA"	O43592	12	64404350-64451127	"Predicted intracellular proteins, Transporters"	Transport	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048067, HPA057602"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA048067: , HPA057602: "	"unprognostic (4.53e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavourable (1.81e-7)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavourable (2.41e-12)"	"unprognostic (2.72e-1)"	"unprognostic (3.68e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (5.79e-4)"	19.3	19.4	20.7	19.3	22.8	26.9	29.9	17.9	21.7	16.9	12.4	18.7	13.2	10.5	16.1	19.8	21.3	12.5	12.6	12.7	19.0	19.4	14.7	35.7	18.3	18.9	22.4	15.5	17.3	30.1	21.4	18.5	18.6	23.5	15.3	14.7	15.8	21.3	13.7	15.6	17.3	11.6	16.7	21.7	14.5	14.7	17.9	21.3	18.2	48.7	14.1	21.4	15.8	27.8	7.9	10.2	10.1	7.5	11.1	14.7	6.5	17.5	12.2	12.4	15.5	18.7	20.0	22.7	23.5	19.7	15.8	14.4	12.1	6.0	35.6	16.8	29.6	13.2	23.5	18.1	23.0	22.2	12.4	19.8	11.3	10.6	33.1	36.4	17.9	14.2	46.7	17.5	54.3	14.0	32.9	71.7	16.7	21.5	20.1	14.5	23.6	21.8	16.0	14.9	26.6	8.6	10.4	13.8	16.2	13.8	15.8	34.0	28.1	36.3	14.7	12.4	12.6	17.8	18.3	45.1	34.6	27.6	27.6	28.5	20.1	5.8	7.5	10.1	10.9	7.5	14.7	7.9	12.4	11.3	10.2	5.3	11.4	9.6	2.3	11.1	6.7	3.5	10.3	6.5	20.7	22.8	17.9	21.2	19.0	19.4	22.4	15.5	23.5	21.3
XRCC1	RCC	ENSG00000073050	"X-ray repair cross complementing 1"	P18887	19	43543040-43580473	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005427, HPA006717"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB005427: AB_2215661, HPA006717: AB_1858896"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.68e-2)"	"prognostic unfavourable (7.33e-5)"	"unprognostic (5.07e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.69e-2)"	16.6	17.5	20.8	18.7	22.4	22.4	16.9	23.6	22.7	20.3	17.4	19.2	18.0	13.6	23.8	18.9	20.2	24.9	16.9	15.7	16.5	16.3	16.3	10.4	16.3	22.8	15.8	21.1	34.2	22.1	19.4	32.0	19.7	15.7	16.7	12.6	21.8	16.4	19.2	18.8	20.4	14.2	18.8	15.3	19.5	17.2	25.0	17.9	38.9	21.5	12.0	21.6	18.1	17.2	14.2	13.6	20.3	14.2	10.6	17.7	12.9	25.2	20.8	24.7	22.0	12.1	11.3	13.1	14.2	16.1	18.8	20.5	13.0	18.5	19.1	18.1	12.6	13.1	14.7	16.3	11.2	21.0	15.1	24.4	20.3	15.1	12.2	13.7	21.2	13.1	11.2	23.7	11.9	16.8	15.3	19.4	16.5	20.9	28.3	24.7	7.7	9.2	23.8	15.4	10.9	16.0	20.2	20.4	13.0	17.6	17.3	8.5	16.3	33.7	9.4	24.9	19.4	7.4	17.6	21.4	20.6	14.0	20.1	12.4	27.0	20.3	14.2	16.8	12.9	13.4	14.6	14.2	16.1	17.7	13.6	12.6	14.0	12.8	16.3	10.6	8.3	10.5	16.2	12.9	20.8	22.4	23.6	22.7	16.5	16.3	15.8	21.1	15.7	17.9
XRCC3		ENSG00000126215	"X-ray repair cross complementing 3"	O43542	14	103697609-103715504	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062422, HPA068953"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA062422: , HPA068953: "	"unprognostic (2.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (6.75e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.53e-4)"	"unprognostic (2.93e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.52e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.72e-2)"	5.4	3.3	8.1	15.1	7.3	22.0	5.4	11.3	8.0	5.5	5.8	6.5	4.6	5.4	6.4	5.1	8.5	6.1	5.3	4.4	6.9	2.6	4.1	3.8	6.0	11.1	7.3	5.4	7.0	7.8	2.1	4.4	5.6	6.8	7.7	6.2	5.3	11.1	2.9	8.9	30.3	7.0	2.3	5.3	13.5	6.8	10.1	5.0	17.6	5.6	6.7	14.2	5.3	9.0	4.5	2.0	3.0	3.3	2.5	3.9	3.6	12.6	23.1	12.7	15.8	1.1	3.3	23.1	14.0	4.6	19.8	21.4	12.8	20.3	20.1	12.1	2.9	20.2	13.9	20.8	12.2	12.4	14.4	19.6	11.3	11.8	2.0	17.6	12.8	2.5	2.1	17.4	11.1	8.1	12.1	12.4	10.2	27.6	30.4	13.9	11.0	16.5	24.8	18.4	7.9	4.4	17.4	12.6	10.4	16.5	8.9	5.7	14.1	13.7	6.9	10.3	12.1	32.7	15.3	10.6	9.6	25.0	6.4	14.6	15.8	2.6	1.6	3.0	3.8	3.3	3.9	4.5	3.3	3.2	2.0	4.0	3.3	2.2	1.2	2.5	2.5	1.4	2.5	3.6	8.1	7.3	11.3	8.0	6.9	2.6	7.3	5.4	6.8	5.0
XRCC4		ENSG00000152422	"X-ray repair cross complementing 4"	Q13426	5	83077498-83353787	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006801, HPA051538"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006801: AB_1858899, HPA051538: "	"prognostic unfavourable (1.80e-5)"	"unprognostic (3.05e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.91e-2)"	8.8	9.4	8.1	12.9	10.1	5.9	9.4	4.8	10.2	5.3	9.1	7.2	5.4	11.4	8.3	7.7	10.1	6.2	8.1	13.0	8.5	6.6	12.2	8.1	7.6	11.7	8.7	5.8	5.8	4.9	4.0	9.5	11.3	11.5	6.3	8.8	3.7	7.2	7.1	5.3	5.7	15.4	5.9	9.5	14.6	6.4	12.5	8.8	20.6	7.4	9.7	12.9	8.7	5.8	7.4	10.3	12.3	19.1	11.5	7.0	6.8	8.5	6.7	8.3	7.3	4.7	6.9	7.8	8.1	6.7	9.0	10.7	5.7	12.7	12.2	6.1	6.5	7.5	5.5	18.4	14.9	5.6	6.8	6.2	5.1	7.2	3.2	7.0	10.2	4.7	8.4	11.7	6.5	7.2	4.5	5.7	10.3	6.8	12.8	9.0	4.6	10.0	10.7	36.4	12.2	8.3	3.9	5.4	7.0	5.1	3.8	10.3	7.7	11.4	4.5	4.9	10.5	5.2	10.8	4.6	6.8	15.0	8.8	12.6	7.9	12.1	13.5	9.2	4.7	19.1	4.9	7.4	5.2	5.2	10.3	6.3	7.0	5.6	12.3	11.5	17.8	7.6	5.6	6.8	8.1	10.1	4.8	10.2	8.5	6.6	8.7	5.8	11.5	8.8
XRCC5	"KARP-1, KU80, Ku86, KUB2"	ENSG00000079246	"X-ray repair cross complementing 5"	P13010	2	216107464-216206303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004468, HPA025813, HPA064685"	Supported		Enhanced	Nucleoplasm			140000	Nucleoplasm		"CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: "	"unprognostic (4.23e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.07e-3)"	"unprognostic (3.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavourable (2.10e-7)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.01e-2)"	53.7	47.6	35.2	47.0	56.8	47.0	56.6	47.0	59.7	51.2	44.3	45.2	39.5	39.5	62.9	43.8	61.1	51.7	41.2	43.7	38.6	36.4	62.4	67.1	43.8	56.2	41.8	45.2	58.7	46.7	63.0	56.1	54.3	58.3	46.0	53.5	36.1	49.4	47.9	65.0	54.7	46.5	49.7	44.2	60.5	47.9	36.9	38.0	112.4	64.2	55.6	65.5	56.5	47.7	38.6	51.5	60.9	61.3	50.4	54.0	82.3	38.4	32.7	73.5	39.3	32.7	37.5	44.4	45.9	47.5	53.1	57.3	70.2	38.4	37.3	37.5	40.1	34.5	72.2	55.6	81.9	35.5	49.7	80.9	51.7	65.6	40.5	72.0	39.6	34.1	29.7	62.3	27.3	62.5	51.0	34.1	69.1	37.1	80.4	36.3	85.3	29.2	70.8	65.0	30.8	57.1	43.9	64.4	54.4	36.9	27.4	33.1	33.6	54.1	45.0	50.0	42.1	32.6	51.9	41.3	50.1	83.3	38.9	56.6	49.0	60.9	51.5	51.8	50.2	54.0	54.0	38.6	49.1	50.9	51.5	37.5	49.9	49.8	59.4	50.4	61.3	31.4	49.3	82.3	35.2	56.8	47.0	59.7	38.6	36.4	41.8	45.2	58.3	38.0
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621119-41664048	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm			24000	Nucleoplasm		"CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716"	"unprognostic (5.55e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.95e-2)"	49.2	67.9	44.4	47.8	54.3	62.3	49.7	44.5	57.5	51.2	51.3	39.5	44.1	44.7	59.9	41.0	68.6	52.4	35.2	63.0	59.3	39.2	50.1	61.6	48.1	66.9	37.2	50.6	61.5	44.0	48.4	53.1	63.5	51.5	46.1	56.4	39.7	59.2	52.1	100.9	58.6	46.9	58.2	68.4	54.4	50.8	113.6	34.2	83.8	49.5	59.2	70.9	51.4	50.1	51.9	63.7	42.7	57.0	46.6	62.6	96.7	64.2	46.4	64.6	56.2	39.4	35.1	50.9	46.9	56.4	98.6	81.3	68.1	40.8	103.7	39.4	56.8	48.4	89.2	58.7	99.5	57.6	112.0	55.6	56.8	67.5	35.7	131.2	64.4	31.8	40.5	61.5	34.0	61.2	54.2	44.0	63.4	70.7	68.2	49.0	59.3	55.0	78.1	68.0	82.3	55.7	48.2	30.1	21.5	76.2	40.7	54.1	46.7	53.1	43.2	49.3	68.6	43.3	61.5	43.7	76.3	105.7	46.2	52.1	58.2	24.5	50.1	42.7	51.1	57.0	53.5	51.9	56.8	55.8	63.7	48.2	62.6	55.8	13.5	46.6	55.5	37.7	61.8	96.7	44.4	54.3	44.5	57.5	59.3	39.2	37.2	50.6	51.5	34.2
XRN1	SEP1	ENSG00000114127	"5'-3' exoribonuclease 1"	Q8IZH2	3	142306607-142448062	"Predicted intracellular proteins"		"DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035005, HPA035006"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035005: AB_10670695, HPA035006: AB_10672750"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (9.43e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.32e-2)"	16.5	12.4	9.9	16.2	15.5	24.4	15.9	23.8	15.7	15.7	17.5	7.5	12.4	14.7	15.2	14.2	13.4	11.5	11.0	10.1	8.4	6.8	9.6	21.7	15.9	16.1	11.7	9.0	17.4	13.2	17.4	26.5	23.6	10.7	12.5	13.0	8.2	14.4	13.3	21.2	17.2	25.0	14.4	15.2	16.2	11.7	11.8	10.9	30.8	12.9	10.8	15.3	15.0	15.2	7.4	6.1	18.3	4.7	4.3	8.4	2.5	9.8	1.9	4.5	3.8	5.0	8.4	2.7	4.6	6.2	6.0	7.4	1.7	2.9	3.9	4.8	6.1	3.8	4.0	2.3	9.2	9.9	3.1	5.8	3.3	1.5	4.4	5.8	5.9	6.6	2.7	4.3	5.6	5.3	3.8	9.4	5.4	1.9	5.0	3.0	1.4	2.1	4.1	57.1	4.9	2.9	5.0	2.6	3.3	8.3	4.5	3.5	5.5	4.5	7.3	4.2	2.3	4.8	3.9	13.5	6.9	6.3	3.9	3.1	3.6	18.3	4.7	12.2	8.3	4.2	5.8	7.4	6.4	7.4	2.3	6.0	8.4	5.8	17.2	4.3	4.0	6.1	4.6	2.5	9.9	15.5	23.8	15.7	8.4	6.8	11.7	9.0	10.7	10.9
XRN2		ENSG00000088930	"5'-3' exoribonuclease 2"	Q9H0D6	20	21303304-21389827	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047118, HPA050485"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA047118: , HPA050485: "	"unprognostic (9.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.54e-5)"	"unprognostic (7.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.31e-1)"	42.9	35.1	12.5	24.5	17.7	38.3	30.4	18.0	16.4	26.8	22.8	18.6	23.3	14.4	38.6	25.2	22.1	30.6	21.8	19.3	13.7	10.3	31.4	35.3	27.5	33.4	17.4	12.1	32.1	26.4	30.0	35.3	26.5	15.9	25.7	20.1	19.1	27.6	25.0	36.8	23.0	21.6	24.1	18.6	40.9	23.2	27.4	18.3	41.1	31.3	20.4	30.6	33.1	21.7	16.0	30.6	35.0	33.9	21.7	24.6	23.8	27.2	32.4	35.8	27.4	26.8	33.0	35.4	25.1	32.8	33.5	39.1	21.6	31.3	26.8	15.0	26.2	32.4	40.2	42.2	43.0	12.1	20.3	34.6	12.2	40.7	23.6	31.1	30.3	31.2	21.4	36.8	32.4	28.7	27.8	23.1	31.0	21.3	45.8	20.6	27.8	21.9	33.6	60.8	22.8	28.5	28.9	27.8	36.1	29.2	36.1	26.8	20.2	37.1	26.4	33.7	25.3	7.6	31.6	20.4	26.2	28.8	13.0	14.6	25.3	15.1	33.9	23.8	18.6	27.2	24.6	16.0	20.4	20.2	30.6	15.1	21.8	21.0	35.0	21.7	32.7	13.2	24.0	23.8	12.5	17.7	18.0	16.4	13.7	10.3	17.4	12.1	15.9	18.3
XRRA1	FLJ00225	ENSG00000166435	"X-ray radiation resistance associated 1"	Q6P2D8	11	74807739-74949200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039263			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA039263: "	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-1)"	7.1	7.9	6.2	19.5	8.6	3.7	10.7	5.7	7.5	8.6	7.3	7.6	22.9	5.8	9.0	13.5	6.6	9.6	8.7	9.5	7.9	5.9	6.9	8.1	9.5	4.1	5.7	7.0	9.3	22.7	11.9	8.1	5.3	10.8	10.5	5.6	7.4	13.1	16.8	15.7	5.8	5.9	10.1	13.7	7.2	6.4	35.0	6.1	5.6	14.3	4.1	5.8	6.3	7.4	3.5	3.4	6.2	5.2	2.0	8.5	3.0	3.9	2.2	0.5	3.7	5.8	3.8	1.6	1.7	1.8	1.0	1.0	1.1	2.1	1.6	6.3	1.9	3.2	4.5	2.2	2.1	6.3	0.4	1.4	1.3	2.2	1.7	0.8	0.7	3.6	2.6	4.2	27.7	2.0	3.6	3.8	4.8	1.4	1.4	2.0	1.2	2.0	0.7	3.0	1.2	0.8	3.0	3.6	3.0	7.9	3.4	10.6	2.1	4.1	1.3	6.0	3.9	4.3	1.6	5.3	4.7	4.4	1.4	0.8	2.0	2.9	4.3	3.8	6.3	5.2	6.6	3.5	4.6	4.7	3.4	3.5	4.6	4.5	6.2	2.0	3.2	2.5	8.5	3.0	6.2	8.6	5.7	7.5	7.9	5.9	5.7	7.0	10.8	6.1
YAF2		ENSG00000015153	"YY1 associated factor 2"	Q8IY57	12	42157104-42238349	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026867	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA026867: AB_1858911"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.20e-2)"	11.2	11.4	15.6	7.6	14.2	9.7	10.0	16.3	19.7	11.0	7.9	8.4	6.9	7.2	10.9	11.1	8.5	7.8	10.1	39.4	12.9	13.3	10.5	19.2	8.4	12.4	13.2	11.3	11.0	7.6	7.4	14.6	10.2	14.5	9.3	8.3	8.1	7.1	10.0	43.9	6.5	8.9	11.6	10.8	11.3	7.0	7.8	9.1	12.7	11.9	8.3	10.5	11.2	9.1	13.6	10.8	32.6	9.8	14.2	14.1	5.2	6.8	5.2	8.1	5.9	10.2	9.3	4.6	9.0	9.2	8.6	7.9	7.3	5.4	4.4	7.5	8.1	5.4	7.9	5.8	11.7	10.4	8.7	9.6	2.8	3.7	6.1	8.9	6.0	6.6	8.4	6.6	13.5	8.5	9.3	10.1	10.6	3.3	9.6	11.9	1.8	5.7	6.7	9.3	6.3	10.6	4.6	5.8	8.2	7.4	9.1	7.7	5.9	7.3	8.0	7.6	6.0	8.8	4.7	9.3	11.7	14.5	8.0	44.7	2.9	17.9	9.3	15.1	10.9	9.8	11.1	11.2	10.3	12.4	6.9	13.6	8.3	8.6	32.6	14.2	8.9	10.8	14.1	5.2	15.6	14.2	16.3	16.7	12.9	13.3	13.2	11.3	14.5	9.1
YAP1	YAP65	ENSG00000137693	"Yes associated protein 1"	P46937	11	102110461-102233423	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038885: , HPA070359: "	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	27.1	15.8	11.6	12.1	10.0	0.0	34.9	7.0	9.5	37.5	21.3	7.0	40.1	9.8	51.7	33.3	36.9	25.5	34.6	18.8	12.5	6.0	17.3	32.1	26.2	7.6	9.3	6.1	41.1	8.9	18.9	6.4	34.0	15.0	34.8	11.4	21.7	22.2	35.2	27.8	23.4	15.1	58.2	17.2	7.6	18.2	15.6	9.7	2.6	34.0	25.7	12.6	42.3	41.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	11.6	10.9	30.5	14.9	33.3	31.8	25.5	27.5	31.5	26.8	22.1	27.2	28.4	0.0	22.7	35.9	20.7	15.1	39.2	28.5	3.4	5.3	0.0	14.9	18.5	25.5	0.0	0.5	25.4	25.8	29.4	48.0	8.3	0.0	0.0	30.3	5.6	0.5	0.0	14.4	10.4	0.0	17.2	0.0	19.8	20.9	0.1	1.0	32.4	12.2	9.2	22.1	0.1	9.1	38.2	15.0	19.1	11.5	0.0	0.0	0.1	11.1	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	11.6	10.0	7.0	9.5	12.5	6.0	9.3	6.1	15.0	9.7
YARS	"tyrRS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase"	P54577	1	32775237-32818153	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol			230000	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavourable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (6.57e-4)"	16.6	36.3	22.8	22.8	40.6	17.4	13.9	26.6	43.1	14.6	17.5	16.3	22.4	17.1	14.2	15.5	24.1	14.4	11.2	15.5	24.9	28.3	14.1	29.6	21.3	23.2	24.9	27.4	21.2	54.8	19.3	13.9	17.5	26.7	12.7	21.9	11.2	23.5	25.7	27.3	16.5	14.9	22.7	22.7	14.6	25.9	20.9	26.0	15.2	30.0	16.8	29.6	17.0	28.0	9.9	17.8	20.9	13.4	36.5	24.3	17.1	28.3	14.8	15.7	37.7	19.5	22.5	16.7	29.4	24.3	24.1	30.8	17.6	19.6	51.7	11.7	30.5	16.7	47.7	34.6	38.2	21.7	18.9	47.3	22.5	16.6	64.2	37.3	28.7	22.2	43.0	38.1	97.1	24.4	52.2	54.8	20.7	14.7	41.8	20.5	28.5	20.6	36.7	15.0	43.5	17.3	14.2	30.3	18.6	16.0	18.8	54.1	18.8	40.7	19.8	14.7	26.2	29.8	24.2	44.3	47.1	48.3	36.7	52.1	40.3	20.9	12.7	6.6	24.3	13.4	23.9	9.9	14.5	22.3	17.8	8.1	10.8	16.5	3.0	36.5	12.4	10.2	15.6	17.1	22.8	40.6	26.6	43.1	24.9	28.3	24.9	27.4	26.7	26.0
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755902	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"				Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: , HPA074097: "	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	12.6	15.8	11.0	12.6	15.3	13.9	13.8	11.6	14.9	13.1	11.8	11.5	18.4	9.8	13.3	12.9	17.5	11.3	9.1	12.1	11.9	9.7	12.4	16.3	9.2	15.5	10.8	11.7	13.3	21.0	11.0	16.6	15.9	13.5	12.9	13.7	11.3	17.4	10.0	15.9	12.0	10.8	11.1	12.6	13.3	12.3	12.5	12.6	17.5	12.3	16.0	16.4	13.3	11.8	11.8	9.5	9.4	9.9	12.9	12.7	5.2	9.5	11.5	6.7	8.0	7.4	8.7	21.3	7.3	7.5	9.1	8.9	28.8	12.3	17.3	12.0	7.4	12.4	13.4	19.3	10.3	7.5	20.9	11.4	8.7	16.0	10.7	12.1	6.7	8.1	12.4	8.5	15.6	14.3	16.1	8.0	9.6	7.8	9.0	14.7	37.1	14.2	10.2	14.4	10.2	11.5	13.7	10.4	5.0	11.2	9.8	7.2	18.3	11.0	9.6	8.6	9.2	14.0	12.3	4.8	5.1	18.0	8.0	9.1	7.1	9.4	7.0	4.1	10.1	8.9	10.6	8.8	10.7	10.4	9.5	11.8	11.2	12.7	1.4	12.9	9.9	9.3	9.3	5.2	11.0	15.3	11.6	14.9	11.9	9.7	10.8	11.7	13.5	12.6
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682427-42702349	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 128.1;testis: 426.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"		870000	Cytosol	Vesicles	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: "	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavourable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	47.5	20.6	15.6	36.4	18.4	57.6	35.2	13.7	14.4	27.9	44.5	21.2	20.1	25.6	35.1	36.4	40.0	25.6	32.5	57.8	15.2	12.3	33.1	38.1	35.3	49.8	17.6	13.2	30.2	36.7	9.4	12.2	26.1	15.5	32.0	33.1	31.1	26.6	23.0	128.1	22.5	27.1	50.0	21.0	47.9	33.2	426.5	15.9	53.2	31.4	64.1	37.2	39.4	41.0	23.5	26.9	21.8	40.5	11.6	23.0	10.6	91.5	54.0	86.5	86.7	84.3	76.3	77.1	67.6	63.0	94.0	73.8	74.0	85.6	116.2	70.9	67.8	55.5	97.4	102.6	93.4	62.0	90.3	118.6	107.3	94.9	68.0	159.2	88.9	70.2	88.4	93.8	116.2	77.7	123.3	50.7	87.5	57.7	179.8	155.0	195.0	73.0	108.8	155.5	125.6	93.1	67.8	119.7	84.4	66.3	89.8	126.2	29.9	317.1	60.6	66.8	114.0	90.5	137.5	74.3	93.1	132.3	63.2	119.4	70.8	4.3	18.1	21.8	16.3	37.8	19.9	23.5	19.5	15.8	26.9	20.1	16.8	17.2	3.3	11.6	40.5	20.9	23.0	10.6	15.6	18.4	13.7	14.4	15.2	12.3	17.6	13.2	15.5	15.9
YBX3	"CSDA, CSDA1, dbpA, ZONAB"	ENSG00000060138	"Y-box binding protein 3"	P16989	12	10699089-10723312	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 612.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034838	Approved		Supported	Cytosol			56000	Cytosol		"HPA034838: AB_10670980"	"unprognostic (1.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (6.17e-13)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.44e-1)"	23.8	5.0	3.0	6.4	6.0	11.2	15.9	2.1	4.6	12.4	14.3	2.0	3.7	3.2	8.5	14.7	25.0	8.4	6.7	91.6	3.2	1.7	7.6	6.5	17.2	6.8	5.5	0.8	17.2	20.6	1.3	8.1	9.5	6.2	12.4	5.3	6.2	12.9	6.8	612.6	29.9	5.0	14.9	5.8	8.6	9.5	30.2	4.1	4.5	18.5	54.2	12.0	27.2	24.6	9.5	4.5	1.0	5.7	0.9	2.3	1.4	17.7	15.6	7.0	22.8	29.2	54.2	51.2	27.8	23.7	23.8	22.4	27.3	43.1	17.4	9.3	22.1	34.1	29.9	57.9	20.7	0.1	53.7	14.4	22.0	16.6	36.5	25.9	1.6	62.5	75.2	22.1	72.7	54.7	19.4	0.0	25.5	19.0	21.3	22.3	70.6	12.8	12.0	32.0	19.7	32.3	23.6	8.7	0.0	21.1	21.0	25.8	6.0	20.4	35.7	16.3	45.9	17.4	31.2	0.1	5.7	2.0	22.5	0.0	17.5	0.0	5.7	0.0	0.7	5.4	0.0	1.6	0.0	2.1	4.5	9.5	0.1	2.3	1.0	0.9	3.0	0.2	0.1	1.4	3.0	6.0	2.1	4.6	3.2	1.7	5.5	0.8	6.2	4.1
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 14.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"			4300000	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	26.2	13.1	17.0	9.4	15.6	2.6	47.2	6.7	12.8	15.8	23.8	8.9	13.7	18.2	13.1	17.4	22.0	10.7	14.9	17.9	14.8	12.4	22.6	43.2	23.6	13.7	15.8	6.6	13.2	21.4	16.7	10.7	31.3	16.8	12.2	17.3	6.5	23.7	21.0	10.6	12.3	24.8	18.8	16.8	34.5	15.5	13.6	12.0	8.1	16.8	15.6	7.1	21.9	17.5	0.1	0.1	14.7	0.0	1.0	2.5	0.6	14.2	7.1	22.4	17.5	13.5	16.7	26.4	9.5	19.4	11.2	15.4	16.8	10.5	0.0	10.1	16.1	8.3	20.9	16.8	22.0	0.0	7.1	4.2	7.0	11.7	11.0	3.2	7.6	12.7	18.1	16.9	18.9	37.8	18.4	6.3	15.9	9.8	1.9	4.2	14.2	9.1	2.4	17.6	1.2	16.3	16.9	4.6	5.3	19.6	14.9	12.4	10.3	6.8	32.5	27.7	30.7	20.8	25.5	5.5	2.7	0.8	10.5	4.7	16.4	14.7	0.0	0.9	2.5	0.0	1.6	0.1	0.5	1.4	0.0	0.0	1.2	1.9	0.0	1.0	0.0	0.1	0.1	0.6	17.0	15.6	6.7	12.8	14.8	12.4	15.8	6.6	16.8	12.0
YIF1A	"54TM, FinGER7, YIF1, YIF1P"	ENSG00000174851	"Yip1 interacting factor homolog A, membrane trafficking protein"	O95070	11	66284580-66289170	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014840	Approved		Supported	"Golgi apparatus,Vesicles,Centriolar satellite"				Vesicles	"Golgi apparatus, Centriolar satellite"	"HPA014840: AB_2217189"	"unprognostic (9.35e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavourable (8.70e-4)"	16.0	19.7	11.3	12.4	11.7	6.4	18.9	8.0	16.5	17.3	21.4	19.3	18.5	26.1	19.4	24.8	18.5	16.4	24.6	20.1	9.8	9.2	26.2	138.8	16.5	16.0	12.8	9.4	21.2	55.2	18.9	26.8	24.7	12.3	16.8	17.9	16.5	24.4	19.2	32.3	14.3	32.1	19.1	15.2	12.8	19.4	16.9	10.7	16.4	28.2	26.4	17.7	18.2	13.7	27.4	40.4	5.5	38.9	13.3	23.6	26.1	20.6	34.2	10.7	19.5	36.2	39.0	19.6	30.4	32.7	26.0	25.8	32.4	25.4	17.6	29.9	42.7	31.5	16.3	28.6	20.8	20.0	18.7	10.9	26.6	40.1	40.4	15.3	16.6	26.9	38.9	26.8	43.7	24.3	20.3	31.0	22.6	50.2	18.3	16.2	10.8	35.8	14.1	16.4	52.5	22.0	18.8	15.7	15.4	16.4	28.5	26.9	41.9	11.3	21.4	22.0	18.6	44.2	14.0	20.8	21.5	15.8	34.5	14.5	24.2	4.9	28.0	5.5	21.8	38.9	23.6	27.4	18.8	20.3	33.2	22.6	15.1	17.2	2.8	13.3	37.2	40.4	15.2	26.1	11.3	11.7	8.0	16.5	9.8	9.2	12.8	9.4	12.3	10.7
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511827-43516990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: "	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	26.8	51.0	26.1	20.3	36.8	19.3	28.1	24.2	48.9	33.5	30.4	38.1	40.3	31.9	31.2	50.5	31.9	34.4	39.9	30.9	26.2	25.5	44.2	62.0	30.0	21.1	26.1	21.4	34.0	73.7	47.0	38.9	59.3	29.7	36.0	29.9	36.8	75.4	31.8	30.6	26.9	38.4	27.4	28.1	28.0	38.8	27.8	22.6	27.9	51.2	31.3	32.9	32.8	26.5	11.7	18.5	74.3	19.7	14.6	18.3	16.0	23.0	16.2	24.0	46.4	54.0	43.8	14.5	27.9	43.3	23.1	29.3	19.4	16.9	9.5	22.3	51.2	23.3	17.6	27.2	14.7	17.3	25.2	14.8	23.9	36.8	42.0	15.7	22.3	43.6	35.5	19.6	19.5	34.8	16.0	21.9	27.5	35.4	11.9	20.0	12.4	18.1	10.5	11.1	24.9	41.2	24.6	19.4	27.8	12.7	16.8	29.4	27.7	32.9	33.0	26.3	13.9	14.4	19.2	25.9	20.7	18.8	18.7	13.5	17.7	26.2	19.7	28.3	15.3	18.5	13.3	11.7	13.8	13.5	18.5	11.7	11.3	12.6	74.3	14.6	18.4	17.0	18.3	16.0	26.1	36.8	24.2	48.9	26.2	25.5	26.1	21.4	29.7	22.6
YIPF4	"FinGER4, MGC11061"	ENSG00000119820	"Yip1 domain family member 4"	Q9BSR8	2	32277910-32316594	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017884	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA017884: AB_1853855"	"unprognostic (5.61e-3)"	"unprognostic (8.50e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.11e-2)"	15.2	15.3	15.7	12.3	19.2	6.0	19.5	24.9	27.2	15.6	16.0	21.7	16.9	13.6	19.6	17.7	15.3	13.3	12.3	19.1	17.7	16.5	18.7	24.0	13.4	12.9	18.5	13.3	17.9	32.9	14.2	22.3	19.2	17.6	16.1	15.0	15.4	24.1	14.2	16.8	16.5	14.6	15.8	17.7	15.4	14.7	15.2	16.3	18.7	23.6	12.2	13.6	14.6	14.2	5.0	5.8	16.5	6.0	7.0	5.4	4.4	8.3	4.2	8.4	7.5	9.8	12.6	4.4	7.2	7.3	7.6	5.0	5.6	6.4	4.5	5.1	7.8	6.6	8.9	6.3	9.9	7.2	13.8	7.2	9.9	10.1	11.6	9.5	6.2	8.7	12.2	6.8	10.9	6.4	9.8	9.4	8.2	5.5	7.4	10.0	6.8	7.3	5.2	12.4	8.4	8.1	3.6	9.5	9.1	6.2	6.3	10.7	3.5	8.1	7.1	10.1	4.8	7.0	6.8	14.0	17.2	5.4	15.9	9.3	5.5	12.5	6.0	5.9	5.0	5.4	4.3	5.0	5.1	4.7	4.9	4.8	5.4	4.7	16.5	7.0	5.2	5.8	4.7	4.4	15.7	19.2	24.9	18.9	17.7	16.5	18.5	13.3	17.6	16.3
YIPF5	"FinGER5, SMAP-5"	ENSG00000145817	"Yip1 domain family member 5"	Q969M3	5	144158159-144170714	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042338, HPA073622"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles"				"Endoplasmic reticulum, Golgi apparatus, Vesicles"	Nucleoplasm	"HPA042338: , HPA073622: "	"prognostic unfavourable (7.83e-5)"	"unprognostic (1.13e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.12e-5)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.49e-2)"	26.6	26.6	18.4	14.7	21.2	15.8	22.5	19.2	22.6	23.9	22.2	17.2	22.5	26.5	25.7	22.0	27.2	18.9	19.0	18.3	15.1	18.5	23.0	27.8	20.4	21.0	16.2	20.5	19.6	41.7	21.5	45.3	37.1	21.8	16.8	23.4	18.9	32.7	18.3	11.9	24.5	30.5	25.2	19.7	18.8	23.8	20.7	16.2	14.0	20.2	21.2	20.1	24.1	19.9	22.3	27.2	28.8	28.1	23.7	36.7	23.4	11.4	7.7	10.0	7.9	24.0	26.0	9.1	39.2	26.6	17.7	28.6	12.2	12.1	6.3	18.9	42.5	10.6	9.5	19.2	23.9	8.8	8.3	4.6	13.4	12.4	19.4	10.3	7.7	19.6	18.0	15.8	13.0	16.7	4.9	10.6	23.8	6.0	5.0	5.9	6.4	8.4	5.4	14.9	10.4	11.0	10.2	6.8	8.4	13.6	7.3	17.4	15.2	6.8	64.4	20.9	10.1	20.1	15.4	9.7	15.9	8.0	19.9	9.9	15.1	25.6	21.0	28.8	30.3	28.1	34.3	22.3	31.0	33.6	25.0	21.5	32.8	30.8	15.6	23.7	25.4	27.2	36.7	23.4	18.4	21.2	19.2	22.6	15.1	18.5	16.2	20.5	21.8	16.2
YLPM1	"C14orf170, PPP1R169, ZAP"	ENSG00000119596	"YLP motif containing 1"	P49750	14	74763366-74859435	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048070, HPA061123"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA048070: , HPA061123: AB_2684435"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.63e-2)"	"prognostic favourable (6.08e-7)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	17.2	19.0	28.9	21.7	33.4	26.1	21.0	51.4	32.6	18.6	15.4	24.9	18.8	13.1	23.8	20.6	17.4	20.6	15.9	15.8	24.2	18.2	15.7	14.0	16.4	20.8	24.1	24.8	31.3	21.0	30.9	30.5	19.8	22.5	20.0	17.2	18.8	20.6	22.8	20.7	23.0	16.5	17.7	21.2	18.9	16.2	28.8	27.6	24.7	22.5	8.7	20.6	22.4	18.7	5.5	7.8	3.3	3.9	5.4	4.6	3.0	18.9	21.1	23.1	4.4	16.6	16.2	12.5	13.2	13.5	13.4	13.5	18.5	13.7	28.5	9.9	14.8	17.2	20.0	13.7	21.3	17.1	11.5	20.6	13.4	12.6	9.0	15.7	15.7	14.2	9.1	15.1	11.4	18.2	16.3	13.6	16.5	19.5	18.1	12.7	13.8	17.7	27.3	23.0	9.9	10.7	27.4	17.0	16.7	21.2	13.1	5.0	15.6	10.4	27.3	16.2	20.8	11.6	16.5	16.7	16.0	31.4	14.1	11.5	12.1	0.7	3.4	3.3	3.8	3.9	4.2	4.4	3.2	3.2	3.1	5.5	4.6	4.6	2.7	5.4	3.1	7.8	2.7	3.0	28.9	33.4	51.4	32.6	24.2	18.2	24.1	24.8	22.5	27.6
YME1L1		ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110112-27155266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"				Mitochondria	"Nuclear bodies"	"HPA066953: "	"unprognostic (2.28e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (8.25e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.09e-2)"	27.8	37.3	22.7	25.0	26.2	41.4	39.2	27.8	27.5	27.6	24.3	15.7	29.8	22.3	29.9	35.9	34.5	25.3	24.4	34.1	23.4	21.5	26.8	45.4	26.9	38.7	19.3	25.5	32.5	33.8	27.8	28.6	33.4	22.0	25.9	26.3	23.3	28.1	31.3	79.0	26.8	25.3	34.6	20.2	26.5	24.7	24.7	20.9	41.7	30.9	32.0	28.9	36.4	28.9	55.6	79.2	73.9	53.0	45.5	56.0	45.9	40.0	30.1	36.1	17.8	35.4	38.1	29.5	39.6	23.2	40.7	46.7	40.7	49.4	42.8	26.4	43.7	38.8	43.3	35.0	45.0	38.8	26.0	40.6	26.9	28.5	38.9	27.7	33.4	31.2	41.4	35.5	36.0	42.5	47.1	43.6	44.9	27.1	51.2	16.0	28.6	14.1	44.3	57.9	39.5	33.2	19.1	27.8	35.6	39.6	30.8	39.7	29.5	34.8	41.6	24.7	34.5	41.4	35.5	21.9	32.1	54.7	35.1	51.5	18.8	53.0	53.0	55.2	55.3	44.8	56.0	51.4	53.8	51.2	42.6	55.6	49.7	51.9	73.9	45.5	47.3	79.2	52.6	45.9	22.7	26.2	27.8	27.5	23.4	21.5	19.3	25.5	22.0	20.9
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Unfolded protein response"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Cell line enhanced"	"Detected in many"		"HEL: 39.4;K-562: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			40000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	4.5	4.6	4.0	4.0	5.3	44.7	6.6	4.8	7.5	6.1	3.9	7.6	2.6	4.1	4.0	3.1	24.5	3.7	3.5	5.0	4.0	2.2	4.5	5.2	9.4	4.2	7.1	4.4	3.5	3.6	2.5	5.1	6.3	5.1	3.4	4.0	3.4	9.7	3.0	6.5	14.9	4.8	2.7	8.5	5.2	8.4	5.6	6.9	14.3	5.8	10.0	8.2	5.8	12.3	0.5	1.3	3.9	1.5	1.2	1.8	0.9	5.3	2.8	4.5	2.7	1.6	2.1	8.8	3.5	2.7	2.7	2.7	5.4	5.5	2.8	1.4	2.1	5.9	0.0	4.3	3.0	2.2	4.8	39.4	11.6	2.5	1.5	5.1	13.9	1.5	3.4	2.2	8.4	2.3	27.4	0.0	2.3	0.0	4.5	2.8	4.3	6.4	2.3	0.2	2.0	2.7	6.0	2.3	5.2	5.8	6.7	7.6	2.4	3.6	1.1	2.3	6.1	1.9	4.6	4.5	0.2	4.2	2.7	0.0	1.5	3.9	1.2	2.0	1.1	1.5	1.5	0.4	1.7	0.9	1.3	0.5	1.4	1.8	2.9	1.2	1.0	0.7	0.8	0.9	4.0	5.3	4.8	7.5	4.0	2.2	7.1	4.4	5.1	6.9
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"				Cytosol	"Cytoplasmic bodies"	"HPA030063: , HPA054080: , HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	31.1	33.0	18.2	27.0	19.9	42.0	52.4	21.5	28.3	23.7	23.6	20.4	31.5	22.1	26.6	35.1	36.0	26.1	21.7	23.3	18.5	19.4	26.8	35.8	30.0	42.5	18.1	21.3	25.5	37.2	29.7	18.4	32.6	20.2	21.7	26.2	22.1	34.4	31.3	39.6	36.5	24.4	25.1	15.1	29.8	24.8	28.0	17.0	44.2	26.4	30.4	31.7	24.7	31.0	36.5	42.2	33.3	39.9	39.0	40.4	41.8	21.5	15.1	33.0	31.9	25.7	19.8	37.9	21.0	26.3	26.3	26.8	13.7	25.5	37.0	21.0	27.0	20.2	38.1	34.2	31.5	23.2	27.7	31.1	20.7	25.1	30.4	32.7	24.6	26.6	35.4	28.3	40.6	32.2	31.2	18.5	29.5	16.9	34.6	25.8	53.0	19.3	30.0	24.4	30.5	36.9	31.0	28.2	30.0	21.9	33.8	56.8	22.3	30.9	21.9	18.6	19.2	17.3	29.7	22.2	14.2	42.5	21.3	25.9	29.5	33.3	32.4	32.6	28.9	39.9	40.0	36.5	33.9	36.4	42.2	25.5	36.1	34.1	11.5	39.0	38.0	25.9	40.4	41.8	18.2	19.9	21.5	28.3	18.5	19.4	18.1	21.3	20.2	17.0
YWHAB	YWHAA	ENSG00000166913	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta"	P31946	20	44885676-44908532	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003759, HPA007925, HPA011212, HPA061603"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol			210000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: "	"prognostic unfavourable (9.18e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.06e-2)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (3.80e-1)"	"prognostic unfavourable (6.14e-4)"	"prognostic unfavourable (1.91e-6)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (8.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (2.52e-5)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.60e-3)"	"unprognostic (8.59e-2)"	39.3	38.6	65.5	39.4	79.2	28.6	33.0	60.1	87.9	34.0	47.5	27.7	28.7	37.9	35.2	26.4	48.1	30.2	29.6	40.3	68.7	63.4	47.3	36.5	37.4	46.8	49.8	76.2	25.8	18.9	41.1	18.4	36.7	50.1	31.4	53.4	22.9	30.7	43.2	28.3	38.4	39.3	43.3	38.4	53.7	36.7	16.8	33.6	48.2	36.1	31.8	60.2	41.2	34.9	30.9	41.9	37.3	58.4	26.8	43.5	26.6	51.8	39.3	31.7	30.4	52.8	46.7	43.0	47.2	46.0	58.2	51.1	81.8	58.8	55.4	49.5	62.3	55.2	44.7	87.8	69.6	21.2	27.3	41.2	34.6	48.5	35.0	66.7	39.9	36.5	65.7	45.6	58.9	58.2	44.4	26.8	59.7	61.3	52.0	55.0	29.9	61.2	40.9	46.0	43.0	62.3	58.0	33.9	36.1	80.0	85.6	55.1	62.3	64.2	66.0	90.5	46.5	51.0	48.0	17.9	32.6	50.8	66.1	44.7	46.0	34.8	40.1	34.4	29.7	52.2	30.2	30.9	37.7	36.3	41.9	28.6	30.8	36.6	37.3	26.8	58.4	26.5	43.5	26.6	65.5	79.2	60.1	87.9	68.7	63.4	49.8	76.2	50.1	33.6
YWHAE	FLJ45465	ENSG00000108953	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon"	P62258	17	1344272-1400378	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008445, CAB016200, CAB021109, CAB047350, HPA061603"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			160000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336, HPA061603: "	"unprognostic (1.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-2)"	"prognostic favourable (6.48e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-3)"	"unprognostic (8.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.94e-2)"	55.2	54.3	107.5	35.3	87.1	32.7	37.3	71.5	118.4	28.4	40.2	60.9	23.8	40.2	35.9	54.1	43.1	44.2	23.4	57.7	92.3	81.9	64.5	50.9	32.8	25.4	94.1	77.9	40.2	40.2	41.0	37.9	45.1	73.7	35.0	42.5	27.9	42.4	27.7	135.9	36.8	36.2	32.2	101.1	26.2	38.5	46.0	53.6	30.9	47.5	36.5	37.2	31.6	32.1	19.2	41.5	17.2	36.2	15.0	23.3	31.5	77.8	58.2	70.5	59.3	31.2	36.1	67.8	50.4	29.7	45.0	34.9	104.0	32.0	52.9	59.2	41.7	54.1	59.7	50.9	63.8	36.5	111.3	36.9	48.6	44.5	37.3	35.3	37.8	32.7	37.6	45.0	69.0	54.1	42.3	38.2	57.8	37.9	46.7	28.2	64.6	37.8	56.8	33.3	37.5	45.8	45.1	39.3	59.7	60.6	24.9	39.4	47.2	32.7	51.1	43.7	37.1	55.1	88.9	24.0	44.3	44.4	52.4	42.3	63.1	17.2	31.8	8.6	12.4	36.2	15.6	19.2	18.7	13.9	41.5	16.1	17.0	14.3	10.8	15.0	30.9	28.8	23.3	31.5	107.5	87.1	71.5	90.2	92.3	81.9	94.1	77.9	73.7	53.6
YWHAG	PPP1R170	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326794-76359031	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 117.8;skeletal muscle: 91.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013274, CAB018389, HPA026918, HPA061603"	Approved	Approved	Supported	Nucleoplasm,Nucleoli,Cytosol			160000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: "	"unprognostic (3.71e-2)"	"prognostic unfavourable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	52.4	31.2	46.3	17.7	54.6	7.3	17.2	36.2	117.8	13.4	14.2	13.3	4.6	14.4	15.0	7.0	18.6	9.0	17.0	33.1	50.2	56.2	15.9	22.0	12.9	12.1	45.9	49.8	13.3	18.0	14.8	7.8	16.6	74.6	14.7	14.0	8.6	10.0	13.3	91.8	11.7	12.5	20.2	22.8	12.7	11.2	8.9	13.5	6.8	8.8	13.8	14.3	14.7	13.2	3.1	5.9	3.2	5.0	1.1	3.3	1.7	37.1	46.7	41.4	52.5	42.4	24.5	18.7	43.2	21.4	26.8	29.2	29.3	40.0	52.4	14.9	38.3	34.8	51.8	47.7	37.8	35.5	22.6	49.6	32.0	32.5	38.7	60.5	48.6	26.8	45.8	31.3	64.9	42.6	68.1	59.3	40.0	35.0	43.2	44.7	45.9	32.8	50.7	41.9	57.9	42.1	25.4	22.2	61.7	47.9	61.4	30.6	42.7	36.7	44.9	52.4	30.5	46.4	57.7	19.7	36.9	80.7	47.1	57.3	55.8	3.2	5.0	1.1	2.1	4.6	3.3	3.1	2.4	2.6	5.2	1.8	1.8	2.0	1.1	1.1	3.8	5.9	2.0	1.7	46.3	54.6	36.2	88.9	50.2	56.2	45.9	49.8	74.6	13.5
YWHAQ	"14-3-3, HS1"	ENSG00000134308	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta"	P27348	2	9583972-9631014	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA007925, CAB010286, HPA061603"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			120000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: "	"unprognostic (2.65e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (8.20e-4)"	"unprognostic (1.53e-1)"	"unprognostic (5.78e-3)"	"prognostic unfavourable (9.83e-6)"	"unprognostic (4.90e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.39e-3)"	40.5	47.3	77.8	32.1	60.8	48.0	50.8	88.5	82.5	52.2	44.0	82.5	25.0	37.9	60.5	48.2	57.6	45.3	40.0	68.5	73.7	76.2	45.9	37.2	35.0	38.2	74.3	54.8	55.9	64.4	39.2	39.0	39.3	69.8	54.2	44.1	31.2	38.9	48.8	17.6	33.3	36.5	57.9	72.2	29.8	36.9	44.3	63.5	58.8	45.4	56.7	43.3	47.7	46.3	31.5	30.9	24.8	28.9	51.4	58.4	60.9	42.7	64.5	58.5	56.5	46.1	63.8	55.0	58.8	57.9	61.8	51.9	48.5	37.7	55.4	30.7	84.2	40.3	64.9	64.1	79.8	136.3	52.8	51.8	42.1	51.8	35.3	49.8	31.4	43.1	37.7	67.4	44.0	69.3	50.8	33.5	75.9	29.8	88.2	50.9	99.3	74.4	64.6	75.9	67.8	68.0	38.3	55.7	94.4	53.5	55.5	42.5	34.5	25.7	63.1	77.7	55.1	67.2	89.6	34.2	46.8	73.1	66.4	52.1	64.4	17.1	22.2	24.8	47.8	28.9	58.4	31.5	45.1	50.8	30.9	28.8	24.7	39.9	6.8	51.4	27.2	15.7	43.1	60.9	77.8	60.8	88.5	69.0	73.7	76.2	74.3	54.8	69.8	63.5
YY1	"DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1"	ENSG00000100811	"YY1 transcription factor"	P25490	14	100238298-100282792	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001119, CAB009392"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"CAB009392: AB_2218501, HPA001119: AB_1858930"	"unprognostic (7.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (6.75e-3)"	"unprognostic (8.31e-3)"	"prognostic unfavourable (3.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	32.7	28.8	26.3	27.0	25.8	45.3	33.8	33.6	26.4	28.1	37.6	24.9	34.6	26.4	29.5	33.7	34.1	24.4	27.4	38.3	27.6	21.9	31.4	42.8	31.8	30.6	26.5	21.1	26.9	27.7	32.5	23.6	35.2	24.1	29.3	28.2	21.5	25.6	23.1	39.9	27.2	31.0	25.9	26.5	30.6	25.3	22.6	25.8	60.2	40.9	23.3	35.2	29.7	47.0	8.2	6.3	14.2	7.0	12.0	9.0	3.0	23.7	12.5	25.8	20.5	20.6	25.8	28.0	23.6	21.3	25.7	26.0	15.1	39.9	36.3	33.6	20.5	24.9	28.1	24.3	35.1	28.2	22.7	33.8	14.6	19.4	19.1	40.3	29.5	15.6	29.2	17.7	24.4	24.3	26.2	25.4	24.2	29.5	43.8	22.0	27.0	21.6	35.8	35.9	19.7	28.8	23.5	27.5	20.4	31.5	22.7	31.9	35.0	37.0	22.1	16.0	20.0	38.8	20.6	26.6	27.0	50.3	22.2	26.1	20.6	5.1	7.0	14.2	5.5	5.9	7.0	6.3	7.6	7.7	6.1	8.2	7.1	6.8	12.2	12.0	4.5	6.3	9.0	3.0	26.3	25.8	33.6	26.4	27.6	21.9	26.5	21.1	24.1	25.8
ZBED4	KIAA0637	ENSG00000100426	"Zinc finger BED-type containing 4"	O75132	22	49853842-49890078	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045341	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA045341: "	"unprognostic (3.82e-2)"	"unprognostic (6.39e-2)"	"unprognostic (7.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.20e-2)"	5.5	4.6	5.9	11.3	7.5	15.0	7.3	11.7	7.5	5.8	9.1	8.9	2.8	8.5	6.7	6.4	11.5	6.0	7.1	4.8	5.1	4.7	7.2	8.0	8.0	11.4	5.4	3.8	6.8	16.5	5.6	6.4	6.6	4.9	6.1	8.0	5.8	11.1	3.7	8.5	8.0	8.5	5.2	6.5	9.5	7.2	8.8	5.3	29.7	6.2	5.4	10.9	6.9	5.9	1.6	2.5	1.6	1.4	6.7	4.1	1.5	9.2	8.3	15.9	12.6	4.9	5.4	9.9	5.5	4.5	6.1	5.6	8.5	4.1	18.3	3.9	5.8	10.6	11.2	7.0	6.5	7.2	13.6	10.5	8.3	8.0	7.1	22.2	15.1	5.1	10.8	6.6	10.1	8.1	11.2	8.8	7.1	7.4	18.4	10.6	8.6	5.8	22.1	14.4	11.1	6.5	9.4	8.4	16.7	5.4	16.1	10.9	7.6	12.7	9.3	8.3	13.2	4.9	7.7	8.8	5.4	16.8	5.0	10.0	9.7	0.7	0.9	1.6	2.2	1.4	4.1	1.6	2.2	2.3	2.4	1.1	2.7	2.1	0.6	6.7	1.4	2.5	1.6	1.5	5.9	7.5	11.7	7.5	5.1	4.7	5.4	3.8	4.9	5.3
ZBED8	"Buster3, C5orf54"	ENSG00000221886	"Zinc finger BED-type containing 8"	Q8IZ13	5	160393148-160400097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA045445, HPA055817"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA045445: AB_10959608, HPA055817: "	"unprognostic (1.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.47e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"prognostic favourable (3.72e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.96e-3)"	3.6	8.1	10.4	1.9	12.4	0.6	6.7	20.1	8.8	11.1	6.3	9.9	5.2	2.9	10.5	13.5	3.8	9.4	4.4	6.8	7.9	6.6	6.7	2.5	4.2	2.5	14.2	6.4	18.8	4.4	6.3	21.7	7.6	9.7	8.3	3.5	5.6	7.9	10.3	4.1	4.8	2.8	8.2	9.5	3.6	4.6	7.0	12.5	2.1	9.5	1.5	3.1	5.5	9.0	0.8	2.9	1.1	3.1	3.3	2.4	1.6	5.6	4.5	11.1	9.8	8.9	6.6	4.6	4.9	4.6	6.0	9.2	4.0	4.5	4.7	9.5	1.7	6.1	6.3	2.8	8.0	4.8	6.3	2.9	6.6	5.1	3.3	1.9	3.8	2.6	6.0	4.4	3.0	3.0	2.1	4.5	6.3	2.2	1.7	3.2	2.7	4.8	2.3	12.9	3.1	2.7	1.6	11.5	3.9	6.5	1.8	5.4	4.3	2.0	2.2	9.1	6.0	2.8	4.0	4.1	6.9	1.2	6.4	2.9	8.8	0.0	2.4	1.1	2.4	1.9	1.4	0.8	2.2	1.7	2.9	0.6	1.7	1.3	0.3	3.3	3.1	2.6	0.0	1.6	10.4	12.4	20.1	8.8	7.9	6.6	14.2	6.4	9.7	12.5
ZBTB1	"KIAA0997, ZNF909"	ENSG00000126804	"Zinc finger and BTB domain containing 1"	Q9Y2K1	14	64503712-64533690	"Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050516	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA050516: "	"unprognostic (4.09e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (4.92e-4)"	"unprognostic (1.11e-3)"	"unprognostic (9.43e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.65e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.27e-2)"	19.5	13.0	15.4	19.2	17.9	47.2	34.4	15.6	23.5	15.3	14.6	9.0	13.7	10.8	15.3	18.4	13.6	16.3	14.0	15.0	18.0	11.3	15.8	14.1	20.2	27.1	24.6	9.3	16.4	17.8	19.1	19.2	16.7	15.7	19.6	14.8	10.2	16.4	17.8	18.4	22.2	18.4	16.2	22.3	26.2	14.9	7.2	20.3	39.0	18.9	11.6	22.4	16.0	25.4	12.1	10.9	25.6	13.4	15.1	18.8	11.3	24.4	8.2	18.5	11.5	19.2	23.2	19.0	10.6	15.9	10.1	12.9	7.9	17.4	23.5	10.7	15.0	17.3	8.9	10.6	13.9	34.7	6.1	11.5	15.1	6.6	12.1	9.5	16.9	29.7	18.6	7.0	10.4	11.6	5.6	16.2	18.6	18.6	16.3	9.6	7.7	12.4	14.7	11.4	9.0	17.6	29.8	12.9	10.4	17.4	13.2	14.1	12.6	12.3	15.3	16.9	11.5	8.0	7.3	20.4	8.7	26.4	17.1	9.1	11.0	25.6	10.4	16.6	15.1	9.9	17.3	12.1	13.5	16.7	10.9	11.3	14.0	16.8	8.0	15.1	13.4	6.9	18.8	11.3	15.4	17.9	15.6	23.5	18.0	11.3	24.6	9.3	15.7	20.3
ZBTB10	"FLJ12752, RINZF"	ENSG00000205189	"Zinc finger and BTB domain containing 10"	Q96DT7	8	80485619-80526265	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021554, HPA050569"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA021554: AB_1858937, HPA050569: "	"unprognostic (7.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.40e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.63e-2)"	12.4	8.2	6.3	8.4	6.8	21.3	14.1	13.5	8.0	11.3	6.9	6.1	8.6	2.0	14.5	9.1	5.7	12.2	7.4	9.0	5.6	5.3	10.7	18.4	11.5	9.7	7.5	3.3	18.8	16.2	9.4	7.2	22.8	6.4	17.6	8.0	7.9	8.7	6.8	17.3	3.8	4.3	14.0	7.6	6.6	6.6	12.1	6.3	14.6	10.3	7.5	4.1	19.2	13.4	2.1	3.6	0.6	0.8	2.0	1.5	0.2	0.0	2.4	12.5	6.2	5.5	4.2	16.9	2.2	0.0	1.8	1.8	5.2	1.9	7.1	6.5	3.3	0.6	9.7	3.0	2.1	0.0	15.9	3.7	1.6	4.1	3.2	1.3	1.7	4.0	2.9	2.2	6.3	4.5	3.3	14.1	1.5	3.8	7.0	3.2	3.1	3.8	8.2	6.8	2.4	5.2	7.1	7.3	8.5	2.9	28.6	8.4	5.4	5.1	5.7	4.3	8.1	0.0	2.0	4.2	2.0	8.1	1.6	0.0	5.3	0.6	0.2	0.0	0.8	0.3	0.9	1.1	0.7	0.9	0.7	2.1	1.5	1.4	0.0	2.0	0.8	3.6	0.0	0.2	6.3	6.8	13.5	5.5	5.6	5.3	7.5	3.3	6.4	6.3
ZBTB11	"ZNF-U69274, ZNF913"	ENSG00000066422	"Zinc finger and BTB domain containing 11"	O95625	3	101648889-101677495	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015328, HPA024138"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA015328: AB_1858938, HPA024138: AB_1858939"	"unprognostic (3.25e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavourable (7.49e-4)"	"unprognostic (2.86e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.09e-1)"	11.6	11.0	14.8	14.8	16.5	44.0	13.7	21.9	16.0	14.1	11.9	8.5	8.4	11.4	13.6	10.4	14.1	10.9	10.5	9.1	12.3	12.4	10.5	12.9	14.2	16.6	11.2	12.9	15.0	16.4	19.1	14.3	14.2	14.3	13.0	10.8	7.1	15.2	13.2	16.2	16.6	12.7	12.3	13.5	16.6	11.7	13.7	13.6	28.7	13.6	10.2	16.4	14.4	22.3	6.8	8.0	9.6	11.6	5.2	9.0	4.6	9.8	10.9	7.3	9.6	11.3	11.2	12.7	9.7	9.3	8.7	9.7	9.9	6.8	11.8	7.9	7.1	12.2	10.7	10.8	15.7	12.3	7.6	26.3	10.1	9.1	8.7	18.5	9.7	8.9	13.9	8.0	18.8	8.5	15.1	14.5	9.3	11.9	16.2	8.3	6.8	16.2	13.3	11.3	14.4	8.2	11.6	21.3	7.9	12.5	10.3	12.8	13.0	10.1	9.7	13.5	10.0	5.5	9.5	16.7	13.9	22.2	8.4	12.2	9.5	9.6	6.3	7.0	6.8	8.2	9.0	5.4	5.8	7.5	8.0	6.8	6.8	5.6	4.3	5.2	11.6	4.8	6.3	4.6	14.8	16.5	21.9	16.0	12.3	12.4	11.2	12.9	14.3	13.6
ZBTB14	"ZFP161, ZNF478"	ENSG00000198081	"Zinc finger and BTB domain containing 14"	O43829	18	5289019-5297053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050758, HPA070819"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA050758: , HPA070819: "	"unprognostic (5.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.72e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.90e-2)"	11.2	9.1	13.1	11.6	13.4	6.8	10.8	24.3	12.8	8.7	8.7	10.7	10.8	7.2	12.5	14.9	10.8	9.3	10.3	7.1	13.1	10.2	9.8	11.3	11.0	19.5	14.5	7.6	14.2	12.1	12.8	8.7	8.5	7.3	9.8	8.7	10.3	9.8	11.1	6.9	11.8	12.7	7.5	16.4	17.4	9.8	10.8	8.2	30.8	15.9	7.0	18.1	11.2	11.8	10.1	8.6	14.3	8.2	7.5	13.4	7.6	7.1	9.6	12.5	9.3	9.4	12.5	8.3	7.2	10.7	10.1	8.9	9.1	9.4	25.2	6.3	8.6	6.7	9.2	10.7	10.3	4.9	4.9	9.9	8.8	8.4	6.7	12.4	12.0	9.9	9.1	7.1	6.6	15.7	6.3	8.3	10.2	7.8	18.7	8.4	11.1	4.9	11.1	8.0	7.3	8.5	8.8	11.1	10.9	11.0	7.3	11.6	8.7	14.4	8.7	13.1	10.9	10.1	10.7	5.3	5.3	15.6	13.8	10.7	11.5	10.9	5.7	14.3	9.9	8.2	9.9	8.3	12.7	11.4	8.6	10.1	13.4	12.7	1.3	7.5	7.3	6.5	7.9	7.6	13.1	13.4	24.3	12.8	13.1	10.2	14.5	7.6	7.3	8.2
ZBTB18	"C2H2-171, RP58, TAZ-1, ZNF238"	ENSG00000179456	"Zinc finger and BTB domain containing 18"	Q99592	1	244048939-244057476	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 114.4;skeletal muscle: 40.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 114.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024656			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA024656: "	"unprognostic (3.48e-3)"	"unprognostic (9.17e-3)"	"unprognostic (3.69e-3)"	"prognostic favourable (1.34e-4)"	"unprognostic (6.83e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-3)"	"prognostic favourable (6.78e-6)"	4.1	3.4	20.1	7.3	14.7	13.4	4.7	114.4	26.0	4.1	4.7	5.4	8.1	6.9	3.5	10.3	3.0	4.6	3.8	7.4	24.8	6.3	6.4	10.0	5.1	8.8	7.1	19.1	4.0	13.0	3.1	2.7	4.9	11.7	5.5	5.8	4.6	5.2	6.7	40.3	4.1	6.2	5.9	7.5	10.0	5.8	11.4	4.6	16.4	4.4	2.8	8.1	6.5	9.3	2.4	2.2	5.8	1.5	0.3	1.4	0.2	11.5	4.1	15.9	0.6	2.1	2.2	11.1	6.5	4.8	10.5	6.4	3.1	9.4	8.8	0.6	12.5	1.2	10.1	3.2	13.2	3.1	8.9	1.5	1.4	1.5	3.3	1.8	4.7	1.8	2.7	6.3	3.9	11.3	1.1	3.8	12.4	0.1	15.1	7.4	8.2	1.8	4.4	10.8	2.5	6.6	4.0	23.5	23.0	2.7	0.1	7.1	0.2	13.4	16.8	5.4	6.6	3.3	13.7	1.6	0.2	3.5	5.5	5.7	10.9	0.2	0.7	2.9	0.3	0.7	0.4	1.6	0.7	0.5	0.9	2.4	1.4	0.9	5.8	0.3	1.5	2.2	0.5	0.2	20.1	14.7	114.4	24.1	24.8	6.3	7.1	19.1	11.7	4.6
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364117-151391548	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	11.1	7.7	10.3	10.6	8.6	14.4	13.3	11.7	10.7	9.3	10.3	8.2	9.2	7.9	11.1	8.1	8.5	10.7	11.5	8.4	8.4	6.6	7.7	9.9	13.1	14.4	11.0	6.8	17.4	14.4	8.6	5.3	9.2	10.3	8.7	9.9	6.9	11.1	12.3	14.0	8.6	10.6	14.6	9.6	12.0	9.4	7.7	11.1	27.7	32.2	8.0	13.0	11.2	13.9	5.7	6.6	15.1	10.7	7.8	14.1	6.3	8.7	6.4	9.7	7.3	10.5	11.0	10.4	13.8	20.0	17.5	16.8	12.2	7.2	22.4	7.7	13.9	10.4	15.6	16.9	21.9	10.1	11.6	10.1	7.6	18.5	15.6	27.2	12.5	11.6	10.1	16.0	19.7	10.2	18.3	13.2	12.3	19.5	14.7	12.7	11.8	9.7	14.1	9.2	8.9	13.3	13.3	10.9	7.6	10.9	14.4	10.8	9.7	16.4	8.4	14.9	16.1	6.7	18.3	17.6	18.3	25.1	6.1	14.8	10.5	13.6	6.0	15.1	11.3	6.6	14.1	5.7	10.3	13.4	6.6	4.4	8.7	10.5	6.9	7.8	10.7	2.7	8.3	6.3	10.3	8.6	11.7	10.7	8.4	6.6	11.0	6.8	10.3	11.1
ZBTB20	"DKFZp566F123, DPZF, ODA-8S, ZNF288"	ENSG00000181722	"Zinc finger and BTB domain containing 20"	Q9HC78	3	114314501-115147271	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015551, HPA016815"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA015551: , HPA016815: AB_1858947"	"unprognostic (1.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.81e-1)"	10.7	7.3	6.3	2.9	12.3	4.0	6.2	17.3	9.3	7.2	4.2	10.8	5.3	1.7	6.6	17.4	3.5	4.9	4.3	6.1	9.7	5.2	9.8	9.8	4.4	3.3	14.9	3.7	12.7	5.9	5.3	26.1	2.2	11.5	10.0	2.7	7.9	5.4	9.2	12.1	4.4	4.0	7.5	19.2	4.4	3.9	44.6	14.2	2.1	9.1	8.1	3.3	5.2	5.0	18.2	4.3	7.8	3.6	4.1	7.7	2.7	2.3	4.3	1.7	4.1	6.3	2.7	0.0	1.8	3.8	1.1	0.9	2.5	0.8	0.6	6.0	4.6	0.1	6.0	1.0	1.1	0.5	0.1	0.6	2.1	1.9	1.5	0.3	0.0	2.7	0.3	2.5	0.8	1.2	0.1	1.0	6.4	0.0	0.3	0.2	0.4	0.2	0.2	5.1	0.0	4.2	0.0	0.4	1.0	0.8	0.0	1.3	0.0	0.5	7.1	1.6	5.5	0.3	2.6	1.6	0.0	0.3	2.5	0.4	1.9	7.8	1.4	5.1	6.1	2.0	4.2	18.2	6.0	5.6	1.6	10.7	7.7	6.6	3.1	4.1	3.6	4.3	2.8	2.7	6.3	12.3	17.3	9.3	9.7	5.2	14.9	3.7	11.5	14.2
ZBTB21	"KIAA1227, ZNF295"	ENSG00000173276	"Zinc finger and BTB domain containing 21"	Q9ULJ3	21	41986831-42010387	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024655, HPA031757, HPA031758"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA024655: AB_1859171, HPA031757: , HPA031758: "	"unprognostic (1.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.02e-1)"	13.1	41.0	11.0	6.8	12.9	39.2	11.8	11.5	14.4	10.3	7.5	8.3	7.4	4.9	15.4	9.2	8.0	11.4	13.8	9.4	9.6	7.3	8.0	19.6	10.3	5.8	8.3	6.2	19.6	10.7	20.9	11.7	18.3	8.8	9.6	6.2	6.8	8.5	8.6	5.3	13.8	7.6	9.9	8.9	8.7	8.9	13.1	10.4	10.1	12.1	6.4	7.1	10.7	14.5	4.9	5.0	5.0	6.2	1.3	5.9	2.4	6.4	5.2	5.1	5.7	7.2	5.6	4.9	6.0	8.7	5.8	8.9	6.1	3.2	11.5	2.7	6.0	4.9	7.3	4.2	9.4	6.0	7.3	1.3	5.2	3.7	5.5	4.4	2.8	3.2	9.1	8.1	10.7	3.2	7.5	20.0	4.1	9.4	12.0	2.2	5.0	6.4	5.1	5.7	13.4	2.5	5.2	7.2	4.2	8.3	12.6	5.8	4.5	2.1	3.6	8.6	4.8	5.9	5.9	32.1	28.0	10.8	11.3	7.5	5.5	0.2	4.9	2.4	3.7	6.0	4.2	4.9	4.0	2.9	5.0	4.5	5.9	4.3	5.0	1.3	6.2	4.3	2.6	2.4	11.0	12.9	11.5	14.4	9.6	7.3	8.3	6.2	8.8	10.4
ZBTB25	"C14orf51, KUP, ZNF46"	ENSG00000089775	"Zinc finger and BTB domain containing 25"	P24278	14	64449106-64505213	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054699	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA054699: "	"unprognostic (1.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.32e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (3.56e-6)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-1)"	12.1	12.0	16.5	18.4	19.2	14.6	18.1	17.1	15.2	12.3	12.6	13.9	7.7	8.1	13.3	18.8	8.3	14.6	11.9	20.0	13.0	10.8	10.1	12.4	12.5	28.0	15.4	12.9	16.3	12.9	18.1	18.6	9.5	14.7	12.9	11.3	13.2	9.0	12.8	19.2	15.9	14.1	13.2	18.5	17.0	11.1	11.5	18.1	31.8	19.2	7.8	22.7	20.0	14.0	6.4	2.9	2.8	2.4	6.3	11.5	6.3	14.9	6.6	4.4	4.4	6.4	8.0	8.7	2.6	4.6	4.3	5.6	3.1	10.5	11.2	3.0	4.3	13.9	4.3	4.3	5.2	11.5	1.4	2.6	9.9	1.4	7.3	1.8	5.9	10.1	4.3	4.2	8.3	3.9	1.5	18.4	5.1	6.4	6.3	2.6	2.3	6.9	4.9	4.8	4.7	4.9	7.1	4.3	4.7	5.5	4.2	3.4	5.3	1.3	4.2	5.9	8.9	2.7	3.9	16.3	3.8	5.1	8.8	2.2	4.4	2.8	2.4	1.5	6.9	1.6	9.0	6.4	9.7	6.6	1.6	4.3	11.5	11.2	2.6	6.3	1.3	2.9	8.3	6.3	16.5	19.2	17.1	15.2	13.0	10.8	15.4	12.9	14.7	18.1
ZBTB33	"kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348"	ENSG00000177485	"Zinc finger and BTB domain containing 33"	Q86T24	X	120250752-120258398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000755, CAB001980, HPA005732"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166"	"unprognostic (9.14e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.59e-2)"	15.4	10.4	12.8	9.3	15.5	20.2	18.0	16.3	13.9	9.6	8.5	11.6	9.1	9.1	7.7	11.5	14.9	10.0	9.0	6.0	12.6	15.0	8.0	22.5	10.7	14.0	13.4	11.6	12.2	11.6	17.7	15.5	10.2	16.7	10.5	7.9	6.2	15.0	10.0	9.5	21.6	10.2	6.0	18.6	12.7	9.9	6.9	14.8	29.3	17.4	5.3	14.6	10.3	9.7	3.4	8.9	14.2	8.9	5.1	7.2	5.2	9.0	10.2	13.9	12.7	10.9	12.5	16.3	7.1	9.5	8.3	10.2	6.2	8.0	13.4	13.5	7.1	14.1	21.9	11.1	10.6	14.8	15.8	14.0	15.4	8.3	8.3	13.9	15.9	8.9	13.6	8.4	12.5	14.0	9.0	15.7	10.2	10.9	13.0	9.0	16.9	11.1	14.8	10.5	21.3	8.4	16.3	25.4	10.8	15.0	14.7	16.6	7.9	19.7	13.8	6.6	4.9	9.8	12.5	8.8	8.9	17.0	9.2	19.9	8.2	14.2	6.1	7.7	4.4	8.9	7.2	3.4	5.6	5.5	8.9	3.3	7.1	4.8	1.2	5.1	5.6	8.5	4.9	5.2	12.8	15.5	16.3	13.9	12.6	15.0	13.4	11.6	16.7	14.8
ZBTB34	"KIAA1993, MGC24652, ZNF918"	ENSG00000177125	"Zinc finger and BTB domain containing 34"	Q8NCN2	9	126860665-126885878	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023893	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA023893: AB_2219180"	"unprognostic (2.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-3)"	"unprognostic (6.59e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.01e-2)"	9.4	5.0	9.7	7.1	12.0	21.8	6.7	15.6	13.2	5.8	6.1	9.0	4.7	5.2	9.4	5.8	6.0	6.4	6.9	5.3	10.0	5.2	6.1	5.4	9.8	8.9	12.2	6.5	6.7	6.3	7.9	7.0	11.4	11.5	5.9	5.3	8.9	7.3	5.8	6.1	7.5	6.8	5.6	10.2	10.6	6.6	5.2	10.3	8.9	7.2	2.2	7.7	6.4	10.8	0.7	1.0	4.5	1.0	1.2	0.8	0.4	2.5	3.4	10.1	4.1	7.9	8.0	14.0	3.0	4.6	3.7	4.1	8.1	4.8	4.8	3.4	3.2	7.9	12.1	3.1	3.7	5.0	5.0	5.6	9.1	4.3	5.5	7.6	9.2	6.9	5.0	4.3	4.9	4.8	11.7	3.9	3.4	3.6	4.8	6.3	8.7	2.6	9.2	11.6	5.0	4.8	3.7	3.2	10.9	4.1	3.7	5.6	3.6	11.3	5.1	3.4	6.2	4.7	3.3	6.9	8.0	4.1	3.1	6.3	3.2	2.3	1.0	3.0	0.8	0.4	0.8	0.6	0.3	0.3	0.8	0.7	0.8	0.4	4.5	1.2	0.6	1.0	0.1	0.4	9.7	12.0	15.6	13.2	10.0	5.2	12.2	6.5	11.5	10.3
ZBTB38	"CIBZ, FLJ35036, PPP1R171, ZNF921"	ENSG00000177311	"Zinc finger and BTB domain containing 38"	Q8NAP3	3	141324213-141449792	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 51.3;RPMI-8226: 74.3;U-266/70: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014865, HPA059378"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA014865: AB_1858957, HPA059378: "	"unprognostic (1.78e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.04e-1)"	18.4	27.6	19.6	16.3	26.5	5.4	20.2	50.9	30.1	28.0	23.2	11.6	15.5	14.9	36.1	11.1	14.4	20.1	25.4	21.7	16.3	12.5	18.8	13.2	20.1	16.7	17.6	21.0	21.3	17.3	43.5	21.8	19.9	18.3	19.7	21.9	13.4	22.8	21.3	56.7	11.1	20.4	30.1	18.7	11.8	17.1	17.4	20.1	2.6	20.3	9.4	19.5	25.7	24.5	11.4	5.1	13.6	5.3	14.8	17.8	6.7	10.6	15.7	1.9	3.7	17.0	16.1	2.4	17.2	20.7	16.6	24.4	8.2	6.3	0.3	7.1	14.9	3.0	2.1	14.5	38.2	10.2	2.9	2.9	15.1	4.7	19.0	0.2	4.4	12.1	8.6	17.7	35.9	12.7	3.1	51.3	18.8	1.1	0.2	0.6	1.9	1.9	0.2	5.4	74.3	10.8	6.6	0.7	2.7	25.2	2.4	9.0	5.2	2.7	30.6	13.6	3.5	26.4	8.0	51.2	29.8	3.8	23.4	0.3	7.5	13.6	3.4	9.4	17.8	5.3	13.3	11.4	11.7	17.7	5.1	5.1	9.1	14.7	4.0	14.8	4.2	2.5	15.3	6.7	19.6	26.5	50.9	30.1	16.3	12.5	17.6	21.0	18.3	20.1
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: "	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favourable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	20.1	23.5	20.1	10.9	22.7	4.7	20.6	27.9	38.3	26.3	21.8	19.8	13.7	9.2	22.8	22.7	16.6	22.5	15.1	22.3	19.6	18.3	15.6	6.3	21.4	10.7	21.0	19.4	35.1	16.3	70.1	15.4	14.6	25.8	22.3	9.9	26.2	19.9	30.0	21.4	14.8	11.3	22.3	20.2	18.7	14.2	10.6	14.7	8.2	23.9	9.5	12.7	23.4	24.7	1.8	1.3	1.4	4.6	2.0	3.5	1.5	6.4	8.9	2.2	4.3	23.9	12.4	4.1	9.1	13.1	8.2	8.2	2.9	3.1	0.6	7.2	17.1	10.3	2.2	12.7	6.0	10.2	3.8	3.2	7.2	2.0	6.7	0.6	7.7	8.6	13.3	7.9	10.1	7.1	1.0	2.1	9.0	4.3	2.2	1.3	0.9	4.2	4.1	3.9	0.9	10.0	5.5	1.3	3.3	4.0	2.8	4.2	5.3	1.4	9.9	9.3	3.7	8.7	7.4	3.8	2.6	0.4	10.0	2.0	4.8	1.1	0.9	1.4	3.2	1.4	3.5	1.6	2.6	2.6	0.7	1.8	3.4	3.1	0.6	2.0	4.6	1.3	1.3	1.5	20.1	22.7	27.9	38.3	19.6	18.3	21.0	19.4	25.8	14.7
ZBTB42	ZNF925	ENSG00000179627	"Zinc finger and BTB domain containing 42"	B2RXF5	14	104800596-104804712	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.2;MCF7: 22.3;T-47d: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000703, HPA066961"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA000703: , HPA066961: "	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.99e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.42e-1)"	"prognostic favourable (2.30e-9)"	"unprognostic (1.34e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-3)"	"unprognostic (5.45e-2)"	4.8	4.1	1.1	2.4	1.3	0.1	3.8	0.7	1.2	4.5	4.7	0.9	7.7	3.9	2.6	6.2	5.4	5.6	10.1	4.1	0.8	0.6	4.8	9.9	9.0	4.6	1.2	0.6	5.1	25.8	2.0	1.7	2.4	1.7	7.5	2.1	3.2	10.6	7.3	6.9	2.8	5.2	1.5	1.3	2.9	6.6	2.4	0.3	3.7	6.7	4.5	4.8	3.1	2.3	0.8	0.7	8.4	0.3	0.2	0.9	0.3	0.9	2.9	0.9	3.6	0.7	0.8	3.8	1.3	1.4	2.4	2.1	1.9	3.5	0.3	2.6	1.3	4.0	0.8	1.3	0.4	13.2	0.9	1.2	1.5	2.2	1.2	0.3	7.3	1.4	1.4	0.9	0.4	1.0	2.0	1.9	0.4	22.3	2.4	1.8	0.5	2.8	3.4	0.2	1.8	1.7	5.8	4.1	1.8	1.0	5.4	2.4	18.5	1.4	1.6	0.9	2.1	0.2	0.4	2.2	1.2	0.2	3.1	1.2	1.9	0.0	0.3	8.4	0.5	0.1	0.9	0.8	0.7	0.1	0.1	0.6	0.5	0.8	0.1	0.2	0.1	0.7	0.6	0.3	1.1	1.3	0.7	1.2	0.8	0.6	1.2	0.6	1.7	0.3
ZBTB7B	"c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B"	ENSG00000160685	"Zinc finger and BTB domain containing 7B"	O15156	1	155002630-155018522	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 54.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006811, HPA025820"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006811: AB_1859046, HPA025820: AB_1859045"	"unprognostic (5.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.53e-2)"	9.4	11.1	3.0	8.8	4.7	11.6	11.1	4.0	4.9	9.5	33.7	11.3	22.3	27.3	5.4	4.5	29.1	5.9	13.2	6.4	4.3	2.1	9.3	19.1	10.5	6.3	8.0	4.3	6.2	18.2	5.1	6.4	11.3	5.9	9.9	8.1	9.6	19.1	18.6	11.8	33.3	54.0	5.4	5.6	10.3	11.2	3.8	7.3	1.8	14.3	11.2	16.0	8.6	12.4	2.0	2.3	5.7	3.4	1.5	2.5	4.3	7.4	13.3	1.2	4.1	6.1	3.5	16.4	5.1	6.1	5.4	6.3	8.9	10.8	3.2	9.2	5.8	11.4	3.7	7.2	1.1	17.7	4.2	5.4	22.3	5.9	9.0	4.1	15.0	4.5	25.9	7.4	9.2	4.2	7.7	15.1	3.1	14.1	0.1	9.3	4.0	11.1	3.0	0.9	20.4	8.1	7.8	7.6	7.8	9.8	26.5	4.1	16.4	14.0	3.5	3.5	6.2	6.9	4.3	18.0	11.0	3.4	8.2	13.8	4.0	0.9	3.2	2.9	1.5	3.4	0.5	1.6	2.0	0.9	2.3	2.0	1.7	0.5	5.7	1.5	2.9	0.2	2.5	4.3	3.0	4.7	4.0	4.9	4.3	2.1	8.0	4.3	5.9	7.3
ZC3H12A	"FLJ23231, MCPIP1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474552-37484379	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.7;tongue: 56.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.4;RT4: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Cytoplasmic bodies"	Nucleoplasm	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favourable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	11.7	8.4	0.8	15.0	2.9	58.7	8.2	1.3	1.3	6.4	13.3	2.9	5.6	7.0	5.0	6.9	25.2	8.1	22.6	6.3	2.1	0.7	6.7	10.7	21.0	11.3	1.8	0.7	7.1	6.8	1.0	4.6	8.1	3.8	16.1	4.2	3.0	10.9	6.3	11.8	23.1	14.1	8.5	2.6	10.9	11.0	3.4	1.1	8.3	4.0	56.9	34.8	17.0	22.2	6.1	2.6	8.9	2.1	5.5	5.5	2.3	3.7	2.7	0.3	1.7	1.4	2.1	3.1	2.7	24.4	1.7	2.3	3.0	8.5	4.2	11.6	2.6	8.2	1.1	17.5	1.0	8.6	1.7	1.1	8.9	4.7	2.0	2.2	1.8	4.4	9.0	15.2	2.7	2.0	2.1	7.0	1.6	4.5	1.7	4.0	2.1	2.4	2.5	1.1	2.5	4.4	30.2	0.8	0.5	5.4	8.7	0.6	3.0	2.5	2.0	5.3	2.9	3.8	4.1	5.6	2.0	3.1	12.0	4.7	1.0	1.8	2.1	5.8	5.4	2.1	5.5	5.2	2.2	3.3	2.6	6.1	1.3	2.5	8.9	5.5	1.9	2.5	2.8	2.3	0.8	2.9	1.3	1.3	2.1	0.7	1.8	0.7	3.8	1.1
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485061	"Disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 38.1"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 26.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Nucleoplasm, Cytoplasmic bodies"		"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	3.3	0.8	0.5	33.4	1.0	3.4	1.2	0.7	0.6	0.8	3.0	0.1	1.0	3.0	0.6	1.2	0.8	0.8	0.9	0.6	0.5	0.7	1.3	0.8	2.0	10.6	0.5	0.0	0.4	0.7	0.0	0.6	0.8	0.5	0.7	1.5	0.9	2.0	0.2	0.4	1.1	7.7	0.4	0.7	9.5	0.7	0.7	0.4	4.8	0.9	1.6	38.1	1.7	0.6	3.2	1.7	1.3	2.7	0.7	7.2	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	6.2	0.1	0.0	0.1	0.0	0.0	0.1	26.4	0.2	0.2	0.8	2.1	0.0	2.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	1.9	0.0	0.0	5.4	0.0	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	3.5	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.3	0.3	2.0	0.1	1.3	1.8	0.4	0.3	1.0	0.5	3.1	3.2	1.5	1.7	3.2	2.0	0.5	1.3	0.7	2.7	1.0	7.2	1.5	0.5	1.0	0.7	0.6	0.5	0.7	0.5	0.0	0.5	0.4
ZC3H14	"FLJ11806, NY-REN-37, UKp68"	ENSG00000100722	"Zinc finger CCCH-type containing 14"	Q6PJT7	14	88562909-88627596	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049798, HPA053510"	Enhanced		Enhanced	"Nucleoli,Nuclear speckles"				"Nuclear speckles"	Nucleoli	"HPA049798: AB_2680888, HPA053510: AB_2682174"	"unprognostic (5.80e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.47e-3)"	"unprognostic (9.57e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.50e-2)"	"prognostic favourable (7.08e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.71e-1)"	"unprognostic (4.25e-2)"	13.5	12.6	16.2	10.8	16.4	9.7	13.3	23.4	19.6	14.0	15.3	14.3	17.5	10.6	17.2	15.5	12.4	15.8	10.4	12.3	14.8	8.4	15.2	24.9	13.9	9.1	16.1	16.3	17.1	19.4	19.3	24.1	14.8	16.0	14.9	16.6	11.3	18.0	16.3	15.4	13.6	15.2	14.8	11.2	9.4	12.7	73.1	14.1	9.3	19.4	8.2	11.4	16.2	12.8	13.3	17.4	21.7	21.1	18.5	17.7	13.3	16.1	31.1	28.5	22.5	22.7	22.0	28.9	24.8	22.5	35.2	31.1	22.1	25.4	22.5	17.9	25.2	19.9	20.2	23.1	48.0	18.9	15.2	11.0	22.2	18.0	22.8	24.0	14.4	17.6	27.2	27.4	27.5	22.9	21.4	10.4	31.8	34.3	21.7	13.3	18.1	27.4	19.0	36.5	9.8	23.7	29.0	21.4	19.2	30.9	35.4	17.3	32.3	15.8	16.8	42.8	26.2	18.0	24.6	13.3	11.5	25.1	21.0	11.8	19.6	12.9	16.0	21.7	15.9	20.0	17.7	13.3	15.5	17.5	17.4	12.0	14.7	14.7	2.9	18.5	21.1	9.5	13.2	13.3	16.2	16.4	23.4	19.6	14.8	8.4	16.1	16.3	16.0	14.1
ZC3H15	LEREPO4	ENSG00000065548	"Zinc finger CCCH-type containing 15"	Q8WU90	2	186486156-186509363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031099, HPA031100, HPA031101"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669"	"unprognostic (1.51e-1)"	"prognostic unfavourable (6.45e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (5.92e-2)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (1.48e-7)"	"unprognostic (9.08e-3)"	"unprognostic (4.95e-2)"	"prognostic favourable (3.98e-4)"	"prognostic unfavourable (9.75e-4)"	"unprognostic (5.72e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.45e-2)"	25.2	31.1	35.7	25.2	40.1	67.3	38.0	32.9	52.6	24.7	24.7	10.5	30.2	29.0	25.1	30.7	28.2	19.8	22.6	25.2	60.0	35.4	32.8	40.3	20.3	29.5	32.3	33.5	24.5	32.7	26.9	35.3	29.4	51.6	24.3	28.9	10.7	25.8	26.2	58.0	27.0	29.9	27.4	43.4	28.5	23.3	23.7	21.7	28.3	30.5	19.0	30.1	30.0	38.8	32.8	31.1	28.3	39.1	32.5	36.9	22.4	26.7	18.2	22.5	28.9	25.6	26.0	33.8	29.9	20.4	27.7	25.1	53.0	21.8	36.6	27.4	21.2	19.5	41.4	36.5	39.3	33.2	31.6	52.5	28.1	58.6	34.7	53.4	32.2	21.3	40.5	30.1	42.9	29.7	50.1	28.7	28.9	24.1	34.0	38.2	42.5	46.1	27.2	30.5	34.0	35.1	32.8	27.2	20.1	18.9	25.9	43.1	18.2	38.9	25.4	31.4	27.1	19.2	35.6	25.0	42.0	52.3	27.9	38.0	27.3	28.3	27.5	26.9	27.2	34.0	33.7	32.8	33.8	34.5	31.1	24.7	31.5	33.2	16.8	32.5	39.1	27.5	36.9	22.4	35.7	40.1	32.9	52.6	60.0	35.4	32.3	33.5	51.6	21.7
ZC3H18	NHN1	ENSG00000158545	"Zinc finger CCCH-type containing 18"	Q86VM9	16	88570381-88631966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040847, HPA041327"	Enhanced		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA040847: AB_10794865, HPA041327: AB_10795005"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (4.06e-4)"	"unprognostic (1.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.07e-3)"	"prognostic favourable (3.68e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.01e-1)"	17.5	13.5	15.5	28.1	19.0	30.9	15.3	28.3	21.4	15.1	17.1	20.7	17.4	20.3	20.5	12.2	16.5	15.5	21.8	13.9	15.6	12.6	11.5	13.6	14.7	23.1	17.1	10.5	18.2	19.7	18.8	17.7	18.7	15.0	13.2	11.8	13.4	18.4	13.0	27.6	16.3	20.2	14.6	14.3	22.4	16.9	31.4	18.4	27.0	15.3	10.7	18.6	17.2	21.3	4.5	5.8	7.6	9.9	6.4	6.8	4.1	15.2	20.5	15.0	14.9	7.4	6.4	24.1	15.4	8.4	14.4	6.6	20.1	13.3	18.7	13.1	7.2	18.3	14.0	11.6	9.2	10.9	17.8	12.4	10.1	17.0	9.5	9.5	10.8	5.8	8.9	15.3	7.4	8.9	33.7	6.2	7.1	29.5	30.5	16.9	23.4	12.4	37.5	10.3	13.7	6.5	9.7	15.9	13.7	29.5	8.2	8.6	18.7	13.0	12.1	15.5	16.2	11.2	15.5	14.0	22.0	44.8	13.8	22.4	16.3	4.5	4.5	4.3	6.0	5.2	6.7	4.4	5.5	6.1	4.0	4.5	5.0	3.9	7.6	6.4	9.9	5.8	6.8	4.1	15.5	19.0	28.3	21.4	15.6	12.6	17.1	10.5	15.0	18.4
ZC3H4	"C19orf7, KIAA1064"	ENSG00000130749	"Zinc finger CCCH-type containing 4"	Q9UPT8	19	47064187-47113752	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040934, HPA041068"	Supported		Enhanced	Nucleoplasm,Cytosol			8500	Nucleoplasm	Cytosol	"HPA040934: AB_10795495, HPA041068: AB_10796567"	"unprognostic (8.02e-3)"	"unprognostic (3.68e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.90e-2)"	"prognostic favourable (2.23e-4)"	12.0	8.2	8.6	14.5	16.9	8.5	18.2	25.6	13.9	8.9	9.6	14.7	9.8	11.5	12.8	6.0	11.8	10.4	6.5	8.2	9.3	7.6	9.2	10.9	19.9	14.1	16.5	5.2	14.6	12.5	10.4	45.4	15.4	13.9	9.7	7.2	10.8	11.8	10.4	14.1	13.5	11.5	8.5	26.0	16.0	11.5	14.5	12.4	17.5	10.5	9.3	11.5	10.3	24.0	5.2	6.8	6.2	3.7	5.2	5.6	1.2	8.7	13.8	8.6	12.2	4.8	3.0	8.7	7.1	4.0	6.7	4.5	9.8	9.9	18.6	5.2	4.8	15.3	3.7	10.0	4.2	11.4	6.1	13.2	8.3	7.4	4.2	12.6	14.2	5.1	2.8	6.1	4.9	5.4	12.7	7.1	4.3	15.3	14.2	21.2	12.7	4.7	22.3	7.4	8.4	5.0	14.4	10.5	14.8	10.8	9.0	5.2	9.5	10.1	9.5	9.1	8.9	5.8	9.9	9.3	7.5	16.6	7.1	10.2	12.9	4.6	2.2	3.2	5.5	3.7	5.6	5.2	4.9	5.5	2.9	5.1	4.3	4.8	6.2	5.2	3.5	6.8	3.1	1.2	8.6	16.9	25.6	13.9	9.3	7.6	16.5	5.2	13.9	12.4
ZC3H7A	"FLJ20318, HSPC055, ZC3H7, ZC3HDC7"	ENSG00000122299	"Zinc finger CCCH-type containing 7A"	Q8IWR0	16	11750586-11797267	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040808, HPA059849"	Uncertain		Supported	Cytosol				Cytosol		"HPA040808: AB_10794150, HPA059849: "	"unprognostic (2.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.27e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.55e-2)"	22.9	19.6	18.3	16.6	18.8	27.3	21.2	25.6	19.1	19.2	18.4	18.4	21.4	14.2	24.4	17.0	13.5	19.2	17.5	15.8	16.9	11.9	19.4	18.0	23.6	21.7	19.0	16.6	25.5	21.3	25.4	20.2	21.3	16.8	20.8	16.5	23.1	22.6	22.5	32.9	15.1	19.1	25.6	18.1	23.3	17.9	8.9	19.3	32.9	23.5	13.5	21.8	20.7	17.1	12.8	10.5	16.0	23.5	17.5	19.2	7.1	13.3	6.9	24.2	13.1	17.0	17.0	9.7	21.5	21.5	16.4	20.1	7.6	11.7	18.7	13.5	25.4	8.6	13.6	20.8	23.6	14.7	15.5	8.0	14.0	12.7	24.1	18.4	17.7	19.1	11.6	15.3	29.0	20.4	13.1	16.9	23.5	10.4	13.9	9.3	14.2	6.3	20.3	13.5	13.3	15.3	10.4	18.6	14.8	17.3	16.8	21.4	12.2	12.1	19.2	19.1	11.7	25.7	14.4	13.6	10.2	27.8	14.0	13.8	49.0	12.3	10.7	16.0	12.5	14.4	17.1	12.8	16.1	13.3	10.5	12.2	19.2	13.4	13.3	17.5	23.5	8.4	19.0	7.1	18.3	18.8	25.6	19.1	16.9	11.9	19.0	16.6	16.8	19.3
ZC3H8	"Fliz1, ZC3HDC8"	ENSG00000144161	"Zinc finger CCCH-type containing 8"	Q8N5P1	2	112211525-112255136	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034803, HPA034804"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA034803: , HPA034804: AB_10670284"	"unprognostic (2.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.49e-2)"	"unprognostic (8.02e-3)"	"unprognostic (4.88e-3)"	6.5	7.9	13.0	9.0	15.9	9.1	13.6	18.2	19.6	7.5	7.7	7.2	9.1	8.8	8.4	7.5	16.1	8.8	4.5	13.7	11.1	8.6	9.2	9.8	5.0	12.8	11.6	12.6	10.3	15.4	15.2	35.7	6.2	13.6	9.8	10.4	5.2	11.3	11.7	33.1	12.5	8.3	7.6	13.7	11.7	7.8	14.1	13.8	12.6	12.2	12.8	13.8	9.0	12.4	7.2	4.7	2.4	2.8	8.7	10.6	2.9	11.7	5.7	7.3	7.6	4.2	4.6	11.5	3.7	3.2	5.3	4.4	13.7	4.6	24.5	7.0	2.6	7.1	10.7	7.5	7.1	8.6	4.9	16.2	6.3	6.9	6.6	15.0	7.5	5.7	15.1	10.2	16.0	3.9	20.6	6.8	4.1	7.7	16.2	13.7	6.8	16.2	11.4	12.6	10.0	4.8	5.2	11.0	8.6	7.0	7.6	15.8	6.0	8.1	5.2	7.0	8.9	4.9	9.4	12.3	14.6	24.1	5.0	12.6	2.7	2.4	2.8	0.9	5.1	2.3	10.6	6.4	5.1	5.3	2.9	7.2	8.8	7.5	1.5	8.7	2.7	4.7	5.1	2.9	13.0	15.9	18.2	19.6	11.1	8.6	11.6	12.6	13.6	13.8
ZC3HAV1	"FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043520-139109719	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: "	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavourable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favourable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	14.3	14.8	6.8	19.8	6.6	52.6	13.8	1.6	5.6	11.2	11.5	6.7	10.8	6.9	10.0	10.9	14.2	9.5	10.4	7.0	5.4	7.2	11.2	13.1	17.2	44.4	7.5	4.0	10.6	11.0	9.8	11.4	8.5	8.6	11.2	10.2	9.3	16.9	11.5	3.8	9.5	14.8	10.8	9.0	22.6	9.6	7.8	6.9	43.9	18.2	8.8	26.1	10.8	29.0	16.3	7.0	28.8	11.9	15.6	27.9	11.8	11.4	14.2	2.0	11.8	18.7	18.0	8.6	13.0	10.0	22.7	23.4	10.1	14.9	10.1	12.2	20.7	13.0	15.8	15.4	12.9	17.9	5.9	20.0	14.4	12.5	10.8	23.2	18.6	18.3	9.9	25.8	5.8	16.9	16.9	11.3	9.7	10.8	19.1	27.1	8.0	8.6	22.7	7.1	9.7	15.6	14.5	3.6	7.5	20.0	14.1	17.3	8.2	14.5	21.2	4.8	7.1	13.2	10.7	8.7	9.1	23.7	10.9	21.7	11.4	28.8	8.2	11.9	19.4	10.6	24.6	14.3	27.9	23.5	6.4	16.3	27.3	26.4	22.1	15.6	11.9	7.0	24.2	11.8	6.8	6.6	1.6	5.6	5.4	7.2	7.5	4.0	8.6	6.9
ZC3HAV1L	"C7orf39, MGC14289"	ENSG00000146858	"Zinc finger CCCH-type containing, antiviral 1 like"	Q96H79	7	139025706-139036029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 10.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 10.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020386, HPA050741"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA020386: AB_2257412, HPA050741: "	"unprognostic (1.12e-1)"	"prognostic unfavourable (7.35e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-3)"	8.2	6.1	2.9	3.1	4.7	1.5	9.4	1.1	3.0	14.7	6.6	2.0	5.0	4.2	10.3	9.7	8.6	7.4	5.6	4.7	2.0	2.4	6.2	1.9	5.3	3.0	1.6	1.7	20.2	9.9	4.4	12.2	14.1	2.0	12.0	4.4	8.4	5.9	10.1	3.0	11.6	4.4	8.8	1.8	6.0	4.5	4.4	2.1	10.5	17.4	5.6	6.2	9.0	9.1	1.0	0.3	10.7	0.3	0.3	0.4	0.3	9.0	7.5	5.5	18.4	4.6	7.1	0.2	4.5	2.0	3.3	4.7	12.3	5.3	0.2	6.5	4.8	6.6	7.6	1.8	10.3	5.4	0.1	11.6	7.3	4.2	3.7	0.1	4.3	5.4	2.9	5.0	2.4	5.7	5.0	0.3	6.9	0.0	12.2	6.9	1.0	4.8	12.9	18.7	0.1	3.1	4.9	3.7	16.8	11.1	1.6	6.9	6.9	4.7	7.9	6.1	5.5	2.1	0.0	0.3	0.0	0.2	3.5	0.1	5.7	10.7	0.3	1.3	0.2	0.1	0.3	0.6	0.4	0.4	0.2	1.0	0.3	0.4	0.8	0.3	0.1	0.3	0.3	0.3	2.9	4.7	1.1	3.0	2.0	2.4	1.6	1.7	2.0	2.1
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018286-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	11.0	13.8	8.1	10.0	10.3	4.9	14.2	9.5	12.6	9.5	9.2	9.9	5.9	6.0	14.5	11.0	7.9	9.4	7.5	16.3	8.2	8.9	13.2	14.8	6.9	13.6	7.3	8.4	10.7	10.6	10.5	9.6	10.0	10.5	9.0	8.4	9.6	10.5	8.4	33.0	7.1	7.8	12.9	5.5	13.7	9.0	24.6	6.6	15.4	8.3	11.9	11.5	8.5	9.6	23.1	20.2	17.4	17.7	17.4	23.8	15.8	7.0	12.0	14.9	16.8	8.5	7.8	10.3	9.2	11.0	17.4	18.1	14.1	12.1	16.3	6.7	11.7	6.5	19.5	13.9	17.2	10.6	16.7	11.3	10.9	13.7	13.7	13.0	11.6	9.4	10.5	18.1	11.8	19.0	33.9	5.7	17.6	12.4	15.3	25.1	30.4	13.7	14.5	11.5	14.2	17.6	4.8	9.6	17.2	13.3	19.3	14.7	8.4	13.8	8.7	11.9	5.8	10.4	15.4	11.1	16.7	21.2	18.8	16.7	20.2	17.4	16.2	14.5	17.0	17.7	19.5	23.1	18.2	18.2	20.2	20.6	23.8	18.8	1.3	17.4	16.3	11.9	18.5	15.8	8.1	10.3	9.5	12.6	8.2	8.9	7.3	8.4	10.5	6.6
ZCCHC11	"KIAA0191, PAPD3, TUT4"	ENSG00000134744	"Zinc finger CCHC-type containing 11"	Q5TAX3	1	52408282-52553487	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavourable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	13.8	19.1	18.4	25.6	19.0	20.5	18.7	50.9	21.3	22.4	13.3	11.8	16.1	7.7	22.1	22.0	11.5	16.8	14.0	13.5	17.8	16.5	14.2	17.7	13.3	27.4	15.4	14.6	28.3	17.6	34.4	56.0	18.8	16.3	16.1	10.5	12.1	12.6	20.6	44.6	28.1	17.1	20.3	26.6	20.9	12.3	24.9	21.1	31.9	23.9	14.6	25.1	18.3	17.0	23.2	26.0	26.7	4.3	10.3	15.0	2.2	10.4	9.9	24.4	16.5	9.6	12.3	16.9	9.3	13.6	13.6	15.7	10.2	5.5	22.3	11.0	12.9	8.7	18.3	9.8	17.3	18.2	16.7	23.5	12.8	21.2	15.9	25.4	13.4	14.5	21.9	14.5	18.0	9.4	19.1	11.2	11.3	0.1	25.3	18.2	17.7	12.6	22.5	24.8	17.4	14.6	8.6	13.1	13.0	14.3	6.1	13.9	8.5	13.4	7.9	10.6	14.3	9.7	11.3	24.5	32.1	32.1	7.0	13.9	7.6	26.7	4.3	13.8	11.8	1.7	8.8	19.1	12.4	9.5	2.1	23.2	15.0	9.9	16.2	10.3	1.4	26.0	9.3	2.2	18.4	19.0	50.9	21.3	17.8	16.5	15.4	14.6	16.3	21.1
ZCCHC6	"FLJ13409, KIAA1711, PAPD6, TUT7"	ENSG00000083223	"Zinc finger CCHC-type containing 6"	Q5VYS8	9	86287733-86354454	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.1;monocytes: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	11.2	9.3	7.7	22.6	11.2	17.0	17.3	9.7	13.7	10.8	13.5	5.6	12.8	9.4	8.6	8.1	23.1	8.3	10.3	10.1	9.4	5.2	7.4	33.1	16.3	19.5	9.8	5.1	9.0	12.9	9.2	18.6	33.3	9.0	19.3	10.8	4.5	14.0	13.6	12.5	30.9	15.6	9.7	13.6	22.2	11.7	10.3	10.7	23.3	8.7	15.2	16.9	13.7	14.3	4.4	4.3	42.1	15.7	4.5	5.7	2.9	9.8	10.7	6.4	9.2	16.3	24.8	7.8	13.5	13.2	6.0	7.0	4.8	8.8	14.1	12.3	8.9	17.5	7.5	7.6	8.9	16.5	4.0	10.1	11.3	9.0	13.9	11.5	14.8	16.4	16.0	9.5	11.3	10.0	9.5	15.3	16.6	10.6	9.6	7.0	5.2	7.2	4.9	11.1	6.5	10.6	19.4	4.6	3.7	8.2	10.9	4.7	4.1	5.2	15.4	5.7	6.9	10.1	9.2	17.7	13.7	10.5	13.6	6.9	7.5	11.5	7.1	7.1	5.7	9.1	4.9	4.4	3.2	4.1	4.3	4.4	3.7	4.0	42.1	4.5	15.7	2.0	3.0	2.9	7.7	11.2	9.7	13.7	9.4	5.2	9.8	5.1	9.0	10.7
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120539-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	15.2	12.7	9.9	28.4	11.3	16.2	16.8	16.5	12.1	16.1	13.4	10.2	20.0	11.3	19.2	14.9	11.5	13.1	12.4	10.2	10.1	10.3	10.0	11.1	10.9	27.5	11.8	8.4	21.9	19.8	8.6	30.7	10.2	11.2	13.5	14.2	9.8	14.3	19.2	9.9	12.7	13.9	14.0	11.8	18.4	11.8	14.3	12.4	19.9	16.1	12.3	29.3	19.2	12.9	29.7	7.5	10.9	8.5	10.1	11.4	5.2	7.2	4.9	6.8	7.3	7.2	11.1	6.4	7.1	8.3	5.5	7.7	4.8	3.5	25.8	3.9	5.5	3.0	6.6	6.7	8.0	11.8	4.6	7.4	8.0	4.2	11.1	12.6	7.4	7.6	10.5	5.8	22.7	6.4	20.2	9.0	4.9	3.4	9.7	7.0	7.3	7.3	46.8	4.5	6.5	6.9	2.9	7.7	5.6	5.0	6.1	6.5	4.4	8.2	5.7	4.1	5.2	5.9	4.3	3.1	5.7	30.7	6.6	8.2	7.5	4.7	4.4	10.9	7.8	5.0	7.7	18.1	8.9	8.8	4.0	29.7	11.4	10.4	8.8	10.1	8.5	7.5	7.4	5.2	9.9	11.3	16.5	12.1	10.1	10.3	11.8	8.4	11.2	12.4
ZCCHC8	DKFZp434E2220	ENSG00000033030	"Zinc finger CCHC-type containing 8"	Q6NZY4	12	122471600-122501073	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037483, HPA037484"	Supported		Enhanced	Nucleoplasm			130000	Nucleoplasm		"HPA037483: AB_10671502, HPA037484: AB_10672485"	"unprognostic (1.96e-3)"	"unprognostic (8.48e-2)"	"unprognostic (5.55e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (7.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (5.36e-4)"	"unprognostic (8.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.48e-2)"	13.6	11.9	12.8	15.0	14.2	44.3	13.9	25.5	17.6	15.8	11.7	9.6	19.3	11.1	16.0	10.9	14.3	13.7	9.5	9.0	11.7	6.3	10.6	14.0	11.9	12.2	12.4	7.2	17.3	16.4	14.2	21.8	13.2	9.9	13.3	10.9	10.4	13.6	15.1	21.7	14.9	13.9	14.0	12.8	14.5	13.8	14.5	14.4	19.5	15.8	10.5	17.3	14.6	13.3	10.5	6.8	9.0	8.8	10.0	12.5	5.4	11.6	11.4	17.0	17.5	7.4	10.4	21.6	13.9	9.5	18.7	14.4	10.8	10.1	21.3	9.4	6.0	14.3	19.0	8.8	15.9	17.2	11.0	13.1	12.6	9.6	18.0	22.6	14.3	8.2	13.4	11.7	16.3	10.0	19.0	12.8	9.1	7.4	16.1	17.4	15.3	13.0	17.8	14.0	16.6	9.0	6.7	12.0	12.8	16.4	8.5	18.9	15.6	17.1	10.0	11.8	11.6	10.2	13.9	13.7	8.0	28.2	6.2	14.0	6.7	9.0	7.2	4.7	8.9	8.6	8.9	10.5	9.9	10.6	6.8	9.4	11.0	9.0	5.7	10.0	8.8	6.6	12.5	5.4	12.8	14.2	25.5	17.6	11.7	6.3	12.4	7.2	9.9	14.4
ZCCHC9	"DKFZp761J139, PPP1R41"	ENSG00000131732	"Zinc finger CCHC-type containing 9"	Q8N567	5	81301590-81313297	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038404	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA038404: AB_10672744"	"unprognostic (1.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	14.4	12.9	11.7	16.1	10.5	8.9	15.2	14.3	11.5	21.1	19.7	7.4	14.5	13.9	18.4	16.4	21.4	13.9	14.3	11.9	10.0	10.7	23.0	36.3	10.7	16.2	11.1	10.1	19.6	13.8	10.9	22.6	23.0	10.4	23.1	14.6	13.6	12.2	18.1	14.4	15.2	27.7	22.5	12.2	18.0	14.5	14.8	10.0	17.9	19.6	19.1	16.4	26.8	23.5	14.9	17.5	12.8	16.2	11.6	19.1	7.3	10.2	7.2	17.8	9.4	15.5	14.7	24.1	15.4	18.4	11.9	16.6	15.9	14.2	9.5	6.4	7.7	7.6	14.1	14.1	19.1	21.2	13.3	9.8	8.1	18.6	18.2	12.4	8.1	11.3	12.4	10.1	25.5	10.0	16.3	9.3	12.2	13.9	20.4	18.6	12.9	9.3	12.2	23.0	13.9	9.3	10.3	8.7	8.3	12.2	7.4	55.0	9.2	20.0	6.8	7.5	9.2	13.3	16.8	13.4	13.7	14.5	13.3	18.1	16.0	12.8	12.3	11.9	12.8	16.2	16.3	14.9	17.2	15.5	14.8	13.2	16.7	17.1	12.0	11.6	14.0	17.5	19.1	7.3	11.7	10.5	14.3	11.5	10.0	10.7	11.1	10.1	10.4	10.0
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type containing 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Enhanced	Vesicles				Vesicles		"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.7	5.2	6.3	9.3	8.0	6.8	7.3	13.2	9.7	8.8	13.2	5.8	7.1	8.7	6.4	5.6	36.4	10.5	6.9	7.7	6.2	7.1	10.8	2.3	4.7	6.9	5.4	5.2	5.8	14.0	10.9	20.1	9.4	9.4	7.1	14.7	6.4	11.2	5.9	2.1	14.9	12.3	4.9	4.7	6.3	14.4	11.2	4.8	15.0	7.7	18.2	27.5	15.3	14.5	6.3	4.3	23.4	5.8	4.3	7.5	3.5	15.8	7.5	7.2	6.1	2.6	3.0	6.9	7.6	7.0	8.5	9.9	4.5	3.8	8.1	5.3	6.3	24.2	10.3	5.0	9.4	10.0	9.0	4.2	4.8	3.6	6.0	5.7	7.3	3.4	5.9	3.6	5.0	53.8	4.0	4.1	8.8	5.1	7.3	4.7	6.0	7.0	8.2	10.0	1.9	8.8	10.5	12.6	9.2	9.1	11.1	4.1	5.2	6.7	15.4	7.6	5.4	11.6	6.1	3.5	10.7	7.5	9.1	5.9	13.2	7.4	3.5	23.4	6.8	5.8	6.1	6.3	5.3	7.5	4.3	4.2	5.1	6.5	4.4	4.3	4.6	4.2	6.8	3.5	6.3	8.0	13.2	9.7	6.2	7.1	5.4	5.2	9.4	4.8
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type containing 16"	Q969W1	10	97446131-97457370	"Enzymes, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	12.0	13.7	15.9	10.8	17.3	6.4	17.9	17.6	24.6	17.1	17.9	15.6	18.1	15.1	15.5	21.2	17.6	11.5	14.4	18.1	13.2	11.0	23.3	37.4	20.8	11.1	10.9	13.0	15.1	22.5	21.8	15.4	30.7	10.5	16.0	18.9	18.1	28.5	14.1	20.7	14.0	15.7	17.6	8.5	13.2	19.4	16.4	10.8	14.7	19.6	15.4	16.1	15.1	20.0	9.3	14.2	9.4	10.4	13.0	12.0	5.8	21.4	25.2	16.8	20.7	26.9	18.5	17.6	23.6	31.5	27.3	26.1	19.6	19.2	18.9	27.3	34.5	25.3	21.1	33.4	24.4	18.7	24.5	12.0	17.7	18.6	21.6	14.3	17.7	20.6	22.1	31.9	23.0	28.0	9.6	14.4	34.5	20.5	21.6	19.6	13.7	21.9	14.8	17.1	17.4	23.1	9.9	8.2	11.7	14.4	14.9	12.8	19.7	14.0	17.1	17.2	16.0	11.1	27.6	13.8	22.3	11.6	19.9	22.2	9.0	0.3	9.8	9.4	7.0	10.4	8.0	8.2	12.0	11.1	14.2	9.3	9.9	9.8	0.5	13.0	10.4	10.9	9.4	5.8	15.9	17.3	17.6	24.6	13.2	11.0	10.9	13.0	10.5	10.8
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type containing 17"	Q8IUH5	12	76763588-76853696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 16.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: "	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	7.9	7.8	10.0	5.8	14.0	11.3	8.8	18.1	18.1	8.0	5.9	9.2	3.8	3.6	12.0	6.8	6.4	7.0	5.5	6.4	8.7	6.5	9.1	13.1	5.4	7.1	11.3	10.7	11.5	5.2	9.5	10.3	8.7	13.2	7.9	5.4	5.9	5.7	7.3	5.4	5.9	6.4	8.0	10.0	7.1	6.1	6.4	11.6	7.5	6.2	4.1	5.7	5.6	6.3	3.8	16.3	5.8	2.2	1.7	3.6	1.4	5.7	7.1	22.2	11.3	13.4	14.2	10.9	11.7	9.7	7.8	6.9	5.6	4.2	8.0	7.1	11.3	5.5	8.8	7.3	12.2	6.7	9.3	11.6	8.7	8.5	9.0	11.6	10.4	13.3	7.7	7.3	11.0	8.9	12.5	3.7	10.1	5.4	8.3	15.6	16.4	8.1	11.3	7.9	8.7	9.0	8.9	8.7	15.1	12.9	4.7	7.5	10.5	11.7	12.3	10.7	8.1	6.5	6.6	6.0	5.8	8.7	4.0	5.5	11.0	5.7	2.1	5.2	3.6	2.2	2.9	2.6	2.9	2.7	2.6	3.8	3.1	2.6	5.8	1.7	2.1	16.3	1.2	1.4	10.0	14.0	18.1	13.8	8.7	6.5	11.3	10.7	13.2	11.6
ZDHHC22	C14orf59	ENSG00000177108	"Zinc finger DHHC-type containing 22"	Q8N966	14	77131270-77142734	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 52.3"	"Group enriched"	"Detected in some"	4	"AF22: 5.2;NTERA-2: 5.5;RH-30: 9.2;SCLC-21H: 10.2"	"Cancer enriched"	"Detected in single"	40	"glioma: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049471, HPA072213"			Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA049471: , HPA072213: "	"unprognostic (1.02e-1)"	"unprognostic (3.42e-1)"		"unprognostic (1.22e-4)"	"unprognostic (1.66e-1)"	"unprognostic (8.86e-2)"		"unprognostic (2.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.79e-1)"	1.1	1.5	11.2	1.1	12.6	1.1	1.1	8.4	52.3	1.1	1.2	6.7	0.0	1.1	1.1	1.4	1.3	1.2	1.1	1.2	14.5	18.4	1.1	1.1	1.1	1.1	10.7	19.5	1.1	1.1	1.1	3.1	1.1	9.2	1.1	1.3	0.5	1.1	1.1	1.3	1.1	1.1	1.2	3.6	1.1	1.3	1.4	5.1	0.0	1.3	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	5.5	0.7	0.0	9.2	0.0	0.0	0.0	10.2	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	11.2	12.6	8.4	29.5	14.5	18.4	10.7	19.5	9.2	5.1
ZDHHC7	"DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370"	ENSG00000153786	"Zinc finger DHHC-type containing 7"	Q9NXF8	16	84974181-85011535	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019215, HPA059642"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA019215: , HPA059642: "	"unprognostic (9.77e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.76e-2)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (1.41e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.04e-2)"	"prognostic favourable (1.12e-5)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.42e-2)"	23.4	20.9	17.7	25.4	14.7	40.3	45.8	17.8	20.0	23.7	26.8	15.5	15.6	19.7	27.7	18.6	20.4	19.2	29.1	24.9	13.0	11.6	23.4	21.3	31.3	36.3	15.5	14.5	21.8	30.0	31.1	15.2	25.1	14.8	24.1	24.3	18.1	18.7	18.4	36.5	23.1	25.5	31.1	14.9	27.1	32.3	18.6	13.9	16.1	19.9	25.8	18.8	27.7	28.9	2.0	6.9	8.5	10.6	1.5	3.0	3.5	20.0	17.7	9.4	11.2	41.6	31.4	12.9	18.6	36.1	29.3	14.6	18.6	23.6	9.2	10.9	30.0	21.2	12.0	24.5	37.0	5.3	9.6	7.2	7.5	21.1	17.4	12.5	7.0	25.9	28.2	23.9	13.8	15.0	21.4	3.2	18.5	24.0	8.5	12.0	14.5	12.9	10.6	8.6	5.0	28.8	26.5	8.0	10.1	24.0	13.5	11.6	25.5	7.6	21.9	17.7	13.5	16.7	10.8	11.1	15.3	20.9	16.8	9.4	14.0	6.7	10.6	8.5	2.5	8.8	3.0	1.6	2.4	2.0	6.9	2.0	1.8	2.6	7.1	1.5	7.2	4.7	0.6	3.5	17.7	14.7	17.8	20.0	13.0	11.6	15.5	14.5	14.8	13.9
ZDHHC9	"CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type containing 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavourable (9.77e-5)"	"prognostic unfavourable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	18.2	7.3	16.7	6.7	24.7	3.2	14.2	7.8	33.9	14.1	14.7	78.3	5.1	21.1	8.4	8.4	9.8	7.9	10.4	7.4	24.1	15.2	25.4	27.0	15.6	3.0	24.9	13.9	8.0	17.4	19.6	7.1	11.5	28.4	13.4	17.3	3.8	13.2	8.3	7.4	19.7	22.2	10.4	32.7	2.4	12.8	2.8	25.3	1.2	9.6	5.7	4.3	10.8	9.4	4.6	7.8	2.6	6.8	3.4	7.6	3.3	15.2	8.0	11.5	23.2	39.9	31.4	9.4	15.1	17.3	7.2	9.1	12.6	19.9	0.5	25.8	16.0	10.3	13.0	15.1	10.5	0.8	8.1	3.0	8.4	16.6	15.8	2.0	5.5	34.1	24.7	11.8	17.6	13.6	3.3	6.1	11.7	13.3	2.9	3.8	6.2	13.9	2.7	7.4	9.0	10.5	8.5	9.1	7.7	4.3	22.3	7.0	9.5	3.4	11.1	7.4	2.5	17.3	12.1	5.7	4.1	1.8	13.3	8.4	3.7	0.0	3.3	2.6	4.8	2.9	6.1	4.6	5.8	4.7	3.7	2.7	7.6	4.3	0.0	3.4	6.8	7.8	2.5	3.3	16.7	24.7	7.8	33.9	24.1	15.2	24.9	13.9	28.4	25.3
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.1;TIME: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB058686: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	18.8	7.4	14.4	13.9	14.4	6.1	11.4	15.5	24.1	31.3	31.2	7.1	8.0	4.9	32.9	14.1	17.3	12.0	16.0	27.9	12.9	14.7	5.9	8.1	12.5	7.0	13.7	11.9	11.5	3.4	2.7	9.3	13.3	13.1	20.4	11.0	4.8	5.9	24.2	36.2	5.1	8.3	40.4	20.4	6.6	14.8	7.3	14.9	22.6	8.3	18.7	8.0	53.1	20.7	5.4	3.8	11.5	0.0	7.2	10.2	2.2	0.0	6.0	15.1	14.7	21.1	46.1	0.0	13.1	18.3	2.4	4.8	0.0	0.0	4.2	6.3	15.9	0.0	6.4	0.0	4.5	8.1	3.2	0.0	3.5	2.6	17.7	3.4	0.1	21.3	0.0	7.9	7.9	23.3	2.9	5.6	16.4	0.0	11.7	1.8	0.9	3.0	4.2	27.2	1.6	4.3	0.0	0.4	5.6	4.5	0.0	0.0	0.0	2.2	35.4	14.9	3.5	3.4	6.2	2.7	2.2	5.0	4.2	0.0	1.7	5.1	0.0	6.6	3.6	0.0	4.8	5.4	4.5	2.3	1.5	4.7	10.2	4.5	11.5	7.2	0.0	3.8	5.8	2.2	14.4	14.4	15.5	11.9	12.9	14.7	13.7	11.9	13.1	14.9
ZFP90	"KIAA1954, NK10, ZNF756"	ENSG00000184939	"ZFP90 zinc finger protein"	Q8TF47	16	68530090-68576072	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029017	Uncertain		Supported	"Vesicles,Plasma membrane,Centrosome"				"Vesicles, Plasma membrane, Centrosome"		"HPA029017: AB_10669653"	"unprognostic (3.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.60e-2)"	9.6	9.0	16.9	11.5	19.3	7.8	16.2	24.0	19.5	14.2	8.9	18.9	10.4	4.4	15.8	18.2	7.6	14.3	9.5	10.3	15.5	19.8	11.6	7.9	9.6	12.4	16.7	20.5	18.1	8.7	29.1	16.5	8.3	20.0	13.1	9.3	11.4	8.7	13.6	10.0	13.2	8.3	13.6	16.1	13.2	11.2	11.6	19.6	15.8	11.0	3.6	15.5	11.3	9.6	5.8	2.6	7.8	1.9	5.2	8.8	3.0	7.1	7.8	14.7	13.9	13.1	14.0	6.6	6.8	7.8	9.3	10.8	5.5	4.8	7.7	8.8	8.6	6.8	9.0	8.6	10.7	6.7	3.7	1.9	1.5	9.2	10.2	0.0	7.3	12.1	14.2	8.6	12.0	7.4	3.8	2.9	11.4	12.8	7.6	7.4	5.5	5.9	14.1	5.1	5.1	6.4	5.1	16.7	12.7	19.4	1.5	7.3	11.7	10.2	5.3	8.8	5.3	7.4	3.9	5.6	10.4	9.4	2.9	2.7	7.0	7.8	1.7	2.8	6.4	1.9	8.8	5.8	6.0	7.4	2.4	4.1	8.7	7.5	0.5	5.2	1.3	2.6	6.8	3.0	16.9	19.3	24.0	19.5	15.5	19.8	16.7	20.5	20.0	19.6
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein"	Q96JP5	11	58579111-58621042	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA024037, CAB025417"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB025417: , HPA024037: AB_1859051"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	17.1	14.7	20.1	13.6	25.6	32.0	14.9	24.4	21.7	15.3	18.1	23.2	15.8	16.2	16.3	11.8	16.3	13.6	13.8	26.5	20.3	15.4	16.3	19.4	15.0	14.4	20.8	18.1	14.9	14.3	26.7	17.0	14.2	19.7	13.1	21.9	11.2	14.5	15.5	33.8	17.5	19.6	16.9	21.6	15.0	13.9	71.0	19.4	15.7	16.8	14.6	15.9	17.8	21.4	4.6	7.0	5.4	5.0	3.7	5.4	2.8	24.5	14.1	16.6	16.8	15.9	19.3	9.1	20.3	38.2	23.6	20.2	7.7	26.0	29.4	20.1	25.6	21.9	16.8	21.6	31.1	15.6	9.4	19.4	14.4	8.3	18.1	24.4	32.0	16.8	21.2	33.1	38.8	23.3	19.2	27.9	30.3	8.2	21.1	13.5	8.7	13.8	16.4	28.0	19.5	17.3	23.7	17.8	14.2	25.9	23.9	33.1	26.6	18.4	26.1	29.8	20.6	44.8	22.5	16.2	11.9	24.5	26.3	13.8	30.3	3.9	5.0	3.5	5.4	4.5	3.0	4.5	3.3	3.3	4.9	4.6	3.6	4.6	5.4	3.7	4.2	7.0	2.6	2.8	20.1	25.6	24.4	21.7	20.3	15.4	20.8	18.1	19.7	19.4
ZFPL1	"D11S750, MCG4"	ENSG00000162300	"Zinc finger protein like 1"	O95159	11	65084223-65088400	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014909, HPA017347"	Enhanced		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA014909: AB_1859055, HPA017347: AB_1859056"	"unprognostic (2.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.12e-6)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.63e-1)"	"unprognostic (7.34e-2)"	"prognostic favourable (2.73e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.34e-2)"	"unprognostic (6.94e-2)"	22.2	23.6	20.9	17.3	25.0	34.9	20.4	17.3	31.8	19.1	23.2	30.6	24.9	24.7	23.6	27.6	24.5	26.3	24.1	26.5	21.6	18.4	21.8	28.8	16.2	15.4	29.1	19.2	26.4	40.0	16.9	30.4	33.0	21.2	22.4	14.0	23.1	38.4	25.7	33.0	24.2	26.4	18.5	21.6	18.6	24.7	28.5	23.7	17.7	26.0	22.0	21.6	24.5	18.7	11.1	11.6	33.1	12.2	12.2	13.9	6.5	26.8	18.8	11.9	12.4	10.6	15.1	19.0	12.7	15.7	15.0	11.9	12.6	18.8	9.3	25.4	18.1	14.7	6.8	15.6	5.2	13.4	12.6	9.6	14.6	25.8	22.9	7.3	13.0	14.2	21.1	11.3	19.6	14.2	11.3	14.5	11.1	37.9	11.2	16.1	8.2	16.7	10.4	6.8	24.0	11.7	13.5	13.0	11.1	10.2	19.4	27.7	28.7	11.4	13.8	10.1	16.9	22.0	10.3	10.1	9.8	11.5	15.6	6.9	18.8	33.1	11.5	23.0	9.2	12.2	9.7	10.7	8.6	9.5	11.6	11.1	9.6	8.5	15.9	12.2	11.0	10.9	13.9	6.5	20.9	25.0	17.3	31.8	21.6	18.4	29.1	19.2	21.2	23.7
ZFPM2	"FOG2, hFOG-2, ZC2HC11B, ZNF89B"	ENSG00000169946	"Zinc finger protein, FOG family member 2"	Q8WW38	8	104590733-105804532	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Gonadal differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.0;ovary: 37.8"	"Cell line enhanced"	"Detected in some"		"AF22: 6.3;BJ hTERT+: 13.6;HHSteC: 9.9;HUVEC TERT2: 10.4;K-562: 5.6;TIME: 6.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 67.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004094	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA004094: AB_1859058"	"unprognostic (4.48e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-6)"	"unprognostic (4.10e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.61e-2)"	10.7	3.8	7.9	3.9	2.7	0.6	15.4	67.0	8.2	8.4	4.2	0.7	2.0	1.1	16.6	7.3	5.5	14.2	6.8	11.2	14.8	3.5	1.8	3.5	5.6	8.2	3.4	4.9	37.8	1.4	1.2	2.5	5.0	9.3	3.3	2.9	0.9	1.5	2.9	23.3	2.0	2.3	19.8	3.5	3.5	3.5	4.9	2.0	0.0	8.0	6.5	2.1	7.6	9.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.3	0.0	5.5	1.8	0.0	0.5	13.6	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	4.9	1.6	0.0	0.0	9.9	0.0	0.0	0.5	0.0	5.5	0.0	10.4	5.6	0.0	1.3	0.0	1.4	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.3	0.0	6.3	0.3	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	2.7	67.0	8.2	14.8	3.5	3.4	4.9	9.3	2.0
ZFYVE1	"DFCP1, KIAA1589, PPP1R172, TAFF1, ZNFN2A1"	ENSG00000165861	"Zinc finger FYVE-type containing 1"	Q9HBF4	14	72969451-73027212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002898	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA002898: AB_1080653"	"unprognostic (2.19e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (5.07e-12)"	"unprognostic (4.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.48e-2)"	19.0	24.3	16.6	12.8	17.3	19.0	15.7	18.2	20.5	15.0	17.1	17.1	7.9	16.4	16.5	13.0	23.7	13.4	14.8	16.1	15.0	13.7	22.0	18.2	14.8	11.2	17.7	14.7	18.1	13.5	20.4	16.6	18.1	17.9	14.1	12.3	16.4	14.4	16.4	26.0	21.2	16.8	17.0	16.4	15.9	13.2	25.6	17.5	20.2	22.5	10.5	14.2	19.2	22.4	4.0	7.6	13.5	8.5	4.2	8.6	5.9	5.2	7.6	7.2	7.0	19.1	13.1	4.9	7.7	12.1	8.6	13.4	5.2	4.6	2.6	5.8	9.9	3.8	5.1	4.8	8.9	10.3	2.8	3.4	3.5	3.7	16.1	1.2	13.1	16.9	12.7	8.2	7.2	13.3	3.1	7.4	11.1	6.2	5.3	3.8	3.4	6.9	7.3	4.8	3.4	7.8	5.6	3.8	6.7	6.9	7.2	8.1	9.7	4.8	14.6	15.8	6.4	4.3	2.5	10.5	10.2	3.8	8.8	2.7	7.2	2.8	8.5	10.8	8.6	7.6	6.0	3.8	4.4	5.9	7.6	4.0	4.8	5.8	13.5	4.2	7.0	4.4	6.8	5.9	16.6	17.3	18.2	20.5	15.0	13.7	17.7	14.7	17.9	17.5
ZFYVE16	"KIAA0305, PPP1R69"	ENSG00000039319	"Zinc finger FYVE-type containing 16"	Q7Z3T8	5	80408013-80479350	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035935, HPA035936"	Supported		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA035935: AB_10672076, HPA035936: AB_10669662"	"unprognostic (1.11e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.23e-2)"	10.7	11.9	11.0	10.1	28.9	6.1	11.6	14.9	19.2	21.2	9.0	33.2	7.7	6.7	17.0	6.6	9.6	9.7	14.6	17.6	11.7	9.5	13.1	13.3	11.6	6.8	25.7	16.8	16.8	7.1	13.4	15.0	16.5	37.3	11.5	8.4	9.0	8.6	9.3	12.7	6.4	8.7	12.8	26.9	11.2	8.4	11.7	21.2	3.8	12.6	4.6	5.8	12.8	10.8	2.5	2.3	17.3	3.9	2.4	1.5	0.3	5.6	6.7	11.9	11.5	7.2	7.5	8.0	8.8	7.6	7.9	10.7	4.9	6.6	3.9	6.4	7.2	5.9	8.5	7.2	8.7	2.5	5.6	4.2	9.1	5.5	6.1	1.2	3.2	8.2	4.0	6.6	6.3	9.0	4.1	6.1	8.5	7.2	2.7	1.2	2.8	3.1	5.7	24.8	4.1	6.8	11.1	4.5	10.4	12.6	6.0	41.5	8.4	3.9	7.9	4.8	5.5	7.3	7.3	1.8	3.5	3.9	6.3	3.9	10.6	11.5	3.7	1.8	1.5	2.3	0.8	2.5	0.7	1.3	1.4	2.5	0.6	0.7	17.3	2.4	3.9	2.3	0.8	0.3	11.0	28.9	14.9	19.2	11.7	9.5	25.7	16.8	37.3	21.2
ZFYVE9	"MADHIP, PPP1R173, SARA, SMADIP"	ENSG00000157077	"Zinc finger FYVE-type containing 9"	O95405	1	52142094-52346686	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017702, HPA065852, HPA065862"	Approved		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB017702: AB_1128462, HPA065852: , HPA065862: "	"unprognostic (5.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.73e-2)"	10.2	10.0	13.6	3.8	18.4	1.0	13.0	28.4	27.7	15.5	8.0	9.5	10.1	6.8	14.1	9.1	10.8	12.2	8.1	10.4	13.8	15.7	15.2	10.7	11.3	4.1	13.8	15.8	19.5	16.9	32.3	14.6	7.4	18.7	13.6	9.9	9.6	9.8	13.8	25.5	12.3	7.4	13.3	11.6	4.2	8.6	14.9	8.0	1.5	19.5	8.8	4.2	10.9	13.8	0.4	0.0	0.0	0.0	0.2	2.1	0.4	9.8	4.7	6.8	8.6	16.6	15.0	11.1	8.0	11.1	9.6	11.1	5.4	0.8	0.0	5.0	11.4	3.6	12.0	13.0	14.8	0.0	8.1	2.8	5.4	6.5	11.0	2.5	1.7	10.0	14.7	8.4	19.1	13.9	4.3	1.8	12.8	2.2	3.5	1.8	8.8	8.3	3.1	11.6	0.9	5.5	22.1	5.7	5.8	9.0	7.7	10.4	3.5	3.3	12.8	9.7	3.9	7.4	4.8	2.5	1.5	1.2	6.9	3.1	3.9	0.0	0.0	0.0	0.3	0.0	2.1	0.3	1.6	0.4	0.0	0.4	1.3	0.7	0.0	0.2	0.0	0.0	0.0	0.4	13.6	18.4	28.4	27.7	13.8	15.7	13.8	15.8	18.7	8.0
ZGPAT	"dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP"	ENSG00000197114	"Zinc finger CCCH-type and G-patch domain containing"	Q8N5A5	20	63707465-63736142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056705			Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA056705: "	"unprognostic (4.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.58e-2)"	"prognostic favourable (6.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-3)"	9.3	9.8	9.6	13.6	14.5	14.5	8.0	20.2	13.2	7.6	8.9	12.0	10.8	11.1	12.9	6.1	9.1	8.1	11.2	8.8	10.3	7.1	11.7	56.1	7.2	11.0	16.9	10.7	7.3	12.6	8.3	10.8	9.0	14.2	8.3	3.9	8.0	14.0	8.8	9.2	10.5	10.8	9.4	8.5	11.7	10.3	14.9	15.0	11.3	8.0	5.8	13.5	8.3	9.2	15.6	21.7	19.2	16.4	20.2	23.8	13.0	8.5	11.1	4.3	7.0	3.6	2.5	10.1	8.9	5.9	14.2	5.9	23.7	11.8	8.9	17.1	5.0	15.8	2.9	10.6	1.8	6.0	7.7	8.4	9.6	24.2	7.1	5.2	14.9	6.4	9.0	5.8	2.3	7.7	9.1	8.4	4.6	8.6	12.8	12.4	7.1	13.9	13.6	3.3	9.1	7.9	8.0	8.3	10.3	12.7	14.4	7.9	9.9	14.8	8.7	22.2	7.9	8.4	11.4	8.3	13.1	12.3	14.0	5.2	9.9	6.6	16.0	19.2	23.8	16.4	23.1	15.6	20.4	21.5	15.1	14.5	20.3	20.5	17.0	20.2	13.2	21.7	19.8	13.0	9.6	14.5	20.2	13.2	10.3	7.1	16.9	10.7	14.2	15.0
ZHX1		ENSG00000165156	"Zinc fingers and homeoboxes 1"	Q9UKY1	8	123248451-123275541	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055357, HPA060251"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA055357: , HPA060251: "	"unprognostic (4.36e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (8.73e-3)"	"unprognostic (5.61e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.76e-2)"	21.1	12.6	23.9	9.4	23.1	9.4	16.8	21.8	22.5	18.8	13.9	13.3	19.0	14.8	14.7	14.3	30.7	15.7	12.5	12.3	23.6	18.7	19.0	31.0	11.6	9.3	20.3	16.2	18.1	13.9	28.6	25.2	11.6	18.8	17.3	12.3	10.6	15.6	18.8	14.4	21.8	19.9	16.8	23.8	14.1	11.8	8.0	24.4	13.1	31.2	10.7	11.8	16.4	24.3	4.4	5.8	4.0	14.5	7.5	6.3	3.3	10.0	4.6	6.4	7.5	12.4	10.4	4.1	12.3	6.8	9.1	10.6	8.1	4.4	15.3	16.5	14.7	6.9	18.0	11.3	11.6	30.3	9.2	24.8	10.6	4.8	8.3	9.0	12.0	7.7	12.8	12.4	10.6	7.1	28.9	12.2	13.5	30.6	20.8	4.0	1.7	9.7	10.7	5.7	10.9	8.0	23.1	30.8	11.5	14.0	39.8	4.8	16.2	10.4	6.6	14.6	19.3	11.6	8.1	11.4	31.4	17.3	9.8	17.0	4.0	1.7	4.3	4.0	4.9	7.6	6.0	4.1	6.1	4.3	5.8	4.4	5.9	6.1	1.5	7.5	14.5	3.3	6.3	3.3	23.9	23.1	21.8	22.5	23.6	18.7	20.3	16.2	18.8	24.4
ZHX2	KIAA0854	ENSG00000178764	"Zinc fingers and homeoboxes 2"	Q9Y6X8	8	122781394-122974512	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;REH: 25.4;U-698: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006769, HPA006996"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006769: AB_10669919, HPA006996: AB_10670555"	"unprognostic (8.28e-2)"	"unprognostic (3.80e-3)"	"unprognostic (6.48e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.61e-3)"	"unprognostic (3.04e-1)"	11.3	12.4	14.6	26.2	14.8	7.1	12.7	11.1	16.2	15.1	8.2	22.2	9.8	6.0	15.8	10.6	10.8	17.7	13.9	16.3	16.0	9.8	9.7	15.9	13.2	26.8	19.3	10.3	31.5	20.3	10.1	13.5	7.1	12.4	16.9	7.7	12.7	13.4	15.2	31.1	9.3	11.7	13.6	14.3	15.9	8.3	5.2	20.0	17.9	15.3	10.9	24.7	17.7	11.3	12.2	5.4	9.6	1.9	6.9	7.5	3.2	2.6	1.3	7.5	1.5	3.7	1.2	0.0	1.6	5.0	1.8	2.3	0.3	8.7	23.7	6.5	5.2	2.2	5.0	3.0	1.9	10.6	3.4	10.9	1.6	8.4	4.0	2.6	3.4	3.2	3.6	1.6	8.9	2.0	0.4	8.4	2.1	7.5	2.5	2.3	4.2	1.8	25.4	4.1	1.9	8.3	6.7	3.2	1.8	6.4	18.9	3.1	3.2	5.9	3.4	1.4	3.7	1.7	3.3	2.1	0.0	24.3	1.3	2.1	2.3	9.6	1.0	5.2	6.9	1.3	7.2	12.2	5.0	6.7	1.2	11.0	7.5	5.9	5.1	6.9	1.9	5.4	5.1	3.2	14.6	14.8	11.1	12.8	16.0	9.8	19.3	10.3	12.4	20.0
ZHX3	"KIAA0395, TIX1"	ENSG00000174306	"Zinc fingers and homeoboxes 3"	Q9H4I2	20	41178448-41317672	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046498			Supported	Nucleoplasm				Nucleoplasm		"HPA046498: "	"unprognostic (6.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (2.53e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (7.52e-4)"	"prognostic unfavourable (1.84e-5)"	15.7	18.6	19.8	7.9	24.7	4.1	19.3	26.8	27.6	13.7	13.9	18.2	7.0	10.6	13.1	7.8	16.8	12.1	10.6	12.8	21.1	13.9	33.2	13.2	11.3	8.0	17.0	16.9	20.4	14.4	22.7	10.5	6.4	15.8	11.1	10.3	13.7	6.1	15.6	29.7	11.4	10.5	20.1	17.7	5.1	13.1	26.6	20.3	4.4	23.2	7.8	6.1	15.7	17.4	3.1	0.9	1.6	0.9	2.3	1.8	0.5	9.2	2.6	2.8	6.0	23.1	25.0	3.2	13.1	15.0	12.2	8.3	4.7	1.2	6.4	6.4	24.5	2.9	3.3	16.5	13.1	1.7	3.0	2.7	3.6	3.6	9.5	3.1	3.4	15.3	8.1	9.1	11.9	5.2	2.5	4.5	16.3	18.6	4.8	1.8	1.2	9.8	2.3	8.0	2.5	16.7	2.8	9.9	3.5	8.7	5.1	3.1	4.9	4.3	8.3	30.6	4.6	10.7	6.4	5.2	3.2	2.9	12.6	4.6	4.8	0.3	0.7	1.6	1.2	0.4	1.7	2.4	0.9	0.8	0.9	3.1	1.8	1.7	0.5	2.3	0.9	0.6	1.1	0.5	19.8	24.7	26.8	21.9	21.1	13.9	17.0	16.9	15.8	20.3
ZIC1	"ZIC, ZNF201"	ENSG00000152977	"Zic family member 1"	Q15915	3	147393422-147510293	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 124.7"	"Cell line enriched"	"Detected in many"	4	"AF22: 60.8"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 124.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 232.6"	"Region enriched"	"Detected in many"	9	"cerebellum: 491.0"	HPA004098	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA004098: AB_1859065"	"unprognostic (1.33e-2)"			"unprognostic (1.82e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.19e-1)"		"unprognostic (5.01e-1)"	"unprognostic (2.61e-7)"	"unprognostic (2.95e-3)"	"unprognostic (1.67e-2)"		"unprognostic (3.01e-1)"	0.7	0.6	1.5	0.5	8.6	0.5	0.8	124.7	25.5	0.5	0.7	12.3	0.0	0.9	0.6	3.8	1.0	0.5	0.8	0.5	6.2	5.2	0.5	7.3	0.7	0.7	5.2	8.0	0.9	0.5	0.6	0.6	0.5	15.3	0.5	0.7	3.0	0.5	0.6	7.4	4.1	1.9	0.5	10.0	0.5	0.5	1.0	4.5	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	6.4	7.0	3.4	3.9	4.7	4.2	3.5	0.0	0.0	0.0	3.2	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	1.0	0.0	3.7	14.7	0.0	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	3.5	0.0	0.0	0.0	6.3	0.0	9.9	3.7	0.0	0.0	0.0	4.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	8.6	124.7	5.2	6.2	5.2	5.2	8.0	15.3	4.5
ZIC2	HPE5	ENSG00000043355	"Zic family member 2"	O95409	13	99981772-99986773	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 63.0"	"Cell line enhanced"	"Detected in many"		"AF22: 27.0;HDLM-2: 13.0;HEK 293: 20.5;NTERA-2: 25.2;SCLC-21H: 56.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 214.5"	HPA055031			Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA055031: "	"unprognostic (6.43e-6)"	"prognostic favourable (2.64e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.12e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.42e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.26e-1)"	"unprognostic (2.11e-1)"		"unprognostic (5.36e-3)"	0.6	0.5	3.9	0.5	2.9	0.5	0.7	63.0	14.7	0.5	0.8	7.7	0.0	0.6	0.8	0.5	0.8	0.5	0.5	0.5	6.1	2.1	0.6	0.5	0.7	0.6	1.7	7.4	0.5	0.6	0.5	0.5	0.5	13.4	0.6	0.6	3.8	0.5	0.5	0.5	0.8	0.5	0.6	2.2	0.5	0.6	2.5	1.0	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.5	27.0	1.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	1.7	0.0	2.3	0.0	0.0	1.2	0.0	0.0	13.0	20.5	1.9	1.2	1.3	0.0	0.0	1.3	0.0	1.9	0.0	1.2	0.0	1.9	0.0	0.0	0.8	0.1	10.3	25.2	0.6	5.9	1.0	0.0	0.1	0.6	56.7	0.0	0.8	0.1	0.0	1.3	10.1	0.0	6.4	0.0	1.1	1.7	0.2	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.9	63.0	7.1	6.1	2.1	1.7	7.4	13.4	1.0
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566142-137577691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 50.6"	"Group enriched"	"Detected in some"	40	"AF22: 24.4;NTERA-2: 27.3"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Region enriched"	"Detected in all"	8	"cerebellum: 50.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA052936: , HPA069523: "					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.3	0.2	1.4	0.4	2.5	1.1	0.4	50.6	5.8	0.3	0.4	2.7	0.0	0.5	0.5	0.2	0.3	0.3	0.4	0.3	1.9	2.2	0.3	0.3	0.4	0.4	2.4	1.2	0.4	0.5	0.4	1.1	0.4	6.1	0.5	0.3	3.9	0.7	0.3	0.5	0.8	0.5	0.2	1.9	0.5	0.4	3.9	2.2	0.0	0.5	0.0	0.4	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	2.5	50.6	2.6	1.9	2.2	2.4	1.2	6.1	2.2
ZKSCAN3	"ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35"	ENSG00000189298	"Zinc finger with KRAB and SCAN domains 3"	Q9BRR0	6	28349914-28369177	"Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA009637, HPA060116"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA009637: , HPA060116: "	"unprognostic (2.71e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.67e-1)"	"prognostic favourable (4.93e-4)"	"unprognostic (6.42e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.50e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (7.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.10e-3)"	6.7	8.7	5.8	10.3	9.0	2.4	8.8	11.8	10.3	9.3	9.3	12.3	7.2	4.9	11.2	10.5	6.4	8.6	7.5	6.0	6.3	4.9	7.6	7.2	6.8	6.6	7.1	8.9	12.9	7.3	14.4	13.5	8.7	10.6	9.6	8.8	8.7	7.6	10.2	5.1	8.2	7.2	10.5	9.0	9.3	8.8	7.1	8.1	14.9	9.7	3.8	8.3	9.3	8.4	4.8	4.2	9.6	4.0	3.1	4.9	2.1	3.1	1.9	7.5	13.4	6.8	4.8	2.8	2.8	3.1	4.8	6.4	2.5	1.8	4.8	6.6	3.0	4.3	8.2	3.7	4.8	4.5	3.4	6.4	4.9	4.1	4.8	6.3	2.1	4.3	3.3	5.3	4.5	7.6	16.1	3.2	5.7	1.0	3.2	6.1	3.4	2.0	9.1	5.8	7.0	5.0	2.3	6.0	6.7	5.0	2.7	4.5	3.8	6.4	4.5	5.1	3.3	3.3	3.5	4.2	6.3	4.5	1.7	8.4	3.4	3.0	2.4	9.6	4.8	4.0	4.9	4.7	3.2	3.7	3.2	4.8	3.0	4.9	3.1	3.1	2.4	4.2	4.2	2.1	5.8	9.0	11.8	10.3	6.3	4.9	7.1	8.9	10.6	8.1
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28244623-28252224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA009637	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA009637: "	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (1.90e-6)"	"prognostic favourable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	5.9	6.1	5.8	5.2	8.9	2.7	7.5	13.2	8.3	6.5	5.7	7.5	6.8	6.3	8.5	6.9	5.7	6.7	5.3	4.1	5.6	4.2	5.8	6.0	5.2	10.4	4.9	5.3	8.4	9.4	7.2	7.3	7.3	5.7	6.0	6.7	6.2	6.5	6.9	3.5	6.4	7.1	5.2	6.8	16.1	5.3	15.8	7.3	16.1	5.5	2.4	10.4	6.7	6.4	5.9	12.8	9.3	5.9	6.8	9.1	4.4	3.4	2.6	6.2	9.3	7.3	7.2	6.5	4.2	6.6	6.6	6.6	3.8	3.0	8.3	7.9	5.1	3.9	6.7	5.6	6.6	3.9	6.2	7.1	5.3	5.2	5.2	13.8	6.1	8.2	6.6	5.8	5.5	6.4	7.1	1.8	5.1	3.5	8.1	14.0	4.9	4.7	7.8	8.5	5.2	3.5	2.6	8.5	7.1	3.6	4.1	7.1	4.0	6.1	4.3	6.7	3.9	3.6	4.3	5.5	5.1	4.0	2.1	13.4	4.1	9.3	5.7	5.9	6.1	4.7	7.0	5.9	6.0	5.9	9.9	5.1	9.1	8.1	7.4	6.8	5.9	12.8	5.4	4.4	5.8	8.9	13.2	8.3	5.6	4.2	4.9	5.3	5.7	7.3
ZKSCAN7	"FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39"	ENSG00000196345	"Zinc finger with KRAB and SCAN domains 7"	Q9P0L1	3	44555193-44594173	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;NTERA-2: 5.1;SH-SY5Y: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048312, HPA049906, HPA071850"	Uncertain		Supported	"Nuclear speckles,Cytosol"				Cytosol	"Nuclear speckles"	"HPA048312: , HPA049906: , HPA071850: "	"unprognostic (3.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.17e-3)"	3.4	6.0	5.7	6.3	3.9	1.9	5.3	9.9	6.1	6.1	3.9	6.0	6.1	2.0	6.9	9.5	2.9	6.4	5.3	4.8	5.6	3.9	4.5	4.6	5.1	5.1	4.4	3.4	13.0	6.7	6.8	18.2	3.4	4.1	6.6	3.5	7.2	3.7	5.8	4.3	2.2	3.8	7.2	3.9	4.8	3.7	18.6	4.4	12.1	6.0	1.9	4.8	5.5	5.9	3.7	2.5	2.0	1.2	2.4	3.4	1.2	0.0	0.0	4.6	6.6	1.3	0.7	0.0	2.2	1.9	2.3	2.7	0.0	0.1	0.1	0.8	1.5	0.0	0.0	1.4	2.9	0.0	0.0	0.2	1.4	1.7	4.1	0.0	0.0	3.2	1.5	1.3	0.0	0.6	0.0	0.1	3.5	0.0	0.0	0.0	5.1	0.0	0.0	2.1	0.0	1.3	0.6	3.1	8.1	0.1	0.2	0.0	0.0	3.1	0.7	1.4	0.5	1.8	0.0	0.2	0.1	0.0	0.3	0.0	1.1	2.0	1.2	1.6	3.4	0.5	1.0	1.3	2.1	2.6	1.0	3.7	1.6	3.2	1.6	2.4	1.1	2.5	2.1	1.2	5.7	3.9	9.9	6.1	5.6	3.9	4.4	3.4	4.1	4.4
ZMAT3	"FLJ12296, MGC10613, PAG608, WIG-1, WIG1"	ENSG00000172667	"Zinc finger matrin-type 3"	Q9HA38	3	179017223-179072279	"Predicted intracellular proteins"	"Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 28.5;LHCN-M2: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027569, HPA028671, HPA054356"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA027569: , HPA028671: , HPA054356: "	"unprognostic (3.53e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.46e-2)"	7.1	11.9	18.8	7.1	19.7	4.4	8.3	7.5	27.3	9.1	8.4	9.6	4.4	4.9	8.5	8.6	10.0	8.2	12.6	8.6	15.8	17.1	9.1	16.2	8.2	9.2	16.9	13.3	7.0	7.3	15.7	10.1	7.8	17.4	8.6	12.6	7.1	7.6	11.5	5.5	8.4	5.4	15.5	14.4	9.2	7.2	4.6	9.4	15.7	10.6	3.2	8.6	9.4	6.7	3.6	1.8	3.9	3.3	4.0	5.8	1.3	2.0	1.4	4.5	2.5	21.6	24.6	10.3	8.0	12.3	1.2	1.5	1.8	1.2	8.4	4.1	13.0	1.8	1.5	8.7	2.7	6.1	2.4	3.5	2.7	5.6	17.1	3.8	5.6	28.5	16.4	2.9	5.8	17.0	1.9	1.0	31.6	2.0	3.2	0.7	2.0	1.1	3.6	4.1	1.8	6.9	4.0	0.9	4.6	2.4	2.3	2.7	2.8	1.6	19.0	18.3	6.7	3.1	3.7	0.9	0.9	3.5	10.9	0.5	12.4	3.4	1.8	3.9	4.8	1.3	2.7	2.3	3.5	3.9	1.7	3.6	5.8	4.2	2.3	4.0	3.3	1.8	2.5	1.3	18.8	19.7	7.5	22.3	15.8	17.1	16.9	13.3	17.4	9.4
ZMAT5	"SNRNP20, ZC3H19"	ENSG00000100319	"Zinc finger matrin-type 5"	Q9UDW3	22	29730956-29767011	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004858	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA004858: AB_1080657"	"unprognostic (2.14e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-3)"	"unprognostic (6.04e-3)"	"unprognostic (5.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.10e-2)"	10.6	20.3	18.7	10.6	21.5	13.4	11.9	11.8	20.2	13.2	12.2	16.4	24.9	12.9	13.8	22.2	15.5	22.4	11.1	20.4	16.7	14.4	14.7	18.4	14.0	13.9	17.1	16.9	16.5	20.9	18.4	8.5	8.9	16.7	14.0	7.9	13.5	19.2	19.2	34.2	13.0	10.8	14.7	17.0	15.0	13.8	13.3	15.0	16.0	21.3	11.9	12.5	13.2	12.2	26.8	34.1	42.2	41.8	26.0	26.8	28.3	10.0	12.8	11.3	21.7	14.2	15.9	5.1	11.0	13.9	16.8	20.6	10.9	6.4	6.8	11.2	11.7	9.5	9.6	11.4	11.2	22.0	20.9	26.4	6.4	20.2	26.5	12.0	8.7	13.7	17.8	21.4	13.1	17.7	6.8	15.1	13.8	14.9	17.1	12.6	4.2	15.0	20.8	20.1	18.3	13.2	6.2	8.8	16.2	10.4	13.0	15.5	19.6	16.9	11.1	23.0	11.5	15.4	16.4	14.1	11.2	11.3	17.7	14.5	16.1	20.7	39.9	42.2	22.8	41.8	22.8	26.8	23.8	23.6	34.1	24.4	20.9	24.6	32.4	26.0	40.7	26.4	26.8	28.3	18.7	21.5	11.8	20.2	16.7	14.4	17.1	16.9	16.7	15.0
ZMIZ2	"DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7"	ENSG00000122515	"Zinc finger MIZ-type containing 2"	Q8NF64	7	44748581-44769881	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040716	Supported		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA040716: AB_10805826"	"unprognostic (2.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.01e-3)"	"prognostic unfavourable (6.82e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.15e-3)"	14.3	16.0	31.7	24.5	31.5	19.8	13.3	24.0	43.2	12.7	15.2	22.9	17.5	23.8	16.4	16.8	16.8	17.3	17.3	15.9	28.2	15.4	19.0	10.1	18.3	24.0	17.0	27.2	17.9	32.3	19.8	23.0	11.0	17.0	16.4	12.5	16.5	32.5	23.0	18.7	31.1	22.2	17.9	16.5	28.8	21.3	20.8	17.5	16.7	25.1	14.0	19.1	15.5	13.2	4.9	4.1	1.0	2.4	3.4	2.5	0.9	14.1	16.3	7.7	14.8	5.2	3.5	8.1	7.3	6.9	6.3	7.6	9.3	22.3	9.8	11.5	7.6	19.5	4.7	8.3	3.8	23.1	9.0	3.9	15.3	7.3	10.7	5.6	8.7	5.3	5.1	9.8	6.5	11.6	11.5	22.3	9.2	13.6	12.5	15.6	14.4	15.9	15.7	4.2	12.7	7.3	10.9	27.2	18.0	9.8	19.3	4.4	18.3	8.7	17.2	6.0	13.2	16.1	16.7	32.8	10.4	7.6	11.6	10.0	24.5	1.0	1.6	0.7	2.5	2.4	1.6	2.7	1.2	1.8	1.6	4.9	0.8	0.9	0.7	3.4	1.2	4.1	1.1	0.9	31.7	31.5	24.0	43.2	28.2	15.4	17.0	27.2	17.0	17.5
ZMYM3	"DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261"	ENSG00000147130	"Zinc finger MYM-type containing 3"	Q14202	X	71239624-71255146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003211, HPA075255"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA003211: AB_1080661, HPA075255: "	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (5.18e-4)"	"unprognostic (5.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.30e-3)"	7.3	23.7	22.5	7.9	20.6	6.2	7.9	16.6	22.7	10.8	10.4	13.6	10.3	7.0	14.0	19.2	8.0	19.8	11.3	9.3	19.5	14.6	10.6	9.6	10.8	10.9	16.8	20.6	36.8	8.2	15.3	14.4	7.8	14.0	14.3	8.0	10.5	11.2	18.0	9.5	11.1	8.8	14.8	14.1	12.1	9.0	15.9	17.3	13.9	12.6	6.4	10.4	11.9	10.0	9.4	13.5	6.8	7.3	6.0	6.8	5.0	7.2	13.3	32.3	17.1	9.4	9.5	8.2	6.7	10.0	14.6	13.7	14.7	11.0	18.3	16.8	12.0	6.8	27.6	10.1	11.0	6.1	14.8	15.9	11.8	13.0	4.4	14.8	9.9	11.2	5.9	10.6	6.6	12.2	18.3	10.1	10.6	11.9	17.8	19.0	32.1	11.7	22.3	9.9	13.5	10.8	8.8	15.5	10.6	11.4	7.2	6.6	10.5	9.7	9.3	7.2	13.4	10.5	6.0	9.3	5.5	15.6	8.7	20.3	7.9	6.8	7.3	5.6	6.1	6.3	6.8	9.4	6.8	5.6	6.4	9.0	6.0	5.9	0.5	6.0	5.1	13.5	6.3	5.0	22.5	20.6	16.6	22.7	19.5	14.6	16.8	20.6	14.0	17.3
ZMYND11	BS69	ENSG00000015171	"Zinc finger MYND-type containing 11"	Q15326	10	134465-254637	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015816			Supported	Nucleoplasm				Nucleoplasm		"HPA015816: AB_1845427"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (6.35e-2)"	"prognostic favourable (4.76e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.42e-1)"	19.9	19.6	35.7	12.8	35.0	5.1	23.9	38.0	32.5	26.4	26.9	27.3	18.5	15.4	28.8	24.8	23.0	21.8	18.5	28.7	34.1	27.7	26.9	17.8	19.7	12.0	33.3	26.2	30.0	24.2	63.6	24.0	17.6	27.5	28.0	17.9	17.0	21.6	30.2	29.1	16.2	15.4	49.2	38.0	15.5	19.5	15.9	28.9	7.1	46.0	13.4	12.4	31.3	29.6	4.4	4.0	16.2	2.8	12.3	10.7	4.3	23.7	25.2	20.6	16.4	23.3	22.6	12.4	24.2	14.1	17.2	16.2	15.1	23.9	0.0	7.8	30.3	14.3	11.2	17.4	22.1	9.3	9.1	26.1	13.8	16.2	25.3	7.0	14.7	15.7	22.6	16.7	15.5	21.3	6.9	17.3	28.4	29.0	10.9	9.5	6.5	4.3	10.4	13.3	12.4	21.7	27.9	9.2	16.9	26.9	31.9	12.5	28.7	13.8	27.5	17.3	6.0	33.8	18.2	13.9	17.6	1.7	17.2	13.3	11.5	9.8	2.0	16.2	10.7	2.8	9.5	4.4	7.7	10.7	3.1	3.0	8.3	8.3	0.9	12.3	1.2	4.0	7.2	4.3	35.7	35.0	38.0	31.4	34.1	27.7	33.3	26.2	27.5	28.9
ZMYND8	"PRKCBP1, RACK7"	ENSG00000101040	"Zinc finger MYND-type containing 8"	Q9ULU4	20	47209214-47356889	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020949	Approved		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA020949: AB_1857223"	"prognostic unfavourable (2.56e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (2.62e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavourable (7.06e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	11.9	30.2	22.0	18.3	26.9	24.1	16.1	33.2	30.5	12.1	15.0	18.1	24.1	11.8	11.2	37.4	15.2	17.7	13.4	10.0	21.0	18.1	12.3	9.5	11.9	13.3	28.7	17.8	15.5	13.1	17.0	43.2	12.6	23.0	10.7	16.0	14.8	14.6	17.0	15.9	17.8	15.0	9.6	17.4	16.8	20.9	13.7	30.0	25.5	12.1	6.2	17.8	17.5	12.6	15.3	12.6	19.3	5.9	12.4	9.4	3.0	8.0	5.1	27.5	11.0	4.7	6.7	18.1	6.4	5.3	6.8	7.0	31.7	7.8	7.7	10.6	4.8	5.6	11.8	28.6	10.3	3.3	4.5	32.3	1.8	27.9	17.3	3.4	17.1	6.5	13.3	7.5	29.0	18.3	26.0	5.3	12.3	9.3	1.2	13.2	26.0	7.3	16.2	4.5	6.6	9.2	14.7	11.6	4.4	3.0	9.8	13.2	5.1	6.6	42.7	7.4	5.2	7.1	5.9	3.8	7.0	7.0	24.9	5.4	24.1	19.3	5.9	7.6	7.0	5.6	6.9	11.1	7.0	7.1	3.5	15.3	9.4	9.3	15.4	12.4	4.8	12.6	6.7	3.0	22.0	26.9	33.2	30.5	21.0	18.1	28.7	17.8	23.0	30.0
ZNF12	"GIOT-3, KOX3, ZNF325"	ENSG00000164631	"Zinc finger protein 12"	P17014	7	6688433-6706923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA063402			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA063402: "	"unprognostic (2.68e-1)"	"unprognostic (6.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.89e-3)"	"unprognostic (5.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.46e-3)"	16.7	12.1	12.1	15.6	11.7	8.8	17.0	25.4	13.5	18.9	17.7	9.2	16.0	12.2	17.4	17.9	15.1	15.1	11.9	12.6	10.1	9.7	15.6	13.8	12.2	15.1	10.3	12.8	19.6	13.2	25.2	20.0	20.3	10.3	23.9	13.2	8.6	14.7	16.1	9.5	13.8	18.6	12.5	16.1	18.6	12.9	7.5	13.9	21.1	21.9	7.9	16.0	21.9	29.3	2.1	1.9	9.4	0.9	1.9	3.5	0.4	12.6	6.0	12.0	15.0	12.3	12.5	11.5	8.0	14.5	10.3	10.8	8.1	7.4	9.6	5.6	9.9	15.2	9.9	7.8	15.7	3.6	7.5	9.7	9.0	8.1	11.5	15.3	10.5	13.7	17.4	7.4	11.9	7.4	15.3	8.9	13.5	10.0	5.9	14.2	14.5	9.3	7.8	17.2	5.8	8.4	12.6	11.0	19.5	9.2	16.8	9.6	10.7	17.5	7.3	11.6	14.7	9.2	10.5	8.5	5.5	9.9	9.5	10.4	15.3	9.4	0.9	1.1	2.5	0.7	3.5	2.0	2.1	2.8	0.9	2.1	2.7	3.4	0.9	1.9	0.8	1.9	1.7	0.4	12.1	11.7	25.4	13.5	10.1	9.7	10.3	12.8	10.3	13.9
ZNF131	"pHZ-10, ZBTB35"	ENSG00000172262	"Zinc finger protein 131"	P52739	5	43065176-43192021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007023, HPA027748, HPA074630"	Approved		Enhanced	"Nucleoplasm,Intermediate filaments"				Nucleoplasm	"Intermediate filaments"	"HPA007023: , HPA027748: , HPA074630: "	"unprognostic (1.23e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.46e-2)"	16.0	14.3	15.0	18.6	16.7	24.3	20.3	24.8	18.5	18.9	13.0	10.6	10.3	10.0	19.3	10.3	15.3	13.4	13.3	10.8	15.1	13.0	12.3	14.8	12.6	21.6	12.8	14.6	21.6	16.1	13.9	17.3	20.0	14.2	13.9	13.8	8.1	11.9	16.0	16.5	18.2	12.9	16.5	11.9	16.1	12.5	31.0	13.0	27.2	15.5	15.3	17.2	15.5	18.0	13.0	8.9	7.9	7.1	11.7	18.3	7.4	10.4	6.4	13.9	18.5	13.2	9.1	11.8	13.8	11.3	13.8	11.7	10.0	9.4	21.1	11.3	9.2	7.4	16.4	8.7	19.5	10.2	14.5	13.0	36.7	7.4	12.2	22.4	10.6	8.2	16.7	10.1	16.6	10.5	16.5	22.6	15.6	10.1	21.9	28.3	9.2	10.6	14.5	21.3	16.4	11.6	10.2	8.6	12.7	35.2	17.1	17.7	9.5	21.4	7.8	17.3	16.1	8.8	12.9	9.1	12.9	24.0	9.1	29.6	11.5	7.9	6.1	4.1	15.0	7.1	15.3	10.1	14.9	14.5	8.9	13.0	18.3	14.6	3.1	11.7	4.8	8.5	10.8	7.4	15.0	16.7	24.8	18.5	15.1	13.0	12.8	14.6	14.2	13.0
ZNF146	OZF	ENSG00000167635	"Zinc finger protein 146"	Q15072	19	36214602-36238774	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003358	Supported		Supported	Nucleoli				Nucleoli		"HPA003358: AB_1080674"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.11e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.92e-1)"	20.6	17.2	24.5	23.5	40.4	8.6	33.0	25.7	27.9	28.9	20.7	28.4	23.5	17.9	30.0	18.2	22.3	23.0	18.0	21.5	25.6	20.0	21.1	25.0	18.1	25.0	46.4	23.7	33.7	20.3	32.5	45.2	25.1	32.0	25.2	25.5	13.4	19.6	23.9	38.3	21.1	17.7	26.2	30.9	19.9	19.2	9.9	36.3	33.6	27.1	24.0	28.3	25.8	20.5	13.7	9.8	5.9	14.6	10.2	18.3	10.3	21.6	30.3	25.9	24.9	19.2	21.6	13.8	19.2	17.8	18.6	18.5	13.7	15.9	21.1	31.0	17.7	10.1	32.9	22.4	33.7	32.7	18.3	35.3	11.7	16.4	22.4	55.4	24.5	17.6	34.8	17.9	51.1	23.0	37.4	23.3	22.3	14.2	25.7	13.1	35.0	18.5	29.8	26.1	18.1	22.6	21.4	32.9	20.8	23.7	30.1	20.3	13.4	28.4	17.5	21.0	25.2	16.4	33.5	16.3	19.2	30.2	14.8	27.5	26.7	4.9	8.2	5.9	12.2	9.9	17.4	13.7	14.1	12.2	9.8	12.1	18.3	16.6	2.0	10.2	14.6	4.9	12.1	10.3	24.5	40.4	25.7	27.9	25.6	20.0	46.4	23.7	32.0	36.3
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225561-125375354	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	10.5	9.2	12.5	13.4	17.4	5.3	9.4	18.4	17.7	10.7	8.9	4.1	3.3	5.7	11.2	8.3	8.9	10.2	8.6	11.7	11.2	7.2	10.6	9.0	8.8	8.8	11.9	11.8	14.5	7.7	15.7	18.2	7.6	10.5	9.1	9.2	6.7	10.3	12.2	12.2	7.6	8.0	11.0	7.6	8.6	7.4	9.5	10.9	25.4	24.4	3.2	10.8	10.7	9.8	13.9	7.3	29.7	12.1	18.8	17.3	10.2	18.1	12.0	13.1	11.6	11.7	12.7	9.9	16.5	19.4	18.6	17.8	11.3	10.1	14.6	11.6	24.4	14.9	14.3	12.5	26.6	6.5	5.5	18.0	14.5	5.8	8.7	12.3	18.2	10.2	13.1	17.5	18.5	12.7	8.8	12.5	13.7	14.2	15.2	4.5	8.4	10.3	11.1	14.4	8.2	10.7	20.3	11.4	9.5	22.1	11.2	18.4	13.9	12.4	16.4	14.2	15.3	17.7	10.5	10.9	12.4	22.3	10.6	7.9	13.0	2.5	8.7	17.4	13.4	8.4	13.8	13.8	11.8	12.5	7.3	13.9	17.3	13.5	29.7	18.8	12.1	6.5	10.8	10.2	12.5	17.4	18.4	17.7	11.2	7.2	11.9	11.8	10.5	10.9
ZNF16	KOX9	ENSG00000170631	"Zinc finger protein 16"	P17020	8	144930358-144950888	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035782, HPA061835"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA035782: AB_10603243, HPA061835: "	"unprognostic (4.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-1)"	"prognostic favourable (2.39e-4)"	"unprognostic (7.53e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.17e-3)"	8.1	6.0	8.9	7.1	9.0	3.4	9.7	8.1	10.1	9.7	10.1	7.8	7.1	7.2	13.8	11.1	9.4	11.2	13.3	6.5	7.5	4.9	8.5	5.9	5.7	5.0	6.4	7.5	17.4	12.1	15.9	7.0	6.0	6.5	8.9	7.3	7.7	7.4	9.2	12.4	14.0	10.8	10.3	4.9	6.4	7.7	10.9	5.3	6.7	10.8	5.3	6.8	9.1	10.1	5.6	6.4	3.5	4.0	12.2	7.8	4.1	4.8	4.3	8.5	4.7	7.4	10.3	6.2	4.4	9.9	8.9	8.1	3.3	5.0	7.7	5.9	5.7	3.9	6.0	9.8	8.1	3.3	5.0	8.8	4.8	4.8	12.3	3.2	5.2	12.5	10.0	5.7	15.0	4.9	6.0	5.2	7.1	6.6	6.3	3.2	5.3	9.8	8.0	5.0	4.9	7.6	7.3	7.2	5.3	9.3	5.7	7.6	10.6	6.0	5.2	4.0	8.6	4.7	4.9	3.8	3.2	7.1	4.7	4.4	6.4	3.5	4.0	2.7	6.9	3.7	7.8	4.1	5.5	6.3	6.4	5.6	5.6	5.1	0.5	12.2	3.7	3.5	7.2	4.1	8.9	9.0	8.1	10.1	7.5	4.9	6.4	7.5	6.5	5.3
ZNF174	ZSCAN8	ENSG00000103343	"Zinc finger protein 174"	Q15697	16	3401235-3409370	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009656	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"				Nucleoplasm	"Actin filaments, Cytosol"	"HPA009656: AB_1080679"	"unprognostic (4.33e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.94e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.06e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.83e-1)"	10.0	11.6	11.1	9.0	16.0	5.7	12.8	15.8	24.3	13.0	14.8	18.1	9.4	9.6	16.8	18.8	11.0	17.7	13.4	15.3	11.8	12.0	11.1	9.9	8.7	11.6	15.1	10.5	21.0	9.1	28.5	15.2	8.2	15.7	14.7	11.7	16.1	12.2	18.2	14.1	11.4	9.7	16.8	13.3	11.9	10.5	13.5	15.7	18.8	12.2	9.1	12.8	14.8	10.8	9.5	6.9	23.1	6.4	6.8	11.5	6.7	6.2	10.3	11.9	13.4	14.5	10.5	8.2	5.9	14.6	12.8	11.7	8.1	10.9	21.6	9.4	10.4	9.0	11.0	9.8	12.1	13.7	11.3	11.2	9.7	9.8	10.4	12.7	13.5	12.5	11.6	10.8	10.8	10.8	17.6	9.8	13.1	10.4	12.6	10.6	13.0	12.8	18.1	13.3	17.0	9.4	3.2	11.2	8.7	11.5	12.8	9.8	12.5	14.2	8.7	9.6	10.4	7.6	7.7	12.1	13.1	17.1	5.1	8.0	9.0	13.1	5.7	23.1	9.1	6.4	8.7	9.5	9.4	10.2	6.9	7.1	11.5	8.5	6.8	6.8	4.2	3.6	8.8	6.7	11.1	16.0	15.8	24.3	11.8	12.0	15.1	10.5	15.7	15.7
ZNF175	OTK18	ENSG00000105497	"Zinc finger protein 175"	Q9Y473	19	51571298-51592508	"Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 25.7;RT4: 23.4;TIME: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA002717	Uncertain		Supported	"Nucleoplasm,Intermediate filaments,Cytosol"				Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA002717: AB_1080681"	"unprognostic (9.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.33e-3)"	"unprognostic (9.94e-2)"	"unprognostic (6.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (3.50e-3)"	6.1	6.7	11.2	6.1	12.6	4.7	8.4	26.2	16.0	7.7	6.5	7.1	9.4	8.4	9.2	8.5	5.5	7.6	4.9	6.6	12.7	7.4	7.3	6.4	8.0	8.7	11.1	10.3	14.5	7.3	19.8	10.9	12.1	11.4	7.6	6.1	6.4	9.1	9.5	6.4	5.5	7.9	8.1	8.8	9.7	6.7	15.0	11.7	9.2	10.8	5.0	9.2	8.7	11.9	2.1	4.6	0.6	1.3	0.9	2.2	0.7	1.8	3.3	3.3	3.5	3.5	4.9	0.0	4.2	5.4	3.9	4.8	3.3	2.8	3.4	2.4	4.2	3.1	3.5	2.9	7.1	0.0	5.2	25.7	5.0	1.1	3.1	4.3	16.6	1.9	2.7	8.0	3.9	6.3	8.6	3.5	4.3	0.0	4.6	3.2	1.8	3.3	0.0	4.3	1.6	2.1	23.4	4.2	3.0	3.9	1.3	2.5	1.0	3.5	23.7	6.0	2.7	1.4	4.0	4.6	8.5	3.4	16.8	2.5	3.0	0.1	1.3	0.0	1.7	0.5	1.8	1.9	1.6	1.4	1.4	2.1	2.2	1.7	0.6	0.9	0.3	4.6	0.3	0.7	11.2	12.6	26.2	16.0	12.7	7.4	11.1	10.3	11.4	11.7
ZNF184		ENSG00000096654	"Zinc finger protein 184"	Q99676	6	27450743-27473118	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003226, HPA064793"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA003226: AB_2218705, HPA064793: "	"unprognostic (8.86e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.99e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (4.41e-5)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.79e-3)"	5.8	5.3	9.9	6.0	12.5	11.3	8.5	10.8	23.4	10.2	6.7	8.6	3.4	5.1	8.5	6.6	6.4	7.1	6.2	4.7	11.8	6.0	10.7	5.2	6.1	8.7	11.5	14.1	9.9	6.0	11.7	9.2	4.5	8.7	7.0	7.1	3.4	7.0	7.1	6.4	8.7	6.0	6.9	10.9	7.4	6.5	13.3	9.9	14.1	8.9	3.7	9.7	7.7	6.8	7.7	4.2	8.1	3.8	7.2	12.0	4.1	4.1	1.3	7.3	13.2	5.3	3.9	2.4	4.1	5.5	4.8	7.4	2.3	2.4	7.6	7.0	2.6	2.6	6.4	2.6	7.0	7.3	4.0	9.1	4.7	3.3	2.8	10.8	6.6	2.8	4.0	3.5	3.7	5.2	6.9	14.2	8.0	2.1	17.3	9.2	4.2	3.0	22.9	10.2	11.3	3.3	3.9	12.5	6.0	4.6	4.0	6.0	4.7	9.4	3.5	7.4	4.9	3.3	4.7	6.5	10.9	14.3	1.6	12.7	7.3	2.2	2.8	8.1	8.9	3.8	12.0	7.7	9.4	8.5	4.2	6.6	7.1	9.0	1.5	7.2	2.9	2.6	10.5	4.1	9.9	12.5	10.8	23.4	11.8	6.0	11.5	14.1	8.7	9.9
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.5;esophagus: 67.6"	"Cell line enhanced"	"Detected in many"		"A-431: 31.0;EFO-21: 36.9;HBEC3-KT: 25.6;PC-3: 22.7;TIME: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.6;monocytes: 13.9"					"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"			5400	"Plasma membrane, Cytosol"	"Actin filaments, Focal adhesion sites"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	3.9	1.7	1.8	2.0	3.2	0.8	1.8	2.7	2.0	14.3	1.8	1.4	10.7	0.0	3.8	93.5	67.6	3.1	2.0	1.9	1.7	0.8	2.0	1.1	3.3	3.1	2.1	1.1	1.2	0.9	0.1	2.3	4.0	1.7	4.2	0.3	1.3	10.1	28.1	1.5	9.9	1.2	1.4	1.2	3.7	0.8	1.9	2.0	1.2	3.9	1.4	6.6	2.1	22.8	0.4	3.8	21.6	13.9	0.2	0.6	10.2	31.0	6.6	0.6	0.4	0.8	1.0	1.4	1.5	0.1	3.9	0.5	0.2	9.4	0.4	36.9	2.3	4.4	0.9	25.6	15.9	0.3	0.6	2.0	2.7	1.0	1.8	0.1	0.1	0.7	18.4	0.4	15.1	19.7	0.1	0.3	0.1	7.3	0.1	0.1	0.4	22.7	0.1	0.1	0.2	2.0	2.9	0.2	2.1	0.0	5.9	0.9	6.0	0.6	60.4	0.2	13.4	0.7	1.1	0.3	0.2	0.2	0.4	2.2	0.4	21.6	13.9	5.7	0.5	12.9	0.3	0.4	0.4	0.6	3.8	0.3	0.6	0.3	9.5	0.2	10.2	2.5	0.5	10.2	1.8	3.2	2.7	2.0	1.7	0.8	2.1	1.1	1.7	2.0
ZNF207		ENSG00000010244	"Zinc finger protein 207"	O43670	17	32350117-32381886	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017013, HPA063908"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA017013: AB_1859124, HPA063908: AB_2685149"	"unprognostic (8.40e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (7.30e-8)"	"unprognostic (2.68e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (4.17e-8)"	"unprognostic (1.28e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	41.0	36.7	29.7	42.6	29.9	101.0	37.1	51.0	35.2	40.1	33.2	39.1	31.0	26.9	44.3	37.5	61.0	35.4	29.5	32.5	25.8	24.4	33.3	33.7	40.3	45.6	35.4	25.5	43.9	31.3	38.4	53.1	52.5	28.4	32.5	41.3	37.7	42.1	31.4	42.4	39.7	34.9	39.0	41.4	41.8	34.7	32.7	33.8	74.9	35.6	46.5	60.4	42.0	43.1	28.3	45.7	39.6	39.1	36.9	38.8	35.6	37.3	46.0	49.8	28.0	26.7	28.9	40.0	37.5	52.9	53.4	48.1	43.8	35.8	51.5	29.0	46.0	38.7	64.3	45.4	60.4	26.5	43.0	52.8	42.1	44.9	28.0	66.8	48.6	33.4	27.4	37.4	20.9	49.2	53.5	39.8	51.1	34.1	53.4	31.4	43.0	26.2	48.1	44.7	48.0	44.0	73.1	35.0	39.0	35.2	26.0	33.1	46.9	39.8	34.8	30.2	36.0	30.5	50.6	34.0	50.4	82.3	25.8	31.7	46.7	39.6	34.2	34.3	33.0	38.4	34.1	28.3	30.4	30.3	45.7	22.1	25.7	29.3	17.7	36.9	39.1	21.6	38.8	35.6	29.7	29.9	51.0	35.2	25.8	24.4	35.4	25.5	28.4	33.8
ZNF212	C2H2-150	ENSG00000170260	"Zinc finger protein 212"	Q9UDV6	7	149239651-149255609	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049807, HPA054178"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA049807: , HPA054178: "	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.55e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.59e-1)"	7.3	10.9	8.0	11.7	8.8	16.3	11.2	12.0	13.0	13.0	12.4	11.5	13.1	14.2	14.4	12.6	19.1	11.4	11.9	6.6	9.3	6.7	9.4	12.8	7.4	11.0	7.0	11.8	13.7	10.8	13.0	10.4	19.5	10.5	12.2	7.7	10.9	16.7	12.8	9.7	16.5	13.0	8.1	7.3	15.0	9.1	20.5	7.8	21.8	11.2	6.7	12.9	9.6	15.8	5.8	5.7	9.4	4.5	10.5	9.1	2.7	8.2	8.2	10.1	12.7	7.1	5.9	11.2	5.0	7.6	9.1	9.2	6.9	10.6	10.9	7.8	5.0	7.6	7.4	8.2	7.5	8.3	13.3	5.9	5.9	5.8	5.5	9.8	7.5	6.6	9.5	6.2	6.6	5.3	10.9	8.4	5.2	11.8	17.7	20.1	13.3	9.9	12.1	6.9	11.8	5.6	7.0	10.2	16.6	7.7	7.5	7.4	4.5	10.5	4.5	9.2	2.6	11.7	9.1	19.5	8.5	9.8	12.1	8.9	8.3	0.0	4.5	9.4	7.0	3.8	6.8	5.7	5.2	5.8	5.7	5.8	9.1	7.5	2.6	10.5	4.4	5.0	7.5	2.7	8.0	8.8	12.0	13.0	9.3	6.7	7.0	11.8	10.5	7.8
ZNF217	ZABC1	ENSG00000171940	"Zinc finger protein 217"	O75362	20	53567065-53609907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.5"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051857	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA051857: "	"unprognostic (4.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.52e-2)"	9.9	3.0	3.6	9.3	2.9	10.9	15.0	2.2	3.1	7.6	6.7	3.1	6.1	4.5	6.2	2.9	10.0	5.7	5.7	5.4	3.4	1.6	6.3	10.3	8.8	20.9	3.0	2.3	6.1	7.1	8.3	3.9	65.5	4.8	7.1	6.8	5.7	11.0	8.6	5.2	11.9	8.9	6.6	3.4	16.8	6.7	9.9	2.4	16.7	6.9	4.9	9.5	10.6	8.6	4.3	4.1	19.4	11.5	5.8	3.6	2.2	9.1	10.8	9.1	13.2	8.5	9.8	20.0	10.1	10.4	11.6	5.7	6.9	10.2	8.8	11.0	12.4	8.9	7.3	10.7	13.5	6.3	2.0	2.8	4.7	12.0	6.6	4.5	12.2	5.3	10.4	6.2	17.3	6.6	6.2	41.9	8.7	36.1	15.6	10.1	9.6	10.8	12.4	7.6	10.2	6.7	20.3	0.9	2.5	9.4	49.0	9.9	14.6	19.3	4.6	23.4	8.7	11.9	12.4	17.4	19.3	7.5	8.5	5.1	7.4	5.9	4.9	8.4	2.8	6.3	3.6	4.3	3.0	3.5	3.9	3.9	3.4	3.3	19.4	5.8	11.5	4.1	2.9	2.2	3.6	2.9	2.2	3.1	3.4	1.6	3.0	2.3	4.8	2.4
ZNF219		ENSG00000165804	"Zinc finger protein 219"	Q9P2Y4	14	21090046-21104722	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030761, HPA056168"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA030761: , HPA056168: "	"unprognostic (9.82e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.35e-2)"	20.9	26.9	11.6	7.9	7.8	4.5	50.2	22.3	12.7	18.1	26.7	5.0	31.7	23.8	15.9	13.6	20.3	10.1	20.1	22.6	10.4	9.4	12.1	10.5	16.7	10.8	13.2	4.8	18.8	13.2	16.1	8.9	7.4	13.1	14.1	11.8	11.3	22.5	27.4	16.4	38.8	26.7	22.6	4.3	5.8	12.1	8.0	4.8	15.3	11.8	20.0	7.3	20.8	17.4	0.5	2.1	2.8	0.4	0.7	1.3	0.2	3.4	11.6	14.9	21.8	2.0	2.0	21.4	4.3	6.6	2.2	3.5	6.6	7.7	5.1	3.2	1.6	25.6	4.7	13.6	1.5	10.4	5.0	3.0	16.5	13.9	1.2	0.6	4.8	3.0	11.5	3.5	6.6	2.6	2.9	1.6	1.1	9.5	6.8	4.8	21.1	2.5	14.3	2.5	1.3	1.6	19.0	17.0	15.3	5.8	3.5	3.2	4.2	1.8	0.5	2.7	12.0	6.5	1.7	2.7	1.7	1.1	1.7	2.6	5.2	0.0	0.4	0.1	1.3	0.1	0.1	0.2	0.3	0.6	0.2	0.5	0.6	0.5	2.8	0.7	0.0	2.1	0.1	0.2	11.6	7.8	22.3	11.8	10.4	9.4	13.2	4.8	13.1	4.8
ZNF22	"HKR-T1, KOX15, Zfp422, ZNF422"	ENSG00000165512	"Zinc finger protein 22"	P17026	10	45000475-45005326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016736, HPA054893"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA016736: AB_1859133, HPA054893: "	"unprognostic (2.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.31e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.11e-5)"	"prognostic unfavourable (8.06e-4)"	"unprognostic (1.39e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-2)"	28.5	7.9	15.3	14.5	14.0	12.4	38.6	13.5	13.7	15.7	12.1	9.9	14.7	10.8	18.0	14.0	11.4	15.1	10.5	14.7	14.2	13.0	17.0	22.8	14.1	19.9	14.9	10.2	21.6	29.2	5.5	11.1	22.6	13.6	18.1	12.5	10.2	12.9	11.9	14.0	6.2	13.1	13.9	15.6	17.8	12.4	9.0	14.5	40.1	25.4	11.7	19.1	12.2	12.1	19.8	24.7	13.4	10.9	25.2	25.2	13.6	11.6	1.8	16.4	10.1	8.7	6.2	0.1	5.5	11.2	14.0	15.2	6.4	9.8	12.0	9.0	8.1	1.9	15.7	5.8	20.0	7.5	0.2	12.5	3.0	0.0	18.2	24.2	4.4	11.1	8.5	5.7	0.2	22.1	16.4	21.8	11.0	0.3	45.1	36.6	9.8	3.3	33.2	22.8	17.0	10.9	9.8	15.8	13.6	4.9	10.0	8.1	2.1	24.3	12.2	10.3	19.0	7.2	18.3	12.5	12.2	11.5	6.5	0.9	10.9	8.0	10.9	13.4	21.0	10.3	25.2	16.0	13.7	21.6	14.3	19.8	18.9	23.1	1.1	25.2	6.5	24.7	7.7	13.6	15.3	14.0	13.5	13.7	14.2	13.0	14.9	10.2	13.6	14.5
ZNF224	"BMZF-2, KOX22, ZNF255, ZNF27"	ENSG00000267680	"Zinc finger protein 224"	Q9NZL3	19	44094339-44109886	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA054045	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"HPA054045: "	"unprognostic (1.01e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.40e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.25e-4)"	"unprognostic (9.61e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (5.32e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.53e-7)"	13.5	13.3	12.4	13.6	17.7	6.9	14.4	29.2	20.2	13.6	11.0	10.8	17.7	14.8	14.9	20.3	10.0	13.5	11.6	9.0	16.4	7.8	12.7	13.3	14.6	17.1	20.3	11.0	18.6	13.1	16.6	25.0	12.1	15.4	15.0	18.1	11.6	13.8	13.9	6.6	20.2	19.4	15.0	12.3	23.6	13.1	5.4	15.8	14.9	18.0	8.7	18.3	12.1	11.3	11.6	6.5	25.0	8.1	10.0	14.5	6.7	6.1	10.3	11.1	9.1	11.1	11.7	9.1	7.8	11.7	5.4	12.5	5.1	4.9	7.5	8.7	10.2	7.0	6.1	6.7	7.3	7.6	12.3	14.3	17.1	5.3	5.9	10.3	16.8	14.4	12.2	6.7	10.0	9.7	4.3	9.1	9.0	1.6	9.0	12.5	4.8	7.2	5.3	12.1	4.5	8.2	19.9	5.7	13.1	10.7	4.6	3.6	4.6	13.5	10.2	12.1	7.8	5.4	5.4	12.3	11.4	4.2	6.5	8.0	5.5	25.0	6.1	14.1	13.3	4.1	14.5	11.2	11.2	13.1	6.5	11.6	14.1	10.9	4.5	10.0	8.1	5.8	12.5	6.7	12.4	17.7	29.2	20.2	16.4	7.8	20.3	11.0	15.4	15.8
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: "	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favourable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	6.7	5.2	6.5	6.7	9.5	2.0	7.4	14.3	11.1	6.6	8.2	11.1	7.8	4.5	8.9	10.1	5.5	9.9	5.5	5.9	7.3	5.4	6.6	6.3	6.3	7.0	9.8	5.7	14.3	10.0	3.8	8.7	6.2	8.7	7.6	5.9	6.5	8.8	6.4	7.7	5.5	6.3	8.5	6.2	6.9	7.2	7.5	10.7	6.4	8.0	5.4	6.1	6.3	6.2	11.8	7.4	1.9	2.1	5.4	7.8	3.9	5.5	4.2	6.9	7.0	2.5	1.1	3.7	2.7	1.4	2.7	3.8	6.5	1.4	11.2	3.4	1.0	3.8	4.8	2.8	1.6	4.4	7.3	1.9	9.7	5.8	3.6	0.0	3.4	2.0	3.0	2.9	2.6	1.9	9.4	4.2	3.3	2.7	9.5	3.9	13.5	4.6	8.2	4.4	7.5	2.3	0.8	7.2	4.7	5.4	2.2	4.4	1.1	2.8	3.2	2.7	4.6	2.1	5.3	5.6	8.8	2.8	7.0	0.3	4.5	1.4	2.1	1.9	4.7	1.9	5.5	11.8	5.2	6.2	4.0	11.0	7.8	7.2	0.1	5.4	1.2	7.4	4.2	3.9	6.5	9.5	14.3	11.1	7.3	5.4	9.8	5.7	8.7	10.7
ZNF24	"KOX17, Zfp191, ZNF191, ZSCAN3"	ENSG00000172466	"Zinc finger protein 24"	P17028	18	35332212-35345482	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024062, CAB025642"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB025642: , HPA024062: AB_1859150"	"unprognostic (1.19e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.44e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (5.25e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-3)"	17.2	19.5	26.9	17.7	39.8	17.9	30.5	33.5	33.3	19.7	17.8	31.9	15.5	16.9	20.6	19.7	16.3	16.7	15.4	17.0	28.3	20.0	20.8	25.7	18.9	22.2	44.8	21.5	23.2	21.6	31.4	32.6	19.6	28.4	22.5	18.5	14.5	20.1	16.6	26.8	13.7	18.8	18.1	37.3	20.4	20.6	16.1	42.8	27.4	28.6	14.5	21.5	18.0	15.1	23.7	21.8	31.0	20.3	15.5	19.1	10.9	8.6	8.7	27.9	14.6	11.9	12.9	7.9	11.8	13.3	14.7	16.9	5.6	7.1	19.6	13.4	9.8	16.0	20.5	11.1	25.3	17.8	11.2	14.0	17.4	11.9	12.5	29.6	22.8	10.8	19.2	13.1	14.2	13.9	21.1	12.8	15.1	10.2	22.5	12.7	14.5	5.9	16.9	18.1	15.6	14.8	19.9	23.9	20.5	14.4	13.5	25.3	12.7	22.6	11.7	21.1	9.5	5.0	11.7	32.6	26.1	20.0	11.8	12.2	19.2	18.6	15.6	17.6	19.0	14.9	18.6	23.1	19.1	16.2	14.2	23.7	18.7	17.1	31.0	15.5	20.3	21.8	14.1	10.9	26.9	39.8	33.5	33.3	28.3	20.0	44.8	21.5	28.4	42.8
ZNF250	"MGC9718, ZFP647, ZNF647"	ENSG00000196150	"Zinc finger protein 250"	P15622	8	144876497-144902168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA020853	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA020853: AB_1859152"	"unprognostic (1.16e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (2.43e-7)"	"unprognostic (2.23e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-2)"	"prognostic favourable (8.26e-4)"	6.5	7.0	8.4	9.4	10.0	4.5	21.2	33.0	11.1	13.8	9.0	8.6	7.3	9.2	15.8	11.4	9.1	10.7	7.2	7.1	6.3	7.6	10.5	5.6	9.3	5.9	9.3	9.5	16.4	8.6	12.5	14.7	10.0	10.0	10.6	6.8	10.4	8.8	12.4	10.6	14.8	9.1	12.2	6.5	8.3	6.9	6.1	9.2	9.7	19.9	6.0	8.8	12.7	12.0	12.2	7.5	6.4	5.9	6.1	12.7	5.0	4.7	3.6	12.9	10.9	7.4	5.3	4.6	5.6	6.2	8.8	7.8	2.3	3.4	12.7	9.7	6.5	6.2	6.4	6.7	6.4	3.6	7.9	10.3	13.2	3.5	3.6	2.0	3.8	4.0	9.1	6.8	8.1	4.8	8.3	10.8	8.0	8.7	12.3	4.7	3.6	10.7	14.9	5.9	5.5	9.0	3.8	12.8	10.2	11.0	4.0	4.9	5.8	5.6	4.9	9.8	8.8	7.9	5.0	5.6	4.3	7.5	4.8	6.9	4.1	4.6	5.9	6.4	12.7	3.3	9.8	12.2	9.4	7.3	7.5	11.0	11.1	9.2	3.3	6.1	4.2	3.2	12.4	5.0	8.4	10.0	33.0	11.1	6.3	7.6	9.3	9.5	10.0	9.2
ZNF256	BMZF-3	ENSG00000152454	"Zinc finger protein 256"	Q9Y2P7	19	57940833-57947675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA055390	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA055390: "	"unprognostic (2.47e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.32e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.83e-2)"	"unprognostic (6.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.28e-3)"	7.4	5.1	8.4	6.7	12.2	16.6	11.0	22.7	11.3	5.9	6.6	7.2	5.8	4.4	8.2	8.8	6.1	8.8	5.4	11.2	7.4	4.1	6.1	3.7	6.8	8.8	7.9	8.3	11.2	4.6	8.7	9.8	8.7	7.4	7.9	5.8	8.6	7.0	8.4	9.4	13.5	7.3	7.6	5.7	9.5	5.4	8.4	7.4	7.1	8.8	4.9	9.8	7.0	6.0	7.5	5.4	1.7	4.5	4.6	8.9	3.0	2.7	0.9	6.9	7.0	1.5	2.4	6.1	2.3	2.5	3.8	2.5	0.5	1.5	0.0	2.2	3.0	0.3	1.6	5.3	6.2	0.0	23.6	6.6	0.0	1.8	2.8	0.0	5.5	4.9	1.5	2.8	0.0	2.2	0.5	0.0	3.9	0.6	9.1	0.0	8.4	5.9	3.0	8.7	4.1	2.8	12.0	3.5	5.1	0.0	2.2	1.6	5.2	2.1	0.9	7.9	4.8	0.0	4.7	3.3	3.2	12.1	0.2	0.0	3.4	1.7	1.3	1.6	4.5	4.5	8.2	6.6	7.8	6.9	5.4	7.5	7.7	8.9	0.6	4.6	4.0	2.6	6.2	3.0	8.4	12.2	22.7	11.3	7.4	4.1	7.9	8.3	7.4	7.4
ZNF260	"ozrf1, Zfp260"	ENSG00000254004	"Zinc finger protein 260"	Q3ZCT1	19	36510695-36528660	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028806	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028806: AB_10795285"	"unprognostic (1.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.89e-3)"	8.4	9.4	10.3	7.6	16.8	2.3	12.0	18.4	14.1	10.8	7.0	6.2	9.4	6.2	11.2	7.9	8.0	8.4	8.2	7.5	11.2	9.5	11.6	8.5	7.3	12.4	17.1	9.1	13.4	6.6	20.4	19.5	10.9	11.9	10.3	7.1	5.9	8.8	7.6	4.8	10.0	7.7	8.1	20.6	8.3	8.1	4.5	15.4	17.3	14.7	5.5	9.7	10.7	8.4	5.9	3.2	6.8	3.5	4.1	7.2	3.0	7.8	8.0	18.5	13.9	5.7	8.8	8.1	6.9	7.4	6.4	8.2	3.6	4.4	5.2	11.3	5.5	3.0	9.3	4.3	9.8	6.8	4.0	7.6	6.1	4.0	8.0	3.8	6.4	7.9	7.1	6.6	10.1	8.5	6.0	5.7	12.7	4.2	14.2	2.4	11.7	3.4	9.5	11.5	3.8	7.1	14.1	13.4	14.7	15.3	8.2	5.6	6.9	7.3	7.3	11.1	11.6	6.5	6.1	7.4	14.1	12.1	0.3	4.1	14.9	6.8	2.8	3.0	4.0	2.5	4.2	5.1	5.3	3.2	3.2	5.9	7.2	5.5	1.6	4.1	3.5	2.2	4.6	3.0	10.3	16.8	18.4	14.1	11.2	9.5	17.1	9.1	11.9	15.4
ZNF263	"FPM315, ZKSCAN12, ZSCAN44"	ENSG00000006194	"Zinc finger protein 263"	O14978	16	3263800-3301401	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035085, HPA035086"	Approved		Supported	"Nucleoplasm,Mitotic spindle,Cytosol"				Cytosol	"Nucleoplasm, Mitotic spindle"	"HPA035085: AB_10671099, HPA035086: AB_10603244"	"unprognostic (2.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.98e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.66e-1)"	28.3	17.8	21.5	16.9	25.7	15.0	23.3	26.4	23.5	21.9	19.2	18.1	14.0	13.8	30.4	23.4	15.4	24.2	17.6	14.6	15.7	14.2	16.9	17.1	18.5	20.4	20.3	18.1	30.7	23.0	36.4	24.8	20.1	16.8	21.8	16.8	20.2	19.5	21.1	15.8	22.7	18.2	18.6	14.0	23.6	20.5	17.3	16.5	18.9	20.1	14.5	28.8	20.2	27.6	6.6	5.5	9.6	5.0	6.7	9.2	3.3	8.4	11.0	13.2	19.1	10.5	13.9	17.1	11.7	18.0	14.1	15.3	12.0	13.4	31.3	12.2	15.0	10.8	17.8	11.9	14.2	17.2	17.8	14.2	14.7	11.5	12.3	21.0	17.5	16.0	24.9	12.8	18.8	12.0	16.0	21.4	11.5	11.7	19.3	16.2	24.5	9.5	31.5	13.3	24.6	9.8	8.5	19.1	20.0	12.8	13.9	14.2	15.3	25.2	12.4	14.9	14.4	11.0	10.9	22.9	24.2	37.8	5.8	10.6	10.5	2.1	3.9	9.6	6.0	4.2	6.9	4.5	7.3	8.0	5.5	6.6	9.2	6.8	5.0	6.7	5.0	4.6	4.9	3.3	21.5	25.7	26.4	23.5	15.7	14.2	20.3	18.1	16.8	16.5
ZNF266	HZF1	ENSG00000174652	"Zinc finger protein 266"	Q14584	19	9412598-9435578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA026836, HPA054110"	Uncertain		Supported	"Nucleoplasm,Vesicles,Rods & Rings"				Vesicles	"Nucleoplasm, Rods & Rings"	"HPA026836: , HPA054110: "	"unprognostic (2.50e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.60e-2)"	"prognostic favourable (3.94e-6)"	"unprognostic (1.72e-2)"	"prognostic favourable (4.47e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.00e-3)"	"prognostic favourable (3.03e-5)"	"unprognostic (2.92e-3)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	"prognostic favourable (9.15e-5)"	14.7	12.1	11.0	21.5	12.5	12.8	17.6	19.0	10.0	21.8	15.7	13.1	9.6	8.6	17.2	55.8	12.7	14.6	12.8	11.7	8.2	5.4	10.9	10.4	15.8	21.0	14.5	4.9	18.9	11.2	12.5	19.8	13.0	11.4	23.8	15.7	14.4	14.4	13.5	9.3	19.1	20.8	17.0	10.9	31.3	13.5	13.0	11.4	34.6	20.8	7.3	23.4	14.4	14.2	6.9	3.8	5.6	5.5	12.6	13.0	5.1	10.6	2.7	7.9	15.1	5.7	11.1	6.4	11.8	10.0	9.8	16.3	5.7	4.6	11.9	7.6	5.8	4.0	10.0	6.3	11.7	3.3	16.5	16.3	14.6	8.3	5.1	9.3	10.1	10.5	8.7	5.3	8.2	7.8	8.5	0.1	9.0	1.0	13.6	45.8	8.3	9.0	6.1	8.2	8.3	7.6	13.3	6.8	10.7	5.4	6.4	6.6	4.7	7.2	7.1	9.1	3.5	13.7	6.0	19.5	25.8	14.2	2.8	8.9	6.8	4.8	4.1	5.6	13.0	4.8	8.5	6.0	7.2	9.2	3.3	6.9	10.6	10.2	3.6	12.6	5.5	3.8	8.7	5.1	11.0	12.5	19.0	10.0	8.2	5.4	14.5	4.9	11.4	11.4
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favourable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	9.9	7.6	5.9	8.8	7.0	8.8	15.4	16.6	6.7	7.5	9.9	11.7	14.0	6.3	10.0	12.2	11.7	9.8	14.7	12.0	5.9	4.8	7.3	14.0	12.0	12.8	12.5	5.5	16.8	8.9	20.3	10.9	7.6	9.5	10.4	5.8	14.5	8.6	11.0	11.2	11.4	10.6	10.6	8.7	10.7	8.3	19.3	7.9	6.1	15.3	8.6	10.9	11.2	12.8	16.3	6.7	23.0	8.0	14.0	18.1	8.8	8.8	6.3	10.5	4.3	6.7	9.9	10.2	7.3	4.0	8.0	7.2	3.6	6.6	3.0	4.8	4.5	2.5	4.9	10.2	11.2	6.2	38.3	14.3	6.1	5.9	10.8	10.2	23.7	7.8	13.2	9.9	19.1	6.4	10.7	13.8	6.0	5.8	5.5	9.1	10.0	6.1	12.4	2.7	13.2	6.0	3.7	6.8	3.1	9.8	4.3	8.2	10.4	19.3	6.1	4.4	6.6	5.0	8.2	6.3	6.6	10.1	1.9	11.3	9.1	13.7	4.7	23.0	9.3	5.1	14.3	13.8	12.2	13.2	6.7	16.3	18.1	13.0	17.3	14.0	8.0	3.1	15.3	8.8	5.9	7.0	16.6	6.7	5.9	4.8	12.5	5.5	9.5	7.9
ZNF281	ZBP-99	ENSG00000162702	"Zinc finger protein 281"	Q9Y2X9	1	200404940-200410056	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051228	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA051228: "	"unprognostic (3.13e-1)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.71e-3)"	"unprognostic (8.30e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (1.26e-2)"	"unprognostic (4.86e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.83e-1)"	8.4	5.7	8.8	11.4	18.3	31.2	8.8	22.4	13.1	8.5	7.9	9.1	4.0	6.2	8.8	4.6	4.6	6.8	11.3	5.2	10.5	9.2	8.1	22.9	9.1	11.4	17.3	8.1	6.7	7.6	7.0	8.7	10.3	12.0	6.1	5.0	4.1	6.4	5.1	7.8	3.1	7.3	9.8	11.2	11.4	7.5	10.0	19.9	19.9	5.9	4.8	12.3	8.8	10.2	7.1	5.3	24.5	5.4	4.7	9.3	2.2	11.2	10.9	15.4	7.1	6.1	8.4	13.4	11.8	18.6	11.9	11.3	10.8	8.9	16.2	7.0	13.4	7.7	16.5	11.0	14.2	17.4	10.1	12.9	8.3	11.1	6.7	11.8	7.5	8.1	12.3	12.8	14.0	10.7	18.6	2.6	12.0	5.3	12.1	7.4	35.7	9.9	11.5	10.7	9.7	12.2	5.7	5.4	14.3	11.7	7.8	10.3	15.6	8.6	14.5	22.3	16.6	5.0	12.6	10.1	9.8	20.8	11.8	9.4	11.8	8.4	5.1	18.4	6.6	5.4	6.7	7.1	5.7	6.9	5.1	6.5	9.3	8.1	24.5	4.7	4.9	5.3	6.7	2.2	8.8	18.3	22.4	13.1	10.5	9.2	17.3	8.1	12.0	19.9
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.2;HeLa: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 3.8"	"Low lineage specificity"	"Detected in all"											"HPA028975, HPA051777"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA028975: , HPA051777: "	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavourable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	4.5	1.3	4.8	4.0	12.0	3.6	7.2	12.5	6.4	7.4	4.3	5.4	4.1	4.1	11.7	5.3	7.5	5.4	5.4	4.0	7.5	3.2	7.3	1.5	3.0	4.4	8.2	2.4	16.6	7.3	1.0	7.3	2.4	7.4	7.0	4.4	3.6	3.8	3.9	1.5	6.9	5.8	6.4	9.2	5.1	7.1	14.9	9.1	1.5	9.3	2.7	4.4	5.5	6.2	3.8	1.2	1.1	1.5	1.7	1.0	0.8	1.2	2.8	17.2	0.0	1.5	3.6	0.0	4.2	3.3	3.7	5.4	1.4	2.1	0.0	3.7	3.5	2.5	0.0	9.6	5.8	0.0	5.6	0.0	18.9	2.2	3.1	0.1	0.0	5.5	3.0	7.7	9.1	6.3	0.0	9.1	3.6	0.0	0.0	0.8	16.5	0.0	0.0	2.5	4.9	2.7	3.1	9.7	16.1	9.9	8.6	5.7	5.7	0.0	2.7	5.0	2.1	3.6	7.6	0.3	0.1	0.0	0.5	0.1	10.3	0.0	0.6	1.1	0.7	1.5	0.1	0.9	1.0	0.0	1.2	3.8	0.7	0.4	0.2	1.7	0.1	0.1	0.0	0.8	4.8	12.0	12.5	6.4	7.5	3.2	8.2	2.4	7.4	9.1
ZNF317		ENSG00000130803	"Zinc finger protein 317"	Q96PQ6	19	9140380-9163424	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042075, HPA048625"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA042075: AB_10796471, HPA048625: "	"unprognostic (3.81e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.70e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.42e-3)"	14.6	17.2	18.4	22.8	19.4	36.1	30.3	22.0	24.1	15.6	17.2	22.1	12.4	17.9	19.4	19.5	17.8	17.2	16.9	13.1	18.3	16.1	17.5	20.5	17.1	22.2	19.7	15.2	18.8	21.5	22.0	19.9	14.5	14.6	18.2	17.1	17.9	15.3	18.5	14.3	22.0	17.8	16.9	17.0	25.7	18.0	8.7	19.4	27.0	17.0	11.2	23.4	16.2	15.5	19.0	14.4	14.5	15.0	21.7	20.9	12.9	8.4	7.3	7.9	10.6	7.9	7.7	6.9	7.1	11.2	9.8	12.0	8.2	4.5	14.4	9.2	7.3	8.6	12.9	12.0	12.8	11.9	17.4	12.6	6.6	9.0	10.9	13.2	13.2	9.2	16.4	11.2	19.5	8.6	11.8	16.8	9.8	7.1	16.7	42.7	14.8	15.6	11.9	10.0	11.5	8.6	14.4	13.7	9.4	9.9	8.8	11.1	6.6	14.2	7.5	7.0	6.3	15.8	9.4	21.2	20.2	16.4	6.7	11.8	8.9	13.9	14.1	14.5	13.6	15.0	20.9	19.0	17.9	15.4	14.4	16.0	17.1	18.5	8.8	21.7	11.9	13.2	20.8	12.9	18.4	19.4	22.0	24.1	18.3	16.1	19.7	15.2	14.6	19.4
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369478	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 6.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.3	7.1	14.2	15.3	13.7	9.9	12.2	24.7	17.7	12.5	8.9	10.4	9.2	7.1	12.7	11.1	7.0	9.0	7.1	7.6	12.8	6.3	7.3	8.3	9.2	23.6	15.4	9.4	13.2	8.6	14.6	8.0	7.9	11.4	10.2	8.2	7.9	7.9	8.6	8.6	11.7	10.0	9.2	9.0	14.6	6.8	39.2	16.8	10.0	13.7	4.7	23.6	9.8	10.9	6.3	0.9	0.4	0.7	0.7	1.4	0.5	16.1	4.1	11.9	19.7	10.4	9.4	5.8	7.0	9.3	8.5	7.5	4.2	2.1	25.8	4.0	9.3	7.4	13.2	6.2	11.2	6.7	6.7	7.1	5.2	6.8	5.2	12.6	5.8	6.0	6.5	7.2	6.4	6.6	9.5	12.9	9.0	5.7	3.8	8.1	5.3	3.9	4.7	11.5	4.1	4.8	3.9	10.9	6.7	5.5	4.8	5.8	6.0	17.7	6.6	12.1	6.0	8.0	7.0	7.7	6.2	18.4	3.8	9.7	6.7	0.0	0.7	0.0	1.4	0.5	0.4	1.4	1.2	0.9	0.9	6.3	0.9	1.0	0.4	0.7	0.4	0.7	1.2	0.5	14.2	13.7	24.7	17.7	12.8	6.3	15.4	9.4	11.4	16.8
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: , HPA046692: "	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favourable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favourable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	8.8	9.7	7.7	5.4	10.9	0.4	10.1	10.6	15.4	13.1	8.6	7.9	9.5	6.9	12.7	10.8	6.8	9.2	11.5	13.3	8.4	6.9	9.5	7.0	7.9	6.7	8.8	7.0	14.8	6.9	15.0	18.0	8.6	11.8	12.3	8.6	8.6	8.2	15.5	7.7	5.0	7.9	9.7	10.7	8.7	7.6	8.2	12.5	4.3	13.6	6.7	7.2	11.8	8.4	11.2	7.9	10.5	11.2	17.6	11.4	4.9	5.7	4.4	17.3	19.8	11.4	15.2	6.2	7.7	10.2	10.8	13.1	8.5	3.6	7.0	18.6	6.7	7.3	12.8	5.0	13.5	10.8	11.6	12.3	5.7	8.3	12.9	0.0	11.2	9.3	17.7	7.1	8.1	9.3	14.1	7.5	11.8	3.3	8.6	10.3	5.0	5.3	9.7	12.2	9.9	6.7	9.2	14.0	14.8	9.2	8.7	16.2	8.1	8.0	9.2	18.0	7.2	7.3	7.8	7.9	15.8	6.7	3.9	2.0	18.1	3.3	8.7	10.5	11.4	7.4	8.3	11.2	5.8	7.4	7.0	10.5	6.8	9.9	8.3	17.6	11.2	7.9	4.4	4.9	7.7	10.9	10.6	15.4	8.4	6.9	8.8	7.0	11.8	12.5
ZNF326	"FLJ20403, ZAN75, Zfp326, ZIRD"	ENSG00000162664	"Zinc finger protein 326"	Q5BKZ1	1	89995112-90035531	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028450, HPA028461, HPA028466"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA028450: , HPA028461: AB_10601777, HPA028466: AB_10601677"	"prognostic favourable (9.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-1)"	"prognostic favourable (2.84e-4)"	12.7	13.4	18.4	12.7	27.8	45.2	17.7	20.2	18.5	11.8	14.1	23.2	16.3	18.5	18.3	17.1	17.5	11.9	13.9	12.5	19.2	15.2	13.4	15.2	11.5	15.3	26.1	14.1	21.8	20.2	14.4	18.0	14.5	22.8	13.3	20.7	23.9	15.7	9.4	19.2	14.5	18.9	17.8	31.3	11.0	14.6	10.6	27.8	17.3	14.1	10.5	15.1	11.9	17.2	6.8	8.4	3.6	6.1	7.8	4.3	2.2	16.9	15.5	24.1	11.5	10.8	5.1	25.5	17.2	6.7	14.3	8.9	14.4	12.3	21.2	12.3	8.8	15.3	25.1	11.2	19.6	12.4	12.0	19.1	15.1	13.0	3.6	22.4	9.4	4.5	5.3	14.2	9.0	8.2	25.5	9.3	11.4	8.0	23.1	12.8	22.7	17.6	16.5	24.5	5.7	11.8	19.0	21.2	13.8	19.8	18.4	8.4	10.1	5.9	11.2	16.8	16.9	14.1	17.0	7.9	7.7	21.2	4.0	17.7	10.7	2.1	5.1	3.6	4.0	6.1	3.2	4.2	3.2	3.4	4.0	6.8	3.2	4.3	2.5	7.8	4.6	8.4	2.8	2.2	18.4	27.8	20.2	18.5	19.2	15.2	26.1	14.1	22.8	27.8
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 80.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015705, HPA056325"	Uncertain		Supported	Nucleoli				Nucleoli		"HPA015705: AB_1859199, HPA056325: "	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (3.66e-6)"	"prognostic favourable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	21.7	15.9	8.9	12.2	13.7	16.2	13.8	17.5	11.2	14.9	17.4	9.8	14.2	9.5	19.0	15.6	13.6	14.0	10.5	80.7	9.0	9.5	14.9	26.7	15.2	13.4	13.7	8.6	14.9	16.5	13.2	15.1	10.4	12.7	12.2	12.3	22.3	44.9	11.4	34.7	10.9	12.6	18.9	14.1	16.0	14.2	14.2	13.3	14.3	23.5	15.4	13.5	18.7	16.0	16.3	21.9	12.2	20.8	14.6	19.3	11.8	7.6	9.5	11.5	9.1	20.6	18.6	16.2	20.7	12.0	13.4	12.7	12.8	14.8	33.0	12.7	13.0	6.2	20.3	13.4	20.5	15.2	13.3	15.3	14.6	17.9	22.1	38.5	12.4	18.6	15.8	12.5	18.4	13.9	31.0	22.5	17.0	17.4	29.7	18.1	10.2	18.1	24.3	16.5	20.9	14.3	8.6	20.1	9.3	7.2	16.7	20.3	8.3	10.5	14.8	17.1	11.6	10.2	14.7	37.7	27.1	31.3	14.3	24.1	12.1	9.7	20.8	12.2	12.9	17.5	17.8	16.3	16.4	16.6	21.9	13.4	18.0	16.2	3.2	14.6	13.5	15.0	19.3	11.8	8.9	13.7	17.5	11.2	9.0	9.5	13.7	8.6	12.7	13.3
ZNF335	"bA465L10.2, NIF-1"	ENSG00000198026	"Zinc finger protein 335"	Q9H4Z2	20	45948653-45972172	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063999, HPA071230"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA063999: , HPA071230: "	"unprognostic (1.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.35e-2)"	"prognostic favourable (4.48e-4)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.30e-3)"	"prognostic unfavourable (7.04e-4)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (4.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.88e-3)"	10.5	8.3	12.0	12.2	13.6	28.8	10.7	17.9	15.7	10.5	10.3	9.7	4.0	11.5	14.2	5.2	11.2	12.3	8.2	7.0	10.7	5.0	8.6	7.8	10.4	15.0	8.1	11.6	15.2	10.5	13.2	10.4	13.7	8.2	10.7	6.7	8.4	12.0	9.2	12.3	22.9	13.5	7.9	7.6	13.9	10.6	16.5	10.1	19.4	14.9	8.8	12.0	11.4	9.5	3.7	3.6	5.0	4.5	8.9	7.3	3.5	9.0	9.3	8.3	8.9	4.4	5.6	17.6	8.2	5.7	8.1	5.9	20.0	10.3	10.9	12.2	8.0	13.1	8.0	12.3	3.7	7.4	10.9	9.1	13.6	10.5	6.9	11.7	15.6	9.0	10.5	10.7	7.7	7.0	8.5	14.8	5.6	18.5	13.8	11.5	5.6	15.3	11.4	5.5	9.2	7.2	14.4	8.4	7.4	12.1	17.1	8.6	12.9	9.8	7.3	17.6	7.7	11.1	11.1	17.2	8.8	11.4	14.2	7.3	9.6	2.4	3.5	5.0	7.3	4.5	3.7	3.3	3.6	4.9	3.6	3.7	3.1	3.4	3.6	8.9	3.6	2.5	3.6	3.5	12.0	13.6	17.9	15.7	10.7	5.0	8.1	11.6	8.2	10.1
ZNF34	KOX32	ENSG00000196378	"Zinc finger protein 34"	Q8IZ26	8	144773114-144787345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA053925, HPA060755, HPA066805"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA053925: , HPA060755: , HPA066805: "	"unprognostic (2.54e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	9.0	5.7	12.3	4.1	11.5	4.6	8.6	28.5	14.4	10.0	9.4	12.6	7.8	3.6	10.0	8.0	6.3	10.4	6.6	7.5	13.4	7.8	6.4	6.5	7.5	5.8	17.2	13.8	17.0	7.8	12.5	11.5	7.6	12.2	8.7	6.0	8.3	5.6	12.7	5.9	8.0	5.4	10.7	11.8	6.0	5.9	7.1	16.0	4.1	11.1	1.8	4.7	8.7	7.8	7.2	10.4	12.7	15.2	5.5	8.5	5.0	3.0	5.2	8.8	6.6	7.5	7.4	2.3	2.8	6.1	7.2	6.1	1.2	5.0	4.9	5.4	7.2	3.1	5.0	5.8	5.4	4.8	4.3	9.5	8.1	4.0	6.8	2.5	4.9	7.8	6.7	5.8	11.7	4.9	6.3	4.1	6.3	7.7	5.5	3.9	6.4	5.5	5.0	3.5	5.9	4.0	3.1	8.3	6.2	6.6	4.6	4.4	5.3	3.2	3.4	6.7	5.9	5.6	5.5	5.1	1.7	5.7	4.9	4.1	7.9	8.1	7.0	12.7	7.4	6.4	6.5	6.8	6.9	8.5	10.4	7.2	4.9	7.4	1.0	5.5	15.2	4.9	5.4	5.0	12.3	11.5	28.5	14.4	13.4	7.8	17.2	13.8	12.2	16.0
ZNF350	"ZBRK1, ZFQR"	ENSG00000256683	"Zinc finger protein 350"	Q9GZX5	19	51964343-51986856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA001521	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA001521: AB_1080705"	"unprognostic (7.26e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.64e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.30e-2)"	"prognostic favourable (2.54e-4)"	10.5	6.5	10.1	5.9	14.4	25.6	16.3	19.9	10.2	8.8	8.3	9.2	7.1	6.4	9.8	10.3	8.0	7.5	6.3	8.4	13.4	6.5	9.0	6.3	7.5	10.1	14.8	10.9	10.6	6.9	9.0	14.2	10.4	10.0	32.1	10.7	6.3	8.3	8.0	10.3	9.5	12.9	7.9	14.9	11.4	8.5	8.1	14.0	13.6	12.5	6.7	10.1	11.6	7.6	10.1	8.4	29.8	9.0	13.0	12.0	4.9	0.7	4.4	5.6	6.5	7.7	6.7	1.1	4.7	6.2	4.6	9.5	0.0	3.3	2.0	3.6	5.2	5.5	5.0	6.5	6.4	0.0	10.0	8.0	6.8	3.9	6.4	2.0	10.2	10.3	9.7	6.2	7.1	5.4	2.1	0.1	5.7	2.6	7.9	9.4	3.5	6.5	3.8	8.3	6.3	7.5	11.5	4.6	6.2	0.0	5.7	4.6	9.5	7.4	5.6	5.1	3.7	3.0	4.5	1.6	2.5	2.6	1.0	0.1	5.5	29.8	7.1	15.6	10.6	7.8	10.8	10.1	10.2	10.2	8.4	10.0	12.0	9.5	19.4	13.0	9.0	5.5	8.1	4.9	10.1	14.4	19.9	10.2	13.4	6.5	14.8	10.9	10.0	14.0
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178694605-178730702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: "	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favourable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavourable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	14.0	7.0	13.0	12.1	13.6	14.2	14.2	13.3	14.4	12.6	15.0	6.7	11.4	7.1	13.7	13.3	10.4	11.7	9.8	14.5	13.2	9.3	18.0	6.2	10.8	12.7	16.7	16.1	10.9	15.0	11.7	14.1	14.0	13.4	13.3	10.0	7.1	8.8	15.1	11.9	12.3	10.6	13.6	12.9	17.1	10.4	14.0	14.4	13.1	15.1	8.6	14.2	17.0	25.1	5.7	5.3	15.0	5.8	6.0	6.4	3.6	4.2	3.3	7.0	18.5	12.2	9.9	29.0	4.9	6.6	6.9	7.4	4.9	7.2	5.7	6.5	4.5	8.5	2.6	21.0	10.6	7.6	8.0	1.7	4.2	0.6	9.3	0.0	4.8	7.7	13.5	6.0	12.4	6.5	1.4	0.0	9.9	8.6	8.5	5.7	6.1	8.7	6.4	1.2	3.6	6.4	4.3	7.7	8.4	6.2	7.1	9.5	5.8	8.4	5.0	7.8	5.1	4.4	4.2	1.9	3.9	3.6	0.2	1.3	9.7	4.4	5.8	14.5	5.1	3.8	6.4	5.7	4.6	5.7	5.3	3.6	5.3	3.8	15.0	6.0	3.9	1.9	4.1	3.6	13.0	13.6	13.3	14.4	13.2	9.3	16.7	16.1	13.4	14.4
ZNF354C	KID3	ENSG00000177932	"Zinc finger protein 354C"	Q86Y25	5	179060415-179083537	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030904	Uncertain		Supported	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA030904: AB_10603842"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.56e-4)"	"unprognostic (4.76e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.83e-1)"	6.4	4.9	6.6	4.6	7.9	1.2	8.2	12.9	8.9	9.3	7.4	7.7	6.5	2.6	10.6	4.1	5.6	7.8	5.4	5.6	7.7	3.4	4.6	3.0	6.6	6.5	9.4	5.3	15.0	5.3	3.4	3.5	6.5	6.7	9.0	3.5	5.7	4.3	7.3	5.5	4.1	5.1	8.8	5.7	6.4	5.3	4.5	9.3	5.5	9.8	3.1	6.8	6.5	10.5	1.3	0.9	0.8	2.0	1.5	3.3	1.5	0.8	1.2	9.6	15.5	5.1	8.2	0.0	4.3	3.8	4.8	5.5	0.0	1.9	0.0	5.2	4.7	3.0	0.0	1.5	9.2	0.0	0.1	0.0	0.4	0.0	4.8	0.0	2.2	6.1	1.4	4.8	0.0	2.3	0.1	0.0	5.7	0.5	8.8	0.0	6.9	0.0	0.0	0.0	0.0	1.8	0.3	6.0	10.0	6.9	0.1	4.6	4.0	3.6	2.8	0.0	6.5	4.2	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.8	0.5	0.5	2.2	0.9	2.2	1.3	2.9	2.0	0.9	1.3	3.3	2.8	0.0	1.5	2.0	0.1	1.7	1.5	6.6	7.9	12.9	8.4	7.7	3.4	9.4	5.3	6.7	9.3
ZNF365	"KIAA0844, UAN"	ENSG00000138311	"Zinc finger protein 365"	"Q70YC4, Q70YC5"	10	62374192-62672011	"Disease related genes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.2;PC-3: 11.1;U-251 MG: 14.3;U-87 MG: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 3.4;memory CD4 T-cell: 3.1;memory CD8 T-cell: 3.5;naive CD8 T-cell: 3.7;NK-cell: 7.4;T-reg: 7.5"	"Group enriched"	"Detected in many"	51	"NK-cells: 7.4;T-cells: 7.5"	"Group enriched"	"Detected in all"	4	"amygdala: 328.0;basal ganglia: 309.9;cerebral cortex: 424.1;hippocampal formation: 348.1;thalamus: 127.9"	"Low region specificity"	"Detected in all"			HPA052446	Enhanced		Supported	"Vesicles,Centriolar satellite"				"Vesicles, Centriolar satellite"		"HPA052446: "	"unprognostic (7.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-6)"	"unprognostic (2.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.89e-2)"	0.9	2.5	11.8	1.0	19.4	1.0	1.3	8.4	41.3	2.0	0.9	13.1	0.0	1.1	1.2	1.5	11.7	1.0	4.0	2.0	9.6	7.4	1.1	1.2	3.1	1.1	7.5	16.0	1.0	1.3	9.0	1.8	1.2	6.9	3.0	1.1	1.0	1.2	3.3	1.0	2.6	0.9	0.9	10.5	1.3	1.0	1.6	9.1	0.0	1.6	0.0	2.2	1.9	1.2	0.1	0.0	0.1	0.1	7.4	7.5	1.0	5.7	0.8	0.5	0.7	0.6	0.3	0.3	4.3	4.5	2.2	1.9	0.6	1.4	0.4	0.7	2.6	17.2	0.5	0.3	2.9	0.2	0.4	0.3	1.5	0.4	0.2	0.3	1.4	0.3	0.3	5.8	0.8	0.7	0.4	0.6	4.2	2.1	0.7	0.5	0.8	11.1	0.4	0.5	0.4	0.5	2.6	0.2	0.9	1.1	0.9	0.4	0.1	0.3	3.1	1.2	5.6	0.6	14.3	0.2	0.5	0.3	10.2	0.6	1.9	0.0	0.0	0.0	3.4	0.1	0.0	0.0	3.1	3.5	0.0	0.1	0.6	3.7	0.1	7.4	0.1	0.0	7.5	1.0	11.8	19.4	8.4	32.3	9.6	7.4	7.5	16.0	6.9	9.1
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418329	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.8;lymphoid tissue: 21.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	7	"T-cells: 1.8"	"Low region specificity"	"Detected in all"							"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA015319: , HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favourable (2.34e-4)"	"unprognostic (2.28e-1)"	2.7	1.2	2.1	8.9	4.6	23.8	4.4	2.9	3.9	2.2	4.9	2.9	1.7	3.2	1.3	2.1	4.5	1.3	3.0	4.6	2.5	2.1	3.3	12.0	2.6	4.7	4.4	2.0	2.2	1.8	3.9	0.6	3.7	3.8	1.4	3.8	2.1	3.2	0.6	3.9	3.9	3.2	2.6	4.3	3.4	2.4	9.6	4.3	21.5	1.3	6.5	5.0	2.1	2.5	0.1	0.2	0.1	0.2	0.1	1.8	0.7	13.2	5.5	5.4	4.8	2.1	3.0	7.3	18.5	11.0	9.3	11.1	3.4	9.4	10.1	7.9	8.8	16.3	6.2	6.7	11.0	11.0	5.4	7.3	10.5	2.8	0.0	10.2	9.0	0.5	0.4	7.5	3.8	3.4	6.7	24.7	11.7	8.8	15.6	8.4	3.7	9.0	8.0	27.3	6.1	2.6	9.0	9.6	6.6	8.1	9.8	5.6	5.1	9.1	3.0	15.3	8.7	14.0	14.0	9.6	16.2	4.1	9.2	9.0	12.8	0.0	0.0	0.1	1.2	0.0	0.8	0.0	0.8	1.2	0.2	0.1	1.1	1.3	0.0	0.1	0.2	0.1	1.8	0.7	2.1	4.6	2.9	3.9	2.5	2.1	4.4	2.0	3.8	4.3
ZNF383	FLJ35863	ENSG00000188283	"Zinc finger protein 383"	Q8NA42	19	37217926-37248738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063945	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA063945: "	"unprognostic (1.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.27e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (9.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-3)"	"prognostic favourable (3.71e-4)"	9.1	7.5	9.3	10.4	12.1	6.9	10.7	20.4	10.8	9.1	8.2	12.6	10.4	7.5	11.6	7.8	8.9	8.2	6.1	9.6	8.7	6.9	9.3	7.4	7.2	11.3	14.2	6.5	12.9	9.2	9.4	11.0	6.5	11.8	9.6	7.4	8.7	8.5	8.7	14.0	11.8	9.5	10.8	13.7	10.8	8.4	10.5	12.1	13.2	11.4	5.7	11.9	10.2	9.4	11.4	4.0	6.3	5.4	5.7	11.6	4.8	3.7	8.5	6.0	9.1	7.4	7.7	3.9	5.1	7.1	5.2	7.9	3.9	4.5	5.1	7.9	4.9	3.8	4.9	6.8	7.7	7.1	5.3	7.7	6.4	3.1	8.4	8.8	8.4	9.8	5.9	5.0	9.8	4.7	4.0	2.7	6.7	1.6	7.6	4.0	5.3	3.0	5.6	10.7	4.6	4.6	10.7	7.2	5.3	8.2	4.9	7.2	5.8	5.2	2.9	6.8	4.6	4.8	4.9	8.3	7.9	9.8	1.0	4.2	6.2	3.6	4.1	6.3	7.6	4.7	10.7	9.8	7.2	9.2	4.0	11.4	11.6	9.1	5.0	5.7	5.4	3.8	7.0	4.8	9.3	12.1	20.4	10.8	8.7	6.9	14.2	6.5	11.8	12.1
ZNF385A	"DKFZp586G1122, Hzf, ZFP385, ZNF385"	ENSG00000161642	"Zinc finger protein 385A"	Q96PM9	12	54369133-54391298	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 81.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.8;HBEC3-KT: 27.4;HEL: 34.4;hTCEpi: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 16.6;monocytes: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039799			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039799: AB_10795117"	"unprognostic (8.56e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (5.20e-4)"	"unprognostic (6.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (9.75e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.07e-3)"	23.7	4.3	23.6	16.3	27.3	16.8	7.9	13.2	32.5	7.9	5.7	12.8	2.3	4.8	3.2	10.7	28.1	6.2	8.9	4.3	18.4	22.6	2.3	3.8	11.6	8.9	31.8	15.4	2.0	2.0	13.8	8.5	12.6	19.4	10.3	5.4	35.5	8.9	10.1	5.9	81.6	5.7	8.7	16.4	13.9	4.4	2.1	16.1	5.5	18.1	21.9	21.9	25.8	14.9	0.8	16.6	1.6	16.8	0.0	0.2	6.6	0.8	3.4	5.2	6.5	6.0	4.0	14.3	0.6	2.6	2.7	2.3	6.9	2.5	1.9	2.3	1.4	28.8	1.9	27.4	0.9	1.8	2.7	34.4	2.2	1.3	2.7	0.5	24.1	3.5	30.9	3.0	7.7	1.6	16.5	0.1	1.2	15.3	1.6	4.9	2.9	2.7	6.1	0.4	6.7	2.1	22.5	2.3	10.4	0.2	19.5	1.4	23.0	14.4	1.7	1.5	3.4	1.7	1.7	0.5	0.1	1.6	6.1	1.6	3.8	1.6	15.3	0.0	0.0	16.8	0.0	0.6	0.0	0.0	16.6	0.8	0.0	0.2	1.2	0.0	11.9	1.6	0.0	6.6	23.6	27.3	13.2	32.5	18.4	22.6	31.8	15.4	19.4	16.1
ZNF404		ENSG00000176222	"Zinc finger protein 404"	Q494X3	19	43872363-43901385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.4;U-2 OS: 30.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA032014, HPA063607"	Uncertain		Supported	"Nucleoli,Intermediate filaments"				Nucleoli	"Intermediate filaments"	"HPA032014: AB_10602591, HPA063607: "	"unprognostic (3.76e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-5)"	"unprognostic (1.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.80e-3)"	0.9	2.2	4.6	0.7	4.8	0.1	2.6	5.8	4.8	1.5	2.5			0.2	2.0	10.9	1.2	3.7	2.2	6.0	4.6	4.4	1.5	1.0	1.8	3.1	6.0		7.5	0.8	2.6	8.2	2.6		4.6	1.6		2.6	2.2	1.5	2.9	1.0	1.8	7.0	3.9	1.9	3.4			2.6		1.2	1.5	1.1	1.9	0.9	1.9	0.4	2.1	1.9	0.6	2.2	0.3	2.3	0.3	5.9	8.4	1.4	3.1	1.5	2.0	2.8	0.2	0.8	0.0	3.3	1.5	0.3	0.4	1.6	2.7	0.3	2.3	0.8	0.0	0.9	2.1	0.2	0.6	5.0	3.8	1.5	1.4	1.7	0.1	0.0	1.8	0.2	0.0	0.0	1.9	0.5	0.0	1.3	0.4	1.9	1.5	1.2	1.0	1.3	0.6	1.6	0.1	0.9	0.7	2.9	30.8	2.5	1.8	4.0	5.2	0.0	4.1	0.0	1.6	0.0	0.3	1.9	0.7	0.0	0.8	0.9	1.4	0.0	0.4	1.9	1.9	1.5	0.0	2.1	0.4	0.9	1.3	0.6										
ZNF419	"ZAPHIR, ZNF419A"	ENSG00000105136	"Zinc finger protein 419"	Q96HQ0	19	57487711-57496097	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003152, HPA003274"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716, HPA003274: AB_1080714"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.55e-5)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (2.53e-5)"	7.1	10.3	11.0	8.9	12.4	4.4	11.9	20.4	14.3	8.6	7.1	8.4	8.7	6.4	7.6	17.0	5.7	11.0	6.5	8.0	10.9	9.4	9.4	8.4	10.0	11.2	11.4	11.7	13.4	6.0	17.4	17.3	10.2	12.4	10.6	6.4	7.0	9.1	11.6	17.4	12.0	7.1	7.1	10.2	12.7	7.4	7.2	12.1	8.4	14.1	4.8	14.2	6.6	5.6	12.4	4.1	5.4	3.2	8.7	13.3	4.5	3.6	3.8	7.4	7.7	3.6	5.5	6.3	4.5	6.4	4.3	24.1	2.6	2.3	1.3	3.6	3.3	1.1	3.2	9.2	6.1	0.3	16.5	5.7	5.8	2.9	12.4	4.5	4.3	7.7	14.0	4.2	10.4	4.6	0.6	0.9	5.5	0.6	7.2	4.7	5.1	5.4	6.8	7.3	5.0	4.5	8.0	6.0	7.0	4.4	4.2	4.4	3.7	6.8	4.6	5.0	5.5	1.7	4.1	10.6	12.0	3.2	4.0	2.5	4.2	3.8	2.5	5.4	5.3	3.2	8.5	12.4	8.5	6.6	4.1	12.1	13.3	7.7	3.2	8.7	2.4	3.0	5.4	4.5	11.0	12.4	20.4	14.3	10.9	9.4	11.4	11.7	12.4	12.1
ZNF423	"Ebfaz, JBTS19, KIAA0760, NPHP14, OAZ, Roaz, Zfp104"	ENSG00000102935	"Zinc finger protein 423"	Q2M1K9	16	49487524-49857919	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 24.2;NTERA-2: 12.3;REH: 10.5;SCLC-21H: 13.1;SH-SY5Y: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.6"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015258, HPA065820"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA015258: , HPA065820: "	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.84e-2)"	10.8	4.1	10.3	3.0	8.8	0.9	7.3	9.1	9.0	14.3	4.8	7.7	6.8	2.2	10.0	9.4	6.7	14.0	9.3	9.1	8.8	9.5	1.9	1.5	6.7	3.7	8.6	7.2	13.6	4.2	5.3	4.7	5.8	7.5	12.2	4.0	14.5	4.0	13.8	28.7	2.4	3.3	9.3	5.6	2.2	2.6	7.1	7.7	0.0	4.9	11.0	2.2	5.3	7.1	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	24.2	1.3	1.9	0.3	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.7	0.2	0.0	1.6	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.7	0.1	12.3	0.0	10.5	0.0	0.0	0.0	0.7	13.1	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	10.3	8.8	9.1	8.8	8.8	9.5	8.6	7.2	7.5	7.7
ZNF425		ENSG00000204947	"Zinc finger protein 425"	Q6IV72	7	149102784-149126346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA020087	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA020087: "	"unprognostic (4.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-4)"	"unprognostic (9.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.21e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.25e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.58e-2)"	1.5	3.1	7.2	3.7	7.4	1.4	4.0	7.7	9.6	4.9	3.7	10.8	2.1	2.3	5.2	5.2	4.8	5.5	4.1	2.0	7.9	5.3	4.3	2.4	2.3	1.9	6.2	9.3	9.0	3.4	8.2	3.0	1.6	7.8	4.6	1.8	4.7	3.8	5.5	7.5	5.6	1.9	5.6	4.8	2.2	3.3	3.1	6.2	3.3	4.6	1.6	2.6	3.8	3.0	4.3	4.5	4.3	1.5	6.1	5.4	1.6	1.8	2.4	5.1	4.4	7.6	2.2	2.9	2.8	4.7	1.5	1.7	0.6	2.5	2.2	4.0	2.1	2.6	0.9	1.3	0.6	1.5	1.9	2.6	3.0	1.1	4.3	1.3	1.2	4.5	2.3	1.5	2.8	0.8	2.0	2.3	5.1	8.8	3.3	3.9	11.9	4.6	3.6	2.6	1.2	3.3	2.6	2.3	4.2	2.7	3.4	6.4	2.3	3.7	0.9	3.4	0.5	3.8	0.7	4.4	2.8	1.8	2.8	0.8	2.8	4.3	1.4	2.8	3.9	1.5	5.3	3.0	3.3	2.8	1.3	4.3	4.9	5.4	3.5	6.1	0.9	4.5	3.9	1.6	7.2	7.4	7.7	9.6	7.9	5.3	6.2	9.3	7.8	6.2
ZNF432	KIAA0798	ENSG00000256087	"Zinc finger protein 432"	O94892	19	52031379-52095738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA052082, HPA060274, HPA065606"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA052082: , HPA060274: , HPA065606: "	"unprognostic (1.62e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.41e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.49e-3)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-1)"	"prognostic favourable (4.11e-5)"	8.6	9.8	8.4	5.9	12.5	9.4	9.6	11.0	9.1	14.3	5.9	4.5	6.4	6.4	8.3	12.8	7.2	7.9	5.2	7.0	9.8	5.9	10.1	4.3	6.0	5.6	7.8	7.3	10.8	19.0	8.5	15.5	6.3	8.8	17.4	6.2	7.3	7.5	6.9	4.2	9.7	8.6	6.4	10.8	8.3	6.9	9.3	11.2	8.9	14.0	4.2	5.6	8.2	7.2	5.6	3.0	4.1	4.1	2.5	5.7	2.9	4.3	3.6	8.8	12.9	5.4	6.7	3.0	4.8	4.1	3.7	6.2	2.9	2.6	3.1	1.7	5.5	3.2	4.4	5.0	6.4	3.0	11.1	8.6	8.1	5.3	2.6	0.0	8.1	7.3	3.6	5.2	7.4	5.1	2.6	13.0	6.9	2.3	8.6	5.0	3.2	5.7	4.3	8.7	4.8	5.3	19.2	5.1	4.8	7.5	4.1	2.5	4.0	3.8	6.4	3.5	5.1	3.6	4.9	6.5	8.9	6.8	6.6	0.7	5.9	2.7	3.6	4.1	5.1	4.1	3.6	5.6	3.1	3.4	3.0	4.9	5.7	4.0	3.8	2.5	2.1	2.3	3.7	2.9	8.4	12.5	11.0	9.1	9.8	5.9	7.8	7.3	8.8	11.2
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369442	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.9;HSkMC: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	14.5	18.6	10.1	4.7	13.0	2.9	12.9	13.6	15.8	10.7	8.7	11.8	8.6	6.3	15.1	17.5	18.4	10.2	11.2	11.7	9.9	6.1	6.7	4.3	7.8	5.6	12.9	9.6	20.3	8.1	11.6	6.5	8.5	11.3	12.1	6.9	6.3	16.9	13.4	7.2	15.6	6.1	12.7	12.6	8.0	6.8	10.4	10.0	5.7	12.3	9.7	8.0	12.5	11.2	1.6	2.8	1.6	2.1	6.6	2.3	1.6	2.7	1.7	6.4	3.4	7.2	14.9	3.0	2.4	3.4	3.2	3.8	1.0	2.4	1.8	2.8	3.5	3.4	11.3	4.3	3.5	2.3	2.4	2.0	3.6	1.6	2.9	0.8	1.4	27.2	6.1	2.7	3.2	4.6	2.4	1.3	3.4	1.3	2.0	1.5	0.2	2.8	2.7	2.7	1.8	2.6	7.1	2.9	3.7	7.0	3.6	2.7	2.0	1.0	3.6	2.8	2.1	2.2	1.4	2.1	2.5	1.6	2.2	1.6	2.2	0.0	1.8	1.6	2.0	2.1	2.0	1.3	1.4	2.1	2.8	1.6	2.3	2.0	1.3	6.6	2.0	0.4	2.2	1.6	10.1	13.0	13.6	15.8	9.9	6.1	12.9	9.6	11.3	10.0
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.1;HUVEC TERT2: 14.3;U-937: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	21.8	5.8	9.8	10.0	10.2	7.9	9.7	11.8	9.9	10.6	12.9	13.0	2.6	6.2	22.6	11.3	8.3	10.2	9.2	13.8	9.3	6.2	6.2	8.6	12.0	7.1	10.1	6.6	10.2	4.5	6.6	17.3	6.4	9.6	9.0	6.9	7.7	9.5	9.6	29.1	8.9	7.6	14.3	8.6	13.6	8.3	10.1	11.9	7.7	15.8	8.7	5.2	10.5	12.1	3.1	3.1	14.1	7.8	3.8	3.9	3.5	2.7	2.7	2.4	2.1	14.1	9.9	1.3	2.2	3.2	3.4	4.3	0.1	3.3	3.7	2.6	3.8	0.7	1.2	1.6	4.9	8.5	0.9	1.6	1.5	0.1	7.9	1.2	1.7	4.7	2.9	4.9	2.8	14.3	3.1	2.6	4.7	2.0	4.2	7.1	0.2	1.1	1.9	3.4	2.1	4.8	0.7	1.7	1.9	1.1	0.4	1.5	1.1	12.0	5.9	1.6	2.7	4.6	2.7	0.6	1.0	0.0	3.1	18.8	1.1	1.4	7.8	3.3	2.3	7.4	1.7	1.2	1.8	3.0	2.4	3.1	3.6	2.0	14.1	3.8	4.4	3.1	3.9	3.5	9.8	10.2	11.8	9.9	9.3	6.2	10.1	6.6	9.6	11.9
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA056895: , HPA065203: "	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (1.87e-4)"	9.4	13.4	15.0	7.1	21.0	3.7	8.3	14.9	20.1	9.0	14.8	12.8	14.3	13.6	10.5	9.9	6.6	11.9	11.2	10.5	13.5	13.3	9.9	37.4	10.9	6.1	12.3	11.0	12.5	25.3	8.5	12.2	12.5	8.0	14.3	5.3	10.4	14.1	25.6	17.2	11.5	11.3	7.5	10.3	8.6	17.2	9.2	10.4	28.1	16.6	2.8	8.2	10.4	6.8	4.3	3.5	3.5	1.7	3.7	7.1	1.8	4.6	9.0	8.3	7.2	3.5	3.6	5.3	5.9	3.9	5.1	5.6	9.8	5.3	8.2	5.3	3.4	4.3	5.1	4.0	2.2	7.1	50.4	8.1	6.0	17.6	5.8	3.6	7.5	4.2	3.7	4.2	3.2	4.5	10.4	3.7	3.6	6.0	11.6	10.1	8.9	16.4	13.5	5.3	4.3	5.6	4.4	8.9	12.1	3.0	10.1	4.4	10.0	6.6	5.8	9.2	7.9	1.9	6.5	8.9	7.6	6.2	5.8	4.9	5.9	3.1	1.7	3.5	4.1	1.4	4.5	2.0	6.9	6.9	2.1	4.3	7.1	4.6	0.2	3.7	1.0	3.5	4.2	1.8	15.0	21.0	14.9	20.1	13.5	13.3	12.3	11.0	8.0	10.4
ZNF45	ZNF13	ENSG00000124459	"Zinc finger protein 45"	Q02386	19	43912629-43935278	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038611, HPA075124"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA038611: AB_10669544, HPA075124: "	"unprognostic (1.67e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.31e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.68e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.82e-2)"	11.8	12.0	7.5	7.8	9.0	8.2	10.9	17.9	10.0	12.9	9.3	12.2	7.2	8.4	12.1	8.8	8.2	10.5	8.0	7.3	11.3	7.2	9.8	8.7	8.9	10.9	9.7	5.4	14.4	7.7	18.3	13.7	8.9	10.3	11.4	9.5	11.1	9.9	16.8	8.8	8.8	9.8	10.0	7.4	14.8	8.5	6.1	11.4	22.1	14.9	6.6	11.5	10.7	8.8	8.4	6.6	7.4	5.7	8.4	11.9	5.4	6.1	8.3	11.9	10.6	5.7	5.1	4.2	8.0	8.8	8.5	12.9	4.0	2.6	9.0	5.0	5.0	3.6	9.0	5.9	10.7	7.5	9.5	13.3	7.1	3.6	5.4	13.0	9.0	5.1	5.9	6.2	5.5	6.7	4.1	3.6	9.0	2.8	7.7	3.3	13.9	3.5	6.4	11.8	3.2	5.2	13.8	8.2	13.5	11.3	4.6	3.9	4.8	8.6	6.9	9.4	13.8	3.9	7.3	14.9	24.1	10.0	4.0	5.1	10.9	3.8	5.0	7.4	8.0	4.6	11.9	8.4	7.7	8.4	6.6	6.3	10.8	7.3	1.5	8.4	5.7	4.4	8.1	5.4	7.5	9.0	17.9	10.0	11.3	7.2	9.7	5.4	10.3	11.4
ZNF470	"CZF-1, FLJ26175"	ENSG00000197016	"Zinc finger protein 470"	Q6ECI4	19	56567511-56588911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA029000	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA029000: AB_10603843"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.88e-3)"	4.6	6.5	11.7	2.9	10.6	1.4	5.3	12.7	12.1	6.3	4.8	5.5	1.3	2.8	5.7	8.8	4.3	5.8	5.1	5.4	12.4	11.7	6.7	8.6	5.1	3.6	11.8	9.4	7.2	4.5	9.3	7.2	4.6	9.8	7.0	3.4	5.8	3.8	6.9	3.0	5.1	3.1	5.4	11.6	4.4	3.6	8.3	9.9	3.6	6.8	1.2	4.6	4.6	5.2	3.2	2.0	2.9	1.0	2.3	4.4	0.9	0.0	1.7	6.4	2.7	3.5	3.2	5.4	3.1	1.1	2.3	4.5	0.4	1.5	0.0	2.0	3.3	0.1	2.7	1.3	2.6	0.0	13.2	5.6	0.1	0.4	3.1	1.2	6.6	3.8	2.0	2.6	0.8	1.5	0.1	0.1	3.5	0.1	1.2	2.0	5.4	0.7	0.2	4.7	0.9	2.7	4.0	2.4	6.3	0.1	0.5	0.9	2.0	3.4	1.1	0.2	2.7	2.2	4.1	2.0	2.8	0.2	0.0	3.5	1.0	1.3	0.8	2.9	2.2	0.6	4.4	2.5	1.9	1.3	1.4	3.2	3.0	3.0	2.2	2.3	1.0	2.0	1.5	0.9	11.7	10.6	12.7	12.1	12.4	11.7	11.8	9.4	9.8	9.9
ZNF471	"KIAA1396, Z1971"	ENSG00000196263	"Zinc finger protein 471"	Q9BX82	19	56507843-56530221	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 10.9;U-138 MG: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066695	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA066695: "	"unprognostic (2.89e-2)"	"unprognostic (2.79e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.47e-4)"	"unprognostic (9.36e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-3)"	5.8	7.2	18.5	4.1	18.5	3.0	7.8	23.1	19.3	7.8	8.2	11.2	5.9	2.1	14.2	17.8	5.4	9.8	7.4	5.8	17.4	7.5	5.5	2.6	6.2	3.2	12.2	13.3	24.7	3.9	16.3	10.9	6.6	15.1	9.3	5.1	4.6	6.5	8.5	4.9	10.1	3.2	10.4	11.5	4.6	4.5	8.7	21.3	1.6	10.6	3.1	2.2	6.7	9.9	3.1	1.6	5.4	1.3	3.0	2.1	0.3	0.6	0.6	6.2	0.9	5.2	5.8	0.7	5.6	2.0	2.6	2.3	0.9	0.9	0.9	3.8	6.0	0.5	0.8	0.5	2.6	1.3	2.3	4.4	1.5	0.7	5.1	1.3	4.0	10.9	2.0	3.3	0.3	0.2	1.4	2.0	2.9	0.7	0.5	0.8	1.6	2.4	0.7	4.0	0.6	4.5	4.7	1.0	3.7	0.6	0.3	0.3	0.8	0.9	0.9	9.7	4.2	1.0	4.2	1.5	1.3	0.6	0.8	0.7	0.7	3.9	1.3	0.9	1.9	1.0	1.5	1.2	1.7	1.2	0.7	3.1	1.7	2.1	5.4	3.0	1.0	1.6	1.0	0.3	18.5	18.5	23.1	19.3	17.4	7.5	12.2	13.3	15.1	21.3
ZNF473	"DKFZP434N043, HZFP100, KIAA1141"	ENSG00000142528	"Zinc finger protein 473"	Q8WTR7	19	50025714-50053414	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA004191, HPA073309"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA004191: , HPA073309: "	"unprognostic (7.47e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.27e-1)"	"unprognostic (8.00e-3)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (1.31e-3)"	"unprognostic (6.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	3.8	3.7	4.4	3.8	6.5	3.8	4.8	9.7	5.8	4.1	3.7	4.6	3.7	2.9	5.9	4.4	3.8	10.1	3.4	3.0	5.1	4.3	3.8	4.1	4.0	3.7	5.9	3.2	4.8	4.8	4.0	7.7	3.1	7.3	5.1	3.3	2.7	3.4	5.6	4.9	3.8	3.0	5.1	5.0	6.4	3.3	38.6	7.7	2.6	5.2	3.3	4.5	3.7	18.6	12.4	5.6	5.0	7.9	2.4	11.6	4.6	9.3	6.4	10.0	8.3	3.8	4.6	5.7	8.8	5.2	12.6	11.8	12.2	6.3	14.3	3.4	5.0	7.1	12.6	5.9	16.2	10.2	11.9	14.7	5.6	5.6	4.6	10.5	8.7	4.7	10.9	13.2	17.4	4.2	20.7	13.1	6.3	4.0	8.1	4.9	7.0	9.8	10.3	13.9	6.3	4.2	10.3	8.3	9.3	12.5	6.9	6.1	6.2	9.7	2.0	17.5	8.9	3.3	8.8	6.1	14.3	12.2	4.1	8.4	14.2	2.2	5.5	2.9	7.2	7.9	7.3	12.4	7.2	8.8	5.4	10.2	9.2	11.6	5.0	2.4	3.5	5.6	3.9	4.6	4.4	6.5	9.7	5.8	5.1	4.3	5.9	3.2	7.3	7.7
ZNF48	"DKFZp762K013, FLJ31751, MGC43952, ZNF553"	ENSG00000180035	"Zinc finger protein 48"	Q96MX3	16	30378106-30400108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023806	Uncertain		Supported	Mitochondria				Mitochondria		"HPA023806: AB_1859335"	"unprognostic (5.35e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.19e-1)"	"prognostic favourable (1.20e-6)"	"unprognostic (5.36e-2)"	"prognostic favourable (7.50e-5)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	5.6	7.7	8.9	9.1	9.8	4.4	6.7	15.7	16.1	9.1	11.5	10.1	12.1	9.0	12.8	5.7	5.5	10.7	9.5	6.7	8.9	8.7	6.6	6.4	8.0	10.0	9.0	8.5	6.7	15.1	18.8	8.8	4.7	7.1	7.6	6.1	8.0	9.7	12.6	12.1	6.3	6.4	11.2	5.7	7.3	7.9	3.9	9.8	16.1	7.5	7.2	7.3	9.0	8.3	1.4	1.6	1.3	0.2	2.6	3.1	0.5	4.6	8.0	19.4	15.5	2.4	2.0	6.5	3.2	5.9	7.8	7.0	3.7	6.1	8.7	6.4	2.9	3.7	9.4	5.1	4.2	6.4	11.6	3.9	3.8	5.4	3.6	5.1	5.5	1.5	6.6	6.1	4.2	6.4	6.7	4.1	3.0	15.0	11.9	6.3	16.5	2.9	27.6	4.3	11.6	4.1	3.6	15.1	18.8	1.3	10.4	1.3	6.9	5.1	2.8	4.4	5.0	4.1	3.9	5.0	5.7	8.5	2.4	3.3	1.0	0.0	0.2	1.3	3.1	0.2	2.4	1.1	1.7	1.8	0.5	1.4	2.1	2.3	0.0	2.6	0.1	1.6	1.7	0.5	8.9	9.8	15.7	16.1	8.9	8.7	9.0	8.5	7.1	9.8
ZNF480	MGC32104	ENSG00000198464	"Zinc finger protein 480"	Q8WV37	19	52297177-52325922	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042218	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA042218: AB_10794791"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.65e-4)"	"unprognostic (4.22e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.97e-2)"	"prognostic favourable (2.03e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.82e-3)"	9.8	8.4	8.2	7.9	15.4	7.0	7.1	13.6	12.5	6.5	8.3	4.8	3.4	7.9	6.2	2.4	8.5	4.5	4.7	17.9	8.7	3.2	10.9	7.5	8.4	9.8	13.1	4.1	6.0	3.8	5.6	10.7	6.2	12.5	5.9	8.6	4.9	8.4	5.5	12.9	8.0	9.3	5.1	8.7	15.0	8.0	3.3	12.6	10.8	8.4	7.9	12.3	8.7	8.2	16.6	17.0	9.4	9.1	14.6	15.0	5.9	3.2	13.2	8.7	10.1	10.2	9.6	6.9	8.5	12.5	6.1	7.2	5.9	4.7	16.4	5.4	7.0	7.1	9.3	8.6	8.9	0.1	15.5	16.8	6.6	5.6	9.9	23.7	13.7	8.7	11.1	8.4	9.9	8.7	12.0	5.9	13.6	5.3	21.6	4.8	6.7	10.9	11.1	9.2	13.6	8.7	23.6	8.5	7.1	12.3	8.9	3.5	7.4	17.4	15.0	6.1	7.7	3.5	13.1	13.5	24.9	34.1	2.7	13.0	10.8	7.7	8.5	9.4	12.0	8.2	13.7	16.6	12.0	13.9	10.4	16.5	11.5	15.0	3.6	14.6	9.1	17.0	13.4	5.9	8.2	15.4	13.6	12.5	8.7	3.2	13.1	4.1	12.5	12.6
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384273	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 29.7;intestine: 25.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 23.1;HDLM-2: 33.5;RT4: 18.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA035957: AB_10672234, HPA035958: "	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.4	0.4	5.7	0.4	18.5	0.3	1.2	2.9	14.2	0.5	3.2	17.0	0.0	25.8	0.5	2.3	0.9	0.5	0.6	0.4	15.1		1.1	0.3	0.5	0.3	19.8	6.0	0.7	0.3	0.3	0.0	4.1	21.4	0.6	1.1	0.0	0.6	0.4	0.3	2.2	12.5	0.4	29.7	0.3	0.6	1.2	12.8	0.0	0.3	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	6.7	1.1	0.3	0.0	0.0	0.1	0.2	0.3	0.4	0.4	2.6	6.2	0.1	0.4	0.0	23.1	0.6	2.5	0.3	33.5	0.7	0.1	0.7	0.2	0.0	0.0	0.3	0.0	6.1	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.1	1.7	0.6	0.0	2.9	0.0	0.1	18.6	5.5	1.0	1.6	0.2	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZNF500	"KIAA0557, ZKSCAN18, ZSCAN50"	ENSG00000103199	"Zinc finger protein 500"	O60304	16	4748239-4767624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA035498, HPA057963"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA035498: AB_10602356, HPA057963: "	"unprognostic (3.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.10e-2)"	"prognostic favourable (3.41e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.19e-2)"	8.1	6.4	10.2	9.4	7.5	5.9	8.1	13.8	11.4	10.3	8.0	11.7	11.5	8.4	12.2	10.9	6.2	8.9	10.4	6.0	6.2	5.1	6.0	5.2	7.2	12.5	6.6	9.4	13.9	8.5	9.1	8.0	6.7	6.6	9.3	5.3	10.6	11.3	14.9	7.5	8.5	7.5	7.5	5.4	11.4	7.7	7.2	8.4	9.9	9.2	7.1	8.3	9.2	8.4	5.3	6.5	3.4	2.5	3.0	4.9	2.1	2.0	8.4	2.8	7.3	3.3	3.0	12.8	6.1	6.7	7.6	5.2	3.7	4.0	4.4	5.3	3.3	4.7	5.8	3.2	5.6	3.2	8.8	3.6	10.6	4.9	4.7	2.5	4.0	3.5	7.8	3.4	6.5	4.3	5.3	7.0	3.0	4.6	5.2	4.4	3.6	3.0	9.3	6.7	8.7	2.5	2.4	10.4	6.8	5.2	7.9	2.3	5.1	4.1	4.8	7.2	5.5	8.0	2.9	6.7	4.5	3.9	2.2	2.1	4.5	2.3	2.5	3.4	3.9	2.4	3.3	4.9	2.5	3.0	1.4	5.3	4.2	4.9	2.9	3.0	1.7	6.5	3.9	2.1	10.2	7.5	13.8	11.4	6.2	5.1	6.6	9.4	6.6	8.4
ZNF507	KIAA1084	ENSG00000168813	"Zinc finger protein 507"	Q8TCN5	19	32345594-32387667	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030964, HPA049728"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA030964: AB_10670562, HPA049728: "	"unprognostic (3.39e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.28e-3)"	"unprognostic (7.24e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.46e-2)"	10.9	8.7	11.3	16.0	13.1	13.5	12.0	18.4	16.4	12.0	11.4	9.0	10.2	10.0	12.4	9.8	9.6	12.2	10.3	10.1	9.4	8.1	9.0	11.1	8.2	10.5	12.3	10.3	18.6	10.9	13.6	15.7	16.9	11.1	10.7	9.9	6.8	11.0	9.6	21.0	8.6	14.7	11.9	12.9	9.6	9.7	28.3	13.0	17.1	18.7	10.0	10.5	11.0	20.1	4.0	0.4	2.3	1.4	2.0	4.7	1.4	9.1	18.2	13.6	8.4	8.9	14.0	11.0	8.2	8.1	7.6	8.5	10.5	7.2	13.6	10.2	7.9	5.3	19.8	10.2	14.7	10.5	17.9	13.9	8.8	7.1	10.7	11.6	7.6	8.8	7.8	9.7	15.8	10.2	20.5	11.0	8.0	5.7	12.4	3.8	14.6	5.8	13.0	15.8	5.5	4.6	10.2	11.2	9.7	10.9	7.4	9.0	5.8	8.4	10.8	12.2	13.1	7.1	10.6	10.7	12.4	14.1	8.6	8.6	11.0	0.4	0.1	2.3	4.1	0.0	4.7	2.5	3.1	2.8	0.0	4.0	4.2	3.4	2.0	2.0	1.4	0.4	2.4	1.4	11.3	13.1	18.4	16.4	9.4	8.1	12.3	10.3	11.1	13.0
ZNF540	DKFZp547B0714	ENSG00000171817	"Zinc finger protein 540"	Q8NDQ6	19	37551406-37614097	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"pituitary gland: 30.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA003444	Supported		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA003444: AB_1080732"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-4)"	"unprognostic (4.24e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.88e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (8.08e-2)"	"unprognostic (8.33e-5)"	2.8	9.3	8.6	3.9	29.9	1.2	6.0	23.7	16.7	5.8	4.4	5.0	5.3	3.9	6.0	9.4	3.0	4.2	3.6	9.1	8.6	12.1	6.3	2.6	5.0	6.3	9.0	9.1	13.8	3.8	13.3	30.7	2.3	11.0	7.1	3.6	9.0	6.1	8.9	2.9	6.0	4.5	3.8	7.9	6.3	4.6	11.5	9.5	2.7	14.4	3.1	6.0	3.4	4.0	3.1	0.3	1.2	0.1	3.0	7.1	1.8	0.4	0.0	2.7	2.7	6.9	4.1	0.2	1.0	0.9	1.1	2.1	0.2	0.0	1.2	0.3	2.4	1.0	1.8	0.9	0.9	3.7	2.7	1.0	1.2	0.0	1.8	1.2	2.0	1.9	2.5	0.7	0.0	0.1	0.4	0.0	1.6	0.1	1.7	0.7	0.9	0.5	1.4	1.6	0.8	0.6	0.4	2.8	3.1	1.0	0.3	0.3	1.3	0.7	0.0	1.0	3.1	1.2	0.9	3.7	2.0	2.6	0.0	0.4	0.6	0.0	0.0	1.2	3.9	0.1	3.9	2.9	4.1	4.4	0.1	3.1	6.8	7.1	0.2	3.0	0.0	0.3	4.2	1.8	8.6	29.9	23.7	16.7	8.6	12.1	9.0	9.1	11.0	9.5
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819874-2835773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060247, HPA063358"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA060247: , HPA063358: "	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favourable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favourable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favourable (5.00e-4)"	4.1	4.4	7.9	2.0	9.1	1.9	5.1	12.2	14.1	6.0	4.6	7.7	5.6	6.1	6.8	4.5	4.0	6.4	5.6	7.3	8.2	8.4	6.6	8.6	5.0	3.9	6.2	6.9	8.2	5.0	9.8	8.4	25.9	6.0	5.7	4.3	7.7	7.6	5.4	8.9	7.4	4.7	5.6	4.2	3.7	4.2	4.0	6.5	5.1	7.9	4.7	6.0	4.5	4.1	2.3	3.6	0.6	0.6	1.8	1.8	0.7	3.7	0.1	3.3	3.6	2.3	3.0	4.2	2.4	2.6	5.0	2.3	0.3	1.0	3.5	2.3	1.9	1.8	0.3	1.9	0.7	0.0	1.7	1.0	1.2	1.5	1.8	0.5	0.8	2.4	4.4	1.4	2.0	0.4	3.6	2.0	1.6	0.7	1.7	0.4	1.6	1.1	1.9	2.2	0.9	3.2	3.0	3.0	5.4	2.7	0.5	4.0	1.3	1.8	0.0	0.4	0.9	1.4	0.9	6.6	7.3	0.7	1.9	1.7	1.0	0.2	0.3	0.6	0.4	0.1	1.5	0.8	0.7	0.9	0.0	2.3	1.8	0.3	0.2	1.8	0.6	3.6	0.3	0.7	7.9	9.1	12.2	11.2	8.2	8.4	6.2	6.9	6.0	6.5
ZNF559	MGC13105	ENSG00000188321	"Zinc finger protein 559"	Q9BR84	19	9323772-9351162	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA059632, HPA065485"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA059632: , HPA065485: "	"unprognostic (1.35e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-3)"	"prognostic favourable (6.99e-4)"	"unprognostic (7.28e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	9.3	11.1	17.7	8.4	16.2	2.7	14.1	39.5	16.1	13.6	10.4	17.2	11.4	5.1	18.8	18.8	5.9	17.3	8.2	11.9	14.2	8.2	11.2	7.5	10.4	11.8	17.6	15.5	24.0	7.6	22.1	29.2	9.8	16.2	13.6	9.3	11.2	8.3	11.4	3.3	8.7	9.8	16.3	16.2	14.9	8.8	13.7	19.8	10.7	14.0	3.4	10.3	10.2	11.3	12.5	5.3	18.9	4.3	14.2	15.8	6.2	8.6	4.6	9.2	11.2	5.4	4.9	2.4	5.3	10.9	8.0	6.8	2.3	1.0	7.1	6.3	7.7	3.1	5.5	5.0	10.1	11.3	7.5	9.5	7.7	3.1	9.7	8.4	10.5	10.4	9.0	9.0	11.1	6.6	7.0	25.0	5.0	0.0	11.3	26.4	15.0	7.8	5.5	11.2	9.5	4.8	12.2	10.5	8.8	10.3	1.7	12.4	7.4	6.4	5.5	14.6	3.3	11.9	8.0	2.0	0.0	6.9	2.6	5.3	9.1	18.9	3.4	7.5	9.1	3.2	12.0	11.9	9.6	9.6	5.3	12.5	15.8	12.7	1.9	14.2	4.3	4.4	8.4	6.2	17.7	16.2	39.5	16.1	14.2	8.2	17.6	15.5	16.2	19.8
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466507-9498607	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"testis: 21.1"	"Group enriched"	"Detected in some"	5	"HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.9"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"HPA045439: , HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.4	2.6	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.8	2.4	0.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	1.0	17.9	0.0	0.0	1.3	0.0	4.4	2.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0
ZNF574	FLJ22059	ENSG00000105732	"Zinc finger protein 574"	Q6ZN55	19	42068477-42081549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023196, HPA057274"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA023196: , HPA057274: "	"unprognostic (3.90e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	11.1	6.8	7.9	6.6	10.2	14.9	9.7	15.6	17.8	11.2	10.2	12.5	4.6	10.2	13.0	4.5	12.2	12.4	8.0	8.0	8.0	6.8	6.8	8.4	8.6	9.0	11.7	8.5	15.4	12.1	8.7	8.3	8.8	8.4	10.8	4.5	10.8	12.1	11.1	10.4	14.3	8.6	10.3	5.6	10.8	8.7	28.5	12.3	15.6	10.2	9.1	12.4	10.6	9.3	18.7	12.5	15.6	10.5	10.1	18.9	11.6	10.2	28.2	6.4	8.1	5.7	5.8	6.8	7.7	6.8	10.1	9.6	11.1	7.0	14.8	7.0	6.2	6.2	7.2	9.7	3.8	7.9	12.2	14.1	6.8	9.3	6.3	8.7	9.7	6.8	9.6	9.2	7.8	5.5	11.5	9.4	6.9	20.8	10.2	7.2	11.4	11.3	14.1	6.1	6.3	5.0	13.5	10.6	9.1	7.9	16.8	5.0	7.9	13.7	6.6	13.7	10.8	4.1	11.4	10.3	6.2	10.8	7.7	8.1	7.8	11.1	10.4	15.6	17.5	7.9	18.7	18.7	13.1	18.9	12.5	14.8	13.8	12.8	13.3	10.1	10.5	11.0	10.1	11.6	7.9	10.2	15.6	17.8	8.0	6.8	11.7	8.5	8.4	12.3
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041499: , HPA046761: "	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favourable (2.03e-4)"	7.9	6.8	13.4	5.8	15.5	4.2	13.9	14.6	12.1	10.2	10.9	9.9	15.5	5.1	12.3	11.1	6.3	10.0	8.9	8.0	14.8	5.6	11.0	5.5	6.8	5.6	7.6	8.7	27.2	7.1	17.4	7.5	10.1	9.9	17.4	7.6	17.2	12.9	16.1	9.4	22.3	8.1	14.4	11.0	10.1	7.1	22.5	14.9	3.8	16.3	5.2	6.3	8.8	10.2	9.4	3.2	7.1	4.0	4.6	4.6	1.8	1.2	0.1	6.6	8.1	11.4	12.4	0.0	7.7	2.9	3.0	6.1	0.8	1.0	1.3	0.8	3.5	2.1	2.6	1.6	1.6	0.0	7.6	12.7	0.1	1.1	8.9	2.8	4.3	9.7	5.0	4.4	1.3	1.5	2.8	0.0	3.8	0.0	7.8	3.6	7.6	0.2	3.4	3.3	2.3	4.9	2.9	2.7	1.4	1.9	0.9	6.5	1.3	3.1	1.0	5.6	7.7	1.6	2.8	5.4	0.0	1.7	1.5	0.5	8.9	7.1	2.6	5.7	1.7	4.0	4.6	9.4	3.0	3.6	2.8	5.1	3.8	2.4	1.2	4.6	3.0	3.2	1.4	1.8	13.4	15.5	14.6	12.1	14.8	5.6	7.6	8.7	9.9	14.9
ZNF589	SZF1	ENSG00000164048	"Zinc finger protein 589"	Q86UQ0	3	48241100-48299253	"Predicted intracellular proteins, Transcription factors"		"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HAP1: 23.1;NTERA-2: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003145	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA003145: AB_1080738"	"unprognostic (2.49e-3)"	"prognostic favourable (2.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (3.01e-5)"	"prognostic favourable (6.45e-5)"	"unprognostic (2.64e-2)"	"unprognostic (9.67e-2)"	"prognostic favourable (1.21e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.19e-2)"	6.6	9.8	15.5	10.2	17.0	5.2	7.4	42.8	16.2	7.7	7.2	10.4	7.6	4.5	8.4	22.6	9.4	8.3	5.4	6.0	13.5	6.6	6.3	3.5	9.0	12.9	18.2	7.9	16.1	6.4	9.9	16.3	3.5	14.0	20.8	7.5	10.7	9.6	18.1	6.4	11.0	14.4	9.2	13.9	22.8	7.0	5.8	14.9	5.7	18.8	3.3	13.0	7.2	9.6	4.0	13.3	1.8	3.1	1.3	5.1	2.2	2.3	1.6	6.7	5.5	8.6	4.6	8.4	2.1	1.8	2.8	3.6	3.5	3.1	9.0	1.8	2.4	2.0	23.1	5.7	2.0	5.7	5.3	10.7	6.5	2.7	1.6	2.4	3.0	1.5	3.9	3.2	2.2	4.7	7.6	2.1	1.4	2.2	3.3	2.0	36.5	3.5	1.6	2.5	3.4	2.0	2.3	2.2	4.8	1.7	1.9	6.7	2.9	3.8	7.5	1.6	3.1	3.6	1.4	4.7	5.8	7.4	1.7	6.6	4.8	1.1	2.8	1.8	3.8	2.4	4.4	4.0	4.4	4.9	2.8	2.7	5.1	4.9	1.5	1.3	3.1	13.3	3.8	2.2	15.5	17.0	42.8	16.2	13.5	6.6	18.2	7.9	14.0	14.9
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169871-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA054363: , HPA059387: "	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	11.7	11.5	9.4	10.7	9.4	15.7	18.3	7.2	12.1	9.0	11.7	7.0	12.1	11.4	8.7	9.0	10.9	8.4	11.3	14.5	8.9	10.0	13.5	30.8	7.7	16.8	10.0	7.0	11.6	36.2	9.7	9.3	12.7	10.9	10.4	5.8	5.9	15.9	12.0	59.3	9.8	11.0	6.5	7.3	13.0	15.2	9.3	8.3	5.4	15.1	17.2	9.2	10.6	10.1	23.5	26.8	0.7	25.0	16.1	21.7	14.1	20.0	11.0	3.8	13.3	3.7	4.8	20.1	8.9	4.5	10.4	10.0	16.9	12.2	23.4	16.5	5.6	13.1	12.9	11.6	3.8	14.0	41.2	15.9	9.0	25.6	15.9	21.9	14.0	8.8	11.4	11.5	12.1	8.7	23.9	9.1	6.1	15.3	8.9	40.8	15.0	39.3	11.2	6.6	23.6	7.4	8.8	10.1	11.0	10.8	27.2	34.0	11.3	12.4	9.0	10.0	11.9	21.0	16.6	17.9	18.0	25.3	11.8	45.6	12.8	0.1	15.7	0.2	14.2	25.0	13.3	23.5	20.1	14.0	21.7	22.7	15.0	14.3	0.7	16.1	25.0	26.8	21.7	14.1	9.4	9.4	7.2	12.1	8.9	10.0	10.0	7.0	10.9	8.3
ZNF594	KIAA1871	ENSG00000180626	"Zinc finger protein 594"	Q96JF6	17	5179536-5191883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA060283, HPA067178, HPA069360, HPA074493, HPA077596"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA060283: , HPA067178: , HPA069360: , HPA074493: , HPA077596: "	"unprognostic (6.67e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-5)"	"unprognostic (4.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.99e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.59e-2)"	4.0	6.2	11.8	8.4	11.2	1.3	8.8	13.8	13.4	7.5	6.3	8.0	5.3	3.1	9.3	8.4	4.2	8.3	4.2	4.9	8.9	5.9	6.7	3.8	4.1	10.1	13.6	6.6	19.8	6.0	15.3	15.9	5.8	9.2	9.6	5.1	6.0	6.5	10.2	6.7	3.8	6.8	6.0	8.3	8.4	5.2	7.8	11.1	11.9	10.2	2.1	10.2	6.6	5.6	5.9	4.5	1.1	1.0	2.4	5.2	1.0	5.5	2.5	10.6	8.2	1.7	1.9	8.8	3.7	1.9	6.7	6.4	7.0	2.0	12.4	5.9	2.9	6.1	6.7	0.2	8.6	6.6	6.8	4.0	8.7	3.5	2.4	0.0	4.1	1.4	1.1	4.0	0.0	0.7	1.6	3.2	2.3	5.2	3.4	1.7	4.7	3.4	7.3	8.9	1.6	1.9	1.4	6.2	8.3	2.8	1.5	5.7	3.4	3.0	0.1	0.1	3.8	3.3	2.6	2.0	4.1	2.9	0.6	0.0	4.0	0.4	0.8	1.1	3.2	1.0	2.3	3.5	3.3	2.9	1.0	5.9	5.2	3.4	0.4	2.4	0.9	4.5	4.4	1.0	11.8	11.2	13.8	13.4	8.9	5.9	13.6	6.6	9.2	11.1
ZNF606	"FLJ14260, KIAA1852, ZNF328"	ENSG00000166704	"Zinc finger protein 606"	Q8WXB4	19	57977053-58003349	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041712, HPA043584"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA041712: AB_10960410, HPA043584: "	"unprognostic (1.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.01e-2)"	"prognostic favourable (4.75e-6)"	6.9	7.1	13.0	7.1	12.8	5.5	12.8	18.2	11.6	9.6	7.8	12.8	11.3	8.6	11.1	14.6	6.6	14.0	9.8	6.7	15.0	6.9	9.0	6.9	7.7	11.2	16.9	8.2	14.6	8.3	18.9	18.1	6.7	12.3	12.4	7.2	10.2	11.1	10.0	9.9	11.0	10.3	9.2	10.8	12.9	10.0	8.9	11.7	20.1	17.8	6.3	9.8	9.2	7.7	9.8	7.9	9.1	3.0	6.3	8.5	2.4	1.3	2.5	11.1	9.3	3.4	4.7	8.1	3.3	1.1	3.3	2.1	3.2	3.9	2.2	2.7	2.2	3.4	1.4	3.3	4.5	0.0	19.8	5.4	0.8	3.1	2.6	0.0	4.4	5.6	1.7	2.8	1.7	2.4	2.7	0.1	4.2	1.3	7.2	1.3	6.7	4.8	8.1	4.1	3.2	3.6	6.8	10.4	7.0	6.0	0.2	2.4	5.4	5.1	2.7	2.6	3.9	1.1	1.1	6.6	7.1	1.6	0.2	0.6	3.5	9.1	3.0	7.4	3.0	2.4	4.1	8.3	4.8	3.4	2.6	9.8	8.5	4.7	7.8	6.3	2.6	7.9	3.2	2.4	13.0	12.8	18.2	11.6	15.0	6.9	16.9	8.2	12.3	11.7
ZNF609	KIAA0295	ENSG00000180357	"Zinc finger protein 609"	O15014	15	64460742-64686068	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040742, HPA040832"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040742: AB_10963581, HPA040832: AB_10960400"	"unprognostic (2.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	11.1	11.2	14.5	14.5	12.6	7.3	11.4	17.1	15.1	17.9	14.2	16.2	19.1	12.1	18.7	8.4	10.2	15.7	14.0	10.9	12.3	10.4	9.1	10.2	13.9	11.3	10.9	11.0	29.9	11.6	18.1	11.6	16.3	10.9	15.2	11.4	14.6	12.6	22.8	9.2	11.9	11.2	16.1	12.7	12.9	11.4	28.9	13.6	21.4	12.4	4.5	12.1	15.6	28.4	1.2	2.8	3.2	1.7	4.0	3.0	0.5	6.1	15.5	16.7	6.4	6.4	8.2	5.7	8.0	10.7	10.0	10.2	9.5	9.7	10.5	6.7	9.4	13.1	24.4	11.0	10.6	12.1	5.2	19.1	8.9	4.6	11.9	11.0	12.8	8.3	10.1	10.5	20.8	18.6	30.0	6.8	8.2	5.5	8.5	4.7	12.6	4.3	7.8	15.2	5.5	7.3	11.0	13.6	10.4	10.9	12.5	7.5	6.1	7.7	18.5	9.4	15.1	4.8	9.9	7.6	8.6	9.5	5.8	12.0	7.6	3.2	1.7	1.9	2.3	0.7	1.6	0.7	1.3	1.6	0.6	1.2	3.0	3.0	2.1	4.0	0.8	2.8	0.8	0.5	14.5	12.6	17.1	15.1	12.3	10.4	10.9	11.0	10.9	13.6
ZNF621	FLJ45246	ENSG00000172888	"Zinc finger protein 621"	Q6ZSS3	3	40524878-40574685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA065518, HPA071440"			Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA065518: , HPA071440: "	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.33e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.01e-3)"	12.3	11.3	14.6	10.6	27.1	11.6	16.6	20.4	17.3	14.2	11.1	26.2	15.5	9.6	16.4	18.3	9.1	10.9	11.3	9.3	17.3	14.1	11.8	10.0	12.5	11.1	26.7	12.1	14.1	15.0	18.4	15.6	10.6	17.6	13.3	11.4	12.1	12.6	14.8	10.5	16.2	10.4	15.9	22.7	11.6	11.2	8.6	24.7	4.8	13.9	8.1	11.5	10.4	10.6	7.4	4.3	5.5	3.4	4.9	4.8	1.8	9.2	4.9	13.0	12.8	9.5	14.1	7.0	9.7	11.8	12.7	12.3	10.4	5.0	3.7	7.2	12.9	3.1	12.5	7.1	14.9	13.0	13.8	12.4	18.5	9.6	15.1	11.8	12.2	11.3	16.3	12.9	20.8	9.9	12.7	10.9	10.6	5.0	2.9	13.7	7.6	10.1	1.3	8.4	3.9	6.7	11.3	4.3	11.4	9.0	7.2	11.4	10.9	9.7	12.2	21.4	10.6	10.1	13.9	16.5	15.4	7.9	10.2	8.7	13.2	5.5	3.0	2.5	3.9	3.4	2.7	6.1	3.8	4.8	2.4	7.4	4.4	3.9	4.4	4.9	1.9	4.3	3.1	1.8	14.6	27.1	20.4	17.3	17.3	14.1	26.7	12.1	17.6	24.7
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA036514: , HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	14.3	10.8	18.3	12.1	19.4	28.8	14.8	20.5	20.3	12.6	19.5	14.5	9.5	15.5	14.4	16.9	13.6	13.2	12.3	38.6	13.8	14.6	14.8	18.8	12.8	14.5	16.8	15.5	15.1	45.9	12.5	15.0	16.0	17.2	13.1	19.8	10.9	17.5	12.8	29.0	18.6	19.6	12.6	12.8	12.4	15.9	14.1	17.3	14.0	16.7	11.9	15.4	13.7	14.9	50.4	45.6	55.4	45.9	39.1	56.9	47.2	11.0	24.2	7.6	15.6	18.6	15.9	27.6	19.9	15.1	16.3	20.8	28.7	10.3	13.0	26.9	15.7	14.6	12.2	15.5	13.1	17.4	16.5	11.8	42.9	20.5	26.8	22.9	14.2	24.5	19.7	15.1	14.3	11.3	15.9	12.9	17.8	18.6	12.0	22.4	13.4	23.9	9.5	9.2	11.0	15.0	16.6	10.5	11.8	27.8	20.9	32.2	11.6	17.8	15.4	18.2	13.9	17.6	12.6	18.6	16.6	18.1	15.8	19.9	12.6	45.2	41.6	52.9	49.1	43.4	51.2	50.4	49.5	53.7	45.6	47.0	56.9	47.7	55.4	39.1	45.9	37.0	50.1	47.2	18.3	19.4	20.5	20.3	13.8	14.6	16.8	15.5	17.2	17.3
ZNF629	"KIAA0326, ZNF65"	ENSG00000102870	"Zinc finger protein 629"	Q9UEG4	16	30778449-30787202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019550, HPA056051"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA019550: AB_1859386, HPA056051: "	"unprognostic (1.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.66e-2)"	"prognostic favourable (4.57e-10)"	"unprognostic (8.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.70e-2)"	8.6	12.8	8.4	5.2	12.7	6.3	9.4	15.1	21.1	11.3	9.8	16.4	8.2	9.4	13.6	8.4	7.4	11.9	9.2	19.5	9.0	7.7	10.9	8.2	9.0	3.4	9.4	7.9	15.6	8.9	30.2	9.1	6.5	12.2	9.6	8.1	14.8	10.4	11.5	14.0	12.0	10.3	11.9	7.6	6.7	10.5	6.4	8.9	11.8	9.9	10.2	6.7	11.2	7.4	0.3	2.9	0.8	1.6	1.4	1.3	0.7	6.2	10.3	16.0	12.3	7.9	7.4	2.4	7.1	10.4	11.1	9.5	6.3	5.8	1.1	6.9	11.5	7.5	7.8	9.4	7.5	0.2	11.7	8.7	9.1	6.5	8.5	3.0	5.4	12.2	7.1	6.9	5.8	5.9	12.7	0.2	9.7	13.3	4.5	4.0	8.4	4.3	15.6	12.4	0.5	9.4	10.3	15.2	17.1	6.9	13.0	1.7	9.7	11.3	7.1	10.6	6.9	7.1	5.3	0.2	0.0	0.3	6.9	7.8	3.5	0.0	1.6	0.8	0.3	0.2	0.5	0.2	0.3	0.2	1.3	0.3	1.3	1.0	0.1	1.4	0.4	2.9	0.0	0.7	8.4	12.7	15.1	21.1	9.0	7.7	9.4	7.9	12.2	8.9
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: "	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favourable (8.73e-5)"	20.7	19.1	22.4	14.9	26.0	18.7	19.8	51.3	25.5	19.8	19.7	23.4	13.0	11.3	26.0	14.8	17.3	20.1	14.3	16.0	20.1	11.9	18.7	22.9	16.4	16.9	25.4	19.9	31.1	15.4	28.9	46.7	16.9	23.9	17.2	14.7	14.1	20.6	15.5	33.2	16.9	15.8	18.4	22.7	16.0	17.3	21.0	29.7	26.0	22.5	11.2	16.1	26.6	17.8	14.8	10.2	32.4	12.8	11.8	14.1	6.0	14.8	21.4	32.9	15.3	19.4	21.4	25.4	17.0	19.7	14.5	13.0	20.4	14.6	24.4	15.8	15.5	12.6	30.5	17.4	21.1	24.8	17.0	32.1	23.4	18.5	16.8	29.2	21.8	13.5	17.0	15.5	29.0	22.2	32.0	14.4	21.0	14.9	20.6	21.7	28.5	13.8	17.7	49.9	17.0	15.5	22.7	25.4	16.7	20.9	14.7	21.4	13.7	18.1	22.7	18.0	26.2	13.3	17.0	11.8	18.2	24.2	15.1	19.2	19.4	32.4	10.1	18.7	11.4	9.5	10.6	14.5	10.6	10.4	7.9	14.8	14.1	10.3	17.1	11.8	12.8	10.2	8.9	6.0	22.4	26.0	51.3	25.5	20.1	11.9	25.4	19.9	23.9	29.7
ZNF639	"ANC-2H01, ZASC1"	ENSG00000121864	"Zinc finger protein 639"	Q9UID6	3	179322991-179338583	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049023, HPA052163"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA049023: , HPA052163: "	"unprognostic (5.64e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.33e-2)"	"prognostic favourable (5.45e-5)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (7.74e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	19.4	17.2	18.4	12.4	18.0	36.7	28.5	25.4	25.8	24.0	23.7	18.3	15.9	12.7	24.6	20.0	18.8	21.7	14.8	22.1	17.7	15.8	18.8	19.2	17.3	27.5	17.0	17.0	25.6	21.4	31.1	25.2	16.3	19.4	23.6	16.9	19.5	19.6	21.5	23.5	12.3	16.7	23.4	17.2	23.1	17.4	13.3	19.1	25.9	36.4	15.3	17.5	25.1	22.8	4.0	1.7	4.6	2.3	4.5	5.7	1.6	25.2	6.0	11.6	14.4	10.7	13.0	11.4	12.1	18.3	20.2	18.2	9.9	10.2	29.5	18.4	14.9	9.6	17.9	16.2	25.4	26.9	13.7	29.9	8.7	9.9	18.6	23.6	11.3	10.5	17.2	10.3	24.2	13.7	18.1	16.0	15.8	12.9	24.5	10.5	19.5	13.9	23.6	12.1	35.4	12.5	10.4	21.5	13.0	12.1	13.5	15.6	34.3	18.8	11.1	13.7	14.4	10.8	30.8	6.3	5.7	55.1	10.1	18.4	9.4	4.6	2.3	2.2	3.5	1.5	3.2	4.0	5.7	5.6	1.7	3.6	4.9	4.7	1.6	4.5	0.9	0.8	4.6	1.6	18.4	18.0	25.4	25.8	17.7	15.8	17.0	17.0	19.4	19.1
ZNF641	FLJ31295	ENSG00000167528	"Zinc finger protein 641"	Q96N77	12	48337180-48351414	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035189	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA035189: AB_10603333"	"unprognostic (1.79e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (7.82e-3)"	"prognostic favourable (3.91e-4)"	"prognostic favourable (8.30e-5)"	"unprognostic (3.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.85e-3)"	10.6	28.6	11.9	11.1	10.8	6.4	10.4	11.3	17.1	14.6	9.2	11.8	7.3	10.1	15.3	10.9	7.8	12.5	13.0	11.4	13.1	8.7	10.9	10.4	13.9	12.4	9.5	17.9	25.6	16.0	17.2	12.2	15.2	13.6	11.0	9.1	11.8	9.7	11.5	22.5	6.2	9.3	19.2	12.6	14.8	10.1	12.1	9.5	14.6	15.6	8.1	13.6	12.7	12.5	1.2	4.7	9.7	5.0	6.4	4.3	2.9	3.0	3.9	8.0	13.6	7.1	2.0	5.7	7.0	5.0	3.8	2.5	8.9	7.9	5.3	10.3	6.6	4.7	2.9	4.8	1.3	13.5	5.0	9.6	7.1	2.1	7.4	11.2	13.3	3.0	7.1	2.8	5.9	3.5	9.2	5.5	3.5	3.4	4.4	4.0	1.7	2.2	2.9	8.0	4.2	6.2	14.0	3.3	4.9	8.5	3.6	5.0	8.7	11.4	1.4	4.1	7.0	4.5	3.4	6.5	5.8	4.3	2.7	12.1	4.3	1.9	4.1	8.6	4.3	3.9	2.6	0.7	2.5	4.0	4.7	1.2	2.3	4.0	9.7	6.4	5.0	1.9	1.3	2.9	11.9	10.8	11.3	17.1	13.1	8.7	9.5	17.9	13.6	9.5
ZNF653	Zip67	ENSG00000161914	"Zinc finger protein 653"	Q96CK0	19	11483427-11505923	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023631, HPA023635"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA023631: , HPA023635: AB_10603940"	"unprognostic (1.21e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (8.37e-4)"	"prognostic favourable (4.15e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.15e-1)"	"prognostic favourable (8.74e-4)"	5.5	8.5	7.5	6.3	9.0	3.8	4.7	19.1	9.6	4.4	5.1	3.5	3.1	3.9	4.3	2.0	4.2	5.3	5.0	4.2	8.5	7.3	4.9	5.6	3.3	4.7	5.0	3.5	5.7	7.9	6.6	5.1	4.0	5.1	5.3	2.4	2.4	5.3	4.1	4.2	8.4	5.7	4.7	3.8	4.1	3.9	13.2	5.7	7.2	6.6	5.7	6.8	6.9	17.2	0.5	1.0	0.5	0.1	0.1	2.4	0.1	9.7	8.0	6.3	5.4	1.7	1.3	4.5	3.7	3.1	5.4	5.0	5.6	4.3	6.7	4.7	4.1	4.4	4.8	3.7	2.7	7.0	6.2	4.4	6.0	6.5	1.8	5.6	7.5	3.8	4.8	5.1	4.1	4.1	6.2	10.3	3.1	13.8	7.8	13.3	6.8	6.2	6.9	4.1	8.7	6.0	8.2	7.1	10.6	2.4	4.2	4.7	4.2	3.8	5.1	7.9	5.1	8.6	8.9	13.3	19.9	4.7	6.9	7.8	4.4	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.2	0.0	0.5	0.1	0.0	1.0	2.4	0.1	7.5	9.0	19.1	9.6	8.5	7.3	5.0	3.5	5.1	5.7
ZNF655	"VIK, VIK-1"	ENSG00000197343	"Zinc finger protein 655"	Q8N720	7	99558406-99576453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029534, HPA050750"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA029534: AB_10603008, HPA050750: "	"prognostic favourable (7.12e-4)"	"unprognostic (3.03e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.93e-3)"	"prognostic unfavourable (7.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.12e-1)"	14.6	19.0	17.4	24.1	20.7	10.3	16.9	31.1	20.3	18.8	20.2	19.7	18.0	22.2	15.3	19.0	39.2	15.6	15.1	11.3	14.7	14.4	19.1	21.2	19.9	23.8	21.3	16.1	19.4	30.8	13.9	25.0	21.1	20.4	16.9	16.8	14.1	25.5	19.0	18.2	25.5	19.7	19.8	21.3	22.2	24.1	11.1	19.4	27.8	16.0	14.3	23.1	21.4	20.7	15.0	17.5	44.7	22.2	14.7	25.7	21.4	16.2	15.8	5.8	8.7	6.6	9.9	5.0	9.8	18.5	17.0	16.4	8.8	16.1	11.5	0.1	13.7	10.3	6.9	11.9	17.2	13.8	9.9	7.9	6.7	11.1	10.2	14.4	15.4	8.5	14.6	15.7	22.3	7.4	21.1	15.9	10.6	0.0	20.2	13.3	6.8	0.0	7.2	5.4	22.5	11.2	18.0	6.7	12.5	9.4	0.3	9.8	5.3	8.6	5.2	9.5	25.2	15.7	17.7	18.6	27.2	24.9	9.7	7.3	15.3	44.7	18.8	31.2	22.3	19.9	20.5	15.0	20.5	25.6	17.5	13.3	16.5	20.7	21.9	14.7	22.2	10.1	25.7	21.4	17.4	20.7	31.1	20.3	14.7	14.4	21.3	16.1	20.4	19.4
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA055779: , HPA062506: "	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favourable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favourable (1.79e-5)"	11.3	12.5	11.1	16.4	13.6	15.1	12.1	18.6	15.3	10.2	13.0	17.3	15.0	13.8	12.1	10.7	15.9	11.3	13.3	20.1	11.4	10.2	14.8	27.5	13.6	16.7	14.1	7.5	12.0	14.1	20.4	14.1	16.1	12.4	18.7	11.1	15.1	24.1	14.8	46.6	13.3	16.8	11.3	11.2	16.0	12.7	12.4	14.5	28.1	21.7	21.0	17.3	14.5	10.4	14.5	20.8	9.6	13.4	10.5	8.0	10.3	10.0	11.5	9.5	10.5	5.4	3.7	17.8	9.6	5.2	6.8	7.5	6.3	10.6	11.4	9.9	6.3	10.0	5.2	7.1	4.5	16.6	2.9	17.4	10.7	8.4	6.9	7.6	13.5	4.2	5.9	9.1	6.5	6.4	21.2	9.6	4.8	7.3	13.4	7.6	10.8	19.6	25.3	8.9	8.9	7.1	8.4	13.9	12.2	8.6	13.1	8.5	7.6	15.5	5.4	9.7	5.8	6.4	19.5	28.7	10.7	6.7	8.9	13.4	7.9	7.6	13.3	9.6	8.0	13.4	6.7	10.8	5.7	7.9	20.8	14.5	6.3	5.6	8.1	10.5	12.4	11.7	6.5	10.3	11.1	13.6	18.6	15.3	11.4	10.2	14.1	7.5	12.4	14.5
ZNF687	KIAA1441	ENSG00000143373	"Zinc finger protein 687"	Q8N1G0	1	151281618-151292180	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.1;neutrophil: 9.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 13.1;monocytes: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021193, HPA023948"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA021193: AB_1859415, HPA023948: "	"unprognostic (2.23e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.54e-2)"	"unprognostic (7.99e-2)"	9.8	13.6	9.9	10.7	11.4	36.1	10.6	16.1	21.0	13.6	17.3	17.1	10.9	11.7	13.5	12.9	12.9	13.2	12.8	10.0	9.2	9.7	13.0	14.4	10.2	14.8	9.4	10.7	16.6	21.4	23.0	16.4	13.5	10.6	13.3	8.1	17.6	16.2	13.3	12.5	14.1	15.2	11.4	9.6	17.9	12.5	22.5	9.8	19.6	14.0	8.3	15.4	13.9	9.9	1.3	0.9	13.1	4.1	0.5	0.9	1.0	9.2	14.0	12.9	7.8	7.3	6.2	17.9	5.2	8.2	8.7	8.7	11.0	12.2	8.0	12.8	7.6	14.4	11.3	9.6	3.9	11.8	12.4	7.5	11.3	12.4	8.0	8.5	11.1	9.8	9.8	7.3	7.7	5.8	11.7	14.1	4.8	27.6	12.0	10.3	17.5	10.6	10.7	10.6	14.4	7.3	13.6	12.1	19.2	13.0	15.3	12.5	20.2	18.6	5.6	7.0	8.2	9.1	7.5	17.7	14.8	19.4	8.9	5.7	8.8	0.4	1.8	13.1	0.6	2.2	0.7	1.1	0.6	0.6	0.9	1.3	0.8	0.9	9.6	0.5	4.1	0.8	0.4	1.0	9.9	11.4	16.1	21.0	9.2	9.7	9.4	10.7	10.6	9.8
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059337: , HPA062792: "	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favourable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavourable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (8.35e-5)"	5.6	8.7	15.3	7.9	25.0	11.1	10.7	27.7	22.3	11.6	8.1	16.5	17.8	8.3	13.6	15.1	9.7	13.1	9.4	7.4	20.1	11.6	9.7	8.6	6.9	9.8	30.4	14.3	17.2	12.2	18.4	13.8	8.1	21.2	14.9	7.0	7.7	21.9	11.1	11.5	19.6	8.9	9.2	18.3	10.0	8.7	22.9	25.7	6.6	11.3	9.2	7.8	9.1	8.8	4.6	4.4	4.8	2.1	10.6	6.4	2.8	4.8	5.1	4.3	10.7	3.7	1.9	18.6	4.1	1.4	4.7	3.0	5.8	7.0	6.0	8.5	2.0	6.9	6.5	6.2	3.4	8.9	4.3	7.0	10.8	1.6	2.8	7.9	5.7	2.4	7.9	4.8	12.8	4.3	14.5	4.4	2.1	3.4	4.0	16.3	8.7	11.1	13.6	2.7	12.0	9.0	3.6	8.5	6.3	4.4	7.8	8.4	9.5	12.9	3.0	2.1	3.5	2.3	5.6	12.4	7.8	3.7	4.6	10.5	3.5	0.0	2.1	1.9	5.7	1.6	4.9	4.6	4.5	6.0	4.4	3.8	6.4	4.6	4.8	10.6	1.4	3.5	4.7	2.8	15.3	25.0	27.7	22.3	20.1	11.6	30.4	14.3	21.2	25.7
ZNF70	"Cos17, MGC48959"	ENSG00000187792	"Zinc finger protein 70"	Q9UC06	22	23738678-23751092	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018821	Uncertain		Supported	Cytosol				Cytosol		"HPA018821: AB_1859423"	"unprognostic (3.17e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.69e-2)"	5.5	5.0	8.4	7.6	8.5	5.5	5.5	14.3	10.3	7.5	5.5	8.2	10.7	3.4	7.8	8.7	3.6	7.4	5.9	6.3	8.6	3.8	4.1	3.0	4.7	4.9	7.1	5.7	15.3	6.5	10.1	6.2	4.5	7.1	5.9	4.8	9.0	7.2	8.4	9.1	4.3	5.1	7.0	4.9	5.2	5.1	4.7	10.9	3.9	6.7	1.1	5.6	5.8	5.4	1.5	1.6	4.2	1.0	2.0	1.2	0.4	1.9	2.5	4.7	4.9	7.1	3.4	1.6	1.8	3.6	4.0	5.8	2.4	1.3	2.7	1.2	3.8	2.1	3.3	2.3	5.2	1.8	3.0	5.2	4.4	2.1	4.3	4.6	4.5	3.3	1.6	5.5	4.6	3.2	1.8	3.9	3.0	2.7	2.7	2.3	1.2	1.1	11.2	4.5	0.6	1.4	2.6	2.7	3.3	2.6	3.4	2.0	1.7	2.2	4.2	4.6	5.7	3.0	2.0	4.1	0.7	2.6	4.0	2.2	3.8	4.2	1.0	0.9	1.0	0.8	0.6	0.8	1.0	0.6	0.5	1.5	1.1	1.2	3.2	2.0	0.8	1.6	0.4	0.4	8.4	8.5	14.3	10.3	8.6	3.8	7.1	5.7	7.1	10.9
ZNF74	"Cos52, Zfp520, ZNF520"	ENSG00000185252	"Zinc finger protein 74"	Q16587	22	20394115-20408461	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003354	Approved		Supported	"Nucleoplasm,Actin filaments"				Nucleoplasm	"Actin filaments"	"HPA003354: AB_1080747"	"unprognostic (1.40e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.44e-3)"	3.7	4.3	6.1	3.1	7.7	1.3	5.9	9.5	11.1	7.0	6.3	8.0	5.8	2.9	7.7	5.8	4.6	7.5	3.8	4.0	6.5	6.2	4.2	3.2	5.0	3.3	7.9	7.0	11.5	6.9	7.0	7.2	3.9	6.2	6.6	4.0	3.8	7.5	8.2	9.7	4.2	3.6	6.4	5.2	3.5	4.1	2.3	6.9	4.3	5.1	3.0	3.1	6.6	6.8	2.3	3.5	1.6	2.0	6.5	5.3	3.3	2.4	2.9	7.1	10.3	2.1	2.0	5.1	2.7	2.1	3.5	3.2	3.1	1.3	0.0	3.3	2.2	3.5	5.4	3.5	1.9	1.7	10.7	2.7	1.2	4.8	3.4	6.8	3.3	2.0	5.9	2.5	2.6	3.3	27.7	0.0	2.4	3.6	6.3	2.8	7.0	3.4	8.7	3.9	1.1	2.1	2.9	13.9	8.7	2.7	4.9	6.3	1.7	2.9	2.6	2.5	5.7	3.9	1.9	2.5	3.7	0.0	0.7	3.0	2.2	0.0	1.8	1.6	4.1	2.0	3.2	2.3	2.9	5.3	3.5	1.8	3.9	3.1	0.0	6.5	1.3	2.5	2.5	3.3	6.1	7.7	9.5	11.1	6.5	6.2	7.9	7.0	6.2	6.9
ZNF766		ENSG00000196214	"Zinc finger protein 766"	Q5HY98	19	52269571-52296046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA044882, HPA063496"	Uncertain		Supported	Centrosome				Centrosome		"HPA044882: AB_10965173, HPA063496: "	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.45e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.85e-3)"	11.9	9.9	9.0	10.5	13.7	16.5	14.9	12.3	13.7	13.1	10.8	8.9	13.1	7.3	12.3	9.8	12.4	11.9	7.7	9.6	8.5	7.3	10.2	7.0	10.2	13.7	13.0	7.3	18.4	10.9	12.6	23.5	11.9	12.8	14.4	10.1	9.9	11.6	12.1	11.3	13.8	10.1	13.7	14.9	14.2	9.7	26.4	13.7	17.5	17.1	7.2	12.9	18.1	11.0	18.8	8.7	22.5	12.1	18.1	27.6	11.5	6.9	11.3	8.2	9.7	8.5	12.3	6.2	6.9	6.6	4.4	8.8	3.0	5.6	11.5	6.4	7.1	7.0	7.8	6.7	7.9	8.9	10.7	11.9	6.6	3.3	5.0	13.2	8.1	9.6	9.8	5.1	12.1	6.8	7.8	6.6	7.7	4.7	17.4	5.7	9.6	12.6	12.1	14.6	10.1	5.7	20.3	10.4	8.7	10.4	8.2	5.8	9.6	7.9	8.2	4.2	5.9	3.7	7.1	11.2	32.3	17.4	4.0	6.9	8.0	22.5	8.6	16.6	16.1	12.1	22.2	18.8	17.5	18.2	8.7	16.2	27.6	21.6	9.2	18.1	12.0	6.1	17.9	11.5	9.0	13.7	12.3	13.7	8.5	7.3	13.0	7.3	12.8	13.7
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407297-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 26.4;REH: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA030730: , HPA046672: , HPA059398: "	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	6.6	6.7	15.3	5.0	14.5	4.0	5.3	10.7	18.3	6.6	6.1	4.9	6.6	4.5	10.4	7.2	4.6	7.5	6.1	4.6	13.4	10.6	9.2	8.6	4.1	3.3	8.8	16.9	10.8	7.3	8.1	6.2	2.4	8.8	10.1	5.4	4.0	4.9	12.3	18.2	6.1	4.3	9.6	5.1	3.6	4.8	3.7	8.1	1.9	5.4	3.5	4.2	6.8	5.6	6.6	3.7	1.9	2.5	1.8	6.2	2.7	3.1	3.5	4.9	4.0	7.1	3.0	3.8	4.5	2.2	2.9	3.0	1.5	1.5	3.7	7.8	2.3	2.3	5.1	2.0	3.0	1.3	26.4	3.1	2.4	4.7	3.6	1.5	3.7	4.5	1.6	3.7	2.2	2.9	7.6	2.3	2.4	5.6	3.7	5.1	3.9	2.8	16.9	3.7	2.4	1.7	1.2	7.8	4.8	2.4	2.2	2.9	2.8	1.8	2.6	4.9	5.8	2.8	3.3	3.4	3.7	1.9	3.2	3.4	3.1	1.0	1.1	0.7	3.6	2.5	4.9	2.7	4.3	4.2	2.8	6.6	6.2	3.7	1.9	1.8	0.5	3.7	4.4	2.7	15.3	14.5	10.7	18.3	13.4	10.6	8.8	16.9	8.8	8.1
ZNF774	MGC75360	ENSG00000196391	"Zinc finger protein 774"	Q6NX45	15	90352245-90369146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA030839, HPA030840"	Uncertain		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"HPA030839: , HPA030840: AB_10602691"	"unprognostic (1.11e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.89e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.82e-2)"	1.5	5.1	5.8	3.6	8.6	1.6	5.7	14.0	8.7	5.0	7.5	4.1	0.0	3.9	5.5	7.3	2.8	5.3	5.1	4.2	4.8	5.4	2.6	2.9	2.1	1.2	3.9	5.9	2.3	6.5	7.1	5.7	1.3	9.4	4.3	12.4	3.0	6.8	10.3	11.9	5.3	3.5	3.3	3.1	1.3	4.6	8.2	4.7	3.8	4.9	3.1	1.7	3.9	3.5	2.0	1.9	4.2	1.1	2.7	1.3	0.4	2.3	1.1	3.1	3.4	1.3	0.7	7.1	1.5	2.4	1.8	2.3	3.7	2.8	0.9	2.8	1.7	3.5	3.0	5.0	1.8	1.7	6.0	2.4	11.3	1.7	2.3	1.4	2.0	0.7	6.1	2.7	2.6	3.1	2.7	1.2	3.0	2.3	1.9	1.3	0.9	3.6	1.8	2.6	0.7	3.7	6.3	6.9	2.9	2.8	4.4	1.2	2.9	0.4	1.6	2.1	1.9	1.7	3.0	7.4	5.0	0.6	3.3	3.9	0.9	3.6	1.1	2.2	1.0	0.5	0.7	0.9	0.8	1.3	1.9	2.0	1.0	0.9	4.2	2.7	0.6	1.2	0.5	0.4	5.8	8.6	14.0	8.6	4.8	5.4	3.9	5.9	9.4	4.7
ZNF778	FLJ31875	ENSG00000170100	"Zinc finger protein 778"	Q96MU6	16	89217703-89237071	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.9"	"Low lineage specificity"	"Detected in all"											"HPA052057, HPA057151"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA052057: , HPA057151: "	"unprognostic (3.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.53e-7)"	"unprognostic (2.51e-1)"	"unprognostic (2.85e-7)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.63e-2)"	5.9	6.7	9.3	4.7	9.5	4.1	6.6	11.2	9.8	5.4	5.8	8.8	4.4	3.1	6.9	5.1	6.0	6.1	3.7	6.0	7.4	4.7	8.7	5.9	5.8	4.6	8.9	6.7	5.8	12.0	22.4	8.9	5.4	7.5	6.5	5.0	6.1	6.3	7.8	10.4	8.2	4.9	6.7	8.1	5.7	6.8	12.5	7.8	4.1	8.4	5.5	6.3	6.9	6.8	1.7	2.0	10.9	2.7	1.4	4.1	1.5	4.1	2.1	6.7	5.7	4.2	3.6	8.8	3.2	5.1	4.8	2.5	6.4	2.4	2.0	5.8	3.8	3.3	9.2	4.4	7.6	0.8	6.5	5.5	4.2	3.1	2.4	1.6	3.2	2.7	3.1	6.2	4.4	3.9	6.2	1.0	3.9	10.9	3.1	2.4	10.0	4.0	8.7	15.7	0.7	2.4	3.8	13.5	10.1	7.4	3.6	2.7	11.3	3.2	4.7	5.2	3.8	3.0	3.9	3.5	5.2	4.2	7.3	3.2	3.2	10.9	1.7	3.9	4.1	2.0	2.1	1.3	1.9	2.1	2.0	1.7	1.5	2.6	0.6	1.4	2.7	0.8	2.3	1.5	9.3	9.5	11.2	9.8	7.4	4.7	8.9	6.7	7.5	7.8
ZNF789		ENSG00000198556	"Zinc finger protein 789"	Q5FWF6	7	99472841-99503650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029500, HPA050793"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA029500: AB_10603009, HPA050793: "	"unprognostic (6.84e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.38e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (7.14e-4)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"prognostic favourable (5.31e-6)"	6.1	5.5	11.0	15.9	10.0	11.6	9.2	31.9	14.4	6.1	9.2	9.2	11.0	15.1	10.9	12.8	5.0	7.8	6.6	4.0	10.0	8.5	9.0	8.1	6.5	10.5	6.8	9.8	8.9	7.8	6.3	13.3	4.6	7.6	16.4	12.5	14.8	10.3	13.8	8.9	13.3	12.6	8.5	8.6	11.2	8.4	17.6	8.1	8.4	9.3	4.8	10.1	4.1	5.6	3.9	14.2	2.0	1.6	4.1	7.0	2.1	11.2	3.8	6.2	11.2	1.8	2.1	8.6	5.8	2.2	3.5	7.7	6.4	7.7	8.6	4.8	2.6	5.7	3.5	3.3	4.9	3.9	6.0	6.5	10.6	10.8	3.1	4.4	14.9	2.3	3.0	7.5	3.3	3.7	9.6	8.4	3.1	10.7	5.3	11.8	6.3	6.0	6.9	5.9	9.0	4.6	3.5	6.2	6.8	4.1	11.2	6.5	3.0	7.0	6.9	6.7	8.2	10.0	5.6	5.1	7.0	10.8	10.6	8.0	7.2	2.0	1.6	1.5	2.7	1.1	2.9	2.7	3.4	2.9	5.6	3.9	7.0	4.2	0.4	4.1	1.4	14.2	5.3	2.1	11.0	10.0	31.9	14.4	10.0	8.5	6.8	9.8	7.6	8.1
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023090: AB_1859457, HPA052194: "	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	17.5	11.2	10.8	14.4	11.7	61.7	18.7	18.6	12.7	11.9	11.9	6.3	12.8	10.3	14.6	10.4	15.4	13.5	11.6	9.5	10.2	5.9	8.9	14.4	16.5	20.7	13.5	9.2	15.2	15.3	16.2	18.6	10.8	12.6	10.5	10.5	7.1	15.1	16.1	14.9	22.7	14.8	11.5	15.7	15.2	13.1	19.1	12.8	22.4	12.7	10.9	13.8	14.4	15.5	14.2	12.0	16.9	6.8	18.9	17.2	5.9	8.9	4.7	5.5	9.6	8.0	10.7	5.3	8.7	10.3	9.0	8.7	4.3	8.6	15.3	5.4	8.2	6.6	9.0	9.3	12.4	13.4	5.3	9.8	4.8	4.0	10.1	13.4	18.9	9.1	8.6	9.9	13.4	9.5	12.1	15.8	9.7	6.8	14.8	9.7	4.6	6.2	9.2	7.8	10.1	6.6	11.3	7.9	8.3	8.6	34.1	11.1	4.0	9.2	10.2	15.1	4.8	9.9	10.2	18.9	8.3	22.1	11.2	12.3	12.5	16.9	6.8	10.1	13.3	6.3	14.0	12.0	10.0	13.5	7.0	14.2	16.4	17.2	6.0	18.9	6.6	12.0	13.8	5.9	10.8	11.7	18.6	12.7	10.2	5.9	13.5	9.2	12.6	12.8
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;testis: 23.7"	"Cell line enhanced"	"Detected in many"		"AF22: 13.8;SCLC-21H: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.3;naive B-cell: 11.5"	"Group enriched"	"Detected in many"	8	"B-cells: 11.5;T-cells: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: "	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favourable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favourable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"	2.0	4.2	6.3	3.7	7.5	3.1	4.8	26.9	13.4	4.3	3.8	5.1	2.3	2.1	5.8	11.1	2.5	3.5	3.9	2.9	5.7	7.6	5.9	2.6	3.4	6.0	5.2	6.0	7.3	2.4	5.6	9.2	2.5	7.1	4.4	5.0	5.2	5.2	5.1	4.0	6.0	4.3	3.0	4.8	3.7	3.3	23.7	3.4	2.2	6.1	0.7	7.3	2.4	4.0	11.5	0.9	0.4	0.5	1.0	5.1	0.7	1.1	0.9	13.8	6.7	2.8	3.6	2.4	1.4	3.1	3.1	4.9	1.9	0.8	2.6	2.4	2.7	1.9	4.6	2.0	3.8	3.9	5.2	0.5	1.0	0.7	1.7	0.9	3.0	3.1	3.5	2.1	1.3	2.3	1.6	1.9	3.3	3.3	1.4	0.9	5.5	0.6	6.0	2.9	4.5	3.5	0.4	13.9	6.6	1.8	1.2	1.5	4.7	3.0	4.6	3.3	3.4	1.2	0.9	4.7	2.3	10.5	1.1	2.6	3.1	0.0	0.5	0.4	2.2	0.0	1.9	9.3	2.3	1.6	0.9	11.5	1.4	0.5	0.4	1.0	0.5	0.0	5.1	0.7	6.3	7.5	26.9	13.4	5.7	7.6	5.2	6.0	7.1	3.4
ZNF830	"CCDC16, MGC20398, OMCG1"	ENSG00000198783	"Zinc finger protein 830"	Q96NB3	17	34961530-34963775	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024754, HPA027211"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA024754: AB_1859464, HPA027211: AB_1859465"	"unprognostic (2.87e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (2.01e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (8.63e-2)"	11.7	11.5	14.2	13.8	17.6	15.4	13.6	26.9	20.0	15.1	13.9	14.0	9.7	13.4	16.1	11.4	14.1	14.8	12.6	9.2	13.1	10.5	12.9	15.7	10.8	19.6	20.5	11.3	21.4	20.2	11.2	12.5	16.9	18.7	13.4	10.3	10.7	12.7	11.4	11.2	13.0	16.6	17.9	11.9	24.1	13.7	15.0	16.3	20.6	17.5	9.6	17.9	12.9	12.0	10.1	9.8	26.7	8.3	10.1	19.3	8.1	5.5	10.9	9.9	9.2	10.6	8.3	6.9	6.8	7.0	9.0	9.0	8.2	7.6	10.2	6.3	6.6	13.2	10.6	6.2	10.2	6.1	14.4	12.0	10.7	10.2	10.9	17.8	17.2	8.1	14.7	7.5	14.8	8.1	17.1	15.1	8.1	4.3	16.2	20.1	6.5	5.4	10.9	13.5	13.5	8.3	7.6	11.8	10.1	6.7	4.2	10.7	9.7	19.6	8.5	9.6	7.0	7.0	11.9	16.8	12.7	13.7	8.2	9.6	8.6	14.6	8.3	26.7	11.9	8.2	11.7	9.2	12.6	12.8	9.1	10.1	19.3	15.2	8.1	10.1	5.7	9.8	11.1	8.1	14.2	17.6	26.9	20.0	13.1	10.5	20.5	11.3	18.7	16.3
ZNF84	HPF2	ENSG00000198040	"Zinc finger protein 84"	P51523	12	133037292-133063304	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA028860	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA028860: AB_10604102"	"unprognostic (2.39e-1)"	"unprognostic (5.11e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (5.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.30e-3)"	9.7	9.6	19.6	10.0	22.2	8.1	18.6	26.1	21.6	16.3	11.3	16.9	11.8	7.8	20.1	25.3	7.8	17.7	12.1	10.0	17.9	15.9	12.1	11.0	11.5	13.3	25.2	17.9	23.6	11.7	18.3	31.5	12.4	20.6	16.3	13.6	9.8	10.4	15.1	8.8	13.3	10.1	19.6	21.0	12.7	10.6	12.2	23.2	12.4	20.0	11.1	14.8	13.8	10.8	9.6	7.4	4.3	4.9	9.1	12.5	4.9	8.8	7.2	21.7	13.0	8.6	14.4	16.5	8.3	7.7	6.8	6.1	4.3	2.6	10.8	7.8	7.5	4.2	8.2	6.6	9.6	3.0	13.3	16.2	8.6	6.3	10.6	17.9	7.1	10.1	8.9	9.4	10.4	10.1	8.0	5.0	16.5	5.5	12.0	17.4	25.4	6.6	16.4	10.1	7.3	9.3	19.5	17.4	19.0	16.4	4.6	6.7	16.0	11.8	13.2	7.5	7.6	6.6	5.8	2.8	0.0	23.9	4.5	13.9	8.2	1.4	3.8	4.3	8.4	4.9	12.3	9.6	9.2	10.7	5.8	8.4	12.5	10.2	0.8	9.1	3.4	7.4	4.9	4.9	19.6	22.2	26.1	21.6	17.9	15.9	25.2	17.9	20.6	23.2
ZNF85	"HPF4, HTF1"	ENSG00000105750	"Zinc finger protein 85"	Q03923	19	20923222-20950697	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA044760	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA044760: AB_10960412"	"unprognostic (1.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (5.20e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.01e-4)"	"prognostic favourable (6.45e-6)"	"unprognostic (2.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.90e-3)"	"unprognostic (6.01e-2)"	5.2	8.4	4.3	7.0	7.0	7.7	8.4	24.7	7.1	5.3	3.4	3.3	7.8	1.0	5.5	3.4	4.8	4.3	3.4	4.9	4.3	3.6	4.9	1.9	3.4	7.8	3.9	5.4	8.9	13.1	6.3	3.5	6.5	5.2	4.7	4.6	3.4	5.1	6.8	1.7	5.4	4.0	4.9	6.3	6.9	7.8	22.8	5.0	15.4	11.7	4.4	8.7	4.7	4.5	8.5	3.2	4.4	3.9	7.6	4.6	2.3	0.8	0.4	9.7	8.2	3.8	3.4	7.5	7.1	2.5	9.6	9.9	0.0	4.3	8.7	8.2	1.7	0.8	0.1	5.3	10.5	0.3	4.4	2.4	0.9	0.6	0.7	0.1	1.8	1.5	1.8	4.6	6.5	2.8	0.1	3.5	5.5	2.8	13.5	5.4	7.1	8.0	7.5	14.7	4.1	3.3	8.1	6.3	4.8	0.1	0.3	1.3	4.2	7.1	2.0	4.6	1.3	12.2	7.5	4.6	11.1	9.7	0.2	0.1	3.9	0.8	1.2	4.4	3.4	3.9	2.8	8.5	3.8	2.6	2.7	6.8	4.6	3.8	4.0	7.6	2.5	3.2	4.3	2.3	4.3	7.0	24.7	7.1	4.3	3.6	3.9	5.4	5.2	5.0
ZNRD1	"HTEX-6, hZR14, RPA12, tctex-6"	ENSG00000066379	"Zinc ribbon domain containing 1"	Q9P1U0	6	30058899-30064909	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055074, HPA077979"	Supported		Supported	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA055074: , HPA077979: "	"unprognostic (4.94e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.55e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.52e-3)"	"unprognostic (5.18e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (2.17e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.97e-2)"	"prognostic favourable (2.75e-5)"	11.7	13.5	6.7	14.1	7.2	8.7	17.1	7.4	8.9	12.3	15.3	6.8	9.1	13.2	12.5	10.2	15.4	13.0	10.4	11.0	6.4	6.3	13.4	12.2	14.8	18.8	8.3	6.1	13.6	22.0	10.2	9.4	11.4	6.2	12.5	14.5	9.7	14.7	10.2	13.5	11.2	14.2	9.1	6.3	17.5	12.7	22.9	6.8	37.0	15.0	15.3	18.9	12.2	15.0	8.2	8.4	6.4	5.9	8.1	13.0	7.9	4.2	0.9	4.7	6.7	2.3	2.8	1.8	1.6	2.5	3.0	2.7	4.7	3.0	3.4	1.4	2.7	3.6	7.8	6.4	3.2	2.4	7.9	8.0	2.1	7.0	9.5	8.4	3.7	5.5	3.7	4.7	16.1	8.1	13.4	2.1	2.0	5.7	7.2	18.3	0.0	5.6	8.9	4.4	6.6	2.6	7.0	1.7	3.2	2.9	4.5	2.7	3.4	7.0	1.7	3.5	3.0	0.0	5.2	5.3	10.0	10.9	1.3	13.7	4.6	6.2	5.9	5.7	12.5	5.6	13.0	7.3	10.8	11.5	5.6	8.2	9.8	10.2	6.4	8.1	5.2	8.4	10.9	7.9	6.7	7.2	7.4	8.9	6.4	6.3	8.3	6.1	6.2	6.8
ZRANB1	TRABID	ENSG00000019995	"Zinc finger RANBP2-type containing 1"	Q9UGI0	10	124942123-124988189	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029239, HPA029240, HPA029241"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205"	"unprognostic (2.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.53e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-2)"	5.1	9.3	4.9	1.9	4.7	7.9	5.3	11.9	6.0	6.3	5.2			1.4	5.9	5.2	4.1	4.4	3.6	7.3	4.6	4.0	4.2	10.4	4.2	2.5	4.4		8.6	3.1	7.1	3.9	3.9		4.6	3.3		3.4	5.8	18.0	5.2	3.0	6.3	3.8	2.8	3.6	7.7			3.8		3.9	4.2	4.8	3.4	1.4	4.6	1.1	3.8	4.4	0.8	7.7	4.4	9.5	6.9	14.8	12.5	4.0	7.6	20.8	14.5	16.9	6.6	6.1	8.1	5.7	9.6	5.6	12.0	5.6	19.6	8.6	5.9	4.6	5.1	7.1	31.6	6.9	3.5	13.8	16.5	10.6	22.8	9.1	0.6	6.7	7.8	6.1	8.1	6.0	3.4	4.8	7.0	6.7	3.6	6.4	5.6	4.8	8.1	6.4	5.0	8.4	5.5	5.9	6.7	6.2	6.4	5.1	9.4	7.2	6.2	9.4	7.0	4.9	3.0	2.1	1.1	3.0	2.2	0.4	1.9	2.4	2.6	2.2	0.9	3.4	4.4	3.3	4.6	3.8	0.5	1.4	2.2	0.8										
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081297	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA053960: , HPA061949: , HPA063298: "	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavourable (5.70e-4)"	"prognostic unfavourable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	26.4	27.4	39.8	31.1	42.2	35.1	34.4	54.1	48.6	39.3	28.8	19.6	33.3	23.4	48.3	45.6	20.2	30.6	20.3	27.5	33.5	30.6	20.1	19.5	26.7	37.8	34.1	40.5	39.5	23.9	23.1	77.5	24.6	32.0	30.5	29.3	17.5	25.1	33.2	54.4	27.9	24.9	35.1	42.2	26.2	23.6	31.6	38.0	40.0	32.8	24.3	30.9	32.8	25.6	31.4	34.0	32.1	16.3	20.9	30.8	13.8	23.3	8.5	34.9	20.1	13.7	23.6	20.0	28.6	15.8	25.1	32.1	15.9	15.1	48.4	25.3	17.6	14.8	29.6	17.8	37.8	34.2	21.3	42.0	33.2	13.2	20.3	45.8	17.2	17.8	22.3	24.5	21.1	21.1	43.9	26.0	19.2	7.9	37.4	14.9	35.6	16.6	42.7	26.1	28.4	16.2	20.0	26.1	16.5	24.3	16.4	24.4	20.1	20.1	28.3	18.6	17.8	14.5	28.2	21.4	26.6	53.3	27.5	42.8	26.1	32.1	16.3	14.2	22.2	15.0	25.1	30.6	23.6	21.3	12.4	31.4	30.8	24.2	14.6	20.9	14.8	34.0	22.0	13.8	39.8	42.2	54.1	48.6	33.5	30.6	34.1	40.5	32.0	38.0
ZRANB3	DKFZP434B1727	ENSG00000121988	"Zinc finger RANBP2-type containing 3"	Q5FWF4	2	135136916-135531236	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035234			Supported	Nucleoplasm				Nucleoplasm		"HPA035234: "	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.52e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.88e-2)"	3.5	6.3	5.5	4.9	7.0	5.2	5.4	7.7	7.9	5.4	3.3	4.1	3.9	2.6	5.4	6.0	3.3	5.4	3.9	4.0	4.7	5.2	4.4	6.3	2.9	4.3	6.0	5.4	7.2	6.1	7.3	15.6	4.3	5.7	5.4	4.7	5.6	3.1	4.0	7.6	3.0	3.0	7.2	4.9	4.0	3.1	12.6	6.6	10.7	6.7	3.0	4.8	4.2	3.6	3.0	1.9	1.4	0.8	1.7	3.5	0.9	3.3	3.2	5.2	3.9	2.8	5.7	4.9	4.3	3.9	4.3	4.7	6.2	3.1	7.3	5.8	3.9	3.6	8.3	4.3	6.1	10.3	4.7	8.2	2.1	11.9	2.7	7.1	2.9	4.9	4.6	3.9	11.3	5.0	9.6	3.2	3.8	4.9	6.9	4.8	3.2	4.8	6.7	4.3	3.0	6.1	1.9	6.4	8.3	4.2	1.7	3.3	4.2	3.1	3.3	3.5	2.8	1.9	3.9	2.4	4.5	8.2	4.2	5.2	3.8	0.6	0.8	1.4	1.6	0.8	3.5	3.0	1.5	1.3	1.9	1.5	1.4	1.5	0.9	1.7	0.3	0.8	0.4	0.9	5.5	7.0	7.7	7.9	4.7	5.2	6.0	5.4	5.7	6.6
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267010-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA027521: "	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavourable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavourable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favourable (1.68e-4)"	4.4	5.4	7.4	4.8	10.5	2.5	8.3	17.7	11.4	8.4	4.3	10.5	7.3	4.2	10.5	7.4	4.9	7.9	6.7	6.3	8.1		5.1	3.6	5.2	4.9	7.3	11.5	18.7	4.0	8.9	7.8	4.6	9.6	7.7	5.0	5.7	4.5	10.7	6.4	4.9	4.4	8.9	6.6	7.6	4.9	2.9	9.6	4.0	7.6	2.0	6.1	5.8	4.6	15.2	9.6	10.7	6.2	16.1	16.3	9.6	5.7	5.0	14.0	12.0	15.2	14.7	3.2	11.5	11.5	15.1	15.7	3.6	4.2	3.3	17.7	7.3	4.4	6.5	8.3	16.7	6.9	7.0	8.7	6.8	7.6	10.6	7.1	5.7	12.1	8.0	11.6	10.6	15.2	7.1	6.9	11.9	4.8	7.6	9.9	4.1	7.5	7.7	12.2	5.5	12.8	6.0	10.2	7.9	7.1	3.0	9.5	4.9	4.9	9.9	12.1	8.9	4.3	13.9	7.4	9.8	6.3	4.4	8.1	10.5	10.5	6.2	10.7	13.4	4.8	15.8	13.4	13.1	14.4	9.6	15.2	16.3	13.5	4.4	16.1	4.0	4.5	11.8	9.6										
ZW10	KNTC1AP	ENSG00000086827	"Zw10 kinetochore protein"	O43264	11	113733187-113773811	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011565, HPA051253, HPA055410"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809"	"unprognostic (4.33e-3)"	"unprognostic (6.65e-2)"	"prognostic favourable (2.70e-4)"	"unprognostic (3.12e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (7.44e-2)"	"unprognostic (8.01e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.57e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-3)"	11.8	11.4	9.0	10.4	13.5	10.7	15.2	19.8	15.2	12.5	11.4	11.2	8.6	7.8	14.0	10.5	17.2	8.9	8.0	10.3	9.9	7.6	12.2	19.6	9.6	11.7	10.3	9.9	11.9	16.8	14.9	14.4	10.4	17.0	11.4	14.3	7.9	15.2	11.0	24.1	22.9	10.7	12.2	12.5	11.7	12.0	25.0	10.9	18.6	9.4	12.4	15.8	11.8	13.1	8.3	12.3	8.6	13.2	7.3	11.8	7.2	12.0	7.7	15.8	11.1	10.3	10.7	9.2	13.6	11.5	17.2	17.5	19.9	22.3	15.1	17.9	13.6	16.9	19.9	17.0	24.6	10.4	8.2	16.0	6.8	12.2	10.9	15.5	9.8	9.1	11.1	18.3	14.9	17.7	18.3	5.6	18.0	6.2	14.9	10.7	10.0	15.3	14.0	16.5	17.0	11.4	11.6	6.3	7.5	15.4	12.8	5.7	23.6	9.1	9.9	14.4	23.1	7.9	15.0	3.3	5.5	16.0	4.7	20.0	16.7	7.4	9.5	8.6	8.8	13.2	11.8	8.3	8.3	7.6	12.3	7.2	7.9	9.4	2.7	7.3	11.1	3.6	7.3	7.2	9.0	13.5	19.8	15.2	9.9	7.6	10.3	9.9	17.0	10.9
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357228-56361275	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.6;testis: 37.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 15.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	1.7	3.5	3.4	14.6	3.1	18.4	3.0	0.9	2.8	3.3	9.4	1.3	2.1	6.8	2.0	4.5	14.1	1.1	6.3	1.6	2.7	1.8	4.6	2.9	2.6	12.8	2.4	3.4	1.7	2.8	2.8	1.9	7.3	1.9	1.8	11.8	1.5	4.2	1.4	0.9	5.2	8.8	3.1	2.5	9.0	6.2	37.1	0.7	35.6	1.9	12.7	17.2	3.1	4.6	1.6	1.3	0.6	2.6	2.9	15.2	3.0	39.5	31.5	22.4	24.9	1.6	2.3	18.3	29.2	22.1	35.3	32.1	55.6	23.7	20.4	11.1	10.0	20.4	31.5	22.0	33.0	51.7	16.4	20.3	25.3	25.7	0.1	33.4	27.3	1.0	1.4	32.8	13.5	17.7	27.4	25.0	31.0	31.9	29.5	21.2	15.9	38.9	30.2	43.6	10.8	11.0	17.7	20.8	12.8	27.6	62.8	7.3	40.7	32.7	9.6	15.5	39.8	15.9	44.5	22.1	10.6	35.4	21.8	42.1	19.4	0.0	0.7	0.6	2.2	2.6	0.3	1.6	5.3	3.6	1.3	0.3	6.4	3.6	0.0	2.9	2.0	1.0	15.2	3.0	3.4	3.1	0.9	2.8	2.7	1.8	2.4	3.4	1.9	0.7
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381080-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.5;granulocytes: 47.5;monocytes: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Approved		Enhanced	"Focal adhesion sites"			420000000	"Focal adhesion sites"		"CAB009321: AB_2221290, CAB075747: , HPA004835: AB_1080771, HPA073497: "	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	52.7	11.7	7.7	39.3	8.8	46.1	34.3	17.5	22.2	61.1	56.8	10.7	20.5	13.6	103.6	38.6	52.3	48.9	58.1	22.7	7.4	7.7	24.7	21.2	52.8	63.0	8.8	8.3	58.1	15.9	63.8	9.1	32.4	15.5	43.8	10.8	17.9	18.8	40.7	28.3	21.1	26.6	74.7	8.5	57.1	28.3	37.4	7.1	24.4	18.9	19.1	26.0	93.7	35.7	0.9	16.5	47.5	22.1	4.1	6.7	9.0	12.6	7.7	10.2	14.2	19.3	43.1	12.1	26.9	31.7	29.5	24.9	26.2	8.2	0.8	10.5	32.9	10.3	6.3	27.2	13.8	13.5	3.3	19.7	9.0	9.1	33.9	15.9	31.5	45.8	12.1	32.3	10.9	37.3	4.8	8.6	31.5	14.2	0.2	32.0	21.3	49.8	3.0	5.5	1.1	22.4	6.7	0.5	7.7	21.2	19.8	11.1	2.3	15.9	65.5	35.3	14.5	37.5	28.3	2.8	3.6	2.1	31.4	16.7	23.4	4.9	18.2	12.5	5.9	19.2	4.7	0.9	5.5	6.7	16.5	0.5	3.5	4.0	47.5	4.1	22.1	4.2	5.0	9.0	7.7	8.8	17.5	22.2	7.4	7.7	8.8	8.3	15.5	7.1